<SEC-DOCUMENT>0001628280-22-006545.txt : 20220317
<SEC-HEADER>0001628280-22-006545.hdr.sgml : 20220317
<ACCEPTANCE-DATETIME>20220317161035
ACCESSION NUMBER:		0001628280-22-006545
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		135
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220317
DATE AS OF CHANGE:		20220317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VYNE Therapeutics Inc.
		CENTRAL INDEX KEY:			0001566044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				453757789
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38356
		FILM NUMBER:		22748607

	BUSINESS ADDRESS:	
		STREET 1:		520 U.S. HIGHWAY 22, SUITE 204
		CITY:			BRIDGEWATER
		STATE:			NJ
		ZIP:			08807
		BUSINESS PHONE:		800-775-7936

	MAIL ADDRESS:	
		STREET 1:		520 U.S. HIGHWAY 22, SUITE 204
		CITY:			BRIDGEWATER
		STATE:			NJ
		ZIP:			08807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Menlo Therapeutics Inc.
		DATE OF NAME CHANGE:	20180201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Menlo Therapeutics, Inc.
		DATE OF NAME CHANGE:	20170728

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tigercat Pharma, Inc.
		DATE OF NAME CHANGE:	20130104
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>vyne-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:74e91f80-5033-4690-868f-a2bf4ea38fc3,g:e1fa6db6-9541-4405-a6db-7ba5e60bcb37,d:3ee2f3590755456d8887827db5ee11c4--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:vyne="http://vynetherapeutics.com/20211231" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vyne-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF80L2ZyYWc6ZjllMjE0NTNlZWYxNDM1YWFkZmRkYjdlN2FkOWYxMzMvdGFibGU6ZWE1Y2RlYzE5ODQ2NGUwMTkxZWU2NTcyYTlkZDZkMjUvdGFibGVyYW5nZTplYTVjZGVjMTk4NDY0ZTAxOTFlZTY1NzJhOWRkNmQyNV8yLTEtMS0xLTIxMzkw_f8314a79-1095-4571-8783-89fa1e8ad9c9">false</ix:nonNumeric><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF80L2ZyYWc6ZjllMjE0NTNlZWYxNDM1YWFkZmRkYjdlN2FkOWYxMzMvdGFibGU6ZWE1Y2RlYzE5ODQ2NGUwMTkxZWU2NTcyYTlkZDZkMjUvdGFibGVyYW5nZTplYTVjZGVjMTk4NDY0ZTAxOTFlZTY1NzJhOWRkNmQyNV8zLTEtMS0xLTIxMzkz_350592f3-b659-454b-90cb-2d6bf561629e">0001566044</ix:nonNumeric><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF80L2ZyYWc6ZjllMjE0NTNlZWYxNDM1YWFkZmRkYjdlN2FkOWYxMzMvdGFibGU6ZWE1Y2RlYzE5ODQ2NGUwMTkxZWU2NTcyYTlkZDZkMjUvdGFibGVyYW5nZTplYTVjZGVjMTk4NDY0ZTAxOTFlZTY1NzJhOWRkNmQyNV80LTEtMS0xLTIxMzk1_08e5ce5b-67da-49d8-90c5-a521047b5265">2021</ix:nonNumeric><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF80L2ZyYWc6ZjllMjE0NTNlZWYxNDM1YWFkZmRkYjdlN2FkOWYxMzMvdGFibGU6ZWE1Y2RlYzE5ODQ2NGUwMTkxZWU2NTcyYTlkZDZkMjUvdGFibGVyYW5nZTplYTVjZGVjMTk4NDY0ZTAxOTFlZTY1NzJhOWRkNmQyNV81LTEtMS0xLTIxMzk3_cca336ce-fc58-40ae-9309-b4d06d31fbff">FY</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjcvZnJhZzo3ZjVkZDQ2MDUxMDU0NWIxYjgxZjEwZjA4NGQwOTA2MC90ZXh0cmVnaW9uOjdmNWRkNDYwNTEwNTQ1YjFiODFmMTBmMDg0ZDA5MDYwXzM1_009fb1d1-e57e-495e-b576-ca5596829340">.25</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjYvZnJhZzphOGY4NjUxZTJiZWY0OWM1YTNiYjVkZTk1MmM3ZTMwZS90ZXh0cmVnaW9uOmE4Zjg2NTFlMmJlZjQ5YzVhM2JiNWRlOTUyYzdlMzBlXzMw_13e41c0f-8061-435e-b5ac-6fca7d0882a3">.25</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vyne-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5c93a1c774774356afee639d2e955920_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife41df1c5a4f4200865c68bb2315c953_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i830539361e424a33bbef8df83b329bbb_I20220302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="id7f1ccafb608431fb6c6c1da15102473_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2bd7331082874ff88a6ef07310db1b10_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe95dbd24c1e41a1bb7c8821c5966526_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i479c60f4404d43ad9851018c65b3dd34_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i516662a4a0d6421a948606bc11a4248c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f3508ae7116426b88ab53b907d0b8a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78c293e52180494c8c19af75d240a16f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47e65e7cf8947d280a6cd3bc2ec52ee_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79b1207beabf4c39905094c110517562_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if43043bf29704f0480ca31e8929ace71_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5d5892bfe124a9f9812002e2a561ca7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i413ad6395c874b3ea0fb49e390a331d2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e006948a7a24010afaf3207af41b5d5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc3ae6194fdc4591b66a1cbe7d6fe9e4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia95c98274f654d0dbb3883e6494fb991_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f00e75a6bfd46a897f7a483a51d3bf3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9705c601c1a4a6790f6dd8fdbe9823f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i730514296aa347cbbdbbd7988e9b1db9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecd12d821ca244dd9d27b10250b62aa9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if44b2ce2087d41208cbc3e7cc5adaaec_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i236481f63a1745d09a131f29f465b969_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ae89d2530b0476aae8a3aac2954a443_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7905f84f35ea488095252b0854ef24b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9b1bde6ee6947c3815be0701e98b131_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b6992a9bef14397a85f536344720b58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i704f51eae14f4b16a31b91248c1468b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>vyne:segment</xbrli:measure></xbrli:unit><xbrli:context id="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-12</xbrli:startDate><xbrli:endDate>2022-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f84161efc234efd80e4eaa6e6f105d5_D20210806-20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i477ed4d994a24491901ffcdf33bca2bc_D20210806-20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vyne:TopicalBETiOptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccf5d6ca3a0e4b62ae5cb3f221bd420c_D20210806-20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vyne:OralBETiOptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-06</xbrli:startDate><xbrli:endDate>2021-08-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d600c9dd1a04a7c8e003a167844054e_I20210806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-08-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="employee"><xbrli:measure>vyne:employee</xbrli:measure></xbrli:unit><xbrli:context id="ia5eadddfbc494126bf9aa92fd1fba8f3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida05e158eeb4498bad602ba50db10863_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">vyne:RetentionPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50aaf6903e0449e78c0c8a43db1571f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5cf7aa626774cfea6cad9737b2d831f_I20210212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:MenloPremergerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba55a12228574923bbb188bfa1675bd5_I20210212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if700df1c23de4808b1135e843d318a8a_D20210212-20210212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-12</xbrli:startDate><xbrli:endDate>2021-02-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a6e3943e4f3499aa05c5f1b79ea9be6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1a583001e26487cab80e9da2a4c8bf1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1270645810f47e9a7e83fb038ed2bf1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5fd0d9bbcec4faaa99fa1d6f9cfcd5a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i842ae2d9ee184a8ab5883bcf17a70e63_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie53f456c44c141d9a86e97266cc12298_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd175173768e4ea8aed9f33191f66791_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bc82390929346cc83aa1a859f646cb1_D20200423-20200423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-23</xbrli:startDate><xbrli:endDate>2020-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb7ed5c301ca4a1fb4df13b64075b204_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vyne:ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf66ae22fce94621a923fc88150b0de4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vyne:ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e320cc859974d9a8611825211a48e4d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04c5ebd48f7b4ed7a5b18e2619c3dc71_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i748a6a56555e4b559d51845f4cf5e925_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:ThreeLargestCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e802c47b5b948f28423b29c6ae7b1ed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:ThreeLargestCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89b5ce1d295243118db097ac730c0000_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:ThreeLargestCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ada4de775684974955fee5f4e5ae4f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:ThreeLargestCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a47ebbee0041dab8fdf54e6e3642fa_I20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="contingentstockright"><xbrli:measure>vyne:contingentStockRight</xbrli:measure></xbrli:unit><xbrli:context id="ic28ecddbecb14089bf87f872b42485b0_I20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b5ca9e470654e73af6168a009123651_D20200406-20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-06</xbrli:startDate><xbrli:endDate>2020-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-07</xbrli:startDate><xbrli:endDate>2020-04-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic600bdee39bf4a4880487b43ba9df188_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d104d36f6484a09b3af55f5a52b179a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ea3fe3e2a474e2c836df31770569ca5_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3d87335d72c46baae89c74cf256abfc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcd1310cc41948fda92510020e6c5311_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia44d040e2d58449fb2c8ccba534d3561_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd2d1d4d5236485dbd015be1f3e9a186_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c4616f3027c41d7a959089637cbe325_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0de48e6f1dee484cb5de248475e21cc0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4538b4163a484df9a5150bc090ab457d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i629adb3cec5646989a6518dee4a69029_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vyne:AllowanceForSalesReturns1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdd96b5be5604cd99fd57eea397b6062_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1d39c3ca7874b59904e3c0e861e4215_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f3653857bf949f4a2ef81a87a83f1fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i894c1d96a0e74f408876a0655283cf8d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2b2fcf164d44dcfa785ffe4c6fc0674_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">vyne:IsraeliMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e9681eeba6644f3af02c673a4fd06b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">vyne:IsraeliMutualFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic65e68488b4a44bfb1349485e00bc902_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fff6625e4e44353b52824e303e6c56c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcce6081c1204eeebe23dd6751efbbda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61ea3c6a2b9643c4b0c38a30feec97fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2e122d5e1c4441fb4e5269084ca195c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i958fd692be7048b692433788e3424109_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic48701016b5b4663afd273a98b086ca0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i101ececdf4914f5ba6e572e864e4cf66_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99a4341caaaf441eaf0074526a0a8807_D20190313-20190313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:OriginalSpaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vyne:BridgewaterNewJerseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-13</xbrli:startDate><xbrli:endDate>2019-03-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="i941659ebe9434514a406d1f56a59ad1c_D20190313-20190313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:AdditionalSpaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vyne:BridgewaterNewJerseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-13</xbrli:startDate><xbrli:endDate>2019-03-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51a910c9c1a147509aff2e6f87810f5c_I20190313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:OriginalSpaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vyne:BridgewaterNewJerseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31d953cfd865427281cfadfbca27bacf_I20190313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:AdditionalSpaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vyne:BridgewaterNewJerseyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5c046f0b00a43cd82cd79465a32a139_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i095f99f5dad646848e17f3e6cf867662_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">srt:OfficeBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7f07698396e4710961b022584df3af9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">srt:OfficeBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdc06dd768af4cf19fdbabdfd9a1e045_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d3b1bab5fa44cbfa425becb06eecfc7_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vyne:ShareholderLenderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if989d0b1c2c24f45b11a284fac301a66_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lender"><xbrli:measure>vyne:lender</xbrli:measure></xbrli:unit><xbrli:context id="i284a65a8749542cdb95cbcc24fe35192_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:RegisteredOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vyne:ShareholderLenderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c259adecd3644dbaca374ee117b6d25_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia96474a494374f3385b000f4f8d33fca_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementTrench1LoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i577c52ea7b5b40aab1df1b785fc2c96e_I20191217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementTrench2LoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04ea1c0a01244363ac01049f1f6c7857_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementTrench3LoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic10e4840e05c4e729cd9e69af333a006_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e9df17c9abb40a896c4e95cd18226bd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66e2d83dcb2e4d44a68e3d1c04503e5c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7de8816c3eb465d9f44397038347e0a_I20210811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-08-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaac44e519733479cb2fd74f4d69991a1_D20210811-20210811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-11</xbrli:startDate><xbrli:endDate>2021-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9949f940927a4c1fb5d8ac40b1e2e0e4_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vyne:ShareholderLenderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fb8e95fc2ea4faea89832a8d5669b5e_I20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vyne:ShareholderLenderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id99703f9fd5b41b2b59fde641c5048bd_I20210212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vyne:ShareholderLenderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i888b43bee8a74b63b94b21ef02c0a940_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementTrench2LoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i160f84d5cf9d48ca8c977e79e5f245b3_D20190729-20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementTrench2LoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-29</xbrli:startDate><xbrli:endDate>2019-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>vyne:vote</xbrli:measure></xbrli:unit><xbrli:context id="i74ce2a3821c540e0b8de1b57d9790d94_I20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34dafd0890e345cb94a8cf7a2e26625f_D20190701-20190729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f0643079f4b4a46a6f72aa2aa70777a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic653c6de73fb47fea4bbe97cf2f5f3ab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0aa0866aa6994b3b9cbbaddb8ed97944_D20190201-20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i371ccbf335764d51b576f9a2336b47b2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88edc7fdfcf4414e8659f3d6de7a6b5a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd040f22c54846a4803901905b00f633_D20210101-20210125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9789581a138e48bf9397a195c54b4c33_I20210125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66bbeb9a734f427982630691149f765d_I20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b46cdcdfa37452ab8c70071f20ab9c7_D20210812-20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib74ed9a5f0a84a079fd6937d9d2f0453_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65dd613b82a44b218deffd9c0f7db2f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i347a6acc4a7a45968674fa63bfa3890b_D20210128-20210128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-28</xbrli:startDate><xbrli:endDate>2021-01-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica625a9375d843ae871ac0d4b3db4352_I20210128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i343a467bc0454f449ea44b8054c6e2f8_D20200609-20200609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:PublicStockOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-09</xbrli:startDate><xbrli:endDate>2020-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1c5a77b02644689af601da56f6c2307_I20200609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:PublicStockOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibea690c21df9415993df8d2c1da95438_D20200406-20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-06</xbrli:startDate><xbrli:endDate>2020-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dd45671031841d1ab0aae6c9fc9d75b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:A2019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic18e51c0667246cbb9cd142b80514de6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:A2018PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cd6043c4c234199b9b39bb81ff103fa_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9421373d63f34d70a76e0ec736a99720_I20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3e6b0bf97f5479c821f53984e43e031_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic37e0b69a2f040aa8c7b53683361dfe7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb7a10a25f4249d48fcd322e6ea012e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie35e2089123c4e50850717116e3c90ef_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf20f8bca32849c7beef794c32d2f471_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idde6935cd313421a8ac1426f77884c47_D20210212-20210212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-12</xbrli:startDate><xbrli:endDate>2021-02-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie847d448f04746f790f534394d63097f_I20210212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1daa38912a5c4a1a9f1feaf635f77377_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:MenloMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5da521456996427aba1e3f15e8a37411_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i900d5480233e4f9c83938266d12b66f5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23969f5a8552485eb663535fe65f545a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac3a8466dc0e4c3ea25864b0e9da2b0c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd305dde41e4448ebecd3c0983d175b3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b3949f3bcbc41f89845a01280213f01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic658972e380d477b81bc9fbdfd31f1db_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1049c5e9d3584238a13d1718e53ffeb3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0696c6f2ddb34f69be35f2bef6534641_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18c931db2ae34ddd8e0b75d2ddb9a6f1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ab92efb006543c0bfb4d9c671f0e6af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5feca1c387ef4ac081bc860e994a1d02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib17baf4771f74c3c866143773332d0a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d8e2ecb65594adebbdada392434f3f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i131bd9ea97144427b459ae81f53e00d2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aa6bb8253084128a90e0a1ebdf5b6fa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i918df004225b4092a0bff129ac010d6a_D20200309-20200309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-09</xbrli:startDate><xbrli:endDate>2020-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d96d676c73c4e51b5dc524d8d621a7f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedd0ba546c49493ba7382642df9946c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9309bf238b44411e899d0dcb4c8d3ef9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f658b6e836f41c9b28abeb2f9bc238f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50ff6dddfd3c429499a4b8c9b226e7d6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71a86bb6a8854c5296b3511aacf7bb04_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic066d03c70d147b5b20e324f40a88075_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if82c661f8a794fdeb31d8f9e4a475fc6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23a16cc6e5f846549e1725fbd52458c5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i910b930cd3714339a6b839e5f00372e1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc98456d2d1a44c78bb669199d845601_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d4bddd1b58c43bc9015bf6630359989_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fc0c8d37b2d4747aeb77bdce809b14b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef12beb3e494c14b255e4114f030a13_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcb524dbad1a4c1982574e2fe8ad19da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d4ee98eed24dd08f8c5f7e4d4cbd41_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3d169fae4d94cbd8c3022cba3a08fdf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff8c8e02a0374a409dd8fd2818c71588_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie156775f95034bcb81ccb6f76520718e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie287f45e91a4400282fc74f2a820b92e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a90103da5ca44acb0b6ef28d135f8d8_D20220101-20220316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99e857b122b54103af3bf50d59fa8745_I20220315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:LincolnParkEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8601e3d553e140d586df45d81ee2c321_D20220315-20220315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001566044</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:LincolnParkEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-15</xbrli:startDate><xbrli:endDate>2022-03-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3ee2f3590755456d8887827db5ee11c4_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTA2_08f9ab4a-a794-4eca-a115-04ce9c8e09c9">10-K</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6N2MxMTlkMzMxYjI2NGM5Mzk4OWFjNDhlOTMwNTQwZjIvdGFibGVyYW5nZTo3YzExOWQzMzFiMjY0YzkzOTg5YWM0OGU5MzA1NDBmMl8wLTAtMS0xLTIxMzE5_454019e8-3b8a-4e57-8f95-a8b7ede30f29">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8xMjk_836ab1bb-ec4b-46c2-894b-f727fd050d66"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8xMjk_486988a2-06a5-4868-9719-2126a369bee8">December&#160;31</ix:nonNumeric>, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6ZjQxMWQ4NDZkYzdjNDlhZWFiNGFjZjI4NzdkMzQ0YWMvdGFibGVyYW5nZTpmNDExZDg0NmRjN2M0OWFlYWI0YWNmMjg3N2QzNDRhY18wLTAtMS0xLTIxMzIx_879acaa8-0137-4509-8edb-f0421e57f12d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE TRANSITION PERIOD FROM ___ TO ___.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTE1_964ed15b-a6a1-4d32-9a29-12959b373726">001-38356</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTA3_3fe50e57-e50c-412d-b15c-3027fde06409">VYNE THERAPEUTICS INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.071%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MWU5MmJlYTgwOTc3NDk3MTkyNDNkODdjYWQ2YTdmYmEvdGFibGVyYW5nZToxZTkyYmVhODA5Nzc0OTcxOTI0M2Q4N2NhZDZhN2ZiYV8wLTAtMS0xLTIxMzI2_993e7bc4-4893-41d8-b507-814444bb3cbf">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MWU5MmJlYTgwOTc3NDk3MTkyNDNkODdjYWQ2YTdmYmEvdGFibGVyYW5nZToxZTkyYmVhODA5Nzc0OTcxOTI0M2Q4N2NhZDZhN2ZiYV8wLTItMS0xLTIxMzI5_cbccf2e0-20b0-4915-831b-dd0956429be8">45-3757789</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTA4_2af6a5ac-07e1-40f1-88d9-75ae540550af">520 U.S. Highway 22, Suite 204</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTE2_95def352-7fe3-42de-96de-4fc1e0312ab8">Bridgewater</ix:nonNumeric>, <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTE3_5aecc775-7b10-42bb-85b9-d4d51d8de36d">New Jersey</ix:nonNumeric> <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTEw_6c96db3d-03b8-4668-9cee-34886900fe1b">08807</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl80MTc_b7fb3ef8-0894-4346-a281-ae5ee375c7de">800</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTEx_d3aef15f-c77c-48ab-ac80-62d889bddd63">775-7936</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.352%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.352%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGZmZTk1Y2MwZWM5NDVmZWFmMGRiNTI0ZDAwYjVhOWEvdGFibGVyYW5nZTowZmZlOTVjYzBlYzk0NWZlYWYwZGI1MjRkMDBiNWE5YV8xLTAtMS0xLTIxNDA1_8754fd78-9670-4cd6-899a-34d5933c839a">Common Stock, par value $0.0001</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGZmZTk1Y2MwZWM5NDVmZWFmMGRiNTI0ZDAwYjVhOWEvdGFibGVyYW5nZTowZmZlOTVjYzBlYzk0NWZlYWYwZGI1MjRkMDBiNWE5YV8xLTItMS0xLTIxNDA4_6be3f274-7298-491b-9fbd-0193b44af5aa">VYNE</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGZmZTk1Y2MwZWM5NDVmZWFmMGRiNTI0ZDAwYjVhOWEvdGFibGVyYW5nZTowZmZlOTVjYzBlYzk0NWZlYWYwZGI1MjRkMDBiNWE5YV8xLTQtMS0xLTIxNDEw_277b6eaa-ac21-4d1a-abad-ca040a4f7cee">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTE5_3d17fd93-1b11-425d-b875-1dcb36aa615b">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTE4_f99d32f2-15b7-4df2-8b1a-a323767bbac9">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTA0_a0ea41cd-3eb6-418c-8ab9-e99b82b55f0f">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160; No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTIw_a826d37a-46eb-4586-a690-39c7724c7db4">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160; No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221;&#160;&#8220;accelerated filer,&#8221;&#160;&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"></td><td style="width:25.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGRjZjBhNWZhZGNjNDRmMWJkZmIyZTdhYzljYTczMWEvdGFibGVyYW5nZTowZGNmMGE1ZmFkY2M0NGYxYmRmYjJlN2FjOWNhNzMxYV8xLTAtMS0xLTIxNDE2_7e78f730-1fee-4a8e-85db-2b533725bfc5">Non-accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGRjZjBhNWZhZGNjNDRmMWJkZmIyZTdhYzljYTczMWEvdGFibGVyYW5nZTowZGNmMGE1ZmFkY2M0NGYxYmRmYjJlN2FjOWNhNzMxYV8xLTQtMS0xLTIxNDE5_41a54362-d489-49eb-bc4e-e30dfc57fd85">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGRjZjBhNWZhZGNjNDRmMWJkZmIyZTdhYzljYTczMWEvdGFibGVyYW5nZTowZGNmMGE1ZmFkY2M0NGYxYmRmYjJlN2FjOWNhNzMxYV8yLTQtMS0xLTIxNDIx_9ecf1616-3d50-4c3b-8288-1297046ea4c2">&#9746;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityExTransitionPeriod" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTEy_e83af971-0d74-4f26-bd2c-14aed21ea65f">&#9746;</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTEz_b3a9c653-7e85-4d50-85f2-3707a9e4cfcb">&#9744;</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2).</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTIy_69f7f730-89a3-4684-b672-e966811941c6">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the voting and non-voting common equity held by non-affiliates was $<ix:nonFraction unitRef="usd" contextRef="ife41df1c5a4f4200865c68bb2315c953_I20210630" decimals="-5" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8yNzM4_d659229d-2e92-4575-af28-54e555650639">155.4</ix:nonFraction> million, computed by reference to the last sales price reported by the Nasdaq Global Select Market as of June&#160;30, 2021. Shares of common stock held by each executive officer, director, and holder of 5% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;2, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i830539361e424a33bbef8df83b329bbb_I20220302" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zMTY0_d0d18ef9-f701-48f5-8866-f2e662b5cb5b">56,165,599</ix:nonFraction> shares of the registrant's Common Stock, par value $0.0001 per share, outstanding.</span></div><div style="margin-top:12pt;text-indent:18pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VYNE THERAPEUTICS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page No.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_22">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_25">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_25">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_28">ITEM 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_28">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_28">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_31">ITEM 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_31">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_31">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_34">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_34">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_34">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_37">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_37">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_37">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_40">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_40">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_40">58</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_43">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_46">ITEM 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_46">Market For Registrant&#8217;s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_46">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_49">ITEM 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_49">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_49">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_52">ITEM 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_52">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_52">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_91">ITEM 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_91">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_91">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_94">ITEM 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_94">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_94">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_175">ITEM 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_175">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_175">72</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_178">ITEM 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_178">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_178">72</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_181">ITEM 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_181">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_181">72</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_1850">ITEM 9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_1850">Disclosure Regarding Foreign Jurisdictions </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_1850">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_1850">hat </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_1850">P</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_1850">revent </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_1850">I</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_1850">nspections</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_181">72</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_184">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_187">ITEM 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_187">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_187">73</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_190">ITEM 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_190">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_190">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_193">ITEM 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_193">Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_193">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_196">ITEM 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_196">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_196">86</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_199">ITEM 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_199">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_199">87</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_202">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_205">ITEM 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_205">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_205">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_208">ITEM 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_208">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_208">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_211">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_211">92</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_13"></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_16"></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_19"></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF THE MATERIAL RISKS ASSOCIATED WITH OUR BUSINESS</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties that you should be aware of in evaluating our business. These risks include, but are not limited to, the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Our business is dependent on the successful development of FMX114 and our BET inhibitor product candidates;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">We will need substantial additional funding to fund our operations, and there is substantial doubt about our ability to continue as a going concern. We could also be forced to delay, reduce or terminate our research and development activities which would have a material adverse effect on our financial condition;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Risks and uncertainties related to the development of new chemical entities;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">We may encounter delays in enrolling patients and successfully completing clinical trials for our product candidates, and may even be prevented from commencing such trials due to factors that are largely beyond our control;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Clinical drug development is very expensive, time-consuming and uncertain. Our clinical trials may fail to adequately demonstrate the safety and efficacy of our current or any future product candidates, which could prevent or delay regulatory approval and commercialization;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">We may be unable to develop a lead molecule for the VYN202 program and exercise our option to license the applicable BET inhibitor compounds from In4Derm;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Our clinical trials may fail to demonstrate the safety and efficacy of our drug candidates, or serious adverse or unacceptable side effects may be identified during the development of our drug candidates, which could result in the abandonment or limitation of the development of our drug candidates or prevent or delay our ability to pursue strategic alternatives for our drug candidates;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Results obtained in non-clinical studies and completed clinical trials may not predict success in later clinical trials;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Topline and preliminary data from our clinical trials that we announce or publish from time to time may change as additional data become available and are subject to audit and verification procedures that could result in material changes in the final data;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">We have a limited history as a clinical-stage biopharmaceutical company developing drug candidates for immuno-inflammatory conditions, which may make it difficult to assess our future viability;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">We may spend our limited resources to pursue a particular drug candidate or indication and fail to capitalize on drug candidates or indications that may be more profitable or for which there is a greater likelihood of success;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">We are subject to various risks and uncertainties arising out of the completed divestiture of our commercial business; </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">We have not obtained regulatory approvals to market our other pipeline product candidates, and we may be delayed in obtaining or fail to obtain such regulatory approvals and to commercialize these product candidates;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Our failure to successfully in-license, acquire, develop and market additional product candidates or approved products could impair our ability to grow our business and execute our strategy;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">We intend to in-license and acquire product candidates or engage in other strategic transactions, which could impact our liquidity, increase our expenses and present significant distractions to our management;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">We may decide not to continue developing any of our product candidates at any time during development or of any of our products after approval, which would reduce or eliminate our potential return on investment for those product candidates or products;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Our business has been adversely impacted and could continue to be adversely affected by the evolving and ongoing COVID-19 global pandemic in regions where we or third parties on which we rely have manufacturing facilities, clinical trial sites or other business operations. The COVID-19 pandemic could adversely affect our operations, including at our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">clinical trial sites, as well as the business or operations of our manufacturers, contract research organizations or other third parties with whom we conduct business;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">We are subject to various U.S. federal, state, local and foreign health care fraud and abuse laws, including anti-kickback, self-referral, false claims and fraud laws, health information privacy and security, and transparency laws, and any violations by us of such laws could result in substantial penalties or other consequences including criminal sanctions, civil penalties, contractual damages, reputational harm, and diminished profits and future earnings. Additionally, any challenge to or investigation into our practices under these laws could cause adverse publicity and be costly to respond to, and thus could harm our business;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Legislative or regulatory healthcare reforms in the United States may make it more difficult and costly for us to obtain regulatory clearance or approval of our product candidates and to produce, market, and distribute our products after clearance or approval is obtained; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">The trading price of the shares of our common stock is volatile, and stockholders could incur substantial losses.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summary risk factors described above should be read together with the text of the full risk factors, in the section entitled &#8220;Risk Factors&#8221; in Part I, Item 1.A. and the other information set forth in this Annual Report on Form 10-K, including our consolidated financial statements and the related notes, as well as in other documents that we file with the SEC. The risks summarized above or described in full later in this report are not the only risks that we face. Additional risks and uncertainties not precisely known to us, or that we currently deem to be immaterial may also materially adversely affect our business, financial condition, results of operations and future growth prospects.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; within the meaning of Section 21E the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements other than statements of historical facts contained in this Annual Report on Form 10-K are statements that could be deemed forward-looking statements reflecting the current beliefs and expectations of management with respect to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. These statements are often identified by the use of words such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;due,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;positioned,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;until,&#8221; &#8220;if&#8221; and similar expressions or variations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements include, but are not limited to, statements regarding the following matters:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully execute our business strategy, including our ability to successfully develop our bromodomain and extra-terminal domain ("BET") inhibitor platform for immuno-inflammatory conditions;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our pursuit of, and ability to successfully identify and execute, strategic transactions;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to select a lead candidate and exercise our option with respect to an oral BET inhibitor under the terms of the Evaluation and Option Agreement with In4Derm Limited;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to raise substantial additional financing to fund our operations and continue as a going concern;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enroll patients and successfully complete, and receive favorable results in, clinical trials for our product candidates;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">estimates of our expenses, capital requirements, our needs for additional financing and our ability to obtain additional capital on acceptable terms or at all;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of commencement of future preclinical studies and clinical trials;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential market size of treatments for any diseases and market adoption of our products, if approved or cleared for commercial use, by physicians and patients;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"> risks and uncertainties arising out of the completed divestiture of our commercial business;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions related to COVID-19 on our ability to initiate and retain patients in our clinical trials and progress preclinical studies and the ability of our suppliers to manufacture and provide materials for our product candidates;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to create and or license in intellectual property and the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and programs, including the projected terms of patent protection;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the regulatory approval process for our product candidates, including any delay or failure in obtaining requisite approvals;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments and projections relating to our competitors and the markets in which we compete, including competing drugs and therapies, particularly if we are unable to receive exclusivity;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with various regulations applicable to our business, including continued listing rules imposed by Nasdaq;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully challenge intellectual property claimed by others;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our intentions and our ability to establish collaborations or obtain additional funding;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our ability to attract and retain key scientific or management personnel;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our defense of any future litigation that may be initiated against us;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding licensing, business transactions and strategic operations; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our future financial performance and liquidity.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We caution you that the foregoing list may not contain all of the forward-looking statements made in this Annual Report on Form 10-K. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in the section entitled &#8220;Risk Factors&#8221; in Part I, Item IA and elsewhere in this Annual Report on Form 10-K as well as our other filings made with the SEC. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management&#8217;s beliefs and assumptions only as of the date of this Annual Report on Form 10-K. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_25"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1 - BUSINESS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Our most advanced product candidate, FMX114, which is in Phase 2a, is being evaluated for the potential treatment of mild-to-moderate atopic dermatitis (&#8220;AD&#8221;). We are also in the preclinical stages of developing products containing Bromodomain and Extra-Terminal Domain (or &#8220;BET&#8221;) inhibitor compounds.  Our initial BET inhibitor candidate in development is VYN201, a locally administered pan-BET inhibitor, which we are exploring in various immuno-inflammatory diseases, including skin diseases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, we continue to explore opportunistic transactions that may enhance our pipeline portfolio, as well as support our current operations and fund our future growth.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2020, we commercially launched two dermatology products, AMZEEQ (minocycline) topical foam, 4%, and ZILXI (minocycline) topical foam, 1.5%, that we developed in-house using our proprietary molecule stabilizing technology (MST) platform and clinical development capabilities. Following a review of our business in the first half of 2021, including the revenues we had received from these commercial products, the market environment for specialty pharmaceutical companies and the potential for biopharmaceutical companies with novel immuno-inflammatory pipelines, we determined to divest our commercial dermatology business and refocus our strategic efforts and resources toward advancing our pipeline and development platform for products to treat immuno-inflammatory conditions. See "&#8212;Divestiture of Minocycline Business" and&#8220;Part II. Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Company Overview&#8221; for further discussion regarding the sale of our MST franchise, including AMZEEQ, ZILXI, and FCD105, to Journey Medical Corporation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Immuno-Inflammatory Disease</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our therapies are being evaluated for their potential to target inflammatory/autoimmune disease (which we refer to &#8220;immuno-inflammatory diseases&#8221;). These immune system disorders are caused by the immune system having too much activation or too little inhibition. There are dozens of known types of immuno-inflammatory diseases, many of which are severely debilitating and/or life threatening. Our therapeutic goal in immuno-inflammatory disease is to deliver a potent anti-inflammatory response while minimizing systemic side effects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our most advanced product candidate, FMX114, is being evaluated for the potential treatment of mild-to-moderate AD. AD is a chronic immune-mediated disease that is characterized by the appearance of dry, red, and itchy skin. FMX114 is being developed to address both the source and cause of inflammation in AD by developing a distinct combination gel formulation of tofacitinib, a Janus kinase inhibitor (&#8220;JAK&#8221;), aimed at reducing inflammation by inhibiting cytokine release from inflammatory cells, and fingolimod, a Sphingosine 1-phosphate receptor modulator, which approaches the reduction of inflammation by inhibiting migration of inflammatory cells, and in addition may also directly support skin barrier recovery. See &#8220;&#8212;Our Portfolio of Product Candidates&#8212;FMX114 for Mild-to-Moderate Atopic Dermatitis&#8221; for additional information regarding our FMX114 program.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="vyne-20211231_g1.jpg" alt="vyne-20211231_g1.jpg" style="height:203px;margin-bottom:5pt;vertical-align:text-bottom;width:609px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, in August 2021, we entered into a transaction with In4Derm Limited ("In4Derm") providing us with exclusive worldwide rights to research, develop and commercialize products containing BET inhibitors for the treatment of any disease, disorder or condition in humans. Through our access to this library of new chemical BET inhibitor compounds (our &#8220;InhiBET&#8482; platform&#8221;), we plan to develop BET inhibitor product candidates in various modes of administration and for a diverse set of indications. Based on preclinical data generated to date, we believe therapeutics generated by our InhiBET&#8482; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">platform have the potential to provide patient benefit in a broad range of immune system disorders. Accordingly, we have chosen to focus our initial efforts for this platform on select therapeutic areas with unmet medical needs in immuno-inflammatory disease.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BET proteins play a key role in regulating gene transcription via epigenetic interactions (&#8220;reading&#8221;), and recent research has determined a key role for these BET proteins in regulating B cell and T cell activation and subsequent inflammatory processes. As epigenetic readers, BET proteins regulate the recruitment of transcriptional factors that are key to the production of several pro-inflammatory cytokines. Inhibiting BET proteins blocks cytokine transcription and therefore may have significant therapeutic potential across a wide variety of immuno-inflammatory/fibrotic and myeloproliferative neoplastic disorders.</span></div><div style="margin-top:12pt;text-align:center"><img src="vyne-20211231_g2.jpg" alt="vyne-20211231_g2.jpg" style="height:270px;margin-bottom:5pt;vertical-align:text-bottom;width:512px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our initial BET inhibitor candidate in development is VYN201, which was developed using the InhiBET&#8482; platform and is a locally administered pan-bromodomain, or pan-BD, BET inhibitor. It is a first-in-class &#8220;soft&#8221; pan-BD BET inhibitor that is designed to address diseases involving multiple, diverse inflammatory cell signaling pathways. Through our license with In4Derm, we are developing VYN201 for local administration for various immuno-inflammatory diseases, including skin diseases. Based on preclinical data to date, we believe VYN201 has the potential to deliver a potent, localized anti-inflammatory effect</span><span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">to the affected area and be rapidly cleared through the body&#8217;s metabolic process.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of our partnership with In4Derm, we also have an exclusive option to license In4Derm&#8217;s highly selective bromodomain 2 BET inhibitors for oral administration. We believe bromodomain 2 selective oral BET inhibitors may present as more conveniently-administered non-biologic treatment options for both acute control and chronic management of immuno-inflammatory indications, where the damaging effects of unrestricted inflammatory signaling activity is common.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Our Strategy</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to execute on our strategy, including the following:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Develop our combination product candidate, FMX114</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. FMX114 is our proprietary investigational combination gel formulation of tofacitinib and fingolimod and is being developed to address both the source and cause of inflammation in AD. We believe FMX114 has the potential to be the first topical combination product for the treatment of AD and is the first topical product in clinical development that utilizes the sphingosine 1-phosphate receptor modulation mode of action. We expect to receive topline results from our Phase 2a study evaluating the safety and efficacy of FMX114 for mild-to-moderate AD in the second quarter of 2022.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Establish our InhiBET&#8482; BET inhibitor platform as a proprietary product development vehicle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  By leveraging our proven drug development and clinical development capabilities and strong network of discovery and preclinical science partners, we intend to discover and develop BET inhibitor product candidates in various modes of administration and for a diverse set of indications. Our goal is to capitalize on these strengths and establish InhiBET&#8482; as a proprietary product development vehicle. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maximize the value of our pipeline and platform via potential partnering activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We believe our pipeline is unique and has broad utility. For example, based on our preclinical efforts to date, we believe VYN201 has the potential to be developed for a variety of immuno-inflammatory indications and multiple modes of administration. We intend to continue to leverage our existing pipeline and platform to actively explore and evaluate potential value-creating partnering opportunities. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expand our product candidate portfolio and pipeline through in&#8209;licensing or acquisitions of additional product candidates or technologies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition to developing product candidates organically within our organization, we may in&#8209;license or acquire product candidates from third parties by leveraging our business development capabilities. With a goal of building a well&#8209;balanced and diversified portfolio, we assess a variety of factors for potential product candidates and technologies. Our criteria for possible acquisition or in-licensing opportunities includes rationale for addressing the disease, likelihood of regulatory approval, commercial viability, intellectual property protection, prospects for favorable pricing and reimbursement and competition. We intend to continue to be opportunistic in our business development activities to achieve our long-term strategic goals.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Our Portfolio of Product Candidates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">FMX114 for Mild-to-Moderate Atopic Dermatitis</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we announced development plans for FMX114 for the potential treatment of mild-to-moderate AD. FMX114 is a fixed combination of tofacitinib and fingolimod. Tofacitnib reduces inflammation intracellularly by inhibiting cytokine release from inflammatory cells. Fingolimod reduces inflammation by inhibiting migration of inflammatory cells and may directly support upregulation of filaggrin. By combining tofacitinib and fingolimod in a topical gel formulation, FMX114 attempts to address both the source and cause of inflammation in AD and support skin barrier recovery. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preclinical Data</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FMX114 was evaluated in a well-known preclinical model in which dorsal depilated BALB-C mice were dosed with 100&#181;l topical dinitrochlorobenzene ("DNCB") solution to induce a type 2 inflammatory response in the skin with AD-like pathology. There was a 32-day induction phase followed by seven days of both DNCB and investigational drug concomitant treatment. Two doses of FMX114 (0.6% tofacitinib + 0.01% fingolimod and 0.3% tofacitinib + 0.02% fingolimod) were compared with tofacitinib monotherapy, fingolimod monotherapy, triamcinolone (steroid) 0.1%, and DNCB control. Key findings from the study include the following:</span></div><div><span><br/></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Treatment with FMX114 0.6% tofacitinib + 0.01% fingolimod combination gel resulted in an 89% reduction in the modified atopic dermatitis index score (mADI) relative to the DNCB control group at day 7.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Both FMX114 doses had comparable efficacy to triamcinolone 0.1% cream, a product widely used in the treatment of AD.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Animal body weight was also evaluated to help determine tolerance to treatment. At day 7:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">In both FMX114 treatment groups, the animals experienced body weight gains comparable to DNCB negative control and vehicle-treated healthy control animal groups.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Animals treated with triamcinolone 0.1% cream lost approximately 21% of their body weight compared to the animals treated with FMX114.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Phase 1b /2a Study</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, we enrolled the first patient in our Phase 1b/2a clinical trial evaluating FMX114 for the treatment of mild-to-moderate AD. After considering the Food and Drug Administration's (the "FDA") recent review of the oral JAK inhibitor class for the treatment of several systemic autoimmune diseases, we believe it was important to characterize the preliminary safety and pharmacokinetic profile of FMX114 before advancing to the Phase 2a portion of the study. On January 19, 2022, we announced the Phase 1b data showing that systemic bioavailability of tofacitinib and fingolimod in topical formulation was substantially lower when compared to their oral equivalents. Specifically, the mean plasma C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">max</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of tofacitinib calculated on treatment day 1 and day 14 were approximately 50-fold and 1500-fold lower, respectively, when compared to the equivalent data for the lowest commercially available adult oral dose of tofacitinib (XELJANZ 5mg BD) and the pharmacokinetics of fingolimod and active metabolite, fingolimod 1-phosphate, could not be determined as all whole blood concentrations were below the assay LLOQ (0.08ng/ml for both analytes). </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to receive topline results from our Phase 2a study evaluating the safety and efficacy of FMX114 for mild-to-moderate AD in the second quarter of 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market Opportunity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AD is a skin disorder that causes long-term inflammation of the skin, resulting in itchy, red, swollen and cracked skin. Onset can occur at any age, but is more common in infants and children. Of the approximately 30 million people diagnosed with AD in the United States, approximately 19 million are characterized as mild-to-moderate disease severity. In 2019, 7.1 million patients used prescription medication to treat AD, with topical glucocorticosteroids accounting for 8 of the 10 highest prescribed topical products for AD. We believe FMX114, if approved, can provide an attractive treatment option for physicians and patients by demonstrating efficacy that is comparable to that of a glucocorticosteroid with an improved safety profile. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">InhiBET&#8482; BET Inhibitor Platform</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of our partnership with In4Derm, we have exclusive worldwide rights to research, develop and commercialize products containing certain BET inhibitor compounds for the treatment of any disease, disorder or condition in humans. See "&#8212;Development and License Agreements&#8212;In4Derm License Agreements." Utilizing our InhiBET</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> platform and through our preclinical activities, we are evaluating the impact that BET inhibitor compounds have on regulating pro-inflammatory cytokines. Based on this evaluation, we are targeting indications whose pathogenesis is linked to the proliferation of these specific cytokines, and we are developing formulations designed to maximize the anti-inflammatory effect of the drug while minimizing any potential safety concerns. Through our InhiBET&#8482; product development platform, we believe we can demonstrate the potential utility of these BET inhibitor compounds and develop therapies for a variety of immuno-inflammatory conditions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">VYN201 - Locally Administered Pan-BD BET Inhibitor </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our initial BET inhibitor candidate in development is VYN201. VYN201 was developed using the InhiBET&#8482; platform and is a locally administered pan-BD BET inhibitor. It is a first-in-class &#8220;soft&#8221; pan-BD BET inhibitor that is being developed to address diseases involving multiple, diverse inflammatory cell signaling pathways. Our goal with the VYN201 program is to develop a therapy that delivers a potent, localized anti-inflammatory effect and is rapidly cleared through the body&#8217;s metabolic process so as to avoid systemic absorption. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To date, we have conducted several preclinical models which have demonstrated VYN201's anti-fibrotic activity and the ability to significantly reduce the expression of certain cytokines relevant to certain autoimmune diseases. Based on such data, we believe VYN201 has the potential to be highly versatile by serving as a locally acting therapy with low systemic exposure. We are continuing to evaluate VYN201 in a variety of preclinical models and will announce an initial indication for VYN201 following such evaluation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following summarizes preclinical data received to date for the VYN201 program:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Th17 Inflammation Model</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2021, we announced preclinical data showing that VYN201 significantly reduced the expression of several key pro-inflammatory cytokines relevant to Th17-mediated autoimmune diseases in an animal model and an ex vivo human tissue study. The pathogenesis of many autoimmune diseases is linked to the proliferation and activity of Th17 cells. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">VYN201 was evaluated in a well-established preclinical model in which dorsal depilated mice were topically dosed with imiquimod cream to induce a Th17 inflammation pathology over a 7-day induction phase. A further 7-day treatment phase evaluated three doses of VYN201 (0.001%, 0.01% and 0.1% concentrations) compared to a class 1 super-potent glucocorticosteroid product positive control (clobetasol propionate 0.05% cream) and vehicle control. Further, an imiquimod-naive control group (healthy control group) was included for VYN201 vehicle treatment. Key findings from the study include:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">A dose-dependent improvement in the signs and symptoms of inflammation was observed for VYN201 treatment groups.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Treatment with VYN201 0.1% resulted in a 94% reduction in the composite inflammation severity score of erythema and scaling, relative to the vehicle control group at treatment day 7.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Animals treated with VYN201 0.1% experienced a reduction in inflammation comparable to those treated with the class 1 super-potent glucocorticosteroid clobetasol propionate 0.05% cream.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Corresponding dose-dependent reductions were observed across all treatment groups in Th17-relevant cytokine biomarkers of inflammation, including IL-1&#946;, IL-17, IL-6, IL-36 and TNF&#945; for VYN201-treated animals.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Treatment with VYN201 at all concentrations appeared well-tolerated based on the following observations:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Animals treated with VYN201 continued to gain body weight in a similar manner to the healthy control group, whereas animals treated with clobetasol propionate cream 0.05% had a mean body weight loss of approximately 17% compared to the animals treated with VYN201 0.1%.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Animals treated with VYN201 had no evidence of dermal tolerance issues, consistent with the healthy control group, whereas animals treated with clobetasol propionate 0.05% cream had significant skin atrophy as evidenced by deep wrinkling and rhytides (fine wrinkles), marked dermal translucency and loss of elasticity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Fibrotic Tissue Model</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2021, we announced preclinical data showing that VYN201 demonstrated improvements in reducing fibrotic tissue mass and overall skin repair outcomes with no negative impact on healing time. In the preclinical study, duplicate identical skin incisions were induced on the flanks of hairless mice under anesthesia. The animals were topically dosed once daily with either 100mg VYN201 vehicle, VYN201 1%, or a hydroalcoholic gel (a negative control known to delay healing) until each lesion had completely healed. Key findings from the study include:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">As early as treatment day 5, and consistent with the vehicle control, animals treated with VYN201 1% had a statistically significant decrease (improvement) in global external lesion severity score, a comprehensive evaluation of length, width, swelling and visibility of lesions, compared to those treated with hydroalcoholic gel.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Consistent with the vehicle control, lesions treated with VYN201 1% completely healed (mean time to heal: 15.5 days) approximately 5 days earlier compared to those treated with hydroalcoholic gel (mean time to heal: 21 days).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Animals treated with VYN201 1% had a significantly lower global internal lesion severity score than those treated with VYN201 vehicle or hydroalcoholic gel, indicative of an improved internal lesion outcome and a positive effect on reducing the formation of fibrotic tissue mass in the lesion bed.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">By the end of treatment, healed lesions treated with VYN201 1% appeared less visually distinct and more macular in nature with an improved overall aesthetic outcome compared to the other treatments.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">VYN201 vehicle and VYN201 1% appeared to be well-tolerated both within the lesion sites, based on the absence of irritation, and in general throughout the treatment period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Vitiligo Model</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2022, we announced positive preclinical data in an ex vivo skin model of vitiligo.  In the preclinical model, VYN201 reduced the expression of key pro-inflammatory biomarkers relevant to the pathogenesis of vitiligo, and demonstrated marked reduction in melanocyte loss. The objectives of this study were to evaluate the potential of VYN201 to (i) reduce Matrix Metalloproteinase-9 (&#8220;MMP-9&#8221;) secretion (reducing the secretion of MMP-9 allows for melanocyte stabilization and limits loss of melanocytes/depigmentation in vitiligo); (ii) reduce soluble adhesion molecule, E-cadherin (soluble E-cadherin is a biomarker of melanocyte loss due to degradation of matrix-bound E-cadherin by MMP-92); (iii) minimize the loss of melanocytes by assessing melanin pigment content and (iv) affect the expression of genes commonly associated with melanogenesis (melanin synthesis, melanosome maturation and transport). Key findings from the study include:</span></div><div><span><br/></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">VYN201 produced a dose dependent reduction in MMP-9 and soluble E-cadherin:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Applications with VYN201 at each of the 0.1% and 1% concentrations resulted in statistically significant reductions in MMP-9 when compared to vehicle, with a 94.7% reduction in secreted MMP-9 for the VYN201 1% treatment (p&lt;0.0001). </span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Applications with VYN201 at each of the 0.1% and 1% concentrations resulted in statistically significant reductions in the release of soluble E-cadherin relative to vehicle, with a 32.6% reduction in soluble E-cadherin for the VYN201 1% concentration (p&lt;0.01). </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">VYN201 0.1% and 1% were both numerically superior to topical ruxolitinib cream, 1.5% in reducing the secretion of MMP-9 and soluble E-cadherin. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">VYN201 at each of the 0.1% and 1% concentrations substantially reduced the loss of melanin pigment in the basal layers of skin:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">Quantified melanin levels for VYN201 1% treated skin cultures were approximately 10-fold higher as compared to VYN201 vehicle treated skin cultures (p=0.03).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">VYN201 positively impacted the expression of several genes implicated in the pathogenesis of vitiligo:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">VYN201 0.1% and 1% resulted in a statistically significant reduction in the expression of inflammatory cytokines IL1-&#945; and IL1-&#946; relative to vehicle (VYN201 1%, p&lt;0.0005).  These cytokines are well recognized as significant contributors to inflammation in vitiligo and their over-expression correlates with disease progression.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">VYN201 significantly upregulated the WNT signaling pathway at the 0.1% and 1% concentrations relative to vehicle, with a 10-fold increase observed at the 1% concentration (p&lt;0.01). The WNT family of proteins and its signaling pathway is recognized as an important indicator of melanocyte regeneration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">VYN202 - Selective BET Inhibitor </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">VYN202 is exploring multiple BET inhibitor compounds that are highly selective for bromodomain 2 ("BD2"). By selectively inhibiting BD2, we believe VYN202 could have a more targeted anti-inflammatory effect with an improved benefit/risk profile. We are diligently working with In4Derm to develop a lead molecule for the VYN202 program. Once a lead candidate has been selected, we intend to exercise our option with respect to these BET inhibitor compounds and commence an IND-enabling preclinical safety program. See "&#8212;Development and License Agreements&#8212;In4Derm License Agreements." </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Divestiture of Minocycline Business</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, we entered into an Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Journey Medical Corporation (&#8220;Journey&#8221;) pursuant to which we divested our Molecule Stabilizing Technology ("MST") franchise, including AMZEEQ, ZILXI, and FCD105, to Journey (the &#8220;Sale&#8221;). Journey acquired, among other things, the intellectual property related to the MST assets, inventory as of closing, and our rights and obligations under the license agreement with respect to the greater China territory. In addition, Journey agreed to assume certain liabilities, including, among others, those arising from ourpatent infringement suit initiated against Padagis Israel Pharmaceuticals Ltd. The Sale was consummated concurrently with the execution of the Purchase Agreement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Purchase Agreement, we received an upfront payment of $20.0 million and we are entitled to an additional $5.0 million on the one-year anniversary of the closing of the transaction. We are also eligible to receive sales milestone payments of up to $450.0 million in the aggregate upon the achievement of specified levels of net sales on a product-by-product basis, beginning with annual net sales exceeding $100,000,000 (with products covered in three categories (1) AMZEEQ (and certain modifications), (2) ZILXI (and certain modifications), and (3) FCD105 and other products covered by the patents being transferred, including certain modifications). In addition, we are entitled to receive certain payments from any licensing or sublicensing of the assets by Journey outside of the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Purchase Agreement includes customary representations and warranties, as well as indemnification rights for breaches of representations, warranties, and covenants, as well as certain other matters, subject to customary deductibles, caps, and other limitations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Manufacturing</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently contract with third party manufacturers for all of our required raw materials, active ingredients and finished products for our preclinical research and clinical trials for our product candidates. We currently have no plans to establish our own manufacturing capabilities and plan to continue to rely on third-party manufacturers for any future trials of our product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, together with our contract manufacturing organizations, or CMOs, have developed the validation processes, methods, tests and/or controls suitable for the manufacturing of our product candidates and for defining their properties. Development stage </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quantities of any products that we develop need to be manufactured in facilities, and by processes, that comply with the requirements of the FDA and the regulatory agencies of other jurisdictions in which we may seek approval. We require all of our CMOs to comply with these requirements and currently employ internal and external resources to manage our manufacturing contractors. The relevant manufacturers of our product candidates for our current preclinical and clinical trials have advised us that they are compliant with both the FDA&#8217;s Good Laboratory Practices, or GLP, and cGMP.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Development and License Agreements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In4Derm License Agreements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2021, we entered into an Evaluation and Option Agreement (the &#8220;Option Agreement&#8221;) with In4Derm. In4Derm is a spin-out of the University of Dundee&#8217;s School of Life Sciences and has discovered and is developing proprietary BET inhibitors for the treatment of immunology and oncology conditions. Pursuant to the Option Agreement, In4Derm granted us an exclusive option to obtain certain exclusive worldwide rights to research, develop and commercialize products containing In4Derm&#8217;s BET inhibitor compounds for the treatment of any disease, disorder or condition in humans. Pursuant to the Option Agreement, we agreed to use commercially reasonable efforts to stabilize, develop and manufacture a product with a pan-BD BET inhibitor as its active ingredient and In4Derm agreed to provide a mutually agreed data package and select an NCE development candidate from its highly selective BET inhibitor compounds (the "Oral BETi Compounds"). The Company paid a $1.0 million non-refundable cash payment to In4Derm upon execution of the Option Agreement, 50% of which was to be used by In4Derm in the development of the Oral BETi Compounds.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Locally Administered Pan-BD BET Inhibitor Program (VYN201)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2021, we exercised our option with respect to the VYN201 program and, on August 9, 2021, the parties entered into a License Agreement (the &#8220;License Agreement&#8221;) granting VYNE a worldwide, exclusive license that is sublicensable through multiple tiers to exploit certain of In4Derm&#8217;s pan-BD BET inhibitor compounds. We have the sole responsibility for development, regulatory, marketing and commercialization activities to be conducted for the licensed products at our sole cost and discretion. We are required to use commercially reasonable efforts to develop and, if approved, commercialize such products. Pursuant to the License Agreement, a joint development committee consisting of one representative from each party reviews the progress of the development plan for the licensed products. Pursuant to the License Agreement, we may develop a product that contains or incorporates a specific BET inhibitor, whether alone or in combination with other active ingredients, in any form, formulation, presentation, or dosage, and for any mode of administration. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We made a $0.5 million cash payment to In4Derm in connection with entering into the License Agreement. Pursuant to the License Agreement, we have agreed to make cash payments of up to an aggregate of $15.75 million upon the achievement of specified clinical development and regulatory approval milestones with respect to each licensed product in the U.S. In4Derm is entitled to additional milestones upon the achievement of regulatory approvals in certain jurisdictions outside the U.S. In addition, with respect to any products we commercialize under the License Agreement, we will pay tiered royalties to In4Derm on net sales of such licensed products by us, our affiliates, or sublicensees, of 5%, 7.5% and 10% based on tiered annual net sales bands subject to specified reductions. We are obligated to pay royalties until the later of (1) the tenth anniversary of the first commercial sale of the relevant licensed product, (2) the expiration of the last valid claim of the licensed patent rights covering such licensed product in such country and (3) the expiration of regulatory exclusivity for the relevant licensed product in the relevant country, on a licensed product-by-licensed product and country-by-country basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selective BET Inhibitor Program (VYN202)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Option Agreement, we can exercise our option with respect to the Oral BETi Compounds at any time until it expires upon the earlier of (i) 14 days following the delivery of an agreed data package and selection of a lead NCE candidate by In4Derm and (ii) June 30, 2022. We expect to exercise our option following the selection of a lead candidate for the program. Upon exercise of the option, the parties will sign a license agreement (the &#8220;Oral License Agreement&#8221;) and we will pay In4Derm a $4.0 million cash payment. The Oral License Agreement will include cash payments payable to In4Derm of up to an aggregate of $43.75 million upon the achievement of specified clinical development and regulatory approval milestones with respect to each licensed oral product in the U.S. In4Derm is entitled to additional milestones upon the achievement of regulatory approvals in certain jurisdictions outside the U.S. In addition, with respect to any products we commercialize under the Oral License Agreement, we will pay tiered royalties to In4Derm on net sales of such licensed products by us, our affiliates, or sublicensees, of 5%, 7.5% and 10% based on tiered annual net sales bands subject to specified reductions.</span></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEO Pharma A/S for Finacea&#174; Foam</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Bayer HealthCare AG, or Bayer, began selling in the United States a product branded Finacea&#174; Foam, based on our legacy foam technology. Finacea is a prescription topical drug which was developed through a collaboration between Foamix and Bayer. Bayer sold the product to LEO Pharma A/S ("LEO") in 2018. Pursuant to our license agreement with LEO for Finacea, we are entitled to receive royalties on net sales of Finacea. In 2021, we received (or became entitled to receive) a total of $0.9 million in royalties from sales of Finacea from LEO.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Research and Development</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal years ended December&#160;31, 2021 and 2020, our research and development expenses totaled $25.0 million and $43.5 million, respectively. In the ordinary course of business, we enter into agreements with third parties such as contract research organizations, or CROs, medical institutions, clinical investigators and contract laboratories, to conduct our clinical trials and aspects of our research and preclinical testing. These CROs and other third parties provide us with project management, monitoring, regulatory consulting and investigative services, and their fees are part of our research and development expenses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intellectual property and proprietary technology are essential to the development of our pipeline product candidates. We are committed to protecting our intellectual property rights, core technologies and other know-how, through a combination of patents, trademarks, domain names, trade dress, trade secrets, copyrights, non-disclosure and confidentiality agreements, common interest agreements to protect privileged confidential information, licenses, assignments of invention and other contractual arrangements with our employees, scientific advisors, consultants, partners, suppliers, customers and others. Such agreements and rights may however be breached, and we may not have adequate remedies for any breach. In addition, our trade secrets and other proprietary and confidential information may otherwise become known or be independently discovered by competitors. To the extent that our employees, scientific advisors, consultants, partners or other contractors use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our success will also depend at least in part on not infringing the proprietary rights of third parties. While we are diligent in our efforts to investigate proprietary rights of third parties, no search is completely exhaustive.  For example, a relevant patent or published application could escape detection because of unusual terminology or use of terminology that is still evolving in developing technological fields.  Also, databases used in the searches may not be entirely complete. It is uncertain whether the issuance of any third party patent would require us to alter our development strategies, alter our processes, obtain licenses or cease certain activities. Our breach of any license agreements or failure to obtain a license to proprietary rights that we may require to develop our current and future drugs may have a material adverse impact on us. If third parties prepare and file patent applications in the United States that also claim technology to which we have rights, we may have to participate in interference or other proceedings in the United States Patent and Trademark Office, or USPTO, to determine priority of invention. We may also have to participate in court proceedings or arbitration to defend and assert our rights. See "Item 1A. Risk Factors&#8212;Risks Related to Our Intellectual Property."</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have various pending patent applications related to our FMX114 and VYN201 product candidates. We have PCT applications in relation to FMX114. Our patent portfolio in relation to our BETi programs includes pending compound and composition patent applications in various jurisdictions worldwide, owned or licensed by us. Subject to filing a non-provisional, the PCT's being filed nationally, and the pending patent applications being granted and payments of the appropriate maintenance fees, the patent applications related to FMX114 will expire in 2040 and 2041 and the patent applications in relation to VYN201 will expire in 2040 and 2042. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, in connection with our legacy business, we have various granted patents worldwide owned or licensed by us related to pharmaceutical compositions and their uses, including various foam-based platforms, various gel-based platforms, and other technology. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Patents extend for varying periods according to the date of patent filing or grant and the legal term of patents in various countries where patent protection is obtained. The actual protection afforded by a patent, which can vary from country to country, depends on the type of patent, the scope of its coverage and the availability of legal remedies in the country. In most countries in which we file, the patent term is 20 years from the earliest date of filing a non-provisional patent application. In the United States, a patent term may be shortened if a patent is terminally disclaimed over another patent or as a result of delays in patent prosecution by the patentee, and a patent&#8217;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the USPTO in granting a patent or by patent term extension, which compensates a patentee for delays at the FDA. The patent term of a European patent is 20 years from its filing date; however, unlike in the United States, the European patent does not grant patent term adjustments. The European Union does have a compensation </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">program similar to patent term extension called supplementary patent certificate that would effectively extend patent protection for up to five years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our drug development activities face, and will continue to face, intense competition from organizations such as pharmaceutical and biotechnology companies, as well as academic and research institutions and government agencies. Our drug development activities also face, and may continue to face, governmental actions designed to promote generic drug competition and lower prices. Any product candidate that we successfully develop and commercialize will compete with existing treatments, including those that may have achieved broad market acceptance, and any new treatment that may become available in the future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the companies against which we are competing, or against which we may compete in the future, have significantly greater financial resources and expertise in research and development, manufacturing, and preclinical and clinical development than we do.  Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and subject registration for clinical trials, as well as in acquiring technologies complementary to, or that may be necessary for, our development programs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to FMX114 as a potential treatment of mild-to-moderate AD, there are several different therapies in the AD market, including prescription products and OTC products. Our primary competitors for this program include topical therapies such as Eucrisa, marketed by Pfizer Inc.; Opzelura, marketed by Incyte Corporation; and generic and branded versions of low to mid-potency steroids such as hydrocortisone and betamethasone.  In addition, there are several prescription product candidates under development that could potentially be used to treat AD, including but not limited to: topical tapinarof and topical cerdulatinib, both under development by Dermavant Sciences, Inc., topical delgocitinib, under development by LEO Pharma A/S and Japan Tobacco, Inc. (approved as Corectim in Japan), topical difamilast ointment, under development by Medimetriks/Otsuka Pharma, oral PF-04965842, under development by Pfizer Inc., and injectable lebrikizumab, under development by Eli Lilly and Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have not yet identified an initial indication for VYN201, there is intense competition for the treatment of immuno-inflammatory conditions, including indications we are currently evaluating. VYN201, if approved, will compete with existing treatments and new treatments that may become available in the future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commercial opportunity for our drug candidates, if approved, could be reduced or eliminated if our competitors develop and commercialize drugs that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than any drug we may develop. Our competitors also may obtain FDA or other regulatory approval for their drug candidates more rapidly than us, which could result in our competitors establishing a strong market position before our drug candidates are able to enter the market.</span></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to extensive government regulation. Regulation by governmental authorities in the United States and other jurisdictions is a significant factor in our research and development activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product approval process in the United States</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Review and approval of drugs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act, or FDCA and implementing regulations. In general, new drug products require the submission of a NDA and approval thereof by the FDA prior to being marketed in the United States. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or after approval may subject an applicant to a variety of administrative or judicial sanctions and enforcement actions brought by the FDA, the Department of Justice or other governmental entities. Possible sanctions may include the FDA&#8217;s refusal to approve pending NDAs, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement and civil or criminal penalties.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process required by the FDA prior to marketing and distributing a new drug product in the United States generally involves the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completion of laboratory tests, animal studies and formulation studies in compliance with the FDA&#8217;s Good Laboratory Practices, or GLP, or other applicable regulations;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to the FDA of an application for an investigational new drug application, or IND, which must become effective before human clinical trials may begin;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval by an independent institutional review board, or IRB, at each clinical site before each trial may be initiated at that site;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance of adequate and well-controlled human clinical trials in accordance with Good Clinical Practice, or GCP, requirements to establish the safety and efficacy of the proposed drug for its intended use;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preparation and submission to the FDA of a NDA or supplemental NDA;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of an FDA advisory committee review, if applicable;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of one or more FDA inspections of the manufacturing facility or facilities at which the product or components thereof are produced, to assess compliance with current Good Manufacturing Good Practices, or cGMP, and to assure that the facilities, methods and controls are adequate to preserve the drug&#8217;s identity, strength, quality and purity;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of FDA audits of clinical trial sites and the sponsor&#8217;s clinical trial records to assure compliance with GCPs and the integrity of the clinical data;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payment of user fees and FDA review and approval of the NDA; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with any post-approval requirements, including the potential requirement to implement a Risk Evaluation and Mitigation Strategy, or REMS, and the potential requirement to conduct post-approval studies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preclinical studies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preclinical studies include laboratory evaluation, as well as animal studies to assess the potential safety and efficacy of the product candidate. Preclinical safety tests must be conducted in compliance with the FDA&#8217;s GLP regulations. The results of the preclinical tests, together with manufacturing information and analytical data, are submitted to the FDA as part of an IND which must become effective before clinical trials may be commenced.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical trials in support of an NDA</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials involve the administration of an investigational product to human subjects under the supervision of qualified investigators in accordance with GCP requirements, which include, among other things, the requirement that all research subjects provide their informed consent in writing before their participation in any clinical trial. Clinical trials are conducted under written trial protocols detailing, among other things, the objectives of the trial, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. An IND becomes effective 30 days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to a proposed clinical trial and places the trial on clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, an IRB representing each institution participating in the clinical trial must review and approve the plan for any clinical trial before it commences at that institution, and the IRB must conduct continuing review and reapprove the trial at least annually. The IRB must review and approve, among other things, the trial protocol and informed consent information to be provided to trial subjects. An IRB must operate in compliance with FDA regulations. Information about certain clinical trials must be submitted within specific timeframes to the National Institutes of Health for public dissemination on their ClinicalTrials.gov website.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials are typically conducted in three sequential phases, which, in some cases, may overlap or be combined:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Phase I:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The drug is initially introduced into healthy human subjects or patients with the target disease or condition and tested for safety, dosage tolerance, absorption, metabolism, distribution, excretion and, if possible, to gain an early indication of its effectiveness and to determine optimal dosage.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Phase II: The drug is administered to a limited patient population to identify possible short-term adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Phase III: The drug is administered to an expanded patient population, generally at geographically dispersed clinical trial sites, in well-controlled clinical trials to generate enough data to statistically evaluate the efficacy and safety of the product for approval, to establish the overall risk-benefit profile of the product, and to provide adequate information for the labeling of the product.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Submission of a NDA to the FDA</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of the preclinical studies and clinical trials, together with other detailed information, including information on the manufacture, control and composition of the product, are submitted to the FDA as part of a NDA requesting approval to market the product candidate for a proposed indication. Under the Prescription Drug User Fee Act, or PDUFA, as amended, applicants are required to pay fees to the FDA for reviewing an NDA. These user fees, as well as the annual fees required for commercial manufacturing establishments and for approved products, can be substantial. Each NDA submitted to the FDA for approval is reviewed for administrative completeness and reviewability within 60 days following submission of the application. If found complete, the FDA will &#8220;file&#8221; the NDA, thus triggering a full review of the application. The FDA may refuse to file any NDA that it deems incomplete or not properly reviewable at the time of submission.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once the submission is accepted for filing, the FDA begins an in-depth substantive review. The FDA has agreed to certain performance goals in the review of NDAs. Most applications for standard review drug products are reviewed within ten to twelve months; most NDAs for priority review drugs are reviewed in six to eight months. The review process for both standard and priority review may be extended by FDA for three additional months to consider certain late-submitted information, or information intended to clarify information already provided in the submission. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective and whether the facility in which it is manufactured, processed, packaged or held meets standards designed to assure the product&#8217;s continued safety, quality and purity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before approving a NDA, the FDA may inspect the facilities at which the product is manufactured or facilities that are significantly involved in the product development and distribution process, and will not approve the product unless cGMP compliance is satisfactory at such facilities. The FDA may deny approval of a NDA if applicable statutory or regulatory criteria are not satisfied, or it may require additional testing or information, which can delay the approval process. FDA approval of any application may include many delays or may never be granted. If a product is approved, the approval will specify the indicated uses for which the product may be marketed in the United States pursuant to that NDA, may require that warning statements be included in the product labeling, may require that additional studies or trials be conducted following approval as a condition of the approval, may impose restrictions and conditions on product distribution, prescribing or dispensing in the form of risk evaluation and mitigation strategies ("REMS"), or may impose other limitations. After evaluating the NDA and all related information, including any advisory committee recommendation, if applicable, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA will issue an approval letter or a complete response letter. A complete response letter generally outlines the deficiencies in the submission and contains a statement of specific conditions that must be met in order to secure final approval of the NDA and may require additional clinical or non-clinical testing in a resubmission to the NDA in order for the FDA to reconsider the application. FDA has committed to reviewing such submissions in two or six months depending on the type of information included in the resubmission. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#8217;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the FDA approves a product, it may limit the approved indications for use of the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess a drug&#8217;s safety after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS, which can materially affect the potential market and profitability of the product.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once a product is approved, marketing the product for other indicated uses or making certain manufacturing or other changes requires FDA review and approval of a supplemental NDA or a new NDA, which may require additional clinical data and review fees. In addition, further post-marketing testing and surveillance to monitor the safety or efficacy of a product may be required. Also, product approvals may be withdrawn if compliance with regulatory standards is not maintained or if safety or manufacturing problems occur at any time following approval. In addition, new government requirements may be established that could delay or prevent regulatory approval of our product candidates under development.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Special FDA Expedited Review and Approval Programs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has various programs, including Fast Track designation, Breakthrough Therapy designation, Accelerated Approval, and Priority Review, which are intended to expedite or simplify the process for the development and FDA review of drugs that are intended for the treatment of serious or life-threatening diseases or conditions and demonstrate the potential to address unmet medical needs. The purpose of these programs is to provide important new drugs to patients earlier than under standard FDA review procedures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the fast track program, the sponsor of a new drug candidate may request that FDA designate the drug candidate for a specific indication as a fast track drug concurrent with, or after, the filing of the IND for the drug candidate. Fast track designation provides opportunities for frequent interactions with the FDA review team to expedite development and review of the product. FDA may initiate review of sections of a fast track drug&#8217;s NDA before the application is complete. This rolling review is available if the applicant provides, and FDA approves, a schedule for the submission of the remaining information and the applicant pays applicable user fees. However, FDA&#8217;s time period goal for reviewing an application does not begin until the last section of the NDA is submitted.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a sponsor can request breakthrough therapy designation for a drug if it is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Drugs designated as breakthrough therapies are eligible for intensive guidance from FDA on an efficient drug development program, organizational commitment to the development and review of the product including involvement of senior managers, and, like fast track products, are also eligible for rolling review of the NDA. Both fast track and breakthrough therapy products are also eligible for accelerated approval and/or priority review, if relevant criteria are met.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the FDA&#8217;s accelerated approval regulations, the FDA may approve a drug for a serious or life-threatening illness that provides meaningful therapeutic benefit to patients over existing treatments based upon a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In clinical trials, a surrogate endpoint is a measurement of laboratory or clinical signs of a disease or condition that substitutes for a direct measurement of how a patient feels, functions, or survives. Surrogate endpoints can often be measured more easily or more rapidly than clinical endpoints. A drug candidate approved on this basis is subject to rigorous post-marketing compliance requirements, including the completion of Phase 4 or post-approval clinical trials to confirm the effect on the clinical endpoint. Failure to conduct required post-approval studies, or confirm a clinical benefit during post-marketing studies, will allow FDA to withdraw the drug from the market on an expedited basis. All promotional materials for drug candidates approved under accelerated approval regulations are subject to prior review by FDA.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once a NDA is submitted for a product intended to treat a serious condition, the FDA may assign a priority review designation if FDA determines that the product, if approved, would provide a significant improvement in safety or effectiveness. A priority review means that the goal for the FDA to review an application is six months, rather than the standard review of ten months under current PDUFA guidelines. Under the current PDUFA agreement, for NDAs for new molecular entities, these six- and ten- month review periods are measured from the 60-day filing date rather than the receipt date, which typically adds approximately two months to the timeline for review from the date of submission. Most products that are eligible for fast track and/or breakthrough therapy designation are also likely to be considered appropriate to request and potentially receive a priority review. Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. In addition, the manufacturer of an investigational drug for a serious or life-threatening disease is required to make available, such as by posting on its website, its policy on responding to requests for expanded access. Furthermore, fast track designation, breakthrough therapy designation, accelerated approval and priority review do not change the standards for approval and may not ultimately expedite the development or approval process.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Hatch-Waxman Act</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 505 of the FDCA describes three types of applications that may be submitted to request marketing authorization for a new drug. A 505(b)(1) NDA is an application that contains full reports of investigations of safety and effectiveness. The Hatch-Waxman Act created two additional marketing pathways under Sections 505(j) and 505(b)(2) of the FDCA. Section 505(j) establishes an abbreviated approval process for generic versions of approved drug products through the submission of an abbreviated new drug application, or ANDA. An ANDA provides for marketing of a drug product that has the same active ingredients in the same strengths and dosage form as the branded reference drug and has been shown to be bioequivalent to the branded reference drug. ANDA applicants are required to conduct bioequivalence testing to confirm chemical and therapeutic equivalence to the branded reference drug. Generic versions of drugs can often be substituted by pharmacists under prescriptions written for the branded reference drug.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, an applicant may submit a NDA under Section 505(b)(2) of the FDCA. Section 505(b)(2) was enacted as part of the Hatch-Waxman Amendments and permits the filing of a NDA where at least some of the information required for approval comes from FDA&#8217;s conclusions of safety or efficacy from studies or trials not conducted by or for the applicant, and for which the applicant has not received a right of reference. If the 505(b)(2) applicant can establish that reliance on the FDA&#8217;s previous findings of safety and effectiveness is scientifically appropriate, it may eliminate the need to conduct certain preclinical studies or clinical trials of the new product. The FDA may also require companies to perform additional studies or measurements, including clinical trials, to support the change from the approved reference, or &#8220;listed&#8221; drug. The FDA may then approve the new product candidate for all, or some, of the label indications for which the reference drug has been approved, as well as for any new indication sought by the 505(b)(2) applicant.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the approval of many products by the FDA pursuant to Section 505(b)(2), over the last few years, some pharmaceutical companies and others have objected to the FDA&#8217;s interpretation of Section 505(b)(2). If the FDA changes its interpretation of Section 505(b)(2), or if the FDA&#8217;s interpretation is successfully challenged in court, this could delay or even prevent the FDA from approving any Section 505(b)(2) NDA that we submit.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Orange Book</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In seeking approval for a drug through a NDA, applicants are required to list with the FDA each patent whose claims cover the applicant&#8217;s product. Upon approval of a drug, each of the patents listed in the application for the drug is then published in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. Drugs listed in the Orange Book can, in turn, be cited by potential generic competitors in support of approval of an ANDA. An ANDA provides for marketing of a drug product that has the same active ingredients in the same strengths and dosage form as the listed drug and has been shown through bioequivalence testing to be bioequivalent to the listed drug. Other than the requirement for bioequivalence testing, ANDA applicants may not be required to conduct, or submit results of, pre-clinical or clinical tests to prove the safety or effectiveness of their drug product. In some cases however, the FDA may issue product specific guidance that recommends the conduct of a clinical trial. Drugs approved in this way are considered to be therapeutically equivalent to the listed drug, are commonly referred to as &#8220;generic equivalents&#8221; to the listed drug, and can often be substituted by pharmacists under prescriptions written for the original listed drug in accordance with state law.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that a Section 505(b)(2) NDA relies on clinical trials conducted for a previously approved drug product or the FDA&#8217;s prior findings of safety and effectiveness for a previously approved drug product, the Section 505(b)(2) applicant must submit patent certifications in its Section 505(b)(2) application with respect to any patents for the previously approved product on which the applicant&#8217;s application relies that are listed in the Orange Book. Specifically, the applicant must certify for each listed patent that, in relevant part, (i) the required patent information has not been filed; (ii) the listed patent has expired; (iii) the listed patent has not expired, but will expire on a particular date and approval is not sought until after patent expiration; or (iv) the listed patent is invalid, unenforceable or will not be infringed by the proposed new product.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A certification that the new product will not infringe the previously approved product&#8217;s listed patent or that such patent is invalid or unenforceable is known as a Paragraph IV certification. If the applicant does not challenge one or more listed patents through a Paragraph IV certification, the FDA will not approve the Section 505(b)(2) NDA application until all the listed patents claiming the referenced product have expired. Further, the FDA will also not approve, as applicable, a Section 505(b)(2) NDA application until any non-patent exclusivity, such as, for example, five-year exclusivity for obtaining approval of a new chemical entity, three-year exclusivity for an approval based on new clinical trials, and additional 6 months pediatric exclusivity if applicable, listed in the Orange Book for the referenced product, has expired. If a generic drug product is ready for approval before the expiration of any patents or exclusivities accorded to the reference listed drug product, the FDA issues a tentative approval letter to the applicant. The tentative approval letter details the circumstances associated with the tentative approval. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA delays final approval of the generic drug product until all patent or exclusivity issues have been resolved. A tentative approval does not allow the applicant to market the generic drug product.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Section 505(b)(2) NDA applicant has provided a Paragraph IV certification to the FDA, the applicant must also send notice of the Paragraph IV certification to the owner of the referenced NDA for the previously approved product and relevant patent holders within 20 days after the Section 505(b)(2) NDA has been accepted for filing by the FDA. The NDA and patent holders may then initiate a patent infringement suit against the Section 505(b)(2) applicant. Under the FDCA, the filing of a patent infringement lawsuit within 45 days of receipt of the notification regarding a Paragraph IV certification automatically prevents the FDA from approving the Section 505(b)(2) NDA until the earliest to occur of 30 months beginning on the date the patent holder receives notice, expiration of the patent, settlement of the lawsuit, or until a court deems the patent unenforceable, invalid or not infringed. Even if a patent infringement claim is not brought within the 45-day period, a patent infringement claim may be brought under traditional patent law, but it does not invoke the 30-month stay.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, in cases where a Section 505(b)(2) application containing a Paragraph IV certification is submitted after the fourth year of a previously approved drug&#8217;s five-year exclusivity period and the patent holder brings suit within 45 days of notice of certification, the 30-month period is automatically extended to prevent approval of the Section 505(b)(2) application until the date that is seven and one-half years after approval of the previously approved reference product. The court also has the ability to shorten or lengthen either the 30 month or the seven and one-half year period if either party is found not to be reasonably cooperating in expediting the litigation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketing Exclusivity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to patent protections applicable to a listed drug, a Section 505(b)(1) application and a 505(b)(2) application may be subject to periods of statutory market exclusivity afforded to an approved new drug. Statutory market exclusivity provides the holder of an approved NDA limited protection from new competition in the marketplace for the innovation represented by its approved drug product, and precludes approval of certain 505(b)(2) and abbreviated new drug applications (ANDAs) referencing the approved drug product for prescribed periods of time. Exclusivity is available for new chemical entities, as well as for significant changes in already approved drug products, such as a new indication or new use. FDA may refuse to approve a Section 505(b)(2) or ANDA application that is referencing a previously approved drug product to the extent that the drug product is subject to market exclusivity. Upon NDA approval of a new chemical entity or NCE, which is a drug that contains no active moiety that has been approved either alone or in combination by the FDA in any other NDA, that drug receives five years of marketing exclusivity and during which time the FDA cannot receive any ANDA or 505(b)(2) application seeking approval of a drug that references a version of the NCE drug, except that such applications may be submitted after 4 years if they contain a certification of patent invalidity or noninfringement. Certain approvals granted for change(s) to a drug resulting from new clinical studies that were &#8220;essential to approval,&#8221; such as a new dosage form, strength, route of administration, dosing regimen or indication, are associated with a three-year period of exclusivity. During this three-year exclusivity, the FDA cannot approve an ANDA or 505(b)(2) application that includes the change(s). Such applicants must also demonstrate &#8220;a significant new use&#8221; such as a new indication for a previously approved drug, and not just refinements in labeling related to previously approved uses, in order to qualify for the three-year exclusivity. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-approval requirements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any drug products for which we receive FDA approval will be subject to continuing regulation by the FDA. Certain requirements include, inter alia, record-keeping requirements, reporting of adverse experiences with the product, providing the FDA with updated safety and efficacy information on an annual basis or more frequently for specific events, product sampling and distribution requirements, complying with certain electronic records and signature requirements and complying with FDA promotion and advertising requirements. These promotion and advertising requirements include, among others, standards for direct-to-consumer advertising, prohibitions against promoting drugs for uses or patient populations that are not described in the drug&#8217;s approved labeling, known as &#8220;off-label use,&#8221; and other promotional activities, such as those considered to be false or misleading. Failure to comply with FDA requirements can have negative consequences, including the immediate discontinuation of noncomplying materials, adverse publicity, enforcement letters from the FDA, mandated corrective advertising or communications with doctors, and civil or criminal penalties. Such enforcement may also lead to scrutiny and enforcement by other government and regulatory bodies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although physicians may prescribe legally available drugs for off-label uses, manufacturers may not encourage, market or promote such off-label uses. As a result, &#8220;off-label promotion&#8221; has formed the basis for litigation under the Federal False Claims Act, or FCA, violations of which are subject to significant civil fines and penalties. In addition, under the federal Physician Payments Sunshine Act, manufacturers of certain prescription products are required to disclose annually to the Centers for Medicaid and Medicare Services, or CMS payments or transfers of value made to &#8220;covered recipients&#8221; and teaching </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hospitals, and ownership or investment interests held by covered recipients and their immediate family members. Reportable payments and transfers of value may be direct or indirect, in cash or kind, for any reason, and are required to be disclosed even if the transfers are not related to an approved product. Failure to comply with the Physician Payments Sunshine Act could result in penalties up to $1.15 million per year.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing of any of our product candidates, if approved, will be required to comply with applicable FDA manufacturing requirements contained in the FDA&#8217;s cGMP regulations. The FDA&#8217;s cGMP regulations require, among other things, quality control and quality assurance, as well as the corresponding maintenance of comprehensive records and documentation. Drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are also required to register their establishments and list any products they make with the FDA and to comply with related requirements in certain states. These entities are further subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP and other laws. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain cGMP compliance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discovery of problems with a product after approval may result in serious and extensive restrictions or other consequences for a product, manufacturer or holder of an approved NDA, as well as lead to potential market disruptions. These restrictions or consequences may include untitled or warning letters, recalls, suspension of a product until the FDA is assured that quality standards can be met, and continuing oversight of manufacturing by the FDA under a &#8220;consent decree,&#8221; which frequently includes the imposition of costs and continuing inspections over a period of many years, as well as possible withdrawal of the product from the market. In addition, changes to the manufacturing process generally require prior FDA approval before being implemented. Other types of changes to the approved product, such as adding new indications and additional labeling claims, are also subject to further FDA review and approval.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA also may require post-marketing testing, or Phase IV testing, as well as REMS to monitor the effects of an approved product or place conditions on an approval that could otherwise restrict the distribution or use of approved products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pediatric trials and exclusivity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even when not pursuing a pediatric indication, under the Pediatric Research Equity Act of 2003, an NDA or supplement thereto must contain data that are adequate to assess the safety and effectiveness of the drug product for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. With enactment of the Food and Drug Administration Safety and Innovation Act, or the FDASIA, in 2012, sponsors must also submit pediatric trial plans prior to the assessment data. Those plans must contain an outline of the proposed pediatric trials the applicant plans to conduct, including trial objectives and design, any deferral or waiver requests, and other information required by regulation. The applicant, the FDA, and the FDA&#8217;s internal review committee must then review the information submitted, consult with each other, and agree upon a final plan. The FDA or the applicant may request an amendment to the plan at any time.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from the pediatric data requirements. Additional requirements and procedures relating to deferral requests and requests for extension of deferrals are contained in the FDASIA.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, in the event the FDA makes a written request for pediatric data relating to a drug product, an NDA sponsor who submits such data may be entitled to pediatric exclusivity. Pediatric exclusivity is another type of non-patent marketing exclusivity in the United States and, if granted, provides for the attachment of an additional 6 months of marketing protection to the term of any existing regulatory exclusivity, including the non-patent and orphan exclusivity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patent term restoration and extension</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A patent claiming a new drug product may be eligible for a limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, generally referred to as the &#8220;Hatch-Waxman Act,&#8221; which permits an extension of the term of a patent for up to five years to compensate patent holders for marketing time lost while developing the product and awaiting government approval during the FDA regulatory review. The basis for the patent extension is the regulatory review period, which is basically composed of two parts, a testing phase and an approval phase, less a reduction, if any, in either part for a period time where there was a finding of lack of due diligence. The restoration period granted can be up to one-half the time between the effective date of an IND and the submission date of an NDA (testing phase), plus the time between the submission date of an NDA and the ultimate approval date (approval phase). Patent term extension cannot be used to extend the remaining term of a patent past a total of 14 years from the product&#8217;s approval date. In other words, the total maximum patent life for the product with the patent extension cannot exceed 14 years from the products approval date, which amounts to 14 years of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">potential marketing time. Only one patent applicable to an approved drug product may be extended, and the application for the extension must be submitted prior to the expiration of the patent in question and within 60 days of FDA approval. A patent that covers multiple drugs for which approval is sought can only be extended in connection with one of the approvals and the scope of the extended patent is limited to the approved drug. The USPTO reviews and approves the application for any patent term extension in consultation with the FDA. The term of a patent which claims a human drug product, a method of using the product, or a method of manufacturing the product may potentially be extended if it satisfies the various conditions including that it is the first permitted commercial marketing or use of the drug. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Review and approval of drug products outside the United States</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to regulations in the United States, we are subject to a variety of foreign regulations governing manufacturing, clinical trials, commercial sales and distribution of our future products. Whether or not we obtain FDA approval for a product candidate, we must obtain approval by the comparable regulatory authorities of foreign countries before commencing clinical trials or marketing in those countries. The approval process varies from country to country and can be subject to uncertainties, and the time may be longer or shorter than that required for FDA approval. The requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from country to country.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Regulation in the European Economic Area</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Economic Area, or EEA, which is composed of the Member States of the European Union plus Norway, Iceland and Liechtenstein, medicinal products can only be commercialized after obtaining a Marketing Authorization, or MA.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are two types of MAs:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Community MA, which is issued by the European Commission through the Centralized Procedure, based on the opinion of the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, and which is valid throughout the entire territory of the EEA. The Centralized Procedure is mandatory for certain types of products, such as biotechnology medicinal products, orphan medicinal products and medicinal products that contain a new active substance indicated for the treatment of AIDS, cancer, neurodegenerative disorders, diabetes, auto-immune and viral diseases. The Centralized Procedure is optional for products containing a new active substance not yet authorized in the EEA, or for products that constitute a significant therapeutic, scientific or technical innovation or which are in the interest of public health in the EU. Under the Centralized Procedure the maximum timeframe for the evaluation of a marketing authorization application, or MAA, is 210 days (excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the CHMP). Accelerated evaluation might be granted by the CHMP in exceptional cases, when the authorization of a medicinal product is of major interest from the point of view of public health and in particular from the viewpoint of therapeutic innovation. Under the accelerated procedure the standard 210 days review period is reduced to 150 days.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">National MAs, which are issued by the competent authorities of the Member States of the EEA and only cover their respective territory, are available for products not falling within the mandatory scope of the Centralized Procedure. Where a product has already been authorized for marketing in a Member State of the EEA, this National MA can be recognized in another Member State through the Mutual Recognition Procedure. If the product has not received a National MA in any Member State at the time of application, it can be approved simultaneously in various Member States through the Decentralized Procedure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to obtaining an MA in the EEA, applicants have to demonstrate compliance with all measures included in a Pediatric Investigation Plan, or PIP, approved by the EEA regulatory agency, covering all subsets of the pediatric population, unless the EEA regulatory agency has granted (1) a product-specific waiver, (2) a class waiver or (3) a deferral for one or more of the measures included in the PIP.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EEA, upon receiving a MA, new chemical entities generally receive eight years of data exclusivity and an additional two years of market exclusivity. If granted, data exclusivity prevents regulatory authorities in the EEA from referencing the innovator&#8217;s data to assess a generic application. During the additional two-year period of market exclusivity, a generic marketing authorization can be submitted, and the innovator&#8217;s data may be referenced, but no generic product can be marketed until the expiration of the market exclusivity. However, there is no guarantee that a product will be considered by the EEA regulatory agencies to be a new chemical entity, and products may not qualify for data exclusivity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pharmaceutical coverage, pricing and reimbursement</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant uncertainty exists as to the coverage and reimbursement status of any product and any product candidates for which we obtain regulatory approval. In the United States and other markets, sales of any product, and any product candidates for which we receive regulatory approval for commercial sale, will depend in part on the availability of coverage and adequate reimbursement from third party payors. Third party payors include government health administrative authorities, managed care providers, private health insurers and other organizations. The process for determining whether a payor will provide coverage for a drug product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the drug product. Third party payors may limit coverage to specific drug products on an approved list, or formulary, which might not include all of the FDA-approved drug products for a particular indication.</span></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third party payors are increasingly challenging the price and examining the medical necessity and cost-effectiveness of medical products and services, in addition to their safety and efficacy. A payor may not consider a product to be medically necessary or cost-effective. Moreover, a payor&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved, or that other payors will similarly provide similar coverage for the product. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS administers the Medicaid drug rebate program, in which pharmaceutical manufacturers pay quarterly rebates to each state Medicaid agency. Generally, for branded prescription drugs marketed under NDAs, manufacturers are required to rebate the greater of 23.1% of the average manufacturer price or the difference between such price and the best price during a specified period. An additional rebate for products marketed under NDAs is payable if the average manufacturer price increases at a rate higher than inflation, and other methodologies apply to new formulations of existing drugs. In addition, the Affordable Care Act (the "ACA") revised certain definitions used for purposes of calculating the rebates, including the definition of &#8220;average manufacturer price.&#8221; Various state Medicaid programs have implemented voluntary supplemental drug rebate programs that may provide states with additional manufacturer rebates in exchange for preferred status on a state&#8217;s formulary or for patient populations that are not included in the traditional Medicaid drug benefit coverage.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union, pricing and reimbursement schemes vary widely from country to country. Some countries provide that drug products may be marketed only after a reimbursement price has been agreed. Some countries may require the completion of additional studies or trials that compare the cost-effectiveness of a particular drug candidate to currently available therapies. For example, the European Union provides options for its member states to restrict the range of drug products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. European Union member states may approve a specific price for a drug product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the drug product on the market. Other member states allow companies to fix their own prices for drug products, but monitor and control company profits. The downward pressure on health care costs in general, and particularly on prescription drugs, has become intense. As a result, increasingly high barriers are being erected to the entry of new products. In addition, in some countries, cross-border imports from low-priced markets exert competitive pressure that may reduce pricing within a country. Any country that has price controls or reimbursement limitations for drug products may not allow favorable reimbursement and pricing arrangements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Healthcare laws and regulations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2010, the then President of the United States signed one of the most significant healthcare reform measures in decades. The ACA substantially changed the way healthcare is financed by both governmental and private insurers, and significantly impacted the pharmaceutical industry. This comprehensive legislative overhaul was expected to extend coverage to approximately 36 million previously uninsured Americans. The ACA's individual mandate was repealed by Congress in The Tax Cuts and Jobs Act of 2017, or the Tax Act, tax reform bill that was signed into law in December 2017 and became effective January 1, 2019. On December 14, 2018, a U.S. District Court Judge in the Northern District of Texas ruled that the individual mandate is a critical and inseverable feature of the ACA, and because it was repealed as part of the Tax Act, the remaining provisions of the ACA are invalid as well. In December 2019, the U.S. Court of Appeals for the Fifth Circuit upheld the lower court decision, which was then appealed to the U.S. Supreme Court. On June 17, 2021, the U.S. Supreme Court held that state and individual plaintiffs did not have standing to challenge the individual mandate provision of the ACA; in so holding, the Supreme Court did not consider larger constitutional questions about the validity of this provision or the validity of the ACA in its entirety. It is unclear how this decision, subsequent appeals, if any, and other efforts to modify, repeal and replace the ACA will impact the ACA.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA requires the pharmaceutical industry to share in the costs of reform by increasing Medicaid rebates and expanding Medicaid rebates to cover Medicaid managed care programs, among other things. The ACA also includes funding of pharmaceutical costs for Medicare patients in excess of the prescription drug coverage limit and below the catastrophic coverage threshold. The Bipartisan Budget Act of 2018, or the BBA, among other things, amends the ACA, effective January 1, 2019, to close this gap, also known as the &#8220;donut hole&#8221;. Additionally, an excise tax was levied against certain branded </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pharmaceutical products. The Administration is expected to evaluate drug pricing and the Medicare parts B and D programs in terms of legislative or policy changes in the current session of Congress.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers, physicians and third party payors play a primary role in the recommendation and prescription of drug products that are granted marketing approval. Arrangements with healthcare providers, third party payors and other customers are subject to broadly applicable fraud and abuse and other healthcare laws and regulations. Such restrictions under applicable federal and state healthcare laws and regulations include the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal healthcare Anti-Kickback Statute prohibits, among other things, persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare or Medicaid. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value, including cash, improper discounts, and free or reduced price items and services. The intent standard under the federal Anti-Kickback Statute was amended by ACA to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Moreover, under the ACA, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil FCA. Additionally, many states have similar laws that apply to their state health care programs as well as private payors. Violations of the federal or state anti-kickback laws can result in exclusion from federal and state health care programs and substantial civil and criminal penalties. The previous U.S. presidential administration issued final rules in late 2020 that, among other things, made changes to certain Anti-Kickback safe harbors; however, implementation of these rules has been and may continue to be affected by a regulatory freeze announced by the current administration in January 2021 and litigation challenging these rules;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal civil and criminal false claims laws and civil monetary penalties laws, including the federal FCA, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, false, fictitious or fraudulent claims for payment from Medicare, Medicaid or other federal healthcare programs, and knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to avoid, decrease or conceal an obligation to pay money to the federal government. Even where pharmaceutical companies do not submit claims directly to payors, they can be held liable under these laws if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims by, for example, providing inaccurate billing or coding information to customers, promoting a product off-label, marketing products of sub-standard quality, or paying a kickback that results in a claim for items or services. In addition, activities relating to the reporting of wholesaler or estimated retail prices for pharmaceutical products, the reporting of prices used to calculate Medicaid rebate information and other information affecting federal, state and third-party reimbursement for such products, and the sale and marketing of such products, are subject to scrutiny under this law. Private individuals or whistleblowers can bring FCA &#8220;qui tam&#8221; actions on behalf of the government and may share in amounts recovered. Proof of intent to deceive is not required to establish liability under the civil False Claims Act;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, imposes criminal and civil liability for, among other things, executing or attempting to execute a scheme to defraud any healthcare benefit program, including any third party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statements or representations, or making false statements relating to healthcare benefits, items, or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations, which imposes privacy, security, transmission and breach reporting obligations, including mandatory contractual terms, with respect to individually identifiable health information including PHI, upon &#8220;covered entities&#8221; subject to the law, such as health plans, healthcare clearinghouses and certain healthcare providers, and their respective business associates that perform services on their behalf that involve individually identifiable health information, including PHI. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. Other federal and state laws, such as the Federal Trade Commission Act, also impose requirements with respect to individuals' personal information;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Physician Payments Sunshine Act requires certain manufacturers of prescription drugs, devices and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program to annually report to CMS information related to payments and other transfers of value to physicians, dentists, optometrists, podiatrists, chiropractors and teaching hospitals, and ownership and investment interests held by physicians and their immediate family members. In addition, Section 6004 of the ACA requires annual reporting of information about drug samples that manufacturers and authorized distributors provide to physicians; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may apply more broadly than their U.S. federal analogues, such as to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third party payors, including private insurers; state laws that require drug companies to comply with the industry&#8217;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state and local laws that require the licensure of sales representatives; state laws that require drug manufacturers to report information related to drug pricing or payments and other transfers of value to healthcare providers or marketing expenditures and pricing information; data privacy and security laws and regulations in foreign jurisdictions that may be more stringent than those in the United States (such as the European Union, which adopted the General Data Protection Regulation, or GDPR, which became effective in May 2018); state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts; and state laws related to insurance fraud in the case of claims involving private insurers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any of the healthcare laws or regulations described above or any other healthcare regulations that apply to us, we may be subject to penalties, including administrative, civil and criminal penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs, such as Medicare and Medicaid, imprisonment, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or consent decree, reputational harm, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and pursue our strategy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental, Health and Safety Matters</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to extensive environmental, health and safety laws and regulations in a number of jurisdictions, primarily Israel, governing, among other things, (i) the use, storage, registration, handling, emission and disposal of chemicals, waste materials and sewage; and (ii) chemical, air, water and ground contamination, air emissions and the cleanup of contaminated sites, including any contamination that results from spills due to our failure to properly dispose of chemicals, waste materials and sewage. Our operations at our research and development facility in Israel use chemicals and produce waste materials and sewage. Our activities require permits from various governmental authorities including, local municipal authorities, the Ministry of Environmental Protection and the Ministry of Health. The Ministry of Environmental Protection and the Ministry of Health, local authorities and the municipal water and sewage company conduct periodic inspections in order to review and ensure our compliance with the various regulations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws, regulations and permits could potentially require the expenditure by us of significant amounts for compliance or remediation. If we fail to comply with such laws, regulations or permits, we may be subject to fines and other civil, administrative or criminal sanctions, including the revocation of permits and licenses necessary to continue our business activities. In addition, we may be required to pay damages or civil judgments in respect of third party claims, including those relating to personal injury (including exposure to hazardous substances we use, store, handle, transport, manufacture or dispose of), property damage or contribution claims. Some environmental, health and safety laws allow for strict, joint and several liability for remediation costs, regardless of comparative fault. We may be identified as a responsible party under such laws. Such developments could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, laws and regulations relating to environmental, health and safety matters are often subject to change. In the event of any changes or new laws or regulations, we could be subject to new compliance measures or to penalties for activities which were previously permitted. For instance, Israeli regulations were promulgated in 2011 relating to the discharge of industrial sewage into the sewer system. These regulations establish new and potentially significant fees for discharging forbidden or irregular sewage into the sewage system.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operations of our subcontractors and suppliers are also subject to various Israeli and foreign laws and regulations relating to environmental, health and safety matters, and their failure to comply with such laws and regulations could have a material adverse effect on our business and reputation, result in an interruption or delay in the development or manufacture of our product candidates, or increase the costs for the development or manufacture of our product candidates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had a total of 28 employees comprising  14 females and 14 males, all of whom are full-time employees. As of such date, 14 employees were primarily engaged in research and development activities. We believe our internal R&amp;D capabilities coupled with our third-party R&amp;D consultants are well positioned to execute our pipeline strategy in a cost effective manner. None of our employees are represented by a labor union, and we consider our employee relations to be good. We value the importance of retention, growth and development of our employees and we believe we offer competitive compensation (including salary, incentive bonus, and equity) and benefits packages. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to foster a corporate culture built on communication and transparency. We hold annual company-wide trainings and hold regular company-wide meetings where management communicates notable corporate developments to Company employees. We are also focused on understanding our diversity and inclusion strengths and opportunities and executing on a strategy to support further progress. We will continue to promote a work environment that is based on the fundamental principles of human dignity, equality and mutual respect. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial and Segment Information</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate our business as a single segment, as defined by generally accepted accounting principles. Our financial information is included in the consolidated financial statements and the related notes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated in October 2011 as a Delaware corporation under the name Tigercat Pharma, Inc. We changed our name to VYNE Therapeutics Inc. in September 2020, following the merger (the "Merger") between Foamix Pharmaceuticals Ltd. ("Foamix") and Menlo Therapeutics Inc. ("Menlo") in March 2020.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act of 1933, as amended (the "Securities Act") and as modified by the JOBS Act and a &#8220;smaller reporting company,&#8221; as defined in Rule 12b-2 of the Exchange Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements, such as the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, and certain reduced or scaled disclosure requirements available to smaller reporting companies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 520 U.S. Highway 22, Suite 204, Bridgewater, NJ 08807. Our website is www.vynetherapeutics.com.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may use our website to comply with disclosure obligations under Regulation FD. Therefore, investors should monitor our website in addition to following its press releases, filings with the SEC, public conference calls, and webcasts.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_28"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A-RISK FACTORS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conducting our business, we face many risks that may interfere with our business objectives. Some of these risks could materially and adversely affect our business, financial condition and results of operations. In particular, we are subject to various risks resulting from changing economic, political, industry, business and financial conditions. The risks and uncertainties described below are not the only ones we face.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the following factors and other information in this annual report. If any of the negative events referred to below occur, our business, financial condition and results of operations could suffer. In any such case, the trading price of our common stock could decline.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Development of Our Product Candidates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is dependent on the successful development of FMX114 and our BET inhibitor product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we divested our commercial business in order to focus our efforts and resources on drug development. Our development pipeline currently includes our Phase 2a asset FMX114 for the treatment of mild-to-moderate AD and preclinical candidates VYN201 and VYN202 which we are developing to treat immuno-inflammatory diseases. The success of our business is dependent on our successful development and/or our ability to pursue strategic initiatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize, these product candidates. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to successfully progress these candidates may be hampered for many reasons, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a product candidate may in a clinical trial be shown to have harmful side effects or other characteristics that indicate it is unlikely to be effective or otherwise does not meet applicable regulatory criteria;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitors may develop alternatives that render our product candidates obsolete or less attractive;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product candidates we develop may nevertheless be covered by third parties&#8217; patents or other proprietary rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a product candidate may not be capable of being produced in commercial quantities at an acceptable cost, or at all;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a product candidate may not be accepted as safe and effective by patients, the medical community or third party payors, if applicable;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">creation of intellectual property rights, such as patents, which are necessary to protect our interests in a product candidate, can be challenging in relation to pharmaceutical formulations and their uses with known active pharmaceutical ingredients and generally used combinations of inactive ingredients approved by the FDA;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intellectual property rights, such as patents, which are necessary to protect our interests in a product candidate, may be difficult to obtain or unobtainable or if obtained may be difficult to enforce or unenforceable;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intellectual property rights, such as patents, may fail to provide adequate protection, may be challenged and one or more claims may be revoked or the patent may be held to be invalid; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intellectual property rights of third parties may potentially block our entry into certain markets, or make such entry economically impracticable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, VYN201 and VYN202 are very early stage programs. VYN201 is being evaluated in preclinical animal models and has not yet been administered to humans and VYN202 is still in lead candidate selection. The development of these NCEs carries even greater risk and a higher probability of failure. Our failure to successfully develop our drug candidates will have a material adverse effect on our business and financial condition. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may encounter delays in completing clinical trials for our product candidates and may even be prevented from commencing such trials due to factors that are largely beyond our control.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in the past experienced and may in the future experience delays in completing clinical trials and in commencing future clinical trials, including due to reasons associated with COVID-19. For example, we have experienced delays in enrolling patients in our Phase 2a clinical trial evaluating FMX114 for the treatment of AD due to COVID-19 related issues. We rely on CROs and clinical trial sites to ensure the proper and timely conduct of our clinical trials. While we have agreements governing the committed activities of our CROs, we have limited influence over their actual performance. A failure of one or more of our clinical trials can occur at any time during the clinical trial process. Clinical trials can be delayed or aborted for a variety of other reasons, including delay or failure to:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain regulatory approval to commence a trial;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reach agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which may be subject to extensive negotiation and vary significantly among different CROs and trial sites;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain IRB approval at each site;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enlist suitable patients to participate in a trial;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">have patients complete a trial or return for post-treatment follow-up;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ensure clinical sites observe trial protocol or continue to participate in a trial;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">address any patient safety concerns that arise during the course of a trial;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">address any conflicts with new or existing laws or regulations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">add a sufficient number of clinical trial sites; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacture sufficient quantities of the product candidate for use in clinical trials.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient enrollment is also a significant factor in the timing of clinical trials and is affected by many factors, including the size and nature of the patient population, the proximity of patients to clinical sites, the eligibility criteria for the trial, the design of the clinical trial, competing clinical trials and clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the drug being studied in relation to available alternatives, including any new drugs or treatments that may be approved for the indications we are investigating.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also encounter delays if a clinical trial is suspended or terminated by us, by the IRBs of the institutions in which such trials are being conducted, by the trial&#8217;s data safety monitoring board, or by the FDA. Such authorities may suspend or terminate one or more of our clinical trials due to a number of factors, including our failure to conduct the clinical trial in accordance with relevant regulatory requirements or clinical protocols, inspection of the clinical trial operations or trial site by the FDA resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we experience delays in carrying out or completing any clinical trial of our product candidates, the commercial prospects of our product candidates may be harmed, and our ability to generate product revenues from any of these product candidates will be delayed. In addition, any delays in completing our clinical trials will increase our costs, slow down our product candidate development and approval process and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences may significantly harm our business and financial condition. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical drug development is very expensive, time-consuming and uncertain. Our clinical trials may fail to adequately demonstrate the safety and efficacy of our current or any future product candidates, which could prevent or delay regulatory approval and commercialization.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical drug development is very expensive, time-consuming and difficult to design and implement, and its outcome is inherently uncertain, particularly as it relates to NCEs. Before obtaining regulatory approval for the commercial sale of a product candidate, we must demonstrate through clinical trials that a product candidate is both safe and effective for use in the target indication. Most product candidates that commence clinical trials are never approved by regulatory authorities for commercialization. The clinical trials for these product candidates may take significantly longer than expected to complete. In addition, we, any partner with which we may in the future collaborate, the FDA, an institutional review board (&#8220;IRB&#8221;) or other regulatory authorities, including state and local agencies and counterpart agencies in foreign countries, may suspend, delay, require modifications to or terminate our clinical trials at any time, for various reasons, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of effectiveness of any product candidate during clinical trials or the failure of a product candidate to meet specified endpoints;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">discovery of serious or unexpected side effects experienced by study participants, toxicities or other safety issues;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">slower than expected rates of subject recruitment and patient enrollment in clinical trials resulting from numerous factors, including COVID-19 or the prevalence of clinical trials for our competitors for their product candidates treating the same indication;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in retaining subjects who have initiated participation in a clinical trial but may withdraw at any time due to adverse side effects from the therapy, insufficient efficacy, fatigue with the clinical trial process or for any other reason;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in obtaining IRB approval for studies to be conducted at each site;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in manufacturing or obtaining, or inability to manufacture or obtain, sufficient quantities of materials for use in clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inadequacy of or changes in our manufacturing process or the product formulation or method of delivery;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in applicable laws, regulations and regulatory policies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or failure in reaching agreement on acceptable terms in clinical trial contracts or protocols with prospective contract research organizations (&#8220;CROs&#8221;), clinical trial sites and other third-party contractors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inability to add a sufficient number of clinical trial sites;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainty regarding proper dosing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of our CROs or other third-party contractors to comply with contractual and regulatory requirements or to perform their services in a timely or acceptable manner;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure by us, our employees, our CROs or their employees or any partner with which we may collaborate or their employees to comply with applicable FDA or other regulatory requirements relating to the conduct of clinical trials or the handling, storage, security and recordkeeping for drug and biologic products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">scheduling conflicts with participating clinicians and clinical institutions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to design appropriate clinical trial protocols;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inability or unwillingness of medical investigators to follow our clinical protocols;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in maintaining contact with subjects during or after treatment, which may result in incomplete data; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">insufficient data to support regulatory approval.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we experience delays in the completion of, or if we terminate, any of our future clinical trials, our business, financial condition, operating results and prospects would be adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New chemical entities may require more time and resources for development, testing and regulatory approval.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our BET inhibitor program is in the early stages of development, involves a novel therapeutic approach and new chemical entities, requires significant further research and development and regulatory approvals and is subject to the risks of failure inherent in the development of products based on innovative approaches. New chemical entities derived from our InhiBET platform are molecules that have not previously been approved and marketed as therapeutics, unlike FMX114 which includes active pharmaceutical ingredients whose safety and efficacy have previously been established which we aim to improve through a new formulation. As a result, the product candidates from our InhiBET platform may face greater risk of unanticipated safety issues or other side-effects, or may not demonstrate efficacy. Further, the regulatory pathway for our new chemical entities may be more demanding than that for FMX114, for which we may be able to leverage existing data under Section 505(b)(2) of the Food, Drug, and Cosmetic Act to reduce development risk, time and cost. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to develop a lead molecule for the VYN202 program and exercise our option to license the applicable BET inhibitor compounds from In4Derm.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in "Item 1. Business&#8212;Development and License Agreements&#8212;In4Derm Licensing Agreements," under the terms of the Option Agreement, our option to exercise our rights with respect to In4Derm's highly selective BET inhibitor compounds expires upon the earlier of (i) 14 days following the delivery of an agreed data package and selection of a lead NCE candidate and (ii) June 30, 2022. We are currently working with In4Derm to develop a lead molecule for the VYN202 program. However, we may be unable to develop a viable lead molecule in a timely manner or at all. If we are unable to develop a lead candidate for the VYN202 program, we may not exercise our option with respect to In4Derm's BET inhibitor compounds suitable for oral administration which could cause us to terminate the program and would have a material adverse effect on our ability to execute our strategy of enhancing our pipeline.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our clinical trials may fail to demonstrate the safety and efficacy of our drug candidates, or serious adverse or unacceptable side effects may be identified during the development of our drug candidates, which could result in the abandonment or limitation of the development of our drug candidates or prevent or delay our ability to pursue strategic alternatives for our drug candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our drug candidates are associated with side effects in preclinical studies and/or clinical trials or have characteristics that are unexpected, our development costs could increase or we may need to abandon development activities or limit development to more narrow uses in which the side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. The FDA or an IRB may also require that we suspend, discontinue, or limit our clinical trials based on safety information. Such findings could result in regulatory authorities failing to provide marketing authorization for our drug candidates. Many drug candidates that initially showed promise in early stage testing have later been found to cause side effects that prevented further development of the drug candidate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before any potential third-party partners can obtain marketing approvals for the commercial sale of our drug candidates, we must demonstrate through lengthy, complex and expensive preclinical testing and clinical trials that our drug candidates are both safe and effective for use in each target indication, and failures can occur at any stage of testing. Additionally, if we or others identify undesirable side effects caused by our drugs, a number of potentially significant negative consequences could result, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may need to abandon the development or limit the further development of our drug candidates, including in various populations and for certain indications;  </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could be sued and held liable for harm caused to patients;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reputation may suffer; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may withdraw approval to market such product;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may require additional warnings on the product labeling;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a medication guide outlining the risks of such side effects for distribution to patients may be required; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to pursue strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize our drug candidates would be harmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these events could prevent us from pursuing strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize the particular drug candidate and could significantly harm our business, results of operations and prospects.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Results obtained in non-clinical studies and completed clinical trials may not predict success in later clinical trials.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Success in non-clinical testing, such as testing for VYN201 and FMX114, and early clinical trials does not ensure that later clinical trials will be successful, and any other clinical trials that we may conduct may not demonstrate consistent or adequate efficacy and safety to obtain regulatory approval to market our product candidates in any indication. We and other companies in the biopharmaceutical industry have frequently suffered significant setbacks in later clinical trials, even after achieving promising results in earlier non-clinical studies or clinical trials. Phase III clinical trials often produce unsatisfactory results even though prior clinical trials were successful. Any of these events could prevent us from pursuing strategic alternatives, including identifying and consummating transactions with third-party partners, to further develop, obtain marketing approval for and/or commercialize a particular drug candidate and could significantly harm our business, results of operations and prospects.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Topline and preliminary data from our clinical trials that we announce or publish from time to time may change as additional data become available and are subject to audit and verification procedures that could result in material changes in the final data. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may publicly disclose topline or preliminary data from our clinical trials which are based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a complete analysis of all data related to the trial. We also make certain assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline or preliminary results that we report may differ from future results of the same trials, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. Accordingly, topline and preliminary data should not be considered complete and should be viewed with caution until the final data are available. We may also disclose interim data from our clinical trials. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as subject enrollment continues and more subject data become available. Adverse differences between interim, topline or preliminary data and final data could significantly harm our reputation and business prospects. Further, disclosure of interim, topline or preliminary data by us or by our competitors could result in volatility in the price of our common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the potential of the particular program, the likelihood of marketing approval or commercialization of the particular drug candidate, any approved product, and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is derived from information that is typically extensive, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure, and any information we determine not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding a particular program, drug candidate or our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the interim, topline or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to pursue strategic alternatives, including identifying and consummating transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our drug candidates may be harmed, which could harm our business, operating results, prospects or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a limited history as a clinical-stage biopharmaceutical company developing drug candidates for immuno-inflammatory conditions, which may make it difficult to assess our future viability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Company's announcement on August 12, 2021, our operations over the last several years has been largely focused on raising capital, undertaking preclinical studies and conducting clinical trials, and commercializing minocycline-based products for dermatology. Since announcing that we would be divesting our commercial business, we have been conducting preclinical studies evaluating VYN201 in a range of immuno-inflammatory conditions and considering initial indications for the program. Our team has limited experience in developing drugs for the treatment of immuno-inflammatory conditions. Consequently, any predictions you make about our future success or viability may not be as accurate as they could be if we had a longer history of being a clinical-stage biopharmaceutical company focused on developing drugs in this area. We may also encounter unforeseen expenses, difficulties, complications, delays and other known or unknown factors in achieving our business objectives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may spend our limited resources to pursue a particular drug candidate or indication and fail to capitalize on drug candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this report, we have not determined which indication(s) to pursue for VYN201 or VYN202. Following the completion of our preclinical analyses, we intend to select the initial indication(s) for these programs. Because we have limited financial and management resources, we may be required to focus on specific indications.  As a result, we may forego or delay pursuit of opportunities with other drug candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial drugs or profitable market opportunities. Our spending on current and future development programs and drug candidates for specific indications may not yield any commercially viable drugs. If we do not accurately evaluate the commercial potential or target market for a particular drug candidate, we may relinquish valuable rights to that drug candidate through partnerships, licensing or other arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such drug candidate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have not obtained regulatory approvals to market our other pipeline product candidates, and we may be delayed in obtaining or fail to obtain such regulatory approvals and to commercialize these product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of developing, obtaining regulatory approval for and commercializing our other product candidates is long, complex, costly and uncertain, and delays or failure can occur at any stage. Furthermore, the research, testing, manufacturing, labeling, marketing, sale and distribution of drugs are subject to extensive and rigorous regulation by the FDA. We are not permitted to market any of our product candidates in the United States until we receive approval of the applicable NDA from the FDA. To gain approval of an NDA or other equivalent regulatory approval, we must provide the FDA with clinical data and other information that demonstrates the continued safety and efficacy of the product for the intended indication.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we believe our clinical trials were successful, the FDA may require that we conduct additional clinical, nonclinical, manufacturing, validation or drug product quality studies and submit that data before considering or reconsidering any NDA we may submit. Depending on the extent of these additional studies, approval of any applications that we submit may be significantly delayed or may require us to expend more resources than we have available. It is also possible that additional studies we conduct may not be considered sufficient by the FDA to provide regulatory approval.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of these outcomes occur, we would not receive approval for our other product candidates and may need to discontinue the development of such product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business has been adversely impacted and could continue to be adversely affected by the evolving and ongoing COVID-19 global pandemic in regions where we or third parties on which we rely have manufacturing facilities, clinical trial sites or other business operations. The COVID-19 pandemic could adversely affect our operations, including at our  clinical trial sites, as well as the business or operations of our manufacturers, contract research organizations or other third parties with whom we conduct business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business has been adversely affected by the effects of the COVID-19 pandemic, which has resulted in a variety of restrictions in order to reduce the spread of the disease, which, among other things, direct businesses and governmental agencies to cease non-essential operations at physical locations, prohibit certain non-essential gatherings, and order cessation of non-essential travel. For example, enrollment and other operations related to our ongoing Phase 1b/2a clinical trial for FMX114 in Australia have been impacted by the COVID-19 pandemic and restrictions imposed by Australian authorities. In addition, some of our third-party preclinical science partners and manufacturers which we use for the supply of materials for our drug candidates or other materials necessary to manufacture drug product to conduct preclinical studies and clinical trials are located in countries affected by COVID-19, and should they experience disruptions, such as temporary closures or suspension of services, we would likely experience delays in advancing these studies and trials. Any delay in the development of our product candidates could have a material adverse effect on our business and results of operations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if our product candidates receive marketing approval, we may continue to face future developmental and regulatory difficulties. In addition, we are subject to government regulations and we may experience delays in obtaining required regulatory approvals to market our proposed product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we receive approval of any regulatory filing for our product candidates, the FDA may grant approval contingent on the performance of additional costly post-approval clinical trials or REMS to monitor the safety or efficacy of the product, which could negatively impact us by reducing revenues or increasing expenses, and cause the product not to be commercially viable. Absence of long-term safety data may further limit the approved uses of  products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may also approve our product candidates for a more limited indication or a narrower patient population than we originally requested, or may not approve the labeling that we believe is necessary or desirable for the successful commercialization of our product candidates. Furthermore, any such approved product will remain subject to extensive </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory requirements, including requirements relating to manufacturing, labeling, packaging, adverse event reporting, storage, advertising, promotion, distribution and recordkeeping.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with the regulatory requirements of the FDA, or if we discover previously unknown problems with any approved commercial products, manufacturers or manufacturing processes, we could be subject to administrative or judicially imposed sanctions or other setbacks, which could require us to take corrective actions, including to:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or impose restrictions on operations, including costly new manufacturing requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refuse to approve pending applications or supplements to applications;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend any ongoing clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or withdraw marketing approval;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek an injunction or impose civil or criminal penalties or monetary fines;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seize or detain products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ban or restrict imports and exports;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue warning letters or untitled letters;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or impose restrictions on operations, including costly new manufacturing requirements; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refuse to approve pending applications or supplements to applications.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, various aspects of our operations are subject to federal, state or local laws, rules and regulations, any of which may change from time to time. Costs arising out of any regulatory developments could be time-consuming and expensive and could divert management resources and attention and, consequently, could adversely affect our business operations and financial performance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to rely on third parties to conduct, supervise and monitor our clinical studies, and if these third parties perform in an unsatisfactory manner, it may harm our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on medical institutions, clinical investigators, contract laboratories, collaborative partners and other third parties, such as CROs, to assist us in conducting our clinical trials for our other product candidates. While we will have agreements governing their activities, we will have limited influence over their actual performance. We will control only certain aspects of our CROs&#8217; activities. Nevertheless, we will be responsible for ensuring that each of our clinical studies is conducted in accordance with the applicable protocol, legal, regulatory and scientific standards, and our reliance on the CROs does not relieve us of our regulatory responsibilities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our CROs are required to comply with the FDA&#8217;s and other regulatory authorities&#8217; good clinical practices, or GCPs, for conducting, recording and reporting the results of clinical studies to assure that the data and reported results are credible and accurate, and that the rights, integrity and confidentiality of clinical study participants are protected. If we or our CROs fail to comply with applicable GCPs, the clinical data generated in our future clinical studies may be deemed unreliable and the FDA and other regulatory authorities may require us to perform additional clinical studies before approving any marketing applications.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the third parties or consultants that assist us in conducting our clinical trials do not perform their contractual duties or obligations, experience work stoppages, do not meet expected deadlines, terminate their agreements with us or need to be replaced, or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical trial protocols or GCPs, or for any other reason, we may need to conduct additional clinical trials or enter into new arrangements with alternative third parties, which could be difficult, costly or impossible, and our clinical trials may be extended, delayed or terminated or may need to be repeated. If any of the foregoing were to occur, we may not be able to obtain, or may be delayed in obtaining, regulatory approval for the product candidates being tested in such trials, and will not be able to, or may be delayed in our efforts to, successfully commercialize these product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in methods of drug candidate manufacturing or formulation may result in additional costs or delay.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As drug candidates are developed through preclinical studies to late-stage clinical trials towards approval and commercialization, it is common that various aspects of the development program, such as manufacturing methods and formulation, are altered in an effort to optimize processes and results. Such modifications carry the risk that they will not achieve these intended objectives, and may also require additional testing, FDA notification or FDA approval.  Any of these changes could cause our drug candidates to perform differently and affect the results of planned clinical trials or other future clinical trials conducted with the altered materials.  This could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our drug </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">candidates and jeopardize our ability to pursue strategic alternatives, including identifying and consummating transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our drug candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Risks Related to Our Business and Financial Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will need substantial additional funding to fund our operations, and there is substantial doubt about our ability to continue as a going concern. We could also be forced to delay, reduce or terminate our research and development activities which would have a material adverse effect on our financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developing and commercializing biopharmaceutical products, including launching new products into the marketplace and conducting preclinical studies and clinical trials, is an expensive and highly uncertain process that takes years to complete. As of December 31, 2021, we had approximately $42.9 million in cash, cash equivalents and restricted cash.  We received  proceeds of  $20.0&#160;million  less total transaction costs ranging from $4.0&#160;million to $5.0&#160;million from the sale of our commercial business in January 2022 and  are entitled to receive an additional $5.0&#160;million deferred payment in January 2023. We do not have sufficient cash and cash equivalents to fund our anticipated level of operations as they become due during the twelve months following the date of filing of this report. The aforementioned factors raise substantial doubt about our ability to continue as a going concern, as reflected in the audit report included with the audited financial statements included elsewhere in this report. In addition, see &#8220;Part II. Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity&#8221; for further discussion regarding our liquidity. We may not be able to raise any proceeds from financing transactions. Accordingly, additional funds may not be obtained for our ongoing operations and we may not succeed in our future operations. Unless we are able to raise additional capital to finance our operations, our long-term business plan may not be accomplished, and we may be forced to cease, reduce, or delay operations. Furthermore, if the Company issues equity or debt securities to raise additional funds, its existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences and privileges senior to those of its existing stockholders. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements depend on many factors, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number and development requirements of the drug candidates that we may pursue;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, progress, results and costs of preclinical development, laboratory testing and conducting preclinical and clinical trials for our drug candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs, timing and outcome of regulatory review of our drug candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we in-license or acquire additional drug candidates and technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact on the timing of our preclinical studies, on the recruitment, enrollment, conduct and timing of our clinical trials, and on our business, due to the COVID-19 pandemic; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to identify and consummate transactions with third-party partners to further develop, obtain marketing approval for and/or commercialize our drug candidates, and earn revenue from such arrangements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additional capital may not be available when we need it, on terms that are acceptable to us or at all. If adequate funds are not available to us on a timely basis, we may be required to revise our operating plan in order to:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delay, limit, reduce or terminate our research and development activities; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delay, limit, reduce or terminate preclinical studies, clinical trials or other development activities for our product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise additional capital through marketing and distribution arrangements or other collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish certain valuable rights to our product candidates, technologies, future revenue streams or research programs or grant licenses on terms that may not be favorable to us. If we raise additional capital through public or private equity offerings, the ownership interest of our existing shareholders will be diluted and the terms of any new equity securities may have a preference over our common stock. If we raise additional capital through debt financing, we may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt or making capital expenditures or specified financial ratios, any of which could restrict our ability to commercialize our product candidates or operate as a business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">SEC regulations limit the amount of funds we can raise during any 12-month period pursuant to our shelf registration statement on Form S-3.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SEC regulations limit the amount that companies with a public float of less than $75 million may raise during any 12-month period pursuant to a shelf registration statement on Form S-3, referred to as the baby shelf rules. As of the filing of this Annual Report on Form 10-K, we are subject to such rules. Under these instructions, the amount of funds we can raise through primary public offerings of securities in any 12-month period using our registration statement on Form S-3 is limited to one-third of the aggregate market value of the shares of our common stock held by non-affiliates of the Company. Therefore, we will be limited in the amount of proceeds we are able to raise by selling shares of our common stock using our Form S-3 until such time as our public float exceeds $75 million. Furthermore, if we are required to file a new registration statement on another form, we may incur additional costs and be subject to delays due to review by the SEC staff.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on March 15, 2022, we entered into a purchase agreement (the "Equity Purchase Agreement") with Lincoln Park Capital Fund, LLC ("Lincoln Park") which provides that, upon the terms and subject to the conditions and limitations set forth therein, we have the right, but not the obligation, to sell to Lincoln Park up to $30.0 million of shares of our common stock over the 36-month term of the Equity Purchase Agreement. Upon execution of the Equity Purchase Agreement, we issued 1,667,593 shares of our common stock to Lincoln Park as commitment shares in accordance with the closing conditions contained within the Equity Purchase Agreement. While our ability to sell shares to Lincoln Park in this transaction will not be limited by the baby shelf rules since the Equity Purchase Agreement was executed prior to the filing of this Annual Report on Form 10-K, we may be limited in the amount of shares we can sell pursuant to the terms of the Equity Purchase Agreement. For example, we are prohibited from directing Lincoln Park to purchase shares under the Equity Purchase Agreement if such purchase would result in Lincoln Park beneficially owning more than 9.99% of our total outstanding shares. In addition, under applicable rules of Nasdaq, in no event may we issue or sell to Lincoln Park under the Equity Purchase Agreement shares of our common stock, including the commitment shares, in excess of 11,227,637 shares (the "Exchange Cap"), which is equal to 19.99% of the shares of our common stock outstanding immediately prior to the execution of the Equity Purchase Agreement unless (i) we obtain stockholder approval to issue shares of our common stock in excess of the Exchange Cap or (ii) the average price of all applicable sales of our common stock to Lincoln Park under the Equity Purchase Agreement equals or exceeds $0.545 per share. If any of the foregoing occur, we will be limited in the amount of proceeds we will be able to raise under the Equity Purchase Agreement which could have a material adverse effect on our financial condition and liquidity. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are subject to various risks and uncertainties arising out of the completed divestiture of our commercial business, any of which could materially and adversely affect our business and operations, and our stock price.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We completed the sale of our commercial business on January 12, 2022. Pursuant to the terms of the Asset Purchase Agreement, we are eligible to receive sales milestone payments of up to $450.0 million in the aggregate upon the achievement of specified levels of net sales on a product-by-product basis, beginning with annual net sales exceeding $100.0 million. In addition, we are entitled to receive certain payments from any licensing or sublicensing of the assets by Journey outside of the United States. Per the terms of the agreement, Journey does not have any diligence obligations to achieve any such net sales milestones and no assurance can be given that such milestones will be met. Furthermore, Journey may decide not to license or sublicense the assets in any territory outside of the United States and therefore we may not receive any additional related payments. If any of the foregoing events occur, we will not realize all of the benefits of the sale.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, we are still subject to potential liabilities relating to our historical commercial business operations that were subject to the Asset Purchase Agreement. Under the terms of the agreement, we retained and are responsible for historical liabilities of the commercial business operations based on events occurring prior to the sale other than those liabilities expressly assumed by Journey. We are also obligated to indemnify Journey against certain potential liabilities and for breaches of representations, warranties and covenants under the agreement up to certain caps, and those liabilities may be set off against any future payments owed to us by Journey, including the deferred payment. In addition to direct expenditures for damages, settlement and defense costs, there is a possibility of adverse publicity as a result of such claims, any of which could have a material adverse effect on our business and stock price. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to successfully in-license, acquire, develop and market additional product candidates or approved products could impair our ability to grow our business and execute our strategy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to in-license, acquire, develop and market additional products and product candidates. The success of this strategy depends partly upon our ability to identify and select promising pharmaceutical product candidates and products, negotiate licensing or acquisition agreements with their current owners and finance these arrangements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of proposing, negotiating and implementing a license or acquisition of a product candidate or approved product is lengthy and complex. Other companies, including some with substantially greater financial, marketing, sales and other resources, may compete with us for the license or acquisition of product candidates and approved products. We have limited resources to identify and execute the acquisition or in-licensing of third-party products, businesses and technologies and integrate them into our current infrastructure. Moreover, we may devote resources to potential acquisitions or licensing </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opportunities that are never completed, or we may fail to realize the anticipated benefits of such efforts. Additionally, we may not be able to acquire the rights to additional product candidates on terms that we find acceptable, or at all.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, any product candidate that we acquire may require additional development efforts prior to commercial sale, including preclinical or clinical testing and approval by the FDA and applicable foreign regulatory authorities. All product candidates are prone to risks of failure typical of pharmaceutical product development, including the possibility that a product candidate will not be shown to be sufficiently safe and effective for approval by regulatory authorities. In addition, we cannot provide assurance that any approved products that we acquire will be manufactured or sold profitably or achieve market acceptance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We intend to engage in strategic transactions which could impact our liquidity, increase our expenses and present significant distractions to our management.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy is to in-license and acquire product candidates or engage in other strategic transactions. Additional potential transactions that we may consider include a variety of different business arrangements, including out-licensing, strategic partnerships, joint ventures, restructurings, divestitures, business combinations and investments. Any such transaction may require us to incur non-recurring or other charges, may increase our near- and long-term expenditures and may pose significant integration challenges or disrupt our management or business, which could adversely affect our operations and financial results. For example, these transactions entail numerous potential operational and financial risks, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incurrence of substantial debt or dilutive issuances of equity securities to pay for acquisitions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">exposure to unknown liabilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruption of our business and diversion of our management&#8217;s time and attention in order to develop acquired products, product candidates or technologies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial acquisition and integration costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">write-downs of assets or impairment charges;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased amortization expenses;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty and cost in combining the operations and personnel of any acquired businesses with our operations and personnel;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impairment of relationships with key suppliers, partners or customers of any acquired businesses due to changes in management and ownership; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inability to retain our key employees or those of any acquired businesses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, there can be no assurance that we will undertake or successfully complete any transactions of the nature described above, and any transaction that we do complete could harm our business, financial condition, operating results and prospects. We have no current plan, commitment or obligation to enter into any transaction described above.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may decide not to continue developing any of our product candidates at any time during development or of any of our products after approval, which would reduce or eliminate our potential return on investment for those product candidates or products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in the past decided and may again in the future decide to discontinue the development of any of our product candidates in our pipeline or not to continue to commercialize any approved product. We may discontinue development of other product candidates for a variety of reasons, such as the appearance of new technologies that make our product less commercially viable, resource allocation management, an increase in competition from generic or other competing products, changes in or failure to comply with applicable regulatory requirements, the discovery of unforeseen side effects during clinical development or after the approved product has been marketed or the occurrence of adverse events at a rate or severity level that is greater than experienced in prior clinical trials. If we discontinue a program in which we have invested significant resources, we will receive a limited return on our investment and we will have missed the opportunity to have allocated those resources to other product candidates in our pipeline that may have had potentially more productive uses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supply interruptions may disrupt the availability of our product candidates and cause delays in conducting preclinical or clinical activities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on a limited number of manufacturing facilities to manufacture our product candidates. Numerous factors could cause interruptions in the supply or manufacture of our product candidates, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">timing, scheduling and prioritization of production by our contract manufacturers or a breach of our agreements by our contract manufacturers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">labor interruptions;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our sources for manufacturing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and delivery of shipments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to locate and obtain replacement suppliers and manufacturers as needed on a timely basis; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conditions affecting the cost and availability of raw materials; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of COVID-19. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Production of product is necessary to perform preclinical activities and clinical trials and successful registration batches are necessary to file for approval to commercially market and sell product candidates. Delays in obtaining clinical material or registration batches could adversely impact our clinical trials and delay regulatory approval for our product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration arrangements that we may enter into in the future may not be successful, which could adversely affect our ability to develop and commercialize our product candidates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek collaboration arrangements with pharmaceutical or biotechnology companies for the development or eventual commercialization of our product candidates in the future. We may enter into arrangements on a selective basis, depending on the merits of retaining certain rights ourselves compared to entering into selective collaboration arrangements with pharmaceutical or biotechnology companies internationally and possibly also in the United States. Any such collaboration arrangements may not be successful.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the success of future collaboration arrangements that we may enter into will depend heavily on the efforts and activities of our collaborators. Collaborators generally have significant discretion in determining the efforts and resources that they will apply to these collaborations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When entering collaboration arrangements, we are subject to a number of risks, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical trial or abandon products, repeat or conduct new clinical trials, require a new formulation of products for clinical testing, may decide not to pursue development and commercialization of a product or product candidate or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in their strategic focus due to their acquisition of competitive products or their internal development of competitive products, availability of funding or other external factors, such as a business combination that diverts resources or creates competing priorities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any safety issues or adverse side effects that result from trials conducted by a collaborator will adversely impact our ability to obtain regulatory approval for our product candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any failure by a collaborator to demonstrate efficacy of a product candidate in its clinical trials could decrease the perceived likelihood of success for our clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disagreements between parties to a collaboration arrangement regarding clinical development matters may lead to delays in the development process or commercializing the applicable product candidate and, in some cases, termination of the collaboration arrangement;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaboration arrangements are complex and time consuming to negotiate, document and implement, and we may not be successful in our efforts to establish and implement collaborations or other alternative arrangements should we so chose to enter into such arrangements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborations with pharmaceutical or biotechnology companies and other third parties often are terminated or allowed to expire by the other party and any such termination or expiration would adversely affect us financially and could harm our business reputation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaboration agreements may be terminated and, if terminated, may result in delays or the need for a new collaborator or additional capital to pursue further development of our product candidates in certain markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">terms of any collaborations or other arrangements that we may establish may not be favorable to us;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could grant exclusive rights to our collaborators that would prevent us from collaborating with others;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we will face, to the extent that we decide to enter into collaboration agreements, significant competition in seeking appropriate collaborators;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may not properly use, manage, maintain or defend our confidential information and intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">collaborators may own or co-own intellectual property covering products that results from our collaborating with them, and in such cases, we would not have the exclusive right to develop such intellectual property and they may be able to develop such products without us;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes may arise with respect to the ownership of any intellectual property developed pursuant to our collaborations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse regulatory determinations or other legal action may interfere with the ability of a collaborator to conduct clinical trials or other development activity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">one or more collaborators may be subject to regulatory or legal action resulting from the failure to meet healthcare industry compliance requirements in the conduct of clinical trials; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaboration arrangements could be adversely impacted by changes in collaborators&#8217; key management personnel and other personnel that are administering collaboration agreements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We might not be able to utilize a significant portion of our net operating loss carryforwards and research and development tax credit carryforwards.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had federal and state net operating loss carryforwards of $315.0 million and $105.6 million, respectively, of which $44.3 million and $105.6 million of these carryforwards will begin to expire in 2031 for federal and state purposes, respectively. As of December&#160;31, 2021, we had federal and state research and development tax credit carryforwards of $6.7 million and $1.2 million, respectively. The federal credits begin to expire in 2031 and the California research credits have no expiration dates. These net operating loss and tax credit carryforwards could expire unused and be unavailable if we do not generate sufficient taxable income prior to their expiration. In addition, under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, and corresponding provisions of state law, if a corporation undergoes an &#8220;ownership change&#8221; (generally defined as a greater than 50 percentage point change, by value, in its equity ownership by significant stockholders over a three-year period) the corporation&#8217;s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or tax liability may be limited. We have not determined if we have experienced Section 382 ownership changes in the past and if a portion of our net operating loss and tax credit carryforwards are subject to an annual limitation under Sections 382 or 383. We have experienced ownership changes in the past, including in connection with our IPO and the Merger, and we may experience ownership changes in the future as a result of subsequent shifts in our stock ownership, some of which may be outside of our control. As a result, even if we earn net taxable income, our ability to use the net operating loss and tax credit carryforwards may be materially limited, which could harm our future operating results by effectively increasing our future tax obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Israeli Tax Authority may disagree with our conclusions regarding certain tax positions, resulting in unanticipated costs, taxes or non-realization of expected benefits. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we initiated a voluntary liquidation of our Israeli subsidiary in order to consolidate the ownership of our intellectual property. In connection therewith, the intellectual property and other assets owned by our Israeli subsidiary was assigned to the Company. Based on our analysis, we notified the Israeli Tax Authority that the gains realized by our Israeli subsidiary from the transfer of its assets to the Company was offset by net operating losses and that the liquidation did not result in tax in Israel under Israeli tax law. In the event that the Israeli Tax Authority does not agree with our analysis, we may be subject to a material tax amount and/or fail to realize the expected benefits of the transaction. In addition, we may incur additional costs associated with defending our position. Such tax liability and increase in costs may have a material adverse effect on our financial results. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to attract and keep senior management and key scientific personnel, we may be unable to successfully execute our strategy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in part on our continued ability to attract, retain and motivate highly qualified management and clinical and scientific personnel. We believe that our future success is highly dependent upon the contributions of our senior management, particularly our Chief Executive Officer, as well as key research and development personnel. The loss of services of any of these individuals could delay or prevent the successful preclinical and clinical development of our product pipeline.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have not historically experienced unique difficulties in attracting and retaining qualified employees, we could experience such problems in the future. For example, competition for qualified personnel in the pharmaceutical field is intense due to the limited number of individuals who possess the skills and experience required by our industry. We may need to hire additional personnel as we expand our clinical development activities. We may not be able to attract and retain quality personnel on acceptable terms, or at all. In addition, to the extent we hire personnel from competitors, we may be subject to allegations that they have been improperly solicited or that they have divulged proprietary or other confidential information, or that their former employers own their research output.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to lawsuits that could have a material adverse impact on our business, results of operations and financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time and in the ordinary course of our business, we may become involved in various lawsuits, in addition to product liability lawsuits and lawsuits to protect and enforce our intellectual property. These lawsuits may include claims initiated by our third-party collaborators, suppliers, manufacturers, former employees, contractors or vendors and claims related to the sale of securities and related disclosure. All such lawsuits are inherently unpredictable and, regardless of the merits of the claims, litigation may be expensive, time-consuming and disruptive to our operations and distracting to management. If resolved against us, such lawsuits could result in excessive verdicts, injunctive relief or other equitable relief that may affect how we operate our business. Similarly, if we settle such lawsuits, it may affect how we operate our business. Future court decisions, alternative dispute resolution awards, business expansion or legislative activity may increase our exposure to litigation and regulatory investigations. In some cases, substantial non-economic remedies or punitive damages may be sought. Although we maintain liability insurance coverage, including director and officer insurance with liability coverage limits, such coverage may not cover any particular verdict, judgment or settlement that may be entered against us, or our officers and directors, and such coverage may not prove to be adequate or such coverage may not continue to remain available on acceptable terms or at all. If we incur liability that exceeds our insurance coverage or that is not within the scope of the coverage in lawsuits brought against us, it could have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We conduct certain drug development activities in our research and development facility located in Ness Ziona, Israel and through partnerships with external contract manufacturing organizations. If these facilities or any future facility or our equipment were to be damaged or destroyed, or if we experience a significant disruption in our operations for any other reason, our ability to continue to operate our business could be materially harmed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently research and develop our product candidates in our laboratory located in Ness Ziona, Israel and through partnership with external contract manufacturing organizations. If these or any future facilities were to be damaged, destroyed or otherwise unable to operate, whether due to war, acts of hostility, earthquakes, fire, floods, hurricanes, storms, tornadoes, other natural disasters, employee malfeasance, terrorist acts, power outages or otherwise, or if performance of our research and development facility is disrupted for any other reason, such an event could negatively impact our development activities and delay our clinical trials. If we experience delays in achieving our development objectives, or if we are unable to manufacture an approved product within a timeframe that meets our prospective customers&#8217; expectations, our business, prospects, financial results and reputation could be materially harmed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, we maintain insurance covering damage to our property and equipment and workers compensation coverage, subject to deductibles and other limitations. If we have underestimated our insurance needs with respect to an interruption, or if an interruption is not subject to coverage under our insurance policies, we may not be able to cover our losses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our facilities and operations in Israel may be adversely affected by political, economic and military instability in the region.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recently downsized our offices in Israel but continue to maintain an office with laboratory facilities located in Ness Ziona. Accordingly, political, economic and military conditions in Israel may directly affect our business. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its neighboring countries. Over the past decade, Israel has been engaged in several armed conflicts with Hamas, a terrorist group and political party that controls the Gaza Strip, and other terrorist groups from the Gaza Strip. During the summer of 2006, Israel was engaged in an armed conflict with Hezbollah, a Lebanese Islamist Shiite terrorist group and political party. These conflicts have involved missile strikes against civilian targets in various parts of Israel, including the area where our facilities are located, and negatively affected business conditions in Israel. Any future hostilities involving Israel, or terrorist activities or political instability in the region, could interrupt or curtail trade between Israel and its trading partners, which could adversely affect our results of operations. Any such further armed conflicts could furthermore make it more difficult for us to raise capital. In addition, operations could be disrupted by the obligations of our Israeli personnel to perform military reserve service as a result of any such further conflicts.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial insurance does not cover losses that may occur as a result of an event associated with the security situation in the Middle East. Although the Israeli government is currently committed to covering the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, this government coverage may not be maintained, or if maintained, may be insufficient to compensate us fully for damages incurred. Any losses or damages incurred by our Israeli operations could have a material adverse effect on our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, certain countries, as well as certain companies and organizations, continue to participate in a boycott of Israeli businesses and businesses with large Israeli operations. Such boycott or other restrictive laws, policies or practices may have a material adverse effect on our business and financial condition in the future.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business and operations could suffer in the event of failure, invasion, corruption, destruction or interruption of our or our partners&#8217; critical information technology systems or infrastructure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the implementation of security measures, our information technology systems and infrastructure, and those of our current and any future partners, contractors and consultants, are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. The ever-increasing use and evolution of technology, including cloud-based computing, creates opportunities for the unintentional dissemination or intentional destruction of confidential information stored in our systems or in non-encrypted portable media or storage devices. We could also experience a business interruption, intentional theft of confidential information, or reputational damage from espionage attacks, malware or other cyber-attacks, which may compromise our system infrastructure or lead to data leakage, either internally or at our third-party providers. While we have not experienced any such material system failure, accident or security breach to date, if such an event were to occur and cause interruptions in our operations, it could cause damage or destroy assets, compromise business systems, result in proprietary information, trade secrets and other sensitive information being altered, lost, stolen, or published and may result in loss of intellectual property and in employee or third-party information being compromised, or otherwise disrupt business operations. For example, the loss of manufacturing records or clinical trial data from completed, ongoing or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability and the further development of our current and any future product candidates could be delayed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, independent contractors, principal investigators, consultants, vendors, CROs and any partners with which we may collaborate may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have an adverse effect on our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk that our employees, independent contractors, principal investigators, consultants, vendors, CROs, distributors, prescribers and any partners with which we may collaborate may engage in fraudulent or other illegal activity. Misconduct by these persons could include intentional, reckless or negligent conduct or unauthorized activity that violates: laws or regulations, including those laws requiring the reporting of true, complete and accurate information to the FDA or foreign regulatory authorities; manufacturing standards; federal, state and foreign healthcare fraud and abuse laws and data privacy; or laws that require the true, complete and accurate reporting of financial information or data. In particular, sales, marketing and other business arrangements in the healthcare industry are subject to extensive laws intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws may restrict or prohibit a wide range of business activities, including research, manufacturing, distribution, pricing, discounting, marketing and promotion, sales commissions, customer incentive programs and other business arrangements. Activities subject to these laws also involve the improper use of information obtained in the course of clinical trials, or illegal misappropriation of drug product, which could result in regulatory sanctions or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations, and serious harm to our reputation. In addition, federal procurement laws impose substantial penalties for misconduct in connection with government contracts and require certain contractors to maintain a code of business ethics and conduct. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our operating results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unfavorable global economic conditions could adversely affect our business, financial condition or results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A severe or prolonged economic downturn could result in a variety of risks to our business, including our ability to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy could also strain our suppliers, possibly resulting in supply disruption and ultimately delaying our development activities. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Government Regulation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to various U.S. federal, state, local and foreign health care fraud and abuse laws, including anti-kickback, self-referral, false claims and fraud laws, health information privacy and security, and transparency laws, and any violations by us of such laws could result in substantial penalties or other consequences including criminal sanctions, civil penalties, contractual damages, reputational harm, and diminished profits and future earnings. Additionally, any challenge </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">to or investigation into our practices under these laws could cause adverse publicity and be costly to respond to, and thus could harm our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous U.S. federal, state, local and foreign health care fraud and abuse laws pertaining to our business, including anti-kickback, false claims and physician transparency laws. Our business practices and relationships with providers, patients and third-party payors are subject to scrutiny under these laws. These laws may impact, among other things, our potential sales, marketing, patient assistance and education programs. We may also be subject to patient information privacy and security regulation by both the federal government, states and foreign jurisdictions in which we conduct our business. The healthcare laws and regulations that may affect our ability to operate include:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the U.S. federal Anti-Kickback Statute, which prohibits, among other things, knowingly and willfully offering, soliciting, receiving, or paying remuneration directly or indirectly, in cash or in kind to induce or reward either the referral of an individual for, or the purchase, order or recommendation of goods or services for which payment may be made in whole or part by Medicare, Medicaid or other federal health care programs. Remuneration has been broadly defined to include anything of value, including cash, improper discounts, and free or reduced price items and services. The intent standard under the federal Anti-Kickback Statute was amended by the ACA to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate it, in order to have committed a violation. In addition, the ACA provides that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. Additionally, many states have similar laws that apply to their state health care programs as well as private payors. Violations of the federal or state anti-kickback laws can result in exclusion from federal and state health care programs and substantial civil and criminal penalties.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal civil and criminal false claims laws and civil monetary penalties laws, including the FCA, prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, false, fictitious or fraudulent claims for payment from Medicare, Medicaid or other federal healthcare programs, and knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to avoid, decrease or conceal an obligation to pay money to the federal government. As a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#8220;any request or demand&#8221; for money or property presented to the federal government. Even where pharmaceutical companies do not submit claims directly to payors, they can be held liable under these laws if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims by, for example, providing inaccurate billing or coding information to customers, promoting a product off-label, marketing products of sub-standard quality, or, as noted above, paying a kickback that results in a claim for items or services. In addition, activities relating to the reporting of wholesaler or estimated retail prices for pharmaceutical products, the reporting of prices used to calculate Medicaid rebate information and other information affecting federal, state and third-party reimbursement for such products, and the sale and marketing of such products, are subject to scrutiny under this law. For example, several pharmaceutical and other healthcare companies have faced enforcement actions under these laws for allegedly inflating drug prices they report to pricing services, which in turn were used by the government to set Medicare and Medicaid reimbursement rates, and for allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product. Private individuals or &#8220;whistleblowers&#8221; can bring FCA &#8220;qui tam&#8221; actions on behalf of the government and may share in recovered amounts. The FCA has been used to prosecute persons submitting claims for payment that are inaccurate or fraudulent, that are for services not provided as claimed, or for services that are not medically necessary. Proof of intent to deceive is not required to establish liability under the civil False Claims Act.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, which imposes criminal and civil liability for, among other things, executing or attempting to execute a scheme to defraud any healthcare benefit program, including any third party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statements or representations, or making false statements relating to healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by HITECH, and their respective implementing regulations, including the Final Omnibus Rule published on January 25, 2013, which impose, among other things, obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information held by certain healthcare providers, health plans and healthcare clearinghouses, known as &#8220;covered entities,&#8221; and &#8220;business associates.&#8221; Among other things, HITECH made certain aspects of HIPAA&#8217;s rules (notably the Security Rule) directly applicable to business associates - independent contractors or agents of covered entities that receive or obtain individually identifiable health information in connection with providing a service on behalf of a covered entity. HITECH also created four new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">damages or injunctions in federal court to enforce the federal HIPAA laws and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. The Department of Health and Human Services Office for Civil Rights, or the OCR, has increased its focus on compliance and continues to train state attorneys general for enforcement purposes. The OCR has recently increased both its efforts to audit HIPAA compliance and its level of enforcement, with one penalty amounting to $16 million. In addition, according to the United States Federal Trade Commission, or the FTC, failing to take appropriate steps to keep consumers&#8217; personal information secure constitutes unfair acts or practices in or affecting commerce in violation of Section 5(a) of the Federal Trade Commission Act, or the FTCA, 15 USC &#167; 45(a). The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. Medical data is considered sensitive data that merits stronger safeguards. The FTC&#8217;s guidance for appropriately securing consumers&#8217; personal information is similar to what is required by the HIPAA Security Rule;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Physician Payments Sunshine Act and its implementing regulations, which require certain manufacturers of prescription drugs, devices and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program to annually report to CMS information related to payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, the physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. On October 25, 2018, then-President Trump signed into law the &#8220;Substance Use-Disorder Prevention that Promoted Opioid Recovery and Treatment for Patients and Communities Act.&#8221; This law, in part (under a provision entitled &#8220;Fighting the Opioid Epidemic with Sunshine&#8221;), will extend the Sunshine Act to payments and transfers of value to physician assistants, nurse practitioners, and other mid-level healthcare providers (with reporting requirements going into effect in 2022 for payments made in 2021). In addition, Section 6004 of the ACA requires annual reporting of information about drug samples that manufacturers and authorized distributors provide to physicians;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analogous state, local and foreign laws and regulations, such as state anti-kickback and false claims laws, and other states&#8217; laws addressing the pharmaceutical and healthcare industries, may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third party payors, including private insurers, and in some cases that may apply regardless of payor, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, even if reimbursement is not available; state laws that require drug companies to comply with the industry&#8217;s voluntary compliance guidelines (the PhRMA Code) and the applicable compliance program guidance promulgated by the federal government (HHS-OIG) or otherwise prohibit or restrict gifts or payments that may be made to healthcare providers and other potential referral sources; state and local laws that require the licensure of sales representatives; state laws that require drug manufacturers to report information related to drug pricing or payments and other transfers of value to healthcare providers or marketing expenditures and pricing information; and state laws related to insurance fraud in the case of claims involving private insurers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">data privacy and security laws and regulations in foreign jurisdictions that may be more stringent than those in the United States, such as the European Union, which adopted the General Data Protection Regulation (GDPR), which became effective in May 2018. The GDPR, which is wide-ranging in scope, imposes several requirements relating to the consent of the individuals to whom the personal data relates, the information provided to the individuals, the security and confidentiality of the personal data, data breach notification and the use of third party processors in connection with the processing of personal data. The GDPR also imposes strict rules on the transfer of personal data out of the European Union to the United States, provides an enforcement authority and imposes large penalties for noncompliance, including the potential for fines of up to &#8364;20 million or 4% of the annual global revenues of the noncompliant company, whichever is greater. The recent implementation of the GDPR has increased our responsibility and liability in relation to personal data that we process, including in clinical trials, and we may in the future be required to put in place additional mechanisms to ensure compliance with the GDPR, which could divert management&#8217;s attention and increase our cost of doing business; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, and may apply more broadly than HIPAA, thus complicating compliance efforts &#8211; for example, the California Consumer Privacy Act, or CCPA, which became effective on January 1, 2020. The CCPA, among other things, creates new data privacy obligations for covered companies and provides new privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. The California Attorney General has issued clarifying regulations, and in November 2020, California voters approved the California Privacy Rights Act of 2020 which modified and expanded the CCPA and created the California Privacy Protection Agency to implement and enforce the CCPA. Although the law includes limited exceptions, including for certain information collected as part of clinical trials as specified in the law, it may regulate or impact our processing of personal information depending on </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the context. It remains unclear what, if any, further modifications will be made to this legislation or how it will be interpreted.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These and similar laws may be subject to amendment or reinterpretation, and implementing regulations may be revised or reinterpreted, in ways that may significantly affect our business. For example, in October 2019 U.S. Department of Health and Human Services issued a proposed rule that would make changes to the federal Anti-Kickback Statute. State and federal authorities have aggressively targeted pharmaceutical companies for alleged violations of these fraud and abuse laws based on improper research or consulting contracts with doctors, certain marketing arrangements that rely on volume-based pricing, off-label marketing schemes, and other improper promotional practices.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of the health regulatory laws described above or any other laws or regulations that apply to us, we may be subject to penalties, including, but not limited to, criminal, civil and administrative penalties, damages, fines, disgorgement, individual imprisonment, exclusion from participation in government healthcare programs, debarment from contracting with the U.S. government, injunctions and private qui tam actions brought by individual whistleblowers in the name of the government. Companies targeted in such actions have, among other consequences, paid substantial fines in the hundreds of millions of dollars or more, have been forced to implement extensive corrective action plans, and have often become subject to consent decrees or corporate integrity agreements that severely restrict the manner in which they conduct their business, including the requirement of additional reporting and oversight obligations. Due to the breadth of these laws, the narrowness of statutory exceptions and regulatory safe harbors available, and the range of interpretations to which they are subject, it is possible that some of our current or future practices might be challenged under one or more of these laws. Responding to investigations, enforcement actions and litigation can be time-and resource-consuming and can divert management&#8217;s attention from the business. Any such investigation, action, litigation or settlement could increase our costs or otherwise have an adverse effect on our business and reputation. Even an unsuccessful challenge or investigation into our practices could cause adverse publicity and be costly to respond to. In addition, the approval and commercialization of any of our product candidates outside the U.S. will also likely subject us to non-U.S. equivalents of the healthcare laws mentioned above, among other non-U.S. laws.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare reforms by governmental authorities and related reductions in pharmaceutical pricing, reimbursement and coverage by third party payors may adversely affect our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the healthcare industry to face increased limitations on reimbursement, rebates and other payments as a result of healthcare reform, which could adversely affect third party coverage of any future products and how much or under what circumstances healthcare providers will prescribe or administer our products, if approved.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In both the United States and other countries, sales of our products, if approved for marketing, will depend in part upon the coverage and adequate reimbursement from third party payors, which include governmental authorities, managed care organizations and other private health insurers. Third party payors are increasingly challenging the price and examining the cost effectiveness of medical products and services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increasing expenditures for healthcare have been the subject of considerable public attention in the United States. Both private and government entities are seeking ways to reduce or contain healthcare costs. Numerous proposals that would effect changes in the U.S. healthcare system have been introduced or proposed in Congress and in some state legislatures, including reducing reimbursement for prescription products and reducing the levels at which consumers and healthcare providers are reimbursed for purchases of pharmaceutical products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost reduction initiatives and changes in coverage implemented through legislation or regulation could decrease utilization of and reimbursement for any approved products, which in turn would affect the price we can receive for those products. Any reduction in reimbursement that results from federal legislation or regulation may also result in a similar reduction in payments from private payors, as private payors often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant developments that may adversely affect pricing in the United States include the enactment of federal healthcare reform laws and regulations, including the ACA and the Medicare Prescription Drug Improvement and Modernization Act of 2003. Changes in the healthcare system enacted as part of healthcare reform in the United States, as well as the increased purchasing power of entities that negotiate on behalf of Medicare, Medicaid, and private sector beneficiaries, may result in increased pricing pressure by influencing, for instance, the reimbursement policies of third party payors. While healthcare </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reform legislation may have increased the number of patients who are expected to have insurance coverage for our product candidates, provisions such as the assessment of a branded pharmaceutical manufacturer fee and an increase in the amount of rebates that manufacturers pay for coverage of their drugs by Medicaid programs may have an adverse effect on us. It is uncertain how current and future reforms in these areas will influence the future of our business operations and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Since its enactment, there have been judicial, Congressional and political challenges to certain aspects of the ACA. For example, while in office, then-President Trump signed two Executive Orders and other directives designed to delay the implementation of certain provisions of the ACA or otherwise circumvent some of the requirements for health insurance mandated by the ACA. Concurrently, Congress has considered legislation that would repeal or repeal and replace all or part of the ACA. While Congress has not passed comprehensive repeal legislation, two bills affecting the implementation of certain taxes under the ACA have been signed into law. In July 2018, CMS published a final rule permitting further collections and payments to and from certain ACA qualified health plans and health insurance issuers under the ACA risk adjustment program in response to the outcome of federal district court litigation regarding the method CMS uses to determine this risk adjustment. On December 14, 2018, a U.S. District Court Judge in the Northern District of Texas ruled that the individual mandate was a critical and inseverable feature of the ACA, and because it was repealed as part of the Tax Act, the remaining provisions of the ACA were invalid as well. On December 18, 2019, the Fifth Circuit U.S. Court of Appeals held that the individual mandate was unconstitutional and remanded the case to the lower court to reconsider its earlier invalidation of the full ACA. On January 3, 2020, the U.S. House of Representatives filed a petition for a writ of certiorari with the U.S. Supreme Court.  On June 17, 2021, the U.S. Supreme Court held that state and individual plaintiffs did not have standing to challenge the individual mandate provision of the ACA; in so holding, the Supreme Court did not consider larger constitutional questions about the validity of this provision or the validity of the ACA in its entirety. It is unclear how this decision, subsequent appeals, if any, and other efforts to modify, repeal and replace the ACA will impact the ACA.  Although we cannot predict the form of any such replacement of the ACA may take, if any, or the full effect on our business of the enactment of additional legislation pursuant to healthcare and other legislative reform, we believe that legislation or regulations that would reduce reimbursement for, or restrict coverage of, any future products could adversely affect how much or under what circumstances healthcare providers will prescribe or administer any products we market in the future. This could materially and adversely affect our business by reducing our ability to generate revenues, raise capital, obtain additional licensees, and market our products, if approved. In addition, we believe the increasing emphasis on managed care in the United States has and will continue to put pressure on the price and usage of pharmaceutical products, which may adversely impact product sales.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several U.S. Congressional inquiries and proposed federal legislation designed to, among other things, bring more transparency to product pricing, reduce the cost of certain products under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies. At the state level, individual states in the United States are also increasingly passing legislation and implementing regulations designed to control product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is likely that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for a pharmaceutical manufacturer&#8217;s products or additional pricing pressure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legislative or regulatory healthcare reforms in the United States may make it more difficult and costly for us to obtain regulatory clearance or approval of our product candidates and to produce, market, and distribute products after clearance or approval is obtained.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation is drafted and introduced in Congress that could significantly change the statutory provisions governing the regulatory clearance or approval, manufacture, and marketing of regulated products or the reimbursement thereof. In addition, FDA regulations and guidance are often revised or reinterpreted by the FDA in ways that may significantly affect our business. Any new regulations or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of any of our product candidates. We cannot determine what effect changes in regulations, statutes, legal interpretation or policies, when and if promulgated, enacted or adopted may have on our business in the future. Such changes could, inter alia, require:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes to manufacturing methods;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recall, replacement, or discontinuance of products; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additional recordkeeping.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of these would likely entail substantial time and cost and could adversely affect our business and our financial results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our contract manufacturers are subject to significant regulation with respect to manufacturing of our product candidates. The manufacturing facilities on which we rely may not continue to meet regulatory requirements and have limited capacity.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and the contract manufacturers for our product candidates are subject to extensive regulation. Some components of a finished drug product used in late-stage clinical studies must be manufactured in accordance with cGMP. These regulations govern manufacturing processes and procedures (including record keeping) and the implementation and operation of quality systems to control and assure the quality of investigational products and products approved for sale. Poor control of production processes can lead to the introduction of adventitious agents or other contaminants, or to inadvertent changes in the properties or stability of our product and product candidates that may not be detectable in final product testing. We or our contract manufacturers must supply all necessary documentation in support of regulatory applications on a timely basis and where required, must adhere to the FDA&#8217;s or other regulator&#8217;s good laboratory practices and cGMP regulations enforced by the FDA or other regulator through facilities inspection programs. Our facilities and quality systems and the facilities and quality systems of some or all of our third-party contractors must pass a pre-approval inspection for compliance with the applicable regulations as a condition of marketing approval of our product and potential products. In addition, the regulatory authorities may, at any time, audit or inspect a manufacturing facility involved with the preparation of our product candidates or the associated quality systems for compliance with the regulations applicable to the activities being conducted. If these facilities do not pass a pre-approval plant inspection, FDA or other marketing approval of the products may not be granted.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory authorities also may, at any time following approval of a product for sale, audit the manufacturing facilities of our third-party contractors. If any such inspection or audit identifies a failure to comply with applicable regulations or if a violation of our product specifications or applicable regulations occurs independent of such an inspection or audit, we or the relevant regulatory authority may require remedial measures that may be costly and/or time-consuming for us or a third party to implement and that may include the temporary or permanent suspension of a clinical study or commercial sales or the temporary or permanent closure of a facility. Any such remedial measures imposed upon us or third parties with whom we contract could materially harm our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or any of our third-party manufacturers fail to maintain regulatory compliance, the FDA or other regulators can impose regulatory sanctions including, among other things, refusal to approve a pending application for a product, or revocation of a pre-existing approval. As a result, our business, financial condition and results of operations may be materially harmed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if supply from one approved manufacturer is interrupted, there could be a significant disruption in supply. The number of manufacturers with the necessary manufacturing capabilities is limited. Switching manufacturers may involve substantial costs and is likely to result in a delay in our desired clinical timelines.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These factors could cause the delay of clinical studies, regulatory submissions, or required approvals of any future products, and cause us to incur higher costs. Furthermore, if our suppliers fail to meet contractual requirements and we are unable to secure, validate and obtain approval of one or more replacement suppliers capable of production at a substantially equivalent cost, our clinical studies may be delayed or we could lose potential revenues.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in funding for the FDA and other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal functions on which the operation of our business may rely, which could negatively impact our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, including beginning on December 22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, and such </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delays could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to various U.S. and foreign anti-bribery and anti-corruption laws, and any violations by us of such laws could result in substantial penalties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Foreign Corrupt Practices Act, or FCPA, and similar worldwide anti-bribery and anti-corruption laws generally prohibit companies and their intermediaries from offering, making or authorizing improper payments to government officials for the purpose of obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. Our internal control policies and procedures may not protect us from reckless or negligent acts committed by our employees, future distributors, licensees or agents. Violations of these laws, or allegations of such violations, could result in fines, penalties or prosecution and have a negative impact on our business, results of operations and reputation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business involves the use of hazardous materials and we and our third party manufacturers and suppliers must comply with environmental laws and regulations, which can be expensive and restrict how we do business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development activities and our third party subcontractors&#8217; and suppliers&#8217; activities involve the controlled storage, use and disposal of hazardous materials owned by us, including key components of our product candidates, and other hazardous compounds. We and our manufacturers and suppliers are subject to laws and regulations governing the use, manufacture, storage, handling and disposal of these hazardous materials. In some cases, these hazardous materials are stored at our and our subcontractors&#8217; facilities pending their use and disposal.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts, we cannot eliminate the risk of contamination. This could cause an interruption of our development efforts and business operations, environmental damage resulting in costly clean-up and liabilities under applicable laws and regulations governing the use, storage, handling and disposal of these materials and specified waste products. Although we believe that the safety procedures utilized by us and our subcontractors and suppliers for handling and disposing of these materials generally comply with the standards prescribed by these laws and regulations, this may not be the case and there may be risk of accidental contamination or injury from these materials. In such an event, we may be held liable for any resulting damages and such liability could exceed our resources and state or federal or other applicable authorities may curtail our use of certain materials and interrupt our business operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, environmental laws and regulations are complex, change frequently and have tended to become more stringent. We cannot predict the impact of such changes and cannot be certain of our future compliance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sanctions and other trade control laws create the potential for significant liabilities, penalties and reputational harm.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to national laws as well as international treaties and conventions controlling imports, exports, re-export and diversion of goods, services and technology. These include import and customs laws, export controls, trade embargoes and economic sanctions, denied party watch lists and anti-boycott measures (collectively &#8220;Customs and Trade Controls&#8221;). Applicable Customs and Trade Controls are administered by Israel&#8217;s Ministry of Finance, the U.S. Treasury&#8217;s Office of Foreign Assets Control (OFAC), other U.S. agencies and other agencies of other jurisdictions where we do business. Customs and Trade Controls relate to a number of aspects of our business, including most notably the sales API as well as the licensing of intellectual property, as provided above. Compliance with Customs and Trade Controls has been the subject of increasing focus and activity by regulatory authorities, both in the United States and elsewhere, in recent years. Although we have policies and procedures designed to address compliance with Customs and Trade Controls, actions by our employees, by third-party intermediaries or others acting on our behalf in violation of relevant laws and regulations may expose us to liability and penalties for violations of Customs and Trade Controls and accordingly may have a material adverse effect on our reputation and our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If our efforts to obtain, protect or enforce our patents and other intellectual property rights related to our phase II product candidate FMX114 and our licensed in VYN201 product candidate, or any of our other product candidates are not adequate, we may not be able to compete effectively and we otherwise may be harmed.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in part on our ability to obtain and maintain patent protection and other intellectual property rights and to utilize trade secret protection for our intellectual property and proprietary technologies, our product candidates and their uses, as well as our ability to operate without infringing upon the proprietary rights of others. We rely upon a combination of patents, trade secret protection, trademarks, domain names, trade dress, copyright, confidentiality agreements, assignment of invention agreements and other contractual arrangements to protect the intellectual property related to our product candidates FMX114 and VYN201, and to our other development programs. Limitations on the scope of our intellectual property rights may limit our ability to defend our product candidates and to prevent third parties from designing around such rights and competing against us. For example, our patent applications in relation to FMX114 do not claim a new compound. Rather, the active pharmaceutical ingredients of our FMX114 product are existing or old compounds, and our pending patent applications are directed to, among other things, novel formulations of these existing or old compounds that are dispensed as a semi-solid or gel or to methods of use of these formulations. Accordingly, other parties may compete with us, for example, by independently developing or obtaining competing topical formulations that design around our various patent claims, or by using formulations from expired patents, but which may contain the same active ingredients, or by seeking to invalidate our patents. Where we have product candidates which are new chemical entities (compounds) or drugs like VYN201, other parties may still compete with us, for example, by independently developing or obtaining competing compounds and formulations and methods of manufacture that design around our various patent claims, or by using formulations from expired patents, but which may contain the same active ingredients, and or by opposing our applications or seeking to invalidate our patents. In addition, other parties may seek to impede us or limit our ability to operate, and or seek to compete with us, for example, by filing patent applications directed to methods of manufacture of our compounds, directed to methods of use of our compounds, and or directed to formulations for use with our compounds.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have various pending patent applications related to our FMX114 and VYN201</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product candidates, including two PCT applications in relation to FMX114 that have not yet been nationally filed. Subject to the pending patent applications being granted and payments of the appropriate maintenance fees, the patent applications related to FMX114 will expire in 2040 and 2041 and the pending patent applications in relation to VYN201 will expire in 2040 and 2042. The FMX114 pending patent applications relate to a compositions of matter, including comprising a claim to a formulation of a JAK inhibitor and or a sphingosine 1-phosphate (S1-P) receptor agonist or modulator, which can respectively include tofacitinib and fingolimod respectively, or to methods of treatment using the compositions and, therefore, may be less protective than patents that claim a new drug. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pending patent applications in relation to VYN201 primarily relate to new chemical entities (compounds), their manufacture and uses. There are also compositions of matter claims sought in the patent applications comprising a claim to a formulation of compounds, or to methods of treatment using the compositions and, therefore, in the event that one or more such claims are issued, these may be less protective than claims issued to a new drug.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we own the patent pending applications in relation to FMX114, the pending patent applications in relation to VYN201 are primarily licensed in from the University of Dundee and from In4Derm and are subject to the terms and conditions of the respective licenses. If we were unable to comply with the license terms, we could be at risk of potentially forfeiting the licenses and rights to these pending patent applications, which could revert back to the licensors, and we would then no longer be able to pursue these programs. Moreover, if we are unable to develop a lead candidate for the VYN202 program, we may not exercise our option with respect to In4Derm's BET inhibitor compounds suitable for oral administration, which could cause us to terminate the program and this would have a material adverse effect on our ability to execute our strategy of enhancing our pipeline. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are looking to license out or sell our serlopitant platform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have discontinued the internal development of serlopitant and have no plans to do further work ourselves in this area. We currently own and have licensed various granted patents. The patents claiming methods-of-use for serlopitant in the United States are expected to expire in 2033, if the appropriate maintenance fees are paid. We also have patents granted in several foreign jurisdictions and patent applications pending in the United States and in various foreign jurisdictions in relation to serlopitant.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to file, prosecute and obtain issued patents in the US and in key foreign jurisdictions and the expiration dates of such patents, if granted, will limit our ability to profit from the commercialization of our product candidates, if approved, as may challenges to our patent applications and claims. Furthermore, any disclosure to or misappropriation by third parties of our confidential or proprietary information could enable competitors to quickly duplicate or surpass our technological achievements, thus eroding our competitive position in our market.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and following the completion of the sale of our commercial business, our patent portfolio included over 200 granted patents and pending patent applications worldwide, owned or licensed in by us, including over 65 granted patents in the United States.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as of December 31, 2021 and following the completion of the sale of our commercial </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business, our patent portfolio in relation to our BETi programs included over 15 pending patent applications worldwide, licensed in or owned by us including 2 pending patent applications in the United States.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we intend to develop and expand our core patent portfolio in respect of our lead product candidates, we may also reduce our non-core patent portfolio.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In patent litigation in the United States, defendant counterclaims, alleging invalidity and/or unenforceability, are commonplace.  The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to validity, for example, there may be an invalidating prior art, of which we and the patent examiner were unaware during prosecution. If a party were to prevail on a legal assertion of invalidity and/or unenforceability against our intellectual property related to one or more of our product candidates, we would lose at least part, and perhaps all, of the patent protection on such products or product candidates. Such a loss of patent protection would have a material adverse impact on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pending patent applications may not issue, or the scope of the claims of patent applications that do issue may be too narrow or inadequate to provide or protect a competitive advantage. Even if these patents do successfully issue, third parties may challenge the validity, enforceability or scope of such granted patents or any other granted patents we own or license, which may result in such patents being narrowed, invalidated, or held unenforceable.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We have in-licensed intellectual property necessary to develop our BET inhibitor product candidates, and if we fail to comply with our obligations under any of these arrangements, we could lose such intellectual property rights.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in-licensed our BET inhibitor compounds from In4Derm. Our arrangements impose various development, royalty and other obligations on us. If we materially breach these obligations or if our counterparts fail to adequately perform their respective obligations, these exclusive arrangements could be terminated, which would result in our inability to develop, manufacture and sell BET inhibitor products that are covered by such intellectual property.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Since patent applications in the United States and most other countries are confidential for a period of time after filing, we cannot be certain that we or our licensor were the first to (i) file any patent application related to our FMX114 product candidate, or to our VYN201 licensed in product candidate, or any of our other product candidates or (ii) conceive and invent any of the inventions claimed in our patents or patent applications or in our licensed in patents or patent applications.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For applications filed before March 16, 2013, or patents issuing from such applications, an interference proceeding can be invoked by a third party, or instituted by the USPTO, to determine who was the first to invent any of the subject matter covered by the patent claims of our applications and patents. An interference is a contest between an application and either another application or a patent in determining priority, that is, which party first invented the commonly claimed invention. A panel of Board members enters final judgment on questions of priority and patentability arising in an interference. As of March 16, 2013, the United States transitioned to a &#8220;first-to-file&#8221; system for deciding which party should be granted a patent when two or more patent applications are filed by different parties claiming the same invention. A third party that files a patent application in the USPTO under the new first-to-file system before we did, could therefore be awarded a patent covering an invention of ours even if we had made the invention before it was made by the third party.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change to &#8220;first-to-file&#8221; from &#8220;first-to-invent&#8221; is one of the changes to the patent laws of the U.S. resulting from the Leahy-Smith America Invents Act, or AIA, signed into law on September 16, 2011. Among some of the other changes to the patent laws are changes that limit where a patentee may file a patent infringement suit and providing opportunities for third parties to challenge any issued patent in the USPTO. Until a few years ago, a lower evidentiary standard was applied in certain USPTO proceedings compared to the evidentiary standard in U.S. federal court necessary to invalidate a patent claim. Under the new final rule, effective for petitions filed on or after November 13, 2018, the USPTO Patent Trial and Appeal Board (PTAB) is to apply the same claim construction standard applied by civil courts under 35 USC &#167;282(b) in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IPR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, post-grant review, and the transitional program for covered business method patents proceedings. The impact this may have in practice on the use and outcome of USPTO proceedings is uncertain. The PTAB proceedings continues to be a developing and uncertain area of practice and law. Because of lower costs and the fact that USPTO statistics indicate that a high rate of challenged claims are being invalidated in these USPTO procedures, they may continue to be a popular and effective means of challenging patents.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even where patent, trade secret and other intellectual property laws provide protection, costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and the outcome of such litigation would be uncertain. Moreover, any actions we may bring to enforce our intellectual property against our competitors could provoke actions or counterclaims against us, and our competitors have intellectual property of their own, some of which include substantial patent portfolios. An unfavorable outcome could have a material adverse effect on our business and could result in the challenged patent(s) or one or more of claims being interpreted narrowly or invalidated, or held not to be infringed, or one or more of our patent applications may not be granted.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on trade secret protection and confidentiality agreements to protect our know-how, data and information e.g., prior to filing patent applications and during the period before they are published. We additionally rely on trade secret protection and confidentiality agreements to protect proprietary know-how that we consider may be maintained as a trade secret rather than the subject of a patent application. We further rely on trade secret protection and confidentiality agreements to protect proprietary know-how that may not be patentable, processes for which patents may be difficult to obtain or enforce and other elements of our product development processes that involve proprietary know-how, information or technology that is not covered by patents. We additionally rely on trade secret protection and confidentiality agreements to protect proprietary inventions and related know-how before patent applications are filed and published. We also enter into and rely on, where appropriate, common interest agreements to protect privileged confidential information.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an effort to protect our trade secrets and other confidential information, we incorporate confidentiality provisions in all our employees&#8217; agreements and require our consultants, contractors and licensees to which we disclose such information to execute confidentiality agreements upon the commencement of their relationships with us. These agreements require that confidential information, as defined in the agreement and disclosed to the individual by us during the course of the individual&#8217;s relationship with us, be kept confidential and not disclosed to third parties for an agreed term. These agreements, however, may not provide us with adequate protection against accidental or improper use or disclosure of confidential information, and these agreements may be breached. Adequate remedies may not exist in the event of unauthorized use or disclosure of our confidential information. A breach of confidentiality could significantly affect our competitive position and we could lose our trade secrets, or they could become otherwise known, or be independently discovered by our competitors. Although we make efforts to protect our trade secrets and other confidential information we cannot be certain that all parties that gain access to our proprietary information, or who may be involved in the development of our intellectual property have entered into written confidentiality agreements, or that such agreements will be sufficiently protective, or that they will not be breached. Also, to the extent that our employees, consultants or contractors use any intellectual property owned by others in their work for us, disputes may arise as to the rights in any related or resulting know-how and inventions. Additionally, others may independently develop the same or substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets and other confidential information. Any of the foregoing could deteriorate our competitive advantages, undermine the trade secret and contractual protections afforded to our confidential information and have material adverse effects on our business. We rely on information technology and access to the internet. Loss of material on servers or the cloud, disruptions and or breaches of cybersecurity could deteriorate our competitive advantages, undermine the trade secret and contractual protections afforded to our confidential information and have material adverse effects on our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in U.S. or foreign patent law and practice could diminish the value of patents in general, thereby impairing our ability to protect our product candidates.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is the case with other companies in the markets in which we participate, our success is heavily dependent on intellectual property, particularly patents. The strength of patents in the pharmaceutical field involves complex legal and scientific questions and moreover in the United States and in many foreign jurisdictions patent policy, practice and case law continues to evolve and change and the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. This uncertainty includes changes to the patent laws through one or more of legislative action to change statutory patent law, rule changes and practice directions issued by National Patent Offices, or court action that may reinterpret, limit or expand on existing law in ways affecting the scope or validity of granted patents and what may be claimed in pending applications. Particularly in recent years in the United States, there have been several major legislative developments and court decisions that have affected patent laws and how they are applied in significant ways and there may be more developments in the future that may weaken or undermine our ability to obtain patents or to enforce our existing and future patents. For example, a bill has been introduced in the United States that is intended to facilitate patent challenges at the PTO's Patent Trial and Appeal Board and if enacted may lead to lower drug prices. This in turn may have a negative impact reducing both the value of patents and the commercial revenues that may be obtained from the development of new drugs and new compositions comprising known drugs.  Additionally, new guidelines are issued by the USPTO and by the FDA from time to time which can impact patent practice in the pharmaceutical industry in significant ways. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we infringe or are alleged to infringe or otherwise violate intellectual property rights of third parties, our business could be harmed.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development activities may infringe or otherwise violate or be claimed to infringe or otherwise violate patents owned or controlled by other parties. Competitors in the field of topical and oral drugs have developed and may continue to develop large portfolios of patents and patent applications relating to our business. For example, for the treatment of atopic dermatitis, psoriasis and vitiligo and for the treatment of other skin or mucosal disorders. In particular, there are patents and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pending patent applications held by third parties that relate to new compounds that act as PAN BD BET inhibitors and also those that relate to BDII selective BET inhibitors, as well as to methods of manufacture and methods of use for indications we are pursuing, or are considering to pursue with our VYN201 product candidate and in relation to other product candidates and activities that we are considering. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in particular, there are patents and pending patent applications held by third parties that relate to formulations with JAK inhibitor-based products (e.g., tofacitinib-based) and S1-P receptor agonist or modulator-based products (e.g., fingolimod-based products) and to methods of treatment with JAK inhibitor-based (e.g., tofacitinib-based) and S1-P receptor agonist or modulator based-products (e.g., fingolimod-based products) for indications we are pursuing with our FMX114 product candidate and in relation to other product candidates and activities that we are considering. There are also patents and pending patent applications held by third parties that relate to formulations with neurokinin 1 receptor antagonists and to treatment of pruritus or itch. There may be granted patents with claims that could be asserted against us in relation to such products or product candidates. There may also be granted patents held by third parties that may be infringed or otherwise violated by our other product candidates and activities, and we do not know whether or to what extent we may be infringing or otherwise violating third party patents. There may also be third party patent applications, some of which may not yet have been published, which if approved and granted as patents may be asserted against us in relation to our FMX114 and VYN201 product candidates, or any of our other product candidates or activities. Patent applications can take years to issue and there may be applications that are pending and in the course of prosecution claims may change or be added and there may be patents and claims of which we are unaware that may later issue with claims that might be infringed by commercializing a product or product candidate. We may fail to identify applications and granted patents that may be asserted against us in relation to our FMX114 and VYN201 product candidates, or any of our other product candidates or activities. Searches and analyses undertaken may miss or not uncover all potential and future threats. It should be noted in this regard that no search is completely exhaustive.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, a relevant patent or published application could escape detection because of unusual terminology or use of terminology that is still evolving in developing technological fields.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, databases used in the searches may not be entirely complete. These third parties could bring claims against us that would cause us to incur substantial expenses and, if successful against us, could cause us to pay substantial damages and legal fees. These third parties could include non-practicing entities that have no relevant products or revenue. Further, if a patent infringement suit were brought against us, we could be temporarily or permanently enjoined or otherwise forced to stop or delay research, development, manufacturing or sales of the product or product candidate that is the subject of the suit.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of patent infringement claims, or to avoid potential claims, we may choose or be required to seek licenses from third parties. These licenses may not be available on acceptable terms, or at all. Even if we are able to obtain a license, the license would likely obligate us to pay license fees or royalties or both and may limit us in other ways, and the rights granted to us might be nonexclusive, which could result in our competitors gaining access to the same intellectual property, or such rights might be restrictive and limit our present and future activities. Ultimately, we or a licensee could be prevented from commercializing a product or be forced to cease some aspect of our business operations, if, as a result of actual or threatened patent infringement claims, we are unable to enter into licenses on acceptable terms.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been and there currently is substantial litigation and other proceedings regarding patent and other intellectual property rights in the pharmaceutical industry. Such litigation can be very expensive, and the cost burden of intellectual property litigation may impact on our other activities. In addition to possible infringement claims against us, we may become a party to other patent litigation and other proceedings, including interference, derivation, review, re-examination or other post-grant proceedings declared or granted by the USPTO and similar proceedings in foreign countries, regarding intellectual property rights with respect to our current or any future products. In some jurisdictions, third party observations or pre-grant oppositions may be filed, for example in Europe, India and Israel. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A third party may initially sometimes choose to submit exploratory observations or oppositions in one or more foreign jurisdictions prior to commencing proceedings in the United States, where the costs could be higher. The cost and burden to us of any patent litigation or other proceeding, even if resolved in our favor, could be substantial. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their substantially greater financial resources. Patent litigation and other proceedings may also absorb significant management time. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings and their outcome could impair our ability to compete in the marketplace and impose a substantial financial burden on us, and may further have an adverse effect on our ability to raise funds to pursue research and development activities and clinical trials. The occurrence of any of the foregoing could have a material adverse effect on our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, several of our employees were previously employed at universities or other pharmaceutical companies, including potential competitors. While we take steps to prevent our employees from using the proprietary information or know-how of others that is not in the public domain or that has not already been independently developed by us earlier, we may be subject to claims that we or these employees have inadvertently or otherwise used or disclosed, confidential information, intellectual </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">property, trade secrets or other proprietary information of any such employee&#8217;s former employer. Litigation may be necessary to defend against these claims and, even if we are successful in defending ourselves, could result in substantial costs to us or be distracting to our management. If we do not succeed with respect to any such claims, in addition to paying monetary damages and possible ongoing royalties, we may lose valuable intellectual property rights or personnel.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining our intellectual property protection, such as patent protection, depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental agencies, such as patent agencies, and our intellectual property protection, such as patent protection, could be reduced or eliminated for non-compliance with these requirements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The USPTO and various foreign patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions to maintain patent applications and issued patents. Noncompliance or late compliance with these requirements can result in abandonment or lapse of a patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter the market earlier than would otherwise have been the case. Similarly, compliance with relevant provisions is required to maintain trademark applications and registrations, while non-compliance can, likewise, result in loss of rights. In some circumstances, however, we may allow intellectual property rights to become abandoned, such as, where they are no longer considered of interest.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We instruct foreign agents including translation agencies to prepare and file applications in multiple jurisdictions. If an agent omitted to file the patent application and where appropriate the translation timely in accordance with the national provisions or failed to translate the application accurately and or introduced errors into the translation we may suffer loss of rights and we may not discover this until after the filing deadline has passed. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to secure trademark registrations, secure appropriate domain names and protect our trademarks or trade dress from infringement, our business prospects may be harmed.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own trademarks that identify &#8220;VYNE&#8221; and &#8220;VYNE Therapeutics&#8221; and have submitted applications to register these trademarks in the United States and in various other jurisdictions. Similarly, we own trademarks that represent our leaf logo which can be and is used with the &#8220;VYNE&#8221; and &#8220;VYNE Therapeutics&#8221; trademarks and our VYNE identity and have submitted applications to register these leaf trademarks in the United States and in some other jurisdictions. We have selected the trademark</span><span style="background-color:#ffffff;color:#424242;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">InhiBET for use in relation to our BETi programs and we have applied to register the trademark in Israel and the United States. We have not yet selected or submitted trademark applications for a proposed commercial trade name for each of our FMX114 and VYN201 product candidates, or any of our other product candidates or activities in the United States or elsewhere and failure to do so and secure registrations could adversely affect our business.</span><span style="background-color:#ffffff;color:#1a1b1f;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applications for trademarks may be rejected during prosecution and we may be unable to overcome such proceedings or we may have to narrow or limit the scope of the applications or rely on a lower level of protection provided by common law unregistered trademark rights, if any. Opposition or cancellation proceedings may be filed against our trademarks, which may not survive such proceedings or we may have to narrow or limit their scope. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the US the FDA evaluates and must approve any trademark we propose to use with products for which we seek regulatory approval regardless of whether we have registered it, or applied to register it, as a trademark. The FDA review will include an evaluation of potential for confusion with other product names. Selecting a product trademark can be an expensive process. If the FDA objects to proposed trademarks this could delay regulatory approval and we may be required to expend significant resources in an effort to identify suitable substitutes that would qualify as a registerable trademark, not infringe any existing third party trademark rights and be acceptable to the FDA.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we take steps to monitor the possible infringement or misuse of our trademarks, it is possible that third parties may infringe, dilute or otherwise violate our trademark rights. Any unauthorized use of our trademarks could harm our reputation or commercial interests. In addition, our enforcement against third party infringers or violators may be unduly expensive and time-consuming, and the outcome may be an inadequate remedy.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have rights in trade dress, including in our packaging materials and products. Trade dress includes the design and shape of the materials in which a product is packaged.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product configuration, the design and shape of the product itself, may also be considered a form of trade dress. In the U.S. The Lanham Act protects trade dress if it serves the same source-identifying function as a trademark.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is possible to register trade dress as a trademark, for practical reasons most trade dress and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product configurations are protected without registration under 15 U.S.C. &#167; 1125(a). Nevertheless, it can be more difficult to assert and protect unregistered rights and if others seek to copy our trade dress and we are not successful in asserting and protecting our rights it could adversely affect our business. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we have rights in certain domain names associated with our business. If others seek to use</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">domain names closely similar and we are not successful in asserting and protecting our rights it could adversely affect our business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become involved in lawsuits to protect or enforce our patents or other intellectual property or the patents of our licensors, which could be expensive and time-consuming.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may infringe our intellectual property, including our patents or the patents of our licensors. As a result, we may be required to file infringement claims to stop third party infringement or unauthorized use. This can be expensive and burdensome, particularly for a company of our size, as well as time-consuming. In addition, in an infringement proceeding, a court may decide that a patent or certain patent claims of ours are not valid, or are unenforceable, or may refuse to stop the other party or parties from using the technology or method at issue on the grounds that our patent claims do not cover its or their technology or method or that the factors necessary to grant an injunction against an infringer are not satisfied.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have received notice letters of ANDAs submitted for drug products that are generic versions of Finacea&#174; foam and we have been involved in lawsuits to protect and enforce our patents, and while we have now settled all these lawsuits we may in the future be involved in other lawsuits to protect and enforce our patents, for example, if we receive new notice letters of submission of an ANDA to the FDA seeking approval to manufacture and sell a generic version of a product with Orange Book listed patents. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VYNE is the owner of patents that have been licensed to LEO Pharma to market Finacea&#174; (azelaic acid) foam. We have various patents listed in the FDA&#8217;s Orange Book in respect of our licensed out product Finacea foam. Paragraph IV Certification Notice letters directed against several of our U.S. patents listed in the FDA&#8217;s Orange Book for Finacea foam were received respectively from an affiliate of Teva Pharmaceutical Industries Ltd., from affiliates of Perrigo Company plc. and from Taro Pharmaceuticals Industries Ltd. and its affiliate Taro Pharmaceuticals U.S.A., Inc. In each case a Complaint was timely filed with the U.S. District Court for the District of Delaware, asserting, among other things, that each company had infringed our patents, as listed in its Paragraph IV Notice Letters, by seeking FDA approval to manufacture and sell a generic version of Finacea foam prior to expiration of these patents. These lawsuits were respectively settled in October 2019, April 2019 and in March 2020 to conclude the litigation relating to Finacea foam. Details of the settlement agreements are confidential. Although the litigation has now settled, a future supply issue and or substitution of Finacea in favor of generic versions has the potential to have a negative impact on future commercialization of Finacea and to result in a loss of license revenue.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In order to list our patents in the FDA&#8217;s Orange Book application must be submitted timely to the FDA. If we fail to do so for any of our listable patents, when they issue, we will have lost the right in respect of such patents to obtain a 30 month stay under the Hatch-Waxman Act, and preclude the ANDA filer from receiving final FDA approval of a generic version, unless a court enters judgment that the patents are invalid or not infringed.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may infringe our patents. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time consuming and may be unsuccessful in whole or part. The infringing party may deny any infringement or challenge the patents or one or more claims as invalid or unenforceable. Litigation proceedings may also fail, and even if successful, they may result in substantial costs and distraction of our management and other employees. Furthermore, in any infringement proceeding, a court may decide that a patent of ours, or one or more claims of such patent, is not valid, or is interpreted narrowly or is unenforceable, or may refuse to stop the other party from using the supposedly infringing technology on the grounds that our patents, or one or more claims of such patents, do not cover such technology. Our product candidates may be subject to the same risks.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An adverse determination of any litigation or other proceedings could put one or more of our patents at risk of being invalidated or interpreted narrowly and could put our patent applications at risk of not issuing.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interference, derivation review, or other proceedings brought at the USPTO may be necessary to determine the priority or patentability of inventions with respect to our patent applications or those of our licensors or licensees. Litigation or USPTO proceedings brought by us may fail or may be invoked against us by third parties. Even if we are successful in any proceedings (domestic or foreign, litigation or USPTO or foreign patent office or other proceedings) they may result in substantial costs and distraction to our management. Moreover, proceedings may be appealed and obtaining a final resolution can take a long time </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and substantial resources. We may not be able, alone or with our licensors or licensees, to prevent misappropriation of our proprietary rights, particularly in countries where the laws may not protect such rights as fully as in the U.S. Furthermore, because of the substantial amount and extent of discovery required in connection with intellectual property litigation or other proceedings, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation or proceedings. In addition, during the course of this kind of litigation or proceedings, there could be public announcements of the results of hearings, motions or other interim proceedings or developments or public access to related documents. If investors perceive these results to be negative, the market price for our common stock could be significantly harmed and this may be so even if the results are not considered material.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not obtain intellectual property rights or otherwise be able to protect our intellectual property rights throughout the world.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filing, prosecuting and defending patents on product candidates in all or most countries throughout the world would be prohibitively expensive. We primarily file patent applications in the United States and may file in some other selected jurisdictions on a case-by-case basis. In general, we may on a case-by-case basis file national applications more narrowly in respect of patent applications directed to compositions of matter and methods of treatment than for those concerning new chemical entities. As a result, our intellectual property rights in countries outside the United States are generally significantly less extensive than those in the United States. In addition, the laws of some foreign countries and jurisdictions, particularly of certain developing countries and jurisdictions, do not protect intellectual property rights to the same extent as federal and state laws in the United States, and these countries and jurisdictions may limit the scope of what can be claimed, and in some cases may even force us to grant a compulsory license to competitors or other third parties. Consequently, we may not be able to prevent third parties from practicing our inventions outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may seek to exploit our technologies in jurisdictions where we have a patent application filed, for example, as it has not been allowed or if allowed where they intend to challenge one or more granted claims. Competitors may use our technologies in jurisdictions where we have not sought or obtained patent protection to develop their own products and further, may export otherwise infringing products to territories where we have patent protection, but protection and enforcement is not as strong or effective as that in the United States. These products may compete with our product candidates, if approved, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. Moreover, competitors or others may raise legal challenges to our intellectual property rights or may infringe upon our intellectual property rights, including through means that may be difficult to prevent or detect.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. In some foreign jurisdictions the patent system, for example, may not allow certain types of claims that are acceptable in the United States or may only accept claims of a narrower scope. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, especially those relating to pharmaceuticals and methods of treatment, which could make it difficult for us to stop the infringement of our patents or of other intellectual property protection, misappropriation of intellectual property rights, or marketing of competing products in violation of our proprietary rights generally. For example, some foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third parties. In addition, some countries limit the enforceability of patents against third parties, including government agencies or government contractors. In such countries, patents may provide limited or no benefit. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims or issue proceedings against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Further, third parties may prevail in their claims against us, which could potentially result in the award of injunctions or substantial damages against us. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our ability to protect and enforce our intellectual property rights may be adversely affected by unforeseen changes in domestic and foreign intellectual property laws and practice.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to enforce covenants not to compete under applicable employment laws,</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally enter into non-competition agreements as part of our employment agreements with our employees. These agreements generally prohibit our employees, if they cease working for us, from competing directly with us or working for our competitors or clients for a limited period. We may be unable to enforce these agreements under the laws of the jurisdictions in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which our employees work and it may be difficult for us to restrict our competitors from benefitting from the expertise our former employees or consultants developed while working for us.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For example, Israeli labor courts place emphasis on freedom of employment and have required employers seeking to enforce non-compete undertakings of a former employee to demonstrate that the competitive activities of the former employee will harm one of a limited number of material interests of the employer which have been recognized by the courts, such as the protection of a company&#8217;s trade secrets or other intellectual property.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to the Securities Markets and Ownership of Our Common Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to maintain compliance with Nasdaq continued listing requirements could result in the delisting of our common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is currently listed on The Nasdaq Global Select Market. On February 28, 2022, we received a notice from  Nasdaq informing us that because the closing bid price for our common stock listed on Nasdaq was below $1.00 per share for 30 consecutive business days, we were not in compliance with the minimum closing bid price requirement for continued listing on The Nasdaq Global Select Market under Nasdaq Marketplace Rule 5550(a)(2) (the &#8220;Rule&#8221;). In accordance with Nasdaq&#8217;s listing rules, we have a period of 180 calendar days, or until August 29, 2022, to regain compliance with the Rule. If at any time during this 180-day period, the closing bid price of our common stock is at least $1.00 per share for a minimum of 10 consecutive business days, Nasdaq will provide written confirmation that we have achieved compliance with the Rule.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notice also disclosed that in the event we do not regain compliance with the Rule by August 29, 2022, we may be eligible for additional time. To qualify for additional time, we would be required to meet the continued listing requirements for market value of publicly held shares and all other initial listing standards (except for the minimum bid price requirement) and be transferred to The Nasdaq Capital Market. We would also need to provide written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If we meet these requirements, Nasdaq will inform us that we have been granted an additional 180 calendar days. However, if it appears to Nasdaq that we will not be able to cure the deficiency, or if we are otherwise not eligible, Nasdaq will provide notice that our securities will be subject to delisting. We intend to continue to monitor the bid price for our common stock between now and August 29, 2022, and will consider available options to resolve the deficiency and regain compliance with the Rule, including seeking stockholder approval of a reverse split of our common stock in order to increase the trading price of our common stock in compliance with The Nasdaq Capital Market rules. There is no assurance, however, that we will be eligible for an additional compliance period or that our common stock will not be delisted from Nasdaq.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The perception among investors that we are at a heightened risk of delisting could negatively affect the market price and trading volume of our common stock. If our common stock is delisted from Nasdaq, the delisting could: substantially decrease trading in our common stock; adversely affect the market liquidity of our common stock as a result of the loss of market efficiencies associated with Nasdaq and the loss of federal preemption of state securities laws; adversely affect our ability to issue additional securities or obtain additional financing in the future on acceptable terms, if at all; result in the potential loss of confidence by investors, suppliers, partners, and employees and fewer business development opportunities; and result in limited news and analyst coverage. Additionally, the market price of our common stock may decline further, and shareholders may lose some or all of their investment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The trading price of the shares of our common stock is volatile, and stockholders could incur substantial losses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock price is volatile. The stock market in general, and the market for biopharmaceutical companies in particular, have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. For example, our stock price, and the stock price of many other public companies, experienced a period of high volatility in 2021. Such volatility resulted in rapid and substantial increases and decreases in our stock price that may or may not be related to our operating performance or prospects. As a result of this volatility, stockholders may not be able to sell their common stock at or above the price paid for the shares. In addition, in the past, stockholders have initiated class action lawsuits against pharmaceutical and biotechnology companies, including us, following periods of volatility in the market prices of these companies&#8217; common stock. If we are subject to future lawsuits we would be subject to additional risks as described in &#8220;We may become subject to lawsuits that could have a material adverse impact on our business, results of operations and financial condition&#8221; above. The market price for our common stock may be influenced by many factors, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of COVID-19 or of another pandemic or epidemic on our business and the broader economy as a whole;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully develop our product candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcement of technological innovations or new products by us;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">development of technological innovations or new competitive products by others;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcement of clinical trial results or any other clinical data results we announce;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the commencement or enrollment of our ongoing clinical trials or any future clinical trials we may conduct, or changes in the development status of our product candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements of clinical trials results by competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse results from, delays in or termination of clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any delay in our regulatory filings and any adverse development or perceived adverse development with respect to the applicable regulatory authority&#8217;s review of such filings, including without limitation the FDA&#8217;s issuance of a &#8220;refusal to file&#8221; letter or a request for additional information;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse regulatory decisions, including failure to receive regulatory approval of product candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to achieve a publicly announced milestone;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated serious safety concerns;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in financial estimates by us or by any securities analysts who might cover our stock;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future capital raising transactions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conditions or trends in our industry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the market valuations of similar companies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">stock market price and volume fluctuations of comparable companies and, in particular, those that operate in the biopharmaceutical industry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">publication of research reports about us or our industry or positive or negative recommendations or withdrawal of research coverage by securities analysts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant acquisitions, strategic partnerships or divestitures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements of investigations or regulatory scrutiny of our operations or lawsuits filed against us;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investors&#8217; general perception of our company and our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recruitment or departure of key personnel;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overall performance of the equity markets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trading volume of our common stock;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant lawsuits, including patent or stockholder litigation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the loss of or failure to obtain material intellectual property rights;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our sale or proposed sale, or the sale by our significant stockholders, of our common stock or other securities in the future;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general political and economic conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sentiment of the retail investor community; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other events or factors, many of which are beyond our control.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consequently, the current market price of our common stock may not be indicative of future market prices, and we may be unable to sustain or increase the value of an investment in our common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in our corporate charter documents and under Delaware law may prevent or frustrate attempts by our stockholders to change our management and hinder efforts to acquire a controlling interest in us, and the market price of our common stock may be lower as a result.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that could delay or prevent changes in control or changes in our management without the consent of our board of directors. These provisions include the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a classified board of directors with three-year staggered terms, which may delay the ability of stockholders to change the membership of a majority of our board of directors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of the board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our board of directors to authorize the issuance of shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our board of directors to alter our bylaws without obtaining stockholder approval;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the required approval of at least 66 2/3% of the shares entitled to vote at an election of directors to adopt, amend or repeal our bylaws or repeal the provisions of our amended and restated certificate of incorporation regarding the election and removal of directors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the requirement that a special meeting of stockholders may be called only by the chief executive officer or the president or the board of directors, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance notice procedures that stockholders must comply with in order to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders&#8217; meeting, which may discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror&#8217;s own slate of directors or otherwise attempting to obtain control of us.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, these provisions would apply even if we were to receive an offer that some stockholders may consider beneficial.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to the anti-takeover provisions contained in Section 203 of the Delaware General Corporation Law. Under Section 203, a corporation may not, in general, engage in a business combination with any holder of 15% or more of its capital stock unless the holder has held the stock for three years or, among other exceptions, the board of directors has approved the transaction.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and amended and restated bylaws provide that we will indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as permitted by Section 145 of the Delaware General Corporation Law, our amended and restated bylaws and our indemnification agreements that we have entered into with our directors and officers provide that:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person&#8217;s conduct was unlawful.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will not be obligated pursuant to our amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person against us or our other indemnitees, except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The rights conferred in our amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not retroactively amend our amended and restated bylaw provisions to reduce our indemnification obligations to directors, officers, employees and agents.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our amended and restated certificate of incorporation and our amended and restated bylaws contain exclusive forum selection clauses, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a breach of fiduciary duty, any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws, any action to interpret, apply, enforce, or determine the validity of our amended and restated certificate of incorporation or our amended and restated bylaws, or any action asserting a claim against us that is governed by the internal affairs doctrine. In addition, our amended and restated bylaws provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States is the exclusive forum </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, against us, our officers, directors, employees or underwriters. These choice of forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and other employees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alternatively, if a court were to find the choice of forum provision contained in our amended and restated certificate of incorporation or our amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an &#8220;emerging growth company&#8221; and, as a result of the reduced disclosure and governance requirements applicable to emerging growth companies, our common stock may be less attractive to investors.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and we intend to take advantage of some of the exemptions from reporting requirements that are applicable to other public companies that are not emerging growth companies, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and registration statements; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">not being required to hold a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Decreased disclosures in our SEC filings due to our status as an emerging growth company may make it harder for investors to analyze our results of operations and financial prospects. Investors may find our common stock less attractive as a result of our reliance on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our share price may be more volatile.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may take advantage of these reporting exemptions until we are no longer an emerging growth company. We will remain an emerging growth company until the earlier of (1) December 31, 2023, (2) the last day of the fiscal year (a) in which we have total annual gross revenue of at least $1.07 billion, or (b) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, or (3) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Section 107(b) of the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">An active public market for our common stock may not be sustained.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our common stock is quoted on the Nasdaq Global Select Market, an active trading market for our common stock may not be sustained. The lack of an active market may impair the ability of holders of our common stock to sell their shares at the time they wish to sell them or at a price that they consider reasonable. The lack of an active market may also reduce the fair market value of our common stock, and may cause the trading price of our common stock to be more volatile. The lack of an active market may contribute to volatility of our stock price, impair our ability to raise capital and may impair our ability to acquire other businesses, applications or technologies using our shares as consideration.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If equity research analysts do not publish research or reports, or publish unfavorable research or reports, about us, our business or our market, our stock price and trading volume could decline.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock may be influenced by the research and reports that equity research analysts publish about us and our business. We do not have any control over the analysts, or the content and opinions included in their reports. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price of our stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts cease coverage of our company or fail to publish reports on us regularly, demand for our stock could decrease, which in turn could cause our stock price or trading volume to decline. If our operating results fail to meet the forecast of analysts, our stock price will likely decline.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of a substantial number of shares of our common stock by our existing stockholders in the public market could cause our stock price to fall.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that our directors, officers or holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. Moreover, certain holders of shares of our common stock have rights, subject to certain conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. We have registered and intend to continue to register all shares of common stock that we may issue under our equity compensation plans. Once we register these shares, they can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not currently intend to pay dividends on our common stock, and, consequently, our stockholders&#8217; ability to achieve a return on their investment will depend on appreciation in the price of our common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently intend to pay any cash dividends on our common stock for the foreseeable future. We currently intend to invest our future earnings, if any, to fund our growth. Therefore, stockholders are not likely to receive any dividends on their common stock for the foreseeable future. Since we do not intend to pay dividends, stockholders&#8217; ability to receive a return on their investment will depend on any future appreciation in the market value of our common stock. Our common stock may not appreciate or even maintain the price at which our holders have purchased it.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act and the rules and regulations of the Nasdaq Stock Market ("Nasdaq"). The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting in our Form 10-K filing each year, as required by Section 404 of the Sarbanes-Oxley Act. This requires that we incur substantial additional professional fees and internal costs within our accounting and finance functions and that we expend significant management efforts.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may identify weaknesses in our system of internal financial and accounting controls and procedures that could result in a material misstatement of our financial statements. Our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to comply with the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner, or if we are unable to maintain proper and effective internal controls, we may not be able to produce timely and accurate financial statements. If that were to happen, the market price of our stock could decline, and we could be subject to sanctions or investigations by the stock exchange on which our common stock is listed, the SEC, or other regulatory authorities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We incur significant costs and demands upon management as a result of being a public company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company listed in the United States, we incur significant additional legal, accounting and other costs, as compared to the costs we incurred as a private company. These additional costs could negatively affect our financial results. In addition, changing laws, regulations and standards relating to corporate governance and public disclosure, including regulations implemented by the SEC and Nasdaq, may increase legal and financial compliance costs and make some activities more time-consuming. These laws, regulations and standards are subject to varying interpretations and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. We may experience significantly increased general and administrative expenses and a diversion of management&#8217;s time and attention from our primary business operations if we are required to invest significant resources to comply with new and evolving laws, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulations and standards. If notwithstanding our efforts to comply with new laws, regulations and standards, we fail to comply, regulatory authorities may initiate legal proceedings against us and our business may be harmed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with these rules might also make it more difficult for us to obtain some types of insurance, including director and officer liability insurance, and we might be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these events could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, on committees of our board of directors or as members of senior management.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_31"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B - UNRESOLVED STAFF COMMENTS</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_34"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2 - PROPERTIES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive offices in the United States are located in Bridgewater, New Jersey. We currently lease approximately 15,000 square feet of office space under a lease that expires on August 31, 2022. We have an option to extend our existing lease for an additional three years on similar conditions. We leased approximately 4,600 square feet of office space and 3,500 square feet of warehouse space in Israel under leases that expire on December 31, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our current office space and facilities in the United States and Israel are adequate to meet our current needs, and that suitable additional alternative spaces will be available in the future on commercially reasonable terms for our future growth.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_37"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3 - LEGAL PROCEEDINGS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in litigation or other legal proceedings relating to claims that we consider to be arising from the ordinary course of our business. There are currently no claims or actions pending against us that, in the opinion of our management, are likely to have a material adverse effect on our business. See "Item 8. Financial Statements and Supplementary Data&#8212;Note 12. Commitments and Contingencies." </span></div><div id="i3ee2f3590755456d8887827db5ee11c4_40"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4 - MINE SAFETY DISCLOSURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_43"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_46"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5 - MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on Nasdaq under the symbol &#8220;VYNE.&#8221; </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 10, 2021, our Board of Directors approved a one-for-four reverse stock split of our outstanding shares of common stock. The reverse stock split was effected on February 12, 2021 at 5:00 p.m. Eastern time. At the effective time, every four issued and outstanding shares of our common stock were converted into one share of common stock. No fractional shares were issued in connection with the reverse stock split, and in lieu thereof, each stockholder holding fractional shares was entitled to receive a cash payment (without interest or deduction) from the Company&#8217;s transfer agent in an amount equal to such stockholder&#8217;s respective pro rata shares of the total net proceeds from the Company&#8217;s transfer agent sale of all fractional shares at the then-prevailing prices on the open market. The par value of each share of common stock remained unchanged. A proportionate adjustment was also made to the maximum number of shares issuable under the Company&#8217;s 2019 Equity Incentive Plan, 2018 Omnibus Incentive Plan and 2019 Employee Share Purchase Plan.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders of Common Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;2, 2022, there were approximately 8 holders of record of our common stock.  This number does not include beneficial owners whose shares are held by nominees in street name.</span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6 - [RESERVED]</span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7 - MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the financial statements and the notes thereto included elsewhere in this report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this report, particularly in the section entitled &#8220;Item 1A. Risk Factors&#8221;.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed through the merger (the "Merger") between Foamix Pharmaceuticals Ltd. ("Foamix") and Menlo Therapeutics Inc. ("Menlo"). The Merger was accounted for as a reverse acquisition, with Foamix allocating the purchase price consideration to the tangible and intangible assets acquired and liabilities assumed from Menlo, and the excess purchase price recorded as goodwill. In accordance with reverse acquisition accounting, Foamix&#8217;s consolidated financial statements are deemed those of the predecessor entity and, accordingly, the historical financial statements presented herein are those of Foamix. The Company changed its name to VYNE Therapeutics Inc. in September 2020.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_55"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Our most advanced product candidate, FMX114, which is in Phase 2a, is being evaluated for the potential treatment of mild-to-moderate AD.  We are also in the pre-clinical stages of developing products containing BET inhibitor compounds.  Our initial BET inhibitor candidate in development is VYN201, a locally administered pan-BET inhibitor, which we are exploring in various immuno-inflammatory diseases, including skin diseases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, we continue to explore opportunistic transactions that may enhance our pipeline portfolio, as well as support our current operations and fund our future growth.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the second quarter of 2021, we conducted a review of our commercial and research and development portfolio to determine how to optimally deploy capital and drive shareholder value. During the course of this review, we carefully considered the revenues received from the commercialization of AMZEEQ (minocycline) topical foam, 4%, and ZILXI (minocycline) topical foam, 1.5%, and the associated costs to drive those revenues, the protracted negative impact of the COVID-19 pandemic during the commercial launches of both AMZEEQ and ZILXI, the payor landscape, as well as the costs to develop each of our pipeline products. During this process, we evaluated several strategic options, including the acquisition of marketed assets, out-licensing our approved products outside of the United States, and possible partnering or co-development relationships with interested parties. Following our review, we determined to initiate a process to divest our topical minocycline franchise, including AMZEEQ, ZILXI, FCD105 (the Company&#8217;s former Phase 3 proprietary novel topical combination foam formulation of minocycline and adapalene for the treatment of moderate-to-severe acne vulgaris) and the underlying Molecule Stabilizing Technology platform.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, we entered into an Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Journey Medical Corporation ("Journey&#8221;) pursuant to which we sold our Molecule Stabilizing Technology franchise, including AMZEEQ, ZILXI, and FCD105 (the &#8220;MST Franchise&#8221;), to Journey. The assets included certain contracts, including the license agreement with Cutia Therapeutics (HK) Limited (&#8220;Cutia&#8221;), inventory and intellectual property related to the MST Franchise (together, the &#8220;Assets&#8221;). Pursuant to the Purchase Agreement, Journey assumed certain liabilities of the MST Franchise including, among others, those arising from VYNE&#8217;s patent infringement suit initiated against Padagis Israel Pharmaceuticals Ltd. There were no current or long-term liabilities recorded by the Company which were transferred to the Buyer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Purchase Agreement, VYNE received an upfront payment of $20.0 million and will receive an additional $5.0 million on the one-year anniversary of the closing of the transaction. We are also eligible to receive sales milestone payments of up to $450.0 million in the aggregate upon the achievement of specified levels of net sales on a product-by-product basis, beginning with annual net sales exceeding $100.0 million (with products covered in three categories (1) AMZEEQ (and certain modifications), (2) ZILXI (and certain modifications), and (3) FCD105 and other products covered by the patents being transferred, including certain modifications). In addition, we are entitled to receive certain payments from any licensing or sublicensing of the assets by Journey outside of the United States.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we transitioned from a commercial organization to one focused on research and development, we further streamlined operations by continuing to eliminate the vast majority of planned expenditures supporting our commercial operations. Furthermore, we  reduced our workforce of 106 as of December&#160;31, 2020 to 28 as of December&#160;31, 2021 through the termination of approximately 70 employees and through additional attrition. We incurred a one-time charge of $1.6&#160;million in the year ended December 31, 2021 in connection with this restructuring plan, consisting of $1.4&#160;million of employee </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">termination costs, including severance and other benefits, and retention payments of $0.2&#160;million.  Additional charges of $0.2&#160;million related to retention payments are anticipated through June 30, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Developments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of selected key developments affecting our business that have occurred since December&#160;31, 2020:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">From January 1, 2021 through January 25, 2021, the Company sold 2,778,012 shares of common stock at a weighted average price per share of $9.76 for $26.3 million in net proceeds pursuant to a Sales Agreement (the "2019 Sales Agreement") with Cantor Fitzgerald &amp; Co. ("Cantor Fitzgerald") through an at-the-market equity offering program under which Cantor Fitzgerald acted as our sales agent.  Effective as of January 25, 2021, the Company terminated the 2019 Sales Agreement.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On January 28, 2021, the Company completed a registered direct offering of 5,274,261 shares of common stock at a price of $9.48 per share. The net proceeds of the offering were approximately $46.8 million, after deducting placement agent fees and other offering expenses. The number of shares sold and purchase price have been adjusted to reflect the Company's 1-for-4 reverse stock split. See below for additional discussion about the reverse stock split. </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On February 10, 2021, our Board of Directors approved a one-for-four reverse stock split of our outstanding shares of common stock. The reverse stock split was effected on February 12, 2021 at 5:00 p.m. Eastern time. At the effective time, every four issued and outstanding shares of our common stock were converted into one share of common stock. No fractional shares were issued in connection with the reverse stock split, and in lieu thereof, each stockholder holding fractional shares was entitled to receive a cash payment (without interest or deduction) from the Company&#8217;s transfer agent in an amount equal to such stockholder&#8217;s respective pro rata shares of the total net proceeds from the Company&#8217;s transfer agent sale of all fractional shares at the then-prevailing prices on the open market. In connection with the reverse stock split, the number of authorized shares of our common stock was also reduced on a one-for-four basis, from 300 million to 75 million. The par value of each share of common stock remained unchanged. A proportionate adjustment was also made to the maximum number of shares issuable under the Company&#8217;s 2019 Equity Incentive Plan, 2018 Omnibus Incentive Plan and 2019 Employee Share Purchase Plan. </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On March 1, 2021, we announced development plans for FMX114 for the potential treatment of mild-to-moderate atopic dermatitis. FMX114 is a fixed combination of tofacitinib, which is a pan-Janus kinase (JAK) inhibitor, and fingolimod, a sphingosine 1-phosphate receptor modulator. FMX114 attempts to address both the source and cause of inflammation in atopic dermatitis and support skin barrier recovery.  </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Tyler Zeronda was appointed as our interim Chief Financial Officer and Treasurer, effective as of June 18, 2021, following the resignation of Andrew Saik. Mr. Zeronda was named Chief Financial Officer and Treasurer of the Company on March 14, 2022. </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 19, 2021, we amended our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 75,000,000 to 150,000,000 shares. The increase in the number of authorized shares was approved by the holders of a majority of the outstanding shares of common stock at the Company's annual meeting of stockholders held on July 19, 2021.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On August 11, 2021, the Company prepaid its outstanding indebtedness in addition to a 4% prepayment fee and accrued but unpaid interest. Following the prepayment, the Amended and Restated Credit Agreement and the security interests thereunder were terminated. </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On August 12, 2021, we announced a licensing arrangement with In4Derm, giving us access to their library of novel BET inhibitor compounds. </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On August 12, 2021, we announced that we initiated a process to explore a sale or license of our topical minocycline franchise and the refocusing of our resources on our immuno-inflammatory development programs.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On August 12, 2021, we entered into a sales agreement with Cantor Fitzgerald &amp; Co. to sell shares of our common stock, from time to time, with aggregate gross sales proceeds of up to $50.0 million through an at-the-market equity offering program under which Cantor Fitzgerald will act as our sales agent. From August 12, 2021 through December 31, 2021, we issued and sold 1,955,313 shares of common stock at a weighted average sales price per share of $1.57 for $2.9&#160;million in net proceeds. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On October 19, 2021, we announced that the first patient was enrolled in our Phase 1b/2a clinical trial evaluating FMX114 for the treatment of mild-to-moderate atopic dermatitis. We expect topline results from the study in the second quarter of 2022.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On October 21, 2021, we announced the formation of a scientific advisory board ("SAB") composed of leading scientists and academics specializing in immunological and inflammatory diseases. The SAB will provide scientific expertise and guidance to the VYNE management team and Board, as the Company progresses its pipeline of innovative treatments for immuno-inflammatory conditions.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On October 26, 2021, we announced preclinical data showing that our pan-BET inhibitor, VYN201, significantly reduced the expression of several key pro-inflammatory cytokines relevant to Th17-mediated autoimmune diseases in an animal model and an ex vivo human tissue study.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On January 12, 2022, we entered into the Purchase Agreement with Journey pursuant to which we divested the Assets for $25.0 million and milestone payments of up to $450.0 million in aggregate upon the achievement of specified levels of net sales of the products covered by the Purchase Agreement.  Of the $25.0 million, $20.0 million was received at close and $5.0 million is due upon the one-year anniversary of the transaction.  This transaction was accounted for in 2022.  See discussion in Note 17 to the audited financial statements.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On January 19, 2022, we announced findings from the Phase 1b safety portion of the Phase 1b/2a trial evaluating FMX 114.  </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On February 28, 2022, we received a notification from Nasdaq that we are not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company&#8217;s common stock was below $1.00 per share for 30 consecutive business days. We have a period of 180 calendar days from the date of notification, or until August 29, 2022, to regain compliance with the minimum bid price requirement. The notification does not impact the listing of the Company&#8217;s common stock on the Nasdaq Global Select Market at this time.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On March 7, 2022, we announced positive preclinical data for VYN201 in a human skin model of vitiligo. In the model, VYN201 reduced the expression of key pro-inflammatory biomarkers relevant to the pathogenesis of vitiligo, and demonstrated marked reduction in melanocyte loss.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On March 15, 2022, we entered into a purchase agreement (the "Equity Purchase Agreement"), with Lincoln Park Capital Fund, LLC ("Lincoln Park") which provides that, upon the terms and subject to the conditions and limitations set forth therein, we may sell to Lincoln Park, at our discretion, up to $30.0 million of shares of our common stock over the 36-month term of the Equity Purchase Agreement. Upon execution of the Equity Purchase Agreement, we issued 1,667,593 shares of our common stock to Lincoln Park as commitment shares in accordance with the closing conditions contained within the Equity Purchase Agreement.   </span></div><div id="i3ee2f3590755456d8887827db5ee11c4_58"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue during the periods presented has been primarily comprised of AMZEEQ and ZILXI product sales and collaboration and license revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AMZEEQ and ZILXI were commercially launched in January and October of 2020, respectively. We generated product revenue of $13.8 million for the year ended December&#160;31, 2021. We will not commercially launch our other product candidates in the United States or generate any revenues from sales of any of our product candidates unless and until we obtain marketing approval. We will not generate revenue from the sales of AMZEEQ or ZILXI after January 12, 2022 as a result of the sale of the Assets. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have generated revenues under development and license agreements, including royalty payments in relation to Finacea, the prescription foam product that we developed in collaboration with Bayer, which later assigned it to LEO. In the three months ended March 31, 2020, we did not receive or become entitled to any royalty payments due to a suspension of the manufacturing of Finacea by LEO following inadequate supply of quality-compliant batches of the API used in such product. In April 2020, LEO informed us that it had reestablished the supply of Finacea foam and resumed commercial sale in the United States. In the year ended December&#160;31, 2021 we received royalties of $0.9 million. Our rights to royalty payments from the sale of Finacea were not transferred in the sale of the Assets. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on April 23, 2020, we announced that we entered into a licensing agreement with Cutia for our topical minocycline products and product candidate.  We received an upfront cash payment of&#160;$10 million related to the licensing agreement with Cutia in 2020.&#160;The Cutia license agreement was assigned to Journey in connection with the sale of the Assets. Therefore, we will not receive any payments from Cutia going forward. </span></div><div id="i3ee2f3590755456d8887827db5ee11c4_61"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Goods Sold</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross margin percentage of&#160;75.8%&#160;was favorably impacted during the year ended&#160;December&#160;31, 2021&#160;by product sales with certain materials produced prior to FDA approval and therefore expensed in prior periods. If inventory sold during the year ended&#160;December&#160;31, 2021&#160;was valued at cost, our gross margin for the period then ended would have been&#160;74.6%.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold expenses consist primarily of:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">third party expenses incurred in manufacturing product for sale;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">transportation costs incurred in shipping manufacturing materials between third parties; and</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">other costs associated with delivery and manufacturing of product.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_64"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses to date relate primarily to the development of AMZEEQ, ZILXI and FCD105, FMX114, VYN201 and VYN202. Our total research and development expenses for the year ended December&#160;31, 2021 and 2020 were approximately $25.0 million and $43.5 million, respectively. We charge all research and development expenses to operations as they are incurred.  Following the sale of the MST Franchise in January 2022, our research and development will be focused on our BET inhibitor platform and FMX 114.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee-related expenses, including salaries, benefits and related expenses, including share based compensation expenses;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses incurred under agreements with third parties, including subcontractors, suppliers and consultants that conduct regulatory activities, clinical trials and preclinical studies;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses incurred to acquire, develop and manufacture clinical trial materials;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with the creation, development and protection of intellectual property;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other costs associated with preclinical and clinical activities and regulatory operations; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">materials and manufacturing costs related to commercial production prior to FDA approval.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our selling, general and administrative expenses for the year ended December&#160;31, 2021 and 2020 were approximately $54.5 million and $89.5 million, respectively. The decline in these costs is primarily associated with cost savings measures related to our shift from a commercial organization to a research and development organization beginning in August 2021.  The decrease is also due to severance expenses for Menlo employees, stock based compensation awards, merger expenses and sales and marketing expenses which were incurred in connection with the commercialization of AMZEEQ and ZILXI in 2020 that were not incurred in 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our selling, general and administrative expenses consist principally of:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee-related expenses, including salaries, benefits and related expenses, including share-based compensation expenses;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with selling, marketing and shipping and handling costs;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">legal and professional fees for auditors and other consulting expenses; and </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">facility, information technology and depreciation expenses.</span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_67"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense primarily consisted of interest expense on our long-term debt.  During the year ended December 31, 2021, interest expense also included prepayment penalties of $1.4 million and the write off of deferred financing costs of $1.6 million.  As a result of the prepayment of our indebtedness outstanding under the Amended and Restated Credit Agreement in August 2021, we do not expect to incur material interest expense going forward. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income, net</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Income, net primarily consists of gains from interest earned from our bank deposits, financial income on our marketable securities and a revaluation of our derivative liability. </span></div><div id="i3ee2f3590755456d8887827db5ee11c4_70"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes and Net Operating Loss Carryforwards</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant net operating losses (&#8220;NOLs&#8221;) since our inception. We expect to continue to incur NOLs until such a time when AMZEEQ, ZILXI&#160;or any other product, if approved in the future, generates adequate revenues for us to reach profitability. As of December&#160;31, 2021, we had federal and state net operating loss carryforwards of $315.0 million and $105.6 million, respectively, of which $44.3 million and $105.6 million of these carryforwards will begin to expire starting in 2031 through 2040 for federal and state purposes, respectively. As of December&#160;31, 2021, we had federal and state research and development tax credit carryforwards of $6.7 million and $1.2 million, respectively. The federal credits begin to expire in 2031 and the California research credits have no expiration dates. As of December&#160;31, 2021, the Company had $270.7 million in federal and state NOLs with no limited period of use.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company began liquidation proceedings of its Israeli subsidiary, VYNE Pharmaceuticals Ltd., to align with its business strategy. As a result thereof, the Company's intellectual property was assigned to the U.S. parent company and we recognized a $163.0 million taxable gain for Israeli income tax purposes. However, the taxable gain was fully offset by net operating loss carryforwards, resulting in no income tax expense to the Company.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOLs and tax credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service and may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant stockholders over a three-year period in excess of 50%, as defined under Sections&#160;382 and 383 of the Internal Revenue Code of 1986, as amended. This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of our company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. State NOLs and tax credit carryforwards may be subject to similar limitations under state laws. We have not determined if we have experienced Section&#160;382 ownership changes in the past and if a portion of our net operating loss and tax credit carryforwards are subject to an annual limitation under Sections&#160;382 or 383. We may have experienced ownership changes in the past, including in connection to our initial public offering (&#8220;IPO&#8221;), and as a result of the Merger and/or subsequent shifts in our stock ownership, some of which may be outside of our control. As a result, even if we earn net taxable income, our ability to use the NOL and tax credit carryforwards may be materially limited, which could harm our future operating results by effectively increasing our future tax obligations.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_73"></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations for the Years Ended December&#160;31, 2021 and December&#160;31, 2020</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Operations</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:0.1%"></td><td style="width:2.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except %)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Variance</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and in-process research &amp; development impairments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CSR Remeasurement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Operating Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes on income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182.2)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.3)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues totaled $14.8 million and $21.0 million for the years ended December&#160;31, 2021 and 2020, respectively. For the year ended December&#160;31, 2021, our revenue consisted of $13.8 million of product sales, and $0.9 million of royalty revenue. For the year ended December&#160;31, 2020, our revenues consisted of $10.2 million of product sales, $10.0 million of license revenue, and $0.8 million of royalty revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested our minocycline business on January 12, 2022. As a result of the sale, we will not generate revenue from the sales of AMZEEQ or ZILXI following such date. In addition, the Cutia License Agreement was assigned to Journey in connection with the sale. Therefore, we will not be entitled to payments under the Cutia License Agreement going forward. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in license revenue for the year ended December&#160;31, 2021 as compared to license revenue for the year ended December&#160;31, 2020 is due to the upfront payment received in 2020 under the Cutia License Agreement for the marketing and sale of the topical minocycline products in Greater China.  No similar payments were received in 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Goods Sold</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold was $3.3 million and $1.4 million for the years ended December&#160;31, 2021 and 2020, respectively. The increase in cost of goods sold was primarily due to an increase in sales volume.  Our gross margin percentage was 75.8% and 86.4% for the years ended December&#160;31, 2021 and December&#160;31, 2020, respectively, was favorably impacted&#160;by product sales with certain materials produced prior to FDA approval and therefore expensed in prior periods. If inventory sold during the year ended December&#160;31, 2021 and December&#160;31, 2020&#160;was valued at cost, our gross margin for the period then ended would have been&#160;74.6% and 82.5%.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses for the year ended December&#160;31, 2021 were $25.0 million, representing a decrease of $18.6 million, or 42.7%, compared to $43.5 million for the year ended December&#160;31, 2020. The decrease was primarily driven by a $11.2&#160;million decrease in employee related expenses due to severance payments made in 2020 to former Menlo employees, a $11.8&#160;million decrease in clinical and manufacturing expenses due to the completion of the FCD105 and serlopitant trials and a $2.0 decrease in depreciation expense related to a write off of fixed assets during the fourth quarter of 2020.  These decreases are offset by $6.5&#160;million of increased clinical costs related to FMX114 and the BET inhibitor assets licensed from In4Derm.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our selling, general and administrative expenses for the year ended December&#160;31, 2021 were $54.5 million, representing a decrease of $35.1 million, or 39.2%, compared to $89.5 million for the year ended December&#160;31, 2020. The decrease was driven by a $21.0&#160;million reduction in employee related expenses in 2021 as compared to 2020, including $8.2&#160;million of incremental stock based compensation related to the conversion of the Contingent Stock Rights ("CSRs") issued as part of the Merger in 2020 that was not incurred in 2021.  The decrease in employee related expenses was also due to a reduction in workforce in 2021 resulting from the decision to divest the minocycline franchise. Corporate and professional costs decreased by approximately $14.1&#160;million including a decrease of approximately $10.1&#160;million for costs which were eliminated or reduced in 2021 following the Merger. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and in-process research &amp; development impairments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we recorded goodwill and in-process research &amp; development impairments of $54.3 million of which $4.5 million was recorded for goodwill and $49.8 million for in process research and development due to the failed clinical trials for serlopitant for the treatment of pruritus associated with prurigo nodularis.  No impairments were recorded in the year ended December&#160;31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Stock Right Remeasurement</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of the merger transaction with Foamix, we entered into a contingent stock right agreement that called for the issuance of additional shares of our common stock to legacy Foamix shareholders upon negative data from the Phase III PN Trials. Since the trials did not meet the milestones outlined per the agreement, the contingent stock rights were remeasured, resulting in an expense of $84.7 million in the year ended December&#160;31, 2020.  No such expense occurred in the year ended December&#160;31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the year ended December&#160;31, 2021 was $5.6 million, representing an increase of $1.2 million, or 27.8%, compared to $4.4 million for the year ended December&#160;31, 2020.  The increase is primarily attributable to the prepayment penalty of $1.4&#160;million associated with the prepayment of our outstanding debt and the write off of deferred financing costs of $1.6&#160;million, offset by the elimination of ongoing interest expense and deferred financing cost amortization.   </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other expense (income), net</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense (income), net for the year ended December&#160;31, 2021 was $0.1 million, representing a decrease of $1.2 million, or 112%, compared to $(1.1) million for the year ended December&#160;31, 2020.  The decrease is primarily due to gains on derivative liabilities and marketable securities in 2020.  No such gains occurred in 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_76"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have funded operations primarily through private and public placements of our equity, debt and warrants and through fees, cost reimbursements and payments received from our licensees. We commenced generating product revenues related to sales of AMZEEQ and ZILXI&#160;in January 2020 and October 2020, respectively.  AMZEEQ and ZILXI were sold as part of the sale of the MST Franchise on January 12, 2022 and, as such, we will no longer be generating revenue from the sale of these products. We have incurred losses and experienced negative operating cash flows since our inception and anticipate that we will continue to incur losses until such a time when our product candidates, if approved, are commercially successful, if at all. We will not generate any revenue from any current or future product candidates unless and until we obtain regulatory </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approval and commercialize such products.  For the year ended December&#160;31, 2021, we incurred a net loss of $73.3&#160;million and used $56.4&#160;million of cash in operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had cash and cash equivalents of $42.9 million. Our cash and cash equivalents are held in money market accounts. We also received proceeds of $20.0&#160;million from the sale of the MST Franchise in January 2022 and will receive an additional $5.0 million payment on the one year anniversary of the sale.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the sale of the MST Franchise, we are refocusing our limited resources on our drug development programs. Research and development activities for these programs, including preclinical and clinical testing of our drug candidates, will require significant additional financing. The future viability of the Company and our ability to continue as a going concern is dependent on our ability to raise sufficient working capital through either debt or equity financing to fund our operations and successfully develop commercially viable drug candidates. There is no assurance we will be able to achieve these objectives under acceptable terms or at all.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (Subtopic 205-40), we have evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that our audited consolidated financial statements are issued. The accompanying audited consolidated financial statements have been prepared assuming that we will continue as a going concern and contemplate the realization of assets and the satisfaction of liabilities in the normal course of business. Our ability to continue as a going concern is expected to be impacted by the outcome of the plans outlined above, including our ability to raise additional capital to fund our operations, positive results from clinical trials for FMX114, and the successful development and positive results from clinical trials for the BET inhibitor programs. Based on our current plans and assumptions, we believe that absent sufficient proceeds received from equity transactions, financing transactions or business development transactions,  we will not have sufficient cash and cash equivalents to fund our operations beyond one year from the issuance of these financial statements. Accordingly, we will, over the course of the next twelve months, require significant additional financing to continue our operations. These factors therefore, raise substantial doubt about our ability to continue as a going concern. Failure to successfully receive additional financing will require us to delay, scale back or otherwise modify our business and our research and development activities and other operations. See "Item1A. Risk Factors&#8212;Other Risks Related to Our Business and Financial Operations&#8212;We will need substantial additional funding to fund our operations, and there is substantial doubt about our ability to continue as a going concern. We could also be forced to delay, reduce or terminate our research and development activities which would have a material adverse effect on our financial condition."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities or any other adjustments that might be necessary should we be unable to continue as a going concern.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_79"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Resources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have financed our operations primarily through private and public placements of our common stock, debt and warrants and through the sale of our products, fees, cost reimbursements and payments received from our licensees.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flows</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our statement of cash flows for the years ended December 31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash (used in) / provided by:</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(56,367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(137,082)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash used in operating activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, net cash used in operating activities was $56.4 million and primarily reflected our net loss of $73.3&#160;million offset by non-cash charges of $8.1&#160;million in stock based compensation and $1.4 million in deferred finance charge write-offs and $4.8 million of net increase in assets and liabilities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, net cash used in operating activities was $137.1 million and primarily reflected our net loss of $255.6 million, partially offset by non-cash charges of $54.3&#160;million of impairments, $84.7&#160;million of remeasurement of CSRs, share-based compensation of 18.1 million and the loss on the disposal of fixed assets of 2.1 million.  The remainder of the cash used in operations is driven by net decrease in assets and liabilities. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash provided by investing activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, net cash provided by investing activities was $1.0 million and was comprised of proceeds from the sale and maturity of marketable securities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, net cash provided by investing activities was $89.1&#160;million and was primarily comprised of cash acquired through the Merger of $38.6&#160;million and proceeds from the sale and maturity of marketable securities and bank deposits of $50.6&#160;million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash provided by financing activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, net cash provided by financing activities was $39.8 million and was primarily attributable to $76.0 million of cash from the issuance of common stock offset by $36.4&#160;million from the prepayment of debt repayment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, net cash provided by financing activities was $61.8&#160;million and was primarily the result of proceeds from the issuance of common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and funding sources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sources of funding in the year ended December&#160;31, 2021 totaled $76.0&#160;million and consisted primarily of $29.2&#160;million net proceeds from our at-the-market program and $46.8 million net proceeds from our registered direct public offering completed in January 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 28, 2021, the Company completed a registered direct offering of 5,274,261 shares of common stock at a price of $9.48 per share for $46.8 million in net proceeds, as adjusted for the Company's 1-for-4 reverse stock split. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From January 1, 2021 through January 25, 2021, the Company issued and sold an additional 2,778,012 shares of common stock at a weighted average price per share of $9.76 for $26.3 million in net proceeds, as adjusted for the Company's 1-for-4 reverse stock split, in "at-the-market" offerings pursuant to the Sales Agreement.  From August 12, 2021 through December 31,2021, the Company issued and sold 1,955,313 shares of common stock at a weighted average per share price of $1.57 pursuant to the Sales Agreement for $2.9 million in net proceeds.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sources of funding in the year ended December&#160;31, 2020 totaled $100.3 million and consisted primarily of $38.6 million of cash and investments acquired in the Merger, $53.6 million of proceeds from an underwritten public offering of common stock completed in June 2020, and $8.0 million of proceeds from our at-the-market program during the fourth quarter of 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no ongoing material financial commitments (such as lines of credit) that may affect our liquidity over the next five years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obligations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant non-cancelable contractual obligations as of December&#160;31, 2021 consisted of:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Obligations under lease commitments (see Note 10)</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Open purchase commitments of $3.9&#160;million</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding requirements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our present and future funding requirements will depend on many factors, including, but not limited to the following:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with the research and development of drug candidates;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time and costs involved in obtaining regulatory approval for our other pipeline product candidates and any delays we may encounter as a result of evolving regulatory requirements or adverse results with respect to any of these product candidates;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">terms and timing of any acquisitions, collaborations or other arrangements;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of potential new products we identify and decide to develop; and</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs involved in filing and prosecuting patent applications and obtaining, maintaining and enforcing patents or defending against claims or infringements raised by third parties, and license royalties or other amounts we may be required to pay to obtain rights to third party intellectual property rights.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating plan may change as a result of many factors currently unknown to us, and any such change may affect our funding requirements. We may therefore need to seek additional capital sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations or additional license arrangements. Such financings may result in dilution to stockholders, imposition of debt covenants and repayment obligations or other restrictions that may affect our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information as to the risks associated with our future funding needs, see &#8220;Item 1A&#8212;Risk Factors&#8221; included herein.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_82"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we did not have any off-balance sheet arrangements.</span></div><div><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_85"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Significant Judgments and Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepare our consolidated financial statements in accordance with generally accepted accounting principles in the United States. The preparation of consolidated financial statements also requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from the estimates made by our management. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our significant accounting policies are more fully described in Note 2, &#8220;Significant Accounting Policies,&#8221; to the consolidated financial statements included in &#8220;Financial Statements and Supplementary Data&#8221; of this Annual Report, we believe that the following accounting policies are the most critical to assist shareholders and investors reading the consolidated financial statements in fully understanding and evaluating our financial condition and results of operations. These policies relate to significant areas involving management&#8217;s judgments and estimates and that require our most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic continues to impact the Company&#8217;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of the pandemic;  the impact on worldwide macroeconomic conditions; the speed of the anticipated recovery; and governmental and business reactions to the pandemic. In addition, the Company further assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December&#160;31, 2021 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, inventory and related reserves, impairments of long-lived assets and revenue recognition. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record revenue based on a five-step model in accordance with Accounting Standards Codification ("ASC") 606,&#160;Revenue from Contracts with Customers&#160;("ASC 606"). For the Collaboration Agreement under ASC 606, we identify the performance </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">obligations, determine the transaction price, allocate the contract transaction price to the performance obligations, and recognize the revenue when (or as) the performance obligation is satisfied.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identify the performance obligations included within the agreement and evaluate which performance obligations are distinct. Upfront payments for licenses are evaluated to determine if the license is capable of being distinct from the obligations to participate on certain&#160;development and/or commercialization committees with the collaboration partners and supply manufactured drug product for clinical trials. For performance obligations that are satisfied over time, we utilize the input method and revenue is recognized by consistently applying a method of measuring progress toward complete satisfaction of that performance obligation. We periodically review our estimated periods of performance based on the progress under each arrangement and account for the impact of any changes in estimated periods of performance on a prospective basis.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Milestone payments are a form of variable consideration as the payments are contingent upon achievement of a substantive event. Milestone payments are estimated and included in the transaction price when we determine that it is probable that there will not be a significant reversal of cumulative revenue recognized in future periods.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Acquisition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial statements include the operations of an acquired business after the completion of the acquisition. We account for acquired businesses using the acquisition method of accounting, which requires, among other things, that most assets acquired and liabilities assumed be recognized at their estimated fair values as of the acquisition date and that the fair value of In-Process Research and Development and Goodwill is recorded on the balance sheet. Transaction costs are expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recorded in connection with an acquisition can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting.&#160; For example, we use fair value in the initial recognition of net assets acquired in a business combination and when measuring impairment losses.&#160; We estimate fair value using an exit price approach, which requires, among other things, that we determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of non-financial assets and, for liabilities, assuming that the risk of non-performance will be the same before and after the transfer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When estimating fair value, depending on the nature and complexity of the asset or liability, we may use one or all of the following techniques:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost approach, which is based on the cost to acquire or construct comparable assets, less an allowance for functional and/or economic obsolescence.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fair value methodologies depend on the following types of inputs:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for identical assets or liabilities in active markets (Level 1 inputs).</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means (Level 2 inputs).</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unobservable inputs that reflect estimates and assumptions (Level 3 inputs).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A single estimate of fair value can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Asset Impairment</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review all of our long-lived assets for impairment indicators throughout the year. We perform impairment testing for indefinite-lived intangible assets annually and for all other long-lived assets whenever impairment indicators are present. When necessary, we record charges for impairments of long-lived assets for the amount by which the fair value is less than the carrying value of these assets.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_88"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain recently issued accounting pronouncements are discussed in Note 2, &#8220;Significant Accounting Policies,&#8221; to the consolidated financial statements included in &#8220;Financial Statements and Supplementary Data&#8221; of this Annual Report.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_91"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a &#8220;smaller reporting company,&#8221; as defined by Item 10 of Regulation S-K, we are not required to provide quantitative or qualitative disclosures about market risk.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_94"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8 - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements</span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VYNE THERAPEUTICS INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS OF DECEMBER 31, 2021</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INDEX</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:93.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.757%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8. Financial Statements and Supplementary Data</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_103">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> (<ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF85Ny9mcmFnOjMxMTE0MDc1NGI3MTQzNTJhM2U5YWY0MTFhOWVmMjA1L3RhYmxlOmY5OGMzODRhNTYwYzQ4ZThhOTMxMGYyZmJjOTc5MjA4L3RhYmxlcmFuZ2U6Zjk4YzM4NGE1NjBjNDhlOGE5MzEwZjJmYmM5NzkyMDhfMi0wLTEtMS0zMDc0Ni90ZXh0cmVnaW9uOmZjOWRjNjI2OTViZDRiOWViNTZmMDRjZGZiY2MyZDc0XzI1ODM4NTIzMjUyOTcz_60e5f222-d427-404d-9e07-7e7149072458">PricewaterhouseCoopers LLP</ix:nonNumeric>, <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF85Ny9mcmFnOjMxMTE0MDc1NGI3MTQzNTJhM2U5YWY0MTFhOWVmMjA1L3RhYmxlOmY5OGMzODRhNTYwYzQ4ZThhOTMxMGYyZmJjOTc5MjA4L3RhYmxlcmFuZ2U6Zjk4YzM4NGE1NjBjNDhlOGE5MzEwZjJmYmM5NzkyMDhfMi0wLTEtMS0zMDc0Ni90ZXh0cmVnaW9uOmZjOWRjNjI2OTViZDRiOWViNTZmMDRjZGZiY2MyZDc0XzI1ODM4NTIzMjUyOTky_f126f79e-ea26-4eb6-9a5a-84f0d84755de">Florham Park, NJ</ix:nonNumeric>, PCAOB ID <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF85Ny9mcmFnOjMxMTE0MDc1NGI3MTQzNTJhM2U5YWY0MTFhOWVmMjA1L3RhYmxlOmY5OGMzODRhNTYwYzQ4ZThhOTMxMGYyZmJjOTc5MjA4L3RhYmxlcmFuZ2U6Zjk4YzM4NGE1NjBjNDhlOGE5MzEwZjJmYmM5NzkyMDhfMi0wLTEtMS0zMDc0Ni90ZXh0cmVnaW9uOmZjOWRjNjI2OTViZDRiOWViNTZmMDRjZGZiY2MyZDc0XzIxOTkwMjMyNTU2OTY_3dfc02e8-8895-42b5-ac56-77c31cb0ad8a">238</ix:nonNumeric>)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_103">2</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_106">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_106">3</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_109">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_109">4</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_112">Consolidated Statements of Comprehensive Loss</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_112">5</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_115">Statements of Changes in Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_115">6</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_118">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_118">7</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_121">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i3ee2f3590755456d8887827db5ee11c4_121">9</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="margin-top:7pt"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_100"></div><div style="margin-top:12pt"><span><br/></span></div><div style="text-align:center"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the Board of Directors and Shareholders of VYNE Therapeutics Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of VYNE Therapeutics Inc. and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021 and 2020, and the related consolidated statements of operations, of comprehensive loss, of changes in shareholders' equity and of cash flows for the years then ended, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Substantial Doubt About the Company&#8217;s Ability to Continue as a Going Concern</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has incurred losses and experienced negative operating cash flows since its inception that raise substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also discussed in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-indent:5pt"><span><br/></span></div><div style="text-indent:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">/s/ PricewaterhouseCoopers LLP</span></div><div style="text-indent:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florham Park, New Jersey </span></div><div style="text-indent:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">March 17, 2022</span></div><div style="text-indent:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have served as the Company&#8217;s auditor since 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_103"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 1</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VYNE THERAPEUTICS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. dollars in thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQtMS0xLTEtMTc2ODk_f4c9ce67-9cce-486c-b843-1be59552484d">42,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQtMy0xLTEtMTc2ODk_dd2b64cb-4089-4f60-b10e-48598fdb9ed1">57,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUtMS0xLTEtMTc2ODk_bfe03fb0-2620-435b-a9d1-1a520121d86d">605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUtMy0xLTEtMTc2ODk_c801fe3a-4d75-43d5-a866-4098a243033b">855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in marketable securities (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzctMS0xLTEtMTc2ODk_97df8f51-643e-4ac2-9821-8d13199f0578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzctMy0xLTEtMTc2ODk_e2aa0e43-b39f-4f02-baaa-cc3ded537e77">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade receivable, net of allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzgtMS0xLTEtMzM1NDg_4b77e0af-b05a-4fde-bd37-4cb5261fab03">7,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzgtMy0xLTEtMzM1NDg_6862724f-8489-4aa7-8432-23cf5360a57d">15,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory (Note 7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzgtMS0xLTEtMTc2ODk_9b82e42b-13e6-4612-ad55-521581a8a6f5">7,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzgtMy0xLTEtMTc2ODk_ae495480-8aef-4c29-9b1e-7b6a750d5ecb">7,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEwLTEtMS0xLTE3Njg5_cdc861ce-4d08-492b-9a4c-d9870a0c3671">5,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEwLTMtMS0xLTE3Njg5_56724078-05d4-4495-9859-e3f258e8ed18">4,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right of use assets (Note 10)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="vyne:OperatingLeaseRightOfUseAssetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEyLTEtMS0xLTM1NTA0_22a8ec2e-e6e8-403f-a9a7-f91729d5bb88">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="vyne:OperatingLeaseRightOfUseAssetCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEyLTMtMS0xLTM1ODYz_ef748d5c-6553-4eda-9371-e2ed558ea6fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEyLTEtMS0xLTE3Njg5_7c94aa10-9884-4a15-88d6-f1c8679e0a5d">63,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEyLTMtMS0xLTE3Njg5_05dd54c7-e88a-4d04-8522-a98866d7efd5">87,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net (Note 8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE3LTEtMS0xLTE3Njg5_d75b656d-7ada-4650-875e-d3c36d5aced2">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE3LTMtMS0xLTE3Njg5_18551e06-55e7-4301-8240-1cfed6c34575">555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right of use assets (Note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE4LTEtMS0xLTE3Njg5_f60fcf1b-430e-46a9-b042-01f329906a91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE4LTMtMS0xLTE3Njg5_b27c21d7-90bf-483c-9c64-1e702bdb7a98">1,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE5LTEtMS0xLTE3Njg5_7f66297d-9e76-4321-9127-c2600abe229d">3,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE5LTMtMS0xLTE3Njg5_bff2f8f8-174d-4b3d-9704-0384b6ac28e8">4,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160; Non-current Assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzIwLTEtMS0xLTE3Njg5_584680b7-b19a-489d-a089-a6144c50559f">3,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzIwLTMtMS0xLTE3Njg5_5520c588-05c4-43f7-a5b3-93829dc488f5">6,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160; Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzIyLTEtMS0xLTE3Njg5_0b42c0db-e454-4b07-8ed0-28ab7e25e1a0">67,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzIyLTMtMS0xLTE3Njg5_c46f4c7a-8ee6-4eec-afe9-45f10c964016">93,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade payables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzI4LTEtMS0xLTI5Njk3_7a143e92-6c8d-44cd-b6db-1361a0a3cead">6,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzI4LTMtMS0xLTI5Njk3_c9b3774d-270f-4272-8d20-2a6a58535b2d">4,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzI5LTEtMS0xLTI5Njk3_92a7ff73-316c-4835-b2e7-f1ada8516b47">8,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzI5LTMtMS0xLTI5Njk3_cb06964a-dbba-462d-859e-aaa08b68e3e7">11,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee-related obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMwLTEtMS0xLTI5Njk3_f431f924-3d38-4618-b654-40d29bf01414">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMwLTMtMS0xLTI5Njk3_decb5c44-5888-478d-b9e1-ec717611fd83">4,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability for employee severance benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMxLTEtMS0xLTMxNjgx_c6bf71d5-dbe3-45ed-a185-0c2e9ef5ac52">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMxLTMtMS0xLTMxNjgx_9ec084cd-a339-48ff-893d-5f958fb8dad7">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities (Note10)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMxLTEtMS0xLTI5Njk3_9163b1b7-7ef2-4f7c-928c-6d38f7ff491d">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMxLTMtMS0xLTI5Njk3_fb9cab36-563d-48a3-9211-2cb9f4181408">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMyLTEtMS0xLTI5Njk3_e5969fcc-88cf-41a1-b64a-8da4fdb5402f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMyLTMtMS0xLTI5Njk3_83e8f617-bb2b-447e-b548-8b1bb7a8c015">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMzLTEtMS0xLTI5Njk3_5dd37d2e-f4a9-4083-ac6e-59a2267f1b44">18,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMzLTMtMS0xLTI5Njk3_84900924-f757-4662-b6fe-f1662bf3088a">21,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities (Note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzM4LTEtMS0xLTI5Njk3_04ba5b0c-cbd5-4f22-8e75-2b35f6f0cbf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzM4LTMtMS0xLTI5Njk3_c18225e9-27ad-443b-8102-6c7cc8201d8c">853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt (Note 13)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzM5LTEtMS0xLTI5Njk3_14748d2e-8299-41cb-8e9b-4a5a13a6bbcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzM5LTMtMS0xLTI5Njk3_9e7b3f86-b55e-4fd3-b4a7-3ea3e46cab25">33,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQwLTEtMS0xLTI5Njk3_22f770bb-8d35-4d8a-b411-c99931cf5c53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:OtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQwLTMtMS0xLTI5Njk3_7a10a7cb-c833-4fce-8098-c3b8f632589c">457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Long-term Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQxLTEtMS0xLTI5Njk3_70e9fb29-cff9-4cbd-899e-48e8df7e84aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQxLTMtMS0xLTI5Njk3_77944091-6ad0-4fc5-a4d5-f3a7687bfea6">34,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQyLTEtMS0xLTI5Njk3_d3536970-c3f7-465c-91cb-ecc5641d565d">18,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQyLTMtMS0xLTI5Njk3_18cad749-795c-42bd-84b2-078de0cc61ca">56,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> (Note 12)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQzLTEtMS0xLTI5Njk3_fff944bd-da0b-417c-9ad7-ffa6b026275a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQzLTMtMS0xLTI5Njk3_ec84571f-61a7-475b-a2c2-57612658f895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shareholders' Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock:  $<ix:nonFraction unitRef="usdPerShare" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfMjI_a6665e37-42e5-4ba0-80c0-8c5874af0a57"><ix:nonFraction unitRef="usdPerShare" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfMjI_ed44bf2d-6604-4a10-befe-c4e1b33d06a8">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfMzY_0aeaba44-600e-417b-91f9-7efbaf20f74e"><ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfMzY_c3788f94-a235-4955-8856-394985c457e5">20,000,000</ix:nonFraction></ix:nonFraction> shares authorized at December&#160;31, 2021 and December&#160;31, 2020, respectively; <ix:nonFraction unitRef="shares" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfODU_7893e53d-0555-44bb-9226-bd867f181b74"><ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfODU_dd5afb82-2ebc-41bb-b971-a20ef79aeb91"><ix:nonFraction unitRef="shares" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfODU_e247aec9-998b-4747-afed-1b9d7587f84a"><ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfODU_e36df299-1436-4b59-bce3-966589f58074">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTEtMS0xLTI5Njk3_25d6625b-48bb-4e8c-81f2-819b292e98e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTMtMS0xLTI5Njk3_1baa291f-bbed-40c8-a8b4-704cc7e118ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfMTg_7bc2de5a-d58c-40e5-a856-19cdcd7dec97"><ix:nonFraction unitRef="usdPerShare" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfMTg_9033aef7-e9ab-4306-ad10-c4578255375e">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfMzI_ffcda176-3269-4538-a549-1c6b53e17258">150,000,000</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfNDY_be1b8fba-57e9-4c04-b8cf-37c364455c87">75,000,000</ix:nonFraction> shares authorized at December&#160;31, 2021 and December&#160;31, 2020, respectively; <ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfOTU_2b24fd20-bdd1-4fd1-b17d-c70ec5d49b28"><ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfOTU_83b77ba7-0bca-476f-ab14-b486249cb4ea">53,577,744</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfMTAy_c6d6aec2-3f71-4751-a16f-fe23b15e97a5"><ix:nonFraction unitRef="shares" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfMTAy_e5e0738e-083e-4422-a34b-0e904801f6bd">43,205,221</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTEtMS0xLTI5Njk3_3323a023-c60e-46bc-9f6a-30de3d6ff7be">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTMtMS0xLTI5Njk3_d4909e44-088b-4195-9c73-db9ae89912fe">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ3LTEtMS0xLTI5Njk3_3e5abe6a-4cd4-4d4b-af66-df1412c5be0e">688,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ3LTMtMS0xLTI5Njk3_35cc23b9-6065-44e3-b5f4-8ace66c6f005">603,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ4LTEtMS0xLTI5Njk3_73b3d97d-ba02-43dc-9c93-128ee6cd33ff">639,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ4LTMtMS0xLTI5Njk3_8970245f-16ba-4805-8456-7b8526925b8a">566,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ5LTEtMS0xLTI5Njk3_6d048e65-aa84-49b3-9efc-5094f2924ca7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ5LTMtMS0xLTI5Njk3_7b6b340f-e71c-4ebc-ad7a-b786aca184b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholders' Equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUwLTEtMS0xLTI5Njk3_d9ab8751-13ff-4a7c-8ddb-ea8a7940a546">48,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUwLTMtMS0xLTI5Njk3_737d8638-ae57-4a2c-993f-5c5c030be569">37,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Liabilities and Shareholders&#8217; Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUxLTEtMS0xLTI5Njk3_4c70e11a-4add-452c-9f0a-a0c678068d05">67,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUxLTMtMS0xLTI5Njk3_49877752-33b9-4311-8587-01c8bc60a932">93,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 3</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VYNE THERAPEUTICS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. dollars in thousands, except per share data)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:70.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Note 4)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd7331082874ff88a6ef07310db1b10_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzMtMS0xLTEtMTc2ODk_e3dad63e-3e7e-4eb2-bc7c-ecd4505762fa">13,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe95dbd24c1e41a1bb7c8821c5966526_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzMtMy0xLTEtMTc2ODk_07668c08-f8e5-47f8-9c0d-42f4fda0cb4f">10,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i479c60f4404d43ad9851018c65b3dd34_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzQtMS0xLTEtMTc2ODk_1023e1ad-5efa-460f-8905-6c4d1c32780b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i516662a4a0d6421a948606bc11a4248c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzQtMy0xLTEtMTc2ODk_dae6c0ee-f78c-43b9-85e4-6de47d2ccd7d">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f3508ae7116426b88ab53b907d0b8a7_D20210101-20211231" decimals="3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzUtMS0xLTEtMTc2ODk_2e4105e8-2c01-4fed-8d43-05740d13bc9e">931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78c293e52180494c8c19af75d240a16f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzUtMy0xLTEtMTc2ODk_c19a2ae7-ab93-4f55-a387-eedb4f459ef0">791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzctMS0xLTEtMTc2ODk_ef8b06d5-d621-49fa-bba7-a65f6861c8f6">14,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzctMy0xLTEtMTc2ODk_d49bd0c2-5e5b-4682-b888-fe3cc28d7d38">20,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzktMS0xLTEtMTc2ODk_31168b83-36a8-4b5f-9fd8-9957c75f8794">3,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzktMy0xLTEtMTc2ODk_33b38b4d-8112-4487-8bce-048866ea259d">1,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzEyLTEtMS0xLTE3Njg5_c31bacfa-8c6a-4baf-8296-55478dc94cec">24,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzEyLTMtMS0xLTE3Njg5_382f7f5e-60a3-4366-8363-b2777a36344e">43,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzEzLTEtMS0xLTE3Njg5_cc83bdbe-f70d-4f69-9224-41336dcf3d65">54,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzEzLTMtMS0xLTE3Njg5_81e47005-1510-4f36-bd28-efdf2019f4c7">89,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and in-process research &amp; development impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE0LTEtMS0xLTE3Njg5_5fe25075-dfff-42fb-8173-dd4a5aeb56d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE0LTMtMS0xLTE3Njg5_cfebeb8e-d194-4481-9853-3928717fadec">54,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Stock Remeasurement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="vyne:ContingentStockConsiderationRemeasurementGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE1LTEtMS0xLTE3Njg5_67c6a973-347d-4097-8749-04e717030849">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="vyne:ContingentStockConsiderationRemeasurementGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE1LTMtMS0xLTE3Njg5_6b7a4e8f-da87-47eb-af77-ee9d97f74319">84,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Operating Expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE2LTEtMS0xLTE3Njg5_1c97a9ac-5dcf-4e1a-992a-5da8de76363d">79,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE2LTMtMS0xLTE3Njg5_f33f9185-28fb-4d91-ad3b-629d44444130">272,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE3LTEtMS0xLTE3Njg5_4c58516d-fa99-4a15-a6b1-e2fc3516081d">68,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE3LTMtMS0xLTE3Njg5_27f7023c-a9bd-4799-9b3f-a25d0e0b5712">252,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:2.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE4LTEtMS0xLTE3Njg5_ce7d74c1-7479-475c-99c8-5e1b1a01c6f3">5,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE4LTMtMS0xLTE3Njg5_d9692822-6abd-4031-92bf-7eab9f7dabe6">4,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:2.25pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE5LTEtMS0xLTE3Njg5_38d175d7-961f-4cf0-808d-4c86be94a1c1">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE5LTMtMS0xLTE3Njg5_69a23f92-cab5-4029-9ea3-b156d1866b9b">1,110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss Before Income Tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIwLTEtMS0xLTE3Njg5_346ce697-d2d5-4f05-a6ea-15fce82368a0">73,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIwLTMtMS0xLTE3Njg5_2eb75a17-a63f-4313-ba70-5adfc00405ce">255,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income Tax (Benefit) Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Note 16)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIxLTEtMS0xLTE3Njg5_59cd0275-83d1-4c0a-96a9-d52acb1694fb">448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIxLTMtMS0xLTE3Njg5_ad9551d9-e67c-45f3-9e5f-9dcbc47ad881">258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIyLTEtMS0xLTE3Njg5_03088a12-916d-4ad9-86f6-ce999a519fab">73,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIyLTMtMS0xLTE3Njg5_3cbc7b16-433e-4aa3-b2f6-964905a560c1">255,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss per share basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI0LTEtMS0xLTE3Njg5_04063859-ef3d-46c9-af1a-6742a57af29d"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI0LTEtMS0xLTE3Njg5_84f603f7-7a58-49d7-8749-6052f786f94e">1.42</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI0LTMtMS0xLTE3Njg5_115eb86b-4ba4-46fc-b4ea-6f74e0ea4154"><ix:nonFraction unitRef="usdPerShare" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI0LTMtMS0xLTE3Njg5_869b53e8-5721-4a47-8362-b56396172c95">7.88</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding - basic and diluted </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI2LTEtMS0xLTE3Njg5_2ee30812-0e72-46ef-9d03-7fa6841bf08c"><ix:nonFraction unitRef="shares" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI2LTEtMS0xLTE3Njg5_bf729396-b8f7-41f5-ad53-82216c0c599f">51,469</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI2LTMtMS0xLTE3Njg5_560a810f-2a70-408d-bd1f-8a9f4e53ca20"><ix:nonFraction unitRef="shares" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI2LTMtMS0xLTE3Njg5_80ca1c92-fa93-445b-9907-7b3f4cdc617a">32,418</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 4</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VYNE THERAPEUTICS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. dollars in thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:70.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzItMS0xLTEtMTc2ODk_e48a146e-e460-466d-a8b0-6226c0e539fc">73,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzItMy0xLTEtMTc2ODk_0e26baef-54e5-4dfc-9a27-ca221b5b68a5">255,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Comprehensive Loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gains from marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzQtMS0xLTEtMTc2ODk_6634b41e-325a-42e7-a84d-4be7f1ac54fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzQtMy0xLTEtMTc2ODk_1f0727f2-9638-4d31-8d2a-06171577dd02">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Losses on marketable securities reclassified into net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzUtMS0xLTEtMTc2ODk_7bb6d9bf-bf67-4cd8-928a-1335b35248f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzUtMy0xLTEtMTc2ODk_da6c1f14-7ca4-44de-8e23-21d5c77c4b95">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzgtMS0xLTEtMTc2ODk_d0544862-37fb-4266-a367-22d0c0e41c65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzgtMy0xLTEtMTc2ODk_42267e7d-2ff9-4668-985b-f45655d780ce">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Comprehensive Loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzktMS0xLTEtMTc2ODk_6e717f82-2ab4-40d8-b576-31ae6f6e956d">73,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzktMy0xLTEtMTc2ODk_93f60177-48bf-4fc5-a82a-a895e151f8fb">255,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 5</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VYNE THERAPEUTICS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. dollars in thousands, except share data)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:34.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional paid-in<br/>capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>other comprehensive<br/>income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if47e65e7cf8947d280a6cd3bc2ec52ee_I20191231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTEtMS0xLTE3Njg5_699598b8-a562-4736-8275-fcba610a26e3">9,120,078</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if47e65e7cf8947d280a6cd3bc2ec52ee_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTMtMS0xLTE3Njg5_edee0ac0-3f75-4362-9207-48648b5eb5aa">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b1207beabf4c39905094c110517562_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTUtMS0xLTE3Njg5_c90d514d-ea7b-4b50-9f8a-dd9b9c52fc2d">328,156</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if43043bf29704f0480ca31e8929ace71_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTctMS0xLTE3Njg5_1d8767cd-f56c-4ef4-848d-3d8d816d3b87">310,587</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5d5892bfe124a9f9812002e2a561ca7_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTktMS0xLTE3Njg5_6e3a2848-df0a-4529-8ef9-756417c9d40a">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i413ad6395c874b3ea0fb49e390a331d2_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTExLTEtMS0xNzY4OQ_8aa65f1a-41b1-4f84-a97a-219e732f424b">17,575</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CHANGES DURING 2020:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e006948a7a24010afaf3207af41b5d5_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE5LTctMS0xLTE3Njg5_8a768d61-7103-48b6-9ee6-3fecaec05c7a">255,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc3ae6194fdc4591b66a1cbe7d6fe9e4_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE5LTktMS0xLTE3Njg5_082e695f-298e-4f85-8556-f56f5c204df0">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE5LTExLTEtMS0xNzY4OQ_648c7edb-3f71-4c9d-8e8e-f89d6906b32f">255,573</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of options, vesting of restricted stock units and shares issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIwLTEtMS0xLTE5OTk3_29dcf0b1-703b-4e0f-b1d8-e88d5f4f05d9">367,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIwLTUtMS0xLTE5OTk3_fc57c25a-a084-4897-bee6-eed9779bb42d">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIwLTExLTEtMS0xOTk5Nw_f0249a0f-6b23-4808-a8b9-2f0f90e7f373">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIxLTUtMS0xLTE5OTk3_335e62f8-637c-4767-a50a-737b99c64c91">18,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIxLTExLTEtMS0xOTk5Nw_9b821c7e-a534-486c-9c3a-82e167bff30f">18,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deemed dividend to warrants holders due to warrant modification</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231" decimals="-3" sign="-" name="vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIxLTUtMS0xLTE3Njg5_805cc5a2-2ed0-41b5-89b0-c95538a335bc">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e006948a7a24010afaf3207af41b5d5_D20200101-20201231" decimals="-3" name="vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIxLTctMS0xLTE3Njg5_7aafd345-188d-4595-93fc-f0707c3ca48a">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIxLTExLTEtMS0xNzY4OQ_2002658f-e716-4203-b1bb-f5c02fea68b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Classification of stock awards to derivative liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231" decimals="-3" name="vyne:ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIyLTUtMS0xLTE3Njg5_1b089feb-bf8d-43e8-b10d-4b27e1927dc0">975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="vyne:ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIyLTExLTEtMS0xNzY4OQ_0692c709-70d7-4fca-8658-d91d792d8f70">975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock, net of $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTAtMS0xLTE5OTU5L3RleHRyZWdpb246NzhjZjY4ZTMxNDJmNDU2M2JlZmMwM2RlNGU0MTg2NDlfMTA5OTUxMTYyNzg3Nw_a45dece5-6167-4bb3-aad5-e1577696920d">4,151</ix:nonFraction> issuance costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTEtMS0xLTE5OTk3_77dc127d-b4c0-40a9-a3d6-82174ae362c3">8,951,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTMtMS0xLTE5OTk3_9d979b81-2b1c-4fff-8966-0b510001521e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTUtMS0xLTE5OTk3_aead2c7c-c8c7-4945-b25f-cc07f0c2fb0a">61,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTExLTEtMS0xOTk5Nw_007413b2-cc4d-42b6-bf1a-476a76567592">61,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of stock related to merger</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTEtMS0xLTE5OTk3_0197e6cd-440e-4140-8891-e34b71a9c879">24,765,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTMtMS0xLTE5OTk3_b17cc078-ec92-43d2-87d0-c500e00bf8f2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTUtMS0xLTE5OTk3_77c01a8d-c13c-4cab-a261-546a6f90eb23">196,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTExLTEtMS0xOTk5Nw_47d5dce5-6bd9-4bab-9e4a-31641ebf5eaf">196,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia95c98274f654d0dbb3883e6494fb991_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTEtMS0xLTE3Njg5_035fd9ee-cf8f-423a-a0b5-0dcf977159d9">43,205,221</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95c98274f654d0dbb3883e6494fb991_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTMtMS0xLTE3Njg5_e46cbbd4-dadf-4a30-9921-cc1646290d31">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f00e75a6bfd46a897f7a483a51d3bf3_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTUtMS0xLTE3Njg5_95564fb6-1362-4324-ac5f-a6122552b137">603,685</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9705c601c1a4a6790f6dd8fdbe9823f_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTctMS0xLTE3Njg5_8be053a2-f8ea-479a-b156-55616eb96f45">566,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i730514296aa347cbbdbbd7988e9b1db9_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTktMS0xLTE3Njg5_9db97d20-57e5-4ce1-8663-ddc912e4e11f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTExLTEtMS0xNzY4OQ_7eb7b734-e23c-4816-aeca-2dd04ce14647">37,493</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CHANGES DURING 2021:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecd12d821ca244dd9d27b10250b62aa9_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTctMS0xLTE3Njg5_02501293-b195-445e-8c4a-0e2f8d26c9e8">73,329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44b2ce2087d41208cbc3e7cc5adaaec_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTktMS0xLTE3Njg5_af47bd19-7886-4784-b93b-cb03aa416637">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTExLTEtMS0xNzY4OQ_e2d3a499-2f96-4203-a03a-609b870a6c50">73,329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of options, vesting of restricted stock units and shares issued under employee share purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i236481f63a1745d09a131f29f465b969_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI2LTEtMS0xLTE3Njg5_799e68d2-a115-44a7-ab5c-7558e6c79fb6">364,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae89d2530b0476aae8a3aac2954a443_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI2LTUtMS0xLTE3Njg5_f0049241-8be6-4b0e-81f7-62599225bf7c">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI2LTExLTEtMS0xNzY4OQ_04bdf1fe-d727-4f32-9ea4-c21bdffcfe16">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae89d2530b0476aae8a3aac2954a443_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTUtMS0xLTE3Njg5_f66128da-d0fb-4375-b574-ff173e5ac14b">8,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTExLTEtMS0xNzY4OQ_9bb628ad-dfff-46c3-950d-e3cea5c1fb34">8,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock, net of $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMwLTAtMS0xLTE3Njg5L3RleHRyZWdpb246NWViY2RlMWZiMTk5NDNmZjg1ZTRjNWU1YWEyOGU5ZWFfMTA5OTUxMTYyNzg3OQ_5d64dcfc-a017-4761-9e85-ec0f98d7c5c4">4,215</ix:nonFraction> issuance costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i236481f63a1745d09a131f29f465b969_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMwLTEtMS0xLTE3Njg5_6338d9e2-3934-417c-b4d0-a05758cd36a2">10,007,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236481f63a1745d09a131f29f465b969_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMwLTMtMS0xLTE3Njg5_54eeebb8-c336-42eb-b7cc-83897092bc2c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ae89d2530b0476aae8a3aac2954a443_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMwLTUtMS0xLTE3Njg5_e47ed337-0a4d-49e5-97c9-97180491ec6e">75,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMwLTExLTEtMS0xNzY4OQ_2df11bfb-8d76-42b4-87b6-5e0f7fb74593">75,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER 31, 2021</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7905f84f35ea488095252b0854ef24b6_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTEtMS0xLTE3Njg5_93045687-ce1d-4d0a-abb5-ad24e7eb10d5">53,577,744.00</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7905f84f35ea488095252b0854ef24b6_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTMtMS0xLTE3Njg5_1f63190c-83b5-4cea-9ac1-306a1116bb5e">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b1bde6ee6947c3815be0701e98b131_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTUtMS0xLTE3Njg5_61ff04de-e2a0-427c-93cb-8c6ae919987f">688,156</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b6992a9bef14397a85f536344720b58_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTctMS0xLTE3Njg5_b03a24a5-3728-4bbd-b9d3-1e3254b7d97d">639,525</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704f51eae14f4b16a31b91248c1468b5_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTktMS0xLTE3Njg5_ffcda9ec-87ff-401c-bd96-9d5d24abcb7d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTExLTEtMS0xNzY4OQ_4c2b8c26-a4d7-4036-96a3-26ad8e67f70f">48,636</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 6</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VYNE THERAPEUTICS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. dollars in thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows From Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMtMS0xLTEtMTc2ODk_2a22a810-7634-4ab5-98c6-b33010e49952">73,329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMtMy0xLTEtMTc2ODk_ddfaa7b6-8faf-465e-a45c-bac329c0a895">255,568</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments required to reconcile net loss to net cash used in<br/>operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzUtMS0xLTEtMTc2ODk_7693a026-27cf-4d2e-9c61-23d1c74782b6">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzUtMy0xLTEtMTc2ODk_b1e11b09-145c-4fbf-a446-927a3b16dd5f">341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and in-process research &amp; development impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzYtMS0xLTEtMTc2ODk_bb149673-f84c-4cdd-be67-7250f5a57aec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzYtMy0xLTEtMTc2ODk_bd9ad5cf-0dde-4a34-b303-e3988e9494c8">54,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent stock right remeasurement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="vyne:ContingentStockConsiderationRemeasurementGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzctMS0xLTEtMTc2ODk_084351a1-9dc1-43cd-8d30-4e5a946c37db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="vyne:ContingentStockConsiderationRemeasurementGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzctMy0xLTEtMTc2ODk_152659f8-f50c-4b28-8de7-22858395ad3b">84,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from sale and disposal of fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="vyne:GainLossOnSaleAndDispositionOfFixedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzgtMS0xLTEtMTc2ODk_6f111da3-40f9-4f0e-922b-bed63110e56b">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="vyne:GainLossOnSaleAndDispositionOfFixedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzgtMy0xLTEtMTc2ODk_468883d9-ba21-4366-b8ac-3e10b55f6e10">2,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in marketable securities and bank deposits, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzktMS0xLTEtMTc2ODk_c5877a0a-fb54-48a9-995d-a61b393bfe46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzktMy0xLTEtMTc2ODk_caf69821-0354-4d02-b6d4-471c4470d788">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt prepayment premium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzEwLTEtMS0xLTMwMTcw_ba43f333-82a7-4e4d-a438-4fe5a1c5a5e9">1,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzEwLTMtMS0xLTMwMzQ0_df488150-aa65-48a6-973c-8d8ea5bfa469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzExLTEtMS0xLTE3Njg5_d296f183-512c-4559-8948-91cc3f69868b">8,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzExLTMtMS0xLTE3Njg5_929612df-df34-4e5a-8927-1f92c53f9f3e">18,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash other expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzEyLTEtMS0xLTE3Njg5_40c5b5f7-0c49-4cf5-8687-f877f0121496">2,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzEyLTMtMS0xLTE3Njg5_00aa4842-10f5-4e45-9676-1d9185fdd6de">654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 30.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating asset and liabilities, net of effects of businesses acquired:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 10pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease (increase) in trade receivables, prepaid and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE0LTEtMS0xLTE3Njg5_206aa785-368a-460a-bd54-3c97d289817b">7,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE0LTMtMS0xLTE3Njg5_a3856915-54ad-44ae-906e-a0ae1741f78c">17,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease (increase) in other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE1LTEtMS0xLTE3Njg5_444195e0-560c-4e45-91fd-f654ed4fe731">841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE1LTMtMS0xLTE3Njg5_c152e8ed-d57b-4a62-9c83-99b9c7fccebe">4,171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 10pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Decrease) in accounts payable and accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE2LTEtMS0xLTE3Njg5_9be6871d-3dbf-4a4d-9f21-ceb1f7ba7a10">2,675</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE2LTMtMS0xLTE3Njg5_9753c9e2-e0fd-4c7c-a362-0ce39d77f362">12,975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:justify;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Decrease) increase in inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE3LTEtMS0xLTE3Njg5_a44b63f5-5ad1-4a51-8269-492b5142306a">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE3LTMtMS0xLTE3Njg5_d3ac9b07-c708-49ff-a7cb-f62a7018984a">6,048</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease (increase) in other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE4LTEtMS0xLTE3Njg5_3027eabc-fdea-4e7f-863f-0c23b39c2d12">1,212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE4LTMtMS0xLTE3Njg5_547581f3-a460-4f08-a99e-84f8c26fad1c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE5LTEtMS0xLTE3Njg5_87a79601-b25a-4b9e-a588-71ce0a1b8c3b">56,367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE5LTMtMS0xLTE3Njg5_758a752e-9044-492e-b43a-fadb7938dd9a">137,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows From Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzIxLTEtMS0xLTE3Njg5_44c33459-7255-4330-b8b7-c277c4c05368">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzIxLTMtMS0xLTE3Njg5_e3434320-de2d-4c07-a2f9-f4a92156a900">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash acquired through merger</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI0LTEtMS0xLTE3Njg5_8135bda9-529d-45bd-97ff-9d08663e0a36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI0LTMtMS0xLTE3Njg5_1c159922-3eb4-4c73-8835-f01597f6bd48">38,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale and maturity of marketable securities and bank deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI1LTEtMS0xLTE3Njg5_9809c9ab-8a48-454b-9cf2-d4037e853718">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI1LTMtMS0xLTE3Njg5_5b32ff89-9d3c-47eb-9b4f-9791979bc752">50,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI2LTEtMS0xLTE3Njg5_cf0fc821-ea65-4b27-b064-94f59d3d5551">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI2LTMtMS0xLTE3Njg5_faf92cab-9cee-4079-a598-e0e0eacf40fe">89,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows From Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt repayment (Note 13)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI4LTEtMS0xLTE3Njg5_865709e9-40d6-48bd-b216-bbb5b886f21d">36,432</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI4LTMtMS0xLTE3Njg5_969a6647-521a-432c-97a8-20139a523f05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercise of options and issuance of shares under the employee shares purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI5LTEtMS0xLTE3Njg5_087f06ba-15ab-4b0a-ad08-62bca8fa19d0">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI5LTMtMS0xLTE3Njg5_c3b30b27-7c69-4d37-be5d-e37d507ddcfc">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Withholding tax from net exercise of restricted share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMwLTEtMS0xLTE3Njg5_0fecce9b-f97b-4187-a426-b33d7fae67ad">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMwLTMtMS0xLTE3Njg5_1fdf5cfa-3306-4c82-be7e-8be390a14dfe">141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMxLTEtMS0xLTE3Njg5_55332cef-26fa-4157-9ebc-586bac4ac726">75,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMxLTMtMS0xLTE3Njg5_1a738cb4-e3a0-488e-a142-aa9108e6f1d9">61,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM1LTEtMS0xLTE3Njg5_583837be-28a4-4cdf-ab1d-0385f290fddb">39,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM1LTMtMS0xLTE3Njg5_c239cdc7-452c-4d52-bcbd-1a8c3417e837">61,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Decrease) Increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM2LTEtMS0xLTE3Njg5_9d4943ca-a35d-4c19-9bba-b3ccaf3d4e78">15,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM2LTMtMS0xLTE3Njg5_23c9a204-bcaa-4e59-be80-4254980b2ed5">13,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of exchange rate on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM3LTEtMS0xLTE3Njg5_c9ede75d-9173-4cba-857c-1ecaeb2e6d77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM3LTMtMS0xLTE3Njg5_b091ddcf-e640-4744-9b65-754e820d610a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM4LTEtMS0xLTE3Njg5_03e15d01-04c7-4993-b704-d3c6232c86fa">58,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i413ad6395c874b3ea0fb49e390a331d2_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM4LTMtMS0xLTE3Njg5_6baa82b2-d1ce-4b61-9090-7aa9b037150f">44,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at end of the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM5LTEtMS0xLTE3Njg5_e67b5bd3-5bb2-4b19-98b7-1e4dde312eb6">42,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM5LTMtMS0xLTE3Njg5_fe655758-ada7-4506-b050-0d7393d817f4">58,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQxLTEtMS0xLTE3Njg5_64ce4476-4e5f-459d-8597-f1a7ed8cccb2">42,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQxLTMtMS0xLTE3Njg5_d4f050d3-cd41-44ec-926a-b340e083ffb5">57,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQyLTEtMS0xLTE3Njg5_394ec21a-fffd-4014-9510-a8b9a57a498b">605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQyLTMtMS0xLTE3Njg5_7f9344ab-9796-4e7e-a569-ab8254c5d8d8">855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash shown in statement of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQzLTEtMS0xLTE3Njg5_b03362a2-da93-4d13-8b54-a4bb93da0398">42,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQzLTMtMS0xLTE3Njg5_548784af-50d0-4564-92e4-66b6a7812477">58,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VYNE THERAPEUTICS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. dollars in thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplementary information on investing and financing activities not involving cash flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of shares under employee share purchase plan</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzQtMS0xLTEtMTc2ODk_0cc48c6b-5ced-44ba-be2a-2121960abb6b">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzQtMy0xLTEtMTc2ODk_d1ad9b62-da03-41c0-94b2-0fab06d15e44">387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to operating lease right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzYtMS0xLTEtMTc2ODk_c9859cd7-669d-4fb1-8929-26d005b54803">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzYtMy0xLTEtMTc2ODk_4211e096-0bbc-4569-9a5c-a445d8cb8b93">1,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions to operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:CapitalLeaseObligationsIncurred" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzctMS0xLTEtMTc2ODk_bb710cdf-5af7-4e0f-90a4-10de3ffa9a0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:CapitalLeaseObligationsIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzctMy0xLTEtMTc2ODk_fc0a4c65-b6ae-4a24-a181-ba2f83e59356">1,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest received</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="vyne:InterestReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzExLTEtMS0xLTE3Njg5_2fbf51e7-6a23-488a-9975-144e2286683a">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="vyne:InterestReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzExLTMtMS0xLTE3Njg5_fab9539a-33d8-4c89-b128-1535b66b3314">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzEyLTEtMS0xLTE3Njg5_f689b74c-712d-424c-a295-1b4a2b82c9fe">2,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzEyLTMtMS0xLTE3Njg5_d67f5d60-f808-4818-93d8-c222bc567f5f">3,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE0LTEtMS0xLTE3Njg5_3f840b88-285f-4b40-8998-ec0fa188d76a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE0LTMtMS0xLTE3Njg5_4fde525e-f5d9-46cf-bfbb-374053315651">117,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE1LTEtMS0xLTE3Njg5_aefb4c53-80b4-4acb-ab59-5bdb8690a4ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE1LTMtMS0xLTE3Njg5_067b349f-2d54-45f2-a248-2cfcbc94a566">5,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net acquired (See &#8220;Note 3- Business combination&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE2LTEtMS0xLTE3Njg5_893d9c15-f5c3-403a-b062-8007451650d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE2LTMtMS0xLTE3Njg5_067d4b97-fad1-492f-a3bb-1adee2ea8c37">111,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="vyne:NonCashAcquisitionOfBusinessCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE3LTEtMS0xLTE3Njg5_f64f3fb7-d074-48d9-83ed-23e23aafb686">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="vyne:NonCashAcquisitionOfBusinessCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE3LTMtMS0xLTE3Njg5_0501851c-7647-4be2-acef-2bf95caacd80">38,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Merger net of cash acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="vyne:NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE4LTEtMS0xLTE3Njg5_71f0c346-c98b-43e7-9384-e5d3760c5b0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="vyne:NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE4LTMtMS0xLTE3Njg5_401fbec7-2337-4118-926e-89ac00e21676">72,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 8</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_121"></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VYNE THERAPEUTICS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. dollars in thousands, except share and per share amounts)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div id="i3ee2f3590755456d8887827db5ee11c4_124"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzIxOTkwMjMyNjc0NjI_dff68b2c-102b-4a07-8295-6e2348b662c4" continuedAt="i5455498fac06444c8ec920aa29bb41cc" escape="true">NATURE OF OPERATIONS</ix:nonNumeric></span></div><ix:continuation id="i5455498fac06444c8ec920aa29bb41cc" continuedAt="i04c4a4a05b474b4c8451c096104e5d36"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Company</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">VYNE Therapeutics Inc., ("VYNE" or the "Company") is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. The Company's most advanced product candidate, FMX114, which is in Phase 2a, is being evaluated for the potential treatment of mild-to-moderate AD.  The Company is also in the pre-clinical stages of developing products containing BET inhibitor compounds.  Its initial BET inhibitor candidate in development is VYN201, a locally administered pan-BET inhibitor, which the Company is exploring in various immuno-inflammatory diseases, including skin diseases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In addition, the Company continues to explore opportunistic transactions that may enhance its pipeline portfolio, as well as support its current operations and fund its future growth. The Company is a Delaware corporation, has its principal executive offices in Bridgewater, New Jersey and operates as&#160;<ix:nonFraction unitRef="segment" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzU4Ng_cd73892d-a5f0-4fcb-bc95-79bbbbb00650">one</ix:nonFraction>&#160;business segment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Strategic Business Review and Sale of the MST Franchise</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the second quarter of 2021, the Company conducted a review of its commercial and research and development portfolio to determine how to optimally deploy capital and drive shareholder value. During the course of this review, the Company carefully considered the revenues received from the commercialization of AMZEEQ and ZILXI and the associated costs to drive those revenues, the protracted negative impact of the COVID-19 pandemic during the commercial launches of both AMZEEQ and ZILXI, the payor landscape, as well as the costs to develop each of its pipeline products. During this process, the Company evaluated several strategic options including the acquisition of marketed assets, out-licensing its approved products outside of the United States, and possible partnering or co-development relationships with interested parties. Following its review, the Company determined to initiate a process to explore a possible sale or license of its topical minocycline franchise, including AMZEEQ, ZILXI, FCD105 (the Company&#8217;s former Phase 3 proprietary novel topical combination foam formulation of minocycline and adapalene for the treatment of moderate-to-severe acne vulgaris) and the underlying Molecule Stabilizing Technology platform.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, VYNE entered into an Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Journey Medical Corporation (&#8221;Journey&#8221;) pursuant to which the Company sold its Molecule Stabilizing Technology franchise, including AMZEEQ, ZILXI, and FCD105 (the &#8220;MST Franchise&#8221;), to Journey. The assets include certain contracts, including the license agreement with Cutia Therapeutics (HK) Limited (&#8220;Cutia&#8221;), inventory and intellectual property related to the MST Franchise (together, the &#8220;Assets&#8221;). Pursuant to the Agreement, the Buyer assumed certain liabilities of the MST Franchise including, among others, those arising from VYNE&#8217;s patent infringement suit initiated against Padagis Israel Pharmaceuticals Ltd. There were no current or long-term liabilities recorded by the Company which were transferred to the Buyer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Pursuant to the Purchase Agreement, VYNE received an upfront payment of  $<ix:nonFraction unitRef="usd" contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112" decimals="-5" name="vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MDAxMTU_9dcc8788-e8ab-4b27-a4d2-5b6c65656cc4">20.0</ix:nonFraction>&#160;million and will receive an additional $<ix:nonFraction unitRef="usd" contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112" decimals="-5" name="vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MDAxMjY_e814d8a0-ff07-4dc7-80bc-48a204b5e041">5.0</ix:nonFraction>&#160;million on the <ix:nonNumeric contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112" name="vyne:PeriodOfClosingTransaction" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMwOTQ2Mjk_69b8a917-36fa-4ea6-9178-b060dd8d7d38">one-year</ix:nonNumeric> anniversary of the closing of the transaction. VYNE is also eligible to receive sales milestone payments of up to  $<ix:nonFraction unitRef="usd" contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112" decimals="-5" name="vyne:DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MDAxMzM_c918adb4-8cf9-435d-ba6b-cf25dc3aa0b0">450.0</ix:nonFraction>&#160;million in the aggregate upon the achievement of specified levels of net sales on a product-by-product basis, beginning with annual net sales exceeding $<ix:nonFraction unitRef="usd" contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112" decimals="INF" name="vyne:MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMwOTQ2MDQ_2ff7e952-568b-4145-9944-51eaa594fd67">100.0</ix:nonFraction> million (with products covered in three categories (1) AMZEEQ (and certain modifications), (2) ZILXI (and certain modifications), and (3) FCD105 and other products covered by the patents being transferred, including certain modifications). In addition, VYNE is entitled to receive certain payments from any licensing or sublicensing of the assets by Journey outside of the United States.  See Note 17 - Subsequent Events for additional discussion of the disposition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By leveraging its drug development and clinical development capabilities and strong network of discovery and preclinical science partners, the Company has transitioned its strategic focus to develop therapies for the treatment of immuno-inflammatory conditions. The Company expects to continue to invest in FMX114 for the treatment of mild to moderate atopic dermatitis and enrolled the first patient in its Phase 1b/2a proof-of-concept study in October 2021. On January 19, 2022, the Company announced findings from the Phase 1b safety portion of the Phase 1b/2a trial evaluating FMX 114. The findings support trial continuation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on August 12, 2021, the Company announced a transaction with In4Derm Limited, a company incorporated and registered in Scotland (&#8220;In4Derm&#8221;). In4Derm is a spin-out of the University of Dundee&#8217;s School of Life Sciences which has discovered and is developing proprietary Bromodomain and Extra-Terminal Domain ("BET") inhibitors for the treatment of immunology and oncology conditions. On April 30, 2021, the parties entered into an Evaluation and Option Agreement (the &#8220;Option Agreement&#8221;) pursuant to which In4Derm granted the Company an exclusive option to obtain exclusive worldwide </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i04c4a4a05b474b4c8451c096104e5d36" continuedAt="i316f2a77e5dc43c6b8d8557839198da5"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rights to research, develop and commercialize products containing In4Derm&#8217;s BET inhibitor compounds, which are new chemical entities for treatments in all fields for any disease, disorder or condition in humans. On August 6, 2021, the parties entered into a License Agreement granting the Company a worldwide, exclusive license that is sublicensable through multiple tiers to exploit certain of In4Derm&#8217;s pan-BD BET inhibitor compounds in all fields. The Company paid a $<ix:nonFraction unitRef="usd" contextRef="i3f84161efc234efd80e4eaa6e6f105d5_D20210806-20210806" decimals="-5" name="vyne:PaymentsForLicensingAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTE5NjA_e49ba9f4-bd30-426f-81b0-d25221684124">1.0</ix:nonFraction>&#160;million cash payment to In4Derm upon the execution of the Option Agreement and $<ix:nonFraction unitRef="usd" contextRef="i477ed4d994a24491901ffcdf33bca2bc_D20210806-20210806" decimals="-5" name="vyne:PaymentsForLicensingAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTE5NDY_ca9140b7-cfaa-423d-980e-0df7328be621">0.5</ix:nonFraction>&#160;million in connection with entering into the License Agreement. Pursuant to the License Agreement, the Company has agreed to make cash payments to In4Derm upon the achievement of specified clinical development and regulatory approval milestones with respect to each licensed topical product in the U.S. of up to $<ix:nonFraction unitRef="usd" contextRef="i477ed4d994a24491901ffcdf33bca2bc_D20210806-20210806" decimals="-4" name="vyne:MilestonePaymentsUponAchievingCertainCriteriaMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTE5MzA_396ef6c0-7518-4bd8-b353-5b3d15baab01">15.75</ix:nonFraction>&#160;million for all indications. In addition, the Company currently expects to exercise the Oral BETi Option following the selection of a lead candidate for the program. Upon exercise of the exclusive Oral BETi Option, the parties will sign a license agreement (the &#8220;Oral License Agreement&#8221;), and the Company will be required to pay In4Derm a $<ix:nonFraction unitRef="usd" contextRef="iccf5d6ca3a0e4b62ae5cb3f221bd420c_D20210806-20210806" decimals="-5" name="vyne:PaymentsForLicensingAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTE5NzQ_afb0869f-3273-4f94-a2d2-e21b0960a3af">4.0</ix:nonFraction>&#160;million cash payment. The Oral License Agreement will include cash payments of up to $<ix:nonFraction unitRef="usd" contextRef="iccf5d6ca3a0e4b62ae5cb3f221bd420c_D20210806-20210806" decimals="-4" name="vyne:MilestonePaymentsUponAchievingCertainCriteriaMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTE5ODg_f69dcc2b-97bd-4776-b206-3289dbe66a76">43.75</ix:nonFraction>&#160;million payable to In4Derm upon the achievement of specified clinical development and regulatory approval milestones with respect to each licensed oral product in the U.S. for all indications. The license agreements also provide for tiered royalty payments of up to <ix:nonFraction unitRef="number" contextRef="i0d600c9dd1a04a7c8e003a167844054e_I20210806" decimals="2" name="vyne:RoyaltyPaymentPercentMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTIwMDQ_ca03480d-b4f0-4a57-a4f9-52b833ffbf92">10</ix:nonFraction>% of net annual sales across licensed BET inhibitor products by the Company. In4Derm is entitled to additional milestones upon the achievement of regulatory approvals in certain jurisdictions outside the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial BET inhibitor candidates in development are VYN201 and VYN202. VYN201 is a pan-bromodomain or pan-BD BET inhibitor. It is a first-in-class &#8220;soft&#8221; pan-BD BET inhibitor that is being developed to address diseases involving multiple, diverse inflammatory cell signaling pathways.  With the VYN201 program, the Company is attempting to develop a therapy that is locally acting and is rapidly cleared through the body's metabolic process so as to avoid systemic absorption. The Company is continuing to evaluate VYN201 in a variety of preclinical models and will announce an initial indication for VYN201 following such evaluation. With respect to the VYN202 program, the Company is exploring multiple BET inhibitor compounds that are highly selective for bromodomain 2 ("BD2"). By selectively inhibiting BD2, the Company believes VYN202 could have a more targeted anti-inflammatory effect with an improved benefit/risk profile. The Company is diligently working with In4Derm to develop a lead molecule for the VYN202 program. Once a lead candidate has been selected, the Company intends to exercise its option with respect to these BET inhibitor compounds and commence an IND-enabling preclinical safety program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company transitioned from a commercial organization to one focused on research and development, the Company streamlined operations by eliminating the vast majority of planned expenditures supporting its commercial operations. Furthermore, following its decision to divest the MST franchise, the Company reduced its workforce by terminating approximately <ix:nonFraction unitRef="employee" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMwOTQ1NzI_1b10ca0a-e7d0-47d7-a0b1-2fa73e839030">70</ix:nonFraction> employees. The Company incurred a one-time charge of $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE2OTk1ODc_db9f28f0-eaab-4d68-bb15-d40f9ecd406a">1.6</ix:nonFraction>&#160;million  in the year ended December 31, 2021 in connection with this restructuring plan, consisting of $<ix:nonFraction unitRef="usd" contextRef="ia5eadddfbc494126bf9aa92fd1fba8f3_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE2OTk2MDc_92fd55f6-00ea-4e22-8ed8-459bd1bde29a">1.4</ix:nonFraction>&#160;million of employee termination costs, including severance and other benefits, and retention payments of $<ix:nonFraction unitRef="usd" contextRef="ida05e158eeb4498bad602ba50db10863_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE2OTk2MjQ_f3c4b1ef-fea4-4cd7-b55c-43f5d8d72e00">0.2</ix:nonFraction>&#160;million.  Additional charges of $<ix:nonFraction unitRef="usd" contextRef="i50aaf6903e0449e78c0c8a43db1571f7_I20211231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE2OTk2NDA_bb70dcd0-8394-4a23-b63d-d38e42ee4bf1">0.2</ix:nonFraction> million related to retention payments are anticipated through June 30, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reverse stock split and recasting of per-share amounts </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 10, 2021, our Board of Directors approved a one-for-four reverse stock split of our outstanding shares of common stock. The reverse stock split was effected on February 12, 2021 at 5:00 p.m. Eastern time. At the effective time, every four issued and outstanding shares of our common stock were converted into one share of common stock. No fractional shares were issued in connection with the reverse stock split, and in lieu thereof, each stockholder holding fractional shares was entitled to receive a cash payment (without interest or deduction) from the Company&#8217;s transfer agent in an amount equal to such stockholder&#8217;s respective pro rata shares of the total net proceeds from the Company&#8217;s transfer agent sale of all fractional shares at the then-prevailing prices on the open market. In connection with the reverse stock split, the number of authorized shares of our common stock was also reduced on a one-for-four basis, from <ix:nonFraction unitRef="shares" contextRef="ia5cf7aa626774cfea6cad9737b2d831f_I20210212" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzI2NjY_15b1d6cc-3acf-489e-9c98-3c180ff04f8f">300</ix:nonFraction>&#160;million shares to <ix:nonFraction unitRef="shares" contextRef="iba55a12228574923bbb188bfa1675bd5_I20210212" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzI2Nzk_a7b1dc44-c750-493b-ad27-acfdc56c3686">75</ix:nonFraction>&#160;million shares. The par value of each share of common stock remained unchanged. A proportionate adjustment was also made to the maximum number of shares issuable under the Company&#8217;s 2019 Equity Incentive Plan, 2018 Omnibus Incentive Plan and 2019 Employee Share Purchase Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless noted, all common shares and per share amounts contained in the consolidated financial statements have been retroactively adjusted to reflect a 1-for-4 reverse stock split.</span></div></ix:continuation><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i316f2a77e5dc43c6b8d8557839198da5" continuedAt="i2486bb9e351f4950ba6da4b3b7a11e9e"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Reverse Merger</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2019, Menlo Therapeutics Inc. ("Menlo"), Foamix Pharmaceuticals Ltd. (&#8220;Foamix&#8221;) and Giants Merger Subsidiary Ltd. (&#8220;Merger Sub&#8221;), a wholly-owned subsidiary of Menlo, entered into an Agreement and Plan of Merger (as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated as of December 4, 2019, the &#8220;Merger Agreement&#8221;). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Foamix, with Foamix surviving as a wholly-owned subsidiary of Menlo (the &#8220;Merger&#8221;) on March 9, 2020 (the &#8220;Effective Date&#8221;). The combined Company changed its name to VYNE in September 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting purposes, the Merger is treated as a &#8220;reverse acquisition&#8221; under generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;) and Foamix is considered the accounting acquirer. Accordingly, upon consummation of the Merger, the historical financial statements of Foamix became the Company&#8217;s historical financial statements, and the historical financial statements of Foamix are included in the comparative prior periods. See &#8220;Note 3 &#8211; Business Combination&#8221; for more information on the Merger.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Serlopitant</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was developing serlopitant, a small molecule inhibitor of the neurokinin 1 receptor, or NK1-R, given as a once-daily, oral tablet, for the treatment of pruritus, or itch, associated with various conditions including prurigo nodularis, or PN. On April 6, 2020, the Company announced top line results from two Phase III clinical trials evaluating the safety and efficacy of once-daily oral serlopitant for the treatment of pruritus (itch) associated with PN, studies MTI-105 and MTI-106. Neither study met their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based on a 4-point improvement responder analysis. The Company does not currently intend to further pursue the development of serlopitant. As a result, in the second quarter of 2020, the Company recorded a full impairment charge related to the IPR&amp;D and Goodwill assets in its unaudited condensed consolidated statement of operations and comprehensive loss. See "Note 3 - Business Combination" for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, the Company has funded operations primarily through private and public placements of its equity, debt and warrants and through fees, cost reimbursements and payments received from its licensees. The Company commenced generating product revenues related to sales of AMZEEQ and ZILXI&#160;in January 2020 and October 2020, respectively.  AMZEEQ and ZILXI were sold as part of the sale of the MST Franchise on January 12, 2022 and, as such, the Company will no longer be generating revenue from the sale of these products.  The Company has incurred losses and experienced negative operating cash flows since its inception and anticipates that it will continue to incur losses until such a time when its product candidates, if approved, are commercially successful, if at all. The Company will not generate any revenue from any current or future product candidates unless and until it obtains regulatory approval and commercializes such products.  For the year ended December&#160;31, 2021 the Company incurred a net loss of $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MjAzMzY_4bcd192e-1a37-4295-84f6-f1d2640f8cff">73.3</ix:nonFraction> million and used $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MjAzNDQ_28f34dde-c9e7-4006-8bc3-183d0d7ae3ed">56.4</ix:nonFraction>&#160;million of cash in operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzExNTQ0ODcyMTU5ODcy_b358fbd1-f185-4ccb-bcda-251b353013d6">42.9</ix:nonFraction> million. The Company's cash and cash equivalents are held in money market accounts. The Company also received proceeds of $<ix:nonFraction unitRef="usd" contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112" decimals="-5" name="vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MjYxMzY_9dcc8788-e8ab-4b27-a4d2-5b6c65656cc4">20.0</ix:nonFraction>&#160;million from the sale of the MST Franchise in January 2022 and will receive an additional payment of $<ix:nonFraction unitRef="usd" contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112" decimals="-5" name="vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MTkwMTg_e814d8a0-ff07-4dc7-80bc-48a204b5e041">5.0</ix:nonFraction>&#160;million on the one-year anniversary of the sale.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following the sale of the MST Franchise, the Company is refocusing its limited resources on its immuno-inflammatory pipeline and intends to support the FMX114 and the BET inhibitor development programs. Research and development activities for these programs, including preclinical and clinical testing of the Company's drug candidates, will require significant additional financing. The future viability of the Company and its ability to continue as a going concern is dependent on its ability to raise sufficient working capital through either debt or equity financings to fund our operations and successfully develop commercially viable drug candidates.  There is no assurance the Company will be able to achieve these objectives under acceptable terms or at all.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that its audited consolidated financial statements are issued. The accompanying audited consolidated financial statements have been prepared assuming that the Company will continue as a going concern and contemplate the realization of assets and the satisfaction of liabilities in the normal course of business. The Company's ability to continue as a going concern is expected </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2486bb9e351f4950ba6da4b3b7a11e9e">to be impacted by the outcome of the plans outlined above, including the Company's ability to raise additional capital to fund its operations, positive results from clinical trials for FMX114, and the successful development and positive results from clinical trials for the BET inhibitor programs. Based on its current plans and assumptions, the Company believes that absent sufficient proceeds received from equity transactions, financing transactions or business development transactions, the Company will not have sufficient cash and cash equivalents to fund its operations beyond one year from the issuance of these financial statements. Accordingly, the Company will, over the course of the next twelve months, require significant additional financing to continue its operations. In addition, the amount of proceeds the Company may be able to raise pursuant to its existing shelf registration statement on Form S-3 may be limited. As of the filing of this Annual Report on Form 10-K, the Company will be subject to the general instructions of Form S-3 known as the "baby shelf rules." Under these instructions, the amount of funds the Company can raise through primary public offerings of securities in any 12-month period using its registration statement on Form S-3 is limited to one-third of the aggregate market value of the shares of its common stock held by non-affiliates of the Company. Therefore, the Company will be limited in the amount of proceeds it is able to raise by selling shares of its common stock using its Form S-3 until such time as its public float exceeds $75 million. These factors raise substantial doubt about the Company's ability to continue as a going concern. Failure to successfully receive additional financing will require the Company to delay, scale back or otherwise modify its business and its research and development activities and other operations. The accompanying financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern.</ix:continuation></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_130"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzIxOTkwMjMyODc0OTI_3842e994-1c67-4476-81eb-6fdf20fa3a56" continuedAt="id4c184b923164ce0b404d0019e0d5c86" escape="true">SIGNIFICANT ACCOUNTING POLICIES:</ix:nonNumeric></span></div><ix:continuation id="id4c184b923164ce0b404d0019e0d5c86" continuedAt="i4ebd4f3ac05a4be98e1f0b8259202505"><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MDk_14be6dec-8e1f-4c67-b521-f1cb819b7b5d" continuedAt="i7052ed5fcb4d4d13ac2d113b5f454121" escape="true">Basis of presentation</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7052ed5fcb4d4d13ac2d113b5f454121">The Company&#8217;s financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;).  Certain prior period amounts have been reclassified to conform to current year presentation.</ix:continuation></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTA_795023f2-476d-4309-b753-9324672791e5" continuedAt="i770946b73e2b4c31a2ef57fd9a8de6f7" escape="true">Use of estimates</ix:nonNumeric></span></div><ix:continuation id="i770946b73e2b4c31a2ef57fd9a8de6f7"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results may differ from those estimates.  Significant items subject to such estimates and assumptions include accounting for business combinations, impairments of goodwill and intangible assets and revenue recognition. Actual results could differ from the Company&#8217;s estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and government measures taken in response to the pandemic have had a negative impact on the Company's operations. Access to healthcare providers has been limited, which has negatively impacted sales and the Company's ability to execute its commercial strategy with respect to AMZEEQ and ZILXI. The length of time and extent to which the COVID-19 pandemic will directly or indirectly impact the Company's business, results of operations and financial condition and liquidity will depend on future developments that are highly uncertain, subject to change and will continue to evolve with geographical re-openings, surges in cases, the emergence of new strains and the vaccination effort. In addition, the Company further assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2021 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, inventory and related reserves, impairments of long-lived assets and revenue recognition. In 2020, the Company recorded impairments of goodwill and certain indefinite-lived intangible assets; however, these were unrelated to the impact of COVID-19 (See "Note 3 - Business Combination" for more information). The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTE_29cd7faf-6559-4a9e-bfd1-a62fab36be3a" continuedAt="i4b547aaf4d2947e78431750c86a3113a" escape="true">Business Acquisition</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4b547aaf4d2947e78431750c86a3113a" continuedAt="i03ebfd9c58ac4147a778ad2003cdb0cd">The Company&#8217;s consolidated financial statements include the operations of an acquired business after the completion of the acquisition. The Company accounts for acquired businesses using the acquisition method of accounting, which requires, among </ix:continuation></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i4ebd4f3ac05a4be98e1f0b8259202505" continuedAt="i24617ea1e5954f748b596af98a475ca4"><ix:continuation id="i03ebfd9c58ac4147a778ad2003cdb0cd"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other things, that most assets acquired and liabilities assumed be recognized at their estimated fair values as of the acquisition date and that the fair value of In-Process Research and Development and Goodwill be recorded on the balance sheet.&#160;Transaction costs are expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recorded in connection with an acquisition can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting.&#160; For example, the Company uses fair value in the initial recognition of net assets acquired in a business combination and when measuring impairment losses.&#160; The Company estimates fair value using an exit price approach, which requires, among other things, that Company determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of non-financial assets and, for liabilities, assuming that the risk of non-performance will be the same before and after the transfer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may use one or all of the following techniques:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost approach, which is based on the cost to acquire or construct comparable assets, less an allowance for functional and/or economic obsolescence.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fair value methodologies depend on the following types of inputs:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for identical assets or liabilities in active markets (Level 1 inputs).</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means (Level 2 inputs).</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unobservable inputs that reflect estimates and assumptions (Level 3 inputs).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A single estimate of fair value can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTI_a5767680-3d67-4f75-b839-3b0e5d92fc4b" continuedAt="if3f28d43c6384a139090d121015a3d9f" escape="true">Foreign Currency Translation</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if3f28d43c6384a139090d121015a3d9f">Transactions and balances originally denominated in dollars are presented at their original amounts. Balances in non-dollar currencies are translated into dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-dollar transactions and other items in the statements of operations (indicated below), the following exchange rates are used: (i) for transactions - exchange rates at transaction dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization, etc.) - historical exchange rates. Currency transaction gains and losses are presented in financial income or expenses, as appropriate.</ix:continuation></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTM_3c7b6e45-0ba5-4651-abde-ac2cb468e1ed" continuedAt="i5038bb33fee74c3a85016d633bc54281" escape="true">Principles of consolidation</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5038bb33fee74c3a85016d633bc54281">The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated upon consolidation.</ix:continuation></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i24617ea1e5954f748b596af98a475ca4" continuedAt="i275c745337314f56bd0ad2fee35bf97e"><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTQ_3a18a933-9575-491b-89c9-9d0d9985e82c" continuedAt="ibfdeb7e22dcd447db38d2f6ee1d91042" escape="true">Cash and cash equivalents</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibfdeb7e22dcd447db38d2f6ee1d91042">The Company considers as cash equivalents all short-term, highly liquid investments, which include short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.</ix:continuation></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTY_dcd83bd2-ce71-47c3-8246-b8de8949ef44" continuedAt="i81896bfbf197498192eb569e2902f405" escape="true">Marketable securities</ix:nonNumeric></span></div><ix:continuation id="i81896bfbf197498192eb569e2902f405"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketable equity securities:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's marketable equity securities are recorded at fair value, with unrealized gains and losses included in other income, net in the consolidated statement of operations.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">h.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTg_3cf59f2f-f0f6-435c-8bd2-558f480e4975" continuedAt="i046d176ee78d4eab88ca961652ae61d4" escape="true">Inventory</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i046d176ee78d4eab88ca961652ae61d4">Prior to the date the Company obtains regulatory approval for its product candidates, inventory costs related to commercial production are expensed as research and development expense. Once regulatory approval is obtained, the Company capitalizes such costs as inventory. Inventories are stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first-out (&#8220;FIFO&#8221;) method. The Company periodically reviews its inventory levels and writes down inventory that is expected to expire prior to being sold, inventory in excess of expected sales requirements and inventory that fails to meet commercial sale specifications, with a corresponding charge to cost of goods sold.</ix:continuation></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.73pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTk_156191c0-5a5c-4188-9edb-52afedddf8c4" continuedAt="if8fdb1ec15b1429ab41b5c9d93917637" escape="true">Property and equipment</ix:nonNumeric></span></div><ix:continuation id="if8fdb1ec15b1429ab41b5c9d93917637"><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Property and equipment are stated at cost, net of accumulated depreciation and amortization.</span></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">The Company&#8217;s property and equipment are depreciated by the straight-line method on the basis of their estimated useful life.</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjA_21fbf068-bfad-451d-a502-7ad98dc5bc0c" continuedAt="if6f7f0506cdd4137921494ab05c4be37" escape="true"><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual rates of depreciation are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0a6e3943e4f3499aa05c5f1b79ea9be6_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzEtMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjozZjY5MzY1NWEyOTQ0ZGMyOGU0MDcwZDk4ZjljMTVhZF80_4743eac8-02be-4a17-a136-658929fd1748">3</ix:nonNumeric> - <ix:nonNumeric contextRef="if1a583001e26487cab80e9da2a4c8bf1_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzEtMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjozZjY5MzY1NWEyOTQ0ZGMyOGU0MDcwZDk4ZjljMTVhZF85_d9654643-e803-4927-add3-493b1948046b">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if1270645810f47e9a7e83fb038ed2bf1_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzItMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjo3ZWM1MmQ3NjhjNWQ0ZTdiYjZlMTYzNjEwYjZmZThkY180_b89ba0f3-d5d8-4250-8268-f4f78299748b">5</ix:nonNumeric> - <ix:nonNumeric contextRef="ic5fd0d9bbcec4faaa99fa1d6f9cfcd5a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzItMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjo3ZWM1MmQ3NjhjNWQ0ZTdiYjZlMTYzNjEwYjZmZThkY185_b8905e0f-df9d-46c5-af96-485180bdd4c1">14</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i842ae2d9ee184a8ab5883bcf17a70e63_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzMtMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjpjMWQyZGY0NmRlYTM0NmE0OTdlNjU1MGU5Yzc5NDdiOV80_7107d355-4c06-4b71-aec0-ad08654ab2fb">7</ix:nonNumeric> - <ix:nonNumeric contextRef="ie53f456c44c141d9a86e97266cc12298_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzMtMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjpjMWQyZGY0NmRlYTM0NmE0OTdlNjU1MGU5Yzc5NDdiOV85_c6986f96-801e-461a-8e92-d069e9f9f640">14</ix:nonNumeric> years</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are amortized by the straight-line method over the expected lease term, which is shorter than the estimated useful life of the improvements.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">j.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjE_faa1cb17-94c4-4774-9e6d-b119f6972aaf" continuedAt="id9f0b5422c5048e2966e313229f1d9b1" escape="true">Impairment of long-lived assets</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id9f0b5422c5048e2966e313229f1d9b1">The Company tests long-lived assets for impairment whenever events or circumstances present an indication of impairment. If the sum of expected future cash flows (undiscounted and without interest charges) of the assets is less than the carrying amount of such assets, an impairment loss would be recognized. The assets would be written down to their estimated fair values, calculated based on the present value of expected future cash flows (discounted cash flows), or some other fair value measure.</ix:continuation></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company did <ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzg3OTYwOTMwNTQxODI_32864cde-f70e-4bbc-a63f-19548ed338bc"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzg3OTYwOTMwNTQxODI_790169db-8fbe-4302-a785-e69b2be18d4f">no</ix:nonFraction></ix:nonFraction>t recognize an impairment loss for its long-lived assets.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">k.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjI_ccdc82d6-49ee-4b9a-9b9f-0f00172152a8" continuedAt="i31d7d05e2b2643b88cc8afedb22be269" escape="true">Goodwill and other indefinite lived intangible assets</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i31d7d05e2b2643b88cc8afedb22be269" continuedAt="i5fcedb10ebb54fc593d5ad202a581428">The Company reviews goodwill and other intangibles that have indefinite lives for impairment annually as of the end of the fiscal year or when events or changes in circumstances indicate the carrying value of these assets might exceed their current fair values.  Impairment testing is based upon the best information available including estimates of fair value which incorporate assumptions market participants would use in making their estimates of fair value.  In 2020, the Company recorded full </ix:continuation></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i275c745337314f56bd0ad2fee35bf97e" continuedAt="i7a22204ccec548eca3b000136dc06134"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5fcedb10ebb54fc593d5ad202a581428">impairment charges related to its $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEyMDY2_24a8902d-5023-4d48-81a1-671c45d22cf1">4.5</ix:nonFraction>&#160;million of goodwill and $<ix:nonFraction unitRef="usd" contextRef="idd175173768e4ea8aed9f33191f66791_D20200101-20201231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEyMDg1_55cb14a4-0ccf-4458-93fe-636bb07b7bea">49.8</ix:nonFraction>&#160;million of IPR&amp;D (See "Note 3 - Business Combination" for more information).  <ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzg3OTYwOTMwNTkxNzk_920572e4-d0a4-45d1-9cad-6c894b1dfa22">No</ix:nonFraction> impairment was recorded in the years ended December&#160;31, 2021.</ix:continuation></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">l.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.73pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjM_0074da50-c437-465f-90ea-e4beeafed65c" continuedAt="i3fc6025e29d64ee49c4639321c5a7060" escape="true">Allowance for doubtful accounts</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3fc6025e29d64ee49c4639321c5a7060">An allowance for doubtful accounts is maintained for potential credit losses based on the aging of trade receivables, historical bad debts experience and changes in customer payment patterns. Trade receivable balances are written off against the allowance when it is deemed probable that the receivable will not be&#160;collected.&#160;Trade receivables, net are stated net of reserves for certain sales allowances and provisions for doubtful accounts. Provisions for doubtful accounts were <ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEyNjcw_3d83089c-0ec7-4f9b-8466-b2c4e88b301f"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEyNjcw_d66be5b0-176f-40d1-be7e-d26d6f865c65">no</ix:nonFraction></ix:nonFraction>t material for the years ended December&#160;31, 2021 and 2020.</ix:continuation></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">m.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.17pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:DebtPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjQ_090623db-7849-47a2-a8f9-118606e1bef4" continuedAt="if6323f87bb384a01bb5ee0a0ffdd5d77" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="if6323f87bb384a01bb5ee0a0ffdd5d77"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt discounts created as a result of the allocation of proceeds received from a debt issuance to warrants issued are amortized to interest expense under the effective interest method over the life of the recognized debt liability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs include the costs of debt financings undertaken by the Company, including legal fees and other direct costs of the financing. Debt issuance costs related to a recognized debt liability are presented on the consolidated balance sheet as a direct deduction from the carrying amount of the debt liability and are amortized to interest expense over the term of the related debt, using the effective interest method.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">n.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjU_71bb280c-417e-4e09-b037-9f6744790cc4" continuedAt="i85aff855530244f5b5ff86b940fe69eb" escape="true">Leases</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i85aff855530244f5b5ff86b940fe69eb">Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. Lease expense for operating leases is recognized on a straight-line basis over the expected lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet.</ix:continuation></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">o.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjY_5bb8fae3-6e4b-42ba-9804-02d10b2b73c6" continuedAt="ifc1ecab6cb364735baddeb4452e7639a" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="ifc1ecab6cb364735baddeb4452e7639a"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain conditions may exist as of the date of the financial statements, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company&#8217;s management assesses such contingent liabilities and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#8217;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management applies the guidance in ASC 450-20-25 when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability is recorded as accrued expenses in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material are disclosed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantees are disclosed.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">p.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3Mjc_58686d38-bbb7-4858-9dbe-4f2972e070ce" continuedAt="i666ee741c8734f13bbc72e03d42a0484" escape="true">Share-based compensation</ix:nonNumeric></span></div><ix:continuation id="i666ee741c8734f13bbc72e03d42a0484" continuedAt="ib8045308d4a043b3a3d4d4fd82e9e4d6"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for employees&#8217; and directors&#8217; share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period using the straight-line method. Forfeitures are recognized as they occur.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based payments related to the employee share purchase plan (&#8220;ESPP&#8221;) are recognized based on the fair value of each award estimated on the first day of the offering period and recognized as an expense over the offering period using the straight-line method.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i7a22204ccec548eca3b000136dc06134" continuedAt="ib0864433efbe46adbaaadee486f422e2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib8045308d4a043b3a3d4d4fd82e9e4d6">The Company elected to recognize compensation costs for awards conditioned only on continued service that have a graded vesting schedule using the straight-line method based on the multiple-option award approach.</ix:continuation></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">q.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3Mjg_96fbff83-1d96-458e-abe7-e8dcc3be1f61" continuedAt="i5d1c6b9787e84dec9ec6611102379744" escape="true">Revenue recognition</ix:nonNumeric></span></div><ix:continuation id="i5d1c6b9787e84dec9ec6611102379744"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its revenue transactions under FASB ASC Topic 606,&#160;Revenue from Contracts with Customers. In accordance with ASC Topic 606, the Company recognizes revenues when its customers obtain control of its product for an amount that reflects the consideration it expects to receive from its customers in exchange for that product. To determine revenue recognition for contracts that are determined to be in scope of ASC Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once the contract is determined to be within the scope of ASC Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when such performance obligation is satisfied.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers include a limited number of national and select regional wholesalers (the &#8220;distributors&#8221;) and certain independent and specialty pharmacies, together (the "customers"). These distributors subsequently resell the product, primarily to retail pharmacies that dispense the product to patients. Net product revenue is typically recognized when customers obtain control of the Company&#8217;s products, which occurs at a point in time, typically upon delivery of product to the customers. The Company evaluates the creditworthiness of its customers to determine whether it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur. The Company does not assess whether a contract has a significant financing component if the expectation is such that the period between the transfer of the promised goods to the customer and the receipt of payment will be less than one year. Standard credit terms do not exceed 75 days. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that would have been recognized is one year or less or the amount is immaterial. Shipping and handling costs related to the Company&#8217;s product sales are included in selling, general and administrative expenses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net product revenues through&#160;December&#160;31, 2021&#160;were generated through sales of AMZEEQ, which was approved by the FDA in October 2019 and was commercially launched in the United States in January 2020 and ZILXI, which was approved by the FDA in May 2020 and was commercially launched in the United States in October 2020. Product revenue is recorded net of distribution fees, trade discounts, allowances, rebates, copay program coupons, chargebacks, estimated returns and other incentives. These reserves are classified as either reductions of accounts receivable or as current liabilities. The estimates of reserves established for variable consideration reflect current contractual and statutory requirements, known market events and trends, industry data and forecasted customer mix. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net product revenues only to the extent that it is probable that a significant reversal of the amount of the cumulative revenues recognized will not occur in a future period. Actual amounts may ultimately differ from these estimates. If actual results vary, estimates may be adjusted in the period such change in estimate becomes known, which could have an impact on earnings in the period of adjustment. See &#8220;Note 4 &#8211; Revenue Recognition&#8221; for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2020, the Company announced that it entered into a license agreement with Cutia for our minocycline products and product candidate, if approved, on an exclusive basis in Greater China.  Under the terms of the agreement, Cutia will have an exclusive license to obtain regulatory approval of and commercialize AMZEEQ, ZILXI and, if approved in the U.S., FCD105 in the Greater China territory.  The Company will supply the finished licensed products to Cutia for clinical and commercial use.  The Company received an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i8bc82390929346cc83aa1a859f646cb1_D20200423-20200423" decimals="-5" name="us-gaap:ProceedsFromRoyaltiesReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzIxMDkz_326d1194-9eba-4d67-b6d1-45a63eb9375b">10.0</ix:nonFraction> million.  The license was determined to be a distinct performance obligation of the arrangement, therefore the Company recognized the revenues from the upfront license fee when the license is transferred to the licensee and the licensee is able to use and benefit from the license.  The disposition of the MST Franchise included the license agreement with Cutia including the rights to future revenues under that agreement.  See "Note 4 - Revenue Recognition" for more information.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">r.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3Mjk_f00bbd2d-78de-4a19-8a94-8ddaf6403e7b" continuedAt="i155a55271fcf40ada02916c692d96331" escape="true">Research and development costs</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="ib0864433efbe46adbaaadee486f422e2" continuedAt="if3f76d143f7e4ddf91f93093a351abba"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i155a55271fcf40ada02916c692d96331">Research and development expenses include costs directly attributable to the conduct of research and development programs, including the cost of clinical trials, clinical trial supplies, salaries, share-based compensation expenses, payroll taxes and other employee benefits, lab expenses, consumable equipment and consulting fees. All costs associated with research and developments are expensed as incurred.</ix:continuation></span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzE_8c66664b-e3c1-4c87-a15f-d99791bc4f03" continuedAt="i38c89c9ad67f4ae2aa6c442241e997ce" escape="true">Income taxes:</ix:nonNumeric></span></div><ix:continuation id="i38c89c9ad67f4ae2aa6c442241e997ce"><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deferred taxes</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is recognized to the extent that it is more likely than not that the deferred taxes will not be realized in the foreseeable future. Given the Company&#8217;s losses, the Company has provided a full valuation allowance with respect to its deferred tax assets.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Uncertainty in income tax</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows a two-step approach in recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the available evidence indicates that it is more likely than not that the position will be sustained based on technical merits. If this threshold is met, the second step is to measure the tax position as the largest amount that has more than a 50% likelihood of being realized upon ultimate settlement.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">t.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzI_cb1aabfe-f170-4c7e-bdb4-dbd62a89b399" continuedAt="i9f3b94d5f7b14e9e952aeb055def1d80" escape="true">Loss per share</ix:nonNumeric></span></div><ix:continuation id="i9f3b94d5f7b14e9e952aeb055def1d80"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the weighted-average number of common stock outstanding during the period in which the reverse merger occurs was based on:</span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">The number of common stock outstanding from the beginning of that period to the merger date was computed on the basis of the weighted-average number of common stock of the legal acquiree (accounting acquirer) outstanding during the period multiplied by the exchange ratio established in the merger agreement</span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">The number of common stock outstanding from the merger date to the end of that period was the actual number of common stock of the legal acquirer (the accounting acquiree) outstanding during that period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted, is computed on the basis of the net loss for the period divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share is based upon the weighted average number of common stock and of common stock equivalents outstanding when dilutive. Common stock equivalents include outstanding stock options and warrants which are included under the treasury share method when dilutive.</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzM_46d4e116-dfcd-41db-b1ef-5c4fa43d6a14" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following stock options, restricted stock units (&#8220;RSUs&#8221;), warrants and incremental shares to be issued under the employee stock purchase plan (&#8220;ESPP&#8221;) were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented (share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding share options, RSUs and shares under ESPP</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb7ed5c301ca4a1fb4df13b64075b204_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo3YjUyMDllNDY0YmE0ZTU3YmYxYTc0ZTRkNzEyMzY2NC90YWJsZXJhbmdlOjdiNTIwOWU0NjRiYTRlNTdiZjFhNzRlNGQ3MTIzNjY0XzItMS0xLTEtMTc2ODk_45f04a14-af31-48fe-9484-308dfd229169">5,306,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf66ae22fce94621a923fc88150b0de4_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo3YjUyMDllNDY0YmE0ZTU3YmYxYTc0ZTRkNzEyMzY2NC90YWJsZXJhbmdlOjdiNTIwOWU0NjRiYTRlNTdiZjFhNzRlNGQ3MTIzNjY0XzItMy0xLTEtMTc2ODk_5227b551-c59d-4956-859f-34ab993a8055">4,994,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e320cc859974d9a8611825211a48e4d_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo3YjUyMDllNDY0YmE0ZTU3YmYxYTc0ZTRkNzEyMzY2NC90YWJsZXJhbmdlOjdiNTIwOWU0NjRiYTRlNTdiZjFhNzRlNGQ3MTIzNjY0XzMtMS0xLTEtMTc2ODk_a0ee7aa7-623e-4819-baf1-fbadb5bc4a32">495,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04c5ebd48f7b4ed7a5b18e2619c3dc71_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo3YjUyMDllNDY0YmE0ZTU3YmYxYTc0ZTRkNzEyMzY2NC90YWJsZXJhbmdlOjdiNTIwOWU0NjRiYTRlNTdiZjFhNzRlNGQ3MTIzNjY0XzMtMy0xLTEtMTc2ODk_160c1cb8-813b-4803-be18-b1a0d7d62409">495,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">u.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzQ_f3a3a284-77c1-46f2-9ca7-c6a0c07cd2bf" continuedAt="i40a8799116df43af82b25a951652c352" escape="true">Fair value measurement</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i40a8799116df43af82b25a951652c352" continuedAt="i08c23c7f054042c1a75f9a9cbdda3b0e">Fair value is based on the price that would be received from the sale of an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in </ix:continuation></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="if3f76d143f7e4ddf91f93093a351abba" continuedAt="id5c89f2ccd6e4e9884111ed3f3f0fb4a"><ix:continuation id="i08c23c7f054042c1a75f9a9cbdda3b0e"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows:</span></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1:&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2:&#160;&#160;&#160;&#160;Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.</span></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3&#160;&#160;&#160;&#160;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers counterparty credit risk in its assessment of fair value.</span></div></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzU_30245d06-11c2-4c42-a872-61504fc75ad0" continuedAt="i24c71447c1244512826cfba50b892bff" escape="true"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzg3OTYwOTMwNjQxOTk_cfd1dfbc-7f69-45ec-9490-a8e010179090" continuedAt="i5c01cf8f22824bcd998dd675df41aa64" escape="true">Concentration of credit risks</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i24c71447c1244512826cfba50b892bff"><ix:continuation id="i5c01cf8f22824bcd998dd675df41aa64"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, restricted cash, marketable securities and accounts receivables. The Company deposits cash and cash equivalents with highly rated financial institutions and, as a matter of policy, limits the amounts of credit exposure to any single financial institution. In addition, all marketable securities carry a high rating or are government insured. The Company has not experienced any material credit losses in these accounts and does not believe it is exposed to significant credit risk on these instruments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2021, the Company's three largest customers collectively represented <ix:nonFraction unitRef="number" contextRef="i748a6a56555e4b559d51845f4cf5e925_D20210101-20211231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEwOTk1MTE2NjQ2Njg_7f8ce33c-61a9-4d64-b833-ccb7e0c2e162">41</ix:nonFraction>% of product revenue and <ix:nonFraction unitRef="number" contextRef="i0e802c47b5b948f28423b29c6ae7b1ed_D20210101-20211231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzI4OTQ3_f071cbf7-7ebd-44f7-9130-2551e61fa9c9">58</ix:nonFraction>% of accounts receivable.  For the year ended December&#160;31, 2020, the Company's largest three customers collectively represented <ix:nonFraction unitRef="number" contextRef="i89b5ce1d295243118db097ac730c0000_D20200101-20201231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEwOTk1MTE2Nzc2MDQ_6f570df8-4dda-438a-bfc5-c46b70f005f4">96</ix:nonFraction>% of product revenue and <ix:nonFraction unitRef="number" contextRef="i6ada4de775684974955fee5f4e5ae4f9_D20200101-20201231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEwOTk1MTE2Nzc2MDk_20296fe7-143d-4f4a-a12c-5f0be0926c67">90</ix:nonFraction>% of accounts receivable.</span></div></ix:continuation></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">w.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzY_0e2dd187-e6b2-4a5d-8053-500c6b3ee446" continuedAt="i02285f8cf9b4467682edf43cf8608ab6" escape="true"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzg3OTYwOTMwNjQyMDA_545a3590-a749-4610-b2c9-9963ce7ae150" continuedAt="ic46a01e06fdf42c697a826d28a3f66c3" escape="true">Comprehensive loss</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i02285f8cf9b4467682edf43cf8608ab6"><ix:continuation id="ic46a01e06fdf42c697a826d28a3f66c3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss includes, in addition to net loss, unrealized holding gains and losses on available-for-sale debt securities and derivative instruments designated as cash flow hedge (net of related taxes where applicable). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification adjustments for gain or loss of available-for-sale securities are included in other income, net in the consolidated statement of operations.</span></div></ix:continuation></ix:continuation><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">x.</span><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3Mzc_882550be-ccd3-45fc-8938-608e7da53a7d" continuedAt="i830725ac74c14b81b9bd362a217f7fdb" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Newly issued and recently adopted accounting pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></ix:nonNumeric></div><ix:continuation id="i830725ac74c14b81b9bd362a217f7fdb" continuedAt="i6ccb65d0b64f4ed890083ac14d5891c2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Guidance Issued:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2020-4, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" (ASU 2020-4), which provides guidance to alleviate the burden in accounting for reference rate reform by allowing certain expedients and exceptions in applying generally accepted accounting principles to contracts, hedging relationships, and other transactions impacted by reference rate reform. The provisions of ASU 2020-4 apply only to those transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. Adoption of the provisions of ASU 2020-4 are optional and are effective from March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-4 on its consolidated financial statements.  Currently, the Company does not expect the adoption of the new standard to have a material impact to the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued Accounting Standards Update No. 2016-13,&#160;&#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#8221;&#160;(ASU 2016-13), which requires companies to measure credit losses of financial instruments, including customer accounts receivable, utilizing a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Subsequent to the issuance of ASU 2016-13, the FASB issued several additional Accounting Standard Updates to clarify implementation </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="id5c89f2ccd6e4e9884111ed3f3f0fb4a"><ix:continuation id="i6ccb65d0b64f4ed890083ac14d5891c2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guidance, provide narrow-scope improvements and provide additional disclosure guidance. As a smaller reporting company, the Company will adopt ASU 2016-13 effective January 1, 2023 or at such time where it is no longer a smaller reporting company.  Currently, the Company does not expect the adoption of the new standard to have a material impact to the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the FASB issued Accounting Standards Update No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes," which clarifies and simplifies certain aspects of the accounting for income taxes.  The standard is effective for years beginning after December 15, 2020, and interim periods beginning after December 15, 2020.  This guidance became effective during the first quarter of 2021. The adoption of the new standard did not have a material impact to the Company's consolidated financial statements.</span></div></ix:continuation></ix:continuation><div id="i3ee2f3590755456d8887827db5ee11c4_133"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzIxOTkwMjMyNjg3MDg_0385fa9f-b2b3-4dcd-af20-897d2d8c41b8" continuedAt="i5c99fb797088454ead2a9e63484c4a66" escape="true">BUSINESS COMBINATION:</ix:nonNumeric></span></div><ix:continuation id="i5c99fb797088454ead2a9e63484c4a66" continuedAt="i4e50db6325004528a8c6919328e06c01"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2019, Menlo entered into the Merger Agreement with Foamix, and Merger Sub, a direct and wholly-owned Israeli subsidiary of Menlo. On March 9, 2020, the Merger was completed and Foamix is now a wholly-owned subsidiary of the Company. The combined Company changed its name to VYNE in September 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Effective Date, each ordinary share of Foamix was exchanged for <ix:nonFraction unitRef="number" contextRef="ib5a47ebbee0041dab8fdf54e6e3642fa_I20200309" decimals="INF" name="vyne:ExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzM1Ng_c55217e3-3330-4bf6-a3f1-b544ca3a708b">0.5924</ix:nonFraction> shares of common stock of Menlo. In addition, on the Effective Date, Foamix shareholders received <ix:nonFraction unitRef="contingentstockright" contextRef="ib5a47ebbee0041dab8fdf54e6e3642fa_I20200309" decimals="INF" name="vyne:BusinessAcquisitionContingentStockRightIssued" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQ1Nw_33d24f3e-6af7-43d0-98dd-41bda8beb22f">one</ix:nonFraction> contingent stock right (a &#8220;CSR&#8221;) for each Foamix ordinary share held by them. The CSRs were issued pursuant to the Contingent Stock Rights Agreement (the &#8220;CSR Agreement&#8221;), dated as of March 9, 2020, by and between Menlo and American Stock Transfer &amp; Trust Company, LLC, and represented the non-transferable contractual right to receive shares of common stock of Menlo depending on the results of Menlo&#8217;s phase III clinical trials evaluating the safety and efficacy of once daily oral serlopitant for the treatment of prurigo nodularis (the &#8220;Phase III PN Trials&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company announced that each of Menlo&#8217;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. Accordingly, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into <ix:nonFraction unitRef="number" contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406" decimals="INF" name="vyne:ContingentStockRightSharesConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE0NjQ_814572c3-1d65-490c-b1d6-881f5c3bc3a5">1.2082</ix:nonFraction> additional shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of <ix:nonFraction unitRef="number" contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406" decimals="INF" name="vyne:BusinessCombinationEffectiveExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE1NjY_6b14ca04-1b71-4d8c-8476-93e782752a75">1.8006</ix:nonFraction> shares of Menlo common stock for each Foamix ordinary share.  The CSR conversion resulted in the issuance and delivery of <ix:nonFraction unitRef="shares" contextRef="i1b5ca9e470654e73af6168a009123651_D20200406-20200406" decimals="INF" name="vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE2OTE_5abbb05d-ad21-4539-b90a-a28b55fa73a8">74,544,413</ix:nonFraction> additional shares of Menlo common stock underlying the CSRs, adjusted retrospectively to <ix:nonFraction unitRef="shares" contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212" decimals="INF" name="vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE3ODM_fa2cd416-accc-4ff6-856e-03e9f1a41fbb">18,636,103</ix:nonFraction> shares of common stock upon the reverse stock split effective February 12, 2021.  Following the conversion of the CSRs, pre-Merger Foamix shareholders and pre-Merger Menlo stockholders owned approximately <ix:nonFraction unitRef="number" contextRef="ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407" decimals="2" name="vyne:PostMergerParentOwnershipByPreMergerSubsidiaryShareholders" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE5OTE_1a06b835-1f26-4a6e-b8fd-71b9c962950c">82</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407" decimals="2" name="vyne:PostMergerParentOwnershipByPreMergerParentStockholders" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE5OTg_6869781f-15d0-4b18-b4f5-b0f2abf2f4cb">18</ix:nonFraction>% of post-Merger Menlo, respectively, each calculated on a fully diluted basis. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting purposes, the Merger is treated as a &#8220;reverse acquisition&#8221; under U.S. GAAP and Foamix is considered the accounting acquirer. Accordingly, upon consummation of the Merger, the historical financial statements of Foamix became the Company&#8217;s historical financial statements, and the historical financial statements of Foamix are included in the comparative prior periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under reverse acquisition accounting, the U.S. dollar amount for common stock in the financial statements is based on the value and number of shares issued by Menlo (reflecting the legal structure of Menlo as the legal acquirer) on the Merger date plus subsequent shares issued by the Company. The amounts in additional paid-in capital represent that of Foamix and include the fair value of shares deemed for accounting purposes to have been issued by Foamix on the merger date and the fair value of the Menlo equity awards included in the purchase price calculation. The Foamix additional paid-in capital was also adjusted for the difference between the number of common stock and the historical number of shares of Foamix&#8217;s ordinary shares.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company incurred transaction costs of approximately $<ix:nonFraction unitRef="usd" contextRef="ic600bdee39bf4a4880487b43ba9df188_D20200101-20201231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzMzMDM_47ce7c06-aa5b-4996-97e1-8ba14405aa3f">11.7</ix:nonFraction> million, which are recorded in the consolidated statements of operations and comprehensive income. This amount includes $<ix:nonFraction unitRef="usd" contextRef="i5d104d36f6484a09b3af55f5a52b179a_D20200101-20201231" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzM0MTg_33665a7e-26ea-44b4-8913-93f1447b9eb7">8.1</ix:nonFraction> million of severance benefits for employees terminated after the Effective Date. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="vyne:ScheduleOfBusinessAcquisitionConsiderationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzYwNDczMTM5NjU5MjY_93a036d5-5d7d-4995-a6a4-219f617fbe8f" continuedAt="i5d6f69e97da7449db7c5b86fd8663861" escape="true">The following is the Merger Consideration (as defined in the Merger Agreement) was transferred to effect the Merger:</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><ix:continuation id="i4e50db6325004528a8c6919328e06c01" continuedAt="i96e254cb48f84378961c9d0226e8762d"><ix:continuation id="i5d6f69e97da7449db7c5b86fd8663861"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTozMzI4MDMyNGQxMGM0OGYwOTViNGM1ZGRkMzZlZGJlYS90YWJsZXJhbmdlOjMzMjgwMzI0ZDEwYzQ4ZjA5NWI0YzVkZGQzNmVkYmVhXzEtMS0xLTEtMTc2ODk_16a78ac6-d3f5-4f5c-97e7-2cb5147f99e8">123,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deemed (for accounting purposes only) conversion of Menlo equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="vyne:BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTozMzI4MDMyNGQxMGM0OGYwOTViNGM1ZGRkMzZlZGJlYS90YWJsZXJhbmdlOjMzMjgwMzI0ZDEwYzQ4ZjA5NWI0YzVkZGQzNmVkYmVhXzItMS0xLTEtMTc2ODk_e0c72c00-87a7-4d6e-8c24-452c792d9385">7,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration*</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="vyne:BusinessCombinationConsiderationTransferredGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTozMzI4MDMyNGQxMGM0OGYwOTViNGM1ZGRkMzZlZGJlYS90YWJsZXJhbmdlOjMzMjgwMzI0ZDEwYzQ4ZjA5NWI0YzVkZGQzNmVkYmVhXzMtMS0xLTEtMTc2ODk_4106c4ea-3d80-4e36-a8b6-7e017954ec21">131,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* This amount reflects total consideration prior to reduction in respect of the CSRs (which had a fair value of $<ix:nonFraction unitRef="usd" contextRef="i4ea3fe3e2a474e2c836df31770569ca5_D20200309-20200309" decimals="-5" name="vyne:BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzM3NDE_35a31f22-1e63-41e2-b3ea-84264b7cc614">19.6</ix:nonFraction> million as of the Merger Date) that were issued to Foamix shareholders and that reduced the Menlo stockholders&#8217; relative ownership in the combined company. If the effect of the CSRs is included, the total consideration deemed paid by Foamix, as the accounting acquirer, to Menlo stockholders and equity award holders in the Merger would be reduced to approximately $<ix:nonFraction unitRef="usd" contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQxMDE_e9039a7e-6b68-42d0-a11c-86d40204b983">111.4</ix:nonFraction> million, as shown in the purchase price allocation table below.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on Foamix&#8217;s closing share price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQyMDE_efb824ca-82e0-4312-b0e9-3cb902bffdd1">2.99</ix:nonFraction> as of March 9, 2020, the Merger Consideration under reverse acquisition accounting was approximately $<ix:nonFraction unitRef="usd" contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309" decimals="-5" name="vyne:BusinessCombinationConsiderationTransferredGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQzMDU_8b635a3a-33be-4df1-8470-95f3434e5a68">131.1</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQzMjM_9bb0622c-7895-43e6-9bb1-e631bed96f7e">123.8</ix:nonFraction> million for the deemed (for accounting purposes only) issuance of <ix:nonFraction unitRef="shares" contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309" decimals="-5" name="vyne:BusinessCombinationSharesDeemedIssuedForAccountingPurposes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQzODQ_f0e4e504-5c4c-4b06-9515-890eae12c5f3">41.4</ix:nonFraction>&#160;million Foamix shares assuming that no upwards adjustment was made to the Exchange Ratio relating to the CSR, and $<ix:nonFraction unitRef="usd" contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309" decimals="-5" name="vyne:BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQ0OTM_62c36c6f-5900-4f34-aeed-9beb63934ad9">7.3</ix:nonFraction> million for the fair value of Menlo equity awards deemed (for accounting purposes only) to be converted into Foamix equity awards. The converted stock options represent the fair value of such options attributable to service prior to the Merger date using the Foamix closing share price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQ3Nzc_efb824ca-82e0-4312-b0e9-3cb902bffdd1">2.99</ix:nonFraction> as of March 9, 2020 as an input to the Black Scholes valuation model to determine the fair value of the options.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzYwNDczMTM5NjU5Mjc_382f7f1b-920c-4e33-b582-7deaab15fef4" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed its analysis of the allocation of the purchase price to the fair values of assets acquired and liabilities assumed as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 9, 2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzEtMS0xLTEtMTc2ODk_7ec7fc2e-5dbd-4595-b678-31bfdef7e5c7">38,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzItMS0xLTEtMTc2ODk_226da1e9-b372-4b64-87d9-28a6e6a2ef96">22,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzMtMS0xLTEtMTc2ODk_c9b4128a-0e76-471c-8ac8-e8d12af456ef">1,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzQtMS0xLTEtMTc2ODk_803d74d9-82c7-4b04-b994-307aa74c8269">49,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzUtMS0xLTEtMTc2ODk_dbbde170-1d87-42fa-9891-d65c3a8e7c51">4,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzYtMS0xLTEtMTc2ODk_bc9eb253-2add-49e9-b7a4-8af2287897be">117,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzctMS0xLTEtMTc2ODk_0923fc50-8d37-41bc-ba91-530bd0df6270">5,827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzgtMS0xLTEtMTc2ODk_b4a17081-f365-4a4b-b408-10286e768e7e">5,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated purchase price*</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzktMS0xLTEtMTc2ODk_f4eaacb3-d297-4ce4-9a02-6397917620c0">111,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Reflects reduction in the purchase price deemed paid to Menlo stockholders in the Merger on the assumption that the CSRs, in an aggregate value of $<ix:nonFraction unitRef="usd" contextRef="i4ea3fe3e2a474e2c836df31770569ca5_D20200309-20200309" decimals="-5" name="vyne:BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzUyMTk_35a31f22-1e63-41e2-b3ea-84264b7cc614">19.6</ix:nonFraction> million, convert into additional shares of the combined company for the Foamix shareholders, thereby resulting in a lower percentage of the combined company&#8217;s outstanding shares being owned by Menlo stockholders following the Merger.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is recorded with the acquisition of a business and is calculated as the difference between the acquisition date fair value of the consideration transferred and the values assigned to the assets acquired and liabilities assumed. Goodwill is not amortized but is tested for impairment at least annually. <ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="INF" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzU3Njg_263a2790-8886-4415-93c6-4928f101ce19">None</ix:nonFraction> of the Goodwill recognized is expected to be deductible for income tax purposes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="vyne:ScheduleOfBusinessCombinationGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzYwNDczMTM5NjU5Mjg_332b4797-45eb-4463-a895-710911bffd8a" continuedAt="id89b4d6303e44f1f8adebe802f806e47" escape="true">The purchase price of the transaction and the excess purchase price over the fair value of the identifiable net assets acquired, are calculated as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="id89b4d6303e44f1f8adebe802f806e47"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 9, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo4NjdhNjdiZGI1YTY0YTJjYjQzMDdlZTY5NmNiMjNjOS90YWJsZXJhbmdlOjg2N2E2N2JkYjVhNjRhMmNiNDMwN2VlNjk2Y2IyM2M5XzEtMS0xLTEtMTc2ODk_1192d5a2-89d2-40c6-9943-54c35530b087">111,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: fair value of net assets acquired, including other identifiable intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="vyne:BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo4NjdhNjdiZGI1YTY0YTJjYjQzMDdlZTY5NmNiMjNjOS90YWJsZXJhbmdlOjg2N2E2N2JkYjVhNjRhMmNiNDMwN2VlNjk2Y2IyM2M5XzItMS0xLTEtMTc2ODk_59e056e8-a1da-4eb9-a725-48a7d8f65237">106,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo4NjdhNjdiZGI1YTY0YTJjYjQzMDdlZTY5NmNiMjNjOS90YWJsZXJhbmdlOjg2N2E2N2JkYjVhNjRhMmNiNDMwN2VlNjk2Y2IyM2M5XzMtMS0xLTEtMTc2ODk_39d5525a-3a5a-48cb-a535-2fdabda8c669">4,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><ix:continuation id="i96e254cb48f84378961c9d0226e8762d" continuedAt="ib7abbef9a17f4280ba11514a9d111b43"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company announced that each of Menlo&#8217;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. The Company does not intend to further pursue the development of serlopitant.  As such, the Company recorded a full impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzY0ODU_24a8902d-5023-4d48-81a1-671c45d22cf1">4.5</ix:nonFraction> million related to goodwill in its consolidated statements of operations and comprehensive loss for the year ended December&#160;31, 2020.  There were <ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwOTk1MTE2NDA3NDE_94f5e9c0-d9aa-4b62-9591-e2f0d58d24b3">no</ix:nonFraction> impairment charges in the year ended December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In-Process Research and Development (&#8220;IPR&amp;D")</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="vyne:ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzYwNDczMTM5NjU5MzY_5fe92181-f735-4718-a7f4-c37771b4e161" continuedAt="ia31e7daa02414680b6da16077d7dc8ad" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D recognized relates to Menlo&#8217;s once</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">daily oral serlopitant for the treatment of pruritus (itch) associated with PN that has not reached technological feasibility as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible asset</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired indefinite life intangible assets*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo1MDJhMDUyYjlhYWQ0NGYwOGYxNGZiZGJjMjRmNTc5My90YWJsZXJhbmdlOjUwMmEwNTJiOWFhZDQ0ZjA4ZjE0ZmJkYmMyNGY1NzkzXzItMi0xLTEtMTc2ODk_db0b4842-4b88-42c8-a6af-3011a16ab64d">49,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of identified intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo1MDJhMDUyYjlhYWQ0NGYwOGYxNGZiZGJjMjRmNTc5My90YWJsZXJhbmdlOjUwMmEwNTJiOWFhZDQ0ZjA4ZjE0ZmJkYmMyNGY1NzkzXzMtMi0xLTEtMTc2ODk_638e8f42-5c5f-464d-9e62-6967487f9826">49,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia31e7daa02414680b6da16077d7dc8ad">* Represents acquired IPR&amp;D assets which are initially recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the associated research and development efforts. Accordingly, during the research and development period, these assets will not be amortized into earnings; instead these assets will be subject to periodic impairment testing.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of IPR&amp;D has been estimated utilizing a multi-period excess earnings method under the income approach, which reflects the present value of the projected cash flows that are expected to be generated, less charges representing the contribution of other assets to those cash flows that use projected cash flows with and without the intangible asset in place.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company announced that each of Menlo&#8217;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. The Company does not intend to further pursue the development of serlopitant.  As such, the Company recorded a full impairment charge of $<ix:nonFraction unitRef="usd" contextRef="idd175173768e4ea8aed9f33191f66791_D20200101-20201231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzgxNTk_55cb14a4-0ccf-4458-93fe-636bb07b7bea">49.8</ix:nonFraction> million related to the IPR&amp;D asset in its consolidated statements of operations and comprehensive loss for the year ended December 31, 2020.  There were <ix:nonFraction unitRef="usd" contextRef="ie3d87335d72c46baae89c74cf256abfc_D20210101-20211231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwOTk1MTE2NDA3ODk_199a756b-18ce-41fe-81ae-44fdd10db4bb">no</ix:nonFraction> impairment charges in the year ended December&#160;31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CSR</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CSR was issued pursuant to the CSR Agreement, dated as of March 9, 2020, by and between Menlo and American Stock Transfer &amp; Trust Company, LLC, and represented the non-transferable contractual right to receive shares of common stock of Menlo depending on the results of Menlo&#8217;s Phase III PN Trials. The Company recognized a liability of $<ix:nonFraction unitRef="usd" contextRef="i4ea3fe3e2a474e2c836df31770569ca5_D20200309-20200309" decimals="-5" name="vyne:BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5Xzg3MDY_35a31f22-1e63-41e2-b3ea-84264b7cc614">19.6</ix:nonFraction> million in the consolidated balance sheet as of March 9, 2020. The liability was measured at fair value and categorized as level 3 as of the acquisition date in accordance with ASC 805-31-25-5 and subsequently at each reporting date thereafter. The fair value of the CSR was estimated as the incremental value that Foamix would be able to achieve on a probability weighted basis assuming three different potential probabilities of the following scenarios: (a) serlopitant significance was achieved in both Phase III PN Trials (b) serlopitant significance was achieved in only one Phase III PN Trial and (c) serlopitant significance was not achieved or was not determined on or before May 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company announced that each of Menlo&#8217;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. Accordingly, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into <ix:nonFraction unitRef="number" contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406" decimals="INF" name="vyne:ContingentStockRightSharesConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5Xzk4Mzk_814572c3-1d65-490c-b1d6-881f5c3bc3a5">1.2082</ix:nonFraction> additional shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of <ix:nonFraction unitRef="number" contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406" decimals="INF" name="vyne:BusinessCombinationEffectiveExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5Xzk5NDE_6b14ca04-1b71-4d8c-8476-93e782752a75">1.8006</ix:nonFraction> shares of Menlo common stock for each Foamix ordinary share.  The CSR conversion resulted in the issuance and delivery of <ix:nonFraction unitRef="shares" contextRef="i1b5ca9e470654e73af6168a009123651_D20200406-20200406" decimals="-5" name="vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwMDY2_106a7080-ce36-4bcd-9d02-49c0894644e0">74.5</ix:nonFraction> million additional shares of Menlo common stock underlying the CSRs, adjusted retrospectively to <ix:nonFraction unitRef="shares" contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212" decimals="-5" name="vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwMTU4_d0f86763-4f8c-457c-beb0-68f112fb6dd5">18.6</ix:nonFraction> million shares of common stock upon the reverse stock split effective February 12, 2021.  Following the conversion of the CSRs, pre-Merger Foamix shareholders and pre-Merger Menlo stockholders own approximately <ix:nonFraction unitRef="number" contextRef="ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407" decimals="2" name="vyne:PostMergerParentOwnershipByPreMergerSubsidiaryShareholders" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwMzY0_1a06b835-1f26-4a6e-b8fd-71b9c962950c">82</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407" decimals="2" name="vyne:PostMergerParentOwnershipByPreMergerParentStockholders" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwMzcx_6869781f-15d0-4b18-b4f5-b0f2abf2f4cb">18</ix:nonFraction>% of post-Merger Menlo, respectively, each calculated on a fully diluted basis.  The conversion of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><ix:continuation id="ib7abbef9a17f4280ba11514a9d111b43"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the CSR also affected the Exchange Ratio of the pre-Merger Foamix equity awards and warrants outstanding as of March 9, 2020 and increased the awards available for grant under the Company's equity plan.    </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration associated with the CSR was recognized and measured at fair value as of the acquisition date in accordance with ASC 805-30-25-5. An acquirer's obligation to pay contingent consideration should be classified as a liability or equity in accordance with ASC 480, Distinguishing Liabilities from Equity, ASC 815 Derivatives and Hedging, and other applicable U.S. GAAP.&#160;The contingent consideration associated with the CSR was initially measured at fair value and subsequently measured at fair value at each reporting date. The CSR was classified as a liability, as it was settled by issuing a variable number of the Company's common stock.  On April 6, 2020, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i1b5ca9e470654e73af6168a009123651_D20200406-20200406" decimals="-5" sign="-" name="vyne:ContingentStockConsiderationRemeasurementGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzExMzgz_a28957e3-db1a-4a78-9e9f-b97b664887df">84.7</ix:nonFraction> million of expense in its consolidated statements of operations and comprehensive loss to remeasure the CSR liability in its consolidated balance sheet to its fair value of $<ix:nonFraction unitRef="usd" contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzExNTUx_fd49f541-be1d-455b-84ad-f90e171fed14">104.4</ix:nonFraction> million (calculated based on <ix:nonFraction unitRef="shares" contextRef="i1b5ca9e470654e73af6168a009123651_D20200406-20200406" decimals="INF" name="vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzExNTc1_5abbb05d-ad21-4539-b90a-a28b55fa73a8">74,544,413</ix:nonFraction> shares issued, adjusted retrospectively to <ix:nonFraction unitRef="shares" contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212" decimals="INF" name="vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzExNjIx_fa2cd416-accc-4ff6-856e-03e9f1a41fbb">18,636,103</ix:nonFraction> shares of common stock upon the reverse stock split effective February 12, 2021, and a share price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzExNzI2_14085b07-351d-4236-8cc4-e8167e96a5c3">1.40</ix:nonFraction> on April 6, 2020) and then settled in connection with the issuance of shares. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro Forma</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual Menlo net loss included in the Company&#8217;s consolidated statements of operations and comprehensive income for the year ended December 31, 2020 (for the period from March 9, 2020, the Effective Date, through December 31, 2020, which are not indicative of the results to be expected for a full year) and the supplemental unaudited pro forma revenue and net loss of the combined entity had the acquisition been completed on January 1, 2019.</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzYwNDczMTM5NjU5NDQ_1782fbcc-d819-402b-93a2-657978b5be1d" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual Menlo results of operations for the period from March 9, 2020, the Effective Date, through December 31, 2020 included in the consolidated statement of operation for the year ended December 31, 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZToxMmM3MDQ0YmNiNjQ0MzliOTczYTc5NGI1MzYxNjY0Mi90YWJsZXJhbmdlOjEyYzcwNDRiY2I2NDQzOWI5NzNhNzk0YjUzNjE2NjQyXzItMi0xLTEtMTc2ODk_0199e08c-b460-4f92-a961-d13a35a8adec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss attributable to Menlo</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZToxMmM3MDQ0YmNiNjQ0MzliOTczYTc5NGI1MzYxNjY0Mi90YWJsZXJhbmdlOjEyYzcwNDRiY2I2NDQzOWI5NzNhNzk0YjUzNjE2NjQyXzMtMi0xLTEtMTc2ODk_e7e30117-7293-4467-b580-d21add72d45e">24,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma Menlo results of operations for the year ended December 31, 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year  ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTAL PRO FORMA COMBINED RESULTS OF OPERATIONS:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzQtMi0xLTEtMTc2ODk_77cfb6be-e6c9-4c57-baba-eefa9ad747be">20,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzUtMi0xLTEtMTc2ODk_76495b10-5ef6-4467-9d22-146ed38f5e4c">252,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss per share - basic and diluted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzYtMi0xLTEtMTc2ODk_6f9c693a-3f05-49aa-879b-7bef21f41ecd"><ix:nonFraction unitRef="usdPerShare" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="2" sign="-" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzYtMi0xLTEtMTc2ODk_9f0879c3-7860-4359-9376-bd3040648db1">7.53</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjustments to the supplemental pro forma combined results of operations, included in the above, are as follows:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="vyne:AdjustmentsToSupplementalProformaTransactionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzktMi0xLTEtMTc2ODk_f6e4493c-c130-4328-8562-4bbf0763cda0">14,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acceleration of stock based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="vyne:AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzEwLTItMS0xLTE3Njg5_deb7e26a-b41d-48ad-857e-e104d0ba1813">7,199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Adjustments</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="vyne:AdjustmentsToSupplementalProformaCombinedResultsOfOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzExLTItMS0xLTE3Njg5_27028568-1898-4b6b-93be-34ca43682043">22,130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited pro forma consolidated financial results have been prepared for illustrative purposes only and do not purport to be indicative of the results of operations that actually would have resulted had the acquisition occurred on the first day of the earliest period presented, or of future results of the consolidated entities. The unaudited pro forma consolidated financial information does not reflect any operating efficiencies and cost savings that may be realized from the integration of the Merger.</span></div></ix:continuation><div id="i3ee2f3590755456d8887827db5ee11c4_136"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzIxOTkwMjMyNjM5NjM_7c1a78a5-cbc7-4268-8b8d-8683b8b523ff" continuedAt="i844dc6821b244fbb93f83239aa911625" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><ix:continuation id="i844dc6821b244fbb93f83239aa911625" continuedAt="id90554ad086b4a39a04b20d33bc283a7"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues for the year ended&#160;December&#160;31, 2021&#160;were primarily generated from sales of AMZEEQ&#160;which was commercially launched in the United States in January 2020 and ZILXI which became available in pharmacies nationwide on October 1, 2020.  The Company&#8217;s customers include a limited number of national and select regional distributors and certain independent and specialty pharmacies, together (the "customers"). The distributors subsequently resell the product, primarily to retail pharmacies that dispense the product to patients. Net product revenue is typically recognized when customers obtain control of the Company&#8217;s products, which occurs at a point in time, typically upon delivery of product to the customers. For the year ended December&#160;31, 2021, three customers accounted for <ix:nonFraction unitRef="number" contextRef="idcd1310cc41948fda92510020e6c5311_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzgxMw_83fd54cb-fd78-4931-9ce0-91675db65a2a">17</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ia44d040e2d58449fb2c8ccba534d3561_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzgxNw_455b04c7-fdb3-4347-a509-a5939a78fe86">15</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="icd2d1d4d5236485dbd015be1f3e9a186_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzgyNA_179445c1-a6e0-4be5-8d29-975f29f27149">9</ix:nonFraction>% of product revenue, respectively.  For the year ended December&#160;31, 2020, three customers accounted for <ix:nonFraction unitRef="number" contextRef="i1c4616f3027c41d7a959089637cbe325_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgwODE_88c231da-1f3f-4257-9008-4287bb6d4d27">42</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i0de48e6f1dee484cb5de248475e21cc0_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgwODY_ea145acb-ddc1-462c-9d7b-a4c1421a2d99">39</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i4538b4163a484df9a5150bc090ab457d_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgwOTU_e6c56b71-69af-439d-8455-23fbc28c98ba">15</ix:nonFraction>% of product revenue, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales Provisions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenue is recorded net of distribution fees, trade discounts, allowances, rebates, chargebacks, estimated returns and other incentives, described below. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company calculates its net product revenue based on the wholesale acquisition cost that the Company charges its customers less provisions for (i) trade discounts and allowances, such as distributor fees and discounts for prompt payment, (ii) estimated rebates to third-party payers, patient co-pay assistance programs, chargebacks and other discount programs and (iii) reserves for expected product returns.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for distribution fees, trade discounts and chargebacks are reflected as a reduction to trade receivables, net on the consolidated balance sheet. All other provisions, including rebates, other discounts and return provisions are reflected as a liability within accrued expenses on the consolidated balance sheet. Provisions for revenue reserves described below reduced product revenues by $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" name="vyne:RevenueRecognitionDistributionTradeDiscountsAndAllowances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzE4NjE_186d4000-3c14-4f49-8526-e8e7808fef3b">62.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" name="vyne:RevenueRecognitionDistributionTradeDiscountsAndAllowances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgxNzY_898dfbd4-bf34-432b-9a9b-39e0404db5d0">39.5</ix:nonFraction> million for the years ended December&#160;31, 2021 and December&#160;31, 2020, respectively. The revenue reserve accrual was $<ix:nonFraction unitRef="usd" contextRef="i629adb3cec5646989a6518dee4a69029_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2Mzc5NTY_6140ff1f-9381-47ab-ba86-60b95d264a66">5.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2Mzc5NDQ_8d32ec69-0884-4c6a-ad01-55ef3b785265">5.8</ix:nonFraction>&#160;million at December&#160;31, 2021 and December&#160;31, 2020, respectively and was reflected in accrued expenses in the consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Distribution Fees and Trade Discounts and Allowances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company pays fees for distribution services and for certain data that distributors provide to the Company and generally provides discounts on sales to its distributors for prompt payment. These fees and discounts are contractual in nature and the Company expects its distributors to earn these fees and discounts, and accordingly deducts the full amount of these fees and discounts from its gross product revenues at the time such revenues are recognized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Rebates, Chargebacks and Other Discounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales made under managed-care and governmental pricing programs in the U.S. are subject to rebates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Managed Care rebates relate to contractual agreements to sell products to managed care organizations and pharmacy benefit managers at contractual rebate percentages in exchange for volume and/or market&#160;share. Chargebacks relate to contractual agreements to sell products to government agencies and other indirect customers at contractual prices that are lower than the list prices the Company charges wholesalers. When these government agencies or other indirect customers purchase products through wholesalers at these reduced prices, the wholesaler charges the Company for the difference between the prices they paid the Company and the prices at which they sold the products to the indirect customers. The Company estimates the rebates and chargebacks it expects to be obligated to provide and deducts these estimated amounts from its gross product revenue at the time the revenue is recognized. The Company estimates the rebates and chargebacks that it expects to be obligated to provide based upon (i) the Company's current contracts and negotiations, (ii) estimates regarding the payer mix&#160;based on third-party data and utilization, (iii) inventory held by distributors and (iv) estimates of inventory held at the retail channel. Other discounts include the Company&#8217;s co-pay assistance coupon programs for commercially-insured patients meeting certain eligibility requirements. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to pay associated with product that has been recognized as revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Product Returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with industry practice, customers are generally allowed to return products within a specified period of time before and after its expiration date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company estimates the amount of product&#160;that will be returned and deducts these estimated amounts from its gross revenue at the time the revenue is recognized. T</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he information utilized to estimate the returns provision includes: (i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> historical industry information regarding rates for comparable pharmaceutical products and product portfolios</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (ii) external data with respect to inventory levels in the wholesale distribution channel, (iii) external data with respect to prescription </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demand</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for products and (iv) remaining shelf lives of products at the date of sale. The Company estimates that between <ix:nonFraction unitRef="number" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="vyne:EstimateOfProductReturnRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgyNTk_39995247-ba5f-4013-a92b-341e4489b0e9">1</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="2" name="vyne:EstimateOfProductReturnRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgyNTQ_bb2a056f-8bb9-443a-9b56-dd25b7aa9b64">2</ix:nonFraction>% of product sold to wholesalers will be returned. The Company does not estimate returns for </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div></div><ix:continuation id="id90554ad086b4a39a04b20d33bc283a7" continuedAt="i699bbde1e06f450aadba7834355d5a3e"><div style="margin-top:10pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales made to the pharmacies as they are not contractually permitted to return product and the Company did not accept any returns from pharmacies in the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> December&#160;31, 2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License Revenues</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2020, the Company announced that it entered into a license agreement with Cutia for AMZEEQ as well as certain of the Company's other topical minocycline product candidates, once approved, on an exclusive basis in Greater China.  Under the terms of the agreement, Cutia will have an exclusive license to obtain regulatory approval of and commercialize AMZEEQ, ZILXI and, if approved in the U.S., FCD105 in the Greater China territory.  The Company will supply the finished licensed products to Cutia for clinical and commercial use.  Outside of the license transferred, the Company does not have any additional performance obligations under the arrangement.  In exchange for the license, the Company received an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="i8bc82390929346cc83aa1a859f646cb1_D20200423-20200423" decimals="-5" name="us-gaap:ProceedsFromRoyaltiesReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzU4MzU_6c3a6c95-3ea7-4a58-b52e-f244daa986ec">10.0</ix:nonFraction> million.  The license was considered functional IP as the licensee was able to use and benefit from the license without the continued involvement of the Company.  The disposition of the MST Franchise included the license agreement with Cutia including the rights to future revenues and obligations under that agreement.  The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i516662a4a0d6421a948606bc11a4248c_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzU4OTE_80503a02-0827-494a-8bf4-13b58b09afb8">10.0</ix:nonFraction>&#160;million of license revenue in the year ended  December&#160;31, 2020.  No license revenue was earned in the year ended December&#160;31, 2021.   </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Contract Liabilities&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any contract assets (unbilled receivables) related to product sales or as of&#160;December&#160;31, 2021, as customer invoicing generally occurs before or at the time of revenue recognition.  The Company did not have any contract assets (unbilled receivables) related to its license revenues as of December&#160;31, 2021 or 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any contract liabilities as of&#160;December&#160;31, 2021 or 2020, as the Company did not receive payments in advance of fulfilling its performance obligations to its customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales Commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions are generally attributed to periods shorter than one year and therefore are expensed when incurred. Sales commissions are included in selling, general and administrative expenses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Component</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected not to adjust consideration for the effects of a significant financing component when the period between the transfer of a promised good or service to the customer and when the customer pays for that good or service will be one year or less.&#160;Standard credit terms do not exceed 75 days.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty Revenues&#160;</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i699bbde1e06f450aadba7834355d5a3e">The Company is entitled to royalty payments with respect to sales of a product developed by a customer in collaboration with the Company. Revenues in the amount of $<ix:nonFraction unitRef="usd" contextRef="i5f3508ae7116426b88ab53b907d0b8a7_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzc5NTA_235d20f4-4310-4b37-bdf2-cff4e01c519d">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i78c293e52180494c8c19af75d240a16f_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzc5NTc_7b44e72f-5932-49d5-9333-38b09ff2d218">0.8</ix:nonFraction> million were recorded during the year ended December&#160;31, 2021 and 2020, respectively.</ix:continuation>  </span></div><div id="i3ee2f3590755456d8887827db5ee11c4_139"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90ZXh0cmVnaW9uOmY3MDJhMDdlYWU4MDQ1NWU5MDQxZWZkZTQ5MjkyNjZiXzIxOTkwMjMyNTc0NTM_6a8c971e-ed87-4a85-bc1d-1168dc11980c" continuedAt="i21d59b9c7fdb462581364734ad7f5cd7" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i21d59b9c7fdb462581364734ad7f5cd7"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90ZXh0cmVnaW9uOmY3MDJhMDdlYWU4MDQ1NWU5MDQxZWZkZTQ5MjkyNjZiXzYwNDczMTM5NTQ2NzA_3b2febab-551a-4ad6-92ae-f608ab8e183b" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s assets and liabilities that are measured at fair value as of December&#160;31, 2021, and December&#160;31, 2020, are classified in the tables below in one of the three categories described in "Note 2 - Fair value measurement" above:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd96b5be5604cd99fd57eea397b6062_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTpkOTRlYWY1ZTE3NGQ0ZTg3YjMwYzMzMzgxOWZhZDFmNS90YWJsZXJhbmdlOmQ5NGVhZjVlMTc0ZDRlODdiMzBjMzMzODE5ZmFkMWY1XzItMS0xLTEtMTc2ODk_7ff90c42-69c8-4568-998d-b80c016a9eb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1d39c3ca7874b59904e3c0e861e4215_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTpkOTRlYWY1ZTE3NGQ0ZTg3YjMwYzMzMzgxOWZhZDFmNS90YWJsZXJhbmdlOmQ5NGVhZjVlMTc0ZDRlODdiMzBjMzMzODE5ZmFkMWY1XzItMy0xLTEtMTc2ODk_5bb70f8e-386a-422f-9cd1-95192bba8c43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTpkOTRlYWY1ZTE3NGQ0ZTg3YjMwYzMzMzgxOWZhZDFmNS90YWJsZXJhbmdlOmQ5NGVhZjVlMTc0ZDRlODdiMzBjMzMzODE5ZmFkMWY1XzItNS0xLTEtMTc2ODk_118f2105-f661-4a8c-b18b-6b473ec64067">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f3653857bf949f4a2ef81a87a83f1fa_I20201231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTo4Y2M1NzgyZjVkMGI0YTAxODk5YzE1ZmNhNmM0OTAwOC90YWJsZXJhbmdlOjhjYzU3ODJmNWQwYjRhMDE4OTljMTVmY2E2YzQ5MDA4XzItMS0xLTEtMTc2ODk_9204264f-0d47-435d-9075-6cdfef08390b">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i894c1d96a0e74f408876a0655283cf8d_I20201231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTo4Y2M1NzgyZjVkMGI0YTAxODk5YzE1ZmNhNmM0OTAwOC90YWJsZXJhbmdlOjhjYzU3ODJmNWQwYjRhMDE4OTljMTVmY2E2YzQ5MDA4XzItMy0xLTEtMTc2ODk_5dcee104-3bfa-413b-b012-f08e24559715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTo4Y2M1NzgyZjVkMGI0YTAxODk5YzE1ZmNhNmM0OTAwOC90YWJsZXJhbmdlOjhjYzU3ODJmNWQwYjRhMDE4OTljMTVmY2E2YzQ5MDA4XzItNS0xLTEtMTc2ODk_f59f23e4-f722-4d93-bbd2-a6c712e52159">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sold its marketable securities during the year ended December&#160;31, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 24</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_142"></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOAMIX PHARMACEUTICALS LTD.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. dollars in thousands, except share and per share amounts)</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzIxOTkwMjMyNTgyODg_520ad63d-6c67-4f66-82b9-3d06f64f79f7" continuedAt="ieadec7feb9064b3a8b33692e852ae180" escape="true">MARKETABLE SECURITIES</ix:nonNumeric></span></div><ix:continuation id="ieadec7feb9064b3a8b33692e852ae180"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities as of  December&#160;31, 2020 consisted of mutual funds securities.  Realized gains and losses on sales of the securities, are included in the consolidated statement of operations as other income, net.  The Company did not hold any marketable securities as of December&#160;31, 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily determinable fair value are measured at fair value. The changes in the fair value of equity investments are recognized through other income, net in the consolidated statements of operations. </span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzYwNDczMTM5NTU1MDU_237ebee3-f611-4afc-8577-310bc91e02ed" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s marketable securities:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli mutual funds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b2fcf164d44dcfa785ffe4c6fc0674_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90YWJsZTo5OTc4ZGE4MTk4OTk0OGExOGFlYzNjMjM3NWRkZDlmOS90YWJsZXJhbmdlOjk5NzhkYTgxOTg5OTQ4YTE4YWVjM2MyMzc1ZGRkOWY5XzItMS0xLTEtMTc2ODk_0f78d0c9-9d83-46e0-8d28-eeadd6172e08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e9681eeba6644f3af02c673a4fd06b6_I20201231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90YWJsZTo5OTc4ZGE4MTk4OTk0OGExOGFlYzNjMjM3NWRkZDlmOS90YWJsZXJhbmdlOjk5NzhkYTgxOTg5OTQ4YTE4YWVjM2MyMzc1ZGRkOWY5XzItMy0xLTEtMTc2ODk_db2bb627-bd95-4478-9f29-c954b3920c5a">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90YWJsZTo5OTc4ZGE4MTk4OTk0OGExOGFlYzNjMjM3NWRkZDlmOS90YWJsZXJhbmdlOjk5NzhkYTgxOTg5OTQ4YTE4YWVjM2MyMzc1ZGRkOWY5XzYtMS0xLTEtMTc2ODk_3269e85d-ef64-48db-bdc2-07334328d1ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90YWJsZTo5OTc4ZGE4MTk4OTk0OGExOGFlYzNjMjM3NWRkZDlmOS90YWJsZXJhbmdlOjk5NzhkYTgxOTg5OTQ4YTE4YWVjM2MyMzc1ZGRkOWY5XzYtMy0xLTEtMTc2ODk_e094f7b3-d9b0-4ba1-bfd2-21454903d218">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020 there were <ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzIxOTkwMjMyNTgyOTA_2e755e5b-ee1a-4c06-89ec-2525f30fb871"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzIxOTkwMjMyNTgyOTA_9ea98dba-4c0e-4dfb-8341-15f2f2f84584">no</ix:nonFraction></ix:nonFraction> available-for-sale debt securities.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has considered factors regarding other than temporary impaired securities and determined that there were <ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="INF" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzEyOTc_a3c5a2dd-1c18-4410-b24b-5d38a7b76faf"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzEyOTc_c5556cd3-ad6e-4d8e-b9ce-a27ee151954d">no</ix:nonFraction></ix:nonFraction> securities with impairment that is other than temporary as of December&#160;31, 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and 2020, the Company received aggregate proceeds of $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzE1MTc_933acc8e-da5a-4ece-a22c-f41226578d82">1.0</ix:nonFraction> million&#160;and $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzE1MjQ_e8c3112b-c458-473c-b4da-cc6e72dff44a">38.5</ix:nonFraction> million, respectively, upon the sale and maturity of marketable securities.</span></div></ix:continuation><div id="i3ee2f3590755456d8887827db5ee11c4_145"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7 &#8211; <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90ZXh0cmVnaW9uOmNkZGU2NjBlOTUyZDQxYzQ5NjQyZGRmZDliOWExN2U5XzIxOTkwMjMyNTY0OTA_136b41d7-e239-45c9-b226-7350e6ee520a" continuedAt="ibeba09433e174855ae9d299e4cde316c" escape="true">INVENTORY</ix:nonNumeric></span></div><ix:continuation id="ibeba09433e174855ae9d299e4cde316c"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost and net realizable value with cost determined on a first-in, first-out basis by product. The Company capitalizes inventory costs associated with products following regulatory approval when future commercialization is considered probable and the future economic benefit is expected to be realized. The Company commenced capitalizing inventory for AMZEEQ and ZILXI upon FDA approval in October 2019 and May 2020, respectively. The Company periodically reviews its inventory levels and, if necessary, writes down inventory that is expected to expire prior to being sold, inventory in excess of expected sales requirements and inventory that fails to meet commercial sale specifications, with a corresponding charge to cost of goods sold. There were <ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:InventoryWriteDown" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90ZXh0cmVnaW9uOmNkZGU2NjBlOTUyZDQxYzQ5NjQyZGRmZDliOWExN2U5XzgxNA_d5d18f2a-50d8-4453-bcae-49fe4d3dba12"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="INF" name="us-gaap:InventoryWriteDown" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90ZXh0cmVnaW9uOmNkZGU2NjBlOTUyZDQxYzQ5NjQyZGRmZDliOWExN2U5XzgxNA_eebfa1c3-eb13-4783-b00c-7ddc4041de5e">no</ix:nonFraction></ix:nonFraction> material inventory write-downs during the years ended December&#160;31, 2021 and 2020.  All inventory was sold or written-off in connection with the sale of the MST Franchise.  See Note 17.</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90ZXh0cmVnaW9uOmNkZGU2NjBlOTUyZDQxYzQ5NjQyZGRmZDliOWExN2U5XzYwNDczMTM5NTM3MDc_309d62f3-0a7f-4b16-879e-9cca9d597aff" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s inventory:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSupplies" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzItMS0xLTEtMTc2ODk_2a1ec11a-735c-4246-9027-91ff2fa4cf1b">3,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSupplies" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzItMy0xLTEtMTc2ODk_aeabcdf7-593b-4559-b9f4-3e4fc50d8738">4,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzMtMS0xLTEtMTc2ODk_a5cb272d-b4fa-40ba-9b58-c35b1064ba86">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzMtMy0xLTEtMTc2ODk_dce17c01-c70f-4980-a7d4-3f7fa510f977">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzQtMS0xLTEtMTc2ODk_81c70307-1a7b-4471-859c-e15f91a3251e">3,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzQtMy0xLTEtMTc2ODk_e5d14729-c86a-45d7-978c-487117874e0c">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzUtMS0xLTEtMTc2ODk_693b9013-ea71-4779-bdbe-2c16db3d0733">7,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzUtMy0xLTEtMTc2ODk_4d130917-83d4-4f19-948c-99aea15d5297">7,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:7pt;text-align:justify"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_148"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90ZXh0cmVnaW9uOjM2YzkwZTZmYWI1ZDRiMjJiOWRjZGZiMzc4NTI5ODAwXzIxOTkwMjMyNTYzMzU_a5b2585d-816d-4451-bfd7-53d46b2db203" continuedAt="i5499d6bdc24d46ee9365823b964d6bfb" escape="true">PROPERTY AND EQUIPMENT</ix:nonNumeric></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOAMIX PHARMACEUTICALS LTD.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. dollars in thousands, except share and per share amounts)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8 - PROPERTY AND EQUIPMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (continued)</span></div></div><ix:continuation id="i5499d6bdc24d46ee9365823b964d6bfb" continuedAt="i9a809829a18d4d56a2073dd7f3d39629"><div style="margin-top:5pt"><ix:continuation id="if6f7f0506cdd4137921494ab05c4be37"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic65e68488b4a44bfb1349485e00bc902_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzMtMS0xLTEtMTc2ODk_4c51a8b4-9605-49f3-81cc-a7094a163f5c">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fff6625e4e44353b52824e303e6c56c_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzMtMy0xLTEtMTc2ODk_9ccbcfc1-0f73-4ca1-a4ea-224a09d2c08e">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcce6081c1204eeebe23dd6751efbbda_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzQtMS0xLTEtMTc2ODk_eaa5c5a6-fbb1-4e9a-b400-16d812a4d532">374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ea3c6a2b9643c4b0c38a30feec97fd_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzQtMy0xLTEtMTc2ODk_24981dad-ba7a-45c2-b606-4047e0f0f411">467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2e122d5e1c4441fb4e5269084ca195c_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzUtMS0xLTEtMTc2ODk_6aa406a7-d6a4-48ad-b579-2667dcf09e1c">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958fd692be7048b692433788e3424109_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzUtMy0xLTEtMTc2ODk_ff4a8ba8-8fae-4bd8-87d5-7dd7e8a03d75">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic48701016b5b4663afd273a98b086ca0_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzYtMS0xLTEtMTc2ODk_d62de771-e268-4d47-8f3a-2dc0a95acc70">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101ececdf4914f5ba6e572e864e4cf66_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzYtMy0xLTEtMTc2ODk_a31c25fd-18f7-4c78-b9d9-b40f4461e4f0">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzgtMS0xLTEtMTc2ODk_5871242f-9c2f-4625-afaf-8d4bded8fbea">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzgtMy0xLTEtMTc2ODk_6de320f0-101b-4e23-8f51-dfa7a1ec9586">998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzEwLTEtMS0xLTE3Njg5_c2ae59d3-92b7-44be-b486-7ec6aa83961f">551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzEwLTMtMS0xLTE3Njg5_3d3f6ba6-0c5d-46f5-a9ba-cc103a38e610">443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzExLTEtMS0xLTE3Njg5_13ec1702-c85e-41be-84ce-9a8a015b796c">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzExLTMtMS0xLTE3Njg5_6b9e8ccc-9048-46cd-b9fb-ecf7c39fffdc">555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense totaled $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90ZXh0cmVnaW9uOjM2YzkwZTZmYWI1ZDRiMjJiOWRjZGZiMzc4NTI5ODAwXzg1_9eef9a0a-e851-4f18-9bbb-196bb7a4ead8">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90ZXh0cmVnaW9uOjM2YzkwZTZmYWI1ZDRiMjJiOWRjZGZiMzc4NTI5ODAwXzg5_7b860541-5ccb-4809-b982-6e1f1e7770f7">0.3</ix:nonFraction> million for the years ended December&#160;31, 2021 and 2020, respectively.</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9a809829a18d4d56a2073dd7f3d39629">During the years ended December&#160;31, 2021 and December&#160;31, 2020, the Company disposed of fixed assets in the net amount of $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90ZXh0cmVnaW9uOjM2YzkwZTZmYWI1ZDRiMjJiOWRjZGZiMzc4NTI5ODAwXzEwOTk1MTE2Mjk0MTM_77fa8f4a-1f9c-4eca-b35e-5a1d188fdc72">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90ZXh0cmVnaW9uOjM2YzkwZTZmYWI1ZDRiMjJiOWRjZGZiMzc4NTI5ODAwXzI0OA_c23ff944-f03a-407b-b3b7-d3fd2e40f59c">2.1</ix:nonFraction> million. Loss on disposal of fixed assets during the year ended December&#160;31, 2020 relates to the write-off of laboratory and leasehold improvements in Israel due to a reduction in office space.</ix:continuation>  </span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_151"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90ZXh0cmVnaW9uOjQyNTNkMDhlY2U5NzQ1ZGNhYTk3N2YzNzgyOWYwN2FiXzg3OTYwOTMwMjg1Nzg_193f4a9f-ff99-40e8-9ee5-f7ffea0ecf48" continuedAt="i93c053de4da54a43aeb3475e060a438d" escape="true">ACCRUED EXPENSES</ix:nonNumeric></span></div><ix:continuation id="i93c053de4da54a43aeb3475e060a438d"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90ZXh0cmVnaW9uOjQyNTNkMDhlY2U5NzQ1ZGNhYTk3N2YzNzgyOWYwN2FiXzg3OTYwOTMwMjg1Nzk_2064f820-febe-4c91-8ab9-e88a46d08c5a" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales provisions (see Note 4)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="vyne:AccruedSalesProvisionsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzMtMS0xLTEtMzI1NzM_85f7b4db-fed6-4841-9261-c8eeb0558fa6">5,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="vyne:AccruedSalesProvisionsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzMtMy0xLTEtMzI2MTc_60af797c-ce84-4fe2-984a-e6c3f976abbc">5,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzQtMS0xLTEtMzI1ODE_cbcdf3dd-cf8d-4bb3-a480-9b51914e460f">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzQtMy0xLTEtMzI5NzM_4a059e8c-1b1f-44d2-bf72-fc386ba5bf7f">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="vyne:AccruedResearchAndDevelopmentCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzUtMS0xLTEtMzI1ODg_9f13a161-2762-422f-8492-c35b4842f90e">969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="vyne:AccruedResearchAndDevelopmentCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzUtMy0xLTEtMzI5ODE_2be39021-54f0-4b8e-a58a-ca8fa7e3c414">862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzYtMS0xLTEtMzI1OTU_a4e1ebd4-165e-4c0d-9c10-27debf106631">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzYtMy0xLTEtMzI5ODg_782239b1-7b8b-4340-84aa-8239984905db">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercialized product accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="vyne:AccruedCommercializedProductCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzctMS0xLTEtMzI5NjY_f5495129-a2c1-4cf8-b007-26f253aa07ba">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="vyne:AccruedCommercializedProductCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzctMy0xLTEtMzI5OTU_bf992c94-a162-4b63-91a7-2ee5cc796f42">1,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzctMS0xLTEtMzI2MDI_d94bb10c-7748-4936-893f-3a48f1d886a2">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzgtMy0xLTEtMzMwMDI_bc0d0686-592f-4f1f-b308-2d1b32646a51">1,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Accrued Expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzgtMS0xLTEtMzI2MDk_09a8a8d9-7d3b-4955-82da-7ea28acc349a">8,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzgtMy0xLTEtMzI2MTc_3a1a8d88-cc29-4271-aeae-2d04f609aeb9">11,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i3ee2f3590755456d8887827db5ee11c4_1991"></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10 &#8211; <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18yNDEx_ceb8fa0e-da49-4fdf-85d3-c36e3d95bcd6" continuedAt="i92aa0a1fbdf442e4ae1c352cd17b3641" escape="true">OPERATING LEASE</ix:nonNumeric></span></div><ix:continuation id="i92aa0a1fbdf442e4ae1c352cd17b3641" continuedAt="i170a52fe493644a1b6e53c72e53fcdb0"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for corporate offices and vehicles. The properties primarily relate to the Company&#8217;s principal executive office in Bridgewater, New Jersey and office space in Israel.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 13, 2019, the Company signed an amendment to the original lease agreement for its principal executive office in Bridgewater, New Jersey (the "Lease Amendment&#8221;). The Lease Amendment includes an extension of the lease period of the <ix:nonFraction unitRef="sqft" contextRef="i99a4341caaaf441eaf0074526a0a8807_D20190313-20190313" decimals="0" name="vyne:FacilitySpaceUnderLease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y180ODk_0ba8d3ef-b2cf-476e-8dcf-87f4303b8b79">10,000</ix:nonFraction> square feet previously leased under the original agreement (the "Original Space") and an addition of <ix:nonFraction unitRef="sqft" contextRef="i941659ebe9434514a406d1f56a59ad1c_D20190313-20190313" decimals="0" name="vyne:FacilitySpaceUnderLease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y181OTM_cd87b867-c5c5-4969-962c-5ae3e3806300">4,639</ix:nonFraction> square feet (the "Additional Space&#8221;). The Company entered the Additional Space following a period of preparation by the lessor completed during September 2019 (the "Commencement Date"). The lease is due to expire on August 31, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i170a52fe493644a1b6e53c72e53fcdb0"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Lease Amendment, the Company recognized an additional right of use asset and liability in the amount of $<ix:nonFraction unitRef="usd" contextRef="i51a910c9c1a147509aff2e6f87810f5c_I20190313" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y185NDk_83e7be14-0e45-44d9-94f2-934e5c7c3cbf"><ix:nonFraction unitRef="usd" contextRef="i51a910c9c1a147509aff2e6f87810f5c_I20190313" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y185NDk_8794716a-fc1f-4233-9b8d-e47d110c26cf">0.7</ix:nonFraction></ix:nonFraction> million. The Additional Space was considered a new lease agreement and was recognized as a right of use asset and liability, in the amount of $<ix:nonFraction unitRef="usd" contextRef="i31d953cfd865427281cfadfbca27bacf_I20190313" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18xMDg2_8ea629e3-ada0-45f2-a10c-402b2a1e4e43"><ix:nonFraction unitRef="usd" contextRef="i31d953cfd865427281cfadfbca27bacf_I20190313" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18xMDg2_a4a14e07-c090-4aca-bb59-b82428d2f48b">0.3</ix:nonFraction></ix:nonFraction> million, on the Commencement Date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease agreement for the office space in Israel expires in December 2022.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company entered into operating lease agreements in connection with the leasing of vehicles. The lease periods are generally for <ix:nonNumeric contextRef="id5c046f0b00a43cd82cd79465a32a139_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18yNDE2_d68aced6-1e07-4c7c-81dd-e9bb552eb59b">three years</ix:nonNumeric>. To secure the terms of certain of the vehicle lease agreements, the Company has made prepayments to the leasing company, representing approximately <ix:nonNumeric contextRef="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231" name="vyne:VehicleLeasePrepaymentPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18xNDk5_002a8c65-3b85-4de9-8704-e3f286457f88">three months</ix:nonNumeric> of lease payments. These amounts have been recorded as part of the operating lease right to use assets.  In connection with the strategic business review and sale of the MST Franchise certain vehicle leases were transferred to members of the commercial workforce resulting in the elimination of $<ix:nonFraction unitRef="usd" contextRef="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231" decimals="-5" name="vyne:OperatingLeaseRightOfUseAssetsTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18xMDk5NTExNjMwMjEz_f66dd906-444b-4bf6-abb1-8179eddaeddf">0.5</ix:nonFraction>&#160;million of right of use assets and $<ix:nonFraction unitRef="usd" contextRef="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231" decimals="-5" name="vyne:OperatingLeaseLiabilityTransferred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18xMDk5NTExNjMwMjI3_15c86525-09a7-401c-b906-987c510e7085">0.5</ix:nonFraction>&#160;million of right of use liabilities.</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18yNDE1_7b1242f5-ff9b-49b4-a003-c7d7ae0c5373" continuedAt="i9abf66084b2540238ff9edaa839026a3" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs for the year ended December&#160;31, 2021 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office lease expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095f99f5dad646848e17f3e6cf867662_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6NGYyMWNlYjZkZTY5NGU5MzhmY2Y5NTI2ZTgzMzIwOTkvdGFibGVyYW5nZTo0ZjIxY2ViNmRlNjk0ZTkzOGZjZjk1MjZlODMzMjA5OV8yLTEtMS0xLTMyNDg1_019717ff-be3a-4dd4-ad64-06d546834c0e">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f07698396e4710961b022584df3af9_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6NGYyMWNlYjZkZTY5NGU5MzhmY2Y5NTI2ZTgzMzIwOTkvdGFibGVyYW5nZTo0ZjIxY2ViNmRlNjk0ZTkzOGZjZjk1MjZlODMzMjA5OV8yLTMtMS0xLTMyNDg1_418bf9e6-47d8-4d77-881b-1c5561e82688">961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles lease expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6NGYyMWNlYjZkZTY5NGU5MzhmY2Y5NTI2ZTgzMzIwOTkvdGFibGVyYW5nZTo0ZjIxY2ViNmRlNjk0ZTkzOGZjZjk1MjZlODMzMjA5OV8zLTEtMS0xLTMyNDg1_2c2d07fd-de27-443b-9320-a6c25144319c">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdc06dd768af4cf19fdbabdfd9a1e045_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6NGYyMWNlYjZkZTY5NGU5MzhmY2Y5NTI2ZTgzMzIwOTkvdGFibGVyYW5nZTo0ZjIxY2ViNmRlNjk0ZTkzOGZjZjk1MjZlODMzMjA5OV8zLTMtMS0xLTMyNDg1_5c9c232a-949d-427d-9769-003ca6035248">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease costs include an immaterial amount of variable lease payments for the years ended December&#160;31, 2021 and 2020, respectively.</span></div><ix:continuation id="i9abf66084b2540238ff9edaa839026a3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows, for amounts included in the measurement of lease liabilities are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095f99f5dad646848e17f3e6cf867662_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6ZmYxMDI3ZDVhNjkxNGY2OWFjMjkwMmM2NjNlZmE5YjkvdGFibGVyYW5nZTpmZjEwMjdkNWE2OTE0ZjY5YWMyOTAyYzY2M2VmYTliOV8xLTEtMS0xLTMyNDg1_e3ed957a-a7ad-4803-beae-2c916452d89c">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f07698396e4710961b022584df3af9_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6ZmYxMDI3ZDVhNjkxNGY2OWFjMjkwMmM2NjNlZmE5YjkvdGFibGVyYW5nZTpmZjEwMjdkNWE2OTE0ZjY5YWMyOTAyYzY2M2VmYTliOV8xLTMtMS0xLTMyNDg1_42735f96-bad8-4f00-81ef-850e05302290">971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6ZmYxMDI3ZDVhNjkxNGY2OWFjMjkwMmM2NjNlZmE5YjkvdGFibGVyYW5nZTpmZjEwMjdkNWE2OTE0ZjY5YWMyOTAyYzY2M2VmYTliOV8yLTEtMS0xLTMyNDg1_418d660e-d615-410e-b865-b6c4e3bbea84">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdc06dd768af4cf19fdbabdfd9a1e045_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6ZmYxMDI3ZDVhNjkxNGY2OWFjMjkwMmM2NjNlZmE5YjkvdGFibGVyYW5nZTpmZjEwMjdkNWE2OTE0ZjY5YWMyOTAyYzY2M2VmYTliOV8yLTMtMS0xLTMyNDg1_25183114-4246-4653-83dd-674483e6c933">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="vyne:OperatingLeaseRightOfUseAssetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8xLTEtMS0xLTMyNDg1_47890850-500e-4f82-906a-fc5abcf3818c">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8xLTMtMS0xLTMyNDg1_65f97efb-997d-41cb-b44e-1547fd8a7daf">1,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8yLTEtMS0xLTMyNDg1_da48c8e8-2115-46be-805c-0ffed8d08690">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8yLTMtMS0xLTMyNDg1_2600f67b-6c61-4479-b918-1e83f58d2938">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8zLTEtMS0xLTMyNDg1_f02efd63-97d5-45f8-9aca-2ebdfd9bfcdf">0.77</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8zLTMtMS0xLTMyNDg1_cfb2a6d4-6b14-4e1f-855e-8d41b2c06e4d">1.96</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF80LTEtMS0xLTMyNDg1_f64507fb-7f59-486e-b9c2-2052d87f57bf">13.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF80LTMtMS0xLTMyNDg1_0e7cf67d-b29e-4b70-8f71-83dad26cd322">13.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18yNDEy_4168fa65-d5a4-46b0-be55-7c8c7def72fa" escape="true"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YTg4ODI0OGM3ZDZhNGFmMGEwNDZlNWJlYWQyMzMwMmYvdGFibGVyYW5nZTphODg4MjQ4YzdkNmE0YWYwYTA0NmU1YmVhZDIzMzAyZl8wLTEtMS0xLTMyNDg1_3a064476-13a4-401b-aa7e-612c4ba42cfb">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YTg4ODI0OGM3ZDZhNGFmMGEwNDZlNWJlYWQyMzMwMmYvdGFibGVyYW5nZTphODg4MjQ4YzdkNmE0YWYwYTA0NmU1YmVhZDIzMzAyZl8xLTEtMS0xLTMyNDg1_ea4df25f-2cba-49ac-a926-5ffb987dd36d">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YTg4ODI0OGM3ZDZhNGFmMGEwNDZlNWJlYWQyMzMwMmYvdGFibGVyYW5nZTphODg4MjQ4YzdkNmE0YWYwYTA0NmU1YmVhZDIzMzAyZl8yLTEtMS0xLTMyNDg1_2ebb5c48-eb58-4513-a271-cea5e1d06107">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YTg4ODI0OGM3ZDZhNGFmMGEwNDZlNWJlYWQyMzMwMmYvdGFibGVyYW5nZTphODg4MjQ4YzdkNmE0YWYwYTA0NmU1YmVhZDIzMzAyZl8zLTEtMS0xLTMyNDg1_0d304644-9978-4a8c-9c96-c3c03a45b2d4">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YTg4ODI0OGM3ZDZhNGFmMGEwNDZlNWJlYWQyMzMwMmYvdGFibGVyYW5nZTphODg4MjQ4YzdkNmE0YWYwYTA0NmU1YmVhZDIzMzAyZl80LTEtMS0xLTMyNDg1_9fcaca36-ac94-484c-8048-124a91d9e84e">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had a lien in the amount of $<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-5" name="vyne:RestrictedInvestmentsToSecureLeaseAgreements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18yMzA5_88816bc0-0303-454f-9dea-03d4f3b3ab27">0.6</ix:nonFraction> million on the Company&#8217;s cash in respect of bank guarantees granted in order to secure the lease agreements.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 27</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_154"></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VYNE THERAPEUTICS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. dollars in thousands, except share and per share amounts)</span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTQvZnJhZzowMzE5MjNhOTE0OTI0NDEwYWEwNzA2OTA3OTRkOWRjZS90ZXh0cmVnaW9uOjAzMTkyM2E5MTQ5MjQ0MTBhYTA3MDY5MDc5NGQ5ZGNlXzIxOTkwMjMyNTYwNDE_07464a27-e6db-4046-955f-17b8f8651e36" continuedAt="i3aeba2ee35af4c278e04b80f8a1ee9f2" escape="true">EMPLOYEE SAVINGS PLAN</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3aeba2ee35af4c278e04b80f8a1ee9f2">Beginning September 2017, the Company has retirement savings plans available to all employees of the Subsidiary, which are intended to qualify as deferred compensation plans under Section 401(k) of the Internal Revenue Code (the &#8220;401(k) Plans&#8221;). The Company made contributions to these 401(k) Plans during the years ended December&#160;31, 2021, and 2020 of approximately $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTQvZnJhZzowMzE5MjNhOTE0OTI0NDEwYWEwNzA2OTA3OTRkOWRjZS90ZXh0cmVnaW9uOjAzMTkyM2E5MTQ5MjQ0MTBhYTA3MDY5MDc5NGQ5ZGNlXzQyNQ_5361f8c4-8942-42a7-96fe-c4859a39f2b4">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTQvZnJhZzowMzE5MjNhOTE0OTI0NDEwYWEwNzA2OTA3OTRkOWRjZS90ZXh0cmVnaW9uOjAzMTkyM2E5MTQ5MjQ0MTBhYTA3MDY5MDc5NGQ5ZGNlXzQyOQ_4c6185a5-d104-4753-a142-7c501d247b3e">0.8</ix:nonFraction> million, respectively.</ix:continuation></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_157"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12 &#8211; <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTcvZnJhZzozOTkyMGRkNmNkNmM0YzA2OTM0OGNkNzk0M2JjYWVkOC90ZXh0cmVnaW9uOjM5OTIwZGQ2Y2Q2YzRjMDY5MzQ4Y2Q3OTQzYmNhZWQ4XzIxOTkwMjMyNTk4MTE_1336c5e2-5dfd-4e5a-bc6a-a07534d69ee2" continuedAt="ieae109683d2b44c8bb8d79c9dd125419" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="ieae109683d2b44c8bb8d79c9dd125419" continuedAt="ied94b14bf22b46bb9bb9665b48833b0a"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation and contingencies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may periodically become subject to legal proceedings and claims arising in connection with its business. As of December&#160;31, 2021, there are no claims or actions pending against the Company that, in the opinion of management, are likely to have a material adverse effect on the Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2021, the Company received a paragraph IV certification notice (the &#8220;Notice&#8221;) from Padagis Israel Pharmaceuticals Ltd. (f/k/a Perrigo Israel Pharmaceuticals Ltd. (&#8220;Padagis&#8221;)) advising that Padagis has submitted to the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) an Abbreviated New Drug Application (&#8220;ANDA&#8221;) seeking approval to manufacture and sell a generic version of the Company&#8217;s product AMZEEQ&#174; (minocycline) topical foam, 4% in the United States prior to the expiration of the Company&#8217;s U.S. patents Nos. 8,865,139, 8,945,516, 8,992,896, 9,675,700, 10,086,080, 10,137,200, 10,213,512, 10,265,404, 10,398,641, 10,517,882, 10,821,187, and 10,849,847 (the &#8220;Listed Patents&#8221;), which are listed in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations, otherwise known as the &#8220;Orange Book.&#8221; The Notice alleges that the Listed Patents are invalid, unenforceable, and/or will not be infringed by the commercial manufacture, use or sale of the generic product described in Padagis&#8217;s ANDA.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ied94b14bf22b46bb9bb9665b48833b0a">On August 9, 2021, the Company initiated a patent infringement suit against Padagis in the United States District Court for the District of Delaware arising from Padagis&#8217;s ANDA filing with the FDA. The patent infringement suit asserts each of the Listed Patents. As a result, under applicable law, the FDA cannot grant final approval to Padagis&#8217;s ANDA before December 30, 2023, or a court decision in Padagis&#8217;s favor. VYNE is seeking, among other relief, an order that the effective date of any FDA approval of Padagis&#8217;s ANDA be no earlier than the expiration of the Listed Patents, the latest of which expires on September 8, 2037, and such further and other relief as the court may deem appropriate. Padagis filed its response and counterclaim on October 1, 2021. The Company filed its response to such counterclaim on October 22, 2021. The liabilities associated with this matter have been transferred to Journey in connection with the Sale.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_160"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzIxOTkwMjMyNjY3ODU_9d4e5a9f-cd10-46a1-9b61-f0efd8b85671" continuedAt="i81015b686d814914b1941a1c3c89eed2" escape="true">LONG-TERM DEBT</ix:nonNumeric></span></div><ix:continuation id="i81015b686d814914b1941a1c3c89eed2" continuedAt="i15b97aca1c014e20a4c65268ad41a9ec"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2019, Foamix entered into a Credit Agreement (the "Credit Agreement") to secure up to $<ix:nonFraction unitRef="usd" contextRef="i9d3b1bab5fa44cbfa425becb06eecfc7_I20190729" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEyOA_caf34afb-28c7-4399-833f-acec9da72090">50</ix:nonFraction> million from <ix:nonFraction unitRef="lender" contextRef="if989d0b1c2c24f45b11a284fac301a66_I20190729" decimals="INF" name="vyne:NumberOfLenders" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzIxOTkwMjMyNjY3ODY_3927fb9a-bedc-4e4c-b466-1c6da1d79777">two</ix:nonFraction> lenders, one of which is a significant stockholder of the Company and is considered a related party, and a Securities Purchase Agreement with <ix:nonFraction unitRef="lender" contextRef="i284a65a8749542cdb95cbcc24fe35192_I20190729" decimals="INF" name="vyne:NumberOfLenders" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI4Mg_52a42d03-d626-4101-b8fa-a103e1bad63a">one</ix:nonFraction> of the lenders for gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i284a65a8749542cdb95cbcc24fe35192_I20190729" decimals="-6" name="vyne:GrossProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzMzNg_22ba1f4f-a8f8-4475-8234-591d124a636a">14</ix:nonFraction> million, before deducting offering expenses (see "Note 14 - Share Capital" for more information).  On March 9, 2020, the Company entered into an Amended and Restated Credit Agreement and Guaranty (as further amended on August 5, 2020, the "Amended and Restated Credit Agreement"), whereby the Company has guaranteed the indebtedness obligations of the borrower and granted a first priority security interest in substantially all of our assets for the benefit of the lenders.  As of December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i0c259adecd3644dbaca374ee117b6d25_I20201231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI3NDg3NzkwNzc1MTk_7791fac1-f1b4-4a35-9191-7957f7a29a1c">35.0</ix:nonFraction> million was drawn under the Amended and Restated Credit Agreement.  The Company did not incur the remaining $<ix:nonFraction unitRef="usd" contextRef="i0c259adecd3644dbaca374ee117b6d25_I20201231" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzg4OQ_0a205b7b-c78f-424b-86ba-e394039d13cd">15.0</ix:nonFraction> million under the Amended and Restated Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loans available under the Amended and Restated Credit Agreement were comprised as follows: (a) $<ix:nonFraction unitRef="usd" contextRef="ia96474a494374f3385b000f4f8d33fca_I20190729" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwNDQ_8aebe24c-9738-47b5-bca1-0048ccb64f99">15</ix:nonFraction> million that was funded on July 29, 2019 (the &#8220;Tranche 1 Loan&#8221;), (b) $<ix:nonFraction unitRef="usd" contextRef="i577c52ea7b5b40aab1df1b785fc2c96e_I20191217" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzExMDg_8d5e696b-07fb-4a09-8757-7a4e2fc8ef4d">20</ix:nonFraction> million that was funded on December 17, 2019 (the &#8220;Tranche 2 Loan&#8221;) and (c) up to $<ix:nonFraction unitRef="usd" contextRef="i04ea1c0a01244363ac01049f1f6c7857_I20200930" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzExODU_8858909e-4757-4067-9c13-72cd57498ea3">15</ix:nonFraction> million that was available prior to September 30, 2020 (the &#8220;Tranche 3 Loan&#8221;). The Tranche 2 Loan was borrowed following the FDA&#8217;s approval of the Company&#8217;s NDA for AMZEEQ and listing of AMZEEQ in the FDA&#8217;s &#8220;Orange Book,&#8221; in addition to maintaining its arrangements with a third party for the commercial supply and manufacture of AMZEEQ. The Company did not incur the Tranche 3 Loan. Subject to any acceleration as provided in the Amended and Restated Credit Agreement, including upon an event of default (as defined in the Amended and Restated Credit Agreement), the loans will mature on July 29, 2024 and bear interest equal to the sum of (A) <ix:nonFraction unitRef="number" contextRef="ic10e4840e05c4e729cd9e69af333a006_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzE4MjU_22210759-9263-42e4-b316-26231cec177f">8.25</ix:nonFraction>% (subject to increase in accordance with the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i15b97aca1c014e20a4c65268ad41a9ec"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">terms of the Amended and Restated Credit Agreement) plus (B) the greater of (x) the one-month LIBOR as of the second business day immediately preceding the first day of the calendar month or the date of borrowing (if such loan is not outstanding as of the first day of the calendar month), as applicable, and (y) <ix:nonFraction unitRef="number" contextRef="i2e9df17c9abb40a896c4e95cd18226bd_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzIxODU_e52fe66d-25d7-4668-9d85-f54fed869848">2.75</ix:nonFraction>%. A fee in an amount equal to <ix:nonFraction unitRef="number" contextRef="i66e2d83dcb2e4d44a68e3d1c04503e5c_D20210101-20211231" decimals="3" name="vyne:DebtInstrumentFeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzIyMTc_118d785c-44fe-428e-b05b-e864f099fab9">1.0</ix:nonFraction>% of the aggregate principal amount of all loans made on any given borrowing date shall be payable to the lenders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans were scheduled to mature on July 29, 2024. However, following discussions with the Company's lenders regarding the revenue targets included in the Amended and Restated Credit Agreement, the revenue expected to be generated for the trailing twelve month period ended June 30, 2021 and the Company's strategic business review discussed in Note 1, the Company determined to prepay its outstanding indebtedness in addition to a <ix:nonFraction unitRef="number" contextRef="ia7de8816c3eb465d9f44397038347e0a_I20210811" decimals="INF" name="vyne:RepaymentOfDebtPrepaymentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI3NDg3NzkwODAyMDg_07655148-3d8a-40d5-88ba-008f872ef903">4</ix:nonFraction>% prepayment fee and accrued but unpaid interest in the total amount of approximately $<ix:nonFraction unitRef="usd" contextRef="iaac44e519733479cb2fd74f4d69991a1_D20210811-20210811" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI3NDg3NzkwODAyMTI_2c33296e-2408-4b70-9fac-73de1bb63fa3">36.5</ix:nonFraction>&#160;million on August 11, 2021. Following the prepayment, the Amended and Restated Credit Agreement and the security interests thereunder were terminated. As of December&#160;31, 2021 there was <ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI3NDg3NzkwNzc1MjU_2f2dfe95-e859-442a-9027-048ec4cb49ed">no</ix:nonFraction> debt outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perceptive Credit Holdings II, LP ("Perceptive") was one of the lenders and the administrative agent under the Amended and Restated Credit Agreement. As of August 11, 2021, the date of the prepayment, affiliates of Perceptive were holders of more than 5% of the Company's outstanding common stock. In connection with the prepayment of the Company's indebtedness, Perceptive received $<ix:nonFraction unitRef="usd" contextRef="iaac44e519733479cb2fd74f4d69991a1_D20210811-20210811" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI3NDg3NzkwODA0MjE_5e8dd772-3258-475b-9c2a-c8fe82f9326a">18.3</ix:nonFraction>&#160;million, representing their portion of the principal amount, interest and prepayment premium.  As of December 31, 2021, Perceptive was no longer a related party. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on July 29, 2019, the lenders under the Credit Agreement were issued warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="i9949f940927a4c1fb5d8ac40b1e2e0e4_I20190729" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzQzNDc_c87b372a-dcf0-4869-a82e-6914dd9e8a35">1,100,000</ix:nonFraction> of Foamix ordinary shares, at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9949f940927a4c1fb5d8ac40b1e2e0e4_I20190729" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzQ0MDE_063eb6e0-dac8-4a6e-bf30-3412f19e18b7">2.09</ix:nonFraction> per share (the &#8220;Warrants&#8221;), which represented the five-day volume weighted average price of the Foamix ordinary shares as of the trading day immediately prior to the issuance of the Warrants. In connection with the completion of the Merger, the exchange ratio was applied to the Warrants such that they became exercisable for <ix:nonFraction unitRef="shares" contextRef="i0fb8e95fc2ea4faea89832a8d5669b5e_I20200309" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzQ3MzA_ad35a5d0-3321-407e-bae5-152715347735">651,640</ix:nonFraction> shares of the Company's common stock, and the exercise price was adjusted to $<ix:nonFraction unitRef="usdPerShare" contextRef="i0fb8e95fc2ea4faea89832a8d5669b5e_I20200309" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzQ4MTA_bd05b6cf-18ed-4ff5-a59d-12688fa32e26">3.53</ix:nonFraction>.  Following the Phase 3 PN Trial results, the Warrants were further adjusted for the CSR and reverse stock split and they are currently exercisable for <ix:nonFraction unitRef="shares" contextRef="id99703f9fd5b41b2b59fde641c5048bd_I20210212" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzQ5NjU_2e855fa1-f1f7-4ec1-acb8-544b2d28f1ea">495,165</ix:nonFraction> shares of our common stock with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="id99703f9fd5b41b2b59fde641c5048bd_I20210212" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzUwMjE_5a4790b7-1b88-4e47-878b-5f804eebea4c">4.64</ix:nonFraction> per share. Payment of the exercise price will be made, at the option of the holder, either in cash or as a reduction of common stock issuable upon exercise of the Warrant, with an aggregate fair value equal to the aggregate exercise price ("cashless exercise"), or any combination of the foregoing. The Warrants are exercisable pursuant to the terms, and subject to the conditions, thereof and expire on July 29, 2026. Any Warrants left outstanding will be cashless exercised on the Warrants' expiration date, if in the money. The Warrants issued were classified as equity in accordance with ASC 815-40. Proceeds received under the Tranche 1 Loan were allocated to the Warrants and the Tranche 1 Loan on a relative fair value basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020 the Company incurred offering expenses of $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzU3OTk_e970a24b-719e-4cb8-b94c-c75bab57b9b2">1.1</ix:nonFraction> million in connection with transactions contemplated by the Credit Agreement and the Securities Purchase Agreement, which were allocated to the Warrants, shares and debt consistently with the allocation of proceeds. The Company incurred additional expenses in the amount of $<ix:nonFraction unitRef="usd" contextRef="i888b43bee8a74b63b94b21ef02c0a940_D20210101-20211231" decimals="-5" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2Mzk4ODQ_7a2fb637-2647-43c6-a192-bc4927dcf902">0.3</ix:nonFraction>&#160;million from the borrowing of Tranche 2 Loan, allocated only to the debt.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021 the company recorded interest expense of $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2Mzk1NzE_5f978f7a-5a44-40f8-9144-75efcc6ba2dd">5.6</ix:nonFraction>&#160;million comprised of interest on debt of $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2Mzk5NzA_f1f22a8f-b794-47d6-9721-67fe206aefea">3.8</ix:nonFraction>&#160;million and discount costs of  $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-4" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2NDAwMDY_d51ddff9-00d9-43a2-a52c-7bb96e6eb582">1.8</ix:nonFraction>&#160;million.  The interest expense includes a debt prepayment fee of $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2Mzk2OTU_95a5c68e-e2b3-4589-a401-895a64baed07">1.4</ix:nonFraction> million and the write-off of discount costs of $<ix:nonFraction unitRef="usd" contextRef="i160f84d5cf9d48ca8c977e79e5f245b3_D20190729-20190729" decimals="-5" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2NDAxMTA_b9a5e683-79b1-4466-8dde-c0e16c0372f1">1.6</ix:nonFraction>&#160;million associated with the Company's prepayment of outstanding indebtedness resulting in a total extinguishment loss of $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2NDAyNTA_9d4c5f29-c47d-4b5b-bbce-b70d59c41219">3.0</ix:nonFraction>&#160;million   During the year ended December&#160;31, 2020 the company recorded interest expense of $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzY5Mjg_9f01e870-5398-4000-a5bb-32f95df1aee0">3.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzY5MzU_fb2fa241-5f9d-4575-8c2e-bf6876ac7498">0.5</ix:nonFraction> million relating to the interest and discount cost, respectively.</span></div></ix:continuation><div id="i3ee2f3590755456d8887827db5ee11c4_163"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzIxOTkwMjMyNzM3NTc_2c6d02b4-4b1c-4125-b3e6-06154d1ab26e" continuedAt="i49d08bb4e7d64fae981bd7c26860de5a" escape="true">STOCKHOLDERS' EQUITY</ix:nonNumeric></span></div><ix:continuation id="i49d08bb4e7d64fae981bd7c26860de5a" continuedAt="i61d149ffbcf24db784ef51703ef17be1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred stock</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company's Certificate of Incorporation, as amended, authorizes the Company to issue <ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE0NA_b5d4a349-6aaf-4796-a001-916d2ca1a240">20,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE4NA_7a9c9a42-7745-42b0-82af-7ab2a0c16547">0.0001</ix:nonFraction> per share.  There were <ix:nonFraction unitRef="shares" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzIxMA_39206bdb-91b0-4224-bfc1-130da654093a"><ix:nonFraction unitRef="shares" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzIxMA_5eae0de2-1949-49b5-afc6-1beaacbd76b5"><ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzIxMA_cb3899ce-0aeb-4973-8e29-f429bd32d9e3"><ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzIxMA_ee589f41-e2bf-44d4-ae9f-2130c6f7ef17">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares of preferred stock issued and outstanding as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of preferred stock may be issued from time to time in one or more series.  The voting powers (if any), preferences and relative, participating, optional or other special rights, and the qualifications, limitations and restrictions of any series of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i61d149ffbcf24db784ef51703ef17be1" continuedAt="i14b46b5a9ed647a9adb098970623a4ca"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preferred stock will be set forth in a Certificate of Designation filed pursuant to the Delaware General Corporation Law, as determined by the Company's Board of Directors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of common stock authorized under the Company's Amended and Restated Certificate of Incorporation was proportionately reduced in connection with the Company's 1-for-4 reverse stock split in February 2021.  On July 19, 2021, the Company held its meeting of Stockholders (the "Annual Meeting").  Following the approval by the holders of a majority of the outstanding shares of common stock at the Annual Meeting, the Company filed a Certificate of Amended and Restated Certificate of Incorporation to increase the number of authorized share of common stock from <ix:nonFraction unitRef="shares" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzEwOTk1MTE2NDY0MTg_be1b8fba-57e9-4c04-b8cf-37c364455c87">75,000,000</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzk3Ng_bc88e878-5f38-4cba-931d-e603f0d1e1df">150,000,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzEwMTM_280aea64-4093-4f83-af0e-b478fcd24ac5">0.0001</ix:nonFraction> per share.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock is entitled to <ix:nonFraction unitRef="vote" contextRef="i7905f84f35ea488095252b0854ef24b6_I20211231" decimals="INF" name="vyne:CommonStockVotingRightsNumberPerShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzExODk_445b4324-903b-47a4-8242-1f5f064c4b74">one</ix:nonFraction> vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors, subject to the prior rights of holders of all classes of preferred stock outstanding. The Company has never declared any dividends on common stock.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to entering into the Credit Agreement on July 29, 2019, Foamix issued to the lenders Warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="i74ce2a3821c540e0b8de1b57d9790d94_I20190729" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NTE_af98629b-1813-43de-87c3-6a8e8f5be9bc">1,100,000</ix:nonFraction> of its ordinary shares, later exchanged to Warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="i34dafd0890e345cb94a8cf7a2e26625f_D20190701-20190729" decimals="0" name="vyne:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE3MjQ_562bcc01-a24e-4408-b418-01587b324490">1,980,660</ix:nonFraction> shares of Menlo's common stock, adjusted retrospectively to <ix:nonFraction unitRef="shares" contextRef="id99703f9fd5b41b2b59fde641c5048bd_I20210212" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE3ODc_2e855fa1-f1f7-4ec1-acb8-544b2d28f1ea">495,165</ix:nonFraction> shares of common stock upon the reverse stock split effective February 12, 2021.  Upon close of the Merger, each Warrant received <ix:nonFraction unitRef="contingentstockright" contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309" decimals="INF" name="vyne:BusinessAcquisitionContingentStockRightIssued" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE5MjA_42260477-9c24-439a-b9be-611722936675">one</ix:nonFraction> CSR as described in Note 3 - Business Combinations.  The warrants were exercisable immediately following the closing of the Credit Agreement, subject to the terms of the warrant, and are due to expire on July 29, 2026. Any Warrants left outstanding will be cashless exercised on the Warrants' expiration date, if in the money.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exchange of Warrants from Foamix warrants to Menlo warrants and the additional CSR was accounted for as a modification, by analogy, from the modification's guidance under ASC 260-10-S99-2.  The Company assessed the significance of the modification of the Warrants by comparing the fair value of the Warrants immediately before and after the amendments.  In its assessment, it also considered additional qualitative factors.  The Company concluded that the change of terms was not significant.  Therefore, the incremental fair value, in the amount of $<ix:nonFraction unitRef="usd" contextRef="i5f0643079f4b4a46a6f72aa2aa70777a_D20200101-20201231" decimals="-3" name="vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzI3OTQ_d3de4e3f-5310-4f39-88d4-ace812a14641">41</ix:nonFraction> thousand, of the modified Warrants over the original ones (as of modification date) was recognized in retained earnings as a deemed dividend to the Warrant holders in the year ended December 31, 2020.  <ix:nonFraction unitRef="usd" contextRef="ic653c6de73fb47fea4bbe97cf2f5f3ab_D20210101-20211231" decimals="INF" name="vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzg3OTYwOTMwNTA3MTg_3ec1f325-cd2b-47ce-a62b-c22d1c6a8dfb">No</ix:nonFraction> amounts were recognized in the year ended December&#160;31, 2021.   </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuance of stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2019, the Company entered into a Sales Agreement (the "2019 Sales Agreement") with Cantor Fitzgerald &amp; Co., or Cantor Fitzgerald, to sell shares of the Company's common stock, from time to time, with aggregate gross sales proceeds of up to $<ix:nonFraction unitRef="usd" contextRef="i0aa0866aa6994b3b9cbbaddb8ed97944_D20190201-20190201" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzM1NzQ_b77211fe-6906-4adb-9a1b-20fdd2e0e63a">50.0</ix:nonFraction> million through an at-the-market equity offering program under which Cantor Fitzgerald acted as our sales agent.  The issuance and sale of shares of common stock by us pursuant to the 2019 Sales Agreement were deemed an "at-the-market" offering under the Securities Act.  Cantor Fitzgerald was entitled to compensation for its services equal to up to <ix:nonFraction unitRef="number" contextRef="i0aa0866aa6994b3b9cbbaddb8ed97944_D20190201-20190201" decimals="INF" name="vyne:CommissionFromGrossProceedsFromIssuanceOfCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzM5MTY_d7b71f35-947a-42ab-914d-360f3f699c85">3.0</ix:nonFraction>% of the gross proceeds of any shares of common stock sold under the 2019 Sales Agreement.  During the year ended December 31, 2020, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="i371ccbf335764d51b576f9a2336b47b2_D20200101-20201231" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQwNzM_afa193c8-4685-4b87-bd4d-07bb27554402">1,175,000</ix:nonFraction> shares of common stock at a weighted average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i88edc7fdfcf4414e8659f3d6de7a6b5a_I20201231" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQxNDA_58b8d9f2-b94f-47bc-93a2-4c34ff08c951">7.00</ix:nonFraction> pursuant to the 2019 Sales Agreement for $<ix:nonFraction unitRef="usd" contextRef="i371ccbf335764d51b576f9a2336b47b2_D20200101-20201231" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQxNzk_cc2c0bd1-91c4-4ffa-8306-1f7237f27eb8">8.0</ix:nonFraction> million in net proceeds, all of which was sold during the three months ended December 31, 2020. In addition, from January 1, 2021 through January 25, 2021, the Company issued and sold an additional <ix:nonFraction unitRef="shares" contextRef="ibd040f22c54846a4803901905b00f633_D20210101-20210125" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQzNzI_fd4ffaf0-d23d-4614-b18e-91a9e16de2dd">2,778,012</ix:nonFraction> shares of common stock at a weighted average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9789581a138e48bf9397a195c54b4c33_I20210125" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQ0Mzk_52835fb0-9acf-4b8b-b18b-c7dcdb1f261a">9.76</ix:nonFraction> for $<ix:nonFraction unitRef="usd" contextRef="ibd040f22c54846a4803901905b00f633_D20210101-20210125" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQ0NDY_c32bd148-e2ff-47bd-a3c2-6721c9ef53be">26.3</ix:nonFraction> million in net proceeds. Effective as of January 25, 2021, the Company terminated the 2019 Sales Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company entered into a new sales agreement (the "Sales Agreement") with Cantor Fitzgerald to sell shares of the Company's common stock, from time to time, with aggregate gross sales proceeds of up to $<ix:nonFraction unitRef="usd" contextRef="i66bbeb9a734f427982630691149f765d_I20210812" decimals="INF" name="vyne:SaleOfStockConsiderationReceivableOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NDkyNjc0NjI2OTA_bc566724-bd2c-42d3-b54f-63d2c506cb77">50.0</ix:nonFraction> million through an at-the-market equity offering program under which Cantor Fitzgerald will act as the Company's sales agent. The issuance and sale of shares of common stock by us pursuant to the Sales Agreement are deemed an "at-the-market" offering under the Securities Act. Cantor Fitzgerald is entitled to compensation for its services equal to up to <ix:nonFraction unitRef="number" contextRef="i0b46cdcdfa37452ab8c70071f20ab9c7_D20210812-20210812" decimals="INF" name="vyne:CommissionFromGrossProceedsFromIssuanceOfCommonStock" scale="1" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NDkyNjc0NjI2OTU_036c9792-39bc-4663-ab3c-b90a93da405f">3.0</ix:nonFraction>% of the gross proceeds of any shares of common stock sold under the Sales Agreement. During the year ended December&#160;31, 2021, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="ib74ed9a5f0a84a079fd6937d9d2f0453_D20210101-20211231" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NDkyNjc0NjI2Nzc_43ed13fd-8722-472d-ba3d-c86f559712c1">1,955,313</ix:nonFraction> shares of common stock at a weighted average per share price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i65dd613b82a44b218deffd9c0f7db2f7_I20211231" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NDkyNjc0NjI3MDA_46e86002-8b61-41f5-b6df-053eed994a11">1.57</ix:nonFraction> pursuant to the Sales Agreement for $<ix:nonFraction unitRef="usd" contextRef="ib74ed9a5f0a84a079fd6937d9d2f0453_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NDkyNjc0NjI2ODE_b310b61b-4977-4b7c-84f3-0b579e9f03ba">2.9</ix:nonFraction>&#160;million in net proceeds.  This agreement was in effect as of December&#160;31, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i14b46b5a9ed647a9adb098970623a4ca"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 28, 2021, the Company entered into a Securities Purchase Agreement with certain institutional and accredited investors for the sale of an aggregate of <ix:nonFraction unitRef="shares" contextRef="i347a6acc4a7a45968674fa63bfa3890b_D20210128-20210128" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQ3NTY_bd1c8f09-21e3-4030-81bc-49f2dee58f84">5,274,261</ix:nonFraction> shares of common stock of the Company, at a purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ica625a9375d843ae871ac0d4b3db4352_I20210128" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQ4MjE_5e4b307c-2a6f-4732-960d-f56b17ab011a">9.48</ix:nonFraction> per share in a registered direct offering. The offering was completed on January 28, 2021 and the Company received approximately $<ix:nonFraction unitRef="usd" contextRef="i347a6acc4a7a45968674fa63bfa3890b_D20210128-20210128" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQ5NTM_3d5577ee-d367-4204-a84d-12fcfd92ecfe">46.8</ix:nonFraction> million in net proceeds, after deducting placement agent fees and other offering expenses. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2020, the Company completed an underwritten public offering of <ix:nonFraction unitRef="shares" contextRef="i343a467bc0454f449ea44b8054c6e2f8_D20200609-20200609" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzUxMTQ_973ce5a2-5320-47ca-8e96-13b1da8b30e6">7,776,875</ix:nonFraction> shares of common stock at a price to the public of $<ix:nonFraction unitRef="usdPerShare" contextRef="if1c5a77b02644689af601da56f6c2307_I20200609" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzUxNjg_0c7c78e3-48fa-45ac-88d9-6d3a74135052">7.40</ix:nonFraction> per share.  The net proceeds of the offering were approximately $<ix:nonFraction unitRef="usd" contextRef="i343a467bc0454f449ea44b8054c6e2f8_D20200609-20200609" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzUyMzU_15d135c4-0bf7-4e30-8019-b84f7b0f5d02">53.6</ix:nonFraction> million, after deducting underwriting discounts and commissions and other offering expenses.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, the Company issued <ix:nonFraction unitRef="shares" contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzU0MDQ_cc382fc0-0d70-44e6-99ad-1be018324e52">36,500,335</ix:nonFraction> shares to legacy Foamix shareholders.  On April 6, 2020, pursuant to the terms of the CSR Agreement, the Company issued <ix:nonFraction unitRef="shares" contextRef="ibea690c21df9415993df8d2c1da95438_D20200406-20200406" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzU1MjA_13cb6fa3-c6e8-46d2-96a4-c804a6829cf9">74,544,413</ix:nonFraction> shares to legacy Foamix shareholders, adjusted retrospectively to <ix:nonFraction unitRef="shares" contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212" decimals="INF" name="vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzU1ODI_fa2cd416-accc-4ff6-856e-03e9f1a41fbb">18,636,103</ix:nonFraction> shares of common stock upon the reverse stock split effective February 12, 2021</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_1818"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl84Nzk2MDkzMDI5NjMy_4c57cc27-02b9-4bde-8918-81cc9bae4fae" continuedAt="i4e3cb67d079c4b779fc8f88acde2f089" escape="true">SHARE BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i4e3cb67d079c4b779fc8f88acde2f089" continuedAt="id3c272b6d2e14c019a1ed65dc90fd560"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity incentive plans:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Merger, the Company adopted Foamix&#8217;s 2019 Equity incentive plan (the &#8220;2019 Plan&#8221;). As of December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="i9dd45671031841d1ab0aae6c9fc9d75b_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNjc_dc1e0f15-a956-414e-9c73-6b3578e7c4b0">979,795</ix:nonFraction> shares remain issuable under the 2019 Plan.  In addition, the Company adopted the 2018 Omnibus Incentive Plan (the "2018 Plan") in January 2018.  As of December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="ic18e51c0667246cbb9cd142b80514de6_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8zMjY_9a0a312c-9e2a-4b71-ba1a-e17953788fce">147,550</ix:nonFraction> shares remain issuable under the 2018 Plan.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee Share Purchase Plan:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Merger, the Company adopted Foamix's Employee Share Purchase Plan ("ESPP") pursuant to which qualified employees (as defined in the ESPP) may elect to purchase designated shares of the Company&#8217;s common stock at a price equal to <ix:nonFraction unitRef="number" contextRef="i3cd6043c4c234199b9b39bb81ff103fa_D20200309-20200309" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl82NTM_c4cf296c-ab9c-4eaf-9b67-d17d121edba2">85</ix:nonFraction>% of the lesser of the fair market value of the common stock at the beginning or end of each semi-annual share purchase period (&#8220;Purchase Period&#8221;). Employees are permitted to purchase the number of shares purchasable with up to <ix:nonFraction unitRef="number" contextRef="i9421373d63f34d70a76e0ec736a99720_I20200309" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl84ODI_79bdc69b-0667-4c7c-9725-da17edcbe4ed">15</ix:nonFraction>% of the earnings paid (as such term is defined in the ESPP) to each of the participating employees during the Purchase Period, subject to certain limitations under Section 423 of the U.S. Internal Revenue&#160;Code.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="ia3e6b0bf97f5479c821f53984e43e031_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xMTA1_e2da3721-5136-4bed-907c-cf6d5a627ad9">2,232,207</ix:nonFraction> shares remain available for grant under the ESPP.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="ic37e0b69a2f040aa8c7b53683361dfe7_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xMTg0_5be0f518-4480-4a02-9f27-742c31b67c32">71,890</ix:nonFraction> shares were issued to employees pursuant to the ESPP. During the year ended&#160;December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="icb7a10a25f4249d48fcd322e6ea012e8_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xMjY3_421e26b2-4a94-4a26-9322-ed68aeffb6ba">61,031</ix:nonFraction> Foamix ordinary shares were purchased by Foamix employee pursuant to the ESPP prior to the Merger, which were later exchanged for <ix:nonFraction unitRef="shares" contextRef="ie35e2089123c4e50850717116e3c90ef_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNDAw_33957555-4d8a-4c19-89f9-b46816b58d86">36,155</ix:nonFraction> shares of the Company's common stock and <ix:nonFraction unitRef="contingentstockright" contextRef="icf20f8bca32849c7beef794c32d2f471_I20201231" decimals="INF" name="vyne:BusinessAcquisitionContingentStockRightIssued" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNDQ0_aa9d884b-7baa-4c76-a76d-dc0ad291e7e4">one</ix:nonFraction> CSR in the Merger, adjusted retrospectively to <ix:nonFraction unitRef="shares" contextRef="idde6935cd313421a8ac1426f77884c47_D20210212-20210212" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNDk0_0af6fff9-f7b0-4a1b-be85-3bef1310899f">9,038</ix:nonFraction> shares of common stock and <ix:nonFraction unitRef="contingentstockright" contextRef="ie847d448f04746f790f534394d63097f_I20210212" decimals="INF" name="vyne:BusinessAcquisitionContingentStockRightIssued" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNTI0_ca8a7499-927a-4ac0-8324-2df32b475eef">one</ix:nonFraction> CSR upon the reverse stock split effective February 12, 2021, and <ix:nonFraction unitRef="shares" contextRef="i1daa38912a5c4a1a9f1feaf635f77377_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNTkz_8fadc3c7-89f3-47fa-b0f8-f1040b41f678">38,716</ix:nonFraction> shares were issued to employees after the Merger.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Options and RSUs granted to employees and directors:</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="vyne:ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MzI2_60816800-7e5b-4f06-9134-071592d97298" continuedAt="i87107e4bda2742f4bffdad45b3153d2a" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2021 and 2020, the Company granted options as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:42.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Award amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise price range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees and Directors:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTEtMS0xLTI5NjY2_4fe45271-94c7-44cd-aa7a-d09612fb3eba">1,686,405</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTMtMS0xLTI5NjY2L3RleHRyZWdpb246MzI4YWQ1OTAyY2JjNDAyMjllYjNkZDkxZmM5YWMzNjFfNA_28c6c875-cb59-4ee3-bae4-ee9f973add19">1.68</ix:nonFraction>- $<ix:nonFraction unitRef="usdPerShare" contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTMtMS0xLTI5NjY2L3RleHRyZWdpb246MzI4YWQ1OTAyY2JjNDAyMjllYjNkZDkxZmM5YWMzNjFfOA_8bef07e9-b20e-4062-925c-f3cb696d8629">11.08</ix:nonFraction></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5da521456996427aba1e3f15e8a37411_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTUtMS0xLTI5NjY2L3RleHRyZWdpb246ZjY4ZjM4YjAzNGYyNGQ0ZTlkMDkzYjNkYmQ3Yjk5MWVfNA_03e1888f-94dd-4210-9ab6-c4b6f46000d8">1</ix:nonNumeric> year -<ix:nonNumeric contextRef="i900d5480233e4f9c83938266d12b66f5_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTUtMS0xLTI5NjY2L3RleHRyZWdpb246ZjY4ZjM4YjAzNGYyNGQ0ZTlkMDkzYjNkYmQ3Yjk5MWVfOA_c16ed683-ed4a-4dc7-84fa-f70771bfbbbb">4</ix:nonNumeric> years</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTctMS0xLTI5NjY2_a782342d-53b8-44e6-8529-d4f20f20d745">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN180LTEtMS0xLTI5NjY2_ad2242fd-cd01-487e-8c7b-c26e5c59286c">970,813</ix:nonFraction>&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iac3a8466dc0e4c3ea25864b0e9da2b0c_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN180LTUtMS0xLTI5NjY2L3RleHRyZWdpb246ZTUzYzM3MmNiZmY1NDJjZGE3NGM3YmYyZmJjMWJmZDlfNA_a68c3eeb-6394-46bd-8bb8-610c76bea9db">2</ix:nonNumeric> years -<ix:nonNumeric contextRef="icd305dde41e4448ebecd3c0983d175b3_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN180LTUtMS0xLTI5NjY2L3RleHRyZWdpb246ZTUzYzM3MmNiZmY1NDJjZGE3NGM3YmYyZmJjMWJmZDlfOA_79e49164-4b4b-49b3-80fc-e130688da16f">4</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="id3c272b6d2e14c019a1ed65dc90fd560" continuedAt="i0a636aec9f3446be8e4fc7756b2e25c2"><div><ix:continuation id="i87107e4bda2742f4bffdad45b3153d2a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:42.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Award amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise price range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees and Directors:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTEtMS0xLTI5NjY2_476bf89b-3fca-4536-9c37-538b15fcb188">1,327,214</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTMtMS0xLTI5NjY2L3RleHRyZWdpb246MGQ3YTcxNTE2NGU1NDA2OThlM2RlMDFkMGFiMDk5YmVfNA_3debd19a-87c5-4ed2-910a-900af0267842">5.84</ix:nonFraction>- $<ix:nonFraction unitRef="usdPerShare" contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTMtMS0xLTI5NjY2L3RleHRyZWdpb246MGQ3YTcxNTE2NGU1NDA2OThlM2RlMDFkMGFiMDk5YmVfOA_fdaf0c04-5b15-4684-bb68-846fff443c62">12.52</ix:nonFraction></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6b3949f3bcbc41f89845a01280213f01_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTUtMS0xLTI5NjY2L3RleHRyZWdpb246YWY5NzE2ZDM0OWE0NGZkZTk3ZmFjMThjYWFjYjg1NzVfNA_18eb280b-fcdd-4bf5-86cb-4e0aec2ca447">1</ix:nonNumeric> year -<ix:nonNumeric contextRef="ic658972e380d477b81bc9fbdfd31f1db_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTUtMS0xLTI5NjY2L3RleHRyZWdpb246YWY5NzE2ZDM0OWE0NGZkZTk3ZmFjMThjYWFjYjg1NzVfOA_fea96945-2389-46da-8836-6f8ec984acb0">4</ix:nonNumeric> years</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTctMS0xLTI5NjY2_21bc9462-a431-4232-a9fa-e095e53d3713">10</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i1049c5e9d3584238a13d1718e53ffeb3_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl80LTEtMS0xLTI5NjY2_d5bc1de9-07cd-4098-9bea-d573fb269d24">654,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0696c6f2ddb34f69be35f2bef6534641_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl80LTUtMS0xLTI5NjY2L3RleHRyZWdpb246NzhkNTZjYzFjNGY1NGViN2IzNzM2NDM2NzM5ZGRiYmJfNA_8d9af7df-1924-4b05-834a-d06126e62751">1</ix:nonNumeric> year -<ix:nonNumeric contextRef="i18c931db2ae34ddd8e0b75d2ddb9a6f1_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl80LTUtMS0xLTI5NjY2L3RleHRyZWdpb246NzhkNTZjYzFjNGY1NGViN2IzNzM2NDM2NzM5ZGRiYmJfOA_07fda7d3-a85b-46ca-903a-bc17639afc7e">4</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options and RSUs granted to employees and directors during 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231" decimals="-5" name="vyne:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8yMDQ3_87cfbdb9-c60f-46ee-ad1d-8b9685464498">9.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1049c5e9d3584238a13d1718e53ffeb3_D20200101-20201231" decimals="-5" name="vyne:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8yMDU0_fed32638-fb2a-44e1-b7f3-383be4bd9cdc">11.9</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of RSUs granted to employees and directors is based on the share price on grant date .</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option granted is estimated using the Black-Scholes option pricing method. The volatility is based on a combination of the Company&#8217;s historical volatility, historical volatilities of companies in comparable stages as well as companies in the industry, by statistical analysis of daily share pricing model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected term of the options granted in dollar terms. The Company&#8217;s management uses the expected term of each option as its expected life. The expected term of the options granted represents the period of time that granted options are expected to remain outstanding.</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MzI1_72a7afa3-4a94-4540-9505-19b9b394d551" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underlying data used for computing the fair value of the options are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:67.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.195%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of stock option</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0ab92efb006543c0bfb4d9c671f0e6af_I20211231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8yLTEtMS0xLTI5NjY2L3RleHRyZWdpb246YTM5MmVkODkzNTY4NDNmMmIzZjE4ODI2Nzc3YjRjNmRfNA_c53c3802-b6c7-47a1-9383-d061895b3390">1.02</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="i5feca1c387ef4ac081bc860e994a1d02_I20211231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8yLTEtMS0xLTI5NjY2L3RleHRyZWdpb246YTM5MmVkODkzNTY4NDNmMmIzZjE4ODI2Nzc3YjRjNmRfNw_0b2a10f6-cc03-408e-8fde-3c44d4ce19cd">6.75</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ib17baf4771f74c3c866143773332d0a3_I20201231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8yLTMtMS0xLTI5NjY2L3RleHRyZWdpb246ZGEzOTllYzBiMThmNGQ1ZTljNjQxZmMzMWExMWIzMDVfNA_1eb075e6-a37d-4943-9c93-aca7f8035690">3.47</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="i4d8e2ecb65594adebbdada392434f3f1_I20201231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8yLTMtMS0xLTI5NjY2L3RleHRyZWdpb246ZGEzOTllYzBiMThmNGQ1ZTljNjQxZmMzMWExMWIzMDVfNw_370fbec4-0920-4286-9325-aa9d7f02afbe">7.68</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8zLTEtMS0xLTI5NjY2_18fb1f18-8ccc-4ee7-961b-9371d638dbbb">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8zLTMtMS0xLTI5NjY2_2784e26f-0d77-4016-bf66-a244b928cfb0">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV80LTEtMS0xLTI5NjY2L3RleHRyZWdpb246ZGNiNzcxZmVhNWI1NDA3ZDg2ODQ5ODE1MWNkZTc4ZWVfNA_9c827c91-5ca4-4f84-8137-564eb58dd6c6">68.38</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV80LTEtMS0xLTI5NjY2L3RleHRyZWdpb246ZGNiNzcxZmVhNWI1NDA3ZDg2ODQ5ODE1MWNkZTc4ZWVfNw_9fa383ed-b9cf-4c23-92af-e8242ce540e1">69.38</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV80LTMtMS0xLTI5NjY2L3RleHRyZWdpb246MmMxNjA1YTYzM2U2NGJkMmFiOTJkNzc3MzBiNGJmNjFfNA_5e0629f9-e5b1-4b0c-aa8c-f104f4c5f49d">60.44</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV80LTMtMS0xLTI5NjY2L3RleHRyZWdpb246MmMxNjA1YTYzM2U2NGJkMmFiOTJkNzc3MzBiNGJmNjFfNw_a0e6a34a-8e45-4bf4-aa68-cd423c97f5b7">69.83</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV81LTEtMS0xLTI5NjY2L3RleHRyZWdpb246NjY3MTE2ZDdlZTg4NDViNGE5YThiODg3MzljYmYxYjhfNA_145cff13-0fbd-41d4-9c22-ddc41f16279c">0.50</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV81LTEtMS0xLTI5NjY2L3RleHRyZWdpb246NjY3MTE2ZDdlZTg4NDViNGE5YThiODg3MzljYmYxYjhfNw_464d0503-301e-47fb-b3e7-aa01da0daa51">1.29</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV81LTMtMS0xLTI5NjY2L3RleHRyZWdpb246NjI1YTk2MGIxODQ1NDYwZGE5YWIxYzE3MWJmZDExZmFfNA_9e5df429-d05d-4cf2-be8b-964a35495d9c">0.31</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV81LTMtMS0xLTI5NjY2L3RleHRyZWdpb246NjI1YTk2MGIxODQ1NDYwZGE5YWIxYzE3MWJmZDExZmFfNw_eb8015a5-ab44-4abc-a0cf-b005aa0cac6d">1.26</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV82LTEtMS0xLTI5NjY2_34419977-1d35-4e2a-97da-c460260822d7">6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV82LTMtMS0xLTI5NjY2_f2ab0c5b-28c7-4faf-8e77-22a60d5b2d24">6</ix:nonNumeric> years</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Modification of share-based compensation:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger, all outstanding options and RSUs granted by Foamix were exchanged for stock options and RSUs of Menlo&#8217;s common stock according to the Exchange Ratio. In addition, for each option and RSU the holder received a CSR as described in Note 3- Business Combination. This transaction was considered by the company to be a modification under ASC 718, Compensation - Stock Compensation. The modification did not affect the remaining requisite service period. As a result of the modification, for outstanding options and RSUs granted to Foamix employees and consultants, the Company recorded immaterial incremental compensation expense.  As described in Note 3 - Business Combination, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into <ix:nonFraction unitRef="number" contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406" decimals="INF" name="vyne:ContingentStockRightSharesConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8zNzgx_814572c3-1d65-490c-b1d6-881f5c3bc3a5">1.2082</ix:nonFraction> shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of <ix:nonFraction unitRef="number" contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406" decimals="INF" name="vyne:BusinessCombinationEffectiveExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8zODcy_6b14ca04-1b71-4d8c-8476-93e782752a75">1.8006</ix:nonFraction> shares of Menlo common stock for each Foamix ordinary share.  The conversion was considered by the company to be a modification under ASC 718. As a result of the modification, for outstanding options and RSUs granted to Foamix employees and consultants, the Company recorded incremental compensation of $<ix:nonFraction unitRef="usd" contextRef="i131bd9ea97144427b459ae81f53e00d2_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xMDk5NTExNjM1NDkz_676e7d55-fc9e-4617-b997-ce87e6d0602f">1.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1aa6bb8253084128a90e0a1ebdf5b6fa_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl80MTc4_50acb4a5-bcc7-488c-b3a2-96f6f8f771d0">11.8</ix:nonFraction> million for the years ended December&#160;31, 2021 and December&#160;31, 2020, respectively.  As of December&#160;31, 2021 there is $<ix:nonFraction unitRef="usd" contextRef="i131bd9ea97144427b459ae81f53e00d2_D20210101-20211231" decimals="-5" name="vyne:ShareBasedPaymentArrangementPlanModificationUnrecognizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl80MjIz_1ef2b6bb-e037-46f8-9e78-5a7f5526c83c">0.9</ix:nonFraction> million of unrecognized incremental compensation expense related to the modification which will primarily be amortized using a graded vesting method over the next <ix:nonNumeric contextRef="i131bd9ea97144427b459ae81f53e00d2_D20210101-20211231" name="vyne:ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl80Mzgx_02ca1feb-02a4-4aae-bdcc-967b587b6312">1</ix:nonNumeric> year.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted to holders who are no longer employed or providing services to the Company are accounted for in accordance with ASC 815-40, Derivatives and Hedging. Under this guidance, the awards are classified as a derivative liability because the award no longer exchanges a fixed amount of cash for a fixed number of shares. Accordingly, as of March 9, 2020 the Company reclassified $<ix:nonFraction unitRef="usd" contextRef="i918df004225b4092a0bff129ac010d6a_D20200309-20200309" decimals="-5" name="vyne:ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl80Nzc3_8e8bb2ec-e121-45f7-82fd-9a20734c1dfc">1.6</ix:nonFraction> million from additional paid-in capital to derivative liability on the consolidated balance sheet. Prior to the reclassification of these awards as a liability instrument, the Company recorded an incremental compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i918df004225b4092a0bff129ac010d6a_D20200309-20200309" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl81MDA0_e12928be-cf73-45bf-8bfb-a6820d94f070">0.6</ix:nonFraction> million due to the above mentioned modification in accordance with ASC 718. Subsequent to the reclassification of these awards as a liability instrument, the Company recorded incremental compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i2d96d676c73c4e51b5dc524d8d621a7f_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl81MjEw_a9ef5f76-0949-4cce-9a37-4f7c3049c5c9">1.0</ix:nonFraction> million for the year ended December&#160;31, 2020.  There was no incremental compensation for the year ended December&#160;31, 2021.  As described in Note 3 - </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i0a636aec9f3446be8e4fc7756b2e25c2" continuedAt="i0139e14aca184764b8b4995dbab922c2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business Combination, on April 6, 2020, the Company announced that study MTI-105 and study MTI-106 did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis.  Accordingly, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into <ix:nonFraction unitRef="number" contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406" decimals="INF" name="vyne:ContingentStockRightSharesConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl81NzQ5_814572c3-1d65-490c-b1d6-881f5c3bc3a5">1.2082</ix:nonFraction> shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of <ix:nonFraction unitRef="number" contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406" decimals="INF" name="vyne:BusinessCombinationEffectiveExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl81ODQw_6b14ca04-1b71-4d8c-8476-93e782752a75">1.8006</ix:nonFraction> shares of Menlo common stock for each Foamix ordinary share.  On April 6, 2020, the awards are exchangeable for a fixed amount of cash for a fixed number of shares and were remeasured to fair value and reclassified from derivative liability to additional paid-in capital.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger, Menlo recognized all expenses relating to awards outstanding as of the Effective Date. These awards were subject to acceleration upon the change of control per the previous Menlo stock option plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of outstanding and exercisable options and RSUs:</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MzI0_81e28ebe-2474-4452-afdc-fa6e0c45d3a5" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of options outstanding for the year ended December&#160;31, 2021, and related information:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMS0xLTEtMS0yOTY2Ng_961b7203-c962-4d47-a5d9-35a1127111cf">4,274,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMS0zLTEtMS0yOTY2Ng_08c29f51-83ee-4863-850e-232f77790959">13.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMi0xLTEtMS0yOTY2Ng_fbcaed6d-eeeb-4e5d-8130-9a17ebd11855">1,686,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMi0zLTEtMS0yOTY2Ng_137a790d-7dbb-4f6a-9334-1b698abe6564">5.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMy0xLTEtMS0yOTY2Ng_d01a134c-1ce1-405e-869c-7cc54bc1cc1a">70,827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMy0zLTEtMS0yOTY2Ng_4f7929ca-b98b-4212-a473-3a1ddfe03c67">7.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNC0xLTEtMS0yOTY2Ng_adfc25d5-1be1-49ab-b671-bf893a5717e4">435,569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNC0zLTEtMS0yOTY2Ng_4f996f33-7c43-4e60-b1ee-cd9cbef96a9a">8.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNS0xLTEtMS0yOTY2Ng_f6935bca-1133-4b55-9f3d-bb2154c3e9fb">1,410,706</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNS0zLTEtMS0yOTY2Ng_21bb57cb-734f-4f00-8181-388ce033178b">17.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNy0xLTEtMS0yOTY2Ng_02bcc227-f8cd-44db-b4a2-88a95acb0814">4,043,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNy0zLTEtMS0yOTY2Ng_068aae77-5b04-4b49-9b00-e4ce860daf49">9.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xOC0xLTEtMS0yOTY2Ng_5edf711b-1bb6-45ba-adf5-e610fb97a17a">1,971,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xOC0zLTEtMS0yOTY2Ng_422975bc-837e-4a8e-b6d1-0c1aeae1e7ae">12.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average remaining contractual term of outstanding and exercisable options as of December&#160;31, 2021, is <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl82NjA3_26875d50-e018-401e-bbc2-4fe4c6606512">7.0</ix:nonNumeric> years and <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl82NjE0_751b51ad-8de6-449d-bae5-2fb933aa587a">5.5</ix:nonNumeric> years, respectively.  Total unrecognized share based compensation for options at December&#160;31, 2021 is $<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl82Njk4_e8956736-1794-47f7-bb12-ad76c2919384">6.4</ix:nonFraction> million, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl82Nzcx_ac710145-5e86-4b7d-9408-2822847ac2ac">2.3</ix:nonNumeric> years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl84Nzk2MDkzMDMwMTYx_48488ab8-92e8-4cdb-a646-1448add9c3ce"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl84Nzk2MDkzMDMwMTYx_b6bf7722-8f32-4092-9126-cdfc5f1ed346">no</ix:nonFraction></ix:nonFraction> intrinsic value of outstanding and exercisable options as of December&#160;31, 2021</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MzIz_a9c2447b-8847-44cb-9a79-c4dbc90a5d2e" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of RSUs outstanding for the year ended December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.421%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of RSUs</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iedd0ba546c49493ba7382642df9946c7_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6NjM3YjlkMTY0M2E3NDJjNjljOGMxYWM4ODYwYzg4NzMvdGFibGVyYW5nZTo2MzdiOWQxNjQzYTc0MmM2OWM4YzFhYzg4NjBjODg3M18xMy0xLTEtMS0yOTY2Ng_ae87ae96-188e-4370-9f84-bb17988bfad6">719,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awarded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6NjM3YjlkMTY0M2E3NDJjNjljOGMxYWM4ODYwYzg4NzMvdGFibGVyYW5nZTo2MzdiOWQxNjQzYTc0MmM2OWM4YzFhYzg4NjBjODg3M18xNC0xLTEtMS0yOTY2Ng_c2ca1161-26f8-43c2-9183-c0b97cf1a5cd">970,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6NjM3YjlkMTY0M2E3NDJjNjljOGMxYWM4ODYwYzg4NzMvdGFibGVyYW5nZTo2MzdiOWQxNjQzYTc0MmM2OWM4YzFhYzg4NjBjODg3M18xNS0xLTEtMS0yOTY2Ng_6060fa09-1ef4-41c6-b9e8-0294ac5373c6">293,034</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6NjM3YjlkMTY0M2E3NDJjNjljOGMxYWM4ODYwYzg4NzMvdGFibGVyYW5nZTo2MzdiOWQxNjQzYTc0MmM2OWM4YzFhYzg4NjBjODg3M18xNi0xLTEtMS0yOTY2Ng_73780001-4657-4e35-8003-8b3b5d479579">134,822</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i9309bf238b44411e899d0dcb4c8d3ef9_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6NjM3YjlkMTY0M2E3NDJjNjljOGMxYWM4ODYwYzg4NzMvdGFibGVyYW5nZTo2MzdiOWQxNjQzYTc0MmM2OWM4YzFhYzg4NjBjODg3M18xOC0xLTEtMS0yOTY2Ng_c5495dba-aeb1-400c-8c85-01856b637cc6">1,262,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized compensation expense related to the unvested portion of the Company's RSUs at December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i9309bf238b44411e899d0dcb4c8d3ef9_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MTAx_e3966632-7d59-467e-be22-e9be77595a8c">5.6</ix:nonFraction> million, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MTc0_eeadc303-5add-4b94-9208-53d85f406181">2.27</ix:nonNumeric> years.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="i0139e14aca184764b8b4995dbab922c2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share-based compensation expenses:</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MzI3_8c99ba4a-493e-49ec-aa88-dd9461f47a04" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the effect of share-based compensation on the statements of operations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:71.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f658b6e836f41c9b28abeb2f9bc238f_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF8zLTEtMS0xLTI5NjY2_da8e645d-99cc-4a38-bfc6-2c0d94fab897">1,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50ff6dddfd3c429499a4b8c9b226e7d6_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF8zLTMtMS0xLTI5NjY2_87ebb494-fd6d-4252-af41-12e93c717d0a">4,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a86bb6a8854c5296b3511aacf7bb04_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF80LTEtMS0xLTI5NjY2_76338ea3-568c-4d04-bb9b-8bc0d5555ee3">6,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic066d03c70d147b5b20e324f40a88075_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF80LTMtMS0xLTI5NjY2_b10042d1-66cd-4c13-bd34-edff561ce243">13,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF81LTEtMS0xLTI5NjY2_ceb34c7a-b8a0-4579-81b1-def79fbac266">8,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF81LTMtMS0xLTI5NjY2_8b2bec86-43d7-4200-82ac-63c0c9637c1f">18,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_169"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzIxOTkwMjMyNjIxNzU_14334a87-0db1-40e4-9925-fe8c3fcb6c8d" continuedAt="i42bd4c693bf344aab2d7c749a0071ecc" escape="true">INCOME TAX: </ix:nonNumeric></span></div><ix:continuation id="i42bd4c693bf344aab2d7c749a0071ecc" continuedAt="i9486b5d3f93d4bc6b24635b28b02c9a6"><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="vyne:ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzYwNDczMTM5NTkzOTI_fe787371-6142-41d1-b667-63b7ea376798" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes and the related tax expense (benefit) is as follows:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:71.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if82c661f8a794fdeb31d8f9e4a475fc6_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzMtMS0xLTEtMTc2ODk_b74482c2-f8a5-444d-9705-eb68378b12cd">69,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23a16cc6e5f846549e1725fbd52458c5_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzMtMy0xLTEtMTc2ODk_d32703cb-9035-426f-b879-5e53056bbb30">211,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i910b930cd3714339a6b839e5f00372e1_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzQtMS0xLTEtMTc2ODk_2d34c999-9da4-44a6-bd18-f4fc5089f165">4,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc98456d2d1a44c78bb669199d845601_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzQtMy0xLTEtMTc2ODk_4095bb07-28fb-4619-926c-06ad5d4810f5">44,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss before taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzUtMS0xLTEtMTc2ODk_f92a8f38-928f-4dd2-8eef-c5f5a9de30af">73,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzUtMy0xLTEtMTc2ODk_6fa22733-4d88-4960-90d1-13d4f3f6ee77">255,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzgtMS0xLTEtMTc2ODk_e7137b30-86f0-4fa1-a6e0-e0f8b2f754ac">456</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzgtMy0xLTEtMTc2ODk_ec0af24a-84cd-4b35-8a9b-f2aabea21d98">258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzktMS0xLTEtMTc2ODk_8fbf2b7a-1a57-420a-b5fa-5e89153e933e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzktMy0xLTEtMTc2ODk_0319c85a-05bb-4a7c-aad5-ae24d602de1f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzEwLTEtMS0xLTE3Njg5_c06d37b7-203f-402e-a570-c83b6b4887ef">448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzEwLTMtMS0xLTE3Njg5_b846778d-6449-45d1-be3c-fab017786fe9">253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzYwNDczMTM5NTkzOTM_1aa77a8f-78fa-4e28-9be5-09a6c529854b" escape="true"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of income taxes at the U.S. federal statutory rate to the provision for income taxes is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax provision at statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzItMi0xLTEtMTc2ODk_62bed4a7-99ce-4d6c-99b8-62c50319fa8f">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzItNC0xLTEtMTc2ODk_0ec0305e-71a5-40c9-b58e-558a83c9b48f">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax provision, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzMtMi0xLTEtMTc2ODk_dc730c01-2497-4c01-bb3a-703efcaff373">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzMtNC0xLTEtMTc2ODk_5b0ab92d-6ef9-449c-9300-ec2d4d3de7a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D Impairment &amp; CSR Remeasurement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="4" name="vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzQtMi0xLTEtMTc2ODk_60c33879-9940-4e18-ae67-d7de61ddb895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="4" sign="-" name="vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzQtNC0xLTEtMTc2ODk_b2f424a7-70a9-4c10-9178-069b04adcbfb">11.42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="4" name="vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzUtMi0xLTEtMTc2ODk_dd0143ee-2d15-466f-a172-de8f4f14565f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="4" sign="-" name="vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzUtNC0xLTEtMTc2ODk_3f8c1bb4-9313-42d3-9daa-b32af87539f3">1.07</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IP Gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="4" name="vyne:EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzYtMi0xLTEtMTc2ODk_b340203f-2f89-4f77-bf42-c99dde36ccd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="4" sign="-" name="vyne:EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzYtNC0xLTEtMTc2ODk_151602db-7586-480b-af1a-969fecfbfa36">14.65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzctMi0xLTEtMTc2ODk_db6679b9-0bdd-43af-92dc-1a9cf3d3dcc7">20.27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzctNC0xLTEtMTc2ODk_d98bfdea-8982-4d69-b148-99ed66a918f4">6.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzgtMi0xLTEtMTc2ODk_55844611-cd62-49e0-abb3-caa99c600c7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzgtNC0xLTEtMTc2ODk_8dcc7ec7-52fe-4282-8178-b7528c0c086d">0.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzktMi0xLTEtMTc2ODk_b8a092c7-3c4f-4f0f-b3ff-30b4495b6cd8">0.11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzktNC0xLTEtMTc2ODk_ddb21e7e-649a-40b3-abcd-a67ebccfe892">0.27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzEwLTItMS0xLTE3Njg5_eeb50e7b-8643-46a3-85e3-2a42d82fb20a">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzEwLTQtMS0xLTE3Njg5_e61e08a0-7bca-4628-9d34-79661e11efa4">0.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense for the years ended December&#160;31, 2021 and 2020 differed from the amounts computed by applying the U.S. federal income tax rate of 21% to loss before tax expense as a result of nondeductible expenses, changes in state effective tax rates, foreign taxes,  tax credits generated, true up of net operating loss carryforwards, and increase in the Company&#8217;s valuation allowance. The Company applies the elements of FASB ASC 740-10 regarding accounting for uncertainty in income taxes. This clarifies the accounting for uncertainty in income taxes recognized in financial statements and required impact of a tax position to be recognized in the financial statements if that position is more likely than not of being sustained by the taxing </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i9486b5d3f93d4bc6b24635b28b02c9a6" continuedAt="ib380d90a179449a8897f57f096c55285"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">authority. Included in Other Liabilities on the Consolidated Balance Sheets, are the total amount of unrecognized tax benefits of approximately $<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzEwOTk1MTE2MzQ0MzQ_5cb1585e-49af-4eb5-95a2-ec23f285284c">2.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzExMjA_f12655c8-6b19-4d2f-8e43-846ea05a7534">3.1</ix:nonFraction> million as of December&#160;31, 2021 and 2020, respectively, net of the federal benefit, if recognized, would favorably affect the Company&#8217;s future effective tax rate. The Company&#8217;s policy is to recognize interest and penalties related to tax matters within the income tax provision. Tax years beginning in 2017 are generally subject to examination by taxing authorities, although net operating losses from all years are subject to examinations and adjustments for at least three years following the year in which the attributes are used. </span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzYwNDczMTM5NTkzOTQ_d7467d1e-97db-4166-9406-c0e186499656" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of the Company's deferred tax assets and liabilities are as follows:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carry forward</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzMtMS0xLTEtMTc2ODk_005ffd1f-68ac-4ebf-bb8a-7a514f37e9b7">73,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzMtMy0xLTEtMTc2ODk_0675e948-2ffc-46d7-aa29-3f937ae190fd">55,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzQtMS0xLTEtMTc2ODk_980da19e-5392-4d9c-90c8-715fd376f515">7,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzQtMy0xLTEtMTc2ODk_9fc9b79b-b28c-486e-9a34-060b2951bf96">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzUtMS0xLTEtMTc2ODk_77e869cf-f152-453d-a46d-afce19fcdc2d">3,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzUtMy0xLTEtMTc2ODk_b9ae5045-953b-4339-b510-4e7cd7edd2c3">4,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzYtMS0xLTEtMTc2ODk_acb0693a-76a7-4c6f-9671-2efadd537e86">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzYtMy0xLTEtMTc2ODk_9f6d2904-add2-47b9-a977-b6eeb55db67b">2,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzctMS0xLTEtMTc2ODk_27f20a81-a7c4-4a29-9e2e-407e004efe8b">85,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzctMy0xLTEtMTc2ODk_685a2d8a-b1c1-4672-9d7c-a13b437e777d">70,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less - valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzgtMS0xLTEtMTc2ODk_f5206dd8-1ff3-4932-bb9f-872690279ea5">85,555</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzgtMy0xLTEtMTc2ODk_ecdc5f59-5d08-42ca-b7d7-822ce69b5bd7">69,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax assets, net of valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzExLTEtMS0xLTE3Njg5_85018529-4f2b-4e29-8c36-f1f9fbf50373">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzExLTMtMS0xLTE3Njg5_74081ae5-908f-411c-b53f-8628f2ce2a8d">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzEyLTEtMS0xLTE3Njg5_64c4328e-d6b6-4e5d-861f-8a158998e0c2">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzEyLTMtMS0xLTE3Njg5_34230e74-0438-4b12-80c1-d804da33e055">345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzEzLTEtMS0xLTE3Njg5_c42efe2a-4314-47c4-a595-a164ffe73ac8">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzEzLTMtMS0xLTE3Njg5_ee76e6fe-6120-4d03-8e38-eab981c50311">386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzE0LTEtMS0xLTE3Njg5_44286dd2-757f-4c5d-8386-7c91df502092">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzE0LTMtMS0xLTE3Njg5_509666da-d9a8-4bd3-b9ae-09a8479af0f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realization of deferred tax assets is contingent upon sufficient future taxable income during the period that deductible temporary differences and carry forward losses are expected to be available to reduce taxable income. As the achievement of required future taxable income is not likely, the Company recorded a full valuation allowance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company recorded valuation allowance against its net deferred tax assets of approximately $<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzIyOTk_c87077b1-982a-493a-bba4-4d9b6ed462e0">85.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzIzMDY_11986982-9f10-4202-833c-b7118e805a7b">69.7</ix:nonFraction> million, respectively. The change in the valuation allowance during the years ended December&#160;31, 2021 and 2020 was an increase of approximately $<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzI0NDM_8704677b-b5af-4197-9bca-e371662339d9">15.8</ix:nonFraction> million and a decrease of approximately $<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzEwOTk1MTE2MzQ3Mzg_3381a7df-693a-4197-8321-8962571b64e5">1.3</ix:nonFraction>&#160;million, respectively. A valuation allowance has been recorded since, in the judgment of management, these assets are not more likely than not to be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences and carryforwards become deductible or are utilized. As of December&#160;31, 2021, the Company had federal and state pre-tax net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i6d4bddd1b58c43bc9015bf6630359989_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzI5NDY_039429ac-f537-423b-a8ba-00f5092cc6cd">315.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5fc0c8d37b2d4747aeb77bdce809b14b_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzI5NTM_eedeaecc-1bb2-4e68-86c5-b345b3441576">105.6</ix:nonFraction> million, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, research and development credit carryforwards for federal and state purposes are approximately $<ix:nonFraction unitRef="usd" contextRef="i6d4bddd1b58c43bc9015bf6630359989_I20211231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzMwNzc_fd5e7576-9a93-4e84-a8f6-622f1a007da2">6.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5fc0c8d37b2d4747aeb77bdce809b14b_I20211231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzMwODQ_66a067f8-867e-4688-b098-f4b2dd554afb">1.2</ix:nonFraction> million, respectively. As a result of U.S. tax reform legislation, federal net operating losses generated beginning in 2018 and subsequent years carryforward indefinitely, however, the Company has federal net operating losses that pre-date U.S. tax reform legislation which begin to expire in 2031 and federal credit carryforwards that begin to expire in 2031. State net operating loss carryforwards begin to expire in 2031, and the state credit carryforwards began to expire in 2031. Sections 382 and 383 of the Internal Revenue Code of 1986 subject the future utilization of net operating losses and certain other tax attributes, such as research and development tax credits, to an annual limitation in the event of certain ownership changes, as defined. The Company may have undergone ownership changes and therefore may be materially limited in the amount of NOL and R&amp;D tax credit available for utilization in the future. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generated research and development tax credits but has not conducted a study to document the qualified activities. This study may result in an adjustment to the Company&#8217;s research and development credit carryforwards; however, until a study is completed and any adjustment is known, a partial reserve has been presented as an uncertain tax position which </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="ib380d90a179449a8897f57f096c55285"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is offset against the gross research and development deferred tax asset. A full valuation allowance has been provided against the Company&#8217;s research and development credits and, if an adjustment is required, this would be offset by an adjustment to the deferred tax asset established for the research and development credit carryforwards and the valuation allowance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Uncertain tax positions:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC No. 740, Income Taxes, requires significant judgment in determining what constitutes an individual tax position as well as assessing the outcome of each tax position. Changes in judgment as to recognition or measurement of tax positions can materially affect the estimate of the effective tax rate and consequently, affect the operating results of the Company.</span></div><ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzYwNDczMTM5NTkzOTU_80ce4a03-0cfd-48da-9d7c-acc2d2c8fd6a" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity of the Company unrecognized tax benefits (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at January 1, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i413ad6395c874b3ea0fb49e390a331d2_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzAtMS0xLTEtMTc2ODk_8a0da086-a5f4-476d-99f1-e99bf109ddb4">714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for prior year positions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzEtMS0xLTEtMTc2ODk_80015fcf-6677-407b-a138-b40c67483b6b">2,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for current year positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzItMS0xLTEtMjEwNDg_e868bdb7-f68c-4944-af24-4d55dd730694">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions related to expiration of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzMtMS0xLTEtMjEwNTU_89a74c4f-cc9a-469c-864a-872ef28da8f3">258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzItMS0xLTEtMTc2ODk_2a19bdb5-bbf2-4f40-80b5-96c75d925c1f">3,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for prior year positions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzMtMS0xLTEtMTc2ODk_0316008b-22e1-4283-81b7-192da0b7151a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for current year positions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzQtMS0xLTEtMTc2ODk_416c364f-83f0-4d49-bc63-42d3f4ae2da2">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions related to expiration of statute of limitations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzUtMS0xLTEtMTc2ODk_8c826c5a-a8c7-4347-b091-4538ce19f77d">456</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzYtMS0xLTEtMTc2ODk_ab77dcc5-dfc2-4365-bc9d-eb0c489874db">2,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance related to research and development tax credit positions acquired through the Merger.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company began liquidation proceedings of its Israeli subsidiary, VYNE Pharmaceuticals Ltd., to align with its business strategy. As a result thereof, the Company's intellectual property was assigned to the U.S. parent company and we recognized a $<ix:nonFraction unitRef="usd" contextRef="icef12beb3e494c14b255e4114f030a13_D20201201-20201231" decimals="-5" name="vyne:LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzU2MDE_0e1b8fdb-81f3-4273-ade6-56155082620b">163.0</ix:nonFraction> million taxable gain in 2020 for Israeli income tax purposes. However, the taxable gain was fully offset by net operating loss carryforwards, resulting in no income tax expense to the Company.  In addition, there was also no Israeli withholding tax due by the U.S. parent company. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate Restructuring is subject to complex tax and transfer pricing regulations administered by taxing authorities in the U.S. and Israel. The relevant taxing authorities may disagree with the Company&#8217;s determinations as to the income and expenses attributable to specific jurisdictions. If such a disagreement were to occur, and the Company&#8217;s position were not sustained, the Company could be required to pay additional taxes, interest and penalties, which could result in one-time tax charges, higher effective tax rates and reduced cash flows than otherwise would be expected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has tax assessments that are considered to be final through tax year 2015.</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div id="i3ee2f3590755456d8887827db5ee11c4_1871"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 17 - <ix:nonNumeric contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF84Nzk2MDkzMDIzNjc5_db5533f0-27e4-43da-bccf-98590b031565" continuedAt="i969bf8a1819e4b1987caeb8ca9e5058e" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><ix:continuation id="i969bf8a1819e4b1987caeb8ca9e5058e" continuedAt="i988edc9c0c1a472d9525d693dc7048f9"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Sale of Minocycline Franchise </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Note 1, On January 12, 2022, VYNE entered into a Purchase Agreement with Journey  to sell its MST Franchise for $<ix:nonFraction unitRef="usd" contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI3OTM5_17af6d90-a247-43a0-bfa7-09db6b9e99d8">25.0</ix:nonFraction>&#160;million of cash consideration which comprises an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112" decimals="-5" name="vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI4MDEw_9dcc8788-e8ab-4b27-a4d2-5b6c65656cc4">20.0</ix:nonFraction>&#160;million and an additional $<ix:nonFraction unitRef="usd" contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112" decimals="-5" name="vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI4MDQ1_e814d8a0-ff07-4dc7-80bc-48a204b5e041">5.0</ix:nonFraction>&#160;million on the one-year anniversary of the closing of the transaction. VYNE is also eligible to receive sales milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112" decimals="-5" name="vyne:DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI4MTgw_c918adb4-8cf9-435d-ba6b-cf25dc3aa0b0">450.0</ix:nonFraction>&#160;million in the aggregate upon the achievement of specified levels of net sales on a product-by-product basis, beginning with annual net sales exceeding $<ix:nonFraction unitRef="usd" contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112" decimals="INF" name="vyne:MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI4MzI4_2ff7e952-568b-4145-9944-51eaa594fd67">100.0</ix:nonFraction> million (with products covered in three categories (1) AMZEEQ (and certain modifications), (2) ZILXI (and certain modifications), and (3) FCD105 and other products covered by the patents being transferred, including certain modifications). In addition, VYNE is entitled to receive certain payments from any licensing or sublicensing of the assets by Journey outside of the United States.  </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:85.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i988edc9c0c1a472d9525d693dc7048f9" continuedAt="if3f10374c65f4b01bd8376c78aaa0c86"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company anticipates recording an estimated gain from the sale of the MST Franchise in the first quarter of 2022 ranging from $<ix:nonFraction unitRef="usd" contextRef="ibcb524dbad1a4c1982574e2fe8ad19da_D20220101-20220331" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTI4_f68645a9-e3cb-430f-ac97-a8ef4c293d7d">13.5</ix:nonFraction>&#160;million to  $<ix:nonFraction unitRef="usd" contextRef="i74d4ee98eed24dd08f8c5f7e4d4cbd41_D20220101-20220331" decimals="-5" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTM3_ae83bb06-49fe-46a4-ad71-3809f5af5b08">14.5</ix:nonFraction>&#160;million.  The Company does not anticipate paying any federal or state income taxes based upon the utilization of net operating losses.  The estimated gain is based on net proceeds ranging from $<ix:nonFraction unitRef="usd" contextRef="ib3d169fae4d94cbd8c3022cba3a08fdf_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTUy_dd0b79dc-f787-4ad4-b38d-e866a8bf5893">21.3</ix:nonFraction>&#160;million to  $<ix:nonFraction unitRef="usd" contextRef="iff8c8e02a0374a409dd8fd2818c71588_D20220101-20220331" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTYx_bb987394-cb59-4213-9cde-2f9569f056e3">22.3</ix:nonFraction>&#160;million  including estimated transaction costs ranging from $<ix:nonFraction unitRef="usd" contextRef="ie156775f95034bcb81ccb6f76520718e_I20220331" decimals="-5" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTcw_00fee7b2-dd1d-4e1d-8924-a87ec1da452e">2.7</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="ie287f45e91a4400282fc74f2a820b92e_I20220331" decimals="-5" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTgw_a30cf224-7d3e-41cb-be9a-4f91df5f5de3">3.7</ix:nonFraction>&#160;million. Under the Purchase Agreement, the Company is obligated to indemnify Journey against certain potential liabilities and for breaches of representations, warranties and covenants under the agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Agreement, Journey assumed certain liabilities of the MST Franchise including, among others, those arising from VYNE&#8217;s patent infringement suit initiated against Padagis Israel Pharmaceuticals Ltd (see Note 12). There were no current or long-term liabilities recorded by the Company which were transferred to the Buyer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Agreement includes customary representations and warranties, as well as indemnification rights for breaches of representations, warranties, and covenants, as well as certain other matters, subject to customary deductibles, caps, and other limitations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The criteria for reporting the MST Franchise as held for sale was met after the balance sheet date, and therefore, the assets of the MST Franchise were classified as held and used as of December&#160;31, 2021.  The total carrying amounts of the MST assets a were disposed were approximately $<ix:nonFraction unitRef="usd" contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231" decimals="-5" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI5MDU0_e68199ab-2bec-4f95-886b-697024d110f0">7.8</ix:nonFraction>&#160;million, as of December&#160;31, 2021.  These assets consist primarily of inventory of  $<ix:nonFraction unitRef="usd" contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI5Njcx_75168722-0e57-4a28-bdb6-35c94cb68949">7.3</ix:nonFraction>&#160;million. <ix:nonFraction unitRef="usd" contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112" decimals="INF" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjU3ODg3_7fd09518-5ff7-4eb9-a501-7b734ad6f3d2">No</ix:nonFraction> liabilities were transferred. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 31, 2021, the Company has sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="i3a90103da5ca44acb0b6ef28d135f8d8_D20220101-20220316" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjYwNDgw_71ecb0dd-65ef-4e0d-9446-f2ece4da8eb8">2,465,500</ix:nonFraction> shares pursuant to the Sales Agreement for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i3a90103da5ca44acb0b6ef28d135f8d8_D20220101-20220316" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjYwNDkx_a6b12688-ba28-45e3-b663-6fb99d1b6ddc">1.5</ix:nonFraction>&#160;million. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if3f10374c65f4b01bd8376c78aaa0c86">In addition, on March 15, 2022, the Company entered into a purchase agreement (the "Equity Purchase Agreement"), with Lincoln Park Capital Fund, LLC ("Lincoln Park") which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company may sell to Lincoln Park, at the Company's discretion, up to $<ix:nonFraction unitRef="usd" contextRef="i99e857b122b54103af3bf50d59fa8745_I20220315" decimals="INF" name="vyne:SaleOfStockConsiderationReceivableOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjYwNTA1_c4fc82b9-d863-4382-a276-21ad0b53adde">30.0</ix:nonFraction>&#160;million of shares of its common stock over the <ix:nonNumeric contextRef="i8601e3d553e140d586df45d81ee2c321_D20220315-20220315" name="vyne:EquityPurchaseAgreementPeriodInForce" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjYwNTIw_bf8c4e2a-e805-47d2-90fd-c9c2a79c8d2d">36</ix:nonNumeric>-month term of the Equity Purchase Agreement. Upon execution of the Equity Purchase Agreement, the Company issued <ix:nonFraction unitRef="shares" contextRef="i8601e3d553e140d586df45d81ee2c321_D20220315-20220315" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjYwNTI4_ea182c59-326b-4bc6-83dc-3ee13bf92f84">1,667,593</ix:nonFraction> shares of its common stock to Lincoln Park as commitment shares in accordance with the closing conditions contained within the Equity Purchase Agreement.</ix:continuation>  </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F - 37</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9 - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_178"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A - CONTROLS AND PROCEDURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to the company&#8217;s management, including its chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act and regulations promulgated thereunder) as of December&#160;31, 2021.&#160; Based on such evaluation, those officers have concluded that, as of December&#160;31, 2021, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the fourth quarter ended December&#160;31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act as a process designed by, or under the supervision of, the company&#8217;s executive and financial officers and effected by the company&#8217;s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes and includes those policies and procedures that (a) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company; (b) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (c) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management assessed the effectiveness of our internal control over financial reporting, as of December&#160;31, 2021. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013). Based on our assessment, management concluded that, as of December&#160;31, 2021, our internal control over financial reporting was effective based on these criteria.&#160;</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_181"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B - OTHER INFORMATION</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_1850"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C - DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i3ee2f3590755456d8887827db5ee11c4_184"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_187"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10 - DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers and Directors</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding our executive officers and members of our Board of Directors (the "Board") as of December 31, 2021:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.218%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Name</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Age</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Position(s)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Executive Officers and Employee Director</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">David Domzalski</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">55</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">President, Chief Executive Officer and Director</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tyler Zeronda</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">36</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Financial Officer and Treasurer</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Iain Stuart, Ph.D.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">49</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Scientific Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Mutya Harsch</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Legal Officer, General Counsel and Secretary</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Non-Employee Directors*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sharon Barbari(1)(2)(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">67</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Director</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Steven Basta</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">56</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Director</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Anthony Bruno(2)(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Director</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Patrick LePore(1)(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">66</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lead Independent Director</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Elisabeth Sandoval(1)(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">60</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Director</span></div></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Member of the Audit Committee.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Member of the Compensation Committee.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Member of the Nominating and Corporate Governance Committee.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Mr. Rex Bright served as a non-employee director until his death on January 11, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">David Domzalski</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as the Company&#8217;s President and Chief Executive Officer and as a director since March 9, 2020, the closing date of the Merger (the "Closing Date"). From July 2017 until the Closing Date, Mr. Domzalski served as the Chief Executive Officer of Foamix. He also served as a director of Foamix beginning in January 2018. Mr. Domzalski&#8217;s tenure with Foamix began in April 2014 when he served as President of its U.S. subsidiary. Prior to that, Mr. Domzalski was the Vice President of Sales and Marketing at LEO Pharma Inc. from 2009 to 2013. Mr. Domzalski holds a B.A. in economics and political science from Muhlenberg College in Allentown, Pennsylvania. We believe Mr. Domzalski is qualified to serve on our Board given his leadership position with the Company and Foamix, and his extensive experience in operating and leadership roles in the pharmaceutical industry.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tyler Zeronda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was appointed as the Company&#8217;s Chief Financial Officer and Treasurer in March 2022 and previously served as Interim Chief Financial Officer and Treasurer since June 2021. Mr. Zeronda previously served as Vice President of Finance of the Company from the Closing Date until his appointment as Interim CFO. Mr. Zeronda joined Foamix in April 2019 and has been responsible for all finance activities related to the commercial operations, financial planning, treasury, risk management and supply chain matters of VYNE. From April 2013 until April 2019, Mr. Zeronda held positions of increasing responsibility in finance at Aerie Pharmaceuticals Inc. (&#8220;Aerie&#8221;), a Nasdaq listed company, culminating in his role as Director of Finance. While at Aerie, Mr. Zeronda supported the company's IPO and helped lead his department&#8217;s growth and transition from that of a pre-IPO, development-stage entity to a fully integrated commercial finance organization supporting the launch of multiple drugs. Prior to joining Aerie, Mr. Zeronda was employed at Ernst &amp; Young, LLP where he focused on assurance services in the healthcare industry. Mr. Zeronda received his Master of Science in accounting from the University of Virginia, holds a Bachelor of Arts in economics and business from Lafayette College and is a licensed CPA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Iain Stuart, Ph.D. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as the Company's Chief Scientific Officer since the Closing Date. From January 2019 until the Closing Date, Dr. Stuart served as the Chief Scientific Officer of Foamix. Dr. Stuart previously served as Foamix&#8217;s Senior Vice President of Research &amp; Development from August 2017 to January 2019 and as Vice President of Clinical Development from </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 2016 to 2017. Prior to joining Foamix, Dr. Stuart held several positions, including Vice President of Medical Strategy and Scientific Affairs, at LEO Pharma, Inc. from 2008 to 2016. Dr. Stuart holds a Ph.D. from Glasgow Caledonian University in Scotland. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mutya Harsch </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as the Company&#8217;s Chief Legal Officer, General Counsel and Secretary since the Closing Date. From January 2019 until the Closing Date, Ms. Harsch served as the General Counsel and Chief Legal Officer of Foamix. She previously served as Foamix&#8217;s General Counsel and Senior Vice President of Legal Affairs from January 2018 to January 2019. In addition, Ms. Harsch has served on the board of directors of Satsuma Pharmaceuticals Inc. since October 2021. Ms. Harsch has over 20 years of legal experience, previously holding positions as Special Counsel, Mergers &amp; Acquisitions at Cooley LLP from 2015 to 2017 and as a corporate lawyer at Davis Polk &amp; Wardwell from 2005 to 2015. Ms. Harsch received her J.D. and B.A. from the University of California at Berkeley.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Employee Directors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Sharon Barbari</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> has served on our Board since the Closing Date and previously served as a director of Foamix from January 2019 until the Closing Date. Ms. Barbari previously served as Chief Financial Officer at Cytokinetics from 2004 to 2017 and as CFO at Gilead Sciences, where she served in senior financial roles from 1998 to 2002.  Ms. Barbari also served as CFO and Senior Vice President of Finance and Administration at InterMune, and Vice President of Strategic Planning at Foote, Cone &amp; Belding Healthcare. From 1972 to 1990, Ms. Barbari served in various roles of increasing responsibility at Syntex Corporation/Roche Pharmaceuticals. Ms. Barbari currently serves on the board of directors of Agile Therapeutics and the Association of Bioscience Finance Officers. She previously served on the board of directors of Foamix from January 2019 until the Closing Date, Sonoma Pharmaceuticals and for Phytogen Life Sciences. In 2017, Ms. Barbari was a recipient of the YWCA Silicon Valley Tribute to Women Awards. She received her BS in accounting from San Jose State University. The Board believes that Ms. Barbari&#8217;s long career as a senior financial executive and her leadership roles in various biotechnology and pharmaceutical companies provides broad experience and knowledge of the global pharmaceutical business and industry, as well as extensive accounting expertise, to the Board and to the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Steven Basta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> served as our President and Chief Executive Officer from September 2015 until the Closing Date and has served as a member of our Board since September 2015. Mr. Basta is currently the Chief Executive Officer of Mahana Therapeutics, a privately-held digital therapeutics company, and has served in that capacity since December 2020. From October 2011 until August 2015, Mr. Basta served as Chief Executive Officer of AlterG, a privately held medical device company. From November 2002 to February 2010, Mr. Basta served as Chief Executive Officer of BioForm Medical, a publicly listed medical aesthetics company acquired by Merz, and from February 2010 to September 2011 served as Chief Executive Officer of Merz Aesthetics, the successor to BioForm Medical. Mr. Basta is currently a board member of the publicly listed company, Viveve Medical (since September 2018) and serves as Chairman of the Board of Viveve (since January 2019). Mr. Basta previously served on the board of Carbylan Therapeutics from September 2009 to November 2016 when it was acquired by KalVista Pharmaceuticals. Mr. Basta served on the board of RF Surgical (acquired by Medtronic) from December 2013 to August 2015. Mr. Basta received a B.A. from The Johns Hopkins University and an M.B.A. from the Kellogg Graduate School of Management at Northwestern University. We believe Mr. Basta is qualified to serve on our Board because of his extensive experience in leadership and management roles at various life sciences companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anthony Bruno</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served on our Board since the Closing Date and previously served as a director of Foamix from November 2018 until the Closing Date. Mr. Bruno is currently retired. He previously served as a strategic consultant to Foamix from 2014 until August 2018, and to various healthcare-focused investment funds from 2011 to January 2018. He was employed at Warner Chilcott from 2000 to 2011, most recently as Executive Vice President, with responsibility for all business development activities including product acquisitions and divestitures as well as licensing agreements. Mr. Bruno also spent 16 years at Warner Lambert, holding several positions of increasing strategic responsibility. Mr. Bruno began his legal career as an associate with Shearman &amp; Sterling. Mr. Bruno holds a B.A. in Political Science from Syracuse University, and a J.D. from The George Washington University Law School. We believe Mr. Bruno is qualified to serve on our Board given his experience as an accomplished pharmaceutical executive with broad expertise in the legal, business development, and corporate development functions within the industry, as well as significant experience in product licensing and M&amp;A transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Patrick LePore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> has served on our Board since September 2020 and was appointed as the lead independent director in February 2021. Mr. LePore previously served as Chairman, Chief Executive Officer and President of Par Pharmaceutical Companies, Inc. from September 2006 until its sale to affiliates of TPG Capital in 2012. He remained as chairman of Par Pharmaceutical through its sale to Endo International in 2015. Mr. LePore began his career with Hoffmann-LaRoche. He later founded Boron, LePore &amp; Associates, a medical communications company, which he took public in 1997 and was eventually sold to Cardinal Health in 2002. Mr. LePore is currently Chairman of the Board of Lannett Co. Inc. He previously served on the boards of Matinas BioPharma, PharMerica and Innoviva, and previously served as a trustee of Villanova University. Mr. LePore earned a bachelor&#8217;s degree from Villanova University and a Master of Business Administration from Farleigh Dickinson University. We </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">believe Mr. LePore is qualified to serve on our Board given his extensive experience as a senior level executive and board member for several companies in the pharmaceutical sector.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Elisabeth Sandoval </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">has served as a member of our Board since March 2019. Ms. Sandoval currently serves as a consultant to the pharmaceutical industry. Previously, from 2016 to 2019, she served as the Chief Commercial Officer and Executive Vice President of Corporate Strategy for Alder Biopharmaceuticals, a clinical stage company focused on developing novel therapeutic antibodies for the treatment of migraine. Prior to this, Ms. Sandoval was Chief Commercial Officer for KYTHERA Biopharmaceuticals until KYTHERA&#8217;s acquisition by Allergan. Before KYTHERA, Ms. Sandoval served as Vice President of Marketing for Bausch and Lomb Surgical and Vice President of Global Marketing at Allergan with responsibility for the Medical Aesthetics division. She spent 23 years at Allergan in sales and marketing leadership roles in the specialties of dermatology, neurology, and aesthetics. Ms. Sandoval began her career in research and development at Johnson &amp; Johnson&#8217;s Ethicon division. Ms. Sandoval serves on the board of directors for Alastin Skincare, Satsuma Pharmaceuticals, Intersect ENT and Procept BioRobotics. She holds an MBA from Pepperdine University and a B.S. in biology from the University of California, Irvine. We believe that Ms. Sandoval is qualified to serve on our Board because of her extensive background working in the dermatology industry and her experience in strategic planning, business transactions, sales operations and executive leadership.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Governance Guidelines</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has documented our governance practices in our corporate governance guidelines to assure that the Board will have the necessary authority and practices in place to review and evaluate our business operations as needed and to make decisions that are independent of our management. The guidelines are also intended to align the interests of directors and management with those of our stockholders. The corporate governance guidelines set forth certain practices the Board will follow with respect to Board composition, Board committees, Board nomination, director qualifications and evaluation of the Board and committees. The corporate governance guidelines and the charter for each committee of the Board may be viewed at http://https://vynetherapeutics.com/investors-media/corporate-goverance/. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leadership Structure of the Board</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated bylaws and corporate governance guidelines provide our Board with flexibility to designate the position of Chairman of the Board, and if so, to combine or separate the positions of Chairman of the Board and Chief Executive Officer, or to appoint a lead director in accordance with its determination that utilizing a particular structure would be in the best interests of the Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Nominating and Corporate Governance Committee evaluated our leadership structure in 2021 and subsequently recommended that the Board appoint a lead independent director. Following such recommendation and a discussion by the full Board, our Board appointed Patrick LePore as lead independent director in February 2021. The Board determined that the appointment of a lead independent director is in the best interests of the Company and its stockholders as it strengthens the Board's independence and commitment to strong governance practices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Role of Board in Risk Oversight Process</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk assessment and oversight are an integral part of our governance and management processes. Our Board encourages management to promote a culture that incorporates risk management into our corporate strategy and day-to-day business operations. Management discusses strategic and operational risks at regular management meetings, and conducts specific strategic planning and review sessions during the year that include a focused discussion and analysis of the risks facing us. Throughout the year, senior management reviews these risks with the Board at regular Board meetings as part of management presentations that focus on particular business functions, operations or strategies, and presents the steps taken by management to mitigate or eliminate such risks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committees of the Board of Directors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has a standing Audit Committee, Compensation Committee and a Nominating and Corporate Governance Committee. The Board may establish other committees to facilitate the management of our business. The current composition and functions of each committee are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:56.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.972%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Name</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Audit</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Compensation</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nominating and Corporate Governance</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">David Domzalski</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8212;</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8212;</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8212;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sharon Barbari</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Steven Basta</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8212;</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8212;</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#8212;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Anthony Bruno</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Patrick LePore</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Elisabeth Sandoval</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</span></div></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committee Chairperson</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a description of each committee of the Board.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit Committee oversees our corporate accounting and financial reporting process. Among other matters, the Audit Committee:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">appoints our independent registered public accounting firm;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">evaluates the independent registered public accounting firm&#8217;s qualifications, independence and performance; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">determines the engagement of the independent registered public accounting firm;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">reviews and approves the scope of the annual audit and the audit fee;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">discusses with management and the independent registered public accounting firm the results of the annual audit and the review of our quarterly financial statements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">approves the retention of the independent registered public accounting firm to perform any proposed permissible non&#8209;audit services;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">monitors the rotation of partners of the independent registered public accounting firm on our engagement team in accordance with requirements established by the SEC;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">is responsible for reviewing our financial statements and our management&#8217;s discussion and analysis of financial condition and results of operations to be included in our annual and quarterly reports to be filed with the SEC; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">reviews our critical accounting policies and estimates; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">reviews the Audit Committee charter and the committee&#8217;s performance at least annually.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of our Audit Committee are Mses. Barbari and Sandoval and Mr. LePore, with Ms. Barbari serving as chairperson of the committee. All members of our Audit Committee meet the requirements for financial literacy under the applicable rules and regulations of the SEC and Nasdaq. Our Board has determined that Ms. Barbari is an audit committee financial expert as defined under the applicable rules of the SEC and has the requisite financial sophistication as defined under the applicable rules and regulations of Nasdaq. Under the rules of the SEC, members of the Audit Committee must also meet heightened independence standards. Our Board has determined that Mses. Barbari and Sandoval and Mr. LePore are independent under the applicable rules of the SEC and Nasdaq.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee operates under a written charter that satisfies the applicable standards of the rules of the SEC and Nasdaq. A copy of the Audit Committee charter is available to security holders on our website at https://vynetherapeutics.com/investors-media/corporate-goverance/. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee oversees policies and makes determinations relating to compensation and benefits of our current and prospective officers, directors and employees. The Compensation Committee periodically evaluates the performance of our Company, and where appropriate, our officers, in light of the goals and objectives it has established, and determines and approves, or may recommend to the Board to approve, the bonus award, if any, payable to these officers. The Compensation Committee may establish compensation and make bonus awards to our chief executive officer directly or may make recommendations to the Board regarding compensation and bonus awards payable to our chief executive officer. Our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation Committee also reviews director compensation and makes recommendations to the Board regarding director compensation. The Compensation Committee also reviews and approves or makes recommendations to our Board regarding the issuance of stock options and other awards under our stock plans. The Compensation Committee will periodically review and evaluate the performance of the Compensation Committee and its members, including compliance by the Compensation Committee with its charter. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of our Compensation Committee are Mr. Bruno and Mses. Barbari and Sandoval, with Ms. Sandoval serving as the chairperson of the committee. Our Board has determined that each of Mr. Bruno and Mses. Barbari and Sandoval is independent under the applicable rules and regulations of Nasdaq and is a &#8220;non-employee director&#8221; as defined in Rule 16b-3 promulgated under the Exchange Act.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers submit proposals to the Board and the Compensation Committee regarding our executive compensation. Our Chief Executive Officer also annually reviews the performance of each executive officer and makes recommendations regarding their compensation. The Compensation Committee considers those recommendations in determining base salaries, adjustments to base salaries, annual cash bonus program targets and awards and equity awards, if any, for the executive officers and other members of senior management.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Compensation Committee retained the services of FW Cook to advise the committee on compensation adjustments for the 2020 calendar year as well as adjustments for 2021. The Compensation Committee has evaluated the independence of its outside advisors, including outside compensation advisor and legal counsel, considering the independence factors specified in the listing requirements of Nasdaq and concluded their work for the Compensation Committee does not raise any conflicts of interest.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee operates under a written charter that satisfies the applicable standards of the rules of the SEC and Nasdaq. A copy of the Compensation Committee charter is available to security holders on our website at https://vynetherapeutics.com/investors-media/corporate-goverance/. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Nominating and Corporate Governance Committee is responsible for making recommendations to our Board regarding candidates for directorships and the size and composition of our Board. In addition, the Nominating and Corporate Governance Committee is responsible for overseeing our corporate governance policies and reporting and making recommendations to our Board concerning governance matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The current members of our Nominating and Corporate Governance Committee are Messrs. Bruno and LePore and Ms. Barbari, with Mr. Bruno serving as the chairperson of the committee. Our Board has determined that each of Messrs. Bruno and LePore and Ms. Barbari is an independent director under the applicable rules and regulations of Nasdaq relating to nominating and corporate governance committee independence. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee operates under a written charter that satisfies the applicable standards of the SEC and Nasdaq. A copy of the Nominating and Corporate Governance Committee charter is available to security holders on our website at https://vynetherapeutics.com/investors-media/corporate-goverance/. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Nominating and Corporate Governance Committee is responsible for reviewing with the Board, on an annual basis, the appropriate characteristics, skills and experience required for the Board as a whole and its individual members. In evaluating the suitability of individual candidates (both new candidates and current members), the Nominating and Corporate Governance Committee, in recommending candidates for election, and the Board, in approving (and, in the case of vacancies, appointing) such candidates, may take into account many factors, including but not limited to the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the candidate&#8217;s experience in corporate management, such as serving as an officer or former officer of a publicly held company; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the candidate&#8217;s experience as a board member of another publicly held company;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the candidate&#8217;s professional and academic experience relevant to the Company&#8217;s industry;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the strength of the candidate&#8217;s leadership skills;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the candidate&#8217;s experience in finance and accounting and/or executive compensation practices; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">whether the candidate has the time required for preparation, participation and attendance at Board meetings and committee meetings, if applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, our Nominating and Corporate Governance Committee and Board evaluate each individual in the context of the Board as a whole, with the objective of assembling a group that can best maximize the success of the business and represent stockholder interests through the exercise of sound judgment using its diversity of experience in these areas. The Nominating and Corporate Governance Committee will consider individuals who are properly proposed by stockholders to serve on the Board in accordance with laws and regulations established by the SEC and the Nasdaq listing requirements, our bylaws and applicable corporate law, and make recommendations to the Board regarding such individuals based on the established criteria for members of our Board. The Nominating and Corporate Governance Committee may consider in the future whether we should adopt a more formal policy regarding stockholder nominations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Stockholder Communications with the Board of Directors</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board will consider any written or electronic communication from our stockholders to the Board, a committee of the Board or any individual director. Any stockholder who wishes to communicate to the Board, a committee of the Board or any individual director should submit written or electronic communications to our corporate secretary at our principal executive offices, which shall include contact information for such stockholder. All communications from stockholders received shall be forwarded by our secretary to the Board, a committee of the Board or an individual director, as appropriate, on a periodic basis, but in any event no later than the Board&#8217;s next scheduled meeting. The Board, a committee of the Board, or individual directors, as appropriate, will consider and review carefully any communications from stockholders forwarded by our secretary.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Business Conduct and Ethics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of business conduct and ethics that applies to all of our employees, officers and directors, including those officers responsible for financial reporting. Our code of business conduct and ethics is available on our website at https://vynetherapeutics.com/investors-media/corporate-goverance/. Any amendments to the code, or any waivers of its requirements, will be disclosed on our website. The reference to our web address does not constitute incorporation by reference of the information contained at or available through our website.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prohibition on Margin Accounts and Hedging and Similar Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our employees and directors are subject to an insider trading policy that, among other things, prohibits them from holding Company securities in a margin account or pledging Company securities as collateral for a loan. In addition, our insider trading policy prohibits employees and directors from engaging in put or call options, short selling, or similar hedging activities involving our stock. We prohibit these transactions because they may reduce the individual&#8217;s incentive to improve our performance, focus the individual on short-term performance at the expense of long-term objectives, and misalign the individual&#8217;s interests with those of our stockholders generally. </span></div><div id="i3ee2f3590755456d8887827db5ee11c4_190"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11 - EXECUTIVE COMPENSATION</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of compensation arrangements of our named executive officers, or NEOs. As an &#8220;emerging growth company&#8221; as defined in the JOBS Act, we are not required to include a Compensation Discussion and Analysis section and have elected to comply with the scaled disclosure requirements applicable to emerging growth companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NEOs for the year ended December 31, 2021 were:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">David Domzalski, President and Chief Executive Officer;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Mutya Harsch, Chief Legal Officer, General Counsel and Secretary; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Iain Stuart, Chief Scientific Officer.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Compensation Table </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the compensation information for our NEOs for the years ended December 31, 2021 and 2020. Dr. Stuart was not a named executive officer for the year ended December 31, 2020 and therefore compensation information for that period has been omitted. Mr. Domzalski and Ms. Harsch were executives of Foamix prior to the Merger and were appointed as executives of the Company as of the Closing Date. Accordingly, compensation presented for 2020 reflects only compensation paid by the Company from the Closing Date through December 31, 2020. It does not reflect compensation received by such person prior to the Closing Date which was paid by Foamix.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.337%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Name and Principal Position</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Salary ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Bonus ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Stock Awards ($)(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Option Awards ($)(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">All Other Compensation ($)(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total Compensation ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:115%">David Domzalski</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2021</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">637,560&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">242,910&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,818,861&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,141,994&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,600&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,852,925&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">President and Chief Executive Officer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">500,500*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">277,200</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,326,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">756,908</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,400</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,872,008</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:115%">Mutya Harsch</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2021</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">405,936&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">142,007&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">345,587&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">406,976&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,600&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,312,106&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Chief Legal Officer, General Counsel and Secretary</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">318,669*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">117,662</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">292,500</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">166,965</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">11,400</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">907,196</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:115%">Iain Stuart</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2021</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">405,576&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">117,620&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">345,587&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">406,976&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11,600&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,287,359&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:115%">Chief Scientific Officer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">For Mr. Domzalski and Ms. Harsch, the amounts shown for 2020 reflect base salary that was paid by the Company from the March 9, 2020 (the closing date of the Merger) through December 31, 2020. It does not reflect base salary that was paid by Foamix from January 1, 2020 through March 9, 2020 as such amounts were not paid by the Company. The base salary received by Mr. Domzalski and Ms. Harsch for the full year ended December 31, 2020, including salary paid by Foamix, was $616,000 and $392,208, respectively.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">See "&#8212;Retention Awards" for additional discussion regarding retention awards issued in September 2021. Represents the grant date fair value of the restricted stock units and stock options granted by the Company to our named executive officers during 2021 and 2020 as computed in accordance with ASC 718. The assumptions used in calculating the grant date fair value are set forth in Note 15 to the financial statements included in this report.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Reflects employer contributions to each individual's 401(k) plan. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at Fiscal Year End </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth all outstanding equity awards held by each of the named executive officers as of December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Option Awards(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Share Awards(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Name</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Vesting Commencement Date (2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of Securities Underlying Unexercised Options Exercisable</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of Securities Underlying Unexercised Options Unexercisable</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Option Exercise Price ($)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Option Expiration Date</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of Shares or Units of Shares That Have Not Vested (#)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Market Value of Shares or Units of Shares That Have Not Vested (3)($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">David Domzalski</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">6/9/2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8,440</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">17.76</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">6/9/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">11/10/2015</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">106,600</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">15.88</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">11/10/2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3/1/2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">27,009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">13.44</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3/1/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/21/2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">32,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">22.72</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/21/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8/8/2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">147,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">12.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8/8/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">5/8/2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">29,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">11.28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">5/8/2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">659</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">672</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1/1/2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">52,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">24,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1/1/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">10,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">10,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/24/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">47,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">60,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8.96</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/24/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">26,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">26,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5/6/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">63,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">106,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">7.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5/6/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">106,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">108,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.33</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">9/2/2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">320,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1.68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">9/2/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">320,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">326,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Mutya Harsch</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/27/2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">21,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14.12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/27/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">705</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1/1/2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">21,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">9,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1/1/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">4,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">4,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/24/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">18,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">24,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8.96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/24/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">10,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">10,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5/6/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">23,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5/6/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">23,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">23,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/22/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">68,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8.33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/22/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">29,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">29,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">9/2/2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">60,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1.68</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">9/2/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">60,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">62,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Iain Stuart</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">11/15/2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">18,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">19.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">11/15/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8/8/2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">12.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8/8/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/27/2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">12,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">843</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">14.12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/27/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">281</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">287</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1/01/2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">23,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">10,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8.40</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1/1/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">4,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">4,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/24/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">18,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">24,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8.96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/24/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">10,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">10,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5/06/2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">10,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">17,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">7.80</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5/6/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">17,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">17,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/22/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">68,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">8.33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2/22/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">29,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">29,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">9/2/2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">60,860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1.68</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">9/2/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">60,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">62,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">On April 3, 2020, the equity awards issued to Mr. Domzalski and Ms. Harsch prior to the Closing Date in respect of services rendered as executives of Foamix were proportionately adjusted to reflect the final exchange ratio in the Merger, following the conversion of the contingent stock rights. Accordingly, the number of shares underlying the Foamix options and restricted stock units that were assumed by the Company in the Merger were multiplied by 1.8006, and the exercise price for each Foamix option was divided by 1.8006.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Except as set forth in footnote 4 below, these equity awards vest over a four year period, with 25% vesting on the first anniversary of the last day of the quarter in which the grant was made, and 6.25% every quarter thereafter. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The market value is based on the closing price of our common stock on December 31, 2021.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Awards granted pursuant to the Company's retention initiatives in September 2021. See "&#8212;Retention Awards" for additional details, including vesting terms. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retention Awards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company announced that it would be divesting its commercial business and transitioning to a biotech strategy focused on drug development. In connection with such decision, on September 2, 2021, the Compensation Committee  approved the grant of an aggregate of 1,204,909 shares subject to restricted stock unit and stock option awards to all continuing employees of the Company, including members of management. The awards were issued in accordance with the terms and conditions of the Company&#8217;s 2019 Equity Incentive Plan and the 2018 Omnibus Incentive Plan and the underlying award agreements. The Compensation Committee determined such grants were appropriate to address the need to adequately retain the Company&#8217;s employees through this period of strategic change and incentivize employees to effectively execute the Company&#8217;s new strategic operating plan and closely align the interests of employees with the Company&#8217;s stockholders over the long term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Domzalski was awarded 320,312 restricted stock unit awards and employee stock options to purchase 320,313 shares. Dr. Stuart and Ms. Harsch were each awarded 60,859 restricted stock unit awards and employee stock options to purchase 60,860 shares. All of the shares subject to restricted stock unit awards will vest on September 30, 2023, and 50% of the shares subject to stock option awards will vest on September 30, 2022, with the remaining 50% of the shares vesting thereafter in equal, quarterly installments through September 30, 2023, in each case, subject to the recipient&#8217;s continued service to the Company through the vesting date. The exercise price for each stock option granted is $1.68 per share, which represents the closing price for the Company&#8217;s common stock on the date of grant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Arrangements with Named Executive Officers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into agreements with each of our named executive officers in connection with his or her employment with us. These agreements set forth the terms and conditions of employment of each NEO, including base salary, target bonus and standard employee benefit plan participation. Our Board or the Compensation Committee reviews each NEO&#8217;s base salary and other compensation from time to time to ensure compensation adequately reflects the NEO&#8217;s qualifications, experience, role and responsibilities. The following summaries of the compensation arrangements do not purport to be complete and are qualified in their entirety by reference to each agreement. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">David Domzalski, President and Chief Executive Officer </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of Mr. Domzalski&#8217;s employment are governed by his Offer Letter, dated as of March 25, 2020. Under his Offer Letter, Mr. Domzalski&#8217;s annualized base salary for 2020 was $616,000, which was increased to $637,560 in February 2021 by the Compensation Committee. Mr. Domzalski's salary will remain the same for 2022. Mr. Domzalski is also eligible to receive an annual cash target bonus of 60% of his base salary, up to the maximum bonus opportunity allowable under the applicable annual bonus plan or program in effect from time to time (such maximum bonus opportunity currently being 200% of the target bonus), subject to the achievement of Company performance criteria determined by the Board or the Compensation Committee. For 2021, Mr. Domzalski's eligibility to receive his target bonus was subject to the following key performance criteria, which were modified in September 2021 following the announcement by the Company that it was divesting its commercial business: (i) the divestiture of the commercial business, (ii) the achievement of certain pipeline objectives, including obtaining Phase 2a trial results for FMX114 and the initiation of certain preclinical activities with respect to VYN201, as well as establishing a Scientific Advisory Board, (iii) expanding the Company's development objectives and executing a license agreement with In4Derm with respect to a selective BET inhibitor, and (iv) the achievement of certain financial objectives, including managing operations within the Board-approved operating plan (collectively, the "2021 Performance Assessment"). Based on the 2021 Performance Assessment, the Compensation Committee approved a cash bonus for Mr. Domzalski in the amount of $242,910, representing 63% of his target bonus for 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Domzalski's Offer Letter provides that if Mr. Domzalski&#8217;s employment is terminated by the Company without Cause or he resigns for Good Reason (each as defined below), then, subject to his execution and non-revocation of a release of claims, Mr. Domzalski will be entitled to receive (i) a severance payment equal to 100% of his annual base salary then in effect, (ii) continued participation in medical benefit plans at active employee rates for 12 months following the date of termination and (iii) full accelerated vesting of all of outstanding and unvested stock options and restricted stock units on the date of termination, with such stock options remaining exercisable for 90 days following the date of termination. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Mr. Domzalski&#8217;s employment is terminated by the Company without Cause or he resigns for Good Reason, in each case, within 12 months following a Change in Control (as defined in the 2019 Equity Incentive Plan), then, subject to his execution and non-revocation of a release of claims, Mr. Domzalski will be entitled to receive (i) a severance payment equal to 1.5 times the sum of his base salary and target bonus for the year of termination, (ii) a prorated target annual bonus payment for the year of termination, (iii) continued participation in medical benefit plans at active employee rates for 18 months following the date of termination and (iv) full accelerated vesting of all of outstanding and unvested stock options and restricted stock units on the date of termination, with such stock options remaining exercisable for 90 days following the date of termination.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of Mr. Domzalski's Offer Letter:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Cause" means (1) the executive&#8217;s commission of an act of fraud or dishonesty in the course of his employment hereunder; (2) the executive&#8217;s indictment, conviction or entering of a plea of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nolo contendere</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a crime constituting a felony; (3) the executive&#8217;s gross negligence or willful misconduct in connection with his employment; (4) the executive&#8217;s willful and continued failure to substantially perform his duties; (5) the executive&#8217;s breach of any of the restrictive covenants; or (6) a material breach of this agreement or any other agreement, plan or arrangement by and between the executive and the Company or any of its subsidiaries and affiliates or any policy of the Company or any of its subsidiaries and affiliates by the executive.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Good Reason" means (i) a material diminution in the executive&#8217;s base salary or target bonus (provided that failure to earn a bonus equal to or in excess of the target bonus by reason of failure to achieve applicable performance goals shall not be deemed Good Reason); (ii) a material diminution of the executive&#8217;s position, responsibilities, duties or authorities from those in effect as of the effective date; (iii) any change in reporting structure such that the executive is required to report to someone other than the Board; (iv) any material breach by the Company of its obligations under this agreement; or (v) a change in the executive&#8217;s primary work location that increases the executive&#8217;s commute by more than 50 miles. Executive shall provide notice of the existence of the Good Reason condition within 30 days of the date executive learns of the condition, and the Company shall have a period of thirty 30 days during which it may remedy the condition, and in case of full remedy such condition shall not be deemed to constitute Good Reason. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mutya Harsch, Chief Legal Officer, General Counsel and Secretary </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of Ms. Harsch&#8217;s employment are governed by her Offer Letter, dated as of April 7, 2021. Ms. Harsch&#8217;s annualized base salary for 2020 was $392,208, which was increased to $405,935 in February 2021 by the Compensation Committee. Ms. Harsch's salary will be increased by 4% for 2022. In March, Ms. Harsch is also eligible to receive an annual target bonus of 40% of her annual base salary. Her eligibility for such annual target bonus, and the amount of such annual target bonus, will be subject to her achievement of performance targets and milestone criteria, as determined by the Chief Executive Officer, in accordance with our current general bonus plan. Based on the 2021 Performance Assessment, the Compensation Committee approved a cash bonus for Ms. Harsch in the amount of $142,007, representing 87% of her target bonus for 2021. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Offer Letter provides that, in the event of a termination of her employment without Cause (as defined in the 2019 Equity Incentive Plan), subject to Ms. Harsch&#8217;s execution of a release of claims, Ms. Harsch will receive (i) a lump sum severance payment equal to 75% of her base salary then in effect and (ii) continued healthcare plan coverage at active employee rates for nine (9) months following the date of termination, provided that the Company&#8217;s obligation under clause (ii) shall terminate on the earlier of (x) the date on which she enrolls in a group health plan offered by another employer and (y) the date on which she is no longer eligible for continuation coverage under COBRA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if Ms. Harsch's employment is terminated by the Company without Cause or she terminates her employment with Good Reason within the twelve month period after a Change of Control (as defined in the 2019 Equity Incentive Plan), she will be entitled to receive a change of control payment equal to (i) one times (1.0x) the sum of her then current base salary plus her target bonus, (ii) her pro rata target bonus for the year of termination, and (iii) continued healthcare plan coverage at active employee rates for twelve (12) months following the date of termination, provided that the Company&#8217;s obligation under clause (iii) shall terminate on the earlier of (x) the date on which she enrolls in a group health plan offered by another employer and (y) the date on which she is no longer eligible for continuation coverage under COBRA. In addition, in the event of such a termination, all of Ms. Harsch&#8217;s unvested stock options and restricted stock units will become fully vested.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of Ms. Harsch&#8217;s Offer Letter, &#8220;Good Reason&#8221; means: (i) a material reduction in base salary; (ii) a material reduction in target annual bonus opportunity; (iii) a relocation of principal place of employment by more than twenty-five</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25) miles provided that such relocation increases the daily commute; or (iv) an adverse change in position, including title, reporting relationship(s), authority, duties or responsibilities; all of the above without consent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Harsch&#8217;s Offer Letter also contains customary confidentiality, non-competition and non-solicitation covenants. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Iain Stuart, Chief Scientific Officer</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of Dr. Stuart&#8217;s employment are governed by his Offer Letter, dated as of March 7, 2022. Dr. Stuart's base salary for 2021 was $405,576. Dr. Stuart's salary will be increased by 4% for 2022. Dr. Stuart is also eligible to receive an annual target bonus of 40% of his annual base salary. His eligibility for such annual target bonus, and the amount of such annual target bonus, will be subject to his achievement of performance targets and milestone criteria, as determined by the Chief Executive Officer, in accordance with our current general bonus plan. Based on the 2021 Performance Assessment, the Compensation Committee approved a cash bonus for Dr. Stuart in the amount of $117,620, representing 72% of his target bonus for 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a termination of his employment without Cause (as defined in the 2019 Equity Incentive Plan), subject to Dr. Stuart&#8217;s execution of a release of claims, Dr. Stuart will receive (i) a lump sum severance payment equal to 75% of his base salary then in effect and (ii) continued healthcare plan coverage at active employee rates for nine (9) months following the date of termination, provided that the Company&#8217;s obligation under clause (ii) shall terminate on the earlier of (x) the date on which he enrolls in a group health plan offered by another employer and (y) the date on which he is no longer eligible for continuation coverage under COBRA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if Dr. Stuart's employment is terminated by the Company without Cause or he terminates her employment with Good Reason within the twelve month period after a Change of Control (as defined in the 2019 Equity Incentive Plan), he will be entitled to receive a change of control payment equal to (i) one times (1.0x) the sum of his then current base salary plus his target bonus, (ii) his pro rata target bonus for the year of termination, and (iii) continued healthcare plan coverage at active employee rates for twelve (12) months following the date of termination, provided that the Company&#8217;s obligation under clause (iii) shall terminate on the earlier of (x) the date on which he enrolls in a group health plan offered by another employer and (y) the date on which he is no longer eligible for continuation coverage under COBRA. In addition, in the event of such a termination, all of Dr. Stuart's unvested stock options and restricted stock units will become fully vested.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of Dr. Stuart&#8217;s Offer Letter, &#8220;Good Reason&#8221; means: (i) a material reduction in base salary; (ii) a material reduction in target annual bonus opportunity; (iii) a relocation of principal place of employment by more than twenty-five</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25) miles provided that such relocation increases the daily commute; or (iv) an adverse change in position, including title, reporting relationship(s), authority, duties or responsibilities; all of the above without consent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Stuart&#8217;s Offer Letter also contains customary confidentiality, non-competition and non-solicitation covenants. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions of 401(k) Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a tax&#8209;qualified retirement plan that provides eligible U.S. employees, including our NEOs, with an opportunity to save for retirement on a tax advantaged basis. Eligible employees are able to defer eligible compensation subject to applicable annual Internal Revenue Code (the &#8220;Code&#8221;) limits. Employees&#8217; pre&#8209;tax contributions are allocated to each participant&#8217;s individual account and are then invested in selected investment alternatives according to the participants&#8217; directions. Employees are immediately and fully vested in their contributions. The 401(k) plan is intended to be qualified under Section 401(a) of the Code with the 401(k) plan&#8217;s related trust intended to be tax exempt under Section 501(a) of the Code. As a tax&#8209;qualified retirement plan, contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Benefits and Perquisites</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our full&#8209;time employees, including our NEOs, are eligible to participate in our health and welfare plans, including medical, dental and vision benefits, medical and dependent care flexible spending accounts, short&#8209;term and long&#8209;term disability insurance and life insurance. In addition, all of our employees are eligible to participate in our Employee Share Purchase Plan, which allows them to purchase shares of our common stock at a 15% discount to prevailing market prices, subject to certain terms and conditions. We do not provide our NEOs with perquisites or other personal benefits, other than the retirement, health and welfare benefits that apply uniformly to all of our employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below is a summary of the compensation paid to the non-executive members of the Board during 2020. In addition, our Compensation Committee approved adjustments to our director compensation program for 2021. A summary of these changes is set forth below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Initial Equity Grants.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In February 2021, our Compensation Committee approved an adjustment to our director compensation program to increase the equity awards for director compensation such that each non-employee director who joins the Board will receive, upon appointment, options to purchase 41,000 shares of our common stock, representing two times (2x) the annual grant described below. The options will vest and become exercisable as to 1/3rd of the shares on each anniversary of the date of grant, subject to the director's continued service to the Company through each applicable vesting date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Annual Retainers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Each of our non-employee directors receives an annual cash retainer of $40,000, payable quarterly. During 2020, each non-employee director who had served as a director on our Board or on the Board of Foamix for at least six months received an annual retainer for service in such capacity, consisting of options to purchase common stock, which vest quarterly over one year. In February 2021, our Compensation Committee approved an adjustment to our director compensation program such that each non-executive director who has served as a director on our Board for at least six months will be granted options to purchase 20,500 shares of our common stock on the date of our annual meeting of stockholders. The options vest over a 12 month period in equal, monthly installments. In addition to the annual cash retainer set forth above, each of our non-employee directors receive fees for their service as a member or chair of a committee of our Board as set forth in the table below:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Additional annual retainer fees for service as a member or chair of the following committees (with chair fees inclusive of fees for service as a member)</span></div></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Member</span></div></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Chair</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Member</span></div></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Chair</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Audit Committee</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Compensation Committee</span></div></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7,500&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Nominating and Corporate Governance Committee</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, if a non-employee director is appointed to serve in a leadership position on the Board, he or she will be entitled to receive additional annual cash compensation of $40,000 for a non-employee chair or $25,000 for a lead independent director. In February 2021, Mr. LePore was appointed to serve as the Company&#8217;s lead independent director and received an additional annual cash retainer of $25,000 for his service. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exercise price per share of each option granted under this policy will be equal to the per share fair market value of our stock on the date of grant. Each such option will have a term of ten years from the date of grant, subject to earlier termination in connection with a termination of the non-employee director&#8217;s service with us. In the event of a change of control transaction, any unvested portion of an equity award granted under this policy will fully vest and become exercisable immediately prior to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the effective date of such transaction, subject to the non-employee director&#8217;s continuous service with us on the effective date of such transaction.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash retainers will be paid on a quarterly basis in arrears, pro-rated based on the days served in the applicable fiscal quarter. In addition, none of our non-employee directors shall in any event be permitted to receive cash and equity-based compensation (calculated based on grant date fair value) exceeding, in the aggregate, $500,000 in any calendar year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our director compensation policy was adopted by our Compensation Committee in consideration of a number of factors, including its assessment of a director compensation report from FW Cook, which our Compensation Committee engaged to prepare a competitive assessment of non-employee director compensation. The FW Cook report delivered to our Compensation Committee in February 2021 recommended a director compensation program based on the median of a comparator group. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vesting of each stock option held by our non-employee directors will accelerate in full upon a change in control. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also reimburse all of our non-employee directors for all reasonable and customary business expenses in accordance with company policy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director Compensation Table</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information for the fiscal year ended December 31, 2021 regarding the compensation awarded to, earned by or paid to our non&#8209;executive directors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.450%"><tr><td style="width:1.0%"></td><td style="width:36.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.789%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.333%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.337%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Name</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Fees Earned or Paid in Cash ($)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Option Awards ($)(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total Compensation ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Sharon Barbari</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">72,500&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34,645&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">107,145&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Steven Basta</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">74,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Rex Bright</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34,645&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">99,645&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Anthony Bruno</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">57,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">92,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Patrick LePore</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">70,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34,645&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">104,645&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Elisabeth Sandoval</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">57,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">92,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Represent the grant date fair value of the stock options granted by the Company to our directors during 2021 as computed in accordance with ASC 718. The assumptions used in calculating the grant date fair value are set forth in Note 15 to the financial statements included in this report.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, our non-employee directors held the following equity awards:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Name</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Shares Underlying Outstanding Options</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Shares Underlying Outstanding RSUs</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Sharon Barbari</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">40,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">&#8212;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Steven Basta</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">236,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">&#8212;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Rex Bright(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">109,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">&#8212;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Anthony Bruno</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">37,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">&#8212;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Patrick LePore</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">&#8212;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Elisabeth Sandoval</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">48,624</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">&#8212;</span></div></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">Served on the Board until his death on January 11, 2022. </span></div><div id="i3ee2f3590755456d8887827db5ee11c4_193"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information relating to the beneficial ownership of our common stock as of February 17, 2022, by:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our outstanding shares of common stock;</span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our directors;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our named executive officers; and</span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">all of our current directors and executive officers as a group.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares beneficially owned by each entity, person, director or executive officer is determined in accordance with the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares over which the individual has sole or shared voting power or investment power as well as any shares that the individual has the right to acquire within 60 days after February 17, 2022 through the exercise of any stock option, warrants or other rights. Except as otherwise indicated, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of common stock held by that person.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of shares beneficially owned is computed on the basis of 53,547,476 shares of our common stock outstanding as of February 17, 2022. Shares of our common stock that a person has the right to acquire within 60 days after February 17, 2022 are deemed outstanding for purposes of computing the percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing the percentage ownership of any other person, except with respect to the percentage ownership of all directors and executive officers as a group. Unless otherwise indicated below, the address for each beneficial owner listed is c/o VYNE Therapeutics Inc., 520 U.S. Highway 22, Suite 204, Bridgewater, NJ 08807.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Name of Beneficial Owner</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Number of<br/>Shares Owned<br/>and Nature of<br/>Beneficial<br/>Ownership</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percent of Class</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">5% and Greater Stockholders:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Named Executive Officers and Directors:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:13.7pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">David Domzalski(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">827,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:13.7pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Mutya Harsch(2)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">148,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:13.7pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Iain Stuart(3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">156,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:13.7pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Steven Basta(4)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">360,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:13.7pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sharon Barbari(5)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">49,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:13.7pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Anthony Bruno(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">60,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:13.7pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Patrick LePore(7)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">79,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:13.7pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Elisabeth Sandoval(8)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">38,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:13.7pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">All current directors and executive officers as a group (9 persons)(9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,753,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*     Indicates beneficial ownership of less than 1% of the total outstanding common stock.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 143,207 shares of common stock and 683,993 shares of common stock underlying options and restricted stock units that have vested or will vest within 60 days of February 17, 2022. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 34,303 shares of common stock and 113,745 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares of common stock underlying options and restricted stock units that have vested or will vest within 60 days of February 17, 2022.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 30,910 shares of common stock and 125,480 shares of common stock underlying options and restricted stock units that have vested or will vest within 60 days of February 17, 2022.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Consists of (i) 51,180 shares of common stock, (ii) 64,821 shares of common stock held by The Shelter Trust under the Basta Revocable Trust (the &#8220;Shelter Trust&#8221;), (iii) 18,130 shares of common stock held by the Basta Revocable Trust dated August 4, 2017 (the &#8220;Basta Trust&#8221;), and (iv) 226,116 shares of common stock underlying options that have vested or will vest within 60 days of February 17, 2022. As the trustee of each of the Shelter Trust and the Basta Trust, Mr. Basta has voting and investment power over the shares of common stock held by each of the Shelter Trust and the Basta Trust. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 18,750 shares of common stock and 30,283 shares of common stock underlying options that have vested or will vest within 60 days of February 17, 2022.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 33,763 shares of common stock and 26,791 shares of common stock underlying options that have vested or will vest within 60 days of February 17, 2022.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 62,500 shares of common stock and 17,416 shares of common stock underlying options that have vested or will vest within 60 days of February 17, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 38,040 shares of common stock underlying options that have vested or will vest within 60 days of February 17, 2022.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 1,284,873 shares of common stock underlying options or restricted stock units that have vested or will vest within 60 days of February 17, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized for Issuance Under Equity Compensation Plans </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains information about our equity compensation plans as of December 31, 2021. As of December 31, 2021, we had three equity compensation plans, our 2018 Omnibus Incentive Plan, our 2019 Equity Incentive Plan and our 2019 Employee Share Purchase Plan. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Plan Category</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Number of<br/>securities<br/>to be issued upon<br/>exercise of<br/>outstanding<br/>options, warrants<br/>and rights and vesting of RSUs</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted-average<br/>exercise price of<br/>outstanding options,<br/>warrants and rights and weighted-average grant date price of RSUs</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Number of securities<br/>remaining available<br/>for future issuance<br/>under equity<br/>compensation<br/>plans(3)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equity compensation plans approved by security<br/>holders (1)(2)</span></td><td colspan="2" style="background-color:#cff0fc;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,801,517&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cff0fc;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.90&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cff0fc;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,359,552&#160;</span></td><td style="background-color:#cff0fc;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equity compensation plans not approved by<br/>security holders</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</span></td><td style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td colspan="2" style="background-color:#cff0fc;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,801,517&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.90&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,359,552&#160;</span></td><td style="background-color:#cff0fc;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes the 2018 Omnibus Incentive Plan, the 2019 Equity Incentive Plan and the 2019 Employee Share Purchase Plan (the &#8220;2019 ESPP&#8221;).  </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The 2018 Omnibus Incentive Plan contains an &#8220;evergreen&#8221; provision pursuant to which the number of shares of common stock reserved for issuance or transfer pursuant to awards under the plan shall be increased on January 1st of each year by a number equal to the least of (x) 750,000 shares, (y) four percent of the number of shares outstanding as of the last day of the immediately preceding calendar year, or (z) a lesser number of shares determined by the plan administrator. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 147,550 shares under the 2018 Omnibus Incentive Plan, 979,795 shares under the 2019 Equity Incentive Plan and 2,232,207 shares available under the 2019 ESPP. An additional 750,000 shares were added to the 2018 Omnibus Incentive Plan pursuant to the evergreen provision contained therein, effective as of January 1, 2022. </span></div><div id="i3ee2f3590755456d8887827db5ee11c4_196"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13 - CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policies and Procedures for Related Party Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board has adopted a written related person transaction policy, setting forth the policies and procedures for the review and approval or ratification of related person transactions. This policy covers, with certain exceptions set forth in Item 404 of Regulation S-K under the Securities Act, any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships in which we were or are to be a participant, where the amount involved exceeds $120,000 and a related person had or will have a direct or indirect material interest, including without limitation purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related person. In reviewing and approving any such transactions, our Audit Committee considers all relevant facts and circumstances, including but not limited to whether the transaction is on terms comparable to those that could be obtained in an arm&#8217;s length transaction with an unrelated third party and the extent of the related person&#8217;s interest in the transaction.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Related Party Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of transactions during our last fiscal year and the year preceding our last fiscal year to which we have been a party, in which the amount involved exceeds $120,000, and in which any of our directors, executive officers or beneficial owners of more than 5% of our capital stock, or an affiliate or immediate family member thereof, had or will have a direct or indirect material interest.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was a party to the Amended and Restated Credit Agreement and Guaranty (the &#8220;Credit Agreement&#8221;), dated as of March 9, 2020, by and among the Company and its subsidiaries, the lenders party thereto and Perceptive Credit Holdings II, LP (&#8220;Perceptive&#8221;), as administrative agent for the lenders. As of August 11, 2021, the date of the prepayment of the total amount outstanding under the Credit Agreement, affiliates of Perceptive were holders of more than 5% of the Company's outstanding common stock. In connection with the prepayment of the Company's indebtedness, Perceptive received $18.3 million, representing their portion of the principal amount, interest and prepayment premium. In addition, for the year ended December 31, 2020, the Company paid approximately $3.9 million in interest payments to the lenders under the Credit Agreement, including approximately $2.0 million to Perceptive. Perceptive received an additional $1.1 million in interest payments from January 1, 2021 through July 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Director and Executive Officer Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see &#8220;Director Compensation&#8221; and &#8220;Executive Compensation&#8221; for information regarding the compensation of our directors and executive officers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employment Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into employment agreements with our executive officers. For more information regarding these agreements, see "Item 11. Executive Compensation."</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification Agreements and Directors&#8217; and Officers&#8217; Liability Insurance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into indemnification agreements with each of our directors and executive officers. These agreements require us to, among other things, indemnify each director and executive officer to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys&#8217; fees, judgments, penalties fines and settlement amounts incurred by the director or executive officer in any action or proceeding, including any action or proceeding by or in right of us, arising out of the person&#8217;s services as a director or executive officer. We have obtained an insurance policy that insures our directors and officers against certain liabilities, including liabilities arising under applicable securities laws.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Independence of Board of Directors and its Committees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Nasdaq listing standards, independent directors must comprise a majority of a listed company&#8217;s board of directors within a specified period of the closing of our initial public offering. In addition, the rules of Nasdaq require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation and nominating and corporate governance committees be independent. Under the rules of Nasdaq, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of that company&#8217;s board of directors, the director does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit committee members must also satisfy the independence criteria set forth in Rule 10A-3 under the Exchange Act. In order to be considered independent for purposes of Rule 10A-3, a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors or any other board committee: (1) accept, directly or indirectly, any consulting, advisory or other compensatory fee from the listed company or any of its subsidiaries; or (2) be an affiliated person of the listed company or any of its subsidiaries. We currently satisfy the audit committee independence requirements of Rule 10A-3. Additionally, compensation committee members must not have a relationship with us that is material to the director&#8217;s ability to be independent from management in connection with the duties of a compensation committee member. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board has undertaken a review of the independence of each director and considered whether each director has a material relationship with us that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. As a result of this review, our Board determined that each of our directors, except for Messrs. Basta and Domzalski, are an &#8220;independent director&#8221; as defined under the applicable rules and regulations of the SEC, and the listing requirements and rules of Nasdaq. In addition, the Board determined that Mr. Bright, who served as a director until his death on January 11, 2022, was independent.</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_199"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14 - PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PricewaterhouseCoopers LLP served as our principal independent registered public accounting firm for the years ended December&#160;31, 2021 and 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding fees paid by us to PwC for all services, for the years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit-related fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes professional services rendered in connection with the audit of our annual financial statements, the review of our interim financial statements and fees for registration statements and comfort letters.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes professional services rendered in connection with assistance in preparation of applications to the Israel Tax Authorities.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit committee&#8217;s specific responsibilities in carrying out its oversight of the quality and integrity of the accounting, auditing and reporting practices of the Company include the approval of audit and non-audit services to be provided by the external auditor. The audit committee pre-approves all non-audit services provided to the Company during year.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_202"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_205"></div><div style="-sec-extract:summary;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15 - EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.34pt">Documents Filed as Part of This Report</span></div><div style="margin-top:12pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6pt">Financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Index to Financial Statements under Item 8 of Part II of this Annual Report, which is incorporated herein by reference.</span></div><div style="margin-top:12pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6pt">Financial statement schedules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No schedules are applicable or required, or the information is included in the consolidated financial statements or notes thereto.</span></div><div style="margin-top:12pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6pt">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. See Item 15(b) below.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.78pt">Exhibits </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incorporation by Reference</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Description Of Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SEC File No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed Herewith</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000119312519289142/d831422dex21.htm">Agreement and Plan of Merger, dated as of November 10, 2019, by and among Foamix Pharmaceuticals Ltd., Menlo Therapeutics Inc. and Giants Merger Subsidiary Ltd.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 12, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000119312519306319/d816729dex21.htm">Amendment No. 1 to the Agreement and Plan of Merger, dated as of December 4, 2019, by and among Foamix Pharmaceuticals Ltd., Menlo Therapeutics Inc. and Giants Merger Subsidiary Ltd.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 4, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1566044/000110465922003788/tm222698d1_ex2-1.htm">Asset Purchase Agreement, dated as of January 12, 2022, by and between VYNE Therapeutics Inc. and Journey Medical Corporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 13, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit31vynecertificateof.htm">Amended and Restated Certificate of Incorporation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920102850/tm2029742d2_ex3-2.htm">Amended and Restated Bylaws</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 8, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit412.htm">Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex4-1.htm">Second Amended and Restated Warrant, by and among Menlo Therapeutics Inc. and Perceptive Credit Holdings II, LP.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 11, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex4-2.htm">Second Amended and Restated Warrant, by and among Menlo Therapeutics Inc. and Orbimed Royalty &amp; Credit Opportunities III, LP.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 11, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1566044/000156604421000037/exhibit101-vynexin4dermxto.htm">License Agreement (Topical), dated as of August 9, 2021, by and between In4Derm Limited and VYNE Therapeutics Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November, 10, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1566044/000156604421000037/exhibit102-in4dermxvynexev.htm">Evaluation and Option Agreement, dated as of April 30, 2021, by and between In4Derm Limited and VYNE Therapeutics Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November, 10, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001566044/000110465921104266/tm2124117d3_ex1-1.htm">Controlled Equity Offering Sales Agreement</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.5pt;vertical-align:baseline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;text-decoration:underline;top:-3.5pt;vertical-align:baseline" href="https://www.sec.gov/Archives/edgar/data/0001566044/000110465921104266/tm2124117d3_ex1-1.htm">SM</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001566044/000110465921104266/tm2124117d3_ex1-1.htm">, dated August 12, 2021, by and between VYNE Therapeutics Inc. and Cantor Fitzgerald &amp; Co.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 12, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1606645/000156761914000434/s000535x7_ex10-1.htm">2009 Israeli Share Option Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-36621</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 3, 2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5(a)#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000162828017012730/s-1exhibit104a.htm">2011 Stock Incentive Plan, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 28, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5(b)#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000162828017012730/s-1exhibit104b.htm">Amendment to 2011 Stock Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 28, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5(c)#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000162828017012730/s-1exhibit104c.htm">Form of Stock Option Agreement under 2011 Stock Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 28, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5(d)#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000162828017012730/s-1exhibit104d.htm">Form of Immediately Exercisable Stock Option Agreement under 2011 Stock Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 28, 2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1606645/000117891315003105/exhibit_10-2.htm">2015 Israeli Share Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-36621</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 21, 2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.7(a)#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1566044/000162828018000299/s-1a1exhibit105a.htm">2018 Omnibus Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 12, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.7(b)#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000162828018000299/s-1a1exhibit105b.htm">Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 12, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.7(c)#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001566044/000156604421000010/a1011c-formofrsuagreement2.htm">Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.11(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 4, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.8(a)#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex10-5.htm">2019 Equity Incentive Plan. </a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 11, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.8(b)#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex10-8.htm">Form of Share Option Grant Notice and Option Agreement under the 2019 Equity Incentive Plan for U.S. and Israeli Employees.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 11, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.8(c)#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex10-9.htm">Form of Restricted Share Unit Grant Notice and Restricted Share Unit Award Agreement under the 2019 Equity Incentive Plan for U.S. and Israeli Employees.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 11, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.9#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex10-10.htm">2019 Employee Share Purchase Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 11, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.10#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex10-13.htm">Offer Letter, dated as of March 25, 2020, by and between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex10-13.htm">VYNE</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex10-13.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex10-13.htm">Pharmaceuticals</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1566044/000110465920059152/tm2015937d1_ex10-13.htm"> Inc. and David Domzalski</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 11, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.11#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1566044/000156604421000025/exhibit102harsch-vyneemplo.htm">Offer Letter, dated as of April 7, 2021, by and between VYNE Pharmaceuticals Inc. and Mutya Harsch.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-38356</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 6, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.12#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit1012-stuartexecut.htm">Offer Letter, dated as of March 7, 2022, by and between VYNE Pharmaceuticals Inc. and Iain Stuart.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.13#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit1013-zerondaxexec.htm">Offer Letter, dated as of March 15, 2022, by and between VYNE Pharmaceuticals Inc. and Tyler Zeronda</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit211listofsubsidiari.htm">List of Subsidiaries of VYNE Therapeutics Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit231consentus2.htm">Consent of independent registered public accounting firm.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="vyne-20211231xexx311.htm">Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="vyne-20211231xexx312.htm">Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="vyne-20211231xexx321.htm">Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="vyne-20211231xexx322.htm">Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Definition Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Label Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data Filed (embedded within the XBRL document)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Exhibits and schedules omitted pursuant to Item 601(a)(5) of Regulation S-K. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224; Portions of this exhibit have been omitted in accordance with Item 601(b)(10)(iv) of Regulation S-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"># Indicates management contract or compensatory plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** These certifications are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing</span></div><div id="i3ee2f3590755456d8887827db5ee11c4_208"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16 - FORM 10-K SUMMARY</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="i3ee2f3590755456d8887827db5ee11c4_211"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i3ee2f3590755456d8887827db5ee11c4_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated:  March&#160;17, 2022</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VYNE Therapeutics Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David Domzalski</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Domzalski</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL MEN AND WOMEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David Domzalski and Tyler Zeronda, and each of them, his or her attorney-in-fact and agent, each with the power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the U.S. Securities and Exchange Commission, hereby ratifying and confirming all that said attorneys-in-fact, or his or her or their substitute or substitutes, may do or cause to be done by virtue thereof.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.306%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ David Domzalski</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director and Chief Executive Officer (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Executive Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 17, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David Domzalski</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Tyler Zeronda</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Financial Officer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Accounting Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 17, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tyler Zeronda</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Sharon Barbari</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 17, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sharon Barbari</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Steven Basta</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 17, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Steven Basta</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Anthony Bruno</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 17, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anthony Bruno</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Patrick LePore</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 17, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patrick LePore</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Elisabeth Sandoval</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 17, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elisabeth Sandoval</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:54pt;padding-right:54pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>exhibit31vynecertificateof.htm
<DESCRIPTION>EX-3.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6291ffd584e04bccb303463a4ad6a47c_1"></div><div style="min-height:51pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div style="margin-top:3.25pt;padding-left:22.2pt;padding-right:22.2pt;text-align:center"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MENLO THERAPEUTICS INC.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:21.82pt;padding-right:21.82pt;text-align:center"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:28.65pt;text-indent:-0.1pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">Menlo Therapeutics Inc., a corporation organized and </font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">e</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">xisting under and by virtue of the D</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">e</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">laware Gen</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">e</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">ral Corporatio</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">n </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">L</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">aw</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">, hereby certifies as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:28.7pt;text-indent:-0.25pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:153%">The name of the corporation is Menlo Therapeutics Inc. The original Certificate of Incorporation of th</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:153%">e </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:153%">corporation </font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:153%">w</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:153%">a</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:153%">s </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:153%">filed with the Secretary of State of the State of Delaware on October 21</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:153%">, </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:153%">2011 under the name Tigercat Pharma, Inc.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:29.15pt;text-indent:-0.7pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">The Amended and Restated Certificate of I</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">n</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">corporation in the form of </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%;text-decoration:underline">Exhibit A</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%"> attached he</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">re</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">t</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">o </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">has been dul</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">y </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">adopted in accordance with the provisions of Sections 242,245 and 228 of the Delaware General Corporation L</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">a</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">w.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:29.15pt;padding-right:10.15pt;text-align:justify;text-indent:-0.7pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">The text of the Amend</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">e</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">d and Restated Certificate of Incorporation as heretofore amend</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">e</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">d or suppl</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">e</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">me</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">n</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">ted is h</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">e</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">r</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">e</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">b</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">y </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">r</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">es</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">t</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">a</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">t</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">e</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">d and further amended to read in its entirety as set forth in </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%;text-decoration:underline">Exhibit A</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%"> attached he</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">r</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">eto. The Amended and Restated Certificate of Incorpo</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">r</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">ation shall be effective as of9&#58;00 a.m. </font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">E</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">astern Time on January 29, 201</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">8</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:28.55pt;padding-right:10.4pt;text-align:justify;text-indent:0.7pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%">IN WITNESS WHEREOF, </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">this Amended and Restated Certificate of Incorpo</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">ra</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">tion has be</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">e</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">n </font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">s</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">igned this d</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">a</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">y of January </font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">2</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">6</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">, </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">2018.</font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:359.8pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MENLO THERAPEUTICS INC.</font></div><div style="margin-top:3pt;padding-left:380.35pt;padding-right:58.15pt;text-indent:-20.9pt"><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:160%">B</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:160%">y&#58; </font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:160%;text-decoration:underline">Isl </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:160%;text-decoration:underline">S</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:160%;text-decoration:underline">t</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:160%;text-decoration:underline">even </font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:160%;text-decoration:underline">L</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:160%;text-decoration:underline">. </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:160%;text-decoration:underline">Bas</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:160%;text-decoration:underline">t</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:160%;text-decoration:underline">a</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:160%"> </font></div><div style="padding-right:58.15pt;text-indent:378pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ste</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">v</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">en L</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basta</font></div><div style="padding-left:380.4pt;text-indent:-4.5pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:102%"> President and Chief Ex</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:102%">ec</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:102%">u</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:102%">t</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:102%">iv</font><font style="color:#211f28;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:102%">e </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:102%">Officer</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:229.37pt;padding-right:229.37pt;text-align:center;text-indent:-0.5pt"><font style="color:#080808;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:122%">1</font></div><div><font style="color:#383642;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:51pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div><font><br></font></div><div style="margin-top:3.4pt;padding-left:22.62pt;padding-right:22.62pt;text-align:center"><font><br></font></div><div style="padding-left:5.59pt;padding-right:5.59pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:174.6pt;padding-right:174.6pt;text-align:center;text-indent:-1.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MENLO THERAPEUTICS INC.</font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:244.07pt;padding-right:244.07pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:149%;text-decoration:underline">ARTICLE I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:149%"> NAME</font></div><div><font><br></font></div><div style="padding-left:28.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The name of the corporation is Menlo Therapeutics Inc. (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#34;Corporation&#34;).</font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:181.92pt;padding-right:181.92pt;text-align:center;text-indent:56pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:149%;text-decoration:underline">ARTICLE II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:149%"> </font></div><div style="padding-left:83.16pt;padding-right:83.16pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">REGISTERED OFFICE AND AGENT</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:29.1pt;text-indent:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:149%">The address of the Corporation's registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, 19801. The name of its registered agent at such address is The Corporation Trust Company.</font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:200.57pt;padding-right:200.57pt;text-align:center;text-indent:33.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%;text-decoration:underline">ARTICLE III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%"> </font></div><div style="padding-left:91.74pt;padding-right:91.74pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PURPOSE AND DURATION</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:29.3pt;text-indent:-0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may be organized under the Delaware General Corporation Law. The Corporation is to have a perpetual existence.</font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:229.4pt;padding-right:229.4pt;text-align:center;text-indent:0.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:149%;text-decoration:underline">ARTICLE IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:149%"> CAPITAL STOCK</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:28.85pt;padding-right:8.65pt;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:147%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:147%">This Corporation is authorized to issue two classes of capital stock which shall be designated, respectively, &#34;Common Stock&#34; and &#34;Preferred Stock.&#34; The total number of shares that the Corporation is authorized to issue is 320,000,000, of which 300,000,000 shares shall be Common Stock and 20,000,000 shares shall be Preferred Stock. The Common Stock shall have a par value of $0.0001 per share and the Preferred Stock shall have a par value of $0.0001 per share. Subject to the rights of the holders of any series of Preferred Stock, the number of authorized shares of any of the Common Stock or Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority in voting power of the stock of the Corporation with the power to vote thereon irrespective of the provisions of Section 242(b)(2) of the Delaware General Corporation Law or any successor provision thereof, and no vote of the holders of any of the Common Stock or Preferred Stock voting separately as a class shall be required therefor.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:29pt;padding-right:9.95pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:146%">Section 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:146%">Shares of Preferred Stock may be issued from time to time in one or more series. The Board of Directors of the Corporation (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:146%">&#34;Board of Directors&#34;) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:146%">is hereby authorized to provide from time to time by resolution or resolutions for the creation and issuance, out of the authorized and unissued shares of Preferred Stock, of one or more series of Preferred Stock by filing a certificate (a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:146%">&#34;Certificate of Designation&#34;) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:146%">pursuant to the Delaware General Corporation Law, setting forth such resolution and, with respect to each such series, establishing the designation of such series and the number of shares to be included in such series and fixing the voting powers (full or limited, or no voting power), preferences and relative, participating, optional or other special rights, and the qualifications, limitations and restrictions thereof, of the shares of each such series. Without limiting the generality of the foregoing, the resolution or resolutions providing for the establishment of</font></div><div style="margin-top:3.1pt;padding-left:28.95pt;padding-right:8.65pt;text-indent:0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">any series of Preferred Stock may, to the extent permitted by law, provide that such series shall be superior to, rank equally with or be junior to the Preferred Stock of any other series. The powers, preferences and relative, participating, optional and other special rights of each series of Preferred Stock, and the qualifications, limitations or restrictions thereof, if any, may be different from those of any and all other series at any time outstanding. Except as otherwise expressly provided in the resolution or resolutions providing for the establishment of any series of Preferred Stock, no vote of the holders of shares of Preferred Stock or Common Stock shall be a prerequisite to the issuance of any shares of any series of the Preferred Stock so authorized in accordance with this Amended and Restated Certificate of Incorporation. Unless otherwise provided in the </font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:51pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div style="margin-top:3.1pt;padding-left:28.95pt;padding-right:8.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Certificate of Designation establishing a series of Preferred Stock, the Board of Directors may, by resolution or resolutions, increase or decrease (but not below the number of shares of such series then outstanding) the number of shares of such series and, if the number of shares of such series shall be so decreased, the shares constituting such decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:27.9pt;padding-right:5.3pt;text-align:justify;text-indent:1.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:161%">Section 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">At the effective time (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:161%">&#34;Effective Time&#34;) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">of this Amended and Restated Certificate of Incorporation (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:161%">&#34;Certificate of Incorporation&#34;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">each one (I) share of Series A Preferred (as defined in the Amended and Restated Certificate of Incorporation) shall, automatically and without further action by any stockholder, be converted into 0.37071362 shares of Common Stock&#59; each one ( l) share of Series B Preferred (as defined in the Amended and Restated Certificate of Incorporation) shall, automatically and without further action by any stockholder, be converted into 0.37071362 shares of Common Stock&#59; and each one (I) share of Series C Preferred (as defined in the Amended and Restated Certificate of Incorporation, and, together with the Series A Preferred, the Series B Preferred and the Series C Preferred, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:161%">&#34;Prior Preferred Stock&#34;) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">shall, automatically and without further action by any stockholder, be converted into 0.37071362 shares of Common Stock (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:161%">&#34;Conversion&#34;). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">Each stock certificate representing shares of Prior Preferred Stock immediately prior to the Effective Time shall, from and after the Effective Time, represent that number of shares of Common Stock into which such shares shall have been reclassified pursuant to the Conversion&#59; provided, however, that each holder of any stock certificate(s) that represented shares of Prior Preferred Stock immediately prior to the Effective Time shall be entitled to receive, upon surrender of such certificate(s), one or more certificates (or book entry shares) evidencing and representing the number of shares of Common Stock into which the shares represented by such certificate(s) shall have been reclassified pursuant to the Conversion. No fractional shares shall be issued for shares of Prior Preferred Stock pursuant to the Conversion. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:161%">If </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">the Conversion would result in the issuance of any fractional share of Common Stock, the Corporation shall,  in lieu of issuing any such fractional share, pay cash in an amount equal to the fair value of such fractional share (as determined in good faith by the Corporation's Board of Directors).</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:211.47pt;padding-right:211.47pt;text-align:center;text-indent:29.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:149%;text-decoration:underline">ARTICLE V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:149%"> </font></div><div style="padding-left:99.05pt;padding-right:99.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BOARD OF DIRECTORS</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:28.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the management of the business and for the conduct of the affairs of the Corporation it is further provided that&#58;</font></div><div style="margin-top:8.8pt;padding-left:28.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Section 1.</font></div><div style="margin-top:8.45pt;padding-left:28.95pt;padding-right:9.15pt;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:140%">(a)&#160;&#160;&#160;&#160;The management of the business and the conduct of the affairs of the Corporation shall be vested in the Board of Directors. The number of directors which shall constitute the whole Board of Directors shall be fixed exclusively by one or more resolutions adopted from time to time by the Board of Directors. Except as otherwise expressly delegated by resolution of the Board of Directors, the Board of Directors shall have the exclusive power and authority to appoint and remove officers of the Corporation.</font></div><div style="padding-right:9.15pt"><font><br></font></div><div style="padding-left:28.95pt;padding-right:9.65pt;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">(b)&#160;&#160;&#160;&#160;Other than any directors elected by the separate vote of the holders of one or more series of Preferred Stock, the Board of Directors shall be and is divided into three classes, designated as Class I, Class II and Class III, as nearly equal in number as</font></div><div style="margin-top:3.6pt;padding-left:28.75pt;padding-right:8.6pt;text-indent:0.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:147%">possible. Directors shall be assigned to each class in accordance with a resolution or resolutions adopted by the Board of Directors. At the first annual meeting of stockholders following the effectiveness of this Amended and Restated Certificate of Incorporation (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:147%">&#34;Qualifying Record Date&#34;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:147%">the term of office of the Class I directors shall expire and Class I directors shall be elected for a full term of three years. At the second annual meeting of stockholders following the Qualifying Record Date, the term of office of the Class II directors shall expire and Class II directors shall be elected for a full term of three years. At the third annual meeting of stockholders following the Qualifying Record Date, the term of office of the Class III directors shall expire and Class III directors shall be elected for a full term of three years. Subject to the special rights of the holders of one or more series of Preferred Stock to elect directors, at each succeeding annual meeting of stockholders, directors shall be elected for a full term of three years to succeed the directors of the class whose terms expire at such annual meeting.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:51pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div style="padding-left:29pt;padding-right:8.2pt;text-align:justify;text-indent:0.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">Notwithstanding the foregoing provisions of this Article </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:145%">V, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">Section l(b), each director shall serve until his or her successor is duly elected and qualified or until his or her earlier death, resignation, disqualification, retirement or removal. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director.</font></div><div style="margin-top:6.1pt;padding-left:28.95pt;padding-right:16.8pt;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:147%">(c)&#160;&#160;&#160;&#160;Subject to the special rights of the holders of one or more series of Preferred Stock to elect directors, the Board of Directors or any individual director may be removed from office at any time, but only for cause and only by the affirmative vote of the holders of sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all the then outstanding shares of voting stock of the Corporation with the power to vote at an election of directors (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:147%">&#34;Voting Stock&#34;).</font></div><div style="padding-right:16.8pt"><font><br></font></div><div style="padding-left:28.9pt;padding-right:5.7pt;text-indent:0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">(d)&#160;&#160;&#160;&#160;Subject to the special rights of the holders of one or more series of Preferred Stock to elect directors, any vacancies on the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:145%">Board of Directors resulting from death, resignation, disqualification, retirement, removal or other causes and any newly</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:145%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">created directorships resulting from any increase in the number of directors shall, unless the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by the stockholders, and except as otherwise provided by law, be filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum, or by a sole remaining director, and shall not be filled by the stockholders. Any director appointed in accordance with the preceding sentence shall hold office for a term that shall coincide with the remaining term of the class to which the director shall have been appointed and until such director's successor shall have been elected and qualified or until his or her </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:145%">earlier death, resignation, disqualification, retirement or removal.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:29pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Section 2.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:28.95pt;padding-right:12.8pt;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:147%">(a)&#160;&#160;&#160;&#160;In furtherance and not in limitation of the powers conferred by statute, the Board of Directors is expressly authorized to make, alter or repeal Bylaws of the Corporation. In addition to any vote of the holders of any class or series of stock of the Corporation required by applicable law or by this Amended and Restated Certificate of incorporation (including any Certificate of Designation in respect of one or more series of Preferred Stock), the adoption, amendment or repeal of the Bylaws of the Corporation by the stockholders of the Corporation shall require the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all the then-outstanding shares of the Voting Stock, voting together as a single class.</font></div><div style="margin-top:5.65pt;padding-left:42.9pt;text-indent:-13.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The directors of the Corporation need not be elected by written ballot unless the Bylaws so provide.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:228.3pt;padding-right:228.3pt;text-align:center;text-indent:-0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:153%;text-decoration:underline">ARTICLE VI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:153%"> STOCKHOLDERS</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:29pt;padding-right:6.4pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">Subject to the special rights of the holders of one or more series of Preferred Stock, any action required  or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of the stockholders of the Corporation, and the taking of any action by written consent of the stockholders in lieu of a meeting of</font></div><div style="margin-top:0.5pt;padding-left:29pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the stockholders is specifically denied.</font></div><div><font><br></font></div><div style="margin-top:3.6pt;padding-left:29pt;padding-right:8.65pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:147%">Section 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:147%">Subject to the special rights of the holders of one or more series of Preferred Stock, special meetings of the stockholders of the Corporation may be called, for any purpose or purposes, at any time by the Board of Directors, chairperson of the Board of Directors, chief executive officer or president (in the absence of a chief executive officer), but such special meetings may not be called by stockholders or any other person or persons.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:29pt;padding-right:8.65pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%">Section 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">Advance notice of stockholder nominations for the election of directors and of other business proposed to be brought by stockholders before any meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws of the Corporation.</font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:22.52pt;padding-right:22.52pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE VII</font></div><div style="margin-top:3.15pt;padding-left:23pt;padding-right:23pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIABILITY AND INDEMNIFICATION</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:28.95pt;padding-right:9.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:146%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:146%">To the fullest extent permitted by the Delaware General Corporation Law, as the same exists or as may hereafter be amended, a director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director. If the Delaware General Corporation Law is amended after approval by the stockholders of this Article VII to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law as so amended, automatically and without further action, upon the date of such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:146%">amendment.</font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:51pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:28.75pt;padding-right:11.1pt;text-indent:0.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:143%">Section 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">The Corporation, to the fullest extent permitted  by law, shall indemnify  and  advance  expenses  to  any person  made </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:143%">or  threatened to be made a party to an action, suit or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that he or she, or his or her testator or intestate, is or was a director or officer of the Corporation or any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:143%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:143%">predecessor of the Corporation, or serves  or served  at  any other enterprise as a director or officer at the request  of the Corporation or any predecessor to the Corporation.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:28.75pt;padding-right:12.55pt;text-indent:0.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:144%">Section 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">The Corporation, to the fullest extent permitted  by law, may indemnify  and  advance  expenses to  any person  made  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">or threatened to be made a party to an action, suit or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that he or she, or his or her testator or intestate, is or was an employee or agent of the Corporation or any</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:144%">predecessor of the Corporation, or serves or served at any other enterprise as an employee or agent at the request of the Corporation or any predecessor to the Corporation.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:29.05pt;padding-right:6.4pt;text-indent:-0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%">Section 4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:145%">Neither any amendment nor repeal of this Article VII, nor the adoption by amendment of this certificate of incorporation of any provision inconsistent with this Article VII, shall eliminate or reduce the effect of this Article VII in respect of any matter occurring, or any action or proceeding accruing or arising (or that, but for this Article VII, would accrue </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:145%">or arise) prior to such amendment or repeal or adoption of an inconsistent provision.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:220.57pt;padding-right:220.57pt;text-align:center;text-indent:0.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%;text-decoration:underline">ARTICLE VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%"> EXCLUSIVE FORUM</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:28.95pt;padding-right:11.1pt;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:146%">Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall, to the fullest extent permitted by law, be the sole and exclusive forum for (I) any derivative action or proceeding brought on behalf of the Corporation, (2) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation's stockholders, (3) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, this Amended and Restated Certificate of Incorporation or the Bylaws, or (4) any action asserting a claim governed by the internal affairs doctrine. Any person or entity purchasing or otherwise acquiring or holding any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Article VIII.</font></div><div style="padding-right:11.1pt"><font><br></font></div><div style="margin-top:3.6pt;padding-left:233.62pt;padding-right:233.62pt;text-align:center;text-indent:0.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%;text-decoration:underline">ARTICLE IX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:145%"> AMENDMENTS</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:29pt;padding-right:8.65pt;text-indent:0.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:147%">Notwithstanding any other provisions of this Amended and Restated Certificate of Incorporation or any provision of law which might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of the Voting Stock required by law or by this Amended and Restated Certificate of Incorporation (including any Certificate of Designation in respect of one or more series of Preferred Stock), the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all of the then-outstanding shares of the Voting Stock, voting together as a single class, shall be required to alter, amend or repeal Articles V, VI, VII and VIII and this Article IX.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:22.75pt;padding-right:22.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">* * * *</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.35pt;padding-left:28.35pt;padding-right:28.35pt;text-align:center"><font><br></font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:51pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div style="margin-top:4.35pt;padding-left:28.35pt;padding-right:28.35pt;text-align:center"><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:108%">STATE OF DELAWARE</font></div><div style="padding-left:28.82pt;padding-right:28.82pt;text-align:center"><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:105%">CERTIFICATE OF CHANGE OF REGISTERED AGENT</font></div><div style="padding-left:28.4pt;padding-right:28.4pt;text-align:center"><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:115%">AND&#47;OR </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:115%">REGISTERED </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:400;line-height:115%">OFFICE</font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:82.8pt;padding-right:49.8pt;text-indent:-0.35pt"><font style="color:#0c0c0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">The </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">follows&#58;</font></div><div style="margin-top:11.3pt;padding-left:83.7pt"><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">L&#160;&#160;&#160;&#160;The name </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the corporation is&#160;&#160;&#160;&#160;</font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">MENLO THERAPEUTICS INC.</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    _________________________________________________________________________</font></div><div style="margin-top:11.4pt;padding-left:116.05pt;text-indent:-33.1pt"><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">2.&#160;&#160;&#160;&#160;The Registered Office of the </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">corporation </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">in the State of Delaware is changed to</font></div><div style="padding-left:83.55pt"><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%;text-decoration:underline">3411 Silverside Road   Tatnall Building </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%;text-decoration:underline">#1</font><font style="color:#0c0c0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%;text-decoration:underline">04 </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">(street), </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">in the </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">City </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">of </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%;text-decoration:underline">Wilmington, </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">County of </font><font style="color:#0c0c0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%;text-decoration:underline">New  </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%;text-decoration:underline">Castle</font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%"> </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Zip Code </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%;text-decoration:underline">19810</font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">. The name of the Registered Agent at </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">such </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">address </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">upon </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">whom process </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">against </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">this Corporation may be </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">served is </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%;text-decoration:underline">United Agent Group Inc.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:115.7pt;text-indent:-33.7pt"><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">foregoing </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">change to the registered office</font><font style="color:#4b484b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;age</font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">nt was adopted by a resolution of</font></div><div style="padding-left:82.05pt"><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">the Board of Directors </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">of </font><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">the </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">corporation.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="text-indent:270pt"><font style="color:#211f21;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By</font><font style="color:#4b484b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; S. Djidji</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:256.2pt"><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Name&#58;</font><font style="color:#5b595b;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline"> </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">S </font><font style="color:#0c0c0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">.</font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Djidji,</font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Special</font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font><font style="color:#343336;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Secretary</font></div><div style="padding-left:340.7pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:51pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CERTIFICATE OF AMENDMENT</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TO THE</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MENLO THERAPEUTICS INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________________________________________________________________</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to Section 242 of</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the General Corporation Law of the</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">State of Delaware</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________________________________________________________________</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MENLO THERAPEUTICS INC., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the &#8220;Corporation&#8221;), does hereby certify as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FIRST&#58;  Upon the filing and effectiveness (the &#8220;Effective Time&#8221;) pursuant to the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;) of this Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Corporation, Article I of the Corporation&#8217;s Amended and Restated Certificate of Incorporation relating to the Corporation&#8217;s name is hereby amended to read in its entirety as set forth below&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The name of the corporation is VYNE Therapeutics Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECOND&#58;  This Certificate of Amendment shall become effective as of September 4, 2020 at 5&#58;00 p.m. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THIRD&#58;  This Certificate of Amendment was duly adopted in accordance with Section 242 of the DGCL.  The Board of Directors duly adopted resolutions setting forth and declaring advisable this Certificate of Amendment. </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly executed in its corporate name as of the 4th day of September, 2020.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MENLO THERAPEUTICS INC.</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">By&#58; &#47;s&#47; David Domzalski</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">               </font></div><div style="margin-bottom:0.24pt;padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58;  David Domzalski</font></div><div style="margin-bottom:0.24pt;padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;    President and Chief Executive Officer </font></div><div><font><br></font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:51pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CERTIFICATE OF AMENDMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> TO THE </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> OF </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">VYNE THERAPEUTICS INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">______________________________________________________________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Pursuant to Section 242 of </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">the General Corporation Law of the</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> State of Delaware</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">______________________________________________________________________________</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">VYNE THERAPEUTICS INC., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the &#8220;Corporation&#8221;), does hereby certify as follows&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">FIRST&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Upon the filing and effectiveness (the &#8220;Effective Time&#8221;) pursuant to the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;) of this Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Corporation, each four (4) shares of the Corporation&#8217;s Common Stock, par value $0.0001 per share, issued and outstanding immediately prior to the Effective Time shall automatically be combined into one (1) validly issued, fully paid and non-assessable share of Common Stock without any further action by the Corporation or the holder thereof, subject to the treatment of fractional share interests as described below (the &#8220;Reverse Stock Split&#8221;). No fractional shares shall be issued at the Effective Time and, in lieu thereof, the Corporation&#8217;s transfer agent shall aggregate all fractional shares and sell them as soon as practicable after the Effective Time at the then-prevailing prices on the open market, on behalf of those stockholders who would otherwise be entitled to receive a fractional share, and after the transfer agent&#8217;s completion of such sale, stockholders shall receive a cash payment (without interest or deduction) from the transfer agent in an amount equal to their respective pro rata shares of the total net proceeds of that sale and, to the extent shares are held in certificated form, upon the surrender of the stockholder&#8217;s Old Certificates (as defined below). Each certificate that immediately prior to the Effective Time represented shares of Common Stock (&#8220;Old Certificates&#8221;), shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been combined, subject to the elimination of fractional share interests as described above. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">SECOND&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Upon the Effective Time, Section 1 of Article IV of the Corporation&#8217;s Amended and Restated Certificate of Incorporation, relating to the capital structure of the Corporation, is hereby amended to read in its entirety as set forth below&#58; </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Section 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Corporation is authorized to issue two classes of capital stock which shall be designated, respectively, &#8220;Common Stock&#8221; and &#8220;Preferred Stock.&#8221; The total number of shares that the Corporation is authorized to issue is 95,000,000, of which 75,000,000 shares shall be Common Stock and 20,000,000 shares shall be Preferred Stock. The Common Stock shall have a par value of $0.0001 per share and the Preferred Stock shall have a par value of $0.0001 per share. Subject to the rights of the holders of any series of Preferred Stock, the number of authorized shares of any of the Common Stock or Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority in voting power of the stock of the Corporation with the power to vote thereon irrespective of the provisions of Section 242(b)(2) of the Delaware General Corporation Law or any successor provision thereof, and no vote of the holders of any of the Common Stock or Preferred Stock voting separately as a class shall be required therefor.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">THIRD&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Certificate of Amendment shall become effective as of February 12, 2021 at 5&#58;00 p.m. Eastern Time.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">FOURTH&#58;  This Certificate of Amendment was duly adopted in accordance with Section 242 of the DGCL.  The Board of Directors duly adopted resolutions setting forth and declaring advisable this Certificate of Amendment and directed that the Reverse Stock Split and corresponding reduction of the number of authorized shares of the Corporation&#8217;s Common Stock be considered by the stockholders of the Corporation.  An annual meeting of stockholders was duly called upon notice in accordance with Section 222 of the DGCL and held on August 3, 2020, at which meeting the necessary number of shares were voted in favor of the Reverse Stock Split and corresponding reduction of the number of authorized shares of the Corporation&#8217;s Common Stock. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly executed in its corporate name as of the 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> day of February, 2021.</font></div><div><font><br></font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:51pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">VYNE THERAPEUTICS INC.</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">By&#58;      &#47;s&#47; David Domzalski</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"> </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;  David Domzalski</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Title&#58; Chief Executive Officer </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:51pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 3.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:109%">CERTIFICATE OF AMENDMENT </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:109%">TO THE </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:109%">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:109%">OF </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:109%">VYNE THERAPEUTICS INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%"> </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">Pursuant to Section 242 of </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">the General Corporation Law of the </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">State of Delaware </font></div><div><font><br></font></div><div style="text-indent:20pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">VYNE THERAPEUTICS INC., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the &#8220;Corporation&#8221;), does hereby certify as follows&#58; </font></div><div style="text-indent:20pt"><font><br></font></div><div style="text-indent:20pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">FIRST&#58;    Upon the filing and effectiveness (the &#8220;Effective Time&#8221;) pursuant to the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;) of this Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Corporation, Section 1 of Article IV of the Corporation&#8217;s Amended and Restated Certificate of Incorporation, relating to the capital structure of the Corporation, is hereby amended to read in its entirety as set forth below&#58; </font></div><div style="text-indent:20pt"><font><br></font></div><div style="text-indent:20.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:109%">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">    This Corporation is authorized to issue two classes of capital stock which shall be designated, respectively, &#8220;Common Stock&#8221; and &#8220;Preferred Stock.&#8221; The total number of shares that the Corporation is authorized to issue is 170,000,000, of which 150,000,000 shares shall be Common Stock and 20,000,000 shares shall be Preferred Stock. The Common Stock shall have a par value of $0.0001 per share and the Preferred Stock shall have a par value of $0.0001 per share. Subject to the rights of the holders of any series of Preferred Stock, the number of authorized shares of any of the Common Stock or Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority in voting power of the stock of the Corporation with the power to vote thereon irrespective of the provisions of Section 242(b)(2) of the Delaware General Corporation Law or any successor provision thereof, and no vote of the holders of any of the Common Stock or Preferred Stock voting separately as a class shall be required therefor. </font></div><div style="text-indent:20.15pt"><font><br></font></div><div style="text-indent:20pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">THIRD&#58;    This Certificate of Amendment shall become effective as of July 19, 2021 at 5&#58;00 p.m. </font></div><div style="text-indent:20pt"><font><br></font></div><div style="text-indent:20pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">FOURTH&#58;    This Certificate of Amendment was duly adopted in accordance with Section 242 of the DGCL. The Board of Directors duly adopted resolutions setting forth and declaring advisable this Certificate of Amendment and directed that the proposed amendments be considered by the stockholders of the Corporation. An annual meeting of stockholders was duly called upon notice in accordance with Section 222 of the DGCL and held on July 19, 2021, at which meeting the necessary number of shares were voted in favor of the proposed amendments. The stockholders of the Corporation duly adopted this Certificate of Amendment. </font></div><div style="text-indent:20pt"><font><br></font></div><div style="text-indent:20pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:109%">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly executed in its corporate name as of the 19th day of July, 2021. </font></div><div style="text-indent:216pt"><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">VYNE THERAPEUTICS INC.</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">By&#58;      &#47;s&#47; David Domzalski</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline"> </font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name&#58;  David Domzalski</font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Title&#58; Chief Executive Officer </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="height:14pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.12
<SEQUENCE>3
<FILENAME>exhibit412.htm
<DESCRIPTION>EX-4.12
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6ad03598e8e94ac88ee35157d7c1d5ec_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 4.1</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">As of December 31, 2021, VYNE Therapeutics Inc. (the &#8220;Company&#8221;) had common stock, $0.0001 par value per share, registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and listed on The Nasdaq Global Market under the trading symbol &#8220;VYNE.&#8221;</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">DESCRIPTION OF CAPITAL STOCK</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">The following summary describes our capital stock and the material provisions of our amended and restated certificate of incorporation, our amended and restated bylaws and of the Delaware General Corporation Law. Because the following is only a summary, it does not contain all of the information that may be important to you. For a complete description, you should refer to our amended and restated certificate of incorporation and amended and restated bylaws, copies of which are incorporated by reference as Exhibits 3.1 and 3.2, respectively, to our Annual Report on Form 10-K.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">General</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Our amended and restated certificate of incorporation authorizes 150,000,000 shares of common stock, $0.0001 par value per share, and 20,000,000 shares of preferred stock, $0.0001 par value per share.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Common Stock</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Voting Rights</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Each holder of our common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Our stockholders do not have cumulative voting rights in the election of directors. Accordingly, holders of a majority of the voting shares are able to elect all of the directors. In addition, the affirmative vote of holders of 66-2&#47;3% of the voting power of all of the then outstanding voting stock will be required to take certain actions, including amending certain provisions of our amended and restated certificate of incorporation, such as the provisions relating to amending our amended and restated bylaws, procedures for our stockholder meetings, the classified board, director liability, and exclusive forum for proceedings.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Dividends</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Liquidation</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then outstanding shares of preferred stock.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Rights and Preferences </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Holders of our common stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may designate in the future.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Forum for Securities Litigation</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Our amended and restated bylaws provide that, unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States of America will be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Preferred Stock</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Our board of directors has the authority, without further action by our stockholders, to issue up to 20,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of common stock. The issuance of our preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our company or other corporate action.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Anti-Takeover Effects of Provisions of our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws and Delaware Law</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Some provisions of Delaware law and our amended and restated certificate of incorporation and our amended and restated bylaws contain provisions that could make the following transactions more difficult&#58; acquisition of us by means of a tender offer&#59; acquisition of us by means of a proxy contest or otherwise&#59; or removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions that might result in a premium over the market price for our shares.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Delaware Anti-Takeover Statute</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">We are subject to Section 203 of the Delaware General Corporation Law, which prohibits persons deemed &#8220;interested stockholders&#8221; from engaging in a &#8220;business combination&#8221; with a publicly-held Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation&#8217;s voting stock. Generally, a &#8220;business combination&#8221; includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this provision may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors, such as discouraging takeover attempts that might result in a premium over the market price of our common stock.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Undesignated Preferred Stock</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">The ability to authorize undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of us. These and other provisions may have the effect of deterring hostile takeovers or delaying changes in control or management of our company.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Special Stockholder Meetings</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Our amended and restated bylaws provide that a special meeting of stockholders may be called by our board of directors, our President, our Chief Executive Officer, or the Secretary.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Requirements for Advance Notification of Stockholder Nominations and Proposals</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Our amended and restated bylaws include advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Elimination of Stockholder Action by Written Consent</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Our amended and restated certificate of incorporation and our amended and restated bylaws do not permit stockholders to act by written consent without a meeting.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Classified Board&#59; Election and Removal of Directors&#59; Filling Vacancies</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Our board of directors is divided into three classes. The directors in each class will serve for a three-year term, one class being elected each year by our stockholders, with staggered three-year terms. Only one class of directors will be elected at each annual meeting of our stockholders, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">with the other classes continuing for the remainder of their respective three-year terms. Because our stockholders do not have cumulative voting rights, our stockholders holding a majority of the shares of common stock outstanding will be able to elect all of our directors. Our amended and restated certificate of incorporation provides for the removal of any of our directors only for cause and requires a stockholder vote by the holders of at least a 66-2&#47;3% of the voting power of the then outstanding voting stock. Furthermore, any vacancy on our board of directors, however occurring, including a vacancy resulting from an increase in the size of the board, may only be filled by a resolution of the board of directors unless the board of directors determines that such vacancies shall be filled by the stockholders. This system of electing and removing directors and filling vacancies may tend to discourage a third party from making a tender offer or otherwise attempting to obtain control of us, because it generally makes it more difficult for stockholders to replace a majority of the directors.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Choice of Forum</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Our amended and restated certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the exclusive forum for&#58; any derivative action or proceeding brought on our behalf&#59; any action asserting a breach of fiduciary duty&#59; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws&#59; or any action asserting a claim against us that is governed by the internal affairs doctrine. Although our amended and restated certificate of incorporation contains the choice of forum provision described above, it is possible that a court could find that such a provision is inapplicable for a particular claim or action or that such provision is unenforceable.  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Amendment of Charter Provisions</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">The amendment of any of the above provisions, except for the provision making it possible for our board of directors to issue undesignated preferred stock, would require approval by a stockholder vote by the holders of at least a 66-2&#47;3% of the voting power of the then outstanding voting stock.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">The provisions of the Delaware General Corporation Law, our amended and restated certificate of incorporation and our amended and restated bylaws could have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions may also have the effect of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">Limitations of Liability and Indemnification</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Our amended and restated certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:13.8pt">any breach of the director&#8217;s duty of loyalty to us or our stockholders&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:13.8pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:13.8pt">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law&#59; or</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:13.8pt">any transaction from which the director derived an improper personal benefit.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Each of our amended and restated certificate of incorporation and amended and restated bylaws provides that we are required to indemnify our directors and officers, in each case, to the fullest extent permitted by Delaware law. Our amended and restated bylaws will also obligate us to advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under Delaware law. We have entered and expect to continue to enter into agreements to indemnify our directors, executive officers and other employees as determined by our board of directors. With specified exceptions, these agreements provide for indemnification for related expenses including, among other things, attorneys&#8217; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. We believe that these bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. We also maintain directors&#8217; and officers&#8217; liability insurance. The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and our stockholders. Further, a stockholder&#8217;s investment may be adversely affected to the extent that we pay the costs of settlement and damage.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>4
<FILENAME>exhibit1012-stuartexecut.htm
<DESCRIPTION>EX-10.12
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit1012-stuartexecut</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:965;"><!-- exhibit1012-stuartexecut001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut001.jpg" title="slide1" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807                 March 7, 2022    Dr. Iain Stuart    Dear Iain,    This letter (the &#8220;Offer Letter&#8221;) contains the terms and conditions of your employment with VYNE  Pharmaceuticals Inc. (the &#8220;Company&#8221;), a subsidiary of VYNE Therapeutics Inc. (&#8220;VYNE&#8221;), effective  as of March 7, 2022 (the &#8220;Effective Date&#8221;). The Company, together with its ultimate parent  and their respective affiliates and subsidiaries, are hereinafter referred to as the &#8220;Group Companies.&#8221;  Your employment pursuant  to  this  Offer  Let ter  will commence as of the Effective Date and  the terms and conditions of this Offer Letter shall be effective as of the Effective Date.  Unless  stated otherwise herein, this Offer Letter will supersede any prior offer letters between you and the  Company or any of its affiliates, including the letters dated September 4, 2016 and May 6, 2019 and  any amendments thereto (together, the &#8220;Previous Offer Letter&#8221;). You may be interchangeably  referred to as &#8220;you&#8221; or &#8220;the Executive&#8221; within this Offer Letter. Additionally, where the context  permits, references to &#8220;the Company&#8221; shall include the Company, its subsidiaries and affiliates and  any successor thereto.     Brief Description of Role, Reporting Structure and Major Responsibilities:      You will report to the Company&#8217;s President and Chief Executive Officer, David Domzalski.      The scope of the Chief Scientific Officer&#8217;s (CSO) role is formulating, directing and leading VYNE&#8217;s  overall scientific strategy and pharmaceutical research and development efforts. Specifically, the CSO  is specifically responsible for the following functional areas within VYNE:    &#8226; Clinical Development and Operations  &#8226; Non-Clinical Safety and Efficacy  &#8226; Pharmaceutical Development  &#8226; Medical Affairs and Medical Information  &#8226; Pharmacovigilance    Clinical Development    Provide oversight and input into the design, analysis, interpretation, reporting and presentation of  data from GCP clinical studies conducted to support research and development programs.     &#8226; Participates (or leads) project teams in providing clinical input and representation of the  medical function related to clinical development strategy and execution.   &#8226; Provide direction to the Clinical Development team in all areas of the development and  execution of a clinical program including:  &#8226; Clinical development plan creation  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut002.jpg" title="slide2" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         &#8226; Clinical study design  &#8226; Statistical analytical plans (SAPs)  &#8226; Clinical operations plans  &#8226; Data management plans  &#8226; Medical monitoring and safety plans  &#8226; Selection and management of CROs or other contractors  &#8226; Develops, maintains and expands collaborations with outside clinical investigators,  researchers and consultants to facilitate and provide guidance for the optimum performance  of clinical  &#8226; Key R&amp;D representative for regulatory agency interaction as required to forward the aims of  VYNE clinical development programs.     In addition, the CSO oversees:  &#8226; The development and management of clinical study budgets.  &#8226; The proposals process for new clinical study vendors.  &#8226; Data management activities to design study specific case report forms, edit checks, and  listings for data review.  &#8226; Provide functional review/approval for the development of GCP-compliant quality  system/standard operating procedures.    Non-Clinical Safety and Efficacy    Provide oversight and input into the design, analysis, interpretation, reporting and presentation of  data from non-GLP and GLP nonclinical studies (research models, ADME/PK, Safety Pharmacology  and Toxicology) conducted to support research and development programs.      &#8226; Approve appropriate nonclinical development plans supporting the clinical  development of VYNE R&amp;D projects.  &#8226; Ensure adequate staff and resourcing of non-clinical study support to development  teams (including budgeting, timing, interpretation, and reporting of all nonclinical  studies and assuring compliance with all appropriate regulatory guidance).  &#8226; Act as a point of contact for non-clinical CROs and consultants.  &#8226; Review and approve non-clinical sections of all regulatory submissions for  development projects and interact with regulatory agencies, as needed.  &#8226; Oversee the development of and operationalization of specific research models to  support early research program evaluation.      Medical Affairs and Medical Information    &#8226; Be the key owner of all medical affairs strategies and activities supporting VYNE  products/projects.  &#8226; Approve key medico-scientific messaging platforms for VYNE products/projects.  &#8226; Ensure the development and training of field deployment of the medical science liaison team.  &#8226; Be the key company liaison with subject matter scientific thought leaders within relevant  specialties of interest to VYNE.  &#8226; Ensure medical affairs provides accurate and timely medical/scientific review of  promotional/commercial materials as appropriate.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut003.jpg" title="slide3" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807       925825-NYCSR05A - MSW  &#8226; Represent R&amp;D in any due diligence activities relating to either in-licensing/acquisitions of  new products or out-licensing of VYNE technologies.  &#8226; Responsible for the strategic oversight and management of the medical information call  center via third party vendors.   &#8226; Develop rigorous, succinct and compliant medical information processes and ensure  adherence to such processes.   &#8226; Strong experience in managing and navigating within electronic data capture systems  relevant to medical information eg IRMS, VEEVA.   &#8226; Introduce insights generation capability within medical information.   &#8226; Serve as a key internal scientific resource and educator.   &#8226; Understand and implement industry leading technology solutions and multi-channel methods  of communications with HCPs and patients.   &#8226; Contribute to the development, review, and approval of medical information responses and  promotional materials.     Pharmaceutical Development    &#8226; Oversee the pharmaceutical development strategy for VYNE Therapeutics.  &#8226; Ensure that timely and adequate CMC supplies are available to support all VYNE  Therapeutics development projects.    Pharmacovigilance    &#8226; Develop a comprehensive pharmacovigilance program to monitor safety data from our  clinical development programs and approved products, including reports from Investigator- Initiated studies, Medical Affairs sponsored activities and review of safety information  reported in the literature.   &#8226; Identify and manage relevant vendors as appropriate to support both medical information and  pharmacovigilance activities.   &#8226; Direct pharmacovigilance activities through identification, communication and  documentation of new processes (e.g., quarterly data review meetings).   &#8226; Strong experience in managing and navigating within electronic data capture systems  relevant to drug safety eg ARISg PV.   &#8226; Participate in signal detection efforts of a structured surveillance program. This includes  collaboration with clinical development on regularly scheduled and ad-hoc reviews of  emerging safety data.   &#8226; Perform on-going evaluation of reports of suspected, unexpected and related serious adverse  drug reactions and provide analyses of similar events for incorporation into investigational  new drug safety reports for submission to relevant external bodies eg. FDA, IRBs.   &#8226; Lead the development of periodic safety reports and safety updates as required eg. IND  annual reports, investigator brochures, Day 120 safety updates, PADERs etc.   &#8226; Participate in the reconciliation of clinical and safety databases for on-going studies such as  overseeing the generation/resolution of SAE queries and MedDRA coding and data quality  reviews in collaboration with clinical CRO drug safety specialists and medical monitors.   &#8226; Work with medical writers, as needed, in the preparation of patient narratives and safety data  analyses for safety sections of Clinical Study Reports and summary documents   &#8226; Facilitate training of all relevant VYNE staff in pharmacovigilance case data collection and  reporting.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut004.jpg" title="slide4" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         Compensation    You will be paid a base salary at an annual rate of $$421,811, payable in accordance with the  Company&#8217;s payroll policies, less applicable deductions and employment taxes.  Currently, the  Company&#8217;s regular pay period is bi-monthly (the 15th and 30th of each month).     You will be eligible to receive a cash bonus of up to 40% of your base salary based on achievement of  milestones and targets set by the CEO, under the framework of the applicable bonus plan of the  Company for the relevant year.     The payment and grant of the cash bonus, if awarded, shall be made no later than March 15th of the  calendar year following the year to which the performance relates, upon evaluation of your  performance and the achievement of milestones and targets set for the performance year, and in  accordance with the then-current general bonus plan.  You must be employed by the Company on the  bonus payment date to be eligible to receive the bonus.    You will receive annual equity awards to acquire common stock in VYNE with a per share exercise  price for the options equal to the fair market value of one share of VYNE common stock on the grant  date. The annual equity grants are expected to be granted in March and will vest over a period of four  years following the last day of the calendar quarter in which the grant was made as follows: 25% on  the first anniversary of the vesting commencement date and 6.25% on the last day of each subsequent  calendar quarter, subject to your continued employment with VYNE or one of its subsidiaries through  the applicable vesting date.  Please note that such vesting period does not amount to an undertaking of  the Company or VYNE to employ you for any given period.  The equity grants shall be subject to the  execution of a share award agreement with VYNE and the terms and conditions of VYNE's 2019  Equity Incentive Plan, or VYNE's 2018 Omnibus Equity Incentive Plan, in each case, as may be  amended or amended and restated from time to time.     Consistent with its policies as established from time to time, the Company will also cover all  expenses directly related to your job performance, in accordance with the Company&#8217;s policies as in  effect from time to time.     You will be entitled to four  (4)  weeks of paid vacation.  These vacation days accrue ratably over  the calendar year and may not be carried forward from year to year or paid out at the termination of  employment, except as described below or if your state laws mandate this payout. You will be  entitled to participate in the Company&#8217;s healthcare plan, then in effect, or, at the Company&#8217;s  election, the Company may direct you to purchase an individual plan providing equivalent  coverage and will reimburse you for all premium payments under such individual plan, upon proof of  payment. All matters of eligibility under the Company&#8217;s plans will be determined solely by the  carriers providing such insurance.  You will continue to be eligible to participate in the Company&#8217;s  401(k) plan.      The Company will also recognize certain holidays. These dates are communicated each year by the  Company and may change based upon business needs.     Termination of Employment    Your employment with the Company is at-will and may be terminated by either you or the Company  at any time, with or without reason.      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut005.jpg" title="slide5" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         In the event of a termination for Cause (as defined on Appendix A) by the Company, your employment  will end immediately without notice and the Company and its subsidiaries and affiliates will have no  further liability towards you except for payment of (1) any earned but unpaid base salary, (2) any  incurred but unreimbursed business expenses and (3) any accrued but unused vacation days that exist  as of the date of your termination of employment to the extent mandated by state law (together, the  &#8220;Accrued Benefits&#8221;).    In the event of your death or the termination of your employment as a result of your disability (as  determined by the Company in good faith), the Company will have no further liability to you except  for payment of the Accrued Benefits through the date of your death or the first day of your disability.        You shall have the right to resign at any time by giving the Company thirty (30) days&#8217; notice of the  termination date, subject to the Company&#8217;s right, at its election, to reduce the duration of the notice  period upon notice to you, in which case the last day of the reduced notice period shall constitute your  employment termination date. The Company shall not have any further liability to you except for  payment of all Accrued Benefits due through the date of termination unless such resignation is for  Good Reason which shall be governed by the provisions below.    The Company may terminate your employment without Cause upon thirty (30) days&#8217; notice, during  which notice period you will receive your full compensation and benefits.     If your employment is terminated without Cause or you resign for Good Reason, subject to  your execution and non-revocation of a release of claims in a form acceptable to the Company  in its sole discretion within 55 days following your termination of employment, you will be  entitled to receive, in addition to the Accrued Benefits, a severance payment (the &#8220;Non-CIC  Severance Payment&#8221;) equal to the better of (A) three (3) months salary plus one (1) month  for every full year of your employment by a Group Company (up to a maximum of twelve  (12) months) or (B) (i) a severance payment in accordance with the terms set forth on  Appendix A to this Offer Letter (the &#8220;Severance Policy&#8221;) based on your then-current position  as set forth therein and (ii) if you qualify for and timely elect continuation coverage under the  Consolidated Omnibus Budget Reconciliation Act of 1985 (&#8220;COBRA&#8221;), continued payment by the  Company of monthly contributions in respect of your coverage under the Company&#8217;s healthcare plan  for the number of months following the date of termination as set forth in the Severance Policy, in an  amount equal to the contribution the Company would have made if you had continued to be an active  employee (assuming the applicable rates in effect as of the date of your termination of employment);  provided that, the Company&#8217;s obligations under this clause (ii) shall terminate on the earlier of (x) the  date on which you enroll in a group health plan offered by another employer and (y) the date on which  you are no longer eligible for continuation coverage under COBRA; provided further that,  notwithstanding the foregoing, in the event such Company contributions, may, in the Company&#8217;s  reasonable view, result in tax or other penalties on the Company, this provision shall terminate and the  parties shall, in good faith, negotiate for a substitute provision that provides substantially a similar  benefit to you but does not result in such tax or other penalties.    Notwithstanding the above, if you experience a Qualifying Termination within the twelve (12) month  period after a Change in Control (a &#8220;Qualifying Change in Control Termination&#8221;), subject to your  execution and non-revocation of a release of claims in a form acceptable to the Company in  its sole discretion within 55 days following your termination of employment , you will be  entitled to receive, in addition to the Accrued Benefits, a severance payment (the &#8220;CIC  Severance Payment&#8221; and, together with the Non-CIC Severance Payment, the &#8220;Severance  Payment&#8221;) in accordance with the Severance Policy as applicable for a termination of  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut006.jpg" title="slide6" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         employment that occurs following a change in control, (ii) a cash payment equal to your target  annual bonus for the year of termination multiplied by a fraction, the numerator of which is the number  of days you were employed with the Company during the calendar year in which the date of  termination occurs, and the denominator of which is 365 (the &#8220;Pro-rated Bonus&#8221;) and (iii) if you  qualify for and timely elect continuation coverage under COBRA, continued payment by the Company  of monthly contributions in respect of your coverage under the Company&#8217;s healthcare plan for the  number of months following the date of termination as set forth in the Severance Policy, in an amount  equal to the contribution the Company would have made if you had continued to be an active employee  (assuming the applicable rates in effect as of the date of your termination of employment); provided  that, the Company&#8217;s obligations under this clause (iii) shall terminate on the earlier of (x) the date on  which you enroll in a group health plan offered by another employer and (y) the date on which you are  no longer eligible for continuation coverage under COBRA; provided further that, notwithstanding the  foregoing, in the event such Company contributions, may, in the Company&#8217;s reasonable view, result  in tax or other penalties on the Company, this provision shall terminate and the parties shall, in good  faith, negotiate for a substitute provision that provides substantially a similar benefit to you but does  not result in such tax or other penalties.    Furthermore, notwithstanding the terms of the Company equity incentive plan under which your equity  awards are granted or any applicable award agreements, in the event of a Qualifying Change in Control  Termination, all of your outstanding, unvested Company employee stock options and unvested  restricted stock units, if any, shall become fully vested and any restrictions thereon shall lapse.      For the purpose of this Offer Letter, &#8220;Good Reason&#8221; means: (i) a material reduction in your base  salary; (ii) a material reduction in your target annual bonus opportunity; (iii) a relocation of your  principal place of employment by more than twenty-five  (25) miles provided that such relocation  increases your daily commute; or (iv) an adverse change in your position, including title, reporting  relationship(s), authority, duties or responsibilities; all of the above without your consent.  You must  provide notice of the existence of the Good Reason condition within thirty (30) days of the date you  learn of the condition, and the Company shall have a period of thirty (30) days during which it may  remedy the condition, and in case of full remedy such condition shall not be deemed to constitute  Good Reason hereunder.    For purposes of this Offer Letter, &#8220;Change in Control&#8221; shall have the meaning set forth in the  Company&#8217;s 2019 Equity Plan.  For the avoidance of doubt, the term Change in Control shall not include  a sale of assets, merger or other transaction effected primarily for the purpose of changing the domicile  of the Company.    Timing of Payment    The applicable Severance Payment and the Pro-rated Bonus (in the event of a Qualifying Change in  Control Termination) will be paid in a lump sum within sixty (60) days following the date of your  termination of employment subject to the provisions of Appendix A and as set forth below.      The payments and benefits under this Offer Letter are intended to qualify for exemptions from the  application of Section 409A of the Internal Revenue Code (&#8220;Section 409A&#8221;), and this Offer Letter will  be construed to the greatest extent possible as consistent with those provisions, and to the extent not  so exempt, this Offer Letter (and any definitions hereunder) will be construed in a manner that  complies with Section 409A to the extent necessary to avoid adverse taxation under Section 409A.    Notwithstanding anything to the contrary herein, to the extent required to comply with Section 409A,  a termination of employment shall not be deemed to have occurred for purposes of any provision of  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut007.jpg" title="slide7" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         this Offer Letter providing for the payment of amounts or benefits upon or following a termination of  employment unless such termination is also a &#8220;separation from service&#8221; within the meaning of Section  409A.  Your right to receive any installment payments will be treated as a right to receive a series of  separate payments and, accordingly, each installment payment shall at all times be considered a  separate and distinct payment. Notwithstanding any provision to the contrary in this Offer Letter, if  you are deemed by the Company at the time of your separation from service to be a &#8220;specified  employee&#8221; for purposes of Section 409A, and if any of the payments upon separation from service set  forth herein and/or under any other agreement with the Company are deemed to be &#8220;deferred  compensation,&#8221; then, to the extent delayed commencement of any portion of such payments is required  in order to avoid a prohibited distribution under Section 409A and the related adverse taxation under  Section 409A, such payments shall not be provided to you prior to the earliest of (i) the expiration of  the six-month period measured from the date of separation from service, (ii) the date of your death or  (iii) such earlier date as permitted under Section 409A without the imposition of adverse taxation.    With respect to payments to be made upon execution of an effective release, if the release revocation  period spans two calendar years, payments will be made in the second of the two calendar years to the  extent necessary to avoid adverse taxation under Section 409A.       Miscellaneous    You represent that (i) there is no legal restriction and/or contractual restriction prohibiting you  from entering into an employment relationship with the Company, (ii) that by doing so you are not  violating any third party&#8217;s rights, including any undertaking entered into with any former employer,  and (iii) that you know that the Company is employing you based upon this statement.    A dispute under this Offer Letter shall be heard and governed by the procedural and substantive laws  of the State of New Jersey or of your primary workplace. BY SIGNING THIS OFFER LETTER  YOU AND THE COMPANY AGREE TO WAIVE ANY RIGHT TO A JURY TRIAL FOR ANY  DISPUTES ARISING OUT OF THIS OFFER LETTER.    This Offer Letter constitutes and expresses the entire agreement of the parties hereto with reference  to any of the matters or things herein provided for or herein before discussed or mentioned with  reference to your employment, and it cancels and replaces any and all prior understandings and  agreements between you and the Company, except the Non-Solicitation, Non-Competition,  Confidentiality and Intellectual Property Agreement attached hereto as Appendix B. All other  promises, representations, collateral agreements and understandings not expressly incorporated in  this Offer Letter are hereby superseded by this Offer Letter.    The Company may withhold from any amounts payable under this Offer Letter all federal, state, city  or other taxes as it is required to withhold pursuant to any applicable law, regulation or ruling.  Notwithstanding any other provision of this Offer Letter, the Company shall not be obligated to  guarantee any particular tax result for you with respect to any payment provided to you hereunder,  and you shall be responsible for any taxes imposed on you with respect to any such payment.    Without derogating from the above, you will be required to abide by the Company&#8217;s policies, rules  and procedures, as may be in effect from time to time, at the Company&#8217;s sole discretion, and that may  be modified or changed as circumstances warrant.      Prior to your commencement of work, you will be required to sign a Non-Solicitation, Non- Competition, Confidentiality and Intellectual Property Agreement, which is attached hereto as  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut008.jpg" title="slide8" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         Appendix B. You will be bound by the terms of the document.    We are pleased to present this Offer Letter to you. Please sign below to indicate your acceptance of  this employment offer on the basis of the foregoing terms.      Sincerely,        /s/ David Domzalski  David Domzalski  Chief Executive Officer            I hereby confirm that I have carefully read and understood this offer of employment and I have accepted  it and entered into it of my own free will.          /s/ Iain Stuart_____  Dr. Iain Stuart       </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut009.jpg" title="slide9" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807           Appendix A  SEVERANCE POLICY       Provision CEO SVP+ VP  Non-CIC  Severance  Non CIC- Severance  Trigger  A termination of employment (i) by the Company and its  subsidiaries without &#8220;Cause&#8221; or (ii) by the employee for &#8220;Good  Reason&#8221;  (each, a &#8220;Qualifying Termination).*  Cash Severance 1.0x base salary** 0.75x base salary** 0.5x base salary**  Benefits 12 months benefits  continuation  9 months benefits  continuation  6 months benefits  continuation  Equity  Treatment  Full vesting  acceleration of time- based awards  As provided in the applicable equity plan  and award agreement  CIC  Severance  Protection Period  12 months following a Change in Control***   CIC Severance  Trigger  Double trigger (i.e., a Qualifying Termination during the Protection  Period)    Cash Severance 1.5x (salary + target  bonus), plus pro-rata  target bonus**  1.0x (salary + target  bonus), plus pro-rata  target bonus**  0.5x (salary + target  bonus), plus pro-rata  target bonus**  Benefits 18 months benefits  continuation  12 months benefits  continuation  6 months benefits  continuation  Equity Treatment Double trigger full vesting acceleration of time-based awards  Excise Tax Best net provision       *&#8220;Cause&#8221; shall have the meaning set forth in the Company&#8217;s 2019 Equity Incentive Plan (the &#8220;2019  Plan&#8221;) and &#8220;Good Reason&#8221; shall have the meaning set forth in the Offer Letter.      **Amounts shall be paid in a cash lump sum within 60 days following the date of termination;  provided that, if (i) the employee was party to an employment agreement or other plan, agreement or  arrangement with the Company or any of its subsidiaries or affiliates prior to the effective date of  this severance policy that provided for severance payments and benefits upon a termination of  employment (each such employment agreement or other plan, agreement or arrangement, a &#8220;Prior  Agreement&#8221;) and (ii) the payments and benefits provided pursuant to this severance policy are  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut010.jpg" title="slide10" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         determined to be &#8220;deferred compensation&#8221; for purposes of Section 409A of the Internal Revenue  Code or any successor provision thereto (the &#8220;Code&#8221;), then, to the extent necessary to avoid  accelerated taxation and/or tax penalties under Section 409A of the Code, the payments and benefits  provided pursuant to this severance policy shall be paid at the same time(s) and in the same form(s)  provided in the Prior Agreement, at all times, in accordance with Section 409A of the Code.     ***&#8221;Change in Control&#8221; shall have the meaning set forth in the 2019 Plan.  For the avoidance of  doubt, the consummation of the merger contemplated by that certain Agreement and Plan of Merger  by and among the Company, Foamix Pharmaceuticals Ltd. And Giants Merger Subsidiary Ltd.,  dated as of November 10, 2019 (as amended), shall not constitute a Change in Control for purposes  of this severance policy.           </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut011.jpg" title="slide11" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807               Appendix B  Non-Solicitation, Non-Competition, Confidentiality and Intellectual Property Agreement    This Non-Solicitation, Non-Competition, Confidentiality and Intellectual Property Agreement  (&#8220;Agreement&#8221;), is made and entered into by and between, VYNE Pharmaceuticals Inc. (the  &#8220;Company&#8221;) and Dr. Iain Stuart (&#8220;you&#8221; and &#8220;your&#8221;).  The Company, together with its ultimate parent  and their respective affiliates and subsidiaries, are hereinafter referred to as the &#8220;Group Companies.&#8221;    The parties hereby agree to the following in exchange for your employment with the Company:    (a) Non-Competition. You recognize that your knowledge of the Confidential Information (as  defined below) and trade secrets of the Group Companies and your role in the Group Companies&#8217;  business may allow you to compete or to assist a third party to compete unfairly with the Group  Companies.     (i) During the term of this Agreement, and for a period of 12 months following the  termination of your employment with any member of the Group Companies (the &#8220;Restricted Period&#8221;),  you agree that you shall not, without the prior consent of the Company and its ultimate parent, directly  or indirectly, as an employee, executive, agent, principal, partner, stockholder, officer, director,  consultant, independent contractor, advisor, investor or any other representative, work with or without  compensation in any business that is developing or commercializes a product with a compound that is  the same or substantially similar to a compound being developed or sold by any member of the Group  Companies(each, a &#8220;Competitive Business&#8221;) within the same geographic territory in which you  operated during your last year of employment with any member of the Group Companies.     (ii) Necessary and Reasonable.  You acknowledge that this non-compete provision is  necessary and reasonable to protect Group Companies&#8217;  business interests.  You further acknowledge  that the Group Companies would suffer irreparable harm and other damage in the event of a breach of  this provision.  You agree that the term, scope and geographic area of the covenants contained herein  are reasonable.  However, if any court of competent jurisdiction determines that this covenant is  unenforceable as to the term, scope or geographic area then this covenant nevertheless shall be  enforceable by such court as to such shorter term, such lesser scope or within such lesser geographic  area as the court determines to be reasonable and enforceable.      (b) Non-Solicitation. You will not, in any manner whatsoever, directly or indirectly, without the  prior written consent of the Company and its ultimate parent, at any time during the Restricted Period:    (i)  induce or endeavor to induce (A) any employee of any member of the Group Companies to  leave employment with any member of the Group Companies, or (B) any consultant or  contractor of any member of the Group Companies to terminate its relationship as such with  any member of the Group Companies during any period of time that the business services  provided, directly or indirectly, by such consultant or contractor are exclusively or primarily  being provided to any member of the Group Companies, provided that this clause shall not  preclude customary non-targeted recruiting efforts or general solicitations that are not  specifically directed to, but which may have the effect of causing an employee, consultant or  contractor to leave the employment or arrangement with any member of the Group Companies;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut012.jpg" title="slide12" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         or    (ii)  employ or attempt to employ or assist any individual or other entity to employ any  employee of any member of the Group Companies or to retain any consultant or contractor  during any period of time that the business services provided, directly or indirectly, by such  consultant or contractor are exclusively or primarily being provided to any member of the Group  Companies, provided, that this clause shall not preclude an employer of yours from offering  employment or consulting or contracting services to anyone without your direct or indirect  assistance    (c) Confidentiality. You acknowledge that by reason of your employment with any member  of the Group Companies, you have had access to Confidential Information and trade secrets of the  Group Companies, and that such Confidential Information and trade secrets are essential components  of the business of the Group Companies, and are proprietary and would be of great value and benefit  to competitors of the Group Companies. &#8220;Confidential Information&#8221; is to be broadly defined and  includes anything respecting the Company and its affiliates or their respective businesses, customers,  supplier or operations, and which is not made readily available to the general public. You agree that  both during and after your employment with any member of the Group Companies, you will not  disclose to any individual or other entity, except in the proper course of your employment with any  member of the Group Companies, or use for your own purposes or for purposes other than those of  any member of the Group Companies, any Confidential Information or trade secrets of any member  of the Group Companies acquired by you. You agree that at all times after your employment with any  member of the Group Companies, you will hold in trust, keep confidential, and not publish, disclose  or otherwise disseminate to any third party or make any use of the Confidential Information of any  member of the Group Companies except for the benefit of the Group Companies and in the course of  employment with any member of the Group Companies. You further agree not to cause the  transmission, removal or transport of Confidential Information from the Group Companies&#8217; place of  business (principal, remote or otherwise), whether by hard or electronic copy, without prior written  approval of the Company and its ultimate parent, except for the benefit of the Group Companies and  in the course of your employment relationship with any member of the Group Companies.  You  acknowledge that you are aware that the unauthorized disclosure of Confidential Information of any  member of the Group Companies may be highly prejudicial to the Group Companies&#8217; interests, an  invasion of privacy and an improper disclosure of proprietary information. You agree, promptly and  without request, to deliver to and inform the Company and its ultimate parent of all documents and  data pertaining to your services to the any member of the Group Companies and the Confidential  Information of the Group Companies, whether prepared by you or otherwise coming into your  possession or control.  You will not retain any written or other tangible material containing any  information concerning or disclosing any of the Confidential Information of any member of the Group  Companies, including but not limited to any electronically stored data.    (i) If information enters the public domain, except as a result of a breach of this Section  (c) by you or a breach of another confidentiality agreement to which any member of the Group  Companies is a party, the information will not be deemed Confidential Information, or a trade secret  protected by this Section (c). If you are compelled by law to disclose Confidential Information or trade  secrets of any member of the Group Companies, pursuant to subpoena, an order from a court of  competent jurisdiction, or other applicable legal authority, you may disclose such Confidential  Information or trade secrets to the extent so required, but you will, if possible, (i) provide reasonable  advance notice of the subpoena, court order, or legal authority to the Company and its ultimate parent,  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut013.jpg" title="slide13" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         and (ii) afford the Group Companies the reasonable opportunity to take legal action to contest,  challenge, narrow or otherwise limit or condition the disclosure.  (ii) Sanctions for Unauthorized Taking of Confidential Information. You recognize that the  unauthorized taking of the Group Companies&#8217;  Confidential Information could result in civil liability  and that willful misappropriation may result in an award against you for damages and attorney&#8217;s fees  and costs in collecting such damages.  The unauthorized taking of trade secrets is a crime and may be  punishable by imprisonment, or a fine, or both, and/or may result in civil liability, including, where  applicable, punitive or similar damages, under applicable federal and state trade secret laws.  (iii) Notice of Immunity Under the Economic Espionage Act of 1996, as amended by  the Defend Trade Secrets Act of 2016 (&quot;DTSA&quot;). Notwithstanding any other provision of this  Agreement:  (A) You will not be held criminally or civilly liable under any federal or  state trade secret law for any disclosure of a trade secret that: (1) is made: in  confidence to a federal, state, or local government official, either directly or  indirectly, or to an attorney; and solely for the purpose of reporting or  investigating a suspected violation of law; or (2) is made in a complaint or  other document that is filed under seal in a lawsuit or other proceeding.    (B) If you file a lawsuit for retaliation by any member of the Group Companies for  reporting a suspected violation of law, you may disclose the Group Companies&#8217;  trade secrets to your attorney and use the trade secret information in the court  proceeding if you: (1) file any document containing the trade secret under seal;  and (2) do not disclose the trade secret, except pursuant to court order.    (d) Intellectual Property.   (i) You have attached hereto as Exhibit 1, a list describing all inventions, original works of  authorship, developments, improvements, copyrights and patents that were made or developed  by you prior to the date you sign this Agreement, that belong to you.  If such list is not attached  or is left blank, you represent that no such inventions exist.  (ii) You agree that all ideas, techniques, inventions, systems, business and marketing plans,  projections and analyses, discoveries, technical information, programs, prototypes,  copyrightable works of authorship, including without limitation software code, and similar  developments, improvements or creations developed, conceived, created, discovered, made, or  written by you in the course of or as the result, directly or indirectly, of the performance of your  employment with any member of the Group Companies (hereinafter called &quot;Developments&quot;),  and all related intellectual property rights, including but not limited to, writings and other works  of authorship, United States and foreign patents, mask works, copyright and trademark  registrations and other forms of intellectual property protection, shall be and remain the property  of the Group Companies.  You further agree to assign (or cause to be assigned) and do hereby  assign fully to the Group Companies all such Developments and any copyrights, patents, mask  work rights or other intellectual property rights relating thereto.  In the event copyrightable works  do not fall within the theory of works made for hire, you agree to assign, and do hereby assign,  all rights, title and interest therein, without further consideration, to the Group Companies.  You,  insofar as you have the right to do so, agree that you will execute or cause to be executed such  United States and foreign patents, mask works, copyright and trademark registrations and other  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut014.jpg" title="slide14" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         documents and agreements and take such other action as may be desirable in the opinion of the  Group Companies to enable intellectual property, copyright and other forms of protection for  Developments to be obtained, maintained, renewed, preserved and protected throughout the  world by or on behalf of the Group Companies.    (iii) If any member of the Group Companies is unable, after exercising reasonable efforts, to  secure your signature on any application for patent, copyright, analogous registration, or other  documents regarding any legal protection regarding Developments or other works and  inventions, whether because of your physical or mental incapacity or for any other reason, you  hereby irrevocably designate and appoint the Group Companies and their duly authorized  officers and agents as your agent and attorney-in-fact to act for and on your behalf and to  execute and file any such application or applications or other documents and to do all other  lawfully permitted acts to further the prosecution and issuance of such patent, copyright or  trademark registrations or any other legal protection thereon with the same legal force and effect  as if executed by you.  (iv) Incorporation into Company Products.  You agree that if in the course of your employment  with any member of the Group Companies, you incorporate into any invention, service, or  product any invention, improvement, Development, concept, discovery or other proprietary  information owned by you or in which you have an interest, (i) you will inform the Company  and its ultimate parent, in writing, before incorporating such invention, improvement,  development, concept, discovery or other proprietary information into any invention, Service,  or Development; and (ii) the Group Companies are hereby granted and will have a  nonexclusive, royalty-free, perpetual, irrevocable, worldwide license to make, have made,  modify, use and sell such item as part of or in connection with such invention, services, or  Development.  You will not incorporate any invention, improvement, development, concept,  discovery or other proprietary information owned by any third party into any invention without  the Company's and its ultimate parent&#8217;s prior written permission.  (v) Subsequent Use Restrictions.  During the course of employment and during the Restricted  Period, you agree to promptly notify the Company and its ultimate parent of any inventions you  develop that are based on, relate to or are a derivative of Developments or Confidential  Information.  You agree that any invention or work involving you after the separation of your  employment shall be deemed to result from access to the Company&#8217;s Developments or  Confidential Information (including without limitation patentable inventions and copyrightable  works) if such invention or work: (i) arose from your work with any member of the Group  Companies; or (ii) is related to the business of the Group Companies and is made, created, used,  sold, exploited or reduced to practice, or an application for patent, trademark, copyright or other  proprietary protection is filed by you and/or with your significant aid by a third party, within  the Restricted Period.  (e) Disclosure of New Employment.  In light of your obligations under this Agreement,   you agree to disclose the name of any future employer to the Company and its ultimate parent in  writing (even if you intend to be self-employed), along with your future business contact information,  including name and full address of the new employer.  Where necessary to protect the Group  Companies&#8217; interests, any member of the Group Companies may notify any future or prospective  employer of the existence of this Agreement and/or the terms and conditions of your employment  with any member of the Group Companies.   This obligation shall continue until the end of the time  periods under the Non-Competition and Non-Solicitation provisions above.     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut015.jpg" title="slide15" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         (f) Cooperation.  You shall provide reasonable cooperation in connection with any legal  action or proceeding (or any appeal from any action or proceeding) which relates to events during  your employment hereunder. The Company shall reimburse you for your reasonable travel expenses  incurred in connection with the foregoing, in accordance with the Company&#8217;s policies and subject to  the delivery of reasonable support for such expenses.      (g)  Restrictions Reasonable.  You confirm that all restrictions and covenants in this  Agreement are reasonable and valid, and waive all objections to and defenses to the strict enforcement  thereof.    (h) Survival of Restrictions.   This Agreement shall survive the termination of the Offer  Letter between you and the Company and the termination of your employment with any member of  the Group Companies, whether such termination is voluntary or involuntary, and regardless of the  reason(s) for such termination.       (i) Remedies.  In the event of breach or threatened breach by you of any provision of this  Agreement, any member of the Group Companies shall be entitled to (i) injunctive relief by temporary  restraining order, preliminary injunction, and/or permanent injunction, (ii) recovery of the attorneys&#8217;  fees and costs incurred by any member of the Group Companies in obtaining such relief, and (iii) any  other legal and equitable relief to which it may be entitled, including any and all monetary damages  which any member of the Group Companies may incur as a result of said breach or threatened breach.   Injunctive relief shall not be the exclusive relief and may be in addition to any other relief to which  any member of the Group Companies would otherwise be entitled.  The existence of any cause of  action by you against the Company shall not constitute a defense to enforcement of the restrictions on  you created by this Agreement.  If you fail to comply with this Agreement during the Restricted Period,  the time period for that the Restricted Period will be extended by one day for each day that you are  found to have violated this Agreement, up to a maximum extension of twelve (12) months.  In the  event that a court finds the restrictions on you in this Agreement are unenforceable as written, then the  parties shall consent to the reformation of the Agreement to make it enforceable to protect the interests  of the Group Companies to the maximum extent legally allowed.      (j) Parties Benefited; Assignments.  This Agreement shall inure to the benefit of the Group  Companies&#8217; owners, successors, assigns and affiliates, and may be assigned to and enforced by any of  the foregoing.  Neither this Agreement nor any rights or obligations hereunder may be assigned by  you.    (k) Notices.  Any notice required or permitted by this Agreement shall be in writing sent by  personal delivery, or by registered or certified mail, return receipt requested, addressed to the Company  at its then principal office, or to you at your last known address, or to such other address or addressees  as any party may from time to time specify in writing.  Notices shall be deemed given when received.    (l) Governing Law, Jurisdiction and Venue.  This Agreement and any issues arising from it  or regarding its provisions shall be governed by and construed in accordance with the substantive and  procedural laws of the state of your primary workplace without reference to such jurisdiction&#8217;s choice  of law rules.    (m) Severability.  The provisions of this Agreement are severable so that in the event any  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut016.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut016.jpg" title="slide16" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         provision(s) in this Agreement is held to be illegal or unenforceable by any court or agency of  competent jurisdiction, or by operation of any applicable law, the remaining terms of this Agreement  shall remain valid and in full force and effect.  Further, such court or agency shall modify the offending  provision to conform to the most expansive permissible reading under the law to protect the interests  of the Group Companies.    (n) No Waiver.  No waiver of any breach or default hereunder shall be considered valid  unless in writing and signed by the party giving such waiver, and no waiver shall be deemed a waiver  of any subsequent breach or default of the same or similar nature.  No failure on the part of any party  to exercise, and no delay in exercising, any right, remedy, power or privilege hereunder shall operate  as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege  hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy,  power or privilege.    (o)  Comprehension; Consultation with Counsel.  You acknowledge having read and  understood this Agreement and further acknowledge being hereby advised, by this paragraph, to  consult independent legal counsel. Accordingly, you acknowledge that you are voluntarily entering  into this Agreement of your own volition and not under duress.    (p) Waiver of Jury Trial.    YOU AND THE GROUP COMPANIES KNOWINGLY AND WILLINGLY WAIVE ANY RIGHT  TO A TRIAL BY JURY IN ANY DISPUTE ARISING OUT OF OR RELATING TO THIS  AGREEMENT.       </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1012-stuartexecut017.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1012-stuartexecut017.jpg" title="slide17" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807           THE PARTIES ACKNOWLEDGE THAT THEY HAVE READ AND UNDERSTAND THIS  AGREEMENT, THAT THEY HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL IF  THEY SO CHOSE, AND THAT THEY ENTER INTO THIS AGREEMENT FREELY AND  VOLUNTARILY.            /s/ Iain Stuart_________   Dr. Iain Stuart              VYNE Pharmaceuticals Inc.        By: /s/ David Domzalski___________    David Domzalski, Chief Executive Officer          </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>5
<FILENAME>exhibit1013-zerondaxexec.htm
<DESCRIPTION>EX-10.13
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit1013-zerondaxexec</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:965;"><!-- exhibit1013-zerondaxexec001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec001.jpg" title="slide1" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807                 March 15, 2022      Dear Tyler,    This letter (the &#8220;Offer Letter&#8221;) contains the terms and conditions of your employment with VYNE  Pharmaceuticals Inc. (the &#8220;Company&#8221;), a subsidiary of VYNE Therapeutics Inc. (&#8220;VYNE&#8221;), effective  as of March 15, 2022 (the &#8220;Effective Date&#8221;). The Company, together with its ultimate parent and their  respective affiliates and subsidiaries, are hereinafter referred to as the &#8220;Group Companies.&#8221;  Your employment pursuant  to  th is  Offer  Let ter  will commence as of the Effective Date and  the terms and conditions of this Offer Letter shall be effective as of the Effective Date.  Unless  stated otherwise herein, this Offer Letter will supersede any prior offer letters between you and the  Company or any of its affiliates, including the letter dated May 11, 2021, April 8, 2019, June 7, 2021   and any amendments thereto (together, the &#8220;Previous Offer Letter&#8221;). You may be interchangeably  referred to as &#8220;you&#8221; or &#8220;the Executive&#8221; within this Offer Letter. Additionally, where the context  permits, references to &#8220;the Company&#8221; shall include the Company, its subsidiaries and affiliates and  any successor thereto.     Brief Description of Role, Reporting Structure and Major Responsibilities:    We are pleased to offer you the position of VYNE&#8217;s Chief Financial Officer (&#8220;CFO&#8221;) and Treasurer.  You will report to VYNE&#8217;s Chief Executive Officer, David Domzalski or his designee.  As the CFO, you will work closely with the CEO and leadership team to craft the long-term  financing and corporate development strategy and play an important role in guiding the Group  Companies in its next growth phase.  The CFO will be a partner to the CEO in communicating the  Group Companies&#8217; strategy to VYNE&#8217;s board of directors (the &#8220;Board&#8221;), investors and other  stakeholders.  The CFO will execute the financial strategy by assessing and leading the execution of  all capital raising for the Group Companies and will provide financial and business expertise in  assessing and crafting the financial structures of licensing and strategic partnerships/collaborations.   The CFO will be the most senior executive responsible for overseeing and directing the financial,  investor relations, supply chain and IT functions of VYNE. The CFO will be relied upon as a  financial thought leader in the Group Companies&#8217; business and as such, be a trusted sounding board  to the CEO and leadership team. You will play a critical role in the Group Companies&#8217; strategic  positioning and will lead the finance, investor relations, supply chain and IT organizations to ensure  they can meet the future needs and direction of the Group Companies.   The CFO will approach the role as a strategic one as well as hands-on to ensure the organizations  they oversee constantly seek improvement, with a balance of superior technical, operational and  leadership skills. As the CFO you must be a strong communicator, collaborator and able to fit in with  an entrepreneurial environment that is dynamic and results oriented.     Specific responsibilities as the CFO shall be as mutually agreed between you and the CEO, and shall  include strategic and tactical business growth and business development, financing and fundraising  matters, financial, tax and risk management for VYNE, participation on board of directors meetings,  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec002.jpg" title="slide2" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         general management of financial matters for VYNE and investor and public relations.       Compensation    You will be paid a base salary at an annual rate of $340,000, payable in accordance with the  Company&#8217;s payroll policies, less applicable deductions and employment taxes.  Currently, the  Company&#8217;s regular pay period is bi-monthly (the 15th and 30th of each month).     You will be eligible to receive a cash bonus of up to 40% of your base salary based on achievement  of milestones and targets set by VYNE&#8217;s Chief Executive Officer (CEO), under the framework  of the applicable bonus plan of VYNE for the relevant year.     The payment and grant of the cash bonus, if awarded, shall be made no later than March 15th of the  calendar year following the year to which the performance relates, upon evaluation of your  performance and the achievement of milestones and targets set for the performance year, and in  accordance with the then-current general bonus plan.  You must be employed by the Company on  the bonus payment date to be eligible to receive the bonus.    You will receive annual equity awards to acquire common stock in VYNE with a per share exercise  price for the options equal to the fair market value of one share of VYNE common stock on the grant  date. The annual equity grants are expected to be granted in March and will vest over a period of  four years following the last day of the calendar quarter in which the grant was made as follows:  25% on the first anniversary of the vesting commencement date and 6.25% on the last day of each  subsequent calendar quarter, subject to your continued employment with VYNE or one of its  subsidiaries through the applicable vesting date.  Please note that such vesting period does not  amount to an undertaking of the Company or VYNE to employ you for any given period.  The equity  grants shall be subject to the execution of a share award agreement with VYNE and the terms and  conditions of VYNE's 2019 Equity Incentive Plan, or VYNE's 2018 Omnibus Equity Incentive Plan,  in each case, as may be amended or amended and restated from time to time.     Consistent with its policies as established from time to time, the Company will also cover all  expenses directly related to your job performance, in accordance with the Company&#8217;s policies as in  effect from time to time.     You will be entitled to four  (4)  weeks of paid vacation.  These vacation days accrue ratably  over the calendar year and may not be carried forward from year to year or paid out at the  termination of employment, except as described below or if your state laws mandate this  payout. You will be entitled to participate in the Company&#8217;s healthcare plan, then in effect, or, at  the Company&#8217;s election, the Company may direct you to purchase an individual plan  providing equivalent coverage and will reimburse you for all premium payments under such  individual plan, upon proof of payment. All matters of eligibility under the Company&#8217;s plans will  be determined solely by the carriers providing such insurance.  You will continue to be eligible to  participate in the Company&#8217;s 401(k) plan.      The Company will also recognize certain holidays. These dates are communicated each year by the  Company and may change based upon business needs.     Termination of Employment    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec003.jpg" title="slide3" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807       925825-NYCSR05A - MSW  Your employment with the Company is at-will and may be terminated by either you or the Company  at any time, with or without reason.      In the event of a termination for Cause (as defined on Appendix A) by the Company, your  employment will end immediately without notice and the Company and its subsidiaries and affiliates  will have no further liability towards you except for payment of (1) any earned but unpaid base salary,  (2) any incurred but unreimbursed business expenses and (3) any accrued but unused vacation days  that exist as of the date of your termination of employment to the extent mandated by state law  (together, the &#8220;Accrued Benefits&#8221;).    In the event of your death or the termination of your employment as a result of your disability (as  determined by the Company in good faith), the Company will have no further liability to you except  for payment of the Accrued Benefits through the date of your death or the first day of your disability.        You shall have the right to resign at any time by giving the Company thirty (30) days&#8217; notice of  the termination date, subject to the Company&#8217;s right, at its election, to reduce the duration of the  notice period upon notice to you, in which case the last day of the reduced notice period shall  constitute your employment termination date. The Company shall not have any further liability to  you except for payment of all Accrued Benefits due through the date of termination unless such  resignation is for Good Reason which shall be governed by the provisions below.    The Company may terminate your employment without Cause upon thirty (30) days&#8217; notice,  during which notice period you will receive your full compensation and benefits.     If your employment is terminated without Cause or you resign for Good Reason, subject to  your execution and non-revocation of a release of claims in a form acceptable to the  Company in its sole discretion within 55 days following your termination of employment,  you will be entitled to receive, in addition to the Accrued Benefits, (i) a severance payment  (the &#8220;Non-CIC Severance Payment&#8221;) equal to the better of (A) three (3) months salary plus  one (1) month for every full year of your employment by a Group Company (up to a  maximum of twelve (12) months) or (B) (i) a severance payment  in accordance with the  terms set forth on Appendix A to this Offer Letter (the &#8220;Severance Policy&#8221;) based on your  then-current position as set forth therein and (ii) if you qualify for and timely elect continuation  coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (&#8220;COBRA&#8221;),  continued payment by the Company of monthly contributions in respect of your coverage under the  Company&#8217;s healthcare plan for the number of months following the date of termination that  corresponds to your severance payment, in an amount equal to the contribution the Company would  have made if you had continued to be an active employee (assuming the applicable rates in effect as  of the date of your termination of employment); provided that, the Company&#8217;s obligations under this  clause (ii) shall terminate on the earlier of (x) the date on which you enroll in a group health plan  offered by another employer and (y) the date on which you are no longer eligible for continuation  coverage under COBRA; provided further that, notwithstanding the foregoing, in the event such  Company contributions, may, in the Company&#8217;s reasonable view, result in tax or other penalties on  the Company, this provision shall terminate and the parties shall, in good faith, negotiate for a  substitute provision that provides substantially a similar benefit to you but does not result in such tax  or other penalties.    Notwithstanding the above, if you experience a Qualifying Termination within the twelve (12) month  period after a Change in Control (a &#8220;Qualifying Change in Control Termination&#8221;), subject to  your execution and non-revocation of a release of claims in a form acceptable to the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec004.jpg" title="slide4" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         Company in its sole discretion within 55 days following your termination of employment,  you will be entitled to receive, in addition to the Accrued Benefits, (i) a severance payment  (the &#8220;CIC Severance Payment&#8221; and, together with the Non-CIC Severance Payment, the  &#8220;Severance Payment&#8221;) that is equal to the better of: (A) twelve (12) months of your then  current base salary or (B) a severance payment in accordance with the Severance Policy as  applicable for a termination of employment that occurs following a change in control, plus a  cash payment equal to your target annual bonus for the year of termination multiplied by a fraction,  the numerator of which is the number of days you were employed with the Company during the  calendar year in which the date of termination occurs, and the denominator of which is 365 (the  &#8220;Pro-rated Bonus&#8221;) and (ii) if you qualify for and timely elect continuation coverage under  COBRA, continued payment by the Company of monthly contributions in respect of your coverage  under the Company&#8217;s healthcare plan for the number of months following the date of termination  that corresponds to your severance payment, in an amount equal to the contribution the Company  would have made if you had continued to be an active employee (assuming the applicable rates in  effect as of the date of your termination of employment); provided that, the Company&#8217;s obligations  under this clause (ii) shall terminate on the earlier of (x) the date on which you enroll in a group  health plan offered by another employer and (y) the date on which you are no longer eligible for  continuation coverage under COBRA; provided further that, notwithstanding the foregoing, in the  event such Company contributions, may, in the Company&#8217;s reasonable view, result in tax or other  penalties on the Company, this provision shall terminate and the parties shall, in good faith, negotiate  for a substitute provision that provides substantially a similar benefit to you but does not result in  such tax or other penalties.    Furthermore, notwithstanding the terms of the Company equity incentive plan under which your  equity awards are granted or any applicable award agreements, in the event of a Qualifying Change  in Control Termination, all of your outstanding, unvested Company employee stock options and  unvested restricted stock units, if any, shall become fully vested and any restrictions thereon shall  lapse.      For the purpose of this Offer Letter, &#8220;Good Reason&#8221; means: (i) a material reduction in your base  salary; (ii) a material reduction in your target annual bonus opportunity; (iii) a relocation of your  principal place of employment by more than twenty-five  (25) miles provided that such relocation  increases your daily commute; or (iv) an adverse change in your position, including title, reporting  relationship(s), authority, duties or responsibilities; all of the above without your consent.  You  must provide notice of the existence of the Good Reason condition within thirty (30) days of the  date you learn of the condition, and the Company shall have a period of thirty (30) days during  which it may remedy the condition, and in case of full remedy such condition shall not be deemed  to constitute Good Reason hereunder.    For purposes of this Offer Letter, &#8220;Change in Control&#8221; shall have the meaning set forth in the  Company&#8217;s 2019 Equity Plan.  For the avoidance of doubt, the term Change in Control shall not  include a sale of assets, merger or other transaction effected primarily for the purpose of changing  the domicile of the Company.    Timing of Payment    The applicable Severance Payment (in the event of a Qualifying Change in Control Termination) will  be paid in a lump sum within sixty (60) days following the date of your termination of employment  subject to the provisions of Appendix A and as set forth below.      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec005.jpg" title="slide5" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         The payments and benefits under this Offer Letter are intended to qualify for exemptions from the  application of Section 409A of the Internal Revenue Code (&#8220;Section 409A&#8221;), and this Offer Letter  will be construed to the greatest extent possible as consistent with those provisions, and to the extent  not so exempt, this Offer Letter (and any definitions hereunder) will be construed in a manner that  complies with Section 409A to the extent necessary to avoid adverse taxation under Section 409A.    Notwithstanding anything to the contrary herein, to the extent required to comply with Section 409A,  a termination of employment shall not be deemed to have occurred for purposes of any provision of  this Offer Letter providing for the payment of amounts or benefits upon or following a termination of  employment unless such termination is also a &#8220;separation from service&#8221; within the meaning of  Section 409A.  Your right to receive any installment payments will be treated as a right to receive a  series of separate payments and, accordingly, each installment payment shall at all times be  considered a separate and distinct payment. Notwithstanding any provision to the contrary in this  Offer Letter, if you are deemed by the Company at the time of your separation from service to be a  &#8220;specified employee&#8221; for purposes of Section 409A, and if any of the payments upon separation from  service set forth herein and/or under any other agreement with the Company are deemed to be  &#8220;deferred compensation,&#8221; then, to the extent delayed commencement of any portion of such  payments is required in order to avoid a prohibited distribution under Section 409A and the related  adverse taxation under Section 409A, such payments shall not be provided to you prior to the earliest  of (i) the expiration of the six-month period measured from the date of separation from service, (ii)  the date of your death or (iii) such earlier date as permitted under Section 409A without the  imposition of adverse taxation.   With respect to payments to be made upon execution of an effective  release, if the release revocation period spans two calendar years, payments will be made in the  second of the two calendar years to the extent necessary to avoid adverse taxation under Section  409A.       Miscellaneous    You represent that (i) there is no legal restriction and/or contractual restriction prohibiting you  from entering into an employment relationship with the Company, (ii) that by doing so you are not  violating any third party&#8217;s rights, including any undertaking entered into with any former employer,  and (iii) that you know that the Company is employing you based upon this statement.    A dispute under this Offer Letter shall be heard and governed by the procedural and substantive  laws of the State of New Jersey or of your primary workplace. BY SIGNING THIS OFFER  LETTER YOU AND THE COMPANY AGREE TO WAIVE ANY RIGHT TO A JURY TRIAL  FOR ANY DISPUTES ARISING OUT OF THIS OFFER LETTER.    This Offer Letter constitutes and expresses the entire agreement of the parties hereto with reference  to any of the matters or things herein provided for or herein before discussed or mentioned with  reference to your employment, and it cancels and replaces any and all prior understandings and  agreements between you and the Company, except the Non-Solicitation, Non-Competition,  Confidentiality and Intellectual Property Agreement attached hereto as Appendix B. All other  promises, representations, collateral agreements and understandings not expressly incorporated in  this Offer Letter are hereby superseded by this Offer Letter.    The Company may withhold from any amounts payable under this Offer Letter all federal, state,  city or other taxes as it is required to withhold pursuant to any applicable law, regulation or ruling.  Notwithstanding any other provision of this Offer Letter, the Company shall not be obligated to  guarantee any particular tax result for you with respect to any payment provided to you hereunder,  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec006.jpg" title="slide6" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         and you shall be responsible for any taxes imposed on you with respect to any such payment.    Without derogating from the above, you will be required to abide by the Company&#8217;s policies, rules  and procedures, as may be in effect from time to time, at the Company&#8217;s sole discretion, and that  may be modified or changed as circumstances warrant.      Prior to your commencement of work, you will be required to sign a Non-Solicitation, Non- Competition, Confidentiality and Intellectual Property Agreement, which is attached hereto as  Appendix B. You will be bound by the terms of the document.    We are pleased to present this Offer Letter to you. Please sign below to indicate your acceptance of  this employment offer on the basis of the foregoing terms.      Sincerely,        /s/ David Domzalski  David Domzalski  Chief Executive Officer        I hereby confirm that I have carefully read and understood this offer of employment and I have  accepted it and entered into it of my own free will.          /s/ Tyler Zeronda___________  Tyler Zeronda      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec007.jpg" title="slide7" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807             Appendix A  SEVERANCE POLICY       Provision CEO SVP+ VP  Non-CIC  Severance  Non CIC- Severance  Trigger  A termination of employment (i) by the Company and its  subsidiaries without &#8220;Cause&#8221; or (ii) by the employee for &#8220;Good  Reason&#8221;  (each, a &#8220;Qualifying Termination).*  Cash Severance 1.0x base salary** 0.75x base salary** 0.5x base salary**  Benefits 12 months benefits  continuation  9 months benefits  continuation  6 months benefits  continuation  Equity  Treatment  Full vesting  acceleration of time- based awards  As provided in the applicable equity plan  and award agreement  CIC  Severance  Protection Period  12 months following a Change in Control***   CIC Severance  Trigger  Double trigger (i.e., a Qualifying Termination during the Protection  Period)    Cash Severance 1.5x (salary + target  bonus), plus pro-rata  target bonus**  1.0x (salary + target  bonus), plus pro-rata  target bonus**  0.5x (salary + target  bonus), plus pro-rata  target bonus**  Benefits 18 months benefits  continuation  12 months benefits  continuation  6 months benefits  continuation  Equity Treatment Double trigger full vesting acceleration of time-based awards  Excise Tax Best net provision       *&#8220;Cause&#8221; shall have the meaning set forth in the VYNE&#8217;s 2019 Equity Incentive Plan (the &#8220;2019  Plan&#8221;) and &#8220;Good Reason&#8221; shall have the meaning set forth in the Offer Letter.      **Amounts shall be paid in a cash lump sum within 60 days following the date of termination;  provided that, if (i) the employee was party to an employment agreement or other plan, agreement or  arrangement with the Company or any of its subsidiaries or affiliates prior to the effective date of  this severance policy that provided for severance payments and benefits upon a termination of  employment (each such employment agreement or other plan, agreement or arrangement, a &#8220;Prior  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec008.jpg" title="slide8" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         Agreement&#8221;) and (ii) the payments and benefits provided pursuant to this severance policy are  determined to be &#8220;deferred compensation&#8221; for purposes of Section 409A of the Internal Revenue  Code or any successor provision thereto (the &#8220;Code&#8221;), then, to the extent necessary to avoid  accelerated taxation and/or tax penalties under Section 409A of the Code, the payments and benefits  provided pursuant to this severance policy shall be paid at the same time(s) and in the same form(s)  provided in the Prior Agreement, at all times, in accordance with Section 409A of the Code.     ***&#8221;Change in Control&#8221; shall have the meaning set forth in the 2019 Plan.          </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec009.jpg" title="slide9" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807                 Appendix B  Non-Solicitation, Non-Competition, Confidentiality and Intellectual Property Agreement    This Non-Solicitation, Non-Competition, Confidentiality and Intellectual Property Agreement  (&#8220;Agreement&#8221;), is made and entered into by and between, VYNE Pharmaceuticals Inc. (the  &#8220;Company&#8221;) and Tyler Zeronda (&#8220;you&#8221; and &#8220;your&#8221;).  The Company, together with its ultimate parent  and their respective affiliates and subsidiaries, are hereinafter referred to as the &#8220;Group Companies.&#8221;    The parties hereby agree to the following in exchange for your employment with the Company:    (a) Non-Competition. You recognize that your knowledge of the Confidential Information (as  defined below) and trade secrets of the Group Companies and your role in the Group Companies&#8217;  business may allow you to compete or to assist a third party to compete unfairly with the Group  Companies.     (i) During the term of this Agreement, and for a period of 12 months following the  termination of your employment with any member of the Group Companies (the &#8220;Restricted  Period&#8221;), you agree that you shall not, without the prior consent of the Company and its ultimate  parent, directly or indirectly, as an employee, executive, agent, principal, partner, stockholder,  officer, director, consultant, independent contractor, advisor, investor or any other representative,  work with or without compensation in any business that is directly competitive with, the business of  the Group Companies (i.e., any compound that is the same or substantially similar to a compound  being developed or sold by any member of the Group Companies) (each, a &#8220;Competitive Business&#8221;)  within the same geographic territory in which you operated during your last year of employment  with any member of the Group Companies.     (ii) Necessary and Reasonable.  You acknowledge that this non-compete provision is  necessary and reasonable to protect Group Companies&#8217;  business interests.  You further acknowledge  that the Group Companies would suffer irreparable harm and other damage in the event of a breach  of this provision.  You agree that the term, scope and geographic area of the covenants contained  herein are reasonable.  However, if any court of competent jurisdiction determines that this covenant  is unenforceable as to the term, scope or geographic area then this covenant nevertheless shall be  enforceable by such court as to such shorter term, such lesser scope or within such lesser geographic  area as the court determines to be reasonable and enforceable.      (b) Non-Solicitation. You will not, in any manner whatsoever, directly or indirectly, without  the prior written consent of the Company and its ultimate parent, at any time during the Restricted  Period:    (i)  induce or endeavor to induce (A) any employee of any member of the Group Companies  to leave employment with any member of the Group Companies, or (B) any consultant or  contractor of any member of the Group Companies to terminate its relationship as such with  any member of the Group Companies during any period of time that the business services  provided, directly or indirectly, by such consultant or contractor are exclusively or primarily  being provided to any member of the Group Companies, provided that this clause shall not  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec010.jpg" title="slide10" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         preclude customary non-targeted recruiting efforts or general solicitations that are not  specifically directed to, but which may have the effect of causing an employee, consultant or  contractor to leave the employment or arrangement with any member of the Group  Companies; or    (ii)  employ or attempt to employ or assist any individual or other entity to employ any  employee of any member of the Group Companies or to retain any consultant or contractor  during any period of time that the business services provided, directly or indirectly, by such  consultant or contractor are exclusively or primarily being provided to any member of the  Group Companies, provided, that this clause shall not preclude an employer of yours from  offering employment or consulting or contracting services to anyone without your direct or  indirect assistance.    (c) Confidentiality. You acknowledge that by reason of your employment with any  member of the Group Companies, you have had access to Confidential Information and trade secrets  of the Group Companies, and that such Confidential Information and trade secrets are essential  components of the business of the Group Companies, and are proprietary and would be of great  value and benefit to competitors of the Group Companies. &#8220;Confidential Information&#8221; is to be  broadly defined and includes anything respecting the Company and its affiliates or their respective  businesses, customers, supplier or operations, and which is not made readily available to the general  public. You agree that both during and after your employment with any member of the Group  Companies, you will not disclose to any individual or other entity, except in the proper course of  your employment with any member of the Group Companies, or use for your own purposes or for  purposes other than those of any member of the Group Companies, any Confidential Information or  trade secrets of any member of the Group Companies acquired by you. You agree that at all times  after your employment with any member of the Group Companies, you will hold in trust, keep  confidential, and not publish, disclose or otherwise disseminate to any third party or make any use of  the Confidential Information of any member of the Group Companies except for the benefit of the  Group Companies and in the course of employment with any member of the Group Companies. You  further agree not to cause the transmission, removal or transport of Confidential Information from  the Group Companies&#8217; place of business (principal, remote or otherwise), whether by hard or  electronic copy, without prior written approval of the Company and its ultimate parent, except for the  benefit of the Group Companies and in the course of your employment relationship with any member  of the Group Companies.  You acknowledge that you are aware that the unauthorized disclosure of  Confidential Information of any member of the Group Companies may be highly prejudicial to the  Group Companies&#8217; interests, an invasion of privacy and an improper disclosure of proprietary  information. You agree, promptly and without request, to deliver to and inform the Company and its  ultimate parent of all documents and data pertaining to your services to the any member of the Group  Companies and the Confidential Information of the Group Companies, whether prepared by you or  otherwise coming into your possession or control.  You will not retain any written or other tangible  material containing any information concerning or disclosing any of the Confidential Information of  any member of the Group Companies, including but not limited to any electronically stored data.    (i) If information enters the public domain, except as a result of a breach of this Section  (c) by you or a breach of another confidentiality agreement to which any member of the Group  Companies is a party, the information will not be deemed Confidential Information, or a trade secret  protected by this Section (c). If you are compelled by law to disclose Confidential Information or  trade secrets of any member of the Group Companies, pursuant to subpoena, an order from a court of  competent jurisdiction, or other applicable legal authority, you may disclose such Confidential  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec011.jpg" title="slide11" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         Information or trade secrets to the extent so required, but you will, if possible, (i) provide reasonable  advance notice of the subpoena, court order, or legal authority to the Company and its ultimate  parent, and (ii) afford the Group Companies the reasonable opportunity to take legal action to  contest, challenge, narrow or otherwise limit or condition the disclosure.  (ii) Sanctions for Unauthorized Taking of Confidential Information. You recognize that  the unauthorized taking of the Group Companies&#8217;  Confidential Information could result in civil  liability and that willful misappropriation may result in an award against you for damages and  attorney&#8217;s fees and costs in collecting such damages.  The unauthorized taking of trade secrets is a  crime and may be punishable by imprisonment, or a fine, or both, and/or may result in civil liability,  including, where applicable, punitive or similar damages, under applicable federal and state trade  secret laws.  (iii) Notice of Immunity Under the Economic Espionage Act of 1996, as amended by  the Defend Trade Secrets Act of 2016 (&quot;DTSA&quot;). Notwithstanding any other provision of this  Agreement:  (A) You will not be held criminally or civilly liable under any federal or  state trade secret law for any disclosure of a trade secret that: (1) is made: in  confidence to a federal, state, or local government official, either directly or  indirectly, or to an attorney; and solely for the purpose of reporting or  investigating a suspected violation of law; or (2) is made in a complaint or  other document that is filed under seal in a lawsuit or other proceeding.    (B) If you file a lawsuit for retaliation by any member of the Group Companies for  reporting a suspected violation of law, you may disclose the Group  Companies&#8217; trade secrets to your attorney and use the trade secret information  in the court proceeding if you: (1) file any document containing  the trade secret under seal; and (2) do not disclose the trade secret, except  pursuant to court order.    (d) Intellectual Property.    (i) You have attached hereto as Exhibit 1, a list describing all inventions, original works of  authorship, developments, improvements, copyrights and patents that were made or developed  by you prior to the date you sign this Agreement, that belong to you.  If such list is not attached  or is left blank, you represent that no such inventions exist.  (ii) You agree that all ideas, techniques, inventions, systems, business and marketing plans,  projections and analyses, discoveries, technical information, programs, prototypes,  copyrightable works of authorship, including without limitation software code, and similar  developments, improvements or creations developed, conceived, created, discovered, made, or  written by you in the course of or as the result, directly or indirectly, of the performance of  your employment with any member of the Group Companies (hereinafter called  &quot;Developments&quot;), and all related intellectual property rights, including but not limited to,  writings and other works of authorship, United States and foreign patents, mask works,  copyright and trademark registrations and other forms of intellectual property protection, shall  be and remain the property of the Group Companies.  You further agree to assign (or cause to  be assigned) and do hereby assign fully to the Group Companies all such Developments and  any copyrights, patents, mask work rights or other intellectual property rights relating thereto.   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec012.jpg" title="slide12" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         In the event copyrightable works do not fall within the theory of works made for hire, you  agree to assign, and do hereby assign, all rights, title and interest therein, without further  consideration, to the Group Companies.  You, insofar as you have the right to do so, agree that  you will execute or cause to be executed such United States and foreign patents, mask works,  copyright and trademark registrations and other documents and agreements and take such other  action as may be desirable in the opinion of the Group Companies to enable intellectual  property, copyright and other forms of protection for Developments to be obtained, maintained,  renewed, preserved and protected throughout the world by or on behalf of the Group  Companies.    (iii) If any member of the Group Companies is unable, after exercising reasonable efforts, to  secure your signature on any application for patent, copyright, analogous registration, or other  documents regarding any legal protection regarding Developments or other works and  inventions, whether because of your physical or mental incapacity or for any other reason, you  hereby irrevocably designate and appoint the Group Companies and their duly authorized  officers and agents as your agent and attorney-in-fact to act for and on your behalf and to  execute and file any such application or applications or other documents and to do all other  lawfully permitted acts to further the prosecution and issuance of such patent, copyright or  trademark registrations or any other legal protection thereon with the same legal force and  effect as if executed by you.  (iv) Incorporation into Company Products.  You agree that if in the course of your  employment with any member of the Group Companies, you incorporate into any invention,  service, or product any invention, improvement, Development, concept, discovery or other  proprietary information owned by you or in which you have an interest, (i) you will inform the  Company and its ultimate parent, in writing, before incorporating such invention,  improvement, development, concept, discovery or other proprietary information into any  invention, Service, or Development; and (ii) the Group Companies are hereby granted and  will have a nonexclusive, royalty-free, perpetual, irrevocable, worldwide license to make,  have made, modify, use and sell such item as part of or in connection with such invention,  services, or Development.  You will not incorporate any invention, improvement,  development, concept, discovery or other proprietary information owned by any third party  into any invention without the Company's and its ultimate parent&#8217;s prior written permission.  (v) Subsequent Use Restrictions.  During the course of employment and during the Restricted  Period, you agree to promptly notify the Company and its ultimate parent of any inventions  you develop that are based on, relate to or are a derivative of Developments or Confidential  Information.  You agree that any invention or work involving you after the separation of your  employment shall be deemed to result from access to the Company&#8217;s Developments or  Confidential Information (including without limitation patentable inventions and  copyrightable works) if such invention or work: (i) arose from your work with any member of  the Group Companies; or (ii) is related to the business of the Group Companies and is made,  created, used, sold, exploited or reduced to practice, or an application for patent, trademark,  copyright or other proprietary protection is filed by you and/or with your significant aid by a  third party, within the Restricted Period.  (e) Disclosure of New Employment.  In light of your obligations under this Agreement,   you agree to disclose the name of any future employer to the Company and its ultimate parent in  writing (even if you intend to be self-employed), along with your future business contact  information, including name and full address of the new employer.  Where necessary to protect the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec013.jpg" title="slide13" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807         Group Companies&#8217; interests, any member of the Group Companies may notify any future or  prospective employer of the existence of this Agreement and/or the terms and conditions of your  employment with any member of the Group Companies.   This obligation shall continue until the  end of the time periods under the Non-Competition and Non-Solicitation provisions above.     (f) Cooperation.  You shall provide reasonable cooperation in connection with any legal  action or proceeding (or any appeal from any action or proceeding) which relates to events during  your employment hereunder. The Company shall reimburse you for your reasonable travel expenses  incurred in connection with the foregoing, in accordance with the Company&#8217;s policies and subject  to the delivery of reasonable support for such expenses.      (g)  Restrictions Reasonable.  You confirm that all restrictions and covenants in this  Agreement are reasonable and valid, and waive all objections to and defenses to the strict  enforcement thereof.    (h) Survival of Restrictions.   This Agreement shall survive the termination of the Offer  Letter between you and the Company and the termination of your employment with any member of  the Group Companies, whether such termination is voluntary or involuntary, and regardless of the  reason(s) for such termination.       (i) Remedies.  In the event of breach or threatened breach by you of any provision of this  Agreement, any member of the Group Companies shall be entitled to (i) injunctive relief by  temporary restraining order, preliminary injunction, and/or permanent injunction, (ii) recovery of the  attorneys&#8217; fees and costs incurred by any member of the Group Companies in obtaining such relief,  and (iii) any other legal and equitable relief to which it may be entitled, including any and all  monetary damages which any member of the Group Companies may incur as a result of said breach  or threatened breach.  Injunctive relief shall not be the exclusive relief and may be in addition to any  other relief to which any member of the Group Companies would otherwise be entitled.  The  existence of any cause of action by you against the Company shall not constitute a defense to  enforcement of the restrictions on you created by this Agreement.  If you fail to comply with this  Agreement during the Restricted Period, the time period for that the Restricted Period will be  extended by one day for each day that you are found to have violated this Agreement, up to a  maximum extension of twelve (12) months.  In the event that a court finds the restrictions on you in  this Agreement are unenforceable as written, then the parties shall consent to the reformation of the  Agreement to make it enforceable to protect the interests of the Group Companies to the maximum  extent legally allowed.      (j) Parties Benefited; Assignments.  This Agreement shall inure to the benefit of the Group  Companies&#8217; owners, successors, assigns and affiliates, and may be assigned to and enforced by any  of the foregoing.  Neither this Agreement nor any rights or obligations hereunder may be assigned by  you.    (k) Notices.  Any notice required or permitted by this Agreement shall be in writing sent  by personal delivery, or by registered or certified mail, return receipt requested, addressed to the  Company at its then principal office, or to you at your last known address, or to such other address or  addressees as any party may from time to time specify in writing.  Notices shall be deemed given  when received.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec014.jpg" title="slide14" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807           (l) Governing Law, Jurisdiction and Venue.  This Agreement and any issues arising from  it or regarding its provisions shall be governed by and construed in accordance with the substantive  and procedural laws of the state of your primary workplace without reference to such jurisdiction&#8217;s  choice of law rules.    (m) Severability.  The provisions of this Agreement are severable so that in the event any  provision(s) in this Agreement is held to be illegal or unenforceable by any court or agency of  competent jurisdiction, or by operation of any applicable law, the remaining terms of this Agreement  shall remain valid and in full force and effect.  Further, such court or agency shall modify the  offending provision to conform to the most expansive permissible reading under the law to protect  the interests of the Group Companies.    (n) No Waiver.  No waiver of any breach or default hereunder shall be considered valid  unless in writing and signed by the party giving such waiver, and no waiver shall be deemed a  waiver of any subsequent breach or default of the same or similar nature.  No failure on the part of  any party to exercise, and no delay in exercising, any right, remedy, power or privilege hereunder  shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power  or privilege hereunder preclude any other or further exercise thereof or the exercise of any other  right, remedy, power or privilege.    (o)  Comprehension; Consultation with Counsel.  You acknowledge having read and  understood this Agreement and further acknowledge being hereby advised, by this paragraph, to  consult independent legal counsel. Accordingly, you acknowledge that you are voluntarily entering  into this Agreement of your own volition and not under duress.    (p) Waiver of Jury Trial.    YOU AND THE GROUP COMPANIES KNOWINGLY AND WILLINGLY WAIVE ANY  RIGHT TO A TRIAL BY JURY IN ANY DISPUTE ARISING OUT OF OR RELATING TO  THIS AGREEMENT.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1013-zerondaxexec015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1013-zerondaxexec015.jpg" title="slide15" width="965" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  Vyne Therapeutics Inc.  520 U.S. Highway 22, Suite 204, Bridgewater, New Jersey 08807             THE PARTIES ACKNOWLEDGE THAT THEY HAVE READ AND UNDERSTAND THIS  AGREEMENT, THAT THEY HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL IF  THEY SO CHOSE, AND THAT THEY ENTER INTO THIS AGREEMENT FREELY AND  VOLUNTARILY.            /s/ Tyler Zeronda_____   Tyler Zeronda              VYNE Pharmaceuticals Inc.        By: /s/ David Domzalski___    David Domzalski, Chief Executive Officer          </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>6
<FILENAME>exhibit211listofsubsidiari.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifd23689dc1e74c718f36fee7fb9e0f98_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 21.1</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">List of Subsidiaries of VYNE Therapeutics Inc.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The following is a list of subsidiaries of VYNE Therapeutics Inc. as of December&#160;31, 2021&#58;</font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.743%"><tr><td style="width:1.0%"></td><td style="width:76.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Name</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Jurisdiction</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VYNE Pharmaceuticals Ltd.*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VYNE Pharmaceuticals Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">*The Company is in the process of liquidating and dissolving this subsidiary. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>exhibit231consentus2.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie94766067a824d52bdbe158c7c650b39_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-255841) and Form S-8 (Nos. 333-253883, 333-229975, 333-237041, and 333-222758) of VYNE Therapeutics Inc. of our report dated March 17, 2022 relating to the financial statements, which appears in this Form 10-K.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; PricewaterhouseCoopers LLP </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florham Park, New Jersey </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">March 17, 2022</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>vyne-20211231xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8ae9e3661f194570ac80d324488e9b66_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David Domzalski, certify that&#58;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this report on Form 10-K of VYNE Therapeutics Inc.&#59;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 17, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David Domzalski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Domzalski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>vyne-20211231xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i32ce97bf38ae425a8ec3820ba500f6aa_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Tyler Zeronda, certify that&#58;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this report on Form 10-K of VYNE Therapeutics Inc.&#59;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 17, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Tyler Zeronda</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tyler Zeronda</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>vyne-20211231xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4b2f89a51ba14d35a7e2c5f61e2c7163_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of VYNE Therapeutics Inc. (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) for the year ended December&#160;31, 2021 as filed with the Securities and Exchange Commission (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), I, David Domzalski, President and Chief Executive Officer and principal executive officer, hereby certify as of the date hereof, solely for the purposes of 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 17, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David Domzalski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Domzalski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>11
<FILENAME>vyne-20211231xexx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icdb42ebf71e8465fbcd218a7edfa279c_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CFO PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of VYNE Therapeutics Inc. (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) for the year ended December&#160;31, 2021 as filed with the Securities and Exchange Commission (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), I, Tyler Zeronda, Chief Financial Officer, Treasurer and principal financial officer, hereby certify as of the date hereof, solely for purposes of 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:47.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 17, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Tyler Zeronda</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tyler Zeronda</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>vyne-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:74e91f80-5033-4690-868f-a2bf4ea38fc3,g:e1fa6db6-9541-4405-a6db-7ba5e60bcb37-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vyne="http://vynetherapeutics.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://vynetherapeutics.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vyne-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vyne-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vyne-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vyne-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://vynetherapeutics.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://vynetherapeutics.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1001003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
        <link:definition>1005007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical" roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical">
        <link:definition>1006008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFOPERATIONS" roleURI="http://vynetherapeutics.com/role/NATUREOFOPERATIONS">
        <link:definition>2101101 - Disclosure - NATURE OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFOPERATIONSDetails" roleURI="http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails">
        <link:definition>2402401 - Disclosure - NATURE OF OPERATIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails" roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails">
        <link:definition>2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Life (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails" roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails">
        <link:definition>2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Equity Awards Not Included in the Calculation of EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails" roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails">
        <link:definition>2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Concentrations of Credit Risks (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATION" roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATION">
        <link:definition>2110103 - Disclosure - BUSINESS COMBINATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONTables" roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONTables">
        <link:definition>2311302 - Disclosure - BUSINESS COMBINATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONNarrativeDetails" roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails">
        <link:definition>2412406 - Disclosure - BUSINESS COMBINATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails" roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails">
        <link:definition>2413407 - Disclosure - BUSINESS COMBINATION - Consideration Transferred in Merger (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONPurchasePriceAllocationDetails" roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails">
        <link:definition>2414408 - Disclosure - BUSINESS COMBINATION - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONGoodwillDetails" roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails">
        <link:definition>2415409 - Disclosure - BUSINESS COMBINATION - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONIPRDandCSRDetails" roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails">
        <link:definition>2416410 - Disclosure - BUSINESS COMBINATION - IPRD and CSR (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONProFormaDetails" roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails">
        <link:definition>2417411 - Disclosure - BUSINESS COMBINATION - Pro Forma (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://vynetherapeutics.com/role/REVENUERECOGNITION">
        <link:definition>2118104 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONDetails" roleURI="http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails">
        <link:definition>2419412 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2120105 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2321303 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails" roleURI="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails">
        <link:definition>2422413 - Disclosure - FAIR VALUE MEASUREMENT - Assets and Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIES" roleURI="http://vynetherapeutics.com/role/MARKETABLESECURITIES">
        <link:definition>2123106 - Disclosure - MARKETABLE SECURITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESTables" roleURI="http://vynetherapeutics.com/role/MARKETABLESECURITIESTables">
        <link:definition>2324304 - Disclosure - MARKETABLE SECURITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESMarketableSecuritiesDetails" roleURI="http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails">
        <link:definition>2425414 - Disclosure - MARKETABLE SECURITIES - Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESNarrativeDetails" roleURI="http://vynetherapeutics.com/role/MARKETABLESECURITIESNarrativeDetails">
        <link:definition>2426415 - Disclosure - MARKETABLE SECURITIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORY" roleURI="http://vynetherapeutics.com/role/INVENTORY">
        <link:definition>2127107 - Disclosure - INVENTORY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYTables" roleURI="http://vynetherapeutics.com/role/INVENTORYTables">
        <link:definition>2328305 - Disclosure - INVENTORY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYNarrativeDetails" roleURI="http://vynetherapeutics.com/role/INVENTORYNarrativeDetails">
        <link:definition>2429416 - Disclosure - INVENTORY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYScheduleofInventoryComponentsDetails" roleURI="http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails">
        <link:definition>2430417 - Disclosure - INVENTORY - Schedule of Inventory Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENT" roleURI="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENT">
        <link:definition>2131108 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTTables" roleURI="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTTables">
        <link:definition>2332306 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" roleURI="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails">
        <link:definition>2433418 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNarrativeDetails" roleURI="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTNarrativeDetails">
        <link:definition>2434419 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSES" roleURI="http://vynetherapeutics.com/role/ACCRUEDEXPENSES">
        <link:definition>2135109 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSESTables" roleURI="http://vynetherapeutics.com/role/ACCRUEDEXPENSESTables">
        <link:definition>2336307 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSESDetails" roleURI="http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails">
        <link:definition>2437420 - Disclosure - ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASE" roleURI="http://vynetherapeutics.com/role/OPERATINGLEASE">
        <link:definition>2138110 - Disclosure - OPERATING LEASE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASETables" roleURI="http://vynetherapeutics.com/role/OPERATINGLEASETables">
        <link:definition>2339308 - Disclosure - OPERATING LEASE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASENarrativeDetails" roleURI="http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails">
        <link:definition>2440421 - Disclosure - OPERATING LEASE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails" roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails">
        <link:definition>2441422 - Disclosure - OPERATING LEASE - Schedule of Operating Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails" roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails">
        <link:definition>2442423 - Disclosure - OPERATING LEASE - Schedule of Cash Paid for Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails" roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails">
        <link:definition>2443424 - Disclosure - OPERATING LEASE - Schedule of Supplemental Information Related to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails" roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>2444425 - Disclosure - OPERATING LEASE - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>2444425 - Disclosure - OPERATING LEASE - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESAVINGSPLAN" roleURI="http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLAN">
        <link:definition>2145111 - Disclosure - EMPLOYEE SAVINGS PLAN</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESAVINGSPLANDetails" roleURI="http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLANDetails">
        <link:definition>2446426 - Disclosure - EMPLOYEE SAVINGS PLAN (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://vynetherapeutics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2147112 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBT" roleURI="http://vynetherapeutics.com/role/LONGTERMDEBT">
        <link:definition>2148113 - Disclosure - LONG-TERM DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTDetails" roleURI="http://vynetherapeutics.com/role/LONGTERMDEBTDetails">
        <link:definition>2449427 - Disclosure - LONG-TERM DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://vynetherapeutics.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2150114 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails" roleURI="http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails">
        <link:definition>2451428 - Disclosure - STOCKHOLDERS' EQUITY - Common Stock, Preferred Stock, and Warrants Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATION" roleURI="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATION">
        <link:definition>2152115 - Disclosure - SHARE BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>2353309 - Disclosure - SHARE BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONNarrativeDetails" roleURI="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>2454429 - Disclosure - SHARE BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails" roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails">
        <link:definition>2455430 - Disclosure - Compensation Related Costs, Share Based Payments - Options and RSU Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails" roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails">
        <link:definition>2456431 - Disclosure - Compensation Related Costs, Share Based Payments - Schedule of Underlying Data Used for Computing the Fair Value of the Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails" roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails">
        <link:definition>2457432 - Disclosure - Compensation Related Costs, Share Based Payments - Summary of the Number of Options Outstanding Under the Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails" roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails">
        <link:definition>2458433 - Disclosure - Compensation Related Costs, Share Based Payments - Summary of Number of RSUs Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails" roleURI="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails">
        <link:definition>2459434 - Disclosure - SHARE BASED COMPENSATION - Schedule of Share-based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAX" roleURI="http://vynetherapeutics.com/role/INCOMETAX">
        <link:definition>2160116 - Disclosure - INCOME TAX</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXTables" roleURI="http://vynetherapeutics.com/role/INCOMETAXTables">
        <link:definition>2361310 - Disclosure - INCOME TAX (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails" roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails">
        <link:definition>2462435 - Disclosure - INCOME TAX - Schedule of Income (Loss) Before Income Tax Taxes and Current Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXIncomeTaxReconciliationDetails" roleURI="http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails">
        <link:definition>2463436 - Disclosure - INCOME TAX - Income Tax Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXNarrativeDetails" roleURI="http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails">
        <link:definition>2464437 - Disclosure - INCOME TAX - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXScheduleofDeferredIncomeTaxesDetails" roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails">
        <link:definition>2465438 - Disclosure - INCOME TAX - Schedule of Deferred Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails" roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails">
        <link:definition>2466439 - Disclosure - INCOME TAX - Schedule of Activity of the Company Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXScheduleofRollforwardofValuationAllowanceDetails" roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofRollforwardofValuationAllowanceDetails">
        <link:definition>2467440 - Disclosure - INCOME TAX- Schedule of Rollforward of Valuation Allowance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://vynetherapeutics.com/role/SUBSEQUENTEVENTS">
        <link:definition>2168117 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>2469441 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember" abstract="true" name="AmendedAndRestatedCreditAgreementTrench2LoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_FoamixMember" abstract="true" name="FoamixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_BusinessCombinationEffectiveExchangeRatio" abstract="false" name="BusinessCombinationEffectiveExchangeRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="vyne_TopicalBETiOptionAgreementMember" abstract="true" name="TopicalBETiOptionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_PeriodOfClosingTransaction" abstract="false" name="PeriodOfClosingTransaction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vyne_StockIssuedDuringPeriodSharesWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodSharesWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vyne_ContingentStockRightSharesConversion" abstract="false" name="ContingentStockRightSharesConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember" abstract="true" name="AmendedAndRestatedCreditAgreementTrench3LoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales" abstract="false" name="MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_IncomeTaxLineItems" abstract="true" name="IncomeTaxLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vyne_CustomerThreeMember" abstract="true" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_A2019PlanMember" abstract="true" name="A2019PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards" abstract="false" name="BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_CantorSalesAgreementMember" abstract="true" name="CantorSalesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation" abstract="false" name="AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_AmendedAndRestatedCreditAgreementMember" abstract="true" name="AmendedAndRestatedCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired" abstract="false" name="NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" abstract="false" name="BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_NonCashAcquisitionOfBusinessCashAcquired" abstract="false" name="NonCashAcquisitionOfBusinessCashAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock" abstract="false" name="ScheduleOfBusinessAcquisitionConsiderationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vyne_LincolnParkEquityPurchaseAgreementMember" abstract="true" name="LincolnParkEquityPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_AccruedCommercializedProductCurrent" abstract="false" name="AccruedCommercializedProductCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_ContingentStockConsiderationRemeasurementGainLoss" abstract="false" name="ContingentStockConsiderationRemeasurementGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_GrossProceedsFromIssuanceOfCommonStock" abstract="false" name="GrossProceedsFromIssuanceOfCommonStock" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_RestrictedInvestmentsToSecureLeaseAgreements" abstract="false" name="RestrictedInvestmentsToSecureLeaseAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum" abstract="false" name="MilestonePaymentsUponAchievingCertainCriteriaMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes" abstract="false" name="BusinessCombinationSharesDeemedIssuedForAccountingPurposes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vyne_PostMergerParentOwnershipByPreMergerParentStockholders" abstract="false" name="PostMergerParentOwnershipByPreMergerParentStockholders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain" abstract="false" name="LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_BusinessAcquisitionContingentStockRightIssued" abstract="false" name="BusinessAcquisitionContingentStockRightIssued" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock" abstract="false" name="CommissionFromGrossProceedsFromIssuanceOfCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_DeferredTaxAssetsValuationAllowanceRollForward" abstract="true" name="DeferredTaxAssetsValuationAllowanceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vyne_RepaymentOfDebtPrepaymentFeePercentage" abstract="false" name="RepaymentOfDebtPrepaymentFeePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets" abstract="false" name="BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_NumberOfLenders" abstract="false" name="NumberOfLenders" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vyne_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_IsraeliMutualFundsMember" abstract="true" name="IsraeliMutualFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_SaleOfStockConsiderationReceivableOnTransaction" abstract="false" name="SaleOfStockConsiderationReceivableOnTransaction" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_CustomerOneMember" abstract="true" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_MenloPremergerMember" abstract="true" name="MenloPremergerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_BusinessCombinationConsiderationTransferredGross" abstract="false" name="BusinessCombinationConsiderationTransferredGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_CommonStockVotingRightsNumberPerShare" abstract="false" name="CommonStockVotingRightsNumberPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" abstract="false" name="ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_BridgewaterNewJerseyMember" abstract="true" name="BridgewaterNewJerseyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_ClassOfWarrantAbstract" abstract="true" name="ClassOfWarrantAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vyne_EstimateOfProductReturnRateMaximum" abstract="false" name="EstimateOfProductReturnRateMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_A2018PlanMember" abstract="true" name="A2018PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_ThreeLargestCustomersMember" abstract="true" name="ThreeLargestCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances" abstract="false" name="RevenueRecognitionDistributionTradeDiscountsAndAllowances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember" abstract="true" name="AmendedAndRestatedCreditAgreementTrench1LoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_CustomerTwoMember" abstract="true" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_IncomeTaxTable" abstract="true" name="IncomeTaxTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement" abstract="false" name="SharesIssuedUponConversionOfCommonStockRightsPerAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders" abstract="false" name="PostMergerParentOwnershipByPreMergerSubsidiaryShareholders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_ShareholderLenderMember" abstract="true" name="ShareholderLenderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_DebtInstrumentFeePercent" abstract="false" name="DebtInstrumentFeePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_GainLossOnSaleAndDispositionOfFixedAssets" abstract="false" name="GainLossOnSaleAndDispositionOfFixedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod" abstract="false" name="ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock" abstract="false" name="ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vyne_AllowanceForSalesReturns1Member" abstract="true" name="AllowanceForSalesReturns1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_OralBETiOptionAgreementMember" abstract="true" name="OralBETiOptionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_AdditionalSpaceMember" abstract="true" name="AdditionalSpaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_RoyaltyPaymentPercentMaximum" abstract="false" name="RoyaltyPaymentPercentMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_VehicleLeasePrepaymentPeriod" abstract="false" name="VehicleLeasePrepaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vyne_AccruedResearchAndDevelopmentCurrent" abstract="false" name="AccruedResearchAndDevelopmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_FacilitySpaceUnderLease" abstract="false" name="FacilitySpaceUnderLease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost" abstract="false" name="ShareBasedPaymentArrangementPlanModificationUnrecognizedCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember" abstract="false" name="ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_RegisteredDirectOfferingMember" abstract="true" name="RegisteredDirectOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations" abstract="false" name="AdjustmentsToSupplementalProformaCombinedResultsOfOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_AccruedSalesProvisionsCurrent" abstract="false" name="AccruedSalesProvisionsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vyne_OperatingLeaseRightOfUseAssetCurrent" abstract="false" name="OperatingLeaseRightOfUseAssetCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_MenloMember" abstract="true" name="MenloMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_RegisteredOfferingMember" abstract="true" name="RegisteredOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_AdjustmentsToSupplementalProformaTransactionCosts" abstract="false" name="AdjustmentsToSupplementalProformaTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_RetentionPaymentsMember" abstract="true" name="RetentionPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_ComputerEquipmentAndSoftwareMember" abstract="false" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock" abstract="false" name="ScheduleOfBusinessCombinationGoodwillTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vyne_PublicStockOfferingMember" abstract="true" name="PublicStockOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_EquityPurchaseAgreementPeriodInForce" abstract="false" name="EquityPurchaseAgreementPeriodInForce" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vyne_OriginalSpaceMember" abstract="true" name="OriginalSpaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vyne_OperatingLeaseLiabilityTransferred" abstract="false" name="OperatingLeaseLiabilityTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_PaymentsForLicensingAgreements" abstract="false" name="PaymentsForLicensingAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_ExchangeRatio" abstract="false" name="ExchangeRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="vyne_OperatingLeaseRightOfUseAssetsTransferred" abstract="false" name="OperatingLeaseRightOfUseAssetsTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales" abstract="false" name="DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_EstimateOfProductReturnRateMinimum" abstract="false" name="EstimateOfProductReturnRateMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vyne_InterestReceived" abstract="false" name="InterestReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification" abstract="false" name="DeemedDividendToWarrantsHoldersDueToWarrantModification" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock" abstract="false" name="ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>vyne-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:74e91f80-5033-4690-868f-a2bf4ea38fc3,g:e1fa6db6-9541-4405-a6db-7ba5e60bcb37-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4244ce86-fbd6-40c7-a907-470c66c7b89f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ca354e9b-3784-480a-9735-bfc409b1f2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4244ce86-fbd6-40c7-a907-470c66c7b89f" xlink:to="loc_us-gaap_AssetsCurrent_ca354e9b-3784-480a-9735-bfc409b1f2b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_8a40c1e2-c043-4d5b-a470-1d12b2bd985c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4244ce86-fbd6-40c7-a907-470c66c7b89f" xlink:to="loc_us-gaap_AssetsNoncurrent_8a40c1e2-c043-4d5b-a470-1d12b2bd985c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_677fea6e-9ce3-4b49-840b-7650bfbe4d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_65c54fc3-4116-4419-8a50-4af4c931057d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_677fea6e-9ce3-4b49-840b-7650bfbe4d73" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_65c54fc3-4116-4419-8a50-4af4c931057d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_b0b6dc4a-332a-4bfb-b300-e01633bd119f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_677fea6e-9ce3-4b49-840b-7650bfbe4d73" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_b0b6dc4a-332a-4bfb-b300-e01633bd119f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_049ad74b-3be9-4c71-ad9b-e7f3f06f4353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_677fea6e-9ce3-4b49-840b-7650bfbe4d73" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_049ad74b-3be9-4c71-ad9b-e7f3f06f4353" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_88346c5b-e0d2-49da-a36c-5b6e24e56fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_677fea6e-9ce3-4b49-840b-7650bfbe4d73" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_88346c5b-e0d2-49da-a36c-5b6e24e56fa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_44758fec-0ea6-4173-9b63-2b94b77785c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_677fea6e-9ce3-4b49-840b-7650bfbe4d73" xlink:to="loc_us-gaap_InventoryNet_44758fec-0ea6-4173-9b63-2b94b77785c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dfe3cb24-bddf-4111-a317-98782332e034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_677fea6e-9ce3-4b49-840b-7650bfbe4d73" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dfe3cb24-bddf-4111-a317-98782332e034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseRightOfUseAssetCurrent_cb8936a6-c06b-419e-a860-5f24f5564939" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseRightOfUseAssetCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_677fea6e-9ce3-4b49-840b-7650bfbe4d73" xlink:to="loc_vyne_OperatingLeaseRightOfUseAssetCurrent_cb8936a6-c06b-419e-a860-5f24f5564939" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_9eb8df19-1bb0-4f57-87e6-fb0926886bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e38a89ee-a2d0-4318-b434-66a9c03cbd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_9eb8df19-1bb0-4f57-87e6-fb0926886bf1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e38a89ee-a2d0-4318-b434-66a9c03cbd5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8880c57a-0425-4ae6-8218-d5ec3772a66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_9eb8df19-1bb0-4f57-87e6-fb0926886bf1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8880c57a-0425-4ae6-8218-d5ec3772a66f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_08ad804a-316e-4fef-b081-478a89fd27f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_9eb8df19-1bb0-4f57-87e6-fb0926886bf1" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_08ad804a-316e-4fef-b081-478a89fd27f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_86cc905f-ae43-4704-9e1b-9c62762383af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bbff8f4c-be6b-4548-8383-3481680d49ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_86cc905f-ae43-4704-9e1b-9c62762383af" xlink:to="loc_us-gaap_StockholdersEquity_bbff8f4c-be6b-4548-8383-3481680d49ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_49a8efba-49d3-456c-9701-fe1e715e43e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_86cc905f-ae43-4704-9e1b-9c62762383af" xlink:to="loc_us-gaap_Liabilities_49a8efba-49d3-456c-9701-fe1e715e43e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_dd62468f-01ef-4fd8-bc70-03197132089d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_86cc905f-ae43-4704-9e1b-9c62762383af" xlink:to="loc_us-gaap_CommitmentsAndContingencies_dd62468f-01ef-4fd8-bc70-03197132089d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_39b6c940-8fad-4371-81e7-e507b93d68c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_a300fb0f-4777-4a80-b41a-0fe33aadb8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39b6c940-8fad-4371-81e7-e507b93d68c3" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_a300fb0f-4777-4a80-b41a-0fe33aadb8e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_642d4a5c-cce3-4b66-bf17-61ff1819d32e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39b6c940-8fad-4371-81e7-e507b93d68c3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_642d4a5c-cce3-4b66-bf17-61ff1819d32e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3a04aeef-01b5-47c3-8cb7-8448ac9d0d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39b6c940-8fad-4371-81e7-e507b93d68c3" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3a04aeef-01b5-47c3-8cb7-8448ac9d0d3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_57b2bd0e-76f2-49c1-81c7-eff0bcf9017d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39b6c940-8fad-4371-81e7-e507b93d68c3" xlink:to="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_57b2bd0e-76f2-49c1-81c7-eff0bcf9017d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6362b5ad-9707-4b88-a499-ebe6ac5e710c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39b6c940-8fad-4371-81e7-e507b93d68c3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6362b5ad-9707-4b88-a499-ebe6ac5e710c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_135734f4-a08c-43c4-8a22-1f6bdcec03f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39b6c940-8fad-4371-81e7-e507b93d68c3" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_135734f4-a08c-43c4-8a22-1f6bdcec03f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_23988185-912e-4d39-86a7-96d949b749e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0c87ad89-0827-4320-b824-56a14bda0c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_23988185-912e-4d39-86a7-96d949b749e0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0c87ad89-0827-4320-b824-56a14bda0c46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_716c235b-48ad-4795-a929-9f6455f2b7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_23988185-912e-4d39-86a7-96d949b749e0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_716c235b-48ad-4795-a929-9f6455f2b7cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_0084dcb0-f683-4267-8978-4c9fce68cd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_23988185-912e-4d39-86a7-96d949b749e0" xlink:to="loc_us-gaap_OtherLiabilities_0084dcb0-f683-4267-8978-4c9fce68cd0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9749d89b-8e84-4e0e-928e-43e514c8d328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_6b27d980-4f48-44e6-8f0c-bc8818953091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9749d89b-8e84-4e0e-928e-43e514c8d328" xlink:to="loc_us-gaap_PreferredStockValue_6b27d980-4f48-44e6-8f0c-bc8818953091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d4d2e0b6-3ede-46de-8f9c-a608ac778ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9749d89b-8e84-4e0e-928e-43e514c8d328" xlink:to="loc_us-gaap_CommonStockValue_d4d2e0b6-3ede-46de-8f9c-a608ac778ff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4edc47e2-64f5-4253-9e9d-b3cee75277ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9749d89b-8e84-4e0e-928e-43e514c8d328" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4edc47e2-64f5-4253-9e9d-b3cee75277ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05a462ec-4b67-4fb6-b290-89f28dcae9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9749d89b-8e84-4e0e-928e-43e514c8d328" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05a462ec-4b67-4fb6-b290-89f28dcae9b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f961957d-4b40-4399-a11d-0f9a1b38c148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9749d89b-8e84-4e0e-928e-43e514c8d328" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f961957d-4b40-4399-a11d-0f9a1b38c148" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1be81d97-a6d7-4662-a0d5-f1f5807040fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_81a5118f-ec71-46d2-b733-4168ca08f936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1be81d97-a6d7-4662-a0d5-f1f5807040fe" xlink:to="loc_us-gaap_LiabilitiesCurrent_81a5118f-ec71-46d2-b733-4168ca08f936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_171337d3-e489-460e-9a85-07e96eb4e5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1be81d97-a6d7-4662-a0d5-f1f5807040fe" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_171337d3-e489-460e-9a85-07e96eb4e5e0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8c590f6b-b9ab-4a99-a078-04bdc927ded0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_22592b63-32fe-410f-b51c-6a2758e0b385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8c590f6b-b9ab-4a99-a078-04bdc927ded0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_22592b63-32fe-410f-b51c-6a2758e0b385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_863db1b6-d9ec-478d-bf78-3b7173b42432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8c590f6b-b9ab-4a99-a078-04bdc927ded0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_863db1b6-d9ec-478d-bf78-3b7173b42432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d400a670-e445-4234-b932-073cef5f5ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8c590f6b-b9ab-4a99-a078-04bdc927ded0" xlink:to="loc_us-gaap_CostsAndExpenses_d400a670-e445-4234-b932-073cef5f5ab8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7adb1a7b-0cb3-4f5b-b4fb-b38a8e831339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_17e07981-4ea3-4a85-a8b6-b2a879439719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7adb1a7b-0cb3-4f5b-b4fb-b38a8e831339" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_17e07981-4ea3-4a85-a8b6-b2a879439719" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_79d8557c-a2b4-466e-a2ab-75d70ca70d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7adb1a7b-0cb3-4f5b-b4fb-b38a8e831339" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_79d8557c-a2b4-466e-a2ab-75d70ca70d9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_647856d8-c0f2-4d15-a504-f468664a133f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7adb1a7b-0cb3-4f5b-b4fb-b38a8e831339" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_647856d8-c0f2-4d15-a504-f468664a133f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_7a861dd2-f737-48d5-98bb-ff09ed3fc0f2" xlink:href="vyne-20211231.xsd#vyne_ContingentStockConsiderationRemeasurementGainLoss"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7adb1a7b-0cb3-4f5b-b4fb-b38a8e831339" xlink:to="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_7a861dd2-f737-48d5-98bb-ff09ed3fc0f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a413edaf-3784-4421-893e-bfeae9a8d097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a460b05f-8ed3-4e24-9ab0-fa4b615f7611" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a413edaf-3784-4421-893e-bfeae9a8d097" xlink:to="loc_us-gaap_InterestExpense_a460b05f-8ed3-4e24-9ab0-fa4b615f7611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_84dc2bf1-f0c3-4799-bb68-8bf18bd9f2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a413edaf-3784-4421-893e-bfeae9a8d097" xlink:to="loc_us-gaap_OperatingIncomeLoss_84dc2bf1-f0c3-4799-bb68-8bf18bd9f2ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8e4e1603-bf09-41f2-9267-93e603a7636f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a413edaf-3784-4421-893e-bfeae9a8d097" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8e4e1603-bf09-41f2-9267-93e603a7636f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bc3562cf-23a9-4d09-bc69-251bf441434f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4209865d-3234-4ced-89d6-36dc86e880db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bc3562cf-23a9-4d09-bc69-251bf441434f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4209865d-3234-4ced-89d6-36dc86e880db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_325e3125-893c-40e0-9ec7-6b0c1161e049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bc3562cf-23a9-4d09-bc69-251bf441434f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_325e3125-893c-40e0-9ec7-6b0c1161e049" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_096b3d28-efe1-4b5a-9d9a-a58d6c673661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea1fd811-0476-4c77-999e-263f88e708c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_096b3d28-efe1-4b5a-9d9a-a58d6c673661" xlink:to="loc_us-gaap_NetIncomeLoss_ea1fd811-0476-4c77-999e-263f88e708c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ec75c2c3-1823-4ac6-87ba-391e63b4235f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_096b3d28-efe1-4b5a-9d9a-a58d6c673661" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ec75c2c3-1823-4ac6-87ba-391e63b4235f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1cf0ac8-f3cc-443b-825d-d0904348cd5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e5661fbb-6912-4e79-bc53-4d3e28e1c2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1cf0ac8-f3cc-443b-825d-d0904348cd5a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e5661fbb-6912-4e79-bc53-4d3e28e1c2d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_bb52060e-f1a4-4782-b428-fab86269c822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1cf0ac8-f3cc-443b-825d-d0904348cd5a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_bb52060e-f1a4-4782-b428-fab86269c822" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cc1b432b-ceb7-4d07-b2f8-64a3df5a34c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ecd783c9-82f3-4ef8-9332-e92dea95d7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cc1b432b-ceb7-4d07-b2f8-64a3df5a34c3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ecd783c9-82f3-4ef8-9332-e92dea95d7aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_0a67b5e3-376a-41e3-b694-a59ee0259309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cc1b432b-ceb7-4d07-b2f8-64a3df5a34c3" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_0a67b5e3-376a-41e3-b694-a59ee0259309" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_fe57e962-dc2c-4baf-942c-ac0e2c33a9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cc1b432b-ceb7-4d07-b2f8-64a3df5a34c3" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_fe57e962-dc2c-4baf-942c-ac0e2c33a9ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c96554f-1517-4a72-8c34-b10590377913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd69281-377e-4454-9452-2c42f12b8686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c96554f-1517-4a72-8c34-b10590377913" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cbd69281-377e-4454-9452-2c42f12b8686" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce75d593-7ad2-4c1c-878b-c8aa3ae3f5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c96554f-1517-4a72-8c34-b10590377913" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ce75d593-7ad2-4c1c-878b-c8aa3ae3f5bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7a2ccd4b-d976-46ab-adad-a3884e543146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c96554f-1517-4a72-8c34-b10590377913" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7a2ccd4b-d976-46ab-adad-a3884e543146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_3092e685-fe05-42f5-a1bf-018ba776fe29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_90db9dc1-85f9-4152-ae62-9ef851c1a543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_3092e685-fe05-42f5-a1bf-018ba776fe29" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_90db9dc1-85f9-4152-ae62-9ef851c1a543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_368022b2-3e41-4ce9-9518-9a5ddbde2a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_3092e685-fe05-42f5-a1bf-018ba776fe29" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_368022b2-3e41-4ce9-9518-9a5ddbde2a2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2bed1fac-6749-4c51-9dbb-89319ef3f275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_NetIncomeLoss_2bed1fac-6749-4c51-9dbb-89319ef3f275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c262febd-1966-440c-8585-6e3cc7a6f1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c262febd-1966-440c-8585-6e3cc7a6f1ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_c92a7eb8-7ce7-4aae-a237-5becb69654ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_c92a7eb8-7ce7-4aae-a237-5becb69654ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_a0a41e14-59a5-4ea0-b778-961fc81dfc98" xlink:href="vyne-20211231.xsd#vyne_ContingentStockConsiderationRemeasurementGainLoss"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_a0a41e14-59a5-4ea0-b778-961fc81dfc98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_GainLossOnSaleAndDispositionOfFixedAssets_72a9302a-4087-4258-b4f0-1443ec2c43ed" xlink:href="vyne-20211231.xsd#vyne_GainLossOnSaleAndDispositionOfFixedAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_vyne_GainLossOnSaleAndDispositionOfFixedAssets_72a9302a-4087-4258-b4f0-1443ec2c43ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_be5deb74-843c-4197-9dfd-dce403c7abdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_be5deb74-843c-4197-9dfd-dce403c7abdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_d5f3aa6c-deec-4b6c-8f39-d5660a4e6878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_d5f3aa6c-deec-4b6c-8f39-d5660a4e6878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8bf15e92-75d1-496b-9aa0-f1f7cbab23f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_ShareBasedCompensation_8bf15e92-75d1-496b-9aa0-f1f7cbab23f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_26955242-fc12-4a9b-97f7-dcfbb4fe216a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_26955242-fc12-4a9b-97f7-dcfbb4fe216a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e01282b8-5b35-4683-89e8-8e26b67b68e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e01282b8-5b35-4683-89e8-8e26b67b68e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_067241b1-f8c9-4142-a4cd-802c53a89f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_067241b1-f8c9-4142-a4cd-802c53a89f03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_528f76a5-39e9-4963-91a4-4a3b353fceb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_528f76a5-39e9-4963-91a4-4a3b353fceb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_83f9e2e8-0c4b-4cc4-aaa7-f5fbad78a96c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_83f9e2e8-0c4b-4cc4-aaa7-f5fbad78a96c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_0796f5f7-064b-4ad9-8724-ac8ee6b51768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d88a9bf-4474-4df7-a1a6-9a211347fe01" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_0796f5f7-064b-4ad9-8724-ac8ee6b51768" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcd58d41-2dfb-4d98-ac1a-b71e402c016c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7612f01a-eb4b-43c0-8414-ade7a4faa7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcd58d41-2dfb-4d98-ac1a-b71e402c016c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7612f01a-eb4b-43c0-8414-ade7a4faa7a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_f9208631-3e50-4b59-afc5-fe3a0523ed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcd58d41-2dfb-4d98-ac1a-b71e402c016c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_f9208631-3e50-4b59-afc5-fe3a0523ed9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired_d5c7e409-bbf6-4ed7-a378-e41fa4b54163" xlink:href="vyne-20211231.xsd#vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_NonCashAcquisitionOfBusinessCashAcquired_f7fac759-5285-43e5-baee-6e078dd09a7b" xlink:href="vyne-20211231.xsd#vyne_NonCashAcquisitionOfBusinessCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired_d5c7e409-bbf6-4ed7-a378-e41fa4b54163" xlink:to="loc_vyne_NonCashAcquisitionOfBusinessCashAcquired_f7fac759-5285-43e5-baee-6e078dd09a7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_94798d05-81ca-48f5-a058-99d41ef42ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired_d5c7e409-bbf6-4ed7-a378-e41fa4b54163" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_94798d05-81ca-48f5-a058-99d41ef42ce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44626ac8-7baf-4ec6-894d-86c64b87a725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c65d8ec8-5378-47f3-ac31-77062d183b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44626ac8-7baf-4ec6-894d-86c64b87a725" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c65d8ec8-5378-47f3-ac31-77062d183b2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_de8853ed-d958-4385-b6a0-b6e2a22755b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44626ac8-7baf-4ec6-894d-86c64b87a725" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_de8853ed-d958-4385-b6a0-b6e2a22755b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fb78fcab-3e21-4762-9f8d-c40673144dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44626ac8-7baf-4ec6-894d-86c64b87a725" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fb78fcab-3e21-4762-9f8d-c40673144dfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c9155015-e815-4c28-83cf-cb1bfc9aa445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44626ac8-7baf-4ec6-894d-86c64b87a725" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c9155015-e815-4c28-83cf-cb1bfc9aa445" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredGross_04cb7024-f246-4791-8eae-fe6e25311914" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_49f40178-e2e0-4db3-983b-5d389fd2cd2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vyne_BusinessCombinationConsiderationTransferredGross_04cb7024-f246-4791-8eae-fe6e25311914" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_49f40178-e2e0-4db3-983b-5d389fd2cd2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_7e6584c6-48b6-44a5-b4fb-6cd7720ebe43" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vyne_BusinessCombinationConsiderationTransferredGross_04cb7024-f246-4791-8eae-fe6e25311914" xlink:to="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_7e6584c6-48b6-44a5-b4fb-6cd7720ebe43" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_56ef6420-99e4-40d6-b5da-27c471c8a9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_3ad4238b-74bc-4345-94c6-3cf7dd2a2cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_56ef6420-99e4-40d6-b5da-27c471c8a9d9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_3ad4238b-74bc-4345-94c6-3cf7dd2a2cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9ff91f49-d2cb-41b9-81f4-10dd2aee954b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_56ef6420-99e4-40d6-b5da-27c471c8a9d9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9ff91f49-d2cb-41b9-81f4-10dd2aee954b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_27250bc2-1618-4e06-a42f-5d56b19439ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_b1f2bfbd-6a83-434b-8437-a87d02961bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_27250bc2-1618-4e06-a42f-5d56b19439ae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_b1f2bfbd-6a83-434b-8437-a87d02961bb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_9343b391-4b8a-4b6b-b7af-3b6473e34682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_920f116b-b201-4e00-aa6a-376a0f0a40a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_9343b391-4b8a-4b6b-b7af-3b6473e34682" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_920f116b-b201-4e00-aa6a-376a0f0a40a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_c026c1d2-26cf-4dd6-b028-b7fc87d9d9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_9343b391-4b8a-4b6b-b7af-3b6473e34682" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_c026c1d2-26cf-4dd6-b028-b7fc87d9d9d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_b52cb8f0-241d-4b40-8549-db00cb25b460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_9343b391-4b8a-4b6b-b7af-3b6473e34682" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_b52cb8f0-241d-4b40-8549-db00cb25b460" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d29cdc78-41aa-4436-96ec-8d7092a20153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_9343b391-4b8a-4b6b-b7af-3b6473e34682" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d29cdc78-41aa-4436-96ec-8d7092a20153" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9c2e94fc-dbd6-45a8-a54f-1949c5b6a5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_9343b391-4b8a-4b6b-b7af-3b6473e34682" xlink:to="loc_us-gaap_Goodwill_9c2e94fc-dbd6-45a8-a54f-1949c5b6a5a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONGoodwillDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_269db4b2-e21d-49c1-94ba-d586a015cfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets_1ef1aacf-a774-4cbd-9854-94f56cb8472e" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_269db4b2-e21d-49c1-94ba-d586a015cfbf" xlink:to="loc_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets_1ef1aacf-a774-4cbd-9854-94f56cb8472e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_73a4f893-657c-4362-a4d0-6264e01d96f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_269db4b2-e21d-49c1-94ba-d586a015cfbf" xlink:to="loc_us-gaap_Goodwill_73a4f893-657c-4362-a4d0-6264e01d96f1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONIPRDandCSRDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_edeb2b9f-c3db-4fbc-ace1-d187419ed434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_9095a56f-7207-4803-a136-8da436636a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_edeb2b9f-c3db-4fbc-ace1-d187419ed434" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_9095a56f-7207-4803-a136-8da436636a36" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONProFormaDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations_5810cf85-2402-468f-970e-1262dee6a47d" xlink:href="vyne-20211231.xsd#vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdjustmentsToSupplementalProformaTransactionCosts_8b93cd10-f0bd-4fcc-8aad-3e90566bf18c" xlink:href="vyne-20211231.xsd#vyne_AdjustmentsToSupplementalProformaTransactionCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations_5810cf85-2402-468f-970e-1262dee6a47d" xlink:to="loc_vyne_AdjustmentsToSupplementalProformaTransactionCosts_8b93cd10-f0bd-4fcc-8aad-3e90566bf18c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation_d23bae53-4786-462e-bf00-e05927963d4a" xlink:href="vyne-20211231.xsd#vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations_5810cf85-2402-468f-970e-1262dee6a47d" xlink:to="loc_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation_d23bae53-4786-462e-bf00-e05927963d4a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INVENTORYScheduleofInventoryComponentsDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_26ae37f0-20f0-4e76-9fcb-8a1ff9aacbac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_2d430972-cd64-4fd2-9c2e-23a79122e13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_26ae37f0-20f0-4e76-9fcb-8a1ff9aacbac" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_2d430972-cd64-4fd2-9c2e-23a79122e13b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_210247c2-2295-4eb0-9b67-dba7025dbb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_26ae37f0-20f0-4e76-9fcb-8a1ff9aacbac" xlink:to="loc_us-gaap_InventoryWorkInProcess_210247c2-2295-4eb0-9b67-dba7025dbb3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_ea52edea-a641-4971-9646-dbfd71d1a2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_26ae37f0-20f0-4e76-9fcb-8a1ff9aacbac" xlink:to="loc_us-gaap_InventoryFinishedGoods_ea52edea-a641-4971-9646-dbfd71d1a2a8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_dc8c2e93-f3c5-4256-b561-6ddeb058c66b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_606d0e1c-a359-4e60-89f9-7de34f001d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_dc8c2e93-f3c5-4256-b561-6ddeb058c66b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_606d0e1c-a359-4e60-89f9-7de34f001d14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_25bd8cf5-a946-482b-98e0-63d425ed075f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_dc8c2e93-f3c5-4256-b561-6ddeb058c66b" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_25bd8cf5-a946-482b-98e0-63d425ed075f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#ACCRUEDEXPENSESDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d57cf7c5-0d2e-413b-9b6c-e5f4ff29e25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4e19329e-3b5f-43e1-9eb8-1f9477f488f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d57cf7c5-0d2e-413b-9b6c-e5f4ff29e25b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4e19329e-3b5f-43e1-9eb8-1f9477f488f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_a9589951-8563-4db8-b6b9-7a16e08480fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d57cf7c5-0d2e-413b-9b6c-e5f4ff29e25b" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_a9589951-8563-4db8-b6b9-7a16e08480fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AccruedSalesProvisionsCurrent_a03e21b6-20e0-43bb-b5b0-2dce3381dae4" xlink:href="vyne-20211231.xsd#vyne_AccruedSalesProvisionsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d57cf7c5-0d2e-413b-9b6c-e5f4ff29e25b" xlink:to="loc_vyne_AccruedSalesProvisionsCurrent_a03e21b6-20e0-43bb-b5b0-2dce3381dae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_80a651fa-7e37-4bac-a7b8-0772ca978444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d57cf7c5-0d2e-413b-9b6c-e5f4ff29e25b" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_80a651fa-7e37-4bac-a7b8-0772ca978444" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AccruedResearchAndDevelopmentCurrent_08e4455c-509a-4bd4-81e0-414b0a4b8869" xlink:href="vyne-20211231.xsd#vyne_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d57cf7c5-0d2e-413b-9b6c-e5f4ff29e25b" xlink:to="loc_vyne_AccruedResearchAndDevelopmentCurrent_08e4455c-509a-4bd4-81e0-414b0a4b8869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AccruedCommercializedProductCurrent_49192837-5b61-4600-af5f-604cd9bf252b" xlink:href="vyne-20211231.xsd#vyne_AccruedCommercializedProductCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d57cf7c5-0d2e-413b-9b6c-e5f4ff29e25b" xlink:to="loc_vyne_AccruedCommercializedProductCurrent_49192837-5b61-4600-af5f-604cd9bf252b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_89e8e5b1-c323-4e3a-99c7-c0c919778d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bf3165cc-8ad2-4ea8-98b9-406a7c5bdec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_89e8e5b1-c323-4e3a-99c7-c0c919778d3f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bf3165cc-8ad2-4ea8-98b9-406a7c5bdec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ffc650c6-0658-4c22-8ee5-aa1e008bb056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_89e8e5b1-c323-4e3a-99c7-c0c919778d3f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ffc650c6-0658-4c22-8ee5-aa1e008bb056" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9c0a71ae-6d33-4a40-bc41-bd27b689bd35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_49057378-c955-4604-8085-5011fdeec881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9c0a71ae-6d33-4a40-bc41-bd27b689bd35" xlink:to="loc_us-gaap_OperatingLeaseLiability_49057378-c955-4604-8085-5011fdeec881" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5f5ff70d-e4a2-4a61-a214-cee457379a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9c0a71ae-6d33-4a40-bc41-bd27b689bd35" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5f5ff70d-e4a2-4a61-a214-cee457379a65" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_505e7589-d804-4b1d-a4b5-9abcf51c1610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_5bf75bae-093e-44b8-b094-df24fad0cffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_505e7589-d804-4b1d-a4b5-9abcf51c1610" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_5bf75bae-093e-44b8-b094-df24fad0cffc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_83347b24-d86d-4ef8-954c-31e591f6a1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_505e7589-d804-4b1d-a4b5-9abcf51c1610" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_83347b24-d86d-4ef8-954c-31e591f6a1d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXIncomeTaxReconciliationDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6e3ab133-a4be-40e1-88fb-e213e7dc99c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9067cccd-85d8-4c07-ae56-04fa42d3a17a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6e3ab133-a4be-40e1-88fb-e213e7dc99c9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9067cccd-85d8-4c07-ae56-04fa42d3a17a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1bb10270-20c0-4f9c-8615-dba1ef909a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6e3ab133-a4be-40e1-88fb-e213e7dc99c9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1bb10270-20c0-4f9c-8615-dba1ef909a46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent_e446bedd-5e73-4274-96d8-31ca2b146adf" xlink:href="vyne-20211231.xsd#vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6e3ab133-a4be-40e1-88fb-e213e7dc99c9" xlink:to="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent_e446bedd-5e73-4274-96d8-31ca2b146adf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent_e3a04fcc-035b-47d8-9477-6c88bbfcfd85" xlink:href="vyne-20211231.xsd#vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6e3ab133-a4be-40e1-88fb-e213e7dc99c9" xlink:to="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent_e3a04fcc-035b-47d8-9477-6c88bbfcfd85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent_d0cd4ca4-a8a8-4355-810a-2a4da02ade01" xlink:href="vyne-20211231.xsd#vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6e3ab133-a4be-40e1-88fb-e213e7dc99c9" xlink:to="loc_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent_d0cd4ca4-a8a8-4355-810a-2a4da02ade01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_7b8a4584-a883-4707-a0a6-68c0dde8da4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6e3ab133-a4be-40e1-88fb-e213e7dc99c9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_7b8a4584-a883-4707-a0a6-68c0dde8da4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1a6a19be-9356-4d7b-8347-9519d6c56483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6e3ab133-a4be-40e1-88fb-e213e7dc99c9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1a6a19be-9356-4d7b-8347-9519d6c56483" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_183bcdbb-e759-4362-972c-9e97ef0be341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6e3ab133-a4be-40e1-88fb-e213e7dc99c9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_183bcdbb-e759-4362-972c-9e97ef0be341" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXScheduleofDeferredIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_751469a8-91b6-4000-9c1f-cc1dc339a59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_40c53f60-8f0d-4253-b63e-16e17b33b648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_751469a8-91b6-4000-9c1f-cc1dc339a59a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_40c53f60-8f0d-4253-b63e-16e17b33b648" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a8c4e970-7363-4279-b213-a7f57ecc78fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_751469a8-91b6-4000-9c1f-cc1dc339a59a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_a8c4e970-7363-4279-b213-a7f57ecc78fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_c9a4cc5d-2403-4a77-8824-fb9790f5dc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9ae64831-bfae-4b25-9c05-ca51dbd0ec9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c9a4cc5d-2403-4a77-8824-fb9790f5dc7d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_9ae64831-bfae-4b25-9c05-ca51dbd0ec9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_69453681-a840-4530-a546-81df9e2219d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c9a4cc5d-2403-4a77-8824-fb9790f5dc7d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_69453681-a840-4530-a546-81df9e2219d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_94129354-2963-4115-8024-d5cca09cc8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c9a4cc5d-2403-4a77-8824-fb9790f5dc7d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_94129354-2963-4115-8024-d5cca09cc8bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_18c3f567-c9a6-4e02-b111-fcf0102de5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c9a4cc5d-2403-4a77-8824-fb9790f5dc7d" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_18c3f567-c9a6-4e02-b111-fcf0102de5f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7c85c437-5aee-4db5-8911-b29745ed44e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ba9461cc-99ce-4c70-8060-4ef61423a6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7c85c437-5aee-4db5-8911-b29745ed44e5" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ba9461cc-99ce-4c70-8060-4ef61423a6cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5447e456-b5ea-4963-b49d-40d8c4c6e366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7c85c437-5aee-4db5-8911-b29745ed44e5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5447e456-b5ea-4963-b49d-40d8c4c6e366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2273ffc1-1ed7-45ad-b0c2-a93ae88b7320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7c85c437-5aee-4db5-8911-b29745ed44e5" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_2273ffc1-1ed7-45ad-b0c2-a93ae88b7320" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>vyne-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:74e91f80-5033-4690-868f-a2bf4ea38fc3,g:e1fa6db6-9541-4405-a6db-7ba5e60bcb37-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="iaacb13982b0e4084898ce11a063728bc_CONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c04fca64-4d35-4ef9-8d9d-81da48c4ae52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c04fca64-4d35-4ef9-8d9d-81da48c4ae52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4fc15955-34ae-45dc-a605-f0a555198fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4fc15955-34ae-45dc-a605-f0a555198fde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5202dd3d-abca-4d40-9761-27b23bbdc716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5202dd3d-abca-4d40-9761-27b23bbdc716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b124b66c-8dae-4f1c-83ed-9b1ba2d6d767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b124b66c-8dae-4f1c-83ed-9b1ba2d6d767" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_22f9dea5-f1a9-464d-a709-7d9622b95a64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_22f9dea5-f1a9-464d-a709-7d9622b95a64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_169156b0-3e15-4480-8348-b5341fd75752" xlink:href="vyne-20211231.xsd#vyne_ContingentStockConsiderationRemeasurementGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:to="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_169156b0-3e15-4480-8348-b5341fd75752" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_aae1e5fa-2540-4d44-8947-4e42095af707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:to="loc_us-gaap_CostsAndExpenses_aae1e5fa-2540-4d44-8947-4e42095af707" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_11be8e62-581c-44bb-b682-bcb8e779c7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_OperatingIncomeLoss_11be8e62-581c-44bb-b682-bcb8e779c7da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3ed58f37-86bd-47f6-b09f-b41adadc4c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_InterestExpense_3ed58f37-86bd-47f6-b09f-b41adadc4c00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1e343ff3-38e1-43ce-a52d-13165a9dfd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1e343ff3-38e1-43ce-a52d-13165a9dfd1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ae5dce4-e7ca-4e67-acae-29084d7cb7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ae5dce4-e7ca-4e67-acae-29084d7cb7bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1a2025e8-a9e4-4d00-9154-9b5813e6c3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1a2025e8-a9e4-4d00-9154-9b5813e6c3a4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ad65764c-0986-4aab-8830-b5015a9d6f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_NetIncomeLoss_ad65764c-0986-4aab-8830-b5015a9d6f09" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_49db6493-9531-48f4-b715-75a220d5a54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_EarningsPerShareBasic_49db6493-9531-48f4-b715-75a220d5a54a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3c03e5e3-d0e5-4b75-bd0c-154c4f62e7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3c03e5e3-d0e5-4b75-bd0c-154c4f62e7a5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5679ce64-f99e-41d4-8ac0-12f657d3df65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5679ce64-f99e-41d4-8ac0-12f657d3df65" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19957dca-7d3f-4b9f-b89e-d481eed4ed6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19957dca-7d3f-4b9f-b89e-d481eed4ed6f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_da76139d-ff06-4626-adfc-c0ba350706ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_StatementTable_da76139d-ff06-4626-adfc-c0ba350706ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_19d6e41d-0f27-4f55-80e9-ca8cd489dad2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_da76139d-ff06-4626-adfc-c0ba350706ad" xlink:to="loc_srt_ProductOrServiceAxis_19d6e41d-0f27-4f55-80e9-ca8cd489dad2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_19d6e41d-0f27-4f55-80e9-ca8cd489dad2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_19d6e41d-0f27-4f55-80e9-ca8cd489dad2" xlink:to="loc_srt_ProductsAndServicesDomain_19d6e41d-0f27-4f55-80e9-ca8cd489dad2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e60fa7b1-d790-44f3-a643-130aaae50bb7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_19d6e41d-0f27-4f55-80e9-ca8cd489dad2" xlink:to="loc_srt_ProductsAndServicesDomain_e60fa7b1-d790-44f3-a643-130aaae50bb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_43023f28-3102-49b6-afd2-4aea2efb5c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e60fa7b1-d790-44f3-a643-130aaae50bb7" xlink:to="loc_us-gaap_ProductMember_43023f28-3102-49b6-afd2-4aea2efb5c65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_1ce763c7-cd56-4f50-a42c-b4982fbfead7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e60fa7b1-d790-44f3-a643-130aaae50bb7" xlink:to="loc_us-gaap_LicenseMember_1ce763c7-cd56-4f50-a42c-b4982fbfead7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_bc01ae2e-3622-4851-9efe-42b283267ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e60fa7b1-d790-44f3-a643-130aaae50bb7" xlink:to="loc_us-gaap_RoyaltyMember_bc01ae2e-3622-4851-9efe-42b283267ad9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended" id="i4423cf71ad6449ae9c0bbb891e7ac6a4_CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2d19bf76-8432-4a52-850e-ed9fcc7c3056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2d19bf76-8432-4a52-850e-ed9fcc7c3056" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d731c41c-3d31-4ff9-8114-5011032af421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d731c41c-3d31-4ff9-8114-5011032af421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f2d19aa5-3d8c-496f-a0d4-23c3fedec12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockholdersEquity_f2d19aa5-3d8c-496f-a0d4-23c3fedec12d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0cf3e91f-12aa-4f13-a318-4290ba32f15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0cf3e91f-12aa-4f13-a318-4290ba32f15a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1605f2cc-0d07-4afb-8075-12aeaf44b983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1605f2cc-0d07-4afb-8075-12aeaf44b983" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_01d933c9-a064-44c1-bb09-d4014dd5c027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_01d933c9-a064-44c1-bb09-d4014dd5c027" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1844ef37-cd70-4470-acc1-673b42bce4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1844ef37-cd70-4470-acc1-673b42bce4f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_60656fab-624a-4f68-b81c-1dd9e69f7797" xlink:href="vyne-20211231.xsd#vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_60656fab-624a-4f68-b81c-1dd9e69f7797" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_1c84e093-f717-4d68-84ec-21d88ea7cc69" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_1c84e093-f717-4d68-84ec-21d88ea7cc69" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fa3091b1-00db-4496-8f26-d03b4751ff90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fa3091b1-00db-4496-8f26-d03b4751ff90" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ae018977-e230-47cc-8c88-33e06b8e9f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ae018977-e230-47cc-8c88-33e06b8e9f09" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_38c1c6c2-2f3e-4357-90bc-e8d2304d885a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_38c1c6c2-2f3e-4357-90bc-e8d2304d885a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e1bcf06c-748c-48cc-8bb4-eaa2a6f7ebeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e1bcf06c-748c-48cc-8bb4-eaa2a6f7ebeb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2ec471a8-d4e8-4ccd-b7d6-bdbfd277a417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e7b4982e-1cde-4c9b-93a3-a85307cb1062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_25015ad3-9d8f-4053-8f45-efec7410d377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2d19bf76-8432-4a52-850e-ed9fcc7c3056" xlink:to="loc_us-gaap_StatementTable_25015ad3-9d8f-4053-8f45-efec7410d377" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9d862982-0c26-4bec-a4f2-59db3194eaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_25015ad3-9d8f-4053-8f45-efec7410d377" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9d862982-0c26-4bec-a4f2-59db3194eaf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9d862982-0c26-4bec-a4f2-59db3194eaf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9d862982-0c26-4bec-a4f2-59db3194eaf3" xlink:to="loc_us-gaap_EquityComponentDomain_9d862982-0c26-4bec-a4f2-59db3194eaf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9d862982-0c26-4bec-a4f2-59db3194eaf3" xlink:to="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c3a701ba-4bd1-4ed6-816e-69f99bd052ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:to="loc_us-gaap_CommonStockMember_c3a701ba-4bd1-4ed6-816e-69f99bd052ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b62319de-441e-4f99-a482-1ce40946b052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b62319de-441e-4f99-a482-1ce40946b052" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_316ce236-399e-44d8-a0f3-18f8179f922a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:to="loc_us-gaap_RetainedEarningsMember_316ce236-399e-44d8-a0f3-18f8179f922a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_559032e3-dda6-4955-b7dd-6a111ae49daf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_559032e3-dda6-4955-b7dd-6a111ae49daf" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#NATUREOFOPERATIONSDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails" xlink:type="extended" id="i5a3a782fa2174d8f8be391ae8fcc9f85_NATUREOFOPERATIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f737e650-397f-4dcc-be68-a908615f6c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_NumberOfReportableSegments_f737e650-397f-4dcc-be68-a908615f6c99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_04c33ace-69e6-4605-be88-b896f9f74864" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_04c33ace-69e6-4605-be88-b896f9f74864" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_71fa5b9a-24b2-4fa8-88e1-c4cf4e45e7af" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_71fa5b9a-24b2-4fa8-88e1-c4cf4e45e7af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PeriodOfClosingTransaction_00ae7723-3eb7-4bb6-8148-8a092a93df7c" xlink:href="vyne-20211231.xsd#vyne_PeriodOfClosingTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_PeriodOfClosingTransaction_00ae7723-3eb7-4bb6-8148-8a092a93df7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_c3ee8718-7cb2-4225-82b0-f8303f530959" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_c3ee8718-7cb2-4225-82b0-f8303f530959" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_ee435213-db33-4fac-a97d-64ebbd03cde8" xlink:href="vyne-20211231.xsd#vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_ee435213-db33-4fac-a97d-64ebbd03cde8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PaymentsForLicensingAgreements_ccce4773-b6d5-43e7-a03c-45b87b1f3c4b" xlink:href="vyne-20211231.xsd#vyne_PaymentsForLicensingAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_PaymentsForLicensingAgreements_ccce4773-b6d5-43e7-a03c-45b87b1f3c4b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum_9d4525b9-8d65-453e-8685-ca05dd84194c" xlink:href="vyne-20211231.xsd#vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum_9d4525b9-8d65-453e-8685-ca05dd84194c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RoyaltyPaymentPercentMaximum_ebc7328c-6377-4327-847a-e6f41de1c069" xlink:href="vyne-20211231.xsd#vyne_RoyaltyPaymentPercentMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_RoyaltyPaymentPercentMaximum_ebc7328c-6377-4327-847a-e6f41de1c069" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_6f3ab9e2-a4d2-4e6d-a44c-ee40720f97d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_6f3ab9e2-a4d2-4e6d-a44c-ee40720f97d2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_915a66ba-a820-4f6d-9c41-6664b9d349b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_RestructuringCharges_915a66ba-a820-4f6d-9c41-6664b9d349b7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_b624bd3c-10d1-4250-8d44-91d4426d2065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_b624bd3c-10d1-4250-8d44-91d4426d2065" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8dc94f69-0316-4814-86f6-372e9c489745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8dc94f69-0316-4814-86f6-372e9c489745" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_60c375e4-764b-481c-8c07-cf3d8ba294d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_60c375e4-764b-481c-8c07-cf3d8ba294d2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_79351ce7-2cec-4e2f-8b30-ca9c996a6731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_NetIncomeLoss_79351ce7-2cec-4e2f-8b30-ca9c996a6731" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b2462abd-26b2-4e50-98f2-aa5200ecbe56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b2462abd-26b2-4e50-98f2-aa5200ecbe56" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_15408861-2565-4572-a851-cc542d2e04b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_15408861-2565-4572-a851-cc542d2e04b1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b0969d59-d5c2-4ce2-a0e3-aab54bf91729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b0969d59-d5c2-4ce2-a0e3-aab54bf91729" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_389b8b37-bfd7-4147-9515-c3cce345c9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_389b8b37-bfd7-4147-9515-c3cce345c9f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_389b8b37-bfd7-4147-9515-c3cce345c9f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_389b8b37-bfd7-4147-9515-c3cce345c9f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_389b8b37-bfd7-4147-9515-c3cce345c9f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a47cc081-fb61-4851-99c5-5e6a076f3711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_389b8b37-bfd7-4147-9515-c3cce345c9f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a47cc081-fb61-4851-99c5-5e6a076f3711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f5b27fc2-08b3-491a-8d61-ff45e2190f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a47cc081-fb61-4851-99c5-5e6a076f3711" xlink:to="loc_us-gaap_SubsequentEventMember_f5b27fc2-08b3-491a-8d61-ff45e2190f1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1d2392fb-08d1-4a89-80a7-35642fd5a119" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:to="loc_dei_LegalEntityAxis_1d2392fb-08d1-4a89-80a7-35642fd5a119" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1d2392fb-08d1-4a89-80a7-35642fd5a119_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1d2392fb-08d1-4a89-80a7-35642fd5a119" xlink:to="loc_dei_EntityDomain_1d2392fb-08d1-4a89-80a7-35642fd5a119_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_23ba0d24-be1f-403a-bec7-4b727c16adc7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1d2392fb-08d1-4a89-80a7-35642fd5a119" xlink:to="loc_dei_EntityDomain_23ba0d24-be1f-403a-bec7-4b727c16adc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MenloPremergerMember_9e14a477-0ad6-462b-805c-82dcdf20a197" xlink:href="vyne-20211231.xsd#vyne_MenloPremergerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_23ba0d24-be1f-403a-bec7-4b727c16adc7" xlink:to="loc_vyne_MenloPremergerMember_9e14a477-0ad6-462b-805c-82dcdf20a197" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_18dcc956-094d-4678-b872-4a2af9ed719f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_18dcc956-094d-4678-b872-4a2af9ed719f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_18dcc956-094d-4678-b872-4a2af9ed719f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_18dcc956-094d-4678-b872-4a2af9ed719f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_18dcc956-094d-4678-b872-4a2af9ed719f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0f44d90e-b376-45ef-b73e-331853d3645f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_18dcc956-094d-4678-b872-4a2af9ed719f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0f44d90e-b376-45ef-b73e-331853d3645f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_98773b9a-cdb4-4f18-a468-c3d68af9ec32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0f44d90e-b376-45ef-b73e-331853d3645f" xlink:to="loc_us-gaap_EmployeeSeveranceMember_98773b9a-cdb4-4f18-a468-c3d68af9ec32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RetentionPaymentsMember_97d6de93-d54b-452b-8dc9-efec2e976651" xlink:href="vyne-20211231.xsd#vyne_RetentionPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0f44d90e-b376-45ef-b73e-331853d3645f" xlink:to="loc_vyne_RetentionPaymentsMember_97d6de93-d54b-452b-8dc9-efec2e976651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_46a2820f-32e7-405c-bc9c-2fe99e60bc96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:to="loc_us-gaap_TypeOfArrangementAxis_46a2820f-32e7-405c-bc9c-2fe99e60bc96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_46a2820f-32e7-405c-bc9c-2fe99e60bc96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_46a2820f-32e7-405c-bc9c-2fe99e60bc96" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_46a2820f-32e7-405c-bc9c-2fe99e60bc96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a0bc8e2-9d1e-4764-a7cf-872b049dfa49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_46a2820f-32e7-405c-bc9c-2fe99e60bc96" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a0bc8e2-9d1e-4764-a7cf-872b049dfa49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_516cd0fb-2b00-4ab5-82f2-b2351e9975c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a0bc8e2-9d1e-4764-a7cf-872b049dfa49" xlink:to="loc_us-gaap_LicensingAgreementsMember_516cd0fb-2b00-4ab5-82f2-b2351e9975c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_TopicalBETiOptionAgreementMember_5889ee8d-6ce3-4553-85d0-b5864e3c173c" xlink:href="vyne-20211231.xsd#vyne_TopicalBETiOptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a0bc8e2-9d1e-4764-a7cf-872b049dfa49" xlink:to="loc_vyne_TopicalBETiOptionAgreementMember_5889ee8d-6ce3-4553-85d0-b5864e3c173c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OralBETiOptionAgreementMember_9e80af27-81f2-401d-b755-a911a68fbefe" xlink:href="vyne-20211231.xsd#vyne_OralBETiOptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a0bc8e2-9d1e-4764-a7cf-872b049dfa49" xlink:to="loc_vyne_OralBETiOptionAgreementMember_9e80af27-81f2-401d-b755-a911a68fbefe" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended" id="ie23008a51ba74504848dbe5914ccd528_SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_001768ff-5250-493c-b21c-1d82feec5d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_001768ff-5250-493c-b21c-1d82feec5d71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e680e757-a86b-4e29-b178-f75a15356bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e680e757-a86b-4e29-b178-f75a15356bc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cb7050ab-6428-469c-8ebc-48e894280f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cb7050ab-6428-469c-8ebc-48e894280f68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_811b753f-bfb0-4280-a27e-6682fda742ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_811b753f-bfb0-4280-a27e-6682fda742ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_22140408-7d0c-4f3b-b463-28fe56b55de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_22140408-7d0c-4f3b-b463-28fe56b55de6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d61b7466-a606-4c0c-b1a0-5f5916a5eb6e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:to="loc_srt_RangeAxis_d61b7466-a606-4c0c-b1a0-5f5916a5eb6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d61b7466-a606-4c0c-b1a0-5f5916a5eb6e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d61b7466-a606-4c0c-b1a0-5f5916a5eb6e" xlink:to="loc_srt_RangeMember_d61b7466-a606-4c0c-b1a0-5f5916a5eb6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_14cbd6ba-3a64-4dfc-a2f5-4e4f08e95a7f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d61b7466-a606-4c0c-b1a0-5f5916a5eb6e" xlink:to="loc_srt_RangeMember_14cbd6ba-3a64-4dfc-a2f5-4e4f08e95a7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2761dd7b-4284-4431-85d0-6eb6cc7320f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_14cbd6ba-3a64-4dfc-a2f5-4e4f08e95a7f" xlink:to="loc_srt_MinimumMember_2761dd7b-4284-4431-85d0-6eb6cc7320f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_66d7f3a9-ed55-431d-95fb-a3ac38d83111" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_14cbd6ba-3a64-4dfc-a2f5-4e4f08e95a7f" xlink:to="loc_srt_MaximumMember_66d7f3a9-ed55-431d-95fb-a3ac38d83111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3a3b9271-f861-4753-8c24-d3136c44e1a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:to="loc_dei_LegalEntityAxis_3a3b9271-f861-4753-8c24-d3136c44e1a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3a3b9271-f861-4753-8c24-d3136c44e1a6_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3a3b9271-f861-4753-8c24-d3136c44e1a6" xlink:to="loc_dei_EntityDomain_3a3b9271-f861-4753-8c24-d3136c44e1a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f6accf03-1940-4eac-b2b8-712850eba537" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3a3b9271-f861-4753-8c24-d3136c44e1a6" xlink:to="loc_dei_EntityDomain_f6accf03-1940-4eac-b2b8-712850eba537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_77daf66b-db78-4ad4-ac2b-986c441de3c9" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_f6accf03-1940-4eac-b2b8-712850eba537" xlink:to="loc_vyne_FoamixMember_77daf66b-db78-4ad4-ac2b-986c441de3c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_50402000-6c9e-473a-9dfe-36b0eb034ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_50402000-6c9e-473a-9dfe-36b0eb034ac9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50402000-6c9e-473a-9dfe-36b0eb034ac9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_50402000-6c9e-473a-9dfe-36b0eb034ac9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50402000-6c9e-473a-9dfe-36b0eb034ac9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_421d1338-fc8a-42fe-ad43-1b2654aa3c59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_50402000-6c9e-473a-9dfe-36b0eb034ac9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_421d1338-fc8a-42fe-ad43-1b2654aa3c59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_e5ccbefc-805f-4492-8d6a-816e94f2898f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_421d1338-fc8a-42fe-ad43-1b2654aa3c59" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_e5ccbefc-805f-4492-8d6a-816e94f2898f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails" xlink:type="extended" id="i7dcf7a2878d34a82b6c3e05acf150ac6_SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ee22934a-9a75-4330-bc04-220283d1e1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_6853f780-8ef8-4575-8fee-04b41e5c6b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ee22934a-9a75-4330-bc04-220283d1e1d6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_6853f780-8ef8-4575-8fee-04b41e5c6b36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b891941-4c55-4b93-82a2-fbefe96fb3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ee22934a-9a75-4330-bc04-220283d1e1d6" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b891941-4c55-4b93-82a2-fbefe96fb3f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f82be658-1fe6-4a97-a80c-5720c5a7e5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b891941-4c55-4b93-82a2-fbefe96fb3f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f82be658-1fe6-4a97-a80c-5720c5a7e5f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f82be658-1fe6-4a97-a80c-5720c5a7e5f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f82be658-1fe6-4a97-a80c-5720c5a7e5f7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f82be658-1fe6-4a97-a80c-5720c5a7e5f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35513651-61b6-4275-a3b8-b0aa3f38b249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f82be658-1fe6-4a97-a80c-5720c5a7e5f7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35513651-61b6-4275-a3b8-b0aa3f38b249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_d7c61938-04bd-48ef-8a39-4ca8061108ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35513651-61b6-4275-a3b8-b0aa3f38b249" xlink:to="loc_us-gaap_ComputerEquipmentMember_d7c61938-04bd-48ef-8a39-4ca8061108ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_387575bb-874a-4198-9b15-160163ac0a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35513651-61b6-4275-a3b8-b0aa3f38b249" xlink:to="loc_us-gaap_EquipmentMember_387575bb-874a-4198-9b15-160163ac0a7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_58175a85-9545-4bd7-a75f-c9278bb9b249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35513651-61b6-4275-a3b8-b0aa3f38b249" xlink:to="loc_us-gaap_OfficeEquipmentMember_58175a85-9545-4bd7-a75f-c9278bb9b249" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5fc3b896-02e6-48af-8518-5ddd643063ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b891941-4c55-4b93-82a2-fbefe96fb3f5" xlink:to="loc_srt_RangeAxis_5fc3b896-02e6-48af-8518-5ddd643063ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5fc3b896-02e6-48af-8518-5ddd643063ba_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5fc3b896-02e6-48af-8518-5ddd643063ba" xlink:to="loc_srt_RangeMember_5fc3b896-02e6-48af-8518-5ddd643063ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_25dd4514-b9ee-4b6d-b8af-ca2f41e04db7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5fc3b896-02e6-48af-8518-5ddd643063ba" xlink:to="loc_srt_RangeMember_25dd4514-b9ee-4b6d-b8af-ca2f41e04db7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bfaa9099-d5c2-4c79-a97e-82afd190f477" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_25dd4514-b9ee-4b6d-b8af-ca2f41e04db7" xlink:to="loc_srt_MinimumMember_bfaa9099-d5c2-4c79-a97e-82afd190f477" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9fb85ba9-0cad-4d80-8a5b-520b37a27bcf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_25dd4514-b9ee-4b6d-b8af-ca2f41e04db7" xlink:to="loc_srt_MaximumMember_9fb85ba9-0cad-4d80-8a5b-520b37a27bcf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails" xlink:type="extended" id="i8c5f6a7908d54e7b99899375217d1e0d_SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_becd46fe-b97b-48e1-b7a0-bd2197725012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_501ea3b6-9254-4351-a433-b811af003c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_becd46fe-b97b-48e1-b7a0-bd2197725012" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_501ea3b6-9254-4351-a433-b811af003c0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6bc58940-5579-4a5f-b419-c5f9f118c5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_becd46fe-b97b-48e1-b7a0-bd2197725012" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6bc58940-5579-4a5f-b419-c5f9f118c5b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_bf176cfd-cf5d-44b0-b50a-a477432b174f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6bc58940-5579-4a5f-b419-c5f9f118c5b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_bf176cfd-cf5d-44b0-b50a-a477432b174f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bf176cfd-cf5d-44b0-b50a-a477432b174f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_bf176cfd-cf5d-44b0-b50a-a477432b174f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bf176cfd-cf5d-44b0-b50a-a477432b174f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_04d34eb8-638c-4d42-b8f7-a9400719a247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_bf176cfd-cf5d-44b0-b50a-a477432b174f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_04d34eb8-638c-4d42-b8f7-a9400719a247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember_733f5ee2-0328-4c8e-b10d-fd08ffa5be1b" xlink:href="vyne-20211231.xsd#vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_04d34eb8-638c-4d42-b8f7-a9400719a247" xlink:to="loc_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember_733f5ee2-0328-4c8e-b10d-fd08ffa5be1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_2961c6b9-375e-4b42-a1e1-c0490e47238d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_04d34eb8-638c-4d42-b8f7-a9400719a247" xlink:to="loc_us-gaap_WarrantMember_2961c6b9-375e-4b42-a1e1-c0490e47238d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails" xlink:type="extended" id="i1361016ddcc5463f8cac83be209de00f_SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_e2f0535a-73a8-429b-b73d-c4e2d5feb681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b70516e1-e004-49be-9e10-09ad41546598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_e2f0535a-73a8-429b-b73d-c4e2d5feb681" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b70516e1-e004-49be-9e10-09ad41546598" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueConcentrationOfRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_e2f0535a-73a8-429b-b73d-c4e2d5feb681" xlink:to="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ccee48fb-34ad-4497-91a3-bb8089cf394e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ccee48fb-34ad-4497-91a3-bb8089cf394e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ccee48fb-34ad-4497-91a3-bb8089cf394e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ccee48fb-34ad-4497-91a3-bb8089cf394e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ccee48fb-34ad-4497-91a3-bb8089cf394e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bf0d8f1-bb6d-4332-b105-7fa68e85d6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ccee48fb-34ad-4497-91a3-bb8089cf394e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bf0d8f1-bb6d-4332-b105-7fa68e85d6b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_59420857-e266-4d94-a8f6-ed0f03c92c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bf0d8f1-bb6d-4332-b105-7fa68e85d6b9" xlink:to="loc_us-gaap_SalesRevenueNetMember_59420857-e266-4d94-a8f6-ed0f03c92c2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_46059c8f-0abd-46a4-a901-45c52bb3fe06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bf0d8f1-bb6d-4332-b105-7fa68e85d6b9" xlink:to="loc_us-gaap_AccountsReceivableMember_46059c8f-0abd-46a4-a901-45c52bb3fe06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d2de0e00-6fae-4f52-b4b1-064dd77fd67d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d2de0e00-6fae-4f52-b4b1-064dd77fd67d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d2de0e00-6fae-4f52-b4b1-064dd77fd67d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d2de0e00-6fae-4f52-b4b1-064dd77fd67d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d2de0e00-6fae-4f52-b4b1-064dd77fd67d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f100d51c-56b2-4e0b-b84b-03de51bc82c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d2de0e00-6fae-4f52-b4b1-064dd77fd67d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f100d51c-56b2-4e0b-b84b-03de51bc82c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_689d3ad3-b955-442b-96f6-a83cc030b110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f100d51c-56b2-4e0b-b84b-03de51bc82c7" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_689d3ad3-b955-442b-96f6-a83cc030b110" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_71928daa-bd03-40d8-b53f-d2b9276e5e83" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:to="loc_srt_MajorCustomersAxis_71928daa-bd03-40d8-b53f-d2b9276e5e83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_71928daa-bd03-40d8-b53f-d2b9276e5e83_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_71928daa-bd03-40d8-b53f-d2b9276e5e83" xlink:to="loc_srt_NameOfMajorCustomerDomain_71928daa-bd03-40d8-b53f-d2b9276e5e83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3e13b061-7977-458c-8eb1-442520039d63" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_71928daa-bd03-40d8-b53f-d2b9276e5e83" xlink:to="loc_srt_NameOfMajorCustomerDomain_3e13b061-7977-458c-8eb1-442520039d63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ThreeLargestCustomersMember_65bea331-2a20-4f92-8a35-5080de4e7bdc" xlink:href="vyne-20211231.xsd#vyne_ThreeLargestCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3e13b061-7977-458c-8eb1-442520039d63" xlink:to="loc_vyne_ThreeLargestCustomersMember_65bea331-2a20-4f92-8a35-5080de4e7bdc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails" xlink:type="extended" id="i32dd84b4122a4638bf208880b8232adb_BUSINESSCOMBINATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ExchangeRatio_4b1f263d-30c8-4b7c-9f71-7e6f7b2b364a" xlink:href="vyne-20211231.xsd#vyne_ExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_ExchangeRatio_4b1f263d-30c8-4b7c-9f71-7e6f7b2b364a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessAcquisitionContingentStockRightIssued_80d4db30-316d-49b2-9091-38894552cbcb" xlink:href="vyne-20211231.xsd#vyne_BusinessAcquisitionContingentStockRightIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessAcquisitionContingentStockRightIssued_80d4db30-316d-49b2-9091-38894552cbcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockRightSharesConversion_c9a2251d-e027-4d16-a19f-61e16db7a55d" xlink:href="vyne-20211231.xsd#vyne_ContingentStockRightSharesConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_ContingentStockRightSharesConversion_c9a2251d-e027-4d16-a19f-61e16db7a55d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationEffectiveExchangeRatio_1c5e388b-0a7a-4608-927c-d547b184ecb5" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationEffectiveExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessCombinationEffectiveExchangeRatio_1c5e388b-0a7a-4608-927c-d547b184ecb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_987e7b7a-c515-420b-9598-7a976f72651a" xlink:href="vyne-20211231.xsd#vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_987e7b7a-c515-420b-9598-7a976f72651a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders_d2c8f3d2-f76f-4404-b363-251f3be7293c" xlink:href="vyne-20211231.xsd#vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders_d2c8f3d2-f76f-4404-b363-251f3be7293c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PostMergerParentOwnershipByPreMergerParentStockholders_6a440948-b80d-4bb7-a590-b96d4d620fad" xlink:href="vyne-20211231.xsd#vyne_PostMergerParentOwnershipByPreMergerParentStockholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_PostMergerParentOwnershipByPreMergerParentStockholders_6a440948-b80d-4bb7-a590-b96d4d620fad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4514b5cd-48da-4111-9483-7a2facdf0ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4514b5cd-48da-4111-9483-7a2facdf0ba4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_90c9490f-20f9-4a9f-bc84-80b1cef11bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_SharePrice_90c9490f-20f9-4a9f-bc84-80b1cef11bc3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredGross_fb197f59-ad52-400d-8603-e3d7134fc09b" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessCombinationConsiderationTransferredGross_fb197f59-ad52-400d-8603-e3d7134fc09b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_7a1c6973-ea68-4471-82b0-3b207cf5b685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_7a1c6973-ea68-4471-82b0-3b207cf5b685" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes_677ab91a-3d80-400e-be60-d028477f064b" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes_677ab91a-3d80-400e-be60-d028477f064b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_71ac9884-0866-4bf8-b871-e8fc57f7f462" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_71ac9884-0866-4bf8-b871-e8fc57f7f462" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_182e91da-6ddf-44bb-806c-ff3d56384163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_182e91da-6ddf-44bb-806c-ff3d56384163" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_64fdba3c-eb3f-4827-92ae-9f63b53007cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_64fdba3c-eb3f-4827-92ae-9f63b53007cf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_aeca843c-fb54-4567-a36d-8be6d48cc7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_aeca843c-fb54-4567-a36d-8be6d48cc7e0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_143ac37f-6a85-4f10-8a52-c65d7c9aeebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_143ac37f-6a85-4f10-8a52-c65d7c9aeebb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_60cdcce9-c950-4dea-bad3-c4054fda2f37" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_60cdcce9-c950-4dea-bad3-c4054fda2f37" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_e47b38e3-6cc5-40ad-9d59-54dca938d868" xlink:href="vyne-20211231.xsd#vyne_ContingentStockConsiderationRemeasurementGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_e47b38e3-6cc5-40ad-9d59-54dca938d868" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2ed679ac-9d30-4350-bad5-77a51edf5b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2ed679ac-9d30-4350-bad5-77a51edf5b17" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ff7a1092-752a-4d1f-bd75-7cd854fc43bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ff7a1092-752a-4d1f-bd75-7cd854fc43bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ff7a1092-752a-4d1f-bd75-7cd854fc43bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff7a1092-752a-4d1f-bd75-7cd854fc43bf" xlink:to="loc_us-gaap_EquityComponentDomain_ff7a1092-752a-4d1f-bd75-7cd854fc43bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0240dc0d-1509-4d58-bad8-b85117d6a132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff7a1092-752a-4d1f-bd75-7cd854fc43bf" xlink:to="loc_us-gaap_EquityComponentDomain_0240dc0d-1509-4d58-bad8-b85117d6a132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6d58f985-637a-4e85-a98d-4dc821c2bbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0240dc0d-1509-4d58-bad8-b85117d6a132" xlink:to="loc_us-gaap_CommonStockMember_6d58f985-637a-4e85-a98d-4dc821c2bbf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_94b51a2f-e185-496d-9164-5eba7b865069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_94b51a2f-e185-496d-9164-5eba7b865069" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b51a2f-e185-496d-9164-5eba7b865069_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_94b51a2f-e185-496d-9164-5eba7b865069" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94b51a2f-e185-496d-9164-5eba7b865069_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2bc195f-4774-445a-be74-d921521b4561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_94b51a2f-e185-496d-9164-5eba7b865069" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2bc195f-4774-445a-be74-d921521b4561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_ccb238cc-ff54-4b03-8c8e-ab9ff6fc3403" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2bc195f-4774-445a-be74-d921521b4561" xlink:to="loc_vyne_FoamixMember_ccb238cc-ff54-4b03-8c8e-ab9ff6fc3403" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3f507580-c55e-434d-9abc-00901b8843bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3f507580-c55e-434d-9abc-00901b8843bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3f507580-c55e-434d-9abc-00901b8843bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3f507580-c55e-434d-9abc-00901b8843bf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3f507580-c55e-434d-9abc-00901b8843bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1ef5749d-eda2-4b8b-8568-81c7407df2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3f507580-c55e-434d-9abc-00901b8843bf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1ef5749d-eda2-4b8b-8568-81c7407df2ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3395a1d0-9272-4a29-86d7-47bc4c46bb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ef5749d-eda2-4b8b-8568-81c7407df2ed" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3395a1d0-9272-4a29-86d7-47bc4c46bb7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_89e9999f-1365-424c-8518-f2bb071aa43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_89e9999f-1365-424c-8518-f2bb071aa43f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_89e9999f-1365-424c-8518-f2bb071aa43f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_89e9999f-1365-424c-8518-f2bb071aa43f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_89e9999f-1365-424c-8518-f2bb071aa43f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_9134c692-fa16-49da-9f6d-69a7af79abd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_89e9999f-1365-424c-8518-f2bb071aa43f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_9134c692-fa16-49da-9f6d-69a7af79abd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_58c67547-eff5-4ed1-b6b6-10c63f6d03f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_9134c692-fa16-49da-9f6d-69a7af79abd7" xlink:to="loc_us-gaap_EmployeeSeveranceMember_58c67547-eff5-4ed1-b6b6-10c63f6d03f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9b33fb7-758b-41bb-9580-36793572ba41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9b33fb7-758b-41bb-9580-36793572ba41" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e9b33fb7-758b-41bb-9580-36793572ba41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9b33fb7-758b-41bb-9580-36793572ba41" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e9b33fb7-758b-41bb-9580-36793572ba41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f42eacfa-e4e3-4e51-852e-86609888761a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9b33fb7-758b-41bb-9580-36793572ba41" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f42eacfa-e4e3-4e51-852e-86609888761a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_87d0c1aa-9524-41b0-ab32-c53e189f4c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f42eacfa-e4e3-4e51-852e-86609888761a" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_87d0c1aa-9524-41b0-ab32-c53e189f4c07" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails" xlink:type="extended" id="ica8832d83cd94cbfa7b025c81a8db876_BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0ec6f3b8-7f1f-43bf-99bd-5c71bff3f386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0ec6f3b8-7f1f-43bf-99bd-5c71bff3f386" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_397519cd-ead2-496e-9fc0-558929578cff" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_397519cd-ead2-496e-9fc0-558929578cff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredGross_67002b8c-c7e4-4b65-a3b2-38a891b102e4" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_vyne_BusinessCombinationConsiderationTransferredGross_67002b8c-c7e4-4b65-a3b2-38a891b102e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_73d16fd9-4add-4794-aa66-b605023fc4d2" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_73d16fd9-4add-4794-aa66-b605023fc4d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_769d10ee-8499-41c5-8161-b993a3fffd91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_769d10ee-8499-41c5-8161-b993a3fffd91" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c1dc7b13-ba8a-4289-9f58-7c3b004cf1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c1dc7b13-ba8a-4289-9f58-7c3b004cf1b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e89f4c26-ccba-4866-9dc7-4ef0daf00c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c1dc7b13-ba8a-4289-9f58-7c3b004cf1b1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e89f4c26-ccba-4866-9dc7-4ef0daf00c57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e89f4c26-ccba-4866-9dc7-4ef0daf00c57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e89f4c26-ccba-4866-9dc7-4ef0daf00c57" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e89f4c26-ccba-4866-9dc7-4ef0daf00c57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6223ad9-589e-4198-8599-da7f74df3e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e89f4c26-ccba-4866-9dc7-4ef0daf00c57" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6223ad9-589e-4198-8599-da7f74df3e25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_bb69752c-ef15-4039-8793-41fde149fb64" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6223ad9-589e-4198-8599-da7f74df3e25" xlink:to="loc_vyne_FoamixMember_bb69752c-ef15-4039-8793-41fde149fb64" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails" xlink:type="extended" id="ib0860204c46b40548fd04b48536a2cb0_BUSINESSCOMBINATIONPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_906369aa-0d53-4934-bbe0-9c78800a8451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_906369aa-0d53-4934-bbe0-9c78800a8451" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bba5f177-5d06-497e-b6f0-ee15ebf00fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bba5f177-5d06-497e-b6f0-ee15ebf00fb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_939d6258-35b5-413b-a706-0c9aa7f6caee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_939d6258-35b5-413b-a706-0c9aa7f6caee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_cfd281a4-836b-470b-ab9d-235b9409e34d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_cfd281a4-836b-470b-ab9d-235b9409e34d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_67220aa9-7a7c-4f94-abf6-a2872d14860c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_67220aa9-7a7c-4f94-abf6-a2872d14860c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7e87b035-b4f8-4042-b6f6-8531dec97948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_Goodwill_7e87b035-b4f8-4042-b6f6-8531dec97948" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c5a4e578-12c0-454b-8ae4-fa8ddb918561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c5a4e578-12c0-454b-8ae4-fa8ddb918561" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_cf0d394b-4caf-46eb-8e2e-c8ad68e2eecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_cf0d394b-4caf-46eb-8e2e-c8ad68e2eecb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cae5e728-1045-410a-acf8-12d58f7c8bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cae5e728-1045-410a-acf8-12d58f7c8bcc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3d4aceeb-e7e3-4080-9057-7010548a326c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3d4aceeb-e7e3-4080-9057-7010548a326c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_f4a2d811-5dbd-46a9-a4ad-bf06da940b78" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_f4a2d811-5dbd-46a9-a4ad-bf06da940b78" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_433279a9-7eef-444b-adce-a9dee3d731c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_906369aa-0d53-4934-bbe0-9c78800a8451" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_433279a9-7eef-444b-adce-a9dee3d731c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1cacd006-20d3-4ce6-a4d6-222b5b202e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_433279a9-7eef-444b-adce-a9dee3d731c6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1cacd006-20d3-4ce6-a4d6-222b5b202e32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1cacd006-20d3-4ce6-a4d6-222b5b202e32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1cacd006-20d3-4ce6-a4d6-222b5b202e32" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1cacd006-20d3-4ce6-a4d6-222b5b202e32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3442f0b1-1596-4985-a07d-a8053d1df1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1cacd006-20d3-4ce6-a4d6-222b5b202e32" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3442f0b1-1596-4985-a07d-a8053d1df1aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_b9e7a466-5309-4992-ba63-44e82ddcd62a" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3442f0b1-1596-4985-a07d-a8053d1df1aa" xlink:to="loc_vyne_FoamixMember_b9e7a466-5309-4992-ba63-44e82ddcd62a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONGoodwillDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails" xlink:type="extended" id="i7a7a3d3a6f0f45ca8236f7f9512f95ee_BUSINESSCOMBINATIONGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9cbfbff8-7516-4fa8-9941-1e4c04defb27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationGoodwillAbstract_936fbfbf-6bae-497d-a79d-0458069a1372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9cbfbff8-7516-4fa8-9941-1e4c04defb27" xlink:to="loc_us-gaap_BusinessCombinationGoodwillAbstract_936fbfbf-6bae-497d-a79d-0458069a1372" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8824d7df-d5ae-4014-acfa-6a94fb807f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationGoodwillAbstract_936fbfbf-6bae-497d-a79d-0458069a1372" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8824d7df-d5ae-4014-acfa-6a94fb807f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets_40aa1c05-474a-48e4-b20a-d5729e516649" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationGoodwillAbstract_936fbfbf-6bae-497d-a79d-0458069a1372" xlink:to="loc_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets_40aa1c05-474a-48e4-b20a-d5729e516649" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cf2d00ee-ced8-4a75-a346-c79f0db760f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationGoodwillAbstract_936fbfbf-6bae-497d-a79d-0458069a1372" xlink:to="loc_us-gaap_Goodwill_cf2d00ee-ced8-4a75-a346-c79f0db760f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d9ca7f4d-d49a-43f9-8364-da63b5e7b5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9cbfbff8-7516-4fa8-9941-1e4c04defb27" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d9ca7f4d-d49a-43f9-8364-da63b5e7b5b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_74d5ef6b-97f6-432d-8380-2184af33b125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d9ca7f4d-d49a-43f9-8364-da63b5e7b5b0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_74d5ef6b-97f6-432d-8380-2184af33b125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74d5ef6b-97f6-432d-8380-2184af33b125_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_74d5ef6b-97f6-432d-8380-2184af33b125" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74d5ef6b-97f6-432d-8380-2184af33b125_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b324f49-481c-4443-8003-73a77da6f9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_74d5ef6b-97f6-432d-8380-2184af33b125" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b324f49-481c-4443-8003-73a77da6f9ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_ab8919a0-e62e-42ff-b99b-5603b0c87b92" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b324f49-481c-4443-8003-73a77da6f9ff" xlink:to="loc_vyne_FoamixMember_ab8919a0-e62e-42ff-b99b-5603b0c87b92" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONIPRDandCSRDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails" xlink:type="extended" id="i4ff7b4bb1dbf48b4b0d8200d010f881d_BUSINESSCOMBINATIONIPRDandCSRDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ddd4e459-da9c-43be-90a8-a1ccab0134f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_051b81c2-e950-4275-bd47-55cb89943ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ddd4e459-da9c-43be-90a8-a1ccab0134f2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_051b81c2-e950-4275-bd47-55cb89943ec0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_9eed64f7-cf17-47fc-9fb4-ba2d946a749a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_051b81c2-e950-4275-bd47-55cb89943ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_9eed64f7-cf17-47fc-9fb4-ba2d946a749a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7525a8ef-a9bc-45a5-925c-074325511b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_051b81c2-e950-4275-bd47-55cb89943ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7525a8ef-a9bc-45a5-925c-074325511b07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a491d65-41bd-41dc-b932-11bde430b4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ddd4e459-da9c-43be-90a8-a1ccab0134f2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a491d65-41bd-41dc-b932-11bde430b4e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_91648958-cb87-4077-98ea-9b463f342734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a491d65-41bd-41dc-b932-11bde430b4e5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_91648958-cb87-4077-98ea-9b463f342734" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91648958-cb87-4077-98ea-9b463f342734_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_91648958-cb87-4077-98ea-9b463f342734" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91648958-cb87-4077-98ea-9b463f342734_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4d62094-d0ef-4e86-9527-10a386aa8a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_91648958-cb87-4077-98ea-9b463f342734" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4d62094-d0ef-4e86-9527-10a386aa8a1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_7aae7a55-22f4-4241-9f41-0dd764c21848" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4d62094-d0ef-4e86-9527-10a386aa8a1f" xlink:to="loc_vyne_FoamixMember_7aae7a55-22f4-4241-9f41-0dd764c21848" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#REVENUERECOGNITIONDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended" id="icad1b384ef0d40928ec1b2246006ee5e_REVENUERECOGNITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1a23753d-5add-47ce-bf20-39c61b6b3233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1a23753d-5add-47ce-bf20-39c61b6b3233" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances_d8c99f0c-b04c-4801-afeb-701adcb69877" xlink:href="vyne-20211231.xsd#vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances_d8c99f0c-b04c-4801-afeb-701adcb69877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ea6c9769-f92f-4ffe-8d10-c1dc3da0e72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ea6c9769-f92f-4ffe-8d10-c1dc3da0e72f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EstimateOfProductReturnRateMinimum_9313f852-43bc-480b-80d3-e115ccd5178b" xlink:href="vyne-20211231.xsd#vyne_EstimateOfProductReturnRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_vyne_EstimateOfProductReturnRateMinimum_9313f852-43bc-480b-80d3-e115ccd5178b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EstimateOfProductReturnRateMaximum_a571c67c-bdad-475b-8347-02a45ec115e0" xlink:href="vyne-20211231.xsd#vyne_EstimateOfProductReturnRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_vyne_EstimateOfProductReturnRateMaximum_a571c67c-bdad-475b-8347-02a45ec115e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_eda181f1-0ab5-4036-8695-de7e2344f072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_eda181f1-0ab5-4036-8695-de7e2344f072" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34bba550-4cdb-4cbf-a459-8c6b9a3b5ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34bba550-4cdb-4cbf-a459-8c6b9a3b5ad6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_68ab19dd-cf03-40c3-a9eb-4b45cc3f0978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_68ab19dd-cf03-40c3-a9eb-4b45cc3f0978" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_68ab19dd-cf03-40c3-a9eb-4b45cc3f0978_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_68ab19dd-cf03-40c3-a9eb-4b45cc3f0978" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_68ab19dd-cf03-40c3-a9eb-4b45cc3f0978_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5471366c-c538-4d45-bf2c-26e4f8f58065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_68ab19dd-cf03-40c3-a9eb-4b45cc3f0978" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5471366c-c538-4d45-bf2c-26e4f8f58065" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_4010aabb-20f4-4151-9543-4afc5df5f598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5471366c-c538-4d45-bf2c-26e4f8f58065" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_4010aabb-20f4-4151-9543-4afc5df5f598" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf051279-40a7-4acf-ac78-2659786910d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf051279-40a7-4acf-ac78-2659786910d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bf051279-40a7-4acf-ac78-2659786910d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf051279-40a7-4acf-ac78-2659786910d7" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_bf051279-40a7-4acf-ac78-2659786910d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_db604016-d72f-4366-b348-f58acd4d1b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf051279-40a7-4acf-ac78-2659786910d7" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_db604016-d72f-4366-b348-f58acd4d1b6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c381629f-e505-4e0c-9f14-533618ad433c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_db604016-d72f-4366-b348-f58acd4d1b6a" xlink:to="loc_us-gaap_SalesRevenueNetMember_c381629f-e505-4e0c-9f14-533618ad433c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_0fa95314-8df4-4c66-9308-75e34de7d108" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_srt_MajorCustomersAxis_0fa95314-8df4-4c66-9308-75e34de7d108" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_0fa95314-8df4-4c66-9308-75e34de7d108_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_0fa95314-8df4-4c66-9308-75e34de7d108" xlink:to="loc_srt_NameOfMajorCustomerDomain_0fa95314-8df4-4c66-9308-75e34de7d108_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a6c42dc4-d481-4a5d-b25d-dd7e20d1b989" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_0fa95314-8df4-4c66-9308-75e34de7d108" xlink:to="loc_srt_NameOfMajorCustomerDomain_a6c42dc4-d481-4a5d-b25d-dd7e20d1b989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CustomerOneMember_a6986da7-c44b-48a9-b9e9-17e1de5fb71f" xlink:href="vyne-20211231.xsd#vyne_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a6c42dc4-d481-4a5d-b25d-dd7e20d1b989" xlink:to="loc_vyne_CustomerOneMember_a6986da7-c44b-48a9-b9e9-17e1de5fb71f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CustomerTwoMember_2ede1f85-b58b-48ff-8268-0e48e05fbea2" xlink:href="vyne-20211231.xsd#vyne_CustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a6c42dc4-d481-4a5d-b25d-dd7e20d1b989" xlink:to="loc_vyne_CustomerTwoMember_2ede1f85-b58b-48ff-8268-0e48e05fbea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CustomerThreeMember_cb5bdb62-bb17-4765-95e6-145d3b0f5a11" xlink:href="vyne-20211231.xsd#vyne_CustomerThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_a6c42dc4-d481-4a5d-b25d-dd7e20d1b989" xlink:to="loc_vyne_CustomerThreeMember_cb5bdb62-bb17-4765-95e6-145d3b0f5a11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f7fbddd4-2b13-4bff-9c57-22d1ff64ba4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_srt_ProductOrServiceAxis_f7fbddd4-2b13-4bff-9c57-22d1ff64ba4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f7fbddd4-2b13-4bff-9c57-22d1ff64ba4e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f7fbddd4-2b13-4bff-9c57-22d1ff64ba4e" xlink:to="loc_srt_ProductsAndServicesDomain_f7fbddd4-2b13-4bff-9c57-22d1ff64ba4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_87004905-046f-4e04-b519-5a5da74597ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f7fbddd4-2b13-4bff-9c57-22d1ff64ba4e" xlink:to="loc_srt_ProductsAndServicesDomain_87004905-046f-4e04-b519-5a5da74597ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AllowanceForSalesReturns1Member_326dbed1-c4cb-4113-89a0-32cb582bebae" xlink:href="vyne-20211231.xsd#vyne_AllowanceForSalesReturns1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_87004905-046f-4e04-b519-5a5da74597ea" xlink:to="loc_vyne_AllowanceForSalesReturns1Member_326dbed1-c4cb-4113-89a0-32cb582bebae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_9c2d85a2-8513-4455-b46c-b16f0ecd50a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_87004905-046f-4e04-b519-5a5da74597ea" xlink:to="loc_us-gaap_LicenseMember_9c2d85a2-8513-4455-b46c-b16f0ecd50a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_3217756f-03fc-4a4b-9306-73709ca23f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_87004905-046f-4e04-b519-5a5da74597ea" xlink:to="loc_us-gaap_RoyaltyMember_3217756f-03fc-4a4b-9306-73709ca23f7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fe74d903-4f18-4ea8-9979-2628bc2e8c3e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_dei_LegalEntityAxis_fe74d903-4f18-4ea8-9979-2628bc2e8c3e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fe74d903-4f18-4ea8-9979-2628bc2e8c3e_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_fe74d903-4f18-4ea8-9979-2628bc2e8c3e" xlink:to="loc_dei_EntityDomain_fe74d903-4f18-4ea8-9979-2628bc2e8c3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_174d1a40-f744-405c-8b1a-774c4fc5288d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_fe74d903-4f18-4ea8-9979-2628bc2e8c3e" xlink:to="loc_dei_EntityDomain_174d1a40-f744-405c-8b1a-774c4fc5288d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_e444862b-ba6c-454d-8360-f10c6148e900" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_174d1a40-f744-405c-8b1a-774c4fc5288d" xlink:to="loc_vyne_FoamixMember_e444862b-ba6c-454d-8360-f10c6148e900" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended" id="i212e2340171449f18684b66863c61e79_FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ee55449-8595-40f1-8151-293e6d50d150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_6a014476-7172-40ec-bd97-62d5869a2434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ee55449-8595-40f1-8151-293e6d50d150" xlink:to="loc_us-gaap_MarketableSecurities_6a014476-7172-40ec-bd97-62d5869a2434" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78e3f542-d751-41d3-a4a5-d80f8a1a2ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ee55449-8595-40f1-8151-293e6d50d150" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78e3f542-d751-41d3-a4a5-d80f8a1a2ee1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6bc250f6-e4ed-4a8b-b239-6b003093c08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78e3f542-d751-41d3-a4a5-d80f8a1a2ee1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6bc250f6-e4ed-4a8b-b239-6b003093c08e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6bc250f6-e4ed-4a8b-b239-6b003093c08e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6bc250f6-e4ed-4a8b-b239-6b003093c08e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6bc250f6-e4ed-4a8b-b239-6b003093c08e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1db8689e-9390-4dbf-9b49-5220c816dccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6bc250f6-e4ed-4a8b-b239-6b003093c08e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1db8689e-9390-4dbf-9b49-5220c816dccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_146c3f70-cd53-4297-9b2e-94c7010b9341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1db8689e-9390-4dbf-9b49-5220c816dccb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_146c3f70-cd53-4297-9b2e-94c7010b9341" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_02059951-8b54-4110-959b-b75d5d16bfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1db8689e-9390-4dbf-9b49-5220c816dccb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_02059951-8b54-4110-959b-b75d5d16bfd5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#MARKETABLESECURITIESMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails" xlink:type="extended" id="i71350a8372b14501abeb869e01ef3a48_MARKETABLESECURITIESMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_26c48379-6db3-4bb9-8cc1-c60fae918439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_a5feefb4-65b4-4aca-a482-ea24dafafd17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_26c48379-6db3-4bb9-8cc1-c60fae918439" xlink:to="loc_us-gaap_ShortTermInvestments_a5feefb4-65b4-4aca-a482-ea24dafafd17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4eeacb05-4a63-4c41-9dc6-110818d9622b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_26c48379-6db3-4bb9-8cc1-c60fae918439" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4eeacb05-4a63-4c41-9dc6-110818d9622b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_28b46391-1a8d-469f-bf50-694c6cee7d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4eeacb05-4a63-4c41-9dc6-110818d9622b" xlink:to="loc_us-gaap_InvestmentTypeAxis_28b46391-1a8d-469f-bf50-694c6cee7d22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_28b46391-1a8d-469f-bf50-694c6cee7d22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_28b46391-1a8d-469f-bf50-694c6cee7d22" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_28b46391-1a8d-469f-bf50-694c6cee7d22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_24e6b58d-a234-4a72-b1c9-0bac6c084fce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_28b46391-1a8d-469f-bf50-694c6cee7d22" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_24e6b58d-a234-4a72-b1c9-0bac6c084fce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_IsraeliMutualFundsMember_2908a7cb-a422-4bdc-af46-187a5d8d9add" xlink:href="vyne-20211231.xsd#vyne_IsraeliMutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_24e6b58d-a234-4a72-b1c9-0bac6c084fce" xlink:to="loc_vyne_IsraeliMutualFundsMember_2908a7cb-a422-4bdc-af46-187a5d8d9add" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="extended" id="ia6e17fb4ba8e4714b1a987d23916766e_PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8c2bd306-2845-47b7-a590-7d327e17bb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_69099721-c611-460c-adab-1131791d7317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8c2bd306-2845-47b7-a590-7d327e17bb4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_69099721-c611-460c-adab-1131791d7317" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e09af244-506c-473a-a2d0-3f44d1dfe2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8c2bd306-2845-47b7-a590-7d327e17bb4f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e09af244-506c-473a-a2d0-3f44d1dfe2c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f84d510a-85a0-46fb-ae13-243ef0110416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8c2bd306-2845-47b7-a590-7d327e17bb4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f84d510a-85a0-46fb-ae13-243ef0110416" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_61105c6f-1f81-4691-8bfb-f79c1f44f0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8c2bd306-2845-47b7-a590-7d327e17bb4f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_61105c6f-1f81-4691-8bfb-f79c1f44f0bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_769b6c89-af8f-40e1-bbc7-ba3ad84d1690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_61105c6f-1f81-4691-8bfb-f79c1f44f0bf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_769b6c89-af8f-40e1-bbc7-ba3ad84d1690" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769b6c89-af8f-40e1-bbc7-ba3ad84d1690_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_769b6c89-af8f-40e1-bbc7-ba3ad84d1690" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_769b6c89-af8f-40e1-bbc7-ba3ad84d1690_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_769b6c89-af8f-40e1-bbc7-ba3ad84d1690" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_cd50653b-4586-420c-b852-45993e03bad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_cd50653b-4586-420c-b852-45993e03bad2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ComputerEquipmentAndSoftwareMember_31914c9b-8a6b-49e1-9aa0-b0a17f99cc1c" xlink:href="vyne-20211231.xsd#vyne_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:to="loc_vyne_ComputerEquipmentAndSoftwareMember_31914c9b-8a6b-49e1-9aa0-b0a17f99cc1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d3dc2a23-8e61-4e95-ad03-b1f825e21ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:to="loc_us-gaap_EquipmentMember_d3dc2a23-8e61-4e95-ad03-b1f825e21ca9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_0c78ca6a-d819-4fb5-a836-ebacef81a266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_0c78ca6a-d819-4fb5-a836-ebacef81a266" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASENarrativeDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails" xlink:type="extended" id="ibc0b858b738841dab29027779b05ae39_OPERATINGLEASENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FacilitySpaceUnderLease_26ffbbbd-6615-476b-940e-955732b12870" xlink:href="vyne-20211231.xsd#vyne_FacilitySpaceUnderLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_FacilitySpaceUnderLease_26ffbbbd-6615-476b-940e-955732b12870" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseRightOfUseAssetCurrent_9554c157-fc01-4963-9559-b93335941a43" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseRightOfUseAssetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_OperatingLeaseRightOfUseAssetCurrent_9554c157-fc01-4963-9559-b93335941a43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_db8f5bd4-b0a4-41fe-b38d-d0fd20532bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_db8f5bd4-b0a4-41fe-b38d-d0fd20532bfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a5314eac-4dc2-4071-8f97-f6fdd73b148f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_us-gaap_OperatingLeaseLiability_a5314eac-4dc2-4071-8f97-f6fdd73b148f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3fcb0961-4a61-4599-bff8-44fc3686c175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3fcb0961-4a61-4599-bff8-44fc3686c175" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_VehicleLeasePrepaymentPeriod_dcc528b7-7ced-4a7f-9832-5494b40b2e86" xlink:href="vyne-20211231.xsd#vyne_VehicleLeasePrepaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_VehicleLeasePrepaymentPeriod_dcc528b7-7ced-4a7f-9832-5494b40b2e86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseRightOfUseAssetsTransferred_d409ca5d-cc20-4014-9c0c-438c796296a7" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseRightOfUseAssetsTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_OperatingLeaseRightOfUseAssetsTransferred_d409ca5d-cc20-4014-9c0c-438c796296a7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseLiabilityTransferred_3e4ff0f9-59df-4eeb-b11d-88f0de86b0c4" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseLiabilityTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_OperatingLeaseLiabilityTransferred_3e4ff0f9-59df-4eeb-b11d-88f0de86b0c4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RestrictedInvestmentsToSecureLeaseAgreements_e03559ef-e3d9-4183-8d68-e4602ac40f45" xlink:href="vyne-20211231.xsd#vyne_RestrictedInvestmentsToSecureLeaseAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_RestrictedInvestmentsToSecureLeaseAgreements_e03559ef-e3d9-4183-8d68-e4602ac40f45" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_e1025e66-38dd-4678-a710-e6d759791d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_e1025e66-38dd-4678-a710-e6d759791d18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4411c64b-2efc-4d59-9898-9665fd65f953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_e1025e66-38dd-4678-a710-e6d759791d18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4411c64b-2efc-4d59-9898-9665fd65f953" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4411c64b-2efc-4d59-9898-9665fd65f953_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4411c64b-2efc-4d59-9898-9665fd65f953" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4411c64b-2efc-4d59-9898-9665fd65f953_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd97bb52-0deb-4b8f-a617-32bbd650f2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4411c64b-2efc-4d59-9898-9665fd65f953" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd97bb52-0deb-4b8f-a617-32bbd650f2e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OriginalSpaceMember_9b6b683b-db6a-4e7b-9659-91c67d8811fe" xlink:href="vyne-20211231.xsd#vyne_OriginalSpaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd97bb52-0deb-4b8f-a617-32bbd650f2e1" xlink:to="loc_vyne_OriginalSpaceMember_9b6b683b-db6a-4e7b-9659-91c67d8811fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdditionalSpaceMember_cb8f26f3-e076-4c9a-94e4-55971fd69438" xlink:href="vyne-20211231.xsd#vyne_AdditionalSpaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd97bb52-0deb-4b8f-a617-32bbd650f2e1" xlink:to="loc_vyne_AdditionalSpaceMember_cb8f26f3-e076-4c9a-94e4-55971fd69438" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_eab1232e-c31b-4a7a-82dc-92aac411c169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd97bb52-0deb-4b8f-a617-32bbd650f2e1" xlink:to="loc_us-gaap_VehiclesMember_eab1232e-c31b-4a7a-82dc-92aac411c169" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_82ee6c7f-4944-4cde-96a1-c1842e0e3cd7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_e1025e66-38dd-4678-a710-e6d759791d18" xlink:to="loc_srt_StatementGeographicalAxis_82ee6c7f-4944-4cde-96a1-c1842e0e3cd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_82ee6c7f-4944-4cde-96a1-c1842e0e3cd7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_82ee6c7f-4944-4cde-96a1-c1842e0e3cd7" xlink:to="loc_srt_SegmentGeographicalDomain_82ee6c7f-4944-4cde-96a1-c1842e0e3cd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9d4a32d0-d898-44d1-a89a-ad358cc9e8d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_82ee6c7f-4944-4cde-96a1-c1842e0e3cd7" xlink:to="loc_srt_SegmentGeographicalDomain_9d4a32d0-d898-44d1-a89a-ad358cc9e8d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BridgewaterNewJerseyMember_0cdbc393-d786-45ab-8c6d-fcefd13d82a2" xlink:href="vyne-20211231.xsd#vyne_BridgewaterNewJerseyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9d4a32d0-d898-44d1-a89a-ad358cc9e8d9" xlink:to="loc_vyne_BridgewaterNewJerseyMember_0cdbc393-d786-45ab-8c6d-fcefd13d82a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails" xlink:type="extended" id="if49cc3305c0f4c9cbc3acbfd95b9f9d4_OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_96230b34-0d5d-4a5f-8d56-3842e8776e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_67532247-7713-4dd5-b179-e3847be89db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_96230b34-0d5d-4a5f-8d56-3842e8776e0b" xlink:to="loc_us-gaap_OperatingLeaseExpense_67532247-7713-4dd5-b179-e3847be89db1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_14417d30-d354-498d-b4f1-c5bb18a35594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_96230b34-0d5d-4a5f-8d56-3842e8776e0b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_14417d30-d354-498d-b4f1-c5bb18a35594" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb863e89-39ee-4669-9625-0f6b39a71b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_14417d30-d354-498d-b4f1-c5bb18a35594" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb863e89-39ee-4669-9625-0f6b39a71b71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fb863e89-39ee-4669-9625-0f6b39a71b71_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb863e89-39ee-4669-9625-0f6b39a71b71" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fb863e89-39ee-4669-9625-0f6b39a71b71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0bb3ca1e-1668-4435-bfc4-e2f247a1d861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb863e89-39ee-4669-9625-0f6b39a71b71" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0bb3ca1e-1668-4435-bfc4-e2f247a1d861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_f41750e7-f296-4815-9684-a8a1233a748f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficeBuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0bb3ca1e-1668-4435-bfc4-e2f247a1d861" xlink:to="loc_srt_OfficeBuildingMember_f41750e7-f296-4815-9684-a8a1233a748f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_d930440c-4217-4005-95e0-78eac9a2ebdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0bb3ca1e-1668-4435-bfc4-e2f247a1d861" xlink:to="loc_us-gaap_VehiclesMember_d930440c-4217-4005-95e0-78eac9a2ebdb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails" xlink:type="extended" id="id4644847cf5342dca01ba48bb58d7d5c_OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_be3b0484-b50b-49c5-a0a4-6dc1a98c4ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_b8df1ad8-d808-4ed5-8704-39d5d4910d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_be3b0484-b50b-49c5-a0a4-6dc1a98c4ccf" xlink:to="loc_us-gaap_OperatingLeasePayments_b8df1ad8-d808-4ed5-8704-39d5d4910d31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_77f79dca-f089-40e3-8e8c-02dd9a431e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_be3b0484-b50b-49c5-a0a4-6dc1a98c4ccf" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_77f79dca-f089-40e3-8e8c-02dd9a431e3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5e113716-8db7-427f-b61d-b36c7bf52c67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_77f79dca-f089-40e3-8e8c-02dd9a431e3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5e113716-8db7-427f-b61d-b36c7bf52c67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5e113716-8db7-427f-b61d-b36c7bf52c67_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5e113716-8db7-427f-b61d-b36c7bf52c67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5e113716-8db7-427f-b61d-b36c7bf52c67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_33170203-52df-4ed7-8995-73899476b31b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5e113716-8db7-427f-b61d-b36c7bf52c67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_33170203-52df-4ed7-8995-73899476b31b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_a234cb4e-5354-4688-9066-d316e2385fcc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficeBuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_33170203-52df-4ed7-8995-73899476b31b" xlink:to="loc_srt_OfficeBuildingMember_a234cb4e-5354-4688-9066-d316e2385fcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_22d57bd9-bb6f-4750-8dc6-40ea0bedf339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_33170203-52df-4ed7-8995-73899476b31b" xlink:to="loc_us-gaap_VehiclesMember_22d57bd9-bb6f-4750-8dc6-40ea0bedf339" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#LONGTERMDEBTDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/LONGTERMDEBTDetails" xlink:type="extended" id="i30cda946a8314299a8bbaa2119a57c7b_LONGTERMDEBTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c496bb0-394b-478d-bbd2-fb7cbb826dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c496bb0-394b-478d-bbd2-fb7cbb826dcc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_NumberOfLenders_6169dc00-95f7-4e19-9946-ebec2c4e5dfb" xlink:href="vyne-20211231.xsd#vyne_NumberOfLenders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_vyne_NumberOfLenders_6169dc00-95f7-4e19-9946-ebec2c4e5dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_GrossProceedsFromIssuanceOfCommonStock_85e818ff-281c-449b-b1e0-47cbf08512cd" xlink:href="vyne-20211231.xsd#vyne_GrossProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_vyne_GrossProceedsFromIssuanceOfCommonStock_85e818ff-281c-449b-b1e0-47cbf08512cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_faea2e89-4155-49e9-8571-e86976175195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_faea2e89-4155-49e9-8571-e86976175195" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_a4a3478b-0369-4885-8411-e7099d85b2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_a4a3478b-0369-4885-8411-e7099d85b2c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_18092adf-844e-42a6-bacd-abad40b89f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_18092adf-844e-42a6-bacd-abad40b89f02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1f195a8c-1b33-45db-a89d-381ddd9643e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1f195a8c-1b33-45db-a89d-381ddd9643e6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_fb3ffd86-5528-4e6c-aa13-2aacfa40d9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_fb3ffd86-5528-4e6c-aa13-2aacfa40d9de" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DebtInstrumentFeePercent_ac546b68-2114-44cb-894a-596bc1bc68f0" xlink:href="vyne-20211231.xsd#vyne_DebtInstrumentFeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_vyne_DebtInstrumentFeePercent_ac546b68-2114-44cb-894a-596bc1bc68f0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RepaymentOfDebtPrepaymentFeePercentage_a72dd871-c982-4448-bcd0-795b2333ff1c" xlink:href="vyne-20211231.xsd#vyne_RepaymentOfDebtPrepaymentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_vyne_RepaymentOfDebtPrepaymentFeePercentage_a72dd871-c982-4448-bcd0-795b2333ff1c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_0b5d30c9-9402-44bc-9295-015d8abcea80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_0b5d30c9-9402-44bc-9295-015d8abcea80" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3980eadb-a88f-42d0-8e8a-f4b99f2d921b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_LongTermDebt_3980eadb-a88f-42d0-8e8a-f4b99f2d921b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_655d1a91-d092-49d8-be22-678c785bb8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_655d1a91-d092-49d8-be22-678c785bb8ca" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ClassOfWarrantAbstract_edf93a14-66ab-4472-afc9-62451929ec81" xlink:href="vyne-20211231.xsd#vyne_ClassOfWarrantAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_vyne_ClassOfWarrantAbstract_edf93a14-66ab-4472-afc9-62451929ec81" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6bb5e356-5d4b-4b59-a21a-61d873974bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vyne_ClassOfWarrantAbstract_edf93a14-66ab-4472-afc9-62451929ec81" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6bb5e356-5d4b-4b59-a21a-61d873974bf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ec77026f-94f8-48e8-82ec-c6c7ec1bd859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vyne_ClassOfWarrantAbstract_edf93a14-66ab-4472-afc9-62451929ec81" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ec77026f-94f8-48e8-82ec-c6c7ec1bd859" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_76ed7c1d-10b7-4567-a43c-8378607bf51f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_76ed7c1d-10b7-4567-a43c-8378607bf51f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_2842b8cb-db21-428d-90ce-0b0b1d3a555e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_2842b8cb-db21-428d-90ce-0b0b1d3a555e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5e5c6acb-b3d3-4966-a61d-22dfc7e72809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_InterestExpense_5e5c6acb-b3d3-4966-a61d-22dfc7e72809" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_8927279d-5d8e-4c9d-9835-964b61f9dd97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_InterestExpenseDebt_8927279d-5d8e-4c9d-9835-964b61f9dd97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_84dfa3d3-b5d6-4f7b-95e1-99b88a2f4684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_84dfa3d3-b5d6-4f7b-95e1-99b88a2f4684" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_debfe15b-328b-450c-a71b-a8c808e2c6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_debfe15b-328b-450c-a71b-a8c808e2c6c3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bdaf90df-4d93-4244-8c29-1b2aedb61ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bdaf90df-4d93-4244-8c29-1b2aedb61ebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_bdaf90df-4d93-4244-8c29-1b2aedb61ebf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bdaf90df-4d93-4244-8c29-1b2aedb61ebf" xlink:to="loc_us-gaap_RelatedPartyDomain_bdaf90df-4d93-4244-8c29-1b2aedb61ebf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c39bccd7-d6f6-4070-8e2d-fb4ebeb8e8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bdaf90df-4d93-4244-8c29-1b2aedb61ebf" xlink:to="loc_us-gaap_RelatedPartyDomain_c39bccd7-d6f6-4070-8e2d-fb4ebeb8e8d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareholderLenderMember_4e6a1624-e661-44ca-b654-6b57295b7840" xlink:href="vyne-20211231.xsd#vyne_ShareholderLenderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c39bccd7-d6f6-4070-8e2d-fb4ebeb8e8d0" xlink:to="loc_vyne_ShareholderLenderMember_4e6a1624-e661-44ca-b654-6b57295b7840" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_30a43864-de6b-4800-bdcf-b9c306adfe9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_30a43864-de6b-4800-bdcf-b9c306adfe9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_30a43864-de6b-4800-bdcf-b9c306adfe9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_30a43864-de6b-4800-bdcf-b9c306adfe9d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_30a43864-de6b-4800-bdcf-b9c306adfe9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5480c67f-9260-429c-b1af-0716117e947f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_30a43864-de6b-4800-bdcf-b9c306adfe9d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5480c67f-9260-429c-b1af-0716117e947f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RegisteredOfferingMember_c967da3b-16b3-4b97-894f-660e14b82ace" xlink:href="vyne-20211231.xsd#vyne_RegisteredOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5480c67f-9260-429c-b1af-0716117e947f" xlink:to="loc_vyne_RegisteredOfferingMember_c967da3b-16b3-4b97-894f-660e14b82ace" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8517ffd3-b32f-424f-b8c0-b7385085ddba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_us-gaap_DebtInstrumentAxis_8517ffd3-b32f-424f-b8c0-b7385085ddba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8517ffd3-b32f-424f-b8c0-b7385085ddba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8517ffd3-b32f-424f-b8c0-b7385085ddba" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8517ffd3-b32f-424f-b8c0-b7385085ddba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8517ffd3-b32f-424f-b8c0-b7385085ddba" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_185a32d4-68d0-440a-8db7-bbde82d757e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:to="loc_us-gaap_SecuredDebtMember_185a32d4-68d0-440a-8db7-bbde82d757e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementMember_c8619000-5db0-4ee7-984f-2c8d79281a4b" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:to="loc_vyne_AmendedAndRestatedCreditAgreementMember_c8619000-5db0-4ee7-984f-2c8d79281a4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember_bbb740ba-789c-4db1-9139-2bef22f1e1e9" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:to="loc_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember_bbb740ba-789c-4db1-9139-2bef22f1e1e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember_de7c631c-ddfb-4e8d-8499-52f67d5f9b9d" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:to="loc_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember_de7c631c-ddfb-4e8d-8499-52f67d5f9b9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember_2ec727ca-ebd0-4ab0-a3e3-08cf9a782784" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:to="loc_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember_2ec727ca-ebd0-4ab0-a3e3-08cf9a782784" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1da0f276-ac57-4113-94eb-5d4340a5041a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_us-gaap_VariableRateAxis_1da0f276-ac57-4113-94eb-5d4340a5041a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1da0f276-ac57-4113-94eb-5d4340a5041a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_1da0f276-ac57-4113-94eb-5d4340a5041a" xlink:to="loc_us-gaap_VariableRateDomain_1da0f276-ac57-4113-94eb-5d4340a5041a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ec794bc3-e7b0-4e4d-83ec-a86098ffaae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_1da0f276-ac57-4113-94eb-5d4340a5041a" xlink:to="loc_us-gaap_VariableRateDomain_ec794bc3-e7b0-4e4d-83ec-a86098ffaae3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3958c997-2295-46eb-99c4-6a485268abd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_ec794bc3-e7b0-4e4d-83ec-a86098ffaae3" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3958c997-2295-46eb-99c4-6a485268abd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_64bb17ee-6e29-4c9c-a47d-77da61c73b7d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_dei_LegalEntityAxis_64bb17ee-6e29-4c9c-a47d-77da61c73b7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_64bb17ee-6e29-4c9c-a47d-77da61c73b7d_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_64bb17ee-6e29-4c9c-a47d-77da61c73b7d" xlink:to="loc_dei_EntityDomain_64bb17ee-6e29-4c9c-a47d-77da61c73b7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a4527372-7885-4278-97a9-dab5283542ef" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_64bb17ee-6e29-4c9c-a47d-77da61c73b7d" xlink:to="loc_dei_EntityDomain_a4527372-7885-4278-97a9-dab5283542ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_dee9658e-61f7-4aa1-930e-2c67a1260382" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a4527372-7885-4278-97a9-dab5283542ef" xlink:to="loc_vyne_FoamixMember_dee9658e-61f7-4aa1-930e-2c67a1260382" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails" xlink:type="extended" id="ibc1e3ef927db46e88688a155fd8449ac_STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_bf5a4b01-b736-4cb2-b6aa-227d67074b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_bf5a4b01-b736-4cb2-b6aa-227d67074b7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_54e9e5e9-15c0-4549-ba1e-c3f533c01978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_54e9e5e9-15c0-4549-ba1e-c3f533c01978" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_d853298c-e824-411e-99e8-11709346cde8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_d853298c-e824-411e-99e8-11709346cde8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6da4180f-2d3b-4837-a781-0cf0aa183444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6da4180f-2d3b-4837-a781-0cf0aa183444" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_0cb029d5-a803-418a-a136-0dacdb881d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_0cb029d5-a803-418a-a136-0dacdb881d01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2e85c95a-d812-48aa-b60f-92f601f2dc56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2e85c95a-d812-48aa-b60f-92f601f2dc56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a14a310a-62d3-4077-bb87-938ef0df5c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a14a310a-62d3-4077-bb87-938ef0df5c0c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CommonStockVotingRightsNumberPerShare_210b5458-5bae-43b1-ba09-7ac84dd059fa" xlink:href="vyne-20211231.xsd#vyne_CommonStockVotingRightsNumberPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_CommonStockVotingRightsNumberPerShare_210b5458-5bae-43b1-ba09-7ac84dd059fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_48b4ae13-c07e-4bce-9693-c5d6dc0a255b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_48b4ae13-c07e-4bce-9693-c5d6dc0a255b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_StockIssuedDuringPeriodSharesWarrantsExercised_29aaca7a-152a-4020-b0d1-4a9e80347395" xlink:href="vyne-20211231.xsd#vyne_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_StockIssuedDuringPeriodSharesWarrantsExercised_29aaca7a-152a-4020-b0d1-4a9e80347395" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessAcquisitionContingentStockRightIssued_a4101570-f3ba-41be-acf8-08afafbecb39" xlink:href="vyne-20211231.xsd#vyne_BusinessAcquisitionContingentStockRightIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_BusinessAcquisitionContingentStockRightIssued_a4101570-f3ba-41be-acf8-08afafbecb39" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_8b319b9c-5c8d-40a4-a1b5-460ac0987555" xlink:href="vyne-20211231.xsd#vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_8b319b9c-5c8d-40a4-a1b5-460ac0987555" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_SaleOfStockConsiderationReceivableOnTransaction_4e276812-04c4-4c8a-b464-f46a51a9bf69" xlink:href="vyne-20211231.xsd#vyne_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_SaleOfStockConsiderationReceivableOnTransaction_4e276812-04c4-4c8a-b464-f46a51a9bf69" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1923fb1-a3b3-4082-96a3-8ae8dc2393fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1923fb1-a3b3-4082-96a3-8ae8dc2393fd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_d63330de-90ea-4d78-8408-9bb594962883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_d63330de-90ea-4d78-8408-9bb594962883" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock_e6c421e7-62f4-4569-a5ad-926c18349d70" xlink:href="vyne-20211231.xsd#vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock_e6c421e7-62f4-4569-a5ad-926c18349d70" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_00e26e67-ce74-4ef4-8c55-4aca2e6b29d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_00e26e67-ce74-4ef4-8c55-4aca2e6b29d7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_0dd2c7d4-b0b3-409d-bad1-a27be6a3cf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_0dd2c7d4-b0b3-409d-bad1-a27be6a3cf2d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d2a97bc4-a710-4d12-b214-1fe8bfce7961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d2a97bc4-a710-4d12-b214-1fe8bfce7961" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_a7c1e5ec-d765-4297-abca-0ff3d111de13" xlink:href="vyne-20211231.xsd#vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_a7c1e5ec-d765-4297-abca-0ff3d111de13" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8d638901-f680-479c-9bb4-582f6a7347ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8d638901-f680-479c-9bb4-582f6a7347ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8d638901-f680-479c-9bb4-582f6a7347ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8d638901-f680-479c-9bb4-582f6a7347ca" xlink:to="loc_us-gaap_EquityComponentDomain_8d638901-f680-479c-9bb4-582f6a7347ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_13240f5d-0132-4e3d-aa52-6ce66773b715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8d638901-f680-479c-9bb4-582f6a7347ca" xlink:to="loc_us-gaap_EquityComponentDomain_13240f5d-0132-4e3d-aa52-6ce66773b715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ce3281e5-5c77-4849-8dd1-805b85cd3c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_13240f5d-0132-4e3d-aa52-6ce66773b715" xlink:to="loc_us-gaap_CommonStockMember_ce3281e5-5c77-4849-8dd1-805b85cd3c5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_9d0f035e-b496-4f64-abd5-9c3e2d7ca117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_13240f5d-0132-4e3d-aa52-6ce66773b715" xlink:to="loc_us-gaap_WarrantMember_9d0f035e-b496-4f64-abd5-9c3e2d7ca117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_a492bfe0-9edd-4b91-ad59-d4ad9aad0fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_a492bfe0-9edd-4b91-ad59-d4ad9aad0fe1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a492bfe0-9edd-4b91-ad59-d4ad9aad0fe1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a492bfe0-9edd-4b91-ad59-d4ad9aad0fe1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a492bfe0-9edd-4b91-ad59-d4ad9aad0fe1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e94d171f-b872-498e-889b-224f3c9eae03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a492bfe0-9edd-4b91-ad59-d4ad9aad0fe1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e94d171f-b872-498e-889b-224f3c9eae03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CantorSalesAgreementMember_f5789313-6143-4c35-9000-c042351c69d0" xlink:href="vyne-20211231.xsd#vyne_CantorSalesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e94d171f-b872-498e-889b-224f3c9eae03" xlink:to="loc_vyne_CantorSalesAgreementMember_f5789313-6143-4c35-9000-c042351c69d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RegisteredDirectOfferingMember_ff5f951e-35ba-44a8-8998-eff8f60052b6" xlink:href="vyne-20211231.xsd#vyne_RegisteredDirectOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e94d171f-b872-498e-889b-224f3c9eae03" xlink:to="loc_vyne_RegisteredDirectOfferingMember_ff5f951e-35ba-44a8-8998-eff8f60052b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PublicStockOfferingMember_ca3b33b9-5511-4536-adba-ba0c7ce2cbb9" xlink:href="vyne-20211231.xsd#vyne_PublicStockOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e94d171f-b872-498e-889b-224f3c9eae03" xlink:to="loc_vyne_PublicStockOfferingMember_ca3b33b9-5511-4536-adba-ba0c7ce2cbb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7d7b8c88-d61b-42fa-857b-693a4f06167b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_dei_LegalEntityAxis_7d7b8c88-d61b-42fa-857b-693a4f06167b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7d7b8c88-d61b-42fa-857b-693a4f06167b_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_7d7b8c88-d61b-42fa-857b-693a4f06167b" xlink:to="loc_dei_EntityDomain_7d7b8c88-d61b-42fa-857b-693a4f06167b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3f590ba1-0857-4012-95df-a6139c4a541a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_7d7b8c88-d61b-42fa-857b-693a4f06167b" xlink:to="loc_dei_EntityDomain_3f590ba1-0857-4012-95df-a6139c4a541a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_5fb7cbc8-3c5a-4aac-9fcb-509f929f8e91" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3f590ba1-0857-4012-95df-a6139c4a541a" xlink:to="loc_vyne_FoamixMember_5fb7cbc8-3c5a-4aac-9fcb-509f929f8e91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fb77b35a-7429-469a-97c4-9b7ca45e841a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_srt_RangeAxis_fb77b35a-7429-469a-97c4-9b7ca45e841a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fb77b35a-7429-469a-97c4-9b7ca45e841a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fb77b35a-7429-469a-97c4-9b7ca45e841a" xlink:to="loc_srt_RangeMember_fb77b35a-7429-469a-97c4-9b7ca45e841a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5a4ff0d2-db07-4eae-8779-8cef09711df9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fb77b35a-7429-469a-97c4-9b7ca45e841a" xlink:to="loc_srt_RangeMember_5a4ff0d2-db07-4eae-8779-8cef09711df9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a14f2fe7-0704-4076-b324-7491e7a15cdf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5a4ff0d2-db07-4eae-8779-8cef09711df9" xlink:to="loc_srt_MaximumMember_a14f2fe7-0704-4076-b324-7491e7a15cdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e4e5925f-8832-4bb8-a827-d5d6c900ee75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e4e5925f-8832-4bb8-a827-d5d6c900ee75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e4e5925f-8832-4bb8-a827-d5d6c900ee75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e4e5925f-8832-4bb8-a827-d5d6c900ee75" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e4e5925f-8832-4bb8-a827-d5d6c900ee75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d911680e-4b91-42f1-9765-84ae0eeb5b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e4e5925f-8832-4bb8-a827-d5d6c900ee75" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d911680e-4b91-42f1-9765-84ae0eeb5b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_c576fd35-64b9-4529-84db-2f0661b4c7bd" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d911680e-4b91-42f1-9765-84ae0eeb5b5d" xlink:to="loc_vyne_FoamixMember_c576fd35-64b9-4529-84db-2f0661b4c7bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6a379659-b44c-4c09-a674-9de413a550ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6a379659-b44c-4c09-a674-9de413a550ef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6a379659-b44c-4c09-a674-9de413a550ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6a379659-b44c-4c09-a674-9de413a550ef" xlink:to="loc_us-gaap_RelatedPartyDomain_6a379659-b44c-4c09-a674-9de413a550ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_94bb544e-4d5d-4d48-a2e0-aa4ca9ec11dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6a379659-b44c-4c09-a674-9de413a550ef" xlink:to="loc_us-gaap_RelatedPartyDomain_94bb544e-4d5d-4d48-a2e0-aa4ca9ec11dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareholderLenderMember_c2018ed2-bc69-43bd-a514-ee3143df8047" xlink:href="vyne-20211231.xsd#vyne_ShareholderLenderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_94bb544e-4d5d-4d48-a2e0-aa4ca9ec11dc" xlink:to="loc_vyne_ShareholderLenderMember_c2018ed2-bc69-43bd-a514-ee3143df8047" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SHAREBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="i8b2dc434e6ce41aeb6753ce87b574b87_SHAREBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ef40ef58-8b5f-4112-bfb3-9487876577f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ef40ef58-8b5f-4112-bfb3-9487876577f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_c8252290-e9d7-4120-af2f-d50649f87351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_c8252290-e9d7-4120-af2f-d50649f87351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_bc00e382-1ec9-4139-adeb-2a23a8f6d272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_bc00e382-1ec9-4139-adeb-2a23a8f6d272" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_590e1c1a-f869-44c6-8cd5-879d60e18523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_590e1c1a-f869-44c6-8cd5-879d60e18523" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_3557b7e7-1047-48bb-abfe-8fb7b2e058a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_3557b7e7-1047-48bb-abfe-8fb7b2e058a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessAcquisitionContingentStockRightIssued_dfa0cea2-1f1c-4ce2-91c5-d115aa876700" xlink:href="vyne-20211231.xsd#vyne_BusinessAcquisitionContingentStockRightIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_BusinessAcquisitionContingentStockRightIssued_dfa0cea2-1f1c-4ce2-91c5-d115aa876700" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue_0c91f516-4dd1-4b69-96d5-e1a19c645cad" xlink:href="vyne-20211231.xsd#vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue_0c91f516-4dd1-4b69-96d5-e1a19c645cad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockRightSharesConversion_46680b11-417d-4c04-86ae-55767895e225" xlink:href="vyne-20211231.xsd#vyne_ContingentStockRightSharesConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_ContingentStockRightSharesConversion_46680b11-417d-4c04-86ae-55767895e225" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationEffectiveExchangeRatio_839bcbdd-62c6-43ee-b137-0d357ba7fea2" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationEffectiveExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_BusinessCombinationEffectiveExchangeRatio_839bcbdd-62c6-43ee-b137-0d357ba7fea2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_a24cd054-69bf-4200-b3e1-b7a79b03556a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_a24cd054-69bf-4200-b3e1-b7a79b03556a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost_f602cc31-eac3-46e9-b35d-65a7dc007fd9" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost_f602cc31-eac3-46e9-b35d-65a7dc007fd9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod_fb8db9e1-b516-40c3-8aa4-1686b923f3f4" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod_fb8db9e1-b516-40c3-8aa4-1686b923f3f4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_9654b379-4f9b-4f81-aa6a-5ed4c40a8414" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_9654b379-4f9b-4f81-aa6a-5ed4c40a8414" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_65aaa3f1-ed41-4a40-8421-53413f6380a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_65aaa3f1-ed41-4a40-8421-53413f6380a1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3602ad91-bb40-4ecf-a3f0-0fa62b8081ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3602ad91-bb40-4ecf-a3f0-0fa62b8081ce" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0e4e69e8-d3e0-4dcf-ac0d-e612a492ef30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0e4e69e8-d3e0-4dcf-ac0d-e612a492ef30" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bf7049e1-d1f4-4d51-91c3-954bb1dcf08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bf7049e1-d1f4-4d51-91c3-954bb1dcf08e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fbed3dac-7370-43c0-a15d-f5f235d174d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fbed3dac-7370-43c0-a15d-f5f235d174d1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e30a927f-54bd-4cd3-a7fb-9d28f24d76a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e30a927f-54bd-4cd3-a7fb-9d28f24d76a4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9bf29c80-28b7-445d-ae02-40afacb6fcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9bf29c80-28b7-445d-ae02-40afacb6fcfe" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8aff2e9b-d356-4ff9-bf46-c0a2de90e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_PlanNameAxis_8aff2e9b-d356-4ff9-bf46-c0a2de90e7f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8aff2e9b-d356-4ff9-bf46-c0a2de90e7f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_8aff2e9b-d356-4ff9-bf46-c0a2de90e7f8" xlink:to="loc_us-gaap_PlanNameDomain_8aff2e9b-d356-4ff9-bf46-c0a2de90e7f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8932eb77-2bdb-489c-9b33-ebb7e52c6cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_8aff2e9b-d356-4ff9-bf46-c0a2de90e7f8" xlink:to="loc_us-gaap_PlanNameDomain_8932eb77-2bdb-489c-9b33-ebb7e52c6cb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_A2019PlanMember_158d7017-ee52-4da4-8e32-6af0d73cc691" xlink:href="vyne-20211231.xsd#vyne_A2019PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8932eb77-2bdb-489c-9b33-ebb7e52c6cb7" xlink:to="loc_vyne_A2019PlanMember_158d7017-ee52-4da4-8e32-6af0d73cc691" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_A2018PlanMember_af0839c2-9108-4958-9bb3-2b67f3e93620" xlink:href="vyne-20211231.xsd#vyne_A2018PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8932eb77-2bdb-489c-9b33-ebb7e52c6cb7" xlink:to="loc_vyne_A2018PlanMember_af0839c2-9108-4958-9bb3-2b67f3e93620" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EmployeeStockPurchasePlanMember_e3a7eb6b-7479-4134-8c64-a0077ec59742" xlink:href="vyne-20211231.xsd#vyne_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8932eb77-2bdb-489c-9b33-ebb7e52c6cb7" xlink:to="loc_vyne_EmployeeStockPurchasePlanMember_e3a7eb6b-7479-4134-8c64-a0077ec59742" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7dbe3e87-ed84-46db-bc36-d8de11256316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7dbe3e87-ed84-46db-bc36-d8de11256316" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7dbe3e87-ed84-46db-bc36-d8de11256316_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7dbe3e87-ed84-46db-bc36-d8de11256316" xlink:to="loc_us-gaap_EquityComponentDomain_7dbe3e87-ed84-46db-bc36-d8de11256316_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1fe02dbc-fd88-475d-b038-68ec03d87774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7dbe3e87-ed84-46db-bc36-d8de11256316" xlink:to="loc_us-gaap_EquityComponentDomain_1fe02dbc-fd88-475d-b038-68ec03d87774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d162df30-6914-4031-ad66-6316272ca965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1fe02dbc-fd88-475d-b038-68ec03d87774" xlink:to="loc_us-gaap_CommonStockMember_d162df30-6914-4031-ad66-6316272ca965" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f4d553df-0b0a-401a-8129-301613dd66a1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_dei_LegalEntityAxis_f4d553df-0b0a-401a-8129-301613dd66a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f4d553df-0b0a-401a-8129-301613dd66a1_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f4d553df-0b0a-401a-8129-301613dd66a1" xlink:to="loc_dei_EntityDomain_f4d553df-0b0a-401a-8129-301613dd66a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5615a8f7-1c16-431a-969f-887a88592089" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f4d553df-0b0a-401a-8129-301613dd66a1" xlink:to="loc_dei_EntityDomain_5615a8f7-1c16-431a-969f-887a88592089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_99bfd40e-6267-4bdc-9c95-63d2a5d4b5d9" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5615a8f7-1c16-431a-969f-887a88592089" xlink:to="loc_vyne_FoamixMember_99bfd40e-6267-4bdc-9c95-63d2a5d4b5d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MenloMember_6176ac91-8401-404a-8efd-d49c34e831b3" xlink:href="vyne-20211231.xsd#vyne_MenloMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5615a8f7-1c16-431a-969f-887a88592089" xlink:to="loc_vyne_MenloMember_6176ac91-8401-404a-8efd-d49c34e831b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_01720483-095c-406e-8c90-5ed3359a07c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_GranteeStatusAxis_01720483-095c-406e-8c90-5ed3359a07c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_01720483-095c-406e-8c90-5ed3359a07c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_01720483-095c-406e-8c90-5ed3359a07c4" xlink:to="loc_us-gaap_GranteeStatusDomain_01720483-095c-406e-8c90-5ed3359a07c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_23c1b2b1-1a9c-438d-9bf4-e43f88711e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_01720483-095c-406e-8c90-5ed3359a07c4" xlink:to="loc_us-gaap_GranteeStatusDomain_23c1b2b1-1a9c-438d-9bf4-e43f88711e51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_979eb01e-efd0-450d-b3e1-addd1657482d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_23c1b2b1-1a9c-438d-9bf4-e43f88711e51" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_979eb01e-efd0-450d-b3e1-addd1657482d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_49a82b90-562b-4ffc-a950-39812b32ee82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_23c1b2b1-1a9c-438d-9bf4-e43f88711e51" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_49a82b90-562b-4ffc-a950-39812b32ee82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bf0ed943-f40a-4503-b46e-b728857205ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_AwardTypeAxis_bf0ed943-f40a-4503-b46e-b728857205ec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf0ed943-f40a-4503-b46e-b728857205ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bf0ed943-f40a-4503-b46e-b728857205ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bf0ed943-f40a-4503-b46e-b728857205ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69a5787c-e016-4701-a935-78d83fd9e2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bf0ed943-f40a-4503-b46e-b728857205ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69a5787c-e016-4701-a935-78d83fd9e2cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_62f7d8d9-2750-4ed5-be2e-2b08461558a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69a5787c-e016-4701-a935-78d83fd9e2cc" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_62f7d8d9-2750-4ed5-be2e-2b08461558a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_006c7af4-11a8-40e5-ad72-cbfdcf3ace02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69a5787c-e016-4701-a935-78d83fd9e2cc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_006c7af4-11a8-40e5-ad72-cbfdcf3ace02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c9d0c0fc-ebe7-4939-a4ba-c55cac0d9642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c9d0c0fc-ebe7-4939-a4ba-c55cac0d9642" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9d0c0fc-ebe7-4939-a4ba-c55cac0d9642_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c9d0c0fc-ebe7-4939-a4ba-c55cac0d9642" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c9d0c0fc-ebe7-4939-a4ba-c55cac0d9642_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_faf0b1f5-1935-4717-8d81-cfdf2bcaf8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c9d0c0fc-ebe7-4939-a4ba-c55cac0d9642" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_faf0b1f5-1935-4717-8d81-cfdf2bcaf8b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_3eead371-bd9a-4a68-8cd5-1c8ec7faff96" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_faf0b1f5-1935-4717-8d81-cfdf2bcaf8b6" xlink:to="loc_vyne_FoamixMember_3eead371-bd9a-4a68-8cd5-1c8ec7faff96" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails" xlink:type="extended" id="i22a60921dba442bba8ae221a856f4f5d_CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4d7d7bc3-d9ae-4f75-a9b8-f228ce2f22b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4d7d7bc3-d9ae-4f75-a9b8-f228ce2f22b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_29a273b6-fe86-4673-948b-70630f014169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_29a273b6-fe86-4673-948b-70630f014169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a8c7ec44-f17e-4121-8898-afeef66571c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a8c7ec44-f17e-4121-8898-afeef66571c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_32da9717-b40e-43d9-8c84-40f530020fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_32da9717-b40e-43d9-8c84-40f530020fc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_26e3fa7c-dc43-40bd-9020-a2ab97812d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_26e3fa7c-dc43-40bd-9020-a2ab97812d07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f0824fe-cc37-4bd5-b9bb-489248122c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f0824fe-cc37-4bd5-b9bb-489248122c9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d81dfca5-5275-4de6-a9ce-5729ee6dc307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d81dfca5-5275-4de6-a9ce-5729ee6dc307" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d646ba08-5a3e-443c-8a80-546c9c6f7af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d81dfca5-5275-4de6-a9ce-5729ee6dc307" xlink:to="loc_us-gaap_AwardTypeAxis_d646ba08-5a3e-443c-8a80-546c9c6f7af4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d646ba08-5a3e-443c-8a80-546c9c6f7af4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d646ba08-5a3e-443c-8a80-546c9c6f7af4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d646ba08-5a3e-443c-8a80-546c9c6f7af4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58a46d1b-799d-40ab-9cc0-fc03e839a499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d646ba08-5a3e-443c-8a80-546c9c6f7af4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58a46d1b-799d-40ab-9cc0-fc03e839a499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fca3447d-afb0-4227-a9e4-c3d2ec1fcc14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58a46d1b-799d-40ab-9cc0-fc03e839a499" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fca3447d-afb0-4227-a9e4-c3d2ec1fcc14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6784c2b3-8403-4223-a597-2fe41840f61d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58a46d1b-799d-40ab-9cc0-fc03e839a499" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6784c2b3-8403-4223-a597-2fe41840f61d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fcdf6cf8-94d7-4819-96f6-6bd0b10dac98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d81dfca5-5275-4de6-a9ce-5729ee6dc307" xlink:to="loc_srt_RangeAxis_fcdf6cf8-94d7-4819-96f6-6bd0b10dac98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fcdf6cf8-94d7-4819-96f6-6bd0b10dac98_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fcdf6cf8-94d7-4819-96f6-6bd0b10dac98" xlink:to="loc_srt_RangeMember_fcdf6cf8-94d7-4819-96f6-6bd0b10dac98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b1f8ab6b-95d3-4f0c-8bb8-635f673bd637" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fcdf6cf8-94d7-4819-96f6-6bd0b10dac98" xlink:to="loc_srt_RangeMember_b1f8ab6b-95d3-4f0c-8bb8-635f673bd637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7a8967a8-5657-41b0-b475-19a684742cb1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b1f8ab6b-95d3-4f0c-8bb8-635f673bd637" xlink:to="loc_srt_MinimumMember_7a8967a8-5657-41b0-b475-19a684742cb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_be4a9ed9-5687-44a0-a51a-0a56140d071f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b1f8ab6b-95d3-4f0c-8bb8-635f673bd637" xlink:to="loc_srt_MaximumMember_be4a9ed9-5687-44a0-a51a-0a56140d071f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails" xlink:type="extended" id="id517b11306064539bf22f19ec8dbf2c7_CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_98a8ed2f-3f62-43e2-b81b-04b2af706e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_SharePrice_98a8ed2f-3f62-43e2-b81b-04b2af706e90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5b70ac83-e7e5-4e93-bdca-38f6696c7f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5b70ac83-e7e5-4e93-bdca-38f6696c7f33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_318466b4-9b4d-43c6-8b5c-46bce0e5aeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_318466b4-9b4d-43c6-8b5c-46bce0e5aeb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70421b43-65b5-4530-a662-719ea2d24452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70421b43-65b5-4530-a662-719ea2d24452" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_67539484-52f5-42df-96a2-be9897c840f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_67539484-52f5-42df-96a2-be9897c840f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dd8f43d7-666f-48bb-b437-3811a67bda97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dd8f43d7-666f-48bb-b437-3811a67bda97" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5b82def4-ce0d-41d6-afb3-2f5708921fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5b82def4-ce0d-41d6-afb3-2f5708921fc8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d448d03e-d687-4588-a5f6-08fe421be724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d448d03e-d687-4588-a5f6-08fe421be724" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bda0e598-9edc-40ce-bcd1-248cde2ab661" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d448d03e-d687-4588-a5f6-08fe421be724" xlink:to="loc_srt_RangeAxis_bda0e598-9edc-40ce-bcd1-248cde2ab661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bda0e598-9edc-40ce-bcd1-248cde2ab661_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bda0e598-9edc-40ce-bcd1-248cde2ab661" xlink:to="loc_srt_RangeMember_bda0e598-9edc-40ce-bcd1-248cde2ab661_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9f12ce91-4761-4905-9adf-bafdd35c221f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bda0e598-9edc-40ce-bcd1-248cde2ab661" xlink:to="loc_srt_RangeMember_9f12ce91-4761-4905-9adf-bafdd35c221f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_64160480-e525-4b00-8a71-3f814d8db826" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9f12ce91-4761-4905-9adf-bafdd35c221f" xlink:to="loc_srt_MinimumMember_64160480-e525-4b00-8a71-3f814d8db826" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_de9c9346-42eb-4c5f-9e38-2400129bc933" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9f12ce91-4761-4905-9adf-bafdd35c221f" xlink:to="loc_srt_MaximumMember_de9c9346-42eb-4c5f-9e38-2400129bc933" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e927e813-2b11-41a0-81af-4ca05788932c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d448d03e-d687-4588-a5f6-08fe421be724" xlink:to="loc_us-gaap_AwardTypeAxis_e927e813-2b11-41a0-81af-4ca05788932c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e927e813-2b11-41a0-81af-4ca05788932c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e927e813-2b11-41a0-81af-4ca05788932c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e927e813-2b11-41a0-81af-4ca05788932c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a7e8d9c-26a0-4109-8c0c-c0e92426effe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e927e813-2b11-41a0-81af-4ca05788932c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a7e8d9c-26a0-4109-8c0c-c0e92426effe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_68553ae9-6a0b-4ba4-ba9a-3427836968e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a7e8d9c-26a0-4109-8c0c-c0e92426effe" xlink:to="loc_us-gaap_EmployeeStockOptionMember_68553ae9-6a0b-4ba4-ba9a-3427836968e3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails" xlink:type="extended" id="i43e601ca7af54ffc9b0452e8f95b9ef8_CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d5cdc25-7931-4f54-a8d2-afd10aa198dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d5cdc25-7931-4f54-a8d2-afd10aa198dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77a5ff48-e5b7-4845-8ae5-fcb29fcaa370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77a5ff48-e5b7-4845-8ae5-fcb29fcaa370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5f1d1381-5a80-4a2a-906d-7edd06c3aca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5f1d1381-5a80-4a2a-906d-7edd06c3aca4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c07fd82d-8655-4414-97eb-6071f3105f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c07fd82d-8655-4414-97eb-6071f3105f76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e6de74a4-b789-4af1-a8b9-9ae52b556093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e6de74a4-b789-4af1-a8b9-9ae52b556093" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8439478d-147b-4d3e-8556-6b08651c46b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b21e93ed-77e8-4cc4-a698-a37b73c3a87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d5cdc25-7931-4f54-a8d2-afd10aa198dd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b21e93ed-77e8-4cc4-a698-a37b73c3a87e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_74958e1f-7ec7-4ff9-abcb-182a63eb5726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b21e93ed-77e8-4cc4-a698-a37b73c3a87e" xlink:to="loc_us-gaap_AwardTypeAxis_74958e1f-7ec7-4ff9-abcb-182a63eb5726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74958e1f-7ec7-4ff9-abcb-182a63eb5726_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_74958e1f-7ec7-4ff9-abcb-182a63eb5726" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74958e1f-7ec7-4ff9-abcb-182a63eb5726_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_322b0ad6-5f17-43ed-ae4a-bd6820dc7e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_74958e1f-7ec7-4ff9-abcb-182a63eb5726" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_322b0ad6-5f17-43ed-ae4a-bd6820dc7e4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_dba58862-52e6-449b-b2db-862244797fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_322b0ad6-5f17-43ed-ae4a-bd6820dc7e4d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_dba58862-52e6-449b-b2db-862244797fa3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails" xlink:type="extended" id="i0866cbbb9bf94c548d3f6a3a455e9977_SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ccf50fb-e2dc-4090-99e6-dde60152bef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ca390c55-a27e-462d-b169-5ab0235f4c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ccf50fb-e2dc-4090-99e6-dde60152bef4" xlink:to="loc_us-gaap_ShareBasedCompensation_ca390c55-a27e-462d-b169-5ab0235f4c5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_583ec143-b36a-4cf7-ba41-e45258ccd52a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ccf50fb-e2dc-4090-99e6-dde60152bef4" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_583ec143-b36a-4cf7-ba41-e45258ccd52a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e5f59b99-2c0e-4ad9-968b-a8f3a417bc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_583ec143-b36a-4cf7-ba41-e45258ccd52a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e5f59b99-2c0e-4ad9-968b-a8f3a417bc5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e5f59b99-2c0e-4ad9-968b-a8f3a417bc5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e5f59b99-2c0e-4ad9-968b-a8f3a417bc5c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e5f59b99-2c0e-4ad9-968b-a8f3a417bc5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_eea1b794-89e8-4726-8b0a-872626c6454f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e5f59b99-2c0e-4ad9-968b-a8f3a417bc5c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_eea1b794-89e8-4726-8b0a-872626c6454f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_68c89e96-7ea2-43bf-88e0-f0b321d18e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eea1b794-89e8-4726-8b0a-872626c6454f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_68c89e96-7ea2-43bf-88e0-f0b321d18e35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_c9181d52-f5c5-4d93-beaa-6520ee3b7dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eea1b794-89e8-4726-8b0a-872626c6454f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_c9181d52-f5c5-4d93-beaa-6520ee3b7dcf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails" xlink:type="extended" id="i7278a1a2ad274481abdba960124a728c_INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_86450b0c-432f-44e7-8101-8585bfe7beff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_d61475c6-cb81-4255-9a5b-3eb02fb483bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_86450b0c-432f-44e7-8101-8585bfe7beff" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_d61475c6-cb81-4255-9a5b-3eb02fb483bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_91a98075-d550-418f-9421-a3de967ed4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_d61475c6-cb81-4255-9a5b-3eb02fb483bc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_91a98075-d550-418f-9421-a3de967ed4ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a426f433-00b4-4d42-869e-c643728e6cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_86450b0c-432f-44e7-8101-8585bfe7beff" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a426f433-00b4-4d42-869e-c643728e6cd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aaca58df-75bc-4fb8-b9f6-3841f7b018c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a426f433-00b4-4d42-869e-c643728e6cd2" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aaca58df-75bc-4fb8-b9f6-3841f7b018c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9fac325a-8aba-4e5a-b0d1-9ac0298eb963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a426f433-00b4-4d42-869e-c643728e6cd2" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9fac325a-8aba-4e5a-b0d1-9ac0298eb963" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7d7d0bf8-3769-44d7-8a7b-4bd43bb7a9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a426f433-00b4-4d42-869e-c643728e6cd2" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7d7d0bf8-3769-44d7-8a7b-4bd43bb7a9aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_3a2bec77-10e6-44f9-bdd5-57456b3e1656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_86450b0c-432f-44e7-8101-8585bfe7beff" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_3a2bec77-10e6-44f9-bdd5-57456b3e1656" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_dab6ab05-423a-46fb-aa0d-e399c73329ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_3a2bec77-10e6-44f9-bdd5-57456b3e1656" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_dab6ab05-423a-46fb-aa0d-e399c73329ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_dab6ab05-423a-46fb-aa0d-e399c73329ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_dab6ab05-423a-46fb-aa0d-e399c73329ab" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_dab6ab05-423a-46fb-aa0d-e399c73329ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_2a592d86-e474-4b86-8eb2-5960dd0d72e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_dab6ab05-423a-46fb-aa0d-e399c73329ab" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_2a592d86-e474-4b86-8eb2-5960dd0d72e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_a2b81508-b9b0-41d6-8c9e-ec8f9b919620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_2a592d86-e474-4b86-8eb2-5960dd0d72e8" xlink:to="loc_us-gaap_DomesticCountryMember_a2b81508-b9b0-41d6-8c9e-ec8f9b919620" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_9e999f04-2096-4886-a1b1-7353f6c2e08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_2a592d86-e474-4b86-8eb2-5960dd0d72e8" xlink:to="loc_us-gaap_ForeignCountryMember_9e999f04-2096-4886-a1b1-7353f6c2e08e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXNarrativeDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails" xlink:type="extended" id="i157553d87fc543d1ac83054644370516_INCOMETAXNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:href="vyne-20211231.xsd#vyne_IncomeTaxLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_600a10ab-1699-4a18-8e33-ad5cb8c686f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_600a10ab-1699-4a18-8e33-ad5cb8c686f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d716ac25-fb38-477a-85e4-e39ed61dbf74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d716ac25-fb38-477a-85e4-e39ed61dbf74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_73f0e613-34ca-4b7a-80fe-d96bcbb10ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_73f0e613-34ca-4b7a-80fe-d96bcbb10ab8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_15cfdaaf-677e-4af0-bdca-80d4a55dbb79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_us-gaap_OperatingLossCarryforwards_15cfdaaf-677e-4af0-bdca-80d4a55dbb79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_fced4147-9e45-423e-8976-137eaf03dd24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_fced4147-9e45-423e-8976-137eaf03dd24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain_6b0c4e1c-8bc8-4754-b380-7bb1be5c0af7" xlink:href="vyne-20211231.xsd#vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain_6b0c4e1c-8bc8-4754-b380-7bb1be5c0af7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_IncomeTaxTable_56b15da0-5940-404b-82d7-ce2bc26c097a" xlink:href="vyne-20211231.xsd#vyne_IncomeTaxTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_vyne_IncomeTaxTable_56b15da0-5940-404b-82d7-ce2bc26c097a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b49d24a1-992e-45a3-8ab2-c6e878973a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_vyne_IncomeTaxTable_56b15da0-5940-404b-82d7-ce2bc26c097a" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b49d24a1-992e-45a3-8ab2-c6e878973a36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b49d24a1-992e-45a3-8ab2-c6e878973a36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b49d24a1-992e-45a3-8ab2-c6e878973a36" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b49d24a1-992e-45a3-8ab2-c6e878973a36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d88a2948-0089-48d1-a218-c8749600be6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b49d24a1-992e-45a3-8ab2-c6e878973a36" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d88a2948-0089-48d1-a218-c8749600be6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_af9c6fb5-f545-4b4d-9ad3-42a85f6681bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d88a2948-0089-48d1-a218-c8749600be6a" xlink:to="loc_us-gaap_DomesticCountryMember_af9c6fb5-f545-4b4d-9ad3-42a85f6681bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_3e047bf3-48bb-4966-b4b7-dc7d834ff1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d88a2948-0089-48d1-a218-c8749600be6a" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_3e047bf3-48bb-4966-b4b7-dc7d834ff1c7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended" id="i79a28e7e887e4b7797ab709abf5eebd0_SUBSEQUENTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a5a21031-114a-462b-9d0e-6dd602c38cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a5a21031-114a-462b-9d0e-6dd602c38cc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_8dacc3ba-46e1-421c-ab30-bd20f5fa760d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_d1324e6a-7bd0-4ee6-b600-5eafd0c1c3e4" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_d1324e6a-7bd0-4ee6-b600-5eafd0c1c3e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_c562c0a5-209f-47f8-ac89-c89624477423" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_c562c0a5-209f-47f8-ac89-c89624477423" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_b70bf80f-4e6b-4bad-b6f3-bb5d8b90896f" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_b70bf80f-4e6b-4bad-b6f3-bb5d8b90896f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_4dad66b0-c2ea-47da-a4a1-9ba0f94a9f42" xlink:href="vyne-20211231.xsd#vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_4dad66b0-c2ea-47da-a4a1-9ba0f94a9f42" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_b1260acf-21a1-4349-9d02-cf87a4b5f54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_b1260acf-21a1-4349-9d02-cf87a4b5f54d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_02605f7f-85cb-4b3f-9540-f89bad762096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_02605f7f-85cb-4b3f-9540-f89bad762096" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_1efb0977-0aa8-4f8f-aedd-ee5c91f7d7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_1efb0977-0aa8-4f8f-aedd-ee5c91f7d7fb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_7301adf8-01ba-4f1e-b489-1f06dd786a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_7301adf8-01ba-4f1e-b489-1f06dd786a31" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_5e400ecc-6959-45da-8ff6-39ba2a951eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_5e400ecc-6959-45da-8ff6-39ba2a951eee" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0c08e652-2ea9-4e2c-9a5a-92766f68cde4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0c08e652-2ea9-4e2c-9a5a-92766f68cde4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_77cb0fc8-5741-492a-bd3c-3c1806305bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_77cb0fc8-5741-492a-bd3c-3c1806305bdb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_db129188-7650-4343-a2a8-99f3c6e1ecd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_db129188-7650-4343-a2a8-99f3c6e1ecd8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_SaleOfStockConsiderationReceivableOnTransaction_39d1c383-52a2-4f17-a139-75b6c31273b5" xlink:href="vyne-20211231.xsd#vyne_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_SaleOfStockConsiderationReceivableOnTransaction_39d1c383-52a2-4f17-a139-75b6c31273b5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EquityPurchaseAgreementPeriodInForce_f331f92e-1045-4894-bb66-191cf2be6162" xlink:href="vyne-20211231.xsd#vyne_EquityPurchaseAgreementPeriodInForce"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_EquityPurchaseAgreementPeriodInForce_f331f92e-1045-4894-bb66-191cf2be6162" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_84a814ed-8f9a-478c-b1fe-e1f5e97cc8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_84a814ed-8f9a-478c-b1fe-e1f5e97cc8bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_84a814ed-8f9a-478c-b1fe-e1f5e97cc8bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_84a814ed-8f9a-478c-b1fe-e1f5e97cc8bd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_84a814ed-8f9a-478c-b1fe-e1f5e97cc8bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2793dbac-3d84-4183-9658-fd755be46c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_84a814ed-8f9a-478c-b1fe-e1f5e97cc8bd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2793dbac-3d84-4183-9658-fd755be46c2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_edff4c06-6343-4edb-a20f-fc63df3a40d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2793dbac-3d84-4183-9658-fd755be46c2a" xlink:to="loc_us-gaap_SubsequentEventMember_edff4c06-6343-4edb-a20f-fc63df3a40d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7a705235-09c2-4d41-a473-304be79b47d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:to="loc_srt_StatementScenarioAxis_7a705235-09c2-4d41-a473-304be79b47d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7a705235-09c2-4d41-a473-304be79b47d3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7a705235-09c2-4d41-a473-304be79b47d3" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7a705235-09c2-4d41-a473-304be79b47d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3854419d-2096-49da-a1a4-bcedf7cdc9fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7a705235-09c2-4d41-a473-304be79b47d3" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3854419d-2096-49da-a1a4-bcedf7cdc9fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_4f904826-4f9b-47e1-a7b8-0b6e62be1464" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_3854419d-2096-49da-a1a4-bcedf7cdc9fc" xlink:to="loc_srt_ScenarioForecastMember_4f904826-4f9b-47e1-a7b8-0b6e62be1464" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a5df1180-871d-4814-9b08-b77306fd4488" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:to="loc_srt_RangeAxis_a5df1180-871d-4814-9b08-b77306fd4488" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a5df1180-871d-4814-9b08-b77306fd4488_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a5df1180-871d-4814-9b08-b77306fd4488" xlink:to="loc_srt_RangeMember_a5df1180-871d-4814-9b08-b77306fd4488_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f3bf8ef1-7919-4065-aef8-95613afa54e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a5df1180-871d-4814-9b08-b77306fd4488" xlink:to="loc_srt_RangeMember_f3bf8ef1-7919-4065-aef8-95613afa54e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3c5bf9c2-2830-43b9-b3f1-91b074689156" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f3bf8ef1-7919-4065-aef8-95613afa54e0" xlink:to="loc_srt_MinimumMember_3c5bf9c2-2830-43b9-b3f1-91b074689156" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6750b6a5-ef64-468a-ac35-fe89b633f4a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f3bf8ef1-7919-4065-aef8-95613afa54e0" xlink:to="loc_srt_MaximumMember_6750b6a5-ef64-468a-ac35-fe89b633f4a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_00540fdf-d54e-4af3-bc32-bdf4490b2a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_00540fdf-d54e-4af3-bc32-bdf4490b2a56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_00540fdf-d54e-4af3-bc32-bdf4490b2a56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_00540fdf-d54e-4af3-bc32-bdf4490b2a56" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_00540fdf-d54e-4af3-bc32-bdf4490b2a56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2975f6ef-e63c-4f70-8ef8-cff21a492a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_00540fdf-d54e-4af3-bc32-bdf4490b2a56" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2975f6ef-e63c-4f70-8ef8-cff21a492a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CantorSalesAgreementMember_460ab178-c25e-4de4-82c3-13dc8a50a79f" xlink:href="vyne-20211231.xsd#vyne_CantorSalesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2975f6ef-e63c-4f70-8ef8-cff21a492a3e" xlink:to="loc_vyne_CantorSalesAgreementMember_460ab178-c25e-4de4-82c3-13dc8a50a79f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_LincolnParkEquityPurchaseAgreementMember_72ddd530-bc61-42af-8b06-7ffa37858148" xlink:href="vyne-20211231.xsd#vyne_LincolnParkEquityPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2975f6ef-e63c-4f70-8ef8-cff21a492a3e" xlink:to="loc_vyne_LincolnParkEquityPurchaseAgreementMember_72ddd530-bc61-42af-8b06-7ffa37858148" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>vyne-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:74e91f80-5033-4690-868f-a2bf4ea38fc3,g:e1fa6db6-9541-4405-a6db-7ba5e60bcb37-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock_78f10b8b-0b22-475f-978c-45b299a83263_terseLabel_en-US" xlink:label="lab_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation awards granted for options and RSUs during the period</link:label>
    <link:label id="lab_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock_label_en-US" xlink:label="lab_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation By Share Based Payment Award Grants In Period [Table Text Block]</link:label>
    <link:label id="lab_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock_documentation_en-US" xlink:label="lab_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the share-based compensation awards granted during the period, exercise price range, vesting period and expiration of awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock" xlink:href="vyne-20211231.xsd#vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock" xlink:to="lab_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_a8e91981-89bb-4013-bd4b-e62e82aec393_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_c7c7cbc2-3482-40f0-906c-3b4341f6bf48_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_RegisteredOfferingMember_be361c22-fb44-400b-9647-389a27e2740c_terseLabel_en-US" xlink:label="lab_vyne_RegisteredOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Registered Offering Per Securities Purchase Agreement</link:label>
    <link:label id="lab_vyne_RegisteredOfferingMember_label_en-US" xlink:label="lab_vyne_RegisteredOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Registered Offering [Member]</link:label>
    <link:label id="lab_vyne_RegisteredOfferingMember_documentation_en-US" xlink:label="lab_vyne_RegisteredOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of entity stock pursuant to a Securities Purchase Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RegisteredOfferingMember" xlink:href="vyne-20211231.xsd#vyne_RegisteredOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_RegisteredOfferingMember" xlink:to="lab_vyne_RegisteredOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fbaf9518-7917-4105-9c84-479f5c071d51_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal income tax provision at statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AccruedSalesProvisionsCurrent_4591dab8-6674-4b19-8d07-c45d19ecd71d_terseLabel_en-US" xlink:label="lab_vyne_AccruedSalesProvisionsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Provisions</link:label>
    <link:label id="lab_vyne_AccruedSalesProvisionsCurrent_label_en-US" xlink:label="lab_vyne_AccruedSalesProvisionsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Provisions Current</link:label>
    <link:label id="lab_vyne_AccruedSalesProvisionsCurrent_documentation_en-US" xlink:label="lab_vyne_AccruedSalesProvisionsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Provisions Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AccruedSalesProvisionsCurrent" xlink:href="vyne-20211231.xsd#vyne_AccruedSalesProvisionsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AccruedSalesProvisionsCurrent" xlink:to="lab_vyne_AccruedSalesProvisionsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_68d5a4a9-d4be-4172-8294-09b14e322bcd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_59f51818-48e3-443d-8135-54f7a578fb14_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b800e6ef-2879-46ac-90ec-ba844b37ad99_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6cc9ec9b-68c9-41ae-b640-5b245619b5ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_7d3eaf08-38b8-4d99-8bf9-07589d954012_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_93b32a21-6a77-4e52-9bdb-991c625fc9a0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7e36d48a-38dc-49f2-ae37-d03ecdb320fd_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_eb6e9aca-ce31-4539-a623-c632240b50d1_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_21966c70-006e-48c9-80a7-8c232b58b118_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_2cfc6e7d-6004-4d2c-abb4-cbf3379756a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_d463d085-c8fa-4eb9-b578-4a95e91f4e8b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right of use assets (Note 10)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4d0e7739-b675-4d96-8f25-8c2614fc5221_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_548a6ad3-5051-44e3-ba44-73ffe57d2776_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carry forward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_38c10993-f0f9-4285-8a03-971cbdd58c51_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_0a903e8e-ef92-4749-b46f-09a7a93530f8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0879f576-68b3-4b13-889e-61772f430eae_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related obligations</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_8d0b4e94-e79f-4101-9512-9f99969205cf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_01359261-6c50-4bed-856d-1936abc42ab5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_16807f7a-f81e-42bb-adc4-609b9118a1f2_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_b9437741-1f9f-4788-a4be-1b07e496b3e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No longer employed or providing services</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_5641088d-295f-4f4f-80dd-b0266b90f455_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_0d6c311e-c38c-44f9-951a-27bf48676fc5_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_be87834a-a1cf-486b-83bd-d5f34d7a73e0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration receivable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_595c7ba6-a01a-408f-a6ed-36d95686db3e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_14ef0e71-4eec-4263-89a5-5d26f53c0553_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of fair market value used as purchase price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0a48dda2-532e-441e-9c39-460a967a82dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_9f7b29f1-c864-4ee1-8399-daa0dacf021d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_32d437ad-356e-4e82-8ce3-68b67d1189d8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_d91c3cf2-677c-43ab-8831-9c4e1493e9d2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AuditInformationAbstract_label_en-US" xlink:label="lab_vyne_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_vyne_AuditInformationAbstract_documentation_en-US" xlink:label="lab_vyne_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AuditInformationAbstract" xlink:href="vyne-20211231.xsd#vyne_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AuditInformationAbstract" xlink:to="lab_vyne_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_A2019PlanMember_456e0945-110a-4cac-a539-3adcffc63114_terseLabel_en-US" xlink:label="lab_vyne_A2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Plan</link:label>
    <link:label id="lab_vyne_A2019PlanMember_label_en-US" xlink:label="lab_vyne_A2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Plan [Member]</link:label>
    <link:label id="lab_vyne_A2019PlanMember_documentation_en-US" xlink:label="lab_vyne_A2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_A2019PlanMember" xlink:href="vyne-20211231.xsd#vyne_A2019PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_A2019PlanMember" xlink:to="lab_vyne_A2019PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c84d7671-a604-4dad-845a-b8e34da29143_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_48ee0131-73e9-46c3-8d27-54a19e51a12b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_4ac6f229-ff16-440e-bd1a-9c9752a6ed61_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_736d9615-36d0-4fb4-a4e5-d68831ff3a64_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_OralBETiOptionAgreementMember_9b730e1a-0bba-4f4d-b9b3-92dd1bec3e05_terseLabel_en-US" xlink:label="lab_vyne_OralBETiOptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral BETi Option Agreement</link:label>
    <link:label id="lab_vyne_OralBETiOptionAgreementMember_label_en-US" xlink:label="lab_vyne_OralBETiOptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral BETi Option Agreement [Member]</link:label>
    <link:label id="lab_vyne_OralBETiOptionAgreementMember_documentation_en-US" xlink:label="lab_vyne_OralBETiOptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral BETi Option Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OralBETiOptionAgreementMember" xlink:href="vyne-20211231.xsd#vyne_OralBETiOptionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_OralBETiOptionAgreementMember" xlink:to="lab_vyne_OralBETiOptionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_840a09c3-cf4a-4deb-8c53-96fc68c57b3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c40c35d2-554b-4720-9d51-54b21e8bce29_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ClassOfWarrantAbstract_0a23b607-929a-441e-817b-3eb0f526e503_terseLabel_en-US" xlink:label="lab_vyne_ClassOfWarrantAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued</link:label>
    <link:label id="lab_vyne_ClassOfWarrantAbstract_label_en-US" xlink:label="lab_vyne_ClassOfWarrantAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant [Abstract]</link:label>
    <link:label id="lab_vyne_ClassOfWarrantAbstract_documentation_en-US" xlink:label="lab_vyne_ClassOfWarrantAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">n/a</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ClassOfWarrantAbstract" xlink:href="vyne-20211231.xsd#vyne_ClassOfWarrantAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ClassOfWarrantAbstract" xlink:to="lab_vyne_ClassOfWarrantAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_e42a33e3-664c-485c-b3ae-d9f700ed0a0c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price range, minimum (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_e648e722-ef9e-4516-abdd-5a69d44bcf19_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_0d64fd5e-7759-4167-8ec7-2f2a9da38b57_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8cc3662c-73d7-4bf9-b0ed-14c832559a12_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7c2b6e4f-a3de-4f20-bfc8-827c9c1b531d_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of identified intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_7bca7f74-1c15-497b-ae58-d5baf69f0697_totalLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net acquired (See &#8220;Note 3- Business combination&#8221;)</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_260a560e-088f-4427-8edf-fe0b22514957_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets to be disposed of</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_9612dc56-f590-4bcf-9a55-0c9544e77930_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for prior year positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_2504409d-1403-45f6-be60-58e946833063_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_b2379264-416d-41f3-a322-d62caddcee3e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_810ca79f-f3c8-4f3f-8d3b-c61faf9be661_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_72fa7be0-7253-45d1-8c9a-5b3adbf46b24_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_510b200b-ab91-4568-849f-bb59c82ae750_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_db0be4d2-dd53-4d79-99a1-a18f0835f783_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_4f59aaf8-59fb-47b6-8909-4b1909ce05b0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_cb9b50b5-edbe-486a-a957-9cdea1149fc4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss attributable to Menlo</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_db81d1ea-3d5a-4512-a5a0-5d71a1a9e4b2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse stock split ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_75adaa7b-aa58-4891-a2aa-4a3ff7fa33f9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_bad3147b-e46a-4637-ae96-2c6e5dab63a4_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gains from marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_3574eb7c-a3a1-4007-8dd2-13d311e09fc5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27edfb15-03e0-4261-9793-a3aa5cc20ad6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_335611c6-b11b-4f29-a32d-4fcc73e6e98a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_26634a5b-4483-4b35-862e-9f8676b51130_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ShareholderLenderMember_462145a0-9782-4688-8f9e-a2a2e744d663_terseLabel_en-US" xlink:label="lab_vyne_ShareholderLenderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Lender</link:label>
    <link:label id="lab_vyne_ShareholderLenderMember_label_en-US" xlink:label="lab_vyne_ShareholderLenderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Lender [Member]</link:label>
    <link:label id="lab_vyne_ShareholderLenderMember_documentation_en-US" xlink:label="lab_vyne_ShareholderLenderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertaining to shareholders that are also lenders of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareholderLenderMember" xlink:href="vyne-20211231.xsd#vyne_ShareholderLenderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ShareholderLenderMember" xlink:to="lab_vyne_ShareholderLenderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_NonCashAcquisitionOfBusinessCashAcquired_6bdea20e-b511-4763-b671-73e242be894c_terseLabel_en-US" xlink:label="lab_vyne_NonCashAcquisitionOfBusinessCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less cash acquired</link:label>
    <link:label id="lab_vyne_NonCashAcquisitionOfBusinessCashAcquired_label_en-US" xlink:label="lab_vyne_NonCashAcquisitionOfBusinessCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Acquisition Of Business, Cash Acquired</link:label>
    <link:label id="lab_vyne_NonCashAcquisitionOfBusinessCashAcquired_documentation_en-US" xlink:label="lab_vyne_NonCashAcquisitionOfBusinessCashAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of cash as part of a non-cash business acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_NonCashAcquisitionOfBusinessCashAcquired" xlink:href="vyne-20211231.xsd#vyne_NonCashAcquisitionOfBusinessCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_NonCashAcquisitionOfBusinessCashAcquired" xlink:to="lab_vyne_NonCashAcquisitionOfBusinessCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_3a403a6c-2683-475d-87d9-e396fb139045_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and in-process research &amp; development impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_241ceed3-1841-4b92-9587-aaaf179ce24a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_345b721b-129f-4122-a0ef-09854cd4764a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other indefinite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_0c3783e0-1c16-4438-8ff2-7e483a9e342f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_38017e7a-27ef-45a5-bbba-330b2046475d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, award amount (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c2def7d1-8d07-45a2-afa6-d97ec0697b4e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awarded (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_c7c0bc04-dc77-4af0-b489-fec4f37a0ffc_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember_36bab98d-e85d-4003-a0d9-b5e9fb438af6_terseLabel_en-US" xlink:label="lab_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding share options, RSUs and shares under ESPP</link:label>
    <link:label id="lab_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember_label_en-US" xlink:label="lab_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share options RSUs and Shares Under ESPP [Member]</link:label>
    <link:label id="lab_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember_documentation_en-US" xlink:label="lab_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share options RSUs and Shares Under ESPP [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember" xlink:href="vyne-20211231.xsd#vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember" xlink:to="lab_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_e2a59944-f07f-4966-bf26-7181cfaa033a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock: $0.0001 par value; 20,000,000 shares authorized at December&#160;31, 2021 and December&#160;31, 2020, respectively; no shares issued and outstanding at December&#160;31, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ffa37ffd-ad50-4381-b95c-3db7f98a20d0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalIncomeStatementElementsAbstract_fec66c04-dda4-498c-9b41-93ef81a6b419_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to the supplemental pro forma combined results of operations, included in the above, are as follows:</link:label>
    <link:label id="lab_us-gaap_SupplementalIncomeStatementElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Income Statement Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:to="lab_us-gaap_SupplementalIncomeStatementElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d5237e31-1ce1-4ab7-a592-3e9c5b3d017a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ffc27f2c-b9dc-4adc-9569-d052bcad79b1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_EmployeeStockPurchasePlanMember_19c88444-16a6-4b3b-9690-e3001b4a5b23_terseLabel_en-US" xlink:label="lab_vyne_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_vyne_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_vyne_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_vyne_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_vyne_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertaining to the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EmployeeStockPurchasePlanMember" xlink:href="vyne-20211231.xsd#vyne_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_EmployeeStockPurchasePlanMember" xlink:to="lab_vyne_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_20a3d264-b183-493e-8ada-6c03979a19c3_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_d9d119cc-4a4f-4c3d-be9d-45579f2e2b73_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a209775c-c889-462b-90f2-ac67375cd26b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in trade receivables, prepaid and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_8c7b12d9-a6ad-452f-ac48-190dbf0325b7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_5374afed-160b-48c2-90f8-0894488ffa57_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_14d4423a-a7be-431f-ade8-700d61284590_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c3dd2c8d-11c0-4761-99ae-c674407f4353_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cfe15141-fecd-45c4-beb2-e7fcbfe9eaaa_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueConcentrationOfRiskTable_11324396-89b7-4628-a21f-d0046f4d76e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueConcentrationOfRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Concentration of Risk [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueConcentrationOfRiskTable_label_en-US" xlink:label="lab_us-gaap_FairValueConcentrationOfRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Concentration of Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueConcentrationOfRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable" xlink:to="lab_us-gaap_FairValueConcentrationOfRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_94860e21-4414-4db4-b874-c0060b3d796b_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b4592417-e73f-44ab-a56e-ab71474662db_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to operating lease right of use assets</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_f0abda82-1f77-409d-a02f-a679c808075c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pro Forma</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_934042fc-8536-4f60-9843-c06e9ccecd97_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_40d1c126-8d33-4fb7-b9c3-22a1e415a332_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of annual earnings that may be used to purchase shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationGoodwillAbstract_965ea4f0-4ba6-4485-a34b-0a1b014259d6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Goodwill [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Goodwill [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationGoodwillAbstract" xlink:to="lab_us-gaap_BusinessCombinationGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_9cd04426-79f9-40ba-ab1c-d3dac59bfc5a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_2f659176-c0a0-431b-a615-5bb9d19a3692_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_67a1210f-7060-403b-a561-cc58389ddeb8_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_RoyaltyPaymentPercentMaximum_423ba804-9998-4c26-8967-b73f8723bac9_terseLabel_en-US" xlink:label="lab_vyne_RoyaltyPaymentPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty percent, maximum</link:label>
    <link:label id="lab_vyne_RoyaltyPaymentPercentMaximum_label_en-US" xlink:label="lab_vyne_RoyaltyPaymentPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Payment, Percent, Maximum</link:label>
    <link:label id="lab_vyne_RoyaltyPaymentPercentMaximum_documentation_en-US" xlink:label="lab_vyne_RoyaltyPaymentPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Payment, Percent, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RoyaltyPaymentPercentMaximum" xlink:href="vyne-20211231.xsd#vyne_RoyaltyPaymentPercentMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_RoyaltyPaymentPercentMaximum" xlink:to="lab_vyne_RoyaltyPaymentPercentMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_f4203223-bdb2-4e27-aef0-e56049ba8e9f_negatedTerseLabel_en-US" xlink:label="lab_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed dividend to warrants holders due to warrant modification</link:label>
    <link:label id="lab_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_305a3a8c-ef2e-425f-965e-dc5be0c024d7_terseLabel_en-US" xlink:label="lab_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed dividend to warrants holders due to warrant modification</link:label>
    <link:label id="lab_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_label_en-US" xlink:label="lab_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed Dividend To Warrants Holders Due To Warrant Modification</link:label>
    <link:label id="lab_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_documentation_en-US" xlink:label="lab_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase in additional paid in capital (APIC) resulting from modification of warrants that is deemed dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification" xlink:href="vyne-20211231.xsd#vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification" xlink:to="lab_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent_604077c2-05ad-4d41-b9a2-3ba095463d56_terseLabel_en-US" xlink:label="lab_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IP Gain</link:label>
    <link:label id="lab_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent_label_en-US" xlink:label="lab_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Gain on Intangible Assets, Percent</link:label>
    <link:label id="lab_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent_documentation_en-US" xlink:label="lab_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Gain on Intangible Assets, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent" xlink:href="vyne-20211231.xsd#vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent" xlink:to="lab_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_BusinessCombinationEffectiveExchangeRatio_4978ce75-a16a-4e7d-ab90-948c85f6644f_terseLabel_en-US" xlink:label="lab_vyne_BusinessCombinationEffectiveExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective exchange ratio of Foamix ordinary shares into Menlo common stock</link:label>
    <link:label id="lab_vyne_BusinessCombinationEffectiveExchangeRatio_label_en-US" xlink:label="lab_vyne_BusinessCombinationEffectiveExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Effective Exchange Ratio</link:label>
    <link:label id="lab_vyne_BusinessCombinationEffectiveExchangeRatio_documentation_en-US" xlink:label="lab_vyne_BusinessCombinationEffectiveExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The effective exchange ratio of ordinary shares for shares of common stock from the merger as adjusted for the conversion of contingent stock rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationEffectiveExchangeRatio" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationEffectiveExchangeRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_BusinessCombinationEffectiveExchangeRatio" xlink:to="lab_vyne_BusinessCombinationEffectiveExchangeRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_89030a9b-6ba5-4a11-96ed-fd06cd6c647f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_303ebe5f-7f67-4a31-b279-868bf54547e1_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated gain on sale of MST Franchise</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f1890ad3-fd23-4623-99b2-8baacbf12b4d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_87ebd871-cd33-4fc4-8e14-a14624276be5_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_376b60dc-4e81-4cc0-8e90-ddcbdf1e811e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_2c9351a2-0c8b-4192-91af-88b09f18408c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGNITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_d88c6620-5541-45f1-b364-d6d94bd2b599_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired through merger</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a4cbdab8-1654-41e7-8d5c-7ae4a2cf592e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_93cb1503-9dc9-4bd6-86eb-6b0f69be76db_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_db1ae488-72bd-470b-9a28-ef455d3f00a4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_c4e3f343-0a38-4f8a-88be-6431055ea6c7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_DebtInstrumentFeePercent_c208e279-364a-4c30-93f8-f82d446124de_terseLabel_en-US" xlink:label="lab_vyne_DebtInstrumentFeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument fee as a percent of the aggregate principal amount</link:label>
    <link:label id="lab_vyne_DebtInstrumentFeePercent_label_en-US" xlink:label="lab_vyne_DebtInstrumentFeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Fee Percent</link:label>
    <link:label id="lab_vyne_DebtInstrumentFeePercent_documentation_en-US" xlink:label="lab_vyne_DebtInstrumentFeePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of the fee that accompanies borrowing money under the debt instrument, as a percent of the aggregate principal amount of all loans outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DebtInstrumentFeePercent" xlink:href="vyne-20211231.xsd#vyne_DebtInstrumentFeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_DebtInstrumentFeePercent" xlink:to="lab_vyne_DebtInstrumentFeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_3ffd5c72-e692-4cf5-87d7-0dc1b99ed149_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company contributions to 401(k) plans</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_41b93dfc-95cb-4c76-a495-9185bf3e22eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent_7bce4963-3168-4962-a019-83d4b24cd73c_terseLabel_en-US" xlink:label="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Costs</link:label>
    <link:label id="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent_label_en-US" xlink:label="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Transaction Costs, Percent</link:label>
    <link:label id="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent_documentation_en-US" xlink:label="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Transaction Costs, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent" xlink:href="vyne-20211231.xsd#vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent" xlink:to="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation_c12e0fa4-7623-4960-87b8-e75a457ab1b6_negatedLabel_en-US" xlink:label="lab_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acceleration of stock based compensation</link:label>
    <link:label id="lab_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation_label_en-US" xlink:label="lab_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Supplemental Proforma Acceleration Of Stock Based Compensation</link:label>
    <link:label id="lab_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation_documentation_en-US" xlink:label="lab_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of acceleration of stock based compensation as adjustment to pro-forma results of the combined operation after business acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation" xlink:href="vyne-20211231.xsd#vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation" xlink:to="lab_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a436920a-b05e-4070-bb97-c8e7dd92aa2b_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_823fde9b-cf88-4be9-b7de-c123dd7767e9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process Research and Development</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_3ebffd2e-f1bc-4215-b419-cd682cdefc7e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_d87345c6-0724-45e9-b3f7-4c71dead494a_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash other expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_8a1137fa-85c9-4fc3-94ef-e6e66b2f7db5_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_709bddf6-8ade-4221-a5cb-68d5e15e1693_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of employees terminated</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_e18341b5-a7e5-4377-911f-86a40b2fa085_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_dcc904fa-0982-418a-b617-f50066a5b0d2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration net of the effect of CSRs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_c70ffddd-140e-4df7-8702-9f2357ca61bc_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_56d192cf-7b37-4c75-9be6-2d3a35de1b01_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less liabilities assumed</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_faccad14-cc79-4c57-a63c-a380d72819fe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_e288728c-fc9f-408f-9cc2-0dc092e442a9_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_fc8f643d-36e1-4d81-a89a-b35410b45b2e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders_b040a9ac-93ec-467e-b474-7f3fffabc134_terseLabel_en-US" xlink:label="lab_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage of parent by subsidiary stockholders</link:label>
    <link:label id="lab_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders_label_en-US" xlink:label="lab_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post Merger Parent Ownership By Pre Merger Subsidiary Shareholders</link:label>
    <link:label id="lab_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders_documentation_en-US" xlink:label="lab_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of post-merger Menlo ownership held by pre-merger Foamix shareholders, as a percent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders" xlink:href="vyne-20211231.xsd#vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders" xlink:to="lab_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_RegisteredDirectOfferingMember_859a71af-64aa-4c47-8796-e809b896a4f9_terseLabel_en-US" xlink:label="lab_vyne_RegisteredDirectOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Registered Direct Offering</link:label>
    <link:label id="lab_vyne_RegisteredDirectOfferingMember_label_en-US" xlink:label="lab_vyne_RegisteredDirectOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Registered Direct Offering [Member]</link:label>
    <link:label id="lab_vyne_RegisteredDirectOfferingMember_documentation_en-US" xlink:label="lab_vyne_RegisteredDirectOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Registered Direct Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RegisteredDirectOfferingMember" xlink:href="vyne-20211231.xsd#vyne_RegisteredDirectOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_RegisteredDirectOfferingMember" xlink:to="lab_vyne_RegisteredDirectOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_646dda23-6177-4ae9-b345-fe73ead30b85_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations_81597df4-3325-4dec-9561-90860a289c97_negatedTotalLabel_en-US" xlink:label="lab_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Adjustments</link:label>
    <link:label id="lab_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations_label_en-US" xlink:label="lab_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Supplemental Proforma Combined Results of Operations</link:label>
    <link:label id="lab_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations_documentation_en-US" xlink:label="lab_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of adjustments to supplemental proforma combined results of operations of the combined operation after business acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations" xlink:href="vyne-20211231.xsd#vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations" xlink:to="lab_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_47ac444b-58a4-474a-9971-9d643c1b9b1b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_234470a0-8214-4e5e-aa97-b05b0fc8dd02_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_adbfd462-96af-427f-8859-f7eca7a911bd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_2a973b1f-7ed1-45d2-8288-c5ab05ff9c7f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_5f033426-75c0-4146-a0b6-e9bc29de48f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_48a52394-d68b-4eec-9c4f-5d81a863d879_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_e386fbab-eeda-459a-ae10-970acc8b6756_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for current year positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_7896ea66-5e4c-4e7f-b98a-0c53077dad73_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_5c0dd1e8-a9c0-4be6-8656-3ab98dae0365_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ae2f7f2b-22fa-4daf-956a-0e88c2756cff_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_351944b7-03bc-4324-8e5d-6fa7ba3bc9a4_negatedTerseLabel_en-US" xlink:label="lab_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classification of stock awards to derivative liability</link:label>
    <link:label id="lab_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_bb0bac14-9dd1-4c60-8d85-3c8a387d0454_terseLabel_en-US" xlink:label="lab_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital reclassified to derivate liabilities</link:label>
    <link:label id="lab_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_label_en-US" xlink:label="lab_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment, Modification of Terms, Incremental Compensation, Modification of Terms, Incremental Compensation Cost, Reclassified Adjustment</link:label>
    <link:label id="lab_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_documentation_en-US" xlink:label="lab_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The excess of the fair value of the modified award over the fair value of the award immediately before the modification pertaining grantees not employed or providing services after the modification and reclassified from additional paid-in capital to derivative liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" xlink:to="lab_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember_fb620946-6d8d-4b94-bd4b-438c0795ad64_terseLabel_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Credit Agreement, Trench 1 Loan</link:label>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember_label_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended And Restated Credit Agreement Trench1 Loan [Member]</link:label>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember_documentation_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents trench 1 loan of the Amended and Restated Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember" xlink:to="lab_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_42379421-3ffc-4543-914c-5ffa0cfea9b2_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b2215f99-b5c7-4123-9c59-1701378ed1b0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale and maturity of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7af42522-a11d-4762-9052-9c37080bfa42_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_b20ebb6c-fca4-48b6-aac4-7c8ae5509769_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_7ad88144-7bf2-4a75-baff-56c34a2ad675_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_52008a51-7112-4106-86e4-6d10f67257d8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Sales</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_357ccda6-0204-4130-af2f-a86a78852014_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_95d44ef2-cbe7-426a-b097-896c8cf2384b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_3ea191b6-987f-486e-acff-aa8be250423b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_b99f407f-e039-4a7f-a180-0264b58d511e_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_4d011980-8c75-46e5-bc31-d1cc824338a0_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_53fddb5a-4f08-4183-98a1-75719394fadf_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in marketable securities (Note 6)</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_5b1cb706-e178-4370-9479-1066cc53bdaa_terseLabel_en-US" xlink:label="lab_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed (for accounting purposes only) conversion of Menlo equity awards</link:label>
    <link:label id="lab_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_label_en-US" xlink:label="lab_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Conversion Of Acquirer Equity Awards</link:label>
    <link:label id="lab_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_documentation_en-US" xlink:label="lab_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of consideration transferred consisting of the conversion of equity awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards" xlink:to="lab_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AccruedCommercializedProductCurrent_7826586a-334e-4d30-b010-7010b56004ee_terseLabel_en-US" xlink:label="lab_vyne_AccruedCommercializedProductCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercialized product accruals</link:label>
    <link:label id="lab_vyne_AccruedCommercializedProductCurrent_label_en-US" xlink:label="lab_vyne_AccruedCommercializedProductCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Commercialized Product Current</link:label>
    <link:label id="lab_vyne_AccruedCommercializedProductCurrent_documentation_en-US" xlink:label="lab_vyne_AccruedCommercializedProductCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Commercialized Product Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AccruedCommercializedProductCurrent" xlink:href="vyne-20211231.xsd#vyne_AccruedCommercializedProductCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AccruedCommercializedProductCurrent" xlink:to="lab_vyne_AccruedCommercializedProductCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_399c5c72-d857-41da-8d19-b54dde1954b0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25a06e24-c3f6-4379-b4b5-3feea471c877_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_ad0ef590-1923-47ee-a856-e5d93e0e38c8_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_42ecd2d6-1e4d-4a6a-a41f-e2902deb9c7f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_138b8b70-41cf-480b-a513-1217f7f9703b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d3dce422-91be-49ad-a7d0-38e406dde5ae_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_891071c5-9783-43e0-897a-ef6f4675498a_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_0055f604-25d1-4b76-aa8a-c116d97c4d6a_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_da321067-a83b-4568-9e55-61319e693aad_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_f7365e0c-feb4-496c-9976-9362ff59f44a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_76aec67c-67b6-41a2-8845-7f879767f742_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_PeriodOfClosingTransaction_564dd0a6-1f00-4f36-87dd-549a9ec23253_terseLabel_en-US" xlink:label="lab_vyne_PeriodOfClosingTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of closing transaction</link:label>
    <link:label id="lab_vyne_PeriodOfClosingTransaction_label_en-US" xlink:label="lab_vyne_PeriodOfClosingTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Of Closing Transaction</link:label>
    <link:label id="lab_vyne_PeriodOfClosingTransaction_documentation_en-US" xlink:label="lab_vyne_PeriodOfClosingTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Of Closing Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PeriodOfClosingTransaction" xlink:href="vyne-20211231.xsd#vyne_PeriodOfClosingTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_PeriodOfClosingTransaction" xlink:to="lab_vyne_PeriodOfClosingTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7aab9731-dace-447b-9aee-676e6f7a6bb4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementMember_0d245bc5-d65f-45d9-8fda-beaaa12b1347_terseLabel_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended And Restated Credit Agreement</link:label>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementMember_label_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended And Restated Credit Agreement [Member]</link:label>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementMember_documentation_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents Amended and Restated Credit Agreement entered into on March 9, 2020.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementMember" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AmendedAndRestatedCreditAgreementMember" xlink:to="lab_vyne_AmendedAndRestatedCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_a7afb742-cdfb-4bf9-9c00-077d2dbcf6e2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum_999c1613-095e-4bad-9f5a-216682197f57_terseLabel_en-US" xlink:label="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments upon achieving certain criteria, maximum</link:label>
    <link:label id="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum_label_en-US" xlink:label="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments Upon Achieving Certain Criteria, Maximum</link:label>
    <link:label id="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum_documentation_en-US" xlink:label="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments Upon Achieving Certain Criteria, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum" xlink:href="vyne-20211231.xsd#vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum" xlink:to="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_f4cde5f0-e6d9-4543-a36a-9662019d1f6b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock related to merger</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_1f36a8d4-dfca-4e3c-a1b8-68c3579b96a9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_2d3e3868-9dbc-4f58-8e6a-829a4cf3da7b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f87c6663-3ca3-4117-99d4-1b2ee9b8c3ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3a62dc00-63e4-4d4f-8d78-8f5a20b00ed2_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHARE BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_a0e7f0e7-4f59-4033-a555-9fdce3056e23_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORY</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_c3e0990a-8a07-4fe8-9120-ee363fa285f6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_24f441d1-56cd-405e-946e-5bfbc2dfa262_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_32b11167-468e-42c4-b0f9-e8af0f9b5f5b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term of outstanding options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_IsraeliMutualFundsMember_0d240060-829f-4809-af4c-4b6a9e116dab_terseLabel_en-US" xlink:label="lab_vyne_IsraeliMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli mutual funds</link:label>
    <link:label id="lab_vyne_IsraeliMutualFundsMember_label_en-US" xlink:label="lab_vyne_IsraeliMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli Mutual Funds [Member]</link:label>
    <link:label id="lab_vyne_IsraeliMutualFundsMember_documentation_en-US" xlink:label="lab_vyne_IsraeliMutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli Mutual Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_IsraeliMutualFundsMember" xlink:href="vyne-20211231.xsd#vyne_IsraeliMutualFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_IsraeliMutualFundsMember" xlink:to="lab_vyne_IsraeliMutualFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock_6e033f7f-a591-4248-b879-253660554af2_terseLabel_en-US" xlink:label="lab_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Merger Consideration to be Transferred</link:label>
    <link:label id="lab_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock_label_en-US" xlink:label="lab_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisition Consideration [Table Text Block]</link:label>
    <link:label id="lab_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock_documentation_en-US" xlink:label="lab_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of consideration to be transferred to effect the Merger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock" xlink:href="vyne-20211231.xsd#vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock" xlink:to="lab_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_ea155a27-d7a1-464f-954a-d0e52060782f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of stock issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e6fc97de-01e1-41d5-a029-4550d479a873_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_7540c553-a33a-4e18-9ad9-f1d5e4ec0be3_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_ac5dd584-9543-4c25-8a8b-a1fed19dfbaa_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_1c81b12a-24fb-424e-a00c-e6443f3befed_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_e657c332-4d85-41a5-8a4a-c7a09af68dd8_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_85c262c6-a8a2-4089-bec8-708c01b5c6ab_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_EquityPurchaseAgreementPeriodInForce_c6cbeac9-ed4d-4960-a0a7-e51a3a6baccf_terseLabel_en-US" xlink:label="lab_vyne_EquityPurchaseAgreementPeriodInForce" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of equity purchase agreement</link:label>
    <link:label id="lab_vyne_EquityPurchaseAgreementPeriodInForce_label_en-US" xlink:label="lab_vyne_EquityPurchaseAgreementPeriodInForce" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Purchase Agreement, Period in Force</link:label>
    <link:label id="lab_vyne_EquityPurchaseAgreementPeriodInForce_documentation_en-US" xlink:label="lab_vyne_EquityPurchaseAgreementPeriodInForce" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Purchase Agreement, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EquityPurchaseAgreementPeriodInForce" xlink:href="vyne-20211231.xsd#vyne_EquityPurchaseAgreementPeriodInForce"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_EquityPurchaseAgreementPeriodInForce" xlink:to="lab_vyne_EquityPurchaseAgreementPeriodInForce" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_a12e9e22-4bc6-4d71-8680-e11c797f40a3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_dd080f0c-640e-4f90-a5ce-67fc366cadb7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock: $0.0001 par value; 150,000,000 shares and 75,000,000 shares authorized at December&#160;31, 2021 and December&#160;31, 2020, respectively; 53,577,744 and 43,205,221 shares issued and outstanding at December&#160;31, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_e1c3ca3d-44e7-48ee-b5d2-ce81f96b31d8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities transferred</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e247d513-1c1b-4843-9dbf-3d63850266ce_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment cost not yet recognized, weighted average period of recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationAbstract_fd7d6e0a-8699-463f-918b-3f8d95b18c33_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL PRO FORMA COMBINED RESULTS OF OPERATIONS:</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_8c658adc-3c74-422a-8687-4306b3616ecb_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customers</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_e6a5ac37-7443-488f-8e4e-b2fdbee7617b_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3032d002-a365-4af8-8ee3-611629bca1b4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) Increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_67fb28a8-1cd6-44bc-8017-48c3a1d6776a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_2fb6e526-d7d8-412c-9ada-f9b87e319bca_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total&#160; Non-current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_8b389723-85ba-4850-9713-f0937f0af1b4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING LEASE</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_852b358c-e6eb-4f7b-953f-e7220588b265_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_MenloMember_cd8586b0-0eca-4707-a912-280b4c3075f9_terseLabel_en-US" xlink:label="lab_vyne_MenloMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Menlo</link:label>
    <link:label id="lab_vyne_MenloMember_label_en-US" xlink:label="lab_vyne_MenloMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Menlo [Member]</link:label>
    <link:label id="lab_vyne_MenloMember_documentation_en-US" xlink:label="lab_vyne_MenloMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Menlo</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MenloMember" xlink:href="vyne-20211231.xsd#vyne_MenloMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_MenloMember" xlink:to="lab_vyne_MenloMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNetAbstract_c2ab6582-7e01-44df-98b7-f537b2d54cae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt offering expenses</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract" xlink:to="lab_us-gaap_DeferredFinanceCostsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b930045e-9a04-41a5-a808-9cc6e37800ed_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_fc7c3b6a-e582-47a0-b5b7-feff0e129164_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_82b4147c-5395-40d0-9e44-204d90161778_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_3b886f97-35b7-4374-a683-0364e2a81b05_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_d5251c0e-95a1-4305-8529-ce7fe956cf79_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_39548978-d24f-4e1f-950d-cebcb00cb464_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of underlying data used for computing the fair value of the options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_EstimateOfProductReturnRateMaximum_6fc21e1e-8dc4-4af3-bbbb-a4ceeff05516_terseLabel_en-US" xlink:label="lab_vyne_EstimateOfProductReturnRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum estimated product return (as a percent)</link:label>
    <link:label id="lab_vyne_EstimateOfProductReturnRateMaximum_label_en-US" xlink:label="lab_vyne_EstimateOfProductReturnRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Product Return Rate, Maximum</link:label>
    <link:label id="lab_vyne_EstimateOfProductReturnRateMaximum_documentation_en-US" xlink:label="lab_vyne_EstimateOfProductReturnRateMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum estimate of product sales return rate at reporting date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EstimateOfProductReturnRateMaximum" xlink:href="vyne-20211231.xsd#vyne_EstimateOfProductReturnRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_EstimateOfProductReturnRateMaximum" xlink:to="lab_vyne_EstimateOfProductReturnRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_9167e25d-0a35-4604-a7c5-18717e91519c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_4e3f152f-3fb8-4b0a-8eeb-9b7a529e725f_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MARKETABLE SECURITIES</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_23894bfa-7cda-4877-9e5a-1a4e85e99dac_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_2cda83f1-92c0-421d-b22e-5ac2031527a2_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_9b21b617-9499-4eed-a040-6a181516ee06_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating Expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_86c4a392-a4b5-4551-ad32-5cd124c295fe_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_69004644-f5b1-42af-b769-df7c9ca5135f_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d8d87b47-3c4a-4f36-8970-abd76b4a85de_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_91af5833-834d-4bcc-ac61-b03e802f6895_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_314d38dd-49e6-446b-bb7e-5ba70502ad51_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_a6a7f147-a6af-4c37-a1c1-fe7c0934a42f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_70a40ca4-38f9-47fd-bc1d-367af4f47b7f_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration received in a transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_GainLossOnSaleAndDispositionOfFixedAssets_f78d59b5-fa44-4ee4-a339-42cdd94b0864_negatedLabel_en-US" xlink:label="lab_vyne_GainLossOnSaleAndDispositionOfFixedAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from sale and disposal of fixed assets</link:label>
    <link:label id="lab_vyne_GainLossOnSaleAndDispositionOfFixedAssets_1b7bfe31-b14e-4db3-bfcc-90cb5d94f8b8_negatedTerseLabel_en-US" xlink:label="lab_vyne_GainLossOnSaleAndDispositionOfFixedAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of fixed assets</link:label>
    <link:label id="lab_vyne_GainLossOnSaleAndDispositionOfFixedAssets_label_en-US" xlink:label="lab_vyne_GainLossOnSaleAndDispositionOfFixedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale and Disposition of Fixed Assets</link:label>
    <link:label id="lab_vyne_GainLossOnSaleAndDispositionOfFixedAssets_documentation_en-US" xlink:label="lab_vyne_GainLossOnSaleAndDispositionOfFixedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale and Disposition of Fixed Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_GainLossOnSaleAndDispositionOfFixedAssets" xlink:href="vyne-20211231.xsd#vyne_GainLossOnSaleAndDispositionOfFixedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_GainLossOnSaleAndDispositionOfFixedAssets" xlink:to="lab_vyne_GainLossOnSaleAndDispositionOfFixedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_RepaymentOfDebtPrepaymentFeePercentage_d594c4d2-7f46-4595-b6b8-e06b6df0e109_terseLabel_en-US" xlink:label="lab_vyne_RepaymentOfDebtPrepaymentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment fee, percentage</link:label>
    <link:label id="lab_vyne_RepaymentOfDebtPrepaymentFeePercentage_label_en-US" xlink:label="lab_vyne_RepaymentOfDebtPrepaymentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Debt, Prepayment Fee, Percentage</link:label>
    <link:label id="lab_vyne_RepaymentOfDebtPrepaymentFeePercentage_documentation_en-US" xlink:label="lab_vyne_RepaymentOfDebtPrepaymentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Debt, Prepayment Fee, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RepaymentOfDebtPrepaymentFeePercentage" xlink:href="vyne-20211231.xsd#vyne_RepaymentOfDebtPrepaymentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_RepaymentOfDebtPrepaymentFeePercentage" xlink:to="lab_vyne_RepaymentOfDebtPrepaymentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_11ea02ba-85e6-47c5-9821-14988e73b6c2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c336291d-c791-415e-bd15-26e08636e67d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued pursuant to the merger (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1ff32b1e-6d66-4c67-8ba1-24f74102ffb9_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_d990768d-1a41-4e2f-8170-cedbb3717e2e_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_0ab15ba8-1292-4356-9270-2d6ea397800a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_7f683548-ab00-4db6-b788-26dec5315fef_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0d45d137-12ef-40bf-9f61-2a603b39bf53_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c8f77d19-3e29-4d1d-8752-92dfcbba3f3f_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_79ecbc75-2093-4586-9430-522d810d37c7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_023887f6-3f7d-41eb-856d-2b2e2138c4f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_c2764de8-2c35-4ddc-aee1-052fef36fb17_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ComputerEquipmentAndSoftwareMember_1c66c32f-bde7-4594-a50c-cfab5e920bae_terseLabel_en-US" xlink:label="lab_vyne_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computers and software</link:label>
    <link:label id="lab_vyne_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_vyne_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computers and software [Member]</link:label>
    <link:label id="lab_vyne_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_vyne_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems and collection of computer programs and related data that provides instructions to a computer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ComputerEquipmentAndSoftwareMember" xlink:href="vyne-20211231.xsd#vyne_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ComputerEquipmentAndSoftwareMember" xlink:to="lab_vyne_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_85697ef2-be59-46ff-8329-9317815e8bae_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current taxes:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_6d6ae0fc-2f20-4474-bbb5-7c0c04d4fe54_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_a5c79bd2-64db-408f-900c-b1431af54d5e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_ea3f7f25-f0f9-4399-b141-2628b05a7a8d_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a093cd62-9576-4a70-a437-cf16f8960e34_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_b11adcfe-59ed-40bb-8716-c7ab60b18a63_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a5eaa9d4-57e2-4669-9583-484c6ecd4e2e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_80f1f154-f1ff-4f66-aaf7-0d0fdc362d14_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_028d9c56-438e-4de7-b99c-294050bab296_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_BridgewaterNewJerseyMember_d3bb2920-37d2-449d-877e-0a10df0a79a3_terseLabel_en-US" xlink:label="lab_vyne_BridgewaterNewJerseyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridgewater, New Jersey</link:label>
    <link:label id="lab_vyne_BridgewaterNewJerseyMember_label_en-US" xlink:label="lab_vyne_BridgewaterNewJerseyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridgewater New Jersey [Member]</link:label>
    <link:label id="lab_vyne_BridgewaterNewJerseyMember_documentation_en-US" xlink:label="lab_vyne_BridgewaterNewJerseyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertaining to the location in Bridgewater, New Jersey.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BridgewaterNewJerseyMember" xlink:href="vyne-20211231.xsd#vyne_BridgewaterNewJerseyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_BridgewaterNewJerseyMember" xlink:to="lab_vyne_BridgewaterNewJerseyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dc7d3612-59c0-40c9-a53a-3cd102ce64ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_284c5e7d-2882-4df3-8371-b01f4e064299_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities (Note10)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_01493872-32eb-41f0-8371-442e6f499319_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_827ed7b2-7e95-4860-887e-13a71eafd9ed_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_2f60a599-2aa6-4804-a57b-c863665e44d3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Recognition and Exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_d2a66aa7-bcae-4756-8b29-9fa0fa72c243_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_35c17ca6-acbc-4deb-b419-91649606ce9a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_7ebf7de8-d542-4b01-aae5-9af4590b615e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_a9960601-b0dc-4183-b714-7c35b9f6babb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e161e9d5-2ec8-4c78-82e9-9e4ce7e359bc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ecfd7400-4be4-45d0-8150-00b78ebd590b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9f06e446-0214-4ffc-b3e5-d955f5c6fbe3_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_0df00405-25ae-4224-b240-00e8803701cb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OfficeBuildingMember_b57c4987-8fe4-48af-ae63-a478004d6853_terseLabel_en-US" xlink:label="lab_srt_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office lease expenses</link:label>
    <link:label id="lab_srt_OfficeBuildingMember_label_en-US" xlink:label="lab_srt_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficeBuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficeBuildingMember" xlink:to="lab_srt_OfficeBuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_1a932bfd-8ca9-47db-8320-29f55443a344_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during the period, conversation units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_23258a8f-3c71-4407-b809-dc2558c56bd3_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_98bf6582-28f6-4ba7-8445-8be23fef2baf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the number of RSUs outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9d451987-0cd6-41ee-b9f0-ad2c18b64143_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of ordinary shares that may be purchased by exercise of warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_59eaa996-2146-45f9-8b47-21d0420dc228_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_A2018PlanMember_2d855a36-9a79-4977-a2c2-655a13aabd4d_terseLabel_en-US" xlink:label="lab_vyne_A2018PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Plan</link:label>
    <link:label id="lab_vyne_A2018PlanMember_label_en-US" xlink:label="lab_vyne_A2018PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Plan [Member]</link:label>
    <link:label id="lab_vyne_A2018PlanMember_documentation_en-US" xlink:label="lab_vyne_A2018PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_A2018PlanMember" xlink:href="vyne-20211231.xsd#vyne_A2018PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_A2018PlanMember" xlink:to="lab_vyne_A2018PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_ae028fd1-29b2-462d-8526-ead61502e12e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee share purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3aeac497-6840-4d1a-b348-6521f76dd90a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of fixed assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_25961aa5-9154-4da7-a3df-6e2ad97140c6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_13209c05-4e40-48ed-9a8c-580431279bbd_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent_7ab62667-eeae-4c74-a2f5-b63630eb7766_terseLabel_en-US" xlink:label="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPR&amp;D Impairment &amp; CSR Remeasurement</link:label>
    <link:label id="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent_label_en-US" xlink:label="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development and Contingent Stock Right Remeasurement, Percent</link:label>
    <link:label id="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent_documentation_en-US" xlink:label="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development and Contingent Stock Right Remeasurement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent" xlink:href="vyne-20211231.xsd#vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent" xlink:to="lab_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_de50ed71-172c-47b0-8043-b3949d31ecad_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AdjustmentsToSupplementalProformaTransactionCosts_93e159d7-c424-4e18-b656-791b126fff1d_negatedLabel_en-US" xlink:label="lab_vyne_AdjustmentsToSupplementalProformaTransactionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_vyne_AdjustmentsToSupplementalProformaTransactionCosts_label_en-US" xlink:label="lab_vyne_AdjustmentsToSupplementalProformaTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Supplemental Proforma Transaction Costs</link:label>
    <link:label id="lab_vyne_AdjustmentsToSupplementalProformaTransactionCosts_documentation_en-US" xlink:label="lab_vyne_AdjustmentsToSupplementalProformaTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount pertaining to transaction costs as adjustment to pro-forma results of the combined operation after business acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdjustmentsToSupplementalProformaTransactionCosts" xlink:href="vyne-20211231.xsd#vyne_AdjustmentsToSupplementalProformaTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AdjustmentsToSupplementalProformaTransactionCosts" xlink:to="lab_vyne_AdjustmentsToSupplementalProformaTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_9edcff4d-2352-45fa-b8d1-6f476724a853_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">debt prepayment penalty</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7ea6247b-46b3-4f86-ac37-66a50f7110ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_98f0aeca-7448-4eaa-910e-c69022265ae7_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8f2d31cd-10e0-4b61-9620-cbce1b65fc9b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1662e68d-b7b3-4431-aa38-8629353433d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d4dbb5af-1310-4d72-aacf-3cadd98dd55d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8b0b9dca-9cfe-4860-bd3f-0dd03af3e36a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_945b4937-3936-4fef-bdee-31e325e5c12e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5001df9c-9062-4e52-900c-dae2ba28a71c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_734e20cd-daf4-427f-8e18-2af76f0349db_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_a26e2972-5728-4d91-907d-2d20d26699c9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected cost remaining</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_RetentionPaymentsMember_6641466f-4d39-453f-b958-9020515be6da_terseLabel_en-US" xlink:label="lab_vyne_RetentionPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retention Payments</link:label>
    <link:label id="lab_vyne_RetentionPaymentsMember_label_en-US" xlink:label="lab_vyne_RetentionPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retention Payments [Member]</link:label>
    <link:label id="lab_vyne_RetentionPaymentsMember_documentation_en-US" xlink:label="lab_vyne_RetentionPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retention Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RetentionPaymentsMember" xlink:href="vyne-20211231.xsd#vyne_RetentionPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_RetentionPaymentsMember" xlink:to="lab_vyne_RetentionPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_59bf7b55-162e-44b6-aafd-8c08cb4414ca_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_442f23d4-3099-424c-8a79-8d08e3864ec3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_TopicalBETiOptionAgreementMember_d203da7f-582f-450d-bfab-f8be625a3d15_terseLabel_en-US" xlink:label="lab_vyne_TopicalBETiOptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Topical BETi Option Agreement</link:label>
    <link:label id="lab_vyne_TopicalBETiOptionAgreementMember_label_en-US" xlink:label="lab_vyne_TopicalBETiOptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Topical BETi Option Agreement [Member]</link:label>
    <link:label id="lab_vyne_TopicalBETiOptionAgreementMember_documentation_en-US" xlink:label="lab_vyne_TopicalBETiOptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Topical BETi Option Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_TopicalBETiOptionAgreementMember" xlink:href="vyne-20211231.xsd#vyne_TopicalBETiOptionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_TopicalBETiOptionAgreementMember" xlink:to="lab_vyne_TopicalBETiOptionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_PublicStockOfferingMember_e8f55ecd-7218-48f0-a452-7499b0e071ba_terseLabel_en-US" xlink:label="lab_vyne_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering</link:label>
    <link:label id="lab_vyne_PublicStockOfferingMember_label_en-US" xlink:label="lab_vyne_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering [Member]</link:label>
    <link:label id="lab_vyne_PublicStockOfferingMember_documentation_en-US" xlink:label="lab_vyne_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PublicStockOfferingMember" xlink:href="vyne-20211231.xsd#vyne_PublicStockOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_PublicStockOfferingMember" xlink:to="lab_vyne_PublicStockOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_88a68970-d890-4ae9-84b4-00cc73e60a84_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_dc79fd8f-a3c8-471e-b44f-0211f3f5880e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f90094e4-339b-4b4e-8bda-7261e6e3a527_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) in accounts payable and accruals</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_54443b14-11ed-4185-89b5-991fe05fd798_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_3ce2adaa-b9c6-449c-b9f5-864b8daa014b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of exercisable options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_7e99e5ff-02c6-4072-bd86-3db245352b9c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired indefinite life intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7693b57f-2840-4161-bfd3-b7ea5fa1022d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7072b0d0-fc51-49e5-b9a5-3f0842bb0f8f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_cf8f9b8a-dcde-49f5-a9ed-cf6cfb1053ff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_623c6108-fda4-4585-bfd7-6484aeba75eb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_42d9a796-6bac-4a4f-ae67-08279174a455_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9309040b-0802-4d88-9e85-1f27b0efb5d7_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplementary information on investing and financing activities not involving cash flows:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_c996e7b2-b56e-48b9-8fc6-438a5104fb4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_834e8ba6-4f87-46a9-92e7-eca4c4acf5a1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of credit risks</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_7561b468-cd0c-45b9-9080-641d902beaef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d365be52-090f-4fa8-861e-2b5519a258b5_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities (Note 10)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_42fc6f33-740c-46d5-b2ee-dd231977b386_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_9194d416-3ed2-48dd-9c29-6ae798afefc3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_849d31d6-e7e2-454f-9d9e-92a7ce449ace_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_a35a7d26-608d-498a-879a-5712ec652264_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_2421de93-763b-4f9d-b66e-70c051695202_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_f75220a5-ad33-4976-8f0e-4b563086d578_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_CustomerThreeMember_f441dac0-792a-4b5d-a5ec-67f92a2ab500_terseLabel_en-US" xlink:label="lab_vyne_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three</link:label>
    <link:label id="lab_vyne_CustomerThreeMember_label_en-US" xlink:label="lab_vyne_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three [Member]</link:label>
    <link:label id="lab_vyne_CustomerThreeMember_documentation_en-US" xlink:label="lab_vyne_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CustomerThreeMember" xlink:href="vyne-20211231.xsd#vyne_CustomerThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_CustomerThreeMember" xlink:to="lab_vyne_CustomerThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ThreeLargestCustomersMember_cf7a96fe-98f2-4af4-ad6b-f84017bb137f_terseLabel_en-US" xlink:label="lab_vyne_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest Customers</link:label>
    <link:label id="lab_vyne_ThreeLargestCustomersMember_label_en-US" xlink:label="lab_vyne_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest Customers [Member]</link:label>
    <link:label id="lab_vyne_ThreeLargestCustomersMember_documentation_en-US" xlink:label="lab_vyne_ThreeLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ThreeLargestCustomersMember" xlink:href="vyne-20211231.xsd#vyne_ThreeLargestCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ThreeLargestCustomersMember" xlink:to="lab_vyne_ThreeLargestCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a578aa06-7e9a-4a96-a84e-94e8280100bb_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_StockIssuedDuringPeriodSharesWarrantsExercised_c7c03fa0-d979-4a95-905e-1cc9d3a7233f_terseLabel_en-US" xlink:label="lab_vyne_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants exercised (in shares)</link:label>
    <link:label id="lab_vyne_StockIssuedDuringPeriodSharesWarrantsExercised_label_en-US" xlink:label="lab_vyne_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants exercised</link:label>
    <link:label id="lab_vyne_StockIssuedDuringPeriodSharesWarrantsExercised_documentation_en-US" xlink:label="lab_vyne_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants exercised during the current period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:href="vyne-20211231.xsd#vyne_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="lab_vyne_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_a835a446-6bf0-4f60-ba4f-3a770274e982_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_f27c6929-3d2f-4918-9886-b5584bcd3499_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of stock option</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_87d212d9-5327-4566-baf1-2fc9ebf1281f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_SaleOfStockConsiderationReceivableOnTransaction_554c975e-c6f1-4551-8795-9fa370e66144_terseLabel_en-US" xlink:label="lab_vyne_SaleOfStockConsiderationReceivableOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration receivable on transaction</link:label>
    <link:label id="lab_vyne_SaleOfStockConsiderationReceivableOnTransaction_label_en-US" xlink:label="lab_vyne_SaleOfStockConsiderationReceivableOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Receivable on Transaction</link:label>
    <link:label id="lab_vyne_SaleOfStockConsiderationReceivableOnTransaction_documentation_en-US" xlink:label="lab_vyne_SaleOfStockConsiderationReceivableOnTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Receivable on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_SaleOfStockConsiderationReceivableOnTransaction" xlink:href="vyne-20211231.xsd#vyne_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_SaleOfStockConsiderationReceivableOnTransaction" xlink:to="lab_vyne_SaleOfStockConsiderationReceivableOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_da1a3bfd-d18d-4d36-a01d-a9560a3e8892_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_2dbd0fdd-1eb1-42bb-9b9e-c09584de70d9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease terms</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_a9228328-8383-462a-992e-5648afad82af_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_f7bb1781-6a55-4d86-8fe7-1089849246b2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_2e4bffe6-263b-459b-83a6-2e7d3863b1f4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_00e0f9c4-4dff-4468-af37-f3d6df712116_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_e6aec78b-ff04-416f-a1c2-8655e4ffc754_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_dfdfbb16-218b-4a08-a949-4e9b65b8428a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_6d434335-de48-4e3f-8609-c69e7398b2dd_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_b7da49c0-7b6d-4a4e-931b-f58024e26e73_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_158197bf-0cab-4156-99c8-72715ed2943f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent impairment loss, debt securities, available for sale</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock_7d91e41e-ae2d-4dc5-a34c-9458301f55ba_terseLabel_en-US" xlink:label="lab_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of IPR&amp;D Assets Acquired through the Merger</link:label>
    <link:label id="lab_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of In Process Research And Development Assets Acquired Through Business Combination [Table Text Block]</link:label>
    <link:label id="lab_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock_documentation_en-US" xlink:label="lab_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of in-process research and development indefinite lived intangible assets acquired in the merger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock" xlink:href="vyne-20211231.xsd#vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock" xlink:to="lab_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_d8f1604b-8c48-424c-a484-004d893af023_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_c8d13660-1929-4a98-b50b-74169fb908eb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain_d883154b-27d6-4a79-bd11-8c3c3c775cc2_terseLabel_en-US" xlink:label="lab_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual property acquired, taxable gain</link:label>
    <link:label id="lab_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain_label_en-US" xlink:label="lab_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidation of Subsidiary, Intellectual Property Acquired, Taxable Gain</link:label>
    <link:label id="lab_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain_documentation_en-US" xlink:label="lab_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidation of Subsidiary, Intellectual Property Acquired, Taxable Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain" xlink:href="vyne-20211231.xsd#vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain" xlink:to="lab_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c37288db-a8d1-4e64-a1e0-24cf848d1aea_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_30fe009d-a985-4972-88f0-ebdc44f15af2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_a96aaacf-3443-4e25-83a6-86bb5bb0ab6c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_1e06a2a2-17c6-4a89-afb5-224006849344_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_d84538ac-eb39-47c8-a84b-31fd2dee7058_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of options and issuance of shares under the employee shares purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod_2e9ffc64-f526-4ecf-bad8-bb6835265d9b_terseLabel_en-US" xlink:label="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental compensation costs, recognition period</link:label>
    <link:label id="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod_label_en-US" xlink:label="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Unrecognized Costs, Recognition Period</link:label>
    <link:label id="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod_documentation_en-US" xlink:label="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Unrecognized Costs, Recognition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod" xlink:to="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue_0312d430-91db-43a2-82e6-cf9fc9d9d994_terseLabel_en-US" xlink:label="lab_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of options and RSUs granted</link:label>
    <link:label id="lab_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue_label_en-US" xlink:label="lab_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options And Equity Instruments Other Than Options Grants in Period Total Grant Date Fair Value</link:label>
    <link:label id="lab_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue_documentation_en-US" xlink:label="lab_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the total fair value of options and equity instruments other than options granted during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue" xlink:href="vyne-20211231.xsd#vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue" xlink:to="lab_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0dc49fce-51fd-47b9-aac2-57475de8b7fa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_80596db3-88f4-4f1f-9d0d-425922466e16_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0c514ce5-159e-4b42-9980-1ccd2e1e10e6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax (Benefit) Expense (Note 16)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_00e88399-c833-4b97-8f0a-15cb47c31730_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivable, net of allowances</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_32d30217-a619-4db0-89af-16ac4f9610cf_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6d1db5fd-8dbe-4fd6-9169-63864b48d17d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_FoamixMember_8ece904b-198f-49b2-8284-94adfd6a8ece_terseLabel_en-US" xlink:label="lab_vyne_FoamixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foamix</link:label>
    <link:label id="lab_vyne_FoamixMember_label_en-US" xlink:label="lab_vyne_FoamixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foamix [Member]</link:label>
    <link:label id="lab_vyne_FoamixMember_documentation_en-US" xlink:label="lab_vyne_FoamixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertaining to the merger of Foamix.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_FoamixMember" xlink:to="lab_vyne_FoamixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ba7d0bc1-a213-47c5-892e-ec31d3f87531_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_34d7d291-2f93-44b4-aa6a-5d7af9d1a796_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_fdb0e5db-7ee0-401f-ab2b-91b49fd31d81_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a6f2a8cc-75da-4cac-8c70-2827d5a62ddc_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_1a51d6b9-3cdc-422f-9ea7-20ea6890b3c9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b966764a-9367-4318-8f7d-4c7465e84b66_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_9536a9b5-40d1-4e03-8ea3-75fb2fb7c7f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt prepayment premium</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_8a193c8b-d3e0-4db5-ae43-819df5bba060_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6006ef5d-31ff-43a9-8810-9b8a22618c40_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_31d24ab4-023e-41ed-b0c9-ffc482011b56_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_62b0567e-984b-44dc-b42d-e24517a5a40e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a577e6d1-d50d-4d03-8a92-98c090ad8632_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_fec12022-a35b-4290-abd6-41a12d977496_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory (Note 7)</link:label>
    <link:label id="lab_us-gaap_InventoryNet_ba06b962-ffac-4df2-adeb-cb53bab83910_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_1ab2e120-2072-4a9f-9b09-4eeb194d5652_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_981c7b62-13d4-48c3-8120-e66f1edc4481_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b0895f1f-225d-4b93-9ffb-fdf5b24b280b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_02c04b27-b4f7-4839-ba7b-e413e366c646_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_a311e1ba-7afc-4b34-acff-1275e83590b8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8fb2263e-5ddb-4dc9-93ae-3edd8b21496c_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in valuation allowance, deferred tax assets</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_933a4fb6-3690-4c99-b3a4-df42670ccd60_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock_20466b06-4745-4724-82c6-d83657285105_terseLabel_en-US" xlink:label="lab_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the Calculation of Goodwill from the Merger</link:label>
    <link:label id="lab_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock_label_en-US" xlink:label="lab_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Combination Goodwill [Table Text Block]</link:label>
    <link:label id="lab_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock_documentation_en-US" xlink:label="lab_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the calculation of goodwill from the business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock" xlink:href="vyne-20211231.xsd#vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock" xlink:to="lab_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_27eade6c-7513-447f-9ad0-96e83bc018de_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share based compensation expense, options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_EstimateOfProductReturnRateMinimum_a05ebab5-fe67-4325-91c6-0abec9954987_terseLabel_en-US" xlink:label="lab_vyne_EstimateOfProductReturnRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum estimated product return (as a percent)</link:label>
    <link:label id="lab_vyne_EstimateOfProductReturnRateMinimum_label_en-US" xlink:label="lab_vyne_EstimateOfProductReturnRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Product Return Rate, Minimum</link:label>
    <link:label id="lab_vyne_EstimateOfProductReturnRateMinimum_documentation_en-US" xlink:label="lab_vyne_EstimateOfProductReturnRateMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The minimum estimate of product sales return rate at reporting date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EstimateOfProductReturnRateMinimum" xlink:href="vyne-20211231.xsd#vyne_EstimateOfProductReturnRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_EstimateOfProductReturnRateMinimum" xlink:to="lab_vyne_EstimateOfProductReturnRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_da8122e0-e999-449e-86b7-86ce48a0d2db_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5a210f43-811b-49e2-a84f-06af2314f987_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_59122812-3669-4330-b5ea-828460e767ba_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_f71c0ba7-ecb3-4ab7-9685-127a7b8f6e97_terseLabel_en-US" xlink:label="lab_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issued and delivered upon CSR conversion (in shares)</link:label>
    <link:label id="lab_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_label_en-US" xlink:label="lab_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued Upon Conversion of Common Stock Rights, Per Agreement</link:label>
    <link:label id="lab_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_documentation_en-US" xlink:label="lab_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number shares issued upon conversion of common stock rights arising form the certain events as provided for in the commons stock rights agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement" xlink:href="vyne-20211231.xsd#vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement" xlink:to="lab_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_b772e2c6-f28c-4ebe-9203-433083674934_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_5296cb20-6346-43b2-ba1c-19d75ec68632_terseLabel_en-US" xlink:label="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments upon achieving certain criteria, exceeding annual net sales</link:label>
    <link:label id="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_label_en-US" xlink:label="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments Upon Achieving Certain Criteria, Exceeding Annual Net Sales</link:label>
    <link:label id="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_documentation_en-US" xlink:label="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments Upon Achieving Certain Criteria, Exceeding Annual Net Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales" xlink:href="vyne-20211231.xsd#vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales" xlink:to="lab_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_f05df34e-a677-4d3f-935e-5c6d20d19496_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_c5626b55-4414-4601-ae60-e62cdd7e0c71_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_d736f70b-4b8e-495a-a856-9dde9f8a2f02_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_446363e4-7b0d-4040-8615-f68dcb5e051b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_82d7984d-6dd2-4889-b1c6-776cd07b1074_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options, vesting of restricted stock units and shares under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c7ca443d-0fc2-4a28-a0a2-bbaf668d1a63_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_1693a07f-1e5d-4529-ab97-c4fdd56694f0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental compensation costs incurred</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_21a91ff9-c3cb-43e0-b811-893215e9d407_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount cost</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8d567b95-928a-479d-9e83-473ef0ab6a84_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_0cd326b2-88ef-46a6-a82b-4e715c3b6ddf_verboseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles lease expenses</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_9e81b08a-5e11-4004-b023-21e497ab1a7c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3529640e-bcf2-4097-97b4-acfa60e47b8b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock related to merger (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_11978339-314a-49aa-a442-145ef14794a8_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_4e81fbfe-fc5b-475e-837d-de8bd7e8b065_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a7e1a28f-2534-4be6-bbf4-1885d990caf3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2b511d7d-d177-42d1-884f-aa41441df725_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options, vesting of restricted stock units and shares issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_2c401a21-8ace-4a44-9bb9-171f8ff45cd3_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_52f1f38d-dce7-4995-b774-c0b19f6a635b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of fixed assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property Held-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f321516d-bdda-4d39-838f-61305d58e069_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities,available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_f11db247-a523-41ea-8d1f-aa942c56ebf0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowances</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets_a2b2262c-bcaf-40c1-bcc3-0bd06fcc3692_negatedLabel_en-US" xlink:label="lab_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: fair value of net assets acquired, including other identifiable intangibles</link:label>
    <link:label id="lab_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets_label_en-US" xlink:label="lab_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Assets Acquired Including Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets_documentation_en-US" xlink:label="lab_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired including other identifiable intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets" xlink:to="lab_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_19cfac15-7653-409d-8cb7-528a47d5bcc7_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for employee severance benefits</link:label>
    <link:label id="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_label_en-US" xlink:label="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Unemployment Benefits, Severance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:to="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_35454448-a642-400a-821f-9274c1230ed7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_18d6a760-06c3-4d7d-8f42-5d1b4c0dfba2_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2d75e2ab-e77d-4c8e-a1f0-55defcb2f2e4_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Before Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_45bec96a-6834-4485-9d2e-92936849bf5d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total loss before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_bbab37f0-3722-4d2f-893c-472f6d5c9029_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_CantorSalesAgreementMember_4171e2fd-face-468f-98da-f0260329482c_terseLabel_en-US" xlink:label="lab_vyne_CantorSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cantor Sales Agreement</link:label>
    <link:label id="lab_vyne_CantorSalesAgreementMember_label_en-US" xlink:label="lab_vyne_CantorSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cantor Sales Agreement [Member]</link:label>
    <link:label id="lab_vyne_CantorSalesAgreementMember_documentation_en-US" xlink:label="lab_vyne_CantorSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cantor Sales Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CantorSalesAgreementMember" xlink:href="vyne-20211231.xsd#vyne_CantorSalesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_CantorSalesAgreementMember" xlink:to="lab_vyne_CantorSalesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0e6a26c3-bb5c-4ac3-9891-790b54c41e38_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_b894b3b4-6d00-480a-a63a-cf9640041353_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_9fcaf11d-9b2f-4f83-8483-1278b4f1baaf_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less - valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0dc95cd4-815c-4c80-b0aa-9b56bc61bf74_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_2a8c2993-6b6c-4252-a97f-d18d1a5ed174_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the end of period</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_448ffd29-66ec-4f42-925b-d735fd73010b_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_66c910c0-b936-4541-b6fe-d815c855ee21_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_7d22bf47-21bd-45a0-84d2-a51172628cc8_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_62c3cd68-61dd-463b-a5fc-4e188f70b3c2_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE SAVINGS PLAN</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_6c338ede-a222-48f5-a400-6fcfee1cb770_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5a1b73e3-5e59-4f31-9692-c7497862e1f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_146afa84-281b-47a6-b0f1-759be343c2a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_fda44d4e-0ecd-406d-86f9-078c187dc2ff_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_573366aa-e902-4ae4-b406-ef32acf34d2e_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_8fab651d-80fe-4244-ad27-233f36ab8f59_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_08140d22-2a39-4d2f-8942-d419206f0fe9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of share-based compensation expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember_d4391c3f-08ec-4090-a728-afdf9b8f611d_terseLabel_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Credit Agreement, Trench 2 Loan</link:label>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember_label_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended And Restated Credit Agreement Trench2 Loan [Member]</link:label>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember_documentation_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents trench 2 loan of the Amended and Restated Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember" xlink:to="lab_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_ad6bb957-97a5-4e8a-9202-0cfe738d9fac_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_8bc51f75-9400-4c20-9e28-b91988ff17f0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_18a2f0e0-6857-4d1f-b03a-1f6c50834e9f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from royalties</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4072a896-894a-4a30-a029-0f6d5117cd0e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_535ba71a-9bb0-430f-9392-19aaf8e40923_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_d14dcd68-a420-4493-a33f-b42b9221cf71_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ca574df4-3df7-4abd-b59e-e1ef13681ef9_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total&#160; Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_518e4a27-d50e-4a7c-a9ee-a886d69b4392_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_1e5c4d97-3d93-48cf-86fa-15486adc3ef1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_3206064f-8eb6-4918-b021-9a63efca3f2a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_186f56fa-d3e0-47c4-b4fb-b2b0b945ebbf_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0cbef310-f8dd-423e-9418-92301293fd49_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_2692f60c-1564-45dd-b784-56dc842a2815_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0c34382e-df77-421a-b123-11ff39482603_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_IncomeTaxTable_45288951-d1a0-40f7-bd3a-e3616c3e6c7e_terseLabel_en-US" xlink:label="lab_vyne_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:label id="lab_vyne_IncomeTaxTable_label_en-US" xlink:label="lab_vyne_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Table]</link:label>
    <link:label id="lab_vyne_IncomeTaxTable_documentation_en-US" xlink:label="lab_vyne_IncomeTaxTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_IncomeTaxTable" xlink:href="vyne-20211231.xsd#vyne_IncomeTaxTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_IncomeTaxTable" xlink:to="lab_vyne_IncomeTaxTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AccruedResearchAndDevelopmentCurrent_53ff212b-e2ca-4035-a165-12d810d460f2_terseLabel_en-US" xlink:label="lab_vyne_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_vyne_AccruedResearchAndDevelopmentCurrent_label_en-US" xlink:label="lab_vyne_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development Current</link:label>
    <link:label id="lab_vyne_AccruedResearchAndDevelopmentCurrent_documentation_en-US" xlink:label="lab_vyne_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AccruedResearchAndDevelopmentCurrent" xlink:href="vyne-20211231.xsd#vyne_AccruedResearchAndDevelopmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AccruedResearchAndDevelopmentCurrent" xlink:to="lab_vyne_AccruedResearchAndDevelopmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_20f0ac86-0c73-424f-bf1a-5e46be43851d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_MenloPremergerMember_af63e30f-5383-484e-944b-a5a49af300c7_terseLabel_en-US" xlink:label="lab_vyne_MenloPremergerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Menlo - Premerger</link:label>
    <link:label id="lab_vyne_MenloPremergerMember_label_en-US" xlink:label="lab_vyne_MenloPremergerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Menlo - Premerger [Member]</link:label>
    <link:label id="lab_vyne_MenloPremergerMember_documentation_en-US" xlink:label="lab_vyne_MenloPremergerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Menlo - Premerger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MenloPremergerMember" xlink:href="vyne-20211231.xsd#vyne_MenloPremergerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_MenloPremergerMember" xlink:to="lab_vyne_MenloPremergerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_248d7612-a858-4fc2-854e-7a6d5c695afa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, fair value of liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_72802c8f-7350-40b1-bbca-8068fa2d9495_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Long-term Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_72b218b6-51cc-4008-bad1-0fd47cc127e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_f06289d8-3e58-4fd4-bce2-a6a0ab4c522e_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b7b673f3-57aa-4712-8a5d-dd87373fea71_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_fcf8a943-d417-401e-b8b8-d729784ca50d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used in operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_4835a4ad-d3d5-4b4a-b244-e0491210d5b1_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_6f7cd898-4404-4796-a8b9-1e42a0453560_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses on marketable securities reclassified into net loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_60d538ca-ac1f-4fc6-8343-3992a30b69df_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9ac67b7b-a76e-4077-ab36-0f6f582a9f19_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_d4db44bb-3c72-4085-a50b-e70717e4b504_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_e7b84dcd-ee5c-4219-b38b-ed1d1735def3_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_aa3cb6aa-19f3-470b-b75c-4898fe41b187_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_93d8759e-29db-4873-893c-6569323c50a9_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e96c3785-7d45-4ed0-b3d6-17fc0a7a4365_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_00aef415-49c9-48e3-97e0-8ca15b038d17_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_7e67acb7-b90c-4559-a6a8-1393afd21023_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_4d562f99-09de-4687-83a6-a06616461723_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_CommonStockVotingRightsNumberPerShare_15e599ba-87b3-48c6-a396-9273a141cd6c_terseLabel_en-US" xlink:label="lab_vyne_CommonStockVotingRightsNumberPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes entitled to each ordinary share</link:label>
    <link:label id="lab_vyne_CommonStockVotingRightsNumberPerShare_label_en-US" xlink:label="lab_vyne_CommonStockVotingRightsNumberPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Voting Rights Number Per Share</link:label>
    <link:label id="lab_vyne_CommonStockVotingRightsNumberPerShare_documentation_en-US" xlink:label="lab_vyne_CommonStockVotingRightsNumberPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes entitled to each ordinary share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CommonStockVotingRightsNumberPerShare" xlink:href="vyne-20211231.xsd#vyne_CommonStockVotingRightsNumberPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_CommonStockVotingRightsNumberPerShare" xlink:to="lab_vyne_CommonStockVotingRightsNumberPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_d36124fa-ce70-464c-b9ba-5590df7fe070_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales, net</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_3c3196f4-e9d0-40c2-ad58-b78f3f06483a_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_4fe98327-43c2-4d10-8fe1-75fee42bd775_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_62006521-3588-4170-8ecb-9ac5ce43a1d9_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_0731d165-fce5-45ad-8a29-50285af214da_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ContingentStockConsiderationRemeasurementGainLoss_28815416-f486-4de5-bfe8-38ef12ddba43_negatedLabel_en-US" xlink:label="lab_vyne_ContingentStockConsiderationRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Stock Remeasurement</link:label>
    <link:label id="lab_vyne_ContingentStockConsiderationRemeasurementGainLoss_fdf1e3e8-2bf6-4ca5-99fa-18e51ca43c9d_negatedTerseLabel_en-US" xlink:label="lab_vyne_ContingentStockConsiderationRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent stock right remeasurement</link:label>
    <link:label id="lab_vyne_ContingentStockConsiderationRemeasurementGainLoss_label_en-US" xlink:label="lab_vyne_ContingentStockConsiderationRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Stock Consideration, Remeasurement Gain (Loss)</link:label>
    <link:label id="lab_vyne_ContingentStockConsiderationRemeasurementGainLoss_documentation_en-US" xlink:label="lab_vyne_ContingentStockConsiderationRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Stock Consideration, Remeasurement Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss" xlink:href="vyne-20211231.xsd#vyne_ContingentStockConsiderationRemeasurementGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss" xlink:to="lab_vyne_ContingentStockConsiderationRemeasurementGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_b000c33a-7830-4880-bda5-768ac34e3bc6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_2815b078-e9ba-4351-a01a-feee610f71b2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for income tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_4bc3e986-feed-449f-be80-51855e677f56_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in marketable securities and bank deposits, net</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c759396-3325-4eaf-864c-be83cdb36207_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_2cecdda8-24b7-49a6-91f6-0f7f3f3b0a3d_terseLabel_en-US" xlink:label="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional consideration receivable</link:label>
    <link:label id="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_label_en-US" xlink:label="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:label id="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_documentation_en-US" xlink:label="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:to="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_ba58bc3e-25b7-46e5-a696-04a926b79fdc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f019bd4b-9d13-4610-8ad0-0ab3ca8a6ad7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_FacilitySpaceUnderLease_aab1bc30-9043-4a88-9c11-a5897873e61a_terseLabel_en-US" xlink:label="lab_vyne_FacilitySpaceUnderLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility space leased</link:label>
    <link:label id="lab_vyne_FacilitySpaceUnderLease_label_en-US" xlink:label="lab_vyne_FacilitySpaceUnderLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Space Under Lease</link:label>
    <link:label id="lab_vyne_FacilitySpaceUnderLease_documentation_en-US" xlink:label="lab_vyne_FacilitySpaceUnderLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Size of the facility under lease, in square feet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FacilitySpaceUnderLease" xlink:href="vyne-20211231.xsd#vyne_FacilitySpaceUnderLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_FacilitySpaceUnderLease" xlink:to="lab_vyne_FacilitySpaceUnderLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_60dfb3c3-459f-4792-8949-ad285b2cdaa9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_cd8e0ffa-1aa2-4405-b0dc-425a74718db2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_f01e3b48-dec1-46ad-a183-fd8856fd5707_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_ebf93a08-6896-4309-821d-78b1ed9cb4a0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_d385c30c-a0dc-4095-8502-7f314fdef9b6_terseLabel_en-US" xlink:label="lab_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of CSR converted into additional shares of the combined company</link:label>
    <link:label id="lab_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_label_en-US" xlink:label="lab_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquiree Common Stock Rights Converted to Common Stock</link:label>
    <link:label id="lab_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_documentation_en-US" xlink:label="lab_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquiree Common Stock Rights Converted to Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" xlink:to="lab_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_55af445e-dd22-475a-b021-c505b468d074_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock_fca642fe-8e7c-4f29-969d-f3f0a8ba5d74_terseLabel_en-US" xlink:label="lab_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Before Income Tax Taxes and Current Tax Expense (Benefit)</link:label>
    <link:label id="lab_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Before Income Tax Taxes and Current Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label id="lab_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock_documentation_en-US" xlink:label="lab_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the components of loss before income tax taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock" xlink:href="vyne-20211231.xsd#vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock" xlink:to="lab_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_fd44736a-6de0-42d6-85be-ef7bd48943d3_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_851e5888-ff7e-47aa-8c8e-218e58a7a894_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_7fbd7900-6bd4-4ccf-8470-646e36afd3da_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_bb74d61c-dbff-4ab2-aaac-c21f53d92bca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_376620f4-ed1a-4514-ab4e-2cb5a853600b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d8725b9c-c6f3-4716-87d5-d25a389eab07_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_BusinessAcquisitionContingentStockRightIssued_eebb55d2-2b8b-44a7-ac6d-8d65c5a93575_terseLabel_en-US" xlink:label="lab_vyne_BusinessAcquisitionContingentStockRightIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of contingent stock rights issued (in CSR)</link:label>
    <link:label id="lab_vyne_BusinessAcquisitionContingentStockRightIssued_label_en-US" xlink:label="lab_vyne_BusinessAcquisitionContingentStockRightIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Stock Right Issued</link:label>
    <link:label id="lab_vyne_BusinessAcquisitionContingentStockRightIssued_documentation_en-US" xlink:label="lab_vyne_BusinessAcquisitionContingentStockRightIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of contingent stock right issued in connection with the business acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessAcquisitionContingentStockRightIssued" xlink:href="vyne-20211231.xsd#vyne_BusinessAcquisitionContingentStockRightIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_BusinessAcquisitionContingentStockRightIssued" xlink:to="lab_vyne_BusinessAcquisitionContingentStockRightIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_b1d5990b-809b-4974-b82b-4e2a16e1990f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) increase in inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_IncomeTaxLineItems_6715abc3-6b0d-46dc-aa1e-90a804d2829c_terseLabel_en-US" xlink:label="lab_vyne_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_vyne_IncomeTaxLineItems_label_en-US" xlink:label="lab_vyne_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_vyne_IncomeTaxLineItems_documentation_en-US" xlink:label="lab_vyne_IncomeTaxLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IncomeTax Line Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_IncomeTaxLineItems" xlink:href="vyne-20211231.xsd#vyne_IncomeTaxLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_IncomeTaxLineItems" xlink:to="lab_vyne_IncomeTaxLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_af16ae8b-b6eb-477a-bf0b-9a765cf828b1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e692a466-d4b1-4325-870b-a9581c21c944_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d39e4fdf-d0ac-4266-b404-a89843b1437d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_GrossProceedsFromIssuanceOfCommonStock_b71b6f34-32b6-4ca7-a03d-4a9287acd92c_terseLabel_en-US" xlink:label="lab_vyne_GrossProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from issuance of common stock</link:label>
    <link:label id="lab_vyne_GrossProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_vyne_GrossProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Proceeds From Issuance Of Common Stock</link:label>
    <link:label id="lab_vyne_GrossProceedsFromIssuanceOfCommonStock_documentation_en-US" xlink:label="lab_vyne_GrossProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The gross proceeds from issuance of common stock before deducting offering expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_GrossProceedsFromIssuanceOfCommonStock" xlink:href="vyne-20211231.xsd#vyne_GrossProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_GrossProceedsFromIssuanceOfCommonStock" xlink:to="lab_vyne_GrossProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_CustomerTwoMember_4bd1ac6a-598f-4c0e-aa4a-6d8d979518cc_terseLabel_en-US" xlink:label="lab_vyne_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two</link:label>
    <link:label id="lab_vyne_CustomerTwoMember_label_en-US" xlink:label="lab_vyne_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two [Member]</link:label>
    <link:label id="lab_vyne_CustomerTwoMember_documentation_en-US" xlink:label="lab_vyne_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CustomerTwoMember" xlink:href="vyne-20211231.xsd#vyne_CustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_CustomerTwoMember" xlink:to="lab_vyne_CustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSupplies_031b33ec-35b9-4a60-9f30-c5d0084ce4b2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSupplies_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSupplies" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_bbb1e88d-2727-40fc-804b-fbf3ba129f31_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_339a406f-e663-4af4-b0d5-bbd8e513a27b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_3260fa62-501e-4d29-b9de-a72aa80f62e6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of franchises</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_646e0349-5a4a-40d0-aeee-c5edd1610822_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_017c0452-2d1a-405e-8a4f-74bfdafc448f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_51da99ce-717f-4c9b-b782-fb20c130014a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f678e85-3fc0-4b3b-aa1d-3f2ba2d10c3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_0afb8145-b55b-424b-9e60-71dee253c654_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1ece0604-b3df-49fe-9c8c-eb7e984ea067_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income tax provision, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_b7eb03aa-c9ae-424e-a740-5bf395b77b6b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_49e1483b-d640-4ab0-9963-f564992daf76_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Lives of Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_be67dd60-1656-4578-af83-e633bbfd46e2_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property And Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_5fbc324c-19ba-4e76-89e2-84e45dc6e489_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_777a6bcc-85bf-4ae3-92b7-bd4e5f58531b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price range, maximum (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_InterestReceived_72e1c4d3-365e-4b48-8b77-d4160f084d6e_terseLabel_en-US" xlink:label="lab_vyne_InterestReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest received</link:label>
    <link:label id="lab_vyne_InterestReceived_label_en-US" xlink:label="lab_vyne_InterestReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest received</link:label>
    <link:label id="lab_vyne_InterestReceived_documentation_en-US" xlink:label="lab_vyne_InterestReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_InterestReceived" xlink:href="vyne-20211231.xsd#vyne_InterestReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_InterestReceived" xlink:to="lab_vyne_InterestReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock_9c3f1c46-339c-4888-902a-32a294f4d8f0_terseLabel_en-US" xlink:label="lab_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission from gross proceeds from issuance of common stock</link:label>
    <link:label id="lab_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission from Gross Proceeds From Issuance Of Common Stock</link:label>
    <link:label id="lab_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock_documentation_en-US" xlink:label="lab_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission from Gross Proceeds From Issuance Of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock" xlink:href="vyne-20211231.xsd#vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock" xlink:to="lab_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_926121cf-3ab4-4197-b8bf-e4d69e13abea_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_OperatingLeaseRightOfUseAssetsTransferred_9dadc29c-ab9f-4f29-a5b9-a57deed6c508_terseLabel_en-US" xlink:label="lab_vyne_OperatingLeaseRightOfUseAssetsTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets transferred</link:label>
    <link:label id="lab_vyne_OperatingLeaseRightOfUseAssetsTransferred_label_en-US" xlink:label="lab_vyne_OperatingLeaseRightOfUseAssetsTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right of Use Assets Transferred</link:label>
    <link:label id="lab_vyne_OperatingLeaseRightOfUseAssetsTransferred_documentation_en-US" xlink:label="lab_vyne_OperatingLeaseRightOfUseAssetsTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right of Use Assets Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseRightOfUseAssetsTransferred" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseRightOfUseAssetsTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_OperatingLeaseRightOfUseAssetsTransferred" xlink:to="lab_vyne_OperatingLeaseRightOfUseAssetsTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_694a5715-253e-4fdb-91da-d576252775ba_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net (Note 8)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_66ebebd3-ce21-4103-81ac-acffd280321a_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_ea8f7aed-f60a-4359-b06a-8907bc4f88e4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_12473d62-9a9a-4af1-b23b-3012d3aa2978_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees and consultants</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1ae15345-5bc8-4d03-9ebc-3bac4dedfa59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_e26d3a36-4e25-490b-bc85-f1dac479e92b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_06f5ce29-6108-4207-9008-74173d4def72_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_5ff98e02-9a49-4f4a-8d71-d9cc9c3b9925_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt repayment (Note 13)</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_7353fdcf-9c96-4f97-a21d-0a0c444f687d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt repayment (Note 13)</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_50743ecf-9103-4cc1-86c2-34ce6be34d90_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_CustomerOneMember_48ef3e80-7c4f-42f3-b038-27a63c0ede27_terseLabel_en-US" xlink:label="lab_vyne_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One</link:label>
    <link:label id="lab_vyne_CustomerOneMember_label_en-US" xlink:label="lab_vyne_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One [Member]</link:label>
    <link:label id="lab_vyne_CustomerOneMember_documentation_en-US" xlink:label="lab_vyne_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CustomerOneMember" xlink:href="vyne-20211231.xsd#vyne_CustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_CustomerOneMember" xlink:to="lab_vyne_CustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_DeferredTaxAssetsValuationAllowanceRollForward_2b97585c-9f3c-4c6c-8f36-b43690a74420_terseLabel_en-US" xlink:label="lab_vyne_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_vyne_DeferredTaxAssetsValuationAllowanceRollForward_label_en-US" xlink:label="lab_vyne_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_vyne_DeferredTaxAssetsValuationAllowanceRollForward_documentation_en-US" xlink:label="lab_vyne_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DeferredTaxAssetsValuationAllowanceRollForward" xlink:href="vyne-20211231.xsd#vyne_DeferredTaxAssetsValuationAllowanceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_DeferredTaxAssetsValuationAllowanceRollForward" xlink:to="lab_vyne_DeferredTaxAssetsValuationAllowanceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_40e9b3a3-6886-4c1a-9d3e-77f839e134d2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_bf8f6551-e6a9-44b7-8c2c-f770d248fafb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_705e0833-1aad-48c5-9b64-348aae98b639_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCRUED EXPENSES</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_6e8253d4-d879-4973-9161-5f16428c0ba5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1807a311-359c-44a0-9e3d-754d70ea5c0e_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_cc801a30-9a8f-4e56-8dd9-f6d01ec4561d_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes_27de27e0-691d-4d5f-9562-8df1d8283fcc_terseLabel_en-US" xlink:label="lab_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares deemed (for accounting purposes only) issued (in shares)</link:label>
    <link:label id="lab_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes_label_en-US" xlink:label="lab_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Shares Deemed Issued For Accounting Purposes</link:label>
    <link:label id="lab_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes_documentation_en-US" xlink:label="lab_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares deemed, for accounting purposes only, to be issued in the merger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes" xlink:to="lab_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_6362dcec-73e6-415b-8d95-4151d60cf1d1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_48052b05-3dd4-4fbe-afca-a74f8714ddeb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5b96dfdd-de4c-4893-ba32-b2db5b2873a9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_5c1cf979-7923-41f4-b864-1a88f30692bc_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ExchangeRatio_233b0f86-e5a6-4c36-ae74-3f017886c641_terseLabel_en-US" xlink:label="lab_vyne_ExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange ratio per ordinary share for common stock (share per share)</link:label>
    <link:label id="lab_vyne_ExchangeRatio_label_en-US" xlink:label="lab_vyne_ExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Ratio</link:label>
    <link:label id="lab_vyne_ExchangeRatio_documentation_en-US" xlink:label="lab_vyne_ExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ratio applied to the exchange of ordinary shares of acquiree for common stock of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ExchangeRatio" xlink:href="vyne-20211231.xsd#vyne_ExchangeRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ExchangeRatio" xlink:to="lab_vyne_ExchangeRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_52a0f3ad-31c1-49d4-a151-36a5d2266ff7_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_9203edd7-a5e6-4ed6-a3fe-990107937ac5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt (Note 13)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2240b6ae-d8d0-4a41-8284-9df109aa9692_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term of exercisable options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired_9f85eb1c-7954-468e-8c1d-92a285725e95_totalLabel_en-US" xlink:label="lab_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger net of cash acquired</link:label>
    <link:label id="lab_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired_label_en-US" xlink:label="lab_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Acquisition Of Business, Net Assets After Cash Acquired</link:label>
    <link:label id="lab_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired_documentation_en-US" xlink:label="lab_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of net assets acquired in non-cash acquisition, net of cash acquired included in the acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired" xlink:href="vyne-20211231.xsd#vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired" xlink:to="lab_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f1e094a6-2a91-4923-977f-7d169eb83e30_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_666f04bf-fc87-4896-95d2-1d017af13197_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9d2052f6-66b2-412f-85ed-cea93cabdbc6_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_527e751a-3a99-4669-b872-dee7d796cb51_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_87636b38-3099-4e77-8723-c67617b98c98_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale and maturity of marketable securities and bank deposits</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c483e285-ecdd-4787-bf9c-d00d8dec70ce_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_388a6259-a2b0-4119-88e0-3a812f5bca33_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue reserve accrual</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_851f7622-c8a5-4c47-adeb-70548fd7d426_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7a5d1930-8f57-4b75-ae5d-bc73c180f684_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_61e7a9e1-7639-4976-bc14-243a575a7820_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash shown in statement of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_77761dd8-fae5-4b39-89da-b87357969a70_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_NumberOfLenders_383c718a-8961-4293-a172-d7ea5c1245cb_terseLabel_en-US" xlink:label="lab_vyne_NumberOfLenders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lenders involved</link:label>
    <link:label id="lab_vyne_NumberOfLenders_label_en-US" xlink:label="lab_vyne_NumberOfLenders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Lenders</link:label>
    <link:label id="lab_vyne_NumberOfLenders_documentation_en-US" xlink:label="lab_vyne_NumberOfLenders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of lenders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_NumberOfLenders" xlink:href="vyne-20211231.xsd#vyne_NumberOfLenders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_NumberOfLenders" xlink:to="lab_vyne_NumberOfLenders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_926dcbd2-6ecb-49b7-934d-c7532b40038d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_bc6b632e-9b7e-404c-b0a2-00ca1bbba84f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a5eedc45-1bb7-4410-82bb-01967eda040c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_bbd1065e-d40a-460b-9825-f470a42e3c26_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e6020cc7-bcde-4fc9-be11-e678a22dc2aa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_RestrictedInvestmentsToSecureLeaseAgreements_c0a389a5-f3ca-43a0-bef7-f2a263fe7b4c_terseLabel_en-US" xlink:label="lab_vyne_RestrictedInvestmentsToSecureLeaseAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lien on marketable securities to secure lease agreements</link:label>
    <link:label id="lab_vyne_RestrictedInvestmentsToSecureLeaseAgreements_label_en-US" xlink:label="lab_vyne_RestrictedInvestmentsToSecureLeaseAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Investments To Secure Lease Agreements</link:label>
    <link:label id="lab_vyne_RestrictedInvestmentsToSecureLeaseAgreements_documentation_en-US" xlink:label="lab_vyne_RestrictedInvestmentsToSecureLeaseAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of lien on marketable securities in respect of bank guarantees granted in order to secure lease agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RestrictedInvestmentsToSecureLeaseAgreements" xlink:href="vyne-20211231.xsd#vyne_RestrictedInvestmentsToSecureLeaseAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_RestrictedInvestmentsToSecureLeaseAgreements" xlink:to="lab_vyne_RestrictedInvestmentsToSecureLeaseAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_f1ec7339-0457-4472-80e7-3ced3d7be5d5_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_PostMergerParentOwnershipByPreMergerParentStockholders_ffa8348e-d810-4da0-befd-441077ec2608_terseLabel_en-US" xlink:label="lab_vyne_PostMergerParentOwnershipByPreMergerParentStockholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage of parent by parent stockholders</link:label>
    <link:label id="lab_vyne_PostMergerParentOwnershipByPreMergerParentStockholders_label_en-US" xlink:label="lab_vyne_PostMergerParentOwnershipByPreMergerParentStockholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post Merger Parent Ownership By Pre Merger Parent Stockholders</link:label>
    <link:label id="lab_vyne_PostMergerParentOwnershipByPreMergerParentStockholders_documentation_en-US" xlink:label="lab_vyne_PostMergerParentOwnershipByPreMergerParentStockholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of post-merger Menlo ownership held by pre-merger Menlo stockholders, as a percent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PostMergerParentOwnershipByPreMergerParentStockholders" xlink:href="vyne-20211231.xsd#vyne_PostMergerParentOwnershipByPreMergerParentStockholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_PostMergerParentOwnershipByPreMergerParentStockholders" xlink:to="lab_vyne_PostMergerParentOwnershipByPreMergerParentStockholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_28543e3f-a9f4-4af8-a2c9-9d56d0f7823f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_1e3c7d0c-ce48-4648-beb5-fba1e47ce8d8_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One-month LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_e0917d20-0208-4088-86bf-8d3bbf300b5f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_89bbceb0-9baf-4f7e-8b0e-c31fdd06bd68_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ab48361d-b325-4328-b495-80ba1fca28d7_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_9ebdfbcd-0b2b-4cfe-8b7f-11f8956e81d8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_26820920-d0d2-40de-b41a-ed7603a27a51_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_998760df-6aa1-42ff-a5dc-3badf32e4d1e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAX</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_eee6e66b-4aa3-40be-b253-a83df96ad707_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and investments</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_b82eba50-9220-4ab3-b56b-7918932187a5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_a864941d-ae63-48f0-8ce1-f3ecc704cd38_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f1712565-4293-4c78-b192-4f762cf49c10_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the number of options outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ebc5d981-2c9c-4969-8327-24e84b8f9c0e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e7647871-dfc4-47db-b445-1480186a3c27_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_07805553-5bc6-4416-abc6-cad30c930969_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions related to expiration of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AllowanceForSalesReturns1Member_20a3ff51-2735-40d4-9c27-d5c4a7925240_terseLabel_en-US" xlink:label="lab_vyne_AllowanceForSalesReturns1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Sales Returns</link:label>
    <link:label id="lab_vyne_AllowanceForSalesReturns1Member_label_en-US" xlink:label="lab_vyne_AllowanceForSalesReturns1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Sales Returns1 [Member]</link:label>
    <link:label id="lab_vyne_AllowanceForSalesReturns1Member_documentation_en-US" xlink:label="lab_vyne_AllowanceForSalesReturns1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance For Sales Returns1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AllowanceForSalesReturns1Member" xlink:href="vyne-20211231.xsd#vyne_AllowanceForSalesReturns1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AllowanceForSalesReturns1Member" xlink:to="lab_vyne_AllowanceForSalesReturns1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c8b23e88-9f65-4659-9f4d-f00f8345e54f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AdditionalSpaceMember_cf5a3ee7-a970-44fc-9b09-ad66a0230d92_terseLabel_en-US" xlink:label="lab_vyne_AdditionalSpaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Space</link:label>
    <link:label id="lab_vyne_AdditionalSpaceMember_label_en-US" xlink:label="lab_vyne_AdditionalSpaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Space [Member]</link:label>
    <link:label id="lab_vyne_AdditionalSpaceMember_documentation_en-US" xlink:label="lab_vyne_AdditionalSpaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertaining to the additional leased facility space.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdditionalSpaceMember" xlink:href="vyne-20211231.xsd#vyne_AdditionalSpaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AdditionalSpaceMember" xlink:to="lab_vyne_AdditionalSpaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_eb7c5830-0088-48e3-8d0b-166e75136d54_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurement</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_bc5574de-e0fc-4afd-b302-49d7425558f1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_17ed1fd5-dabc-4693-a6c1-89f319184f5d_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_d96fb48b-d2dd-4336-9af7-38e036413e3f_terseLabel_en-US" xlink:label="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment</link:label>
    <link:label id="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_label_en-US" xlink:label="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Upfront Payment Amount</link:label>
    <link:label id="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_documentation_en-US" xlink:label="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Upfront Payment Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" xlink:to="lab_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_dfade30c-bd5f-4796-af6e-966eedcce5d3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c1eba16-5dd2-4f3f-9e00-f9d1868ea66a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_72c67817-1e70-472e-a39e-e5a5cffaf63d_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty revenues</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9c91a966-9cd8-4b7c-90eb-c454c4c658be_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_3eca7a67-ce83-4b6d-a8d4-d4bfb33181e2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1a5bf1f5-7f0c-4df0-94d4-8e0337603f55_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating asset and liabilities, net of effects of businesses acquired:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f7571d53-09eb-4df3-9105-af62fd99fc7d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_54c9bed9-10ba-4805-86d2-8e62fa6518c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_7f25c338-0ec5-41c2-a4d7-832ae2e7cd4e_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_a14b3263-09e6-4a09-be29-fc95142bd4ce_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_LincolnParkEquityPurchaseAgreementMember_eb525095-d55d-489c-8793-144f8733f313_terseLabel_en-US" xlink:label="lab_vyne_LincolnParkEquityPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Park Equity Purchase Agreement</link:label>
    <link:label id="lab_vyne_LincolnParkEquityPurchaseAgreementMember_label_en-US" xlink:label="lab_vyne_LincolnParkEquityPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Park Equity Purchase Agreement [Member]</link:label>
    <link:label id="lab_vyne_LincolnParkEquityPurchaseAgreementMember_documentation_en-US" xlink:label="lab_vyne_LincolnParkEquityPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Park Equity Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_LincolnParkEquityPurchaseAgreementMember" xlink:href="vyne-20211231.xsd#vyne_LincolnParkEquityPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_LincolnParkEquityPurchaseAgreementMember" xlink:to="lab_vyne_LincolnParkEquityPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_OperatingLeaseRightOfUseAssetCurrent_314756f2-4b95-44bf-a3d0-93c8f2117233_terseLabel_en-US" xlink:label="lab_vyne_OperatingLeaseRightOfUseAssetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right of use assets (Note 10)</link:label>
    <link:label id="lab_vyne_OperatingLeaseRightOfUseAssetCurrent_0a01bfe1-78da-4684-83ef-d939c3b2d900_verboseLabel_en-US" xlink:label="lab_vyne_OperatingLeaseRightOfUseAssetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, right of use assets, current</link:label>
    <link:label id="lab_vyne_OperatingLeaseRightOfUseAssetCurrent_label_en-US" xlink:label="lab_vyne_OperatingLeaseRightOfUseAssetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right of Use Asset, Current</link:label>
    <link:label id="lab_vyne_OperatingLeaseRightOfUseAssetCurrent_documentation_en-US" xlink:label="lab_vyne_OperatingLeaseRightOfUseAssetCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right of Use Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseRightOfUseAssetCurrent" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseRightOfUseAssetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_OperatingLeaseRightOfUseAssetCurrent" xlink:to="lab_vyne_OperatingLeaseRightOfUseAssetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4f9916fd-3b9f-4aeb-9ce4-f336033c4086_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_92e5897e-02d3-4e45-a65a-6a1e1ccaa5df_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a25e90c1-9b3d-4dc1-90ee-cc0df9292f96_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withholding tax from net exercise of restricted share units</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_57bef6b0-2006-447c-8249-71f8c18b755a_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred expenses related to Credit Agreement and Securities Purchase Agreement</link:label>
    <link:label id="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Financing and Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_80706ebb-be96-4e98-8de9-d866a47c20f2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocations of purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsIncurred_cbca1a3e-65f4-4143-b1eb-562c63fc5601_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsIncurred_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Obligation Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsIncurred" xlink:to="lab_us-gaap_CapitalLeaseObligationsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_524a7fea-427f-4daa-aaea-c2ac43f55ccf_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_112deb7e-9101-44dc-8912-b8ea9e81084e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade payables</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_cf4cddb3-b1d9-4d07-8da7-426230c9b13e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d8edcc62-cd09-4155-8a2c-e09a5c6a7b0c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember_ab912675-b9ca-4d78-88d0-f4b61ddf69ab_terseLabel_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Credit Agreement, Trench 3 Loan</link:label>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember_label_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended And Restated Credit Agreement Trench3 Loan [Member]</link:label>
    <link:label id="lab_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember_documentation_en-US" xlink:label="lab_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents trench 3 loan of the Amended and Restated Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember" xlink:to="lab_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ContingentStockRightSharesConversion_d5ed3551-df76-455f-9456-e6760c4a0361_terseLabel_en-US" xlink:label="lab_vyne_ContingentStockRightSharesConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common stock issued per CSR (in shares)</link:label>
    <link:label id="lab_vyne_ContingentStockRightSharesConversion_label_en-US" xlink:label="lab_vyne_ContingentStockRightSharesConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Stock Right Shares Conversion</link:label>
    <link:label id="lab_vyne_ContingentStockRightSharesConversion_documentation_en-US" xlink:label="lab_vyne_ContingentStockRightSharesConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued per each contingent stock right.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockRightSharesConversion" xlink:href="vyne-20211231.xsd#vyne_ContingentStockRightSharesConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ContingentStockRightSharesConversion" xlink:to="lab_vyne_ContingentStockRightSharesConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_63f0153d-1ca6-4815-a83a-b59b93005875_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in marketable securities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_93ceebb4-8f59-4a4f-9326-25df5be1a360_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_71035335-860e-41bf-8bca-9173ca6ea2aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_f23d7fb9-3339-492d-af67-dd2b97d8ddf3_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4db073f1-cda6-4653-86d8-56dcd40a2733_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_VehicleLeasePrepaymentPeriod_ecb0a4a6-88c3-42a8-9e9b-51244ac753b9_terseLabel_en-US" xlink:label="lab_vyne_VehicleLeasePrepaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles lease prepaid period</link:label>
    <link:label id="lab_vyne_VehicleLeasePrepaymentPeriod_label_en-US" xlink:label="lab_vyne_VehicleLeasePrepaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicle Lease, Prepayment Period</link:label>
    <link:label id="lab_vyne_VehicleLeasePrepaymentPeriod_documentation_en-US" xlink:label="lab_vyne_VehicleLeasePrepaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The period of prepaid to secure lease of vehicles.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_VehicleLeasePrepaymentPeriod" xlink:href="vyne-20211231.xsd#vyne_VehicleLeasePrepaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_VehicleLeasePrepaymentPeriod" xlink:to="lab_vyne_VehicleLeasePrepaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_18f09115-f67f-4942-8afd-c48ccb19812a_terseLabel_en-US" xlink:label="lab_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments receivable upon achievement of net sales</link:label>
    <link:label id="lab_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_label_en-US" xlink:label="lab_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Milestone Payments Receivable Upon Achievement of Net Sales</link:label>
    <link:label id="lab_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_documentation_en-US" xlink:label="lab_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Milestone Payments Receivable Upon Achievement of Net Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales" xlink:to="lab_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bf0af022-d2fb-45d8-8525-263fa80220d5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Newly issued and recently adopted accounting pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_e7362a06-d945-401b-a2ab-e6b1646d97fd_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2446f06c-f902-467f-80fe-960882fbb20d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) in other non-current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_519ecab2-1778-464a-adb7-3e74f322c8ae_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_BusinessCombinationConsiderationTransferredGross_597f03a9-5081-418a-b97d-814b49b3d430_terseLabel_en-US" xlink:label="lab_vyne_BusinessCombinationConsiderationTransferredGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_vyne_BusinessCombinationConsiderationTransferredGross_e573bdf1-817a-41b9-8021-dbee6df9a227_totalLabel_en-US" xlink:label="lab_vyne_BusinessCombinationConsiderationTransferredGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_vyne_BusinessCombinationConsiderationTransferredGross_label_en-US" xlink:label="lab_vyne_BusinessCombinationConsiderationTransferredGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Gross</link:label>
    <link:label id="lab_vyne_BusinessCombinationConsiderationTransferredGross_documentation_en-US" xlink:label="lab_vyne_BusinessCombinationConsiderationTransferredGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer prior to the reduction in respect of the contingent stock rights issued to acquired shareholders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredGross" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_BusinessCombinationConsiderationTransferredGross" xlink:to="lab_vyne_BusinessCombinationConsiderationTransferredGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b33830e1-65dc-4869-8610-7591e018fead_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_PaymentsForLicensingAgreements_842bc7f1-2048-4ff3-87d8-d077545bdebe_terseLabel_en-US" xlink:label="lab_vyne_PaymentsForLicensingAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for licensing agreements</link:label>
    <link:label id="lab_vyne_PaymentsForLicensingAgreements_label_en-US" xlink:label="lab_vyne_PaymentsForLicensingAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Licensing Agreements</link:label>
    <link:label id="lab_vyne_PaymentsForLicensingAgreements_documentation_en-US" xlink:label="lab_vyne_PaymentsForLicensingAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Licensing Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PaymentsForLicensingAgreements" xlink:href="vyne-20211231.xsd#vyne_PaymentsForLicensingAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_PaymentsForLicensingAgreements" xlink:to="lab_vyne_PaymentsForLicensingAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_OperatingLeaseLiabilityTransferred_a6032a9e-8923-4ecb-8110-7f93d6b8e71e_terseLabel_en-US" xlink:label="lab_vyne_OperatingLeaseLiabilityTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use liabilities transferred</link:label>
    <link:label id="lab_vyne_OperatingLeaseLiabilityTransferred_label_en-US" xlink:label="lab_vyne_OperatingLeaseLiabilityTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability Transferred</link:label>
    <link:label id="lab_vyne_OperatingLeaseLiabilityTransferred_documentation_en-US" xlink:label="lab_vyne_OperatingLeaseLiabilityTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liability Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseLiabilityTransferred" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseLiabilityTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_OperatingLeaseLiabilityTransferred" xlink:to="lab_vyne_OperatingLeaseLiabilityTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_49d68baf-ab07-4b08-9733-e5564b132701_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_9afa9d95-3484-4f6f-b0c9-df86e6af6862_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost_4e8e7573-5c38-4d6e-a243-9a1c7cddcb84_terseLabel_en-US" xlink:label="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental compensation costs incurred</link:label>
    <link:label id="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost_label_en-US" xlink:label="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Unrecognized Cost</link:label>
    <link:label id="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost_documentation_en-US" xlink:label="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Unrecognized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost" xlink:to="lab_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_5c8a3daf-09af-4995-acef-c3c3cfda1417_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances_5a4239a4-31ea-429f-a2b8-b7e8a1fc316f_terseLabel_en-US" xlink:label="lab_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales provisions</link:label>
    <link:label id="lab_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances_label_en-US" xlink:label="lab_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition, Distribution, Trade Discounts and Allowances</link:label>
    <link:label id="lab_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances_documentation_en-US" xlink:label="lab_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate of fee the entity pays for distribution services and certain date that distributors provide to the entity and sales discounts given by the entity, including, but not limited to, early payments of accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances" xlink:href="vyne-20211231.xsd#vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances" xlink:to="lab_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_80828522-1497-4852-a2be-0c239545a687_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_f63d68e5-6e71-418b-a156-54548cdebb94_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License revenues</link:label>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_962931a5-6317-4a41-8239-95eaaaa01d42_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_c632a402-e794-4a87-a4f4-20d653c86775_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_04e7afc6-9262-451b-8935-9c55628fe34d_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NATURE OF OPERATIONS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8fa21672-d3d5-4aa0-917e-adb9e82607c9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_5d609ec2-a1a9-4d70-bca5-1703333b18f9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_c4889032-16b5-4087-98ec-ee5c44e76f73_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computers</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseNoncurrent_776ffca2-3f38-4b48-99fd-f6f0db4430c2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_9d542923-89f7-42a1-884a-101384335a07_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_vyne_OriginalSpaceMember_716e0b71-410e-4c02-8470-81d7eff2cfca_terseLabel_en-US" xlink:label="lab_vyne_OriginalSpaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original Space</link:label>
    <link:label id="lab_vyne_OriginalSpaceMember_label_en-US" xlink:label="lab_vyne_OriginalSpaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original Space [Member]</link:label>
    <link:label id="lab_vyne_OriginalSpaceMember_documentation_en-US" xlink:label="lab_vyne_OriginalSpaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertaining to the original leased facility space.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OriginalSpaceMember" xlink:href="vyne-20211231.xsd#vyne_OriginalSpaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_vyne_OriginalSpaceMember" xlink:to="lab_vyne_OriginalSpaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_5900f25e-57a3-4c6d-862d-9c668a291757_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM DEBT</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_2451cc06-1096-4a67-8099-251583bf2754_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount, interest and prepayment premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_9f845b7a-a28a-4210-8c88-c8ac890b9172_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>vyne-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:74e91f80-5033-4690-868f-a2bf4ea38fc3,g:e1fa6db6-9541-4405-a6db-7ba5e60bcb37-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://vynetherapeutics.com/role/Cover" xlink:type="simple" xlink:href="vyne-20211231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4b7bc7f0-edd7-4bbb-a9ec-7b2f272b5def" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_DocumentType_4b7bc7f0-edd7-4bbb-a9ec-7b2f272b5def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_3a507b0a-b96a-4beb-8fd9-ff5866c4ab34" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_DocumentAnnualReport_3a507b0a-b96a-4beb-8fd9-ff5866c4ab34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1381ae97-441a-4d87-b8ef-d3668d01fb67" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_DocumentPeriodEndDate_1381ae97-441a-4d87-b8ef-d3668d01fb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c8d86345-220e-463d-be22-eca24ac99d99" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_CurrentFiscalYearEndDate_c8d86345-220e-463d-be22-eca24ac99d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5d829ff0-1241-40b5-b799-90635ca0dbc2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_DocumentTransitionReport_5d829ff0-1241-40b5-b799-90635ca0dbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c3892244-70e0-4904-8238-ef1bc5d0d106" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityFileNumber_c3892244-70e0-4904-8238-ef1bc5d0d106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2dae52de-7ab4-4fd6-8951-c61bfc011d95" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityRegistrantName_2dae52de-7ab4-4fd6-8951-c61bfc011d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b8576cc0-9a1f-421b-8237-8d6fd1aad204" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b8576cc0-9a1f-421b-8237-8d6fd1aad204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d55777b1-1084-4ba9-a3ce-6cd8664a6b8a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityTaxIdentificationNumber_d55777b1-1084-4ba9-a3ce-6cd8664a6b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_659e8a84-d53e-453f-a9b6-4e23530f1127" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityAddressAddressLine1_659e8a84-d53e-453f-a9b6-4e23530f1127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_fc00f452-1b16-4b21-bcc0-1e5fde4ea605" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityAddressCityOrTown_fc00f452-1b16-4b21-bcc0-1e5fde4ea605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_9a3e40b8-9735-45e8-9682-b50a01d38879" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityAddressStateOrProvince_9a3e40b8-9735-45e8-9682-b50a01d38879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9b9c41bf-3b22-4c5f-8f0d-4ad96fcb75fa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityAddressPostalZipCode_9b9c41bf-3b22-4c5f-8f0d-4ad96fcb75fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6fc9036e-f75e-4778-9fbc-81defc195016" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_CityAreaCode_6fc9036e-f75e-4778-9fbc-81defc195016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_db66a6e2-16bb-4822-8fee-86cbf2e98d6b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_LocalPhoneNumber_db66a6e2-16bb-4822-8fee-86cbf2e98d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_113728e3-f667-41f5-8af3-ee36e6510748" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_Security12bTitle_113728e3-f667-41f5-8af3-ee36e6510748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7c2953b4-c74f-4be0-91e8-f634c9febc4f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_TradingSymbol_7c2953b4-c74f-4be0-91e8-f634c9febc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7d88459f-d17c-4d57-bd93-cf01dc7d0cc1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_SecurityExchangeName_7d88459f-d17c-4d57-bd93-cf01dc7d0cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_a79cd0dd-f828-4811-8bcd-6f7b4a7f7b18" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_a79cd0dd-f828-4811-8bcd-6f7b4a7f7b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_c5c66810-49f4-405a-9747-76d6f4a8c763" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityVoluntaryFilers_c5c66810-49f4-405a-9747-76d6f4a8c763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b4209ec8-36e5-4bda-b7a3-0901a4fa9424" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityCurrentReportingStatus_b4209ec8-36e5-4bda-b7a3-0901a4fa9424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f8302ed0-e17d-4025-afba-16d6547b82ec" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityInteractiveDataCurrent_f8302ed0-e17d-4025-afba-16d6547b82ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_34fd00d4-c1b6-4560-adcc-b6f8bd8c03a1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityFilerCategory_34fd00d4-c1b6-4560-adcc-b6f8bd8c03a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8b1e0e18-c1f2-4d62-81b9-4eacfe77258d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntitySmallBusiness_8b1e0e18-c1f2-4d62-81b9-4eacfe77258d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e3a85570-1e7d-4312-a526-bd40507f316a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityEmergingGrowthCompany_e3a85570-1e7d-4312-a526-bd40507f316a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_7b3c1da1-0185-4166-b852-148e128d4281" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityExTransitionPeriod_7b3c1da1-0185-4166-b852-148e128d4281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_25b0a3c6-6ce2-4edb-8a39-08d8b47c5327" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_IcfrAuditorAttestationFlag_25b0a3c6-6ce2-4edb-8a39-08d8b47c5327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6ec3447b-899f-4026-a37b-62a6e9c3eb4c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityShellCompany_6ec3447b-899f-4026-a37b-62a6e9c3eb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_532cdb15-4d6b-42ef-8d3f-933a9de3f6ab" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityPublicFloat_532cdb15-4d6b-42ef-8d3f-933a9de3f6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_aee07de6-205e-41bb-9883-776a240dfa29" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_aee07de6-205e-41bb-9883-776a240dfa29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a5d27ae2-4ad4-4c57-b4e8-9fd06b739132" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_AmendmentFlag_a5d27ae2-4ad4-4c57-b4e8-9fd06b739132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_66d30bc6-3346-4b2d-b9b3-12f427528650" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_EntityCentralIndexKey_66d30bc6-3346-4b2d-b9b3-12f427528650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_fa0e3da5-1deb-48e5-860d-186d6a4f49ab" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_DocumentFiscalYearFocus_fa0e3da5-1deb-48e5-860d-186d6a4f49ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_600c986d-1199-4441-b9f1-5126cee7cc2f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bcae24e8-0806-4832-b155-3233a62bb754" xlink:to="loc_dei_DocumentFiscalPeriodFocus_600c986d-1199-4441-b9f1-5126cee7cc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/AuditInformation" xlink:type="simple" xlink:href="vyne-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AuditInformationAbstract_c51152c5-a507-4347-b571-11eafa91d542" xlink:href="vyne-20211231.xsd#vyne_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_cdd61a7e-04c1-4b44-947c-787343f598f0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_AuditInformationAbstract_c51152c5-a507-4347-b571-11eafa91d542" xlink:to="loc_dei_AuditorName_cdd61a7e-04c1-4b44-947c-787343f598f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_cda1f860-df84-4de0-ab8a-5a632a6a0ca8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_AuditInformationAbstract_c51152c5-a507-4347-b571-11eafa91d542" xlink:to="loc_dei_AuditorLocation_cda1f860-df84-4de0-ab8a-5a632a6a0ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_f89f4fe0-aecf-441c-9769-36187c331d9b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_AuditInformationAbstract_c51152c5-a507-4347-b571-11eafa91d542" xlink:to="loc_dei_AuditorFirmId_f89f4fe0-aecf-441c-9769-36187c331d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a1c7015d-34f3-41f5-adb4-d52f26d2a587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c1becaad-7d91-4927-9f93-2b595428464a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a1c7015d-34f3-41f5-adb4-d52f26d2a587" xlink:to="loc_us-gaap_AssetsAbstract_c1becaad-7d91-4927-9f93-2b595428464a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d7308308-1936-4821-9599-a4d5096a3fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c1becaad-7d91-4927-9f93-2b595428464a" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d7308308-1936-4821-9599-a4d5096a3fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0f70dbf3-ffa3-46b2-a060-2394b37fa34b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d7308308-1936-4821-9599-a4d5096a3fe8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0f70dbf3-ffa3-46b2-a060-2394b37fa34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_9032e497-2d74-4a5a-b05b-41862f02ca94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d7308308-1936-4821-9599-a4d5096a3fe8" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_9032e497-2d74-4a5a-b05b-41862f02ca94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_96c037e3-a530-4d0e-92b4-d6884fcf9c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d7308308-1936-4821-9599-a4d5096a3fe8" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_96c037e3-a530-4d0e-92b4-d6884fcf9c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f66d1d1c-6567-4fd9-99da-8edac6c202a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d7308308-1936-4821-9599-a4d5096a3fe8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f66d1d1c-6567-4fd9-99da-8edac6c202a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_654af3a9-e609-4a34-8012-bac536c0eb10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d7308308-1936-4821-9599-a4d5096a3fe8" xlink:to="loc_us-gaap_InventoryNet_654af3a9-e609-4a34-8012-bac536c0eb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_335508e7-7d28-4032-8bf1-c82ad785c986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d7308308-1936-4821-9599-a4d5096a3fe8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_335508e7-7d28-4032-8bf1-c82ad785c986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseRightOfUseAssetCurrent_c2216c56-9f66-4c0a-aab4-b34b6aeb6e57" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseRightOfUseAssetCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d7308308-1936-4821-9599-a4d5096a3fe8" xlink:to="loc_vyne_OperatingLeaseRightOfUseAssetCurrent_c2216c56-9f66-4c0a-aab4-b34b6aeb6e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c13d634b-6468-49b7-bf6f-a66e1a505fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d7308308-1936-4821-9599-a4d5096a3fe8" xlink:to="loc_us-gaap_AssetsCurrent_c13d634b-6468-49b7-bf6f-a66e1a505fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_7b56af61-ad68-4699-83f2-618b761b8e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c1becaad-7d91-4927-9f93-2b595428464a" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_7b56af61-ad68-4699-83f2-618b761b8e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f36589bc-7048-4c13-b6f3-cce91ba7408d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7b56af61-ad68-4699-83f2-618b761b8e8d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f36589bc-7048-4c13-b6f3-cce91ba7408d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_035799f6-324e-464a-b5b7-25a1a0694baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7b56af61-ad68-4699-83f2-618b761b8e8d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_035799f6-324e-464a-b5b7-25a1a0694baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_115d0907-de8c-445e-8d7b-cfd48ef727f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7b56af61-ad68-4699-83f2-618b761b8e8d" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_115d0907-de8c-445e-8d7b-cfd48ef727f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_44201df1-91ba-413f-9deb-55edd2f4ca7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7b56af61-ad68-4699-83f2-618b761b8e8d" xlink:to="loc_us-gaap_AssetsNoncurrent_44201df1-91ba-413f-9deb-55edd2f4ca7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0719c27e-086f-4bec-b11a-930f757ab3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c1becaad-7d91-4927-9f93-2b595428464a" xlink:to="loc_us-gaap_Assets_0719c27e-086f-4bec-b11a-930f757ab3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_44b5c652-5313-490b-9d7d-bc48af8c79d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a1c7015d-34f3-41f5-adb4-d52f26d2a587" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_44b5c652-5313-490b-9d7d-bc48af8c79d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_91872122-25db-40f3-80cd-08a6a89a9a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_44b5c652-5313-490b-9d7d-bc48af8c79d3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_91872122-25db-40f3-80cd-08a6a89a9a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_2fa84f86-19df-4273-9add-cf63eb1a2d80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_91872122-25db-40f3-80cd-08a6a89a9a92" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_2fa84f86-19df-4273-9add-cf63eb1a2d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e1c0ee1e-dd43-485f-a696-7d377301bacb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_91872122-25db-40f3-80cd-08a6a89a9a92" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_e1c0ee1e-dd43-485f-a696-7d377301bacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1b42ac6e-b7a8-4cde-b270-c1997a7341db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_91872122-25db-40f3-80cd-08a6a89a9a92" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1b42ac6e-b7a8-4cde-b270-c1997a7341db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_3d789125-f3c2-431b-8bf4-30e4207a83ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_91872122-25db-40f3-80cd-08a6a89a9a92" xlink:to="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_3d789125-f3c2-431b-8bf4-30e4207a83ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_10dafe82-38c1-44dd-b305-0b1ae0a74a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_91872122-25db-40f3-80cd-08a6a89a9a92" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_10dafe82-38c1-44dd-b305-0b1ae0a74a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d79881ac-69f3-479f-be08-c87aaec68248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_91872122-25db-40f3-80cd-08a6a89a9a92" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d79881ac-69f3-479f-be08-c87aaec68248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_77d79a26-7e65-4794-8c87-f24f8c0ca50a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_91872122-25db-40f3-80cd-08a6a89a9a92" xlink:to="loc_us-gaap_LiabilitiesCurrent_77d79a26-7e65-4794-8c87-f24f8c0ca50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_22f39d48-e661-4cdc-9d5c-973541b813e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_44b5c652-5313-490b-9d7d-bc48af8c79d3" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_22f39d48-e661-4cdc-9d5c-973541b813e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_53c17a2d-49ff-49ad-acf0-e442690789a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_22f39d48-e661-4cdc-9d5c-973541b813e2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_53c17a2d-49ff-49ad-acf0-e442690789a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_357e5d3b-e3fe-4fcf-be7d-cc4bcb600dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_22f39d48-e661-4cdc-9d5c-973541b813e2" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_357e5d3b-e3fe-4fcf-be7d-cc4bcb600dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_eed5b2f7-dc5d-4354-acad-0609dd793011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_22f39d48-e661-4cdc-9d5c-973541b813e2" xlink:to="loc_us-gaap_OtherLiabilities_eed5b2f7-dc5d-4354-acad-0609dd793011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_5096a7ae-9a6f-4f6a-9773-6b9629594b73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_22f39d48-e661-4cdc-9d5c-973541b813e2" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_5096a7ae-9a6f-4f6a-9773-6b9629594b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8a8087d2-386d-4dca-9b36-9814b6cf5859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_22f39d48-e661-4cdc-9d5c-973541b813e2" xlink:to="loc_us-gaap_Liabilities_8a8087d2-386d-4dca-9b36-9814b6cf5859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_969287ca-9a57-4a13-8407-4420f24dd41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_44b5c652-5313-490b-9d7d-bc48af8c79d3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_969287ca-9a57-4a13-8407-4420f24dd41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_3e0bc0a9-0c2a-49e2-a991-0245dfbc8708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_44b5c652-5313-490b-9d7d-bc48af8c79d3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_3e0bc0a9-0c2a-49e2-a991-0245dfbc8708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f2045471-f876-4852-8821-227f8fb0e15d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e0bc0a9-0c2a-49e2-a991-0245dfbc8708" xlink:to="loc_us-gaap_PreferredStockValue_f2045471-f876-4852-8821-227f8fb0e15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3ea1ae5f-3a16-4af1-a3ef-153c7f3b2917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e0bc0a9-0c2a-49e2-a991-0245dfbc8708" xlink:to="loc_us-gaap_CommonStockValue_3ea1ae5f-3a16-4af1-a3ef-153c7f3b2917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5bb37b9c-f19f-4162-849b-ee03350ecc20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e0bc0a9-0c2a-49e2-a991-0245dfbc8708" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5bb37b9c-f19f-4162-849b-ee03350ecc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b72dabc3-147c-4bfe-9723-71eae33cf4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e0bc0a9-0c2a-49e2-a991-0245dfbc8708" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b72dabc3-147c-4bfe-9723-71eae33cf4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e3c6885a-026e-4e3f-816c-bb0d31141479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e0bc0a9-0c2a-49e2-a991-0245dfbc8708" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e3c6885a-026e-4e3f-816c-bb0d31141479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_312927b6-5362-42e7-b66f-a66a1cd8a474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_3e0bc0a9-0c2a-49e2-a991-0245dfbc8708" xlink:to="loc_us-gaap_StockholdersEquity_312927b6-5362-42e7-b66f-a66a1cd8a474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_17dcfc9a-3d83-427c-8930-d8b9862727b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_44b5c652-5313-490b-9d7d-bc48af8c79d3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_17dcfc9a-3d83-427c-8930-d8b9862727b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d4b478fb-2f81-48fb-b526-966f4c6474a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4de1415f-6148-4498-a824-98882d1c3403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d4b478fb-2f81-48fb-b526-966f4c6474a2" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4de1415f-6148-4498-a824-98882d1c3403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_11a74696-fd9e-4762-8fa5-4e085af06da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d4b478fb-2f81-48fb-b526-966f4c6474a2" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_11a74696-fd9e-4762-8fa5-4e085af06da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_33e42564-9374-42e3-a272-296f28c95198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d4b478fb-2f81-48fb-b526-966f4c6474a2" xlink:to="loc_us-gaap_PreferredStockSharesIssued_33e42564-9374-42e3-a272-296f28c95198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_11276c8b-43e9-485e-8aad-d6b257ed5945" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d4b478fb-2f81-48fb-b526-966f4c6474a2" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_11276c8b-43e9-485e-8aad-d6b257ed5945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4d4dbebc-407b-4c89-a0e3-575e37cdffd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d4b478fb-2f81-48fb-b526-966f4c6474a2" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4d4dbebc-407b-4c89-a0e3-575e37cdffd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f4a9365f-6eac-4775-830b-2a7de0b1ebc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d4b478fb-2f81-48fb-b526-966f4c6474a2" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f4a9365f-6eac-4775-830b-2a7de0b1ebc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ece2a14e-1926-45e4-aaff-7a56a981889c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d4b478fb-2f81-48fb-b526-966f4c6474a2" xlink:to="loc_us-gaap_CommonStockSharesIssued_ece2a14e-1926-45e4-aaff-7a56a981889c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_06c3b800-d1d5-4b2b-a56a-f7d94a634051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d4b478fb-2f81-48fb-b526-966f4c6474a2" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_06c3b800-d1d5-4b2b-a56a-f7d94a634051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_600fb3d1-721b-4a50-9aaa-7762d687a0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_da76139d-ff06-4626-adfc-c0ba350706ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_600fb3d1-721b-4a50-9aaa-7762d687a0c4" xlink:to="loc_us-gaap_StatementTable_da76139d-ff06-4626-adfc-c0ba350706ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_19d6e41d-0f27-4f55-80e9-ca8cd489dad2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_da76139d-ff06-4626-adfc-c0ba350706ad" xlink:to="loc_srt_ProductOrServiceAxis_19d6e41d-0f27-4f55-80e9-ca8cd489dad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e60fa7b1-d790-44f3-a643-130aaae50bb7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_19d6e41d-0f27-4f55-80e9-ca8cd489dad2" xlink:to="loc_srt_ProductsAndServicesDomain_e60fa7b1-d790-44f3-a643-130aaae50bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_43023f28-3102-49b6-afd2-4aea2efb5c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e60fa7b1-d790-44f3-a643-130aaae50bb7" xlink:to="loc_us-gaap_ProductMember_43023f28-3102-49b6-afd2-4aea2efb5c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_1ce763c7-cd56-4f50-a42c-b4982fbfead7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e60fa7b1-d790-44f3-a643-130aaae50bb7" xlink:to="loc_us-gaap_LicenseMember_1ce763c7-cd56-4f50-a42c-b4982fbfead7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_bc01ae2e-3622-4851-9efe-42b283267ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e60fa7b1-d790-44f3-a643-130aaae50bb7" xlink:to="loc_us-gaap_RoyaltyMember_bc01ae2e-3622-4851-9efe-42b283267ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_da76139d-ff06-4626-adfc-c0ba350706ad" xlink:to="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c04fca64-4d35-4ef9-8d9d-81da48c4ae52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c04fca64-4d35-4ef9-8d9d-81da48c4ae52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4fc15955-34ae-45dc-a605-f0a555198fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4fc15955-34ae-45dc-a605-f0a555198fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5202dd3d-abca-4d40-9761-27b23bbdc716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5202dd3d-abca-4d40-9761-27b23bbdc716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b124b66c-8dae-4f1c-83ed-9b1ba2d6d767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b124b66c-8dae-4f1c-83ed-9b1ba2d6d767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_22f9dea5-f1a9-464d-a709-7d9622b95a64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_22f9dea5-f1a9-464d-a709-7d9622b95a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_169156b0-3e15-4480-8348-b5341fd75752" xlink:href="vyne-20211231.xsd#vyne_ContingentStockConsiderationRemeasurementGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:to="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_169156b0-3e15-4480-8348-b5341fd75752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_aae1e5fa-2540-4d44-8947-4e42095af707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_9339573d-f046-4df5-9521-12ad263bbe8f" xlink:to="loc_us-gaap_CostsAndExpenses_aae1e5fa-2540-4d44-8947-4e42095af707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_11be8e62-581c-44bb-b682-bcb8e779c7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_OperatingIncomeLoss_11be8e62-581c-44bb-b682-bcb8e779c7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3ed58f37-86bd-47f6-b09f-b41adadc4c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_InterestExpense_3ed58f37-86bd-47f6-b09f-b41adadc4c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1e343ff3-38e1-43ce-a52d-13165a9dfd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1e343ff3-38e1-43ce-a52d-13165a9dfd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ae5dce4-e7ca-4e67-acae-29084d7cb7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ae5dce4-e7ca-4e67-acae-29084d7cb7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1a2025e8-a9e4-4d00-9154-9b5813e6c3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1a2025e8-a9e4-4d00-9154-9b5813e6c3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ad65764c-0986-4aab-8830-b5015a9d6f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_NetIncomeLoss_ad65764c-0986-4aab-8830-b5015a9d6f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_49db6493-9531-48f4-b715-75a220d5a54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_EarningsPerShareBasic_49db6493-9531-48f4-b715-75a220d5a54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3c03e5e3-d0e5-4b75-bd0c-154c4f62e7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3c03e5e3-d0e5-4b75-bd0c-154c4f62e7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5679ce64-f99e-41d4-8ac0-12f657d3df65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5679ce64-f99e-41d4-8ac0-12f657d3df65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19957dca-7d3f-4b9f-b89e-d481eed4ed6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0bcc87c8-1ba3-4d24-afb6-4c67ca4b4e6d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19957dca-7d3f-4b9f-b89e-d481eed4ed6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e811252d-9386-4c8b-bd92-037919d9a9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c045eff2-7f55-4b5c-813b-1264c30e3326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e811252d-9386-4c8b-bd92-037919d9a9bc" xlink:to="loc_us-gaap_NetIncomeLoss_c045eff2-7f55-4b5c-813b-1264c30e3326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_0da11672-d600-4f0d-ac39-c33b033711af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e811252d-9386-4c8b-bd92-037919d9a9bc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_0da11672-d600-4f0d-ac39-c33b033711af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_80687a33-37a1-4ed0-ba9b-59757f6a6c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_0da11672-d600-4f0d-ac39-c33b033711af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_80687a33-37a1-4ed0-ba9b-59757f6a6c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_3c6c1f68-a115-4100-9c34-a76ed39baf26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_0da11672-d600-4f0d-ac39-c33b033711af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_3c6c1f68-a115-4100-9c34-a76ed39baf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cfb9249e-e2d6-4fc0-9e6a-7adf8e497fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_0da11672-d600-4f0d-ac39-c33b033711af" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cfb9249e-e2d6-4fc0-9e6a-7adf8e497fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_bcca499d-d4b9-42a7-92e0-ff5585c30bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e811252d-9386-4c8b-bd92-037919d9a9bc" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_bcca499d-d4b9-42a7-92e0-ff5585c30bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a5fc5eab-7d3a-422f-aa56-3e19e3195dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_25015ad3-9d8f-4053-8f45-efec7410d377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a5fc5eab-7d3a-422f-aa56-3e19e3195dea" xlink:to="loc_us-gaap_StatementTable_25015ad3-9d8f-4053-8f45-efec7410d377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9d862982-0c26-4bec-a4f2-59db3194eaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_25015ad3-9d8f-4053-8f45-efec7410d377" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9d862982-0c26-4bec-a4f2-59db3194eaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9d862982-0c26-4bec-a4f2-59db3194eaf3" xlink:to="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c3a701ba-4bd1-4ed6-816e-69f99bd052ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:to="loc_us-gaap_CommonStockMember_c3a701ba-4bd1-4ed6-816e-69f99bd052ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b62319de-441e-4f99-a482-1ce40946b052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b62319de-441e-4f99-a482-1ce40946b052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_316ce236-399e-44d8-a0f3-18f8179f922a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:to="loc_us-gaap_RetainedEarningsMember_316ce236-399e-44d8-a0f3-18f8179f922a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_559032e3-dda6-4955-b7dd-6a111ae49daf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b80acf59-dd45-4638-8587-a75085207b41" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_559032e3-dda6-4955-b7dd-6a111ae49daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2d19bf76-8432-4a52-850e-ed9fcc7c3056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_25015ad3-9d8f-4053-8f45-efec7410d377" xlink:to="loc_us-gaap_StatementLineItems_2d19bf76-8432-4a52-850e-ed9fcc7c3056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2d19bf76-8432-4a52-850e-ed9fcc7c3056" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d731c41c-3d31-4ff9-8114-5011032af421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d731c41c-3d31-4ff9-8114-5011032af421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f2d19aa5-3d8c-496f-a0d4-23c3fedec12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockholdersEquity_f2d19aa5-3d8c-496f-a0d4-23c3fedec12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0cf3e91f-12aa-4f13-a318-4290ba32f15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0cf3e91f-12aa-4f13-a318-4290ba32f15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1605f2cc-0d07-4afb-8075-12aeaf44b983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1605f2cc-0d07-4afb-8075-12aeaf44b983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_01d933c9-a064-44c1-bb09-d4014dd5c027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_01d933c9-a064-44c1-bb09-d4014dd5c027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1844ef37-cd70-4470-acc1-673b42bce4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1844ef37-cd70-4470-acc1-673b42bce4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_60656fab-624a-4f68-b81c-1dd9e69f7797" xlink:href="vyne-20211231.xsd#vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_60656fab-624a-4f68-b81c-1dd9e69f7797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_1c84e093-f717-4d68-84ec-21d88ea7cc69" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_1c84e093-f717-4d68-84ec-21d88ea7cc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fa3091b1-00db-4496-8f26-d03b4751ff90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fa3091b1-00db-4496-8f26-d03b4751ff90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ae018977-e230-47cc-8c88-33e06b8e9f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ae018977-e230-47cc-8c88-33e06b8e9f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_38c1c6c2-2f3e-4357-90bc-e8d2304d885a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_38c1c6c2-2f3e-4357-90bc-e8d2304d885a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e1bcf06c-748c-48cc-8bb4-eaa2a6f7ebeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_e1bcf06c-748c-48cc-8bb4-eaa2a6f7ebeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2ec471a8-d4e8-4ccd-b7d6-bdbfd277a417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2ec471a8-d4e8-4ccd-b7d6-bdbfd277a417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e7b4982e-1cde-4c9b-93a3-a85307cb1062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c7284f41-c1e5-429b-b972-9c6d131c17b3" xlink:to="loc_us-gaap_StockholdersEquity_e7b4982e-1cde-4c9b-93a3-a85307cb1062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ea5b900f-3b45-47a5-a9f7-8eb74ed5a23f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_bad1da52-8ece-4fad-9561-d61db2ed048a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ea5b900f-3b45-47a5-a9f7-8eb74ed5a23f" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_bad1da52-8ece-4fad-9561-d61db2ed048a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="vyne-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8aa949f5-fc3a-439e-9d1e-ad09fa7f6c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8aa949f5-fc3a-439e-9d1e-ad09fa7f6c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_84ab9889-2b09-4d40-949e-a33849d99bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8aa949f5-fc3a-439e-9d1e-ad09fa7f6c10" xlink:to="loc_us-gaap_NetIncomeLoss_84ab9889-2b09-4d40-949e-a33849d99bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2a0f4ad3-0257-488b-9bac-23a75642869e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8aa949f5-fc3a-439e-9d1e-ad09fa7f6c10" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2a0f4ad3-0257-488b-9bac-23a75642869e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b57d91bf-cc73-4b90-a959-741b36ba079d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2a0f4ad3-0257-488b-9bac-23a75642869e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b57d91bf-cc73-4b90-a959-741b36ba079d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_5827ae0e-4254-4004-87e8-eb0022ac98ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2a0f4ad3-0257-488b-9bac-23a75642869e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_5827ae0e-4254-4004-87e8-eb0022ac98ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_b866dd1d-bc50-44f5-b39c-477eec09035e" xlink:href="vyne-20211231.xsd#vyne_ContingentStockConsiderationRemeasurementGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2a0f4ad3-0257-488b-9bac-23a75642869e" xlink:to="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_b866dd1d-bc50-44f5-b39c-477eec09035e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_GainLossOnSaleAndDispositionOfFixedAssets_e867bd11-d0b6-46eb-975e-0cae32f78447" xlink:href="vyne-20211231.xsd#vyne_GainLossOnSaleAndDispositionOfFixedAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2a0f4ad3-0257-488b-9bac-23a75642869e" xlink:to="loc_vyne_GainLossOnSaleAndDispositionOfFixedAssets_e867bd11-d0b6-46eb-975e-0cae32f78447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_c16a31a3-9302-4d3a-a950-a978240a3cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2a0f4ad3-0257-488b-9bac-23a75642869e" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_c16a31a3-9302-4d3a-a950-a978240a3cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_7f4f4ac2-d7e8-4768-827d-8a56bcab8c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2a0f4ad3-0257-488b-9bac-23a75642869e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_7f4f4ac2-d7e8-4768-827d-8a56bcab8c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7c2f004d-c926-4292-8d84-97e020900e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2a0f4ad3-0257-488b-9bac-23a75642869e" xlink:to="loc_us-gaap_ShareBasedCompensation_7c2f004d-c926-4292-8d84-97e020900e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_735455a5-4c83-4b6a-97d1-2be4ae14eb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2a0f4ad3-0257-488b-9bac-23a75642869e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_735455a5-4c83-4b6a-97d1-2be4ae14eb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b45888d4-1063-4a1b-9644-448178865367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8aa949f5-fc3a-439e-9d1e-ad09fa7f6c10" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b45888d4-1063-4a1b-9644-448178865367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6bdbe789-13f1-4112-bfe2-bb24852666a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b45888d4-1063-4a1b-9644-448178865367" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6bdbe789-13f1-4112-bfe2-bb24852666a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a6949268-03be-4656-a99d-f7f9d181a2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b45888d4-1063-4a1b-9644-448178865367" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a6949268-03be-4656-a99d-f7f9d181a2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ad25c986-cfdb-4c46-87fd-657b1e29c96d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b45888d4-1063-4a1b-9644-448178865367" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ad25c986-cfdb-4c46-87fd-657b1e29c96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7c750f55-4f9f-4268-aa62-a3ee4fd30dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b45888d4-1063-4a1b-9644-448178865367" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7c750f55-4f9f-4268-aa62-a3ee4fd30dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_d77a01d2-f4e2-4945-b696-de33f90a44ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b45888d4-1063-4a1b-9644-448178865367" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_d77a01d2-f4e2-4945-b696-de33f90a44ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd0bbf5a-bf58-4a81-a27a-cab992bb00b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8aa949f5-fc3a-439e-9d1e-ad09fa7f6c10" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd0bbf5a-bf58-4a81-a27a-cab992bb00b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_b031a8be-96aa-484a-ac3c-c220fd16ce8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_b031a8be-96aa-484a-ac3c-c220fd16ce8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_32ed7378-2010-47c9-b108-df49ba90439a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_b031a8be-96aa-484a-ac3c-c220fd16ce8b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_32ed7378-2010-47c9-b108-df49ba90439a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_72cba3b0-7891-4da8-b823-8271a4892f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_b031a8be-96aa-484a-ac3c-c220fd16ce8b" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_72cba3b0-7891-4da8-b823-8271a4892f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_a9d88f91-0376-42ab-ab70-5424a1fb5093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_b031a8be-96aa-484a-ac3c-c220fd16ce8b" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_a9d88f91-0376-42ab-ab70-5424a1fb5093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1079e191-de46-485c-8aa3-452ee5b992bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_b031a8be-96aa-484a-ac3c-c220fd16ce8b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1079e191-de46-485c-8aa3-452ee5b992bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_471aa77d-ef56-473c-b849-f1d01c266c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_471aa77d-ef56-473c-b849-f1d01c266c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_3a5236c9-7715-462b-a7d2-b65efdafe58c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_471aa77d-ef56-473c-b849-f1d01c266c0e" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_3a5236c9-7715-462b-a7d2-b65efdafe58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_815a556c-acd4-4530-a35f-3f6b5c8386d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_471aa77d-ef56-473c-b849-f1d01c266c0e" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_815a556c-acd4-4530-a35f-3f6b5c8386d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9d119684-06df-4967-95d9-2549d1e4bc46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_471aa77d-ef56-473c-b849-f1d01c266c0e" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9d119684-06df-4967-95d9-2549d1e4bc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_7dff1d3d-8af6-4fe1-9440-60eee8cc74b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_471aa77d-ef56-473c-b849-f1d01c266c0e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_7dff1d3d-8af6-4fe1-9440-60eee8cc74b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d55ba42-684e-4547-8e40-fd0e4c5b9850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_471aa77d-ef56-473c-b849-f1d01c266c0e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d55ba42-684e-4547-8e40-fd0e4c5b9850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_c483f824-5d73-4b7e-855f-bc61447ee131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_c483f824-5d73-4b7e-855f-bc61447ee131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e3813c6a-b783-4542-b463-ee6b694d74d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e3813c6a-b783-4542-b463-ee6b694d74d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_afb69825-88eb-42b7-a48c-c9956572df90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_afb69825-88eb-42b7-a48c-c9956572df90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e4203324-a9bf-4a8b-a044-1ea3b1d86a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e4203324-a9bf-4a8b-a044-1ea3b1d86a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ab1ab5ae-d68f-4522-8e19-e860faccf634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ab1ab5ae-d68f-4522-8e19-e860faccf634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_815c9a6f-47d3-45d2-96c4-b1896038b709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_815c9a6f-47d3-45d2-96c4-b1896038b709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_41d60383-6e04-43b3-963e-a58775f4a078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_41d60383-6e04-43b3-963e-a58775f4a078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_7893fd21-b132-4bb9-9ec0-78580ffc3fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_7893fd21-b132-4bb9-9ec0-78580ffc3fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_bb2746de-82f7-42ac-9411-164ecef3eb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_7893fd21-b132-4bb9-9ec0-78580ffc3fe8" xlink:to="loc_us-gaap_StockIssued1_bb2746de-82f7-42ac-9411-164ecef3eb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7f9026c2-4c65-4820-ac9c-abebcf72ff00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_7893fd21-b132-4bb9-9ec0-78580ffc3fe8" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7f9026c2-4c65-4820-ac9c-abebcf72ff00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsIncurred_5f95b159-7627-405d-8708-80e6ddb8a204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_7893fd21-b132-4bb9-9ec0-78580ffc3fe8" xlink:to="loc_us-gaap_CapitalLeaseObligationsIncurred_5f95b159-7627-405d-8708-80e6ddb8a204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_1c228045-b107-46cd-96ac-b84cddda9fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_11c3c384-b73e-40e8-a0f5-4f30ebc278c4" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_1c228045-b107-46cd-96ac-b84cddda9fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_InterestReceived_9d109406-dbe3-48b8-b1c1-7e2b1c1ab86b" xlink:href="vyne-20211231.xsd#vyne_InterestReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1c228045-b107-46cd-96ac-b84cddda9fcb" xlink:to="loc_vyne_InterestReceived_9d109406-dbe3-48b8-b1c1-7e2b1c1ab86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_4802216e-c2d5-4d2a-bb73-c1dae5b6add0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1c228045-b107-46cd-96ac-b84cddda9fcb" xlink:to="loc_us-gaap_InterestPaidNet_4802216e-c2d5-4d2a-bb73-c1dae5b6add0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_48590b62-81c9-4163-b8c5-0b8cdaf63ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1c228045-b107-46cd-96ac-b84cddda9fcb" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_48590b62-81c9-4163-b8c5-0b8cdaf63ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_a8b4530c-a1b9-4387-82e0-2bb46e3744b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1c228045-b107-46cd-96ac-b84cddda9fcb" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_a8b4530c-a1b9-4387-82e0-2bb46e3744b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_3199819f-fe96-451b-9975-ff4d156a9cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1c228045-b107-46cd-96ac-b84cddda9fcb" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_3199819f-fe96-451b-9975-ff4d156a9cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_NonCashAcquisitionOfBusinessCashAcquired_d9719e4e-d129-4167-83e5-f93028d30b82" xlink:href="vyne-20211231.xsd#vyne_NonCashAcquisitionOfBusinessCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1c228045-b107-46cd-96ac-b84cddda9fcb" xlink:to="loc_vyne_NonCashAcquisitionOfBusinessCashAcquired_d9719e4e-d129-4167-83e5-f93028d30b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired_af94a31b-a615-40de-aec0-ef24f540cd27" xlink:href="vyne-20211231.xsd#vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1c228045-b107-46cd-96ac-b84cddda9fcb" xlink:to="loc_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired_af94a31b-a615-40de-aec0-ef24f540cd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/NATUREOFOPERATIONS" xlink:type="simple" xlink:href="vyne-20211231.xsd#NATUREOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/NATUREOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf986c4f-ff80-408b-bfa4-6c264ea01281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_648165e3-ea9c-4e4f-8093-ea2be0a32637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cf986c4f-ff80-408b-bfa4-6c264ea01281" xlink:to="loc_us-gaap_NatureOfOperations_648165e3-ea9c-4e4f-8093-ea2be0a32637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#NATUREOFOPERATIONSDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9820d698-44cb-4435-91d9-87dc0179259c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9820d698-44cb-4435-91d9-87dc0179259c" xlink:to="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_389b8b37-bfd7-4147-9515-c3cce345c9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_389b8b37-bfd7-4147-9515-c3cce345c9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a47cc081-fb61-4851-99c5-5e6a076f3711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_389b8b37-bfd7-4147-9515-c3cce345c9f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a47cc081-fb61-4851-99c5-5e6a076f3711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f5b27fc2-08b3-491a-8d61-ff45e2190f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a47cc081-fb61-4851-99c5-5e6a076f3711" xlink:to="loc_us-gaap_SubsequentEventMember_f5b27fc2-08b3-491a-8d61-ff45e2190f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1d2392fb-08d1-4a89-80a7-35642fd5a119" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:to="loc_dei_LegalEntityAxis_1d2392fb-08d1-4a89-80a7-35642fd5a119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_23ba0d24-be1f-403a-bec7-4b727c16adc7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1d2392fb-08d1-4a89-80a7-35642fd5a119" xlink:to="loc_dei_EntityDomain_23ba0d24-be1f-403a-bec7-4b727c16adc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MenloPremergerMember_9e14a477-0ad6-462b-805c-82dcdf20a197" xlink:href="vyne-20211231.xsd#vyne_MenloPremergerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_23ba0d24-be1f-403a-bec7-4b727c16adc7" xlink:to="loc_vyne_MenloPremergerMember_9e14a477-0ad6-462b-805c-82dcdf20a197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_18dcc956-094d-4678-b872-4a2af9ed719f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_18dcc956-094d-4678-b872-4a2af9ed719f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0f44d90e-b376-45ef-b73e-331853d3645f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_18dcc956-094d-4678-b872-4a2af9ed719f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0f44d90e-b376-45ef-b73e-331853d3645f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_98773b9a-cdb4-4f18-a468-c3d68af9ec32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0f44d90e-b376-45ef-b73e-331853d3645f" xlink:to="loc_us-gaap_EmployeeSeveranceMember_98773b9a-cdb4-4f18-a468-c3d68af9ec32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RetentionPaymentsMember_97d6de93-d54b-452b-8dc9-efec2e976651" xlink:href="vyne-20211231.xsd#vyne_RetentionPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0f44d90e-b376-45ef-b73e-331853d3645f" xlink:to="loc_vyne_RetentionPaymentsMember_97d6de93-d54b-452b-8dc9-efec2e976651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_46a2820f-32e7-405c-bc9c-2fe99e60bc96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:to="loc_us-gaap_TypeOfArrangementAxis_46a2820f-32e7-405c-bc9c-2fe99e60bc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a0bc8e2-9d1e-4764-a7cf-872b049dfa49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_46a2820f-32e7-405c-bc9c-2fe99e60bc96" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a0bc8e2-9d1e-4764-a7cf-872b049dfa49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_516cd0fb-2b00-4ab5-82f2-b2351e9975c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a0bc8e2-9d1e-4764-a7cf-872b049dfa49" xlink:to="loc_us-gaap_LicensingAgreementsMember_516cd0fb-2b00-4ab5-82f2-b2351e9975c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_TopicalBETiOptionAgreementMember_5889ee8d-6ce3-4553-85d0-b5864e3c173c" xlink:href="vyne-20211231.xsd#vyne_TopicalBETiOptionAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a0bc8e2-9d1e-4764-a7cf-872b049dfa49" xlink:to="loc_vyne_TopicalBETiOptionAgreementMember_5889ee8d-6ce3-4553-85d0-b5864e3c173c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OralBETiOptionAgreementMember_9e80af27-81f2-401d-b755-a911a68fbefe" xlink:href="vyne-20211231.xsd#vyne_OralBETiOptionAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a0bc8e2-9d1e-4764-a7cf-872b049dfa49" xlink:to="loc_vyne_OralBETiOptionAgreementMember_9e80af27-81f2-401d-b755-a911a68fbefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_7063e25f-ff2e-4680-9c9c-2591bfdd0454" xlink:to="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f737e650-397f-4dcc-be68-a908615f6c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_NumberOfReportableSegments_f737e650-397f-4dcc-be68-a908615f6c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_04c33ace-69e6-4605-be88-b896f9f74864" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_04c33ace-69e6-4605-be88-b896f9f74864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_71fa5b9a-24b2-4fa8-88e1-c4cf4e45e7af" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_71fa5b9a-24b2-4fa8-88e1-c4cf4e45e7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PeriodOfClosingTransaction_00ae7723-3eb7-4bb6-8148-8a092a93df7c" xlink:href="vyne-20211231.xsd#vyne_PeriodOfClosingTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_PeriodOfClosingTransaction_00ae7723-3eb7-4bb6-8148-8a092a93df7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_c3ee8718-7cb2-4225-82b0-f8303f530959" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_c3ee8718-7cb2-4225-82b0-f8303f530959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_ee435213-db33-4fac-a97d-64ebbd03cde8" xlink:href="vyne-20211231.xsd#vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_ee435213-db33-4fac-a97d-64ebbd03cde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PaymentsForLicensingAgreements_ccce4773-b6d5-43e7-a03c-45b87b1f3c4b" xlink:href="vyne-20211231.xsd#vyne_PaymentsForLicensingAgreements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_PaymentsForLicensingAgreements_ccce4773-b6d5-43e7-a03c-45b87b1f3c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum_9d4525b9-8d65-453e-8685-ca05dd84194c" xlink:href="vyne-20211231.xsd#vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum_9d4525b9-8d65-453e-8685-ca05dd84194c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RoyaltyPaymentPercentMaximum_ebc7328c-6377-4327-847a-e6f41de1c069" xlink:href="vyne-20211231.xsd#vyne_RoyaltyPaymentPercentMaximum"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_vyne_RoyaltyPaymentPercentMaximum_ebc7328c-6377-4327-847a-e6f41de1c069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_6f3ab9e2-a4d2-4e6d-a44c-ee40720f97d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_6f3ab9e2-a4d2-4e6d-a44c-ee40720f97d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_915a66ba-a820-4f6d-9c41-6664b9d349b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_RestructuringCharges_915a66ba-a820-4f6d-9c41-6664b9d349b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_b624bd3c-10d1-4250-8d44-91d4426d2065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_b624bd3c-10d1-4250-8d44-91d4426d2065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8dc94f69-0316-4814-86f6-372e9c489745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8dc94f69-0316-4814-86f6-372e9c489745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_60c375e4-764b-481c-8c07-cf3d8ba294d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_60c375e4-764b-481c-8c07-cf3d8ba294d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_79351ce7-2cec-4e2f-8b30-ca9c996a6731" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_NetIncomeLoss_79351ce7-2cec-4e2f-8b30-ca9c996a6731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b2462abd-26b2-4e50-98f2-aa5200ecbe56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b2462abd-26b2-4e50-98f2-aa5200ecbe56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_15408861-2565-4572-a851-cc542d2e04b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_15408861-2565-4572-a851-cc542d2e04b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b0969d59-d5c2-4ce2-a0e3-aab54bf91729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5e632df2-583b-4da1-b97e-85e674c55185" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b0969d59-d5c2-4ce2-a0e3-aab54bf91729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b7272eb9-bed0-44e5-b024-6d9ac9649f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3d63b498-f824-448c-b29a-6a0790ba4f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7272eb9-bed0-44e5-b024-6d9ac9649f9e" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3d63b498-f824-448c-b29a-6a0790ba4f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a7d98d23-8fc1-4a96-a663-1929cad4b69a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a7d98d23-8fc1-4a96-a663-1929cad4b69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_6401b683-8646-467f-9240-5fdf3027d9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_UseOfEstimates_6401b683-8646-467f-9240-5fdf3027d9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_52996f70-e8f9-4735-8417-fb57de9ad5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_52996f70-e8f9-4735-8417-fb57de9ad5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_29ebaa58-43c9-4ef5-9378-ba51f473f37d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_29ebaa58-43c9-4ef5-9378-ba51f473f37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_93b10746-25ad-4353-892a-3dd07a2853a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_93b10746-25ad-4353-892a-3dd07a2853a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_865b0f0a-bf8f-481e-8ee2-2ca20118e571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_865b0f0a-bf8f-481e-8ee2-2ca20118e571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_3ad65fe9-e21e-46a9-88fa-4db5008a9634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_3ad65fe9-e21e-46a9-88fa-4db5008a9634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_bb7a9ee8-19bf-43e3-9189-aaae4df23d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_bb7a9ee8-19bf-43e3-9189-aaae4df23d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_03fe62f1-43a6-46d3-905e-a97aa2adeb33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_03fe62f1-43a6-46d3-905e-a97aa2adeb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_adcd8821-d245-4d9b-ab16-2f36c9af552d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_adcd8821-d245-4d9b-ab16-2f36c9af552d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_153cd325-b7a4-499c-af91-7aefcc03be0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_153cd325-b7a4-499c-af91-7aefcc03be0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_7a65d46a-aac6-488b-8aa3-55b1de0451f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_7a65d46a-aac6-488b-8aa3-55b1de0451f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_b6d5ddd6-ff3f-443a-ab9b-9ce302e10fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_DebtPolicyTextBlock_b6d5ddd6-ff3f-443a-ab9b-9ce302e10fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_4e408a1a-d678-4097-a9ac-a5c03a0cd3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_4e408a1a-d678-4097-a9ac-a5c03a0cd3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0f440263-a9a7-435d-8d1e-ee2058b469e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0f440263-a9a7-435d-8d1e-ee2058b469e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8a3c0fed-cbcd-47f6-b23a-553a1968ccd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8a3c0fed-cbcd-47f6-b23a-553a1968ccd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_09b36cbe-5904-48bb-aa24-50a84fb6d089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_09b36cbe-5904-48bb-aa24-50a84fb6d089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_4f38c6c2-c70a-40f6-8a21-142bca72d84d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_4f38c6c2-c70a-40f6-8a21-142bca72d84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_afbbf731-d390-40c4-aca9-f33569c1f85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_afbbf731-d390-40c4-aca9-f33569c1f85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_a56b5698-c785-4c41-a628-1f5b42d3046e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_a56b5698-c785-4c41-a628-1f5b42d3046e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_5689e3ee-2f4c-4b7e-84eb-e9438547130b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_5689e3ee-2f4c-4b7e-84eb-e9438547130b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_107a5a5b-31b8-4aa3-a007-c90742b0f399" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_107a5a5b-31b8-4aa3-a007-c90742b0f399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_8a7d38cc-81c4-4cba-86dd-4348877456ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_8a7d38cc-81c4-4cba-86dd-4348877456ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fa7e0da2-33de-48c9-928a-2b12a42b7727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b97cfeef-ecc7-4445-9c27-5b0b471f5654" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fa7e0da2-33de-48c9-928a-2b12a42b7727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e6cf55a2-e725-4efa-9a24-7bbbe0c28859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_297771bb-b07b-47d2-a295-ddbb19fa873c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e6cf55a2-e725-4efa-9a24-7bbbe0c28859" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_297771bb-b07b-47d2-a295-ddbb19fa873c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_33d75cdb-ce9b-4985-a401-fc5e1bd74aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e6cf55a2-e725-4efa-9a24-7bbbe0c28859" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_33d75cdb-ce9b-4985-a401-fc5e1bd74aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1ec48d50-dbee-40fc-94e4-3e93021d264e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1ec48d50-dbee-40fc-94e4-3e93021d264e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d61b7466-a606-4c0c-b1a0-5f5916a5eb6e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:to="loc_srt_RangeAxis_d61b7466-a606-4c0c-b1a0-5f5916a5eb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_14cbd6ba-3a64-4dfc-a2f5-4e4f08e95a7f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d61b7466-a606-4c0c-b1a0-5f5916a5eb6e" xlink:to="loc_srt_RangeMember_14cbd6ba-3a64-4dfc-a2f5-4e4f08e95a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2761dd7b-4284-4431-85d0-6eb6cc7320f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_14cbd6ba-3a64-4dfc-a2f5-4e4f08e95a7f" xlink:to="loc_srt_MinimumMember_2761dd7b-4284-4431-85d0-6eb6cc7320f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_66d7f3a9-ed55-431d-95fb-a3ac38d83111" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_14cbd6ba-3a64-4dfc-a2f5-4e4f08e95a7f" xlink:to="loc_srt_MaximumMember_66d7f3a9-ed55-431d-95fb-a3ac38d83111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3a3b9271-f861-4753-8c24-d3136c44e1a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:to="loc_dei_LegalEntityAxis_3a3b9271-f861-4753-8c24-d3136c44e1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f6accf03-1940-4eac-b2b8-712850eba537" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3a3b9271-f861-4753-8c24-d3136c44e1a6" xlink:to="loc_dei_EntityDomain_f6accf03-1940-4eac-b2b8-712850eba537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_77daf66b-db78-4ad4-ac2b-986c441de3c9" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_f6accf03-1940-4eac-b2b8-712850eba537" xlink:to="loc_vyne_FoamixMember_77daf66b-db78-4ad4-ac2b-986c441de3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_50402000-6c9e-473a-9dfe-36b0eb034ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_50402000-6c9e-473a-9dfe-36b0eb034ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_421d1338-fc8a-42fe-ad43-1b2654aa3c59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_50402000-6c9e-473a-9dfe-36b0eb034ac9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_421d1338-fc8a-42fe-ad43-1b2654aa3c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_e5ccbefc-805f-4492-8d6a-816e94f2898f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_421d1338-fc8a-42fe-ad43-1b2654aa3c59" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_e5ccbefc-805f-4492-8d6a-816e94f2898f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_10c68fbc-f8f7-48a8-9ff7-9204a236712e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_001768ff-5250-493c-b21c-1d82feec5d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_001768ff-5250-493c-b21c-1d82feec5d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e680e757-a86b-4e29-b178-f75a15356bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e680e757-a86b-4e29-b178-f75a15356bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cb7050ab-6428-469c-8ebc-48e894280f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cb7050ab-6428-469c-8ebc-48e894280f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_811b753f-bfb0-4280-a27e-6682fda742ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_811b753f-bfb0-4280-a27e-6682fda742ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_22140408-7d0c-4f3b-b463-28fe56b55de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5753f5d4-15e3-4db0-920d-e09bd7affa4d" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_22140408-7d0c-4f3b-b463-28fe56b55de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_70a9211f-e499-4cf0-9c4b-abe1babb31aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b891941-4c55-4b93-82a2-fbefe96fb3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_70a9211f-e499-4cf0-9c4b-abe1babb31aa" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b891941-4c55-4b93-82a2-fbefe96fb3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f82be658-1fe6-4a97-a80c-5720c5a7e5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b891941-4c55-4b93-82a2-fbefe96fb3f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f82be658-1fe6-4a97-a80c-5720c5a7e5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35513651-61b6-4275-a3b8-b0aa3f38b249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f82be658-1fe6-4a97-a80c-5720c5a7e5f7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35513651-61b6-4275-a3b8-b0aa3f38b249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_d7c61938-04bd-48ef-8a39-4ca8061108ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35513651-61b6-4275-a3b8-b0aa3f38b249" xlink:to="loc_us-gaap_ComputerEquipmentMember_d7c61938-04bd-48ef-8a39-4ca8061108ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_387575bb-874a-4198-9b15-160163ac0a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35513651-61b6-4275-a3b8-b0aa3f38b249" xlink:to="loc_us-gaap_EquipmentMember_387575bb-874a-4198-9b15-160163ac0a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_58175a85-9545-4bd7-a75f-c9278bb9b249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_35513651-61b6-4275-a3b8-b0aa3f38b249" xlink:to="loc_us-gaap_OfficeEquipmentMember_58175a85-9545-4bd7-a75f-c9278bb9b249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5fc3b896-02e6-48af-8518-5ddd643063ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b891941-4c55-4b93-82a2-fbefe96fb3f5" xlink:to="loc_srt_RangeAxis_5fc3b896-02e6-48af-8518-5ddd643063ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_25dd4514-b9ee-4b6d-b8af-ca2f41e04db7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5fc3b896-02e6-48af-8518-5ddd643063ba" xlink:to="loc_srt_RangeMember_25dd4514-b9ee-4b6d-b8af-ca2f41e04db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bfaa9099-d5c2-4c79-a97e-82afd190f477" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_25dd4514-b9ee-4b6d-b8af-ca2f41e04db7" xlink:to="loc_srt_MinimumMember_bfaa9099-d5c2-4c79-a97e-82afd190f477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9fb85ba9-0cad-4d80-8a5b-520b37a27bcf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_25dd4514-b9ee-4b6d-b8af-ca2f41e04db7" xlink:to="loc_srt_MaximumMember_9fb85ba9-0cad-4d80-8a5b-520b37a27bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ee22934a-9a75-4330-bc04-220283d1e1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b891941-4c55-4b93-82a2-fbefe96fb3f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ee22934a-9a75-4330-bc04-220283d1e1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_6853f780-8ef8-4575-8fee-04b41e5c6b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ee22934a-9a75-4330-bc04-220283d1e1d6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_6853f780-8ef8-4575-8fee-04b41e5c6b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3eb2a64e-4136-418b-9c7e-4bcabd5a3aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6bc58940-5579-4a5f-b419-c5f9f118c5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3eb2a64e-4136-418b-9c7e-4bcabd5a3aed" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6bc58940-5579-4a5f-b419-c5f9f118c5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_bf176cfd-cf5d-44b0-b50a-a477432b174f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6bc58940-5579-4a5f-b419-c5f9f118c5b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_bf176cfd-cf5d-44b0-b50a-a477432b174f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_04d34eb8-638c-4d42-b8f7-a9400719a247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_bf176cfd-cf5d-44b0-b50a-a477432b174f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_04d34eb8-638c-4d42-b8f7-a9400719a247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember_733f5ee2-0328-4c8e-b10d-fd08ffa5be1b" xlink:href="vyne-20211231.xsd#vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_04d34eb8-638c-4d42-b8f7-a9400719a247" xlink:to="loc_vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember_733f5ee2-0328-4c8e-b10d-fd08ffa5be1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_2961c6b9-375e-4b42-a1e1-c0490e47238d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_04d34eb8-638c-4d42-b8f7-a9400719a247" xlink:to="loc_us-gaap_WarrantMember_2961c6b9-375e-4b42-a1e1-c0490e47238d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_becd46fe-b97b-48e1-b7a0-bd2197725012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6bc58940-5579-4a5f-b419-c5f9f118c5b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_becd46fe-b97b-48e1-b7a0-bd2197725012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_501ea3b6-9254-4351-a433-b811af003c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_becd46fe-b97b-48e1-b7a0-bd2197725012" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_501ea3b6-9254-4351-a433-b811af003c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c93eec24-63c9-4b1d-be9a-146a4b0c938c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueConcentrationOfRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c93eec24-63c9-4b1d-be9a-146a4b0c938c" xlink:to="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ccee48fb-34ad-4497-91a3-bb8089cf394e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ccee48fb-34ad-4497-91a3-bb8089cf394e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bf0d8f1-bb6d-4332-b105-7fa68e85d6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ccee48fb-34ad-4497-91a3-bb8089cf394e" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bf0d8f1-bb6d-4332-b105-7fa68e85d6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_59420857-e266-4d94-a8f6-ed0f03c92c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bf0d8f1-bb6d-4332-b105-7fa68e85d6b9" xlink:to="loc_us-gaap_SalesRevenueNetMember_59420857-e266-4d94-a8f6-ed0f03c92c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_46059c8f-0abd-46a4-a901-45c52bb3fe06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7bf0d8f1-bb6d-4332-b105-7fa68e85d6b9" xlink:to="loc_us-gaap_AccountsReceivableMember_46059c8f-0abd-46a4-a901-45c52bb3fe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d2de0e00-6fae-4f52-b4b1-064dd77fd67d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d2de0e00-6fae-4f52-b4b1-064dd77fd67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f100d51c-56b2-4e0b-b84b-03de51bc82c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d2de0e00-6fae-4f52-b4b1-064dd77fd67d" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f100d51c-56b2-4e0b-b84b-03de51bc82c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_689d3ad3-b955-442b-96f6-a83cc030b110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f100d51c-56b2-4e0b-b84b-03de51bc82c7" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_689d3ad3-b955-442b-96f6-a83cc030b110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_71928daa-bd03-40d8-b53f-d2b9276e5e83" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:to="loc_srt_MajorCustomersAxis_71928daa-bd03-40d8-b53f-d2b9276e5e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3e13b061-7977-458c-8eb1-442520039d63" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_71928daa-bd03-40d8-b53f-d2b9276e5e83" xlink:to="loc_srt_NameOfMajorCustomerDomain_3e13b061-7977-458c-8eb1-442520039d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ThreeLargestCustomersMember_65bea331-2a20-4f92-8a35-5080de4e7bdc" xlink:href="vyne-20211231.xsd#vyne_ThreeLargestCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3e13b061-7977-458c-8eb1-442520039d63" xlink:to="loc_vyne_ThreeLargestCustomersMember_65bea331-2a20-4f92-8a35-5080de4e7bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_e2f0535a-73a8-429b-b73d-c4e2d5feb681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_89e24623-11f2-4022-985c-c418a5062228" xlink:to="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_e2f0535a-73a8-429b-b73d-c4e2d5feb681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b70516e1-e004-49be-9e10-09ad41546598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_e2f0535a-73a8-429b-b73d-c4e2d5feb681" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b70516e1-e004-49be-9e10-09ad41546598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATION" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATION"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3e32ac65-5a59-4ddb-a4b5-47c678e32f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8f370b96-83a4-4703-a6fe-15bab7dae90b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3e32ac65-5a59-4ddb-a4b5-47c678e32f77" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8f370b96-83a4-4703-a6fe-15bab7dae90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONTables" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONTables"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a2925d47-a125-4cd0-b5e1-d42ddcfb001b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock_2879f431-1235-466a-8509-40bdaecae4f7" xlink:href="vyne-20211231.xsd#vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a2925d47-a125-4cd0-b5e1-d42ddcfb001b" xlink:to="loc_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock_2879f431-1235-466a-8509-40bdaecae4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_2f7aa30e-7ea7-4964-9aec-f4a2f46b3f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a2925d47-a125-4cd0-b5e1-d42ddcfb001b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_2f7aa30e-7ea7-4964-9aec-f4a2f46b3f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock_e302e4d3-40e3-45bd-8659-52f38e672023" xlink:href="vyne-20211231.xsd#vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a2925d47-a125-4cd0-b5e1-d42ddcfb001b" xlink:to="loc_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock_e302e4d3-40e3-45bd-8659-52f38e672023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock_a291728f-3753-4fbe-8869-3f3551aa0336" xlink:href="vyne-20211231.xsd#vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a2925d47-a125-4cd0-b5e1-d42ddcfb001b" xlink:to="loc_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock_a291728f-3753-4fbe-8869-3f3551aa0336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_c9ebb729-dd6a-4363-8f03-197f587380b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a2925d47-a125-4cd0-b5e1-d42ddcfb001b" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_c9ebb729-dd6a-4363-8f03-197f587380b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_51414cfc-1ac0-4e8e-ab92-5db28076db66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_51414cfc-1ac0-4e8e-ab92-5db28076db66" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ff7a1092-752a-4d1f-bd75-7cd854fc43bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ff7a1092-752a-4d1f-bd75-7cd854fc43bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0240dc0d-1509-4d58-bad8-b85117d6a132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ff7a1092-752a-4d1f-bd75-7cd854fc43bf" xlink:to="loc_us-gaap_EquityComponentDomain_0240dc0d-1509-4d58-bad8-b85117d6a132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6d58f985-637a-4e85-a98d-4dc821c2bbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0240dc0d-1509-4d58-bad8-b85117d6a132" xlink:to="loc_us-gaap_CommonStockMember_6d58f985-637a-4e85-a98d-4dc821c2bbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_94b51a2f-e185-496d-9164-5eba7b865069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_94b51a2f-e185-496d-9164-5eba7b865069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2bc195f-4774-445a-be74-d921521b4561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_94b51a2f-e185-496d-9164-5eba7b865069" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2bc195f-4774-445a-be74-d921521b4561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_ccb238cc-ff54-4b03-8c8e-ab9ff6fc3403" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2bc195f-4774-445a-be74-d921521b4561" xlink:to="loc_vyne_FoamixMember_ccb238cc-ff54-4b03-8c8e-ab9ff6fc3403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3f507580-c55e-434d-9abc-00901b8843bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3f507580-c55e-434d-9abc-00901b8843bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1ef5749d-eda2-4b8b-8568-81c7407df2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3f507580-c55e-434d-9abc-00901b8843bf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1ef5749d-eda2-4b8b-8568-81c7407df2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3395a1d0-9272-4a29-86d7-47bc4c46bb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1ef5749d-eda2-4b8b-8568-81c7407df2ed" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3395a1d0-9272-4a29-86d7-47bc4c46bb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_89e9999f-1365-424c-8518-f2bb071aa43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_89e9999f-1365-424c-8518-f2bb071aa43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_9134c692-fa16-49da-9f6d-69a7af79abd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_89e9999f-1365-424c-8518-f2bb071aa43f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_9134c692-fa16-49da-9f6d-69a7af79abd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_58c67547-eff5-4ed1-b6b6-10c63f6d03f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_9134c692-fa16-49da-9f6d-69a7af79abd7" xlink:to="loc_us-gaap_EmployeeSeveranceMember_58c67547-eff5-4ed1-b6b6-10c63f6d03f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9b33fb7-758b-41bb-9580-36793572ba41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9b33fb7-758b-41bb-9580-36793572ba41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f42eacfa-e4e3-4e51-852e-86609888761a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9b33fb7-758b-41bb-9580-36793572ba41" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f42eacfa-e4e3-4e51-852e-86609888761a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_87d0c1aa-9524-41b0-ab32-c53e189f4c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f42eacfa-e4e3-4e51-852e-86609888761a" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_87d0c1aa-9524-41b0-ab32-c53e189f4c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_14bb38f9-eafc-492d-ae76-d9dd4ddf51a7" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ExchangeRatio_4b1f263d-30c8-4b7c-9f71-7e6f7b2b364a" xlink:href="vyne-20211231.xsd#vyne_ExchangeRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_ExchangeRatio_4b1f263d-30c8-4b7c-9f71-7e6f7b2b364a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessAcquisitionContingentStockRightIssued_80d4db30-316d-49b2-9091-38894552cbcb" xlink:href="vyne-20211231.xsd#vyne_BusinessAcquisitionContingentStockRightIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessAcquisitionContingentStockRightIssued_80d4db30-316d-49b2-9091-38894552cbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockRightSharesConversion_c9a2251d-e027-4d16-a19f-61e16db7a55d" xlink:href="vyne-20211231.xsd#vyne_ContingentStockRightSharesConversion"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_ContingentStockRightSharesConversion_c9a2251d-e027-4d16-a19f-61e16db7a55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationEffectiveExchangeRatio_1c5e388b-0a7a-4608-927c-d547b184ecb5" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationEffectiveExchangeRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessCombinationEffectiveExchangeRatio_1c5e388b-0a7a-4608-927c-d547b184ecb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_987e7b7a-c515-420b-9598-7a976f72651a" xlink:href="vyne-20211231.xsd#vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_987e7b7a-c515-420b-9598-7a976f72651a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders_d2c8f3d2-f76f-4404-b363-251f3be7293c" xlink:href="vyne-20211231.xsd#vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders_d2c8f3d2-f76f-4404-b363-251f3be7293c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PostMergerParentOwnershipByPreMergerParentStockholders_6a440948-b80d-4bb7-a590-b96d4d620fad" xlink:href="vyne-20211231.xsd#vyne_PostMergerParentOwnershipByPreMergerParentStockholders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_PostMergerParentOwnershipByPreMergerParentStockholders_6a440948-b80d-4bb7-a590-b96d4d620fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4514b5cd-48da-4111-9483-7a2facdf0ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4514b5cd-48da-4111-9483-7a2facdf0ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_90c9490f-20f9-4a9f-bc84-80b1cef11bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_SharePrice_90c9490f-20f9-4a9f-bc84-80b1cef11bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredGross_fb197f59-ad52-400d-8603-e3d7134fc09b" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessCombinationConsiderationTransferredGross_fb197f59-ad52-400d-8603-e3d7134fc09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_7a1c6973-ea68-4471-82b0-3b207cf5b685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_7a1c6973-ea68-4471-82b0-3b207cf5b685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes_677ab91a-3d80-400e-be60-d028477f064b" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes_677ab91a-3d80-400e-be60-d028477f064b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_71ac9884-0866-4bf8-b871-e8fc57f7f462" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_71ac9884-0866-4bf8-b871-e8fc57f7f462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_182e91da-6ddf-44bb-806c-ff3d56384163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_182e91da-6ddf-44bb-806c-ff3d56384163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_64fdba3c-eb3f-4827-92ae-9f63b53007cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_64fdba3c-eb3f-4827-92ae-9f63b53007cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_aeca843c-fb54-4567-a36d-8be6d48cc7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_aeca843c-fb54-4567-a36d-8be6d48cc7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_143ac37f-6a85-4f10-8a52-c65d7c9aeebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_143ac37f-6a85-4f10-8a52-c65d7c9aeebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_60cdcce9-c950-4dea-bad3-c4054fda2f37" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_60cdcce9-c950-4dea-bad3-c4054fda2f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_e47b38e3-6cc5-40ad-9d59-54dca938d868" xlink:href="vyne-20211231.xsd#vyne_ContingentStockConsiderationRemeasurementGainLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_vyne_ContingentStockConsiderationRemeasurementGainLoss_e47b38e3-6cc5-40ad-9d59-54dca938d868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2ed679ac-9d30-4350-bad5-77a51edf5b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e7ac9790-d8bc-40fe-89d2-6f424e97bf58" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2ed679ac-9d30-4350-bad5-77a51edf5b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f48607a2-68ca-44be-ab74-1b2b0da7882a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c1dc7b13-ba8a-4289-9f58-7c3b004cf1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f48607a2-68ca-44be-ab74-1b2b0da7882a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c1dc7b13-ba8a-4289-9f58-7c3b004cf1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e89f4c26-ccba-4866-9dc7-4ef0daf00c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c1dc7b13-ba8a-4289-9f58-7c3b004cf1b1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e89f4c26-ccba-4866-9dc7-4ef0daf00c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6223ad9-589e-4198-8599-da7f74df3e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e89f4c26-ccba-4866-9dc7-4ef0daf00c57" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6223ad9-589e-4198-8599-da7f74df3e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_bb69752c-ef15-4039-8793-41fde149fb64" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6223ad9-589e-4198-8599-da7f74df3e25" xlink:to="loc_vyne_FoamixMember_bb69752c-ef15-4039-8793-41fde149fb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c1dc7b13-ba8a-4289-9f58-7c3b004cf1b1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0ec6f3b8-7f1f-43bf-99bd-5c71bff3f386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_0ec6f3b8-7f1f-43bf-99bd-5c71bff3f386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_397519cd-ead2-496e-9fc0-558929578cff" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards_397519cd-ead2-496e-9fc0-558929578cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationConsiderationTransferredGross_67002b8c-c7e4-4b65-a3b2-38a891b102e4" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationConsiderationTransferredGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_vyne_BusinessCombinationConsiderationTransferredGross_67002b8c-c7e4-4b65-a3b2-38a891b102e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_73d16fd9-4add-4794-aa66-b605023fc4d2" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_73d16fd9-4add-4794-aa66-b605023fc4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_769d10ee-8499-41c5-8161-b993a3fffd91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f6a83cca-8860-4555-9b71-1795a29da5a4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_769d10ee-8499-41c5-8161-b993a3fffd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_45627ccf-629b-43ed-8aa4-df310f1165de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_433279a9-7eef-444b-adce-a9dee3d731c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_45627ccf-629b-43ed-8aa4-df310f1165de" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_433279a9-7eef-444b-adce-a9dee3d731c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1cacd006-20d3-4ce6-a4d6-222b5b202e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_433279a9-7eef-444b-adce-a9dee3d731c6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1cacd006-20d3-4ce6-a4d6-222b5b202e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3442f0b1-1596-4985-a07d-a8053d1df1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1cacd006-20d3-4ce6-a4d6-222b5b202e32" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3442f0b1-1596-4985-a07d-a8053d1df1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_b9e7a466-5309-4992-ba63-44e82ddcd62a" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3442f0b1-1596-4985-a07d-a8053d1df1aa" xlink:to="loc_vyne_FoamixMember_b9e7a466-5309-4992-ba63-44e82ddcd62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_906369aa-0d53-4934-bbe0-9c78800a8451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_433279a9-7eef-444b-adce-a9dee3d731c6" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_906369aa-0d53-4934-bbe0-9c78800a8451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_906369aa-0d53-4934-bbe0-9c78800a8451" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bba5f177-5d06-497e-b6f0-ee15ebf00fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bba5f177-5d06-497e-b6f0-ee15ebf00fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_939d6258-35b5-413b-a706-0c9aa7f6caee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_939d6258-35b5-413b-a706-0c9aa7f6caee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_cfd281a4-836b-470b-ab9d-235b9409e34d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_cfd281a4-836b-470b-ab9d-235b9409e34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_67220aa9-7a7c-4f94-abf6-a2872d14860c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_67220aa9-7a7c-4f94-abf6-a2872d14860c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7e87b035-b4f8-4042-b6f6-8531dec97948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_Goodwill_7e87b035-b4f8-4042-b6f6-8531dec97948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c5a4e578-12c0-454b-8ae4-fa8ddb918561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c5a4e578-12c0-454b-8ae4-fa8ddb918561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_cf0d394b-4caf-46eb-8e2e-c8ad68e2eecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_cf0d394b-4caf-46eb-8e2e-c8ad68e2eecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cae5e728-1045-410a-acf8-12d58f7c8bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cae5e728-1045-410a-acf8-12d58f7c8bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3d4aceeb-e7e3-4080-9057-7010548a326c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3d4aceeb-e7e3-4080-9057-7010548a326c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_f4a2d811-5dbd-46a9-a4ad-bf06da940b78" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_f21e1bfa-1fc7-487b-b37a-494d02318c3e" xlink:to="loc_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock_f4a2d811-5dbd-46a9-a4ad-bf06da940b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONGoodwillDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ec9c3168-1bb1-47a7-a51c-f2e4023beb84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d9ca7f4d-d49a-43f9-8364-da63b5e7b5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ec9c3168-1bb1-47a7-a51c-f2e4023beb84" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d9ca7f4d-d49a-43f9-8364-da63b5e7b5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_74d5ef6b-97f6-432d-8380-2184af33b125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d9ca7f4d-d49a-43f9-8364-da63b5e7b5b0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_74d5ef6b-97f6-432d-8380-2184af33b125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b324f49-481c-4443-8003-73a77da6f9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_74d5ef6b-97f6-432d-8380-2184af33b125" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b324f49-481c-4443-8003-73a77da6f9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_ab8919a0-e62e-42ff-b99b-5603b0c87b92" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b324f49-481c-4443-8003-73a77da6f9ff" xlink:to="loc_vyne_FoamixMember_ab8919a0-e62e-42ff-b99b-5603b0c87b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9cbfbff8-7516-4fa8-9941-1e4c04defb27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d9ca7f4d-d49a-43f9-8364-da63b5e7b5b0" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9cbfbff8-7516-4fa8-9941-1e4c04defb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationGoodwillAbstract_936fbfbf-6bae-497d-a79d-0458069a1372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9cbfbff8-7516-4fa8-9941-1e4c04defb27" xlink:to="loc_us-gaap_BusinessCombinationGoodwillAbstract_936fbfbf-6bae-497d-a79d-0458069a1372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8824d7df-d5ae-4014-acfa-6a94fb807f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationGoodwillAbstract_936fbfbf-6bae-497d-a79d-0458069a1372" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_8824d7df-d5ae-4014-acfa-6a94fb807f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets_40aa1c05-474a-48e4-b20a-d5729e516649" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationGoodwillAbstract_936fbfbf-6bae-497d-a79d-0458069a1372" xlink:to="loc_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets_40aa1c05-474a-48e4-b20a-d5729e516649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cf2d00ee-ced8-4a75-a346-c79f0db760f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationGoodwillAbstract_936fbfbf-6bae-497d-a79d-0458069a1372" xlink:to="loc_us-gaap_Goodwill_cf2d00ee-ced8-4a75-a346-c79f0db760f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONIPRDandCSRDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6c4dd01e-34d5-4dfb-a037-efe1afa567a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a491d65-41bd-41dc-b932-11bde430b4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6c4dd01e-34d5-4dfb-a037-efe1afa567a6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a491d65-41bd-41dc-b932-11bde430b4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_91648958-cb87-4077-98ea-9b463f342734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a491d65-41bd-41dc-b932-11bde430b4e5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_91648958-cb87-4077-98ea-9b463f342734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4d62094-d0ef-4e86-9527-10a386aa8a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_91648958-cb87-4077-98ea-9b463f342734" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4d62094-d0ef-4e86-9527-10a386aa8a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_7aae7a55-22f4-4241-9f41-0dd764c21848" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b4d62094-d0ef-4e86-9527-10a386aa8a1f" xlink:to="loc_vyne_FoamixMember_7aae7a55-22f4-4241-9f41-0dd764c21848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ddd4e459-da9c-43be-90a8-a1ccab0134f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a491d65-41bd-41dc-b932-11bde430b4e5" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ddd4e459-da9c-43be-90a8-a1ccab0134f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_051b81c2-e950-4275-bd47-55cb89943ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ddd4e459-da9c-43be-90a8-a1ccab0134f2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_051b81c2-e950-4275-bd47-55cb89943ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_9eed64f7-cf17-47fc-9fb4-ba2d946a749a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_051b81c2-e950-4275-bd47-55cb89943ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_9eed64f7-cf17-47fc-9fb4-ba2d946a749a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7525a8ef-a9bc-45a5-925c-074325511b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract_051b81c2-e950-4275-bd47-55cb89943ec0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7525a8ef-a9bc-45a5-925c-074325511b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#BUSINESSCOMBINATIONProFormaDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_631e1b86-a14c-49ff-a2b2-b56c2e85ae77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_fe2c5e7e-752b-4fdd-a8f5-5fad41f53c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_631e1b86-a14c-49ff-a2b2-b56c2e85ae77" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_fe2c5e7e-752b-4fdd-a8f5-5fad41f53c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_e96634b9-ff6f-4348-b3e0-6a36362a5436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_631e1b86-a14c-49ff-a2b2-b56c2e85ae77" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_e96634b9-ff6f-4348-b3e0-6a36362a5436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_fb1e7380-9ffd-46c4-9818-0abfaa0c36c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_631e1b86-a14c-49ff-a2b2-b56c2e85ae77" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_fb1e7380-9ffd-46c4-9818-0abfaa0c36c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_67ce49a8-8ed0-4a23-b35c-4b80575d44cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_fb1e7380-9ffd-46c4-9818-0abfaa0c36c8" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_67ce49a8-8ed0-4a23-b35c-4b80575d44cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_27fdaa48-fbc9-4096-817b-5a4897d07293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_fb1e7380-9ffd-46c4-9818-0abfaa0c36c8" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_27fdaa48-fbc9-4096-817b-5a4897d07293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6b4ef5dc-c604-428c-85db-38acb78d52c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_fb1e7380-9ffd-46c4-9818-0abfaa0c36c8" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_6b4ef5dc-c604-428c-85db-38acb78d52c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_999d34bc-2338-4def-9c57-988a3bbe4d42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationAbstract_fb1e7380-9ffd-46c4-9818-0abfaa0c36c8" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_999d34bc-2338-4def-9c57-988a3bbe4d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_96206597-4ce7-470d-a902-a99551818032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalIncomeStatementElementsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_631e1b86-a14c-49ff-a2b2-b56c2e85ae77" xlink:to="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_96206597-4ce7-470d-a902-a99551818032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdjustmentsToSupplementalProformaTransactionCosts_3e32ecfc-ceb4-45b1-b03f-05f58989ebf1" xlink:href="vyne-20211231.xsd#vyne_AdjustmentsToSupplementalProformaTransactionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_96206597-4ce7-470d-a902-a99551818032" xlink:to="loc_vyne_AdjustmentsToSupplementalProformaTransactionCosts_3e32ecfc-ceb4-45b1-b03f-05f58989ebf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation_d092a74b-26ad-45fa-9e46-cef83fd802d8" xlink:href="vyne-20211231.xsd#vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_96206597-4ce7-470d-a902-a99551818032" xlink:to="loc_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation_d092a74b-26ad-45fa-9e46-cef83fd802d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations_ec33330e-0562-481c-85e0-aa2c187d2d1f" xlink:href="vyne-20211231.xsd#vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalIncomeStatementElementsAbstract_96206597-4ce7-470d-a902-a99551818032" xlink:to="loc_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations_ec33330e-0562-481c-85e0-aa2c187d2d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="vyne-20211231.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c070143c-5321-4e8a-b38b-4993a3562403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_d3cb7db1-b32c-4dcd-ad5e-ca3af9e8982a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c070143c-5321-4e8a-b38b-4993a3562403" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_d3cb7db1-b32c-4dcd-ad5e-ca3af9e8982a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#REVENUERECOGNITIONDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3b64a6f0-b15d-4ff7-8d86-b672d85bf652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3b64a6f0-b15d-4ff7-8d86-b672d85bf652" xlink:to="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_68ab19dd-cf03-40c3-a9eb-4b45cc3f0978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_68ab19dd-cf03-40c3-a9eb-4b45cc3f0978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5471366c-c538-4d45-bf2c-26e4f8f58065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_68ab19dd-cf03-40c3-a9eb-4b45cc3f0978" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5471366c-c538-4d45-bf2c-26e4f8f58065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_4010aabb-20f4-4151-9543-4afc5df5f598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5471366c-c538-4d45-bf2c-26e4f8f58065" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_4010aabb-20f4-4151-9543-4afc5df5f598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf051279-40a7-4acf-ac78-2659786910d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf051279-40a7-4acf-ac78-2659786910d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_db604016-d72f-4366-b348-f58acd4d1b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_bf051279-40a7-4acf-ac78-2659786910d7" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_db604016-d72f-4366-b348-f58acd4d1b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c381629f-e505-4e0c-9f14-533618ad433c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_db604016-d72f-4366-b348-f58acd4d1b6a" xlink:to="loc_us-gaap_SalesRevenueNetMember_c381629f-e505-4e0c-9f14-533618ad433c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_0fa95314-8df4-4c66-9308-75e34de7d108" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_srt_MajorCustomersAxis_0fa95314-8df4-4c66-9308-75e34de7d108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a6c42dc4-d481-4a5d-b25d-dd7e20d1b989" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_0fa95314-8df4-4c66-9308-75e34de7d108" xlink:to="loc_srt_NameOfMajorCustomerDomain_a6c42dc4-d481-4a5d-b25d-dd7e20d1b989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CustomerOneMember_a6986da7-c44b-48a9-b9e9-17e1de5fb71f" xlink:href="vyne-20211231.xsd#vyne_CustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a6c42dc4-d481-4a5d-b25d-dd7e20d1b989" xlink:to="loc_vyne_CustomerOneMember_a6986da7-c44b-48a9-b9e9-17e1de5fb71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CustomerTwoMember_2ede1f85-b58b-48ff-8268-0e48e05fbea2" xlink:href="vyne-20211231.xsd#vyne_CustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a6c42dc4-d481-4a5d-b25d-dd7e20d1b989" xlink:to="loc_vyne_CustomerTwoMember_2ede1f85-b58b-48ff-8268-0e48e05fbea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CustomerThreeMember_cb5bdb62-bb17-4765-95e6-145d3b0f5a11" xlink:href="vyne-20211231.xsd#vyne_CustomerThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_a6c42dc4-d481-4a5d-b25d-dd7e20d1b989" xlink:to="loc_vyne_CustomerThreeMember_cb5bdb62-bb17-4765-95e6-145d3b0f5a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f7fbddd4-2b13-4bff-9c57-22d1ff64ba4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_srt_ProductOrServiceAxis_f7fbddd4-2b13-4bff-9c57-22d1ff64ba4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_87004905-046f-4e04-b519-5a5da74597ea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f7fbddd4-2b13-4bff-9c57-22d1ff64ba4e" xlink:to="loc_srt_ProductsAndServicesDomain_87004905-046f-4e04-b519-5a5da74597ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AllowanceForSalesReturns1Member_326dbed1-c4cb-4113-89a0-32cb582bebae" xlink:href="vyne-20211231.xsd#vyne_AllowanceForSalesReturns1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_87004905-046f-4e04-b519-5a5da74597ea" xlink:to="loc_vyne_AllowanceForSalesReturns1Member_326dbed1-c4cb-4113-89a0-32cb582bebae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_9c2d85a2-8513-4455-b46c-b16f0ecd50a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_87004905-046f-4e04-b519-5a5da74597ea" xlink:to="loc_us-gaap_LicenseMember_9c2d85a2-8513-4455-b46c-b16f0ecd50a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_3217756f-03fc-4a4b-9306-73709ca23f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_87004905-046f-4e04-b519-5a5da74597ea" xlink:to="loc_us-gaap_RoyaltyMember_3217756f-03fc-4a4b-9306-73709ca23f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fe74d903-4f18-4ea8-9979-2628bc2e8c3e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_dei_LegalEntityAxis_fe74d903-4f18-4ea8-9979-2628bc2e8c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_174d1a40-f744-405c-8b1a-774c4fc5288d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_fe74d903-4f18-4ea8-9979-2628bc2e8c3e" xlink:to="loc_dei_EntityDomain_174d1a40-f744-405c-8b1a-774c4fc5288d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_e444862b-ba6c-454d-8360-f10c6148e900" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_174d1a40-f744-405c-8b1a-774c4fc5288d" xlink:to="loc_vyne_FoamixMember_e444862b-ba6c-454d-8360-f10c6148e900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_5db61e30-b0d4-4344-bc2d-de7d49ae2b4e" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1a23753d-5add-47ce-bf20-39c61b6b3233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1a23753d-5add-47ce-bf20-39c61b6b3233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances_d8c99f0c-b04c-4801-afeb-701adcb69877" xlink:href="vyne-20211231.xsd#vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances_d8c99f0c-b04c-4801-afeb-701adcb69877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ea6c9769-f92f-4ffe-8d10-c1dc3da0e72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ea6c9769-f92f-4ffe-8d10-c1dc3da0e72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EstimateOfProductReturnRateMinimum_9313f852-43bc-480b-80d3-e115ccd5178b" xlink:href="vyne-20211231.xsd#vyne_EstimateOfProductReturnRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_vyne_EstimateOfProductReturnRateMinimum_9313f852-43bc-480b-80d3-e115ccd5178b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EstimateOfProductReturnRateMaximum_a571c67c-bdad-475b-8347-02a45ec115e0" xlink:href="vyne-20211231.xsd#vyne_EstimateOfProductReturnRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_vyne_EstimateOfProductReturnRateMaximum_a571c67c-bdad-475b-8347-02a45ec115e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_eda181f1-0ab5-4036-8695-de7e2344f072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_eda181f1-0ab5-4036-8695-de7e2344f072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34bba550-4cdb-4cbf-a459-8c6b9a3b5ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_20acccec-f3a5-4d4d-8b94-6c62aa4315f4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_34bba550-4cdb-4cbf-a459-8c6b9a3b5ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="vyne-20211231.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5547b2b9-b5ce-43e2-b094-523e9dbdbd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_618dcf7a-d395-4a08-b771-12c19c55a3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5547b2b9-b5ce-43e2-b094-523e9dbdbd5f" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_618dcf7a-d395-4a08-b771-12c19c55a3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="vyne-20211231.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ded9a6dc-8fd5-4f6e-9c91-142a8145ca95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_06a0cae6-dce9-4667-afb1-af817a346f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ded9a6dc-8fd5-4f6e-9c91-142a8145ca95" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_06a0cae6-dce9-4667-afb1-af817a346f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_000eaa01-6a29-4d91-9d55-5e3e26663491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78e3f542-d751-41d3-a4a5-d80f8a1a2ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_000eaa01-6a29-4d91-9d55-5e3e26663491" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78e3f542-d751-41d3-a4a5-d80f8a1a2ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6bc250f6-e4ed-4a8b-b239-6b003093c08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78e3f542-d751-41d3-a4a5-d80f8a1a2ee1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6bc250f6-e4ed-4a8b-b239-6b003093c08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1db8689e-9390-4dbf-9b49-5220c816dccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6bc250f6-e4ed-4a8b-b239-6b003093c08e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1db8689e-9390-4dbf-9b49-5220c816dccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_146c3f70-cd53-4297-9b2e-94c7010b9341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1db8689e-9390-4dbf-9b49-5220c816dccb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_146c3f70-cd53-4297-9b2e-94c7010b9341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_02059951-8b54-4110-959b-b75d5d16bfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1db8689e-9390-4dbf-9b49-5220c816dccb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_02059951-8b54-4110-959b-b75d5d16bfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ee55449-8595-40f1-8151-293e6d50d150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78e3f542-d751-41d3-a4a5-d80f8a1a2ee1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ee55449-8595-40f1-8151-293e6d50d150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_6a014476-7172-40ec-bd97-62d5869a2434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ee55449-8595-40f1-8151-293e6d50d150" xlink:to="loc_us-gaap_MarketableSecurities_6a014476-7172-40ec-bd97-62d5869a2434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/MARKETABLESECURITIES" xlink:type="simple" xlink:href="vyne-20211231.xsd#MARKETABLESECURITIES"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/MARKETABLESECURITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1b6a8306-6616-4c36-9b4f-726b2a63d3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_82c18fb4-4db3-47b2-9863-b8a844df5a88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1b6a8306-6616-4c36-9b4f-726b2a63d3a5" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_82c18fb4-4db3-47b2-9863-b8a844df5a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/MARKETABLESECURITIESTables" xlink:type="simple" xlink:href="vyne-20211231.xsd#MARKETABLESECURITIESTables"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/MARKETABLESECURITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bafe5b10-48e9-4f4e-9f5d-2d1cdc8eb802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_070d2bac-2dff-4bae-a0b7-7f504287c8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bafe5b10-48e9-4f4e-9f5d-2d1cdc8eb802" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_070d2bac-2dff-4bae-a0b7-7f504287c8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#MARKETABLESECURITIESMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8bf832b1-d325-4e56-bab5-d15e43a1b6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4eeacb05-4a63-4c41-9dc6-110818d9622b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8bf832b1-d325-4e56-bab5-d15e43a1b6c7" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4eeacb05-4a63-4c41-9dc6-110818d9622b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_28b46391-1a8d-469f-bf50-694c6cee7d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4eeacb05-4a63-4c41-9dc6-110818d9622b" xlink:to="loc_us-gaap_InvestmentTypeAxis_28b46391-1a8d-469f-bf50-694c6cee7d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_24e6b58d-a234-4a72-b1c9-0bac6c084fce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_28b46391-1a8d-469f-bf50-694c6cee7d22" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_24e6b58d-a234-4a72-b1c9-0bac6c084fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_IsraeliMutualFundsMember_2908a7cb-a422-4bdc-af46-187a5d8d9add" xlink:href="vyne-20211231.xsd#vyne_IsraeliMutualFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_24e6b58d-a234-4a72-b1c9-0bac6c084fce" xlink:to="loc_vyne_IsraeliMutualFundsMember_2908a7cb-a422-4bdc-af46-187a5d8d9add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_26c48379-6db3-4bb9-8cc1-c60fae918439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_4eeacb05-4a63-4c41-9dc6-110818d9622b" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_26c48379-6db3-4bb9-8cc1-c60fae918439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_a5feefb4-65b4-4aca-a482-ea24dafafd17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_26c48379-6db3-4bb9-8cc1-c60fae918439" xlink:to="loc_us-gaap_ShortTermInvestments_a5feefb4-65b4-4aca-a482-ea24dafafd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/MARKETABLESECURITIESNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#MARKETABLESECURITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/MARKETABLESECURITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_960b8e70-227c-441d-a239-513449fb618e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d6449f7f-a248-41ec-96de-e4896c8ceeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_960b8e70-227c-441d-a239-513449fb618e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d6449f7f-a248-41ec-96de-e4896c8ceeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_cf66da3a-ec86-477f-8884-ea54d675b315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_960b8e70-227c-441d-a239-513449fb618e" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_cf66da3a-ec86-477f-8884-ea54d675b315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_ac456e0b-4de2-4dfd-a8d8-b24f906a88e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_960b8e70-227c-441d-a239-513449fb618e" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_ac456e0b-4de2-4dfd-a8d8-b24f906a88e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INVENTORY" xlink:type="simple" xlink:href="vyne-20211231.xsd#INVENTORY"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INVENTORY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c0b400a9-aeb9-4f20-b631-b01c79f92893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_d9cf55b9-bb34-4e3b-92ea-172dbb118683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c0b400a9-aeb9-4f20-b631-b01c79f92893" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_d9cf55b9-bb34-4e3b-92ea-172dbb118683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INVENTORYTables" xlink:type="simple" xlink:href="vyne-20211231.xsd#INVENTORYTables"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INVENTORYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_de78f565-4473-4d77-811a-9b3f17b65171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_55f92e6e-d13f-4045-a12f-7f763c555dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_de78f565-4473-4d77-811a-9b3f17b65171" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_55f92e6e-d13f-4045-a12f-7f763c555dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INVENTORYNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INVENTORYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INVENTORYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_2d79125a-64cb-412d-accf-00c3652778ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_ef07940b-ca6e-41ae-b655-986ba2621413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2d79125a-64cb-412d-accf-00c3652778ad" xlink:to="loc_us-gaap_InventoryWriteDown_ef07940b-ca6e-41ae-b655-986ba2621413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INVENTORYScheduleofInventoryComponentsDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_19720e2e-28d7-4b17-ba26-184b4d07d735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_af522bf1-9743-42aa-86e6-5fcde3b5e683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_19720e2e-28d7-4b17-ba26-184b4d07d735" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_af522bf1-9743-42aa-86e6-5fcde3b5e683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_aff808a7-d986-466e-9b10-17b0d7254d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_19720e2e-28d7-4b17-ba26-184b4d07d735" xlink:to="loc_us-gaap_InventoryWorkInProcess_aff808a7-d986-466e-9b10-17b0d7254d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_2437191f-12b0-4809-9967-c25f0381a0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_19720e2e-28d7-4b17-ba26-184b4d07d735" xlink:to="loc_us-gaap_InventoryFinishedGoods_2437191f-12b0-4809-9967-c25f0381a0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8fb6e8da-aa67-4941-8510-23f55659236e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_19720e2e-28d7-4b17-ba26-184b4d07d735" xlink:to="loc_us-gaap_InventoryNet_8fb6e8da-aa67-4941-8510-23f55659236e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="vyne-20211231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7ff6b056-44e9-4f94-af75-35164eb08654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_ef7991b1-a539-4383-942d-a317bcb2b70a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7ff6b056-44e9-4f94-af75-35164eb08654" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_ef7991b1-a539-4383-942d-a317bcb2b70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="vyne-20211231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_615154a5-41d1-4d57-bc4b-11d32a727435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_767c71a9-bc61-442f-9689-5c75ef89854b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_615154a5-41d1-4d57-bc4b-11d32a727435" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_767c71a9-bc61-442f-9689-5c75ef89854b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6b3bc711-a284-4a50-9628-bffe42f937ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_61105c6f-1f81-4691-8bfb-f79c1f44f0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6b3bc711-a284-4a50-9628-bffe42f937ff" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_61105c6f-1f81-4691-8bfb-f79c1f44f0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_769b6c89-af8f-40e1-bbc7-ba3ad84d1690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_61105c6f-1f81-4691-8bfb-f79c1f44f0bf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_769b6c89-af8f-40e1-bbc7-ba3ad84d1690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_769b6c89-af8f-40e1-bbc7-ba3ad84d1690" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_cd50653b-4586-420c-b852-45993e03bad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_cd50653b-4586-420c-b852-45993e03bad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ComputerEquipmentAndSoftwareMember_31914c9b-8a6b-49e1-9aa0-b0a17f99cc1c" xlink:href="vyne-20211231.xsd#vyne_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:to="loc_vyne_ComputerEquipmentAndSoftwareMember_31914c9b-8a6b-49e1-9aa0-b0a17f99cc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d3dc2a23-8e61-4e95-ad03-b1f825e21ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:to="loc_us-gaap_EquipmentMember_d3dc2a23-8e61-4e95-ad03-b1f825e21ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_0c78ca6a-d819-4fb5-a836-ebacef81a266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75b1093a-2075-4f00-b03f-2acbe52a9f66" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_0c78ca6a-d819-4fb5-a836-ebacef81a266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8c2bd306-2845-47b7-a590-7d327e17bb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_61105c6f-1f81-4691-8bfb-f79c1f44f0bf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8c2bd306-2845-47b7-a590-7d327e17bb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_69099721-c611-460c-adab-1131791d7317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8c2bd306-2845-47b7-a590-7d327e17bb4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_69099721-c611-460c-adab-1131791d7317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e09af244-506c-473a-a2d0-3f44d1dfe2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8c2bd306-2845-47b7-a590-7d327e17bb4f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e09af244-506c-473a-a2d0-3f44d1dfe2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f84d510a-85a0-46fb-ae13-243ef0110416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8c2bd306-2845-47b7-a590-7d327e17bb4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f84d510a-85a0-46fb-ae13-243ef0110416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#PROPERTYANDEQUIPMENTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fa953a1f-ca6d-45a4-89f7-8b57576f94a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b0160a71-62a3-4ff6-a8fc-824f625c86e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fa953a1f-ca6d-45a4-89f7-8b57576f94a0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b0160a71-62a3-4ff6-a8fc-824f625c86e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_GainLossOnSaleAndDispositionOfFixedAssets_badb098e-3663-409f-b2fb-c7154100e5bf" xlink:href="vyne-20211231.xsd#vyne_GainLossOnSaleAndDispositionOfFixedAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fa953a1f-ca6d-45a4-89f7-8b57576f94a0" xlink:to="loc_vyne_GainLossOnSaleAndDispositionOfFixedAssets_badb098e-3663-409f-b2fb-c7154100e5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_92f0332f-87df-4a82-8af9-2440ff8b55a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fa953a1f-ca6d-45a4-89f7-8b57576f94a0" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_92f0332f-87df-4a82-8af9-2440ff8b55a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/ACCRUEDEXPENSES" xlink:type="simple" xlink:href="vyne-20211231.xsd#ACCRUEDEXPENSES"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/ACCRUEDEXPENSES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_bc9db026-a134-4b4d-b3b9-a66b9afa9959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_f7a64a09-ac7b-4cd6-9d27-fa0b4111a331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_bc9db026-a134-4b4d-b3b9-a66b9afa9959" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_f7a64a09-ac7b-4cd6-9d27-fa0b4111a331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/ACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="vyne-20211231.xsd#ACCRUEDEXPENSESTables"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/ACCRUEDEXPENSESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_6946b4d8-f4c9-489d-8580-96eb43e3c988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_39297861-227e-4d1c-b215-5fde16478dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6946b4d8-f4c9-489d-8580-96eb43e3c988" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_39297861-227e-4d1c-b215-5fde16478dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#ACCRUEDEXPENSESDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_cfb2daeb-317f-4961-9b82-30452b260345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AccruedSalesProvisionsCurrent_ca778778-cf28-4817-aff2-539ba62307d9" xlink:href="vyne-20211231.xsd#vyne_AccruedSalesProvisionsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cfb2daeb-317f-4961-9b82-30452b260345" xlink:to="loc_vyne_AccruedSalesProvisionsCurrent_ca778778-cf28-4817-aff2-539ba62307d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_43f2927f-925f-4f79-8281-b763a5218475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cfb2daeb-317f-4961-9b82-30452b260345" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_43f2927f-925f-4f79-8281-b763a5218475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AccruedResearchAndDevelopmentCurrent_6cefe875-d941-4b73-9902-1c5120ba4f87" xlink:href="vyne-20211231.xsd#vyne_AccruedResearchAndDevelopmentCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cfb2daeb-317f-4961-9b82-30452b260345" xlink:to="loc_vyne_AccruedResearchAndDevelopmentCurrent_6cefe875-d941-4b73-9902-1c5120ba4f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_b4563f62-8b8b-48b7-b107-a8861db46d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cfb2daeb-317f-4961-9b82-30452b260345" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_b4563f62-8b8b-48b7-b107-a8861db46d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AccruedCommercializedProductCurrent_926cae33-ca49-4226-a52b-9ecc383fa49b" xlink:href="vyne-20211231.xsd#vyne_AccruedCommercializedProductCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cfb2daeb-317f-4961-9b82-30452b260345" xlink:to="loc_vyne_AccruedCommercializedProductCurrent_926cae33-ca49-4226-a52b-9ecc383fa49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a660e358-da30-4225-a7ad-4c03a78eb373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cfb2daeb-317f-4961-9b82-30452b260345" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a660e358-da30-4225-a7ad-4c03a78eb373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_396a2aab-5917-4d4f-bad4-12b3541f8c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_cfb2daeb-317f-4961-9b82-30452b260345" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_396a2aab-5917-4d4f-bad4-12b3541f8c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASE" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASE"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c801915a-a865-43a6-aedd-22bda92ff3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1755b1ff-0868-46b7-ae45-ba47af61103d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c801915a-a865-43a6-aedd-22bda92ff3e0" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1755b1ff-0868-46b7-ae45-ba47af61103d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASETables" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASETables"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d2220c7d-6cff-4671-969a-377f307ba1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_e14e78e3-59ad-4810-bf35-5ee48715a997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d2220c7d-6cff-4671-969a-377f307ba1c2" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_e14e78e3-59ad-4810-bf35-5ee48715a997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a069ddba-ab9f-4283-a158-b03409ed0b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d2220c7d-6cff-4671-969a-377f307ba1c2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a069ddba-ab9f-4283-a158-b03409ed0b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASENarrativeDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e3d16fd5-63bf-44a4-bba1-19dd307f2433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_e1025e66-38dd-4678-a710-e6d759791d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e3d16fd5-63bf-44a4-bba1-19dd307f2433" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_e1025e66-38dd-4678-a710-e6d759791d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4411c64b-2efc-4d59-9898-9665fd65f953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_e1025e66-38dd-4678-a710-e6d759791d18" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4411c64b-2efc-4d59-9898-9665fd65f953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd97bb52-0deb-4b8f-a617-32bbd650f2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4411c64b-2efc-4d59-9898-9665fd65f953" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd97bb52-0deb-4b8f-a617-32bbd650f2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OriginalSpaceMember_9b6b683b-db6a-4e7b-9659-91c67d8811fe" xlink:href="vyne-20211231.xsd#vyne_OriginalSpaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd97bb52-0deb-4b8f-a617-32bbd650f2e1" xlink:to="loc_vyne_OriginalSpaceMember_9b6b683b-db6a-4e7b-9659-91c67d8811fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AdditionalSpaceMember_cb8f26f3-e076-4c9a-94e4-55971fd69438" xlink:href="vyne-20211231.xsd#vyne_AdditionalSpaceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd97bb52-0deb-4b8f-a617-32bbd650f2e1" xlink:to="loc_vyne_AdditionalSpaceMember_cb8f26f3-e076-4c9a-94e4-55971fd69438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_eab1232e-c31b-4a7a-82dc-92aac411c169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dd97bb52-0deb-4b8f-a617-32bbd650f2e1" xlink:to="loc_us-gaap_VehiclesMember_eab1232e-c31b-4a7a-82dc-92aac411c169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_82ee6c7f-4944-4cde-96a1-c1842e0e3cd7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_e1025e66-38dd-4678-a710-e6d759791d18" xlink:to="loc_srt_StatementGeographicalAxis_82ee6c7f-4944-4cde-96a1-c1842e0e3cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9d4a32d0-d898-44d1-a89a-ad358cc9e8d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_82ee6c7f-4944-4cde-96a1-c1842e0e3cd7" xlink:to="loc_srt_SegmentGeographicalDomain_9d4a32d0-d898-44d1-a89a-ad358cc9e8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BridgewaterNewJerseyMember_0cdbc393-d786-45ab-8c6d-fcefd13d82a2" xlink:href="vyne-20211231.xsd#vyne_BridgewaterNewJerseyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9d4a32d0-d898-44d1-a89a-ad358cc9e8d9" xlink:to="loc_vyne_BridgewaterNewJerseyMember_0cdbc393-d786-45ab-8c6d-fcefd13d82a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_e1025e66-38dd-4678-a710-e6d759791d18" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FacilitySpaceUnderLease_26ffbbbd-6615-476b-940e-955732b12870" xlink:href="vyne-20211231.xsd#vyne_FacilitySpaceUnderLease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_FacilitySpaceUnderLease_26ffbbbd-6615-476b-940e-955732b12870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseRightOfUseAssetCurrent_9554c157-fc01-4963-9559-b93335941a43" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseRightOfUseAssetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_OperatingLeaseRightOfUseAssetCurrent_9554c157-fc01-4963-9559-b93335941a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_db8f5bd4-b0a4-41fe-b38d-d0fd20532bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_db8f5bd4-b0a4-41fe-b38d-d0fd20532bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a5314eac-4dc2-4071-8f97-f6fdd73b148f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_us-gaap_OperatingLeaseLiability_a5314eac-4dc2-4071-8f97-f6fdd73b148f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3fcb0961-4a61-4599-bff8-44fc3686c175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3fcb0961-4a61-4599-bff8-44fc3686c175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_VehicleLeasePrepaymentPeriod_dcc528b7-7ced-4a7f-9832-5494b40b2e86" xlink:href="vyne-20211231.xsd#vyne_VehicleLeasePrepaymentPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_VehicleLeasePrepaymentPeriod_dcc528b7-7ced-4a7f-9832-5494b40b2e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseRightOfUseAssetsTransferred_d409ca5d-cc20-4014-9c0c-438c796296a7" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseRightOfUseAssetsTransferred"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_OperatingLeaseRightOfUseAssetsTransferred_d409ca5d-cc20-4014-9c0c-438c796296a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_OperatingLeaseLiabilityTransferred_3e4ff0f9-59df-4eeb-b11d-88f0de86b0c4" xlink:href="vyne-20211231.xsd#vyne_OperatingLeaseLiabilityTransferred"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_OperatingLeaseLiabilityTransferred_3e4ff0f9-59df-4eeb-b11d-88f0de86b0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RestrictedInvestmentsToSecureLeaseAgreements_e03559ef-e3d9-4183-8d68-e4602ac40f45" xlink:href="vyne-20211231.xsd#vyne_RestrictedInvestmentsToSecureLeaseAgreements"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_03f74c63-f796-4c9c-88ae-b327bb54e70e" xlink:to="loc_vyne_RestrictedInvestmentsToSecureLeaseAgreements_e03559ef-e3d9-4183-8d68-e4602ac40f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2c355d3b-4db9-4844-a5fb-370b8301ccd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_14417d30-d354-498d-b4f1-c5bb18a35594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2c355d3b-4db9-4844-a5fb-370b8301ccd6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_14417d30-d354-498d-b4f1-c5bb18a35594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb863e89-39ee-4669-9625-0f6b39a71b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_14417d30-d354-498d-b4f1-c5bb18a35594" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb863e89-39ee-4669-9625-0f6b39a71b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0bb3ca1e-1668-4435-bfc4-e2f247a1d861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fb863e89-39ee-4669-9625-0f6b39a71b71" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0bb3ca1e-1668-4435-bfc4-e2f247a1d861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_f41750e7-f296-4815-9684-a8a1233a748f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficeBuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0bb3ca1e-1668-4435-bfc4-e2f247a1d861" xlink:to="loc_srt_OfficeBuildingMember_f41750e7-f296-4815-9684-a8a1233a748f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_d930440c-4217-4005-95e0-78eac9a2ebdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0bb3ca1e-1668-4435-bfc4-e2f247a1d861" xlink:to="loc_us-gaap_VehiclesMember_d930440c-4217-4005-95e0-78eac9a2ebdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_96230b34-0d5d-4a5f-8d56-3842e8776e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_14417d30-d354-498d-b4f1-c5bb18a35594" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_96230b34-0d5d-4a5f-8d56-3842e8776e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_67532247-7713-4dd5-b179-e3847be89db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_96230b34-0d5d-4a5f-8d56-3842e8776e0b" xlink:to="loc_us-gaap_OperatingLeaseExpense_67532247-7713-4dd5-b179-e3847be89db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4f71896b-8c9e-4a43-9dc9-1f4fca94b2df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_77f79dca-f089-40e3-8e8c-02dd9a431e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f71896b-8c9e-4a43-9dc9-1f4fca94b2df" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_77f79dca-f089-40e3-8e8c-02dd9a431e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5e113716-8db7-427f-b61d-b36c7bf52c67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_77f79dca-f089-40e3-8e8c-02dd9a431e3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5e113716-8db7-427f-b61d-b36c7bf52c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_33170203-52df-4ed7-8995-73899476b31b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5e113716-8db7-427f-b61d-b36c7bf52c67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_33170203-52df-4ed7-8995-73899476b31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_a234cb4e-5354-4688-9066-d316e2385fcc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficeBuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_33170203-52df-4ed7-8995-73899476b31b" xlink:to="loc_srt_OfficeBuildingMember_a234cb4e-5354-4688-9066-d316e2385fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_22d57bd9-bb6f-4750-8dc6-40ea0bedf339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_33170203-52df-4ed7-8995-73899476b31b" xlink:to="loc_us-gaap_VehiclesMember_22d57bd9-bb6f-4750-8dc6-40ea0bedf339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_be3b0484-b50b-49c5-a0a4-6dc1a98c4ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_77f79dca-f089-40e3-8e8c-02dd9a431e3a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_be3b0484-b50b-49c5-a0a4-6dc1a98c4ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_b8df1ad8-d808-4ed5-8704-39d5d4910d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_be3b0484-b50b-49c5-a0a4-6dc1a98c4ccf" xlink:to="loc_us-gaap_OperatingLeasePayments_b8df1ad8-d808-4ed5-8704-39d5d4910d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c58becfd-79b7-477b-b400-928c3c764e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e09480be-8880-417f-ba9a-91585ecf24a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c58becfd-79b7-477b-b400-928c3c764e30" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e09480be-8880-417f-ba9a-91585ecf24a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3a67c8c8-9c71-4abe-8aa4-1ed9b49e5b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c58becfd-79b7-477b-b400-928c3c764e30" xlink:to="loc_us-gaap_OperatingLeaseLiability_3a67c8c8-9c71-4abe-8aa4-1ed9b49e5b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4a0edf69-a277-4a97-858a-10fb2eb1a83b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c58becfd-79b7-477b-b400-928c3c764e30" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4a0edf69-a277-4a97-858a-10fb2eb1a83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f844bba8-1c86-4654-b25f-73ba5073af72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c58becfd-79b7-477b-b400-928c3c764e30" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f844bba8-1c86-4654-b25f-73ba5073af72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a0657ab2-80a6-43ed-9e4b-83695f01c5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d4e3ddce-bdfc-4a6f-8cd6-d93098a0d649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a0657ab2-80a6-43ed-9e4b-83695f01c5b6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d4e3ddce-bdfc-4a6f-8cd6-d93098a0d649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1e146297-59fd-4193-99e8-3720a9a7774d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a0657ab2-80a6-43ed-9e4b-83695f01c5b6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1e146297-59fd-4193-99e8-3720a9a7774d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2b2070aa-eb16-431e-908a-5436dddfe0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a0657ab2-80a6-43ed-9e4b-83695f01c5b6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2b2070aa-eb16-431e-908a-5436dddfe0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4004ca19-d0fb-4770-8958-29b4ce9f7378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a0657ab2-80a6-43ed-9e4b-83695f01c5b6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4004ca19-d0fb-4770-8958-29b4ce9f7378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a5a635a9-4e84-46de-8601-e03a318d0fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a0657ab2-80a6-43ed-9e4b-83695f01c5b6" xlink:to="loc_us-gaap_OperatingLeaseLiability_a5a635a9-4e84-46de-8601-e03a318d0fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="vyne-20211231.xsd#OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLAN" xlink:type="simple" xlink:href="vyne-20211231.xsd#EMPLOYEESAVINGSPLAN"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLAN" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e7b9d09a-cb2d-4b5e-9fb8-8f78985df79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_fb38a5f2-2809-4e50-9a9a-9cec54f43563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e7b9d09a-cb2d-4b5e-9fb8-8f78985df79e" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_fb38a5f2-2809-4e50-9a9a-9cec54f43563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLANDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#EMPLOYEESAVINGSPLANDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLANDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3b6f079c-d15f-4352-9394-540ea0c3ca96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_e90b95c3-97aa-4841-a8a1-8ac761f95474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3b6f079c-d15f-4352-9394-540ea0c3ca96" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_e90b95c3-97aa-4841-a8a1-8ac761f95474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="vyne-20211231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_45abc680-1811-4ffd-bc36-a09bb61ea061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_68194351-8b69-4e46-a786-9ed62007aba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_45abc680-1811-4ffd-bc36-a09bb61ea061" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_68194351-8b69-4e46-a786-9ed62007aba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/LONGTERMDEBT" xlink:type="simple" xlink:href="vyne-20211231.xsd#LONGTERMDEBT"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/LONGTERMDEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1dcaa4c8-74a0-4a83-b34c-8fb37b0f6607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_4b3859e8-5bba-4148-bf48-d89f1d78c869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1dcaa4c8-74a0-4a83-b34c-8fb37b0f6607" xlink:to="loc_us-gaap_LongTermDebtTextBlock_4b3859e8-5bba-4148-bf48-d89f1d78c869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#LONGTERMDEBTDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/LONGTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e5679bcd-afbb-4ecb-b5ab-7b4a5bb21067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e5679bcd-afbb-4ecb-b5ab-7b4a5bb21067" xlink:to="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bdaf90df-4d93-4244-8c29-1b2aedb61ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bdaf90df-4d93-4244-8c29-1b2aedb61ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c39bccd7-d6f6-4070-8e2d-fb4ebeb8e8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bdaf90df-4d93-4244-8c29-1b2aedb61ebf" xlink:to="loc_us-gaap_RelatedPartyDomain_c39bccd7-d6f6-4070-8e2d-fb4ebeb8e8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareholderLenderMember_4e6a1624-e661-44ca-b654-6b57295b7840" xlink:href="vyne-20211231.xsd#vyne_ShareholderLenderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c39bccd7-d6f6-4070-8e2d-fb4ebeb8e8d0" xlink:to="loc_vyne_ShareholderLenderMember_4e6a1624-e661-44ca-b654-6b57295b7840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_30a43864-de6b-4800-bdcf-b9c306adfe9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_30a43864-de6b-4800-bdcf-b9c306adfe9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5480c67f-9260-429c-b1af-0716117e947f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_30a43864-de6b-4800-bdcf-b9c306adfe9d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5480c67f-9260-429c-b1af-0716117e947f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RegisteredOfferingMember_c967da3b-16b3-4b97-894f-660e14b82ace" xlink:href="vyne-20211231.xsd#vyne_RegisteredOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5480c67f-9260-429c-b1af-0716117e947f" xlink:to="loc_vyne_RegisteredOfferingMember_c967da3b-16b3-4b97-894f-660e14b82ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8517ffd3-b32f-424f-b8c0-b7385085ddba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_us-gaap_DebtInstrumentAxis_8517ffd3-b32f-424f-b8c0-b7385085ddba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8517ffd3-b32f-424f-b8c0-b7385085ddba" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_185a32d4-68d0-440a-8db7-bbde82d757e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:to="loc_us-gaap_SecuredDebtMember_185a32d4-68d0-440a-8db7-bbde82d757e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementMember_c8619000-5db0-4ee7-984f-2c8d79281a4b" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:to="loc_vyne_AmendedAndRestatedCreditAgreementMember_c8619000-5db0-4ee7-984f-2c8d79281a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember_bbb740ba-789c-4db1-9139-2bef22f1e1e9" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:to="loc_vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember_bbb740ba-789c-4db1-9139-2bef22f1e1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember_de7c631c-ddfb-4e8d-8499-52f67d5f9b9d" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:to="loc_vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember_de7c631c-ddfb-4e8d-8499-52f67d5f9b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember_2ec727ca-ebd0-4ab0-a3e3-08cf9a782784" xlink:href="vyne-20211231.xsd#vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a365dd5c-90a4-4e41-bc07-674ffcbeaebb" xlink:to="loc_vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember_2ec727ca-ebd0-4ab0-a3e3-08cf9a782784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1da0f276-ac57-4113-94eb-5d4340a5041a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_us-gaap_VariableRateAxis_1da0f276-ac57-4113-94eb-5d4340a5041a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ec794bc3-e7b0-4e4d-83ec-a86098ffaae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_1da0f276-ac57-4113-94eb-5d4340a5041a" xlink:to="loc_us-gaap_VariableRateDomain_ec794bc3-e7b0-4e4d-83ec-a86098ffaae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3958c997-2295-46eb-99c4-6a485268abd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_ec794bc3-e7b0-4e4d-83ec-a86098ffaae3" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3958c997-2295-46eb-99c4-6a485268abd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_64bb17ee-6e29-4c9c-a47d-77da61c73b7d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_dei_LegalEntityAxis_64bb17ee-6e29-4c9c-a47d-77da61c73b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a4527372-7885-4278-97a9-dab5283542ef" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_64bb17ee-6e29-4c9c-a47d-77da61c73b7d" xlink:to="loc_dei_EntityDomain_a4527372-7885-4278-97a9-dab5283542ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_dee9658e-61f7-4aa1-930e-2c67a1260382" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a4527372-7885-4278-97a9-dab5283542ef" xlink:to="loc_vyne_FoamixMember_dee9658e-61f7-4aa1-930e-2c67a1260382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_58797b21-5486-4ab4-9d36-92c071d22ed7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c496bb0-394b-478d-bbd2-fb7cbb826dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c496bb0-394b-478d-bbd2-fb7cbb826dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_NumberOfLenders_6169dc00-95f7-4e19-9946-ebec2c4e5dfb" xlink:href="vyne-20211231.xsd#vyne_NumberOfLenders"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_vyne_NumberOfLenders_6169dc00-95f7-4e19-9946-ebec2c4e5dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_GrossProceedsFromIssuanceOfCommonStock_85e818ff-281c-449b-b1e0-47cbf08512cd" xlink:href="vyne-20211231.xsd#vyne_GrossProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_vyne_GrossProceedsFromIssuanceOfCommonStock_85e818ff-281c-449b-b1e0-47cbf08512cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_faea2e89-4155-49e9-8571-e86976175195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_faea2e89-4155-49e9-8571-e86976175195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_a4a3478b-0369-4885-8411-e7099d85b2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_a4a3478b-0369-4885-8411-e7099d85b2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_18092adf-844e-42a6-bacd-abad40b89f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_18092adf-844e-42a6-bacd-abad40b89f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1f195a8c-1b33-45db-a89d-381ddd9643e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1f195a8c-1b33-45db-a89d-381ddd9643e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_fb3ffd86-5528-4e6c-aa13-2aacfa40d9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_fb3ffd86-5528-4e6c-aa13-2aacfa40d9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DebtInstrumentFeePercent_ac546b68-2114-44cb-894a-596bc1bc68f0" xlink:href="vyne-20211231.xsd#vyne_DebtInstrumentFeePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_vyne_DebtInstrumentFeePercent_ac546b68-2114-44cb-894a-596bc1bc68f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RepaymentOfDebtPrepaymentFeePercentage_a72dd871-c982-4448-bcd0-795b2333ff1c" xlink:href="vyne-20211231.xsd#vyne_RepaymentOfDebtPrepaymentFeePercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_vyne_RepaymentOfDebtPrepaymentFeePercentage_a72dd871-c982-4448-bcd0-795b2333ff1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_0b5d30c9-9402-44bc-9295-015d8abcea80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_0b5d30c9-9402-44bc-9295-015d8abcea80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3980eadb-a88f-42d0-8e8a-f4b99f2d921b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_LongTermDebt_3980eadb-a88f-42d0-8e8a-f4b99f2d921b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_655d1a91-d092-49d8-be22-678c785bb8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_655d1a91-d092-49d8-be22-678c785bb8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ClassOfWarrantAbstract_edf93a14-66ab-4472-afc9-62451929ec81" xlink:href="vyne-20211231.xsd#vyne_ClassOfWarrantAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_vyne_ClassOfWarrantAbstract_edf93a14-66ab-4472-afc9-62451929ec81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6bb5e356-5d4b-4b59-a21a-61d873974bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_ClassOfWarrantAbstract_edf93a14-66ab-4472-afc9-62451929ec81" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6bb5e356-5d4b-4b59-a21a-61d873974bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ec77026f-94f8-48e8-82ec-c6c7ec1bd859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_ClassOfWarrantAbstract_edf93a14-66ab-4472-afc9-62451929ec81" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ec77026f-94f8-48e8-82ec-c6c7ec1bd859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNetAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_422c49bc-2968-49cf-a3c3-40bbbed26e6a" xlink:to="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_76ed7c1d-10b7-4567-a43c-8378607bf51f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_76ed7c1d-10b7-4567-a43c-8378607bf51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_2842b8cb-db21-428d-90ce-0b0b1d3a555e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_2842b8cb-db21-428d-90ce-0b0b1d3a555e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5e5c6acb-b3d3-4966-a61d-22dfc7e72809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_InterestExpense_5e5c6acb-b3d3-4966-a61d-22dfc7e72809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_8927279d-5d8e-4c9d-9835-964b61f9dd97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_InterestExpenseDebt_8927279d-5d8e-4c9d-9835-964b61f9dd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_84dfa3d3-b5d6-4f7b-95e1-99b88a2f4684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_84dfa3d3-b5d6-4f7b-95e1-99b88a2f4684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_debfe15b-328b-450c-a71b-a8c808e2c6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFinanceCostsNetAbstract_cc326254-4776-4515-89e4-fdb71b6b66be" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_debfe15b-328b-450c-a71b-a8c808e2c6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="vyne-20211231.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_e1f64254-8500-45e0-bd77-955d294f3523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c5a385dc-7172-4542-9390-6ded0aaaf6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e1f64254-8500-45e0-bd77-955d294f3523" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c5a385dc-7172-4542-9390-6ded0aaaf6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_271768a6-4cb6-4c3e-838f-85cb8069f7de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_271768a6-4cb6-4c3e-838f-85cb8069f7de" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8d638901-f680-479c-9bb4-582f6a7347ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8d638901-f680-479c-9bb4-582f6a7347ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_13240f5d-0132-4e3d-aa52-6ce66773b715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8d638901-f680-479c-9bb4-582f6a7347ca" xlink:to="loc_us-gaap_EquityComponentDomain_13240f5d-0132-4e3d-aa52-6ce66773b715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ce3281e5-5c77-4849-8dd1-805b85cd3c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_13240f5d-0132-4e3d-aa52-6ce66773b715" xlink:to="loc_us-gaap_CommonStockMember_ce3281e5-5c77-4849-8dd1-805b85cd3c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_9d0f035e-b496-4f64-abd5-9c3e2d7ca117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_13240f5d-0132-4e3d-aa52-6ce66773b715" xlink:to="loc_us-gaap_WarrantMember_9d0f035e-b496-4f64-abd5-9c3e2d7ca117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_a492bfe0-9edd-4b91-ad59-d4ad9aad0fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_a492bfe0-9edd-4b91-ad59-d4ad9aad0fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e94d171f-b872-498e-889b-224f3c9eae03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a492bfe0-9edd-4b91-ad59-d4ad9aad0fe1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e94d171f-b872-498e-889b-224f3c9eae03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CantorSalesAgreementMember_f5789313-6143-4c35-9000-c042351c69d0" xlink:href="vyne-20211231.xsd#vyne_CantorSalesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e94d171f-b872-498e-889b-224f3c9eae03" xlink:to="loc_vyne_CantorSalesAgreementMember_f5789313-6143-4c35-9000-c042351c69d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_RegisteredDirectOfferingMember_ff5f951e-35ba-44a8-8998-eff8f60052b6" xlink:href="vyne-20211231.xsd#vyne_RegisteredDirectOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e94d171f-b872-498e-889b-224f3c9eae03" xlink:to="loc_vyne_RegisteredDirectOfferingMember_ff5f951e-35ba-44a8-8998-eff8f60052b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_PublicStockOfferingMember_ca3b33b9-5511-4536-adba-ba0c7ce2cbb9" xlink:href="vyne-20211231.xsd#vyne_PublicStockOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e94d171f-b872-498e-889b-224f3c9eae03" xlink:to="loc_vyne_PublicStockOfferingMember_ca3b33b9-5511-4536-adba-ba0c7ce2cbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7d7b8c88-d61b-42fa-857b-693a4f06167b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_dei_LegalEntityAxis_7d7b8c88-d61b-42fa-857b-693a4f06167b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3f590ba1-0857-4012-95df-a6139c4a541a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_7d7b8c88-d61b-42fa-857b-693a4f06167b" xlink:to="loc_dei_EntityDomain_3f590ba1-0857-4012-95df-a6139c4a541a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_5fb7cbc8-3c5a-4aac-9fcb-509f929f8e91" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3f590ba1-0857-4012-95df-a6139c4a541a" xlink:to="loc_vyne_FoamixMember_5fb7cbc8-3c5a-4aac-9fcb-509f929f8e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fb77b35a-7429-469a-97c4-9b7ca45e841a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_srt_RangeAxis_fb77b35a-7429-469a-97c4-9b7ca45e841a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5a4ff0d2-db07-4eae-8779-8cef09711df9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fb77b35a-7429-469a-97c4-9b7ca45e841a" xlink:to="loc_srt_RangeMember_5a4ff0d2-db07-4eae-8779-8cef09711df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a14f2fe7-0704-4076-b324-7491e7a15cdf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5a4ff0d2-db07-4eae-8779-8cef09711df9" xlink:to="loc_srt_MaximumMember_a14f2fe7-0704-4076-b324-7491e7a15cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e4e5925f-8832-4bb8-a827-d5d6c900ee75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e4e5925f-8832-4bb8-a827-d5d6c900ee75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d911680e-4b91-42f1-9765-84ae0eeb5b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e4e5925f-8832-4bb8-a827-d5d6c900ee75" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d911680e-4b91-42f1-9765-84ae0eeb5b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_c576fd35-64b9-4529-84db-2f0661b4c7bd" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d911680e-4b91-42f1-9765-84ae0eeb5b5d" xlink:to="loc_vyne_FoamixMember_c576fd35-64b9-4529-84db-2f0661b4c7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6a379659-b44c-4c09-a674-9de413a550ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6a379659-b44c-4c09-a674-9de413a550ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_94bb544e-4d5d-4d48-a2e0-aa4ca9ec11dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6a379659-b44c-4c09-a674-9de413a550ef" xlink:to="loc_us-gaap_RelatedPartyDomain_94bb544e-4d5d-4d48-a2e0-aa4ca9ec11dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareholderLenderMember_c2018ed2-bc69-43bd-a514-ee3143df8047" xlink:href="vyne-20211231.xsd#vyne_ShareholderLenderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_94bb544e-4d5d-4d48-a2e0-aa4ca9ec11dc" xlink:to="loc_vyne_ShareholderLenderMember_c2018ed2-bc69-43bd-a514-ee3143df8047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_13f05769-3d37-4a61-8fe1-9502746f53aa" xlink:to="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_bf5a4b01-b736-4cb2-b6aa-227d67074b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_bf5a4b01-b736-4cb2-b6aa-227d67074b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_54e9e5e9-15c0-4549-ba1e-c3f533c01978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_54e9e5e9-15c0-4549-ba1e-c3f533c01978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_d853298c-e824-411e-99e8-11709346cde8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_d853298c-e824-411e-99e8-11709346cde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6da4180f-2d3b-4837-a781-0cf0aa183444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6da4180f-2d3b-4837-a781-0cf0aa183444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_0cb029d5-a803-418a-a136-0dacdb881d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_0cb029d5-a803-418a-a136-0dacdb881d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2e85c95a-d812-48aa-b60f-92f601f2dc56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2e85c95a-d812-48aa-b60f-92f601f2dc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a14a310a-62d3-4077-bb87-938ef0df5c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a14a310a-62d3-4077-bb87-938ef0df5c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CommonStockVotingRightsNumberPerShare_210b5458-5bae-43b1-ba09-7ac84dd059fa" xlink:href="vyne-20211231.xsd#vyne_CommonStockVotingRightsNumberPerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_CommonStockVotingRightsNumberPerShare_210b5458-5bae-43b1-ba09-7ac84dd059fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_48b4ae13-c07e-4bce-9693-c5d6dc0a255b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_48b4ae13-c07e-4bce-9693-c5d6dc0a255b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_StockIssuedDuringPeriodSharesWarrantsExercised_29aaca7a-152a-4020-b0d1-4a9e80347395" xlink:href="vyne-20211231.xsd#vyne_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_StockIssuedDuringPeriodSharesWarrantsExercised_29aaca7a-152a-4020-b0d1-4a9e80347395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessAcquisitionContingentStockRightIssued_a4101570-f3ba-41be-acf8-08afafbecb39" xlink:href="vyne-20211231.xsd#vyne_BusinessAcquisitionContingentStockRightIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_BusinessAcquisitionContingentStockRightIssued_a4101570-f3ba-41be-acf8-08afafbecb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_8b319b9c-5c8d-40a4-a1b5-460ac0987555" xlink:href="vyne-20211231.xsd#vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification_8b319b9c-5c8d-40a4-a1b5-460ac0987555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_SaleOfStockConsiderationReceivableOnTransaction_4e276812-04c4-4c8a-b464-f46a51a9bf69" xlink:href="vyne-20211231.xsd#vyne_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_SaleOfStockConsiderationReceivableOnTransaction_4e276812-04c4-4c8a-b464-f46a51a9bf69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1923fb1-a3b3-4082-96a3-8ae8dc2393fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c1923fb1-a3b3-4082-96a3-8ae8dc2393fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_d63330de-90ea-4d78-8408-9bb594962883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_d63330de-90ea-4d78-8408-9bb594962883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock_e6c421e7-62f4-4569-a5ad-926c18349d70" xlink:href="vyne-20211231.xsd#vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock_e6c421e7-62f4-4569-a5ad-926c18349d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_00e26e67-ce74-4ef4-8c55-4aca2e6b29d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_00e26e67-ce74-4ef4-8c55-4aca2e6b29d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_0dd2c7d4-b0b3-409d-bad1-a27be6a3cf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_0dd2c7d4-b0b3-409d-bad1-a27be6a3cf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d2a97bc4-a710-4d12-b214-1fe8bfce7961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d2a97bc4-a710-4d12-b214-1fe8bfce7961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_a7c1e5ec-d765-4297-abca-0ff3d111de13" xlink:href="vyne-20211231.xsd#vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1f79e919-1712-444b-bdda-984072e6924a" xlink:to="loc_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement_a7c1e5ec-d765-4297-abca-0ff3d111de13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATION" xlink:type="simple" xlink:href="vyne-20211231.xsd#SHAREBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6ed16cd1-bb7a-445c-a332-04ae298f4fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_229299b6-dbf9-4c79-bae9-8f7789ab0b78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6ed16cd1-bb7a-445c-a332-04ae298f4fa9" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_229299b6-dbf9-4c79-bae9-8f7789ab0b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="vyne-20211231.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_901ffa80-35c3-4af3-82b7-e5a9590defb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock_0c97abe9-267d-41b0-bc33-5f8d7619f4a9" xlink:href="vyne-20211231.xsd#vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_901ffa80-35c3-4af3-82b7-e5a9590defb2" xlink:to="loc_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock_0c97abe9-267d-41b0-bc33-5f8d7619f4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_d1c2a112-c41d-4834-9f26-167767830c51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_901ffa80-35c3-4af3-82b7-e5a9590defb2" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_d1c2a112-c41d-4834-9f26-167767830c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9ba3fa63-cb85-4a05-a70e-2febcf1bea31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_901ffa80-35c3-4af3-82b7-e5a9590defb2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9ba3fa63-cb85-4a05-a70e-2febcf1bea31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_aed2304f-9a10-44eb-97a8-7f30e8cc7317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_901ffa80-35c3-4af3-82b7-e5a9590defb2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_aed2304f-9a10-44eb-97a8-7f30e8cc7317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1822a0f4-55d8-49ba-ad30-f88aa17d7b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_901ffa80-35c3-4af3-82b7-e5a9590defb2" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1822a0f4-55d8-49ba-ad30-f88aa17d7b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SHAREBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9098cc26-40de-41b2-ad0a-06275f59c3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9098cc26-40de-41b2-ad0a-06275f59c3f9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8aff2e9b-d356-4ff9-bf46-c0a2de90e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_PlanNameAxis_8aff2e9b-d356-4ff9-bf46-c0a2de90e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8932eb77-2bdb-489c-9b33-ebb7e52c6cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_8aff2e9b-d356-4ff9-bf46-c0a2de90e7f8" xlink:to="loc_us-gaap_PlanNameDomain_8932eb77-2bdb-489c-9b33-ebb7e52c6cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_A2019PlanMember_158d7017-ee52-4da4-8e32-6af0d73cc691" xlink:href="vyne-20211231.xsd#vyne_A2019PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8932eb77-2bdb-489c-9b33-ebb7e52c6cb7" xlink:to="loc_vyne_A2019PlanMember_158d7017-ee52-4da4-8e32-6af0d73cc691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_A2018PlanMember_af0839c2-9108-4958-9bb3-2b67f3e93620" xlink:href="vyne-20211231.xsd#vyne_A2018PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8932eb77-2bdb-489c-9b33-ebb7e52c6cb7" xlink:to="loc_vyne_A2018PlanMember_af0839c2-9108-4958-9bb3-2b67f3e93620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EmployeeStockPurchasePlanMember_e3a7eb6b-7479-4134-8c64-a0077ec59742" xlink:href="vyne-20211231.xsd#vyne_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8932eb77-2bdb-489c-9b33-ebb7e52c6cb7" xlink:to="loc_vyne_EmployeeStockPurchasePlanMember_e3a7eb6b-7479-4134-8c64-a0077ec59742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7dbe3e87-ed84-46db-bc36-d8de11256316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7dbe3e87-ed84-46db-bc36-d8de11256316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1fe02dbc-fd88-475d-b038-68ec03d87774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7dbe3e87-ed84-46db-bc36-d8de11256316" xlink:to="loc_us-gaap_EquityComponentDomain_1fe02dbc-fd88-475d-b038-68ec03d87774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d162df30-6914-4031-ad66-6316272ca965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1fe02dbc-fd88-475d-b038-68ec03d87774" xlink:to="loc_us-gaap_CommonStockMember_d162df30-6914-4031-ad66-6316272ca965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f4d553df-0b0a-401a-8129-301613dd66a1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_dei_LegalEntityAxis_f4d553df-0b0a-401a-8129-301613dd66a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5615a8f7-1c16-431a-969f-887a88592089" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f4d553df-0b0a-401a-8129-301613dd66a1" xlink:to="loc_dei_EntityDomain_5615a8f7-1c16-431a-969f-887a88592089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_99bfd40e-6267-4bdc-9c95-63d2a5d4b5d9" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5615a8f7-1c16-431a-969f-887a88592089" xlink:to="loc_vyne_FoamixMember_99bfd40e-6267-4bdc-9c95-63d2a5d4b5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MenloMember_6176ac91-8401-404a-8efd-d49c34e831b3" xlink:href="vyne-20211231.xsd#vyne_MenloMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5615a8f7-1c16-431a-969f-887a88592089" xlink:to="loc_vyne_MenloMember_6176ac91-8401-404a-8efd-d49c34e831b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_01720483-095c-406e-8c90-5ed3359a07c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_GranteeStatusAxis_01720483-095c-406e-8c90-5ed3359a07c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_23c1b2b1-1a9c-438d-9bf4-e43f88711e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_01720483-095c-406e-8c90-5ed3359a07c4" xlink:to="loc_us-gaap_GranteeStatusDomain_23c1b2b1-1a9c-438d-9bf4-e43f88711e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_979eb01e-efd0-450d-b3e1-addd1657482d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_23c1b2b1-1a9c-438d-9bf4-e43f88711e51" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_979eb01e-efd0-450d-b3e1-addd1657482d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_49a82b90-562b-4ffc-a950-39812b32ee82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_23c1b2b1-1a9c-438d-9bf4-e43f88711e51" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_49a82b90-562b-4ffc-a950-39812b32ee82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bf0ed943-f40a-4503-b46e-b728857205ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_AwardTypeAxis_bf0ed943-f40a-4503-b46e-b728857205ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69a5787c-e016-4701-a935-78d83fd9e2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bf0ed943-f40a-4503-b46e-b728857205ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69a5787c-e016-4701-a935-78d83fd9e2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_62f7d8d9-2750-4ed5-be2e-2b08461558a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69a5787c-e016-4701-a935-78d83fd9e2cc" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_62f7d8d9-2750-4ed5-be2e-2b08461558a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_006c7af4-11a8-40e5-ad72-cbfdcf3ace02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69a5787c-e016-4701-a935-78d83fd9e2cc" xlink:to="loc_us-gaap_EmployeeStockOptionMember_006c7af4-11a8-40e5-ad72-cbfdcf3ace02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c9d0c0fc-ebe7-4939-a4ba-c55cac0d9642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c9d0c0fc-ebe7-4939-a4ba-c55cac0d9642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_faf0b1f5-1935-4717-8d81-cfdf2bcaf8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c9d0c0fc-ebe7-4939-a4ba-c55cac0d9642" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_faf0b1f5-1935-4717-8d81-cfdf2bcaf8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_FoamixMember_3eead371-bd9a-4a68-8cd5-1c8ec7faff96" xlink:href="vyne-20211231.xsd#vyne_FoamixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_faf0b1f5-1935-4717-8d81-cfdf2bcaf8b6" xlink:to="loc_vyne_FoamixMember_3eead371-bd9a-4a68-8cd5-1c8ec7faff96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_29517030-efcf-4940-a799-a248555700ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ef40ef58-8b5f-4112-bfb3-9487876577f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ef40ef58-8b5f-4112-bfb3-9487876577f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_c8252290-e9d7-4120-af2f-d50649f87351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_c8252290-e9d7-4120-af2f-d50649f87351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_bc00e382-1ec9-4139-adeb-2a23a8f6d272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_bc00e382-1ec9-4139-adeb-2a23a8f6d272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_590e1c1a-f869-44c6-8cd5-879d60e18523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_590e1c1a-f869-44c6-8cd5-879d60e18523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_3557b7e7-1047-48bb-abfe-8fb7b2e058a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_3557b7e7-1047-48bb-abfe-8fb7b2e058a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessAcquisitionContingentStockRightIssued_dfa0cea2-1f1c-4ce2-91c5-d115aa876700" xlink:href="vyne-20211231.xsd#vyne_BusinessAcquisitionContingentStockRightIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_BusinessAcquisitionContingentStockRightIssued_dfa0cea2-1f1c-4ce2-91c5-d115aa876700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue_0c91f516-4dd1-4b69-96d5-e1a19c645cad" xlink:href="vyne-20211231.xsd#vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue_0c91f516-4dd1-4b69-96d5-e1a19c645cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ContingentStockRightSharesConversion_46680b11-417d-4c04-86ae-55767895e225" xlink:href="vyne-20211231.xsd#vyne_ContingentStockRightSharesConversion"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_ContingentStockRightSharesConversion_46680b11-417d-4c04-86ae-55767895e225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_BusinessCombinationEffectiveExchangeRatio_839bcbdd-62c6-43ee-b137-0d357ba7fea2" xlink:href="vyne-20211231.xsd#vyne_BusinessCombinationEffectiveExchangeRatio"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_BusinessCombinationEffectiveExchangeRatio_839bcbdd-62c6-43ee-b137-0d357ba7fea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_a24cd054-69bf-4200-b3e1-b7a79b03556a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_a24cd054-69bf-4200-b3e1-b7a79b03556a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost_f602cc31-eac3-46e9-b35d-65a7dc007fd9" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost_f602cc31-eac3-46e9-b35d-65a7dc007fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod_fb8db9e1-b516-40c3-8aa4-1686b923f3f4" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod_fb8db9e1-b516-40c3-8aa4-1686b923f3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_9654b379-4f9b-4f81-aa6a-5ed4c40a8414" xlink:href="vyne-20211231.xsd#vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment_9654b379-4f9b-4f81-aa6a-5ed4c40a8414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_65aaa3f1-ed41-4a40-8421-53413f6380a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_65aaa3f1-ed41-4a40-8421-53413f6380a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3602ad91-bb40-4ecf-a3f0-0fa62b8081ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3602ad91-bb40-4ecf-a3f0-0fa62b8081ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0e4e69e8-d3e0-4dcf-ac0d-e612a492ef30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0e4e69e8-d3e0-4dcf-ac0d-e612a492ef30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bf7049e1-d1f4-4d51-91c3-954bb1dcf08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bf7049e1-d1f4-4d51-91c3-954bb1dcf08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fbed3dac-7370-43c0-a15d-f5f235d174d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fbed3dac-7370-43c0-a15d-f5f235d174d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e30a927f-54bd-4cd3-a7fb-9d28f24d76a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e30a927f-54bd-4cd3-a7fb-9d28f24d76a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9bf29c80-28b7-445d-ae02-40afacb6fcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10a2b060-1f76-4d58-a06f-e99a6be10b62" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9bf29c80-28b7-445d-ae02-40afacb6fcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f93edf63-2675-4055-86c6-9f207d0710aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d81dfca5-5275-4de6-a9ce-5729ee6dc307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f93edf63-2675-4055-86c6-9f207d0710aa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d81dfca5-5275-4de6-a9ce-5729ee6dc307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d646ba08-5a3e-443c-8a80-546c9c6f7af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d81dfca5-5275-4de6-a9ce-5729ee6dc307" xlink:to="loc_us-gaap_AwardTypeAxis_d646ba08-5a3e-443c-8a80-546c9c6f7af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58a46d1b-799d-40ab-9cc0-fc03e839a499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d646ba08-5a3e-443c-8a80-546c9c6f7af4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58a46d1b-799d-40ab-9cc0-fc03e839a499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fca3447d-afb0-4227-a9e4-c3d2ec1fcc14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58a46d1b-799d-40ab-9cc0-fc03e839a499" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fca3447d-afb0-4227-a9e4-c3d2ec1fcc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6784c2b3-8403-4223-a597-2fe41840f61d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58a46d1b-799d-40ab-9cc0-fc03e839a499" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6784c2b3-8403-4223-a597-2fe41840f61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fcdf6cf8-94d7-4819-96f6-6bd0b10dac98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d81dfca5-5275-4de6-a9ce-5729ee6dc307" xlink:to="loc_srt_RangeAxis_fcdf6cf8-94d7-4819-96f6-6bd0b10dac98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b1f8ab6b-95d3-4f0c-8bb8-635f673bd637" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fcdf6cf8-94d7-4819-96f6-6bd0b10dac98" xlink:to="loc_srt_RangeMember_b1f8ab6b-95d3-4f0c-8bb8-635f673bd637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7a8967a8-5657-41b0-b475-19a684742cb1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b1f8ab6b-95d3-4f0c-8bb8-635f673bd637" xlink:to="loc_srt_MinimumMember_7a8967a8-5657-41b0-b475-19a684742cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_be4a9ed9-5687-44a0-a51a-0a56140d071f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b1f8ab6b-95d3-4f0c-8bb8-635f673bd637" xlink:to="loc_srt_MaximumMember_be4a9ed9-5687-44a0-a51a-0a56140d071f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d81dfca5-5275-4de6-a9ce-5729ee6dc307" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4d7d7bc3-d9ae-4f75-a9b8-f228ce2f22b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4d7d7bc3-d9ae-4f75-a9b8-f228ce2f22b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_29a273b6-fe86-4673-948b-70630f014169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_29a273b6-fe86-4673-948b-70630f014169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a8c7ec44-f17e-4121-8898-afeef66571c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a8c7ec44-f17e-4121-8898-afeef66571c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_32da9717-b40e-43d9-8c84-40f530020fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_32da9717-b40e-43d9-8c84-40f530020fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_26e3fa7c-dc43-40bd-9020-a2ab97812d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_26e3fa7c-dc43-40bd-9020-a2ab97812d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f0824fe-cc37-4bd5-b9bb-489248122c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_078965a1-a125-43ae-b4f7-35739d13f6d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8f0824fe-cc37-4bd5-b9bb-489248122c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91f15673-c35b-4311-a30f-bdde0f81bd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d448d03e-d687-4588-a5f6-08fe421be724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91f15673-c35b-4311-a30f-bdde0f81bd4e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d448d03e-d687-4588-a5f6-08fe421be724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bda0e598-9edc-40ce-bcd1-248cde2ab661" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d448d03e-d687-4588-a5f6-08fe421be724" xlink:to="loc_srt_RangeAxis_bda0e598-9edc-40ce-bcd1-248cde2ab661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9f12ce91-4761-4905-9adf-bafdd35c221f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bda0e598-9edc-40ce-bcd1-248cde2ab661" xlink:to="loc_srt_RangeMember_9f12ce91-4761-4905-9adf-bafdd35c221f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_64160480-e525-4b00-8a71-3f814d8db826" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9f12ce91-4761-4905-9adf-bafdd35c221f" xlink:to="loc_srt_MinimumMember_64160480-e525-4b00-8a71-3f814d8db826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_de9c9346-42eb-4c5f-9e38-2400129bc933" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9f12ce91-4761-4905-9adf-bafdd35c221f" xlink:to="loc_srt_MaximumMember_de9c9346-42eb-4c5f-9e38-2400129bc933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e927e813-2b11-41a0-81af-4ca05788932c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d448d03e-d687-4588-a5f6-08fe421be724" xlink:to="loc_us-gaap_AwardTypeAxis_e927e813-2b11-41a0-81af-4ca05788932c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a7e8d9c-26a0-4109-8c0c-c0e92426effe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e927e813-2b11-41a0-81af-4ca05788932c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a7e8d9c-26a0-4109-8c0c-c0e92426effe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_68553ae9-6a0b-4ba4-ba9a-3427836968e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a7e8d9c-26a0-4109-8c0c-c0e92426effe" xlink:to="loc_us-gaap_EmployeeStockOptionMember_68553ae9-6a0b-4ba4-ba9a-3427836968e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d448d03e-d687-4588-a5f6-08fe421be724" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_98a8ed2f-3f62-43e2-b81b-04b2af706e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_SharePrice_98a8ed2f-3f62-43e2-b81b-04b2af706e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5b70ac83-e7e5-4e93-bdca-38f6696c7f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5b70ac83-e7e5-4e93-bdca-38f6696c7f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_318466b4-9b4d-43c6-8b5c-46bce0e5aeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_318466b4-9b4d-43c6-8b5c-46bce0e5aeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70421b43-65b5-4530-a662-719ea2d24452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70421b43-65b5-4530-a662-719ea2d24452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_67539484-52f5-42df-96a2-be9897c840f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_67539484-52f5-42df-96a2-be9897c840f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dd8f43d7-666f-48bb-b437-3811a67bda97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dd8f43d7-666f-48bb-b437-3811a67bda97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5b82def4-ce0d-41d6-afb3-2f5708921fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dbf2bd35-ce8c-4708-b870-0b7e95827391" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5b82def4-ce0d-41d6-afb3-2f5708921fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e1997b36-2c5e-4cb0-ba03-48cf96cab2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f6a4d303-f6fa-4b2f-90cf-e1a0296f5d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e1997b36-2c5e-4cb0-ba03-48cf96cab2f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f6a4d303-f6fa-4b2f-90cf-e1a0296f5d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f6cf3e90-1e6f-4501-81d9-65421d02c669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f6a4d303-f6fa-4b2f-90cf-e1a0296f5d7a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f6cf3e90-1e6f-4501-81d9-65421d02c669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2e05b9ae-0ecf-48d5-9f7a-835e0f18eaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f6a4d303-f6fa-4b2f-90cf-e1a0296f5d7a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2e05b9ae-0ecf-48d5-9f7a-835e0f18eaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_be214273-43e7-4e47-91b0-ebf74abe204c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f6a4d303-f6fa-4b2f-90cf-e1a0296f5d7a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_be214273-43e7-4e47-91b0-ebf74abe204c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5df8abcf-a831-47b4-9121-74dc152d6dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f6a4d303-f6fa-4b2f-90cf-e1a0296f5d7a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5df8abcf-a831-47b4-9121-74dc152d6dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_e4c7be71-c226-42d6-93a4-770222ae6092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f6a4d303-f6fa-4b2f-90cf-e1a0296f5d7a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_e4c7be71-c226-42d6-93a4-770222ae6092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2bdbe5c2-eaf7-469c-9521-321c70e10139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f6a4d303-f6fa-4b2f-90cf-e1a0296f5d7a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2bdbe5c2-eaf7-469c-9521-321c70e10139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ae20d283-6605-425d-904d-1eee8a5b963d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e1997b36-2c5e-4cb0-ba03-48cf96cab2f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ae20d283-6605-425d-904d-1eee8a5b963d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_003268b1-251c-4bc5-ab51-59b0b8052940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e1997b36-2c5e-4cb0-ba03-48cf96cab2f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_003268b1-251c-4bc5-ab51-59b0b8052940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dae45903-fcac-4fa7-8771-c770fa087eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_003268b1-251c-4bc5-ab51-59b0b8052940" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dae45903-fcac-4fa7-8771-c770fa087eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3db6e66c-cafb-413d-8aaa-93f728103133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_003268b1-251c-4bc5-ab51-59b0b8052940" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3db6e66c-cafb-413d-8aaa-93f728103133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90aeeecd-3053-4984-a720-f4c54915e5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_003268b1-251c-4bc5-ab51-59b0b8052940" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90aeeecd-3053-4984-a720-f4c54915e5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3abb773f-1a14-48bb-a0fd-c6c5caaa5ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_003268b1-251c-4bc5-ab51-59b0b8052940" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3abb773f-1a14-48bb-a0fd-c6c5caaa5ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_9c5fe49c-e7c8-4c24-aa1e-11fdcac3e74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_003268b1-251c-4bc5-ab51-59b0b8052940" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_9c5fe49c-e7c8-4c24-aa1e-11fdcac3e74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a948d356-4708-4504-9514-a7ce94c3dc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_003268b1-251c-4bc5-ab51-59b0b8052940" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a948d356-4708-4504-9514-a7ce94c3dc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_24976686-7664-46fa-98e6-04fbf88cb4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e1997b36-2c5e-4cb0-ba03-48cf96cab2f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_24976686-7664-46fa-98e6-04fbf88cb4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_502d195d-5ccb-4117-8e60-88ab362fffff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b21e93ed-77e8-4cc4-a698-a37b73c3a87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_502d195d-5ccb-4117-8e60-88ab362fffff" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b21e93ed-77e8-4cc4-a698-a37b73c3a87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_74958e1f-7ec7-4ff9-abcb-182a63eb5726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b21e93ed-77e8-4cc4-a698-a37b73c3a87e" xlink:to="loc_us-gaap_AwardTypeAxis_74958e1f-7ec7-4ff9-abcb-182a63eb5726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_322b0ad6-5f17-43ed-ae4a-bd6820dc7e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_74958e1f-7ec7-4ff9-abcb-182a63eb5726" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_322b0ad6-5f17-43ed-ae4a-bd6820dc7e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_dba58862-52e6-449b-b2db-862244797fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_322b0ad6-5f17-43ed-ae4a-bd6820dc7e4d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_dba58862-52e6-449b-b2db-862244797fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d5cdc25-7931-4f54-a8d2-afd10aa198dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b21e93ed-77e8-4cc4-a698-a37b73c3a87e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d5cdc25-7931-4f54-a8d2-afd10aa198dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d5cdc25-7931-4f54-a8d2-afd10aa198dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77a5ff48-e5b7-4845-8ae5-fcb29fcaa370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77a5ff48-e5b7-4845-8ae5-fcb29fcaa370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5f1d1381-5a80-4a2a-906d-7edd06c3aca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5f1d1381-5a80-4a2a-906d-7edd06c3aca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c07fd82d-8655-4414-97eb-6071f3105f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c07fd82d-8655-4414-97eb-6071f3105f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e6de74a4-b789-4af1-a8b9-9ae52b556093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e6de74a4-b789-4af1-a8b9-9ae52b556093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8439478d-147b-4d3e-8556-6b08651c46b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_caeb0d82-895b-4962-a9fe-914c2030fb4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8439478d-147b-4d3e-8556-6b08651c46b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f20d4846-0692-4939-a453-c35a30e391ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_583ec143-b36a-4cf7-ba41-e45258ccd52a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f20d4846-0692-4939-a453-c35a30e391ff" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_583ec143-b36a-4cf7-ba41-e45258ccd52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e5f59b99-2c0e-4ad9-968b-a8f3a417bc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_583ec143-b36a-4cf7-ba41-e45258ccd52a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e5f59b99-2c0e-4ad9-968b-a8f3a417bc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_eea1b794-89e8-4726-8b0a-872626c6454f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e5f59b99-2c0e-4ad9-968b-a8f3a417bc5c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_eea1b794-89e8-4726-8b0a-872626c6454f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_68c89e96-7ea2-43bf-88e0-f0b321d18e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eea1b794-89e8-4726-8b0a-872626c6454f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_68c89e96-7ea2-43bf-88e0-f0b321d18e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_c9181d52-f5c5-4d93-beaa-6520ee3b7dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eea1b794-89e8-4726-8b0a-872626c6454f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_c9181d52-f5c5-4d93-beaa-6520ee3b7dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ccf50fb-e2dc-4090-99e6-dde60152bef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_583ec143-b36a-4cf7-ba41-e45258ccd52a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ccf50fb-e2dc-4090-99e6-dde60152bef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ca390c55-a27e-462d-b169-5ab0235f4c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7ccf50fb-e2dc-4090-99e6-dde60152bef4" xlink:to="loc_us-gaap_ShareBasedCompensation_ca390c55-a27e-462d-b169-5ab0235f4c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAX" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAX"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAX" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dda2c7a6-ee5f-4dd8-a519-62534573b178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8c280808-2674-42f1-8551-bb8cbc7ff654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dda2c7a6-ee5f-4dd8-a519-62534573b178" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8c280808-2674-42f1-8551-bb8cbc7ff654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXTables" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXTables"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_36c0a079-2506-4ae3-900f-09210768379a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock_6391c2a1-4337-4f79-9204-53c75b297577" xlink:href="vyne-20211231.xsd#vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36c0a079-2506-4ae3-900f-09210768379a" xlink:to="loc_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock_6391c2a1-4337-4f79-9204-53c75b297577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3b697e4d-a608-44ad-85e9-04d998798714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36c0a079-2506-4ae3-900f-09210768379a" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3b697e4d-a608-44ad-85e9-04d998798714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_009efc90-67ee-4563-92fa-4d47b9192916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36c0a079-2506-4ae3-900f-09210768379a" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_009efc90-67ee-4563-92fa-4d47b9192916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_f819a0cb-01b9-4acb-85ef-9647b100a426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36c0a079-2506-4ae3-900f-09210768379a" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_f819a0cb-01b9-4acb-85ef-9647b100a426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_972c8414-8d70-4827-8da0-cfe2d193a442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_3a2bec77-10e6-44f9-bdd5-57456b3e1656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_972c8414-8d70-4827-8da0-cfe2d193a442" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_3a2bec77-10e6-44f9-bdd5-57456b3e1656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_dab6ab05-423a-46fb-aa0d-e399c73329ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_3a2bec77-10e6-44f9-bdd5-57456b3e1656" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_dab6ab05-423a-46fb-aa0d-e399c73329ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_2a592d86-e474-4b86-8eb2-5960dd0d72e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_dab6ab05-423a-46fb-aa0d-e399c73329ab" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_2a592d86-e474-4b86-8eb2-5960dd0d72e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_a2b81508-b9b0-41d6-8c9e-ec8f9b919620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_2a592d86-e474-4b86-8eb2-5960dd0d72e8" xlink:to="loc_us-gaap_DomesticCountryMember_a2b81508-b9b0-41d6-8c9e-ec8f9b919620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_9e999f04-2096-4886-a1b1-7353f6c2e08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_2a592d86-e474-4b86-8eb2-5960dd0d72e8" xlink:to="loc_us-gaap_ForeignCountryMember_9e999f04-2096-4886-a1b1-7353f6c2e08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_86450b0c-432f-44e7-8101-8585bfe7beff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_3a2bec77-10e6-44f9-bdd5-57456b3e1656" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_86450b0c-432f-44e7-8101-8585bfe7beff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_d61475c6-cb81-4255-9a5b-3eb02fb483bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_86450b0c-432f-44e7-8101-8585bfe7beff" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_d61475c6-cb81-4255-9a5b-3eb02fb483bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_91a98075-d550-418f-9421-a3de967ed4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract_d61475c6-cb81-4255-9a5b-3eb02fb483bc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_91a98075-d550-418f-9421-a3de967ed4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a426f433-00b4-4d42-869e-c643728e6cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_86450b0c-432f-44e7-8101-8585bfe7beff" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a426f433-00b4-4d42-869e-c643728e6cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aaca58df-75bc-4fb8-b9f6-3841f7b018c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a426f433-00b4-4d42-869e-c643728e6cd2" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_aaca58df-75bc-4fb8-b9f6-3841f7b018c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9fac325a-8aba-4e5a-b0d1-9ac0298eb963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a426f433-00b4-4d42-869e-c643728e6cd2" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9fac325a-8aba-4e5a-b0d1-9ac0298eb963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7d7d0bf8-3769-44d7-8a7b-4bd43bb7a9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a426f433-00b4-4d42-869e-c643728e6cd2" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_7d7d0bf8-3769-44d7-8a7b-4bd43bb7a9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXIncomeTaxReconciliationDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e465e979-69a9-4458-83b8-bc413a0b35ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_a1cb9d27-9ec1-4b8f-aca1-5f681968e2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e465e979-69a9-4458-83b8-bc413a0b35ec" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_a1cb9d27-9ec1-4b8f-aca1-5f681968e2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_30de94a0-bcaf-46b3-9065-89d49d39d056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e465e979-69a9-4458-83b8-bc413a0b35ec" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_30de94a0-bcaf-46b3-9065-89d49d39d056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent_b589c664-a512-424a-8258-8fea4ff0880d" xlink:href="vyne-20211231.xsd#vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e465e979-69a9-4458-83b8-bc413a0b35ec" xlink:to="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent_b589c664-a512-424a-8258-8fea4ff0880d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent_5f45b59c-f962-417a-b4d9-29221003780d" xlink:href="vyne-20211231.xsd#vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e465e979-69a9-4458-83b8-bc413a0b35ec" xlink:to="loc_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent_5f45b59c-f962-417a-b4d9-29221003780d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent_bb1e92c4-a12f-4bb3-b91f-1ca33bf757c0" xlink:href="vyne-20211231.xsd#vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e465e979-69a9-4458-83b8-bc413a0b35ec" xlink:to="loc_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent_bb1e92c4-a12f-4bb3-b91f-1ca33bf757c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_19c6801f-ac07-4020-817b-bed88056766e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e465e979-69a9-4458-83b8-bc413a0b35ec" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_19c6801f-ac07-4020-817b-bed88056766e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_aa95f4a5-47cf-4c17-8e4d-e59b79944f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e465e979-69a9-4458-83b8-bc413a0b35ec" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_aa95f4a5-47cf-4c17-8e4d-e59b79944f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_be0b705e-d0da-4fdd-b4b2-90df41b5b730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e465e979-69a9-4458-83b8-bc413a0b35ec" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_be0b705e-d0da-4fdd-b4b2-90df41b5b730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_46a78420-8017-42b7-9adb-fe3aa160767f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e465e979-69a9-4458-83b8-bc413a0b35ec" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_46a78420-8017-42b7-9adb-fe3aa160767f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXNarrativeDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1ef47936-0cd3-4988-a4d6-5fe038ade2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_IncomeTaxTable_56b15da0-5940-404b-82d7-ce2bc26c097a" xlink:href="vyne-20211231.xsd#vyne_IncomeTaxTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1ef47936-0cd3-4988-a4d6-5fe038ade2d2" xlink:to="loc_vyne_IncomeTaxTable_56b15da0-5940-404b-82d7-ce2bc26c097a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b49d24a1-992e-45a3-8ab2-c6e878973a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_IncomeTaxTable_56b15da0-5940-404b-82d7-ce2bc26c097a" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b49d24a1-992e-45a3-8ab2-c6e878973a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d88a2948-0089-48d1-a218-c8749600be6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b49d24a1-992e-45a3-8ab2-c6e878973a36" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d88a2948-0089-48d1-a218-c8749600be6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_af9c6fb5-f545-4b4d-9ad3-42a85f6681bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d88a2948-0089-48d1-a218-c8749600be6a" xlink:to="loc_us-gaap_DomesticCountryMember_af9c6fb5-f545-4b4d-9ad3-42a85f6681bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_3e047bf3-48bb-4966-b4b7-dc7d834ff1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d88a2948-0089-48d1-a218-c8749600be6a" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_3e047bf3-48bb-4966-b4b7-dc7d834ff1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:href="vyne-20211231.xsd#vyne_IncomeTaxLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_IncomeTaxTable_56b15da0-5940-404b-82d7-ce2bc26c097a" xlink:to="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_600a10ab-1699-4a18-8e33-ad5cb8c686f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_600a10ab-1699-4a18-8e33-ad5cb8c686f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d716ac25-fb38-477a-85e4-e39ed61dbf74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d716ac25-fb38-477a-85e4-e39ed61dbf74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_73f0e613-34ca-4b7a-80fe-d96bcbb10ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_73f0e613-34ca-4b7a-80fe-d96bcbb10ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_15cfdaaf-677e-4af0-bdca-80d4a55dbb79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_us-gaap_OperatingLossCarryforwards_15cfdaaf-677e-4af0-bdca-80d4a55dbb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_fced4147-9e45-423e-8976-137eaf03dd24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_fced4147-9e45-423e-8976-137eaf03dd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain_6b0c4e1c-8bc8-4754-b380-7bb1be5c0af7" xlink:href="vyne-20211231.xsd#vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_IncomeTaxLineItems_d1d870f0-a9ef-4b99-aef4-a4cf7308376f" xlink:to="loc_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain_6b0c4e1c-8bc8-4754-b380-7bb1be5c0af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXScheduleofDeferredIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ca525c31-9f06-43a0-a975-ed5baa310449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_e4e096bd-6057-47fc-8c92-d2c5424d847a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ca525c31-9f06-43a0-a975-ed5baa310449" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_e4e096bd-6057-47fc-8c92-d2c5424d847a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ad226d70-4f1b-4a5f-b2d8-3bada2750896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_e4e096bd-6057-47fc-8c92-d2c5424d847a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ad226d70-4f1b-4a5f-b2d8-3bada2750896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_76e6f1b6-9f7a-4a65-9d05-6e994b746acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_e4e096bd-6057-47fc-8c92-d2c5424d847a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_76e6f1b6-9f7a-4a65-9d05-6e994b746acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_8fabbd47-6abd-47d8-9e13-c2e987bd3f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_e4e096bd-6057-47fc-8c92-d2c5424d847a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_8fabbd47-6abd-47d8-9e13-c2e987bd3f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_16232826-dcba-453b-85ea-465383c05676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_e4e096bd-6057-47fc-8c92-d2c5424d847a" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_16232826-dcba-453b-85ea-465383c05676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_c9912a9b-dee9-4aae-ba69-a346c701967e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_e4e096bd-6057-47fc-8c92-d2c5424d847a" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_c9912a9b-dee9-4aae-ba69-a346c701967e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_122b9e5c-7a4c-4393-9548-de29bc287fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_e4e096bd-6057-47fc-8c92-d2c5424d847a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_122b9e5c-7a4c-4393-9548-de29bc287fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_e4207804-b3bf-45b2-9a5f-3ef3d971a395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ca525c31-9f06-43a0-a975-ed5baa310449" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_e4207804-b3bf-45b2-9a5f-3ef3d971a395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_831820e6-a0e9-4d25-a8c4-ad9e10ac1566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_e4207804-b3bf-45b2-9a5f-3ef3d971a395" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_831820e6-a0e9-4d25-a8c4-ad9e10ac1566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_c3141099-f0f5-47de-b5be-b486a1d659e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_e4207804-b3bf-45b2-9a5f-3ef3d971a395" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_c3141099-f0f5-47de-b5be-b486a1d659e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6eb44bec-55c8-4c6c-8e64-9145cb55e78f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_e4207804-b3bf-45b2-9a5f-3ef3d971a395" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_6eb44bec-55c8-4c6c-8e64-9145cb55e78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a4698b02-8f15-461c-981c-d6ca9a42f57a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ca525c31-9f06-43a0-a975-ed5baa310449" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a4698b02-8f15-461c-981c-d6ca9a42f57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_54564b55-559d-41d4-b94b-1fd17c4ae761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_d8b3a90a-fc94-4a4c-9d95-11aae41ed9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_54564b55-559d-41d4-b94b-1fd17c4ae761" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_d8b3a90a-fc94-4a4c-9d95-11aae41ed9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_754f105c-59f4-44a5-b010-8d1bd0816419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_d8b3a90a-fc94-4a4c-9d95-11aae41ed9a8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_754f105c-59f4-44a5-b010-8d1bd0816419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_21fc8ce2-6344-420c-9c3f-2b3613c865f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_d8b3a90a-fc94-4a4c-9d95-11aae41ed9a8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_21fc8ce2-6344-420c-9c3f-2b3613c865f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4328ea3b-7575-4c07-89fc-6e099d797b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_d8b3a90a-fc94-4a4c-9d95-11aae41ed9a8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4328ea3b-7575-4c07-89fc-6e099d797b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3da61f7f-a687-4d74-96b9-c62b715f5ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_d8b3a90a-fc94-4a4c-9d95-11aae41ed9a8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_3da61f7f-a687-4d74-96b9-c62b715f5ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_3ed938a2-c94f-4810-b856-bd081e16d0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_d8b3a90a-fc94-4a4c-9d95-11aae41ed9a8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_3ed938a2-c94f-4810-b856-bd081e16d0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/INCOMETAXScheduleofRollforwardofValuationAllowanceDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#INCOMETAXScheduleofRollforwardofValuationAllowanceDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/INCOMETAXScheduleofRollforwardofValuationAllowanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f07bada3-2304-4283-9dff-33d7c71d131b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DeferredTaxAssetsValuationAllowanceRollForward_f150d448-53e8-4400-80dd-c56c1b68a842" xlink:href="vyne-20211231.xsd#vyne_DeferredTaxAssetsValuationAllowanceRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f07bada3-2304-4283-9dff-33d7c71d131b" xlink:to="loc_vyne_DeferredTaxAssetsValuationAllowanceRollForward_f150d448-53e8-4400-80dd-c56c1b68a842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_01a2d33e-18b0-44d5-84e9-642554c27559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_DeferredTaxAssetsValuationAllowanceRollForward_f150d448-53e8-4400-80dd-c56c1b68a842" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_01a2d33e-18b0-44d5-84e9-642554c27559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_f7411d3f-b391-4182-906c-6fdc5a355fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_DeferredTaxAssetsValuationAllowanceRollForward_f150d448-53e8-4400-80dd-c56c1b68a842" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_f7411d3f-b391-4182-906c-6fdc5a355fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a3b6ff28-92b6-4989-8b79-5269fc152c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_vyne_DeferredTaxAssetsValuationAllowanceRollForward_f150d448-53e8-4400-80dd-c56c1b68a842" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a3b6ff28-92b6-4989-8b79-5269fc152c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="vyne-20211231.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_89b17bb1-e520-453d-8dfd-c235a3ef1120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_2777ed1d-42e8-44e5-ac9f-93222fa5fa3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_89b17bb1-e520-453d-8dfd-c235a3ef1120" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_2777ed1d-42e8-44e5-ac9f-93222fa5fa3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="vyne-20211231.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_c54962bc-9a5d-4afc-b3ed-309d2ffd3996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_c54962bc-9a5d-4afc-b3ed-309d2ffd3996" xlink:to="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_84a814ed-8f9a-478c-b1fe-e1f5e97cc8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_84a814ed-8f9a-478c-b1fe-e1f5e97cc8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2793dbac-3d84-4183-9658-fd755be46c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_84a814ed-8f9a-478c-b1fe-e1f5e97cc8bd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2793dbac-3d84-4183-9658-fd755be46c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_edff4c06-6343-4edb-a20f-fc63df3a40d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2793dbac-3d84-4183-9658-fd755be46c2a" xlink:to="loc_us-gaap_SubsequentEventMember_edff4c06-6343-4edb-a20f-fc63df3a40d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7a705235-09c2-4d41-a473-304be79b47d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:to="loc_srt_StatementScenarioAxis_7a705235-09c2-4d41-a473-304be79b47d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_3854419d-2096-49da-a1a4-bcedf7cdc9fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7a705235-09c2-4d41-a473-304be79b47d3" xlink:to="loc_srt_ScenarioUnspecifiedDomain_3854419d-2096-49da-a1a4-bcedf7cdc9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_4f904826-4f9b-47e1-a7b8-0b6e62be1464" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_3854419d-2096-49da-a1a4-bcedf7cdc9fc" xlink:to="loc_srt_ScenarioForecastMember_4f904826-4f9b-47e1-a7b8-0b6e62be1464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a5df1180-871d-4814-9b08-b77306fd4488" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:to="loc_srt_RangeAxis_a5df1180-871d-4814-9b08-b77306fd4488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f3bf8ef1-7919-4065-aef8-95613afa54e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a5df1180-871d-4814-9b08-b77306fd4488" xlink:to="loc_srt_RangeMember_f3bf8ef1-7919-4065-aef8-95613afa54e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3c5bf9c2-2830-43b9-b3f1-91b074689156" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f3bf8ef1-7919-4065-aef8-95613afa54e0" xlink:to="loc_srt_MinimumMember_3c5bf9c2-2830-43b9-b3f1-91b074689156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6750b6a5-ef64-468a-ac35-fe89b633f4a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f3bf8ef1-7919-4065-aef8-95613afa54e0" xlink:to="loc_srt_MaximumMember_6750b6a5-ef64-468a-ac35-fe89b633f4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_00540fdf-d54e-4af3-bc32-bdf4490b2a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_00540fdf-d54e-4af3-bc32-bdf4490b2a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2975f6ef-e63c-4f70-8ef8-cff21a492a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_00540fdf-d54e-4af3-bc32-bdf4490b2a56" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2975f6ef-e63c-4f70-8ef8-cff21a492a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_CantorSalesAgreementMember_460ab178-c25e-4de4-82c3-13dc8a50a79f" xlink:href="vyne-20211231.xsd#vyne_CantorSalesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2975f6ef-e63c-4f70-8ef8-cff21a492a3e" xlink:to="loc_vyne_CantorSalesAgreementMember_460ab178-c25e-4de4-82c3-13dc8a50a79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_LincolnParkEquityPurchaseAgreementMember_72ddd530-bc61-42af-8b06-7ffa37858148" xlink:href="vyne-20211231.xsd#vyne_LincolnParkEquityPurchaseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2975f6ef-e63c-4f70-8ef8-cff21a492a3e" xlink:to="loc_vyne_LincolnParkEquityPurchaseAgreementMember_72ddd530-bc61-42af-8b06-7ffa37858148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a6d8161f-de5e-4f57-94d7-1d4234b958f1" xlink:to="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a5a21031-114a-462b-9d0e-6dd602c38cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a5a21031-114a-462b-9d0e-6dd602c38cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_8dacc3ba-46e1-421c-ab30-bd20f5fa760d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_8dacc3ba-46e1-421c-ab30-bd20f5fa760d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_d1324e6a-7bd0-4ee6-b600-5eafd0c1c3e4" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount_d1324e6a-7bd0-4ee6-b600-5eafd0c1c3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_c562c0a5-209f-47f8-ac89-c89624477423" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_c562c0a5-209f-47f8-ac89-c89624477423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_b70bf80f-4e6b-4bad-b6f3-bb5d8b90896f" xlink:href="vyne-20211231.xsd#vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales_b70bf80f-4e6b-4bad-b6f3-bb5d8b90896f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_4dad66b0-c2ea-47da-a4a1-9ba0f94a9f42" xlink:href="vyne-20211231.xsd#vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales_4dad66b0-c2ea-47da-a4a1-9ba0f94a9f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_b1260acf-21a1-4349-9d02-cf87a4b5f54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_b1260acf-21a1-4349-9d02-cf87a4b5f54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_02605f7f-85cb-4b3f-9540-f89bad762096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_02605f7f-85cb-4b3f-9540-f89bad762096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_1efb0977-0aa8-4f8f-aedd-ee5c91f7d7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_1efb0977-0aa8-4f8f-aedd-ee5c91f7d7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_7301adf8-01ba-4f1e-b489-1f06dd786a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_7301adf8-01ba-4f1e-b489-1f06dd786a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_5e400ecc-6959-45da-8ff6-39ba2a951eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_5e400ecc-6959-45da-8ff6-39ba2a951eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0c08e652-2ea9-4e2c-9a5a-92766f68cde4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_0c08e652-2ea9-4e2c-9a5a-92766f68cde4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_77cb0fc8-5741-492a-bd3c-3c1806305bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_77cb0fc8-5741-492a-bd3c-3c1806305bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_db129188-7650-4343-a2a8-99f3c6e1ecd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_db129188-7650-4343-a2a8-99f3c6e1ecd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_SaleOfStockConsiderationReceivableOnTransaction_39d1c383-52a2-4f17-a139-75b6c31273b5" xlink:href="vyne-20211231.xsd#vyne_SaleOfStockConsiderationReceivableOnTransaction"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_SaleOfStockConsiderationReceivableOnTransaction_39d1c383-52a2-4f17-a139-75b6c31273b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_vyne_EquityPurchaseAgreementPeriodInForce_f331f92e-1045-4894-bb66-191cf2be6162" xlink:href="vyne-20211231.xsd#vyne_EquityPurchaseAgreementPeriodInForce"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a65130cd-9c6a-4bc7-af27-20107e6e9732" xlink:to="loc_vyne_EquityPurchaseAgreementPeriodInForce_f331f92e-1045-4894-bb66-191cf2be6162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>exhibit1012-stuartexecut001.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEJ)*Y+15>*^M9WV17,+N>BJX)J9Y$B0O(RJHZDG %"DFKIC::T8ZBJ@U.Q)
M%Y;DG_IH*M9S0I)[,&FMQ:**JOJ5DCE'NX%8'!!D Q0Y);@DWL6J*CBFCG0/
M%(KH?XE.13)KRVMV"S3Q1D\@.X%',DKA9WL3T5%#<0W"EH94D4'&48$5+0FG
ML)Z!14,UU!;8\^:./=TWL!FB&Z@N<^3-')CKL8'%',KVN.SM<FHI*J_VG8CK
M>6__ '\%#DEN"3>Q;HJI_:EA_P _MO\ ]_!_C1_:EA_S^V__ '\%3[2/<?)+
ML6Z*AANH+G/D31R;>NQ@<4W[?:%V3[3#N7[PWC(YQ_.GS+N*S+%%-61'9E5E
M++PP!Z?6G50@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI_\ PD&D?\_\'_?50LNHO_EX6\SKW_A_F8/@2VGMTO?.ADCW%,;U(SUK4N]
M68WABBAC>:1&#@8( ()[>HS6U#+'/$DL3!HW&58="*DKU*6&C&DH/6QY%7$2
MG5=39LS-(L+BS-P]RZO),P9B#WQC_ ?A6G116\(J*LC&<G)W844451(4444
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M'^+T%>H@!0 !@"N"^'W_ !^7G^XO\S7?5&5PBJ',MV5FLY2Q#B]D%>>^/O\
MD*VW_7'^M>A5Y[X^_P"0K;?]<?ZU69_[NQ95_O*+?A"PAU+PY>VTZY1YOR.T
M<URFHV-QHVI-#(2)(V#(X[^A%=KX _Y!-S_UW_\ 916EXCT--8L3M %S&,QM
MZ^WXUR/">VPD)1^)(ZUC/88N<9?"V</KFM#6+"P+\7$.]9!Z_=P:W?A]_J[W
MZK_6N(DC>&1HY%*NIP5/8UV_P^_U=[]5_K7-@JDJF+4I;_\  .K'4XT\&XPV
M_P""=JWW37BCC,S =2QKVMONFO%6.+@D] _]:ZLX^Q\_T.7)?M_+]397P?K3
M*&%JN",C]XO^-+_PAVM_\^J_]_%_QKJ8O&VE)$JGS\@ ?<_^O3O^$XTGTG_[
MX_\ KU"PF"M\?XE/&8^_P?@S8T:VEL]'M+>9=LL<85AG.#5ZLS2=<M-9\W[+
MO_=XW;ACK_\ JK3KV:3BX+D=T>+54E-\ZLPHHHK0S"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*YSQ'K$L#BRMB
M5<C+L.HSV%='7&:C;R3^(;C"EB" H ]A7DYQ4J0H*-+>3L=>"A&52\]D49=.
MEU'2-1L$)::ZM)8P2>K%3C]<5X=H7B#<19W[%9%^57;O['WKZ?TK339J9)<&
M5AT_NBO"/BS\.;O2]5GU[2[9YM.N7,DPC&3 Y.3D?W2>_;\J]+(Z;H4?9U-W
MJ<^83YZG/#H26EW/97*7%M*T4J'*LIQ7MGA?7D\0:2MQ@+,AV2H.S>OT-?+.
MC^))+,+;W>Z2$<!NK+_B*]:^'6N16VNQJDP:VNU\LD'C=U4_T_&O4Q%+W;G-
M3FF>SU4U&S74-/FM6QB12 3V/:K5+7G-*2LS>+<7='GL7@*^$R>9<6_E[ANP
M6SC\J[Z*)884B0850% ]A535IKFVLGN+8Q_NE+L''4 =J;#<W2Z2]U.8R_EF
M10@P -N<&LJ&#IT5>GU-<1C:E=I5.AHT5BVNN1W3V$4;HTDPS*HS\IVY_G3=
M2U::VU46JRPQ)Y(DW2*3DY(QQ]*Z?9RO8Y/;1M<W*P?$N@R:XD"QS+%Y1).X
M9SFK=[>RVNCBY#Q&0[/G/"_,0,_3FFZ7J,MW<30N\$RHH82P'*\YX^O%9U*"
MJTVI;&M/$NE43CN4?#?AR70YYY))TE$B@ *",8KHZR+C5_)U9+8!3 "$E?/W
M6;.W^7ZU-JU[+9QP^4T:F20(6DZ"E2PZI14(+0*V*=63J3>IHUS7B/PS-K=Y
M%-'<)&$3;AE)SS6GIU_+<V]P9#&S0L5#QG*MQGBJFF:I/>S1AKBW^;):)5.X
M?CTIU<,JL7&>P4<6Z,U.&X_PYHLFB6<L$DJR%Y-^5&.P']*V:H)>R-J-[;D#
M;!&C*?7(/^%-MKJYO-'BN8C&LSKGY@2**=%4X*,=D%2NZDW*6[,K7_":ZK=+
M<V\BPRGB3*Y#>_UJQX;T"70UG$DRR>801M&,8JYI%S=WEOY]P8MC9"A 01@X
MJ2WORUE<7,H&(G<8'HI-9?4J<:KJ):FOUZI*DJ3?NEX\C%<&W@&Y9V(O8N3G
M[IKJ;.74YVBGD%N+>0;M@SN4'ISWJ'4=4GMK\6Z-#"FP,'F!VN?3(Z4ZV#A7
M:4];"H8Z>'3E#2YS7_"O[G_G^B_[X-'_  K^Y_Y_8O\ O@UWJ$E 3C)'..E+
M7+_9F'['9_:F)_F_ P/#7A^70S<&2=9/-VXVC&,9_P :Z"BBNNE3C2CR1V..
MK5E5DYSW84445H9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5&L,:RM($ =NK8Y-244FD]PN%-95=2K*&4C!!&0
M:=13 XW5_A;X0UF5Y9])6*9^3);N8SGUP#C]*QK;X,:3IMRMQI>K:G;.KAMK
M,CIQ[;0?UKTNBM%5FE:Y/)&][#5!"@$Y('7UIU%%9E$%Y;"[M)K=F*B5"A([
M9IIM0;#[)N.WRO+W=^F,U9HIW8K(H1Z9'$++:W-J, X^]\NWFH[O26N+\7D=
MTT,GE",@(&XR3W^M:=%-3DG<ETXVM8ISV/VFP6VFE+8*DMM'."#T_"BWL$M+
MF:2%BL<N"8@. WJ/2KE%+F=K#Y(WN9+Z!:2)-Y@+32,6,O\ $#GC'TJS<Z>E
MU';I*Q81,&.1]['K5VBGSR[B]G'L1B%%B,:*J*1C"C%9]EI4MD\>+UWB3/[L
MQJ,_CUK4HH4FE8;@FTS.NM,:>Y:>&ZDMW= DFT A@.G7OS5JWMH[:U2WC!"(
MNT9J>BDY-JP*"3N5K*T6RM5@5BP!)R?<YI(+)(;>6$DNLCLQS_M'I5JBCF8<
MJ,ZVTR2WDC'VV9H(_N1$# ]B>II+_3)+UFQ>21QN-KQ[0P(]L]#6E13YY7N+
MV<;6&1H(XU0=%  I]%%26%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5CQ^%])BL-7LA;%K?5I99KQ&<GS&D4*WTR .E;%% &&?".C?V)INCBU*V6
MFRQ36T:N1M>,Y4D]3SR<]:K7W@/0=2O;VXNH;ATON;FV%RZP2OMV;S&#MW8
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M% '&VOPQT&QA2&UN=:@A0DK''JUPJC)R> ^.I-=E110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#<7%F\%M-Y#R#:9@,L@/4J/[WIG@=><8)I]A;:5IUO8640BMK>,1QH.R@8%
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MG&!DUS_AN'4;SP3X.FT>]LI-3MK2[$=AJ +174(D56&>JLH" 'T)!XS7J_\
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MSZ8KK[:^L+KXB>*;+Q UMA;.W%BET0%:V*$R%,\8+D[B/0>E=M_8^E^6\?\
M9MGL<[F7R%PQ]2,<TZ72M.F:W:6PM9&MO]07A4F+_=X^7\* /']%^R2^ _A?
M,IA>:+5XHMX(++\LN5SV[<?2MJRMM)&J_$>UFALQ,9,K$R+NV&U0D@=<9Y^M
M>BG2=-,4,1T^T,</$2>2N$_W1CC\*DDL+.62622T@=Y5"2,T8)=1T!..1[4
M>7:'=%#\,H+[:=*FTDJF_F,W?E)L#=L[=^WW)QS6;XHL4@\/_$*&.-/[&AO[
M-[,?PQ3L8S/L/\/S,,XZ$L/6O8'TO3Y+(V3V-LUH>?(:%2G_ 'SC%*VFV#VB
M6C65L;9/N0F)=B_1<8% 'GVHV&F:7\0]1@MRFFVUQX6GDN9+90K<2@>:<=6
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M%N&M]K1%AW(/YA<=,UZ35673;":Y%S+96TDXQB5HE+<=.<9H S?%+JEA8[F
MSJ=F!D]3YZ5P7BO2[WP1->SZ5 TOAO6I MU:I_RY7+, )5'9&. 1V./85ZE<
MV5I>!1=6L,X0Y7S8PV#[9J1HHWB,3(K1D8*$9&/3% 'GWB2*"X^,7AR&:XDA
M']F71W1S&)OO+W!!['\JZC1$L;"^OM.MK^6\F=_M<GF2F5H@P50&8DGG8<9[
M ^E:$^DZ;=2F6XT^TFD/5Y(58G\2*DM;"SL0PM+2"W#XW>5&$S]<4 6****
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M68:G )(A]G51NR&+8DRN2 N>G;C.M>^+95%D-'T2^U8W5H+T&$I&BQ'&,LY
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M$OW7Y>N!G%)JMOJ?B*Z\;W5KH]_'#>Z!'!9>? T;3L/-R IY!R?NGG&#CD4
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M$_=8KMX!ZY% 'H=%<+I'BC7-8\0W,5O-HWD6M_):SZ:Q9;R.)6*^<26P<X#
M;<$'KFMSQ=KTWA_1XY;2!)[Z[NHK.TCD)"&61MH+$<X')/TH WJK0ZC8W%Y+
M:0WMO)<Q#,D*2J73ZJ#D5RD6L^)K/Q"OA_49M*DNKVSDN+"\AMY$C#QE0Z/&
M7)(PP((85SWP1LKQ= N-0G&GLD]S<!I([<BX9_,Y+2%CE>.!CTYH ]4R,XR,
M^E*2 ,DX%>-?$/[59_%6#7K,.TVB:+'?-&O62$7#)*O_ '[=C^%;/Q3OQK6@
M6VA:?-NCO[:74;B1#Q]EA3S/R9_+4?C0!Z8#D9%%>=V&K:EIO@#P@MG>Z/IU
MO)ID)GOM4?Y$(B3:BIO4L3D\YP />H!\0-:OM-\+MIEKITEYJ]S=6<A+,T(>
M+>/,0@Y*97=W)7@'/- 'I=1?:8/M7V7SH_M&SS/*W#?MSC=CKC/&:XY]9\57
MNLSZ'I<FD+>:;:0RW]S<0R-')-)N*I&H8%1A2223C(XK'>X\1WGQ(L&M[2UT
M[59O#N;A;H^<EO\ O^<!&&_G 'S#@Y/3% 'IU-,B X+J#]:P/!NN7NN:3<MJ
M4<"7UE>SV4YM\B-VC;&Y022 1C@FN:\?>%?#AMBT.A6$NO:S<BUMYI(MQ$CY
M+2GU"*&;_@/O0!Z,"",@Y%(2 "2< =2:IZ1IEOHNCV>EV@(M[2%88]QR<*,<
M^]4_$?AVV\2VMM:7TTHLHYUFF@0X6X"@X1_5<D''? H UT=)$#HRLIZ%3D&A
M9$<L$=6*G# '.#[UXU=21Z1H_CC4?"0^QZ')';VEL\'RQ&Y+^7+)".@ #J-P
MX)7CI717WA[2_!7B3PG<:%:)9_:KMM.NA'Q]H1HG8%_[S!D!R>>M 'H?F)YG
ME[UWXSMSSCZ4-(B%0[JI8X4$XR?:O*O$/A+2=(73+'3-]SXRNK^.XBU!CFY*
MB4-++(PZ1A-RXZ<@ 9K7\9>&O#-O#J^N^(HSJ-Q=HL-I%*-SQMMPD5N!R&9N
M>.<G/04 >@45D>%;?4++PEI-OJTA>_BM(TN&9LG>%&<GN??O7,Z7XBN;GP)J
MOCB*W6YG=+B:TAD?:L=O&S!5SVR$WG'))]A@ [*TL(-/>;[/F..:0R&+/RAS
MDL5';)Y(Z9R>I.;=>6W5]=W&N_#G5KFQ:2_EBN"5B=2TN;7.>P'))YZ<UT]I
MXZM)-'N[R]M7LKBTO_[.EMI)%/[_ .7 #YVX(8'/&!GTH ZNBN=T#Q=;:WJ^
MH:28TCO+)4D8Q3":*1&Z,CC&<'@@@$5%?Z5XCFUG5I+6]LH[.ZTYH;61@_GV
M\^,#&/EV9RQ/7./04 =/17E?BF":TOO 2ZW;VOVAKN2*\CT^*1XW41L0H7!9
M@.#@@\Y-=9HZZ0=6OI]%T^:"XM;<1O$\+VRRESN'RN!TV?>QCYCZ4 =/N&[;
MD;L9QGF@,"2 02.N#TKQZW:XO_ .K^*;C3 VL6$NH7-O?K<;9(V4RJ!D<E5
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M4]Y,^=T:3L(X"I!P,L3G.>!0!T6EVEEX2\.V6G3:@!:VJ);Q37;HA( PJD\
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M.SE\P$[49'8E<$<Y4=<UC^)=;N9;KQ3H31Q?9H/#S72N =Y9_-4@G.,80=J
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MXM-PL*2:O.TL"K)N S B8)P/XE/X5OZUK6G^'M(N-5U2X$%G;@&20@G&2
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M,0,'&:[^B@#F?&FCZCJEII=QI20RWFF:C%?)#-)L68*&4INP<$AS@X[5C?\
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M,!/D";?<8'ZUG:-X1U#27LK8^)+J71[#(MK-8A&VW:559) <NJ@\# Z#.<4
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MV%I'!.\[21T'7-6]>\.76IZKI^JZ=JATZ^LTEA#FW$RO')MW J2.<HI!_0T
M<'!KNN7NB:':Q:I?6\K>)9=->XG0"=H LI <8QO  ZCJH)!J76-:U?P=_P )
MA9VVJW=ZMM86MS9R7SB5X))7:(\XY&0&P?2NAL?AZ+*:W_XG$\T-OJW]JHLL
M0+F0HRN&8'G<7W9P,=*O:OX(L];O=:FN[B0Q:K81V3QJ #'L9F#@^N6ST[4
M<Y>:)<Z+\0/!"/K-_J$;RW6_[;('8.+=OF4X! .3D=.!C'.=_P =RZE#9Z>]
MI_:8L!<_\3 Z4,W(BV-M*CKC?MW;><=*BM?!>HMKVCZQJ_B.74)]*,@A46JQ
M*RO&4.0"<L<@Y]N ,FMO7-+O]06VDTW5Y=-N;=RP81B6.0$8*NA(W#N.0010
M!QNF:U(^K^#X+#Q#<:G875S?))),FR1E2(E8Y1@$LA[D ].*R_'>H7UQI_Q!
MLS<%HK633/LT;\K&6:,G\SR:Z5_A_,L-I<V^N21:W!?2WYOC;*RN\B;'4Q9
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M;XP!@1)NWJT9.""&QU[ T\?#QI;+Q/'>:U-<W/B"".*XG:%5V%%9<JH.,88
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MZ,A(RIP.X.0#F@#R;QNVI:E\(]7?4)M9C2PU%(K4WT1@>Z@:2(J95906*DD
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M;SMN0PW?-W].PZUHWG@X:EK]]J-_=I+;WVF?V9-;+ 5S'EFR&W'!RQ[>GUH
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M53QA_P B3K__ &#KC_T6U5/AW_R3?PW_ -@V#_T 4 =')(D4;22.J(HR68X
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M42G!)/7CO0!W-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHK(DP)0Y=5YP0>A]: -^:&.>WD@D7,<BE&7ID$8(KD(_A7X0C@2W^P73VR
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M(XMO'S>7%M_6N?\ "D=O?VG@R";QA#+):M&]OI<5D@EB>.)E='*G<H W*2P
MSCN17KC11M*DK1H9$!"N1RN>N#VZ5%%8V<-S)<Q6L$=Q+_K)4C 9_J>IH X_
MXKNL7@Z&:1@D46I6;R.QP%43+DD]A6%>7@3Q[K]TOBVRTFTN[*VF@EFABFCN
M855U;:S'!"MNR!_>KU*:&*XA:&>))8G&&1U#*P]P:KR:7I\T4,4MC;/'#_JD
M:%2(_P#=&./PH \U\/:;:V?COP?;P3O>06WAN4V\\L1C8J70*=IY7Y6QBKUI
M%&=4^*#E%W-L5CCJ!9KQ^I_.O1##$9A,8T\T+M#[1N ],^E(((09"(HP9?\
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M'!"]\9[5VMM9VME#Y-I;0P19SLB0*N?H*2VL;.R5UM+6"!7.YA%&%#'U..M
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MDLK=8YR3*@B4"0GKN&.?QH XSPW=Z7I$GB+7+OQ3%J2/-!'=W*6XCBCD"A5
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M<_*03QR>: *E_P#$*^NK_P )MH.ES7%IJLDWF([QQN6C1PT1W'Y65@"3T.,
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MU><9'7M5&+2=0'@+Q_:FRN!<7EWJ;6T7EG=,'4["H[Y[8ZT :MSKNECXA:;
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MKP>9_H]YI^1'/'@8;;EMISD8W$<9H U9IXK:"2>>5(H8U+R22,%5% R22>
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M#D*WVA\C/>N+MYY-!^,.L^( Q%E)JD6EWW/"K+#&8G/IB10,_P"W0![0[I&
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MAL 4J,X;D]#1\*#N^&&A'&,PL<>GSM0!V5%%% !1110 4444 %%%% !1110
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MMOS. S '<!TZ5Z2S!5+,0% R2>U4]*U>PUNT:[TZY6X@$C1%U! W*<,.1V-
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MEQ:SJ'CE0Y#"K- 'FU[X2\2:O=:U-<0:9:)JVBMIZQ13LPM6!<ID[!O!+G)
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MS"J2I_O=!BN_K@XOAS-#8V-BGB*Z%MI^I?VA:+]GC+(2SL58G[Q^=L'WY!H
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M-U<@26YC5=ML6(\P2%\[P "1C'4=LUS=]?\ B!/ GQ"O/[97S+?4+F$,+?#
M*D:X4[L*-O'0D=<YYKK])\#7&BW;P6?B&[70&F,ZZ5Y2$(2VXH)/O!,_P_AG
MDY=-X"CGL?$NGOJD_P!AUR229HA&N89'"AF#=6^Z,#COU[ "W.M:G%JEOH$$
MF^[%C]KFN(K8'"E]J (S@=CDY/0>N1F2>)/&,8\,6MU:6-A?ZE<S6MRDL9<
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M^T) <.2V<J6PVW XXSFM[P?X</A/PW:Z(MY]JAM0PCD:/8V"Q;GD@\GVK/\
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M50,= 2!@\U2U.XUKPK'+#=:N/L>HZI9PQC[0\TMC#(2)#YKC.&*D*3]W)]*
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M-;,%U;W6_P"SSQ2^6Q1_+<-M8=0<=#[4VWO;2[:1;:ZAF:([9!'(&*'T..E
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MQ-+JL%\NJS6<-S#JEQ8Q+&=@D$3;1@,22>]=!-?V=O,D,]W!%*XRJ/(%9A[
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M%W;W%FM]!:RW$,-RW^LV*6P%!!/3M6CI%U)?:+87DH423V\<KA1@9903C\Z
M,67P!X:GT&/17T]C8Q3&XB4W$I>*0DL61RVY3DD\'N:V-)TBRT2Q6SL(C'$"
M6)9V=G8]69F)+'W)[5-#?V=Q<26\-W!)-%_K(TD!9/J!R*Y1O%-_JFI:I!H=
MSI2+IES'#(MXQ_TA2JM(0ZM\N ^!\K<K[\ &EJ'@?P]JFM'5[JQ)O&4)*R3.
MBSJ.@D52 X'^T#Z=*MWOAO3;[4EU)XYH;T1>09[:=X6>/.=K%",C/3/3MBN9
ML?$GB#Q#IMGK&B7>A0V$TK":*]#[X8Q(55MRM@LP4\$#!8<G'.R-;OA\1O[
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M2C&!;AL!V Z8R"?PH T**QO".K7&O>$-)U:Z6-;B\M4FD6,$*"PR<9)XK9H
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M6<!!AM((RK%QLC PQZGCN: /%-2U*PN_@SXC@U:6W'B!+Z5KV*9@)1,+C*$
M\X$>T CC QT%;NH:AH=]XH\4Z5XEUQ;&VOH83:.[0B.XM3$!^[=U/(?>>#U.
M17ILFGV4L[3R6=N\K@*TC1*6('(!..G I\UG:W+Q//;0RO$=T;2(&*'U&>E
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M>6-^/3=UI'L+.2Y6Y>T@:X4Y65HP6'T/6@#S36VN+3Q?X[?1%"ZD?#\,D8A
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MUHYH493&PZKD$$$\=: -67QN]P]A;:+HMU?WUW9_;6MI76W,$6=OSE^C%L@
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M*ZM8)XWCE#I+&&##S7Z@]:[\C((]:\]T/P/XMT#0+?1+'QC:PV< 94==)!E
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M4=64$'!!Z@UFP^ YKG5=7O\ 7-5%\VK::+"XCB@\I4&6Y3YC@8/0Y.<G/.
M/TO0O$R"UFE\57-Q%=VS"]$D<0:&1ERKV^$PN#V;<,5YWX=O-6T3X'ZQX@M-
M:O/M7GR[$=8RD;&Y 9Q\F23DYR2.> *]*T7PUKUG?V#ZIXD^UVFG1-'!!!;F
M#SLKM#3'>0Y Z  #/-8]E\-+N#PGJ_A2XUJ*71[OS&M]MJ5FA=G#@LV_# $=
M,#/J* -KQ9JM]IVM>%(+2<Q17NI^3<*%!\Q/*<XY''('2N7TJY\2^*?'/B[2
M!XCN=/TW3+F,1FWBC,OS*<*&93A>"3P2>.1SG<;P?KNI:IHFH:WX@MYWTFY\
MZ..VLC$D@V%26RY.XY'(X'/'/&CX>\)G0O$OB/5S>"8:S-'*(O+V^5L!&,Y.
M[.?04 <-K'C*_DOO$%S:ZOJD%YIET\%AIUMIKS6\_E@9$KB-LEVW#AEVC%>J
M&ZW:5]L)6#,'FYGX$?RY^;T [US4_A368-0U'^Q=?CL+#4I_M%Q&;7S)8I"
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M2@R1&^U1L)Z#);KQ78^*_#<7BC1&LC.UK<QR+/:7:#+6\RG*N/IZ=P35*_\
M#FL/J=KK.FZM:V^JBS%G=M-:&2&=0=P8('!4ABQ'S'[Q% ''R>*-8N=(T2[U
MK4-5TC37AG6ZU"RL<,9TDV(TBLC&-&0%_N@9.,C%:%QJ.O7_ (G\,Z/:>)5-
MM>Z5+/=7MG#'^^VE<21Y#!2<X[@9/'3'0RZ'XE@ALCI_B9'GC@,5R;^T\V.9
MB<^8%5EVL.0!DC&!VS7'2^&[K2/'GA32=*U(17-GI%TR7$L =)&,BE@R CY3
MN/ (QQSQ0!)>^*M=\+1^+M)?4&U&?3UM'TZZND7>/M#>7B3: &VL<].:VPVK
M^%_%OA^RGUV[U6TU<S03K=I&#'*L9D5TV*N =I!4YZBGK\/C?V/B Z[J7VG4
M-;$8EGMH?*6 1?ZH1J2Q^4_-R>35RQ\,:M/KVGZKXAUBWOGTU)%M([:T,"[W
M7:TCY=LMMR,# &30!Q%KJ'BJ]^%-QXP?Q/=1WEHEQ+##'#%Y3K%*XQ("F6)V
MD<$ #'&<DZOB#Q!?+JD4NH:[?>'M/FL89;&Z@MEDMFG;<7$S%&P!\F 2HQGF
MMVU\#&V^&=QX/_M ,9H;B+[5Y.,>:[OG;GMOQUYQ2ZCX8UZ6V>QL-?MX[">S
M2TGANK+SMF%VEX\.N"1V;<,T 58M<U,_&&WT1KU7T]O#PNVBC4;&F\[;O!Z]
M.V<5Q7A:V\067P4B\0V/B&XMI+"WGN+>R2*,P,D;N2) 5+,6PW(88R,#CGT*
MQ\$II_C.SUV&])AM-%724MV3+$*^X.7SZ<8Q^-85I\-];LO!R^$HO$\)TB56
M2X8V/[X*S$NL;;\ ')Z@D9//0  LP^*-0O?B3X;M(YVCTW4-$-[);;01O/(.
M<9X!]:X[3=6OM"^$WC[4M-N#;WD&OW)CE"@E29(@>"".A->DGP=&GC72]?@N
M1'!I^GM8I:^7G()X.[/&!VQ6.WPT9O _B/PY_:HSK.H27HG^S_ZK<Z-MV[OF
MQLZY'6@#%UJSOM1^*WA$?VYJ%O\ :--GE4PB+]R=B[MFY#]['.<^V*LWOC75
MM+UOXDLT_G0Z-!:-8PN@VQO)%ST&2-Q!-;^M>#;^ZUK0M9TG58+2^TJW>V_T
MBU,T<J,H!. RD'CUI&^'\-QJOB^YO+TR0>(X88FC2/:T'EQE-P;)R<G(X&,=
MZ .?T_Q%K$=^]IH^IZMKDEQIUP__ !,=-:W6*[108]I,:#8QW#:<XP.:U_ F
MJM?W\D1\37U[.ML&O--U.U6&XMY<CYE 1<)U&/F'3!]=2TT+Q+(DR:IXG#C[
M*]O";*T\DACC]\^6;+C' &!R>.:-*\.ZLOB"'6==U6UO+BVM7M;<6MH8!M=E
M+,^7;)^0<# '/K0!KZ'8WVG:8MOJ.JOJ=R&8FY>)8R03D#:O' XK1K.T.TU.
MRTQ8-7U-=2NPS%KA;=8003P-HXX'%:- !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2%0
M2"0"1T]J6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D"A1A
M0 !V%+10 4444 %%%% !2$!A@@$>AI:* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "D*AAA@"/0TM%    ,#I1110 4444 %%%% !2;1
MNW8&1WI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^&]GJ%O.9+0WKS#RF<6PD1O+5F (7&0O)ZBNHT[?8_%;71+:W(COK*S^SR+
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ME+!2 Q89P0"1@D<<<UQHBA_X2*6YTZ'Q#=65UH-Y:1W>H"YE,DYV-M D&4&
M><*"<@9Q6Y<V%V?!'P[A6TG\RWO--:9!&<Q!8B&+#^$#OGI0 WQEX]9_"7B1
M]*L=42"U26V75X=JQK.O'RX;?@-\NX+C/?'-=Q-J,>G>''U*Z+&.VM#/*>I(
M5-Q_'BO*+NYN=-^&/B'P<VDZE-K"O>+&D=G(R31O*T@E$@&W&UNF<Y&,9KU.
M[TT:MX4GTN4F,7=DUNQQRNY-I_G0!R>CZ7XL\3:+!KMUXKNM+N;V,7%M9VEO
M$T-NC#**V]2TAP1GD>E1:EKFOZ1K7@Q-61YKZ>.]2YL],8E+IU5=A ; _P!K
MYN%YYP*70/&<GA[0+71=>T76$U>PA6V$=K8R3)=;!M5HW4;2& !Y(P<U/_Q.
MM1\5^"=0U33/LLXCOVGCBRZVX9%V*S= V,9]\XH ?JWC2PO/!6OW5[#K.EOI
MCK#>PP.B741)4@HP8K@AASGIFM2Z\61V+65C8Z9J6K7DEFMT88-F](>@=V=E
M&2<@ $DD&N(\8:9?SZ1\4%AL;F1KJ2S-N$B8F7$40.W ^;!!Z>E3ZGIL=AXD
MM=1U677[6QN=&MX$FTMIP5FC+$QR"($\AP1D8R&H 7Q_XRO+W3O"ZZ"FJI9:
MO>PA[FS9(I)%.X- I9@5DR.<@#C[W45VU]/<:=\/[NYA^UP7-OILDB?:W$DR
M.L9(WMDAF!')R:XG5M&:'2/A]%INF:E%!#KL5S)#<@R2PJQ=V:0C..6R<],\
MUW_BJ*2;PAK<42-)(]A.J(HR6)C;  [F@#B]#M=1U/0--O[CXDWL4]U:Q321
MA;0!&902.8\\$UUX\16EEKG]A7S313I9_:8[J<*L=PB\.5(/WEZL,#@YZ5YU
MH,G@*V\.Z9!J/@F5[Z.TB2X9O#<CDR! &);R^3G//>M?QII=S\1I[71K""6T
MM;:W^VR7]Q;LGSNA$< R >0<R#L!@\F@#?7QW:3:/87]KIFHSR:E*T=A:JB+
M+<*H)\P;F 5,#.6(X(XY%./CO3UT4WS6=Z+H7G]G_P!G;%-Q]IZ^7C=MZ?-G
M=C;SFN2UAYM9A\+ZUJ-CJ^EQ:<US9ZC%IXE22V=E4!EV#<T64ZKD88>],;38
M;.VTWQ)I=AKD]K:ZW]INC>B26XGB,)A\]4;YR!E< C.%SB@#K(O'UEQ%>:=?
MV=ZM_;V$MI,J%XWF_P!6^0Q4H>>03T/%7-9\5Q:5?7>GQV-S=7EOIS:@$BV
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M*%LLX;.=Z$]JM:?J^M^'_&%KX<U^_CU.VU&"66PO_)6*0-& 7CD5?E/RG(8
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M*B7 +'+,>Y)[DG))[DU8HH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "H+6S@LHFCMXPBO(\K#).69BS'GU)-3T4 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<)=_$LV%S9V]UX/\
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MH4#<,GG)SN/-<Q/IUG9?LW175K;1PSW5W&9Y$7#2;;I@N3WP.* /H,D*,L0
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MLK^YN[>UN$DFLY!%<(.L;$9 /X'-9UQXP\/VMDUW+JD(@6Y:UW*"Q:5?O(H
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M6*PN%NX2LQ+&8$D.S')8Y)/).<\YJO?^ ]%U#79-7;[9!<SJJW2VMT\*70'
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MPUIL-I+>:M#$MW"+B'(8DQ'HY &57W.!0 DW@G09M%T_2/LC)9Z?<I=P(DC
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M$KF-RN048=58'!!Y'!'>@#G_ (>Z#<:+8:I/<6)L/[0OVN8K1I [Q1[%1=[
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M=]@U&-GM_-27"N5.Y&##D>XKF(OB%I]CX@U^VUG4(+>TM981:?(Q8HT".S$
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M1TD(^YEQG(R,$=:NV-YXQMM8M(-8L=,N;&YW*\^G%U-LP&1O#GYE.,9&.>U
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M%6$6K6NG/%I]U&;NZ@$R-=.8WD'++AF^<@YZ BO5KFSM;P1BZMH9Q&XDC\U
MVQAT89Z$>M-O;"SU*V-M?VD%U 3DQ3QAU)^A&* /([O3;86WAP'5;?68KKQE
MY\DL-OY46_8^Y57<P(WJ3D'!)-=+XAU61?&MW;1ZAINC"TTR.62\GM5EGN$=
MW_=IDCY05Z<Y+"NV73[)8;>%;.W$5LP:!!$NV(C@%1CY3R>E)<:9I]Y=075U
M8VT]Q;G,,LL2L\9_V21D?A0!XMI,BR#X.@.&*&Y1AG[I$8&#Z$>E=?X _P"2
M@?$+_K_@_P#19KN(](TV)XWCT^T1HW:1&6%05=OO,..">Y[U-#:6UO---#;Q
M1RS$-*Z( 9".A8CK^- 'G_BN5--UG6]3TO7--CNTLD_M+2M3BS%<QJKE,-D$
M9!8<;@>XJ+0-7TRU\6^);G63!I\=YI]C<00W)" 6WDD,HSU"MN! ]:[Z\T?2
M]1GBGOM-L[F:'_5R3P*[)]"1D?A2WVD:;J9B.H:?:79B.8S<0K)L/J,@XH \
MU22QF^*?@:32H#!8/HUPUM&R%-L97Y1M/3C%9?ABSGNO"_AVRO\ Q;86Q@U*
M,BP%AFX6ZCF+,A829R2&RQ7HQ)XKV1K.V>ZCNFMX6N(U*I*4!= >H!Z@5"ND
M::FI-J*:=:+?,,-<B%1*1_O8S^M 'FL,$0^'7Q.?RUW/>ZJ6..20AQ^56]'N
M88/BCHYN)TC,WA.)(_,8#>_G#@9ZGVKT3[%:"&>$6L/E3EC,GEC;(6^\6'?/
M?/6HYM*TZXEMI9["UEDM3FW=X58P_P"X2/EZ#IZ4 >+V/_)%_B)_V%;[^:5N
M>*/]7\+/^O\ MO\ T6*]-&F6"VTUL+&V$$[%I8A$NV0GJ6&,$GWITEC:2^1Y
MEK _V<AH=T8/E$="OI^% 'GFF:GH>E-X^@\336ZEM1DEGAG(W36S0H(P%/+
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MDQ_L_P"HZ9>30'54GG26V+ S"X%RS$E>N0/FSZ5[5#I&FV]_+?P:=:17DO\
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M  C6@_:]/\3Z7J]IH\-M!?Z?:SB1I$&UH&4*<X9<@.-I#9!ZUZCHGVZY\-6
MUJ-1?R6D?VQ,#'F%1O&!QUS0!DZCX[TO34\/R.D\D>N,GD/& 1&K[ '?GA<R
M(._WA5'QCXMTZUL/$-C<#4U33;2&>ZN+"41R)YCX54;((;C/T-<;I7A;5]0T
MK7M,N[2YB;1=,DTS3)9(R!,PF>1)$)ZC$=N,CTJ;4-.U;6/A+XOU:;2KQ-5U
MN<2K9F!O.6-&2-%V8ST0M_P*@#J)?%^HP^-M#T.STF[N+&YL#.\K21%F&8P'
MRS@X7+;NY)X!K'\/>/9])\.W=WJ.GZK?65KJ5U'=:AO5E@7[0P489MS!05^Z
M" /H0+EQY^E>.O">H7%C>M:G2'LFDAMGE\N5C&0'"@E>AY/'!]#5";2M0/P3
M\26(L+HW<MQ?&. 0MYCAKABI"XR<C!'J* .J&K60^)TVF^9J1O4T?[28_._T
M3R_,QD)G_69_BQTJC8_$NVO;72M1&B:G%I&HRQP1W\@C")*YV@%=V[&[Y=V,
M9]>M5ET^]_X7;<7WV2X^R'PV(1/Y9\LR>=G9NQC=CG'6LV+2]0'P9\+V7V"Y
M%W#<V#2P>2V] LZEB5QD8')STH [;QG%J\GA._;0;E[?5(H_.MRJ@[V7YMF"
M.=P!'XTW3?%NGWW@:+Q4[A+,V9N9>?N;1\Z_4$$?45T%>.7WAO5UU^Z\"0V5
MQ_PC6I:DFI-=*A\J*W.7E@W=%)D1<#T:@#5M)O&S^ K+Q2EW+-J7GMJ,FEE5
MVRVK\B <9#!,%3UR2.:NZIXRD\3KI&D>#;S%UJD8NI[Q5#&QM@?F8@Y&\D%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!GZYHEAXCT:YTG4X?.M+E=KKG!X.00
M>Q! (^E8?@OX=:!X#6Y.D).\US@23W#AWVCHHP  /P^M=910 4444 <_/H5S
M+X_L]?$D0M8-.EM&0D[R[2(P(&,8PI[U@:IX NY/B%IVOZ9=00Z>+I;N_M),
M@M,J,@D3 (R5;#=,[0>:[.\U?3=.D6.]U&TMG8;E6>94)'J 323ZOIUOIO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ6H4>7(XCWA\YW98-C&.<=LG?.A:[?ZO'K?B*73D.G6<\=K;V!=@7D4!W9G
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/O;5!..YQ5]_B#?:;INOI::J-<-O;0265[-:^25DEE\HHX"J&VED88 X)!H
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M#!3RX@ASZYQFMNBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MIZ];W-E9PF*.."T\MY^  TK%FY '10.3GVKIJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &B- Y<(H<\%@.33J**
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT;!P<$<=10!:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!W.Y=^S<-V,XSSBEKRV+6-6U3QUH>I:78VS7NH>%EF*SRLL4(>5')) )..@
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M]ZK,US,PE8$29&,#'&": /5J*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N.\)>$;>QM[^75=(LS>RZI=7$<K
MQ1NY1Y69#NY(X(XZBNQJGJNJ6>BZ7<:EJ$WDVELA>63:6VKZX )- &'J6CWU
MQ\1M!U:*$-96EG=132;P-K/LVC&<G.T]*SOLVO\ AGQ'KUQINAMJUIJTB7,)
MBN8XS#,(PC+)O(^4[0<KGOQ7< A@".AYI#)&)1$742%2P3/) QDX].1^= 'G
M4W@O5M)\ ^'XM-2*[U_0[A;M%#A%E9F/G1ACC"D2-U]!5?7/ ^JO\$)O#EG"
M+G6K@1SW ,BKYD[3+)*=Q('7=WZ 5Z?45U=065I-=7,JQ6\*&221S@(H&23[
M 4 <9<V6N:%XUNM8T[1FU2UU&QA@E2*XCC:&6(M@G>0"I#]1DC'2N<A\#:JN
MBZ5<ZMH5IJMS8ZE>S7&G,\;+-%.Q.Y"YVY!VL V.,C@UZ/H7B'3/$MD;S2IY
M)K<-M$C0/&&XSD;U&1SU'%:E '.^$--&GZ?<-_PCMEH0FG+):6P3=L  !D*?
M+NZ]"0!CFLG[-KWAGQ+KUUINAOJUIJSQW,1BN8XC#,(PC*^\CY3M!RN>_%=Q
M10!YQ+X+U;2OA_H$.GI%=:_HERMZBJX1979V,T88XPI$CCGT%-N/ =U_PKK2
M+&6SM]1U*TO$U.\M9RNR[E8L9D+'CGS& )XX%>DUB:SXP\.>'IU@U;6;.TG8
M;A%)(-^/7;U ]Z .(U3PG=ZEX'\26>E>#+'1)[R.*.V@C,*S3;6#,9"AV >@
MW'OZUUGBZUGN[2VMW\-0:_IS;A<VS,@E1L#8Z>80O]X'D'D8[UNZ?J-EJME'
M>:?=PW5M)]R6%PZG\16++X^\)0:D=/E\1::ET&V%#.O#>A/0'VS0!QQ\':^U
MCX/C^R,$T[7&O'@>Y61K2U+,40N3\Y52!QGVSBGW:ZSH=AXWL;*SMKJSNIKF
M\_M 7<86U\R(%UD3.[<N"0 .<C)%=UK'BG0O#[PIJ^K6EDTP+1B>0+O ZD?F
M*R%\/^"/&DTFLPQV>I>:0LTMO<L4E*]!(J-M8@8X8'C% &9X+T>^6_\ #.K-
M!BR3PI#:,Y89$N8VV[<YZ \XQ5#4/"FO+HMZ]OIXGN8_%G]L16XF13- ) W!
M)P"1G@D5Z>JJBA5 "@8  X K/U#7=-TJ_P!/L;RX\JXU&0Q6J;&/F,!DC(&!
MQZXH KZQ#J.K>#KZ"U1K'4KJQ=(U>09AE9" "RDC()Z@GVKAM)\-ZC:Z_P"'
MM0L_!EOI-M9Q2VUTD<L'G,70#S6*GYE!'J6.XG'KZ)9ZO97^H7UC;R.UQ8LJ
MSJT3*%+#(P2,-P.Q-7J /.(_"NLK\)M"T,VH_M&TFM'FB\U?E"3J[?-G!PH)
MX-$FF>)M)_X2K2=/T87D&L7$UU:WWVF-$A,J ,)%)W?*02, YSVKN=-U>RU?
M[5]CD=_LMP]M-NB9,2+U W 9'/49'O5Z@#'\*6-QIG@_1+"[C\NYM;""&5-P
M.UUC (R.#R.U<#IO@O7K?PI>6,MD!<2>*5U%4\Y#F 31MNSG'12<=?:O4KB>
M.UMI;B9ML42%W;&< #)-5M(U:RUW2K?4].F\ZSN%W12;2NX9QT(!'2@#D_%F
MDWK:_?:P(A]AC\-WELTFX<2,RL!C.>BGG&*P])M/$'B+PIX,TJ71_(LK4V5Y
M-J!N$,<D42AE"J#OW-A0<@ <\FO4+FVBO+6:UG3?#,C1R+DC*D8(R/8U'806
MEE916-D%6"T18$C5MWEA5 "DDYSC'7F@#S:]T7Q3!H7B_P .6>AB==5N+NXM
MKXW4:QE)AG:5)W!^2HXQG!R!6M'I.M:;X_TC58]+:ZLWT6/3;AXYXU-LXD#%
MF#$;EQG[N3Q7>53U75;+1-.DU#4)O)M8RH=]I;!9@HX )ZD"@#F?BAH.H^)/
M!<FG:5 )[HW,,@0NJ?*K@DY8@=*O:?I-[!\0=;U62("SNK*UBBDW [F0R%AC
M.1C<.OK6M%J]E-K,^DI(YO((EED0Q,%"GH=V-I^@.:O4 >5Q^%_$.F^'O"TD
M6E&ZN]*U>YNIK1+B-6:.1YL%69@O1U.,]ZUH(/$GAK4->_L[0&U&'5KC[=;N
MMS$GD3/&JNDNY@< J#E=W%=]10!B^$-#;PUX1TO1GD$DEI;JDCKT+=6Q[9)K
M@T\,^(QX8U70&T=@?[;6^@N1<1;)HC=+(<#=D$*"<$#IQFO5J* .-\2^&+O7
M?%$;A-MA)HMY82S;A\CRE O&<G@$_A67X2\-O8W^F)-X"TK39[.,BYU,>23(
MX7:##L^;YCR2P&!D<FO1JIZKJMEHFESZEJ$WDVENNZ23:6VC..@!)ZT 8/C3
M2]2N9=$U;2;47EUI-[YYM?,5#-&R,CA2W ;#9&2!Q7,ZCX6\0>*[[Q-<7VFQ
MZ?%J.E06]G'-,DA5XY&<+)M)')P3C(PW4D&O4** //M&T:YMYKFZTWX?Z1H=
MU%9NL;RF(M-,<80&+.(^N2<$Y''6J5CX9OWN]9GT_P ,GP_;76DSV\MG]IC*
M7-RV-C*J,57: PW'!.[I7ICR1Q[=[JNY@J[CC)]![TZ@#RO3]"UKPY8>!+@6
M44^I:=:SV=QIWVJ-))%=028RQVL5* D9Z&J3:;K7B)_'T M(_M\U_IK>0DJD
M($\MRI<X!8(.??.,\5Z?K.@:7X@MHX-4M!.D3^9&0S(T;>JLI#*?H:J^$X=!
MBT)7\.1JMA)+(2P#9>0,4<L7^9CE2,GTH KZEI-[<?$#0M5BB#6=K:7<4TFX
M#:SF/:,9R<[3T]*O>&M6N-;T&"_NK1;2>1I%>%9/,"E79.&'4';G/O6HLD;L
MZHZLR'#@')4XS@^G!!_&A$6- B*%4# 51@"@#R+7/!FLWUOXCMD\,6MUJ5U>
MR74&L3RQ$M#N#)$A)WJP "8.%')SZ]KX?TW48O$OB;4[NS:VBU+[*\*/(C-E
M8 K*=I/(;(]#VR*ZJB@#R33O"&L:?8^&$U/PS%K45GI;VK64DT)2VN"X/F$.
M=I!7C*Y(QTYIL?@SQ$-"\+Z:VEQH^D>)OMDKQ2QB-K?S7?S$&[( #@;2-W'2
MO7:* /+?B%HT]WXTTJTT^54/B* Z?J,8.&^SQNLAD'N%WID_WP*W/&.ER7\D
M=G+X.AUS3E@ MWAFCAFMI<D'EV7:N-N"AR,'(Z5T-EX;TG3]8NM7M[0#4+K(
MEN'D9VP3DJ-Q.U<\X7 K5H \YL/"OB"'QAX.U"]Q<C3M(DMKVZ,H/[XKCN=S
M<]\4EAH>J7'B_3=3_P"$7CT6^AF=M3U"VN4\F\38PVA%;<VYBK9=05QUS7H]
M-\R/S3%O7S NXIGG'KCTXH R_#NK7&LZ8]U<VBVLJ7,\!C63>/W<C)G/OMKD
M[CPOJ\GC3QGJ*VH-KJ6D):VK^8OSR!"",9R.>YP*] 1%C7:BA5] ,"G4 </<
M^'=4D\,>![-;<&?2[NRDNU\Q?W:QQ%7.<X.">V:QKCPEK=Y9>,]"DTM#!J6H
M'4[.\DF0PRD&)EB9<[ADQD$D8QG\?4:* /.+7PX\^GZTMEX#T_09)M+FMXF4
MP>=+*ZD;08R0$Z<D@DXX&*A\46=_IOPT\(6/E(NHVUYI</EN_P HE5D&"1GC
M<.HS7IM4]1TNRU:.".]A\U8)X[F,;B-LB-N5N".A'3I0!Q5QI>N^(]?N]4N]
M'?38K?1[BQMH9IXW>::7&3\C$!0% Y(/--O?!]]=_#'PUID^G6]U?:0+2:73
MYV4I.8TVO&6Y7D,V#TSBO0ZIMJMDNM1Z09L7TENURL6T\QJP4G.,=6 QG/-
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MAA#VTL8*X/F$?(PV\C)!4\55 U'0_B-IBV.B6\SP^&]L]A8.L2IF<9\K>0I
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MC56541%^Z &/<GGK6;!X/\5V>GC1K3QGLTI5\J.1[$-=QQ= @DW8R!P&*Y%
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M*V"S8&<':"3VK0/BO6K+2Y]0BO[^YTS1]5@\VYO+,PR7-E( '#*R*2R,3\P
MR!6_:?#VYT[2X5M-:)U2UU.;4;>\FM]P)E!#I(H8;@0Q!((YP1C%;L&@WEWH
M6I:?X@U%=0;40ZR^7#Y4<2,NW9&N20!UR23DYH YOQ-XLU"R\0:Q)82YL/#^
MC/=7,> 5FN9 3$C'K@*I;@]ZK>&/$%Z?$VE6B:QJ^KQ7T,@OOMFF/ EO*J;U
M:-C$@"G#+M)/45M>'O ,6E^$]2T74[YM2EU,,MW=>7Y;.IC$:@#)QA5&.>O-
M7=$T;Q#9W4!U7Q!%>6MK"8HHH+3RC+T >4EFRP _AVC))H \V\$:I?VGPVT'
M3-,N?LMSJVMS6IN0@9H8]SN[*#D;L+@9!ZUOZSJ^M>%I?$>DKK-S>A/#\NJ6
M5S<K&9H)$)4J2J@,,E2,CU%:&G?#9M.\'V6D1:OB^L+]M0M+T6_"2%F.&3=R
MN&*D9&<U6\3>';ZW\+^+=>UK4(;S4IM$FM8Q;0&&*&(*S;5!9B26.22>PH 7
M[5X@T.X\*:I>:[/?)K%S':7EG)'&(D:2-F4Q;5#+M*XY)R*P[C6?%*^!=3\5
MKXAG%QIVHRQ06GE1^3+&MSLVR?+N)P<9!& !WR:ZC2/"NJ7H\.SZKK,5SINE
MJEQ:VZ6I21Y/+VH97W$-M#'HJY/)J>3P$TG@34?#7]H@&\NI+C[1Y/W-\_FX
MV[N<=,Y]Z *?VW5_#'C2"UO=:N=4M+O2[F[ECFCC41RQ%#F/:HPI#$8.?J:P
M_#GB[4;JY\/7HU;5;^XU.5%O[%],=+:!)%)!B?RA@(=HSO.X9-=_J'AQ=0\4
MV&L23CR[6TGMFMRF?,$NSG.>,;>F.]9VA>&-<T=K"Q;Q"DFBZ?\ +! EKMFD
M0 A$ED+$$*".B@G S0!QLFK>)Q\/;_Q>?$5R)]/NYQ#:K%%Y4L:7!0K)\N22
M 1D$8 '?).WI=E<O\:]<E;5KTQPV-LXA_=[&5C)A#\N=H))&"#D\DUI2>!&?
MX>7_ (5_M$ W<DS_ &GR?N^9,9/N[N<9QUJZ?#5[!X\D\16>HPI;W5M';W=K
M+;EF8(6*E'##;][N#_@ 4_&M[J\.K^&=/TK4#9?VA>R0SR"-7.P1.QP&!&1C
M(]P,Y'%<UKFNZ]X9LO&6EC6;B[DL=.AO["\G2,RQAV965L*%;E<CCO6WX_MK
MB[\1^#(;6Z^RW!U&5HYMF\*P@D(RN1D'&",C@GD=:+KP#>ZMIGB/^U=7ADU/
M6H$MC/!:E(K>-,[55"Y)Y))RW?VH KWLWB"S_L'2#KTYO_$%TS377E1_Z+&D
M)D=(1MP.@ +;CU/6J&M>)=;\&GQ'I?\ :,FI/!IT%YI]Q=HGF1F64PE7*@!@
M&PPX]CFNQU_PU)JMMIDEI>BTU+2Y1-:W)BWKG:4967(RK*2" 0?>L'5O!QET
M3Q)J'B2^DO;R^LUB=M/M2OD119=1$A9B2&.[D\GTH 1AK_A_QMX6TV7Q#<ZC
M8:@;G[2+F*,/O2$L,%5'RDX..HV]2#6?X9U+7[SP9J'B;4O% M_*%W! )H4\
MB(+*RB5P!EF&, #C '!)JGH][)XC^(/A:YC\10:\UA%<R3O9VIABMT:+8"XW
M-^\9B.,C&W@#G/50^ _*^'UQX6.HY:2629+H0XVL9C,N5SR < \\X[4 <Y8>
M);ZWN]:LK76-7OH%T*:_BGU2Q,$D<R'&4S&FY#N!Q@XQ[TW[5XJAL_!FH#Q-
M.TVOF."YB>"(Q1!X2^Z,;<AUV]22">V.*WI_!6M7^IRZE?Z];27-SIL^FSI'
M9%8EB< J8QYF00PR22<YQQQC1?P@6L/"EM]M _L&2)RWE?Z_9"T>.ORYW9[T
M <S)J7B731XPT>SU"]U.;3392VT[0QO<I%-_K< *%=E56*C'7CFNB\#ZA%J$
M-\;;Q)-K-LCJ%6[A$=S;-@[ED 5>#P1E1WY-/N/"E[_:^NZI8:RUG=:D+3RF
M6$,(C!NX8$_.K;L$<<=ZA@\+ZZHUB_?7K>'7=1BAA2ZMK'$4"QEB,1LS;B=[
M9)/<>E '7T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 (0&&" 0>QI:** $ "C
M   ]!2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !2$ @@C(/8TM% !THHHH **** "BBB@!" 2"0"1T]J6BB@ HHHH 0*!G
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MW5)Y/X4 /HIKR)&"7=5 ZDG&*RO%.NCPSX8U#6C;FX%G$9/*#[-_/3.#C\J
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M2+EK158P"3:2"P7K@XZ^E;1.!DT %%-$B$L ZDJ,D9Z"A9$= ZNK(>C Y!H
M=135D1RP5U8J<, <X/O0)$+;0ZEL9P#SCUH =134D21<QNK@'&5.>:$D2091
MU8 XRISS0 ZBFI)'(I9'5@#@D'.#0)(S)Y8=2^,[<\X]<4 .HJCI^L66J37T
M5I+YC65P;:;C&'"JQ ]>&%6)+NWCM9;EID\F)2SN#D #K0!-16-_;DU[INDZ
MAHUD+ZVOWB9F><0F*%QGS,$?,0"/EZG-:SRQQLJNZJ6.%!.,GVH ?136=4!+
M,% &22<8%*K*ZAE8,I&00<@T +13'ECCV[W5=QPNXXR:Y_Q?XL'A:WT\1V+7
MUYJ%XEG;6XE$8+MGEF.<#CKB@#HZ*K6]S(=.CN;V)+:3RP\J"3>L9QR-V!D#
MUQ6(WC&TE_X1N2RB-Q;:[*4BE+;#&OE-("5QS]W&..M '244U)$E7=&ZNOJI
MR*$D21=T;JXSC*G/- #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .5^)&I:QI'@#5;[0
M49M0BC4H53<44L S =R%R?PS7GOP$\4^*?$,FK1ZQ<W%[81*K1W$_)60GE W
M?CG'; Z9KVRD550850H] ,4 +1110!YYK;ZVGQ;B.A0Z?+<?V$=XOI7C4+Y_
M8JK'.<5!JNDSZ;HNM7_B15O=1U^ZM;7[%ILABC.&"1Q!VYP<G<Q X)&*[W^R
M;/\ MS^V/+/V[[-]E\S<<>7NW8QTZ]Z;K.C66O::]A?QNT+,K@HY1T=2&5E9
M2"I! ((H \@U"WDTW3_B'I_]E6&DQ?V'#,;&PG\R)7/FC=]Q K$!<@#L#DU?
M\3^$="M?"GA)AIMO+-<ZQ8?:9I4#O.9"/,+$]=W?M7;'X?>'F6XWPW3M=6K6
MMT[W<K-<(23^\);+,,G!/(Z#C%:6K>&M,UO1HM*O8I#;1-&T1CE9'C9/NLK
MY!&.M '!W(&E_&F\&GPI&+7P<WV>)%PJ[9OE4#TX Q5SP?X:\.KX<\*>())4
MM=7F2*=KX2JDMY-*F7C=CS(&)/R]>.,8KKK3POI=GK46L1QS/J$=B-/$\L[R
M,T(8-AMQ.3D9W'D^M4[#P%X?TW4X;VWMYQY#M+;V[W,C06[MG<T<1.U3R>@X
MSQB@#RE$5_AYXU1I6B5O&I!D5L%/W\'(/8BNMU:RT?P3XXTZ?3+86%G/I%^^
MHI:#;N2%4=7([N"6PQYYZUI>*/!-LOA*_P!.T73S*=0U:&_NHFDW!V,T9E;Y
MCP-J]/:MNQ\%:)8W%U/Y5Q=27%N;5FO+J2<K >L:[R<*?04 >?Z)ID=EXK\)
MQKX<LM*M=2M;F.0+=^=/>1>3N_T@; "<[23EN2:R=-TZ"T^&VGQZ=I=L[ZGX
MB:TNXU80?:8EFEVQ.X!^7*JOT..]>GV?P_T&RFLIXUO6N+*17MII;V5WC500
M(P2W$>"1LZ'/.:='X"T"*UU"T$%P;6^E\Z2 W4A2.3=OW1C=^[;=SE<'I0!Q
MQ\):Q-::[90:9I>BV=Y]DDBTQ;S?!)*DA+J0JKL610JG YQWYKI/ GV&WNM7
ML(M ;0;Z)HI+JPCD5X/F4A9(MORX;:<X .5Y%7X_ NAKI]W:2175P;MTDFN9
M[N1YRR<H1*6W KVP1CGU-7]%\.V&@BX:U-Q+/<L&GN+JX>:63 PH+.2< =!T
M% '.VG[_ .-6IM+]ZVT2!( >RO*Y8C\5 _"N7AT32]:\#>+O$&JV\<FLI<W[
M"\?_ %UJ8681A&ZH%"J0!C]:[76]*O;;QCI?B;38#<$1'3[^!2 S0,VY77/=
M'Y(ZD$XJ2^\ Z!J%]<7,\-R$NI!+=6T=U(D%PXQ\TD88*QX&>.<<YH XO3M,
MM_%7Q%TV378!<Y\*6EU)!)]UIC(WS,.^-S8![G/85U7Q4_Y)?XA_Z]#_ #%=
M FBV$>NMK20D7S6JVA<,<>4&+!=O3J3S3]7TFSUS2;G2]0C,EI<ILE0,5)'U
M'(H \MEM[G5M>T2P?0+/7+6W\-V\T=K>7(BC1W)5G *L&;"J,XXS[U873I_[
M-\->'=4T6'6=2B^U3PV<]]FUC@5]JF5BC;RJNBCY3SD\5W.H>#])U"*Q5A=6
M\EC%Y%O/:74D,JQX *;U()!P.#Z5%<>!]"GM-.MHX;BU73U9+=[2ZDA=4;&]
M2ZL"0V 3D\GGK0!YMI,2ZC%X:\/:A#%_9+>(=1CDLTD,D($(D:.+) W(&Z C
MG XJ_+X9@D\2^.="T5[>R66RT\1PLQ2%27=C%@?=5^A _OG KM6^'WATV,MG
M':S0PO<K=H(;F1/(F P'B(/R'UVXS3HO 'AV*"^B-I-*;](TNI);F1Y)2C%E
M8N6W;P3D-G/ ]!0!F>"8K"VU/5M,/AL:#?F&*2XLH9%>VEC.]5DCVX'.&!X!
MX&:D^$SL?AQI\98LD,MQ#&Q[HLSJOZ #\*L76@R>'-%U"3PY!=7NM7JK MQ>
M7;2NO4*S/(Q(1-Q; _+)K9\-Z'!X;\-V&C6[%X[2$1[SU=NK-^))/XT ><6/
MAG1-;B^(5SJEM%<31:E<K&\G)M@(4;<G]TYYR.NT>E5='T^'Q;XK\*#7HOM:
MR>$DGGCE)*S-YB8+COR=W/?!KH],\ 6^H7GB676H+R%;W597"PWCQ+=6Y1,!
MPC ,N=W!YY/K781Z#IL.L0ZK%;A+J"T^Q1E6(58=P;:%Z=0* .$TWP_H_BBZ
M\:7>OVD-S<0:A+9Q23+EK6".)"GEY^YU+9&,DYK#TN]N]1\2?!^[O79[F6PO
M"[OU?]P &/J2,'\:]&U7P/HFKW]Q>7"7<<ETH2[6VNY(4N5 P!(J, W''/;B
ML&\T74M0^*7AJYMM&>ST;P_#<)]H=XPD@DB"*L:JQ.![@=/S .4T?2M9UG2X
MM9MM L5U9]4:X_MN2_"S K<%6C*[,[=H,>S=C%;FFZ!HGB9/%NI^(=B7<&KS
MP+J#2!)+**';Y?EN?]6 /FSWSDYKK3X&T)M6.H&&XR;C[6;87,GV<SYSYABS
MLW9YSCKSUINI> ] U74IKVZMY]UP5:ZACN9$AN2OW3)&"%?&!U';F@#G?"VC
M:4/BYXMNX[.V>:&*REAN!&NX-)')O<$#JW<CK3_B%H^FZEXP\%"^L+:Y$M]+
M#)YT8;<GE.VTYZC/./6NK_X1?3!XF_X2"-9XK\QB.3RKATCE500N] =K8!.,
MCBG:]X;T[Q)#;)?K.&M9?.@EMYWADC?!&592".": /+KK2-2\0W/BV:'P_97
M-['J$MO:ZK/?B*6Q\I5\K8-AVA>&X(SN.:F\80)JL?BB[_L"UO;S3K!8KK4;
MR\V"TE6'S/\ 1E",01N#9RN2>M=[?^!-"U*]DN;B*Z_?A!<Q)=R)%=;0 OFH
M&P_  YZ]\T^^\#Z%J.IW%]<V\S&Z"BX@6XD6&8JNU6>,':Q P 2.P[@4 <A9
MZ38^)/B-%_;-O'?1GPS:2M%.NY'<R2?,5/!(R<9Z9-<U#H>GV_P@BUU8 VJV
M>I*MM>.2TL*)>B-45CR%"C&WIR:]=TKPOI>C74=S:),9X[1+(22SO(?)5BRK
M\Q/0L>?3CM3/^$1T8^'6T'[,W]G-+YQC\UL[_-\W.[.?O\_I0!P^OZ3#I.OZ
MEK>L:)#J>G2WD4ZZO;3@7>G;=BA<'G8K#/R'HQR*[#XA?\DY\2?]@VX_]%FE
MN_ VAWFI2WLL=UB:59Y[9+N1;>:08PSQ!MK'@=N<<YK9U+3[;5M,NM.O$+VM
MU$T,J!BNY6&",CD<&@#RRQTNTU>X^%]I?1":U;09FDA;E) (K<@,.XS@X/'
MKIO %K#INJ^+M+LXUAL;;5 8($&$B#PQLP4=ADDX''-=#;>&M+M)=)EA@97T
MFV:ULSYC'9&P4$'GGA%Y/I5BRTFSTZ\O[JVC*37\HFN&+$[G"A0<'IPHZ4 <
M-'H&D:_\6/$\>K6D-Y''8V12WG&Y,D2 MM/&1T!ZC<?6N3T^RCUBW\ Z7>M)
M-9)J>IVJ[G)\R",2!5)[KM4+].*[F3P;_:OCW7]0ODO+>":VM([6ZM;IH7;
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MIX=;J"33XO)MI[6ZDAE2/ !3>I!(( ZT >0:];P6GPM\76ULQ:"'Q68TRQ;
M#Q #)].GX5WDF@Z9KOQ:UJ/5;2*\@CTJT(@G7?&6+RC<5/!(&<'MDUNM\/\
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MG/>V<<]X!^]F62!MZLW4CIP>!@ 8KN['P3HU@EV MW</=6YM'DN[N29Q"?\
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M$)A5LIG[I9F8Y'/'M7#W-E:ZUX6^&MWJ=M#>7$NKI8O/.@=YK=9) JL3U4@
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MGC&X\CFH]%\*Z;H5S+=6QNIKJ1!$9[NZDG<1@Y" N3A<\X% &U1110 4444
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MXZN#*S<(C&,[">P&\]?4UU>C7=A>?&;7)+&2*3&D6ZS/&009!(_<=2%VC\*
M.KUGQ#I/A^.)]4OH[83$K&K9+.0,G"@$G'?CBEB\0:3/+I\<6H0.VHHTEGM;
M(G"C)VGH<#G%<;XE%_'\4K"2WUBSTH2:1(D$UY;><KL)09%7+KAL;#UZ"LB]
MM;6'P#8:;IVI1ZKJ][JLLVC7%K%Y*QS^:SLZC+8B3Y\GD%3CN* /2FU_24DU
M!'OX%.G*&O"S86 $;AN/0<<U%I7B?1=;M[B?3]1AFCMAF<DE3&,9!8-@@8!.
M>G%>7383X57EB3]FU:QU:!M>:=?-)D\]&>9QQOC(PPZ#:,9XJ3Q787ESIOB>
M\_X2:SU?4!H@BEM["S\K$/FA]S,)&!.T2 #KAC0!Z+I_C7PWJJW366KV\PM8
MC/-@D8C'5QD<K[C(K0?6=.CM[&X>[C$5^Z1VK'I*SJ64#Z@$UR/B'4_#.J:;
M+!I[6]WJ3Z)=M9M;#>8X3& <E?N@_* #U(XK$N-7T^[\/_#*UMKR&:<WMDY2
M-PQ4+ RL2!TP2!SWH Z*R^(>E:[9^(4T^_@M)M,\T+<3JSIL5%/G%<#Y0S8Q
MG/R^]:Y\3:9I?A[3;_5M6M2+J*/9.BD"X8J#F-.6P>N.<"O/A<0CP9\5[4S1
MBX^W:A)Y6X;]I@0;L=<>]6/#TL-IK/P]N-0D2.U?PR8K5Y2 HN"L)(!/0E ?
MK@T >@1>*="FTJ/5(]4MFL9)A )MWRB0G:%/H<G&#BC1_%.AZ_//!I6I0W,L
M #2(N00IZ-@@9'N.*\LUA;?4)_$LL CFTFY\3Z9&I7!CD<>4LV.QYX/O7;7!
M2+XR6LAPH_X1Z;<WL+B/K],F@#M**@LKVVU&RAO+*=)[:9=\<L9RK#U!J>@
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M&\6Z%K]R]OIE^)IE3S=AC="R9QO7<!N7/=<CF@#5N;6WO+=[>Z@BG@<8>.5
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MD#!QGFFZUXPUBW3P7(+)]-EU;4DMKVTN%#,BG.0#^'!],4 =\JJBA5 "@8
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M(=+\01S/IEUYWDL%E1HVC="1D95@&&1TXYH MFQM#--,;6 RSH$E?RQND4=
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MGS$BB55?/7( YH \SL+T?\+)ACG\1V^K,=#N8UEABCCC#;XF\M2I.3CYL9)
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M '\A^5>Q>3$9Q/Y2><%V"3:-P7.<9],]J8;.U,,D)MH3%*2TB;!M<GJ2.Y-
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M)7KHTS3U55%C;!4C,*@0K@(>JCC[OMTI_P!BM<0#[-#BW_U/[L?N^WR^GX4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<[K'B>6QU8:5INCW.JWRP?:9HX9$011DD*2SD LQ#84>AZ5';^-M/N9]$(AF
M2SUF(FUNG "B4<^2X_A? ./4J17-^)]'@M_'=SJNI66NW%C>6,4<4FD/<;DE
MC9\HZPD'!#J03QD'I3-1\/2:UX<T7P59:/=Z7I\Z_;+V:8F5K1 ^_8LC9!F9
MSZG:,^U '0+X]M)=(EU*WL+J>%[[[#IX3;F^DSC,>3@)D-\Q(X4FE_X3NVM=
M-U2?5-/NK*]TUHTFLLK([F7B+RRIPVX\#IR#G&*Y.^TS5+SPAI6G:AI-[YOA
MO4HEN%L%>(W5NJ,@E@*$$G:X)53D$,/2DN?#T5WHFH:EX?T36A/;WEE<+_:4
MTQEO5@DWE528[E !;&<9)H Z:X\?MIEAJDVL:!?6%Q86PN_(9TD$L1;;E74E
M<@]0>?K6WJGB!--U72].%K+//J0F\D(P !CCWX.3WZ"N2\2ZCJ?C7PIXATW3
M-!OXK<Z>?+EO86@DEGSGRTC8 D8'WNF2!S3FU*Z\1^./"-[;:+JMO9V?VK[1
M->6CP['> @+AAGJ,9Z9( )YP 9H\;7.H_#+7=8\0Z=?P6EO<NBR65RD<C*+C
M8$5D;(*_*"3C/.,UU]_XJ:TO[32-+TJYU34)+4731)*B"*'.T,[N0,DY ').
M#7G%]8:I-\'/%'AM=&U/^TXKV1UC^R/MF5KL.#&V,/\ +SQG%==(UQX9\;?V
MS<:=?W.GWVDPVS/:6SSO#-&S':R("P!#]<8R* +LGQ%L4TFPO5TZ^>:[OVTU
MK,*OFQ7"AB489QU3&<XY!R!6EH'B9]7U+4-+O-+GTW4;$1O)#+(D@9'SM964
MD'[I!]*XFRT352^D:A+IMS$;WQ9+J;P,F7MX6A=5,@'W3PI/H6QUKJ]/L[E/
MBAK=X]O*MK+IMK&DQ0[&97ER >A(R/S% %O6_$[:;JUMI%AID^IZI/$UQY$3
MI&(XE(!=V8@ 9.!UR:XSQYX[OI?A?JVH:-:7ME>03&SNV,B))82!T# X;G(;
M@IG[P/%;NLF?0?B)#XADL;VZTZXTO[#(UG;M.\,BREU)106VL&(R >0,UR7B
M+0]7U'X7>-;F/2KP76LZBES;6/E$S>4'A4%D'(8A"Q'84 >C^$;66S\/PPS6
MM];."24OKS[3*?<ON;@^F>/05GP^-G;4K6.XT*_M=.O+IK.VOIB@#RC=C,>=
MZJVTX)'/'3-=3&"(4&,$*.OTKQ6*UOI(-"O[S1_$=SK=EJ<5QJ\\ZSLB .01
M%'G:XY!'EJ0%'7U /7-=UJU\/:-<:G>"1HH< )$NYY&8A551W)8@#ZURVK^*
M;VY\-^);*[TF^T;4H-(GNH2TBN&78P#+)&2 P;&1P1P:TOB!IMYJ7A8_V? U
MQ=6EU;WB0*<&7RI%<J/<@''OBLS5==O_ !/X?\1V=CH&I16G]D3JLMW;O#++
M<,C 1)&PRW'?UP!F@#-TS6K>+PW\./[2DU*:[OQ$L<D5R5#2>6"3+S\X]CFM
MB\^(#Q/K(LO#U_?)HTSQWLD;QH%55#%EW,-QP3\HYXYZC/,?V+JG]D_"I/[.
MN]]A+$;M?);, $8!W\?+SZUT&G:=>QZ3\0$>SG5[N^N7MU,9!F4V\:@K_>!(
M(X[B@"U/K^EW7C7PLD9OVEU&SEN+5HYBL!39N_>)GYC@\<<4J>/EEN!/%HE_
M)HAN_L8U1"A0R;]F[9G?LW<;L5SFGZ/J:>+?AK.^GW2Q66BO%=.8FVPOY"C:
MYQ\ISQ@U;\+ZEJOAC1;;PJOA[4+C4[>[>%93"RVKPM,6\[SL%0-C9Q][(QB@
M#=O?&SV-_+YNA7XTJ&[2SEU%BBJLC,J@A"=S)N8#<!],UG:#>W4OQE\66DES
M,]M#9VC1PM(2B$KR0O09KDM>L-0U"RU876D^(+W78M3,P;]_]F2U2<,GE*#Y
M;YC  4 MDDGI76>';.\_X6WXGU1[*YBLKNRM/)FEA9%<A.0,CJ.XZB@#<\0^
M*UT'5=+TQ-.NKZ\U-9OL\<!49:,*2"6( &&SD] #69-\1K2RT#5=1U'3;JTN
M-)N8K>]LW96>,R,H5@02&4AP<CT-5O&=\VF_$3P=="TGN42*_P#,2WC,D@4I
M&-RJ.6QQP.<9QFN;UW3-3UW1?&6KV^DWRIJ=[IRVEO+;LLTD<#QAI#&1N /S
M'D9PN: .VF\:3V]G9>=X>ODU+4)VBLM.:2/S)55=QD8[MJ*!UR<CTIG_  L"
MSMM+UBXU/3[NRO-):-;FR.V1V,F/*V%3A@Y.!R.<YQBF^+H;JS\3^&_$4=G<
MW=KIYN(;J.UC,DB+*B@.$'+ % #C)P:Y76-)U7Q#_P )+XBL]+O$1I-/:SM9
MXC%-<K;2>8YV-@C.2%!P3CWH ["Q\9R3>(K+0=1T.\T[4+J&2=5D='0(@'.Y
M202<D8ZC'H034T7XB#6]"FUR#P_J?]F1VYD68!6::0,%\I$!W$Y/WN%R#SQ6
M<VL/K7Q4\,3+IM[:6Z6-Z$:\@,,CL1'N&QN0!\O)X))QTJIH]EKNF? >QM+:
MUO[;48U430PH5N5B-QF38.H?RRQ'?TYQ0!T@\<FVMM8_M71;K3[S3+$Z@ULT
ML<GFPX;E64D9RA!!Z<55/Q%9+K3XY/#>IK'JL9;3'#1DW+  [2N[,>0<Y;''
M)Q7'WFF.;CQ$VDZ%KB6>H^')[6U>Z2XE>69=Q((D)9,Y 4-C)!P.1GKKO3KU
MM7^'KK:3%+3S/M#",XAS:LHW?W>>.>] &[X;\2?V\VH6T]A-I]_I\XAN;:5U
M<J2H92&4D$$$52N]3LH_B?I^F.+[[=)ITDJ%9R+?8&(.Y,X+>^*;X<L[JW\<
M>,;F:WEC@N)[4PR,A"R 0*"5/?!XXJA?Z=>O\;=)U%+2=K*/1Y8GN!&?+5RY
M(4MT!]J $B^)J2Z7#K T#4!HQG%O/>EXP(F,GEYV[MS*&QD@=^^#6AJOC5K+
M4;^UL-#OM433$5[^6W:-1#E=VU0S NVWG ]1W.*Y8Z-J?_"AVTW^S[K[?YQ/
MV;RF\S'VW=G;C/W>?IS6DM_?>#O$'B<-HFI:A_:5PMY8/:6[2)*QB5#&[#B/
M#)U; P<T ":M-=?&RQ2"ZG.GS>&OM*P%F"$F;ABAXW8XZ9K:3QQ:/X+T_P 3
M"TG^SWKPHD61O4R2",9[<$YK&CL-5G^,MCJESI\L41\-^5-(@+11S&7)CWXP
M2/U'-<U!_:A^&VC^%5T#5O[0T^\M5NRUHXC5([A275\8<'@_+GC). * .RUO
MQI(/[=M=/TB]NK?38VCO+Z%T40R&/=A5)#-M!!..1VR:RM#UJW'_  K6WOI-
M1FU"_P!-9XY%N2(V*VZLYF7/SD]B<X/-,6:_\/R>,='.B:E=SZG=S7=A+;VS
M/#*)8E7#2#Y4VLISNQQTS5/3]&U1-:^$TCZ==*EAIL\=XQA8"W8VRJ _'RDD
M8Y[T ;]Q\21%::E?P^']0N-/TNZEMKZY5XP(_+<JQ52V7X^;CH#ZYQIW_C$Q
M:T^F:7H]YJTL%NES=-;,BB%'SM'S,-S$ D*.U<U_9.H_\*P\;V?V&Y^U75YJ
M300^4=\H=V*E1U.>V.M6+"2]\+^+M3N9]&U*[@U6RLS ]I;F0+)$A1HW/\!Y
M!!; Y/- &]I/C%-<T'2]8T[2[RXM[^[:WPH&85#NAE?T7*?7D5TU>>?#G4Y=
M.^'>AB33[JXDNM1N('%I'O6 M<39=SQB,8Y/N*]#H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HJIJ>IV6C:;/J.HW"6]I;KOEE?HH_KZ8[UD^%O&_A_QG%.^AWXN# 0)
M49&1EST.& .#CK0!T-%%% !17$^(;G4M<\;6WA2PU&?3;2.R^WWUS;$"9U+[
M$C1B#MR023UP*NZ7X:U;0]=ADM?$%[>Z1)&PN;;4YC-(K_PM&^,CW!.* .IH
MKQ72]9@L_A%XJO\ 64O+ZVAUJ9&CCNFBD(\V,*%<'*@$CI]*] U'Q;<6OB)?
M#^FZ++?WIL$O5_?K&@0NRG<Q'&-H]2=W3J0 =517G6L^,=-U'PIH^IWVF7BF
M36H[)K9+DQO!<*[(=S*?F4%3QT.16SJOC*ZMM4U"RTG0;C51IB*]])',L>PL
MNX(@/+OMYQQU SDT =917*ZEXMOX0LFE^&[V_@6S6]FED86X5&!(1=P^:3 )
M*\8XR>:P-2UC^T?BA\/;JSGF%C?V5W.$W$!U,(9=PZ9&: /2:*Q_$OB"/PYI
M2W;6\EU/+-';6UM&0&FE=MJJ">!]3T -<?'XDNH?B3--K=I+ID=EX=FN)X?/
M$L943(=ZD8!X##H#P>V,@'I%%<;;>-KYGA2\\.7%H][:R7&G*;A'-P47?Y;
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY'0^]>8)96=HWQ2N;>-8[I5E 96.X*UHCGO_ 'LFK*Q6^K^(/#6EZTQDTUM
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBN#\9:7>:CXLTIO[$O-4T^*RG#1P70@42L\>TLVY?X5;UZ]* .\HKA+.WT
M'6_"J!WO-)TO2[J4:A937!7#IG<DK[B2H+!N&P>.W%<^J74>E+;VCWMGH&MZ
M_;V]G$\CK(MJ4S(5).Y%D9&P.#ANV: /6Z*XO1[6+0/B'<:+I_F1Z;<:6MY]
MG:1G6.59=A*Y)QN##(']W-3B63_A;SP^8_E?V"K;-QV[OM!&<>M '6T5R5I+
M(?BSJL)D<Q+H]LP3=\H)EFR<>O JMXUTZ_N-8TZ[DTR[UC1(89%N+"TG$;B4
ME=LA4LHD  8;<\9SB@#MJ*Y#P/+HQ?4X-)EU. HZ--I>H!U:S)'&U7Y"MC/!
M*\<8YK<\1LR>&-696*LME,00<$'8: -.DR,XR,^E>377BV[/P;>$:#KZR?V$
M%^VF--F?(_UF[S-V.^<9K1NO%,NARZE-#I]I+=PZ3IOE2L"'EDFD>-5=L\H"
M0?7EO6@#TGI0"",CD5P.HZSX@M]2NO#^K?V=/%-HEU=BYM87B)9=J[=K.V,;
MCSDYR.F#FEX?UCQ%I6A>#(I#IKV>IVL=K#$(G\R%A;%XV9]^&!V<@*N,\$XR
M0#TNBO/K?X@7EP_A<BU@$=]$IU7(;-N[.(55.>/WVX<YX6GS^,]1DLH[E+O2
M+""YU"Y@MYKF.25VAB)0%8E8&1F96.00 ,<&@#OJ*\_TOQY?W-II]W<Q6K6O
M]KR:5>S1QN@R>(I5#'**6*@ALXW=:Z70=8N=8U#628XET^TN_LELZ@[Y&11Y
MI)SC <E1@?PF@#;HKSSQOHVG(+Z:6>^O?$&HJ8](MXKAE>!PH"F,*0%4-\[.
M?Q/05:\0Z3I<%I!J/BN\NKZ5;6.UALX9&427&#N,2(06D8]^P'89H [&WLK:
MR2865M!;F:1I7\N,*'D/5FQC)/<]365H&@SZ=>ZCJFHW45UJFH,GFR0P^6B(
M@PB*I).!DG))))/M3_"-KJ=EX2TNVUF5I=0C@43,[[VSZ%NY P">Y&:I>.K#
M5-0T6W33(I;A8[N.2[M(KCR'N8!G=&KY&"25/49 (SS0!NMIM@UO<V[65L8+
MEF:>,Q+ME+=2PQAB>^:BU'1-*UB*.+4],L[V.,Y1;F!9 I]@0<5PVD7NAZ9J
M-W)I]IJ^B:DEA-(-*OU98;C8 =X&65BO3*,#@G-;2^*KUM+\%W1AM]^N21+<
MC:V$#6[RG9SQRH'.>* .J@BAMX$AMXXXX8QM1(U 50.P X%(UK;O=)=-!$;B
M-"B3%!O53@D ]0#@<>PKS+2M8UB[U+PK'ISV&G6ES>ZDLUM%;OL?RI9 2<.,
MDCGV8D\]*1/BA<RV_P#:L4^G-:?:O*&F+;RFY,/F;-_F;MN['S;=N,<9S0!Z
M<EK;QW$MPD$2SS!5ED" ,X7.T,>IQDXSTR:KRZ/IDVF#3)=.M'L%4*+5H5,0
M Z )C%+JMB^IZ5<V4=Y/9M.A3[1;D"1 >I4GH<=^U>;N8=&N]<U7PCYRZ7IF
MCW(N9#*\D,]VH#)MW$[F3:VYA_>QG.< 'HL&B:5:V4=G;Z99Q6L<@E2%(%5%
M<'(8*!@," <]<TNHZ+I6L>5_:>FV=[Y)W1_:8%DV'U&X'%<'_9D/A=/"&J64
M]P;N]NX;:_EDN'?[4LL3%F<$D$A@&![8]*9=:E=ZUXS\,ZU'=21:0VI26ME"
MK8%PGD3%IF'<,R@+[+G^*@#J-7\&:=J6HZ=<QVME"L-X;F[3[,O^E9B>/#^O
MW^^>F*VK#2]/TJU^RZ=8VUI;DEC%;Q*BY/4X Q5NO+=:2UNOB;K$5_HVK:M%
M'I]JT4=C(1Y1)ER2/,3K@>O2@#T'3] T;29Y)].TFQLYI>))+>W2-F[\D#FF
M6_AS0;6Y>>WT;3HIVD$K21VR*Q<9PQ(&<\GGZUP.C^(M6TOPE80V+K<7EQKS
MZ>(-1:1Y+*-][)'(20Q9 $)ZY!X)X-7K[Q/>:#>^)&:RT^;5+>WTV(311M&+
MB:9G0;_F)V*3D#.0">30!VSZ/I4E[/=OIUFUW<PF&:9H5+RQ\91CC)7@<'C@
M4E]HFE:G9QVE_IEG=6T6/+AG@5T3 P, C XK@-2U/5/#WCF34M::TNS8^&KR
MY5[2)H1)MEB)0JS-@Y'7/.>@Q6HGB+Q-IVJ^'(-772Y+;5O-:5K:*1&M]D#2
M;!ESNZ#YN.AXY!H ZN[T32;^PCL+O3+.XLX\>7;RP*T:8X&%(P,>U3V5C::=
M:I:V-K#:VZ?=B@C"(OT XKS;3/B;=WJZ9J!FTZ2VO[F.,Z;#;R_:((Y&VJYD
MW;6(R"PV@8S@\<W;OX@:C9Z78N]K:F]34)X=20!ML5O!)MDD3G(.UHV&21\U
M '<S:7I]Q]I\ZQMI?M2JEQOA5O.49P'R/F R< ^M3/:V\ES%<O!$UQ$K+'*4
M!9 V-P!Z@' SZX%<;J/B^_C.JO!-I5I:V^I1V$%Q>[SD^6&E(12#(P8[0HV]
M#SQ6#J7C/6[_ ,*ZTMI>VB7FG:C:0&\AMI8UFBE:/HC/N0Y;!Y((!QU! !Z*
MNA:0NJG55TJR&HGK=BW7S3V^_C/2K45K;P3S3Q6\4<TY#32(@#2$# +'O@ #
MGM7 ZGXYO[?7;_2$U+2+2?38HA*]S:RN+J9T#D(%?]VF".26//?'-C3O&&M>
M(-8T>UTZVM+2&[TM-1N#=QNSQ?O-CQ@!AD]@3TY//2@#O***\NFO[[0OB%XD
MU_[1-)I5O<VUMJ%N6)6*%H(R)E';8Q);'\+,>U 'J-%>93>+)/#P\2W"2122
M7'B&*SMGN&9HHM]O"VX@<E0 QP.OXYIX^(6H0"^4RZ?J,=E]GN'O+>VDB1H&
ME"2KM9CM= =P.2".U 'I5%<'=>/I[/5/$J36\/V'3[666Q< [IY(53S5/.#\
M\B*,8Z&NTL&NGTZU:^6-;LQ(9UC!"A\#<!DDXSGO0!8HKS'4-0MO!/C'Q3J,
M$4KP0Z+#>&W,S$/,TTHS\Q.W)VCCIZ5=TKQS>R:S;6$]YINHBZMY7#V-M+%]
MFD1=VUM['<I (!^4Y'3F@#T&BO.H?%_B;_A!=.\17$%@O]H-;G,-K+*ME$RD
MO+(H;<XR!@#&-W).,T^Z\>7-AX86_.H:)J#W-_'96MY:%Q"-PR6ECRS*5 ;Y
M0Q)P.F: /0J*\V_X3_5([?5Q";#56TZ"*]^T6UM)$DL&_$R;68E9%4%@<D'(
MXKJK37I=1\6OI]D(9-.@L$N)Y\$L9)3^[53G&-BLQX/5>E &_17$75A!XG^(
M6HZ?JGFRV.FZ?;M#;"5D4R2M)ND.TC) 10/3G'6N4BO9[RW\.V.H?;=8@M[S
M4;26QA<F:Y6*0I'*W(#*@&#N8<L#R: /8J*\<6YD/AB& R7KVW_"2-$=$$C_
M &KR-I(MCSU'$F-VW;QNQ3C>30PZSIEDU[I-K>:OI]DEA+(1/:1RL%D=3DA1
M(,@;6(X/0\  ]AHK@X=(L])\=+H%JDJZ3JFDS23VOG.5#QR(N\$G*DK(0<$9
MP*CT7P]IC^/YY]+BE@L]$7R7(N)'$]S(N2IW,1A$8?\  G_V: /0**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>exhibit1012-stuartexecut002.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI-B[]^T;@,;L<XI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF?=&8U/#@@@>@QSB@#K=4\=:)I&H36=RUTWV;9]JGBM7>&VWX*^8X&%R"#[
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MB-3MW,0.!N/7T!/0&O-_".D7&J? *VDLE/\ :>GW4M_9''/FQ3,P'XC*_P#
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M#4HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HIDTT5M \\\J11
M1J6>1V"JH'4DGH*IZ5K>E:Y \^DZC:WT2-M9[>57"GT.#Q0!?HHHH 1E5U*L
M 0>Q%+@ 8QQZ5R'B+6=8N/%%IX6\/RP6MU);&]N[Z:+S!;P[MJ[4R S,V>O
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M[7C=3T-=-K7C;3=$OIK26VO[I[:$3W;6EL95MHSG#2$=.%8X&3@$XH Z,JK
M @'!SR*7 KF]0\;:78ZA%I\<5Y>W<UHMY##9P&4RQ,2 1^74X'(YY%1KX\TB
M72++4+:*^N7O)7@ALX;<FX,B9WJ4[%=ISDX_,4 =12*JH,*H ] *HZ/J]KKF
MG+>V@E5"S1O'-&4DC=20RLIY!!!J_0!B>(/#W]LRZ=>6]S]CU'3I_.MKGR]X
M (PZ,N1E67@C(['M6R45L%E!(Y&1TIU% !1110 4A 8$, 0>H-+10!B>(?#P
M\1"QMKBYV:;#.L]Q:B//VDIRBEL\*& )&#G Z5MT44 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@*?N^?)S]*ZE=>LO!OBKQ:-;653?RQ7=D!"S_:U\E4\M, Y8,I&/<=J](HH
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MR6SS- N V]AG 4@\<Y/. <&K]UXVTR&VTR6T@O=2?4H#<VT-E!OD:( $N02
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDNXK@//=;9DV"<KR^,JI(^\ W3K4_BS5;[Q#X<AU&'0[^.QL-<M)XRT+^=/
MCJ7E\G:&4 D@#DD#/% &]!K5K+\1H+&8:K;:B^B"Z:VDG7[-&ADP=RAB/-!X
MW#(QWJ*'XBVLL=O?MH^HQZ'<SBWAU5Q'Y3,S;58KNWA"W 8KW%9,EG<:Q\8!
MJ,-K=QZ?=>%3"MS);NBJ[3$A3N PV#G:>?:LEFO+_P"&FG^ QI.HQZVGV>TG
M#6D@AB6.12TWFXV%=J9&"221Q0!V%]X^2"\U>UL]"U/4'TA\7A@$85%V!]P+
M.-W!/RCGY3P.,]-IM_;ZKIEIJ-HQ:WNH4FB8C!*L 1^AKDM)LKJ.[\?,]K,H
MN;HF F,CS1]F097^]R"..]:O@B"XM/A[H,$L+Q7,6FPHT4JE65A&.&!Y'- %
M:T\<Q7&I6D,NC:C:V-[<-;6E_.J!)9%W<;=V]0=C8)49Q5*X^)=M%:W]['H>
MJSZ?IMS);7UTBQA8"CE2<%P7'\7R@X!&>>*XJW^TSIX;U&\M?$UUJUIJ44VL
M27"7)B@/S*0D7W",L,&-3A1R>>=UM,O_ /A57C6U^PW/VFXO-2:&'RFWR!I&
M*E1C)R.F.M '5W_C!;?6GTO3])OM5F@@2XNFM/+Q C9VYWL-S'!(49.!5;X9
M:A-JO@&PO;BYFN9)9;D^;,Q9F47$@7)//  'L!6-8WDGA/QGJ]Q?Z=J,L&JV
MEF]J]K:/-F2.,HT1V@[6Z$;L#D\UL?#"VN[/X?6$%_:26ET);DR02*5*9N)"
M.O;!&#W% %>]^)-M:IJLT6B:I<VND7+V]_<1+&%AVXRPRX+<'. "0.N.*O6'
MC:&\UVRTZ32K^UBU&-Y-/NY@FRY"#<< ,67Y3D!@"1Z5S3:9??\ "!?$> 65
MSYUU?W[6\?E-NF#1J%*C&6![8ZUJ:C97C>(? ,L5K*RVR7'FMY9VQ$VQ WG^
M')XYH OVGCF*XU*TAET;4;6QO;AK:TOYE0)+(N[C;NWJ#L;!*C.*I7/Q*MX;
M?4;N'0M5N+'2[J6VO[F-8PL)C;:Q +@N/XOE!P",^E<5;_:9T\-ZC>6OB:ZU
M:TU**;6)+A+DQ0'YE(2+[A&6&#&IPHY///0#3;[_ (5GX[MOL5Q]HN;S5&AB
M\IM\H9FVE1C+9[8ZT =/K/C'^S+B2*TT74=32"V%W<RVH0)%$<XP79=S84G:
MN3BFWGC:W2[L;32M-O=7N+NS%^$M=B[+<]'8NRCGL.IP:X[5XKRZO[[3M1AU
M^0G3H(](M;)IXH'8QD.9'CPH(?KO/ QP:3PM=S:!J&D:G=Z5JS6ESX=M; F.
MPE=X;B L&C9 NY<YX)&#CKCF@#J[?XAZ;>:&-2M+.^F>2_;3[:U"*LL\PSP
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MG(.6)"_>^7U(K0\#/.-8OX+"YUFY\/+!&87U:*17CFW-N1#(H=E"A>N<'H:
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MQ,8I&#DA]WS84K@$COBI_#/CEO[+\,V^H:9J:PZA!#;Q:I.4*3S^5DY&[?\
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MI\]_?W$=O:P+ODED. HK+\->,O#_ (OAFET+4DNQ 0)5V,C+GIE6 .#@\]*
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MHF8C)9B-O0?]] 4 ==17&Q?$".\T^S:QTB[FU2YNIK,Z<SHCQ2Q F0.Y.T
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M)Y=M;1--*_7"J,G^5<U8^-Y9;S3(]3T"\TRUU5MEE<321N&8J657522C%02
M<^E '745RS>-[5?!>H^)OLDWD6,DR-#D;F\N0H<=N2,UGGQCJD?Q$O\ 2I=-
M<:3::>ER\OF1Y0$N3+UR00 -HYXSB@#N:*YC1?%5UK!B-QX?O[*TN[8W-K<L
MZ2*Z8! ;83Y;$," >O/.16'X>\9Z?:_#W0[W3+'4KM]2N'MK*TGN!)/(^]\[
MI&/0;6.2>!B@#T.BO-[+Q;):^,?$]]K$%Y90:?I=LTMF[B3:^Z3[FT[6+ J
M1UX!P1QTVC^)Y[[5_P"RM3T>XTJ]>W-S DLJ2"6,$!L%2<,I9<J?4=: .BHK
M"U_Q&='NK&PM=/FU'4[XN8+6)U3Y4 +NS,0%49'U) KBO&OB:YU#0?#MS;QW
MVEW \36]G=6[ML8$%MR$J<.IX.02",4 >I45QJZY86_C_7;<17S7=GIB7$NZ
M<F%DZ@*F<!O>HK'XB?:UT6[DT&]M]*U>2.&WO9)$XE<94% =P4D$!N_7H0:
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M(!#(Z\,.>W0@@UJT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <]XW\+K
MXR\(7VAFX-NUP%*2@9"LK!AD=QD<UR'PG^%=SX N+^]U#4(;FZN4$2I;@[%0
M'.22 22<=N,=\UZA10 4444 >?>)YKK2OB=HVLC2=3O;./39X':QM6F*NSJ0
M#CIT-)=_VIX\U_15_L:^TS0]+O%OYIM0012SRH#Y:)'DG;DY)./\?0J* /'H
M?#%E;R7VC:IX?\0W]W-J,K1F"ZN$M)H9)2X<LKB-=JMR#SE>AS5_QOH6L_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '%:]K_B+_A.H/#.AKIZ>=IIO#<74;OY1$FTG"L-PP0,<
M<G.>,5BZO\1[NTGUF\@U/08K72+AH&TVX?%U=^7CS"IWC:<[@HVMG'O75OH5
MVWQ*B\0 Q?8ETA[(C<=_F&97Z8Z8![UAOX8UO3M2U6+3=+T2[M]1O&NX[V].
M7M2^#(&CVG?SDKAAUYH <?%FL7_BF^L-,O-&B^R2Q+'IUXK+<7D3(CF1'W
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M^\1G'TK8'B'7M$\46]CX@DTZ:SO;*XND:SA=&MVAVEE)9CO&UNN!R.@K&O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SM=UW3_#>CSZKJD_DVD
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MODP6XYSQVS7L58_A_P /6WA_1WTV*1YX7FFF8R@<^8Y8CZ?,10!R.DWB^"?
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ME20=P"  R9 ^8YZ>A.0#B'U\Z%X>UZ6QN_$-KJ\-@I;3M99IG5V<)Y\;.2&
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M$Q\[*K+@Y[?,:JZQX8EO]735M-U>YTJ_\C[-++#&D@EBR6 *N",@DD'MD]:
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M_*\CCRPV OF>N[:-OTH X2]U>6+58-7TZ\\1W9?7([=KQFV6!B:<1M"L9?!
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M+BUNH,;XI ",X(((()!!&"#5*P\();KJL]]J5S?ZCJD/V>>[E5%*Q@$*J*H
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M"MZB@"*UMH;*TAM;=!'!"BQQH/X5 P!^0J6BB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%'M<?<D$8&#]#7F&G:+>Q2>%[\^%]6_M*PO$?5[RY;?+*Y1T8IECO3<VXD8
M&,=\ %_QMXSU#5?A[X@N['1YDT<"2VAU%+D!V97V%Q&!D)N!&<Y[XQ76W7BR
M]&OW>DZ1HCZB=/BCDOI/M*Q;"X+*B @[VVC.,@<CGFN%O;+Q!:_"_5/ \'AS
M4)[Z-IDCN55?(EB,ID#AL\L5.-N,YZXYKIT?5/#/C;7[E-#OM0@UA;>6VDM5
M4JLB1^6R2$D;.BG)XP3Z4 <_X>UFSC\'_#]M0M;B\FO=1>.WE%R\9B?S'PS
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\\\*NQ^,OCU2Q*B.PP,\#]T:W]<\1:A9Z[;:+H^FV][?2VSW3"YN_(0(K!<
MA6+,2>F,#N: .DHKSZ[\4>)7\=>'+&#28[>WN[*6>>VN+K:^1L#;L(>4R< '
MYL]JTSXWQX,USQ#_ &?_ ,@N:ZB\CSO];Y+E<[MO&<9Z''O0!UU%<E<>*]3N
M->ETK0]&AO7M+:*XO'FN_)">9DK&GR-N8@$\X'3GFN<^'?BEK30_#&GW%HXM
M]7EO_*NGDP4E6XD81LN.ZYP<]1C% 'J%%8=AXA.H>+-5T:&U_<:;%%YUUYG6
M60%O+"X[+@DY[@8KE]1O]5MOB]=PZ1I\=[<2:'"=L]P88HP)I<DL%8YY   Y
M]L4 >B45QFF^/OMYT6)M,:&YOK^?3[J)I@3:RPJ[,,@?./DXZ<'/M4NK>.H=
M'N/$B7%D[)HUO;2@I)EIVFW!4 Q\OS #.3U]J .NHKS:ZU/69?B-X0CUO3(=
M/<1WL@,%UYT;+Y0R"2JX9>,\$<\'KB1_B3J<>@P>(#X:!T>\GCAM)!>?O2'D
M"*\B;,*I!)&"QZ XSD 'HM%<9J?C74+:;5[C3]$2\TK1GV7UP;K9(2%#R")-
MI#;%()R5R<@513Q;K/\ PL34K?[+!)H=KI<=UE+D[MA+MYH79RQ  VY  &<G
M- 'H-%<QX;\1:QK+6L]YH<5OI][;_:+>YM[P3A1P0L@VKM8@YXW#@BNGH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@##\7^&;;QAX7O=#NI7ACN ,2H,E&
M5@RG'?D#BN6^&?PJA^'LU[=/J1OKRZ41[A%Y:H@.<8R<DG'/M7HM% !1110!
MB^+[.XU'P7KMC:1&6YN-/GBBC! +.T; #GU)K-N-*OG^$LFD+;L;\Z&;80Y&
M?-\C;MSTZ\5UE!( R3@"@#BM1T;4)K7P,D=LS-I]Y#)=#(_=*+=U)///S$#C
MUKF=%\&0:9+;Z5<^!OMEY#>D_P!J/*H@:'S"PDSNW;PN!MV]1UQS7K?49%%
M',^/=(O=9\*30Z;&LM[!-#=0Q,P42-%(K[<G@9"D?6N?O+76?%OBW3+J70[S
M3=,CT^]M7>Z:/S%>54&=JL>..#WP>!QGT:B@#RWPCX7AL;K1K6;P)]GO[$ 7
M6IR2KY6Y%($D6&)8L<'!48!.>E2/X1U8^/S8BU_XI=]2&N-+N&//"8\K&<\R
M /TQ7IU% 'EFK^%(K;Q+KMQ<^#)-?.I2K/93QR(%1O+5&CE+,"H#+G(!X8]Q
MBM)O#%X/B=IEW'8"'2(?#S6#/$X*1/O.$&>3@=#BO0:* /*#I/B&Y\ 6_P /
MY=#N4F0QVLNI;X_LWD)(#YBG=N)*@?+MSDU:T_5]3TKQCXY-GH=WJ:R7<(B^
MRLF5E^SQ\/N884Y'(SC!SVSZ;5&RTBST^^U"\MT99K^59;@EB=S*@08';A10
M!P_A7PCJ>@ZOX42:'=%8:+/;W,RL"JS/)&VWU/1N?:DD\.ZLW@7QY8"R?[5J
M-]>RVD>Y<RJX&TCG SCO7HQ8 @$@$]!ZTM 'EFI^%([;Q%<:CJ'A*;7HKVRM
MUB\ATW031H5*-N=<*1M.X9Q@UNZ)H%W8>,]-NETN*RLH?#YMFC@DW1PS&97,
M:GJ>_.*[:B@#RK4/#FMQZ)>RQ:9+/+#XO&K)!&R[YK=9%.5R<9([$BN\UD:C
MJ?@V_&FQS6>I7-B_V=)2%>*5D.T$@D @GJ"0#WK9HH \HT70);3Q1X>U33_!
MEQIMM!%+;7DDAC,[NZ ;WPY)0$'YB<G<>/6W'X;UA?@[HFC&R?\ M&WFM&E@
MW+E0EPK-SG'"@GK7IE% 'FQMM?T1_%FD6N@W-Z-7N9KJRO(WC$*F6,*PDRP*
M[2#T!R.E=?X/LKC3O!6A6-W$8KFWL((I8R02KK& 1Q[BMJB@#S!/#.LCX.6^
MC&Q?^T5OUE:#<N0OV[S,YSC[G/6MK7]'UBY\9S7^FH8\^'KFTAN=P 2X9U*#
MU[9S[5VM("",@Y'M0!Y+HGA^XL]?\+:G:>#;BQ%F6@U&>5HS<2O)$5,A.\ED
M5N2Q.3NX'%7CX:UC_A2;Z']A?^TC*6^S[ESC[7YG7./N\]:]-HH \C\4^%M0
MU>Y\56\_AE]3U&\W?V9J,SH8+>'RE 5<ME'#!^B\E@2<<UJZ4^M:+XEO[Z'P
M]=W:ZO96C>4LT*O:S1H4*R@OPI&#N&>AX)KT>L'6?!VCZY?"^NDN8KKRO)::
MTNI(&DCSG8Q1AN7D]: /+]"\.MJ/A#PIJ]WHQUJWM'U"*ZM8"-Q$D[$2(&90
M<,G3/1O:NE7PW.;/PZ^G>&1I,47B!;V:V656=8A&Z"23G 8_+D G''O7H-A8
M6NEV$%C8P)!:P((XHD'"J.U6* .8TK3+R#XB>(M1E@*VEU:V:0RY&'9/,W#U
MXW#\ZX*Q\$W-GHGA2ZUGPW+JB6=E/:7EC&RF6(M('2106 ;H01GHV:]DI"0H
MR2 !W- 'G=KX<N$D\*367AU=)@@U6:ZN+9)0QB1H9$5GYQN/R9 )QGK1XB\-
M:MJ-UX]^SVI8:EI-O!:,6 $LBK+E1SQ]Y>N!S7HFY<@;AD].>M+0!D^&KF>Y
M\/V9N=/NK":.-8V@N=NX%0!GY21CT_E7 ?V7XALO M_X#AT*YEEF:>WM]1#Q
M_9O(ED9O,<[MP(5SE=I.1QUKU3<-VW(SUQ2T <-_PCU]!\5=(U"*W=M,M=#:
MS:X)& ^_@8SG..:T_'.E7VIZ19SZ;")[S3;^"_CMRP7SO+;)3)X!*DXSWQ73
M4@8$D @D=1Z4 <#KTWB/Q7X4\2VL>@365M+8&&SANB@N9YCG=PKE57H!GDG)
MJI+X;U=M5^&,PLG,>D6TB7S;E_<DP(H!YY^8$<9Z5Z510!Y_'H&J#P-XZL#:
M-]JU&ZU%[2/<,RK(I"$<\9]ZCA\.:F?B)X?OY+-Q8V_A\V<\NX824G[O7.:]
M$HH \\\+OXHT+2=)\*IH#^992B&;4970VS6RL?G3#;BY7 "D<'KQ7-WOA?5)
MK29I/"<UWKUOJHO)M4E>-C-"MR'58&+9SY>!MPH !'7&?9@0PR""/44M '$>
M&M(U&V^)GB_5[FSDALM0BLOL\CE?G*1888!."#Q4GC:RAO[BVBU#PG<:S9K&
M6BN+)U%Q;S9Z#+(5!&/F!ZCD=*[.B@#S*VTSQ)I>K^#-3O\ 3[O4I+:QGM+P
MPR(\D3.4*%RS -@#!8$\@GZTK_3?$</A'Q7X5MO#UU//>W-W-;W8DC$#Q2N7
M');=OY*[<=<<XYKUJB@#@(8M8\,^+]3OH="N]3MM6M;78;5XP89HD*%7W,,*
M00=PSWK'?0-0TWX)(=16.TUC1IYM4B+,-JR)<22C!]&4D?\  J]6) (!(R>E
M9.M>&=,\0R6QU..:>*W;<+?SW6)SD$;T!"O@@8W T 9W@"PGM?#*WU['LU#5
MIGU&Z4]5:4Y"_P# 4VK^%9VHKJ^D_$JXUR'1;K4-,DTF*V8VK(9!()9&X5F&
M0 1GG^(=><=S10!Y3#X?U[3;32M??299KI=>N=4NM/@=#+''.KH "2%9E!4D
M9]:-3\.^(?$7_"977]E/9O?PV$FGPSR)N=H'9]K[20K' [X&X<]:]6HH \\G
M76O%'C+P]?2^'[W3=.M(;N.=KIH]X>2+;P%8_*,8SW)Z<5S&I2:U9?"[3O#U
MSH[QK8W5I;R7WG1M#.JW"!#%M8L2<*2"!C#=^*]JKF+?P!X=M=0CNXK6;$,Y
MN8K8W4AMXI<YWK$6V Y)/3CM0!Q^H>$HK77==^T^"FUV74+HW-E="15B =5#
M)*2P*!6!.0#D'UXK9-AJNC?$2YN[+1)+BSN](AM8'B=1%#)&7.V3)#!>1R ?
MI7?44 >;^&M*N+;Q3#>Z7X9OM MA;R_VE;23(+>>4XV"-%=AD'=\P"\?6N\T
MJZNK[2K:YO;%K&YD3=):LX<Q'T+#@U<HH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#/US6[#PYHMSJVIS>3:6R[G;&3R<  =R20!]:PO!7Q&T'QXMR-):
M=)K;!D@N4"OM/1A@D$?C6GXK\-6GB[PU>:)>NZ0W*C]Y']Y&!#*1]"!7,_#?
MX5V?P]DO+E=0DO[RY41F5HO+5$!S@+D\DXR<]ATH ] HHHH X;XA^&-.G\.Z
M[KI:^34+?3YI(WBOIHU5DC)4[%8+U [<UCCPOIMC\*+W68C>M>S^'9&D>:^F
ME5B]OECM9BO7VKN/%MC<:GX-UNPLX_,N;FPGAA3(&YVC( R>!R>]9UQH]\_P
MIDT58,Z@=$-H(=X_UOD;=N<XZ\9SB@#)T/Q-K5A'X6M]1TJUBTO5(TMK>1+@
MM/&XB+*9%V@#<%/ )Q4L?CN_=(M8.FVH\.2WHLUF^TG[0 9/*68IMQL+XXSG
M!S[58U#0M1GM?!*1V^YM,NX9+L;U'EJL#H3UY^8@<9KG-%\$KI4\&F2^!-/N
MYX;PM_;4OE;&@\PL'//F>8%(&,8R,YQ0!W/C'Q"WA7PK>:TMM]I-L8_W6<;M
MTBH<>_S5G6?B;6;?Q/8Z1KVE6EJNIQ2R6<EM<F4JT8#-')E1\VTYR,C@U#\6
M Y^&NJB(@2%K?:6Z9\^/&:8MMK?B#QKHNH7VBR:9:Z/'<,S2SQR>?-(@0!-A
M)V@;CEL'D<"@"CI/Q'U*[\&S>+;[188-*6#]RD=P6FGG\P(% VX"ECC).>,X
MQ6Q:>)-;L_$&G:5XBTVRMSJ:2&UEL[EI KHNXQN&5>=N2"..#6)8>#=6D^"=
MMX;FC2VU>%!(B2.&42)/YJ@E21@X S[UH+!K?B7Q7H=_?:'-I%II'G3/]HGC
M=IIGC*!4V,?E +'<<9XXH S;/XC:W-X8LO%=QH5K%H4DB1SD73&= 9/+,@7;
M@J&/3.2.>*U[GQ5KMYJ&L)X?TBSNK32)/)G>YN6C>>4*'9(P%(& 0,MW/XUQ
M'AZVU[Q#\(]*\,1:,_V>[*!M3\^/RD@$V]B5SOWX!7&W!ZYKK([?Q#X7U#Q%
M!IVA2:G!JETU[:3Q3Q(L4CHJLLH=@0 5SE0V0?6@"0>.KW6)].@\-V-E-)=:
M:FI;;^Z,)96)7RT"JV6!4Y/0<>M7]4UWQ)$MN=/T.UC'V07,[:C=^6JN?^6"
ME0V7&#D].G6N;N/"<NG>&](T"^\)KX@M[2Q1(KJUG2*:&XYWX9V4JI."&4YX
MY'2H1X5UL7UN-<T*'Q'.VDVUK#=7+QO#:3J&\UG5SDY)4[E!)VXH 76=6BU[
MQK\*M6A1HX[Q;N=4;JNZ!#@_3I72:+XIUK6K[S[?2;.31_MDMHYCN\W,&QF7
M?(A4* 2OW0V0&!YKF=,\*Z^MS\-FGTMH5T%;F&^+31G;F-45AACD,1QCD=P*
MNMHFI7GBVQOH_"W]EZG#?![O5K:X18;FW!.05#;G++@89>#WXH ZCQAXDF\,
M:7:W<%C]MDGO8;40A]I/F-C@^M9:^+]7T_4=1TW7-,LXKN+3)-2M6M+AI(Y4
M3AD)95(8$KVY!IOQ/-PNBZ,;1$>Y&N61B5SA6;S. 3V&>]4[K3-<\2:YJ&JS
MZ--IT4.BW%A:PW$T32332D$GY&("C:!R><T 26WCW5F\*0:_=:) B:C]FBTN
MU2Y)DGFEXPY*X1<\@\G;R1GBM"W\67^FZQ-IGB>SM+5Q8R7\5Q9S-)&\<9'F
M*0RJ0RY!]"#VJA<^&-6?X;>&;2&!/[7T7[%<BV>0 220@!H]PR!D;@#TSBFW
M&BZIXRUV2]U'3)M'LHM*N;")+B2-Y7DGP&;",P"@+W.230!>T?Q1X@NSIU_?
MZ###HVHH9(Y8+AI);9=N]6F7:  1Z$X) -0:;XXU*Y;2+^[TRUAT76)EAM'2
MY+3Q[P3$TB;0 'P.A.-PZTW1#XL>PTKP]=Z&EG;VT'V?4+Z2=)$F18R@\D*V
M[+'!RP&!GK61X4\(?V5-I%C/X#T]+NP8"?6F\K:X0';)'@ER[$*>0,<\T =!
MX?\ %>LZX\-^FDVC:+/++'O@NRUQ;[-V#*A4#DKC )(W#KS3_"OB?6O$*V5^
M^E60T>_C9XYK:\\R2WP,A95*@9/3Y2<'@^M8EOHFJW'BNPU&#PLNBZG%.S:C
MJ$-P@MKN/:PV[%;<^YBI^901CK3]%T34&\9:?JD7A8Z!,GF'5IHKB/R+S*$
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MQA(9(<ACN .5RK'.,D#@9-6['Q7K<MMKUG-HT$VN:3+%'Y%K<'RIA(H9&W,
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MY2,ZHNYV"CU)Q7#KX[O+FRL;2STV!M?NKZ:P-N\Y\F-X06D<N%R4V@$8&3N
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MP"05?(!&<C%6+SQ3XET^[T33KG1K ZEJ\LZQQ1W3%(51 P+MM[<[L ].,YH
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M\5W5GJ=GJ$UY#:SB22SF\B< $;'VAL<]>&!X]:M,RHI9F"J!DDG  H Y'5M
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M$:XBVL-@<97DC!R/0T <5XELO%GC#P;XBLY-(CL!-%$MA9RS(TSLK!G+LK%
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M K$NO!VK7/A+Q=9Z3H,FDVVHV\*6>E27,;?O58F1QABD8(*C /\ #GBO6Z*
M///L>K:%XLTR_L]/3499=#CLKFSCNHHY8C&V1( Y 9,L5./;K6+X>TK5=6L4
ME$,4DUMXUEO+HQ.-BHH8.5)QN 8X]3Z5Z-K7A?1_$+P2:E:&66#(BECE>*1
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MZY>+0[F=)6BM954!59R4+*R!@-V,$@&NY\'Z:-/TZX(\/66A":<LEI;!-VP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\M3F%I8HBO(^4@M*>,?ZNNQT73O$\%Y$^LZU:7%M!"8ECM;4QF=N/WDA9FY
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M$.;O>L63U&TA#Q_>JGK6L:CK/AWQ+$+IC%JNL+H>FQ@#"IE8I6!ZG/[T_P#
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M',F^)U=<D;E.1D'!_48KB)M4U.Y^,%UX=74)H-/?P\;A5B"[HYC-L\Q20?F
M/&<CVKCO#%WJWAWX8:)XFCU>\GLXK]FU"VE",@MVGD1RN%#9!8.<D]#T'% '
MM=%<K!JE[J?Q(N+*UN2NE:58J;E5 Q+<2G* GT5!GC^\*ZJ@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@"MJ&GVFJV$]C?V\=Q:SJ4DBD&585F>&_!WA_
MPC#-%H6FQV:SD-(0S.SXZ99B3@9/&<<UN44 %%%% &/_ &%_Q68\0_:/^8?]
MB\C9_P!--^[=G\,8_&F>+_#W_"5>%KW1?M7V7[3L_?>7OV[75NF1G[N.O>MN
MB@# \1^'IM8GTW4+"]6RU3396DMIGB\U"&7:Z.N1E6'H01@&F:%X9EL;K5-0
MU:\CU#4=4")<,D/EQ+&@(6-4)8X^9LY)SFNBJG=:I9V5]8V4\NVXOG>.W3!.
M]E0NWTPJD\T <]X'\#KX.2]WZ@]_+.8XXY'CV&*"-<1Q=3G&3SQG/2LVT^&K
MV7A.+2H-8VWMKJ9U2TO/L_$<FXD IN^88)!Y&<UW^><49Q0!Q \!7.H:GJ5_
MX@U=+U]1TLZ;-%!;>2D:%L@IEF(QD]<\G.>U:NBZ/X@M+R*35_$*7L%O"8HX
MH+3R?,)Q\\I+-N; [8')KHN^*R6UQ/\ A+4T!(&:3[$;R27=Q&N\(HQW).[_
M +Y- %3QAX8_X2O3;.T^V?9?L]]#=[O+W[O+.=N,C&?6H-6\-:I+XI77M%U:
M"RGDM!9W"7%KYRL@<LK+AUPP+-UR.>E;VI:C:Z1IEUJ-[+Y5K;1-+*^"=J@9
M/ Y/TJPCJ\:NI^5@"#]: .,TOX?G38=%C_M5YO[,U.XO][P_-+YHD&T\\$>9
MU[XZ#-6=5\#0:Q=^(9;J\<1:Q;6\ 5$PT#0EBKAL\G<P.,#[O>NLH!R.* .1
MB\*ZU>_;/[?\1&[6:QDL8XK6W,$8#C#2.N]MS^G0#G YJ@OP_P!0GTCPQ8ZA
MK<$K:!?PW,+Q693S(HE"JA&\X;CEOTKIKG74M_%-AH?D,SWEM-<"4-PHC*#&
M.^=_Z5KYH XZ[\):O#J.JS:#KD-A;:LWF744UIYS1R;0K21,'7!( X((R,^U
M6M*\&6VC:QI5W9W!6VT[2FTU(&3)8%T;>6SU^3ICO73UD:GKJ:;K6BZ:8&D;
M5)I(E<-@1E(VDR1W^[B@#GYO =TDDMW8:M'%?C6I-6@>6V+QKOB\LQLH8%AC
M/((-5+_X<7VHZ9XDLKCQ K_VZD332M9\QS(5Y4!\;-J@!>HXY/?T*@'/2@"&
MT@^RV4%ONW>5&J;L8S@8S7+V'@6&V^'9\(W%Z\J8DQ=1IL96:4R*P&3RK$=^
M<5UU&><4 86BZ9KUO>O<ZUKD5Z!%Y4<%M:>1'UR78%F)<XQP0!SQS69X8\!Q
M>&_$>HZJ+XW$<P>.SMS%M%G&\K2N@.3G+L.PX KL*,T <1'\.T%IXE@DU)]V
MLZ@-0BD2+:UK(K!DQDG=AE![9Z5M:1I>M1SW$VNZQ#?B2(1);V]KY,*CG+$%
MF)8YYYQCM4LFO?:M$N=0T*T;5989G@6W600[W238X#/@<$-SWQQUK64DH&8;
M3C)&>E '!Z7\,UT[P;JV@MJSS37SJT5VT.# (U181MW<[/+4]1GVJ_I_@?[#
M'X7@-\)H-$,LT@,>#<SNI'F=?EP7D;'/WASQ77T4 <;J7@N_O-3ULVVM+:Z;
MK:K]MA%MNF!$8C.R3=A05 SE2>N",Y'.V6B:Y9?$*&SL]9MEO['PW!"9I+,F
M&9!-(!F/?D' 7D-U!XP<5ZI28&<X&?6@#RO6O"T^COX0L(=3<ZC<:Y-=S7YB
M'SSM%*Y;9G&W.!MSTXSWK<N/ 5[JEAXB.K:Q%+J>LVJVGGP6I2*WB7. J%R3
MRQ)RU=P=IY..._I2T <[KGAA]4T_3%MK[[)J&ERI-:77E;P&"E2&7(RK*2",
MCZTFA^'+NSUF]UO6+^*^U.ZA2W!A@\J*&%22$52S'DL223^5='G/2C.>E ''
M>$? ,/A6\U&8WS7:7"^1:HT>S[+;[W<1 Y.>9#SQT'%9T'P^UF'3M(L3XCA,
M.B3QRZ>OV' (3('G?/\ .=I*C&T<DX)Z=7J.NII^O:+I1@:1M4>9%D#8$?EQ
MESD=\XQ6O0!SOAOPM_PCVJZ_>_;//_M:]-WL\K;Y7&-N<G=]>*76/#']K>+O
M#NN_;/*_L<W!\GR]WG>:@3[V1MQC/0Y]JZ&C/.* .-N_!^K17FK_ -AZ[%86
M6KN9;J*6S\UXI"H5WB;>N"P ^\#@\^U6K/P7;Z=K6A7EG<&.VTC3WL8X&3)<
M-MPQ;/7Y?3G-=110!4U6P35='O=.D<HEW;R0,R]5#J5)'YUS&C^#-0LW\-/J
M&L073:"LL47E6AC\R-H1&H/SGYAC)/?.,#K7944 <AJ'@9;^[UZY_M%HIM2G
MM;FW=(AFUEMU&QN3\W*@XXXR/>M;1=/UJVN+BYUK6(KV2152.&VMO)AB SD@
M%F)8YY.>PXK9HH YC6O#6H7'B2WU_1-4AL;Y;4V<PN+8SQRQ;MPX#*0P.2#G
MO67:_#R>RTMDAUMFU1-6DU6"]DMP<2.NUE= PW*P+ X(Z\8Q7=T4 8=EHE[+
MI>H6OB#45U%K\,DB1P^5%'&5VE$7+'&,DDDY)K*\+^ 8M#\-ZEI6HW[:G)J*
M^5<W+1^6S1"(1*F,GH@ZYZDUV-% ',Z%H.OZ=<6B:AXB2[L;*(Q0PQ6GE-+P
M &E;<VX@?W0O//M658_#=;/PA)HO]JM]I743J5K>)  8)=^Y?E)(8#H>>03T
MKNZ* .#U/PWJ"66MZ]KFI07M\FCW%K;I;6QABA0J68X+,2S$#G/08JGX9\*:
MGJ?A[PD=0UF.;2+&*VOH;5;7;*SK&"BO)NP54GC"@G SZUZ1U&#0!@8'2@#D
M)/ YD\+>)=%_M#']M75S<>=Y/^I\TCC&[YL>N1GVK0O?#0O-;T#4&N0%TE)D
M,1CSYPDC"=<\8QGH<UOT4 <CHGA76M&:QL4\0AM#L&)@MUM=LSI@A8Y)"Q!5
M<CHH)P.:&\$%O!>M^'O[0_Y"DUU+Y_D_ZOSG+8V[N<9QU&?:NNHH Y8^%KV'
MQI;Z_9:G%'&;*.RNK>6VW^8B,6!5@PVGG'(-7/$OAY];6PN+2\^Q:EIUQ]HM
M;@Q^8H.TJRLN1E64D'!!]ZW:* .4LO"-T7UF^U;4X[K5-4M1:&6&W\N*"(!L
M*B%B3RQ)RW/M6IX6T/\ X1KPOIVB_:/M'V.$1>=LV;\=\9./SK7HH Y35?"=
MZ?$$NO>'M7&F:A<1K%=I+;B:"Y"_=++D$,!QN!Z<4_2/"U_%KRZ[KNLG4M0C
MA:"!(K<00P(Q!;"Y)).T<DUU%% '#V_@O7=":>V\,>)(K'2YI&D2TNK$3_9B
MQRWE-N7 R20IR!5J+P+'!9:- FI3RRV.I_VG/<7 WO=2%7#9Y 7)?MP ,8[U
MUU% !67XBT.#Q)H%WI%S(\<=PH D3[T; AE8>X8 _A6I10!QP\':GJJ7L?B?
M7C?P7%D]DL%I ;>,!NLC+N;=)P,'H.<#FBS\(ZO-?Z3)KVNPW]KI#^9:Q16?
MDM)(%*J\K%VR0">  ,G/M78T4 <9+X",G@74O#7]I8^VW4MQ]H\C[F^;S<;=
MW..F<^_M6EK.@_:M=M==^T[?L5C<P>3LSO\ ,"G.[/&-G3'.:Z&B@#RGP9X4
MU/6O /A>WN]9C;0T2"\:U^R_OG*D.(S)NQLW8/W<X&,]ZZJ'P48M>\6ZG]OS
M_P )!!%#Y?D_ZC9$8\YW?-G.>U=8  , 8%% '"6?@&_TC3O#B:5K4$=]HUO+
M:^=/9F2.:.0J6^0."""JD?-]:6S^'US;- LFM>?%!K8UA2]M^\9RCJZLP;'+
M-D$ 8Z8/;NJ* .9U/P@FIZMK5Y)>%(]4TD:8T:Q\QC,F7!SS_K.F.W6KWAC3
M-0T;0+;3M1OH;V2V18HY8H#$/+50J@@LV3QR>.O2MBB@#ROQAX2U/2/!'BN*
MSUM%T.6.YO?LGV7]\C,"[1B3=C86Y^[G!(SWK?3PSJC:C:ZYHNL0V+W.FPVM
MU'/:><&"9*NGS+AAN(YR/:NU(!&",BB@#@K+X?7VCV6BC2M;C6]TM[L+-=6I
ME62.XDWL&4.#N&%YSS@\<U!=?#*YN]$OM*DU[?%<:I'J:RO:YD$@P9 V' (8
MC(P!MZ<\8]$HH YU?"VWXBOXL^V?>TS^S_LOE?\ 33?OW9_#&/QKGHM-L/ 7
M@B^T?Q)K$%SHLPEAM(A;%)F$A=FC^\?,8[N, =/R]#I" <9 .* ./^&.@76@
M>"[5=2WG4[O_ $BZ,GWPQ "J?=45%^H-=C110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'F_CC0WEUZ?5[_03KVE"R6/RX;@)<6!4N6DC
M4D E@1R"&^05'%J]EX4\5+K N9'T'7](%TLLAR3-;Q[LG/=XCGW*UU>L>#=-
MUF_DO))]0M99HA#<?8[MX1<(,X5PIYQDC/7!QFL#Q9X?;Q/=:3X6BT*2+1["
MYAGFO9-HB$2+Q%$ =Q)!V'(  SUXH P8?"6IS^&]%U*ZTF'6I;B6XU'4M*FG
M\OS))]I5EW?*3&H"X;CD]*@DTOP[K?B#X>K'I\SVK2ZA;207^6EC\I)#Y3<_
MP/D#D]!S7IFM>&K/7)K:XEFO+6ZM@RQ7-E<-#(JMC<N1U4[1P?051N? 6BSZ
M?IMHAO+8Z=*\MO<6]TZ3!WSYA+YR2VXY)ZYH \\ETW6?$$GB*_L_#XN=8CU6
M>*SU9K]8WM?*?;&JJ>0H"C(_BW'UK6D\/:?XA\6>/_[7M_M @CMC%$[';$YM
M02RC^]P,'J,<=3777O@31K[4)[J4WBQW,BRW5I'=.L%PZXPSQ@X)X&?7'.:T
MXM!L8;[5;Q$<3:H$%T=YP=J;!@=OEH \LL=,M[7PY\._$:>8VM7E]:1W%\\A
M,LL<B,&1B3RN, #VK;73KOQ3!XYOK&=(I[NY73;5G<JK1V^ R[AR [F521ZU
MV \*:4NDZ/IHCD^S:1+%-:#S#E6C!"Y/?K38O".DQ^%O^$=,<KV))8EI")-Y
M?S-^X8(;>=P([T >6^(K+2(_ ?BW3V\.2Z'J$%G%=-8&426_WF59HBIQD_,"
M< \#(KH]6T;2)-0TG0+/PV-4-M8-<BQDN1#:0K(^/,.027+!@.#@;NE=/'X%
MT?[!J5K=O>WYU&$6]Q->7+2R&,9PH8_= +$\=SFHCX TIOLI:\U9I8(3;F;[
M?())H2V[RY&!RRYZ#M0!P.CP#7K7X<6NH222P2?VC'*GG%O,CCR%0MU9<*H]
MP.>M)JD":./%7AW3B]GI,FLZ9;^5$Y40QSB/S0O]T-ST]37H^F^"M&TFXLI;
M1)U%C-/-:QF4E(?.&'51V7K@=LFI;WPAHVHKK"W5NTBZOY9N@9",F-0$*X^Z
M1@'([B@#C+S2]%\)?$G3Y+&,6-E'HE[-+#!]V,*8\NJ] 2!^.T5G^';4:9XO
M\(3VFA-I46HI.'GEO1+<7J>09 9E QNR%;.3@G'%=S:> M&MKW[;,U[?79MY
M+5YKVZ:9GB?&4.>W' 'J?4U':?#W1K26PF6;4I)["16M9I;QW:%0"OEJ2>$(
M)!'?C.<"@#S?3;&/3/@OJ_B>W,@UAENK9+HN=T,)N64JG/ ZMQW.:Z:^\+Z-
MX;\>^!5TBW6U5Y[E7CC8XEQ;/AV'=N?O=3NY[5VEGX6TFR\-R^'TMS)ILHE$
MD4C%MPD9F89Z]6/TK/T_P#H^GZC87_G:A=76GD_99+N[>4Q*4*%1DX"X8_D,
M]!0!5^(A:>'P_I;NZ66I:O#;7>QBOF1[7;82.<,5 /Y5RWB/3[7PWJ?B72M&
MA6TT^Z\)W5U+:P\1K*AVJX7HI(8@XZX]J],UG1;'7].:QU"-GB++(K(Y1XW4
MY5U8<JP/0BN<U7P;!9>%/$OV#[9?ZK?Z;-;^?=3F:63]VP2,$]!D]!CDT <T
M^B6&@6O@/6],5EU.[O;6WN;H.2]U'+$V_?S\PX!'ICC%9?A_3M;U?3]/U^T\
M/#^V)-0^T2:RVH*'=/.(>,IUV; 4"=!@5WOA_P #:=8II%[-]M>>R@4PVL]R
MSPVTA3#%$)P#R1Z#/&*M)X%T9-3%XIO!$+G[6++[2_V83YW>8(\XSN^;TSSB
M@#D_#&F:8=<\:>(=2\QGTS5KAH'W$_9@(5+L@Z;B#Z=A69HFGQ6OB;PF8= .
MG6NK1W$<TT]Z);B_B-NSYG4#&<A6SDX)QQ7I]GX=TVR358XX2R:I.\]VKL2'
M9U"M] 0!Q63:?#S1K26PF6;4I)["17M)9;QW:%0"OEJ2>$()!'<8SG H \KG
MTRRT_P#9Y\1W=I;)#<37;I)(G!94O,*/P'%=Q<:+8Z]\4(;34XOM-FOAV*0V
MSD^6[><P!8?Q8R>#QWZ@5M/\.M"DTK5=*8WIT_4Y/-EM3=-Y:-O\PF,?PY;D
MXK<CT2RBUL:NB/\ :Q:+9[MW'E!BP&/7)ZT >464*W6GZ+X7G>0Z.WB>]M'B
M+G#0P^:T<1.<E<@<>PKIO#.F6FC_ !5UVQL"4M$TNU9+<,2L&7DRJCL/XL?[
M57?$GA>VM_#S0V&CW&H9U/\ M"1(+LPW$3LQ9I86R/G!/"Y'!(S5?P/H5Q;^
M)-7UM].O;"WN((;>)=0F$ES.5+L\DAW-CE@H!/1>PP* (_$>E6>M?%?1['4%
M\VT;2+AWMV8A)L21X5A_$.<X]A7'ZI;&UTC5-!LYI8;"S\6V<-H4<Y@5_+8J
MA[!68D#MFN[U[PS)K7Q$TZ[D2ZBM(-,G1;NVE,;13&2/&&!SDKN]B,YK3B\#
MZ+%I,6G>7.\:7JZ@TDDS-)+<*P;>['ECD#\J .9NO#>D-XZT?PHUDBZ#;Z;<
M7R618F.6?S47+ GYL!B><\G-8-T#9W>H>$K>25-";Q-9VGEK(0$AEA\V2%3G
M(4N ,#^\1WKT_6_#=CKSVLUPUS!=6A8V]U:S&*6/<,, P[$=0<CBJR^"=#'A
M^;1FMY9()YOM$LKS,9GFR#YIDSNWY YSV]* ./\ %NBV/A?1KJT\/,\2ZG=V
M4$^EPW(C1$:7:Q3O'Y@^0MT_&LG6K/6O#7A[Q-=6.C+X>TV>PBC\F"\60),9
M0C2*%^X3&YR1_=!ZUZ%!X$T2.PU"UN%NKTZ@%%S<7=P\DSA/N?.3D;3R,8P>
M:=;>"=(AM=0@NOM>HG4(1;W$M_<-,[1#.$!)^4#)/&.3GK0!RUYX9T;PW\1O
M R:1;+:+(]X'BC8XDVVYPY'=N>6ZG//:LGS2/V=X6+D,;A!G//\ Q_"NZT[P
M'I&G:G8ZCYVH75Y8[A;2W=V\IC5D*%1GC&&/Z9S@57?X:>'Y(YH'-^;.28SI
M9F[?R(9"V\LB9P#G/YG&,T 8^F:'9:Q\7O%=QJ$;3C3VL)K:-F.Q)?*)WX!Y
M8;1C/3)]:YOP[IVMZOI^F:_:^'@-7EOQ<RZPVH*'D3SB)(RG79LR@3H,"O7+
M31;*QUG4M5@1Q=:B(A<,6R#Y:E5P.W!-94?@71HM36\4W@B6Y^UK9?:7^S+-
MG=O$><9W?-Z9YQ0!R,&E1Z!XLBNM<T>5Y;G5F-KXAM+C<6,CGRX9E^\JX81X
M&5X'2O4ZYF'P+H\&I)=*]\88[@W4=DUTYMHYLEMZQYP#N)('0'D"MC3=)MM*
M^V?9C)_I=R]U)YCEOG;&<9Z#CI0!>HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHKR_PSXPUB'QIJ=KK=QYVCWFK7.GV$I4+]GFC;Y8B0
M.0ZG@GG*X[T >H45QL'B5[+Q=XR&IWFW2M*M;2= 5&(@R2%R,#)SM''/M5C3
MO&RW6I6%G?:)J6EC4@QL9;L1[9B%W;3L=BC;<G# =#WH ZJBN&;XF6[Z;>:C
M9^']7N[&PDECO9XUB A\MB&.&<%^!N^7. 1G'2NSM+J&^LH+RW??!/&LL;?W
ME89!_(T 345P=Q?:UXL\9:IHNF:K)I&E:0(TN;BWC5I[B9UW;5+ A548R<9S
M6IHVE^)M(USR;C6?[7T22(G?>*JW,$@(P 44!U//4 C^8!U%%>-Z+XD\OX.W
M&J:]J.M2!=4>(SV=R1< >< H#,?N]B,]*[[4_&<5CXCD\/VVE7^H:FMJMTL5
MN$ 9&9ESN9@%P5YSCJ,9- '345P&M^-M+O\ X<ZOJ]PNLV$=C<"UO(K5UBNX
M)5D0%0P;'\2\@\@FMO5/%B:=?0Z98Z5?ZM?&V%R\-KLS%%G 9F=E&20< $DX
M- '245RS^.+>:QTN?2=+U#4YM2C:2&"%%0HJ\-YC.RJF#Q@GD],UR_Q!\827
MWPDU/5M'FOM-O+>[2VE7=Y<T$BS*KH2I]^QP0: /4:*;*S)$[(N]@I(7U/I7
MEWARYUGQ1HL6JZ?XX(\0GYYM+E6(6\+!OFA>+9YB@#(W9SWH ]3HKG=6\52Z
M?J;:=9:%J6J7,4(GG^R! D2DD#YG90S'!PHR:XWX@^-+NZ\*>'[CP\NI)::Q
M>VZ&[M62-]C$YA!+ K(<=<8X.30!ZI17%Q^*SI%O%IMOH>NW]S:6HN+R-I(Y
M9K:,EL>8[28=SM)"J6) JAJ_Q#NXO%7AJRTC2;F_T_5();D/%Y0:Y01AE\O<
MXQMSEMV/;- 'H=%8NC^)K/6(]38)+:OIER]M=1W& 4*@'=P3\I!!!]*G\/:U
M%XCT&TU>WMYX(+I/,C2< /MR<$@$]1R/8B@#3HKC_P#A8$"S12RZ+JD6DRW0
MLTU.1$$1D+[ 2N[>%+<;BN*EN_&Z)KVI:'I^BZEJ6H:>(VEC@$:KM=-P;<[@
M#KC!Y)Z X)H ZNBN1_X6'I3>%['6H;:]E:^N/LEO8K&!.T^XJ8R"< @JV23C
M K,L?$5_J/Q9L[">VU#3531YI)K"X=2I;S4"N-C,C<9&0<CD<4 >@T5Q'Q'U
M._L$\.P6.JR:8M]JL=M/<1A"5C*.3]\$#D"G:?I<XU&W8?$2]O-LBL;8FU(E
M .2IVIG!Z<<T =K17D@U_6]2^+6I02:?XA:UTR")H;"TNH8UR<G?(/, <-C@
M9/!Y JAX=\0WU_8^,M<UT^)4M[::[CW6]Y&D=M&FW$:('XE'][!'^U0![517
M)+XNM[+2=!@L++4M5O-0LDGM[<,AF,0129)79@H^\H))Y)XS3_\ A.;672;.
M[L]+U*ZN[NX>U2P2)5F25,[U<LP5=NTY);'IF@#JJ*Y:'QWIW]B:GJ%[;7=E
M+I<H@N[.5%:59#MV*NTD-NW+M(.#FJ=S\1K?3;>\?5M#U6PFM(H[AX9%C9C
MSA/,!5R"%)&X9R/2@#M:*R-5\0VNE76DVK1RSS:I<BW@2'!_A+,YR1\J@9)&
M>HXK7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN+?R&\PKYX.=N,XQSFO2;6TN!\8=1O#;RBV;18(UF*'86$KDJ&Z9Q@XKL:*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY$=HVVN%8$JV <'T."#^->96UUKVGV/@K7;C7[RZEU>XMK>[M'5!!LEB+?*
MN0P('.>>?I61I]W?^&-"\>ZQ!JM_/<PZR]G&)@LB[G,""4JJY9P&' X(&,4
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M&,CWQUH [:BO*]6UBYB\1WFA2:[XB@BTJT@6&:QL6N9)YG4L9)F2-@<#:-O
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M45SW@2_NM4\!Z'?7LS374]G')+(V,LQ')XKB%\27<.O:;=6VOZKJ/VK5Q:3
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MLZ]\*:I'K6HZCH&NIIO]IA/M<<MIYXWJNT21_,NUMH YR. <5U0=2JDD#<.
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M*N0 >"0<_=ZU[ "& (((/<5E^(/$-AX:TX7M^TA#R+%##"A>2:1ONHBCJQH
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M8V[N,XQUXJ"\\#:@]UK46G:_]BTO67:6[MOLH=U=D"N8Y-PV[@!G(/MBNVI
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M$ZQX<_M XU*6YD\_R?\ 5^;(7QMSSC..HS[5TEA>K?:;:7FWRQ<1)*%)SC<
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MD;7:-04^;'![&O0=;\-6&NRV\\[W5O=6VX0W-I<-#*BMC<NY3R#@<'T%4I?
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M<9#LP!C'S=>M>@PPQV\$<$*!(HU"(J]% & !0 ^BBB@ HHHH **** "BBB@
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MB:(?*8TD94/OP!S6#XL\1>-O#:K=+;^'Y;.>^CM8 6F\P"1]J%NWIG'X5/\
M"=[>3PC<O:*%MFU2\,2@8PGG-@8[<8I?BI_R+VE_]AJR_P#1HH V;+4=7TO3
M[V^\7SZ-:VT(5EEM'D"J.<[B_OMQBI+'QCH&HVMY<6FI1R)9)YEP"C*\:8SN
M*D!L8!YQVK&^)16/3=#N9\"PM];M);QF^ZL08C+?[(8H35:XU"PG^*\-Y;W5
MN]O9Z'.=0G1P41#(A0.1QV<X/;)H ZV77M*BMK"X>^B\K4'2.T93GSF894+C
MKD<U1TO68WO->-UK5E/!8S894C\O[&H&2LC$X)[YXKSKP6L=AXMT_4+^VF@T
M+4//3PRLS?+:;V+%2,?*9%Y3GA?EK/O4D?2_BIL1G1=6@>95&28E=&D_#8&S
M[9H ]:TCQ;H.O&<:;J<,[0)YDB\H53^]A@/E]^E,TOQGX=UJ_%EI^JP3W# M
M&@!'F =2A( <#_9S7*^.=1T76=#UBVT5X;W6VT.=HY;3$A6W.-REEZ;NP[XX
MINLZAI6J'P!!H=Q;S3#489H4@8%H[=87\S('1=N ?P% &KX4\6SZA+XMDU>>
MWAM-(U2:V20C8$B0 Y8D_K6WHWBS0M?GD@TS48YYD02&/:R-L/&X!@"5]QQ7
MD+J6\._$%V4M:Q>*UENU SF!9HR^1Z #)]@:Z_Q5=1:OXUT%="N8KF[BT[4'
MD:V<-MC>(+'DCL9-N/I0!TT7CSPM/<-!%K5LT@D$0 )PSE@F%.,-\Q XSC-:
MUAJMCJD$L]E<I-'%*\,C+_ ZG#*<]"#7D-SJ>AS_  P\!6=O-;R7D5[IP$*$
M%XI%=1(6 Y7DL"3W8>M7O%,]WX8\0:[HNGAE/BZ-&T\@<)=,RPS'_OAEDS[&
M@#K7\7!-=T6XAN(;KP[K>;:WN$4@Q7(R5&>ZN%8#C@KZ&NLFFCMX9)II%CBC
M4N[N<*JCDDGL*X#QWIUOI/@_PWI5DNW[/JVGP6@[Y5QC\< _K6I\3XII?AMK
M:P*[L(0SJG4QAU+_ /C@:@#4T?Q=H&ORRQ:9J<-Q)$GF.HRIV?WAN RON.*C
MTWQIX<U?4%L;#5H)[A]QC49 EV]=A(P^/]DFN:\7ZGH6LZ+?6NB/!>ZU)H=T
MUH]H YCA*@$97[N[@ =R*IZIJ&EZEI/P_MM%N+>:?^T;.2"*!@62%$/F$@<@
M!<@_E0!UESX]\+6D_DSZU;H_FM"V<X1PQ0ACC"_,",G X-6M6\5Z%H=Y%::E
MJ4-O<2IYBQMDD)G&YL [5SW.!7G9@B'PB^(#"-=TE_JCN<?>(D8 GZ8'Y5K:
M#J-AIGCSQ*^KW4%L9M.L)86N7"[H5C8/C/4!LY^M &YX.\5KJ^@Z9+J5S"M_
MJ$UTD*(,"012N./HJ@UNMK6FI)J"/>PH=.56N][;1""NX%B>!\O->0^$+BUL
M[#X;W4C+;68NM5C#2G8J%C+M4D]"<8Q3O$%W#J2?$2ZM'%Q9)>:8T[1_,'BC
MV>;C'4 *V?H: /07^(7AHZ-J.IVVI1SQV$7FRH RM@_=X(S@G@'&*?9>/-!N
M/#-EKEQ>I;PW(50A#,PE*AC& !EB,]AVS61XJU7P[J6G:]'8/;W>JCP]=,)[
M?#[8"IPI<<#+8('?&:YQ+B6>?X?7%CKEC8QKH\D"74T0GC6?RX24(WJ%<J#W
MSP1CF@#TB7Q7H4&A1ZW)J=N--E(6.<'(=B<;0!R6R",8SP?2LOP_XL77_%^J
MV=G<0SZ;;V=O+$R*0P=VD#AL\C&P<$ BN*CAM=,U/PW?W&N6VI:=)XBNY9[M
M(/(@CG:%E4 %B,>8&.[.,L:Z/PS=V-[\6?%DUA)'*GV.R622(@JSCS >1P<#
M ^HQVH U]6\<Z5H_BS3O#]R^)[Q'=GYQ'C;M& .=Q)[\8YJQ=^-O#=CJ;:=<
MZO;QW*.(W!SMC8]%9L;5/L2*P_$%S!:?%SPK)<S1PHUC>HK2,%!;]WQD]ZYJ
M"^TVT^$7BW3M2F@74_/U".X@=AYDD[R/Y?R]23F/!^E 'KTDB0Q/+(ZI&@+,
MS' 4#J2:PK+QMX;U&&[EM=6@D2TA-Q,<,NV(=7&1RON,BB6")?A\UOKLDD</
M]E^7?.H)95\K$AX!.>O:N OKR[BTG5-#DO\ 3-?23PY>/97]K$JW$4:HHV2;
M21ALK@C&2O2@#U&35["%;%I+I%%^X2U)S^]8J6 'X G\*R9?'WA6"X6"76[9
M9#(8CG.%<,4PQQA?F!'..E<C>:SIU\OPUM[2\AGE-W#(5B<,546SCG'3DXY]
M#Z&L>WU#18OA1XZM)IK=;I[W45:%F =Y6=A&0.IYV@>X]J /3=4\8^']%N)K
M?4-3BAGA"EXL,S@,"0< $D84\]N]2W7BC0[+1[?5I]3MUL;G:()E;<)2>@4#
M)8^P&>*XGPW=V>F?$G5UU>XA@OO[&L%WSN%Z*WF#)]]I/T]JP?"CPV=]X*OK
MMEATA[C5A9O)\J(9),Q<G@;D#[?KQUH ]2A\6:#/HLNL1ZG"UA"XCEEY'EN2
M%VL,94Y8<$=Q6'J7Q1\-6+6/DWJ727-Z;1Y(]VV/"DL^=OS ?*..NZN%\9/#
M?:9\3+JS=9;"1M-B\V(Y1YE9?,P1P2 4!KLO'IMM/U/P06,5O:PZPJY)"H@\
MF0 >@H [2ZO[6RTZ74+F98[2*(S22MT5 ,DG\*RD\:^&Y+2]NTU>W-O9.L<\
M@)VJS=%!Q\Q)XP,G/'6H/'[*_P -_$;HP96TNX((.01Y9KD]?MY+7PIX -I=
M0:=:P7-ONN)H?,BA8V[A&9<K_$0,DC!8&@#MD\7^'Y-%DUA=4@^PQ2>5)(<@
MJ^0-A4C<&Y'RXSR*6/Q=H$NB2ZPNJ0?8(G\N24DC8_'RE2,AN1QC/(K@WTVQ
MDFU2ZO?&]JVH2ZC:>7>6]D(X;>[C1B@;+,K;D(!R1T SDBL_5=2U"^>T%Q=Z
M1;S:?XAA2YUBUM]]O*S6[>6[J6'S*613EL [>>U 'I]OXIT.ZT:XU>+4X/L%
MN2)YF)7RB.H8'!4\C@C/(]:BM/&&@7VF7NHV^IQ-:V0W7+,K*81C.64@$#'/
M3FN"O)/[,M]>O7UO2=;NKZ]T^TG=['9:VDF["R.-[!B R'J,%5S65K5TS2?$
M&*?68-3F/AZ,>=%$L2L5,V0 "0VW."<G&<=J /45\:>''LKV\75[<VUE((KB
M7)VJYZ*#CYCGC SSQ61K?CJS_L"UU/0[^VFB.J6UI<,X(\M7D4.&!P5.TYY^
MM9FN+;Z9I?P^FF"0Z3:WD'G$\)&3 RQLW8 .1R>Y%5O&=WX>U>.6/3DAGF_M
MO3(M0FC7*2DR#:I8<,0IP1VR,T =QHWBG1/$$\\&EZC%<30 -(@!5@IZ-@@9
M!]1Q4^L:[IF@6R7&J7B6\<C^6F069VZX50"2< ]!7/2 #XSVQ P3X?E!]\7"
M8_F:3QAJ$D/B70;"&XT_3Y9DN9EU*\A$AA"*H*1Y( 9@_//13P: -H^+- 72
MK75&U6V6QNF*0SEL*S ,2,]B C9STP:72_%.AZU;W<]AJ,,L=G_Q\ELH8AC.
M6# $# )STX->4Z7)#?VNC))<1WO_ !6\DA?8%#Y21E?9V!^\/K6AX]BG?4_'
MJ6BMYC^';9F"=6 DEW?^.@T =/-X_L-0U[P]9Z%?P7,5[=O%<@HP;RQ"[JRY
M X)7[PR*ZS4]4L=&T^6_U&ZCMK6( O+(< 9.!]23QBN UK5=$U#QE\/ETRXM
MIV6>5X_)8-Y<1MVP#CIG P/]D^E:GQ)=(+;PW<W+!;&#7K62Z=N%1/F 9CV
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M4< ^%HB0($8*NT= ;-LBH=!O(M(O_#]CI^JZ;KFA7=TZ6,3Q 7EB=DC;@>X
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MIS:='IUFEBP(:V6!1$<]<KC%-&AZ2L:1C2[()'$8446Z86,]4 QPI].E7Z*
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M:R6Z&,NKI*)9 @*2+P<$\CJ./45J^*5CD\.7<<^D/J]NX59K./[SH6&XJ.Y
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M_?%>.>),?\(9\4\C(_M-/_08*V;&T\ 37]M'#X!OH97E54EDT&5%1B1@EBN
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MSMN&&!!X/!XH [>BO,]/\;>)CX$A\47L&G,U^D$%A91(ZGSY'"!G8L?E));
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M<C<I]B*["L^'7M(N-4FTR#5+.6_@4M+;).IDC QDLH.1C(_.@#SF#X?>)CX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD @J1P>>*Z/4?#OBS5[1+R^N=,DO;?4H;VVT[<WV9$C5E*&39N))8MDK@$#
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MXBG<LP)"DJWW#T(!&.1S6[=>'=1U[P5JFDZV]DEU?!_+%HI$=N>#'AB 6*L
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M<DRQ8"[BI^]\OWASR<$$YIJ:7>2Z5XWB?Q!K7EZ%++_9I6^D#1$0B4;F!S(
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MOD;SLW^;C=MZ9QQFN;34]2U.6#1'U.]CBO\ Q7?V\LT<[+(MO%O<1*^<J#M
MXQ@<"@#T67Q%:QZKJ&FK!<RW5C9K>.D4>XNC%@%3GEB4/'TJ_87?V^P@N_L\
M]OYR!_)N$V2)GLR]C[5Y=/:2Z#XA\=I;7]V_D^&TDMY)9V>6' F('F$[C@Y(
M))(R.>*+"XU/6++X:VDFL:A$FH6$[7LD5PRR3[8D;ELYSG^+J,G!!YH ]9HK
MR&\O]3TA/$'ANSU:^$7]MV%C;74T[236\=PL9<*[9/&6P3TS6]:65SH7Q1TW
M2X-6U&?3)M+N)OLUU=/-MD#QC=EB2>#QG./FQC- '7W^M6NG:II>GS"0S:E(
M\4!500"B%SNYXX4UHUP7CZT>_P#%/@NUCNIK4R7LX:6%MKA?L[[@I[$C(R.1
MG(YKF_$%WJ'AJW\8Z/9:KJ#6]O;V-W:22W3R2P&2;8ZB0G=@[<X)[GUH ]AK
M.UO6K70-/%[>"0Q&:* "-03ND<(O<<985SWBC5+K3_&WAT132B V>H2RP*Y"
MRE$C*[AWQSCTS7#WVFW$_P --"\17.L:A<7U_=V-Q=++<L\3[YT8*L9.U-I(
MQM .!CO0![517F0AOM?_ .$RUDZUJ-I<Z9=SVEA'!<LD,(BB4Y:,':^XDYW
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MDD07$4I"JY$;AL*PRIX[$=/6@#F-'\ VFC7.D217US)%I,ET;2)PN$2?&4)
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MJP*$#C:5!&<^]=&FJZ=)?M81W]J]XOWK=9E,@^JYS39]8TRU8+<:C9PL9/*
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MLX;+[;+=P):;0WGM( F#T.[IBD74+)K'[<MY;FSV[OM E7R\>N[.,4 <O8^
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MQ)Q(_P A#;ODY^0;N<+@4 >?R:)IL_PY^(=]/90RW8O]399I$#.FQV*[2>0
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MP<GN8A@?CD?G3-/\#:A)J.DQR>&=,TD6=\EW=7MK=&1)?+)8)#&>8U9MI(X
MQWXKM+SP/X:O]2N+^ZTJ*2XN1B8EV"R<;<E0=I;'\6,CUH XBU_Y*=X#_P"Q
M>?\ ] %85QI^ER_L^IJMS!!_:<LPEDN2H\UKAKG#Y;J3U!'I7L2>']*34+*_
M6S075C ;:VDR<QQXQM'/\ZS9OA]X5GN;FXET:%GN',D@WOM+GDL%SA6/<@ ]
M?6@#A?&ZIJ-KXYO;72=*6*TA^SW5]?2.TS2+"&40KC"8WKCD9;G%:^EZ=9ZO
M\3)YM1MHKLIX?LV G4.NYGDRV#QGJ,^Y]375W?@WP]?ZI-J5UI<4MU.NV5F+
M;9/EVY9,[2=O&2,^]6M-\/:5I$HEL;012"W2V#;V8^4I)5<DG@%C^= 'E/AZ
M""=O!6DW<22:4NJ:L%@D&8R\;OY2D'@X!<@>U:GBG3].M;G3]+\.Q6$D<_B!
M6OK*XD9;83^0S*C!0=H)56V@8+8KNY_"6@W6D?V5-IL36?GM<"/+ K*S%BZL
M#E3ECR".M(G@_P /QZ$^BKI</]GN_F-$<DL^<[RV=V[('S9SQUH QO"6BWEA
MJ'B,:D-'A@NS$S6.FRLZ0ML(<LK*NW<NP].<$TWX4W'_ !;#P^)Y0&:)HX][
M8+*'8*!Z_*!5O4_#;Z9X6N])\)V<=M/?OY<EP\A)B#C:\K,Q+.P7H,DYQVK4
MM/#&E6EAH]HML'32%46;,3E"$V;N.I()_.@#7HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BOFCPW%\2Q\9(3=C5<_;
M?],:3?\ 9S!N^;&?EV[?NX[XQS7TO0 445S7CSQ!)X;\)7=W:C?J$V+6QC'5
MYY#M0#UP3GZ T 9^E?$2#5/&T^@"P>*U,DT-I?F7*W,L(4RH%QQC<><G.TUU
M.HZMIVCVXGU._M;*$MM$ES,L:D^F6(YKQ_4=$\6:1X#TJWMO"\$5QX>=;]+M
M-261W=<M*2FP$[P7R,]QUQ746M_I_B7XE:1>R+'/8W'AXW%@LP# .TH\S /\
M078#WQF@#H]4\;:!H]]I5K=:C;*=2),4GGH$5 C,'8D_=.W:#W) K?DD2&)Y
M975(T!9F8X"@=23V%>67-EX<_P"$M\"PZ+%!)IPO]1CQ@L@81.64;OX0^< <
M#M78^/+JWM?!UY]ILDO8YFBMQ;R2&-':2147<PY"Y8$^PH U;#7-)U2VEN-/
MU2RNX(?];)!.KJG?D@X%.T[6-,UB-Y-,U&TO4C.UVMIED"GT.TG%>6W.GM<^
M*?$>D:QJ&D:?]HT"..:6QC,<41,I";PS?,?F [9# =ZZKPQ)<6GBNZTS5])T
MRWU7["DJWFFDB.>$.5 9",J03[]3@\4 =/J6LZ7HR1OJFI6=BDAVHUS.L88^
M@W$9JXCI)&LD;*R, 593D$'N*X;Q#(UWXV>VL[+2!<6>E^=<7NJ!W1(7=AL5
M 0/^69);/3 J[\+W,GPTT(EMV("H^@9@!SZ 8H VW\2:%'<PVSZUIRSS,4BC
M-T@9V!VD 9R2"",>HQ4FI:YI.C>7_:FJ65EYIQ']IG6/=]-Q&:\EM['1I/A+
MXZN)HK=KA;W42\C %TE5V,8!ZCG:1[GWKH_"D"7WCCQ VMPQS7J:?8+&+A0Q
M$1B)? /8R;L^] '7ZKJ4]O)I1L[K2EBNKE4<W<Y4R(>T./O.>PZ5)>>(]#T]
MBM[K.GVQ$GE$37*)A\ [>3UP0<>XKQN(G_A'OAXJ$FU7Q4ZVI_Z8B:0)CVQT
M]L5U5AI5A=S_ !)GN;2&:1KEXMTB!L*+9#@9Z<G^7I0!U]]XPT73O$=CH=S?
M0)=WD;.NZ5 %QMP&R<Y;=\H[X-;<LL<$3RS2+'&@+,[G 4#J23T%>3>'889_
M$GP[DGBCD=_#3,6=026"PX/U%=/\3MK>'+".?']GR:M9I?;ON^091N#?[.=N
M: .BM?$>AWUI/=VFLZ?/;6XS--%<HR1?[Q!P/QKF? ?CF?QG=7TN[2HK.-Y$
M@MXK@O=;58*'=>@4^WM3;^TM(OBUHD-G;PJ9M*NA?1H@PT(:/R]P]-V0,^]5
M/@Q;P)X+EF6&-93?W*EPH!QYAXSZ4 =QJ.M:5HXC.IZE9V0E.V,W,ZQ[SZ#<
M1FC4-9TO2K9+G4=2M+.!SA);B=8U;Z$G!KDK:WL[[XI^)8]6A@F,>FV@M5N%
M# 0'S/,(![;L9_"LW0(-#N/B%IL-@$GTB'P\#I0E+.H'GL)"N_G. @^F.U '
MH7]JZ=]E@NOM]K]GN#B&7SEV2'!.%.<'@$\>AJA+XMT!-&O-6BU>QN+.S4F:
M2&X1PI[+D'&X] .Y->6M9VURB6 B1]*'CSRX8@/W>SRB74#IMW[QCIU%:_B>
MSMK?Q%XWAAMXHXI?"8E=%0 ,ZF<!B/4 #GVH [NS\6Z'=^'H-<.IV<%C*JDR
M37"*(V(!V,<X##/(S5XZKIPTS^TS?VOV#;O^U><OE;?7?G&/QKSZ$(VE> M-
MT_3-.EOYM/\ M4,UX&\F';#&';8N-[G> /3DUS^DLDXT:VO6M)=,/B^Z640+
MBW9_+=HPJDGY2YR!SSB@#TO5O&_A_2?#XUIM2M;BS:18HVMYT;S&+!<*<X.,
MY/H 36U'?6DMC]NCNH'L]AD^T+(#'M');=TQ[UYE\0[/PY!X?UQ=-C@6]&H:
M>]_&@.U&,J!3C[JDKUQR>]>HK!$L'DK$@BQMV!1MQZ8]* .(\)>/G\5^(]5@
MAFTB/3K*XEMXE%UNN9PF/WH4<>6<]:ZO3]>T?5YI8M-U6QO)(O\ 6);W"2%/
MJ%)Q7C,$"P_#3XE2V\*I(OB"[B9XT 98/,B#@$<@;"W%=QKMK86?C+P*=)AM
MXI6FFC46Z@!K;R&+=.J@["/?% '86^M:5>7*6UKJ=G/.Z-(L44ZLS*K;2P .
M<!@03Z\4Z]U?3=-W?;M0M+7;'YK>?,J83(&XY/3) SZD5Q7PBTVSA\(?;DMH
M_M<UY=[YMHWD"=P!GKC@<58U*QMKWXR:5]J@280Z)<2('7(#>=&,X^C&@#K8
M]6TV73/[3CU"U>PVEOM2S*8L#J=V<8J.TUW1[^QFOK/5;&XM(03+/%<(R1@#
M)W,#@8'/->2^1 K_ &&6-%TG_A.W26+ $>/+#(I'3:9,<=,XK1\9PPVWB3Q7
M'8QI'')X.N'NUB  +AF$98#^+;OQ[4 >DV^NZ1=Z@^GVVJV4UZB[FMX[A&D
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M5[6VMK[2[:6&U&+==FWRAC&%(P5& !@>E:#WMJEXEFUQ$+J1&D2$N-[*" 6
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MFMK<G$$YG4)(<$_*V<'@$_@:;I>O:1K8<Z7J5K>;%5F$$H<J#G!('0'!Q]*
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M'S,BDE0?89/YU =?T<6%O?G5;(6=R<03F==DA ).ULX/"L?P/I5'_A./"O\
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M)9:C:0W=K)C=%,@93CD<&@#QC7VG>P^)4%Y>6=U.(]-$KV4)A3=O(/!=CD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S=<URR\/:8U_?L_E
MAUC1(D+O(['"HJCDL2>E:5<9\2 T.GZ)J1CD>UTW6;>[NMBEBD0W*6P.2%+
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M0B>=+&V,WD1G.&?'3.#@=>#Q7#R0./@OXR01-O>[U$A=O+?OFQ6C!K=EX/\
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M%?V\]S:A0;9WERH;<K *=A&<=<<\T >GR>.M'CT.'5!]J?SKG[&EHL#?:#<
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MBVN&4B.8QA]A]=IZ_2LSPWX>C\/VMP&NI;V]NYC<7=W, &FD( S@<    *.
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M%\'^(]'^'/ANW.FB74](U@W\EF)T!DCW2 A6SMSB0'D]JMZKH'BK7;KQ-?\
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M#[R/E.U3D9(YXJIX?\&ZGHM]X.\T1RKIUK?_ &V5&&U99V1\ 'DC.X9QV[4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@""]O;73K*:\O9X[>VA4O)+(VU5 [DUG>'
M_%>A>*8)9M$U*&\2%@LFS(*$],@@$9YY[XJIX[\,-XQ\&W^AI<_9Y+@*4D(R
M RL& /L2,5QOPB^%NH^ KG4+[5;VWFN+E!$D5L6**H.<DL!D].W'/K0!ZK11
M10!Y[XOU&]_X6#I.CKXCFT6PGL)IY)(C$-SJR@<R*1T)I_A;5M27QS>:*-?_
M .$@TF.P%PUXR1[K:;?@1,\8"G*Y;!&1BJ7C:*TC^)6BWVJZ)<ZGIB:=/&XC
MT]KM5D+KMRH4X/!J+3;)=3\;6MQX9T*\T32!9W$6I22V9M([EF4"(+&0-S*<
MG=CIQF@#I=/\>6U_=V7_ !*[^#3=0E,-CJ,H3RIW&2. Q90VT[2P&?QIWQ!\
M2WWA;PPVH6%D]Q,9HH@1MVQ[G5<D,1G.<#&>2,X&37%>$]'LDC\/Z3?6GBF3
M5K"6/SX)9I_LEN\724%OW90E1M"D\,!BNN^*5K<W?@&\6TMIKF2.>WE,4*%W
M*I,C-@#DX )_"@#,F\3ZG;_$8PII6J3O-H<4R:4DL?[M_.D#.Q+^6#@*,[N>
M!S6Q'X]LKC1+&^M+"^GN[ZX>UATY543>:A;>K98*H7:223C'UJOI<C:C\39=
M7@MKI;&;08426:W>+YA/(2I# $'&#@\X(-<:=#N8H+'4;ZWUB&SM-=U,W!L/
M-2=(YG;9* GSE,@9QGAL\B@#U'0==BUVVG=;:>TN;68V]S:W &^&0 '!VD@@
MA@002""*YFU\0KIGCGQQ-JNH21Z986]A(JR2$I%N23=M7L6(' Y)Q6CX'L[&
M*UU"\L;;5HTNKG)FU221I;@*BJ),2?,%P,#=@X7IC%<;K/@W5-;^(/B?4K-Y
MX+BS%A<Z>LJ?Z+=3(K'#Y&&Q@KD'Y=^?2@#M)O&3);Z:L.A:E+J6H1O-%IW[
MM)4B7&7D+.%0?,O!.<L!C.<%AXZTV_OM)M%M[J%]3\](S,@7RYH3B2%^>'&#
MZ@XX-<EJTG]KZQHOB?4K3Q#IUE)I\MG<I9">.:UG#JP#B,;BAPP! (.%/>IM
M1T.*/X:OJNDV>H6MWI]XVM6ZZE(S3NR,2Q?<21O0-P>?FYH [FWU^WNO$][H
M4,4S365O'//, /+0N3M3KG<0">F,55UCQ2-.U>/1['2[S5=2:#[2T%L8U$46
M=H9F=E R<@#J<&J/P\MY)M%N/$%S&R7>NW#7[*WWDB/$*?A&%_,U3OK@^&?B
M->:Q>VMY)INHZ?#"MQ;6SS^5+&S_ ",$!(R'!!QC@T :6F>.],U6]TNUB@NH
MY-0-PBB5 IAE@QYD3C/##D\9!P>:DTSQKI>IW^O6L:S1'12?/DD "NH+@LG/
M(!C<'IR*X=M+U2R\+/XH32[O[;'XC?68;$1GS_L\C>6R%1R&,9+$51U3P[K>
MG>'M#@M+.YDO-<TY]-U)HXR?)>>596=_0+YDXR?6@#M;?XBQ7\EO;Z=H.J75
M[<6$6H1VZB)3Y,A8 LS.%&-H[_Q#&><68_'ME<Z)IM]8V%[=76I2O#;V"JJS
M;XR1(&W,%4+M.23CIZU'IFG/9_$V_>*UDCLDT6U@BDV'9E9)?E!Z9 QQ]*X>
M/0[F"QT34=0@UF"SM-3U1+DV'FI/$LTI*283YRGRC.,\,#TH [FY^(>FV6A#
M5+NSO82E^NG7%L44RP3$]& .",$'*DY!&*Z'2+Z?4M.CNKC3KG3Y')_T>Y*[
MU . 3M)'(YZ]Z\SO='BF\/64^DZ;K3+<>)K.>1]0\R2:9$95,Q#Y94P,?-C@
M9Z5ZU0!Q<OQ&M(HIK\:1J+Z%!.;>75E$?E!@VQF"[MY0-P6"XX-<[XCUG6;_
M .+=EHB6VN)I\-BUP(+"[CA,Y\S;YI/F#,8'&TD'VJFIO+3X87?@$Z5J#ZX1
M-91@6DAAD5Y&(F\W&P)M;)).001BNC73+N#XTZ=.+>=[2+PX8#<^6=F\3?=+
M=,XYQ0!UVMZNFB::;M[:XNF+I%'!;)N>1V8*H&2 .3U) %<?XE\63WO@'Q7Y
M5O?:/J^F6W[R)Y%$D19=R.KQL001GD'L:U_'TU]#HMH;5[Z.U:^B6_DL%8S)
M;<[BNT%ASMR5Y )KSZZL93I?C^VL=,UORM1TR&2P-VD\LDZH'5OF?+ Y(PA.
M[!!QUP ;<^K:B/$/PKB%_=".^M)FNT\YL3D6Z$%QGYCDD\]S7=^)->M?#&@7
M.L7J2/;VVW>(P"V&8+W(_O5P4^FWY\1?"F065R4L[29;EO*;$!-L@ <X^7D$
M<]ZZ7XFVMQ>_#W5+>UMY;B9S#MCB0NS8F0G ')X!- $)^(&S55TN3PWK$=_<
M1&:Q@819ND!P2#OPF.I#D$#WXJ:'Q]93:#_:'V"^%W]N.F_V=M7SS<@\Q_>V
M]!NSG&.:-1M;A_BGH5TMO*UO'IMVCRA"45BT6 3T!.#^1KBKS0KUH;Z]FM=4
M2WM?%T]U*+,2).;=XMGF1[?F(!8'Y>H#4 =NWCRQMM'U&\O[&]M+K3I4AGL'
M57F+R8\L)M8JV[<,$'USC%9=MXBU"_\ B;IEC<6>H:6!I=S++93R*5<[X]CY
M1F5OXAZCGUYP;W1X9]#O-8T/3]?NFM]2L;EWU!I7FO8X'W'RTD^? #-U SCC
M-;=KJ+Z_\4-,U*STZ_338M+N8OM5Q:20AI"\9VX< ]!U(YYQG!H D\.>,M+M
M_ .GZG:C6;Y;NZ>VM(;N037<\I=AMW%L8^5CDG 45IQ^.8?L%Z\^CZE#J-G/
M';R:=L5I6>3'E[2K%"IS][=@8.<5Y]X5TO5-(^'W@[4I]+O2=(U2XFN[40-Y
MRQ2&5-XCQN.-P. ,XYKIM?\ $NI:SI1FLK#6++14U&"*>\ABD2YFMR&,C)'M
M$BJ&V#<.2"V,8H E\3>+)[SP!XK\FWOM'U?3+?\ >1/(HDB++N1U>-B"",\@
M]C76^&II+CPKH\TTC22R64+N[G+,Q0$DGN:\GNK&4Z3X_MK'3-;\O4=-@DL/
MM:3RR3JH96^9\L#DC"$[L$''7'J_AJ*6#PEH\4D;)*EC"K(XP581C(([4 9-
MOXYBFU*VAET?4K>PN[IK2VU"94$<LHW<;=V]0=IP2HS7':3K^NZK\3_$,D^F
M^(9(=+\A8-.M[R&..'=$2?-7S KEB,CDXSSBLV,W<\&@:A?6WB6ZUBSU2*?5
MVF2Y,-N Y!$<7W&&2,;%.%!)/KVGA*RN[?XF^/;F:VFCM[B2Q,,KQD++MA8'
M:3P<'@XZ4 <WX \3Z@UCK?B76H-?N=L\T:@3K)!_K%588X0_#Y.-V,=?FKKY
MO%L-UHWB&'4M/U/2;K3K%KB>$2)YWDLCD/$Z,5S\C '/!%<=H<&MZ5\++Y(K
M?4;25M;=K@P0L+A;5IQYCQC&<[,X('3D5$]I_I'BX:?I^NO:ZCX<>*REO5N)
MGN'42[AF3+)]X84XSU YH ZV/QUI^DZ%X86*TU:_?6+3=9*Q62>0JBD!R6Y8
M[AD]."20*M3^.6AGEC7P]JTXM(XFU!H1&WV1G0/L*[]SD @G8#^-<WHVF7T=
MQ\*3)8W"BSL+A;@M$P\AC;* 'X^4YR.:?XR,<&M:C<Z7;:_I_B8(@M);&&22
MWU$A1L$@ ,9 .5.[! &<XQ0!Z#J^JVVB:/=:I=E_L]M&9'V+EB!V ]3TKE=9
M\<ZA8^&M:NSX;U*SO[*T-Q''<>4R%2#A]RN5(4CYESNQT!KH=?"OX7O%O-,?
M4D: B>RA&6E!^\%]3C.._''-><-;WM[X?\5:9H3ZY?:,^CN((]3AD#I<G</*
MB,BAV&WMS@XP>: .G;X@FQL-"6_T34CJ6K1.8+:(1LTC(JD]'( ;=D<\ '.,
M5:U+QPVF^:3X>U6=+2U2ZOWC$>+564M@[G&]@ 20F:P;2235_$GP]OK>RO1!
M:6UY%.TUK)'Y3^3&N&W 8R<@'H<'&:I^+8KS4M6\3Z?>0Z_<7#P"/1K:S:>.
MV=##\S,R80X<MN#GH  #G% '1-XROI/B/:Z%:Z7//ITVG"Z\]#'\P9T EY<'
M8H+ C&XGH".:L67CVUO+NT/]F7\6EWMP;:TU-PGDS29(& &W@,00I*@'CU%<
MQI4[P>,O#E]-9:BEK=^&UTU9!92_NY_-7*N-N4Z$Y; QSG'-4?"NAV4$&AZ)
MJ%IXIEU6QN(Q+;M-.+2$Q-E9@3^Z*?*" #GG&* .LO\ XE6=A!JE]_8^ISZ3
MILDD,VH1+&8S*G!506W$;OEW8VY[XYJR-:L9OB+860EU1;N?2#=)$)@+7RR_
M5DS_ *S/?'2N%U*\N=#^&'BGPS<:3J!O8VO667[,WD/"[M()?-QLQM;IG.1C
M%;D>FW<WQ9TBZ%M.+3_A&/):Y$9V*Y?[N[IG'.* -ZQ\>VM[=VA_LR_BTR^G
M-O9ZE($\J:3G& &WJ&VG:2H!_$5+IOC1=3OX4BT74ETZXF>"#42J&)W0L#D!
MBZJ2I 9E /XUPOA31+*&'0=&U"T\42ZK83Q^= TT_P!DA:(Y$H+?NBF5! !/
M7&*T=.;[/XIL1X>MM>TZXFOF_M32KB&0V:1G<7D#,-BDG!!1N<]* /0-;U=-
M$TXW;6MS=.9$BB@MD#/(['"@9( Y/4D 5@R_$"SL]%U:_P!2TZ]LIM)DB2[M
M)-C.@D*A&!5BK*=V>#V-2>/YKV'1[(VSW\=HU]$NH26"L9DM\-N*[ 6'S; 2
MO.":\[O;"9K#QC;6.EZV8K]=.GLOM:3S231I, Y+/D@YYV$Y"\X'. #TBP\9
M)<:XNEW^DW^ER36[W-M)=^7MFC0C<?E8E2-P.UL'%<OX@\=W&IZ-I5S8:?JU
MA9WNJVB6M^S*JW"&90PPK%E#+G&X $?E6QXMTNZU+QGHBP12>6VFZC"\P0E(
MV=(PNX]!GG'T-<F]_=WG@;PMX>CT/51J.FWFGQWR/92*D BD0%MY&U@< C:3
MP2>@H ]7U;4H='TJYU"X262*W0N4A0N[>@4=R3Q6)9^-+=GU"+5].N]&FL;7
M[;(EV4;,'/S@QLP."I!'4<5+XYEU*'P??2:3]I%T#&"UJNZ58S(HD*#NP3<1
M7FU[HK:MJ&LVVCVNN&WU/09+:TNM2-P_G3J^\@F7)C4C &[:"<X[9 .[MO'A
MGD2.;PYJUM)<V[W-BLPB!NE4 D##X1L'.'QQ7.Q^-WU/X;:5K6O6^K6)N+R%
M%ET^9(S,S,<$8;/E]B&P3Z5T6D^+)M;EM=-M-#U&/-LQOI;N![=;5PN @W+A
MV+<?*< #.:\\DM[V]^#.@:1%I>I#4--U&V2Z@>SD5D(=B2,K\P ZD9 S0!Z[
MIGB"VU/6-7TI(IHKK2Y$299 ,,KKN5UP3E2,_D:Y:Z\9Z5JS>';M?[8@AN]7
M>TM&MY1&D[(2NZ0!OFB)!XZ^U5/B#;:SI.N+J_A^RN+F?5;"329A A;RI"<P
MRMCH%RX)/3BF^)O#<FF/\.M-TVTFFMM,U*)9'CC+!%5<%VQTR>23ZT :&G^,
M;_4=<\6:?>:5>V]CIB[1/&\8:,>5N.2'SN;JN!P,9P>*ETCQ?90>$- ET^WU
M;4Y]35A9V\\BO<R!<EFD=F"@ =23W K,@\ZT\4^/[&6RO1)J4:S6CK;.T<JB
MVVG#@;<Y&,$YS7/:?H=Q:^$_ =]J<&M6UM8VUS;W@L?.CN+<R$%6*Q_/MRF#
M@=Q0!W__  G=L^GV\EOI=_-J,UV]B-- 19EF12SJQ+!  HW9W8((QUK<T;5?
M[8L/M#65U92K(T4EO=(%=&4X/0D$>A!(->?'3]!C\.B:XT;Q*+*ZU)I_M[M,
M]W#($"K<8&95#!=HR/3(P:ZKP)+J,NA3?;Y;V>);J1;*>^B\N>6W&-K." <Y
MW<D D 'O0 B>-%EU5[>'1=2EL8[PV+ZA&J&)9@VT@KNW[0W!;;@'VYJ8>,+$
M^'M;UGR+CR-(EN8IDPNYS#G=MYQ@XXR1^%<A>M]G\4-+H%MKVG:W)J:"YLA#
M(UE=1F0!YF)!C ,>6W AL\=:HWMQ=6/A3QUX<_LC4YM3O+J_FMTBLY&26*7+
M!Q(!MZ$\9SD8 R: .SNO'4::O_9-AHVHZAJ!LX[U8H/+4>6Y(R6=@!C'XY&,
M\XA;XCZ8=.TB[AL=0F?5)Y;:*V2-?-2:,',;@L #E<9SCN2!S6!::Q'H'Q%G
MEO;6[,!\/V:2206SS-$P:3 94!89YYQ@$#/45CP"[T>Z\*:I=Z==*UYKVHW_
M -D$1,T<4B2$90<[@OS;1SVQGB@#O8?'VGI8:Q/JEG=Z9<:0$-W:SA6?#_ZL
MH4)#;CP,'KQ4^F>+S=:S;Z5J6C7^DW5W$TUH+HQL)E7&X HS88 @E3@XKAM:
MTZ_\62^*M;TNPNS!Y=@EI'/"T+79MY3+)M5P#CG:,CDUT!OO^$N\<^&[O3K*
M_CM-*%Q/=37=I);A6>/RUC&\#<V6).,@8ZT 5[CXH/>^#M2US1= U)X+>SDD
M2YF$:QK*O&""^6 ZG&>A'7BK4OB1)[CP:^J0:Q87NH3,L4,,Z+&[! 290K$,
MAZ@<D=P*R='TC4#^SS<Z7]AN%OWL;M1;-&5D+&20@;3SDY&/7-1WS3:WJ/PV
MO+*POS#:7#K<&2TDC,)$2@[@P&!GC/0]J .AN_B-! NK26VA:K>6^D3R17\T
M(C"Q!.2PW."W'.!D@=<9%7K[QI!#J-O8:;IE]J]Q+:K>NMH$ C@8X5B791D\
MX4<G!K!M-/O%\'_$2$VDXEN;W4&@0QG=*&A 4J,?,">!CK5;1I;CPKX@AO+[
M3-2EMM0T.RA1[:TDF,<T08&)@H)4G<#S@=>>* .V\,^)+/Q5I+:E8),D GDA
M'G+M8E&*DX[ X[\UB^'-8U"W\<:_X9U>Y:=AMU#39' !:V?@IP!G8PQGKS47
MPL:23PK=O-#Y,K:K>EXL@[#YS97(XXZ4>/[*[L[C1_%FF6DUS>Z1<8F@MT+2
M3VLGRR* .I'##Z&@!UQJFHZU\2SHFGWLEOINE61DU%H@N7FE&(DR0<$#+\?C
M5/2O&S^&[75]+\970.H:0AG2YVA?MUL3A'4#C=DA"!WQZUI_#O1[K3_#KZAJ
M<935M7G:_O PP49_NISTVKM&.QS6=X_T;^TO%?@FX&G&Y6WU(F600EQ&FW/S
M'' W =>XH H:KJ'BS3_A;JNO7U_)9ZM>2Q26\"HI%A&\J*L8!'S-M;YB>Y]J
MV-*\37UWX,UN*^80>(M&@EBO H'^L5"4E4?W7&&'XCM5CXFVMQ>_#_4;>T@E
MGF9[<K'$A9CB>,G '/0$_A67\1]'O[:.7Q)H=M)<71M'L;^TA4EKFW<$ @#J
MZ,=P]LB@#-N]:U:^3X?6[^(Y]+75-+DN+RYC$0,DBQ1,"=ZD#EFZ>M=9X>L)
M(-1:4^,[O65$9!MI&@*CD?-^[0']<<UPNH64-O#\-9=:T&[O[&TTF6.Z@&G/
M<^6YAA"AT"G!R#U'8UUWA>_\+?VMY.B>&+G3+B5"&F.B/:J5'."Y0#MTS0!V
ME%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<?J^OZ
M^?&X\-:+;V )TT7IN;L.5C_>,A&U2-V<# R.YSQBL>?XA:S%H=DR:9:/K!UT
MZ)<PAV\HR -AD;J%.$/.< GK0!Z117%2ZYXH?6+3PY;KI']KK9F]OKITE-NB
M&0HBHFX,6.#U88P?6J7_  GFJRZ=%8Q65FOB)]7;2&1F8VZNJ[VE[,4V8..N
M3C- '?">(SF 2H9E4.8]PW!3P#CTX-25Y/=:UK.A>+/%FJ7\%D]_I_AZ&1#"
M&$,P$DK [2=R]2",GIUKM=1\0W%GJGABU2*(IJTKI,6SE L+2?+SZKCGM0!T
M=%<+I'B;Q3K4-IKEEIMA-H5U<F-+=6870AWE/.+$[.V[9CIWS6%I7BKQ+I>G
M>,]5U"6QNH[+56MD0^8%B?\ <IG))VPJ&+$8SU.>: /5ZP-=T&V\6VL4,FJW
M2Z=EEN+>TD4)=#(RCM@M@$$$*1U(-9P\2:KIOA;6=7U9M+N(+2V-Q:W>G.3%
M/\I^7:22"& &<D'</>L72+G7O#Q\/>#-+M[(W,FD&\N+B[WD1R[QYA(4@L"S
MGCCDYS0!Z0B)%&L<:A44!551@ #L*=7F]S\0M8LM"=I=-M)-8M=<CTBXAC9A
M'+OP0Z$\C(9<9SCFM.;7?%"ZGI_AV--'.N36\MY=7&V4V\,*N%7:N0S,2P'4
M="?:@#L+BY@M(6FN9XX8EQEY'"J,^YJ6O+/%'C6XB^'WB)]7T;3+O4-'O8K6
MXM9D,EM-N9"CA3S@AP0#T(K=UWQ;J$?B.[TC2;C1;9K&WCEF?5)2OFN^2L:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSI$%EB(;/WB2.S87LN&&.: .)U7Q+XEU?1O"L\-S965V_B Z?=!8G9'EC:0
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M[QCX>'BCPK?:4'$<\B;[>7IY<RG<C9[88#\,T <[XA7_ (2GXDZ/X>'S6&C
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MG;A<<8&,?A5JO&?#?BV32?!/A72EU33]&DO5O)YKR_PRQ*DS#:H+*&8LP[]
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M%ZCJ]BL;7-L$*+(,J<NJD?D36#<:EXSM/%MEH4E_I;_VI:RSI,MHP^Q&,KN
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M!(LD,JAT=#E64C((/<$5'>V-KJ5H]K>V\=Q;N5+1R+E200PX]B ?PK.\(?\
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MLL*%%E\ML!PI)QD$<9KI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#.UW1+#Q'HMSI.IP^;:7*[74'!X.0
M0>Q! (^E8?@KX<Z#X#6Y.DK<237.!)/<N&?:.BC   _"NMHH **** .-U[1/
M$?\ PF]KXAT%=+D\O3GLGBOI9$^](KY&Q3_=%+<V7C+6M$UC2]5@T*".[T^:
M"%[6XE8B5UVKNW(,+R<D9/M72WFK:;ISJE]J%I:LXRHGF5"P]LFI;2]M+^+S
M;.ZAN(\XWPR!QGZB@#G+[PS>7-OX2C26 '1[F*:XRQ^8+"\9V\<G+#KCBL__
M (1SQ%J.OZ3<ZO%HP.F7)F&IVQ87%PFUE";-H" [AN&XCC@5W5% 'E\G@CQ6
MW@^3PE'+I*Z=%<^;#=&63S)4$_FA&39A3ZD$],8YR.NTC0+FP\9^)=8FDA:V
MU06HA52=R^5&RMN&,=3Q@FMH7]H=1;3A<(;Q8A.8<_,(R2H;'ID$?A5B@#AM
M \.^(]#6QT:)=(_LBSF)6\.YKB2 $E8S'MP&Z#=N/ SC-;'CG0+CQ1X,U+1[
M26**XN$7RWESMW*ZL,XYP=N/QKH:K0ZC9W%_=6,-Q&]U:A#/$I^:,."5R/<
M_E0!S^G:-K$GB^W\0ZHME"_]E-9RPVTK2 2&;>""5&1M'Y_G6.?!&JVZR7MM
M)8R:A#KMSJ=M',S>5)%,"IC<[<J=K=0#@@=:]!HH R- @U>."XEUA+"*663,
M=O99*1)@  N0"YSDYP.N*Q+G0_$6F^+=5U703ILL&KQPB<7DCHUO+&I0.H53
MO!7'RDCD=17944 >;Z7X&UK0=(\/26C:?>:GI<=S;S17#LL5Q%+)OX?:2K A
M3]TCJ/>MO4O#6IZ[X%OM+U*6RBU.<F6%K52L5O(K;HL'&3M*KEL GGBNMHH
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MVO4+RXN(G+-L59)O, 8[<YQUP#S7<VUM!9VT=M:P1P01C:D42!54>@ X%2T
M<SK?AJ75_%&E7[/%]BMK.[MKA"Q#MYP0#;QC^$YR?2J7AS1?$^E_V9IMT-'&
MG:>GEF[BW-/=(J[4!0J!&>A)W-R..M=G69!XAT>YT0ZU%J=JVF $F[\P", '
M!^8\=>* .5D\$:DWPKO_  N)[7[;<23NDFYO+ >X:49.W/0^G6M%-#UBS^(]
MUK=J+*73;^UA@N!)(RRQ&,M@J I#9W#J1_CJ6?BK0=0>Q6SU:UG:_,@M0D@/
MG;.7V^N.];% '-^*-#O[^^T?6-(>W_M+2I7:.*Y8K'-'(FUT+ $J<8(.#R.E
M9D?A75[Z'Q1?ZH]G'JFLV/V*&&"1GBMXPCA07*@L2SDD[?I7;U7>_M(]0BL'
MN$6[F1I(X2?F95P&('H,C\Z ,_PGI,^A>$M)TFY>-Y[.UCAD:,DJ650#C(!Q
M^%<Q?>$==?4_&26S:>UAXAM=JR22NLD,@@\H J%(*DX.<Y [&N_HH Y6^\-7
MES#X21)8 ='N8YKC+'Y@L+QG;QR<L.N.*H:-X<\1:(8-(M5T?^R(;II$O'W-
M<>07+^5Y>W;NYV[]W3G&:[FB@#G_ !MH=SXD\'W^D6<D4=Q<! C2DA1AU8YP
M">@/:EOM#N;GQQI&MI)$+:SM+B"1"3O+2%",#&,?(<\UKQW]I+?S6*7"-=0H
MLDD0/S(K9VDCT.#^56* //Y? ^IK%?7,$UD;X>('UBS64L8V1HQ&8Y#C(RN[
MD XXZU8U+PUX@U[P]=QWC:78Z@+J&ZL(K<,\<+1,& =]JEMQ!SA1@'C-=G<7
M$-I:RW-Q(L<$*&21V. J@9)/T%-LKVVU&RAO+.9)[:9 \<J'*LIZ$4 <E8Z)
MXDO/&]AXBUC^S8(K:SFM?LMK*\A!<H=VYE7.=IR,#&!UR<8^C?#S6='\$Z+9
M175B=:T?4'O8&+,89 Q<%&.-P!5SR!P17IE% ' ZEX>\6ZU:"[OYM,:Z@U"W
MO+;3 [&W5(P05:39N+,6W9VD JN!UJM?>#O$VI1^*_M,NF!]?T^.(!)7Q;2I
MN54'R?,FULEN#G/RX/'?B_M#J)TX7"?;!")S#GYO+)VAL>F015B@#/T.PETS
MP[INGS.IFM;2*!V3D%E0*2,]LBN37PQK^JZ[I5SKD&C+_9SN7U"T9O/NU,;)
ML*E0$4[LD;F&0,5WE% '":#H'C#2+?2]"6]T^/1].E'^F1EFN+B!2=L1C*[5
M)& 6#'@<553X>W[6GBR.2ZM4EU355U&Q<;F$;(RN@<$#NH!QG@FO1:* .*NM
M%\2ZWH&NV5_%H]B;S3WM+:&U=I!YC*07>0HI Y'RA35Z_P##EW=2^%&22$#2
M+@2S[B?F A:/Y>.>6'7'%;=CJMAJ3W265U%.UI,8)Q&V?+D'53Z$5(U_:+J*
M:>UP@O'B,RPY^8H" 6QZ D#\: .*TOPYXMT6VBT#3KS3H=&BNS+'>Y8W*P&0
MR&+RRI7/)7=GISC-26GASQ%I%S<V&FKHYTR>^>Z2[GW&:!)'WO'Y>W#')8 [
MAP>G%=;J>JV&C637FI745K;*P4RRMA02< ?B:N4 9GB+3I=7\,:MID#(LUY9
MS6\;.2%#.A4$XSQDUR'_  @FI_V?X"M_/M-_AZ1&NCN;#A4"G9\O/([XKT*B
M@#S34?!/B6?2_$&C6DFE1VFHWLM\EV[OYTA9PZQ.NW  ("[LGY1P/34A\+:X
MOC/5_$2W-E:S7VDQVL00M+Y,Z\DD%0&0'Z$^@KMZIZ?JMAJJ3O8745PL$S6\
MIC;.R1?O*?<9% '$3>"-3\17U]<:Y;:5IQN-,FL)&TUVD:X:0J1(Y95X7;D#
MD\GFK47A_P 3ZM<Z%#KYTR.RT>=+DR6DKO)=RHI5"590(QD[B,MR,5W-% '"
MOX+U%OAUKWAX36OVO4)KN2)]S;%$LK.NXXST/. :[-K<R6#6S-@M%Y9([<8J
M>B@#S72_!GB6Q\/:#"ZZ0^H>'Y&6V!E<Q74+(48.2F48@@C ;E:T=2\/>)-3
MTRSN)X]'^WVFJ)?16*EA;^6J%1&TFW);YBV[;UQQQ7<T4 >::CX)\3:I'XA%
MS-I>_6?L<N4D<"!X95/E@;/F78OWN"6_A /'67&AW,WCVPUU7B%K;Z?-:LA)
MWEG=&! QC&%/>M^B@#DM)T+7=$MM3%E)I[37NN27I\TN5%N[ L. /WFT'';/
M>NMHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'D!@<>O% &4WCW5%T[75TO6;37'TF&#4%NH8 OFP;R)HF X#!5)!'8BNMO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDKGJS&W3)_$U%ING1Z5X4^)U_9W%['=6US?012&\E;:JQ(P/+$;P?X_O=LT
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M/NPK4H YJ#PI=1Z;?V<WBG7;C[7&$69Y8UDM\9^:-D08/USTKHT79&J;BVT
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MS;=S%F'UP 3BM72[^;4(9GFT^YL3',T2I<;<R ='&"?E/;O0!>HHHH ****
M"BJ-]?S6EW90Q:?<W*7$A1Y8MNV 8^\^2#CZ9J]0 4444 %%%-=UBC:1SA5!
M8GT H =17/>$_%D?B^R>_M-,OK:P/_'O<W(0"X )!*@,2,%>X'6NAH ****
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M+XAN+YHXV(\Z%6 E0^H*$G\!7IVC>#+;1KRVG&J:K=QV<9BM+>ZG#1VZD8P
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M84 <#% '$ZSH]KI>J>+="M6NETR7PW]O,#74C!9U>0;@2Q(SM7(SSCG-4KB
M:/X/^%R:?+/"MWJ=@\X$[G>7B&X')/RG'W>GM7IUWX9L+[5[O4I_-:2[T_\
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M(]$TW4(;"^U>QMKR;'EP33JKMG@8!.>37!_$RPM=-T#PC;6=O'!"GB&R 5%
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MN ['D\^](?"7AXQ31?V+8B.:!;>1! H#QJ<JI'<# _*MFB@!L<:0Q)'&H5$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JCJ.KV>E/9K>2&/[9<+;0G:2#(P)4$CIG
M!'/?BKU8OBS13X@\,7NGQOY=RR"2VD_YYS(0T;?@P% %S4M7L])^R?:Y"AN[
MA+6!54L7D;.!@?0DGH #5ZO.= U!?B#XBL]0FAQ::38;98CQB]F7;(O_  !
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MNMIM@UO<V[65L8+EF:>,Q+ME+=2PQAB>^:BU'1-*UB*.+4],L[V.,Y1;F!9
MI]@0<5PVD7NAZ9J-W)I]IJ^B:DEA-(-*OU98;C8 =X&65BO3*,#@G-;2^*KU
MM+\%W1AM]^N21+<C:V$#6[RG9SQRH'.>* .J@BAMX$AMXXXX8QM1(U 50.P
MX%(UK;O=)=-!$;B-"B3%!O53@D ]0#@<>PKS+2M8UB[U+PK'ISV&G6ES>ZDL
MUM%;OL?RI9 2<.,DCGV8D\]*1/BA<RV_]JQ3Z<UI]J\H:8MO*;DP^9LW^9NV
M[L?-MVXQQG- 'IR6MO'<2W"01+/,%660( SA<[0QZG&3C/3)JO+H^F3:8-,E
MTZT>P50HM6A4Q #H F,4NJV+ZGI5S91WD]FTZ%/M%N0)$!ZE2>AQW[5YNYAT
M:[US5?"/G+I>F:/<BYD,KR0SW:@,FW<3N9-K;F'][&<YP >BP:)I5K91V=OI
MEG%:QR"5(4@545P<A@H& P(!SUS2ZCHNE:QY7]IZ;9WODG=']I@638?4;@<5
MP?\ 9D/A=/"&J64]P;N]NX;:_EDN'?[4LL3%F<$D$A@&![8]*9=:E=ZUXS\,
MZU'=21:0VI26ME"K8%PGD3%IF'<,R@+[+G^*@#J-7\&:=J6HZ=<QVME"L-X;
MF[3[,O\ I68GCP_K]_OGIBMJPTO3]*M?LNG6-M:6Y)8Q6\2HN3U. ,5;KRW6
MDM;KXFZQ%?Z-JVK11Z?:M%'8R$>429<DCS$ZX'KTH ]!T_0-&TF>2?3M)L;.
M:7B22WMTC9N_) YIEOX<T&UN7GM]&TZ*=I!*TD=LBL7&<,2!G/)Y^M<#H_B+
M5M+\)6$-BZW%Y<:\^GB#46D>2RC?>R1R$D,60!">N0>">#5Z^\3WF@WOB1FL
MM/FU2WM]-B$T4;1BXFF9T&_YB=BDY SD GDT =L^CZ5)>SW;Z=9M=W,)AFF:
M%2\L?&48XR5X'!XX%)?:)I6IV<=I?Z99W5M%CRX9X%=$P,# (P.*X#4M3U3P
M]XYDU+6FM+LV/AJ\N5>TB:$2;98B4*LS8.1USSGH,5J)XB\3:=JOAR#5UTN2
MVU;S6E:VBD1K?9 TFP9<[N@^;CH>.0: .KN]$TF_L(["[TRSN+./'EV\L"M&
MF.!A2,#'M4]E8VFG6J6MC:PVMNGW8H(PB+] .*\VTSXFW=ZNF:@9M.DMK^YC
MC.FPV\OVB".1MJN9-VUB,@L-H&,X/'-V[^(&HV>EV+O:VIO4U">'4D ;;%;P
M2;9)$YR#M:-ADD?-0!W,VEZ?<?:?.L;:7[4JI<;X5;SE&<!\CY@,G /K4SVM
MO)<Q7+P1-<1*RQRE 60-C< >H!P,^N!7&ZCXOOXSJKP3:5:6MOJ4=A!<7N\Y
M/EAI2$4@R,&.T*-O0\\5@ZEXSUN_\*ZTMI>VB7FG:C:0&\AMI8UFBE:/HC/N
M0Y;!Y((!QU! !Z*NA:0NJG55TJR&HGK=BW7S3V^_C/2K45K;P3S3Q6\4<TY#
M32(@#2$# +'O@ #GM7 ZGXYO[?7;_2$U+2+2?38HA*]S:RN+J9T#D(%?]VF"
M.26//?'-C3O&&M>(-8T>UTZVM+2&[TM-1N#=QNSQ?O-CQ@!AD]@3TY//2@#O
M***\NFO[[0OB%XDU_P"T32:5;W-M;:A;EB5BA:",B91VV,26Q_"S'M0!ZC17
MF4WBR3P\/$MPDD4DEQXABL[9[AF:*+?;PMN(')4 ,<#K^.:>/B%J$ OE,NGZ
MC'9?9[A[RWMI(D:!I0DJ[68[70'<#D@CM0!Z517!W7CZ>SU3Q*DUO#]AT^UE
MEL7 .Z>2%4\U3S@_/(BC&.AKM+!KI].M6OEC6[,2&=8P0H? W 9).,Y[T 6*
M*\QU#4+;P3XQ\4ZC!%*\$.BPWAMS,Q#S--*,_,3MR=HXZ>E7=*\<WLFLVUA/
M>:;J(NK>5P]C;2Q?9I$7=M;>QW*0" ?E.1TYH ]!HKSJ'Q?XF_X073O$5Q!8
M+_:#6YS#:RRK91,I+RR*&W.,@8 QC=R3C-/NO'ES8>&%OSJ&B:@]S?QV5K>6
MA<0C<,EI8\LRE0&^4,2<#IF@#T*BO-O^$_U2.WU<0FPU5M.@BO?M%M;21)+!
MOQ,FUF)615!8')!R.*ZJTUZ74?%KZ?9"&33H+!+B>?!+&24_NU4YQC8K,>#U
M7I0!OT5Q%U80>)_B%J.GZIYLMCINGV[0VPE9%,DK2;I#M(R0$4#TYQUKE(KV
M>\M_#MCJ'VW6(+>\U&TEL87)FN5BD*1RMR RH!@[F'+ \F@#V*BO'%N9#X8A
M@,EZ]M_PDC1'1!(_VKR-I(MCSU'$F-VW;QNQ3C>30PZSIEDU[I-K>:OI]DEA
M+(1/:1RL%D=3DA1(,@;6(X/0\  ]AHK@X=(L])\=+H%JDJZ3JFDS23VOG.5#
MQR(N\$G*DK(0<$9P*CT7P]IC^/YY]+BE@L]$7R7(N)'$]S(N2IW,1A$8?\"?
M_9H ] HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q=8T;4+V
M^@O=,UNXTZ>*-HFC*":&120<F,D#<".&!!ZCD5M44 <1<_#TRZ7;VD6M3K(+
M]M1NI9H$D%W.>A=.%P#C"]!M7TK1N/"]]J6E26FJZ[+<SK-'<6ES';)$UM(A
MRK #(;GJ#VR.]=-10!A:-X>EL-3NM6U'47U'4KB)(/-,0B6.)22$51G'+$DD
MG)^E-UKPW)J&JVVL:=J4FFZI!$T'G+&LB21,02CHW49 ((((K?HH YW2_#$N
MGG4[R75I[G6-0C$;WS1JOEA00@1!P I8G'.2>2:6^\/:C-/9WEGXANK6^@MQ
M;RNT:R0W ZEFB. &SSE2#SCI70T4 <Q:^%+NW&J7C:[.VM:A''$;\0(!"B$E
M52/&,?,W7).:WM0LQJ&F75DSE%N(7B+ 9(#*1G]:LT4 84WAJ*;P*WA<W+B(
MZ=]@\_:-V/+V;L>O?%8VO^#()-.U>XS>73S:?;6ZPVP42!K=V='0L<;MQ!P?
M[OO7;44 >::3I>HZ_P"+I+^[EU-[<:--8R7-Y8_9 'D="%2,@$X"L2W()(&?
M3JAX4A%EX9MOM3XT)HVC;:/WNV%HN?3AL_A70T4 <<OP^M$A\0(E],K:M()(
MVVC_ $0B1I5V>N)'9_J:>/!!M!H<FE:H]I<Z5:-9K(\"RB6-MNXE21AB4!R#
MW/6NNHH \[U?PTVB>%-=TJ$ZCK$FM3/+;HL&7CN6 .]Y!\JC>%;)  QQG@5V
M/AW2!H7A^RTT/YCP1@22?\])#R[_ / F+'\:TZ* .1E\(:HOB/4-:L_$;037
MFU</91RF*-1PBDGA<Y..Y.31>^$=4NM?@UF/Q&T=U#:K;)OLHY O]]U!/REC
MUQV '2NNHH Q$L];BOM(#ZF;B&%9OMS>4B";('E\#D$'TXZY[5-KFCRZO#;F
MVU*ZTZZMI?-BF@((S@@AT/#J03P?PQ6K10!RT7A&>[U.._U[5Y-2EA@E@@C2
M!8(XQ(-KM@9)8@8R3@<\55L/ MQ;'0DNM>GNH-#D#6D7V=4RHC:,!R/O$!AS
MQTZ<UV=% '(0>!?L:Z.UGJDD4^FW=U<*[0AA(L[LSH1GC[V ?:I;+PC>:81:
M6&OW%OI N3<+:+ F]<OO,8D/(0L3QC.#C-=510!FZ_I<NM:#>:;#?2V+W,?E
M_:(AED!ZX^HR/QK+TOPQ?6=K_9UYK$=WI/V=K<V2V,<*[",8RO(&*Z:B@#D;
M#P3)%-IR:EK,VI6&E@_8K66%%VG84!D8?ZPA"0.!UR<FB\^&OA:XO=.N(=%T
MVV^QW!F9(K.,"8;&4*W'0%@WU45UU% &;IL.HQWVJM>SF2W>Y!LU(4;(_+3(
MX_V]_7FLF]\+:@_B6[UO3->>PENH(H)8_LJ2@B,L006Z??-=110!R4'@2"%+
M9Y-1N)[M=575;BYE5=T\H0IC  "KC  '3%2ZKX)M=7FUR6:[FC;5([908P,P
M/ S,CJ3U.Y@<'TKJ** .,G\$RW=W=ZCK&IS:I--I4^FM!'"D*M&Y4_+SPV5/
M)/?L!7/Z-8:IJGB;PN\YUB:'2DF,QU"Q%LL2M"8PN<8E<EAEE)&%/3//J=%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
9BB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>exhibit1012-stuartexecut003.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **1F5%+,0% R23P!4-I?6E_"9K.Z@N8@=
MI>&0.,^F10!/1110 45QFO:QXB;QS:>'M#N-.MEDTY[UY;NW>7E9%3 VNO\
M>_2ET[7/$.G^,+7P_P"(?[.N1?6TL]K=6,;QD&,KN5T9F[,,$&@#LJ*Y^Q\;
M:#J.J)I]M=R-+([QPR-;R+#,R9W+'(5V.1@]">AJH_Q(\+1L<W\OEK,8)9Q:
MRF*%PY3$C[=J?,.Y'8]"#0!U=%8%_P",]#TW5SI-Q=2'4 8_]'C@D=L29VGY
M0>/E.3T'?&12'QMH(UG^R_M<GG>?]E\W[/)Y/G?\\O-V[-_;&<YXZT =!17/
M_P#":Z%_;/\ 9?VJ7S_/^R^9]FD\GSO^>?F[=F_MC/7CK0WC;05UC^RS=R><
M)Q:F7[/)Y(F/_+(R[=F_MC.<\=: .@HKF+_X@>'-.FO(I[N=GLI#'="&TEE\
MC !+/M4[5PP^8\'G'0X@O/'VGVWC#3-"2.>9;VW,_P!HBMY'49*>7M*J05.X
MY;.%P,XS0!UU%<UX]UR^\.^$KC4=-$'VM9H(D\]"R#?*J$D @GACWK$UW6/&
MOA'2I-;U*YT/4=/MF4W,$%M)!+L+!248NPR,]".: /0**YOQGX@N] TJRDL(
MX#<7U]!9))< F*$R'&]P""0/3(Y(YJEX9\1:E>^*=3T.[N;'4X;.!)3?V,31
MHDC$@PN"S#< ,\'IU% '8T5P3ZSXMU;QSX@T;1[O2;6UTI;8@W5I)*S^;&6Z
MK(O0@]N]7]#\2ZJOB5_#7B6TM8=1: W-K<V;,8+F,'#8#<JP)&02?6@#KJ*P
M/%FIII=MIKOK)TH3:A# '%KY_GEL_NL8.W=C[W;%1ZGXYT'2;V[LKBXG>ZM-
MIGAM[669HU*AMQ"*?EP1D]!G'6@#HZ*KV-];:E807UG,LUM<1B2*1>C*1D&L
M:+QOH$VLC2TNI3,TYMEE-O((6F&<QB7;L+<'C/;'6@#H:*Y:]^(?AJPDN4FO
M)V-I*T5T8K261;<J<$N54A1[G@X..AK8L]<T[4-3N].MKD275HD<DJ;2,+(,
MHP)&&! /(S0!HT51T[6+'5I;V.RF\TV5P;:<A" L@ )7)&#C(Z9K#U_QSI.E
M_P!I6*74OVZU@)=TMI)(H'*DH)'"E%)X^\: .JHKF_"WB.+4=)T&WO+G?J][
MI$5^ZB,C<N$#MP-H^9QQ[]*LS^+=$M[&]O)+PB*SNC92XB<MY_'[M5 RY^88
MV@YH VZ*S=&U[3]>MY9;"20F&3RIHIHFBDB? .&1P&!P0>1575O%VCZ+J$=A
M=S3M=-'YQCM[:28QQYQO?8IVKGN: -RBO.M)\6SWOA30-0OO$(M);W6GM4=+
M191=J)I%2'@80%5'S^W7FK]AXAU&?XF^)=&FN@-/L;&":%?+7,;,N6.<9/T-
M ';45R.E>+]+M/!.G:O?:Z^IQ7+F*&[6R9)+I][ *L*C.>", ?PYJ]9^-O#U
M]#?RQ:@%73XEFO/.B>,P*=V-P8 @_(W'7CIR* .@HKG[/QKH=[;7TZ3SQ"Q@
M-S.EQ:RPR+#@GS CJ&9< \@&F6/CKP_J.IVUA;7<IEN@?LTC6TB13D#)"2%0
MK$#L#VH Z.BN<E\=>'H=7.FO>N)5G%LTHMY# LQZ1F7;L#=L9Z\=:?<^-M!M
M-6;39KN02I*L$DHMY##'*V-J/*%V*QR.">XH Z"BH;N[M["SFN[J58;>!#)+
M(YP$4#))_"LG1O%VCZ]/+!9S3K-'&)C'<VTD#-&> ZAU&5]Q0!N45S-GX_\
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M$NRUO2U>31=&LYHA>E"J7$TI *IG[P4+R>F:[Y[6WD;<\$3-ZL@)J0    8
MZ 4 >>?%_P#Y!7AG_L8[/_V>M#P[&G_"Q?'+;1N)LE)QU'D=/UKLGC20 .BM
M@Y&1G!]:4(H9F"@,W4@<F@#D/A7_ ,DO\/\ _7J/YFO/;KQ M[8:+?7GB".-
MTUZ&6YT>"&%(K!%N<%I3MWK@XRS,,EJ]Q5%10J*%4= !@"H_LMO^\_<1?O?]
M9\@^?Z^M 'FMDD9\$_$UPJG??:EDC^+]PM5=7O3X.L/"OC9(FDA&E+I]\B#)
M=6B#PG\)!MS_ +=>KB- K*$7#?>&.OUKG-9\-7FO:M9K>7\*Z%:RQW L8X"'
MFD3E0[EL; V#M"CIS0!+X)T670?"5E:71W7T@-Q>.>K3R$NY/XDCZ 5P\6M:
M7HNG_$+2M6N(H]1GOKJ6*UD(\RYCEB41[%ZOGIQG&*]8J-K>!YEF>&-I5&%<
MJ"0/3- 'E'A_4K'1-6\#WVJ7<-E:3>$A;I/<.$0R P-MW'C. 362;@W=G-J\
M%^]A81>,YII+TQ!A"C0;4E*N,;<LO)'&X&O;)+:":-8Y8(W12"JL@(&.F!3C
M%&5=3&I5_O#'#?7UH X_P1%9RZKKFHVWB)]<FF:&&>X$*)$&13@*R *QPP!Q
MG&!FJ,6L:;X<^*'B:36[V"R6]L[.6TDN'"B1$#JZJ3U(8]!SS7?111P1B.&-
M(XUZ*B@ ?@*22"&9D:6*-RAW(64':?4>E 'A$;*W@'X>E(VB4^+\B-EP4'VB
M;@CMBNOT_P#Y+'XV_P"P5;_^@5Z3Y,6%'EIA6W ;1P?7ZTOEH'9]B[F&"V.3
M0!X;X/N8=,\&_##5K^18=,MKF]2>>0X2)Y/-6-F/0#.1D],U-KMQ#KM[\0KK
M1W,D'DZ7*UQ F\2I'(Q=U'1P%4CN#M[BO5M=TF]O]/BATG4$T^:&42#= )8I
M1SE'3(RISV(.0*K>&_#MSI5[J6IZE?1WFI:@8Q(T,/E11I&"$1%)8X&6.2><
MT <+>_8=0MO$-_%XQ;7[J#PY=QGRH(A&D;KG#/& -V4X4G/7BM/446/1/AFJ
M*%"W]HH '0?99.*]#CMH(8V2*"-$<DLJH #GKFGF-"%!1<+RO'3Z4 >7>&?$
M&A:-X3?0-<6.YU:/5)H9=+*+)//(]RS(XC;[PPRMNZ8&<\5C&"!K/Q%H>K^,
M9=.:?5[A7TQ+6)YI?-EW1N@*F1MP92".F/:O:#;PF<3F&,S 8$FT;@/3/6AK
M>%IUG:&,RJ,+(5&X#V- &%XWU";2?!&JWL,,4\D4'W9H]Z8) +,O< $L1[5Y
MS-/]N\5W5K:^)SK<]WX;O;6VN=L*1M.3&?*C,:@,P&&(R2 17LQ 8$$ @\$&
MHTMH(EC6."-%CSL"H %SZ>E '"^%_%7AF\TOPII4*Q7FI+ B+;QHKR6+QQ8=
MI >8\8*YZG.!G->>ZG?6LG[.&KZ>ES$U[:7C"XMPX\R'=?$C<O49'3->^I;P
MQRO*D,:R/]]U4 M]3WI/LMOF0^1%^\.7^0?,??UH \\\<ZC_ ,(5XAL/&"QE
MH)[*;3[I0/O.%,L'3N65ES_M"L+Q/HDGA_X>^";*X.;QO$%I/=N>K3R%W<G_
M ($2/P%>QO&DB[716&<X89H>-)  Z*V#D9&<'UH X'2[ZUM/C#XIM;FYBAN+
MRSLC;12.%:;:DF[8#]['?%<!X666'X;> K\ZD=,M+?4;M9K[RT=;<N9E1F#@
MJ 2=N3TW5[VT$33+,T2&51A7*C('L:/(A\DP^4GE$8*;1M/X4 >5FWT"2RU#
M4;KQC<S/-JL&W68X8TB@N8XB%8,%\LKM.PD\9X)S75^!=7NM4AU6.XO+/4A:
M78A35+2,(EV/+0YP"1N7.TD''%=2+> 6_P!G$,?DXQY>T;<>F.E.CBCAC6.)
M%1%X"J, ?A0!Q'AR-#\6?&\I4;Q#IZANX!C?(_0?E7%^&[>&70]&T/5/&,L=
MY;ZBB-HR6L1F2>.8OSA?,"Y&XN>,'.:]K"*&9@H#-U(')IHMX1.9Q#'YQ&TR
M;1N(],]: /&X]1ETJ;XHW<,<+,NHVRDSQ^9'&K$*79>X4$M_P&K$5[#/XQU:
M)?$;ZXT_AR>&&X98E620-N:.+RU ? .3C)&3SP<>N^3'\_[M/G^_\H^;Z^M-
M2W@C$82&-1&"$"J!MSUQZ4 >)WVH65_\-_A@MI=0SM;ZSID,PC<,8Y!&<JV.
MA'H:[?0HT_X2_P"(;;1N::W4G'4"T3C]3^==HMK;HNU((E&[?@(!\WK]?>I
MB@L0H!;[QQU^M 'C7@W4;/0KWP=J.L7,5I8S^&/LT%Q<.$C$HD5BNX\ E<?7
M%=7\,+B"[7Q9<VJ%()O$$\B97;N!CB.[!]<Y_&M[7=(U6\DLYM&U."S-ON#6
MUS:^=!*#C&5!4@KC@@]S3_#&@-X?L+E)[LWEY>73W=U<>7L#R/@':N3M  4
M9/2@#CKV:-/B9XJT\W,4%]J.B0QV22.%:9\2CY,]2#Z5DRZOIFJ?##PQX=TZ
MXB;6Q+80"R0CSH)8G0RETZJ%"/DD#]:]>:")Y4E:)&D3[KE02OT/:D6W@2=I
MUAC69AAI H#$>YH Y7XG03S^ [PP,Z^5-;SR-&F\K&DR,[;3UPH)Q[5S8%E?
MR:[J$7B]M?NH= GB8Q01")(W^89>,8W97A2<X)KU.HHK:""-HXH8XT8DE40
M$GVH \9TZ[M].\(_"F^O9X[>TAN#YD\K!43,,@&6/ KJM#$4FH?$25-K"2Y7
MYQSN7[*A'/<<G\Z[Q[:"2$0O#&T0Z(R@K^5/$:+NPBC=UP.M 'B>BM)8S>%K
MN?Q(- M[CPM;10W4D<11W1BSIND! .&0^IQ[5I6%C90^(/ANMI=RW]J\^IW,
M<\\/EERR,^0N!@9)(XQC!%>KR6T$T0BE@C>,8PC("!CIQ3RB%E8JN5^Z<=/I
M0!%>_P#'C<?]<F_E7BW@Y%?P!\+@RAA_;$IP?4?:"/UKW#K3!#$JJJQH ARH
M"C@^U '#);WES\2/%4.GWHL;I]-L=EP81+L.^7G:2 >,C\:Q?B79ZI8^!+&+
M5M6&IW!UNV99A;+!A<\+M4GN"<^]>JA%#EPHW$8)QR:1XTD&'16 .<,,\T >
M8WT,US\;=:@MCB>7PFR1G.,,9<#]:G\)^)O#LGA;PIH96.YU=(XK<6:QJ\UG
M/'&0\CJ>8PI#?-UYXSFO1_+3S/,V+OQC=CG'IFFK;PI,\RPQK*XPSA0&;ZF@
M#QCPI!;SZ-X:T?4/&$JWEK>Q#^Q4M8C+%/$Y8AL+Y@7*G+'C!R3S6B(T'PE^
M()"C+7VJLW'4[VY_0?E7JPMX5G:<0QB9A@R!1N(],TOE1[&38NUL[AC@YZYH
M \HUS4K/17O]1TWQ)!8:LEC UUI5_&KQ:CB(; @.&)(^3*$\C!'%3)(TOQ@U
MJ1XC$S^%58QGJA+CC\*]/>V@DDCD>"-GC^XS("5^A[4_RTWE]B[R,%L<D>E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% ',:OXLN;+Q./#VG:-)J%\UD+Q?WZQ(%WE#
MN8@XQ@>I.1QU-5(/'PNM&LYK?2)GU:ZO9;!=-,J@I-%N\S<_0*H4G=CTXYJR
MMA=_\+5?4?L[_8SHBP";'R^9Y[-MSZXYKB9_"EV8UO[_ $B]NK:U\1ZC/+:V
M[,DSP3%@LB;6!.#M. >1F@#KK?QX#?V=A?:5+:74FH'3KE#*'$$IB\R,@@?,
MKCH>/I5S3O&5KJ/C'5?#RV[QFP3<+EF&R4@(7 ';;YB _6N6F\.)-X,U6ZT3
MPY>:=>17<-[9I=3.\]P\!5E8JQ)0G#(!G./3.*S-3T#Q';^$-,U2PTZ9]=NY
M+X7D*CYXQ>!CEO\ <81?]\T >E>&-=7Q+X?MM82V>WBN=S1H[9)0,0K?B!G\
M:Y2#XG32Z'%X@;PY<)H0F\JXNS<)NB_>;"P3&64'&3QWX.,UV^EZ?#I.D6>G
M6XQ#:0) GT50!_*O'-)EU+6?@]'X5M=%OGN+Z22&*[6,&W$9N&+.SY^7:-PP
M>21QUH ]"/C&YG\9WGARPT.:Z>RD@^TW/GJB1Q2*&W\]2,\*.3@]*HR?$61;
M"77$T&=_#44YB;41<+O*A]AE$6,E V><YP,XJYX>TV[M/B%XPO)K>1+6Z%B+
M>5AQ)LB(;![X/%<B+'6K?X<3_#Y="OWOSOLX[SRQ]E,32$B4R9X^0YV_>R,8
MH [&[\87(UV^T[2]$EU&+341KZ=)U3877<%13]]MO.,CJ.:Q?AUXC*>&_!^D
MSI+-/J-A//\ :&?./+8<'/)SO'Y4^T_M+PGXI\011Z)?ZA#J;0S64]N@9-ZQ
M+&4D8D;.5!R>,&L70].U?PWIW@/4+G1K^=;"RNK2\AMHM\L+2%2IV=2/D/TR
M* .PN_'5O:)K -C-)/8W\6G0PQL-UU-(J% N<!?O]^@!-8WB;QQK^F^$M>E_
ML"73M5L;=9%<S++$$?($BOMPQ4CE"/3J*RGT;7KM-7UC^QKB.>'Q';:M!9L5
M#SPI$BD YQNVYXS]X8S6KXGN=<\9>#?$MG::!=VMNUF%M1=IY<]Q+G+ )GA0
M  ,]2: -1_%VL+-:Z?#X;-QJK6GVRXM_MJ(L<>\JN&QAF;!., #N:ZBSNQ=Z
M=!>/#+;"6)9&BG7:\>1DAAV([UY_K;VNMPV%QJ'A#Q"C);?Z+>V2M'=P29(9
M"%(*#A2"25.3G&.>OT.VU*;P;96NMN?[2>S6.Z;()WE<'.."?7'&: .?C^(D
MK6,&M2:#/'X;GG6)-0-PN\*S[%D:+&0A8CG.<'.*O1>,;F[\8WWAZPT.:X.G
MS1)=W1G5$BCD17#X/)/)&T?W3R.*Y V>M7GP[L_ +Z%?Q7Z&&TFNS&/LJQ1R
M*3*),\Y5>!UR>E==X;TZ\M?'7C.\GMI([>[GM6MY&'$@6 *V/7!XH U/$GB%
M/#]I;,MK)>7EY<+:VEK&P4RR-DXR>%  ))/0"L2;Q[)I]MK2ZOHSV>HZ79?;
MS;+<+(L\/(W(X [J0<@8XZU8\;6%Z\NA:Q8VDEX^DWXGEMHL;WB9&1M@.,L-
MP('?!KF]8TC5?&-SXDU.WTRZLXI- ?3+..]0123RLQ<G:3E5^ZH)QU- '::A
MXC6QN]#MEM&E?5W=(_G V%8FDYXYSMQ^-9'P_P#$>M>(H=5DU6R6&.'4)X8G
M$JMM"N1Y> !G;_>/6LI;G5->U_P9,GA_4K.VTZ:0W<EW$$V,;=U  SDC/&[I
MR,9YP_PIHDES9:_X=UG3]3M5.JW%VEQ&[0I*CR;D*2(P)XZC\Z )?BC<3V\O
M@SR9I(_,\2VB/L8C<I+9!QU'M5R#7M)M?'OB=)8)X9K"PBN+JZ>X9HVCVY^6
M/HI ')'6LSQAX4F@M/"%GHUM>7,-GXBMKJ8R2O,T<8+%F9F).!GUJ*[\+:EJ
MGC?QXIMY(;75='CM;>Y<81G,94\^Q/- &_I/C&^O;JQ-_P"'+JPL-0B:6UNS
M*L@ "[QYJK_J\KR,D\\=:CTWQU+>SZ9-<:)-:Z1JLGE6-ZTRL7)!9-\8Y0.%
M..3VSC-5M)U76M4LK#0'\.WMB!:-!J5S=J%CB(CVCRB"?,);TXQ6#X2\-VEI
M)H6GW7A#5!JE@R"YO)KJ46L;1KQ*A+E7R0,*!QNYQB@#9F^)-PFF7^K1>&[B
M72].NI;>\N/M**5\N0H612,OQ@GIUQDX-:=]XPO(]6OK32] GU.'3A&;R2*=
M5<;U#@1QGESM(/4>@R:YY]#U0_";Q5IHL9OMMS<W[0P;?FD#S,5('N""*9XL
ML99[NX>T\.:Q!XAC@1-.U737(24[!M$Q!"@!\@JX/RC@\XH VQKFGV_Q"UR%
M;*X-]::2MS),;AO+=.H41GA3[XJ.Q^(5Q<QZ'>S^'I[;2=8DBA@NVN%++)(N
M5!CQG:2" V?0XYJ@VBZL?B+XEOI+.1H;G0$MXYE7Y))<<JOO4DNC:D? ?@.S
M%E-]ILKO37N8]O,2H!O+>F.] %N_^(<UK#K.H6V@7%UH^DR203WB3J"TD8^;
M;'U*AN"V?4X.*Z^SODNM*M]08>5'+ LQ#'[H*[N3[5Y9J;ZKX?\ !'C30GT6
M[D\QK^XAO0%^SF"4,Y9FSD, 2-N,D@=CD>B:9:_;/!5G:,Q3SM.2(GTS&!_6
M@#GX/B',]G::Q/H$\'AZ[G2**_:X4N [;4D:+&50DCG)/(XKGA<:OK'QNGM[
MW3;B2VT^"%X8$U(QQPCS/]>57 <D?PGZ&G&UUK4? .F>!)-!OX+V%K:VN;MD
M'V9(H9%)D63.&RJ# '.3TKHM-TN^B^,.MZF]K(MC-ID$4<Y'RLX;D ^HH ?\
M1;S4=$L-/\26-Q.(-+NE>_MHV.V:V;Y7RO<KD$>G-3^//$4FD^#7GTIQ)J&H
ME+33=A^_++PI'T&6_"NFO+2"_LI[.YC$D$\;12(>C*PP1^1KR_P=X:UYO$>G
M66NV\HTSPK'+%8SR=+MV8K&X_P!V( >Q- &IK UCP,NDZZVHWNI:9;0):ZS%
M+(TAQQ_I2@]"#]X#^'Z9J>VU:Z\:>,T&D7TD7AS1WS<7%N^!?7)&1&&'5%!R
MWJ3BNTOHA/I]S"4#B2)E*$9#9!&,5R_PNTNZT;X;Z/8WMHUK=1QOYL3KM8$N
MQY'KR* .7T3Q-JVE>-]8N-4O9;CP_<ZS+IB^8V192@*T9'HC[ROH"%K6U/5=
M0B\1>.88[R=8[30XIK= YQ%(4F)9?0_*.?858T/PR+_3O&6F:S9NMIJ6KW#H
M'&"\;)&%=?Q&0?45S>B:+XH5_&L.L6<LMP='6PM[L#B^*+*%<?[1#)D>N: $
MT.3PW>:!IMS?_%#4(KV:UBDGC.OHI20J"PVGD8)/%>J3&:TTQC;1M=S11?NT
M>0*92!QECW/K7G>@ZI;:=X=TRRN_A[KDES;6D4,KC3(F#.J $Y+Y/(/->D6\
MQNK.*;RI(3+&'\J48=,C.&'8CH: //O"_CW5KGP/I6HZAIC76I:E-Y%E'',B
M_:6)<DG  C554Y)ST]ZV&\>):Z7?O?Z7-!JEG<Q6C:>DBR-+++CR@C\ AMW4
MXQ@Y'%<)IN@7TO@3PU9ZCX>U1Y/#UVPO;508WFC<2*6A96!?;N4\$9&1S6M-
MX<\W1)-2T'PS>V<MIJMK>I!=SL9[Y(3D_*['8<,X4$\X[9% $_C7Q+J4O@;Q
M#;:AI-SI%]:Q03*Z3>;&Z-*HRLB@?,,$%>OU!KI+'Q;>/XCMM(U30IM.^W0R
M364K7"R&0)@LKJ/N, P.,GZU@^*;W6_%WA/7+6T\/7MO:^5"(!=1[)YY?-4L
M F3A0H')ZG.*WM<L+NX\?^%KV*W=[:VBO1-*!\L9=$"Y^N#^5 &18_$N>[TK
M2];;PY<0Z+?31P&[:Y3=&[ML!\O&2@8XSQZ@$8SHWOC2]%]JD6C^'Y=3MM*;
M9>3BY6+YPH9DC4@[V (STY.*YZ+0=57X+:%I1L)Q?PS6C26^WYU"W"LV1[ $
MU<@FU3PE>>)[-=!U'4/[1O9+ZQFM(P\;F1%!1SGY,,O4\8- $&JZVFJ_$CX;
MWEA<2_8;^WO9@NX@.I@!7</49_ UIW/Q!GCMK_5;;0)[G0+"9XI[Y;A0Y"';
M(Z1XRRJ0><C.#@5AV7A'5-)\0_#*$VSS1:39W4=[/&,I$[0@ $^A;(%-%OK6
ME^!M7\#QZ#?W%Y.UW!:72(#;O%.[L)&DSA<"0Y!YXXS0!UM]XOG_ +<;2]$T
M>35I(;9+JY=)UB6-'SL W?>9@I(' QWK O\ QKI>M:!X8U>?3;LQ7NO):VR+
M<M$T<@D=%=\8W#Y22AXYYZ5+9VNH>#?%MZZ:1?:I:7^GVD44MHJG;+ K(5?+
M#:""#N/'6N4L=*U35? 7@UK>S::6W\6&YN1 -RQHMQ-N;/\ =![T =]JGC>>
MRN=4>ST.:^T[2#MU"[2=5*$*'8(AY<JI!/(]!FGW?C.Z_M*\@TC0I]4M[%(G
MNI89U5\.H<>7&>7.T@]L]!DUR>H^&K>SUSQ E_X5U76)-0NC<64EI<2)#(KH
MH,<A5PJ88-DL.A'7I5CQ7I>+F>/3O#6KVNMV]ND.E:EI<I*/A!M65L@!5;((
M<'Y1D'G% 'J .0#Z^M+6=97UW+J,]C<6,J""&)_M?_+.9F!W!?ICGZBM&@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJ6KZO8Z#I
M-QJFI7"V]G;KNDD8$X'0<#DDD@ >IK&\(^/O#_C>.X.C73O);D>;%*A1U!Z'
M!ZCCM0!TU%%% !17G'BLPW7Q-T_3M1UV]TS3CI$LV(-1:U5I1*H&2&&3@FFZ
M)>1:;\0X-+T;Q'=ZQI<EA+/?)<WGVH6C*5V,)"25W98;<]LT >DT5Q>G>.;N
M[?2[RYT3[-HFK3"&RN_M.Z0E@3&9(]HVA\<88XR,]:GT+Q;J>MSVUS'H.-&N
MI9(XKN.[#R)M+ -)'M&T$KCAB02,T =;6?H>C6OA_1X-+LO,^SP[BGF-EOF8
ML>?JQKBH/B9J$OAZ+Q))X:\O0A+Y5Q/]M!DC'F>675-GS*#UY!Z\8&3L7GBS
M59M8U*QT#0H]172]JW4LMYY&9&7=Y<8VMN;:1G.!DXH ZVBN(_X6"U])H<6B
M:2U[)K-E)=0>9.(A&4*@K(=IP!N.2,\C !S21^/[EM+8/HRIK*ZM_9!LVNP(
MO.V[PWF[?NE>?NYSQB@#N**\]\6^(/*\()<>)/#+^9'J<-N;5;TA"Q(VRI(H
M!9>>A Y!!Z5&-3UBU^*'BBWTC2UU"9K2R?;-=>1'& ),_-M;YCD8&.QR1B@#
MT:BO)O$OB)?$47P\U2WCEMO/UY$E@9OF1U+*Z''7#*?K72ZCXYN[5]4O+71/
MM.BZ3,8;V[^TA9 5 ,ACCVG<$SSEAG!QTH [2BJM]/=)ITD^G6\=W<;08HGF
M\M7_ .!8...>AKQWX:ZW/HO@*/Q'>Z4UY?ZI/Y$-Q]N9YKZ=YF54*L,1@8ZY
M/ )]J /;**Y&#QA?VVH7>FZWH\=G?1V#W]N(+OSHIT3AEW%%*L"1Q@]<U9\'
M>);_ ,5:='J<NC?8+">".2W=K@.\A(^8%=HP > >XYP* .EHKAQX@U]_BM=:
M(+. Z9%I\<I_TG! 9V'FXV<GC;MSVSGG%<[X)\7:II'@#PU/<Z*7T>1HK1[U
MKK]Z&=]@?R]O*;B!G=GOC% 'K5%<7J7CB\M9-5N[31/M6C:1*8KZ[^TA),J
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M/^L- 'H5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% &%XP\,6_C'PM>Z'<S/"EP%VRH,E&
M5@RG'?D#CTKE?AC\*H_A[->W<NI?;KNZ41@K'Y:H@.<8R<DG'/M7H]% !111
M0!Q>J>&QJOQ/L[Z^TN&\TN/2)8BT\:R(LIE0@8/?;NYQ4>F>')O#WBK4]/L;
M$+X=UJ)IMT*JHL[@#:RX_NL,$>A!'&:[BB@#RCPGX4@TZ31=/N?!$G]I6#J+
MC4Y)@+?]V/EFC(8EF)"D+M&,G.,5;L-+NV\76%[8>&+[0K_[4SZM,DR_8[B+
M:V< -AV9MI!V CJ:],HH \3T8:QKGPAA\+6NB73M?R21)?@I]G2(W#%G8[MP
M(&X;<<D#'6NOA.K>$=?\0F#0;W5+;5)UO+22T*$"3RU1DDW,-HRH(/(P?;%=
M=HVD6F@Z5#IM@C);0[M@9BQ&YBQY/N35^@#SCPMX2U/0=5\)1SQ;TL=)NHKJ
M9""J3221OM'KSNQ]*)-(NH(O$RZCX8;5]/OM;,S6X*F0P^2@$L8)&2'7&,@]
M2*]'HH \=U7PSKM[X%FLK/3M0%O_ &W!/865Y,))X+90N[<2QP-P<@$D@$5T
MKOJ^@_$'Q!JPT&]O].O+:UC1[38SET#_ ,+,./FP3V./J.QL]5L-0N+NWM+J
M*::SD\JX1&R8F]#Z&KE 'D?_  B&NQZ3X)#V)-S!KS:C?(C@BW5Y&<@G/. P
M!QGFG77A&&TU?6X;OP5-K5Q?WTES:W2S!(&24@E96W93:2W\)R,8S7K55[2_
MM+XS_9;A)OL\S02[#G9(N,J?<9% $L<:Q0K&BA510JJ.P%>3Z#X3UVS^$7AN
MV;3V&K:-J(OS9,ZAI LSDH#G )1R1SUQ7I\FJV$6JPZ7)=1+?3QF6. M\SJ.
MI ]!5R@#SVXM-4\4>(9]7.CWEA:VFD7-I EX$66>:7&<*K'"@*!DGDFND\$V
M-SIG@;0[&\B,-S;V,4<L;=58* 1Q6M<W]I9S6T-Q<)%)=2>5 K'!D?!; ]\
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M[2B@#S#PCX<M[6]T>&7P-+:7]DO^EZA-,/*1U0@-%ACO+'V& 3GTI3X<U?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;:H558%1DEB>.P Q4FKZCKNE:7I=MK/B6QTRX>:5)KJUM_-GN57_ %?EQ%&
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M!4X.<T >I45YMK7B+5X/%4^GW'B.WT-U2'^SXY[0-:WS%07W2L,CYLK@%2
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MZ4 >J45F^']3;6O#FFZG)"89+NVCF>(C[C,H)'/H:TJ "BBB@ HHHH ****
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M:7<,T;%P$9B&0@XYW=ZO:]H,FL:EH-U'.D:Z9??:G5@3O'ENF!Z?>S^%;E%
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M!=WH.E7KWPMX@M=2UB3P[JUG:6NL.)9_/A9I+:78$:2(A@"2 #ANA'X5VM%
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MX^R^=NW;MN,XW?-MW;<]JFD\"V#ZC-<)J&IPVD]R+N;3XIPMO)+D,6(QN&2
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M#+' '       Z5GZOX)M=7O+R9M4U2U@OE"WMK;3A8K@!=O(*DC*@*=I&0*
M*?AJZ:;QOXR'VAY8$-D8LME0#;@Y'89Z\5QOA3?XEM/!>AZI<7,E@VBS7TR"
M=T-S()%10[ @D ,3C/7'I7>WG@:PN=7FU"&]U&R%S%'#=V]K,$BN$0$*&&"1
MP<94@XJ,^ -,CTG2;*TN[^SETE62TO+>51,BM]Y22I4@\<$=A0!S6M>'([?6
MO!NB_P!J7EQ:G4KL*QF/FQ1&!SY.\'=@#*YSG!ZUL^#;9-)\8^*]%M7F&G6Q
MM)H(9)6D$1DC;?M+$D E0<5I6'@?2M.DTR6)[IIK"YFNA+)+N>>652KO(<?,
M2&[8Z#MQ6I9Z+:V6MZEJT32FXU%85F#,"H$8(7:,<?>.>M ''ZKI<6N_%M].
MOI[AM/70DF:TCG>-9'\]P"=I!.!_3T%<K<RWS^';+1H]3O$CM?&O]EPW F8R
MBW^;"[NI(#8!/]T>E=?JGARYU7XI/>K-J-A&FBQQQWUH0N'\YRR992IX()!!
M['TK6B\"Z1#I>FV"O=%+#4%U)96D!DFG!8EI&(^;)8YZ?A0!S\F@V-QXZM/"
M3_:1H=AI#7J6OVJ7][*\Y4L[;MS8P< GC=6(MU=[CX2-]=_V;_PE!T_S?/;S
M/LWD>=Y/F9W=?ESG..*]%UOPO;:S?6VH)>7NGZA;(T<=W9.JOY;8)1@RLK+D
M X(X(XJH? >CGP__ &3NNQ_I7VW[9YW^D?:<Y\[?C[_X8QQC% ',>*M+?PKI
M0L-'N=0FM-4U.U@;3XKK$D*$,76.1V!7S-H'+ #)QC-0)HGB9K#7;'2]&U#3
M-.F2VE@M+K44+,ZR?OXXY$D<QAXP!G(P<],UU2> -+-C?0W5UJ%W=7LD<LM_
M-,/M >/F,JR@!=IY&!W.<YJ1?!%HUE=PW.J:M=75R\3F]EN )HS&<Q[-JA5P
M<GA><G.: .3@M#?^'M8TSP_9ZQ97L-Q;2W>B7MV4/E[LLL4NXX61589#8R.V
M36?>ZA#;:&-*T>SUZVDN=8M[:]TB>X"RPHR,Y6*1FX63R^N_')QC-=RO@2R-
MM="?4]5GOKF2*0Z@\ZB=#%GR]I50H W-QMP=QSFE'@/3GL+R"[O-0N[JZECF
M>_EF G5X_P#5E"J@+M[8'<YSF@#DX]$\3-IVN6.FZ-J&G:=+]EFM[*YU%-SE
M7_?Q)(DC&,.@7N.2>F:Z3P')IRG4[2SMM5T^:%XS/IFH2%_LQ93AHR2V5;!/
M#$9!X'-6E\$6C6-U#<:IJMS=7,D<IOI+@"9&C.4V;5"J <\;<')SFEB\$VR6
M&HP2:KJLUUJ!B\^_:<+/B,Y15*J H'/ '\1]: .FHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKE?B/K6J>'O .JZIH\>
M^]@1=AV;O+!8!GQWV@D^G'/%<#\"_&_B?Q5/JMMK<[7MM;HKQW+1A2CD_<R
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MK'_:%P9A%"WWD4'H#@ GDG'6G:/X*T[1KV"YBNM1N/LL;16D5U=-)';*1@A
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MDL>PV@    5TU% &?<Z-:76MV.KR!_M5E'+'"0WRXDV[LCO]P5CP> -#M_#
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MVNWUXZK*2XEFEPI"AB2 J#D>V[IS57P7X(M]%\ '0M1MHRUZ)'OHD8E<R<%
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M+4='^&^NZ_::AIFH7=E=^5&T,3>6@\U%V.-V2P#')R.U)JEQIMUXM^'ZZ/)
MY1IW00D'9;?9R#TZ+G8/KBO/[G_D@?CG_L.R_P#I1%0!['/K#P^(-.MI-3L(
M89K1YI+21#YTF!G<AS@*._!JEH/Q'\.Z[YHCOX8F6^:SB5WYE.XA"./X\$@5
MA:A_R6KPA_V";C^54-#TA?$GPZ\3:3;S(NHIJ][-;X8;XIDF+QGU'S ?@: /
M3[G4;.TN[2TN+F..XNV9;>-C\TA49.!WP.:5M0LTU*/3FN(Q>21-,D)/S,@(
M!(]@2/SK@/!>J?\ "=^*$\3/&5@TO3TM(T(X6[E >?'NH")^)K1\?SQZ'?\
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M]>]-I;FZ>/R6G\L;V3.=I;&2N>W2D_LVP^R06GV*V^S0%6AA\I=D94Y4JN,
M@],=*S?&>JW.A^#-8U2S*BYM;5Y8BZY&X#C([U-#KMG''I,%Y<HM]J,0:&$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUTZQL0HM+*WMPJ>6OE1*F%SG:,#IDYQ2WEC::C;FWO;6"YA)R8YXPZY^AXH
M\GM$LM)UWPIJ$NMP:AIDNKZB[WOD^1 MQ)&0 ,DC&Y9,$'!)XJAXCNK/4/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:5U@93M.\JI"C/&3@'G'2KFJ^+M$T6[@M;R[<W$T?G)'!!),PCSC>0BG:O\
MM' KB+>)!\/OB<VQ<O>ZJ6..N(N*7P[JVGZ#XQN)M;O8+-;O0+!K26YD"*RH
M'$B@GC.2#CK0!M^'?&]NWA,ZOK5\K+)J-Q;6[0Q%VE"RN$5$0$L=J]@>F:V#
MXT\/+H\.JOJ21V4MQ]E$CQNI67GY'4C*$8.=P&*\FTAF73?"VH0:E_8MDNJZ
MI']JEA4K TCMY88/PN0&7GH3BM#5+.RETNTGBUK^VTO?%]E]HG\A8XF<;48+
MM^5A@ $CC.>^: /09/B!X;BL[:Y:[N"ERKR1JME,S[%;:SE FY5S_$0!5>;X
MA:4GBW3-$A,DZ7UJ;A;F*&1U^8IY>"%(*L')+9PN!GK5'Q=)96OB:.[MO%,&
M@ZU'8X_TU%:WN8-Y.T[L9(8'[IW -[BL73-<@E\<^#]3U%+?2Q?>'I%2-B(X
M_,:2,A$SCKU ZX(H [:#QMX?N-9&E17Q-RTS0*Q@D$3RKG*+*5V%A@\ YXJ"
M\^(?A>PEGCGU%@;>9H;@I;2NL#*=IWD*0HSQDX!YQ7FLFOB]L?#E]=:];1 Z
MW#--I%M!%''8*)R"9#C>N"0"6(R6Z5O6\<?_  KSXG,$7+WNJECCKB/B@#N-
M5\7:)HMW!:7EV_VB:/SEC@@DF81YQO(13M7_ &C@54\":W<>(/#KW]S.DY-[
M<QQR(  8TE94QC@_*!SWKE/#NK:?H/C&YFUN]@LUN]!T][26YD"*RHKB103Q
MG)!QUK9^$[QR>"-\,9CB;4+PHA7:5'GO@$=OI0!L77C;P_9ZN=+GOBMPLJPN
MP@D,4<C8VHT@78K'(X)'44W4_'/A[2+NZM+N]D^TVA'GQ16TLK1@J&W$(I^7
M# [N@SUS7F7BW6VO-#\2B36X+-H]4>(:-;6\6^18Y5S-*2"_*KO+# QBNU\-
MF"X\;>.[B(QR)*UGB12"'3[,I&#W'/ZT ;U_XPT+3K2PN9KTR)J"[K1;>%YG
MF7 ;*J@+$ $$G'&:H^"_$4GB.77Y?M*3VMMJ1@M650N(_*C;![YRS=>>U<!X
M)OK71[SP3?:M<Q6ME-X;DMX)YW"()A*C$;CP"5'Z5UOPTNK:^N/%]U9X-M-K
MLCQL!@.#%%\P]0>H/<'- &X-5C7QQ/IS:TI,>G?:#I?V7E1OQYWF]_3;^-5(
M_B3X2E:WVZL!%<+NBG>"183\N[;YA7:&QSM)S[5@/_R7K4O^Q7_]K"L:U@B/
MPC^'<9C4H=6T\E<<$F0Y_/)_.@#T.S\;^'[VUU*XBO75-,C\Z[6:WEB>),$[
MMC*&((!Y /2DT_QQX=U/5(M.M+\O<3AC!N@D1)MHRVQV4*Y'?!-<7XU&/$7C
M7'?P<2??YIJ)]5TO6+/X=Z=I%S!+>PWUO*UO$P,EO%'"PDWJ.5Q]T@XYH V_
M"OB^:?\ X3&YUV]BCLM(U::WCD90HCB7& <#D\_4UMVWC30;K3M0OEO)(X=/
MC\VZ6:WDBDB3!(8HRAL$ X('.*\G$4SZ'XZECE:&.W\8+//*(P_EQ+,A9RIX
M8+]X@\86M;6X[:ZT?Q?J"^+4UZ[C\/O!)Y%NBQHC%F7+Q_*6R&XSG!S0!W(^
M(GA;[2T!U,APAD0M;RA9@" ?*.W$AR0,)D\U;M?&6@7>B7>L)?A+*S<QW#31
MO&T3C'RLC ,#R,#&3D8KFM0@B'BGX:((UVQI<;!CA<6O&/R%<UXBCF_M'Q;/
M%<&VAM?$.FW$\XC#B&,11YD*G@A20QSZ4 >D0>-- GTN_P!1%X\=OIX#78FM
MY(Y(01D%HV4-@CH<<TVU\;^'[W46L(+UVN!&\J V\@694^\8V*XDQ_LDUYYX
MABMKCP[XTU!/%2Z[=KHRP3-#;HD2+N9D^9/E+<MQG(!'M76:W&D7C/X?)&H5
M4DNE4 8P/LK<?H* -+P=XSL_&%M=RVT4L1M[B2/#Q.H9 [*K990,D+DJ,D=#
M5B74E7QU!IG]M*C/8&;^R_LN2XWX\WS>WIM_&L#X4WMJ^@W]@MS$;RWU.\,U
MN''F1@S-@LO49J"[_P"3@]._[%Y__1QH VX/B+X6N9K2.'4RXNG6.*7[/+Y>
M]ONH7V[58^A(/3UJ76O&NBZ5<W>GR7K+?0Q;WVP.Z0EAE/,<*53/^T17G\,:
M1_L[Z=L4+_I-NW [F]7FM.UUC2]%G^(-AK%S#%>SWDDT<$K /<1/ BQA%/+Y
MP5P,\\4 =5X/\3)JNAZ#'?7*OK%]IB7SH(R-R_*&;@8'S,./>K=SXOT.TM;F
MXEO3LM[LV+A(79S. #Y:J 2QP<_*#^E>=>%-0L]'U#P+=ZE=0V=M-X6:!)IW
M"(7#1-MW'C.!FDTZXTC4;'5;R;6I-(9O%<\VG:CL&Q)/(7!;<-NUD+<-C.1B
M@#KM9^)>BZ=IVFWMLTMU'>WRV>!!*&B.X"3<NW(90<A" 3V%:4_CGP];7J64
ME\_VMQ"5@6VE+XE!*':%R!@'/IWQ7GNJZY)>:%I=UJ%S82Q:?XOM4EU.U41P
M7"* 3,>2!C=M)R1E>M=/X>:VNOBYXFO(6CF5M-L3%,A#!D8.<@CJ#@'\J .I
MM/$6DWOA\Z];WBOIBQO*TY5@ J9W$@C(QM/&,\59AOH;W24U"T<M#- )HG*E
M<J5R#@C(X]:\GU:UGM-?U+X=PJXM/$%_'?0,HXCMGR]TN>@P8R /^FE>N3HL
M=A(B*%18B%4#  QTH XGP5XX$_PPTGQ#XEO!]HNGDC+1PDM*_FNJJD: DG"]
M .Q-="/&.@G0GUG[>!9)+Y+EHG$BR9 \LQXW[\D?+C//2O'O"XFA^'OPXO1J
M@TJVAN;V-[YXE=(7=I0A8-P,X9<GINKH9+N'3K2:[M/$EK?G4]>A@N=6GLT$
M%HZP_P"L3^ M\B+NZ!CSS0!W\'C'09]%O-6%^(K.R;;<F>)XGA;CAD8!@3D8
M&.<C&:Q[7QK'J_CO2]-TVX?['+97$MQ#-;-#(&4Q["0ZA@,,V#T/X5YY?WL4
MDGB69]6;58(-3TJ[GN&1%,]M&P#N%0 ,BD8W 8^7K7:?VQI6L?&/1GTRZ@NQ
M'I-RLD]NX=.7C(7<.,CKCMN'K0!JZ-XOTJW\*6FIZEXECOX+BX>!+\VA@5W!
M8[=F.,!2,GKCWK2TWQAH6JQWSV]Z4^P+ONEN87@:)""0Q60 [< G/3BO)?"*
M))\-/ BNH9?^$I!P1W#3$5M?$.VN+K6_&$-HC-*WA>%MJ#E@)Y2WU^4&@#N=
M.\>>&]4NK6UM;]S/=MMMXY+:6,R_*6W+N497"GYNG'6G>,_%MMX.T9+Z>)YG
MDFCACC5&(.YP"25!Q@$GGKC Y-<GJNOZ#KGC;P$='N;>[,=Q,V^W8,(4:W?"
M,1]TG'W3S\I]*UOBRZQ>!_.<A8XK^T>1ST51.F2?:@#6OO''A_3DMVN;N93/
M#]H5%M)F=8NF]U"DHONP%6-4\6Z)I$%I-=7FX7B[[9;>)YWE7 )95C!)7!!S
MC'(K@[Z^1/'VM7J^,+31[.]L;:6WG>.&6.YB0.K!7?@[6SD#^]2:"VF>%/%&
M@R7FI;=*E\."WL;V]7R S"7>5.[&TE&3@]EH WM4\=VEOK?AJXMM1C?0]1@N
MI)'CC+F1D\L(% !;=N8C:!G/&.*V8?&_AV?1GU8:B$LX[@6LKRQ/&8I20 KJ
MP#*<L.H'7/2N4@N])U;QQX+OM(LU@LG75'B/DB,2-\@,J@=F.3GJ<Y[UC>(8
MTDF\8Q.H:-O$>EAE(X.1!F@#TG2/%VBZ[?365A=.US#&)6BF@DA)C)P'7>HW
M+GN,BJUEX\\-ZAJ$-G;:@6>>0Q02M;R+#,XSE4E*A&/!Z$YK!\56\]U\0/L]
MIG[5-X8OHXL<'<7C"_J:PI]6TO5/AOX1T32[F%]7^T:?&EHC#SH)(F4REDZK
MM"ODG^M '5>'_$UY<^-O&UCJ-U&NG:.;8PEE51$K1LSEF[CC//2M72?&V@:U
M?1V=E>2&>9#) )K:6$3J.IC+J X[_+GCFO,=4M+J^OOC';V2.\[169")U8"(
ME@/J 174:OK6D^(]<\$P^'[RWNIH[[[61;N&,%NL+AMX'W =RK@XYXH WKCX
MB>%;6:YCFU3:+9VCDE\B0Q[QU17"[68?W02>#Z5M6&L6&ISWL%G.));&;R+A
M"I4QO@''(&1@@@C@UXK>:OI4/P%DT"XGA;68)3%-99!FCE6YW,[+U ZMN/'/
MO73^.+V[\%^*+C5M/B=SXBLOL**@_P"7].(&/U5B/^ 4 >B:5J]CK=HUUIT_
MGP+*\7F!2 60E6QD#(!!&1Q6;;>-- N]7&EP7Q:Y:1H4)@D$<DBYW(LA78S#
M!X!/0U;\.:+#X=\-Z?I$'*6D"QEO[S?Q-^)R?QKS_2]4MM*UC3+70]>M=4TR
M[U)XO['N8E^U63,79W4\. K;B0Z\ ]>E '8/X]\-QZBUBVH$.L_V9I?(D,"R
MYQL,NW8&SQC=UXK/C\2WJ?%74]&N)U&E6NCK>!?+&5??@G(&3QVKAUU&PB^!
MEUX9FGA.O_O;)M/W#SVNC,<83J<DAL^G-;!AF?XP:_!S).WA94X_B;=C^= '
MH!\1:4-,T[43=C[)J3Q1VDFQOWC2_<&,9&<]\>]<_8^/K#6;KQ'8PR369TQ7
MVW3VLC !8PS.05 RK$_*3D@9Z&N-BU_2KOP'\.].M;Z&>]CO],66"-PSQ;"%
M;>!RN&XY[FM&WO;6*7XHV$ES$EX[2RI;LX$C)]E7Y@O4CWH Z^V\5Z7I_A72
M]1U#6?MJW:JL-Q':L'NV(S\D*@MGCH!Q5B+QGX?ET:;5AJ 2SMYE@G:2)T:&
M1F"A70@,IRR]1WSTKSCPW<0:9:?#'4]1E2'3ETZXM_/E.V.*9U0KN8\#<%8"
MHO$DEOJUOX[U&S:.XTNXO-(MUF0[HYI$E028/0X#*I/M0!Z9IOC30-6O)[2U
MOB)H83<,LT,D(,0.#(I=0&7_ &AD4[1O&&AZ_=FUTZ[=YO+\Y5DMY(O,CR!O
M3>HWKDCE<CD>M<YXL6U_X3_2_MJ.UHVB:B)Q&I+&/]UN  Y)QG@57\(ZJ8/$
M6G:/:>(++Q'IKV,DEO.J)]ILD78 LC)P0P('(!ROM0!V>M>(=,\/QP-J$[JT
M[%(8HH7EDD(&3M1 6.!UXXJJ_C3P]%I=EJ;ZG&MG>NT<$A1OG=0Q*XQD,-K#
M!P<C'7BL;QEJS6GB;1K%M5M-%ADM[B8ZG/%&S KL'E1M)\JDAB3UR%KB="FA
MNV\.1-<&YD3Q==NYE0+)RDSJS( -I/#8P* /4+#QCH.HV5_=PWWEQ:>,W8N(
MGA: 8R"RN 0".0<<UACQW;ZIXP\-V&D74GV:\-P;F*:U>)V58BT; 2*#M)!Y
M'!Q7+>.X9);_ .( BC9]NG:9+*JC):-)G9__ !P-6WJ&NZ-K?Q0\%'2KVVO3
M&EXSRV[APBM#\JDCH3@G'7B@#MM8UW3- MX;C5+M;:&:40H[@D%R"0.!QPIZ
M^E8P^(_A=HIV%[/YD#!9+?[%/YZ\9SY6S?MQSNQCWJK\1$61O"2NH9?^$BM3
M@CT60TFF1I_PN'Q!)M&\:5:#=CG!>7/\A^5 '06WB71[PZ6+>]27^U8WELBJ
ML1*J %CG'& 1P<5A^-_%G]F>$?$L^CW2C5-(1/,!CR(F?:P^\,'*MGOUKA?"
M]Y;:99?#:]OIX[:S0ZG"T\K!(U9B=H+'@9VG'TIGB._MM3\-_%6\LY!+;R/:
M^7(OW7 BC7(/<'!P>A'- '<_\)_:VFM:!HMTDSW&H60GFE2"0A&(3;C:I!!+
M')SA<<XS6OX=U);^^UN)=:743:WK0F(6OE?9"/\ EEG^/']ZN/>]M=/\=>!I
M[VYBMHI-$FB229PBLY$6%!/&?:F>";>_NK[X@0Z9?I8W;:\^RX> 3!>F?E)&
M<C(ZT >@:SKFG:!9K=:E<>3&[B- J,[R.>BJJ@LQX/ ':N7UWQY9KI>CZGI6
MHHMG)K$=G>M+&5,:;7+JRN R$8!Y /YU2UM;W0O$/@[4/$FK0W5M!<W4<U\8
M!;QQ/)%B+<,D#HPW$_Q56\0ZEH>NW&CS:3!%)&OBJU2>[CC7R[F18V^8,/O[
M>!GVQVH [+3?&.A:K'?O;WI3[ GF72W,+P-$F"0Q610=N 3GIQ3=,\:Z#JPN
M?LMY)FV@^TR+-;2Q,8O^>BAU!9>.HS7&^,-0?2?&'B6^BMH;AH_#$1\N9-\9
M_?R#+KW4 Y(]!69+?Q'Q>ZR>)X]9#^';V))TCBCB$F8V\M#&,$X&[:22!CUH
M ] L_'OAK4+^TL[;4"[WF/L[FWD6*4[=VT2%=I;'\.<]NO%1WGQ#\+V$L\<^
MHL#;S-#<%+:5U@96VG>0I"C/&3@''%<I+&D?P[^&@10H%]I9&!W*<_S/YT01
M(/AY\3"$7+WVJ%CCKA* .WUCQ?HFA31PWUVPEDB\X)#!),5CZ;VV*=J_[1P*
MQM9\3W<7Q!\%Z=I]U&^EZO'=23;55A*J1!T(;L,G/'6N2MY9=/\ $EQ+<^*8
M= CN=&L9(GN((G6=$1@X!D[JQR0/[XI8;*WT_P :?">UM+F6YMDM;[R9I8C&
MS(8,KE3R.".* /5-5U>PT.Q-[J5RMO;!TC,C D!F8*N<=.2.>E8:_$7PP[3(
MM]-YT6T^0;.82R!LX,:;-SC@\J".,U4^*:+)X*V.H9&U"S#*>A!N(Z26-&^-
M=JY0%E\/2X..1_I"?XF@#8_X3+0/^$?AUQ;\-83OY43+&[.\F2-@C WEL@_+
MC/!K*USXCZ/IGA8ZW:M)=J;E;81>3(K+(74,KC;E" <X8#/ '45P,:S0_P!G
MWBZF-+M8/%.J(]ZT2ND#/O5"P;Y0"<KD]"U6/$,5HG@GQ%J<7B#^V/-U:Q:Z
MNE@6.)6C>($J5^5AMVY([CUH ZV;Q[;6GC-X+BYE&E2:3#<V\2V<C3-(TL@)
M"!?,^Z@XQQBMY_&.@)X?M]<_M%&T^Y8)!(B,S2.21L5 -Q;((VXSP?2L/3I[
M2_\ B_=7MK-#<1-X?@\N:)@ZD&XESAAP1P/RKC]*EBTZY\.:I>NL6EVOB'5H
MYI7.(XGD:18RQZ 9R,GH30!Z=9^+]"OM-O=0COA'!8Y^U^?&\+P<9^=' 8<=
M..>U8(\=V^I^,?#UAI-T_P!ENEN7NHY[9X7*K&&C8"10=N<\C@X/I7'>,98]
M:G\:ZGI++=Z;#9Z?'<RVYWI*T<_F2 $<-MC/..G2M_6-=T/6OB3X4-A=07\<
M5K?--):MY@"-$,+E<\D G;U_.@#K=)\9Z#K=\+.PO6DF=&>+?!)&LRCJ8V90
MK@9ZJ36]7F'A/5(K+6]!TC2_$%IK^CSP2"VC:-?M6G1I'E=S+_#T0[@#D@>M
M>GT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 -DC2:-HY45T8896&01[BH[:TMK./R[6WB@0G
M.V) HS]!6'K'BB:RUN/1=+TJ74]2:W^U21K*L211;MH+,W<D$  'H>E<1\0?
M&]_>?#2:\T:VO+.5KK['>.)ECELY%E56CX.23R,KVY[T >K>3%L=/*3;(277
M:,-GKGUJ.6SM;@1B:VAD$1S'O0'8?49Z5G^&K5K#0(()+.XLBF[,-S=FY=?F
M)R9"3G/7KQTK%T_QX^H365PF@WRZ+?3_ &>UU$,K!SDA6:,'<J$@X8^V<9H
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M/+:PO!G/E-&"OY=*<;6W*.A@BVN &78,,!TSZU+10!#+:6TXC$UO%((SE Z
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MCG4D <V$\.X[Y"3^[)9>05PV3SWKJO'NF7.I^#[P6,327]J4O+15&6,L3!U
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M@KC'VGR^W;[_ .%>>Z+8-%XH\*ZG;:#KZ)#YD&H75^)GD,TD6 2KDD*&SEP
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MJ&81GS-H0QQ&3!X[XQ[5R7ASQYJ[^&K[4]7TPR2'4I+2QBAF4M-(TQ1(1P
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M2);!D\.OIT)W,+0P(3QD[-HH \OC\2Z[>Z%\/]4O[.26\GO>%AF7-WNMWPQ
M " L>0>!C-=;'X]:UM]=&M:1)97ND+"SV\,XG$PEXBV-A>68;<$#!KG?#]AJ
MTVD> ;6;1K^UET6Z\N[\^,* !;R+O!!.5R0,^]6/%/A74M9U/QCY-FTB7-KI
MSVP9MBW#0R.[1ANQ. ,]MPH ZO1O$=[=ZR^CZQI']FWWV?[5"JW(G26/<%;Y
M@!AE)7(QW&":77O$MQINK6&CZ9IO]HZG>))*(FG$*1Q)C<[-@]V   .36-X/
MTO3$UV6]L/">H:6([;R_M6H3/O+,P)C5&9LCY02W'(&,U-XBBOM)\=:7XD@T
MV[U"T^PS6%PEH@>2(LZ.K;<C(RI!QTH Q= \5S6+>*KVXL;E[R77([.WT\R#
M<9FBC78&^Z%R&.[I@$UK7?Q!FTFVO#J^BM:W-A-;B[C2Y$B);S,5696VC< 0
M01@=#7+W'AK5]7LM:OK[0KC_ )&&'4EL/,"R3VXA5"%8,!O"D\ _>4C-=%HG
MAC2-3L-=MXO#-WI-I?6PM/.O96,TP(;/R,Q*A2>#GDD\#'(!T.L>)H=)US2M
M*\@RR7PFD=]^T00QKN:1N#QR /4FLO2_&]S>W&E2WFAR66EZNVRPNVN%=F)4
MNGF(!\FY5)')[ XK#\&^'M<U1=3O/$ML]K>+IB:);E^245?WDH]G<@_\!JOX
M1\.6EK<:':7'@R_BU*QV_:KZ>Y<6\;HI'F1_.0^YL84 8#'.,4 )X-\2C0M"
M\9ZA>>?=M'XHN;>W@5LO([&-4C7/3)/X<UU-OXPO8-2?3=<T3^S[MK.2\MO+
MNA,DRQXWKNVC##(XP1@]:XVQ\*:XOAWQ$ZZ?)]LA\7-K%I;N0OVF-'1A@GCY
M@&QGO6UJ'V[Q-K\6KG2;[3K#2=,O%W7T8C>6695&U5R3@!2<],GB@"Q8_$6Z
MN+/1M5N?#LMKHNJ210I=M<JSQR2<+NCQ]S=QNSZ''-+??$2\@BUVXM/#DMU:
M:'<R0WLQNE3Y4 8L@(^8X))7C'')S7-Z2VJ>(OA[X0\/1Z)>QD?89IKQE7[.
MMO&5?<'SRQ"@;<9R3Z9K;&B:G_PB'Q$M?L4OGZA=WKVB8YF5X$52OU((H UK
M'QK<7&NZ59W6B26MEK".VGW33JS/M3?AXP/DRN2.3Z'!J.U\>2W$EI>-HLD>
M@WMV+2WU#[0I9F+%$8Q8R$9A@'.>02!FH[O2;^35? $BVLACL/,^U,!_JLVK
M(,_\".*YCPUX1M--&F:/>>#K^XU&TN0)+YKEUM=B.668'>03@*0FW.>..M '
M077Q$ODL]9O[3PU+<6&C74]O>S&[5#B)L,T:D?,=OS$<#G&2<XE7Q3K5Q\4(
M='MK))-)?2TNPQG525:0#S<;<Y'*[,\]:J)HFICP!X[LC92_:;Z[U)[:+',J
MR9V$?7M3K:TU'2OB)H]_)I5Y-:3Z!%IS2P(&$$HEW'S.?E4 ]: /0JY,^,;N
M?QI>>'+#0Y+EK)X#<W)N%1(XI%!+\CDC)PHZX/(K9T+5SK5C+<FTDM6CN9K<
MQR$$YC<H3QZXK%T'3+RW^(?C"^GMW2UO%LA!*1Q)LB8-CZ$T 06OCR6XDM+Q
MM%DCT&\NQ:6^H?:%+,Q8HC&/&0C,, YSR#@9JW8^-[6X\':EX@NK9K4Z:UQ'
M=VQ<,T<D1(*YP,DX&./XA7%>&_"-IIO]FZ/>>#K^XU&TN@)+YKEUM=B.668'
M>03@*0FW.>..M7=>\+:K<>-+C2K:T=_#NN75M?7\HQLC,0/F(?>39#^M &O:
M:_:7?C[2$N])FM=3N=#^UF1KMBL$9;F-DX4L#_%C/:IK'QW<7;:==2Z')!I&
MJ2^387C7"EG8@F,O'C**^W@Y/49 S5;4]"OKSXP6U^+:7^SCH,MJ]R!\JNTA
M^7ZX.:P_"?A>UL7T33KKP;?G4["1!<7TERXME,8XF0[R&)(4A0HZG.,4 ;][
M\2[>S\!V/B;^S)I&NI&C-FL@WQE-YDR<<[1&YZ=JZ!O$49\56>AP0&8SV3WK
MSA\".,,JKQCG<2?R-<7IOA._?Q[J%C>V3CP_ ]Y=VTQ^[(]TB!D _P!G,_\
MWU4O@+3];TJQU?6-;T^;[;:6D6GVT1(WS16\9.Y3_MNQH ])KD$\97Z:E9K?
M>';BSTR]O#96]U+,!*7^8*6AQE5;:<')ZCCFNCTN_&JZ-9:@D9B%U;I.$;DK
MN4-@_3->00:)J2P:)>3^&-5FUO3]2BN-5OIFWM+AR#Y.6^<<@\  ** .MN?B
M+>I9ZQ?VOAJ6XL-&NI[>]F-VJ'$389HU(^;Y?F(X'.,DYQJ7?B^ZDUPZ7H6C
MG4WBM8[JYD-RL*QI)G8HR#N<A2<<#WK$71-3'P^\<V/V*7[5?7>I/;18YE63
M.PCZ]J+%-4\*>*+J];0]0O[;5-.LT4V:*QBFA5E*/DC:"&!W'CK0!I_"VZ>^
M\#0W+F4F2\NV'F_> ^T28!^@XI^K^,K_ $BXNYY/#MP=&LYTAGOGF$;'<5!>
M.,C+H"PYR.AQG%/^&]AJ&F^#(;;5+8VUY]JN7DBSG&Z=V&/4$$$5POB7P]J6
MIV_B2&;P[J%_K;WDDMK>2/\ N$M@P9%C^;&[:-NT#.XY- ':W7C+4F\0:QHV
MC^''U"XTORFE=KM8497C#@ E3\W4 >W)'%0?\+%6\&@+I&D37LVMVLL\"-*(
MO+:,J&5R0<8RV3S]W !R*R-,\07.G>._&-TFA:E>13_8F5+:(&6-_LZD(ZD\
M9SUY (.>U9>F6FI>$-6\"V]QI\MU<PZ=?O=6]MAG3S)(W(49PQ4L!@'H#C/<
M ZFX^)"V&@:A?:AI$T%[IM]%97EDLH<J7*[75@/F!5@1P">E6Y_%^JV_]G63
M^'&&MZ@TK0V)O$VI$@!,DD@!"_> P >3CFN3U+0M9UC3->U9=*N89-4UFQEA
MM)% E6"$QKO89XSM8X]*ZKQ+;7NG^,='\2VUA<7]M!;3V=U#;*&E17*LKJI(
MW#*8('/- $+?$06T+?VAI$EK<VNI0V&H1>>&%L)0"DH8#YD.5]#S6UJ'B1++
MQ18:%':27$US;S74S(?]1$F #MQEMS':!7,VWABY\3VOC.YU&SEL(]?$<5M!
M<8$D:Q1[4D8 G!W_ #8ZC J'POIOB>]TW7]?U*U>S\0W-BEC9I*1F/RXOO9Z
M -,S-^ H W=+\7:A<ZOI]EJOAZ;2TU.-WLW>X#N2J[BLB8!C;;SC)Z$=:ROA
M%/+/H&M--*\A77+M078G !7 Y[5AZ+H\MOXA\*:I;>%M5M_LK/#J5S=$M,\L
MD)7<06)*!N2W3YACO72_"_2;_1]%U>'4+62VDEUBYGC608+(Q&UA[&@#0U'Q
M3?#7[G1M#T7^T[FSA26[:2Z$"1;\[$!(.YB 3C &,<UQ'Q \5WNO>#_#T^E6
MEQ%9:GJD-M<C[5Y,N\.RM;MCD9*G+ ]JZ:1K_P +^.-<U(Z/?ZC8ZO';O&]C
M&)&CEB0H48$C (VD'IUKG;WPGK:>"?#-NUBSWX\21ZE=PQ$-Y"-+([9/3Y0P
M!([T >BZ<O\ 9/AA-UC]E^S0,QM?M!FV8R<>8>3]:Y./XF79T_1M4D\+W*Z;
MJ[)#;2)<JTIG=2539@?*2" Q(]2 *[C4XWFTJ\BC4L[P.JJ.Y*G K@4T+5!X
M&^'UF;*7[187MC)=1XYA5$8,6^A(H UHO'IM5UU-=TI]/N=(@CN&BBG$XFCD
MR$V' ^8LNW!'4CFIK?QG/:W%Q!XCT@Z2Z6,E_&5N!.KQ1X\P9 &'7<N1SUX-
M8/BOPKJ>N:QXL2"U)2[TJT2W9CM662*5W*9[9X&?>J\'A>PUFSU6VTWPEJ&E
M33:7/;B\U&=P5ED7;Y:J6;<.Y;@<#&<\ "ZQXFU?57\'376BRZ9;7NLV\L$@
MNA(70HYVR  ;200<<C@\Y%:5AXKT;2[CQM?&QN(?[,NE%TWGM*;AR,+L4\)D
MD# XR:S99M=UNW\'67_"-:C:-I>H6TE_)<*H12B,AV$$[ER2=PXQCUJM+X0U
MJ^M_B+#'9M'+?7\-S8F4A5G\LAP ?0E<9/K0!V%GXIU59KB'5_"]Y9R):/=P
M_9I/M0E"]8\J!B3D87OV-.T?Q1?W>M1:5K&AMI=Q<VK7=MBY$P=5*AE; &UQ
MO7CD<]>*R=6UKQ3XAT;5+?1M!OM,(T^3$MWB*8W!QA(L,>V[YNF<8K,T+21:
M>.=(U33?"VI6&G-:3VDLMSS,9&,;!I 6)"_*1N/4YXQ@D T?@K/+<?"S2Y9Y
M7ED,D^7=BQ/[U^YJQ_;^GV7CCQ4(].F^VZ?IL=S-,;EBLRA=P4(>%/'4=:7X
M1Z3?Z)\-].L-3M9+6[C>8O%(,,,RL1^A%9ESH6J/XY\<WBV,IM[[1D@MI,<2
MR",C:/?- &G9>/;N>30[BZ\/RVNE:TZ16UTURK.)'0LNZ,#A3@X.?3(&<5RN
MB7^H7GQ5\3ZCK>GN(=($!YU)O+T^/R68D( !)NQD\<5T=WHVHOX5\ VRVDAF
ML+RQ>Z3',2I"P8GZ$XJ"S\,ZA=^)?B5'/ ]O;:S!!!:W#CY7_P!'=&(^A- %
M^T\>7C+I5]J'AZ2RT?59HX;6Z-TKNID_U9DC ^4-QT)QD9J6R\;W>I:UJEE:
M:#(]MI=S+!=W;7*JJ[4W*5&,L2>".W!SS6"8]:U[0O#GAF70+ZSGLKBU:_N9
ME40(D!!)1P3O+%1C [\XQ6UX9TJ^M(_&@N+62,WFJW$UON'^M1HD 8>Q(- %
M&+XFW;:;HVK2>%[E=,U9T@MY$N5:4S.IVKY>!\I8%0Q(]< 5L:=XPNI;O6;'
M4]#FM=0TRW6Z%O;2BY-Q&P;&S &6RI&,=<5@1:%J@\ ^ ;(V,HN;"_L9+J+'
M,2H#N)^E3>(])U^37_%=WI$,R2W&A0P6LR-M+2*\A95;LV#P>Q(H U+;Q?JQ
MNY+&_P##GV._>Q>]M(OMBN)E0J&1FVC8PWKQ@CGK7*1^+9[WX7:+J_BC2WNC
M<7L"QM!>&(R,S'$AV 8 Z;>]3Z/H_P!G\9Z=J&F>%]1T_3I;"XLY);GF7S6,
M;!I 6)"_*1N/).>.A.2^C:Y>?"30M"&A:A%J&F:A;">.2, ,JNQ9T(/*@8Y]
MZ /0=0\57_\ ;UWH^A:)_:<]C$DEV[W2P)&7!*("0=S$#/8#(YYJD?B)'<P>
M'VTS2;B[FUM9_)A,@C,4D6-RN3D#!W9/^SP#D"HV>_\ "OC37[\Z-J&HV6KB
M":%[&,2%)(X_+9'!(QG"D'IR:S?#WA?5]+O_  6]W:D/ =2GO2A#+ \Y#JA/
MXXX[@T =;X9\1RZX^I6M[IYT_4-.G$%Q!YPE7E0ZLK #((8=A5+5_&-W9^+A
MX:TW0Y-0O39I> BX6)!&79&+$CC&T>N2P&.IJ3P]I]W:^,O%UW/ \<%W<VS0
M2$<2!;=%)'T((J./3;P?%RXU0V[_ &)M#CMQ/CY3()W8K]<$&@""Z\>2V\EY
M>)HKR:#8W9M+G4/M"AE8,$=ECQED5C@G(/!P#BIU\77]QJUU%8^'Y;K3K2]%
ME<74=POF*_R[F$6,E5W#)R#@$XKC5\(VEK>:CIM_X.O]5N;G4998;E+ETMI(
M99-^78/A2H8@C;D[1C.:T-=T^YG\1R3Z7X;U33_$(O(Q'J-I)BUN( R_-,<A
M2-F0592V1@9ZT :D_C_4&.MOI_AF6[M]%N9(;N7[6J9" ,3&"/F;'.WCMR<U
M=G\:R7=Y967AW2_[4N+FQ34&,EP((XH7^X2V&^9N< #M7)Z;JNH6EOXZL;30
MKZ_>ZU>[2VDME5D\QHT7;(21L ^4Y/&"?2KVDZ5J/@/5;*X?3;S4K231+6PF
M:Q02/%/#G^'(.U@QY'0CF@#4?XBQ_P!F:;<1:/<R7=WJ+Z9)9>8H>&X0,2I/
M0C*CG(&#GVI3X_EL[?6UU?17M+_2E@8V\=RLJS"9ML95\+CYN#D<=>:Q+#PY
MK"R:+?W%A)%+<^)I]5N(,AC:Q/%(JAR#C.-N<=S6IJ>G7J>*?%%Z^@G5;&YT
M^SA^SL5 N KR>8JYX+!6R <9.!D4 :4OBZ^TW3+ZXUKP_/:7$#1)!%#.LR73
MRML1$?"_-NP"".,@\BH)?'<NF6^J+KFCM97MC;)=)!%<+,L\;-L&U\+@A\ Y
M QD'D5R$WA:^U'2-5M]*TK5HM$ADL[FUTS4IBKR2QREI4BW,612FT#)'S=,5
ML:=I=A';ZM>:9X"O-GV18#'J,Y62[5FS)&J.S#  !!)&X\#UH [#1-5U6]N+
MBWU70WTZ6-5='2<3Q2JV> X ^88Y!'<=<U#K>N:O8WZVFD^'I=280&>65YQ!
M$HS@(K%3N<X/R\<8R>:P_ UA-9ZS?_V?8:MIWA\P1B*TU)CE9]S;O*5F8JFW
M;GG&>G2J_B?3;B\\93'4-#OM7LI+*--.2)R+>*;<_F&7Y@%SF/YB#P#CGB@"
M^WC_ .TR:'%I&D37LNLV+7ENK2B()MVY5R0=O#'GGD8 .::OQ"*Z%/<3:/*F
MK1:F-)&G+.K;[DX*@28 VE3NW8X /%8O@K1M5M=0\)?:]-N;<:;I%S97#2*
M%DWQXP<\@A20?:H[_0-9BDU/4X=-GG:T\5QZI' F-]Q (41BF3@GEL>NV@#5
MTC4]2O/BV\&I6+V$T>A9:!9_-C;,XPZL ,]QR >#[$]_7"Z.VIZK\39-;ET>
M\L=-_L?[+$UTH5V<3!CE03MZ\ \\9[UW5 !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLG4C!<?&G2[5_+D_XD=SYD3 'Y6D0<CT.#7&>'K.UB^!?BZ>.VA2<G4(S(J
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MK;F8.IBE*%%X0Y /OBH-%U6;QUJGA"QN0=VDP-J&J(W:YC8P(I]#O$CX] *
M/31J=@VH'3UOK8WJC<;<2KY@'KMSFL/P]XHEUKQ/XETF2V2)-'FBB216),@=
M2Q)],8KSKP[H^M:EX9TJ_,?AVUD_M07+:A-.ZW1F%P=ZGY,%F^9-N>A J#5)
MIX$^+[V[NC>;:JS)U$97#G_ODM0![-9ZMINHR21V.H6EU)%_K%@F5RGU /%,
MEUS2(6C675;&-I6*1AKA 78'! YY(/%<;K>FZ9I'BSP,VB6MM;3/<R0 6Z!?
M,MO(8L#C[RC"'GOBN?\ "NBZ!??#WQ?<7UK:S2?;=0$\LJ!FB"EBH!/*XSN&
M.Y)[T >LW.H65F3]JNX(-J&0^;(%PH."W)Z9(Y]ZKOKVC1VL-T^K6"V\YVQ2
MM<H$D/HIS@_A7EOAZU76?$/@ ZO"+EQX;>5EF&X,08]I8'KU!Y[X/6K&C>'=
M'D@^(XDTZV=8[R>.)&C!6)?)5B$'\/S'/&.@]!0!ZC>:A9:= )[Z\M[6$D 2
M3RJBDGMDG%.>]M(UB9[J%1,"T9,@&\ 9)'KQS]*\?TA-4U.[\&106NF7Q3PN
MDL4>JNVS<2BNRX5LMC8/H33VT'R[KP-I.I/875O_ &Q?%8K.0R0HFUV$.2!D
M*<J5(Z#!H ]6AUO2KFTENX-3LI;:$XDFCG5D0^[ X%5/#/BC2_%FDQZCI<P:
M-\YC9E\Q,,5&Y03C.TD>U<@=-L;;XJ:W9P6=O':W/AV.6:!8@$=Q*X#%<8)Q
M5CX+VMM%\+=&GB@B2::-_-D5 &?$K@;CWQ[T >@4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$DY&_))48Y %<A;Z]97O@GP)HUL99-0LM2TV.\A$3 VQC=5;S,CY>> .IZ]
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M=:8--6^^RZD4EN?LUI']D;S+MMNX-$O\2D G=P, UYKJEU"/ /Q+T8EAJ/\
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M5Y=WM@E_!;VT(9FB8]\L ",<Y('3G) IK_$71$T:RU)DO=EU>-8"#R#YT=P
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MM;SW7PRUJ*WADFDV1OLC4LQ"RHQP!Z $_A7944 <-IUY#K'Q1MM6LA))92Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.Y^I-=3X7\//J'B36M2EMM7AL;K34L&GU3Y;FY<LQ=]I^Z I51P!QP*Z#_A
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MF"W6]G#K AQD* HR?E RV3QUKH: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\-] AGB>*5+10R2*593SP0>E &3XK\>HF@^)H]-LM4(L8)[=M4A1?*AN AP
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M406[1$[@S;NX7(P#P1G&:-/\>VE[=:?'/I6J6%MJ3;;&[NXD6*=B"P'#%E+
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MDQN0C[A@G!ZC'(/'>KMIXQM=+?QU>KH]M%)IM\D1,)V->2-A4+D]"68#/84
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M:/ P,#'7J0>G&<SQ)9:GJ_QMTVUGM-(O((M,DGMH;P.\87S,%B,']YZ8XX%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXYH Z&BJ>E6][::5;0:C?"^O(TQ+<B(1^:WKM' ^E7* "BBB@ HHHH ****
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MJ]G%K<&CM(1>SP/<(FTX**5!.>G5A5ZO/O$MC<ZC\5=$MK>_GL5;2KKS9;?
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M]*SQ[1#G V\$Y^M8?PUT.)-0UWQ'%%/'9W]RZ:;'.I4I;;RY*J>55Y&9@#V
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MK<^('E.KK;M<LUJ,B6&0,&7#8"[1MV\]CDG.>SM+V.YTZUO'VQ">-'"LW0L
M<9[]:LEE7J0.,\F@##UCPS%K&N:?J,UPRI:6US;-"%_U@F" G=GC&ST/6L&V
M\ ZI$FAB;Q,93H<B?8@+(*OEA"A5QN^9BI W9&,=.37<JZN@=&#*>00<@T)(
MDB[HW5E]5.10!X7K=O%)X>U#PAINL:@S->F.TT*2PV3(QFW?-(,[H1DN#QP!
MD]J]+U#PIJ3:OJ%[HNOMIBZD$^V1_91*=RKL#QL6&QMH Y##@'%=2DB2#*.K
M#.,J<\T/(D2[I'5%'=C@4 ,2'9:K!O=]J!-[G+'C&2>YKF;3P/;P?#R'PC+>
M2R1PQ!4ND4(ZNK[U<#G!# '\*ZIF55+,P"@9))X%4=3UFQTFUAN;N8+%--%!
M&5YW/(P50,>Y'X4 9$'AW6)K;48]8\0F]:ZM&M46*U$,40((+[-QW/SUR!Q@
M 51M_ <VG:)H%OINL&#4=%C>*&[>V#I(C_?5X]PX.%/#<%172_;+W^W!:_8%
M_L[[-YOVW[0N?,W8V>7C.,<[LX[5>R,9R,>M & WAE[WPG?Z)K&I2Z@]\DBS
M7#H%P7Z;%'W0O&!D].M9MKX BA\#7_AV?4I9[B_D>>XOS& [S,P8/MR1QM48
MST6N@34+M=1OTNK%(-.MXU>*\^T*WF\9;*8RN/4GFJ_]NRWVD:7J>B60O[>^
M>)COF$)CA<9,GS#D@8^7J<T 8<G@?4[O4QJ=_P"(Q/>/8SV$VVR"1F&0# 1=
M_P I##<22<YQP,8T)?""2:%X;TO[:P&B36LHD\O_ %WDKMQC/RY_'%=(TB*R
MJSJ&;[H)Y/TH9T5E5G4,WW03R?I0!SNB>&+G0_$.KWT.J"33]2G:Z:S:W&Y)
MB%!(DW<C"],=^M/\8^%AXLT>.T2]>PNH)UGM[J--S1, 0>,C.59AU[UT-% '
M-7O@^%_#^DZ;IUTUC-H[1O8W(C#[&12GS*<;@RE@1D9SUJ"Y\(7^IZ1):ZKK
MTEU<R7L%V9%MPD<8B=6")'N.T';R22<G/M7644 8&I^%K?5M?&I7,Q,1TV?3
MI+?;]])64D[L\<+C&.]8,/P^U)HM$MK_ ,3O=6>BW4,]I$+-4)$?"B1@WS';
MQD8ZDD$].]HH XF[\"7S#5K+3O$#66CZM*\UU:_90\BF3_6".0L-H;GJK8R<
M5K6?A2WL/%46LV\Q2*'2DTN.U"<*BON#;L_AC'XUT%% '(W/A#4[V[2&\\1/
M/HZ7JWJVLEJ#,"LGF*GG;ON!@/X<X&,UJ>)M!?7]/MXH+S['=6MU'=V\YC\P
M+(AXW+D;@02,9'6MJB@#B4\#ZK'J-_J2>*9TOK^&$3RI;  2Q.2A5=V!'M8J
M4.<CG=GFM?0?#]WIVI7^J:GJ2W^H7B11,\5N((TCCW%0%W,<Y=B22>W3%;]%
M '+:AX3N[GQ!>:C8ZRUE!J,$<%]"+<.[JFX QOD;#AR,X/J,&N1MO"^IZ3XV
M\/Z39ZUMGT_0YU@NFM 5*"6-0CIN^;Y3U!'(!XZ5ZO10!Y9XE\*2:7HVDP-J
M4T^HZAXGM[JYODC"$2MD!E7D*%"K@'/2NB'@F[NYM7N]8UD7E]?Z<^FQ216H
MA2WA;.<)N.XDD$DGL!Q78T4 <U>>#XKOPCIFB?;9(I],6W:UO40;DEA "OM/
M!Z'(]"16/J_AF\M](\1:YK&J#4M1.C7%I"8K;R(XH]K,0%W,220,DGL!7>T4
M >>^'/"%]>Z1X6EU'6VN-,T^*"[M[+[,%?S!'\F^3/S!<\#:.@R3BNET+PTN
MB6FKP+=&;^T;ZXO22FWRS*<[>O./6MVB@#A-/^'4^C^'/#UAINM^5?:)),\-
MW):AU<2[]RM'N'9^H;M3+CX;SW&F:U9-X@E8ZE<PWWG/; M%<IL)?J 5)0?)
M@8Z9KOJ* .1F\*ZTM]_:=AXCCM=2N+9+>^E-@'CGV%BCJF_Y&&XCJ1CJ*Z:P
MM6LM/M[5KB:Y:&-4,TS;GD(&-S'U/6K%% '"Q?#IUTO5-+DUIVL;F\-]9[+<
M++9S&3S V_)WX;L0.,UJ:7X8OH_$":WKFKKJ5Y!;M;VPBM1!'$K$%VV[F)8[
M1SGH.E=-10!C:WI>JWL]M<Z1K1TZ:$.CI)!Y\,JMC[R;E^88X(/<]<U@_P#"
M 7%K%I,^FZV;?5=/EN96NI;42).;AMTH,89<#=@C!XQWKMZ* /*O%GA&32?#
M-_YFJ7%W-JVMV,TLVP(Z-YD:$KC([9''' YQ6[>^%[Z,:IKFLZP-2NH=+GM;
M5([40+$K#+$C<VYCM49X''2NXHH \U\*>$+[4?"WA(W^MM+I-I#:WL=C]F ?
MS%0,JM)GE%8\#:#P 2<5J7?@2^8:M9:=X@:RT?5I9)KJU^RAY%,G^M$<A8;0
MW/53C)Q7;44 <_9^%;>P\51:S;S%(HM*32X[4)PJ*Y8-NS^&,?C4>E^&+G2?
M%FK:K!J@-CJ;K-+9-;C<L@0+D2;NF!TQ^-=)10!S.N>%KK4O$ECKMAJYL;RR
MMI((P8!*C;V4G>,C(PO08YP<\50'P^#Z-<17&K2OK$VHKJG]I)"%V7"X"E8\
MD; HV[23P3SS7:T4 <I9^#YY+Z^U'7-5_M"^NK(V"O#;B!(82<L%7<W)."22
M>@JMHW@:[T^+PY'>:V+Q=!D?[-MM!%NC,)B"-\QY&<[N_I7:44 8]AH2V/B7
M6-9%P7.I);J8MF/+\I6'7/.=WZ4?V"O_  F?_"1?:#N_L_[#Y&SC'F;]V[/X
M8Q6Q10!Q\O@-)?!.J>&_[08+?W,MP9_*Y3?+YF-N><=.M2ZCX4U)M7U"^T77
MVTQ=25!>)]E$I+*NP/&Q8;&V@#D,. <5U=% '*7WA*_&NKJ^BZZUA<R6B6EU
MYUL+@3JA)5^2,.,GGD<]*S?^%9Q#PWI>C#5I2NGZR-569X@S2$.[;#S_ +?W
MO;I7>T4 <?J?@W4)=4U.[T;Q ^EQZJJB]B%L)26"[-\;$C8Q7 S@] >M-E\#
M7"7]TUCKDUM87UM#;7L+1"2618U* K*3E25."<$]Q@UV5% '$Z;X DL]0\*7
MD^K^>_AVWFMHP+;9YR.FQ<_,<%0!ZY]JVO&'AQ?%OA2^T)[HVJW:J#,$WE=K
MJW3(S]W'6MRB@##MO#BVWBA-:^TEF73$T_RMF,A7+[\Y]\8Q6)J/P[CU#PMJ
M>AG4V1;[5'U$S>3DH6E\S9C=SZ9S^%=O10!SFM>&KJ[UV#7-(U1=.U*.W-K(
MTEOY\<T1;<%9=RG(;)!![GK6>OP_B&FV,#ZE))=0ZRFLW-RT0S<S Y(V@@*"
M, 8S@ =:[.B@#'ET%9/&%MX@^T$-!8R6?D;."'=6W9SVVXQCO65+X'23POXB
MT3[>P76;FXN#+Y7,7FG.,9YQ]1FNMHH XZ[\$7,^HZD]OKCVUAJL4<=];K;@
MN^Q/+^23/R94 '@GT(-16W@74+.Z\.WD&OJMWI-H;&1S9 K<097 V[_D;"@;
MLGUQVKMJ* .*B^'-J-+\1V,U_*PUG4GU%940*UM(6#+MY.=K*#GC-6[/PG?R
M:S'JNNZTNHW-M;R6]H(K00)$),!W(W-N8@ =0,=JZJB@#DQX(0>#=%\/?;VV
MZ9+;2B?RN9/)<-C;GC.,=3BM7Q+H8\1:%-IOVEK9V>.6*=5#>7(CJZG:>HW*
M,CO6O10!PMUX!U#4+F]N[[Q%YUS?Z9-IMR19A4V,#L\M=_R[22>2V[)Y'&-N
M[\,+=+X=4W97^Q9TF'[O/F[8FCQUX^]GOTK?HH \\OOAG>76AZCX>A\2/!H-
MU))+':BT4R1%GW[?,W<H&.<8![9Q7H2C:H'H,4M% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'G>J:-INN?&86VJ6\5U GA]9!;3#<CL+A@"5/#8R<9]<URL=A#<0:;H3ESI
MEKXUGM((PY^6 0R'RP>NW)9?IQ7;ZKX3;6?B0=0N8[J*S32$ABN[:X:%TE\Y
MR5#*0WW6Y['-;5MX0T2SL]-M8+5EBTZY-U;YD8MYI# NQ)RQ.]LYSUH X*^@
MTGPQK'C6RM[22VTN73+-C::>1%NED>2+Y.R%OE!/XU7CLY-(UOQ!8#1-/T2*
M;PO-,]G87/FJY5BJNXV* V"PSSGUKTC4/"FCZK+J$MY:F1M0MX[>X/F,-R(2
MR8P>""Q.1STJE%X!T*.;[05O);DPRV\L\MY*\D\<BA661BWS# & >A (Q0!Y
M]/X>T^R^#N@W%O$8[S49-*:YNE8B5R73'S=1MW$#T%;(\'>'T^*YTQ-+METR
M31!<RV00>3+*LQ17=.C, QY/UZUW$OAG2IM#LM&>!C8V1A,$?F-E?*(*<YR<
M;1UZU9_LBS_MW^VO+/V[[-]D\S<<>7NW8QTZ]Z /*-*2UF\,Z7X?;2SJK+K=
M]'96$MQY=OY<+R?ZTD-E%!&%P><<<57M [Z:N@7,$-KILWC'[%/9VTQ>%(O)
M$AA#87Y#)VP.I%>DS^!M#FM8H%CN;<Q74MW'-;W4D<J22$F0AU.0&R<CI31X
M \.+:7MHMG(MO>-'))&+B3 D0 +(O.5?@98<G')- '*^+=&T?0--N-/T:<6<
M&J:C80ZA8V\H1((7DVLRHO,>\#:3T./K4FK>%M(L_&^G:)IEE#966MZ5>V]_
M;VR!$95";'*CC<"Q ;KS756_@?08-,O["2VENX]0Q]KDNYWFEFV_=R['=\O;
M!&.HJ;1_"FF:)>R7T!N[B]DC$)N;RZDGD6,'.P%R<+GG Z]Z /.[:^N/%&A>
M%?!EV=UW'>/%JZ]?W5DPR&_WV\KG_:JAJ=Y<6%Q\8;BUE:*8?8U$B'!4,A5B
M#VP":]7LO"^D:?XBOM>M;79J-\H6>7>2"!CH,X&=JYQUQ5:[\+6$,/B*YLM/
MBN+W6(L7,5Q(WESLJ%54]=HP<<>M '):AX:T3P[X_P# B:/;168DFN5>*'@3
M!;9\.P[L,XW=3NYKE3_R23XH?]A^[_\ 0XJZ?P_X6NI/%.@WH\/W^E0Z4LC3
M2ZCJ NF9C&8UBA.]R(QN)_A' XS78?\ "$:#_8VK:3]D?['JUR]U>)YK9>1R
M"Q!SD?=' H Y"_M;36[[2[ >'K?6[FTT6*21=0NO*MK=). 0-CDR'8>0. .M
M9&AVD/B'_A6L.J#[5 ^FWOF1R-N655\H*K?WAP.#UP,UZ->^"M%O[JWN)8KA
M7AMUM2(KF2-9H5.1'(%(WKG/!]3ZT_3?!VC:3/9S6D$JM9&;[,&G=A$)<%U4
M$\+\HP.W;K0!YK=01:>-;\.VB_9M&F\565K)!$2JI#*D;2(,?=5FXP/[Q]:V
M?&>C:5X6\/:R/#Q2SN+U+2.?3K>=84$;3K&9 H&4+!F0N../45VMSX3T6\AU
M6&XL_-CU619;M6=OF=5558<_*0%7!&.1FJ]GX(T.TL[^W>":\_M!!%=2WMP\
M\DJ#HI=B2 ,\8QCKUH P_">A:AI7BV2XC\/V&A:;+8F.6UM+P2"257&Q]H1<
M$*7!/?BI/&,-MJWB?3=+&@Q:W>16LMR+>]N!%:QH65-[#:VY\\#@XYKH-%\*
MZ;H5S+=6YNY[J2,1&>\NI)W$8.0@+DX7/.!^-&L^%=,UV]@O+L7,=Q"C1"2V
MN9(6>-B"48H1N4D#@T >9:$JZQIG@71-25)M+FO-2$ML9#)%)Y#2>3&2<;U4
M= 1SL'%6_&OA;PW8Z;8V5E'!-$/$=H'LV976T\UEWQJN,HK@ E3P<^E=L? 7
MA_\ LQ]/2VFBM_M1O(1%<.AMI3DEHB#F/DGA<#D\4K> ] ?09=':WG:&6X%U
M),;AS.TP((D,N=V[@<YH Y2;2[)_C@-)^SQK8MX1-MY"+A1&9]NT#L,<5DQ7
M%QJ?A#2?AW/(S7PU1M+O#T)M+<B1F'L8_*'ONKTVT\+Z99ZU!K").^H0V0L%
MGFG>1C"&W8;).3GG<>:6'POI%OXHN/$<=KC5+B+R9)MYP5^4?=S@'"J,XSQ0
M!YU+9VUUX^^)EM/!')!_9-M^[=05^6$D<>Q /X5EW^GV=A\+OAL;.UA@-QK&
MFSS>6@7S)#&<LV.I.!S7K<?AO2HM8U/51;$W>IQ)#=,SDB1%7:!C.!QZ5FP?
M#[0(-+L]-\N[EM+*\2]MHYKN1_)D084+EN%']WI0!PFHZ7J'B36/&#_\(_9W
M]S%=&UMM0N+\0R6(6%&0QC82N"V_((R3[5:\0Z)/!/=ZYK^AV^O6ILH/M4]O
M.!=:8T<>9&B!QQGY\J0?KQ7;ZKX(T36;^:\NH[E7N%5+J."ZDBCNE7@"55(#
MX''/;CI3=2\#:'JEY+<S1W4?GHJ7,-O=R0Q7"J, 2(K , ./IQTH Z"WECFM
MHI8G+QN@96/<$<&I*H6^C6-KJ]QJ<,12ZGAC@<ACMV)G: O08R>E7Z "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **Y7XD7FMV
M'@#5;GP\LAU)(UV&-=SJNX;V4>H7)KSSX!:[XLUA]576;F]O--15,4]VS,1+
MGE59N2,=1VP.F: /;:*** .7\0>+Y](\06>B6.B7.J7EU;O<*L,T<855(!R7
M('<4FF>-8KG6HM%U;2K[1M2G5FMXKL(R3XY(CD1BK$#DC@UG:E_R6O0O^P/<
M_P#H:5'\0Y8[K7/!NE6S!]4.M0W:HOWD@C#&1CZ+CCWH ZRSO[N2]U)+R"V@
MM;9U$,J7(<NI&277 V8],FKGVRUVRM]IAQ#_ *T[Q\G?GT_&O&;O_4?&;_=3
M_P!$M6GK.B0Z?I/@W3],TJRN$U"Z62\CN7\I+V5;=W7SG"L6)8%L$') % 'J
ML=Q#+ )XYHWA(R)%8%2/7-9^I^(=+TK0KG69[N-[*W1G9XF#9P.@P>3[5Y?J
M&DW^G0-87]KIUCI.J>(+%)M/L+DR1QHP/F*WR+M#LL?&.=Q]:O?$;P[X9TSP
M;XJ&GP6D-VUG%/)91!0D95BJS",#Y6.67<.N* /4H)XKF%9H75XV&0RG(-,^
MVVGFQQ?:H?,DSL3S!EL=<#O4>F65KI^FP6UE;0VUNBY6*&,(BYY. ..22?QK
MQ6'1=(7X&ZEK8MX?[6@GN)HKS:/.AE2Y;8%;JO0<#^\?6@#U:T\3PR^(=<TR
MZ$5K'IC0*)Y)0!(98]_?&,=.IS6U/=6]K%YMQ/%#'TWR.%'YFO/-*\/Z7KWQ
M"\8OK&GP7;*ED@CG0.J;H/F(!Z'@<]>*P?#A&M^'?!FG#1K36-1ATJ2<?VG.
M5MX8MXCR5VMN;@ <<#//- 'L33Q*J,TJ /\ =)8?-QGC\*B.H60A\XWEN(MN
M_?Y@V[<XSG/3/>O%K>UBU7PCX$L;K8]LWB&Y@*1.60Q!IQL!X)3:-O\ NUUD
MGAS1I_BW#82Z9:M86WAX-%:&)?)4_:& .S&.,G''>@#OS>VH>%#<PAIAF)?,
M&9!_L^OX4LMW;02QQ37$4<DAQ&CN 7/L#UKP]M"TRV^#VLZC':1?;K/4Y1:W
M++F2W6.[VHJ,>54#/ XY/K6QXYA@U1?&EY:Z%ITWV"V\BXU+4+DB2.18=X%N
MH1MI7>IZKEC^- 'K$]U;VH4W%Q%"&.U3(X7)]!FEN+JWM(O-N9XH8\XWR.%&
M?J:\YT?3['Q3XTU1/$-K!?\ V?2+$6T=T@<*LBN9'4'N6 !8<\"H]+TS1=3\
M>6&F,\>KZ/8^'U?3A<L+A&)F9'?GAB JKGL* /2Q/$3&!*A,@R@W#YA[>M1W
MER8+:8P^4]RL3/%%)($#D#C)[#.,GM7CIMSI>C:GJ]@A^S^%/$\LELB=%M2$
M$\2^BC>YQVVULW6WQ!=^._$8(>ULM,FTBR8=#MC+S,/^!D+G_9H ]"L[]CH\
M%YJ7V>TD9 90LX>-&/8/P"/>DU.^FM]+N9].2WNKJ)04BEG$:$G&,M@[>#GI
M7E?ANTMM5B^&>FZE#'<6']DW%PL$RAHY)E6, E3P2JLQ'UK/UVSL[#PQ\5K3
M3PHM8IK9413\L?R)E!Z '( [8QVH ]-O_%<MAXN\-:"]DC-K$4[O*LW$)CCW
M8 Q\V>F>*Z$7=L;HVHN(OM &XQ;QOQZXZUYC>_\ )1_A=_UX77_I.M9-P$E_
ML;Q!8:)IUG;7?B.(Q7\MRSWTY:<JV?DX5AN&W><+]* /8Y+ZTA($MU A9]@W
M2 9;T^OM3KBZM[2,27,\4*$X#2.%!/IS7E*>'M)U/2?B3>7UC!<W"7UVL3S(
M&,6V!&!3/W3DYR,'@>@JQX>M+7Q+XGT^'7[>&_2'PQ9S6\5T@D4M(3YLF&XW
M':HS0!Z=/<P6T/G7$\<47]^1PH_,U(K!E#*001D$=Z\DN;"*3Q-H6CZ'::?K
M^E6>F7$EK#J-YF(,)@C$$(X8H/D (X!-=MX#TZ]TGPXUE>_95\NZF\F*UG,R
M01ER1$&(!^7)7IQ@"@#H&N[9+E;9KB(7##*Q%QN(]0.M$MW;P2QQ37$4<DAQ
M&KN 7/L#UKQOQ.([BPUG7K#1-/ACBUE%_M2YN6-XTT<Z1DQ#8=JY4J%W#C)Q
MS706>BZ+XCU;QS-XDMX)9(+O[.)IP-UK;+ C*R,?N<LS9&.>: .W77].;Q"^
MAB=?MR6ZW!3(QM+%0/KE3QZ4:/J%U=V@?48;6UN&E=$BAN1*& Z$' YQU':N
M(T32](?XP75Q#;VUR%T.UGANF179V+N/-W8Y8J!\W4UR>@6LJ_"(:[:H6O-"
MUN;48PO5D20^:OT,9;\A0![A<3B&-@IC,Q1FCC=PN\@?R]^U8H\40V.G:5)K
M?D6EWJ$P@6&&<2H'.X_?XRN%ZXKE4EB\4>)O$FOQ,);#2],;3[)QRK2.GF2L
M/< QK^=<GI6FV%]X%^%GVNRMKC?J/E-YT2ON0B8E3D<C(!QTX% 'LL%[>2ZY
M<VKV]N+)(E>*=;@-(['J#'C@>^>:N175O/))'#/%(\9Q(J."4/H0.E>2:K-/
MI_C[X@SV&8Y[?PTK0^6,;"J'&/IBK.@^'=0M[SP_>PZ;H>B6B6DB375I?%I;
MF)H2<L#&NXAMKY).,$]Z /4HKJWGDDCAGBD>,X=4<$J?<#I5'5=>T_19;&*^
MG$;WMP+>$9'WB"<GT&%/-<+X1TV+PUKNBZ;J.@6$-XUM)#9ZSILOR7H50S>:
MN =Q W9;<,YP:N_$;3;"^U_P7]LLK:XWZMY3>=$K[D,3DJ<CD9 ./:@#H=/\
M4076L:W8W/DVT>FW$4"2O, )B\2R=\8^]C'/2MJ6Y@@!,TT<8"EB7<#@=3SV
MKS:S\-Z/JOB?Q^^H:=;W7ER111+-&&$0^RIG8#]T].1SP/2L32-/M_$%_P##
M6#58Q=P-H4S2Q2_,LNT18#@_>&0#@]P* /8I;ZT@$9FNH(_-_P!7OD W_3/6
MI3(@D$9=0Y&0N>2/I7G>C:%H^N>*_&*ZSI]K<FUFALX8IXPPM[80*5" _<!)
M8Y&/TK&\"7,]SJ?@26YD>1SHU]&CN<ET6:,(<]_E"T >N>=$%D;S4VQ_?.X8
M7OSZ51U'5X+31;S48'BN/(M9+A4208<(">HSQD8S7E%^8KR?5K*1@]C>^.(+
M:[7/RO'Y4>4;V+*H(J]K.EZ9I/CS7X-,@AMD?PA<R26\"A45BX&X*. 2 ,XZ
MXS0!Z/HNM0:OIEA<;XH[FZM8[EK82!F0.H;IUQSUQ4NKW5W9:5<7%C!#<7*
M&.*>;RD8Y'5\'''M7F2:'INDZ!\-]1LK.&&_EOK-9;I4 ED$D#[PS=2#Z'T%
M=)\8/^24:_\ ]<4_]&+0!UQO(8+>&2\FAMVD &&D &XCH">M9F@^(EUBUU.X
MFB2U2QU">S+-)D$1-MWDD#&?3M7(V6GV6M_$.WM=7M(+N"U\.6[VT%Q&)$!=
MV#N%/&?E49]*Y.Q@=K2PTG3[2VO[&3Q5J %M=SE(9O+5S&KMM;(XW $')44
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMOAUX6M)HI(M-;]Q,L\"-<RLD#JP<&-2V$^8 X  /3I74T44 %%%% !1110
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M,5O9-);2!(\J,J2?E"L<G:>*SK^]M6^!?B_3UN8C>V^H3F:W#CS(P;L8++U
M->XI8VD:%$M8%4OYF!& -W][Z^]!LK4M*QMH=TN/,/ECY\>OK0!P%O?6>B?$
M>&[U>YAM+>[\/P16MQ<.$0LCL9$#'C/S*<>GTKGK14NVTN^10UA?>.I+JS8C
MY7C\IP'7V+*Q!_&O89[6WNHA%<0131@Y"2(&'Y&GF*,A 8T(0Y08^Z?;TH Y
M#3QCXOZWCOI%H3[_ +R6JVJWEKHWQ;L]0U6XBM;*XT5[:WN)W"1B83!V7<>
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M 8@?,1DD UZREM;QH42"-5*A"%0 ;?3Z>U)'9VL*Q+';0H(L^6%0#9GKCTH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-7VC<5L!G';RFKA/!U]:Z"G@;5M6F2VTU])N[1;B4XCBF,RL 6Z+E5(&>N*
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MXN=BRRE(D\N4!54;-Z !@,$8]>0#U.\UJQLM5L=+FF9;R^$A@14+9"#+$D<
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MM&C@!D4@'(!'>AHT8,&12&Z@CK3J* &^6FX-L7<!@''('I2@!1A0 !V%+10
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[2NY".H.#G%4;_PWXCU+0O%/F:28KK4=8M+N" 3(3Y2F'.3G&0$.?<'&1@D
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MVT<S37$L\D;++*T9C58MK$E?F)R0. .,UG:?X.U6X^"3>&IXEM=4/FNB2,"
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MW%P)SF\Q 752,83 &W(SZU;L_&FJM?Z$VH:'%:Z9K;>7:RK=[Y8W,9=?,3:
M-P4]"<=ZR;KPQK,FO?$^X6R8Q:QIL4-@V]?WSBV9"!SQ\Q YQ6QJ.B:C-:^!
MTCMBS:==PR78W#]TJV[H3UY^8@<9H ;;^,]8OF_M&P\/?:M ^V&U$\5P6N'
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MS;!(R1+M(8JA!Y(Y.*;/XTU&\U&>#P[I%OJ,5M:0W<OFWGDRRK*I91$NT@G
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ML=]+&^A7-J(]UN&8*\;XW.Q4*^02.2,"I=&OO%OB.R3Q)IVIVR6LEXZQ:5+
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MV7[01 FYGD>1=D:EE(4,!DCBNNA\!6:ZA)?W.J:G=W4]I)9W;S2)_I,3C[K
M( H7J-FWOG.3F"W^'<-I9Z;#!XAUE)M-5XK6Y#Q&1(655,7^KVE<(I&1D$=:
M '?#:YN9_#][!<BX7['J5S;11W,PEDB16^5&?)W%<XSD].M=C7+6'@:STR&2
M"RU3588'OH[_ ,M+@??7!8%MNYE<CY@Q.?:NIH **** "BBB@ HHHH ****
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MU]IX/A=\0M->UDLX+.[MQ#9O<>=]G#B%BH;)XR2<=LT >XP2BXMXIE! D0.
M>V1FI*X?2I9/^%G)#YC>7_PC5NVS/&?.<9QZUS-O<07VBMIUS'J.HRW7B2_$
M-C:SB,7"H[DK([$8C48.,]0HYH ]4U'4;32;&2]OIA#;1E0SD$XR0HZ<]2!^
M-1RWMS'K%O9)ITTEM+&SO>!EV1D=%(SG)]A7B^L6PN?AIXCM+NUE@33?$$,5
MM;/<F7[.K- 2@8'D?O'QZ9]JZZ[A73/C)X6TVS,D=FFE7.(?,8C@G&<GG\:
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MUMIMD\T$5K;V.FY,4$2%FZE5R2SD_='XUU#V-K)>Q7KVT374*LD<Q0%T5L9
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M9P1SW9!N)$C :8@8&X_Q8''-5-,\,Z%HMS+<Z7H]C9SRC#R00*C$=<9 Z>U
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M?PJAXL5(M"^)**%2-=7L7P. "1;EC^/>O7HM*TZ V9BL;:,V49BMBL0'DH0
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MC+96[WT"E(KAHP9(U/4!NH!R?SJOJOAW1=<>%]5TFRO7A_U;7$"N5^F1T]J
M//;32KC3K*SN-%UW2-1N[;0H;>[MK]"([FU!=HW5LY3(+#G(/&>E6/#]]:7O
MQ*T2\@MUL[>Y\((\%N<#RP9D(0?0<?A7<:GX9T+6G@;4]'L;QH!B(SP*^P>@
MR.GMTJ6[T'2+^ZL[F[TRTGGLB#;220J6A(P1M...0.GI0!XMI^P>#]4-SC[
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MI*BNH<88 C/([&I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BH+R\M
MM/LY;R\GC@MH5+R2R,%50.Y)K/T'Q3H?BB"6;1-2@O4B;;)Y9.4)Z9!P1G]<
M4 :]%%% !17':QK.H6WQ2\-:3#<E;"[M;J2>':,.R ;3G&1CV-=1J%];:7IU
MS?WDHBMK:)I97/\ "JC)- %FBN9TSQG#>WBVM[I6H:4\ULUU;?;%3]_$N-Q&
MQFPPW E3@\TW2/&T6IZC:6D^D:CIRW\336,UVJ!;A5 )X5B5."#A@.* .HHK
MR_Q1X_DU#PK]JTNRU6TM+B]MXK34QM5)@+A V-K;U5E#8+  CCN >W\5ZQ-H
M'A74]5M[5[F6UMWE5$V\8!.XY(X'4]\ X!/% &S17F,WC'4WU'P/>S6.I1O?
M6]R9+"(IFZ?RHRK!0Y7;DD@L1@9)Q710^/K Z1J%W=6-]:W5A<K:36#HK3F9
M]NQ4"L0V[<N#G% %C5_"]Y?ZC/=V/B34]-6YB6*XABV2(0,C*!P?+;!/*^QZ
MUL:3I=KHFD6FF6*%+6UB6*-2<G &.3W-4-#\1KJ]W=V,^GW>FZA:JCRVMUL+
M;'SM=2C,K*=K#@\$$&HM9\5)IFL6^D6NF7NIZC+";AH+38/+B!V[V+LH&3P!
MG)P: .@HKSGPSXT\K1-2OKD7]]-<Z_<VMA:8S,W.5C <@*%4$G) 4 ULKX_L
M%^SI=V%]:7#ZBFFSPRJFZVF==R%R&(VL",,I(Y% '6T5BZCXGL-,UVVTF<2&
M6:VFNY)% V00QXR[G.0"3@8!YJCI'C6#5+^SMI=*U&P34(VDL)[I4"W*J-QP
M%8E3M^8!@"1F@#4U[2[O5]/^R6FK7.F;VQ++;(A=D((*@L#M//4<C%6-*TRT
MT72K73;&(16MM&(XTZX ]?4^IKSWP/XO:P\#7^IZU<WE](-9FM8$R9996+A4
MB0$^_ R *Z2'QQ O]I0ZEI5_IU[8637[6L_ELTL*YRR,C%3R,8R,$B@#JJ*X
M^P^(-I>7.E^9I.IVMCJK!+*^G1!%*Y7<%P&++D X) !QQQS5>Y^)MC;PWUT-
M'U66PTZ\>TOKM$39 ROL)Y?+#H?E!P",XZ4 =&NAQ+XLD\0><_FO8K9>5@;=
MH=GW9]?FQ6K7,:=XT@O==@TN?2]0L3=P/<64]TJ!+E$QN(PQ*G# X8 X]*CT
M[QY::A>62_V9J$&GZA(8K'4)E00W# $@ !BR[@I*E@,XH ZNBN&D^)UBME-J
M*Z-JKZ9:W#V]W>!(]ENRR;"2"^YAT.5!P".^0+%MXMU"?XE7GAW^R;G[%!:Q
MOYX\O"LS/^\)WYV$   #.0<@"@#L:*R/$'B&V\/V]NTL%Q=7-W,+>UM;909)
MI""<#)   !))(  K$NO'$C:-K8AT;4(-9TV'?)92^474,I*R []C)P<X.>",
M4 =E17 ?"2XO[[PI'J&HMK$MQ=1I(T]_<+)'*3NYA4,=B^Q [5I7OCR*#5]5
MTNRT/5=2NM+*&Z%JD>%5D#A@6<9R#@ <D@\=Z .MHKEI/'-E-;:6^D65YJT^
MI6YNH+>U"*RQ#&6<NRA<$@<G.>*@NOB-I5O8:1=):7\YU226&"".(>8LT8.Z
M-E)X;<"OIGOCF@#L**X^'7+:X\?:;9SKK%IJ,^DFY^QO*OV=%WX.]03F0'C(
MR,=Z8GQ&LGCCOO[*U)=#EN!;IJY5/(+%M@;&[>$+<;MN* .SHKD=7\:QV]UJ
MMC9Z9J-VNG1?Z;>6RIY=LS)N Y8,Q ()V@D5AZ#KT36?PX34K[5WU#4;1V0Q
M3_NIF$2EC."<MUR.O.: /2J*Y"Z^(-E;75R1IFHRZ7:W/V2YU.-$,,4NX*1C
M=O(#'!8*0#6_K>L6^@Z1/J5TLKQ1;0$B7<[LS!551ZEF _&@#0HKF5\9+%IV
MH7-_HFJV4]EY9:U>)7>7S#A/+*,5;)XZ\=\=:JS>-IVTO60FAZC;ZMIT"RM9
M2>47V.&VR A]K+\K9YS\I&* .PHKRGP!XGN;'P3;ZOJ\>OWU]J3Q1PB>9)1=
MRL7P(%WX0  D[MHP,]JUO$GQ$GT_PAJ=_9Z1=PZI8SQV]Q:W C)MRY7:[8?#
M*0P *D\GM@X /0**P=)\4Q:EK<^C3Z?>:?J$5LEUY-ULRT;$KD%&8'!&#]15
MG1M?MM<GU-+6*8)I]VUF\K@!9)% W;><D G'..0: -6BN7'C:WE\677AVUTO
M4+F[M)8DN9(T7RH5=%8.S%NF&Z8R<' XJ.R\>V=[>6@&FW\6FWLYM[/4I%3R
M9Y!G  #;@&VG:2H!_&@#K**X>3XFV2VMW?1Z+JTNG6-Q);WMXD:;+=D<J21O
MW,.C':#@$9YXK3U'QA';ZJVF:9I5]K%U% MQ.MGY86%&SMRSLH);!(49) H
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MWTK3;G3-(O'N)M7CTZZMY%C#P/O7=&<N!N93\I!*\Y)% 'H%%8NB>)8-:O\
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M/\.1\M9UC&MSKWA>\A_X22Y!6:WOKS4%N66.>6 J%$;#"_-G+*H4<<^GLM%
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M@^G>N2\*:-8Q0:#HNH0^*9=6L9XQ-:M+/]D@:(Y$N6_=F/*@@ DG( %>Q44
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M.!@<LX.W)RYP#V%=3XJTK4GUG0M?TJV6\N-+>99+0R",RQ2H%;:QX# JI&<
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M:<9.3TR, <Y. [3K'Q#XATGP;87.E);6.G/:WTU_]H1EF$29140?,"Q*DY
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MN<;L=<9[UXEK6JIK?P%T+4(]/L]/6;4XL6MG'LB3%PX^5>V<9/N37H U=/\
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MPIQZ@Y(/08K>N_$&O7WBK4-)\/V^G&+3(8I+E[TOF5Y 66--OW?E'+'/4<4
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M"3(.<,-H W?>/6NTT*?5+C3MVKQ6JW(<@26CEHID_A=<Y(R#T)/2@#3HHHH
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MB)K71=5DEF>V%H&DC>3E@LFX?(6Y*XSC(R,YKMK&V^Q:?;6N_?Y,2Q[L8S@
M9Q^% 'C/PJ<^'9M%G8[;'Q'%<0N3T6[AFE*$^FZ/(]R@IUH6UGXH>'?%CDF/
M4M2NX++/:UA@=5(]-S%V_$5V,GPVBD^'4'A3^TY%EMIC<6]^D6&BD,K2!@N[
MT8KUZ&M63P;;+>>%Y+6<P0>'PZQ0[,^8K1>6 3GC'7.#F@#@4\7ZK=K+K5K<
M^();X:BR1:=#ILCV;6ZS&,IO$9!;8"V_=PW';%:ET=7\2:?XSU,:W=VJ:?/=
M65K9Q[/(*Q1C=Y@*Y;<2W.00,8KH;?PAJ=A=/!I_B)[;17O#=FT2V'FJ6?>T
M:R[N$+$G&W."1FJ]YX%OGGUJ'3]?-GI6LNTMW:_90[AW4*Y23<-H8 9X/?!%
M '.Z%SXF^&?_ &+DG_HJ*M?XBVL&GZGX7UVSC2+5AK-O:"6,8::*0E7C;'48
MYYZ8JQ<> ;]9/#D^E^(%LKK1+ V*R/9"42J552VTN,?=]^M7+#P9</KEMK/B
M+7)M8NK//V2/R%@@@8C!<(N<MCN2<4 <SH_B&XT3Q5XV\OP[JNIQ_P!I"1I+
M)8V"8A3@AG4YXSP#6GX"D7[-X@\:3QPV&F:NZ7D,"R*WE11QX:1]O 9L$D#I
MCGFNFT3P^-&U/6[P7)E_M2[%R4V;?+PBIMSGG[N<\=:P;SX>/-HNM:)::R]K
MI6J70G\A8,F!2098T;</E<CT^7)ZYH \MD\3:+<Z'=>,_P"U[5/%1U4:E!:L
M^'$"?NUMS]8MWU)KZ TW4+?5=,M=0M'WV]U$LT;>JL,C^=2QVT$-JEM'$BP(
M@C6,#@*!@#'IBL?PCX</A31#I*7C7-K'/(]L&3:88F;<(\Y.[&3SQ]* .8TZ
M/Q#XJ75-9LO$-Q8SV^I36UE:;5-MY<3[")%V[F+88DYXR,=*? FL>+=2\23Q
M:_?:9'IMXUC90VFP('1%8O)N4[\LW3@8'XU;N/ M^)]0M].\1S6.CZC=&ZN;
M:. >:KL07$<VX% Q&>AQDXJ:\\':E'J&J3:%KXTVWU4A[J%[03%9-H0O&VX;
M6( SD-R,T <]HFOZKXZOM!M&U*YTR)]$&I736)5'EE,GE@9(.%!5C@>HK!N]
M4U?P[\/?%ES;:BZZA%XH:)KI% 9P3$I)&, D=<>M=[)X$?3Y])N?#>IC39]/
ML?[/S-;_ &A9H,@@,-R_,&&<@]S5"Y^&'VGPCJ>A2:W*[W^I_P!HR73P MNR
MA((! .2IYXQGIQ0!-<IJNM_$/6-'77+VQTZWL;:8+:%5?>QD'#%3@<<^N!VR
M#B:5KNN>(+'PCH\NK3V\MZ]]]MO;=5661+9RB@$@A2Q*DD#L?6N^M="%MXKU
M'7?M!8WMM#;^3LQL\LN<YSSG?Z=JXG6=!M?"&EZ!*VLSV=Q8WMRT6IBR\V&,
M3L[LDR;N%.0H;/4 \4 ;7@ZYU9?%7BG2=2U*2_BT][9;9Y%4,$>,MSM &[ID
M]\9J+QC?$Z]!8C7-7M\6IE%EHUHTLY8M@2NP5L)Q@ XR<]:K_#B%Y]9\4ZPM
MU->VM[<0"*]EC\L7#)'AV1>R G:/9>IZUM:GX7OKCQ)-JVFZR; 7=JEK>1_9
MQ(S*C,5:-B1L;YV&<,.G'% ')Z=K>N^)9?!4!U::R74]*N)KY[=5#NR&,;ER
M"%))/;@,<=B(WUW7+2PO- 35[AYSXEBTB'4) IFC@D19"<XP6 W $CN*Z7P_
MX$;0[K1I6U3[1'I-O<6L"?9]A:.1D(#'<>5VXSCG/:B^\ K=Q:JT>IO#=76J
M1ZK;3K"#]FF145>"?G'RG/3AC0!G:5IUSI?QB%O-J5S?Q?V [12714RK_I"9
M4L ,C(R"1GD^U:7B>YOK_P 8:)X<M=1N-/M[B">[NIK8@2NL>T*BL0<#+Y/'
M:I](\)W]IXL;Q'JFM"^O'L39%$MA#&J[PXVC<2.AZDYSU& *L>(O#=SJNI:;
MJVF:D-/U/3_,6.5X/.C>.0 ,C+E<_=!!!&,4 </9RW.C3>.TN=?DMIQJ-I"+
M\P"29E,48 5%'S2E<*,+UYQ5#5=1O;SPGX[TO^TM<-K9:?%<P/J,7E7&'60.
MC90$H=GIGDC-=:/AU<"+4)CKSOJ5UJ%OJ27+VP*QS1*!@INY0X/&1@$#)QFG
MS?#^[O'UM[[7FG;6]/%I>8M0H#KNV/'\WRJ Y&TYSC.<DT 9]ZQT[3?#^F2>
M)=< DM6F:"PM_.O)N%P=R(=L:Y(Z#.1SQ71^ -5N]:\&6=Y?2/+<[YH7DD38
M[^7*\8++V8A1D>N:SXO!NNP7%A?1>)H5U""S-C+-_9P*R0[@R[5+_*X(ZY(.
M>E;/A/PZ_A?29-,%\;NV%Q++;EX\.BNY<JS9.\Y8_-Q]* .)N+O7=5\.>+O$
MUOK]Y:2V$U[%9VL6SR5C@!7Y@5R6;:QW9X)&.E;?AK5]0N_%T%G<74DEN?#E
MI=%&Q@RL[AG^I %9OBGP?J&G>&O%K6&N&+2+R&ZOI;+[,#)YC(6=5DW<(Q'(
MVD\D C.:OV/AC4+A=$UW2-873[HZ/!9W"RVHG5XP RD#<NU@2W/(YZ4 94>O
MW=UX:C^VZ_>VKRZW>6^+*W,MU/'')(%BB"J<8 7+8X ZC-<YXLU:[U/X/>((
MKN>[G^PZU':Q27L7ESF,-$Z^8,#YAOQG S@5W%M\/+G3+73O[,UTI?6%W=7$
M=Q<VHE#K.265EW#)Z?,".1TYJO??#&:_T#6M(EU]VAU2\BOFEDM@728;=YX8
M AB@P !M]Z +-_J>HR?&*WT%+Z:'3YM!>8QQX&)/-*AQD'D#\*X[P^^K:!\-
M$\2VFJW\ZVFJRS7MK(RLKVZW$BRX 4')#;R<]5XQ7I4OA99?B!!XJ^UD-%IQ
ML?LWE\'+E]V[/OC&/QK$@T^Q^'_AW4;;7=82XT.ZEE6WMS:D2 REW:/()\PG
M) X'2@"_'JMUJ_Q'CL[&[(TK3; 3W7EXVS2S?ZI3[!%+<?WA76UQ7PM\.W'A
M_P &P?;A*+^\(FF$W,B*%"1HWNL:H,=CFNUH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* $9U0$LP '))-(74,%+ ,>@SR:\YU[0[#Q!\9;2RU.$7%F-!>5X&)V2$3@
M,.X&<X]0/2N>N-*U7Q#+XIN;?P_:W&HQZG-!9ZO+?B*6R\H@1! 5)51@,0"-
MVXYZT >TY!Z50O;N^@OK&*UT\7-O,[+<3>>J?9P!P=IY?)XP*\^GUAO &N^*
MC<*!'?6 UBVC'W3<@"*5!ZEG,9_X%67<:&_AW4?A;I\Q+70NYY;IB>6F= SD
MGO\ ,3^5 'L>]0X3<-Q&0,\T9&,YXKQ2/2]9UZWU?4[3P_:2:P-6G\C6);\)
M+;F*8JB!2N0H50NW.""?6KVH(;>Y\0^".0-6UNVDB .#]GN/WDV/8>3,/QH
M]>R/6D#JQ(5@2.#@]*\@THSZ]+X8\-R7)CET&"\>[D/_ "SD@)MH6/OR7_"M
M3P9IMOX=\0:?IVH>'DTW57M'BCU"RG#P:B%"EV?HV_\ B&\=SS0!WVHW=];2
MV:V6G"[26=8YV\]8_(C/5\'[V/[HYJXSHGWF49..3WKSWXH?\A;P+_V,5O\
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MSAPVX@%OFR,@X- 'J5%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!BSKOBDZ-XI\.:*+03#69)D,OF;?*\M V<8.[.?45T+2(A4,ZJ6.%!.,GT%
M'-OX"T)TUB(I=?9]7+-=VXNG\IF8@LRKG"L2!R*L:AX0TK4(+!&%S;RZ?'Y5
MK<6MP\4L:8 *[U.2" ,@YZ5N>8GF>7O7S,;MN><>N*8;F!<YGC&"0<N.,<G\
MJ ,:'P=HEOI]G8Q6SB&TO%OD)E8NTX).]V)RQ)/.2:T!I%F-=;61&?MS6PM2
M^XX\L,6 QTZD\U%_:5R=:2!(+9M,:T\_[8+H;MV>@3'*XYW9I='U[3M=TYK^
MQN%>W621&9B!C8[(2?094X/I0!'XB\-:5XJTU=/U>W,]LLJRA0Y7##(ZCV)'
MXTE]X9TK4=>T[6KJVWWVG!A;OO("[ACD=#[9Z5I)=6\EO]H2>)H3_P M X*_
MGTIK7MJB2.US"J1-MD8R !#Z'T- %&/P[IL6OWFMK ?MUY MO,Y<D,B]!MZ5
MGZ;X$T32H;*&W6[,-C<_:;6.6ZDD6%MK+A03PN&;CWKI%974,I#*1D$'((H)
M"@DD #DDT 4H=(LX-:NM6CC(O+J*.&5]QP50L5&.@^\:IZYX7T[7YK>XN3<P
MW=N&6*YM+AX)55OO+N4@D' X-:L-S!<1>;!/'+'S\Z.&'YBEAN(;F/S()HY4
MSC=&P89^HH PU\%:#'#H\4=F4CT>4S6861OE<]6//S$DDG.<DT]_!^C23:]*
MUNY?78UBOSYK?O%5"@QS\ORD]*V);F" ,9IXXPHW,7<# Z9.:5IX5@\]I8Q#
MC=YA8;<>N>F* *,^A6%R^EM)$Q.F/YEK\Y&UMA3GU^4GK5./P9H4=AK%B;+S
M+;5[A[F\C=V(>1\9(Y^7D C&,8XK:$\30>>)4,.W=Y@8;<>N?2B.>&:$31RQ
MO$1D.K KCZT <W#X T&.TOH)X[J\-]$()IKR[DFE\M3E55V.5 /(QCGFGVO@
M71K6]CO5-[)>+')$]Q->2/),C@ JY)^8# P#P",BK#>)(F\5V&C0)'-%=V<U
MR+E)00OELB[< <YW]<]JV$N8)99(HYHWDC^^BL"5^H[4 5-#T6Q\.Z-;:3IL
M;1V=N"L:,Q8@$DGD\GDFL_6_!FCZ]?1ZA<)<6^H1IY:WEE</!+L_NED(R/8Y
MIWBCQ-#X=T*\OXUBNI[4Q[K<2A6P\BID]2/O9Z5O4 <_:^"M"L]"O](AM&^S
MZ@K+>.\K/+/N&"6D)+$X/KQVK2NM'L;W0Y-&N8!+820?9VB8GE,8QGKG'>FW
M]Y>V^H:?#;6D$T$[LL\DEP(VB '!5<'>3Z<8JT]Y:QLJO<PJ6;8H9P,MZ#W]
MJ ,N_P#"FCZIH=MI%_;M<6UL%\AGE;S8RHPK"0'<&'KG-5M)\$:-I.I)J0^V
M7E_&I2*XO[N2X>)3U";R=OX<UT3,J*69@J@9))P *Y:?QS8OIFD:AIJ"[@U#
M4X]/Y?:4W.R%\<]T.!QD4 =!J.G6FK:=<:??P+/:W"&.6-NC*?Y?6L33? NC
M:9J5IJ*?;;B]M RP3W=Y),R*5*[1N)^7!/%=!#<P7*LT$T<H4[6,;!L'T.*(
M;F"X+B&:.0H=K[&!VGT..AH S;3PQI-EX<D\/QVN[3)%E5X7<MN$A+.,YSR6
M/TJAIO@31=,O[&^3[;/=6.X6TMU>23&)2A3:-Q.%PQX_P%=&\L<9 =U7.<;C
MC..33$NK>2W\])XFA_YZ*X*_GTH \DU'P;>:BMQI$/A6[LY)[\2?:?[0\RPA
MC\T,TL<9?(=E!& @P6/(%>KZEIUIJ^G3Z??0B:UG79(A)&1]1R#WR.14AN[8
M1RR&XB"1';(Q<80^A/:G">%D1Q*A23&Q@PPV?3UH YQ/ .AFTO;>Y%[>F\B6
M&2:\O))9 BMN559CE0&^88QSS4VG^"](TW4X=2A-X]]&CQO<37<DCS*V,B0D
M_,!@8!X&.*W8+B"Y0O!-'*H."T;!@#Z<4D5U;S[_ "9XI/+.'V.#M/H<=* ,
M2#P5H5MX4C\-1VKC3(CNC3S6WHV\N&5\[@0QR"#Q3(_ ^B+I.I:=/'<7::DH
M6\ENKEY990!A07)R,=L=*WENK=V*I/$S!=Y <$[?7Z>]5KO6=/L])N=4DNHF
ML[:-I))$<, %&3T[\=* .,\5^&[K4M!@\$6.GWMQ8SM&T^JWER)!!&)-S8+,
M7:3Y< 8P-PYP*[V""*UMXK>! D42!$0=%4# 'Y5E-K4URNDSZ9!!<VEZP,LD
MEP(VB0@$$+@[CSTXK4DNK>&5(I9XDDD^XC. 6^@[T 8%[X&T2_U&:[F6["W$
MBS7%K'=R+;SN,89XP=I/RC/'..<U@V7@.'4M9\4SZM'?6\=[J&4-O=O"+F#R
MHQM<(PW+D,,'GD^M=[+<P0!C--'&%7<Q=@,#U.>U/1TD17C971AD,IR"* ,/
M4?!^D:@MGA;BRDLHO(@EL;A[=TBX_=Y0C*\#@^E-NO!>B7.DV&G+;RVT>GG=
M9RVT[Q2P$@@E7!W9.3G).<\YK;ENK>W=$FGBC:0X17< L?;/6N;\8>,?^$9E
MTRTMK..]U#4KCR(8I+@0HO&2S-@X'X4 2GP)H!TFUTTVLC06UZM^K-,Y=[@$
MGS'<G+$YYR:+[P)H6I7]Y=74-PZWHS<VPN9%@E;;M#M&#M+  <X[ ]1FMVWG
M=K"*>Y$<3M&KR!9-R(<9(#8&0/7 S3DN8))FA2>-I4&617!91[B@#(LO"6E6
M.J66IQI.]Y9V?V**66=G/E9S@Y/)SW-5E\!Z#'I4FG103Q1->-?K)%<.LD<[
M=71P<J>HXXP370"Y@:X:W$\9G49,8<;@/7'6LJ/Q):WT>L1Z4T5S>::6C:)Y
M BO($5P-W.%^8 MC@Y]* *DG@/0Y=$FTN6.ZD2>X6ZDN'NI&G:9<;9/,)W;A
MM '/ %1W/P_T2[=FE?42)8TBND6_E"W84;1YP#?.<#!)Y(X-;MK>G^R;>[U
M06DCQJTJ^<&1&(Y ?@$9[]ZLF:(!29$ ?E3N'/&>/PH @OM.M-2TR?3;N!9+
M.>(PR1= 4(P1QTX]*P;?P#HEO<6USF_EN[<,JW,U[*\A1A@H6)Y3 'R]._4F
MM?4-=T[3=$NM7GNHVLK:-I'DC8-D*,D#'4\=*N6US%>6T=Q X>.10RD'- &7
M_P (MI/]BZ;I'D/]CTZ2&2V3S#E6B(*9/4X('7K5"_\ A_H&HWUY<SQ706^.
MZZMH[N1()WQC>T8.TMP.<=@:Z(WEJ'C0W,(>0D(I<98CKCUI9;F"!XTFGCC:
M0X0.X!8^@SUH ;96D-A8V]G;J5@MXEBC!.<*HP.?H*R8_"&C1:!8Z(ENXL+&
M6.:!/,;*LC[U.<Y/S5L2W,$ 8S3QQA5W'>X&!G&>>V:#=6ZN$:>(,6V!2XR6
MQG'UQ0!2GT'3KG5I=2GMQ)<369L9-Q)5H2Q8J5Z=2:H:1X+T?1;M;F 7<SQQ
M&" 7=U).MO&<92,.2%!P!]!BMQ+JWDEDB2>)I(_OH'!*_4=JQAXFAU#2-1NM
M#6&]N+.9X/*EG$2LZ-M;YN<#K@XYH SX/AMX<@:#;%>-#;3K<6L$EY*T5LZN
M''EH6PO(_+(Z$UKQ>&=)BU;5M2%MNN-6C2*\WL66147:!M/ &#CWK1MY_-C7
M?L6;8K21JX;82/7^M.,\2^9F5!Y8R^6'RCKSZ4 <YIW@#0--F,B0W-P%@>VA
MCN[J29((F&&2,,2%!''';BFVGP^T*SELIH_M[SV,BO:S2WLKO$J@@1J2W"8)
M!7H>^:Z1;F![?[0DT;0XSY@8%<>N>E.BFBGB66&1)(VZ,C @_B* ,_0_#^G>
M';:XM]-B:..XN'N9 SELR/C<>?ITJ6'2+.#6KK5XXR+RZBCAE?<<%4W%1CH/
MO&K,MS;P21QRSQQO(<(KN 6/H!WHEN;>!6,T\<84!F+N!@'C)S0!D)X0T9/#
MUMH2V[_8+:59HH_,;(99/,!SG)^;FJ^J>!M%U>_N+N87D3W:A+M+:[DA2Z4#
M $BJ0&XX]<<5T#W$,<'GO-&L.-WF%@%QZYZ5D:=X@74?$^K:0D*^7806TRSK
M)N$HE#GICC&SU.<T 68=!TZWU6WU&&W$=Q;V9LHMA(5(=RMM"].JC\JH7G@G
M0K_3KRPN+9VM[R]^WS*)6!:;(.<YX'RCCI6Y+<P6Y0331QESM7>P&X^@SUHF
MN;>W*">>.(N=J;W"[CZ#/6@#+N_#&G7GB.VUYOM,6H01B'?#</&)(PVX(Z@X
M89).#5"#X?Z!;WL4Z177DPS_ &F&R:ZD-M'+G.]8L[0<DD<8!/ IOB_QD?#=
MWI6GVEG'>ZAJ4QBBCDN1"B #)9VP<#\.:Z&*\3RK87,D$-Q,@(B$H;+8Y"GC
M</?% %>UT/3[._U.]BA_?:FR-=;F+!RJ;!P>!\HQ6;I7@C1]'OH+NV^V2&U5
MEM(KB\DECM@1@B-6)"\<?3BM!O$&FKKSZ,URBWB6XN64D !"Q7KZY!XK1,D:
MQ>8741XSN)XQZYH IZ/I-IH6EPZ=8JZVT.[8'<N?F8L>3SU)J]2 @@$'(/>L
M*^\30VVO:'IMNL5RFIS31-,DH/E&.(OT&<YQC&1B@#>HJ);FW>X:W6>-ID&6
MC#@L![CK5'2]>T[69;Z.RN%D:RN&MY>1]X!2<>H^8<^N: -.BHH+F"Z0O;S1
MS(#@M&P89].*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** .5^)%[K6G> -5NO#ZN=1CC788UW,J[@'91ZA
M<G]:\\^ ?B#Q7K3ZJNLW-Y>:=&JF*XNB6*RYY56/)&.2.V!TS7MM% !1110!
MP/C2>/PYXW\->*)#LM7$VF7C_P"PZEX_R=#^=<WI2MX>LO!_C&]_=-J-S<G4
M6_V;O,J9]E*1BO4->T#3/$VE/IFKVHN;1V5FC+LO(.005((_.FZMX<TG7-".
MBZC9K-IQ"+Y(9EP%(*X*D$8P.AH \KM[22;P#X>EOU*Q^*/$<=WJ*$\/'*79
M$/\ LD+$,>^*U=>T^RT3Q;JUGI%K#:6UWX6NI;JWMT"1ED8!'*CC.&89KT*\
MT'2]0T0:-=6:2:>$6-822-H7&W!'((P,$'(Q5.P\'Z+IT-]'%;RR-?1>3<S7
M%S)-+(F"-N]V+ 8)X!H \RU'2++2/@;I%]8V*-?78TR:>08$EPV]" 6/IG S
MP!75> W.HZ]K-[KT93Q9!)Y,UNY!6UMSS&(?5&');J6SGM753^&M)N-"M=%E
MM-VGVHB$,/F,-OE$%.<Y.-HZGG'-32Z)I\VN0:TUOC48(FA2=7928VY*L <,
M,\@'.#R* .4\7W<7AGQGHOB>8[;5[6YL+M_8(9X_UC<?\"KA(1>Z#X;U30W=
MAJ'BFSM;F,?]/%R_E3_D&4U['KWA_2_$VF'3M8M1<VA<.8R[+R.ARI!I+[PY
MI.I:KINIW=FLEYII8VDFYAY>[&> <'H.H..U ' 6>F6:?&+5]+-O')9)X9B@
M$,BAE*!P "#P1@5S^D:-ITWPR^'D7V2)%O=8A-T8U"&?Y)P=Y')R..>U>Q)H
M6FQZ_-KJVV-2FMQ;23;VYC!R%VYQU[XS6;I_@3P]ID4$5I92)%;W0O((VN96
M6*4!@"H+84?.W XYZ4 9&@Z=9:-\5-:LM,M8;.TETJUG>"! B>9YDJ[MHX!P
M!4?B/3+/5OBMX>M[^W2XMQIMV[0RKN1R'BQN4\, ><'N >U=DFE64>L2ZLL.
M+Z6!;=Y=QYC4E@,9QU8\XSS22:593:Q;ZJ\.;VWB>&*7<?E1R"PQG!R5';M0
M!X\_AG1_^$!^(4QL(&DL+Z]2R9D!-HJ .JQ?W &8GY<=:TIK.^\1>+M62;0-
M+UM8M-LXT_M&[,7DI)&S,R#RWY9LY88/RBO1CX:T@Z=JFGFT_P!%U2226\3S
M&_>M( '.<Y&0!TQ5;5/!FAZQ)#)=6TRR10BW#P7,L+/%_P \V*,"R^QSW]:
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MVB= SV\42CRPC'E %PPQCKFNQMO ^@6L.F1):S.NF3&>S,MU+(8GP!P68Y&
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M0Q[@NYF0@#)P!SZU4T/P3H^ES66H"TD%];P[8UDN))([<LN'\M"Q5,\CY0*
M//%$;R>&M?T_1+"QM;W7XS#?R71>_N!)(X;?\GW64M\N\X&/2I[/2=-M?#?Q
M5GM["UAFCEO8$DCA566/[.K; 0.%SSCIFNY_X5SX8V.GV&8*9/,C NY@(&WA
M\Q8;]U\P!^3%6W\%Z"][JEV;20/JD30WBK<2!)590K$H&VAB!C<!GWH \VL8
MKS4(? %@FDV.JP)X=^T):7\_EPM(!$I;[CAF56X!'&XFI_\ A'YHY_"6CZO#
M:"V;7+PQVEM<&:.*$PR-Y)8A<@'<I7&,<=*]$NO!VB7>EZ?IS6LD<.G*$LWA
MN)(Y8 %VX616#=.#SSWJ2U\*Z+9QZ:EO9!!ILCS6W[QB5=P0S$YRQ(9LEL]<
MT >7>*-)TZRL_B=86UC;16<5E9W45ND0$<<I1P75<84_*.17K.@V5II^A6=O
M96T-M (E81PH$4$C).!QR3FH[GPWI%V^J/<6:R'585@O-SMB5%!"C&>,!CR,
M&I](TBTT/38["Q$PMX_NB69Y6'MN<DX]L\4 >-SZ%IO_  ISQ%K36<3:G%>7
M<L-VR@RPE+IMNQNJC()P.Y/J:W/&D%OJ^H>*7AT'3KQ]/T]8[N^U.Y*^1^Z,
M@$"A&P0&#$Y7)QZ5WS>%M&;0+G0FL\Z;=-(TT/F/\Q=B[<YR,L2>#4-]X,T+
M4=6?4KJS9YY%595\]Q'-M^Z7C!VN1V)!Q^ H X*QTNT\3>/?#BZS"M[$?"4=
MQ)'.-RROYBC+ \-]XGGO@]JO>'],TL^./'&LZA;),^GWB/"SKN,&(%+,@[,0
M!SUX%=GI?A31M&N;:XLK:1)K:T-E"[SR2%8"^_9\S'C(&/0  <<5;M=%TZSN
M=0N(+8"347$ET2Q82,%"]"<#@ 8% 'E&DV:V^M^![N'0--TRUU&278RW)FN[
MF%[=W/G_ " -GY6.6;!Q6?)IEA9_!7QQ-;65M#*=0NH2\<2JQ1;@;5R!T'8=
MJ].MOAYX:M1;B*SG!MI5EMV:\F+0%<X5"7RJX)&T8!SR#4C> O#CQZK$UE)Y
M&JL6NX?M,HC=BP8D+NPI) )*XH YEY(_#/B?PSK\K"*PU/3!IUZYX571/-B8
M^^ Z_E7.M:WUUX;T;49+&&YF\4:_]MN+6ZE,<<D7ER-!"[;6^7:B'&#D\=Z]
M6U;PSI&NZ&NC:E9B>P4(%BWLI&W[N&!!_6I=1T+3=5TD:9>6JO:+MV(K%#&5
M^Z592"I&!@@@T ><GPCJTUKK%H;70M.BGO;2YM](6Z,EM)(F3(CC8NT.%0X"
MGE2<5U'@5[.-M7LHM"&AWT%PC7=E%*'A#,@VO'MPN& [ '(.1FKJ^!_#ZZ7-
MIYM)'CFF6>2:2YD:=I5^Z_FEM^X8X.>*T-&T'3] @ECL(I 9G\R:6:9Y9)&P
M!EG<ECP .O% 'F_C>"WU6Y\7SV^@Z?=-I]D(;G4-2N2#"PB,@%NH1MI <'.5
MRQ'IFK6F:99>(/B#:/K%M'?*/"UG*8[A0Z,YDD^8J>">3@GIDUV-]X+T'4=5
MFU*[LVDGG"B9?/D$4Q484O&&VL0.A(R./058TKPQI.BSQSV-O(DL=JMFKR3O
M(1"K,RIEF/ +''MQT H \KT:U@NW\*:!=QK)HRZ[JJ?9I!F,^29#$A!X(!)(
M!]*ZSP?86.F?$SQI:Z=%'# L-@?)B&$C)64D #@#G.!ZUT%SX+T"ZTPZ?)9,
M(/M37JE)G5TG9BQ=7!W*<L>A[U/HOA?1_#\]S/IMJT4URJ+/(\KR-+M+$%BQ
M))^=N>IS["@#E/&>A27/B"XU;^Q=.\16BV"V\]A/(%GM@&=M\6X$ L#_ +)^
M08-8VI'3/$HN9M,T&RU""UT. O=ZS=,!!"\;.@1=CG?MY9LCH.>*[_6/!^BZ
M[>?:[V"<3F/R7>WNI8/-CR3L?8PW#D\'/4TRX\$^'[F^BNWL-KQQ1P^7'*Z1
M.B?<5XU(5PO8,#0!YE>:=8ZK/\);G4+*VNIKVW NI)H5<S@6ZD!R1\P!)/-6
M+K1+W6[_ ,8Q1:!H]QY-Q]D@O+N\,$EA&D*&/RE$;;%7.\$$9)/I7H]MX,T&
MT325BLWQI#N]CON)&\DL,$#+'(QP <@=L4W5?!6@ZU?O>WMI(TLJJDXCN)(T
MN%7[HD16"N!_M \<=* .-L/#UA??%.ZBU?3[&XN7\.6[7#B)6#2L[H[@XSDC
MC/7&*S();C4- T_X:7,C/>0ZH;&[)X+6,.)0_L&0Q+^->E7_ (:TN?5X=>^Q
MRMJ=I#Y<1@G:+>H)8(0&"L,] W'-8_AK0KR;Q=JGB[5]-33[RZA2TM[;S%D=
M(EY+.RDJ68XZ$X"@9H D^)\\UG\--;>V=HF\A8RR<%49U5L>GRDUB:KH6AZ!
M\1/ QTNSMK+<;M62W0*)$6V;#,!]XC/4\_,:]#O+.WU"RGL[N%)K:=#'+&XR
M&4C!!K"TWP'X>TJ]M;VVM)FN;3/V>6>ZEE:(%2NT;V.%VL1MZ<^M 'G5G&BW
M7A#6['0[#3K:_P!7#0W9NC)?7"2K(6\WY!D,#DC><<"I-+L=#TOPSXYD;1XW
M\S7YM.CBM0L#NCO$J0AP/E3<PR.F,\5W<?PY\,1($2QF"I()(<7<W^CD-N_=
M?-^[&><+@&IIO ?AVXGU.62RD)U/FZ07,@1VRIWA0V%?**=P /'6@#G/"-K-
MIGQ*U*R?3=*TL/I,,KVFER%HLB5P&;Y$PV,CITQ7H]86G>#M$TK4(=0M+>9;
MR-&0SO=2N\H;KYA9CYG08W9Q@8QBMV@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#$UOQ9HOA
MZ>.#4;IUF>,RB.&"29@@X+L$4E5]S@4V]\8Z!IXM3/J"G[9!]IMA%&\AGCRH
MR@4'<?F7@<\YQP:YGQ)K+)XTO;)]:M]#2WTZ)TD6WBDN;TN[C8A<'(!4#: 2
M2]8/@)X+G5/ 15DD:#0+I#@@F-P\2D'T(R1B@#T./QIX?ET%];74!]A27R&8
MQ.'$N<>7Y9&_?DCY<9YK'\2^-H3\/-<UOP]=_P"E6";<2P,CQ297AHW (X/<
M=ZY>34GTV;74CFM+1;KQ>(6O;F)72TS;HWF -P&RH )X!:L;5[V*?PY\3$_M
MC^TY'@MI$N65$,Z!0I=0@ *@C;N P<=: /7-#\06NHK;V+W(;5%L8;J>+85^
M5U^\.,$9STZ4R\\9Z!8O=I-?'S+6=;:5(X9)&\UEW!%"J2[;>2%SCOBN.UV=
M?"]CX2\;;6\BTM$LM1V#EK>5!M)_W9 I_P"!5'!I-KI_A+1+K5]9;0]=OKZ3
M4EORH*1W,J,61]PVX\MMF"1G;Q0!VK>,] 718]6^WYM9)?(0+"YD:7G]V(PN
M_?P?EQGB@^,] &BKJWVXFU:;[.H$+F0R_P#//R]N_?P?EQGO7F\^JWVHW>@:
MC<:O8V,5GJEY9OK5M IMYG,2[)<,2HW?.F<D;@<&KRVNB&SGO9/&KBYGUH2P
M:NELD<$=TD&PCIY;*4RI.<$Y&<T >DZ1K-AKMC]LTZ?S80YC;*,C(XZJRL 5
M(]"*X*Y\=W-[\5%\/6FHO9:?;1QF0#3))7N)3)M*$E?D3'&_IWS71>!=6N-5
MT_4?M,ME=/;7SP?;[)-D5X B'S ,GGG:<$C*\5BV:NWQSUY8SM<Z%"%/H=_%
M '0+X\\-MJ0L1J)\PS_9A+Y$GDF7.-@EV[-V>,;NO%3W'C+0;;7/[%DOC_:7
MG)";=(79@S@%<X7&,,N6Z#(R17E[:A82? J#PU%/$-?.RR&G[QYXNA.,_)UR
M""V?3FNT\+Q)_P +4\>2[1YG^@+NQSCR"<4 =3K&N:?H-HESJ,YC22011JD;
M2/(YR0JJH+,< G '8U1;QGH"Z(FKF_S:/-]G7$+F0RYQY?E[=^_@_+C-4O'"
MZ<8]*>[UIM%O([LM8W^U2D<OEL"'W#;AE+#!(SVKD1XIN[FTTZ"XO](MM^LS
MVS:_';H86\N'<)(PY*AVR4SDC*MC- '0>*OB+8:=X"OM>T>8SS)NAA5[:3Y)
MAC*R+@%,9S\V.WK3M"\96EIX8M+O6]9FO;FZD*IMTR2.1F"*S*D2KN8+G.X#
M'/6N!O[R*?X<_$J,:D;Z4W:2B9U5&E0QP!9-J@#:<<$#!'-=)K/GVOBCPO=M
MKD>BV\FC201WDT2.GFYC8I\_"EE&0>^TB@#?UGXD:-ID6ASP.]W!JMQY:R10
MR,%0!MS8522P*XV?>Z\<&NBTK6]/UN.Y?3[CS1;3M;S HR%)%QE2& /<?G7E
MES_9VF6GA345UM;VQE\3RW$E_+&((MS+(&(_AVE@2".#GBK7C"[NO#/B+4&T
MGYU\7V:06C1\J+T%8PP(X ,<@;/?RZ /3-)U>QUW3H]0TV?S[20L$E"LH;:Q
M4XR!QD'FLW3_ !IH&J:HNG6E\7N'+B(F&14E*?>$;E0KXP?ND]#6AH^EV^A:
M'9:7:C$%G L*<<D*,9^IZUYQH6HPZ??Z)IF@Z_::OI-Y))';V,T2_:]-_=NV
M[(^8*I&TAU!&[&: .WM/&F@7NKC3+>_WW#2-$A,+B.1USN5)"NQF&#P">AIL
MOCCP[!K!TN340+D3"W9O)<Q+*>D9EV[ WL3FO-_"<$-SHGA73;[Q@JW%K>18
MT=+.,S1SQ,2R-M^<#ALL>,')ZUK>&M=T#2?"$^BZ\(;C4H]5FBGTUE62:>5[
MDLC",\L"&1@W3 SVH Z"S\?V&KWOB/3H99;-M,1MMV]K(P $89G(*@?*2?E)
MRP&1P:O6OBK2]/\ "FF:EJ&LB\2[55BN8[5E>Z8C/R0J"V3CH!Q7'Q7EK%>?
M%*PDN8DO) \J0,X#LGV0?,%ZD>]4/#MQ#IME\+]3U"5(=.2PN(#/*=L<4SHN
MS<3P,A7 S_6@#T:+QGX?ET:?5AJ 2SMY5@G:2)T:&1F"A70@,IRR]1WSTHTW
MQGH&K7LUG:7Q\^&$SL)87B#1 X+J74!E_P!H9%>9^)I+?5H/'NHV;1W&ESW&
MDVXF0AHYI$E428/0X#*#76>+5M?^$_T;[8C&U.CZD)Q&I+&/$60 .2<9X% '
M0Z-XPT/7[LVNG7CR3>7YJK)!)%YD>0-Z%U =>1RN1R*MZSKVF^'[:.?4KCRA
M*XCB18VD>1_[JHH+,?H*XGPEJGV?Q#IFCVFOV7B/39+*1[>943[39(FP*'9.
M"K @<A3D>U:'BRXATWX@^$M3U"5(=.1+N#SY3MCBF=4V;B>!D*X&?ZT 6-9^
M(&EVO@O4]<TV<SR6JR1K$UO*&2<(6"2)MW(.!DL ,=Z=\.M9O-=\,Q7]]J;7
MUQ*J2/FQ:V6$L@)1<@;P,_>&0:Y'4YX=1M/BIJEA(DVG2Z='"D\1S'++' ^_
M:1P<!D!(]*[_ ,$_\B%X=_[!EM_Z*6@#&DU[Q'X@U[4K#PP-.MK+3)?L]Q?7
MT;R^9/@%DC167A<C))ZG@5%J'B#Q3IG@[Q--JEE;VVHZ9;-);7ML-UO<?*2&
M56R001@@Y^IJGX<UO3_!WB'Q'HFOW<.G/=:G-J5G/<N(XKB*7!(5SQE3D$9]
M*=XI\4V?B7X?^,AID<DMA:V+HM^/]5.^T[A&?X@O&3TYXH T[/Q!+-;^"7N]
M<2UN=4MA(]K]DW_;7,2LP##B/!.??.*MWGQ#\+V$L\=QJ3 V\K0W!2VE=864
M[3O(4A1GC)P#@X-<-+_R$_@U_P!>K_\ I-'5VWB0?#[XG,$7+WNJECCKB/B@
M#M)]5C'C6QT]=;1/.LWF731;;C, ?]8)>@ ].]-B\<>'9]8&EQZB#<M,;=6\
MEQ$THZQB7;L+<'@'-<1:[F^*?@_:<,?#+8/O4_@O7O#UGX'\/Z'J:PW&K172
MVK:=M62>.Y60Y<H>1@Y??V'- '8_\)MX?.M?V3]O/VKS_LV?)D\KSO\ GGYN
MW9O_ -G.<\=:SO#GB#4=1^(GC'1[F56LM,-I]E0( 5\R,LV3U/([UP&J:[]M
MTFWN[C7+:VQK\;RZ-;01*+94O #),V-X/ 8L2 2P]:ZOP8RO\7?B&RD,I_L\
M@@Y!'DF@#=\3:WJ=KK6CZ%HYLXKS4A,_VF\5G2-(@I("J068[A@9' -5I/$.
MN^&M)UJ\\46]M-!8PB:WO+&-E6XR#\C1Y9D((&6^[ALY&#2^-;CPI/<V&D>+
M+=4M[@-);WLS>5%'(N/E$H(*.0<CH" >>U<<TX72O&^D:+K=SK>A1:%(ZRRS
M_:/(N"K@Q++_ !#: <9.* /0-#\8:7K5KI)61XKK4HFDB@>&122BJ9 "RC(&
MX<]#VS5JY\4:+9PZI+<7Z11Z6RI>,RL!$S*&4=.20RXQGKCK7 6^MZ4FH_#C
M46U*T%C'87%M)<F9?+CE,$1",V<*W!X/-8^IW]M>R^)=7A?S=+@\2Z;<7$BC
M*M B1!G]UX!ST(YZ4 =@_P 0[)_%D21WDB:1#I=Q=WB2VDB21E&CPQ1E#@;6
M8],'\*ZR^U_2].T9-7NKM4L'$92559MV\@)@ $G)8=!WKBCJ&C^(/C!:)9SV
MU]#_ &%<0SR0L)(V!DC^3<."0#DCMN'K6+X=@N;W7=*\"78D>'PO>2W4[N/]
M9"F/LG/_ &TSC_IG0!Z'XUUNY\.>#-5UBS2)[BTA\R-902I.0.0"#W]:Y_5-
M4\>Z%HEQK=RWAV]M;2$W$]O%#-#(T8&6VL78 XSU%7?BK_R2[Q#_ ->I_F*Y
M?Q?X7DTG1K'4KS6=<U70H94.K6-Q=DJT!XW ( 2%."5[C/I0!W-[XST33;:R
MFN[B5&O(!<111V\DTGEX!+%4!(49&2>*=>^-/#U@EFT^HJ1>P&XM1%&\IG0%
M1E H.X_,.!S[<&N-U>8VGQ&FND\36VAVEUH\'V2XDBB>.9$>0LJL_ QN5L#J
M&![5GZ9)HWA_Q+X&:34A-8?V=?-!>W,7D >9(C*2#@(,,5'8Y&.HH ]"B\9^
M'YM EUM=206$,ABD=T9620$#84(W!LD?+C/(I;'QCH6H6M_/#=N@L(C-=1SV
M\D4D28)W%'4-C /('.*\PNYX)M<O?$44BOX>C\66LLEPIS%A+?RVEST*B0KE
MNG&>U:_B*]M=9\4>(;S2KB*ZM;7PG<P7,\#AT$C-N1"PXS@,<=L^] &YK'Q3
M\/V&C3W]A+)?F.6&,!+>4(3(P'W]F.!N)'J-O4XK5N_'OARP\K[3>RIYD(G/
M^B3'RHR2 TF%_=C@_?QTKC/$*16OP#T)@%CABATR1ST"C?$2Q_F35CQ-J^F6
MVI:IK6A^+-/MKS[$CW-E>*DEMJ$:AMFTY!.<LN4)YX(S0!Z89HA"9C(@B"[]
M^?EVXSG/I6)H_C/0==NS:Z?>L\QC,R"2"2,2Q@@%D+J XY'*YZT:EJ<MOX"N
MM573E,J:8UP+)UR,^7N\LCT[$5Y]IVIQ2>-?"#2>)[?5%-K<+M@BBB@MV>)=
ML:E!U..%))PH]: .WMOB)X6O)[.*WU,O]L94@E^SRB-G;[J%RNT,?[I(/M1K
MWCC1M*:_L?MQ74+> LVV!W2%BI*"1PI1">,!B*X2WC2/X!>&]BA<75DW [FZ
M4D_J:NP:QI>D6'Q#TW5KF&._FO[F1+:5AYEQ')"HB"+U;/W0!F@#OO"FH7&J
M^#]%U&[<-<W5C#-*P  +,@).!TY-5].\;>'M5O?LEG?EY2KO&6@D1)57[QC=
ME"OC_9)J/P.5'PV\/%P2@TJWR "21Y2]AUKC?#^H16=[HVC:-KUIKND74,R6
MMN\:_:].58F*Y8<[>-AW $%@,T >@#Q+I!T:RU<7@^P7KQ);R^6WSM(0J#&,
MC)(ZCZU0U#Q_X9TN:ZANM1826DGE7(2WE?R3@'+[5.U<,/F/'OP:\X@UW3)O
MA9X+TN*]ADOX[_3TEMD8&2(I.H;>O50#@9..2/6MV&-#I?Q5?8-S33JQQU M
M%P/U/YT =A:>-/#]]K,>DVVH"2ZEW>3^Z<1S;1E@DA&QR.X!-5I/B)X6BF$;
MZIC]^;=I/L\FR.0.4VN^W:GS CYB,]>E<U)&D=A\*PBA0LL0&!T'V1ZQ+N*/
M_A1_B[Y%^?5+LMQU/VK&?T'Y4 >F:5XPT+6M3DTZQO3)=)'YP1X7C$D><;T+
M* ZY(Y4D5'IGC7P_K&I+86-\9)Y YB)@D1)MOWO+=E"OC_9)K#\32?8OB+X?
MFA@$C1:3J)6)1]_:(B%_I7):=K,=QJW@*[G\1VERCS[WL[6"**WL2]M(%CRH
MW*<DJ%8\X/'% '?R?$CPG&)F;5"4@#&9UMI66+:^P[B%X^8'KVYZ<UN:CK%A
MI,5M+>W C2YG2WAPI8R2/]U0%!ZUQ/P\TJTU/P%K%A<1 PWVHW\<X Y8-(RY
M^N /RK)\&R7OB#Q!I&CZDK,W@Z.1+MF'RRW.3%">>O[I6?/JPH ]-U;5[#0]
M-EU#4KA;>UBQN<@GDG   Y))(  YKF--\9QZOX]-A:71_LV/26N98YH&A>.4
M2J,L' 9?E.>>.<TWXE.MM8:!?3G;96>N6L]VY^['&"PW-[!BIKE_$=W;^(_&
M7B*/0)H[R9O"$\ EMF#J\GF A PX)PPZ?WA0!WFF^.O#NK7\-E9W[-+<;OL[
M/;R1QSXZ^6[*%?\ X"32S^./#MMJYTN740MPLP@9O)<Q)*>B-(%V!N1P3FN-
MOM9TG7-&\":?HMU;SWBZA9S+;PN"\$<2DR%E'*@+E3G'7%'A[7= T?PMJ&C>
M(!#<:@FKSQSZ:ZK)-<227!:,K&WWP0R$'IQ[4 >A1Z[ILUOJ4\=R#%ILCQ7;
M;&_=,BAF'3G"D'C-4+KQOX>LQ;>;?,7NK5;N"..WD=Y8FZ%5522?;&0,G&!7
M$#6]-TG3?B/I][>0PWTM]</%:LX$LHDMXPFQ>K9([58\(HK>-/#+%067P9%M
M)[?O(Z .E'Q(\)M%;3+JH:&X("RK!(40EMH$C;<1G(QA\&KVL^,-#T"Z%KJ-
MXR3>7YK+'!)+Y<><;WV*=BY!Y; X->:7D4:?!7QOM15SJMZQP.I%Q@']!^5:
M.J2-8>//%1O/%4&A0W,%O*BW%O&XN(1$5.TOUPP<;1_>]Z .YU+QCH.E7"6]
MU?9GD@6XCBAA>5I(V) *!%.[H>F>!GI63K'Q*T73M*TC4;5WO+?4[Q;>-HX9
M#M&[:Y("DAEY^0@$D<#K61X5T^WL/'VE6\,TEQ';^$X8X9IHRCE/.XRIY4X
MXKGKF:*TT6WN)Y$BMK?X@N\DCG:L:"9\DGH![T >DW/CKP[:7B6L]^Z2,(RQ
M-O+LB\P H)&VXC)!'#$'FNBKRCQ%K-AI=YK6L:#XCL99)&BDO-#O$5TOF,:!
M3#T;+IM *[E)%>K Y .,>U "T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(Z.\:,R'*EE!*_3TIQ56()4$CH2.E &!XXU"?2O!.K7MM#'++% 2%ECWH 2
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M88FD\QHT,F-NXJ,X],T\    8 H **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#/L]'M+'5=2U*$/]HU%HVG);(RB;%P.W K0HHH ***
M* "BBB@#E6^'NA->M,1>?9GN?M;6'VM_LK3;MVXQ9Q][G'3/:NJHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;V<UFUG>R6\UL]SYZ1. K$1OW3YA@<8Y&!0!N6^K6=UJU[ID4A:[LEC>=-I
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXNIG0.0@5_W:8(Y)8\]\<V-.\8:UX@UC1[73K:TM(;O2TU&X-W&[/%^\V/&
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MB5R6&64D84],\^IT4 <MI/A.^T=;2RMO$%P-'LY-T-H(4#[ 21&TG4H.G0'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.PSWV"NUHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
(B@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>exhibit1012-stuartexecut004.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBO.]*&K?$"^U._?7;_ $O1;6\DL[.WTYEC>7RSAI7<
M@GDYPHQC'Y@'HE%<E9#5/!UKJ]UKVM_VAH5K#Y\%Q.O^E1@ [D?:H#CI@]<G
M%+8>,YI=3TZTU70;S2DU//V*6:2-P[!=VQPI)1BH) /H1G- '645P$GQ/"Z5
M=ZO#X=U";3+"XD@O;D21CRMC[254G+]B<=,]<@XTK7QN9==TVPNM%O+.UU4/
M]@NY70B7:N_YD!W)E>1GGU /0 ZVBN%'Q%FNHM4FTWPSJ%[!I5S-;WDB21H%
M,9(.P,<N<#.!ZCN<5H2^-H;B/3%T+3I]6N-1M?ML<4;I$$AX&YV8X!RP '7.
M?2@#JJ*XV;XB626VB2PZ=?3RZM+-;QVZ*HDCFCR&C8$X!W KG.!USCFEB\?Q
M6_\ ;46M:5=:9=:3:B\EA+I+YD)SAD93@G*D8..: .QHKF[7Q3=B&^?5?#NI
M6!M;;[2H4+.)DY^53&2-_'W>O/>J]AXRNIM5M=.U+P]>:;/?0236(EFC?SM@
M#,AVGY&P0<'CKSQ0!UE%>;>&O&FK:Y8>+7U;29XK*PN;N'S(IXU:%8T7,7RG
M)?[QWCCGKQ6AIGC"TM?"?AL:987][<ZK&?L5I).&E95&6:21SC &,DD]10!W
M-%<9<?$2VL=!UF_U#3;JUNM&DB2\LF9691(5V,K D,I#9S['BIX?&LHU[3M.
MU'0;W3X-3+K97,LD;!V5=V'522A(' /TXYH ZRBBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFDF=$)$:^4XRQ[#) KKZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "J&E:UIVMPS2Z=<K.L$S02@*5,<B]5
M8$ @CWJ_7F?C@WO@35G\7Z%#'*NH[;2_LG;:LDQXAF'N&PK>H/XT =[#K6G7
M&LW.D0W*R7]M&LD\2J3Y:M]W<<8!/IG-7Z\^N;2?X<?#'6=2CE6ZUQXVN;J\
M<9\VY<@;O]U21@=,#W-%S;:CX/UGPS(-=U+4$U&\%A>Q7DWF*[-&["1!CY,,
MG0<8.* /0:*\M;7=5'P,N]6^WS_V@LTP6XW_ #@"\9!S_NC'TKU*@ HKS?6O
M$&I:%>>-;$W4KS-;P7&DAVR4:?\ <A5]A* <?[55[76=7ET_0O#AU&=]6779
M;.\N=V'D@MRTC,3_ +4?E#_@= '9W/BS3[+2=6U.ZBO(+;2Y&CG:6W92VW&6
M3/WUYX(X-.?Q7I::EH=@7E\_6XGELQL."JH'.X]N#7F.H:I?ZE\//BBE[=RS
MK:ZG<P0"1L^7&"N%'H!6C<?\CS\)/^O"Z_\ 25: /6*H:7K%IJYO1:,Y^Q73
MVDVY<8D7&<>HY'-7Z\CT_1[Z\L_'6H6^NZA826FK7CVL=K*$02*BMN<8^<'@
M8/&![T >N45Y!_PE5YXDO+5;F7Q#!"NCVEUMT.!V)GG5F+.5!X  "J>#SUKT
M3PC>:E?^$]-N-8AEAU%HL3K+$8V+ D;BIZ9QG'O0!MT5Q'BPZC=^.O#6D6NJ
M75C9W=O>-=?9GVLX01D8/8Y.,]0"<8ZUB'5+O2X?$_A^[\1:@D=C?VL=K=B,
MSW;I,JOY*8Y+GYE#8) .>U 'I-_>IIVGSWDD<TJ0H7*01F1V [*HY)]JDM;A
M;NTAN421%EC60+(I5@",X(/(/M7DYU[4[/PWX\M[>ZUF(:=9Q7%F^I'_ $F(
MNCY^;J1E,C/J:TK"YU'Q+K'A_1Y]6O[6W3P[#J5P]I-Y<EQ,Y"#<PYP,,<=R
M>: .\TS6+35S>BT9R;*Z>TFW+C$B@$X]1\PYJ_7#?#**:"V\30W%PUQ+'K]R
MK3, "^%C&3CC)[X[UK^-;Q;3P^,ZI<Z>9KB*$/:0F6>7+<QQ <AV (!P<<GM
M0!T54-:U>TT'1[K5;YF6UMDWR%%W$#V%<KX!U&ZFU?Q!IDLFJM:V;6\ENNJ\
MW""1&W GJ1E<C/K5GXJ?\DO\0_\ 7J?YB@#L <@$=Z*\^EBU+POXI\,N^N7]
M[%JLDEM?0W,@:/=Y3.'C7&(\%3P.,&L73M<N8]=T"\M-7U[48]0U%K>>XN8#
M'8SQLLA'E(?NX*K@CJ >3F@#UNBO+M(U.[LM?1==U;6[/61-.SVMTFZRO8QO
M*K 0-HPNTC!#<$$&J'AO7M:O&\/:M$?$US=W]Q&;^.:T?["(9>I3C:H3*D,#
MR <YS0![!117F>FWMW!XN2'7-7UK3]4DU"58HYDW:?>0EFV1Q$#:#LV]2&R#
MUZ4 >F5E:;XAT_5=7U72[5I#<Z6Z)<ADP 7!(P>_ KSEM=N(=;T[4++5]=O_
M +3K26LD[0F/3GB>4H8T4\?+P PSDJ3GFETN\%AXE^*MT=173=CVV+PQ>;Y)
M,3 ,$_B.3P.YQ0!ZU17DMMK%_8W>N65M=>(1;GP]<7L;:QD2K,A #QD\@$-T
MXP0.!3_^)[I7P[TOQF=<U*]NE2TO[ZW>7,36^W]XBICCY7W$G))3- 'J]%<A
M!J=SK?Q'6&RNW_LG2[ 2SB-OEFFGYC!]0$7=_P "%=3=S+;V4\[S)"L<;.97
M&50 9W'V'6@":HK>Y@NXO-MIHYH]S+OC<,,J2K#([@@@^A!KRK0]1NG\0Z%:
M0ZMXDN;?6(+B.YNKZ,PQ3$1%UEMU/,?(X [$=:VO@Y9F#P#;W37=U,UQ-<92
M:7<J%9Y1E1VSU/J: /0**Y_QG>+9^&Y6.ISZ<998XEFMH3+,Q9P-D:C^-AE0
M<'&<]J\[N_$&JZ?X=\;06EWK40L+:TN+1M4)^T1-(S!ANZE3L&,^IH ]DHK@
M_(U#P_X_\/VYUO4+V+58KI;N*ZD#1[XT5PR+C"<Y&!QBN\H **\DM]=N(M;T
M>^L]7U[4%O=6^S37$L)CT^6)RXVQ*>FW PPZ[2<G-0W$NMS>!O$GB0^(]3CN
M]+OKS['''+B()%,V%=<?/T(YX QCOD ]AHKSY8M0\2>/-:T^36M1L]/AL+.9
M8K.;RV$CB3D-C(''('7C/2L_PIX@U>^NO R7=_++]HAU*.Y).//,+A$9AW.!
MGZDT >HU3U74[;1M)N]3O"PMK2)II2HR0JC)P.]<%?:W<K-XSAN-;NK**+4K
M6WMW@B,TJAXHB8X5'\;$L <'!.>U8]SJ-U)X6^(6E/)J[6EMI2S0+J_,Z&1)
M0PR>2OR C/J: /6-.OX-4TRTU"U+&WNH4GB+#!*L PR.W!JS6#X'_P"1 \.?
M]@NV_P#12UB>.9M3E\4^$M)L-3N;"/4)KF.X>!L,46+=QGC/!P>Q.: .YJ(W
M, NEM3-&+AD,BQ%QO*@@%@.N 2!GW%>:>*97L[FZL;?7O$MQ/ING)Y<6GH28
M'PQ$MQ)T<M@':>P)QSFJVDK-J_Q,T35KF_OEDG\+Q:@\<4VU-Q>/<@7^X>I7
MN: /6:*\<\/>(=:U!-#UJ'_A)KB]OKN-KR)[5S8BWD;!"<;0$4@A@<G:<DYK
MV.@ K$\0>*],\-RV4%[]HDNKYF2VMK6!II92HRV%4= ",UQJ+JOB33O$^NC7
MM2LI[&[NH+"&VE"0Q"#@%TQARS D[L\' Q6)J,3^)?''PTU.:_O[>75K&XG<
M03E/(;[,K'R_[N2>?6@#V:-Q)&K@, P!PPP1]1VKGM<\>>&O#NH06&IZK!#<
MRN%9-X)B!4L&?^ZO'4^HKH479&J;F;: ,L<D_6O+/$&EZSX?\3V]W8V5IJ]C
MJ&MFZ%OY@CN/--K(C1DL-I3:"1DC'3OF@#N->\9:#X<TI-1U#48%AEC,D"HX
M9IP!G]V,_-QCGIR*T-+U?3];L5O=,O(;NV8D"2%PPR.H/H?:O)]>T^.[\&2^
M)/"D%O#8)HEQI\^G7FY9((P[%MA&<.&# @\''7@5L3>,K+2['5HH--CT+Q-=
MWD<$T%U*OEK-(GRSEP=I0(I8GC)7!&30!WEIKNEW]SJ%O:WL4DNG/LNP#Q"V
M,X)/'0'Z8K.TKQUX:UK44L-/U1);F0,8E,;H)0O78S !\?[)-<CX$LO#XUWQ
M;H%M>VU]:316R-B<.UR##B5R0<DEF.XCN:TRL'BGQ-H]MH\*KHOARX,DEXHP
MCRJAC6"(]P-WS'IP!UH ZMO$&DIKT>AF_A_M1XS*+8'+[1W..GX]:T68*I9B
M  ,DGM7"ZCIUGI_Q4\,-:6T<+7,6I33,HYD<B'+,>Y__ %5U7B VB^&]4-_*
MT-F+27SY%ZI'L.XCW S0!GZ?XY\-ZKJ$5C9ZFLDTQ80DQ.J3$=?+=E"OT_A)
MJ_-X@TF#7;?1)+^$:G<JSQ6P.7*@$DD#H, ]<9QQ7F%M)K!TGP)!KNGPV>C6
MUY;>1=PN&E=PA6 21](@V1NPSX)QQFNFUK3K.R^)GA&:VMHXI;J>]EGD4?-(
MWV?&2>_''M0!U.L>(-)\/PPRZK?PVJS2"*+>>78]  .36E7"?%/3K-O"5WJ3
M6T;7JO:0K.1EE3[5&< ]LGKCKQZ5W= !16-XON9K/P5KUU;2M%/#IUQ)'(AP
M481L01[@BN*!U?0X?!VMOKVH7DVJ75M:WUO-(&@83(>43'RE3C!')'7- 'IU
M%>23Z[<0ZU9:A8ZOKM_Y^N1VDDQA*:<8GF\LQJIX)4' <9RRYS6BOBJ^\-:7
MXRL+^XENK_2I/-T]I#N::.?_ %"_[6')0_04 >E50DUBTCUZ#1F9_MDUN]R@
MV\;%95//KEA7GVI+=6O]GZ1>:_XBNM0M=,1YX-)1C()F)S-+)T()!"H?[IZU
M1T][_P 6^(?!=Q/J%Q:S7?AV66[FM6$<C_/%D*V/ERV"<=L@8H ])\1>(;#P
MMHLNK:FTBVL3*K&--QRS!1Q]2*U:\,\;7=ZOPT\8Z+>7L]Z-*U6WB@N+AMTC
M1.T3J&;^(C<1GZ5T7B#6+R^\7ZUI_P!H\20QZ=%#':C1K=W42O'O+RE0=W50
M%/& >.: /4:HW6J16FIV-@\%T\EYOV21PLT:;1D[V'"YSQGK4/AN[OK_ ,,Z
M9=:G;O;W\MLC7,3IM*R8&X8/3G/%<UXJU2_M/B=X&L+>[EBM+PWOVF%6PLNV
M)2NX=\$YH [FBO(;EM:NO"?C#7SXCU.&XTG4+_[#'#+MC58I&(5UQ\XXQ@\
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MJ5SI=[%J$>H[+>\>.TEU&$QS2P;592P(&2"S+GOMKJJ "BBB@ HHHH ****
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M8@\OIL"97&>_6NR,\(@\\RQ^3MW>9N&W'KGIBD2Y@D2-TGC9)/N,K@AOIZT
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M6\M4@1SN<8D,;GE-P'/!Y)(Q5^?P;:/K_AG4H)F@CT"*:&"W5<JRO&(P">V
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M^*.E75FEP]OHT;C4;@Q,D4LBN##$,@;BKAGXR!^->C"ZMS<FV$\1G R8MXW
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MQ<?.[ +S[FI 0R@@@@\@CO0!Q[>!&O++7/[4U>6\U'5[/[$]WY*QK#%AL*B
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MC)R4?8PW*2/NG(IMCX/T/3;JWN+2S,;VTTT\ \YRL32C$FU2V #_ '0, DD
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MT,+01R[CPC$%AC..JCMVJJWAC1VTS4]--I_HFIRR2W<?F-^\>3[YSG(S[8H
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M8:#>:)=:Q'J"K96C%+AY4:-H6&,JR, P/(XQDY&*YSQE?6.G?$GP1=:A)'#
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MM6O $!N3"OF,57:#NQG(&1]#5R&WAMU98(DB5G9V"* "S'+$X[DDDF@# O\
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MPQJFEPO'!/?6YA\YDSCTSCDBMNB@"O;V5M;,9(X(4F< 22(@#/CU/4T@T^R
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M]<3S0SR-&+E96WY^XP0JQ(V_,"#U&.7:'X(U'3;[PY<.;.**PN;ZXEMH';9
M)P=L<61RJY[X]A0!L>%-8U6ZU/7=&UF2VGN]*GC47-O$8UE22,.I*DG!&2#S
M7/JFO3_%+Q5#HES9VA-I8M+<7,#38(63:H4,O7)R<\8Z<\=3H^B75AXL\2:I
M,T1@U)[=H0I)8".((VX8XY''6LF?2/$VF^--9U[28-.N[>_M[>$6UQ<-$VZ,
M-\VX(PXW=.^>HQR 9UCXXUG7K30-/L([.TUC4#<B[ED1I(K<6[;'*IN!;<V,
M G@'G-,U#QOKVC:5XAMKB*RNM7T>YLT62-&CBN8KAU"G:6)5L%AU(R :DLO
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MQW#CI@8XY.*Z;3-(UK4/%T7B'78+.S^R6CVMK:6T[3<NREW9RJ]E   ]:?\
M#SPW>^%/",6E7[PO<)/-(3"Q9<.Y8<D#L: +6DZW=7WBWQ'I<JQ"WTW[-Y)5
M2&/F1[FW'///3I7)V'C7Q+K%MX.BLUTZ*YURUNI;B:2%F2$QE<,JA@3P2,9Y
M)'(K9GT?Q'IWC#5]1T>/3YK76(X \ES,R-:O&I3<%"GS!@@XRO(ZCK7*PZ)K
M7AK5?A]IEN;.?4;&QOPZ/(RQ3#]WE=^TE>#G.T\CI0!VWA/6M2O+_6M&UDV\
ME_I,Z(9[9"B31R('1MI)VG&01D]*PX+S6D^+NLB;4[<:;::;#*\/V=L^46D.
M =^ ^>K8.1@8&*W?"FBZC9W^M:SK MX[_5IT=H+=RZ0QQH$1=Q W'&23@=:J
MW'A_54^(5UJL,-I/I6HV$=G="29DDBVESE0%(;(;U'^(!BKXN\3P>%[/QI=-
MIW]CW$D3OIRP-YL5O(X56$N_#. RDC:!UKO=7U6UT32;K4KQBMO;H7; R3Z*
M!W). !W)%<&GA#Q-/X9L_!EW_9W]C6TD2OJ"SL9IK>-PRH(MF%8A5!.XCK7;
MZYH.G^(M/%CJ44DD D64".9XB'4Y4AD(/!YZT >;Z8-3T?Q?K^LZB3_:MQX<
M_M"6+.5@822;(A[*JJ#ZD$]ZCN-!T_0OAIH/BBTMHUUN![*\EO@/WT[32()0
M[]6#"1A@^U=%;?#6QMO&4NHJURVGMIWV8)+J$\CF0L^[.YCE=K# )(SSC/-5
MK?PIXGN-,TKPQJ3Z<=$TZ:%FO(Y6,UU%"P:-#&5PI^5-QW'IQ0!AV]WINGZQ
M:3S201:]:Z]?7&IR' E2S"S'<YZ^7L\G;GC[N*UM'\4);:QJ&M:IIEZ9IVMX
MYY@$V:;!(?W$3 L&R=P=]H."XSTXZ[7M&GUR\L+:0Q#24D\^\3)WSE"#''C&
M-F[YCSSM Q@FL/6_">K7VI:Q!;&T_LW6IK::YFDE82P>4$5@J!2&W+&N#N&"
M30!M>,->N- T>*2RACFO[NZALK5)2=GFR,%!;'.!R>/2LJ+5/$EAXDC\/:E>
MZ?<3:A92SV-[':,@CEC*AE>/S#N&&!!##H1[UJ^+]!N-?T:**RFCAO[2ZAO;
M1Y02GFQL& ;'.#R#CUJAIVD:WJ7BZWU_7H+.S%C:R6]K:VUPTQ+2%2[LQ5<<
M*  !Z\T <S\%[*^73]4OIY[)XY-0ND?9:%9FDWC+&3>?EX/RX].>*Z^TU^[3
MQ[J7A_4!"L/V2.]T^1007CSMD#$G!*MCIC@U%X!\-WOA?1+NROGA>66_GN5,
M+$C:[9&<@<U@_%:T>\?0HM*O$AUZ:Y>R@4<L89HRLQQUPJX?/;:* "S\;:]K
M%OI45BEE!/KM[=&PFEB9EALH?^6C+N!9VXQR!\PI=1\::[H6G^([.]^Q7&IZ
M3]DDAN$A9(YXII F2FXD,/F'#8Z5LZQX7N8&\.WGAY+?[1H(:*&VN'*1RP-&
M$9-P!*G"J0<'D5D7_@G6=>TWQ-=7\EG:ZKJT<$=O#'(TD5NL#;T#/M!8LV<D
M#CMF@#I=3UNZL_&F@Z1$L1MK^"[DE+*=P,0C*X.>/OG/'I63\.]<\1^*='M]
M=U5K"*RGB=([>")@Y=7V[RQ8X'##;CT.>U+;Z1XFU/QCHVNZO#IUI#8P7$)M
MK>X:5LR!/FW%%SDKT[ =3GC2\":%=^&?!>G:/?/$]S;!P[0L2IR[,,$@'H1V
MH Y[4UUF;XPSP:-/:VLCZ#$9+FYA,H11/)P$#+DDGN<  ]:=#XOUBY\,-)-=
M:-IE[::G+IVH7UTV+>+R\_.BE@6+?+A2W<^E:&J:/XAM_'C^)-(BL;J Z8ED
MUK<3M$SL)'?<&",!C(['.3TXK'A\$ZY8)IFJ+%IU_J<>I7>H7=I+*T<)><8^
M1MK'*   E>>>E $*?$2^FT&-QJ6D)C6'TV;6A&7M%01^8LNT/P6RJ\M@$GFK
M^J>+]4TK3](M+S5-"M[O4KB54U5F_P!%\A%W>8%+CYCE0%W8R<Y[4EAH7C'2
M&U5EAT6_COK\WDL$DK(LRO$JM&/D.W8R#!.=PZ@&J]MX$U2QM;34+:TTK[=;
MZA<7:Z7O/V5(9D"M"K[.""H;.W&[/&* .B\%>)7\06^HPS75C>3Z?=?9VNK$
MYAG4JKJZ\G'#8(R<%365_P )/K5YXOO].M+_ $>W>RNDB72KM&6>YA(4M*K[
MO1FQA2/EYKIO#UMJ4%G,^J6]A;3RREU@L02D28 "EB!O;@DG ZXQQ7->)?#O
MB#Q!<26,UEH\MM]I26UU5I&6XLT#*V%38<N,$ AP#GF@"GXG\;:EX?U.ZEEU
M?0(HK>XC2/2&;==7,3%0S[MXVM\S$#:>!SUHL7=/CIXB>- \BZ)"54MM#'<,
M#/:H=2\%>))]-\0Z/:)I20:A>R7R7[RMYLFYPZQ,NSC! 7=D_*.!Z7KGP9J^
MH^)O$&J32VUJNK:$-/41RL[0S$<G.T94$\'@GT% $?A[QI?3^*M.TF]UK0=3
M>_AE:6#3/O64B*&VEM[;UQN&<#D5GV'B_P :WW@6Y\7(FEF"V60BS6!R\RQS
M8=]V_P"7Y%< 8/(SWQ6E8>'?$RZIX9O)K+1[2#1PUNUI;7#$,CQ[&E#>6.1@
M$)CURW/&WX+T*7PSX(M])U5[=FB:<RLK9C*O*[CD@=F&: &7_BB:;6?#%AHI
MAE750UW-(ZE@EHJ EA@C!8L@!]SQ6;X\:^'BSP6--$/VQKRX6-IP2BYMV!8@
M$$X&3C(SC&1UK.^$VC&,ZEJAN/M-E#(^F:1+ZV<<KL"#W!9L9[^6*Z/Q9H>K
MZEJ_A_4M(>T$NEW$LSI<NRB0-&5V@@'&<XSVSG!QB@#*7Q-XBLG\0:1>3:2^
MI:<EO-#?2@V]N89207D4L<%-K<!N>.E9\/Q"OHM)\2>5J&DZS+I:VSQZA9QG
MR=DS%6,B*[?ZO:S'#<CTJ2_\&>(-8N+_ %R\ATY=1ENK.2+3O/9X3#;L3L>3
M8,EBQ/W<#"U=@T3QE;ZYJFL0+H\<U_;6ZB RNR0F)V_=9V?,&1S\_&"?ND4
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M*** "BBO%[R?6O\ A ]?\3KXAU-;[3=4N%M(UN"(@B7&W:Z='&"1ST& ,8Y
M/:*YN]\;:;IOATZW?6VH6ML+@6^R>V*2;BVT':>Q/>L:W@O= ^(VCV7]LZC>
MP:G8W+W,=W,77S(S&0Z+T3[Q&%P,=J\^U'4[[5O@1)<ZA=S74_\ ;83S)G+-
MM$^ ,GL* /?J*\M\0:K>:AXPUVP\SQ*B:='#%:#1D;8LCQ^87DQ]X_,H"G(P
M#QS46J7^M/%IVH>)6\0Z;92:5"S3:4&"VEU\WFM.B?-C[F,@K@&@#U+[5;_:
MS:>?']I$?F^3N&_9G&['7&>,U+7E5K J_%.\U3^U;V\6#P]!>J\<Y6.?YG_A
M'&PXW!>F3FH6EU:P^'>G>.VUW4IM3D-M=SP-.3;21RR*#$(ONJ KX!'.1UH
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M;3%#& <C[K9[CG!(&,U!J&I:WIT&J:!;:W>F2R\0V%M;7LLF^413A&V,Q^^
M6/7.1UH ]:"V^GV.V*)(;>"/Y8XU 55 Z #@<=JQ;'QCI^I>'M-UNQMK^YM-
M0F$,0AMB[IEF7<X'W5!4Y/;BN=,=UX=\9OHZ:IJ%[8:AH]Q<&.]G,S1RQLHW
M*QY (?ITR*X[2M3OM,^"WP_>QNYK9I];B@E,3E=\;2S94XZ@X'% 'NE%>?\
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MJ-C%J>F7=A.6$-U"\+E3@[64@X_ TZ*\M9Y!'%<PR2%-X5) 3MSC./3/>IZ
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M^2D@FAX.'0\<$9!'3GUKL:* *6DZ>VEZ9#9O>7-XZ E[BY?<\C$DDGTY/ '
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6 S"&17&&=1U3D@^@)-<KHJS>)O'^I7*ZU9ZH#H#V<UU81XM8'DD!5%^9LG
M9C\Q//;@4 6]+U/Q!_PKB'Q'JOBJ&VGO[:V8/+:IY=L"0"R*JY>1@> <C<0
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M>2,,3]2:7XH"X.AZ0+1D6Y.MV0B9QE0_FC!([C.*W=2T)K_Q1H>L"X"+I@N
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M;-LBN V#&W( &" >IQ0!C:G?ZCX/\8>(;^YO6U.6S\-));2SQJKM^_<*'V
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M1"7+)OR>6#*,97 % 'L%%%>?:UI5MKOQ<M]/OWD>Q&A-*]L)65)6$X W $9
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M"02I"*3[TQ[F+5+#Q'K]X^HR6^K:E%IFG6]C*$>:.)]@56/"K(X?<<CY<\T
M>DZYJL>A:#J&K2QM+'96[SLBG!8*I.!^5.T;4DUK0]/U2.-HX[VVCN%1CDJ'
M4, ?SKR=TEL=$^(^EC3FTNUCT9)X['[5YZQL\<P9@1P-P1<CVSWK7\+R.-5^
M'<8=@C>&')7/!(2WQQ0!Z?5;4+^UTK3KG4+V40VMM&TLLA!.U0,DX')_"O,9
M[N"2/Q5:79U"Y%UXECMH;6SF"/.WDQ-Y18GY4(5MW(X!K!UJTV^#?B%IDVG-
M86]BEM<V]C]J,RV[NAR5(/0X!V].: /9KB_N8[_3X;?3I;FVNMQEND=0MN
M5+ G)W=. ?>K]>7:O:0Z/X[^&EA8!X+4F])B#L0<Q*W.3SR2:I)I5OKG@;Q+
MXKOI9QK<4U])!="=U:T\EG$:)@X4#8..^3F@#UZBO+=+L(?&'C.4ZV)9H)-
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M]5L[S[/_ *[R)0VSW..W!YZ<4S3/%.@ZU)/'IFL65V]N-TJPS!BJ^O';WZ4
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MQO;(W 8&!VXK6K)U;Q/H6@S0PZMJUG92S<QI/,%+#.,\]O?I3]1\1Z+I /\
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MGR75TACGE:W4M*I&"&..01Q5NSTO3]/W_8K*WM]ZHC^5&%W*B[5!QU 4 #T
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MY#[7)Z@,!]*]-<A48L<*!DFLM/#.A1ZPVKIH]BNI,23="W429/4[L9S[UJT
M>46'VG0[?1-.M9M+UK3;B*>/0[V%-MU;MY+L"1R&& 5+#!R>14'A6PO+O0_
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M:O.]O;Q1//)YLS(@4R/@#<V.IP ,^U3T %%%% !1110 4444 %%%% !1110
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M20:$ZRK=3VKW4;E1L958*R@YSN&X'&.E9UAXYT;4;+7+R%IEAT5Y%N6= ,A
M<LG/*G:V#QT-9/Q)>ZTF'2?%%C;2W%SI4[JT42%F:.6-D(P.OS>6?PKC]5\-
MW^D0Z/X>@MYW3Q!IMM87TL:DA)(YE>5V(Z9267KZ4 =K:>)[&Z\6DP-K<ET^
MA+?KIN$\KRRPP0N<^=D@=<8KF_\ A85_J?@_PYKDL%W8"76H8YC''\MQ$6E^
M5 "2W"J".YZ5L6UI+'\>[B=;=UMAX<6-9 A"9\\?*#TSCM7+>'6:7P'X,TH6
M]R+[2]?@%Y"]NZF']Y,<DD8(QSD=.* /3-#\56^M:E=Z:UA?Z??6L:2M;WT:
MJS1L2 Z[68$9!'7K6=J7C&ZLOB'I_AR/2KJ:">V>625(U/.Y K EA\BY;=QG
MIBECAE_X7!<S^4_DG08D$FT[=WVB0XSZX[51UVY32_BUH5]=I,MI-IL]HDR0
MLZ^:TB$*=H.,@=Z ,[P[\0UT_0)I]7M]5NX8-1N(;G4$B#16X\]E0.2P. I7
M[H.!BNHUCQK9:1?W-H+#4KTV<2S7LEG"'2U0@D%\L"3@$X4$XYQ7$SV5S_PH
MGQ';BVF\]Y[TK'Y9W-FY8C ZGBEUBTM=-\7>)'UB_P#$-I'J!BGM$TW>5NQY
M*QL@"J07#+C!(X([4 >DW^KQ6F@2ZO!%)>0I!YZ+;X+2+C((R0.G/TKSQ?'N
MH7FE>"-7N;>]M3>716YABCXNLV[,!&H8DJ7QC..1S7<Q:<MKX'73+.&=5BT[
MR(8IB#( (]JJV.-W0'%>>>'9UO\ 2/AM###<&33K@P7:O;NGDNMK("#N [XY
MZ4 =M;>/-+DLM7N+RVOM-DTD(;NWNX@)%#C*$!2P;=T&#UXHA\<V1M]2>\T[
M4M/GT^S:^DMKN)5D>$ DLF&(/3&,@@XSBN/\6Z1?:CJWC@6UO=,?(TF9/(!#
MR"*1W<(>[ #@>N*9-:Z5J.E>);S2KSQ%JMQ'H%U +B^#&,;USY2AE5B^5!P
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M]K),)&C#JT?R@X;)! ..M &K%X_TFZT*QU6R@O;P:A/);V=M!$#-.R%@Q +
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MYGFN)K&*221SEG8J"2:Y'PE\14MO"=G-K$&JW""XDAN=4,0:")C,RJ'8MNP
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M^5O7S,;MF><>N*=7$R:W96WQ9N[.73;=)8-!^UOJ SYOEB7!C_W>_P!:SO\
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M9?A+Q-KGB)++4)+#36TF]C,BO:71>6U.,A900 3V.WH>V.: .QHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *RO#VAQ>'M+:QAF>93<33[G !S)(SD<>A
M;%:M% !1110!@6OAC;XG?7K_ %*XO[A%>.SCD5%CM(W.2$"@9)  W')P*WZ*
M* "BBB@ K \0>&/^$DN+>.\U*X72D*O-I\:H$N&5MPWMC=MSC*@X.*WZ* "B
MBB@ HHHH **** "BBB@ K*FT.*;Q3::Z9G$MM:2VHB &TAV5B?J-@_.M6B@
MHHHH CN$DEMI8XIC#(R%4E"@E"1P<'@XZ\UD>'O#<>A&\N)+R>_U"^D$EU>7
M 4/(0,* % "JHX '3)K;HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!1TBXU"ZTN&;5+)+*];=YENDHD"?,0/F'7(P?QJ]110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M><:]HUMXA^,%OINHF62P_L%II+=9&192)P!NP1D#.?J!7.W-EK6OW'B2]LM
MN;K5H-2G@L-3&H)']E\I@L:JA8$+QDC'S;CUH ]IHKS2VT2T\9Z[XKEU\RK/
M8SI:VI6=D^Q*(4?>F#@,68G=[#M69?VEUKOBK6+.32+KQ#%86MK!:7*W\</E
M;HMYF7D NS'.X?W0!0!ZA/>7<>KVMI'ILDMK*C-+>"10L)'0%2=QS["KU>3[
M=4;X@^ +/7"WVQ]'N8[U/,W!W$>&)(.#GK^-5?M]]%X&F\!K<R?VO_:W]B)*
M6^?[.Q\P2_3R">?:@#V*BO&[_3+W6=:\2V\'AZYOWT^1+'3KE-06'[ %@1E*
M!F!SN;<6[\#M7JVG2W46A6DNJ[8[M;9&NL$$*X4%^G'7/2@"]17C6E!;;6?"
M>L:=I5[:Q:E?E3J=Y>J\]_%)%(W[R->,'"L/3 X%5;C1K:3X8>(O$,CSOJME
M?7LEG<F9@UMLN&P$YP!G)/KGZ4 >WT5YQ#H5CXF^(WB6'5T>YM8K.Q9;8R,(
M]S+)\V 1R,<>F363X+N[F>]^'XGN)93]AU.,L[DE@DB*N?7  H ]=K-\0:Q'
MX?\ #U_J\L32QV<#3-&IP6 &<"O.[RZMVE\8VEU]NN%NM>MK6&VLY@CSL88C
MY6X\*AP=W(XS67<)+8^&OB3I?]G#3+:#3H98[!;GSDB9XY-Q![;MJG'^- 'K
MVDZ@NK:-8ZDB&-+NWCG5&.2H=0V#^=7*Q/!O_(C>'_\ L&VW_HI:\OTVTUW6
MK0Z[9>'KB76FU-Y4U8ZBB@(EP5,6PMD)L4IMQ[T >UT5Y(VDVFNZ/X\U[4&E
M.IVEW>P6UR)64VT<*815P< =R.^XYS6CX,D<^*]"0NQ4^#;5MI/&=XY^M '>
M:K>7=E;))9:;)?R-*J-%'(J%5/5LL0,#TZT^/4[.759],28&\@A2:2/!^5'+
M!3GIR4;CKQ[BO&=?N9O^$$OG2=\_\)I(H8.?N^>>/I6Z/"6E:U\3_&-M-!L>
M33[<I*K-NC>590SCGKW_  H ]4HKR6VU6[\5:+X7\*W+LNH"\:/60&.0EF1O
MR?\ ;;RO^^J]!\6WEMI_A/5+F[GNH(%MV5I+,@3#=\H\LG@-D@ ^IH V:*\8
M30)Y-9U'P[:Z/)H::AX>GD$ OO.,DR21B.1L'A@6()SSZTE]XBN-=DT7Q-%/
M((= L+.[NT5B 7GE"S*?7;&CG\: /:**\CNI(-6N]8N[J&^O?[4UQ;"QL;6<
M1K<):HP8.QX$982LV.NT?2LG4VN[/P3XQTV&)]+6TU>Q%O;1W'G"UWF!B%;T
MR2<=!DB@#W*LG3M=CU'7-9TM(71]+DB1W)&'\R,.,>F <5Q>J>&M+A\6>&O"
MRPR?V-,EW?3P/,["YF41@%R3EL;BV/6L=/#EQ+J7C/3-'0W4-OJ=C(]E+<LG
MVB$0*3!YG4#D 9XPH!XH ]BJH=3LQJZZ49A]M: W(BP?]6&"EL].I KG? ;Z
M<MGJ-I8V-]IDEO<XN--NW#?97**<1D$C8P^88.,D].E8=UI%@_QTDNFM!),F
M@K=K\QYE6;:&Z^@ H ])HKQ1K"&+X/Q>.EDE;Q-M2^-_YK;VD,HS'UQLP=FW
M&,=J]=UB\@L-#O[RZFD@@@MI)9)8OOHH4DE?<#I0!>HKQW2%ET#Q+H4UCH=Q
MIB7FGW3.;B]$TM]LC5U:51P'S@Y_VB*VO!OAK3;CP_X;\3RWT\.LW(CN;B\^
MT'==O(,M$X8X*DG 4#C:,8H ](HKPJ^TJUOO@E?>++AY1KEVSRS7?FL&.;C9
MY9YQM"X4+T& >M>@Z%*W_"9^/ \AV)+;8!/"C[,I_"@#IKN\NX-1L;>#39+B
MWG+B>Y6156WP,@D$Y;)XXS[U>KQ+1[B8W'P<S-(?,@N]^6/S?NEZ^M:&DV:Q
M6GCWQ03+-J>E:CJ7]GEI&*P8CSE5SC)W<Y'0"@#UVBO*O"6C:M;:KX?U"R\/
M7%C$T9_M*\EU%)?MB-&2'90Q);?M8''&2.E=+\0Y9&L-&TX2R16^IZO;V=T8
MW*,8FW,R[AR-VT+QV- '845YEXJT:T\)Z%?6^A7T]E#J5Q9V\MK%-Q;(\H1Y
M$[H6!()Z<>M3W.DV7A+QWH-MH<1M+;4[6\CN[='8H_EHK(Y!)^8$XW=3NH ]
M&HKPNST*W7X>>!]82>[CU:\OK2VEO4G<2F&5BC(#G@;3@8],]<FM/Q#86_AR
M[\<:;I*O;64GAD7AA61BHFW2KO&3P2 ,^N* /8:*\ENO"]A!XB\$I&]RK:M%
M-'J<@N'#7BK ),.<]-R]L<$CIQ5*\WZ+#XF\.Z;--:::^OV%HHCD8&WBG6,R
MA#G*@Y/3IN- 'L]%>7ZUI=IX2\3VMIH<;6MKJ6DWXNK='8H3$BLDF">&RQ&>
M^:S;31[;3/#/P^U^W:;^UKF[L(I[MI6+R1RIAHSSC;@@ =L"@#V*JVHZA:Z3
MIMSJ%]*(;6VC:660@G:H&2<#D_05G>+=/OM5\*ZA8Z;*(KN:,!"9"@;D$KN'
M*[@"N1TS7E7B*TTE? /BVQ_L.]T6_M[2*Y?3II_,A!W,JS1$$@Y^92>/NC(S
M0![<CJZ*ZG*L,@^U+7F@T'3;_P ;V'AFXM\Z+9:+]MBLB[>6\SS%69AGYL <
M9Z;JQ5>7?_PB9N+C^QO^$J-C_KFS]G\CSO(WYSMW<=<XXH ]-\3^((O#.B/J
M<T#SHLL46Q" <O(J \^F[-;%>4>/="T[PQX&UE-+FF,#W=C-_9JR;U@(F3[B
MGD;\=,XR.,<UL^"+A_$.OZKJ^M"6#7+.4VJZ7(>+"(\J0 <,7')D[]!@"@#L
M-3O+NSC@:STV2^:2=8Y%CD5/+0YS(=Q&0/0<\U>KSWXN2R1:5X<,;LA;Q#:*
M=IQD?-Q4$7AS3_$OCWQI#JZ27-O";00PF5@D;-;C+@ _>X&#VYQU- 'I-9&@
M^([+Q"M]]E6:.2QNGM+B*=0KI(O7@$\'.0>]9OPWN[B^^'&@7-U*\LS6BAI'
M.6;'&2>YP*R;S'A/XK07^1'IGB6+[/<$\*EW$"8V/IN3*_44 ='J/BBST_7X
M-$%O=76H36LEV(K=%;;&G<Y(QN/RCU/I5G0-?L/$NBPZKITC&WER"KC:\; X
M96'9@>HKE?A[&VMZAK7C:=3_ ,32;R+#</NVD1*KCTW,"Q_"L+QAHU[IGC"W
MTG1;_P"PV'C&1X[]%7F)T :22/L&=,J??GZ '5S_ !(T6'PU?^(1#?2Z99W/
MV831Q*?/;<$S%\WS+N.,\=\9K;D\0:>OAB3Q%'(9]/2T:\#Q#):,+NX'K@=*
MY;X@Z?:Z5\/+6PL85AM;>]L8XHUZ*HN(\5AZ_GP7I_B;PX_RZ+JVG7EQI3?P
MP3>4S2V_L#]]1]10!UU_X]L;*XTZWATO5K^>_LQ>Q1V=NLC"+CEAN&/O#\ZO
MZ)XD;6KJ2 Z%K.G[$W^9?VPC1N0, ACSS^E<!&FL/XP\)#1)K&&Z_P"$7Y:]
MB>1-FZ+(PK*<YQW]:]"T2/Q)&\W]O76ES(0/*^PP21D'G.[<[9[=* -FBN,\
M52_V/XR\,:X\ICM7>;3KHYXQ(F^,GZ/'C_@5<'8ZUJ&B:'KM[))*USXDTPZG
M9(S'Y)I9FC55'LLUOQ[4 >PF\NQK8LAILALS;^:;[S%V!]V/+VYW9QSG&*S;
MKQ?I\5CIEY:[KNWO]273D=,KM?>R$\CD!D8>_:N+LM+2R^+NG^'Y7>:TC\'B
MWD1F.),3%23[GGGKS7-Z-HEE_P *Q\)F%'@EOO$:)/+$Y#L%N)U&#G@A>,CG
MO0![Q17!:%IEIX>^*5_I>EQFWL)]'BNGMP[%/-$SIO )."1C/KBK7CH6E[>:
M-I4VGW>J3SR2S1Z?%.L4,JHH#-,Q_A7>N!W)'!H [.BN+^&<DW]A:E:RQM"M
MGJMS;Q0&;S?(0$$1A^X4D@5F#0-/\1_%#Q1;:LKW-K#:612U:5@FYED^? (Y
M&, ]LF@#T>BO#=.NM0U>U\-:+<6%QKMG"NHDV[70C^TB&<11L[,0&"J>GK@]
MJNZEI>KQ:-X<TG4H[K3H9?%'E6\0NQ)(EH\3G9YBD],LHYR !Z"@#V6BJFFZ
M;9Z/IT-A80B&UA!$<8).T9SU.3U-><>'M.7P]XETZ+7=,O+?59KB5(]:@NO,
MAU%F#MME!.5)'(4C@KP: .]\,ZY'XE\.6.LPPO#'=Q^8L;D$KR1SCZ5JUX7I
M6B6>G_"3PSXD@\T:Q'<VA2Z\ULJC7"H8P,XV;21MQ@]3R35SQN\4L7B;7M.T
MN]N+G3[@(-7GO1&+66/8"D*#DJ#U]2S<F@#VBBO.(-&M=;^,'B#^T#+-!96]
MC/#!YK*@EP^UR 1DC!QGCDUS>B6FNZQ96FOV?AZX;69-0,[:LVHH T8G(>(H
M6SLV IMQVS0![717-?$'4+O2_ &M7EB[1W*6Y"2*<%,D+N![$ YS[5R^A^&+
MR/78X5\+S:5HMS936VHI)J"3"X)"['PK$[Q\PW=?FH ]-HKR'PC=S:[XKM=!
MU'46N--T$R2:=,=P_M0HY0.6Z-Y0X..K?-R*I:=::[K5HVNV7AZXEUIM3DD3
M5CJ**%1+@J8MA;(0(I3;CWH ]KHKS#1=,@NO&7C35KE9;F;2[X/91-(VR)_(
M4DA0<$G@<^G'4U/X-\-:;<^'_#?B>6^GAUFY$=S<7GV@[KII 2T3AC@J2<!0
M.-HQB@#NM,O+N\CN&O--DL6CG:.-9)%?S4&,2#:3@'T//%7J\9\.:?J>N>#/
M$4%H/M;1>*IWEM)+@Q"YA4J6BW_P@_EQ@\&EO;J!=*M-#TK1]3MA/K:0W^B3
MW00H/(:3RT?=@1OL#<-@_,.,XH ]EHKC/ NFZGIEYK$4^D/I.E2-%)96C723
M"-L$2!=I.U20IQZDXKLZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *R]?T"Q\2:<MCJ D,*S1SCRVVG<AW#GZUJ5@2>-_
M"\5U%:R:[8K/*YC1#,,[@Q4@^GS CGN#0!L7EG;ZA93V=W$LUM/&T<L;=&4C
M!!_"L'2O!&FZ7J%K>FZU&]DLT*6:WMR95M@1@[!ZXXR<G'>K]_XHT+2[LVM]
MJMK;W&Z-/*=\-F3.P8]\'\C4.E:N9KK6_M6JZ;-!93E<094VR@9(E).,]\\"
M@#)N/AGH=S%=VTD^I?8;F5IS9"Z/D1R,VXLJ]CG)P<@$Y %=E61I/BG0==6=
MM+U:TNA;C=+Y<@^0>I]O?I3M(\3:)K\DL>DZI:WCP@%UBD!(!Z'W'OTH IZ?
MX*T73$UM+>&39K3NUVK/D'=NRJ^@^=N/<U7D^'^AR>!SX19;C^RV.YOWO[QC
MYGF9+=SNJE\1_'2^#=-M4M9;(:E=W$<42W1.Q$8X:1@""5'U[U>A\::+I^CV
M$^L^(=,::YC+K+#E$E )!95)8A1TR3C- &C+X<L)O$]KX@<2_;K6W:VC(?Y=
MC')R/6ET#P[8>&K6ZM]/$@CN;J2ZD\Q]QWOC./;BG77B/1;&UM[JYU2TBM[E
M&D@E:4;)%5=Q*GH0%&:F76=.;11K O(O[.,7G"YS\FS&=V?2@",Z)9GQ*NOX
MD^W"S-F#N^7RRX?IZY'6LJ_\":5J&H7-R\U_%#=R+)=V<-R4@N6  RZCU  .
M",XYS6(GQ/L=1TWP_J6GSVL=K>7_ -GOA.V3;IY4C\G("GY >>U=;IGB;1-9
MM+B[T_5+6X@ML^>ZR#$7&?FST&.<F@#.UCP+I>LZA<7CSZA:O=QK%>)9W+1)
M=(!@"0#KP2,C!QQFEU#P/I=[.LT$U]IS?9UM9!I]P81+"N=J,!V ) (P0#UK
M1T?Q)HOB#S?[)U*VO##CS!$^2N>A(]#V/0U+JVMZ9H5JMSJM]!:0LP16E;&Y
MO0#J3["@"D/"6DKK&DZG'$\<VDV[6UHB/\BQLNW!'?BD/A'23XP'B@Q/_:0A
M\K._Y.F-VW^]M.W/I4\7B?0YM,BU*/5K1K*640I.)1M,A. N>QSV-5H/&WAJ
MZL+V]MM:LYH+%0UPR2 ^6#T)]CV/0T 1:MX)TW5]0N+M[G4+5KM%CO([2Y,2
M72@8 D Z\<9&#CC-= L$2VXMUC40A-@3'&W&,?3%<=:^.;77= T35=+U33K,
M7=[#!/%=DN<L,F!2",2],=O:MS5?%OA_0[M+75-8M+6=EW>7+( 0O3)]![GB
M@#(@^&^C01VB+=ZHWV&17L2]V3]D"_P1^BD<'.20 ,\5HMX/TIO#5]H!$WV&
M^>5YAO\ FS(Y=L'MR35K4/$NB:4 ;_5+6WW0^>N^0#<F0NX>HR0./6F'Q7H"
MZ&FM'5[3^S7;:MSY@VLV<;1[Y!XZ\4 3V>B6=CK%]JD(?[3>QPQRY;(Q$&"X
M';[QK&?X?Z1_9VF6EO/?VCZ8\KVMS;W&R5/,)+C=C!!ST(["M_3=3L=8L4O=
M.NX;JVDSMEB8,IQP1]1Z53N_%.@V&K1Z5=ZM:0WTA4+ \@#9;[H/H3V!Z]J
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M\*SZS?8T]['>FI02GFUE3[ZGU]1Z@B@#?L+&WTS3[:PM(Q';6T2Q1(/X548
M_(53U'0+'5-6TK4[D2?:-,=Y+?:V!EUVG([\5QU_X_UVS\$V?B >'T,VH7Z0
MV=BTA$C0OG86XX=L=/<5N:KXSMX?AU<>+M+5;J%;7[1$CG&><%6QT(.0?<4
M;&M:+::_IXL;T.81+'-\C8.Y'#K^JBH?$OAG3/%NC2:5JT326[LK@HVUD8="
MI['J/H36)JWB7Q!_PET&@:%8:;-(VFB_>2]G>, >9LVC:K>U;&B2^)Y)I1KU
MKI,,04>4;&XDD)/?.Y%P* *&H> ],OYM/G6]U2SFL+06<,ME=F%O*XX)'7H/
MRJWHOA:/1;UKI-9UN\)0IY=]?O,@R0<[3WXZ^YJYK&OZ3X?MTGU;4(+..1MJ
M&5\%SZ =3^%,N?$VAVFD0ZM/JMHFGS8$5QYH*R$] I'WCP>!Z4 'B/P]8>*=
M%ETK4ED-O(RMF)]KJ58,"#V.1574?!NC:I/HDMQ"^=&8-:*CX QMP&'<913C
MU JS!XFT.YTM=3AU6U>Q:40^>)!M$A(4*?0Y(&#ZU33QYX4DM[FX37[!HK9@
MLK"4<$],>N<'&,YQ0!<;P[8-XL7Q*1)_:"V?V('?\GE[]_3USWK*LOA]H]A'
M'##-?FVAODOX+=[@M'!(K,V$&.%)<DCO6M_PDVAC3+74CJUF+&Z)$%P90$<@
M$D ]. K9],&J/_"?^$_L!OO[?L?LXD\HMYO(;&<8Z].>E &F-&M!XA;7 '^V
M-:BT)W?+Y8<N./7)/-5M<\-6FNSV=S+<WEI=69?R;BSF\MPK@!ESSP<#\A4M
M]XDT73--@U&\U2UAL[C'D2F0$2Y&1MQ][(YXHB\2:)/ID.I1:I:/932K"DXE
M&PN3@+GL<\8H CT'PSI_AO[6NFF=(;J02M"\I=5?&"RYYRV 223D\US+>$I=
M3^(/B*^FEU*PCDMK2.WN[.8Q%P%?S%SR",[>W'&,5U&D>)M$U^2>/2=4M;QX
M,>8L+@E0>A^A]>E/UGQ%H_A](GU?4K>S$I(C\U\%L=<#J<=_2@#.E\#Z.=*T
MRPM?M-C_ &9G[)<6DQ26+</G^;G.[OG.>M/C\%Z3':Z;!_I+_8+W^T$DDF+/
M)/\ -EW8\MG<?TJO?_$'P_I^OZ5I3W]NS:C$TJ2K*"JK@;#[[\\?0U>N/&'A
MRTU;^RKC6K*.^W!#"TH!#'HI[ GT/- &V1D8/2N8T[P+I>FWMK/'<ZC+#9L7
ML[.>Z+P6S$%<HOL&(&2< \5H:QXIT+P_+%%JVJVMG)*,HDT@!(Z9QV'OTJBG
MB&XD^(L>A1^0^GR:,;]9%&6+^<$&&SC;@^GXT 2KX.TI/"MIX< F_L^U:-HQ
MYGS9C<.N3]0*IW_P[T34I-1%S)?&UU!FEGLUN2(/-88,@7^]W],@'&:Z&QU.
MRU-)GL;J*X2&5H9&B;<%=>JY]15#5/%WA[1;U;/4M8L[6Y(#>7+( 5!Z%O[H
M]SB@!^E^'+/2M3N=1BEN);NZ@A@FEGDW%Q$"%)XZ_,<GO6>O@324U+[4LU^+
M?[5]L^P"Y/V;SMV[?L_WOFQG&><5HZEXFT/1R1J.J6ML?+$H$D@!*$X! [Y(
M/2KFG:E9:O817VG745U:RC*2Q-N5N<'GZ\4 /O;.WU&QGLKN)9K:XC:*6-NC
M*1@C\JYZU\"6%LDV=1U:>1[9K2*6>[+O;Q-C<L9Q\I.!\W)X'-9U[\2=,=?%
M-IIMQ ^HZ/:22Q!VW"9TB+G &#A2,'FM;0O&6BZNUI8KJMF^K20+));1R<[M
MH+ #U'.1U'>@":3PCI#6FCV\,+6RZ.ZO9/ VUH\#!&>X8<,#U[U5;P)I+:D]
MT)K];=[D7CV"W)%L\V0V\I_O -C."><5H+XIT%M;.C+JUH=1#;?L_F#=NQG;
M_O8YQUK2N+F"SMI;FYFCA@B4O))(P544=22>@H I:=H=GI=]J5Y;!_-U&83S
M[FR-P4+QZ# %8]E\/M%L+^WN(I+YK>UF-Q:V$ERS6UO(<_,B=B,G'4#/&*T-
M.\7>'M7>--/UBTN'EW;$CD!8[0"W'7@$'\:2V\8^'+PS?9]:LI!!;BZE*RC$
M<1_C8] .G7UH I1^ =&ATRYLH6O(1-J#:D)HYRLL5PW!9&'3C(QR,$TX>!=)
M;3)[2:6^GFGN$NGOI+@FY$R !'#CH5  &!C';DU<L_%WA_4-.N]0M-7M9;2S
M&ZXD5^(AC.6[@8[TD'C#PY=7\]C!K-G)<VZ-))&LH)55^\??'?'2@";1/#]K
MH2W!BGNKFXN7#SW-W*9))"!@9/0 #@  "M6N=\)^,]*\86]U)ILR,UO,\;QA
M\MM#LJO[!@N1714 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5XM;S:.OP<\;12/!Y[7M^)$)&XS&1O*XZY^YCZ5[37(>&
M_ UCI]L'U;3M-N]0CO;BX@N?)#M&KS-(H#,N01N_ ]* ,CPW:;_BMJ,UY&&O
M(=#LE+.,E6.[=^.17(78<Z/\42 QB76H&G"C_EB)$,GX;-V?;->WK9VJ7DEX
MEO"MS(H1Y@@#LHZ MU(&3Q[U'#IMC;M<M#96\;73;K@I$H\X],O@?,?K0!P'
MQ#NM#N]"U=-,>&;6CHLC*]L"^+/>N\$KQM/8'KSCO5K1[.XG\8Z/>W/B/1;E
MX;"806VG6;1&2W;9R3YC?*"$QQZUU^FZ#H^C+*NF:5962S',HMH%CW_7 YI-
M-T#1]&>9]+TJRLGF.9&MH%C+_7 YH X_XN?\@CP[_P!C!9_S:K&DS6UM\4_%
MIU"2*.5[2S:V,Q S;A6W[<_PA\Y_"NQN[&TOTC2\M8+A8Y!*@FC#A7'1AGH1
MV-5M4T#1];\K^U=*LK[RCF/[3 LFWZ;@<4 >0Z+:PW2^ (Y(@]@^MZC+:(PX
M\D>:T>!Z< CVQ7M<X_T:0 ?P'@?2HFT^R9[9VM("UK_Q[DQC,/&/D_N\<<=J
MLT >*:"MK>^!/A="_E3*NJ+O3(.&$<Y&1]1^E6O'<<@U3QV+?:F_3-->8[20
M4$[[RP'4; V?:O3K7PYH=E)YEKH^GP/YWG[HK9%/F8(W\#[V"1GKR?6KGV*T
M^T37'V:'SID$<LGEC<Z#.%8]2!D\'U- '&:)9W4GCFWOKWQ#I%W<IICQK;:?
M:-$7A9T(9B9'& 1QT^\:DUMXX?BQX:DOF5;8V-VEJSG"BX)CSC_:*9Q^-=-I
MFA:1HHE&E:79V/FG,GV:!8]Y]]H&:EU'2]/UBU-KJ5C;7EN3N\JXB61<^N".
MM 'C/B5[&2]\2SL8VT1O$NF"1A@QEPJ^?[>F?>NJUYX+CXC,UBT<C+X:NA=&
M(@_(77RP<>^['XUT&O\ A2.]TC2]-TFWLK2WL]2MKHPA/+C\N.0,P 48R1GV
M]ZU]-T+2-&$PTO2[.R$QS*+:!8]Y]\#F@#R"]FBE^&WPK$<B/LUC3E;:P."%
M;@^]==X?N-.M=<\?#69($F-Z'F\\@9M/(0)UZKC>/SKK(/#.@6L2Q6^B:=%&
MLXN55+5 %E'20 #AAZ]:?J/AW1-7N8KC4M(L+R>+B.2XMTD9?H2* /,/A[:N
MVN>##?1$S0^&)GB\P<H#,@0_]\-CZ&I["RAN)-32'5H-+U&#Q;=2Z<T\6^)Y
M/)&Y"N1U5G[@YY%>J?8[;[6MW]GB^TK&8EFV#>$)!*@]<9 ./:JMSH.D7EK/
M:W.EV4UO/*9IHI(%99)/[[ CEN!SUH R/!&HOJ%CJ0N+.Q@O+;4)(;J2P_U-
MQ(%4F1<\\A@#G)!!&:X&:SO;RR\<V=WK^CZ;9RZG.+H7=FSSJK!?*<,)%_AV
M;?E/([UZ[96%GIMHEI86L-K;1\)#!&$1?H!Q5:Z\/Z->ZE%J-UI-C/?0X\NX
MEMU:1,=,,1D8H X31IK"SO/B#%KD\)G\U//,N 9(/LR!.#U!^; ]367X(FBM
MK[X?//(D22>';B-&<X#-NB.![X&:],U'P]I.I7*WMUI=C/?1+B&XF@5GC],,
M1D8-96A>#;.'P3H^A:_8Z?J+V$"H?,B$L8<#JNX?T% '#VVK12#6/L2V$[7W
MC$0VUS=J7AA<0HPEP"-Q&P[>1DD<UD^(IY)/#/Q02?4;:_F LM\]O#Y2.1A3
MA=S=,;2<GE?:O9I?#^C3V,UE+I-B]I,P>6!K="CL  "1C!("@9]AZ4P^&M"9
M"AT73BI@%L0;5,&('(3I]T$ XZ9% $^C_P#(#L/^O:/_ -!%>.Z9- /AUX6\
M^2/[);^*";X,1B-//FVE_0;RG7VKVU$6-%1%"HHPJJ, #T%9\?A[183>F/2+
M!/MW_'WMMT'G]?O\?-U/7U- '-+)%/\ &='LG1_+T-EO&C.0"9E,8;'?AR/;
M--\7RQP?$?P'),Z1QB:]!9S@ FW..375Z9HNEZ) T.E:=:6,3G<R6T*QACZG
M YI=2T?3-9@2#5-/M;Z)&WJES"LBJWJ P/- 'G%M:VY\#_%"4PH7DO=2#L1R
MP6+Y?RY(^M5M+&J-XFF,.J:59&3P_8%3J5J9O,AVOOVGS$P V=W7J*]473K%
M;>Y@6SMQ#=%FGC$2[92PPQ88^;(ZYZU6O_#VBZI#;Q:AI%A=QVXQ"D]NCB,>
MB@CCH.E %+P39II_@K2;6*_2_ACMP(KE$*+(G5< DD#& .>U>>Z9?Q:7HGQ1
MNYK.*\C35YPT$OW'#!5PW^SSS[9KV!$6-%1%"JHP% P *JII>GQQW4:6%JJ7
MC%KE1"H$Q(P2_'S$CKF@#S(2747CXV]]JVG7DP\-W2[;&V\E(QNB(3[[;N,D
M=,#G'-8FA6T-WX#^%4,\:R1'5&)5AD' F(S^(KUZ#PQH%K'!';Z)IT26[,T*
MI:H!&6&&*\<$C@XZU8CT?3(8;6&+3K1(K1M]LBPJ%A;GE!CY3R>GJ: +@  P
M!@5XG9V%I)\#O!L+V\;1RZI9EP5^\6N,-GZ@D?2O;:IKI.FK90V2Z?:BU@97
MA@$*[(V4Y!5<8!!Y&.] 'GGBV^AT?QMX@OGLTNHX_">Z2W;A90)G&&]L'!]J
MCLWNH/B-HMO>:MIEU(-&NE6/3[;RDA4F(JF2[;AP2.G SCFO2Y-/LYIWGEM(
M'FDA\AY&C!9H\YV$]UR3QTJE;>&=!LXX([;1-.A2WD,L(CM47RW(P67 X)'&
M10!Y(;:.V_9>@:VB19)%MY"3QO<W:<D_D/H*VM-^WV3>,--U=5;QE=64T]O=
MQD[;F'80BPYY4(W!7KGGG->E?V1IITQ=-.GVGV!< 6ODKY0P=P^7&." >G6I
M)K&TN+J"ZFM89+BW),,KQ@M%D8.TGD9'7% 'F7AFSGNQX(FE\1Z*8;>/?8VU
MI9,DSKY!5T+>:W !^;Y>JCO6Y\)I8V\%F)9$,D=]=[T!Y7]^_4=JZBS\/Z-I
MU]-?66DV-M=S9\V>&W5'?/)RP&3S4EGH^F:?=7-U9:=:6UQ=-NGEAA5&E/7+
M$#)ZGKZT >>>+-6?P%XLU;4X5)CUW3<P*!G=?0X1!C_:5U^NVG06$OAR;PQX
M9LY=,L[VUTV>YEU2^A,NT[D\T1C<O+,Q))/ %>BW>GV5^83>6=O<&"02PF:,
M/Y;CHRY'!'J*BU+1=*UCR?[3TVTO?);?%]IA638?49'% 'B7G";PQX+Q.DV/
M&Y^9$V YGE.0N3M!SG';-=I9:A::?>_$@7=Q'"RW D*NP!*M:H%('?)&!ZFN
MV.@:,9C,=)L?--P+HO\ 9TR9ATDSC[X_O=:+GP_HU[J4>HW6DV,]]&,)<2VZ
MM(H]F(S0!Y1X<75!J/A0V6HZ=8LWA*W$+W]L95;#9D"8=,''ED]>,5Z'X"LH
M[#PC;PPZC;ZA"99GCGMXS''AI6;:@)/R@D@<G@5IWGA[1=0L(+&\TBPN+.WP
M(8);=&2/ P-JD8'''%7X88K>%(8(TBBC4*B(H55 Z  =!0!Y!#-I\?P/\36U
M^\7]H^;?I=1N1O-T97\O(ZEC^[Q^%:H6=?C!X56ZS]H'A^02YZ[\C/ZYKNI?
M#FB3ZJNJ3:/82:@I!6Z>W0R@CH=V,\5;:QM'ODOGM8&NXT,:3F,&15/50W4#
MVH Y/XH8'A:U><9L$U2S:^S]WR!,N[=[=,UG>)Y8+GXA:6;"2.26/1;\WAB(
M.(2$\O=CMNSC\:]"EBCGA>&:-)(G4JZ.H*L#U!!ZBJ.G>']&TB*:+3=)L;..
M;_6K;VZH'_WL#F@#S6.VAM_A7\.O*B5,:CI<@P/XF8;C]3N/YU1BL;^^\/\
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MNI:/I]Y(B[$>XMDD*KUP"P.!R>*73O#NB:1.T^F:/I]E*Z[&>VMDC8KG."5
MXR!^5 '-WTT-M\8K"2^=(X7T25+1I2 OF^<ID"D_Q;-OX UBQ7&@-XZ\*W.F
M>4FC%M22!P"L1NRR[BI/'.),$<'G%>AZGH^F:U;BWU33[6]A#;A'<PK(H/J
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M:PBY6+R1,(QO$><[-W7;GG'2@#'\%WND7WA.Q?0X!;64:>4+;&&@=>&1AUW
MYSGKU[UR^A7&FVO_  L%=9D@2;^T9GN1,0";8PIY><]5VY _&N_MK&TLWG>V
MM88'G<R3-%&%,C_WFQU/N:J7_AW1-5NXKO4-(L+NYBXCEGMT=E^A(S0!YO\
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MN;NSTZTM[FZ.Z>:&%4>4]<L0,GJ>OK5V@ HHHH **** "BBB@ HHHH ****
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M-?)+))) &C4R%GR<94\$Y QD#% 'HMMXYM9+G4+6\TK4]/N;.R:_\FZC0-+
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M8'.,UR=]XSBT?1/&NHZ7_:U]=Z;=/&Z7;(\4$FW@H-P(B!QD=:RX]6_M;1?
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MW=B8K5W2X5X57;O VKM*D'<0 .:S? ]K,^H_#ZY$$C0Q^'9E:4(2JL3'@$]
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M_P#0[RYC41715=QP0Q8$C)&X#(I]MX]L+J^@C6PU!+"YN3:6^IO&OV>64$C
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M[Z-!H\ME+-- \2S/+(I**' ) 53DXQR* .FU7Q-8:38Z==.);A=1N(K>U6
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M W#)PV,9P:GUB>77K[QQ?65C>FUG\,>3;226[IYY'G?=5@#U.,8R>O0@D ]
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M[O5YB6M;:W:Y8KU*JN[C\!7/Z+K/BRXN+";4]&L_L%_"95-G*QDM#MW*LF[
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MPM]5G-SJ6B2LULS* 9XIAFWX  )W'9QZ5NZ3X6N;+Q+#KEWJ$4\ZZ3'IKI'
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MT"566=(V2) ,F+(9,$C.2>:L:M?7.F>//B3?6;%;FWT&*2)AU5A&<-^'7\*
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M@5-(A%LLEQ<+)&CG$VVV?#L,\L,_>ZG=SVK+>9E_9XNI#(0WGRC=GG_C^(H
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M=>CC.6.6L]HNF.?3@K6;J-O%>>%/BQ]I3S?(U.22+<?N,!P1^= 'KQ\0P_\
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M35[6:]8$K$K<M@9(!Z$CN!R*PO&'Q$TS1]%U==+U.SEUBR7"P/EAO!&Y>P)
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M5U&73K1[Y$*+<M"ID"D$$!L9Q@GCW-+#I6G6\=M'!86L26I+6ZI"JB$G.2@
M^7.3T]30!Y+XU3%[\03MS %T>2Y '6,2'>3_ ,!'/L*Z'4[W2;WXO>$6L)K>
M>=;.\\R2!@P"%%* D?\  B![^]=EJFEM<V&H#3V@L]0NXO+^U&W63) .W>"/
MG R1@]B:YK0?"&HP>(++4]2AT6RBT^&5+>TTB%D1I)=H>1L@=E   /7K0 >*
M)H;;XE>#9[UTCM0EZB/(<*)BB;>3QDJ' _&N2GU:QBU;QS+80V%S#=:KIMNL
MERN^W21@JF5@",A7!/4<CK7K5_IMCJMJ;74;*WO+<D,8KB)9%R.AP1BHAH>D
MBUFM1I=D+>9%26+[.FR15&%##&" .@/2@#R;4YY6N?B'#<:O;ZE<?\(VH:6W
M@$2DJ)\@ ,VXKGDYXSCM5Y9KJ?Q)X4FT[6M/LE;P^8X)[J#SXS(#&71<.N'V
M[3UZ UZ7#H6D6_E>3I5C'Y430Q[+=!LC;J@XX4]QT-0GPSH#:<-..B::;$/Y
M@MOLJ>6&_O;<8S[T 8G@M[#1M!CB?7;.]6^U&X^SRQ1^3&\C.S-'&I8Y 8/C
M!-=A58:=8B.VC%E;[+4AK=?*7$) P"@Q\O!(XJS0!YM;:9K&H?$CQ@=+\02:
M4JM9AU2TCFWGR!@Y<<8K.\?:#!X=\)>'K.&::XDD\2VT\]Q.07FE=F+.V,#D
M^G8"O58[:WBGFGC@C2:;'FR*@#28&!N/? XYIMU96E\D:7=K#<+&XD031APK
MCHPST(]: /*;R&[?6?'MO<^(=*TNVEE!N4O;+S7>W:W0*P;S%^7[P P>0?7%
M2WUU/$=6T^+5--LQIVCVT%Q=SV?F7&H[HVP "XPO) 'S'<Q%>DWNB:3J5U#=
M7VF65U<0?ZJ6>!7:/O\ *2,BG3Z1IMSJ$.H7&GVDM[ ,17$D*M)&/]EB,C\*
M /+=+?9H.DZIH^O:9'J4?ANTCOK#4DW13PJC%3NR"IR9 2,CU%)IMU=WOB2]
MO+74-+T""[T2PFBMK^S$JBWV/E$^= %5B01CN.E>E2>%O#TT4,4N@Z8\<!+1
M(UI&1&2<DJ,<9//%6-0T32M6$0U'3+.\$)S%]H@638?;(.* ,KPM9QZ?\/\
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MO"Y\#^"[2Y,$EV##';P*-TD=TJG>2HY7!W[B>.>>M8"6\47[.Y=(U5FNQ*6
MY+_;@-WUP /PKU>'1-)MM2DU&#3+**^ESYERD"K(V>N6 R:E_LRP^P?8?L-M
M]CSG[/Y2^7G=N^[C'7GZ\T 4?%6AIXD\+:EH[D W4#*C'^%^J-^# '\*\\T+
M4[SQ]JME>A6$V@Z0XD!XQJ,H:,C_ ("$8^V\5ZW5>VL;.R,QM+6" SR&64Q1
MA?,<]6;'4GU- 'DOA2TEN]#\$"?Q3I:16\L4EM90Z>1<>8D;>9&6\PG.-X8[
M>M:6@W*:->^';&TU#2]=T&ZN733B8MMY9DI(V?\ :  92<*PW<]Z]!@T32;7
M49=1M],LHKZ7/F7,<"K(^>N6 R:2VT+2+/4);^UTJR@O9<^9<16Z+(^>N6 R
M: /$M5GA?]G'4X%E0S1:B_F1AAN3-Z2,CM7I%E#&WQEU*9D4R)H=LJL1R 99
M<X_(?E71'P[H;?:LZ-IY^UL'N<VJ?OF!R"_'S$'GGO5Y;6W6Z:Z6"(7#((VE
M"#>5!)"D]< D\>] 'C?AR2WL]6\(2W;QQ6,>I:U%&TA"HDID.P9/ . X%=5X
M'FL+GQ_XZFTXQM;O/:'?']UW\HAR/7Y@<GUS6WXC\/W%WIL%OH\&DB-)S+-9
M7UJK6]P#G.< E6R=VX#KUSFF^$_#EUHTVIW^H/:?;=1DC+162%88(XT"(B9Y
M. "<X'7I0!C6=UIUK\:->-W+#%<-I5MY32L%^7<Y< G_ ("?PKBM#2\$_A:>
MPU"TTZRDN]7^P3W5OYL0#2@H -RX+*'VG/3/K7I;>#[>]\6ZOJ6JVMC?6-Y;
MVT<<$\0DVO$9,DAAC^,8Q[UNW.DZ;>Z>-/NM/M9[)0 +>6%6C '3"D8XH \E
MU+2X/[/TA)=5M-8CO/&L4D[6]OY42N4(= I9LC*DGG!+&NA\0 _\+Q\)!< _
MV?=X_P"^:[I-*TZ.VMK9+"U6"U</!$(5"Q,,X*C&%(R>1ZU(]E:27D5Y):PO
M=1*5CF:,%T!Z@-U - 'C@N+(?L]S:<\D?]JY:!K?</.-[Y_3;UW[\'UQS71:
M3>:?8^(/'\>N30),SQ/*)6 \R#[.H7 /49W#CN:[@Z#HYU3^U#I5C_:'_/U]
MG3S?^^\9_6G76BZ5?7L-[=Z;9W%W!_JIY8%9X^_RL1D?A0!S/PV$A^$NB"'B
M4V'R?[W.*X2:^T@_ KP[:>; ;Q;JT419'F).)QYF1U!^_GZ^]>U6UM!9VZ6]
MK!'!!&,)'$@55'H .!5'_A'-#^TSW/\ 8VG^?<$&:7[*FZ0@A@6.,GD \]P#
M0!Q^@WFFZ?J_CU-;F@BF-\99O/8 M:F! G7JN P_.N3\*PZU;7?A8?VK::7*
MWAH+ ^H6QE# 3$LJ_.F#L,1/)X'M7K]]H6D:I<17&H:58W<T7^KDN+=)&3Z$
MC(J34=)TW5X%@U+3[6]A4[ECN85D4'U 8&@#S+2M,CL(=-GT/QAIAU6.&[>(
MW%J5M;FW><LRJ-V5"N, JQX[8Q7>>#-0BU3PAIM[#90V22QG]Q !Y:D,0=F
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MVLME;/;P%3%$T2E(ROW2HQ@8[8Z4TZ1IICN$.G6A2YD$LZ^2N)7!!#-Q\QR
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MS:20B#$3*(R7 RQ9L8&>A-8ITFY'Q"D\%"(G1I+]?$1/\(BYS%CT,X!QZ9H
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MM$&AVFKK;:A);76H/IT*I""[2KNQ\N[.&V$ =<D<"K=QXRE@6UC3PUK$]]-
MUS)9QI'O@C#;<L2X7)[*"2:\_P!)M[N^T7P](+&573QK/--$J[O(&Z;.XC@
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M5Y9R"*YM+D+OC8@,#E25((((()!K7KC_  -::<LNJW^G+K4BW#QQF[U5W+7
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MQR >D45Q$/BS7;?7])@U.PLQ8ZQ!-+:I;LQGA,<?F;7S\K$K_=QSZ]3+X/\
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M7>AV^@V5K_Q-M+>^WW;-BW*LH(;;]X#)'&,G'(% '?5&UQ CNC31JR)YC*6
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MB9=5TQ-.N=Y'DK<B<;>,'< /?CVK0K-UOQ!I7ARS2[U>]CM())!$KN"07()
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M_P#A(D@+HX&Y?M "YX_AP"/?UKTBS\(:D?$6EZWK'B W]UIZ2QHB6@AC*R*
M3@,<-P"3GG P!WH0_#1;?P-_PCL.KNLJ7WV^&[\@'9()-XRF>1VZT 266J7/
MAGQGJ.DZOJ5Q<:=+IRW]E/<L"RB(;9U) &3]U_Q-:?@.;4[WPK!J>K2R/<ZB
M[WBQO_RQB<YCC'L$V_B37)^-[&/Q5?Z%X66[ENM;MK@'4+FWA,2Q6SQD3;NH
M4.K* N3DD>E>H(BQQJB*%10 J@8 'I0!YY\4/^0UX#_[&""AH=7U_P 3>,;4
M^(=0LK73I(1:):,JE6:W5CDD$E<\[>.ISGC'2>)O"R>([S0[AKMH#I5^EZ%"
M;O,*_P /48^O-3V/AY;+5=>OA<ESJ[QN4V8\K;$(^N>>F>U '$Z/K.K>,G\-
M:9-JEU8K-H8U.\FLBJ232%EC !P=HSN8X]A3M<U#6-(N]$\.:EJVJ3I(ES//
M=Z5:L]U+&C*(E.Q3M/S_ #, ,[1TS6Q#X!GTZRT,Z1K1M-2TJS-D+I[82)/"
M<$J\>X=U!&&X]ZE_X0BZ@@T^XM-?N!K5G),YO[B(2B;SB#(K1Y "Y"X (V[1
M0!S":UXCN;'0[(7VI6;2Z])8K=7=KY4\]KY+NK%74#<!QG&-R9P>15/Q8-0M
M-&\>Z%)K>HW-K::=!=P//(K2#S!(KQLV.4.T<5WO_")7$PT:2^UF>[NM.OVO
MGEDC \UF1UV!0?D4;^!STIFK^"(-8N/$,DMZZ+K-A'9,JH/W6S?A@<\_?Z>U
M '/7MWJ.AZ[\.]*M]4O);:]><7/G.&:4"-64$@#@$\4Q?%FIZ+X+\3V5W<27
M.NZ5>-96KOCS)C,1]F;'?AQ_WP:W?^$)N[F]\,7NI:T+FYT)Y6#):B,3AU"@
M$;CMP!UYS[5+J?@2VU+QO9>(VNWC2#RWFLP@V3R1A_*=CG@KYA_(4 <E?:IJ
M*ZW<Z'>:OXC5]*LK>-9M*LWF\ZX="S2RE4;(^[A3@=:]#\+WU]J7A;3+S4[9
M[:_EMT:XB>,H5DQ\WRGD<YXK.U3PQJ$FMW&JZ)K?]ESWD*0W:M:B=9-F=CJ"
M1M<!B,\C&..*Z"RMC9V-O;&>6<PQJAEF;<\F!C<Q[D]30!P-]K3Z-\6M2==(
MU/4?,TBV&VPA60IB6;ELL,5RGCC3[V'X7^,=4N[!]-35=3M[B&R<KNC4-$FY
M@I(#,5+$9->LPZ$L/BR[U[[02US9Q6IAV\*$9VW9SWW],=JK>-?"Z>,?"USH
MCW;6JSM&WFJF\C:X;ID>F* .:\9Z@XU>Y@AUS6HY;:Q$D=GH]J7\ESN(DF?:
M00< !3C@$]ZK:=J&L^*]>T2UDUBZL;6\\-0ZA<K9E49I6< [20=O7MSP!71:
MAX/N;K6]0O+76I+2TU2&.*_MU@#.X0%?DDS\F5.#P?48-'AKP6^@7UC=2ZG]
MK:STI=+0>0(\QJ^Y6/S'D# ]^OM0 O@"^O;O1;ZWO[N2[ET_4[FR6XEQOD2-
MR%+8P"<8&?:NKKD#X=U'1K)H](OI3+=:\+^;;&H_<R2AI8SD] N>1R<#UKKZ
M /,1)K6O:'XC\2Q>(+^RFLKBZ2PMH"H@18"0-ZE3O+%23D]^,8IMEJ.K^+_&
M5E;KK%YING3^'[34Y(K0JK>8[-\H)!P#D9[G:!ZUM7?@2\8:K9:?X@>RT?5I
M7ENK46JNZF3_ %GER$_(&YZJ<$G%:UAX5M]-\3G6+:8K&--BTZ.V"<(D;%@=
MV??&,=J .@KSWPO+'X/\8>(/#-PXATZ4-K.GLW"I&Q_?(/0*PSCT.:]"KD_'
M'@:'QG#9C[?+87%N9$\^% S/#(I62,Y/1ACGMB@#-^'EC_;-IK'BO48 S^(I
MB8XI5SMLU!2)"#ZKDGUR*YN>QUS3=4/POL;@II=_FXM[_P S][;6.3YL([E@
M?E4^C>W'KMM;PV=K#;6\8CAA01QHO15 P /PK&N/#2S^-[/Q+]J*O;63V@@V
M<,&8-NW9]NF* .7\?>']+.G>#O#XM$73#JT=MY Z!/(E&/K[]<\U@>(M2NK;
MX;^(?"6KRF34])^S^5,_6[M3.@CE]S_"WN/>O3==T!=;N='F:X,/]FWRWH 3
M=YA",NWKQ]_K[5D>.? -KXUAM2UY)8W5NV!/&FXO&2"T;#(R"0I]B* ,34+[
M5['XQ7[:1HRZG(VBVX=&NU@V#S9.<D'-=,EO?>*]%N]/\2:)_9L3LF$CO%F+
M@,&SD 8Y455U;PCJESXKDU_2/$7]FS2VB6DD9LEG!569@<L1C[WZ5IZ)INNV
M,TK:MX@&J1LH"(+)(-A]<J3F@#CYM1O8/&<T6L:[JVD7#:@JZ>&@#:?<097$
M>0,;V&X'+ @D8]*]+KD=0\(:EJ5Q-;W'B*2319KI;E[.2V#2C#AQ&LN[A-P'
M&W(' -==0!YWXIL-/NM-N/ 'A^T4W5^_G7C+EELT=][32,<_.3G:N<DXZ 5H
M>%(DN/%WC:6=0\IO8;8[QG]TMNFT?3YF/XFJ^G>"/$>DO>-8^,5C-W<O<S,^
ME1N[NQ[L6R<# 'H *OZCX1U)]6NM2T;Q"^F3W\*1WW^BK*)2@VK(N2-CXXSR
M.!QQ0!RFF:;9W_P,EGN[=)WT^RU%+1I/F\L*944@=,A0 #V[5H>(\?\ "M/"
MS1Y>^6;3WL;?;D7$ZA66-N0 I ;)SQC/;%;6H^#+AO"=MX;T36#IFGQVKVLP
M:U6=ID9<$DDC!^\21U+5"/ ]_-X>MM,OO$3S3V$T,^G74=HD9MGB&%RN2'&"
M0<]B: *>ASWUS\4I[C7+%-,U Z0([6VBF$R31"7+N9,#Y@Q4;=HP#GG-:?Q/
MO+FQ^&FO3VCLDPMMF]>JJS!6(_X"35C2/#%Y;^(&UW6=6&HWZVQM8?+MA!'%
M&6#-A=S$L2!R3VK>O;*WU&QN+*[B66VN(VBEC;HRL,$?E0!4L-&TNU\/PZ1;
MVL!TU8!$(=H*.F.X[Y[^N:\I\.WFJ_8O"^A6&JW%K9OJVHV*S)AF>VB#E<$@
M\@# /; ]*["'P5XAL[$:59>-KJ+257RXT:SC>YCCZ;5FSV' )4D5I0^";"SF
M\-?8'-O;:"93%#MW>;OC*'+9ZY8L3W- '(P6FMSW'C#2V\5:LL&B%7LI5=/-
M+/ ),2/M^95/ ''4YSQB:PU/6O$^K>%[5M7N;*"_\."^O/LNU6>3='RI(.TY
M;J.V1[UU\/AA(;_Q)=?:F)UO9N79_J=L(BXYYZ9[56T3P:FC7VC72WK2G3-(
M_LL*8\>8,H=_7C[G3WZT <)J_B/7=,\":FD>K7+W.G>)!IT=VY'FO#N4@,<8
M)PV,X[5MKI%SK'Q2\4PQZM>Z? MI9%S9.J2.VV3;\Q!P!\W'<D>E:&J?#F+4
M]'U+3SJ;QB^U@:J7$(.P_+\F,\_=Z^_2K=YX1U$>)M1U[2->^PW5[#%"T<EH
M)HPJ \XW#+<\'/'/!S0!SOAKQ-K%_?\ @ZWO+UG>1]3MKPJ !<- =J,1Z\9X
M[DU)JVJ^()=0\6V]C-?R06>H62,EDJM/%;-"C2^4".6R<]SR<5J_\*^-GIN@
MQZ1J[VM_H[RNEW- )A,9L^;O3(^\3G@\4^V\$7]D=3NK;Q+<IJ5]=1737/D+
MMWHFPJR9PR$?P\8XYXS0!;\$7MO>Z;=-::]<ZK DY51>1%+BV.T9CDR 2<Y(
MR <'OUK*^*$MS GA26SMA=7*:_ 8X#((_,;RY<#<>!]:Z'P]H,^DS:A>7U^+
M[4-0D62>981"F%4*JJ@)P !W))S47BWPU-XDMM.6VU(Z?<V%ZE[%-Y E^958
M ;20/XOTH 32=7\37>H1PZEX62PM2#NN!J23;3CCY0H)R>*\\OK[7[OX5ZEX
MWA\17\%[,97CME91!%$)B@15QD$*,[LYSUR*[ZQT3Q7!?0RW?C!;JW1P9(/[
M+CC\P>FX-D?6N*\<>#;[1?AUKUK:ZW(VB)ON(=/%L ZEI-^SS<Y*!B3C /;.
M* .QT34;RX\7^,+2:X=X+-[86Z'I&&@#-CZGFN.L?$VM26?PO=]1F9M4>07I
M)'[_  N1NKL+OPA>MXAU#4M.UU[&#5$C2^@%LKLQ1=H:-R?D.WCH?6JMO\.X
MK>#PA$-2=AX<9F4^2/W^1CGGY?UH Y+2]+UF+3_'U[H^M:DVI6>J2>0DDBLL
MQC2)_F&WEF4%/3!Z5U+>)9O$NN>$[?1KEXK6YMSJUZ4//D !4C/^\[8/^X:M
MP:9'X+U'7-=NM;6/1KV?[5-;R6V3',VQ-P<')!P!C;WK-^%OA]=/M=4U@0SP
MQ:C=/]@AG7#PV8=FC7!Y4$N[8]"* /0:\/T'4+_3/A=XCN=,N?L]Y_PDY1),
M9 W7$2G([@@D&O<*X>U^',5MX6O]$&INRW>JC4C+Y(!4B5)-F,\_<QGWH HW
M=[J/@WQ3(C:O?:I:2Z+=7SQ7K*V)82I!7:HV@AB,#BK6@6&NQZ9I/B27Q'=W
M33VPN=0M)PIA=6CW8B4 ;"I(QSR.M=!J/AJ#4_$5MJL\N8XK*>S>W*\2+*5R
M2<\?=Q^-9.D^";^PETVWNO$EQ=Z3IG_'I9^0(V("E5$K@_O JG &!GC.: .2
M\.>)=8O)/#^J)/XCN[K4+B/[?;RZ?(+)(9<\QMLPH3*D-NY .<YIL]WX@?P%
MKGBG_A([]+K3+VZ^RPH5$12.=AMD7&7R,CKP /?/::-X1U+1Y+*TC\1S-HMB
MY-O9+;A7VX(6-Y<_,BYX&!T&2<4/X'C?P1JWAK[>P34);B0S^5RGFR%\;<\X
MSCK0!B:18RR?&/7[DZE?8BL+:41>8-A#^9\A&/N@DD#U]:Q/#/B?7/\ A /!
MOBB^U*>>'^T)+;5-Y&'BDE>-';_<;9^==Z/"MQ!XS?7[35?*BN+:.VN[5K</
MYH3=M*OD;?O>AJII/P_M=.^&C^"YKMKF!HI8S<&/:079F#!<GE2PQSVH PO$
MOBO5K:_\6:CI]RZV6BVL-C$BIO5KN5UW/C^(H'08]35OPGJ5\OBN.RAE\1WF
MF3VCO-+K%E)%Y4ZLN"K,B\,"WR]BHQ6Q8^!;6#P5>>';R\FNVO7EENKW 222
M5VW>9W (.W'^Z*NZ+H^LV=\UUJ_B%]1VP^3'%';"",<@EV )W/P.> .<#F@#
M/^*/_),/$/\ UYM_2LC5;J_\92Z+96OAG5;'[+J$%Y)>ZA$D2PI&VX[<,26;
M&W '?FNO\3:(OB3PUJ&C-.8%O(3$90NXKGOC(S6JHVJ%]!B@#R72+S[!K'Q2
MNAJ2::4N8L7CQ>8(24(!"?Q')X'<XZ]*?:Z]?V4_B&RMK[7G@30);Z%]8A*3
M1S+D;DRH.TY!P1P1713_  [BF'BC_B9R*^N7$-RK"(?Z.\1#+U/S#< >WI23
M>!-0O+^XO[[Q$9[J[TZ;3KG%H%0QN/EV+N^3:WS<EMV2.., &1!+K6F1^"M9
MFU^^NI=7N(+>\MI2OD%9(6?Y5 R"I4<YR>]>G5SMSX42XT[PW9F[91HEQ#.K
M>7_KO+C:/!YXSNSWZ5;T.+4XI]7_ +1GDEB:_9K/>H!6'8F%&.P;?C/)'- '
M/_$W5]0T?3=!DT^ZDMWGUNUMY2G\<;;MRGV.!57[/JWB'QGXLT\^(-0L;*P-
MM]F2S9597>$,2203C/..Y)SVKH?%OA9/%5KIT#W;6WV+4(;X$)NWF//R]1C.
M>M6-/T%;#7M;U07!<ZHT),>S'E^7'LZYYSU[4 5? >JW6N>!-%U*^</=3VRM
M*X&-S="<#UQFN:\5ZY-)XUDT9[O7K:RM;&.?_B36KRR/+(S@%RJ-A0$X'&23
MUQ78^&-#7PUX9L-&6<W"V<7EB4KM+<]<9..M4M8\-WMSK:ZSHVKC3;YK?[+.
M7MA.DL88LOREEPRDM@Y[G(- '(G6[_4=%\/QZOJ6MV5])#,9['3;%UN[@H^Q
M96&TF-,#=C R7'IBH]*U_6/$6G^$]'DU.[M7OWOC=W<:K'<.ELY15Y&%9LJ6
MP,\'IFNGF\':@E[87UAXCGBOH+,V5Q<7%NL[3H6#[N2 K;LX/(YQCBJ5O\.I
MK"QLX[#79(;K3;N>?3[E[<2&..8DO%("W[P$D\_*>!Z4 97B+2-9M;SPKIT^
MN2SNVN.+6\9%,\<)MY.&.-K./FPV/3(.*W?"LE]8^,?$.@SZG=W]I;0VMQ;O
M=L'D3S X9=P R,H"/2I+;P3,+C3KR^UJ>\O;;46U"65X\+(QB,81%SB-0",
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MQV;6Y(.[=D@X[.D\"3ZJ+^3Q#K)OKFYM!9QR6]L+<0J'\P,!ELMO"G)...E
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MGO+5Y! EY(D3%?,;:=V,;L$'.P4 >Y>8AC\P.NS&=V>,>N:R(O$"3>+WT%(
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MSLW#./I0\T48)DD10" 2S =:\5&EV$WP4NO%TT,8\1GS+TZD1^_2X68@ /U
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MW'VI[3[5)]F:;.=YAW;"<\],9YK7AT:QM]2U'4(XB+G4%C6Y;>3O"*57CH,
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MR&_CG2W6U>:"^FCDFB7HLC*P+_5LGD\UTE% %>QL;73+""QLH$@M8$$<42#
M51T%8,O@+0)FU<-!<>5J^XWD NI!$[,068)NPK$J.1S7344 9EMX?TVTU&WO
MX8"MS;V7V&)M['$.0=N,X/*CGK5>3PEHTNB:AH[VS&QU":2:YC\ULN\C;F.<
MY&3Z5MT4 <]J_@K1=:O7N[J.Y226,17 M[J2%;A!T60(P#CDCGL<=*T8]#T^
M'6(]4B@V74=I]B0JQ"K#N#;0O3J!SBM"B@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KSS2H]6\>S:AJDFOZAI>DQ7<MM8V^G,D;.L;%3([E222P.%Z#%>AU
MYQHM]>_#^74-%O\ 1=4N]-:[EN=/O-/M6N%,<C%S&X7E6#$\D8- &S'J.I^#
M- O)O$E[_:J17"Q6$D,8%Q<!R B,H 7?N.,C@CDXJ2V\9N+VYL-6T:ZTR^CL
MWO8HI)8Y%GB3[VUD)&X$C(/J#6'K9\2>(_#ZZK)HCP+8:M;7]GIY_P"/F6")
M@6WC. Y^8A?8#K27[7/BWQ(NI66F:C!9:=I-Y%ON[5X&FFF"@(J. QP%)SC&
M2!0!I6/Q#6[_ +%N9-"O[?2]7>.&VO9&CQYKKE5*!MP!((#8P?H0:N6?C&2^
MU()!H.H/IC7;V:Z@A1E\Q&*$E =X3<I&XCW.!S6#+I6H'P#X M18W'GVEYIC
M7$7E'="$4;RP_A [YZ56\J2/Q9!-H>E:]I6J2ZF#J%OL<V$\._\ >2EB/+R4
M^8%<-N/3.: -/3?%NF6$?BBZA@U.>2UU?[(T,L_F&6=V5%6+<<(I9AQP!4?B
MKQSK6E>#M3OH_#UY9:A:2Q1L)VC:-1(P =6!VN,G;@<@D9&.:R=*TN6VM/'@
MU?PY>WUC>:XTGV=8V#RPDK^]C'!;;]X;>>..:IZGI^KW_@+Q59:;#KMYI8-H
M^G1:E&_VDE9 TRH' =E 5<9[Y S0!W5UXNO(;F"PM_#EY<ZJ;?[5<6:3Q#[/
M'N*C<Y;:68@X )Z'I4,OQ M'.C)IVG7E_-K%M)/:Q1[4.4*AE<L0%(W'))P-
MIZG /-:O;6MWXK/B&^T[Q*=-U"PCCB-BMS%+'+&[Y62.,AAN# J6&.O3-:.D
M:(]EXD\(/::1>65E#IUZ9(YG:4P/(\;A7<D_,3N/)]?2@!FO?$6_B\'WM_I^
MCW$&I6>H1V%U!,\9^SN73G.<,&#@ CN<]!7?V4TUQ9Q37%J]K,ZY>!W5BA]"
M5)!_ UY7XBT;5)-"\;F+3;N5I-<MKJ&-(B6FC3R"S(/XONMT]#7J5A>)J%C%
M=QQ3Q)*-P2XB:-Q]5;!'XT 9!\6V<<OB..>*6$Z"@EN"V/GC,?F!E]L CZ@U
M3A\>6<_A73];6SN0U]>+8QVC8$BS&4QE3S@8()/L*Y_QYH>I7/BNW2PLIYK+
M7K>*PU"2)"5A6.=7WN>P,;2KS[46VAZD?B@;%[*<:':WLNM1W#(?*:62)$"
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MT:W@9VNY"AWRAPOE(H.6))QGIGC-+HVGWL7Q@\37\EI.EG-8VJ13M&0CL!R
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M)(2P&<J"35O5?'FMZ#HWB..\M[*XU;19;3#PHRQ7$4[J 0I;*M]X8W$9 [4
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M *\]T;PMK&BO!I,.C:'+90W;2+JDWS2F N7V>7MSY@!VAMV. ?:O0J* //\
M4_!.JZ[>:AKEW=I;:W#(/[#,;EDM$0Y&[U,ASOX/! [54EN/$$?Q4^U6VGVD
M]Z/#D NK-KDHN3/)DI)M/0CN.0>QKKIO%NEQ>)AX>0W,^HA5:5(+9Y%A5ONF
M1@,*#[FJ^D:_H&M^)[[^S8)IKVU0VD]\+5Q%\C9,7FD;206)P#ZF@#F8_ NJ
MV]E9:H]OI][K":E<ZA<V4KGR)!.,-&K%3@J F"1U7WK1G\-ZSJ-AIK36&E6$
ML.MV]\;:T/$<$9Z%L#>_4] .<=LUW5% '):KHFMGQA=:YI368<Z.MI"+DDJ9
M1,7(8#HI7C/8GH:YZ;P'J.LKK4[:9IFA/=V\*QVL$OFQRSQ2^:LLF%48R O
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M5S_C*XC\3>([M?#ES%>S1>&+Y)I+1Q(/WFWRTRO<D,0/QKU:2*.4 2(KA6#
M,,X(Z'ZU';6=K9[_ ++;0P>8VY_*C"[CZG'4T >;>&?LFIZUX7F_X3.'49;:
MW>6VL;>S12B&+8P<H24 W#AL<J!UKHOB?#-/\.]46 L"ODR.53>1&LJ,YV]\
M*&X[UT\%E:6TLLL%K#%)*<R/'&%+GW(ZU/0!Y)J2V]]!KU]_PF$.MW</AN[3
M9;6R*BQ.H(+.A(SE> >>I'>M348TBTCX9K&@54OK95 &,#[+)Q7?0:?96T4D
M4%I;Q1RY\Q(XPH?/7( YJ4P1,(P8D(C(* J/E.,<>E 'BEU>6Q^%/Q#L!<1?
M;(]4OG>WWCS%4S#!*]<>];\%Y;6'COP3+>7$5O'+X?>)'E<(&<^5A03U/M7H
MYT^R:2:0V=N7F&)6,0S(/]HXY_&G2V5K.(A-;0R"$YCWQ@[#ZC/2@#Q QS/H
M/C]XY#%'!XL6:>01[]D2S1LS%?X@H&XCT%7/%=JFH:1XBO8O%*:_>0Z7$DT=
MK;(J+!]H60Y9"03M63@G."3TKV9+>&/S/+AC7S"6?:H&XGJ3ZTRVLK6SB,5K
M;0P1L<E(HPH)]<"@#S_4M<T;6?B;X'_LN\MKQHQ>,TENX<1JT!V@D="<'C_9
M-=1XY4O\/O$BJ"6.EW( '?\ =-6M!IUE:[?L]G;P[6+#RXE7!(P3P.I%62 0
M01D&@#RFRU;34U7X?:K-?6S:;'IDMG]H\U3'#<F*(A6;.%8JK#!Y[5O^#9HM
M0\;>,M3L9%FTV:6UBCGC.4DECB(D*D<'&5!(]*ZT:;8+:-:"RMA;,<M"(EV$
M^ZXQ4\,,5O"L,$211(,*B*% 'L!0!P/Q?_Y%K2?^PU:?^A&K?C^1+34?">I7
MC!=-M-6#7,C_ '(BT;JCL>P#$<GID5V<L,4ZA9HDD4$, Z@@$=#S2R1I-&T<
MJ*Z,,,K#((]"* .'TJ[MM6^+>H7VESQ7-G!HT5M<3P,&0S&5F5=PX)"Y^F:X
MZ^UK3K+X5^-=*GO(5U'[?J"?9-X\TEI68$)U(VG=GI@$]J]EMK6WLX1#:P10
M1#D)$@51^ IC:=9/.\[V=NTTB['D,2EF7T)QDCVH XCQS%',_@-)%#K_ &Y;
MG!'&1%(1^HKT"F/#%)LWQHWEG<F5!VGU'I3Z .(\5?)\2? DLG$/FWL>3T$C
M0?+^/#59\:6&N:C<Z2FGZ=;7^G03&XN[>:[\CS77!B!.ULJ&^8C')5:U/%'A
M\>(M)6W2<VUY;S)<V=R%SY,R'*MCN.H([@FM:#S?(C\_9YVT>9Y>=N['.,]L
MT <)\-[K59M0\5+?:9#:H=7E=F2Z\TK+LB!3&T9 &#N]\8JQI7[SXR>(GA_U
M<6EVD<^/^>A:0KGWVUV@C6,2&*-%9R6.!C<WJ?TYK%\,^'WT2&\GN[A;K4]0
MN#<WEPJ[0S=%51U"JH"@>WO0!KW=K%>V<]I.NZ&>-HY%]588(_(UX=907NOZ
M)>6K9:]\':4UM'D?\O<<Y92/?9:Q_P#?=>[U&D$,9D*11J9#ERJ@;CZGUH \
M7O)7UWP_J'C.&<VUM>:_:.+@QAQ%:6Y$:R%3P5#[F/;O4OB.T%YIGB'4(/%:
MZS=0P62W;6UFGEQ0I<"3)*95R%WDKUQUX->QI;PQP>1'#&L."/+50%P>HQ3;
M:SM;.'R;6VA@BSG9$@5<_04 >5:FEO>6OB6__P"$OBUR\B\-W412VMD5%C<;
M@6="1G*G /."32>!C<>'-9TJ;Q&\5R=;TZWBTW4 I58-J _9,$G;D88'C<<Y
MR<8]4@T^RMH9(8+2WBBDSO2.,*K9ZY '-/>V@>-(WAC9$(**5!"D=,#MB@#S
M'0=3MM+U70['1M=L]9T>[NWCATZ:)?M=A\KL6!'S *05(=00#C-=7\1[6ZO?
MASK]O9([SO9OM1.K <D#UR 1BN@CL;.&ZDNHK6!+B3[\JQ@.WU/4U8H \WU?
M6-(\0:EX&@T"[M[F=+];H+;N&,-NL+A]P'W1\RK@XYXJ?X>?\C;X]_["X_\
M0*[F"QL[6626WM((9)3F1HXPI<^Y'6I8X8HF=HXD1I#N<JH!8^I]: .(^*DM
MO!HFC378S;1ZY9O*,9^0/D\=^*P_$VO6K^+M2UC1A:ZJFG^&+C[2$(EB8M(I
M1'QP1A7./3/K7=^)M"DUV'3$CF2+['J5O>MN&=PC;)4>YK4M[*TM$=+:UAA1
MSN=8XPH8^IQUH \OTJ_C/Q(\-K)XGM]6'V"YC#0111PQLWE$1H4ZDA<[220
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M7/BAX5?1KRWO!:V=Y+<O;.'"1.J*@8CIEN@]J[<V-H2";6 D*$!\L?=!R!]
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M(X;&ZO;6R6YM[J*TC,DJ+*J[75!RP!3!QS@T 3)XQN9=+$L7AW46U/[8;)K
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MJUNK6!H>490Z,I9NS @@^M '757NK^SL?)^V7<%OY\HAB\Z0)YDAZ*N>K''
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MW*I>.!I )'4=2%ZD#UKR?3M3\2Z-X;\5ZSICZ<MEIVL7\SP7$+.]R!*2V&#
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M%NQG'EG&['7G%6K_ ,,:QX@\*ZQ97=KI6DW%R8FLXK7,@B:-@ZF23:N[+*.
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M,=M8_,(T   9\+O;.3T&,XK:HHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%J.C>'VU3Q)>PW8N+R[GM,R73E=BA%*#*1Y8D@=.!WKI/ EWJ5SH]U'J4>H
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M&.-JXX8C&3R2<UVE<M<Z!?Z5\.!H6AWDPOK6T2"UN%"JQ9<8)SP,XY]LUU-
M'&^-KI/MVEV)U+5XC()9#8Z/$QN+@ * Q<'Y$4GGIDL.>*X6[>\\0:)X-:]U
M'4TE3Q))8ES+Y<I5&F"LX''F *!GZ^M>EZWX;N=0UJTU?3M7DTV]A@>V=U@6
M421.58C#< @J"#^AK$;X;&/2H;*TUVXB-IJIU.RF>%9&B<[MRMG[X)=CDX-
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M7'S+EB?6M/Q1I26VH:QX@U#1;'7M*EBB>YD24)>:<(XQN\LGMCY\*RMEC[4
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M#)P5!A8$CTP":W]4\/Z%HGBGX?G2;2VM6:Z=/W"A?.06[_,V/O$9ZGGYCZT
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MU867AS1VUG3Y$U*U/FR0&Z<Q"4,=KF-6\MF QS@UU4WA71+B^U.\FL%DGU2
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M*Z)&NK(-/1DU=R]\KLS"8D8Y!)QQZ8KF?&_Q'M-(^'L^O:%<+<SR_):L8'9
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M^M?#>.]B(GBT2Z=5<<IDICZ':V*=J&VVU?QO9ZKXMCT:&YN#(]K):QR-<P/
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M7?V&F_%/PC<ZC+'#"+6]432D*D;'R@"6/ SG&3W('>NZCMH(G#QP1HP0("J
M$*.WT]JQ]1\/?VAXKTS5WDC,%I:W%N\#IGS/-V?A@;/UH \F\9S0W_@KXGZG
M8R++IMQ>V20RQG*2.GDK(5(X(W<9'I75:UK+CQ'>V+ZS!HJV^F6YCV6\3W-^
M7W_(I<'< 1@*H)RU>C"TMA:BU%O$+<# B"#9Z].E*]K;R31S/!$TL7^K=D!9
M/H>U 'DW@22"ZU?P&R/'*8?#<R$@@['#0J1[$<BNA\*ZG9:-)XRNK^=8+?\
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M,0P4-OW$[LDC &:7Q&^H:-X0\*>*M.LYH]6L+==.>TG3RY)!*GEA2#R<2A&
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MU@PZ5YT%W +-O.0M;A =G4KN[T =%?>//LD]]<1Z/<3:-IUQ]FO-165 (W!
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M0NZB-" 6;G*!@2?XLUT6G^-+.[\*:EKEQ ]J--:>.\MW8%HGB)W+GN2 "/\
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M=8\<226TJI>7"-;L5XE MD7*^O((H F?QO\ :TTM="TJ;4[G4+(7ZQ&581%
M<8+LW ))P ,\@^E1OX^CN+31_P"RM+N+S4-4,HCLVD6(P^4<2^8QR!M;Y>^3
MTKBK3PPUC!X:OM;T76+FW708K&6/3VF6:WF1BP#I&P8@AB.^"O.,UJPZ;)X<
MU'PUKUGX;U&&P2&[ANK*)FNKB S.KJ[#)8DE?FQG&Z@#8\#:G<ZGXF\8/<Q7
M%N8[R!!;3/N\DB! P&"1C()R.#G/>N@\1:[_ &%:VK1V<EY=7ERMK;0(ZIOD
M8$\LW &%8Y]JP_!$>H2>(/%>HWVFW%C'?7<,ENLZX+((54'Z\<CL<CM6CXTB
MMKC1HX;[0KC5[)IU\Z.VR981@D2(%^8D-@?*00"3VQ0!7N/&<MCI4<M[H5[#
MJDUZ+&#3]RDS2D;@4D^Z4VY);M@CJ,53O_%,]YHOB;2[W3YM*U>TTN6Y6/SE
MD#QLC@.CKZ,I!X!!KG8=-UR.VL-7CM-7O+#2=9\^TM;[YKPVC0['X8[B5=F*
MAOFVCZ5H7=KJ'B35/$>N0Z7?6UM_PC\FFVL=U"8Y;B1BSDA#\P ^4#(&230!
M+X6\3W-EX$\)6L%G/JNKZA9;TB,P7Y4 WN[MT W*.Y)(K/\ '?B:35/!^DW=
MJ+FPN8_$$%I=0&3#QNK,'0E3@CH?0@BJ,'AB:VT/P5>:MI&J7%O9Z9)9WEO9
M-*D\#ML96VQL&(RA! SU!Q4VO^'))_!&FIHOAV_M/,\00WDEO-(\TQ0':97W
M$E<JJD@GCZT >A:3XBBU/6-:TMX&M[G2IE60.P(>-UW)(/8C/TP:=X8U]/$^
MB1ZM#;/!;S2.(=YR9$5BH?V!QD>U<1\2[74+#7+"^T7 N==A;09AG!&_YDEQ
M_L 2<^AKT73;"WTK3+73[5-EO:Q+#&OHJC _E0!Q6KZSJ-A\6!;6%C<:C)+H
M:LEJLPCC!$[9=BW XP,X)Y J[:?$*VN%TIIM.N+;[9J$FEW D92;2Z4'"-CA
MMQ& 1ZCUJMJTM]I/Q1&L_P!D7UWIIT46TDMI"9&1_.9@-HY/'4#)&0>F:S;?
MPO>ZOX \3-=02:?>:GJ,^JV:3862W8%3"6_NG]V"?0,: .T/B",^,!X=BMWD
ME6S^V33!AMB4MM53[D@GZ"L[XC:]J/AKP/J&J:9"'N8E #DKB'/&_!^]@D<>
M]4/AF;C5M,O/%U_#Y5YKDJR*G]R"-=D:_HS?\#J]\2M-O-7^'6M6-A ]Q=20
MCRXD^\^&#$#U. : ,.ZU[68?B'IN-(N7N[C1)O\ B7+<KL5Q.GS,_P!T#:#S
MR>0.]:T/CZ.;14N%TFY_M1M0;3!IOF+N^TKDL-_W=H4%MWI46G&YU3XA:?K:
MZ;?6UFVAS0DW4!C9)//0A6!Z$A21[<US%[X7O)4N[VZTN^GM[;Q3<7<EO;L\
M<TMO)%LWQE2&."0< \@$4 >AZ!K[:P][:W-C)8:C8R+'<VSN'QN4,K*PX92#
MUXZ$8XK:KDO!.GV%M_:5W8:'J&FI<2(@DU":5I;A4'#%9&+( 68#/)Z^E=;0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M6=HNBVN@V+VEF9#&\\MP?,;)W2.7;MTR36C7!Z7KGBW7;==?TQ=.DTI[QH8]
M.:,K,\"R&-I/-+X#?*6"[<8XSF@#O*Q;SPO9:AK]MJ]Y-=SM:L'M[5YOW$<@
M&!($_O<GDYQVKD?$'C;4M"UB9YM8T%(XKV*!-&!W74L+,JF3=O\ E;YBP7;C
M K2M-<\1ZK\0-9T>U>P@TS29K<RR21,TDJ21JQ0?-@'.[YNW'!YH [.::*V@
MDGGD2*&-2[R.P554#)))Z "FVUS!>6T=S:S1SP2J&CEB8,K@]""."*\ZTGQ-
MXEU?P?K6OW@TP6-I;WR);?9V8SO$7PS$M@+A=I7OR<C.*BB\=3#0?"=LM_HN
MAS:GIYNYKJZ0+!"JA1LC0NH));@;N IZT >GT5YA)\0M7N-"TE],_LRZOY];
M;1Y94):WD.UBLJ$-D*?D8\GC(JU>>(O$EKKO]A2:WH=IJ$-K'-%]LMF1=2D8
MME4/F#8!A1QN.3F@#T6BFQ%VB0R*%D*@LH.0#W&>]>7KXO\ &$GA"]\5J=+%
MIIT\ZO9_9WW7,4<K*S!]_P AVC@8/*Y[X !ZE17"IXA\0:OX\O=%TN2QATZU
M@M;IIYH6=RD@)* !@,MC@]L'@YJC)XK\477AO4O&%@^G+I-G),T6GR0,9)X(
M7*NQEW_*QVL0-I XZT >D57NM0L[)X$N[N"![B010K+(%,CGHJYZGV%<WHOB
MJ6Z\3:OIU^88[>.UAU&PE"E2]LZ_,6Y/*L",^XKF'\9ZI=Z=X0U*ZL;!DUG7
M/+@66 EH;8L1&P)/$A4 [O?I0!ZC)(D4;R2.J1H"S,QP% ZDFJJZOIKRV<2Z
MA:M)>H9+5!,I,Z@;BR#/S#'.1VKAM2UGQ'KEKXLFTV6PBTS2VFLA;2P,TETR
M1@R'>& 3[V%^4].:IZ%K4MG>?"[25M;1XK[2&+S21;I8]ELI&QL_+GOZB@#U
M&BO+I_%_BX^%]8\2Q2:7':Z3>7$1M6MW9KJ.*4J3OWC8=HQT.2">AP-V76_$
M.L>*=3T_09;"VM]*AA:7[7"TC7,LBEP@(8;%"XYP3D]#0!VE%<[X%UV[\2^#
MK'5[Z*.*YN#+OCC& NV1E ZGLHK$F\3ZU<^,-0TNSU'1[62RN(XXM+O(V6:\
MB*JS2+)N&/O,!A6Y7F@#O:*Y"T\3W\^C>,;MT@\S1[NYAM@%."L<*NN[GDY8
MYQBJ,'B3Q!X@NM-TS29[&RN&TB#4KRYGMVF7=+PL:('7'(8DDG Q0!V[7=LE
MW':/<1+<RJSQPEP'=5QD@=2!D9/N*FKS&^E\2W7C?PJ'ALK#69--O4G9LS11
M8>++JH8%L@#"[AC=R>.>H\':SJ.IQZM9ZL;>2]TN_>S::W0HDRA5=6VDG:</
MR,GI0!O2ZA9P7L%E+=P1W=P&,,#2 /(%&6VKU.!UQTJQ7&ZYK4MI\3O"FDK:
MVCQ7T5VSS219ECV1Y&QL_+GOZUSS^,?%H\'W?BS?I:6=A=2QO9_9W+7,:3F,
MMOW_ "''08/(SWP #U.BN!OO$^M2^,=0TFQU'1[26S>(6^GWT;"2_1D5F99-
MPP,EE&%;E>:U].\07EW?^+()%A":3.([?"G)!@63YN>>6/IQ0!T]86M>%;36
MK^"_^UW]C?0QF$7%C<&)VC)R4;J",C/3@UR,?C'Q-JG_  B%IIPT^*ZUS2WN
MIII8F9(74(2P4-DC#$ 9ZD<]:?XN\7ZQX;DO)9-;\/6WV*W26*QGYGU A<O@
M;P8\G(48;)H [G1M&LM TJ'3M/C9+>+)&YBS,Q)+,S'DDDDD^]7ZX;^V_$NM
M^*=6TC1[C3[*WL[:VN$N+BW:9LRJQV;0ZCG;U[8Z'/%/3_&FM>(=.\-6NG"S
ML]4U6">:YGDB:6.!86V,53<"2S$8RW SUH ]%HKS[5?%>NZ);:=INL7.CZ9J
M-Y=S1#4KAL6_D1KN\T(7&&;*J$+=<]JV?!7B5_$%OJ,,UW8WL^GW7D-=V)S#
M<*55U=>6P<-@C)P5- '45A:;X<T[1=3NM5>ZN;B^N@(C<WL^]E3.1&G0*N><
M#KWS6[6;K^A67B30[K2=0CW6]PFTD?>0]0RGL0<$?2@#2IL<B2H'C=74]&4Y
M%>3?V[XFU& ?#F3S8_$*L8KO5%7Y?L(Q_I"G^^P(7'][/2NEG>YT?4](\#^%
M!:6"QV+W,EQ/"91%"C!1A0R[F9FY)/J><T =M17G?_";:S:J;"\2S;4K37[7
M3+B2.-A'+#-M(D52V58JW3)P172?VU=?\+"&A;8_LG]E?;,[3OW^;LZYQC'M
M0!T%%<]KVMW>D>(?#L(6+^SM0N)+2X9E.Y9#&6BP<]RK \=Q6%I/CVXGUWQ&
MFH1PII=G#-<6,B AI(X':.8L2<'Y@,8QP: .V?4+.*_BL9+N!+R92\=NT@$C
MJ.I"]2!5<Z[I L;B^.JV0M+:0Q3S_:%V1." 59LX!R0,'U%<-I/B?5KKQ7X.
MM=3LM/%QJ>E2W<\BP$21'&X*C$D@8(!'?FN(G_Y(=\0O^P_-_P"CH: /?U97
M4,I!4C((/!%+5;3_ /D&VO\ UQ3^0KC+?7/%NM_;=6T1=.?3[6^>UBT^6,B6
MZ2-]COYI<!#D,0-I' S0!WE%<*^M>*-;O->FT&?3K:TTBX:UCBN;9I6NY40,
MX+!UV+DA1@$]3[55LO&.N>)]5TNTT0V5E#?Z(FI/-<0M,8&,FTJ%#+NYP.H[
MGVH ]$JNNH6;Z@^GK=P&]2,2M;B0>8J$X#%>H&>]>4ZSXA\2:IH.B@7MI:7L
M/BA=+NGC@8I*Z2X5P-X(7Y<E<\YZBMUO$5_:>/=9TV2"P>6R\/B[^U);[9))
M >03N)V9YVYX]: /0:*\XL_%'BE+#PKKE_)IK6.M36]O)916[!XO-3*R"0N<
MG."5V\ XR<9K23Q9J+>#_%^JE+?[1I%S?16XV':1"#LW#//3G&/PH Z1=%M5
M\1R:Z#)]KDM%LR-WR;%=G'&.N6/>M&O-]1\=74FIBP@UW0=%>WL(+F5]3Q_I
M$LBEA&@+KA0!RW)^8<5V7A?6U\1^&-.UA8Q']K@61D!R%;HP![@$'F@#6JMJ
M%F;^PFM1<W%MY@QYUL^V1/=3@XKS'3O$6MZ"WC[6M1O8+V#3[LQK;+ R%Y/+
MC$>UBYVKR 1@\DG/:NA35O$VA:WHEOK]SIUY;:O*UN?LMLT1MIMA=0"7;>IV
ML,D ]#[4 ;VG:=I'A#0S$DJVUG&QDFN+J;EW8\O(['EB3U-;%<;\5V*_#'6V
M )(C0X'?]XM0-K_B#0/$>F6_B":PGLM4CG(%K T;6LD<?F;=Q8^8"H89P.1T
M% '<UG:[HMKXAT:XTJ],@MY]N\QMAOE8,,'![@5P&B?$:YN[O0[FXUG0;B'6
M)UA.EVK@W-EO!,9)WG<0=H8%1@GVKM_%FNCPSX6O]8V)(UO&-BNVU2[$*N3V
M&YAD^E &O)(D,3R2.J1H"S,QP% ZDFJ0UO26@M)QJ=F8;UQ':R"==L['HJ'/
MS'V%<%#XOFNGU'1;G7=$UK[1I-Q<QSZ7@>2Z !HV =^"&!5N.AXK'T#6I=(^
M'WPTBBM;2<7U_';.;B+>8P6;YDY^5O>@#V2J\FH6<-]!8RW<"7<X9H8&D >0
M+R2J]3COBN(G\1^)KV3Q'J.D'3UT_1)I+=;6>%FDNGC0-(=X8!.3@<'..:KV
M/BR\OO$O@&.>TL6?6-*>[GE\G]Y&_DA\1MGY02>1SQ0!Z#:W=M>P^=:7$4\6
MYDWQ.&&Y201D=P00?<4U=0LVU!M/6[@-ZD8E:W$@\P)G&XKUQGO7DNA:GXGT
M7P'J6MV$FG_V=IM]>2M:2PLTER@N'+GS P"$ D ;3]WGKBKZZK!:?&/6]88%
MK>'PLMT<=2@<-_*@#U.BO-?#_CZZNM7T2.\UO0;]-8RK6=@P\VQ?RRZ@G>V\
M?*5)(7!Q6M\6+F_L_AKK%QI]T+:1(OG;:2Q0G:0I!&T\CGGIT] #M**XF?5/
M$DFN6/A>UO\ 3UOQ8M?7NH-9L4"&0HBI%YG4\Y)8_=SWQ6GX1UR]U>#4K74T
MA&H:9>O9SM "J2X"LKJ"21E6'&3@YH Z.BN,U;6/$5QX^;PUH\UC:P_V6EZU
MW<0-*48RNF H9<YP.XQ@]>*H0^+]8N?##R3W>CZ9>V>IRZ=J%]='$$?EY^=$
M+ L6^7"ENY]* /0J*\O;XB:K_P (C)?6;Z;J5W;Z['I?GP B&Z1BA#+\QVDA
MP.I (/6GWW_"81?$+PK976N:>7E@NY'$-DXC.W9D$>9SP0 >W)YS@ 'HMMJ%
MG>37$-K=P3RVS^7.D<@8Q-Z,!T/L:EEECMX7FFD6.*-2[NYPJJ.223T%>:Q>
M-[FP3QO<+I]D9M/U*.TM5BC\LS/(0BF4_P 7+#)],UMS7'BS2M/UAM8.FZC:
M1Z;+<1W$4!B"RJIS$\9=BRD<YXZ$'K0!UEK=6][:QW-I/%/;RKNCEB<,KCU!
M'!%35YE8>+-=N=(\#6^EP:;;S:Y;S&4F!O*@V(&RJ!AP.?ESSQR*T(/$WB""
M'Q+I=W+I3ZKI#0,E[*#!;M%*,B1U+'!4!\C=S@#/.: .]HKR#5O&.J7_ (1\
M8V5IK^EW\FGV*3IJ-A$0KQR!PR8$AVN-O# GJ.*UKKQ3J6E_V-H=UXBT73[J
M:Q-Y/J-[%L39D*B(C2C+'G)W=%)QS0!Z35==0LWU!]/6[@-ZD8E:W$@\Q4)P
M&*]0,]ZQ_!GB%O$OAY;V1K=IXYI;>9[9MT3M&Y7<AR<JP 8<]#6+)XAN(OB9
MK6F):V82UT07:3^5^]9MWW6;/*^U '=45YI8^*_%0TCPMX@OI---CJ\]M;2V
M45NP=!-P)!(7ZYP=NW@'&3C-=QXBDO(?#FHS6$\<%U';N\<DD9<*0,] 1V![
MT 79;NV@N(+>6XBCFN"1#&[@-(0,D*.^ ">.U35XQIQUY]/^&,@O+6YOIA*U
MO)+"P$:-:'_6?.3(P&XY!7=P..M;]QXXU?0+/Q'::K+I]Q?Z9/:PV]UL,$+_
M &C&UI 6.T*<D\]!VH ](HKB?"?BR34/$=SH<^M:3K)6T%W%>:;A0!NVLCJ'
M?!!*D'/(--\?>9J>K>&?"[32166KW4OVPQL5,D449<QY'(#' ..U '8P7MK=
M,ZV]S#,R?>$<@8K]<=*GKE)/AUX<CNK&[TNQCTB\LY5D2XT]%B=E'5'XPRL.
M#G-9TFN^*-8EU^\T.?3K>STBXDM8X+FV:1[N2-07RP<;!D[1@'IF@#H5\+V1
M\2C7IYKNYNXPPMTGFW16VX8;RTZ D#D\FMNO/+;Q?KGB76M.L=#>RLK>^T.+
M4S/<PM,T+,Y4J%#+N[#MT)YX%9H\:>+AX.D\3S'2TATZ[-K=6BP.3<[9A$[J
M^_Y.O P>G7G% 'JM9/B#P_;^([);.[N[V&V)/FQVLYB$RG@HY')4^@(KG)=6
M\5:MXO\ $&BZ1<:;9P:8L#)/<6S2LYDCW;,!UP,@Y;L,<&J@\:ZCJ7A30]5&
MHZ-H"78E6\N;\AE26-MFR-"Z[LL&YSP!WS0!Z!;V\-I;16]O&L4,2!(T48"J
M!@ #T J2O-K;QUK>IZ5X7?3UTYKK5;VYLII<,T/[H2#S4PV=OR;L9Y'&1UIE
M[XP\3:'%K\5V;&^DT&:TN)YH;=H_.M)<[\)O.UU"L<Y(P.E 'IE'6N9O?$-S
M)XQT31=+,,D-Q;R7UY*P+;8!A4V\]6<]?0&LO4;;_A7_ (>UO4]+CBB-Y?)*
MWF&26*W#NJ/,PSDX!+D# Z#MD@'=45@>%KW4;VTFDO-2TO5+?<#;7VGC:LJD
M<AEW, 0?1CGVK?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ K@=-\/^+M$MAH&ESZ?#I*WC31:@7+3QP-(9&C\HH5+<LN
M[.,'.,UWU9VJZ[IFB-9KJ-VD#7MPMK;J029)&Z*  ?SZ"@#@KWP7XFDTC5]&
MM4TE8+C4'U!+UY6\VX)F$JQN-GRX("ELG@  <\=1X>T._L/%'B/5[S[.J:JU
MJ\<<4A<H8X0C DJ._0]QZ=*LZWXPT/P[<I;:E>,EP\9E\J*"29EC!QO8(I*K
M[G JU=^(='L="&MW.HV\>F&,2+<ELJRGIC'4GL!R: .=TGPEJ%C\-M4\/2R6
MYO+I+U8V5B4'G,Y7)QG^(9X_.J-MX,U?2=,\+W%K!IU[J&E:>;"YMKB0K%,C
M;3E7VG!#(",KR">E=W9WUM?Z?;W]M*'M;B)9HY,$!D89!YY'![UBV?C72+^?
M2XX/M!759IXK.0QX67RE+,X.?ND X/>@#+N_#.M:E;^')+K^S8KFQU<7]Q';
M K&L85P$4X^9@&49(&<'I3_%^CZ]K2WNGQZ=HNHZ;=0[(C>NR/:.006P$;?V
M(P5(/YUT6M:U::!8?;[_ ,Q;42*DDJ+N$08XW-Z*"1D]JT 0P!!!!Y!% %?3
M[5K+3+6T>9IG@A2-I6ZN5 &X^YQFO)O#^D^)==^'MYH=FNGC3=1O;N-[N29A
M+;QFX<.!&%(<G!P=P^]R.,GV*L*#5M&TOQ'#X4M8/L]U+;/?)'%$%CVESN.1
MW+$G\: *VD>';C3?&NLZMNB^Q7=I:P0(K$NOE!@<C&/XACFN>D\)>)[?P]J/
MA"Q_L[^QKR281W\DSB6""5RSIY6W#,-S '<!TZ5Z/10!P7C;P-?ZO#IO]@7,
M-I+%;2:;</*Q&ZTD4!@" <L-H('N:N>)_"$^I2^$DTO[/#:Z+J$,[I(Q'[I!
MC"X!R<8ZXKL:* //Y_#7B>RD\2:=I']FMIVMS27"W,\SK):O(@60; I#\C(Y
M&,\T6G@G5(-:\ WCRVOE^']/DMKL!VRSM (QLXY&1WQQ7H%% '"/X-U)OAUX
M@\/B2V^V:A/=R0MO.P"61F7<<9'!YX-5I5OM#\:ZNVE:AHV^^L[>6\COIVC>
MU**4$J@*0ZD#D97D=17HE9NI^'M%UIXGU72;&^>+_5M<VZR%?ID<4 <_\*(W
MB^&>CARS%EE<,PP65I796_$$'\:J^*O#OB'Q"]QITEGH\UI),KVFI.[+<62@
MJ3M0(<N"#@AAG(S7=(BQHJ(H5%&%51@ >@IU 'GMUX9\3P'Q1INFC36T_7)9
M)UNYIG$D!DB5'7RPI#?=X.X8SDYZ5+#X9\0Z#=Z9J>CQZ?=W*:1#IM[;7$[1
M*6CY61'"G."6!! R,5WM% ''Z?X=UQ?$.A:KJU_;W<]I97,-U(B[,O*Z,H10
M/NJ%*Y.#P#WK1\.:)=:3J/B&XN&B9-1U$W4(0DD)Y:+ALC@Y4^M;]% '*:SX
M:O=0^(OAK7X7@%IID5RDZLQ#DR)M7:,8//7)%9DG@K4W^%FI^&1+:_;KJ6X=
M&WMY8$D[2#)QGH1GCK7?44 <)XN\.^(/$27FEM9:-<64Y!M;^9V2>QX&2%"'
M<P()4AEZC-+/X?\ $MEK?B'^RQI\ECK>QS<7$S+):N(A&QV!2'X4$<CGK7=4
M4 <)H?@W4M-O_!\\\EL5T?29+*X".26=@@!7CD?*>N*JZMX/\07+^*[&S73!
M;:\6?^T)I&\Z,&%4\K9MY&5X.[@,3@GBO1:* .3\*Z%JFG:YJFIZDMK&;VUL
MXA'!*9-K1*ZMR5''S#'XUB:=X+U[0=-\.W=@;&?5=*6YAFMY)62*>*:0O@/M
M)# A3]W'6O1Z* .#NO#GB:\33M8O)--O-8L[N:5;*0E;<02*%,(?9DD85@Y4
M\Y[5KV=OXFM])9UM]%@OY;M6\A _E16^0&7< "[X#'. ,G&,"NEHH **** .
M7@\.WD?Q.N_$;/#]BETM+-5#'S-XD+$D8QC'O2:]HVJIXGL?$FAI:SW4-M)9
MW%K<RF)98F8,"KA6PP9>XY!/2NIHH \ZN/!&MW.E7M^\MC_PD%SJ\&JB(.WD
M+Y.T)%NQD_*OWL=3TK5TC1M?E\<MXDUA+&"-M,-FMK;3-(8SY@<$L57=GGG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMH"\CF",O(-KML&6'H?6@#ROQC=W7AWQ#>RZ/^\3QA9);6KQ'<HO 5C5P1P
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M/#M[$K-<RL44M$#AP2,,"-RG&:[;QMJ$VE>"M7OH+>*>2&V9A'*F]/0EE[@
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M.UB";60?)(8U&W)"_*W/!XXKTS2M,M=%TFTTRR39;6L2Q1KWP!CGU-6(K>&
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MMA!?I<;N'24L ,?\!S^-9$?CV2\M;$:;H[W-]>W-U!%;O<+&N+=RKL7(]A@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(=!M_$6F"TGEE@>.5+B"XA(#PRH<JZY!&1[CH35/1_"[V&KS:QJ.J7&J:G)
M+99I8TC6*('=M54  R>2>2<"@#E/@;IT<'PZL+X7%VSSF93$]PS1+B9QE4)V
MJ>.2!S3;F?7(/C-JYT.QLKN0Z3;^8MU<M"%&]\$$*V:[/PEX:M_"/AJUT2UG
MEGAMRY624#<=SECG'NU9NJ>"[B[\3SZ]IWB*^TNYGMTMY%@AB<,JDD??4^M
M"7=]XF'A;7YM6LK*P>*PE>WDL;QY6W!&.>47;C P17%W%OJUKX8\$:U#XDU<
M:EJUQ9VMS(]RSQF.>,YQ&?EW#@AL9R,G)KN8?"NJ-;WMMJ7BO4-0MKJUDMS%
M+;P(%WC&X%$!R!GVYJ:?P?:SZ)X>TLW,PCT2>VGB< 9D,*X4-]>^* .4F^U^
M'?%FOZ1::KJ4UH_AM]0075V\S13*[)N1F)*\<X!ZUD74>J:5\)=-\;CQ#JTV
ML0VUK=,)+MC#*C% 8VC^Z?E;DXR3SFN[\1^'8Y+C5_$"22M=-H<VGB!1E2,L
M^1WSGBN=\-^!)M3\#>';/4M9U#^RA;6UQ-I3QH 7"J^QGV[]F[G:3[9P!@ I
M:EJ<FC_%/QCJD*AI;3PP)T4C@LOS#/XBK,MO?>'-)\+Z_'K>J75Y>7EI#?+<
M73213K/@-B,G:F"V5V@8Q77-X/L9?%6I:Y/))*=0L!836S ;#'GGWYZ50L?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC3[/&=J9!W-PQQ@#WYKH)/&[7;Z3;Z#I;:C>:C8C41'+.($A@.,,[8;DDX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ)J">7E7VM&H9@VT[LYP3ZU!8ZFK>!/AJ@O-UQ-?6@8"3+/A'#9[G!P#[XH
M],;4K?;?"$M<360_?0PC+AMH<*!ZD$8^HJQ#)YT$<FQX]ZAMCC#+D=#[UY@E
ME9VC?%*YMXUCNE64!E8[@K6B.>_][)JRL5OJ_B#PUI>M,9--;0/M$4,DA5)K
M@&,,3R-Q5#D ]-Q- 'I-%><:CIUGJ6B:!:Z+K%OJ-M%/.8;/4[IPM^J[E*[P
M,MY9/'##@9SUK>\!W5M-I%Y;6]G-9M9WLEO-;/<^>D3@*Q$;]T^88'&.1@4
M;EOJUG=:M>Z9%(6N[)8WG3:0%$@)7GH<[3TJ[7DGBZ62&;XG21.R2+IEB593
M@@[9*Z%=+MM ^)6B1:?YD:WUA=_:]TK-Y[(82K-D\M\S<]>: .ZHKS#PM!HU
MUI.G:]J]_-!K\NJ/'),L["1IO.91;E>?DQ@;<8P,\=:]*CN8)IIH8IXWEA($
MJ*X+1DC(##MD$'F@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLHWWLD<A)#%D 0GKD'@G@U>OO$]YH-[XD9K+3YM4M[?38A-%&T8N)IF=!O\
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MMSC(& ,8W<DXS3[KQY<V'AA;\ZAHFH/<W\=E:WEH7$(W#):6/+,I4!OE#$G
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MRA"F,  *N,  =,5+JO@FUU>;7)9KN:-M4CME!C S \#,R.I/4[F!P?2NHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>exhibit1012-stuartexecut005.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCC+8X ]#TQ0!V=%<:?B%;7$NE0Z9I=Y?7&J6DES;Q*50@HP5D<L<*02<G/\
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MX+H,\G))R1\O(SGBETW7)]"M['0+30=4N=6EB>Y:UN=025HX@0/,>9G(PS<
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MX8@"\LCL%5%SW)(H U:*\[7Q)>O\2;!-4L[K28X-'NIYX))EDC90\>'RA(.
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M %^XTOPK>/!)HEB=0N]@R)I"08X#]55SCW% 'I=%<U/(OC?P+%>Z3>2VLMW
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M!(5V,K*<,"'SZ\&KVG>+Y;CQ!!H^IZ)>:7->0O-9-.\;B94QN!VD[6 (.TT
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MB^/[#Q(;&[O+!].EL)_LD+3/"QD616*+EB#@C@''%=K10!Y--I&JZB]QK?\
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M=\BJDQ$T1;JRLJ$X-:%UXEOI?B/9W5K>N= BDMM.EA4_))+<122*Y]P3 /\
M@5 'H5[96VHV<MG>P1SVTR[9(I%RK#T(I+*QM--LXK.QMHK:VB&(XH4"JH]@
M*\Q36+G4=+^VW>MZK%#JFLW!L[338V>XGMH@45(R/]6N5WLWH<9&:I2:_KK^
M%((+74M0M[B/Q7%ID4UV!YXA;!"R_P!XC?WZX&: /8ZH:9K%IJTE^EJSEK&Z
M:TFW+C$BJK''J,,.:XR:PNY/&.G^$1KVL+96VFR:A+.+K%Q<.TNQ0T@ .U?F
MX&.WI7.:?'K-GI^N1Q3ZK=6T7BF9=1ETT 7;PB! I&.^[9NV\]<4 >RT5SW@
MR[M[S0!):ZS<:K )G5);E"LT8!_U<F0"67ID@'I]:HZ[J%[HGCS0;E[F0Z1J
M:OITL)/R1W!^>)P/5L,GY4 =?17E-WK^M7L=]?6FHS6]KK&OPZ-8.I!$$*$K
M)*@/&YF5\$^@JWJLVH>$]8O-,M]7U"ZM;O0KNZB-W-YLD$\(&&5SS@ANGJ.*
M /2Z*X&\U;4$\,^ )UO)1+?7MDERX;F56A9F#>N2 :[Z@ HKQO0O$>LZE%I&
MN6__  D\]]>7B-<0&T<V/V9Y-I5>-HV(00V<DJ<GFM'6=:UO2?$TO@F#4R9=
M:E66PU"64%[*%MWF(<\EAL/E^N[K\M 'J=%<$]M>>(?&.IZ&-:U2QLM&L[8(
M;6?9)++*'.]VQEL!1P>,YS65JVHZHGB&U\/ZM?Z[.+/2XYIIM!MF5YYG=U#O
MM!*@!.G0DGTQ0!ZE45Q<P6D#3W,T<,*XW22.%49..2?>O+K6]\1ZSJ'@[3;^
M_P!2TU[JUOA? )Y$TRQ.@1L$?(S#!R!P&.,=:Q_%IOAX8\6:#<ZM?W$>D:G8
M_9YY)OWCQS-$=CMCYMI8X)YZ>E 'MU86M>+=,T+4K/3;@74]_=J7BMK2W>9R
MHZL0HX ]:U;*U^Q645MY\\_EKCS9WWNWN3W->8ZSH@N?CMIR?VGJ47G:5+-F
M*X*E,/C:O'"^HH ]6HKRH2:QK'@S7/&2:_J-K>6\EW+9V\4H%O'' S!4:/&&
MSL.2>>>U68+G4_%7CZ.V_M>^L--;1+34&@M)=A,C,W&2#@'OCD[1[T >F445
MXU%-KW_"K[GQD?$>I'4+*6>6&'S1Y+1QSLNQTQ\^0#R>1QCI0![+17E'C36I
MEFUR]L-8U][G3[1988=.A(MK-Q'OQ.WW9,\$@]%/2MRRUZYTOQK-'JMVW]F:
MKI:ZA:^8WRP/$H\Y%]MI5_SH [NBO)+6\\17\/A&2;5[VT?Q#J%U<2(C<Q6S
M1,T<:YX&$ (]"<U/;Z;JMQJ'C#2&\4:RMKH^R2R=;C]\&DA$GSR8RZ@C@'U.
M<\8 /5**\A'BF_UK_A'+6^FUT12Z##J%P=$A8RRS.=H+%!E5&UC@8!+>U68-
M0\1ZG-X.TV\OM2TZ2ZDOX;J1H_)FGBB&8W*D?*Q4#G'&XD=J /2+B+3K2Y;5
M[D6\,R0^2UU*0NV/=G:6/09_6KM>(^+TO4\,>,M&FU?4;B#2M0L3;R33[I"D
MWE$H[=6 +$C/MZ5[-8VOV&RBMO/GG\L8\VX?>[?4]Z +%8?BS5=$TG0)7U]1
M)8SLMN8/*,IF9NB! "23Z5@O'>>*?'.NZ=)J^HV%CI$5O'%'83>27DE0NSLP
M&3@;0!TZ\5PGB26\U_P9X6NM1U&[:\@\21Z;*\4FQ9-DLB"7:!@/A1S]: /9
M=#6R31;4:=8-86FS]W;-;^08QGH4P-M)J&M6>FWMA93,[75_*8[>&-=S-@99
MCZ*HY)[<>M6;&U^PV45MY\\_EC'FSOO=OJ>]<AH__$P^+OB:XFY.EV=I9VX/
M\*RAI7/U)"_E0!TH\0:2=?\ ["6_A;5/*,QME.65!CDXZ=1UI;36K.\U:^TM
M&=+VRVM+%(NTE&'RNO\ >4\C([@@URL^G6>G?%K1?L=M'#]HL;^>8H.9)&DB
M+,3W/_ZJD\4_Z!\1/!VHP_+)<R3Z?/C_ ):1M&74'Z,@/XF@#MZ*:[K'&SLP
M55!)8] /6O)]&UJZB\0^')[?5=?U"+4[J2&XN+R Q6=PICD=6A0_<P5&,=1G
MDT >M45XU+<ZX/AMJ7BT^(M3^W:?=W!MHEEQ$42Y9=KKCY\C(YZ# '3GJ4\1
M3>&/$WBFSUBZDELX[7^V+$R-DB(#;+&#_LN!@?[= '>45@>"HM3C\(V$FLW$
MDVHW"?:)S(<E"YW;!Z!00N/:N6\4ZQ/<>-YM(>7Q#'96EC',!HD3L[2R,XW.
MR@D !. >"2<YQ0!Z117ES:MJ&H:1X?@UF]U^WU![>9I]/TRU:.ZGV/L69R,>
M6N!G' )<>F*HPZUKVL:1X'MUU>\M9K^^O+.ZG&%E>./S%!8=-^U,YQPW- 'K
M]%>=C3K^\\>7/AT^(-7CTVUTBWD)CN<322&21=QDQGD#G&,X';@X$7B?5)M%
M\.:7>7FKS":ZOX[JXTZ,O=31VTA1!E1D9W+N8<_+[T >QU0AUBTN-<N](C9_
MM=K#'-*"O 5RP7![_=->9P:MKU[+I?AJ2YUJRM[S5Y8X[VZC,-W):)!YNW)&
M<[LKNZX6MSPK8RZ;\3_$MK)>SW:+867E27#;I I,O#-_%@YY/.,=>M '8:OK
M%IHEFEU>LZQ//' "JY.^1@B_J15^N)^*JS/X.C6WD$<QU*S$;D9"MYZ8.._-
M9FI-J/A/Q']AAUK4;RVU'2+R;%Y-YC130JI#H<#;D,>!Q0!Z3445S!.\R0S1
MR-"_ERJC@E&P#M;'0X(.#V(K@I]8U%?!/@&Z%Y,+B]N].2YDW<RATRX;UR>M
M,^&6FFWU3Q;.U_?3F/6I[?9/.65@%C(<CN_;/I0!Z+17+>/[^[T[PY#/9W$D
M$IU"TC+H<$JTZ*P^A!(K/\4ZI?VGBXVUO=RQP_\ "/7MQL5L#S%9-K_49/YT
M =S17E=J^KZ?I7@?7Y-?U&YNM4N+2"[@EES \<T9) 3& 1Q\W4G.>M5U77+[
MPCXI\0'Q+J<5UI5[?M91QR@1*D+L0KKCYP<$<\ 8Q[@'KE49]4B@U>UTUH+I
MI;E&=94A9HE"]0S]%/H#UKSCQ#K<FHK+=0:KKPN8]*BN4L]'A(CM)'0N'F?H
MV>,*>@4\<YJU#XBU2\\<^ 4:[D2#4M(DN;J!#A)'\H,"1[$\4 =YK6L6F@:/
M<ZK?LZVMLNZ0HNXXR!P/QJ_7B&MQZCKOP;U3Q5<:U?FXO/,<VAD_T98O/V",
M)CC"@'=USU)'%>WT 4--UBTU6:_BM6<M8W)M9]RXQ(%5CCU&&'-7Z\IT[1+S
M4[OQW<0:YJ&GFWU24VZVDOE@2B&,[GX^<?=&#QP?6E.O2>(M/T"6XU371=7&
MD)<RV.APD.)&X\YW' 7(("'WZT >JT5Y -;U;4=!\.ZMK5WKL.DS:9F:[T=3
MN2Y#8+S! 6V[0#P"N<Y%6;_79M0UNWTU]5U^\L;;2;><76@V[;KF60M^]?8#
M@80$+T))]* /5J*PO!MYJ=_X2T^XUB&:+4"C),)HC&[%6*ABIZ%@ V/>N7\:
MW5W:>(7EU*_UW3]$%FGV:]TM2T4$VYM[3A021C9C(VXS0!Z+65<^(=/M/$EE
MH,K2"^O8GFA4)E2J=<GM7#>*-1:>YF6#7]<NI[;38Y431(-L<;E6832L#M8/
M@$(3@ '@YS56WOYM5^)7P\U&XQY]UH,D\F!@;FC#']30!ZQ17DD.NW$6MZ1?
MV6KZ[J"WFKBVFN)83'I\L3LR[8U/3;QAAU*DY.:M:9I^N^*+CQ>X\2:G;/8Z
MG=6NGQ03;$1M@P7XRR@LN!G P?6@#U&BO-5\57_B70?"%E9SRVNIZG<XU QG
M:\26_P#Q\#VRP"_\"KTJ@!DTT5O!)/-(L<4:EW=C@*H&22?2N?E\=:!;:18Z
MG=74D$%_DVJ/ YEF4?Q+&H+$8P<XZ$>M9OQ1=Y/"]KIBL535=2M;"5@<'RWD
M&X?B 1^-:VN3Z%X<\K7;RW'VJ*+[':K$A:63<01%&@ZDD#IZ>E "CQEH;Z?8
M:C%>"6PO9Q;1W**2B2'@*_=,GCD=< XS6]7G]OX6F;X=>)8=7A2&YUE[F_EM
MU.X6SNH*J#W*[5)/][-='X+U&;5_!&AZA<,6GN+*)Y&/\3;1D_B<T ;M%<!X
MRNO.U\V<>K:]YD-EY@LM%B(:)BS8EE<<$'& A_ND\YK*T?4=8\6:KX;M[C6+
MNT@O/#8O+L6C^6TD@D09!Q\I);J.<<=Z /5**\D76=:TC1'U235+NYM?#WB*
M6SNS*^YIK(D+E_[S)O!S[&NNL+^\U?XCZD(;F0:3I-JENT:M\DMS)\Y)]=J;
M1]6H ZVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 1Z;9'3M-M[-KJ>Z:% IGN'W22'NS'U-8VM^'=4U&\GEL/$=Q807,(AGMS
MLR8&1N3=]QB#@]0<#BMT7=LTR1"XB,KKN5 XRP]0.XJ:@#B_^%?+;S30Z?K%
MS::9=6L-K=VJQJS2I$GEKMD/*93 .!],&G:5X!&GZIX=OYM5DN9-$LGLH@80
MHDC(VKG!X(7 ]\5J:MXFAT^^T>V@6*Z_M"_^Q.R2C]R?+=\G&<GY,8XZULBY
MMS<FW$\?G@;C%O&X#UQUH X:/X;W,>G6%@OB2Y^S:5<)/ID?V9,0E6R-_P#S
MTP"5&<<$\9K?TS2K7PE;ZY?37;M#=WLNHS,4_P!5N500 ,D@;:W4D21 \;JR
MGNIR*C-Y:J8@;F$>:<1Y<?.?;UH X'P#HL,_BKQ%XLA@N(;*^F*:>DZ%"5.T
MS2A2,@.X!&>?ESWKK=%@U*&]UEK^>22"2]+68DQ\L7EIP,=M^_&>:UF944LS
M!5 R23@ 5RT_CFQ?3-)U#3D%U!J&IQZ?R^TIN=D+XY[H<#C(H E\>:+=:YX4
MGBT\ ZC;21WEH#T,L3!U'XX(_&LNXT>X\:7.C^*=+UR?2WAMF2."2S24PNQ_
M>9#_ '7&-IX['UKM(;F"Y5F@FCE"G:QC8-@^AQ35O;1XY9$NH62(XD82 A/K
MZ4 <=X@_MO2?!]WIDFIR:SK.JL;2R;[,D6PNNTDA!@*HW.6/T]*ZK1=,CT70
MK#2X3NCL[>.!6]0J@9_'%-T36;+Q!I%OJ>GR;[:X0.F>" ?4=C5N2Y@ADCCE
MFC1Y#A%9@"Q] .] '.ZCX2GNM?NM2M-9GLHK^"."^@CB5C,J;L;7/*'#L"1G
MVP>:A\->!QX>O;"Y.IR77V'3FTZ%6B"_NC(KKD@\D;0/>NK$B,[(KJ77&Y0>
M1GIFL_4=0NH'LQ86]O=+)=+#<%[D1^4G\3#@[F']WC- '-:M:Z1X4\.Z[!J)
MN;V/6[JXE%M% SO(\J@>4H4'TX)QUJ]\._#L_AGP796=Z2VH2@W%X['),K<D
M$]\#"_\  :Z0W, N!;F:,3$;A'N&XCUQUJEIVNZ?JM[?VEG.));&;R9AD?>V
MJW'J,,!GUS0!I4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7A$ZEO!_Q04,RD^(@-RG!'[Z+D5[O6$?!N@FTU.U-C^YU2Y^
MU7B^:_[R7<&W9SQRHX&!Q0!R.LZ59>%_'6BR:!806DTVE:BKB",+YQC6-DW8
M^\=QZG)YI_A#P_X97PMX1UR5H;;5)5BF%\KJDUU<2(2Z.YY?<2WRGT]J[R?2
MK*YU2SU.:'=>6:2)!)N(V"3&\8S@YVCKZ5D6/@3P[INJ1ZA:V#)+$[20QF>1
MHH6;.YDC+;$)R>@'6@#SZ61$_9UO=S ?Z3.O)[F^;BM[1M$T_4_B_P"+[R^M
MH[B2R-@]L)5W")S%G> ?XOE&#U';K6Y-\.?"]Q+=-+I\C)=2-+)#]JE$0D8Y
M+JF[:K'U !Z^M;EKI%C9ZI?ZE!!LN[_R_M,FXG?L7:O!.!@'MB@#QZQTZ"Q^
M%7BG7K:%?[6^TWL*79_UD41G*LJMU48+'CN2:T[O2-9T"*]U33]%T?0D@T.\
M0QZ?>F1[@J@:-MOEKDHP^]R?GKTJST#2[#2[C3+>T065PTCRPN2ZN9"2^=Q/
M!)/'2J>D^#=#T69YK2UD:1X?LX-S<23[(O\ GFOF,=J].!QP* //[W0-#TS1
M?AS=Z?:V\%S+J5B#-$H#W 9"S%R/O<X.3G]:Z_XI?\DP\0_]>C?S%36?P[\,
M6,UM+#82DVLJS6PDNI76W8'($89B%&>PX/&>E;NJZ79ZUI=QINH0^=:7";)8
M]Q7<OID$$4 <#?Z+I>@^)_ ]QHEM##<7,TL$TD*@-<Q&!F9I".7Y"MDYYYK&
MBD1?V?\ P^"P!:YLU49ZG[6IQ^A_*O1=.\&Z'I>JKJ5K:R"YC1HX?,N))$@5
MNJQHS%8P?10/3I5-?ASX75G_ .)?(8VE$ZPFZE,<3[P^Y$W;4.X?P@=QT)%
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MP_I]KJFF_"BTO8EFMGM[PR1.,JX$>0&'<9 XZ&KD/A70Y$^(\,FF6SPVCO\
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M4I"[0S1AMI8#@$C(X]*ANOA]X<O(K:.:UN/]'@^S*Z7DRN\.<^6[!\NOLQ-
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MZDOC30&UK^R1?'[5YQMP?)D\HRCK'YFW9N_V<YSQUK=DD2*-I)'5$0%F9C@
M#J2:\MCU6UTC681H>O6FH65WK7ES:%=1*9X)7F/F21'AQM8E\,",9((XKL_'
M=K=7W@'7K6R5GN9;&541.K':?E'N>GXT )IGCGP[J]]#9V=\[2SAC;F2WDC2
M<+R?+9E"O@<_*3Q7*^'/'=SXE^(^HV,>HO!I=HZ1V]J--DW7&8RS-)(R_N\$
M< XS_-FI:SI&OVW@2RT*[M[BZ74;:X$,#AG@ACC;S"P'*@#Y2#CDXJ]X%_Y*
M'\0?^OVV_P#11H W_&?BVV\':(-0GB>9GECBCC5&.XLP!R5!Q@$GGKC Y-8\
MWCVVM/&;07%S*-*ETB&ZMXEM)&F>1I9%.$"^9]U!QCC&:=\6F6/P#-*YVQQW
MEH[L>BJ)TR3[46$]I?\ Q@N+VUEAN(F\.P^7-$P=2#<2YPPXQQ^E &VWC'0%
MT&VUL:@'L;I_+@:.-W>5\D;%0#<6R#QC(P?2K^D:S8:[8B\TZ?SH=Y1LJ49&
M'!5E8 J1Z$ UX[;K- =%O%U1=)M8=?U:)KUXE=(7=V"9#?*,X9<GU]Z]"\"P
M6H&LWEMKO]L&ZO<S7"P"./S%C13LV_*PP%R1QD'OF@#8UKQ+I7A][:/4+AUF
MN21### \TDF.6(1 3@=SC KGM \<VL^G^(-4U+4(SIUKJIMK61(R24*1E5"J
M-S,2YXP3^51:O?6FC_%VPO=5N8;6SGT66WMY[APB>:)E9EW'@$KC\JY+3]<A
MCLM6GL)K2UM=0\8NJZA<PJZ6ZF%7$RAN,L5&UCQ\^: .VUKXDZ-IOA2ZURU:
M6Z\B9;<P-!)&ZRG'RN"N4X.<L!GC'45I7GC?0+&WM9I[J<?:HVECC6TF:38I
MP7:,)N50>[ "O)=;O8IO#_Q!']KG4V,VG3+<LJ(9HU>-2ZA  4!&-P&..M=1
MJ5^A^(EUJ,'BZTTJRO-*A-K>%8I8IUCDD$BJ[G&5+ D ]_:@#TVUNK>^M(;N
MUF2:WF021R(<JZD9!!K&U?QIH.B7KV=[>2">.,2RI#;R3>2AZ,Y12$'^]BD\
M#V=M8^#--@LKR2\M?+9XIY(3$75F+#Y3T'.![ 5S>D:SI7ASQ/XVCU^]M[2:
M6[2[4W+A?.MS"JKMS]X JRX&>>* &^/_ !^=*;0K+1K]8GU.>,O>K9O<*ENP
M)W( -KL<=!DX[<YKN],E,VE6<K3M<%X48S-$8C)D#YBAY7/7':O'8+6YLO#W
MPF@NXWCE&I!MCC!56#,H/IA2*]MH HV6L6&H7M]9VMP'N;"18[F,JRF-B-PZ
M@9!!R".*S9O&WAZ"R:[;4-T0NWLE$<,CM),OWD10I9\<\J"..M<GXZOY_!'B
M<>)+.%I$U:R?3WC1<YNT!:V)]S\R?E40TNV\$ZUX#34)DCL;6UNK>2ZE;"+=
M2*C%F8\ N1)@GZ4 =I#XRT"?2)-42_Q:Q3K;2EXG5XY68*$9"-RG++U'?/2M
M"?5[&VU.+3II]MW-"\Z1[2<HA 8YQCC</SKR+Q%<0WT?CK6[)UFTH7NE#[1%
M\T;M#(IE8$=0H*@D>GM72W6M:=J_Q2TW^S;R&[CBT:\#RP.'3):([=PXSC!(
M[9'K0!U.A^+]#\23M%I%Z;HK$LQ98750IQCYB ,\CCJ,]*I>)O'%AX8UK2--
MNHYF:_=M[)#(_EH$8[@%4[CN4#:.0#GI53X2Q)%\+- $:A0;<L<#J2S$G\ZK
M>.KNVT_QIX'O;VXBMK6.\N0\TSA$4F!@,L>!DT ;UWXT\/V.K'3;B_*7"ND<
MA$+M'$[8VJ\@78A.1PQ'44Z?QEH-MKG]BR7Q.I><D)MTA=F#. 5SA<8PRY;H
M,C)%>8RQ1/;>+-*U7Q@FF17.JW'F6'V2.265)6!C9/XVRI7&T'IQTKL/"<"I
M\3O'3M\TH^P(9".2/(H TA\1O"ADA7^U1MFE,(E,$@C5]Q7:[[=J'(/#$>O0
MBKND>+M$UV^GL=/O&>YAC$ICD@DC+1DX#KO4;ESW&17F301-^S].K1J1)JC%
MP1][_B8XY_ 8KM;T ?&'32!C.A7(_P#(T5 $FB^,=)M_"FFZAJ/B6/4([N22
M.*_^QM )F4N=H0#Y2 I'OCCDBM*Q\9:!J%CJ%Y%?>7%IPS=_:(GA:$8R"RN
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M(K2>X<(A9)6,B!CQGYE./3Z4 0^.OB/;:/X!.M:#<QW$]T0EI(8'= 0ZJ^[
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MF/96L$45O8%[>0+'E1N4Y)4!CS@\<4 =SH'Q'T;6-(U+4YW>SM[&>1'>6*0
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MMY1&Q\QW;:JA<;LEN.E>:>)I0FM&PLI1)!XTL;2W26-MRLZ2+'*01_TQD_\
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MB[7RH.X>A]1R:DHH @CLK6$1"*VA00@B(+&!LSUQZ9]J2/3[*)0L=I;HH?S
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MV-'VL&7<H.".A'O3#:6S7!N&MX3.5V&0H-Q7TSUQ[5-10!$MK;J(@L$0$/\
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M)YX([A#&\D#!7"GK@X.,CC/O4EE9VVG6,%E9PK#;01B.*-1PJ@8 H GHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI"H;,R+AL=1\V<>H![5E:S=3)XKET!KCQ5+8Z=81.C:6[O,\LC/\\KCDX"@
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MFE>*1(MZRQL>5/7@<<CBL]/$FK:IX%TG0UNY8/$EQJ(T>ZFC8B2(PG,TH/\
MUS7.?]L4 >J45Y3=PZGJ0\>W!U_5;==(F<V,=O<L@C9;=7^;^\N<?*>.6[FI
M[675+*[\#:U+K5_<3ZVZI?022_Z.PD@:0;8^B[2!@CGUS0!Z?17C6F:_K>HP
MVNNVL?BB?4IK\,T2Q,; V_G;6C"_=XCR=V,[AUK0D@U/5M-\<ZA)X@U:!M*O
MKI;&.VN3&L92)7&<?>&2!M/ &>.: /4&NK=+N.T:>,7$B-(D18;F52 Q ZD
MLN3[BI:\IL()-9^)_AO4;B^ODEG\.+?.D5PR)OWQ97:.-A[KT->CZW=)8Z%?
MW4EZMDL5N[FZ9-XAPI^?;_%CKCOTH OT5Y1HU_JMOXAM[#3;CQ QO])N9%;7
M#\LDZ>7LD16)*#+G*\#!'%:?@:[QJZ6EWJ6OP:K]D)N]-UC<XE<%<RPL?EP#
MD?(<88<#% 'HE%8/C*\6R\+W3MJ4^G%RD2SV\/FRY9P-L:CJ[9VCT)SVKGO
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M1P<&@#L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA6<9VC.,GM0!4T71KVPDNI]3UFXU2>X"K^\18XHU7/"QKP"<G)Y)X]*H>#_
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MG8? UM#X5T/01>2F+2;F"X27:-TAB?< 1VS53QOX>5M,\4:Y')*]Q-X>FL1
MJY! $C@CN22V,5V<<L<REHI$=02"58$9'441S12Q>;'*CQ\_.K CCKS0!Q6A
M^#9WC\/W.HZS=75GIL:36EC)$B^7)Y>T%F R^T$@9Y]<U8C^'NG?V=XCL9[F
M>2+7+UKUV&%:!R01L/JI4$$^E=6;JW6!9S/$(FQMD+C:<],&H[VY^SV\AC,1
MN/+=XHY) @<@9Z]ATR>U '/V?AJ6RU2/7M=UN?5)["WD2W+6ZQK"K ;VVH,L
MY"@9].@K#\)Z5;ZO\0]9\8V]O<Q:>R+#9^?&T8EE*J)9E1@" 0B+G'.#6MJO
MC&[T>#PO]IL+=I]9OH[.58KC>D);/S*V/GQ^%6]*\4OJ/CC7_#IM%C72H[=Q
M.'R9/,7=TQQCZF@!Z>$X$A\21"YD(UUW:4[1^ZW1"/CUX&>:'\)P/;>&X/M4
MF-"='B.T?O=L1CY].#GBIM9U\Z3K6AV!A5TU.>6)I&?;Y02)I,].?NX[5JP7
MEM=0>?;W$,T(S^\C<,O'7D4 <S:>#+BPNUCM/$%]!HRW1NUT^-57#%]Y3S!\
MWEEB3M]#C.*N0>%((--\0V0N9"NM3SSR,5&8S)&J$#UP%S6O%J-C- 9XKRWD
MA#;3(LJE0?3.<9J:26.$ RR(@)"@LP&2>@^M '+?\(28-3T+4+'5I[:?2[);
M!_W2.+B %25(/W22O4>M;FN:1;Z_H5]I-T76"\A:%V0X901U'N.M6A>6K7;6
M@N83<J-QA#C>!ZXZU))(D4;22.J(HRS,< #W- ''-X$N[G4+74;_ ,37\]]#
M#+;-+'&D6874 JH7[C9 ;>.<_08NZ5X6N[;5[;4M5UVXU26SA>&U$D"1[ ^W
M<S;1\S$*!GIUXYK?CO;6:X>WCN87GC&7B60%E'N.HI#?6@NQ:&Z@%R1D0^8-
M^/\ =ZT 4/$>A+X@TM;3[3):S13QW,%Q&H8Q2QL&5L'@C(Z&J&D>$Y]-\1R:
MY-K5Q=W5S;B"[$D2!9=I)0J!]P#<1@=>_.2>DDD2*-I)'5$499F. ![FN/\
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MI80J,,H8-O\ KQ5S0_$>F>(=-MKZPN4:.Y!:-&8!R!U^7/XUI&6,2K$9$$C
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M"D ,,Y]Z]<OXKBXT6ZAC(%U);NJE3P'*D#'XUFWW@GP]J.J-J-UI^^XD97E
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MY1X9T?6M3\/Z'JRZ=H-M='45NI-5DO&%U(_G$2(P\KDL-R;=V.@[5Z'\2/\
MDFOB/_L'R_\ H)JQ'X)\/1:P-433\7(F-P!YS^4)3UD$6[8&_P!K&>]:^HZ?
M:ZMIUQI]]$)K6YC,<L9)&Y3P1D<T >?7.BZ=HOB;P#-IUG#!<2R3133(H#S
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M""&Z^-GB."XBCEA?P_&'CD4,K#?T(/6NO'@SP^NBZ?HXTY?L&G3K<VL/FO\
MNY%)(;.<GECU)'-7H]#TV/79]:2U U&> 6\DVYCNC!R%QG'7VH \DTK2HM/^
M#?ACQ5IMG&E_H[+?RF&,*\\62LP8CKF,GD_W179^%WC\1^-];\41L);2W1-+
ML''0JN'E8?5V"Y_V*FN_#Y\,:#<:=X/T!9S?;D:.:\(@@R#\Q5V/R\GY4'/I
M6SX4\/P>%?"^GZ+;D,MK$%9\8WN>6;\6)/XT <OXZTVPOO'7@<7=E;7 DNKB
M-Q-$K[E$#$*<CD9YQZU1TS1M(URV\>7>N6=M<7*:C<V[2SH&:&".-?+"D\J
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M3DG."K'S%7 ZK78:WXDTSP^L'V^63S;ABL$$$+S2R$#)VH@)( ZG&!7G=_\
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ML[N1Y92X@=K>1(IRGWO+D*A7Q@_=)Z5IZKJUCH>G2ZAJ5PMO:QXW.P)Y)P
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M@ HHHH **** "BBB@ HJM8:C9:I;?:=/NX+J#<5\R"0.N0<$9'<59H ****
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MD$9%>;?\(5XC'A8^"1)IW]@E]GV[S7^T?9O,W>7Y>W;OQ\N[=C'.,UZ2 %4
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M510,DDGH *D5E=0RD%2,@CN*\O\ 'GABYTGX?^)F37]3N-/-H'CM[FX>21)
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M!%4>P' J221(HWDD=41 69F.  .I-8OC"\2Q\*WTKZC-IV56-;B"+S)5+,%
M1>['.T>A(/:O.+F:Y:Q\8Z.)?$5O9+H)OHDU2Y)G60>8"5?<S;&VJ"I/8C&#
M0!Z_!/%<V\=Q!(LD,JAT=#D,I&00>X(JK)J:QZS%IOV.\9I(C+]H6 F!<'&U
MGZ!O:LKP'9+8^!M&59[B7S+.&4F>4R%28UX!/11V'05BZK?7K?&72])6]N8[
M&?1IGDACE*J7W$!L#^(#H: .KN;/1?$=JT5U;6.IV\4K(5EC694D4E6&#G#
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ML OH,DGCN:YZTDU77]4\&:;)KFI6]O>^&Q<WC6]PR22L/+.[=V8D\MUP2.]
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MV;S+"EW TK[MJ"0%CM^]@>W?TH L4444 %%%% !1110 4444 %%%% !1110
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M.1YLDDKRR/CH"[DM@9.!G S0!RATZQD^.[RO96S2#0$G#M$I/F"X*A\X^]@
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M(4A5YX)X/..AJS8^--#U'6DTJWN93<2J[0,]O(L=P%^\8Y"-KX_V2:XC8O\
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MFE$8:Z192K&,(JAD#';D#KWZ5W-UK&F>(_B-X0_L2[AO#9)=SW1@8-Y$;1!
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MV,*^2 JDEPR@%.HY)'%<_H5]HWA7Q_);W]^MO!'X>L8(;J^(BR%+_*Q; #$
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M.M-D@AEV^9$C[#E=R@[3ZBO.[K6]9O/'7@N'4]'ETHS37,@1;H3+(OV=_E;
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MMD">;(<#A>=J@  #/ %;E8/AGQ')KO\ :$%WI[6&H:=<?9[FW,HE )4,K*P
MR"&'85D>+?$>NZ5XQ\,Z9I=@EQ!?/,9 9E3SMD3'9DJ=N/E;(ZXQ0!V*6\,9
M<QPQH9#ERJ@;OKZT[8FU5V+A<;1CI7F&F>*-6T>3QG/;:+-J=M9:O/-/(UT(
MQ'&(T.U 0=Q !..!R.<FNEN/&5Q<74=OX?T9]5D^Q1WTVZX6 1QR9\M<D'+L
M%8XX''6@#J/L\.Z1O)CS)PYVCYOKZTX1H"Q"*"PP>.M4]&U:VUW1;/5+3=Y%
MU$)4#C#+GL1Z@\'Z5S>J>,+Q[S6K/3-$EO;72TV7MTMPJ%7*;BL:$?.54@GD
M>@S0!V*JJ*%4!5'0 8HVKNW8&[&,XYKS[PMKNKV_@3PM!IVBSZK=3Z:LLDLD
M_E1( %'S2$'+$GA>IP3VJ'4O'NKW4OA";0],+0ZK/()HI9D1F9$D#0DD'&&7
M.X==N.] 'HIBC:-HS&I1LY4C@_A0D4<<8CCC5(P,!5& !]*X_4/'<UI)J5S!
MHDMQH^ER^3?7JSJI1@ 9"D>,N$SR<CH<9Q79*P90RD$$9!'>@!L<4<*!(D5$
M'15& *<%4,6  )ZG'6N&F^(DZ6%SK<.@2R^'+:9HI+\7"ARJOL:18L9* @]P
M<#.*YWQ+<:KK'Q?T[2Y-.EN=/BT]KF&VCU,PI+^\QYQ*XY'3:<T >L-;PN$#
M0QD(=R@J/E/J/2G>6@WX1?G^]Q][ZUE>*M2N]'\*ZIJ-C )[BVMGE1&<*.!D
MG)!Z#)QWQBN;TKQEK#>'?#R3:/\ :]<U2W$D<0N519(UC1GF=@N$!+#Y0#R0
M* .Z"A5"J  . !38H8H%*PQ)&I.<(H S^%<7>?$6.RT6UO9-(N6NY-4_LF:R
M612\4^&. >C9PN#QD,#Q4LOC/5HM5M-&/AECK%S9/=_9Q>J4C"R;,-)MQC&#
MD \D#'>@#L)(XYHS'*BNC=589!_"D,,1.3$F<!?NCH.@KS[_ (6==?V%-K1\
M,W"V-C.;?4V:Y0-;R*^QP@Q^\"\'/'7V.-4:IIX^*\VGBRF_M!=$^T&Z^TMY
M9B\T#9Y?W<YYW=>U '4W,<KP2_9VC2YV,(I)$W!6(X) ()&<9&1FL7PWX=FT
MB?4-0U&^%_JVH.K7%PL7EH%482-%R<*HSW))))K L?B3<W>F:1K+^')H=%U"
M:*#[4URI>-W;8#Y>,E-W&<@]\8QG1UGQE?:1<7D[^';EM&LI4BN+YYA&WS;<
MO'&1ET&X9.1T.,XH ZZFB-%4JJ*%/4 <&N+T[Q)KEU\3=8T62P3^S+2WA(83
MKF/=YA$F-N3NPHVY^7'UK.\,^,M.M?AWI%[I.D76[4+M[6RT][HRN\N]\YD?
MHORLQ)Z"@#T.."&%56**-%7. J@ 9ZTX(BIL"J%Z;0.*XZ7QY+I]MK::OHS6
MFHZ58_;_ +,EP)$GAY^9'P.ZD'(XXZU)9>-+N76M)M+[09;*SU</]AN6N%9F
M*H7PZ ?)E02.3Z'% '5QP11!1'$B!1@!5 P*=Y:%678N&^\,=?K5'7M570_#
M^HZL\1F6RMI+@QAL%PBEL9[=*I7?B5+1_#ZFV9O[9F$2_/CRLQ-)D\<_=Q^-
M &RL$*0B%(D6(=$"@#\JDKS^7XE72:1=ZRGAN9])L;F2WO+@W2ADV2%"R)C+
M@#!/3KCG!J-KXP?'BY\VX9;./PSYS*6.P8GY;'T[T >A;%W[]HW 8W8YQ33!
M$T;1M$A1OO*5&#]17)Z7XVN+VYTM[S0Y;'3M7)73[IIU<N=I=1(@'R%E4D<G
MT.*71O&EWJJ6]\V@3PZ+=)))!?).LA"J"09$ RF0IQR>< X)H ZOR(>/W2<+
MM'RC@>GTI4ABC=WCC1&<Y<JH!8^_K7->'?%.HZV]G+-X>FM=/OH/M%K=K<+*
M-N 0) !\A(.1R>XS6EXBUP:!I:W0MFN9I9X[:"!7";Y)&"J"QX49/)H T_)B
MV%/+383G;M&*78I</M&X#&['.*Y67QA>V%I$^JZ#-9W#ZC;V.P3AXV\U@!(C
M@?,!GD8!R*O7_BJUTSQ!-IMU&4B@TN34Y;G=PJ(X4C'XYH M:S8ZC<63IHEY
M:Z=>2L/,N9+;S3MP1P-R_-TP3D<=*7P_HEMX<T.UTJT+M% I!D<Y:1B26=CZ
MEB2?K6'IGB[4M0FM%O/#=U8V>HPM):7(F$N %W 2JH_=DKTY//&<US/@KQGJ
M&G>!_#$E[HT\FF3^39MJ+W(W^8[;0WED9*;CC.<]\8QD ]495=2K ,I&"",@
MBHVM;=X1"T$31#HA0%1^%2UP6E?$E]1\.S^(9=!N+?2(H6*S>>K/+.) @B1,
M G).-QP,\>] '>@ # X%<]XIT#4/$ENNFIJB6>DS#;?1I 3-,F>45]V$!'!X
M)YK-E\=S:7'J"^(-%DT^XMK%K^.**X6<31@A2 P PP8J"#Q\P.<4Z]\07S>'
M->.O^')[2*WTZ2X(AO-Z3Q[6W()5 *OQ^&00: .NCBCAA2&-%2-%"J@'  X
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MN)%-U)<*<RJ^W8JXR1CG=P,@B@#K**** "BBB@ HHHH **** "BBB@ HHHH
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MFG7FD^ [&SO[=[>Y26X+1N,$!IY&'Y@@_C76T4 %%%% !1110 4444 %%%%
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MB6>V5RI)EW<.5!;ICH*UUUGQ!KWB36(=$N[.VLM)$2!)K<R&[E>,2$%MPV*
MRC(!.23[5G'P3XC3PS-X,AGTT:!)(RK>%W^TI;LY<Q^7MVEL$J&W8QVK2;P[
MXATGQ'JUSH#Z;]AU81&3[4[J]K(B"/<BJI#@J <$KR.M $OPIY^%^@'_ *=S
M_P"A-7":1?\ @2RO/%C^)])M[BY37;QC/+I#W(6/<,9D$;  <\9XKT[P5H=Q
MX:\':9HUU)')/:1%'>(DJ?F)XR >_I4/AKPW+I5MKUOJ'D3Q:GJES=A%RP\J
M7'RMD#G&<CD4 </I&KS^#_!%_?6\2Z;I^HZR(]'CU'*I:P2;1YC*3E4X=PN1
M^M:NE^-KRX77;"UUS1-7N+.S2[MM05A%  Q96$V&(&TC/!&01TZU:C\$ZM%X
M4_L47MM(=,OTNM&FE+-B-&W)',,=AN3()X(],5)JGA[Q+XA\/:E;7_\ 8]K-
M(]N]K:P%Y(LQ2"0B5RH)#X P%X [T 9%IX]U&--?@M-3T_Q)+9Z8+ZWN+2 H
M ^XJR,JL=P& W!SC(JVOC*_T[PGJVNKK.D^(K6&&/[-):IY++.[;!&ZAFPN6
M4YR#U&.]63H/C*3Q#+KBW.D6US-IYM%B5GD2V*OO3&5'F;CD,?EP",9QS5N?
M 6I>(&UJ?58],TN:_LDME73F:0-(LGF+-(65<D,!@8Z9YH T8]2\1Z!XCT2R
MUN_L]0MM7:2$M!:F$V\RH7 'S'<I"L.>>E<_!XM\6GP3:>,9KK3Q:K<I%+8+
M:G=+&9_*+>9N^5N<@ 8XYS71P:)XCU?Q#I&H>(O[,@ATDO)''8RO(9YF0IO;
M<J[% +$#GD]:J#P1J/\ PJJ/PK]HM?MJR*YDW-Y>!<B7KC/W>.G6@#>\:ZI?
MZ)X1O]5TU4>>S59V1UW!HU8&0?79NK$U'QG=P^/M+T^T\F319%A2[EVY823K
M*8<'T_=C/^^*[2[M8KVSGM)UW0SQM'(OJK#!'Y&O.M+^'FL6G@?4-/N;ZTEU
MR6>WEMKH%MB?9Q&(03C/_+/G _B- &?KNM:OKFJ:;-;?9A'!XK-EIY=#MQ'!
M(KNV#\PW[^!C.W&>];$WB#7-,A\9:;J=Q9ZA/IFD_;[:<6WEJX9)/D=-Q! ,
M?KR#5NU\$W=KHOA"R6X@:72+T7EXY)Q*Y23S"O')+R$\XXJ?6/"5]J&H^*KB
M*:W5-7T4:? &9LK(!*,MQ]W]X.F3P>* ,RP\2ZSJ^G>$M+TR6SL;[4]+^WW-
MP;?>D,:J@PD>0,EG Y.  >M5->/B8ZIX.BO18KJR:K<Q17"J3%(GD2 2E,Y!
MVDG9GJ,9&:T8/!^MZ18^%[K2Y;"75='T_P"P7$4[NL-Q&57.'"D@AD!'R\\Y
MJW%X:\076H:!J&K:A:SW%EJ$]W.D8(2-'B9%BC^7+!<CEL$\^PH L>%M4U>3
MQ!KNA:Q<P7DNG>1)%=10^5O256.&7) (*GH>:SO$_B74K7Q9_9$&LZ;HJ_9$
MFM7U" NM[*68&,/N4*%VKD#+?/FM[3=#N++QEKVL221&WU"*U2)5)W*8@X;=
MQC^(8P35'Q3I?B'4S=6EK;:+?Z7=0"/R=1+*8'Y!<;4;>,$<'!!'6@#",6O7
M?Q0U.*PN[33[AM&M&N)VA-P$;?+\J*2N023R>PZ<\21>+]5N_!6EZA<ZKI&C
M2R74UM>WMR,JIB=T_=1EAN9B@X)X&>M;7ASPI=:'KS7<ETEQ -)M+!6)/F,\
M._+,,8YW#N>]8EIX*U[2%T6ZLCIEU>:?<7[F&XE=(RMQ(7#*P0D,HP.G<C-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH/0D=LX/Y5D:GXMT729-.2YOH?\ 3YS!$RR*0" Q+$YX4;""?7 H VZ*0$,
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M,B%]QW,Q()R2<G)Y/K3?!/AN3P]I5T]X(!J6HW<E]>>0/D$CG.U?91@?F>]
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M7M\JR2H&9 L*LNTG[N"2>.]6/#5K;7/Q+TBXGMX9)V\(V\YD>,%C)Y@&_/\
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M<,$5N'$4:IO8NVT?>8]2?4UC:7X,\/:+?B]T_3(X9U#*AWLPB#=0BDD)G_9
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MR8XA#@;V55:-55F&XYZXW"@#T31/$6GW\EKIB7TES?'3H;W?)"8S-$XP),8
MY/4#H33;KQGHEH=162YD+:?/';2K'"[EIG *QH /G;D<+G'>N'OKA/#7ASP+
MXT*MY-C80V=]M')MY8EP3_NR!#^-4[C2+S3?!GAG5KV]ET^:?5SJFJ7D<:L;
M=YTD <A@5 7<B$D<=: /4-%UZQUZ":2S,RO!)Y4\$\+12Q/@'#(P!'!!'KFG
MKK5BWB!]#\UAJ"VPNO+*$ Q%MNX'H>>#7.>!HK";4=;U*R\07.N/.T,,UV\<
M:Q$HIP$:-55L!L$C/0"H?B$?["GT?QFBL1I,YCO @R6M9<*_'?:VQA]#0!M7
MGC30K!]22XNV#:=)%#.%B9B9)!E(T 'SL1CA<D9J*+QUH;V&I74LEU:G38Q-
M=P75K)%-&AZ-L89(.#R,UPK6$VD^&?#'B+5(ROFZX-7U4X)$/G(X5F] FZ-?
M;%1^+IXO%6H>*;_09%O[.W\,/:23VQWH\QD\P(K#AB%!/&<;J /4[C6;&UOM
M-LY92)]29EMEVD[RJ%SD]OE!/-9VB>--&\17GV;2Y+B<A79Y/L[B-"K;2K,1
M@-GG;UQSTKDIO$ND:_XS\ C2;V.\6.2X:5X3N6,FU?"L>S'GY>O%:OPD14\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*;B%6RT6X97<.V1TH MT444 %%%4=5UK2]"M1<ZKJ%M90LVU7N)0@)]!GJ:
M+U%,AFCN((YH762*10Z.IR&!&00:?0 445%<7,%G T]S/'!"OWI)7"J/J30!
M+15:RU&QU*(RV%[;W48."T$JN ?J#5F@ HHHH **KS7UK;W=M:S7$:7%R6$$
M;-AI"HRV!WP.:L4 %%9P\0:*S!5U>P+$X %RF?YUH]1D4 %%%% !1110 444
M4 %%%% !115>]OK73;5KJ]N([>!2H:21L*"Q"CGW) _&@"Q1152QU.QU(W(L
MKN*X-M,UO/Y;9\N1>JGT(]* +=%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5YIX.CGE^(7Q*CMIQ!.T
M]J(Y2F\(WE-@[<C./2O2ZY7PWX8N]&\7>*=7GFA>'5YH)(40G<@1"IW9&._;
M- '+_!BSOX]-U:YFOXI(&U.Z1XA;!6:3>,OOSG''W<?C76>-]:O_  YHT&L6
MFQK6UNHC?HR;B;8G:Y7T(R#] :3P+X:NO"VD7MI=S0RO/J$]TIB)P%=L@'('
M-:VO/I:Z'>1ZS/##I\T+Q3-,X52I4Y&3[9H R+K7[J3QW:Z39O']@MK![[4)
M-N[(8[8E![$D,WN!7,?\)5XHB\&P^.Y;RT_LYV29M*%M]VV:0*,2[L[PI#9Q
MC/&*O?";1KB#PBVHZD[S76IA,/*NUC;1H(X01[H-W_ S4*^!_$+>&X?!TUWI
MQ\/1R*IN@7^TO;J^\1[,;0> N[=T[4 =+I^LW=SX[UO2)"GV2SM+6:(!?FW2
M&3=D]_NBN4F\:Z]_P@.B:K;?9GU&^UK["0Z81E,\D8''3A5Y^M;U_H?B"U\8
MW6M:%)IK17]I%;W"7I<&)HRQ5UV@[N'/RDCIUK-M_ 6HP^#_  _HS7MO)/IF
MLIJ$LIR!(@G>3 X^\0P]LYH [32;>_M=-BBU.^2^O!G?.D A#9)(PH)Q@8'7
MM7%>*O&;6?BN31$\1Z=H,=M:).T]Y$)&GD<L%102 % 7)/7YATKT*N4U71=;
MMO$TVM^'SITCW=JEM<P7S.JYC9BDBLH)R-[ C'/'(H PU\:ZSK&F^#)=+:T@
MFUR2:&X9D,B(41MS+R"0&0D#// )J.'4O&EQ<^)M+76K%)="*NMY]A!:Y#Q"
M149-V% Y!(R3D=,<]%<>'-3N]1\*7MU>P33:3)+)=R!-GFEX63Y%' Y;H>U/
MMO#=U#K'BR\::$IK(B$ !.4VP",[N/49XSQ0!AS^+-=U&V\#_P!EFUMIO$$#
MO<-)$76+$(D)49&<<X&>>,T'5M5;3_&WA_6;F&[GT[3S+%=QP^5YL4L3D!E!
M(!!4CCKQ6=?Z-JFC7?PUTFUGMO[1L8IXM[[C$Y2VPP/< @$9QD9S@]*W[+PM
MJTT7BB]U6:S74];MQ;)';LS10(L;*@W$ DY=B3B@# \.ZU?Z=\,/ ^G:484U
M#5=EM'-,F]85"L[OMR-Q"KP,]36S'J?B:VU?5_#,E];7FHC3/M^G7GV<1Y.X
MH4D0'!^8+R,<&FP^!]1M?!?AJQM[NU76=!=)89&#&&0@,K(>,A65CSC(XK2T
M?1M2B\17OB?Q#-8Q7+6BVD4-J[&*"%6+L6=@"22<]  !0!ER^-KS4O!OARYT
MD1IJVMW,5J%=-PA8$F<E?10C_I3+W5_%.H^(?%=AIFHVEC;Z.L,D+O:^:TA:
M$/L.2 !G.3R>1CIS1\%:1!=_$37]5LKD7&B65Q(+#;RBW,ZHUP4/< J!QQ\[
M"NJM?#EU!KGBN^::$QZPL(A4$Y39#Y9W<>O/&>* .9LO%/B9K+PGX@N[JS^Q
M:W<PVTFG1V^/*$JDJXD+9)R,XQCG';)J^(/B+-:ZIKQM_$6DZ>=(D,<&FW,8
M:2^94#-EMP*@D[%QW&3Z5OIX,OE\*>$-)-Q;^=HEU:SSOEMKB)2&"\9R<\9Q
M3YM \2Z=JFK-X?N-+6TU687+278<R6LI14=E4 B0':" 2O.>HH @N=>UO6/%
MECI6C7<%E:7>C+J)GE@\UX\N -HR 200.>!S7->)=:U[4OAC?^=?Q17MAK0T
MZXFB@P+@+<(H8#/R]02.<X([UZ NA7(\=QZ\9HV@72C9%>0Y?S0^[&,8P*Y_
M4/ FHW7A'7]+BNK5;J^UA]2MV;=L \Y9%5^,_P .#C/7O0!W%E'<0V<4=W<+
M<W"KB298_+#GUVY./SKE7UV['QCCT#;!]C.A_:]WECS-_G%<;NNW':NHL#>F
MQB.HI;I=X_>K;L6C!_V20"?Q%<^WABZ;XI)XI\Z'[(ND?8/*R?,W^:7STQC'
MO0!C>%O$NKZUK8676],$R3RI>:'+ 8I[:,%@I1LEG/"DDC:0QP1Q7>7B3R6<
MR6TX@G9"(Y2F\(V.#MR,_2N-_P"$;\1ZCK>DSZS)I#QZ7<F=+^!6%S.H5@$*
M[0J [ANPQ!QTKN",C% 'D'AKQ)J7A[X,Z=JUUJ=O)+?3)#;R7,6U+8R2L&>0
MYRX'S-VZ8K8T7QO+</K]C%KMCK;66FF^MKZVC"X.&!1U!(R"%(QU#4[2O VN
M6O@2#P]<W6G+/I=Q'<:9=1;V#,DAD'FJ0,9^Z0">":WX=/\ $>H:;J\6L2:;
M";JU-O;V]GN9(R58%V=E#')(XQ@ =\T <TOB3Q3;?"J[\87E[:-/+I\5S:VJ
M6V%A.!DEL_-N!!Q@8Z<U8NM1\96?BG2=)?4]/8:W!,X;['_QXM&%8[?F_><-
MM&['//M6C>^$+VY^$J>$EGMQ>KIT5IYI)\O<JJ">F<<>E:6H:#<7?B[P_JZ2
MQ"'38;F.5&)W,950#;QCC:<YH YI?$^L0^!O&3WLMM<ZCH4L\"3^0%28+&KJ
MS)DC/S8(Z<5+/XCUQ]*\")ISVD5SK<2B=I(<HF;8R%E4$=",@9YQCBK5QX,O
MIM"\:6*W%N)->GEDMV);$8:)$&_CU4],U/#X3O(X_!*F> G0$VW&"?WG^CF+
MY./4YYQQ0!#H^LZY#>>*=(O[NSO+K28HIK:ZD3[.CB2-F DP2% *')':LWPU
MXLOK_P 1KHP\2:=JYN]/EG%Q:VVT6LR%!@8.'0[\CO\ +UYK2U?P5=ZI-XQ(
MNXHDURS@MX",DQM&K@[AZ$L.G;-%IH/B:3Q3I&MW[Z3&MI!+:26=LTFQ(WV'
M>C%1ELH/E(  QSZ@'+^&?$.J^'?A3J.OWFH074CWLR0+-%L6*5[IT+NP.2NY
MMV., 8K5T+QZJZIJ-E+K]AX@@@TR341<VD8C:,QD!XV )'.Y2#UZYS4VG^!M
M8C\(:EX:NKJQ6 7+7.G7<6]G#^>9E,BD <-MZ$Y&:W;/3O$&HQWT/B)]-BM+
MBU-L+>PW/DL"&<NX!'!P%QCW- '#ZM-XEOO#_A+5]4O[2>#4=7T^=K6.V\O[
M-OD5E"ODEL#@Y'4YSQSZX<D$ X/K7FZ^#O%MQI6@:/>7NDBRT2\M9DEB\SS+
ME(6& P(PAVCH"<G'(%>DT >77GCCQ O@*W>U%N_B<WUQ92H8_DW0>8[G;GND
M8_[Z%=+:^)I]7\7:39:>R?V?+I)U*Y)7)(D*K"H/;^,_A5>Q\%7%K\1;S77N
M(6TN02306HSN2XD2))&/&,%8O_'C2^ ?!EUX3_M%KVZBN'E9(+8QY_=VL8(C
M0Y'4;FSCB@#B+[Q!J^N?L^7VK_:(+6X\YTE$$ 4/'YVS: #\IY!S[>]='X@M
MM;7QUX.M8M1@;43:7ZO>O;851^Z)81AN3C  SC//M26?PYU"'X/WG@Z2\M?M
MLS.Z3+N,8)E\Q0>,]@#Q^=;Z:)K%[XB\/ZUJ36,<UA;W45S%;.[*3*4V["R@
MD83G..O>@##_ .$SU?1O#/BE]0,%_J.BWB6D$JQ^4LYE$?EEE!XP9!G'85H1
MZAXAT#Q/HFGZSJ5MJ5MJYEBW1VODM!,B%QC!.Y2 PYY''-)>^!9=2L_%UK/=
MI&NM7,=Q;R1@DPLB1A2P.,X>,' [5-;:%XAU3Q'I6I^(GTR./2A(T,5BSOYT
MKKL+L7 V@*3A1GD]>* *+>+=4'PY\2ZWNB^VZ?<7L<!V?*!%(RID=^ *KWC:
MQ<_%[1$BU58K<Z3)<>5]G##;OB#K][JV!\W;T-1W_@CQ/)H?B'P[9WFEIIFI
MSW%Q%<2&3SD\UBYC*@;<;CC=D\=LUMZAX=UA?&&BZ[ILEBPMK-K&ZBN6=?D9
ME8LA4')^4\'% '7,=JDXS@9KSGX=^'])\0>%8_$FM:?:ZCJ>L/)/<3742RE1
MO8+&NX':JJ ,"O1ZX.S\.>*_"KW-GX9N-(N-'EF>:"WU'S$>T+G<RJ4!W)DD
M@'!YZT :$NEIX(\&WT6AWD%K$LIEB?4YOW%HKL-P'3Y5!)52>3QGFN?T_P ;
MWK:=XMCBUBTU=M*TW[;:WT5OY8+%)/D9<X.#&#QU!K5O/!^LW'A86\VK)J&L
M#48M29KH,+=G1U;R@HR5CP,#KSS48\):]?ZGK5SJMU8"+6M*^PS);ER;8CS
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MF2)07+MN!4%CM&WIC/-6X= \2ZQKVF:EXCN=,@@TR5IX+33@[EY"A3+R.!P
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MXYRSD!FW'&1@8 XJ*WT#Q1+XIT_7+V;2H?)M)K)[:V+E8D8HP="R_,VY.00
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MXMK=538K %53>1UY89/I6W#H^MW/BBQUWQ'<:9#;:1!,L M7?YWD #2.7 "
M*.%!/4\URO@G28?%/AOX@6*7&V&^\07?DW*?, ?D*N.Q (!]Z -7PYXXW^(X
M],G\2Z;KL,]E+<F6RB"&W>/:64@$Y4AB03S\IJWX=U#QAK%GI/B$7-C)8:@X
MDDTWR=AM[=L[667.6<#:2",')QBMG2;7Q--<O_;[Z4EH(#%Y%B'8S.<9=F8
MJ, @*,_>Y/ K'T/PWXLTB#3-%&IV":+ITH*W$08W,\*D[8F4C:O8%@3P.,4
M0>"%U>3QOXP>[U59X(KU(C%]G"Y/E)M(.?E '&._6K_Q5DO(?AIK<MG=?9W6
MW;>=FXLAX91SQG/6K&BZ#JVC^,M<O0]E)I.J2K<?><3QN(U3;C&TCC.<_A5_
MQ?H<GB7PCJFC0S+#+=P-&DCC*ANHSCMD4 85[J6NV?\ PC7AVVU&!M3U,2O+
MJ#VO$44:ACB/=@M\R*,G'4U?\,ZMJ;:_K/A[5YXKJXT\0S17<<7E>=%*&QN7
M) 8%6''!XXJI>>'_ !#=Q:#JV_3(]?TDR+Y0>0VTT;KM92VW<#@*0<'!'0U?
M\-Z%J%GJVK:WK$MLVHZEY2&*UW&*&*,$*H9@"QRS$G Z]* .EHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD8!E*G.",<'
M%>4?V]JNE>#-<\,&\GE\06U^-+LIY9"99%N#F&4MUR$9CG_IG0!ZQ5>\T^RU
M&)8KZTM[J-7#JD\8<!AT(!'7D\UPTFG-JOC>/PQ=ZAJ!TS2]'AEV1W<D3W$K
M.R;Y'1@S8">O4DUCMJNIP>%KFS.HW<C:;XKATZ.X:4^;)!YT9"NW5N'VG/7'
M- 'K(&!@=**Y.:[N!\6;.S%Q*+9M$FE,.\["XFC ;;TS@D9]ZR/A597%YH,6
MOZAJ>H7=W(]S BS7+M&D8G8 ;2<$Y7[QYQQT% 'H=%<!X[OYW\3:)HQMM7N;
M&:"XN;B#2I/+EE*%%4%MZ$*-Y)PW)VU#96FM7?@+44N;O4M'N-/O))].N=0F
MQ((4 =//(8ATY9#DG(&>M 'HM%>;^"_$5YXIAU3QC<R20K;6_D0:2LK;8MJ!
MV=UXRSD_*2.%QZFLCPM<ZU<'PUJUM8^)I+R\>.34[FZF#6DT,BDL53S"%"DJ
M5VJ#@<]: /7Z*\WTS2;OQ@VN:JVMZC8ZA;ZK/:V3PSN(K9(7"@&$$*^[!+;L
MYS6YI-U<O\3/$-K)<2/!%863)$6.Q6)EW$+G )P,_04 =!?OIUL8+V_^SHT4
M@CAFE491Y"$ 4GD%B0..N:;/J1AU>UT_[#>2"=&?[3'&##%M[.V>">W%>0ZA
M&^L_#'PS<7UY>RRMXB$)D%U(I93>.O)!Y("C:>JXXQ75:G-<Z?\ %KP?I5O>
M78L387(>)KAV$FU/E+Y/S$>IR: /0J9-#%<0203QI+%(I1XW4,K*>""#U%>9
M0V4_B?3_ !7K=SJNI07ME>W=O8?9[R2)+58.%^12%8DC)W YSBE%Y?>*=3\"
M+<7]Y;0:GH\]Q>Q6LS0^<=L)QE2".3U&#@D9YH ]*MK6WLK=+>U@B@@082*)
M JJ/8#@5+7&^ C-;7/B726NKBXMM.U,Q6QN96E=(VBC?9N8DD L<9-4_&#07
M_B5-/QX@OI8;/S#9:1/]G6$LQ"S/)YB M\I 4D]"<4 =]17E$&H:IKVC?#=9
MM4O()-1,BWDL$I1IE%NY.2.YV]>H)R,'%-OM2O?"-C\0[33KV[>'3K:VFLOM
M,[3- TR,&PSDG (# $GF@#T?4=;MM,U'2[&=)3+J4S0PE " RHSG=SP,*>F:
MTJ\QO_#D6@^,/ WD:A?SB2[F$PN[IY_,D%N_[P;R=IZY"X!R..*Z'XF75W9?
M#[4[BQN9+:Y4P^7+&Q5E)F0=1]: .MHK@4L'\-_$?0K:UU'49X=4M+O[6EW=
M/,KO'Y95P&)"GYC]T 8[5SH2\U#X9ZAX[;5]1BUM?M%W 4NY!#"L<C!8O*SL
M*X3!R"22>: /8**\[E@E\3?$1K.ZOK^'36T&WNGM+:Z>$-(TL@R2A!''7!&<
M#/2I_"6OW.F^!VENX=4U=[34;FR4P1F>=D25U4MSS@  GZ4 =[17G7C75+W5
M-)\*/8R:IHS7^MQ6TBR PSK&5E5@5S[9&<CH:@\1J=/UW1?"\<.OWVEQV4]U
M+%8W3?:)F\Q57?(9%8JNYCPW4KV% 'IE%>4W-UX@TKP99ZW=G5+<:)JY=X[N
M3][<:>S;3YH5B&95<<G/W,ULRZM=7OC?6[^VGE;3?#VF%1"DA$<]S(OF$D#A
MMJ!1ST+4 =[17D;PW>D_#_1?&J:OJ4VL2M9W%R9+N1HIUF= T7E$[ H#X& "
M,"MMM.E\8>+O$]O=:GJ-I'I;0VUDMI=/"(F:(2&4A2-[9;C=D8% 'H-075[;
M6*1O=3I$LDJ0H7.-SL<*H]R3BN&\2+YFH:3H][<:[J]Y%8F26UTE_LOFG*KY
M\CB1-HR&PN[&2>.*Y;41+X@^'_@2YU*YOFN#KL5J[BY9'9?.=,L4;!<"-?FZ
M@Y(/)H ];FU(PZO;:?\ 8;R03HS_ &I(P88MO9VSP3VXJ]7GVIW%S8_%WPCI
M<%Y="R.GW(>%IV82%5^4OD_,?<Y-4(K*?Q-IOBO7+G5=2@O;.]NX+#[/>211
MVJP<+\BD*Q)&6W YS0!ZA17F N[[Q3JO@5;B_O+:#4]%FN;V*UF:'S3MA;&5
M((Y;J,'!(SR:W? 336\_B327NKBXM].U0Q6QN96E=(VBC?;N8DD L<9- '95
M1UK5[/0-&N]5U"0I:VL9DD8#)QZ =R3Q7)WELWB?XBZAI-[=WL6FZ;802);V
MMU)!YDLK/EV9""<!  ,XZUQ_B3SM3^#7B>&_O+NYET34+BTAG:=@TR)*H7S,
M$!\!L?-GD9ZT >L:%K UW3$OUL+VR1S\D=Y&$=EP"&P">#FM*L?POIL.E^'K
M2&"2YD5XUD)N+AYF!*C@%R2!QTZ"O-_%>IO%-K.LZ;)XBNKJQOD1;V.<165M
MM9%:'RS(!(.H8[#DGKQ0![!145P2+:4@D$(>1]*\CT*XU'2O@M+XO;5-0N]9
MGT[:KSSM(L?S[5*H3C<."2>2<YXH ]AK&\.>);+Q1:7=S8QSHEK=R6CB90"7
M3&2,$\<UR?A>/4;/Q5:)9Z;XE@TR6VD6^;69Q*IE&TI(O[QR&/S@@8'(XXKF
M-!U2[TCX5^*KFQ:5+E_$,L"/"!O7S)HT)7/&[#''OB@#VRBO.O#DEYIFN7C)
M9:_I^@_V<\LTFLS>=Y<Z,,.I,CGE2Q(X'RCBLKP[>3VWBKPNUJOB/R-469;F
M[U6X!CO0(3(KK%YC&,Y4$85>#B@#UJBO,--\[3O%D*>()M>L]4FU"00WGGM)
M87D;,WEPA<E$^7& 54Y7@FLBXU#6]4?6M3L+#Q+<:S;ZE-%82VTP%FB12;!&
M8_, ((4[B4)RWL* /9J*R?$NI3:1X3U?5(%S/:64UPBL,_,J%AG\17!RV5QX
M<TCPKK]OJVI7%_>7EG%?&>\DDCNEGP''EDE5P6RNT#&* .QO_&%E9>*+?P['
M:7UYJ$L2SNMK$&6"(MMWN21@9],GVKH:\IMO#]I)\?=0!GOQMTJ.[&V^F'SF
M;.#AN4_V/N^U=9\0+^[LO#]O!97$EM+J&H6UB;B,X>)99 K,I['&0#VS0!TT
M\RV]O+.X)6-"YQUP!FL[PWK]IXH\/VFM6*3);72ED690'&&*\@$CJ#WK*@\-
M'0(=5>UU2]ET^:S8?8[N9Y]D@!RZR.Q8 @\KTR,UQ7A6YAA^!GAF&6ZU"(W4
MWDK%IP_?W)\UV,2G(VY"G+9& #S0!ZU=3_9;2:X$,LWE1L_E1+N=\#.U1W)Z
M"J>F16=RJZQ'I?V.\NXU,IF@5+C&!A9".<C XR>E>?:5?WMMH/CZR1=4LHK"
MV,EI#?7/FSVY:W+'$@=CC(W#YB1FH#>:E>?#SX=;=5O89[^^MHKFXCF;S)$:
M*3<"W<G'?/.#VH ]9HKS'3_#:W/C;Q#X>?5]9_LBVM[>YB@&HS;DDD#@GS-V
M\@;,[2<9.<54L[C6]:^'?A+4+A-5U.T59/[3BT^Y,5S,!E4;(96;!&2 V22#
MSB@#UFJ,.I&;6+G3_L-Y&($5_M3Q@0R9[(V>2._%9_@VYM;KPU ]EJ%Y>P*\
MB![T'SX\.08WSSN7[O//'?K7/:5?WDGQA\56;W<[6L.G6[Q0&0E$8CDJN< G
MVH [^BO&-/AO;;X=>%_%;ZSJLVK/=6BR/)>2&-XGE"&-H\[2-IY)&2><UZSK
M5W%8:'?W<UW]DBAMY':X"[C$ I.X#OCKCO0!>JAK6L6?A_1KO5M0D*6EK&9)
M&5<G'H!W).!7GGA>XN+'QIHMM!!XA@M=0L9VG;6+GS/M3IY9654\QRC?,<C"
M\,..*T_C/9177PPU:9WF5K=%=!',R*274?, 0&'/0Y% '0>&_P"R]2A.MVOA
M]M,N+@G+W%I'%/(" =Q*DD@Y[FM^O-KRQ-L_@_PO;7VHPV.J-+/=R?;96E=8
MX0WEB0L6522. 1P#C%(TMSH5WXUT*VOKR2SM]'%]:&:X>22V9DD5E61B6QE
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M;."""<\=<5R-Q:GQ5\0]6TN^O+V+3M*L[=HK>UNI(!))+O)D8H03@( !G H
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MVN&&,@CJHJ:_U?3-*$9U'4;2S\PX3[1.L>X^VXC-32WMI D;RW,,:2_ZMGD
M#\$\>O )^@H I7FAV][X@TO67DD6?3HYXXT7&UA*%#9XSQL&*P)_AU:S)<6*
MZOJ$>AW,YN)M*3R_*9BVYE#;=ZH6Y*ANYZ9KJ;#4[#586FTZ^MKR)6VE[>59
M%!],J3S4LUS!;F(3S1Q&5Q'&'<+O8]%&>IX/'M0!0CT*WB\32ZZLDGGR6:69
MCXV!%=F!'&<Y8]Z-"T.WT"RFM;>221);J:Y)DQD-(Y<C@= 3Q5[[7;&\-G]H
MB^TA/,\G>-^S.-VWKC/&:S-7U>2&UCDTRZTMG%VMO,;NYV*O]Y01G]YTPIH
M?K>@6^NR:6]Q++&=.ODO8_+(^9U#  Y'3YCTJ+7?#@U>ZL[^VU"YT[4;,.L-
MU;A&.Q\;D97!5E. >1P0"*6?Q7H]MXHA\/2W<2W\L)F"F10!AE4(<G.YMX(&
M.0#5'2/&5E=2ZE'J=U96#V^J36$"RSA#,$VX(#'D_-T% &C;>'K>+P[/HUS<
M7-]%<)(MQ+=/N>7S,[B>,#J<   =A4'A;PI9>%=#;2[>6:Z621I)IKDAGE9N
M/FP .@ Z=!5J_OKNWUO2[6%]/%O<&7SEGG*SMM4%?*7'S<_>]!4MUKND6)(N
M]5L;<B3RCYUPB8? .WD]<$''N* .<M?AY;VXL[236-1N-&L9UGM=,E,?EHRG
M* L%WLJGD*3V'7%6=8\%)J.J7=_9:SJ&E27T2PWRVA3%PJ@@'YE.U@"1N&#B
MNI!! (.0>A%<GJ?BK5H?$]QHFC^'AJ3V]M%<32->K %WLX P5.?N&@!UQX'M
MQ<V4VEZG?:5]FLET]A:E#YENIR%)=200<_,,'DU7;X=6:^&8=#@U.^AAM+\7
M]C(NPO:N'+A1E<,H+-][)YZU;UGQ/J.C:%IMU+H8?4KZ[2T6Q%VN%=]V/WFW
M!X7/3O5_1-0UN]>8:OH2:8J >65O5G\SKGHHQCC\Z *[^$X)O$>CZ[<7MS-?
M:9;/;JS; )MXPS, !SWXP/:J%_X"BNKC4A:ZUJ-A8:HYDO[*W\O9*Q #$,RE
MDW <[3S[5ULDD<,3RRNJ1H"S.QP% ZDGM7.+XMMKKQ5I>EZ=-:7MI>6UQ*US
M!,) K1&,;05)'\?- %S_ (1JR36-*U&$O$=,M9+6"%,;-C[!SWX"#'-2Z5H=
MOI-]JMU#)([ZE<BYE#XPK;%3"X'3"CK4\>KZ9+J+Z='J-H]\@RULLZF1?JN<
MBK$%U;W2NUO/%,J.48QN&"L.H..A'I0!AZQX6_M#6$UBPU6[TK41!]FDFMUC
M<2Q9W!65U8$@DD'J,FH)O NF2^"+KPL)KI;:ZW&:X+AII'9][.21@L3[5LS:
M[I%M:)=SZK8Q6SL469[A%1F!P0&)P3D'BKJ.DL:R1LKHP!5E.00>X- #+:!;
M6UAMT)*Q(J GJ0!BN/O_ (<6NH1:G:2:QJ2:;?3O=&RC*!(YW.XN#MW'#?,%
M)(SSBF>+O'IT7Q'IF@:<VEM>W8D>:6_N_*BME50P#X!(+9X_^O74W>M:7IK0
MQZAJ=E:R3#Y%FN%0O_NY(S0!9C@=;)+>:=YG$81YF #.<8+$   GKP,5CV'A
M'3K+P4GA5_,N=/6W:V8RD;V0YSD@#GGJ*K>,O%$WAE=",%O'.-2U:"P?>2-B
MR9RPQW&*#XHG'Q.'A7[/'Y!TG^T//R=V[S=FW'3&.: )]%\-3Z9?+=7>OZGJ
M;10F"!+ED58T)!)(15WM\H^9LG\S56Q\!:59^&]5T)I;F:UU*YDNI69@'1W(
M.5( QM*@CW%;DFM:5%J*Z=)J=FE\V-MLTZB0YZ87.:LI<P2SRP1SQO+#CS8U
M<%DR,C<.V1SS0!@V7A1D6]&JZUJ&K&ZMC:$7!1%6(YR J*HW'/+')^E4+7X?
MB"XTFYE\0:I<7&DN/L;R"+"1;2C1E0F#N4X+'YN!@C%=0NIV#6'V];ZV-D,_
MZ0)5\OKC[V<=>*JV]]=R>([NS>33S:10H\:QSDW 8]=Z8P%]#F@#)B\$[;^W
M>?7-2N=.MKK[7!83%"B2 EER^W>RJ3D MV'7%$W@A6U"ZDMM;U.SL+RX^U7-
MC;LBI))D$D/MWH&(!8*PSSTS6TFNZ/+=0VL>JV+W$Z[XHEN$+R+ZJ,Y(^E2W
M.J:?9W4-K=7]K!<3G$44LRJ\G^Z"<G\* )KFWAN[66VN(Q)#,ACD1NC*1@@_
MA7*V'@&*UFTU+G6M1OM/TN026-E<>7LB900A+*H9]H/R[CQ[UU<%Q#=0+/;S
M1S1/]V2-@RGZ$4B75O+<2V\<\3S0[?-C5P63(R-PZC/;- &5%X:M8O&4_B83
M3&[FLULVC)&P(&W9'&<Y]ZL:]HEIXBT>;3+WS%BDVL'B;:\;J0RNI[$$ BK7
MVZT_TC_2H/\ 1O\ 7_O!^ZXS\W]WCGFH[#5M.U6-Y-.U"UO$0X9K>99 I]"5
M)Q0!CZ9X1%G=7E[?ZM>ZG?W5M]D-Q<!%\N+D[55% ')R3C)-5(?A_:6GA/2=
M#L]1O+=M)G^T6=X-AD1\OU!7:00[#&.AKIO[0LC9K>"\M_LKD!9O-7823@8;
M..3Q]:9=:MIMDY2[U"T@<;<K+,JD;CA>I[D''KB@#G[;P);VQUK=JNH3?VS:
M&"],I0EWVE?-!V\-M. !\H&..!4\7@NQBT;P]I@N+@Q:'/'/ Q*[I"BLH#<=
M,,>F*Z.21(HVDD=41 69F. H'4DUD:!XITGQ+9SW6G74;I!+)'("ZY7:S+N(
M!.%.TD$]10!+:Z%;VOB/4-;264SWT,,,B'&U1'NP1QG)WG-8\'@==/T32M/T
MK6]1L9--#K#<1E&+JYRP=&4JPZ8XR,<=ZZ&QU73M3B>73[^UNXXSM=[>99 I
M]"03BF1ZWI,N_P O4[)_+A\]]MPAVQ_WSSPOOTH BT+18=!TXVD4TUP[RO/-
M/.07ED=BS,< #DGH  *K6WA>TM?%FI^(4FF-SJ$$<$D9(V*$& 1QG/XU=77-
M(>>:!-5L6F@3S)8Q<(6C7KN89R![FFOJUO=Z)=7^DWMA<JD3F.8S@P;P,_,Z
MYP,]3V% &4O@FP7PAIWAL7-S]EL9(9(Y,KO8Q.'&>,<D<\5M:MIEMK6CWFEW
M@8VUW"T,FTX.UA@X/K45EJ2_V397&H7-C'-/&"6AG!B=MNX^6QQN& 3]!FI[
M#4[#5(6FTZ^MKR)6VE[>59%!],@GF@#G+3P.T.K:;JMSX@U*[O['<B2RB(!H
M2,&,J$ P< EA\Q/?IC7\3:!;^*/#MYHMW++%!=J%=XB-P 8'C(([59M-9TO4
M))H[+4K.Y>#_ %JPSJYC_P!X \?C658^,--URPU:31KRT>>P::/]_,H0L@^^
M2I)$9/\ %Z9H EUCPO;ZM9:?&MU<6EWISB2TO("OF1,%VGJ""""001@U7L_!
MMO!9ZREU?W=[>ZQ$8KN]FV!RNPJJJ%4*H 8X&.I.<UJV>HA=!@U#4KFQBS"K
MS30S9@!(Y*N<97T)J6UU33[ZS:\L[^UN+5<[IH9E=!CKE@<<4 95YX1L[WP.
MGA22>=;-;6*U$JD>9M3;@],9^4=JN76A6]WXBT[6GEE$]C#-%&@QM82;<D\9
MR-@Q4T.M:5<7HLH=3LI+MD$@@2=2Y4C(.T'.,<YJ]0!EZ/H=OHLNIR02RN=1
MO6O9-^/E=E52!@=,(*S]2\()?ZY-J46J7UFMW"D%];P%-MRB%MH)*EE.&8$J
M0<'MUK6&M:4=2_LT:G9F_P#^?7SU\W_OG.?TKE/%?CXZ/XFT[P]IK:4;NY22
M2>:_N_*BMPH! ; )W-GC\/6@"TG@"WAT32K"WU:_AN-(=FT^]7R_-A4C;LQM
MVLNW@@CG J5? >GOH%YIMU>7MQ/>7(O)K]G G\\$%9%(&%V[5P , #ZUU0Z"
MJ<.K:;<7\MA!J%I+>1<R6Z3*TB?50<B@#!MO UJ\>IG6=0N]8N-2MA:337.Q
M"L(SA$"* O))SC.>:MZ-X:N-,OA=WFOZEJ;QPF"%;ED58T)!)(15W-P/F;)_
M6K]QKND6CA+G5;&%S(80LEPBDR#&5Y/WN1QUY%2Q:KIT^H26$5_:R7L0S);I
M,ID0>I7.10!YOX)\"27W@;1[?4]1U.&Q#_:)](=55&=92P!)7>%) 8KG!-=I
M=^%UG\7V_B2WU&ZM;E+<6LT480QSQ!RX5MRDCDGD$&K\^NZ/:R+'<:K8Q.TA
MB59+A%)<8RH!/49''7FLCQ'XHGT3Q)X:TN*WCDCU>XDAD=B08PJ@Y'YT 9S_
M  UMWLQ9#7=36SM[D75A OE[;242>8&'R9?!R 'R "?K5NZ\#L^LZEJUAK^I
M:?>ZBL:7+0")E940(,!D.#QG(Y!)[<5OWVLZ7IDD<>H:E9VDDO\ JUN)UC+_
M $!(S5C[5;_:EMO/B^T,GF+%O&\KG&['7&>] '-W?@'2;GP_HFBQR7$%IH]U
M#=0;&!9VCSC<2.<EB3TYJ?5O"AO]6?5+#6+[2;N:$6]R]J(R)HP25R'5L,-S
M88<C-;<NH64$DD<UW!&\47G2*\@!2/\ O$$\+QUZ5 NN:0\\\"ZK8M-;IYDT
M8N$+1K_>89X'N: )[&SCT^PM[.)I'C@C6-6E<NY &,ECR3[U@67@JUL[G7%:
M]N9]-UEY9+C3Y0AC#RX#L&"[N0,8S@9K>LM0LM2M1=6-Y;W5N21YL$JNF1UY
M!Q3+'5=.U02'3]0M;L1';)]GF638?0X)P: .?T[P,MK>:=+>ZWJ.I0:6<V%M
M<^6%B.W:&)5078*2 6)QGUK=UK2;?7M$O=)NRXM[R%H9"APP##&1[TB:]H\E
MS!;)JUBUQ.NZ&);A"T@]5&<D?2JL?BO1Y?%,WAU;N/[?%"LI7S%P22PV#G)8
M;<D8X!% %6S\(B"30IKO5;R]GT=I3#)*L:[P\9CPP51P >._KFII?"6G7-SK
M\MSYDR:Y%'%<Q,1M"HA0;<#(.#^=;U1-=6Z7*6S3Q"X=2R1%QN91U('4B@#$
MT7PU/IE\MU=Z_J>IM%"8($N615C0D$DA%7>WRCYFR?S-7]<T2P\1:1/I>I0^
M;;3 9 .&4@Y#*1T((!!JY]IM_M?V3SXOM.SS/)WC?LSC=CKC/&:K6FM:5?W4
MEK9ZG9W%Q%_K(H9U=T^H!R* .:7X??:6@AUGQ)K&KZ? ZNEE=/&$<J<KYA50
M9,$ X8XXYS6CJWA4WVLC6-/U:\TK4# +:66V6-Q-&"2 RNK#().".1DUN+>6
MS).ZW,)6!BLQ#C$9 R0WH0"#S4D4L<T22Q.LD;J&1T.0P/0@]Q0!S:>!],AT
MC2=.BEN5CTZ_34%D+AGFF!9B7)'.XL2<8]L5I0Z%;P>)KO75EE-Q<VT=LR'&
MP*C,01QG/S'O5U;VU>.>1;F%DMV*S,) 1&0,D-Z$#DYI/[0LA;17/VN#[/*5
M$<OF#:Y;[N#G!SV]: //_$?@];'P_P"$]!L7O9((-=25IX_]9$&\Y]^0,#:S
M#!(QTS706G@JW#ZK-JNHW>JW6IVOV*::X"(5@PPV*$4 #YB3QR:O6VJ7C-K3
M3MISI9L?(6VG+N %)Q*,?*WL*Y*7XDWL?PDLO&0L(#<W$BH;?<=@S*4Z]>@S
M0!K6G@+R+W2;Z?Q!J=U=Z6V+:24186':5:,J$ .X=6^]P.1BKI\&6)\,:OH7
MVBX^SZI+<2ROE=ZF9BS;>,<9XR#725S%GXQL_P"V-;LM4N;*PCL+Q+:!YIPG
MG;HD?^(CG+8P* ,/XA6 \16-EX.L[2^>[::%S>K"RQ6L2\.YDQM+%-R[0<G=
M7?6]O%:6L5M @CAA01QH.BJ!@#\J9>7]GI]J;J]NX+:W&,RS2!$&>G).*D@G
MANH$GMY8YH9!N22-@RL/4$=: )**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KQK3O\ D5/C!_U^:A_Z*->RUEIX<TB.WU.W
M2PB$6J,[WJC.)RXPQ/U% '#7&E6&ER_#B:RM(H9C=+&TJ( [A[:0MN;J<D9.
M>IKTVJ4NDV$WV'S+9&^P.'M<Y_=,%*@C_@)(_&KM '@VG11R?LUZZ717*37+
M+N&=I\WJ/>N^UW07FU#1KC1(]%FN[.SE TJ^4!)(I"A9TV@[&RH&[:1\Q!KI
MH/#6C6NB3:-#IT*Z;/O\RWQE6W?>SGUJE+X%\,S:?:V+Z5&;>TW>0 [AH]WW
M@&!W8/<9Q0 _P5=6=YX1L9;"P^P6XWQBTW[A"RNRLH/<!@V#Z8Z5R_BW2Y(]
M8UK68+/1]<M39)'J6G7;[9X416;]V^"%RK$X('(R#7H%E96NG64-G901P6T*
MA(XHUPJCT K+U;P?X?UR]%YJ6EPW%P%"%V)&]1R%8 @,/8YH Y>R%CK/Q/MW
MN(%EM1X=AGT^*X7=M#R'>P!S\V-@)ZXKC/$JI%\&?'UM;@+80:ZT=HJ_<1//
MA)5>P4.7Z>]>P:OX9T;74@74K".;[/GR6!*-&#P0K*00#Z9Q1+X8T2;P]_8#
MZ;;_ -DX ^RA<)PP8=/]H9^M '&Z_!J5Y\1]*@M+;2[GR]&>2&/4RWEAC(H<
MJ%!^;&P?0FNB\!Z=-I?AK[)-<V,ZI=3F,6,A>*)3(Q\I21GY22N.V,5I:OX<
MTC7H88M3L8[@0$F)B2K1Y&#M92",CKSS5RPL+32[&&RL;>.WM85VQQ1KA5%
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M=64,D5C,D]LF,")T^Z5 Z8[4_P#LC3_[;_MG[*G]H_9_LWVCG=Y6[=M^F>:
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M+:]U=6^[Y<TF0C?[( B4CVKII;6VL/B_ID>FP10&;1YS>)"H4%%D3RRP'N6
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MV$Z7$0R6W.U2&W#OGKS0!LUYKHVEZ)J'C+XA-J5O;3LLT22>>H;9$;=<D9Z
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MH80EL&4(RRE(U*GD84G.5Z<57\ :3#KGAOQ[I5T/W-YKU_"QQTW!1D?3K^%
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MXW!P5]2<\$@$ \$C!P ='CG-)M&2<#)ZFLV37;2/7TT1EE%[);M<QC9\KHI
M.#TSE@,'%5(_&&D/H<FK^9*MNER;0JT9#F8/Y>P+W.[CT_"@#>P,8QQ2*JJN
MU0 !V K(M-9M=;&IV,?VFVN[,B*YB?Y)(BR[E(()'(.0036;\-;NYOOASH=U
M=W$MQ<2V^Z265RS,=QY)/)H ZK HKF]:\4MI7BG1=%2PN)OMXE=I43("HN<#
MGKDJ3Z"K6H>)['3Y+Q#'<W'V%!)>&VBW_9U(R-W<G'.%R<8..10!LA0"2 !G
MK0JJHPJ@#KP*BL[NWO[.&\M)DFMYT$D4B'(92,@BN.N/$&OK\6XM"@LX'TS^
MS?M#9N=I(,B*9<;#\R_,H7/(.<CI0!V](%"@   #I@5Y5I/B?5]#L?%U[;:)
M]OL;#6KV6ZEDN_*8(&R1&NT[B%&>2H[#)SCL-1\4W7V^RT[0M-34+RYM/MI$
M]QY$<4.0 2VUCEB<  =CTQ0!TU(%5<[0!DY.!UK,\/:U'X@T6'4$A>!F9XY8
M'(+12(Q1U)'7#*1GO7):UJ&I6?Q<MXM,L1?7$NA,%BDG\J-<3@EV;!P.W )R
M1]: /0:*XV'QZ'\-SWTNER)JD%__ &6VG+*"3=%@H4/C&T[@V['3/%*_BS5H
M[/6[6YT>"WUK3K07:0+=[XIHFW8=7V \%&!!7J!ZYH [# P1C@T!0H 4  =
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M#S5+PV]K'X]6R\-ZS?:II2V<HU07%V]S'%,&41X=R<.?GRH/0=* /2&4,"&
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MF97D Y95V@GU R<?G3L#T%8WB;Q"/#UE;/':->7EY<I:6ELKA/,E;. 6/W0
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MGMW\2-0AL-7U.'PYYNF:/?2VMY,;P*Y$;[2T:[/FXP2"1Z GF@#T*D90P(8
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M2!CK5+6O"\-OXJUV[O/"%SKHU)DFLY8) JJXC5&CD)==HRH.[!X8^F*]3HH
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MAB.4KMVQ ,V\'+<\#'OQ77^*-/DU;PGK&G0_ZV[L9H$_WF0@?J:F&NZ.;_[
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MM["ZBEEXPK,T>T?CM/Y5S=QX5UBY\.>*(H;7%ZWB(ZG91R,%$ZHT3 9[;MC
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M<!B$)(SQFM35+'4].N/!6KQ:7<WJ:7;R07=O;;3*GF0JH(!(!PRX//>N_HH
M\ZL;/62WC+4+WPQ]H34KBW>/3II$S-"(D1AU*[PH/&<;AC/>KO@339[#4M3:
MTT[4=+T%XXA;65_)N9907\QD7<Q1""@QGJ#@5UFI:K8:/;+<:C=16T+2+&KR
M' +-P!]35R@#E?&VFWUU'H^I:=;&[N-)U!+MK96 :6/:R.%R0-V'R,D=,5GV
M=KJ6N^+KWQ#+I=UI]K'I+:?;17>T2S.S[V;:I. -J@9/.37=44 ><#P_JO\
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MU4EY.J288MCH, <UZ=7F][X&\1S:1JNBV]]ID=A<7\FH13%7,TKM+YH23C
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MT#PCXG\/?:9I]9L[[[#ISR2%I)%NCF!MQY) 9O\ OW0!ZLB+&BHBA548"@8
M'I2UY9K2SP^)M/\ #-Q;:_JUC8:-'*RZ=<^7)+,SLGF2,9$8X$?')Y8U#JLG
MB%O"7@ZSOKK4=/OI]=6SEE:4+.T!\X*6*D@L4"GJ?F&: /6:KP6-I;3S3P6L
M$4TYW2R1QA6D/JQ'7\:X?Q'8V%G+HOAZ(:_J 2*:4:=8W95Y5R!YDLS2*=JE
MN 6Y)[XK!74-5O/A]X?B.H7]M<-XD%@TQFS.(A/(@5F!(9@H SD@D9YH ]>H
MKSJ#=X2\:ZS9V$]Y+9#0?[1%O=7,D^)ED=<@N21D 9YJ?PAX<FN-*\/>)!KF
MH_VC<PQW5\9;AY8[H2)N*>66VH 6&TJ!C;0!WU%>,17NMZK%=ZU8Z7XDGUH:
ME+]FN(KA19K%'.4\GRS* 5V*0<IG<2:]GH **X7QE#/?^.?".EB_N[:SNEO?
MM*6T[1&551"%RI!'/<<X)QC-9<%W_P (^GCO1Y-7U"'3=/6W>UGWM//;^>AR
MB%B23N V@G@M0!Z=3)8HYXGBEC62-U*NCC(8'@@CN*\S\.0S?\);>Z"MKKNE
MV%[HSRF+4+[SI/,\P)YJ$2.4.'.>1R!QQ56/7-4U/P3IGA5KN:/Q!)J?]CW<
M\;D2*D)WR2ANO,2J<^KT >J6UM!9VZ6]K!'!"@PL<2!57Z <"I:\Z;2?^$@^
M(GB73KS4-173[:RLVCMX+N2(!V$GS94@Y&.G0GD@X%<WIPOE\"^$?%<VKZE-
MJ\NH6L$LCW3['A:7RRACSM(*]3C)/.: /::*\GURXO=9\5^)8/L'B.Y>P,=O
MI[Z7<"*.V<PJ^]AYJ;F+/W##  ]:O&'4M=\8:!I^LW-[:";P\T^H6EO<-$'F
M#Q@@E",88GD$=,9P2* /0[V]MM-LIKR\F2"VA4O)(YP% [FIZ\3\00O+\(?&
M-E/=W<T>D:Q)!:-)<.7$8:/"LV<N )&&&SV]!7L6G6$.F:?#9VYF,48.TS3/
M*_)SRSDL>O<T )J=\VFZ;->+9W-XT0R(+5 TC\XPH) /YU8BD\V%)"C(74-L
M<89<]C[UR7Q4NKBR^&6N7-I/+!/'"I26)RC*=Z]".167K"7.I:]X$T]M0O(;
M:\LKEKL03M&TP6*(@%@<]>_7DX(S0!Z)44EM!-+%+)#&\D))B=E!*$C!*GMQ
MQQ7(>!UDL=:\5:*MS<366GWL7V87$S2M&LD*.5#,22 2<9/>NS9@JEF(  R2
M>U "T5X_I]])%K/AS5=/7Q#)'J.IF&74[ZY @O8G60@+!YA*C@%3L7A?>MFQ
MTB;QE=^)+^?5]1L[VSU.6RL'M[EU2U6(+@^6"%?<22=V<@XXH ]'HK@;BR;Q
M3X]U/2=2O;U+/2["V:..TN7MP\LI<M*=A!)&P  D@<U'J=I?2:UX4\(W^L7=
MQ;26]Q->7$<C027?E!0BLR'(^_DX/.* /0J*\KN[B[T;2OB/HMM?7;6VF6"7
M-D\D[O)!YD+DJ)"=V 4R.>,U)J%M=:/\/M.>'5=0-_KUS8P7=X]PS,GFLH<Q
MY.$X) QTX[\T =S?:GI\FN6WAV[MC/)>6\ER \:M%MC90<Y[Y8$<=JUZ\YM]
M%M]"^+>DPVEQ<M:MI%TRQ7%P\WEGS(LD,Y+ 'CC.,@^IK$L[]TU?P_J^G#Q!
M+'?ZKY,FJ7MR!;WD3[_E6#S#A1@%3L'"T >PT5Y<=*?7;[QU)>:GJ82QNB+.
M."\DB6!OLZ-N&TC/..#D#GCDT^"]N_%">!-*O[RY2WU#26O[TP3-$UPZQQX4
MLI! RY8@'GB@#T::QM+BYAN9K6"2>#/E2O&"T>>NTGD?A5BO-_%$%_X7\-V&
MDP7^JZA!?ZPL $,G^E);E6<PK(S D_)C<6!P<9XK3\#IJ-OJ>K6[:;J]EHQ6
M*2SCU282NCG<)%5M[G;PA&3P2: .UJ*"V@MO,\B".+S',C^6@7<QZL<=2?6G
MN@DC9&SA@0<'!_.O&+F_US4/!VG^&+74KM-;L[F^2>X25O,<6BL4R>I#%X,^
MH- 'LTV/)DW1^8NTY0#.X>F*R['5K*'PY!?SVDFCV@ 06]U&L30_-L52JD@9
M., >HKE+#6I?$_B>34+2XE73[+0(Y3&DA"F>X&\9 ZE40?3=7&R"36?V>=!N
M]0NKN>X^V1!I6N7W/F[V_,0?FXZ9Z8!&"!0![%-K=M!XCM-$9)3<W5O)<(P
MV!4*@@G.<_..WK6E7G.M:#!<?$7PWI0N+R.T32KL/LN9!)(@>+Y3+G?UQDYR
M<8S@UJ?#]I85\1:8US<3V^G:O);VQN)6D=(_+C<+N8DD L<9- '95BZEXITW
M3O#DNNAVNK*.01EK?#$L91$<9('#'GZ&M6YMTN[6:VE+B.5"C&-RC8(P<,""
M#[@Y%>(V&G1V_P"SG-<02SB>ZF3<TDSR*I6]P"JL2%]\ 9[YH ]SHK@8M/\
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MU$BB24+_ '03ZX&>G- &%%X(LET/6M/N+R\N9]91EOKZ5E\Z3*;!C"A5"KP
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MI,EC>&0N9+G]Y* H(\@#A^>OH*M7VNZ1I=Q%;ZAJMC:32_ZN.XN$C9_H">:
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M:8W[.^F-J;R(L=L'MGA&95N!(?*,?^WNQC_#-;7PU:>:ZUF?7P5\7>:BWZ,
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M!;^!- D=I]*753]H:?!$TQ21U+CIS(2<>N*TK.&&U^+FKPV$:1P/HD,EVD0
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ME>>0=9"JA03]  * +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1][G)'&!D]JI?\+0\.FQ6] U!K57V7,HLGVV;;MNV8X^0Y[=>AZ$9S]*C/\
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M7YCDC4F.27$9$8/<\#('3<*Q-+UBVN=?\$:E+XBO=2/G,MZ71$MK2:2W=5B
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MLVG2K#=6TR?O4=\;% 4G=NR-NTG.:Q=/U*XN?C!-;,NH6T0T3S6M;F3*!_.
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M,L<\<?WE+%%*L"5!X(^;(J.T\;:JUYH<E]H,=KIFML([687>^5',9=?,38
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M%U$;>X,T<L1;:>2JD,IP",=P10!T5%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5P/ABQU#P'/J.D/IEU>:/-=O=6-U:*',8
M<Y,4B9W @]& (.>U=]5#4=<TC1R@U/5+*R+_ '/M-PD>[Z;B,T <WXPT[6=?
MT&"XL;3R[FPO[>_M[.5P'G\ILE6.2JY[#/89(S@)<6-SK'BVS\0BPNK>#3].
MGB"2H%DFDEV_(%ST4*>3QDC&>:["">&Z@2>WECEA<922-@RL/4$=:DH \MLM
M%UB#P9X"L7TJZ^TZ5J$,MX@V_ND1)%)SG!^\.F:N)H=_#XLCU/1;6_TRXFU-
M_P"TK9FW6=U!N;,V,D!V4*1C#9/(ZFO1J* /,+;0=9M?A_K'@B33I9IY7N(K
M2\X,,D4SLPD9L_*5WG(//'&<UM6NE7EA\1K*X6UN)-/MM!^P?:L @R"16 QG
M/W5ZXQFNUHH \F3P_P"((_#5K<0Z7,;S3?$DNJ_8G95:XA9Y#\ISC=M?(!/4
M5H7B^)+OQ/K>L:5H-S"\^@+;VAO/* ,RO(P5EWG^]]/7 ->DT4 ><Z%8:HOC
MW3=7?1-1BMY-'>UGFO)D:19?,1R6 <X&%. /R K(M/#WB&V\">'8O[ ,]YX>
MO&>6QN'C*WD9$B-LY(R%<$;L=^/7UVB@#S36=(U'5M"BU/1_"R:7<6>HVM\E
MC(L44]V(6)97*$J/O?*"<\'ID5IZ?_:5_P#$R+6FT._M;!]&^RF2X\M2DGG;
M\%0Y/0=OY<UT^L:]I/A^V2YU?4+>SB=MB-,^-S>@'<_2KT,T=Q!'/"X>*10Z
M,.C C(- &%XV\,KXO\(7^B^:(9)U!BE/1)%(92?;(&?;-0KK>M?V((CH5U_;
MGE;#'\OD>9C&_P W.-F>?[V/X<\5TU% 'FEMX.NO#5KX&TRT@FO4TN[DGO;B
M,# +QR!FY.2-S\ 9.!5B33=3:;XB,-,N<:K&JV7"_OB+81<<\?,.^..:]#HH
M \\TG3M3@U_P=<2Z9=)#8:(]I=.0O[N4B(!>#S]P\C(Z5EW&B:U)X!UK3UTB
MZ-W<Z^UY%%\F6B-TLN[.[ ^4'C.<UZC=74%E:3W=S*L4$$;22R-T50,DGZ 4
MZ":.YMXYX7#Q2*'1AT92,@T <B8K[3?B'?ZP=,N[BRO=-@AB>!58B1&<E6!(
M*Y#C!/'J16$GAC5?#]GX6O5L)+R2RU2YO+RVM"I:,7"R<+D@$*74'GU->A6.
MK6&IS7<5E=1SR6<Q@N%0\QR#JI]ZNT >:1:1>W*^+(]8\,7-Q9:GJ4,PA$J;
MC'LC4LI#@AD*[N.XP":Z'P5I^JZ9'J-M=W=Y=::LZ_V=)?\ -QY>P;@QZD!L
M@;N<#TQ7544 <5\1++4-03P\NGZ?<7AM-:MKV81;1MBC+;C\Q&3R.*J:WH^H
M^(O&WAS4;'29M-739S+=:A.R(\D>/]2 K%F#=\X KT"B@#RK6-)UQ-(\>Z+;
MZ)=7#ZM/)=6MPC((F5XD7&2V=P*D8QZ=!S6K:0:SH?C>75GT:\NK'5=/MX76
M%HVDM9HMPVL-V-IW$[@2,UZ!5+4]6L-&@CGU&ZCMHI)5A1G/!=NB_4T >70Z
M?J>G>"?#]M<:)>C5K76IKF".&2(RA2\LA=5+88;6"D$C[V?3-JXL)=?T3Q#9
M6FEZE9^(;^2+42-6A1([DPO'A%V,R[0$5<$Y^;)S7:ZIIFB>)M0-M+/*-1TL
MAA):W#PS6_F#^\I'# =.0<5?TS1[;2U8Q/<32N 'FN9WFD8#H-S$X')X&!S0
M!R=G;7&N:1J0C\&1Z'<R:?-;EYTB#O(RX"HR'.S/4G&>,#KC>\&+=Q>#]*MK
MZPFLKBUM8K=XIBI)*(JD_*2,9!QWK>JE-JUA;ZK;:7-=1I?72L\$!/S.%Y8C
MZ4 <IXKTV[O_ ![X3NDTN:ZT^Q-W]L?:I11)$%7@G+<]< T>']+U3POJ%YX<
M6UN+CPY,#)I]U&RDV>[.Z%@3G:"<J0#@'!]NXHH \T\'Z;?Z?;:?H&I>"[<7
M>FLB?VN8XF@>-#\LBG._S"HX&.#R2*M>$!XB\/VG_"*W&A32_9[B0P:IO0V[
M0M(7#M\V[>-Q&T#D@<CK7H-% 'G5II>KZ3I/BS0'TV>[_M&XNI[&X3:8Y%G!
M^60D_*5).<]1TSTJ;1M!OM"\8Z,#;3SV.G^'!ISW:@%6E#H<8SGD*>WM7=17
M5O---#%/%)+ 0)45P6C)&0&';(YYJ6@#R2PT7Q'I.D:!JD&CSRW6D:G>RSZ>
M70/+!<._S(<X+ ,#C/J*W_%Z:SXD^'^H10Z'<0W%S+#]GLW*>=M61&9G(;:I
MPIXR>@[G [RB@#D)[:]D^)^GZHMC<&Q329;=YL#"R/(C!2,YZ*>U<_;6GB33
MO#^I"UTJZ#S^));J6-"GG-9R2%BT1)P'QCN".<8.#7I]% 'E%QX;UJZTSX@V
M4&BW$ U6*.2R\Z=&,A$*J5)W$[L@Y).,]S6]J$.IZAK_ (*OQH]W%%9RS/<J
MY0M"K0M&N[#'G)Z#.!U]*[FB@#S6VT;6-/\ "?B7PF^FS7,E[)=_8;H8,4B3
MY(9VS\I4L=P([<9J_I6C7FC^.K5_LMQ+86GAV+3Q=  AY$?.,9SR.^,9XKNZ
M* .4^'%A>Z7X(L['4+22UNH9)M\<F"0&E=@<@D=&%6-;MIM7U[3].FM+P:9%
MNN9;F*0QAI5P(TW*P88RS9'=5KHZBN+F"T@:>YGCAA3EI)7"JOU)H X2ZT6\
M\/?$C3]7T:PO[NRO+5[752TYEV@$&)\R/DD'(P.@^M)HO_"1>'-1UC1?[!FO
M8;S4)KRRU!'3R%65MQ$V6# J2>@)/85WEM=6][;)<6L\4\$@RDL3AE8>H(X-
M2T <CI5EJ-A\1O$-Q)82M9:E%:M%=JR[%\M&5@1G=G)&..]6/'VB7VO>$YK;
M3-IO8IHKF&-VVK*T;A]A/;./SQ7344 <=)9W/B#Q?X?UMK"ZLH-)AN6D%PH5
MVDE54$8 )R  Q)Z=,9YP_P "6E[91ZZE]8SVIN=8NKN'S,?/$[ J>"<?0\UU
MU% #)I/*A>38[[1G:@R3]*Y/P!I]QIGPWT[3-7L9(IK>!HKBWD029&3D87.X
M$&NOHH X;2/!=L?%5IK"Z9'IUAID;II]K_&SN,-(W)VJ!PJ=LDG!XK*OO"E[
MJ&BRVUS9S?\ "3Q:F]U::LF,#,N4DWYX41[5*'GY< '@UZ=10!@W^J7;WEYI
M7_".7ES&T>V.<F/[/,&7D,2V5 )(.03CH#5SP]I(T'PWINDB4R_8[:.#S#_%
MM4#/Z5I44 <996LFG?%S59I!^ZU73(7A8]"T+%77Z@.I_&NSJ"YLX+OR_.3+
M1/YD;@X9&Z9!'3@D>X)!X-3T <+>VFM>%_&>HZ[IFE2:MIFK)$;NWMY%6:"6
M-=H=0Q 92N 1G.1FK,,6N^+H]5M]8T\Z3H=U9/:Q6LI5[EV<$&5BI(0 ' 7)
M]:U9_!WAZYGDGFTJ!Y9&+NQ!R23DGK3/^$(\-?\ 0'M_R/\ C0!S^DZSXLT#
M1X-&O?"5YJ5[:1B"&[LYXA!<*HPK,68,A( SD'O63JO@[6[;P"RBV%_K=WK<
M>K7L-LP W>8&94+$<*J@<^E=M_PA'AK_ * ]O^1_QH_X0CPU_P! >W_(_P"-
M '*>*!XA\<:;%I$'A.[TQS<12_VC>SP_Z*$<,60(S,6P,<8Z]:UK3PPMS\1/
M$>I:II5O/9W%O:):RSQI("5#[P <D=5J^WA+PBES';/IUDMQ("R1%L,P'4@9
MR<5-_P (1X:_Z ]O^1_QH Y[3['7O!NG^(M(TG2VN[.-&NM$9&4 -(3F%LD?
M=<Y!/\/?C%,T#X56%EX>M[6]U#6/M4D>Z\$&IS1QO*PRYVJP'))^M=)_PA'A
MK_H#V_Y'_&C_ (0CPU_T![?\C_C0!G_#[2]3\/:9?:!?0O\ 9+"Z==.N&8-Y
MMLQW*.N<KD@Y]JZN>:.VMY)YG"11J7=FZ*H&236=H^G:)ILUU#I,5M%*"HN$
MA?++UV[AGCO5Z[M(+Z'R;A-\6060GY6]B.X]CP: .#\#37GAOPAX9M)]/=GU
M>[F9\N%-N)/,F7*XR3M'(XQS7=W]JM]IUS9LQ59XGB)'8,"/ZU*\,<CQN\:,
M\9)1BH)4D8R/3@D?C3+F[MK.+S;JXB@CSC?*X4?F: .(\,7/BFPT[0_#;^'V
MA-@J6U[?S2(8&@C7:&BVMN+-A>JC&3FL0:-XAC^'TGP^70[@RG=:KJ>^/[-]
MG,F?,/S;MVP_=VYS7JL4T4RAHI4D4@,"K @@]#].#3Z .6\/Z3=V'C'Q1=RP
M,EI=&T%M(2#Y@2':WOP>.:X[3="U[0M+^'EV^BW5U)H\=S%>VUN\9E0RIM4C
M<P!&>O->M44 >5W7A;6Y'^*!6P<_VQ#&MA\Z_OR(F4XYXY('.*Z;5=(O[C5_
M!<T5N6CL)W:Z;(_=@V[H">>?F('%==10!X_<Z5XF7X=W_@R'P[=/<I<R,MX9
M8Q!)$;DR@J=VXL0<8(&.<GM5[6?"D5OXGUVZN?!C:^=2D2>SG1T"QOY:HT<I
M9@57*[L@'ACW%>I44 >?P6>I^$?%=Y=67AZ>^L-1L;6%([&2/%M+ K($.]E^
M3###>W2M;X=:9J.D>#H;35H!!>BYN9)$5@P^>9V!!'8@@UTTT\5O$99Y4BC!
M +.P4#/ Y-24 >>ZQ?7>G?&"&XMM-GU!!H)$L-N5\T+Y_#*&(!YQD9[Y[5CO
MX<UAK)-0U+1+FZL[_79]0OM'AD0R>4T6R(,-P5L%58KG'/?%>F'2;,:Y_;10
M_;1;?9=^XX\O=OQCIU[U9MKJWO(1-:SQ3Q$E=\3AER#@C(]""* /-]#\(23:
M7XOT*^T-=)T_5&$]L(BGE1*8D4#Y3PZLN3QC/0FHO ]IJFO>"=;\07Z"35-7
MLS:0A6R&CBB,:D$_WWWM_P "%>@:YH5EXAL/L-^;@VY;<R0W#P[Q@C:Q0@E2
M"<@\5=MK:"SM8K6VB2*"%!''&@PJJ!@ #TQ0!PKZ!JA\/_#VW%HWG:7<6KWB
M[E_=!;=T8GGG#$#C-5/$G@_4]:U#QILM%>.]@TYK3S' 2=X'9V0^F>%R?[U>
MB-=6Z726K7$2W$BEDB+@.P'4@=2*+FZM[*!I[JXB@A7[TDKA5'U)XH \VA\.
M0W&D^(!I/@9M'EETB>VBDG=!-+*ZD>6JJS#;P/F)'...];.H:+J,VG^!HX[9
MF?3KR"2[&X?NE6W=23SSAB!QGK7;44 <7X(M=2TG5O$FGWVEW$45QJMS?P7F
M4,,D<A7:HPV[=UXQCCK4OCRPU6[_ .$>N-)L3>2V.K1W4L0=4_=K'(#RQ R<
M@#W([5U]% '$Z38WNN^-=1U[4=(GL+!M,738K>\*>9,"[.[$*S +R .>>:P_
MAGI-V=<O6O9!-:^'!)HNG2;MV\>879O8A/*3_@)KTC4;"+5-/ELII)XXY0 S
M6\S1.,'/#*01T[&F:3I-CH>F0Z=IMNMO:P@[$4D]3DDD\DDDDD\F@!^IV[W>
ME7EM'CS)H'C7/3)4@5YSH&E:W)IW@.WN=$N[-]#G,=V9FCQ@6[IO7:QRI8@>
MOMWKTYW6-&=V"HHR68X %-@GANH$GMY4FAD4,DD;!E8>H(ZB@#S?Q/X/U+6=
M4\62I8K-'<)ILMJDC@)<M [L\9YXR#MR<#YA6OX.TBRMM6N;RR\&-H48@$0F
MN&032$MEE"JS#8,+R3R>U=K10 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7GGP_TG3]>M=3\2:K:07NHWU_<(7N(Q(88H
MY"B1+G[J@+^.>:]#KB!X9\1Z!JNH3^%;[338ZA.US+8ZC&Y6&9OO-&R'.&/)
M4CZ4 -U>VB\ Z)+'X:C6"?6-3A@MX9/F@MY96"EE08PN 6VCC/M3)=6U[PYK
M_P#9.H:JNIQ7NFW-S;7#6R1/%+" 2I"\%2&!Z9X[U+/X(U*^T&Y6_P!=:?6Y
M;V+4(KG8?(MY8B"BI'GA !@\Y.234B>&-:U35I-5UZYL!/%8365G!9AS&ADQ
MOD9FY).T# ' ]: .<CU_QFFA>$=:.K6DC:Y+!:O:-:*(XC+&Q67<#N)&W<5R
M <X&.M3ZEXE\1>'[3QG9SZFE[<Z780WMG=-;(C#?N!5E'RG!3CCO6Z/!MT/#
M7A#2_M4/F:'<VTTKX.)!%&RD+]<]ZQ_B'H4UMHOC;7&F0PWFD10+& =RF,N2
M3]=X_*@"^-2\2:+X@\/'5-2AO+/6I&MY;9;98_LLAC+KL8<L/E*G=GUK*MO&
M6H0^)=,BD\26.I&\U%K.XT^TMLPP*0^TI-@%F4JH.3SD\#%;4'AK7=2U71I]
M:OK)['20TD'V9'$L\AC*!Y,\+@$G SR:S;;P/XF@TG0]._M'2Q!H-S'+:*D3
MC[0%R,RG^$[6/"YR3G- %2YU[Q=-X<\3:_!K%O;QZ+?7:0VWV17%Q'"YX=CR
M.!M&W!XR2<\='IGB2[7QI>:9J<B+9W6GQZCI[%0NQ ,2H3W()!^AIO\ PAMU
M_P (;XFT3[5#YNKW%Y+')@[8Q,20#],\US_Q$L8=27PYH&G:BB^(1+]DVP$,
MZ6TD12=F'55V8.3W Q0!UW@?5=1UWP[_ &Q?L E[/)-9Q[ ICMMV(P?4E1NS
M_M5B?VCXF\0W'B&[TG5XM/M]*NI+.VMS:K*)Y(U!8R,>0"QP-N, 5W5K;0V5
MI#:VZ"."&-8XT'15 P!^0KC9_#'B*PNM;CT"_P!.CL=8F:XD-U&YDM974*[)
MMX;. 0#C!]: .-UV[U#Q3X@^&NKP:C]D_M$22Q1"W5Q;2>2"Q&?O<\<],5ZC
MXAN[O2/!FJWL4P:\L]/FE24H.9$C)#%>G49Q6%+X$\J]\%FQN$6T\.!U99 =
M\H,80$8XSD9/UKI/$&G/K'AO5-,B=8Y+RTEMU=NBET*@GVYH X)M7\90S>%I
M3K%J_P#PD"^6\#6:[;0F+S Z$'+$ '@G!/8"EG\7:]H-KXGT^XNH=2U#3[JT
MM[*YDA$8<W(7;O5<#Y23TQG%=)+X6N)&\(D7$0_L-LR\']Y^X,?R_B<\U2U3
MP))JMSXHD>]6$ZJ]I+:R(N6@D@4;6([_ # <>F: $6_U[P]XJTO2]3U==5MM
M5AGV2-:I"\,T2!^-O!4C/!Y! YK L/$?BT>$?#GBN[U:!XKRXMH;BP6U4*T<
MD@C+;_O!^=W& .F.,GI[;P]KNH^(;/5_$-SIX;3X)8[6"Q5]I>0!6D8MS]T8
M"CID\U G@F[7X>Z+X<^UP^?I\MK(\N#M812JYQWY Q0!RLT.IM=_%5[C5FFA
MAM&0PF!0&!M"5Y'(V@XXZ]36MIE]XBT1/!DMUJD-Q8ZH8K22Q6V51!F!F0J_
MWB1LP<\')P!6A>>#M8?5?%IMKNQ_L_Q#;%&$BOYL,GD>4,8X*YP3WK2O/"]Q
M<VGA6%;B('1KF*:4D']X$A:,A?Q;/- ' :7J.J:/:_$35M)PTMCX@:XFB*!O
M-A7!D7GH=N3D>E=W=>(;B_\ %WA_3-'G0VMQ;/J-Y)M#9M\ 1@9Z;F;ZX4U#
MHNA0>$F\47VLW]FMCJM^]UF5MBHC#&UBW&:R_A%HC6>CW>JO)+-%=2>1I[S+
MAA8Q%A#P>F<LWT(H Z#Q=J]_9RZ/I6E2QP7VK7?V=;B2/>(45&=V"G@G"X /
M'-9&JZGXK\.Z<+*XO+2\NK_4H+'3K]H0I DY9I(UP,IM;&#@\<>N[XIT"YUF
M/3[K3KF*WU/3;H7-L\REHV.TJR.!SM96(R.1Q61=^$]?UG3YYM4UBW754O8+
MVQ2"-FMK5XONC!.Y@V6W'CKP.* *MWK6O^&]4OM*OM4741+H]Q?V=R]LD;QR
MQ8RI"_*R_,"..Q'-5[76_%%K;^$-9OM5@GM]:G@MY[!;556,2Q%E97^]N! S
MV.3@"M-O"FLZO>W^I:Y=6"W;Z9+IUI#:!S'$).6=F;DDD*.!P!WJU<>$[F;0
MO"=@+F(/HMS:S2L0<2"*,H0OU)[T <1I^H:]H?ASXB:RNL^?/9:A<(BO;( 9
M%2("3_OD8V]*V/$NM>)O#WA&PU*YU*">[O\ 4[9?+%JH2WCDZQCKNQ_>//TJ
MQ=^!=9EL?&&E17MA_9^NRRW,3LK^;%*X0$-VVC:>G-:_C#PG<^)/#NFZ;!<Q
M0R6EW;W#.X.&$?4#'<T 84-GK=]\3/&$6DZLFF(L5DSS?9UF9F\IMH ;@+US
MWZ8Q4WASQGJNL7GA%+CRH_M]O?B]1$X:6W=4RI/(&=QQ[UH3^'O$ECXLUK7-
M%O--(U)((_L]XKX7RT(#97ODGCN#U&*I1>!-3T:S\-2:+?6DNH:.MPLIO$81
MW'GG=(?ER5.X9'6@#"\?:OJU_P"&?&MNM]Y,.G:C:P1JL2DM$XA)4G_>?.?;
M'2NCNM8U?3/B+X6T":]2ZAN[6Y>YE:!5:1D&5(Q]WZ"JMW\/M5O_  ]XIL[G
M5+9KW6KF&Z258F"1L@C.TCKMS'@<DXQWK3;PQJU]XQ\.^(]0N+)9M.M[B*XB
MMP^US("!LSV QG- & ?$?BBY\&7GCJVU.!+2%I9X=*-LI1[>-RI#2?>WE5)R
M#@$CBM--1\1>(O%FMZ;IFL1Z;8VEO:S12_94EDS*A./FXQQDYYZ8QS4#^!M>
M70;KPG;:C8)X=N)7_>F-_M4<+N7:(#[IZD!CV/2NFTCP^^F>*-;U,21_9[^.
MUCBB4',8B5E.?KN% '#CQSJEWH/AF\OM6CT*VOK:4W.I"T$L9N$<(J'=E8PW
MSMD^F 17I&C274VC6DE[<6MS<-&"\]I_JI/1E]B,'\:Y32_#/B?P_P"'=,TS
M3KW2[E((98KFVO(F\J0M(6#JRC=D X(/!]JZ'PMHA\.>&K/2FE65H Q9D3:N
M68L0H[*"V /0"@#GI?%3Z=_PFUW%H5FMSHNR28I-M-V!#O#,VS.0N  0>F,U
M;L/%FHR>(-'L-0TN"WM]7M'GM9([@NZLBJS*Z[0!D-Q@GI52\\(:M<KXU426
M2CQ#&(XB9'_<XA\K+?+SQSQ]/>K?_"-ZHVM^%;YFLPFCVTL,RB1B9"Z*F5^7
MMMSSUSCCK0!>\7^(;CPSI,-]!8K>![J&W9#+L(\QP@(X()R>A(^M4G\4:G;7
M,>F7UA:6^J2++,%29YHEA5@JL2J;LL6QC Z$YZ V_&>AWOB#1H;*Q>W1TNX+
M@M.S 8CD#XX!Z[<55\1>']:N-;T_Q#X?N[.WU2WA:VF@NPS03Q,0Q4E?F!##
M((% %*'X@EK72A?62Z1=7TTT!-^S)$KQXX#%1G?D%2<9&>XP;-_XKUJSU+0]
M-&AV[WFJQSD*;PA8GB&2"=G*\@[ASC/RU8O=%U?4+."#4TTO5895D^W6MPK)
M$6.W9Y?RN0%PPYY.[/';E6T6\\->(?AYI5O-%=3VR:@ )Y&"[2JG8&P3A0<
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MG&,[>G;WSPOACP[XJT&&WT:;5K"?0[,@6\HC<731J<I&Q^Z . 2 20,8&<@
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MJH/"'B/3)=%U+1+[3DU*TTV/3+R"Z#M!<1IRK J RL#D].^/J =3X:UF77]
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M@UFZNI\V[L2BS]5Y4<CU[^@H =8^+;Z?7M.LIM)8VVH1.PG@$C"V=5W;924
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MF1SYB$X"<<G!8FO1?!(U9?"EI'K<5Q'>QM)'_I+JTIC#L(RY4D%MFW)R><T
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M'8DCJ0.>-U;&HV:^$O%5O8:3<7:66I:3>M+;R74DH22)5*R*78E2=Q!P>>*
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M/WNP'3B@#TJBO%_[0OX=.@\.I_:E]9_\)+>61BM[G%Q);Q(TBQ"1F4XSC)W
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MP*ZSPU:+HGQ#UO1;.:Y.G&PMKM(9KAY1'(S2*Q4N21G:,\T =S1110 4444
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M06$$DTD<*XWSR%W<DY)9CU)))J*37]&BM8[J35[!+>2-IHY6N4"N@(!8'."
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MYIL5S;J7FA>Z17C4=2P)R!]:T([NVFN)K>*XB>>$*98U<%HPW*[AU&<'&>M
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MY5T!\'^'6UC^USHUF;_S/-\[RAG?_?QTW?[76I+_ ,+:#J>J0ZG?:3:W%[$
M$FDC!; .1GUP>1GI0!YAX/L[>]E^&"W,*2K'I-[(JN,C<#%@X]L_G4'B2W@A
M\.^/(4BC2&/Q#9NJ!0%4L;<L1Z9R<UZ[;:%I=D;,VUA!$;*-HK;:N/*1L;E7
MT!P/RIMQX?TB[MK^WN-.MY8=08/=HR9$S   MZD!5Y]A0!9N4>'39ULT59%B
M;RE48 ;!QQ]:\F\)Z5J-UX>\$W3WGA^UMXIXIHI$#K<RN5;S8RQ."[ ON'J/
M:O6;#3[32[&*RL8$@MH1MCC0<*.M9]KX3T"RUA]6MM(M(K]BS&=(P&!;[Q'H
M3W(ZT >37L.FO^SSJES>I#]O:YN&FD8#S/M7VEAR>N[&!_N^U=WH,\5O\1_&
M;32+&JVUA(2YP HCDRWT'K1XR^'VF:OHNLR:9I-BFMWL3*MPRA27.,L3V)&<
MGJ:W]0\*Z%JU];WVHZ5:W-W H5)9(P2 #D ^HSS@T >9>$9Y+S0/!EAI]GI\
MFH"SO+N.ZU .T<$8E"MM12-S'<.I& #ZUDW<GF?#S00)('1?&N$-NI6+'GRG
MY 2<+SD#/0U[!=>#_#M[9VMI<Z/:2V]H6:"-H^(]QRV/8]QT-/;PIH#;\Z1:
M8>Y6[($8 \Y?NOC^\,]: )?$2+)X9U574,IM)>",C[AKS/2(+9K#X3Q7$<1L
M)(6=U91L>X%L/+W=BWWL9[BO7F574JP#*1@@C((K#B\%^&H=)FTJ/1+-;":3
MS7@\OY2_9AZ$=L=* ,70$BA^*GBF.R55MOLEFUPJ#"B<^9_X\4VY_"H]8@@?
MXR>'3)%&Q.F71RR@Y(:/'Y5UFDZ+INA6AM=+LH;2$L798EQN8]23U)]S3-4\
M/:1K<UK-J6GP74MH^^!Y%R8SQT/X#\J /*I=,LC\'O&UT;6)IWOM0D,A4%MR
MS-M.>V,<5?DM-4U+Q;XN1?[$:(VMJDAU1'9EMS!DE2#@+N\PGW%>D'0]+.FW
M.G&Q@^Q7+.TT&WY9"YRQ(]R235?5?"F@:Y-#-J>DVMU)"NQ&ECR0O7:?5?8\
M4 -\/P7%IX+TVW%Y%>SQ6,:+<QG*S$( &![@\'-<;X-M_#)^'OA.ZU-81=&Y
MC:*7YA*U\6.02OS%BV[(/'KQ7I:JJ($10JJ,  8 %8\'A+P];:TVLPZ/9QZB
MS%C<+$ VX]6'H3W/4T >:106#_ GQ!<WT<7]HF2]>YD8#S!=B9]F3UW9V8_"
MNA\-6$5[\1?$,VI6T<UVFFZ>C>:@;:61]XP?4@9^E=1-X/\ #MQJ_P#:TVC6
M;WV\2><T0R7'1B.A8>O6M.*PM8;ZXO8K>-+JX5%FE ^9PN=H)]LG\Z /&_#\
M$#V/PO66*-E%[?1?.H/R@3!5Y[# XKJ_ ^G6<GC+QK?26\;W*:J$21E!* 1(
M?E/;.><=<#TKI[KPEX?OM*@TNYTBUDL8)#)%"R?*C$DDCT.2?SK0L]-LM/>X
M>TM8X6N'\R8HN-[8 R??  _"@#PG24M)/A?HL=_L^R-XO59@_P!TH96R#[8Z
M^U=1XVMX8/$_B..PB2/?X-NC<I$H )#8C) [XW@>U>A+X7T)=/33QI-I]C28
MW @,8*>8<Y;'KR?SI=*\,Z)HD=Q'INEVULMS_K@B?ZP8P <]1@GCIS0!QNJW
M4#_\*TB65&>6ZCD10<[E%JX)'M\P_.N?>&&/X7?$LQQ1JPU74$RJ@$#<N!]/
M:O2M/\%^&M*D22PT6SMY$E$J,D?*L 0"#VP&;CIR:>WA'P\]U?W+:1:&;4$*
M7;;/]<IP2&]<D#/TH XO0HXI_&?A)+Y$>)/"JO9K(,CSLQB0KG^+9M_#-8-[
M:6T\FH6,<2-I#>-K2-(U'R$E4\U0.F-Q.1[FO5]0\-:+JMA;V-]IEO/;6P @
M1D_U6!@;3U'''%/B\/Z1!86MC#IMM':VDJS00I& L<BG(8#USSF@#F[>WAM?
MC+,MO$D*R>'T9UC4*&(G(!('<#BHO&<$$GQ \">;%&X:ZNE.]0<CR&P/SKL_
ML%I_:/\ :/V>/[9Y/D>=CYO+SNVY],\U6UG0-)\06\=OJ]A!>11OYB+*N=K>
MH]* . L=+L;FP^)MQ/:PRRO>W,99T!.T6R$#GW)-9NA1:Q?:YI0MAI,LG_"*
M6)0:FCN"C;O,*;3W.W=_P&O58M)T^"&[ABLXDCO&+W"A>)25"DMZY  _"J>H
M>$O#^J6=I:7VDVL\%F@CMT9/]4N -JGJ!@ 8Z<4 5O MD=.\%Z=:&^MKU8E<
M)/:L6B*;VVA2>RC"_A6+\-KF&T37= N'6/5+/5;F26)SAW21RZ2 =U((Y]J[
MBWMX;2WCM[>)(8(E"1QQJ%55'   Z"LG6O"/A[Q'+'+J^CVEY+&,+))&-P'I
MNZX]J .1\=^(--UOP_/:VL_G6%GK%E;ZI(!^Z\LRH77=T(&0&].AI/%\-O;^
M.=/&GQQQROH>H"[$2@9A"IY>[';?G'XUW<.BZ7;Z2=)ATZU33BA0VJQ*(RIZ
M@KC'-5=,\*:#HT5Q'IVE6UNMRNR;8G+KTVDGG'MTH \T.BZ:? ?PP4V</[V^
MLC(=@R^^%V<$]P3U'>D\:0Q6TWQ,C@C2)'T:SD94& 6S(,X]< 5ZM_8VF_9;
M&V^Q0^18,CVL>WB$J"JE?3 )%8OC/PP-:\,Z[!IUO NJ:C:B RM\N_:?E#'T
M&3^= &!K$&F6.O?#^;2(H5;S)?+,*C+VWV=BW3J/NGZXKG[6:9QX$OX[?1]/
ML;W5!/9VMLKM<JCI(6+REN<[ANXZD<UZ?IOA70])OWU"RTJUM[V12KS1Q@'!
M.2!Z GDXZU7C\#>%HEF6/0K%1+(LKXB'W@=P(],$DX'K0!YX^F63_"WXA7+V
ML3SOJ&IN9&4%LI(VW![8(R/?/K6GK&JKX$\10^)9LFQUC2O+N!_>NX8R\6?=
MUW(/<"O0?[$TS^S[NP^PP_9+MI'N(=ORRLYRY([Y).:Y[7O#^H^(]9TZPN+2
MSA\.Z?<QW>_S"\MPR+\J!-N$4,3DY.0.V30!>\#:++H7A&RMKKF_E!N;QCU:
M>0[WS]"<?@*\^ELH[G6;KX=2@_9Y]=:^9!T^QM']HQ]/-^6O8ZI?V1I_]L?V
MO]CA_M'R?(^T[?G\O.=N?3- 'D%E>7^O6#M&6:^\,>&KJW)7[RWS;X?SVP$_
M\#K7O[?38/ O@&72HX%N/MVG_9'B #-G'F<CGE=^[\<UZ18Z1I^FSW<UE9PV
M\MY*9KAHUP97/\3>IJC8^#_#NF:F=1L=&LX+OYB)4B *[NNWLN>^,4 <$;F&
M#X9?$GS953&H:HGS''S-PH_'<,?6GQ[O^%L^%-GW_P#A&FV_6NYNO!OAN]U*
M?4+G1;*6[G0I+*\0)<%=IS[X)&>N*O+HVFKJ%O?BRA%W;P_9X9MOS)'_ '0?
M2@#QR>'2S^SYI=Q*D/VUKF!O,('F&Y-R/,R>N[&_/L*]3\;_ /(@^(_^P7<_
M^BFI&\#^%WO+B[;0K$SW#;I7,0^9L@D^Q) )(ZUM7-M#>6DUK<Q++!,C1R1L
M,AU(P0?8@T >;7.G6>GV/PT>TMHH9!>PIO10&(>VD+9/4Y/)]:Q+FYEN;#P_
MJL%MI%AIUYXEA>WA5'>[=C<D.[2%L9/S9&#@'&:]=DTJPE2S1[2)ELG#VP*_
MZI@I4%?3 )'XUF-X(\,.]XS:%8EKPYG/E#YSN#?A\P!X[@&@#S[6;NX\,S>+
M/"5D=EQK<\4VDCT-T?+EQZ!&5F]LU<31KZS\=WFDZ7%H[06>B6D$":I&[?N,
MR!]@4]V W9_V:]&GT73+K4;/4)[&"2\LP1;3,@+1 C!VGM4&L^&=$\0&(ZMI
MEO=M#GRVE3)4'J,]<'N.E %3P/9MI_@O2K0WUO?"*':EQ;L6C=,G;M)[!<#\
M*\PN]-LS\%O%%S]GC^T/JUP_F[?G#"[P"#U&!_7UKVR&&*V@C@@C2*&-0B1H
MH"JHX  '051;0=);3)M-;3X#93NTDL&WY78MN)(]2W- '&:['8^'_B!HUQ;V
MB100Z'?^9' H4M''Y;!>/3G%8FEBY@\1?#UFAT6RM[A9GM;2Q1S)'$UL[8>1
MF^<?=SP,D9KU6;3K.XO8KR:VBDN88WCCD9<E5;&X#V.!GZ5E6W@CPQ9HJ6VA
MV402=;A=L8RLBYVD'MC)P.@R?6@#RNYATUOV=HKFY2'[<UP&:1@/,-R;GY^>
MN[&X'VSVK8N]/U+4]9\?1,^A) TJQ7$FI(Y>.#[.A1@0<!1EB#_>#&N\D\#^
M%YKVXO)-"L6N+DDRN8A\Q/)/U/<]34^J>%- UJ]CO-3TBTNKB,!5DEC!) .0
M#ZC/8Y% %K1HY8=#T^*>Y6YE2VC5YT.5E8*,L#Z$\_C7@QC1OV6;YV12Z73;
M6(Y7-VN<5]#@8&!TK)_X1?0_["?1/[+M?[+=MS6NS]V3NW9Q_O<T :4$,4,(
MCBC2-/[J* /RKQRX66RAU+X71,R->ZFBV>W@KI\VZ63'LH25/Q%>S]!7(Z/H
M6IW?B^;Q1K]M9VUQ':_8[*VMY3+Y:%MS.SE5RQ/  ' ^IH S_#]G8-\0?&45
M[;P$PQVD4"2J"$M?)Z+GHN[?GMD5S/@IR+SX=[F/DF/5TMBQZQ;U\L#_ ( !
MCV%>F:QX5T'7YHYM5TJVNY8UV*\B?-MZ[2>X]CQ3]2\-:+K%C!9:AIEM/;6Y
M!AC9 !%@8&W'W>..* .?\&3Q7'B[QQ)#(KH-2B3*G(RMO&I'X$$?A4<=A:W?
MQGU&6XMXY7BT2W";U#;=TLN<9[\8_/UKJ].T?3=($BZ=8P6JR[=XA0*&VJ%7
M@>B@#\*F6PM4U"34%MXQ=R1K"\P'S,@)(4GT!)_.@#R7P^Y_LS0-'L;"PEO#
MJFJ/9R7NXPVJQ2N#A%(W-A\ =N35'2&6?4-)@O9+2:P_X3"[$GD)MMS*("8]
MJDG +DD#)YKU:[\(^'[ZR2SN=(M9+>.9IT0IPLC$EF'N23GUS22^#_#D]O=V
M\FBV1AN_+,Z"(!7*#"' Z$#@$4 <[X?CLHOC!XI6R6-3]@M#.L8  DS)G..^
M-M3ZC'#/\8-+BOT1X!HT[6:R@%?.\U-Y4'^+9C\,UT>E^'M'T1BVF:=;VC&,
M1DQ)@E020#Z\LQ_$TNL:!I/B"W2#5M/@O(XVW()5R4/J#U'X4 <"(/#Y\<>%
M;72UB;1TGU(I'\QB%X-N0H;CC,F .!SBL7Q7!"?^%A6MLJK8-=Z3O6/A1,TB
M>9C'1L;,^]>J3^&-#N=&BT>;2K1M.AP8K?R@%C(Z%<=#R>1SR:6#PSHEMI!T
MF'2[5+ N)# L8VLX8,&/J<@')]!0!S5_86=I\5/#T=M:P0QR:5>1.D<84,BM
M%A2!V&3Q7GES'&O[-_A]T1 S7<&XJ.21.W6O=9+"TEOX;Z2WC:Z@1HXI2/F1
M6QN /O@?E63'X*\,PVUQ;1Z)9K!<2K/+&(_E9U)*G'L2?SH P]/L+2[^+OB.
M:XMXY7CTVS5#(H; 8RYZ^N!7*^$-L3_#E<A46YU>),]!AI JC\!Q]*]<CL+6
M*_GOH[>-;J=%264#YG5<[03[9/YUG77A/0+W2H]+N-)M9+**0RQPE.$<DDL/
M0DL>1ZF@#R_Q-.;G4?&OV62W> ZSI,5PTV3%M C5A)C^'< &_&I/&6FZK9Z3
MXIO;R\T>.>72H8KBTTP.K&/SA^\=2?[AD7/IQVKU&W\-:):6ES:0:5:1VURB
MQSQ+$-DB@;0&'0\<4W3?"^A:/:7-K8:5:P07(Q.@C!$HQC#9ZC!(P?6@#DM;
MM])M_B;X!%E';QRE;P((0!F$6YV].WI]3CO5KXK1QOX5M&D13MU2SY8= 9ES
M6[IG@WPYHT\4^G:-:6TT3%TD2/YE)4KP>O0D8]S6CJ>EV.LZ?+8:E:Q75I*
M'BE7*M@Y'Z@&@#D-,MK67XL>(H[V&%GBTVT6R1U&%@/F>9M'IOQG\*F^%^!X
M5N5@_P"/!-3O%LL?=\@3-MV^W7%:]WX,\-W]I:VMUHUI+#:)L@4IS&O=0>N#
MZ5L6UM!96L5M:PQP01*$CBC4*J*.@ '04 >::-9Z+<77Q*>_BMW<7D@G,H!*
MP^0I'7H,[_R]JQ?"T6NWFI:*J+I;SCPM:F-=41WS&6<.5 /7B/=GMMKTR^\%
M^&M2F>:]T2SGDDE,SL\8R[$ $MZ_=7@\<"K.K^&=$UZ."/5-,MKI8,^5O3E
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MU'[#YWD2WOV1O(@??LP[]N<<\@9&<5%::W?'XQ:KI,UVW]F0:/'<+"V J.7
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MV(M9 \8._CY>>,^]5_%X;5?A]\0=9LXY'L=1U*U-HVPCSEC,*,ZCN"0>>^*
M/5=6\7V.C72V;V]_>70@%Q+'96YE,,7(WOCH"0<#J<' K:LKRWU&Q@O;259K
M:XC66*1>C*1D'\J\RUM;?2?'FJ7>K>(=5T2VO;.V:VELPNR<H'5D):-_G!((
M48SN[UW?A*PMM,\)Z9:6BWB6Z0*8UO0!,JGD!P  ",].U %&Q\>Z/J%]=6UN
MEZR6;3+=7)MSY-N8B0P=^@)VD@=<8]12:=X[TW4I#''9:I%(]JUW;)-:,ANX
MEQDQ?WCRO'!^8<5SOAB6^TOP'XSN]/MB]_'J>I301E,[W#';QWZ#CO67H^H6
M<OCCPK>1:YJ6K0O#/#+=W2XA6=T0B- $4*QVG([<"@#I?#OQ'M]2\()KFHV5
MU;M).88HX[=C]H8R,J+$,DNV%&?0YZ"M1?'.D_V7<WDD=[#+;3I;264ENPN!
M*^-B!.Y;(((X/KP:\NTIXYOAWX9A-Y>VCZ#JKG5#;1_OK-7,ZAR&4C@L,\'
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M?5_&6FZ1=FU,%]>RI +F86-N9O)B.<.Y'0'!P!DG!XKC5@<?##XB+Y3;WO\
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MY';GMD\=*MV'C?2M0UJWTR..]C:[1WL[B:W*0W0498QL?O<<^XY&17'&!_\
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MQC5O.QN"DX!P!T% ':45SFG^,]/U&YT^&*WNT&I6[W%A)(BA;E$ )V_-D'#
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M%Y<0!9F.=H)/ R1Z4 >F45D:GXAM].:=$M;J]DMX1<3I:JI,<9S@G<PSG:V
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M/ ES;RP2@F.5"C ,5.",'D<C\*HZ)H.G^'K#['IT3I'G<S22-([G &69B2>
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M_$^CRZOX(U32(=@GN+&2"/:-J[RA P.PSBN9U>"\\1_!)+33+22XO;K3X81
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M=PG2;C?I!C^VC?'^ZVV[1G^+GYCVSQ7H=O/%=6T5Q X>&5 Z..C*1D'\JDH
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M<@$D<Y/3U>B@#D?"EGJ%EKWBJXO-/F@AO+Y;BW=F0B11$B'&&)!RIZXKF)-
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M;*]L[F^D1)YI1:VQ<D_.P)VJ.@) //H* $UFQDO/#>H6%O@RS6<D,>XXR2A
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M=&"IV\CJ#D=QTJ'4OASJ&J>#=3TZXU&V_M75-274+F98V$2D%<(HZX"H ,T
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ME3S#*8QQOV_+C&,D&NB\"^))=9O-7T]]3&JQ6+1-#?B#RC*D@/RLH &Y2IY
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M(Z[V)D3. F!R<9-8FH+JT<GPUBUN*>.]BUB5"+B17D,8)$9=E)!;9MR<GG-
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MU2[+"WM(7FDVC)VJ"3CWXH SM:\+PZO?P:C#J%]IM_#&T(N;)U#-&2"48,K
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M9*E2=I(.1@Y/%8.L^ [*TTC6KF)-5U:>]@C%S;_:562XDC?<LJMMXE7MC"\
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M$#.T;B2<#)P.@R: +E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP,1$3,)S]G0>6I .6Z<?[7UJ#PCI%YIGB/P-;7L#K-;^'IA(&7_5N60[3Z$
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M;1R2.1U&MX7T76(O%FDZG>Z;):00^&DT^422QL5G64';\K'((&X'I@CH>*]
MHH \\72-:M]=\;VXTF66VUF+S+6[26/9N%OLV,"P8'<,=,>]8\7@>[@\->#9
M=4\.1ZL^EVDMM>Z:S1,X#[2'3<VPE2G][HQKUNH+V]M=-LIKV]N([>VA4O)+
M(V%4#N30!P1T8P>&([9OA[8OIUQ=227&E0-%YL:XQ')R0A?CG#<9&"<&M_P+
MIM]I7A]K>]BEMT-S*]K:S3^<]M 3\D;/DY(^IQG&>*L6GC'P_?BP-MJ22"_D
M:*UPC#S64 L!D>A'6MP,"2 02.OM0!PWC?39=4NC!<>#VUB(0_Z%>6L\<4UO
M-SD%F92H^Z05SWR*F\-:'K5CXJ%[JG[[_B16=I+=;P?-N$9S)QG/\0.2.<UV
M98 @$C)Z#UI: /)AX4U:WL=)74?#[ZK8P:EJ$USIJRQ'?YLA,,A5F", ">">
M-V<<52O_  9XAF\$ZUHEOX?BMY9=:BO[>*VEB6'RFV$JOS#!3:0<@9X(SV]F
MHH XQ]"U(_&>/7Q;?\2P:$;0S[U_UOG%MNW.[ISG&*WO#NK3:UI'VRXL_LDH
MGGA:$2"3!CE:/.X#!SMS^-:M-CC2) D:*BCHJC H X[Q5H6I:EX]\%ZE:6WF
M6>G37374F]1Y8>-0O!.3D@] :IIX<U8>!O&VG&T_TO4KK49+2/S%_>+*#L.<
MX&??&.^*[^JMGJ5GJ$EU':SK*]I,8)P ?DD !*G\&!_&@!-*ADMM'LH)5VR1
MV\:.N<X(4 BO.KI=9T&S\;6%II\=U:W<UQ>)J NHQ';>9$"ZRH3O!7!( !SD
M=.M>H5SFJ^!_#>K:A+?7]ANFGVB?;<21I/CA1(BL%?L/F!]* .2\/66JZ/#X
M8\166E3:E;S>&K6PN;>W=%EC90'5P'901\S C.1P:5?"FO16\?B$6*-JXUY]
M6;3A,N?):/RC$'^[O"8.<XSD9KTY$6-%1%"JHP% P /2JU[J5GIS6JW<ZQ&Z
MG6WAR#\\A!(48]@?RH \[UKPOK/C:3Q!?W&GOI7GZ0-.L8+F1&D=O,\TN^PL
M%&X*HY)ZFKDB^)_$/B7PK>W/AV73K;3;B1[PS7$3$LT+KE K'*@G&>IW#C@U
MZ%10 AY!KR72_".NV/PBT'1KS2GGFM+_ ,[4--29,W$'FR,4SNVM]Y&P3@XQ
M7K=% 'D%QX2UE],\:6EAX5BTZ'6;"$V5O;/ BQNFY3&X# !SN#9&5ZC=D<[D
M^D:WIVK^"=2ATF6]73]/DL[R*&6,/$SI& ?F8 @%3G!KT.B@#SX>&]7_ .%?
M^,M,^R?Z9J-UJ$EK'YB_O%E+%#G.!G(ZD8[XKH]/U&ZM]9LM!ELML8TM;@W/
MF@X=65#'M'U!SGGMT-;I8 @$C)Z#UI/+02F78OF$;2V.2/3/IR: .<^(&EWN
MM^!-6TW3H?.NYX@L<>X+N.X'J2 .!47B/0[O5?%GAVXCA+65O'>1W4@8#RQ)
M$%7@G)R<],UU5% 'EOA/P@-+GT>RG\!V,=Y8,!<:RQBV.$!VR1X)<NQ"G! Q
MD\UAZZFM:/\ !_6?#HTZ-[2U:5%U1;F-HI(C.6 "@[_,RP3:0 #SGL?;JY'5
M?"O@[2WN?$.I6BPQ12_:YBTTOD>9G_6&('86SCG;UYH JO!K7AKQ=K>HV>AS
MZM::NL,B_9IHD:&:-/+*N'9?E("G<,XYXK$3PKKV@V'@V[CT\ZE=:;>75S?6
M]M*BD&X#D[2Y4$*7QU[5Z=!<0W$$4T4@:.9 \9_O*1D']:@U35++1=-FU'4;
MA;>TA ,DK D+D@#ISU(H \\NO"WB.36?B/=6D#6YUBUM4T^7SE!D9(BKKD'*
MG/RY..N:-(\.W-MXNTW4M/\ !D>C:<;*>RF1# )E9MA$DFUOF7Y2!RS=21S7
MIL;K+&LB'*, RGU!IU 'CUEX2U:7P;X;M-5\*FZD\/S,DUC-+"RWD;*ZEHSN
MQE<JP#;<XKN_!FEQ:?:WDD7AFVT".>8>7;Q[/,= !AI-A*@Y+< G Q7344 <
M=\1=$U'7=.T6+3;?SWMM9MKJ4;U7;$A.YOF(SC/0<TR[MM6\/^-]1UJQT>?5
M;/5+6&.1+:6-9(98MP&1(R@J0W4'((Z5VE57U*SCU2+3&G47DL33)%@Y9%(!
M/IP6'YT >>6?@_6X!X;N)K9#<_V]<:KJ"1RJ5MQ*)#@$D;L;E'&><]J]-HI-
MPW;<C.,XH \?\1^#=5U.+Q1;?\(M#?:I>7$DUIJ]R\3*D. 4C0L=ZL,; , #
M.2:]<M97N+2&:6WDMY'0,T,A4M&2/NG:2,CV)%2T4 >;-HNI7?BZQOHO"QTK
M5(KX/>:K;7"+!<VX)R"H;<Y9<##+D'OQ67>Z)XJ'@'6/!UMX?DDD>XG>*^-S
M$(I8GG,HP"V[>0<8( '7/8^NT4 <&4\0:%XY\1ZM!H$^I6%_%:I#]GGB5]\:
M,.CL/ERV">HXP",XRX?#%YI_A'2M)UKPG'KT1$T]PMM+&);:XDD+X4NR_+AB
M-RMG(]*]0HH \QAT3Q+I=UX)U&;3Y]2ETZ&[@NXTN4:2(2[?+RSL ^T *3GM
MGFHYO!VN3VGQ*A%H%;66!L"TJXFPA'8_+SQ\V*]1+!1EB /4U6&I6;:J^EB=
M3>I MPT.#D1EBH;TZJ1^% '",GB"+5?#GB%?#-XYMK*:QNK%9X?.3=Y95QE]
MI!*'OG!Z5FWGACQ+=^$O$WF:6HO[O7(M2@M5G0[XU\D[0V<9&QASCD>A%>KT
M4 >8:MX=:[\23:_?^!3K,>HVD2BVE: S6<R%AAMS[=K KDJ3@KTKOM!LO[/T
M&RM396UBT<0W6UK_ *J)CR57VR36C10!YO!J6IZ9\2_&,MCHL^J1M'9!H[>6
M-'1_*;;G>RC:><D'(P.#V9H?@[6-,N_ C3P(YT\ZA-J#I(NV)YP6 &3EOF;;
MQGI7?6VE65IJ=]J,$.VZOA&+A]Q._8"%X)P, GI5V@#B9H-8\-^,M:U2RT2?
M5K/5XX&Q;2QH\,T:E,,)&7Y2-IR,XP>*S6\&:M:_#NR2**.7Q%9:A_:T<<<@
M"F8REVC#' P4=DSTKTBJ.KZSI^@Z<]_JETMM:HRJTC D DX'3W- '!7?A#6'
M^#>K:9]F$OB#5=]W<Q"11F>20,5W$[?E&%ZX^6IM?T:XNM.L+"_\&G5TAL(T
MM[FUN(XY[:<+A@69U*CA2&4GH<CI7HF1NVY&<9Q5+2]8L-:@EFTZY6>.&9H)
M&4$;77[PY':@#B++PQKZ>.?"^HZ@OVF.ST(VE]=^8IS.1SP3N.?7%9W]@^)/
M^$!_X5]_8TFW/V7^UO/C\C[-YF=^-V_?MXV[>O?%>K44 <OHFCWMEXK\67DL
M&RUOGMC:OO!WA( C< Y&",<XJ7P#I=YHO@/1M-U"'R;NWM@DL>X-M;GC()!_
M"NCHH XRYL=5L_BJNKPZ9+=:==Z6ED\\4B#R'65F)8,P)&&[9K)C\+:ROP=T
MG0C9?\3.":V:2#S$^4)<J[?-G'"@GK7I-% 'D'B3P=JNJ)XIMCX6AO\ 5+V>
M26SU>Y>)E2':-D:%CO1A@J  !DY)KIK*VUFW^)#:PVB7/V+4]-@A=_-BS:2(
MS$B0;N?O#E=U=S10!QOQ6R?A?KN#@^0N/^^UJ V^N^(?%^@7%]HLFG6VCF::
M>:2:-UGE:,QJ(MK$E?F+98+V&,UUFK:59:YI<^FZA#YUI.H61-Q7(R#U!!'(
M%7: /.-.\&:I/\%I?#-S&MKJ;><Z*[AE#_:&ECR5)&#\OTS5TQ:[XI\1>'Y[
M[0IM)M=)E>ZN&GGB?S9?+**L>QFRN6)W''3I7=44 >:+X.U8?$#R#;K_ ,(L
M-1.MB3S%_P"/DQ[?+VYSC?F3IC\:L7OA'4M2\=^*[AX?*T[5-#%A#<EU(\P@
M@_*#NXSZ5Z'10!Y>UIXLU73_  EILWAR2T_L>_M)+V=[F(K(L0VEHP&R1_%S
M@]  :@@\$I8W]W8S> [+5)9M0DFBU68Q>7Y,DF\^9D[]RABN IS@<UZO10!Y
MMK^BZEJ?B#SK?PL;76([R,V^O6MPB)]G#J3YGS!V.P%2A4@]N*]&E\SR7\D*
M9=IV;^F>V?:GT4 >9:9X=OKGQ'%=6_AA_#C/!.FJND\9@NF="%"(C'=ASNW%
M5.![U5MM+\57'AKPIH,GAV2W.BW]D]U</<Q%)(X7&6C ;)X&XY Z8 )KU>B@
M#S2.W\4Z-'XNM8/#DMXNK7\\ME+'<1!5WHJAI-S A>,\9/!R!QF+5?"UQ!H6
MG:'<>$SK#66G1066I6<Z12P3*N&RS,K*N0&!7/N*]0HH \\ATCQ)IWC6POY+
M62^\_0(M-N+Z*1,17"N6:1@Q!*\YX!/M6!IGA75+1/#5Q'X,6&_TN[234KTR
MP-<7K%&1W1]V67+;SN(/0 <5[%10!YO+X7UEOA/XAT46?_$QNY[QX(?,3YQ)
M,S)SG R"#R:TX[#5M/\ B@^I+I<MSI]]IL-JUQ'*@$#H[$[E+ D8(Z UVM%
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M,A@I!.2,CC/>K$OA'4],URTU#PU>64"1Z9'IDD-["T@$<9)1UVL/F&2,'@T
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M-M()+8)'&[O5Z;POJVE:G-=^%KVQMH[FUAMIH;V%I AB!5)$*L.0IP0>#@4
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M_$$']MZF-1T^WUS4A BO;VQ\F)8B>2&)+,0S D^WI0!V-%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 UT22-DD56
M1AAE89!'H:(XTBC6.-%1%&%51@ >PIU% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %,CBCA4K%&J*23A1@9/)-/HH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN+\-^/TUOQ;
MJ^@75E]CEM;B:.TE,FY;I8FVOC@88?*2O/#9H [2BL/3_$!O/%>NZ,\"QII<
M5M)YV_[_ )JN3D8XQM]>]2:?XL\/:K/-!I^MZ?=2PJ7D2&X5BJCJW!Z#UZ4
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M2[@2Z$)G,+2 .(P<%\==N>,]* +5%9.E>)]!UR>2#2M8L;V:(9=+>=7('3.
M>GO5C^V=,.F+J?\ :%K]@8@"Y\U?+)+;1\W3[W'UXH O44C,J*69@JJ,DDX
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M,7ME<68T_4Y)%O6EE!-KMMS*59@<*PP,Y[&MZ3Q+I^H>'+[4]#UC2I5@1O\
M299MT$3 9_>%3D#UZ<4 ;M%8_P#PD6FV.F6L^K:OIL+R6JW#2+,%C=<*&=-Q
MR4RPP?\ :'K5W3=4L-8LDO=-O(+NV?(66!PZDCJ,B@"W17-GQOHG_"72^&A>
MP?;XX!)@RKRY)'E@9SO &XCT(JGX2\>Z9KFCZ.-0U+3H-:OX%E-DDH5LGH I
M)/3H.M '845EW7B31++58M+NM6LH;^7&RVDG57;/3@G//;UJUJ6I6FD:;/J%
M_/'!:P+NDDD8* /J?? _&@"U16!X:\9:+XIL;2:PO[9KB> 3&U$RM+'PI8,
M>J[@#Z9%:D&J:?=-=K!>V\ILW*7(20'R6 R0W]T_6@"W16-=>+?#EE':276N
M:="EXH>W9[A0)5/1E.>1[]*S-5\57.G_ !#T;00EM]@O;.>XFF<'>NP9&#G
M'KD4 =9151-4L'TO^U$O;=K#RS-]I$@\O8!DMNZ8QWJG=^*O#]C+:Q7>M6$$
MEVJO;K)<*ID4]&&3T/8T :]%%<KIGBN?41K>II:F31;&1K>V\B-I)[J1#B1E
M .-N[Y5&.2"<@4 =517-^$O$UQXBL-2N+W33I\UC>R6KP>9YK#8JGD@8S\W0
M9Z=36,OC?7[>.PU74O#L5IHE]=1VR;KEOM</F-M1Y(R@ !)&5#9&: .]HKGM
M)U^YE\4:GX>U..)+N!1=6KQ A9[9C@'!)PRL"K=NA'6M>]U&QTU(WOKR"V21
MMB--($#-@M@$]\ GZ T 6J*P/^$X\*_V>;__ (2+3/L@D\HR_:4V[^NWKUQS
M]*OWNO:1IVF1ZE>:G:06,@!CN))E"/D9&TYP<CIB@#0HK.AU_1[G38]1AU2S
MDLI'$:7"S*4+D[0N<XR20,>M5K;Q?X<O(;R:VUW3IH[(;KETN%(B'JQSP/>@
M#:HK@_\ A95E?Z)H.JZ5+:M#?:E%:7:S."ULC*['=@_*V%!Y[&NKTG7]'UZ.
M632-3M+Y8FVR&WE#[3VSCI0!HT444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7E&F^'Y];T?Q+/ISK#K6G>)KRZT^8]I 1\A_
MV6&5(]_:O5Z@M;&ULO.^RV\4/G2M-+Y:A=\C?>8XZD^M 'B$^NR>)-)^)>IV
M$<L,\FEV2SP?QPLHE69#[C#CZ5VOB(:=_:_@ :,(/,^W?Z/Y./\ CT\A]^,?
MPXV?I7:6VD:;9W5Y<VUA;0SWI!N9(X@&F(S@N1][J>OJ:K:7X6T#1+J2ZTO1
M[&SGD&&D@@5&(ZXR!P/:@#R^WMMWPVU^_ME5KO1_$5SJ,87J##/N8?\ ?&X?
MC2G5X+#5V^)+-NLKC4;JRWCHUJL.R,_0RP9_X'7J4'AW1;:\O;N#2K..XO@5
MNI%A4&8'J&]<]_6E?P]HTFC+H[Z59MIBXVVAA4Q#!R/EQCKS0!Y/)IDNEI\*
MXK@?Z7-J$EU<D]3+*/,;/T+8_"K5]Y8T7XN*-H<._'?!MEKU:YTRQO)[6>YM
M()I;1]]N\B F)NF5/8_2J=QX8T&ZO[B_N-'LI;NYB,,TSPJ6D0C!5CCD8 'T
MH Y+4K2UL-6^' MX4A6*:2-=BXPIM7)'XX%5- 0Z#=^&;%FTK6=#N)I(])OX
M5VW,):-VRPY#@J&4L,'GD5Z+)I]G+):R26L+O:'=;LR F([2N5]."1]#5&R\
M+:!INIR:E8Z-8V][)G=/% JN<]>0.,]_6@#S/P_=1P_#/1+6*TLKBZN]>DMX
M?M>3%#)Y\KJ[@$$XV<#(R2*H:X9IM)^(\%W>6=U-YNG"5[*$PQEMZ@X!9CD8
MP3GJ/:O5G\&^&I$O4;0M/*WSA[D?9U_>L"2"W'7))S[FI!X4\/!=HT33PODK
M;X%NH'EJP8)TZ!@#CU% '*^*K;['XX\.C385AF_LK4HHA$NW[J1E%&.P/05S
M5R='_P"%0^ _+\CSC>Z?Y6W&[S=Z^;^.=^?>O8)+*UFO(+R2WB>Y@#+%*R@M
M&&QN /;.!GZ5EQ^#O#4-W-=1Z#IRW$SB2206ZY9@P8'IUW 'Z@&@#S>__P"1
MH^,/_8'A_P#25JV;RSMK*R^&?V:%(BE[$BE5P<-;2%N?<C)]:[QM%TMYKZ9M
M/MC)?QB.[<Q#,Z ;0KG^(8..>U2/IME(MHKVD+"T8/;@H#Y3 %05]#@D<=C0
M!XO?_P!EG]GW6?MWD_V@;NY\[=CS/M7VANO?=C'_  'VKV+40&\/W8(S_HK\
M?\!-<'K?@35]8NM3MWT[PXB:A*5?6$C*7:VY()38$P7Q\N[>,]Q7I84!=N.,
M8Q0!X[IEO:WGA'X50RQQRQF[0LI ()6"0C/XC]*/&T;Q:CX^6V$<:O::4\^Y
M3L*><P<L!C(V Y]@:],L?"N@:84-CHUC;[)C<+Y4"KMDP5W# X."1]#5TZ;8
MM/<SM:0&6ZC$4[F,$RH,X5O4#<>#ZF@#D=%T_4%\=QWVH:IHCW TQHOLNG0O
M&SQ%U*N=SMD*00/]XU+XENKB7QII=AI\>F0WT5C/=?;]0C:188]R*RH@9<DY
M&22, >]=!I'AW1M $HTC2[2Q\T@R?9X@F['3./2EU7P_H^N& ZKIEI>F!BT7
MVB(/L)ZXSZX'Y4 >/Z(]E-%X#%]);RVPU[4@I";(RVZ4Q[5).T;MN!DXR*L^
M,P@U3QU]F %AMTK^T?+Z?ZT^9G'_ $SQN]NM>I/X5\/RO*TFBZ>YE=Y)-UNI
MW.Z[68\=2.#ZU-I^@Z1I6GR6%AIMK;VDI)DACB 5\C!W#OD<<T <GX@@LKCX
MC>#X+9(7\RVO4N%C P;4Q  -C^'?MQVSTKE;#S;^#2?AG.S.^GZK(MYN_CL8
M-LL1(]&WPJ/H:]2TGPUH>@O*^DZ39V3R\.T$*H6'ID=O:K4>E:?%JDNIQV5N
MM_,@CDN5C D=1C"ENI' _*@#R::PU+4++QU;SZEH5E:2:G,MU+?0.9XEPOE/
MN#@#"["O'45ZU:W,.X637<,M[#$C3(KC> > Q7J 2#BJEYX8T+4-4BU.\TBR
MN+Z+&RXD@5G&.G)';MZ5)#H\,/B&ZU@$>=<6T5N0$ X1G.2>^=_X8H XSXA_
M\CM\/_\ L)O_ .@"E\.QI_PNKQG\B\6MD1QT^0UW-UIMC>W%M<75I#--:N9(
M'D0,8F]5)Z&EBTZR@O[B_BM(4O+A56:=4 >0+PH8]3CM0!ROQ'M98=&M/$=H
MA:\T"Y6^ 7J\(XF3Z%"3_P !%<9KK'7O"/C?Q? S26]V8[&T=,\V4,BB5E]F
M)E/T%>D^*K?7;[2VL-#6Q4W2/#/<73M^X4C&Y4"G><$\$@9Q5S1]%L]%T"TT
M:WC!M+: 0!6 .X 8)/KGDGZT <IKXL_^$U\"?V6(?-\R?9Y&,?9?(;/3^#.S
M';.*Y+[7;Q_L^:? \R"5[N*%4SR76]!*X]0%)_"O4]*\,:%H4\L^E:1964LH
MP[P0JA(ZXR!T]NE1?\(=X:^UW%W_ &#IWVBY.Z:3[.N7.X-D\?W@#]1F@#/^
M)?G_ /"M]>^SDA_LIW8S]S(W].VW=65INGW0\6:;?:EJWAX)%ILR);V$#1^=
M;'9R=SL"BD+CMR:[]E5T*.H96&"",@BL:S\(^'-/ANX;/0["".[4I<+' JB5
M?[IXY'MTH \S\'?9T\8:=)=I.OAIY+@>%O./R*Y/S9[C(W>5G^'/?%6;!-'/
M@OXG&Y%N9/[2U'[1OQNZ'R^OOT]\XYKU&?2M/NK2"UGLK>2W@9&AB:,%8RGW
M2H[$=L=*Y?1O .G+-J-QKFEZ=>7,FJW%Y;2/&)"D;ON4$D=>^.F: .2T2'79
MM=NT:?1XYSH&GB4:M \A,7EMYFW#KA=^[=[XJ;3-'MU\6?#ZSN+F#5(K;1[E
MHIU7,<@'E[& .<@ C&?0&O1]6\-Z)KS0MJVE6=ZT/^K-Q"KE?4#/;VJU_9UE
M]K@NOLD'VBWC,4,FP;HT.,JI[ X''M0!Y7K N%^(OCP6(87 \+_N0G4-M.,>
M]7_#^G7DUUX-NIM5\/QV\%NQLH;*W=)9XC"0R9+D$#*L>.JUZ*FFV,>I2ZBE
MI"M[*@CDN @WLHZ*6ZD53T[PQH6D7LU[IVCV5K<S B26&!58@G)&0.A/- 'E
MMI9VUO\  3P_-%"BRB]LY@X7YMYNE!;/K@X^G%;^E'1"GQ"_X2;R/+&HR&\\
M_P"]]E\I/*Z?-C&=N.<].:[L:+I@TR+31I]L+&(J8[?RAY:E6W+A>@P0#]:K
MZAX7T'5=0BU#4-'L;J\AQLFF@5F&.1R1V[4 >=^1?7?B;QA':76C0V#VMJ&_
MM6WD=_LAMQ@@[U(7/F9R.N<UWFDG^Q_ =F9KD:@MGIJDSQ?\MPD?WA]0/UJS
MJGAG0]<N(9]5TBRO98>(WGA5RHSG'(Z9[5J;5V[<#;C&,<8H \@TV6Y76OAU
M)+)HUM;3M)+:6-A P>")[9SAI"YW#D _*,D>U=3\3@UOI6BZLR,]KI6LVU[=
M[1DK"NY6;'?;N!_"MN#P;X9M8S'!H.G1H9EN,+;J/WBYVMTZC)QZ9/K6VRJZ
M%'4,K#!!&010!S/BKQ+H]IX+O[YKVWFAGM72!8Y _P!H9E(54 ^\22!Q7+^%
M;*;1/&'A6POR([B/PF86#'^-9(BRCUQ_2K]S\.TTSQA!XA\+Z?H<+&+RI[:Z
MM]JJ=V1+$4'ROR0>Q%==J_A[1]?2)=7TRTOEA8M']HB#[">N,^M 'F&GZC'<
M17<-C!8W4U_XQN!:3W>6@B98]XDPI&XX4[1D9)'-97B&65_!'Q02:[M+F5;J
MVWR6D)BB+[8@Q"EFP<C!.3D@U[!<>&-"NM/DL)]'LGM))?.>$P+M,F -V,=<
M #--;PIX>:.6,Z)I_ERPI;R+]G7#QJ050C'(! P/:@#A[S_DK/@'_L%7'_HL
M4>%=)M-9USXE:9=1J8+F]$+8'(#18X]^:]$;2M/:]MKUK* W5JAC@F,8W1*1
M@A3V!%126*:?#?W6CZ?:?VA<GS'#'RA/(!@%V )_'!H \T\.7=UXHU/PWX;U
M#+3^&6DFU3/1IH28K?G_ &N9/PK%O%#>%OBNIZ'60./]]*]1\)>'KK27U/4]
M4:W?6-6N!/=&V!\M J[4C4D D*!U(Y)-:AT#2&AO(FTRT,=[)YMTIB7$SYSN
M?U/ Y- '(>)[5;+QQX5338$AE%AJ,40B4+P(D*KQV!Z"N3N?[%_X4QX,V>1]
MI^UV)BVXW>=YJ^;[Y^_GWQ7LLME:S7<%W+;Q/<6X80RLH+1A@ VT]LX&?I7G
M0\!ZM=WL<-WIWARVB-['<W>IV492XNT202*ACV *257<=QZ9H ],KAM"_P"2
MQ>+?^O&Q_D]=S5>.PM(;Z>^CMHDNYU599E0!W"_=!/4@9.* /-+RWU.Z\9^-
MXDNM$AMVA@6;^TX'=OLQ@Z@AU 3=YF??-&A:3 ?B7H<%W+#J1M/",7EW!7*R
M,)=HD /<J3S_ +1KOM4\,Z'KEQ#/JND65[+#Q&\\*N5&<XY'3/;I5P:?9K?B
M_%K"+L0^0)P@W^7G.S/7&><4 >8BRMI/#_Q8G>"-I6GND+,N3A;564?@235H
MVD%I)\+3!$D95BH*C!PUHQ;GW/)]37H(TK3Q#>0BR@\N^+-=)Y8Q,67:2_KD
M #GM3CIEBQL\V<!^Q'-ME!^Y^7;\OI\IQQVH \1:-9O WQ&B<91_%FUAZ@W$
M-=MXF>VT;Q]H]VEJHCAT34"\<0VEXXQ$P08[=<?6NQ_L#2!;W4']F6GDW<_V
MBX3REQ++D-O8=VR <^PJS+86D]W%=RVT3W$2-''*R LJMC< ?0X&?I0!Y5IC
MW2>)OAZ+B71H8)HIWMK&P@93!$ULQ :0N=PZ?PC)&>U9&H>7_P ,]>)PNW>-
M0G# =1_I@ZUZS;>#O#5G&L=MH.G1*LZW*A+=1B5<[6''!&3CTR:<?"7AUC?D
MZ)8'^T"#=Y@7]^0=WS\<\\_7F@#F-+$9^*B?;-N__A'H/L6_T\QO-V^_W,^V
M*Y2WMK:[&GPB-)-+;QW,;5 ,QF,12$[1TV[P_M7K&J>'=&UNWA@U32[2\BA_
MU2S1!MG;Y?3\*F71]-2"S@2PMEALG#VT:Q +"P! *#^$X)''J: .9TN-(OBY
MX@$:A!)I=F[A1C<P>49/O@8K'\?ZB_A+Q*-=@!W:EI%Q8*!WN4^>#\3N<5Z(
MME:I?27JV\2W4B+&\P4;V522 3Z D_G4=]IEAJBPK?V<%TL$JS1":,-LD'1A
MGH1D\T >//I0T:;_ (5JG,6HWEA.%_O0"/-P?INM6S_UT]ZU;50?'OQ8&,_Z
M#:\?]NS5Z9)IEA+J<6I26<#7T*&..X,8,B*>H#=0.:(M+L(+V[O(K.!+F\"B
MYE6,!I@HPNX]\#@9H \NTZWM;S2OA)%)''+'@,RD C<MHQ&?<$#\J3Q.BQM\
M5U10JMIEHY & 6,4@)^O _*O1[#PMH.E>7]@T>RMO*E::/RH578[+M+# X)7
MCZ<59FT?3;@WAFL+>3[:BQW6Z,'SE4$ /Z@ GKZT >=Z-;0W/B7X=F:-7,7A
MR21-PSM;; ,_J:WO :+%JGC**-0L8UUR% P 3#$3^9.:ZB+2["&6VEBLX$DM
M83! RQ@&*,X^1?0?*./85);V5K:23O;V\43W$GFS,B@&1\ ;F]3@ 9]J .*@
M\L?&;6 VT,=#@(SU/[V3FN5L[.VM_@;X3EA@1)!?6,P<+\V\W"Y;/K@D?2O5
M;O0=)OM3M]3NM-M9KZV&(;AX@7C'L>O<_G3QHVF#3H=.%A;"R@*M%;^6-B%3
ME2!T&" 10!Y1+8:EJ-AXYMY]3T*RM)-4G6ZEO8',\0^7RGW!P!A=A7CM7IVN
MHX\(:DDK"1Q82AFQ]X^6>:=>>&-"U#5(M3O-(LI[Z+&RXD@5G&.G)';MZ5J,
MH92K %2,$'H: /([>XM]#\'_  Y\5,RB"QMX[6[9?^>4T(4D_1U2L5FO/#VB
M21C*7_C+20P!ZF\EN,-^(2Z'X1UZ_#X3\/6^E7&EPZ+8)I]P_F36P@7RY&X.
M2N,'H/R%7+C2=.NY;22XL;>5[-M]LSQ@F%O5?0\#I0!YE'I5]:^*O%&F64^B
M064%A:0;=3@=S]D6#;\I#J FX29]Z996IL_B-\/+5KQ+X1:',@N4^[,H3 8>
MQ&*]'U7PUH>NS0S:KI-E>R0\1O/"KE1UQR.GMTJT^EV#W\%\UG ;NW0QPS&,
M;XU/4*>P- 'D,B216MS\+8RRF;61''CJNFOFX8@^P#)^E7[BRU"XUSQY:K=:
M%:V9,<=Q_:%N[,EM]G4*5(=0$'SXXZ@UZ>=*T]M575#96YU!8O)%SY8\P)G.
MW=UQGM574_#.A:S=PW>IZ197EQ",1R3PJ[ 9SC)'3/.* %TJ&:V\+64 N1=3
MQ62)]H7I*P0#</J>?QKGOA4\$7PKT)]ZH@@8NS'&&WMNR?\ >S7:]*Y31_"8
MT\:QHUU!:WGAR[F-S;P2C<8F=MSQ%2,%-WS*?<CM0!3\ 7=MYWBL?:(LG7[E
MQ\XY79'S]*KV-W'X[U2VU2YN88/#]E<>;I]L7 DO)5.%F<=D!Y1>IX8]A716
M7@KPOIUQ]HLO#^F6\VUD\R*V16VL,$9 Z$$BH8_ '@^&5)8_#&DI(C!E9;1
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M+L.7RIP0.^:J7]Y<RW4FEW][K%L%TJV&EV5@K)]KD:,[]S!>2&PI!( ')]:
M.TO/'.EVUU9VMO!>W]Q?68O;6.SAWF:,D<C)&.#GG QWSQ3!X_T<^'TU;RKW
M+W9L5LO(_P!)-R"08MF?O<$]<8[URG@',VO^%Y5BE"P>$A;2%XV79*DL2LIR
M.H(/Y51,,^GW+:S-:W#6=AXRNI[C9$S%8GC*"7:!DJ"PY% '=6OC[1YY]0@N
M$N[&73;3[7>)=P[#"F3P<$Y.!GC(((P:L:-XMM=8U#[ UAJ.GW30_:(8[Z 1
MF:+(!9<$]"5R#@C(XKSCQ S^+M>\7KI%M<,9?#]O]GS&8VN0LSL2H8 \X*C(
MYQZ8KHO"R:+J?BFUO++5?$>J7%I;2'S+X8BM]^T%&RBG><#@9^Z<]L@'0>)-
M3M+'7?#EO<7VHV\MW=M'#':[?+F;;G;+D9V_2JE[\1M,M'U()I^JW2Z7*T=\
M]M;!E@"@$LQ+#C&3QD\'BL_Q_!-+XS\!/'$[I'J3EV520HV#D^E1:?;2KX;^
M(ZF%PTM_>E!M.7!MT QZT =]'>V\M@M\DH:V:(3+)V*$9S^5<)HK>+_&>EKK
M\/B+^P[.Z)>QLX;*.8B+)"M*SY))'.%QUKI/#MI]H\ Z59S!D\S2X8G!&",Q
M '\:Y+PKXNM?!_AZV\-^)X;NSU'35^SH5M)9$ND7A'B9%(.1CCKG- '1)XCO
MM!\.VTOBFW5M4DN#:Q0Z>OF&[;)VE%[949()XYSBD'C[2TTS5[R[M;^SETE%
MDN[2XA"S*C?=8 ,58'!Y![&L#5M1U*YE\*^+-3T>XLK.RU"<S0;3)+%!)&R1
MRR(!E2,@D#.,_7&)XK9O$D/C37-+AGDT[^PHK"*7RF47$HD=V* C+ !@,^M
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M&U98P\JH03G;STR.XR* /1-&\66VKZI+IDEAJ&G7Z0BX%O?0A&>+.W>I5F!
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M !1MGE^%VH6\$+.?]&"QHN3@31]A[4 3M\1M,CU!+&?3-8AN)XS)9)):8-Z
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M\MYX@LT#N5"[AG&#N!R"1CI7%Z%OT'3OAYKFH03II]MI<UI<R")F^S.X0JS
M D ["N<<9&:J^(HI=:L/%^N6=M.^GW]]I<5J6A93.(9%#N%(SMRV,XYVF@#T
M.Q\;65YKMMI$VGZI8SWB.]H]Y;^6EP$&6V\D@@<X8 XK.$WC9=))%W92WD>J
M!4;[$RK<VV!\N,Y3#%AN/9<]^7^*897^(?@61(W9([B\WL%)"YMV R>U=I0!
MR6B:E>6/C75/#-_</<(T(U'3Y9#EO)9MKQD]]C].^&'I76UQ%S_I/QJL%BY^
MQZ)*\Y';S)5"@_\ ?+'\*ZC1=8M=>TF'4K,2""4N%$J;6!5BIR.W*F@#(M?&
M]A>:G':QV6I"WEN'M8K\V_\ H\DJD@J&SGJK#) !(ZU<B\4:?+INM7RB;R='
MEFBN<H,EHE#-MYYX/'2N%LKZ&Q\46L7AJ[U>":XU)EU#0;J!FBB1F8R2J2,1
MC/S@JVTY''-03ZK'I.E?$#0KB"Z.J7MU=S6MNEN[>='+"H5U8#&.#DYXP: -
MW6O%[6GBSPO-!]MFLM1T^XF6RMX]TD[?NBGRYQD!F/)  SS6E-XNTW5/!VMW
M^_4M/%@DL=X@C"75LRKDX!R-V""#R#7,R7:Z/KO@"^O+>?[+!HLR3RK"SB#*
M0@%@ 2!GCVSZ U5O6.H>%/B=KT,<BZ?J$1%JTB%/-6.W",X! ."V<'OB@#MA
MXHL=-\-Z)<+_ &AJ$FH0QBTB6,/<W.8]VXC(7.WECD 5*GC323X=N=:E-Q!#
M:RF">"6(B:.8$#RR@SEB67 &<[A7"7EICP]\.M5N+S4++3K;31#<75AG?"9(
M(]K'"MA24*DX_B%276F0-X/GU;1EUK4(X]<MM1G:]7,MVD+(&>-< E=J\9 )
MV'VR =:GCNUDM=3+:7JEO?6%N+E["X@"S/&<@.H#$%<@YYXQS5KP3XAN/$_A
M2QU2ZLY;6>:)&<,FU')4$M'R3LYXSSQ5%?$MMXIM]8MM'L[BXMTT]A]N,3(K
MRL& B4, 20.3C@9 ZT?#&_M[SX?Z/!$7\ZRM8K:X1XV0I(J@%?F _2@ A\97
M$OQ'N?#0TNZ^S0VL<GGB(<.S-\Q.[_5X  .,YS1/\1=)@DGD-IJ3Z;;SFWFU
M1+<&VC<-M.6SN(#<%@I'O5%;J/3?C3=B[$L:ZAI4$5J_E,5D=9'W+N P",CK
M7+K>BQ^%FH>!I;6Y?Q$?M-G':"W<F8R2L5E#8V[,,&+9P,&@#V"YG%O:2W'E
MO*(T+[(QEFP,X [DUB/XRTA/!2^+/,D;3&@68;5RYR0 N,_>W';C/6MFRA:V
ML;>!VW-%$J%O4@8S7D]OI=ROC@> C"W]D6^HG7E;^'[.?F6+'IYY/'H* .[U
M'QE:V.H'3X=,U34+U(%GG@LH [6Z-G;O)8 $X.%!)..E31^,-(GL=%O()))K
M?6)Q!:NB?Q[6;# X(QL8'T(KG5U6U\(^/_$MSK/G06VJ+;3VDZP/(LFR/8T>
M5!^8$9QU.ZL"*TN]$\&>$=2U&TN((;?7I+^YC\HLUM#*9RI90"1CS%SZ9H ]
M)?Q#9)JNH:<1+Y]A:I=S848*-NQ@YY/R']*J^&?%]EXKB,^G6=^MH8ED2ZG@
MV1R9ZJISR5/![9SR:Y>QOEUCQAXLO[2"X^QRZ+ D$SQ,@FQYV2H(!QDX]\9Z
M$&N@^',+6_PX\/1/&T;K8Q[D9<$''.10!U%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5D^'M"C\/:;)9Q3M,KW,UQN88(,
MDA<C\-V*UJX*+Q[?NL.KFPLAX>FO1:*XN3]I"F3REF*8QM+XXSG!S[4 =[17
M'ZMXZC\.:KJ5IK=MY*) +C3GB)8WHR%,:C_GH'*C;W# TZ^\2ZS9V>AV;:?9
MQZ]JH=C#+.1!;JB[G+, 2<95< <D^E '745Q7_">2P>';VXN=/C;5[2_73?L
MD,V8YIW*^7M<C[K!U;)&0,]<5.?$/B'3-/UJ36M'MEDL+![V&>TE9X)MJL3&
M2R@JP*CL<@YH ZZBN9N_%,MM8^%[@6J,=:N887&X_N@\329'KC;BLOPQJWB*
M]^(7BFRO?L9T^REA1569R8PT6Y=@*X.<Y;)&#TS0!W".L@RC!AZ@YIU>:^&O
M&-EI_P ,[C6[31(K8+>R6\-A;/Q+,TH1>3TW,02>W-;UAXAUJU\2V6B>(;&Q
MB?4(9)+2>QF9U+1X+QL&4'.#D$<'!H ZRBO-F^(6O?\ "-S^)1HMD-)L[F2&
MY#7+><ZK,8R\8VXP!@\GD@^Q/I- !17$ZQXNUK1KZ2YNM+LHM'CO([7$ET?M
M4B,ZIYRH!MVY;IG) /2I[SQ)KL_BS4O#^BZ;9226EO#<?:+N=DCP^_Y2%4G.
M5&.W7/0 @'7TFY=Q7<-P&<9YQ7#KX]N;OPGH=_9:;&=5UBZ-G%:RRD1QR*7$
MC,P&=J^6QX&3Q4'AV?49OBOK"ZK;0074>D6R-]GD+QR#S9"&4D XYQ@CJ#UZ
MT >@45@^,/$,OAC0AJ,-I]K?[3##Y(;!;S)%3CWYXJEIGB+6%\6'0M>L;&!Y
M;)KVWEM)VD4*KA61MRCD;@<CB@#JZS-<TF36+!8(=1N]/GCE6:*XM7PRLO3(
M/#*>ZD$&N/'C_6!H*>+'TFT'AEI0/^/AOM0A+[!,5V[?]K;G..]:=YXDUZ?Q
M7J>@:+IME))900S_ &B[G9$P^[Y2%4G.5X[8SGL" :6@^&CI-_>ZG>:E/J6I
MWBI')<2HJ!8TSM154 */F)]R:WJQ?"FO?\)+X8LM7:W^S/.K!X=V[8ZL489[
MC*FJ7C#Q/=^'7T>&QT]+V?4KO[(B-)L 8HQ4YP>,@9/89- '3T5R%]XBUV"\
MT_18;32SK<UJUU=-+<.MM"@8*,';N8L3@<#H35>+Q[*T&@7,U@D4-]J,FEWW
M[W<;:X4LJ@'&&4NI&>."* .WHKE[[Q@MEXFU&P, :QTO3#?WUR#S&23M0#U*
MJS?E6;;^,=>MUT74-8TBRM]*U>>*"+R+EGFMVE'[OS 5"G/ .#P3WH [JBN+
MO/%6O7.H:NOA[1[6]M-'D$-QYUPR2W$@4.R1 *1D!@,L>2<>]7=:UK7X98%T
MG3+-8FMO/DGU.X,*[CTA 4$[^Y)X'O0!T]-WKOV;AOQG;GG%>;:[XNUO4+'P
M1J&@1V\,.L749>.>9E))C=O+8JI^3CD]<J.*UY-3MU^+MGIDNEVQOFT4SF_#
M'>J^:08Q_LYYH [2BN G\<:V^F:GXAT_2+.;0-.EE1M]PRW$Z1$B21!MV@##
M8!/.WM6AJ'BO4I/$EGHVA6-M<M>:;]OCN+B5D1%W@9; )(P1TYR1T'- '7UC
MZ7X?BTC6-3O+2=UM]0<3RVA VK-T:13VW #(]1GUJ#PEK]QK^FW+WMK';7ME
M>2V5S'$Y=/,C."5) )!!!Y'>H_$/B"]L=6TW1-(M(+C4[]9) ;B0I%#%'C<[
M8!)Y8  =SUXH Z.D#JQ(5@2." >E</-XFUJ]\/\ B:S%I:6VO:0I68"=C$4:
M/>LB,%SRN< CJ.M4O@QICV?@>UNWL-/@^V0I)Y]NS--<<MDRY4<C/&">IH ]
M&KF[CP?"?$[Z_8:G?Z=<S^6+R.V9#'=!/N[U93SCC(P<5/XAU'6;.2UATBRL
MW\W>TMU?3F.&$#& < DLQ/&/0U)X5UT^(_#\&HO L$I>2*6)7WJKQNR-ANXR
MI(/H10!LT5R7B;Q1JFE^)-*T+2=-@N[K4H9GC:>4QI&8]O+$ G;AB>.<@#O4
M>H>)M;_M:;2M)L=-ENK&UCGO6N;EHT+N"1%'A22?E)R>!D>M '7LZJ0&8 L<
M#)ZFG5Y5XMU>#7Y?AIJUNK)%=ZM%*$;JN5Y4^X.1^%=%J_B[58]4U6WT:PL;
MB'1T5KHW5R8WF<IO\N(!2,A2.3QE@/>@#LZY_2O#!LM=N=;O]2GU+4)(_(B>
M5%18(<[MB*HQR<9)Y.!5:^\0ZI=66EW7A^SLWMKZV%T;S4)S%%&I"E4^4$EF
MW?08-9Y\>7%UX>T"[LK.TBO=8G>W47EP5@A= ^_+@$MS&0H &<B@#N:*Y._\
M3ZMIFB6AO-)MX]:O+W[#!!]IS [?,?,WXR$VJ6Y&[C&.]6_#>OW>I7FI:9J4
M%M%J.GF,N;64O%+'("4920"/NL"#T*^] #]9T"^O]1BO]-\07VES+$872-4E
MB=<YSY;@@,#_ !#GL<U;\/Z';>'=&@TRT>61(RS-+*V7D=F+,S'U))-4_$_B
M"?1O[.M+"U2ZU/4KC[/;122%$&%+,[D G:JJ3P,GBJ6G^(=;GU'4]!N[&PBU
MRUMX[F I.YMYXW) ;.W<N"I!&#VH ZL.I8J&!8=1GD4M>4?!"QN'T.?6;FSL
M/-NY9]]\KLUS*PE.0^5QMXXY_"NZ\3Z_-HEO916=JEUJ.H72VMK%(^Q-Q!8L
MQ )"JJDG )[=Z -QF"J68@ <DGM0"&4,I!!Y!'>N"\1ZAK-S\//&-KK>FQVM
MQ;:?,%FMW+P7"M$QRA8 @CH01_.IM$O]5LOAMX372;*">:;3[97ENIO+AMT$
M()=R 2>@  '4]J .W9E12S,%4=23@5!?6B:AI]Q:---$D\;)YL$A1UR,95AT
M/H:X/5O%J7OPQ\0W^IZ5:74FG2O:W5H)2\$S*R\JV =I#*>F>U:5_P"*+W3V
M\+:=I6EP2RZQ _EH\I1(-D:L,D G: 3VSQQUH LZ9X/GM]8L]2U;7KS5I;"-
MX[-9HXXQ%N&UF.T#<Q48R?4\<UU->=#QMXJDM-<6/0]-^UZ"[?;2UTXCF4('
M B^7.2O][&..N3C3O?&-Y<2Z#;:+;60N-7LC?1MJ,[1H$ 0[!M4EG/F#CL 3
M0!V5-WKOV;AOQG;GG%5M,N+NZTRWGOK,V5VZ9EM_,#^6W<!AP1Z'^5<Q-J5J
MOQBM],.EP&[;1#.-0R?,"><1Y>.F,\T =E17FTGQ!UY?#MYXC31;+^RM/N98
M;D/<L)I%24H6C 7' P>3R01V!/I/49H **XG7_%VM:'<75Y+I=DFCVLZ1-YU
MT1<SH2H,D: $8!;H3D[3TKMJ $+J&"E@&/0$\FEKQ_PQ::GJ/QF\3WNJ6&DS
M3:>UHIE>9V-JK1,1Y&4[]6SM_&MT>/\ 6/[!3Q8VDV@\,M*!_P ?#?:A"7V"
M8KMV_P"UMSG'>@#T.BN.U/Q3K(\;MX9T?3+6>464=XUQ<S,B(A=E;. 23P,
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M359K"WG!2Y\J)':6,C!7+#Y?J*C\<Z[/X:\$ZKJULH-Q!#^YW#(#L0JD^P+
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MD4C)]JV_#]EKD_CW4M>U/3/L%I<Z?#;P1M,CNI1W)#[21GYL\9&".<YKM**
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M5V-G\Z_O ;94]>/F!'.*IWFC7B^$_#^DZEX1AUVU@TZ**>%98Q-;SJBC*EV
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MCN#0!A:+K=U;>)X]$UCP_9Z7=W5N\UI-9S"6.94(WH3L4AAE3TP:Y;1[G6O
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MI&M[-J[/]5MA$?///3-9=QX"FGT7P98"_0'P[<6TSOY9_?\ E+M( S\N?QH
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MV<@':4R66."%YIG5(HU+.[' 4#DDUC^%EUR/2&A\030S7L4SJLL1!+QYRA?
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MM54R1EL!2P)4$@'&<9Z="* ,G2O!]GIFJ1ZE-?ZCJ5W#$88)+^?S/(0XW!0
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M5A@\]NM6J* .5L_ =A::A8:BVI:K<WUD2(KBXN0S&/&/+/&-GT )/>NJHHH
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MZ ,.3PM:-XK7Q%%=7L%V8EAFCBEQ%.JYV[UQSC<>A%;E%<S=>.-)M#K0DN(
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M\^FW?FQB9MC[6C ! .,<G([]ZYM=3GT7X<7UO%/+#80>)9-/DE#G-M9_:=K
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MY\F3[.?#802[#LW?: <9Z9QVK#ELKG_A1.OVPM9OM#SWA6+RSN;-TQ&!U/%
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M!-XP Q4Y7D$&N%T^[U.P\ 12,M_I4%QXBN/[0>*(^=;V[2R,2, D?-L7< <
M\57V;M+^(MO;)JTJWNEK-9/?+(\MQ&(G0L"PS][H#S@CB@#O[#QU87VKV-@;
M#4K9-05FL;JX@"PW.U=QVG<2/ER1N R.E1:A\0=+T^\NT>SU&6RLIA!>:A#
M&M[=^,ACG)QD9P#C/-4]8MIFU/X?E(7*PW+&3"G"#[*XY].>*S-)U\>$$UW1
M[O3;VZU635KBXL[:.W<B\29]R,KX*@?-@DGC:<T =1K'C.STF_ELX]/U'4);
M>$7%T;&$.+>,YP7)8<G!("Y.!G%;UI=P7]E!>6LBRV\\:RQ2+T96&01^!KS#
M6[>WTSQOKUUK&H:]80ZA%!+:_P!F;RDY6/8T?RJ<N"O ..&KT+PY8P:;X:TV
MRMH;B""&V14BN2#+&,#"OCC(Z''I0 :YKEKX?M(+J\64PRW,5L7C4$(9&"AF
MR1A<D9/O5>3Q5IL7C"'PPWG?;Y;;[0K!1Y8'S84G/WB%8XQT%)XQT<Z]X.U;
M3$_ULULWDD=I!\R'\&"UYM#/J%SH#_$*;3KD7T>K07 MA$1+]G2,6[J%QG^.
M5J .L\2^+])D\.:C<O=:Q9V]CJ:V$D]AL61I0R@A2V04R<'IT-6=8\8W6G>/
MM*\/Q:3=3P7,$DDLL<:G."@4J2P^5<MNR/3%<9XFT.]M?@9I]LUO++J$]U!=
MW*(A+>;)+YCY YX+$?A73^)+E-+^*7AO4+I)ELWLKFV\Y(6=1(S1E5.T'&<'
MK0!2T[QV^E3^*OM]IJVI16.JS;GMH@ZVEN$0C)+#@?.<+DCDXKT2VN(KNUAN
M8'#PS()(V'\2D9!_*O/["UG7PS\1U,$@>:_OC&"AS(#;H 1ZY-==X41X_!VB
M1R*R.MA &5A@@B-<@B@"GXZ\13^%?!VH:O;6KW$\,9\L!<JC$<,_(^4'&<<U
MA:WXLNK;5?!MVUMJ-M#>27*SV'ECS9B(CL7:I(.6P1SQG)QS6I\3;6>]^&NO
MV]K"\TS6IVQQKEFP03@=^!69/>0ZYXE\ ZC8+-+:K)=[I&A=-G^CLO(8 CGC
MF@#<T_QIIMY8:M=745UIK:3_ ,?T%[&%DA&W>#\I8$$<C!.:?HWBVVU?4182
M:=J.G73P&XACOHE0S1@@%EPQZ;ER#@C(XKC=>T:_U2?XEVUK;RM+<061@ !'
MFE(LE5/<\8^IJ]X6CT;4O%%I>6=]XEU"XM;:0F34-PBMM^T&-MRK\Y]!G[O/
M:@#T2N$UC5;^^\>2^'E\1?V##%9Q3P;(XC+>.[,#M,@(PNT# &>:[NN&\5ZI
MX>?4YM*\8Z#NL%17L[V2U>XCE)'S@%%)C8$=,\CF@#5M]0O_  UX:NKOQ5>1
M7)M92([BWBP\\9($>4 P)"3MPO&<>M1)XYLQ9:I-=:9JEI<:;;?:YK.>)1,T
M//SIABK#Y6[\8YKAAH][<?#_ %06$.K+H]OK$%WIL#[Q<BUC:-G\L-\P&0[(
M#SP..:Z7PE::)J&NWM[97>NZIBS%M)=:CN\DJS9,:[E4EAC)XP-WJ: .BU+Q
M5IVFZ%9ZNWFSV]Z\,=LD"AGE:4@(%!('?/7H#5+5/'6GZ5?7D#66HW,%AM^W
M7=O"&AM<@-\YR"<*0QV@X!YKB_"FEZC/XFTSPU?6\XT_PE+<2I-(AVW!8XML
M'H2L;,>.F!46HV-G8:QXHLM:O/$D37]V\]M::;O,=]')&HVKA2"V05.2. .U
M '=ZWXWT_1=6@TO['?WU]<6QN8(;*(2&50P! Y'/?GC /-)K'CBST>[N(&TW
M5+H6D*SWDMK &2U1@2"^6!)P"<*"<"LN'3FM?BOI C@F^S6_AV2%9'&=I$L8
M +#C=@?SK#\7W%W?ZMXGTR[N=;$_V<1Z186(=([A6A^9F91AAO+ [C@!>E '
M:ZKXRT_2[ZPLEM[R]N=0MWGM([2,.957;D#)&#AL\X& <D4RV\<Z3-X<OM:G
M2ZM(K"9K>ZMYXL31R@@;-H)R3N7&"<[A7.Z'F[\2^";N**4PIH,\;.T3+L<&
M%2#D<'(;\JS-1TR_ETSQ?/!93S-;>)H+\0(AW3QQB!FVC^+@'IU(Q0!V^F^,
M[&]N+RVO+2^TFYM;?[7)#J$:HQ@YS("K,"HQ@\Y'<4W1_&EGJ]_;6AT_4;(W
MD336<EY"$6Z08)*88D'!!PP!QSBLK4];7QQHGB#2-"M+F6.32I46^DB:%#,X
M(6$!U!)[D]!FLKPG#I%_K>BO'=^)[N_LHGD>*]W"*R<QE&5]RKR=Q  STSTY
MH ]/KB=;FU[4/B#%H>FZ])I5L-*-VQCM8I2S^;L_C4XX/Z5VU<!K?AV+7OBI
M"+LW\=M'HAQ+:W$D'S^?]TLA&>#G&: +F@^(;S3KGQ+8>(]1BN8]#$4S:@(1
M$6B>,OAU7C<NT].H(XJWIGCBSU#4;*SGTS5-.-^K-927L*HEQ@;B 0Q(.WG#
M '%9_B3P5;P?#;7M&\/VK"XNXFD.^1I)+B08/S.Q)8G;CDU1O=9@\9ZUX4M]
M)M[O?97POKTRVSQBU58G78Q8 ;BS 8&>A[4 6/"6KWMWXH\>07EY/);65VBP
M+NSY*^620OI5O0?%FDVOPZL-<%WJMY:2DQP-> 27=PYD*JF%X+%N!CMCWK+\
M)6MQ%XG^(SR02HLUTAB9D(#CRV^[Z_A6!H5A?6WP:\&7;65RQTG5$O;JW6)C
M*(A+*&(3J2 X;'H* .X?XAZ;;Z;J=U>Z?J=I+IBQR75I-"OG)&YP)  Q#+UR
M03C!K8U7Q#9:0--\T23-J5TEK;+  Q9F!.[J/E !)/I5#3]:L?&?]J64-A/)
MI)@$+WDL;1K.7#!D4, 2 ,9/3)KC? %MJ&H^)(+/5%=E\'026$<C=)IG8JKC
MZ0*G_?9H ]7K#UOQ-#HUY;V2:=J&HWL\;2K;V,:LRQJ0"Q+,H R0.N23Q6Y7
M ^+K^2/Q?;6>H7VKV>D-8F2 :8KAKFYWX*%D!.0NW R,[CZ4 ;4OC;3?['TS
M4+2WO;XZF2MK;6\0\YR 2P(8@+MVG.2,8K4T;5X=:T\7<,-Q!\[1O#<Q[)(W
M4X*L/KZ$BO,-)&F1_#W1K378M9L)[*]N8S?6JN);";>Y^9@"2&5L9PRG/-=S
MX%O-1OO#[R:A/-<A+F6.UNIX/)DN( ?D=EP,$\]AD ''- '2NZQHSN0%49)/
M85S&D>.;'5]0M+5=/U*U2_1GL;BZ@"1W049.S#$CY?F&X#(K=U22ZATB]EL8
MQ)=I [0(1G=(%.T?GBO)=+NTF\0^#-3:]UZ_=)G749[M)?*@GD@=0@3: IWD
MCY1A>,GD4 =C<?$O2X1J$B:9J\]MIMQ);WUS#;!H[<HV&+'=DCO\H) Y(%7]
M3\:V&G:K;Z9%:7U_>75K]KMX[.-7\U,XX)8 >N3@8[YP*X&U\06MEX8\=:3)
M;73WUYJFI16D45L[BY9R5 !4$9SP03P,'H:OPW4?A/QYH*:HLFRW\++;331Q
MM((F$B#)V@G!*XSZD4 :7B_QA]N^$VN:UHLUU97=K^Y8.OES6\JR*&5AV(SZ
M]ZT;_5[:WO/!L5Y?:I'<WQQ$EJR^5.WE@D39Y(YR,=ZXO5K2ZOOA3X\OX;2Y
M$>K:B]S9Q&)@\D68E#[",C=L)Z=,5L^([2YD\0_#-DMY66&9C*0A(C_=+][T
M_&@#I-8\<V.D7]W:#3]2OOL,:R7TMG '2U4C<-Y+ YV_-A03CFIM1\8V=F]G
M'9V-_JTMU;?:XTT^)7(AXPY+,HP<C SD^E<U%K<7@SQ'XK34K2\E>_N%O+ 0
MVSR?:\Q*GEJ5! 8,F,''4'I1K^J7,GB2UM]7EUK3;*33(Y;>TTW?NFNF9M\9
MDC')4; !D#DF@"QXC\8QI_PANKZ?<7+Z=J%VVZ.!"7G4PN53;W._:,>M:B^+
M8M6TC7XH;:^T[4].MF:2WNT"2)N1BCC:2"#@X(/:N"TZ66R\,^ 'EL;QWTO4
MIDO8E@=GAPDNXD8R<9!R,Y[9-;T,O_"0:_XNUS3XIVT\Z,EC%*T+()Y )&;:
M& )QN SCK0!=\)^*S:?"W0-5U:2ZOKR[58D6-?,FN)69L* 2,G )Y(  -=/H
M?B"WUU+E4M[FTNK2017%K=(%DB8@,,X)!!!!!!(->7VNEW*?"[P)=7 U&VAT
MZ??>&T5A/ C)(F\  G@LN<#.":[7P-;:8;C5M1TV?6+L7#Q1O>:D3B?8IP8\
M@,0-Q!)&,CC.* .QKROP_P"(]5U_XK:Q#<IKUO96#01P6B"-(H=T9+&X&23D
MC*X)KU2O/O"]G<'XC?$0O')%'<-9B*5E(#?N6!*GO@^E &BGQ&TIRD_V'4QI
M,EQ]F35C OV8N6V YW;MI;C=MQGO5K4_&UCIOB+^P5L=1O-1\J.<16D(?]VS
M,-V2PP!MY)]1U)KSYKAKGX3V_@)+.[7Q%B.Q>V^S/A"LHS*7QMV;1NW9QTKM
M+2WE'QEU*Y,+^4=$@192IVD^:Y(!]>G% '9UCZ[XAAT,VD1L[R]NKMV2"VLX
MPSOM&6/S$* !W)'6MBN(\<7\MMK.C6]U?:C8:),DYN)[!'+M*-GEQED4LH(+
MGCJ1B@#I=#UNU\0:8+VU6:,"1XI(ITVR12(Q5D8=B"*NW,QM[6:<0R3&-"XB
MB +O@9PN2!D]N:XOX8[H=,UBTEBO(9X]4GE*7H;S=DAW(68_>)'4Y/-=S0!P
MWACX@KJ7@B;Q%J]E<6<43N-PB^6;,K(BQ@,2S<*IZ?,>.*V=-\6VU^U]#/87
M^GW=G"+B2UO(U61HCG#KM8@C*D=>",'%>;:7!->_!Q-(BBOUU'1=06>\MHH7
M295%VTAV$C#-L!88SR!71:';Z3>76KZAIEYK^IRIIC6_VN_W>5AB6\M=RJ2P
M*@G P,^IH U[+XC:7?>'[S7HM/U0:7:VHN3<O JK*,?,J?-RR]#VR#R::?B/
MIJ7L%J^EZPC7D9DT]C;#%]C'$7S9S@@_,%XYZ5AK9W"_LY_9!;2BX_L0KY.P
M[]VWIMZYK6U*VE;QEX!=8'*0QW>]@APF;< 9]/2@"U+XNT_5?!^O7KC5--_L
MY98KR,*J75NRIN)7DKG!!!R13_\ A,-,TC0?#DLG]I72ZK"BVC-&))I3Y6]=
M^"/G8#''&X]AS7,:G9W+:/\ %55MY29R?) 0_O/]%0?+Z\\<58MK2X^R?"H-
M;R_N(U\T%#^[_P!"8?-Z<\<]Z .HTSQE8:A;ZL\]M>:=+I*[[RWO(P)(T*EP
MWRE@00#C!/2H]+\:VVIW36ITK5;.Y:U:[MXKJ%5:YB&,E,,1GYEX;!^85SVH
MOJ]AKOQ#O]*MY3>#3K1K5A'NW.J2YVCHQ'IZXK/T2:T_X6%H5[:7FN:A9R6=
MS;F^OQ*R&=O+;8H91MX4DX ';J#@ UM(\;OK_@+7-6U*TU+38;87/^D6RJK^
M6KN!Y9+']XJJ,Y &[IQ6ROBK3]+\*Z'=YU"^;4(85LHM@>ZN2T88%AD#=MY8
MY '-<1I4A;X.^*]"\BX&IVJ7XEMV@<'YWD*X)&&R#VS5\1S:5I/PUURYMK@V
M>F60AO D3.T'F6RJ'*@9P&&#QQF@#K+7QI87&G:Q<S6M[:3Z/$9;RSN(U$R+
ML+@@!BI! ."#CBH+'Q]IU]J&G6_]GZG!!J?%E>SP!89VVEMH.[() .,@ XX)
MKF;K?KS^/-=L8+@Z?-H?V*V=H60W+K'*S%5(!(&\+G')SBM#4K6<Z5\.E6"0
MF&^MC( A_=@6T@.?3GB@#T&L37/$]MHEW:6(M+R_U"Z#-%:6:!I"BXW,=Q"J
MHR!DD<FMNN&UVX7P_P#$BR\07Z3#2YM*DL6N(XFD$,OFK(-VT$@,,C/J* )=
M6\<HW@/6-9TFTO3=V:30O T*B2TF5"<R*3C X)P3P1C-)\,+F\OO"5O>W\NL
M37%S%',\NHE"KED!)BV]$YXS@UBQV]S?>$?B+J\=K<)!JRSM91O$RO*BVPC#
MA",C<0<9&3QZUV'@6.2'X?\ AV*5&21-,MU9&&"I$:Y!':@#?HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.='DMY
M$BE,4C*0L@ )0XX.#P<>]244 8GA[PW'H37MS+>3W^HWT@>ZO+@*&?:,*H"@
M!54= /4UMT44 %%%% !1110 4444 4[+3HK.6XN,F2YN6#33-U; PH'HH' '
MU/)))N444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% %;4+>XNK"6"TO7LIW&$N$C5RASU"L"#^-4O#V@6WAS36M()9IY)96
MGN+F<@R3RL<L[$<9Z#V  K6HH **** "BBB@ HHHH RM"T.+0HKY(IGE%Y?3
M7K%@!M:1MQ4>PH.AQ'Q:OB#SG\U;$V7E8&W:9 ^[/KD8K5HH **** "BBB@
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M@Y'7/.>@Q6HGB+Q-IVJ^'(-772Y+;5O-:5K:*1&M]D#2;!ESNZ#YN.AXY!H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "L76-&U"]OH+W3-;N-.GBC:)HR@FAD4D')C) W
MCA@0>HY%;5% '$7/P],NEV]I%K4ZR"_;4;J6:!)!=SGH73A< XPO0;5]*T;C
MPO?:EI4EIJNNRW,ZS1W%I<QVR1-;2(<JP R&YZ@]LCO7344 86C>'I;#4[K5
MM1U%]1U*XB2#S3$(ECB4DA%49QRQ)))R?I3=:\-R:AJMMK&G:E)INJ01-!YR
MQK(DD3$$HZ-U&0""""*WZ* .=TOPQ+IYU.\EU:>YUC4(Q&]\T:KY84$($0<
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M+;HL&7CN6 .]Y!\JC>%;)  QQG@5V/AW2!H7A^RTT/YCP1@22?\ /20\N_\
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M'=Z3]G:W-DMC'"NPC&,KR!BNFHH Y&P\$R13:<FI:S-J5AI8/V*UEA1=IV%
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>exhibit1012-stuartexecut006.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMT'C'E%)"A*J3EQT)QT!]0<6(/%.KS?$^YT%=,=M.BLHY?,$D?&YF_>]<D'
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MRO[6*S>SN)?*DA=MP!C#[L. 3_=./EYX.:S4^)=PQ75O[2T+^S6OQ:_V7O\
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MR9C/,Z;-W*KM4 L0.3DU8\#^';WPZ/$/VTQ'^T-:N+Z'RV)Q&^W;G@8/!XH
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M2%Y+R%%*H@C*?(3\NX[CTXJN?!>J'X2/X8W6_P#:#2LX.\[,&Z,O7']WVZT
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M?\!:%=^&O!ECI-\8C<P-*7,3;E^:5W&#@=F% '24444 %%%% !1110 4444
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MD=_FE=1G "X Z')SG%=KX-O-3OO"5A/K$4T6H;6243Q&)VVN5#%3T+ !L>]
M&[5"QT32]-N[J[LM/MK>YNW,EQ+%$%>5B<Y8]3R2?QKG/B%K%SIUII%G;/?1
M_P!HWP@FDL(R\XB".[", $[CM R.@)-<E?ZUK]EX6UU+.;6[>&&\L/[/N]5A
M=)L22JLB$L 74$=^</C- 'K]%>;/I6I1?$)/#R^)M9;3KO3&O9R]P#+O20)\
MCX_=@[P2%QTXQ64FJZ]+HFCZ='K=VDR^*IM)>\)!ED@42CYB1@M@#DCJ >:
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M&0,#ISS0!<KA]*^';:;I6F:6^M2SV6EZ@E[9HUNJL@4N=A8'YL[^OMTKN**
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M<_9XY4*[$;:S?-DYZ*>@H UHXTBC2.-0J( JJ!@ #H*R_$N@0>)=#FTV::2
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M@<E6QDCH: ,'_A#(?^$7T+0_MDFS2)K65)=@S)Y!! ([9Q43^#;R*_N_[/\
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M3Z5V^J:58ZUITNGZC;K<6LH&^-LCH<@@CD$$ @CD53T;POI6@S3W%E%,US.
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M4N[G4M&M5DEB:YBMY%DB59612IVD;CMYQG&<'% ':W%M!=PF&YACFB/5)%#
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M<=O:FQV%G"D:16D$:QL6C58P A/4CT-4(_%&D7%A97MK=_:8KY2UL+>-I'E
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M2I!7Y<$'KCH: -F*QM(+=K>&U@C@;.Z-(P%.>N0.*?-:V]S!Y$\$4L/'[N1
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MUJ:GK5E9R-9O-<"Y,)E*VL+2R1ITWD!3@9SC(YP< X- &BD4<<0B2-5C P$
MP /3%0)IEA$X>.RMD<'(98E!'Z5RG@/Q"9?AWHM_JMY-=7=WYBJVTR23-O?H
MJC)^4>G '8"M)O'7AV.QCO)+\QQ/=_83OAD#1SY V.-N4//\6..: .A:*-W1
MV169#E6(R5^GI2211R[?,C1]K!EW#.".A'O532=7M-;L?MEDTIAWM'^]A>)@
MRG!!5P".1Z5D_P#"417'C&Z\,I#=Q216JRFX6W8C<Y(&#M( &T_,>">.QH Z
M&*&*",1PQI&@Z*B@#\A0T,3R)(T:,Z9VL5!*YZX/:N \!^-;5_#&B6^L:A<3
M:C>S2PB>2%V1Y/-?:AD"[ Q4<+D'&..E=1J?BK2-(,IO;B1(H76.>987:*!F
MQ@.X!"]5ZGC(SC(H O:7IL&D:9!86VXQ0K@%\9))R2< #)))X%3"SMENC="V
MA%PPVF4(-Y'IGK4P((!!R#7%:!JEYXUU'5[I+V:TT>QO'L;>.W(5YW3&^1GP
M3C)PH&.ASF@#KFLK5[I;I[:%KA1A93&"X'L>M2B-%D:0(H=@ S <D#IDUB0&
MZT*74[K5]5,VEI'&\$LX56B^\&4[0-QSMP<9.0.2.9[?Q)IES>368DFCNX8?
M/:WFMY(Y#'TWJI&6&>.,X/!YH OR65I+;_9Y+6%X<Y\MHP5SG.<=.M.^S0 R
M'R(\R+M<[!\PZ8/J*YR+XA^&)HK&9-0<6UZQ2"Y:WD6$MS\I<KM5CM. 2#^8
MJS#XTT*6WU.<W,T2Z8H>[6>UEC>-""0VQE#%2 3D#L: -PPQ%8U,2$1D%!M'
MRD<#'I436%F\[SM:0-,Z['D,8+,OH3W%8MAXZ\.ZEJMOIEM?,;FZC\VW#P2(
MLP R=CLH5B!U .1SZ&IH?%VBW%Y;V\=TY^TS/;P2^2XBEE3.Y%?&TD;6[\X.
M,XH U9[.UN3&;BVAE\LY3S(PVT^HSTI;BTMKM56YMXIE4[E$B!@#ZC/>N>N/
MB#X:M5NVDO9MMG/Y%TRVDK"!N.7PORK\P^8\>_%:B^(=-?Q!_82S2?VCY'VD
M1^0^TQ9QN#XVD9..O7B@#12-(]VQ%7<=QVC&3ZU@>'O"\6D178NA;W4LNHW%
M[%(8AF(2N6 !/0C/44S6Y[K7O#UZGAW4;JTO89S$LL=O@F1&P5_>  KG@D>A
M^E:%YKEGI?[F\DD>>.#SYA! \FQ.1O(4$@$@X]<'T- %][6WDN$N'@B:>,$)
M(4!91Z ]17-ZYX7NM<NK6RDN;2W\.12)/-90VY$EPZMN"LV=H3< 2 N3CKS7
M312I-"DL9RCJ&4^H/-<!:>+HM"\4>,8]:U&[FM+.>W,0$#2^1&T"NQ(C7Y4!
M8_,1^- 'H#QQR;=Z*VUMR[AG!]1[T".,2-($4.P 9@.2!TR:S[O7;"S2-B\L
M[2Q&9$MH6F9HQCYL("<<CFJR>+M%FMK&>UNS=+?QM+;+;1-(\B+]X[0,C&0#
MG'/'7B@#4DLK66V^S26T+V__ #R:,%?RZ4\00A8U$48$7^K&T?)QCCTXKB_$
MVO\ VO3_  IJFAZG*+.]UFUB8Q?*LT3,<JV1N'3&..X-7&\5)J6K^(=#MTO;
M:;3X$Q<BW8?.RNQ()4J!@+@GKDXSQ0!U/E1[W?RTW.-K':,L/0^M-@MK>VA\
MFW@BBB_N1H%7\A7%>!O&=E=^'O#=GJ%[/)JE]:*1+)"^R:0+N9?,QL+8R2,Y
MXK?O/%FC6$_EW%TRJ+A;5YA$YB24]$9P-H.2!UX/!Q0!II8V<<ZSI:P+,B[%
MD6,!@OH#Z>U84/AV_NO%R:YK-];SI9"1--M;>$HL(?@NY+$L^T!>, <X'-6;
MSQ=HMA<3Q7%TX%O-'!/*L+M'#(^-JNX& 3N7OQD9QFHK_P ;Z#INI3Z?<W4H
MNX/+,D26TKE0YPIX4\9[]!QGJ* .AJO#8VEOCR;6"/#%QLC PQX)X[UFW/BO
M1[.YCAGN'19+C[*L_DOY/G9QL,F-H.<CKU&.O%;+L$1G;.%&3@9H 011J[N$
M4.^ S <MCIGUJ.WL[:S5EMK>&!6.YA$@4$^IQ7-)\2/"KFUVZDWEW,Q@28V\
MHC$@8KM9RN$)(. Q'KTJ*WU&YM_B;K-M<ZA(=.ATF&Z$<K )"2\@8C '91R:
M .MEBCGB:*6-9(V&&5QD$>XIMO:V]G%Y5K!%!'G.R) H_(5E6/BS2-1N8[>"
M:7S);;[7")+>1/.AX^=,CYAR.!SR..:IVWQ \-WGV$P7LC1WLYMX9?LTHC\W
M<5",Y7"L2IP"03QZB@#?6RM4NFNEMH5N&&&E$8#D>YZU)Y,0\S]TG[S[_P H
M^;C'/KQ3Z\DM+_5=5^,NJ+J-C>BTTN*!HX5U+RXK53DF5E5@),]<'/'!H ]7
M\B+$8\I,1_<&T?+QCCTXK"\-^%XM%LY([D6]S/\ ;;BZCE\H9C$LC/@$\@C.
M*R;?XAM);V>J3:#=P:!>SI#!J+RIGYVVH[1YRJ,<<^XR*N6OC*:_\67NA6.B
M7$YL+A8KRY\U%CB5D#!N>6)R1M'/RD^F0#IFM;=[E+EH(FG0;5E* LH] >M$
M5K;P;?)@BCVKM&Q ,#.<<=L\UE^+=4N]$\)ZIJ=E;^?<6ML\JKN"XP"2W/7'
M7'?&*X63Q-K4E_X!O;C3[EKN[M[DFTAF3%TQAC(<X(51R6Y^Z,_2@#N/$&FZ
MM?:>UGHE]:Z;]H+"XG:W+N%8<LF& #^YS5[2-+M=$T>TTNR39;6L2Q1@]< 8
MR?<]37.0^/8DTK5KC4=+N;2_TRX2UEL5=9'DDDV^4$8<'=O7'3'.:T=$\1SZ
MAJEQI6I:7)IFHPPK<")IEE62)B1N5E]""".W'7- &_1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %>4V^EZG%\-=9\$W6G7<
MNIL]Q#;S>0QAN!+(SI+YN-H WY.2"-O3I7JU% '#26MQ:?$7P\3!>3V]II,U
MK+=BW=DWL8]N6 QSL)]N]=O)((HVD8,0HR0JEC^ ')IU% 'D5C8:A#\-/!=E
M)I>H"ZL]7MY;B'[)(6B1)F9F(QTP0??M5OQ+H6I:]K'C:TLK>YB.H:1;PVTS
MPND<LB%RR;B,<@@?C7J50_:[;[;]C^T1?:C'YOD;QOV9QNV]<9XS0!Q%XEQX
MKO?"<\>GWME+IUU]LO#/;/'Y($3*8P2 '+,0/ER, GTSSUU8:A)\-/$=DFEZ
M@;JXUU[B&'[))N>,W:R!@,=-H)_^O7KU% '%6QN+'XFZK>R:?>O9WVFVWE3Q
MP,R@QF0L&[AOF'R]3V%<MI]AJ$/P[\$6<FEZ@MU9:S#-<Q?9)-T2+(Y9B,=,
M,/SKUZB@#C="MY?^%A>+Y9[.X6UNTM%BDE@81R[(V5P"1@X) ]ZJ>"M'OK'5
MKS3+DA],T"9X=-?=DLLH5P&]XT;8/9S72^)+C3!I;V6I:V-(%V/+CG6[6WE!
MR/N,>_\ C5O2],@TBP2T@:5P"6>69R\DC$Y+,QZDG_.* (/$FGSZMX7U;3;:
M01SW=G-!&Y. &9" ?S-<QX?U&^UO1[/2[CP[?:;J-K:M;S75U;A8X&\O83"_
M\>3C&WMU/3/=T4 >4II6HZG\+M/\&2Z;=VVKVTMO;O(8&$4:Q2J3,LN-I!12
M1@Y).,5?FM[HZA\26_L^]*WUO&EJ?LLF)R+;RR%XY^;C]>G->CT4 >:V%O?V
M>J> [U]+OWBM]'DLIPD#;H92L6 X.-HRC#)XXZUK^!5ELU\3O<V=W )=9N;J
M/S+9U,D3;=K*".<X/ YKK;F[MK-%>ZN(H$=UC5I7"@LQPJC/<G@#O4U 'D>F
M:;J5MX \$&72[X2:5JXGO(?LS^;''^^&[9C<P^=?N@]?:M+7O#]]KS>,=5L;
M25%O=%%A;121F-[F1=[%MK8(^\JC(&<'M@GTJJU]J-CI=L;G4+RWM( <&6XE
M6-0?3)(% '!6UQ=ZEXR\'7T>BZK%:V]C<PS27%JT?ENRQ##!L$<J>>_;.*R)
M;#4Q\'/$&@'2-1_M 3W*H@MV(E+W#.I3'WAM(.>GO7K4,T5S!'/!*DL,BAXY
M$8,KJ1D$$<$$=ZBN+^SM+BWM[F[@AFN6*P1R2!6E(Y(4'EC]* ..7[7I7Q$E
MUF:TO)M+U+38H4EBMI)&MY(V8[&1064,&)SCKP:P&T'4+"PTN0V-VPN/%[:L
M8(X&<VUNQ?&X*#MX*DCMN]C7J$%_9W5S<6UO=P33VQ"SQ1R!FB)&0& Y7(]:
ML4 >;7=D+CQ!XX^WZ/J-SI]\EC&HBMY 90N5=HR!R4R&X].*V?!5OJ]G>ZI:
M7=Y>7^EQB+[#=W\!CN#D-NC8D N%^7#$?Q'TX["H[BX@M+:2YN9HX8(E+R2R
M,%5%')))X H Y3XCP7%UX<MH;6UN+F4:C:RE((6D(5)E9B< XP :K0+-'\1/
M$-Z]E>_99M+MXXY?LLA5V4R%E'R\GYEKM()X;JWCN+>5)H95#QR1L&5U(R""
M."".]24 <M\.+>XL_A[HEI=V\UO<V]L(Y8IHRC*P[8-5VBG'Q?6[^R77V7^Q
M3;?:/(?RQ)YP?;NQC[O/I^-=C10!Y9;6CV=]K7A_6O"=_JGVN_FN+2X1"]K/
M'*Y=1(V=J%2<'([<9XJQJ.FW]MXAFU'PZFI6M^U_$EU826[O97J J#*&(VH0
M@SN!!RF,'(SZ+!=VUT9A;W$4QAD,4HC<-Y;@ E6QT/(X/K4U 'F-A<I]J^(M
MA]ANKJ6YO62..*W9UE+6Z*%+ ;5Y_O$#!SZU6CTF_P#!NH:*]_I.H:OIXT2W
MTZ9].5I'@GB+'.Q2"4.\C/L*[_1O#L.BWVIW<5Y=3/J,_P!HF68IM#[0N5VJ
M".% []*TKJ[MK&V>YN[B*W@3&Z65PBKDX&2>.I H \YD@NO"^O:)KUEX9NET
M<V<]G+86,/F36GF2K(KF-3R6V_-C.#Z][OB".[G3PQJD&A7,,%OK/VB2VA@S
M,D;1R+O=%[EFR?3//.:[^B@!$8LBL5*DC)4XR/;BO*;?2M3C^&6K>![K3KN7
M5"\\$$WD,89Q+*SK-YN-H W9.2"-O3.,^KT4 </):W%K\2="8V]Y-;VND2VL
MEV+=RGF,T97+ 8Y"$^U=Q16<NHZ9K'VS3K/58))T0QS+:7*F6#.1G@Y4^F>X
MH Y'2-$N[+QU?Z0H0Z#%*NLP@'E)9=R^5C^[O5Y!Z$"H;&"]T:+QEI%_IUY=
M-J-W<7=E)#;M)'<),@ C+ 80J1M.X@8P>E=EH>AP:%9F"*YN[N1R&EN;R8RS
M2D  ;F/H !@8'ZUIT >9Z?I5_P"$=;\)/=6EY>Q6VAOILLMI"TVR;=&P!QT7
MY2 QXXYQ67!9:DGA;2X)M&U%)8?%GVR2/[,S$0BX9R_R@\8(^O;->P44 (#D
M C//J,5Y^;F_\.>./$ O-"U'4].UKR9;::S@\Y05C$;12<X4<9!/&">:[J\O
M;33K22[OKJ&UMH\;YIY B+DX&2>!R0*F5E=0RL&4C((.010!PMK%?:#X^N-2
MO+"8Z?J6FV\*FSA:9;66+=F+:@)"G>2#C'%5+7P7>7/P^UFR*M;7MYJ-QJFG
MHW#6KF7S(1['A<^FXBO1J* //]4TO6];^&UW<_8]FNWS07SV;-MP8W1EASV^
M5 /]XGUI+66UU:QU#4+?PGJ=A=KITL#RWMLPF)8<11C)9AG))'' ]>.Y:_LT
MOTL'NX%O)$,B6YD D9!U8+U(]ZL4 ><JVIZ?\+/"\,&DW3SV_P!CAO(_L9>>
MV5  \D<;#EU(&#@]<C.*QKS3I&TWXA0W6D:P+6]^SS6S2?ZR4B.,+M9B<MO&
M=O)XQ@' KU^L[6]%M=?TXV5V\\:B1)4D@E,;QNA#*RD=P0#0!PMC=1:UK\LM
M\NK6NL7>ER:9:R7.DRVD/.78Y)8%B5SU'"\4>$$\^#2-+U/P??P:MI>Q9+FY
MC)MHR@V^;'(3@D@<!1U/H,UV>G: +*9)KG5-0U*6+)B:\=#Y9(P2 BJ,X)&2
M">3SR:V* *>K6\EYHU];1 &2:WDC0$]RI KS/33J$UI\.X/["U9&TAQ#>F2U
M9!&PMVC/7JN3]X<<]<\5ZQ10!Y%J-AJ$_P /?'UG'I>H&YOM5GEM8OLDFZ5&
M*;67CI\I^F*Z"UN+S1/B)K%]<Z;J-QI^M6]LUI/!:O)Y31J5,3@#*9+;@6 '
M)R:[VB@#QG2]/UC2_"?@[49] U*XBTQKJ&^L(T(N DK9614!!;&!QUPQK8UJ
MS2?1M.N=,\-7UHDNO6EY+%]E8SND;@O+(HR5X&,'DX]\5Z#!J^F7.H2Z?!J-
MI+>P@M+;1SJTB#(&64'(Y(Z^M7: $!#*",X(SR,5QQ2YL/BK=WLEA>26=UI,
M,23PPET#))(6#$=#A@<=3VR:[*H6N[9;Q+-KB(7+H9$A+C>R@@%@O4@$CGW%
M 'D]E8:A%\./"5F^EZ@+JTUR*>>'[))NCC6X=RQ&.FU@:NQV[V&LZ[H^L^%=
M1U:+4+V2ZLYX8R]O*DF"$D)(5"IX^;L/IGU&JZ7]G)?R6"7<#7D:"1[<2 R*
MIZ,5Z@>] $D$?E6\4>U5V(%VIT&!T'M7 ^&(;GP'J&L:3>V-[-IEU?27MC>V
MML\Z@28S&ZH"RD$<$C!SUKT*B@#BO&MOJGB'PK(^EV4I:UNK>[B@E!C>Z$4@
M=EVM@KG P&P21T'!)-$VN>-]"UZWM;V"TTNTN3<-/:R1.YD"!8PK ,Q&&)P"
M.!ZUU_VNV^VBS^T1?:C'YH@WC?LSC=MZXSQFIJ /(K*PU"+X:>#K*32]0%U9
MZS;S7$/V20M&B3EV8C'3:0?>M#Q#%.-6\>W36MTEM-X<\J.=X'5'=$F+ ,1C
M@,*]-K,U^VL[_1+K3[Z]-G;WD30/(KHK%6!! + C.">U '%6]H_B/3O *6EI
M<Q'37@O+B>6!HUC1("I0,0 Q9BH^7/ STK( UB\7PW=7&@:K%>66NF2ZMH;;
M9;P(1*!Y:C 8'<"9.>2<L,XKU/2K*/3=)M+*&>2>*WB6..20J690,#)4 =/:
MKE 'E=Y97LOAKXD6Z:;?F;4+F5K1/LDF9@T*("O'/S*?YUK>*+6]@T;0/$FD
MP9U;3&BB6"8&,S1R[8WB;/(.2I&>ZUWU8\OARWG\0KK$U[?RE NRS:X/V9'
M(#B/INY/)^O49H MZ3IXTO2K:S#F1HT_>2'K(YY9S[LQ)/UKCO&NG27&M/>Z
M:^KZ?K-M8@VU[9V[S0W'S.?(E4*5(! /./OY[5WU% %32C=MH]D;^&.&\-O&
M9XH_NI)M&X#V!R*X"YMKMY_B9C3[XC4(%6T_T63]^1:B,A>.?GX_7IS7I5%
M'E*1WNBZCHFJ7FA:K?Z=/H=O8S):0N9K6>(L?FC&&VG>1GU%:9CGT_4M$M;;
MPU=6&D26]PV+" &:-V<%8G=?]4K#YF((^; W8!SZ'2.ZHA9V"J.22< 4 >0:
M?8ZE!\/_  ?8RZ/J4=Q8:]'+/&;9F9(UF=F<XSQAASW[9KI(DN['QKXPDETZ
M^:#4+6W>WGB@9T;9$RL,C^+=@;>O/3&37;Q7,$Y(BFCD(ZA&!Q4M 'E-E97T
M7A?X<6[Z;?B;3[N)KM/LDF80L+H2W' RPJ_X<GU+1TO?"VH^'+V[G%_--;79
M@#VLR22F19'D/"E2W(Z\#&37?R7]G%?0V,EW EW,I:*!I )' ZE5ZD#VHM+^
MSOS.+.[@N/(E,,WDR!_+D'5&QT8=P>: /*_%\6KZGI_BJR.AZE]H6]ADM8[.
MW(AGB5HCYK,,>;(0I!4DD87 &":ZC21._P 4-5OGL+R&WN-,MHXY9;=@N]6D
M++NQC(#+WKM** /*M#LGMHY?#&M>$[^]NXKN1H;QHR]G,C2%TE9R=JD9R1C/
M'&2<5ZK1547UI/=SZ?%>P_;8T#20I(IDC!Z,5YQ[9&* /)=.M6\0_"&]\.6M
MG</>7=_<1HYMV\I?]+9O,,F-N% )ZYRN ,XKI+R+48?'/B&[M-,FNB= 2"W\
MZ!O)GF0R-Y98C!SN7OSFNI\.>'X/#.E_V?:W5S/#YKR@W!0L"[%F^ZH[L36O
M0!Y;HPOCXM\,:I)I.M>6NF3P7+S6IC6&0^6=HC& BC:0, 9P,;C5."QU!/AC
MHUDVEZ@+N#75N)(?LDFY8Q>-*6QCIL(/Z=:]>HH 0'<H(S@\\C%<!::'>S_$
MGQI++;S0V>H:?;P0W)0[&/EE6P>^,UZ!10!Y,8M7U/P#I/@9M"U&#4(6M;:Z
MN'A(MXXX'0F19?NMD1\ <Y/2NK\*:?=VGBSQC<7%M)%%=7T3P.ZX$BB%02I[
MC((KKJ* ,?Q79SZAX.UNRM8S)<7%A/%$@_B9HV 'YFN.T6.^O[_P!<?V5J%L
MFFVMQ;W7VJW:,QOY$:C.>Q((![X->DT4 >6>(/#.HZE=>,I$L+B5&U'3[R"-
M&,9NDBCC\Q48$<X# $'J!6YX.T[2UUJZO]/T#6++;;K#]KU2:??)EMS(L<K$
M@#:IW<<GBNWHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KRZ?QAXN_X175?$T;:6EII5W/&UJUN[-<QQRE2=^_Y#M&.A
MR03T.!ZC7!R>#-2;X;:]X>$EM]LOYKN2)MYV 2RLZY.,C@C/!H V](UVYO\
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MA.U"<$CL<8([BN5L;>YE?PAX7AU;4H+*XTQ]0NI4N6$TFU8PL:R=54%R<#L
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M[GP.9M4\07$6KSQ6FNVYBNK7RD8!_*\H.K'D8'./6I=<\$VVM^ 8_"<EY+%
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M&49DVCIGV/)%=";VU$JQ&YA$C.45/,&2P&2 /7'.*1+^SEEEBCNX'DAYE19
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MRB1.9"@0L'(W ':I*]\>A(HU_P"'\/B30M+T^^U.X$]@"ANHD56EC9"CH1T
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M[=SN.'QNV;OFV_AG&<]F^I6,=LES)>6Z0.<+(TJA2?0'.*M @C(.0: .6O\
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M=_/=VUL&-Q<0Q!5WGS'"X7.,\]O>FS7]G;/$D]W!$TO^K5Y I?Z9/- '+?\
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MF"Q-U10[':IP.!CH* //=6MDTGP]XCTN^\-V.EZJ?#TYCN=,D_T>ZA3 8E,
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M^ISMF/\ =&0"!0K;2 X.<KEB/3-,O=*FNK.+7IM*TWQ);RZ);1WUK<RA;FW
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M<OJDQ%O#$65/N!6W.=N,XX //-4-+LK+4M'^''VRTL[E3JMY;_,@D0Q*9]J
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MY()ZBNQ@O+6Z>5+>YAF:%MDBQN&*-Z''0_6O%1<Z?_PI3['YT"W,6L*EQ&&
M=/\ B8D@-W!V\C/:MO7(#8^,O$]IX<CBM[N7PH'BBM0%+2B24*0!_%@C'X4
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MGM-3T/X>W&@-&+Z*\MPHB(WI $(N%8#D  $-GOCOB@#TA]3L(W"/?6RL9?)
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M ,8KF_%L]SI>JZ[J=C-9ZI9*8%U71KCY9E(5=CP,.Y#*0",;@<<TVXMM,O\
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M2[!<GUQDX%8>C:M;6'PV\$SO=&+3[2\"ZK);JKM;L1*(S(""  Y4G(XX/7%
M'M5K=VU[ L]I<13PMTDB<,I_$4V[OK2PC$EY=06Z$X#32! 3Z9-<YX.MM$%[
MK-_HFIRZBE[*DMQ,'C: RA2#LV*%W8QNQ[=\U12Z6'XM:E!JY189]+B&G&;
M1E#-YZC/&XDJ2.N .PH [1[F"-8V>:-5D8*A9@ Q/0#U)I+:\M;U&>UN89T5
MBC-$X8!AU!QWKQC[##'X:\-Q7BQ-9?\ "7E--\W&?L1>0( 3SL(Z=B,=L5V?
MA1+2U^)/C2TLUABB"6+B&(!5#&-PQVCOP,_A0!W5%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5$;6W,CR&"(NX =M@RV.F3
MWI[EEC8HNY@"0N<9/IFN(O?B79V?@73_ !.=/GD%Y(8_LJN-\94.9,G'\ C<
MGZ4 =P44L&*@LN<''(J);2V12JV\2J7WD!  6]?K[UQ'Q#\2B'1M7T:T21IW
MT*YOC<QR;1$@^53ZY))Q]#5G2/&%V+[1-/U#0Y[2VU.(K9W;SJQ=ECWX=!RF
M5!(Y/O@T =+J.CV6IV%Y:3Q!4O(S%.T8 9U/!!./3BK]>?:-XNTG3M(\4:A!
M87B_9=<FM&A-P9GN;@LJCR]Q^4,S#"]!S57QGXDU2?P+XFL[_1[K1[Z"P$\<
MB3"6-T+8^610,,".5Z\YY% 'HK6ELP(:WB(+;CE!R?7ZTJVT"2"18(U<<!@@
M!_.N9L?%]U)XAL-+U'0I["/4HY'L9WG5S)L 8AT'*':<XR:T=5\0II.OZ-IL
M]NWE:H\D27.[Y4E5=P0C_: ./<4 :L5M;P22/#!%&\IS(R( 7/J<=:EKE=7\
M=66CZGJUM/;RO!I5C'=7,\9!P\C%8X0O=FQD<]Q2V'BR].N6.E:WH4FERZ@C
MM9O]I697*#<R-@#:VWG'(.#SQ0!T,-A9VTSS06D$4K_?=(PK-]2.M.FM+:X>
M-Y[>*5HSE"Z!BI]1GI7,)XZA?P%9^*OL,@BN7B06_F#<N^81=<=B<UN:]K-O
MX?T6XU.Y221(0 (XQEI'9@JJON6('XT 77MX9)!(\,;..C%02/QIGV*U (^S
M0X/4>6.:Y63QQ<6%OJPUC1)+*]L-/?44@6Y659XESG#@<,#@$$<9'6ELO&]S
M-JND07F@SV=CK&1973SJQ9@A<!T'*94$CD^X% %B3PO)-XY.M3164EA_9XL1
M;,N2,2&3?R,=3C'XY[5TDD$,JJLD2.JD%0R@@$="*X[3?B#_ &@NI7;:/-!I
M&EO<I>7SS+A&A)X5.K9 !XZ9 Y.:DLO&]XUUI7]J^'Y].LM6<1V=PUPDAWLI
M9%D0?<+ '')YX.* .K:TMFSNMXCEBQR@Y)ZGZU6U&RG:PN/[*-M:Z@R$0SR0
M[U5O<#!(_&O)_MUW_P (Q\67^U3;H+V<0GS#F,;>B^GX5Z?X2=Y/!FAR2,S.
MVGVY9F.228UY)H FT739]/M9&O+E;J_N9/-N9TCV*S8"@*N3A0J@ 9/3/4FM
M%E5U*L RD8((R#7G&C>-=,TOPG=:G::7>^2=<:R>%K@S2-(SA2RENV3PM='H
M_BB[O/$<VA:IHSZ;>+:B\A_TA9EDBW;3RO1@<9'/7K0!T%O:V]JK+;P10JQW
M,(T"@GUXI9H(;F)HIXDEC;JDBA@?P-9&N:SJ-A=6UII>AS:G<3J[D^8(8HE7
M'WI""-Q)&%ZG!]*L>'M:B\0Z';:G##)")=RM%)C=&ZL493CCAE(H T%BC6$1
M+&@B VA .,>F/2F0VEM;P&"&WBCA.<QH@"\]>!7#7_Q+DL]*U/6XO#US<:'9
M220B\6= 971MA(3J$WC;N_'&,XT;KQK<KXJ/A[3]#FO;M;>&Z9A.L:+$Y(9B
M3_=P..IS[&@#I_L=KMV_9H=N<XV#&:YBY\-:R-9O;B"[TBZM+N0.$U&Q,CVX
M"A=B%7 *<9 P.2>>:KW?C^XCBU/4+/P_<7FBZ9*\5S>K<(K'R_\ 6-'&>75>
M><C.#BMO2O$EOJ^N:CIUO&2MG!;SB?=D2K,K,,#M@+^M %G2M%M-+L(+5(HF
M\IWE!$04*[L68J!]T98\#MZU=^SP>6(_)CV!MP7:, YSG'KGFN+3XC">ST"2
MTT6XN+C6VN4MX%E4%6A.#N)XP<$Y[ =ZVO#?B1];GU&QO-/?3]2TZ14N;9I!
M( '7<C*XZ@CV'0T ;:P0K*95BC$AZN%&3^--CM+:&:2:*WBCEDY=U0!F^I[U
MP(UG5K/XD^*;?3=+FU23[-9.L)N1%'& LF?F;(!)(P .<'.,5IQ>/5U'3-%F
MT?2IKR^U:.26.T>58O*6,@2%W.< ,0O .2: .J^Q6N"/LT.#U'EBD-A9M)'(
MUI 7C.48QC*_0]JYR/QC<7>D0S6&@W=QJ+W;V4MEO"BWE3._S).5"\<'ON7
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M96&014<5I;0+MAMXHQM"81 /EYXX[<G\ZR_$/B%/#K:8]Q;L]M>7B6CS!L"
MOD*S#T)P/;(J#5_%UII&O)ILT3,J6$VHW<X;BWACX!([[CD >QH W([:"+9Y
M<$:; 53:@&T'J!Z4OV>'RGB\F/RWR77:,-GKD=\UR-EXYNVGTF34_#\^GZ?J
MTBQ6=RUPDC;V4L@D0<H6 XY//!Q5D^-81X2UK7_L3[-+FN8FAWC,GDL5)!QQ
MG% '30PQ6\2Q0QI'&O"HB@ ?0"FW%K;W:!+F"*90=P61 P!]>:BDO1%I;WQA
MED583-Y42%W;"YVJ!U/8#O7/Z7XNO;C5(M/U;09=+FN;1[NUW7"R>8J;=RM@
M#8XWKQSUZ\4 =-);PS8\V&-]O3<H.*$MX8Y#(D,:N>K!0"?QKAM-^),FH^'5
MU[_A'KJ.PF6..T/GH7N;AW"")5X(&XXW' X/:M_0_$-QJ&I7>E:GIC:;J5O$
MD_E><)4DB<D!E8 9Y4@C Q^- &]1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %>7Z9X3OI?'&HZ;?64B^'[9KVYM9B/DD:[5
M 5'^[NG'_ J]0HH \>TSP]X@NO OBR74]/G&J/I::3:Q,N7E2&(C<OL[NQ_"
MNOU;3;V;5? \D=M(R6=PS7! XB'V9URWIR0*[*B@#Q^S\+ZXN@>)I$TZ7[7%
MXM;5[6!\*;F-)$;Y2>.0&Q[UL>*K_6_%WA#Q%967AV_M[4V(6'[7%Y<\TY;E
M53)^4*.O<]*[^SU&RU'S_L5W!<_9Y6@F\J0-Y<B]4;'1AW%6: .5UVPN[CQO
MX0NX;=WM[5[LSR*.(]T)5<_4\4[XA:8VH^#+V2!UBO-/Q?VDK' 26$[P<]LX
M(^A-=16/X@\-V?B6&&WU":[%JA/F6\,YCCG!Q\L@'WAQT]S0!P=OH&I>)/A?
MJVII;A=9UZX35$A=L?*CHT,63_TSC4<]V-;#37WBSQ?X=NDT;4=/M-*::YN9
M+Z'RLNT918TY^;EB21Q@=>:[M$6-%1%"HHPJ@8 'I2T >-);:X/AK9>$5\.Z
ME]NL;N$7$K1 0F-+E7W(V?GR,' Z#.>G/?\ C_1KC7O!UW9VL)GG62&=(0^P
MR^7(KE V1@D*0#D<D5TU,EEC@A>:9UCBC4L[L<!0.22?2@#RR70K.\T+Q*^B
M^$]7M+A]&GMHI[^64R2NX_U21NS9&54[O7 &:Z'5-,OIIO ICM9&%E=*]S@?
MZH?9W7+>G) _&NE_MW23;V=Q_:=GY-\XCM9/.7;.QZ*AS\Q/H*T* /.=*\+Z
MA>?#CQ3HLT+6UU?WE^8!*,9#NQ1OH>/PI)I-4\5-X7TXZ#J-@^G7L%Y?S740
M2*/R5/RHV?GW,0 5[<G%=]/J-E;7MM93W<$5U=;OL\+R /+M&6VCJ<#DXZ4Z
MUO+:]1WM;B*=8Y&B<QN&"NIPRG'0@\$4 >5?\([K'_"._$^#^SKCS=1O)GLT
MV\SJ5X*^M>C^%[>:T\):-;7$;1S0V,$<B,,%6$:@@_C5PZC9+J2Z:;N 7S1>
M<+8R#S#'G&[;UQGC-6: /'M'\-ZS!X.%K+IMPD__  ET=YY93GR1.C%_]W )
MS7</879^*L&HBW?[&-$D@,V/E$AG1@N?7 )KI+FYM[.VDN;J>."",;GEE<*J
MCU)/ J.PU&QU6S6[TZ\@N[9R0LT$@="0<'!''6@#C/&-K-/XJL6O]+U34]%^
MQNL=O8LVW[5O&#( R\;> 6.!S5WX:V=WI?A%=+OK"6SN+2ZN%9&!V$-,[J4;
M^)<,.:Z^B@#Q76GU70?A+X@\,3:+=^9;_:<7I"_9V@>5I X;.=V&QMQG..@R
M1W&D:;>1?$K4M0DMI%M)=(M8DF(^5G5G)4'U&14]Q\/=$N;R>5WOA:W%Q]JG
MT];IA;2RYW%FC]R 2.A/:NKH \L$>L:+X4U_PC'H.H75W=2W:6-S%&#;R1SL
MQ5GDSA-N\Y!].,YJWI=OJ'@OQ/=H='U#4H+K3+&WMYK.,,OF0(R%7)(V9R#D
M\8KTBB@#QC38]3\._P#"N5N],GDN[<ZF9[6(9D"G))4'&>"#CJ1TYKMO"-O>
M7?B;Q)XAN+&YL;?4&MX;:*Z39*R1(079?X<EC@'G K7>WT?6/$5O=I=I-J&B
MF1#%%*"8C*N"'4<@D#C.*VJ .6T:PNH/B'XHO9;=TMKF"R6&4CY7*+)N ^F1
M^=<%9>$Y[32/"][K&B:E=06L-Y;75M:,ZSPEY]\;[48,PX((']X'%>S44 >5
M7&D?9].T<Q>&M8MM"FO;B:_T^WGDEN)"4"PO( V[!VY*Y('&:P]4\.:O)\/_
M !/HUKX>O+>:;68;VVMP-X,+>5@!LG++L.X9.#W->XU6L=1LM3B>6QNX+J-)
M#&SPR!PKCJI([CTH Y&YCO+#XOQZB=-O)[&\TA+-;B"/>D4@F9CO.?E&"#FL
M5-!U4? VRTG[!/\ V@DT!:WV_. +Q7/'LH)^E>HT4 <;\5\_\*PUS;C=Y28S
MTSYBU5DDU#Q-XV\.3'1;^P@T@SSW<EU&%7>T9C5(SD[^6)R.,#WKK-<T:U\0
MZ-<Z5>^9]FN  _EMAN"#P?J!6A0!XWI>B:YI_@8VUQIVIB!O$<L]];6NY9Y;
M0Y^[M(8@ML) .2 :CN= O_[-\6VEAX;O[2#4?L%Q91,I<E8Y5#ACDX?@MMSD
M#Z&O:** .6U>PNYOB+X:OH[=VM;>VO5FE ^5"PBV@_7!_*H/%5M>6?BK0/$=
MO8W%];V27%O=0VR[Y524+AU7^+!0 @<X-=A10!YC=:5JFL:5\0-773+JW.KV
M"VMC:3)MFD$<3C<5[;F<@ \X%'B+0M4N?AAX0T^"QGDN[6?3FGA5?FC"*-Y(
M]N]>G44 >9^(M!M[?QMJ6J:EH.K:I:W]O#Y#Z;)(#')&&5D<(ZXR-I#'CKR*
MN:5H%Q8^-?#<T&CO8V-MHDT3Q+(95MY&=&\O>>IZ\^U>@44 >2ZAX:MK/6_$
M$>H>%M6UB74+MKBS>TN)$@E5U4%)"KA4PP;)8=".O2M>S6^\'^+=<$.@7]Y:
M:E';/9-9KYB(T<0B,;L2-OW5(8\8->AT4 <K\-M/O=+^'VDV6HP-!=Q+()(V
M&"I,C'^M<1'%KJ?#C4_"9\.:C]OU">ZCMY?*'DB.69SO=\_)@$G!ZC&.M>PU
M!:WEM?0F:TN(IXP[(7B<, RG##([@@@_2@#S/XAZ=J&D7VD7.B,/M>JVQ\/2
MG.#AQF.7'^QASGT->DZ;I\&DZ7::=:+MM[6%88QZ*HP/Y5GCPQ8GQ*->GDNK
MF[0$6ZSS%HK;< &,:=%) Y/6MJ@#Q2'2=1^SZ+>7/AS69]<L-3BN=6O)BS[P
M'(/D@MAQR"-HP%7UKIDT;4A\/_'=G]BF^TWMWJ3VT6WYI0^=A7USVKO+G4+*
MS9%NKRW@9_NB64*6^F3S5D$$9'(H \[L4O\ PEXCGU&;2-0O;/4]-M$)LH?-
M>&:%64HRYR 0P.>F0:R)-"UG3=$T'59M*NI9QXDEU:[L[91)+!'+YF!@'DC<
MN<>IKU*'4;&YG>""\MY9D^]&DJLR_4 Y%.GO+6V8"XN88B>0)'"Y_.@#E-"L
MKP:[XRNY;.>&*_D@>W\Q<%P+9%/Y$$'W%<79>%7L;/PQ?:WH6J7D$>B)8SPV
M32":WF5]PW*C*2"&8=\$"O8XIHIXQ)#*DB'^)&!'YBJYU33PQ4WUL&!P09ES
MG\Z . @\/RQ:AX'FL= GTZV@O;NXN('E,S0!XW :1B3RQ()&3@G%=AXOTB77
MO!^KZ5;D">ZM)(XRQP-Y'&?;.*V@<C(J-9XGF>%94,J8+(&&5SZCM0!YQX?T
MC3Y=1@FM_"&KV5W;VLIDN;^YE*PRLFW9&&=A)G+<C@ =>:;;Z%JB_#OP'8FQ
MF%U9:A8R7,6WYHE1CN+#L!7IM% 'F'CNPNTN_&FH-;R"SD\+^2DV/E+AI25S
MZ@$'\:F$FI>)I_!]C_8M]:+IEQ'?7ES-&%A'EQ,H5&S\^XOQCMUQ7>:OIEOK
M6CWFEW>_[/=PM#)L.&VL,'!]:LP0K;V\<"9V1H$7/7 &* /)+;PKK;:!XNV:
M?(+L>*6U2SAD^7[3&DB.-I/'S!3CWKIHGO/%/CK1-332=0L+'2(+AI)+Z'RF
MDEE54"*N<G !)/3I7<U'<0_:+:6'S)(_,0IOC;:RY&,@]C0!Y7H&BW(^(\WA
MPJK:)H-U)JT&#D!YU_=1X[;"T[#\*BF\+6EKJ.M66H^$]5U6YO=1EGMY8+F5
M+:6*9MWSLKA4V[F!R,G'&<UWWA?3M$TR*_@TB\^V3BY/V^>2X\Z9I@ ")&SD
M$# QQCTK8DO+:*[AM)+B)+F=6:*)G =PN-Q ZG&1GZB@#E_#NF75G\0O%]W)
M;21VEREBMO*P^639$P;![X) IOCR"ZG;1LVNH7>D+=,=0M]/+>8Z^6WEY"D,
M5#XR ?2NQJ"[O+;3[5[J\N(K>W3&Z65PJKDX&2?<@4 >1VN@ZE$MU9P>'[RS
MB?Q+8:C"A&]5MQY626R?F782PR<>IKHO%OAS4-<\3ZFEO"PANO#%Q9).>$\Y
MI054G]?I7H)( R3@51T[6M*UCSO[,U*SO?)8++]FG638?0[2<=#0!Y[/=:SK
MP\&VR^&]3M?[-U&"6_>XB"K&5C=/EY^9<D_,..GK6W\4HW7P>FH*I==-O[6^
MD4#)*1RJ6_(9/X5VM,FABN()()HUDBD4HZ,,AE(P01Z4 <9\2 (O#5MXGM&1
MKC1+B/4(6# "2/[LB9]&1C]3BI?#L1\*?#N;4M5PEV\4VIZ@3Q^]?,C#\.%_
MX"*='X.T"X:UTEM0N[J'2-C?V:]YN1!DM%YB#E@,?+N[*.N*W=:T2TU^TBM+
M_P Q[59DE>%6PLNTY"OZKG!QWP* ,?X:Z=-I?PXT&TN%*S+:*[*>J[LM@_3=
M7%2Z9JY\*^+=!_L:_P#M4NN->PR>5F*:)KJ-P5;/)V@DCM@UZ_10!Q7BO0[O
M6/%NEB*)Q;-I>H6TLX'RQM*L87/UP?RK!\(Z!90W6AVTWA#58=2L0#=75S=2
M_9X9$0C?'ERLFX\  <!CG&,5Z9/>6UK)!'<7$43W#^7"KN 9'P3M7/4X!./:
MIZ ./\:VM[#JOAO7[2QGODTJ[D:XM[==TACDB:,LJ_Q$$@X'-<OJ$7B34KWQ
MAJMAI6I67VNQLX[3($<\B)(_FA>?E?:6P,YY7H37K%% 'DUCHKKXFNIM*\-Z
MC8Z??Z)<644ESN+F;(;,FYB4!' )ZD'VJK#H\][X<\&SZEX=UAXM#@>QOK1%
M>*;YHT'F1A6!=0R <'H>AQ7L=% ',^"M/M++3;J6TT2YTE+FX+B.ZF:264 !
M1(X8DJ2!C;GH!]*Y^&75/"DWBC3QH.HW[:C>S7MA-:Q!XY#*H^1VS\FU@<EN
MU>C44 >>>$_#&H:!XET.*>)FAL_#7V26=1E/.\U&*@_@?P%;7@FPN[!?$/VN
MW>'S];NIXMXQOC8KM8>QKJ:K7NHV6FI$]]=P6RRRK#&9I @=VZ*,]2<=* //
MYO#VI_\ "TO)6SD.@37<>LO,!\@G6%HMA]RP1_PJKX5\-ZM;ZAK"7UE+';Z3
M8SZ9I;,.)T>61]R_\ $*_@:]1=UCC:1V"HH)9B<  =Z9;7,%Y:Q7-K-'-!*@
M>.6-@RNIY!!'4&@#SUM%U+_A7?@6R^Q3?:K*\TQ[F+;\T2QE=Y;TQCFLVZ\(
MZOJEY\3H$M7B_M/[*UC)(,),T:$X!],@#\:]9HH X:ZUW6O$>FW]C!X:O[.%
MM,N!</>IL;SBF$CB )W\DY/3IZU#=Z1J#^%O %NMG*9K&]L7N4"\Q*D+!BWI
M@G%=_10!C^*M#C\2>%]1TB1@OVF$JC_W''*-^# '\*X#PMIFH^-_ WB'6;\+
M%J6O6?V* DY54CC* @^C2>8WT(KO?%.GV&H:)(FJZE<6%@AWSRPW7D!DP05=
MO[ISSTJU92Z38RPZ#9S6T4MO;JT=DCC>D(^4';UV]LT <-(^J^)H/"^D-H.H
MV,NGWMO=7\US&%BC\D9*HV?GW, !M[<G%95_!K=MX.\7^%X?#VHSWMW=7LUO
M,D8\B2*5BX(?/WL'&WKG ]QZ]10!@:]#JI\"7T.D;DU7[ RV^TX82;.,'L?3
MWKAM+TL0>+M'U+3?#.KVME]DN+6>:\WM,TKA""X9B0ORD;NY)]J]8J">\MK6
M6"*>XBBDN'\N%7< R-@G"@]3@$X'I0!YE#X6U&;X+Z!I\^G3O>:?)!<S6(8Q
MR2*DA+H#D88J3CD<XKH/!NFZ;%JM[?:?X<U+34\E(1<ZC-)YDW))41NS$*,#
MGC))QTS7:44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJF7[TCN47T48 X&:M7'A6^E\/>$-/66W\W1KFTFN"6.UA%&5;;QR<GC./PH
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M&01L@3 .3@MD\=LUT;>%;X_$JZ\1^;;_ &.71?[/5-Q\SS/,W9(QC;CWS[4
M<_8>+/%A\.>&_$][/IQL]1N+:WGL8[9@P65@GF"3=UR<[<8P<9.,FY<^)/%%
MY!XFUC2I-/2PT6:>WCLYH&9[DPKF1C(&&TYS@8/3GKFK2^#-1'P]\/:!YUM]
MJTV>SDF?<VQA%(K-M.,G@<9 _"N<UB2YT;3_ !S8V.L:.NG2R3W-PTTK+=6S
MRQ@M&(\8;=_"<_Q=#C% '=P:AJ&H?#ZWU.&>*#4)]-2Y\PQ;T5S&&/RY''7O
M7FNG_P!N-X1^&\OVVWNKN:]4VS2PLHB4V\@^?YB9".3_  YZ<=:]-\/64A\
MZ583 Q2G2X87!'*'R@#Q[5S.B>#_ !#;Z9X3LM0_LU1H%WNWP3.WG1")T!P4
M&&RPXZ=>>U $5YXUUGPS%XEM-6N+"\N=.6T:UNO*-O&WVAB@\P;C@*PR2#R*
MT/"?BY[_ ,3S:'+KVDZX#9_:X[K3P%V8<*Z.H=A_$I!R._I1KG@B\UC5/$-T
MMS;Q"^M[+[(S L4FMW:0%QC[I)4<'IFMG0;?7_MLUQJ]MI-G#Y02."Q9I"S9
MRSERJX'3"X/UH Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *R-6\4:/HC,-0NS$(]GFL(G=80YPI=E!" D=6Q6O7F5G?S
MZ'X@^(FK7UR+FWL/)EEA\D#S<6JLH!SQZ4 >FT5P]UXAUC1D\-:C>307-IJ]
MQ#:W$*1;?(>9<HT9SDJ#P0V2<Y&.E4K7Q/XC%MXBU>\N[ Z?H-]=1S016K![
MB..(,H#%SM.2/7J?I0!Z+17(:=?^+'UK3'EL3-I5U"QNW80I]F?;E#'MD+,I
M.1@@D<'/:L2'QAK]]H_AW4[26U2?5]2:RFLI;8R"V +Y. RL601_-DXY)P*
M/2JPM1L_#;>(M/\ M^FV4NK7&\VLTEF'?]V 3\^T[< C&2/:L<:_J^LVOB.\
MT>>"#^Q[J6U@ADBWB>2)07WG.0"25&W&,9YSBH[/QE>ZKJO@R2U$,6GZ[:3S
MRQ/&3(CI&& W9P1EO0=.O- '<T5Y=<^+O%,'AO7-<-UI^S1]7DM6@6U8?:(U
ME5",E_DX8GOSWKHM4U^_/B35=)@N([!;'2Q?12RH&\]B6!)S_ NT XP?FZB@
M#KZ9-,EO!)-*2(XU+L0"< #)X%8_A'4=1UCPKIVIZHD4=U=PK,T<431A P!
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M,1)C *8^8@###(]1UYKD=/O_ !)HGA+Q!KFE7%B;73]8OYI;*: EKA!,Q?\
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M1A<[0[!<DNO7/ /!KL?"]QK\]C<IXALUM[B*Y>.&0%/W\/&QRJLP5CT(SU%
M&Y5._P!3M---J+N1D-U.MM#A&;=(V<#@''0\GBL"[UR^TOQ_;:=?W$*Z/?6<
MDEL_EX831X+HS9Z;,L.!T/I5/4->US3[+PS<-- 1JFJQV\J26^'6&3<RCK@,
M%4 \'DG&* .WHKA+WQ#XEU)=7E\-V1EDTZ\:UAA81>7.R;=X=FD5ESD@8'&
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MUOH?.M+F&XBSC?$X=<^F10!PTUCIWA3P=%X*G-]JSWMO-!:QFV)#@]$+(NU
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M<=TEKI^!=0&VE,DTDC>4>J LQ*K[# H X7^QM.TO0?AM?V=G#%>R7UHLERJ
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M(MTTQ(;"*)-+)-FJ940DJ5) '7(8]<]<]:LP:99VVI7>HPP!;N\6-9Y,G+A
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M%<6+L+:(PQN+F57,9.2C.&#.N>S$BM&/0=+AO;*[BLHXYK& VUL4RHBC.,J
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MLL>)Y,Q,#D>6=W[L9[+@>U6AX,\/K=:G<?V:A?4U9;Q6=S'-NQDE"=H)P.0
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M4ZD8RO\ IU])>,%!PI? /4]?ER?<F@#D+_\ Y. TG_L R_\ HTUR5OHVG0?
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M+!:6LD\@B_OLJ*2J^YQ67K7Q'TK38]!GM!-?6VK3[4EM[>20"/:Q)&U3E@5
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M1]#2-;PO$8FAC:,]4*@@_A4E% ###$V<QH<C:<J.1Z4NQ-P;:NX< XY%.HH
MYO1/#=Y:ZY<Z[K6HQW^IRPBVB,,'DQ00@[BJJ68Y)Y))[#TKI*** (EMH$4J
ML,8!;?@*/O>OU]ZD=%D0HZAE(P01D&EHH C6"%81$L2"(=$"C _"G[5W%MHW
M$8SCFEHH ;Y:;-FQ=O7;CBC8FXMM7<1@G')IU% $;6\+Q>4T,;1]=A4$?E2F
M&,L6,:%CC)VCMTI]% !4;6\#LK-#&S*VY25!(/J/>I** (Y8(IPHEB20*<C>
MH.#ZT_:N[=@;L8SCG%+10 WRTVLNQ<-]X8Z_6D2&*.+RDB18\8V*H _*GT4
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M%A5F)4%<@_PY(QTKT*UF>XM(9I(6A>2-7:)_O(2,E3[CI4M% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7)2_$K
MPQ#=W-J;F]DEMIG@E\G3KB15=3AAN5"#@^AKK:\J\'ZSX@L7\1PZ;X5EU.W_
M +?O3YZWT,0SYG(VL<\4 >EZ=J%OJNGPWUJ9#!,-R&2)HVQG'*L 1^(JU7&6
M>I:E<?$NR@NTFLUDT!YY+$SAT23ST&3M.TD D9'K7):GJFL2:1<I;:O>03OX
MV%E',LI)2(L!L'/W1G[O3VH ]:EO+:&Z@MI9XTGN-WE1EL,^T9; [X%5-(UJ
MUUM+Q[42 6EW+9R>8H'SQMAL<],]*\^U;PO;VGQ(\&62ZEK$B&WO6+R:C*7)
M78WWL]RQ!]0 #P!66-+F/A/QUK<6K:E;75AJFI3VBVMRT2(R,6RR@X?)&#NS
MQP,<Y /9J*\FU#5KO7?$=[;W,7B22*TL;4P#1',:QRRH7:1\.NX\@ '(X/'-
M.C_M[Q!XF\-:5J^H:EIS3Z"\NHP6\QA9Y%D09^4_*2<'(YP2.AH ]7HKRNYL
M;S5=0\>";7-7BBTLH;%+>]>,1/\ 9E;=P>><'!XR2<9--M&U&TM_ /B)]8U&
M>]UF>".]CDN&,#I+ [X$7W5VD#! ![G)H ]6HKR98[_6? ^O>,FUK4[?4X'O
M)K18KITA@2!G"QF('8P(CYW DYJTK7WBOX@VEM-JFH6>GR^';;4)+:TN6B#2
MF1NX/ YYQR=H'2@#T^BO&9=6UO4O[5U:QM?$\^K0:E*EE]F;_0A'%+L$3)O"
ML"%.XE<Y/!XKV8<B@ HK@)+"?Q!\1_$&G76K:E#IUM9VCK;VMV\(WMYGS J0
M1]WH.#QG.!6%HFI:IXAL?!FB7FJ7JQ72WSWEQ#,8YKA;>3RT4R+AAG(+$')Q
M0!ZM=W=O86<MW=SQP6\*EY)9&PJJ.I)J:O$?&J3V_A?QYH#ZA?SVFEK9W5HT
MMR[.HER&C=R<NH() ;/4>@KI[S4)/ ?B+4%EOKVXTV30Y+NW6\N7F(F@8[E!
M<DY82)^5 'H]9\.K)+?:C;26EW;I8A2US/%LAE!7)*-GY@,<^E>6V^H:]9>$
M+CPI=ZK>/KTNI6EHEVTS>:J3JDK,&SD;0)P/3;4M]<7>H:E\6;"?4+TVMG96
M[VT:W+@1'[.SD+@\ D#<!UYSF@#TB7Q%I\=_H]HKM*=7#M:R1 %&"IO))ST*
M].M:M>/6^BAH?AC9Q7]_$MS!++)+]I9I%!M%+*C$DH,# QC )Q@U=:'7+?\
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M.<= 0" ,F@#OIKRVMYK>&:>..6X<I"C-@R,%+$#U.%)_"JFEZU:ZO-J,5L)
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M7H3SC-<KI=E<Z7\)-.\36VK:BE[;72>5$ERRP"-KO84,0.U@0Q))!.3UQ@4
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MUKXBZM/'=2_V5I5NEDL22'RY;A\2.Q X)52B^V30!T+:EMUM-,^Q7AW0>?\
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M)?LG]A"7R-YV;_/(W;>F<<9KC9M0U:[M;:"/6+Z!IO&MQ9-+',=P@Q+\@SV
M' Z @''% 'KM9U_K5KIVJ:7I\PD,VI2/% 54$ HA<[N>.%->::[J.H>"G\8V
MFFZC>RQ1:5;W5M]LN&G:"621XB59R3C@-@\9%7]0T >'_'/@@1:EJ-VC3W/F
MK>73SEG%L_S@L25)YR!@=.* /3:*\:\.ZKK>I0:)KMM:^)Y=1N[N.2[>1LV+
M6[OAE5-^T*JG((4'*\]:Z+P/:W>J^(/$&J7VKZC*MAKEW;6MJ;EO)5./O+_%
M][@'A<#&.: /0Z*X#7=?N/"GBW6Y[BYE>RN-$-[:Q2.2BS0$JRH.@W!XR<=3
M7/07^NV?A.3PC=ZK>/KKZM:V0O#,QF$<RI,S!LYX43#VVT >GZ3K5KK+Z@ML
M) ;"[>SEWJ!EU"DXYY'S"GS:EY.L6VG?8KQ_/C9_M*19ACQV9^Q/85Y='HTE
MUI7Q!U-=5U*UELM2O);5;2Z>)4D2)&W,%(WYX&&R,#CJ:TX-;U*Z^(?@=7O)
MQ#?:(]Q<0*Y$<DA0')4<$@GB@#TRL[2-:M=;2\>U$@%I=RV<GF*!\\9PV.>F
M>E<1X1TS4?$NAZ;XL.OZC;ZG<W!N'C,S/;^2)"/(\G(4#:,9Z@\YK!&ES'PG
MXZUN+5M2MKJPU349[1;6Y:)$9&+990</DC!W9XX&.<@'LU%<SX@@U/6O $K:
M9=36VJ/:I<020.4/F@!PO'9B-I'H:PD\2S>,-2\'Q:9<36\,L!U?4!"Y4A$&
MQ8FQU!E)!'?8: /0Z*\=\W49/A:_Q!_MG4AK6TWRI]K?[.$$G$/DYV;=HQTS
MGG-=EX?O[FY\7^,XY;B9H8'M?(B=R5B#6RL0H[9)R<=Z .PHKQK3;C5M<M?A
MM8R:WJ4*:E87;7LL5RPDF"JC#+9Z]MW4 G&#7;>.KVY\/^"$BT^6[\YYK:Q6
M6,[YPKR*A*D]7VDX)[D&@#KZ*\>O]8UKPYI'B*XTRU\06NGC30\,FLN9&AN3
M($RC,S'!5]V"<93WK:N=(G\-^-/!MM:ZUJLUO=3SK=175X\PF9;=R&^8G'.2
M0.,X..* /1ZHIJ6_6I=-^Q7B^7")?M318@;)QM#]V]J\W.KZD/@--J7]H77V
MX3.!<^<WF ?;"N-V<_=X^G%:,EQ=WOQ<U[2)+^]2Q_L)'6**X= CEP"RX/RM
M[CF@#O[2\MK^U2ZM)XYX).4DC;*MSC@U-7BGA^.Z\/?"/PUXHL;W4"EE*ES?
M6YN7>.2W9BD@"$X  (8#'!!-=WI][<ZW\2+^2"[E_LG2+1+?RXY#Y<UQ+ARQ
M X;:FP<]-U '84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !63H.@P:!%?QP322"\OIKUR^/E:1LD#'85K55&IV#7YL%OK8W
MH&3;B5?, ]=N<T 9&M^%WU/6;36+'5KG2]0MX7MS+ B.)(F()4JX(ZJ"#6?!
M\.["#3XK,7UXZIK*:QYDC!G:52#@G'()&3WYKJ3?V8L_MANX!:_\]_,&SKC[
MV<=>*D>XACDBC>:-7E)$:E@"Y R<#OQS0!AZ_P"%_P"V=6TK5;?4[C3[[33(
M(Y(41PR2 !U(<$<[1SVI@\'V@\/:]H_VF;R=9FN997XW(9\[@O';/&:V;74]
M/OI98[2^MKB2$XD6&57*'W /'XTD.J:?<2>7#?VLC^7YNU)E)V9QNP#]W/?I
M0!@7?@QS=K=:5K=[I<[6L=I<O D;^>B9VDAU.'&3AAZU<MO"MK:Z]I^K)<W+
MRV6GFP197WET+*=S,>2WRCGWJ*;Q9;/XDT33=/EM;RWU'[2'GAF#^68E5L<9
M'.ZMFVU*PO)Y8+6]MIYH3B6.*569/J <C\: ,R+PO;13>(9!/*3K9!F!Q^[_
M '0C^7\!GGO41\(6ATKPW8?:9MF@R0R0-QF0QQF,;N.X;/%;-[J%EIL0EOKR
MWM8R=H>>54!/IDFEEOK.!$>6Z@C612Z,\@ 90,DCU '/TH Y2[^'L<XO[.'6
M[^VT74)FGN].B$>UV8Y<*Y7<BL>H![G&,UM0^'+6W\5-KT3NLIT]+ 0 #8J*
MY<$=\\XJY+K&EP0V\TVI6<<5SCR'>=0LN>FTD_-^%7: .4?P4PO[E[37=1L]
M.NKK[7<6,!0!I"06VR8WH&(R0#W/3-:EA9W\/B76+J>XF>QG2W%M$\@*QLJL
M'*CL#E?J0?:K<.KZ;<.R0ZC:2,L@B94F4D.<X4X/7@\>U.&I6#7*6PO;8SNS
M(L0E7<S+RP SDD=QVH JVFAPVGB/4=:661IK^&&)XSC:HCWX([\[S^58B> +
M6WTG2[6RU*[M;S2YIIK2^0(77S69G4J0593NQC'85TMOJ>GWES+;VM];3SP_
MZV**569/]X Y'XTP:QI;7$-N-2LS-.,Q1B==T@Z?*,Y/0]* .=D^']E=:!K>
MG7]_=W=SK6#>7S[5D8J $V@ *JK@8&/7UI=7\!Q>(--TFVUC5;NZN-/G\TW.
MQ$:=2>8V"@#:1M!P/X16M:>)])O?$5[H<%TC7UFJ&1=Z\EMWRKSDD;#D8XR*
MO6VI6%[-+#:WMM/+"<2I%*K,A]& /'XT 8]SX.L;KQO:>*7FF%S;P^4(!CRW
M(#A7(Z[@)' ^M,C\%6*ZGXGO7GG?_A(8DAN8\@!%6,Q_*<=PQZTOB3Q=::-8
M226DUI=W<5U!!+;B<;HQ)*L9+ <C&[O7122)%&TDCJB*,LS'  ]2: .6TGP3
M_9QT)KC6+J];1#(MJ9(XU_=M$(PAV@9  SGJ2>34UWX/CGOM6OK?4[VSN]0E
MMYA+ P!A>%=JX!!# ]PV0:V[34]/U"%YK*^MKF)#AWAE5U7ZD'BEM]1LKN4Q
M6UY;S2!!(4CE5B%/1L ]#V- '+7/P_BU'1M6M-2U>\NKW4VA:6^VHC)Y1#1A
M550H (].<GFI&\$3R7SW;^(K_?=6Z6^H[(XE^V*A;;G"_(<.5RF./0\UTDVI
MV%O>16<]];174O\ JX'E57?Z*3DTVZU;3K$.;O4+6W"$!S+,J;2>@.3QG!Q0
M!@Z#X(M]"N=+F74+FX.F6DME )54?NG92 < 9(V 9I+OP'8W=EJD'VRZBEO=
M275(YXRH>VG4(%*<8XV#KGJ:Z5+NVDF6%+B)I6C$H17!8H>-V/3WIPN(6N&M
MQ-&9E4,T88;@#T)'7% ',Z?X*^S:Y-K5]K-YJ&H3V+6,DDJHB^66##:J@!<8
M_4YIFD^ ;'2-+\.6$5W<.FA3R30LVW,A<."&X_Z:'IZ"NCFU/3[:\BLY[ZVB
MN9?]7"\JJ[_12<FFW6K:=8AS=ZA:V^PJ'\V94VD] <GC.#CZ4 <YXE\*64]I
MXEOY8+R^;4K.*.2TMRH?]SN*F,G^++9&>X%<SH-M-K'CW0M1BN];U%=.MKC[
M3=ZG9FV$>]0J1*NQ 7R26(!Z#GI7ILM_9VZ*\UW!&KH75GD !4#)(SV (YK#
M\4>*XM%\$:AXCTXV^H);1ATV2@H_S!?O+GUH E\2>&/[?N-,O(=2N-.OM-E:
M6WN(41\;E*L"K@@Y!I;;PM;6UEKUJ+B9AK,TLTS'&4+QJAV\>BYYI\6K7L][
MHP1+%;:]MS+,))R)@=@($:8^89/)R,"M$ZG8+?BP-];"\(R+<RKYA'KMSF@#
MG7\$& :?)I.M7FFW=I81Z>T\:1OY\*?=W*ZD;@<D$=,FNATVP33=,M[%9IYU
MA0)YMQ(7D?W9CU)I7U.PCOUL'OK9;QQE;<RJ)"/9<YK%L_%UJ^LZW8ZA-:V4
M>GW4=O%)+,$\TM$K]\<_-C H S;'X<QV&@P:3%KE_P"78W N-,EV1A[)ANX!
MV_."'8$-G(]*MW7@D:CH%WINIZU?WDMW<Q7$MS(5!!C96540#:J_(. .<DYS
M4NN^*9=(\7>&=%CMDECUE[A7E+$&/RT## [YS6X=2L!?BP-[;"\(W"W,J^81
MZ[<YH J7^A07^OZ3J[RR++I@F$:+C:_F*%.?IBJR>%;9$\1*+B;&N,S3=/W>
M8A'\OX#/-;<LL<$3RS2)'&@W,[L %'J2>E5X-5TZY@CG@O[66&5_+CDCF5E=
M_P"Z"#@GVH YV3P5<1VUM;Z;XDU*PBCLHK&5$6.19$1=H8!U.Q\$Y*^W'%;#
M^'M-D\+_ /"./"6TW[(+/RRW/EA=HY]<=ZT/M,'VG[-YT?VC9YGE;ANVYQNQ
MUQGO4,VJ:?;02SSWUK%#"_ERR/,JJC?W22>#R.#0!@:=X,>#4["\U/7+[51I
MH86,5PL:B(E=NYMJ@NVWC)]3WYJ_H7AJWT&_UF[@GED?5;LW4JOC",1C QV^
MM:?V^S,$,XNX/)F($4GF#;(3T"GOT[5"^MZ3'9Q7CZG9+:RMMCF:X0(YSC ;
M."<@_E0!FWWA?[3XOM/$=MJ=Q:7,5N+6:-$1DGA#[]IW D<YY'-5AX'LAX&C
M\*_:KC[*CJXFXW\3"7TQU&/I5WPWKSZ[_:Y:%(Q8ZE+9*5;.]4"D-^.ZM)M3
MT]+];!KZV%XPR+<RKYA'KMSF@#G]0\&/<ZC?7%CKNH:9!J)5KZWMMF)6"A=R
ML5+1L5 !*GL._-=)-:P7%G):3QB6WDC,;I)\P92,$'/7(J.;4K&WNTM9KVVC
MN9!N2%Y55V'J 3DTDNJZ=#")I;^UCB:/S0[3*%*<?-G/3D<].: .13X=3069
MTJU\6:U!H9&T6*M&2J?W%E*[PN.,9Z=ZTKSP5:[]-GT6[FT:ZTZ VL$ELBN#
M"<9C97!##(!]<\YK<EU33H9X();^UCFN ##&\RAI,_W1GG\*6[U*PL&B6\O;
M:V:4[8Q-*J%SZ#)YH YV+P%8IIUM;M>74L\>JQZM/=2%=]Q.K _-@  < 8 &
M !6O'H4$?BJ?7Q+(9YK-+,Q\;0JNS@^N<L:N76HV-D'-W>6]N$3>WFRJFU<X
MR<G@9XS49UC3 ]LAU&T#70S;KYZYF'^QS\WX4 >?ZIX.-AJ?@O2;&ZO5B@O;
MZ?[9&H+0LZ/(">"N-S8P1@CCO6V?A]#-9:C]KU>\GU2^G@N&U$JBO&\)!BVJ
M!M 4CICG)]:ZBZU*QL9(H[R]MK=YCMC6:54+GT&3S2W6I6-B'-W>V]N$4.QE
ME5-JDX!.3P,\9H Y.?X=K=R:A-=Z[?SW&I6#V-[(RQCS%.=I "X3;DX X/?)
MR3N7?AVWN[G0YWFE4Z/(9(@,?.?+:/YOP;/%)JWBO1]%MK"XNKR(Q7TZ00,D
MBD,6.-V<XVC.2>PJ\VJZ<EQ#;OJ%JL\X#0QF90T@/0J,Y/X4 <+I&FV_B;XH
MR>+;>SNX-/M+184>YA>'[3<?,/,". <(C%=Q'\7'2NUUS1K;7]'GTV[,BQR[
M2)(FVO&RL&5E/8A@"/I6C68U[=CQ*EB!8_8C:F4DS_Z1OW8XCQ]S'\6>O% &
M4O@TWEAJ5KKNLWVK"_M_LS^9LB6-.>51 %#9.=Q!/ [<5SUUX:U#3O&O@R>Z
MU;4-7\BXGC$DT:*L$?V=QSL49).W+-R<#\>\76-,>XAMTU*S:>9=T48G4M(/
M51G)'TJ#Q#X@T_PSI$FI:E+L@0JH (W.20 %!(R>?RS0!R\_PRBGTVZT@Z]J
M*Z-+.UQ%8JL86)S)YGWMNYE#9(4G'UQ6_%X6M8O&5WXE\^5KBYLELWA.-@4-
MG([YJNWB^TC\5/ILD]HFGKIBWWVUIP%R93'C/3''7-;C:A9)8_;FN[=;/;N^
MT&0"/'KNSC% '$3:5:^!O!%SH,\NJ:W:7,<EM96*6F]P&!_=[D7C.[[SGBMO
MP#X<D\+>#;'3KAM][M,UVY;<6F?ELGOCIGT KH+>Y@N[=+BVFCFA<962)PRL
M/8C@U%)J5A#>QV4M[;)=R#*0-*H=A[+G)H S9/#%M)XWB\4F>47,=@;$1<;"
MI??N]<Y-4E\#V2^"+7PM]JN/LUN\;K-QO.R42C/&.HQ]*Z6&XAN-_DS1R>6Y
MC?8P.UAU!QT(]*KS:OIMO:FZFU"TBMP_EF5YE5 W]W).,^U '.ZIX$6^OM1E
MM-;O].MM5Q_:-K;A"LY"[2064E"5 !*GFGWO@G=>S7&D:S?:.MS!';W4=LJ,
M)%0;5(+J2CA?EW#L!Z5TCWUI$B/)=0(DBET9I  R@9)'J .?I69JGBO1M*\.
MW.NR7T,]C I.^WD5]Y ^ZO."WMF@!;3PY;V?B ZO'/.TOV".PV2-N^1&9@Q)
MY+'=R2:Q[GX?6TNCQ65OJ5U;30:J^K07**C-',S,V,$8*_.1@UUEM=07MLEQ
M;31S0N,J\;!E/;J*AAU73KF\DLX+^UENH_OPI,K.OU4'(H RK#PK#9>*[CQ$
MU[//>7%E'9R!PH5@F#OP ,$D?2H=*\$:?I/B[4?$4,TS37F[$#D>7"7VF0KQ
MG+% 36='X[>_^(,WAS34TUK:T6(W%S/>;6D+_P ,2@'<P[Y(Y]*ZZ]U&RTV(
M2WUY;VL;':'GE5 3Z9)H YU_!3+?W+VFNZC9Z==77VNXL8"@#2$@MMDQO0,1
MD@'N>F:@^)MB^I>%(;1(YI/,U&S#B$'<%\Y-Q&.1@9.>U=BCK(BNC!E89# Y
M!%<:?&VHZE>7<?AGPU+JUK:2M!+>27:6\;R+]Y8]P)?!XSP,]Z +^F^$WM=;
M?5]1UB[U2\%N;6!ITC00QD@M@(H!8D#+>U9MC\.(-*\/Z+INF:O>6UQH\LLE
MM>;$=L2EMZLI&T@AO3L*U] \6V6MV-U-*DFG7%C+Y%[;79"M;OQ@$YP0<@A@
M<&MMIXDFCA>5%EDR40L S8ZX'?% ''Q_#JUC6ZC.JWTD5S?6^HR+)L8F>,J2
MV<9^?8,CH.P%= ^APOXJAU\RR>?%9/9B/C:59U<GUSE15J'4["YO);."^MI;
MJ+_60I*K.GU4'(KE]*\8WNKV_BKR;6SAFT:^DM(3<3E(Y-N,,[8^6@#0UKPL
M^HZY;ZU8:O=:7?Q6[6KR0)&XDB+!MI5U(R",@U3LOA_86-K9V\=Y=NMKJ[:L
MK2,&9I"&!5CCD?,3GK5?Q5X[?P]#HEK#'I\VJZI(D>V2\V0P@KDNS8)V9Z''
M/Z5U>F7JW]A%,)[663:!,;67S(UDP-P#=QSW .,<4 9&I^#=.UB_U6YO7E=-
M2T]+":($ !%9F#*<9W9?]!5*S\"R)K&DZIJ7B'4-2N-*+_9O.6-5"LA0@A5&
M2002QY^4>^=B[U67^T-.CL)=.EMYI7CN&DN<.-HZ1@ [FSU'&*M3:QI=NZ)/
MJ5G$[R&)5>=5+..JC)Y(STH P=/\%-IMU EOKNHKI%M.;B#35**B,23M+@;R
M@))"DXZ Y'%:FA:!!H']I^1-))_:%_+?/OQ\K28RHQVXJ]=:A96)B%Y>6]N9
M6VQB:54WGT&3R:FBFBG4M#*DBABI*," 0<$<=P: ,#Q5X.L?%CZ:UY--$;&X
M$P\HC]XN06C;/\)VKGZ43^#K&?QS;^*FFF%S#!Y0@&/+9@' <]]P61A]#5"7
MQIJ%[J=[:>&O#LNKQ6,I@N+I[I+>(2CJB%@2Q'?@ 'O4;^/MVC0W::9-;W8U
M6#3+NSNOE:%W=5)!&0PPP((X- &M#X4M8=,U^Q%Q,4UJ:>:9CC,9E0(0OT X
MS4$'@JS@US0M56ZG,NCV)LHD.-KJ5"Y;CKQVK<L]2L=0,@LKVVN?*.V3R95?
M8?0X/!I+75-/OGE2TOK6X>$XE6*97*'_ &L'C\: .8B^'L,,\<":S?C1([O[
M8FE ((Q)OWXW[=^S=\VW.*OCP?:#P]KNC_:9O)UB:YEE?C<AGSN"\=L\9K63
M6-,DN8K:/4;1[B5=\<2SJ6=?4#.2/>GRZG86]VMK-?6T=RREUA>50Y4=2 3G
M'% $,]S:^'M#$MPTS6UI$B$QPM*Y PH^5 2>W05R?PV\._V<NL:W)9S6;:M=
MO);VTXP\%ON9D4K_  Y9W;;VW#TKL;C5=.L[>*XN;^U@@EQY<DLRJKYY&"3@
MU:!# $$$'D$4 <6?AS 8&TS^V+X>'FN//.D[8]F=^_9OV[_+W<[<^V:N7W@P
MW&O7NI6FLWUC'J*1I?VT*H5G"#:"&92R';P2I!QZ'FM/2-3FN+.274I-.C?[
M2T,9MKGS$(SA020/G/\ =JY9ZE8Z@9!97MM<F([9/)E5]A]#@\&@# TSP-9:
M7)X;>*ZN'_L&":"#=C]X)  2W'48[5L:YHUMK^CSZ;=F18Y=I$D3;7C96#*R
MGL0P!'TK/\1^*ET2[L]-M+"?4]7O=QM[.%@ORK]YW9N$49')[]*KZ7XLOI-=
MAT;7= GTJZN49[5UG6XAEVC++O4#:P'."* %7P:;RPU*UUW6;[5A?V_V9_,V
M1+&G/*H@"ALG.X@G@=N*Y^Y\-:CIWC7P9<76K:AJ_D3SQB2:-%6"/[.XYV*,
MDG;EFY.!^/>C5=..H&P%_:F]'_+OYR^9_P!\YS3;G5],LMWVO4;2#:XC/FSJ
MN&(R!R>N#G% '(3_  RBGTVZT@Z]J*Z-+.UQ%8JL86)S)YGWMNYE#9(4G'UQ
M6_%X6M8O&5WXE\^5KBZLULWA.-@4-G([YJ34/%&DZ9K6GZ3=7<:75\KM$"Z@
M * <MD\9S@>IJ^-2L#<I;"]MC.[LBQ"5=S,HRP SDD#J.U '&C3;3P%X,GT>
MYFU/6K&9'M[2Q2T\Q]K!OW68U[Y/S/Q6E\._#4OA7P78Z?=$M?,/.NV+;B96
MZ@GO@87_ (#6_#JNG7%[)90W]K)=1YWP),I=?JH.16+X?\42ZUXI\2Z.]LD2
M:/+#&DBL29-ZELD=L8H Z6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *\5F830^']:L]*TO3[&]\20M!*97DO92UP0Y9B/X
MANRN3@<=J]JKFF\ >%F-SG2(O](;>_SO\K;P^4Y^3Y@#\N.10!Y]+8)>7-Q\
M-I"5ADUV6X*#H+,Q_:1^'F,JTNG:TFJI!J>J1R30^%_#DWVQ(V*L;EBT3@$<
M@[8'Y[;Z]470=+37?[;6SC&I>1]F^T<[O+SG;Z=>_6H[7PWHUDNI+;Z?"BZF
M[27JXR)V;.[<#ZY/'3DT >>:-9SZ9X[\*1/IVCZ:)=.N52WT]V9_*"QD"5B!
MNP0,'UW5A:=IEE9?L[I?Q6\:7-X(X[RZ"CS&A:Z564MUV[!C'3 KU2S\#>&]
M/>V>UTQ4DMI!+#)YKLZD# &XMG;CC:3CVJ_;^'])MM!_L.*QB&E^6T7V9AN0
MJV21S]30!Q&NZ7HVG?$WPJMG';V#/97PE, 6,+&(UVL<<#&6P?KZ4SPI8#PY
MK6@:9J&D:7(S6TD.FZUIK[3.JH&/FIZLJ[LY89],UUFF^"/#FDW$5Q9Z7&D\
M(94D=WD8*PVE<L22,<8Z#G%/TGP;X?T.]^V:=IJ0SA2B-O=A&IZA Q(0'T4"
M@##\3J-1\:6EA:Z1IMY?V^GO<-/J<C&&&)W"X6, @L2O7C '7G%</I%I;:QI
MWPQM+Q(I[5KS4%*#F-D3S=JX/5,*!@]N*]:U?PMHNO74%SJ=@EQ- I1&+,N5
M)R5;!&Y>/NG(]J;:^$]"LKF"XMM/CCE@N);F(AFQ')(,.5&<#()XZ<T <+>:
M3>7WC_7[*TTC0;JVMK"U@BAU%F188&5R1&JHP +;LGC[HK:F34-*^"=R@OHK
MJ]MM%D"75K(75]L9VLK<$\8YKH-9\)Z'X@GCGU.P6>:-#&) [(Q0G)4E2-R^
MQR*T&M5BTUK2TB@C18?+BC9,QJ,8 *C'R]./2@#R_5-(T'3[?X;2Z=;VT,[W
M]LL;0J%,T9B8L6Q][G:<GNWO5KP?::79+XZ\17EHLMQ::S?GS@N9(XE7)5&Z
MKG<W3&<TS2/!%^VJZ+YOAK3M&CT^Z%W<W-M=F43LJL%2%3RB%FW$'&,#K7HE
MIH^GV,5Y%;VD:1WLSSW*\D2N_P!XD'UQTZ4 >7Z+;2V'BSP(PTS2-+@N8;CR
M(+.1GF,1MRV)7(&_G:2>?FK-ATC3X/@3!JB6D(U%;R.9;HH/-5A>A00W487C
MZ5Z;:> _#-CY!MM*1&MYEFB?S'+(R@A0&+9"@,?E^[R>*O?\(WH_]A#1/L*?
MV:"&%ODXR'W]<Y^]S0!YU?6Z6GB/XI7EC;1)?6^F02V\J1@.CM;REF4]02>3
MCK3])T/5K.7P]J-M;^&[".WL91#]AG<S7D;0$A<%!O\ FV.>3T)[UZ#)X9T>
M7Q -=>Q3^TA'Y9G#,-RX(PR@X;@D<@U#I/@[P_H=Z;S3M-C@GVE%;<S"-2<E
M4!)" ^BXH \NGTS1D^#?A2_2" 7LMW8O]H"CS))6F4R MU;^(D'^[[5W'Q+
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M_P"$F%V/[)\C[1YVT_=^G7.>,=<US^MJJ>*_AZJJ%"S7  '8?9'XKDC:2?\
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MT?<O5(1'/I^[<G_MG0!UY\?:"UA9WEO)=W:WID%M%:VDDLDJQG:[A%&=H/\
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MS_9EB$#F8SYQY7E8W;\@\8]^E9V@>*I-<\>ZG90RS"QM]/@D^S3VYBDBF9Y
MVX, P. O!XQ@CKFN.?\ L[37T7Q&FKW.I:2/$,DU[?W$2I'O: Q"0;%"^7N"
MC<!C/>NB\-:K8:S\6->N]-E2>V.EVJK/'RDI#R996Z,!]W([J?2@#T&BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *, ]J*X
MC3_B#+>G5KI]%>#1](ENHKV^:X!PT.>$3&6R #VQN YYH [9E5U*L RG@@C(
M- 50H4* !T '2N.M_&]W;RQ#7M#;38KFTENK5DN1,6$:[V1P%&U]O.,D<'GB
MDMO%NO7&E27S>&%CCDL3>6DBWPD1P #MD(7Y&PV1C<#@C- '9X&<]Z3 YX'-
M>:Z5\0-7LO WAK4-5TEKR]U66.VA\FX7=.S1EE<C: N6&,=!G.:TI-81O'OA
MBUU71#!K%U:7#J\=\SI;A0<K@ *^1W(XH [C SG'-&!C&!CTKC+7QQ?WKQWU
MIX<GGT"2[-JM]%-NE.',9E\D+GR]P/.<XYQ69I'CG5H9O%U[K=@JZ=I=T8XQ
M#.'=&"1A8E7:-VXMG<3U;'2@#T78F_?M7?C&['./2CRTRIV+E?N\=/I7)Q^-
M+BPFNH?$FD#2WAL)-0C,5R+A9(H\;QG:N'7<O'(.>#7.ZOXAUG4[SP6]]HK:
M9#=ZO%-"R78EW)Y4GRR *-K$$''S#@\\4 >GX &,#%(D:1IL1%5?11@5D^)-
M=.@:?#-':_:KBYN8[6WA,@C#2.<#<QSM'7G!^E<GXK\7>)].\-+-'H8L;\:C
M!:N3=*Z%6="#&Q3Y@P)0D@%>?2@#T3 XXZ55L[""RDNY(MV^ZG,\K,<Y;:J_
MD%51^%<Y<>*]6;51H^FZ#'=:G#:I<WR/?".*WWDA4#["68[6_A P,U"OQ 6[
MTK3'T[2I9]6U"XEMDT^641^5)%GS=[X("KMZ@'.1@<T =G35CC4 *B@ YP!W
M]:\V\2ZW?ZC:^'1>:;<:7>0>*;2WFB+ED<<G*/@!T(([=001Q77:-XD&O:I>
MQV%H7TNU/E?VB9,+-,#\RQKCYE7H6SC/ SUH W-HQC QZ4M8\VNB+Q?:Z!]G
M):XLI;OSM_"['1=N,=]^<Y[5AWOQ!6SMKR8:5+,;;6UT<1QRC=(S!2'&1ZL!
MM_6@#LV4,I5@"#P0>]"HJ($50% P !@5R-OXJNY[[5-&UO1!97,.GF]18KOS
M5FAR5/S!5*L",=._6N5B\7:A;^%/ \GAC1Q!9ZE>>7Y$U[N;'[P^4792<'&=
MW;&.] 'K.,# JGJD-_/I\L6F7D5I=MC9-+!YRKSS\NY<\9[USH\7ZI/J=W#9
M>'6NK.QN4M;N6.['FJY52Q2/;\RKO'.1G!P*ZZ@#(\-Z!%X<TG[&D\ES-)*\
M]S<R !IYG.6<@=,GMV  K5\M/,\S8N\C&['./K7(ZWJ5C;_$GPU8RZ<\U_<0
M736]R+ED6(*F6!0<-GID]*Y3P2VJZQ\4?$-_JFF;I;.Y6$.=29ELAY1^1$P%
M<'N>,9S0!ZR8T+ARBEEX#$<BEP!V%8^N:KJ=A-:6VDZ*VHW%QO)9YO)AB50.
M7?:V"<@ 8YY]*PI/B"1I.CW46C3R76HWTFGM:"90T,Z;P1NQ@C='C/'!S[4
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M;1##&FYY#P<@<#'&<]:R=-\<W5Y+I=S=:&UKH^KR^58WAN0SL2"T9DCVC8'
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MC9>(1<1BVU:SE @FB!7YICN (VY!5E)XP,UZ3#!#;Q^7!$D2;F;:BA1DDDG
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MJ** /,KW3KJ?Q5'=:;X:U'2]<&HH9[^WE M+BV$@W-)A@'W1YX*[@Q]LU/\
MV#JG_"N?&NG_ &*3[7?7>I/;1<9D61F*$?7(KT:B@#RG5M O;W5+ZWU#P]=Z
MHTUA!#I3LX^S6K",B3?\PVD/R3@DC %.TC1=8D\1?#B\DTJZ@BTO2YK6\,H
M\IQ"$&<'H2./;%>J44 <1\/M(U#2M1\7R7UJ\"7FN37%N6Q^\C.,,/:DU;2-
M1G^+^A:M#:NUC;Z=/%)/_"CMT!KN** /%;70=22'0KR7PKJ,FM:=J,=QJM_,
MP=Y\,0WE9?Y@<[NP &*MZ??ZK_PC_C71[+0KR]EO]6U&&UF@V>4&=BI\PE@5
MP3G.,$=.<UZ_5#2M'M-&2Z2T5P+JZENY-S9S)(<MCVSVH \ZU_0'ALX+!?#6
MI2ZM8Z?%;:9K.ES!&+K&!B1MR[0''1MPP<]>*BO_  P;37M5NM8\+7FO3ZC'
M#+!-9R[4\T1+&\;_ #KL&Y=P;!&&/IBO6:* ,;3'FL)['18M':VLH=/5A-'+
MNBB92%$(SR<#D'T%;-%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>;D#:_J.U $NO:2NO:'>:5)<2017<30RO$ 6V,""!D$#@UDP^$KJ+2;?2O\
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M'.$:XF6,,?0;B,T <Q+\-["XTO7;*XU+4)FULPM=W$C(7+1XP1\N!G'3&!T
M%=GT%<GXX\;VWA'P_'?PFVNKFXD2.UA>X"*^X@;\\_* <DBMS1+N>^T>WN;F
M6QEF<'<]A*9(3@D?*Q STY]\T 9.J>#Q>^(WU^SUB^T[4FM4M \ C9?+#,V"
MKJ0<EOPP,8YS57X?6MK8Z9'IVJW]G>V$DTBWR[))96FYE+AE*G<<'IQ@8KJX
M+JWNE9K>>*94<HQC<,%8=0<=QZ55FUO2;:R%[/JEE%:%B@G>X18RP."-Q.,Y
M!X]J .<@^'R6 N#IVOZM:R277VQ'#HY68ILD8[E.\/P2&R 1D8J;_A!+;^S1
M'_:=]_:0O3J U,%!-YY786QMV;=GR[=N,?G71KJ%D\$$ZWEN8;A@L,@E7;(3
MT"G/)..U.DO;2&22.6YA1XHO.D5I "D?/SD=EX//3B@"EHFCOI$$XFU*[U"Y
MN)?-EGN6&2<  *J@*J@ < 5J56M=1L;V66*TO+>>2(*9%BE5B@897(!XR.1Z
MU9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ KRW2K6/PS>Z-]KLM*U32IKV3^SM9LGQ<*\@D;]X!P^1N!(;!X)%>I5A6?
M@WP[I^J_VG::5!%=AF97&<(S?>*KG:I.3D@#J: /-;0L6\#ZG;Z=I.FV5[JH
MEM(X7>2[*2)(6+R'KD-\PYY(&:;9W-M;P?$A;JQ6^2XUV.V6V>4QK(\CJBAF
M'(7)&?;(KT:/P#X6B618]%MU#R"3C=\K!MPV\_(,\X7 JV_A;0Y;?4K=]-@:
M+4Y/-O%(.)G_ +Q]^!R* /-;Z*ZM-4\;VMTFEPRGPHS2Q:8C+&"/-V[@>K8/
M7T(J]<^&X;3X2Z/J^C6<2:KID%MJRNB /.Z(&D#'JVY6<?C7:Q>"?#<*A8])
MA7]S);DY;+QR##ACG+9]\U)K"ZGIVAQ6?AO3+:XD"""))Y_+C@4+@,>"6 P.
M!R: .<\,SVWC#QAJGBA")=,MK5-.LF;[K;@))F_-D7_@)KM--MK&STZ"WTV.
M&.RC7$208V >V.,5F>%O#-OX8\(V>@Q%9$AB*R/MP)';)<X]"2>/2K/AS1D\
M/>'K'28W#K:Q!-P7:">I(&3@9)XR: .<OOWGQIT=9O\ 5Q:+<O!G_GH98PV/
M?;6-9?\ )5OB'_V#+;_T4:ZOQ5HEY>7FDZWI(1M4TJ8LD;MM6>%QMEC)[$C!
M![%16K'HFFIJ%YJ"V2+=WT:QW,G\4BJ, 'GL.* /,="2*3]E^59L;!I-TPS_
M '@TA7]0*]-T"267PYI<D^?.:TB:3/7<4&?UK U[PG]KT/3_  II5K%::$TH
M-Z5;&V%6WF-!UR[<$]AFNO "J%4  #  [4 >,^.7-YH?C;4[/3M)M[>WG^SS
MW=TSO<RSQJ@!C[)@E0HSU&<<U[+&<QJ<YR!6)<^#/#EYJ-S?W.D6\MS<J5F9
M@2'RNPDKG&=O&<9QWK7M+2"PLX;2V3RX(4"1IDG"CH,GF@#R"YTG3[CP/\3[
MV>TAEN1J-]ME= 638BLN">F"2>.YK<?3;+3?%GPZ>TMHX7DBN4D=% :0?9MQ
MW'JQW#//?FNX.@Z6;'4+(V4?V;4'>2[CYQ*SC#$_4 5*^E6,EQ8W#VR&6PW"
MU;O%N7:<?5>* /(DD,T/A+5[73M)TZPOM>CDM0C/)>/O=]Q=S_>!.1SC(&:9
M=VT=MX0^(\EI!;Q2?V[Y#/MV[8&, =21R$VELX[9KTG_ (0'PL!.!HMN//?>
M^-W!W;_EY^3Y@#\N.:MCPIH0U.]U'^S(#=7T9BNF()$RD $,OW3D =J .&N]
M%U*SN-6O+H>'[('P_<PM:::[!I5 !1RI4<+R,_[>*P_$VEV.G_LS++:VT4<U
MS86,D\JH \K%XSECU/).,]*]1T[P?X?TF&ZBL=,BB6ZC\F;EF+QX(V9))"\G
M@<59NO#VDWN@+H5S8Q2:6L:1BV;.T*F-H_#:/RH XCQ#MU'7M82VTS2&;3]*
MC6]O=4+N!&X=@B(.   Q+<9R!SBL*TD>75?@P\C%V-C/EB<D_P"C)7I][X6T
M/4=4AU.\TV&:\A5521L]%.5!&<-@\C(.*;:^$M!LGT][;3(8VTYI&L\$_N3)
MP^WGC/I0!KR_ZI_]TUXCINFP6?[.]K=VEM;K=7@A2[N)!@O$URJL'<<[-O!]
M%%>XD @@]#5"VT33+311HT-E"NFB,Q?9BNY-ASE<'J.30!YEK^EZUI=IXCU%
MCH5E,?#TT1M-*=P[@$;92I4<*-X!]ZMZOIVB65U\-VT^"VBD-[&(3$H!>+R&
M)/'7G;S[^]=SI/A70]#2X73M-AA%PH24G+EU'126).WD\=.:K6'@7PQID\4U
MGH]O%)#*)8F!8F-@"!MR>!\QX''/2@#S^YGBA^!_C'S)%7%[J$9R>C&X8 ?7
MD?G6]IECIVJ^//%::U;V]P(;*SCA%RH8);M&Q?;GH"^[)'H*Z&Y\">%[N]NK
MR?1K:2:[W>>3G#EAAFVYQN(S\P&>>M3ZQX0T#7Y8I=4TN&YDB3RT<Y!V?W20
M1E?8Y% '%:59:(_Q0T Z8D5Q8+X<9K65QO+!9HPC;FY) '!/.*Y>$_\ %(^,
MXY"5LY?&QCO#G \AIX@^3Z'H?8U[#>>%]$O[G3[BXTV%IM/P+1E!3R@,8 VX
MXX''3BI(?#NCP6FH6L>G0?9]1E>:[B9=RS._WBP/K0!QWB"SM-.^(>A+IEO#
M;O-IE^EVL"!=T*JA3<!V#]/J:YVTTJPL_A7X$O8+6)+O^T-.D,X0>82TBAOF
MZ]#CZ8':O3-)\)Z%H;3-IVG10O.GER.2SL4_N[F)(7V'%6/[ TK^S+/3?L4?
MV.S:-[>'G$;1G*$?0@4 :5>"Z?!'=?#O4[>4$QR^-51@#C(,\8->]5D1>%]$
MAM'M(].A6![L7K(,X,X8-OZ]<@'\* .=BL;33OC%;)96L-LDN@2[TA0(&VSQ
M[<@>F3^=;/C;0G\1^$K^P@.V[V":T<<%)T.Y"#V^8 ?0FM8Z=:-JB:F8%-ZD
M)@6;N(R0Q7Z9 /X5'JUQJ%KI[RZ98)?78("0/.(@?<L0>GTH \YTS69?'NLV
MNLVJ'&B:.THC ^[J$RD%<=RBJ?\ ONLZ6RTV#X'^']1L88?[4\RRF@N%4>:U
MTTR;_FZEB2X/XUZ%X*\-OX:T26.Y,+:A>W,E[>M N$,TAR0O^R!@#Z5+!X*\
M-VNK#4X=(MTNQ(958 [5<]65<[0WN!F@#EM/GBM]/^)C32*@2]G9BQQ@&UCP
M:QM$TRSU3Q+X!BOK>.XA3PJ)/*E4,C$"(#(/!QG//< ]J]#O?!OAW4=6?5+O
M28);QP \C9^? P"PS@D=B1D8%7+?0M+M+BTN(+...6SMOLENPSF.'CY![?*/
MRH O[%"; HV8QMQQCTKQW2DTZU\%:Y$VD6UW)>>)Y;&*%V\I&8W(\L.R\[ <
M''.<8QS7LE<_+X(\-32:@\FD0$ZBVZZY8"1LAMV,X#9 .1@Y% 'FNJI<6R_$
MBUN5TV.4:#"TL6G(5C#8FQD'^+;CGTQ6QJ&C:99VOP^L?L<"6%S>QM=908GE
M%N[(9#_$2_/.<FNS7P1X:2-D72( K6[6KXSEXF)+*QS\V22<G)Y-1^+-%FU#
MPY'86.F:=?1Q21DV=Z2JO&O9''W'Z8;G]: /-O%D-MI^M?$!-'$<)_L>T^T)
M%\JIND;S.!TRAR<>I/>MX^'[Z+5&N;R+PW:0_P!C7,)M-/9BUQ'\I5MK* 0A
M P>V_P!ZUO"7A.6TU+5=0O\ 2;+3[>[MH[.+3H9/. B4NS&1L ,S,Y]>.I-;
M^D>$]!T&2633--A@>5/+=N6.S^Z"Q.%_V1Q0!E_#""&'X;: T,4:&2RC=RB@
M;FVCDXZFJ?B3_3O&T5E::9I<U[:Z8T\MUJC,T44+R%=JQC@DE#EN, 8[UTVB
M>'M)\.6TEMI%DEI#(^]D0DC/MD\?05'JOA?1-<NX+K4M.AN9X 51WS]W.=IP
M?F7/8Y% 'EOABUMM57X91W<<=Q L6I%4890A&&S@]0,# /3 ]*/$=I!!I'Q$
ML((Q#:_VOII$<7R!2YMRQ&.A)YXKU.S\,:+I]S%<6FGQ12Q22RQLN?D:7'F$
M#.!G XI]QX=TBZ%Z)[&)Q?21RW.<_O7CV["?IM7\J .-UO3;/3/B!I2:=9PV
MHET2_B=8(P@95\HJ"!UP3Q629XA\*?AVID7=)?Z6J#/4AUR/PP?RKU&73K.;
M48-0D@5KNW1XXI3U16QN ^NT?E6-;> O"UG/YUOHMM'()5F4C.$<,'!49POS
M ' P.!0!YSXJD-QHFOZM9Z=I-G:+K*QFXF9WO)9XYD0NAZ)RO"]E!Z9KI=(_
MY+SXC_[!-O\ S%=+/X(\-75W>74^CVTDUX&\\L"0Q888XS@,1U88/O5ZST'2
M["_:_M;-([MH$MVER2QC3[JDD]L4 <W\6]O_  J_6M[%5VQ98=0/-3FLOQ#8
MVFD^,O"3>'K6W@N'M;Z,"V0#S(A!N7..H#[,9[GWKO\ 4-.M-5L9+*_@2>VD
MQOC?HV""/U JAI?A30M%OY+[3M-AM[F1/+,BY)5<YVKD_*N>PP* /,I++3H?
M@9H>I64,/]J[[.:&X51YK7;3)O\ FZEB2X/XUL66CZ=?7OQ'GN[.&XD-RT8:
M5 VU?LR'C/3D]O0>@KL(/!7ANVU8:I#I%NEV)#,K ':LAZN%SM#>X&:THM)L
M(3?&.V13?,7N<?\ +5MH7)_X" /PH \X\#RL_B;PH\KDN_@R/ECRQ\R+-5=-
MT_\ MR"_DT^\TTWD'BN]N+6WO_FANR$*LN!R<!BP(!QC.*] O?!OA[4;2PM;
MK2X7BL$\NU +*8DP!M!!!Q@#CVI9?!OAV;3FT]M)MQ:F?[0(T!7;)C&Y2""I
MQQQCB@"IX'N8)M,OX4TF+2[FVOY(KNVADWQ";"L60\?*0RGH.2>,UG7UO!??
M&.S@U"*.:"+0WEM(YE#*)3,!(R@\;MNP?0UU>EZ38:+8K9:;:QVUNI+;$[D\
MDDGDD^IYJ'6?#VD^($A75+)+CR6+1.25>,G@[64@C/?!YH \AU"WLO*N=/98
MUT1/',$21](U#(/,0=@NXL".G)K6\9VEM8>(O%$.GP1012^#+E[F.%0JE@Q$
M;$#O@N/H*ZKQ%X-M[G2-#TG2M.MDT^TU2&XGM\ (8ANWY!^\3NY]<U+J7@K3
M[7PCXAL- T^*&\U*REAW%R3(QC94!9B3@9^@H Y>ZT_3+'3/AO=:3! ET]_;
M*LT2@/+$\+F4DCELCDD]ZS8[+3IO@9KNI7T,)U4O>33W#*/-6Z69]GS=0P(0
M#\*]"T'P9HND-9WZ:7!'J<< 1I02=C%0'*C.%).<D 9J:;P5X;N-6.J2Z1;O
M=F03,Q!VM(.CE<[2WN1F@#DM%TRWU/XKZG<:K:13W,&D6+;9D#!)#ORP!X##
M!&>HR?6N;N+2UM_AS\098K>&-D\0RIN5 "J">$[<]@.N*]DCTRRAU.?4H[=%
MO)XUCEF'5E7.T'Z9/YUG_P#"(>'_ +9J-V=*@,VHHT=X2"5F!QG*YQS@<XSQ
M0!B:_-&WQ3\)0AU,BV=^Y4'D K& ?QP?R-<19:586WP1\.:A%:Q+>B]LYA<[
M!YF\W*KG=U^Z<?3BO4=,\'>']&FAGL-+BAFAW".3+,P#  C)))& !CMVJR/#
MVDC1H-(%C%_9\#(T4'.U2K!EQ]& - 'G0BCF^(WQ-25%=#I=ME6&1Q 2*@BL
MX](^&/@KQ;90(DVC107%SY2 &2WD14GSCJ=N&R?[E>H1:+IL.I7NHI9Q"[O4
M5+F7&3*JC"@]N!Q7,ZMX9FTOP[/H'@_1K.&#4EDCN)9IR([8, I;8<E^"<*,
M#@>M $'ABWL_$5_XG\2WRQ36%^YT^W\S!C:TARK')XVNYD/T KM[6*"&TABM
M51;=$58EC^Z% X ]L5DQ^&K2W\%_\(S;A!:BR-FID7<""FW+ $9SG)Y&:T=-
ML4TS2K.PC8LEK D*L>I"J #^E ')6'S_ !IUAI?OQZ+;K!G^X9'+8_X$!7-V
MG_(S_&'_ *]+?_TFDKM=:T2\'BK2O$>E*CW$*&SO(6;;YULYSP3QN1@& [Y(
MK470-*2XU.=;*,2ZHH2];G,X"E0&_ D?C0!Y!_S(_P (O^PK:_UKNM?_ '?Q
M:\'-%Q)):WZ38[QA4(S[;L5T/_",:+]DTVU_L^+R-,D66S3G$+KT(Y[5GZ=H
MEY/XUO\ Q%J:JGEP_8=.A5MVR'.YY&_VG;''8*/6@"UXSOK73?!FKW5[;-<V
MR6KB2!9"AD##;MW#E<YQGM7':':W>F?%+3;2ZM]'M)#HDP,&F*P 021;0Y/W
ML?-@X'>O1[NTM[^SFM+N%)K>9#')&XRKJ1@@BLBQ\&>'=-EM9;32XHI;5V>&
M0%BZE@ <L3D\ #!ST'I0!E?%?_DEOB'_ *]O_9A6'XET<6%]X+T[1[#31"\\
MLC17@*PRS+!\C.5!+/C>03G)%>B:CIUIJVGS6%_ L]K.NV2)^C#T-1:IHNFZ
MU8"QU&TCN+8,&5&_A8="".01ZCF@#QWQOI=WIGPX\3K<RZ6/.U:VE^RZ=(S)
M;.3'N!! *EL!L?[6>]=M86=IJ/Q6\3#4[>&XD@LK-+19T#;86#E]H/8OU^@K
MH/\ A$/#_P#8;:+_ &7 =.:3S6@.<,^<[F.<DY Y)[4_6?"NB>()8IM4T^.>
M6)2BR996"GJNY2"5]CQ0!Y;X:CANK_P?I]RB3:(NHZN+..0;HWV,1#P>#A3)
MM^G'2NCUB'P_;/#HVAZ=9WEW=ZYDV\TKK;6]RL1D9F4<<*N=@&"2#UKLKSPS
MHFH:/#I-SIEN]A!M,, 7:(BO0KC!4CU%5V\&>'6T6/1SI, L8Y?.2-<@B3^_
MN!W;N3SG- 'DNN0_\4AX_@N4T\M!JUDVVS3$,<A\@.5!Z'J#[YKK]9@BMOC;
MX/A@B2*);"["HBA5''8"NJ_X0KPWY%U -'MA#=0+;SQ@$+(B_=!'J,#GK[U/
M:>%]%L9[&>WL(TEL(WBM7+,6C5L[@"3WR>M 'ER6>GR_ ?5M3NX8?[6+74\U
MRRCSENQ.VWYNH8,% ]L5TF@:5:ZG\1?%$VJV4-Q.ME8(5FC#!2T;;\ \<X'Y
M5TTO@KPW-JQU232+=KLRB8L0=K2#HY3.TM[D9K4ATZTM[^ZOH8%2ZN@@GD'5
MP@(7/T!- ',?"LD_#/1023MC=!D] )& 'X  56M;2UU#XN:ZNIP13O!IEJ+)
M)D# 1,TGF%0?]H*"?I78:=IUII-A%8V$"P6T6=D:=%R23^I-4M9\+Z+X@>*3
M5+".>2(%4DRR.JGJ-RD'!].E 'CFKVUN_P ,PJPQ/:6_BMX+!BH(%O\ :#A5
M/]WJ/3BO=H+>&UA6&WACAB7[J1J%4?0"L^;PYHUQI5OI<FG0&PMF1X;=5VHA
M4Y4@#T-:E 'E.N:I-X$U[Q-:6H/_ !/K<7FEH.]ZQ6%U'J2S1O\ G5G2/#ME
MI7C_ $/0+J*.>VT_PZ3:K*H*M.9@)G /\1&"?9C6Y>:'J7B'QKI]]JEC;6VE
MZ+))+:XE\R2YE(VJQ&!L4#G&2<X]*WM9\/:3X@2%=4LDN/)8M$Y)5XR>#M92
M",]\'F@#RK;';7C6]J%338/'<*P*O"(3&-ZKV WD\#N36QXKECD\7>,$1U9H
M_!S*X!^Z=TQP?P(/XUW#^%="DT :$VEV_P#9@Y%N%PH.<YXYSGG/7-,M/"'A
M^QBGBMM+AC6>W:UFZDR1$DE6).3G)Y/- %3P!I=CIO@G1GM+:**6XL8))Y%0
M!Y7* EF/4G)/7UKIJBM;:&RM(;6WC$<$*+'&@Z*H& /R%2T %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R$GQ+\.1AY#)
M>&WAG:WN+E;.0PV[ARF)' PO(_(@]"*Z^O$8?$&DP_##Q3H<DBC5;N\U"&WM
M,?O+EY)75"B]6Y(&1TVF@#TV_P#&NCZ?K9T9S=3:@!&WD6]N\K;7SAOE'W1@
MY/0<>HJA:>*M.L?^$GO+O6KBZM]-N@DZ/;!1:9P-BD#+CGJ<UF^&;5[;XHZJ
MDX!GAT.QB9_?+YY^HKC;Y2?#OQ:!4G.I+QCKRM 'J>F^,](U36%TR'[7%/+&
MTMNUQ:O$ERBXRT;, & R#QV.>E16GCW0KW4X;.*2Y"SS-;V]V]LZV\\HSE$E
M(VL>#WYQQFLWQ7"\OCSPA%"=CM#J"*P_A)A4"LKP9XHT6U\,^&O#4]NUQK<#
M1VLNGB(-+;2)D-*X/W5&"V[WXS0!N6'B[2["P\0ZC>ZY/=6EAJC6TS2VX06K
M%E41C &Y06'S'/7K6CI?C/2-6U)]/C^UV]P(3<1K>6KP>=$#@NF\#<.1^=>2
MW&%\!_$@M$TB_P#"5Y,8&2X^T0\ =\UUNLZ_:Z]XTT>\\-R1ZG+I.GW]Q<+$
M"0I:-5CC?T9F'W3SQTH ZK2/'&C:UJ$-G:F[4W*,]I+/:O''=*OWC&S !L#G
MZ<UG?#C6]1URV\1OJ5R9VM-=NK2 E579$FW:O &<9/)YKB]+UFUN/$7@?4)?
M$T^I9E=;K*11VUI+);N$B 5!M8ME0I)/'/45TGPC!%GXMR,?\5->?^R4 =5K
MGBK2_#]U:6M\\YN;Q7-M## TKRE-N54*"2?F''U]#7+^+_'(D^&.NZSX>NIK
M:^L&6)UF@V2V\GF("K(XX.&].].\9:E9:3\2?!U[J#B*V2"_#3,/EBRL0W,>
MPYQGMFN-\63Q:KX0^)NM6#>;IMY+91V\Z?=F:/RU=E/<9.,C@XH ]-O?&.GZ
M/%9P7:WES>2VHN7BL[5YF2/H9&"CY5SG^E37_C'1[&RT^Y62>\_M%/,LXK.!
MYI)TP&+*JC. ""2<8S7'ZKK+)X@33KS7+C1X$TJW>TCM(H_/OY&+ JK.C$[<
M*-J]VS6+X.U:QT23PCJ^IW*0Z<-#ETQ[AS\EO=+(C%'/\!(!'..E 'HS>.-#
M_L>UU*&:>X6[E:""WAMW>=Y%SN3R\;@5P<Y QBM/1]9LM=L/MEB[E [1NDD9
M1XW4X9&4X*L#V->;:YJ5IJ6I>'?$5K=W>@:-Y]]"VHK!&H9WV;93O5@$DV-A
MF /(Z9KK? 4%B-/U&]L-4O-3CO+UI7N[F-$$KA50LFU5!7Y1R!R0: -+6O%&
MGZ)=06<RW5S>SJTD=K9V[32E!U8JHX4$@9-<MXY^(B:?\.+C7?#SS23R?NH9
M?LK,L#AU5A*"/D89( ;&3ZU-J.HV?ASXJ2:EK5Q':6-[I"06]W.=L8D25F:/
M<> 2&!YZXKB_$B/-\&/&^HI&ZVFI:R;JTW*5WQ&:%0X!YPQ5B/8YH ]6\)S3
MSZ!$]S=ZA=2ECNEU"T%M*?\ @ 5<#TX_$U7U'QQHNEZC-9W#W)^SLBW5Q';.
M\-L6QM$D@&%SD'VR,XKH8_\ 5)]!7C5]':6MYXNTG6_%.HZ:;V^E==-MX87:
M\BF50IB#1LSDCY/E/!7M0!Z'J?CG1]+U"[T^07MQ>6B))-!:VCS,J,,[_E'W
M0!R?<>M0V_Q#\/7=U81V\US)!?NL5O>"UD%N\C#(C\PC&[MCL<@\@BL[PU;+
M;_$/Q=%\S^79:=&'?[Q CD'-<O8)M^#O@$!<8U6P. ._G\T =Q>_$30+*:^B
M8WTIT^5HKQK>SDD6WP 2SE1@+SU]CZ&J6I>(KS_A9WA73K*]!TK4;*XGD154
MK+A,HV[&??@USMCXFT71%^(-MJ=Q'!/-J=P8DD&#<YA0!$_O-GL.1N'K4&E6
M-SIWC?X86=VC)<0:',DJL.481#*GZ=/PH [B?X@Z!;7<T3O=FW@G^S37RVDA
MMHI<XVM*!M&"0">@/4UL6.MV.HZGJ.G6\C?:M.=$N(V4J5WKN4C/4$=Q7DZ:
MK8V7PCU/P;<N#XDS<V8T['[Z6625RCJO5E(8-NZ>]:_C*:^\#ZE8>(;.)YYK
M[3SI$ZH,[KD*6MV/K\VY<^A% '52?$'P_&(SY\[>;<S6D/EV[L998OO*@ RW
M/ QU/2JQ^)GA\6D\X34F>U9ENX%L)3+:A1DM*N/D7!SD]><9P<8PT&/P]KWP
MUTA</]E^V!WZ[I/L[%F_%B3^-2VB#^T_B>=HRQ09QU_T-?\ $T =-J/C#2=/
M6SVFYO9+R'[1!%8V[SNT7'[S"CA>1R?6H[KQSH-K;Z9-]IDF75(WDLA!"\C3
M;=N5"@9W?,.,9Z^AKS;3R--G\-W]]XDN?#]G<^%[.&*[18MCNF6:,M(C '#J
M0.,\]<5LZ/8VEIXB\ +937=Q;-%JD\<MY&$D/F;&)*@  '<<<#@B@#:UOXEV
M%CX/O=;L;:[FFM;@6LEM+:R(\,I(XD7&5&".>A) ZFNQL+Q-0LHKJ.*>)9!D
M)<1-$XY[JP!'XUY!XO1O['^)Q5&(6_L)#M&<*$@+'\ "?PKU[3]1L]6L(K[3
M[F.YM903'+$V5;!P<'Z@T <-9^/XM.U;Q/!JSWMRECJ!5!;6;2BVMQ%&=SE%
MX7)?D\\'TKK+'Q)I>I:H^G6MQYEP+6.\7Y3MDA?[KJ>A%<!8>)M%T#4_'R:K
M<1V[RW[M&)!C[1^X0;$_O,#_  CGYAZU4E@NO!'@[P7XKN()!+I5FMGJ40'S
M&WE48!_W)-G'N: /4-/UJRU2]U&UM)&DDT^807!V$*)"H;:#W(!&<=,U2U?Q
M=I>BZFFFW'VJ6^D@\^*WMK=Y7D7=@[0H.3W^@S4'@32)](\)VPO1_P 3&\9K
MV]/<S2G>P/TR%_X#5"10?C5;L5SCP])@XZ?Z0E #A\3O#36D5VLMXUJS!)IQ
M9R>7:L6V[9FQA#GC!YZ'H03I:OXPTS1]0.GO'>W=VL0FEALK5YVBC/1GV@[0
M<''<XKSF^C ^#/CL!,$ZI?G@=?\ 2/\ ZU=%!K6F^%/B#XIEUZ[CL8]02UN+
M2:<[5F1(MC*I[L&!^7K\W2@#?O?'GAZQL=,O'O&E@U-&:S:&)G,NT9V@ 9W<
M@ =<\=:;>^.](L!$)HM1,C6RW<T<=E([VT3=&E 'R=#P>>#QQ7G_ (?L9H+W
MX;"ZMWB\V]U2YCAD7!C1UD=,CL<$&K^M20Z3X\\1RZIXJN]!@O8;>6W$<<++
M=(L>QE4R1ME@P/RCGYAQS0!ZG!/%=6\5Q!(LD,J!XW4Y#*1D$>V*\^U#XA37
M-OXVM+*TO+6XT>SE:WN6M' #K"7RQ8;0=WW0?O#GD5U_A>Q@TWPKI5E;-<F"
M&UC2/[4NV4+M& P[''45YKJ=_:VUW\6--GG2.]N;-IH(&X:5!9\LH[@8H [/
M0?'6F:C)I>GRM=B[O( 89Y;5TAN75,N(W("MW/'!QQ5F'QUHD^K)IZ-=8DN&
MM([HVKBWDF7(,:RXVEL@CW((K!U5 L?PW"K@+>Q  #H/LLE<=<:^M[9:-J&H
M:_.;J#7()K_3(XXX[?38UN,$R )N7''+-R3GIG !Z/>_$70+%[U7-]*+"5HK
MQX+.21;;;U9R!@+[^Q]*ZF*6.>%)8G#QNH964Y!!Y!%>:V**?!OQ,8*/GOM1
MYQU_<+7;^%O^10T7/_/A!_Z+6@#FM.^)UA/?ZO%>V=]:VUE>I:).]G(%^;RU
M^=B,*V]^GI@UTL_B32[?Q-:^'I9R-2N83/%%M."@SWZ _*W'L:\[MK:UUA_B
M1X5>9$U2\O)+BWMV.'(\J,I(!Z;@.:S;75'U71I?B1-&ZM::A9'&T[A!'&(Y
MP/\ @4\__?- 'I=SXUT6U2[)EGD>VO!8F.&!G>2<J&\M% RQP<G'3FFGQSH2
M:*=5FN)8+9+I;.830LCPRD@;74C*]0>>QSTKSK^S[BR\/^#]=O=0N-*6YO+F
M^O[Z)$8V[W2,R,V]64#!"$D<9[5/>VVGS:*]_9:O>:RMYXDTX37=Q&BI*R/&
MN8]BJK+C"D@<E30!W,7CS29EU!1!J4=Q96_VEK::QECEDBS@.B$989_+O57P
MK\0++7['1!=P7%G?ZI&S11R6[I&[(@9@C,,,,'@]\''2JFM1O)\3I%1"S-X7
MN5  Y)\Y,"N;T]H=6^"FC7VCS1SZKX;2&[$:'YDDB&9(F'7E-PQ[B@#U$:U9
M-X@;0UD9KY+873J%.U8RVT9;H"2#QUXKF?BGXLO/"/@NZO-.247S[4AF%N9(
MXB74$L<;5X8XW=3ZU6\(6UUXATO6_$]K=RZ?=:[< VEQY2N\5M%\D7R-D<@,
MW_ ZR_BCI^I6'P;UF'4M7EU6=IX&69X$B*KYT?RX0 =B<]>: -C3M9,6H^&+
M.[\0ZN;F\:Y"V][IJPM>;%R=XV*4"]1C&?>NCLO$^E7_ (:D\00W!&G1)(\C
MNA4H(R0^5/((VGBN3\8 GXO?#PXX!O\ _P!$BN?UNUN+?Q'J?@"%'%KXBU"&
M^C90<);MEKH9[<Q=/^FE '>7/C_1+:*WDQ?3"6U6]806<DA@@;D/(%!V X/7
MG@\5TEO/%=6T5Q;R+)#*@>-U.0RD9!'L17E>L&#1?'7B!M1\477AZVN[>VDM
MA%%"4N42/8RKOC;+*0?E'/S#BO0?"UC!IGA72K*V:Y-O#:QK']J7;*%VC 8=
MB!QB@#7KA=,U[Q!K>EZYX@TF);J(R-;:/8L51) C;&F=C@G+;CC(^5<#DUV\
MJLT3JIPQ4@'T->;>#O$5MX6^!=GJMQ$S#3X'CDA'!,HE9-I],N1SVSF@#6LM
M1\1Z-XQTO1M:U&TU2'4[>>0/#:^0UN\04G^(Y0[L9/.:S_!^I^*/$=EIFI3>
M*M*C%R!.^GKIX,GE[NF[S<\@==O&:3P9K?A^]U22[GU^UU?Q3?Q%62 D+%&H
M+>1"#C"C!.2<L1D^W,:@_@BY\.6-GX1TR*R\4+>0_9+582M[;2B0;_-/+!0H
M;)8D8_"@#T2PU:^L?'=YX>U&<SPW4'V[3I64 JH(62$X SM)!!ZX;DG%;FLZ
MO9Z#I-QJFH2&.TMP&D8*6(!('0>YKEM=_?\ Q<\(11<R6UI?338[1LL:+GVW
M?RJ7XKC=\+]=&,YA7C_@:T 3?\+%T'[6UH1J"SM'YEM&;&7==KG&81MS)U'3
MMSTR:K:UXSTNZ\"7VLVVL7FDPV\X@FN!:;IK>0.H*-$X//(!R.AS2ZU&O_"U
M/"!V#Y;*_P <=.(A_C7GWC-3_P *U^(X //B-2!C_KWH ]!O]<U&'XO:1HL=
MR1IT^F2SR0[5^9PQ .<9_6M&T\<:)>ZG%90O<XFE:""Z>V=;>>1<[D20C:Q^
M5N_.#C-<WK"._P =-$5"5)T2X ;T.XUSGA.WL9M/\-:)?^*=4;4K*ZBW:(D,
M.8)H6R=V(]XC^4_,3R#U.: /1[;QOHUWJJ6$9NQYLS6\-T]K(MO+*N=R+*1M
M)^5N_.#C-;.I:A;Z5IEUJ-VQ6VM86FE8#)"J"2<#KP*\TTS5[73?$5C:>&]<
MEN(;K47CN?#UW$&EM-S,9)%.-\84Y.#D'/'45VGCS_DGOB3_ +!ES_Z+:@"+
M3_'FAZEJ5K90M=H;P'[)/-:R1PW) R1&Y&&.,_7MFG6/CG1-1U*>RM9+AVMV
ME6XE^SN(H#&2&WOC:OW3C)YQ7&/K.FZ_:^ ='TF59-0M;VVN+BV4?/:QQ0L'
MWC^'J%YZYXS3]$TVXU#X:^/+.QC)N[K4=45%7J[$D ?CP* .MT[Q[HFIWEK;
MQ?;8A>Y^QSW%G)%%=8&?W;L #P,CU'2K]EXGTJ_\-2>((;@C3HTD>1W0J4$9
M(?*GD$;3Q7!W>NZ7XGLO!6E:+.L]_!J-I<SVT8^>TCA4F3S!_!C[N#C)/%9^
MMVMQ;^(]3\ 0HXM?$6H0W\;*#A+=LM=#/0<Q8Q_TTH [JV\0VFH>+],B@U:Z
M07FE_;(M.:V 5T+<2EB-RMVVY_"L/Q3\1[4^'YY-#GNXYOM<,$%Z;1O(F/GH
MLBH[+M8[=_Y''2H]3@)^.FGQ0 1_\4Y*B8& O[P@5RLVO:9_PIO2_#F\?VS:
M3VL-S9[3YENT=PFYG'\(XZG@[AZT >HZGXXT72-0FL[E[IOLVW[5/%;/)%:[
MN5\UP,+D$'V!R<"I-4\8Z5I6J#3I1=SW"Q">86EJ\P@C)(#N5!VC@^_%><Z@
MMI9:EXOTW6O%.H:6+V\>1-/@AA<WL,L:*/+W1LSDX*84\;>U;.EZIIG@SQSX
M@@UF[-LMW:V+63W ^:X2.(QLJX'S.&'W1S\W H Z7X>ZM=:[X(L=2O;C[1/,
M\^9< ;@)G5>@Q]T"JQ\;J_CJ\\-)8W@$%HL@G%M(0)"6ZG& F%&&/!.1VJ+X
M3 CX::4#$8CNN/W9&"O[^3C\*H2W]KI_QCU.&\G2"2^T:!+42''G,'DR%]2/
M2@!?!OQ%L[OP[X?75IKR2\O4CA>]-HP@:X;HGF!0FXGC [\=:W[SQUHECJDM
MC,UT1#,D$]TEJ[6\$C8VH\@&U3\R_3(SBN%A0+\$/!X5<8N].. ._GKFL[QC
MK#ZAI7BJ"ZUNZBO;>]D2/1;6*,#R(V4^=)\A<@J-^[<!T ]* /0[+QJEYX_O
M_#(L+Q5MHHR)_LTFW>=Y.YL8"85=K'[Q)Q6[K&LV>A6!O+UI!'O6-$BC:1Y'
M8X55502Q)["N+TC5]/C^+^L![R$?VIIUD]@=W%RH$A)0_P 7![5N^.1I1T&,
MZQ<W5G;K=1LE[;<-:R Y60G!"@'@D@CGF@"2#QMHT]O'(6N87>]CL#!/;O'+
M',_*JRD9 ((.>F#6C-KNGV^KRZ9-/Y=Q%9_;9-PPJP[BI8MTZ@UY9?:Y<W6C
M1W5WJ<>K:7H_B*QE_MB*$(LD/!<MM^4["P!9>*E\074?B_Q'XD30)/M8E\*/
M!#+%RDS^:Q*H>C=0,CC)([&@#M;7QWI.J[[>S:\AGEMI)[-[FT>%;E5&2T98
M ,!D'Z'/2LKPA\0[*\T+P]'J<MV][?111->M:,L$EPR\IY@4)NSD8'&>.HQ3
MK+QEX?UJTL-/TZ/[9>"QD9O+C!.GA8L$29Y0D_+CJ3[5AJ@7X1> @JXQ?:6<
M =_,7- 'K!(523T S7+:?\1/#NI6-Q?P3W L+>W\^6[>V=8E''R[L8+\CY1D
M\UU$G^J?_=->.Z?933?LYZ4+82IY+0W,OD(&<(ET'=@I!!( +8(.<=#0!W%S
MXQMK[P]KK:?]KL]2L;"2X$-Y;-#(HV,4<*XY7*^_(P:JZ!XSCM_ /AW4=:GG
MN=1U*!=D<$!DEN),9.U$'8<G@ 5SP&EZC;^(]1L_%-]X@N(= N(&E:.+R8U<
M%@NZ-%&_*]#R 35+P_<0Z-8?#?6]2<0Z7%I<UK)<2<);R.$*EC_"&"D9- 'H
MUMXRT2XT:^U5KE[>"P8I=I<Q-') P .UD(SDY&..<C&:AL_'6B745\TSW5@U
ME!]JGCO[9X'$//[P*PRR\8X[\5Y[JX?6D\8^(=,C>[TDWNF2*T2DBY6W8&9D
M_O #N.NPUT/B#QWIE[I.KW'AM(M0N;6P#OJ*0"6*%6D4%6/4D#+[>GR<T ;L
M/CS2I[6^E6WU))K.W%TUM-92)*\1. Z*1EESW'3OBL6'QQ'J_@_P_J]Q>7NB
M27E];PL$LRPG=U)\M=XYC;^^/3K6#:7MI-XWE%OX@N]:2[\/W5O;W4_E[)I@
MR,T<11%#$+R0,X_ UDW>HV>H?"KX>Q6EPDTEIK.G07"H<F*0*V58=C0!ZKJW
MC32M(U"6QD2]NKB",2W"V=I)/]G0]&<J#MR 3CK@9Q27GC?0K-=//VF2X.I0
M-/9+;0M*TZC;D*%!)/S#CZGL:YRQUW2_"/C'Q<OB"[CLFO)XKNVDFX^T1>2J
MX3^\592-HYYK'\&:=<V&J?#^"]MVAF73-1D\MQAHP\D;*".Q"L!B@#TG0?$%
MAXCLY;FQ,H\F9H)HIXFCDBD7&596Y!Y'YUJ5QW@L8\1>-.,#^UP?_($5=C0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M+X:T >'M-DM#.+@M=3W(?R]N/-D9\8R>F[&>^*VJ\VM/&.G:+I?C35K7170Z
M=JYAN5%TSFY<NJF09!V?>SM''% 'I-&!Z5R5KXNOXO$4.EZYHR::EU;2W-K,
MMV)<K'MWK( HVL P/!8>]1:1XRU75)--O&\,S)HNIOMMKJ.?S944@E'EC"_(
MC ==QQD9ZT =E2;5#%L#<>"<<UPEA\19[NPU/5IM#:#1]--Q'<7)N0S-)&Q
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M<'@!CT]: -[3/#WV/7]3UNZN?M5]>;8D;9M$$"_=C49/<DD]R>@Q6W7#W'Q
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M"2::18XHU+N[G 51R23V%,M+N"^M(;NUD$L$R!XY%Z,IZ$>U '&Z-HVHV_Q
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M7TYD::R6X=8LMAD\V,'#=,C.: *_@#3Y[7PRM]>ILU#59GU&Z4]5>4Y"_P#
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M!>-_"^LWGB25-(MW:P\16T5GJDJ,!Y CD!,ASUS$SIQZ"M+XC1)+H^B>'[5
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M4:1(C!23C/WL9QR*O:9?WFI_&.*XN=-GT^+_ (1^410W)7S2/M$>68*2%!/
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M#\*] HH X;PSH6HV_@WQ%I]Q;&&YO+V_:%7(^99&;8?H<BN:ETC7-3\$>!+
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MIO@LQ^%_$.B:A.CQZO=WDV^+.428DCK_ !#- &%X8\<2W7B;2M-D\2Z=K?\
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M&5W0[$(Z]2&9AGIQ0!RGC?Q-?Z-J%YY7B73-.%O:">VLC!Y\MRX#$^8.J(<
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M-''M;J.F>GM0!S&F>+]<\4VWABQL9X-/O-1T^2^O;H0^9Y:HP3$:DXRSGOG
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M$# L%XSSCC-5I_"OB2R77-/T2\TU=,UB>6<R7(?SK5I1B3:%^5^<D9(P3WH
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MT4QR88D*!( ..@; Q73>$9[G6=?\1:Z]Q*UBUS]@L8BYV!(?E=P.GS2;N?\
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MD4-O<[054C)_B- '9UFZ'K=MK]@]Y:I*D:7$MN1* #NC<HQX)XRIQ7*SV?\
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MGBN7PXMY%]OCA64KYJX))8;!SDN-N2,< BGZ-JTDVBR7VJ7>E 1R.'FLKC?
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M\.1O':Y9?W@9 AW_ "\\#MBFGP':[_$*+J=^EEKJR_:;0&/8DDBA6D0E=P;
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M%U";3R_-\_S!Y>S&=V[IC'.:K-KVCI>06C:M8K<W"AH83<('D!Z%5SD@]L4
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M//#M,L2N"T>[D;AU&>V:FH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1VU%HF4F^O9+QPJ[0&8*,=3_ '02>Y)Z4R]\,:)J6K0ZI>:9;S7L( 29UR<
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MTJY=/"5JT:ZH'9?F)$A0 'GB,'VQZUZS;Z/I]JEVL%I'&MV<W  _UAVA.?\
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MG5X-)MDOR[/YH7HS?>8#H&/<@9.:OZEIEEK&GRV&HVT=S:R@!XI!D'!R/Q!
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MQ8MUL[:&W63P]<!UB0(&VS1[<@>F37G^B6D-]\'OAS:7"!X)O$*I(AZ.IDN
M5/L1P?8U[F^FV<FHKJ#VZ-=K"T"RD?,(V()7Z$@?E5.#PSHMKI]C80:; EK8
M3BXM8@.(I 2=P]\LWYT <IJ&FV$'Q?\ #D,5E;1QC2[HJBQ* "'0C QVYKF[
MPS:7!K/PTMV,<FHZ@BZ=C^&RN"SRX'H@28?B*]2U3P[I&MW%I<:E817$UFQ>
MWD8'=&3C."/H./:L+2]#U/4/&C>)]=L[6T>VMC:6-O#+YK*&;+R,^!R>@ Z
MGUH ZNVMXK2UAMH$$<,*".-!T50, ?E7 _#_ %2ST;X=7NKZG*8ECO[V:]D"
M,Y5O/8$D $],5Z'7+Z1X?N-(U_6H5BBGT'56-V4<@F*=N)5*G[R/PWL<C'-
M&#JL,^G>/_#FJW&J_P!KV^H74L%G;2*!]C#QLWF1;,!@%&TE@3ANO-9$%Q%!
M^SG=VDA'VB*VGL'B_B^T>8R;,?WBQ''O7?Z3X*\-:%?&]TS1K6VN=I42*N2@
M/4+G[H^F*<_@[P[)K@UI]'M3J(<2>>4YWCHV.F[_ &L9H YWQ'$]MXO^'BYS
M=I//$2.Z?9SO_#@5:^*9'_"#R)(<6LEY:I='H/),Z!L^V.#[5?CT2\OO';:[
MJ(1+:P@-MIL(;<<O@RRMZ$X"@>@/K6]>6=MJ%G-9WD$<]M,I22*1=RL#V(H
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M:1=^(KA"MUKUTU]AARL)^6%?PC"G_@1KL:9##';P1PQ($BC4(BKT4 8 %/H
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M[9:O"L\0(!="PY R/0\UYOK&JW&I>#_$FGQ:T?$.E0?86@U Q*&W-<+NA9E
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M/V^5@[0V[R$(J,<)MZOD+QZ9-2ZEX\TC3+V[MFBU"X^Q &]EM;1Y8[7(S\[
M<'') R0.M9'Q O;?2O$W@O5+Z006-O?3":=@=L>Z!@N3VR:R['Q!IGA=/&&G
M:S+Y5Y=ZA<7EK"R$M>12HNSR^/G/&W Z8YH ].M[B&[MHKBWD66&5 \;J<AE
M(R"/8BN=U;QWHVCW]Q:SK>RBT"F\GM[5Y(K4,,CS& PO'/? Y-3^!]/NM*\"
MZ'87JE+F"RB21#U1MH^7\.GX5R-GXBTWP??>+[#7%<W=UJ,EY:VWE%FOHY(T
M"K&,8<Y4J1V[T =7J?C72].OC9)%?7]PD*SRKI]LT_E1M]UF*\#."0.IQTIM
MUXZT*V@TN99Y;E=5B>6R%M"TC3!=N0% SN^8<?7.,&N;T_7-.\)^,O$LNON-
M,341:W5H9EX=%A"-&I&065E(VCGD8K*\)Z?<V6H_#Q+NV>&0Q:M.(I%P8ED=
M74$=CM8<?A0!V\7CO1I='GU#%XA@N19R6CVSBX$YQB/R\9).01CC'XUEZ[\2
MK73]!^W6=A?27(OHK.6VFM'5X69DR'7J"4;*]F.,5AWR:6-5\9-K,MY:6O\
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M0 4444 '6BBB@ HHHH **** "BBB@ ZT444 %'6BB@ ZT444 %%%% !1110
M4444 %%%% !1110 =**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]7HH HZA=WEK+8K:Z>UVL]P(IV60)Y$9!)D.?O $ 8'K5ZBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA4$I\V,?,.I%<?H4\EKXC\*7ME;:\D&J32)-?ZE=AA?HT+NK&$2'9RJL/E7
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M;_WTAWQDOA !UP=W - 'JTU_:V]Y;6DLRI<76X0QGJ^T9;'T%6*\>72+J_\
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M(+>*,@1[77:<C&> .,$5MUCWVN-%K2:-86R7.H&W-TZ22^6D<>[:"6PQR6R
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M*9).T=QTXK:.=IV@$XX!.*X<?$*<6>N7K>'YWM-$NI+:\:&X5G&P LZJ0,J
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MUJ_F0$K_ *MMI7(]/E8C\: .)2&./Q_8>%+O=+I=OHAGACE8D7$WF!79O[S
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M1Z=9Q75W=);1K/=A1<2 <RA1A<^N <4^RLK;3K*&SLX$@MH5"1Q(,*JCH *
M.7^'>LZ?<_#S2BDT<)L+1+:[C=@IMY(U"N'!^[RI//:L;6;_ $OQ?XA\"74"
M&XT^74+O898R%D\N&3# 'JN5!![UU&H^!?"NKZB;^_T"PN+HG+2O",N?]K^]
M^.:U7TRQ>6SE:TAWV63;$*!Y.5VG;Z?*2/I0!YAJTEIIVN>.[<Z=!<Q74NE0
MK:R,8XFEE)4,Y7HN=I/KC'>L_7A=PW7CRWO9=-:X'AE3*NG0M$@(,N P+'+
M$<^A'%>L7>@:3?+?+=:?;S"_5$NMZ ^<$^[N^G;TJHG@OPU'$L2:+9A%A>#
MC',;_>4^H/.<T <O?:=9Z=K7PY^R6T4)6:2+<B@$J;5R03WR0"?>N.O8-+;]
MG=KF[2'^T6N&9Y"!YINC<D-SUW8W _[.>U>V2Z;932VDDEM&SV;%K=B.8CM*
MY7TX)%><:IX#U35;J_M9-$\/P_;KG=-K4!*S&#>&(\K;_K"!M+;L'K0!7O+#
M4M3\0^/(BVA+ QCBG?4D<O';_9U*D$' 09<_[P-=/XABE@^#>I0S7274L>A2
M*]PARLI$!!<'T/7\:VM5\*:!K=Y'=ZGI-I=W$8"K)+&"=H.0#ZC/8Y%:5U:6
M][9S6=S"DMM-&8Y(F&592,$$>F* /*]+L[>]?X2QW,22QKI4KA'&1N%O$02.
M^#S]0*Z;PA%';>-?'%O BQPK>VSB-!A0S6T98X]SS731:-IL!L#%90H=/C,5
MIA?]2A 4A?08 'X5-!86EM=75U!;QQSW3*T\BC!D*J%!/K@ "@#B_!5S#IWB
M_P 7Z)=NL>H3:F=0A5S@S021H%*_W@"I!QTJ#XB^(K._\&^*=+TVX>6YLK>+
M[8T()6-'<!UW#C=L#$CT-=;K?AC0_$:1KK&EVM[Y?W&EC!9/H>HJ?3]$TO2=
M-.G6&GVUM9$$-!'$ C9X.1WSWS0!R&O6]A:^,? ATF*".4SS(GD* #:^0Q;I
MU7.SVSBN1CTZSA^ 'VQ+:(71O!-YVT;]XO0H.>N0 !]*]3TCPGH&@W+W&EZ3
M:VDSKL,D:8(7.=H/8>PXJQ_8.E?V/_9/V"#^S\Y^S;?DSNW]/][GZT </:P0
M#Q]\16\J,.+"T93M&1F&7)'U[U@IIUE9_ [PTPMXX[6ZFL#J4FT O"TJE]YZ
ME>@Y[<=*]2N?#6BW>L+J]QIMO)J"QF(7!3Y]A!!&>_!(_&K*:3I\>DC2ELH/
M[/$7DBV* Q[,8V[3QB@#DM2AM[;XL^&QI\<<<KZ=>"[$2@9A'E^7NQVWYQ^-
M5/@A_P DLT__ *[7'_HUJZ[1_#.B>'S*VDZ9;VC2@"1HU^9@.@)ZX'ITJWIF
MEV.C6*66FVL5K:H25BB7"@DY/'U- 'G>EV__  C][HJR1:3K&AW.I.-.U& [
M;F&60R-ENHD'+*2"#W(K"&G6<7P"O;Q+:(737DDQFVC?O6](!SUR  *]2M?"
M/AZRU=M6MM'M(K]F9O.6, AF^\1V!/<CKFK/]@Z4=(;2?L$']GL23;[?D)+;
MSQ_O<_6@#S+QK,][IWCVYM;71[6VMH_LMW/=H\EQ<2+"I79\P"8WJ%Z\\XJ_
M YD^-VA.S%F;PODL>Y,E=O<^%- O-5?4[G2+2:]D38\SQ@EAMV\^ORDC/7'%
M2V?AW1]/N;>YM-.@BGMK?[-#(J_,D6<[ ?3/- ''?!S_ )%G5_\ L-W?\Q69
M;Z98S^%/B=<S6L4DS7M^I=T!("P@J >V"2?J:]+T[2[#289(=/M(K:.25IG6
M-<!G;JQ]S2+I&GI;7MNMG$(;YG>Y0+Q*SC#%O7(X- ' >$DCO/'$)U%4EF7P
MS9-9^:,_(=WFD9[[MN3]*YQ(;=M-T=(XXVT]/'CQV?R@H("TGRK_ +.[=[5Z
MOJ7A70=7MK:WO]*MIXK5=D 9.8UQC"D<@8 X]J?=^&M$OM&CT>YTNU?3HMOE
MVWE@(F.FT#I^% '/?%M0OPHU]5  %NH ';YUK.TZRMKSXE:&US"DOD^%U>,.
MN0K>:HSCUP2/Q-=U<:1IUWI']DW%G%)I_EK%]G9<IL&,#'H,#\J='IEC#>1W
M<=K$MQ'!]F20+\RQ9!V#VR!0!Y%:Q0I=V-E.B+I"^-KQ'B('EAMCF)<=,;^@
MZ9Q6C\4(=!M_ /C=-*6-+\_9&U!(]P4,9$V$C[H)4<XYZ9[5Z)-X>T>XL+NQ
MFTVVDM;N5IKB)XP5DD)R6(]<@'-0Q>$O#\&B3:-'I%HNFS-NEMQ'\LC9!RWJ
M<@<GT% '.Z:RK\5L,P!;PS 1GOB=\_ED?G7'Z-);WMYX9,S1RZ9/XIU.3+<H
M\G[TPGT/)XKU35?"VA:XUNVIZ5:W36PVQ&5,E1Z?3VZ4MQX7T*ZTN33)]*M7
MLI)3.T!C&WS"<EAZ')/(H \G\6I;Q:WX^CTT6Z(R:2+P8Q& 9CYFX#MM(W>Q
M-=OH.E:E;^.GO=0NM#CE;3/*:STY61G42 I(RL>B_.H/^U70V7A?0M.@F@M-
M)M(8IXA!,BQ#$B#<=K#N/F;KZFET;PWHOAX2C2=-M[0S8\PQ+@MCH">N!V':
M@#5HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "N8B\>:1-JJ62Q7PADNC9QWQMB+9YP2"@?UR",XP2,9KIZ\-N]9:^M-,O\
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M3-C",_8Y90>P)Y-=-7E&HZO::=X@N+CPUJM_;ZM/?Q^=H<\.^*]W,H:5 1E
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M$O-,<9("=1@ YSC&.:X?_A)=1O)]'3Q'JE_I$,VE^>AL8-DE[/YK+M&58@[
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M7326*VQ\R:5?*V[4Y)'S,0<XQDGBNAA\=:--H5SJK"[A%M<_9);66!A<"<D
M1[.I8[EQCUKFM+O[36/%G@>\L9//@CTJ[C:0*0%<+ ".1P>HK%UNQGDN?$%T
M)+RWM[/Q3;74\]JN9(XA;HID4%3G:6!/!X!]* /3=$\16FNFZCBANK:ZM659
M[6[B,<L>X94D=P1T()'!]*J:EXSTW3=7FTTP7US-;QK+=/:VS2):HV<&0CID
M G R<#.*RO!$.E7&L:IJ>FZSJVKLT4-O)>7FSRG"EF"QE47<5W'/7&X50M];
MLO"WCOQ9'JWF))J+V]Q8@1,QNE$(0HF <L&4C'O0!/X7\;+!X#\/76JR76H:
MIJ2.(H;:+S)IRK') &!@#&2< <5L'Q]H<>AW&K3O<6\-K<I:W44T)26WD9E
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M;KRQ]"L+C]H242).0-"6\&+F0?O1< 9X;IQ]W[OM7J= !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!->>W=Q:/K&JR6>I:IJ=M=^&+VWM[R\RPFF&&9(SM X7G@8SD#H:Z?4H)/[
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M5O$\E8RBYC;+@J1MR."/K6YX;TU-.^(*V\$5RMM;^&;."(W &\!99!M8CC<
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M82OV1ID'ED_5DQ^(KMB0JEB< #)KG-0U?POKNA6<-[<Q7.G:TX@MLA@)F)X
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MWK(&C^);_P &:;X'N=$>%;=[>&YU/SXS T$+JP9 &WEF" 8*C!/6O4:0,"2
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MD@'GFL[6/#.M^+HO%&I2Z>VG37NE)I]A:W$J&1MK-(6?82JY8@#D].:].HH
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M*;A&&L3>8@"G]W^Y6/!]>5S6)8>"=;T632Y=*U2Q66'2(=*N7GMV? C)(DC
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M6>SF:XA5UB?/; <<?[ H J0ZYX@M/B/9^'9[M;M5\.?:Y4\M%\VZ$FTMD $
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M* */]BZ5_P! RS_[\+_A1_8NE?\ 0,L_^_"_X5>HH H_V+I7_0,L_P#OPO\
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MN8+4%KB2*=6$0 )RQSP, G/M1:^*- O=4_LRUUFPGOMN[[/'.K.1C/0'TYH
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MW^9GC;C.<^F*X2[^)VGW7AS4=0T*>TN+BROXK4QO('W(TZ1>9A3G:0Q*GZ4
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M+.H!^Z"VTGU!H Z.BLG2_%&@ZW<R6VEZS8WD\8RT<$ZNP'3. >GO6J2%4LQ
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M>Z@&=E!)"Q J/P))'N:GT-XQ\1= DG9<MX05BS=2?,CY^M>AKI=@MO=VZV<
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M !X6_P#UR7^0K,N/"'AN[U">_N-"T^6[G4I+,]NI9P1@Y..<CCZ5LJJHH50
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M0VS,_#%QW)[YZUE>)]+U>[T-="\/Q:?;6EQ"UK--,Q'V:(@+^[C"X8[=P )
M&!UH H>!E&KZAKOBTG<FI7/D6;=OLL.44CV9M[?B*H_&E0?AU,2 2+NVP?\
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MW1 ^> NT;_[W''/:H](T'2=!@>#2=.MK*.1MSK!&%W'U..M &A1110 4444
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M <0YD&]CC.7$>X ] P]ZZ/QGHNH^(/#[:;IUS;PF65#.+A6*2Q Y:,[2#AL
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MX/>@#T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG2,R!9AMQR ?NYP?7K0!VE%<1\-=6U[6-+U"YUDVS)]ON$B:.5F92)6!3!4
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M%% !7E*Z/XN@\&ZUX7700[:I<W8ANQ=1>7!%-(V3(-V[(5BP"@]0.#FO5J*
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ME\:^%WU'^ST\0Z8UYNV>2+I-Q;TZ]?:KNLZYIGAZP-]JUY':VVX('?)RQZ
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M;9<1(<<A!_=STJY61=^*=%L=<M]%N+]%U*X ,=NJLS8)P"< [03W.* /,_\
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MU*74(+Y9D*,'" )MSN#<'MCCZ5V5(K*Q(5@=IP<'H: %HHHH **** "BBB@
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M7+*@7#%0>I!."3SBNZU'P^]]KOA[41<*BZ2\K,A7)DWQ&/@]L9S6+H_@S5]
MT?48-,UJ*.\N=7EU)'>WW1LKXS$ZYR1QU!!SB@#3\&7_ /:.E331^(8]=MO.
M(@N1&J2J,#*2!0!N!SV!P1D51^*-U/;> [M+>9X#=306KS(<%$DE5&.?]TD?
MC6EX:T*[TNXU._U&XMIK_4IEEF%K"8XDVH$  )))P,DD\Y]JT-<T:S\0Z)=Z
M3?H6MKJ/8^TX([@@]B" 1[B@"G-X/\/S>'SH1TFU&GF+RQ$L0&T8QD'KN[YZ
MYYKQZ^;4]9\"?#:[GUBY5VUR"T&$C;YDEE1)\LI);:HX)*GN#7HC>'/&\M@=
M(E\66?V$IY;7B6)%XR=,9W[ V.-V,]^M6M7\"076F>&--TV9;2UT+4;>\167
M<76+/RYSU.>M '(WNBZHOQKTFW;Q-?/.=(D<7)M[?>JA\%<>7MP>N<9]#4:?
M$"]FSK$6MW+S?V@8ET1-/)B-L)O+/[SR\^9M!?=OQGC%=]<>&))_B%9>)Q=*
M([>P>S,&SEBS;MV<_IBJ-CX8U_2IOL&G:W;0:']L:Z5/LI:X16<R-"&+;=I8
MGDKD X]Z *GA^[\0:WXSUY9M9:+3-)U'RH[9((\S QJ=K-C(49R,<DL<G@5W
ME86@>'WT74]>NVN%E&J7OVI5"X\L;%7!]?NYK=H X#X5_P"J\8?]C1??S6K'
MCOQ(^E:GHNE+J<NEQ7WG23WD%OYTJI&%^5%VL 27')4X -5M,\(>+= NM7.D
M:YI*VVHZE/?[+FP=V0R'ID2#H .U:=WX>\07:Z7J3:I8#7].>4+*+5A;RQ2
M!D9-^X=%.0W5>E '!ZQJNJ:_H.D)_;-T!;^*;>R2[%HL1N4+(\<I5TX93Q@
M*2#D&MB%=0TWXHZW=W.N7ES'IVB0S.C10CSD!D.PX08&06R,')].*WM7\)ZW
MK'AZUAN=:@DU>VU*/4HIC;8@5D;*QA =VP>I8GW]''PIJC^*SK$E]8O%>Z?'
M9:G;FW?Y]NXDQ'=\H.XC!SCWH YCPYXTO[F_\/SMKMQJ4FJ2!+[3SIQCBM0Z
M%E,;[ <*P53EFW YK<^'UWX@UV*;5]4UEI+:*ZN;6.T2"-5<+*P#LP&<C&T
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MX!!_AW9!'.* ..\1SWNJ^&?#\MKXO.H6\GB*VACN[>&(,REU*^8-N/,1@>
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M\J\MXU:-]H;!WJ.A!'0FCPWX<U+1=9U:^O-2AO1J;1S2X@*,LJJ$(7YB-F
M!U&.2:M^+]!?Q/X4O]&CN%MVND"B5EW!<,#T_"@#E;O_ (2NR\::9HI\3N\.
MKVL\LK_98@;5HBA/D_+T.[;\^[ YY-0V_B'5HO#&L07_ (BBMI]/ULZ=_:4M
MNK2O%\C#;&JD-*0V -N.,XKL+[07N_%^D:X+A52P@N(3$5R7\W9SGMC9^M8%
MQX%OE:YNK+4;=;W^W3K%OYT):,9B$9C< @GC)R.^* .?E\9ZS;^%/$YL=4GN
MY],N[-;2\O;/R9625XP5="B^K#.T<'/O6_\ :M=T'QG::==ZY)J5OJ.GW,^)
M;>-/(EBV'*;0/E(?&&STZFH+KX?ZM?1ZVMUK5O*VL&UFF86Q7RY89%.$&[[F
MU=H!R>^3SGI-4\//J/B;3=76X5%L[6YMS&5R6,NS!SVQL_6@#AK#6O%,?A3P
MMXIN]>:9KZYM(;FQ%M$L3QRL$)R%W!^0V0<9XQBJ^J>/;T7.MWUMK=Q%<:=>
MR06ND1Z>9(KA(FVL'D\LG<Y#8(8;>/>NN'@F4>"-"\/?;DWZ9-:RM-Y9Q)Y+
MAB ,\9Q2_P#",:]8WU_%HVMVUIIE_=F[DWVI>>!V(,@C;=MPQ!/S*<;CUH H
MV-]K^N?$?6["+6&M-)TMK.80K;H6D$D>XQEB,A3ALGKR,$8KOJPM*\/OIWBS
MQ!K37"NNJ_9ML07!C\I"IR>^<YK=H \*N;6_3P#\2Y[G5[F[5-3F@,4D<:AV
M7R,2$JH(;  P#MQVKO5N->T/QQH=G?:VVH6^KQ7'G0O!&B021H'!C*@-MY(P
MQ/US5:[\ :G/9>*M+CU2T73=<G>[7=;L989F*9R=V"N$Z8SSUKHM;\-G6->T
M?4#<>7'8I<H\87EQ+'LX/;'6@#B]+\67P\1Z*O\ PDTFK#4;R2VN8([ I:1C
M8[*89O+&[:4 Y9LY)[5H?#"UODN_%,UUJ]S=JFMW,!CECC 9E"#S"54'<0 ,
M [?:EMO WB"*TT"WEUNQ*:!+&;-$M&5945#&3+\_WMIXQ@ YZYXV_#?AS4?#
M^M:T_P!MMIM+U&\DODC\EA-'*^W(+;L%1M/;//6@#IZ*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKS'PMH5KXC\/P^*KZ
M_NK76I;Z64WJW##R@D[((0I.W9M4+M([^M 'IU%>4PZ1;>)-$\7:]J4UQ_:=
MM>WL5K.MPZ&S6#(C" $!<;=Q]<\TW2H/^$R\6Z3_ &TTTL%QX3M;N>V61D22
M5I&Y8*1GJ>/IZ"@#UBBO#/[,6#X5W/B W5Y)JNF:@T5E<O<N6@CCNQ&J#G!&
MW.<]<^PQU4'AZQ\3?$3QE;ZL\\]M!]C$-N)W18V: 9<!2/FX&#VY]: .LUSQ
M/;Z'K.AZ;+;RR2:O.T$;H1A"HSDU?M+VYN-1OK:;3IK>&W*"*X=E*W&1DE0#
MD8Z<XKQVUOKK48?A1<7D[SSB_N8C*YRSA"45B>Y(4<U9OM7U#3]1^+$]I<3"
M:'[$D)5^8MZ%25SPIYSGU% 'L]-:-&969%+(<J2.1]*\OT_P_K\%]<PZ+HEY
MH%M<Z9<6\LEQJ"3+]H('DRX5V(8'=EL<Y]JO^!X;33->.GS:3J6BZLUD6DMY
M+KS[:["LH,J-DY8$CT.'Y![ 'H=%<AX[:33Y/#^NQR.B6&IQI<8/'DS?NFR.
M^"ZG\*Y"Q\13:/XCU7Q5=3N^G:K'?^0C,=H^QX$>!VW*DI]Z /4+F]N8=5LK
M2/3IIK><.9;I64)!M&1N!.3NZ# -9VK^+M.TO0M3U6,M=1Z=.+>=(N")-R@K
MSQQO%>>:?:7NE>*_A?875Q,TTMG>RW89S\\CQ;VSZX9B!]*R7T6QLOAQX_FM
M8C%,NMRVJ/O9ML:SQ;1@D@X]>M 'O%5M1U"UTK3KC4+Z98;6WC,DLC=%4#)K
MA_['M?#7Q+\/1Z8UPBZE:WBWGF3O)YY01LKMN)RV2>?>NK\3:=8ZOX;O].U*
MX%O:747E/*7"["3@$$\9SC'O0!EV?CRQN+^SM;K2]8TY;UQ':SWUIY<<KD9"
M@@G!(!P& S755P$NH^*_"LVGKXA;3=:TF2ZBMA>PQF&XB=V"H[(<J>2,[2#S
M7*+!KVN)JFKZ?H%_<ZVFJ3"TU(:C'&D*Q3%5B\MI!\FU<$%><D\T >U5574;
M1]5DTQ9@;R.%9WBP<B-B5!STY*M^5>?VFAVOC+4?%EYJUS<Q7-EJ#V=G-'<-
M&;)$B1@Z $ $EBQ)Z_2C1-$L/^%RZK<,#/-#IEK.L_F'YG8N&? ..1VZ>E '
M>:3>W.H6 GN].FT^4LR^1,RLP . <J2.>M7J\-\,W=U>_#GPSILUW<"#5/$$
MEM=R+*P9X@9'\O<#D!B@'!Z9%;'B&UC\,7_B?2-(:6WT^X\*75Z;<2LRQ3(2
M@=<D[20W..NV@#UJBO+ETB#0]0\":I:2W/V^_G6"]G>=V-RKV[L=P)Q]Y00,
M8&.*[_Q!K$?A_P /WVJRQ23+:Q%Q%&,LYZ!1]20* ('\4Z8GBV+PSYCMJ4EN
M;C:JY5$']X]C[5EW?Q#T>SO;B)[?47L[6?[-<ZC';$VT$F0"K/G/!(!(! [F
MN$T/6M%@\=>&)GU-;G4KN.]>_G$$@#7$I@"J,K]T!=B]@%&<5JZ7Y0^ .M?:
M,;_L^I^?NZ^9YDV<^^<?I0!V&L^,['2-2;3DLM2U&[CA$\T6GV_FF&,YPS\@
M#.#@#)..E;&F:E::QIEMJ-A,)K2XC$D<@XR#_(^W:N#TBV\0Z!JTFIVVC/JT
M6KZ?9^9LN(XGMYHH]I#[R,J<YR,D$'BN<@UR^T?X(1VML#)JNK7MU9V26JER
M=\\FYD'4@+N(_P" T >D>&/&VC>+I;Z/2I)6:S<!_,3:'4E@'3U4E3S[5T5>
M,?VI:>%_$WA?4+'1=:T_3H8%T>_EO;)HHS$Q'E.6Z9#\D_[1KV9E#J589!&#
M0!6LM1M-1^T?9)A+]FG:WEP"-LBXW+SZ9JQY:"0R;%WD8+8YQZ9KQ"PLXM&\
M&>)9=,,MI/<^)7TQKF.5MT4#7*(<$G@X)&[KSUKL?[*M/"7Q#\-VNBK);VNJ
M0W45W;^<[H_EHKJ^&)^8'(SU.Z@#N+^^MM,T^XO[V40VMM&TLLA!(55&2>.>
ME4'U^!?$EEHJQ.SW=I)=I*/NA49!@]\G>/RK"^+-K#<_##7#,I;RK<RI\Q&&
M'0\=>M84_AG39O&_AC2?+E33QHUR[PK,X\S+Q$JS9SC<<XSVQTXH ]1HKQ66
M6ZLM,NO#UE%=W5B?%K6*VL=SL<V_D";R5D9AA2P]1QD=Z[;P-I^J:;?ZO%-H
M]QI6D2>5)9VL]VD_EOAA*%VLV%.$./4G% ':45Y_X_DN;KQ)X>T==,N-3LIX
M[FXGLH+A8?.,80+N9F4%1O)VYY./2LN;3M3TWP%J-[J!GT2;1[U[S2#<7(F*
M184B%RC-N5F+IMR3@KZ"@#TR\DM;:VDO+O8L5LC2M(ZYV #)/Y"GVUS%>6L-
MU;OOAF19(VP1N4C(//L:\D91XI^'/C/Q)JV_^T9;:XB-B79?[/$*DI$1Q\V0
M'8XYR.U->R"?\(EH5KHMUJ.G/I#:A-8PW@B$LN(EW,7<9"[B=N>K XXH ]BJ
M"]O+?3[&XO;N416UO&TLLAZ*BC)/'L*\HDT[5U@\+:3JJ7MA#)KT\<,1O \O
MV0PR,L;2(QSQE>N0 /8U5\1Z19Z?8?$;1K=)%TZWTRWO8+<RN5BE*R[BN3WV
M@D=* /989H[B".:)MT<BAU;'4$9!I]8_A;3[73/#.GV]I&8XO(1]I8MR0">2
M2>M<E%H%EXE^(GBZVU8SSVD"6?E6XG=$5FB.6PI'/ QZ<^M 'HM%>):=?ZCK
MFC^"=.N["\UN!]-N+B>V2Z6(SM&ZQH79F7<%!SC/)(/:M*&TU9Y/#WA;6X+N
MSTV\U2[*VSW8>1K:.+S(HFD1CE=Q(QG.$% 'K=%>6^)]+_X1^VL-#TE[V]L-
M1U=1)IL=V%:.,0LYA5V8%58H&P2.,@=:C3P]XE?2=8LK71;BRTPW5K<6^ES:
MBN9D&?/A61&;8K84X) R2.A- 'JU%>4KIXU+P]<6.AZ9J49L]3CEU'P_>W?E
MDIY9_=QODC8Q*N!NVDJ>F<4IN=%E\,1:1;6FOAY=7\G^PWG"2+((_,:$N3Q#
MM&_AN_!QQ0!ZK17AVI37MGX)\7Z? DVEBSU>Q%M;_:?.-KO,!(5LGC))QT&X
MBNKU?1[;P)JWA_6M-,Z6 N39:D))WDWK/@+*Q8GD2!<G_:- 'HU5;O4;2QFM
M(;F81R7DWD0*03O?:S8X]E8\^E<OX-:35]=\0^)'D=K>>Y^PV*ECM$,&59E_
MWI-Y_ 5F?$/1[#4_%_@L7<)D$M[)"^)&7*")VQP1W[]: /1:*\SL-#L_%MSX
MMO=7>=I[/4);&S9;AT^R1QQH59 ",$EBQ/>NJ\!ZE=:QX#T/4+UB]U/9QM(Y
MZNV,;C]<9_&@#HJ*\:\=21S)XHUK3K#4[JZTU@JZH]ZL4=E+&JG9"F02 2"W
M')8C)KH9=97P9XR\027TC?V=?Z;_ &M K-PLL0VRHN>Y!1L>] 'HE5-3NY['
M39KFVL9;Z:,96VB95:3GH"Q ]^:\MTO2+JXN?"6@Z[-.Z:C;W>K:C$9643SD
MH0C8.<)YGW>GRBJ?B9I-&\,?$C1+&>=+&P6TFM%,K,8#* 716)R!E<XSQNH
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MPVEY+&9;5BJ0(N/EE+$X<?Q=!TJ;2_%&A:VD[Z9J]G=B ;I?*E!*#U([#WH
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MIUSHUA-90-NBMWMU*1GGE5Q@=3^=7KNRM;^SDL[RVBN+:1=KPRH&1AZ$'@T
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MI^'C0PHA&HZ9("!SN9QN/U.3^==]XS;6AX9N(M M9)[Z8K%F*1$>)&.'=2Y
MW!<XYZXK3_LK3OL=M:?8;;[-:LC00^4-D13[A4= 1VQTJY0!Y%IXOO\ A-9]
M'MO"]YIL9\-K9QI)/ WDH'EVN2KG()XXR<\D8YI;O4+74/@5HVEV\J&^N4LM
M/CMP?G$Z21JZXZ@KL8GTQ7JPM+87IO1;Q?:C&(C-L&\H"2%SUQDDX]ZHQ>&]
M#@UA]7BTBQ34GR6NE@42$GJ=V,Y/K0!PFJJVC3^+I-+\3:?:Z>[-<:E;SP%I
M[:5HADQ'<!EP%QD$9Z9Z5C:C;ZI<^#O!?@"SMXY;^>TAO-0@GD,:K;Q88HY
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M[E3)M.T,98L#/KUH JGXI:3_ &;)J TS6&MK:0Q7[BV'^@N&VE9?FZCJ0N[
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MP-<Q0Q/*YNK0[$4L2!<QD\#VS0!:TWQG9W^L-I<]AJ.G7'V=KJ(WT(C6:)2
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MC7C,FJB7X7:-X933[[^U[&XLX;RW^RN/L_ESIERV-N#@8P3G=GL<>V4 >1^
M_&4\ECK?B;Q'<ZT((I9E_>*GV6-1(JI&B+\QER0/?)YKNM+\86^H:JNF7.F:
MEI=[)"T\,5]$J^<BXW%2K,,C(R"01GI7G.DZ3J,GPDO1'8W$D]KKK7IMO+(>
M6..X5R%!ZY4$CUQ74'4H/%OC_P /WFCK<2V>E074EU</;O&JF1%18_F RW4D
M=L4 ;?A;QK8^+T$VFV.HK:&+S!=3PA8BV0"@.3EAGG''!YR,5/KWBVR\/ZC8
M:?-;7ES>:@LIMH;6(.TACVY7DC!PV>>, DD8K+^%%O+:?"_0H)H7AD6%MR.I
M4@EV/(-4O&.HPZ5\2/!]Y<QRM EO?^8\<9<Q@K$-V%!.,X!P. <] : -6+Q]
MI;Z1<W\MM?6[VMY'97-I-$%FAED957(W8P=ZG()&*UKK7[2SUR'29%E-S+:R
MW:E5&W9&5##.>OS#%>8:K%<:OIOC'Q'96=U)8W&I:=+ /)8/-';F/S)%0C)'
M#8XYVUMMJT7B'XB6=[IL-U)8)HMW&+I[=XT=R\9VC< 3@8]NW8X -*#XH:-/
MX?GUX6.J)I,,<;F[>!0C%W5-JG=R5+?-V&#R2,5I:;XTL[_6%TN>PU'3IY86
MN+<WT(C6XC7&XJ0QZ9!(;! /2N"NX);3]FJSBDMG$J0VN8&7:2?M*'!!Z9K6
MU>X3QOXNTF+1TN0MC97WVJ::W>(0M+$(T0[@/FR2<?[- &Y:_$33+F2TD^P:
MG%IMY.+>VU.6 "WE<G"X.[< QX!*@&K/_";V1U9K--/U-[=+O[$]^D -NLV=
MNTG.[[QVD[<9[UPS7W]K?#K0_!<%G>1Z[&UE;7%NULZ_9O)="\C,1MVX0D$'
MG<,5<O+N*P\3R/X=GUFSUB;4U6ZT>6!GMKE3(!)-R"J IE]ZL.G(S0!U4OCS
M38M0DA-GJ#645T+.74EA'V:.8L%VEMV[AB%+;< \9I[>-[(:J]FNGZG);QW0
MLY+]( ;=)B0-I.=W#$ G;@'O7GMMI-A%%>>'M9N_$YO9-2E TZT+>5/&\Y=)
M5^7;MPP9B6X(/>M74+N*P\332>'9]9LM:EU)%N-(D@9[:[4NJO-T*J"F6WJP
MZ<C- 'IMW=P6%G/>74JQ6\$;22R-T55&23^ KF]/\>65]>6,$NF:K8QZAG[#
M<7<"I'<';N !#$J2H) 8+FK?C?3+G6O ^MZ;9C-S<6<B1+G&YL<#\>GXUR5W
MJ\/BZ3PCIVEVUV+JSU""]O4EMI(Q:)$C;E<L  Q)"@#KSVH @\*>(M5\0_$W
M6?M::]!:6<R106@$:00 Q$GSP"26)Y&"><5W^NZ[;Z#:0S307-S+/,L$%O:H
M'DE<@G !('0$Y) &*Y;P/;SP^.O'DDL,B1RWT!C9E(#CR^H/>KOCV^N;,:.C
M7E[8Z5-=LFH7=DA,B*(V*#*@E0SA02!^(S0!*_Q TF#19-3NH+ZV6&]2PN+>
M6$>;!*Q&-R@D$893E2>#QFHV^(5C"NIK=Z3J]I/86GVYK>>!!)+ #@NF'(('
M<$@CTK@(H79=1M8[?5&,GB;3KN+[:DCRR6Y\H"0LPSCY3P>0."!BN]N;1I_B
MU$TL#/:OX?FB=BN4),\?RD].1GB@#8U+Q/IVF:18ZDQDGAOY88;58%#-*TI&
MS )'8Y^@-6]9U6#0]%O=5NED:WLX6FD$8!8JHR< D<UYEX.T^]G\6V_AJ\1V
MLO!KRM'(_(F,O_'M^*Q,_P!#BNU^(G_)-_$G_8.G_P#0#0 S3_'FGW^J6-F;
M#4K6/4 38W5S %AN<+NPIW$@E<D;@,CI3-.^(.E:G+=^3:WZ6EEYPN[V2$""
M Q$AE9L]<#( !X(SC-<Y)J<7B:Z\$Z9I]M=+=6%W%>7JO;N@M4CA92&8C')8
M 8)SU'%,TK0[[4?A-XKTR"!X[RZN]0\I'7:7)D;;U]>!GWH Z?3_ !Y97UW8
MP2Z7JMBFH9^PSW<"I'<G;N 4AB5) ) 8+FK=KXQTJ[\'2^* 9H["&*6219%
MD3RR0RE<_>RI&,^E<G=ZO#XNE\(Z=I=M=BYL]0@O;U);:2,6B1(VY7+  ,20
MH Z\]JS=4T>^_P"$LO?!4=K,='UG4X=5>4(?+6'!>>,MT!,D2X'^W0!UMMXD
MTZ?QM&KW6K6\[Z$+\V<VT6T<)?[[*,D2CH><8JYI'C*UUJ>.$:;JMFEQ ;BU
MFN8 J3QC'*D,<'# X;!P>E<]>6TH^.%S=-8S7%J/"S(51,B0^?GRP3QDCL35
M;PI=)#KMK8>'+[5[C1GM93=6&H0OC3R /+57=00<Y79EN 3VH UM \9:1:^
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M44 %%%% !1110 4444 %95YH45YXDTO6FF=9-/BGB2, 8<2[,D_38/SK5HH
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M$8^HJQ#)YT$<FQX]ZAMCC#+D=#[UY@EE9VC?%*YMXUCNE64!E8[@K6B.>_\
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M6Y7GY,8&W&,#/'6O2H[F":::&*>-Y82!*BN"T9(R P[9!!YH EHHHH ****
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MX_?;ASGA:?/XSU&2RCN4N](L(+G4+F"WFN8Y)7:&(E 5B5@9&9E8Y!  QP:
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MS"89IFA4O+'QE&.,E>!P>.!27VB:5J=G':7^F6=U;18\N&>!71,# P",#BN
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M4 >HT5YE-XLD\/#Q+<))%))<>(8K.V>X9FBBWV\+;B!R5 #' Z_CFGCXA:A
M+Y3+I^HQV7V>X>\M[:2)&@:4)*NUF.UT!W Y(([4 >E45P=UX^GL]4\2I-;P
M_8=/M99;%P#NGDA5/-4\X/SR(HQCH:[2P:Z?3K5KY8UNS$AG6,$*'P-P&23C
M.>] %BBO,=0U"V\$^,?%.HP12O!#HL-X;<S,0\S32C/S$[<G:..GI5W2O'-[
M)K-M83WFFZB+JWE</8VTL7V:1%W;6WL=RD @'Y3D=.: /0:*\ZA\7^)O^$%T
M[Q%<06"_V@UN<PVLLJV43*2\LBAMSC(& ,8W<DXS3[KQY<V'AA;\ZAHFH/<W
M\=E:WEH7$(W#):6/+,I4!OE#$G Z9H ]"HKS;_A/]4CM]7$)L-5;3H(KW[1;
M6TD22P;\3)M9B5D506!R0<CBNJM->EU'Q:^GV0ADTZ"P2XGGP2QDE/[M5.<8
MV*S'@]5Z4 ;]%<1=6$'B?XA:CI^J>;+8Z;I]NT-L)613)*TFZ0[2,D!% ].<
M=:Y2*]GO+?P[8ZA]MUB"WO-1M);&%R9KE8I"D<K<@,J 8.YARP/)H ]BHKQQ
M;F0^&(8#)>O;?\)(T1T02/\ :O(VDBV//4<28W;=O&[%.-Y-##K.F637NDVM
MYJ^GV26$LA$]I'*P61U.2%$@R!M8C@]#P #V&BN#ATBSTGQTN@6J2KI.J:3-
M)/:^<Y4/'(B[P2<J2LA!P1G J/1?#VF/X_GGTN*6"ST1?)<BXD<3W,BY*G<Q
M&$1A_P "?_9H ] HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-:L_$;037FU</91RF*-1PBDGA<Y..Y.31>^$=4NM?@UF/Q&T=U#:K;)OLHY
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MI/,D5_0,P4GZ5TNMZ7_;6D3V'VNXM&DP4N+=]KQL"&!'X@<'@C(K0HH Y)/
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? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>exhibit1012-stuartexecut007.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(2^"4ZY .>QH ]QHKRSP/KMUH_@W2II].U:^U76/+\A9]0$QNVV%VD!9R(D
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M17-GE9'9G"F/85.&W;@!TYH ["BN4L?&<LOB.QT'4M"O-.O[R*29!)(DB!$
MYW*2">2,=1CT(-9'QBUG5M(\&,-+2YC-Q-'%)>6\RQM""ZC YSELD9'3O0!Z
M%17$6>O3:)#8>'['0-2N=5:![E[2>_65H8MY&Z29V(.X] "?3C%/N/B186V@
M6VIOI][ODU+^RYK,*IEAN/FRI .&Y48P>=PH [2BJ%C>WMSHRW=SI<MI>%68
MV32HS @G W [>0 >O&:\MG\::UJG@-=5O;2YM!'KT*+)#(I,D8NRIC"H<G"@
M*<_>]Z /8:*Y:P\9%]7N]-UC2;C2)X+,WZF:5)%>!3AFRA.""1D>]-TGQJVH
M7^GPW>BWFGV^J(SZ?<3.C";"[\,JDE&*Y8 ]@>XQ0!U=%87BCQ/#X7@T^26S
MN+IKZ\6SBCMP"QD969>I Y*XZ]_2J-IXVS)JMMJ>C7MCJ&G6PNVM%*SM-$<X
M,90D,<J1CL: .KHKC3XZN+>/4$U#P[>VE[:V#:C';&6.0SPJ<-@J2 PXRI]1
MUK1U'Q?966@:9JT$<EVFJ2P16<49 :1I<;>O3 R3]#0!T-%<)>?$H6\&K7</
MA^_N+'2+N2VO[E'C CV-@LH)R_!S@= 16C8>-#=>(++3;G1[NRBU**273[F5
MT(G" ,<J#E#M((!YQZ'B@#JJ*X^T\>I=7%I,=(NX]&O;K[):ZFSH4DDR54E
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M%VP) 2<#L!6OH_A"UTK5/[3EO]1U*]$)@CFOYQ(8HR02J@  9(&3C)QUKH:
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M>HH \8OUU6'X;>(/",?A_59M3-S<LC):L87C><R!UDZ-E3PHR<]NIK>@UO\
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M:3:7+27^G089I5*$(VPD!PK<[>_X5DZ1K/@S1;;Q!K^@1S64UI9>9>:,8C;
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MTD=CD8Z884 =!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %4-3UK3=&-H-0NX[<WEPMM;ALDR2-T4 ?_JJ_7BFOZ[I/B*\L
M_$<VJV7EP:S9V^FVYN$W1P+<(99RN<@N5ZGHBCU- 'I^M^+]!\.W$=OJE^(9
MI$,@C6-Y&"#@L0@)5?<X%2ZCXIT32]+MM2N]1B6TNMHMWCS(9LC(V!02W'/
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M27P:>YW212I(%RC8^4$'D#BLC2;;4=/^&_A&6&XU^;2981+J']G2%KB(&(;
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M>5)/E'P5^=AW?WH ]1HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M27$<@(8HI.W(SCI7*CXB,=$\'ZC_ &8,^(;J*W,?G_ZC?GG.WYL8Z<4 6O\
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MDS;(D<D+;3M"@_*=RYW<DYQTP!JZYI-_J#VL^FZS-IMS;EN1&)8I%8#(>,D
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MC/ P3QS5KPOX9B\,1ZJD5R\_]H:C-?MN4+L,F,J/4#'6MUW6-&=V"JHR6)P
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M,A)?.XG@Y/'2LFP^'_AO3;BTN(+*4RV<@>U::[ED\C ("IN8[5PQ^4<=/08
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MDC26)XY%#HX*LK#((/4&@#Q[1+4V/B3P+=V^A:=I,%\TWEO%=&6[N(FMW?\
M?G8 W.QC\S8.*S7_ .2=?%G_ +#=U_Z$E>FVWP]\-6GV?RK.?=:RK+;NUY,S
M0[00%1B^53#$;1\ISR#5L^#=!.G:MIYL/]%U>=[B]3S7_>R-C<<YR,X' P*
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M:5:+;02RF9T5B07( )Y)QPHH Q_'TELVCV5C<:?_ &B]]?PP06C3>5'+("7
MD;!^0!"2,'.,8K)^'T4MGXH\6V#VFGV0BDM7-II\A:"-VC.2,JN"0%)X%=?K
M.AV&OV*VFH1,\:2++&T<C1O&Z]&5E(*D>H-5]*\*Z/HE\][I]L\,\D(AD;SY
M&\P!BV7!8AFR3\YRW)YYH V:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M#/.P6-)_-1L%CPI**<9ZXQ0!VNK_ !+T/3X-%N+:1[R#4[GR0\4,C;% ;<2
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MBERTT;QM"PQ\K(P# \C QSD8I=+\8Z%K-]'8V=XQO'1I!;RP212!5VY)5U!
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M!_L9J]+XCTB'PV/$,EZ@TDPK.+G:2-AQ@XQGN.,9K \0QHOQ&\$HJ*%"WR@
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M.J!5(W$QJW,FT<G'N.M58_%.L3?%!]"BT_?IBZ?'<>8)4Z,Y'F^N.-NWKWH
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M^\JL5."?;@9K!LO&&I:EHOC>76]*FCT_39+F/,%RBN@2)"8@5YW<LV_WQVH
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M+=K;FX5/*@ 4;GD;OD@#J2<T?\)P]Q;Z='8:)>3:K>B4_8)66%H1$0LA=CP
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M*\'B3@_=+ J(L=AYV7 ]!7K-8V@^&K+P^;J6"6YN;N[</<7=W+YDLN!A03Z
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M%Q9-I\\Z12AHU4QR;'"H0RGYF'0CKC%>GZ?:QV6FVMI##Y,4$*1I%N+; H
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M'D <UZQ10!RLUC='XK6E^+>0VBZ+-"TVWY YFC(7/K@$X]JZJBB@#QN#P]K
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M8E.V,W,ZQ[SZ#<1FKM '$^#=.TM-8N[_ $_0-7L0(%A%UJDTV^7+%BBQRL2
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M"&(VX[5T%MX8NT^(^K:],T#6%[IT=HJ!COW*><C&,8]ZP1X.\2R>%8/!,_\
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M6D.DF820V]P\K2EX63>"4&.<87T)Y/ H R['QAXKN_!NM>)Y#ID=MI\5XL,
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MN WN<\US<>A^)]:O-"BU^+3;>TT>=;IY;6X>1[N5$*H0I1=BY8L1DGH/>@#
M^'NGZJ_Q(\7W5W=Z=,\-[&ERXL2'D/E$+Y;&0^6!QD'=GVK?\?Z?-/J6AZC/
MHDNNZ/9M-]KT^)5D8LP4))Y;'$FW##'^UD5H>%_#=[HWB7Q3J-R\+0ZK=I-
M(V)8*$P=V0,'/IFK6OP>)4O[2_T":UFCC1H[C3[MC&DH)!#JZJ2K#&.000:
M.1L?$'A/P_HGB37_  W$]M-%'']ITF6,VR12YVHQC(&S<6 +#@@>HJ2U^(C:
M;=7<6HZUHNMQIIDU^LFE$*8VBP6B8;WX(;Y6XZ'BK%WX+UCQ.=:OM<:QL;R]
ML$LK6&U9IEB"2&57D8A=QWXX  P/>KL>@:SK=GJ%CK6GZ/IMI<V,EH18$RR.
M[C!DW%5VJ!G"\GGD\4 .TN;QS.MG/<R:3)!J%LSMY5NRG3Y"FY,YD_?+G@@;
M3]!7#V?B+6M,^!]OK=Z^GZFTUTHBBNK4L%#7#!MQ+G<<\@C&/>N\T*T\9QW.
MF6VIR:=;Z?81&.9[60R/?$+M7AD'E@?>."3D8Z5RS^ /$L_PO/@^0::CVMTC
MVUR+AR)D$S2$L-GRG!  YS[4 =1>:MKVK>+;_0]"N;*QCTR"*2YN+FW:<O))
MN*HJAUP-JY)R3R*QX?'.O:C%X=MK.WL8=1O[R[L+P2*S1Q20!LLN""1\N[!Z
M],CK6S>Z1KVE>++_ %S0;>QO8]3@BCN;>ZN&A*21[@KJP1LC:V", \#FJ.D^
M!K_3;KPQ<27-O-+8W=Y>:@XRN^2X1P=@QT#.!SC@9]J -3PKJ^K7&L:[HFLR
M6UQ<Z7)#MN;>(Q+*DJ;AE"S8(P1U]*J>-[B75RWA6RD9/-MVN=2E0X,5L,X3
M/9I"-O\ NAS6KI.B75CXO\1:M*T1M]1%L(0I)8>6A5MPQQR>.3576/ .BZM>
M7^H,EY'?WB 2/#?SQ*Y5-JY5' X ';UH X[3[>+5]'^%^A7L8FTZXL&NKBW?
ME)C% FQ6'<;GS@\<"JOB>W.@#QKHNCQ/;:<]I97SV]J-HA1I2EQL4?=S&A)Q
MZ&N@LO >HZ'X<\-/I4D#ZUHWS.ES<2-#/OB$<J!CDH#@%<# (Z<UHV.@>(L:
M]K,UQ8VFOZE''';(F9H;9(P=BDD MDLQ8X[\=* .?LKKPM8?$KPU#X.:Q6*^
MMKB&]73MOE,BQ^9$7V\;\JV,_-@G-5_%=B?B#XIUFTANQ#%X>M?+LG\P+G4&
MP^X'_9"JI]-QKH;'0-?GU:/6+VPTBPET^VF6PLK25FC>XD #22-L7 PH  !.
M":;X<^%^A6>AP)K^E:=J>L2%I;R[EA$ADE=BS<D9P"<#ITH W_!WB%/%'A/3
M]6 "RS1XG3^Y*ORNOX,#^&*VIF=()'C0.ZJ2JEL!CC@9[5P$>B:KX!M/%ESH
M,5@=,D07NGVC[L13A<2)L4?=; P >O%=EK-A+JWAW4-.27R)KNTD@$@_@9T*
MY_ F@#BO#_C2_G\5:=I5[K6@ZD]_%*TMOIIRUC(BAMI;>V]<;AD@<BJ5GXR\
M6OX/TOQ=<MI:V,MQ%#/8I;OO9'F$1<2;^#DY"X/'4U?L/#GB=-2\,7<UEH]K
M!H^Z!K6WN&(='CV-*&\L8(P"$QZY;GB1/!6IK\*K'PP9;7[=!+"[MO;R\)<+
M(<'&?NCTZT )>ZUXCUJ7Q.VE26$6FZ2SVGD30LTETXC#2?.& 3[P X;GK6W\
M//\ DG'AO_L&P?\ H K'F\/>)M/OO$5KHZZ<^G:W*UP+B>9EDM)'C"/\@4A_
MN@CD>]=+X4TN?1/".D:5=-&UQ9VD4$AC)*EE4 X) XXH \SU+6=2USX6^.I(
M%TZQ%GJ-Y;2B&U(\Z%5 .<,,2'/+<].E=[\/[&YL/!FFI</9MOMXGC^RVWDA
M4,:X##<VYO5N,^E<_:^ ]6@\#>,M%:6T^U:S?75S;,';8JRA=NX[<@\'. :[
MG1;.33M!TZQF*F6VM8H7*G(+*H!Q[<4 <+J/C;4M*\1117.KZ 5DU..S_L>-
MMUT(G<(LI8/][D,5VX XSWJ:?7_%E_<>*1IDVEVT.B3LL9GMWD-QB)7V'#C;
MU/S<]1P,<T6\&>*(]#&D6\.DA+34QJ"7+3-OOB+CS0KC9\AQP6RW('&*Z73O
M#E_;Q^+/.: /K%PTL 1R0H,"1X8X'\2GIVH JZ)XQO+_ %_1X+R&&*QUO1TO
MK(J#N$P ,D1.>?E8,.!T-:7A37+SQ"VKWDBQ+IT=\]M8%%.Z1(_E9R<\@N&Q
M@#@5QWC#3;C1/AQX8M(+J%/$^EM:06 C.3+-M$3JO0E2I8].@KT+P_H\/A_P
M]8:3!S':0+'N_O$#EC[DY/XT <R^L^)]<U'73H$^G6MII$YM42ZMVE:ZF5 S
M@D.NQ?F"@@$]3[5QOBB_U#Q?J'PZU*WFLHK;4)3)%;W%J91%*(\L7^<!P#P!
MA>F<UV3Z+XGT34=='A^+3KBTU><W2O=7#QM:3,@5R0$;>ORA@,@]1[U"_@&Y
MM3X%@L9X7M_#TC&X>4E6DRF"5 !Y)R<$T :GC9]1L/AKJTEI=00WEOI[EI5A
M(7Y4.[8H;Y2><<G''7%<BZ^(#K7P]5+RREU&73[S;<O P2-#' <LF\EV X^\
M,D]J]#\3:7)KGA;5M*AD6.6\M)8$=^BLRD GVR:YW2O#^NOJ?A6^U.&QMSH]
MK<6TR07#2;PR1*C#*#KL;([<<F@#-F\=ZKI&EZK:ZG-IO]J6>JQ:;%>.IBMR
M)45Q+(I8XVJ6) ;MUK8\(>*I-5UG4='GU73-6>UBBN(KW3L!'1RP*LH9@K*5
M]>0PJCJ7@?4;NYUV[BDLS/-JMMJ5BLI)1C%&B%)!C@-AAQGJ#[5T/AVVU9)K
MJXU2PTRP5PJP6UD3(5 SN+R;5SDD8 '&.^: ,K5-8\17/CV3PWH\MA:PKID=
MZUU<0-*R,9'0J%#+G.T=^,'KQ5"'QAK%SX8,LUUHVEWMKJ4NG:C?7;8MXC'G
MYT5F!8M\N 6XR?2FZB^L0_&*YGT>"UNI%T"$26]Q,80X,\N"'"M@@CH1R">E
M0P^"=<T]-+U-8M.U#4X]0N[^\M996CA+SC&4;:QRF  2O//2@!MI\0M1_LBW
MU-YM.O+"TUO^S-0O+53Y;Q,%V3I\QV@%T!&3WQ6MXB\6:E9:QK-KIB6[0:1H
MDM_<O*A;]\0QBCX(P,(S'VQTJG'X>FL?#GB^T\5W.GII^J2/=FZCD($9>)0R
M[2!@(4&TY)/' -5_!_A_5-1^%>IRW[J=<\16DC/)+E<;HO+B#=P-H4^VXT *
MWB7QG%-X;D=M(=/$"[(X/(<?9&,?F!BV_P#>< Y&%] >]/E\;ZMH6G>*8=7:
MQN;[1YK>*"X5#!%+]H"["X+':%+<\]!6S-X8OI'\&$/!_P 25LW.6/S?Z.T?
MR<<\GOCBJ.J^![W5+KQ;)Y]O'_:CV<UDS9;9);@$;QCH64=,\$T 9@\?WEI#
MKEL-9T36KBUT>;4K:YL!A%:/AHY%#MW*D'(R,UH0^(/%%KJ?AR749=-:SUTF
M(6\,#![5S$TB'>7._P"[@\#VJ6XT/Q#K&A:[:76GZ+IIN].DM+>*V<R%I&4@
MNTFQ<+T^4 GO6AJ'AR]NG\)&-X1_9%PLMQEC\P$+1_+QR<L.N.* .*T7Q#XC
MTCPSXCU2ZU"SG":[+:F22U?9;?OE1YFPY/EJ#D(,8_O&O0?"]YJ-[9S27NH:
M9J4&\?9K[3_E65,<[EW, 0<CACGVKGM*T+Q;H2:Y;6,>E20W&IRZA \TS_OD
MD<%HG79\G&?F!/..*T_!^@7>E7NKW]U96.G?VA)&RV%C(7CB**07)VJ"S9YP
M!T'6@"WI.MW5]XP\1:3*L0M].%J82JD,?,1F;<<\\CCI7)V/C7Q)J]KX.BLT
MT^.ZUV&[:>62)F2'RBN&"A@3P3QGDD<BMJXT?Q'IWC'5=3T:+3Y[;5H8$D>Y
MF9&MGC#+N"A3O&"#C*\CJ.M<G'H>M>&M2^'FEV[6D^I65MJ.Y'D98IA^[)&[
M;E>#UVGD=,4 :\OCC6]+M]7TJ\BLKK7;2_M;&UE1&CAF-SCRW9<DC'S9 /\
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M><=J /0:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KF[+P;96MWXDEFE>XBU]@;B%P %784*@CU!KI*@-[:B[%H;F$7)&X0
M^8-Y'KMZT <K8^!IHI]+74=>N]1L-)<265K+$B;652J-(RC+E0>.G/)S6KH_
MAFWTBUUBW$TDR:I>SWDFX ;3+C*CV&*U);ZT@N([>:Z@CGD^Y&\@#-] >32S
MWMK:AC<7,,(10S&20+@$XR<]LT <GI'@)M-M=#MI]:GNXM%N#+:!X40A/+9
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MXE"ZU8I92JH \M5#@,I]?G/7TK1T#3;K2-'@L;O46OWA4(LS1+&=H  &%XX
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M-%DLIO,,@96Q\WS'OVXK5T?PQ-9ZW)K6J:K+JFHFW^RQ2-"L211;MQ"JO<D
MDGT'2MO[;:_:5MOM,/VAEW+%Y@W$>H'7%+)>6L5S';27,*3R#*1,X#-]!U-
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MLQFBCB\J1A"25&0IRI4CH,>U>BWWA'0]0L+*SFL0D-B-MK]GD>%H1C&%9"&
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M9N))8GYQR>N>O%:VF>!_#VD7=M=V=BXN;;/DS2W$LK("I7:"['Y<$@#H,\4
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M,MN\@MY#"DK8Q&TH78K'(X)[UY]X4^U:SKNA>%+W<X\(/-)>,PXD="8[4_\
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M$G\Z .THHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "H_(BPP\I,.<L-HY/J:DKR>&[M]8UK6;/6_&.I:+KT=Y+':6BWGV:-(
M@V(61#A905P3G.<GI0!ZN44L&*@LN<''(H95=2K*&4C!!&017+W6OZGI<NG:
M)#9#6M<:T\^X9)%MXPJX4N2<XW,>%&>_0"H&\>)<6&E'3-+GN]3U)ID2Q>18
MC$83B7S'.0 K#'&<DC% '5QVT$,/DQ0QI%S\BJ O/M3VC1HC$R*8R-I4CC'I
MBO.M>\=:[%:Z*UCH4]M<SZPMA=03R(/F&3L5B"&5QT<<#'K6E:ZWI\?Q$U."
MYM)[:]M](CN;F=KIFB6//*A.F1_> YQ0!V,5O# %$4,<84;0$4# ]/I21VT$
M)D,4,<9D.7*H!N/J?6N.M?']Q)'IE_>>'[BTT74YDAM;UKA&8&3_ %;21CE5
M;CG)QD9IEW\0;Q(];FL?#=Q=VVBW$L5Y+]I1!M0!B4!'S';SMX[<\T =PJ*B
MA44*HZ # %,E@AGV^;$DFP[EWJ#@^HIEG=17UC;WD!)AGC65"1C*L,C]#7GO
MB/Q#J=WXRT>/3+IX-(L]7BL;ID./M4SJS,F>ZH% /JS8_AH ]$:V@:X6X:",
MS*,+(4&X#Z]:EK@%L[_QEXA\1'^W-3TZVTRX6QLX[&?R@)!&KO(X'W^7  /&
M!TYK)TK6]2\;3^&-.N]2NM/BGTN:[NWL9/)>YGCD$14,.5 .YL#UH ]/6TMD
M4JMO$JE]Y 0 ;O7Z^]2>6GF>9L7?C;NQSCTS7(>"M6E6/Q!IE_J+78T2^:!;
MN=@7:'8KC>W=ERRD_P"S7*:'XEUM-?TSQ5J%Y.?#_B*\ELX+60_):KP+9P.Q
M?8V3_M"@#U>6V@N&1IH(Y"ARA= =I]1GI3VC1V5F12R\J2.1]*=6/XBUTZ%9
MVSQVC7=U=W*6MM KA \C9(RQX484G/M0!IM:V[S><T$32[=N\H"V/3/I4@ 4
M    < "N7/B^YM8K!=2T.XLKJZU1--,32!E!9"XD5P,.N!CMSD=JFU+QA9:3
MJVIV=Y&Z0Z=IJZC+.#G*EG7:%]?D_'- &[]DM@)!]GBQ(VY_D'SGU/J:R_%N
MA/XE\,W6DI.L#3F,B1EW ;9%?I_P'%84OBG4[JPN[;4?#MWI?VK3IY[6<3+*
M/E3)5RO^K?!! .1UYR*SO"OC.]M/#OA*._T6X73[^&VLX]0>X4LTQCX+1]=K
M%3AL^AQS0!Z)';PPO(\4,:/(<NRJ 6/J?6G(B1J%10JCH%&!65XHUZ/PQX:O
MM:E@:>.T0.T:M@L,@=?QK+LO&%R^OV.F:GH4^G)J2.]A,\ROYA1=Q5U'W&V\
MXYZ'F@#IH;:"W+F&".,N<N40#<?4XZT[R8_+\ORTV?W=HQZ]*Y.U\9WLFHV$
M5[X=NK"SU*5X+.>>4!VD"LP$D>,Q[@C8Z^^*DM_'5E+X#N_%$UO) MHLHGM&
M8%TEC8J8R?4L !]10!U'E1[V?8NYA@G')'I35M;=)A*L$2RA=@<( 0OIGTKD
M&\;ZE+J5UI=CX9GN-1MK2"ZEB-TL:J)%)*EB/O C&,<\],57L_B4;RTT?5%T
M&Y31-3GBMEO))D#)*YVC,?4J'^7=GMD#&,@'="-%9F5%#/\ >(')^M1?8K7[
M.;?[-#Y+')C\L;3^'2N4U#QV]G-J-Q#HLUQHVF3^1>WZS*I1AC>5C/+*F>3D
M=#C.*?=^,KXZ[JNCZ/X?EU&YTY8GD;[2L2%73<,$C[W4 >QY% '5M!"\'D/$
MC0XV^65!7'IBECABB $<:)@!?E4#@=!7G=WX_P!4O=4\&/H6FF:QUJ*69DDF
M1&?;&Q,9R#MVG#9'7&*W+/Q?>7^ILMMX?N9=*6^>Q:]296971BC,8NH0,",Y
MZ<XQ0!T\UO#<ILGACE3.=KJ&&?QH,$+*RM$A5CE@5&"?>L[Q#K:>'])-Z;=[
MB1I8X(848*9))'"(,G@#+#)/05QGC+Q!J9\)O+?:3=Z7<VNJ66Y8Y/-69#,A
M_=NN-W&01@<\=Z /0Y+:":1))8(W>,Y1F0$J?8]J5X(9)4E>)&D3[CE02OT/
M:N9T_P 774FNSZ1JVA3Z?<K9-?0!)EN/.B5@K#"]'!(^49Z\&C2?%U[=ZO8V
M&JZ!/I?]HPO-9M).KE@@!974#*-A@<<]QG(H Z<11B+RA&HCQC9CC'TI&MX7
M38T,;+MV8*@C;Z?2O!+G4;T? #Q'<B\N!.FL.JR^:VY1]H08!SG&*]^7[H^E
M #!!"L'D+$@AQM\L*-N/3%$5O# JK%#'&%&U0B@8'H*X.U^)<]SH]CKA\.7$
M>B7$Z027;7";HV:3R\A,990Q )X[X!')T[[QC>_VGJ5KHN@2ZI'I>%O)A<+$
M Y7=LC!!WL%(ST'.,T =.MI;(NU+>)06WX" ?-Z_7WI9;:"X9&F@CD*'*%T!
MVGU&>E<%<^.M2O?%'A6/0['[1I6K6DMSEI41I  O7()4IGD9YSCM6G\4;E[/
MX;ZO<1RO$T8B.]"01^]3.,>U '7%%+ARH+ 8!QR*%15+%5 +')('4UREIXRN
M!KMKINLZ)-I2WT,DUG-).D@<1C<RN%^XP4YQR.#SQ4>F>.9;V?3);G1)[32M
M6?R["]>96,A*EDWH.4WJI(Y/;.,T =9+;PS,C2PQR-&=R%U!*GU'I2B*,;<1
MH-I)&%'!/6L?Q7XDB\*:&=4FMI;B-9HHC'%][YW"Y'KC/3O6=:^,;I=8ETO6
M-#ETVY:T>\M<W"2K,B8W+E?NL,CCGKUH ZK8@9FVKEOO''7ZTR*UMX%588(H
MPI) 1 ,9Z]*XFP^)!NO"[^))]"NK?3&BC-JWFHTES,[!?+5.H^8X#'&>O2K3
M>-=0L[F:RU3P[):7[64MY9PI=+*MR(P"\88#AQD<8(YZT =8EO DSS)#&LK\
M,X4!F^I[T]45!A%"C.< 8YKF;WQO:6_@W3_$-M;O=?VB8$M;97 :224@!,^H
MR<_[IK,MO$^CZ9XB\<W$MM<PMI,=O+>RM<-(LH,191&A.$.!CC&210!W,D:2
MHR2(KHPP589!IL%O#;1B."&.)!_#&H4?D*\YOO$&KWWBKP7'?Z//I*W%Y)*H
M^TB19$^SO\K[<8894X.1Z'@UL67CQ[N:QN7T::'1-0N?LUIJ!F4EV)(0M'U5
M6(P#D]1D#- '6Q6\$+N\4,<;2'+LJ@%CZGUH6W@2=YDAC65QAG"@,WU/>O-/
M&/C2]O\ P5XFFT_1[@:7 D]HNI)<*&\Q?D+*G78&XW9SWQBO0XI9DT2.6&'[
M1.MN&2,OM\QMO W'ID]Z )_LMOND;[/%ND^^=@RWU]:6:W@N(O+GACECZ[74
M,/R->>>&OB#J4G@2TUC5],>:[O;LVMBD,J9NI&E<*N, (%"X)/92:Z;1?$UQ
M>ZW<:)JNEMINI16ZW21B<3)+$6V[E8 <AN""!U'6@#H#&A"@HN$.5&.GTI=B
MAR^T;B,%L<XK&OO$*:?XJTS19[=@NI12M!<[OE\R, F,CU*Y(/L:S-4\>V>E
MWNMPO9S2QZ2D D>,@F6>8_)"J]VY7G/&Z@#K::J(JE550#DD >M<M:^+[N+5
M!IFMZ(^FW4MK)=6NVY69)A'C>NX 889!QC&.]/\ ^$TA_P"$6T+7/L3[-7FM
M85BWC,?GL "3CG&: .DAMX;9-D$,<29SM10HS^%)';00R2210QH\AR[*H!8^
MY[U1\1ZRGA[PYJ&L/"TR6<+3&-6P6 [9K$L_&MQ)K&F6NH:%/86FK!OL%T\R
MOO8+O"N@Y0E02.3Z<&@#K$C2) D:*BCH%&!08T9U<HI=?NL1R/I7#V/C>3Q%
MI6JSKH%PFEVL5U'<7)N54EX]P*(!\QR!G<.F<=0:;I7B^VMO"?AE-'TJYN+G
M5HS]BL9+G+*BC+L\K9X QSR>0,4 =Q-!#<($FB21000KJ&&?7FCR(=Y?RDWD
M@EMHR2.AKC;GXB)IVA:Y>:CI4MM?:*\2W=GYRM\LA&QU<#!4@D] ?E(Q71Z'
MJ-]JED]S>Z5)IN9#Y,4LJN[QX!5R%^Z3D_+U&* -'8N\OM&XC&['.*CCM+:'
M_56\2?-N^5 /F]?K7#:=XUU-/%/BV/5K(0Z/HP1FE$RDPJ(M^< 98N.?;I5Z
MR\;7C76E#5O#\VFV6K.([.X:X20[V4LBR*/N%@#CD\\&@#L'170HZAE88((R
M"*9'!#"%$44:!1M&U0,#T^E<S\1M=U'PWX%U+5-+B#7,28$A9?W.>-^""&P2
M./>L&ZUS6HOB%I+#2)GO9]%G_P")>MTNQ6$R89G^Z!M'7!/(% 'HK0Q-&\;1
M(4?.Y2HPV>N1WHCBCAC6.)%1%& JC 'X5R$/CX3:*)_[(G&K'46TL::)5)-P
MN21OZ;0H+;O3M6OH&OOJ\M]:7=BUAJ-A(J7%N9!( &7<C*P^\I'L#D$8H V=
MB>9OVC?C&['./2F-;P/.L[0QM,@PLA4%@/8U@:OXFN[767TG1]&DU2[AMQ<W
M($ZPK$C$A1DYRS;6P/;DBH3XPN;^QTRX\/Z%<ZE]OMS<Y>001PJ, JSD$;\G
M&T>A["@#J!&@D,@10Y&"V.34:6EM&@1+>)5#[P%0 !O7Z^]<C=_$2W@T+0M3
MM]+NK@ZQ.;:*W5E$B2@-\A[?>0KG.._2LJYO]1F^+WA);N&2R>;3+EIK,3^8
MJL,XR1PWUH ]$6V@4R%8(P9?]80@^?Z^M+%!#!$(HHDCC'1$4 ?E7!:)XMTN
MQT?Q%>VFG7F^'7I;$6[7!E>YN69%&S<<(I+#CH ":T)?';Z?:ZFNKZ/+::C9
M)#(MJDZR"=97\N,J_ ^_\IR!CWH ZR*UMX%588(HPN=H1 ,9ZXQ3IH8KB,QS
M1))&>JNH(/X&O/\ Q;XS\1Z5X(UN]&@2:?J%FB;9&F26(*^0)%;&'*D8*D=P
M>E=SIT]U<V$4U[9_8[EL[X/-$FSDX^8<'C!_&@"8P0DL3$A++M;Y1R/0^U)%
M;P0*JPPQQA1A0B@8'H,5Q<_Q#ECM+S5X- N)_#UG,\4NH+.H8A&VO(D75D!!
MYR#P>*YSQ5>:KK'Q8TK2CI]Q<Z:EB]S%;PZF8%G^8 2DJ1T[*?ZT >M+&BNS
MJBAF^\0.3]:8;>!IUG:&,S*,+(5&X#T!ZUF>*]<7PUX4U/660.;2!G1#T9^B
MC\6(%<?J20>%_#'AB/7$O-0O[W6;?SI4NFC(NI Q+'!Y13D;.F /2@#T8(JL
MS*H#-]X@<GZTR.V@BE>6."-))/ONJ %OJ>]<B)YO#_Q,BL/-=M.\00231QLQ
M(BNH@"^WT#(02/52>YJ7XCZ_JGAOPE)?Z5 'G\Z*,R%E'EAI%7."#G.<>V<]
MJ .I2W@CF>9(8UE?[[JH#-]3WJ1T61"CJ&5A@@C((KSF;6]:A^)FR'1Y9[R7
M08G-B+M5CB/GR99GZ>@X!)R.P)&K!X^%WHUA/::3/)JM[=2V::<TJJ4EB+>9
MN?H%7:3GGJ..: .L%G;+Y6+>$>3_ *O"#Y/IZ4Y((8G+1Q1HQZE5 )[UE^'M
M>.MQ7:3V;V5]93FWNK9W#[&VA@0P^\I5E(/'6L[5O%MW:ZK>6.E:'-JC:?"L
MUZRSK%Y88$JJ@_?<J"<<#D<\T =));02K(LD,;B0 .&4'=CU]:7[/#_SQC^Y
ML^Z/N^GT]JYQ/&U@=0TY)D,.GZG9?:[._=P(Y,+N9&_NL%^;GJ ?2L^3XA[-
M&TO4UT.Z>/5KXVEC&' DE4JQCD(.-H;;T)X!!)H [*.V@B""."-!'G8%0#;G
MKCTH:V@>=9V@C:91A9"@+ >QZUQMQXO^T:7XFL-;T::RN]/TY[J6V2Z#>? 4
M;F.1<$'Y6'0$'%01>-X=+T+PC!INBW5T^LVA-G;_ &C+J5C5@K.W7AN6)X )
MYH [T(H<N%&XC!..30J*B[44*/0#%<EJGBW5].CDD7PK=3):6B75\_VA46/(
M)9(R1B5E .<8'3GFJ7_"7:O<_$C3M+L; 3:1<Z7]LWF9%+(SQCS>1D;06&W/
M.<^E ';-;0/,LSPQM*HPKE06 ] :<L4:E2L:@J-HP.@]/I7 :+XOTC3= \2:
MG!8WBBVUR:T: SF9[FX)11LW'Y0Q8 +T'-:]KXPNX]3;3-:T1]-NWM)+NV"W
M*S),J8WKN &&&1QCH>M '4&&,HZ&-"KYWC:,-GKGUI(K>& *(H8XPHVJ$4#
M]!7$6/Q%GNK?1-1F\/7%OI&KRQ017;7"%DDDX7,?7;NXW9]\8(KK-;UBT\/Z
M)>:M?%A;6L9D?:,L?0 >I. /K0!:BMH(6=HH8XVD.7*J 6/J?6GHBQH%10JC
MH , 5R=MXPU%-3LK#5_#LNG2ZBCFQ)NDD$CJN[RWP!L8CZC@\UROPZFU36/'
M'B/4M3L;EI+?49K996U$LEHH48B$0.UNOWL4 >L4444 %%%% !1110 4444
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M2KFWU#4+>3[07 412Q ;LC_:Y(]JL^,HH)]$6&\T&76;)YE%Q# ?WL:X)$B
M8)(;;]T@X)(Z8K=:WA>XCN&B1IHU94D*_,H;&0#VS@?D*DH \E;3M;CT:VNX
M;#6;G3M-\007EI:7AWW@M5CVO@$[B [,54G.!4FL:-J_C+4O$\D>EW5C!?:%
M';6;7:["\BRNV&'\.2>AYQ@]Z]6HH XC^WM:UZSFL8O#5_9QG3YA=R7B;,2E
M,+'%@G?DYYZ8 ]:IS:-J+>!O 5H+.8W%C=Z:]S'MYB5%PY;TQWKNAJ-DVI-I
MHNX#?+%YQMA(/,$><;MO7&>,U9H XWXK@GX7Z\!C/D#K_OK5"]DU;Q/XIT%X
M=&O;#^R?/N+B:[C"QB5HC&B(V3O^9B21Q@>]==XBTRPUGP]>V&J2&.QEC_?N
M'";5'S$Y/3I5^":*Y@CG@D26&50Z2(<JRD9!![@B@#QS3M)O$D\+:@WAO6FU
M*QO$?6+RZ+.[N4=&* L=R[FSE1@#'OB_J6BW+?$]_#4*JVC:K/#KUTH/W#%D
M.I'H\BPG/UKUBL71/#%CH=S=7<4EU=7MUM$UU>3&61E7[J@GHHR>!0!G:3I]
MW#\1?$]]);R+:W-K9)#*1\KE1+N /MD?G7+VN@ZJGPG\*Z<UA.+RVU&TDFA*
M_-&JW&YB1Z <UZG10!Y%<>%K6UU+7+/4?">JZM<7VH2SVTD%S+';2QRG=B1E
M<*FTE@<CD#C.:[+P]IMQ9>-_%5P]L\=I.+,6[D?*X2(J<'O@\5U=% 'D&EZ7
MJ^AZ5\.+Z?1K^8:4MU'>06\6^6(R(54E<],]?2M"XL[AO%<5SI/A[5])UIM2
M4WDT3G[%<VX?YW<YV,6CYZ!@Q'IFO3Z* ,3Q8B2^'IXIM%;6;9V59[-"-[1[
MAEE!ZLO4#(/'!S7GQT?59]&O+?3['61I"ZII\EC;:B6::,)*#,0&)81@!<;C
MV:O5KN[MK"TENKN>.WMXEW22RL%5!ZDG@"I00P!!R#R"* .&\4:=K4WB^2]T
MB&02KX=O(+><<*MPSH8QGL>,_A7/Z)I;6_BGPQJ=GX:UFWAA62"^N;W>TK2R
M1XW,&8G:"#E^GS#'2O3+;6]*O-1GTZUU.SGOH 3-;Q3JTD8!P=R@Y') YJ]0
M!X?<>%M=;X':_I*Z5<G4)]5:6*WV?.Z>>C;@/3 )KV\?=%+10!Y<F@ZJ/@=8
M:3]@G_M!)H&:WV_. +M7/'LHS]*T+>XU+PAJ_B6'^PM1U"/4KPWUE+9Q!U=G
MC53&YS\F&3J>,&O0:1F"*68@*!DD]A0!Y59:#JGA.Y\ /+IUU>II]E<VUX;-
M/,,4DH0C(S]W(89]JZOXDV%[JGP_U6STZW:XNY1'Y<2C)8B1#_(&NEM;JWOK
M6*ZM)XY[>50\<L3!E=3T((X(J:@#SO48;_QGXIT=?[(U#3K?3H;LW4UW&%7S
M)83$J(03O^\QR., <\UF>$O#MG;2Z%8W/A#55U2P*_:;N>ZE%M$T:D"5"7*O
MN(&% X#<XQ7J]07%Y;6CP)<7$433R>5")'"F1\$[5SU. 3CV- '(?%5I5\&(
MT$8DF&HV91"<!F\],#/;FJ=P+_Q1XOM]0CT?4+*TTS3;J,M>1>6TLTP4!%&3
MN "DY''2NRUG1K77;%+2\\SRDGBG&QL'=&X=?PR!6A0!YHGAS5G^#>@V<5D_
M]JZ;]ENOL;D*SM$X8IST) /XXK2A:\\4>.]&U1=)U"PL-)M[@N]]#Y322RA5
M"*N<D  DGITKN:* /+/#_A?58/&5OH]U9R)X>T*[N;ZQF(_=RF7!B0>\?F2_
MD*@U#PCJ^JZE\484M)(UU6&T%C(XVK.R1'(!^H _&O668*I9B H&23VJEINL
MZ7K*2OIFHVEZL3;)&MIED"-Z':3@T <+=WFJ^*?$7A.9?#NIV5M9W$CWLEU%
ML\MF@=0%YY&2?FZ<KUSQE>%O"UI8#1])O?"6JRZG8SJ)KQ[F5;11&V5G4[RK
M9PI" =3@@8KUVB@#Q^[M]<L/AYX@\&0^'M1N+UGNQ;W"1@P2Q22-(&WY^]AB
M-O7./J/6;)62PMT<$,L2@@]C@5/10!X[HVEZS;^"=!MSH=^+_P ,ZM]IG@>,
M#[3&SS!O)).'(5P>WIWKK=(2\USX@OXB;3;RQL+;3#91?;8_*DFD>0.Q"=0H
M"@9.,D\5VM% '(?$FS9_"4FJP%5O-%E74[=F.!F+EESZ,FY?QKGD\-ZG??#4
M:A%;>9K=YJ,>O26Y8 NWFK((LGH1&%49[BNVUWPQ8^(VMUU&6Z>UB;<UHDQ6
M&?!!'F*/O $#@\5H6>HV-^9ULKN"X-M*89A%(&\N0=4;'0CT- '%3)>^,?%N
MF7L6E7^GV6FVET&DOX?*:269 @15SD@ $D].E8%LFMW/@_PGX?'AS4XKG2=0
ML?MLDT0$:I%(H+(V?G'&<C@ ')Z9]>HH Y7XE_\ ),_$?_7C)_*L5I-2\3:O
MX4MCHM]9II<_VR]GGC"Q K$R*L;9^?+-V[#GTKMM9TFVUW1KS2KS?]FNXC%)
ML;#;3UP:9I6KZ3J2R0Z7J5I>_9<)*+>=9#'Z!MIXZ'\C0!R/AK2-0M?AEK-A
M/9RQW<SZ@8X67#-O>0I@>X(Q]:Q]&TC5M!T;P'JTNE7<S:7:3VM]:0INFC$H
M&&"=\%!D#G!KU>B@#R+Q%HNL>(-!\;ZK#I-W$VJK9065I*F)G2%P6<IVR6;
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M4^4J!&>A)W-R..M %[QQKMUH&C6]Q;30VJS7<<$U[/$9([6-LYD901D9 ')
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M<E&BF9 K;_E*D\G!W>BU-J'@KQ+/I>O:-:/I4=K?WTE^EV[OYTI:02+&Z[<
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ME\V61=C.Q95V@+G Y//)J]X%T&Z\,>#-.T>]DADN+8.':$DJ<NS#!(!Z$=J
M.BHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA7L@E19"H] &+'\:L^/%U/[/ISVL>J2Z<EP3J$>DR%+EDV';M((8@-C(4YH
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M5Y<7:Z=J\]I!+<N7D,:A64,QY8C<1DT =1%:6MO/<7$5O%'+<,&GD5 &D(&
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M ,8KUVVE,UK#*0 716('N* ):Q/$7BK3_#7V)+M+F:XO9#%;6UK"99)6 R<
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M\J+\HX'J3UKJZAN;NVLX#/=7$4$(ZR2N%7\SQ0MW;/!',MQ$8I2!'('&UR>
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MC@$*SN!ND*@G&:ZB&^L[F>6""Z@EFA.)(TD#,A]P.E322)%&TDCJB*,LS'
M]2: ,;PYX:@\/#49%N)+FYU&[>[N)Y  S,W11CHH P!1<^&H9O&%EXDBN)(;
MJ"V>UE10-L\;'(#?[K<BKXU;3FL)+Y+ZVDM8_O3)*I0>V<XKG/ 7C"Z\::<^
MIO9V=I9R9-O&EWYL^ S+F1=H"YVY')H ZF\M8KZRGM)UW0SQM%(OJK#!'Y&N
M/A^&UG#X#?PP-1NB6G%S]OP/-$BN&5AVR H7Z"NNN;^SLWC2ZNX('E.(UED"
MESZ#)YHN+ZTM YN;J"$(N]C)(%VKG&3GH,\4 <_J'@>QOM,\-V"SRP0Z#=07
M$ 0 [_*& K?7O3+OP5Y^NZSJ,.K7$$&LVHM[VU$:,KD1M&K!B,K@-G ZD5U$
M4L<\2RPR))&XRKHP(8>H(J*:^M+:>*">Z@BFF.(XWD"LY]@>M &//X4MY],\
M/V)N90FBSP31, ,R&)"@#?4'/%9=W\/O.74+*WUR]M=%U&9YKK3XT0ABYS(J
MN1N16/4#U.,9H\4>.9-(\2Z=X?TVWL;B^NDDED>[O/(B@50#AB%8Y/88HMO'
M4FI>/KOP[IUO8O:V(B^TW4MYM9S(I8") IW$=^10!;OO!SOKHU32=8N=)=[5
M+2XC@BC=9(T)*XW [6&XC/Z52_X5S!!X>TC2[#5;JUETF]>\M;K8LC!F9R58
M-D,,2$<^@KKH+ZTN9I8;>Z@EEA.)$CD#,A]P.E(NH637;VJW=N;F,;GA$@WJ
M/4C.10!/$K)$BNYD<* SD ;CZX%<7<?#M)H/$%F-9N5T[69S=26WE(?*F9D9
MF5L9_@Q@\<UJ)XLM=3TK5)]#EM;BYL97AV7$XC1F4@$EAG"\\'%;-I=+/$BN
M\/VGRU>6..0-MR/Y=<'O0!1U'0(-2U[2]5ED8-IZ3HL6 5D$JA3GZ;:S-'\'
M7&D3V42>(=0DTJP)-I8$*H48(57<#<ZJ#P#Z#.<5TCWEM'YV^YA7R #+EP/+
M!&06]./6EM[F"[@6>VFCFA;[LD;AE/T(H D(R"/6N-TGX=V>D:'H&EQWT\D>
MC7S7L;LHS(Q\SY3[?O#^5=7<7]G:;OM-W!#M4.WF2!<*3C)SVSQ1)?6<5U':
MR74"7$@RD32 .P]AU- %&TT&*T\1ZKK*S.TNHQ0QO&0,((@P!'UW'\JX6Y\'
M2Z9X@\#Z1IU]=PC3K.^$=\D:DHQ\K&X$%2""PP>O;GFNKM_%$D_Q%O/"YM5$
M=OIZ7@N-_+%FV[<8_7-;L-]:7,\L$%U!+-"<21I(&9#[@=* .77X?VDNCZA;
M7VH75SJ%_=)>2ZB J2K,F/+9 !A0NT8'/?UJ6#P6\EU=7NKZW>W]_-9M917"
M*MN;>-CDF,(.&) .[V':NCCO[.:[DM([N![F,9>%9 77ZKG(HCOK.6[>TCNH
M'N8QEX5D!=1[CJ* .:C\%SSR7$VL:]=:E.]C-80.\,<?DQRXWG"CYF.U>3Z=
M*AD^'\:Z!X?TZRU:YM;C0G#6MV(T<GY2IW*1@Y!KJUOK1[QK-;J W2C<T(D&
M\#U*]:L4 <Q'X)L?[<U[4KJ:2Y&MVL=K<PN %VJFPXQZBJ]AX&DAN=,.HZ]>
M:E9Z4P>QMIHXU",%*JSLH!<J"<$X]:W+F^NX==L[5([3['+&[2R27&V52!QM
M3'S#U.>*Y_1/'$GB#QEJ&DV5O8C3["7R7N7O/WLS;"V8XPN"H/!.[IS[4 7#
MX+MCX4UG0/M<WDZI+<RO+@;D,S%B!],\5TD,0@@CB!)"*%!/? Q69JWB/3-$
MN]/M;ZY6.6^F\J(%@,':S;FR>%^4C/J15/3/%=M=:AK-M>O;6:6%\+2)Y)@/
M.S&CYYQS\^,#TH IW_@B6:\U-]-UZ\TRUU5MU];0QQL'8J%9D9@2C,H )&?6
MK-QX+L)+_P ,W$$DEO%X?#K;0H 5960)@D\\ 5O75[:6,8DN[J&W1CM#32!
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MKGTR* )Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5W(0<' R,XH \]M/"NIQ6&C2"+P_X@N;"SGMWTR:XWIY+3$HT3LO!"J(R64
M[<9XINC6^@:]XY\-8L -/7PY(UM971\S8RS*NT[B=VWYL=>F1TKN[SP1X=O8
M+.&33A&EG%Y,'V>5X"D?]S*,"5]CQ6/=^!;6[\9V3OIR+HEKH[6L/DRF(Q2^
M:I4(5(9?E#<CU(SS0!PS03K=-HFG6MG-I:^+YHXK2Z<QVQ(M_,$1VJV%$FXA
M<$;@!5[5-)O]-MKJVU&/2;73-3UW3DNK#3;AGCB1B!)O!1=H?$>1CG)]:]('
MA#0!H T,:;&-.#^8(]S;@^=V_?G=NSSNSGWH@\(:#;Z-=:0NG1O979+7"2LT
MC2MQRS,2Q/ P2<C QTH XGXAZ#X9T_PKXJ%C!:P7[Z8DLEI$%50%8A)=@& W
M+#=UXKT/1K2VLM&M(+2WB@A$2D1Q(%4$C)X'')YK.L_!?AZPT^^L8=.4P7Z;
M+KS9'E:5<8 +N2V "<#/':M'2=(LM#TZ.PT^-X[:/.U7E:0C\6)/ZT >.RV=
MK8>!OB#-9VT-LW_"0/:230QA&2V:2 .H(Y"[2W'2NPU/2].T/XA>#/[&LK>S
M>?[5!,EM&$$D AW?-CJ P0C/<^]=*GA#08]0U&^73D\[4D9+P,[&.8-C=F,G
M;DX&3C-)H_@_0M!NS=:?9%+CR_*$DLTDK(G]U2[':OL,"@#!^*<-O<Z1H4%V
M<6TNNV:2\X^4L01GZ&L3Q"-)\*^,]4>WL5AL)/#$TE[:V0\GS-LJJA^7&&(9
ME#=1^%=;XXT&?Q#9:3:Q6R7$,6JV\]S&Y !A4G?G/7@]*M67@SP_807T,.GA
MEOX_*N3/*\S2)@C:6=B=O)X!Q0!P=CH?E^-].T>^TG1].@O=#NH)K73I"Q:+
M,0 D)5<D?-@\\[JKZ?<7&O:?H/P_O6\RZT_4'CU3/\=M:%60D>C[H.>_-=[%
MX+T+24BO-/TIY;VRWR6Q-U(9&;;C9O9N0< 88[1Z55\*:!>1Z_K/BC5[*&TU
M+4_+B2WC<2&&&,8 9QP68\G''"CM0!Q\VAZ9?Z/\4KR\LH;BXCN+D1/*@8Q[
M;9&!7/W3G!R/0>@JW%I5CIU[\-;VUMHX[RX9A/<*H\R;?:LS%VZL2W//>O0A
MH&EBWU.W%HOE:HSM>+N;]Z64(V>>,J .,4YM#TU_[-W6JG^S#FS^8_NCL*<<
M\_*2.<T >2>&]&UK4_#NCZH+/P];7!U);I]4ENW6Z>3SR)$;]UR6&Z/;NQT%
M7!H.EWWA/XE7UW8P7%TM[J CEE0,T>R,,NTG[N&)/'>O0$\%>'H]9_M9=.47
M?G&X'[Q_+$IZR"/.P/\ [6,U>70=,2RU&S6T46^I/))=IN;]ZT@PY//&1Z8H
M \]TBSL[KXG:)=W=M;R3-X4CN7FDC4MYHD0"3)'W@._44[PQID?AG5_#]GJ&
MD:=<"4R1Z;KVGR8:<F-G_?+U)9 QSEER >.#7;7'A'0[J\TV[EL?](TU%CM9
M$E="B @A3@C<O X;(J/3/!7A[1]02^L=/$4\>X19FD=(=W7RT9BJ9Z?*!Q0!
M@_%:TMKG1=&-Q;PRXUJS0>8@;"M* PY[$=?6H],TC3-2^)7B6VU'3[6>*QL[
M."Q@EA5DB@9&+;%(P 6&#CT KLM9T73O$&FOI^J6PN+5RK%"Q4@@Y!!!!!![
M@UFWO@CP]J"6RW%BY:VA^SQR)<RI)Y?]QG5@S#V8F@#-^%[,?!:Q*Q>U@O;J
M&T8G.85F<)@]P ,#V%<_I>A:%JNH_$275+2VN)%O71C,@8Q1^0ARN?NY.>1_
M='H*],LK*UTZRALK*"."VA0)'%&N%4#L!6%?> O#.I3W,]SINZ2ZD,EPR3R)
MYQ( P^UAN7"CY3Q[<F@#S7P_'K.NWNAI+INE:H\7ABV=(]7F95 =W#NH$;Y8
MA4!)QQCUKTSP-8W6F>#K"RO+BUGDAWHKVLQEC";VV*&(!.U=J].U6-5\)Z)K
M*6RWEB/]%0QP-!*\+(AP"H9"#MX''3BM*RLK73;&&RLH$@MH$"1Q(,!5'84
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M4)H!;R3;CEHP<A<9QU]JHZ9X+\/:-?B]L-.6*=0RQYE=UB#?>$:L2J _[(%
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M^\M&6!WD;9NW@JH.UER?[WO6E<6UC):6%Y:ZS+K*WGBZS::Z>%$C>10%)38
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MUGG%RT9EA\ZVDC6=!@%HV90''(Y!/KTKR[4;VT'@GXF:4]Q$+_\ MB>X-JS
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M6OD!C_U641<<YY^3KQUJC/XOO4ATVVB\/SG6KYI0+":98Q&L1P[M)@C9RN"
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MMI.5))ZE6W*?P% '9^1#Y_G^4GFXQYFT;L>F:#!$9A,8D,H& ^T;@/3-244
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M(],^E.2../[B*O ' QP.E.HH R]>L]7OM/\ L^CZE#ITSG#SR6_G%4(.=@W
M!NF"<CVJ30]'M?#^B6>DV086]K&$4L<LWJQ]R<D^YK0HH CC@BB9VCB1"YRQ
M50-Q]3ZTBVT"+M6&-5W;\!0/F]?K[U+10 BHJC"J /0"F1016ZE88DC4G)"*
M ,_A4E% #'BCE*F2-'*'*EE!VGU%)Y$)G$WE)YH&/,VC=CTS4E% !4<=O#$
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MC,N/WR@ B1?]DY(_"KU%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&&5.00>A!%=_7@EI<1R:9X!M_-=KFV\57"7"2X$L;&:1@) ,8;!!Q@=:][H
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MTS4;G3I#>3WUNB226]K:23.$8$AL*#QQR>V1ZBEN/&VAPZ3INHQW$MU%J?\
MQY1VL#RRS\9.U -W !SD<=ZQ/"5Q;7WQ"\2WEM+'/%)8:<8Y8R&#*5EZ'TKC
M_"][;:+'X$U;4YDM],6+4[;[1*=L<,K397<QX7(5@/I0!VWA_P 8#4-0\7WD
MUT[Z7IC1-"KQ>6T*B -(I! 8$,&R&Y!XHT;QC_9_AG1/[>DNKO6]0MOM9MK.
MT:64(QW?<C7A5#*N3UQW-<1=:E!K,WC&STYCLU_5[&PAD48WH\2^8X]5**Y!
M[@YKKKJ^L/#'Q2FO-7N(;&QN]'B@M+F=@D0:.1RT>X\ X93CO0!N3>.O#MOH
M=IK,E_BQNIC;QR>4V1( Q*LN,J1L;((ZBMC2]1BU;38;Z".>.*4$JEQ"T3C!
M(Y5@".G>O'S$+FRTF_\ +/V+4?'HN[3>N-\1#!7 /9BI8?7->UT 96M^(M/\
M/QP&\:9Y;ERD%O;PM-+*P&3M102<#DGH*HMXZT :/#J:W,KQS3FVC@2W=IVF
M&<Q^5C=N&#D8XK)\4WEOHGQ!\.ZSJ<JP:6+6ZM3<R'$<,K&-EW-T7<%8 GTK
M&O=>TB?Q+X;\4PP&UT&"]O;>:^>,)$\CQJJSY'5&*LN\X_*@#KT\<:$VCWNI
MR7$T$-A(L=W'/ \<L#,0%#(PR,[ASTQ3;;QWHMW=36T8OQ,ENUS&CV,JFXB7
MJT0*YDZC[N2<\5YSXIGM]:L_'NL:>ZSZ5+%IUJMPG,<\B2Y?:>C !E&17<Z^
M/^+G^#\#_EVU ?\ CL5 $&A_$W2K[PG:Z[JB3Z?%/.(-TEO((RS%MNUB,,,+
MR1D \5IR^.](BM+.?R=2>2\5WAM4L)6G*(<,YC"[E7..2!G(KR[2;RRO/A;X
M(TY9HI;BS\06<5W;Y^:)C-)\KKVS@]:[CQ;K7V7QG;V%WKIT&R_L\S)<PQ1F
M:YD\S!B1G5N@"G:HR2PH Z"Y\9Z);Z38:DMQ)<Q:A_QYQVT#RRSG&2%11NX
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MR-U(NGSZC.PDVB*.,87L<[FR/;!/- '28&<XYIJQHA8HBJ6.3@8R:X!?B/J
M@T6\E\+S+8ZT%CLG6[5I&E9-RJR;0%4X.&STY('2KB>/I+6WUU-7T=K74-),
M -M!<"83^><1!&PO);CD<4 =K28&,8&*XV?QQ>:9;:NNLZ(+2^L-/;48X(KL
M2I/$N00'VC# X!&.X/-$'C;46U/2X+KP\;:UU=7^P3-=@LSB,R!9$V_)N ..
M3CN* .Q:-'969%8J<J2,X^E.KB_AUX@UOQ#IU_<:M:1QHE[/'#(LP8X61AY>
M HX4 #=WZU;\2^+KG1-<TS1K+1WU&]U**9X%$XB ,>W(8D$ 88G/^ST)- '4
MD ]133&A<.44NO 8CD5QU]XUU*"6_P#L?AXW<6E1HVI.+L*8W*"1DB&W]X54
M@GE>H%98OQ>?'/2YK>9GM)_#1F0 G:P,I(./I0!T.LZ!KUWJ%S/I?B7[%;W,
M0C>":T$_E$ @M$=R[21USD9YK6T?1K31-%L-*MDW6]E$L41?EOE&,GW_ ,:Y
M^T\8ZFVI:?%J/AR73[/4Y7ALY9+@&7>%9E$L>T;-RH<<G'>N:M_%NIW_ (,\
M97GB/2%FL+&ZN(O*BO=K81E'D@JH( Z[^I]* /5-JYSM'7/2EKC1XJEBBT/2
MM"T?[7?7>G)>""6Z\M+> !0"\A5B3DA1P2<$G%0R_$40Z0ES)HT_V]=672;B
MQ652T<S#(VMC# Y7!XSN[8H [C SG'--\M/,\S8N_&-V.<>F:XM_'L^FMK,.
MO:*;*YTZQ%^J070G6>(DKPVU<'<,'([YS6?XPUG6KGX?>)H]2T5M-D33S+#/
M!=">-P>,;PJX8>F._!H ]$\M/,\S8N_&-V.<?6CRTW%MB[B,$XY-<CI_BW4!
MKFDZ9J6A-9P:I&YLKC[2'9BB;R)$P-A*Y/5NF*Q-+\:Z=H_A;6M6LM$G6.'7
MWLYH!=-*TLC.BM(I;IG<,(...V: /2R >HIK1HY4LBL5.5)&<'VKF=+\4W\O
MB4:%K6C#3;F:V:YM62Z$Z2JI 920HVL-P..1SUJ_K.OC1M4T6UEMB\&IW+6I
MGWX$3[&9 1CG=M(ZC% &N45BI902O()'2E  Z"N8TSQI;ZCXPU?0?LS1+IZ;
MENF?*S;0OF #'&PNH/)ZU@6OBZQUSQ)X)NIM$E2[U2*\DLY3=L! BJ>60 !]
MZ@'G[N: /14C2-=J(JKZ*,"EP...E>-:IXG\0:M\/_&DNIVJV\=GJ)@CDBN
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M\G2&19@QP)6&S:%& H  /.>M=G0 4444 %%%% !1110 4444 %%%% !1110
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MDU&7S+5D:[M[2Z:)P&4X63:0=K GCO6O:6EO86<-I:0I#;P((XXT& J@8 %
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M6STN0/\ Z+ Z(5D,@+#;\VULX)(&!Z5H>"-)U6WUGP[/>:;<VL=EX9.GS&8
M8F66/C@GJ%)!]*])HH \Z_X16YO_  EXTL+Q#:27>JW-Y9S.0-I&QHY >PW+
M^AI_@*YO9?"FJ>-KZT+ZCJRFZ%NIP3%$FV) 3P,[2V?]NNMU[P_9^([-;2_D
MNA;;LR107#Q"4=U?:1N4^E7Q:6ZV8LQ!']E$?E"':-FS&-N.F,<8H BTR]&I
M:39WXC,0N8$F\MCDKN4'!^F:Y/PY_H'Q/\7V,WRO>K:W]OG^./9Y;X^C+C\1
M7;*JHH55"JHP !@ 5D?8](\07&FZ[;3"62U9_L]U;R=0<JZ$C[RDCD'N/44
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M5(!P<<'TKSR/QSJ%M\.-5O[Q8G\0:=<RZ<T:)A7N=^R/"^AW(WTS7HE<+>^
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M'A\TPMN3[H)&?O8Y]<\XQ6EJ'AS7/^$HU2^TRXL$MM6MHK>>:?=YUML# F,
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MB2&.7Q#I$Y?54LFT>WCWM'$\@0,9<Y\P9#$$8ZBIM&\/^(-9TOPE'J5QI_\
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M3!!0D E>H.0#R/0F@"KX5N[R]TMYKG5M/U:(RG[->V0P)8\#[Z@D!@=PX.,
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M3X+J.1&SN8RA,8XQQL.:S%\(W@T7QG9>?!YFNS7$ENV3B,20K&-W'JI/&>*
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M<8Y)XQF@#H:*R/#UUJ5W;WK:FL8:.^GB@,:%0T*MA3SU/'7H<<<5KT %%%%
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MVL;9+:TMXK>!.%BA0(J_0#@5-10 4444 %%%% !1110 4444 %%%% !1110
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M NGJWA9OM-S_ ,4Y&8[;E?W@V!/GX]%'3%=310!QV@VEQJWCK5?$\\$L%M%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%>;>-K.3QSXJC\'V]S)#:
MV-H][>RQL1MF=2D"Y'H27QW % 'I-%<SX"UZ;Q!X3MIKP;=2MF:SOD/59XSM
M?/UP&_X%3-9U[5SXK@\.Z%#9?:!9F^N9[W>42/?L55"D$L2&YS@ =Z .B>]M
M(XVD>ZA5$?RV8R !6_ND^OM4]>*_VTVF>!/$5]J&C65W*WBF1);2Y'F1JY=
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M,3ACGD,,,#Z\4 =Q17$W/CMY/ FBZUIMO%+?ZQ+!;VUNY.T3.<.#CG"X?/\
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M'BC6+35MC&ZYW/YB%CGZ8KDXOB#K=[IOA)K#3;)[[7Q<KMD=A'$T8R#D<[0
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M* "BBB@!"2%) )('0=Z\\T#X;6E[%>ZMXNL4GUO4+J2>8)</B),X2,%2 0%
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MG3Y_".A1_P!GX6;6-L;/,J A610 XD)VDECQSUXK,O/"WB]/A]?^![/3+5X
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M7%\3^#M4N[..WCTO2'LKI?.5RKXVC&.H.,^V:["S\4:)J!TX6NH12G4A*;,
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M85\R38#'+$4;GV;8P_W:[BN5N_B1X/L;V>SN==MX[BWD:*5"K$JRG!!P.QH
MR]7\#"VT?PQ%I^FVFJ+H0,;6-UM"W"-'M8@L" ^[##/'6M_PI8365E<O/H>F
MZ,9IMR6MDJY"  #S&4 ,V<GC@ @<U!-\0O"EO86U]+K4"VUT76&0JV'*$!L<
M=LBHK3XE>#KZZBMK77K>6:9Q'&JJ_P S$X Z>M &3J'A'6;KQCXKU"W=((=3
MT465K/YG*RX(R0.0 >]5-)\.:S;:YX:OXO"]AI=MIRO;3PP31F1@Z!3*2!@J
M"!@9+')-;A^*?@@$ ^(;8$]/E?G_ ,=JV_Q!\*)I4>IMK4 LI)C DI5L&0#)
M7IG.#F@#F-'^'U\ESXCL]1$0TR2TGL=+VMN*Q3RR2OD=B"R#_@-6O#^A>)M+
M\)WMQ>V%C?:Y?W2RWMK/("DL2JL>P/TSL3(SD9)!K?TOQ[X7UK48M/T[6(;B
M[ESLB56!; )/4>@-5I?B;X,AFDBDU^V5XV*."K?*0<$9Q0 SP/H-SH\^KW#:
M7%H]G>2QO!ID4PD6$A<._P ORKN..%X^6NOJ"ROK74K.*\L;F*YMI5W1RQ.&
M5A[$5/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7E'VS7=1\!:GXZBU^]@NX3<W-M9J5^S+%"[*(V3'S9"')SG)[8KU>
MN%G^'MR]G>:-!K\D'AV\F>66Q%LID57;<\:2Y^5"2?X21D\T <Y>:>VK?&?1
M;A=4U*W%YHK70\J508@6'R+E>%]1^M>K7L)N;&>%9Y8"Z%1+"0'3CJ"0>:Q9
M/"L3^-K'Q&EP4^R6+62VPCX(+9SG/&.F,5T! ((/0T >%Z/871^&/@)X=3NA
M/=ZW"5>4JXMSB<$H,?CSGFNAU;6]6\%77BBSAU2\U!(-)@O;5KTB5X97E>(X
MP!E<A6Q[5M:3\/)].TG2-+EUPW%II.HI>6@^RA&"KYGR,0WS9\S[V!TZ5J:M
MX+M-:U75+N[N',6H:8NG/$BX*!7=PX;URW'':@# \+:E?IXKMK.&;Q)>Z?<6
MLAN9-7L9(A%,I4JRLR* &!<;>@P,5UGBS0V\2>%=1T=)Q ]S%M21AD!@01D=
MQD<^V:AT;1=:L[X7.K>(I-16.$PQ0I;"!.2"7< G<_ &> ,G YJ]KNCQ:]HU
MQITL\]N)<%9H'VO&RD,K ^Q H Y$ZY?0ZEI%GXU\+0P'[6B66I6DPFMQ<$%4
MX.'CSD@9!ZUA>'HY-)L?'^HOXDN[4P:G-;BXN0)D0[(L2%  6DZ*/P&#76)X
M0UB^O+%_$'B8ZC:64Z7,=O%8I;^9*G*-(P8YP><# R!5:Y^'L\S:_#'KC16.
MK7*WRP_959H+E6C8.'W?,N8Q\N!]: .>@U"\EE\0:-%J7B(6C:(U[')J<?E7
M"2*Q!*$J#M88R,<<XQ52PU"XT?P?X&TI=1UO[/JEF;JXDLHC-<(B11XBCVJ2
MJ;G!S@D 'GFNTB\%7LFM/JNHZ\UU/<V,EA=JMJ(T:)N5$8W'9@Y/.[.3[8KV
M?@/4;+1M(MT\1 ZAHQ*6%W]B "PE AB=-WS@@#G(.0/2@"]X#U#4+W3[^&^&
MHO';7C1VEQJ%LT,TT)564L&49()9<XYVU!XAN+[5/&^F>&;?4+G3[5K*:^NI
M;4A99 K*BH&(.T98DXY.!70:+I]YIUDZ7^IRZC=22M*\SH$49_A11G:H X&3
MWYYJCKWAN;4M3L=7TW4?[/U2S5XDF,(E22-\;D=,C(RH(P1@B@#SCQ<]_/X'
M\=:)>ZM>W']AR1M#.64/-%)&KA)<#YL$GG@G KTOPA8-I_ABQC:]NKO?#')N
MN7#%<HORC 'RC' ]ZR)? "W/A;7=+NM4DFOM;8R7=^80,MA0 J \*%4 #/XU
MU=C:BRT^VM ^\01+'NQC.T 9_2@#S;Q?X?;Q%\3S!;S?9]0M]!%U8W/>&=+G
MY3]#D@^Q- \0CQ)XB\!74D7V>]AOKRWO;8]8)TMV#J?QY'L17<_V O\ PF?_
M  D7V@[O[/\ L/D;.,>9OW9S^&,5D77@&UF^(5EXM@O)+>2'+3VJIE)W\MHP
MY.>&"MCH<X% '%6GBO5[Y(];M9?$<]^^H8%C'I\C61MA-L*!@F,A 6WYSN'X
M5?GUO7I/#EUX<@U*5=?_ +>?38KHX\P1<SA_^_/&:Z>T\'ZCI]S]GLO$4UOH
M@NS="R2W D&7WM&)<\1EB>-N<$C-3?\ "%P#X@GQ7]K?)@V_9-GR^;MV>;NS
MUV?+C'XT 8^C>);WQ'KGA..WN'CB.E/J&I1C@.QQ$J'Z/YA_X!7H%<OX6\%P
M>%]2U>\CNWN/M\I:-&0 6\>]W$:\\C=(QK1\1Z(VNZ8MO#>RV-S%,EQ;W,8#
M&.1#D$J>&'8@]0: //=;UJYT;5_%GV22XAEO=:L+0S6T)EEC1K:,L44 Y;:I
M X/)J#4/$.LZ=X8\6_8;G7OLMM8QW%E>ZI:O%+'*6*N@9U&X8"D>FXBNN7P&
MTFCWD=YJ\LVL75ZFH'4DA5"D\>T1E8^1M 0#:2<@GGFGWW@[4M9\.ZSINL>(
M7N9=2B6$/';".*!5Y^6/<>3GDEN>.F* ,C6K;6])TK3II]6UZ[M+F<S:I-8*
MK30 Q_*L2A<K$&ZX!/OUJA?^)6%CX;T^V\0ZIJ-C?/=227^GVC-=M%$1MC(5
M20P+@,VT'Y>V:[O5](U*ZCLGTK67T^XM<CYH?-BE4@ ATR,XP""",<^M8R^!
M)8+6TGM-9>+6[>[GNS?-;JR2/-_K%,60-AXX!R-H.: .:7Q#KVG:5!K$\^J?
MV;I6L>1.VH6S0R7-C*J@2.K*"6C9\9 &=I-=;I^H7NK?$;4XX;EUTG2;6.W:
M-?NRW,GSD^^U-HQZM5777M- \&7UEXFU*YU6;4EE3:L)W3,RX$<2+G:.F!DX
M/.:N?#SP_<>'/!MG:WS,^HS9N;UV.29GY()[X&%_X#0 >.]3OK#3-.M=.N#;
M7.J:E!8"Y506A5R2S*#QG:I SW-8EW<:EX7\0W&DIK%]>VEWHUS=0M>.'D@F
MBQR& 'RD-T/0CBNM\2:!%XCTM;1KB2VFBFCN;:YC +0RH<JP!X//4=P363;^
M#KN:]O-1UK6!?W\]B]A"\=L(8X(VY8A-QRQ."23VQQ0!'\.8=2N/"]AK>JZQ
M=WUUJ%G#(T<A411C;P54#.2#\Q).3Z4_Q=>7TWB#P[X=L[V:QCU-YY+BXM\"
M41Q(&VJ2#@DLO/7 -;OA_21H/AW3M(68S+96Z0"0KMW[5 SCMTJGXB\.MK4N
MGWEI?-8:GITK26MR(Q(!N7:ZLA(W*P//(/ YH X;6A?KIWCCPS<ZS?SV]CI8
MOK6=W7SMKQR!HG;;\RY3TS@XS73?#"P:S^'^BR&]NK@7%C!($G<,L7R#Y4P!
MA?KFI(/!;G3_ ! -0U1KO4]<MS;SW8@$:QIL9%5(\G &XGJ22>M;>@:2-!\/
M:=I"S&9;*VC@$A7;OVJ!G';I0!A7VI7NC_$G3H9[EVTC6+5X(XV^[#=1_,,'
MMN3/'JM<NOB#6]4MX9[?4IK>#Q%KQM+.1 ,V]E&K9:/((#/Y;')S][-:GQ1D
M@U?3K?PU8O*WB&>XAFLA"IS;X?!F9L850N_/Y5O:CX.M;KP[IFE65P]C)I+Q
M26%PBAC$\8V@E3PP()!'?)H Y'7=1U;PK-XDTB#6+VZB'AZ74[2:Z8/+;RHQ
M0@-@9!RI&<X(-=#JNJ7T-_X(2.Y=5OKDI<@?\M1]G=L'_@0!IR>!VO?[7GU[
M5&U"]U*Q.GM+% ($A@.<JBY;DELDDGD#TJ&S\$:E]OT.[U3Q&UZ=&D)MT2T$
M2LIC9#NPQRW(^;VZ<F@"K\/_ .UM8GU#5]2UJ\ECMM1N[2"T!41%%D(!?C+,
M.@YP ![UI_$;4-1TWPBUQI5R;:\-Y:QI)C(&Z9%(([@@\UI>&?#Z^'+&ZMEN
M3.+B]FNRQ3;M,CEMO4],]:Q?BG;FZ\$FW!D7S+^S4M']Y0;A.1[B@"E,VI^%
M_&%II_\ ;=_J%KJFGW4A%XRLT4T(5MZD*, AB-O2L&WO=?@^"EWXMG\07TNI
MSZ:KQC<HCAPP 91C.XCJ23G)KM+7PC>R:TVJZSK7]H3QVDEI:A+40K"KXWL0
M&.YS@#/ XZ4U_ \;_#/_ (0S[>P3[(+;[5Y7/!SG;G^M &+]IU?6?$_A[2AK
M-W:6MUX?-U=&W(#NX:,9#$':<MU],^N:PI;GQ%'X&\1ZPWB?43<^'KZYM[3&
MP+,D,G68;?G)!QV& .,Y)]#LO"R6>NZ9J@NV8V.EG31'LQO!9#OSGC[G3WJG
M+X'CE\+>(=$^WL%UFZN+EI?*YB\ULX SSC\,T 8'C'5YC?7YM]<UI+BUL%FB
MM-)M2R6\A5F#SOM((; PI(X!XYS3#?:UXG\5Z%IZ:S=:=:7WAQ+^Z%F55]Y=
M?N$@[3E@,^F1WK>O/!%Q<:CJ;V^MR6UAJL4<=];K "[[(_+^23/R J #P?8B
MI=!\&2:1JNFZC/J?VJ6QTG^R@!!Y8= X96/S'! 4#WZ\=* ,B+Q5=>&/^$RL
M]7N'N9=+'V^Q:7[TL$H^1!ZXD!3/N*ZSPO;:C:>&-.AU>YDN=1$*M<R2=3(>
M6'T!.!["N*UZRL/&?Q+T>*P,LBZ49/[7E5"(BJ.KQPL2,,?-0' Z &O3* /-
M+_7]6L8?%NB_;9#J7]I00Z;*<;DCN]H3;_N'S/\ OFBP\1ZI?P>#],-Y(M\M
MQ<?VK(N-SK:;D<-_OOL_.NCU/P7!J?C?3/$C7;I]C4![4)E9F4/Y;$YX*F1C
M1H_@N#2/&&K>(%NWE-\"([=D 6#<09,'/.YE![4 <6=1UU/ANOQ".NWIOB!>
M&QW+]E\DR8\K9M_N<;LYSSFMRQ.JZW\3O$%J^M7MOIFE/9316T!5?,9X]Q5B
M03LX.0.N[KQ4H^'4XTY=!.NN?#*S^:-/^S+YFP/O$7FY^YN_V<XXS70Z;X>7
M3O$VN:T+DNVJ_9\Q%,"/RD*]<\YSGM0!Y9X,\03Z@L?@W2[QM/N)=0O9[J]*
MX8(LQ)BAR,-(002?X5.>3TZN.TU77_''B?3#XAU&QT_3UM1;I:.H<.\622Q!
M)'&<=R3FKH^'5N/# TM=0D2[AOI+^SOTC >WE:0N"!GD<E2.XK)LM)UNZ^('
MB^33M;%A<[+*.61K,2QR?N/O!2PVL#G')'."#Q0!@R:Q>:Z?A;?Z@X>\.I3Q
M3.!@.T9,9;'OMS^-:'B+Q#=66H:AJ5EKFLW<]IJ,<(CM[0C3XD\Q$:&1BN&;
M!;+ Y!(Z8Q73+\.[2&+PI#;WLJ1^'Y6E7<@8W#,/F+'(P223^-5;WX=75W8Z
MCIB^(I(=+N;I[V&W6U7=',TGF?,^[YT#\A<#MD\4 1QQ:SXNU7Q)-:>(+W3#
MIEX;&PB@V^7O2-&+R@J=X+/C'H/QK)UK7]2NO$6M64E_KUO/ID4,5L-&L'EA
M:=HA(SR81LC+ !2>@]\UT=WX(U-KK4)-.\2R:?'JJJ=02.U5B\@0(TD1+?NB
MP _O8ZU-<^#KZ&_N+G0=?DTP7<$<-TKVXG9S&NQ9%8L"K[<#)R#@''% &[H-
MY=:AX>TV\OK=[:[GMHY)X74J8W*@LI!Y&#FD\0_\BSJO_7G-_P"@&B'3;N#4
M[:8:I.]G#:?9VMI%#&1\C$K/UW8!'OG-6=0M!?Z;=69?8+B%XMV,[=P(SC\:
M /(]-N/%=_\ !NSTNV\*6\]G-I2PBY^W*[F,IC>(2HRV.0NX<XYKK$T'2_&/
MPQTBWTR]DQ!;0OINH$8DAEC4!7/H<C!'U%1V'@?Q+I^B6^C0>-Y([&&$0*(M
M-C60(!C <DX..^*ZW0]&L_#VB6>D:>K+:VL8CC#')/J2?4G)/UH \^\)-J?Q
M!UN/5O$,$4-OX=F:U2T1MRRWZ<23'V7(VCMDFO4:PO"_AI?#,.J1I=&X^WZC
M-?DE-NPR$';U.<8ZUNT >>"U\2>$)M7C@T"'7]%OKN:\;R)@ER@D.75D<8DQ
MR!@Y(Q6/XQNM+O?#WPXN-%3R]-?7[+[/'MQL4;AMQV(QC\*ZG_A$-=LGN8=%
M\6RV>GSRO*()K)9WA+DLPC<L,#)) (.*6]^'UG/HWAK2[6[EM[?0KZ&\C++O
M:8QY)#'(P6)))_2@"MX=BCO?BKXPO+I0]U8K:6UKN&3#"T6\[?3<Q)/TJ2QU
M_2+GQY;I+X:U73]9NH)88KRZMUC66./#,,ASD="..XJ_K7A*:\UM==T;5I=(
MU;RA!+(L*S13Q@Y DC.,D=B"",TW2_"5W'KL.MZ[KDVJW]M&\=L%@6"& /C<
M0BY))P!DDT >>>&%?PIIL7C.W5C8O?W5KK42C.8OM,FR?'JA.#_LD^E;]LZR
M'XI2(P9&&Y64Y!!LUY%=CH'AF#1?#\NCRR"\@FEGDD\R/ 82NS%2,GCYL>]8
MOAWX=P^'=%U[2XM3FGBU0,B-*F6@3R_+5<Y^;:N!VZ4 <:MG;ZA\(?AW9742
MRV]QJ5G%+&W1E;S 1^1I_B&]N-+^'/BKP9JDK27>FV@>RG?K=69<!&]V7[C?
M0>M=O!X%CA\,^&]&^WL5T2[AN5E\KF;R\\$9XSN]Z/'O@*U\<Z=#"]W)8W4)
M81W4:;CL88=",C*GC\0* *%C%'?_ !COWO%#OIVDV_V%7Y""1F\QU'KE0N?3
MBIY_$&D-X[TZ.]\-:K;ZD99;*SU&:W58GX)8!@^2I"$C(_*M'7O"1U/4;35]
M-U.;2]9M8C"EW'&LBR1$Y,<B'AESR.1@]Z@LO"&H2ZU9ZKXA\02ZI-8LSVD,
M5LMM#&[*5+%026."1R<#/2@#K*X;4_\ DM6@_P#8(NO_ $-*[FL2Y\.K<>,K
M'Q$;DJUI:2VP@V<-O(.<YXQCIB@#D_'EQ?VOQ(\$3:98)?W:I?[+=YQ"&_=I
MGYR#C R>E9OC#4_$E[?^$(]7\-PZ;;CQ':,LR:BLY+?/A=H08XR<Y[>]=]J7
MAU=1\5:'KAN3&VE+<*(0F1)YJA>N>,8]Z/$GAU?$1T@M<F#^S=2AU 83=YAC
MW?+U&,[NM '*:<,_'[7!SSH<73_?%4TCU;P5X3?0=?\ #<.M>&+6-DDO;*0%
M_(R3NDA;!)'4E2>F:ZZ/PC$OC?4/$;W3/]ML%LFMMF  #G.[.?TK)/@76SI3
M:%_PF-P=#:,P&)K-#<>21CR_.SZ<9VYQ0!VMK+#/:0S6S!H)(U:-AT*D9!_*
MN*\!Q1W?B+QEJMRH?41K$EGO8?,D$:)Y:CT')/O7:VUO%:6L-M FR&%%C11V
M4# 'Y5S&H^#[O^WKC6O#VMOI%Y=JJWB-;K/#.5&%8H2,,!QD'I0!G74,>G_&
M2V:R4(=2T>8WR(,!_+=?+=AZ_,5SZ5A_#CQ7?V/P\T6VB\(:Y>)'!@3P+#L?
MYCR-T@./J*[70?"ATR_N]5U'4I=4UB[C$,EW)&L82,<B.-!PJYY/7)Y)JYX6
MT%?#'ABPT5+@W"V<?EB4IM+<DYQDXZT <4^N7.E_%?6I8-!U+46FTRSW1V@C
M+1<R?>W.!W[9Z4OCO6+W4O"&GW?]AWME<QZ[9B.TO61&E(D4C!5F !)QD^AX
MKL[70%MO%NHZ\+@LU[;0VYAV8">66.<YYSN].U1>+?#C^)])ALXKXV,T-U%=
M1SB(28:-MP^4D9YH @TW6?%-SJ$,-_X2CL[5B1)<#4TEV#'7:%!/-<=H'B2[
MT+4_&IB\.:GJ4":U/*\UH8MJXCCRN&<,3@9X!ZBNLMM"\7174,D_C19X5=6D
MB_LJ-=Z@\KD-QD<9K1T'P^NA7&L2K<&;^TK][T@IM\LLJKMZ\_=Z^] &#\-[
M::>VU7Q&T,-M!KURMY;VL,@<1IL506(XWMC) Z'WJO\ %_\ Y%*Q_P"PM:?^
MC*Z/PWX<7PT+^WMKHOI\]RUQ;VI3 M=W+JISRI;) P,9/6HO&?A<^+=#33EO
MC9.EQ'<),(A)AD.1P2* .AKROPCJOB*SN/$\6E>&DU&W_P"$@O"9VU!(?FW#
M(VE3[<^]=79Z'XLAO8);KQDMQ;I(K20_V5&GF*#RNX-D9'&:H6W@KQ!IEWJ3
MZ3XN%I;WU]+>F%M-238TAR1N+9/:@#K=,GO+G3H9M0LA973 ^9;B82[.3CY@
M #Q@_C7(?";_ )$Z?_L)WG_HYJZK1K34K*Q,6J:H-2N-Y/GBW6'Y>,#:I(]>
M?>JGA7PZOA?2'T]+DW :YFN-Y3;_ *QRV,9/3.* ,#QI_P CYX"_Z_KC_P!$
M-47Q'GN[;6O!LUC9B\NEU1S';F41[SY+\;B"!72:QX=75]<T+4VN3$=)GDF$
M83/F;D*8SGC&<]ZK^*_#-SXADTN>SU0Z==:=<FXBE^SB8$E"N"I('1C0 _1]
M6\1WE^(M4\,)IUMM)\\:BDW/8;0H//K7GWA/QE<>&O!-]-)X8U2\L;:]O)'N
MX#%Y>//<G@ONP._'8]J[S3M%\46VH0S7WBY;RV4YDMQID<>\8Z;@V15GPYX:
MAT'09-)>47<,DT\KEXP PE=F*D9/'S8]Z ,_X>:1<Z1X:<W2P1/?7<U\MO;N
M'C@25MRQJPX( QR..>*ZRL;POH+>&M&72A>O=6T,C?9?,7#11$Y6,G)W;>@/
M'&/2MF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "L30/$UKKUQJ-HL$UK?:=/Y-S:SX#KW5A@D%6'(/>MNO-/BG;76BBU
M\5Z'="RU8LNFROLW++%*=HW#U1B&4T =;8^++'4-8U>R@23[/I(Q=7S$"!9,
M99 <Y)4<GL*QH_B'+=VQU'3O">N7ND#)%[&D:^8H_B2-G#LOIQS4/B7PTF@_
M!O6-%T=79H["0L_5YFQF1F]6;YOSQ75Z%=65SX<T^ZL73[$UK&T14_*$VC'T
MQ0!FS^-])32]#U*V:2[M-9O8K.WDB X9]V"P., %2".H/:KWB;7[?POX<O=:
MNHI98+1 SI%C<<L!QD@=Z\BC91X9T74$PNEOX\^TVS]$6W,C@-[+G/YUW?Q@
M=5^%FM(2-\J1QQKW=C(N /4T =NK;D##H1FN9\8^.-.\%Q6C7L%S</<ER([9
M0S+&B[GD.2/E48S]:Z6,%8D!ZA0#7D=OJLWB#QMK^M'PSJ6LZ4L+:/9M;&+R
MR@)\\_.ZYW-QD#H.M 'IFK:U;:3X=N];<-/:VULUR?*P2Z!=WR]N147AGQ'9
M>*M"AU6PWK'(2KQ2C#Q.#AD8=B#7F6F:G<M\&/%GAW4HIH-1T.RFMFBN,>9Y
M!C+0LV"1]WC@G[M;<7_%$ZKINMK\NAZU%!!J(_AM[G:!'/[!ON,?7:30!JR_
M$>S'AK0]9M]*O[G^V9_L]M;1[!)O^;KE@/X#WJ:'Q]!%?VUGK>C:KHC74@B@
MFO8T,+N>B>8C, Q[ XKS_2!CP/\ "L'K_; _]K5VGQ>EM_\ A7&H6D@#W-XT
M4%G$/OR3&1=H4>HQG\* .VN)6AMI94A>9T0LL28W.0.@SQD].:X>?XCW5MJE
MIIDW@S7$O;M7>"(M;Y<( 6/^LQQD5W$"R+;Q+*VZ0( Y]3CFN)\0?\E?\&?]
M>M__ .@I0!JIXO5+S0[*^TF^LKK5Y9HXXIBA,7EJ6);:Q&"!QC-7O$/B&V\.
M6]G-<Q2R+=WL-F@CQD-(< G)Z"N1^(<%[<^-O T.G7J65VUQ=^7</#YH3]SS
M\N1GC(Z]ZRO'.E^)K2'0)=6\26^H6W]NV0\F/3A =WF<'<'/Y8H ZR]\<2P^
M(=1T:P\-ZIJ<VGB+SY+8Q!1YB[E^^X/3/Y5M:)JMWJL$LEWHM[I;(P54NS&2
MXQU&QFX^M<-:V6O7?Q0\9G1=9MM."_8?-$UE]HW_ +GC'SKC'/KUKO-%MM5M
M;-H]8U*&_N#(2LL-MY "X&!MW-WSSGO0!4\1>*;3P[]DA>"YO+^]<I:V5H@:
M68@9) ) "@<DD@"J6F>-!<:U!H^KZ-?Z-?7*LULMUL>.?:,D*Z,1N YP<5G7
MCI;?&W37NR%CN=$EALRW0S"4,X'OLQ^ KK;O4M/M+ZQM;J>)+N[=DM8VY9R%
M);'T Y- '/7'CHRZE=V6A:!J.M&RD,5S/;&-(D<=4#.PW,.X'2K%MXXTR[\,
MZKK20W2'2HY&O+*:,)/"R*6*E2<9('!S@^M9GPD9%\ P6C$"]M;FXAO4/WEF
M$K%MWN00?H17/:X5GU/XJ7%J0;=-#2"=EZ-.L,I(^H4J#Z4 >@>%?$UGXNT"
M'5[%)8XW9D:*8 /&RD@JP!//?Z$51T_QWINI^,M4\-6T-P;C3H3++.0/+;!4
M,JG.<@M@\=0:X;3=97X=K--(A-CJ^BQ:C:Q]FO(XT1XQ[OF,_G4WA/1)- ^(
M,-G<MOO6\+&>\D/5YY+IGD/O\Q(^@% &];?$])='AUJ?POK=OHTB"0WQ6)T1
M#_&RJY;:._'%=;K&M6>B:#=ZS=2?Z);0F9F7G<,< >I/ 'UKS'PKIGC#7_A7
MIFCHVB6NDWE@(&N=\KW A88;";0NX@G^+ J_X_N7GU;P_P"#M/TZZU&W@V7^
MH6UL4+FWB($:G<P&&<#//\- ':>%O$UKXKTAKZV@GMFCF>WGM[@ 20R(<%6
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M%/\ (2I8%OFZ?+VJWK>N^,-"TS3$G&A2:GJ.JQV4;)'-Y*(R,<D%MV<K],4
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MRQ;=*V-QYZ=!P.*Q]5\07UKXVTO0+6*W*7UG<S>9*&)5X]NWH>G/-<]J.O\
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MQ=9,)(T9#*<J0RD$8(K&@^'>A6UQ%/'+JV^-PZ[M5N6&0<\@O@CV-8>H:_\
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M%S!,\,T6>NUT(./;I2:%X3T?P[+/<6,$C7=P )KJXF>::0#H"[DG'MTK;HH
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MZ@ +F17.'QWVYP#W) YJQ?:'I^HZKINI74)>ZTUG:U<.1L+KM;@'!X]:T:*
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M4L+:(E5P%(P&.6(]:]8=%D1D=0R,,,I&01Z4V*&*")8H8TCC085$4  >@ H
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M^% ' ^([2VUCQ5\/[;2]<N1;F*^2+4+.Y661@D2#/F,&#$X().>_>I--TO\
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MH:C?PJ&F@TZT>=H0>F\J,+GT)S5[1/$VE>(+&:[L+@E;=BEQ'*C1R0,.JNC
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MKPLR] Z,58?@01^% %FBBLCQ-XCL?"FA3ZOJ E:"(JNR%=SNS$*%49'))]:
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M7A@N8@@=SDD QFM"?P9'/;:?_P 3O5EU&P\P0ZEYJ&<JYRR-E-K+P."O\(H
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M\DVQB.X8"/9NVE2 0<@YW?2NGT[3SKWQ5\1&]NKS[+IZZ?<06B7#H@E*$AB
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M9III8R5BVE3%@(!M8=3C<<#YN!5^Q\(:;8^#9?"RM/)I\L4T3&1QO*RLS-R
M!U<XX]* .$OHCHS?#&UL)[F&"XNE:9/M#MOS$I(.XG(SVZ#M5&:77-9?7-3L
M-&UVYUJ#4YXK"\AO$2WA6&3:L?EF4?*0IW94YW'KQ7>1> K(1Z$+G4]2NWT2
M?SK5YG3)^4*%;"#*@#V/O3[GP-:3ZA<SQZIJ=M:7<XN;JP@F589I.,D_+N7.
M!D*P!H Y?6('TWQ1=ZAXBAUJ&"6[B>QUBQNF,-I'A (I(PV%&[<"2K [Z['Q
MW_R3WQ+_ -@JZ_\ 1356OO UK?WEPTFJZHMA=3">XTY95\B5P0>ZEP"0,@,
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M?T;4;Z:QLM6L;F[ASYL$-PKNF#@Y4'(YKB-?AT6V^)W@DV@MX9/(O-Q@PH$
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M<@ L?4X 'X58KD? .N3:_#K]S)<230Q:Q-#;B1=K1QA(R$((!&"3P>0<UUU
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MH/+X5\<!NU>KT4 >5^'=2M[+Q%I=CX8U/49+2XG=;W0KV$DZ>FUV+!B,QA7
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M>O<?C61X3U"*'7-/TKPWJ]_?Z1+;RBXTZ]B)?30J?(-Y *_-A-C$^W2O4J*
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MPZFT3!'J*YGPO?0>&+SPGJNL%[:PN/"\=DD[1L5297#E&P/E)4\9Z[:]CHH
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MG(XJEX0\*QZ?>Z1#+X!L[*\LEQ=ZJ6B*LRK@/#M)8EC@_,%P">] #/#'C?Q
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M?,".<4 ,L_'&IS7>@75SHT,&BZZXBM9?M):=&:,NA=-NT!@IZ,<=_2JC^/\
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MFHP&6RO4U2UMKR!7*O!,)T62,X[?S!'K72>(M*O;[Q7X3O;:#?;V-U/)<ON
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M?B-+-%#I#W']H?V"+IO[5.GEQ((]AV9V?-LW8W8IUAX1CO[WQ5#KNGB6PO\
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M/;.>U '?45E:5JTVHZCJ]I+9^0-/N5@5_,#^:#&K[L ?+]\<<_K6K0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6;JGB+
M1=$9%U75[&Q:3E%N;A8RP]@3S6E7GWP[TVRUBSU3Q%J-M#=:G?ZA<+)).@=H
MHTD*)$,]% 4<>] &Q-X,\)Z_<-JWV9+I+LK)(8+I_(N2.C.BML?IU(/2NI
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M,T =QJ>LZ?HXM3J%TD N[A+6#<#\\K9VJ,=S@T0ZQI\^L7&DQ72M?VT:R30
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MH]1U33KB2S^SHB0!Y5=1&P&XXR =Q.<YXKV"@"K%J5G-J5QIT<ZM=V\:22Q
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ML3//-]H@=I;:210)#'A@&SC(!Z$]Z[FB@"GI.FP:-H]EIEKGR+2!((]W7:H
M&??BL;Q#H6J7>N:7K6CW-G'=V4<T!2\C9XV279DC:00P*#Z@D5TM% '"Z;X6
M\5:%'<C3]<L9FDOI+LK=6QVS^:/G#[3E2&Y7;QC@@]MWPKH4N@:;/%<2PR7-
MU=27<WV>/9$K.<E44DD 8'7J<GO6II^H6FJV$5]8S+-;3#,<B@X89QW^E6:
M./\ B8]JW@V:RO=;M]'M[Z5+>6YFSRAR61<=RJL/IFLI/%?PHCM5MEO=!\I4
M$84Q*?EQC&<>E=_<VEM>QB.ZMXIT!W!94# 'UP?K57^P='_Z!-C_ . Z?X4
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MGO _AV7PGX-T[0YKA+B2T5P944@-EV;H?]ZI_%.@?\)'HILTN3:W,<T=S;7
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MDUFXC%Q&+= 1\RD'!R,CD'/- ',Z7)=^+7^'MMJE]=M%=Z?>K>>7,T9N5C*
M;F4@\[02>IR?6K&H6M_JVM^)+:VT36+U].=++3)[74$B6RVPHRL TJDL6;<6
M(.1@9ZBO1+;PAI5G>Z+<VR20_P!CVTEM:QJWR['"@[LC)/RCG/K5?5?!-GJF
MHW5XFHZG8F]18[V.RG")<A1@;LJ2#MXRI4X[T <9KMGJ$,QU?Q7IVK2VSV$!
M^V:7=D/I4JI^]/EJP!^;+;@&&!@@@4S5C>>(O%7B&)-)U;54LXX(=/GLK](%
MMBT*R>8 9$RY9\YP>% ]J[/4O MEJ,]PR:EJMG;W4:Q75I:W 6*=579A@5)'
MR@*2I!(%/U+P18WUY)<VU_J6F-- MO<)83"-9XU!"A@5." 2 5P<=Z .5L],
MN]?\;VEAXE:X#+X9MI;RSCN"B/<>:X8G8>><]#CIZ"N=N;"'4- \+VUZ]Q<+
M:^+Y--C9[A]WD!Y0%)!R2 J@'J,<&O7+7P[8V6M+JL'FK,MC'8*F[*")&++U
MYSDGG-9=UX!TNZTD:>+F^@V:DVJ17$,JB6*=F9LJ2I&/F88(/!H XGQJL#_\
M))=:;9:Q=SZ1;!$O5OA##ITD<0<",%P7/*LW!)SC/:M*STRTOOC1!>SQN9V\
M/0WA(F<#S?.VYP#C& ..G?&:W[GX=Z9=O>B?4-4>VOU'VRU\\"*=P@3S& 7.
M["J3@@$@'%6(O!%I#JVF:I'JFJ+>6%LMH9!*G^DPAMP24;>1GTP: /-]'U&_
MF\&369OKE!J/C%M/EF64B1(6<%E5NJY V\?WJW]7LX_"GB*ZT[1Y)X;&^T"\
MFDMS.[K'+%MVR+N)*DAB#CK@=ZZ>#P!HL&@7VC W+6]W>-?%S+B2*8L&#(P
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M('VRPNHP&4X(S@D'((()XJE_PA&GR:1<V%U>:A=2W$ZW+WLT_P"_65,;'5@
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M=K345U/SY9@TDLZYY<XQCGH .@QBI=8\*Q:KJ!OHM5U339WA$$IL9E02H"2
MP96&1N;!&#SUH XC3].TG4OBMHE]%<7-["_AQ;N*ZEG</*RRQA78 @9( R,
M$]15&UN FJ>'M<TRSU@1W^KB,ZO>WB_Z9%)ORODAN$QC;\HP%!XKOCX&TR/4
M-(O;*XO;&32[86D2VTH"RP @^7)N!R,J.F#[U03X9Z7';6UNNIZOY5E*LM@I
MN%(LB&R!&-N/;YMQQP#0!QUQI*7O@KQMKEQ=WS7^GZCJ+V,BW4B_9O+<LNT
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M#MW9W-Y;Z[ILMM:D">9+I"D63@;CG R>F:T+N^M+" 3WEU#;Q%E0/*X52S'
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M#$=SD Y/H*UJ* *]S86EY+;2W-O'+);2>; SKDQO@C</0X)'XU8HHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)'>!=ZN!V+@,N!Z"M[P3?7NM2:UKDUS(]C=7K1:?$3\BP1?N]ZC_ &V#'\J
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MDC%=C=5YYXQR37IU]X/T34!I?GVTBMI:[+-XKB2-HUP 5W*P)!"C().<5/\
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M/AVNX;FGE8#/4"U?G]1^=;^G^#]$TV&_BCM9)O[03R[M[J>2=Y4P0%+.Q.T
MD8SWJOIO@+P[I5U:75O:3-/9MFVDGNY93"-I7:NYCA=K$;>G?J!0!PWA7PK8
MZIX)\27&^&VU*ZO+^UCOYNL"&5@$!ZJI).0.NXU2\0PV^F^$_%>G7'AFUT35
MCI D/]GR!K6ZB5P-X  PP)Q\PS@]37JL7AG1X=&NM(2R4V%V\CSPLS,':0EF
M.2<C).>.G;%5;/P3H-E!>1"UEN!>P_9YVO+F2X9HN?D#.Q(7D\#% &1XDGB3
MQ]X&+..#>O\ \!%N<FN-L8E2\\':U8Z'8:;;7^J[H;LW1DO[A)4D)\WY "&!
MR1O;'RBO1M-\"^']*O+6\M[69[FTR()I[J69HU*E-H+L?EVL1MZ<YZU!%\.?
M#$**B64X6.020?Z9-_HY#;@(CO\ W8SV7 - 'GD^@:7-\+O&6K36<4FHQ7]_
M)!<NH,D!2=BNQNJC.3QCDGUKI=,TS3YOC1=74EA:M<#1+>X$AA7<)3(X+@X^
M]@ 9ZX%=B?#&CG1;[1S:?Z!?/*]Q%YK_ #M(Q9SG.1DD]",=J;/X6TBXUVTU
MIH)%O[6(0QRQSR)E <A6"L X!.<,#0!JSP17-O)!/$DL,JE)(Y%#*ZD8((/4
M$=J\/T+3K)?AEX1MQ:P16^K:\+?461 IN(UFGVI(1]X955P>W%>Z5S<'@+PY
M;Z??:>E@YL[V022P-<2,BL&+ Q@M^[.XDY3'/T% &/8V%GHGQ<%EI%K#:6MU
MHK37-O;H$CWI,JHY4<9PS#/?'M72>*[ZUTWPGJUY>B8VT5K(9! VV0C:1A3V
M//![4NB^&=+T&6>:RBF:YN !+<7-Q)/*X'0%W).!GIG%7[ZQMM2L+BQO(5FM
MKB-HY8VZ,I&"* /*;'3YM%\7V=M_8FE:,L^@W8:WL+@R-(J^7M,WR*"P).#S
MG+<U5L]#TW3_ (??#_5[:TB34WO]-W7@4><P=@K*7ZE=IVXSC  [5Z';^ O#
MUM+;S);7#3P;@D\EY,\A5EVE"Q;)3 'RG@>E7_\ A&M(_LG3M+^R?Z%ITD,E
MK'YC_NVB(*'.<G! ZDY[YH \ZO\ 4+CP:WBWPQ9\3Z@Z7.B*/[UTWENJ^@20
MEL>AKTO0M(@T'0;'2;4?N;2!85./O8')/N3S^-<R^BW_ (B^(%AK.IZ0MC9:
M(LRVC22H\ES(^!OPI.U !D \Y/08KMJ /.?%=M;:UXJO[>/0-.U.:PTU?M,^
MJW)2"W20N1L4(_SD*26&. .:P/#UG::_K/@)-85+M6\-.YCG^=9F#18W \-C
MKSW4'M7I6H^$M%U75DU.[MI&N0BQOLG=$E122JR(I"N 2>&!ZUS,OP\LE\6Z
M8EO93QZ):Z=/&DB7CJ\$K2HRA&W[UX#8V\ 9'?% ''ZC96D4=]HD?[G1X?&=
MI%$B-M6)9$4R(N/NC+'@=,UT=]IECH7CW4;/1[2"SMKKPS/+<V]L@CC+(X5'
M*CC.&89K4\0^![4Z%I&D:3IPDLTUF"ZO$>7<73<?,=V<Y8G//)-;NF^$-&TL
MWK003227L?E3RW%S)-(T>" F]V)"C)X!H \DC_Y)?\*?^Q@M/_0Y*ZZTT/1?
M$VK>.)_$D$$LEO=_9EFFQNM+=84961C_ *OEF;(QSS76#P7X?&EZ3IHL/]#T
MFX2YLH_.D_=2*25;.[+8)/!)%,U?P/X?UR_>]OK.1II55)_*N)(EG5>@D56
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M/2;*.WMKY)=\;2.59Y%VDDY+ 8P.#P!Q6OIED-.TJSL5?>+:!(0Q[[5 S^E
M'">)-'L=;^+^BVFHP)<6HTBX=X)!E),2)@,.A .#@]P*YZZT;4->N?&/EZ%I
M,\L=Z]M!J-W>F&6Q6.-/*\L>6VT+D/D,,DG->L2:18RZU#K#P9OX8&MXY=[<
M1L02,9QU YQFLS4_!.@:QJ,E]>6DC2S!1<*EQ)''<!?N^8BL%?'^T#QQTH Y
M32-&L?$'B[Q6WB6"WNKJSALX$=\'[.A@#LT9/W,N6.X8/'M6-X$(/_"LSO+9
ML]3PQ_B^9:Z7Q1H4\OB5[Y/" U9'MDCCEMM0^SEB"?DN$+JKITQPW<8JYH_P
M_LAX,T/2=95I+S3E+K/:SO"T4C9+['0AL?,1[B@#B?&+J_AGXKE&# 7=L,CU
M$<(/ZUN:C;6VM:M:V<>@:=JEQ9:+$T\NJW)2W@CDSC:H1_G.PY; P .:ZS_A
M!?#?]DZCI?\ 9W^AZB4-W'YTG[TJ  2=V<_*,D')/)R2:DOO!NA:C>P7=Q:R
M&6&%;?Y+B1%DB4Y"2*& D4'LV>M 'F.CV%EJ]Q\*)=1L[:\>:QNDD:>)9"ZQ
MQ H"2.0IY&>A.:CU&[N;&3XP3VDCQ3!K1?,3AD5D*L1Z84DUZ5)\/_#DEE:6
MGV2=(K.9YK8QWDR-"S_>",&RJG^Z#CVK0A\,Z/!=:M<)9(9-7V_;M[,ZS *5
M *DD 8)& !0!Q^JZ'I/AKQ-X*D\/V5O9S2W;VC_9D"F>W,+LV_'W\%5;)SSS
M7)#0]-C^"<^N"TB.JQ7CRQ7A4&6(K>D*$;JHQV'')]37J>D>"]#T2]CO+.WF
M,\49B@:XNI9_(0]5C#L0@X[8J<^%=%/AQ_#YL_\ B5NQ9H/-?DE_,/S9W?>.
M>OZ4 ;->>:9HNE^)?&?C)M>L;>^DMYH;6%+E _DP>2K#9G[NXLQR._TKT.L#
M5_!FB:W?->7EO.MQ)&(IGM[J6#SD'19-C#>.3US0!Y=HUHGB1OAC;:OF[MWM
M]15UE.1-'&5$8;U&%0^^*]L@@BMK>.W@C6*&)0D:(,*J@8  [ "J \/:2MWI
METEFB2Z7&\5EL)58490K *#@C"@<@XQQ6G0!YS8:)I^J_&3Q-/?VT=P;.WL)
M($E&Y4D*OAP#QN&W@]1D^M8=PZ)\ O$F]@O^E7J\GN;I@!^HKU2WTBQM=7O=
M5A@VWMZD:7$F]CO$8(08)P,;CT K#NOASX7O)KU[C3Y'2]=I)X/M4HB9V^\X
MC#;0Q_O  T 8<'_)PK_]BN/_ $H%<5H%M'>_#'P[:S;O*F\6+&X5B"5,C@C(
M]1D5[2N@Z:OB$Z\+;_B9FU^Q^?YC?ZK=NV[<[>O.<9]ZIVG@W0+'3K6PM[#9
M:VMX+Z%/.<[9@2=V2V3R3P>/:@#SSQ9;Q>%]7\6IX?MHM/23PL)FCM$$:[Q*
MZ;P%X#!2>:O:IX=T'0_$/P_.D6T%J[WFW$"A?/00.=[8^\1G[QY^<^M=[J.A
MVMS->ZA':02ZE/8M9 W#,8WCR6",N<;=Q.3C.#7!:%X/O&U[093X9?1H=,D:
M:>6?4?M6]A&R+%#EV*QY<G!V]!QF@#U($'H0<4M4M-TBQT@70L8/*%W<O=3?
M.S;I7^\W).,XZ#BKM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %<!X9\?7FH^,]5T/5K:""$7EQ;Z9<1 @3>2V'1LD_.%
M*MQ@$9]*[^O+M)\/?\)'H'BNWAE^SZA;^)KNYL;D=89T8%6^G8^Q- '6V/B.
M67Q;XETV[-O#8Z3!;3+,<J0)%=G+DG&!L'8=Z=IOCGP]JUTMM:7LAE>-I8A)
M;2Q^<BC):,LH#@#GY<UY4-0O_%FF?$N6.SEAU,Z=90W-H =R2QB42H/4':V/
M4$5V.L:SI/B+6_!$/A^\M[J:.^^UD6[AC#;+"X;=C[H.Y5P<<\4 :?A_XE:)
MKC.CO);.VH/8VXD@E E()"?,4 !8*3M)R.AKHDU[3)/$$N@I=J=3B@%P]OM.
M1&2!G.,=2.,YYKRBU\JZ^'OBF&UFB;5](UNZU..W#CS$,4_F [>HR 1GWI)=
M9CL+=?B< 7@GU2Z3)&"UJ8O)C_ O!&?^!4 =_>>*+"YU+24LO$"6R2:A+9M"
M;-I/M4B<-&&(^7!_BZ&L74?B5#<:;XPBTL217FCP2-;RO;OARL88D[E &&.,
M$Y(&>E<]=:3)HG_"JK*?/VD7K2W!/4RNN]\_\"8TNI7EK%8?%FPDN(DO'WRI
M S@.R?9E^8+U(]Z /0-&\;:)JMW:Z;'?%M0FBWJ#"Z)*5&7V.5"OCOM)IUMX
MZ\.7=X]K!?L\BK(RD6\NV41@E_+;;B0@ \*2>*PM81(=6^'2H@54N'50HZ#[
M(_ K+\-ZE;:9JV@:;HNNVFM:-=3.D%C+$OVO3@(W;=D<[5P4(=01N S0!T.@
M_$C1=7\.W6LW#O9PV\[1-OBDY'F,D>WY1N9MH.U<D$XK4A\9Z!/H]UJHOBEK
M:2+%<&6&2-X78@ ,C*&&=R]N^:\TT'7H;+X=:980WNGP7?\ ;LD%S-<JDAT_
M=/,RR,C'Y6^4!2W&6JCJUW!=:5\0(7U<:J9?[.9;AT1//02*K,H0 ,H/R[@.
MW6@#UK2O&&A:UJ;Z=8WI>Z6,RA'ADC$D><;T+* ZY(Y4D5SNO_$?3C9VZZ#J
M&^X?4;>W#M;OY<JF94D$;LNU\ G[I..M+XQAED\<^'8K48G?3=32/''/EQX_
M6N1FUS1;CX6^#-,@N8'OX;S3D>V5@9('215D+KU7G(R<<L/6@#T>+7[6VU[Q
M&+K7DE@TR".::S%H5-DFPL6+C_6;@"<#ITJ2Q\;^'=2U6'3;74"]Q.&,&89%
M2;:,L$<J%8@=0">_I7GM_P#\C1\8?^P/#_Z2M6[J4:16'PT6-0JI>P*H Q@?
M99.* -^[^(7A:QN+N&YU4)]D9DGD\B0QJZC+)O"[2P_N@D^U=,I#*&'0C(KP
MN_U;2K;X%ZUH-Y/"=9BFN8YK(D&;S?M#/O*]< 8;=TP.M>Y0_P"IC_W1_*@#
M#U3QKX?T;46L+Z_,<Z;3+MAD=(=WW?,=5*IG_:(I=3\9:%H][-97=XXNX41W
M@BMY)7VMG!"HI)'RG)'3OC(KSCQKJ\EW8^.+=M8M].>'?;)ID%M$T]Z/(4^8
MY8%R"">5QM5#SQ73>$Y+>[^(FLW<+QS*VCZ?LE0A@0?-S@_@/RH Z>Q\4Z)J
M4]C!9WZ2O?V[7-KA6Q+&IPQ!(QD$\CJ/2K<>KV,NLSZ1'.&OH(5GEB"GY$8D
M*2<8YP>,YKR>RMWL_A?HGB:U0FX\/ZE=7)"CEK<W$B3(/;8<_P# :[3X?1&]
MM=3\42J?-UV[,\>X8(MD^2$?]\C=_P #H Z;4]3LM'TZ:_U&Y2WM81F25SP.
M<#ZDD@ #K61;^.- NK:]FBNI@;*(33PR6DL<JH>C"-E#$>X!%9OQ*_=:/I%[
M*#]BLM9M+F\.,A85?EC[ E2?I69J-[::[\1$FT:YAO$M-"NDNYK9Q(H\QD\M
M"R\9)5B!^- #1\3$O=)\+:O$_P!BMKV\\J_26)L(ODN^U691NY"\KUZ"NLL?
M&6@:A8W]Y#?A(=/YN_M$3PM",9!97 (!'3CFO-]!N['4/"_PNBAN(+AK>]1)
M41PQC=;>4X8=B",\T_QQ#-)K7C0P,R".VTF>9E3?B-)W9VV]\*"<>@H ]$L_
M&>@WUE?W45XZQV$)GN5FMY(GCCP3OV,H8K@'! .<58T7Q+I/B$W']E71N%MR
MHD<1NJY.<88@!NASC.#P:\ZU)+>\L_%%_P#\)?'KMW%X:NHF6WMD6-(W4LI9
MTR,Y4X!.<$FO0?!T20^"=!CC4*BZ?!@ ?],UH L:SX@TOP_%!+JMXMM'/(8H
MV920S;2V. ><*?Y=:HVOC;P_>:=J-]'?,L.FKNO!+!)')"N,@LC*&P0#CCFL
M/XDW-I9WG@^YOBJVT6N1N[MT3$4GS'T ."3VQFN9\77=KJVH>.K[2YXKFSA\
M,+;SS0,&0S;I& R."0I_#- 'H*^.?#CZ?=WXU(?9+640R2F)\,YX"I\OSG/'
MRYYIL?COPX^G7E\VH-%#9,BW0FMY(Y(=Y 4LC*& )/7&/>N;\0"'3=(\ WLP
M6+2;"[@-PQX2$&!D1V[ !B.>V:;-:Z?XT\?ZY#:3Q76FOX?%A=7$#!T$KR,R
MC<."RKD^V10!W>HZO8:2+7[=<"+[7<):P#:6,DK9VJ  ?0\].*P]-\4:?;6.
MMWU]XACO+>SU*2V9EM&C-NV0!   3(P) R!SFN0\%WEUXM\1:+#?J=_A6S>.
M\![WQ9H1GUPD;-_P,50\/IIDFB^,1J>HR:8@\93-!?(!_H\P9"C$D%0,C!W<
M<X[T =SK'C#2[GP?J&IV'B :6EK(D<MW-8N[6[%EX:%@&Y# <C^+-:NK^*]'
MT*:"WO[J3[3,AD2&"WDFD*#JVV-20ON>*\H\;ZO=:A\+/&5K=7EAJ;6<]H@U
M2RC"+<Y>,X8 D;UZ'!QR.E=E#J%EH?Q2U6;6;J"T2\TNV^Q37,@1&6-G\Q0Q
MXR"RDCWS0!T4OC+P]#IMCJ#ZI%]DORPMI5#,)"JEB!@<'"G@\Y&.O%3Z)XDT
MKQ$MP=-N&D:V<)/')"\4D9(R-R. PR.G'->7Z-$L][X9NA'_ *%>>*M0N[(,
MN 82DI1@.P)&X?45VFA#'Q3\7X[VNGD^_$M '4W]_::783WU]<1V]K I>260
MX"BLBQ\;:!J/VD6]U-YEM";B2&6TFCD,7]]490S#W4&LWXGHQ\(I.R,]K:W]
MK<7:J,Y@292^1W  R?853N=2L=>^*/AN31KR"]%E9W<EY+;2!U2-P@0,PXR6
M&0/;- %?X<^,K[Q=JFISW6H?N4FF2WL$L'14C5E"N9B.6YY7.>>@KI?&GBNW
M\'>'WU2>)YFWI''&JL=S,P') .WC)Y],=2*Y_P"#_P#R*^I_]AF[_P#0ZM?%
MPA?AMJ+GA4FMF8^@%Q&2: &3^/K6U\9+#/=2#29M)2YAC%I(97E,KJ<(%W_=
M7ICC&:OZIXJTZY\/:=JVG^(H[*TNKR.)+@VAF\TDD&+:<%22",GIBJ-E<6>H
M?& WMI-!<Q-X=3RYXG#J1]I?.&''4?I7!:WQX* ' 'CJ0 >G[]Z /6-0\::!
MI>J'3KR_,=PA19,0R,D1?[H=PI5,Y'WB.HK>KRSQ1J=MH6IZ]J.D:]:?:1)&
M;_0+^($7<FQ%'E9PX+)M (W*2/K7J0.0#C&>U '&3Z_XAUWQ!J.F>&$T^WM=
M,<0W5_?(\@:8@,8XT4K]T$9)/?I2Z9XMU"PU>\T3Q7!;QWD%K]MAN;!':.YA
M!VL0G+!E.,KSUXK-\/ZQ8>#O$_B31]>NHM/^W:B^I65Q<N(XIXY%7(#GC<I7
M!&<]*FT^]M_%GQ0AU729!<:7I%A+;O>1\QRSRLOR(W1MJKDD9 R* .9TKXJ7
MLGAS7M?O+XO)&+A;'3ETR7RT*G]V6E YZ<@D8SVKJ/"OC6!/"-KJFO:T]U/=
M,@5$TV2)A(R!C'&@4M(!S\P!%<GH/_)OWBGZZA_Z$U7KP3P0_#B\&L)I%N-*
M:'[;)$CHDK0Q%5._Y06"N ?;'>@#OG\9^'H]&M]7DU.-+&XF^SI*RL,2<Y5A
MC*D;3G<!C'-:&E:K::UIL6H6+N]M+G8SQ-&3@D'Y6 (Y![5Y/J%E9-HVDR1:
MN-:BO?&EM)-/Y CC9^$8*!\K+\O4<$D^]>RT <OJ/B.\M/B)HOAZ.. VE]:3
MSRNRGS R8Q@YQCGG(-=+--%;023SR+'#&I=W<X"J!DDGL,5YQXLU.PTCXQ>%
M[O4KRWL[9=/N@99Y B@G&!D\5=\9Z]I/B;P)X@T_0-8LM0O?L+R&"TN%E<H"
M-WRJ<]./QH VK/QWX=OH;F2WO96%O#]H=6M959HLXWHI4%USW4$5SD?Q=TQO
M#6BZJ]K<++J-U';O"()2(@2-Q#;,/A3D =>@Z&H=+%KJVOV5TOC./6KF#3KA
MX+>VM(U"Q.J@[S']WG;@-CD<=#7-VFJ:>?A5\/I!>V^RQUFR^UGS1BWP7SO_
M +OXXH ]/U#QQX>TN6..\OG1GA6=L6\C>5&WW6DPI\L'_;Q3]6\:>']$NUM+
M_4 EP\2S)$D3R,Z,2 5"@YY5NG8$]*\^OKB./Q-XO>Y\86VD6=ZD-P@>"*47
M=LUNJAHV8Y89##"YY^M:GA_3X;/XI:;;K(]P+7PA!%%-+&5=@)B-Q4\J2!R.
MM 'I=<_XT\50>#O#4^KSQ-,4(2.-5;#N3P"0#M'7D\=NI%:MKJ=E>WEY:6]P
MLEQ9.J7" ',;,H8 _@0:Y3XN_P#)+M9.#@"%C[ 3(2?RH CN/'MM;>,((Y;J
M1=(GTDW$4?V23S7F\[;PFWS#\H/&.@S[UNCQEH!\/QZXNH*UA))Y2.L;EVDS
MC8$QN+9!^7&>*PK6YLM2^+\%[9SP74)\/-Y4T+AU/^D@'##CMBN+=9H;B*\7
M45TRUM_&&HK)>/$LB0,ZLJ,P;@ DE<GH6H ]>T?6]/UZS:ZTZ?S8T<QN&1D>
M-QU5E8!E/(X([U2\6^(O^$:T=;F.U-W>7$Z6MG;!MOG3.<*N>PZDGT!K+\#P
M6QO-=OH?$ UJ6XN(UN)XX%CC$B1@84K\K?*5!(],&F?$F&XCTS2-9@MY+A-&
MU2&^GBB7<QA 97*CN0'S^!H ;)=?$+2TBO;JWT;5(2ZB>RL(Y(YD4D F-W8A
M\9S@@9QVK8U?QEH6AWAL[Z[D%PL?FR1PV\DQB3^\^Q3L''4XK.N_B5X:2R@D
MTS4(=7O+EE2VL;&0//(Q/3;U7'4EL8Q69I6L:9X>\;>,QKM[;V4D\L%U$US(
M$\V 0A1MS]X*RL,#O]: .FOO&&@:=%927&HIMOHFFM3&C2>>HVYV;0<GYUP!
MR<\5GM\2_"2V:W1U1O*W%9"+:4F$@X/F@+F/GCYL5Q'@^SD@O_AJEU T;BRU
M26-)!@HC,A3CM\C 5H1Q1CPO\5V"+N:ZO 3CKBU0_P R?SH [;5/&6@Z/=BT
MO+X_:FA6=(889)7=&+ ,H13N^ZW3IC)H?QEH":%;:T-062QN7\N!HHW=Y'Y^
M14 +%N#D8R,'/2N'T;5--TOXAZ7+J5S#;>9X2M4CGG<(N?,8E=QXR0,X[[36
M;I>JM!' UO>V>FZ?JWB'4;BUU6XB1A%$ <>7O^52YWX)[9ZYH ])'C/P\='C
MU9M21+*2?[-YDB,NV7.-C@C*'CG<!BH(_'_AJ2UO[G[?)''8(LER);66-T1C
M@/M90Q7/< BO,K:X@O+&:![[[>S>-[.1GD14:6-A%MDV* -K8)! P17<7]C;
MZE\5[FQND#P77AEH95_O*9R"/R)H ZO4=9T_2K6"YO;E8XIY8X8F"EO,=SA5
M 4$G-7Z\C\(F\UO7M'\.:B'?_A#O--V[#Y9903';'_OWN>O6G(6-BP) !) &
M3^5 '/6WC?0=2GDL]/O_ #+GRY&A+0R*DNP?-Y;LH5\?[)-8_A#XBZ9J6BZ%
M%J>H9U6^AC5F%NZQ-,PSL#A=@;_9SFL'1-2M]-N-'TO1]>L];T6YCF2VM9(U
M^UZ<JQ.P)8<[1C8=P!&X#/:HXHTC^#'@<(H7%]IK# [F923^9/YT =[=>-?#
M]GJYTN>_*W*RK"Y$,ACCD;&U&D"[%8Y'!(ZBLRT\0ZC+\4]9T)Y5-A:Z9'<1
M)L&0['DYZFN$\7:TUYH?B42:U;V1CU1X1H]M;Q;Y%CD7,TI(+\JN\L,# '-=
M)I<L<_QO\0RQ2+)&^AP,CH<A@2""#W% &Y\,=>U#Q-\/=,U?5)%DO)S+YCJ@
M4';*ZC@<= *V]7\0Z5H)MQJ=XMN;@LL(*L=Y5=Q P#SCH.YX&37(_!'_ ))'
MHOUG_P#1\E7O%L:2>.? P=0P%[<L 1W%NY!_.@#7L/&&A:CIM[?PWX2WL21=
MFXC>%H,#/S*X!''MS45AXW\/ZFTZ6UW-YD,!N3'+:RQNT0ZNBLH+C_=![5Y]
MXPA>34/B R1M)%$VD3W$:KDM$C;GX[_*I)]A71WVJ:?K_P 2/"+:+>V]\;2.
M[GN9+:02".%XPJ[B.FYBN![4 ;?@OQA:>,]':^MHI(F61U:-HW  #LJD,R@-
MD+DXSC.#47C7Q%)X;.@S?:8[>UN-36"[=U!'E>5(Q^ARHZ<UE_!^\M9?A_:6
M<=Q$]U:RSK<0*X+PDSR$;EZKD=,]:7XF7%K:2>$;F](%M%K\+R,PX0"*4[CZ
M =2>V,T =!IOB_0M5M[Z>VOMJV"[KH7$3P-"N"0S*X! P"<XQQ3]%\5Z-X@F
MDATZZ=YHT$ACE@DA8H>C@.H+*?49%>9>-9$\0:OXKNM#G2ZM[?0;>*YFML2J
M7%P9"O'#$1AN/?%=+X=%KJ/C.TO?^$SBURZ@L)-L=M:HJK$[)]]DX!RJX4\\
M''>@#OIIHK:"2>>18XHU+N[G"JH&22>PK"TGQMX?UJ^CL[&]=IYD+P"6WDB$
MZCJ8RZ@.._RYXYJM\2+6ZO?ASKUO9([SM:-A$ZL!RP'KD BL'5]9TGQ%J_@>
M#0+RWNIH[X796W<,8;=87#[L?<'S*N#CGB@"?PQ\2=-ETB :[J(6^>[F@=Q;
MOY<>)W2-7=5V(2H7[Q'KWJ_!X@U!_BY>^'VE7^SHM'6[5-@R)#(%)SUZ=J\_
MAU?1_P#A2>NZ3Y\']ISW-W$EIN'FS2O<,(RJ]6_AY']T^AKIM-22/XZWJ2G,
MB^&8PY]3YHS0!O:/XNTRV\$VFM:CXB34;>61HDODLVB,[[V 58@"V>,8 .<9
MJ_9^,_#U\EV\&I(!9P?:+H2(\9@3+#+A@-I^5N#SQTY%>1^"YX;#P#\-M2OG
M6/3;;5+H3RR'"1L_G+&S'H!N/4],UKZIX@LE\1>.M6TJ.TO(AIEDC22()()#
MYCHSGLZJ#SV^0CM0!W]OX[\/W=G>W,%U,19Q">6-[25)/+/1E1E#,I]0"*J:
M-\0](U#PA9Z]>,]H)RD9A\F1F,K#.Q!MS)QW4$<'TKD[:]27Q]=1-XD76GE\
M/7$4<ZQQ(C2!T8QH4&&('S$9) -9>GWL<WACX<75IKUO80V<4EM<7F$E6VF:
M$!5<,<*3AEYQU]Z /4CXQT : VMG4%%@LGE,QC<.),XV>7C?OS_#C/M67H_B
MX:YX^GTZRN"^G1Z4D[120-'(DQE92&# ,/EV\$=P>]<7=I961L-<;7QJUB/%
M$,NH7@@$4,;B QAP1\I4'9EAQGW!KI-'U+3M5^,VI3Z;/%<1KHD4;S0L&1W$
MS$X8<' (''T[4 =7XFUZ#PSX<OM8N$=TMHF<(JL=[ <#@' )XR>!U-9\7CO1
M/[ L-5N9Y(1>X6*$6\K2N^,LJ)MWMCU QWIWQ!5G^'/B15!)_LV?@?[AKD;3
M5],B\3>#-7GO[4Z6='ELX[GS5,45SB)BK-G"L5!&#SQB@#T+1];T[7[(W>F7
M(GB5S&^59&1QU5E8 J1Z$"M"N(\$RQ7_ (J\8ZK8NLNF7-Y D$T9RDKQPJLC
M*>A&<#(ZD5V] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %,2*.+=Y:*FYBS;1C)/4GWI]<#?_ !-%EI6HZVGA^]GT.SDD
MA%\DB?O71MA(3.X(6&W=Z]@.: .Z2"&.221(D623&]E4 MCID]Z9!96EK)))
M;VL,+R'+M'&%+'W(ZUGZ?KT6H>(-4TA8'233XX)'D)&'\T,0!]-OZUD6_C6?
M4="TN_TK0;N\GU%I0D(=42(1L02\AX7..!U.?8T =0MG;)-+,MM"LLHQ(X0
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M>MK:&SM8;6WC$<$*+'&B]%4#  _"N6TCQM<:E=:<TWAZ^M=-U//V*]9U</\
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MR [@I/ ;Z'&"*MZ?XW;4]>O]/M]'N/LVFW4EO?7KRHL<(5<AL'EL^@Z=3UH
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M0M+Y"'#/M&2![\4 3VUI;6<1BM;>*",G.V) HSZX%);V=K9AQ;6T, <[F\I
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M?Q=<>'=/T:XO9[<022S)*B1K%)G+DGTX^4<G/'2@#J8HHX(EBBC6.-1A408
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M5(X'.>O )KJ;?2K_ /X7+K&H&TE%E-HJ01W!4[&?>#M!]:[VB@#BOA9]JMO
MMAI5[IU[97>GIY,JW,)0,VX\H3PP]Q3==TV]G^+/A+4(K69[.VMKQ9IU4E(R
MR *">V:[>B@#S*.34O#=AXHT/^PM2O+B^O+JXL);: O#*L_*AY.B%6)!W8X&
M1FK7AOPY?Z+XWT5)8'>WLO"J6+W(4^695E7*@^N 3CTKT.B@!&570HZAE88(
M(R"*\H\$Z1=_\)K)HMR-VF^$'F6S?=G>UQ\T8/ND19?;<*]1O+8WEG-;B>:W
M,BE?-@;:Z9[J2#@U2T'0++P[8-:V7FMYDK3333R%Y)I&ZN['J3Q^5 'GRKJN
MC>#]>\'KH6I7-]<RWD=E/% 6@E2=F*NTGW4QOY!(/'>KUE#>>#/%K&32M1U"
MVN-'L[2*:Q@,H\V'>I5O[N=P(+8'O7H]% ')_#:ROM/\#VMOJ5J]K=BXNFDA
M<<KNN)&'U!!!![@U@^+M U.X\=6\5E9RR:7K:VR:E*BY6/[-+YGS'MN0[??%
M>A27]G%?0V4EW EW,I:*!I )) .I5>I [XJQ0!YKI&@ZFOQ,E@GLY4T;3;FZ
MU&UN"O[N22X5/E'NI:?\Q6&WAO6G^'/Q#LUTRY^U7>O3W-M"4(::/S(F#(.X
M(4XQUQ7LU% '%Z<;G4_B-:ZVNG7UM92:&\.;J!HF5_M .U@>AP,X].:M>"+&
MZL4\0"ZMY(?.UR[FBWKC?&S#:P]0?6NJHH Y%=/N_P#A<$FHFVD^QG05@$^W
MY/,^T,VW/KC!Q7&MX7L[>[U?3-3\,ZYJ5S=ZC-+"UO<SI:S0RR;@797")M#$
M,",G;WS7L%% 'E_B6UE.NW4^CZ'K=AXD$T:V]Y9[C:W:#;AIC_J]N,@AAN&.
M">*9IVN7&E:GX[ACT;4;XS:FX@:S@,H:3R(QL;'W!]TY/')YXKTV"[MKHRBW
MN(IC#(8I1&X;8XP2K8Z'D<'UJIIFBVNDW.I3V[2%]0NC=3;V! ?:J\<<#"B@
M#RV#P=_PC\NCR:WIFKWUN-$@LW.E23%H;B-F8JPB8$J0^ >0"O;-:UMITOA?
M4?#^NVGAW4(]/%C<6MS8PEKJ>V,LJRAB,EFR0V<9P37IM% 'FOB&[UK4[;PW
MKL_A^^CCLM;,QM88S)<+;;'579!R&.02HSC(KT>-_.@60*R;U!VN,$9'0CL:
M?10!XWH=AJ]KX*\,*VAZD+WPSJ/F7=L\!4S1MYJL8<\2$!P>*Z_15NM;^(5Q
MXC_L^\LM/@TP6$7VV$PR3.TF]B$/(4  9(&23BNUHH XSQW'<R76B"2WU2YT
M432?;X=-WF1CL_=[A&0Q3=G..,XS7'Z?HNHQ(+--"O[55\6VNHHCJT@6V*+\
MQ?)R5VG=R=I[U['10!R;Z9/-\49[J6T=]/DT$6S2,OR,WG,2F?7!Z>E<KX T
MN]?Q9)I][^\LO" ELK*0MGS&E;<I^JP[5QVW5Z-?RVEZTNC#5/LU]+#Y@2WG
M5;A4SC>H.3C/&<8JOI6FZ3X2TR.SBF$*33\RW4V9+B>0]69OO.Q_P% &3\4O
M^28>(?\ KT;^8K*N9M1\3^(?#,<.C7]G_94DEU=S74)2)7\ID5$;I)EFZKD8
M%=GKFC6WB#1+S2;PR"VNHS'(8R V/8D&KZJ%4*.@&* /%K/3[XKX;OY]!\03
M:O8W\<VL75SYKY;#*WEH20RY;.4& H]ZT=;T:Y;XD/X9@0-H^O30ZO>*#P@A
M_P!:I'I(RP\^YKUFL31O"]EHVH7>H+/=WE_= ))<WDOF.$!)"+P J@DG 'US
M0!GZ;8W47Q-UZ^>WD6UFL+2..8K\KLIDW 'U&1^=<K;Z'JJ_!W0]..GW O8=
M0@DD@\L[U47>XDCT"\_2O5:* /)=1\/6UGK?B*/4O#NNZI)J%T;BS-C<3I!,
MKHH,<A1PB$,&!+#H1UZ5U7AS29M.\<^()!:20636.GPV[')4^6LH*ACUQE<_
M45V%% 'C]GINJZ/H'@6]GT?4)1INHWCW4$$!>6-9#,%;8.<?,#^->FZ\V_PO
MJ;8(S92G!&"/D-:=0W=M'>V4]I*6$<\;1MM.#AA@X_.@#R?3IK_Q#X'\%Z!#
MHVH1RQ-83SW+PD6Z01!7WB3[I+!1A1SD\XQ72^&M$NVM?'%I<PR6PU'5;DPN
MZD;T>)%#CU&<_E77:7IT.D:19Z;;%S!:0)!&7.6*HH49/K@5;H \H*:MJW@?
M1?!3:%J-O?V[VD%W/) 1;Q1P.A:19?NMD1\ <\U+XR\/:Q)XIO+#3+2=M,\4
M1V\6H7$8^6V,3@2,3VW1';[D5ZE10!P>LZ1=GXL^$+RULI3I]G:74<DJ(?+B
MRF%!/09Z"N3O(=:M/A3J7@B+P[JD^IPM-&LJ6Y,$L1F,@=7Z$E3]T<Y[5[11
M0!Y5K&@V]GXKUZZU+0M=U)-1\J:S;39IU1F$2QM')Y;@*<J#N88PW7BKUK!-
MX+\6?:4T'4)-,O-)M;:)+&-KDVTD.X>4QZXPPPQX..M>CT4 <A\.+34+/PW<
MKJ=E)9W4NI7<S0OV#2LPP>XYX(ZUG:C9W2?$^],EA>O9:KHJ64=W!"7CCD#O
MG>1]WA@<FN[N;F"SMI+FZGC@@B4M)+*X54 [DG@"I%8,H92"",@CO0!Y,8=6
MU+X?:9X%;0M1@U&(VUK<W#P$6T<<,BDRB7[K JG '.3TKUHC(P>E%0W4!NK2
M:W$TL)E0IYL+8=,C&5/8CM0!Y9X4T:Z7Q[)X=E4'1_"T\MW:G.03< &%"/5%
M:7\Q6M;75_X/U/Q/;/H>IWXU"]>_L9;.W,J2%XU4HS#A"&3JV!@YKKM!\/67
MAVTEAM#-))/*9KBXN)#)+-(>K,QZG  ]!BM6@#RK1])U'P-?>%KB[TV]O88=
M#DT^X-A"9S#,9$DP0O.W@C/3BNE^'UM?PVVOS:A8364EWK,]S'%*.?+94VGC
M@^G&1D&NPHH Y9+&Z'Q7GOS;R?9#H<<(GV_(7$[DKGUP0<5P\OABZ$-O?ZAI
M6I3VMKK^I23V]HTB3F&9FV2H$(9AD*< \@GK7L-% 'E%[H"3^'HI=&\.ZG:B
M77[.9UNY))9YHXV7,K*Y+( ,C![+GBM7QIHL3^,+#6;[3M4OM.-B]I(-,>42
MPR;PZL5B8,RD;AWP0,UZ%10!Y=_9S:))X5URR\-ZG!96]W>/<VBE[JY03(56
M1@26). 2,G&ZJ>J:=K.KV7C>Z71;V$ZA=Z;):PR1?.Z1M&"<#N I)';OS7KM
M% '%>*]%O-6\8:2(89/LYTO4+>2<*=L;2+&%R>V<'\JY9IM9OO"'A7P^OAO5
M8KS2[VP6^>2W(B1(74%D;HX. ?ES@9)Q7KU% 'D5WX;M;35-?M=2\-ZYJD]_
M?23VIL[F=+:>.7!VNRN$3!+ [AT'>NK\/Z5<67Q&\37!M)(K*2TL8K>5@=K[
M%<$ GKC(S7944 9ND:PNK-J"BVFMVLKQ[1A* -Y4*=P_V2&!%:5106T%L)!!
M$D?F.9'VC&YCU)]ZEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KSBY\;:EIWB6UM[O5M <7&IK8G1X6W7,4;OL20N'^]
M]TE=N #7H]>6Q^#/%,&B6>EP6^D!=,U)+])S.P?4"L_F /\ )^[."<GYN0.U
M %JX\3>+KJP\4ZC82:5!;Z#=W$:QS6[NURL2A]I(<;.#UYR3T&.;Z^)-;\0Z
M[#I^A2V5C''ID%_<RW4#3DM+G9& &7 PI);/IQ4]MX6U"+PYXPL':W\_6;F[
MFM\.2JB6,*NXXXY'. :IV_ASQ'X?U6TU'2(=/O&ETJWL+R&XN&B"R1 [9%8(
MV1\Q!& >E %CX6O-)X8O7N(UCG;5KTR(IR%;SFR >_-2Z?XQEMXO%::X(8[C
M097D;R@5$EL4WQ-R3R0"#[BKG@?0;_P[H4UGJ<T,US)>W%P9(<[6$DA8'!Z'
MGISCU-<GXVT>/6OB/HVGV5RA-_;F/68%YS:PR+(I;'3+93GJ&(H OV'B+Q7K
M$^E:,CZ?8:G)IBZG?SR6S2+$'<B.-8]X^;@Y);M2VWC?52FGVMS#:"_7Q%_8
MU\45MCKY;.'0$Y7(V=2<<UJZQH^L6OBZ+Q)H<-I=R/9?8KFTN9S#N4.71U<*
MW()8$$=#6+)X)UN/1X[R.2REUT:Z-;EA+LL#':4\I7QD )@!B.HZ4 =/;ZU=
M2^/K[0V6+[+!IT-TC '?O=Y%.3G&,*.U97BKQ)J%AXEL]'M=3TO2$GM6G2ZU
M*(ND\@;'E+\Z@'')Y)Y&!4V@Z-KB^,[_ ,0:NME$MW8PVZ6]O*TGE%'<X+%1
MN^]G.!R2,<9,_B>SUN\E\FVTK1]7TR:'9)::A(8]DF3\^=C!@00,8!&.#S0!
MSEP?$%S\3K-;9K&RU*7PX#<RNK3Q0GS_ )MB@J6YP!DCC)]C:M_%FMW'A26:
M:YT>QO;35)=.O+^Z.VWC6-B#(J%@23A0%W=3[8JWX8\'W^A:UIES/<Q3PVFA
M)ISL&.XR"3=P"/NXX'.>*S7\%ZU:31WT$.GWTL&O7FI+9SS%$DCF#!26V'#K
MG/0CKS0!SGC3Q++XB^"WBQ9[NRO7L+V*V%Y8\17"^9"X<#+8.'P1D\@UT5__
M ,ES\-?]@6;^=4]9\!^)M5\+^+=*=],\[6;F"[AD65U5&'E!HR-G0"/AN_&0
M*Z:Z\,7TWQ*TCQ"KP?8[/3I+612QWEV/&!C&/QH J?$Y[F.P\.M9QI)=?V]:
M^4LA(4M\V-Q';/7VJM>>,M8\)WNKV?B![._-OI3:G:S6L+0;]K[#&REF_B9<
M'/0UM^-M"U+7;+2UTJ6WBN;+4X;W=<$[<1[CC@9/)'ZUBWG@[5_%=[J]YKR6
ME@;C2FTRUAM9FGV;FWF1F*K_ !!,#'04 .\.^,KF?Q+9:3>ZYH6K?;[>213I
M1&;:1 "4;YVW*03AN#\IXK2\9^(-8T>_T"QT:*U>;5+I[8FY5BJ?NRP;@C@$
M9([@8XZU)H%EX@748I-4TW1+*&&$HS69,CSR''S E%V+C/')Y]JF\1:%=ZKK
M_AJ^MVB$6F7CSSAV()4QLHV\<G)'I0!SFI^+M4M-8DT-_$7A[3KNPM(Y;BXU
M!=JW4S[B$1#(NU0%!)RQ&X5 /B!J&L/I"V-_I.C?;M-6\C;48S(MQ,696A1@
MZ@;2O)Y/S# K:U;0-6MO%%YK.D:?I>HK?V\<4T-_(8S%)'N"NI"-E2&P5X/R
MC!IFKZ1XCGT^+3WTS0-9M)+18Y8KC,"Q3\[G4!'RIR..",=>: &7&M^*KSQ@
MOAVR.FV+#2(;Z>>6)IQ%(SNK(H#+N!*C!., $\Y JE;>.-:O[/3M)AALHO$-
MSJ=SITTK(S01?9P6DD"Y!.5VX7(Y;KQ5#3[#7=!\?6]GIOV;4KBR\,6EO.ES
M,T(FQ+(-P<*V"".A'()YJ_;^!]:L+/3M5@ELI?$-MJ=SJ,T3.RP2_: 1)$&P
M2,*5PV.J].: &ZKXTU[P[I_B:TOS8W6I:5:17MM<1PM''/$[%?F3<<$%2.&Y
MR*TEUOQ+I7BO2['5FL+FWU:&X:.&UA9'MI(T#[-Q8[P1D9PO/8=*S=6\%Z[X
MATWQ/=WPL;?5-5M(K.VMXYF>."-&+?,^T$DEB>%XXKIM<T.]U#Q1X?U.UEBC
MCTX77F%\ELR1;5('?!Z\B@#'\$^)=9\1-;WDNI:+=6TT1:ZLK=&CN-/D[(V6
M);G*G(7GD<5QXUV]UOX9^&=2AL+"&\/B2%8K>WC\J$LLS!<@9QDXR?K78:=X
M?UVZ\6Z9K&K:?I%G/8)(L]Y92LTE\63: 5*+M7/S8);! QZUCZ?\/=?L?A[H
M^BQW%BFI6.KK?^869H]JR,X[ D\CCCOS0!JR:QKEIJFJ>'-=GLKOSM'EOK:Y
MM8&AQM.QT92S=-RD'/K7,^%?%#Z)\-?!6FP:AIVG3:C%.3>Z@?W4,<;$MQN7
M<Q+* ,CJ?2NMBT#7=6U^^UK5X;&SD_LN33K2VM[AIAESN:1F*+CD* ,=,UEZ
M=X%U?2/#/A41Q:=>:GHB312VTTA$,\<I^8!]I((PA!*]B* .D\%>)'\16%\L
MUQ974]A=M:O<V39AG&U65UY.,AAD9."#7%SV&K7?[0$@>\TUS%HPFC\ZQ+A(
M?M'W0/,XDY/S]/\ 9KT3P];:C;V$AU."PM[B65G$-B#LB3C:I8@;SQRV!UZ<
M5EIX;O1\5)?$I:'[ ^C"Q"[CYGF>;OSC&,8]_P * .=/C+Q,WA%O'*'3O[%#
MF0::8&\XVPDV[_-WXWX^;&W':M6'7O$6J_$#5-$T]K"'3=-^R3232Q,SNDB[
MB@PP&3@X;MCH<UE?\(;XE'A-O ZC3_[$+F,:CY[><+8R;MGE;,;\?+G=CO74
M:-H%UIWC7Q'J\C1?9-1CM$@56)8>4C*VX8X^\,<F@"WXGO[W3=%>XL9K"WD\
MQ%>YOWVPP(3AG;D9P.@R,G%<0WQ$U&'PUK\]M=:5K%UI5W:1175H"L-RDSHN
M,!FVL-S#@D9P?:NK\9Z+>ZQ::9)816UQ-I]_'>&UNG*1SA59=I(!P?F# X/*
MBN7OO!GB;41KWGC3%.K/8W $<S 0-!*A,?W/F&Q<[N,MV / !I2ZOXNL/$#:
M-<3Z7=7%]IL]U8M%;/&L4T94>6V7.Y3O'/!I)?'5U>>!-#U/2XH?[7U>XALX
MX95)2.8MB7< 0<(%D[]A6Y?Z-<S^.-)UM7B%I9V=S#*&8AMTAC((&,8^0YYK
MC_"FC)<?%#6[FUN$GT72[B26V5.52\N$3S@#T.T*>.WF'WH Z+XG7%_:?#C6
MKC3[E;>:.V;<Y0D[",$*01M;G@\X]*I:CJVN:1I.D1W?B'0-.$D+--J-['M5
MF&-D:1-*"3@\MN/3IS70>,-%F\1>#]5T>WD2.>[MVCC:3.T-VSCMFN:&B^*Q
MK.G:T=,T=[M-/-@\,MVY2W(?<)5/E_-D=5P#P!F@!;?QOJ<GA'1?%3P6KZ8S
MO'JPA#,8U#F/SHSG[@9=Q!!.T]>*2;QUJ,7A;4O$QAM(M/FN([?1UN,IO5G"
M":5B>$).X# ^4=>:@L/!>OMH%AX7U*6T_L>*\FEO9HI6\R\B,AD1-NT! S-\
MPR>%P#S4\G@?4UT#4O#\%Q;'3X;F*[T5IB6,!5Q)Y,@QS&&& <D[6QV% %'_
M (6%>V46LVZZEH^O7%KIXOH+G3@=BC>$=9$5W/R[E;@\C-=3X3U'4M12:6XU
M;2-7L2JM!>Z<I3YCG<C)N;IQ@Y[\BJMK9^*F@OITL="TJY\I%M88B9@SALL9
M'"KA6 P  <=?:CPQH%_:>(]1UN\TW3M*^U6\<)M+"4R"1E9B97.Q1N^; XSC
MJ: &:OK4MM\4_#FD+:6;QW=K<2-.\69HRJYPC9X![^M<[-XV\6IX3N_%2KIA
ML["^>W>R\E]]RBS^7D/OPAP1Q@\@GOBNHU3PU?7OQ)T#Q#$\(L["VGBF5F.\
MEQ@8&,$?C65)X)U1_AEJ7AT26OVVYO))T;>=@5KGS1DXSG;[=: +<&M^(M-\
M6II.L2Z?<1WFG37D!MH&C,#QE04.6.]<,/FX/'05BV?C'Q8OA/1O%^H'2_[-
MNG@2YLHH'$BI(X3S%D+D9R0=NWH<9SS74:UHEU<>+;/6T:+[+::;=6\BECO+
M/L(P,8Q\I[UQ7A?1?$?B'X;^&=&FCL%T8K;7$MV)F\UHD82",1[<!L@#=NQ@
M9QGB@#H)->\4:N^OWNARZ;;V6CW$EM'!<V[R/=R1*"^6#C8,G:, ],FJ<WCO
M4-5N]-CTV_TK1UO=+AO[<:G&S_:I'+9A5@Z@;<#)Y/S# JY)H'BC29-?LM#C
MTV>RUBXDN8Y[FX>-[2250'R@0[QD;A@CK@TE_P"%M8M=!MO#MGINCZSI$=A'
M:HNH.8FAD52ID.$;<#P>,$$<4 1:SXTOX]<GTJ/6- T2>RM(IIQJ3[A/,X)\
MM,NF$  RW)^8<4ZT\9:MXINM$L]!:TL)+S2_[3NIKF$SB,;@@C50RY.[=SGH
M*;%X1UO0+I)]-MM,UEI]/MK6X.H2&,I-"A02@[&RI!Y7@\#FKEUH'B#3]=TS
M7M,CTZ]O$TW^S[ZW=S;1O\P</&0K8PV[@CH: &_#1KIXO%!O4C6Z_M^X$HB)
MV%@D8)7/.#U&?6II=7\1ZWXBUFPT"XTZRM](,<327=NTQN)F0.5X==B@%1GD
MYS5OP3H6J:';ZP=6EMI;F_U.6]S;D[0'5!CD9X*D?3%5)M(\1Z)XBUF_T"WT
M^\M]7,<K)=W#0FWF5 A;A&WJ0%..#D&@#,MO'&MZ\?"T6DPV5K)K-K=/<-<(
MT@MY(616( 8;AG<,9&<CG@YZ#P?K.I:B=8L-7-O)>Z7>FV::WC*),I175MI)
MVG#<C)Z5F:'X'NM#OO"I2XBFATJSNXKESD-)+,R,2HQTW!N_I6SX?T2ZTO6?
M$5W.T1CU&^6XA",20HB1/FXX.5/K0!!8>(KE?&6MZ%JGD1I;P1WME(H*[[<Y
M#ELD\JX(SQP17/:?XR\1:W;Z);VB65K=ZX]S=02S0LZVUE&1L)3<-SL&7N!S
MTJ/XI6!U+4] M=,O%AUB\EET]T3EC:2H?.8CT4 ,#Z_6N@UOPY>PZCH6K>'H
MK4SZ3%);"SGD,:2P.JC:' .T@HI'!'6@#%N_&NMZ59ZU97@LIM4TJ]LHO/CB
M98IH;AU ;9N)5@"PZD9 KI[K6KJ#QYINB*L7V6YL9[AV(.\,C1@8.<8^<]JY
MF]\$ZWJVE>(;RZDLH-;U2>UFAA1V>&%;=E:-"^T$YPV2!_%P.*TK'2/$=[XW
ML?$.K0V%I#!8S6OV6WG:5E+,A#;BJYSM/&.,#KDX -+4M;N].\::)IK+$=/U
M.*=-VT[UG0!U&<XP5W\8ZBN9TOXC74VG^*+Z_AMXX+&![W3M@(,UN'E1"W/)
M+1=L?>%=!X[T'4=>T.$:-+##JUG<I<VDDS%5##*L"0"1E6;M7/:O\.;JXB\,
MV>GS6Z65I;1V.IJY(,T"21287 Y):-NN.'- $ECKNLW'CZRT>YMM,AU&;PP+
MR2Z^RDO'.9-NW[V3&#SMSSCK7)6=UKUU\-/#E_=75O>SS>(X6MD:-D(<74@(
M=RS9!;&, ;1QS7HK>&KT_%=/$X>'[ NC&Q*[CYGF>;OSC&,8[Y_"N?TKP7XA
MMO#NEZ%<)IXATK6HKV*X2X8F:(3O*V5V?*P#  9.>>G< W]%U;7(/&=SX=UN
M>RN\V"WT%Q:V[0[1YA1D*EVSS@@YIGB[7];T_P 1^'M%T1+/S=6^TJTETC,(
MO+56#<$9P"W'?@9'6M#^Q+K_ (6%_;VZ+[)_97V/;N._?YN_.,8QCWIFL:%=
MW_C7PSK$+1"VTP77GAF(8^;&%7:,<\CGD4 <QJWC;4K35-0TY=>\/6-QI%O%
MYJW_ ,IOIVC#L$!D78F"!GYCD^U+)XZU+5M0M(M+O])TK[1IMO?6D.IQLQO6
MD!)C5@Z@!< ' 8Y/2M'4O#VM6?B/5=1T?3](OTU58V;[>Y0VTR)LW<(V]2H4
MXX.0?6D\2:%X@U*QETHZ;H.J6,]JL2-<DPFUEVX9PH1LC.&&"".GO0 LNL^*
MM3\8:GH6FR:;8I9VEO<-/- TY5W#93 9<@E?O=@#P<\9(^(]W=:;HMO)>:3H
MVHWCW*7EU>',$!MWV-L!9=Q9B, MP,]<4W3(-?TKQ_K4.DI:ZE);Z5I\$RW<
M[0F0A9 ) P5N<@Y!'.[KQS9M? FJ:19:+>VZ:?J.JVANFO8)V*13_:'\Q]C;
M6P58+@D<C/3- "6GC[4=4L++3]/ETR;6;G5)=.^V1YDM=L:>8TRJ&R?D*X7=
MU/7BJWC:[\9VGA.6&[NK*&1-3M8DO;>)@+J-I$P=GF9C(;A@2=PX&,YK8N_#
M>OW%GI6IQQZ5#K>FWKW4=K%N2!HW4HT1<+DMM(^?;U'3%0ZWX>\6^(O#-^E[
M-81WSWEO<V=BKDPP+$RL5,NP,Q;!).,#C% '9&/45T8H;JV.HB(CS_(/E>9C
M[WE[LXSVW?C7F7A/Q)XAM/ASX=/VJUO-1UNZ^SV;31/B $R,[R'?F3 4X V]
MA7J-FUU-81-?0Q073+^\CBD,BH?0,0,_D*\ZTKP5XDL_"6D:<RZ<E_X>O!<6
M,HG=DNERX97^3,>5?'&[F@#H]%UC6(/%MQX:UN:TNI?L2WUM=VT)A#IOV,K(
M6;!!QR#R#4GB_5[[2S9+;ZMH^D6LN_SK[4B"%(QM1$+KN)R<G/ 'O4>BZ/J\
M_BRX\2ZW%:VLQLUL;:TMIC,$CW[V9G*KDDXX X IOB#1M7?Q;8:[I=KI][Y5
MG):&&]F:,0EF5A*I"MG[N".#C'- &':^.M;U33O"QTY--:ZU:ZNK2:4AFAS"
M'_>IALE?DW8SR.,CK27GB_Q-H]IXCCN18WUSH$UM/-+#;M&)[20;GPF\[74!
MCG)''2IM#\%ZY87VA?;)+.2+2]3O;EIHW8-,DZR8.S;A3NDY&2,#K6[;:&;7
MQ)XHU/47MO[.U2&WC"L_\*(ZOOSP =WK0 M]XCN)/%6@:1I)@EBO(9+VZE8%
MMELH 4K@CEF90#ST-1>-?$-UH9TJ""\LM.COIVBDU&^C+Q080L 0&498C )8
M#K6!\(M)ECT^\U:>X-U&S?V?ILQ'WK*!F$9'^\2Q_ 5U_B.+69(H/[+M-/OX
M,LMU97K%!,I'!#[6 (/8C!SVQ0!DP^(=:@U?POIU\=.E.I/=+-/:[BDB1H6C
M=.?ER,$@[OK535O&]]IEYXH@2WMY7L)[*VL$.1ODN%7&\YZ!FSQC@51MO!6N
M:1;:+?Z?#IQO=/O[JY_LT3,D"13@@Q1OM.-N0?N@9SQ3YO VNZI'XEN+ZXL8
M+_4I[2[LS"S.D,D !56R 2,J 3WR3@=* &>,/^$HM_ _BBUUMK&\M#I3R17M
MK$8=LG0QLA=B>.0P]\UH66L>)-,U_P .V>J2:?+9:PDD:PP0LKVKI$9 -Y8B
M3A2"<+STINJZ/XR\3:'K=IJ!TZQCN=/:UM[.&8RJTI/,KR% 0,<!0#U.:V-3
MT&[O-<\*WD;1"+2I97G#,<D- T8V\<\D=<<4 ,\;:[J6@V6EMI4-O+<WNI0V
M6V?.W$FX9R#QR!SZ9JA;:]XBT[Q!J&A:FVGW]T-,;4;*:&,VR,5;:T;AF; R
M5^;/0FF_$U;E[+PXMF\:7/\ ;UKY32 E=WS8W8YQGK5'5/"'B#Q3+K5]J0L=
M/N9]);3+.""=IE 9][,[;5X8A1@#IF@"+3O&6M7>HW.D6NL^']9U"73);NW:
MP4[()T*CRG D;<IW<-D'@\5HS^.;F]\&>'M0TB.$ZIK<\-M''*I98GS^^) (
M.$"2=^PHLM%\1?\ "5:3K=U9:396MK:S6<EG;W#$1(VP^8&V $Y3&W  &.3S
M63X-T9)_B3KMW;7"3Z+I=Q*;()RJ7-PJ-. >AVX(]O,(H DO?%GBQ].\5:I9
M/I<5KX?O)XQ'+ [M<I&JL5R'&PX/7!R3T&.=*U\1^(;?Q'X>34VL&T_7HY62
M"&)EDM"L7F@%RQ$G ()VKSTIY\(ZC_PB_C73?,M_/UNYNY;4[SM598U5=YQP
M<@YQFKMUX;O)]4\'W(:'RM'$HN06.6W6YC&WCGD]\<4 <MIGQ+GNY=*U%]7T
M*2TU*]2V&DQ,/M5NDC;8W+;SEL[2R[!@$^E3W/BOQ=+HOB36[1]*AM="O;J(
M026[NUU'"QS\P<;/EXS@Y.>@J_X>\-:]H:Z?HZV.BG3K&7C46):>6 $E5\O:
M-K] 6W$<9Q4Z^$M1'@SQ;I&^W^TZO<7TMN=YV@39V;CCCKS@'\: *$%]KE]\
M8(4AU""/3GT..[%NUNQ/EM+@KG>!OR/OXZ<8[UZ+7$Q^'M:L/&^EZS:QV<]L
M-)CTR[629D:/;)O+I\IW=2,''U%=1I)U0V1.KK:+=>:^!:[MFS<=GWN<[<9]
M\T 7J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ JE9:/IFG7-U<V6GVMO<7;F2XE
MBB56E8G.6(&2<D]?6KM% !1110 4444 %%%% !1110 4444 %%%% !1110!
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ME9P7=LQ#&*>,.I(.1P>*MT4 ,BBC@A2&&-8XD4*B(,!0.@ '04^BB@ HHHH
M**** (+JRM;WR?M5O'-Y$JS1>8H.QUZ,/0C/6IZ** (KFWAO+:6VN8DF@F0Q
MR1NN5=2,$$=P14=CI]GI=FEG86D%K;1_<B@C"*OT XJS10 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG7RV\&U<':8D?GU.6-5;GQ-/I?C'4M/U QC3X])_M*W<+A@$8K*">^/D/XT
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MW<H./PSBN)\(:'IGBVYUKQ%K]E;ZE=2:C/:P)=QB5+>")MBHJMD \$D@<YH
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M% !1110 4444 %<%K'@2\U#XD6.O0W%NFE;H9KZ!B?,EF@$GE,.,8&]<Y/\
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MU:ZI=ZE;6XD$FGW'V:;>N!OV*_'J,,*T: ./N/#^LQ>/KO6++[#)8:A8):W
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M)R>M>H6GANTLO$9UB!F0_P!GQZ>L  V)&C,P([Y^;'X5G'P+9GP6_AG[7/\
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M,B*NZ-7+*3@=0,#\/6LK7;/3?#/A76=->WOM3?6Y[N6.UAMVD:228DE,J,*
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M:H^G_%?Q+JT29DM_"?VE4;U5MP!_*NB?X=1-;R:6-9O5\/2SF=]*"1[.7WE
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MI*9H<YPZN""=V2",8)-6+'P/8Z?>:!<0W5RS:.EPJ&5@QF:;&]G/KD9XQUH
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MC>@6EK?:Q\,);NV@GDDT.8NTL88L42+;DGKCG'I7L22)(6".K%3M;:<X/H:
M'4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5S3_#[PM),)6TB,D2F9E\Q]DCEB^YUW;7^8D_,#BNEHH P]
M8\'Z#K]VMUJ6GK-.$\HN)'3>F<[7VD;UZ\-D<ULI%''"L4:*D:J%5%& !TP!
M3Z* ,E/#6CQZ39:6MB@LK&5);:+<V(W1MRD'.>#SS5EM)L'U.34GMD:[DMQ:
MO(V3NBW%MI'3&2>W>KM% &!I?@KP[HM\E[8::L4\:LL3&1W$(/41JQ(0'_9
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MP!D$G.*TK'2[+37NWLX%B:[G-S.02=\A !;GV _*KE% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMT.PM,%#; S8&<,O/3FG)K$,;:7;WRFTO]10F.U8[R&5-[J67CY1WS@]J .
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M[!%#=?;;=KABT:[5E4[U^?;@'=D' -;IUF&XM]4.FH;ZZT]VBDMT.PM*$#A
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M$<RQMOP9".R!?,R3QUK9O_!<,GAK2-+TVY^QSZ,\4MC<&/>%>-2OS+D;@P+
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MJW(MC<^7^]*;]NUU?ID?W<=>]:/]IV9U<Z5YP^VB#[28L'_5[MN[/3J,5;H
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M@_>\TRDY/_ =M=S7,:IX$TO4=6EU2"YU'3+Z=0MQ-IMVT!G Z;P."1ZXS[T
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MMYY?#Z)!+N.(I&X#_@2#7I]85QX0T>ZUC4M3N(7EFU*S^Q7*LYV-%Z8['WH
MY;P/:VFC>(%TZYT.ZT35WLFW*MSYUM?*K*&D#9Y<$CJ V'YS7HU8&C^$K+1]
M0%]]LU&^N4A,$4E]<F4PQD@E5STSM7)Y)P.:WZ /%[AHC?:;XBTO2KM1<^((
MHQK5U>CS9T>?RV01C_EEC<H!QP <4T^&M'-C\5)38Q^9;F81-D_+BW63U_O
M&NZ?X:Z')"\)GU(0";[1;1"[;9:2;]^Z(?PG=WYP"0.":N_\(3I7]IZI>^9>
M;=4B,5Y;>>?)FRFPL5_O;>,T <4NEZ2/#G@_1H-&N-1FN++[<=.CN!%;R?NX
MPTDQ;K@L, =STJAI3RZE:^'_  U?>9'IDVNZA;S6XN"X\N$2-' 7ZLH.![A1
M7<Q_#S38;2PACU+6$DL0R6]PMZ1*L3!08MV/N?(N!VQP:>/AYH2:?+90B[AA
M:Z%Y#Y5PRM:S 8WQ-U4G)SUSDT <OXK\-Z=I.G6.EZ;>SI;3^(K$_94FS]CW
M'!$?\29^\.>"<C%4_$,:^"-8\31^'4:SC;PRUWY<;DJ)A*4$H!/# 'K[5W-O
MX%T>"W1&-W/,+Z/4)+F><O++-']PNQZ@  8X&*T;KP[IM[JTVHW,)EEGL382
M(QRC0EMQ!'N30!YU;:9K'AV1M4TKPY)I-M!IES]LD?4$G^TL(]T;LH)R^]?O
M=<,:IW'AS3+'PCX%U>W+C4+S4]-ENK@RLS732$.Q?)^8YY'ICCC->AZ3X*TW
M2KI9_/O[PQP-;P)>W+3+!$V,J@/J !DY.!C-4;?X:Z';FS7S]2E@L;A+BRMY
MKMGCMF1MP"*>W&.<G&1GDT =C7GNJ:'8Z]\7WMM2C,]JN@(S0%B$<^>X&X#J
M!SP>,\]A7H54!H]H/$#:V _VQK46A.[Y?+#EQQZY)YH \@A>[?3](\.1V<^I
MZ>NNZE!]B-UY?FQ0%C'&SL>5&<X)YV 5/K6FZQIWA22SFM9M'LY?$%D=/A6Z
M65K=&90P5E)P ^6 [;J]$E\$:1+I[VJ_:8B;Z34(YXIBLL,[DEF1AT^\1CI@
MXI%\#Z1_9HLI6NY\WL=_)/-.7EEF0@JS,>OW5&.!@4 <=KNBP6OBK3/#5AX>
M;4M(@T^:\_L_[9Y:-*TJJ9'+GY\9Z'/+YK+O?#<CS^"[/Q%IY#?VO<0112W'
MFL+79(\:,X/.W@>ORBO4-;\-6>N36UQ)/=VEY:[A#=6<QCD56QN7/0@X'!!Z
M"J-UX#T>YT>PTY7O8/L-P;F"YAN&$XE.[<Y<Y)+;FSGUH YK3O#^F^+;[Q==
MZVC2S6>H26-H3(P^R11Q(5,>#\I)8MD=:ZCX?ZC=ZMX T.^OG:2YFM$,CMU<
M@8W'W.,_C4>H> ]+U"[N+C[5J5L;N-8[Q+6[:-;H*-H\P#J<<$C!(KHK6U@L
MK2&TM8EBMX46..-1@*H& !^% ',^/7M9=-T_3KBVO+R2]O4CBLK:81?:2JLY
M61CTCPI)^@KB[#2=3OM.\2Z)8Z?';Q66JVTO]CF^)C:,Q(\D(E'W0Q^;'0$X
MZ9KTO7?#]IX@@MTN);F"6VF$\%Q;2^7)$^",@^X8@@\<UC?\*YT0&=XY=0CE
MF:.5I4NVWB9,XF#=?,()!/<$\4 '@)M.CMM2L[+3[W2I;>X'VC3+IPPMF* C
MRR"1L8<\'&<]*ZZLK1/#]IH27'D2W-Q/<R"2>YNI3)+*0 HR?0   # %:M !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'4=7L]*>S6\D,?VRX6V
MA.TD&1@2H)'3.".>_%7JQ?%FBGQ!X8O=/C?R[ED$EM)_SSF0AHV_!@* +FI:
MO9Z3]D^UR%#=W"6L"JI8O(V<# ^A)/0 &KU><Z!J"_$'Q%9ZA-#BTTFPVRQ'
MC%[,NV1?^ ("/^VE5-%EN[[4=)\%3S2M+H-Y)+>R%CND@AP;;)[[_,C/OY;4
M >HT5X[JFFP3^$O'VL2O.U_8:C=M9S><P-N4"L-F#\O/7UZ=*UO$"7VL?$&/
M3Y;2PO;5-(CG@MK^]D@C9V=A(X"(VY@ @Y^Z#QUH ],)P,UR3?$;1$NTM&M=
M;%S(A=(3H]SO91@$@;,D#(Y]Q5KP-'=1>$[:.[O[:^9'E6.>VN&G7RQ(VU?,
M(!8J/E)Q_#5+4/\ DK>A_P#8)O/_ $9#0!MZ9X@L]5U"ZLH$N$FMH()Y!-$8
M\+*&*C!Y!^4Y! Q6K7GIT'3]=^(OBQ-1B::*.RLML>]@H)$WS8!^\,<'MDXZ
MU@&]U/4O!WPZMY6CN8+],70O+IX8[AUA)C22158G)!.,?,5&: /8:*\?OK"^
MM-(N[%[RS@M7U[3HX[33;^28V1:1!(NYE4KG(8+VR:W_ !'8V(UC1O#%GIL,
MR06LUTL%W>O#:J@95)8 ,9&!;@'IDF@#T&BO$M/NDOM%\,VMY?D60\3W5IF*
MY<J8=LVR,.<,4.0HSU!%:]W-<Z#9_$:U\.O)';V-I#+;)&Y86\S1L9=G7! "
MM@=": /5J*\OT;2;NRUO29[-M%LH)[6;S8[759;B34$\O*OM:-0S!MIW9S@G
MUJ"QU-6\"?#5!>;KB:^M P$F6?".&SW.#@'WQ0!Z8VI6^V^$):XFLA^^AA&7
M#;0X4#U((Q]15B&3SH(Y-CQ[U#;'&&7(Z'WKS!+*SM&^*5S;QK'=*LH#*QW!
M6M$<]_[V35E8K?5_$'AK2]:8R::V@?:(H9)"J37 ,88GD;BJ'(!Z;B: /2:*
M\XU'3K/4M$T"UT76+?4;:*><PV>IW3A;]5W*5W@9;RR>.&' SGK6]X#NK:;2
M+RVM[.:S:SO9+>:V>Y\](G 5B(W[I\PP.,<C H W+?5K.ZU:]TR*0M=V2QO.
MFT@*) 2O/0YVGI5VO)/%TLD,WQ.DB=DD73+$JRG!!VR5T*Z7;:!\2M$BT_S(
MUOK"[^U[I6;SV0PE6;)Y;YFYZ\T =U17F'A:#1KK2=.U[5[^:#7Y=4>.299V
M$C3><RBW*\_)C VXQ@9XZUZ5'<P3330Q3QO+"0)45P6C)&0&';((/- $M%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !117!^,M+O-1\6:4W]B7FJ:?%93AHX+
MH0*)6>/:6;<O\*MZ]>E '>45PEG;Z#K?A5 [WFDZ7I=U*-0LIK@KATSN25]Q
M)4%@W#8/';BN?5+J/2EM[1[VST#6]?M[>SB>1UD6U*9D*DG<BR,C8'!PW;-
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MM+6WU*.P@N+W><GRPTI"*09&#':%&WH>>*P=2\9ZW?\ A76EM+VT2\T[4;2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
I44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>exhibit1012-stuartexecut008.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT:\D$(NPR,1*20%$8.XC<-N?6@#T*BN3MO',:7>J6NMZ7<:1-I]E_:#"61)
M]OD@L"A(R"I!'\Z=IWC*2XO8K74M$O-,>ZMGN;,S2(WG*@!93M)V. 0=I]^>
M* .JHKA;'XD"\MM'U%M OH=(U26*WCO7>/Y99.%!3.[;N^7=_3!,_ACQ1K&L
M>,/$6G7>EO#9V,Z11R&2,^7^[4X.#EBV=P]!P: .SHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@!"=JDG. ,\#->9>&_".J:[=ZIXJU+4];T2^U.X8)
M:P%(VCMHSMB5PZ,0< GMUKTJ>+S[>6'S)(_,0KOC;#+D8R#V-<5_PK-?^AT\
M9_\ @W;_ .)H Y;4-%O_  AI7CS1LWUYH]_I4^HP7LRAMLY1EE1V4!=S<,.!
MQ5B]N;WQ1X*\.^&;;1=2BNW:R-Q-);,L$,<95F<2_=8$+P <\] >*W+GX56U
MY:RVUSXN\7S02H4DCDU4LKJ1@@@K@@^E.B^%T,$*11>,?&*1HH5575B H'
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M& 23V%8VJ177CCQ18"WTW4;&VL;"]CGGO;9H1YD\8C5%S]['))7(X'->CT4
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MF^&M/M(+!["-(@1:R2F5H2?F*EB3D@D]ZUJ* /&ET>_N/"^I:3-H^J_:-/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOOB)X4TV^N+*[U98Y[9]DR^1(0C=<$A<=QWJ[?>+-'L$TB1[GS8M7N$M[.2
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M: ,2Y\'7GV^_?3/$-UIUCJ,WGW5M#$I;>0 QCD/,>X*,]><D8J/4? CW]YK
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MSR('3G 958!L9/4&G_\ ",Z1_8]AI/V3_0;!XI+:+S&^1HR"ASG)P0.I.>]
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MRS-AXE8L%QG P6)R.?>@#F_!J6VG>(;[3[CPW:Z%JOV2.1Q82AK6YB5BH=0
M,,"2/F7.".37=5SL'@;0(+*_M3;3SI?P^1</<W<LLCQ\X0.S%@O)X!%;\420
M0I%&-J(H51GH!P* 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%0R7EM#,D,MQ"DK_ '49P&;Z#O0!-15>>_L[:[MK6>[@BN;DL((7D"O+M&6V
M@\M@=<=*L4 %%%% !1110 457^WV?]H_V=]K@^W>5YWV;S!YGEYQOV]=N>,]
M,U8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KQ^YL]$TB[UR'QSX7GN!>7DTJZZ+3[2GDL?D&]<M$47 Q@ 8R*]@KC/+
M\?6 N;&%-(U2%Y'-O?7<[Q.B,20LD:H0VW..",@#I0!2O=8CTWQ'\/M+L#;:
MC97\<ZI?7($LVQ(E*LD@Q@MGDXYJA<>+O%S>'-<\0P/I4=KHUY<Q?9GMW9KJ
M.*0@G?O&P[1CH<D$\ XJ[#\/KRQU#P";:YAEMO#J7"W+R$JTAD0 %% (QN!X
M)&!CK5@^#M2/@#Q+H7F6WVO4[B]E@;>=@$SLR[CC(X/. ?QH EN=;\0:WX@U
M#3?#DUA:)IMO#++)>0-*9I95++& K+M4*!EN3SP*S]3\:ZDNJ0:3-J6B>'+R
M*PCNKLZDXD!E<L!$GSJ"!M)+9/!7BKTNA^)-$UV\U/0(M.NAJ5K!%<17<[1>
M3-$I59%(5MRX(RO!X'-0R^&O$%AJ<.K1)INNWD]A%:WWVT^0&EC+%94VHP ^
M=@5P. .: **^.]=UMO"D&B1Z?%+K=K<M+),K2) \)4,RX(W+]_ [Y7D<TS6/
M'FH6E_JUO%KOA^SDT9$1K>]^62_F\L.X7]X"B\A0<-SGTK?C\-:HWB7PQJEQ
M)9'^S;2YBNQ IC4R2A,>6N.F5/4BJE]X=URQUS6+G1K'1[R'576827SE6M)0
M@1C@(V]2%4XRO.: ,*&_FU;XQ1ZAI>Q)[OP8)[7SAE0S3!DW 8R,D9K8?QW>
MW/PZTS5;&"$:YJ$\5@EO(I*)=%]D@(SG"[7/7H*OP^%[Z#XG1^)'EMOL*:&-
M/8+E6\P2[\A<8"X]ZY_P]HT=W\6M8GM+A)M%TV9KM43E4OYXU609Z'"JQ/H9
M* /3QD*,G)QR:6LC3+_4+G7-:M;F. 6EK+$EJ\8;<P:,,P<G@D$]NQ'>M>@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** &2Q1SPO#,BR12*5=&&0P/!!'I4&GZ98Z39K::=9V]G;*21
M%!&$4$]3@5:HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHKSVX\0M9^+?$6LE)KF"Q^R:/:6\<@
M59;B1@S<G@',D8)/0 T >A45R=YXKOK'PKKNHZGH\NFW6G0,ZJT@ECE)7*;'
M &[YL C (-:OA;3IM)\*Z787,CR7$-LBS.[%F:3&6))_VB: ->BO*_ FA:AX
MG\'6VL7/BWQ%#>S2SC,5X"B[9G5?D92,84<5L:%XLU:VT_7M/U2UEU76-$ND
MMO\ 0XMK7:R &)R.B9#?-V !- '>45P]S\0I=+MK]M6T.2UN-.EMOM<:7"R*
MD$S%5E5@!D @Y&!TK>U3Q#'IVO:-HZ6[7%SJ;R8VM@11HNYG/MR![DT ;5%>
M<:#XSTZR\'B[TS2KQY;G5GL;:SDNC(\TY8_QO]U< GT %6=$U34+_P"*][#?
MV<MC)%HD6^V,PDCW><YWJ1P000,X!X([4 =]17!^.3>77C#P?I$&J7]A;7\M
MV+@V4YB=@D09>?J/UJMKB:M\/EM=:@U[4-3TC[3%!?VFI.LK*CL$$D;@!@02
M.#D'- 'HM%<?>^-;P7FJII'A^;4K726\N\N%N$C^<*&9(U/WR 1GISQ39/'O
MVK4K&QT/29=2EOM-74K=O.6)?++8^<D?+CCUY(&.] '945YZOQ.F;1#K7_"-
M72Z=;3_9]1D>X0-;2!]C!5_Y:!21DC'7V.-3Q9XOU/PO'<W9\.FZT^'8%N%O
M45I&; "JF"Q.XX [T ==17,:GXFU>T:..R\+W5W(MH+JY+3K$D6<_NU8@AW&
M#P/;GFN;U;6AJGQ$^&E[8S3+9:A;WD_E[BNY3 K+N'3(S0!Z717*:+XOO-9N
M;:6/P_<KI%W))'!?K,KGY=WS/&.44[2 <GDC.,USG@OQ4=-\#:7 8YM2U>^O
MKJ.VM5D^=P+A\LS'[J*.K'IP* /3J*Y'2=2L9_B5KVGI:3QW\%K;O/,;EFC<
M,. J'A<>H'-==0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7(W?@F:/6+O4_#^OWFBRWS;[N***.:&5\8
MW['!VN>Y'6NNHH Y!?A]8+HLEB;RZEN;B]AOKJ^F(>:>2-U8;N, ?*    !T
MK6O/#L-YXBBUAIY%DCL9;(1@#!61E8M]1M_6MFB@#C+/X>P:;X8T;2K'5+F"
MZT>1Y+2^"*7!<MN#*1@J0Y!'L*L:AX).K>#M2T#4=9O;I]0<237<FW<I#*<(
M@^55^0# ]SU-=710 R&,0P1Q Y"*%!/? KBK+P'J^E)/#I?C2_L[66>2<0K9
MV[A6=BQP60GJ?6NXHH YG_A$YKN727UG6;G4QITS7 62*.-9I?X&<( /DYP
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M:1;*;.:TN[D7MO:S0+."T8DD5"2!R",]ZZ&::*VA>:>5(HD&6=V"JH]23TH
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M[)$3&8>,?(RD%??!Y[TZ'PKH=OI<.FPZ=$EI#.MRD8)_UJL&#DYR6R <DG-
M',KH^F6OQ;2SM]/M8K6X\/2>= D*B.3;<1A<J!@X!(KSRSL[6+]F75KF.VA2
MX=I%>54 =@+H8!/4BO=SIMF=675# OVY8#;K-DY$98,5].H!_"L]?"6A+X<D
M\/KIT8TF0DO;;FVG+;CSG/WN>M '%/I5CJ_Q2T"'4+:*YAC\-&7RI5#(S"5
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MMOLD<B\;8<AM@'3&0.W:L]O!?AU]9_M9M,C-X91.6WML,@Z.4SM+=]V,YYH
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M!9-=:?*S+'(T,J21M&\4B]4=6 *D>A%94^N0VOC:YLWU6ZD:'2C=MI45GO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+"$ZAXFU&2#4+V'S%MP"[!D!(^=@<#GH3UH ]-B\5:%-I":JFIP&Q>40";.
M)"VT*>X.3C!K"N?BEX8AU+2K6"_CN(K]Y%,Z;ML816Y^[\V6&WCUS7GE])%?
M>$_$UO-?1:AYGBFTWR)&(Q*K>0-P4$_*<'!'!ZUWGBZ:WLOB-X#EGDC@@1KY
M=[L%5<P8 R>!0!WE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M \4B,596P2,@CL:XTW\^N^+M;TV\\7W.AW5G<"*QL+<Q1F2/8I$IWJ3)N)/
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M+G_D>C_BN_\ J7/_ "/7444 <O\ \5W_ -2Y_P"1Z7_BN_\ J7/_ "/73T4
M16OVC[+#]K\K[3L'F^5G9NQSMSSC/K4M%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %>7>%]?'A>^\56U_H^N/)<:]=7,)M],FE62-MH4A@N#G:>]>HT4 >5W>DZ
MQK6F>-O$UYIEQ:37^D/8Z=8,NZ?RE1SEE7/S,QX7J.E=I8WIT3PAHGFV%Y*_
MDVUNT-O#N>,LJKEAQA5[GL!7044 ,F!,$@ R2I_E7C/AJ#5=)^$WA*TO(=8L
M+/[=,-4%I#*MS'$6E*\(-ZJ6V9*C.#[U[310!X7K&G74G@OX@6%GI&LAKR2U
MN+..YCFFEFB'E+G<V26RI.TG<HXP,<>@:=9W*?$N*Z:VF6 >'8H?-*$+O$Q)
M7/3..<=:[2B@#D_ -K<6EAK2W,$L)DUN]D02(5W(TI(89Z@CH:R=>U31KVZO
M=-\8^$;F9HI66SDBTZ2[6>(_=*2(IV-ZC(P>]>A44 >0)::IHNC^!+[4[+46
MAL-0N&D01/<36\#K((5<+EB0I4'KCI5I[V?2[3QSH[:5J<U]JEQ/<V*Q6<C)
M,DL"*#O VK@@Y!(/;!/%>JT4 >3*MVCZ18ZO#X@%HFA6BV-KIQGA66YP1(LK
MQ8*L,)]\A0,FH_"-A>KJ'P[673[R,Z;9W]M=&6W=1#)A  21WYP>A[5Z[10!
MPMK))IWQ@U4W%I=B+4K&V2VG2W=XBR&3<&< A<9'4C]17=444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !5'4=7L]*>S6\D,?VRX6VA.TD
M&1@2H)'3.".>_%7JQ?%FBGQ!X8O=/C?R[ED$EM)_SSF0AHV_!@* +FI:O9Z3
M]D^UR%#=W"6L"JI8O(V<# ^A)/0 &KU><Z!J"_$'Q%9ZA-#BTTFPVRQ'C%[,
MNV1?^ ("/^VE5-%EN[[4=)\%3S2M+H-Y)+>R%CND@AP;;)[[_,C/OY;4 >HT
M5X[JFFP3^$O'VL2O.U_8:C=M9S><P-N4"L-F#\O/7UZ=*UO$"7VL?$&/3Y;2
MPO;5-(CG@MK^]D@C9V=A(X"(VY@ @Y^Z#QUH ],)P,UR3?$;1$NTM&M=;%S(
MA=(3H]SO91@$@;,D#(Y]Q5KP-'=1>$[:.[O[:^9'E6.>VN&G7RQ(VU?,(!8J
M/E)Q_#5+4/\ DK>A_P#8)O/_ $9#0!MZ9X@L]5U"ZLH$N$FMH()Y!-$8\+*&
M*C!Y!^4Y! Q6K7GIT'3]=^(OBQ-1B::*.RLML>]@H)$WS8!^\,<'MDXZU@&]
MU/4O!WPZMY6CN8+],70O+IX8[AUA)C22158G)!.,?,5&: /8:*\?OK"^M-(N
M[%[RS@M7U[3HX[33;^28V1:1!(NYE4KG(8+VR:W_ !'8V(UC1O#%GIL,R06L
MUTL%W>O#:J@95)8 ,9&!;@'IDF@#T&BO$M/NDOM%\,VMY?D60\3W5IF*Y<J8
M=LVR,.<,4.0HSU!%:]W-<Z#9_$:U\.O)';V-I#+;)&Y86\S1L9=G7! "M@="
M: /5J*\OT;2;NRUO29[-M%LH)[6;S8[759;B34$\O*OM:-0S!MIW9S@GUJ"Q
MU-6\"?#5!>;KB:^M P$F6?".&SW.#@'WQ0!Z8VI6^V^$):XFLA^^AA&7#;0X
M4#U((Q]15B&3SH(Y-CQ[U#;'&&7(Z'WKS!+*SM&^*5S;QK'=*LH#*QW!6M$<
M]_[V35E8K?5_$'AK2]:8R::V@?:(H9)"J37 ,88GD;BJ'(!Z;B: /2:*\XU'
M3K/4M$T"UT76+?4;:*><PV>IW3A;]5W*5W@9;RR>.&' SGK6]X#NK:;2+RVM
M[.:S:SO9+>:V>Y\](G 5B(W[I\PP.,<C H W+?5K.ZU:]TR*0M=V2QO.FT@*
M) 2O/0YVGI5VO)/%TLD,WQ.DB=DD73+$JRG!!VR5T*Z7;:!\2M$BT_S(UOK"
M[^U[I6;SV0PE6;)Y;YFYZ\T =U17F'A:#1KK2=.U[5[^:#7Y=4>.299V$C3>
M<RBW*\_)C VXQ@9XZUZ5'<P3330Q3QO+"0)45P6C)&0&';((/- $M%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@(H'ISCK7*17L]Y;^';'4/MNL06]YJ-I+8PN3-<K%(4CE;D!E0#!W,.6!Y-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
F%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>exhibit1012-stuartexecut009.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.DH5)"/[V"1FH/@?_P DOLO^OBX_]&-0!VNM:WIOA[3)-2U:Z6ULXR TK*2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKFWBO+2:VG
M7=#,C1NN<94C!'Y5+10!PK> =3ETO^P[CQ=>S:#L$+6QMHQ,T(X\LS=<8X)Q
MDCO5K4_!5[-XH.NZ/X@DTF9K)+)HTM(Y5**Q8??Z=?TKL** .?T?1]?L;[SM
M2\4R:E;["/(:QBB&>QW*,\50\2_#^Q\2^(]/U>>YEA^SA4N8$ *7:)()$5_8
M,,_C77T4 8?B[PXOBSPY/I#7;VHE>-Q,B!BI1U<<'KRM9G_"-^+_ /H?9O\
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MQ3)J5OM(\AK&*(9['<HSQ5C6- CU?5-&OGG:-M+N6N%4+D2$HR8/I][-;%%
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MX%QT?VEK/_0 ;_P+CK3MKB.\M(;F$L8ID61"RE3M(R,@\CZ&I: ,?^TM9_Z
M#?\ @7'1_:6L_P#0 ;_P+CK8HH Q_P"TM9_Z #?^!<=']I:S_P! !O\ P+CK
M8HH Q_[2UG_H -_X%QT?VEK/_0 ;_P "XZV** .?L]>U.^A:6#09"JRR0G-U
M&/F1RC?JIJQ_:6L_] !O_ N.D\,?\@NX_P"PC>_^E,M;- &/_:6L_P#0 ;_P
M+CH_M+6?^@ W_@7'6Q10!C_VEK/_ $ &_P# N.C^TM9_Z #?^!<=;%% &/\
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MI?\ 8.M/_1EQ6S0!C_VEK/\ T &_\"XZ/[2UG_H -_X%QUL44 8_]I:S_P!
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MC23ST<!@C/R![*:V:QM8_P"0SX>_Z_9/_2>:@#9HHHH **** "BBB@ HHHH
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MS1*RY?8"/F;&2 <Y(%,D\0R0>!O%-]H_BJ]OI+.T#I'?P*EU9RX.=PVKP>,
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MW_7[)_Z3S4 ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"@"G_@:O\ A1_:.N?] %/_  -7_"MFB@#&_M'7/^@"G_@:O^%']HZY_P!
M%/\ P-7_  K9HH QO[1US_H I_X&K_A1_:.N?] %/_ U?\*V:* ,;^T=<_Z
M*?\ @:O^%']HZY_T 4_\#5_PK9HH QO[1US_ * *?^!J_P"%']HZY_T 4_\
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M\#5_PH_M'7/^@"G_ (&K_A6S10!C?VCKG_0!3_P-7_"C^T=<_P"@"G_@:O\
MA6S1UH QO[1US_H I_X&K_A1_:.N?] %/_ U?\*V:* ,;^T=<_Z *?\ @:O^
M%']HZY_T 4_\#5_PK9HH YB^;7KN]TR==$C46=RTS WB_,#%)'@<>K@_A5[^
MT=<_Z *?^!J_X5L @YP1Q2T 8W]HZY_T 4_\#5_PH_M'7/\ H I_X&K_ (5L
MT4 8W]HZY_T 4_\  U?\*/[1US_H I_X&K_A6S10!C?VCKG_ $ 4_P# U?\
M"C^T=<_Z *?^!J_X5LT4 8W]HZY_T 4_\#5_PH_M'7/^@"G_ (&K_A6S2;E]
M1UQUH Q_[1US_H I_P"!J_X4?VCKG_0!3_P-7_"MD$'H<T9 ZF@#&_M'7/\
MH I_X&K_ (4?VCKG_0!3_P #5_PK9HH QO[1US_H I_X&K_A1_:.N?\ 0!3_
M ,#5_P *V:,C.,\T 8W]HZY_T 4_\#5_PH_M'7/^@"G_ (&K_A6S10!C?VCK
MG_0!3_P-7_"C^T=<_P"@"G_@:O\ A6S10!C?VCKG_0!3_P #5_PH_M'7/^@"
MG_@:O^%;-% &-_:.N?\ 0!3_ ,#5_P */[1US_H I_X&K_A6S10!S$3:]'KM
MUJ!T2,I-;0P!/MBY!1I6)Z=_,'Y5>_M'7/\ H I_X&K_ (5LT4 8W]HZY_T
M4_\  U?\*/[1US_H I_X&K_A6S10!C?VCKG_ $ 4_P# U?\ "C^T=<_Z *?^
M!J_X5LT4 8W]HZY_T 4_\#5_PH_M'7/^@"G_ (&K_A6S1D9QGF@#&_M'7/\
MH I_X&K_ (4?VCKG_0!3_P #5_PK8R,XR,^E+0!C?VCKG_0!3_P-7_"C^T=<
M_P"@"G_@:O\ A6S10!C?VCKG_0!3_P #5_PH_M'7/^@"G_@:O^%;-% &-_:.
MN?\ 0!3_ ,#5_P */[1US_H I_X&K_A6S10!C?VCKG_0!3_P-7_"C^T=<_Z
M*?\ @:O^%;-% &-_:.N?] %/_ U?\*/[1US_ * *?^!J_P"%;-% &-_:.N?]
M %/_  -7_"J%U=:C/KV@+>::MJ@NY"'%P),G[/+Q@"NHK&UC_D,^'O\ K]D_
M])YJ -FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPKQX\Z3D \=#U]#[US?A2_>+3/AF]Y(#I!2ZB+N<HMP,K"&/3. P7WH ]?\
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M!YA4HFW<N!P.=E;GPM\/:59^"=#U..R@.HSV,;27C(#,05'R[SSM   '3 %
M'=%02"0#CD9'2@J&QD X.1D4M% !1110 4444 %%%% !1110!C>&/^07<?\
M81O?_2F6LM?%7ARWU;4U2PN5O=/"_;GBTYV:(,-PR54D@CGC-:GAC_D%W'_8
M1O?_ $IEKSJ\U?6-#\7?$G4-)L8KHQ&P:8LQ+1)]GY=4 ^?:,G&Y>E 'IFGO
MH^LV::I8K:74%XJN)T0'S0#QDXR<$=^A%6Y[*TNGC>XM89GB.8VDC#%#ZC/2
MN#LS:^!?A;I%OH5Z+N&>:"&&]; !\^4;I,'(&-Y(!R!QG/-6+M_%&D1ZU/-J
M]I:Z>UEOM9K^02/;3@X8_*@W(00<')W8&,'% ':7-C:7H NK6"<+T$L8;'YT
MKVEM*Z/);Q.Z !69 2OT]*X.VUC7AXAU[2K&2YD9=%2\L%U%45A.3(H)Q@A2
M54X;!'/ K/?Q^VG>']?OQ+J"ZGI]DC/I.J1!7AE+;?,! &^,EEY!Q@<8S0!Z
M3+I]E/,9I;.WDE9=A=XE+%?3..GM3S:6QF$QMXC*.CE!N'XUQ^IWNJ>'M?\
M#:#4Y[ZTU68V=RLJIE9"A994PHQ]TY'(QVKFCK?B.'PA=>('U^XDFT_7&M1!
MY,0CFB%T(B'PN<[3U4KCZ\T =E<>)_#UC<:O;M:2B;2=MQ.D=BQ+%N-\>!\Y
MYP2/7TK:TT:;>Z;#>6,,!M;R%9598@HD1AD9&/0]#4KZ? \UQ,=XEG01LZN0
MP4=E(^[U)X[FIH(8K:".""-8XHU"(BC 50, "@"K=KIMCIDQN8;>.RQ^\0Q@
MJV<#&W'))P ,9)P*>EG:3V$<$EC$L 48MY(UPGMMY KEO%UR\GC?P1I+$_9K
MF[N+F0?WFAA+(#_P(@_51Z4[4M1U/5?%.J:'I\TEO]BLX9 T4J(Y>0O\QW*V
M57:./4G.>, '7Q0Q01+%#&D<:C"HB@ #V IQ12RL5!9>A(Y%<,+K7R-)L=5U
M-/[0-C*;FVTD RRS*P42[F 54 SG.T;CCGI5'PYXLU+7K/P?8W5V8;C5+":Z
MNKB)55I#$57:O& 3NW' _AXQF@#L=8UO3]$EL8+J&4_VG=+:Q^7%E3(_]X]!
MP#^5: L;187A%K (G^\@C&UOJ.]>>^*;35;;3_#EK?:K'=W*^)X1#<"(!EC(
M<H' P"P!'/&>*V_"MYJ">*O$VB7FHS7\-@UM)!+<*@D E0EE.Q5! *\<=Z .
MF:QM&D:1K6 NPP6,8R>W6@V%F;9[8VD!@?[T7EC:WU'0U8KS6V\0:M'K'AI_
M[3DOHM0U">VN9HXU%K*NV1E$0(#?+M4;AP<'DT =].]GIUG'"8D2%V$,<$:#
M#$_PA1QZ^V,D\ U';'3899X[:&&(6:^7(R1A%C!&[;GMP0Q'N*CU[P_IWB73
M?L&IPO) )%D&R1D96'0AE((ZD?C7#?%70(--\#^*M;TJ*:/4;V"&.Z9)6(:,
M.BL=N< [!@G'04 =3'XMT>&Q>_@MKH:427>_BM6\D^K\#)7_ &P"N.<XYKH8
M9H[B%)H9%DBD4,CH<JP/((/<56LX[0Z-;QQ+&;(VZJ@_A,>WC\,5Y'X U/5K
M#POX'ABO)4LKO5+FV$;*I$EN!*R<D9'*\8(XH ]DGMX;J%H;B*.6)OO)(H93
M]0:K.++1=,FDBM5AMH5,ACMH?3KA5'6N+?7-51O&\!UJ.W&GW,$=I<7,2D0*
M\<;$ *N6.6(4$$Y('-2:7JU_-KOBG2;B2[:S@T^&XMUO GF)O60-RO8[0<-R
M.>G2@#=L-7TN?1]%U.PTN=[?4'7[/Y-J"8!("=[X^XO')]Q2ZMJ6E:5<S(-+
M>\O3#]LFAM($:4QH<!SDC.#T'+'!P#BN,TK4;_3? /PV-E>/#'=7%I:W$852
M)(VC8D9(R.5'0CO6HEC-)\9K[&IW:?\ $DA?Y1'P#/)\G*'Y1U]?>@#L+6'3
M[Y;?5(K2+S)8UDCE>#;( PSSD9!P>E1^9:7.OO!)IDAN+:%9$O)+<;,,2-J2
M?WACD>XKC=-UK6/L^H^&;S59G\0PZDMO%<^7&&:W?]XLH4+MXB5\\'YD([U>
M.H:J/&OB+3!JDWV>#28;BW_=QYA=C("1\O/W!US0!VU%>7:1K.OII_@/6+G6
MI[G^V)$M[NV:*-8B&A=PPPNX,"H.<X]@.*?K/B'7C:>)1;7LMMKMGJ2P:;81
MHA\Z$[-I"D'?N#,2W\..P!H ] N%T_2H;S57MXHBD32SS1Q#>RJ,G.!D]*PH
M_%VA6VJ1V,>G7\-]<1&9(ETV17= 1DXV],D5TL4)6T2&>0W!V;7>15R_')(
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MM\T[6T4TZ1$/MC#2%<'Y?7GGCO7 7'B#5K:_T>XBU.2\2ZUXV,[Q1J+0Q,9
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M/M=*TZWT^RB$-K;QB.*,$G:H& ,GFK-% !1110 4444 %%%% !1110 4444
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MW<'&.F,#& ,1WOA&!Y-<NXKS4Q<ZM$D<_P!GG2-AL&$V-M&T@$C/N<YKIJ*
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M?]?LG_I/-6S6-K'_ "&?#W_7[)_Z3S4 ;-%%% !1110 4444 %%%% !1110
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MY#^@_P#7:;_T4U;- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &-X8_Y!=Q_V$;W_ -*9:V:QO#'_ ""[C_L(WO\ Z4RULT %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C:Q_R&?#W_7[)_P"D
M\U;-8VL?\AGP]_U^R?\ I/-0!LT444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% &-XN_P"1+UW_ +!UQ_Z+:MFL;Q=_R)>N_P#8
M.N/_ $6U;- !1110 4444 %%%% !1110 4444 8VJ_\ (?T'_KM-_P"BFK9K
M&U7_ )#^@_\ 7:;_ -%-6S0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!C>&/^07<?]A&]_\ 2F6MFL;PQ_R"[C_L(WO_ *4RULT %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C:Q_R&?#W_7[
M)_Z3S5LUC:Q_R&?#W_7[)_Z3S4 ;-%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!C>+O^1+UW_L'7'_HMJV:QO%W_ ")>N_\
M8/N/_1;5LT %%%% !1110 4444 %%%% !1110!C:K_R']!_Z[3?^BFK9KG_$
M*7;ZOH2V4\,,_GRX>:$RKCRFS\H93^M3_9?$O_07TK_P62?_ !^@#9HK&^R^
M)?\ H+Z5_P""R3_X_1]E\2_]!?2O_!9)_P#'Z -FBL;[+XE_Z"^E?^"R3_X_
M1]E\2_\ 07TK_P %DG_Q^@#9HK&^R^)?^@OI7_@LD_\ C]'V7Q+_ -!?2O\
MP62?_'Z -FBL;[+XE_Z"^E?^"R3_ ./T?9?$O_07TK_P62?_ !^@#9HK&^R^
M)?\ H+Z5_P""R3_X_1]E\2_]!?2O_!9)_P#'Z -FBL;[+XE_Z"^E?^"R3_X_
M1]E\2_\ 07TK_P %DG_Q^@#9HK&^R^)?^@OI7_@LD_\ C]'V7Q+_ -!?2O\
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M'[/+R29&R.O&/QH ZBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8V]..#6)KGQ!NXK_ %^:W\06]E)I,[0VVE-:^9]K,:@MO?&06;<HVD8P"<T
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MQ:/RPV=RY/S;N3DD8X CO?!6M:XNM7.JW&EP7U]I3Z;']BC?80QSOD+<D@@
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M=IO_ $4U;-8VJ_\ (?T'_KM-_P"BFK9H **** "BBB@ HHHH **** "BBB@
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M]@^X_P#1;5LUC>+O^1+UW_L'7'_HMJV: "BBB@ HHHH **** "BBB@ HHHH
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MPMNT\0F896,N-Q'L.M &7_PC%A_S\:M_X-[K_P".4?\ ",6'_/QJW_@WNO\
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MC \X;OWAP,9/)'!H Z:&1)H(Y(VW(ZAE;U!'!I](JA5"J % P .U+0 4444
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MK/2Y(I;./S7'EM&,(<YR<#U)SWIE[X/T/4-:DU:YM&>ZE@-O-B9U2:/!7:Z
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M90.@'(.1FNNK-T;0=/T""6*PCD!F?S)I9IGEDE; &6=R6/  ZUI4 %8VL?\
M(9\/?]?LG_I/-6S6-K'_ "&?#W_7[)_Z3S4 ;-%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!C>+O^1+UW_L'7'_HMJV:QO%W
M_(EZ[_V#KC_T6U;- !1110 4444 %%%% !1110 4444 8VJ_\A_0?^NTW_HI
MJV:QM5_Y#^@_]=IO_135LT %%%% !1110 4444 %%%% !1110 4444 %%%%
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M &-K7_(6\._]A!__ $EGK9K&UK_D+>'?^P@__I+/6S0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-;_\ (Z:E_P!@ZT_]
M&7%;-8UO_P CIJ7_ &#K3_T9<5LT %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %8VL?\ (9\/?]?LG_I/-6S6-K'_ "&?#W_7[)_Z3S4
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M$_[Z% #Z*9YT7_/1/^^A1YT7_/1/^^A0 ^BF>=%_ST3_ +Z%'G1?\]$_[Z%
M#Z*9YT7_ #T3_OH4>=%_ST3_ +Z% #Z*9YT7_/1/^^A1YT7_ #T3_OH4 /HI
MGG1?\]$_[Z%'G1?\]$_[Z% #Z*9YT7_/1/\ OH4>=%_ST3_OH4 /HIGG1?\
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M.B_YZ)_WT* 'T4SSHO\ GHG_ 'T*/.B_YZ)_WT* 'T4SSHO^>B?]]"CSHO\
MGHG_ 'T* 'T4SSHO^>B?]]"CSHO^>B?]]"@!]%,\Z+_GHG_?0H\Z+_GHG_?0
MH ?13/.B_P">B?\ ?0H\Z+_GHG_?0H ?13/.B_YZ)_WT*/.B_P">B?\ ?0H
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M38=1DO8$LI]GE3EP$??C9@^^1CZT 5_^$6\/?] '2_\ P#C_ ,*/^$6\/?\
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M_A1_PBWA[_H Z7_X!Q_X59TW5].UB*273;R&ZCC?RW>%MRAMH;&?HP/XU=H
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MC#J".H/L: *__"+>'O\ H Z7_P" <?\ A1_PBWA[_H Z7_X!Q_X5K44 9/\
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MOXN^(DC1(7>2WC8D=5^RKQ].37->!;JWL]8\&SZC-'%"_A4QVLDS!5\P2*7
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MD%\%B"!WP,^N!4\5M! \KPP1QO,V^5D0 NV ,MCJ< #)]* ):*** "L;6/\
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M#K6W\877B2TU#4+:>\\O[7;1R+Y,Y1=JE@5)X'H171T %%%% !1110 4444
M8WAC_D%W'_81O?\ TIEKS?4]09+\:YIG_"07#_VW%#_:<ER$M/+,ZQ-"L7F?
M,@R5W!.2,Y[UZ1X8_P"07<?]A&]_]*9:Y]OAWI][9SV<>O:B;!+MKBVMXI(R
MMG/YGF$J=N20V?E<D#)X[T 4;#2)O&5UXDOY]8U&SO;35);*PDM[EU2U6(*
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M]XD5S<O/Y<A>16VLY) (4$\]:77(FU_XC6GAZZN;J/3(=+>^DAMYWA,\AE"
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M&.)0JF61I&Q[LQ))]R:GJO8V\MI8Q037<MW*BX:>8*'<^I"@#\@*L4 %%%%
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M])YJ -FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH QO%W_(EZ[_V#KC_ -%M6S6-XN_Y$O7?^P=<?^BVK9H **** "BBB@ H
MHHH **** "BBB@#&U7_D/Z#_ -=IO_135LUC:K_R']!_Z[3?^BFK9H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH QO#'_ ""[C_L(WO\
MZ4RULUC>&/\ D%W'_81O?_2F6MF@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH QM:_Y"WAW_ +"#_P#I+/6S6-K7_(6\._\ 80?_
M -)9ZV: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"L;6/^0SX>_Z_9/_ $GFK9K&UC_D,^'O^OV3_P!)YJ -FBBB@ HHHH ****
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M .?ZV_[_ "_XU'_8NE?] RS_ ._"_P"%']BZ5_T#+/\ [\+_ (4 2?VGI_\
MS_6W_?Y?\:/[3T__ )_K;_O\O^-1_P!BZ5_T#+/_ +\+_A1_8NE?] RS_P"_
M"_X4 2?VGI__ #_6W_?Y?\:/[3T__G^MO^_R_P"-1_V+I7_0,L_^_"_X4?V+
MI7_0,L_^_"_X4 2?VGI__/\ 6W_?Y?\ &C^T]/\ ^?ZV_P"_R_XU'_8NE?\
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M[3T__G^MO^_R_P"-']IZ?_S_ %M_W^7_ !J/^Q=*_P"@99_]^%_PH_L72O\
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M1_V+I7_0,L_^_"_X4?V+I7_0,L_^_"_X4 2?VGI__/\ 6W_?Y?\ &C^T]/\
M^?ZV_P"_R_XU'_8NE?\ 0,L_^_"_X4?V+I7_ $#+/_OPO^% $G]IZ?\ \_UM
M_P!_E_QH_M/3_P#G^MO^_P O^-1_V+I7_0,L_P#OPO\ A1_8NE?] RS_ ._"
M_P"% $G]IZ?_ ,_UM_W^7_&C^T]/_P"?ZV_[_+_C4?\ 8NE?] RS_P"_"_X4
M?V+I7_0,L_\ OPO^% $G]IZ?_P _UM_W^7_&C^T]/_Y_K;_O\O\ C4?]BZ5_
MT#+/_OPO^%']BZ5_T#+/_OPO^% $G]IZ?_S_ %M_W^7_ !H_M/3_ /G^MO\
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MGB:;PW%XB;P;&VEO;BZ8P:HKRB+&XD(8QD@<XS77Q>(M'EM+*Y.HVT27MO\
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M*GDMDOHV,6\O'O*!?X]N/P)K*LM-%CK'A&PU"ZTZ[TY]7U&01VO-M%-M8I$
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M?\AGP]_U^R?^D\U &S1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 8WB[_D2]=_[!UQ_Z+:MFL;Q=_P B7KO_ &#KC_T6U;-
M!1110 4444 %%%% !1110 4444 8VJ_\A_0?^NTW_HIJV:QM5_Y#^@_]=IO_
M $4U;- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-X8_
MY!=Q_P!A&]_]*9:V:QO#'_(+N/\ L(WO_I3+6S0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !5+4M'TS68%@U33[6]A4[E2YA610?4!@>:NT4
M16UK;V5M';6L$4$$8VI%$@55'H .!4M%% !1110 4444 %%%% &:_A[1)-5&
MJOI%@VH@Y%T;9#*#Z[L9S6E110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5C:Q_R&?#W_7[)_Z3S5LUC:Q_R&?#W_7[)_Z3S4 ;-%%% !1110 4444
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M(R.U &1]I\2?] G2?_!G)_\ (]'VGQ)_T"=)_P#!G)_\CUL44 8_VGQ)_P!
MG2?_  9R?_(]'VGQ)_T"=)_\&<G_ ,CUJ33PVT+33RI%$@RSR,%51[DTPWEJ
M)88C<PB2<%H5WC,@ R2H[\<\4 9WVGQ)_P! G2?_  9R?_(]'VGQ)_T"=)_\
M&<G_ ,CUHO>VL=TEJ]S"MQ(,I$T@#L/8=34] &/]I\2?] G2?_!G)_\ (]'V
MGQ)_T"=)_P#!G)_\CUIQ7-O/)+'%/%))$=LBHX)0^A':I: ,?[3XD_Z!.D_^
M#.3_ .1Z/M/B3_H$Z3_X,Y/_ )'K8HH Q_M/B3_H$Z3_ .#.3_Y'H^T^)/\
MH$Z3_P"#.3_Y'K8HH Q_M/B3_H$Z3_X,Y/\ Y'H^T^)/^@3I/_@SD_\ D>MB
MB@#'^T^)/^@3I/\ X,Y/_D>C[3XD_P"@3I/_ (,Y/_D>MBHH;FWN'E2&>*1H
MFV2!'!*-Z''0T 9GVGQ)_P! G2?_  9R?_(]'VGQ)_T"=)_\&<G_ ,CUL44
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MGKIEY&,P7]HQ6XB<=&WYRQ^N<U%)X&NKSX<:%HK7:6FL:0EO+;7*?.L=Q$N
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MK6??^//$T?A/5/%UCI^F2:/ \J6\#E_/94<Q^:QSMQN!.W X[^N]K?AV_O\
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M $GFK9K&UC_D,^'O^OV3_P!)YJ -FBBB@ HHHH **** "BBB@ HHHH ****
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MS""(9!LQ&\F?O\_<Q^-7-GB3_GXTG_OQ)_\ %T ;%%8^SQ)_S\:3_P!^)/\
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M #\:3_WXD_\ BZ-GB3_GXTG_ +\2?_%T ;%%8^SQ)_S\:3_WXD_^+HV>)/\
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M=^)K#P9;Z9.]M=:K+]HOC'P8HH!^_3VR^$_&@#T2BJ6JWEW8V+3V6FRZC.&
M%O%(D;$=SER!Q]:X;P5X@UZ?5-9AF\-7_DR:Q())GO(&6U&R/*D;\G'7Y01S
MQ0!Z%//#;0M-/*D42_>>1@JCMR34E<%\88'F^'\[)=7$&RZMLB)@ X,R+AN.
M0,Y^H%5O$KM:ZC%I2^(_$,DEO8[Q!IMN99]Y9L2S.%QCC 4XZ'K0!Z-17E":
MQKOB6X\"6RZO<6"ZQI4TU]):[59BJQG*Y!"DDD9QP&/M6G:QZQK>L>(F@\07
M]JNB2)9V4:E2LCK"KL\P*_/N+>W&<8/- 'HE1RSPPF,2RI&97V1AV WM@G ]
M3@$X]J\>L?%6H:CIOA:RO[_7 DVD&^NIM*MVEGFD+[%!*JQ51AB>.3@4V]&J
MZX_@H:E?:Q:S#5Y[82-']GDD1$D\N8HR\.4P"<8Y/% 'L]8VL?\ (9\/?]?L
MG_I/-6PJ[4"Y)P,9/4UCZQ_R&?#W_7[)_P"D\U &S1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 8WB[_ )$O7?\ L'7'_HMJ
MV:QO%W_(EZ[_ -@ZX_\ 1;5LT %%%% !1110 4444 %%%% !1110!C:K_P A
M_0?^NTW_ **:M::&.X@D@F0/%(I1U/1@1@BLG5?^0_H/_7:;_P!%-6S0!P.F
M>'O&GA6T_LG0K[1[W28B?LAU,2K-;H3D(2F0X';H:6]\$ZU+HMBQUA-1UFVU
M5=49KW<MN[ %?+51GRT /&,\C/>N]HH X-?#/B[_ (26[UT:GIL5U>:?]E8(
MC,MJR,S)L!'SJ2?FS@\DCL*@O?!6MZVNNW6H?V19WM_I3Z<BV6\HY8Y\R1BH
M)(Q@#!P">37H=% '*ZWX7NM3T?P[9Q3PH^EW]I=2LV<.L/W@O'4]LUM:Y876
MIZ-<VECJ$NGW4BCRKJ,9,; @CCN.,$=P36A10!Q%QH7BWQ!+86VOS:+#86MU
M%=2&Q\UI)VC8,H^< ("0,\D]JDM- \3Z1<7-CI-[IL>D3WSW8FE5C/ LC[Y(
MU3&ULDM@DC /0XKLZ* .&\8^!+CQ)K]G>6]W%!:2Q);:K$X.;B!)5E55QWR&
M'/9C6EK.BZQ'XDBU_0'L6N#:?8[BWO2ZHZ!BZ,&4$@@EN,8(;M73T4 <1KOA
M#6==A\*/=:C:RWFE:E'?7<GEE%D"G)5 ,].@SZ<U?\5:#J6HZKH>KZ2UFUWI
M4LK""]+".02)M)RH)##J#@]ZZBB@#S6^\!^(K^'Q6EQ?Z=(WB"TB5G =1!*G
MRA5&#E-O<G.1TYKI?$/ARYUA/#@AFB3^R]2AO)=^?G5$92%P.OS#K72T4 <(
M/"_BG3I-2T_1-3L+;2[^\>[^T.K&YM?,8-(J+C:W.<$D8SWJPV@>)]+O]430
M+W38[+4KC[49;I7:6UD95#E5 VOG;N )&"3U%=G10 @&  3D^M+110!YQJN@
M^(?$OA6_TC3+G3(+&YO+U)FN8Y&D#"[D/RE3C' Z@UU$$/BI]/MQ=7>E)>+>
M(TS6\+^6]L,;E 8DASSSTZ5Q&GZ_?Z;\0)[.UM;[4?-M;QX[&"157?\ VA-F
M0[V"+@ #)YY KJ%^(-@^A07\=C>M>37C:>NFA5\_[2I.Z,\[1C!);.,<T &H
M:5XR2^U!=(UJP-C>MN3[=$[2V9*@$1[2 PXR <8/K4$7@"+;H>EW,T=QX?T>
MWPEHZY-S<8QYDG; !) ]3GL*F?Q];VNGZU+J6E7MC>Z1;BYGLI"C,\1SM9&5
MBK X(Z\$<U-8^-5N==L=.N-&O[*+4D=["ZGV;;C8NX_*&+(=O(# ''H>* +G
MA71;SP]ILFESW:W-E!*18,<^9'!_#&Y/7;T!],>E8J Z#\5KQYB4M?$=I$(9
M3T%S &&SZE#D>NT^E7_^$XL?^$'_ .$J^S7'V3?L\KY?,SYWE>N.O/7I4=]X
MKB;5+BU3P]?:A9Z?=1PW-Y$D;K!,0K A"V]MH=22J\9]J *3>%/$&JZAIIU[
M4-.EATYI&CN[:!DN9]T;1_-_"@P^2%R"0.E5+3P7XFBL_#MO+J.E[/#\T9MX
MXHG"SHJ-&6DYX;:W '&2<YR,:EC>W6C?$6YT*XN)I['5+=K^R,SES#(I"RQ
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M3B@F,:RK'M9F96)52  <Y*GIZ$]*9J7C;PYI&H/8WVJ117$>WS1L9EBW=-[
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M" #D@CGZ<T >97TM]9^#O&WAI=%U2;4[J[OI;=8K-VCDBE8N'$@&WH>F<DC
M&:N^)8XX9I)K6Q\0Z?XCCLHELKO389'CO&"95)  4PK9!$F,#OBO2QJ-DT-S
M,MY;F*U9EN'$J[82HRP<Y^4@<G/2JMYXCT/3S;"]UC3[8W(#0>=<HGF@]"N3
MR/<4 4?%)G/PYUHW047!TF?S0O0-Y+9Q[9KBH+R?Q'I'@;1K;2]0BN;*YL[N
M[>6U=(8HX4SD2$;6W' 7:3U[5N^/?&.C:;IMSHUZT@>\9+*;<KQ!8YOE:1)"
MA5BJL3@9Z'-6&\9:%X?\*P21273V]O;-';O/:S1K(8E  9RF%SQ@G /.,XH
MR]$T"^O/!WCO2V@DMI]1U/4A 9D*;Q(,(PSU4^M5);NZ\2:3X6T&'2-2MKZS
MO+2:_P#M%H\<=LL&"W[PC:V2N%VDYSFNQ\+>++#Q5I\-Q:;Q*;>.691&^Q&8
M9*"0J%<@Y!Q^E;] '+R>%19-J-]'J^MW4DL$P%K/>-)""P/"I[=O2N:AAU?3
MO@QX?MXH=1MI(UM4OTM8V%S%!N'F[5 W!L>@R!FO3:* /%[C3)95\9P:7I.M
M>1J>AJ+%[Q9Y7G9/-W F3+(26&$;!(P0.:U+C4FU&30?MMMXECT,:<8_(L[>
MYAD>[4J-LFP!P-N<$D*3GGBO5** .-^&4,]EX2;3[NSN;2YM;VY62*=7XW3.
MZX=O]8-K#Y@3GUKLJ** .$^+'_(HO_USO/\ TAN:Q[F_TS4-.^'%EI$\$EU'
M?6[K#$P+Q1)"XEW <KCH0>]=QKT4<^HZ!%*BR1O?2*R.,A@;6?(([BM"'2]/
MMKM[N"QM8KEQM>9(55V'H6 R: /(X[_3K?X(:WH][-#_ &P'O+>:U9AYSW33
M/L^7J224(]L5U?A.W9/B)XF:Y4-=1Z?IL;N>3DI)NY]R!^5=B^E:=)?K?O86
MK7B\+<&%3(/HV,U.L$2323)$BRR !W"@,P'3)[XR: /&_"ES;V$?PWN+J:.W
MM@NJP^9(P5 Q;Y5R>!G:<?2K8N-'U?5/%UQ)K(L(FUJR:RU!%#(DZ0IL8Y&T
MJ2I&3P<]>17J,VDZ=<6:V<^GVLMJIW"!X59 >N=I&.YIQTVQ:"6 V5L8I0%D
MC,2[7 & ",<X  _"@#C]!UB2[T_Q3#JDFFW;6*[9]1L4VQW*F'/S#)^=1P1D
M@<5-\.[Z"Q\ >$K*]N%CN[RR46\;GYI %W8'T7!K1\0>&?[1\/?V#IOV?3=/
MN'"WGDIL/D=75 !@%ONDGH">M7AIFFWS:1>6SHT&GDO:>05*8,9CX([;6/0^
MGI0!S7Q8>WC\(VSW:AK9=4LS*",Y3SESQWXS5>]O;/5/BC82Z7<PW(@T2Z-U
M) X<!&=/+!(XY(8@?C72^*M#FU_3[2VAECC:"_MKHE\X*QR!R..Y K3M-,L+
M 2BSL;:V$IW2"&)4WGU.!S0!XMX0GALOA]\,+RYD2&VCU6X5Y7.%4M]H R3T
MR>*VKVZT/6?$OCC[3JGD:>;?3(_MT/S+'(LDFU@<$$!]N2>!@@XP:].;2]/>
MP^P/8VK6?_/N85,?7/W<8Z\TL>FV,4311V5LD;1B)D6)0"@SA2,=.3Q[T <M
MX/U6[N/$&JZ;?7>F:I/;00.-4L8PAD5B^(Y "0&&"< XPW052EO]-L/C?</?
M3PV\CZ!$L4DS!1_KY"R@GN0,X]%/I7;V6GV6FPF&QL[>UB)W%((E1<^N *Q)
MO"T5YXRO-7O8[6ZLI]/BM/LTT8?YDD=]Q!&,?.* /-+6*&\A\/RJBOI]SXWN
M)[3CY6B_>%2/;<"17:O=VNF?&"[FU.>*W6YT:);.69PBD+*YD4$\9Y0D>F*[
M/[':[($^S0[8"#"NP8C(&!M]...*;>Z=8ZE$(K^SM[J-3N"3Q*X!]<$4 >?>
M$K?6K[1]7NO#FI6EG:W.NW<]O)/:F9)820,H RX!<.<U86VF/QCT4:B\5Q>0
M>'I6:5(]BF3S44LJY..">_>O0(XTBC6.-%1%&%51@ >@%--O";@7!BC\\+L$
MFT;@N<XSUQGM0!XQXUU>2[\/^,L:G8:>D=X]O_9D%JAGNF0)^]=B=V2!NR!P
MJCGBMUM9M-/^('C&Z+P7#/HEO/;P%Q_I05)20O\ >!Z<9ZUZ&^EZ>]U+=/86
MK7$J>7)*85+NG3:3C)'M2#2M.$T$PT^U$MNFR%Q"NZ)?13C@>PH \KTO4=_B
MWP&T^O:?=(\<I6ULK=(H;0/;G9&""3SC !/.WIQ7L%48M%TJ"-8X=,LXT643
M!4@4 2#H^ /O>_6KU !1110!Y7\29;6#Q+ILU[M%K'?Z4\I;[JJ)+LDGV'4^
MPJGXX<ZWK_B5M!E2Z:/PH\4[6S!P6:7<J9'\1028'7!]Z]#2WAN/&=^)H8Y
MEA:,H=0=K>9<<C/?FM2RTZQTV-H[&SM[5&;<RP1*@)]2 .M 'G^LZGI6L3>
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M_I/-0!LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5W;M=>5L8%&#JVT@C*D&GZ;H/B;2=&OXY].TK56O=6N+J[LI'PDL4@!&QF!
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M_I3+6S7(>'?#>GRZ;.S/?Y%_>+\NHW"\"XD Z/[=>]:W_"+Z;_?U'_P9W/\
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MY_\ CE &S69K'AW1_$$<2:OIMM>"(DQ^<@)0GK@]1FH?^$7TW^_J/_@SN?\
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MW]1_\&=S_P#'* -FBL;_ (1?3?[^H_\ @SN?_CE'_"+Z;_?U'_P9W/\ \<H
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M?_CE'_"+Z;_?U'_P9W/_ ,<H V:QM8_Y#/A[_K]D_P#2>:C_ (1?3?[^H_\
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ME*<8 'S_ "D'GH>* /5:*9#(DL$<D;;D=0RMZ@C@T^@ HHHH **** "BBB@
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M5HP&9%Z*3ZB@#U.3Q/"GBJUTC;&8)]/EO3=>: %V.B;<=/X^N>U;/VF#[/\
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MY!AAQ\G?/48KH8=>T^?7KG18YP;VWB261,C #E@!]?D.1VXKQW4M.L;'X/\
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M&[/MC- '6Z=K6EZP)3IFI6=Z(CMD-M.LFP^AVDXI++7-(U.2>.PU2RNGM_\
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M09C:KJ@=EV^?M)0#^+R_*_X": /9IM6TVWABFFU"UCBE0R1N\RA74#)8$GD
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M:7R.MNDLJM+O^4;AC!P,Y!^[QC)H Z74_".BZK'9K-;20FSC\JW>TG>W>./
M!0-&0=N ..G%36WAK1[.33)+:R2(Z9')%:;&8"-7QN&,\YVCDY/YU2\":Q>Z
M[X0M+W461[P/-#,Z+M#M'*\>[';.W./>NCH Q[CPMHMW'JD=Q8K(FJ.LEV&=
MOWC*H56'/RD!5P5QR,]:CL?"&C6%C?VD5O+(FH(8[N2>XDEEF7:5P79BV "0
M!GC/%;E% &)/X2T.YT;3M(ELMUCISQR6L7FN/+:/[ASG)Q[DTE[X0T34-:;5
M[FT9KMX#;RD3.J2QX(VN@.UQACU!K<HH PM&\'Z-H-W]JLH9S.(_)1[BZEG,
M4>0=B;V.U>!P,=!6[110 4444 8/B.VAO+S0[6YC66":\ECDC;HRFUG!!^H-
M06/P^\(Z;?0WMEH%E!<PL'CE1,%6'<4>+]3MM%&DZG>,5MK2ZEFD(&3M6TG)
MQ[U7L?%^I"5&USP[-IME-:R74=TD_GJBHNXK+A1Y;;>1R0<$9S0 Z3X:>"Y9
M&D?PW8,[DLQ,?4GK72O:P2V;6CQ*UNT9B:,C@J1C'TQ7'6OCR_,>E7^H>'FL
M]&U6:.*VNOM8>13)_JC)'M&T-QT8XR,U%=?$'4EM]<N['PTUS::)<S0WDK7@
MC)6,9)C&T[CMY(.!TY)Z '7'1M-,%A ;.+RM/96M%QQ"54JI7TPI(IQTG3S<
M7EPUG"TM[&L5RS+GSD4$!6SU&&/YUQX\5ZU=?$RPTRRLHY-(GTH7@+3A2R,\
M8\TC:3E<L-F><YS5+2_&>FZ/X8\0ZO9Z+.D=KK[VD\(NFE::1I(T:1=V<9W
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M%W_(EZ[_ -@ZX_\ 1;5LUC>+O^1+UW_L'7'_ *+:MF@ HHHH **** "BBB@
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M HHHH QO#'_(+N/^PC>_^E,M;-8WAC_D%W'_ &$;W_TIEK9H **** "BBB@
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#&\6_P#(F:[_ -@^X_\
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M*VTR%<\+G&,GG(Q4LWCG21:Z?-9Q7VHM?Q-/##96YDD\M2 S,.-N"0#GG/%
M#;^?6;N]TN=/#]PJV=RTS@W,.6!ADCP/FZY<'\#5_P#M;5?^A<NO_ F'_P"+
MK NOB)$/$/A^RL-/O+JTU6"28RI;,6 4# 49'().[(XJ6U\5Z9I[>++V?4]0
MN8=+N +F.6-=MOQ]V/&"1]: -K^UM5_Z%RZ_\"8?_BZ/[6U7_H7+K_P)A_\
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M),"1L5^YR" <8)& : &Q3ZS'KUUJ!\/W!CFM88 OVF'(*-*Q/WNG[P?D:O\
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M@5SG(SM/8C(XYK=T[QOI>IZC!:PP7Z17+O':W<MLRP7#*"2$?Z*Q&<9P<9H
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MIU1$&2Q\L\ =S7044 >/W]_;ZR_PON-/<SQ0WBQR,J'Y&6)00<CC!K2C@?\
MX1KXI_NFW27-YM^7EA]D3&/6O3J* /.KB%P_PQ"QL!&XW87[O^B,.?2N9\.:
M?IXT_2_#NJZ[XA.J6]\JOI$2IM1XYMZR<QY\K@/NW=#USQ7M=% '-2:%J5O=
MWU_+XDO[FU9)F6P>*(1J&!PH(4-A<\<]N:\XM-4M=3^%?AGPI:I*NN2260^R
MF%@\:I*KM*>.%VJ6W>_K7ME% 'B7C/4;C4]-\66MWJ6J'4H+B1+?2+6/;&+9
M-I$KX7+ J"Q8MZ <X%:OB36]/M-3U#5O#NL7]EKLJQ21V!@,D&K?(OEE4P<[
MAA-RD$;>1Q7K%% 'C=_!9V.J^*K'7=;UVP>_NFFAL+%487L4D2+B/,;%FR"A
M&1C Z=:V-,U&P\$>-==@U1[B&*]M;)K!WB9VG$47EE!M'+@C[H_O5Z910!QG
MPI22/X;:6LL+0.&N,Q,,%/W\G%<%KNK2ZCIEY)?ZIJCZI;:NK7&EQ1[8+2WC
MNEP[@+DC8JMN).2?8U[A10!Y-<6LC_$C_A'XHF;3-3U"WU_S I,95(FW@GWE
MBB./]JH/"\6I+JU[!':22/X/T^[M+)74XEEDD?R]OK^ZCC'_  *O8** /&-*
MU2"X\1^"M2?6]3U(^:Z7LLZ;8+:>2W=5C"A %8L2,<XP,]1FYI^DW=]\#_$=
ME:0.;N:>^98POS2$3,< =R0,"O6Z* /+[WQ-IGB7Q+X'.D"2=8+QVG80L!;D
MV[@1L2!ACSQ_L_2H_#VIV]EXBTRR\,:GJ$EK<7#K>Z#>PY-@FUV+!L9C"L -
MI8@[N.U>J44 %%%% !1110 4444 %8VL?\AGP]_U^R?^D\U;-8VL?\AGP]_U
M^R?^D\U &S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 8WB[_D2]=_[!UQ_Z+:MFL;Q=_P B7KO_ &#KC_T6U;- !1110 44
M44 %%%% !1110 4444 8VJ_\A_0?^NTW_HIJV:QM5_Y#^@_]=IO_ $4U;- !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-X8_Y!=Q_P!A
M&]_]*9:V:QO#'_(+N/\ L(WO_I3+6S0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !6-K'_ "&?#W_7[)_Z3S5LUC:Q_P AGP]_U^R?
M^D\U &S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*H V:*QO^$:MO^?[5O\ P93?_%4?\(U;?\_VK?\ @RF_^*H V:*QO^$:MO\
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M N3]XAP,_05N>-_MFF>'=/\ $,MS$FNZ9(A1+<,([QG(5H O)(?.!U(.#ZT
M=U4-Y-);V5Q/#;O<RQQLZ0(0&D8#(4$\ GIS7DYN[B?X>3:Y]OE&I>(-2M[>
M]DC=E-DC3+&8%SRA1<J3UR2?2M[7?#.G>&?#/BF;1[J:U271+C-B)RR[E1L3
M ,20W."1P>.] '<6,\MU803SVSVLTD89X)&!:,D<J2."1[58KR.'2[[4?!_@
MW49]*N->TR+2%6XL8KKRY!(RH1, 6 D( 88)R,Y%0R7$>O:OH^GVFF:GXAT:
M#1A/%;S7BPR>896C+2[F7<R!-O?!)/O0![%7$:E\3;'2 &OO#_B.&-IA DCV
M&%=R<  [N<]JUO!-OJUIX6M[;6HI8[J%Y$59IEE?RMY\O<RD@D)M!.>U8/Q;
M_P"1?T?_ +#EG_Z'0!TNA^(AK<DR#1]7L/* .Z_M?*#Y[+R<UM5SGCJ[MK3P
MC>?:IK^)9RD"?V>P6=W=PJHA/ +$XSZ$]*X[P[:-IWQ&CTD:))H]C?:1,T]D
MU[YZRE70!R 3AL,PSGG- 'JE%>/:--+?^+X/!%UJ3RZ)I5U+);3EFW7QC"LM
MLS=&\K>=W)W!5XX->PT %%%% !1110 4444 8WAC_D%W'_81O?\ TIEK)N?'
M\$6N:CI5KH&NZA-I[JEP]G;QNBEE##DN#T/I6MX8_P"07<?]A&]_]*9:X72+
M7Q%<?$/QP=$U2PLT%W;^8+JS:8L?(7!!#KC]: .[\.^);#Q-9S7%CY\;6\Q@
MN(+B(QRPR#JK*>AY%;%>*SWE]H?AWQMI#EI-?6]M9+V]@EVBX6Y=%!3@>5A,
MKCG'7)K5M_"NNA]6M=(T9/#5E>:5) 5%\LB&XW#8^%Y4E2ZEAST/44 >G7MY
M!I]C<7MU(([>WC:65R,[549)X]A3K>XCN[6*YA;=%*@D1L8RI&17CFIV&DP^
M$O%FFS^&Y]#U%-(:Y:S\\2VTH3=MFC(/+!B 20#R,@UZ;X1TZTTSPIID%E D
M,36\<A5>A9E!)_$T ;=%>(W.A64_PW\6:[,LCZG9ZA?R6=R9&W6Q2=BHCY^7
MG)/KGZ5HZG:WGB;Q=K\<_AYM8%K!;0VLGVY8/LF^$.70'HQ9C\PY^4#M0!ZE
M)J=G%JT&EO-B\GA>>./!Y1"H8YZ#EU_R*MUY-8Z$)_B;X9;7[2*35ET#SKER
MV[-Q&\:A\C@FNB^*$?G:+H\'GR0"76[*-I(W*LH:3!((Z=: .WHKRK5=+L_#
M'BG4K#18OLMG?>&KN:XMXV.SS(R LF">&PQ&>]4(=(M]/^&GA9X7F2?Q%-IE
MMJ=T)6\R2%QG9NS\HP=@QC@T >R45Y?J?A;3K3Q>OAO28A96&MZ-=+<V\)(1
M'0IY<P7LP+$9[U5M]6N?&&E>#O#<Y879G9]87/*K9G:RM_OR!/SH ],LKN]N
M+R]BN=->UAA<+!,TJN+A<<L .5QZ&I-1N+FUT^>>SLVO;A%S';K(J&0^FYN!
M^->5V%A?ZSJ/Q.T^QG"7$E] (P\C(K #+(6'*A@"N1_>JOJWV&P\ ^-+&WT6
M[\/Z@EC'+-IYF#PX)8++$5.#G!!(Q]T9% 'L5O)));1231&&1D#/&6!V$CD9
M'!QTJ2O+[2RM_$?B;P]HVKQ_:=-M_#45ZEK(3Y<DS,J%F'\6U1QGINK%NH66
MWD\/Q7%PFGVGC*WM;<I*VZ*)T#-&K9R "S <\9]J /:J*X+0]+L_#WQ4OM,T
MF$6MC<:-%=26Z$[#*)G7?CL<<'UKO: "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *QM8_Y#/A[_K]D_P#2>:MFL;6/
M^0SX>_Z_9/\ TGFH V:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#&\7?\B7KO\ V#KC_P!%M6S6-XN_Y$O7?^P=<?\ HMJV
M: "BBB@ HHHH **** "BBB@ HHHH QM5_P"0_H/_ %VF_P#135K31+/!)"^=
MLBE3CT(Q63JO_(?T'_KM-_Z*:MF@#B;/X9V>G6<5G9>(O$UO;1+MCBBU(JJC
MT  XK6@\(623:7+=7FH7[:8[R6_VRX\S]XW\;<?,P!(7/3/%=!10!ST_@K1K
MD:S'+%*;?6"KW5N'PGF#'[Q0.5?@$D'D@'K4%OX#TV.#4EN;S4;^?4+-K&6Y
MO+CS)5@((*(< *.2>G)Y.:ZBB@#EW\"Z>MIIL-G?ZG8/I]J+.*>TN-CO",85
M\@@],YQD=J67P)I?V;3X[*XO].FL8FABN;2?;*48Y96)!W9;YN1UY&*Z>B@"
MGI6EVVC:9!I]F'$,(.#(Y=F)))9F/)))))]ZK:]X?LO$=I;VU]YOEV]S'=)Y
M;;3O0Y7/M6K10!FZ]H=GXBTF33K[S1$S*ZO$^QXW5@RLK=B" :Q5\ 6"ZA!J
M7]IZL=3B1XC?-<@RR(P'RME<;1@$   ')[FNLHH YQO!.C#0=.TB*.6"+3I4
MGM9HGQ+'(IR7W8Y+9.<]=QKHZ** "BBB@ HHHH **** ,;PQ_P @NX_["-[_
M .E,M9MY\/\ 3+K6+W5([_6;.XO65Y_L6H20JY50H)"D=A6EX8_Y!=Q_V$;W
M_P!*9:V: .>L_!&@66CW^EI9M+!J&?MCSRM)+.<8RSL2Q([<\=L5##X#TA8+
MR.[DO]0:[@%L\M[=/(ZQ Y"J?X><'(YR <\5T]% '-VW@C2HH;^.ZFOM0:^M
MC:32WURTK^2<Y13_  CG/'.:T]#T:'0=+CT^"YNYXHN$:ZF,C@8P!D]@!P*T
M:* ,,^$M*/A_4-$*2_8M0DFDG'F'<3*Q9\'MR34&J>"M,U2[-R9[^TE>!;><
MV=TT/VB,9PKXZXR>>O)YKHZ* .?N_!VE7-_I5[$;FSFTR+R+<VDYC'E<?NV
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "L;6/^0SX>_P"OV3_TGFK9K&UC_D,^'O\ K]D_])YJ -FBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH QO%W_(E
MZ[_V#KC_ -%M6S5+5[#^U=%O].\WROM=O)!YFW=LW*5SC(SC/3-4_LWB7_H+
M:3_X*Y/_ )(H V:*QOLWB7_H+:3_ ."N3_Y(H^S>)?\ H+:3_P""N3_Y(H V
M:*QOLWB7_H+:3_X*Y/\ Y(H^S>)?^@MI/_@KD_\ DB@#9HK&^S>)?^@MI/\
MX*Y/_DBC[-XE_P"@MI/_ (*Y/_DB@#9HK&^S>)?^@MI/_@KD_P#DBC[-XE_Z
M"VD_^"N3_P"2* -FBL;[-XE_Z"VD_P#@KD_^2*/LWB7_ *"VD_\ @KD_^2*
M#5?^0_H/_7:;_P!%-6S7.7&D>(;F\M+E]8TL/:LS(!IDF#N4J<_O_0U:^S>)
M?^@MI/\ X*Y/_DB@#9HK&^S>)?\ H+:3_P""N3_Y(H^S>)?^@MI/_@KD_P#D
MB@#9HK&^S>)?^@MI/_@KD_\ DBC[-XE_Z"VD_P#@KD_^2* -FBL;[-XE_P"@
MMI/_ (*Y/_DBC[-XE_Z"VD_^"N3_ .2* -FBL;[-XE_Z"VD_^"N3_P"2*/LW
MB7_H+:3_ ."N3_Y(H V:*QOLWB7_ *"VD_\ @KD_^2*/LWB7_H+:3_X*Y/\
MY(H V:*QOLWB7_H+:3_X*Y/_ )(H^S>)?^@MI/\ X*Y/_DB@#9HK&^S>)?\
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M^2*/LWB7_H+:3_X*Y/\ Y(H V:*QOLWB7_H+:3_X*Y/_ )(H^S>)?^@MI/\
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M** "BBB@ HHHH **** "BBB@ HHHH ***HZS;2WNB7UK BO+- Z(K3-$"2"
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M-FV+<<<;2>V.G?/%7(/%,\?B#7M+U*&"U&FVRW<,BLS>?"P;+XP,;2I!'/-
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M#<1;F3?$X==RG!&1W!!!KGK7Q%J@\8MH-_I]K%YUB][:/%.S'"NJE)/EX/S
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M.<8'.3U/'%4[CP%?W=EK2'4(K6[NM675[&XA!;[/,H4*&! W#"\_[QXKOZ*
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M[>"23[[11*I;ZD#FLR7Q5I\>H1VHCNI4>Z^Q&YBB+Q)/C[C$<CTSC /!.<T
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MF5XY(H\D;3G(*#COGM6U/XHM-0\67/A2/1[G4#;I&U]*5C\B .,KNW-EN.<
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M;0 H7J, <DGKS3[+PS!;7-K<W=[=ZC-:1-#;M>%#Y:L &/RJN6( !)R<?4Y
M. UJ[U#7O ?AWQ!<:A(!>ZK93&T5$\I$:==J [=V5XR<\G/L!ZAJ?_()O/\
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M>"+&2XTRZCO]2@O+ 2 7*3@R3"3&\2%@<YP.F,8&,8%-T[P1:Z1#%'I^J:I
M(KB6=#YROCS"2R$,I!7))YYSSG@4 8]IXK;4)O#&F:?K1NX]7:[E;45C59/*
MBR0FTJ K_,H/R\;6X!((HZQXFU[2]/\ &^G+J#-=:+;1WEG?-"A=HY%)V.,;
M<@J1G'(KJ'\#:4;6U2*2Y@N[6[DO8;V)E$RS2$F1ON[2&R05VXQVX%27?@VQ
MOM)U6QN+F[9]5 %Y= H)9% VA?N[0 .  !W/4DT 95IJ&LV/CG2+&ZU5[RUU
M73IIFA:%$6&2/R\%"HS@ASPQ/UKJ$T>T2&&':S1Q3>?AFSODW;M[>IW<^F<>
M@Q1_X1> ZUIFJO?7KW&G0/!$"8]K*V-VX!.2=J],=*W: ,#Q??:GIVC)<Z9:
MW-SLG3[2EHJM/Y/.XQJW!;IQZ9QS7$ZUJ\>N^%M&N['5S?J?$UHD<L\(5X2'
M'[N1 %^93],C'/->CZGIG]I);8O+FTDMYA-');E0<[67!W @@ACQBL6X\"Z?
M<PJC7=XDAU%=4DF0QAI;A<;2WR8P-HX '3G- &.FKZUI^H>,=,DUN&4V%G#=
M6EYJ*(BP&17R'V* 5!0$<9[<U:\/ZUJ+^.KC1YKB[GLFTJ.\C:\A2.3?YC(2
M H!"G X8 @CH!5[4? FFZK/K,MY=7LG]K6\=O<('10%0DH5PN0023U/OFI+3
MP;;VFM)K!U759K];/[&TLTRG>N202H4#()[ #N03S0!Y_8_\D:\'_P#89M?_
M $K->I^(/^1:U7_KSF_] -8B> -/C\-:?H*:AJ M+"Y6YA;='OWJ^]<G9R W
M/2NBO[)=0TRXL9)I46>(Q-)'MW8(P<9!&?PH \X\,WNK:39_#E?[3>6QU2R2
MWELS"@1 MKO1E.-V[Y><L0<]!5FX\1ZQ:ZCI$JZF;M+K7383^3$OV01,9 J*
MQ4.77:,D$C<&!/:NCC\%6<46@1+?W^W0L"T!:/H$V#=\G/RG';\^:I)\-M+C
MMK>U34=66VM;[[=:PBX 6W?<S$+\N=I+'KDC/!'- %;^W=4TKQ)XATC4+^6X
M=K:.ZT<&.-2P<^7LR%&6$I4<YX85+-J&L7.N7/AVWO;LSV.GPRR74(@62660
MN-Q#KMVC8. /XN:Z*^\/Z?J.L:7JEQ$6NM-+FW;/]]<'/KT!^H!K/U[P99ZY
MJ]OJR7^HZ;J4$9A^TZ?,(VDBSG8V001GGI0!H>'SJ\GAZT&N&!=5"%;AK8Y3
M<"1D<=\ X['BO*;R.Y_X4_XREGU&ZNC_ &G<1@3[#]VZ #9"@YP!WQZ 5[%8
MV<.GV<5K!O\ +C&,NQ9F/4EB>22222>I-<U<?#W3;C2]6TPWVI)9ZG<-<RQ)
M*N$9GWL$RIP"P!YR?0@$T 4+G7-5\.^,+^VO-0DU&R_L.;4Q$T2)Y<D3@%4*
MC.T@]&+'CJ:ETBY\4WEQH6J)/YFG740>^CG:()AU!5H=HW#!.,,3D>_-;<GA
MBVF\01ZS/=W4TZV;61C?R_+>)B"P8!.Y /7]*I:!X$L/#LZ&UU'59K.%BUM8
MW%SO@MR<_<&,\9.-Q./KS0 WQYJ6IZ7IVF3:9>"VDEU2UMY,Q*X=)) I!S]>
MV#[UFP_\)!-XTU?PX?$MR+=;*&]BN/LT/G1,S.I0?)MVY4'E2??O73Z_X?M_
M$5M;07-S<PI;W,=TA@*@ET.Y<[E/ (S4:>&XH_$5SKB7]X+NXMEM6'[O:$4D
MK@;.H+$_C0!R&A^,=6UK2/"=L[.+W5+.>>XFM_+1F\EE3"[_ )026W'CC'&.
MU\7?B:QTJ"#5]3@@F;5#$DJ*KW-Q;;2R*JJI7SCP#@8V@GCK5AOAMI/]@:9I
M4=[J4+:7(TEC>Q3*EQ!N^\ P7!!SR"#FK=QX'LKBUL%.HZFMY97)NH[\3 SM
M(5V$L64J05^7&W&  ,4 <E<^*?$*>"=<NH[Z2&\TW7EL8WFAC9VB:2)=KA?E
MR!(1E?05T6GW6L6_C^_T"YU>2[@ETM+Z*1X8U:!S(R$+M497@$!LGCJ:=)\.
MM,DL-1LO[0U18-0O%O9E\]6_>J5;(+*>I12<Y/'IQ6K_ ,(W%_PDC:Z-0O1>
M-9BR_P"6>W8"6!QLZ[B3G^G% '#VGB;Q%=^"?!.H#50EYJ>IK:W;FW0B16,O
M; QC8.F*U;76M?L)/&]@L\FL76D11SV)EB02.9(2^PB,*#AEXP,\XK2@\ :?
M;:/H^EQZAJ(M](NA=VV6C+;QNQN.SD#<WY_2HM?\.O8V'B?5-/&H7]]JUNL4
MMLDB+P!L!CP%(*JS'&[G'K0!GZ3K.IZCXCT"+3];>_T^ZT\W-^1'$WE.-NT$
MA1MWEF&WK\O'0UT'C'4-3TS2[>ZTZUNKB-;E?MBV:J\X@PV3&K<$YVY'7&<>
MHYSP]:7@O[-M+UCQ;)'&ZB>#6;41PB(=1EHE8G'3:3SC/&:[74],_M+[*RWE
MS:26TWG));E<D[64@AE(((8\8]* .,M_%[7MMHMMI>JR:A_:MY<(+D)''-&D
M:%_+*LH57' .1T!/4@UF^*4\31>&)X=5U"6-%UFT%K)&T?FR0/,@VRA5VY!S
MC'!P,YYKJK[X?Z/?Z6]I))=QW#7IU 7T,@CG2X/!D4@8!Q@8QC Z9YJ6?P39
M7?AZ72;N_P!1N'EDCF:^EF#7&]&#(0<;1@@8 7'7CDT ;ZPR+:>2;F5I-FWS
MR%WY_O8"[<_ACVKRG1]6N_#'@O7-0BO9III-?N+2(3HA1'>YV>:=J@Y&2<9Q
MVP*]6A@,-JL FE<JN/-<[G)]3VS^&/:N>@\"Z6F@ZEHMS-=7EEJ$TD\RSLN1
M([;BRE5!!W<CT- %2ZO]5T7QOH^CMJ$UY9:S!<*KS1Q^9;S1*&W JH!4@]"#
M@@?2N-NKGQ)J_P &K_Q!>^);C+Z?<J]O#;QQAB)6 ;<%R/E!! QP?;)]*M?#
MD<%U%=W&HWM[>00-!;W%SY9:%6QN("H 6.U<D@GCZYJVG@K3;7P;/X5:>[GT
MZ:.2,^:Z[U5R2<%5'<DC(- '/:Q:77_":>!K>/4IA,UK?_Z4\<9=04BZ *%R
M.V5/N#6YX%U*_O\ 3]4@U&Z-W-IVJ7%DMPR*K2(A&TL% &<'' '2IT\(0+J.
MD7[ZIJ4UQI<<D<+2.AWAP V[Y.X5>F,8X[U;T+P_!H'V_P"SW-S-]NNGNY?/
M*G$C_>(VJ, X'% &5_:&IM\2[S1A?$61T=;J)!$O[N0RE,YQD\+T/%<KI'B'
MQ(WAOP;K]UK33MJ6HQV=S:_9XUC=)&==V0NX,,#H0.,8ZD]ZWAR%O$TNOK>W
M:7<EI]CVJ4V+'N+# *YR&).2?TXK,B\ V$&AZ3I$>H:B+;2KI;NV.Z,MO4DK
MN.SD D_G0 OQ,,R_#?7Y(+F:W=+-VWQ$ D8Y&2.A[XP?>L/5K2Z_X2_P';QZ
ME,)FMK[_ $EXT+J#%'T 4+D=L@^X-=UJ^E6VMZ->:5>AC;7<+0R;3AL$8X/K
M63'X/MUU#1[Y]4U*6XTI)$A:1T.\. &W?)W  XQT^M ',67BS5[?2FL;BZ:Z
MO/\ A(Y-%CNRD:N4 +AB,!-^!M'&,D'!Z'J/#R>(8=3U*+5I/-T\E'L6E9#.
MO'SJ^P $ XP>O/-59?A[I-SI6I:?<W%[-'?WIOVD,BK)#<''SQLJC:1@>OZF
MM;0M!31(G#:A?ZA<28#W-],))"HSA>   ,GH._.: .<.P_' ?:<9&@#['NZ9
M\X^9M]\;<^U'Q("[_"C18^W#7[40$?>QD^9^&S.:W_$'A?3_ !(MLUT;B"ZM
M&+VUY:RF*: D8.UAV(Z@Y!]*J:5X*LM.U:/5;J_U+5M0B4I!/J,XD, /WMB@
M!5)[G&?>@#B/#WA/1KKXL^-[6:WF,,"69C NI007B);D-D_CT[8KG_#MLND?
M"[4+_3([I;^ZU@Z<7@N&5_*>Y12%W-M5B. W!!.<U[+8^'++3_$>K:["TQN]
M46%9PS H/+7:NT8XX//)JC:>!M'M/#%YX? GDL;J9YWWR?.'9MV58 8(8 CT
MQ0!P]W9ZOI.B>*WMM$U'1=';09V"7%\DVVY4'#)MD<J2I.>G*CO7<>"-&@TW
MP]:W8DGFO+^WAFNIYIF<R/LSD G"CD@ 8&,4V/P1:-8ZG;7NIZIJ#ZC:FSEG
MNIU+I$01M3"A1]XG.,D]<UT%E:QV-C;V<18QP1+$A8Y.%&!G\J .'T__ )+O
MK/\ V!(/_1AK1^)%]>6?A0)9"?S;N\MK1OL\@20I)*JL%8D!6(RH)(QGJ*DU
M;P)9ZIXBDUV/5M7T^]D@6W=K&X6,,BDD Y4]S4D?@FU;2[[3K_5M8U*"["9^
MVW6]HBIW*T9 &ULX.?510!P6JZ-?0^&_%L;:!J&DZ$VBR3)!<WZ2@7488AEV
M2,0"I&0>#MYZT7'A;2#JOPT@,$OEW,4WFC[3+SBVW\'=D?,3TQZ=.*[^W\&6
M:6FI07U_J.IMJ-L;6>6\F!818(VKM"A?O$Y SGJ:J/\ #VS?3=+M3K.L^=I<
MA>TO!.GG1@IL*9V8*[>.F?>@#A[E-=UR?Q%?V&AZM=:Q;ZG/!I]_%J$4<5N(
M7VHGEM*ORG;\V5YW'KQ6_IFEKKGQ6\2/J,MR8M._L^>"U6X=8TF,9.XA2 <;
M>AX.3D&M^[\"6%U?W,XO]3M[>[E6:[LH+@+#<.,?,PQN&=HSM(SCFM:RT*TL
M-=U36(6E-SJ0A$X9@5'E*57:,<<$YZT :=%4=,TR/2X[E([BYG$]S)<$W$F\
MJ7.2J^BCL.U7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)[,V>HS16TR07-Y#;[H()&"D*S9ST9<X! SS6!:>.7TO5_%D=[;:IJ,=C?Y
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M''PWBDMI5>+77>16C(*#-SR1V'(KO;&*0?%G693&PC;2;50^."1)+D9KKZ*
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M)^)QX*O+N^LT/B=;RTN+>+SE(86RQJHW9P-P60]?XZGD\(:C9^'/"<-UH_\
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M7/"ECHGVJ*^FN?L>H_:8UBCCG))\P$[\KO/13G J'X@:1=Z)I/AF30YU&K0
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MX[9R#]WC&<UCQ>(/%H\!P>+;C707M+U;:2T2UC$=R@N1 S.<;@QY/RD <<4
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M*@8COC)./:LF.YUKPYXPTG2KW6IM6M-6@N,-<01H\,T2A\J4505(SP0<8'-
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M&J/)'*I(#A0%R"K#( R,4 =7N7?LW#=C.,\XJKIFIV>L:?%?V$XGM9<[) "
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M<6H1?;-.DBGAN&B)C:2.7S%W)G)4XP>:[>J.DWMS?V7G7>G3:?+O9?)F=6;
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MQ N <\8Q72T4 <=:^&-?TRYEL]+UJVM]%EO6N]IM2UQ$'?>\2,6V[2Q;DJ2
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MB:!D52CKNSD[0<@\$=*U_#?A^ZTN\U35-3NXKK5-3D1IVAC,<2*B[41 23@
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M7K7O%<G)\/=)D75XC=:@+759_M$]J)QY2R[U<NHQP24&>?6@#+71[7PS\3=
MBTPSQIJ5G>"\#SO)Y[1^65=MQ.6RQY]ZY7PK8ZKKGPMMOL\4FHB'6II+JR:Z
M,374(+CRP^>Q*M@D [<5ZS=:-:W>N:?J\OF?:;!)8X<-A<2!0V1W^Z,5BV_P
M^TBST2#3+.XO[86]T]W!<PS[9HI'SNPV,8(8C!!&#0 [P)+I[:/=0:?%J%JM
MO=O'+8W[9>T?"DQCD_)@AAR1\W![#E]3L/[(\57.I>(+#43#-J$<EGKME=$B
MV0E L4D>?E3/RGY2"&]>:[[0]"MM!M9HH);B>2XE,\]Q<R;Y)7( W,>.RJ,
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MDWAM8'_L^>-XY=SEG<ODLY8\EB23GUH X/7)I]6M/B)X@6:1;:RL)=*LMK$
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M-U#7-1.C)<S6HNE@@4,0HF<D@F0E6 Z]S@=:;H=_>V&F>!_%5Q<S20R;](U
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M(Y<3E9(P&<,3DX9AGT.*F^$=O:0?#O36@BA25Q(92@ +8ED S^1'X4 =U17
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M1HU=H@Q;:RJ3M88 R2!G/2NRL=?TG4K^XL+/4;>>[MQF:&-P649QG'IGCZT
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MF8=0 I&2>Q'K79>&9?L_Q \86TL<RR7-S!/$?*;:\?V=%W!L8QD$=>M=M10
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MWA"?0M7BT"QN--U4>(-("*]M.;A5LW5=K/DG9M(!P.<Y QZ;/Q3,*^&;!KA
M\(U>R+J5W97SER,=^.U=Q6'XG\/OXCLK6V6\%L(+N*ZW>5O+-&P91U&!D<_T
MH XS7XHKCQ1K/B#2]/35+.'P[+;74</*7<C-E8LC[Q"ALXR0"!W%)X?O$G^)
M&DW:2W5Q!/H#P))]B>*)7\V-MBC;PH /WB<="<UZ>N=HW$%L<D# J*[BDN+.
M>&&X:WEDC94F0 M&2,!@#P2.O- ' ^']*O+#Q1<>%6A/]B:=<?VK:R9XV2%O
M+AQ_LRB1A_N+6=,8&LOBI\JEK@.(OEYE_P!%51M_O?/D<=Z] T/1Y-)MG^TW
M\VHWLQ#3W<RJK2$# &U0 H '0>YY))K5H \S1X5UGX9&/:%AMIED*CB/=;!0
M&_NY<8Y[C'6L[PR=*NM/L/#6OV&K2>(M.NPYMF:X$;2*Y(N X.P+SNSGUX.1
MGUVB@#QZ^6&3P?\ $]%C#37-],80$^:8&*,*5[L-P;&.^:Z*"Y6'XG:7=NLS
M07?A\012I&S*T@F#%<@<$#DYZ"N_HH \Q\'O<V&M:/9:9??VIH$\,CI!<QXN
MM)PN0C,.JD_)AAGIC(%;_C34$L-4\.F6V*H]U(/[1$!E-F?+(&T 'YGSM!((
M'/!KKZ* /$6*GPCJ5G-%<LX\8"8K<6[*6C-RK%B"H!^7).!QGG&:V?$\-Y?^
M)?&,&C$FZN?#L44)C_Y:.&D)53T+;6'YBO5:* /+)-=T[5]7^'\UA!< 6L\B
M3Q"UDW6Q-NR[&&WC!P/PSTYKH_B=;O<^"I%2W>=4N[621$C+GRUG0L< '("@
MD^PKL** /,_$.F2^)?$%YJ'ADJQ'A^ZM'NX3A999,>5&&Z$C#$_W<C.,U)X8
MO_#FN76CW/V'5$UC2HV\U+LSHNGY3;)N+_(0<  <YZX&#CTBB@#Q;3Q%#\,/
M!\?E^7-%X@BED380Z 7+EF8=0 I!)/8BM!I=*34_$?AWQ59ZK+)?WTD]K'!Y
M[1WT+[2@4H=N1@*<XQ@<\''K-% '"3210?%C1D;Y%CT6:!LL6".9(RJ%CW(4
M]>3BN=U"&2\\-?%*"UB>66:X>2)$4DR+Y,8)4?Q#*L./2O7:* /-]<N8KZXL
M=5T;7)-(U.+3\P27<!^S7D9/,3JP!SE>",'G(S7:^')[BY\,Z7-=6(L9WM8V
MDM0,"$[1\N.V/3M6G37#F-A&RJ^/E+#(!]QD9_.@#Q/3[:TUOX+VVB6"QMK4
MM^3 B+B2.079/F^H 0'+=,#&>U=IX>2WE^)7C-F1"TALS$[)G=LBP=I[[6QG
M'0UO^%- ;PQX?ATG[7]J2%Y&20Q[#\[LYR,GNQ_"MN@#QR.&>Z^#UQX0N8W'
MB>.5H?L[ B1IC/O693W4Y#[^G7FNG\36>J:1XITK6M)C::>_A.DWA5<@$@M#
M,P]%8-GV:N\HH X3Q3;V^GZSX%M801%:7Y'/.Q! Z L>PR0,GN:Y>[O_ +'X
M/^(&@ZK%.NL3S7L\2F%F^TQNO[MT(!!   _V=O.*]CHH \I;4[;1_$<-UKT>
MIQ:5J6D6L-M<PI.HC>/?OB=4&X$[\C(J6V^R>$O%OA^Y:QNK'PT=*FM+3S0\
MGV:9I@_SYR4+H%Z].G:O4:* .(^&\BNGB;;#-&KZ[=2IYD#1AE;;@C<!GH:I
MP7>E6GQ4\6?VFT"+)I]FH,R@AEQ)N4>I/'R]3CH<5Z'6%8>'Y;+Q9JFN&]63
M^T(XHF@\G&P1[MN&W=?F.>/RH \[TFRG\*67P\N-5BG@M;66^64LC,;<3*YB
M1\ D'!"^QXJKJLJW'@GQW$UM<AKGQ DL4<ENX,B;K?D CGA&)'48Y KVNB@#
MAO%MO;2:EIEUINM#1-32":2UO-BM;2J?+W1R@\'=A".<_+QTK'74IX-4\ ZW
MK-@=.C^QW<$RQ0N4BD<1[!C!*A@A(!Y[5ZC10!X]:ZFMGI.H2S:;-L?QA*_V
MBXM)"+168D3[<<D8QZ L,^AHZL^[PK\1K7;>S2W%[#+"9[9E:8%(<$#:!DX)
MP!T&<<5[?10!PS26Y^+NG26Y3R3H,L(=!\N3+&RKD<9P"0/2I/A5+CX?Z;9/
M'-'<6:M%.DL3)L?>V5Y R?IZBNUHH \VNXKQO%OCW3[59HK_ %/3(!82>6P5
MF$,BYWXP,,0,D]2*JL5\0>%?!>G:?&\.K:?>V;30%"LEF(1B7>/X1@$#/#9&
M,YKU.B@#DOB=;S77PVUR*WB>64P A(U+,0&!. /8&LV[O[/4/B9X7O8B6MQI
M]WMDDC*A2QCV_> P2 V,]1TKOZ* /&+IE/PR\0P*K%V\2-)%&%.2AO$<,HZE
M=H)R., UL^+9)K;5]5U/0=1'V[R8EN-(NH_,AU1-ORB+OOPQ7Y<]!D#.:].H
MH R/$:VUQX2U)-1AF-K):.MQ'!S)M*X8+CJ<9Q7G-W'XCN=#\0Z3:WB>(HDL
M(9;;48DV32*LN3;2%>&?:&Z<_-R/FKUVB@#A?#5UX:\2:U#JVFVFI2WT5LT,
MTM[YX^SHQ!,3>9\K,3V&<8)STS%X-TR^L=3N/#US XTW0;EY;*9NDJ2C,2@]
M]@:53_P#TKOZ* /(M-.E307GA3Q+8:K-K"ZA-+';JUP([O=,TD<JLIVJ.1DD
MC&#FM_PX8/\ A+O'4PMEN)#<PRQ+MYF"0*/E)ZX;(R.A-=]10!XYH^H13:QX
M O%BN88(?M,4EK%9.D-BS0D"($KDD'@DD],\ U#.(O\ A5NO)''^_D\0M,B*
MAWLOVQ6# =2-@SGT%>TT4 >:KJ]EI/BWQ/IWB*UGGM=::*6RD2U>>.[B,*H8
MAM!Y!!X_VL]ZBO[RT\/^,9CK]I?V>DZAIMM#:/:^:T<+1[PT#>5W^?(XQUKT
M^B@#*\-6-IIOAVRM+"SEL[.-#Y,$S,SHA)(SN)(.#G!Z9QVKRBWM[+6/A'JF
MAVL<<FKW&IW @A5<2>;]J;;)ZX4=6Z  C/&*]K;<48(0&QP2,@'Z5B^%?#[^
M&M);3S>"Z4SRSA_*V$&1R[#J>['% ',Z7<IHGBSQ9:^(B0E^T4]K-(A*W,0B
M"&-?5E((V=3NR <UB:;87FBZ;\,K'4]ZW-M<RO*K\F%&BD"!O3&Y5Y[C%>N4
M4 >2ZS:WFHR_$ZWTN-I;F?[(T4:C_7JD2"15_O9PRG'<XKKM"UO0?%=_%?6.
MFR/<I:M#/-<6K1FW0D$PDLHR<]AD<$^F>LJMJ%O/=Z=<6]M=O9SR1E4N(U#-
M&2.& /!Q0!PWA+3+ZSUR7PU<1L=*T"=KBSF)SYB2@^2GOY8:4'Z(:V?']XMC
MX<CF>Q6ZC%[;[F>)I%MAY@/G%5Y;9C./7%:^BZ4=)LV26\EO;N9_,N+J8*K2
MO@+G"@  !0  .@_&M*@#QVYF#1?$Y-U[.;W38S;RSVS(9S]F91CY0,EL  #)
M[9ZUKZX18^&?!^L06L\NFV+Q-?)9!A(B&!HP^%PWR%N1U'->ET4 <OX030[B
M;4M6T."Z\J^:,RW=P91]H=01PLG. ,#(&#[XKJ*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?<?:?.L;:7[4JI<;X5;SE&<!\CY@,G /K4SVMO)<Q7+P1-<1*RQRE 60-C<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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)** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>exhibit1012-stuartexecut010.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDO8[5)96>69[='$#F-I$#%E#XVY&QN_52.HJY>WUMIMH]U=S+%"I +'G))P
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MDY<JI#$#IGUXK2TCQ-:ZQK.IZ9%&Z2V(AD#,05FCE7<CK[=1]10!MT5QL/Q
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M,IDD,6<^4'D9PG'H& _"N62TNE\.^-] ETN[>^U/4+QK5#;/Y<BS "-_,QL
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MPZT5M,T>:1[MKJ(R-;V,C=19QNPA&>_5B#W!6M#Q5HXUN.WL[K1[?5-,8/\
M:(9'"R(W&QXR<<CYAU7KU[4 )_PE,D6JZ)I]WIDD$FJM/&N9 3$T09B&&.00
MO!![U%%XVMC;ZFT]I)'-8ZDNF+"CAC/,P3:$/'7>.N,8)/2L./PIX@TVR\*7
M$3QZE>:-<7!:*XN2"895=57S"IR45E&2.<&J\_@GQ%=66N-YEA;W\FM1ZQI[
MB1F3S$5 $<;1\ORD9Z\YP.E '42>+#IZZL=9TVXLUTZ-)?.CS)%.'X C?"Y?
M=\I7 Y(]:<_BB2PNKN/6=+FLK>WL6OC=HQEA"*<,C, ,2#KM&<CH36;JFC>(
M?&'A+4=/U9+329YXU%O';S&<+*CAP[-M'&Y5X X&>3GAS:9XE\4^'+_2O$<-
MEIRSVCVQ-I,9C)(PQYG*C:HZ[<DG/)&.0!T/C^T&L06%U B"YMI+B&2WN%GP
M(UW,D@7[C[><<@X.#5FU\7K-I#:Q+9#^R_[/DOUN+>83?*@!*$ ##X/3)'!&
M:KZ-_P )PUE]FU:#3();:%E6Y@F,GVN3:0I*E1L&<,>2<C& *S=/\(W^G:K>
M:IH^GV^DO/I\J7%@)]]M<79QY;A0,*HPP)P"0>G7(!O)XLCATRXU34((H=,B
ML_M@NX)_.C=><J" /FZ<>XP32'Q4]KJFFV6J::]H-4#"TD$H?,@7=Y3\#:Y'
M3!(.",US#_#;[;#KEI;0_P!B:;JEAY4EE'-YD0NMP82JHX51@#C&<]!CG:;1
MM8UR7P\VM6T$#:1.+J5HIM_VB949%V<#"Y8L<X/ &#UH GT#Q?=>(+UHX/#]
MW%:175Q:W%S)-'B&2(XP5!RV2,9&0/7KBQKOBE]&US3=)BTFZO;C4$E: Q.B
MJ3&H)!)/'4<G QZ]*C\%:1J.C6>J0ZC%$C7.IW%Y'Y<F\;)7+ '@8(S@UF>+
M))XOB/X*>W@$[A;_ #'O"DCRTS@GC/UQ]: &M\2XH= U&_N=%O(;S3+M+2]L
MMZ%HF=E"MN!^93N&" <^G>M9?%%T+BWL;C1I;74[N>5+6VEN$(>*-0QF9EW;
M5^8#&"<G&.]<_K?@S5M1TGQ#-#%;C4];OK6<Q--A(8H#'M!;!RQ$9S@8RV.@
MR=O7M$U&?Q%H?B33DC>YL%DAN+223;YL4@&0K= RD C/!]10!!=>/1:Z/K=T
M=*F:]T-P+^R60;E0C<)$;&&4K\W8X!XR,5N?VP[W=E!;VRW"W-JUR7BE&%4;
M<8R!G<6&.1G!]*H:/X=9-6U_5M1BC$FLF*-[8-O"0QQ[ K'N3EB<<<@<XS47
M@OPY>>&=(EMKR?[7+&Q@MFSR+6-F\E"?4!C^?M0!GZ%XJTFT\*:5-8::FG1:
MC?SVMO;33!$64/*6+.,@9*-TSRP JSK^LVXT[2)-:\/R2&76(K9(S(I6"42[
M4ESP2.-PP.AYQ6=I?A74;?P5:Z%JNCV.HP?;)WN[=I00T<CR.I0D#YP67TZ'
MFH6\&ZU!X7TS3(&$XM-;COXH[BY+&"V23<L6\@EF X]!TS@ D Z>Z\22F\U*
MVTO3S?R:8JFZ E"'<R[A&G!W/MP<' Y'/7&?_P + M;F30!IFG75]'K<,LMM
M(K(@!1<LK9/!!X.>!SUZ46FCZOH'B?7+[3[>&\LM79+@(\WEM;SA=IW<'*'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIOB?7)?">KH-2F^V77BUM)@N7(9K:)W0?+GC@;L>YH ]=2&*.221(U5Y""[
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M-S#U ZT 9-AX=CTSQ)J&JV=PT<&H*IN+/:-AF''F@]B5P#ZX!KG/$6FWM_\
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M$H5@'D5,GJ1][/3M0!@S_#B:73I=,7Q%<QZ>ET;RR@6W3]Q+YOFC<W610Q.
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MOFV_AG!-=S!<07*%X)HY5!VDQL& /IQ20W,%P&,$T<H4[6V,&P?0X[T 0R6
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M\<.A/JH((/'/7-3:EX*_M71-)T^[U>[FEL-0CU!KJ8!GF=69L$<!5RV !T
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MLNX_,B$E1C.!C)Z"LF\\!^'+[4)KRXL7)GD$T\*W$BP3.,89X@VQCP.HY[T
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M%CTNU,<%P@=.6D!;:>,CIGMN/K7/^%"4U7P5;JY:VM=4UBVM2QS^Z17" 'N
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M^UR&22/SW:,,222J$E5R2?N@47'AG2KKQ#!KTD$BZE#&(A+'.Z!D!) 95(#
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MJO.3QCDFNDL=.L/%'CW5HO$%I!?+:Z59"UBN4#JJRAS(Z@\9+ #<.>!78_\
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M&WAM#-Y22R;MP$C8/R?*21@YQC'-.L/A]X:TZXM)X+*4R6<@DM3+=2R>1@$
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MOW7Q7\911?ZJ2WL9I .@D*.OYE5'Y5J67@K0=(O5U"SL9C+;[WMX#<R/'$S
MY\N-FV(3DC@#KVJ/P?HM[9?VGK&K1K'JVKW'GSQ!@WD(HVQ19'!VJ.2.,DT
M=/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;RL!)<120((PBGE\X*X&>:Q=#:>TN/"MRWB*+0H)_"MO%#<SQ1LDC(VYTR_
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M((W9LY7: -HP2<-GC-6_#7CW2-4MM'L[B_+:I>6R$DP.L<DNP,ZJ^W86!SD
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M*24YD=$"ES[D=:FHH ;'%'"@2)%1!T51@4ZBB@ HHHH **** "BBB@ HHHH
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MNM%O;:V5&GF@>- [;5RRD<G!P.?2@#E;/Q?#9:;X0M=.T"40:S: VL,4J!8
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MF.S.1M[ ]:T+C2?%6E^*KK6=$ATZY@U2*);RTNIVC\F6-=H='"G*[< C&>*
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MWRS$WS;<\KAL8X( ]Z (E\<ZS?Q?\2^*S!U/69-.TJ21&*B&)3YD[X;Y^4?
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M0J6PIX)[@]QWKF9-#9_$W@C3X]4U".-]+NWDG\\F8J1"=JN>5&<#CD#@8ZT
M>JU%<W,%G;2W-U-'#!$I>261@JHHY))/ %>8Q:C<6.C>(-(NM?U18[36X[.U
MG0&>\EC=(W\E&Z[CE@&Y('/:L'Q!<W5SX%\=Z=)/K<5MIZ6\UO'J,Q,X$BD,
MCMDED.,@$GK0![B"" 0<@]Z*HZ39KINDP6RSW-P$7/F7,IDD.>>6/)ZX'MBN
M'\(V&K^(]$TKQ8/$5_#?7<WVB6W:0O:^3O(\D1< ?+@;NN><F@#T:BO&H=?U
MK4(IM;LX_%$^IC47$,,,3&P,"3E#&5^Z?D4Y;&=W?BM_1K._\0>-?%27>NZI
M%9:?>K';6]M<F,#?"N[)') Z@= 230!Z#;75O>0^=;3QS1[F3?&P8;E8JPR.
MX((/N#46I7RZ9IT]Z\%Q<+"NXQ6T1DD;V51R37DGA-4T[X3VL[ZYJ]N^H:B\
M.VW+332$7,N8X1GY&< DL/0FG7FNZI9>"O'D-O=:Q;_V:L#V;:A+FZAWJI(+
MY)(R"1DYP: /7X)1/!',$=!(H;:Z[6&1G!'8U)7FX_M'6_%NB:6^L7]M9S>'
M1=7"VTQ1I7#H,[AR#\W)'/&,\FMOX?W-W)INK65W>3WG]G:M<6<,UPVZ1HU(
M*[F_B(W8S[4 =#JNJV.AZ9/J6I7"V]G  TDK G&3@<#D\D#BG:;J5GK&FV^H
MZ?.L]I<()(I%! 93]>1]#7G?Q"\0Z;)XRT#P[?W#1V%O(-3U I$\F=F?)C(0
M$\N,D'LHJ+X>^)-/LKWQ-H%C*TUE:,^I:<&C>/,+_,\8# '"N2/^!4 >IT5X
M[+_;</P\T;Q2/$FIF_U&XLY+M&G/E%)94^1$Z)C('R]1D'.:W["/4-7^)_B=
M)]9U&+3](ELY8+2"8JCLT(8AO5>#\O0ECGM0!Z'17C?A[7=;U&/0];@3Q//?
M7MW&]VKQ,;#[/(V&"#[JA%((8<G;R>:1-?UO4([C6[*/Q1/J:ZC(((8(F-B8
M$F*&,J/E.44Y;&0W?B@#V6BO+[R#4M8U;QYOU[5+:'2V1K*.UN3&(W^S*Y)Q
MU&?X>G)ZYXCM)]6MK?P)XAEUO4)[K6;B&*\@>7_1V26%GPL?W5*D#!'/KF@#
MU2BO&K77];U&(ZY9Q^*)]3.HMY<,43&P-NLY0Q[?NG]V#EL9W=ZU'MM2UD^.
M)Y?$&JVZZ9>2BRCM;DQB-A C\X^\N2/E/'7CF@#TQ[JWCNHK9YXUN)59HXBP
M#.%QN('4@;AGZBI:\DL8IM>\>>"M2N[^^6:[\/\ VR00W!1=^(B0 . K$\CO
M7<>-KM+70 K:E=V)GN(H5:RB,EQ+EN8HP.0S $;NW)[4 ='17C5WKNK67AGQ
ME;6=UK%L;&2Q>S;4Y"UQ%YKJ&!;))4X[GH2*Z"]:]\'^,;$1ZMJ5_!>:;>S7
M$-[.9%,D*HRL@Z)G<1A<#VH [76-9M-#M(KF\W^7)<16Z[%R=\C!5_#)%2ZG
MJ5IH^FW&HW\PAM+=#)+(5)VJ.^ ":\DO].OI? 7AG7[K6]0NKK4+_3[BZCGF
M+0MYDJ, B=$VDC&W' .<UW/Q/_Y)CXB_Z\GH L:;X_\ #&K:A#86NI_Z5-D1
M1S020^8?12Z@$^PJ_IOB.PU76]6TFV,OVK2FC6YW+A<NI9<'OP*Y+49-:\8?
MV/8+X8OM-AM[^WO);R^DA C6)@WR!'8ECC';J:R=.O%L/%GQ6NGU#^SA&+3%
MWY7F&$F%@&"?Q')X'<XH ]9HKR?3M4O;'5M4L;>;Q%';/H$]V/[9<F03(5 >
M,DDKD/R..0.*=:_VKIVC^!?$#Z]J=Q=ZG<6<-W%+.3 \<T9)'E] 1Q\W4D$G
M.: /5J*Y?Q_J=[IOAM%T^<V]U>WEO9)<  F'S9 I89[@$X]ZQY;&XT'QEI6B
M1:SJUQ8:W:74<HN;MI)(I(U5A)&Y^920Q'''3B@#HM%\7:;X@U.\LM-CO)5M
M'>.2Z-NRP%U(#(KG@L,]*L7OB;1]-URQT6\OEAU&^!-M"RM^\Q[XP.G<UPOP
M7TM8-(U*\%Y>N1J5U!Y4EPS1X#CYMO3?Q][KR:J_$31KC6_B!;PV1*ZC;Z%+
M=V3#JL\4\;ICZD8_&@#T_5-4LM%TRXU+4;A;>SMUWRRL"0H^@Y/X4NFZC::O
MIMOJ%C,)K2X0212!2-RGH<'!KS3Q!K<7C[3-!T^T_P"/:YM&UC4$'\"1#"QG
MZS<?]LS69INK7">%O >C*=8%G/I;W-PND!O/DV;%5=RX*KER20>P% 'M%%>0
MWFI>)&T'1+/[9JVGO+XF%A%<W:[+B2T:-R"X/WB,XR>I0$UMG3KF[\:Q^%_[
M<UB/3]-TM;HNEXPGGEDE< O)U8*%X'3F@#T.BO&8_$&M1Z;'I5YJ&JW<D_B.
M\M)[BQ7-RT,*D[8P/NY(&=N,#=BI=4U?Q!8>"M=%M)K5K'!J%G_9MSJ:LL^R
M21 Z,3RZAMPY.<-@T >PT5G:+I1T>P^S-?WM\Q<NTUY+YCDGK]!Z <"M&@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N!
MOOAD;O2M1T1/$-[!H5Y)),+%(D_=N[;R ^-VS<=VW]2,Y[ZN?\.>*;?6[$S7
M!@M)VN[BVCA:8%G\N1DR,X)SMSB@"O?^$KE]9GU71M;GTJZNH4AN]L"2K,$R
M$;#=& )&?3M5>3P!!;Z?H<.CZE<:?=:,TAM[HHLQ?S ?-WJW#;B<GISTKK4E
MCE+B.1'*':P5@=I]#Z&B.6.7=Y<B/L8JVULX(Z@^] '%3_#6VNM,UFSNM6O)
MFU>YM[FXG8*'WQ%3QC  .SMTSQTK2T[PG/#KZ:QJNLW&J7$%NUO:B2%(Q"C$
M%C\H^9CM )X^E;YO;478M#<P_:2-PA\P;\>NWK39M0LK?_77EO'\_E_/*H^;
M^[R>O(XH Y"R\'ZMX<\.6FD:5K5U/#;WT#0J4CC,5N)<R(S#&X;2WN< "NNU
M*QBU32[O3YRPANH7@D*G!VLI4X]\&I+F\MK-%>ZN(8%8[5,KA03Z#/>LOPYK
MK:ZFJ,UN(?L6HSV0P^[>(R!NZ<9STH S-(\%2:>^@/=ZS->MH@E2V+0(F8VB
M$84X] ,YZG-2WW@BSU"?79I+N=)-5DMY@\> UM) H".A]<J#S]*Z&6]M8+B.
MWEN88YI?]7&\@#/]!U-)/?6=J'-Q=00A,;C)(%VYZ9STSB@#.T71K_3[BXNM
M2URYU.XF54 9%BBC5<_=C7C<<\L>3QT JOKGAB74M6MM8TW5)M+U2"%K?SXX
MEE62)B"496X.",@]N:VOMMH+B.W-U#Y\B[DC\P;F'J!U(I)[ZTMIHXI[J"*6
M3A$DD"EOH#UH Y<^ D@M=,>QUB\@U6P:5UU"0+*TIE.9!(I&""<' QC Q1_P
M@,$FF7,%UJ5Q<7MY?PW]U>NBAI'B92JA1PJ@( !VKJIKNVM@QGN(H@J[V+N%
MPN<9.>U'VNV-K]J^T1?9]N[S=XV8]<],4 8^J>%X=4UO^TWO+F"3^SYK >0V
MQE$C*2ZL.0PVC%9\?@F6[EFDU_6[C52UC-81YA2'RXI<"0_*.6.U>?;I74PW
M5O<;?)GBDW+O&QP<KTSQV]ZH7_B'3=-UBPTNZN%2ZOMYB4D  (,DGGCT'J:
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M:ZC=26SR1S ^25B9^V<GY<8XZUH:YK=CX=T>XU349#';0 %MHRS$G 51W))
M ]Z .4MOAS+9:;'8VOB&Y2.SOC?::3;QDVKDR%@?^>@/F,.:=<?#<7=KKL%Q
MKEW+_;<")>.\:$F13Q(N ,#'R[>@&*=-X[U:PMAJ.J>"]3M-)X+W FBDDB4_
MQ/$IW #OC)%=)/J%T-7TV"VAM9+*Y1VEF>XVR+A<KL3'SY[\C% %6S\,0V>N
MV6J+<2,]KIG]FJA PR[E;<??Y?UJ?0]"BT/^TO*F>7[=?2WK;@!M9\94>PQ5
M\7MJ;LV@N83<@;C#Y@W@>NWK39=0LH"!->6\99_+ >51EO[O)Z\]* ,S1?#4
M.CZQK6JM<27-YJLZR22. -B*-J1CV49_.DU;PQ!JGB'2=:\]X;G3_,0A5!$\
M4@PT;>W<>AJS/XATVW\0V^AR7"B^GA>95R, *5&#SU)<8'?!J['>6LMQ);QW
M,+SQ_?C5P67ZCJ* /%7L!>Z?IOAJPN=?=[;4X3!I5Y9;!8QI,&9I)0N'4(#M
M^8CYAU(&/6=.\/Q:=XBUO6$G=Y-5,!>,@8C\M-@QZYZU6\9^*XO!N@?VK+9S
M7@,R0K#"0&9F.!C-:NG:G:ZGI%MJEO(#:W$*SHY./E(SSZ4 <_IG@RXTJXMH
M;?Q!?+HUK.9H-/157;DDA#(/F:,$G"GV!) H3P9<6]]*++Q!?6FDS79O)+"%
M5!WEM[*LGWE1FY*CU(R :=X*\<V?C:VU"YM+6:WBM)_*#3$?O%*A@X] 00:Z
M.&^M+F!YX+J"6%,[I(Y RKCKDB@#(B\+PQ3^(I1<R$ZV09!M'[K$0CX]>!FH
M3X/MSI/AK3_M4NS09898GVC,ICC,8#>F0V>*W5OK1_-VW4!\I0TF)!\BD9!/
MH".:6"\MKD*8+F&4.NY3&X;(SC(QVS0!S,/@RXM+QDL_$%];:0]V;QK")57#
ME][*)/O!"V25'J1G!J_;>&(;:+Q!&MQ(PUF9YI"0/W9:-8\#UX7-:T-Y:W+R
MI!<PRM$<2*D@8H?0XZ417EK/)Y<-S#(Y3?M1P3MZ9P.WO0!RX\#&WG\.7%AJ
M\]K/HMF+'?Y*.+B'" A@>A.P<CUK6\2:#_;]G:I'>265U9W27=M<(@?9(H(Y
M4\$$,PQ[U7UOQ--I^KP:/IFDS:IJ4L!N6B25(DBB#;=S.WJ>  ">#4NA>(O[
M5ANQ>V$^EW=G,(9X+EE(#$ J5<':P((P10!A3_#@72ZL+C7;N9M6C@^V,\:9
M:2*0,KK@#:,#;M'&,=ZZ'4?#UOJ6OZ;JLTC9LH;B$0X!6190H.?IM_6K][>)
M:6TSY4R1Q/*L9;!8*,UG>'/$5OKVBZ9>,\$-W>VD=R;42AF0,H/3J1SUQ0!S
MB?#5_L%CIDWB.^ETO3KF*>RMC$@\ORW#*K,!EP!E1G&,]R!CJ?$>BQ^(_#M_
MH\TSPQWD)B:1!DJ#W&:N_;+7[7]D^TP_:<;O)WC?CUV]:J:=>WES=:@EW!;1
M103;(6BN/,+ICJXP-A]N: -%%V(J^@Q7(7'P]LKF;Q3))>S@^(#"S[0 8&B'
MRE?7G!Y]*T+GQ1 GB+1-,M/(NHM2-P&GCF!$9B0-CC.<Y]>*NZ5J%S<6-Q<:
ME':6QBF=08;D2IL'1F; P?4=J .?/@6YGU+^TKWQ#=7-[)936,[F!%1X7 PJ
MJ.%PPW9Y)).>, :,GA&"31/#VF&ZD":+-;2QOM&9#"NT ^F:VX[ZTEM?M4=U
M ]O_ ,]5D!3\^E$=[:33-#%=0O*A(9%D!92.H(]LB@"GX@T.U\1Z+/IEVTB)
M(5998CAXW5@RNI]00#6;I?A6X@UR/6=8UB;5;V"!H+8M"D20JQ!8A5ZL<#)]
M!TKHO-C\[R?,3S=N[9N^;'3./2L:^\2PV/B[2O#S6\C2ZC#-*DH(VH(P"01[
MYH 3PKX9A\*Z;<64%Q).L]W+=%G !!<Y(X["I9?#\4OB^W\1&=Q-#9/9B+ V
MD,ZMG/K\M:5W=P6%G+=W,BQ01*7=V.  *I:=K^FZEH5OK,5U&EE/$DH>5U78
M& (#<X!Y'% &1HO@/3="GUZ6UEE)U=FR&QB!#N.Q/1=SNWXU$G@46NCZ%;:=
MJL]I?:+"8;>\$2ON1@ RNAX(.%/L0#6GI7B$:IXCUK2TB3RM.%NR3J^[S1*A
M;\,8]3FMR@#EY/!OVFTTB.]U>\N[C3]2&I&>;!,L@##;CHB?/P!TQ61XR^SZ
M;XKL=5^W:MI,TEH]N]_:V0N870,&$3KM8J^22IQCJ.>E=_10!YIX2\'R7GA/
MS#+?:;<C6+C4M.N)5S/&K$JID5ASN0G<#UW5OW?@N74_#]SINIZY>7<US=17
M,EPZJ IC96"(@^55^0=/4DDUUE% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7B4.AZ+-\*/&&J36T#ZA#=ZA(ET
MR@RPR)*QC"MU7G!P/[Q]:]MKEW^'?A9Y-[:7P9C.\8N)1'*Y8ON=-VU_F.?F
M!].G% '*7&L'P+XBGUF]&+77-(%RZGC-]!'DK[%T/XE:[#P+HLNA>$;*VNN;
M^8&YO&/5IY#O?/T)Q^ K.\2Z)J'BSQ#IEA=:7'%H>FWB7SW<DJLUPRJ=J(@Y
M4;F^8MC@<=:[2@#Q75MD]HOB"PT;3;2VE\11>5?S7#-?2R"Z$;%?EX4[6&W=
MPH/':M:#P_I6J-\1[F_L8+J5;N5(VF0/Y8%M&<IG[ISCD<\#T%==+\/O"\[W
M;2Z9N%TYDD7SY-JN6#%D7=B-BP!RN#6I;:#IEI#?0P6VU+]BUUF1F,A*!"22
M<_=4#B@#SCPM;6^O^)= BUJ"*^2'PC:S01W*"1=[MB1\'C=@*":WOA;#;V^E
M:_!:'-M%KUXD6#D!0P  /IBMN\\$>'[ZWT^":Q95TZ(06K0W$D3QQX V;U8,
M5P!P2:T-(T/3= M9+72[1+6"24RM&A.-QQDC)XZ#@<4 >5>.DCO[#QKJEGHN
MF[;,^1-J5]<-YXFCC4CR%"G9M)7'S#+$^M;UCH^G:Y\4-=;5+."\5=*LL1SH
M'3+>9D[3QG'&>HR?6NFO/ _AR_U"ZO;K3A++=@B=3*_ER$KLW&/=MW;>-V,^
M]7M,\/:7H\[SV5NR3/!';M(\KR,T<>=@)8GIN//7F@#R#3=(L+;X2^%M72VC
M_M-=5M2+QES-@7/EA=_7:$ 7'3 KIM*T;2->;QW=:]:6]S<IJ,]L9+A S0P)
M$OE[2?NC!+9&.3FNT7PMHJ:);:,MD!I]M*LL,/F-\KJ^\'.<G#<\FJ^J>"/#
MVLW\M[?6+--,JK/Y<\D:S@=!(JL ^.GS \<4 >?>$[-/$7B#PD^NP+>,/"GG
M%+A=ZNPE0*S \,<'//<YZU5@M+9FM-"EB0:*?&MS"UL1^ZVK&SI'MZ;=_.WI
M7KJ:/I\>IQ:E';(EW%;&TC=20%BW!M@7IC*CMVK \2^&(7T"YM],T2UOS<7X
MO;FUGG>,RL2-S1OGY).!@Y _.@#*T#3].TSXQ:W;Z;'%#%_9-NSPQ *D;F1R
M0%'"Y&&P.[$]Z7Q7IEA=_%CP6;FQMIC)!?[S)$K;MB1E<Y'."21Z9-6/!?AJ
MYL/$&HZS/I2Z3%+;16L%H;@3RL%9G:21P3EB6QU)P.:Z/6O#.D^()+274K5I
M9;-R]O(DSQ/&2,'#(0<$ 9'0T >9MH&E7O@WXDZA=V,$]VE]J)BFE0,T6Q=R
M["?NX;GCO3XK74?$'B>[631M(UCR]&L55=5N&3RTD1B[(!&^2S Y;@_**],7
MP_I:Z?J5B+0"VU)Y9+N/>W[UI!ASG.1D>F/:J>I>"]!U86WVJR?-O#]GC:&X
MDB;RO[C,C LOL<B@!_@ZUO++P?I5K?W4-U<0VZQM-#(9$<#A2&(&[C'-8/PC
MEC3P'#IS$"_L+BX@O8S]Y)?-<G=]00?QKM;:V@LK6*UMHDA@A01QQH,*B@8
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M>B"R']G1RB5(/,;AQ)Y@.<Y^_P ]?THG\+:-<7FIW<EF?M&IP+;WDBRNIEC
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M6)241F)"\\D@B0]5C#,0@XZ+BM+2M*LM$TNWTW3H!!9VZ[8HPQ;:,YZDD]Z
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M+5M0LM27X62V-W#<QI?11LT+A@K")<J<=".XI;V>%I/BOI(FC_M&XB:2"U+
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MUGTNX.G6\<\9S'-)&ZB0J1P<;E&1Z4 >O:-KEAK]I)=:=))+ DIB\QHF0,0
M<KN W+R,,.#6/=_$7PQ937,4U]*3:S-#=-':3.MNRG!\Q@I"C/<\'G'2NH55
M1%1%"JHP !@ 5Y#9^(-#TS0?B+9W]U;P74NI7Y6&5@'N R!5" \MS\N!G]:
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M'DB@C1Y#EV5 "Q]SWJ6B@"-8(4F:98D65QAG"@,WU-$UO!<H$GACE4'(#J&
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M<IN/WL'C-:-% 'B.BR:EKOP<TSPK;Z+?&>\*(+L1C[,L7G[S(7SP0H(V]<]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ" #T5="TA=5.JKI5D-1/6[%NOFGM]_&>E6HK6W@GFGBMXHYIR&FD1 &D(&
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M.$4D\+G)QW)R:+WPCJEUK\&LQ^(VCNH;5;9-]E'(%_ONH)^4L>N.P Z5UU%
M&(EGK<5]I ?4S<0PK-]N;RD039 \O@<@@^G'7/:IM<T>75X;<VVI76G75M+Y
ML4T!!&<$$.AX=2">#^&*U:* .6B\(SW>IQW^O:O)J4L,$L$$:0+!'&)!M=L#
M)+$#&2<#GBJMAX%N+8Z$EUKT]U!H<@:TB^SJF5$;1@.1]X@,.>.G3FNSHH Y
M"#P+]C71VL]4DBGTV[NKA7:$,)%G=F=",\?>P#[5+9>$;S3"+2PU^XM](%R;
MA;18$WKE]YC$AY"%B>,9P<9KJJ* ,W7]+EUK0;S38;Z6Q>YC\O[1$,L@/7'U
M&1^-9>E^&+ZSM?[.O-8CN])^SM;FR6QCA781C&5Y Q7344 <C8>"9(IM.34M
M9FU*PTL'[%:RPHNT["@,C#_6$(2!P.N3DT7GPU\+7%[IUQ#HNFVWV.X,S)%9
MQ@3#8RA6XZ L&^JBNNHH S=-AU&.^U5KV<R6[W(-FI"C9'Y:9''^WOZ\UDWO
MA;4'\2W>MZ9KSV$MU!%!+']E24$1EB""W3[YKJ** .2@\"00I;/)J-Q/=KJJ
MZK<7,JKNGE"%,8  5<8  Z8J75?!-KJ\VN2S7<T;:I';*#&!F!X&9D=2>IW,
M#@^E=110!QD_@F6[N[O4=8U.;5)IM*GTUH(X4A5HW*GY>>&RIY)[]@*Y_1K#
M5-4\3>%WG.L30Z4DQF.H6(MEB5H3&%SC$KDL,LI(PIZ9Y]3HH Y;2?"=]HZV
MEE;>(+@:/9R;H;00H'V DB-I.I0=.@. !FD?P-8RZWKNH23R.FK6S6[VY4;8
MMZ*LC+[L(TS_ +M=510!QL?@/[-I6CPVFK2IJ&F7,MTE[+"LGFR2[_,+ID9S
MO/0C'%13_#U[B+6EDUVX=]5,$TLCPJ2D\3*5<8P-OR ;<=!UKMZ* .6?PKJ,
M6H7&H:?K[6EW>Q1I?-]D1UE=%VB15)^1L<=QP..*OVGAU;77X-6:]GGEBTX6
M!\W!9P'W;V/]XGVK:HH S='AU&%;[^T9S-OO)7M\A04A)^5?E].>O.,9YJ.T
MT""WU'6KJ1O/35G1I874;0%B6/'N"%_6M:B@#A[#X:VFG:)<Z=#J=WN.H)J%
MI<$ O:NBJL:C.0P"H%YZ@FME?#UW=Z?J=KK6KR:@M_;FW9%A6*.-""#M49.3
MNY))Z#IBM^B@#BF^'-K+I&C6,NH3R-I]TUS-,5&Z[W2>9(K^@9@I/TKI=;TO
M^VM(GL/M=Q:-)@I<6[[7C8$,"/Q X/!&16A10!R2>!H[N+6#KNHRZG<ZI;+:
M2S")81'$NXJ$49P=S%LG/.*NV.A:M')G4?$4U[$L#0I$MND0;( WOC.YN.V!
MR>*Z"B@#GH/#5Q8>&-*TC3=8GM9=-CC1+@1JPE"KMPZ'@@]<9'('-9Y\ I-%
M>SW.J2MJMS=PWHO(85C$4L0PA5.1C&0<DYR>>F.QHH YX0W>C65]?:S?W>L"
M1%3[-;67RA>1A(DR23NY))X'8"J?PZ\.R^'?"R1W22)=W+^;(DK;GC4 +%&3
MWV1JB_4&NMHH Y_5O#=Q=:RNL:5JKZ;?-;_9IF\A94EC#%ERI_B4EL'W.0:H
MIX%CL(M*DT?4IK.]TZ.6(7$D8F\]96#R>8IQDEQNR",'VKKJ* ..'@)5C6Z7
M5IQK2W[:A_:'E+S*8_+*^7TV;/EQG/?.:>W@6.\AU234]3FN=1U P$W<4:Q>
M083NB\M><;6)/).<\\5UU% &!I'AR>SUB76-3U-]1U!H!;1R>2L211;MQ"J.
MY."23V'3%6M"T1-#M[R-9VF:ZO)KQW88.Z1BV/P&!]!6K10 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>exhibit1012-stuartexecut011.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@""\O+?3[*>\NY5AMH(VDED;HJ@9)/X5
M!H^LZ?K^F1:CI=TES:2Y"2H" 2"0>#R.0:X3XKZY9+_8_A>[N?(@U2X$E^X5
MF*VL9#,,*"?F("C\:K^!O$6DP?$+6]#TNZ$NFZD/[2LQY;($EZ31@,!UP'XX
MQF@#U&BO*M$L=9\2:/XDO9_$^JV\MIJ=[#8K;S[%C",=N\8^<9XP>, 8[FH-
M+UK6O%^K^$8GU:ZL8-0T.2XO5M6"&1U=1E>/E)/<<X) QUH ]<HKR+4/$.L>
M%QXMT.+4KV\^RR6(L;F4>=<1+<L%8=/G*\E<]\=:2ZU?5]-TKQ*+!_$RV":+
M+<Q7.KPNKP7*''R.P!^8'..Q4XH ]>HKR^_75M$MO".N?\)!J5Q=:AJ-G;7D
M,LH-NZ3##!8\87'8]>.23S5S1XM2\7:SXEOGUW4;(:?J4FGV4%M*%BC\M5R[
MIC#DLV?FSQQ0!TMEXOT[4=,TO4;.*]GMM2F,,+1VS-L(8J2^/NKD'D\5OUX?
MX?U74-.\!_#*.TNY(%N]7,-PL;8$B&63*GU%=%XIU_6?#'B.70K6_64^(B/[
M-FN) 3I\I94?=GDIA@R?[0VT >G5R'_"T?!G).MH%!*ES!*%!!P?FVXZUT]A
M:FQT^WM6N)KAHHPAFF;<\A Y9CZGK7DO@"]\7+\-X[?2/#VG7EN9+I8IKB_V
MELS29S'LQUR,;N?44 >NVUS!>6T5S;31S02J'CDC8,KJ>A!'45+7(?#'[#'X
M TZSL9)W6SWV\PN$"R)*K'>I ) PQ.,$\8YKKZ "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ.>406\DQ!(C0L0.^!
MFN>\%>-;#QOH[7UE%+;R1OMEMYL;TR-RGCLRD$'_  H Z6BLC0O$$&NV]_/'
M$\*V=[/9OYA')B;:6^AK2ANK>XA,T,\4D0SET<%1CKR* ):*A%W;&=8!<1&9
MEW+'O&XCU ]*FH **XE_B!</:3ZK9>&-2N]#@9PU]')$"ZH2&=(BVYE!!]"<
M=*ZTW]HMK%=/<1QPR@,CR-L!R,CK0!9HKG/%_BH^%X-(E6T%T-1U."P_UFS8
M)-WS]#G&WI[]:TX+R]DUN[M);2%+.*-&BG6X#.['J#'CY0/7/- &A144=S!-
M))'%-&\D9PZJX)4^X[5@2>*TTGPO_;'B.*&Q82;&AMYQ/U<(NU@!GJ"?2@#I
M**A>\M8K?[1)<PI">/,9P%_/I5#7?$.F^'=$EU?4)PMI& <IABV2 -H[\D4
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M\'B/3+GQ!=:)%<*U[;1))(N1C#D@ 'N?EZ?2@#6HHHH **** "BBB@ HHHH
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M!>A:3J46I6UK*U_&CH+J>YDED*MC(+.Q)'RC&>G;&30!SOQN_P"21:W];?\
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M&,\XS7>:EIUKJ^FW.G7T7FVMS&8I8]Q7<IX(R,$?A4\,200QPQKMCC4*HSG
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MY4U-0JF6*XDC$@7[H=58*P'N#0!N4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT6$?ZIU4C$NX<G)/7'%=5<^(M0TAM*T/[(=:\0S6QEF$#+!'M3"M*Q;[H+$
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ML.>PS71:MI=[<_$)KB*VD-N_AZXMA-CY/,:5"%STS@$UV=('5F90P)7J >E
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MR.<BI+WQ7=Q>)Y] L=$ENKI+);Q':X2-'4N5Z\XY![9Z<8Y'/^*/"'B/6_\
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M7[K%2>AQCO56_P#$_BI++QC=076FHOA^=BBFU8^>BQ+)M/S_ "\$\\Y]!CD
M])9E1&=CA5&2?052TG5[#7+ 7VFW GMB[H) I&65BK#D \$$5A0^(;K6_$/]
MD:?*MH(=/BO;B4H';=+G8B@\8 4DGW &.M5?A4)1X( F*&47]YO*#"EOM$F<
M#TH T]7\<^'="U,Z;J-^\=X(Q*8DMI9"%.0#E%([&KNB>)=%\1Q22:1J,-V(
MCB14.'C/^TIP1^(KFM/_ .2VZS_V!;?_ -&/47B.**S^+7@^ZLE5+V]6Z@N]
M@P98%CW#?ZA6QB@#OZ*\^^&<.H:EI[ZYJ6LZA=2"YNK:*!YCY2QK,P!*_P 3
M<$ GH, =*]!H S[37--OM8O])MKD27VGB,W46QAY>\;EY(P<CT)K0KRW2;E+
M+XF_$^ZDNULTAM;-S<LF\0X@)WE>^.N.].\+:C=6WC'1[2.X\12VNH64[3-K
M.=LSIY962)224^\<KP,$<4 >A:3J::O8BZ2UN[92[)Y=W"8GX.,[3V/8U>KQ
M71-:UW4? /AI_P"VKQ+J\\2M:2W/F;G,1\T%>>N !C.1D#BNT\/)<Z1\0=5T
M+^TKZ\L3I\%[&+V<S-$[/(C ,W.#M!Q0!T>M>(-+\/6T<^IW0A65_+B549WD
M;KA44%F/T%1:-XIT;7H[EK"\W&UQ]HCFC>%XLC(+*X! P#SC'%9_BO0]5O;_
M $G6=#FM!J6EM+LAO WE3)(H5@2O*G@8-<SJVJMJFE>)[#5]$DT3Q%'HSS^=
M;SA_/@3<1ME4 [=W!4@<-[T >E03Q75O'<6\J2PRH'CD1@5=2,@@CJ"*DKR_
MPQ]ITN7X<V4-_>O;7NFSS3QRSEP2((2HP?X5R<#MFI[_ %FX2Z\:P7&M7EG%
M'?V=O;-;H995WQ1DQPKV9R2 1T+9[4 >DU%/=6]KY?VB>.+S9!%'O8+O<]%&
M>I/I7D-SK>IV&@>.K6VN=<MTLM/@NK0ZG*3<PL_F!L/DG:=@(R>.:F\4>'9E
MA\'27>NZQ/<7VM0>>QNV549XW),:CA,$<8Z GUH ]=JK)J5G$TRO.H,&T28!
M.TMC:O\ O'(PO4Y''(J/4+D:1H5U=?-*+.V>3YVR6V*3R>Y.*Y+P]H0\1_"W
M2H[J_O+>ZO8X]0DO+239,)G/F%@<'N<?3Z"@#MEN(FN&MU<&5%#,H_A!Z9],
M\U+7+WOAW4+&XU36-#U2Y.HW%J%2UNFWVSRJJ@.5X(8A%4G/X57T7Q1<:[I_
MAV:UGC62YB>?40T7^K6,;9%QGY6\PA><\!O2@#L**\ZG\::L/ 2>.H/(>Q#^
M:^GF/DVWF;.'SGS,?-Z=L=ZT%\2:H]WXTMTF@VZ1!%/9OY//SPF3#C//(QVX
MH Z2?7M*M=8BTF>_@CU"6%IT@9L,T8SEOIP?R/I3])UC3M=TZ/4-+NXKJTD)
M"RQG()!P1^=9NAQKK^D^'O$%\B&\-E'< (H"K))%\Q'?H[ #..>YP:U-,TRW
MTJU,%LN TC2.< ;F8Y)P !^7I0!<HKS_ ,2>+-7T1KZY\VU(M=0MX4LXXS*&
M@D:-2TKC_5N2[$ XZ#@YS4UUK'B6Y\3^)-)LKS3[>+3[2"X@D>U9V^<2':1O
MP?N#GL.W.0 =UTJAI>LZ?K4=Q)IUR)TMYVMY2%(VR+C*\@9QD=*Y71O&-YXC
M?P_8VYCM+J_TD:I=R!=WEKE4"H#W+$\G. O<G(=\-5G2#Q.MS(DDX\070=T7
M:&.$Y R<?3- '8M=0+.T+2J)$C\QAG[J],GT'!Z]<'T-/AFCN(4FB;=&XRK8
MQD>M85]X3MK_ %:_O9+_ %!([^Q:RN+2.;$+ C&_&.' ) .:R9+C5/"&K^'-
M-GU.2]T6[9K22ZO%WW N#EHPSY PW*CC@@#O0!VU4;S1M,U"]M+R\L+:XN;0
MEK>66(,T1.,E2>G0?E7,7'BF_A%HJ/"S:QJIL]/9H^(X5W;I&Y^;.QBO3(9?
M>J>L^*]9T.[\0Z5)+!-<V>COJ]C<F' =$)5HY%!QG<!R,<'VH ]!JIJFJ6.B
MZ;-J.I7*6UI  9)7Z+D@#]2!7--XAU,:]X2M5:#R=8LYI9P8B2KI$K@J<],M
MT]NM5/#%YXC\4VT\U_>Z>EC'=7=G+%#:'>^QRJNI9B%Z="&^O/ !T@\4:(U\
M+)-2@>Y-J+Q8D)9FA/1QCJ/IVYK5BECFB26)U>-U#*ZG(8'H0>XK.M]!L+6Y
MLIH8@OV&V^S6RX&(TP!UZG@ <GU]36!X(NW36/%6AGF'3=1W6X[)',@DV#V#
M%L>@(':@#LJR];\0Z9X=MXY]4G>&.1]B%())<G&>B*2*U** ./@^*7@^YE\N
M#5)9'#^60MC<<-Z'Y.#S70:7K-IK#7PM=^;*[>TFWKC]XH!./4?,.:Y;X<?\
M?GC3_L8[C_T".N9BTNZFTGX@:I#K.I64ECJ=[-;):3F)1(D:MN<#[^< 8/&!
M[F@#U^BO);GQ!>:[K$5O=-XB$$.DVEP%T)6!,\RLQ=RO8!0%4\?>XKO_  A=
M:G>>$].GUF&2+43%MG66/8Q8$C<5[$XSCWH AUGQOX>T&_\ L%]?G[9MWFW@
M@DG=5]66-25'UQ6EH^MZ;X@T];_2KR*ZMF)7?&>A'4$'D'V/-<I\+TCDTO6;
M^0 ZC<ZQ=?:W/W@RR%54^P4# [9I_C#R]!TV3^PO+L=0UO5+6TN+F$#<C2LJ
MF3'0-M[XZG- ';T5YMJOVWPCK\>GVFKZE<VFI:3>R;;RY:9X9H55@ZLW(R&(
MQG'2LA8M:BT+P+JR^)M5^V:U+;VMYNGW1^7+ S$JA^4.-HPV,YY.: /8*0
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M YD^"YH-7LM7T_6'M+^&S6RN6$ >.YB7[N4)X8=F!_#'%:/A7P[_ ,(QI+V
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M^'=II>BZ3IJ7\[IIVJ'4D=D&7;Y_E/M\Y_*MV/0HH_%=QKXF<RS64=F8L#:
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M":A%#IMO=:C-;6K2(I?,PV!R,D!CC(]#WJQ)=6\*JTL\2!E+ LX&0!DGZ 4
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ME44EL$EB223SCL*W'O;6.Z2U>YA6X<96(R .P]AU-$E[:Q2>7)<PH^]4VM(
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MCB1@06V+P7Y^\?3 Q5K7_%-MH>DIJ*P27D+7:6C&%EPCF3RSG)[-QP#TK>H
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M#R0R7>Z74M/W8O)<#<><#=A?;&,=L5Z7;^#M"M;B[N(+1TGO(5AN)1<2[I%
MP"3NSNP3\W4YY-!\':$= @T,V;_V? Z/#']HES$RG*E'W;EP>F#0!S4_]H>(
M==\2:%:WLEM)IJ0PVK"_FC>(-$&$I"_ZP[B1\Q.=N.YS4CLM1U?QM'I%[XDU
M$Q/X>AN)9-/N#"KS>:5,B8^Z#MSQU^E=5J?@3PWJ]Y;7EYIV;BWC$*213/&3
M&.B,58;E]CFK\7AW2X=;76(K=TOE@%LKK,X41 Y"!,[< \XQ0!B_$Z>YL_AQ
MK-U9W=Q:W$$.])8)"C Y ZCGO6=J:7&C^)-'T:/4KV>/67N)Y3=WSIF2-$Q&
MC*,HIRS;5QRN.G%=CK&CV.O:9+INI0M-:38$D8D9-P]"5(./:JNL>%M&U[2H
MM-U.T-S;PL'B+ROYB,.C!\[@??- ' >,=(OK+X8>(+;4]4>],-TDELJW,C-!
M&\D>(G8D&3&3@MDX(]JWK^6:3QI'X6AEE%LFE_:T634)HWE9I65CY@)=MH X
MSQN]AC;E\&Z#-X?.A26;MIS-O>+[1(#(V0<NP;<QR!U)Z#TI=:\':'X@CM%U
M.T>9[0DP3"XD66//7$@8-S]: .,EL]:AU;P;HU_XENYWFDO;>ZFM)F3S52)F
M4,>[KTW=<C/!YJQ!HMQ/X]O- ?Q#KOV*VTFUF0B]82%_,<;BW?(09]>]=<?"
M>BF;3)5M&1],#?8_+GD01;AAC@, 203DG).3FK$>@Z=%KTNMI%(-0EB$+R^?
M(04!R%V[MN 23T[T <)HTNL^)]#T_P 16^K)97"7C27#-=R,FQ9"K0-#C8.,
M =^ <Y.3GZU<OXH^&?C75;JZNEGMYKNWCACG=$A2([0A0':<@9.02=WL,=W#
MX%\.6^O2:U%IH2]DD\Y]LKB-I/[YCSLW=\XSGGK3;WP'X=O[F_GGLI =0&+N
M.*YECCG.,;F16"EO?&>_6@#4BA2Y\/QPR%PCVJJ2CE&P5[,I!'U!KR_PQ>R:
M=X&\ 6$4]S##K-P(KJ;SWR %=@B$GY-Q 'RX[UZU;6L-G:Q6L";88E"(I).
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M'12  K <YR>>,$'CO0!V-%</9?$*:[\.IK;^'[F*UNA FGJ9T,EW-(<; O\
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MWL#*@_&L_P =>+M/MM-\26%YIUS=6FF6MM-=-!<F%BTLF%0,O(. &)STX[T
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M0(>/<D8ZT =?17&W'CJX6XO9K+P]=WNDV%R;6YO(9%WAP0'V1?><*3@GCH<
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M6$_]H237!6WV_.0UVSCCW4@_2NS\;:-/X@\%ZMI=KC[1<6Y$08X#..0">V2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI5TK5[&]:+_6"WG60J/4X/2HXO%7AZ>]M[*+7-.DNKA0T,*72%I >05 /.:
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M[2'[F]<?=8\;L\'K1XD\4-H]]IFE6%F+_5M1EVQ6WF; D8Y>5VP<*H]N3P*
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M1-$>)-5U>QL7FYC6YG6,L/4 GI4MWK6EV$227FI6EO')&TJ-+,JAD7&6!)Y
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M,?:!F2-1 H4.1P&[?6@#=M/$NGV.K>+))M1U2?\ LFV@GNK:=%V0+Y1;]W@
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M>HBTA%N[&[,F579@8)SP?08/0T >@:KXQL-,N8K:*VOM1G>W%T8["#S2D).
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M-]6LKJ,2:4@7RX9(GW!SF/B+Y0=V[D'C)KU?Q!I?]M^&]3TH2>6;VUEMP_\
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MW7S/L24IMV["V.-V0"#5O3/&4<VE:_=:G MI-H<\T=U$'W?(@W*XR!PRX(H
MZD].*Q_#_A^/0X[R1IVNKZ^N&N+JZ==ID8\  =E50% [ 5-X>U"[U7P]8:A>
MVJVEQ=0+,\ ;=Y>X9 S@<X(S[U@>)O%.N:&^H7<.C6KZ5IT0EEEN+HQR7 V[
MG\E0I!VC^\1D\>] '89&[;D9ZXH!##((/TKSEY5F^/\ I\J'*/X:++]#.:Q_
M ?B ^'O -[-%:F[N[KQ#-:6EOOV"25W 4%L' ZDG'04 >OT5P.I>.-;T%=2M
M=5T>S;4+;3VU*W^R7+-%/$C 2+ED!5E!ST(-7]5\=16'B30--@MA<6VIHLDM
MSOQY*R$+"<8YW,<=NE '7T5B:/KSZMKVNV26ZK:Z9-';K.&SYLA0.XQCC;N4
M?C3-1\0OIGB[2-(GME^R:G'*L5SOY6=!NV$8[KD@YZB@#>HKBM5\?G3KW78X
M].-S#IC6]M&5DPUQ=S$8B'& !N7)[9Z5+%XIUC3M772_$&FV<,]S:375I+9W
M#2(YB +QMN52& (.>010!V%%<C_PF<G_  B/AS6_L2;M8GLX6B\SB+SR 2#C
MG&?QKK)3((G,04R;3L#' )[9/I0 ZBO+_#WC?7;7PMJ6JZO:V]W(VJR6=C##
M<-ODF:8HL7* *@XPW)P#QVKI]-\1:M%XEAT'Q!86=O<75L]Q:S6<[21OL(#H
M=RJ0PW ^A% '4T5F>(M;@\.>'[W5[E&DCM8]WEIU=LX51[DD#\:PE\4:WI*7
M<_B?18;:SBLI+P7%C.TR)LY,3Y5</CIC@\T =A17$VWB[7+:?1IM<T:TM=/U
MB98(&@NFDEMY'4LBR H <XQE3P:SKKXB:U%I.K:U%H5LVEZ1?RVMT7NB)9%2
M386C7;C@8/)'.0.F2 >CT5R%EXIUA/$]GI6L:3;6L6I6TMQ9O#<&1U\O:2D@
M*@!L,#P2.W/6L:R^(NM3>&M.\4W.@VL.A7$D<<Q%V3/&&<1^8%V8*!CTSDCG
MB@#TBBN'U+QMJ5N^L7UCI5M<:-HTIBO)'N2L\A0!I3$FT@A >Y&2"!5:#Q-K
M7_"R=6AE-G_85GIL5RQ$[96,^8WF!=G+G !&0  .30!Z#17%:5XQU6>YT:75
M-*MK73M;.VS>*Y+RQ,4,B+*NT %E4_=)P>/>NKU+4(-)TN[U&Z)%O:PO/(0,
MG:H)./P% %JBN'MO&6N0?V->ZSHUI;:7K$T<$+0W3/-;M(,Q^8I0#G@'!X)[
MU8\/^*M7\0>(-1M8=)MXM-TV_GL[BZ>X.YB@^78NWD],Y( !XS0!V%%<UX_U
M+4=(\":Q?Z7Y8NH;9V#NY78-IRRX!RPZ@=/>LR+Q/KZPZ)I$>GV,^O7UJURY
M:Z?R(H5VC>S;-Q)+ 8 ZD\\4 =Q16!X9\03ZR=1M+^T2TU/3;C[/<Q1R>8AR
MH971B 2K*0>0#UJQK]_JME%;)I&GQ74\\A5I+B;RX8%"DEW(!/8  #J: ->L
MC6]"36I])E>=HO[.OEO5 7.\JCKM/I]_K[5S0\?7DFF6T:6%DFKRZI)I;++=
MD6RR(A<MYFW)!4# QDEL59O/%6NVB:982Z196^LW]Q+ @N+PBVQ&N[>KA2QW
M#&%V@]?3D [(D#&2!GIFEKS_ ,1:VT8\(G7?#D/VZXUI+=4:XW+;R9($R,!\
MP(&0"!UYK0A\4ZS?ZW>Q:=I-I<:?87PLK@?:]MU_#ND"%=NT;LX+9(!(]* .
MPHKAO!FL>(M3\5>)X=22T^Q6EX(4$<[,8B(TPJ@H 5.2Q)(.2>.]=1KE[?6&
MFF73=/\ MUVSI''$TFQ!N(!9VP<*HR3@$\4 :-%<[X9\07>JWFIZ;J5M;0W^
MG/&)&M)C+%(LB[E920".A!!':LWXCZOK>D:=I)T;R USJEM;R-)*R'YI%PO"
MGY6P0QZ@'@&@#=CT.-/%\^OBX)DDL8[,P[> %=GW9]]V/PK6) QD@9Z5YK;7
M7B&/XC^(4T[3K&6_DTZP:<S7++!$0)<J&"%FR3QP. 2<="M]XOLM7TWP/J=U
MH<<LNH:JD*)+*<VDP9E+J0/FP5..F: /2J0D 9) 'O7'VWBS5M0\9:IHMGI5
MO]DTJ>-;N\FN"O[MXU<;5"G+<MQG "]>:Y+Q5XFUGQ#\/O[3.DV\.BWUW;?9
MI%N"9U07*;7=-H4!MO0$D;AUYP >O445YTWC_7GTC5=:MO#]J^F:1=3PW6^[
M*RRI$Y#-&NS'"C/)'.1VR0#T6BN0USQ1K5HDMYI.DVD^FP6BW;7%Y=&$W (+
M;(@%/S!1U; R15:]\;ZE/KFG:3H&DPW4NH:4NI127,YC2-2P'SX4G&".G<CZ
MT =Q17F$?BSQ;::QXWG-A97=OI'ELMLMTX*J(@^$^3DE<DY[\#/6NIU+Q='%
M:>'I-,A6\DURXB2W4OMQ$REWD/7A5&<?2@#IJRM?TR^U?3_LEEJ\VF;SB66&
M)6=D(((4M]T_[0Y%7[QKE+.9K-(I+D(3$DKE4+8X!(!('O@UYKX7\;ZZOP_T
M:^OK2WOM2U:Y^S6"BX(,C,SDM*2OR*H4]-W 'K0!Z)I6F6FBZ5:Z;8Q^7:VL
M8BC7T '?U/O5RN:T3Q#J$WB&Z\/ZW96UMJ,5LMW$]K,TD4T18J2-R@@AA@@^
MHJ[XFUY?#NC->BW-S.\L=O;VX;:999&"HN>PR>3V - &Q17&7/B_5] T[5+C
MQ)HJ1_8X$FAEL)FDAN"S;!$&95*ON*CIT.:FL_$NMVGB#3=+\1:796W]J+)]
MEEL[EI0DB+O,;[E7G;G!''% '6T5YG'\2=;;PY8^)6\/0'2)[@6SHET3<%C(
M8PR*5V[=V!R03["M8>,-7L-1U;3]9TJSBN;72GU2W^RW+2(Z*2"C$HI# XY
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M@P<F,'&[.,=?>@#E8= U-8/'RM;8.JR.UG\Z_O0;94'?CY@1SBFR>'M4;2_
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M+*[LDQ=:J3$0[*N \.TER6.#\P7 )ZFNZ\0Z5_;GAO4])W^7]MM9( _]TLI
M/X9K2HH \Y^Q>(]?M?#FC7^A26":9=6]Q>WCSQM%)Y'($05BQW,!U P*W?!6
MD7VDGQ']N@\K[9K=S=P?,K;XF"[6X)QG!X/-=310!A>,]+N=:\%:UIEFJM=7
M-G)'$K' 9BIP,]JY>&VU^VU'0_$R>';II;?3WTR]T_SX?."91ED0[]A&Y#P6
M!P:]%HH Y;PAI>H0W^NZWJEM]CN=7NDD6UWAVBBCC6- Q7(W'!)P2!GK57QS
MI-SJ&HZ'<'16UO3+9YC=:>KQ_.[*!&Y61@K!3NX)XW9[5V=% 'EFF:%JNF:3
MJNFWW@BUO=-N-3:Z:R@>'8(I(Q@0@L!N1EP<[<YROM+:Z%J%KX9^PZAX1;5-
M'EO99(]+FN(Y;BRA*KY84N^TX(<X#Y 88/!KTZB@#RF3PCX@DTWPC&+.798>
M(/MC02W*R/:6FYBJLY;YRH(Z$^G.*N^(-%U+5-?\V#PL;;5X[R,V^O6MPB)Y
M =2?,^8.QV J4*D'MQ7I-% '&>&K'5=)\9^)4N-,D-CJ-V+N"^65"F/+5=I7
M.X'(/;%6?'VF7FJZ/91VUB^H00WT4UY8HZJ;F 9RGS$*>2K8) .W%=510!PG
M@K1KW2/%&MSMX<ATG3M1A@EMX[<Q!(2FY2CJA^^<AL@%>HSQS>^(6EZCJ>B6
M+Z9:&[N++4[:]-NKJC2+&^6 +$#./4UUM% '*:!8:C_PFFMZS=V$EI;WUE9+
M&LDB,P=!)O4[2>1N'L>Q-<DG@[7AH/@>V-A^^TS7'N[M?-3]W$9I&#?>YX8'
M R>:]8HH Y/0=$O;;Q3XPN;N QVNI3PFW?>IWJ( C' .1@@CG%<=)HWBYOA[
M:^#5\/L9+&:!7O?M,0BGBCF5@4&[=N( )# 8P><X%>NT4 %>.Z6VOWO@SQ-H
M6G:(]T-2U'4+>&\6>-8H5>5U<R!F#<9)&T-GCO7L54M,TJRT>WE@L8?*CEFD
MN'&XMEW8LQY)ZDGB@#S?5/!EZ^IZI:2>'(=8$]C!:Z9J%TT3162K%L;*L=RG
M=E_E!SD<C&1I^%=#UF#Q/H>HWNF26D-MX:&G3>9+&Q6=94X^5CD$*6!],9P>
M*]"HH XO1M/U33OB%XE>?2Y)--U9X9HKQ9(RB[(0C*RD[LY'8$5@?#S19T\6
M:C%*ZS:9X:>;3],8'=S*_F/S_>1=D?YUZ7?64.I6,UG<^9Y,J[7\N5HVQ[,I
M!'X&HM)TBPT+3H]/TRV2WM8\E44D\DY))/))/4GF@"X1D$5Y-HOASQ)9>#_#
MUNVB.NH^&;[S1&UQ%MO8V\Q7\M@W!VN"-V.>*]:HH X_1++4]3\;W/B;4--E
MTR!-/6PMK>>1&E?,F]W;8S!1D* ,D\'I5SQOH][K&A1?V:J27]E>07UO$[;5
ME:)PVPGMD9&?7%=)10!Y_K=KXH\:Z%JUE)I*:1;^3$UG'=R*\LERD@DR2C,J
MQ_*%]><^U6%AUOQ-XJT&]OM#GTBTT@RSR_:)XG,TS1E J;&/RC<3N.,\<5W%
M% 'F</A36D^$VDZ(UEC48+Z*:2'S4^5%N_,)SG!^7GK^M7_%NE7IU[6-8\G_
M $ >%KJU,NX?ZTMNVXSGH"<XQ7>U#=VL-]93VEPF^">-HI%R1N5A@C(Y'!H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %-DCCFC:.5%=&&&5AD$>XIU% !THHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY610A#$9"G ZANAK1.A(]AIMQI'A_4[-'\1VD\GVR222:2*/CSG#DL@'3![
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M ZO/I5[+_95O<6]]:Q0EIXA*!AA'U."HR!S@]* .K/Q MK72]8GU/3KFTO\
M26C2>QW+(SM+CRMC X8,3@'C!!STK-76]4O/B9X=M+_3;G2W^Q7DCP&=9(Y
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M\K@$G&1@XR<>M87A_4IM>U#Q!JJQK+]AO)-/L87?:H\L .V<'!9R03@\*/Q
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M+-?,0UI*45&)4(?,7Y0P&5Y)'O6M8>'[NU\>WNM.T!M)M-@M$"9#;T9B?EZ
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M>WY^2VWYAU&>E=\2 ,G@5A>'/%NF^*DFFTI+M[6,D+=26[)%-@D'8Q^]@@T
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M7$*L.=Q!/S]@#76Z-X*M-%U'3;N"ZF<V-C+: 2 9D,DBR,Y([[@> ,<U6N/
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M?*7$R -CUP2*V/$V@1^)-&:P>XDMI!+'/#<1 %HI$8,K '@\CI6;I_@^>#Q
MVN:AK4]_?O8O8L6A6- A96&U5Z8*GUSN//0  \JT>Q^V?"GX:C[7=P!]<$)$
M$Q3AI9CNX_B&W@]LFNVEU/4;;XFZWI::A=-9VWAH311O(2!(&QO_ -[WK0B^
M&\5MX)T;P]:ZM/%+I%V+RUO/*5B) [L,H>"/G(Q6@O@Q#XCN];GU"66YN]*&
MFRCRU4'G)DX[D]NE '#1+KD?AGP/K*^)M4^W:Q/;6EUNEW1>7+$Q)$9&T.
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M!K5Y%A65982P;:RMW##(/N>M8T_PQM9_"M_H3ZK=.MYJ7]HR7$BJTA?*D@]
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MSURB$\A<Y&!V%=1XO\-:##\2? -K%HFFQV\\EZLL26J!) (@0&&,'!)(SW-
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M[#*IYA7:&/\ =)S0!5T#0[Z]\:7OB[6=,CTZX-JMC:6WF+(ZQABS.[+E=Q)
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M22WWE [Q-'N([@, 2.>#T-/U;5['0]/>^U&?R;="%SM+$L3@*J@$L23@ #-
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MDEE9<[E$:J7R,'(QQCG%$GC7P[%I=GJ4FI*MI>2-%"YC?+2*&)0C&58;6&"
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MV>@/K=S+)%IZ0^>\CP.&5.N2F-P^F,TR]\1Z1IUYIEI=7JQSZHQ2S7:Q\T@
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M:,]O*HD4*F22R@*=S$;2<X&<8H ZJBBB@ HHHH **** "BBB@ HHHH ****
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M#&&0'8?;TJ&PTV#3C=&'<6NKAKB4L1RS8';L  /PH \TNO\ DJ?CG_L74_\
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M&5O&L8((X(\\5WNHV,&I_%:>QN4W077AF2&5?56G (_(FNV%O"JA1#&%#;P
MHQN]?K3MB>9YFU=^-N['./3- 'D7A&2[U_7M"\/W^YCX024WI(X>=6,-N?\
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M;PBX,XAC$Q&TR;1N(],]: )**** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=+TM]2U.6!KEH_.6%(H@=NYG.>K<  '.#65<?$BUM= BU&72[L3C5!I5Q9
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M'S !,8P,]ZS_  M>^)HCXXO)-1L+M[74)HHXIXS"GFK'%ABY<[(PO5<>IW4
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M. >IKLM$T;6)O%UWXDUR*SMI39K8VUM:S-*%0.79F<JN23C@#@"NDN;*UO#
M;FWBF,$@FB,B!O+< @,,]#@GGWJ>@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "N%^%J))H>J7T@!U"ZU:[-XQ^]O60J%/
ML%"X';-=U7(W?@F>+6+O4_#^OWFBRWS;[N*.*.:&5\8W['!VL>Y'6@"MXP\K
M1-/*:&4L+[6]6MK2ZN8,;T,A 9_0-L'!]\U0O1=^$_$\>FVNJZC<V>HZ5=R[
M+RZ:=H9H0I#J[$L,AB,9QP*V%^'NF?V!=Z=+=7DUW=SK=3:D[@W!G0@I(#C
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M%]/YAWR06I9CN/4[P8<^NZN9UB[OM8^%_CY[W4;V0V7B*6*']^W$8DC41^Z
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MQ&'! (*@@_SKC-1\$R:5KOA;3;#4KX6QU.\NHI@H9K4M"[\L0=P+_P![KG%
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MG>>[_/-;F%G"R$?>(W '/7:*ZVVO;IOBGJ-BUQ(;1-(MY5A+'8KF64%@/4@
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M\1+[6+>"6[AO9HA/*H+P11P(8RI/*XY8$8YYKK? &1\-_#A R?[,@P/^V8H
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MM[ZTN[<SVUU!-",@R1R!E&.O(XKQO2)K9-$\=6US8F_%[XN>UCM3,8EED>1
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M1U&T^SLVQ9?/786] <XS7E1T"2&?PCI.JK826YUZ[*6MG,988HS%(WDY*KD
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M4U*L\+2^4LL9DVA]@89V^N/3WK@=.T'2]9^)7C1M3L8+P(MG&BSH'5 T/S$
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M&4@J1D$'@TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5SMQX%\-W6IOJ$VF*TTDHG
MD3S7$4D@_C:(-L9N!R5S7144 </)X(@U;QMX@U#5[-FM+F"U2UFBN&B<[5D$
MBY1@P'*Y!X/'7%;MUX1T*\TJSTR33T2ULL?95A=HFAP,?*Z$,..N#SWK;HH
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MH6'49'DNUW-^]9U"L3SQE0!QBM&B@#"O_!N@ZE;64%Q8G;91>1;M%/)$Z1X
MV;T8,5P!P3SBM:RLK;3;*&RLH$@MH$"1Q(,!5'85/10!@:SX)\/:]?"^U#3@
MUV%V&XAF>&1E]"T;*2/K4MIX2T&PT6ZT>TTR&&QNT9+B-,@RAA@[FSN)P>I.
M:VJ* ,Z]T'2]0T9=(N[-);!55%B8GY0N-N#G((P,$'-0:7X6T71X+N*TLAB\
M&+EII'F>88QAF<EB,$C!..36Q10!S>G^ O#.ES6TMKINV2UD$ENSSR2&(@$
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MV5K&([>WC6*) 2=J*, <\]!4]%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%9^L:U9:':)<7KL!+*D$4<:[GED8X554=2?Z$]J:NM0-
M>ZC:?9KP/81K)(QMVV.&7=B-NCGU Z'B@#2HK$B\4Z>[:4LJ75L=4W"V^TP-
M'EQSL;/W6(!(!ZX.*VZ "BBB@ HHJAK&LZ?X?TN74M5N5MK.(J'E8$A<D =
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MJG'0CTH EHHHH **** "BBB@ HJC-JD4&KVNFM!=-+<HSK(D+&)0O4,_13Z
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M$F_:RJ9)<Y? 8]AGC.:ZV@#R:X_MJ_\ #WC763XCU.WETB^OOL,<$H5%$0W
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M]+FO8IVU."8+>:<5V*%]=JE0<*P."<BGZ?H>D>(H/'-_KMG;W-W'J-S;":=
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M ?,O)&T\<GC/-=3/J%ZOQ'T9!=3FUN-'N)WM0W[LNK1X('K\QZYH [6BO-M
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M33/#6DWVFVFDO/#I]U*(8$=Y<.X78X9L;1R.-Q]: /3I;B&"/S)IHXTZ;G8
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MFBAMY)F1/[SB-6VCW.!0!6?P#X>DNQ</;7+$LCR1&\F,4SH %>1-VUV^49+
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M'C[PW:J/-OY Y@CN!$MK*TGEN"5;8%+8PISQQWQ1%\0/"\]U9V\.JI(UXR+
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MI[C>B@8D:4CY6Y^Z<'VH ](HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT)P>.O!KOK:QM+.-H[6U@@1CEEBC"@GW IL&GV5J%%O9V\(5BRB.)5P2,$C
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MIH;F:W<.@=I-R*6'&<!SCT-<YI GA\)_#.\754TFWCBN8FO9(E=(Y'7Y =W
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M,2,P9VP6)+$JOH ![UTD-E:V\\D\-M#'-+S)(D8#/]2.M '!?&7_ )%/3?\
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M\8^)387=E8KH(T^ 7D1BDF(=I&;8>0!D 9 SS0!VEEXUDFUG3K.^T2[L+;5
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MSDD$T(R"5=>,@C!!Z9'7-<W)X6U+4_AUJ=Y<6,YU?4]2759K,L8Y=B2J5A#
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MXCD6;1UF\.22B60VSD7NU!( %W_N_E(R<MR>V* /1I+^SBO8K*2Z@2[F4M%
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MD,@Q&9' R^T=.G(!.:LZGX&LM4\9V'B.2XE1K;87ME V3O'O\MF[Y4R,1^%
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M[?'RNDC*6)/7^''XT <%H4^L7-]I4,$OBUEU"WDBU.XOXG6)&:(E98CTC(<
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M),-T2^8,N/51W_"IZ\*CT/3;;X,S:K':1_VA;:I_H]TRYEA"7H151CRJA1C
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MV^RC3XK6X9KM(;@37(B\M#G)'!W,.,+QG-5+GQ9IT=QK-G!*LM[I=L+B6+<
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M(QE2-C9! Y&.M #M1\'Z%JB6@GLC$;./R;=[69[=XX^!L#1LIV\#CI1<>#M
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MU=M21;&:X%L)61AME)QL88RASUW 8[T :=QI=E=:E9ZC-"&N[(2"WDW$; X
M;C.#D =:;J^D6&O:5/IFIP">SN !+$6*[@"".00>H%9,GCO0(M.M+YKBY*7C
M.MO$MG*TTNW[Q$87?@>N,<CUJ:7QGH,>CVFJK?&:VO&*6P@A>225AG*K&H+$
MC!R,<8.<4 /U7PCHNLFV:\M9-]M&8HI(+B2%Q&<90LC E>!P3BHKSP1X?O8K
M.-[%H5LX?(@-K/);LL?]S,; E?8YIS^,M!30XM8^VEK2:7R(PD+M(TN2/+$8
M&_?D'Y<9&#6+X@\<VR>'].U?2;]8[8ZQ;VEX\T10Q(7 E5U< H0/4 CK0!JW
MG@/PY>I;J]@T2V\ MD%M<209B'1&V,-R\G@YZGUJ34O!>@:H+87%B4^S0_9X
MC;3R0$1?\\R8V&4_V3Q3+7QCI6L0:C%IMQ*+VTMS,8KBVDA<+@[7"R*"5R.H
MXK'\(^-E?X:Z+KOB*[+7=[N3]U 6>:3>P"I'&"2<+T [9H Z>'P_I5O>V-W#
M9)'-8VYM;8H2!%$<94*#C'RCMVJ[=6L%]:36EU$DUO,ACDC<9#J1@@_A5?2-
M8L-=L1>:?/YL.]D;*,C(ZG!5E8 J1Z$9J]0!@Z7X-T+2'F>VLW=IH3;N;F>2
MX/E'K&/,9L+[#BDT?P5X?T&[-UI]B4F\LQ(TD\DOEQGJB!V(1?9<5OT4 <[8
M>!?#FF:A%>VNGE9(&9X$:>1XH&/4QQLQ1#R?N@5@Z3\/+&\FUR77]/<M=:M/
M.@2Z95G@)!3>J, PSGY6!QSQS7H%% &)K'A'1-<FAFO;1_-BC,*O!/) WEG^
M F-AE?\ 9/%:MK:P6-I#:6L*0V\*"..-!A44#  %344 <Y=^!/#=]J,M[<:>
M6DFD$LT8GD6&9QC#/$&V,>!R0:UDTFQCUF75U@ OY8%MWEW'F-26"XSCJ3VS
M5VB@!&4.I5@"I&"#W%8,/@KP[!X7E\-Q::BZ1*27MO,?D[@V=V=W4#OVK?HH
M R;OPSH]]8Z;97%DKVVF313V<8=E$3QC"$8/. >AR*BNO".B7FM2ZO-:-]ME
MA,$KI/(@D3:5PRJP5N&(!(R/RK;HH S&\/Z6]AIMDUJ#;::\4EHF]OW31C"'
M.<G ]<^]5Y/".A2QZQ&]@"FL$&_'F/\ OB!CUXX],5MT4 4KC2;&ZO;"\F@#
M7%@7:V?<1Y992C<9P<J2.<TW5]&L-=L?L>HP>;"'$BX=D9''1E92"I'J"*OT
M4 <]_P (1X>.BSZ2U@9+6>43RF2>1I7D&,.9"V_<,#!SQBI=-\(:%I4\L]K8
M_OIH#;S232O*TJ$YPY<G=]3DXXZ<5N44 <[IG@7PYI$[S6>GE7:)H%\R>201
MQMU1 S$(#Z+BKW_".:2=+T_3?L@^QZ<\4EK'O;]VT6"ASG)Q@=<^]:E% $-W
M:07]E/9W*>9;SQM%*F2-RL,$9'/0UD7'@W0KC2+'2VLF2VL !:>5/)')!QCY
M9%8....O/>MVB@#GI?!'AZ72[73Q8M'#:NTD#PSR1RH[?>;S%8/DYY)//>FR
M^!/#LMC:V@L7B2U+M#)!<RQRJ7.7)D5@YW'DY)SWKHZ* ,"X\%Z!<:99:>;$
MQ06))MC!-)%)$6^\1(K!N<\\\]\U-#X5T2WATV&&P1(],E,UH [?NW((+'GY
MB=QR6SG.:V:* "O)+_P/?ZB]QIP\*6UF]Q?"234XKXM;K&)0Y>. L2LC*-IP
MHY)YQ7K=% &!JO@O0-;OVO;^Q9YI%5)MD\D:S*O02*K .!_M T_5_"&B:W<Q
M7-Y:N)XX_)66WN)(&,?783&RDK['BMRB@#C?%/AJ,Z-I5EIGAVVO[.QE!%K'
M<&VFB7:0&AD#+AL]<D9&>:I^&_ \4MEX@36](BM+/5Y8L::LY<QQQ* "[J>7
M9@6.">O4\UWU% &5K7AS2_$ M_[1@D=[9BT,D4SPNA(P<,A!P1P1G!KEO$/P
M]L)#I46DZ4GV9M7@N+^$2D1B)(9(]P4M@'YE'RC)X/.*[ZB@#G[;P3H%I8ZC
M:)9/)'J2>7=M-<22R2I@@*79BV "< 'C-:4VCV%Q-I\TMN&DTYB]J=Q'EDJ4
MSUY^4D<YJ]10!CP>%=$M['4[*/3XS;:I/)<7D3EG$LC_ 'B<DXS@=,8[4W1/
M"FC>'9IIM.M76:90CRS3R3/L'10SL2%'H.*VJ* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\.NM?%[8:+>W>OP0E=?@E
MN-'MX(4CL46ZP6E.-ZX.,L2 2U>XU!]CM<RG[-#^^YD^0?/]?7\: //?#=H]
MU#\25LP/M=QJ,\4;KU)\A=O/U8_G63X8:TOH/"43^+VO+FR598-)BM(A)"\<
M+*R2;1N0 %E);&3CVKUU(TCW;$5=QR<#&3ZTQ+:WBF>:."))9/ONJ ,WU/>@
M#Q2WUY+V/P9?7/B*W?=J<4\^FV\$,4&GY6088@;E(+;?F;DYXXX]'\?ZE)IG
MA^"2-[:$37UO ]W<QB2.U5G'[T@\?+Q@G@'!KHA96H$@%M"!(V]QY8^9O4^I
MJ62..:-HY45XV&&5AD$>XH \92[T6YUOQ7!K/B:>[M)[2P,>I*L:-E)I,21^
M6H4I')MRV"!@Y.!79^"M8NKW6-6T^;5;'7([6*!DU6TC52^[?^Z?:2I9<9X[
M/T%=@+6W 4""(!4V#Y!POI]/:E@MX+6+R[>&.&/.=L:A1^0H X6[O;6P^.-L
M;RYBMQ<Z!Y$!E<+YLGVGA%SU;V'-<RJ(G[.@VJ!FY#' [_;QS7L$EO#,\;RP
MQN\9RC,H)4^H]*/(B\KRO*3R_P"YM&.N>GUH \@U#R[75/&UEJWBT:/%=7+2
M/:-;12-=020HH,>X;GZ%,+G!7U->B:IIUP?A_>:99/)+<_V6]O"[#:[OY152
M1V).*VI+:WFECEE@B>2,Y1V0$K]#VJ6@#SK1/$GAW4O#OAO1[,PW6K&T$<$,
M:*\EC(D)5F<'F+'*YZY.!UKFWU/3KKX+:9X8M9XO[?+6UFNGAAY\=PDRER4Z
MKC:S$GC'/>O9([:WBFDFC@B263[[J@#-]3WI!:VZW)N1!$)R,&4(-Q'IGK0!
MYK'KFFZ+J/Q"L[^[B@O)KCS8+=V DG#VR*OEKU;)!'&>:I^'HTDUKX6,RABF
M@3,I/8^5$,_D37J[VMO).L[P1-,HPLA0%@/0&G"&)2A6- 4&U,*/E'H/2@#A
M-*O;6T^,OB2VN;F*&>[LK+[-'(X5IMHDW; ?O8[XJ7QC=6^E^//!VIZA,EOI
MT9O(7N)6VQQRO&NS<QX&0K@9KM6MX7G2=H8VE0860J"RCV/:B:"*XB,4\22Q
MMU1U# _@: /$]8N8=7NO'.H:5<?Z''J&DSR7,*"0&.,C?(!T=5VD]P=OI6KJ
M$5M?Z=XMO8?%9\07J>')X&\BWC$:HP9E&^,8+9#?+G.#7K"0Q1@A(T4$ ':H
M' Z"FP6T%M&8[>".)"<E8T"@GZ"@#R(ZA!/=^"]1M?$UOIMD-'>S^WJ(I8X[
MC$+&)B^51BH/7!^7%$]G8_9?"LMMJ;ZM!=^+OM)N7@$:N^V3<5  !7<I((X.
M:]:^P6?V8VWV2#R"<F+RQM)^G2I?)BVHOEIMCQL&T?+CT]* ..V*?C9O*@LO
MAW /IFX-<9<1HGP-\3;4 SJMR3@=Q>  _H/RKV78GF>9M7?C;NQSCTS3?(B,
M9C\I-C')7:,$]>E 'GEO_P E\U;_ +%Y/_1HK$MXTC^ _A38H7%U8-P.YN5)
M/ZFO7_*C\TR;%\PC:6QR1Z9H\F+RUC\I/+7&%VC QTXH \9NHX5'C#2=7\7G
M2TN=2G+Z=]EBDEGCEQL:,$;WRI &W."OM6CKVHVWAR]U>ZT?Q#"UZLL0OM O
MXE)OI=B*#&#APS*%P1N4D=.*]3>VMY)TG>"-ID^Y(R LOT/:A[6WDN$N'@B:
M9!A9"@++]#U% &%X]5G^'GB154LQTRXP .3^[:N,LM9TN+7/!&LS:A:MI0TF
M6R%UYJF*"Y*Q-M9LX5BJD8..F*]5(R,&H!8V@MC;"U@\@]8O+&T_ATH X_P5
M-%J/BWQAJ]BZRZ9<W-O'!.ARDKQPA9&4]",X&1P<52CUC2='^+^OOJ=W;VGF
M:9:".:X<(G!D)7<>,G@X[[3Z5Z%'&D4:QQHJ(HPJJ, #V%1S6EM<*RS6\4H;
M&X.@;..F<T >(Z8D]NGAC5?[6.B:;<76JFVO)(4*1B64-$#Y@VJ'56P3_6O2
M? 4%HFG:E=6>LOJZW>H23271A$:-(%5&V;0%9?EZC@G-=/)!#-"898DDB(P4
M905(^E.1$B14C5411@*HP * .%\,P[OB)\0GC 6=I+- _<?Z.,?J:Y+PG#;W
M.C^%=+OO&#"ZM+N+&C):1&6*>$DLK;1O"\-ECQ@Y)YKV=8T5V=44,WWB!R?K
M3%MK=;AKA8(A.PPT@0;B/0GK0!XGJNO?;=)ANKK7H;=EUZ-YM%MX(56U2.\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWC)DE>,QA$",V0-Q)8XZ"LQ/#.L#X+6&AFR;^THI8&>#>N0%NE<\YQ]T$]:
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M'.*YB+PSJ$,?AV+5_"\FM6UOH,%I':-)&8K:[7[YD#-C!&T;@&QM.!0!T/\
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MAU::?P:?$*7JQ-93*\8\MUB6,I(68%5R@;< >I]*T_&&@:U9V6B:EX5TZ/\
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MLHKJZTQM-M5LD<I$I;>SMNY)+!>/08KNY8(9]GG1))L8.F]0=K#H1GH?>I*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2>* +%%0VEU!?6<%Y;2"2WGC66)P.&5AD'GV-34 %%5?[2LQJPTOSU^VF W
MAP<^6&V[O3J<5:H **** "BBJEIJ=E?75W;6MPLLMFXCG"@D(Y&=I/3.",CM
MGF@"W156+4]/GU&;3XKZVDOH%#2VR2J9(P<8++G('(Z^M(-3LCJS:7]H47RP
MB?R2""8\XW#U&>..E %NBBB@ HHHH **** "BBB@ HHJC8:SI^IW5[;6=TLT
MUC+Y-RB@YC?K@YH O4444 %%%% !1110 45DWOB?1=/UFVT>ZU")-1N<>5;<
MLYR< D < GC)Q6M0 4444 %%%% !1110 4444 %%5;K4K.RN;2VN)UCFO)#%
M;H0?WC!2Q _ $_A5J@ HHHH ***H:OK6FZ!8-?:K>16EL&"^9(<98] .Y/L*
M +]%5[*]M]1LH;RTD\RWF7<CX(R/H>:9<:G96EQ9V\]PJ2WKF.W7D^8P4L0,
M>P)_"@"W1110 45'<7$-I;O<7,T<,,8W/)(P55'J2>!6;IGBC0-:G:#2]:T^
M]F49,=O<H[ >N <XH UJ*** "BBB@ HHJGJ6K:=HUM]IU._MK*#./,N)5C4G
MTR3UH N452TS5]-UFV-QI>H6M["#@R6\JR 'T)!ZU=H **** "BBB@ HHJCJ
M&L6&E2V<=[<K"]Y.+>W!!/F2'HHP/YT 7J*** "B@D 9)P!0"",@Y!H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH XOXFS2MX;M-*BD:/^V=2MM-D=3@B.1_G_-5(_&D\0ZQ>
MZ+XY\$:)I[I!IU\;F.>%8UP5CB4H 2,KCVQ5GXB:;=7WAA+NPB::]TJ[AU*&
M%>LAB;<5'N5W8]ZCN](B\7:[X0\6:=?1&RT\3S!=I)E65 HQZ$8YS0!!8?\
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M5&58G ] ,5'K?B76-(ET30]:UN'3+J:&>>\U"SMO-+JC!4"*RL%+;LMD$#!
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M1MHTCB\_@&-E&[Y6(^\3D9Z5KVWA/4M1DU"X\4ZJMV]Y9O8BULD:*WAB?[V
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M%?KIVG2.Y+M#=',3[NN54R<]O+KU33[./3M-M;*)F:.WB6)6<Y8A1C)/<\4
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MDFTG4K6^CC;:[6\H?:?0XZ57\2^(;;PSHS7]Q%+.[2+#!;PC+SRN<*B^Y/\
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M)\W[4GG>?C_CT\A-F<_P_?\ ;K7,>"K8SZC\.3?1EWBT:\DB\T9(7>@C//\
ML$8KT_5/"^@ZW<QW.J:/8WD\8PDD\"NP&<XR1R/:KQL+,W<-V;6'[1 C1Q2[
M!N1#C*@]@<#CV% 'D_\ 9UFO@+XIN+:+<;Z^&=HX"QJRC\&)(]R:UM"^Q2?%
M8-=>6UV?#5J8O,P21O?>1GOT_6N]_LC3OLUY;?8;?R+UF>ZC\L;9F888L.Y(
M !S7.7'@BSU+Q?>WNIV%C=:5)I]O;0PRH&*/&\AR 1P,. "#ZT <7X>N'V:;
MIVE6^GYFUK5)M,NKQ&>&WAC8@E$5EW$[R!R,#)JI;I'J&C007,MK>1-XZ57,
M$>R&0%<G:I+?*22<9.<^]>LW?AC0K_3;?3KO1[*:RMB#! \"E(\<?*,<4Y/#
MFB1W#3QZ39)*TD<I=8%!WQ@A&Z=5!(![9H XO78TA\>>)1&BH)/"6YPHQN(D
ME )]\<5S6AKJ#:'\+Q8RV,1^S76QKZ-GB\[:-O"LOS;?,QSZU['+IMC/<RW,
MMI"\\L'V>21D!9HLD[">ZY)X]ZK3^'=%N='32)M*LY-.CQLM6A4QICI@=OPH
M \_M]!FWEH?$>BC6EUN6[M8HX&-MYWD!98BA8G."6.#D$DUUO@F^^VZ;?K)I
M]K97=O?RPW:VC;H9)A@LZG .#D=>0<BK\OA;0)M&CTB31K%M.C.Y+8P+L5O4
M#'!Y//7DU>T_3K+2K*.RT^TAM;6/[D4*!%7UX% ''3[!\<8,[ S>'7V[N[?:
M%KD +7_AG63>$_M(LV[IYOV[S_SW[_QQ[5ZS?:%I.J7MI>7VG6MS<VC;[>:6
M(,T1R#E2>G(!_"H#X5\/G6?[8.BV']H[M_VGR%W[O[V<=??K0!JH&,2B3&[:
M-WU[UXE$)#\.85@>U11XL87!N5+1*OVEMOF $?+NV9Y%>WUDIX7T&.6_D31[
M$/J (O#Y"_O\\G?QSSSS0!YKXMT^^@T+QS>:AJ>DS7<NDQ)/:Z?$T>W#-L=P
MS-R06'T45L^)=)L(8? %DEK$+<:M#F,*,-B"0C/KR.]=C:^%]!L=+GTRUT>R
MBL;C_70+"H27_>'?\:NS:?9W!MC-:Q2&U<20%D!\I@" 5]#@D?C0!Q6CZ=92
M_%'QL\EK$S&TLE.5!X=)-WY[5SZX%<5IK%M)^#I8DGSW'/LM>UQV-K%=W%W'
M;Q)<7 59I54!I N=H8]\9./K59- TB-+%$TRT5+ DV@$2X@)_N?W?PH \^L[
M&UD\.?$^:2WC>22]O49F4$E5@4@?@23]34=E>SW2VZ6O]D6CV7ANT:]OM1@>
M=I(I%8[%4.HVC:23GDD#%>EKIE@D-W"MG (KQF>Y0(,3,PPQ8=R0 #FJD_AC
M0KFYLKF?1[*2:R54MG:!28E7[H7C@#MZ4 >9>&71KWX3M*RG.DWBY;VCCP/P
MQ45CIVJZCX6U&*?5=!L8CKDS32W$#_:8[D71*?/O W'"!>/ND"O3I?!_AN:U
MBM9-"T]H(96GCC-NNU'/5@,<$U+)X8T*;65UB32+)]24@BZ:!3)D=#G'4>O6
M@#5KP/2=H^#MDSXVKXGC))Z ?:17OE99\.:(=(ETDZ59_P!G2L6>U\E?+9B<
MY*XQG/.?6@#B_$\#V-_XBU?39M(U&U%I&-8TF^&&V(A(V./NY0]&!&>]>@V,
MT=QI]M/$C)')$KJC#!4$ @&LF;P5X8N&M6FT#39#:((X-UNIV*.BCCH/2MV@
M#QK3[$1?!_QK=V4(%[+=:CNE5?G*B1@0#UQMSQ[GUKHM*TZ];Q-H5[<ZKX?"
MPV$RVUOIL#QO/;LJ_P!YVRBD(17=6FGV=C \%I:PP1.[2.D:!0S,<L2/4GK5
M/2_#.AZ)---I>D65G+,,2/!"J%AUQP.GMTH \E\!W,G_  K7P/IUM;64E]=7
M]TUO/?*S16[(TS%]JD%FQD 9'7VJ+492_@GQGY]U:7#)XDM2\MM$8XB=UMN*
MJ6; SGN<G)KUR7PIX?GT>+2)-&L6TZ)_,CMC OEHV2<@8X.2?S-.;POH#QW,
M9T:P\NZB2&=?LZXD1.$4C'(&!CTP/2@#C]6Q_P +V\.^7MQ_9%QC'3J:YP"U
M_P"&=9=X3^TBS;NGF_;O/_/?O_''M7J]IX?T>QDM9+33+2&2TB,-NR1 &)"<
ME5/8$U$?"OA\ZS_:YT6P_M'=O^T^0N_=_>SCK[]: .<T"S@G^)_B^:Y@CDF6
MUL8\LH. T;[@/8X&?H*YCPA87,_AGPM=Z-J.G1ZS:V%S&MEJ"%HYK=IN<$'*
MD%%&1GT(KUJ*RM8;N>[BMXDN+@*)I54!I-H(7<>^,G'UK,N_"/AV_L;>RNM$
ML);6V),$30+MCR<G;QQGOCK0!PGAZ2PUKQGX2NX],AM(X]'O&CMDPR0NLR(2
MAZ$9W8/H:YWQ>BQ?#;Q_'&H5%\3C:H& ,_9R?U)/XU[9#I6GV\UO-#96\4EO
M"8(62,*8XSC*+CHO X'H*AGT#2+JUN;6XTRTE@NIO/N(WB4K+)Q\[#N?E7GV
M% ')6ZV+?&[4OM B-R-#@\D/C.WS'WXS_P !JS\+PH\,WHM\?8?[6O?L6W[O
MD^<VW;[9S4]WX+MM6\9:CJ.KV-G>Z=/96\,4<R[V61&D)."..''(/K746MK;
MV-K%:VD$<%O$H6.*)0JH!V '2@#SKQ1=S7.L>*TM%TBRCLM.CBO;F]@:>6X5
MT=E10'4*O)'?+'IQ5#3K:Z;1-,U?2;W2KJ['AJSBU'3=2!Q) $9@P<<IG+@Y
M!4XYZ5Z1=>'M&OM5AU2ZTNSGOX !'<20JSJ!TP3Z9./2J4W@?PK/#;PR^'=,
M>*VSY*&V7" G<0!CIDDXZ4 7?#MW;W_AG2KRTMS;6T]I%)% ?^6:% 0OX#BN
M#M0="N].*/I6M>'KO66^S2!=MU:W$LC\YY#[6+ GA@/7%>FJJH@1%"JHP !@
M 5DP^%M @UEM8AT:Q346)8W*P*'R>ISCJ>YZT >77=W;P? +78I9D607MW#L
M)^;>;MB%QZX.?IS74:=_9Q\<>.AK7D;?(MO]?C'V3R><9_AW;\X[UTLO@_PU
M/?7-[+H6G/=7((FE:W4M(#USQW[^M3:KX9T+7)H9M5TBRO9(>(WGA5RH],D=
M/;I0!QOA^WTBX^)D%QIL0>QB\+VWV)G5LK$99,8W_,/E Z\XK4^&2K'X9O(4
M 6.+5KY$0<!5$[X ]!75I86D=Z;Q+:);DQ"$RA &\L$D+GT!)./>EM+*UL8F
MCM+>*!'D:1EC4*"['+-QW)))H \O\<S2Z'XEU>WMB4D\5:9%:P'UN5E$''OY
M<ZG_ (!56WM(XO$=I\/HEQ;6FNG4@G86BQB=1]/.<+^%>K7>F6%_<6L]W9P3
MS6K^9;O)&&,3>JD]#]*!IE@NJ-J@LX!?M%Y)N1&/,,><[=W7&><4 >,S@'P[
M\8,C.+N0_P#CM=<UO:W7Q#\&LT<<BQ:/<RQ\ @-^Y&1^!-=JFBZ6BWRKI]J%
MOR3=CRAB<D8._P#O9''-1:=X=T72?(_L_2[2U\A76(Q1!2@<@L!Z9(&?I0!S
M_@1%BU7QE%&H6,:XY"J, $PQ$_F>:[.H+>RM;22>2WMXHGN)/-F9% ,CX W-
MZG  S[5/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% &9KNNVV@64=Q<17$SS3+!!!;Q[Y)9&SA5' Z
M GD@8!K(;Q_H\.BSZG=Q7EHMM=I9W,$\.)8)&*XW*">,.IR">#QFHO'NH7-C
M!I*_;;JPTR>\\N_O+5,R11[&*C(!VAG"@MCC/O7GS)OBURVB34I?.UW3+J%K
MU':66#=$OF$L.GRGKR!U H ]#_X6#IZ'44N=,U:TGLK,WQ@N+8*\L .&=!NY
MQW!P?:M/4?%&FZ=H=IJ[-)-;WCPI;+"NYYFE("!1D=<Y^@-9%Y;&;XM6+/"7
MMVT*XC<E<J<S1?*>W(SQ7*>$]/O)O%UMX3NHW:P\(3S7"2/R)1)_QZ_BJ/)_
MWR* /7*XJ7XG:+##+<M::F;&WNFM;J\%N/)MG#[/G;=TS@\ \$9QFNUKQ^[L
MYS\%?%<'V:0RR:E=L(]AW,#=9!QWXH [S3?&MAJ.L_V8UIJ%E*]NUS ]Y!Y:
M3Q*0"R'.>,@X8 X/2F:7XZTW5;ZTMX[34((;[=]AN[B#9#=;03\ASGE02-P&
M0.,UE>+]/N-0\<:/! K#S=)U*$28^5698PN3VKGO"-II=U)X:L9]0\33ZI8%
M'DL)1B&RDCC*DOE  O51@DG<,9H Z=OBCH:6PO6M-3&G+<&VGOC;CR;>0.4P
MYSGKCD ]1G%6D\:6VH27^FI9ZE87R6,EW!]L@\OS8QQO3D]"1P<'GI7%R6<Y
M^!-_;_9I#*VI.?+V'<1_:&<X^G/TKI/$L$K_ !"M9%B=D&@7RE@I(R6CP,^M
M $'A'XA6\WA[PVFI0:F7O88;<ZG+!^XEN2HRN[.<ELC.,9[UMW7CS2[34)X&
MMK][6VN%M;C4$@S;0RD@;6;.>"P!(! )Y(K@;;4(]5^'7A+PK;VUTFL^;8F2
MW:W=3"D;*[2DD8"[5SG/\6.N:8VEZ?$VMZ%K>H^)5NKK4YRFFV7W+J*64LKI
ME-N,-\Q+<%3G% 'HC^-M/_X2B;P]#9ZA<W\$L<<_D0;DB5U#"1FSPH##)Z]<
M X-=(2 "20 .I-<7X7MWB^)'CF5HG"R/8A'9>' @['O@UU>I6SWFEW=K&VUY
MH'C5O0E2 ?UH YNV^(NDW,MLXL]2CTZZG%O;ZG);XMI7)VK@YW $\ E0#ZUS
M5SXDU74_C#_8_P#Q/;;3K*"-Q!:1QJ)'\W!DD)R3$1Z<X["J#7ZZI\,](\$V
M]K=)X@0V=K-:M;N#;F&1"\C-C 7"$@YYR,5TEC!,/CIJLYB<0G1(E$FT[2?,
MZ9]: .XNIS:VDTXAEF,:%_*B&7? Z*.,DUY<?B)?:GX0\.ZY)!=6 EUJ**<I
M$=L\1:3Y4 )+<*H([GI7JYZ5XIX>D$W@/P9I8BG^VZ9X@@6\A>%U,)\R8C.1
MCWR* /1K+QQIEPVII>6][I<NFP"YN([^((WDG/[P;201\I'KGC%2Z-XOM-8U
M!;%K'4;"YDA-Q E] (_/C! +)@GIN7(.",CBN-\=:/?:OXD\26UE!*\DOAB-
M8]H^^RW#ML!Z9(&,>]7/"R:-J?BBRO+/5?$FIW-I;R-NOAB*VW[5*/E%^<^@
MS]TYH [S4]0ATG2KS4;DGR+2!YY,==JJ6/Z"N*TJT\;^(](@UJ3Q.ND/>1B>
M"P@L(I8XD894.SC<QP1G!7VKKM?TO^V_#FIZ5OV?;+66W#_W2RE<_K7GT/B?
M26\)VGA[Q6=8TC5+)$AEBM8YU>5D&T-')$/F5L9X- '5R^)IO#7A6SU#Q>D4
M-TTR6TQL\O'N9MJN,\@$8)'./>DE\<6D-K8LVDZO]MOF<6^G&V N65/O.5+8
M5>1R2.H[UP<NG:G_ ,(#9K=P:FR2^)X)K:*_9I)UM?.79OR21P.0>E=9XAN$
MT'XBZ7X@OUD&EOITUB\ZQLZP2&1'4M@' 8*1GU% &E%XZTF72Q>E+N(B_CTZ
M6WEBVRPSNP4*ZYX^\#D$C!XS5Z_\26.G:I)ITXF,\=A)J!VJ"/*0@-SGKDCB
MO--2BN+VQ\0^*(+2Y.G3:[87<2^2P=X(/+5Y0F-V#@GIT&:OZEJT&O>+[^_T
M])Y+!?"UW$MTT+(COO0D+N S@8YZ=?0T =+8?$72;^;3=MGJ<-IJ;+':7TUO
MM@DD89";LYR<$#C!(X)KKZ\>M=5@UWP9X&\/6,-Q_:<4^GRS1&!QY$405FE+
M$8VD#@YYW"O8: . T^[\2^-KF_OM-US^Q-'M[F2UM1#:QS27!C.UI&,@("[@
M0 !VYK5M=9U/PWH-[<>,)89?LLPC@NK6/YKQ6P$_=#.'+';M'&?:N>\.Z[;?
M#Y;[P]XACN;6".\FFL+Q;:26*XAD<N!N0'#@L00?:E\0:EJ?B/P]!K*Z)=PV
M&FZU:WD,;H?/N;>-AOD\K&1U) ZD#.!0!TUCXTLKJXNK6YL-1TZ\M[4W9MKV
M$*\D(ZLF&(.#QC.1D5FI\4-%:.PG:SU6.RU  6MVUK^[FD*[A$N"6+G! &,$
MC )K)U*^A\6>*1J&C"6:QT[1;Q)KGR717DE"A8QN R0%)..G%1?9)O\ A!OA
M?']GDW17U@TB[#E,6[Y)';F@#I5^(.EKIVM7=U9ZC9R:.BR7=K<0A90C#*LH
M#$$'![]JFT_QOI]_K-MIIL]1M6O$9[*>YM]D5T%&3L.<_=YPP!Q7#^.XI%E^
M(TIC<1OHEH%<KP2#+G!K5O-6B\3>)/"=MI-O.;C399+J\1X'C%J!"R!&) &2
MS 8'IGI0!T%CX\TR_P!1MK9+348[>[F>"TOI8 MO<2+NRJMG/.UL9 !QQ56Y
M^)FD6\=Y.+#59K6QN)+:]N8K8-';,C[26.[IW^7)P02!FN#AU)[U?"^IWU_K
M=WJ$&IQ3:M'+&ZV]BQ#J5V!0 0S #&3@$GK6Y]EG_P"%4^/(A!)YLM[JA1-A
MR^7;! [YH ZU]6LO^%C0:=_:&H?:7TLW"VJE?LK1^9C>>^_/'7&*;IWCO3-2
MOK6".UOXK:]=H[.^F@VP7+ $X1LYY"DC(&<<9KE9+"YN?BS8JL<B*_A(P^:5
M.U7,AXSZUG^$K'398O#6EWE_XFFU:P>(RZ:W^IM)(5.6;* "/(P,,<AAC- '
M>:9XWL-4U"WMX;+4DM[IWCM;V6WQ!.R@DA6SD<*Q&X#..*Z4D*"20 .237EN
M@7T-GXDTRU\,W>K)!<7#C4-"O8&*6*;79F#$?N\/@8#%3NXKTG4K=[O2[NVC
M;;)-"\:GT)4@4 >?>(?B$E[HUG-I$.J6L5SJ5M%;W[P;8KE3,H<(<DX*[OO
M9&<5VD'B.QN8]9D038TB5XKG*CEE0.=O//##TKRR368;GX<>&O#T5G=G5;"Z
ML(KVW-LX-MY4J!F8D8P2!C!YW9['&NVK1:)=>/-)NH+HZA?W$D]E#';NWVA7
MMT4%6 Q@%2"2>,<T =-=?$/2;8:8J6NHW,^IV0OK2WMH \DB';\N,_>PV3V
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M+ZS"T#K,Z:D=A0AF)>7''N,5F:%OT+3OAYKFH03II]MIDUI<N(F;[,[A"K,
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M!:N#GTYK"TS2M/CM?^$<UC4O$QU$:BZG2[;_ %3@W!=)5RF/+P0Y8MQ@]^*
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MA,(&8J'"PY89'?&<>]=EJ7B]$LO#LNE0I=R:[<1);JS8Q$R[WD./[JC./7%
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MG,4^^,H(V<2H<9P=N,, 1S[935_'":+?^(8[FUW0:18P72E&^:9I2ZA,=N5
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MS*'^RR1^65+D[#(/O=0.V:[+4-8L-+FLXKV?RGO9A;VXV,V^0]!P#CZGBKU
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MPP9<\_+G<!WK*M]*\5W>A>$=&G\/_95T2]LVN;A[J)A*D/R[HP&SC'S'.#V
M/;U)F5%+.P50,DDX JJVIV::M'I;3@7LD+7"18.3&I"EL].K#\Z ."U70]4U
M/Q)!<)X7CL]4@OT==>MKA$1K99 2'4-O8F,%"I!&3UQ5_P ->%KN#6O&_P#:
MUJ!8:S=9B^=6\V(H5;@'(Z]ZZO5]8L-"T]K[4I_(ME95+[&;!)P.%!/4U>H
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MH I^"='FT;PK:Q7G_(0N"UW>MW,\I+O^1./H!70TBLKC*L&'3(.:6@ HHHH
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MN#Q,[S6-S&L>F6M@9;<1Y3<LTOEG:YRQ^^,<5ZC%$D$*0Q*%CC4*JCL!P!7
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M#*<<]ZGUKX=3:KX;U_2EU*.-M4U8:BLAB)$8_=_(1GD_)U]ZTO$?A_Q#J_\
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M9GBWF0!G7+DG[W.-F*?8:)+<_$;PHWB*V)U<:&TMU^^)S/&\8#95L'UXX.:
M/6ZIZMJ":1HU]J4B-)':6\EPR+U8(I8@?E7D.@0:_J]EIWB"S\/W[:O-?BXE
MU1M1C"/%YQ#QF,R9"!,J%V\$ ]:LW.E6VN^#_'?B"_EG.IPSZA%#-Y[#R(X0
MRK& #C:0.1CG<<T >L:?>+J.FVMZBE$N(4F56Z@, <'\ZLUE>&?^14T?_KQ@
M_P#0!4?BYF3P7KK(Q5ETZX((."#Y;4 ;-%>.S:>VE_#[PS):1WM[>>(9K%-1
M*W922Y3RFD\L,S (.-O!''%%[%KFB:3J=K'IMYH6CZC=V%O"C7J2M 9)=DY0
MJ[% 5V^F"210![%17GGB/PU8>&?"OBB;2+N>V271ILV(G9E#JK8F7<2P;L2.
M#QWK.ETJ'1M!\&74$MPUYJ.KV$E[/),[&9C&Y.<G '/08&,>E 'J%Q(\5M+)
M'$TKHA98U(!<@< 9XYK/AUN)+/39-2A?3KF_D$,=K,0SB0AFVDKD9PI.<XKD
M=<N)5\<^(XUE<*GA7>%#'"MYDO./7I7'VFF6FL>&_A8^H(\[SS-%(S2L"R^7
M(<9!]1UZT >R07MS+J]W9R:=-%;PJC1W;,I28D<A0#D8]Q5ZO)+J>:/QG\38
M5FD$<.AQ&)=YPA\AN1Z&GQZ3#HUOX UJVFN3J=]=6\%W</.[&=)('+*P)QC(
M&!CC Q0!ZLD:1[MB*NX[FP,9/J:=7BEYIT>I_"[Q+XMGN[J/6WDO"+A;AP8T
M25HQ"!G&W:N,8[YZX->Q:>2=-M23D^2G\A0!9H)P,GI7+?$:_N].\!ZC/8M(
MEPQBA5HF"NHDE1"5)Z'#'!['FN=T7PW=?VS<6S^&;S2_#]S8LEU!-J*RAYU=
M2CC9(6!QN!/&>,T :^F?$:SU'PSJ'B4Z7?0:):QO)%=2&,FX"L5.U V1R,?-
MBM_P[K$^NZ3'J$^EW&G"7#11SNC,Z$ AOE)QG/0\\5XCI/AS2I/V:I]5:V)O
M3;S2>9YK_>69U!VYQT]JZVWT6Q>_\'>&PDL>DW=A+J%U L[@7,JI$H#'.<#<
M3MSCIQ0!ZM5.>^L=,DLK661(&NY?(MXPOWWVL^!@<<*Q_"O(/$S3Z-H'CW1-
M.N9XK.PN--ELP9&8VYED0LJDG.W(SCI\QK4\3^"M#LO$W@RR2WF>.XOYQ.TM
MS(S2GR6)));.20#QB@#U>BO+;S3QHWBN:^\06&I!)=21[/7;.Z++"C,H2&1,
M_(G\!^4@[NQYKU*@ HKC?'SR7$WAS1S-+%9ZGJ:PW9B<H7C6-W\O<.0&*@''
M;-<QKULGAJ^\6:-I+2P:=-X5GOO($K,L,RETW)D_+D'MW7- 'K-%<OX#T6VT
MSPU9WB--+>ZA:P37<\LK.9'V9Z$X4#<0 ,<8KJ* &O&DB@.BL 0<,,\CH:=7
MC-UIL>J_#[Q?XIN+NZCUE9K\1W"W#J88XV9%A SC:57&,?Q9ZXJ:9+K7_$%S
M:7&A7^LV]CIEFD"V]^EN(&DC+-)\SKER< -SC90![!17E-AI6H:OXLT'2_%+
M3F5/#C->VXGXFD695!<H<-USUZUE>?>1:?%X;MX+R^L/^$HN[,6D=UL=[>.-
MI%A\QV'RY]3R%Q0![717C.OVNMZ1\/?%"?8+K1K$W5E)IT,EVDS0DRQB0*59
ML+D X)_B-=#K^A:/IATCP_:V&IZE)<2S79L4O2JW!"JKRSN[9P"5( ."QZ4
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M]"I'X5:KS[X-:;:6?P]L[J"(K-<O-YS%V.[;-(%X)P./2O0: "BBB@ HHHH
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MU8H<X8# /!KU/^V]+&G3Z@=0MOL=NS+-/Y@V1E3A@Q[$'@TMSJ]C;VMO,UY
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M>9T964EL8XV*,   =!5[Q#X8M/$@LFGN+NUGLIO/M[BTEV2(V"IY((P0?2N
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M:!UCN+*41OL?&Y#D$$':OOQQBDBUDQZ[K,5WJ>E_8[&&.4Q(Q$]NI7<S3$G
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M;;N0-]H.[> 1G]UU&?NU:\3V&LFVU^]EUG1Y]0'AV:(6NF6SQN\)8$.<R-D
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M2GQ:;8P7MS>PV<$=U=!1<3+& \NT87<>IP.!F@#D;Z?PH^GZ:+<V[7QTJ?\
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M=N\-P#P#7':W8:??>!_%]YH\FNZE+-;06YNKX,PG"ON"Q@J&.W<<G&.>,\T
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MQ'/[P'?MV\8Y8') QFN5GTZTETS3KS2EUFZ2X\4V,LEQJ"DM,$*KYJ@@'9@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
MK7="BUV.P269XA9WT-ZNT [FC;<%/L:U:* "BBB@"GJMI=7NGR6]EJ$FGSMC
M;<1QJ[+SS@,".1Q4&@:':>'=(BTZS,CHA9WEE;=)*[$EG<]V)))K3HH ****
M "BBB@ HHHH **** "BBB@ HHHH 0@,I!Z'C@XKD+?P(RW5B+[Q#J>H:?87
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2" <=00 >BKH6D+JIU5=*LAJ)ZW8MU\T]OOXSTJU%:V\$\T\5O%'-.0TTB(
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M;68E9%4%@<D'(XKJK37I=1\6OI]D(9-.@L$N)Y\$L9)3^[53G&-BLQX/5>E
M&_17$75A!XG^(6HZ?JGFRV.FZ?;M#;"5D4R2M)ND.TC) 10/3G'6N4BO9[RW
M\.V.H?;=8@M[S4;26QA<F:Y6*0I'*W(#*@&#N8<L#R: /8J*\<6YD/AB& R7
MKVW_  DC1'1!(_VKR-I(MCSU'$F-VW;QNQ3C>30PZSIEDU[I-K>:OI]DEA+(
M1/:1RL%D=3DA1(,@;6(X/0\  ]AHK@X=(L])\=+H%JDJZ3JFDS23VOG.5#QR
M(N\$G*DK(0<$9P*CT7P]IC^/YY]+BE@L]$7R7(N)'$]S(N2IW,1A$8?\"?\
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M-1N)[M=575;BYE5=T\H0IC  "KC  '3%2ZKX)M=7FUR6:[FC;5([908P,P/
MS,CJ3U.Y@<'TKJ** .,G\$RW=W=ZCK&IS:I--I4^FM!'"D*M&Y4_+SPV5/)/
M?L!7/Z-8:IJGB;PN\YUB:'2DF,QU"Q%LL2M"8PN<8E<EAEE)&%/3//J=% '+
M:3X3OM'6TLK;Q!<#1[.3=#:"% ^P$D1M)U*#IT!P ,TC^!K&76]=U"2>1TU:
MV:W>W*C;%O15D9?=A&F?]VNJHH XV/P']FTK1X;35I4U#3+F6Z2]EA63S9)=
M_F%TR,YWGH1CBHI_AZ]Q%K2R:[<.^JF":61X5)2>)E*N,8&WY -N.@ZUV]%
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M]\9W-QVP.3Q7044 <]!X:N+#PQI6D:;K$]K+IL<:)<"-6$H5=N'0\$'KC(Y
MYK//@%)HKV>YU25M5N;N&]%Y#"L8BEB&$*IR,8R#DG.3STQV-% '/"&[T:RO
MK[6;^[U@2(J?9K:R^4+R,)$F22=W))/ [ 53^'7AV7P[X62.Z21+NY?S9$E;
M<\:@!8HR>^R-47Z@UUM% '/ZMX;N+K65UC2M5?3;YK?[-,WD+*DL88LN5/\
M$I+8/N<@U13P+'81:5)H^I36=[IT<L0N)(Q-YZRL'D\Q3C)+C=D$8/M7744
M<</ 2K&MTNK3C6EOVU#^T/*7F4Q^65\OILV?+C.>^<T]O L=Y#JDFIZG-<ZC
MJ!@)NXHUB\@PG=%Y:\XVL2>2<YYXKKJ* ,#2/#D]GK$NL:GJ;ZCJ#0"VCD\E
M8DBBW;B%4=R<$DGL.F*M:%HB:';WD:SM,UU>37CNPP=TC%L?@,#Z"M6B@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>exhibit1012-stuartexecut012.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .1\<V=X7T'5[2TFO/[*U%;B:W@7=(T11D8JO\1&X''?!KG-8M[[Q
M/=^)]:M-+OX;4>&YM-MDN;9HI;F5RSG;&PW8&%'(&2>*]1HH R_#4,EMX5TB
M":-HY8K*%'1A@J0@!!'8BM2BB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?ZTC"!0VX$./NC@\U?CTS5(/B3XLU-M':\MY](ACB1OEBNG ^:,,01STY]:
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M:W5,L^T*6C<C=&6"@$CTR,&C6/!MUJTE]!_PD5]%I6H8%U8E$DR-H5E1V!9
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M=7^+OB==3M+>[,=A9^7#<('7!$@9MIXSP!GW/K0!W[W-O$J-)/$@<$J6<#<
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MY /0(^YOH: /1/$6O+HWA/4=<MUCNUM+9YU57^63:.FX9J]9ZE:WN$CN(&N
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MFA$@+J/4KUKSS6-%T71O'_@3^R;.VM9&>Z15@4*)$6W;!./O8SP3_>/K7/\
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M:H)X;J%9K>6.6)QE7C8,I^A%25P_@:"&P\4>,].L8UBTV"_A:&*,82-W@1I
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MCEN)9Y+R/SH([.WDN&:+C]YB-2=O(YZ53\"Z]/XAT_5+N6Y6XBCU6YAMI%4
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MQ%[.5!<1K]YHB5_>8X^[F@"YHOA?1_#\DTNG6K)+,H5Y99GF<J.B[G8D*,]
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MM!"D5E,[SE0&9D0+ED (.X#;[T 3ZCX*\/:MJ3:A>Z>)+A]OFXE=4FV_=\Q
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M  SN$+*V3RIP1W&*L^ /'DE]X5E\0>)-7F8R%?\ 1QIK1QQ$NRJD3!<S$X'
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M8.W89!M4R$-@D=,XZU5M+FWNK.6W:^>]D/C>TE+7"JLDL;K%LD**  K8)!P
M17MTEO#+$(I(8WC&,(R@@8Z<4IAB+ES&FXX).T9XZ4 <#K?_ "4C4SZ^%)/_
M $<U<5H8EM_"7PVOSK!T>TC@O(7OS&CI%(Y&P-O!49".,GUQWKW0HI;<5!8C
M&<=O2FM!"\)A:)#$1@H5&W'TH \ICM] 6P%^WC.YCN+C6))K;6S!''"MP(1&
MPSM\MD901GHQ!P<UTWA3Q7&^C+)JU[:2-+JK:=:WMK"5COW_ (74#(&<,"<X
MRIYKL&MX7@\AH8VAQCRRH*X],57O-+MKV.UCD4K';3I.B)@#<GW<^P.#^ H
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M[F1(8+>+&^:5V"H@SQR37/\ @F*]TS7_ !3IUYIMY$+G5IK^&Z,?[B2-UC
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M,8,NT;NG'7/2N,O]-O6^(.O0O87C6>N:3':17D4>Z*)@) V\Y^7[PH N6WQ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPP)(SR.,UZ!10!P5MX>\42ZUH6I74>CV\6G126IL[:5RHC=5!D5B@YRHPF
M/XN:<G@K45^&NB^'#/:_;+&:U>1]S>61%*KM@XST''%=W10!PLOA[Q7I5YK4
M'AVYTU++5KEKH7%RS>;9R.H$A5 I63IN )')YR*=-X<\1:9JFJ2Z)_95S%J9
M25Y=0+*]O,(UC9PJJ0X(56VY7G/:NXHH 9"C1P1H[!F50"P7:"<=<=J?110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M68Q-]U\ _=.1@]* +M%07-Y;68B-U<10B6188_,<+O=ONJ,]2>PJ>@ HHHH
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MB*$SR"&$2.%\QR"0JYZG )Q[&IZ "BBB@ HHHH **** "BBB@ HHI"0H))
MY)- "T51TW6=+UA96TS4K2]6%MLAMIED"'T.TG!J]0 4444 %%%% !1110 4
M444 %%5FU&R348].>[@6]DC,J6YD'F,@X+!>I'O5F@ HHHH **** "BBB@ H
MHHH **K7^HV6EVWVG4+N"U@W!?,GD"+DG &3W-6: "BH+.\MM0M([NSN(KBV
ME&Z.6)PRL/4$<&IZ "BBB@ HHHH **** "BBB@ HJ"ZO+:QA$UW<101%U0/*
MX4%F.%&3W)( ^M3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %><:'JT<,7C;QS>H9GMKB>V@7/W;>V& B^FY]Q/
MN17H]>=:#I44J^-? ]\QB-S<3W4)'5K:Y'#+Z[7W ^X% &OH;^,7N-/N-4DT
MZ[T^^A+W$4,)B:S8KN4 ECYBG[IX![U7\ L=.U#Q+X8!)M])O@UJ/^><$R"1
M4'LI+ >V*GT2R\8PW&G0ZM=:;!IVGPE)6M69WO2%VJ6#*/+ ^\<$\]\5!X!4
MZC?^)/$X!%OJU\!:G^_!"@C5Q[,0Q'MB@#MJ*** "BBB@ HHHH **** "BBB
M@#@-<LH?%'Q1M=!U1?.TFPTO^T#:-]R>9I2BEQ_$%"G /<UM0>"]"TC78M=T
MRW&EO%$Z3Q62K%%<(1QYB 8.WJ",&L7Q@]G;>)K76=+\2Z)8:_91&VFM=1NE
M1+B!L-L?!W*0<,#CO5?3_$3:EK,-[K_B[PW9V5NCJNG:=J:N)V88W2NVW( Z
M*!UYSQ0!#_PEWB>/PA%XYEFL/[)=UE;2Q;GS%MFD"AO-W<O@AONX[5H3ZOXJ
MU37O%%CI=YI]E!H[Q^5)-;&5IBT"R;#\P &2<MSU'''/+A8G\+Q>"I?%/A4Z
M%'(J&^&IK]H>V5]PC\O&T-@!=V[&.<5TVFZGH-GK7BF\D\4:"8]6EC> +J$>
M5"P+&=W/'*GIGB@#E/%-YJGBH_#?4Q<VD$>H3QR+;R6AE6*;9DL<N-Z^B\?6
MNG3Q-<:3XWUNQO(;.6'2M 2]DGAM_+DD9?O#.3A>#A><>IK$BMM*33/ =L?%
M?AS?X?E5[H_VBF' 3;\GKSZXJ[<+X?O?'&O:I<>*M!&G:IH_]G;5U"/S%)ZD
MC.,8/K0!6U:X\37FF>#-3U>ZL9K>_P!9L)S;P6YC:U+'<H#%CO&#@Y .<4^_
M^)TMO+J.IKKNB16UC?-;C1I"/M,\2/L=]V_(8_,RC;C 'K5-;FXO+'PWIM_X
MI\(1VNAWMK,9H=3#/=)"< D$ (=O.,G)[@5>MK^#2;J[L=-\0^#VTVYOGNDN
M[B^0S0)(^^1/+Z.<EL'<.#STH U9]:\5ZGJGBFWTR\T^S@T:51$\ML96FS"L
MFP_,-HR3\W)Y'''.6-8USQ!XN\"WMMJ$%G#J&ERW;6YMBX4[8RX/SC=G. ?X
M>>N:T]/U'0;2^\53OXHT$KJTPD@"ZA'E0(%C^;GCE3TSQ6#;&UTH^"[FR\3>
M%I[C1;%[*ZCFU145@ZH"R, 2<;3P0,T ;ND>)=1G?QU]G@TN*?3+TQ6[RCR8
MS\OWIFSSCJ3QTJK9>+)M3C\1Z-)K>FZW''H[W27EC'Y84D,K1L S _PD'/>L
M>:QTN2R\81CQ7X:+ZOJ45]:H^H(4*HZOLE] VW!QGK5MK]+W7+K4[SQ'X3B6
M]TF73FMX=44BVZE"&P-^23GA<#&,XY *NBZW/HWPX^&J006LHO=1@M7,\6\H
MK,V63T;T-:,4WBW_ (3/QZVG:G:RS644#6]M):$AR8F>- =_RXS@G!W'GCI6
M8MAI@\*^!]+_ .$L\-^?H.HPW5TW]HIM=$+$A/4\]\5O:?JVG:;\0]9U6/Q)
MX:ETK5D@,A;4T6:%HHR@ 7D,"<=QCF@#0N?&LVH:'X6GT01&\U^>-55UW"*,
M M.<9&2H4CZXKMZ\<\%7?AVT\=Z[=/XBTP:58320Z2DEU&H4SE9)RF3R V%!
M'!YKU73_ .U//OO[1-IY7GG['Y&[=Y6!C?G^+.[IQC% ')^,["YT#58O'.D1
M-)+:Q^7JMJG_ "]6HY+8_OIU'L"/:HO"T$GC+7_^$WOXV6PB5H=#MY!C;&>&
MN".S/V]%KL=:LI-1T'4;&$JLMS;20H7. "RD#/MS53PGI,^A>$=)TFZ:-Y[.
MUCAD:,DJ648.,@''X4 <6?%WB>7PA/XY@FL/[*C=Y4TPVY+O;*Y4L9=W#D M
M]W'05U6B:]<:GXH\16#>6;6P^S&W*KAB)(MYR>_-<R?!?B1/"\W@N&33AH4D
MC(M\97^T);LY8Q^7MVEL$J&W8QSBM230?$.F>*M5O=$_LUK/58H$=KF1U>U:
M-"FY5"D.,8."5Y'6@#5\$:S=>(?!>E:M>B,7-U#OD$:X7.2.!^%<K%XVU&V\
M3Z?:W>N:'=->:@;.72;/YI;53NV-Y@<[B-J[@5'WCTQ75^#=#N/#O@O3=&NY
M8VGM8?+=X22I.3R"0#W]*Y"T\&>*[71=#TQ1HRQ:'>1W$>V5P;TJ2"SG9^[.
MUB>-V6[CN :-AK7B[78IM<TAM/;3H[Y[>'3I(B))XHY#&[F8MA6X8@;<< <U
MA6'B8Z/XH\7:9IT<=UKVHZQY=C:NV!Q A:1SV11R>YQ@5NVOAWQ;H\=QHNCW
M>G0:3+>O<Q7S,QN+>-Y/,>,1E2K')8!B>AZ5%/\ #;[;<^)+R:2"#4+V_2\T
MV^A&9;9D0!<D@<;@V5Y!!- %N]U/Q./%=AX:M;VQ6672FNKB]>V+!'615)5-
MPR#G !/&<Y.,'.A\::ZVDQZ=BR?79-<DT9;GRF$.$!8S%-V?N#[N>O?%;VG:
M)K+>++#7M4:R66/1WLKA+=V8&8RH^Y<J/EPIZ\C..>M9,G@?5$BN;JUN+1=1
MB\02:Q9;RWELC+M,<A R,J6Y ...M %76O%?B?PT=8T^XEL]0N[/3TU6"X2V
M,8D@64+,C)N.& Y!![UHZEXTNH/'FE:=:+!)H\JPK=S8)99)Q)Y.#G &8QG_
M 'Q5K3_#FHZCKVH:UXCCLXWN+#^S8K.TE:54A+%G+.RKEF)'0  #O6%I7P\U
MFT\#ZC875[:2ZW)-;R6MR"VQ1;",0 G&1_J\G _B- &+X]UJ\US0+J601BQM
MO%-O9VFU>6$?#L3GGY]P'TK<\1>/+BVUW6K2UU_0]+_LA5"6VH8+WLA02$#+
MJ57!500"<Y],5+J/P_U"X^'FB:!!<6IO;2\AO+J61F".X<O*00,G+,<9 _"M
M"^\/Z_8Z]JU[H4&DW$6J[)&-\S*UK,J!"P 5MZD*IQE>1UYH KVGB?6O%FL)
M;^'[FTT^UATVVOII+FW,[.\X+)'@,N %4Y/6N?\ "NMZQ#X>T71M.^S6NIZO
MJVH^9-,AE2W2.5WD(7(W') &2.M=3/H/B+2O%$NL:)_9MU]NLH;:\CNG>$+)
M%NVR+M5LC#'*\=N:YT^&[_PGIWAN:;5=,_MFTU.[,)NG>."Z%P7+(6"G8Q&"
M.",C'- %JY\=:YH8\5PZM_9\DVD+91VLP4Q12M.642/ECM4?*2,\;6YZ5I>$
M_%SW_B>;0Y=>TG7 ;/[7'=:> NPAPKQNH=A_$I!R._I7/:?HU]XJU?QW%->V
MC7<C:>8YK<%[>*>'=((P>K!?D#'K\QX'2N[T&WU_[;-<:O;:39P^4$C@L6:0
MLV<LY<JN!T 7!^M '/ZXVM/\7M!MK75(8+4V-Q*(FMB_ :,.#\XR3Q@X^7G@
MYKG--U/Q+H?@K7==T^YL4LM.U2]E-I+ 7:Y47#%\ON&SJ0, ].O/';Z[H>L2
M^-=%U_2A92K:P2VUQ%<RM&=CE3N4JK9(VG@XJB_@O46^'6O^'A-:_:]0FNY(
MGW-L EE9UW'&>AYP#0!!XS\6:AHUS<20Z]H>F10V@N+:UNQYDUZ^"2I&]2B\
M!00#DD^F*JI?ZUJWQ1T&:VU&*WLKC0S>BV:W+X1GBWIG>,L>S8X]#5V]\)Z^
M=4U];%M-%KK<$<4EW*S>=;!8A&RJFW# XR,L,%B<'H6V/ACQ)8:QX:U18]+>
M6RTS^R[V(W#@!-RGS(SLY.$^Z0.3C/>@";XF-=J/"?V!8C='7X5B\W.P,8IA
MEL<D#K@=<51U'Q'XMT6;7-)::QU'4;33DU6SF2V,0EB#E9(V3<?FP#@@]Q70
M^--!U/7(M%?2I[:&XT[4X[XFXW;6"I(-O SR6 ^F:@TC2=3'B>^\3^(OL%J[
M6:6,$%O,TB1Q!B[,SLJY)8CMP!0 7WBR6[N?"EOH9B<ZT_VEWD7=LM%3>YX/
M#'<BCW-2>/-?U/P_INF2Z3'!)<W>IP682<':1(2.HZ<XYKF_A9HJI?ZOJD4X
MN-,MI9=.T=P.!;"5I&*GN-[!0>XC%=9XNT&ZU^+1EM9(4-EJUM?2>:2,I&Q+
M 8!Y]/YT <YJ_BC4]'U.Q\/:AXGT73KPVCWESJ5U $1P9"L<<<;2#G@Y.X_=
M]Z$\;7NI>$M,U)-8T325EN)K>\OYV#Q[HV91Y*EAOWD9'/ />MK7M#U3_A)8
M-?T>"PNYOLAL[BUOG,:LN[>C*P5L$$MQCD&J5UX>\2+?:#J\:Z1>:C90W$4\
M,A:&%3*5(>,A6.5"[>1EAGIF@#''Q O[CP[ILQU+3;-9M1N+&XUDPE[8"/=L
M<+N 'F8&,M@<^U:UQK_B'_B0:+!=:6VJ:J\[?VC"AD@%O$,^8J;OO,&08W$
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MO)FAPT9;9(K*K=F((QZ<UD#P/K.GZ?I-[93V5SKEIJ<^I7*S,T<,SSAQ(JD
ME<!@ 2.U $GB/QGJFE#QN;86_P#Q);2UFM=Z$Y:0,6W<\CY1CI74^'O[9DL6
MN-9GMGEN")8X;>(J($('R$DG>1_>X^E<;?>"/$6K6/C)KR?3DN]?M;>*%(W<
MQPF,,"I)7)&".<<G/ XKT6",Q6\4;8RB!3CV% 'ENJ_$R6UGU>_CUS1(8-,O
M'MQH\Q'VFY2-MLC!MX*L3NV@*>@SG-:MYKOBC4-<\56>DW>GVEMHRPR1236Q
ME:;? )-A^88&<_-SU'%3Q^'/$6EWNH6NE1Z.]A>WSW:W=UN,UN)&W2+Y>W#\
M[MIW#KSTK2M?#EW!K7BZ\:2#R]8$(MP"<KL@$9W<<<CMGB@#G[/Q9XE:V\*:
M[=O8#3M<N(;9K".!M\(D1BKB4MR<KDC;T..V:8?$7C&^T[Q-JME<:9#!HE]=
M11V\ELSM=)"<X+;QL^7C(!R<]*U%\':@/"G@W2_.MO/T2ZM9KEMS;66)&5MG
M&2<GC.*YS1['Q-J&F>,=-TG^SC:W^LW\+37,CJ]MN;:Q"A2'XY RN#ZB@"RN
MHQZG\9/#&IH"D5UX<>X /8,V[^M/_P"$O\3_ /"'_P#"=>=8?V3N\W^R_LQ\
MS[-YFW=YN[[^WYONX[5L0>"9[3QQH>J02PG3--T<Z;L<GS&/8XQC&/>LO_A"
MO$?_  BP\$F33O[!#[/MWFO]H^S>9N\OR]NW?CY=V[&.<9H W=-\52PZSXFT
M_6FBC&E@7L$J+M#V;+D'D\E2K GZ5@V/BCQ=J,GA>TS86ESK=G<W<CO SBV1
M2ACPNX;CL8 @D<G/;!B^(FE0ZWXNT#3=.NU6]O5DLM1BC.6^P95WW8^[RNT9
MZES77WF@SS>-=%UB%H4M+"TN('CR0V9-FW:,8P-A[CM0!QI\3>-&\.^(K\7F
ME*_AN>>*4FT8_;O+ <\;_P!W\A'3/.>E6]7\>2RZRUC;:_HNA+#8PW1;4\,9
MY)06$8!=<* !EAD_,*T_^$0U#_A&O&NG>;;>=KES=2VS;FVH)8E1=_'!RISC
M-1-X9US2=2%_I%OI5ZUS86]K<Q7TC((Y(@0LB,$;(PV"N!T'- %.R\9:YXEO
MM MM(:SLUU327O)I98C-Y#HZJ=H##<,D@9(ZY[8.-X@U[Q'J'A)H9-0MH+RQ
M\21:9/-%;G$^)8V1P-_R]1E<G/(R*[>S\.ZC%XLTO5[JXMI!;:3)9SF-2A>5
MGC;<JXP%^4]_2L/4O VKSZ+K4-M-9_:[C7UU>U$CL$*J8R$<A<@_(>@/:@#H
M_$MYK&C>!KZ^M)(+G5+.U\XL82J2E,%\)N)&0&P,G''6L35?'-S#XKT"WL%A
M?2;F.&2]D8$LHN&*08.<#YAS[5V4"3W.FHFI0PK-)'MGBB<N@)'(!(!(_ 5Y
MYI/PXU2T\&Z[IEW>VTFH7(BBL)E9BL<=NH^S[B1D$,"3@'KQF@"'Q9XUU.#1
M_$E[#;V,UE8:M;Z?:K<0;PS#;YI//.&; ]-M:<;:U)\;+F :I"+*/28IO(-L
M3E#*PVYW\-D9W8Z8&.,U!JGP_P!3OOAA#X>2XM/[4>[6\NIF9A&\AE,DA!VY
M/)(''85MW&AZQ#\28_$%D+*6QGL$LKE)I622/;(S[D 4AN&Q@D?6@#AO"6J^
M)-!^&7AO6%N;$Z6)8;9[$VY,C1R3>67\W=PV6R!MQCUKU77;JZL="O;FR^RB
MYBB+1M=R;(E/J[=E'4_2N1C\$ZDGPMTOPP9K7[;:26[N^YO+(CG60X.W/0<<
M=:Z#QEHEQXA\+W.G6C0B=WBD03Y\MRDBOL?'.UMN#]: ..MO'M[';^)88M;T
MK7'T_1I-2M[RTBV(KJ&S&ZAV!&0I!!'!-7X=>\46E_X:N-1N;![/76\EK6&W
M*M:LT32(0Y8[_NX/ ]JAU'PIXIU>[U2[N!I4)U+1)]+^SQS.5MB03&0VSY\L
MQW<+@8P#CG=OO#=Y=)X2"20#^Q[E);C+'Y@L+QG;QR<L.N.* ,>+QU?0?#O5
M=1O883K^FSR:?)!&I"/=;]L>!G.&W(>O0FNDUO4-0T7P)?ZB[0OJ5GISSLP7
M]V95C)/&?N[ATSTKBY=)@UCXSG[!=)-IL,<&I:E%'\RBZC#I""1T)#!L?],P
M?2N\\3:;-K/A75]+MV19[RSE@C:0D*&9"H)P#QDT <6^O^,X;WPX&N-+<>(4
M94A^S,/L3"/S-V[?^\PH;(^7)':DN/'&KZ%8>(;/5+C3YM0TZ^MK2"\:,P0D
M7"J5>1=QP$#$G!Y [=:Z"?PS>2WO@Z99(-NBEOM +'+9@,?R<<\GOCBL[5/
M]]?W_B6[CN+5);V[LKRP+Y8+);HHQ(,="5(XSP?PH R6^(-W:Z?XCA@UO2-;
MN+#2SJ%M>6: )D$JR2*';D':1@\AJN3ZWXSMM;T*S:ZTMAK\4A1?LK 6+(@?
M.=_[WY<C^')QT%7K_0?$FN^&M>L;V'1[&2]LC;6L%L[.JL0<N\A0'!R. O&.
M]:-YX>N[CQ!X5OTDA$6DK.)P6.YM\.P;>.>?7'% '#^)=:UFZ\)ZWIVH&WN]
M1TC7+*&.6)#$LX:2*1,KD[3\V#BN@N?$VM^$]::W\0W-G?VDVFW-]%):VY@:
M-X &>/!9L@JW!Z\5%K7@75M1B\2+:W=I#)J>IVEY;R,6/EK$(\[ACK\AP._'
M(JU/X6UGQ-K+W7B5;"VMHM.N+"&*RF>4N9P%DD)95Q\J@!>>O6@#-\.^/;BZ
MUO1+>ZU_0]2&KAE>TL,"2QD\LR $AV++\I4D@<X]<5J> =9\1^)K7^U]1FLH
M[ //;I;Q0'?(R2E1(6+<# QMQSC.>U6/#NE^)K.>PMM1BT:.SLHO+>>VW-+=
MD+M4X*@1^IY;GCI5WP/H-UX:\+Q:9>20O,D\\A:$DKAY6<=0.S"@#HJ*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J![*UDO
M(KQ[:)KF)62.8H"Z*W4 ]0#@9^E3UY('U34OAYJGCH:[J<&IQFZNK:&.Y86\
M20R.%B,7W6!"8)()R>M '<^(O$^DZ;>V^AWEK<W]UJ$;D6=O;&8M$.&+#IM[
M<UOPPQV\*0PQI'%&H5$0850.  !T%>27>F1ZM\9=$G:\U*'[;HC71$5XZ&,[
MA\JD'Y5]5'%>HZO!]IT>\A\V:+="W[R&0HZ\=0PY!H K7/B33+==+=9_/BU2
MY%M;208=68JS=<],(>:UJ\.TG2G_ .%??#E(+^\CDO-4B8R&4N8LPS ^6&R$
MXSC'0\UKZOJFI^#I/%]C8ZEJ%S'#96<UJ;J9KB2"2:5HF*E\D]F )QD4 >M4
MR66.")Y976.-%+.[G 4#J2>PK@/"<VH0>*TMX+?Q,=)FLW,[:WN;9.K+M9&8
MDC<"^5&!P,"K?Q88CP'-$SE+::[MH;I@<8A:9 _/H1Q^- $X^*'A NO_ !-'
M6!GV"Z:UF%N3G'^M*[/QSBNO5@RAE(*D9!'0US_B2Z_LW2DLH?#-QJ]C+$T4
ML%MY02., #!#L!@@\ >E<=?:E)XBOOA_;:+>7NCZ5JMK=%XK:3RW6)(T*J,<
M C& >V3CF@#U*BO/+/3I_$7BC7=-N-:UB"ST1;>SM5MKUXG9C$':61AR['(^
M]D<=.:H^%O$6K:IJ/@D7E[([30:G%=;3M6X:%UC5V X)X)^I- 'J-%>3>(=8
MUA(O%B6FJ7,$L.O6%O;.')$*N(<@#^Z2QR.AR:WK:"Y\-?$72]-BU74;VRU6
MRN&DBOKEIMDL10AU+?=R'((&![4 =O*L"JTLHC"J-S.^, #N37(K\2?!;2A?
M[040L_EBZ:TD%N6SC'FE=GXYQ3/BQ(\?PXU(!VCBD>"*=U."(FF17_\ '21]
M#74S:;I\FCMILMM =.,/DM 5'E^7C&,>F* + BA8 B.,@\@A12^3%_SR3_OD
M5PDML=;\</X>BO[RQT;2]+@ECAT^Y: R.[,%)=""554  SCFN?.JZU<6>F:1
M_;-XDEOXKETE[Q7Q+- L;L-QZ%L$#..J@]: /6_)B_YY)_WR*/)B_P">2?\
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M_3]2_<VEM<#_ $Q_G).=K<_,GHIXQ0!Z1I6IKJML\ZV=Y:A)6CV7<!B8X_B
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M#Y\A>Y'!KF;K73>W&@Z7;ZEX@U72S837;W&F!DN9R)1&@D*E64)\P/0E@,T
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M(DDB@Q"'[H 5\ @9R.M3Z?H43?'G5O\ 3]2'EZ?#=#%XXW$RYV'GF/\ V.E
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MV)S6CX;\40ZQX/LM?OC!8)<*2P>4!5(8KC<<>E;R.DD:R1LKHPRK*<@CU!H
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MNYAMXLXWS2!%S]30!R$'P[2."VTN36[R7P_;3K/#IC(F!M;>J-)C<R!L$#V
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M\QP#QDD*":VOA5';P^'=3BM&W6R:S>K$<YR@D..>_&*V[[P5X>U*.Q2YT_\
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M1M&OFX09ZIA0,'J.*W+S1KF_\>:_86FA:!>6EK8VMO##J$K1+!"RN3Y2K&P
M+;LD8^Z*[NU\(:#97,$]OIZQR07,EU#B1]L<L@(<JN<#()X QSTHUKPEHGB"
MX2XU*R,DR1F+S(YGB9D)SL8HPW+GL<B@!OA6WO;'P7IEO=74%Y=PVBH9X)#(
MDI PI#$#.1CFO-/">BZQ?:#X5U5;3P]:O]LBNI-2-VXNYRS'SD;]URS N"NX
MC./2O9+>"&UMXK>WB2*&) D<:#"JH&  .P K$M_!7AZUU<:I#IRK="1IE_>.
M8TD;.76,G8K')Y !YH XO3=.A\.:OICZAI>FW]E<:E(UCK]E+B<22ER!,.K
MY*DAB.!D>E?3+!O"DFEPW&D:==2.LZZ3KVGR?//(T3N!,O5BR@G.64D ^AKO
M+7P3X=LM574K?3@EPLC2H#*YCC=LY98RVQ2<GD =31IO@KP]I&HI?V.G"*>/
M=Y69G9(=WWO+1F*IG)'R@=: ///"6A:I-IG@W5(K3P]9JKQ3M?I=O]JN@Z'S
M58&(;F;+$C<>5]JHSZ+IW_"F?$NJFSA;4$O+R6.Y9 9(V2Y;;M;JH&,X'<GU
M->HV/@KP]INJC4K33ECN59GC_>.4B9L[BB$[4)R>5 ZFK+>&=';0[G139*=.
MN6=IH-[88NQ9N<YY8D]: .4TO3K%OC3K4YLK8S+IEM*K^4NY7+2 L#C@D<$U
MQ_@YX)OAGH>FMID.I7-[K<XMH+B8QP[T,C[I, [E 4G;@Y.*];N/#.D7.OP:
MY+:?\3*!!&DZ2NOR@D@, 0&&2>H-5#X'\.?V+%HZZ<$LHIS<Q(DTBM'(2265
MPVX'D]#WH \LUI9+?P#\3;-XK* 0W4!,%@3Y$;E(=VW(&.1SQUS7LNE%AX?L
MB@RPM8\#U.P5F'P)X9-M>6W]EH(+R)(;B-97"RJIRN0&Y.1][J>YK?AB2"&.
M&)=L<:A57T X% 'F7@O2/#EQX%\.:WJ@AAU.2Z6<W^0DTEVTC J7ZG+$J5/4
M<5EQ:9IE[\(/$NM:C;P-K!EOYIKMU'G17$<CB,!NJ[=J  ?UKT2'P/X;@UD:
MM%I:+=B4SJ?,<QK(>KB/.P-_M 9I+KP-X;O-3?4)],5YI)1-(OFN(I''1FC#
M;&/ Y(- ')Z)I5KKOQ#U*36[*&ZE&B6!>.XC#J'82;CM/&>HSU&3ZFN:T_2+
M"V^$/AO58[6/^T4U6V*W97,HQ=>6!OZX" *!TP*]GBTNRAU6XU.. +>7$:12
MRY.65,[1CIQN/YU37PQHR:+;Z.MBHT^WD66*'>V%=7W@YSG[W/6@#AM*T+0M
M6U[XA/JMI;7++=[&,Z!O*C-NAW+G[N2#R/[H]*SO!$0U[6?#$6O0I=I#X62>
MVCN5#J7,NUGP>K; @SZ'WKI;3X?V6H:UXDN==T_?'>7_ )D#)<,AEA\J-2&V
M,,KN4_*WY<UT>J>%=%UB&TBN[$8LQMMF@D>%X5QC"LA! P , XX% 'E<UC;R
MPMHZH/[)B\<I!#"O"*ACR\8 Z+N9A@>I%6_&4":!J_B^/1(([%)?#4,LB6RB
M-<^<Z%\*."$SS7I</A?1;>PL;&'3XTMK&X%S;HI(V2C.'SG)/S'KG.>:L2Z-
MIT^H3WTMI')<3VWV25GR0\.2=A'3&6/;O0!Y['X>U+3[\7GV#PYI5LND74#P
MZ;=.SW,>U2IVF-0=I YS_&?6LZWT;3M/\"?#G4;:SACOWO\ 32]T$'FMY@ <
M%^I!!QCI@ =A7H>F>"_#^CM,UE8;&FA-NQ>:20B(]44LQVK[+@=*N'P_I1T[
M3]/-HOV73GBDM(]S8B:+[A!SDX]\T >;V7AW3]0F^(UI']BT^66]6WCN7C50
M@:.,[">/E9N" ><^M=)X0"67B._TZ\\.V6D:O]DBD=].DS;W,09E#!<#:0<C
MD9P1R16S<^"_#UYJ-]?W&FH]Q?1^7=9D?;*, <IG;G '.,\=:GT;PSI'A]YG
MTZV9)9@!)++,\SL!G W.Q.!D\9QS0!KT444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7,W/C_ ,.VE]-;2W4VV";[//=+:R-;
MQ2YQL>4+L4Y(')X[UTU>,)JVG6'PAUOPO>3Q?\)!OO+0V!(\^:>25S&RIU8'
M>I##C'TH V?%7C>]C^(=AX<L;Z]T^U6!Y;F:'2GN))&! "J"ARGJR@CWKK_&
M?B:/PAX6O-8>!YVA0^7&J,0SX^4,0#M7/4GBN3$,MO\ &;PW#.=TT?AUT<YS
ME@X!_6MKXK(TGPM\0JBEC]FS@#/ 8$_I0!3N/'D</BS3-TETFEW>ES3+;&QD
M\Z299448CV^9G&_C&,<].:W8_&N@R: =:6\?[()OLY4POYOG9V^7Y>-^_/&W
M&:P+._L-7^*.BWMA<P7=N=!N#'-$X=<B:('!'?J/SKD[U)8WO;T7[Z?:VGC6
M9Y[M8U<6X:W"+(0P*X#, 21QNS0!ZSHVO6&O6\LMB\FZ&3RIHIHFBDB? .&1
M@"#@@].]<YJOC'^Q/B&^FWDTS6+:3'/%;6]LTTCS&5P2 BEC\J_08IW@>*SE
MU/7-1M?$4NNRSM#%/<^3&L6Y%. C1@*QPX!(SC %9^H:MIFC?&DSZI<PVD;^
M'TC2XG8(BG[0YVECP"<<9Z[: .HM/%VAWUKIEQ;WN^/4YF@MCY; M(H8LI&,
MJ1M;.<=*DO/$^CV$VHQ75X(FTZ&.>ZRC?(CDA,<?,25(P,G/UKRNTNH+5-,\
M0S2"'1IO&-U<QW+_ "QB%XW17)/12P/)XYK0N=1T#6_$7C6>ZNY3H[6>G*;V
MTYVD228E1AD%5?!W<@;3V% '7WGC'2[WPWJ]S;:G<Z7)8Q!IY9[!Q+;!ONOY
M3J"P.#C@@X/I5B7QCH^F6^GP7=]-<75U9K<0B*U=I+E?E!9413R=P.T<@9[
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M._ )&025)!QE>* +FK^,M&T6^:RN9+F6Y2,32QVMI+.88S_$^Q3M'!ZURWQ
M\?MIUCH,>@WDBG5KJ$?;HK)[A5@?=DI\I5GX^YRWM4MCK6F>%_'?C Z]?6]@
M;M[>ZMY+EP@FA6$)A,_>*LK# YY]ZY,VL]GX*^&4=Q"\+-XDCE6-Q@HCR2N@
M([?*R\4 >MV=^MOX;BO[F>ZN52W$CRM:,DKC'),07(;_ &0N?:N%/Q-.H>&O
M#FMPF33XKG58X+T26[;3$4E)"LR_-]Q>4SSQ7IDH)B<#DE37B?AZ]LKSX?\
MPYLXYX99[/7($N(0P+0OMG(##JIXSS0!ZAIWC+1-2BU!TN);<Z<@DNTO('MW
MB0@D,5< [2 >?:GZ+XLTG7[E[:RDN%G6,3"*YMI(&>,G =0ZC<N>XKS_ ,>V
MEQ>Z_P"+H+1':4^';5]L:[F8+<2,P [G:#QWK8\-OI^K>,+.]B\9R:_<VUE*
M56*WA5(XY"F0[1J,,2JD*W/RGCK0!T7B[Q%/H%E:1V%JEUJFH7*VEE"[;4+D
M$EG(Y"J 2<5F,/B#ICP73SZ3K432*+BR@MVMG12<$QNTA!QUPV,@4GQ!BN+2
M;P_XCAMY;F+1KXRW442EG$#HR.X Y.W(./3-<YXU\4Z5JM@]WX8\;7S:L\'E
MV6FZ7*K^=+DD%H]A8'GG)' H [G6?&>B:%J(TZ^N)1>M$LR6\5N\CNK,5! 4
M'/*M] ,U%J?CK0=)OKBTN9[AGM0#=/!:2RQVP(R/,=%(3CGD]*QK:,GXUH\R
MYF3PP@)/4$W!S658ZYI/ARS\<:=KEU!;WLNHW5PEO,P#W,4JCR]@/+Y'RX&>
M1B@#T*+6M/GU9=,BN!)=/:B\55!*M"6VA@W0\^]9USXW\/6=J;FXO_+A%])I
MY8Q/_P ?";MR8Q_LM@]#VSD5POARYA\(^(?#H\1W46GY\*16XDNG$:^:D@+1
MY/&X CBL@:C:+I>F:G<*RVG_  GEQ<$NA!12)F#,.HQP3Z8H ]:T/Q/I?B"6
MZALI)UN+4KY]O<V[P2H&Y4E' .#C@U0\5^(;_3;S3-&T6W@GUC5'<0FX)\J&
M-!EY'QR0,@ #&2:RM%OK/7/BQJ.I:3<Q7=C;Z/#:S7$#AXVF,K.%##@D+Z=,
MTOC.4Z!XO\/^*YXI'TNVCGL[Z1$+&W63:5D('.W<N">V: +MJWC?2]7LH]0;
M3]9TZY?RYI;6 V\MJ<$AL,Y#)Q@]#R.O2K%YX^\/6%]/;3W4^VVE$-Q<I:RO
M! YQ\KRA=BGD9R>.^*B3X@:+?ZM8Z;H4RZS<7+_O39N&2VBQS)(W0=ACJ<UQ
M$6L:9I7PT\3^'-1N(EUPS7\'V)C^^N))G<Q,B=6#!TP0#^E 'H6J>--$TB_E
ML+B:XDO8HEF-O;6LDSE&SA@$4Y'RG)[<9ZBJT/Q%\,7$MDL%]))%>,D<5PMM
M(8=[_=1I-NU7.1\I.1WQ6-X4M9;7XB7<-T ;J#P]812-U.X&0-S]17-VZ(GP
M&TK:H7_B:1'@=_[0H [_ %#Q_P"'M,N[RUFN+EY[)MMTD%G+*8!M#;GVJ<+A
MASTZ^AJSJ/C+1=-BLW:>:Y-[%Y]NEG;R7#/$ "7P@)"\CD^M<=IGB/0M!\6>
M/AJ]W;VI>ZC<>>P7SE%NF57/WB,_='/S#UK&T*_NM'TWPWI&IZT/#J1Z$LXG
M\F(W$[-(?W*F16^Z IV ;B6% 'I%SXV\/VEIIUT]_NBU*-I+,Q1/(9@ ,A0H
M)W?,/EZYXQ5&_P#&.EWW@_5=3L]8FTQ;)O+GN)+)C+:OE>&A=<DX([=ZX?P;
M)%/<_#J/>'FMGU6.56QOBD'56 ^ZV"./>D\:\:3\60/[]E_Z)BH ]'O?%NE:
M/;V*7=Q<7,]Q )D6VM))9'0 9D*(I*KR.3QSBDO/&VA6=O93BYFNEO83/ MG
M;27#-$,9<JBDA1D<G%<+<N^G>+;.ZN?$_P#PC]O<Z!;)!<O'"4D*,Y>/=*"
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M'(Y'KGI7DFL7EM/I_C^'^V9-5\^VT]X;B<1J;F-92K,@15#(&.W<!^/2N_\
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MI87G,Y5AA%SN^4C.1@C&,\5S'A:2VN_BIXPO('CF1[33C%,A#!D:-SD$=0<
M_E7,ZA93P^)+WX<I&_V#6-1CU*-@/E6S.9+A,]OWD>T#_II0!ZY:W<-Y8PWL
M3'R)HUE1G4J=I&02#R./6L72?&VA:WJ$=E97$YDF5GMWEMI(X[A5^\8W90'
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M;W4V7'RB":(",#Z/<2<?[% 'J5YKVFZ??VUE=72QSW,4LT8(.WRXP"[%NB@
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M)9?GQ]W<648.#^5 $'@CQE?^*?&6L":^NX[*VNY;>VL1IC*A10,-)*RY5_\
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M+6*.2=-LA02N!N'8X R/:@#ICXTT+^P+;6DNWEM+J3RH!%"[RRR9(V+&!N+
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M7$_+LQR!Z< G)%78?'XN=)A>'2)FUF6_?3?[,,R@K.@+/F3IL"C=NQT(XYH
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MITC@I+#'Y;*P5UP& 4ACQUZ5Z9I.C6FC)=K:!P+NZENY-[9_>2'+8]L]JT*
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M<6G7$=I&))8)4;>"4SD@[F'&<$5GQ>']8G6TU.73IHI;WQ9'J;6YP7M[<1E
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MW;B6(.T,"HZG&,5T/_".Z]K/B+3+KQ =.%EI:3>6+5W9[J21/+W,&4! %+<
MMR>M+X=T+Q/HZ:9I,CZ1_96G_NQ=H&:XN(E!"*4*A4/W<L&/3CK0!6TW6/%V
MO0-K^E2V#:=]M>&'39(2'E@24QLYEW?*_P K,!C' '-96DW6N6^J?$2]N-3@
MN8K(MB!K7 9EMU*?Q'"@<$8YY.16K9^&O%FCQ2Z)I-]I\&CO>O<1WA+&Y@B>
M3S'C$94H3DL Q/0],T__ (176XM5\7)"^GMINO1LR2/(XEBD,/EX*A2"N1G.
M<^U &;8>*M>O-'\"Q:>+""XUR";SF: ^7%MCW;E4$=.>,\\<BG3^,M>T>S\0
M:=<O:7VK6-[:6EG<"$Q)(;D+L+H"?N[CG!YQ6AHO@K4--B\$++/;,=!AFCN=
MC-\Y>+8-G'//KBJ7BSPPT,/BO6+O4K6RBN9[&[M)W#,(9( H'F #[I88XS@'
M- &C::IXET[QWIGA_5+NSO;6ZLY[C[3%;&%F9"@VE=Q QNSGON'IDP?$U]51
MO"ZZ;J*6BSZU!"X:'?ECDJQ^89 VG*]\CD8YH:?<ZEJ?Q8TB:]NM-FD@TJX9
MX=-E,L<*LT85BY )+'/&!PHZ\FNE\;:#J.N66EOI3VPO-.U*&_1+IF6.39N!
M4E02,[NN#TH YFRMO$4_C_Q?#I>IVEI*D=B9KF6U,GF/Y' ";@%!Y).3V ]:
MA_X61/?Z9X;635M,T&;4;%[RZN[M0R*58($C5F )9MQY/ 7O78:%HE_9>(M<
MU:]:V!U-+4B.%V;8T<6UQD@<9Z>W7%<YI7@G7/#VG>'Y[ Z;=:EI]E)8W,-Q
M(ZPS1NX<%7"D@J1W7G)Z4 ='X(\1-XF\/FZEEMIIH+B6UDFM3F*4HV Z<GAA
M@]>]<]H.D6'B[Q;XFU;7;6&_-A?G3;.WN4$D<$:(I8JIXRQ;)/7BNTT6#48-
M,1=5DMGO69FD^RH5C7))"KGD@# R>3C-<W=^'?$&C^);_6?"TVGR1:EM>\L+
M]G1?-4;?,C=0<$@#((YQ^0 S4K'3OAMH>OZ_H]NZ)(B,NG*P6W$V=BE5 ^7<
M67....E*FI^)- \0:)::Y?V6H6VKN\#&"U,)MY@A<!3N.Y3M8<\]#3;CP?K?
MB#1-;A\1:O&+G4HDBA@L]QM[/8=RE0V"[;L$L<9QCBI8-$\2:OKVCWWB+^S(
M8-)9Y42RD>0W$S(4#'<J[% +' SR>M ',CQCXQ'@JW\6^=ISP+>_9VL/LY!G
M4W!AW>9N^4YQP 1QGG.*W#KOB+1O$&H:5J5[9WN=%FU.WDBM3%Y3QL%*8W'<
MOS Y)SQ2+X&U$?#*'PS]HM?MB7@G,FYO+VB[\[&=N<[>.G7\ZN>)]#N7UF^U
M\21?98_#]U9E,G?O9E<'&,8PI[T 8UKXF\56VC>&?$FI7-A)8:K+:PSV4=L5
M:)9@ L@DW')R02,8P<=LT:WXVU#1M=D\W7M$;9J$5N-%B7?,T+NJ;R^[*R88
MMMVX &.>M0^'M!\1:[X1\'6=Y)IRZ-:QV=\9D=S/*J(KQQE-NT8. 6W'('09
MQ4MSX)\3MHE]HEM-I*6IU%M0BN&=_-N6\_SE24;<+@\%@6.%'% %R?6/%>IZ
MIXJM]-OK&R@T:4"%I+4RM,3"K[#\PVC)//)^8=,<RZ%XRO[[6O#RWL<,=AK^
MD"YMMJ\I<J TD><\C:<CZ&M/2O#U]:W'B>>Y>W#:O*LD:QNS!/W"QD$D#^)3
M^'Y5R7BS39-!^&?A[2X[V >)],>T73EB.XRSC"$*#@E2I?/'3KTH ['PIK5[
MK]SK=W)Y8TR*^:UL-J\NL?RNY/<%]V/]VL+QOXJU'0KV[,?B'1--2VM1/;6=
MPOFS7C@$D,-P*+P%! .22?:NN\.Z-%X>\.V&DPG<MK"L9;^^W\3'W)R?QKE]
M3\*Z]+J_B06$NG)9:]&BRW4I?S[<"(1E54+A@<9!+#!8\'N -/B#Q!KGBBWT
MK2;BUL+:?18-2:>:#SGC9W8;0-P!S@<GI@^O%*U\9:_J.G:-I<,EI#K=[J5U
M837?DEHT6W+[Y%3/4A5P"<9)K9\,^&=5TW6[74M1:S!BT2'372WD9\O'(QW#
M*C@J1^.1[G,'@?6K&*SOK">Q?5+'6+R_A25W$4D,Y;<C,%RK;6'." 1WH E\
M(KJ,?Q*\61:G-#/<1VEBHGAC,8E7]Z0=N3M/.",GIGO@7?$6N7-C\1_!VE11
M6[0:A]K\UY(MTB[(@PV-_#SU]:F\-:#K5GXHUO7-9FLB^I0VZ+#:LS"'R]X*
MY8#(PP.>YSP.*=KOAF\U3QYX6UV&6!;;2/M7GHY.]O-C"KMP,=>N2* .,T75
M_$FCZ'XTU:34H;QK76)+<@V;8C(:)&FP')V*A+;!_=ZUW7A&_O=0MKB:;6M,
MUFS)4VUY8KL)X^974%@".,8/?D#'.1IWA[Q7HMSXB339]*$%]J#ZC;2RLY8L
MQ3=%(NW 4A6&X$D9!Q6AX6T"_P!/UG5M8U"VTZREOUA3[)I[,T8V;\R,Q5<N
MV_'3HHZT 5O&6NWNEZA!#'XBT?1+9H&=9+Q1)+-+G 4)N&$ ZL,GG'%</XJO
M=4\5V_PXU075K;IJ%Y"PMVM?,6.?:<ORPW+Z+Q]:[S4="UV/QC<ZQI#:<4O;
M*.TDDNF;S+78SG=& I# [_NDKRHYK&MO 6LKI/@VRFGL<^'[\2NZR.?-A4$
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M%;:0Q;C'0]>*K7OACQ2T_AC55OK#4-7TI[EKC[26ABD$RXPA520$X R.0.:
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M=@==JG<"N,J<?=Z\U<MO#E_%XXLM=GN8)8X=%-A*54HSRF17+!0,!?E/?C-
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MZJ>$/)X4 8[5RN@:YJ]]X'TVTDU6]$VJ>)7L);OSB98X<LQ5'/*G";0>V>*
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M>>N1GH0#U% '?45Y\-.;6?&]WX>FU/58],TC3X&2.*^E22:25G^=Y P=L!
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M!=TFW>X4,<9/IG.*ZNN:\.^+[35[/?>36EG=/>7%M% TX#2".5D! /)SM[4
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M#A6);CL.<5Z#!!';6\5O"@2*) B*.R@8 K+U#PKHFJ:K%J=[I\<UY$H42%F
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M (?&]I<W_@77K2S5FN)K"9(U7JQ*'@?7I^-)X2U?3KWP1I>H6L\2V:6:;FW
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MS:V<I4"&$1PI(4!#M&BX8E00IY^4\5<^+#B+P6MPYQ%!J%I+*^.$03+DGV%
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M **** "BBB@ IOEIO+[%W$8+8Y(]*=7GEQ\3+N'2[[6%\..VDZ=>R6EY/]K
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M[37N&MGM;F&>2VN;=V#&*5#AEW#@CH0>X(H U2 RE6 (/!![TBHJJ%50%7H
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M8$<#.>U=9I%SJ%WIR3:GIZZ?=,3NMUG$VT9X^8 #.* +K(KJ5=0RGJ",@TH
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M\B.WV@HJ$MPW!&T+RQR3CD>E^%XM%LM#M]-T&\AN;*S7RU,4ZR[1DGD@ULT
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M\: ,[XNR7D/PSU:6RNOL[*JB0[-Q=&8*5!S\OW@<^V.]9MW::\?B=I]I!JL
MOCH,OG7S6HX7[0I^6/=C/W1R<=3[5U?C;0)O%'@W4M%MYDAFNHP(WD!VA@P8
M9QSCC%5=.T36'\66OB#56L4E72WLI8K5W9=YF#@J64<;5YSWH YB;Q]J5AX:
M,6H7]A;Z@NN2Z.^I2Q[855,L9BF>NT8VYQN([5N^!O%1UV\U?3FU6TU;[ T3
M1W]JH02I(#@,H) 92K X[8XJLW@C4H[:ZGMKJT&HIK\NL69D#&,AQM,<G&1E
M2P)&<<'FNFT.+7%6YFUN2R$DCCRK>S!*0J!_?8 L2<GH,4 <SXLMH_$'C_P]
MX<OAOTK[//?W%N3\EPZ%516'< L6QT/>J^JM\/-)\66$;A-*UBRG01M96;Q!
MRX $;LB;65MPX)_+FN@\4^&[G5[C3M5TF\2RUG3'9K:65-\;JXP\<@&"58 <
MCD8R*RKO0?%WB5K6UU^XT>STZ"XBN9$T\22RS-&P91N< (,@=B: $M=8\0ZG
M\0->TV*^M;32=&EMGD)M]\DR/$KF,'(V_P 1W<GD8'6LG_A*_$Z>"T\>/>6G
M]G,RSG2OLW(MC)M_UN[._:=V<8SQBNNTCP]/8>*O$VJ3R1/;ZL]N8D7.Y1'$
M$;=QCD^F:YH>!_$)\-)X-DN]./AY9 OVK+_:FMP^\1[,;=W&W=NZ=LT =!I>
MNWEWK/BRVD*&+3)HTML+@@- KG/KR37-6?BGQ+K"^#+:TN;2WFUK3);F[G>#
M?Y;*(SN5<C^\1C..<\XP=:X\-^(K;Q%KL^DW&G+8ZT(S*\^_S;9EC$9**!A\
M@ C)&#ZUSO\ 8NL:%X@\!:7936;ZAI^D74;"0MY,VWR01D#<!SD'!Y XH Z_
MPCJ^IW5[KFBZQ+%<7NDW*1_:8H_+$T<D8=&*Y.&P2#CCBLKQ!:0^)?BAIN@:
MD@FTJSTQ]2:U?E)Y?,$:[Q_$%&3@]S6UX5T*_P!,N-7U/5Y;=]3U6Y6:9;;<
M8XU1 B(I8 G 7DX')Z5'XG\-7U_JFGZ[H=Y#::S8*\:_:$+0W$38W1R <XR
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M=>LH89UC\I9@TD3IN49P?FP<5T4WB#6_"GB#[)KU];ZE9W.FW-[$\-MY#1O
M%9TQN.5*MP3SQ3-9\!ZGJ,7B);>^MH'U/5+2]AD(8^4L0CSD8Y/R' Z=.15O
M_A%M7UW7C?\ B9K!((;">R@@L6=MWG8$DC%@,?*H 49Z]: ,'PY\0IKK6-"C
MN/$6DZD=7)2>PM8PKV+F,NN#N)8 C8<]R#[5M_#[5?$?B2R&LZG>VRV6^>W2
MUBM\-(4E*B0OGC@%=H';.:M^'M+\5Z>VG6-_=:7_ &=81>49;=6,UV NU-P8
M8C[$X)R1V%7/!.@7'AGPQ#I=U+%+*DT\A:(G;AY6<=0.S"@#H:*** "BBB@
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M8 \'!QUKBM,NM3T_X4ZGXO.KW\^J#[1:VYFN&>.!#<F,'83@L#SN.3C Z#%
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MYES<FY!!$Q<C[P(';&.,8K>OM6T[3/*_M#4+6T\T[8_M$RQ[SZ#)&:N=1D4
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M!+D("HRQ4LORG!VD9%=/6!_PD$O_  L'_A'/(3R?[*^W^=D[MWF[-N.F,<T
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M;<SS7#[=JKLC7 4 8 P /QJC\.O"!T'P5):7<+V]UJ+/+-&7W-"K#:D>?]A
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M2[M;;2X!#>+LN%DS)YJ\@*Q8DD#)XZ#-3:+X:T;P]YW]E6$=NTV/,<$LS =
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M!+5?+W95@,N6 SC)Q7#6Z!?@'X8"KC%S8G '?[4N:G<'_A._BKP>=)@Q_P"
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M\+Q\3G'']FVM</H9^R^ ]/U*96^QZ?XP:YNV"DB.(,R[S[ LIH ] L/&8O\
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MYX/..].OO%>J'Q-J&@:1H27ES9P0SF6:[\F,J^[@G:Q!RO P<\\C'(!UN*,
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MU>*T^PRR$!)FCC.1Z@;@ ?K7JE% 'F^AZ1!%=RW>E_#]["Z@LI/GO[@*'F(
M$2X9\J><L<#IUJ7PAI<EKXJ^T:3H.I:#I)M9!>6EU(OE/.64H8D#L!@!\D8!
M!%>AT4 <-XUTZ>[\1:5-=Z+>:UHJ6\R-9VS+@7!*;'=6901M#@$Y )K \/>'
M-8LY_#]K+HSVB:=KMW<2>65,2Q2)*4*'.2HWJO0'VKUBB@#S/Q1X5UC5;[QF
M]I:Y:ZM]-DLBS +-) [R,F>W0#GUJZ)=9\0^//#6J'P_?:?I]C'=+,UWL#[W
MC 'RJQ^7C&>Y/M7?T4 <3\5-'U#7/!HL],M7N;C[9!)Y:$9VJX)//H*OZ7IM
MY!\1/$6H2P,MI<VEFD,IQAV3S=P'TW#\ZZ>B@#F/A[IMYI/@JSLK^!H+E);A
MFC;&0&GD8=/4$'\:Y+4=(UD)\1-*31KN4ZPKSV=RFPQ/F%5V9W9#9&,8KU2B
M@#D-7TF]N=6\%RQV[-'8SNUTP(_=@V[ID_\  B!7)>&O!UOI;:;I5UX(EGO[
M.Y DU-Y@MN8U8E9E.XDM@+\FWKUP.:]<HH YSQUHUWKOA&[L]/56O5>*X@1V
MP'>.19 I/;.W'XUA:S_;_CO0]7T==$FTFSFL&59-0*B1[G(*JH5B-@QRQ]1B
MO0** . F.L^+=3\-PW&@7NF1Z9=K?7LUT4V^8D;*J1[6._+.>>!@?A7.WNF^
M(T^'6K^#8/#EY)=_:9W2ZW1B"2)K@R@J=V2Q!QMQP>N*]AHH Y32=+O8/B5X
MDU*6W9;.ZM+1(93C#L@?<!],BN=M-+NY/%MC>6'AB^T/4#=LVK3QS+]CN(<-
MG@-B1F.T@[ 0>3C%>FT4 >1^&O!UMI;:;I-UX(EGO[.Y DU-Y@MN8U8E9E.X
MDM@+\FWKUP.:[GQWHUWKWA&[L[ *UZKQ7$".V [QR+(%)[9VX_&NCJO-?VEO
M>6UG-.B7%UN\B,GF3:,MCZ#F@#CE_M/Q1XRT#4)-$O=,L]($\LK7NP-)+)'Y
M81 K'( +$MTZ5+\.=(O]'MO$:ZA;/ ;G7KJYA#$?/$VW:PQV.#7:44 %%%%
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M[L(]&OKFX$TKA_M$4?VE]Z(!\K9P>21C<>#BNP;P6TWCG5M8GEB.G7^DC3C
MN=XYY/3&,4 8ZZ]XITW0M$\4:CJ-K/9ZA-;BYT]+4*((YR I1\[BR[ESG(//
M2KUKXTN=-T7Q8=:9'O\ 0)I"-J[?.B8;H#@=VR%^HJ*#P?XCN-.TC0-4O=-?
M1M,FA?SH0_GW*0D&-&4_*O1<D$YQVK.\0Z;9^)/BOI=OIUXDT:P"36XHB&39
M#('@5R/XC)D8/. : +EMJ/C&[\06'AZ34K:SN7T..^O+C[*KLDQD*E57./0<
M]E/&3QE#Q5XP3P3+XGFU&R TR[-M-:I:C%VJ3B)W+$Y0G)P!P,>_'>#0IQX^
M;Q!YL?V<Z6++R^=VX2E\^F,&L*7P->R?#O5/#@NK<7%W=RW"2_-L4-<>: >,
MYQQ]: ,CQ)X_FMM=URW@\2:;I1TG:D%G<PAVO9/+#G<2057Y@@V\YR?:M&#Q
M!KWB;Q)'8Z3?0Z;8SZ+:ZD)6MQ-(C2%_E ) Y ')Z;>G.1HW6A>)+#6=6N?#
MMUIJ0:JRRR_;%<M;2A A= HP^0JG:<<CKS6A9Z#<V_C.YUN6Y26.;38;/&,.
M71W8L1T .X=* //=1U?Q!KVD^#97U.*VNCK[V4[16X*O)&95$F">F$^[TR?:
MO8(U=8D61][A0&;&-Q]<=J\]F\":O#H6FQ65U8F_T_7)=4C$V\1.KO(=A(&0
M<2=<=17H,/F^1'Y^SSMHW[,[=V.<9[9H Y_6=8O=+\8>'K7<G]F:D9[>3*\K
M,$WQ\^X5QCZ5R^E_$&],/BB]U'ROLEO:RW^E[5P7@226+!]23&A_X&*ZGQIX
M?N_$6@K!IUS';:C;W$5U:3R [4D1N^.>5+#\:Y[5_AM)>6/AFQL[N&&WTZ!+
M._# YN;</$[*,=RT7?\ O&@!FGZ[X@D\;Z/H5[- EQ<^'/M<\HMUW)<%L''^
MR#_#WQ7(V7]L/\,=-NY;]+N:;Q+$T$<D6P)(+U\EF!R0S8/MVKTR;PQ<R_$Z
MV\4">(6L6EM9&(YWEC(6STQC!K L/ FN6^AP:)-=:<UG9ZS'J%M*F_S'07!E
M97!& W.!CB@#6T>_URQ\=R^']5U*+489M-^W13+;"%HV$@1DP"<CY@1GFNQK
M";0YSX]C\0>;']G33'LC'SNW&57SZ8PM;M 'F?C;QAJ.@7VJ31^(]+MS8Q++
M;Z4(?-DN!M#,)6ZQD\A<=L'FM-]2\1:UXRU;1]-U.#3K.UM+:X68VPED#2!_
MEP2!@[<DGTP.N:KZIX*UZ[B\3Z9:7VGPZ;KDCSM<.KFX1FC5?+Q]TKE1SG(!
M(QGFMKP]H&H6'B#4-6U"2U+WEG:P&.W+$*\0?<<D#@[QB@#GM$\:ZQ,GA&^U
M(P"QU9I]/NMB8"72.PC8'KA]C#'J171Z%K-]K/BKQ BLG]D:=(EG#A>7G"[I
M3GVW*N/K7)^(-*MO#/PBDT74;^ :E$\EQ8>2<N]QYYDB$:GDG<5!P.Y[5VG@
M[1I-!\+6=G<G=>L#/=O_ 'YY"7D/O\S'\ * -VO)9/%?C!?!,GBU;^S,=K?M
M!]@^S "XC%SY7S/G*GGL/X<\YKUJN#;P+>GX:W'AG[5;_:9+MK@2_-L -UYV
M.F<XX^M #)?$&N>&/$=S;:U?P:E:'1[C4AY5L(3$T)7<@P3E2&[Y/%9?AOQ_
M-=:WH<,WB33=4.K92>RMH0C63^677:0<LH*E#NYR0?:NLUGPJ=9\3QW\TJ?8
MCI5SI\T?.\^:5Y';&%-,\/Z;XLL7L+/4;_36TZQB\K?;HQENP%VH7##$>.IV
MDY(["@#C4\5^,O\ A"++Q=]OLG4W@MSIYM@%F0W!AR7SE6SCH,8'>M:_U#7;
M'4M;T#5M1AU"&?P_/?12);"$Q,IV,@ )ROS C//%6T\"WJ_#:U\,FZM_M,-V
MMP9?FV$"Z\['3.<<?6M'6O"]UJ7B2XU.*>%8Y=$GTT(V<AW<,&Z=./K0!RFB
MZEXD\/\ A7P;J=SJ%M-IMW]BLI+ 6P7RHY%"(XDSDL/E)SP<G&,55N?B@\<M
MUJ@\1:<BV]^T"Z&8@9)(%E\LL7SD.0"X[8P,&MVT\&^(Y+'P[HNIWNFOI.CR
MP3F6$/YTYA'R(5(VA00,G.3@<#-7['P_XGT>:73M+OM.CT:2]>Z661&:XA1Y
M/,>)5QL.26 8G@'H2* (=+U3Q'K/CS7+%+^WMM*TB[B4K]G#O.KQ*VS.1M .
M3GD\CTY[FN?T+0)]*\1>(]1EFC>/5+B*:)5SE L00AOQ':N@H XV\U#7-;\9
M:AH>D:E'IEOIEO#)/.;83/+++N*J QP%"KD]SGM7!>-M3U;Q)X$TN:ZNH8)[
M;7ET^\AC@#(\T<I02#)R!QG;[UZ'J&A:W9>*;K7?#TFGLU_;QPW=O?%U7='N
MV2*R G.&((QSQS63>_#N[F\'6&D1W\+WJ:JNJ7=PZE5E<R%WV@9QUP/I0!W.
MGP7-O8Q17ET+JX4'?,(A&&Y_NC@<<5QOQ<-ZG@61[.\^S?Z5;K)B,,7#3(,9
M[<D'WQCO7=USWC?P_<>)O"ESIEG/%#<L\4L3S E-R2*X#8YP=N./6@#EIK+7
M9/BF]I:ZO%#<CP_#Y]\;4,3B>7&V/.T$GN<X Z<Y%23X@W\.A:5;:AJMEIU[
M/J%W97.IR1?NU6W9@65"<;F^08/ R:Z_3-$U1?%Q\0:D]F))-+CLY(K8L0'6
M5WR"P'&&'OG-9$/@C5=/AM[RPN[,ZI::I>7L(F#>5)%<,VZ-B!D'!!R <%>]
M &AX#\3-XAMM3ADO[?46T^Z\E;ZW3:EPA175L= PR5..,K76,<*3C.!6;HD6
ML1VLKZW<VTMU)*76.U4B.%, ! 3RW0DD]ST K3H \P\$66AW'@5O&7B*S@O;
MS43)<WEQ/;?:&5=Y545<$A5  V@4S_A(="T#X>>)[OP-<R!K%OM!@G@D5+=Y
M"/E5)%&%."<#CFMFT\-^*/"\MS;>&+K2I](FF>>*UU$2*UJSG+*C)G*9)(!
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M/+G*L<,1@8&!G-4/&/C/4/#]_J5P/$6F1FR:-H='CA\UYH\*6\U^J,<M@#@
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M'^K=D=DWKGLV P^M86G^"]9\-II=SHESI\UY!9-97,5T'2%U,AD4H5R5VLS
M @Y4]L5V.DPW\&F01ZI=1W5Z 3-+''L4DDG"CT&<#OQSS0!F^-VNH_ VN2V5
MS]FGBL99%DV!N%4DC'N 1GMG->?P6VLAOAG%#J43WDUK.8[B2W&((S;)QM!^
M8@9P2>21FO4-;T[^U]!U'3!)Y9O+66WWXSMWJ5SC\:Y;1O"NN13>%)=4FT_=
MH4<T!%J7(E1H5C4_,!\V02>WI0!D7GC;5_#UAX@L=1O[2>]L+^UM(-0EA\M
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M\,75KJ&H7+:E)+;WZ3W3RK<'R6<.%8D*0R\;0!@XZ4 >CT5XT1=1_"F/Q_\
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MA,;< J 1USGFK?G)H$OCG2/[5U2#3K?[$;4QRM/<1/.""D1<DY9@ .>"V>*
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MEZ?!>O>PV%K'=2??G2%0[?5@,FN7TCQ#>ZMXQ-DEPZ:?=:%!J42%$WPO([#
M..< #KGG-8-AXK\2ZAH7@J>.^MDGU>ZFM[EWM@<[1*0P (Z;!P,9]: /4:J:
MCJ5EI-H;J_N$@A#!0S'[S'@*!U)/8#DUS/A35=:7Q/KOAS6[J.^>Q6&XM[Q8
M1$9(Y WRLHX!!4CCK6?KTCW'QJ\+65S_ ,><5E<7,"G[K3_=)]R%Y'IF@#JD
M\3:6US;V\DEQ;S7+^7 ES:RPF1L9PN]1DX!/M6O4-S:078B$\8?RI%E0GJK*
M>"/\]S7G[^*M9O? -[XUL+I42VDFECT]XU,;P12,I#-C>'*J3D$ $@8]0#T:
MBN$CU?7-:\8W.EV>J+964FD07\#"U5I(S(S#'S9!/RCKQ[=ZR;#Q5XDF\->%
M/$,^H0%;[4(;&YLTME".KR&,ON^\&R-W&!VQWH ]1HKSF6_\8:I?^+;;3]:M
M;5M(G7[,/L2MYF85D"-DG YP3R?IC!=%XKU36M&TS4(;M;+[7HYNEM[2,2SM
M/W)#J0(1_>)') S0!Z)534]0ATG39[^X65H8%WN(HS(V/95Y-<)!XHU_4QX#
M:"[MK8:[;2/=#[/OPZP%\KD\#/0?GD<5!=^*/$-EX#\87']H12:CH5[)!%=/
M;KF1 J,,J,*&^?&<8XZ4 >F*P90PS@C/(Q2UQ]_K6I7WB"[T33FNH7M;&*X:
M6V6!F+R%P,B4XVC9V&3GJ,<Y=_XIU[1K'2)/%"3:5#);.+R]L(5N(X;@, N_
MAMJ%>>.YQGB@#L=1\0Z7I.IZ=IU]=B&ZU%V2U0JQ\QAC(R!@=1U(SFM.LNTM
MTU32]+N+JYCNRB1S^9"1Y4TFT$.,=1GD=NA[#%O47GCTRZDMG1)DB9D9TW $
M#N,C/YT 6:SM/URPU34-0L;621KC3W6.Y5XF3:S#<!\P&>.<CCFO/+;Q-XLM
MO#GA7Q3=:C;W-GJ$MM!>6*VH7"RD+YBN.=P)!QP.<=LF_!=75EXB^)-S936<
M%S&UHT<MXVV%#]E3ESZ"@#T6BO.CXTO-'U+Q MQ)<WUE8Z,NIP&Y@6&1FRZE
M<!5^4E1U7(Y[8K:%QKVGPV^LSZE!=Z8+"2XO8&C"E7";U\C:N<?>!#D\8Y-
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MO+"--/737M[9EV20*257YE)4C)Y4@^];L>JZ=-917D>H6KVLK!(YUF4H[$X
M#9P23QBG76IV%B7%W>V\!2(S,)954A 0"QR>F2!GWH YS3_ 5OIW_"/>7JU^
M_P#82NMMO\LA@R;"&^3IMX&,>O)YI+CP#:W.DZ_ITFJ7WDZW.9[D@1[E8A00
MGR<#"J.<]*U_#?B33O%6BP:IILH:*502A92\9_NN 3@^U6KW6=+TS?\ ;]2L
M[78H=O/G5-JDX!.3T)!&?:@#"U;P2FHZE9ZK:ZSJ&G:I;P?9GN[4H#/%G.UU
M*E3SDCC@FKA\-&/:+74[J)#;FWE20)*LV6+%VW#E\LW/3DY!K3.JZ<+:"Y-_
M:BWN#B&4S+MD."?E.<'@$\>AK/\ [:-UJ^E+IU]I$^G7:2LS?:<S2;1P80,A
MP"/FYXH OZ3I=MHFD6FEV2LMM:1+#&&.3M48&3W-+JDBQZ3>.V<"%^@R>GH*
MBDUW1X=3739=5L4OVP%M6N$$ISTPN<T^YUG2[*4Q76I6<$@9%*2SJI!?.T8)
MZG!QZX- '%^ _#QO/ _AE=3N+ETL$CF%G+$$V3*. _ )VDY ^F<X%:M]X!LM
M1'B$7-_>E=<,33A2B^4T84(4PN1C:O7.<5T]S=6]G"9KJ>*"($ O*X502< 9
M/J2!39+RUANH;62YA2XG#&*)G >3:,G:.IP.N* .<3P-;/JLVH:AJ=]J$ESI
M_P#9]TDYC"3QY8\A5&/O'A<#OR>:=H/@J/18DMYM7U'4K*!#%:VMXR%($(*X
MX4%OE)4;B< X%;LFJ:?#,\,M_:I*CI&R-,H96?[BD9X)[#O6=+K@N;[2#I>H
M://8W3RK(S769)-HZ0A<AR#G=Z4 9^@>!8?#\T<<.LZI<:9 Q:UTZ>16BA/;
MG&Y@.P)('7J :V]=T2R\1:+<Z5J",UM<* VUL,I!R&4]B" 1]*Q/^%C^&OLN
MMSC48"NDEA(!,FZ;:BMF,;OF&6"CIEABM6+Q/HDFB0:N^J64-C,!B:6X15#$
M9VELXW#TS0!'9^'O*U"VU"^OY[^\M86@MY9E1?+#8W-A0 6.U<GVX R<KX?\
M.)X??46BOKFX%_=O>2B8)\LCXSMVJ..!QS5]]4T^.&&:2^MEBF4M$[3*%D4+
MN)4YY 4$\=AFC3]4T_5K<W&FWUM>0!MIDMY5D7/IE2>: +=%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XK!8:,_P '_&MU
M+#;M=+>:@S2LH+I*LC&, ]0<["/K[U[57//X%\+R7,=P^B6C2I(902O!<L7R
MPZ-\Q)YSC- &%X2F=/'/B:2]<)-_9VFR2ESC&(Y-Q/T.:YKPIIEQJ/A3PK?Z
M1-I5QJ-M;7FW3]1!*S0O/\SKC)4@JHW8(^;!KTK4_"F@ZSJ$5_J.EV]S=1+L
M61UY*YSM/]X9['(J.Z\&>'+VQMK.XTFW:"U+&!1E3'N.6P0<@$]1GF@#SF:[
MM+W6_A=-96 T^$7E]']D#[A$RC:Z@]QN#8/ICI4Z:3I]QX+^)MU/9PRW!O=1
M_>.@9@$3*@$],')'N<UZ0/#FC*=-*Z=;K_9F?L05,"#(P=H'3(J5=%TU;.^M
M!9Q"WOVD>ZCQQ*SC#D_44 >8V%OJVJ>*+D1P:-=$:%8 #5@Y_=,KERF!T+9W
M'V6IK+P]?066F7&GW>@>(+JUT=+6YL[B3<DEOO<H\4G.W(RN6&#MZ\5WNI>$
M?#^L1VR7^E6\XMH_*AR""J?W<@Y*\#@\4W4O!WAW5Q;B^TBVE^S1^3%A=NV/
M^Y\N/E_V>E '!-;PWMA_PD6A6.DZAI\FBVZ7>C:@^)K>!59E"2<[<JQX88.T
M'->F:/<V]YH>GW5HC1VTUM')$C]50J" ??!%9^H^"_#>JRPR7NC6LK0QB%/D
MV@1CHA P"H]#Q6XJJB*B*%51@*!@ 4 >:>'?F\&_$&1_]>VIZGYN>O"X4?\
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MNU(ADE5)C&'V\GD<>X%>B>#-,O-.U7Q ]Y<:3ON)XI'M--9ML$GE@,64_=+
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MENG]HO-J -P%!D5!(P(#=0,9.!ZDUZ1;^!?"]H@6#1+6,+,LZX4Y5USM(.>
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MT&HJLMJFDWC6J2C*F=9%7@'J1'G'H,UZS8:/I^F22265I'"\J1QNR]66-=J
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MBHN!"2""1[D$Y^IJS#I]I;W]S?10(EU=!%FE'5PF0N?ID_G0!9HHHH ****
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M"X%F6^S$2!75U8860<@*PZYK1T_6$@UC0+*XUK6WN9[:XD6UO+-8WN0I.6D
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M^"YX+WQM'=V[K+$WABR59%Z9$D@(S]1S]* .C?QWH@T&QU>)[B>._E,-M!#
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MTFUU.*TTO2S:3,/LRN\@=,F/)Z X;+=1QBJ@\":X?#R>$'U&Q/AM90/-V/\
M:C 'WB+^[G^'=Z=LUTNE>'YM/\8>(-:>:-HM36V6.-0=R>4C*<_7- '"3>*/
M%Z>"KSQ8NIV^VPU"2 6/V5=MS&MSY?SOU4X.!M_NY.<UTEKJ'B'2?'$&D:GJ
MD&H07VG372#[.L(@EC9 0",DH0_?)XZTR3P+=O\ #J_\-"[@\^YNY+A9<':
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MI3)&$4\LP8IT[UT_@71[G1O"ELFH'=J=TS7E\Y'+3R'<V?ID+_P&@#HZ***
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M!++Q)KE[K"R66@W]XC6:6B#[3''&"JENJX)!R/?.<C%N[UW6M(T_POK,M_\
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MT<D(&//S8SMST '%6KCP-:S:A<S1:KJEK9W=P+FYL()56&63@DYV[UW8&0K
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M6Y19&STPI.>:Y?QI\0%T#7])T*PN=(2]O&D,\VH7.R.T54##> <@MGY<XS0
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M;G. _(XSFM--9TM[&"]34K1K2X8)#.)UV2,3@!6S@DGC H HQ>&88O$\>O\
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M?=)]ZYB[AA3X$>,6CC16_M&Z4E5 .!<C KU;2?">B:3=C4+72K2"_:/:\T:
M'G[V/3)Y..M(?!WAQFU!CHUIG4>;S]WQ-SN^8?7GZT <AJMQ%X2U?PUXME;R
M["XL1INHMV V;X7_  8%<_[0K?\ AW836_AC^TKQ-M_K$SZE<@]5,ARJ_P#
M4V#'M4?BSP_J7B5;?P\MK9P^'2\3W<[2DR.B,&\I(]N!DJOS;NF>*Z\ *
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MNF6OB)]!6"^N-1C,6^*WMS)M63HY(Z(.Y/3(I/ 6IV>J>"-(>SF$H@M8H)<
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MM#G\?0:@S1RS:G-Y(\MC]H)@C'EK@<MG''^T*@M)[O18/#V@ZWJNHZ3;P:%
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M=B\<L#-DQ2(Q1USWPRGGO0!JT5P_B>2\USQMIOA*"^N+*R-G)J%]):R&.65
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M,I' ZUE>-KN^N=7\/^&+"]FL?[7EE:XNH#B1((D#,J'^%F)49[4 =G17'P^
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M!SN.XKC  'I[/110!XIH4.N:_P#"*S\+V^BS&.]<I_:0EC\B.'SRS,P+;]P
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MSCT^91TKL*X&V\(^);B3PW_:NI:<8=#G1T2VB<&=5C9-S%CPW(X''+>V.^H
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M*\>_<1GL2_'?B@#AQ\0;Z?0_#4-[J\.E7%\+HWFH);B0X@D\O"(00"YP>00
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M0M8I5$.I32K<C8#N"V[.,>GS =*SO 6H>(O$'VC5-2U2/[%#=W-K':1VRCS
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MQ/S!ESD8ZD=* /0Z*\D^WW?_  S^MW]KG^T^>!YWF'?_ ,?N/O=>G'TKUN@
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M&)#^Z/DN?EY^7GTK;.F#0/%7@V[M;N]>XU)I8;]I;EW%S_H[/DJ3M&&4$8
MZ=* /2:B^RV_VK[5Y$7VC;L\W8-^WTSUQ7BEW:2W/P<D\8G4[^/6[MA--.+N
M0*RM.%\K9G:% ( P."!7N% !17E/CEH[V_\ $4UI:ZW?76F68_?P7@MX-.D$
M9D!4;U+M@JS<-Q@>U6;:T/BGQS%!JES=/9OX<M+F6VBG>)))6D?YCL(/KQTZ
M>@H ]-HKQVUO+[2O"FE>(/MMU+#H&M7-I<^9*S%[(S-$=W/S%!L()Z;:['09
M9M:\?Z]JHFD.GZ>J:7;('.QI!\\SXZ9!95S[&@#L:*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS#PWX!_M+0KV'5+K5[.W
MN=3NI+G3PPCCN5\]BI8,NX!E"_=(!&*]/K#T_6O^0K+J6I:/]GM;LPHUM/\
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M*3@'D]"01]10!B#X?Z5_9+V;W-^]T]X+\ZBTP^T_: ,"0-C P/EQC&.,4J^
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M\@XWC'.W<2.1@FC3_".FZ;XKU+Q' 9_MM^@6168&-.%!*C'!;8N>3G%6]/\
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M/9((@<,B;<$Y)YYH ZFN4U'P'9WUY?S0ZIJEA#J1S?6MI,JQW!QM).5)4D
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M6P<>N#43^*?#\=U#:OK>G+<3N8XHC<IN=@Q4@#/)W C'J,4 :U<I?> --O\
M4]8NY+R_2+6(A'>6B2J(G(38KCY=P8 #&#C(Z5M6.O:/J=Y<6=AJEG=7-O\
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MH]IX=T:PN$N+33;:"5'DD1XXP"K28WD>F[:,_2H=3MKVPM[JX\.:;8R:E=R
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M[,R:@NV[;RA^^&03N]>0#4NH^&]%U>R@L]0TRVN+>WQY*2(#Y>!CY>XXXXH
M\GN+6VN6N;1(T?27\=0)'&!^[.4'FJ!TV[MV1TZUV]K#%;_&6[6"-(UDT")G
M"# 8B=P"??'%=+'H.DPV5I91:=;):V<BRV\21@+$XR0RCL>3S[U8%C:C43J
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MN\0ZNO)! /'7(SS7+^(M5O\ Q)X<BUB+1KN/3=-UFUNX@Z-YUU;QL"\@BQD
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M"=Q#<-KB27H^RB!RTBO(SB4'&"NULYSV]<5T5O#+_P +MTB7RW\L>%PI?:<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH;IU(&>N*XFRTRP3QY\1IUL;99HK6V:.01*&0O!(7(.,@L>OKWK+MM$TW3_
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MYC64KL+#!X![5%?>/_#>G7=Y;W-](OV+(N9EMI&BB8#.PR!2N_'\.<YXZ\4
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MS.BE0VXA%/RX(R>@SZUGZI\1M*L-4\/V\"SW=OJZ-,L\%O+(!&$8@J%4[CD
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M4JRL#@JRL 5(/!!&:S_%WB)O#>CQSP6OVN^NKB.TL[?=M$LSG"@GL."2?04
M+H_@[0M!N6N=/LBDQC\E6DFDEV1YSL3>QV+P.%P.!4>F>!_#FCZDNH6.FK%<
M1[O*S*[)#N^]Y:$E4S_L@5E3?\+%TZ)+XR:+JV&4S:=;P/ VTGD1RLY!(_V@
M!6QK/C+1- NTL]1N9([MX?/2".!Y'==VWY0H.3GL.< GH,T 0'X?^&&L=1L3
MIF;349!)<P>?)L9@V_(&["?-S\N*N:QX5T;798)K^U<SP*4CFAGDAD"GJNY&
M!*^Q.*J:EX[T#2KR:UN;F<O;JK7+0VDLJ6P89!D9%(3CGD]*U8M:TZ?54TV*
MY62ZDM1>(J@D-"6VA@W3K[T 0P^&M&MX--@AL(XXM,<R6:(2!$Q!4G@\DAFZ
MYZYZU:ATNSM]4NM2B@"WETB1S2[C\ZIG:,9P,;CT]:R[GQIX?L[.2[N-0$=O
M'?-I[NT;X$ZYRO3_ &3ST]ZFT3Q3I/B">YM[&687-L%,L%Q;R02*K?=;:X!P
M<=: -FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\KT>TNKSX;^/M-M59M1.H:G&47[SNV2!^(9<?6O5*PK;P^UAXMN]9L[
M@);ZA$HO+4KD/*G"2*<\';\I&.<#TH QO#_BOPQJI\.6%EY-[?\ V;=&L**[
M6(6/#&3O%_<]23BD\(?O?'WCNXBYMS=VL0(Z>8D"A_QY%==+;>7#<-91P174
MBG$C1\%\<%L8)Y]ZH>&= C\.:,MDLS7%P\C3W5RXPT\SG+N1VR>W8 "@##^+
M(!^%^M@J7!2/Y1U/[U.*S[W5M+\1?$'P<NBW4%V;1;J>Y$+!O(B:'8 X'W26
M*C:><CVKT-D5U*NH93U!&14+6ZQI.UJD,4\@)W[.K8X+8P3^= 'D>GV4Y\0V
M_P -7C<V.G:FVIEB/E-B,21(?7]ZX7_@%>QUSOAWPY<Z;J%_J^JWR7^K7VQ'
MECA\J.*),[8T4DD#)).3R3714 >4^-IKWPOXFU :8C$^+;1;2#:.$O@1&&]O
MW;[L_P#3.KWD:;X)\?:&+R:*TTE-!;3[6XG8)&)4D5B"QX#,HSSUP:Z0^'+V
M^\60:QJVH13VM@7.GV<,!01LPP7D8L=[!<@< #).*Z&:&*XC,<T22(>JNH(/
MX&@#QBZN86CO?$:.%T-_&-I<I<_\LS&BK&\P/]PO_%TXKK-*U>PUGXPW4^G7
M,=U;QZ$D?GPL&C9A.Q(5APV,C.._':N[,4;1>48T,>-NPCC'IBDC@AA"B*)$
M"C: J@8'I]* ,?QI:75_X'UVTLE9KJ:PFCB5>K,4( 'N>GXUP][K>D^(-*\#
M:;HEU!<7L>H6<YMH6!DMHXE)D+J.4P,KSCDXKU2HDMX(I7ECAC223[[JH!;Z
MGO0!Q?PUC13XN=5 9_$EYN/<X*XKJ-?NY;#PYJEY!;BYE@M)94@89$C*A(4C
MOG&*OJBIG:H7)R<#&3ZTZ@#QW2M6@F\8^"II/%,>J*T<J,(XX8[>VDDA^2)2
MB@AC@@(Q)^4>HS[%4*6MO&@1+>)5#;P @ #>OU]ZFH \(MM7TNY^ W_"/V]Q
M#_;-Q*8(;+</.>5KG<K!>I'1MW3CVKO?#,2GXH^/9  )<6"A\<@>0:[46MN)
M$D$$0D081M@RH] >U/"*K,P4!F^\0.3]: /%?"T$$VB^'=&U'QA*MY:WT:G1
MDM8C+'/%(6(;"^8%RI)<\8.2>:BUW7?MNC7,UUKZ6\J:VIET2W@A46Z1W:@R
M3':9!PH8OD E@.]>VBWA$YG$,8F(P9 HW$>F:0VUN6D8P1;I1B0[!EQ[^M '
MFFF>(]!\/?\ "96OB":!I)]2ENDM7"NU]!+&GEB-3_K 0-N!QQSBMCPHD9^(
M7C!TM_)S%IX$;* 47R3\I Z8]*[-K:!Y(Y&AC9X_N,5!*_0]JD"*&9@H#-U(
M')H X_X4_P#),-!_ZX-_Z&U0>+KB'2_'OA/5]1D2'38EN[=KB4[8X99$386)
MX&0K#)_K7;HBHH5%"J.@ P!221QS1M'*BNC#!5AD'\* /)M1N(=4L_BEJ^GR
M+-ILVF)!'<1G,<TL<$F\J>AQN49'I[5WO@C_ )$#PY_V"[;_ -%+6VL,20B%
M8T6(#&P* N/3%.50JA5 "@8 ':@#C/'&K/8:MH%JVIV^CV]R\YDU.:.-C"50
M81#("JELGDCHI%<%I]Q!=06\#7C7DJ^.89BTZJLCHT>4D9   &QD<#->VRP1
M7";)HDD7.=KJ",^O-'D1%RYB3>2"6VC)(Z4 >5^/K*ZO_$7BJUL49[B7PHFU
M$ZOB>0D#U) (_&KVJ:YI'B?4/!-KX?NX+JXBU!+QTMV#-;P)$X?>!]S[RK@X
MYXKTG8N_?M&[&-V.<>E1QV\$+N\4,:/(<NRJ 6/OZT >*3W=G)\/?&6E//";
MQ/$CO+:EAO"->Q88KUVG/7I77>-;:>Z\:Z7;VG%Q-HFIQQXX.XK$%_4UWOV:
MW+N_D1[WQN;8,MCIGUJ0HI<.5!8< XY% 'D?A/[%J1\(02>,9+NYM LD6E1V
ML0>V9(61EDV+N0 %E^;&3CK72?">-$\&RLJ@%]2O&8CN?.89_(#\J[5+>&.5
MY4AC61_ONJ@%OJ>].1%C7:BA1UP!B@#F_B'9W>H?#S7K6Q1GN9+-PB)U;C)
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MJ[[1N&BVPSCGF67_  'Y5Y_HPEMM*\$WS:S_ &-:*=4M_MS1QLD<C7!*JWF
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M^;Y,^9L#97ZG=UK8A@AMU*PQ)$I.2$4*"?7B@"2BBB@ HHHH **** "BBB@
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MSM@W'CMNS7D]AI%\O_",W\GAK67U6POHY=7O+DL[R,596\L%CO7<V<J,  4
M>H>*O$$7A;PW=ZU/ TT5ML+1H<$AG5?TW9_"LVQ\7W;>(;72=7T*?3#?Q22V
M4C3K+YNP LC!?N.%.<<]^:K?%C?_ ,*SU?RP"_[G:&Z9\Y,9K/OVUCQ/XKTB
MYL]'OM..D07<CRWL813/)%Y:(AR0^"221Q@#GF@#6T_QE>SZKIUMJ/AZYTVV
MU-G2SFFE4N652^V2/&8R55B!D],'%9B_$+4]2T75[_2O#DK0:>MPCW$MTBJ)
M8F(P%(RPVC=GIVY.:YO2M)N8K_PEJ2^&M9%W97 &K7=V6>5Y'A="R@L=R;SD
ML,  C'?'2^&]$U&+X<:]ILMH\5W=3:AY4<@VEO,9]A^AR* )?"_C6_GM?"UM
MKNGF&?6;/?%>"566618E<DJH 4L"Q ]B*Z&S\0)?>*M2T2&V8KIT,3SW&[Y1
M))DB,#UV@$GW%<-<V]S<?!FPG:QNM.U3PU!;W$8O8_+/FVR*6QSRK*'7/?-:
M_ARXF\/_  ^O_%-[92S7M\9=7N8$(WX;E4Y_NQA1^!H [B5G6)VC3>X4E4SC
M<>PSVKQZ\\6Z[JOP^O\ 4=1M9(%@UR-(I()5+%%NP#$%4 G:!MR?O5[%&_F1
M(^"-R@X/:O(H=+U?_A$=0T%M&OUNH?$"W0<Q?NY8C>*^Y&SSA>3Z4 =I8^,)
M_P"W)M+UO1WTIULGOHI#<+,KQ(0'SM^ZPR..?K3-*\:W%[=Z6+W0YK"QU?/]
MGW+SJY<["ZAT'W"R D#)Z8X-5_$FA7FK^-(_+B=;6;0;VS:XQ\J/(T84$^N
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M]H.J#2KBR#*9(9^> 1PW08QUW#I4TOC/5(=1L=(?PS)_;%Y:27*VPO$*QA)
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M97!\76MUI/A[5]&U-M0W:DR.?L,\.3O<G.QRPP00H;)YZ5G:/X2L[ PZ-?\
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M*FX;03N).3C@<]:9_P )O?7]A\/[U[2R\W5[TPW(:+=L(R"8R3E>0?6@#O\
M6]&M/$&D3Z9>[_L\Q4MY;8/RL&'/U45?9@JEF("@9)/:N!L?$VLZCXMO+*+5
M=)@DM;\P'1KB(I/);@_ZY7W9)*_,,+CH">]:_C_2K[6/"S6]A;B[9+B&::S,
MFS[5$CAGBW'@;@.] '06M_9WP8VEW!<!#AO)D#[?K@U8KSC0+OP=+XIM98=&
MNO#>MP6\H%I+9_9?M$>/F'RC;(%QD8.1C-4-'^)<UY<Z->RZ[HD\6JW:6[:/
M#C[1:K(2(V+;R68';N!4#DXQB@#O=>\,V/B3[.FHR736L3;GM$G*0S\@@2*/
MO $#@\5HWJV9T^<7RP_8Q&3,)@-FP#G=GC&*XK3=9\7:];G7]*?3VTW[:\,6
MFO"1)+ DIC9S*6P'^5F VXX YK*TF\UVWO\ XB7MSJ5M=161?$#VI"LRVZE?
MXSA<#!7'/)R* /3+2[M[^TBNK2>.>WE4-'+$P97'J".HJ:O-]-\5:QJ6A^#K
M#3?L5GJ&LVCW$T_D;H[>.-06VQ@C))90.<#FFZEXTU_1-*\1VD_V2[U;1Y[,
M13)$8TN(IW4#*Y.UOOC@XZ&@#TJH[BXAM+:2XN94A@B4O))(P544<DDGH*Y*
MQU/Q#IWC>TT;6;RRO8-0LY;B-K>V,)@>-D!7EFW+A^IYXJ'QR3J>O>%O##_\
M>FHW<EQ=KVDB@3?L/L6*9^E ':0S1W$*30NKQ2*&1U.0P/((J..^M9KR>SCN
M8GN8 IEA5P70-]TD=1G!Q7)7NJ>(]7\2ZOI?A^ZL;)-'CBWM<VYF-Q-(F\)P
MR[%"[<GD\^U4_$4MWINK>#?$D]NMKJ$]U'I>H0H^Y2DX/RDC[P60 CZF@#T"
MF--$DR0M*@E<$JA89;'7 [T^O.O$G_)</!'_ %ZWO_HN@#MI=;TF'58M+EU.
MS34)1F.U:=1*PQGA<Y/ -7Z\F\#Z=JS?%CQE-<ZC9S/;S6HN6^PX:4&$[0AW
MGR\<9^]G':NSN]=O-.^(&GZ3<B/^S-3M)/LSA<,MS&=S*3GH4.1[@T =-17G
M-QXWUF5KYK!+7R[K6TT72FE0E0P!\Z5\'YE!5\ 8^[4E_P")?$'AN?6M-U&Z
MM+Z>+1)]4L;I+8Q?-'PR.FX@\E2"".,T >A45R5]XCOK>U\'R((MVKW445SE
M?X6@=SMYXY45?\6ZC=Z7HZSVM_IVG[IE26\U!L1P1G.6 R-S= %R.OM0!O45
MY;+\0]2A\#>(-1MKNPU2ZTF^@MXKNWCVQ7*2-%SMW'#8D9>N,BK^M>)=9\/O
MI>E:MK^C6-[J+33R7\L.R&VB0+^[56<;V+-@$D< G% 'H=%<QX'\2-XDTF[>
M2YM+J:RO)+1[FS/[J?:%977DXRK+D9.#FLFUUGQ=K@O=8T5]/-C;7TEK#ITL
M)WW,<;['<R[AL8D,0-N.!G- '>T5PC:QXHUV[U^?0[NPM+32+A[2*&XMC*UU
M*BAGW,'&Q<G:, GJ?:JMKXPUOQ+JFAVNC/:646IZ*=0DDGA,I@8.JG W#=RV
MWG'7/;! /1:*\H?Q=XR3PCJVNO<:6O\ 8-W-;3PBV8_;O*DVLV=_[O(Z  \@
M]C@;\VK>)=7\9ZMHFDWEE8VMG:V]PMQ-;&9PT@;Y=NX#G;G/;'3G( .XJK?:
MC9:9"DU_=P6T;R")7F<(&<]%!/<^E>;_ /"R+JYTS1+>XU'2]$OKMKI+V\NN
M8HC;OY9"*S#)=B",G@9ZUC^+/$C>)?A]9RR7%I=36?B6"T>YLS^ZGVG(=>3C
M*LIQDX.: /8!J-DVIMIJW<!OEB\YK8./,$><;MO7&>,U:KS&XOH],^.&M7\H
M)BM?"WG.!U(67)_E2:!\0I[G5-#%WK^AWZZN2DMC98\VP8QEUYWDL!MVL2!R
M1]* /2+R\M=/M7N;RXBMX$P&DE8*HR0!DGU) _&B\O+;3[26[O+B*WMHANDE
ME8*JCU)/2O(?$>K>(_$/PMG\0S7%D-,OIHBE@MN0\,7VA0C>9N^9N 2-N.3C
M&*[7XJ?\DO\ $/\ UZG^8H ["BN#DU;Q5I6N:1:ZC=Z?+#K0EAC6*V*FRG$9
M=!G<?,7@@Y Z9XZ5"/'>H/\ #5=22"$>(VN!IGV8@[1>^9Y9&,]/XL9Z4 =Y
M=W=O8VDMU=SQP6\2EY)9&"J@'4DGH*=!/%<V\<\$B2PRJ'21#E64C((/<$5R
MWQ&#K\+M?65@\@T]PS 8!.WDX[5BG6;S2_"'A2./7M(T.TDTN(O=7P$CNXC3
M:B(67(Y))R>U 'H]%>?^&O&^H:M?>&GNUMA9ZQ9W*[H0<?:8'P2I)^ZR!B![
M=:HZ9\1[^3PWXGU2^B@5[2'[;IBJI'F02%U@W<\DLG)']X4 >G45QWC*;6(/
MA3J4_P!JCM]3CTQGN)%CR-WE_.%&1M[X.3CWK-M-4\1!/#GANUU&T-_=V#7D
M]^]H2(H%"!5$>_YF)8#)/8G% 'H=(S!5+,0 !DD]JYKPIK6H7E[K6C:NT$E_
MI-PD;3P(42:-T#HVTD[3@D$9(R*RI]7\1ZUJGB)=)N+*"PT=OLPAFMR[7<GE
MAW!?<-@^8 $ ^ISTH ZQ-<TE_L.S4K1O[0!-GB9?]( &3LY^;CGBK]>1^'=;
MN-.TSX5Z=%!;/%J%O(LCRQ;G0+&I&P_P]>:W="\3:SK'B.:$:KI*/#>RP7&B
M2Q&.XBA5F"R!]V6) 5ON[2&ZB@#OZJV^HV5W=W5I;W<$MS:%1<1(X+1%AE=P
M[9'3-<9I.L^+M>M8O$.FOI[Z9+>-''IK0E9&MUD,9D\TM@/P6QC&..M<_9:Z
M/#/BCXK:R8O.-J;-TCSC>WE,%&?0DB@#UVBN(&J^)O#^LZ'%KMY8WUMJTQMG
M6WMC";:;874*=QWJ=I'.#T/M5+PMXNU75G^WW.K:3)%&LK:AI*Q&.YL H.!R
MQ+D$ '( YR#VH ]$HKRS0_B//=WNAW$^NZ'=)J\ZPOI5J1Y]EO!*$MO)8@A5
M;*CD\=*W?B*\MVN@: LTD-OK&I+;W;QL59H51G9 1R-VT#Z9H ZVWU&QNYGA
MMKVWFE3[R1RJS+]0#Q5FN4NOASX9D2T:PTZ+2KJTE22"[TZ-8IE*GH6 ^8$9
M!#9SDU3.J>)O$&LZY%H5Y8V-KI,PM4%Q;&8W,P0.P8[AL4;@.,GJ?:@#MZCF
MGBMH'GGE2*&-2SR2,%50.I)/05YY9>--;\2W7AR'2/LEDNK:7+=3O-$9?L[H
MZ*=HR-W)8 $CJ#VP<#QKJNNZK\)_%4-Y>6HFTF^:RN7BMB!=(&C*D#=^[/SC
M/WNE 'J-MXFT&\%L;76;"<74C10&.X1O-=1DJN#R0".!ZUHW%Q#:VTMQ<2I%
M!$A>21VPJ*!DDGL *\YEOM2\.W_@72Y3IMT+^XD1I$L1%Y:"-2H0;C@^I[^E
M5M=U?Q'K_A+QEJ%K<646E6BWMDEFUN2\J1HR/(9-W!SN(&TC@ ]<T >H12QS
MPI+$ZO&ZAD=3D,#R"#3Z\I_X36:W%MI%OXAT31/L&EVLF=2 )NI7CW!!EUVH
M %R1DY;VK0LO%^N^)]3T>TT>2TL8M0T4:A++-"9C XD"D*-PW<G'/U]J /1J
MJ_VC9'4SIGVN#[>(O/\ LV\>9Y><;]O7;GC->4ZYKOB/4_#FG1MJ%M;WEKXH
M32[B6*W.V=DF&R0#?P. 2N>?45U-MK-^GQ870+A;.8)X?%T]RD&R1Y?-"G!R
M<(>NWG'K0!V]5;/4;+4?/^Q7<%Q]GE:";RG#>7(O5&QT(R.*\_TCQMJ#>*M*
MTZ\UW0]0?49989['3QEK)E1G7#ACO'R[3D#DU-\)^GC/_L9[S_V2@#T$S1+,
ML)E02L,JA8;B/4"GUYUK7_)>?#'_ &"[G^M49O%OB[_A$M4\4)<:<EMI=W<1
M_9#;,QN8XYBI)?<-AV\# /(SWP #T+5]7T?2H%76=0LK2*?**+N94$GJ!N//
M6K\<:0Q)%&BI&@"JJC 4#H *\G\36&JW_P :M"6+4;-0^GSR6WG6/FB%> P(
MWC<3Z\8]#6I)XC\4ZAH^M>)=+N-/BT_39KA8+&6V9VN8X"0[-)N&TL5;&!QQ
MG- 'HU%>?/XGU_7/%]KI.A36=I9W&CP:H;BX@,K('=@5 ##)(V_3D^E4KWQ1
MXMDTSQ9JME<Z=!;>'[V>-(I+9G:Y2-5<J3N&W@]0#DGMCD ].HKA+37O$5OX
ME\.IJ,UE)8Z_'*5MHH"K6C+%YBC?N._@$$X'/( Z50B\;:A;>)]/M;K7-#NG
MO-0-G-I-H-TEJIW;&\P,=Q&U=P*C[QZ8H ]%NKJWLK66ZNIHX+>)2\DLC!51
M1U))Z"EMYX;JVBN+>5)8)4#QR(<JZD9!![@BO)M)U'7[#PS\0M4O-0M;[[%>
M7:+#):$*TB(F&Y<_)@8V?K6];>(]9U6/POH^DR6=E=W^CKJ5W<-;[TACVH L
M<>X#EGQR< #O0!W]%>:W?C;Q!86%[9.EE/K.GZS:Z>SA"D5Q'-M*MC)*$AL'
MDX(K;T?4]=M/'$OA[6;RTODET_[=#/!;& H1($9"-S9'S @YS0!U]%<GK>K:
MO<^+K;PSHMQ;V<ALFOKF[G@,Q5-^Q55=P&2<Y)/ %<]?>.M?L=$FB\JSEUFR
MUZ'2Y2$*Q7"/M*L!DE"58=S@@T >FT5F6-MK$>B-#?:A;3:F5?%S';%8U8YV
M_)NY X[\X[5Y=H'B/Q+HWPJL-86[M[^>\U40Q12PE2 ]U(K@ON.<GH<#:..:
M /9**X;6M2U[1+'3X=2\4:%I[2F1I]0G@V@GC9''$7YZG+9Z <<UGV7C;6=?
MTWPS::=-90:AJTEV)KP1&2)([=BK.B;AG<=N,GC)ZT >A17EK/=7%K%<1/<6
M^WSHE8%H]PRNX=LCD5/7DD>OZAX6U+Q]J&H/9R7\4FGP)*08X79TV([ DE5
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M*$M%#M&?WC?PYZ#U- 'G<W@?Q:?!9\'0SZ2--MY5,%VTLGFRQ+*)%1DVX4C
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M&6#J5=5;#!L]0003TK%D\!ZK<::)+BYLSJESK\&KW>TL(D6,K^[0XR<*H )
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MOK][I%C!>S-92-#<70@(@21>J;_[WX4 ;]%%% !1110 4444 %%%% !1110
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MRP1BHRV.![US&B^#Y](N+)3XAU&XTZP!6TLGV*J#:5 =E :0*#@!O;J174T
M>??#29K/X46FHVME)?7\QEGN(XRJRSSF5@^2Q SVY/05D:]XEQX$\:G3-(N?
M#NJV312W&'19&EDVMOW1D\E<9.>]=1)X&GM+^[N?#WB*_P!%CO)#-<6T4<4T
M)D/WF59%.PGOCCVHE^'>GS>&=7TB2^OIIM6*M>7\\@>:1EQ@]-H       H
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M2Y&:"QTDZ?ITJ>Z"2>0>A&Y5R/[IH ]5MM3T^\GD@M;ZVGFB_P!9'%*K,GU
M.13S>6HMFN#<P^0A(:7>-JX.#D].#Q7G>KZ3I.C'P%<:%:V\$YU&&".2W0*T
MMNT3^9DC[P( ))[\UC7<L<7P!\3;W5<75ZAR?XC=, /KR* /9*AGN[:VQ]HN
M(HL@L/,<+D 9)Y[ =:E7[H^E<+XQL;;4?B%X(MKR%)H"UZS1.,JV(E(R.XR
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M/N+L1_$"V1DX&!VKIO '_)0/B%_U_P '_HLT >B4444 %%%% !1110 4444
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M &"D*%!R<L..O?H#4&H>.M"TRY,%U-<!DC26=DM9'2V5_NF5E4B//^UCUZ4
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M/^)8=#-V8=B_ZWSMN[=C=TXQG%'PRU[4O$7A>>\U2X\^X6_GA#[%3"*V%&%
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M=TFYCU2.:R1UU4 7H+-^^PH09YX^4 <8JE>^-]"L-4>PGN)@\4B13S);2-#
M[8VK)(!M4G(ZGN,XI-5\;Z%HNH2V5Y/.'@"-<R16TDD=L&^Z9752J9]STYZ4
M 7KCPYI-U#ID,]DCQZ9(DMFI9OW+(,*1SS@>N:J7_@KP[JFJOJ5YID<MU(%$
MK;W"R[?N[U!VL1V)!Q3=6\:Z'HM\]I>3S[XD62=X;626.W5ONF1U4J@/7D].
M>E+JWC/1M'O39SR7,]PD0FE2SM)+CR8ST=]BG:.#UH =>>#/#]_8V-G/IX\F
MPC\FU\N5XWB3 &T.K!L8 R,\XJY!X?TFUDT^2WL8HFTZ)X;39D")'QN '3G:
M.OI5&\\:Z!91:?*]Z9%U&%IK,01/*9U7;G:%!)/SKQU_(TD/C?09M"N=8^U2
M1VUM-]GF22!UE27( C,9&[<2PP,<YH M77AC1;ZVU.WN;".6+5&5[Q6)_>LH
M !//! 5>F.E):^%=%L[JPNH++%Q81/#;2-*[M&C?>&23G.3US7.^)/'$;^!=
M9U/0[B:VOK!HDD2YMC')"6=/O)(O0J3@XQ6WI7C/1=8U3^SK6:=;EHS-")[:
M2(3QC@O&74!QR.1]>E $'_"OO"NV8#2$ E?><2R#8VX/^[^;]W\P!^3'2M>Q
MT73M-OKZ]L[58KB_=9+EP23(P& 3D^GI7'>"/&DDW@F^UOQ)?!A!J$T D$0!
M*APJ(%098Y(  !)KK-%\0Z?KR3_8VF66W<)/!<0/#+$2,C<C@$9'(/0T :E%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XR
M?^/KXU?]>@_])I*]FIOEI\WR+\WWN.OUH \^U5%CA^&RHH4+>Q* !T'V63BL
MBTM+G4-5^+UG9@FZGCCBB ZEC;, /SKUG:IQE1\O3CI0%522% )ZD#K0!Y1=
M:WI7B#P_X)TC1KF*;48[^QD:TB.9+58<&0NO5-H!7G'6K_A:-%T7XBN% =M9
MOP6[D")<?S->C+#$DC2)&BN_WF"@%OJ:<%4 @*!GD\=: /*/*C_X0/X5KL7'
MV_3VQCOY#G/Y\T_Q)J,VD^)/'5Y;QQ-(FFZ<"98_,1 TDBL[+W"J2W_ :]3V
M+A1M&%Z#'2@HISE0=PP>.HH \BMKVWG\;7R1^(Y=<^T^'KB&"Y<0A)90P9HX
MC&JAR <D#)&>O!QE7FHV5_\ "[X<):74,[VVLZ=#.L;@F*0(V58=C[&O<5AB
M0($B10GW0% V_3TI%@A486) -V[ 4=?7ZT >?:;KNE>%?%/C*/Q!>P6<MQ=)
M>0M<,%^T0&%5 3/W\%67 R<UC^"+"XL=6\!07L+1SIHMZXCD'S1AI(RH]B%8
M"O6I(8I65I(T<H<J64':?:G;06#8&1T- ''^!^-9\9@=/[;;_P!$15175=/\
M-?$_Q!/KMY!8Q:A96KV<]RX1'6,.)$#'C()!QUYS7?!0,X &3DX[TV6&*90L
ML:2 '(#*#@T >,:;;ESX,GDA9+:\\37MY:QR+@B)A*T9P>G9A]17M5(54D$@
M$CID=*6@#PB6[LI_A%J^DM/"]Y!KN+FU+#>BM?#&Y>H!%=]XTU@V7B31K*?6
M8M"LI;>XE;46CB+EE* 1(T@*J2&)/!)VX%=KY$6YF\I,O@L=HYQZTLD4<H D
M17"G<-PS@^M 'A^B:E:V-YH6I7UXWV.Q\0ZDMY-=!4>)IU?RGF4 !-V>N !N
M[5-KMS#X@O/B!=:-(9H!!I<OVBW0.)4CE9I'3J' "L.X.WO7M30Q.KJT:,'^
M\"H.[Z^M*L:)]Q%7@#@8X% ' ^%?[/U'QC_:$'C";Q!=0:>T9*0Q"*.-W4X9
MHU W93(4\XSQ5SQPVEQZEI,USX@?P_J4:S?8]08)Y.#MWQOO^4YPIP2#\O!X
MKL8X8X01%&B G)"J!D^M$L4<R;)8TD3^ZZ@B@#QQ=4O;S5/#VN:CKL>AP36=
MY:+J<,$8@F=9P0W[T$()47>#WQP:GMO[/T6_\+^(3JLUYHK:E?O<:C<Q")%E
MF3:K\ *$+*V&QCY_>O7'BCEC\N2-'0_PLH(_*E:-&C,;(I0C!4CC'TH \L\7
MZMHWB+1K>;2[97MCXDL89;M8U$=XP9065A]\ ?+D^F!D"K_C+?9?$'2K^?Q
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M?OKJ?4)[V6SN8E4P-'."?F8GAEW$;<9) QUJ*;PPECJ5M?ZOX<U+5(+C2+2
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M<R6B!Y8V#R8^7(R."#CH<=LD4DT+58;+3[G5M'U&?3K[5+Z_O]-M&S(AE.8
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MEI(8YC$SCT#CE?J*X!H_$-SX'T#PS_PC6H1W>F75DEW,ZKY)CAD4;HVS\^0
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MM;>[\/"UM%G4!Y'!EX*@G:<MT]"/7% &1H_B?Q!IOA7X=VNG6@NO[07$S27
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L_4M'M-5FT^6Z#EK"Y%U#M;'SA67GU&&-:%% !1110
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M1[32&OFM0X-[=/=S;FS^\8 ''H/E'%:%% !1110 4444 %1K;PI/).D4:S2
M!Y H#,!G )[XR<?6I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOH+<6\KM&LD-P.I9HC@!L\Y4@\XZ5T-% ',6OA2[MQJEXVNSMK6H1QQ&_$"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
; "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>exhibit1012-stuartexecut013.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBN2_X3:2/4X4N-!OX-,GO?L$5_*4 :7<54^7G<$+#
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MZECGMYVC1R45\Q@L<=0&#@X('!YKT $D D8/I0 M%%% !1110 4444 %%%%
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M6TUU#'<7&X01/( TNT9.T'DX'7%1^=I^J)=V0FMKI4S#<PJZOMR.5<=LCL:
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MX<LK"-<!N0><KT.:]BHH \OUF&1?$LUQHFD:[IOB!KZ,,\"N;*\B#J#)*?\
M5X,><]&!]:]0HHH \]N([NR^)'B(OIM])#JNEPQVUQ#;L\6Y%DW*S#A3R.O6
MJYTC4?\ A6W@6S^PW'VFUO-,>XA\L[H@C+O+#L!WSTKTJB@#QT^&;*WN=6TK
M5= \0W]S=:E-)"+:YN$M)X99-X+,K"--H8A@<'Y>^:]A    Z"EIDTT5M!)/
M/*D4,:EWDD8*JJ!DDD] !WH Y..PNA\89]0-M+]C.@I"+C8=F_SV)7=TSC!Q
M7&'PS907.K:3JN@>(;^YNM1FDA%M<W"6D\,LFX,S*PC3:&(8'!^7OFO61J-D
MUU%:B\MS<31^;'$)5WNG]X#.2/<4^[N[:PM7N;RXBM[>/EY9G"(O..2>!S0!
MY)XMTR_U8^+;*ZTO7+[4Y ZZ4(WF6T2#REP05(C+9WY!R2<#%6->/VL/>Z?H
M?B73_$7V2,6%Y90R*MR0@VK.,;%"ME2)!T&0<&O6%974,K!E(R"#D$4M 'GM
MG=WOA#Q'XADO](U&\34Y(KNWET^U:=6<1*CQG;]PAEX+8&#UJGX5\-ZKHVI>
M"8[NT<-;:??FZ9!N2&261'"%AQGDCWVFO3J* /+-2LM9MO\ A)Y(K74TM;G7
M[>2<V:.)I;3RHQ(8MOS'D8.WG -86IZ-=M8>-+?2O#^KQPZI86;6"W"2RM+Y
M<KA]Q8DJWS A2<[><#FO:[>ZM[M&>VGBF179"T;A@&!P1QW!X(J6@#@9;F[\
M3^./#<D6D:C9Q:29[B\DN[=HU5VB,:QHQX<Y8G*Y&!UKD=.\+:D? J_;-+U'
M_0_$TM]+;0[XIY(#N0M'@AB</N&#S@@5[945Q=6]I&)+F>*%"RH&D<*"Q. ,
MGN20 * .3\$Z?IL5WJ5]I^DZO:+*(XOM&J33&2X"[CPDI+*JECUQG)K0\=:-
M<^(/ ^L:79X-S<6Y$0)P&8<@9]R,?C6U'?6DUW-:174+W, 4S0K("\8(R-R]
M1D=,U/0!Y[=7MWXQU?PQ##HVIV2Z?>B_O9+RU:%8BD;J(U+<.2S_ ,.1@9KE
M=.OKR^^%-_X:M-&U">]O[B[@MI8[=F@97N'!=I!\J;?FR&(/'O7M;,$4LQ 4
M#))/ %9'A>PTS3= A@T>[%W8F266.82K(&+R,[89>" S$?A0!Q.G:O\ \(W\
M0?%JR:=J%Y#Y-@@>RMFG;>L)PI5>1GL>G!R1Q5+0-'U7PB/"^M7VF7<R+:WD
M%[!:Q&:2V,\WG(=BY) ^Z< XKTFST2VL=:U/58FE-QJ/E><&(*CRU*KM&..#
MSR:TJ /(-;TC5=:T;Q7K$6E7J?VKJ.GFVM9(2)C% T:F1DZKG#'!Y '-=1XY
M6YMO$7A+6(["\N[6PNYC<"S@:9T#PLH.U><9-=O10!Y<\VH:6GC?2!H>J7%S
MJMQ-<64D5LS0R+) B\R=%*E3D'GT!-7_  II=_;>)]!GGLIXHHO"<-M([QD!
M)0Z$H3V;@\=:]"HH \:U_0=7G\'ZK;Q:9=O-)XO>Z2-86+-#YN?, Q]W'?I7
M6XN=.^,-Q<RZ?>R6FH:9#!%<PP,\2NLCDAV'"\$'FNXJ.>,S021"1XRZE=\9
MPRY'49[B@#RG1M&N1\16\*E =$T6\?6X2#P#*/W46.VUVF8?05ZU6/H'ANS\
M/)<F"6YN;F[D\VYN[N3S)9F P-QP!@#@   5L4 >>:A977_"R-:ADLKW[-K.
MCQVD%W% SQ(X,@.]APN-P/-93?VGJ_@;1/!1T/4K?48'LX+N62V98(4@="T@
ME^ZP(CX"DDYKUBB@ KS[4!J>G?$[4KFVT^\D_M#1HX+.YC@+Q+.K2'#L.%Z@
M\\5Z#10!XWI5G,NK>$-4&C>(Y+FUGVZM=7PG=A+) Z?*C$@J'/+* H&.?1F@
M>%M:\.0GQ?9VE]/J$-_=)<Z9*IS+9O,3^Y4CANCC'WLGV%>ST4 >2ZEH]K!X
MBUZYU'1?$EZFJ-'=60T^2YC20&)5,4@1@$8,O5P.#[8KT_2[2.PTFSLX8#!%
M;P)$D)??Y:JH 7=WQC&>]6Z* .%\8:;>W?Q&\"7=O:3RVUI-=FXE1"5B#1J%
MW'MD],UR]GX8L;8SZ)JF@>(KV\;49"IAN;A+.6%YBZR%@WE* K<KURO0DYKV
M*B@#S"2?4/#D'C33'T6_N'O[FXO;2YCAS;LDL2@[Y.B;2#D'G'0&LW3HIY=-
M\+QZC8:W>Z2?#MJ+2#3FE6-KG'S>8T9&T[=F"Y"CFNYU7P+8:K>WEP=1U6UC
MOP%O+:UNMD5P -OS#!(RO!VD9%=);V\5I;16UO&L<,2".-%Z*H& !^% 'CFG
M:-JWV/X=6[:3>QR:3J<Z7@:!]L0R<-N(Y0Y&&Z&O9Z** /)_%FGWVJ:IXHL[
MS3-;OKJ:$1Z,L#RI:(AA +,5(3<'W$ALDX  -6-%O+KPWJW]KW&B:Q/9ZGI-
MI$!!9.\L,\ 93&\>-RYW @GCWKU"B@#SB\N=7'C#PCK^I:%>1AK.Y@N(K2-K
MC[,\A0H'VCC@<GH#FL7_ (1C6;O2OB#%%I\RSSZTE[9I*I07*QNKX4G@@[2
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M/N#6G44=K!#/-/'$JRSD&5P.6P,#/T% $M%%% !1110 4444 %%%% !1110
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MPDAMY7+,IBV_,X#, =P'3I0!HR^)=?U+QQ)H>BC3X[-+&WOC<W,;LP1V8%0
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MDD88HN&QN^]\W0<<'-:GBS7+O2+?3[;38X7U'4KQ+.W,^3'&2&9G8#!("J>
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MIQS[=*R;OPKXK@T+Q'X9TV+3FT_4Y+F6"]EN&5XEFRS1F,*<G)(#;L8.>V*
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M)1U?:W]Y@01Z52M/!.J11Z5<3RVK7O\ PD#ZS?A&.Q=\;ILCR,G *#G&<$T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!D/X6T"36!J[Z+8-J(8,+HVZF
M3<.ASC.??K6O110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQZ;I_A*+5?\ A)XKJ^OE$1GU$2F9S&IW2$.<Q'LG8YX% 'J-%<)XC\;L-/\
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M&2W<'N7PLA;:!R3C@4^X\>VT%W.W]EWSZ3;77V.XU1=GE1R[@I^4MO*AB%+
M8!SZ4 =;17+?$/Q%>^%?!EYJNGVK3SQE5#?+MBW' =@2,C) P,G)'&,D8EUX
MFU2W^(=F@TK4WDN-$=UTE9H^)!.!O8[_ "Q\H^]GN!U.* /1**Y2'QS!=: F
MH6^DZA+=M>-8'3U5?-2X4D,K'=M &"=Q.,?E61XB^(=W:>#+_4K#2+J+4;.\
MCL[FWG,9-L[,F"?FPP(=<%2?O#H,X /0J*R+W5[JT\+SZL=*N!<10-*;)GC\
MP8[$AMO YX;I[UY^OC/5[K3_  %JMW9W\4EW.PE@@9?].S;,5*JK8VER,!\8
MQDXQF@#U>BN2@\>VBV.LRZGIUYIUSI!C%S:2;)';S/\ 5["C$-N/ YZU?T7Q
M*=3U*;3+W2[O2]0CA6X$%RR-YD1.-RLC$<'@CJ,CUH WJ*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MJ-IX4G2!I8UFD!*1E@&8#J0.^,C\ZDH XB\_T/XTZ9<3<1W^B36D)/>1)5D(
M_P"^3G\*RK?3;]?'GQ)N#97(AN["V6WD,3;9F%N00AQAB#QQ7;Z[H-MKUO;I
M-)+!/:SK<6US"0)(9%[C((Y&0000036A/<06ENT]S-'#"@^:21@JCZD\"@#R
MDI/I/[-HL[VVFANWT\VHMY4*R>9(Y15VGG.6%>I:=;M::9:6SG+PPI&Q]2%
MJEJ.AVFLZAIE[<RR216,GVB&W!'E/+C"R-QDE<G'.,G/I6M0 445&D\,DTD*
M2QM+%CS$5@2F1D9';(H DK(\1ZC>Z5I8N[+2WU(+*HN+>+F3R3PS(O\ &P_N
M]^:UZHZEI46J+&LMQ>P^620;6ZDA)SZ[",_C0!YW:6VFZAXXTC4?".@7FFR1
M/(VI7+6+V<+Q&-@(V5@H=BY4\ XQG-8D"W4T?AS4+RR\376KV>I13:Q)<)<M
M% <LI$<7W&&6&#&IPHY///I47AK39GE2+5]7D>)MLBKK$Y*'&<'Y^#2/X<TN
M.YCMGUG5EGE!,<3:S.&<#J0-^3B@#E3IE_\ \*N\<6OV&Y^TW%YJ;0P^4V^4
M,[;2HQD@\8QUJ>VO)O!_BG5+V^TW4I[75+*T:![.T><B6)"C1,%!*L<@C.!R
M>:ZC_A$K3_H(ZW_X-KC_ .+H_P"$2M/^@CK?_@VN/_BZ .8FO-0C^('AK7-4
MT:\MENM*EMI([>-[@6\SR(P1V5>.!U( Z^E<_;^']8DT#QJ8]-N3.GBIM1MX
M'C*FYC25'^3/W@0#C'4UZ/\ \(E:?]!'6_\ P;7'_P 71_PB5I_T$=;_ /!M
M<?\ Q= '.SW3^+O&>BWVGV.H1V>E6UV\\UW:209DE0(L:AP"QZDXX&!S6<FE
MZ@/@_P"$K+[!<BZ@N=/:6#R6WQA9E+%EQD8')STKK;KP]I5C%YMWK6JV\><;
MY=9G09],EZE7PI9,H9=3ULJ1D$:M<<_^/T <=?9@\4-+H-GKVG:Y)J2"XM5B
MD:QNXO, >9R08P#'D[@0V>.M;?Q=LKO4?A;K5I8VLUU<R"'9#!&7=L3(3A1R
M> 3^%:__  B5G_T$M;_\&UQ_\71_PB5I_P!!'6__  ;7'_Q= &)JYET'QYIO
MB*XM+N;3I-*>PF>VMWF:!_,612R("VTX(R!P0,US.HZ5J6IZ;J>KIIEXB:GX
MDLKB&W>!A(((S&GF,F,J#M)Y P.M>@_\(E:?]!'6_P#P;7'_ ,71_P (E:?]
M!'6__!M<?_%T ;]>9>$]8D\!:&?#6LZ/J[2V<\WV:>SL9+B.ZC:1G4JR @'Y
ML$'&*Z[_ (1*T_Z".M_^#:X_^+H_X1*T_P"@CK?_ (-KC_XN@#@IM"UA_ >N
MWMQIL\=YK&O07Z6(7?)%%Y\. P7/(5"Q]/P-='XIMM5_X36RO=+MI7FAT2_6
M&0(2BS'RS&I/0$D=#UP:VO\ A$K3_H(ZW_X-KC_XNC_A$K3_ *".M_\ @VN/
M_BZ //='C'_"2>$-3CL_$LYB=XM1N]06Y?9/)"R@"-^%&[(+*H49'/I622^'
MPML_":Z+JK:K97<"W*_8I B(ETK;P^-K@@ C:2<$GH":]+_X1*T_Z".M_P#@
MVN/_ (NC_A$K3_H(ZW_X-KC_ .+H Y&\6YM?&'CZV>POF.KZ=$;*2.U=XY"E
MNZL-X! .>,$\DC'6K5YIUZWA+X>0K9W!EM;VP:X01-F$+"P8L,?* >#GI72?
M\(E:?]!'6_\ P;7'_P 71_PB5I_T$=;_ /!M<?\ Q= '#)/=Z)X.\0^$9-(U
M*?5+B6\CL_*M'>*Y6=F*/Y@&Q0-_S;B,8-;/A[1;S2_B)&LL$K06_AFUM/M.
MP^6TB2-D!NF>AQUKH/\ A$K3_H(ZW_X-KC_XNC_A$K3_ *".M_\ @VN/_BZ
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M-5FYR"@)(&/>N[HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;O%%!+O$82,KM)P,D<<XY.: *&M7OB$?%K1;"SN[5+%K&:8Q2*_S -&&W88
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MIMC.2J["Q)/;('X5=TK2]0M_'WB'4Y[7;8ZA!;1PR"12<Q!P<C.0#OX^G.*
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MM,U]5C.GV^FRVTI+_-O9B1@>E<O-X4\8?\(&/!<5E8_9K65!'J!NN9X4F#J
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MM7-U):?/P1) B+N/;E30 EGXIU\:]X?74+73TTS7E<P1Q;_/MB(C(H=B=K9
M(. ,'U[P-XSUBR\0V-OJ+Z&L-YJ'V/\ LZ&?=>0!BP21B&*G. 2 HQNZ\5HW
M'AV_EN_!4BB/;I!;[4=_3-NT?R^OS$5RMKX.\26FDZ1:1Z+IBS:1?QW<MR+@
M>9J)5R2<[<ID,6.XDY % #M,UGQ NA_$.^U9M.O[:PGND%M)&[*SI#'\F&8C
MRB,Y7KDDYYK9L_%&I76G>%-+T*STZVOM2TM;Z3S(V^SVD*HG"HI!/S.% R,
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MIF158%>P4^:P]VH DAU?[3XS\;:6=/L8GL["!FNX8MLT^Z(G#MGD#H/05/\
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M1(G+,RD$;_F7*\,IQSWQ3M$\5ZAK>AZ))&+6/5+JX>&]A:%L0&+=YPV[\C!
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MCT;2#;[_ .TA.?-WX\ORD#=,<YSZC% %"TT#Q NG3+?^)S<ZB558+E+-8DB
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M!G.<_B:;9^!M$L=2BO(8[K$$K306SW<C6\,ASEDB+;5/S'MQGC% '/\ QO\
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MQ-.OVJ0B1XW#J[9;E\@98\GOU-;+:19-KB:R8C]N2V:U63<<",L&(QTZJ.:
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M,.<^6SALLOH">.V*G'@?0$T3^R(K-H;1;DW<0AF='AE))W(P.5().,'H<=*
M*/@72]1TF36(KG3K;3+&6X26UL;>Y$RV^4&\#"C:"1NVXQ\QKG/%NCQ6.N:Q
MKVK:)%K&E/Y4C7UO.%N]+$:*#L!YV@C?\I!^8Y!KT'1=!L=!MY8K)92TTAEF
MFGE:665\ ;F=B23@ ?A6=J/@;1-4U">[N$NA]I*M=017<D<-R5  ,D:L%;@
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M_4;+6_#U]9^';#2;98'2\N(=0$KWL;1Y!<;!O;?M;<23R:]"ET33Y]8_M66
M/=_96LR6)*F)F#%2O0Y(%9VD>"M&T2^BN[5+IW@0QVRW%U)*ELAZK&K,0@X
MX[<=* ,_QW]ENY-%TJ72O[5N+JZ:2&RDG$4#^6A),Q(.5&<XP<G'%< +9I=
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M1"1;4K$[94,0 YP5!)[FO.I)X;ZTURWEU"/4O,\4Z<6E,:H)D/DKN"CC:<$
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M"#M/3TKR\Q6OA^PCFT;Q99I>6VBVZ7-MJUMMBOK=5<Q'#$,IP6!VD^A&:TM
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M4^![75=3:-KJ2656,:;1A7*CCZ"LG3P!\?\ 5@!@#08L#_MH*7X(?\DNL?\
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ML8MZ/B4EMJ')4 ;B#P>G>NFN]5L;&]LK.YN%2YO79+>/!)D*C<<8]!SFO,]
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MW.8%:%2(CZKQ\OX53T'7UUK[9#+9S6-_92B*YM9BK,A*AE(920RD$$$>_I7
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MMP-SNW3)) 4=26)P*PIOB#:V6A:CJ&HZ;=VD^FW45K=VA*NZ&0IM8%20RD2
M\<]>* .KN+:"[A,-S!'-$2"4D0,IQTX-*((EG:<1()64*T@4;B!T!/IR:YJQ
M\9A]9ETW5M(N](D%H][$]R\;+)"A 8G8QVL,C*FN8UKQK>ZK:>&KB#2]3TVR
MU#6;/[-=-(H%Q$9/NL%8E0R\X88(_*@#TR&"*WC\N&)(DR3M10HR3DG ]ZAO
M--L-0,9O;*VN3$=T9FB5]A]1D<56U[6H= TIKZ6&6<^9'#%#%C?+([A$49(
MRS#DFN1\4^.M8TOP=J5]%X>O;+4+26*)EG:-D42, '5@VUQSMP.02,@#F@#O
M&MK=KA+AH(C.@*I(4&Y0>H!Z@4?9;?[5]J\B+[0$V>;L&_;G.,]<>U<]>^)]
M1MC:V\'A?4+F_FA:>6W62("! <8,A;86/902?I6)?^/[V;5O"(T32KB[L=92
M68C?$CN%C8F/YF&UE.">QQ@$T =X+:!;EKD01BX9=AE"#<5],]<46]M!:0B&
MV@CAB!)"1H%49Z\"N5N_'L-K<W<@TF\ETBRN?LEUJ:LGEQ29"M\I;<RJ2 S
M<<]<5M^(]2GT?PYJ&I6UJUS-;0-*L2LJYP,DY8@8 Y_#CF@"^UM ]PEPT$;3
MQ@A)"@+*#U /45&=.L6@G@-G;F&X8M-&8EVR$]2PQR3[UQ%C\0[BU\+^&[O5
MM&O'OM714B2$QL9W\D.& #84.> #C'? K5OO%]_9JBIX6U*>X2T%W=QI)$!;
MJ<_+N+ ._P IX7/ZT ;W]D:9Y:1_V=:;$C,2+Y"X5#R5'' ]JD@TZQM;J:ZM
M[*WBN)O];+'$JN_^\0,G\:YZX\;Q23Z9;:-IMSJUSJ%F+](XG2/R[<XP[%R
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M0KY.7QZ *2?3!!Z&NOU"RNG^)UK=I;2M;+H=S$9@A*!S+&0N>F2 3CVKKZ*
M/$])TK5=-^$/@@W&DZAYVF:VEU=6R6SF9(A-+EO+QN/# ].AKK-+M;NX^,]Y
MJ_V&ZCT^XT")4FF@9%W&0'8<CA@.J]17H%% 'E'A_P /:HGBZT\/75C.F@^'
MKRXO[6=T/E3!\&!%;N4\R7Z;1563P[9V]WK>E:KI'B6]N+S4II8([.XN%M;B
M&9]P+,K"-<;B&W8Z=\U[#10!SOC?1;C7? FKZ19?\?$]JR0@G&YAR!D^N,?C
M7.W=_<^,M4\+V]MH^IV?]GWRW]])=VCPI!LC=?+#, ')9\?+D8&:]$HH X_X
M<V-U8:%J$=W;2V\CZM>2*LJ%2RM*2K<]B.AJ#QQ#ILNH69U'3=;#1Q,;;5='
M65I87)&8SY0) (P?F!4XKMZ* /*H['Q#=^*OAG?:I:74D]M#>_;9C%_JMT8"
M>81PK$8X]<U)-I.HGX=?$&U%A<FXN]1OWMXA$VZ96QM*C&6![8ZUZC10!QFI
M6-V_C#P-.EK,T-M'="=PA*Q9@ &X]LGCFN"ET#6#\%?&=@-*O3>7&L2RPV_D
M-YDB&:(AE7&2, G(]*]PHH \SUJ&YF\1&UU.RUVYM#IT"Z;!8/-'"T_S"3S7
MC("D?)RYP!FJ?A/3M074?AZ9=-O81INFWEM=&:W=!%(%C !)'0X.#T/:O6**
M .?\<Z3<ZYX&UK3+,;KFXM'6)<XW-C('XD8_&N3N=5N_$FM^#&MM!U:".RO?
M,O7N;-XA WDNNWYAR,DY8<=.>17IE% 'B4EO?3VVF7M[I?B.ZURRUB&YU.21
M;AHHXUGZ0QYV.,8("*<*"?KT/]EZ@? WQ'@%C<^=>7M\]M'Y3;IE:% I48RV
M2,#%>F44 <-?6%ZVN> )([28K:+/Y[>6=L)-J5&\_P //'/>N,M[>\DB\/:A
M=Z7XDN=8LM2BGUB>X6X9(^6!$<>=K#)!'EJ0%'7GGVRB@#QK4[F^T'X:>*_#
M<^C7[7*->NEQY!^SO!([2>9YOW<A6/RYSD8Q5JZTF"Q\07.H:G9^(IK:_L;5
MK9]'DN #(D>QHW$)&#PI!;CD\BNNOOA]IVH7-V9=1U5;"]F\^ZTY+D"WF;()
MR"NX XY 8 UU@    P!T H \KU72]-T^ST^!=!\1Z5>V^G(MC=Z499Y%)R3;
MNR9!VM_?^4Y.#UKM-%UJ[\[2M&U>UF75I=*6\N)@H\K>I19%!!^\&8' &,&N
MAJ'[+!]L%WY2_:!'Y0D[A<YQ^>/R% ')^-A/9ZUX7UM+.ZNK73KR4W*VL+2R
M(LD+H&V+DD D9Q7(:W:ZIK=G\0;N'1=1C2_AT\6<<MNPDF"$AB%QG/?'4 C(
M'2O8:* .-\5:9=:AXT\-&&&4P+;ZA'+,J$K$7B4+N/;)SCUQ7&23ZG-\.=%\
M+KX>U8:EI]Q9Q7>;1Q&BQ3)EU?&'!P#\N>"2< 5[+10!Y#>Z#:V>J>(K/5-)
M\2WLM_>R3VL>GSW"VUS'*!\K%&$:8.X-OQQ@\UU6C:7/9_$_5IQ:3)9?V3:0
M0RLI*$JSY4,>I QFNTHH Y?QZVH+X>B^Q?;O*-Y"+TV 8SBVW?O-FWYLXQ]W
MG&<5Y?X@M?L6C^-GMM*U6VL+_3K-K.2^$S^9Y<S!M[2$E#EAA6(..<5[Q6;X
M@T2V\1Z'=:1>/*EO<@!VA(###!N"01U'I0!R<MW<>*/''AJ2#2M1M8M),]Q>
MR7=LT2HS1&-8U8C#G+$Y7(P,YKC-,NKG6/@S#X4M=)U![^^=H8I5MF,&PW!)
MD,H&U0!G()SD=.0:]QK-T#1+;PYHEOI-F\KP6^[:TI!8[F+'. !U)[4 <A9Z
M;?)\7/$]ZUG<"TFTJ&.*<QG8[#JH;H3[5S7A?2=6T3P+X#U2?2KYI-&NKHWE
MFL#>>L<OFIO$?4XW*< 9P:]FHH \YU_7-6UO38IX]*UFRT1=3BCG>!)$NY[;
M8Q9A&H$B+YFP<?,1D\5RU_I=\-,\66^F^']7 O)].NK&*Y261I425 VYWSM.
M03M8Y"GD#!Q[?10!P:7,WB?XAZ'>VVFZC;6FD6]R;B6\M7@!DE"J(UW ;B,$
MDC(Z<UQ6A>&=0@^'7AF74--U9!IVJ7$MW;6PEBN5BD\Q=ZA</P64X')&>M>X
MT4 <EX(L=/A.IWMAI^K6R7$B)Y^J2RM+<!%X8+*2Z@;B!G&<53U/3[R3XS:%
M?I:3M9Q:9/').(R41B> 6Z GTKN:* /'-/\ #=E:J^@ZII'B6[OO[0?"PW-R
MMG)$TQ=9<AO* "D$CKN!XR:T&FO]#L/&F@G1=3N;S4;N[N;%X+5GAF2=.,R
M;5VG(()!XXS7J=% 'C_]A_89_#^HZQ9Z^+1_#MK9O_9;7"R0SQY.V1(2&P0^
M.1@%3TK4LM#>V\0> 9;+1K^TLX3J,TR7#-*\!E3(,CDG#,23R>IQ7IE% 'E?
MBRTO-2USQ'97ECKEY++;I'HT5L\T=K@Q?,SLA"9#[L[^<   YQ2:-97UQXY\
M$W_]FWT5M;Z"]O.\UL\?E2 ;=K;@,'(.,]>HX->JT4 <CX^:\%GI8C&I'33?
M :E_9H<S^3L;&/+^?;OV9V\XK@Y=*N_L'B:TM-#U>&.[U#3KNT2>.65GA62(
M,2[9.X;2Q4G*CJ!CCVJB@#A/%NBWNK^+[>.WAD\J;0K^U,^T[$>3RPH+= 3S
M^1KGGOM0U3P[X-T:+P]JT=WINH:?]O,MFZI"(B%8AB,,,\Y7(VY)Q7KE% &'
MXN2VE\.7$5YI$^JVCL@GMH 3)LW#+J!R2OWL+SQQS7G&J6.KW_@+Q59Z=%KE
M[I:M:/IT>HQ/]I8K*KS*@<!V4!5QGOD#->QT4 >::U>OK'B.WGO-/\22Z/-I
MX-C:VL=Q;[KGS'#B;9M*':$P7(7!)K$TJ*_T>T^']W=:/JA71I;ZVO4BLY)'
MC9T(4A0,LA)'S#(]Z]FHH \=/ARS@GU;2-5TCQ+>W-UJ4SQ1VMQ<):7$,LF\
M,65A$N QW!L'([YKT_Q#:RW?A?5;2W0O--931QKW9BA 'YUIT4 >4Z7'>:A9
M_#8+I6I1'2I/(O!<6CQ^4RVNTD[A]W=P&Z$U<\4075[XKU.UU"SUR[ADM(ET
MB&R>:.W,A#;S(\9"@AMN2YX7IFO2J* /(O#$MWX=O- U6]T?5S;-X=ATN416
M,CR07$+DD,@&X*V3AL8.*J+H>HW6G-JM_I.K01P^)[J\GM;8O'<B"6,J'380
MS8+#.TG(#=:]HHH Y+P18Z?"VIWMAI^KVR7$B)Y^J2RM+<!%X8+*2ZJ-Q SC
M-<_XTC UC4+C3M-\067B-8E%C>:;&[PWI"Y02X!CP&RI#X( SG&*]-HH \BO
M]&CL=;\0#6=,\1W<NHRK<6RZ3-<+!/NB16C;RV"*0RD9?'RD<X%;$(;P/XKN
MKIM(U*;3+W3;2&#[% ]RT+P!E\IMN3R&&&/!YYKT6B@#@;5-7U'X@^'=7O\
M2);,G1[@3H,NL#LZ%49\8W8'3Z^E8.HZ';66M>)(-4TKQ+>OJ%VUQ9IIL]PL
M%RDB*"C%&"(0P8$OCC'45ZY10!P%C!)H?Q3=3IU\+&[TFVM;::*%Y8T:-GRK
MN 0N 1RU2?%+3[W4=-\/)96D]RT6O6LT@AC+E$&[+''0#/6N[HH \B\76-]J
MMQXLLKO3]=O;^5&32(X'F2T$)A'S94B,MOWY#9). !S1KNE:CJ%]I'V#3;TV
M7B"PMK'42UNZ&W$,R,3(",KF-I5YKUVB@#S*TT343\4#8R64XT2TO9M:BN&0
M^4\LD2($!Z;@[3-BF:7&\/BJP;0=,U[2IY;MSJMA-')]A6,ABSJS#9N+;2IC
M/.>G6O4** *.E:B=3MI)C97=ILFDBV74>QFVL1N _NG&0>XJ]110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
M-^)M=N[/4-)T32A&=3U.4[7D7<L$*#,DA'&<#  XR6%.CU:1M:\06IUFQ9;*
M"-U@$)\RTRA.Z4YPP/48QQ65-\OQOM#+]UO#T@AS_>$Z[L>^,5@6W_)1/BG_
M -@ZU_\ 2=J .G&O3'0O#EU_PD6EEKZ\BB:X^SMY=X&)'EQ#/RL<8!.>E6[#
M7+N+QG?>'=3$9+P_;=/F1=OF0YVLC?[2-CZA@<"O+(_^2:_";_L/V?\ Z&]>
M@>(^?BMX)$?^L6*_,F/^>?EH.?;=B@#MZ*** "N=\<>(+OPQX4N-4L+:*YND
MDACCBE8A6+R*G)'^]715QGQ3_P"1%E_Z_;/_ -*8Z +EOXOCO_ %WXDM(<36
MUI-+):R\&*:-26C;N"&&/UJ<>+M,L_#VE:GK%W#9O?P1R)'R2S,@8A5&2<9K
MBOB#&_@Y=<U.%3_8NOV4UO>HHX@NS&RQRX[!^$;WVFI= FAL_&7A::_D2*&7
MPI'':/*0%,H9#(%)_BV[?P% '2ZY\0M!T?0+36$O(KNWNYTAA,3\-EPKG.#C
M:"21UXQ5J#7$O/%-I;VVKV3VMQIWVI+/RCYT@+8$H;.-F.,8SFO,M3EA;1]<
MOH'0:6_C&VDBE!_=G#1"1P>FW>#STR#70Z@[7'QUMWLY%9G\+R>4ZL""?.;!
M!^M '96WC#P[=ZR=(M]7M9+\,R>2K=67[R@]"1W .13E\6Z ^MG1EU6V.H!S
M'Y.[^,#)3/3=C^'.?:N-\':GX97P%X1LKXPR7BS1116^-TL=XI.XE1RI#;B2
M>F>:P-!LKJ[\*Z?97_BK3;,1ZN,VAL"URMVMR6V[O,SN+#KM^ZWI0![56/K/
MBK0_#\T<.J:E#;2R*76,Y9MHZM@ D+[GBMBN$TNZM-/^*/BTZE/#!)+;6<EL
MT[A=T"HP;:3V#[L_44 ,\?\ Q#@\.Z+ITFDWEC)=:E/$D$LN9(EB<G,ORGY@
M,>O>NNT*Z:]T2TN7O8;YI$R;F"(Q))SU"DDC\S7C=PI'PV\),BE;63Q<DEH"
M,8A:>4ICVP<CV(KW2@#E_&OBBX\+QZ(UO;Q3?VCJT%@_F$C8LF<L,=QBKFJ>
M,?#NBS30ZCJUO!+ 5\R-LEEW#(. ,XQSGM7+?%S_ %'@_P#[&:S_ /9ZM:3;
MPR?$GQU(\:L_V6RCR1GY3$^1]#@?E0!OQ>,O#D^J6^FQ:S:27=P 841\A\KN
M #=,D$'&<X-1WWCCPQILSPWFM6L,D<Q@D5F/R.,9#<?*/F')XYKSO3X8HOA+
M\._+15_XF^GOP/XFE.3^.3^=71;PGPC\5Y3&I=[N]5FQR0MLA'Y$D_C0!WUI
MXKT&^UE](M=4MY;] Q,*MR=OWL'H<=\$XJ<^(-)&C2:P;^'^SHRRO<9^4%6V
M'\F!%<3+#%!?_"Y8D5 F]%"C& ;-LC]!7-7>IV-O\!M6L);J);P7ES";?</,
M#_;&;&WK]WGZ<T >HZIXQ\/:---#J&JP030E1)&<EER-PX SC'.>U1ZCKD9N
M-!DLM9L(K;4)@%$B&0W:D9"QL#@'OGFLK0((F^*/C.5HU,GDV*;B.=IC<D?0
MX'Y5Y_I__("^$H[#4I /H&:@#T2U^)GAN?4]8M);Z*!--D5&F<G:X(7)Z< ,
MVWGO737VIV6F)"][<I"L\R01%OXY&.%4>I-<%HME8ZSK_P 1="O)$_TVZ1&C
M+#?M:W4;@/;KGVK.\)7=WXJUS0M+U$$R^%(I#J&>0UV&:&(^YV*\F?\ :% '
MK-<]I7B&;4/&GB#0W@C6'3([9XY 3N?S59CGZ8KH:\]LK^UT+XO^(UU2XBM%
MU6TM);-YF"++Y:LK@$\;@2..N* .AN?$,T'CZQ\/"",P7-A+=-*2=P*,J@#M
MCFB#QWX7NKRUM(-;M'FN]H@4,<.6&5&>@)[ \G(KGX+VVU[XS0W&ES1W5MIF
MD217,\+!HTDDD4JFX<;L*3BN:LX(H?V?_#ACC52+JRD! YW&Z7)^O)H ]$US
MQEHND27-C)JEM'J<<)=87.<,02@;L,G& 2,]JK:?XUTZW\(:#JFOW]O:W&HV
M44Y4 _,Q0,Q51DX&?PKE[6^TRSTWXDV^K30)<O?7#212L-\D30((@ >2".!C
MO65X?&H1ZCX9>VUFQTOS/"-HL,E[;>:K[3F15^=,$9C)Z\8]* /4+[Q7H.FV
MMM=7FK6L5O=1--!*7RLB* 25(Z\,/S%:5I=0WUG!=VT@D@GC62-QT96&0?R-
M>3:?I=I#X@^&]NE_#JELLFJ3Q3I#Y<;9&\;5). I/'/8$5Z_0!S.N>.=(T#Q
M+IFB7DJK->J[%B3B( ?*3QSN/ K,TOXB:9%+J<.OZG:6DT&JW%K"IR,1(^U2
MW7&>1DX!Q3?%,\-M\4O!$L\J11^3J*[Y&"C)CCP,FL.*WA'PY^)K^4F^2^U4
MN<<DA3C\J ._UCQ3H>@2Q1ZIJ<%M)*I=%<DG:.K$#HON>*UHY$EC62-U>-P&
M5E.0P/0@UY)9?;T\4ZB?[=TW3%ET:Q<?VA:>=YL(1@VTF1< -NR.?O"O0/!E
MG'I_@S1[6"^^W01VJ"*Y\LQ^8F/E(4DD#&* *WC37]2T&VTE=*M[6:[U'48[
M%1=,RQKN5SDE>?X12Z<_C@ZA"-3@\/+99_>FVFF,F,?PAE ZXZUB?%>.&6T\
M+I<7DEG"VOP![B.7RFC'ER_,'_A^M7-#M-!L]7@EM_&U]J$W*I;7&L"9')&/
MN9Y/I0!LGQAX=&M_V,=7M?[0\SRO)W?Q_P!S/3=_LYS[4V_\:>&],U(Z?>ZQ
M:PW2E0Z,W$9;H'/1<^Y%<7X2U'P];?#ZUL=?:&2\34WBGM6&Z8W9N6*G:/F+
M9*MGT]J@LKW3+/P!X[M=5F@2\^VZA]JBE8!W9\^60#R=RE-OX8H ] U3Q5H6
MB3/#J.IP6\JHLAC;)8JQ8 @ 9.=K=/0TLGBC0XM"BUM]4MAILN/+N-^5<DX
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MY54X# CH3VJCK&F^+O#>F7&KZ=XHGU7[)&9I+'4;:+;,BC+!7C52K8!QU&:
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MB1)YITU?0UFF $L@T5PT@' W'[1SC)QFNEKC?'6K:FL^D>'=!N_LNK:K.?\
M2 @;R((QND?!!'HHSZT 61H&O+;06PU'P^((&5X8AH;;8V4Y4J/M& 1VQTI?
M["\0>5<1?VGH/EW)+3I_8C8E)&"6'VCYL@8.:/!7B5M8\')>ZHRQ7UCOMM2#
M<>7-%PY/IG&[Z&J]EX_BO9+7_B0ZM#!?QN^G3RK&%NRJE@H^?*%@,KOV@^U
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M+.\:"STZ 0K^[ &R1E=2T@;.>"!VKJ[S6;CPSX(EU7Q!)!)=V5KON#;Y"2R
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M%X8UB#36TZ&\\.1V+?>MDT%A$?JOGXJP^D>)9+B*X?5]#:>(,(Y&T5RR!L9
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ML7BW_H/:1_X*)/\ Y(JE>^&M:U+=]NO?#MUO3RV\_06?*YSM.9^F><>M5_\
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MM<Q%65L;6XR< YP">U>RNF^-D)8!@1E3@CZ&L+_A$[?_ *"NM_\ @SF_^*H
MQO%^EW6I^,M"C@BD\MM.U*%Y@A*1LZ1A=Q[9YQ]#7.^$M-L))?#UC<VWBJ35
M+#8T\%U+/]ELY(T(W9?]V5)X4*3PWIFN[_X1.W_Z"NM_^#.;_P"*H_X1.W_Z
M"NM_^#.;_P"*H R/BO!<7'@25;:VGN)%N[9S'!&9'*K,I)"@$G !JKKOC"ZU
MW1[K2?#>A:Q-?WL30+-=6,EM! &&"[O(!T!)P,DXKH?^$3M_^@KK?_@SF_\
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MF>6UT+0XM"U%;N*!8=0-Q \,=GL3!.\KM?+ !0IY!SQBMK_A$[?_ *"NM_\
M@SF_^*H_X1.W_P"@KK?_ (,YO_BJ ,3X4R/;^$_[&N;:[M[ZPN)Q.D]NZ+\\
MTC+M8C#<'/RD_K48OQX2\=^([O4K.^>TU9;>>UGM;22<,R1^6T9V X;(!&<
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MRMM1U66[M;>9-CK&54;BIY7<59L'UK1_X1.W_P"@KK?_ (,YO_BJ/^$3M_\
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MV,Q1L;@.ZGJ#W%86G> K&PU>?53J>L7%[*RYDEO7.(U.5CX/* YX.<Y-=70
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH[<XW$$E@6(!!(4'%&I>/M+L+RRM(+:^U&XOK/[9:)91!S,F0/ER1S@[N<#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q/Q4!3P='>$
M$PV6H6ES,/\ IFLR[ORSG\*[:H+RSM]0LI[.[B66WGC:.6-NC*1@@_A0!PGQ
M M+WQ7K.C>$K)Y(+64G4+Z[6+>BQQG]VO/RMN?!P?05G^+?#WB/1VT[Q;_;M
MSK5SHLX?[,+**-G@<A95'E@$G;S@^E>@Z'I;:+HUOIINY;M+9?+CEFQOV#[H
M)'4@8&>^*T: .%UR5-0^*'@E;8[C!;WMY)Q@K$T:HI/IEF'Y5W59&GZ!#9:Y
MJ.LRS/<7U[M3>X $,*_=C0=ADDGU)S6O0 4444 %>>?$G1H=3U_P7(]@+G9J
MRK*WE[@(L9(;_9RJGGCBO0Z* .2^(EG=7/ARWN+6WDN6L-0MKY[>)=SRQQR!
MF"CN<9..^*Q;VY3QKXPL+C18YY+33].O%FN9('B0R3*JI&-X&3P2?2O1Z* /
M&[?5EOO!W@;1+>ROVOM.U#3DOD:TD06WEL%;<2 .OIGC)Z"O0_'.DR:UX*U6
MR@!^TF RV^.OFH0Z8_X$HKH:* /&S/J T'_A8G]FW/VXZS]H^S>4WF?9O+^S
M;=O7_:_6I=0T"[TS1OAE:&"62>'5H9[QE0G;(^7D+>@W,>37K]% 'F%M:7(^
M(/Q+E-O*(YM/MEB?8<2$0$$*>_/I6_\ "R":V^&.@PSQ/%*EN0R2*58?,W4&
MNPIH="Y0,I=0"5SR,T >>6-I.OA;XC(;>0//?WS1J4.9 8$ (]<U2T2Y7PGK
M=AJ6KQ7$5C?>'K.!+@0.XBEB!W1L%!*DA@1GK@]Z]2HH \9NK:ZM?#UEKMS9
M74-I-XS&K,A@8R0VQ+*'9 -PS@'&,_-7HWBN0:A\/-;DM5>07&E3M$ A#-NB
M;'RD9R<CC&:Z"B@#RK^T%UZQ\#Z%:6=VFH6-Y:7-Y%);.@MDAC.XLQ&WDX P
M><\5F:/I%A#:0^'-6NO$[ZDFH%&TZ MY##SRZS E=OEXVN3N]>_%>T44 <C\
M3X);GX<:S##$\LCQH B*6)_>+V%5_%UC/?>-?#"0H^TV^HQM*%.V,M"H&3VY
MKMJ1W6-"[L%4#)). * /(/"5AITB>&]+O+CQ/+JU@\7G6$A;R+22)2-S94+Y
M>1A<$Y##&:HP:9J"^'O%URMC<R&U\9'4/)6([IH4EC9BH_BX!/'7%>VJRNH9
M2&4C((.012T >>6^L0>(?BGHU]IT%R]A%IMU&;M[=XT9RT9VC< > ![<^QQ?
M\9E]-\3>%_$,L,TFGV$EQ%=-#&TAB$L8"N54$X!7!('&ZNTHH \S\3:J_BG3
M-*N+32[I;*/Q+9"*62)E-Q&K#=)L(!" DC)ZXS5WQA;3R_%/P!-'!(\43WWF
M.J$JF8EQD]LUWBRQM(T:R*77[R@\CZBGT >6O9W/_" ?$J+[-+YD]_J#1+Y9
MS(#&N"H[Y]JU[ZVF/B;X>,L$FR%;@2$(<)FU(&?3GBN[HH \2L-/O!X#\11-
M9S[W\8B54,1RR?:(3N QR, \].*[#Q2-2@\<Q7NF6SRW,/AZ^\@A"5,VZ,HO
MIDD=.]=[10!X]I%S#)XL\(:BEYKVH(/-BO+J^67RX[B2+ 0*5 4YSG P. 36
M)=:;?'X">*[865R;B3679(O*;>R_:(SD#&2,"O?** /.?B'-=>&+G2O&6GV[
M33P1/IUQ$HYE24?NL_24)_WT:ZSPEH?_  CGA73]+9M\T,69W_ORL=SM^+$F
MJVIZ!!JFN6^HZCJ\LEA82K+%I_R+"DZCAW.-S$9R 3@'%='0!YC:ZM%X37Q=
MI>I6MXUY>:A<7=DD5K)(+M)E&T(5!&0?E(/3%-\*Z)>Z1XP\*6UY ^^T\+M#
M*^W*I)YD>5W=,]1^%>H4TRQB01EU$A&0N>2/I0!S7Q#TR[UCP#J]E8Q&:Y:)
M7CB'60HZOM'N0N/QJD?&%MXCBNK/2M/O98_[/F>XN);=XA;OMPL6&4;G.3P.
MF*[2B@#Q_3-*O8O@AX;U&&UF&J:'(M_'#L(=@LC>8F.O,9;COQ5F73[N\^%?
MC'6YK:;^T->6>X6$QGS%B V0ICKPB@X_VJ]7HH \GN;*Z.I_",BVF(MX&$Q\
ML_N_]'0?-Z<^M7_"^C#4/$_Q(L]0MI!9W]S''ET($B&-@2I/7K7I-5-3MKF\
MT^6"SOY+"X?&RYCC5V3D9P&!!R,CD=Z /-OAY%J.KZ^C:NC%O"EL^DH[=);@
ML0T@_P"V21?]]FM7XR6T]WX >*V@DFD^V6YV1H6.!(,G KJ_#^@VOAS2EL;5
MY9<NTLT\S;I)I&.6=SW)-:+2QK(L;2*';[JD\GZ"@#SV_@O5^.7VRWMG<+X9
M=8W*G89/.)"D],^U<S97C7-UX0U.YNM?O;R&]1]6:YCE$-K*\4B[!'M"CYVQ
ME0< <GD9]KHH \5BU/R_A=K7AEM/O?[7O[B\AM+?[*_[_P R=P'#8VX&3DDC
M&W/<9U9]$O9_BAJEHB28E\'FS2X*D(9"X&-W3/>O5:* /)O"5IIEU<>'+2:X
M\43ZG8[7EL[C<(+&1(RI+[E V\E5P3G<.U=/\10\6G:+J AED@T_6;:ZN?*C
M+LD0+!FVC)(&X$XKLJ:7175"RAFSM!/)^E 'DVN7A\0:MXNOK"TNWM)/",EO
M!*]NZ"=MTI^4$ GEL=.<<<5NZI:S&#X>!()#Y-[$9 $/[L?9I!SZ<\5WU% '
MA][?-8_![6/!KV%])KL#7$;6ZVLA#*9V<2AL;2NTYSGD\=:U]7M;;3/%_B*7
M5[[Q!:1:@L,UHNF[RMT!"L;1_*I&\%<8..&%>LT4 >=Z#I0T[XEZ?'!:745G
M;^%(K>,W RR8GX1F'&X #(![5T/CN[U"Q\)74^FO/'*)(EDEMX]\D4)D42.J
MX.2$+'IVS71T4 >'ZHL4DWB<V!UJ\MK[PW+#:7-\)9#<2*7+!"PR -PP.,G.
M/?N-8MIFU7X?E(7*PW+&0A3A!]E<<^G/%=Q0>E 'D-WI5ROCN?P,L+'1]1OT
MUYCU581DRQGV,R)QZ,:]<?\ U;?0U@:)X;CT;4+K4[[4Y]1U2\"PM=7(1,(N
M2L:*H 49).!U/-=#0!XEHFCWI^!OAGS(=0A.GZG]JN4MU9;A(A/*&91C.0&W
M=.@JUJNE6FJ>']=U'0FU_5IX19EI[W<1<)%.)6CB# ,Q4;CTQEL#)S7L=% '
MF&IZG#XP\;Z =(BNFM4L;^)KR2VDC17DC4!<L!R,<_4=ZS_"5CITH\-Z9=W'
MB>75;!HS-8R%O(LY(D(W-N4+LR,+@G(88KU^FB1#(8PZEP,E<\@4 >;>'?[6
MTOX9>)IM-M9%U1;S4);=#%\S-YC;2%/WO4>O%4M%FM3X^\/7UK=Z[J%H]K<6
M[WM^)63SV$9"*& "<*<D +T&>./5G=8T+NP50,DDX IP((R#D&@#@/@S;3VG
MPXM8KF"2&07-P2DB%3@R-C@U%9ZQ!X,\2>*8]6@NQ]NNUO;)XK:247*F)5V*
M5!^8,I&#CJ#TKT(RQB01EU$A&0N>2/I3J /)?#&A:AI.K_#JWO;61);;3;XS
M?*2(6?8P4GH" <?@:]:HHH **** "BFAT9V0,I9<;E!Y&>F:=0 444U98W9E
M1U9D.& .2/K0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** (;RX%G97%R49Q#&TA1!DM@9P/?BN-TCQ-XGU71_
M[3CL=&EM;FS:XMY;>[9Q X (CEXR3@GE>A4@CO79W/G_ &6;[+Y?VC8WE>;G
M9NQQNQSC/7%>>Z3X<U&;Q,NHIX:B\.[K2:*_:*X1H[R1P N$0] <MN8 ]J %
M\*:[XKD^'&C7KPV5W=W03_2KBX94BB(),DQ(R3D8PN>HYJCXA\::]=>"+N>R
M^Q6]_9ZO%I]S+!.Q1LO&0T; 9PP< YZ MUJ"Q\-^(4\,^%K'4O"XO(=$D:.X
ML&NH66Z!0JDHR=I"DYPV#S[43^#_ !%_PC/B*PAT6UBDGU6WU2TAMYD6)E'E
M%H1TPR^61D@ GD4 =+>^*->&J2Z38V^CF^LK6.>]:YN72-G?=MCCXST4G<>F
M1Q71:+K*^(/#5IJ]D@0W=N)4CE/W6(^ZQ'H>#CTKB=2\.W4_B&XUZZ\#VFL_
MVC:Q*UK<R0-)9S1[A@L_RE6!7)4D@KT-=WHMHUAHMG;/:VEK)'$H>"S7;"C=
M6"#TSF@#S;2?&_B+2O .L>(M3BMKP0ZF\4<:2.7YN?+91D?=4'Y?ISBNKN=5
M\76^G6QET[2(;N>5S)*]TWV>UB !4.<!F<GCY1CC.:Y-_"OB5_ ^M>&_[)&\
MZJ+NVN1<Q[)T-TLIP,Y4A0>N/:NE\8Z->7WB'1M070X]=L+6*=)+&22-0DK[
M-DN)/E; 5AZC=D"@"K'X^O[S2M,ALK&T?7+[4)M/"&8FW1H=QDD# 99-JY Z
M_,*R8/$-YH/BOQIJFKV47VNTL+!/*MY3Y<SLTBIM9AD EE!R.#GKC)CL/"OB
M72/L5]%HUO)=:7K%S=I;6\Z)'/!<*P819QM*9  ;&<5/?>$O$'B67Q9/J&GV
M]F-3M;,6<$LRR@- [/LDVY') SC(PV.<4 =-H?B34IO$/]B:S'IWVB6U-W!+
MI\S.A"L%=&W#(8%E.>A![8IWB'Q%J-GX@L-#TJ/3EN[J"2X$FHS,B,%95V(%
M!+,=V?8#O5;PII'V?5I+H>"-,\/1K!L\R,0F>1R1D Q\!,#OR3C@8J;QC97.
MH-#;3>%+;Q!IC1G,9E1)H9<\,"Y P1W4Y&* *][XJUHWUCI-M8:?9ZJ]E]MN
MUU"Y_=0#=L"*4^\2P;GC 7\*BC\=7FJ6.B0:186_]KZHUPK1W,Q\JV\@[926
M498;L!< 9R#Q6$O@C4+)]'O]3\/6OB:2/3!8W%M-)&[P,LC/&5:7 8 .4)R#
MP#S6K)X?U?36\.:WIN@V"75@EQ%=:38NL2>7-@_(QPNY2JDYP#D^U $NJ>--
M?T;2]/-WH$7]IW.K#3!$LQ\J7<C,LD;$9"D@#D9'/I4]WXE\00W]KH:0Z*NL
M"T-W>237#K;HI<JBIQN).T]<8P>O%5M1TOQ3K\>@W6H64$,EMX@CO3;)*I-O
M:JCK\S9P[Y.3M]?:E\4^&&G\71ZZ?#%IXBMY+$6DEM-Y0>%E=F5U\WY<'>P/
M.>!UH R[KQAX@UC6?!4FCI:6\6H/=+-;S3/@S0HZR(Q4<H",J>Y .!75?$?_
M ))MXC_[!\W_ *":P;W0-9LI/!VIZ=X>LO,TN2Y:YTW3Y4A1/.C*_(6PIP3S
MZG.*ZCQGIMUK'@G6=-LHQ)=75G)%$A8+EBI &3P* ,#3-3UJR\$^%(=*MK!8
MWTJ!IKS4)S'#'B)-J8'S%FR?8 &I]!\=3:O?Z#%-91P0:M:W)5UDW;;B"3:Z
M ]"I 8@^U8[>%]5MY/#4EUX<M];BL]$CL6M9IH]EK<@+N<A\@@@8RH)^7@'-
M5#X2\3VG@"RM+&QA37M%U*>6T*2HL<\<C29*\_*NV7[IP?DH VM,^) O-'\3
MZC<V:0QZ2CW%L Y_TB#,BQM[%FC8?B*ZN&XU6Y\-P7,<%M'JLMNCF&9F$2.0
M"RD@$X'(Z5P6L?#_ %'S/#FGZ=%&^FBS@T_5F+A3Y4,L<H(!Y8DB0<?WZ]0H
M \.^&NHW/AWX>0Z\=+T^YOM5NC:V\JNPN+J=YV4"5RO"C!/!/ ]:[^+Q1K.G
M:O-I.O6=B+EK"6^M)K.1S')Y>-Z,&&01E3GH0>U<]HO@C7;+X4Z+IKP1)K>D
MZ@-0CMWE&R1EG9PA89 W*QY[$UKOI>N>(O$#ZO?Z2=,BM-,N+2UMY+B.2266
M7&YB4)4* H YSSVH T_!&OZUXGTF#6+^QL[.QNK=)+=(Y6:4MCYBP(P%)^[@
MDXZTWQ/KNO:7<R_V=9Z:MI!;^<T^H7)C\]^?W48'(( ZGCYA5[P7IMUH_@G1
M=-O8Q'=6MI'%*@8-A@,$9'!KF->\,ZC>>+=6N#H%IJD=_:Q06=[=/&4L,!@^
M4;YNIW?(.>A(ZT 7/^$TU34]4TJPT+3K9FU+2%U-);N5E6$%E&&V@D_> P.Y
M]*@M?']\L6G2:CI]O$O]L2Z-J+Q2%EBE'$;H2/N,<#GID4WP=X?UJQU?0[K4
M+#[,EEX=&F2YF1_WJR)C&TG@A2?Y\T2^%7?P9XSL=79+2.]U"ZO8)V<8C7Y6
MCD)'3!4'UXH Z)-?FN/'4N@6\"-;VMDMS=7!)RCNQ$<8'J0&;Z 57US7]4C\
M267A[0[:TEO9K9[R:6\=A'%$K!1PHR26./;%4?AC;WLWAM_$.JJ!J>N2"[FX
MQM3:%B7Z;%!_X$:DUVPUBP\;67B72M-.IH;!["YMDG2)U!<.KJ7(!Y!!&>_>
M@#AI]9_L[P'XZU'5=%M;MT\1;9K&=MT1;%NO!QR >0<#MP*[C4_$^M'Q+>Z1
MHEEILTMC;QSO#=W)CEN=X)VQ # P%QN/&3VZURFK^#/%&J?#[Q;826,(U/5=
M96]AA2=2OE_N3C<2!QL8<XSCIS6[XWT;4=;DN;4^%+;4LP@:=J4=RD,MI(1U
M9B0PPWS#9G(XQ0!?OO$NOW>M:AIWA[3+*5M+AC>[^VS,I>1UWB)-H(SMQEB<
M9(K#N+F2\^,_A.ZFMI+6271)G>"7&Z(GDJ?<=*O)I_BCPQK>IWFGZ8NM_P!J
M6]N7D%RD)BN(X_+)8-C*-A3D9(YXI_\ PCNO3?$/P[K5\D$J6NE26][/"0J^
M<W95)SC- %<^/=:_X1]O%RZ79'PTLI^7SG^U& /L,N,;?]K;Z=ZT&\5:W>>(
MM2L](L=.N(--GCAFMY;HI=2JRHQD08VA0'XR>=IY%8'_  C?B=? S> %TI/L
MQ)MAJ_VE/+%L9-V[R\[]^WY<8QGG.*M^*_#^JZS>RP1>&+;[9'(G]G:]!<)&
MUL@P<OSYA*_-P 0?:@#H[/Q/-=1>*'-LB_V-<20QX8_O L*R9/IRV*PV\<ZW
M>3^';+2M+LY+S6=)%^&GE98X&^0G<0"2N&/09SBFSZ7XET^_\665AI"75OK<
MAG@O3<HB0EH5C8.A.XX*Y& <YZBI- \,:M8ZYX3NKBW58M/\/_8;DB13LF_=
M_+P>?NGD<4 &I>.=5MY-7N+.STV2QT5MEVLMR5FG=4#R"(8QA0<#=U((XKL+
MS6+2RT"?6I&)LX;5KHL!R4"[N/PK@;[PA/::YK3IX+TG73J-S]IMKZ[\K$!9
M5#+*&^<J&!8;<Y!QQ7<ZQHT>J^%K[1!L@CN;-[4%%PL89"HP/0>E ',V_B[Q
M!:C1+_6M+L(=,UB>*"-;>=VFMFE&8]^0%;)P#C&">]<WX5L=3U'XS>*+S4K+
M2)[BQ>T5I69W:V4Q$CR,KQGOG%;(TSQ/KEMX=T?4]&2Q@TNZM[B[O?M22)/Y
M'W1&JG=\S 'Y@,#/6M;PWH.H:=\0/&.JW,(2SU)K0VKAP2_EQ%6X!R,$]Z -
M7Q%J&K6,-LNDVMJ[RR%9;B\F\N&W4 G<V.3DX  [GDBH_"6OR^(=*GFN(H8[
MFUNI+2?[/)OB9D/WD;J5((//K67XUT>\U#5]"O4T9-;L;,S^?8/)&H+NJA),
M2$*VW##GD;LBG^ =(U+0X-8M-0T^"T26_>[@-LZF(K( =B@<C:1CD#/44 9E
MCKGB,?$'Q=#*;-].TVVA=8O,?*J4E="HQC<W&[Z#&<58T3Q5XHUGPF-?31++
M9<P1-9VXN2'+$@.\A(PL8Y88R<#U-))H^M6WCCQ+<1:;]HT_6[*&-+I9T7R7
MCCD7:RD[CDL.1QS5:?POJW_"J=!T5K%;FYLOLIO-/,R@7"1D%XMQ.TYQW.#B
M@"4_$&YTW3O$+:I;V-Q>:3%!(ATZ<M%<><2J+DC*G>,'KU!JG>7>N)\1?!X\
M06UC$5CO95ELY&9,>2-RD, 01QST.>V*S[SP5K=^?$*6N@V>E0ZG96S6L<3Q
MA8)K>5G5) O4MP<J"!G&3CG;EL?$GB3Q;H&H:CH?]F6%E%=1SHUU'(Y:6+;D
M;21MR !WY.0* %TSQYJ%U)I%_=6FGQZ1K$ZPVZQ7!:YAW@^4TBXQAL#('3<.
MO-=#XMU^3P[I$5S#' TT]S%:QM<R&.&,N<;G8 X4?X"N0\+>$9])ETG3Y_!&
MC++8.!+K;+"3*J [9$ _>>82%)W8P<\FNU\2I>R:04L]*M=55I%%Q97!4":+
M^(*6^7=T/S<<&@#$O?%.N:3I42ZAIU@-3NKY+.R>.Y/V:8,N_P TDC<JJ ^0
M1G*\=159O'UU8V.JP7UG:3ZQ936\$,=G.3#<M<';$0Q&5Y# @YQM/6L+_A [
MZ72Y)4\/V\5I!JL=]:^'[F=)4,8B,<BYY12Q8L!D@$#IFM";PE>7V@7<FG>%
M]+T"\AO+:\LK:/RU:9H6#XF:/*\G<!@G&>: -+4/%'B;0-%UNZUC2+-GL;/[
M7!<6DK&"4YP8VW ,&'7T(/:FR^+M>M]/L&GT_38;W6+@)IT+W#!8HO++L\YQ
MP0!T7/) SWJ#78/%WBKPUX@LY=&BTZ&?3S!:VDEQ')++.3RQ=3M5<8 !.>_%
M6O%?AB;4M/\ #]P-*MM4DTJ0--IUP4VSHT91@"WR[@2&&>/EZT 8'B?QGK[>
M&+Z&V^PV^J6.I6UK<RV\[E&21T9&C(&<,#M8'I\W6O20=2_L@EDM/[2\H_*&
M;R?,QQSC=MS[9KS_ %3PKJ%[X)OXM,\*Z;I%TU];W$%A;M&CRI$Z-^\=?DW'
M#8YP!CFO1+*:>YL8IKJT:TG=<O SJYC/H2I(/X4 >-P:QK^I?#[P?JE^D-Y<
M2Z_"]L%E;?(=TPPY8849P.,X _"N[L?$VNQ:OJVCZGI=K-J-K8+?VJ6$QVW"
ML64)EP-K;EQGIS7.:'X8\1P>%?#6B7>DB%]%UF*=YA<QLLT(:4EU .1C<O!Y
MYZ5J>+?"^M:MK6NW.G*J+=Z EE#)YH7=*)G9D]1E3C/3F@">Q\6:Z^J3Z1>0
M:,VH/I[WEL;6Y=XT*,JM'+QD'YQR.O/%0>!=5\5W_P .M*U!X[.^NYV0AI)V
M#-$6.]F)'WAV XJMI7A[48/%VGZG;>$[71M/-A/8R00R0^9$6*,)'V'##Y2H
M )(ZGKQ<\&P^)_#O@6PTF7P\K7EBZ6Y!O8]LL98[I5(SC YVG!- ';WES'96
M4]W+_JX(VD?'HHR?Y5Q7@K3;S4O [ZLUZ]IK'B#%Y/>(H9XT8_(B;N %CP!G
MH23BNQU.S_M#2;RRW;?M$#Q9]-RD?UKD?!.JWJ?##3UM-.-YJ>FQK8367G+$
MRR1$1L"S<# &[W&/6@!/AS:(WAS6M/N&DNX$U>]MC]I<REXQ(5PQ/7CKFIOA
M_/+:KK7AJ>1I/[#O?(MV<Y;[.ZAX@3W(5MOT457\!1>(].FU"TU7PZ;.WN[^
MYOA<?;8I GF/N";5.2><9J3P%_Q,-8\5^(4_X]=0U$16S=I(X$$6\>Q8-^5
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MMW[MHSNW=:V%DU[Q'XM\36%MXAN--L;$6S6WV>&(ONDA#8)93\N><=3GJ *
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M  . *6N#\&Z]/<^)+O2TU/4=6T_[(MQ'=7UD8'CD#;6CSY:!@058<9'-=Y0
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MP39CRMD0CZYYSC/:N?M/ >H:-8Z#)H^K6\>JZ59M8M+<6Q>&YB8@D,H8$88
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M"6/'!SC%5KCP5JJR^&[RTU_SM2T?SQ)<:A"TPN!-C?D!@5QCY1G &!VKMJ*
M.2T[1[3P;J7B?Q#J6JP1V>IW$<[-*/+6  ;0"Q/.21Z5C?"K0H[6+5=;B\W[
M'=W#Q:4LRX,=DLCNN >0I9W(SVVUZ*R*ZE74,IZ@C(I: ,/Q/X?;7[2T^SW?
MV2_L;I+NTN#'O"R+D89<C*D,01D=:RD\'ZA>R:Q?ZUJ5O-J5_IS:;$;:W,<5
MO$<DX4L2Q+'))/8"NQHH S]"TTZ-X>TW2S*)396L5N9 N-^Q N<=LXK0HHH
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M<:?:S7MN,0W$D*M)&/\ 98C(ZGI4=KH&CV.H2ZA::58P7LV?,N(K=5D?/7+
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M"?V3:W?V230;ZT2\FMI(4,K[!M^< \<<].3CH:]3HH \I\)6>F75YX?MY/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6F=(\;F [#/% &C16/;Z\UW%HL]MIEW+;ZI")C,NW;;*4##S.<\YQQGD5L4
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M1U*9X;'< YKI* "BBB@ HHHH ***HZO?S:9ILEU!I]SJ$B%0+>VV[VR0.-Q
MXZ]>U %ZBBB@ HHKG-'\80:[KVHZ=8:=>O;Z?.]M/?L$$(F7&4'S;CUZ[<4
M='1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q/Q48OX-2RR5BO[^
MUM)B/^>;RKN_,#'XUVU8/C+07\2^%+[3(9!%<NJR6\A_@E1@Z'Z;E&?;- ',
M?$!+Y?&G@1-)^RI=BXNA#]I5C$/W'.0I!Z9Z>U077]LV'Q#\-ZAXM^PS1NTM
MEIS:;N589I%Y,BODMN5< @X'<=ZVYM"7QSIVBZIJ)U71=3L=[!8&$4D4K#8X
MRRG*\'!'!!S5FP\"V-IJUOJEYJ.JZM=6N3;-J-SYBPDC!*J !G'?% %"'_1/
MC;<Q0_*E]H*SSJ/XGCFV*Q_X"Y'X5V]<AX;L+N_\6ZQXIOK:6V65%L+"&9"C
MBWC8EG93R-[DD \X ]:Z^@ HHHH *\5T&QM[_P"&OQ(2X5V6+6-2F3;(R898
MP1]TC(]CP>]>U5SEAX+TS3M&US2H9+DV^LSSSW)=P65IEVMM..!@<9S^- %#
MX7:7::?\/M%FMDD5[JRAEF+2NX+;!T#$A?H,"L*77[GP6WC/2Y)))IHP-0T@
M.Q8N)SL$8SV6;C'HU>A:/I<&AZ+9:5:M(UO9PK!&9""Q51@9( YKB]1TH^+O
MB/I-TVDW=O9Z"TK2W5S&8Q<R9'EH@/WU#+OW=.!CK0!0T[P_]H\36/A/6+JZ
MN;/2]#BN'C^TNHN+B21@\C$$%L;3@$\9JC:7UY#-INF?;;F2#3_&;V,+R2LS
M- ('<(S$Y;!;'.>@]*]!UKPM;ZOJ-OJ45]>Z=J,$;0K=63JK-&3DHP965AD9
MY'!Z53E\ Z2_A^#2HYKV%H;O[<EZDW^D?:,DF4L006.3G(Q@XQ0!%8SRM\5]
M9@,KF)-)M6$>X[58R2Y./7I7.?%+1K&]\3^"Y9XY2]QJJ6TA6=U!CPQP " #
MD]1@^]=EHOA*TT75KK55O+Z[OKN%(9YKJ0,9-A8@\  'YL<8& .*L:UX<LM=
MO-*NKMYEDTRZ%U (V !<#'S9!R/RH Y'2=]I\;KS3(99A90>'XA'"TK,HQ(!
MGDG)QW/-<1X5N[H?#+PCI<%M>74%_JETMQ;V<PBDF1/-?8'+* "0">1D CO7
MLD7AJRB\7S^)E>?[=-:"S92P\O8&W9 QG.?>LJT^'FD6/A:UT&VN+Z..SN#=
M6UTLH$\,I).Y6VX_B88((P<&@"/P+;:I92:M;W6F7NGZ7YR26$%Y<I,Z K^\
M4%7;Y=PR 3_%6)XU6WU/7-3BBLM8U.XL+!2PM[P6T%@S!F#@[U+2$8/0X"CU
MKN-$T./1(IP+R\O;BXD\V:YNY SNV !T 4      5GZCX+L=2UBYOWO+^%+R
M-([VTAE"Q72J"!O&-W0X.",C@T 7/"5Y/J/@W0[VZ<R7%QI\$LKG^)FC4D_F
M:\M\,3V\?@+6;>X?4#]K\4301P:>P26Y8LI\H,2-H8*<G(P >:]9T+1XM T2
MUTJ"XN)X+5!'$UPP+A!]U<@ 8 P!QT%84?P\TJ#1Y=/M[J_A+:DVJ1W"2+YL
M,Y[J=N,8R,$'@F@#@Y6U#3]/\4_9;:^TY-!N;'5(+&2[\XQJ,F5=P9OE9%)V
MYQS6R=9G;XE#Q MZ_P#8HNUT3;O/E\P&7?CI_K"%S75V'@?3["[U"X^UW]PV
MI6WV>^6XE5Q<=?G;Y<[L,5X(7'&.!5<?#G11X(/A02WOV,R^=]H\T>?O\S?N
MW;<9SQTZ4 <5::?JNJ:'IOB&[L-1UC3+^>[OKG3[:[:*5!*Z^0RC<N\+&N N
M1C?D5MZ#?PW'BWPJNGZA?W-@VD7F#>.?,)66-<2#C+*<KSSQU/6NGO?"-O<1
MZ>++4=0TN2Q@^S1264B@F+ ^1@RLI'RCMD54E\ :=]GTM+*^U&PN--$HAN[>
M9?-82G=)O+*P;<WS'CKTQ0!P'C'4+R+X??$:6*\G22'7(TB=92#&O^C\*<\#
MD\#U-=&^C65Q\=(9Y4E,@T);H$3R >8LZJ#@-C& /EZ'J1FMB?X;:)<>&M6T
M%Y[\VNJ7*W5RYF!D,@V<AB#U,8)SGDFM*^\*VUYXEL=>2]O;6]M8OLY^SR*%
MGBWA]C@J<C([8/O0!SWQGL;>Z^&.K3S*YDMD5XBLC* 2ZCD X;@]#FJ":-:3
M>(O#WA?==1Z.VF2ZE- +N7_2)<QH S;MVT;B=H.,]J[OQ%H5IXFT"[T:^:5;
M:Z4+(86 8 $'@D$=O2JFK>%+35!I\B75Y97FGJ5MKRU=5D12 &4[@58$ 9!'
M:@#S37Y[W2]%\6:%87]TD&G:OIXLI6E9WA68Q,4#$DE02< D\'%>LZ-HMIH-
MA]CLO/,>XNS3S/*[,>I+,2>?RK&/@'27T*?2Y9KR7[3=I>W-U)*#--*K*P+'
M&,?*HP !@<8KJ: /*-%A=8_''B>6XNKB\T?4M1%A$T[^7%MCS]S.#G=CD'&!
MC%1^&M-U:2YT&Y@T/6XH[J(KJ]Y=ZBCI=QR1'+X$I(;?M(( (!(XKT72O#MC
MI,6J10^9+'J5W+=W"S$,"\@ 8#@?+QTYK/T?P5:Z/>6LJ:IJES!9*RV=I<3A
MHK<$;> %!;"D@;BV!0!Y[X8L]-T_X8AC_:GG:EJSVODV-PWFW16XDVQ LP"
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M6L7KW7V5CEK>(L2D9[ _,S$#H7([5O:_X?@\006JR7-U:3VDXN+>YM6"R1.
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M.1C.?E'>@#R6X@DFT*WT?[;<I;VOC@65O(9F,D4/.%5R<Y&X@'J.*N^))IO
MFJ:_:Z!-<16\OAYKQ8GG>40SK,(_,4N3@X?)YY*BNUN_A_H][:36TLMX$EU4
MZL2DH5A.1C@@9 '4=\]ZDM/!&GQ/J4NH75[JT^H6_P!DFEOG4D0<_NUV*H Y
M)X&<\YH Y?1M.U73=9C>RT'6=-TY[&=+][^_CG$L@4&.0 2N=^0P) 'WO:M#
MX3Z4B^#=,UNXN+JYU*]M%$LTT[N-@/RJ%)VC  Y R3DGK6WI?@Z#3IS--JVJ
MZ@RV[6T(O)U80QMC(4*HR>!\S9/'6M+0M&MO#VAV>D6;2-;6D8CC,I!8@>I
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MF:;QPMI8Q:3!<VNE&XFO]2C:4)"\A4HJ!E'5,LQ/3%3_  MD#_#72&+ @+*
M0"  )7  '8 #IVH WK7Q%HM]J<NFVFKV,]]#GS+:*X5I%QURH.>._I4PU?3#
MIR:B-0M#8R$!+GSE\MB6VC#9P<DX'OQ7GV@Q'P_>>&[5QI6L:+<7$B:3J, V
MW,+-'(^6'(<%0RE@1ZD5BQW4$?[/^@Q-*@DDN[6)5SR76[4E?J I_*@#U67Q
M%HL&KII,VKV,>HOC;:M<*)3GI\N<\U%=^*_#MA,(KO7=-@D,IAV272*=XQE<
M$]1D9'N*XC58SHEQJNJ1#2M:T&;5$DO;>0;;FVGW(GR,,ABK!2%.#V!J+2(-
M&DLOB:UZENT@O[D7!D R(O*4KU[9WX]\T >AZIK^CZ&D3:KJEG8K,<1FYG6/
M>?;)YIVHZWI6D627NHZE:6EJY 2::945L\C!)Y_"O)_#,6OW&K6"H^E"Y_X1
M>QP-5A>0F([_ #-NUAWV[L_[-:'ABRBLO%7A.RO;VTU"UBT2Z^P3Q\PM)YR\
M1YSR(L#Z T =EJ_CWP[HSZ2+C5+,QZE)MBE%P@14VL?,))QLRNW/J16E<>(]
M$M-2@TZYU>QAO9P#%;R7"J[YZ84G)SV]:\_U./P]_;W@]=#6'[$->NDDVAMG
MF^6^\+NXQNSPORYZ5G3:?J>I6OCN"6^T&TM)-1F2ZGOXG,T*[5\I]P8  +M*
M\=: /4K_ ,0:-I=Y!9ZAJME:W-Q_JH9YU1GYQP">>>*I>#]?EU_P=9:U?+#!
M),CO($R$4*S#/)/8>M<UH$=H?&7C==;:WED2&T61Y@,&W^SC)Y_A+;R?>M#X
M3!3\+=# R5,3XSZ>8U '5+J5@^F_VDE[;M8>69?M0E4Q; ,EMV<8QWK/M=6>
M[\2/:Q:AI,UD;-;B.&*4M<G)&'(SCRR#P?6O,)%DBLKGX6QEE>761%'@\KIS
MYN&(/L Z?I6E?I/#\6O$J:>I6X3PF1;K&,$,&^4#\<4 >A6WB?0;S5'TNVUK
M3YK]"0UM'<(T@(ZC:#G([^E9.@^*;G4_&/BO2+F.WBM=&:W$4JY#,)$+,7).
M.,=L5Q]U'IR_";P4VF+"+K[5IQLS&!N,Q=?,_''F;OQS5=KZ#3?$/Q;NKJT6
M[A5+-7MV<JL@:(KAB.@YY/IF@#TJV\6^';RTN[NVUW3IK>T&;B6.Y1EB'JQ!
MX%9%OXWM=<\,Z?J^BZEI%N)[B..5=0G V;NL?RGB4C&%-<W#%>0?$,V>HS:2
M\P\-W ,.GV[1JBB2+:K;F;=CG'3CMS6!J C'P3\!% O.I6.XKW.6ZT >OZIX
MDT30Y(H]5U>QL9)>8UN9UC+#U )Z>]37FMZ5I\22WFIV=O')&TJ-+.JAD&,L
M,GD#<O/N/6N2T)+23X@^.#J2PM,/LP'G $"U\D=,_P .[?GMGK7)>$;6.[N/
MAJMU%YL4<.JO;B09'EB1/*.#Z+M(_"@#UW3=5T_6+-;S3+VWO+9B0)8) ZY'
M49'>JVJ>)-#T26*+5=7L;&27F-+BX6,L/4 GI[U@>#(T@\5^-H8E"1#4XG"*
M, ,UO&6./<U6T%+.3QWXZ.IK"TP>W!\\ @6OD#'7^'._/;.<T 2>/?'\/A:+
M3+>RN=,:_P!1N(XU^V7 6.&%L_OG .=@QC/3WK>FU::#P9-K"S6=U/%8O<B2
MV):"1E0ME3G)4D>O2O)8XR_@GX7F5-P.OQK&7&28?,E\L<]MFW'M7K?BI53P
M9K:J %&GS@ #I^[:@"AH?C&TG\#:5XAUZ[LM.%Y"KL7D$<88]EW'VZ9K;M]8
MTRZ:U6WU&TE:ZC,MN(YE8S(.K+@_,!D9(]:\N\,SS3>'O .G6%MIW]H?V9+<
MQWE^K.D"+L5@J*R[F.\=Q@ U2TF9+#0M+\2F>!HM+\3744TT"%(1;W$C1N57
M)VIN9& R>* /8H-0LKJXN;>WO+>6>U8+<1QR!FB)&0& Y7(]:=:7EKJ%I'=V
M5Q%<VTHS'+"X=&'J".#7B/VZY\.Z5+KBJRW?B[3+AT'<W+S9@'UV7&/^ 5[#
MHEM9:)ING^'X9X?-M+-%6+>-Y10%W[>N,]_4T 73?6BWZV!NH1>-&95MS(/,
M* X+!>N,\9IDFIV$5Q-;R7MLD\,7GRQM*H:./^^PSPO!Y/'%<G\08SI;Z-XN
MB'S:-= 7..]K+A)?KC*M_P !-<=JL8U+PEK7BJXYL]8UFU61CT&G13+&N?0'
M#,?9J /4],\2:'K2S-IFKV-X(!F4P7"OL'J<'@>]6?[5T[[';WGV^V^S7+(L
M$WFKLE+\*%;."3VQUKB/$T4(^(?A]=/1!.VEWXN!"!DP;$V;L=M^,>^:POME
MO_PJCX>1^<A>2_TQ$4-R2KKN'X8.: /6;J[MK&W-Q=W$5O""JF25PJ@L0 ,G
MU) 'N:RU\8>&GBNY5U_3#'9D"X8728BR<#=SQSQ]:Q/BS&LOPYOXW&5>>U4_
M0W,=5KO2[ ?&31MMG HBT2<H%0 *5D15X]@S >F: .M.OZ.NCC6#JED-,(R+
MLSKY1YQ][..O'UI+?Q!HUW;6MS;ZM92PW<GE6\B3J1*_]U3GEN#P.>*\QTV4
M11OI-I8V4EQ/XOO5LS>!O(MB@9]VU2,G&0%R.3[4V#2;O7-&\<PV]Q:S:K9:
MM'>VDEE$8XQ<QPQM\JEF()*E3R<DF@#UN:^M+>ZM[6:YACN+DL((GD :7:,M
MM!Y.!R<=*KZKK>E:' DVK:C:V,3MM1[F98PQ]!D\UQ?A'4HO'7BY_%,0S8V%
MA':6H/($\JK)-^*@HA_&KEZ(G^,^FK=A2@T28V@DZ>;YJ;]N?XMF/PS0 1^,
M;N]T;Q#>6]WHMJ-/U/[);75[(5MVCVQ,&9@>I\P@8X/%=)J'B+1=)NH;74=7
ML;2XG_U<4]PJ,_;@$^M>)^(A9CX5?$(6&S[*/$WR>7]W[UOG&.V<UW'B>TEM
M-1\0:QI[:1J=O]CC75]+OOE<(B,1L<9V[E)X88SSF@#M-2\1:)HT\,&IZM8V
M4LW^K2XG5"_;@$]*R+GQ/=0_$VP\,I% ;.XTU[QI2#O#!RH .<8Q[5S_ (?D
MT>^UWQI-J\4*P/!:MLN0/DLC; @>RY+YQWS52,VA^+OAPZ.2;/\ X1AOLF[=
M]S=\GWOFZ8Z\T >@#Q/H)U?^R!K6GG4<[?LOVA/,W>FW.<^W6G3>(M%MM6CT
MF?5[&/49,;+5[A1(V>F%SGGM7E+):?\ #.]M)$J?VD6C9&P/-^W>>,^^_=GW
MQ[5M:Q&=$GUG58AI6M:%+J,<FH6LHVW-M.#&GR,,AB"%(4@'L#0!WMQXAT6U
MU6+2KC5K*+4)<;+5YU$C9Z84G//;UI==UJR\.Z+=ZKJ$R16]M&7.Y@NX@<*,
M]6)X [DUY2^G:KJ>E>-(9=0T&RM7UBX%Q<7L3^?"0P\EMP8 87RRO%>@^/D)
M^&OB$2X=QIDY)QQD1GF@"B_Q!L'U#P_)!>6']D:C;7,UQ<O,"(#$L9"E@=H.
M7(.:Z2VU[2+S2GU2VU2SET] 2]TDZF-<=<MG Q[UP8L[2Z\2_#0/#%)&FFW,
MJC *[A%!@X_7Z\U@Z[%+%?>([>T%K%;GQ38-*MPA, W11G,@!'RF39F@#UW2
M]8TS6[4W6EW]M>P!MIDMY0X!]"1T-4M6\11Z?J=II%K;M>:K=JTD=NK!0D:]
M9)&YVH#@9P22< &L?PSIU_;^,=8N]0U#2'NIK6!9[73D9-I!?9(X9B<D$C/H
MH]*S$9M+^.\\E_\ +#JNDK%82M]TM&P+Q ^O5L4 =6-7U*#5+&ROM)1$O'9%
MN+:Y\U$*HSX;**03M.."/<< [5<;XDU/4[3X@>$M,M=0DBLM3:Z%S$(XSGRH
MMZX)4D9/!Y^F*Y>PL3!I'C37;<W=QJFCZG?MI^^YD<(1"N!M)PW7H<]!0!ZU
M17F-RJVFC^!];T21FO+R[M8;B0.2;R*5"9?,_OD %LG)7:>E9.JS>1\-?B)^
M^,;6NL7 MSO(,7$6T)_=ZG 'K0![)17G5YH]IK?Q4O=.OY;J6RDT.&9K<74B
MHS&9US@,,< <#C.#C-:GPS>\/A)H+NXEN4M;ZYMK:XE;<TL,<K*A)[],9]J
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M#M=TGP]IME97&HVDD640(&8J0NX@9P,_A6AH_A/1=(G2^M]*LX=2,026XCB
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M^S]*M;;[,7,/EQ@>7OQOQZ9VKGZ"K$FBZ9,E\DMA;2)?D&[5XP1/@!1N!Z\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>&Z7*ES\,/#6CB.4WVG>(+9+VW:)@8LW+GG(].:]RHH X+QAJCP>++
M*QO]4U'3-)>R>2-[!#ON;C>!Y>X*QX7D*,9S[5Q_AR\30SX4U+4DN8;73IM4
MLKYIHV9K6667>GF8'<#&X<<U[;10!XIJ*3:[/XNU2S@OXK5=6TR\#PPE9GAC
M50TD:D<D %QQV'%=CX-BTB[\17FI:=JVM:M)':I;M=WN/)P6+;%.Q26!&3U
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M&GM4DU:Q2:ZCBWM# 8XEDD4$') SS@XZ]JRY_+N+CQC%8W&JZA'?^&F2RGO
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M B+JV0Q('&".<'CI7=Z9I5[;_$#Q!J<L.VSN[6SCADW [F3S=PQG(QN7KZT
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MB@#U:DR-VW(SC.*X_P "^(9]7FU>RDU!]3BLI8_(OWM_):9'7.&7:HW*P89
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MCG''S 'BN:T/5_&6I>&=:U]-0%S+:->P6>GI:I^^9'8(S$#)(Q@*,9V\Y)H
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MA^XSD=:P['Q%XL7X>:?K]QK$<E_K36MI:P_94$=N\CA/-.!EB1EL'@' QQR
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MG.T##<[1S@=*[2B@#C]"\.>(M%%CI<>LVG]AV+GRMMN?M,D0SMB=B2H R!N
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M49)"X^5NN,X/K[5U-% '!W7@?4]?.JS:_>V"7%YICZ:AT^!E 5F#;VW,2Q!
MP.PSSS4MOX5\0WFN:#J>MZK8O_9/FJL-G R"0/$T98EF/S<@\8 P>N>.WHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR+3Q7X=U"Y2VL]?TNYG<X2*&\C=F^@!R:UZ "BBB@ HHHH **3(R!D9/:EH
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MSV=S#<P2MNB9U8E"N,-\O?BL$:KX:U7XNC6+75TDTB*".ZN"JEHI+U \<9!
MY*QOD_1?P /7[2.:*S@CN)O/G2-5DEVA=[ <M@<#)YP*FK-LVO+G4FODO8I=
M(FMD-O"(\,'R27+>A!''M6E0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %,:&)Y4E:-&D3.QRH)7/7![4^B@ ID44<$2Q0QI'&O144
M#\!3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "F+%&LKRK&@D< .X49;'3)[XI]% !1110 5'!;PVT8C@ACBC!
MSMC4*/R%244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXLUK0GO[T:) =&T\KYTTUT4FG4@%FB3:00N>Y&2#6;$<_M"S8/!\,@_^3 H
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MMNUN"<9P>#S7955AU*SN-1NM/BG5KNU5&GB .4#YVD_7:?RH M4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% '.^,M1FTW1HI(=8MM)$EPD<EU,GF.%.<B),'=(<# (/&3VKC;?QKJO\
M9%TD.IM>-:Z]9V27LMH(7F@E,9(9"HPPWL,@#L179^*-#OM4FTF^TR>VCOM,
MNC/&MTA:*0-&R,#M.0<-D'U%<Y<> -:N8=9,NLVK7-]<VVH13?9V BN8MF%V
M[N8\( .<X[GN :>N:KJ@\8OHUI?&U@?0Y[M66)6995E10W(]"1CIS7 Z7;:H
M/ WPX\K4O,GGU%# TT*XMP8)0< 8WXY/)Y-=]9>%]9G\4G7M:U"S>1],DL#;
MVD3*D89U8$%B23\ISGU'''-'1O ^L6>E^&]/OM0L9(]!O1-"\,3JTL0C=,-D
MG#?..G'% %&^\5:YX47Q9:WE\-6ET^UMKBRFFA2-MTS-&%<( " P!X .,UJ?
M:O$'AKQ)H-MJ>MG5K75I'MI1);1Q&&41EU9-@'RG:1AL]N:LZSX&77-0\0R7
M-WL@U:P@M5"+\\3Q,[!_0\LIQ[4MKX<UZ_UW2]0\1W]A*FE;VMXK*%D\V5EV
M>8^XG& 3A1W/6@#F]%UOQG?^"=1\2C4!<RQ"YAMK&*S1MVR8KYIQR64 @*.#
MM'4FJ7B#59-4^&'B>2'Q/#KUJL,6TM L,\$GF#<KJH& >,9 /7K7:Z)X7U+0
M_!+Z-9ZHD-^)IIHKI8=RJ7E:0 J>HP=I_'&*R-2\"ZQK]MK<VJ7FG0W^H6D5
MFGV.%Q&JI)OW.6.68]/8#O0!;BNO$&C>.-%L-1UA=0MM7AN"\/V9(Q;R1JK?
MNR.2O)&&)/O7-67C7Q+=^"([Z*[A.HR^)!IJ.\*[/+,@4*0 /7KU]Z]!U/0I
M+_Q5H6KK.J)IHN \9'+^:@48/;&*\]U?PE=>&O!NGZ7]O0SW/BF"XCN(X_\
M5F24;>#U(_6@#JM+O=:TKQXN@:IJIU2VO+![N"9[=(GB='563Y  5(8$9YXK
MLZY*P\/ZTWB*?Q!K-[9->1V+6=G'9PN$C!;<SMN))8D+P.@'>MKPY+J$_AO3
M9M6&-0DMT:X!380Y&3E>Q]NU '(S7OB'Q#?>*);#5EL[/296LX;3[.CK<.L0
M=S(Q&X EL#:1C&>:YK2?%;6/A_PEH9UTZ)!_845W+=);">20D[$0 JP ^5B3
MCT Q787/A/7(-5UO^Q]3LX-.UIO-N%FA9I8)"@1VC((!R #\W0^O2HK'P9K&
MA6NB3Z/?V1U&PTT:;<"ZB8Q3Q@A@1M(*D-GUR&- %#0_&FK7%[X9N;V='T[4
M)+G39V6'8K7*,3%*N1N D53\O3FHM9\<ZI;OXAO(+N*#3H=0M]'LY'A#K'*2
M//F( RVW) '3*UTVK^&-0UGP='IMWJB2ZQ%*ES%?>2%5)TDWJ0HZ*/N]<XZG
M-5HO S0^!+/0XKX)J-K*EXEZ8]P-TLGF%RN>06R",]#0!RMWXFEU'PUXSTG^
MV&UJUCT.6YAO7M1"ZDJZO&P"J#CY2"!W/6KN@ZCJMWI/@CPSI5]_9_FZ!'>W
M5VL2R2"-4C150,"H)9N20>!71W&A>(]9T#7;'6=3L@^H6;6L$-I"1%"2K N2
MQ+,3N''  4?6JB>#-2TVT\-W.DWUJNJZ/IXT^0W$;&&YBVJ"#@Y7YD# _G0!
MB:AXL\2Z;9:GI2WL,^K:=K-G:)=O H$\4^QEWJ. <,02N.G&*T+K5?$'AO7K
MG3+W6/[2BNM(N;RVFDMHXWAFBQD84 %2&!YR>.M9?BOPU>:?X>:XO+]'UC5]
M?L99KB"+:D1$B(BHI)R% '4\UT7_  BFLZIJMWJ6N7UBT_\ 9LNGVD=I$ZH@
MD^](VXDY.%&!P .] '/+K/C*/2_!^JG7(9&UYX;:6V:T3RX?,B+"12,,6&W)
M!."3C %3WGBS6_"T/C"VO=174I-,CM)+.YG@5"#<$IAQ& "%89X&2*Z$^#YS
MHOA"P^UQ[M!FMY)&VG$OEPM&0/3);-1ZIX'.K7_B6:6]$2:O;6L<11,M!) 6
M97YX/S%3CVH YJ#QM>6XUFVM/$3:T$T6YO8KI[(0M;SQ#[N H4J=V0""?E/)
MK0@U3Q-82^$M2OM96Y@UN9+>XL1;(J1%X6=61@-V05YR<'/0=*V9-%\3ZKI>
MK6FLZIIX6[T^2SBALX&"!W4CS6+$MGG[HXQGKQB:[\+37-EX6@%RBG1;F&>0
ME3^]"1-&0/3);/X4 </H$_B+2_#OC74;74I[VYAUJ>'9]D1R,/&KSA5 +,$R
M=G3Y>E=KX*U-]3@NY8_$T&O6891%*(EBFB;!W)(J@ =B,@'KFJ=AX5\1:3+K
M\>G:O90P7]^^HV[M;EI$E=E9HW!.#&0I7C#<Y!%13:-XCTVS\1^(%FLCK]U:
M1QP16-LQCS%N*Y#$EW8N1D] !Z4 =W7E%SXVUZ+P]\0+Q+E#/H^I>19?NE^1
M-RC!XYX)Y.:]67.T;OO8YKSZ?X=74NC>,;$:A"&U^^^U1ML.(AN4X/KTH ;=
M2^+K/QEIVAMXC22+5K6:9Y/L<8-HT94GRACD'< -^['7FL^3Q5XFM_#\MO'?
MPS:G;>)TT<74D"@31L5P74< X<9VXZ5W%[H4EWXQTG7%G58[&VN(6B(Y8R;,
M$'VV?K7$>+/#ESI>G!4O5675/%]M=PRJF?)WE%&0>I!7/O0!H7.K^(/#FLZE
MI5YJ_P#:*R:)/J%I<26T<;PRQ'!7"@ K\P(R.V*IP:]XI@\$Z1JMQJL,VH>(
M9+*VM4-LHCLS*.9..7)7+$'C/08K:_X1+6-3U#4M2UN^L3=3:7)IMK':1.(X
MU?EG;<22Q(7CL!WJQ<^#99_ NCZ&MZL5_I2VSVUV(]RB:$##%<\J<$$9Z&@#
M)O[OQ5I&KS^'XM;-_<7VESW.GW,UM$LD5Q$5^0A5"E6W#J,BGS^,[S5_#OA$
MZ-*L.HZ]/&'.P-Y,:#=<'!R/EVE?J:U]*\/ZM)XF'B#7[JSDN8;5K6U@LHV6
M.-68,[DL22QV@=@ .]4_#O@-M#\7WVK/>+-9_O?[/M0F/LWG.))?S8#&.U '
M*3?$>Z+W.JQZ\ \.H-"FAK9;ED@67RR3)MW>85!<$-@<#%:=[JWBJ]'C2XL]
M<6RAT*9S;(MK&YDVPK)L<L/N^XY^8\\ 5MV?AOQ%I,\MCI>KV<&BR7K70+6Y
M:XB5W\QXER=A!8MAB,@-T. :L1^$YDM/%T/VJ,G79)'C.T_NMT*Q\^O(S0!A
MVFM>(X-0\(ZE>ZI'-::^VR;3UMU5(-T+2)L?[Q(Q@Y)SZ"L6T^(]U<-;:LFO
M"1I[\1-HBV7RK;M+Y>1)MR7"X<G=CJ,5VTGA.9[;PC%]JC!T)T:0[3^]VPM'
MQZ<G-0:5X;\1:,T.F66KV<>A0W33(?LY-R(RY<PY)VXR2-V,X]^: ,.?5/%>
MH6'C#4+775LX]$O+E+:);2-_-$<:OM<L/N\XXP>223P*9;3:GK/Q4T"]&J26
M\4_A\7OD+"C*JM)%OC!(SAB <]1C@UT]OX4F@T;Q58FZC+:U<W,T;;3B(2QJ
M@!]<8S5)/!^JV.M^']2T^^M-UCIBZ7=+/&QWQY0EDP>&^7C/% &?X.\0ZIJN
MLPQWWB*(:@#)]OT*YM5A> <X\HX#, =O)+ @D\5Z-7&6_AKQ!=:QI%QKFI:?
M<PZ3*TL,\%LR7$Y*,@WG.U1ALD+P2!TK<\-2ZI-H^_5SFZ%Q.H/E>7NC$K!#
MM[94*?QH PKV[US7O&&J:-I.L?V3!I5O"[R);I*TTLNX@'>" @"CI@G/6JYO
M_$^J>(K/PV^HPZ7=6^EK>ZA<V42R[Y&<HJIYBD!?E9CD$]![UH:GX>UN#Q)=
M:WX<OK&":^MT@NXKV%G0E-VR12I!W ,1@\'BJQ\):UIU]I^JZ5J\5SJD-C]A
MNWU)&9;I=V\/E3E6#%L=>#CMF@#"F\6>)?[/M=/BO+<:I%XF_L6>Z, VRQ&-
MG$A3L<%20".5QP#4VI:EXNTF]US0K?5_[0OHM+75;"XDM8U?Y9"LD+*H"G..
M#@$;JJ^(O#5YH^G>'HAJ*-JU_P"*DO9KH0_N_.:*7&$SG8 JKC.2!U&:ZC3]
M+NM,UN_\5^*=2TZ.4VJ6B>3F*""$,6)+.>2S,/R H KW'BR?6+GPA!H,PC_M
M?_3;AMH<I:HH+J<C@EF5,]CFLWPWJ_B;4]#UG7KO5T$%DU]!!:I;)\YC9MKL
MV,Y& ,#CY<G.:;\+=$A2[UC7+>1Y--DGDM='W+@+:B1I#M_V3(YP>X05T.B^
M%)M*\):GHSW4<DEY+=2+(%("^<S$9'MNH YG3/%&OZWX>\$6D6H+;:CKB32W
M-\L",42)<MM0C;DDJ.1QSQ67XJU+77\/>/M'U6\CO%TV.Q^S2+$L9<2/N);'
M<X /;(R ,XK3OM"7P;X=\'"76[2SU'2)7MX;JYA8VLOF*P9)""-@( P2>HJC
MI>B7/C!O'D<>K6]V-0>RB&H0I_HYDC&YUC )RJ@JO4\T =&\_B32_&&F:5=Z
M]]JBUFUNL8M(T^R2QJI#1X&2OS='STZUR?AG4=<TGX5Z?J(U>X%O=:E*MS<)
M9K*UC%YT^^0*%.[<X7)8';N.!7IFI:%)?>*]#UA9U6/34N5:,CE_-50,'MC;
M7/:'X5\5^'=#72]/UC3?*M+IY;426[$31NTC,DW.1RX(*_W><T ;WA&\EO\
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MHR[P)%*OR?[J<^YJO<> [WR+B>SU""/44UV36+222,M&-R[3&X!R05)!(]J
M(M M]0M/BUJD&HWWVYUT6W\NX:-4=D\Z3[P7"YSN' '&.*T_&FIZQ9ZEX<L-
M'NH[9]1O7MY7>(/A/*=L@'N,9'J1SQ3M"\-ZO:^+;SQ#J]_:SS7=E';&&VB9
M4BV.Q 7))(P>_<GM5#X@0W4^O^#4LKA(+K^TI&CD=-Z@B"0X89&0<8."#@T
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MQ6GX.AOK?XB^,(-0NQ=RI!8!;CRPAD7;*064< ]N, XS@=*N:AX7UZ[M]'U
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MEO-'//)L+/(T@*Y)P>$X &>M #K?X?Z+;^')]$5KHV\MV;U9?-Q+%,6#!T8
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M8N8VE+ZJX>XW,, B,1C;QQPH]>:Q)?'FG0^)HH'U'3AH<FEM>B^,PVEQ,L8
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M.,'=TP<CGWJM<>(]$M=4ATRXU>QBOYL>7;/.HD;/3"YSSV]: *?_  B&G?\
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MXG@K2T\(V?AH/<_8;1HGC;>/,)CD$BY.,=0,\=*BU/P+9:A?WMU%J6J:>-0
M%[#93JD=Q@;<L"I(.W@E2I(KJ** .;NO!6FRW^D7EI/>:=)I4/V> 6<@56A^
M7]VP8'*_*/0^]:&OZ#;>(;".VN)KBW:*9+B&>V<+)%(IR&4D$>HY!&":U**
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M(:X95 ,I"[06]> !]* /)_#6Q]1^%32[23HMT,MWQ'%C\JZGXOA3\+=9+ '
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M<Y<+Z9/)]: -.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MIW5VD/AQ1/+%(T#7)$Y +%"#CN0#R0/I0!Z=4-W.;6RGN%@EG:*-G$,(!>3
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MA.U<,H(V@8Z5RNI:>=5^"UUXLNK^];5;UO.F9KIS&5-P%$7ED[ H& ,#((H
M]SHHKR^ZTLZ]XF\>I>ZAJ @L5@:TBANY(EAD-L&+@*1DY X/'7CF@#U"BO(K
M*.YMM'\ >)6U*_EU74[RVAO))+IRDL<L;$J8\[ !@8P.HSUYJ+6+XK>2Z]IB
M:_<2)K4<(U22Z"6H3SUB>%8O,^:,99<[.3SGO0![%65X<UZV\3Z%;ZO9QS1P
M3EPJS !AM=D.<$CJI[UR&B:>^L?$WQ3+>W]ZUOIEW;/:6R7+K&KM I)*@X8<
M=#QRW'-<?X U2;6K#0?"<TMUI>G W,[3#=&VHNL[-Y,3CHH!!;!R<$#&": /
M=*KB^M6U%M/$Z&[2(3-%_$$)(#?3*D?A7DNI3:KK6H^)YK73/$5QJ-G>/:Z7
M<6-TD=O:F-%V@H95W98Y;*G(.*UM#TJ*?XQ:A>727,=VNDVMPT?VJ3:DC%PP
M(W8*C^[R!U H [[2=1?5+$7,EA=V+;V7R;M K\'&< D8/4<U>KP_0[[4[[X:
M:!G5;V.>Y\3K;O<+,QD\LR.",GVZ9XZ5K:[<3^!]3\40:-=78@'AW[=''/<O
M/Y<_F,F]2Y)'&"?7% 'K5%>87FB'PYK'@G[#JNHLMW?!+Q)KR247+>2YWD,3
MCG.0, Y'' KT^@ K%B\36<WC*X\,+%.+R"S6\:0@>64+;< YSG/M7ET5E<'X
M4W_BPZOJ1UBQFN9K67[9)MB6.=P(]F=K X.<@GG'0"MN&]CB^-&L7T\OV:-/
M#"3228SY8#@DX]J /4**\E\-S36?BWPPUK;:_#;ZG%.MQ<ZI=A_MV(MZR>7Y
MC;&R,]%P&Q6;#:W$7PHM?%S:IJ3ZS;W2F*5KR3:J?:_+V;,[2I4G.02<]<8%
M 'ME%>7ZU')IOBJ\OO$ UR""2\B:PUBQN6-O;1X0>7)$&PH+;@2R$'=UKU"@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** .<\<:'<Z]X9EAL"JZC;2QWED6Z>=$P90?KC'XU&FDVGBN
M[\.>)[F*^LKO35E>*UE7RRK2*%=9%9<\8X(QGKR*Z&YO+:S5&NKB&!7;8AE<
M+N;!.!GJ< G'M5:UUW2+ZSGN[35;*XMH,^=-%<(Z1X&3N8' X]: ,.32X?!L
M/B'6]-@OK^^U.43_ &55W[I<;550HX7)&2>@R<U<\%Z#)X:\)V6FW$@DNE#2
MW,@Z-,[%W/TW,0/8"M&/6M*E2Y>/4[-UM0&N&6=2(01D%^?ER.>:9;ZU8:GI
MUQ=:3J-A=K&K?O(YU>-6 S\S*3@>OM0!HUCZ-X<M-$O]7O+:29Y-4N?M,PD(
M(5L 87 '''?-%CK447ANWU/6M0TJ$,N9;BWN0;;.2!M=L9']:N_VII_]F_VE
M]NM?L&W?]J\Y?*V^N[.,4 9&K>$TO]8.K66JW^E7TD(MYY;,QXFC!) 975AD
M9.&&",U6F\ Z:-)TFRL+N]T^72I&EM;N!U:4.X(<MO!#;MQSD=ZMZMXVT#2?
M#_\ ;3ZE;7%FTBQQO;SH_F,6"X4YP<9R>> ":F&KO<:[8Q6=[I$NG7%NTO%S
MFXD(/!C4<,GJ<T ,T#PM:^'[W4;R*[N[JYU QM<RW+ABS("-W &,YZ=!P  .
M*L>(-"A\0:>EK+<3VTD4R7$%Q 0'BD0Y5AD$'Z$$8)J5M>T==4&F-JMB-0/
MM3<)YO\ WQG/Z4E[K^C:;O\ MVK6-KY;!'\^X1-K$9 .3P2.: .4U7P%:PZ?
MK5XTFJ:O<7UB(KNW::-6O&0ED8':-KKG"[<+P.*R- TVXU+QUHFI1KXBGCTZ
MWG^T7>N0>2PWJ%2)%VJ"?O$L <X&6/%>BWNM:5IMO%<7^IV=K#-_JI)YU17[
M_*2<'\*N(ZR(KHP9& *LIR"/44 8-AX.TNQ\'OX7;S;C3I%E5_.8;R)&9CR
M,8+'![8%1V'@^.!ISJ6KZEK"RVK682]D7:L+?>&$502<#+')XZUTE(2%!)(
M'))H YS1?"(TB\MYWUO5;Z.UB,-K!=2KLA4X'\*@N< #+$G%=&0&4@C(/!JA
M9:[I&I).]AJMC=+;_P"N:"X1Q'_O8/'0]:2'7]&N+Y+&#5K"6[D02) EPC.R
MD9#!0<D8YSZ4 8&F?#RRTRQTZQ75-1GM--O5O+.*5HR(BH<!,A 2OSGJ<\#F
MKNK^"]-UN[U*YNI;D/?V4=G((W V*CEU9>.&#-GG(X'%/\1^*]/T33M3V7UB
MVJ6EE+<QV3SJ)'V(6'RYW8XK6TRZ:^TJSNW4*T\"2E1T!90<?K0!S]KX'AAU
MF#5[G6-3O+]8)+::69H\3POC]VRA % (!&W!R3DG-7O"WAI/"NDKID&HWEW:
MQ\0+=%"84[*"JC(^N36Y39)$BC:21U1$!9F8X  ZDF@#'U[PXFN36-TE_=Z?
M>V+LT%S:[-P#KM92'5E((QV["L*Y^&&E7.CZII3ZAJ?V/4KB.ZF4R(S"9=N7
M#%2<OM4MG(],5T]IKVCW]G/>6>JV-Q:P9\Z:*X1TCP,G<P.!QZTMOK>DW=^]
MA;ZI937B#<UO'<*TBCU*@Y% %23PS9R^,H?$YEG^VPV1LEC!'EE"V[)&,YS[
MUM5036])DU1M,34[)M07EK59U,H[\IG/Z5@Z+XR%[XD\3:=?_9;2VTFY@@BF
M:3;YAD4G!).,YX % #(?ASI-OX8_L.*ZOD1+TW\-R)%$T,^[<&4[<<<CD'@F
MI;7P%81WU[?:A?7VJ7-_8FQNFNV7$D9.<855"^G&!WZ\UTMQ=VUIY7VFXBA\
MV011^8X7>YZ*,]2?2J]OK6E7=_+86VIV<UY#GS+>.=6D3'7*@Y% &+8^"8K<
M.E]K.J:G!]E>SBANY5VQQ. &'R*NYL #<V356W^'EO#-I<\NN:M<SZ6X%I)*
M\?[N+:4:+ 0 AE."2-QP.1BND@UK2KG49=.@U*SEO8O]9;1SJTB?50<BB#6M
M*N=1DTZ#4[.6^BSYELDZM(F.N5!R* ,33?!,5C?V,\VLZI?6^GDM96MU(C)
M2I3.0H9B%8@;B< UI>&=/O-,T1;6_N9[B<3SL))Y?,?8TKL@+=R$*C\*UZ*
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M?SZP%%W>3,JRD(/D"[5"J%ZC Z^M%OX$MQJ=MJ6HZOJ>I7D$$MN)+B1 #'(
M"N$5<=,Y'.3R3Q@A\90:WX<T_5]"O-+1+F>-)%U&X"; W5/ES^]QC"FMW4-<
MTC2'C34M4LK)Y?\ 5K<W"1E_IN(S0!D:7X-2PU"VN[K6=3U(V<;16<=V\9$
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M#+YA?<K;<9RQ'3I7644 <K?>!X;N]NYX=9U2RAORIOK>UD14N&"A=Q.TLA(
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M@"J=YX*\-7^HS:A=Z-:2W4ZE99&3[^5VY(Z$X.,]:VX88[>"."% D4:A$4=
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M% '#_%T1'X;:@)VVP^?:^8V<87[1'DY^E5M7LK'3_B3X8&EV\$!DT^]2=;=
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MFM__ (3/2M-T_1(II[V]N-1LA/:[+<O+<@*F3M4?>.\''0<G@"O/_+?^P?C
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MR>>XAB DMXY(BJR%74@#++G(X#'I0!Z_HFO6>O03O;+/%+;R>5/;W$1CEA?
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M-YJOQ'TI+Y8$TJQ@DM9$A4LI:$N^?7.,<],\5UI\/2#Q]!XA26-;:+2GL/)
M.[)E5P1VQA<5F1^"I_\ A(?&=_+=QB#Q!;101JJDM%MB,9)['KF@#B3::V/#
MGPSB3Q ZK<30&/\ T6/]U_HQ*_[VT9'/7.>U7];^(%W;WNNO#XCM;.72)3#;
MZ;):AS>M&H+%VQE=S$J-I&,9YK6_X0WQ*?#?ANV-YI/]I:!<QM;G;)Y4T21>
M7A^X;DGCBM#_ (1[Q1I]YJ0T74M-@M]4F%S,\T+/):S%561HQT8';D!L8/K0
M!5BU3Q#XD\5:IIVFZLFF6,%E:7,<GV5)9%:57.W#<8XR<\\#&,FMWP-K5WX@
M\&Z=J5\$^UR*Z2F,85F1V0D#MG;G\:DT[0IK+Q=K.LO.CQW\%M$B8^93$'R3
MVYWCI2^#]#E\-^%[72IYDFDA:5BZ @'?(SCK[-0!Y[IA\2VVC>,]5TK58;2+
M3]8U&:.U:V607)1RS!V/(!^Z-N,=<GMU&A>*[JY\4FUOW1;#4M*AU3325"[%
MP/-C)[D$JWT-46\&>)X-/\0:79:IIHLM;O;F>1Y8G,ELDS'(3'#':>AQ@Y.3
MGBC\1--L[BV\.>&M%OQ'KD,HLX$B8-+':O$8YBX_A7R\'/J!B@#K? ^JZAKV
M@/K%\P\J]N99;*/8%,=MNQ&#ZD@;L_[58]MXSN]*T;Q<-:=9=0T"5RI"!?.B
M<;K<X'&6SM^HKM[.TAL+*"SMD"001K%&@_A51@#\A7FFOZ?8^)_BOI<.FWB3
MQPP[];CA(9-L,@>!7(XW>9GY>N : +]C?>*]5U6U\/OJZ6%W9Z7#=ZC=):H[
MO/*6 C56&T*-IR<9/'2HM/\ &.LS3:-97,D)N5UZXTF^DCC 6<1QNP8 YVYP
MAX]ZWM5T'5XO%!\0:!/9"XFM1:75O>A]CJK%D<,O(8;F'3!![5DMX"U*VTBQ
MEL]0MGUVWU9]6EEFC80S2R!E=< Y5=K8!Y/RB@#<T[5[RX\>Z[I,CJ;2TM+6
M6%0H!#2>9NYZG[HJAK^O7]C\2_"6CP.@L]02[-PIC!8E(]RX/4<^E6?#OA[5
M;'Q-JVN:M>6LTVHP6\9BMT95B,>_@9Y(PPY/).>G IVL>&+C4O'?AOQ!'<1I
M#I*7*R1,#N?S4VC';B@#D+CQ#XN;PEKOB6+5X(DTF]NDCM/LBL+B.*4C#MU'
M P-N.F23GCT;4WN)= N9;.X-K.;<O'*$#E#C/0\&N:;P5=-X"U[P]]KA\[4I
MKN1)<':@FD9@#WXSS76FUWZ<;1FQNB\LL/IC- 'C.FP:J/ ?PY,>H)+<3ZE$
M;=IH1MMP8)1T&"^.3R>>F:Z*_P#%NM^$U\4VVHW\6I/I]K;7%I<2P+%@S.T>
M'"<$!@#QSC-6]&\$ZW::1X:TZ^O-/=-!OEFC>!7!EB6.1,'/1OG'MQ6AK7@A
M]:U/7IY+Q8HM2L;>WB*KEH9(G9U<CH1N*G'M0!G^$_%LEWXK71SXAAUZ">S>
M<3I;"%H)$905(4 %6#9&>1M/)K6\1:EJD_B?3/#>D7JV$ES;S7=Q=F$2LD:%
M5"JK<9+/U.< 5>T6#Q/]M:?7;W3_ "5B\M+>QC;#OG)D9GY!P,!1QR>3Q5?Q
M%H.HW6LZ;KNB7%K%J5DDD!CNU8Q3128RI*\@@J""* ,>\U/Q7:3:+X<GO;2/
M5-1NKA1J4<(;_1HEW;_+/ D.5&.0.3],W6/%?B#P[8^)].GOX[J]TV&UN;2]
M,"HSQRR;&#H/ER"",@#.:V)O"6ORQ:=JCZQ;S>(;&\EN4:2-OLVR5=K0  [@
M@7&#R<C/>H+OP'J&M:;XCDU>_MEU76(8H4:V1C%;)$=R ;N6^8DD\=>E &UK
M.L7EGXU\.Z9#(HM;V&\:=2H))C5"N#VY8UQNC>(O&-U\-O\ A+9]0CE>:)42
MVAL0_DKYP1YSCER%#MM'&,>AKHX/#OB.^\4:1KFMWNG V$4\7V>S1]I\Q0-V
M6Y)R.G8#O4NA^&=8\/\ P]L-#L-2MX]2LP-L[1;XGQ(6*L#SM(.TD8(SD4 8
M%QXSNM-\)3W\'BC3M6AN+R"UM=0\D*UL7.',J+@?*/F X)Z$5J>"_%+ZGK^H
M:0=:CUN"*WCN8;U8!$PRQ5HV  !(PI! Z-[5"_@;5+]M3U*\NM/M-8N)K6>W
M^QQ,88Y+=F96?."Y;<0>G&*Z;1(?$ GN9]=N[)@X58;:R0[(\9RQ9OF8G(XX
M  'N: ,C5M0UC4_&W_".:5J(TV*WL!>W-RL"RR,7<JB*&^4#Y6).#V%<!X_U
M+5]9^%.MQ7U\@GTC5!87?E0 +=XEB*/SG9PP) [Y[5Z/K&@ZLOBB/Q%H,]FM
MVUI]CN+>]#>7(@8NK KR&!+=CD'M6)J?PZO-0^'^J:(=0@;5-4OA?W5R4*Q^
M89%8A5Y(4*@4?2@#MM-M[JQT]8KZ^-Y*F2TYB6/([#:O' KSD^)O%'_"#?\
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M&P.9!+'L&*Y%_ /B9_"\'A?^UM._LJRGC>WE\I_.EC24.J2?PC '49R0.G-
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M?,Y+!<C@87 ZDT#0/$VKPZC'K^JV:17&GR64=O8(_E[G&#,VXY+#H .!SR:
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M9=RI+&VY<CN#R#[&J.EZ#K$_BA/$'B">Q,]O:M:VMO9!]B!V!=RS<ECM QC
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MY!SQMQ^&*X=K.T\4>/+G2IY9/[$TW2[>2TM;2X:&)S(7^?\ =D9 5 !S@=J
M/0:*\;2YU"\@T;1I-4OO+MO%5SIGVA9V$LMNB2$*S@Y)Q\N>O&>HS6EIWA:U
MN_%?BS0I+S4O[)L8[::UM1?2@122QMN;=NW'!3(!) )/% 'J5%>.Z/)>>)V^
M'L&H:E>>5=Z1<O>+'</&;G9Y8&YE(.<\DYR>?4U8:X32U\2^&9;W5Y+*#5;2
M&QAM9BUQ()HUD-NLC,"%X;DL"%SS0!ZI<6EM=A!<V\4PC8.GF(&VMZC/0^]3
M5XI?7FH:=X7\=6-M'J&E)9FQDM;>XN_/DMS(PW8<.W!V@XW=SZUU@TQ/#7Q(
M\/PV-U>LFIVUV+T7%U)*)FC",KD,2 V2>F.N* .QTK4)-2M&GET^ZL6$C)Y5
MTJAB ?O<$C![5>KPS2-9U.7X?Z?;%]2O3?\ B2:UG6WGVSR0J'?RU=F&W.P#
M[PXSBMV/2_$TFE:S96&D:M::9Y]K/;V-U?J)I(P3]HACE$C%00JD98?>(XS0
M!ZM5#6M8L] T>YU2_<I;VZ[FVC+,>@51W))  ]36!X$FT]H-1M[$:M;-#.OF
MZ=J;,SVA*CA2Q)*M]X?,1UQBJWCK_2O$?@O3)/\ CVGU4SR#LQAB9U!]MV#^
M% &]8>(HKW6SI#V=S;7BV,5\Z2A?D5V90IP3\P*G/;WK9KSN_P!#MM=^+U];
MWLEQ]E70[=FAAG>+S#YTN-S(0<#GC.,X]!7,P:GJ$^D^'=#ECU75+4W^HQ31
M6UR$GGCMW*QHTC.I*C<"?FR=HH ]JHKQO4UU^V\/V5@XU72()?$]K#8FXN0\
M\=O(,%2RNV0K%L9)XQZ5HZ[9I9>)]/\ #$&F:UJ6D6VG/=_9;2^*N\CRD;I'
M>568#G W'!;IP* /1=0U"2QELTCT^ZNQ<3B)F@52(0?XWR1\H]LGVJ]7CVH7
M.OV6G^!;?46O[6;_ (200;9YP99+?<WEB0JQ#';M!Y.<5?.CKKMWX\EOK[4"
M+*Z86:17<D:P,+=&W*%89.<=<@8/')R >I5SWB'7=*\&6B7DEA(\VH7:6\<-
ME"OFW$SYP.2 3P>2:XD72^)-/\-17=OK6LWSZ'#=S6=E="WC4R ?OI'+IEB0
MP R>YQ6!K-NNO>#OAMJ.I27,UW/J]M9RR&Y<%H]T@YVMC?Q]\?-[T >S6.KP
M7DJ6SH]M?FW6X>SFQYD:,2!NVDCJI'!/2M"O)DT>QT/XE>(;JT2Z9]-T..Z@
M62\F?YQYG!W.=PXZ'([]:9X3CUEKCPUJ=II&OK-<;7U6]O+Q'@NHY(R2VSS3
MC#%2N%&!Q0!ZY17G7PVTTWKZCK=]>7ES=0ZI>6UNLEPYCBB$IXV9P3G/)!XP
M!C%;/Q!O+FWT*SM;6XEMCJ.I6MC)/$VUXXY) &*GL<9&>V: .LJO?7::?I]S
M>RJS1V\32L%ZD*"3CWXKB]7T2R\(Z)K$UOK.K6NGW,$<0M896GE25GVAH6=B
M0S[@N,XSSD5@V)GL-0\2Z6FG:CIEE)X?:Y%G?7@N3ORZ[P0[[<C@C/5: .M'
MQ"TPZ-X<U/[+=^3K]U':VR[5W1LY(!?YN!QVS752PQ7$+PS1I)$X*LCJ"K#T
M(/6O#D_Y)_\ "3_L-6O\VK4U5]4UW6?%$D&E:_=7MG<FUTRXL;Q(H;1DC0J=
MIE7)+-N;*G((% 'KZJ%4*H  & !VK-\/ZY;^(]%AU2UCECAE:10LH 8%'9#T
M)'537%:993>+O&.L)KLMY#)I=I9)#!;W3Q""62(R2/\ (P!;<< G/W:T_A,&
M'PUTL-)YC>9<Y?\ O'[1)S0!L:CXMTK2]0OK*Z>436.GG4I@L9($ )!(/<Y!
MXJG?>/\ 1[&73XO(U*YFO[07D$5I9O,YB..2%!(ZBM:\\/Z5?W5U<W5FLDUU
M9FQG<L1O@))*<'IECSUYKDWMXK/XS:+;6Z!(8?#\L<:#^%1*@ _*@#H-$\9:
M+KU[)86TTT.H1KO>SNX'@F"^NUP"1[C-;]<%\0EC7Q#X(EMP!JG]M(D97[YM
MRC></]W&,UR=M/KNKP3ZW8Z-KT^M?VE(8+Q+Q%MEBCG*>3Y9E'R;%*G*9R2?
M>@#VFBO,9/$5SX-7QO87$TLTML1?Z6)&+%UN/E5%SV6;*_C69)97MMJ^G^&=
M0LM<UN'3]&BFE2RO1&6N)'??([&1"V-N%Y.,GVH ]&UKQ-::'J^C:=<0SO+J
MT[00M&!M1@,Y;)''TS6W7CE[_:PO?A@FN1SI?QZC<(XN&5I"HR$+%206*!2>
M>N:T(=-_X272/%FO7M_?QZC:7MY#9217<D8M%@R$VJK!>JY.0<YH ]3HKRC2
MEE\9^+-+&K75V+6X\*VE[/:0W#PK),TC_,=A!QR>/IGH*H_:-0ETC3-'_M2^
M6.U\8R:6MP)V\U[<+(0I?J3@XS[ ]J /9:*\PT[PK9W/CGQ#X?DN]2_L:WMK
M:XBM!?S8660."V[=N_@S@G&3G'2L+3=8U'6M(\':??6VK:O ^FW%S<0V5R(I
M+ADD6-"[%T)"@Y(W<D@G- 'ME4[@:?IRW6JSQP0%(B\]R4 ;8HR=S=2 !^E>
M7M#KC6_AG2]0?5=.CDUV>",2W(-PUH89&57=&.3C*YSD8!SG!JMXCTV&PTWX
MBZ)#-=G3K;3(+RWA>ZD?RI&63=@EL[3M!*DD>U 'L44J3PI-$P:.10RL.X/(
M-9-_XHTW3=6ETVX>47,5@^HL%C)'DH<,<^N>U<-J&@R6>GZ#(NF:OJ>@1V!\
MZUL+^031S-M(EQO#2#&0 #\O85UFA:7HFK:18ZI')+J1ETXV0O;ECYLL#'+*
M_3G(YXSD4 36'C#3M0O]-M42>-=4L_M=C-(H"3KC+*.<AP""01T/L:Z"N!^(
M-E;Z-X7T&6PB$(TC4[(6JJ3\J;Q'LR><%6(KOJ "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R]>T&V
MU^SBAGFGMY8)EGM[FW8+)#(N0&4D$="1@@@@FLMO!%I/I4MG>ZEJ5Y)-=Q7D
MMS-*OF,\;*R@ *%5?E P%'?OS707M]::;:27=]=0VMM&,O+-($1?J3Q4$&N:
M3<V$=_!J=G)9RN(TG2=2C.3@*&S@DGC'7- $9T.V/B==?WR_:ULS9!,C9L+A
M\XQG.1Z].U<9XB\%I%)X>L;'^T'@?7Y;Z>>,_/;LZ2MO#*,* Y&,^P.:[;3M
M=TC6'F33-4LKUX#B5;>=9"A]\'BL+5O'.GPSZ;!H]_IU_-/JD-C<I'.)&B5]
MV3A3P>.] $L'@:S6SUN*\U#4+ZYUFW-K=7EPR>:(MK*%0*H50 Q/W>IR<TLO
M@:Q.EZ+:6M[?6=QHT0AL[V%T\Y5VA2&RI5@0!D%<<=JZ*YN8+.VDN+F:.""-
M=SR2L%51ZDG@"L'5O%EG'X+U;7]$O++4196TDJF*421EU7.TE30!"ME9>"-&
MNYUMM5UBXO)B]PZ0_:+BYD*X&X*  N%"] HXJG\/_!W]@>!6TV[B,-S?[Y;E
M%?<8MXVJ@8YSL0*OIQ4+^.+Y9/ :_9;?'B./?<?>_='RE?Y.?5N^:[6ZN[:Q
MMVN+NXBMX%(#23.$4$D 9)XY) ^IH Q1X/T\:1H&F>=<^3H<L,ULVY=S&)"J
M[_EP1@G. /PIU[X0TO4;W5[F[$TO]JVL=I<1E@%")NVE<#(;YCSGL.E6V\1Z
M&EA/?MK%@+."4PRSFX38D@ZJ6S@-R..M8?C/QG_87A*WUS1VM+Z.:ZAA1]^^
M-E=L$@J>?SH LVW@R-(KU;[6M6U%KFT>R#W4J9BB8<[0J@;NGS,">!5J;PM8
MS:=H=DTMP(M&FAFMR&7+-$A1=_'(P3G&/PJWJ&OZ-I-Q#;ZCJUC9SS?ZJ.XN
M%C9^W )YYJC=>,M%L_%=MX<GOH$OIXC( TR#:VY J$$YWMORH[@&@!=(\+0:
M+KFIZC:7][Y>H2M/+9.RF$2MMW.OR[@3M'\6.3QTQ=UW1;;Q#HEUI5XTJ07"
M@%XF ="""&4D'!! (X[4L>O:/+JSZ5'JMD^HH,M:+.IE'?E<YK*\3^,=-T/3
M-5$.HZ>^KV=G+<I8R3KO8JA8 H#NQQ^5 $&H?#O1-2\/Z+HLS72VNDLAA*.H
M:0*NTJYV\A@?FP!GVK3O?#-E?>*M,\0RR3B\TZ*6*%%8>6PD&#N&,D^F"*T+
M*Y:ZTRWNF"J\L*R$=@2H/Y5EZ-KJ2:!9WNK:IHIEG9U$UC<YMY""QPC,>2%4
MY^C>E &8WP[TYH=7M?[2U(66IW0O)+42)LCE\U92R93(RR#@DC!/UK>N=$MK
MKQ!8:T[RBYLH988U4C81)MW9&,Y^08Y'>J=QXR\/0Z!>ZU%J]E<V5FK&22"X
M1QN R$!!QN/0#OD4^#Q;H,V@0:V^K6,-A,%_?27*!58C.PMG&X=Q0!;US1K;
MQ!HUSI=X9%AG4 M$VUT((964]B" 1]*Y\_#VTENGO+K6=6N+R:SFLKB>22/,
MT,@QM(V84*1N7:!SG.<G+_%_B]]#TW0[W3/LMY#J6J6]GYF[<ACDW992IY/'
M':I++Q/=7/Q)U/PTT$(M;2QCN4E&=Y9C@@\XQ^% %Z;PM8SV.AV;2W CT::*
M:W(899HT*+OXY&&.<8YKF+?2QXI^)]MXC;2KRTL])MC"LEY$T1N9R6"D(W)5
M%9\,1U;CI796.O:/J=W/:6&JV5U<P?ZV*"=79.<<@'(YIL?B'19=3ETV/5[!
M[Z($R6RW"&1,=<KG(QWH TJP1X2L!I_B"R\VY\O7))9+D[ERADC$9V<<< 8S
MGFH=&\=>'=;COI+?5+-4L[@P.7N$Y^8*KCG[K,0%/?M6\]W;1W4=J]Q$MS*K
M/'"7 =U7&2!U(&1GZB@#+D\,64CZ"QEN,Z*<VV&'S?NS'\_'/![8YJA:^!K6
MSOHWAU35%T^*Y-W'I@F46Z2%BW&%W[=Q)V[MN>W:MBTU_1K_ %";3[/5K&XO
M8<^9;Q7"M(F.#E0<C%8_A#Q/=>(K[Q'!<00QKI>J2641CSEU7&"V3U^E %@^
M#M..C:]I?G77D:W---<MN7<K2J%;8=N ,#C(/XU:F\.6<U_HEXTDXDT<.+<!
MAAM\?EG?QSQZ8YJ;4-?T;2BXU'5K&T,84N)[A$*AL[203WP<>N#Z4^36=+BM
MH+F34K-+>X!,,K3J%D 4L2IS@\ GCL,T <M#\,--@L(M,75=6;21-Y\M@\J&
M*=]^_P";Y-P&<952 <=,Y)T-3\$V^H:C>7<.JZGIZWZJM]!9RJJ7&T;03E25
M.W"DJ02!6C<>)] M+"WO[G6M/AL[G_43R7**DO\ NDG!_"K,FL:9%;07,FHV
MB03@F&5IU"R *6)4YP?E!/'8$T 5K;P[9VOB.;7(GF^TRVD=F4+ H$1B1CC.
M?F/>M5E#J58 J1@@]"*I6&M:5JMH]WIVI6EW;1DAY8)E=5(Y.2#@5'9>(=%U
M&UN+JRU>PN;>V!,\L-PCK$ ,DL0< 8!/- &#:_#O3[9[2$ZEJ<VE6<XN+;2Y
M94,$3@Y7^'>RJ>0I8@8K8MO#=G:>*K[Q%').;R]@C@D1F'EA4Z$#&<_B:HZS
MX_\ #6BV$MU)JUE,8WB1HH;F,OF0@*<9Z8);_=!-;5AJVFZIO_L_4+2[\L*7
M^SS+)M##*YP3C(Y'K0 _4+&#4]-NM/N03;W4+PR@'!*L"#S]#6#I7@FUTQ]&
MD?4]1O'T@2I:FY>,X1T5-IVH,@!1CODG)-=!;WEK=O,EM<PS-!(8IA'(&,;]
M=K8Z'D<&JW]NZ0;U+(:I9&[>5H5@$ZERZC++MSG(!!([9% &9>>"]+OGUIYG
MN=VK20S2LL@4PR1*JQM&0,J1M!YSS[<5:T3P_P#V1/<7,VJ:AJ5W<*J-->.I
MVJN<*JHJJ!R3TR<\FH](UQ6\.'5-8U/1MB,PDNK*XS; !L#YV/7L?>H=9\6V
M%MX6U35=)OK&^FM;"2]B2.97#JH;!.TYV[E(SZ@B@#8U32[+6M,N--U&W2XM
M+A-DD;="/Z'N#VKEC\.8I;?[%=>)_$5SIF-ILI+Q0K+_ '&=5#E<<8W5MZ9X
MGTC42ELNJ6#:@L(EGMDN%+Q\ G*YR ,]ZJZ-XZ\/:W;ZC/;ZI:+%83/',[W"
M8"J<>9UX0GHQX- %K_A&-/76M+U.(20OIEL]K;0QD",1L%&",9X"C&"*I:GX
M,AOM5NM0M-7U/2YKU%CO!8R(!.%& 3N5MK <;EP<5MZ=JFGZO:BZTV^MKRW)
M*^;;RK(N1U&0>M3W#M';2NK1JRH2&E.%! ZL?3UH YN[\"Z=)#HZ:;=7FDR:
M1&T-K-9,NX1L &5MZL&!V@\C.>:YWQ+X%@L=!CL=/74;P7^OVEW=EG+R#YD6
M1]R@$#"[B>Q)/';K],UV#^P[*[U;5-'$TZ.WFVER#!)MR6,;,<D!02?3!J[8
M:UI>JV;WFGZE:7=JA(>:"9712.3D@X'% &;H_A2+2]8FU>XU*_U._> 6R37C
M(3%%G=M4(JCDX).,G K9O;.VU&RGLKR%)K:=#'+&XR&4C!!K*D\4:9=:'J=_
MHVHV.H-9022,()UD 95) ;:>,XJ'PEXF77O#&BZA?/;6][J4)D2W5\;R.6V
MG)P.3UQ0!E+\,[,VRZ?-K^O3Z,N -,DNP8BHZ(6"[RG;;NK5U/PA;7NH0:A8
MW]YI%Y#;_91+8%!NA!R$*NK+@'IQD9K9;4;%#=!KRW!M #<@RK^Y!&X%^?EX
MYY[5ST7C.TO_ !7I.FZ3=V-]97EO<R23P2B38\7EX4%3C^/G/M0!-;^"-*M;
M;2((7N0-+NVO8W,@9IIF#!FD)'S9WL3C'..W%:%KH-K::WJNK1O,9]32%)E8
MC:HC5@NT8R.&.<DU6T77!+HT5WJNIZ*SRS-$LMC<Y@<@G"JS'EL Y'L:O:9K
M>DZS'+)I>IV=ZD1VR-;3K($/H<$XH X2Z\$?9/$GA#3-/FU.&STS3[N.._BP
M7A8F/;N;;LR1N&",$9XK<'P^L!I;V_\ :.HF^>^&HG4C(AN#< ;0WW=N OR[
M=N,=JVK7Q+H-])LM-:TZ=_-$.V*Z1CYA!(7@]2 >/8^E5?%6NS:!::=-#'$_
MVG4K:S?S,X5)) K,,'J : ,J7X;:;.FI+-J>JR?VG#%'>LTJ$S/&^Y9"2G##
M[N!A=O&.!CH;S1+:]UW3-7D>47&G+,L*J1L82!0VX8R?NC&"*++Q%HFI07,]
MCJ]A<PVH)GDAN$=8@,G+$'@8!Z^E66U"R2.VD:[MUCNF5+=C( )F8$@(<_,2
M 2,=A0!S=M\/=)L_#AT6&XOE07AOH;D2*)H9BV[<A"XXY'(/!(.:F'@J)K">
M*?6M7FO9ITN/M[3J)4=!A=H"A  ,C&W!R<YJQX?\8Z+XEO-0M=-OH)I;*9HB
MJ3(QD4!29% ))3+;=WJ#6A?ZYI&E;_[1U2RM"B"1A/.J%5)(!.3T)! /J* *
MVA>'HM$:[F:]N[Z\O'5KBZNF4N^T848554 #H .YK.\=:3>7VF66HZ9%YNI:
M/=I?00@X,P7(>//^TA8#WQ6XVLZ6NE#5&U&T&G%=PNS,OE8]=^<?K6?=^,-!
MMO#=WKR:I9W%A;(Q:2"=&#,!G8#G&X] .N2* );#3;2XUD^)HQ=1W%W8Q6YA
MF79M169QE"-P;+D')[=*SF\!Z>NG0VUM>7UM/;WLU[;WD3KYL4DK,7 RNTJ=
MQ&"#Q^=;>CZO9:YI<&H:?<13P2J"&CD5PIQRI()&1T(KE=*\9:AJMAXMD/\
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MZL" >0<9!)J_?:YI.FV,=]?:G9VUI)CRYYIU1'R,C#$X.1S6;X<\1-KNIZ[
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MIXM-3>RMO.G$9E58XVS\QY.7[>U;VI:YI.C1Q2:IJ=G9)*<1M<SK&'/MD\T
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MQ\.7&AV-G;V5K<2))($CSN*NK9//+?*,$]./3%=!)&DT3Q2*&1U*LIZ$'J*
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M$W5#ZJ?0U#HWAK1?#PE_LG3;>T,N/,,:\MCH">N!V% &K1110 4444 %%%%
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M.\TZ73H!<W$=_ 8F$//[P=<K\I_*O-+ JZ):?Z;)*GC6VN<7BGSFA>-=DC9
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MB +P'QP&'0USU]JUM9?!&?PM/!/_ &S9L(;BV,+#R]MP&\PL1C:1@@YY) %
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M4I]:OM,O+:PEANW#&9T21P9T( .V-RIR!T&0"*A\0:A?:GX \4V%KK$^N:;
M;$V>HR0 /O:==\9( $FT*ISC^+!H ]9.OV)\1+H41DFOA%YTHC7*P)V+MT4M
MV'4_2M2O/_"4-QX/\37GAW5':Z_M.1KVTU5TPUR^!YD<I'\:]5[;>!TQ7H%
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M&Y 5%V@;2!U)ZY&.,TH\6Z_#/?:=>Z5IT6IIISZA;"&]9XBJL%9'.P%6&X=
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MQ7,3!L%6*@CE2""./>F7'CC6;/1].U*X\/Q[=4OH;:RMTNOWA21&*L_RX4Y
MXYP#R>* .[HKA(/%GBJ?6;_0%T#3O[6M(TN/,^W/]F:)\X^;R]V_((QM X)R
M,<I;>/KS6+'P_P#V1IMJ+_5[>:?R[ZZ,4<?E,JNH958NVYN !T!)H [RBJ6G
M7MQ<:1%=ZA9FPG*%IH'</Y9&<_,.".,@^GI7&1^/]5_LBV\2SZ);Q^&KB9$6
M7[43<I$[A%E:/9MVDD' ;(!H ] HKR&:VU36?CO+'?Z9IUU'86<4MNDMY)M@
MC\[B51Y>/-_V>G^U76^/]1LM/;PQ]MTJ._\ M&N6T$.^0I]GD;.)1CJ1Z>]
M'8T5Q-WXNUV;5M?L-&T.UG_L9T\V6YNS&)5:)9 J@(?FY(YP!@<\\9DWC#7=
M4\3>#&T>VMET_5K*6Z,4]RREL*A8-A#]W=QCJ<YQB@#TFBN&E\=7Z+/JR:5;
MMX<@O39O<FY(G.)/*:58]N-@?(^]G )K$M?^2D?$_P#[!UK_ .DYH ]4HKRW
MP/KUUIOPV\':;IMI%=:GJ,4@B6>4QQ(B$EW=@"<#*C ')85N-X[N(])*OI:'
M71J8TH62W'[MIRN\-YFW/E[#OSMSVQF@#MJ*\T\8>*O%NG>"]9=]*AL-0LY(
M%^U17#-#)'(P&Z)B@)8$@%2!C.<G@5U-AX@OI/%*:!J%C;PW/]FB^D>"<R("
M92FT9521@ YP/3% '15QMWX'N[]GL[WQ-?7&B/<BX:QEC5G;#[Q&9C\VS<!Q
MUP,9J2'Q9JFH:9=2Z7HR3W46K3:<%DGVQ(L;$&61MI(7CH 3D@>]<A\1-?GU
MOX-^*X[RVBMK[3[J&UN$AE\R,MYL+AD8@$@JXZ@$<T >NT5FWU\=+\-7.H",
M2&ULVG"$XW;4+8SVZ5RMGXYU<IH.HZCH<%MH^M210PR)=EYHGD7*%TV ;6/'
M!)&1GTH [#5K :KHU]IS2&,75O) 7 SMW*5SCOUI=*L1I>CV6GB0R"UMXX Y
M&-VU0N<=NE<GIOCB_P!0U#67;2H8-&T6ZN8+V\>X)8B($@HFWDX )R1C/&:9
M;>-M9CBT?4]4T2VMM&U::*&%X[LO/!YO^K,BE N#QG#'&>] '=45Y_+XZUZ:
M#7KS3O#UM-9:'=SP7+2WA1YA%R?+4(1G;SR0.<#-:$WB^_U*\BMO#&G6UZ?L
M,5_-)=W)A54ER8T&%;+L%8\X QUYH ["BN"F^(=U=RZ!;Z)HPNKC6K26>)9Y
M_+$+QE0RN0#P,MDCNH ZU4C\2>,!XV\0VRZ?8W$5AIT,HM%O''S%9&&S]WRS
M$!3G   ZT >D5#>6L5]93VDV[RIXVC?:Q4[6&#@CD<'K7+W?CF(>#-(UW3[4
M74^K200VML9-N9)#@J6P<;0&SQ_":O\ B_Q&_A;18]02R:\9KJ&W\E7VL?,<
M+Q[\]/UH W8XTAB2.-0J(H55'0 =!3JXV+Q;JUEJ]QI>NZ3:V]P;"2_M&M;H
MRI(J8W1L2BD,,CL1@U1LOB%J4OA)/$EUH216UVL":?;I<YEN)Y&"[3\H"KN/
M!Y.!G':@#T"BN.3Q/KUKJIT;5-)T^+4;BTDN;!X;QVAE*8W1L3&&4C<#D @B
ML3PKXSU]_ V@S7=I;7FK:O)Y5EFY*B089VDE.SY H4\+NSQZT >F45Q3^.Y[
M+2]16_TQ!K5G=PV0L[>?<D\DVWRBCD#"MNYR,C:W7%4/$WB?Q;IOA/Q!]HT>
MWM+ZULC/%>6]R[P%6!!*L4!\Q3@[2,'@YH ]$HKSN[U=TU?P''KNC6DVIWLD
MPBGBN686Q$8.X94;BPQD$<>]6[KQKK,D>L:CI.B6UUI&D32PSO+=F.:<Q?ZP
MQ*$(P.0,D9Q0!W-%<7+XSU"_UV'2O#VF6]T;C2X=3BN;JX,48C=F&&PK'/"X
M ZY/3%;/A37V\2:$E]+:_9;A99;>>#?O"21N48!L#(R,CZT ;=%8GBG7G\/:
M7%<101S3SW,5K"LTOE1AW; +O@[5'T/IWKC_ !EJ6LMH>EOJFD)%>6WB&R$:
M6L_F1W(W @HQ"D9)V_,!@CTH ]+HKD].\3ZL->OM%UG28([R&Q^WP"QN#,LT
M>XJ4^95(<$ >AS3=)\4:P^O66F:YI-K9-J%O)/;"WNC*T93:6CE!5<-AAR,C
M@T =*ME;KJ,FH!3]HDB6$L6. BEB !T'+'Z\>@JS7SO*?^,=;_\ [#)_]*!7
MM'CK_DGWB3_L%W/_ **:@#H**\^T3Q7J]A:^&$U31X(-)U18K6VG2Y+3(YCR
MGF)M &[:>C''>K$?CJ_=8M7.E6X\-RWHLUN?M)\_F3RA*8]N-A?C[V<'/M0!
MT6L:$NKZCHUVUP8CIEV;D*%SYA,;)CKQ][/X5<U.WO+K3Y8;"^^PW38V7'DB
M79R,_*>#QD?C46M7MYI^ER3Z?I[7]WN5(X ^P$LP&6;G"C.2<'@5R=SX^OM*
MT?Q%+J>F6QO]%2&5X[6Y+Q31RG"E6*@@C# @CM[T =-X=T&W\.:2+*"66=VD
M>:>XF(+SRN<L[8[D_I@5K5R5KXHU>'Q/8Z7K6DVUG#J4,LMI)#=&1T,8!9)0
M5 !VMG@D<8R>M<=XK\4:OXA^'LFI?V1!%HE[=6XMI1<DSA1<IM=TV@ -M[,2
M,CWP >C:[H][J?V673]9N=,N;9RRM&H>.0$8*R1GAAZ=P>E-\.>'AH,5X\MY
M+?7U].;BZNI5"F1\!0 HX50J@ 4GB_7V\+^%-0UM;<7!M(P_E%]N[D#K@XZ^
ME9$OBO7(H+&%M%MDU+5;AEL+=[HA5A5-YDF8+\I ZJH/) S0!V5%<)=?$"[L
M=/ GT97U6+5XM*GM(KC*EI%#(Z.5&0P*XR!U.>E+%XL\4RZ[>^'O[ TX:M!"
METLGVY_LQA8D<MY>[=N&,;<'DY&.0#NJ*XZR\7:KK?AC2-2T?18VN;YI%E%S
M<%(;4QEE;>X4D_,I P.?:L7Q%XNM+WP/#?:MH4-S+#K"V,UH;@[$F60KO5P/
MF'<<#K0!Z717(7?BC6Y_$^JZ#HFCVL\UA%#*T]U=&.,B0$[>$8[LCCMU)(Z'
M6\-:]_PDOA:SUF&W\E[F(MY+MG8X)4KG'3<#SC\* -FBO%=1UW7]5^''B6YU
M>&W:*WUI8H_(G9W!2[C'E@%%&T8P#G)[@5W4/B[4K'7SIWB/3+6RBEL9;Z":
MVNC-A(B-Z."JX8!@<C(H ["BN,TKQCJD]WH[ZII%O::?K1(LI([HR21L4,B+
M*NT %E4GY2<$8-7_ !3XFNM!O=&L[/31?3ZI</;HIF\L(P0L"3@\<<^@R<'I
M0!TE%<)-X\U#3-.\2KJNE6\>J:);)=>5!<EXKB-P=I5BH(Y4@Y':I9/&6L0Z
M993RZ'"MYJURD.EVOVHY964OOF.WY,*"2 &]* .VHKA;OQWJ&CVNO0ZQI5NF
MJ:58B_2.WN2\-S$21D,5!4AE(((]*GMO%^K1:QI$6KZ-!::?K)*VDL=T7DC?
M87595*@ LH/W2<$8]Z .SHKAK+QU?W T_5)=*@C\/ZC=K:VTXN29QN8K'(\>
MW 5FQT8D;A3;/QGK^L7&M#3-#M/LVDW5S:RSW-VRB1X\[=H"$\\$^F[C/- '
M=T5YIX2\::U'H'A&37K6"2#66^SB_2X+,'*;H]ZE  6(88!.,#DYKKH/$#W7
MC6\T&"V#0V5G'/<W._[DCL=D>W'=06SGTH W:*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#E?'&DWVKP
M:"MC 9C:ZW:74V& VQ(Q+-R1G'H.:R?&/AB.Z\76NN77AH>(+,V)M)+=?+\R
M%@Y=74.R@@[F!YR.*] HH \T72;[0-2\-:O8>'+>%XX;JWN-'LKB,.BR,KAD
M+%58C:-V#WXR*Q+O3=:\2Z%\2[.*Q4ZG=W=NJ6R2J<$1Q'86)"[@N,\XSG%=
MX\GA'X@[H(KF._?3Y-PFM9GC>%CD961"#S@C@XK9T?1=-T"R^Q:;;B&)G:5L
MN7:1SU9F8DL3QR2: .+\3:1/>VMK9WG@Z75#%91K9WMG/''-;3X((9F=2HSM
M(*DCKD4^RTOQ#I7CC1-2O+*74E?08M-O+J&1/W<XD#.[!B"5ZG(R?:NXT_4;
M/5;07=C.L\!=T#KG&Y6*L.?0@C\*M4 ><6'AO7[;X0:AHT<+0:K))<LD0F"E
ME:=FVAP< LAQG/&>U5-.\-W,7BA+W3?!RZ-IUUI5QI[*ODK(DA*,))0K'*G:
M5&"QXR<9KU*LW5/$.BZ(R+JNKV-BS\H+FX2,M] 2,T >9R>'O$>H?#SPEH[:
M%<6]YHVJ69N%DFB(:.,-ND4ACE>1QU]JZ01ZUX7\3Z_<V>A7&K6FK21W,#6T
MT2F.41A&23>RX4[00PSU-=I:W=M?6R7-G<17$$@RDL+AU8>Q'!J:@#SKPWX/
MU31-1\'B:-9$L+&]6\E1AM269T?:,\D9W#(':GRZ-J5M+XH>X\.1ZO8ZAJJ2
MM:.\>Z:#R$4L@8XW!UZ,1T..U>A44 <EX"TN[TNSU%7LKG3].ENM]A87,XE>
MWCV*",AF !8,0N3C-<3KOA#5;^#Q!"?"B7NL37SW,&KSR1$& .&CCC);<K;1
MLVX ')SZ^QT4 <GX?T[4(_$7BK4;FRDMHM2-M);K(R%CMMU5@=I."&R/PXR.
M:Y;0="U_PHGA;5/[%GO9+?1VTR^M()8_-B)=75AN8*PR"#@]Z]!U+Q+H6CW"
MV^IZUI]E,XRL=Q<I&Q'K@FM&*6.>))89%DC<!E=#D,#W!'6@#D_ FG:O9OXB
MN=8LA:2W^J-=11B17Q&8XP!D'J-I!]P>V*I1QZ[X4USQ";'0;C5;?5;@7EK)
M!-$HCE,:HR2[V! R@.1G@^M=Y10!Y?;^%M9\+OX#D@T^35!I-O=07JVTB*RO
M,%.X;RH*A@WX5H)X=U4>!/&^G&T/VO4KK49+2/>O[Q9<[#G.!G/?'O7H%% '
ME5]X/%MK3ZA?^#5\0I=V%M&H5HM]M/&FTJV]@-C#;\PSC!XZ5N6'AV]M/&7A
MV\33(+2RM-'FMYDMG'E0RLR'8H."1PW..U=S10!E>)[2?4/">LV5K'YEQ<6,
M\429 W,T; #)XZFN-B\.ZUIOAOP+?0Z>UQJ.@1!+FQ61 [H\/ER!6)VEEX(Y
MP<'FNYCUC3YM9GTB.Y1K^")9I(,'*H>A]*O4 >9:MH.N>([?Q=JSZ5+:3WVD
M#3;"RFDC\UP-[%GVL57+/@#=VYQ6WKNB:C>:7X0A@MB\EAJ5I/<C<H\M$1@Q
MY/."1TS7944 <S8:7>P_$?6=4D@(LKBPMH8I=P^9T:0L,9SQN';O7)67A^\L
M_ VBZ1KG@TZQ!&)S+'#+'Y]O(969"I+J,%3U5LCBO4F8*I9B  ,DGM4-G>VN
MHVJ75E<PW-N^=DL,@=&P<'!'!Y% &)X6TN_M_!5OINL-)]I,<B,'E\QT1F;8
MA?\ B*H54GU%<;_8WB2[\"V?@*?1)8_*:*WFU3SH_LYMXY V]1NWEBJ@;2HP
M3UKTR.^LYKR:SBNH'NH IFA60%XP>1N7J,]LU8H XVST348OB]J6MO;$:=-I
M,5O'-N7F0/DKC.>GMBF_$+0]1UM_"QTZV,_V+7K:[N,.J[(DW;FY(SC(X'-=
MI10!R>E:1?V^M^,KB6W*Q:A-&UJVX'S +=$/?CY@1SBN9L="U[15^'UY_8TU
MTVE6$UI>P0RQ[XFD1 #\S $ J<X-=YIWB;1=6U.YT[3]1AN;NUSYT<1)V8."
M">F03CK6M0!Y-:>"8K"\FT^?P):ZE.^H/+'JLK1B(P/*7R_._>H8K@*<[1SB
MMF#P[JR>-_'FH-:$6NIV4$5G)O7]ZRPE2,9R,'CG%=^2 "2< =S58ZC9C55T
MPSK]M> W"P\Y,88*6^F6 _&@#RNV\#7D/A#P8=5\/+JCZ1'/#>:87C+[93G<
MI+!25*KQGH36H_AB[CT33]1T?PM;Z9<V&KB_33(Y4#SQ!#&0Q!V"0JQ.,D#
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M)HC):I%<6TZHQP\84#;P,!AG@]:=9^(->UZ+PAIEKJ8L;G4-(_M*^O$MT=R
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ME:>5D#DOO!PHW*,#!//-95U\//$$GA2Y\)0:Q81Z)YA>W<P.9]OF>8(V.=N
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MU&VCE$$X?,CRPL7W*!DD,,^M:FI:#:VWB;P[X42>]_LN[6ZOKP/=R%[N5%C
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M>:A*K/':P/.RKU(52Q ]^*\T\8:U?Z3JWC>>RNI(Y(=)LA$0QQ"SR2(7 [$
MYS["M?5_"%CX?T+6+G3KZ[C1]'NHY[6:X:5;AO+)$AWDD,.>1UW4 =IIM\FI
MZ59W\2LD=U DRJW4!E! /OS2:GJ,&D:5=ZE=%A;VD+SRE1D[5!)P._ KS&VT
MB+0M/^'VKVEQ=_;[RYM;:ZD>X=EECD@<E"A.T ;5P .,"NX\>_\ )//$G_8,
MN?\ T6U &8GQ.T46T=W=6.MV=C(H87ESIDJP[3T)< @ ^O2NP@GANK>.XMY4
MEAE4/'(C!E93R"".HK'\,")O NC"<(83IL </C;M\H9SGMBO)-#N;N7PSX5T
MB&QO[_2+N\U&6.TM;@0O-!&_[M2S,OR9<G&>=H[4 >[T5Y!/'KGA_1X]<N;6
M_L++1=86:&WN;I9G^P2JJ2HQ5VR%9F(R3@"I?%>KZC<7OBW6M.N9UM](M8=*
MM3"^ 9Y70RN.<;E5U4$]* /5KB9;:VEG8$K&A<@=2 ,UD>'M9L?&GA:TU9+0
M_9+Q2PAN55B,,5Y'(ZBN-TC3M3T[5+DVOA_5-+T>33)DNEOKZ.<-,,%' $KD
M,1O!/&>*Y_PAOU#P5\./#\DTT>GZ@UX]T(9&C,HBWLL992#@DY('7;0![7'&
MD4:QQHJ(HPJJ, #V%.KQGQ4TWARR\;Z+IEW<16,.GVE[;JT[-]ED:4JP5B20
M#M!QGU]:Z.?2H_"OCSPL=.N;P_VFUQ;WXFN7D%QMB+B0AB0&#+U&.I'2@#T.
MF10Q0)LAB2-,D[44 9/)/%>'6NFR?\*N\/>(DU+4$UJ2_AA%V+IR4C>X,90*
M3MQM/IR>:W-89_!'B#Q&FB27"1?\(S)?B.6=Y@+A)"HD^<GG!Y]<4 >L45Y9
MX>T[5[+5],GL]"UBRM)+:5-3N;W4(YEN,Q[DDVB5COW@<@#ACVK(T_3S9_#O
MPAXG%[?/K#W=DKW#W4AW1O*$,97.W;M..G/7J30![#!J%I<WMU9PS*]Q:%1.
M@SE"R[ES]1S5FO)-/\-O/K_Q'717D@U4.D5K*;F0;2\"D\Y."23@XRO;&*Z#
MP.;"UUB\L8]/U?1K\6Z/-IM[<&:)@&(\Z-RS;N?E)!';([T =W17%^./LUYJ
M6D:7):ZEJ,T@EG&FV<XA255"@O*Y9<*I88&>2>AKC;22]O\ 2O#6FS75];(O
MB6[L6471:58$6;]T9 <G &W<#V!!X!H ]FK+O]<@T_7-)TJ2*1I=3,HC=<;5
M\M-YS]1Z5YAKDL_A)/'.G:-=7-M;+:V#P S._P!G::1HY&0L21Q@]>HK9NO#
MEAX>^)/@J/3GN$BD^VAXI;AY0S"#[XW$X//..O'I0!Z517-^.;BWA\--%<27
MZ_:IXK=(]/8+-.S.,1JQ(V[L$$Y&!GFO-=1N+W2O#WCZQ@M;S28K:RL[B"UD
MO/.:%W9PS*P9L [%XS_.@#VZBO.;W0+?1O'7A^UM;B]*ZQ;WEOJ#274CFXQ$
M&#')(# YY&,9K'35=2NO!5OX)>[F&N_VI_8LTZL1)Y*'S&F!Z\P@<^IH ]>H
MK*\07<FC>$]4O+1?WEG8RRQ \\HA(^O05RNA>&X--TC2/$=MJ5[_ &@;/S[L
MR7+R+J#-%N(96)'WN1M'&/2@#OZ*\:>T-E\++#QS'>WC^(6^SWDER;ER)3)*
MH:(IG;LPQ4+CC K7L_#UOXE\1^-EU*\O&2VO%2U2.ZDC%NQ@0EU"D<YQUSC'
MN<@'IU,EBCGB:*6-9(V&&5QD'ZBO*?#.M7]O/X,\0ZA=2O;:YIXT^\,CG:+A
M06BD/NP5E)^E4-0DU#4O#$&OK?W5M)KWB>V^S,DA!BM=_EQ #H,J-WONH ]7
MGN3IMS865II4TEO.S*TENJK'; #.6&1P?8&M&O,O$=E'X>\7?#W2],DN(K,W
MMSO1KAW+Y0-\Q8DMR2>:S+FP.K^"_&?B>>_O8M6@GOTMYDNG401P[E6(*#MP
M0O/&<MGKB@#TQ-<@?Q3-H BD^T16:7ADXVE6=D ]<Y4U;O-0M-/^S_:IEB^T
M3+!%G/SR-T4?7!KS2PT:V\0>.[:'47GDMQX7LW>))GC\UC))@L5()QSQG&>>
MPK!GL(M2T'PE;WTEQ<"W\5RZ<CO</N, >8!20<D@*H!ZC'6@#V^.&*)G:.-$
M:1MSE5 +'U/J:?7EFNV T;Q#>7VN6VL#3O.A-CK%A=L181JJ+L>/=PNX,2Q5
M@0W->IT %%<)XTMCJ/CCP?IKW5Q#:7/VS[1'#,T9E58U;:2I!QD?EGUK ED@
MT.?Q?X<^U:J--2>P%G!:3%I]\_WH8W<Y 8KZC 8\B@#U2[NH+&SGN[F016\$
M;2RR-T55&23] *?#-'<01SQ-NCD4.C#N",@UXIJ5LR:%X_TF73KO3K.#28;R
M&RFO3-Y4A$H+!E<X!V+E<XXZ<UHW5KY=[X<\/V^D:EJ6F+I#7TEE:WOEF24L
MB[G:21<JN3A0>K#CB@#UVH+V]MM-L+B^O)5AMK>-I99&Z*JC)/Y5Y4+/6I'\
M(Z1JS:C8I)JMY$J/=AIGM1$[(CNC')V_+G.>,YSS5#Q/IMO9:)\2-&A:X_L^
MRMK6ZM87N'81.Z/NP2<X.T'!XH ]I1UDC61#E6 (/J#3J\PUKPZUDFDR#1]3
MU7P_#8E6M;&]<303,VXRA2X,G!P!DD8X%=YX<N+:Z\-Z;/9WL][;/;H8[FX.
M9)!CJ_ ^;UXZT :=%<;\4)+B/P83:W,MM,U]:(LL389<SH./SK#/A:QC^)HT
M..>_&DW.D&[N;4WLI$TJRA S,6W='.<'D@9H ].HKR&QN(Y/"UOH5TVK:@4U
MZ\M+6RMKC;)<Q0L^$DD9@1&HP3\W91STHL+36M0\-:OIMI97;0Z=KP#Z4VH8
ME:V\I&: 3!O[S[@-W08S0!Z'XBU>QT9M)EO;0W#W6H164#!%)B>3(#9/0<<X
MYK;KQ?7+^PM?#.D/IMMK.;/Q5:F32KS+SV[A=WE)DG(/#+\Q'S<'' ['X?SO
MKHOO$6H7$C:K)*]K+8DD+IP1O]2%_O="6[Y]* .WHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,C7_#T
M&OI:%[JZL[FSF\^WN;1PLD;;2IQN!!!5B""#6,OPZTV)[F2#4M6AFGECN&E2
MY&\3J-OF@E3\S D$'*D'I74RWMK#=P6DMS$ES<!C#$S@/)M&6VCJ< C..E-A
MU"RN;RYLX+N"6ZM=OGPI("\6X97<!R,CD9H YT> [,6[$:KJPU%KD7)U,3K]
MH+A-G]W9MV\;=N/QYI)OA[I5UI*6%S<W\Q&H)J4MR\JF6:=0 "QVXQ@ 8 '
M%:MUXJ\/66GPW]UK>GQ6DY*Q3/<H$D(."%.><'KCI5E]:TI+*WO'U*S6UN2%
M@F,ZA)202 K9P> 3QZ&@#AO$]E';>*[ZZ.D>)"EW;1K(VD/OBORH(V2@#,9
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MHE1[E 2ZG:5QGJ#Q]>* .3\6^#1:> /$<=E]OU75-16,S33?O)IMK*%7"@
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MZTEC;N;Y0MUNC!\\ ;0']0!QS0!YCXCT[48;#QE>ZEJ.C-=/X=>.6TTZ-T)
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M%QJ6@6<0UHR/+-"XNENUNB<%M^-Y(V]/NG%>MG1M-:>PG-C;F73U*6C^6,P
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M;K@@A@ F=Y_WLTMS=K\/M4TG7;JZ6ZL[[0_LEW<(<+-<6\7F1/GU=0ZC\*]
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MI+(J HX^K!36UJOAC0M<N(;C5=(L[R:$81YX0Q SG'/49[=*U0 H    X %
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ML>-U8JRLO8@@BN=LH7'Q6$QC;8/#D2;]O&?/8XSZU-\/(I(M,UD2(R$ZY?,
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M#%:P>9\CDC?UX48Y)Z9'7->9Z]:7+>#;E%MY2W_";R2!0ASM\]OF^GO7=Z;
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M );.>>E)9_$+2[N\TVUDL=4M)=3DVV8NK;8)EVEMX.?NX'U^9>.:XG4=(O\
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MX6+3B)BR*1,2V"0"1UYP*U-,\;ZE<OI%_>:7;0:-K,PBM'2Y+3Q[P3&TB;0
M' [$XR.M '<45E:_?:G8VD/]DZ?'=W,THCS-+Y<4*X),CL 3@8Q@ DDBN6D^
M(-Y;:)+/-I44NH6VKQ:7-!;7&Y'9]I#1L0,Y#KP0.<@T =]2$@8R0,\"N+7Q
MIJ&E:EJEEXET^UMS::8VJ))93M*K1*2&4[E4[@<>QS6#K.K:_J-QX(FU?2K6
MT@NM9@N(3;W+2-'F*3"2 J/FPV<C(X/MD ]2+!1EB /4TM<;\3]1L]*\&275
M]I<.IP"YA4V\KE5)+@ Y'IUJ2^\2ZW)XKO\ P]HVEVDTUK;0W/VB[N&CC <N
M"#M4G/RC'XY(Q@@'745Y;?\ C;Q#JMMX-O-(M;6V_M*^DBG@FN6&9(Q*K1DA
M#\F5)SUR!Q6SJ/C;58&U>[L=*M;C2]%<QWKO=%99&50TGE+MP=H/\1&2"!0!
MW-%<7<>,-4N?&#:!HNF6UR!:07INIYRB")R0> I)/ P.^3G&*@D\=WZI+JZZ
M9:GPY#>FS:8W)^T$"3RFF";<; ^>,YP,^U '=T5Q]GXIUK4M9NEL-)LY],M-
M0-A/B[Q=+AMK2["NW:#SC=D@9'I5;P7K'B+4_%/B>'4DM/L5I>^2HCG9C$1&
MF%4%0"I!+$D@Y)X[T =AJ$%S<V,T-G=FSN&&$G$8DV'UVG@U0\-Z!;^'M.>"
M*XENIYYFN+FZF(+SRM]YCC@=  !T  KGKS6/$0^+UKH]LMH=,_LQKAD>=E)3
MS8U9\!3\XY"C.""<D=*YGPOXGUGP[\/HM272;:71;2]G2XD>Y*SN&NG!:-0I
M&%+=R"<'IP2 >OT5Q>J^+]5BOM8&D:7:W5GHH'VQIKDQR2OL$C)$ I!(4CEB
M,DX]Z9<^-=2N_$]OHOA_2[>[-QIL.I)<7$YC18G9@=V%)S@+@#J6]!0!V])N
M!8@$9'45PMQX[OXUN]6CTRU;P[:7AM)9C<D7#!9/+>54V[=JMG@G)"DU$?$-
MK8>,O'+P:/ MYI>G17,ET)#NNL1%E5AC@#&,B@#T"BN&L_&FM&X\/W.H:-:V
M^E:XZQ0,ER6GB=HRZ%UV@8(4\ \=_2NYH **XZ?QN]IIWBJ6>R476B3^5' )
M/]>'53"<XXW%P.^*(?&\ESI'AF>*Q4WFLW@M9+?S/]1M#^<<XYV;&],\4 =@
M&#9P0<<<49&<9&>N*\=NO%%U;?#CQ'J/AO3+73)(->>VF99FRQ,D:F4?*?F8
ML 1Q@9//2MF>Z\0I\4D6VT^PDU63P^GF!KEQ;Q 7#Y.[9N;L -HZ^U 'I5%<
M)#X_N[C1K$0Z5&=>N]0FTT69G(B26(MYCE]N=@"D\#/('O3+_P >ZCHFG^((
M]6TNV75=)M$O42"=FAN8G)4$$J"N""""* .^HK!UC7I]/UW1-+M[:.5]4^T
M/(Y4(8XBXZ \$\'TK'^&FKZ[K6CWEWK(MBGVVX6)HYF9AB5P4(*@!5P O)R.
MN* .U) ZD#-+7D&J6FJ:S\=X[:\T[2[N&STL7%O#/<2;(T\_'F@;/];[=/\
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MTS3+EK6ZUC4(K'[2@^:%&#,[K_M;5('UH ZZJXLK==1>_"'[2\2PERQ^X"2
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M3\-1XL^P)YAD"?9_,./^/CR?O8].>E=K0 4444 %%%% !1110 4444 %%%%
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M@ $=JY2Q\$KIUY)I\O@.PU&9K]Y8]7F\KR_(>4OE\GS-ZJQ4 *0<#G%>KT4
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M5G8-I\HNX&D1D)0[U"L"&!3IGD&@#EO^$P\17_A[PS]AU"-+R^UB?39KE[4
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MD[LG/H*V=$MM9@2XEUN_@N9YI R16T.R*!0 -JY)9L]22>_ % '(:K;:A/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR/S 0[K#U;:2">,_C6/?V O_ (0:UXPDO;R+7)VN9&N%N7&U1,T8B"YV[=H
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M:M<BW)F;9;*(E+L%S@G![@].*S=",FE^)_"]S9:7JEI#J,5QYMQ?7PEDU!1
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MPP+(#D'Y>2S<FM^'28M;^+NOI?37$EK96]C/%;+.Z)YOSX<A2,XP>.G/(/%
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M[L$B$S (%)P.4!SC.2>: /1J*** "BBB@ HHHH **** "BBB@ HHHH ****
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M#[$5+10!QB?#;31%%9S:MK=SI414KIL]YNM\*<JI&-S*,#@L1Q6A?>"M-O\
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M&F'5#<3O(+K4);F(/(7\M&QA03T&02!VSBM>B@#.CT2UC\1SZXID^US6J6K
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MLF^9W'(;)'S=N*]#HH YFTT.U\*G4-;:35M7OI8T1Y),33F-3\J(JA1@%B<
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MTFQ,IMH"Y0RL&;YG+') '=C6G10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 51U'5[/2GLUO)#']LN%MH3M)!D8$J"1TS@CGOQ5ZL7Q9HI\0>&+W
M3XW\NY9!);2?\\YD(:-OP8"@"YJ6KV>D_9/M<A0W=PEK JJ6+R-G P/H23T
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MM=5EN)-03R\J^UHU#,&VG=G."?6H+'4U;P)\-4%YNN)KZT# 299\(X;/<X.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-[YHU7RPH(0(@X 4L3CG)/)-+?>'M1FGL[RS\0W5K?06XMY7:-9(;@=2S1'
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/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>exhibit1012-stuartexecut014.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#M=EC)W,JG.2/0XSB@#M:*Y2\\:2#7;K1M*T6YU.\@MXKG]U*D<;1ONP=[$
M=!QU.?0$C7\.ZY;^)- M-7M8Y(XKA2?+E&&1@Q5E/N""/PH U**Y"^\<R0W.
MJ#3M!O=2L]*8I?7,,D:A6"AF5%8@N5!&0,>E<GX[\0:AJ_B'P?8Z9!J$FD:G
MYEP#97JV[7RB(.%#!@RA<Y.<9[4 >MT5B:YJ-SH?@R[U"VLY)KBTLS((&E!8
M;5YRQ.#@9)YYQW)KA3XJUF:3X?ZA=6%Y]INXYBUK#*G^F$VRE7P#M"EB3\V-
MH!- 'JM%<A%X^@33M5EU'2[NSO\ 3)X[>6Q#)(\CR[?*"%3AMVX8Z8YS6CHG
MB.34M1N=+U#3)M,U&"))_(DD20/$Q(#*RD@\J01V/UH WJ*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
MC_'EM=K)X?UBULY[Q-+U(3W$%NF^0Q,CHS*HY8C<#@<]:Y36M+U3QKJGBE[;
M2[VT@O= CMK.2[A,/G.LKM@AN5))Q@X.,'H:];J-+B"25HDFC:1?O(&!(^HH
M X"ZO;SQCJGABWAT74[(:?>K?WTEY:M"D12-U$:LW#DL^/ER,#-0^%M1U?PS
MHEGX47P]J%QJ5M=-")C$5M6A,I;SO.P5QL.=OWL\8KTFB@#R2\.IV/AOQUX=
M30M4N+Z_N;Z:U:*V9H9(IER&$GW<@$C;G)(P!S71Z#IU[!X^6ZEM)DM_^$<M
M8/-9"%\Q9')3/]X CCWKN** /*3HNJ?\*4ET[^S[K[<=1,@M_*/F%?M^_.WK
MC;\WTYJ+4]!M;+7O$::GHGB'4&U"Y-Q9_P!G3W"PSJ\:J8W\M@B$,I!+XX(Z
MUZW10!QOA_29M/\ 'NJLMG+#8C2K&"!FR5^3S 5#'[Q (S]17(P:=J>E>&_!
M]W-I.H2#3]<NYKF&&V9Y4C>2?:VP#)'S*?H17KB7$,DK1)-&TB_>0,"1]14E
M 'ENK)(_B"2[T31M?TSQ!)>1_-"C_8[N+<N7F/\ J\;,YSA@1CG%=EXW_M3_
M (0[4?['^T?;=B[?LW^MV;UW[/\ :V;L=\XQ7044 >-R::1JVJ3:3H6N)97W
MAV[LX9;M)Y)))^&PPD)9 1P-V-Q!P.F>FU#3+Y]"^'\26<[/9WUH]RHC.856
MW=6+>@!('/K7?44 >-W:ZMI_PUU_P8GA_5;C4@]VL,D=JS0S1/(T@<2?=SM;
M[OWLC&*]4E6[3P\ZV8Q>BU(A#=I-GRYS[XK0I&8*I9B H&23T% 'CFE64HU;
MPAJ8T;Q&]Q;3%=6NKX3NPED@=/E1B1M#GEE 4#'/7%35)]0TGX-OX6N=%OX[
MNQ>.&:XDAQ;[!<*5=9.C[OEP!SD\]*]IM+RVO[5+JSN8;FWDSLEA<.C8.#@C
M@\@US'_"O=+-T"][J;V N?M8TQKG-L)-V_.W&<;OFVYQGM0 W1["ZB^*'B>]
MDMI4M9[2S2*9D(5RHDW 'H<9&:XS1O#%E:)!H6I:!XBNM0COB"RW-PMDT?G%
MUFW;O+ "X;;C.X8QFO8J* /'5\,65O<:GI&JZ!XAO[JYU&9XOLUS<):30RR%
MPS,K"--H8[@<'*]\UT]IIMZFI?$)S:3A;PI]F)0_OL6JK\O][YN..]=W10!Y
MP=)U#_A$?AM;_8;CSK*[LFNH_+.Z$+;NK%Q_#@D Y[FL2'PQ96\E]HVJZ!XB
MOKN;496C^SW-PEI-#)*7#EE81KA6Y!YRO0YKV*B@#BM*T^\BO/';26LRB[NM
MUN2A'FC[,BY7UY!''<5SEI:ZAHQ^&E]<:3J,D5CIDMM=K!;-(\$CQ1A0Z@9'
M*D9[8KUBHI+JWBN(;>2>))IL^5&S@-)@9.T=3@<G% 'FD,,D?BRUFT/2-=TG
M4)-1SJ5N5<V$L6X^9(6/[LDCD%<')Y'6NI\>_P!H?\(XHL!>E/M</VP6&[SS
M;;QYFS;\V<?W><9Q717-U;V5M)<W4\4$$8R\LKA54>I)X%/CD26-9(W5T<!E
M93D$'H0: /$M4T>Y:S\90Z7X?UF.VU32(!8B>.:5Y6C=]P;>2R,=P(4X..<=
M:] \2:==7GC+PE)%!*UO";P3RHA*Q;H"JECVR>!77U ;ZT%\+$W4(O#'YHM_
M,'F%,XW;>N,\9H \?E.K_P#"KK/P>/#NJG4[*6WBN&%JWE;(YU.]'Z." #A<
MGDD\"O6M8@DNM#U"WA7=++;2(B^I*D"KM% 'C]E+>R>%?!]E?:7XCATRRA:U
MU2WMK:>.5IEB41\)AVCSNY'&<9JB_A[4;K0)='32-6L=WBRWNQM#L\5L^W$@
ME.064 [CD[2.>U>W50_MO2?L'V_^U++['OV?:/M">7NSC&[.,YXQ0!YU-X;U
M>S\+Z_X!AM9I[)[9YM'O IVD%MQ@E8<!PW1CU!]JT?"FGZ3/XBMKNUT'Q%!/
M;0.6N-6N+C; [8!C596(<D9R5X&T<\BO0Z* .2\<PV$\5@FIZ-J-Y;!V9;O3
M1(9[.0 ;6 C^?!R1D<<#(YKEH?[<L9/"FN:E9:O>VUC=7T1+6YENUMY!MA:5
M%&2<*,\9Y&>:]6HH \BO-+UK5Y/%.K0Z->1/_:>G:A:6TR;'N(X%3(&>-Q"G
MCJ#@'!K6\5:OJ?BSPAXCLM/\/:E':_V<1&]U;O%++.3_ *M(B,D =6]>!FO1
MZ@EO;2"Z@M9KJ&.XN-WDQ/( \NT9.T'DX'7% ',ZY8W4WC+P7<16TKPVLMR9
MY%0E8@;=E&X]LGCZT_Q]I]Y>:/875C;/=3:9J5O?FVC^_*L;?,JYZG!) ]JZ
MJB@#@/\ 2O%GC.WU.VTZ_M;'3]-N8?,O;=K=I9IMH"JK@$@!22<8R:PO#UMJ
M$_ASP#9/I&I03Z1J*I>">U= @$,HW D8*Y(&X<<BO7** /,/%WAO4]9U;Q<M
MM9S.L^G6!@(R@F>*9Y&17X^;  Z\;A19:5IMW'JMQI>@^(DG329XEN-4EN"=
M[C_5(DK$L3@$E1C@<G->GT4 87@JVFLO GA^UN87AGATZW22)UVLC"-001V(
M-<MXGMKF[\87L&HZ?K5[:O9Q+I45D\J6_FDOYAE:,@*<[.7.-O2O1J* /(O#
M O\ PV_AW6+O1=5>W30QI-U'%9N\L$T;[@2@&XHWS , 1P*T];O=7NKWP?XD
MO/#]_%%:WURTMM;Q-//%$\;)&SHHR">"1SC.*]*HH \KO?#.IZQXM^(L:6LT
M,6J:5!#:3R(5CD?RB,!NG!P#Z5:FN;[Q4GA72X]$U.SGL+ZWN[^2ZMFBBA$(
M)*JYX<EL ;<\<\5Z510!YDVD:E_PJSQE9?8+G[7<W>HM!#Y1WRAY&*E1U.01
MCUKT*W69-)B5 !.L "ANS;>_XU;HH \5LK.[8^%]0FT;Q'-JEG?1R:Q<W0G?
M#E74^7&259=S9RBX"@<\UM:9#)%XKL)-#TC7=(N)+QCJUG*K_8/+(;<X)^0L
M6VE2G7/(ZUZA10!RGQ!LKJ_T*QBM+>6=UU2SD98T+$(LREF..P R31]BNO\
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M=,'C 4J.^3TQUKT.B@#R*308].U:.]UG2_$$]O=Z39I&=*>X5HYHD*M'(L3
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M'-B1N._S#*7Z8Z8[YH YRR\:^+)/">D>++I-*73[F>&&>S2%_,*O*(S(K[\
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M^TEMXXB=Y\O(D#'G&>@]* '3ZUXTM?%5GH4K:,SZG;23PS+#)BS,97<&&_\
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MX'8T ='1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG4+F ^&Y=3MI+J;S);>9"4.U^N#E3CL1Q2S6VM0:MX05/$VJ;]>C>._W2 J
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M9HX8]RKOD<*,L0 ,GN20![FN<\#WEK=Z;=_9-9OM1ACN"HCU!"MQ:G:,QON
M8\Y()'0]3BLCXMVIN?#>GXNKF$?VI:(1#)M#!I5'/J1U'H: ._HK@([2[UWQ
MCJ>AOK>JVUAHEI;(GV>YV2SR2AF,DC@9; 4#'3.:U_ .J7NI^')%U&<W%U97
MEQ9/<$ &7RI"H8@<9( S[T ;-YK%I8ZIING3LXN-1>1+<!<@E$+MD]N :OUP
M7CNUGOO&/@JVM[N6T>2YN@9HL!U7[.V[:3T)&1GMG-8>JZ[JWA-?%>D0:E?7
M@@%BUE//^_GA^T2>6X!QER,94'OQ0!ZS17 ^$+R_3Q3-91+XCETB2R\TRZU
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#!\7>&O^$JT9+
M7KV;QW$5PDR1ARK(VX<'@\UD7'@2^UDQP^)?%%[JNGHX=K);>*WCE(.0)-@R
MPSVSBNS+HKJA90S9VJ3R<=<4+(C.R*ZEEQN4'D9]: .>U;PQ<W.L+JVCZN^E
M7IMQ:S$6ZS)+&"67Y3C#*2V#[G@TS6?!RZQX3MM%?5+Q;BU>*6'47.^994.=
MYSU)Y'XUT$EY:PPB:6YA2(G =G 7/IFGF6,*K&10'X4D_>^E '.W'@RT;PKI
MFB6EQ):-I9B>SN8U!:.2,8#D'@YRV0>H8U7O?!MWJWAK6-*U;7[F[FU-51IO
M*")"HQ@1Q@X'OSDU/?>+DM?&>@Z##!'<1:M%<2"Z2;B/RES@  [L].HQ5GQ5
MXEA\-^'M2U)5BN9[*#SC:^:%9AD=>I YZXH I7?@^7[3IM]I6K/8:E968L3.
M8%E2:$8.UD)'0C(((QD]:YOQ-X2&FZ5X>L8+R[EN[KQ+%=W-^%'F&9DD)DP!
MM &%P,8P .:]!U6_.FZ)>ZB(_,-M;23^7G&[:I;&>W2HM&UB#5M,L;G=%'/<
MVL=RUN) S('4-]<<]<4 <^W@26]CUN75M9DO;_5+ Z<+@6ZQK!"0W"H#R<L2
M23S@=*U)O#$4U[X=N3<N#HF_8NT?O=T1CY].#FMQ)$DC$B.K(>0P.1^=".LB
M!T8,IY!!R#0!R][X'M;Z77I9+R9'U6:WN%>, -;20JH1E/<Y0'GZ5'<^#K_5
M-%U>PUCQ%<7CZC;BV#+ L4<*C/*Q@X+'/))[ < 5U*75O)</;I/$TR#+1AP6
M7ZCJ*#<P"18S/&'9B@7>,E@,D8]<4 9E]X?COM8T/46N&1M)>5D0+D2;XC'S
MZ8SFL*R\"W^F6MW;:?XGNK:%KUKVU58%_<LS,S*_/[Q#N/!QV/45V<DB11M)
M(ZHBC+,QP /K3$N8)(!.D\;0GI(K@K^?2@#)\/Z#)H\E_=7=^U_J%_*LEQ.8
MA$#M4(JJ@Z  >I/7FCQ7X=7Q1HAT_P"UO:2+-'/%.BABCHP93M/!&1TK6CN8
M)99(HYHWDC^^BL"5^H[5EZ]KQT2XT:+[.)1J.H+9$E]OEY1VW=#G[F,<=: ,
MN?PCJ0U$:K8>(7M-4EMDMKV;[(CI<A22K;"?E8;C@@]#T-;/A[0K;PYHL.FV
MSR2JA9WEE.7E=F+,['U))-:$%Q!<Q^9;S1RIG&Z-@PSZ9%4M0U>&TT74-1MV
MCN?L<$DI1)!R44MM)&<=* ,_Q)X7.OWVDWL>HS6-QIDDDL+Q(&RS)MYSQCU'
M<9'%4(_ 4=Q8ZTNK:G->W^KF,S7:1K$8_*YB\M1D+M/S=\GK6]HVL0:MIEC<
M[HHY[FUCN3;B0,R!U#?7'/7%7?M-O]I^S>?'Y^-WE;QNQZXZT 9&BZ-JEC>2
MW>JZ_/J4C1B)$\E88D .<[%SECW;\!BM#5=,M=:TF[TR]0O;74312*#@[2,<
M'L:QM,\6K?\ C'Q'H4MLL$>C"W/V@RY\SS4W<C VXZ=3FJ_@?QC<>-+2745T
MV*TTYF86SF[#RR!6*DL@4;.GJ: "P\&W:ZCIEQK&OSZI%I9+6<+6Z1X?:5#R
M$??8*2 >.N<5FCX:S+I$VB#Q'<_V/=W#S7=MY";I-\A<JK]44\ ]>_3)KNI[
MJWM0IN)XH0QPID<+D^@S7/\ C3Q<GA'3+6=;47EW=W4=I;VYF$89WS@LQ!PO
M!YQ0!'=^#?/\4SZO!J3P6]Y9K9WEF(59947=C#=4/S'I6?;> +V+^Q6F\2W$
MSZ+(OV'-LBJL00H58#[S%2!N[8X')SUUA=33:9%<WT<%O*4W2+%-YD:_1\#(
M]\"L"3QQ92V&@WVG(+JVU;4$LPQ?:8P0YW$<_P!SIQUH J1_#JWCT76=-_M"
M4KJFL?VJS^6,QMYB/L SR/W>,^];6H^&K;5-?MM4N)"RQ6<]FUOM^61)2N[)
M_P" X_&M:"Y@N4+V\T<J@[2T;!@#Z<40W,%P&,$T<H4[6V,&P?0X[T <YHGA
M74-*GLTG\27=WIUBACMK0Q+'E=NU?-8<R;1TX'/)R:QI/AC+)HO]@CQ'=+HD
M4PFM;06Z9BQ)O"L_5U!S@<=NN*ZGQ'XCLO#-A'<W:33232K!;VUNF^6>0]$0
M=SP?:L9/'%Y:7MI%K_A?4-)M[N588;II8IXP[<*'V,2F3QD\9H VK.#4D\4Z
MK--/(VFR06XMHVQM20;_ #-N.>1LZ]_I4VO:2FO>']0TF25HDO;=X#(HR5#
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M]UB'[48U"&?Y9@=Y')R..>U>Y]:YS3_ GA[3(H8K6RD2*"Z6\@C:YE9(I0&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT:]U 2";39VO5A7;'-*H^_CMSSBJWA+4KU_$-K;:SKVJVNNLTOVK2[Z "WN
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MHV\J01TP?:N9@O\ Q"GPVL_&4OB.^>\BND MOD$#Q&Y$15UVY8D$G.>.,=*
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MTT>>\-X]HEN/-5F?>Z)+GY49LDC:3R0#77 @@$'(/>FM(BNJLZAF^Z">3]*
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M \8I$D21-Z.K)_>4Y% '.2Z;K=E::);V^K7-W,E^)+Z>1%_?1$.S C^!<D
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MQ/>2RBWP" J!F(5>>G? ST%;>F:-8Z0U\UE$8S>W37<^6+;I6 !//3[HX'%
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MAXY$G*[2ZL#E<CC XJ _#[PX;34+4VDQ@U&)8KJ,W,A$I4Y#G+??R =_4^M
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MZ1I_AOXDVMMHEI%9V]]HUR;N"!=J,8V38Y4<;OF89Z\UPEM_R0?P%_V'HO\
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M,SRJ(BKDGJPR<'WK,%Q-;^'_ (C"&9X1-XF6WEE1MI2)Y8T<Y[?*2/QKTQ?
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M>FZ% FW7(PFM7-Y_I1=;A8F6- A_=\,H4L.,G%:\7AK2-<UKX@RZI9179CN
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MH[:.^B,BVUS'=1 ,5Q(ARIXZX/:J^M^&]/UYK>6Z^T17%L6\FYM;AX98PW#
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M=O>*T]TD2[1.YL\L7QUW8 .>HX->E:9X2TG2_MC(EQ<S7D?E7$]Y<//)(@!
M0LY)"\G@>M0Z5X(T71UT];9+IAITKR6@GNI)/)W)Y95=Q.%V\ =!UZT ><:W
M -"?QMI&BVRV]C)=Z4GV6%_)C43,%D (X0.  2!WJY>Z)J&EZ/XNF70+#0M,
MF\.W"O9V=V)%>95;;)M"*%.TL">^!7HMSX7T>\DU9[FT$O\ :L<<=X&8XD5
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MVGIG4='\376HV@'=HV#,O_ E+C'O0!ZD^JV*:O'I+7"_;Y(6G6$ DF,$ MZ
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MFWGU*?S[26R669DD"^6R_,&;*E0N >5XZ5?\57]SX$\0:C<6I>23Q!IBQ6Y
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M;V\,?_"[+^78OF#0( &QSS/)G^0_*@#;F\6:%!HEMK+ZE$;"Z(%O*@9S*3G
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MR[]H!8>8P7DA>V/6IM5\8O:/G3=$OM5@2T6]FGMRB(L39(VER-[$ G:/;UH
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M_A&Y=-MEGMGBEN96+N=D; -@?*!D<DG%>A>'HG@\-:5#+&T<D=G"K(PP5(0
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M=KF[CLH<;/.=U0(3P,$\9]*S] \-6GA\W<T=Q=7EY>.'N;R\D#RRX&%!(
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M7R\6.K0WDN]L?NU#@X]3\PK(\2^"[KQ#KFM2F6**UOM$CL8G)R5F65Y 2O\
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M R 6X/?VKEM/\#:KH^E^';@:=IVIWFGVT]I=64\@".DDF]61RI 92!U'()H
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MO$#:]HVI'1M*T^VL[::S:SM[C)575?WFX( >4 "^G.><  KV'C7Q5)X>\/\
MB6\@TI=-U&>W@FM8XY/-42L$\Q7+8ZG.W!X[YJ9_&::3XD^($LNF62IHMO;2
MB6&/9-<EHB0LC]\' '' -6%\'ZH/AOX>T$^1]MT^>SDF^?Y<12JS8..> <5#
M<^ ;W4=;\>R7$L,5IK]O;16KJ=S(T<97++CH&Q]10 VV\>:A:7;6][=:)J\L
MNGW%W#'I#DLDL2AC"PW-G(/#<?=/%;'@[7-8UM4NKB]T34-/F@$@ETTLK02<
M?NW#,V>">>""O(YJ#2]-\1>9))_87A[2)XK1TCFB'G&6X( 5AA5*Q]<@Y)S[
M4S0= U/_ (3$:[=Z+IVBE;22"X%E/YAO79D(9L*HPNUL$Y;YJ .V<LL;,J[V
M )"YQD^E<!HOC/5'\4:7I6IWN@7#ZB)0UIITNZ:Q=$+[7.]@XP""<+S7:ZM:
M2ZAHU]90S&&6XMY(DE'\#,I ;\,YK@-,\,>(K>\\*W']C:391:*QAE@@N,M.
MK1-&TN[8,8R"%Y)R<D4 10>./%;^$+7Q;-!I*Z:+A8I[41R>;(AG\HNK;L*<
MGA2#TSGG U[K7O$6JZGX@BT9-.73](/V=TN$=I+J3RP[JK!@$P& !(;FJ_\
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M>1@JC)P.3[F@W$(N5MC-&)V0R+$6&XJ" 6 ZX!(&?<5XGKUW>ZGX UVUGO\
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M%VE2^)+I+2VT^"ZM[V^'VA[5I"ZG X+\J,+ZU!H^IW*:SJVDK<:]+8R:))=
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M@)ZDDDDG/'2ND9E1"[L%4#)). !3%GB=$=949'X5@P(;Z>M '''X>0GX6_\
M"#_VC)Y7E^7]J\H;O]9YF=N?PZUI:IX2CU/7?#>J-=M&VAF0K&$R)=Z!>3GC
M&,]ZZ(NH8*6 8]!GDTU)HI7=(Y4=D.'"L"5/OZ4 <;/X"N3/>V]GXAN;/1;Z
MZ-W<6,4*[][,&<)+G**Q&2,'J<$9JQ<^#[X:A?OI7B&XTVQU&4375O% K.'P
M%9HI"<QE@HSP>>1BNI6>)IFA65#*HRR!AN ]Q3O,CV;]Z[/[V>* ,>P\/)8^
M*=6UQ;AG;488(C$5X3R@P!SGG.[]*S+?P?J!O[ ZCXCGO[#3[C[3;02P*)=X
M#!?,ESE\!CV!/&<UNQZW83:[/HR3 WL$*3R)V"L6 &?7Y#Q]*NI-%)(\:2HS
MI]]0P)7ZCM0 VY@CNK66WE!,<J%& ..",&N)MOA_?Q1:*LOB:67^Q)$-@/LB
MJJQJI0JX!^=BIQNXQC@<G/=U''<0R[_+EC?8<-M8':?0^E '+/X%B?P'?^%O
MM[B.[>9S<>6,KYDIDZ9[9QUIU[X0O&\07VJ:5KLNG+J4<:7T2VZR&0H-H=&)
M^1MO&<'H..*Z<7$+2B(31F0KN"!ADCUQZ52UK5XM'TB_O3LEEM+66Y$'F!6<
M(I;'MTQG% $/A;08_"_AJRT6*=IX[12JR,N"06)Z?C5+5_#%W>^(4UG3=9?3
MIVM?L=QBW67?&&+#;G[K EN<$<]*V=+O?[2TFROO+\O[3 DVS.=NY0<9[]:Y
MV]\9RIXZB\+Z=IL=U*L"W-U<278B6)"^W"C:2[=\<?6@#FM3\.V_@NTT-AK-
M_;?8KJY6TU!+(3QVT,OS&*<9RP)Z/ZXSBCPOX9'B&U\3W#7E\(;W48+BQU&6
M/9*TL*(?.52 -OF X&,8&*Z77?%]]X>\&ZQK]]I$8:PFV1V\=X&\Z/>JABP7
MY2=Q.W!QCWKI8[R(VD%Q*Z0B95(#L!R1G&>] ',7G@W4-7T'5]/UCQ%-=R:C
M"L(=+<1Q0*ISE8P3\Q)Y)//'3%;&H:"E_K^BZJ;AD;2S,5C"Y$GF)LY/;'6M
M>HWGAB=$DE1'<X168 L?;UH XW3_  -J>D6$UGIWBB>WA6\:[LP+93Y6YF+)
M)S^]4[SP<8(![5N>'M!DT<W]Q=WQOK^_F$UQ/Y0B4D(J*%0$X 51W)Z\UK23
MPPJS2RH@498LP&![TX2(Q4!U)89&#U'K0!A^(?#UQJ]WIM_8ZD;"_P!/=S%*
M8!,I5UVLI4D=L<YXQ61:^!=1TUKR33O%-W#-<7@OB\D"N&E,823>N0'5L A>
M-I Q7:;UW[-PW8SMSSBDDD2*,O(ZHB]68X H R/#NA/HD-X]Q>M>WM]<&YN9
MS&(PS[50!5'W0%11U/UK(^)-]IX\)WFD7,4]S>:E \5E:P1LSRRC&TC P,,5
M.3TQ77"2-@A#J0_W2#][Z>M*&4L5# L.HSR* .4T_P %6_\ PKI/"^I2/(TT
M.;J=&^=IV;>T@/KO.1]!3]/\*7W]N66JZYKC:I-I\;I9HMLL"H7&UG;!.YBO
M&> ,GCFMC5-7BT_0=2U.'9<BRMY9BB2#YBBEMN1G'2GZ5JD6IZ=:7(*)+<6\
M<YA#AF0,H/\ 7KB@#C!\-+G^QH]#;Q).='MKA9[2V%LH9-LHD"N^<N!R!P.Q
MYQ74:7X?33/$6N:NMPTC:L\+M&5P(_+C"<'OG&:V:CCGAE=TCE1V0X<*P)4^
M_I0 R]M(K^QN+.;/E7$31/@X.UA@_P ZXZV\!:A%)HDMQXEDGDT5U%G_ *(J
MH(MAC964'YF*D#=GC' Y.>T%Q 9%C$T9=AN50PR1Z@4/<01X\R:-<MM&Y@.?
M3ZT >':I:1SZ#/X2TW4M69A?A+30YK'8\/[\,2\H!#0@;G!SC&W)XQ7I6H>$
M;]]4U"ZTCQ!-I<6I[3>1);K(2X4)OC8D>6Q4 9P>@/6K.K^*?[*\9>'?#_V/
MS?[8%Q^_\S'E>4F_[N/FSTZC%:6G7E]<W-\EW91V\<,Q2!TN!(9D_O$ #8?8
MYH K67A]++Q+>:R+F21KFT@M3&XS@1ESNW=R=_Z5@R?#UDT32K.RUA[>[TS4
M);^"Z-N'&Z1G8J4)Y&)".O:NSBGBG!,,J2!3@E&!P?3BD6ZMW1W6>)EC.'(<
M$*??TH ?&KK$BR/O<* S8QN/<X[5PU]\.I[VSU/31XAGATJ\N9+Q+9+==T<S
M/YG+YRR!_F"X';)-;B>)#J6@V6K:#;1W\5U(@VRSB#;&2<MR#R/[O>MN6XA@
MV^=+''N.%WL!D^@S0!C:5X=;3K_6;V6\,\^J^4TI$6P*R1+&2!D]<9QVSBL6
M#X?S:;:Z$VD:V]GJ&E6;67VEK99%GA)!*LA([J""#Q[UVK2(GWW5>">3C@=:
M2.6.:,21.KHW1E.0?QH P_"OA@>&8M24W\U[)?WC7DLLJA6WLJANG'5<\8QG
M':G>(O#\VLS:;=V6H&PO].F:6"8PB5<,A1E9"1D$'U&*VWD2)"\CJB*,EF.
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M<9.*[9W6-"[L%51DDG  K%A\0I/XODT*.%61=/2^%RLF0VZ1DVXQ_LYSGO0
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MFPU W[32(!YC%778%!PB@/P!G&/>NGK%\3^(8O#GA[4M3")<2V4!G-MYH5F
M_ X^N* ,W6_ \.M7FL7+WTD+ZC:V\"[$!\EH9#(CC/7YB./;WJ*+P7?MK?\
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MP_:7*M=27EW>7#75W<R*%,LC8&0!PH    Z 5LTQ)8Y&94D5F0X8 Y(^M/H
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M*)+>Q@U")X;>,;4C+V\;-M'0 GG KHXO#NDP3Z7-#9I$VEQ/#9A"56)' ##
M.#D*.N:GM-)LK&^O[VWB*7%_(LEPVXG>RJ$!P3@?* .* .4\86\.J>./".D:
MA&LVF3F[GDMY!F.:6-%V!AT.-S'!]/:N(\7VT.DZ3\2=*TR-+?3HH+"X2"(8
MCAF=OFVJ.!D*IP*]=UK0=.U^VBAU")V\F02PRQ2M%)$XXW(ZD,IY[&J"^"-
M&A7NC/:22VE\P>[,L\CRSL"#EI"VXGY1W[4 :&BZ'IV@6/V73;9($9O,D*CY
MI7( +L>K,<#)-<AXJMK;6O&!L4\/V.KW-GIX>9M4N?+MK>.1VP578^7.P_,
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MQ$KN#;6VD;ER <'(JDW@'P\VH&[-I-M,_P!J-K]ID^S&;.?,,.[9NSSTZ\T
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ./\
MB5XAU#PSX3&H::Z)<?:X8LN@8;68 \'VK3UCQCH&@78M=2U 0S;!(RB)W\M"
M<!G*@A%R#RV!Q7,?&K_D0!_U_P!M_P"C!6?XMU:274_%UH-5L]*%O:1PB!+6
M-[G42\1(&6Y(RQ0 #CGF@#T:VUG3KN\O+2"Z1Y[-4>X49^177<IST((!.1Z5
M3B\7:#/X;_X2&+48VTG./M(5L9W[,8QG.[CI7E6J7SZ5I.C7NGR!V\1^'(M(
MC>,Y'VH%%C.1W ED_P"^*NFP2T\7P_#^!"+-M4M]652./LR1;F'T,T0_[ZH
MU++XAR:K\2-1TZ/5([31]/$6U#I\C/=%D+/N8_ZL#'<<^]=V?$&E#3K#4#>+
M]DU!XH[63:V)6D^X!QD9SWKA=)C>7XC_ !0CC4L[VUDJJ.I)MFK(37-,N? '
MPZL+>]@FNUO],62&-PSQ["%;<!RN#@<]R* .CB\6ZL^J_$6W,D?EZ%;QR60\
ML?*3 [G=_>Y45K^#/%4>L:'H::A=)_;%]IZWC1A"N]<@,1QC@D<9S7%V_P#R
M'OC'_P!>D/\ Z324VVB;3_A;X'\60*?-T..*2; Y:UD 28?@"&_X#0!ZI%JM
MC/JUQI<5P'O;:-)9H@#\BMG:2<8YP>,YIFK:UINA6T=SJEW':P22")9),[=Q
M!(!/;H>3Q7._#V!KK3[_ ,2SJ1/KMTUTNX<K;CY(%_[X /\ P(U5^*4UM;Z;
MX>GO<?98]>M'E+#("@L23[#J: .ATKQ;H6M"[^Q:@K&S4/<+*C0M&I&0Q#@'
M;@'GI3-*\8Z#K<DT=A?B1XHO.*M$Z%H_[Z[@-R^ZY%>=^.)%U_7O$#Z#,EYY
M7A66*X>U82 EI@RID=6*K(0/0^]:5BMOJ.LV%V?&=KJTUOIUS);VUK9*F(71
M0=S(3M&=F V.1QT- '50>/\ PM<V\]Q#JT;P01QR2RB-]JK(0$R=N,DLO'49
MYQ35^(?A5WG1=64O"H8IY,FZ12< QC;F0$]TS7 O;PK^S)9Q"-0CP6Q9<<$M
M<H3GZY-=?J,,1^,6@L8URFD714XZ?/&./P)_.@"WJWBO3KGPDNLZ9XA@L;5I
MUC%Y):M* =VTH8S@@D\<]*2X^(&E6OC*X\/3>:K06GVAYA%(V&R?DP%/\(SG
M..W6O-/%  ^'?BL#@?\ "7OQ_P!M$KNUN[:U^.%REQ<10O<:%"D(D<*9&\]^
M%SU/L* +N@?$71=:\-7&MS2_8X+>1DE\Q7P!YC(F"5&XL%!PN2"<=:U+;Q=H
M-UI%WJJ:BBV=F2+EY5:-H3C.&5@&!Y& 1SGBO)=.N5?X7^&4@U2"T?3M?9[V
M1E63[(&FG"/(A/ W,AYQZ]JN^(+>+^SM;U5_$D>M[+O3?[3-O:B.-(HYMW)4
ME6.UN<<@ 9[4 =I;^-X-6\;Z/INE70DLY[6YEN(Y(&CD#)Y>PX<!@"&;M@_A
M78RRQP0O+*ZQQHI9W8X"@<DD]A7G\VJZ7JGQBT%M.NK>Z:/2[H22P.'7!,95
M=PXSU./]H>M=3XOU Z5X-UF_6TCNS!9ROY$J[DDPIX8=U]1Z9H 31O%^A>(+
ME[;3+[SIEC\W8T3QEDSC>NX#<N<<C(Y%06OCOPS>WS6=MJB23 .5Q&^V39DM
MY;8VR$8/"D]*\\N+B:?Q3IUM#XEMM4N9-%OH8#:PQQ112.D>R-"O4G&0I)(
M![UT7A37_"\WAGP;II^SW6H".**&V15>6VF2(AV9>J;<,"??WH T=$^)6A:M
MHUYJ<TQM(;:Y: AXW)8>8R1D?+\S-MSM&2,XKHM'UO3M>M&NM-N1/$CF-\JR
M,CCJK*P!4\C@CN*\L\/SZ-<>!$LKS74TN^MM>G>&==K&VG\Z0H9%/ 4C(^;
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M?Q&Y4D_7D_G0!W6C>.=.UKQ7JN@P+();%E17,;XD.W+=5 7!XY//45U%>?\
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M5&"@MG !( /0YQG&,'%:M8G@Z&.#P3H442!$73X, #_IFM;= !1110 4444
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M#@]QTJ+5/!.J:MX^\4ZU9M<6][:2V5SI1E'^C7$B0X8,",-T*Y!^7<:]:HH
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M$C:'/+* H&.>N+IT74_^%)S:=_9UU]M.H,XM_*;S"OV_?G;C.-OS?3FO5Z*
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MG);/OF<X$>!D-]00#^% &+X@\<3Z-K6L)';Q2Z=HVE_:[ML'>T[DB*('.!D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JNHZ;9:O826.HVL5U:R
MXWPRKN5L$$9'U -6J* (K:V@L[:.VMH8X8(E"QQQJ%50.@ ' %5=3T32]:$
MU/3[:\6!_,B$\8<(WJ :OT4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:M\MC>S",)*^PN!M#%ER <$CFKEGXTTV[\'77B5DF@MK19C<0R@"2-HB0R$
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MJ*Y'2_'D.I7=@'T;4K73]28K87\RIY<YP6' 8LFX E=P&:A'Q&M3"NH_V1J
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M+0W<,K8\N10VUE!SG<,@D8Z&@#7HKE;SQ[IME+JT9MKN4Z?<PV0\I0QN;B0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@[P;HLFCZA;7=CJ6FP7AN;9HXXFC=4^5R,/DCC;GC).*]C(#*5(R",&N3M/
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M#:RNA;!VY5C@XZ@5@WOAS7O$,GB'5;ZS@L;FZT.72;&T%P)#\^YB[N  ,MM
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M&FW/QLDNY;"V>X_L*"[$AC&1,967?G^]@ 9]!7(Z"3-X#L].D9A9ZCXP:UO
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M[P*&)V[E12.?4J3Z#.* .?N_](^-FFQ3<I:Z%-/ #V=ID1B/^ @#\:I>&/\
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M>C2+XC>!TC1454OD4*, +Y*\?3@5U6GZC9ZK:_:;&X2>#>R;TZ;E)5A^!!%
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MDO[RZ2.U=D5).2&+D!0,<G)(KB[_ /L[Q+\3K2WM)8;NW&B7,.HM"X=?+E9
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M.X298)G@D*?PR(<,I]P:M4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3G&QG==VU?<#&?J*S-8U.RM_B%X;T^4ZA]KNHKEH1%.5@PJ9;S$S\QQTXX-
M'0C3[);-;,6EN+5,;81&-@P<C"XQUYHN]/LK\1B\L[>Y$;;T\Z(/M;U&1P:X
MV7XF1)I]UJ::!J,FEV-S);WMV#&!"4D*$A2VYQT)P. ?4$#"\5ZIK.H?%73-
M$2SUC^SX[-YQ!8Z@EN;D[@/,+!P=H_ND@^U 'IDNDZ;/'-'-I]I(D[!YE>%2
M)&'0L".3[FI$L+.-V=+2!7:,1,PC )0=%/M[5R=W\0D@6_O8-#O[K1M.F:&Z
MU&)H]JE#ARJ%MSJIZD#L<9Q5B^\<1P>(UT+3]*N]2O6MHKM?(9 GE.Q!<LQ
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M#GA?3])5MS6\($K_ -^0\NWXL2?QJ.^\+VNI:_:ZK>W=Y.MHXEM[)I!]GCE
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M/CT<V9^;Y_,,I;IZ8[T 8&B@>./AOK<?V&RT^XBOK@6QL8O*"31',<O4_/N
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MNA2+4-/N93%YA3(21' .& ."",8H <N@Z3X CU?Q!IYFMM-CLGEFTR)OW)=
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MHT>W+D$MMPPZC.,4_P 3^'M=U^[>TDT?275;E)++61+LFLXPRM]W:6+C!'#
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M,[2V/E)VGL:GN] UN/7+W68?#FD7\NJP0F6"[N!_H<Z+MX8H=Z$;<X .5]Z
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MIM!63[N26(&"><T >@UB>*-0U#3=,CETY]/A9IE26ZU"3;#;Q\Y<C<I8\
MCD^U;=<KXRT:^U*XT2]LK*VU :==--)8W,FQ)0T;(&!((W*6!&1ZT /\%>))
MO$-KJ*7$]C<S6%V;8W-@V8)QL5PR\G'#8(R>0>:Z>N2\'Z-K&D:IKLFI06:1
M:A<)=QFUD)"'RU0Q[2H^[L^]WZX'2NMH **** "BBB@ HHHH **** "BBB@
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MJ37[^>]F:VN;FT9E^S/%-(BF-8\?+A7&".<BM6/Q5=>&#XSM-6N'N9=,!O[
MRG)E@E'R(/7;("GXB@#T.LO4_$&GZ1J>F:?=R.MQJ<K16P5"0S*,G)[<5PER
M;^UMM%TG5O$.ORZDNG^?<VVD0%IS*S<R.X! 0'*A3C..^,5D2ZK=:U/\)]0O
MGWW4UQ-YK[=NY@FTD@="<9H ]BCN(9998HYHWDA8+*JL"4) (!'8X(//8BI*
M\?TS1M6?_A84VD:UJ8U.WOF%L&E#"1ECC<;ACDD#9]#71'Q1/XIOO!T&CW#P
M1WT9U2^,9Y6",8\L^S2,%/\ NF@#OB0!DG K#\/>+-+\4B>323<S6\1P+EK9
MTBDY(.QV #8(/2J'_"1:;XKM[[2K*75K280L[3?9);<@*1]UW3&3TQZ9KS'P
MT=2T7X'Z'J6E:O>175W>PPJCN&BB!NF4A5QT/?GF@#W.ZM;>^M);6ZA2:WF0
MI)'(N5=3P013H(8[:"."%=L4:A$7T & *\VUZXN=&UG2O#4FK>);FV:VFO;F
MXLXS-=2MO557*)E$!9CP!_"*SI/%&LFST32=0;Q!#'/=WBO<06+K>SV\.TQG
M:%RN?,7<P'\!Z9H ]5N]/L[]K=KNWCF-O*)HMXR$<=& ]1DX/:K-<IX#OM1N
MK#4(;Y=2:*VNV2TGU&W:&:6$JK L& R02RYQSM%=70 45P>H1:EK/Q-N]&&M
M7UEID>DPW#1VD@1S(99%R&(.!@<XZX';.>9'BO56M-.T*]OM5D*:I?V=S>:=
M 7NIX[8C;@(IP3O3<P'\)]: /8J*\@O-=\1Q>'(K>WNM5MG_ .$BMK2SO-1M
MFBEEMY .'5@-V&+*3CD**VKS3]4A\9:)X:A\2:M]BDT^YGN9GE4SRXD3&&VX
M!!;&0.%R/>@#T6HY[B&U@>>XFCAAC&YY)&"JH]23P*\DN_$NKZ3;WOAV34=2
MN&BUZ.Q6]AB\V[^S/#YV  #N? *[L9P<]JSO%5SJ-UX \5VKS^(%TZU-K-9S
MZE"\,L@=]DD3%E!=0<-Z_,.>* /<**XZPDO+#XCQ:(=1N[FSCT,SXN'#,TGG
MXW$X&3@X^E8?]N74N@:J+S7+VU8^);BSB-K"9;B2-7.((@ 2#@=<' !^M '>
M:[K=EX<T6YU;479+2V4-(RJ6(!('0>Y%78)DN+>.:,DI(H=21V(R*\6\0ZG=
M77PO\>Z?/+J,L-C+ MN=37;<*CB)]K^N"3@GG!%>PZ3_ ,@:Q_Z]X_\ T$4
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MO#T-OJ%W/96T4R7KS$,9_D 1G/7=NYXXY/H*Z&F--$DB1O(BN_W5+ %OIZT
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M01QPORX"@GYFXR<]NU5K+P)>(+6UU/Q)=WVFV4#P6UJ(EB.UD,8,C@_O"%)
MX'//6NQ\Z+>$\Q-S9PNX9..M0:E<7-KIL\]E:K=7*)F.!I1$'/H6(('UH Y"
MV\ ZC$=$>?Q+),^B2+]B_P!$55$00QLKJ#\S%2!NSQC@<G->/X:7*:&V@'Q'
M,VBSSM-=6QMEWR;I"Y17SE%/&>">O(SBNZAN";2*6Y5()#&'D3S P0XY&[N
M>]3(ZR('1@RD9!!R#0!SB^$+?_A,[[Q#).76\T\6#VI3Y0H.<YSWZ8Q4.A^%
M-3TB:QAD\27-QI>GJ4MK00+&Q7:542N#^\"@\# Y )SBNH>1(D+R.J(.2S'
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MR"UTSPIXJTZ;PQ!H.JMHQ<K8RAK6ZB5P-Z@ ?,"V/F&[!ZFNT\0R+_PG/@(
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M-Z,9 A$<19B/0'!/TKHM1O;36OB7I[Z/<PW?V71[O[9);N'4*Y3RU)'&20Q
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M)_2NZ1UD174Y5AD'U% '-V_B"VM]6\3->:[#-;:8L4DMLMJ4:Q4H6.Y^?,W
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MN5C+_=#N!M0G(P&(ZUYMI<,MUJ.F_#67<T>CZK)<W&[G=91;98 WJ&:5%_X
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MVVG6-DQ:UL[> MP3%$JY_(5G^)/$,?AVRMY#:S7=U=W"6MK:PD!I96S@9)
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M&3WIHM+8111"WB\N(AHTV#"$="!VQ7 :]X]UNWL]'NK#PY=10W^J0VT3S2Q
MSQ-R,*6RA<9 SC&.<<5U.A^)8]8O]4T^6TELK[37C6>&5E;Y70,K @X(/(^J
MF@#3?3[*2\2\>SMVND&$G:)2ZCV;&14JP1(\CK$@:7F0A1E^,<^O'%9GAK7X
MO$VC)JMM!)%;2R2+"9,9D16*AQCL<$CVKE--\::3I.@>(=62#4Y(+377M)UF
MF,S>871"8P2<)\P(4>^!0!W$NFV$T$4$ME;210D&.-XE*H1TP,<4RQTR#3[B
M_GA+%[ZX^T2YQ][8J8&!TP@_'-<_!XSNVU.XTRZ\.7MI?"S:]M89)XC]H12
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M"?B36IXA\,VWB:.&WOKN]2S4GSK6"4)'<C(.V3C)''0$=3FME55$"(H55&
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MNM_MTEZTZG>=FTW?G=<==OMUH MQ>(/$6F^)I=)U@Z;.)M+EO[=[6)T\IHV
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MAY0DHZOM8'[S @CIBLY? VK?8=,DEEM6OSXE76[\(QV("&!1"1DX&T<XS@T
M=C$-:B\.R"XELY]96&0JT4;+"TG.SY2V<?=!Y]:XC4OB5>0>%?#.K6EK;O+?
M1_:M01U;$4$>T3E<'@AF &<_C7I=>=Z-\/KJ#5O$2:A) VE7-O/:Z=&A),<4
M\C22@C''S%0,=A0 _P 6^.=3T:?Q&=-AM)+?1M-AG=I48DSRR<+PP^78,^N2
M.:B\2:WKFE:5H-QK%EH]S-?Z];0QPM;LXM8W!Q@EN95P?G&!STJK%X"UZ7X8
M:]I5]+:R>(-5*[Y!(?+PBQH@W8S]V//3J371>.?#5_XBM- BL3"&L-7MKV;S
M&(_=Q[MV.#D\CB@#$M+OQ3)\1/&,4&I6 AL[:W,<<MM(P4,DK)@"0 '^\?XL
M#&*SO#WBO6-)^&_AI[S4M.-WJTBQ6]U>AE2!-K.SRDO\Y&T@8*Y) KJ8M"UB
MT^(&M7\4%M+I>LVT,<DQF*R6[1HZ_<VG=DL.XQ6#IW@WQ##X1T*RN;#3'OO#
MUQN@1[@O%>QE71PV4^0D-D<-R!0 ^3XB:E!I%^L#Z5JFH6.HVEJ)K1CY%S'.
MR@$89MC?>!Y(!&>>E;VDZQKUOXU;P_K<FGW"S6#7T$UG"\6S;(J,C!F;/W@0
M>._%4;SPWK6K:)Y<NGZ3ITQU2UN4MK4YV0Q2*QWN%&YCAB,  9QFMR71;I_B
M%:ZX#']DBTN6T8;OFWM*CCCTPIH J>*M=UG3_$'A_2-'BLVDU4W"M)=*Q$7E
MH&W84C/?COP,CK6'<>/-5T6VUNPU8:<^K6%S:P07 W0V\@N/N.X+$J%PQ;G^
M&K7C8WZ^//!;Z8D,ETC7K+%,Y1)!Y2Y4L =N1G!P><55N/!.LZS'K6K7T=C;
MZM>75I<6MJ9#+#&+;E$D;:,[LOG XW#K0!%+\0;^QT[Q%'_:&BZM>:=IW]H6
MUU8@^4XR5*.H=B""!T;D,.E6[[Q-XLT[1]&O)8-+>XUG4H+>"W"N!!')&[ .
MV[E@0N2!CJ .E/OO#VN:UX8\06<FD:-I4E[9FWM8;=][;CG<SR!5^4\8 !Z9
MK4UOP]>ZA9^%HH3%NTS4;>YGW,1E$C=6V\<G+"@#)MM8\;7/B'5/#:SZ*+JS
MBBN5OS;2;&1\X3RO,R#E3\V[H.AJC)XVGU'2_ .HRZ9I[S:MJ AF$T1?R&&5
M9HCGY3D'!YXKK;'1;JV\>:QK+F/[+>6=M#& WS;HS(6R,=/F%<E;^ =9BT7P
M/:,UKYNB:B;FZQ(<%"S'Y>.3@CTH T['Q1K>I^*+VTM;G1E2SOS;2:7,&6[,
M((!F#;L<@[@-N".,YHT+Q1K>M:[,L5SHWDP7TMM<:60RW<$:,RB0L6P2<!L;
M0,'@TS6O#VOZYJL$=UIFD?Z/?I<6^M)*5GBA60/L";<[MHV'YMISGVHN_#VO
MZMX@TZ:_TS2(Y+"_6X&LP2D320JQ(C";<@LN%8%B.IYXH H6?C>:QT[QE=QZ
M58"YLM;-A;1P1^7]HD9E16E.3DY;)/H*VH=;\0Z/XET_2=>ETZ[34X)GMY[.
M!XO+EB4,R,&=MRE2<'(/'2LB/X?:G)I?BZW>>VAN-1UDZGI\@)8*5=73>,<<
MK@XSP:UHM(U_7/$VG:MK=G9Z?%I<$RP007)G:6650I8G:NU0N<#D\T 8MAXT
M\5R>&] \47D>E+I]_/;P36<<3^:%D<)YBN7QU.0N#QWS7IU<"G@[5%^&F@^'
MRUO]ML)K1YCO.S$4JNV#CG@''%=A:-J9U+4%NX[9;%63[$T1/F,-OS[\\ [L
MXQVH O4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 V2-)8VCD4,C JRGH0>U1VEI;V%G#:6D*0V\*"..-!A44#  'I4U% !1110
M!0GT32[G5H=5GT^VEU"!-D5R\8,D:\G"D].I_,U?HHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JA;:-I]GJ5SJ-O;A+NZQY\H9B9,<#=D\X
M' ].U7Z* "BBB@ HHHH **** "J]W8VM\(1=6\<PAE6>,.N=DBG*L/<&K%%
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M17-?$'4;O2/ &M:A83M!=P6Q>*10"5.1SS7.:_8ZYX:\)W7B"'QQJ+S6EO\
M:!#?10-#*0,^60$4_-T&#G)H ](HKEKCQA)";&UMM$O;_4Y[);V:UMRBF",\
M?,791DG( ZG::8WCNWN8K Z-I5]JLUY:F[$,/EQM%$&VG=YC*-V[*[1DY!H
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MH@XWA?4CKCWH \UEO9_$]AX4T2WTG4K>]LKZTN+_ .T6<D4=LL'+#>P"L20
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M+21DFC98@-K@;2<@\9SP?0UZO:)I^E0V>D6[PP".$1V]OO&[8@QP#R0 *NT
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M;6%I,ALKV*'4-8@'/-LQ\HGM\[%!CN(ZZ"\TW7-%\8:AKFC:?#J4&IV\,=Q
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M-&E:*2UNI2+JZ**&D,?S +C)"Y#9(/2NB\9>('T;P!J>NV)!DCM#) Q&0&8
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MB/GA3S[UTD6G>(=?\3Z+J.LZ;;:;;:1YLH2.Z\YIYG38,8 VJ 6//))'%6/
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M#8QZ7I[SQ-*8A(6E*HP;)8#:2.!GOFKT-WKGB7Q;8V$VHWVD6\_AV"^N;>W
MCE29I&!4%@2OH>,_*!ZT >ARSQ0!3-*D8=@BEV RQX &>Y]*DKQ74I-2U?0O
M#<5[K-\9K7Q:VF&>-E5I521PLC?+C> HP>G7(-;FJW]]I_BBXM]6\1:OI"++
M"FEW30"2RF38F1*0N"[/O!W%>HQB@#O=6T'2M=2%-5L(+Q('\R-)EW*&]<=#
M^-:(    P!17$WK7_B/Q[?:(FK7NG:?IEE#*XLF5))I92^"6(/RA4Z#N>: .
MVHKR*?Q%XCN-+TC3H]6>*^3Q+-HT]ZL:YEC59,.5QC=C:?3*UZGIMDVGZ?#:
M-=W-VT0P9[E@TC\]6( !/X4 +?W]GI=E+>W]S%;6L0R\LSA54>Y-9&C^./#.
MOWHLM,UBWGNBNY8N49QZJ& W#Z9K%\911ZAX^\%:5>*)+"26ZN7A?E9)8HP8
M\COC<QQ[5U6I:)INK2V4M]:I++93K/;/DJT;CH000?PZ'O0!H45YDLNM^(-(
M\2>(8?$%]8RV%S=16%M!L$*K!D#S%*G>6*DG)Z'C%.L=1U7Q?XGLH!J]WING
MW7ARUU&2*S*J_FR._P!UB#@>O?Y1[Y .[UO7-.\.Z5-J>JW(M[2+ 9RI8Y)P
M   222>@JM9^)K"^GL(8XKY'OD=XA-9RQX"$@[MRC9TXSC/:O(_%KW^K_"RW
MEO\ 5;N6>QUMK%G!51.$N"BNXV_>  P1COG-=I<W>I:/\3?"F@IJMY<V4]I=
M//\ :&5FF8 E2Q '3.!C'2@#L]8U:ST+2;C4[^0QVMNNZ1@I8@9 Z#GO5ZO$
MM<_M;7_@]JGBJXUN\+WA=OL)V_9TA$^Q4"XR"  =V<YZY%:^O^(K^[\1^(+>
M&_\ $%L^F;(;"/2]/>>)I?*60M*51@V2P&TD<#/?- 'JU96F:/HGAFW\C3K2
MUL(YY1D( IE<].3RQKC+2YUOQ1XK2QN-3O\ 2+9]!M+V>VMP(Y4G=G!7+*2O
M3D8S\H]\\[=R:EKNC>"S?:S??:$\12V#S0LJ%_+:95D(VD;P% STY/% 'KD6
MK6TVLW&EJLWVF"-97)A8)@],/C!/L#5ZO/K76[^'XE^)--FU,KI]CI$4T9N,
M%(FQS(V,9]36?X8UR[3Q9H=M'JVN:C;ZE;3&XEU&T,,,CJJNLD&44@'GCD8(
M^M '?:%K^G>([*2\TR5I88YG@9F0KAU.",&M.O._@S_R)]]_V%KK_P!"KT2@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** ,+Q1X=;Q#:6GD7K6-]8W*W=K<B,.$=01RI(W*0Q!&1UK&
M7X?->7FKW6MZN]_)JNGK93B. 0J@#$AHQD[<9'!SR,YYQ6]XI\1VWA/PW>:Y
M>132V]J%+I" 7.Y@HQD@=6'>M..=)+=)\A49 _S'& 1GF@#$T71M;M+X7&K^
M(FU%(X3#%#';"!3DC+OACN?C&> ,GCFJ6A^!+?1/%^HZZMX\JW/F&WM6C 6V
M,C!Y=ISSN8 ]!CI6IXI\26OA7PQ>Z[<(TT-L@;9&1ER2% !^I'-3:-J-Y>Z2
MEYJEBFG2MR8?M E"KV)8 #/M0!B1>$-2L[R:+3O$4EIH\]X;Q[1+8&569M[H
MDN[Y49LDC:3R0#3SX&M9O$/B74KNY::#7K6.UFMMFWRU5-APV>20?08KJMP(
M!!&#T.>M()(RI8.I SDYZ8ZT <?9>"M0-SI*ZQX@.HV.D2"6T@%H(F9U4JC2
MON.\J">@7GDUS/ASPMJ>O>'M;LH]=:STR^U:]2[M_LP=ROG,&$;DC8&48.0W
M<CK7JOG1;4;S$P_"G</F^GK2O(D>-[JN3@9.,F@!(88[>".&)0L<:A%4=@!@
M"N>\1^&;G6-9T;5[#5!87NEF8(7MQ,KI*H5@1N&#\HP<UK7.KV5IJMEILTNV
MZO1(T*8^\$ +?3J*+"ZOKB[O8[O3Q;0PR;;>43B3SUQ][ 'R?0T 8R>#E3P[
MXDTC[:2-:FNI3+Y7^I\\8QC/S8_#/M5-O ]U%>S-9ZX]M:7EI!:WT0MP7D$2
ME 4?=^[)4X/!]1@UV*2))NV.K;3@X.<&CS$WA-Z[F&0,\F@#A[?P#?V2^&I+
M;7U2ZT.![19&L@RS0,% 4KOX8!1\V?PKNJ** .(U+P#<WYUVTCUU[?2=9=IK
MBV2V!D$C1A"1)G[IVJ2N.V,X-:>C>%IM-U]]9N=1%U<2:?#9.%@\M3Y;,=_W
MCC.[I[=:LZ=XFM;_ ,1:EH+PS6VH6(63RY@!YT3=)(R"<KG@]P>#0GB:UG\7
M2>';:&:>XMX!/=3(!Y=OG[JL<YW-U  Z<T 9D'A#4K*[EAT_Q%):Z-+>&\:T
M2V'FJ6?>Z++N^5&;)(VDX)&:ZZFB1#(8PZEQR5!Y%+D<\CB@#E+_ ,)ZBWBF
M\\0Z3K@LKJXMH[8QRV@FCVJ6.2-P).6&#D8P>N:IP_#^?3;?2'TG6C!J-A]H
M\RZN+82BX,[!I2R[EP=P!&#QC'-=Q31(AD,8==X&2N>0/I0!Q=EX(U?2$N/[
M+\4RQO)>-> SVHD#LZXD$H##?E@&&-NTYZBG+X#N((+>ZMM:,>NQ7DUZ;XVP
M,;M* LB&+/W" O&[.5!S79%T#[2R[L9QGG'K0TB("6=5 [DXH Y.]\&WVH:1
M;I<^()GUBVOA?P7Y@&V.0 KL$6?]7M)&W/?.:FT/PI=Z=XFN]?U#6#?WEW:I
M;2*+<1(NUB1L&XX&#T.><G/.*Z8N@<(77>1D+GDB@NBLJLZAF^Z">3]* !T6
M2-D=0R,"&!Z$5PT/P]NEL;31)]?:;PY:3)+'9&U E94?>D;R[N4! _A!( &:
M[NN:O?&EE%I-IJ5E&;N&XU---^]LVL9O*9NAR 0?K0!-9^&5M'\1-]J+?VS,
M93^[QY68ECQUY^[GMUJMINC:EHD_AG3+6\DDTVPL'M[K]VJK*55%C8\D@YS@
M#WR>!73+(CYV.K;3@X.<&A9$8L%=3M.&P>GUH =6%I'AF+3+K7I9)_M$>KW1
MN'C9-H0%%0KUY^[UXZU?TG5K/7-.2_L)?,MW9T5L8R5<H?U4U<:1$*AW5=QP
M,G&30!RVA^%=6TB2PMG\22SZ1IX*VUJ+<([*%*HLLF3O"@\8"Y(!/2L^'X<F
MUTJ^M[;5REU-KC:U;SM;@B&0D$(5W?,, CJ.O:NY9U0$LP4 9))Q@4H96 (8
M$'D8/6@#B)/A_<W3ZX]]KSSG6[ 6EYBV"X==P1X_F^50'(V\YQDG.:F3P?K$
M4>FW</B*)=9L8&M?M1L 8YH#M.QX]_4%000PYSQS799&<9YJCJ%U?6T]DEGI
MXNHYI@D[F<1^0G]_!'S?04 &D6-QIVFQV]W?S7]P"S27,H +LQ). .% S@#L
M *I>+?#H\4^')]*^U-:.[QR1SJ@?8Z.'4[3C(RO2MEI$3&YU7)P,G&3Z4[(S
MC/- '(S^%-8&I1:Q9:_%;ZN]J+6\E:Q#PW"JQ96\O>"K+N.#N/!K7\-Z#%X<
MT@64<\EQ*\KSW%Q( &FE=BSN0.!DGIV&*UBR@$E@ .I)Z4!U90RL"IZ$'@T
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M7JRZIHNI7OB,7-SI1,<:K9!(VA9=KKM#_?.!\V<# PO7/9Y''/7I1D#/(XH
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MEA,B"5AE4+#)'L*\=L-#T^/PG\.M4TB"--=DFL@9X3^\EBV#SU<]2@0'(/3
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M"0J2,8Y-6O$0T[2=!\0:IH.L/>PWDEH=3^QE###%O"NR^6,!F3.['..3C@T
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M,<< C))Y)'6GR_$.RM-%U"^OM/O+6XTVZBMKRS8*TD9D90K#:2&4AP01UP:
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M-2'P3\/:>=/NA>13V1DM_);S$"W"LQ*XR,#)/M7J$$;101QM*\K(H4R/C<Y
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MG(!^0\YP">M;.H:-JVD>*UUW0;*VO(I;!+&>SDG\@KL8M&ZMM(Z,00?:LE/
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M7BW7=#/B#3]573[B_L='DU6SGMXGCCE5=P*NA8D$,!T;D'M42>"]5MO"NAO
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M=8D5;9+VUBN-C/D)O4-MW<9QG&>* ,L>#XQI/BFP^VMC7Y9Y&?R_]3YD2QX
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MY]<>M;<7B!)O%\F@I &5=/2^%RLF0P:1DVXQ_LYSGOTK7EECA3=+(D:YQEF
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M,N,@')&>E.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#D_'6BW.LVNFBVM[*^-K=>>^FWK[8KQ0C#
M:3@\C<&&01D<UQD:Z9J=YX9\/#2I=/TQ]7NUU#2IG#1K/'#YBQ#!VF,E@P4<
M'TKTS6M L-?AA2]697@D\R&:WF>&6)L$95T((X)'O5%O!.A-HJZ6UM*8EG^U
M"8W$GGB?_GKYN=^_WSTXZ4 <%KUI;:++\0])TJ%+?36\/+=-;0C;'%,5E4[5
M'"[E4$XZXI^A6-IKFH^ ]+U:WBNM/A\++=QV\ZAHWFQ$F2IX8A2<9Z9KO+;P
M;HMMI6HZ<()I8]34I>RSW#R33@KM^:1B6Z<#GCM3;SP5HM[8:7:&*X@&E1B*
MRFMKF2*6% H7:'4AL$  Y/.* ,3X;VEM87WC"UL^+>'6F2-<Y" 0Q_*/8= .
MP&*T/B7<W-I\/=5DM&996$41*OL.QY41_F_A^5FY[47?@+2AX;O](TR 6R7U
MQ%/*6E=OG5D^?))).$!]SUZFNEO;*VU&QGLKR%)K:=#'+&XR&4C!!H \^T7P
MK/'X@E2X\-:5H^C76FR6UY9VUX)%N/F78Y4(O(&\%N3\U8O@J8:SXJL=-U2\
MDN=+T=)7\/O*F!?A'*>:3T9HUPH]<[J[VV\":);07<0%[*;JW^RO+/>RR2+#
M_P \T=F)5?88J_/X:TFXATN(V@C72W62R\IBAA*C: "#TQP1T(ZT >51>'=&
MN_AUXUU>X@C?4;:^U*2"Z;_66SQR,R!&ZI\V#@8R6/K6E%=W;_%NRO67=>'P
M9YI7'63S,XQ]:U?#_P .[.XL[\Z[:7*-/JES.]NMVZQ7"&9FC,B*VU^,=1G&
M >F*[$Z!II\2+X@\@_VDMK]C$N\X$6[=MVYQU[XS0!Y2^DZ=9_![2?%5I!'_
M ,)#NM;P:@!^_EGDE0.&?JP.YE*GC';BKSVT%Y\0OB=!<PQS1-I=J2DBAE)$
M)(X/H0#^%=K!X!\/6U_%<QVT^R&?[3#:-=2&VBESG>L1;8#DD].#TK1B\.:5
M#K&I:JMM_I>I1I%=LSL1(JKM VDX''I0!Y/9:<B>'/AUIUAH5C>V]]:O>75E
M)(((KJ=84PTAVL&."QP0<[1Z5:N=(O;2WTS0]4L[:ST?4/$R8T^"Y\Z..+R2
M_DDX4;3(N[;C'.*[N'X?Z!!HT>EQI>+;P3":V;[;+YELP&!Y3[MR#&1@'')J
M=O!&@OH+:.]K(UN\_P!I:1IW,QFSGS?-SOW\#G/MTXH Y[1-*T[1_C%J5MID
M$5O =$A<P0@*D;&9\[5'"YP#@=R3WJ2;3+'Q%\5=2M-;M(;VWL-,@:TMKE \
M8\QW\QPIXS\JKGVKHM'\):1H>H2:A9Q3M>RPB&6XGN))9)5!S\S,3D^_H .@
MIVL^%=,UR[AO+@7,-Y"AC2YL[F2"383DH60@E<\X- 'D\MHE[I6BZ+(\C:=;
M^-)[& ;SG[,%D'EANN,%E^E>JZMI]II?@C4K*QMH[>UBL9UCBC7"J-C'@?C3
MD\):)%9:79Q60C@TN<7-HBNPV2 ,-Q.<L3N;.<Y)R:UKJVBO+2:UG7=#-&T;
MKG&5(P1GZ&@#QL:-!IWPI\+-86$<]SK4NGQ7^^4QFZ0KN$;R8)"Y"IC'0XI=
M>TS5-&T37_\ B666A:5J!L89;2QN]X0M.$D< *H0.A"G YVUZE)X:TF;PW%X
M?DM=VFQ1)#'$7;*JF-N&SN!& 0<YR*J0>"=#BTW4+&6WFNX]14+=R7EQ)-)*
M!]T%V); [8(QU'- '*W^@Z1H?Q0\-1Z39P68EL+[S(+=0B<+& VT<9/(SU.!
MZ5E1.H^!O@\%@"UWIX'/4^>O'Z&N^TSP1HFEZC;ZC$EU-?6Z-''<75W),X1@
M 5R['Y0!P.@Y]356+X;^&H=JK:W+0QS+/!;O>2M%;N'#YC0MM3YAV'3(Z$B@
M#G;#0=$\3R^,K_Q&D?VBWU.6W6]D<))90Q(A1HW/^KQDOD=SDYK*O--N_$FN
M>*P-$L=8,1BMK:_NK\1O:IY".KQ_(<9+%]RD9)]J[_5/ F@:QJ,U[=V\^^XV
M_:8XKF2.*YV_=\U%8*^/<4_5?!.AZQ>/=7,-PCRQK%.MM=20I<(O19%1@' R
M1SVXZ4 <GI6D1^(/'5Q:^*[:VU"?3]$LE2.8"2,/)O\ -D4'C)90-W7 %:GP
MICB3P9-%&YEB74KQ5=FW%U\Y\$D]<UM:KX-T;5[NWNYHKB"X@A^SK)9W,EN3
M#G/EL8R,K[5?T;0].\/V'V'2[<6]KYCRB,$D!F8L<9Z#)Z=J /'(M.LM+\$>
M,)+"UALFD\2R:=)<6Z!'CM3<1J4##D+@D8Z#-=E<:-IOAGXD>%(]"LH+!+Z*
M[@NXK9 BRQI&&4L!U(;')Y^:N@3P1H*3ZM(;61H]5W&\MWG<PR,V"S>7G:&.
M!\P&:DT?PAI.B7QO;<74]WY7DI->74EPT<><[%+L=HX'2@#G/&6FV6K?$CP;
M9Z@BRVSPWQ:!^5EPL9"L.XR,X]JXWQ-:1:;H_CW1=-'V;3K?4M,DMXHN%@>1
MHB^P=!S@X'3->@^*?#+Z_P",O#L\MO*UC:PW8EGBF,;PNPCV%64A@<J>15]/
M ^@IH=QI#6TLEM<SK<W#2SN\DTJLK!F<G<3E5[]J .<U[0=%LK[1/#NF>&K:
M_DQ/>)9W$_EVH "HTLN5?>WS*!P3DDUS.BH-0C\-^'M0BA_LA]>U*.2T20R0
M8B#M'$"0-R!LX! SM'%>IZUX9TW7YK6>\%RD]MN$4UM<R0.%;&Y=R$$J<#(]
MJHGP!X=^PSV26<D5O+<+=*D5Q(GD2@8#Q8;]V?\ =QF@#BO'/ACPU8:+]EL(
M[:11KEFTEEE'2T,C(&54QF,.O)7H<^E7KF"/3OCC806-O'''!X8=888U"JH$
MIPH Z"NI/@/P^V@W&CO:RO;W,PN)I7N)&FDE!!#F4G=N&!SGM5NU\+:5::O:
MZLD<TE_;6GV*.>:X>1C%NW88L3N.>YYH XKP7X?\/W/A+PWXDO98[?6)I4N7
MU'S%2:XG<G,;.>6#$E=GX"L'0=*UG5](L-:@T'3H]3?4OM+ZW)?XG8B<AT*[
M,[2H,>S=CI7H]MX"\/VFJQZA%:S!HIC<16YN9#;Q2G.72(ML5N3R!QGBG#P-
MH2ZM_: @GW?:/M?V?[3)]G\_.?,\K=LW9YSCKSUH Z.O/+'1-+\4^.O%_P#;
M]C!?FT>WM;>.Y0.((3"'R@/W2S,QR.>/:NLTC11IFJZU>@K_ ,3&Y68*"3C$
M:KSGN2#TXQBJ^K^#='UJ_:]N%NH;F2,0S/:7<D!FC'17V,-PY/7UH \MTNU3
MQ(OPSM-59[JW<:G$XD8GSHHSA Q[@A$SZCZUZ=XL?3]'\"7T<D$RV,=L+98+
M-O+?#8C5$/\ #R0,]JNKX:TB.YTF>*S6-M)1X[(1L56)74*PP#@\ =:M:II=
MGK6F7&G7\(FM;A=DB9(R/8CD'.#D4 >3-92:1K.OV(T33=%CF\*7$KVFGW!D
M5RK;5=QL0;@&89YSZU:30M-TC2_AUJUE:QQ:E/>6L<]X!^]F62W?>';JP.!P
M>!@ 8%=HG@#0$D$K1WDMP898))Y;V5Y)HY%"LKL6RPP!@'@8!&*TY/#VF2VF
MEVKP$PZ7)'+:+O;Y&12JG.>< GKF@#$\>&VN8M(TJ73/[4N+R]S!9//Y4,A1
M&<F4X.4 &<8.2!Q7G5W 5\/ZQI<T-OI]O#XKLD%O8SEHK8,(2XC;:I'))X P
M2:]@UOP_8>((8$O1,KV\OFP36\[PR1-@C*NI!&02/QKD?$WP]L?[/BCT?3I'
M^T:C9/>PF=F1XXY%WNP9L%MHY;[Q]S0!E>(-)T_PYXIN[71+.&RM[WPU?&Z@
MMU"(WE[=CE1QGYF&?>JB:)IFD>$? &N:;!&FK2WFGJ]XG^MG650)%9NK#:3P
M>@ QTKMKCP786&DZW)IT=U<:E>6$ELLMU=/.^W:=L:M(QVKD]/SJ#POX#TS3
M]/T.ZNK:X%]9VT;"WDNG>&"?RP'98]Q0-DMR!U)- '%+_P >'QE_[:?^B&J]
MHMG;:W<^ =(U:".YTU/#?VM+:9=T<LX6%064\,55F(STS7??\(AHHCUN/[*V
MW6\_;QYK?O<J5..?EX)Z8IEYX-T6]TO3;!H9HDTQ EE+;W#Q30 *%PLBD-R
M >>>] ')ZKIFA6D6E>&]+LEUP-J%Q+#I\]ZHM8&1<NDF%;"IO&$()!(KDKK3
M[:Y\(O:WNG6*K9^,H[:*WC/G16Z,\9>-"5'RDELC ],5ZF_@/0#IUG916]Q;
MK9R/+#-;W4D<P=_ODR!MQ+9YR>:8_P /?#;6%[8K9RQVUW)'+)''<R*%DC "
MR)\WROP,L.3CG- ',7$2:=\<;>*PMXXTM_"C+!#&N%4+,=J@#H. ,5AOI6GV
MWP8L/%EO#&?$6;>]&I ?OY+AYE# OU(.XKMZ8[5ZE:^%M+M-8M]72.9[^WLO
ML*3RSO(QBW;L-N)W'/.3S[U2B\ ^'H;]+E+:?9'/]ICM#=2&VCESG>L.[8#D
MD].#S0!RD7AO2-<U_P"(,NJ6,5X8YU6(3+N$1-JA+(#]UCQR.>!74^"T35_A
MGH<>HHMVEQID*S+,-XD!0 [@>N?>MB#1+"VGU*:*$A]2</='>3O(0)Z\?* .
M*FTS3K72-,M=.LHS':VL2Q1(6+;5 P!D\F@#PO1-.LK+X5:E=VMK#:SW.M'3
M[B\A0)(MJURBLF\<A<<8KN[K1]-\,_$;PS%H5E!8)?VUW#=PVR!%E1$5D9@.
M"0W&>OS5U%KX1T.TT*[T2.Q5M.NW>2:&1V<.SG+').1SSQT[4W2/"&DZ+>M>
MP"ZGNS%Y(GO+J2X=(\YV*78[5SV% '+?!K0]/M? >EZNENIU&Z@99;EN7*!R
M F>R@*O'MGK3;3P[HWB#XH>,DU>S@O5BBL@D,Z[E7=$<L ?XN ,]1VZUW6C:
M/9:!I-OI>G1&*SMU*QH6+8!)/4\GDFN1_P"$*75/&_B6_P!1BNX(+E;9+:XM
M;MX6D41D2*2C E<XR#0!R>@,FN>'O"NER:/'KU[!#>211W]SLME@2<Q*[Y5]
M[8VA?E..3Q5*'3;+4O#_ ()CO[&TG6/Q+<680@3(L >?$09AED&U<9 R%'%>
MIW7@?0;F#3X5MYK5+"(P0?9+F2 B(XS&2C LIP,@U#+\/O#LE@UBMK/#!]L^
MW1K#=21^1-S\T>&^3J>%P.: ."O-'O=>U'Q>(_#NGW<T%T;2UOY[[R9+!4B0
MQ^6-AV $[\@C))S6UIV@6FN?$75D\0VEO?21:38>9%* \1E(E#-M/!(YP<<
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MV%C;V=NNR"WC6*-<DX51@#)]A4U !1110 4444 %%%% !1110 4444 %%%%
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M.&,86!U.['W3DXP??T-=WXUU Z5X*UB^%I#=^3:N?(G3=&XQCYQW7G)'H#0
M:7XS\/ZR;@6.H"0V\/GNKQ/&?+_O@,H++[C(J*T\>>&;^_M+*VU5))KL#[.?
M+<)(2NX*'(V[L?PYS[5P+WJCQG%'-XDMM6)T"]C5X(8XHE8^4WEJ5SDX&=I)
M(&#WJV8HXOAE\-@B*H^WZ4W [M@D_CD_G0!TWBCQ[I&DZ?K5O;:C&-6L[25E
M4Q,R),(RR*SXV!B<?*3D]*6\\0WXM?"$%LZ?;M8FB,Q* @0K$9)2!VX 'MNK
MBGU72[#X=^/],U&X@34FO=1#6SL/-D>3)B8+U((*D'T'M70>%\ZMXOLI <Q:
M)H%O"N>T]P Q/X)&G_?5 '1MXZ\-+JATXZHGGB;[.6\M_+$O39YF-F[/&,YS
MQ4MWXPT&RUC^R;C4%74/-CA^SB-V;=(,KT'3WZ#N17EPOK$? -] :>+^W/FL
MS9;QYYN_/Z;>N=WS9].:['PS"O\ PMCQI+(JM.EOIZ;\<@&-LX^I _(4 =AJ
M.J66DP1SW\X@BDE2%78$C>YVJ..F20,GBHY=<TV'7(-%DNT74IXC-';G.YD&
M<GT['\JH>-](?7?!6K:?%GSWMV>#'42I\Z?^/**\TAUA-5B;XF-E(;34;*+=
MCE+81>7-^ >YD)_W* /0M:\362F".UU^"Q>+58K&<O;-*))"-WD#IAB"/FYQ
M5.;X@V4NN:_H=L&6\TZUWQR-&Y#RA9&9<;< +L').&SQTK@]6M9(_ '@V_N%
M*W6K>*K?4IL]<S-(Z_DI4?A7127=O;^//B';33Q1SW.EVI@C=P&EVPS;MH/7
M'?% &[X7\?Z1JNGZ);7>I1G5[VTB9U$3*CS&,,ZJV-FX'/R@Y'2NFU/4[/1M
M-GU"_F\FT@7=+(5+;1TS@ FO-Y(HXOAS\,Q&BJ!?:6W [E.3^.3^=>EWUE!J
M.GW-C=('M[B)HI%/=6&"/R- $-_K&GZ79Q7=Y=)'!+(D4;X+;V<X4 #).2:S
M+SQUX:L-2DL+G5$2:)Q'*WEN8XG/17D V*>1P2*X+PJ;O6M<T7PMJ 9SX0>6
M2\=AQ*Z'R[4_BA+_ / :9!J>F6'PI\6:1J5Q NK>=J$4UL[#S99I'<QD+U;<
M&3!']* /5HM3LY]3N--CG#7EM&DDL0!RJOG:<].=I_*LR;QIX=MM/MK^;5(D
MM;EI4AD96P[1;MXZ=1L;ZXXS7(^'[^W\/>-K^/7KV"SF?0M/.ZXD";R@D#D$
M]<$USV@K%=Z5\-C)&2C:U?R!77!!#SL,@]""!^5 'LMA?6^IV$%[:.7MYT#Q
ML4*D@^Q (_$5E67C+P_J.K?V9::DDEV6=478X60K]X(Y&UR,'.TGH:W:\MT'
M4;?2M2T&QTG6K'6]$N[ITMK.6("\L/DD;<#UPN&4[E##=C- '5:5XFL8=!U+
M5-1\0VUW:6MY)&]RMN85AP0!$1R68$@9'4FK-EXU\/:@TJ6VI*TD-N]S+&T3
MH\<:8W,RL 1C<O!&3D8KR72'2#P8;NX(6QM?'/G7;M]U(PX&YO8,5-=#K&HZ
M9J?Q#UJ;39H;C9X1N8Y9X6#(S"12%W#@D CZ9% ';V?CGPUJ&I6]A:ZHDEQ<
MC]Q^[<)(<9PKD;2V/X<Y'I5&3Q7;Z9%XFN[C6(KY-.DVBVCM&4VS;21&Q&=^
M3_%CBN>N(HXO OPR6-%4"_TTC Z$PMG\\FH- _Y"'Q7_ .NS?^B6H =X=\;7
MVJ>"TUC4?%5I9W$T\ 8?V4^R#>S?NAD_/NP/F[8]Z[G6O&&@^'KE;;4]06&9
MD\W8L;R%4SC<VT':ON<#BO*-6_Y-\\)_]?-G_P"AFNQM]5TO0_'WC0Z]=6]J
MMQ#:S0FY8*);=8BK!<_>PP<$#N?>@#I=5\9^']&, O=21?/B\^/RHWES%_ST
M.P'"?[1X]Z??^+M!TPPBZU&-6G@^T0JBM(98\@90*#N^\.!D]^E<%<:W;3WU
MS!IUW:>'+&#2+9H(VL8S=7<<@<K&H;^%<8" $[FJ+P$T%UKG@EU9)3#X5< @
M@['#Q*1[$9(H ZO6/B3H6F^'K76+6;[9#<W26T81'4@[PK[OE)4J"3M(!.,=
MZZNUNHKVTANH&+0S('0E2I((R.#R/QKQO5G2#0-?ED98X8O'$4CNQPJ+NA))
M/85[-!/#<P)/;RI+$XW))&P96'J".M &+'XS\/3:U_9$>I(;SS3 %\M]AD'5
M!)C86&#\N<\4S3]:@_M;Q$MQKMO/!IY1I(/(\K["NPD[W)P^0,Y[8KS&XUS[
M9IWA^]GUBQMHGU^&5M'M;>-!:*+G#-(WW@<GYF. 6?WJ/5HIK@?&%;=6=LVC
M$)U*!,O_ ..@T =VWCZSU/Q1X;L=$O5E@O9IEN5>!T9D$+NC+O ."R_>'!K6
M\=ZQ=Z!X,U#4[%D6Y@$>PNNX#,BJ>/H37,ZMK6BZM\1/ 0TN[MKID>Z<-;L&
M$<;6S8!Q]W.. ?[I]*U/BT ?A?K892R[(LJ.I_>IQ0!IVOCGPW>S7,5OJ:N]
MM UPX\IQNB7JZ97YU'JN:OSZ_I5OX?&NRWL:Z68EF%SR5*-C!]><C\ZX_4=0
MTO6_B!X+32+FVNUACNY9A P81P-#M 8#H"Q48/<>U<YI]K-)J]K\,I%=K;3=
M4:^<D$AM/3$L*D]\R.J?\ H ]C5PR!QPI&>1CBL/2O&?A_6]0^PZ?J*S7!5F
M0>6ZK*JG!*,0 X'^R36CJ]R;+1;^Z6#[08+>200X_P!9M4G;^.,5Y3IFJ++X
MF\ RS>(+&Z1Q(WV6SMXXH+/?;.$C!4DC)^4*3SM/'% 'I/BSQ);>$_#5[K%R
MC2"",E(QG]X^#M7(!VY(QD\"N=G^(-K'K^CN;H1Z/>:?/.^Z!]YE5XU 48W$
M_,W '/6K_P 3U+?#'Q$ "3]B<\5DV]Q9:E\1?"ES;307,:Z+<E)(V#@-NA!P
M1WP2/QH U]6\6Z;=>"[C6M+\0P6%NDJQF^EM6E$3;P"K1G# \XP<8R#6AJ_C
M#0=!NQ::EJ*P7)C601>6[,RLQ4$!0<\JW3T)Z5Y-XV 'P[^(P' _X2*,X^OV
M>N[6&-_CJ960%X_#2;"1]W-RV<4 7?$WCO1])M-7M8=10:K:6LC*OE,R)+L+
M(K-C:"3C"DY.?>MW0KN6_P##VFWDY!FN+6*60@8!9D!/'U->7G5=+T_P1\0]
M-U*X@34'OM0S;2,!+*9!F(JO4Y!7!'I[5Z3X5_Y%#1/^O"#_ -%K0!0F^(7A
M2WG\J76(U82F%V\MRL;ABA#MMPGS CYB,U9UCQCH&@78M=2U!89B@E91&[[$
M)P&<J"$7(/+8'%>9P:MHL'PP\=V,]Q;I>RWVI+]G9@))9'=EC*KU;)V@$=U/
MI5G5-1NE@U[3I]4L])FL]+M[>2%;5)+G47:#.,MR1EB@ !YW<T >AZMXQ\/Z
M'*L6HZE'#(T(G1 C.70MM!4*#NY[#GOTK(A^)V@'5M;L[F9K>'2V0-<-%(0V
M0-Q(V_* 2!SUZ]*YWPD;>]\>>%IU:.;R_!R%'!#8;S$4\^O+#\ZOZ1#I^H^-
M_B%H=_+%F_>W3R&<!W0VP!*CJ<>HZ4 =UJ&KV&E0P37MRL27$R01'!;?(YPJ
M@#.2:NUY)X0EO/$.NZ+H>I!F?P@LOVUB/EDN 3% ??\ =AGS[BO4;+4K/4OM
M/V.X2;[-.UO-M_@D7&Y3[C(H ;%JEE-JMQID<X-[;QI++#@@JC9VGT(.#T]*
MHP>+=!N=!N-<AU*)],MBPFN #M4KU[9KC?B1?2^%];MM?ME/F7VFW.DC'_/8
MCS(/_'@X_&L*YTA='UB'X=Q#-MJD^GW.T#AHHHR+C\_LR9_ZZ4 =[)XJM-/U
M'Q%/<ZREQ;:=!#*UBEHRR6H9<C<W._?P>GR]ZQQ\28+I/"6HI*EK8:B91?K(
MC'RV6W\P(I*@MABHRH^;H*RD4MX]^*RJ"2=,MP ._P#HS4W1KBRU&'X3K#-!
M<B&)TD",&\N1;,G!QT8'''44 =K/XMTK4O#&J:AI>M1VJV:E9;F:V<FV8#.7
MB8!NAZ=ZF?Q;HVF65B-1U6-IKBT6X1EA;-POR@LB $\EA\HR>?:N!\6@!/BO
MCO8V9/U\IO\ "M/1(T?QCX(9E!,?AAV0D?=/[@9'X$C\: .\T?6].U^P%]I=
MTMQ;EF0L%*E6'!4J0""/0BK]<;X# %_XQ X']OS''UBBKLJ "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH P_$FA2:X^C&.6-!8:E%>N'&=ZJK@J/?YJTH--L+6VDMK>RMH8),[XHXE5
M6SUR ,'-<WX_\2:GX;T_39-,L6N)+K4(+=F#(,!I%^7#'JPRH/0=3BL>'Q%K
M%OX_UN&'1[Z^G?3[*5;!;A%6W.)-^69M@.2HXSNQZ#( /0C!"T'D&)##MV>6
M5&W;TQCIBLK5?#]O<^%=4T;3H;:R%Y:RPKY<81%9T*[B%'O65'X]M[W2='NM
M+TVZO+S5A(8++<L;*(SB0NS'"A3QWR2,=:VM UR+7M/>X2"6VFAF>WN+>;&^
M&5#AE)!(/8@@X((- "Z1HMII=K;8MK;[9';I#)<)$ S[5 Y;&2.*O);P1(Z1
MPQHLC%G55 #$]2?4FO/H[74/$/C_ ,56DGB?5]/MM/>U6"&SEC10'A#-G<C=
M_P"=/T+Q-+HE[XLM-5UB35=+T2.&9+UU4RC>K%HF* !F! QQGYL&@#NFT^R>
MR^Q/9V[6F,>08E*8Z_=QBE-A9FQ^Q&T@-IC;Y'ECR\>FW&,5S4?CE;7[4-=T
M>\TEX;&34$65TD\V%,;\;2<.,KE3ZBH+OQGJL.A:I=/X6O[6XM[%KR 221ND
MB#KEU8JK*#N*GD@'&: .I72]/2:&9;&V$L";(G$*[HU]%..!["GP6%G:E3;V
MD$)12BF.,+A2<D#';//UKB+3XA75IX<\-SZIHMW)?ZP@2&.%HR9G\H.&&#A0
MY. #C'? JY%K4$OQ"TRSO+34+35)M(:X:$W0:")=Y!5E4[6<'^(=J +B^'=1
MOO%\.M:Q=VTEOI_F#3;6WB9=A?@R2,2=S[>., 9)KIZXZR\?"^GM)X]#OQHU
M[<?9K74LH5D?)"DH#N5&((#$>F<9K-T'X@WTEAXBU#6])G@MM/OY+:+RWC=B
MX9$6 !3EG+-UZ<]: -_1/"<%A+J<M_%:W;W.J37\#-$&,(<+@ D<'Y>HKH/(
MB^T?:/*3SMNSS-HW;<YQGKC/:N73QS%:1:E_;VFW&DSV%I]M>*1TE\R'D91D
M)!.1@CU(]:Q+OQ-JE_XN\&P7.E7^D+<W4T@22966>/[.YPVPG!!VG:WMC.#@
M [V?3;"ZN8[FXLK::>+_ %<LD2LR?0D9%/N+&TNWB>YM8)FB;=&9(PQ0^HST
M-<S\0KF\@T;3HK*^GLGNM5M;5YK<@.J22!6P2",X/I6>%U+PMXST&P'B&_U2
MTU4SQS07YC=X]D9<2*RJI R,$'CYJ .T&G60OC?"SMQ=D;3/Y2^9CTW8S1+I
MUE-=QW<MG;R7,7$<SQ*73Z-C(KF;#QY'>W-C(VD7D&D:C.;>RU%V0I*_.W*
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M9.,]:UKG5;SQ-XM\'W-MH.K6]M9W,SWDEW:/$(6:!U"\CD9R"PXSCGFO1Z*
M.0^(NDOK6BZ;9+:2W43:M:&>.-2<1"0;R<<@ 9R>U7],\$^'M%:XETO3(K:X
MFB,33@EW"GL&8D@>PKH** /(?"GAZRMET+2;[0?$4FJV$R><\ES<BSB:(Y$R
MDMY3*2H(5?7&!BNG\&:?>6>C>*8[BTFA>XUF_EB5XRID1F^5AGJ#V/>NWHH
M\<\,Z/JVB>#? .J7&DWS/H\UT+RS6!C.B3>8N\1]3C*G &<&K'B#2-5\7#Q1
MK5AIEW%&UG:064-U$89+HPS><YV-@@'[HR!FO6Z* //'U*Z\2?$#PI?6NB:K
M;V%FMWY\]Y:/#L=XL!<,,]L9Z$D $\UVNDZBVJ61N6LKJS/F/'Y5TFQ_E8KN
MQZ'&1[$5>HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YK3]>N=6\7:
MI;6QBCT?2 (+B5AS-<D!BH/0*BD9]2WM72UY/IT5S-\+_B!!;!C?F_U19%7[
MS,23@>Y4C'X4 =U8>*='\1&YL]$UBWDO%B+(0I.!T#@'&]0<<CCWIOA#7YM>
MTF7[;$D.IV-P]G?1)]U94ZE?]E@0P]C7*^'[<7OB#PS=2>+],OOL]K*]I9V>
MG^6S0M&%(+"1MJC*'D=5Q6GX1^;X@>/'C_X]_M=JHQT\P0#?^/3- ';T444
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ME-CY&/!& VW.>,=>*9XEU&^FTC7-/U*73=4:T6PN+C4M/BVF6U^T99)5!."
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MGY*QX+E"Q#L"V"P]<8]J;XX>.V\2>#+R]94TV'4I!,[G")(T+B(GT^;H?4T
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M-N%/(XS5CQ)#)8>*;_PQN+CQ4;%@P&,[6V7)Q[QH"?K0!Z;_ &_I7]GV5_\
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M-N[>P =22JG&:BU/QY!I]Y?I!H^HWUIIC!=0O+94*6YP&(P6#.5!!;:#@&@
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M<-$\0*;<KJNB VP(@(T5OW0(P=O[_P"7CCCM0VAZ^_VC?JFB-]I 6?.BL?-
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MS8(XR#SS0!T-Y8VFHVK6U]:P75N_WHIXPZ'Z@\5"FC:7';O;IIMFL+QB)XQ
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MMR)#_P!]&O6ZPM%\+P:1J-WJ<M]>:CJ-RJQO=7C*66,$D1J%50JY)/ Y/)H
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MXR.!S7(>&=(U73? /AF_FTN]+Z3K<MS<VOD-YWDL9$+JF,MC>#@#D9Q7ME%
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MM"JQX^E=C!INOZSXSTK5=7T^VT^VTB*<((KGSC<2RJ%)' VJ%!Z\\]*Y_1O
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MM_B((SVQ6-J/@/5]0\'>++.QTFSTEM6-N;;3(K@&.-HV!=R0 JEAC@?W1ZT
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M,C.WD,.5S[5VU<I?>-U75KK3-&T74=:N;,A;IK0(L4+8SL+NR@MCL,T /O\
MPE=:IX0GT>]UN::^EF%PNH&( Q2K('4HF>%4J !GIWK.U3X:6FHZ!X>TE;]X
M8]("QR.(LFYBPOF(>>-Y4$GG\:WO#OBBS\1QW0B@N;2[LY!'=6=W'LEA8C(R
M,D$$<@@D&MD.I+ ,"5ZC/2@!U<]K?AV[O=7M=8TC4UT[4H87MV>2W\^.6)B&
MVLNY3D, 001WZYK?61'3>CJR^H.13LCCGK0!S,?A.8WWAZ]N]7FN[G27N)'D
MEC&;AI4*GH<(!NX SP />I8?"RQ77B6;[63_ &X5)'E_ZG$(B]?FZ9[5OF1
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MY3<-X&2N><4 <M>>"()_A_;>%;>\:V^RQ0K!>+'EDDB96$F,]25SU[FA_ \
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MVT[S7C*3K*9X44MO &-I(!^4U'X2U^[\2:-%J=SI8T^*X19;93<B5GC89#'
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M9[Q#<-^\<XR<]1G X&!Q5Q?#EBNMVVL%[AKVWMS;1NTQ(\LD$@CH<D YZ\4
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MSO7Y([OPI\4[^R=7TR>:(0R1G*/(L4:RE3T/S<9'<5ZQH/\ R+VF?]>D7_H
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MDF0%C7=QR.K8!'(XH ZL6%F++[$+2 6FW;Y'ECR\>FWIBIU540(BA548  P
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M5656)0L < BJ<_Q+CBL[[4(M U*;3=-N9;:^NE,8$)1RI(4MN<=&X' /KD
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M-BH8'*D@J5(((K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KRG3?#%Y<^-=0T*]L9TT*S:^N;>=HR(I/M:H-BGH2N^<
M'TS7JU% 'DOAK3-;O/"WBB^U;3KJ/4!I*Z1;Q21,'D$,#;F48R0\CG&.N*CM
M[2_TCPW\-+VYTO4&33"PO(H;5Y)8=T+*,Q@;NI]*]>HH X/2K&\%IX^+6=PA
MN[R5[</$P,JFVC *@CGD$<=P170>#()K7P-X?M[B)X9XM-MTDCD4JR,(U!!!
MY!![5K1W=M-<36\5Q$\\&/-C5P6CR,C<.HR.F:FH \2>"^GMM+O;[3/$EUKE
MEJ\5SJDDBW#111K/R(HQ\CC&" BG"@GZ]/;:;?#P1\08#97(FN[S47MXS$P:
M8-& I48RV>V.M>A3W$-K \]Q-'#"@RTDC!54>Y/2I* /*O%HU#PSH?ACQ3I]
MLS:E:6BZ;+;D;6D$T8"*0?[LH0X]S7?>%]$3PYX8T_24;<;:$+(_]^0\NWXL
M2?QJ*]\+VVI>(+75KV[O)UM&$MO9-(/L\<@&!)M R6'.,DXSQ6Y0!PMG87BZ
MW\0Y&M)PEWY/V=C&<38M54[#_%SQQWXK.&EZA_PA7PVM_L-SYUI>6+7,?E-N
MA"PN&+C'R@$@'/2O2Z* /'++PY96PFT+5=*\37=ZVHR;8X+BX6SEB>8NLN0W
ME* K D'G(/&371P:=>K%\1P;.X!NY'-MF(_OA]E5?DX^;G(X[UWD%Q#=0)/;
MS1S0N,K)&P96^A'6I* /.Y--OCHGPUC%E<;[.>V-ROE-F "U=27&/EP2!SWK
M"CN=0M/ OB;PZ^@:L=1U*[OX[(+9N4E6:1@'+XVH!DGYB. ",@U[#4<UQ#;[
M/.FCC\QQ&F]@-S'HHSU)]* /)KKP_#H>OZD=6MO$=Q'<VUM]E?1Y+@)*\<(B
M:-A$0 V4!!; PW7BMW1-$DT[XB:4T&F7%KI]OX8%LN_+K"_G*?*,G0L![]LU
MZ!10!SGCW1[K7_ NL:99 -=3P'RE)QN92&"_CC'XU@76H3^,M=\,1VFDZG:+
MI]Y]NO9+RT>%82L;*(P6 #L6?^'(P,UZ%G%% '#> ;"\L]?\:275I/!'<:PT
MD+2QE1*FT?,I/4>XI?'7GVGB/PCK LKRYM+&[F^T?9+=IG0/"RJ=J@G&3Z5W
M%% '!:987BZ9X_#6=PC7=[</;JT3 RJ;:, J,<Y((X[BN9AT,:=-HM]K-IXA
M6UF\/V=MG2S<+)%/$#F.1(3NY#C&1@$$<5['10!B^$K&#3O"]C;V]C<6$>UI
M!;7,IDEC+L7.YB22<L2>>,XKD+.27P9-KFB:MH^I7FBW]U-<VMW86[S@)-R\
M3A/F4@DX/<'J*]'5T<D*RL0<'!SBG4 >1:;X><6_BZ^T?0=1TW2KG17M;:VN
MRYFGFQ(2PC8LP!RH ."<=*U]0TO4(_ '@FYBL+B6;19+&ZN+-(SYI18BC@)U
M++NSMZ_+BO1J* /,M4MKSQGK&L7^G6%[#:)X=N=.A>[MWMVGGFY 57 .T;1D
MD8R:A6_N]:3P+:V^B:M'_9M[";Y[BSDB$#+ Z8^8<C)/S#(''/(KU.B@#QFR
MU:<^!?%F@P:1J-S>ZA?ZE;VA@M6>.0R2.F6D VIM).=Q' S7J]GIHB\/V^ES
MMO"6JV[D=\)M-,T31+;0;2>VM7E=)KJ:Z8R$$AI'+L!@#C)XJX+NV-X;,7$1
MN0GF&'>-X7.-VWKC/>@#SSPUK][X+T.'PWK>A:Q/<:>#!;W-A9-/%=Q _(5*
M_=;& 0V,5)J3>()SX9\4ZEHSHVGW\[S6%JIEFBMI8VC5BHSN=<@L%]>!Q7?W
M-W;64)FN[B*"($#?*X5<GH,FIJ /(_$EI?\ B>'QAK=EIE^MO)HB:=:1RVSQ
MRW+AW=F6,C=@;@!D<\XKJM4L;J3QOX)N$M9F@MHKP32+&2L1:)0NX]!D@@9K
MLJ* /'/$UM>V5KXFN&L9CYOB>PEMU9=HG \D?*3P02",],UKZM<ZKXC\1R:K
MH&GZA ^E:+>)%+=VCP%[J0+LC4.!N(V9STZ<\UW6N:);:]9PVUT\J)%<Q7*F
M(@$M&X=0<@\9'-:5 'D>C6Z)XN\+:E:Z;XD>)$E@O;S45N7;SI(P!E'SM (.
M7 "\CGCB:+2-2'P+T?3CI]T+V.:U+VWDMYB@72L25QD8&2?;FO5JC^T0_:?L
MWG1^?L\SRMPW;<XW8ZXSQF@#RS4_#6J:MXO^(T,5I,B:CI,$-K.Z%8Y9!'C:
M&/!YX/I4^AV.FW%];W-OH'B:YO;.TF=TU6XN!%%(8]IB'G':Q;<1E<C'.:]0
MS10!YKX24VGB."/0+;Q!;:*+64WMCJ4,HBMI!M\M83(,[L[@0I*X_"N^TG4#
MJNE6U\;.ZLS.F_[/=Q[)8_9E[&KE% !45T"UI,H!)*, !WXJ6D)"@EB !U)H
M X_X;V5U8_"_1[2[MIK>YCMF5X94*.IW-P5/(KG8])U$?!OPO8_V?="\AN+!
MI;?R6\R,+.I8LN,C R3GI7J2LK*&4@@]"#2T >8Q:==0^.OB/=W6@W5_875M
M9JD/ED+=J(<.J$\,1SP._'6M#P.LL.O74.EG7/\ A'1:J5CU>.13#/N^Y$90
M'*[<Y'(!QS79_P!J:>+>>X^W6WD6[F.:3SEVQL.JL<X!Y'!]:M*RNH96#*PR
M"#D$4 <5KAFT/XAV?B.6SN[G3I=,>PE>T@:9H'$@D5BB MM/(R >0,URE_I^
MKSVT^OQ:+?,;SQ3:7L-D82)?(B55WLI^YG:3\V,9&<5ZW+=VT$\,$UQ%'-.2
M(HW<!I".NT'KCVJ:@#SF1I_$OB^^U>ST_4(K*TT*>S#W5J\#2S2,&VJK@,<!
M.N.IKFX]#U8?#7X;6ITN]^TV>N6TMS#]G;?"@>0EG&,J!D<GUKVJH;B[MK01
MFYN(H1(XC0R.%W,>BC/4GTH \^2YO?#6K>+[.31]0NFU*X-Y930VY>&3="JE
M7D^ZFTJ<[B..F:Y_1/.;0/",6HP:Y/HIT-3%%I7G#S+K<.)#$01\N,;B%Z\U
MZ#J_@JVU6_NKM-6U:Q^VQK'=PVEP%2< 8&0RDJ<<94BM^RL[?3K&WLK2(16U
MO&L448Z*JC 'Y"@#Q[3[>_TG1?!TMSHVJ+_8NL7:WL4=K+*Z!_-VLO!,B_.O
MSC(/KFM&Z\.:GK/BGXE1QVEQ#'JFF6T5I-+&R)*_DD8#$8X. ?2O5Z* /-9[
MRZ\5KX4TN#1]3M;BPOK>\OVNK1XH[<0J25#L '); &TGCFHFTK4?^%4>,K,6
M%U]JN+O46AA\EM\@:5BI5<9.1C&.M>GT4 4</'H6/LOVB1;;_CW.!YAV_<YX
M&>G->9:?;R*]S:>&[/Q#;Z7)I=R+S3M0AE$5O)L'EI#Y@SNR2,(2N/PKUNHY
M[B&U@>>XFCAA09>21@JJ/4D]* //KC3;X^"/A[;K97!FM+O36N(Q$VZ$+'AB
MXQ\H!ZYZ5S.KVM_?6-V]YIOB*\UZWU43S?\ 'Q]FBMDN0R^4@/ER#RPN  6S
MD]J]I1TEC62-E=& 964Y!!Z$&HVN[9+I+5[B);B12R1%P'8#J0.I% 'G5EI]
M\_C_ ,?7WV"[6VO=-MA;2/ RB4B$@A<CD@\$=0>*W/A=9W6G_#30[2]MIK:Y
MCA8/#,A1U.]CR#R*Z^B@#SBSU._\&WGB6Q.A:E?W5YJ,M]IYM[=FBN!*%PK2
M $1[6!!W8P.>:EM+^Y\(^*/$4VHZ3J,T>J/#=VSV%J]R&<1*CQ$J/E(*\;L
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MWC"N9B=C9 VMCG:>:F^$^GWNG>&]2BOK2>UD?5KF14GC*%E+## 'L?6N\HH
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MLH'GN9+8[(HQEG((. .YXZ5FZ;++JWC[1=7AL+^*S&BW$+/<VKQ;'\V+Y2&
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M1N8\\]![T <5I6I_V-\._B/J!LK2]\CQ%='[/=Q[XGR\8PR]^N:[>77];O\
M5;71/#T>FV\T>FQ7MS-=QN\:!\A(T16!_A8YSP,<&L%_ .MMX!\;:,!;_:]8
MU::[M?WGR^6[H1N..#A3Q6W+HNO:)KL&M:/96VH--ID5C=VLESY)5XR2KJVT
M@CYF!'T(H K7_B&_C\0^!;?5=!L(;_4)+E)O- E>U9$',+@\!NOK@@'FJWA;
M5?%9E\:7,TEC?-:7TL4-OEHQYJQQ[0&9R$CQR1USDYJY=^&/$>H:YX(U+4)[
M6XN-*DN9+]X_D4>8H"A!CD#IGC.,]ZH7OA'Q%);>,=*BM;1[35KS[?;W#7)&
M\YBS Z;<@,$8%L]^E $L7C+69SK.F)J6@7M[!I;7T%UI^YHXRK8='7>3GH0<
MCW%9B:[J>G?#7P3=:K;Z;JLM[?V,,;7,+.8T>/B0EF.9@0?F]^E:\7AO7KGQ
M#)?R:5IVG6EWI,VFFW@F!-MDAE<D* ^3D8'0 =>:HR^$?$NH^!O"NC7%E:V]
MSHFI6CN1=;UEAA4@N/E&"<_=_6@#?FUSQ)J^O:Q9>'5TN*WTEDA=[Z.1S<3%
M Y5=K+L #*,G/)Z5GV_CO5]<D\-1:+9V<3ZS8SSR-=[F%L\3(K?=(W#)88XR
M<<CFKKZ;XD\/Z_K=UH>GV>H6NKR)<*)KKR3;3! C;AM.Y3M4\<]1[U%X?\$W
MF@ZEX7Q+'-!IFG7,%Q+G!:65T<E1Z9#?I0!K^$-<U#5H]5M=6CMEO],OFM)'
MM0PCE 575@&)(R''&3TK.N-=\3W_ (PUG0=%CTN&/3X8)1<WD<CY,BL=A56'
M4KU[ =#GC4\-Z-=Z7JGB.XN0GEZAJ/VF#:V3L\J->?0Y4US,5QK=I\3_ !;-
MI&GV]^/LUBLD$MQY)!V2;6#8(QU!'N,=* &#X@ZW?V?A9=,T^R6_UB2ZMIXY
MRQ2&6$$$@@YV@JQQU(XX/-:O]M>*-0URXT/3&TB.YTRU@?4+JXAD>-YI 2$C
M0."%P,Y))Y'%4-(\#ZGIESX+DDD@E;3)KVXU!U8@;YT?[@/4!GQVX&:T[O3=
M=T7Q=J6M:+86VI0:K#"L\$MSY#12Q JK E2"I4C/?B@"EI/CV]O;[P\+NS@@
MMM2DN;&YP23!>0D_*&S@JP5L<9Z<U!XF\877V/QIY>GV%WIFB6\<>VZC+K/<
M$!G5AG!505!&,Y/6I7\#7\?P\73TF@?7XKS^U8Y@2(Q=>:9< GG;R4SZ'-))
MX+U)OA-J>ADPOK>IK+/<OOPC3R/N;GT'"Y] * "X\6:I]JT;2M-DT339+G2H
MKQ/MZN(YF;CR8@K+C&.>20&'%69]<G7XD>&]-N])L$N;O399I9F7?-;N!RB2
M?W<YSQS3-4T767T:QTJ;P[I.N6"V$4+17$WEM!.JX9LE3E2,8(P1@]<U#IW@
MO5[+Q7X2OYYX[F'2=(:SNIBYW/(5QD \D>YH KGQOXC;PO+XSBMM-.@)(SBS
M*/\ :7MU?89/,W;0V 6V[>G>M*37_$^J>)M<TG0DTJ*/35@=+B\21_,\R/<%
MPK#OGYNPQP<\9'_")^)H_!\O@2*VL_[+=VA753<G<MLTF[!BVY+A25ZX[YKJ
M]$T.YTWQ9XBU!P@M;[[*+?:V3B.+:<CMS0!S47Q!U'5;3PY]CDTG2YM5L7NC
M+J6YHVD5E4Q1X9<G))Y/3L:[[39+R;3;>34((X+QHP9HHWWJK=\'N*X'3_#F
MO:5X+T?0[K0-)URUAM3%<VL\P4I+N)#!F4@K@XZ @\\UUWA72+K1/"6GZ7=S
MA[BWAV,R,6"]<*I/)"@@ GL* .83QIJ]KXCT^UU*?0ME[?&T.FV\V^[M@=VQ
MV(<AONC("C&X<UAZ+JOB?2?#_BG5-+@TUK#3M7U":6&Y#F6X5969]C*0$P.!
MD-D@]*FL?!WB6STG0K1-'TJ-]%O8[B29;C]YJ!!(+9V?)D,6.[))_6S_ ,([
MXPM=!\1:%;V5A+#K-[>/'=-=%?LT<[G.Y-IW':<C!ZG';) -G_A)M:\0:W+8
M>&/[/@AM;."YGN+^)Y-S3*61%5&7'RC);)Z]*JZ5X^OKR]\/+=V=O!;ZA-<Z
M?=;228+R(G"ALX*MM;'&>G-2Q:#K7A379[W0;&WU.TO+*WMY89KGR'CD@4HK
M@[2"I4@$=<CO4+^!M03X>'3UF@?7TO#JL<RDB,7?F^;@$\[>2F?0YH =K'C^
MZL+_ ,0"WM[1[/36MK*&25BHDO)B,AFS@(@92W&>O-7O#'BFZO\ Q!<Z)?WN
MDW\R6JW<5SI;'RRN[:R,I9L,#M[\ANU9Z^!;V3X>-ITQM6UR6\&J3&3YHI+G
MS1(5;CE< )TZ5I:19ZS NI7B>&]%TJ86Q2T@A8.\DO)^>154!"=HP 3P3QTH
M ZZBH;1KAK*!KM$2Y,:F98SE5?'S 'TSFIJ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K6.GVFFP-!9P)!$TCRE4
M& 68EF/U))-6:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@"M'I]I#?SW\<"+=7"(DLH'S.JYV@_3<?SJS1
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %5H=/M(+ZYO8H$2ZN@BS2@<R! 0N?ID_G5FB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJZ%I"ZJ=572K(:B>MV+=?-/;[^,]*M16MO!/-/%;Q1S3D--(B -(0, L>^
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MG6-0C$;WS1JOEA00@1!P I8G'.2>2:6^\/:C-/9WEGXANK6^@MQ;RNT:R0W
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M)9A$L(CB7<5"*,X.YBV3GG%7;'0M6CDSJ/B*:]B6!H4B6W2(-D ;WQG<W';
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
1HHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>exhibit1012-stuartexecut015.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBN%TO4K_6-?\0ZY#%/=6^E3-IEA81S"-9'7'G2'<0I
M.3@$] I]: .ZHKQ'P5%KVO\ P\NM?\[5EUH>9=V]_+J!>&:2.1L1"'=A5(!4
M@J <_2O7/#VL1>(/#NG:O"NU+RW2;;G.TD9(_ Y'X4 :5%%% !1110 4444
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M0M)[6?[=</Y<R%&VE\@X/8UW=%% !1110 4444 %%%% !1110 4444 %%%%
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M*\6]I9&QECR, \=>*I^&_$NKZCJ7@R*[O7=Y&U.WNRORK<- 0JN0.,\9^I-
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M;742S1%EP2K#(R.U1W,'V7P_/;^;++Y=JR>9*VYVPI&6/<^]>6:)!J.B^!_
MVM0ZW?M)/<6-K):F0?9S!*0FWR\8R 0=W7.3] #TR[\+:!?ZHFIWFBV$]\F"
MMQ+;JS\=.2.W;TK7KQN\\1:S>R:SJ=B?$TNI6FHRPV-M:6KO9-'%)LV. ,,6
MVMDGD$\8Q716 U+6?B9XDCFUG4(-.TF2SFAM()-H=FB#%6X^YP<J,9+<]* .
MYGL+2YN[:[FMXWN+8L8)2OS1[AAL'MD=:LUXYH'B+6M031=;@_X2>XO;V\C:
MZA:U<V(MY'P0G&T!%((8')VG).:V&UO4Q\+/%^H?;I_MEK=:@D$V[YHPDC!
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MO\.[$ZY?6PU73KE[Z>&3$DFQ48$$YPW49[ G'-7]8GN])\17$>L:YK^F6R-
MFEZ@@,EGM"(")\#!=GWY+X&",$4 >HT5Y#J^O:M?ZCXDGM)?$HO=/NGM]-BT
MZU=[7,:J<28!#EF)SGH",8KTC4(;W6/"LT5O+-I]]<VF8W4E7@E*Y'Y'K0!K
M45YFOBG4/$?ASPG86D\MKJVIW7EW[1G:\*V_-Q],E0O_  ,5$IU;7O#OB/Q0
MNOZC:75I<78L(()0L$20%@H>/&'W%"6+9Z\8H ]1HKAO"VOWNL^+G>65Q;3Z
M!8WBV^?D1Y"Y8@?D/PK0^']_=:CX8:XO+B2>7[==Q[W.3M6=U4?0  ?A0!<N
M_%NF6GB6'P_BZN-1D59&CM[=Y!"C':&D8#"C/<UNUY+9:4MO\:_$,YU'4R+;
M3X;O N#^\^8MY;<<IV"TUKO6;7X<6OCYM>U"346\J\EM3+_HK1O(H,0CQ@ *
MV >N1G- 'HL?A;0(M8.KQZ+8+J)8L;I;=1)N/4YQG/OUJ]:V%I9/</;6\<3W
M,AEF9%P9'/&YCW. /RKB-+CU+6?B=XFBGUJ_BT_2;BT>"T@DVJ[- K$/QRF0
M?E&,ECGM6EX^OK[1+#3_ !!:W$JVVG7B-?PJ?EEMG^1\CN5R&'I@T ==17FO
MB;Q1J-MJOB74]/N&^P^']*VB,',<MW*-P)_O!$VG'^U4UQ;ZEX2O/#%Y_;VI
M7YU"^CL;Z*[FWQR&1&.]%Q\A#+P%P,<4 >B45Y=+KNJCX*ZWJ@OYQ?PSW:QW
M&_YU"W+*H!]@ *T-FIZS\4M4TYM:O[73;.TM+D06TFS=(2_!.#\IP=P'7 ]*
M /0:*Y#XGZC?:3\/]0O=-N&M[R.2W$<BG&,S("/H02#]:P?$+WF@W^BZ ^J^
M([V*]^T7EY/: R7+[!& B;!E(]SY('3&,\T >FT5Y9'J^H/X=CLM2U#Q!9_\
M39X+4"S8:A?VX3>JC@%<9.7QTCZC-06VJ:_=^&;^"!]>EM]/UWR)]N/[0%GY
M2O@=RP=UY'S%: /6J*\M&L27EAHNC:/XDU">'4]6DMY+J9-EW:Q)$9'A)89#
MY'WB,X;OP:C\0:AJGA;_ (2K1[;5[ZXB30?[3M)KB7?-;R!V1@'ZD' (SG'-
M 'JU%>>*FIZ)XK\)R/KE_=_VN9HKV&>0&$D0-("B8PF&7MVZYZUCVVNW$>MZ
M-?6>KZ]J"WNJ_9IKB:$QZ?-$Y<;8E/3;A<,.NT\G- 'IFE:Q::S%<R6;.5MK
MJ6TDW+C$D;;6Q[9'6H9/$.GQ>*(?#K-)_:$MJ;M5V?+Y8;:>?7/:O,;'3-1;
MPSXTUFUUW4+*>PU74I[2*WD"Q H[/^\7'SY(P<\8QCOFXFJFZ^+6AZO)'AI?
M"1N60>[[L4 >KU%<7,%G;O<7,T<$*#+R2N%51[D\"O)?#6NZU=OX>U6(^)KJ
M[OYXSJ"36C_8?)E!R8^-JA,J0P/(!SG-='\8X#+\-K]UN)XC'+ <1/M#@S(I
M#>H^;./4"@#O**\WU*RU*X^(6G^&(/$.JV^G_P!C/<3ND_[Z0K, #O(X;D#.
M,X!'>LOQ?KEQ8S:WJ6GZQKUU<Z=,@C%K"5L;?;LW12YXD)R=QZC<!QB@#URB
MN$B\0S>&_$_BRTU>ZDELX;4:Q9&1LD0[2LB#V#J,#_:%<S'JNM+'X?TO6KO7
MGDN["75+S^RD=YR[N/+CRHRB(&(..X% 'IFM^(=/\/\ ]G_;VD7[?>1V4&Q-
MV97SM!]!P>:U:\6U^\U.[\/>#1JD=Z)8/&$$,4E["8IIH0S^6[*0.=I )[D&
MO2_&NL7&@>"]7U2U -S;VS-%D9 <\ X[X)!H WJ*\TT"746\06]A#)XLEL+R
MTFCO9]4@DC\J4 %)(W(&PGYA@<=..*@T+6];UGQ-%X-N-3VRZ%*TFH7T,@#W
M\:X\I1CD$[AYGH1CO0!ZE17E<5OK.LZ?XRU$^)-3MI-,U&[2PC@F"HGEJ&&\
M8^<9.-IX 'O54^*;SQ)?0+<R^(H(4TBSN0NAP.Q\^=2S,Y4'@8 53P>: /7J
M*\NL+OQ#X@UOPYIVI7^H:8UQHDTU_%$/)D=TE10V",H3UR.<$@8S4*7GB ^'
M[ZS2[UB^M=,\0RVES+:,&O6M!'N&#U8AG7)'S$ XH ]7JAJVAZ5KMNMOJVG6
MM[$C;E6XB#A3ZC/0UYO>>(]FAZ/9:;KFLZA:WVIRQ2S0P,;^&..,NT!&-V_(
M&6(!"G\:>E[XEDT+5;:SB\1O96]];M'+/"8[Y[5AF5(RX!9E8'!ZX.,YQ0!Z
M;9V5KIUI':65M#;6T0PD4*!%4>P' J>N7\#WEK=Z==_9-9OM0BCN-OEZ@C+<
MVIVC,;[@&/.2"1T/4XKJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO'2LI?ATPLET4ZY<'PTL_G#3?(3=M#[Q%YO7R]W;&<<9KM;>1YK:*62%H7=
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M)_8-M-;1@H!YPD"C)YXQMI=:\'WVL27]N?$=U'I&H$?:;)H5D(& &6.0\HI
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M3R ."1TH X>;5M23X8:E?#4KP7=IKK013>>VX1_;5CVDYY&PD<YK:-G>ZO\
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M=)-]>-I[Z S^09VP'$R)N!!SNQ_%G/)YKI?[%TX7=A="TC$VGQ-#:L!_JD8
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MG'&D421QJ$1 %50,  =!6?>Z'9WU\+V1KF.X$1AWP7#QY0G."%(!Y[]1V(H
M30[B'4/#.GSVM])<PS6J%+LC#R#:/G.>C'KSWKRE9]=A^%EMXPB\1:I+J=E=
M.1#)-F*=!=-&8W3'S9'0]1P!@8KV"VM;?3-.BM;.W$=O;QA(H8AT4#  KB_
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M9CRQ)ZD\U:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ0RM;2+#,Z9W*DA78Q&#T/8U7\)>-[3Q7>ZK;06]S$;*Y>)#);2H'10G)+*
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M))H ZRBLO1?$.G:_'.;%Y@]NX2:&>!X9(R1D;D< C(Y!QS6I0 4444 %%%%
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M[O6@#RVRU?2[SX$:;X>M+B'^VIY(88;$,/.,AN0^\+UQCYMW3'>M'6;2ZO\
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M ?@*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW;7 &"#@$$=P>:ALO'ES/<:)+=>'YK32]9=8K2[:X5FWLA=0T8&0&"G!SZ9
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M);ZKI]S;VQLTN%=9&G($1$F  "3R2.,&M_1-4U#4/M,>IZ/+IMQ P&#*)8Y
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MER1$H )/]:W+_2-0DUGQ]*EI*T=]I,,-JP'$KB.8%5]3EE_.LVUT75M,\*^
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M!I-N-:-H=1P?.-IN\K.3C;NYZ8ZU>HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8SBJVC_\3GXJ:QK,/-GIMBNDI(.DDI?S9<?[OR*?>@#MZ*** "BBB@ HHHH
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MFGZDKM=-)M^9\A<*NW(')R>M #-*UWQ-H_@+P1';75G>7.KR16\;3P,HBC:
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M,$'F,Y ^\2 !CC;U.:U-.\"W4?PH7PG=W,"WBAV6:++HLGG&5#R 2 =N?QH
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M:FA$OEF3=OSOZOMVXV_G6UX5\"7FA^*[F]NKB"33+59H](@0DM LTADDW C
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M_C.%P,%<<G)R,XJWIOBK5]2T/P=I^FBQL]0UFT>YFF\@M%;QQJ"VR,$9)+*
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M]4])M7L=&L;.4J9(+>.)BO0E5 ./;BKE !1110 4444 %%%% !1110 4444
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MBJL>2W50W4 ^U=9X&GU'^T=7M9;?6TTI!%)9OK 8RAB&$B!F)+*"JD9)QN-
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MXR* /2J*\<_M_5(],LM"EO-8NH_[>O;*2>S8M>2V\&YE4-D')^7+ @X!KL_
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M95"[/*^Z,#'S8SD9S7IWB*\2P\-ZC=27_P!@6.W<_:_+\PPG'#!?XB#T'<T
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MXAN+O4EU2&XC"[K:95505!!!&%Y!ZAB*U=$TB[TS[3+?:Q=:G<W#*6>4!$0
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M;KB(>0,RY<?NQC/S>G'K0!S \$O-?^&[[4-8N+NZT-IC'(843S1(H7#!1Q@
M=*AO/ !G.IVMKKM[9Z1JDKS7EC%&AW,_^LV.1N0-W'N<8S707FLVT>@7VJV4
MT%XEM!)*/*D#*Q52<9&?2JWA;Q"OB'PSI6JS)';37\/FK 'S]0,\G% #[/PY
M:V'B&35K=V3=8Q6*P #8B1LQ7'?^+'X5)X>T.+P]ITEE#,\JO<S7!9P <R.7
M(X]"V*OM=VR&0-<1*8R%?+@;2>@/IG(Q]:C34K"7S_+O;9_L_P#KMLJGR_\
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M^#M/\."\F,%E<1W"R[1N8I+YH![=>*+OP7,^H7TEAK]_IUEJ$HFO+6W5,L^
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MO/)/%:[]LD@ 9MSLW./]ZMNF0S17$*RPR))$XRKHP(8>H(I] !1110 4444
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M3.* /,-,"V]YI-I#A;"T\:W,%FH^ZD?DR':OL&+ 5-XYD1[WXD*K E-!M%8
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M6L>YL1-']P@YR<>^:IW/@KP]=ZN=4GTY6NFD65_WCB-W7&UVC!V,PP.2">*
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MFAABA2WM'DMG"PC8H(8G*A&8GCITH ])TOQKH>LZA'96=Q,9)0S0/);21QW
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$*,L1W/K4E% #&AB>1)'B1I$^ZQ4$K]#VIP5020H!/4XZTM% "*JHH50 !T
M%-$,:R-(L:"1N&8*,GZFGT4 1QV\,4;1QPQHC9)55 !S[4XHA !4$+@@8Z4Z
MB@!-J[MVT;L8SCG%-\J/ 'EKA3D#'0^M/HH 0*H+$*,MUXZTQH(7"!HD(C.4
MRH^4^H]*DHH C:WA=65X8V5CN8%003ZFG!$5BP50QX) Y-.HH C2"&.1Y$B1
M7?[S*H!;ZGO3O+3:R[%VMG(QP:=10 @10VX*-V,9QSCTI:** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%0E<L,,H! 3:_/(P:[(>']45F8>+-2#-U(MK3)_\@U+::)J%M=K/)XDOYU#
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M!(STQVKV+8@##:N&Z\=:4*JJ%50%'0 <"@#S;QO9W.H>,;JSLU)N;CPG?Q1
M=2Q>, ?F:R]&2PUY]'BM_%^H:EJ-O:2O#8^1"HM&,)C*R[(PR8W8PQY(%>O4
MT(JEBJ@%N20.M 'B4OB'29_A=X7T.*56U2TN["*YM /WEL\<R*Y=>JC/&3UW
M"O7M?_Y%S5/^O27_ - -7PB!F8*H+=3CK3J /&(-8TW5OA]X'\/Z?,C:P+C3
MR;1?];"(RKO(R]0NT$[NA!&.M=%X;M)+JY^(\5N MS/J$D2-T.3 H7GZFO0]
MBA]X4;L8SCG%.H \>\*?V??Q>%;*7Q5J-W?V.R1='$$(-I+%$599-L8=%'S+
MECSD=<UG1^((KV#PKJ-]XBDEG358IKZP2.*.VTW)=</A R$,0HW-SR?I[@$4
M,6"@,W4@<F@1H,X1?F.3QU- 'EWAWQ'H_A[P_=>'M9B^TZPFJ3HVF",/-<F2
MX+HZHW#*596W=!CKQ5S3$7^QOB6VT9:_NP3CJ/LT?^)KT78I</M&X# ;'.*=
M@4 8?@O_ )$7P]_V#+;_ -%+7FL'B+1M/\(>/M+NYDCO[K4]32"V8?/=,[%%
M\L?Q\_+QG&.:]FII1&()525.02.E 'E'B![WP##X?\2I \LYTD:1>Q*-Q:81
M[H#C_KHI7/HU=]X1T/\ X1SPII^ELVZ:*+=._P#?E8[I&_%B:KZGX:NM9\06
MEU?ZF'TFRF6Y@T](-NZ91\K229.X Y8  <XSG%='0!YM\0+RY\&^(;;Q78P/
M+]NM)-+FC1<[IL%[9L?[X*Y]&JO-I<'@:]\!RW\H33M/ANK>[NW^Y'<3(I\Q
MCV#,'&3TW>]==J/AJZUCQ':7NH:F)-+LI5N+;3T@V_O@N \CY.[!R0 !SCKB
MNB90RE6 (/4'O0!XQXBF36+3QYKVF9N-+8Z:JW$0+),8)0\K*1]X*I R/0^E
M=)_PD&F:_P#%7P[)I5W'>01:?>@SPG=&6)B.T-T) P2.V17H84*H50 HX  I
M%144*BA0.@ QB@#C_B0CIH^E7YC=[73M7M;R["J6(A5OF; Z@9#'Z53MM3L?
M$OQ2T^^T2ZBO+2PTR=+JZMVWQ[I'39'N'!;Y6;':N^IJ(D:[44*/0#% ' ?!
M;_DF]O\ ]?5S_P"C6IWBW6OLOC.WL+S77T*Q_L\S)<011F:ZE\S!B1G1N@"G
M:HR2PKOP,=*0HK$%E!*G(R.E 'C/@R6*:\^'\)8M<6DNKQ3I)CS(I,Y*N!T;
M##CWK;ET%?$FI_$G2<[))Y;4POTV2BV1D;\& ->E@ = *H:S:ZE=Z>T.DZC%
MI]RQ'^D26_G87OA=PY]"<].AH X?X?7MQXPUN?Q5?0/$UG9QZ7&CKC$P >Y8
M#_?*KG_9-7_BE-';Z+HL\T;211ZY9.Z*I8E1)D@ =?I73>']#MO#FB6VEVK.
MZ0@EI)#EY78EF=CZEB3^-0^(M".O1::@N/(^QZC!?9V;M_E-NV]1C/KV]* .
M#UG4['Q%XJU2^T:ZBO+2R\,7<5S<P-O0.Y!2/<.,X5CCM2W4)@^$?@6^$3&T
MT]],O;L(I.(E4%VP.N"P8_0FO4E14!"J "<G QDTZ@#SU;S3?%WQ*M)M*GAO
M]/M=)N(;V>%M\1\UDVQ%AP3A6..U<_X7BN=1\0Z/X-NP[Q>$9YI[AG'$FT[;
M3_QQ]W_ :]@1$C7:BA1Z 8IV* /'K1--?6?BBNL?:%T\W=IYLEN#OBXXD&.F
MTX;/.,9J/5]9N+WP5XTT]-<A\0Z?;Z8KQ:G'&H968L#"[)\KD !LC!^;FO9<
M#TIJHB+M1%5?0# H \NT^]M= \0>%-7U>=+739_#*6<=U,=L<<P,;[68\*64
M<9Z[:RY]FH23ZO N[3-0\96+VK%?EF5 B-(OJI93SWQ7LS(KJ590RGJ",BC
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M=$<YV%U# 'UQFO)['0-0B3P[>-X3U ZOIU]'-JU],ZO+<-AE8QDN=ZY;=V
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MO@JXU2YGU&26&\\_9;/!)(7W.V[Y2H8@C:22HQG- '7KXPOKKQK?^'-/T,W
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M%W-\WFNNWRXUW-N!YRW X'7/%V?0]3;P9X#LULY#<:?=Z>]U'QF)8TPY/T-
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M0/4C8T'4VUK0K+5&M_(6[A6=(]^_",,KS@<X(H OQQI%&L<:*B( JJHP !T
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M]*<\B1J&D=4!(4%CC))P!]22!7EWQ$UJ3Q#\,M?NK/3[>;3(9&A2>27YV9)
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MQ%,FEQV=U8>6L5T92T4J28&^,[02RDX(( !YR>E '=/<0QS1PO-&LLN?+1F
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M&\<P^2'R$C/RD[R5;M@8SW%.M_%5Q>3Z;I\.EM!JUW9M>RVMW)L^S1JP4[B
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ME6!(SP>#GVK"^'MH=;T1-0U>QM99X=3N[B"Y\TO(LOG2*>JC  ^4<G( X&*
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MRP@6U9P;@3XC.^0L,EPN#EL8KJJ@O+&TU&U:UOK6"ZMWQNBGC#HV#D9!XZT
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MU=)X;\86?BJ2Y;3K.^^QPLR+>RQ!89BK8(0YR>?4"NAH XJYT'Q18>*KO6M
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MKJ6,#8,@+$28)S\V<8KW"N>M/!VFVMSXAE<RSIKS9NXI2-N-A0JN #@@]\T
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M5^G3(S3[K3I/"?C#P[:Z1?W[1ZJ+FVN([R[DN%=UA,B2X<G# KSC (/2M9/
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MM\3$$HRNK*1D9''!JE)X TYO#HTI+R]2<7HU#^T-ZF<W0;=YI)&TGMC&,<4
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MJ%I!IGA]K>#4(U5B&62-0&W*48E<_*1[C&,@ SHKYK?2]4\/7>HZS<1VVO\
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M:GJDB0^1"+ID"QID$\(JAF.!\S9/'UH Y#X'Z7;P>!H;]'N3-++/&RO<R-&
M)6QA"=H/'4#)KT:^N([33[FYFF$$4,32/*1D( "2V/;K7+#P8^B?#RY\.:!?
M7J3'>T%QYP217:3?]X 8&3SCG&1UKJ;ZSAU'3[FQN5W07,30R*#C*L""/R-
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MJ%!^;;M'T)K$TW2OLGB/P=I>HS:==V0N]4EBBM6\RWCD&"L8W#JFZ4 =L>U
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M)#=Z!XUU.ST_2;6V@N3!-=7)=[J:>,( R=DP=H4>V<#-=);'/[0ET?7PTO\
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MB>"73K8:)J*VT<-O@%658R'R/]XYR>3UK7TOPCH&BSPSZ?ID,$T(<)(,EP&
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M%Q>RV_GR33E0Q1%)  4$9)YR>* .KU32K'6M.ET_4K6.YM)L>9%(,AL$$?J
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MZ;R5V>,#%% 'B.EW<&F6?@:\O$86\&LZHTC!"?+7=,-QQT R"3V S4OB _\
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M[<;;FYU&>*-NG)@0+S]36))K%AK/P]\->%=/;.O1RV,,MD%(EM6A=#(SKU4
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M"IKW7M,\8>+O"2Z!=+>&SN)+NZDB!_T:/R67:_\ =+%@-IYXKT6D  S@ 9H
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M:DTN_L6^(,4L/B"\UB"YT2Y@AO+DIY<DP>-VCB*(H)"C) SC\#7K8 '0 4
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MB$ME7&"N HY.2<<T =I=^+-7E\2:KH>BZ%%>3Z?'#*TL]YY,96120/N,=W&
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M6-PISP<%L9QR*+SPR+SP5XIAT3P=)I,MW:K!;K+(HGN3R3E0Q"@$\9;GGIW
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MLHXR,L,CUS6U'J/B+0_&.D:;JNI6^HVVL13[0EL(?L\T:A\ @DE",CG)XZT
M=O17F.A^,K]_%.C64_B/3M6.HR2Q7%M9V^([9EC9P8Y?XP-FTYZYSQ55O$_B
MX>!KCQ>=3M5BLKJ1/L0M 1<1)<&,[GSE3C@8_N]\\ 'IBZK8/J[Z2MU&=0CA
M$[6X/S",G ;'IFKE<%>>+;K3OB-KEE,L;:=I^@G4-H0!RRMS\W7&!TK'\/\
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M6MA 9[RYAMX00#),X11GIR>*GJ"\LK34+<V][:PW,#$$QS1AU)'3@\4 4/\
MA*?#W_0>TO\ \#(_\:MVVIV-Y=3VUM=1330*CRHC9VAQE#]" 2*\]\/^&]"E
M^*?C*VDT73G@AAL3%$UJA5"R/G:,8&>^*?;6&KW'Q&\6VVB:C#I44<%CF06R
MRG(C<*JJ> O7/X8Q0!Z517D__"Q[F\TCPREWK%GH<VH6DMS=WKQ!P#&XC"QJ
MW&6;)YS@"NR\"^(I/$F@27$T\-S+;74MJUS NU)]A^60#ME2IQZYH Z:BN!\
M8^+_ .SO%%MH?]OVNA1_8S=R7<T(E9R7*(BAN!]UB3[#&*K6WC?5&\*:7XJ=
MX)M-MYY;?5UACX**Y07$?? (#%>?E;VH [W4=1L])L)K_4+B.WM81F260X51
MG'/XD52UG0].\4Z=%!>O<26;8<I!</$LRD='VD;E(/0\5QFK>*=>3X9:[XM_
M=0QRA9=+MI(0VR#<H5WSU9P=V.P(I^M^*-2AU2PLWUZUT"&;3HI[>XN;4/%=
M3MG<A<D*@4!>!@G=0!Z)##';P1PPQK'%&H1$08"J!@ #L*?7FR_VRWQCA-QJ
MT4<<>@K<RQ10ADV^: Z*3S@LN0W7'%9>C?$N:\N=&OG\0V%P=3O$@DT6.$![
M:.1MJ$/U++E=V>#DXQB@#UVBO*[CQ%XND\+^(/$4.J6L,6CWMU'':FT#"XCB
MD(P[9RORC V^F<G/&Y-JFO\ B/Q'J6G:'J4.EPZ9;0.S/;"9II95+A3D\(%
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MX$\03PZLSZG8/=7.H6VK6\IC<*EQ%LRC+_SS^0 '.<=:[6?6K==.O;RSBFU
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MI&03/L(V 84*JC' "]S6U<Z';77B*PUMY)1<6,,L,:*1L(DVYR,9S\@QSZT
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M^YR.:ZC4-8TS21$=2U&TLQ*VV,W$RQ[SZ#<1FO(M7T[Q/H'A30KBW\*P6O\
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M K?Z&M]K$=F2>##\VP#VP#CV%=CX4FCG^(/CEHG5U6XM$)4Y&1  1^!!'X4
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M  _^&T5Q%%]@N-3 N@5&V1P)?+#^OS@=>X%=M8PPVWQDOX[&-(X7T2)[M8@
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MM\8^9R.B\_H>.*M6/C?2-0UJWTR);M6NU=K.XDMV6&Z"C+>6YX;CG/0CD9H
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M45PMK->K;,;:*8D (TG0') /8$@$BEN/'&DVVJR6+QWI2*X6UEO$M7-O%,V
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M;VL"WB+=[OL=Q-;,D-UM&3Y;'KP">V0,C-;6I:E::1IMQJ%],(;6W0O)(1G
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MP<UM7]];:7I]Q?WLRPVMO&TLLC=%4#)- &:_A'P^^MC6&TFU.H!Q)YQ3G>.
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M3&5 01EIG8$8[$$'\: ,^77/$/\ PMT:)%;6S:8NF"X(:Y(.TRA3)C8?F!!
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M'!.:I)X:N/LGAM]/\-1Z1%#KXO9K6.12R1")T$CX.-Q^7(4G'%=!I>EWMO\
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M\&D:YI%O8S7=J]W;&WNC-PA4,CY1<,-Z],@\UH>+K34;[PCJUKI#E-0EMG2
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M+K)$RA]\3%06.TD[2!R,5SU]X;U=;;4O/TFXO+"7Q1)>W%E#(H:ZM3$%! +
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M/*%9'\TKD+AL_=SQCO57QKKTUM\/=4N?%/AB*46UQ#&UK'>$PW +IM=) H;
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M9 @5L,PR/E.>:R].\(:B/B%?I=V@_P"$=C>ZO+:3<,/+<I&KKMSD8_?=OXZ
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M#N+01O#&"P1HF/S2$ (V>5()Z4 =?K?AG2_$#V\M['*)[8MY-Q;W#PRQ[N&
M="#@XY'2F6XT#P=9V.F1M%8Q7-QY-NC,S--,YSRQR68G/)->8Z9J^O\ A[X9
M^(-<AU3[3=+K$B)') @&XW81SG'\08\=!VKIO$&J>(O#3>%;>YU:*]GU+7(H
M+B06B(HB8<HHYQ@@X;K0!Z'1GG%<$+[Q5XCO=>N-#U6WLHM+O&LK:TEME=;F
M1%4L9'/S*"6VC;C &>:KZ3%JTOQEU9I]4*QQ:;;,]N(E*E6:0B,-C. Q)W=3
MWH [C2M7L-;L5O=,NH[FV9F421]"0<$?G5VO)]!\;:]JG@;0V2>!=7U?59+%
M;DP#;#&I<LX08!(5, 'N>:T-4\0Z_P"&G\1:7<ZFM_-!H<FJV-X]NB.C(2K*
MRJ-K<[2.!U(.: /2**\_@U3Q+IVL>%I]0U6*ZM=;<Q36:VRHL#&%I%*./F."
MN#GKZ"HO"/B/5=7UN..[\06JWHDE%]H,]J(9+=1NVF(_>?&%R3D$$GCB@#T6
MF-%&TJ2M&ID0$*Q'*YZX/;.!7,^+-6U&#4M#T/29TM;O5IY%-T\8D\F*-"[E
M5/!8\ 9XYKF=:\5>(/#5CXJT^>_2\O=.L8;ZRO&@5&9'<H5=1\N05/( X- '
MI]%<1'>^(M(\:Z'9:EJL5];:Q'<;X%MEC%M)&@<;&')7J/FR>]7_ !/K5]H.
MN>'[CS%_L>[NC97BE!E'D'[I\]0-PP>WS"@#:TS2;/1XKB*RC*)/<27,@+%L
MR2-N8\^I/2KU>=:_XTU6QO/$]U8>4]EI4=O8P1NORR7LKKDENN$#H",]S5Y+
MW7_#OBK1-.U36%U6UU<31%FM4A:"5$W@KLZJ0&&#DCCF@#MZKWU];:98SWM[
M,L-M A>61NBJ.I-<%%XMUAOA'I'B SI_:-S+;++)Y:X(>X5&XZ#Y2:Z?QMJ5
MSH_@C6=2LV5;FVM'EC9E# ,!QD'@T ;-M<PWEI#=6\@D@F19(W7HRD9!'X&I
M:\[CUSQ%J=_X4TZSU"*T_M/1#>74_P!G5V5P(CN0'C/S$8/'.<'%;G@G5-2O
MH-8L]5N5NKG3-2DLQ<K&(S*@5'5BHX!P^#CCB@#I)[B*UMY9YW"11(7=CT50
M,D_D*2UN8;VTANK:0203QK)&Z]&5AD$?4&O+&AU-O%_Q(:75G>W@T^,& P(
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MY>2<'C!!](K$?Q/:)XUC\+F&;[7)8F^$N!Y>P/LQUSG/M0 GBC07\1Z ;(7
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MRY:9([L,8I T;(0=O((#9!]JT=!UB#Q!H-CJ]M')'#>0K*B28W 'L<$C-:-
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M:T(;^UGOKFRBF5[FV"&:,=4#@E<_7!JS0 4444 %%%% !1110 4444 %%%%
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M$KV2QK:23M-LE+A?.4R,2&PWT. >U5=(CO="U62[BTK7-'T1=.G;4)M1NTN
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MC62%_$F'1AD,-UQP1W'M7=Z5I&G2?%OQ0SV4#?\ $OM!@Q@CYO,#<>X51^%
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M%R>^!Q6;=^$?#U]I=MIMUH]I+96IW00M&-L9_P!GTZUM44 07ME;:C936=Y
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MH2I.* +M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.8D@MGT)QU['FLS1/!?B.WU&:^DTOPWI\,EBVG_V?"9'C,;/N9F( R6Z?04
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MS65N?^)5:G:8QC+-("<=,D*!]*XSPS'J4UMX"ALO[/.RUU'[.NH*S1^8LP'
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MH'*^X)KTJ2%_^$2,-U*ES(+';)(.5D8)RWT)YIFI>$] UC4([_4=(M+FZC
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M)G:"?;<?SK/N/"N@W>DQ:5/I5J]C$YDBA*<1L222O<')/(]30!Y5XQTIM/\
MA!K23W&FW+_VR)$%B#Y=L6FCWQKGE<-N)'O73>)H8H?C)X CBC2-!'J'RJH
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MY$ 4L",DCL#Q0!WE%</<>/+K2K#58]5TN/\ MBP>WCCMK6X+QW)G.V(J[*"
M6# Y'&T]:EA\8ZG9>)(-%U_2K:T9[*:]>ZMKDRQ!(]O RBG/)R,<8&,YX .S
MHXS[UP4'CK5UL=,UR_T.WM] U*:*..1;LM<0K*0(Y)$V!<$E<@,2-W>H%\36
M>EZ]\1;JVT6-+O2+>">>83'-[^Y9E!&/EP!CC/6@#T2BN+M/&&K_ -L:)'J6
MC06VGZUN6UD2Z+RQL(S(!*NT 9 /0G'>LN^^)&K6_AJ]\4P>'X9]"CD>.!_M
MA$SX?RQ(R;,!"PQU)'7&* /2**** "BO.OB9%J]WK7A6RT749;*\EGN'C97(
M5WCA,BJX[J2H!SV)J/7O%+:YX!TS4K5I;.Z_M:TM[N!7*O!*)U62)L<]<_4$
M>M 'I-'&<5QFJ>,-4ANM8?2M'@O-/T7B]DDN3')(P02,L2A2"55@?F(R3BJY
MURSNOB;##8:3!-J$WAW[7;7\D[)N0R?+$0 <*3@[N2/2@#LI;&WFO[>]D4F:
MW5UB.XX&_&3CIGC&?<^M6:\5_M_7M6^'6BZKJEO'.Y\0P-!Y,Q:2;%TXV$%0
M%Q@*O)R.3BNV7QM>Z7J&J6?B73K>T:STUM41[.X,RO"I*LOS*IW@X]CF@#M*
M*Y'3O%.KC5+*SUS2+:R_M*"2:S,%T92K(H8QR JN&VG.1D<&E\#>*M5\8:;#
MJTVD0V.F3PYB8W!>1W!PWR[1A<Y .<G'3!H ZVBN)\?:UKVE7WAN'1H[8K>:
MDL,GFSM'O.UB$.$;"G&2>O XYXRK2]U^'X@^,4T?2[2ZN=ME)+]HNC'&N(/N
MJ0I+,3G' '')H ]+XHKSFZ\6Z;K$W@#49-%6:359F-N\DQ#6;[1N(P,-Z<XZ
M5KZ=XJUC5=4F:ST:VETF'4)+"5UO/])C*,4,C1E<!<CINW8YQVH Z^BBO(O%
M-]K>M:[K>MZ)=W"VOA+RUC@CD(2\F5A)<*P'7"#;CUH ]=I'7>C+DC(QD'!%
M<SJ_C&*U\-Z9JFF6XOI=6EAAL(C)L#O*,C<V#M  )/!Z5G+XVU2TU75-+U31
MH(;O3])?4B\-R7BF ) "DH#@X(.1D$'@]: .QLK.#3K"WLK5-EO;QK%$F<[5
M48 R?85/7!VGCK5Y_#UIJ\FA0Q_VH]O#I4!NOFFDD!),AVX1  6!&20.@/%3
MR>.;O3K;4[?5=+B&LV;V\<5M:W!>.Z,[;8BKLH(!8,#D<;2>: .UHKA[SQOJ
M6BV6MKK&E6J:CIUA_:$26UTSQ7$62#AB@*D$8/'<&HY?&OB&#5M,L9/#MMG6
M8G?3@+TY4H Q$_R?)\IS\N[ICF@#K=9TV35M*FLXK^ZL)7P4N;5]KQL""#Z$
M<8(/!&167HWABXLM;EUK5=7DU/46MQ:QN8%A2*+=N("KW)P22>PZ5DP^/;N/
M2]02\TF,:W::DFF+:0W&8YI9 I0ARH(4ALG(R #27_CN_P!#TS73J^E6ZZEI
M5O%="*VN2\5Q%(Q4,K%00058$$=AZT =U17'1^*==AU^STS4-%M+?^TX)I-/
M*WA8AXU#;)OD^4D'JNX#GK3/AEK.N:[X;DO=82WP]S.(9(YB['$T@*D%0%"X
M &"<@<XH [2BN9\0^);[2_$&DZ+IVF1WEUJ44[QM+/Y21F/9RQ"D[<,>@)X
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M&Q*+AAN7D @@^U '8T5P5CX]U6Y\,6^NS:#%''J'V>+3;<769)YI#@ACMPB
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M:_9W3/7GYB!QFN UQ-:T?X/:IX;_ +,#6UH[QC5%N(VAEB,^5"J&+^8<A=I
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M*>;6U.\%;:<2&95W=.!\I(]372?#VRN(O#7]J7\?EZAK,SZC<K_<,GW$_P"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ J*WM;>TC\NV@BACR3MC0*,^N!4M% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]<0O87@MGM$M8Q'=(MP(69R1N5CR?E( P.*Z"76]8NOB1K^@1:@UO:0:.EQ
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ML S A@!P,=:U[W4/$^I:GXS2SUXV%OHI5K58[6)RY-NLFUBRGY<Y]_FZX&*
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MU@I(.#P?QKE8M:\1:M=^#K&VU46G]JZ(UW>3K C/O"Q'<@(P#EB,8Q\QXX%
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MH5,:*-I$D:-2Z9VL1RN>N#VH XRU\"2Z9#X:N=,O(K?5-)MH[.XE$9\N\@
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MD6./!+"1_,SO(8CCL,]<UZ)65::Y#>>(]3T58I%EL(H97D.-K"7=@#Z;#^=
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MQ;VK31MM:-))41B#V.TD9]ZCD^&FAR:;=:=YU^+.XNX[UHO/!VRI_$"03EL
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MW /)QD XR* ,RWN)C\?;F ROY/\ PCJOY>X[=WGCG'3-,^"?_).8O^ORY_\
M1AKIK'PG96/B)==^T7<^H"P73VDFD!WQAMV2 !\V1U_2LX>"(=+\)PZ'HEQ<
MQ(E]'<^8\^&QYP=P2!R,;N._2@"'XL2SP_#N^DM9W@G$]L$D0X*DSQBL+Q'I
M,>EZUH7ARPTO4-3T^>.ZO;FU6^VO<RKY:AG>1QD#<25SU(..*[_7]"M/$>CR
M:9?&46\CQNQB;#91PXYP>ZBHM=\.VVNFUE>XNK2[M'9[>[M) DL>X88 D$$$
M=001P* /+-7T*Z?2_#=MKNGW5O&OBI(+.&>\\R1;212VPLCG.&! ).0%%=OX
M9/D^-O&=LKOY%N;)8D9R0B_9QTS5RZ\!Z9=:%!I;W6H*T%X+]+T7&;C[0"3Y
MFX@C/)&,8QVI+CP+8W&I/??VEJL4D\$<%XL5P%6\5!@&7C.<$@E2O6@#SK2;
M>37++X7Z?=7=U]FO+*]^U!)F5IE55;:6!SR1CUP3ZUTMGX9T_5_'OB32[W[3
M)IEC:6"06@N9%1<HXW'#9) 7@D]R>M=-8>"M*TUM!:!KC_B1QRQ6FYP?ED #
M;N.>!QTK2M-%M;/6]1U:(R?:=02%)@S97$88+@=OO'- &)\-+JXO/AWI$MU/
M)/,$>,R2-EF"2,HR>YPHKSO1H)M/^"Q\30W%[-K5VOV(3_:6W1PO="/:F3M4
MXYW=<G.:]?T+1;7P]HT&EV1D-O!NV&1LM\S%CDX'<FJ5GX/TFT\'_P#"+^7)
M-IA1XRLKY8AF+'D8Y!.01TP* .!E77/"UGKNI:9X?OM&TZ/1IF*7-['<#[2N
M#'(H$C$'!;/K@9K;7P[:>&-$3Q!I=_=)?1:;-+*LEPT@OW\K<&<,3E@PW9'J
M1TKH-.\'V=F]T]W>ZAJKW%N;5CJ$PDQ">J   8/<D9/K5;2O .F:9>6]P]WJ
M-^MI$T-G#>S^9';(PVD(,#^'Y<MDXXH Y#PEI^LI>>&]2L]!U. RJ&U2_N=1
MCE2\C>,DNR>83G>58<<#(K#M+F\G^'VK 7]Q%*WC(0K.LAW1J9HQP>P&>G2O
M3])\$6&CWMK-%?ZG/!9!A9VEQ<[H;8$%?E& 3A20-Q. >*P/$O@:WL_";:7I
M=O=74=[KL%[<IDLP#3(9""H!"@#/MZT 5=2T.RT/Q@NDV/VA=.U71[IKNV:Y
MD8%XBA63)8D-\Q!.>:V?A-I]M9?#;1I+>,J]S;)+*2[-N;&,\GCIT'%:NF>#
M[+3]3GU&>]O]1NY8/LHEOI@YCA)R47 & 3C).2<=:G\,^&K?PKIG]G6=Y>SV
MJG]TEU*'\E?[JX X^N: /--)BDL/ GBKQ8L]S-JUG-J,5G(\SE;= [?=7.WJ
M2<D9Z=A5NQM-:T"9-3TWP]J.GVT6G7!OI;O4(YUN&$1:.0J)&)?>O4#HQ[5Z
M%IWAC3=-T>\TI$>:SO)9I)DF.[=YI)<<8XY-4])\%V6EW*3/?ZE?B&!K>WBO
M;CS$AC;&54 #.0 ,MDX'6@#SZ;0[:Q\&^"M9ANKK^T+_ %'39+R9KEV^U&1U
M9@P)P>3D<< 8Z$UOV-S-_P (K\2':9\Q7]^$8L?D MT(QZ8J#7?A^FF6FAKI
M<^K7L-GK%F\%I+-YD=I$)06*@#. N1EB<#/2NAOOA]I=_>:E*U[J4-MJ9W7E
ME#<;8)GVA=Q&,YP!GG!QR#0!PZ-=:YJ.GV-SHNH:U:VF@64B0V]ZL 224-NE
M;<ZEF^0 'G&#TS5NXT;Q"^EZ)<^)-%U#6+>VLI(+FSM[T">*02?+-A7 E8QA
M1PV0<^M=G=>"+&86+6M_J6GW%G:+9+<6<P1Y(5Z*^5(..N< @DXQ23^![$I:
M"PU#5-,>VMA:B2SN<-)&#D!]P;)R2<]>3S0!QEIINC:M\1O"=W!+=7T#Z(\T
M=Q<3.)7,;QA6?&/F'<8Y/7-4-"CU_5[*P\06>@:D^L2WXGDU-M0C$3Q><0\1
MC,F0@CRH7;U ->A/X$TI9]&FLY[VQDTF(P0-;38+QD@E'W [@2,GOUYI(O F
MG0Z@L\=[J2VBW7VQ=.%QBV$V[=NVXSC=\VW.W/:@#B+C2H->\)^.]?OY[C^T
MH+C4(8)1.Z^1%"I58PH.-I Y&.=QS7I/A?\ Y%'1?^O"#_T6M8]_\.]*O[C4
MF:\U.&TU)C)=V,%QM@ED(P7(QG)P"<'!QR#5^WT"2RU[2Y[:>46-EIKV9B:4
MD,=T>P[<8) 5LGW% &+XT2TU+Q!IVEOIVHZO<+;R7!T^"Y6" +N51+(Q(R0<
MA1D]6..]<IHLD_B&U\$:)JLMP]C,^IM/$UPQ,WV>0I$CN#E@H/KSM%>C:SX5
MM=8U.#4?MNH65U'"UNTEE-Y9EB)!*-P>,C.1@CUK-'PXTB*Q@MK2ZU&S^R74
MEU92V\P5[0R9WI&2I^0Y.5(/6@#@]1C?0[KQOIVGW=Q%%/J&E6?FB5C)#%*%
M# .3GA6('/ (]*Z-] L- ^*?AZ'31)% ^G7I^SF5G5&'EY8;B2">,^NVMV/X
M=Z(MAJ]I*UY<+JWEM=R33EI&=/NN&QD-GGTR!@ <5+I_@BQL=9M]8FU#4[_4
M((9(%GO)PY,;8^4@*!QC(P!U.<T >;:/;S:?\%K77X)KZ?6=16&R>X%TP=87
MN538FYMJ';P&X.3G-;</A_Q'_P 3BST31KW0;*ZTPJJ7&HI(#<JXP5*NS(60
MN"WL#UKMK;P?I-MX.7PMLEETQ8C&!(_SXW;@=PQ@@\@CI@56C\#6)MKV.]U'
M5=0DNHEA,]U<YDC56W+L*A0I#8;.,D@9)H Y&WL#<Z5KFC:+IVJ:+K+0P2RZ
M5=7A\J6,2?,T4H+8WJ&C+ CMD#K5&]OHK#0;S2])T[6],O+C4+*WN])EN0"B
M2.03!(6( D"E=P;&1V/7N1X"T]XKK[9J.JWMU.L:B\GN1YT(C;>GEE0 N&YZ
M<GKFGKX$TQ[*_@OKK4+^:^$8EN[F?]\OEDM'L*@!=K$L,#J><T <'JO]O>&O
M#OB:XL=)OM!TR6SA2))KU)C%.THC=X]KL5RC@_5<ULW?AK3O#OQ&\$1Z;YT4
M<C7@>)YFD#D6Y^?YB<-SR1UR,]!730^"=.-CJ5MJ%U?ZI_:,(@N);Z;<_EC.
M%7: %P6)X&<\U%8> [&RU;3]4FU+5;^\T_>MO)>7 ?8K(4*X"@8P>O4D#).*
M ,/Q[HUAJ?C[P2MW"SB:>XBDQ*ZY5868#@C'/<<U5M=&MO%47B_5-5FN3>6F
MH7-I9R)<NGV-(5 0H 0 <_,3WSS7:^(?"]IXC:QEFNKRTN;&4RV]Q9R!)$)4
MJ1D@C!!]*H:AX"TZ_NKV5=0U2TBO\?;K>UN D=R=NTEA@D$J "5*Y[T 9_GO
MXC^"7VO4P9)KC1?/E.2I9Q'NW<8[@&N5L= LGT_X6V4?G0PWD#SW'ES.&<FR
M!8;LY4-C! QP3C%>LMIMHVDG2Q JV1@^S^4O $>W;M'IQQ6'I/@:PTD:0%OM
M1NO[(=S9_:9E;RU:/R]G"CY0O04 <#JDEQX=_P"$NT/1S=K9F_TR&&&*X(>(
M7&!*L;N?EW8P#D %L\5U/@W3M3T[Q+=B/0;S1]$EM%/D7%ZDX^T*WWE"NQ&5
M//8[1WK=O/!^DW\FM/<K,_\ :ZPBX'F8VF(81D(Y4C@Y]0*ET7PW#HUU/=MJ
M&H:A=S(L9GOI@[*BY(4   #))Z9/<T 8&A[/^%P>+/M./M/V.R^R[NOD8;?M
M]M_7WQ6QXJU&STG3-2OHOLO]MV^F7$UJ&"F4JBY..Y7=MSVIVO\ A'3O$%U;
M7LDMW9ZC; K#?6,QBF13U7/(*GT((INC^#-,TF>ZNI)+O4KVZB\F:[U"7SI&
MC_N=  OL ,T <1-I,'AWP]X3\0V%Q='5;B\LENKA[EW-XLY D#@D@YW9''&!
MBLZ^TJ.]\*>/]9GN;MKW3=3O6L76Y=1;% K J <9SU]L"N^L/A_IEA<V+&]U
M.YM=/?S+*RN;C?#;L 0I48R=H) W$X[5<;PAIC:-K>EEI_L^LS337)WC<&E
M#;3C@<<=: .4ATV/1?&W@RYM9[DW&JPW*ZA)).[?:2(1(&8$X!##(P!C.!Q7
M+P::L'P:/B];R[;7+1Y)K>Z-R_[O9<%1&%SC:0"",<Y->NS>'[*?4-'O7,OF
MZ2'%OAA@[TV'=QSQ]*X?P=\/H[CPCI\>KRZK @G>>XTMI=L,CB9F4NA&<<*<
M @'J10!E^.)([O\ X2C5;"PU6ZNM-C &H&]6&+3Y4C#[8EW MC(+<').,]JV
MH]*@\3?$75K?57GFLUTJRE-JLSI&SL9?F(4CD<_GZ@8W-0^'^DZE<ZDT]SJ
MM-2)>ZL4GVP22% OF8QG=@*>N,@''%:.D>&K31[^2^CN+J>YEM8;5Y+APQ9(
M]VTG '/S')H \WTR[O-,\*>%/%$EW/+#IM_<:??&20G=:O.\*LWKL(C/YUV'
MA=I=9\8>(M>:1S:12#2[)=QV[8N96 Z<R$C/^Q5?Q#I::+X(G\+:1H]]JC:B
MEQ'$, QQO*Q8M*_ 509"1W^6NE\,Z)%X;\-:?I$3;Q:PA&?^^_5F_%B3^- &
MK1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M9*>)]"DUHZ,FL63:F"0;43KYF1R1C/7';K6M7BT]_/=Z;X;U!'TBQTZ[\20R
M6]C# QN,_:2'=Y2^,GG=\O\ %C- 'HVA^-]$\0ZUJ6E6%[!)<64FW"RJ3*-J
MEF4#G:"VTGU%6K[4Y;;Q)I]G]OTR*WFBE>2WG8BYDVC.8^<;1_%D'BN?\"F,
M>*/&Z94/_:X..^/)2JGB+_DN'@S_ *\[W_T"@#;T7X@^'-;M]2GAU2TCBT^5
MTE=YUQL4X$G7A">A[UMZ5K.F:Y:&ZTJ_M[V ,5,D$@<!O0XZ'VKS+1K.SU#P
MIK]I-J4.GS_\)5.UO-(H=1,MP&C5E/4$@#''6NN\(WUS-K&N66IV6GQ:M;-"
MUS=:?GR[D,IV$@\A@%(()/;GF@!TOC[1CKVJ:%;WENVHV5MYBJTH_>2 .6C
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M#T;/I7CNCVD%['X!@DB633FUS46M4894PCS6CX].!CVQ7LFI(JZ-=HJ@*('
M4#C[IH QM%\=:#K/A9?$ U"VMK0 >?YTZCR&/\#G. W(X]ZU]*UK3-<M3<Z5
M?VU["&VL\$@<*?0XZ'VKRG1&@;P[\*3<M&=.$K"7<1L$_D/Y6??=G'O77:5Y
M9^+^OFRV^0-,M1>;.GVC?)MS_M;,?AB@#H=4\2Z'HES#;ZIJ]E933<QQSSJA
M89QG!/3/>KT=]:S7DUI%<1/<PJKRQ*X+(K9VDCL#@X^E<+XGMY[;6M:U72KK
M2;MA81IJNE:B"-T*AV4JX^[D,PP05--\*:C9GQSK=W\EG;SZ-IMS%'*0NR+;
M+G\%R ?2@#L)_$>BVNDC5I]5LX]/+%!<M,HC+ D$ YY.01CV-8^L^,K:U@\/
MWNFW=C<:=J.H"WFN3)N18_+D9F# X!!3OTYK@O!\L+_\*[EN2OV)Y-5,1DX7
MSS*VSK_%MWX_&MCQ##X<O=2T2#2HHI(CXK4WRJK&-K@0.6Z\'HN<<9Z\YH [
M_2-?TC7X9)M(U*UOHXVVNUO*'VGT..E&KZ_I&@0QRZMJ5K9)(=J&>4+O/MGK
M7.Z6BQ?%SQ $4*)-+LW? QN8/*,GWQQ3#Y8^-+&[VY_L-?L6_IGSF\W;[XV9
MQVH T==\=:#H.D66IS7]M+;7LR1V[QS+MD#.%9P<X*J#DGL!5)?'^FP>(M2@
MU#4M.M](AM+6>UNFDQYIF\P\-G##" C ]:X.Y\H>';R2'8-.'CF,VS#&P)YD
M>XKVV[]_3CK7;:5:VTWQ=\1SM%&[QZ99HC$ X5C+N ^NT?E0!TUWXAT:QTJ/
M5;K5+.*PEQY=RTRA'STVG/.?:E.OZ.-/MK\ZI9BSNF"03^<NR1B"<*V<$_*?
MR->0>'DU$)X'CT^:P@V'54MS?1-)$)!/@ !67YMF['/3=5K5M(5=)TFUN[[3
M]0CN_&L3S)91E88RRD21;2Q_B#$C/\1H ]<T[4;+5K&.^T^ZBNK67.R:)MRM
M@D'!^H(JG8>)]"U74)M/T_6+*ZO(<F2&&=69<'!X!['K5J_FATS1KNX$&8;>
M!Y#%&,9"J20/K7EFG2W:Z]\/#)-HT,,RS26EC80,I@C:V<@&0N=PZ?PC)&>U
M '6^*_'^FZ/I6HC2]2TVYU>S9 ;1I0Q&9%5LJ"#D!C].];FH^)M%TJ]CL+W5
M;*WO9ES%!+,JLV>!P3W/ ]:\CN'TW_AG:S6<Q?;#<QY#8\S[3]I^?WW8WY]L
M]JZW2WTY=?\ B+_:YA#>;'YWFX_X]OLZ[>O\/WOQS0!M>'O&EG=>#M(UC7;V
MQL)[ZU,Y5I/+4[>6*ACG !'<]:TKKQ;X=L5LVN];L(!>HLEOYLZKYJ-T89/0
MYZ]*\M\/VD%['\(8;F)98A;7C['&02L0(R/8@'Z@5KW5MJ4WC+QM!%=Z';6S
M06ZRC4K=W/V;R,?*0Z@(&\SMUS0!W^I^)M"T6YAMM3U>QLYIQF..>=4+#.,X
M)Z9[T7WB;0M,U"&PO]8L;:[FP8X99U5FSP.">YZ>M>>G3[C2=-FO=,U;1]8,
M.BVT.JV=\I N(4C8JZ/DE=RD\$$&C4Y4M[+6?$6E?V5>Z7-902ZMHM^NV2-%
M@4JJ..A,97"L",]#S0!ZL[JB,[L%51DL3@ 5DZ5XIT#7+F2VTO6+&\GC&6C@
MG5V Z9P#T]ZQ/B4\LWPLUF2V61=]JK,H&&$192__ (YNS5/Q ;%O%7@(:3Y!
ME%Q(8O(QC[)Y#;L8_@^Y[9Q0!U=MXCT6\OTL+;5;.:[<.RPQS!F(0E6.!Z$$
M?4&EU?Q#HV@)$^KZG:6*RDB/[1*$WXZXSUQ7)_"FRMHM#U.Z6%!/+J]YODQ\
MQQ*P SZ<=/K4NOWD[^.'MK(Z3936FD^?<:AJ,+2GR7D8;%4.@QE"6)/<"@#I
M]0\0Z-I5A#?W^J6EO:38\J:290LF1D;3WXYXK'T3QA!J$_B*:YNK&/2],N$6
M&[5\(T;0H^YF)P>6/(QQBN#\"R1MJ?@$WC+Y(TF^6UWC $PE4$ 'H=@(QU J
MG=M8&77S!Y7]D?\ "967VLC'E[,)OW=MOF=>U 'HMEXVM-5\86^GZ9>6-WI;
MZ;-=/<1/N*R)(B[<@X PY)!&>E:]OXHT"[,PM]9L9?(@%S*4G4B.(C(=CG@8
MYS7(7S6+?&63[.8S<CPS/YY3'_/5-N<=\9_#'M7-6UBEM\ =!>UCMHEEGLWN
MY9DW(4-PNXR8()3.,C/08H ]5L?$VA:GI\]_9:O93VEOGSIDG4K%@9^8YXXY
MYIMIXJ\/WVFW&I6NM6$ME;?Z^=9UV1?[QSQ^-<)J>B/>W^L-X@\2:+;2W&GV
M\#BRMV0(?/!@DD#NP8;LKSC(.*6\$FH7&IZ)X@FTBPUA?L,\.K6B9BF(F8PI
M+&W?>A^4D@AN#0!WMIXET.^TJ75+75[*6PASYMPLZE(\==QSQ^-/T[7](U>P
MDO\ 3]3M;FTBSYDT4H*I@9.X]N.>:\L\0WNHS)<6-]:Z-!J5MK&G-?7L*LUK
M/&V[RC*I(8895R">XYQ3O%FGZG%I?BR\NM6TB:[EMK)+RWLH'14C$^?,E!=B
M<QEP>1\JT >G:9XDT36H)YM,U:SNXK?_ %S0S*PC'7+<\#@\^U+I'B/1=>\[
M^R-5L[XPD"06\ROMSTSBN#OM(:ZU#4)?$7B'1((I="FMI5TZ!HF%N[+B5MSM
M\JG..WS&M?PW<7UKXM72=8ATJZO/[,,EMJ=@A0O KJNQT.=N2P(P<'!QTH [
MBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MQ&\'^&F:\9M!TXF].;DFV3]Z<[OFXYY /UYK;KEH_'FFRZI':_8M16VENS91
MZ@T %L\X)78&SN^\"H.W!/>@#9CT'28=7?5XM-M4U%T\MKI8@)"N ,%NO0 ?
M@*FETZRGU""_EM('O+=66&=D!>,-U"MU&:PXO&]C-JHLTL-2-N;IK(:@+?-N
M9@2I7=G=]X%<[<9[UK:UK-KH.F/?7:RN@98TCA3?)([,%55'<DD"@"N_A3P]
M+/>S2:)I[R7PVW3-;J3,,Y^;CGD _49JUI6C:9H=J;72K"VLH"VXI!&$!;U.
M.I]ZP_\ A/M,BTC5;^\M+^R;2BGVNUN(E$J!\;6P&*D'/4'L:(?'EC+?M9R:
M9JUO(UM)=6OGVX47:( 6\OYLYP0<,%/- &Q=>']'O=3CU.ZTNTFOHT,:7#PJ
M752"",]<8)_,U-_9.G&TM;3[#;_9K1D:WB\L;8BGW"H[$=L=*RYO&.DP^#$\
M5;Y7TYX4E0(N9&W$ *%S][) QGK5_6=9MM"T&ZUB]246]K$99%107 ';&<9_
M&@".?PSH5SK":O/I%C)J*$%;EX%,@(Z'.,Y'8]JNQV-I#-<S1VT2271!G=4
M,I V@L>_  Y[5@Z?XXT^_P!8M=.-EJ-J;U6>RN+F#9%=!1N.PY)^[SA@,BF6
M7CS3;[4K:V6RU&*VNYWM[6_E@"V\\B[LJISGG:V"0 <<4 =':VEO8VD5K:01
MP6\2A(XHU"J@'0 #H*Y+P=X"T[1-%T@ZEI>G2ZU91[3=I$&8')P0Q / /7M4
MB_$.PGN[^VLM*U>\>PEFBN7@MP4C>/.06+ <X.._3.,BJOA/XA)K&F^'_P"U
M+"YM+S5U812&(+ [JN\[3N)P1G&>N#0!V,-C:6]U<W4-M%'<7)4SRH@#2E1A
M2Q[X' S5=-!TB.W>W33+189+C[4\8A4*TV0?,(Q][(!SUXIBZ[:/XF?0$65K
MR.T%W(P4;$0MM )S]XD' QT%4M8\766CZQ#I#6E]=W\]NUQ#!:Q!S(H8*0,D
M 'G/.!@=>U &R;*U:^2^-O$;M(S$LQ4;PA()4'K@D X]JHV7AG0M-U*74;'1
M[&VO9<[YXH%5VSUY []_6N<_X6EHQTXZ@-/U<V<,GE7LWV48L7#;2LOS<$'J
M%W8!![BM/6O&UEHM[<6QL-2O3:PK<7<EG '2VC.<%R6'92<+DX'2@"+Q#X1B
MO-+L[+2+2SMHTU:WOYT"!%<+(&<X Y8@=^M:VG>&M#TB.YCT[2+&U2Y&)UA@
M51(.F&P.1R>.G-1Z?XET_4M:N=*MVD^T0VT5TK,N%FBDSM=#GD9&#TYJ72-=
MM-;EU%+-92MA=-:22,H"M(H&X+SR!G&?6@"&T\)>';!(%M-#T^$03>?%LMU&
MR3&-PXX..]7[#3K+2[<V]A:06L)<N8X4"+N/).!W->;2>(]5U7XPOI)&O6VG
M6,,3+;VJ1JKN9,&24DDF(CTYQV%=)IWQ(T74K.YOT@OXM.M89)9[V:#;#&4;
M:8\@G+]P #P?7B@#9U+POH.LW<=WJ>C6-Y<1@!99X%=@!R!DCD>U7+C3;&ZG
MM9[BT@EEM6+V[O&"8B1C*GL<>E8FE^-+34=4MM.GTW5--GNXVDM/M\ 07 49
M;:0QP0.<-@X[5F#XIZ']C@OVL]433))O(>_:V'DPR;BNUSNSU'4 CD<YXH Z
M_P#LZR_M/^TOLD/V[RO(^T[!YGEYSLW=<9YQ4<6CZ9!%>11:?:I%>R-)=((E
MQ.S?>+C'S$]\]:S-'\76NKZS-I+6&HV%[' +E8[V$1F6(MMWK@GC. 0<$9Z5
M1\7>,+GPYK6A6%OI=U=B_N&60Q1AB4".2J?,/GR%//&,T ;6F>'-$T:VGM]-
MTFRM(9_]<D,*J).WS8'(Y/6C3/#>B:+'.FE:3960G_UOD0*N_P!CCJ.>E8D7
MB+3[7Q/XHWWFJ22:;9Q7-S:R;3#$GEEOW0Z[B!SD]:B7XFZ07LM^GZND%^F;
M*X:U^2Z;&0B8))8]L@ ]B1S0!TNB:5%H>AV6EPMNCM85B#;0N<#K@=/I5>3P
MMH$NL#5Y-&L&U$,&%R;=3)N'1LXZ^_6L^U\=Z5+IVK7=W!>Z>^DE1=VUW$!*
MFX I@*6#;LC&#R:MZ+XHM]8O9K%[&_T^^BC68VU]$$=HR2 Z[6((R,'G(/4"
M@#4CL;2*]FO8[:);J=52694 =U7.T$]2!DX^M-U#3K+5K&2RU&TANK63&^&9
M RM@Y&0?>N:\1>,;G1?&6AZ+#I5U<QWZRO(\488D*O 3YAR"06SV(Q3K[X@Z
M;8SWP%AJES9Z?(8KV^MK</!;L/O G<&.W/.T'% &I=^$?#E_:6MK=Z'I\\%H
MNRWCDMU(B7T7C@>U:T,,5O"D,$:111J%1$4*J@=  .@J*:\2/3GO84DND$7F
MHL #-(,9&WD D]N:\Y3QZFL?#./7=6&KZ2C7"+Y^GJJL^9"%";B<KP V<=\4
M =%IN@:I=^,#XCU];*.2VMVM;"WM7:01JQR[L[*N6. , 8 SZULZMX<T37C$
M=6TJSOC%_JS<0JY7U )'3VK-U/QK9Z=K-QH\>GZG?ZA! EPT%G ')C;<-P)8
M#C;SDCJ,9JC;?$S1;N/3[F"UU)M/O98X$O\ [/B".5S@(Q)SG)VD@$ \9H Z
M*_T#2-4TZ/3K_3+2XLH\>7!)"I1,# VC'&!QQ4MAI.G:6'&GV%M:AU56$$03
M(484''H.!6'J?CO3=+OKN![34)[>Q95OKV" -!:D@'#G(/ ()V@X!YQ6]J&H
MVNF:9<ZC=RA+6VB::23KA%&2>.O% %>Z\/Z->ZK#JEUI=G-?PC$=Q)"K.H[8
M)&>,GZ5 ?"7ATPV<)T/3_+LG,EJGV=<0L3DE>.,GGBLY?'EDECJ%U>Z7JU@+
M*T-XT=U;A6DB'5DPQ!/3@D'D<4[3_'>G7^JV5D;+4K9-0#&QNKF )#<X7=A#
MDG[O(W 9'2@#1\1#77TXPZ EC]IERC2WDC!801]X*%.XCT./K3O#>@6OAKPW
M8Z+:_-#:Q"/<1C>>K,1[DD_C67;^/-,N=0A@6UU!;2>Y-I!J+0@6TLP)&U6S
MGD@@$C!(X-,O/B%I-E>W$;VNHO96MP+:YU*. &V@DR 59LYX) ) (!ZF@#6T
MWPOH.C7DEWINC6-I<2 AI8(%1B#R1D#@>U1R^$/#<]]<7LNA:<]S<@K-*ULI
M:0'KDXYSW]:RHM?M8/%?B:&"36;Z[L8K=I;%0C1(&7CR1P<D<MD_2N1^&_C:
MXDT:PU7Q%/K<TVL77V9)Y4C^QI(7<(L>,%?NX)(ZT >JI8VD=])?);1+=R((
MWF"#>RC)"D]2!D\>])J&G66JV3V>H6D-W:R8+PSH'1L'(R#QU -5;G7;2V\1
M6.AE97O+N*2=0B@K&B8RSG/ )( Z\UF^*-3M-/U3P[#<WVHVSW5^(H4LRNR9
ML?=ES_!].: -.Z\/Z/?:G!J=WI=G/?6X BN)(59TP<C!(['D>E4YO!/A:XMX
M+>;P]ICPP%C$AM4PF3DX&.A/.*SK[XB:=9RZG''INK7ATN5H[TVMN&$("AMY
M)89&">F3P>*Z%]5MAH3:Q%OGM1;?:E\I<M(FW<-H..2.E #+SP_H]_/9SW>E
MV<\MD0UJ\D*DPD8QMXXZ#IZ"K-U8VE\(1=VT4XAE6:+S$#;)%^ZPST([&L*^
M\=:+I^EZ)J,SS&WUEXDMBB D!P"&?GA1D9/.,TNN^-]*\/7%]#>)<NUC9+>S
MF) P5&D\M1R1\Q.3CT!H U[G1]-O;EKBZL+::=H&MFDDB!9HF^\A/=3Z=*>^
MFV,B6J/:0,MHP>W!0$0L 5!7T(!(X[&N1U?Q=876GZ5=RMKVF03:S#:VSQ1+
M&;LL"5)#9)A;N>#Q3[#QI/J'B_Q%HDNF7L-MIR(%N%C *DHS%F.[^( %./K0
M!O7/A;0+S55U2YT:PFOU((N'MU+Y'0YQU'8]JNW.F6-[=6MS=6<$T]HQ>WDD
MC#-$3U*D]#P.E<AI'C?1['P?H-Y]HU>_AU*1X;66YC$EQ*X+G#!<#)VE1@>G
MUK1M_'NE/8ZQ<WL%[IK:0JO>07D061%8$H0%+!@V"!@]: -Y-,L4U.34DLX%
MOI(Q$]R(QYC(#D*6ZD<#BF'1]-.GSV!L+8V<Y9I8/*&R0L<L2O0Y))-8EAXZ
ML;S6;'2)M.U2POKY7>&&\MPA**I8MD,1CC&.H/4#-=10!%-;07%L]M/#'+!(
MA1XG4%64C!!!X(Q6;9^%?#^GBV^R:+80?97:2 QP*#&S##,#C@D  GV'I3_$
MMY/IWA76+VU?9<6]E--$V =K*A(.#P>17.?#KQ3?ZSIYT[7F3^VX(8[@NJA1
M<P2#='*H''?:0.A'O0!NVOA#PW97#7%KH.G0S-*LQ>.V0'>IR&!QP0>:==>%
M/#U[J,FHW6B:?->2(8WGDMU9V4C:021SQQ].*YSP[XW,?@2PU76GFN[Z[O)K
M:&&VA!DG<32*JJHP.%7J<#C)-3:E\0H;?PWKMY!IE_%J>E0>9)8W4(#IN4E'
M;#8,?!R58]#WH ZN+3+&"[6ZBLX$N$@%NLJQ@,(@<A ?[N><=*J77AG0KW58
M]4NM(L9K^+!2YD@5G&.G)';MZ5S;^*(+QO",]\VL:;<ZA,5CMXU14F;8"?,!
M).SG(P<U=U#X@Z5IUY=QO::C-:64HAO-0A@W6]LYQD,V<\9&=H.,\T :UQX7
MT&[U=-6N=&L9=00@K<O I<$=#G'4=CVH;POH+ZR-8?1K%M2!#"Z,"^9D=#G'
M7WZUFZIX[TW2[V[@-IJ%S#8A3?7=M 'AM0PW?.<@G"D,=H; .32ZCXYT_3[Z
MXMQ9:C=Q6JHUW=6D DBMPX##<<Y/RD-\H. : -;3M(ATV^U.[C(WZA<"=P%"
M@$(J8]_NYS[TS5O#FB:\8CJVE6=\T7^K-Q"KE?4 D=/:K&J:G:Z/I5SJ5XY2
MVMXS([*-QP/0#J?:N*\5^,YI? _B)[2UU31]3L[,3QB[B$;[2<!U()!Y!'7(
M[B@#MCI=@S6;&RM\V7_'J?+'[GC;\G]WCCCM5OK7,Z=XULK_ %FVTMK'4K5[
MN-Y+.>Y@"1W2J 6*')/0YPP!Q3-/\>:;J.HVMLEEJ,5O>2O#:7TT 6"X=020
MISGD*Q&0,XXH T(O"7AV#3[G3XM#T]+.Z;?/ MNNR1O4C&,_RJYI>CZ;HEK]
METNPM[. MN*01A 3ZG'4^]>9?\)%K']@?$^;^T9_,TVZF2S;=S  F0%]*]$\
M+7$UYX1T6YN)&DGFL())';JS&-22?J: %U/PQH6M745SJFCV-Y/$,))/ KL!
MG.,D=,]J74?#>AZO=6]UJ.D65W/;\1230*[(,YP"1TSVKAO#'Q%CM/#2S:Q#
MJMS'%>SPW6I"$-#!^_<(';(. I3D @ C-=/J_C>PTB^NK4V6HW@LHUEO9K2
M.EJK#(+G(/W?FPH)QSB@#4N/#VC7>E?V7<:59RV&XN+9H5,88DL2!C .23GU
M)IUOH6D6MK:6MOIEI%!9R>;;QI"H6)\$;E&.#R>>O)JVEQ#):K<I*A@9!()
M?E*XSG/IBO.==^((U"PT>32K?5;."\U:TB@O)80D5U&9@&"G)."N?O 9&<4
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M])$)3!#NV*$0\%F;/7@ '@U-IVG^+]+UNW6YUN+6M)E5A.;BW2": @94J8P
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M.S-\8+FW"R2P X+H Q! R,@D$9Z53UGQY:ZEX9U<^%I[F74[>U,JYL)E*KN
M9@'0!B <@<YQTKG])33KWQ];*E[J^I:9?Z/<V7VR_P![++(6C9D7*C'R@D\
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MRL)V)V[@,@;L?@:D\9:E)!XHT^SO]1U+3M&DM))!)IZ-OGN R@1EE4L/E)(
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M#?Q:=:P/+/>S0;84*-@QYR<OW  /'OQ5O2_&EIJ.J6^G3Z=J>FW%U&TEJ+^
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MTFY0VW<-V,XSSBO/K?QYK;>$[?7I]&M4&I&VATNV6X;?+-*<?O#MPJ9Y&,G
MYP:BM;C5F^+,$>M6EK'<1Z!.0UK(SQ2*9H^FX @@@@CZ'// !Z*CK(H9&#*>
MA!R*=7EWASQH;7X>^%+G1O#UM"-6O9+.*QBF*QQ'=*<[L'C<F3QP">#TK5D\
M>7VC0>(X]?TZW%WH\$-P@LI69+A925106 *G<,'CO0!WE-=UC7<[!1ZDXKC(
M/%'B&S\3Z'HFMZ191-JOG,L]I<,ZQB.,N5(*CY@<>Q!XZ4_XG:E:Z5X0^TWF
MEP:E%]K@3R)R0N2X ;CN.M &W>Z'+>7;SKK>JVP;'[J"1 BX&. 4)]^M5_\
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MH85B$Y>&4$C;*AQN&,]" <@]L&MF^\1:U=^)+[1?#MC8ROIT4<EW/?3,B[I
M2L:A5))P,DG@9% $6E^ FTZ6ZNG\3:U-?WA4W-P'C7S-HVKQL. !Q6E_PC,W
M_0R:W_W^C_\ C=8"?$&\OX/#HTS2$>\U=[F%X9Y]HMY8>&#, <J"&Y R0!@<
MTV3Q]J5E:ZE::AI]C'J]GJ%O8Y%RPM3YRADD9RN54 G(QU ]: .A_P"$9F_Z
M&36_^_T?_P ;H_X1F;_H9-;_ ._T?_QNK6AW6KW,$RZS8V]M/%)M22VF\R*=
M" 0RY 8=2"".H[BL*;Q3K=QXBU.QTC3+&ZATN:.*XADNS'<R[E5BT:XVA0'X
MW$9(/2@#2'AR5B0/$NM$C@@31\?^.5%=^#A?6S6]SX@UJ2%\;D,T>#@@C^#U
M%<I9ZAK]EXE\=2:+I]G<+!>)/*UW.R!L6T?R(%4Y;@\G &1USQT$GBC6-1TK
M2+[0].LD@O[-;N2XU&Y,<46X*1%\H)+')YP!@4 :#>')%(#>)M:!8X&9XN3_
M -\4#PY(691XFUHLO4">+(_\<KA?$FMKXC_X5IJZPF#[3K"%HBV[8PRK#/<9
M!Y[UK>$O^2R_$'_<T_\ ]$F@#I/^$<E#!3XEUK<>0/.CR?\ QRE_X1F;_H9-
M;_[_ $?_ ,;KGO%=QJ$'Q.\-#2[6&XNY+"\1!/(4C3F(EF(!. !T Y) XZU(
M/'U[#87EK=Z;;KK]OJ4>FBW6<^1(\BATDWD9";,L>,_*: -W_A&9O^ADUO\
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MP(W==NW:Q X!R-PH ]*HKC-'\4Z[K=VUQ9Z7I\FEB[EM&"W9^TP%&9=\B%<
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MMK!*7!+-&6R,9R.".U3?$/1[[7O!MSI^G0B:Z>>W=4+A<A9D9N20.@)KJ**
M.)\;>&SJ6LZ1K!T&#78;1)H)["7R]Q5]I#IYF%W*4[D<,:R)M$O-+3P]J]AX
M=TW3;JTU&9QH]O-%$9HY8S&<-PAEVA3@''&,\5Z;6?K&B:;K]D+/5+5;B$.)
M%!)4HXZ,K @J1Z@@T >7W-GKOB'6?'<*VBQ7LUIIP%DMP,^6'=FA:0<;G0-G
M!P-^,XYJ_;^&M336[V[L?"5OI-C?:+/8)! \"M')]Y6E"G!W?=&TMC R1GCO
M]&T#2_#]O+#IEJ(%E?S)6+L[R-TRS,2S'ZFK-EJ-EJ*2O8W<%RD4AB=H9 X5
MP 2I([C(X]Z .(NO#&L?\*T\,V<%LC:OHILKG[*TJ@2/"!NCW]!D;@#TS4ME
M:>(-4\?IKM[HS:=8+I$UFD<L\;R"0R(V6"$@ @'&"?N\XSBN[HH \L\+^#==
MTWP=X%T^ZLPESI6IR7%XGFH?+C/GX.0<'[Z\#/6K?C#PM?ZE=>+;C?!;6UWI
MEHMO<SRJJ>;#(\F&YRHSMY/'->A75U;V5L]S=SQ001C+RRN%51[D\"F.EGJN
MFE76*ZLKJ+D'#)+&P_(@@T >>W.H:SJ?Q&\$R:CI(TQ%^V$0M<),[GR#ELH2
M @R #G)W=!QG9^)^@ZEXC\'_ &#2K<3W/VN"3875/E5P2<L0.E7/#/A[PI8W
M$U[H$<$LL>;5IDN6G\K&"8P69MHZ?*,=JZ:@#BKS3];L_B;)K%EI@NK.\TM+
M/S_.11!(LC-EU)#%<,/NY-4- T._'C&SU6/PN/#Q6*0:FT5Q&8KQB,*%1&.<
M-\VY@I_.O1** .#\=2WD'C'P5+86PN;A+FZ80%PGF#R&W $\ XSC/&<9(ZUC
MZYX8\0^(](\97[:4;6\U6"VM;*QDGC+[(FR6=@Q0$ECQGM7I%UI=E>:A8WUQ
M#ON;%G:W?<1L+*5;@'!R"1S5R@#E/%6E:D^I:!KNEVHO+C299/,M/,5&EBDC
MV-M9N-PX(!(!P>:JZ5H5YK6M:]J^NZ<;*#4K./3XK)Y%>00C>6+E25!8N< $
MX KK+[4;+3+<W%]=0VT(_CE<*.F>_L"?PJ2WN8+RVCN+::.:"50R21L&5@>A
M!'!% '!_#WPQKFG7\]]XC11/9V<>E6#"16WV\9),G!."QV\'GY>:I>'_  [K
M>B>#+VQO?#MMJ:W&KSS3V$LL9,MN_(9"3LW9"G#$< ]#BO11J-DVHMIRW<!O
M5C\UK<2 R!,@;BO4#)'/O5F@#R'4?!.N77@>[TZPTI[2*36(;JSTR6Z1S:P*
M%W#<6*C+!FV@G&:ZF>UUKP[XRUC5=/T:35[35XX&*P3QQO#-&I3!WD J1MY&
M2,'BNUHH \ZT/P=JVF7OA&:XCC=[6:_N=0>-QMC>X!(49Y8 G;P.V:L7>C:O
M;ZUXKO%T*VU6RU&XM/\ 19I$_P!(A2$*^T,<!@P& V <'VKO:* .0\!Z-=:1
M%JF[3I-*T^>X5[/39)Q*;==@#'*DA0S9.T$@?C6-XQT/5-;O[A(?"\9U%77^
MS=>M[A(S;KQS)\P?*G=\H# CZUZ110!R6F:)J%M?>,I)8 JZE<![4[U/F#[.
MB9Z\?,".<5RMKX3U6S'AX:CX8@UJ.VT.*R%O/-$8[2Y4_.S!B001M&Y0Q^7I
MS7J],FFBMX7FGD2*)!EG=@ H]230!Y1:^#O$*Z3X)LI--5'T/67DN666,(T.
MYB)$ ;H=WW?O#'2NH\/:#J-A\2_&&L7-N$L=16S%K)O4[_+C*MP#D8/J!746
M&IV&JP--I]Y!=1(YC9H9 P5AU4XZ$>E6J .-\26.MIXWT37-,TW[=;65I<Q7
M$:S(CMO,> NX@$_*3S@<'D9%<[>^#-6UNVU+6K_1H'O+C6(+]=(N)$<20Q1>
M5Y;-RFYE+'J0#CFO5** .5\'Z5'92WUQ'X2LO#T4FQ(XXA'YT@&<F3R\J!D\
M#)[U1OH]4TCXBW6HZ981ZFNH:?%'+;I=QQ2PM&[;7(<C*'?C(R01TKN*QM:\
M*Z+X@FAGU*S\R>%2B2QRO$X4]5W(02/8G% 'G'AG2M7GT73=?LX(KZ_TS7M0
MED@CD"+<)([QR>6S8&<G(S@''6NLTK1;[6?$6LZWKFFFRM[VQ338;*21'<Q
MNSLY0E1DO@ $\"NKT_3[32K"&QL+>.WM8%VQQ1C"J*LT ><^!/".LV=Y<2^(
MT&;*Q71]/99%;S+=68F3@G!8;!SS\M5/"W@]](ETG3YO NE?:+"0"76V$)$B
MIG;(F/WGF'"GD#!SS7I-E?6FHVPN+*YAN8"S*)(G#+E201D>A!%6* .%TCPY
MJEKX-\6Z?-;!;K4+S4);9/,4[UEW;#G.!G(Z].]/O/#VIR^'_ ]JEN#-I=Y:
M2W:^8O[M8X65CG/."0.,UV]% 'E>G>"CIET=.D\"Z7?N+]Y$UF<0E3 TI?+
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MM+>7QN8WCF6 @@1*IW9<J/O 8&:U]"\.7D3^,H;Z/R8=6OI'@<,&W1M$J;L
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ME1F619)"RG:3T#+STYKHX-1LKJ\N+2WNX);FVV^?%'(&:+.<;@.F<'KZ59H
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MITL[73;P-@:W9!QG)^8@<9KJ*@BO+6:ZFM8KF&2X@QYL2R O'D9&X=1D=,T
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M >;6_ACQ!I"Z5JT&F_:KK3M8U"=K)9T5I;>X9P&5B=NX J<$CN*W_"MAK?\
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M:=@(F <C^'I\G)Z^QKKHKG58/#IN;ZVM/[3CA9Y(896\DL,\!BN<8]JY+3?
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MK9_:]&A2YMXR6 NH64D'/8DJ5P,\CWJ]:>*_M5CIVHJ]NUA)IK:C>2A6S$@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1DGCV%/MYX[JVBN(6W12H'1L8RI&0>: )**** "BBB@ HHHH **** "BBB@
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M2U*Z&H,'N[BYU.)YY67&UBY?(*X&,8QCB@#'E\'ZQ<V6O6=CH<F@V4U@LMK
MEZLH%[$^Y&4*3MW# /KBKT6N'QUKGA/[-G[/:V7]MWD:G \W!CBC/N'\PX_V
M:U=%L]1T2YGNE\/ZO>7<ZK&]S>ZG#*^Q<E5'S8 !)/ Y)YS3/#^ER^&;C49]
M,\'WL;W\OFS;K^%@.6.U?FX4%F./<T <EX3L-;U"S\.Z_::!,NHSW,=S>:NV
MH(3<0NW[U63.=NTG"XXVC%:/ABQTV&/QEXGU2:Y\W3M6U)89DD.;:(9+&->F
MX[CR0>WI6E:>'9;/48KF+PUK'D03FY@L6U6(VT,IR=RINXY)('0$\ 5=MK"X
MMM-U;3QX0O'M=5GFGND>^A.YI?O@?-P* .9T*U;1_%N@I;:)-I$-_870E,UZ
M)I;P*B,'E4<!P3G/^T163I^BV6E?!W0/%5H9/[<MWM7CNA*VXAIU0Q8SC9M8
MKMZ<>N:ZJV\,3VUS979T'79[NS.(;B?5X7<1[=OE_>QLP>F.?6HK'P>+!+""
M+PUK36-C(LL-C)JT30>8O(<INY.>?3/.* ([:1V^(/Q20NQ1=/M=JD\#_1CT
MKG8Y'C^%WPLV.R[M=M%.#C(W2<5W::=<QZMK6I+X3O\ [1K,20W9^WP8*HFP
M;1NXX-5?^$=/]BZ)I/\ PB6H_9=&NH[JT']H09$B$E=QW<CYCQ0!FV?@_2=9
M\?\ Q"M7MQ'(\5LL<RD[HFFA<LPYZ[CFF6NK77B_3/"GAJY9A?)=.=:4'D+9
MD!@W^^_E_G6W+;7UEXCN?%$/AC65NI(@+B"WU"$I<;%*KNCW?,P!XJCX7LM9
ML_$VO>)Y/"%Q#-J[IY<1N80T4:J 2P+<,Q&XCV% 'IE%4;#2H-.GOIH7F9KV
M?SY!)(6 ;:!A1V& .*O4 <I\3?\ DF7B+_KQD_E5/QA_R1?4O^P/_P"TQ74Z
MQI-KKNCW>EWH<VUU&8I C8.T^AJ._P!#L]2\/3:'<!S92V_V=@K8;9C'7UQ0
M!PKZ)9^'/%O@NZTY95NKXSPWLID8M=#[.S_/D\G<H(].U87A6QUS4[+0/$%K
MX?F74Y[J.YN]7;4$S/$S_O49,YV[20%QQM&*]7N=#LKN]TJ[E#^;ICL]OAL
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M6\EGRRAAR,[0O'K7INE^!M+TJ^M;B*XU":.RS]BMKBZ:2&VRI7Y%/HI*C.<
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M3#"V-RIGIG YY/ YH X.UT:UTOPW\/->M_-&K75U81SW;2L7DCEC^9#SRN"
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M2WLA8[I((<&VR>^_S(S[^6U 'J-%>.ZIIL$_A+Q]K$KSM?V&HW;6<WG,#;E
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M71[9@F[Y03+-DX]>!5;QKIU_<:QIUW)IEWK&B0PR+<6%I.(W$I*[9"I91(
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M[3'\?SSZ7%+!9Z(ODN1<2.)[F1<E3N8C"(P_X$_^S0!Z!1110 4444 %%%%
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M+=0102Q_94E!$98@@MT^^:ZBB@#DH/ D$*6SR:C<3W:ZJNJW%S*J[IY0A3&
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M0[>\C6=IFNKR:\=V&#ND8MC\!@?05JT4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
&4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>exhibit1012-stuartexecut016.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9W;=WR[L?3(P2 =W17(:AX\2RN+^2/1[NXTK39A#?:A&Z!8FX+80G<P7<-Q
MXYZXIUYXUG76M4TG2] O-3NM.6-YC'+&B;'3<"&8]>P'?!H ZVBO(_'GBV^U
MG2?"+:+;Z@FFZS>P%Y+>Z6"24-NS;Y# J>.3T]ZZF+Q1<V<BZ)I7AV_O[NPM
M8GO(VNT)M]PRJ-(['S'(&>I^O- '9T5QES\1[!-/T&[LK"\O?[;,B6T4857$
MB Y1@3@'<"I.<#!/2IKKQE>1W2V%GX;O+W4HK5+J^MHIXA]E#9PA8G#.=K8
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M@0%\LXQ\HY')KI!<W'A/QMXBN[G2M2N[35O(GMI;&U:?YTC\MHV"_=/R@@G
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M-2?#'3KW3=,UY+ZTFMFEUR[FC$J%2Z,5PPSU!]:[BB@ HHHH **** "BBB@
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M!M@!Y3&W' [\G%#2/AQ>P:;XFT^_E@:"YM7L-**,28H-\LB[N."&D7IG[@H
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M]HTNYL);@ESM(AV[]IQST.*TH]$NE^(EQKI,?V.32H[,#=\^]97<\8Z88=Z
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M4EK<+=VD-RB2(LL:R!9%*L 1G!!Y!]JP?'][<Z=X UV\LYW@N8;-WCE0X96
MX(-<M#/JNM:OX0T\ZS>VUO>>'S<WA@DVO*P\GD-V;+=1S@GUH ],K"N?%NF6
M_B:/P\HNKC4657=+>W>1858X#2,!A1]:SO 5S>-#KNGW=[/>#3=6EM8)KAMT
MACV(X#-_$1O(S7*Z/HNWXU>)B-3U+-O:6TX_T@_/G)V-QRHZ >E 'K%8R>*-
M,DUC5]*5Y/M6E0I-=#9P%9=PP>_%<3%KNJ'X.^'-3-_.;ZXN+)99]WSN&G56
M!/N"13+3_DI_Q)_[!EM_Z(- '9^#?^$?F\.6]]X:L8;33KO,JK% (MQR1D@=
M^*=:>+=,O_$=SH=F+J>YM6V7$L=NYAB?&=K28V@X[?A6)\)D\SX2Z$FYEW6[
MC<IP1\[<CWKA=$,WA>Q^(^N6M_?RW&F7\ZQ)+-N21B@ >1<?,02#GVH ]RJO
M:V-K8^?]EMXX?/E::78N-\C=6/J3@5PES;:EX0U#PQ=#7=2U :C?)87T5W-Y
MB2&2-B'08^0AEZ+@8.*QM/U76+7PIXH\6W&L7MQ-IEQ?P6=HTG[@!7(4NN,L
M03QSP%'O0!ZY17$)I6K>&+%]<'B&^U".'3Y9KVVO7\Q99 FY6CQCR^0>!Q@_
MC7/^%]5UA]1\/74;>)[M[[ U3[=:.MJ%>,MOC)&U K[0,<%30!ZO17(^-[M(
MY-+LVU/5+<SR.QM-*B9KFZ"KV<<HJD@D]^!D5R$.MZW>Z'HMI%JE_;2GQ-+I
MK3S@"X, 60@2=BX&.2#RH)S0!Z[5"]UBTL-3T[3YV<7&HNZ0 +D$HA<Y/;@&
MO-M9UC5?!I\86=IJEY>+;Z=;7-H]])YKP22R-$<,>HR V#Z5=O=#GT3Q_P"!
MT.L:A?QO-=;Q?2^8V\6S?,IQD Y.1TZ8QSD ]+K/UO6]/\.Z/<:KJD_D6=N
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MA?.ZYFF@9$P">0KD\XQP.]<G%KNJGX(Z3JIOY_M\LULKW&_YV#72J<GW4D4
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M@/MR,N1SM!SR16]X.O+\>)KJR1/$4FD/9B59=:@=6CG#X*J[ $AE(..VTXH
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MV."VU02.>#71>%&U*T\>>)-(NM5N;ZSM+:T:U^T-N9 _F$Y/<Y&,]2 ,Y/-
M';T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[29"O^L;;QDXZDXS4NB>%-0TB>RCE\27ESIM@I2UM#$J';MVJ)7',@4=.!R
M3DBM;4_$&FZ2EB]U<J%O;A+> J00S-G'X<=:T@0P!!!!Y!% &!KWARXU35-/
MU33]4?3KZS26(2"!95>.3;N4JW?**0?;O659?#U+*:#_ (F]Q-#!JW]JHLL8
M+F0HRN&;ON+;NG%=@EU;R-*J3Q,8N) K@[/KZ4XS1+%YID01XSO+#'YT <WJ
MW@FRUJ^UF>\GD,6J6$=C)&H V!&9@X/KEOTJK:^"K\Z[H^KZMXCGU&?2C((%
M-ND2E7C*'(!Y8Y!)]N ,FNKDN[:''F7$*9;8-S@?-Z?7VI9[F"U0/<3QPJ3@
M-(X4$^G- &1K_AZ35KJQU"RU!]/U*Q+B&X6(2*4< .C(>H.%/4$$"LW5_!#Z
MYX)N?#VH:U=3RW,RS2WDB@MN$@?"KT5>, #H*ZMYHHQF21$X+?,P' ZFFK<V
M[V_VA)XV@QGS X*X]<]* ,;6_#$6MZWH6IO<O$VD3O,B*H(D++MP3VJC>>#K
MQM1U"72_$-UIEIJ4@EO((8E9B^T*S1N>8RRJ,GGD9&#6SJNHW,&D&[TF"VOI
M2RA%DN1$C G!._!''ZUHK(CLRJZL5.& .<'WH Y?5/"-U/K,^J:+KL^DW%W
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M-C\*ETG7=/UK[7]AG$GV2X>VEZ??7KCU'/6KL%U;W08V\\4P4X8QN&P?0XH
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M1"YD$+RC!#M$&V%L@')'49JY#X;TB"]U6[2R0S:L%%\78LLP52H!4D@#!(X
MS0!QNK:'I'AK7/!,WA^RM[2:2^^R,UN@4SV[0N6WD??QM5LG//-<H^AZ:GP5
MU+7/L<1U2*\GEAO&4&6(I>,%"-U4<=!QR?4UZEI/@G0M%OH[RSMIC-"AC@,]
MU+,($/58P[$(.W&..*L'PKHS>'9= -G_ ,2R5G9X/,?DLYD;YLY^\2>M %W5
M;>"[TF[M[F&.:%X6#QR*&5ACH0>M>.:!IMC)X-^'&GR6D":?J=T7OU6,*MRZ
M12-&)/[V64<'.<"O;2 P((!!X(-<U!X \-VVCR:3'8R?87E$RQ-<RGR7!R#&
M2V8\$G[I'6@#+T2SM=&^*VJZ=I4$5M83:3!=3V\"A8UG\QU!"C@$J.<=<4OB
M"TMM8^)VB:7JL$5SIR:=<W45O.H:.2</&N2IX8JK'&>F372:+X<TS0!.;"&0
M2W#!IYYIGFEE(&!N=R6.!T&>*-;\.:9XAC@74('9[=B\$T,SQ21$C!VNA##(
MZ\\T <'>:1H:>)O"_ANUDCNM"-]?RS6;2"2)+A$#+"5Z *69@AZ5B^++2#3(
M?B!I6F1K;:>(=.G\F ;4AF>7#%0.%)"J>/3->F/X*\/OHD&D"PV6D$OG1&.5
MUD23)/F"0'?NY/S9R<T1>"]!BT:ZTK[$SVUY()+DR3R/),X((+2%MQ.5'?M0
M!S5[X>T?2/B/X:MK#3;6"&^L;Z"[1(ABX0+&0)/[_)/)SG-</I]C9Z=\,_&U
M]9VD%M<KKDUE]JAB59(K9IHE=0P&0H4MQT%>X7&E65UJEGJ4T.Z[LUD6"3<1
ML#@!N,X.=HZ^E5+3PQHUEIU_I\-BGV34)I)KJ)V+K*\GWR=Q/7T'% '*:AHV
MF>'/'O@W^PK&WL6N6N;:=+:,()81"6^;'WMK!3D]S[UQFGZ+I\'[/^L:PMM&
M=1GM[N-KEERX07# (#V7Y0<#C/->KZ/X.T30[T7EG;S-<+'Y,<EQ=2SF*/\
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M:R>:TN)EGG\VXD>261<89I"VXD;1W[5>U[PUI'B:V@M]8LENHH)A-&K,RX<
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MQF@#Q:70-,M_A'XDU!+.+[98:E<+9W#+F2V6.YPBQL>54<\#CD^M=/<Q^?\
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M)+%9 P89W'/-.@\$^';?3[^PCTU/LVH;3=(TCMYI4 !B2<[N =PYSSG/- '
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M;ZU_8.NWWCB5LVVLC48UW'@BV ^S_FL,N/\ >KT7P1HS:+X'TK3KA<S"W#W
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MME'.T\X59)[BXDGD95SM7<[$X&3QTYH UZ*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KF[GQYX;M-1DLIM1*O%,()91!(88
MY#QL:4+L4Y(X)KI*\9CU/3;/X-ZYX>O9X1KN^\M7LF8>?+<22N8R$ZMG<A!
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *@:RM6NENFMH3<*,+,8QO
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCRF60$@(I8_*H]ABM.3QUX;AT2SUB34E6PO)#%#+Y;\N Q*D8RI&QN"!R,4
M=%17.7'CG1+:TLYW:\+7:-+%!'93/-L4X9VC52RJ/4@5+>^,M#LK&PN_M,ER
MFH*7M$M('G>90 20B G !&3CB@#>HK$E\7:'%X?@UPWP:PN"$A=(V9I7)("*
M@&XMD$;<9X/I7/Z_X\M?[$LM1TF^,")K%M:7PN(3&\*,XWJZ2 %?E.<X^E '
M=T5B:-XKTG7KRXL[.2=;J!%D>&YMI('V'@. Z@E3CJ*TK^_M-+L)[Z^G2"U@
M0O+*YP% H LT5A:/XPT?6[TV5K)<QW7E><L-U:RV[21YQO4.HW+R.13=!\9Z
M'XFG,6CW4ESB+SC(+>14 R."S*!NY!V]<'- &_15#6=:L- TYK_4I_*@#*@P
MI=F9CA555!+$GL!7,Z9XR35/'=U:17+QZ7;Z0MS+#<P&!X9?-8,7#@,OR;3S
MQCF@#M:*YRP\=:#J1E%O-=$I URBO93*9XAU>(%<R#D?=SU'K7(^"/'\NKS:
MYJ^M:M+!I]K).$M3IS1PQ1(RA6,Q7)?G&S.>>E 'J-%<[;>-]"N;+4;KS[B!
M-.A\^Z2YM)8I$CP2'V,H8@@'! /2M*?6]/MY--CEGVMJ3[+4;&/F'87QTX^4
M$\XH T**\MM_B->Z7H/C75=3+7G]EZS/9V420X 48V*Q1>!_M-^?(KTC3=0A
MU33XKVW$PBE!*B:%XGX)'*N PZ=Q0!:HKAYO&R:5XXU[3]2FGDM;>WM9+6WM
MK5II 6$AD;"*6(X7)/ X]:VI_&6APZ18:FMV]Q!J'_'HMM \LD_&3MC4%C@
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M>)9I$/57L8"#^!6@#@9+*Q6U\&26NH2ZG;W7BA[H7,T(C$CD2DLJ@ ;=P)!
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M3>:VL6LS8LSE#CRQDJ6\S;@H ,9SUQ6-H/AW7-)\#:#<R:3<O=Z5KLEY+9@
M2O"Q=25!(R<."!GG% '63?$26REUFVU#0IK:[TG33J$T?GJRN,D (P'(('7
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MF)>W+1PZLNJAV"Y,@??MZ?=R/K6Y_8</_"5CQ!YLGGBQ-EY?&W;OWY]<YXH
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M'!!(PIR.1]"0=0> +*WTC2K73[^[M+W2Y'EM[\;7D+R9\PN&&&#Y.1CTQC%
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M7Q$5"E&5@0RD*OT(!%1OX-BGL](ANM4OKF;3M1&I>?,P9I9!NX(QA5^<X"@
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MQ<7&2 5\X895QV':J-IX&FAU+2M2NO$5_=WFF$I"\D<87R2NUHRH7'(QENO
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MI+4G'G)*I3.<8W XZG%<_P"/9(#I6GV4NG1:A+?:C#!;V\\ICA,@RX,A .4
M0DK@YP!BO-M8AEBT3X@V,R6-NRW.F%XM-)6)'9TR5R!AB N?<4 >SIJVFRFX
M$>H6CFV_UX693Y7^]S\OXU/)<P16QN9)XT@ W&5G 7'KGIBN!U3P_I-I\1=
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MF&XA/ DA<.I_$<5XB]LD5OJVFZ1%:RV4GC2*!H+ARL#*(E(C8@'""157&".
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M7E]!;*MU>E3<2DDF3:,*#GL!V'%9LO@KP[+I4&F-IJK:6\C2P(DCH86;.=C
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MZ+=:=J5[YT\*Z9&9+V&XMI(IH%VELF-@&P0"1@<XJUH?B33?$2SOIDDLL4)
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M_P"N#_\ H)JSM&XM@;CQG%+0!X_-&D?[+P5%"@Z4K8'J6!)_,FM"RU.Q\/\
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M-5EM8(YKF1[H0(@D!**"0=S$#/0 #'/-)H?CNUUW4M-M8K.6&/4+*6YCDE8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-*GBNK*W\*/:SW$#!HS,6=U7<."0N?INH [<?$3PL;@P'4F5MA>,M;2A9@"
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MP7/H-XKZ=K&H>3*YB_UD>.@W#*\@^E7]*^(.EZEKVN:<WF01Z6<F>6&14*A
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MN3Y6;YFSW (SVKNO#&J65GX8\)V-Q.J7-[I\2V\9!S(5A5FQ]!SS0!TU%%%
M',>,M>U/PS;VFKP6\5QI$,N-30(QFCB/'FH0<84\D8.1Z8J'Q+XLG@DTK2_#
M@MKS5]6(DMS)EXHK?@M.^T@[<=.1DGBNKDC2:)XI45XW4JRL,A@>H(KS3X2:
M/96-UXLEBC8R6NLSZ; TCEC%;18*1KGHH+']/2@#KM6\8Z+H5T+*_NI6NEB$
MLD=M:RS&-/[[!%;8O!ZU<B\0Z5<7&G00WJ2OJ4+SVFP%A*BA2S!@,#&Y>I[U
MR.GZOIOAWQ_XQ.N7UO8M=&VN8)+F0()85A"_*3UVL&! ]?>N8\,S1Z$_P_N]
M5=;"T>'4PCW)$:QB1P\2DG@93H#0!ZY9ZK97]W>VMM-YDUC*(KA=I&QRH8#)
M&#PP/&>M6G=(HVDD8*B@LS,<  =S7$> ;ZWU+7_&5W:N)()-3C,;CHX\B,!A
MZ@XR#W!!KIO$=Y)IWAC5KV*V6YDM[.658&&1(50G:1W!QB@"IH_C/0M>O1::
M?=R/,T9EC$EO)$)D! +1EU <<CE<]:CL_'/AV_U9--M]0+3R2-%$YAD6*5US
MN5)"NQB,'@$]*\[AU#[5XF\+A/%,&I2265S&GDQ0Q06TLD(V1J4'!)'"DD_*
M*V_!WB+PVGA'PGHEPD-SJL;16WV (KS6UQ&"'D9#RFTAB6]_>@#6\->,%_X1
M*\UCQ#>HB0ZC<6P?R^2%E*(H51ECT& "36EJ'CKP_IES/:W-W-]I@57E@CM)
MI)$5EW!BJJ3C!&3VZ'!KRKP]'=Z.\'BO4BE[X>LM7O8GMA&<V):8C[5U^8@Y
M!X^53D<YKT/PUY,OQ*\93Q['#Q6&V1><J8F/!]* -F[\7Z%9Z78ZB]]YEO?@
M?9!!$\KSY&?D106/'7CCO3;3QEH%[':/!?Y^UW1LXU:)U83@%C&P*Y1L G#8
MKS/P;<V^DCP%J6IS1P:<=-O+6.>9@L<4YE# %CPI958#UQBI]20:I#XW\2Z4
M1/:V6H6=_931G*2R6L:F8J>A&-RY'7F@#U&'7]+G\07&A17:MJ=O")Y;?:V5
M0XP<XQW'&<\BN3UCQJ\GBGPE;Z)>*^GW]]=6MV?)^^8@ 0"PSPV>1P?6N2N-
M7_L>QC^)* LM]?WRYQRT#1[( ?;=;1?]]U;N]'.@:M\)M,?/G0R3^<3WD:,,
MY_%BU 'H-SXUT"TU<Z9->LMPLJPNP@D,4<C8VHT@78K'(X)!Y%1ZSXUT72KN
MYT^6\87L,6^39!(Z0;A\ID<*53/^T17FS6\3V/B31=6\8G3?/U>X633A:1O-
M)YLNZ-D&/,;<"A!'3'M6Y9ZQI>B7OCZQUFZACO9[MIHX96 >YB>!%0(O5^05
MP,\\4 ;FB^.;.W\&^';[7KMFU#4[59 D%N\CRMM!8A(U)P,\G&!6K'XU\.S:
M1<ZK%J<<EE;3"WDD5&/[PA2$48RQ.]>%!ZXKSKP=J%EHFH^#[_5[J&TLY_"H
MMX+BX<)&)1(K,NX\ E<'\*SDE2XL+S5+*[.G:?'XV>=[LP@K"C0!5E*MQM+.
MIR>FX&@#V/1M>T[7X)9=/F=_)?RY8Y8GBDC;&<,C@,#@@\BK5_*\&G74T9P\
M<3LIQT(!(KD_!4-K)K6NZA#XD_MR>7R(;B:.!$B4HK$!63Y6.'YQR,#-=3JO
M_('O?^O>3_T$T <CX2^(>F:EH^@PZA?L=4OK>(-)]F=8GG* E!(%V;NOR@^W
M6MF?QMX?MM8.ERWK"X69;=V$$AB25L;4:4+L#'(X)[UPRQI'\)_AZ$4*/M^E
M-P.Y=23^I_.LGQ1KC7FB:X9M<AM'CU<QG1;:WB#;(IUS+*2"_*KO+Y Z#Z@'
ML.FZQ8:O]K%C<>:;.X>UN 493'*N,J00/4<]#VK!;Q7IVI:IX<DT[Q"(K;4)
M+A(K?[$S?;O+&" Y V!2"<]&[5R'B_4)_#/B#5AI1#_\)=8QI8-&<J;P,L.5
M(XYCD5\]]E6-=TJ#0_''PLTJU&(;07<*\==L*#)]SU_&@#J[OXB>%[*29)M1
M?_1YF@N&2VE98'5MI\Q@N$&X$9. >U7=7\6Z+H=U!:WUVXN)HS*L<,$DS",<
M%R$4[5]S@5PD<:#X9?$DA!EK[5F8XZD9Y_059TG5M/T#QU/<:W>06:7>@V1M
M)KEPBL$W^8JD]3EE..O- '?Z3K.GZ[9&\TRZ6YMA(\7F(#@LIPV,CD9'4<'M
M3]4U.ST73+C4M0F\FTMT+RR;2VU?7 !)_"N1^$[1/X/G:&)H8CJ=X4C9=I1?
M.; ([8Z8JY\4/^28^(O^O-Z +?\ PG/AXZ?/?"^=K>*<6VY;>0F60]%C&W,F
M>?NYZ&I5\9:"=#DUC[<5M(Y?(?="XD67('EF,C?OR1\N,\URGB^%[./P1<Q:
M@NDV5K*8FNS$KI;EH"L9(;Y0.JY/3<*RI;R'3X9KRT\36U\=2UN"WNM7GM(_
M)M'2$_.G_+,MA47=T!//- 'H$'C'09]%O-7^W>59V3%;HSQ/$\+<<,C ,"<C
M QSD8S6-:^-(]6\=Z7ING3R"TELKB6X@GMFAD#*8]APZA@,,V#T/X5Y[?7L4
MC>)IFU9M5@@U/2[R>X=$4SVT;*'D"H &0$8W 8^7.>]=I_;.E:Q\8M&?3+NW
MNQ'I-RLD]NX=.7C(7<.,CKCMN'K0!Z)7/WGC;P_8:LVF7%ZRSI(D4C""1HHG
M?&U7D"[%)R."1U%=!7B/C+6GO-$\5I)K<-D\5_)"NC6UO%YDRQLO[Z0D%SE1
MOW#   YH ],U/QQX?TB\NK.ZO)3=6N#/##;2RL@*AMQ"*?EP02>@SZU+>^,=
M"L+'3[R2],L6HC=9K;0O,\XQNRJ("Q !R>.*Q?"S6]S\0O&ES"T<L<PL"LJ$
M,'0P9&".HY_6N*\#WUKH\G@34-5N(K:QET&XMH9YW"QK-YJ-@L> 2H./7% '
MH/@WQ')XBO?$+BY6>SMK\0VI5-N$\I&(/ .=S-UY'3M75UP7PXN[6_U/QC=6
M1#6TNL%XW4<.##'\P]0>H/<'-=[0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !6%:^'WT_Q=>:Q9SJEKJ$2B\M67[TJ#"R
M*>QV_*1WP#VK=KE'\<6Z>"-2\3?8I?*L9)T:#>-S>5(4.#[XS0!TL5I;0S23
M16\,<LGWW5 &;ZGO61X>\/OI5UJ>I7MPMSJ>I3>9/*J[55%&(XU']U5_,DGO
M5"\\8W8\07^B:5H,^H7EG#%.V)TB3:X/5FZ'C '?GIBH%^($=YIFA3:3I<]Y
M?:R)#!9M(L7EB/\ UA=CD *>.^210!V=%>::/XMDLM5\9ZA?6EX)$O;.VAT\
MN&?SFB1!&G.WYG.<],'-;,_CM].T[6I-6T:6SO\ 2[5;QK43K()HF) 9'''5
M6!R."/>@#LJ*XW_A-[Y[:S>/PW<>?J4Q3389+F-#/&$+F1C_ ,LQM'0Y/(X]
M,_Q!XU\06H\/"T\/W%O/>:D;6X@GD0$E0^44G@AL!@XXP/>@#T*BN1N_&5Z=
M0OK32?#T^I'357[:ZW"1A'9=_EIG[[ $9Z#D<T2>.X;N/2$T'3Y=4N]4MC>1
M0^8L0CA& 6D8YV\D+@ \YH ZZBN-;X@P)HDMPVEW(U2/4%TPZ9O7>;EL%5#Y
MV[2#NW=,9JGH^KZA??%B:WO[.>P>+0P6M6F$D9)GX=2.#QQG /!% '?45B>,
M-5O-#\(:KJEC;^=<6MK)*JE@-N%)W<]<=<=\8KB)O$FMR:KX#O)].N'O+NUN
M\VD4ZXN&\J(AV(PJCDMSTY[\4 >G7"2R6TB0S>3*RD))M#;#V.#P:YVX\-ZK
M=,C7&NQS,G*F3386*_3/2L/6O&5M=>!O$DNL:3>6TNE2)#>V<-UM?DHRE)4Q
MP0P.>.XK5NO%ES;7$6G:1H5QJ<L5A%>3*+A$,<;Y"@;N78[&X]NO- %Q]%UV
M1&1_$I9&&"K6$1!%1Q>'=6AMS;Q:^D<!R/+73H0O/7CI706TXN;2&X$<D8E1
M7V2KM=<C.&'8CN*Y?X@ZQ=Z?H<&G:5*8]7U>X2QLV7K&6^_)]%4,<]CB@"X=
M$ULLA/B3E/N'^SXOE[<>E97B#P9K6MZ7)9GQ(H\R:&5B;&,;C'(KC)'/\-2^
M M3O675O#NK7,EQJ>C71B::4Y>>!_GBD/N5./^ U0N_B<;;1;C7E\/7DFAI*
M88+U9D_>L'V;MG54+9 ;Z<#- &Y%X>U>W,AA\0)&9#N<IIT0WGU..M/31-<C
MC$:>)-J 8"BPB  ^E59_&4Y\87/ANPT2XO+BV$$DTHF5$2*3.7)/=>/E')SQ
MTJ&/QX9)H[K^Q[@:%+>?8H]3,JX+[_+#>7U"%_E#?0XQ0!;B\-ZK! T$6O1Q
MPMDM&FFPA3GU%2G1-<9D8^),E/NDV$7R]N/2L^Y\>&":ZN5T>XDT.TN_L=QJ
M0E0!'#!&81]616."WL>#BH]0\>W-O?:[:V'AZYOCHI!NW$Z1KL,8DRN>K8)^
M4?W>HR,@&B/#VKK<M<KKZ"=AAI1IT6XCT)ZT[^PM:\MX_P#A(AL<DLO]GQ8;
M/7([UG6?C\W5[HS/HEU!I.LOY=E?22)EG*%EW1CE0P4X/Z"G3>/3%-/<KH]P
M^A6UY]CFU(2H KAPC,(^I0.<%O8\$"@"Y)X<U::6.677HWDB_P!6[:;"2GT/
M:GC0];$IE'B/]X1M+_V?%G'IFLV\\=W:7>MV^G>';F^.C2;;IQ.D:[?+#Y7/
MWFP3\H].O(JI/XVU2Z\7^&;;2=.:;2]4L'O,M*BM(I$9!YY78&.1WS[4 ;2>
M'=6CN'N$U]%G<8:5=.A#-]3U-/&AZV%=1XCP')+C^SXOF)ZY]:Z*N2B\:7/]
MI6:7GAZ\L]-O;MK.VO)G4,T@W;=T7WE5MIP3[9 S0 Z7PIJLVHV=\WB1O.LT
M=(<6,0"A@ >/H,?B:N?V1K__ $,[?^ ,585S\1YX[/5;^W\.7=QI^D74UO?3
MB=%V^6V&9%/+\?,1QUQDG.-.\\7S'7#I>BZ/-JLD-LEU<NDR1+$CYV ;OO,0
MI../K0!/-H6M7,313^(A+&W5'T^)@?P-$.A:U;1+%!XB$4:]$33XE _ 50^%
M]Y)J'@2WNI))9#)=71!E)W8^T28!SSP,#':L3XNZCJT*^']-LK>Y%I?:I!#-
M);W8A:;.[,&00RYP#NZ4 =/'X=U:&>2>+7T2:3[\BZ="&;ZGO3_["UK8Z?\
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M=VGG02@XP< JRLN."#WZ4_PUX=.B:;=PW=RM]=7US)=WDICV(\CX! 7)PH
M R>E9$GCJ]L[B\M-1\-W-K>QV,E_:PBX23[3&F-ZAEX#C(^7GKUK0O\ QE9V
MOAG3-:MH7NQJDEO%9P(P#2/*1@9[8&2?]TT =!!!#;1"*WBCBC7HD:A0/P%2
M$ @@C(/:D)(!(&3Z5X[JGB_7M5\ ^,)[ZTDLEL=1\B.:.928]D\2F+Y.21S\
MW?.* /7_ "(O+2/RDV(057:,+CI@=J8;.U,DLAMH3)*NV1B@RX]">XKGM/\
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M%*@;67KDDCMC;TY!,.D^/;K5_#KZ[!X9U V30HUML=7DN)&8*5"#D $\N<#
M)Z4 =@+: '(@C!V>7G8/N_W?I[4D-G:VRJL%M#$$SM"(%QGKC'K7(S^/GT[3
M-<FU;19;2]TB".YDMA.L@DB<D*RN..JL",<8JS9>,IY-=L-.U'0[G3XM35VL
M+B25'\TJNXJZCE&V\X.?3K0!U=0FTMC-),;>(RR+L=R@RR^A/<>U>7>#_&U]
MI7@72KJ]TB\N-,$YM[C4GG7*L\Y0,$/S,H+*I/'? .*]7H 9'#%#_JHD3( ^
M50. ,#\A4<EE:S6XMY;:%X1R(VC!4?ATK$\=ZS?>'_!6JZIIT'FW,%N[(2P
MCX/SX/7!P<=ZSU\8ZA';:19_V')<:[?PM,+1;A J1KC,COT4$L,  G)Q0!V"
M11QYV(J[N3M&,]J=6+X<\0KK\-VKVDME>V,YM[NUE8,8W !&".&4@@@]ZVJ
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MVT<7DYVY^^02VW.>/6M_1I;_ %;XGS:TVD7UEIQT86T4EW%Y;.XFW'*]5Z\
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M&.01DE>^:Z:VTN^6\^(3-:2A;YA]E)7_ %W^BJOR^OS CZUW5% 'G3:/J/\
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MV6_M[7*W/D!QYJIC!W;<].<9KKM%\*66BW\VH"YOKZ_EB$)NKZ<RNL8.0B]
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MFP2W8.T1D$9D$F_AN<A<8QWS73>'=,\26MS90ZE9Z)!;6<)CDGM2SRW38PK
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M/EW%S Q/F-<QQR1HP&,8VR#OU44 %CXRO=5/@R*UCA6;5XI+B^#*3Y21I^\
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M5(**1P1UK&O?!&M:MI/B&[NIK*#6]5GM9XHD=G@A%NRM&A; +9PV3C^+@<4
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M HHHH **** "J<6D:;!J<VIQ6%K'?S@++<K$HD<   %L9(X'Y"KE% !1110
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M1RV54Y/ITKJ:* *]A;R6>GVUM+<27,D,2QM/)]Z4@ %C[GJ?K5BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME=K.BH5^8@'@D^F: .RHKB_%WB9[.^\,0Z5J4/\ IFLPVURL;(Y>(JY([XY
MY'-9'CJ/Q/H,$%_9>,;U4N]3AMA ;2W*Q)*^, E,G /&?QH ]+HK(T/2]2TQ
M9QJ.O7.K&0KL,\,4?EXSG&Q1G.1U]*UZ "BBB@ HHHH **** "BBB@ HHHH
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MFA2(E03U4LC 'IR*ZYOB5;/8&.#1-:;7"F%TQK"4,)/0OMV!<_Q9QCFNYHH
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M%_AV;6K9[J6**4(QGD4C,K9^ZPST'6K]I<^/]/T&'1$\.V4MW! +:/4_MZB
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M)3=.[HZD?Q#*D>XK'T'P)K5]X8\5:5XIDC6YU6=2EU"P;>4C15EQV.Y V.*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM_),;(M(@D7<RJ5SD,%[9-;_ (CL;$:QHWABSTV&9(+6:Z6"[O7AM50,JDL
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*8PI 50WSLY_$]!5KQ#I.EP6D&H^*[RZOI5M8[6&SAD91)<8.XQ(A!:1CW[
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MD@@''4$ 'HJZ%I"ZJ=572K(:B>MV+=?-/;[^,]*M16MO!/-/%;Q1S3D--(B
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q=8T;4+V^@O
M=,UNXTZ>*-HFC*":&120<F,D#<".&!!ZCD5M44 <1<_#TRZ7;VD6M3K(+]M1
MNI9H$D%W.>A=.%P#C"]!M7TK1N/"]]J6E26FJZ[+<SK-'<6ES';)$UM(ARK
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6BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>exhibit1012-stuartexecut017.jpg
<TEXT>
begin 644 exhibit1012-stuartexecut017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&=D*R(4=&4D%64\@Y%<%\0KV*.?PYX+6"^O+8F.ZU&.TMVGD-K"1M!503AW
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MUY9<V#R^#/&MWIBC;H_B.34K#;]U6AV/)M]O]8..Y-6?$6?&%SXC\0Z<=_\
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M^E:-% '$0?%#2KF>X@@T?Q%+-;L%FC32I6:(D9 8 <''/-=)9:]9:AK6I:3
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MV10"3QQ]":S-)UVTTGXHVYM-,U/3M*URV2T=;VQDMT6YB!\K:6 !R@*X'H*
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M)YD1 =,C&5)!Y':IJY[Q#JGB/3I"^DZ)9WUHD)DDDFOS"P89R NQL\ <Y[T
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MX;PG_P E.\?_ /76Q_\ 1%=S5:#3[.VO+J\@MHH[F[*FXE5<-+M&%W'O@<4
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MG7FG66H:>^GWEK%/9R*$>"104('08_ 4 8[?\DX/_8(_]HU6^'W_ "2[0/\
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M:QMY$U?6%U.5GRDBVJP;5QTP"<_6M2BB@ HHHH **** "BBB@ HHHH ****
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M/+?DT 1:[?>(?"MCH2W&N+?S7VOVMK+,UHD6('R&3 R.V=W7FM'XBZ]=^'_
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MB1/8_:A<&%))+A]Y7RTW_+P!D\$\BMWP]%KUM!<V^NW-O>-'-BWNXD\MI8R
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M<=BL3?993AC\A);:VU@*UK#1[;6_%OQ!L-0@,EE>BSC.1PP^SCE3Z@\Y[$4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(+":>^+)J$)GM/)B>0SJ-OW0H.3\ZX'7GZT 0C6_%>!GP>F?^PI'_P#$TO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MY5X-\8>'?#UYXPMM7UFTLYV\17<@BEDPQ7Y1D#OR#^5>JU'Y$1;=Y2;LYSM&
M: /)-0,OB&S\>^+TMYH=,DT)["Q::,HUPJH[-)M/(7)P">HKO-(U+3]"\$Z
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MAB\/6<D!@AB:XOG8$%$,BMG;M'R*,DM5/P>\%SJ/PO4,DDEM8:A&XR"8I%5
M5/HPST]Z]F,,3,C&-"R?<)497Z>E*(T4Y5%!R3D#UZT <%8WUI8_&G6[:ZN(
MH)KW3[06J2,%,VTR9VYZX]J[^F&*-I%D9%+K]UB.1]#3Z "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'MAALTN#&?/?YB&( ],^]=AX3.ER?:I-/\*3Z$PVJ_G6,=N91SC&PG('OZT
M;5YJFGZ>RK>WUK;%QE1-,J;OIDTV;5]-M],DU.2^MQ8QC<UQY@* 9QU'%<%X
MTNM!M/B5HLGB*"*>R.EW(59;0W W^9%@[0K=L\XKFM:AM6\*>/\ 4-#L)+/P
M_/:6XA0V[0)+.K'S'2-@,#!0$X&2/:@#V^BN*BU'Q'I/C/1K#5;^UO+;5XY\
MPQ6WE_99(U#X5LDLN"1SSQGVK'T[QIJ"^)]*M;CQ#I6I-?W<EM<6%E%E;7Y7
M92DN?FP4 .?7H* /3:*\VTKQ#XHU#2O$FM27]K%::3+?P0VZVP+3-%NV.S9X
M ^48 YP<]:A_M[QG%#X5O6U#3W'B#9";8VF%M2\1<.&#9<@ D@X!Z#'6@#T^
MBN MM?\ $%F/%NF7>I:=-=Z0L$EO?W:?9X@LJDYD ./EVGIUXZ5GV7Q"EL$\
M0F75[;7X-/TP:A#<PP>02V64QD#@C(4@CL3UH ]/HKB8[OQ9H-HVKZQ>V>HZ
M>MC+=7<4<'D-;.B;PJ')WJ>5YYZ'VK#\-_$":ZUO0X)_$FEZH=6#+/9VL05K
M*3RRZX()++\I0[N<D'VH ]2IKNL:,[L%51DD]A7GT?C#5F^$FG>(R\7]H3RV
MZNWE_+A[A8SQ_NDU%HS:POQ(\;R2:JLEO:1VY\@VXPRM$[( <\;<\_WO:@#O
MM.U&SU:PBOM/N8[FUE!,<T395L$@X/U!JU7EV@^,-:U?P9X/AMI+6VU;7I9U
M:X\@&.".+>S,L8(!.%4 =,G-;=_>^)M%T"Z&IZOI%N8[M$CU:X78# P&6,6<
M&0'*@9P>#[$ ZV_U"TTJQEOK^XCMK6(9DED;"J,XY/U-3QR)-$DL;!D=0RL.
MA!Z&O&_$GB.?7/A7XWM)M0AU(:>T217T4/E"9'\MN5[$$D<<' K;U+Q'J%E>
MZ9I:Z[9:# VEPRVL]Y;;X[N8Y!C+D@*% 7CJ=] 'I=1075O=>9]GGBF\MS&_
MEN&VL.JG'0^U%J9VM(3<B(7!C4RB(DINQSM)Y(STS7COA[6;OP_X$^(VK6.W
M[3;>(KMX]ZY&<QCI^- 'L]%</_:WB'0_%NDVNL:A:W=GJD-P[116WE_97B0/
MA6R2RXR.>>,^U,\.7_C#6;/2?$2W5D]AJ#AY--,&PP6[9PRRYRS@;201@Y(&
M* .[HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% #719(V1QE6!!'J#6%_PA7AS_H%1?]]-_C6_10!RU_\ #OPQ
MJ-N()+!HTW!B8)Y(R?8D-G'M4\7@3PQ!$L46CP)&@PJJ6  _.NBHH P/^$*\
M.?\ 0*B_[Z;_ !H_X0KPY_T"HO\ OIO\:WZ* ,#_ (0KPY_T"HO^^F_QH_X0
MKPY_T"HO^^F_QK?HH P/^$*\.?\ 0*B_[Z;_ !H_X0KPY_T"HO\ OIO\:WZ*
M ,#_ (0KPY_T"HO^^F_QH_X0KPY_T"HO^^F_QK?HH P/^$*\.?\ 0*B_[Z;_
M !H_X0KPY_T"HO\ OIO\:WZ* ,#_ (0KPY_T"HO^^F_QH_X0KPY_T"HO^^F_
MQK?HH P/^$*\.?\ 0*B_[Z;_ !H_X0KPY_T"HO\ OIO\:WZ* ,#_ (0KPY_T
M"HO^^F_QH_X0KPY_T"HO^^F_QK?HH P/^$*\.?\ 0*B_[Z;_ !H_X0KPY_T"
MHO\ OIO\:WZ* ,#_ (0KPY_T"HO^^F_QH_X0KPY_T"HO^^F_QK?HH P/^$*\
M.?\ 0*B_[Z;_ !JM_P (#I X6\UQ1V5=:N@![ >97444 <O_ ,(%I/\ S^Z]
M_P"#N[_^.4?\(%I/_/[KW_@[N_\ XY7444 <O_P@6D_\_NO?^#N[_P#CE'_"
M!:3_ ,_NO?\ @[N__CE=110!R_\ P@6D_P#/[KW_ (.[O_XY1_P@6D_\_NO?
M^#N[_P#CE=110!R__"!:3_S^Z]_X.[O_ ..4?\(%I/\ S^Z]_P"#N[_^.5U%
M% '+_P#"!:3_ ,_NO?\ @[N__CE'_"!:3_S^Z]_X.[O_ ..5U%% '+_\(%I/
M_/[KW_@[N_\ XY1_P@6D_P#/[KW_ (.[O_XY7444 9FCZ%:Z(DJVLU]*)2"W
MVN\EN",>GF,<=>U:=%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML=>M=0U_5M&BCF6XTL0F9F VMYJEEV\YZ#G(%3WFHO:7UC;+87EPMT[*TT*
MI!@9S(200#T& : +U%%9&O\ B;2_#<4#:C,XDN'V6]O#&TLLS>B(H)/]* ->
MBN?T7QGI.N7\FG1"[M-0C3S#9WUL]O*4_O!6 R/I5[P_K=MXDT&SUBTCECM[
MI-Z+* & R1S@D=O6@#2HJC!J+SZO=V!L+R);=4874B 0S;AG"'.21WR!5Z@
MHKG="\86GB/5+ZTT^QOS;V<KP/?/&JP-(A 9%.[<3S_=QP>:=KGC+2_#^I0:
M?=)?37<\1F2*TM))VV X)(0' R1^= '045AZ)XJLM>NI+>VM-4A9$WEKNPE@
M4C(& 74 GGI6Y0 4444 %%%5YKZU@O+:TEG1+BYW>3&3R^T9;'T% %BBJ-CJ
M+WEW>P-87EL+60()9T 2?(^]&03D?7%7J "BBH;JZM[&TENKJ9(;>%"\DDC8
M5%'4DT 345QJ?$_PZ1'-*-2M["1@L>HSZ?-';-GH?,*X /J<"M7Q)XKL?#-O
M923PW-W+?3K;VMO:('DE<C(QD@8]R: -VBN8OO&UM9:KIND_V5JD^IWUN+K[
M)#$A>"/."9"7"C!R.">1]*V=/U%[^6\C:PO+46TQB#7"!1,!_&F"<J?4X^E
M%ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%X=UNVTSQ$^H7=Q%+J%[/<J;6:"0_.!'YIPJA@5P@(VCWKK/BKM;PM913_\
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M&@:%9:3:O(\%G"L,;2D%B ,#. !G\*T* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "J.HZO9Z4]FMY(8_MEPMM"=I(,C E02
M.F<$<]^*O5B^+-%/B#PQ>Z?&_EW+()+:3_GG,A#1M^# 4 7-2U>STG[)]KD*
M&[N$M8%52Q>1LX&!]"2>@ -7J\YT#4%^(/B*SU":'%II-AMEB/&+V9=LB_\
M $!'_;2JFBRW=]J.D^"IYI6ET&\DEO9"QW200X-MD]]_F1GW\MJ /4:*\=U3
M38)_"7C[6)7G:_L-1NVLYO.8&W*!6&S!^7GKZ].E:WB!+[6/B#'I\MI87MJF
MD1SP6U_>R01L[.PD<!$;<P 0<_=!XZT >F$X&:Y)OB-HB7:6C6NMBYD0ND)T
M>YWLHP"0-F2!D<^XJUX&CNHO"=M'=W]M?,CRK'/;7#3KY8D;:OF$ L5'RDX_
MAJEJ'_)6]#_[!-Y_Z,AH V],\06>JZA=64"7"36T$$\@FB,>%E#%1@\@_*<@
M@8K5KSTZ#I^N_$7Q8FHQ--%'966V/>P4$B;YL _>&.#VR<=:P#>ZGJ7@[X=6
M\K1W,%^F+H7ET\,=PZPDQI)(JL3D@G&/F*C- 'L-%>/WUA?6FD7=B]Y9P6KZ
M]IT<=IIM_),;(M(@D7<RJ5SD,%[9-;_B.QL1K&C>&+/389D@M9KI8+N]>&U5
M RJ2P 8R,"W /3)- 'H-%>):?=)?:+X9M;R_(LAXGNK3,5RY4P[9MD8<X8H<
MA1GJ"*U[N:YT&S^(UKX=>2.WL;2&6V2-RPMYFC8R[.N" %; Z$T >K45Y?HV
MDW=EK>DSV;:+903VLWFQVNJRW$FH)Y>5?:T:AF#;3NSG!/K4%CJ:MX$^&J"\
MW7$U]:!@),L^$<-GN<' /OB@#TQM2M]M\(2UQ-9#]]#",N&VAPH'J01CZBK$
M,GG01R;'CWJ&V.,,N1T/O7F"65G:-\4KFWC6.Z590&5CN"M:(Y[_ -[)JRL5
MOJ_B#PUI>M,9--;0/M$4,DA5)K@&,,3R-Q5#D ]-Q- 'I-%><:CIUGJ6B:!:
MZ+K%OJ-M%/.8;/4[IPM^J[E*[P,MY9/'##@9SUK>\!W5M-I%Y;6]G-9M9WLE
MO-;/<^>D3@*Q$;]T^88'&.1@4 ;EOJUG=:M>Z9%(6N[)8WG3:0%$@)7GH<[3
MTJ[7DGBZ62&;XG21.R2+IEB593@@[9*Z%=+MM ^)6B1:?YD:WUA=_:]TK-Y[
M(82K-D\M\S<]>: .ZHKS#PM!HUUI.G:]J]_-!K\NJ/'),L["1IO.91;E>?DQ
M@;<8P,\=:]*CN8)IIH8IXWEA($J*X+1DC(##MD$'F@"6BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHK@_&6EWFH^+-*;^Q+S5-/BLIPT<%T(%$K/'M+-N7^
M%6]>O2@#O**X2SM]!UOPJ@=[S2=+TNZE&H64UP5PZ9W)*^XDJ"P;AL'CMQ7/
MJEU'I2V]H][9Z!K>OV]O9Q/(ZR+:E,R%23N19&1L#@X;MF@#UNBN+T>UBT#X
MAW&BZ?YD>FW&EK>?9VD9UCE6782N2<;@PR!_=S4XED_X6\\/F/Y7]@JVS<=N
M[[01G'K0!UM%<E:2R'XLZK"9',2Z/;,$W?*"99LG'KP*K>-=.O[C6-.NY-,N
M]8T2&&1;BPM)Q&XE)7;(5+*)  &&W/&<XH [:BN0\#RZ,7U.#29=3@*.C3:7
MJ =6LR1QM5^0K8SP2O'&.:W/$;,GAC5F5BK+93$$'!!V&@#3I,C.,C/I7DUU
MXMNS\&WA&@Z^LG]A!?MIC39GR/\ 6;O,W8[YQFM&Z\4RZ'+J4T.GVDMW#I.F
M^5*P(>62:1XU5VSR@)!]>6]: /2>E ((R.17 ZCK/B"WU*Z\/ZM_9T\4VB75
MV+FUA>(EEVKMVL[8QN/.3G(Z8.:7A_6/$6E:%X,BD.FO9ZG:QVL,0B?S(6%L
M7C9GWX8'9R JXSP3C) /2Z*\^M_B!>7#^%R+6 1WT2G5<ALV[LXA54YX_?;A
MSGA:?/XSU&2RCN4N](L(+G4+F"WFN8Y)7:&(E 5B5@9&9E8Y!  QP: .^HKS
M_2_'E_<VFGW=S%:M:_VO)I5[-'&Z#)XBE4,<HI8J"&SC=UKI=!UBYUC4-9)C
MB73[2[^R6SJ#OD9%'FDG.,!R5&!_": -NBO//&^C:<@OII9[Z]\0:BICTBWB
MN&5X'"@*8PI 50WSLY_$]!5KQ#I.EP6D&H^*[RZOI5M8[6&SAD91)<8.XQ(A
M!:1CW[ =AF@#L;>RMK))A96T%N9I&E?RXPH>0]6;&,D]SU-96@:#/IU[J.J:
MC=176J:@R>;)##Y:(B#"(JDDX&2<DDDD^U/\(VNIV7A+2[;696EU".!1,SOO
M;/H6[D# )[D9JEXZL-4U#1;=-,BEN%CNXY+NTBN/(>Y@&=T:OD8))4]1D C/
M- &ZVFV#6]S;M96Q@N69IXS$NV4MU+#&&)[YJ+4=$TK6(HXM3TRSO8XSE%N8
M%D"GV!!Q7#:1>Z'IFHW<FGVFKZ)J26$T@TJ_5EAN-@!W@996*],HP."<UM+X
MJO6TOP7=&&WWZY)$MR-K80-;O*=G/'*@<YXH ZJ"*&W@2&WCCCAC&U$C4!5
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ^7]HB&60'KCZC(_&LO2_#%]9VO]G7FL1W>D_9VMS9+8QPKL(QC*\@8KIJ*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
; **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>exhibit1013-zerondaxexec001.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "N.\8QAKN!E)5]G##J.:[&N8\71';;R@<<J37'CHWH,[<OE;$(Y_3O%^
MH:=*(;S_ $B('G=]X#V-=WIVIVNJVPGM7W+W!ZJ?0UYC=V_G1[E'SKT]Z7P_
MJTFDZI&^XB%B%E7U%>5AL=4HS4*CO'\CU\5@*=:#G35I?F>LT4FX;=V1CKFL
MZZURQM<@R[R.H7_&OHXQ<MD?,RG&.LG8TJJZC9K?Z?/:N 1(A ]CV_6I+6<7
M5I%.%*B10P![ U-42BFG&1<)M-2B>+L)+*](.5DB?\B#7KNF7BW^FV]RISO0
M$_7O^M<#XUT[[)JWVE%Q'<#=_P "[_XUK^ ]1WV\U@YY0[T^G>O"P+>'Q,J,
MNO\ 2/H,P2Q&%C7CT_I_B=BS!5+$X &2:\@UF^.I:M/<]F;"_3M7HOBO4/L&
MAS;3B2;]VOX]?TKS_0-/.IZS! 02@;<_^Z.M7FDW4J1H1_KL9Y3!4Z<Z\OZ[
MGH'A73_[/T.+<,23?O&_'I^E:MU;17EK);S+NC<8(J8    8 HKUZ=*,*:I]
M#QZE64ZCJ=6[GCVJZ=+I.HR6TG\)RC>H[&O0O">L#4],$4C9N( %;W'8TGBO
M1!JFGF:)?])A&5Q_$.XK@M%U.31]4CG&=H.V1?5>]>&KX#$_W7^7_ />=LPP
MO]]?G_P3T;Q%JZZ1I;R _OW&V(>_K^%>9V-G/JVHI F6DE;ECV]2:N>(M8;6
M=2+H3Y"?+$OMZ_C78>#]$^P67VN=,7$PX!'*K_\ 7IS;QV)Y5\*_K\14TLOP
MO,_C?]?@;]C91:?9QVT(PB#'U]ZYKQ__ ,@FV_Z[_P#LIKK:Y+Q__P @FV_Z
M[_\ LIKT\:E'"R2['E8&3EBHM[W.%LKR:PNX[F!BLB'(KUC1]5AU>P2XB.&Z
M.O\ =->36MG->&00+N:-#(0.N!C/\ZT/#^M2:-?A^3 _$B>H]?K7B8'%/#RM
M+X7_ %<]W,,(L1"\?B7]6/2-=_Y -_\ ]<'_ )5Y;I'_ "&;+_KNG_H0KT[5
MIX[GPU>30N'C>V<JP[\5YCI'_(9LO^NZ?^A"NK,W>M3:_K4Y,J35"HG_ %H>
MQ5Q/Q"^Y8?\  _\ V6NVKB?B%]RP_P"!_P#LM=^8_P"[2^7YH\_+/]ZC\_R9
MR5AI=YJ;NEG"96098 @8'XFKW_")ZW_SXM_WVO\ C5OP?JMGI5U</>2^6KH
MIVDY.?:NN_X2_1/^?P_]^F_PKR<-A<-4IJ52=GZH]C%8K%4ZKC2A=>C.&_X1
M/6_^?%O^^U_QKT?2;>2WT6UMYEVR)$%9>N#BJL'BG1[F=(8KHM(YVJ/+89/Y
M5L5ZN#PU"DW*E*_S3_(\G&XJO52C6C;KLU^9CS:'YMO;QBX*/"I"N!SDGK^7
M'XU?L;-;&V\A#E0Q(]@3TJS177&E"+YDM3BE6G*/*WH%%%%:&84444 %%%%
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M<JG/&G/[+M^)ZBC3Y)5*?VE?\#V*N)^(7W+#_@?_ ++7;5Q/Q"^Y8?\  _\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ=U)):_./G4P(@)YX^93UK8\*6%QI?@[1-/NT"7-K8002J"#M=8U!&1P>0:
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M%&/X5 QGU.2:L:A;^)W\<W&JW'A4ZK:6A":4HU"*-(1CYI=K=9">,GH!@=Z
M.P\,KJ*>%M)75R3J0M(A<ENOF;1NS[YZ^]:M5[":YN+&&:[M#:7#KF2 R!_+
M/IN'!_"K% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% ";5W[MHW 8SCG%+110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5P-AXH\8:Y>ZR-(TO16M=-U&:Q_TF[E220QXYX0@9!'
M>N^KSGP!JVFV$WC%+S4+6V;_ (22\;$TRH<83GD].#0!T7ASQ:FL-J-IJ-FV
ME:IIA'VRUED#*BD95U<8#(0#SQTYJ]I/BC0]=,PTO5+6Z, #2"-\[0>C?3WZ
M5Y3XBF?Q+_PG?B/1R7TM-,BT]+E5)2YV2;YF7'WE525R.O:MC4'ELKB77+_6
MM&U5K+0KMTT^PLS%]HMB%.&/F/\ )D+CCN<4 =YI/BO0==N9;?2]6M;N:)=S
MI%)D[<XW#U&>XXI=,\4:%K-W]DTW5+:[G\D7'EPON(C)P&/XD?G7 Z=-<Q^/
M_"4-WJNEW!_LZYV6^GVWE);HR1E4W%VW [>.GW2:VO@[;0V_PNT9HHU5I5D>
M1@.6;S&&2>_  ^@% %[Q9J_BK1+:_P!2TZQT>?3+.V:X8W%Q(LQ"*68!0A';
MCFH=%\2Z\VEV^N^(XM$L-$EMDG,T5S(SIO *[@R #[P!YK4\=?\ )/O$G_8+
MNO\ T4U5]$TRWUGX8:9IEVNZWN]'AAD'LT(&1[T ;M]J5EIL,<U[<QP1R2+$
MC.<;G8X51ZDFN9\*>*[C5KSQ6-3:V@MM'U&2VCD'R 1*,Y<DX_'BN3\+W-WX
MGUCP_H&H9:7PKYDFI9Z-<1DPVY^I7=)6-*LK>&OB;Y3*H'B%6E9T+*(Q+&7+
M $94+DD9'&: /7=.\5:#J]K=7-AJMM<0VJ[YV1_]6N"<D=0, G/0XJ72_$6C
MZU//#IFHV]W) D;RB%]VQ7&5)^HKA+RSNGO=8O[[Q%I5[=KX=N(OLUA:&(F)
MN5=B9'X!! _WC70>")=.T/X7^'[B>2"SMO[/MWDDD8(N]U7DD]RS?F: .NHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8?-'@Y&,'O0!T3>-K*'49]/N[&]MKN.T:]2)@CF:)3AMA1R,CN"0>_2LNXU
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M1J)!G.X9/SC@>AK9ATK6;/5O&BKIC36^J8FMIDFC <^0L>S!((;<.^!COVH
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M' QS^F<'''7WA[Q*/">O>'K?0VE>76#>P7/VF)8Y8FN5EX&[(8#.00!P<$\
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M#Q#/<^*9M*36+[6;%[+[0+F[L3 \,JN%9,^6@(8,".,C:>: .^HHHH ****
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M]]QXAU'5[*6XBTJZM)K>&U9(O*90PV9<D/N3))R"#C QSZ%2$!@00"#P0>]
M'FGACPOJ^K>%O""7^K6SZ+9Q6E\D*VY$[LJ!D1GW;=JDCHN2% ]ZW+?POKVF
MW4]KI>N6]MHT]ZUX4-KNN(M[[WC1BVW:6+<E20&/6NO5510J@*H&  , "EH
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M)2WN7&.73WP,X(SCG-.U+P)9:AKDNKIJFL6-U+"D+?8KOREV)G P!TY)^IH
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M <9X:A?2O&?AD6ND7VF0:C:W FDN[X32WH5%=7D4$@.#SG_:(]JR-&MI-/\
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MVHVUE'(VU#-(%W'T [US.AV-]_PG?V[4-:T>XNAIAB-KI]LT1:(R*4=LR-D
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M=E/*QG!4@G([\D]Z /=**\>\87%K)I_B/5+"3-Q9ZQ;Q&\N9!YT4JO"#%
M50 D\GG+\8.:VI=&T[6?B5XCMKU&N;5])MI#$TS%"Q:49QG'88].M '=WDE^
MEU9K9V\,L#RD73R2%6C3:<%1@[CG QQ5RO(='GFNM&^%5W//+).\QC=FD)W
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M8HYX7BFC22)P59'4$,#V(/6N8MO'NFLUXFI6>H:/+:VAO6CU"(*7@!P77:S
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M-U."".1^()!]:Q=2\=V=A>W]O#IFJ:A'IV/MUQ9PJT=N=NX@DL"Q"D$A0<4
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M\G^P-GF;3MW?:,XSZX[5R&GV-T+;PZ&M9AL\87<K QGY4)GPQ]!R.?>O7J*
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M&:1B+X H=P  & %YZ=<5[77E5MX7\1KX%N_#4FDA9(-52Y@N!<QE+B,W8E)
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MS.D:DF9EC()=B1C*[1@]ZUX[S7/$7Q ;3DU6[TO3UTJUOW@A11()&9LIEE.
M?XN_R@<9- 'HU%<OXXU&]T;3].U6UG:*WMM1@%\H (>W=O+;.?0LI_"L2U\4
M:@/B5="XN\>'W>?3X8R  L\,4<K/GKSF9?\ @% ':W>K6EEJ-C83M*)[XN(
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M #,&;GVK%BAU_P 1^)_%MI'XCO-/MM.N(TLUMECR':!&.\LIRH)SCC.3STP
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MJ*6!"Y9\DXS@5QWBB74IO"/CS0+S6+R<:+&DT-SB,23Q21%A'+\N" <\@ G
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MIJ6H+I6M0W^MW%W>7J"?3AIDGV1;9Y-N%?R\912&W[^2#ZT >QT444 %%%%
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MQW%IYZ.4R$=0'4A@"1W!XXKJ 020",CK1D$D9&1U% '#R?#V2UT_P^FCZO\
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M@M/!<$6L^*[VYN?M$'B%8HY;?R]OEJL9C(W9.<@^@Q73@@C((QZTH((R#D4
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MD\IT$P/V9PH8@D##8)QQZ5KZWK-GX?T>XU2^9Q;P 9$:[F8DA551W)) 'UH
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MP)HTVA^$+*"\)-_.&NKQCU,\AWOGZ$X_"O.ETFQU'X4:QXPNT_XJ,&[NUO\
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M9T+3WTGP]INFR2^;):6L4#2<_,50*3SZXH Y35O^*VNIO#.FQ+'H5M.HU2\
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M$KW$<#7#F"*5P0\BQD[0QR>?<U7O/ASH%_+J)F%[]GU!WDN+1;MU@:1A@R;
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M)[>"*7Q*_P"\N) UVZDRB0R-QM3H-I!^79D]J /9BZ*>74<XY/>DE?RXV;*
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M6/BSQ?8VPVZ-#<P-:QK]R*5HMTRKZ#)4X' +&FZ'YG_"W?%WGYS]BL/L^?\
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MCFM+(SFWB:)7B3<2;4L2HQW()..XS0!Z98ZA;ZCI=MJ-N_\ HUS"L\;-Q\C
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M'5?L8X^G)K/CACA\$?"ORT5/].LCP,<M;R%OS)R: .\7QAX??6_[&758#?\
MF&+RLG_6 9*;L;=W^SG-7[#5K#4[-[NRNHYH$=XW<' 5E.&!ST((KQZ]UA[S
M2M(OGU+3+*VE\112+I-M;*KP[;O#/(^[(/=C@#+ =ZO^)9+KP]KFO>&K#<H\
M6^7+I[*.(YI"(KDY]EQ)0!ZG8:E::KIL6H6$ZSVLR[HI5SAAZC-<AX.^(NEZ
MOHFC)JFJ6B:S>QKNA4%5\QNBYZ!B,87.>:["QL8-,TNWL+5-EO;0K#&OHJC
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MZG;QV^IS07*PF-&W,K#:I)P!NP.>@!% '?ZAXV\-Z6UNM[J]O";B)9HPV?\
M5MT=N/E4^K8%9=SXYM-+\8ZC9:I>V\.FQ65O-;L%+,[N9,XQDL,(#P..:SK+
M4=)TOQ9X\77Y[>$2F&4BX8#S;7R OR@_>&0XP.Y]Z?X62PE^(][<V-MY5N-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0*7^7[O.,\8&/3%<UX;U>_\ &Z7VIV^H3:?I4=R]M9K;)&7F"'!E=G5NIS@
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M;"NU,C!))(XKU^B@#@=-L;M-+^(2M:3JUS?7+0 QD&4&VC *_P!X$@CCO6#
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M5=2YW%<YV_./R-51IGBV_'A-;S2+6*71KM6N9?M@*2J(FCWH "<'.<$9[>]
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M3C)(&,T-0L?%-GXGA\2Z;I5I>&[LUM+[37NPAC*.S(ZR%<' <@C'TSUIVO\
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M\URIBN;I+.)H_G!E9M@7CI\P(/ICFEL]+>TT0:<VI7UP^QD^V3.IGRV?FR%
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MG;M&Q8\X"[%VCDD9)S7544 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M" :LT4 17-M!>VLMK=0QS6\R%)(I%#*ZG@@@]16=?^%]"U2QMK*^TBSN+:U
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M;>5O#VFE[?\ U1^S+\O);T]23]36_10!5DTVQEU*'49+2%KV%#''<% 713U
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M10 4444 %%(&5LX(.#@X/2@LH(!(!/09ZT +1110 4444 %%(2%&20!ZFEH
M**** "BBB@ HHHH **** "BBB@ HI"0O4@?6EH **16##*D$>HI: "BD#!AD
M$$>U+0 44A900"0">F3UI: "BBB@ HHI"0HRQ  [F@!:*.M(64$ D GID]:
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M%V[< AL G)V]JMR^+=7U#Q%=:/X?TVSG,=G!>)=7=PT<>R3=P0JDYX&/QR>
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MNE^5ID@F*B"8+A4,>,8SSN] !57XA?Z#=^&->?\ X]M-U5?M+'I'%*K1ES[
MLOYUV] 'F]V^K^(=>T/PGJ#S:5&-.?4-3BM+MF>0!Q&D0F^]@DY8]3TSWK=T
M_P $1:%KEM>Z'J-Y:68#+=V$LTEQ%."."-[$HP/.1],5%XHT?5X?$>G>*= @
MBN[RUA>TN;*201_:8&(;"L> RL,C/!J2PO\ Q9K.M6CRZ3_86E0;FN!<2QS3
M71P0$4(2$4$Y)SDX '>@#A?#MOX-U!=6F\2:^(=0&K7:>7+KDEN502L%&P2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDOICP6D+(D2LV05+$DGJ<GN?:NZHH Y;3M'\5@"'4O$%L(8K5X(FL[7;)(Y
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MVNJI(JB0B=5)PK;U5L, 2.?;- 'J=%<KJ_C4:=?W\%KHU]J$6F(LFH3VY0"
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M) I 8Y1C@C(RIH ZFBN5TCQJ-2O[""YT:^T^'4T:33Y[@H1. N[!"L2C%?F
M;L#W&*ZJ@ HKSRPUB6U^+7B\7M]*NFV6FV\_EO(3'$ N68+T' .<5IV/CS[1
M/IC7NA:AI]AJKB.QO)VC*R,P)0,JL60L!QD?E0!V%%<-<_$E(;;4[R#0-2N;
M#2KJ6WO[E#&!$8VVL0"P+\?-P. 1]*TK_P 9+#K)TS3-(O=6FBMTNKDVI0"&
M-L[?OL-S'!(4<X% '3T5D>&/$5KXJT&'6+*.1+>9Y%02##'8[)G'OMS6)<>*
MM5C^*,7AR/2I9+'[!]H:57C'615\WEL[5^92.I/(!'- '945R-CX]AO+JS<Z
M3>Q:3?W!MK/4G*>7,_(7Y0VY58J0I(YXZ9I+'QXFI:EJ-M::-?20:9/<07EV
M2@CC:(' &3EBV.@'&1G&: .OHK@H_B? UKI5_)X?U5--U3;':7.(V,DS*2L>
MP-N&2"H) !(].:W= \3G6=2U#3+K3+G3=0L1&\D$[H^Y'!VLK(2#]TY]* .@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $)
M"J2<X SP,UYCX;\*:MK][JOBR^U76M#O-3N"L=K$L:,EM&=L0<21L0>">W4&
MO3ZJR:E80WBVDM[;)<LI80M*H<@#).W.<8!H \TL]%N_"=[XET&YTS4?$.AZ
MC"-00F,$O(S!9T)4!=Y^^ ,9QQR:VO PGCUB_AL'UM_#RV\9A&KQR*\<VYMR
M1F4!R@7;UR >AKMK:ZM[VW2XM9XIX'Y62)PRMVX(X-2T %>-Z':Z@? _AO17
MTG4H[W2O$,#W2R6CJH3[1(V]6QAE ()(X&1GK7LE% 'FWC3P]J.N^)=:AM+>
M4K<^&&MXI2I$;3><6";NF3Q^!S3_  K8Z7=>(;&Z@TOQ.+FU@=WFU:>Y\NV=
M@%* 2G#L03RN1QG/2O1JAAO+:XFFAAN(9)8"%E1'!:,GH& Z?C0!-7G>GWEW
MX!UK6K.^TG4;O2;^^DU"TO+"V:XV&3!>-U7)7#9P<8.:]$HH \U\4W>O^*?A
MWXI_XD5S;6\L*IIUL\3?:YN1N9HQG;D]!UP#FM_3_AOX0T^YMKVVT&WBNH&6
M2.0%LJXY!Z^M=710!YUH]]=> +C4M(U'2-3N=-DO);JPO+"U:X79(VXQN$R5
M8,3R1@U;T1;^^\3:MXUO=+O+2!+ 6=A9R)BXEC5C(S%/X2S8"J>>.<5W5-DC
M66-HW&58%2,]0: *NDZC%J^CV6IPI(D5Y DZ+( &574, <=^:SO&6A'Q'X3U
M#3HVV7#1^9;29QLF0[D;/;Y@/PS6K UG:M%IT+0QM'"#';JP!6,84$+UVC@5
M2U_0QX@L/L3ZC?V4+'][]CD5&E4C!0DJ2 <]L'WH \ZT;3=0\>> ?$VO2PB+
M4?$%MY%K&QP%CB3:JY[!I-Y^C"M*YOKGQ=/X5L+?1]3M);"_AO;][NT>&.W$
M2-\@9@ Y+$ ;<\<UZ#96=OIUC!96D2PVUO&L<4:]%4# 'Y5/0!XQJ+:C;_#G
MQ/X3CT+5IM5>YNVC$=FYBDB>8R!UDQM/RG@ Y)XQ7LJ?ZM?H*=10!PWQ)AU.
MTM],\0Z+97%YJ.FRRJL-O&7=DEB9#P.3AO+/X5S&K>$-1T^?1?#]E93RZ?JM
MC:6.I3Q(66/[/*'=G/0;U9QSUKV"B@#@[33[Q/CAJ&H&TG6Q;0TB6X,9\LN)
M0=H;IG':N$B\/ZR/@/ING'2;X7R:L)&MOL[^8J^>QW%<9QCG->[T4 %<'\2X
M-4M8=,U_0[*XO-1L6FA$-O&78I-$RYP.<!Q&?PKO** /(=6\(7^GZCH_AVQL
MII=+U.TLK74)XXR4C^RR;F+GHN]25YZUO07TO@_Q5XE:\TO4[F#4YH[NSELK
M1YQ(?*5&C.P':P*\;L#!ZUZ!4<-Q!<!S!-'*(W,;[&#;6'53CH1Z4 >7>'O#
M>JZ3J7P[CNK*7=:6^HO=,BEDMVEPP5F' /S%??!Q4>M>"M2UWX@>)-2MGN;6
MXM$L;C36D3_1IYT5C\P(PV,;>#\N\FO6:* ,SP_JDVLZ+;WMS87-A<N,36MQ
M&5:-QP1SU&>A'!&*QO'UE>3Z;I=]9VLMVVEZI!?26\(S))&N0P4=V 8D#OBN
MLJ&UO+:]A\ZTN(;B+)7?$X=<CJ,CO0!Y_P"*M6U#Q9X(\46VGZ%J*VHL@EO)
M/ \<MS*3\RI$5W8 QSW)..E1VR77AK7=!UR\T^^ELI/#T6G3FVMGFDMY4(<;
MT4%@#DC..".:]*HH \J73XYM.U34]=\/ZHUEJNLFZB%O&XNK)%B"1S;$^=22
MIX'(##(ZU2FTS4[RSTK4M17Q#=:3I^I7"1./-CU#[))$H61@F)#B0$=-Q4Y(
MKV*B@#QGQ7H*WOPH\2?V#HNN-->W4!47IFFN;H(\?S['RX& 0 ><+G&*Z#XE
MM?:!=:9XKTB+S+Y%?3'B!P91,/W7UVRA#CW->C5AW?A>UU#Q#;:O>WE[<"U8
M26]D\@^SQ2 8\P*!DMUP23C)QB@"?PSHL?AWPUI^D1'<+6%49_[[]6;\6)/X
MU5\;:1)KG@S5;"$$W#P%[?'7S4^=/_'E6M^B@#R!H-=3PT/&ZZ->_P!N'6&O
M?L/D-YX@*&V";,9^[AL?C4^H>%[_ $[3/AK8PVEQ.]CJ,4MZ\<981L1ND=B.
M@W%N37K%% 'E6HPWL.I?$O3SIFH/)JMGYEE)':N\<V+3:0' QNW#&.I-;>J:
M?>20>  EI.QM;R)K@+&3Y(%M(I+?W1D@<]S7=44 %>?3BXL?B=KC26%\\.IZ
M5#%;3PVSR1;T\S<K,!A3R.N/UKT&B@#S$:5J'_"K?!5G]@N?M5M>::T\/E-O
MB"R*6++C( [YZ5ER>';.WN];TK5M+\37EQ>:E-)##9W%PMK<0S/N!+*PB7&X
MAMV.G?->Q44 (JA5"CH!@5Q?BVTU'3?$^C^+-.L)M02TBEM+ZUMQF5H7((9!
M_$59<XZG-=K10!R-IXMU#7-7LK;1]#OXK,.6OKS4K5[=43!^6,-@LY..V!7'
M:.NCZ9?>((]>\$:C?7,NM7<T=P-":X#Q,_RD/M.1U/XUZ_1TH \[U6WDO]-T
M+7_#.A7,#Z%>.ZZ9-:_97DA=2LH1&  .&R.Q(/>D\1>(;SQAH-SX>T/0]8BN
MM13[/-/?V3V\5K&W#LS-C)VYP%SDUZ#;W$-U D]O-'-"XRDD;!E8>H(X-24
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M>(U4.I'');GJ.*ZNN*UG0M7/C675K+3M/OX[FQCM$DNY,&R97<E@NT[@=P.
M025QQUH I0>-]:UEO"\6D6EC%)K>GS7,CW.YUMV39DC:1N7YF&.,\<CFF?\
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M_@E<YQWJ.3P_XHTW3==\/:5:V,UCJ<]Q)!?2W)0VJSY+AH]I+%2S8P>>,XH
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MT>YBQ#YQ@X QGOWS_$FE:O>:9XK\2ZS:P6+)X=N;&VM(I_.(4JSN[-@#)(4
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M8Q'MX;(5<YQQGO@ &]-XF\3ZBNNZAH<6EKI^D3RVXANDD:6[>(?O,,K (,Y
MX;IS44OC37-8US2=.\.6]@J:GHRZFLUZKMY.6 .0I&[@@8XY.<X&*<^A^*-(
MC\0:7H]G8W-GJUS-<P7<UR8S:M,/G#)M.X!LD8/.<'%7-%\'W&B^+=*N8G1]
M.L/#XTO>3AVD$BG./0A2: ,W0=1\4-XR\:^9-9W<5BT8BM0'3+>0&149G*H#
MGYB0<GGCI3]*\;:D=6FTZ]OM!U"5M-FO4.F.3]GDCVYCD&]LCYA@\9VGBHM6
M\)>(+C4?&EM:1VWV+Q!"ABNS<%6B=80FQDVY(8C&0> >_2E'ASQ!/K-EJ*Z+
MI>G6Z6%S8&S@N 3&) I$FX( >5QM[#G/)  "R\8^*#IOAC7+^#2UT[69[:W>
MVB23S8S,,+('+8QNP=N. <9)YJSX&O/$%YXK\5C4KVTFM;>_\D1I&X*L(X]N
MS+$*N.HQDL2<U*WA34CX*\'Z2/)^TZ3<V$MS\_R[8<;]IQSTXJWX=TC6-&\7
M>(6EM8)-+U.Y^V1W2S_.K;%788]O^R><T ==7F6C^/\ Q!+X!F\9ZG9Z>+'[
M.1;VD <2RS^8(U)))"H6XQR>ASVKTVO/]/\  U\WP<B\)7<T4-^L)Q(IW(L@
ME,B'W&0N?QH O0:WXCTCQ%H^G^(?[,GAU;S(XY+&-XS!,J%]IW,VY2 0#QR.
ME<9X/\1/X<\%ZQ-#]F%S=^*9[2![I]L*,Y'S.?[H4,??&*["+3?$6O>)-%O]
M;L+/3[;2#)-LANC,;B9D* CY1M0 L>>>E8=C\/M5@\+7=M+'92WL?B!]7MH9
M6W13+G&QSCC*EAT.#B@#I?"?B>?5=5U+2+V[TR]N+-(IDNM-/[J6-]PP5W-M
M8%#D9/!!KJ+AMEM*V VU"<'H>*PO#-G?PRWEQ>Z+I>DI)M6&WL\/)@9W%W
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M17'G%MSAW<MM 'W5 'UH ZZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG(Y*C!Y('-;O@W4+X^);JP3_ (2"?26M!,DVLVKQO','VLJNRC(92#CMM.*
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MB$W)MA-'YX02&+<-P4D@-CKC((S[55TG58-9L1>6\=Q'&69-MQ"T39!P?E8
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MK8 !'0@=*Z;4=;L-+:Q%U.%-]<+;P8YW.02/PPIYJZTT2D!I4!)"C+#DGH*
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M: $DB+RP5DSE>.<8ZU'9>"KX7>E'5_$$FI6>DN)+.W-LL1+A2JM(P)WE03C
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M+VRGM921'/&T;%>N&&#C\ZY'1_ ESIT/AZ*[ULWB:%*S6V+41DQF(Q!&PQY
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M\O.U@!QTXK>T/0=,O/BQXNNKNUCE_LY[%K56'RPMY .]1TW#:N#VQQUKII_
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M$)^TVTH2[TE(HU&$!Z*,;_E8'D\&O0U\.:2EWI5S'9K')I43Q600E5B1U"L
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MB3G/O6KJ7@K1-5OH[RXAN$G2$6[-;W4D/FQ#HC[&&]?8UIZ/H]CH.F1:;IL
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M[ D2,64_>PIW [U! .,T =%H7Q'T36-&U#5)9C:6]E.\;M(CX*"0HC#*C);
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M\DD<]AGK52\U+XA:/ILFKWEIH-Y;P(99["T$JS*@Y;9(Q*LP';:,XXJGXO\
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M+?6(GFNGC#I "CJKL#@8#LO)Z9![4 ;<?C3P_)I4FIC4 MI%,L$SR1.AA=B
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M<VHV@V07 5,^;R2!]X*>2,J>: /0YO&WAV"^CL9-1 NY#"%A\F0N?-&4X"Y
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MJMIEEJ"RW80NJ&-U$B@X+(Q 5Q[J37DU\ ?#GQ=!Z'4!_2N[\40E?''@R*V
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MZ>WOOEL8C-<I+#)%)&F"=Q1U#8P#SCM7D>@%8?A]I5[/Q8V?C#S[QS]U(P[
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M+-;.'\JW\EE);'W02RCGJ?I1\,?^0CXY_P"QCN?Y+0!Z#1110 4444 %%%%
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MB)L,8TPZ(9< @<X&>,UZ110!X7J=O<:7IFN"+1-0MH[C6=-NK**ZWMYJ!HE
M,CD_.2O*DY7/M7;)+<>)O'UEJ4&F:C:V6F:?<1O)>6S0F264H BAN6P$))''
M3FNLUO1+;7K**UNWE6..XBN5,9 .Z-PZ]0>,@9JW:WUI?H[V=U!<)&YC=H9
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M0Q2K&=DDFWE5/<Y[5/-I6H'P+\/[865P9[.[TUKB,1G="$3#EAV [YZ5Z*2
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M-V.\Y.=I9=@P#UXK5T'Q1K>MZW*([K1C##>RV]QI1#)=V\:,RB0L6Y)P&QM
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MEB.IYXH RX_&][8^'_&VI6FF:<EQI>N&TC2*$H)P98T+2<\N0Q^;CG'%;?\
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M?$E5,BK@[05YWJPZ<BM;PG>06GQ%\8Z;<,T=W<W<5Q!&R$>9&(5!8'&",C%
M'7ZQJ]KH>F27]X9/*5E0+$A=W=F"JJJ.22Q  ]ZR4\<:6-,O;RZAOK-[-TCE
MM;BV*S;GP(PJC.[<3@8S4OC1=-;PS,NKQWC67F1EY;,'S+<AP5E!'(V, V1G
M&.AKSB^N-0U?1;E8M:U#5=%TG4[*YCU6* "X\O+>: 0N)#'\C;@O<^E '?\
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M6\B[%"G^(A';'<L* /0=%\56>M7LEB+2_L;Q8A.L%] 8F>(G&]>N1G@]QD9
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MR3V -9.@>(=0O=:OM%UBRM;>_MH8[A6M+@S121N64<E5((*$$$>E '24444
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M% 9P#CH  3]*T* /-7T;4+KQ=9WMOX6ETK58[\/>:I;W"+;W%L&.00&W.67
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M5,@[76-01D<=0:R/'.GZM=W'AR[TBQ^V/I^IBYFC\Q4_=B*0'!8]3N 'N1G
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M6DEE+]IC8PW$3L&['*D%00?K6C>>%]5U.'P\^HZI#/>:=J8OYW6'8K##CRT
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M,4P655(X.5Y (//3&.:[/PGH$^@V%V;VYCN;^_O)+VZDB0JGF/@;5!).T!5
MSZ4 <^ME;>(OB[J2:I$EQ!HMA;_8[>9=R!Y2Q>3:>-WRA<UN7>AZ-H-Y>>*[
M>T%O<V]E()EM_P!VDR*-WS*."1MX/O4&O^&-0GU^#Q%X?U"&RU:.#[-,ES$9
M(+F+.0K@$$$')##GM3++PUK-_?S7WBC5(I]]L]K'8V"O%;HC\.S;B2[$ #G@
M=A0!@#6O%&F>'-%\6WVL)<6][+;&ZTT6J+'%%.R@;& W[EWKU)S@U'>ZSXKN
MK#QIJ-IK:6D6@74XMXA:1OYJQQ+(4<D=.< C!Y// K2@\%:[+I^E:#J6J64V
MA:9-$ZM'"PN+A(B#&CY.T 87)'7;VS6@O@^<:)XPL/M4>[7IKB2)MIQ$)(5C
M ;UP5SQ0!EVFL>(K;7?"EQ?:G'/::^'$MBMNJK;'R3*NQQ\QQC!W$YZ\5D)K
MWC&3P-?^+1K40&G3W!6R^R)LN(HI64AVQN!P"!MQT'4DUV4WA>:6?PG(+F,#
M0R3(-I_>_N#'QZ<G-<1X:\/:]X@\!7.E0ZE9PZ/?WUVMP7B8SQ)]H<.J$':=
MV.I'&X]>* -'QAXLO;&:^N;7Q1!9&WLEN;73H;/[0\IVEOWYVDH&X P1QSFK
MW]J^(-?\7_V78:H-,LFT:VORZ6Z2R([LXPNX$8.!G(/W>.N:DO\ P5JTESK]
MK8:C9VVE:VH\]FA9KB+$(B*H<[=I"CD\C)QZUH>'?#%_IFM)J=]<VTDG]DP:
M>R0*P&Z-W.X9[$,/QS0!REQXUU^'P?X;NFN8OMTWB1=*O)5A7$T:R2(2%/"D
MA >.G:CQ!X[NDU?7UMO$4>G/I+^5:V!L_-%VZQJ[>8VTD!BVT;2,8S6I<_#N
M[GT/2]/%_"'LO$)U=G*'#)YDC[![_.!GVK2N?#OB&RU359?#VIV-M:ZK()IO
MM,#.]O+L5&>/!PV0JG#<9'<<4 8.H>+=2N-<"'7X_#R36UO-ID5W:*8+PN@9
M@\K#@ACMPI4CKS7;3>'K.X\36FO20PB\MH6B614^=@<C!;NHR>,=3GM6-XC\
M.^)-8@U#3(]3TZ72=0B$3_;+8M+;Y7:Q3;A6)^\,]&/I@5UL$(M[>*%2S+&@
M0%CDG QS0!R7Q5)'POU\@9/V<<?\"6JPO?$6@^*M @U/5DO[36#+#+"+9(Q;
M2K&9%\LCDK\I7YB3WS6]XPT*3Q-X2U'1HIE@>[CV"1AD+R#_ $K,M_#6N7?B
M/2K_ %S4+*:VT@2&U6WB97FD=-F^3)(!"D\+W.?:@#'C\6ZPWP>L/$)N5_M*
M:6!7E\M<$-<K&?EQC[I(I9O$6J-XUNM.F\10Z5<1WB)9:9=VJB*\@PN6$I&6
M9LL %/! &*C_ .%?^(?^$9C\,?VO8+I-K<I-;NL#^=(JS"0)(<X&.>0.2!TY
MSK:[X9\0ZXUQIUQJ6GR:-/<I.'DMS]I@4,&V(00O48#'D ]Z ,BZ\7:S%J7Q
M,A2Y4)H=E%-8#RE_=L8&<D\?-\P'7-6H=3\2Z=JWA6YO]72ZMM;?R9[(6R(L
M#&%I%*,/F."N#DG/H*L3^ [F:^\=W O80/$MK'!"-I_<E86CRWKRV>*U;[PU
M-=/X8*W"+_8TZRR9!_> 0M'@>G+9H X.P^(]U=-9:LNO)*;F_6)M$6SXCMVE
MV B3;N+A2')SCJ,5M:3XBU2]\726=UXBAL[U+Z6-M#NK58P]L&8*T4F-SL5
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M@TN[MFM(/M#K'&Y@4EB ?FZ#@Y')XYH ]'JM::A:7SW26LRRM:S&"8+_  2
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M2R\/:PTVFWMU';RV^R2QEN'E5W!!$HWDD-C@XX.>: .CHHHH **** "BBB@
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M=/'<*4BQS\QS@?C0!AO\-]*D74%DO]3?^T4A%X7F5C,\<@=9"2OWN-O&!MX
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MP].M $:^&K)?&#^)P\_VY[(6)7</+\O?OSC&<Y]ZQO\ A6NB?\(:?"_G7OV
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M^E:[I.N122Z3J5I?)&VUVMIED"GT.#Q0!H4444 %%%% !1110 4444 %%%%
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MRV)ASY7S, ,@9P,]L\\5:FU.Z$FO>(;"XNK'1M5UNUA>_CA.];9(0DDJ J<
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M\,)"A)SVQL_6M:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M T4*.KEF53QG*@9ZC;BN1NI9&\->#;=I7EAL_&HM;:1V+$PI+(J<GK@#'X4
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M)@&M6X<1F4%@P5E R=K$88CN 2?:K%MXR\/7>DW6J0ZG&;.UD$=P[(RF)B0
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M(BK,Q#DA<  YSM;IZ&@"&S\%Z1:0:@C"ZNI=0@-M<W%W=/-*T1!&P.Q) Y/
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M%''!IEG%'')YJ*D"J%?^\ !P??K4_P!AM!;);"U@\B,@I%Y8VJ0<C Z#!YH
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MYMXCY'^J^0?N^,?+Z<<<5B^+O#G_  D'AO4=.M/(@NKSRMTS+][8ZL-Q R>
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M]CU)QU/O0!F>*XM.G\)ZI#J\SP:=);.EQ*@),:$8+# /3KTKS/Q#J%]-X?\
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M"?#,>FTEAANAR,=:T/$6F7\]Y\1FBL;F07>B0Q6Q6)CYSB.8%4X^8Y(X'J*
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MFTR2^LYX(9 D;(ZJR.I?+#Y@005^E3?"VYU:\^'^EW6JW45RTT(>-U#;]O\
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M2,9W<YZ#KMR^((U^*]OIQL+(1MH)O3>M%_I"CS2-F_/W.^/6@#MJ*X?0M?\
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M@5Q+;HTRLA9BQ#Y& <!<$]Z]"\9:U<>'?!^JZQ:QQ23VD!E1)02I(]<$']:
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MX(['!!J2N$^'[WDGB#QF=0CB2[&I1K((2=A(@C&Y<\@$ '!Z9QS7=T %%%%
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M,_*-WRC.[CGC%=5X@\.7&L^*=)N_D%E#97MM<'=\P\Y4 P._W37444 >7_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA$)64L&42;U(4GE=P![>A-<5!X(NK?1_#=UJWAQM56Q%[#=Z>K(9%668NDB
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MPD"C)SCKGO0!SUA82>/M=UVYU2_OH]*TZ^?3K6QM;EX%9HP-\CE""Q+' YP
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MN&U;PWKOB#3O%FK#3'M;K4/L8LK&>1!(R6SA_G()52QW #/'&:V(!K6M^/\
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ML>'[B^TR:TCLO#G]G3&1T.)ED3@;6.00I(/IZ4 7%^(%R^B1LNCK_;DFJMI
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M@@<$J4D'S,X&WKP>>E;WB_4+C3=!:>WU.RTPF5$>[NQD1H6^8HO\3XZ*>":
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M,P2M(D*G^]\R+S_M4FC6^O'XCZJ-2UHRRP:+;&X06Z /D2948Z ,6.1R<XH
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M6QTVXZ#KDU?\<>*M0T2^U22#Q-8VC6-L)[;38[;SWG(4L1,<9CW$8&"..<T
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MCY0C*K_"5(4<GID\5T]CJTUW?_99-(O[5?LR3^=,J; S=8\JQ^<=^W'4UIT
M<-:>%->M?$6CZO\ :-,=HM+72[^)E?#1B3=NC/J1Q@\58T#P_P")M$2PTA-3
ML/[#L7PCK$QN981G;$V?E&,@%AR0O;-=C10!X9XBD^Q>"_$OAO3_ !%ISV0N
MIHH;+RF6^,KR;O("L1E=[?> .5SCU'HH\(32>/XO$,TT1M1HO]FO;X.XL7W$
MYZ8QQ73-I]D]XMXUI;FZ48$QC&\#_>QFH;_4)+*XLHDT^[NA<R^6TD"J5@']
M]\D87Z9H Y71/#'BC2H],T@ZS:+H>FRAHY(8V%S/$N=D3Y^4#D D=0!TK8\6
M:)>ZQ!ILVG2VR7FG7R7D2W0)BD(5E*MCD<.2".A KH*Q(/$UI/XQNO#*PSB[
MMK1;MI"!Y95C@ <YS^% '*WO@37M1A\1)=:E8N^MI;.[+&ZB&2)Q\JCG*;1C
M)YSSWKI=9\.-J_B72-1:1!;6<%U#-$<[G$RJO'TVG\ZZ"J]O?VMU<W5O!,LD
MUHXCG0=8V*A@#_P%@?QH \]'@7Q/)H&F>'Y]5TXZ;I5S!)!(D3B6>.*0%5D[
M+A1VSD@=.<]MXDTDZ]X9U/2!*(FO;62 2$9VEE(!QWK4HH X*W\,^*[:ZTG4
MDN=%.H6EB^G2*Z2F+RR4*NO0[LIR. <]14%IX#UO3;>SEM=3LY-1TR_N;FTF
MGC;;/%.29$E Z'+=5_NCBO1** .$U3PCXCU?0LW>KVDFKIJD.HP(4;[-#Y1&
MV(?Q;>"2>I)JZOA6_N/'MCXFO9[4B/2#8SP1!L-(7+$KG^'G'/-==69XAUNW
M\-Z#=ZQ=1RR06J!W2( L1D#C) [^M ',Z-X5\3:1%IVC1ZS:)H6GSAXY(HV%
MU+$"2L+Y^4#D D<D#H*SU\"^)8M$LM(BU+3%M=+ODO;,^6^ZX99O, F/88)S
MMSDX.1C!])JEJU_)IFF37D5A=7[QXQ;6J@R/D@< D#C.>O0&@#$\/>&+G1_%
MWB?69KB*2/6'MWCC0',?EH5.<^N:9KOA[6+GQ;I_B#2+NTCDL[.6W\BY5BLN
M]E."5Y PN<CN!P1FNJ4[E!P1D9P>U9<6OVTWBFY\/K%*+FWM$NVD(&PJS%0!
MSG.5/:@#DY/ >JS:1<W$FH6G_"03:O%J_F"-OLZO'M"1X^\4VKC/7FK47ACQ
M+-KU[KMSJ]E;ZA/IGV*'[-"62W82;U.'^^.N<X//&,9KMZ* .%?PAK6JS:Q>
MZM+I<-[>Z3+ID8L4?:=_.^0MR<'&!V!/)S4^D^#+K3CX-+W4+_V#:36\VT']
MZ7C505]OE[UV=% '$ZAX'NKN]UZ\BOHH;F[OK2_L7*%A%) BJ-XXR"5(..QJ
M^MEXRGL[R2?5M.MKUO*^RPV\!>%-K9;>6^9MX^4XQM'3FNGHH XBV\->)8KS
M4]:CO=*L]8N_LZ^5;PLUNZ1%R1(3\Q+;R-PP0%'6M/PQH-]IM_JVIZDUDMYJ
M3QL\-BC") BX!RW+,<G)P.WI7244 >;ZO=+H7CK69;/Q)I6FOJ%K#->1ZE&P
M:/8"@EA.0K_*,%><$#/7%0>!?"]U<^'/ 6HF3RDTO[5.T<P.^1)@X0_7# \U
MZ/=6%E?%#=VD%P8SE#+&'VGVR.*L4 <G?:!KEEXGO=;\.W&G[M1ACCNX+Y7V
MAX\A)%*<]#@CO@<UE:C\.KJ3P':Z-8:FB:M;W+7@OI$(#32%_,.!T!$C@#Z5
MZ#10!PFL?#PWNH>'#9W4<-AIT,=M=PLI)N(8GCDC4?1H^_8FKT_AO58_'=UK
M=E<69LKZR2UNHIE;S$V%L%"..=W>NKD=8HVD=@J*"S$] !4=G=V^H64%Y:RB
M6WN(UEBD7HRL,@CZ@T <@O@JZ'@/0/#_ -KA\[39K21Y<':XA<,0._..*V?%
MVAS>(?#D^GV\T<4YDBFB:52R%HY%D 8#JI*X/UJ%_&%L?&#^&K73[Z[NH41[
MJ:%$\JV5_NERS ].> :Z*@#S[4/!OB/5[O4[R]U#3A+J6CS:9)%&CA( <E"A
M/+<L2Q..O'2MR^\-3W1\+E9XU_L>X667(/[P"%H\#\6SS72UEZGK]AI&HZ99
M7KO')J4IAMVV$H7 SM)[$]O6@#AKSX?^(Y/">H>$;35-.CT6621[>5HW,ZJT
MAD$;?PX#'&[J1Q@=1Z#J5FU]H]Y9(P5Y[=X@QZ LI&?UJ2_OK?3-.N;^[D$=
MM;1-+*Y_A51DG\A6/8>,M(U"_P!.LD:>&;4K3[99B>(H)H^^"?X@.=O7'- '
M.V?@KQ VG>'M$U+4=/ETC2)()B\4;B>8PC*(0?E"A@.>I ' YI+WP5XB:R\2
MZ/8ZEI\>E:U-/<>9)&YGC:5?F3 ^7:3WZ@$\=*Z_5O$.GZ-=Z=:73N;K4)O)
MMH8D+NYQDG Z*!U)X%0:;XMT?5O$.I:%:W!.HZ=CSXF4KP>ZGN!D9QTR/6@#
M$U;PYXENM,DTBWO-)GTRXLTMG2]@8FW8)M9DV_?SU ;&#WQ4UCX,FL?'EOKJ
MW:O:P:&FE!&!\QF5PV\GIT'YUMS>(M/@U.]T]W<7%E:"]F 0X$1+ $'N?E/%
M8,'Q+TJZMX[BWTGQ%-!*H>.2/1YV5U/(((7!!]: (H_ ]VGPWTKPP;N'[192
M6[M-@[6\N99#COR!BIF\/>)-.O\ 4X]!U*P@L-2N3=-)/$SS6SL )-@^ZV<9
M&[&"3UKKK>87-M%.J.BR('"R*589&<$'D'VJ2@#BO$WAKQ%K\5_I+7VF2Z/>
ML")+B _:+48 (3;\K'()5C@@GOBC7/#7B+7'ETZYOM,ETA[M+B.:2%OM4"JR
MML3'RY&,!^N#SDUVM% &+XLT#_A)O#5WI2W'V>678\4VW=Y<B,'0X[C<HS[5
MA)X7\0:KXFTS5_$%WIICLX+BW:ULT?:PE4 MEN<G'3L!WKK[Z_M=-M&NKV98
M8%*JSMT!9@H'XD@?C4,FH21ZS!IXT^[>.6)I#=JJ^3&1_"QSG)^E '/>']#\
M4:0NFZ7+JE@VCZ<OEH\<+?:+B-5*HCY^5<#&2O)V]LFJ\_@.2;XAIKOVN,:4
M94O9+(J<M=I&T:OZ8VD'ZBNWJC8ZA)>7-["^GW=JMM+Y:R3JH6<?WDP3D?7%
M '/7F@>(K+6M4O/#M]I\46J['G%Y&S-!*J!/,0+PV5"_*V.5Z\U)+X4NI?B!
MIGB.2\CDBM-->RD5EP\C$YW<< >U=710!YT/ >N?\(\/"!U&Q_X1L2X\W8_V
MHP;]_E==N?X=WIVS4-E!XA/C_P ;OH%QIZ,TUK&Z7J.54_9EPZE>XR<@]>.1
MCGN9M:@_L^^NK*.74'LW:*2"U +F1<909(&>1WJU9K&\0NUM?L\URJO*K( ^
M<# ?'4@<=3TH Y31? K:'?>&GANUD@T>QGMI-RD-*\I1BP]!E6./>G?\(=<_
M\(YXPTS[5#YFNW%S-$^#B(2Q*@#?0KGBNQHH XP^&M>TG4!?Z!=:=YL]C!:7
M<=ZC["T0(212O.<,05/7 Y%7K3P[?1>*=.UF[U!+I[?2GL9G,81I9&=&+X'
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M7VC+8^@H XFS^'MQ9:EX*N$OH6C\/I<B8;"OF&9<?(.< '. >V*N?\(;=?\
M"&>)=$^U0^;JUQ>2QR8.V,3,2 ?IGFNDLM0DN[Z^MWT^[MUMG55FF50D^1G*
M8)) Z<@5>H \TOF_X1GQC/\ 8_$>DZ?<7FFP?;(]3C8+B+<BRQ-E58XR"N>P
MS6Q\*8'M_AQI@<R$.\\J-(,,Z/,[*Q^JD'\:ZNZL+.^""[M(+@(<KYT8?:?4
M9Z58  & ,"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8UVKO^7</EX.TC(X- '+Z29?&FO:1;:Q=79MHO#=K?F*"X>#S+B4D-(2A!.
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M*8V:/R9"5R.><8SU'4<BMF'1[VW\1:;<B_NYK2VTZ2VE\Z;/G2;H]KLH !;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *HZCJ]GI3V:WDAC^V7"VT)VD@R,"5
M!(Z9P1SWXJ]6+XLT4^(/#%[I\;^7<L@DMI/^><R$-&WX,!0!<U+5[/2?LGVN
M0H;NX2U@55+%Y&S@8'T))Z  U>KSG0-03X@^(K/4)H<6FDV&V6(\8O9EVR+_
M , 0$?\ ;2JFBS7=]J.D^"KB:5I=!O));V0L=TD$.#;9/??YD9]_+:@#U&BO
M'=4TZ&;PAX\UF1YVU"PU*[:SF\Y@;<IM8;,'Y>>OKTZ5K>(H[[6/B''ITMI8
M7MJFDI/!;7]Y)!&SF1A(X"(VY@ @Y^Z#QUH ]+)P"?2N3;XC:(EVEHUKK8N9
M$,B0G1[G>R@@$@;,D#(Y]Q5KP+'=0^%+>*[O[:^*22K'-;7#3KY8D;:OF$ L
M5'RDX_AJE?\ _)7-$_[!%W_Z,AH V]-U^SU74;JQ@2X2:V@@GD$T1CPLH8J,
M'D'Y#D$#%:M>>G0=/UWXC>*TU&%IHH[*QVQ[V"Y(F^; /WAC@]LG'6L WNIZ
MEX/^'5O*T5U!?H1=+>73PQW#K"3&DDBJQ.2"<8^8J,T >PT5X_?6%]::3=6#
MWMG!:R:_I\<=IIM_),;+<Z"1-S*I7.0P7MN-;_B*QL?[8T?PS9Z;#,D%I-=+
M!=WKPVJH&5<L &,C G@'@9)H ]!HKQ+3[I+[1?#%K>WY%F/$UU:9CN7*F(+-
MLC#G#%#PHSU!%:UY-<Z#8_$:U\.O)';6-K#);)&Y86\K1L9=G7& %; Z$T >
MKT5Y?H^DW=CK>E3V9T6Q@GM)O,BM=5EN)+]/+RK[6C4,P;:=V<X)]:ALM35_
M OPT07FZXFO;0,!)EG C<-GN<' /OB@#TM]2M\7PA+7$UD/WT$(RX;:'"@>I
M!&/J*L0R>;#')L>/>H;8XPRY'0^]>8"RL[1_BG<V\:QW2I( RL=P5K1'/?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC]]N'.>%I\_C/49+*.Y2[TBP@N=0N8+>:YCDE=H8B4!6)6!D9F5CD$ #'!H
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M':V4*0W;7-VGV9?]*S$\>']?O]\]*VK#2]/TJT^RZ=8VUI;Y+>5;Q*BY/4X
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M\4D5O&D"P1QB0 .V!DEB!CDX'/%4;'P%/;1:';7&O3W%GHDZ26</D*GRJK(
MY'WB%; /'?CFNUHH Y!? OV?^SY+/5)(;FRU&YODD:$.#YY?>A7/HY /M4MM
MX1O-/>2VT[7[BTTI[EKG[*D"%T+/O9$D/1"Q/&">2 :ZJB@#-U_2Y=:T&\TV
M&^EL7N8_+^T1#+(#UQ]1D?C67I?A>^L[3^SKS6([O2?L[6YLEL8X5V$;<97D
M#%=-10!R5AX)DBGTY=2UF;4K'2P196TL*+M.PH#(P_UA"$@<#KGDTEY\-?"U
MS>Z=<0Z)IMM]CN/.9(K.,"8;&7:W'3+!OJHKKJ* ,W3(=1COM4:]G,EN]R#9
MJ0HV1>6F1Q_M[^O-9-[X6U!_$MWK>F:\]A+=0102Q_94E!$98@@MT^^:ZBB@
M#DH/ D$*6SR:C<3W:ZJNJW%S*J[IY0A3&  %7&  .F*EU7P3:ZO-KDLUW-&V
MJ1VR@Q@9@>!F9'4GJ=S X/I7444 <9/X)EN[N[U'6-3FU2:;2I]-:".%(5:-
MRI^7GALJ>2>_8"N?T:PU35/$WA=YSK$T.E),9CJ%B+98E:$QA<XQ*Y+#+*2,
M*>F>?4Z* .6TGPG?:.MI96WB"X&CV<FZ&T$*!]@)(C:3J4'3H#@ 9I'\#6,N
MMZ[J$D\CIJULUN]N5&V+>BK(R^["-,_[M=510!QL?@/[-I6CPVFK2IJ&F7,M
MTE[+"LGFR2[_ #"Z9&<[ST(QQ44_P]>XBUI9-=N'?53!-+(\*DI/$RE7&,#;
M\@&W'0=:[>B@#EG\*ZC%J%QJ&GZ^UI=WL4:7S?9$=971=HD52?D;''<<#CBK
M]IX=6UU^#5FO9YY8M.%@?-P6<!]V]C_>)]JVJ* ,W1X=1A6^_M&<S;[R5[?(
M4%(2?E7Y?3GKSC&>:CM- @M]1UJZD;STU9T:6%U&T!8ECQ[@A?UK6HH X>P^
M&MIIVB7.G0ZG=[CJ":A:7! +VKHJK&HSD, J!>>H)K97P]=W>GZG:ZUJ\FH+
M?VYMV185BCC0@@[5&3D[N22>@Z8K?HH XIOAS:RZ1HUC+J$\C:?=-<S3%1NN
M]TGF2*_H&8*3]*Z76]+_ +:TB>P^UW%HTF"EQ;OM>-@0P(_$#@\$9%:%% ')
M)X&CNXM8.NZC+J=SJELMI+,(EA$<2[BH11G!W,6R<\XJ[8Z%JT<F=1\137L2
MP-"D2VZ1!L@#>^,[FX[8')XKH** .>@\-7%AX8TK2--UB>UETV.-$N!&K"4*
MNW#H>"#UQD<@<UGGP"DT5[/<ZI*VJW-W#>B\AA6,12Q#"%4Y&,9!R3G)YZ8[
M&B@#GA#=Z-97U]K-_=ZP)$5/LUM9?*%Y&$B3)).[DDG@=@*I_#KP[+X=\+)'
M=)(EW<OYLB2MN>-0 L49/?9&J+]0:ZVB@#G]6\-W%UK*ZQI6JOIM\UO]FF;R
M%E26,,67*G^)26P?<Y!JBG@6.PBTJ31]2FL[W3HY8A<21B;SUE8/)YBG&27&
M[((P?:NNHH XX> E6-;I=6G&M+?MJ']H>4O,IC\LKY?39L^7&<]\YI[>!8[R
M'5)-3U.:YU'4# 3=Q1K%Y!A.Z+RUYQM8D\DYSSQ7744 8&D>')[/6)=8U/4W
MU'4&@%M')Y*Q)%%NW$*H[DX))/8=,5:T+1$T.WO(UG:9KJ\FO'=A@[I&+8_
M8'T%:M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>exhibit1013-zerondaxexec002.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **JVM_;W9<12 LAPRG@C\*LTE)/8;36C%HHHIB"BBDH 6BL&Z
M\6Z7:74MO,\HDC8JP$9ZUJ6%_#J5HMS;L3&W3(Q6<:U.4N6+U-)4:D8\TE9%
MJBDJCJ>K6ND0+-=,P5FVC:,\U4I**YGL1&+D[16I?HK'T[Q+I^J70M[9I#)M
M+<H0,"M*ZN8[.UDN)=WEQC<V!DXI1J0E'FB]"I4YQERR5F345SJ^--'9@HEE
M&3C_ %9KH%8.H93D$9!I0JPJ? [CG2G3^-6'44E8$WC'28)WB:23<C%3A"1D
M43JPIZS=A0I3J:05SH**JV-]%J-HES!N,;]"PQ534_$-AI,ZPW3N'8;AM4GB
MG*I",>9O0(TYRERI:FK15'3-6M=6A:6U8LJMM.1@@U>IQDI*\=B91<7:2LPH
MK,U37;+1VB6[9P9 2NU<]/\ ]=.TO6;35UD:U9B(SAMRXJ?:PYN2^I?LI\O/
M;3N:-%(>A-<[_P )MH__ #TE_P"_9HG5A3^-V"G2G4^!7.CHKG/^$VT?_GI+
M_P!^S1_PFVC_ //27_OV:S^M4?YD:?5*_P#(_N.CHK.TO6;35TD:T9B(R VY
M<=:B_P"$ALQ)(C+.AC<(Q:(@9) '/XBM/:PLG?1F3I33<6M4:U%5[:\ANI9X
MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBC(SC/- !12$
M@8R0,]*4D 9)P* "BC(QG/'K1G(R* "BDW+C.X8]<U@>)O%">&[C1(7M6G_M
M748[!2'V^67S\QXYQCI0!T%%%)D9(R,CK0 M%("",@@CU% (89!!'J* %HI
M020",CK1D9(R,CM0 M%&1G&>:0D#&2!GI0 M%!( R3@4F1D#(YZ>] "T4A(!
M )'/2@D 9) 'J: %HJG?ZI9Z8UH+N78;NX6VA&"=TC D#CV!_*KE !12 @D@
M$$CK7,V7BZ34_&>H:#8Z3++!IK(EY?-,JK&S(64*G5O2@#IZ*Y_Q=XIC\*Z?
M:3?8Y;VXO;R.RMK>-@I>5\[06/ '!YJW::AJTU];0W.B&W@DMO,FG^U(XBES
MCRMHY;CG<.* -6BDR,XR,GM1D @$C)Z"@!:*0D 9) 'O2D@#).!0 451U2[O
MK2"%]/TTW[O,J.@F6/RT/5\MUQZ#DU=) (!(R>E "T5S\_BA(/'EKX6-JQ>X
ML6O!<;^% ;;MVX_7-=!0 44FY<9W# [YH) &20!ZF@!:0"JFH:I9Z6MLUW+Y
M8N;B.VBX)W2.<*.*$U2SDUB;2DES>0P)/)'@_*CE@ISTZJW% %RBDR"2 1D=
M:7(SC//I0!2OM)T_4DVWUE;W QC][&&_G6$_PY\*&<3QZ-##,K;A)"2IS^!K
MJ@01D'-<UXG\6-H&HZ1IEKIDNHZEJKR+;P)*L:XC7<Y9FZ8!IJ36S%9'1JNU
M0!T Q3J9&[-'&9%$<C*"4W9P>XSWIY( R>!2&1SPI<0O#(,HZE6'J#2&%&@,
M!'[LKLQ[8Q5#Q%KD/AO0+O6+BWN+B"U3?(ELH9]N0"0"0,#.3ST!J_;7,-Y:
MPW5O()(9D62-UZ,I&01^!H%9#%LX%%N G_'N,1^W&/Y5%=:7:W<XFE5O,"[<
MJQ''7M]:YH_$K1Q:-?M:WXTQ-2.FO?F-/)5P<>83NSY>3C=CK6YXB\16/AC1
MI-3OC(T894CBA7=),['"H@SRQ]*:DUJA.*:M8O&TA:V6!E)C7& 3Z'(I5M8D
MN7G5<2. &([XKG[OQWI>G^*-*\/7T%U;7NI0++$TBKY:%B0(W8,<.2I'&1GO
M6GJ&NVNFZQI.F31S--JDDD<+( 54HA<[LG(X'8'FB['RHMBPMUMGMQ&/*<DL
M/7/6G26D4@A#KGRF#)ST(KE/^%A++?ZA:V/ACQ!?BQNGM)9K:&$IYBXR 3(#
MW';O71Z/J4FJV N9--O=/8L5\B\55DX[X5F&/QHNQ<J[%UE#*5/0C!JE;Z1:
M6LJR1*ZE>@WG _"KV0"!D9/04$@#)( ]Z$VM$-Q3=V4[K3+6\D$DT>6 VY!(
MR/0U:6-4C$:J H& !V%.) &20![UDZ5KJZIJ^M:>L!C.ESI SEL^9NC5\@=O
MO8_"B[M8%%)W-*WMX[:%8HEVH.@I(;>."(QQKA22Q'N3DU7:ZOAKBV@TTFP,
M'F&^\Y<"3=CR]GWNG.>E7<C.,C/I1=A9%*'2;."<31Q8922N2<+]!VHN=)M+
MN7S94)8C!PQ&X>_K5ZD) &20![T^:5[W%R1M:PBJ%4*!@ 8 IU!( R3BJ=SJ
MEG::E9:?-+MNKWS/(3!.[8,M], BI*+E%)D @9&3T%*2 ,DX% !112 AAD$$
M>U "T4F021D9'45D^)]>3PUX>N]6> W M]F8E?:3N<+U_&@#7HHI,C.,\^E
M"T45CV6O)>>)=7T;R"C:=';R-*7X?S0Y QVQL_6@#8HKG_$GBA/#M]H=J]JT
MYU6^6S5@^WRR?XCQS]*TK>ZOI=6O+:;33#9PA#!=^<K"<D98;!RNT\<]: +U
M%(""2 1QUI: "BDW+@'(P>AS6!K?BA-&\2^']&:U:5M8DF190^!%Y:ALD8YS
MF@#H**3(SC(SZ51CU:VN+W4+&U;SKRP5#-%TP77<HR>.1^5 %^BJ>F7-W=:;
M#<:A8FPNG!,EL95D\OD_Q+P>.>/6K@((R#D4 %%(""2 1D=:7()(STH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1GC+7%B)! =W \Q=K9'?@5@1?#?0(8H(U;4-MK(LEGF]D/V3!SMBY^4=CZC
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 444A( R3@4 +1110 4444 %%%% !1110 444
M4 %%-=TCC:21E5%!+,QP !W-)#-%<PI-!*DL3C*NC!E8>Q'6@!]%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %>8^&M!L/B#-JOB#Q+$=03
M[?-;6-I*Y\FVAC;:,(#C<2"237IU<#;Z1XF\':MJ;:#86NKZ-J%RUV+62Y^S
MRVTK_?VL059"><<$?S +#:=9?#/1]<UFTGNFTF. 2QZ6SEDBD''[MCDJ&) Q
MT%+%X@\2Z3JVBP^(H-,-KJTIMU-D)%>VFV%U5BQ(<':1D;>>U0W7AOQ+XJT/
M7H/$%W;V2ZC;""TT^W;S([8@[@[O@%F+8SC P._9W]G>)?$>KZ"VMZ;:Z?;:
M3/\ :Y7CNA*;F8(R+L  VK\Q///08[T 9$GCSQ4_A;4_$D%CI*V6EW4T4L,G
MF>9<)'(5)0@X3CUSD@\ 8K8C\3^(;7Q'H,.J6NG+IVN%UA2#?YULPC,BAV)V
MOD#!P!@^M4U\':L/A=X@T I#]NOIKMX1YGRD22%ER>W!K9U?0+Z\U;PA<0K&
M8]+G:2YRV" 863CUY- &+9^*O&.MVFN76EV6CQQ:5?7-J%N1(6N?*8\+@_*<
M8Y.<DG@ 4\_$.;5HM%32)=+L);_3_P"T)9=4<^7$N=HC !4LQ;=SD8"D\YK'
M\*3^)HM,\56^CZ7;7J7&MWZPRR70B\ARY!W@@[EZ'CGJ,=ZNQ^ ;C0$T*6WT
MBPU\6>F?V?<V]R53Y@V\2(7!'WBX(.#@CTH L#X@ZI>0^&TTZPLI+S5+JZLI
MU:4F..2$,"RL.J97=T)*^]2OXTUS1KCQ%8ZU9V5U=Z9IHU*W:P#HLR'<-K*Q
M8@@KU!/%3+X9U234_!]X]CIMI_9T]S-=PV0V1QB2-E4*/XCR 3QDY.!5F]T/
M6T\;ZIKNFK:?O=&CM;;[025,RR,V& Y"X(YH ?I&M>(KG3KR[:/1M7B^S>=9
MRZ7/L223G]TQ=CCM\V<=>!6;I7C+5F\2V&C7]UX?NY=1AF,?]FR,QM98UW;9
M 6.X$9Y&.1TK*O/!&L:M!K\EGH]EX<:^T[[,;:"Y#+<R^8&WML  &T,F>I#G
M-78O#^NMXE\.:S!X;TS2[737DBDLH)TWE9(]IDW!0N%XPO4\_@ 4?"&L^([G
M2_'%YJLUC>VMG?7T302+(WS1QK\B@M@18'W>O)]:T-)\6WUQX;\(V6B:=IMK
MJ&LV[RK&49;:UBC +$(I!/+* ,CD]:;H_AOQ#I<?C+2&L()+/6+J\O+>]6Y
MP9DPJ%,9Z@9.<4FG>$M=T31O!UY:V]O<:GHEM);7-H9M@FCD SM?!&054C/!
MYH DU/Q]J^B:#XF^WV=G)J^A-;L?(W>3/',P"L 3N!QN&,GD=:OOXB\2Z5XE
MT2UUFVTS[#J\KPHMKO\ -MG"%P&8G#C@@D!:Q]8\&Z]KV@^++J>WM[?5-;-J
MD-H)]RPQ0L"-SX +'YR<<=!74>)M$O-5USPQ=VRH8M.OVGGW-@A#&R\>O)%
M'34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M%6PTVSTQ)DLK=(%GF>>0+_%(YRS'W)JU110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1GJ-HXJC!X%T.VU1+Z..YQ'.;F*U-U(;>.8DDR+%G:&R2>G!.10!TE>1W?\
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M21D=ZI6?C"PL_"6@ZEKEXD-QJ-G%+M2-F:1S&K-M103@9].*7XC?\DV\2?\
M8.F_] -<)8B\AU'P9-%K=MHZ2^%8HX;BZMQ*C./++H,LH#8VGKT6@#T>[\7Z
M!9:;9ZA-J<1M;P9MGC#2&7C)VJH).._''>F7?C7PY96-G>S:K"8+Q2]NT:M(
M9%'4@*"<#/)QQWKAK*PL+:STF;3O&MM#J?G7\]G=RV>RVG1Y09HPK'&W> 05
M;..1D4MIJ,>J1:7JUGK6EZ!K\<%U'L,0:RO(A.0[+DCAG0/E6W?-SG.: /4+
M2[M[^SAN[29)K>9 \<L9RKJ>00:KZMK&GZ'8F\U*Z2W@#! S DLQZ* .23Z
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M'9R3:9\3S91_Z?/J%W#&RCYB?(78/S8_G5?PO#'?S>#'D\86-P;:/S+.PMK
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MR,K%3RI!YX(K+U_Q?;7/A1-3OM.UJQL'O8$M9()UBDN Q^5_E;(0^AP2,<4
M=M;:5IUG=2W5KI]K!<2_ZR6*%5=_J0,FFZ3I<&C:>ME;%C&))),D ?,[L[<
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MQO"G[I...1@_C7")XEU-O#GBCQS")[B./SK?3+59 (HX825,Q4D DN&8]3@
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M<EW)IUF]S(AC>9H%+LI&"I;&2,<8JPMK;I/YZ01++L$?F! &VCD+GT]JEHH
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MB2WNBAYB,+#S7Q[P$K]0*]8K#LO"]M:>(9]<GO+V^O75HXC=2*5MHV;)2-0
M .G)R< <T ;,44<$*0Q($C10JJHP !P *\M\.V=Q<_ K6=!@B:34;.*_L'A4
M?,90\A QZD,I_&O5:R[70;6QU^]U>VDFCDOD47$ (\IW7@28QD/CC(." ,CC
M- '&Z4T^IZ]X%O(M/OXH;33[N"X-Q:O%Y3[(0 =P&,D$ ]\'%96N^'[^[N_$
M=U]AU!H8=?M+W;;;XY9H5@1',3#!)&2?E/5<=:];HH XOP79:9_:>H:AI]CK
MB Q1P"\U:6<M, 6;:BS'<%4GK@ ECCO5;XK7TC^$-1T2UTO5+R[O;<>4;2S>
M5 =XX9E! /%=[10!Q^H>)$NM-LM57PKJ%[:PWFV9+BR9;BVPO$T<3+N8 D#*
M\\G&<&JWAM9=6^(&J>([?3KNQTV2PBM ;J!H'NI5=F,FQL-A5(7)'/;I7<T4
M %<OX]>_3P_$;(WPB-Y"+UK ,9Q;;OWA3;\V>GW><9Q7444 >'ZGID[67C2#
M3=%UL6^IZ;:M8_:8YYGF\N1P^2^64_,"$8@XYQ7?^*-.N;[QIX6:*&4P)'?)
M+,J$K%OA"KN/;)Z9KL:* /&))]2D^&.F>%%\/ZK_ &I83VL5T/L;^6BQ3IEU
M?&UP< _*2<$GH#7J^N7&HVFB7=QI-HEW?Q1EX;=VVB0C^'/J1G'O6A10!YC
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&33H[^1T;4+M+.WVH6W2MT!QT''6N*OM3CN;#0(%\6:K?I-;22C^QK4_:;L
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M$<DH*,&@#?,,?PYP/0>M 'HE%%% !1110 4444 %%%% !1110 4444 %%%%
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M:T;W1M+U*59;_3;.ZD4;5:>!7('H"1TJZ&4D@,"1U /2FQRQS*6BD1U!P2K
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M-/C+:CX?G%[&!UDBZ3)]"F?^^:[.&*."&.&) D<:A45>B@#  I719$9'4,C
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M'DWD B\NW5=F^1=^,#C=@9]<5;^(>G66E/X"L]/M(+2UC\2VVR&",(BY+$X
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M;1RM&\<B_=964@@B@#B=.\+:)JWQ%\60:AIMO<VUM;V,4-O(@,<8,3#*KT!
M  /4#IC)KE=#-]J]CX*L)-)MM;MXM)N9EM+^Y\N)G658PQRC!RJ' !'&XFO8
M=-T*PTJZN+JUCD\^YCBCFDDE:1G$2[4R6)YP3D]3WS6?)X'T)M)L-.C@GMX]
M/+&TEM[F2.6'=G=MD5MV#GD9Y_"@"+P'IU_I6@2V=]%!"J7<QMK>&X\Y8(2V
M5CW8'W22,8X %<E)X>T6?]H*1)=)LG5M!%X0T"D&?[3CS>GW_P#:ZUZ/I.DV
M6B:='8Z?#Y4"$M@L69F)R69B26)))))S4?\ 86G?\)&?$'D'^TC:_8_-WMCR
MMV_;MSC[W.<9H \O\-V&BZ=X(\3^(]0MI9;A+N_@$T+8F2,RLOEQM_#DL>?5
MLTZSL)-%\5R68T/3=$2?PY=,]M8W/FF38T85I?D4;AEAGG.3S7H\?A;1XM$O
M=&%F#87KRO/$SL=[2$ESDG(Y.>.G:J,'@+08)H;CR[R2YB5T^T2WLKR.CJ%*
M,Q;++@#"G@8R* /-T\,:4G@KX<7B6JI>7EW9PW-TAQ+-%)"V^-G')0@!<=@,
M"K'B*!/#5QX]M-!@2QMWT^P?R;?]TBEY&C=A@84E.I [9KT__A&=)&G:38?9
MC]FTF2.6S3S&_=M&I5#G.3@$]<T^;P[I5S>:A=3VBRR:A;K:W0<DK)&N["E<
MX_B;IZT >;W/@?4+P:A9P>'M+T*TNM(FMWM[.]\SSI5*M#(5"+RK _-R?FJA
M=:X_B&\TOQ@KGR_#UK82S =GN'Q<C\(\5Z?HOA+2M!NGNK1;F2X,0A66ZNI)
MVCB!R$4NQVKG' ]!Z4VS\&:!8:1JFE6U@$LM4>1[N/S&.\N-K<DY''0#&.U
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M!+W3]!^$6AWMY+':V<5A')+(1PI;J3CU)_6NVH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+DG&1G&<9S6KX6LM5LO$NEO9Z)KMG9202)J<VHWJ3+,VW*28$KD/N!&0!PU
M'I=%<9\1C<&QT&"VO)[0W&MVL#RP.5;8VX$ _2N8UR>;P+JOBB'1)KE8%\.B
M^CBFG>81S^8Z;QO)(XP3ZXH ]:K-U_68/#N@7NL74<DD%I$972( L0/3) KA
M[S24\(7/A*_TV]OGN+W4(;*],UW)*+M9(V)9E9B-P(# C&.>U;OQ0_Y)CXB_
MZ\WH Z33KV/4M,M+^)66.YA29%?J R@@'WYHN;^ULY[6&XF6.2[D,4"GJ[[2
MV!^"D_A7FTZVVHV7AC3&L]8U6:/18ISI]C<BWC12JJ)9'+ISE6"C)[G%8D-J
MOB*#X:S:K)=S333W5O*YNI%=EC64+DHP^;@98<GUQ0![;17C-X^M:S<^([RQ
MTC7KG5[749K?3;RWO$2"W$1"HFPRKD$@ELJ<[CUK>T[3WU[XJ>(!J-S>"WT^
M/3[B*S2Y=(UF*,<D*1G&T\=#GD&@#O[^_M=+L)[Z]F6"U@0O+(W15'4U5;7+
M=?%$>@&.7[2]DUX'P-FQ75".N<Y8=JY;XR6T=Q\+-9>3?F%4D3:[+SO YP>1
MACP<C\JHWGAFQG^)NFZ1ONTL(M"F9HUNI-T@^T(=K2;MY&3GKV Z<4 >E45Y
M):W"1^'KO0KBXUBZ2/Q)/8V=I:3GS[B)!O$)D9@0@&26+#A<9JC<7>HVWA3Q
M)IT+7^E_9-;L8[:*6Z$TMJLA@)7>&8$98D#)X;!]* /::Q_$WB;3?"6CG5-5
M>1;82+'F-"YW-TX%<U8Z='X=^*%G8Z?/>?9;[2II;B*>ZDF#R))& _SDX;#$
M'%2?%-$ET#28Y%#(VMV2LIZ$&4<4 =I;7,-Y:0W5O()()D62-QT92,@_D:R/
M#7B[2/%L=Y)I$SRQVDY@D9D*@MC/&>HQWKSZ+5KS0?!^K>"()&_MBVO5TK3F
M8\F&XR89,_[,>_Z>746BP6/AO1O'6GI<7MK;07]O9Q-9 &X8F*)%5/\ :8D#
M/OG(ZT >Q45X\9KO2H_&>GV]EJ6D6X\-O>1VUU?"=TE E7S%8.^W.!QGJN:M
M/826/A/PO&NH7YN/$MW9Q:E=&Z?>R&)I"J'/[L'&WY<<>] 'HFOZY;^'M+^W
MW,<LD?G10[8@"<R2*@/)'&6&:TZ\N\;>&DT+P?J,%AJ5T+2XO; PVTLIE^RO
M]H0%D9R3@\'!XR/>M2RTV/PY\4+*RT^>\^RW^ESRW$4]U),'D22/#_.3AL,0
M<4 =EJ>IV6CZ?+?:A<I;VT0RTCG\@/4GH .36?;>*]+N_"+^)XI)?[,2"2<L
MT9#;$SN^7KGY3Q6M-;P7'E^?#')Y;B1-Z@[6'0CW'K7G7A?2YM;^! TJWFBA
MEN[6YA624D*NZ5QDX[4 =+I?C2VUBZCM[72-<1I$+I)<Z=)#$<*2/G88&>WU
MK#T_QOK%X=,NSI+NESIMS=/:Q2(/N21@/N8\<,PQGDG\1*M[XE\+:QH-MJVH
M6.HZ?J<WV(I!:&%K:38S*5.X[E^0@YYZ'VK5TGP<NF)"C7[S+;VD]G%F,*1'
M(R-SSR1LZ\9S0!OV-Y%J&GVU[!N\FXB65-PP=K $9_ U8JE8VHTC0[:S0M*M
MG;+$I(P7"*!^N*\F:*6+X3Q^/AJ%ZWB':E\;C[5)L;,HS%Y>=FS:=NW% 'H>
MH^,+:Q\56_AR#3[Z^U"6 7,@ME3;!$7V;W+,.,]ADUM7]_:Z78RWM[,L%M$,
MO(W11TKS*/P]ITWQ_N@Z7./[&6]XNY1^]-Q[-]W_ &/N^U;/QDM(KGX::@\F
M_=#+ Z;9&7DRHIS@C(PQX/'?J!0!U7]N6_\ PE']@>7+]I^Q?;=^!LV;]F.N
M<Y]JTZ\UN?#-C<_%&WTIGNUT^'P_DQ+=2!I/](. TF[>1DYQGL.PQ6 NH7ZZ
M=8^'0NJ:A9CQ#?VC0V]SMN);> ,R1>8SJ<=,_,"0N* /::*X_P "0ZI:C5;>
MZT^_L=-$ZOI\5_.LLB(4&]=P=OE# D9/1J["@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "LK5?#]IK&HZ3>W$DRRZ9<&X
MA$; !F*E<-D'(P>V*U:SF\0:,NKC26U:Q&HGI:&X7S3W^[G/2@!-1T2VU/4=
M+OIWE6739FGA"$ ,S(R'=D<C#'ICFJ-[X.TO4+G6IKKSY/[7AAAN$W@!1%NV
M,F!D,"V<Y/(%7Y/$&C1:LNDR:M8IJ+XVVC7"B4YY'RYS6/IOB>ZO?B+K?AQX
M85MK"VAFCD7.]BXR0><8_"@"[HOAO^R;R6\GU?4M3N7C$(DO9%.Q <X"HJKU
MZD@D^M8GC#0[C6?&OA-H_ML,4 O&:\M1@V[%$VG=@@9((PP(/(P:Z:PU_1]5
MFGAT[5;*[E@_UR07"N8_J >*CB\3Z!/>P64.MZ=)=7"AX84ND9I%(R"H!Y!'
MI0!CCX?:>=-NH)=0U&6^N;N.]?4FD3[0)H\;&&%V@*!@#;C&:1- M/"=W=>)
M/M.MZA=20+#=HB"=[HACM8HJ9RNX@;< #MQ6GK7BC2M(6XMGU.Q34U@>6&TE
MG42.0I(^7.3G%06'B[34\*Z+J^MZA8:<^HVD4V)IEC4LR*Q"[CR!F@#+^&_A
MIM%L=3U&>R:RN=7O)+H6KG+6\)8F.,^A&YF('0L16BG@?3$\)6WAL37?V*WG
M6='WKYA99O-&3MQC=QTZ?G6Q=:SI=C'%)=ZE:0)*C21M+.JAU4;F89/( Y)'
M:K%M<07EM%<VTJ303()(Y(V#*ZD9!!'4$4 9EWX:T^^UQ]5N1))))I[Z<\)(
M\MHG8,V1C.>,=>E4-+\%0Z;-&SZQJU[%;P-;VL%S,I2!&&#C:H+'' +EB!70
M2WMK#=P6LMS#'<W&[R87D >3:,MM'4X')QTI)+^SBNUM)+N!+EHS*L+2 .4'
M5@O7 ]: ,8>#=.'AK2M"\ZZ^RZ9)!+"V]=[&%@R[CMP1D<X _"GV7A:WT_Q1
M?ZY;7UZC7^UKBTWJ8'<*%#XV[@<#LV*O:;KND:R)3I>J6=Z(3B3[-.LFP^^#
MQ2:=X@T;5YYH--U:QO)8?]:EO<+(R?4 \4 5-=\,Q:U>V5\FH7VGWMF)$CN+
M-D#%'QN0AE8$':IZ9!'%9UE\/=*L)8##=WYB@U$:E%"\JLJS;&1N2NXAMQ)R
M2<\Y'.=VSUW2-0NEMK+5+*YG:(S".&=78QAMI; /3/&?6M"@# U#P?I>J7FJ
MW%X)9?[3LDLKB(L OEJ6(*\9#9<\Y["J5CX#MK;5],U6[UG5]1N],WBU:[E0
MA59"A4A4&>#G/4D#)XQ67I?Q$&N_$&\T33[W1!IUH8T$CW6Z:\9D+'R0#@[2
M,'K76VOB30[[47TZTUBPGO4SNMXKE&D&.OR@YXH H^-[%-0\*7<+:?=7Q4I(
ML5G*(YPRN"'C)_B7&X#OC'>N3\-:++J7C>753'KK6B:5)9RWFLQ^5-,[NI"J
MFU<*JJ>0H&6[\FM%?'-^P\>G[-;?\4XA:VX;]YB)G^?GU';%;FD^*;23P7I7
MB#6;JST];RUBF=I91'&K.H. 6- $;>"M//A"R\.1W%W'!8^4UM<HZ^=&\;!D
M<';C((],>U9]S\-=.O!?FYU75I9-1M!:WLC2QYG 8E6/R8#+G V@#':NE@UO
M2;J&UFM]3LI8[MBENZ3J1,P!)"$'YC@'@>E3K?V;WTEBEW UY&@D>W$@,BJ>
MC%>H'O0!4O=#M;[6-*U.5Y1/IAE,*J1M;S$V'=QD\=,$54\.>%K?PRUXMG?7
MLEK<3-,MK.ZM' S,6;9A0>2>Y-+=:V&U33(=/U/1F@FGEAN$FN/WKL@Y2( X
M+@_>!Z5/<^*/#]G*L5UKFFPR-(T(22Z127!P5P3U!X([4 5M9\*PZKJD6JV^
MHWVF:C'";<W-DR9DB)SL8.K*0#R.,@FJEQ\/]'N/#,&@F2[6WBNEO&E$@,LL
MP?>6=B#DDGGCZ8K;U'7-)TAH5U+4[.R:<[8A<3K&7/MD\U9MKNVO(VDM;B*=
M%=HRT3A@&4X9<CN""".U $U<>/AWIP@U&U_M'4OL5[>+>FU\Q-D4HE$I*?)D
M LHR"3QG&.M=/J&H6FE6$U]?7$=O;0KNDDD8*JCZG\JY%/B+8WJ>&;NPFM#8
M:I)(MTTDJEK7; TI5B#A6&!D'H#0!T5YX?LK_7+?5;CS&EAM9;01$CRV20J6
MW#&2?E'?UK.T?P7!H]W:RKJ^JW5O9*R6=I<3*8H 1MXPH+87@;BV!6O8ZYI.
MJ6,E[8:G9W5I'D/-#.KHF!DY(.!@<TNF:UI>M1/+I6I6E]'&VUVMIED"GT."
M<4 1Z[H=GXATI]/O?,$;,KI)$^V2)U(971NS @$5@M\.[">WO?MNIZG>7]UY
M/_$PFE3SH?*;?'Y>U0JX;G[O)/.:["H+6^M+ZW^T6=U!<09*^9#('7(.",CC
M@@@T <JWP[L9;F:[GU?5Y;NYM_(N9S.BM+AMR-P@VE"!MVX'J#SETOP^L[VQ
MU&#4]5U34)K^%+>2ZG>,2)$C;PJ!4"CGD\$FMFX\4>'[2SMKRXUS38K:Y)$$
MSW2!)<==K9P?PJ;4==TG1[>.XU+4[.SAE.(Y+B=45_H2>: &WFB6U]KFF:M*
M\HN-.$PA52-I\Q0K;AC)X'&"*A\1^&[+Q1IT5C?O.L,=Q'<#R'V,60Y SC('
MTP?<5:GUK2K6&&:XU*SABG1I(GDG55D4+N+*2>0%Y)';FK-M<P7MK%=6LT<U
MO,@>.6-@RNIY!!'44 8.G>#;2TU"[O[Z^O=6NKFV^QF2^9#L@SDQ@(JC!/4X
MR<55L/ %E97&GF75-4O;/37$EC97,J-% P!"D84,VT'"[B<5I>)O%6E^%+*&
MYU.XCC$TZ0QHTBJ6+,%+<D<*&W$]@*FO/$^@Z?;6US>:UIUO!=*&@DEN4595
M/=23R.1R* *J^$=/70];TD2W/V?6);B6X;<NY3-]_:<8 &>,@_C5:[\$6T^H
MVU_::KJ>GW$5HEE(]I(@\^%3D!MRGD9/S+@\FNEBECGB26&19(W4,CH<A@>A
M!'44RZO+6QA\Z[N8;>+<%WS.$7). ,GN20!0!S$'P_LK#3;*STK5-4TYK-YV
MAG@E0MME?>Z,&4JRYQC(R,#GKF6+PJVFOH46FW=WY-I>37-X\D_-SYB2%C(
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M7DJM'%&V 1A5&XX &6R<5TM9^H:[I&DEAJ.J65H402,)YU0A2<!L$],\9]:
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M"^\W>'N<RS;1T@VG#%3G=Z5=N?$FAV>IIIMSK%A#?/@+;27*+(<]/E)SSVH
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M["W.G>7Y7V7RQY>STV],4VYT+2KO1ET>XT^WDTY46-;9D&Q57&T =L8&/3%
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M"R$$9!#;LY[UPWA:YC\.0^"-9U4/!IPL+VS>=D)6"5I@R[L#C<%(!]JZ_P
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M!=S2QWFA7L))T]2KDN&QF,*^!MW$'=QVJEX2L]-DM?#>C7VM>(9-6L)XC)I
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MP%SM5&.$P>6! )]%KK@   !@"N!\<WD&D^-_!6JWK-%86\UXDT^PE4+P84'
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MW%J$@WS7*A4R2!QN(8,>@')X J;XB(TGPX\1(BEF-A,  ,D_*:YKP_"XU_P
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MY(PP5@2RJ0RDKVP=U4/B/K&M:/INE-HP@#7.IVUO(TDI0_-(N%X4_*V"&/4
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MT;^9<2H$79L8_*O)W'&>.*[/5M)LM;TZ2PU"(RVTC(S(&*Y*L&7D$'JH-7:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1@2I
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M8@#T KSOP[X?U[7O!VJZ7:ZG9P:5J&I7L=P9(6:>)#.X<1D':=P'<<$GKQ@
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MVMFMK6WLHV6- Y!=R6))8[0,= !WH J^-]5UNSUGPUINBWD=JVIW,L$KO$)
MJB(G< >ZXR!W(P>*P-7\4WMIKUUH<_BXZ=)IEK#_ *0=/61KR=U+%G 4A4 V
M\+@\GGBNTUOP_+JOB#P]J23I&FE7$DSHP),@:,I@>G7-4]1T'7+?Q!>:MX=O
MK&%M0ACBNH[V%G"LF0LB;2.<-@@\' YH P]/\2:YXQO-,L;&^.B,=(CU&\DC
MMUD<R.Q01J) 0%!1CG&>G2H]:\3ZQI4^BZ'K.MV^E7<MO-<7FH6EMYV\(X5
MBLI"EMVYL@@8(%;=[X9UR#5K/6M(U2UDU1+ 6%VU_ ?+N5!W!\1D;6#%C@<8
M;'%1'PIKEH=*U*TUF*ZURTBFAN)KZ-C'<QRL'*X4Y4*RKMQG &#0!S=SX[UC
M_A&-#N(+Q'G?Q+'I<]T+<*+J EOG"L/E++MSCH<XKI;+Q3<:9JWBZSUV<.FE
M@:A;/M"DVC(2 ,==K*RYZGBFZWX/U?7]'T2#4-7AEO;'5XM2FE$&Q"JECY:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ ID4,<*E8HTC4DMA% &3R33Z* "HQ;P"X:X$,8F8;3(%&XCTSUQ4E% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)88YXFBFC22-N&
M1U!!^H-$44<$2Q0QI'&O"HB@ ?0"GT4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8%@\]=YD #%=N<YP0<>X]:;!XDT.ZU>32;?5[&748\[[5)U,@QU&W.<COZ4
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M\!7K&270+V2342?XX;?'V<GV??&??8:]$\;7\&F>"M7N[FT6[A2V8/;LQ59
MWRX)'0<\GTS5;PMX?O;'4=6UW6?LO]KZHZ>8EL28X8D7:B!B 6/4DX&2?85T
M=Q;PW=M+;7,2302J4DCD4,KJ>""#U% 'E,FDW.H^.1H.JW.DL]UX;NK<QZ=;
MM$L2,\04$L[;L<D=,>G-8@O[CQ#I4>OLK-<^$=-M6<'DBY68-<#Z^7!C_@5>
MN67A/P]IWV4V>C6,!M7:2!DA ,;, &(/7)  _ >E6H-%TNUAO8H-/MHX[YVD
MNE2, 3,PPQ;U)[YH \PBN1J$LVL06MG=7/B#Q$(=/FO-QACCMHV6.0@$%O\
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M6^CV4=BT@E:!81M9P00Q'<@@<GT%79M.LKB_M[Z:UA>[M@PAG9!OC### 'J
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M7/VZ_F\^RA2!V-RK6Z*-I Q]Y2"2>.] '4R^.=.%IIDUI9ZC?S:C:B\AM;2
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M>:Q::3+8ZG8ZA=1O+'!>6^QMBC.[J1@\CUR#G%5=/^).BZEI-QJT-OJ*Z;!
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M,$/W2<$CK573_'VHW5GK&KW.E6\&BZ1)=17$OGDRRO$3@1KC&" ,DD<G Z4
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M'"@ DG!Z5E0>(_$"ZK=Z!>:?IJ:P+/[;:/'<N;>9 X5P24W*RDCL<Y'2@#L
MRDD @D=1GI2UY5\#+&?_ (1%-7GLK$27WF%KY9&:YN&$K@^9E<8&.,$UZK0
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M@\B]@,OF1[U;&Z5V'*DCH177T44 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 A&00#CW%>+: ;SPYK7Q&UDZQ?7)TI_->*
M18@MVP@8KYF$!&#C[NW\:]JKD[+P1#%=>+&O+G[1;>(6_>1*FTQKY90C.3D\
M]<"@#%:X\0>'8O#6K7FOW&H#4[RWM;ZUFBB6)?.& 8MJAEVMCJ3D4I\2:O\
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M[@!N '4'!Z5%9^!M5TAM+?2=;@AEM]*BTNY>6T+[DC)(>,;QM;);KN'3@XH
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MWLX+  #<O?)R, UE7'A;59?%FL:AH_BB/3?M$-O$T,5K',Z&-6V[M^< [B<
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M*9&Q;*6(RJYQG+$Y]AZ4 >L45Y-:ZM=>+M,\*>&KEF6^2Z<ZTH/(6S(#!O\
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M<<__ %JZFN:B\<Z-+XUF\+BYC^V1Q*^=_P!Z0ELQ@>H"Y/UH L+X2TQ=7O\
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M&[M]6M9()KA;5'$G68](SZ,?0U=O=4L-.EMXKRZBADN&985=L%R 6./7 !-
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M5:Z+IL5A9JRPQ[CEV+,S,2S,Q/))8DD^IK$F\=:/:^+[7PS/=1"\G@\POOP
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MIWD-I;[@N^5L L>@'J?856M_%&AW>DOJL&J6LEC&XCDF#\(Q( 5O0Y(X/J*
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M>'83;PW5KYL802R>8L>'0  ["?4%:]0U'0-&U>.&/4M)L;Q(/]4MQ;K((_\
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MR[6R%IAD'#G'S#('7T% &+X.U&YNM2URSU&#33J-K+$)[W3P0ER&3*E@<D,
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M_9VO+)K2=+MM.OE$!C(<L6EP-N,Y.1^= '26_BVTM-"T!+&UU75KG4+)9[:
M;&N&B"*3)*S,%!^9<G/)/&:>?'ME-;6+:?INHW]W>"8BRAC198O*8+)YF]E"
ME6(7KR3QFN'72S8VW@W4M5EUJQL5\/1V4TVG>:LD$P$;!9 @+!3\PZ=5&:MO
M8^'K72M/FG@\5::)I;FXM]6 D:XC=F 8/M#,!( & =<''/- 'IFE:C%JVF07
M\,<T23+GRYXRCH0<$,#T(((KG?&OBR\\-7>A06>F7%Y]OOEA<Q*ARNUB47<P
M^<X&,\8!YZ5H^#;C5+KPI93:QYAO6#@M+%Y;N@=@C,G\+% I([$UB?$<M;2>
M%]1:&>2ULM9CFN6AA:0QIY;C<54$XR1V[T 9]GXTN]/\0>+4ET[5]22UN8I/
M)MPK?9(OLZ,?O,!UW':I))!K;O\ XA:7:-I4=M:7]_+JUH;NRCM8@S2K\O')
M&#AL\\  Y-4M!BEDO_'5P()ECNYT> O$RF13:H. 1GKQ]>*Q/"FGW<6L_#YY
M;.=%M_#TL<K/$0(WQ'\K<<'KP: .KO?'$5O?7%G::)JNHS6<22WHM8XS]FW+
MN"MN<;GQSM7)J[IOBW2]6U*RL[)I)?MNGG489@H"&+<JX/.0V6'&/6N9M-53
MP9XE\4)JEI?,M_=+>V4EO:23"X!B53&"@.&#)C!QU!Z5A>&[:X\#7WA>YURU
MNHX#HD]K(T-N\WDS/.LHC8("1P2/J* .XN?'>F6UA=W/V>\E>WU(Z4EO'&#)
M/<#'RH,XP<YR2. :R-;\<I>:#XGT^WM=1TW6+#1IKMA,JHT)VL%PRL03P""I
M(Z<YR!S4$-_';?V]+I5^L-KXOFOIK?R&,JV[Q;1)L R<;@2!GOZ5)K=\=?\
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MU=@L[.A <(#L) SS@#GTK&@TN_\ ^$,\:1&QN?,F\7^=&AA;+Q_:(3N QRN
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MX.23@5D>(OB0UCX1U6_L=+O(]3T^:.WN+2Y1-ULSD;6?#X*D$8*DY)'OCGM
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MWIS6]X2UV^UF'4[?5(+>&_TV]:TF^SL3&^%5@RYY (8<'TH Z*BL+2]=FO\
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M;YZ\'(88^Z>* .SHKB/&TESJ?B'P[X5CNIK6TU)IYKV2!RDCQ0J#Y88<@,6
M..<"IX/AWI6DZI9:AX>DGTF6"4&=(I'>.ZC[HZLV#_O=10!V%%<#<>+_ !%<
MVNM:QI&GZ=)I&DS31&.>1Q/=>3_K"A'RKR"!G.<=JE_X2_6M8UYM,\.VE@8W
MTRWU&.YO6<*%DW?*0O))P,>G/L" =S17FEK\0/$,_AW3?$TFE6$.DRW4=K<Q
M&5S/DR^4SH<;=H?. <D@=16E)XF\4ZAK?B'3]$T_3"NCRHOF7;N//W1*X0!>
MC<GD\#Y>#S@ [FBN(/B_5=5T/1M4T:#3+2UOK7SY;G5+C;'$_ \H!2&+9W<]
M,+[XJO'X]U/4;7PM_9>FVS7.N+<*RS2G9"\0Y.X=5R&[9/'3.: ._HKSJ7Q]
MK&E1WPU:QLM^DZG;VVHRV[/Y8MYE4K*N>0067(.:Z6ZU^=?'%AX>M(8Y%>TD
MO+V5B<Q1@A8\>[-GKV4T ;TB++&T;9VL"IP<<'W%<I9>!$M[S3WO-=U34;33
M9/-LK2Z9"L;X(5F8*&<J"<;B<59\1:_J%GK&F:'HUO;2ZE?K++YETS"*&*,#
M<S!>226  &/K6!J/Q!U+1O#_ (@DO]/MFU;1+BVCEC@9C%-',R;77/(.&/![
MKUH ]#HK.T5]8DL2^MPV<-TSDK':.S*B8& Q8#+#G)'%<EX.>3P]XSU[PC.[
M&!V_M33"YS^YD.'0>ROT'O0!WU%><V-G%X[\=>(+V[W2:+IT+:/;(&(#RGF=
MQCN,A0:SHO%FL^$;.?P7/%)?^(D98-$F=25O(6R$D<]O+ ._/]T>N: /5Z*\
MH\6^%!I7@+1-".H7+7%[K=JEY?*Y$DDLKD.^?QX'H!4FKZ_>WOPG\4Z;JC^7
MK^D6S6]YM./,X^29?]EUY^N1VH ]3HKQ[Q(_AQOB5;1^*!<26?\ PCT+1)&L
M[?O/.?G$7/3N:[+P/!X0!O9O"T,Z'Y%G,J7"YZE<";\>E '7T5P?B#4O$47Q
M0\/Z=836BV4UM<2M'(SC?MV!MP'!(S\OU.:@E\;Z_)H=]XILM.T^3P_:2RXB
M>1Q<S0Q.5>13]T?=8A2.@ZT >AT5GZCK-KIWAZYUJ0EK6"U:Z.WJR!=W'N17
M)Z;XTU4:A80:K'I)74[>62W6QG+O!(B>9Y<F>N5!^88Y4C% '>45YC#X_P#%
M!T/P_KTFC:<UEJ\L5JELDSB82R A&+$;0A8=.2 0>O OW'C37-'C\36VK6>G
MO?:5IPU&W:U9_+E0[QM8-R""GXY[4 =_4<4\4X8Q2I)L8HVQ@=K#J#[UQ=OX
MKU^VU+0GUC3["+3-;<0P^1(YFMY&0N@DR,-D*0<=#ZUR_@[7V\.^&_%EU#;"
MYNY_%EQ:VL!;:))I&C503V'.3["@#V"BN$N_$_BC2;N?2[ZQTR?49M/FO-/:
MU,@CE>+&^)E;G.&&"#5N\\;>9X9\/ZCI$,<]UKD\$-O%(3A=_P TA;'/R*&S
M[B@#L**Y[Q?X@G\,:9;:FL$<MFEW%'?,Q.8H7;:9!CT)7\,U!KGBTZ5XD@TY
M(D>WBT^?4M0E.<PPH,+M]2S9Z]@: .HHK@8/&'B*VM=&UC5M/TZ/2-5GAB$<
M$CF>V$W^K9R?E;DJ#@#&>]7X_%]R_A?Q7JIMH?,T6XO(HDR<2"%<@M]>^* .
MOJ-;B!YV@6:,S*,M&&&X#U(JG!=7=]X?AN[58%O)[99467/EAV4'!QSC)KQ[
MP#J%UX<\+ZSXGGTW3;JZGU":V21 1=3W#S*JH7(_U>3G\,XH ]QHKD+3Q!KN
MG^)+/1O$-OIQ.H02R6L]BS[0\8!9&#\]#D,/0\4WP#XDUWQ;I-OK5]96-IIU
MQ#^Z6-W,S2!L$D'@)P<<D\ ]Z .QHKD_%.NZ[I=TPT^+28;2*W\TSZE<;//?
M)_=( <@@ $L>/F'!YJ@OC35M6U'1K/0["USJFCC4A)=NVV#E>&V\M][&!CGO
MB@#NZ*\^L_'VI*=/_M.QM8T_MF71M0DA9BL<P'[ITS_"Q(!STR*Z*'7Y[KQU
M=:%;P1M:65DDUU.2=RRR,=D8[?=!8_A0!OU'-/%;IOFE2-,@;G8 9].:YK6-
M?U<^*H?#N@V]DURMG]MN)KUG"(A?8J@+R6)#<]@.]<GK7C>6\\"WFH:IH%E+
M):ZX-/-G<9D12K@;L]R"3@T >JT5SNF^(I9_%FN:'?110-8I%<6\@)'FP.#\
MQS_=96!_"N;M?B#J>IV6F&TM].MKC5I+F:UDO)&6..TB8*KN.I9LK@#'7/:@
M#T:BO/!\0-3FATRWM=/LYM2N-3FTN=5G)A61(RX=6QG81M;IG!(ZUN>&==U2
M]UK6=%UJ"T2]T[R7$MF6\N6.4,5X;D$%2#0!H:[H;:REL\.IWNG75K(9(9[5
MAU(P0RL"K @]"*;X?\.PZ EV_P!JN+V\O9O/NKNY*[Y6P%'"@      8%9.J
M^(==/C9O#6BV=BS#3DO3<W;/M3,C(00O)S@8''<YXP<R/X@WUQIMG;+:V-OK
MLVH3Z?,MQ,1;0M "9'SP2N-N!P<L.: .QU[2(M?T"_TB>1XXKR!H7=,;E##&
M1FK49@LX[>U:9 VT)&'8 O@=AWK@;OXBW]CHDTC6-I<ZG::M!ITT=M*3%*LN
MTJ\9[9##@]"#4NJZM?V7B+P7:Z[I6D7&HWMU<*)H0S"VPH(,9;G)& ?I0!Z!
M17G\_C/Q#/IFK>(-,T[3Y-$TV69/+FD<7%RD)(D=2/E7[K8!!SCM5T^*M7UK
M7I+'PS;V#P6MG!=7$UZSC>9@61%V]#M&2QSC/2@#L(Y8YDWQ2*Z9(W*<C(.#
M3ZXKX42-+\/K21XS&SW5VQ1NJDW,G!KM: "FR2QPQM)*ZHBC+,QP!]37F_Q5
M\*:+_P (CK_B 6CKJBP;Q<+/(,,-J@[0VWH/2J_BKPCH>A?"S7+[3;(PW,VF
M;9',TCY!VD\,Q'4"@#U*BN+MO$FNV/B+2+#6K.PBLM5BE,!@D<R6[1IOVR$\
M-\N>5[BJ&F?$"_NGTG4+B+3%TC5KE;>"&*<FZA#DB)W'0Y.,@8V[AUP: /0Z
M*P?%GB!_#^FV[P1PR7=Y=):6PGDV1AVR=SGLH56)QZ8KG)OB#>:=I^L0WEO8
M7>K636ZVXLI3Y-R9VV1]<E<,&##G@>] 'H-%<)+XI\2:5X@MM(U:STUC+87-
MX+BU+[6,87" -R,$\GG((QCFK;>,+H>$_"VL?9H?-UFXLHI4R=L8GQN*_3/&
M: .L2>*222-)4:2/&]58$KGID=JDKRO5/$5U%_PLS^R+"PLK[3(8F:\4,LDP
M,+'<Q'\2@?+6UH?B76;2]\,Z;KD=HT6K6+&&ZA9R3,BA@K%N[(2?J#0!W5%8
M&BZ_/K'B+7;2.",:?IDJ6R3@G=+-MW2#TPN5'US6_0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7D*>#O$$&FV<$?ARQ:
M^T[54OYM0,\9EU';/OPK8RI*G)+D8V@ '/'KU% '!+X7U4^$_'=B84%SK%U=
MRVB^8,,LD*JN3VY!ZU>NO#]_+JG@J=8T,>E>9]K.\?+FW,8QZ_,>U=?10!Y=
M_P (QXG3P3)X"33H39,S6ZZO]I7:+8R;LF/[V_:=N.F><UKG3?$.C>+M<GTO
M2X;NTU>.W\NX:Y5!:O''Y9WJ>6' /RY]*[JF&6,2B(NHD92P3/) QDX].1^=
M 'GWA+PEJ^D7/A)[N%%73=)N+6Y(D!VR.Z%0,=>%/-5]8\(:Y-IVOM:VT4MQ
M+XAAU2VA,P7SHT$61GHI.QNM>F44 4@+B_T9EN+?[)<3PE6B9P_EL1C!(X./
M:O.M)\-^)[/P[X7<Z3$FI^&I2BP&[4K>1-&T;E6'"G!!&[TKT75-5LM&LOME
M_-Y4'F)%NVEOF=@JC !/)(%7: .3\/Z9JMQXKU'Q+J]FM@\UK%96UH)A(RQH
MS,6=E^7)9N "< 52\0Z%J,WC8:I'H5GK-O)8+:P_:I$"V<@=BSE6!R&#+DJ"
M?EQ7<USA\=^'!X?DUTZ@?[.CN/LS3>3)Q)NVXV[<]>^,4 <UX0\*:WI>H>&S
M?6L<<>DV=Y:22+*I$F^1&1E Z @'CMBNE\,Z1>:9JGB6>Z15CO\ 4OM$!# [
MD\J-<GTY4UT=4].U6RU9+A[*;S5M[B2VE.TKMD0X8<CG![]* .4DL/$6D^,]
M=O--TN&]MM82 I.URL8MGC0H=ZGEAT/RY]*I>%_".KZ6_@DW4,8&DV%W!=D2
M [7D*;<>N=IZ5Z)10!YOJO@_6IKC6[^TAA:Y&N6NJV,;R@"<11HI4G^'.&'/
MM2W7AW7_ !5XBO;S5=/CTRQNM!N-,5/M"RR1N[J=S;>/7@9^[UYP/1Z* . \
M-:#>6UY9K/X*T/3&M8&6:_B$3/+)MV@Q;0"H/));!P<8[U%;^#]6_P"%&GPJ
MZ1)JGV!H=A<%=^XD#<..?6NXAU6RGU>YTN.;-Y;1I++'M(VJ^[:<XP<[3T]*
M;J.KV>E/9K=NZF\N%MH=D3/F1N@.T':/<X'O0!PMSI.O7NM:;J][X3M;S;IQ
MM!9W5W&RVDN_/FY(((88!*@L O2LRQ^'-]>_\(MIVOZ7;3Z?I,VHK<_O%V2K
M*=T3JH.0,GIU&*];HH \PUCPGXFN?AMKW@\*MZ$,::5=23*&EA$BL$DST9 "
M,]" *Z;3M$OK?QTVJR1J+0Z+!9[@PSYJR.Q&/3##FNF\V/S1%O7S"N[9GG'3
M./2E=TCC:21E5%!+,QP !W)H \N_X1_5=";1]05+1]1MM;OY8;*6Z6,W45P7
MX1CQO"X;'L:U/!LE_<?$7QA/J$44,QAL5,,4F\0_+(0A;C+8()_WN_4]AJNC
MZ9K]@+74K2*[MBPD57YP1T92.0?<4FD:'IF@6K6VEV45K$[EW"=78]V)Y)]S
M0!S^I:?K.D^-9O$&DZ:NIP7MDEK<6PG6*1'C9BC@MP00Q!&<\ \USNK>!M<O
M/AY?V0C@;5]2U<:G/"DHV19E5B@8XSM50,]S7I[2QHZ(SJKN2$4G!; R<>O%
M5=/U6RU7[5]CF\S[+</:S?*1MD3&Y>1SC(Y'% %VO+-&\*^(X/"^AZ%<Z;'&
M='UN*Z^T"Y1EGA$TCLP'48##@\G->IT4 <+XH\'7GB+7]68%([2\T V"3%@=
MLWFEQE>N.AJ3PQI%S#JT,\W@K1-$$$#"2Y@6)I9)3@?NR@&U,;L[N3D#'6NV
MHH Y;QAH&HZA<:5K6B/"NKZ3*[PQSDB.>-UVR1L1TR ,'L14$-UXUUG4;))=
M+A\/V,,HENI#=)<R3J/^6: #"@]V/..E=A10!YPVC>*-)TK7O#NFZ7!=6NI3
MW$EK?M=*BVZSDEA(A^8E2S8VYSQTK6\.^%[G0O%4DP ;3X]&M+"&3<-S-$7S
MD=N"*[&D9E12S,%51DDG  H \Y3PAK"_"BST PQ_VA%?),R>8,;1>>:>>GW.
M:@T^\U^S\7>.3I&DQZB)+R)5!N5B,4GV>/EMW53D=.1CH<\=_=ZU865S8032
MMOOW*6^R-G5SC/+*" ,=S@5+:Z;9V5U>7-O L<UY();AP3^\8*%!/X #\* /
M-[3P/J>A2Z&G]C66O16ND"R N)56.VN-Y=Y,.#E6R!E06PO3FK/AGPGKFG7'
MA2.\M8D31I=02:5)%VR++RCJHY .<8ZC%>DT4 <:/"YN=2\;_P!JHBZ9K*PJ
MCEQ]Q;<(S'TP0>OIFL[X26E[/H4OB#5)%FO+\1P1RC.&MX%\M&&>?F(=_?=7
M9ZQH>FZ_9"SU6U6YM@X?RV8@$@$<X(SU/!XI-2U/2O#&BM>7TT5EIUJJKG;A
M4' 50H'T  % &+XDTO5$\2:1XCTBT2]ELXIK:XM#*(VDBDVG*LW&590<'&03
MS7-ZMX/U[6M"\3WDMI%!J>LW-FT=F)PPBA@=,;GZ%B Y...@S7HFF:E;:OI\
M5]9F4P2YVF6%XFX)!RK@$<CN*MT %<9X]T'5[UM,UOPTD1US3)'$2R.%62*1
M2KJ2>/[K#/I79TA( )/04 8OA'P^GACPM8:2K;Y(8\S2?\])6^9V_%B:SM7T
M*_O/B1X;UJ&-396-O=1SN7 *EU 7 ZGI70:5JEGK>EV^I:?+YUI<IOBDVE=P
M]<$ BKE '-^,M'O-9@T5+)%<VNL6EW+N8#$<;Y8\]>.U<_\ $[P7J>O6;WWA
MT1C4Y;9K&YB=@JW-N_8D_P 2-AA^(KT2B@#@;ZP\2:7X[BUO3-#CU*!M&BL7
M4WJ0%761F/4'/!%=%HFIZ]?7$B:MX>73(E3*2"^2?<V>F% Q]:W** ./\1Z9
MJX\<>']=TVP6^AM8;BWN(_/6-D$FS#C=U VG(ZU@GP[XHM/".H>"+338)+.X
M>>*#5&N5"QV\KLQW1_>+J'88'!XYKTZB@#(U;08]1\(7F@+(4CGLFM%<\[<I
MM!_#@URN@Z!>Q30)+X*T/2I(+5TEOHA$SRRE=H,6P J#DDEL'!QCO7H-% 'G
ML/A/5D\#>"]+,*?:]*OK.:Z7S!A5C)W8/?\ "J_CS1[R-?&>LLB_8IO#?V9&
MW#)=3*Q&.O1AS7>IJME)K,NDK-F^B@6X>/:>(V)4'.,=5/&<\5+?V-MJ=A<6
M-[$)K6XC,<L9) 92,$<4 <+;Z?XB\07/A:+4--BM+'29$O);M;E7%RZQ%4"*
M.0"6R=V,=.:S[+P)K<7AW6H]D$>HCQ,VM6"O("D@5T90Q&<;@&'M7J$<:0Q)
M'&NU$4*H] *=0!QMC8:UK7C.RUW5M,72[?3;66&"!KA99)))2NYB5X"@)@<Y
M.>U<_P""=#<?$'5XUE271O#]Q,FG!>D<MSM>1/J@ROMOKTR[M(+ZSFM+E-\$
MR%)%R1E3P1D<BH-*TG3]$L$L=,M(K6U0DB.,8&3U)]2?4T &L:?:ZMHM]I][
MC[+<P/%*3QA2""?;'6O._AWH5UKW@K5;W6)Q)/K%M_9T<Z@\VT49B5QGGYCO
M?WW"O0=8T33M?LOL6J6JW-MO#^6S$ D9ZX(SU/'2KL,,5M!'!!&D44:A$1%P
MJJ.  !T% 'G::-XHU;2]!\.ZEI<%K;:;<6\EU?K=*ZW"P$%1&@^8%BJYW8QS
MUJ&\T+Q5!I?B_0++2H)H-8GNKB"_:Z5559DY0I][=G(!Z<@YXKTVB@"GI-O)
M::-8VTP EAMXXW .<$* :\\TWP)K*?#F\TF00PZHNJMJ-IN?<A*S"1 Q'0'&
M/;->GTR.6.9-\3JZ9(W*<C(.#^M '&PV&N^(/%NF:OJFE+I5MI4$XBB:Y69Y
MI95"D_+P%"@]>23TK0^'^CWGA_P)I.E:@BI=VT16158, =Q/4?6NEHH \_US
MPWJ=SXOU.[71++4XK^TBM[:\NG0BPV[@WR,"2"6#?+U(P<=:3P=X;UK3]5T&
MXU"S2W2PT Z9+B97S()$P1CL0A/MTKLK;6+*ZU*_T^*1_M-CL-P&B957>,KA
MB,-QZ$X[TLNLV$-_I]D]POGZ@KM:A06$@10S$$<="#R>: .*N_"S+X+\:VVK
M21VL5Y?W-_!.7&(QA&CD)'3#)G'7BM'X:VEX?#)UO55 U36Y/MUQQC:I $:_
M0(J\>YKH-8\/Z3KZP)JME'=I ^]$DR5S[C.#TZ'-3MJ=A%J<6EM<Q)>R1&6.
MW)PS(#@D#N!0!RFL1:CIWQ&AU72H+74);K2_LTUBUVL,JJDA990#U7+E3Z<5
MQD/A_6/$_@#6;6V6">]?Q3+<.4?;&0L@WE2>H!! ]<5Z9XGTCPY?V/VWQ%;V
MY@LE9Q<2L4,0/7Y@00#QD9YJ70;K05A.DZ'):JEE&A-M!@>4KC<I*_[0.<]Z
M .:^(/A?6M5N[6^\.F-+N6VFTR\9W"XMI0/F]RI&0.O-.\1>#T2YT"[L-"L]
M7M=+MGLFTZYV<Q,$VLA<;=RE!UQD,>:Z^XU2PM+^UL)[N*.[N]WD0EOGDVC+
M8'L.M-TW6--UA)WTZ]@NE@E,,IB<-L<=5/H: .0M_#6H-<^&;I=%TW2TM-2G
MNKBUL=JK%&T+HN<8#ORH) _05M:7I%Y:^._$.JRHHM+VWM$A8,"28Q)NR.WW
MA6E-KVDVT5_+-J$"1Z>0+MF?B$D C=Z<$'\:QE^)7@IW5%\3::68X $PY- &
M-J5SJEG\89Y]-T\:AC08A);B98G(,\F&4MQP1T)'7VP<_P#X074A8V>K7NDV
M.I:@-4NM0NM*E=6C*7 P45F&TLH6,Y. <'FO21IMFNK/J@@7[:\ MVFR<F,,
M6"^G4D_C5J@#SF\\+:C?Z!:I;>'M,TB1=;MKO[):;%*P1L"3(RX5GX8\=L#F
MM;Q7X?U#5?&/A#4K2-6MM,N9I+EBX!560 8'?D=J["B@#S5M"\4:;X?UGPGI
M^F03VE]+<BVU%KI56"*=B6WH?F++O;H"#QTJY;:'KGA+Q%<7&BZ8FJ65[8VM
MN=URL+0R0*44MGJI4CID\=*[+2M5LM:T]+_3YO.MG9U5]I7)5BC<$ \,I%63
M+&)3%YB^8%W;,\X]<>E ''>#=,\0^'/#6D:9<6EO-*;RY:^D$H C1Y)'5U'?
M.5X[9]J[2J>E:K9ZWI=OJ6GS>=:7";XI-I7</H0"*N4 <[X\TB\U[P+J^EV"
M*]W<P%(E9@H)R.YZ5%XNT6]U?X=:AHUG&K7LUF(44L "V!W/':NGID<L<N[R
MW5]K%6VG.".H/O0!S>N:%=:CXF\,7:1JUK8FY^U'< 5#P%!@=^37-^&/"5WH
M[Z7IDO@[0\V$@$FM,L3-+&F=KHH&\2GY<D\ Y.37I=% ',>.?#\NOZ59>1:6
MU[-87L=XMI<X\NX"AE9"2"!E7;!(QG%<]>>$[_4_#NH"R\,Z1H-VMQ;W%E!$
M$#RM"X?$KQC;@D$ #..IZUZ110!YA=MK&L_$?14U73ETM9M*OX8H3.LS@D1A
MF)7C'(P.O!]:;;:%XNN-!\*Z)<:/;VT>AWMF\]Q]K5_/2$@911R./F.<'C !
MSQZ/+IMG/J5MJ,D"M=VR/'#+DY17QN'ISM'Y5:H \W?P9J\UW\224B1-?@CC
ML6,@^8B%D.['*\D4SQ-'?0_"BWO=2LTTS5=#:"XM4:99=TL6T  KUW_,N/\
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M=E/:K]CNK;(VA'V\NRYYWY#<8XQ5A/$&JGP#XVU$WC?:]/NM12UDVKF-8\[
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MJ?.7;C&?FQ]1GVH Y+4?%\VI:T;2;6-4TB*#3K:X3^S-/:X,D\JEB7(C?"*
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MXZ'G.,U7U_PE)HUAJ.KZAK\S>9?6VH"ZCL-[6URF$\PJ&YAV\%<9 [G%0:#
M_BGQKK%W'K<>JQ2:$UA+J%M!LMXY'?(2,;CG !8_,>6ZC@  0:YKNF?#W2-;
MO]>NY+S739PEX[99!:*REF>.-5)9RH/7/S'@8XJ*?QMJ&DZ;K,-G?ZI>6P-H
MMEJ&H:<ZRPO+)Y<B[3&OF%1AU 4YSCFNTD\';_!6DZ$FH&.ZTM+<VUZL6=LL
M( 5RA/(.""N>A(SWID_A75=7TB_MM<UT2W-PT3V[6EMY4=H\3;T9%+,2=P!.
M6YQCB@#D)/%.HV6F^)8]-U76+VV@T:2\M[W4;!H9()UX*@M&@8$%6 P<8-79
MSXFM];\+P#Q/=-_;\4JW8:&(K 5B$F8!M^4X!4;MW7)S707/AC7-7T76;'6=
M?BE;4+-K2,6UGY<4.007VER68Y_O <8J]<>&3/JOAN]^U[?[%$@V>7GSM\7E
M]<_+CKWH X>[\4ZQX?L/$&E2ZK<W$MKJ]M8V^H20"6:**9$<G8B_.R@MCY>3
MCCM5>^\6ZKI^A>)!I>IZK>06UI#<VE]J-BT,D<AEVO&2T:!AC:1QQDCM787O
M@47D^NW U%HI]1O+>]MI$B!-K+"J!3R?G&4Y''!(]Z;J'A+6M=\/ZMI^LZ_%
M)+?)''']GM-D, 1MV0A<EF;N2WIQQ0!3FCUO2O&6DZ9+XCOKJ+6K6Z6;='$O
MV>5%5@\.$^7&XC#;NV<TGP<MYT^'=C<S7]S<_:#*PCEV[8B)7SMPH/)Y.2>?
M2NFU'03?^)M%UC[3L_LQ;@>5LSYGFJ%ZYXQCT.:I^"O#5[X3TAM)FU**\LH7
M8V@6W\MXU9F8ASN(8Y;L!T]Z *FI:]<:%XZD2^N3_9$^CRW42$#"2P-F3!Z\
MHP//]VN2LO%OB6+P+JMO>WF[Q')-:)9OL4%?M:H4 &,'83(.?[E=GXX\&+XR
MLK. 7S64EO*Q:58]Y>)T9)(^HQN!Z^U-U+P1'J'CC3/$/VSRH;-%$ED(OEF=
M!)Y3%L\;?-;L>U '+7FJ:O?7_P 3=)DU:Y6WTNPMVM60(&0FW9WYV_Q$<_4X
MQ5&RTR^*_#&V@UBZ62XLIG^TNL;/ AMHR4C&W' & 6!(SDYQ7;1^!U&M>+[^
M2_+1^(X(H&B6+!@"1&,G.?FSG/08]ZAT7P7J%C)X;DU#5X+HZ%'+#%Y5H8_,
MB:)8U!RY^8;<D]\]!C- $O@Z[U!-9\2:'?:A-J":9<Q""XN HD*21*^UBH .
M"3SBJGQ+M)K6PT_Q98QEKWP_<?:2J]9+<_+,GXKS_P !KH-+T'^S?$.N:K]I
M\S^U)(7\K9CRO+C"8SGG.,]!6M-%'/#)#*BO%(I5U89# C!!H \^\9W,7C#4
M?#OA2RD$MGJ174[YEZ&SCPR@^SMM ^E6_'.G3Z1-%XXT= +W2HB+R$':+NS'
M+H?=0-RGU%3^!_ *>#IKV9]1?4))52"W>2/:;>V3)2(<G.,G)XSQQ71:[IG]
MM>'M2TKSO)^VVLMMYNW=LWH5SC(SC.<9H Y?P+IT^JSR^.-64?;M4B7[%#G(
MM+,\H@_VFR&8^IKB_"F_PE8Q>+X<_P!FW%_=6FLQCHJ?:9!'<8_V"=I_V3[5
MZYH6F?V+X>TW2O-\[[%:Q6_F;=N_8@7.,G&<9QFJ&@>%X='\-SZ+=2)>P3RW
M#R;H]H9979BI&3V;'O0!YQXD97\/_%AE(93- 00>"/)BKM;'6?$,CVT<O@.6
M&)BJM,;^V(1>,M@-DXZXZUE67PK:R\)>(]!&N22IJS*(II8,M;QJH5%/S?/A
M5 SQTK671/'2(%'C'3< 8'_$E_\ MU '85Y3'XGO(=?TR>#Q#J&I&[U;['/&
MM@5T\1,S*%CD,8&Y<+SO.2#7JH!V@$Y..37GL?P\UB+2M-TU/$4(MM'N4N-.
M7[">J-D>=\_SX4E?EV]<G)Q@ Q[C4/$TWA#Q-XC7Q'=0RZ1?7BVEO'%'Y;I%
M*<+)E26X&W@C  [YK?BN=6\4^,-4M+?6KK2K72K:V*):I&?-FE0N6?>IRH&!
MMX[U?/@DGP=KV@?V@,ZM-=2^?Y/^J\YBV-N[G&?49]J9/X1U6UUV74]#UJ&R
M:\MHK>]2:T\X,8P0LB?,-K $CG(Z<4 1_"?S/^%<:=YVWS?.NM^WIG[3+G'M
M6=%8W,GQOOW.K7HCCTB&40CR]A4R./+/RYVY&>N<GKCBNI\(>'1X4\,6NBBZ
M:Z%NTI$S+M+!Y&?D9/(W8SWQFJMSX9O?^$Z3Q'9:E%#'):+9W5M+;[]Z*Y8%
M6##:?FQR#0!YWX<;6M$^&'A?7X=<N HFMH3IX2/R&A>81D'Y=V[#9W;NO05<
MU?QEJ$M[X@NK75M6AO=-NY+>PTZVTQYK>;RL B1Q$<EVW#[PVC%=:G@4IX T
MSPO_ &B";*2!_M/D_?\ *E$F-N[C.,=>*=-X4UB"_P!1_L;7TL-/U*?[3<1F
MU\R:)R ',3[@%W8[JV"210!U,;FZLE<;X3+&"./F3(]^XKQK1]2U#PYX*U6]
M36;YYKSQ#+8B1X5F\G=.0\RHJ99RH)QR,XP.U>UC@5P</P^NXK'4[#^VD%K-
MJ!U*P=;7][:S^8) 22V'4$8Q@9!/- &!-XJU.ST/Q4FG:GJUW;VNE_:[._U"
MQ:&6*7+!DRT:!Q]UAQW(J_?R>)K&W\, >(YVN];OT6X8PQE(4:!V*1KMZ# (
MSGD#.>16]=^%M:UG0-:T_6=>BEEU&V^S1_9[3RX;<8/S!"Y+,<\Y;L!Q5[4/
M#)OG\.M]KV?V/<+/_J\^=B)H\=?E^]GOTH Y2RM?$5YX@\2^'SXLU%+72TAF
MM[@)%]H9I4)"NVS!12I.  3GKQ5 ^*M4OO#_ (9U/5M4U+2]+NM-,ES?Z;;*
M_P#I.0!YGR-L3&3P ,GKQ7?67AXVGB37=7^U;_[5C@3RO+QY7E*RYSGG.[T&
M,5CZ?X1U[0M%TJPT;Q% GV.T^RRK=61DBEYR) H<%6Y(ZD$4 =+HDLD^AV,L
MM_#J#O"I-W H5)^/O@ D#/7BO./&/B>[TN[UF^M/$.H2W&G2IY5C9V!DM(U
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M;R21HA'AF15(P">,J2/0$#MFNBH **** "BBB@ HHHH **** "BBB@ HHHH
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MK>/1K4I$K'$.5E.U?0=\=LT >KIK$*7&FV=ZIMM1OX6D2U)WE2BJ7&X<?+N
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M,C*/*E4-@JISG<.I&.G-'B7Q'9>%]*%_>I/*'FC@BAMU#22R.<*J@D GOUZ
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MKJ+4H$'-Q9FYD+''=D/S#VR* /0;[QWI=AI6O:A);WCQ:+<K:W"HBEG<[,;
M6P1^\7J1WJ*#QK<231Q?\(9XGB#L%WO;0A5R>IQ+TKSS6;F*^^'_ ,1[JTE2
M2&?5X9(I!RK*PMB#],$5Z/:67CA+V!KS6M$DM1(IF2+3Y%9DSR 3*<''?!H
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MNT@^SI>6UV\<[1\95W!RP)&>>_-+<>#-+ET*UT6WDOK&QM@0B65V\)8'.=S
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MR]5FMKJ)HI0K8)4C!P>U<_H/Q#T'6_#D^M&\BM;>W=EF$K_ZL;V5"3@<L%!
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M/ 7#'],YP*>? >A-H>K:.89?LFJW;7ER/-.[S6*MN4]L%5(^E=+10!Y[XO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKZV>VO+>*XMY!AXID#JP]P>#57^P='_LO^R_[)L?[/SG[)]G3RNN?N8QU]J
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M#(S]17H$<:0Q)%&H2-%"JJC  '0"J-[H&C:D7-]I-A=%V#N9[9'W,!@$Y')
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M0.NX!HH54C<<MR!W(!/KBEETK3I[>XMY;"UD@N6WSQO"I65N.6&,,>!R?04
M<9I%U87?QHUI[&2*3&CVZS/&009!(_<=2%VBGZW;Q3_&3PNTJ*YBT^\=,CHV
M4&?U-=?9:3ING;?L.GVMKM3RU\B%4PF2=HP.F23CU)J=K6W>ZCNF@B:XC4JD
MI0%U!Z@'J <"@#R6\AN9+_Q];7GB/2]+MIK@_:H[RR\V1H&@0(RMYB\8R  #
MR#W-3ZL1X>M]8O[#6],U 0VD"ZQI6IP[?M)2!0"A)R"Z8P"&4D^N:]*N]%TK
M4+N&[O=,L[FY@_U4TT"N\??Y6(R/PI+K0])OKV*]N]+LKB[BQY<\MNCNF.F&
M(R* //AJ]OIOC/Q[=S0H[#1[6=+.0@-,%AE8ICOZ'ZU5TR[E_P"$U\#K<ZQI
MEP&M9S':V%L(H[56A&U VYL@[< '&=A/:O3IM)TVXU"._FT^UDO8E*1W#PJ9
M$4YR Q&0.3^=0P>'=$M8TCM]'T^%(YA.BQVR*%D'1P .&]^M 'CVE3,_PR\%
MBWU"UMC:ZX_VB69!*ENQDN!&9$W#C<5QDCD@U=\16AALM:U"\U^RU56U+2_[
M46UM3%'%''(,EOG8$E67// 49KU9-!T>-+M$TJQ5;PYN@MN@$YY^_P ?-U/7
M/6I+;2-,L]/:PM=.M(+)@0UO%"JQG/7*@8YH XNXO=.O/C3HQLYH9IDTBY$K
MQ,&^4NA4$C_@1Q[^])\6_P#D%>&_^QAL_P";5V5EH>DZ9Y?V#2[*U\O=L\BW
M1-N[&[&!QG SZX%6+FSM;U8UNK:&=8W$B"5 P5QT89Z$>M '%K;Q2?'>:9T5
MI(O#L>PD?=S<."1[XX_$UA65[IEG\/O'5KJLT"7GVS4?M44K .[/GRR >3E2
MFW\,5ZF+6W%V;L01?:2@C,VP;RF<[=W7&3G%5;C0M(N]0CO[G2K&:]CQLN)+
M=&D7'3#$9% '!^";66/QR/MT?^G0^%]/CD+CY@Q+[Q^:\_2L&UMX8/@+IS11
M*A_M:-\J,?-]OQGZXX^E>R+;6ZW3W2P1"X=0C2A!O91G )ZD#)X]ZB_LRP%F
MMF+&V^RJVX0>4NP-NW9VXQG=S]>: ,3XA@GX<>),#/\ Q+9__0#7%:M<0W.O
M?"B2":.5-T@W(P89\A..*]8=$EC:.1%=&!5E89!!Z@BJ-OH.CV:P+;:38P+;
MNSPB*W11$QZE<#@GN10!YD]O#_PK_P"*<GEJ7?4+_<V.3MC4C\C6S>P)!XB^
M&T=NBQ[(;E$ & !]EZ?3@?E7=_V?9>1<0?8[?R;EF:>/REVREN&+#'S$]\]:
M>UG;-)!(UO"7M\^2Q09BR,':>W''':@#QWPK97-WX6\+6U[XITVW6#4(F6R%
M@?M(N4D)>,MYF=Q(<,=O0DUV/Q;8)\.KQV("K<VC,3T ^T1\UU*:+I46IMJ<
M>F6:7[\-=+ HE/U?&?UJS<VMO>VTEM=013P2#:\4J!E8>A!X- '$6-]90_%G
M5[B[NH +C2K8V,K2#:T:O)YH5NG#;20/:K'PRPV@ZG-!_P >$^L7DMD1]TPF
M4X*_[).XBNAG\.:'<V4%E/HVG2VEO_J8)+5&2/\ W5(P/PK1BBCAB2*)%CC0
M!511@*!T ':@#R=YX5TSXMVS2H)S]H<1EAN*_9!SCKBC08HY;OX2&1 VS2+E
MUR.A\B'G]:],DT72IKR:\ETRR>ZFC,,LS0*7D0C!5FQDKCC!XJ5-/LHC;&.S
MMT-JA2W*Q*/)4@ A./E& .!Z4 >:PVL T;XKN(4W//<ACCJ!:J1^K$_C5'1S
MJ*>( R:YIVF&7P[I[1MJ%KYPEB"OOVDR)@!CEAS]X5ZR+&S"7""U@VW))G7R
MQB4D8.[^]D<<]J@O-"TC488(;[2K&ZBM_P#4I/;HZQ_[H(XZ#I0!C>#7T_2/
M#&@Z0FKPWC2V[-:2;#$9XUYRJ$DX"LH^F*ZBH39VS3PSFWA,L"E8I"@W1@\$
M*>P.!T]*FH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@*8G2 Q[2A&3DXY'8U0T#P9K&GZ%X#M+B.(2Z-<RR7@$@(4,D@&/7EQ7I%%
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M(KW6KW%W%L?=F-]NTGT/!XKKZ** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW%L]W:RW00B:- &;A&)5@I!VM@X^E.TSQJEXGGWNC:CIED]HU[#=7(1HWA4
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MB*.<X8LA^C52OO'.M0S:C%%)H,,ND0Q_:X;J5E:ZG,8D=(OF^4 $ $[LGZ4
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M; R#G()% 'J]%0VHN!:0B[,37.P>:800A;'.T$DXSZUQGQ'OM<LG\,IH]U!
M+K6(;>3S ^6)#%0=I&4^4[AWXH [59X7G>!94,J %XPPW*#T)';.#^58VO\
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M*CCGBF+B*5',;%'VL#M8=CZ'D<4 <%XW\%ZI?C3G\.21PS"SDTFZ>1]I^R2
M<CU*E<@>YJWXA\)E+W0[[3-'LM2ATRV>R;3[HJH:%@FTH6! 92@Z]03S7;44
M <%/X8U6\M?#C_V;I=A)::V+^>VLL*D<05U S@;WP5R0!G\*[VBJFJ:E!I&F
MS7]T)3#" 6$,32-R0.%4$GKVH Y[QOI&J:@VA7VDVT5U/IFHK=-;R3>5YB;&
M4@,00#\PIVCZ)J%OJGBJ\N8HXQJLD4D*K)NQBW1""?\ >!KJ(I%EB21<[74,
M,C!P?:G4 >7V?@G4M)M/#UV^B:?K,]KI*Z==V=Q(@VE6W*Z,RD'!+ ]."*[W
MP]:7%EHD$5W:6%I<?,TD%@FV)"22 /4@8!/&3DX%:+NL:,[L%102S,< #U-4
M;[6;/3TLI)3+(EY.D$+01-*"S="2H.%_VCQ0!F^,M$O-:TJU;3FB^WZ?>PWU
MLLQ(21XS]QB.@(+#/O6!K>F>+_%&D7RWMC96T DMG@TEK@2?:!'*'D$D@7 #
M@!0.1QSUKT&B@#S5O#.OW&H:W<_V1864.J:(]C';P3+_ *.XW[0V% ;<7ZCI
MTYQDLA\$ZCI^D>%)VTFPU6ZTO3VL;NQN'7:X;:=R,P(W*R=^H8\UZ;10!PP\
M-ZI/_P (W.VG:98-9ZJ]Y<6UE\J1QF.1%&<#>_S*"0!^E0>)/!6HZY?>*FB>
M*)-1L;2.TD9NDT+N_P P[#.WGZUZ!6)K?BS2/#]W:6=]-,;N[W&"WM[>2:1P
MO4[4!.!ZT <X^F^*]>\5Z!JNH:?:Z7;Z<MRLB1W0F<O)$5WC  P#C Z\G.*Q
MM/\ "'B*ST_PY F@Z9 ^B7<<L\D=P#)?D!E9PVWY?O%B&Y)/;'/J]% '->"]
M$O-#L]6BO0@:YU:ZNX]C9_=R/E<^^.U=+110!Y=>Z&;WXR_8K:9&TUE@UC4H
M!_!<1!DB![#=E&QU/EYJ_J7AC4;3Q#K-W8^'-'UA-49)HIKUE!M90@0[@5)9
M/E#?*<]1[UV.D:!I.@12QZ5I\%HLS[Y/*7!=O4GJ:37M=T_PUHL^K:I*T5G!
MM\QU0L1N8*.!SU(H XF_\(ZP=8UA8-*TJXCU.TAMX;Z0A5L L6QE6,@G&<LH
M!QD\GBK?A3PWK-CXBTO4M0MH8$MO#L>ER*DP<^:DN<CCH5 /XXKO%8,H8=",
MBEH *\[UKPKK%UXA\0M!IFGW,>L01QPZC<R M9*(]C+L*DGG+#! RW->B44
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M@8Y [9K<HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQUS7[WQ''X!DU+;?6$QGO-31E#SVB[610.TC;U5N. ">XKK-+T+Q!:3>9?\
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M(VZ2-)=WRJQ)ZJ2,GF@"G<>,+O2=0UVZN9G:UFT*+5M/A;I&P!1T'KEC&?\
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MC9.>=H P.W'2N</@"'_A'['3!J$IE@U1-4N+IXP6N)A)YC9 ( R>/88ZUV-
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MN+61EEA(#*0I/!(/7&/H:\PBTZYC^'_PVBM]3N?.N=0M'2:7:YMPUL^0@QC
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M$!/? X%=?K5C<:_X_P!;MI_#=KKL-I9VT4"75X(1;B169F0%6^9B,;A@C8*
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M>(8[OQ'K&DM"(AIJ6[&=I.)/-5B.,<8V^ISFO%M%TNPU#X1?#K[99PSY\0+
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MH+US-=+$-GG,;1BQ;'7=@ ^HXH ]F1TD7<C*RGNIR*%D1U+*ZLH[@Y%>,ZY
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MQN)#%',Q(!<!B5.1\I 1L@XZ5!!XZ\-7%C=7J:K&(+21([@O&Z&(N<)N5@"
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M<&KNA^'M,\-VDUKI5OY$,TQG=-Y;YR ">2?[HJ[>WD&GV4UW=/L@A4N[;2<
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MAE5WXVAB""%)SR.*DN_&7AZPU?\ LJYU.*.\WJC(58JC-]U68#:I.1@$CJ*
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MB2Q1"<+DGG%;-9VC:[IGB&S:[TJ[6XA20Q.0I4HXZJRL 0>1P1WK1H ****
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M*':0#T8K\Q')P/4T >;^#+R[\6^(=(BU)&\WPK:O%>;APU\6:('GKA$9L_\
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M>".&>ZMUD5V4@R(NYE ."A]P/:G:4ECH>M^#;N76(KS2'_M(0WS1>1")Y7#
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M2;5W919Y"Y([_(&X]*W]!B2\\:V5])XPLM6NH=/E"06=F(P879.6978 95<
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M]RJ@;FZ9/J>!S4E 'G?QP_Y)7J/_ %VM_P#T:M:%C$A^,>L2E 9%T:U56QR
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M2[8P,!;L;95 DX^4DC'..: .BN?B2D5MJ5[!H&I7%AI5U+;W]RAC B\MMK$
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M?[73/:@#URBBN8\1:YJ<.O:9X?T1;47U['+/)/=*SQP11[03M4@L26 '([T
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MS,Y*!SG& >V<5L:AX3OWU6\O]&UZ32VOXTCO%%LLN\HNU70DC8^WC/(X''%
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MNK.YEO-8E?69;V*_34(H%012QJ$3;'DC;M!!!)SD\^EFU\'SM<:E?ZOJQO\
M4KVR-@LR6XA2"$Y.%0$\DG)))S@=* //M$UJ>U\#^ ]'2;5(;6[M)Y[E]*@:
M2X98R JC:"5!+Y) [8SS3?%E]J-Y\-'CU!=0*VWB""*UFU"W:&::#*LK,"!D
MC<5SCG;7=6W@%].T+0;33M7>WU#14=+>\: .'1_OJ\>>0>.X(*@YI^K>!IM<
M\,)I.HZ[<3W'VU+R2Z>(<E6SL5,X5>P&3CWH CCUV?P_XXUVQU>[=M.ELO[4
MLFD/$2(-LT8/L=K >AK1\"/J=QX2M;_6)I'O+\M=E'/^I20[DC'H I48]<US
M'C^SLO&7B+1O#MGY[WUK=%[^2-&"P6C)^\1FQCYP5  _I7I2J%4*H  & !VH
M \LT[1;_ %35O'4MOKE_IP@U)C MHX0>;Y$9W/D'<.%&WIU]>+7AKQ1J<VL>
M&;[4;AFL/$6E ;#PD5Y&-S$>@==W'JM:D_@;44N]<GTSQ+)9+K,QDN4-HL@4
M% GR$L-K8!^;GJ..*Q_'>G6#>&]*\"Z-]H_M>)[;[!Y:L3;(IVF9WQ@ ('SW
M)/O0!T?@2^O=:LM1URYN)'M;^]D-A$Q^6.V0[$('^UM+?B*PXM.>3XW:E*=1
MO@L>D0S",2C809'&PC'W.^/4FN^TZP@TO3;73[5-EO;1+#&OHJC _E6)<^%[
MA_&J>([/5#;[[5;2ZMF@#B9%8L,-D%3\Q]: /.- CU/1?ACX6\00:Y?"03VL
M1LPRBW,+S",H4QR<-G=G.>F!@"WJGB35[R\\0WEE/XC_ +0T^]DM].M;&Q>2
MT;RL#;)A2&+L&R2> 1C&*[-/ T2>!M-\,?;W*6,D#B?RQE_*D$F,9XSC'6BX
M\'WZW]^VE^(I].L-1G^T75O' K.'( <Q29RFX*,\'G)&* .I@D,UO%*R-&70
M,48<KD=#6/XRUF;P]X-U?5K=0T]K;.\089&_&%S[9(K<JGJNF6VLZ3=Z9>*6
MMKN%H9 #@[6&#@]C0!S=EHFK:%LU&7Q5<W%L+21KX:CB1 ^W(D3 &P YRN<$
M?3-<YX9UF[C\6:#!%JFO7]OJ<$WVB74[8Q0S,J!UD@! *CKP.,$?6MZ/P)>W
M4)MM<\2W6H6B64ME#$D*P861-C,Y!/F/MX!. .3C-+:^"-2CU'1=0O/$CW-S
MI)*0C[(J1F$KM=2H;[S#'SYXP,#KD Y'2KS7G^$6J>+KGQ#J$E]]AND@CW@1
MQ!)& ?&,E\H?FST.,5=\3SZUX=\#Z7J*Z]?S7^H:E9F=V<;4#_>CC 'RI[<G
MCK746W@:*W^'$W@\7[M'+%-%]I\L9'F.S9VY[;L=>U3^)/!\?B+P_IVDO>-
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M?<Y"8!QP,\\U3T;3-/U@_#/^T;&SNP\VHV[>8@F5HHQ+Y:98?,JX&,_6@#W
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M=CL;6"2*2.%5,,7DQ^B)Z =!T'UP/04 3+-$\C1K(AD7[RAAD?44XD*I9B
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG8A=CM7V'I6_10!QX^&7AD7PO?+U'[2!M\S^U+G.,YV_?Z9YQTJ:32;W3/B
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/8Y&#0!:T;QAK$_@_0KN?P_=W>J:C%&42)XPD@\H.9F?.V-3DX!YSQBJVO\
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M6>/=)?6?%WA^RMIHX;W58&L]5MXVW'[&K+*YSQ@ JR D#/F5ZDJJBA54!0,
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M1C';Q,[,(HR1SM!QT ZUT>G^';VV;Q<9#%_Q-KAI;?#'@&!$^;CCE3ZUU5%
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M"V\^Q@FE\F,)YCF)<LV.I/J:Z6@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'4=7L]*>S6\D,?
MVRX6VA.TD&1@2H)'3.".>_%7JQ?%FBGQ!X8O=/C?R[ED$EM)_P \YD(:-OP8
M"@"YJ6KV>D_9/M<A0W=PEK JJ6+R-G P/H23T !J]7G.@:@GQ!\16>H30XM-
M)L-LL1XQ>S+MD7_@" C_ +:54T6:[OM1TGP5<32M+H-Y)+>R%CND@AP;;)[[
M_,C/OY;4 >HT5X[JFG0S>$/'FLR/.VH6&I7;6<WG,#;E-K#9@_+SU]>G2M;Q
M%'?:Q\0X].EM+"]M4TE)X+:_O)((V<R,)' 1&W, $'/W0>.M 'I9. 3Z5R;?
M$;1$NTM&M=;%S(AD2$Z/<[V4$ D#9D@9'/N*M>!8[J'PI;Q7=_;7Q2258YK:
MX:=?+$C;5\P@%BH^4G'\-4K_ /Y*YHG_ &"+O_T9#0!MZ;K]GJNHW5C EPDU
MM!!/()HC'A90Q48/(/R'((&*U:\].@Z?KOQ&\5IJ,+311V5CMCWL%R1-\V ?
MO#'![9..M8!O=3U+P?\ #JWE:*Z@OT(NEO+IX8[AUA)C22158G)!.,?,5&:
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MI4D 96.X*UHCGO\ WN:LK%;ZOXA\-Z7K3&336T#[1%#)(52:X!0,3R-Q5#D
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M%(=->SU.UCM88A$_F0L+8O&S/OPP.SD!5QG@G&2 >ET5Y];_ ! O+A_"Y%K
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M8L@"$]<@\$\&KU]XGO-!O?$C-9:?-JEO;Z;$)HHVC%Q-,SH-_P Q.Q2<@9R
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M *6)QSDGDFEOO#VHS3V=Y9^(;JUOH+<6\KM&LD-P.I9HC@!L\Y4@\XZ5T-%
M',6OA2[MQJEXVNSMK6H1QQ&_$" 0HA)54CQC'S-UR3FM[4+,:AIEU9,Y1;B%
MXBP&2 RD9_6K-% &%-X:BF\"MX7-RXB.G?8//VC=CR]F['KWQ6-K_@R"33M7
MN,WET\VGVUNL-L%$@:W=G1T+'&[<0<'^[[UVU% 'FFDZ7J.O^+I+^[EU-[<:
M--8R7-Y8_9 'D="%2,@$X"L2W()(&?3JAX4A%EX9MOM3XT)HVC;:/WNV%HN?
M3AL_A70T4 <<OP^M$A\0(E],K:M()(VVC_1")&E79ZXD=G^IIX\$&T&AR:5J
MCVESI5HUFLCP+*)8VV[B5)&&)0'(/<]:ZZB@#SO5_#3:)X4UW2H3J.L2:U,\
MMNBP9>.Y8 [WD'RJ-X5LD #'&>!78^'=(&A>'[+30_F/!&!))_STD/+O_P "
M8L?QK3HH Y&7PAJB^(]0UJS\1M!->;5P]E'*8HU'"*2>%SDX[DY-%[X1U2ZU
M^#68_$;1W4-JMLF^RCD"_P!]U!/RECUQV '2NNHH Q$L];BOM(#ZF;B&%9OM
MS>4B";('E\#D$'TXZY[5-KFCRZO#;FVU*ZTZZMI?-BF@((S@@AT/#J03P?PQ
M6K10!S%OX4N)]6AU+7=7?4IK>*2*WC2!8(XQ( '; R2Q QR<#GBJ-CX"GMHM
M#MKC7I[BST2=)+.'R%3Y55D <C[Q"M@'COQS7:T4 <@O@7[/_9\EGJDD-S9:
MC<WR2-"'!\\OO0KGT<@'VJ6V\(WFGO);:=K]Q::4]RUS]E2!"Z%GWLB2'HA8
MGC!/) -=510!FZ_I<NM:#>:;#?2V+W,?E_:(AED!ZX^HR/QK+TOPO?6=I_9U
MYK$=WI/V=K<V2V,<*["-N,KR!BNFHH Y*P\$R13Z<NI:S-J5CI8(LK:6%%VG
M84!D8?ZPA"0.!USR:2\^&OA:YO=.N(=$TVV^QW'G,D5G&!,-C+M;CIE@WU45
MUU% &;ID.HQWVJ->SF2W>Y!LU(4;(O+3(X_V]_7FLF]\+:@_B6[UO3->>PEN
MH(H)8_LJ2@B,L006Z??-=110!R4'@2"%+9Y-1N)[M=575;BYE5=T\H0IC  "
MKC  '3%2ZKX)M=7FUR6:[FC;5([908P,P/ S,CJ3U.Y@<'TKJ** .,G\$RW=
MW=ZCK&IS:I--I4^FM!'"D*M&Y4_+SPV5/)/?L!7/Z-8:IJGB;PN\YUB:'2DF
M,QU"Q%LL2M"8PN<8E<EAEE)&%/3//J=% '+:3X3OM'6TLK;Q!<#1[.3=#:"%
M ^P$D1M)U*#IT!P ,TC^!K&76]=U"2>1TU:V:W>W*C;%O15D9?=A&F?]VNJH
MH XV/P']FTK1X;35I4U#3+F6Z2]EA63S9)=_F%TR,YWGH1CBHI_AZ]Q%K2R:
M[<.^JF":61X5)2>)E*N,8&WY -N.@ZUV]% '+/X5U&+4+C4-/U]K2[O8HTOF
M^R(ZRNB[1(JD_(V..XX''%7[3PZMKK\&K->SSRQ:<+ ^;@LX#[M['^\3[5M4
M4 9NCPZC"M]_:,YFWWDKV^0H*0D_*OR^G/7G&,\U'::!!;ZCK5U(WGIJSHTL
M+J-H"Q+'CW!"_K6M10!P]A\-;33M$N=.AU.[W'4$U"TN" 7M7156-1G(8!4"
M\]036ROAZ[N]/U.UUK5Y-06_MS;LBPK%'&A!!VJ,G)W<DD]!TQ6_10!Q3?#F
MUETC1K&74)Y&T^Z:YFF*C==[I/,D5_0,P4GZ5TNMZ7_;6D3V'VNXM&DP4N+=
M]KQL"&!'X@<'@C(K0HH Y)/ T=W%K!UW49=3N=4MEM)9A$L(CB7<5"*,X.YB
MV3GG%7;'0M6CDSJ/B*:]B6!H4B6W2(-D ;WQG<W'; Y/%=!10!ST'AJXL/#&
ME:1INL3VLNFQQHEP(U82A5VX=#P0>N,CD#FL\^ 4FBO9[G5)6U6YNX;T7D,*
MQB*6(80JG(QC(.2<Y//3'8T4 <\(;O1K*^OM9O[O6!(BI]FMK+Y0O(PD29))
MW<DD\#L!5/X=>'9?#OA9([I)$N[E_-D25MSQJ %BC)[[(U1?J#76T4 <_JWA
MNXNM976-*U5]-OFM_LTS>0LJ2QABRY4_Q*2V#[G(-44\"QV$6E2:/J4UG>Z=
M'+$+B2,3>>LK!Y/,4XR2XW9!&#[5UU% ''#P$JQK=+JTXUI;]M0_M#REYE,?
MEE?+Z;-GRXSGOG-/;P+'>0ZI)J>IS7.HZ@8";N*-8O(,)W1>6O.-K$GDG.>>
M*ZZB@# TCPY/9ZQ+K&IZF^HZ@T MHY/)6)(HMVXA5'<G!))[#IBK6A:(FAV]
MY&L[3-=7DUX[L,'=(Q;'X# ^@K5HH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>exhibit1013-zerondaxexec003.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<T 4K[2=/U)-M]96]P,8_>QAOYUA/\.?"AG$\>C0PS*VX20DJ<_@:ZDD 9)
M'J:J:AJEGI?V7[7+Y?VJX2VAX)W2-G X^AIJ36S%9%I5VJ .@&*=112&1SPI
M<0O#(,HZE6'J#2&%&@,!'[LKLQ[8Q3;Z:XM[&>:UM3=7"1LT< <)YC <+N/
MSTR:P-1\6OI6H>&;"[TQTN=;<QNGG _9G"!B"0,-@G&1Z4"LC>6S@46X"?\
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M:*3(SC(SZ49 (&1D]* %HI"0" 2!GI2D@#).!0 4444 %%%% !1110 4444
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MNIQ6SLQQ I4Y"CH"=QR?IZ5VEEX%T6PU&&ZA%V8[>5IK>S>Z=K>"1LY9(R<
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M22"S\YC-*9IIIY6DDE<@ LS'DG  ^@% ',6K)%\;-16Z($TVBP_8RW=%D?S
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M%/"FG:+&P<VT6)''\<AY=OQ8F@#;HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/;S1S1/RLD;!E/T(H DHHHH ***@N;VULPANKF& .=JF60+N/H,]: )Z***
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MG #*R$D$#*N<$@\@57TOP^U_I.L6FI>'],TBVU"/R%M[,*9-A4@F1U 4G))
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M[-!OA<1E(\%=Q8DD<]!WKNM*EOI],MY-3MX[>]*_OHXGWH&SC*GT/4?6O/\
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M0>XJ.\\.^)?%FAZ[!KMQ;V"W]L(;.P@;S4MV4[A([X!9BV,XP,#N: )XM?\
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MR?$TFEVNE)!H=Q(A:Y$A-PJQJ^T;2-K<GYCD<CCJ:R+KP9XA.E7VGP:-IK7
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M([I96MF1!OCB?YP"I 9N0>V.@%>MZQ!=7.BWT%C.T%Y) ZP2KU20J=I_ XH
MNU3U74[?1M,FU"[$I@AP6$,32-R0.%4$GD]J\NU'QQJUUH?AG4+"Y>,V]BNJ
M:NH4?.B21Q2(?3DS'_@%2>./$VM0Z?XYU+3-1E@M])CM+2U,>,><SJ\K=.NV
M15_.@#T27Q%IL.NV.BR3,M]?0M/!'Y;?,BC)).,#Z&G:+K^G:^EX^G3-*MG=
M/9S90KME3&X<]>HYZ5P^HNTGQG\&.YRS:5<$GU.VI_A'_P >GBS_ +&6\_\
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MR.1W .^HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'<1CT%2W/P_?^V+C6K'5S;:HU^U[;RFW#I&'B6)XV7<-ZD(#G((./2NT:1$
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M8[%] .>.:Z;(QGM10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% #719$9'4,K @@]"*\0DL;C6?#5G\/XI'^TZ7<W^YE/S;
M;=3]G/T)F@/_  &O<:R+7PUI5GXDO?$$%N5U*]C6.>7>2&4  <=!]U>G7 H
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MNRKMW$L223W/<Y)JOK/A#2]<O1>7!NX+GRO(DDM+J2 RQ9SL?81N7)/7IDT
M<%KO]K^&="\,:S"5NO&26WV%K:,F7^T(PI+;B.3MP)-WKD?Q4OV#37\/>#;"
M&Z-]IVNZGY^IW3'!O9#$\A#^Q=0-IZ;0.U>B6GAK2;'4H+^WM0DUO:"SMQN.
MV&$?PHO09P,GJ<"JDG@C0I-.NK VLBVUQ=?;=J3,IAGSG?&0<QG//RXZGU-
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MAS7%B0:M=W5C-<7F?WMR\DR,X=NK#))P>FT>E>A_%#_DF/B+_KS>D7X:>&U
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MTO4[H)#:[)!&XER'W%6.U  <#TK EDD;PIX%B<*JV_C,01HDAD6-%GE"HK$
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M#VAWIL]1U..&X5 \B!&?RU/0N5!"#W;%2:CXLT'2F1+S4HD:2$3QJH+F1"<
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M>F:ZG]G--;ZE:QJLT<8=!Y<FTD8;(((QG8>* .]HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "N=@\-M9^*=1OX&A?3-5B'V
MZSE7.9E&T.O8AEX8'K@&NA8D*2!D@=/6O(=3\;:WJG@+Q;=3V5UIOV"_\B*Y
M29 8PLT:F/Y&+;@"V2.#G@F@#TZ+0-&@E26'2+".5"&1TMD!4CH00.*H^'=
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M"DD\FHV\ERLB8VQQH%^9O8E@!0!LT444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1110 4444 %%%% !1110!6M].L[2ZNKF"WCCGNF#SR ?-(0,#)]AP/2K-%%
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MT4CNB2(S(<,JL"5^OI0LL;NR)(C,G# ')7ZT /HHID4T4REHI$D ."58'!H
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M'&* .);0M-T34?A_?Z?:QPWUQ<>5<W*C]Y<*]L[-YC=6R0#ST[5C;8GG\/\
MB#3M"M;."]\01^7JDUWNOKD22L&#*$^XR[OE+G  XKUF;0M/N#IAE@)_LQQ)
M:_.PV,$*9Z\_*2.<UB'X<>&BCI]FNMGF>;"HO9@+9MX?,(W?NCN&?EQ^5 '$
MV6C:9::-\5;BVT^UAGB:\@CDCB566,VRL4! X7/./6G:%:P:Q'\-](U.))],
M.BR7/V:4;HYID2,+N4\-M#,0#ZUZ _@K1'OM4NS#.&U6%H;R-;F01RAEV$E
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MWB_MNXD>::^(_?-(;G:4+=<8^7;T]J]XKDKGX;>&+MKH36EPT%S(TKVHNY1
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M9RRDJQV[\CJ!UXQ71ZAK&DZM\5_!YTV[M[MX[:],DENX<*K1KM!(]<,<?XT
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M$\CS+C.5106(P1GCC-<3;ZII.EQ?$2PUF>%+R>]F<6\C#S+B*2!!&$7JV>0
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MU77-"U76OAY'I=U;7#K>!U$+AC%'Y#C#8^[DXX/]T^E=OXN_Y$K7O^P=<?\
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M^YL(_-NO,A>-XDP6W%&4-C )!QSCBK.C^(])U]KD:7=BY%LP65E1@H)SP"0
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M-;FJ^(;?3-1T>P$4EQ<:K.8H5C(^554LTA_V0,?F* --;6W0Q%((E\E2L6$
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MC7DD@QMB3=M7/N3G'T-:] !1110 4444 %%%% !1110 4444 %%%% !1110
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MWS)\V,GYLUTTWA>UNO$L.MW=U>7+VYW6UK+(/(MWV[2ZH /FQGDDXR<8K<H
M\CUK3-4U[3_&.NVFE7JI=OI_V.VEA,<\Z6T@=V\L\C.6"@\G'3FMM;VY\0?$
M/1]2MM(U.'3H-.NXC/=6KP_O&,9V[6 (Z<$]><9P:]!HH Y+X8V5SIWPVT2T
MO+:6VN8H")(9D*.IW,>0>15&]N)_#?Q(O=4GTW4+NPU+3X8DELK5IRDL;/\
M(P4$C(<$$\=:[NB@#QB#0-0DT+3=1U/2=5B2UUV^GN[6S,B7"13%P'3RR&8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\.+GQ^FO7\>H+YEY%:"0?95B20@1&/'(*K@GKDYS0!ZY14=O*)[>*8 @2(&
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M7]YJ_P 1M4$5S(-)TFVCMC$I^26Y?YV/OM3:/^!4WXGWT^G?#?6IK9RDSQ+
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M&6C1L*0N6;L,9-;.J^#M.NO&&O>'-,M8-/M[_P /13".W01HMPD[B.3 X!!
MY]J[2W\#>'K1PUO8M&HNHKQ8UGDV+-$NU7"[L XZ\?-@9SBK>H6<5E=S^(+7
M3);W51;+;".*4*TD8?=M&Y@@P23D\T <)I.KOX_U;PG!.N/[,A;4M3C(^[=(
M3"BGT(<2MCT45VGB?1DU#PSK%G;W$=G/?Q%#<2,<;CP QSG;VP/4XJAX&\.3
MZ/'JNJ7]K#;:GK-XUW<0Q,&$(_ACW#AB!DD^K&NDU'3[35M/GL+Z!9[6==DD
M;=&'X<CZCI0!QO@R.VT[Q%>:=-X9M]!U4VB2.EC(&M;F)6*AU"@88$X^9=V"
M.35_XG?\DR\1?]>3UIZ+X7TS09YKBT6XDN)E"//=7,D\FP9(4,[$A1D\"KVJ
M:9::SI=SIM_%YMI<H8Y4W%=RGJ,C!'X4 >5^.]$T_1?A[H2V-LD;SZM8RW$H
M'SS2'.7<]2Q]36U:Z-I?B'QWXSDURWBN'L_LT%N\P!-K$80^Z,G[A+%CN&#D
M>U=CJOAW2]:T^VL;^V,MM;2QS1)YC+M=/NG(()Q[UR?BG1+B;Q-+?+X1;5ED
MMDC2:UU#[/O()^2X0NJNG3'#<9!% ''^$=,L]93X<V]_$MU;?V=J#M'(,I+B
M1,;EZ,,X.#W IGB'2M/A\*^,K!+*W%I9>(K4VL/E@K!YA@WA!_"#N88'8D=Z
M])\)>#X=$T305O4235-,M9(A*C-M4RD-( .A&0.2.W:KUYX1T._L]5M+FRWP
MZK*LUV/,8;W4*%8'/RD;%Z8Z4 :UI:6UA:QVMG;Q6]O$-L<4*!%0>@ X J/4
MKJ&QTJ\O+AG6&"!Y9"GW@JJ2<>^!639>%K?3_$5KJ=NSE;?3GL09IGED<-(K
M_,S$YP5//7YO85NS0QW$$D$R*\4BE'1AD,",$&@#Q_1=.2T\3^#"OA[3=+M=
M1BN4(2Y\ZXNX3;ER+CY &YVDY+<FNB^$.FV%GX5N+BULK:":2_NHY)(HE5F5
M)G"@D#) ' ':MFT^'WAVR:T>&VN?-LY5DMI7O9F>':" BL6R$PQ&S[I!Y!K0
MT?PQI>@W5Y<:;%+";R0RRQF=VC#$DDJA)5<D\X H YOXS?\ ))->_P!R+_T<
ME9YTC3+CXP:)-<:?:2R?V";C?)"I/F))&$?)'WE' /45WNM:+8>(=(N-*U2#
MS[*X $D>]EW88,.5((Y JI?^%-(U+4=/OYX95NK ;8)8;B2,A<@[6VD;EX'!
MR* .&\/:5#X:UW1X]4T2TDDFN95L_$5A,-UT[J[8G'#$LN>[+D#IQ7J=<[IW
M@?0=+U&*]M;:<- S-;Q/=2O#;E@03'&S%4X)' XSQ714 >3:OIMYX@\;>+(7
M\/:;JR01P6T,E]>>4UJC0A\QCRVQEF8[@0<CVI88[Z#XG^!(]0E2>^CT*59I
M$?<LCA<%@>^3SGWKNM9\&Z+KMX;N]@G$S1^3*UO<R0^='R=D@1AO7D\'/6K)
M\-Z3_:]CJHLU6[L(#;VS(Q58XR,%0H.,8]J /*?"ND:SJ6C>'M9BT328+UKY
M+N;6&OL7,VZ0^:C#R\G<"R[-V!QZ5LZ%H>@:WX?U;7/$!BM]0&KW#2ZFSK'-
M:F*<K&JR'[@ 51CIS[UV$/@?0+?5EU&.UE$B3FY2$W$A@24YS(L6[8&Y/('4
MYIMUX$\.WFK/J,UDYDDE6>6(7$@AEE7&'>(-L9N!R1VH XC3](TRWF^*%Q!I
M]I%-%YL<<B0JK(K6P9@"!D GDCN:J>&+6#5K?X;Z3J<23Z:=)GN1;RC='-,F
MP+N4\-M5F(SZUZ1)X.T635M0U(V\JSZC$8;L)<2+'*"NS)0-MSMXSC-)-X+T
M*;1K#2OLLD=OI^/L;13R)+ 0,960'<.#Z\]Z /,O$%G#90>--$L1]FTR+5-)
M>&* [5@DE>,R!,?=Z*V!T)KK8-'TW0/BQID6D6,%C%<Z/<"=+= BR%)(MI8#
MJ1N/)YYKH8O!NA0Z.^EK9LUM)<+=2EYG:2656#!W<G<QRJ]3VQTJ_<:/8W.J
M1:G+#NO(H'MT?>1B-R"PQG')4<]>* +]>=7.DZ=)\=&N&TVTEN%T 7*LT*EO
M.6?:KYQ]X   ]<#%=AX9T8>'_#6GZ2&5OLL(CRN<9[XSSCZTR_\ #&EZCKEG
MK4\4HU"T79'-%.\>5W;MK!2 RY&<'(H \I.F:>OP.C\5I!$?$7RWO]I;1]H-
MR9AQOZ]?EV],<5[:,X&>M<VO@+PZNHB\%G+Q/]I%M]ID^SB;.?,$.[9NSSTZ
M\UTM 'BFGZ?#8_#OQKXBMH0=8BNM1C@NL9>"/S&!"'^$<LW'<UH+HVK:$PU3
M3="TC1([?2;I7^Q7WFO= 1;HR5\M=Q5P#N.3\Q]:]*L=!TS3K"ZL;:U46UU+
M++-&Y+AVD)+YW$\')XZ51TCP9H>B77VBTMYFD$1@C^T7,DXAC.,H@=B%7@<#
MTH \YN= T2P\'?#W4;2V@BO9]2TUGN44"2Y+D.^]NKY/S<YP16M:NJ>!_B:S
ML% OM2R2?^F*UTEM\./#%I+ \=E,1;3+/;1O=RLENZL&'EJ6P@R!P!STZ5->
M^ ?#NH7]Y>7-I*S7O-S$MS*L,S8V[FC#!2V,<XSD ]>: .2T'3+#Q%XGMK+6
M[."]M[/PW9-:6]R@=!YFX2.%/&[Y5&>O%4[C3XI_%.E:/I-A8^)M)L='=[:/
M4;X&,,9RCL#L<.5"JG3Y17?:CX*T/4X[-9K>:-K.'[/#+;W,D,@BP!L+HP)7
M@<$FBZ\%:#<V5A:K:26J6"&.U>SGD@>)3U4.A!P<<@GGKUH C\"V%]I?A:&R
MO_)#PS3+$D,YF6.+S&*1[R!G:"%Z?PU@2:1IDWQY$\NGVCRC05N0[0J6$JSA
M1)G'W@H !ZX&*[C3-,L]'TZ'3]/@6"UA&$C4DXYR>3R22223R2:I7_AC2]1U
MRSUJ>*4:A:+LCFBG>/*[MVU@I 9<C.#D4 >20:%IEO\ !.#7DLXO[7CO$ECO
M2H,T9%[M 5NH7'&!QR>YK4U32[_Q%XD\9*V@:9J+Q2):PW5[>^5)9(($93&/
M+;;\S%]P(R?I7HW_  BFC?\ "-CP_P#9#_9@;<(?-?KYGF?>SG[W/7]*@U?P
M7H>MWSWE[;S>;*@CG\FYDB6X0=%D5& <#)ZY].E &GHZW::'8+?R))>"VC$[
MHVY6DVC<0>X)S7EK:1I>K>$OB%K&IVT,FI17NH(MW(H,L"Q+B)5;JH  X'7/
MO7KJ(D4:QQJJ(H"JJC  '0"N<O\ P#X=U*_NKRYLY2UWS<Q)<R)%,P& SQJP
M4L!W([9ZT <WX/\ ^1VTOW\'6?\ Z,:N7N;:'4]"TNV=BUO<^.YT<HV-R,\P
M(R/4$C\:]0O?!&A7YL#)!<1/8P"VADM[J6%_)X_=LR,"R\#@YI\/@S0+>VM;
M:&P$<%K?'48(UD8!)SGYAST^8_+T]J .5UO1]+E\1Q:)IGA;3+[^S].WM'?S
M>5:6L<CM]U C_.2C98 8 Z\US.B:?8:Q=?"N74;*UO'EL[R.1IXEDWK&G[L$
MD<A3R,],YKU/5?"6CZUJ4>H7L$K7"Q^2QCGDC66/.=DBJ0'7))PV1R:IR?#_
M ,.26EI;"UN(TLYY)[8Q7DR-"S_?",&RJG^Z#CVH \UU*ZN+-OBY-;2O%(9[
M*-I$."B, KD'MA2W-=;J6B:5X9\9^#6T"QM[&2XFFM9EMD">?!Y+,=^/O8*J
M<G//UKK8O"^C13ZO,+)6;6,?;@[,RS84J 03@<$CC%5](\&:)HE\EY:0W#W$
M<9BA>YNI9_)C/58]['8.!TH \K@T/38/@G;Z\EI%_:\5XDL=Z5!FC(O0H"MU
M"[>,#CD]S7N=8W_"*:-_PC8\/_9#_988,(?-?J)/,^]G/WN>OZ5LT >*+I>G
M77P6U+Q1=01?\) 3<7C:@5'GQW"3,% ?JN-JJ .,?6M.70]*O?CAIIO='L7:
M?0#=3H]LA#3^:/G((Y8=,]:[.7P%X=GU![Q[.4^9/]IDMA<R"W>7.=[0[MA;
M(STZ\UJ/H>G/XACUYH,ZE';&U6;>W$1;<5VYQU[XS0 NNVT%YH&H07,,<T+V
M[[HY%#*W!/(->1Z9H>F3>"OAI;_8H8XKV]22Z$2!///V>3._'WL@8.>HXKVM
MT61&1U#*PP0>A%<[IO@;0-)CM([2VG$=G<?:;9)+J5Q"^TK\H9C@89N.G- '
MG/B:V30KSQKI^B6L5I:3Q:5OMX#Y$8\R9HY/NC";EX) ]ZZSPKH>HZ9XPEN?
M[$TG1+"6P\N2TL+OS!)(KC9(4$: 84N,]\BNHN?#>D7EQJ,US9K,^HP);W0=
MB1)&N[:,9P,;CR,&H]%\+:5H,\MQ9QSO<2H(VFN;F2=]@Z(&=B0HST% &S11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<Q+
M\0_"L$@2350/WIA=Q!(4C<.4P[!<)\P(^8C/7I73UX])%&OP.\8D(H+WFH,Q
MQU(G8 _H/RH ]%UCQ?H>@W:VE_>.MRT?F^5#!),RIG&YA&K%5]S@5EZW\1=&
MTBYT)%D-S!JK%EGAC>15BV,=XVJ=QRH&T<\Y[5FZ3JEAH7Q"\4MK-[;V1N[>
MSGMI+F0()(5B*MM)ZX?=D>]<II4L>F6/P]OKUUL[!M6OY8GG/EK'%()3'DG@
M9!!'UH ],TW6(9/$/B*&778IX[ 0L]J;?ROL*E"Q+2'APP&[_9Q3]'\:>']=
MNFMM/U#?,L?G!9(7BWQ_WUWJ-R^ZY%>8:E;W-]JGQDBL0TDLEK8E5CY+KY+$
M@8ZY7-=7K>N^'O$>BR:?H1@O]6FT:Z:R>U59&M5,6,$CF/<2JX[D8[4 =+I/
MC+0-<OOL>GW_ )LQ0N@:)T650<%HV90' ]5)K=KROPN+74K_ ,).WC*&^EMH
MFEM;""S16C'DE&5RAR@ ;'S8Y '6O5* .7@^(OA2XGMHHM65OM+B.-_(D$>\
MG 4N5VJQ]"0>GK5K4_&?A_1]1-A?:@(KA0IDQ$[)#N^[YCJI6//;<17D]MJF
ME3_ '^Q;>X@_M::8PQ688><T[7.Y2%ZGLV?3Z5IWJB&]\;V.J^+8-'AN+IWF
MM9;1)'G@DA159,G<V0"H"YP5]: /1M1\8Z!I6I_V;>7X2]S&/(6)W8[\[<!5
M.1\IY[8YQ4.EZY;?:O$+W.OP7,&GSXE0V_DBR4+DJS'[_KNK \.6:6_Q7U)"
MQEDM]"LXEF=<,1N;)([9V@D5QMY!+<:5\5%BC>4)JT$LJ(,EHD=&D&/]P-0!
MZOH_C'0M=O/LEA>LUP8_-2.6WDA,B?WDWJ-PYZC-<[XG^(^FPZ1,-#U%7ODN
MX(%<V[^6^9T214=EV.0I;[I..O:H-=U.R\1>,_":>'[ZWO)X%N[AY+:0.(HF
M@*@L1T!8H!GN/:N4FUG1S\%- TE;B ZE#<VD3VH8>;#*EPOF%EZK_$,G^\/4
M4 >XU2@U>QN;F_MXK@-+I[!;I=I_=DJ'';GY2#QFKM>;VVM:=HWBOQ]%J%Y#
M;S2R02PQ2. \RFV51L7JQ+ C SSQ0!T\WCGPW;VUE/)J0V7UO]IM0L,C--'D
M#*J%R3\PXQGVX-2P^,- GT"77$U*(:="Q225U92C@XV%2-P;) VXSR..:\S\
M,7^GZ=J/PXGU&:*&/_A'YE264A51R8P,L>!D9'U..]1W<T,U_J&OPNK^'X_%
M]I/).O,6U(0CR9Z%1(5R>G'M0!Z?8^,M!U"VOIX+U@+"(S7*302121QX)W%'
M4-C /(%1V7CGPYJ.IP:=:ZB'N+@'R,PR*DI R0KE0K$#J <CFN+\47MIK'B?
M6KK2KB&Z@M?"=W%=SP.'0,YS&A8<9^5CCT^M6[^-(O#?PR6- H74+(* ,8'V
M:2@#TJN8N_B%X6L998[C5-IAF:"8K!(RPNK%3O8*0@W C)P#C@UT]>4QQ1CX
M9_$M@BY>_P!69CCJ0#@_H* .\UCQ9HNA3Q6]_=L)Y4,B0P023N4'5BL:L0ON
M>*R=;^(VBZ3!H=Q%*;NWU6<)'+"CNHCPV7^53D@@#;UY]C6)X>U&RT7QO?RZ
MS=P6@O=&L'LYKF0(K(BN)%#'C(8@D>^:YR":*TTCPOJ<[K;:9-XNN+FWDE.Q
M%@?SBAR>@/4?6@#TVQU>.X\6ZA:+K:2K%:Q3?V>;4HT 89WF0_>SZ=J72_&W
MAW6M0%C8:D)9W5FC!B=%F"_>,;,H5P/]DFN!O8YM0^('Q"BTYO,GN/#L:VYC
M.=S-&=N"/7(Q6G%KWA[5_!^C:3II@O-8ETQX[**%5>2SD6W*DMWCQ]W/J<4
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MI[]5T^UD>.>8HPV,K;&!7&<[N.E;%>1WEOM\?W/@LIFUU+5X=:*D?*T(C+R
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M9Y<,I7'T]JQ/&NKO>:%XUB.K6VG&*5[==)@MHS/=!8U/F2$Y8Y'.1C"IUXH
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M4VL6%O-I\,MP%DU!BEJ-I_>$*7QTX^4$\XKRK7;NSUG5OB/)I3I<J?#T:F2
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M8/"^=P&>AX^HJUH?B#4+[XE^*M$GD0V.G16K6Z! "ID3<V3U/->:K<)-X/\
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M V]LYR.*S]9\<:[#J/AJ"S\.W<3WUS-'<6\[QH[&-'S&"3C&0KAP<$#@\XH
M[N&QM+::6:"U@BEE.9'2,*S_ %(ZU/7GD_B:.PU#Q_-IEE>S:EI4$$LRRW68
MFS$S QJQPH4 D@?>QW-:/ASQA=W=MX8M=5TZ2&]UBU>42>8A5A''&Q?"] V_
M@=L4 :'A/PM#X>T#3[*Y2VN+RS5U%R(ANPSLV 3R/O5MS6-I<3Q3S6L$DT7^
MKD>,%D^A/(KAO&GCR\TO0O$C:38N;O2)X;=YF9=J^8JL'P>H&\+CU.>E:USX
MMOXKFWT^W\.7-QJS6YNKBT6YB46\>XJN7)VDL0< >ASC% '3B*,2M*(T$C
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ME+&=PN7SDJ/3TKK)_%^NQ?$'5-)BT22XLK/3EN J31AF)+G>,\_-M"A>Q&:
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MK^YT?49$T[[='=Q06S22Q&4$(2@YP?6O8J*;)(D,3R2.J1H"S,QP% ZDGTH
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M3GG#2C=NP/IUJGK-MJ'BB[\2ZS::5?PVR^&I]-MDN;=HI;F9\N=L9^; PHY
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MI_ UE>$M'TXZCHJ/X9\00ZA9)ON)[ZZN/(MI%0J2F]RDF22!M!&#GCI7J%%
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ML%#]1GY1D<X%.UK4-;T*W^(%K'KE[.NG6-E)8R2RYDBWER<D=3VSU( SD\T
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MKGA:;QM!#J]S=BRM+!=/:Z;S#"9I&0L?[Q!.<GJ%7.: /7**\]O;"]\,^(M
MLX=>U:ZMM8::RNA=W)D8-Y3,LL9/W&!4]..>G%98\3:Q-\.+?1Q>2+XHDU+^
MPGG!^=9%?YI<]?\ 5#?GWH ]6HKR/5M6U*]U?Q#%;S>*//TR06NG#38FDA#K
M$K;IL<.69N0V?EQZYK0B?6?$?Q CL+K4]1TRU&AVM]/:6TAC83%V!7V'J.IV
M@>M 'IE%>2SIJ]_X<\;:RWB+58)M(OK[[#'!/L1!$-X##^,=L'@ <#K3K[7[
MS6M>EMKB3Q''#;:=:R1KH<3']]*I=GD*]<?* IXX/% 'K%9^E:Q::Q]M^R%S
M]CNI+27<N/WB8W8]1SUK@-+NM<\5:YI.DZQ=ZCI;6^B)>W<5LYMI);AI6CRV
M.0N$)V],M6O\,8I8+#Q%#/.;B6/7KM6F8 %R"HW''&3WQ0!U%EK%IJ&IZEI\
M!<SZ=(D<^Y< %T#C![\$5H5YE9:#/KGCWQPHUG4;"-)[;RQ8S>4?,-LGS,1R
MP&!@=.N<]H?#/B?5WG\':QJ5W))9:W:OI]PI/[M;M&)20#H"X5AQ[4 >IU7D
MOK:*6:)IXS-#%YSQ!@7"<X;;UP2I&?8US7@F]O-:FUO7)KF5[&ZO6AT^(M\B
MPQ?)O4=M[!C^5<]'IF[XL^*)S?7Q\G2X9!'YYV'<)?E([J.H'8T =]IM_9>(
MM"M[Z%/-L;Z .JRI]Y&'1E/MVINE>'M%T(RG2=*LK$R_ZPVT"QEOK@<UY9HE
MOJ&B^ _!&MPZUJ!EFN+&VDMO-_T<P2,$V>7TR 1\W7/-+>:_K5]+K>I6(\3R
MZG::A-#8P6<#-9%(GV[' X8MM;)/(W<8Q0![)16#XSNY[3P'KMY;2207$6G3
M21NIPR,(R00>Q!KDBNJ:!)X/U=M=U"\DU2[AM+ZWGEW0OYL3-E$QA-K*,8[=
M<T >ET5Y7I-]JJ6/C+Q1=:O?S_V+?:BEG8^;^Y*H"1O'5L9  S@;1CO4TB:I
MX=TOPQK_ /;VI7ES?7EI#?Q7$^^&59\!ML>,)M+ C;CISF@#TZJ+ZI&FM1:6
M;:[,DD)F$ZP$P@ XVE^@;VKST>*-2T'PCXJTVXN9KG6M+O#:V3R-NDE%P0;9
MLGJ?GQ_P U8@N-7TSXG:#H#ZI<7$:^'V>82R$K-.K8\QO4YH ](JCI.J1ZO8
M"[CMKNW4LR^7=P&)^#C.T\X]*X+P7>7":W9VFL:KKMMKS0O]KL-2!:"[8#YF
MMV^X IY&T_=ZCO6)X=\0ZWJ?@/P]:/JMTMUJ^MRV<U[OS*D*F1B%8YP2$"@]
MLT >S45Y;KEWJ7A:Y\2Z/:ZOJ$]N?#<^I6TEU.9);>9"4.US\V#E3R3@CBK,
M::GH^K^#;YM<U&[DU:7R+Z&>;="VZ!G!1.B891C'..N: /2:S]4UBTTAK%;H
MN#?726D.U<_O&!(SZ#Y3S7!>&;N[A\2VEMKFJZY9ZY)+*);:\!:RO5PQ @/W
M!@;6&"&P""#6G\389KB#PO!;W#6\LFOVZ"90"R920$C/&0.F>] '=4UV"(SG
MHHR:\JUW5]4\"ZAK]C9ZG?7T1T07UL;Z0SO!-YPB.">2OSJVT]Q5WP_<ZC!X
M@CMH%\43:;/92B[?6H7 29<%'1FZ;OG!4<=,"@#MO#OB"Q\4:%;:QIID-I<;
MO+,B[6^5BIR/J#6I7B/@:[O)/AQX!T"TO)K)=5NKM;BX@;;((XVED*JW\)8@
M#(YQFM3Q!=:UX<N=?TRPU;4+F/3[&VUJW,\QDD55E(FB+GEE94)P<T >M45Y
MM<^)+Z7XDVMW;7LAT"*6WTV6%6^1Y9XGD#GW!,"_\"K?\!WMWJVF:AK%S<22
MPWVHSO9J[9$=NK>6@ [ ["W_  *@#JJ*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *Y[3?"-E9:+J^DS2/<VNJ7-S/,&&W F)W*,>F>
MM=#10!RNG^$]1@'E7_BC4;NVCMGM8(XPL!56&-[,G+N !AN,'G&:2R\(7@OX
MKS5]?GU-[:VDM[7=;I%Y8D #,Q7[[84#/ Z\5U=% 'FFI^%[/PAX.\.VJ7FI
MJ^CW3&#4[6U$S0>9OW&2/G,9#;3@'M5/0O#/_"5-XS+WM])8ZO':VZZC<0>6
M\[QAB[(A"X0;E4<8X[]:]7HH QM5\.P:MK.E:A-*X_L]9U$0'$@E38<GM@5S
MUO\ #NYAM](A?Q+=2+HTJ-IP-N@$2*"NUP/OG:=NXXQV')SW5% '%2?#XO9^
M)=/&LS#3=<>69K<P*3#+(068-U(XX!]:M7'@QE71Y],U66PU+3+0627(A603
M0X4%70]>5!&",&NKHH Y"+P%;I8P12ZA/-=C5H]7N;IU7=/,A!Q@<*N   .@
M%;/]A1_\)=_PD'GMYOV#[%Y6/EQYF_=GU[5K44 8.O>%X==UC0M1DN7B;2;E
MKA$501(2,8/I5";P;>75XB77B*[N-)2]6]6REB5F#J_F*OFGYB@8 @=< #.*
MZVB@#-\0Z.GB'P]?Z1+*T*7D#0M(HR5!&,@5E7O@Y9[#0UL]1FL]0T6,1VEX
ML:O\NP(P9#P58 9''(&#73T4 <7<_#V*_P! UNROM5GN+[67B:[OC&JG$978
MJH. H"XQ[DYKM*** .4U'P;,VN7&LZ#K=QHU[=JHNPD230S[1@,R-T8#C((I
MVG>"8(I;^[UC4;K6;Z_M39SS7&U%$!SF-$0 *#G/<^]=310!QMEX%GBETJ+4
M-?NM0TW29%ELK62%$(9 1&9''+[0>.G."<TR[\ 22KJ5C::]=6FBZG,\UW8I
M"A)+_P"L"2'E%;G(P>IQC-=K10!REYX-E76O[3T/6)M(>2UCM+B.*!)%DC3.
MPC=]UE!(!YX[5I>%?#L/A30(M(MYY)XHI)75Y?O?.[/@^N-V,ULT4 8^C:!'
MH^HZS>).\C:G="Y=6  0[%7 ]?NUFKX%L18:]IAN9AIFK2F<6ZX'V60X+-&>
MV6 8#& 17544 <E)X,O-1T_4;/7?$5YJ"7EH;10L:PI&IYW[5X9\@?,?3&!D
MU W@6]N=0MM1O_$][-?102VK2Q1+#F&0 $*%^XV0&WCG/L !VE% '(P^"I;F
MY\WQ#K,NL(EI+9Q1O D0$<H D+%>68A0,\#KQ3+'P-/%/I2ZEK]SJ-AI+B2R
MM9(43#JI5&D<<N5!XZ<\G-=C10!S'_"&0?\ "+:YH7VR3R]6FN97EVC,9F8D
M@#OC-=%;PBWM8H 21&@0$]\#%2T4 <=I?P\T_3+;Q%;?:)9H=:$B,CJ,01,9
M#L7V!E<_C2VW@"VM_"%MH!OYY#'>I?2W3J-\T@F\TEA[D8^E=A10!CW&@1W'
MBB#7#.XDBLI;,1 #!#LK%L^HV_K6!8_#BWT[P?I&B6NJ7$5UI$[7%G?K&N]'
M9G)RIX*D.5([BNWHH X]? K31K)J&LW-Y?'4K?4);AD50QA(V1J@X1<#MSR3
MS6U_84?_  EP\0>>WFBP-EY6/EQYF_=GU[5K44 8FLZ-J5]>PWFEZ]<:;*D9
MB=/*6:*12<Y*-P&'9AZX.:IZ-X*M=%U'3;N"ZFD-C92VF) ,R&219&<D=#N!
MX QS73T4 <=<> PQGGL]5EMKYM7;5H9_*5Q$[1B,H5/#*5SZ'FJMU\-Q>6&O
MVD^N74JZY%&+IWB4MYJ$?.N,8& !MZ 5W=% '-2^#X)?$?A[6#=R"31;>2".
M/:,2ATV9)[>M6O%/AN'Q3I,>GS7,ULBW,4_F0_>RC!@ >W3K6W10!R=OX*,^
MHW=]K^J2:O+/9/IZ*T*PK' YRXPO5FXRWMT%3Z)X9U'2[JV:[\27M]:V<1AM
MK=HUC&,  R%?]8P P"<>N,UTM% ''_$&&!;/3-1=]1MI[*\#Q7UC;B<VVY65
MFD3DF,@X. >HKG?#7AV#Q-?>,);R:^O-,U6"VMOMMQ$87G= Y9XU*C:JED"\
M8RO?DGU*B@#EM/\ "5VFLV6IZUKL^JRZ>CK9JT"1*A8;6=MOWGV\9X')XYHC
M\#64?CU_%0N92[*2+3 \M9BBQF4?[11<?B:ZFB@#E=0\(7<VJ7]WI6OW6EQZ
MEM^VQ0Q(Q9@H3?&QYC8J ,C/0'K6A;>'(K;Q7-KRW,K226$=EY;\_*C%@V[J
M2=U;5% '-IX0@30?$.E?:Y"FM37,LDFT9B,RX( [XJO/X-N8;F*ZT;7)M,N?
ML<=E<,($E$R1YV-M;HXRV#[]#7644 <G=^#)_MVGZAI>NW=GJ%I9_89+F9%N
M&N(L@_/NZMNYW>YJ_P"%O#,7A:QN[:*[GNOM-Y)=O+/C>6?&<XZ\C/XUNT4
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M72]/OYK6#3&BSL S<(BD%&]FSD^XK<HH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXJ8!./$5R3@=A)$3^E=];7=CJOQ;L;ZRN(+NW;P_*8IX7#J?](0'!''J/SH
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MLYKMKR\2SCBA(W%W#%<9XZKCMUZUFP>.EMY-8AU_3)-*FTNT6]=?.6820G<
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MQ.^($,D\CQ0RV0C1G)5,Q-G [9KH=?\ $;Z3>6.G6.G2:CJ=]O:&W218P$0
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M,?7;NXW?CC!%:&G^+[O4K]3;^'[I])>[DM%OTE5B'1F0LT8^94W*1N^A( H
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M+$L$XDRW^\C.M&GZ!J8^)\D,MG*NB65U<:K;W##Y'FFCC78/=6:=OQ%>DT4
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M<1;/FB",N\L.V,<U MI/_P );;7.CZ#K.CZH^H@ZCL+?89X-QWNQSL8LO(P
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M-PLLD4KR% >F> /Q%>G44 >>27^H^)/''A*^A\/ZI9V5D]R;F2\@\LH[P,
M.I&>-W0DC&>:T_B)::A<Z9I#Z;8R7L]MK%K<F&/&2J,2>3P/J>*["B@#RS7=
M)U'Q[JFK3VVFWMC;IH,UA"U]$86EN)'5@ #SM&P MTYXJ;0](TZ>]2:U\):U
M:7D%G*7N-0N9BL,C)MV1AW82$Y;D< #KS7IM% 'FO]BZG_PK+P78?89_M=I=
MZ<]Q#L^:((ZERP[8QS64_A:SMKW5].U+PKK&J7-YJ,LL$D%U,EK-#*^[+LKA
M$V[B"",G;WS7K]% '$6^E7L?QJN-3^R2C3SH"VZW&WY#()L[<^N.:Y ^&M;;
MX:^/K(:9<?:[O7IKJVA*8::/S(FW*.^0IQZXKV:B@#S7Q-);:W)%?2^%_$D%
MY]E_T#4+!'CN4;<P,<@4C9@@$;\J0V>.:Z[1+[5%73M-U6RF-W_9L<UU>J!Y
M/G\*T>1_%G)XXQ6Y10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY(RO&?6@#LZ**\^\<27EOKT<]]+K\.@"SPMQHS-F"?<=SRJGS%=NW'!'!R*
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MM':B B,W:% 6W ?ZS  ;)Z'FN)\-W5K:?#SQV][;274$GB&Z@,$<IB,ID:-
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M3]$COO#WC+0K.6TLXE\18MH9QB D>1((2H_@<Y&T?WCQVKTJ;2[*XU.TU*6
M-=V:2)!)N/R*^-PQG!SM'7TJI-X6T6XL]0M);!'@U"?[3<J6;YY?E^<'.5(V
MKC&,8H Q/!+00:IK-A)X?@T75(Q!)=16DN^WF5@P21,  9VL#\H/ SGBNRK+
MT7P[I?A])AIUNR-.P:6229Y9)"!@9=R6.!T&>*U* /*],_Y'_P"*W_7K:?\
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M9%=JK$"51D_>^I&0<4 5/B9XME\'>#+S4+16-\5"VY,#R(K%E!+$#"X!R-Q
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MQ121(R(<'#NJ9Z=MV<4 :ZV\"3M.L,8F88:0*-Q'N:&MX7F69H8S*HPKE1N
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M*05!'0^U<?9ZK:GXA>)+.STZ=]4M;*&1G:[/ESY7*H%/RH>Q.*R_#'CS5)O
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MG:N5^[QT^E*$4,S!0"W4@=:XJ7XBPIHHU9-*GFMI=7_LNV\MP6G^8IYBCT+
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M;49Q<63V<\B1ONC53'(5<!,,I^9AT;OC%>GV%M'9:=;6L4(ACAB2-(E8L$
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M-"U&STZSMKM'EO(A&PD<)P5R2!\HP>YSCI78ZS%)/H6H0Q(7DDMI%51U)*D
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M<,Y=E7 QP%P?<T <P?$GC&W\/:!K\]UISP:S>6B-:I;%3:Q3.N,/N.\[3@Y
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M>,=>N2* .%/Q/DWMJHU[11;+?_9O[%./M)@\WR_,W;\[_P"/;MQM_.O5IO\
M42?[I_E7$Z9X<\1:-)_95BNCG21>M.EY+N:X2%I#(T7E[=I;DJ&W=.<9%=E>
M30VUE/-<31PPHA+RRL%5!CJ2>@H \B\+ZOXD\._"[P]KS7%BVD0B"&6P^SGS
M/):01^9YN[[V6#8VXQQ6WXC\=SVWB'6+"V\0:)I/]DQIM@U  O>RLGF;>77:
MN"JY )R3Z8KG;%,>#]*\'W_BOPBVEP/"US=Q:F#*R(XD\M4( Z@#=GIVS6W?
MZK:67B#5=0T+Q!X0N(]5$;2?;]113;RH@3>H4-O4J%^7CD=>: %U+5=7USQ;
MX O-,U*.SM=3LY[I87MS)L(B5FW?.-V0^!TP03SG M:#=:O#\1O&LU[JL<EA
M8"!GA%L02AA9U"G?\NT'G@[CSQ5?7]3L)M9\,:OIGBCPO/<Z2LT<T=SJ"0I*
M)452R[=V,%<XQWI;;4-)MO'&OWI\2>&IM&UN.(39U-%FB*1&/ 7D,#QSD8H
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M%+C.R1&#H<=QN45D6VB^(M7\2Z3JGB%--MHM)$C0Q64SR^=*Z;"[%E7:H4G
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MV6PCDU[1-!BD@+RS7?[UGE&/D1"RY49)+=>G J3Q7I/B#5OM=E;VFBZAI=W
M$6/4"R-;/@@N,(V\<@_PD$=:J'POKVEZW8WVE26%V4TB+3))KYG#Q&,D^:H
M.[=GE<KD@<T <QXQUR3Q)\-/!^KS)&DMSK-H9!&?EW!G4E<]B02*ZKQGX@O]
M)U!(H_$.B:-;_9C+&;T"26XER?E";EVH !EADY/M63/X UN?P+HWA]KBQ\[2
M]62Y$QD;$L"NS9/R<.=W3D<=:VM0\/ZZGB[4-2TLZ>8=3M(K:2>X9O-M-A?)
MC4*0X(?."5Y'- &;?>,];N],\%3:1%:17'B $2"=2RQ$P[\C!!(4\X[@8XSF
MM:'6=6TKQGIFAZO/!<6^H6#&&YCA\LM=1G+KC)P"AW >QK.TOP9K%O:^"8KJ
M2Q!\/R2+,8Y&/FQ^48U*Y4<G()!Z>IIWQ6=%\/6DEG<I'K\%]!)I<8(+R3%M
MNT+U(*LV>WY4 ;/A76[W7[G6[IQ&-,AOFM;':OS.(QM=R<\@ON _W:I^(-7U
MT>--,\/Z/+:0)>64T\MQ/"9#%L9 &"AAG[V,9[Y[8.YX<T:+P]X<T_28CN6U
MA6,O_?;JS?4MD_C7)^)1J8^*FAR:2+9[F/2KIC%<N425?,B!7< 2O4'.#TZ<
MT 9NO:UJ.H?#;QUIFKM!)J&DK);O- A19D9%='VDG:2&Y&3TK9TK6KJP@^'N
MF0B/[/J-D5GW+EL);!UP>W(J%_!6K7GA#Q7!=S6:ZSX@=W81LQAA^141-V,D
M +R<=3TJS?>%]9AL/"5QIC64NI:"@C>&XD9(IE:'RGPP4D'N#B@!FI^+M5LI
MO&BV\$4W]C1VS6R^6Q_UD>YF8 Y8#K@8X%:7A#4K[4HYYI-<TK6[ JIAN[%/
M+8-SN1T#,!CY2#D'D@BJ&F^'O%%I=>)=4-YIL>IZH;>2W"!GBC,:X*-D D$<
M;ASR3@=*L^&M U&U\1ZAKFH6>FZ?)=6\<!MM/=G60JS$R.Q5<M\V!QT[T =;
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0
M/9VLEY%=O;Q-<Q*RQS% 70-U /4 X&?I4]>1@ZCJ?PZU3QU_;>IPZK&;JZMX
MX[IE@B2&1PL7E9V,"$P<@DD]: /7**\\N3=^(_'UA8OJ5_9Z=/H O);>UN&B
MW.90!\RG(^]U&"< 9QD5C/KNJV'@FZL%O=2N'3Q(^D)<1MYEWY DSA6/5]H*
M@GUH ]<HKAO!4FH1ZYJ-J+378M&,$<MN=98O(DN6#JK,S$J1L.">#FNYH S;
MG7+2VUVST;$DM]=1M*$C7/EQKU=SGY5S@#U/3O48\3:,WB/_ (1]+^-]5\HR
MFW0%BJC&=Q P#R."<\USW@W_ $[QIXTU.7F9+Z.PCS_!'%$I 'H"7)^M-O+&
MUL?BOX?%K;QPB:SU":38N-[LT)9CZDGO0!TXURT'B(Z'()(KPP?:(MZX29,X
M;8<\E3C(X/(/2M*N(^(O^B/X8U:+Y;FUUNWC5AU,<I,<B_0@_H*[>@ HKB_'
M<EZVK>%;*TU"YLDO-1:&=K>0J6C\ER1^G!['!'(K!LM#N;KQ!XMT-_$.N#3]
M-6"6T5;^3S4>6(L29,[F *Y"DXY.0: /4J*\LL=7U/Q)I?P_TRYU&Z@75;.6
MYOI[:4Q2S>5&N%#KRNXMDXP>*==WM_HEE\0=&@U*]EAT[2UO+&::=GF@+Q29
M7S"=QPR C)R,T >HU3FU2SABOW\Y9&L%+7$<9!:/Y=^".Q*X(^M<"EO>Z+K'
M@N_&LZE<S:K+Y%]'/<L\,NZ!GR(S\J891C:![YJGH>EI#J?Q(N/M=](T4CQA
M9;IW4@VZG)4G!(Z GH.!Q0!Z7I>HPZOI-EJ5L'$%W D\8<8;:ZAAD>N#5NO(
M=,L[K0_#'P_UB#5]2:>[FL;6:%[EC T,L>-@B^Z-HQ@XSD9)R:]>H R/$?B3
M3_"VF+?:@92DDRP11PQEY)9&^ZJ@=2<&K]A=_;K&&Z^SSV_F+GRKA-DB>S#L
M:\Y^,6FQW47AB=KB[0MKMI;[8KAD4!BWS  X#CLW45H7=E+?^.+7PHVIZG%I
M=EI/VQO*O9$FN)&E*#?*#O(4*>,]2,]* .^HKR'5]:UC3_AQXQMHM3NGNM&U
M1+:TO'E/F^69(6 9QR2 Y4GN*],T32/[&L6@:_O;Z220RR37<QD8L0 <=E7C
MA1P,T :5%9?B74I='\+:MJ<*AI;2SFG0$<%E0D9_$5P'A>?5EUK0W@@\5217
M4;+JLNIDF!\QEED0;B$.\  * ,-0!ZG17E/_  D>JZ5X$US0FO)Y_$5IJ!TF
MTFED)EE,[ P29ZYV/G/^Q3]7N+D^*&T"X?Q1=VFEZ9;A6TF5A(\S[P997# D
MX08!R,[LB@#U.BO*M0N_$=YI7@.TO;V_TR_OKN2VOF0^5(Z"-P20. Q"[AZ$
M@CI6Y<_:?"?C3P\GV^]GT;4(&TUUN;AI-EP,O$Y)/WF 9<]\"@#N:*Y'P-=7
M>L_VSK\]S,]I?7K)81,Y*);Q?NU95Z#<0S'UR*ZQT$D;(2P# C*G!'T- &%9
M^+]/U'Q-=:%9P7L\UHVRYN$@/D1/MW;6?U_K6_7D/@31X[36?'=S%?:B9+*_
ME2/=>2,'_=?><$_.WN>:T_[6U'_A6?@:\^W7/VFZN],6>;S3OE#LNX,>ISWS
MUH [./Q'83^++CPT%E^W0V@NW)4;/++;>N>N>V*J^$-0T&]M-1@\/V"65O87
M\MG-'' L2F5,;B O!'(YKG;'_DX'5?\ L 1_^C11\)?]3XP_[&:\_P#9* /1
M**0C<I!S@\<'%>5CQ%JNE>#->\//=S3^(K.^&F6<TKDRRBX;,$A;KD(Q.?\
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M5>:^)-1N-0\<:EILL?B5[2PM(/)71'*;99-Q,CD,N3@*%!R.&XI)+C7]3D\
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M50LEW:13LHZ L@8C]: -&BN;\;W<=MH"(]_?6AN+F*%18(6N)B6SY4>"-K,
M?F[#)K)\ 7ER=8\0Z9(NJQVMH]N]O#JLOFSQ>8AW#=N8E<KD9)QF@#NJ***
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M3[6T6&-[B%X1<W/S#S%1@#A8V*9([\=*[V'4;*XNI;6&\MY;B+_60I*K.GU
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M::?*L85"AR@9PNYU7L">PSG%6K[P:UQK][J=GK5[8)J,<<=_;PJA$P0%00S
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MA@49:61PJ@>Y/% '!>$-'BU+QYKGC&.TN;:SG"PV27,;1F1BJB68(P!7=L0
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MFB6&27)RR*25'IP6/YT >,66D6%M\&='U..UC&H1ZK R717,J[;SRU ;K@(
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MY+Z4O,P8LQ'\0W97)P,#M7IFE^"_#^C7<-W8Z<([F$,L<S2O(X#  C<S$D8
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M"NDMM)L;.^GO8+<)<SQQQ2R9)+*F=@Y/;<?SIVFZ;9Z18I96$"P6R%F6-22
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MAG!Q@;0>>*\^U&^U+7/!?BS3X=6BUV&R^RRQ:K9P)NE4.'DC(7*.R*F>.#N
M(K>\+-I^J>,([^#QC<>(;JWL'7*00B*..1D.&:)%^8E00IYX/% &YX'\71^,
MM"&H):SV[;W!5X75"-[!=K, &X49QG!XK,^*7B^[\*>&E;3?-CO[F5(HYQ:M
M,D0+ ,3P5W8/ /7L#4/P=O[2;P!::?'<1M>6+S)=0!OGA)FD(#+U&0#UIOQD
M_P"1)@_["5K_ .C!0!KV_BFRT?0=-;4KW4;Z[NV=85?3G2ZN"I.?W"H" !WV
M@8P>_-M/&6AOX<N]=^U.MC9EEN=\+K)"RXRK(1N!&1QCO6)X@N[;0_B=HVKZ
MK,EOIDFFW%FES,VV.*<NCC<QX7<JD#/7%<GK<J:AX.^)VM69WZ7>O&+64?=E
M,<2([KZ@L",C@XH Z_7?B3IVG>')M6L;>[NU6ZCMD;[)*$D+,H+!MO*X)P1P
M2,#.:35?&GV#Q9HBM)=)IM[I]Q,;7[&YFDD5HP@$>WS-V&;C'J3TJO\ $I4M
M_A>C!0D%O-9,V!PB+-'D_0"IYKNSU/XH^&KVSGAN;=])O'BFB8,K?/$,@C\1
M0!TVAZ_I_B*Q>[TZ1V2.5H94EC:-XI%^\C*P!!&1P?6EUK7M/\/VD=QJ$KJ)
M9!%#'%&TDDKGHJ(H)8\'H*P/ W&K^,Q_U''_ /1,-0^-9H],\5^$-:OF$6EV
MEQ<1W$[?<A:2+;&S'L,@C)X&Z@#:L_%^CWNF:C?)+-$NFJSWL,\#QRP +N^:
M-@&^Z,CCGM5>Q\=Z#J.IVMC;S7&Z\!^RS26LB0SD#)"2%0K$ 'H>U<=?74&L
MW/Q#UC3)4GTS^P1:_:8CNCFF6.5FVL.&VAE!(]:OZDBIHWPT5%"A;^U  [#[
M+)0!Z/7!>/?%VM:3?PZ;X;MX+F]AM)=2O%E4MMMX^,#!^\QR!]*[J::.WADF
MF=4BC4N[L<!0!DDUY5X1L/%/B"YU/QI8:CI]G'K<F((KRQ:9UMHR5CY$BX!&
M21CG.: /1(_$.G2>%QXB\XC3C:?;#(%)(CV[CP.<@=JRK?XA^';F[LX$N+D1
MWKB*VNGM)5@ED/1%E*[2W;KUXZUP=C]J\.^"O'/@?498Y)M/TZXN[-XT*+);
M2QL?E4DD!7W#J>HI=6UO2=9^&7AOP[I=Q$^LRO811V*']] R%"S,G50 K?,>
M,<YYH ]#U/QKHNE:K+I4TES+J,<:2?9;:UDFD96S@@*IR.#D]N,]14EOXPT*
MY\.2Z^E\!IT)*RNR,K1N#@H4(W!LD#;C))&.M<D=:TK1?C5K,NJW,-FDFDVR
M)<SL$C4[F.TL> 3C(!Z[:YQXIK[PMXAURREF@TN7Q3'?QW$40<^0C1AYU4@A
M@""W((.PT >HZ=XLTK4K>^EC:YA>Q3S+F"ZMGAEC7!(8HP!P0#@CK@UGQ?$C
MPU,;)DN+HVMXR)#>&SE%N7?&U#)MVAN<$9X/!P0:YZP6PO7\1ZE;^*I_$%Q'
MH[6\DPBA$*J0[*H:)0I8?,<<D!JS]614_9TT8*H'^CZ<W [F6(D_J: /0M9\
M6:7H=_!87!NI[V=#*EM9VTD\FP'!<J@)"YXR:YC1O%TFJZ1XUOY-8:&RL+F1
M;6[2W#&VB$*MG9C+$$DX89SP:9=:I8^'/C!>WFMW4-E;7VD1):7-PP2,E';>
M@8\ \@XKG;2Z@OO _P 5KNV0K!-<7,D>5*[E,"D-@]FZ_C0!Z3:>(]/M]-\/
M_:M0><ZK'&MM=O 4%PY0,"<#",PY"G'H*O6FM6%]JU]IEM*9+FQV?: $.U"P
MR%W8P3CG .1WKSZ_FAN/A%X8T&. 7&JZM86L-A'N(,<BQJWGY'($>-V1Z =Z
MV?ARZZ;;:AX:O5"ZW8W#2W<A/-X)"66Y!/7<.#Z$8]* .XKS;3/B!J-WXTB$
MT5N/"]_>3:;8W 4[S/&%^8MG!5V$BKQ_#6[\1=<N-&\*21:><ZKJ4BV%BH//
MFR< CZ#+?A7)ZC\.O%:>!(=!M=:TIHM.1)K-8M/=)?-C.Y2'\T@,6SDX_B/%
M 'K%<I>^-H+/Q]:>&#9W;F:V,KS);2, Q9%3!"XV_,VYNBD $BM'PCX@C\4>
M%=/UB,!6N(AYJ?W)!PZ_@P(KFM6O[33/C1I$U]<1VT5SHTMM"\K;1)*9T(0$
M]6/I0!M:CX\T'2[VYMIY;IQ:$"[G@M)98;8D9Q(ZJ57@COQWKHT=)8UDC971
M@&5E.00>A%>4VVN:7X?T#QKH^L7,4.IRW]](EK(<2W:S9,1C7J^X$+QG&*[_
M ,)6=SI_@W1+*\!%S;V$$4H/4,J $?F* ,VS\;07GCV^\,BSNA]FBC(F^S2;
M2YWELMMPJX488G#$G&:QO"OQ(LFT"S;7;JX>Z>ZE@FNELW\F)O/=8U=U78I*
M[.I[@GKFI=/O[2Q^-&O6UU<1PSWUC9_98Y&VF;;YF[;GKCVKFBBK^SK=D* 3
M<3$\=3]N//Z4 >B7>J1Q>.M.TPZQ)%)-:R2#3A;!EF /WS)C*X],\TEOXVT2
MYU==.CFN-[S-;QSM:R+!)*N=R+*5V%AM/ /8USFL?\EY\.?]@FX_F:SM.U:U
MTO7[&U\/:\+NVNM3>*?P_=1*9K0LS&21.CH%.6PV1@\'F@#U1F5%+,0% R2>
MPK@=*U/QAXRLSK.D7VG:1I4C-]BCGLVGEG0$@.YWJ%!QD  G%=U=0"YM)K=B
M0)49"1VR,5YUX+\8:/X7\,6_AWQ+>PZ5JFDH;>6*Y.P2JI.V2,G[ZL,'B@#5
MT[QO<+HFMG6;$QZOHDGDW4-G&\RN2H:.1  6V,"#STYSTKE-#^(.JQ_#'4O$
MM_>7U[J#0%X8CI+);P/B3;M94^=/E&6+$# R1FMSP\DNI+XU\4^1+!9ZLJI9
MK*A1GBAA*"3!Y 8DD9YQBLC3?^38G_[ \W\VH Z#PIXL$'@B'6-?U6^NI9FC
M'[[33"QD=5(CA14!D&3P0#GGGBMV+QCHTFA7VL---%;:?D7:30.DL! !(:,C
M<#@@].<UQ.MQRIX)^']__:$FG6MH;=KB\2-'^SAK9D5R'!7&Y@"2.-V:JZI%
M92^ O'VI6GB"XUR2>U6*:[:*-8BR(<;#&H5N& )&>@% 'I6B^(+#Q!'/+IS3
M/#"^SS7A9$D]T+ ;A[CBLGQ=XAO=$U?PQ:V@B\O4M2%K/O7)V%2>.>#Q6[HR
M)%H>GQHH5%MHU51T "BN%^*5[;:;JW@J]O9T@MH=8#R2N<*JA#R: /1ZYV/Q
MOH<FKC3EGGW-<&U6X-M(+=IQUC$N-A;@C&>O'6ETWQWX5UC4(K#3M>LKF[ES
MY<,4F6; ).!] 37F>@V]N^CV'A[5?&-Y%>Q:D$;1([: R+*D^\-]SS-A(#[\
MXP3S0!ZI#XIT>?Q!>:(E]!]LM(T>53(O!;<=O7J F2.P(IVA>)=*\1P3S:9>
M13I%*\9*."?E8KNQ_=)!P>XYKG=*N+:V^+WB2WGDCCGNK.R:"-N&E"B7<5'<
M#N>U<Q9W,A^%'B6STXF74;74+IKFVAP95B^U$NI'8F/=@'K[T >JVFJ:??\
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M '8;1NW8&1WIHBC$IE$:B0C!?')'UKE=)\8WFM>)+_2[30W^S:=>/:W=X]R
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M">V*T?'=[::?X'U:[O[1[NUBAW201S-$SC(X#KROU% &\D$42LL<2(&)+!5
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MN,YJ?6-"MK/2]$TG4O#>H:FEAI\<-OJ6E/B>*95"D#!5E! !!R0>X&.?1Z*
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MJ0036$ VG(7"E6(8X?C<5[9ZU[1534-3L=)MA<ZA=PVL)<())7"C<> ,GN:
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M< '"C/)ZT_P'HVK^'?#%MHVK&Q?[$HB@EM7<^8@SRP91@^PS]: .GKSI]?\
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M#C:IXZ!AZT :]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3N8W*-(2?0@$XS4JRZKIT.N&PL_$UGIAT.Y=WU:<NR7*+E'C;S&8$@MG&!D
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MOW]NFGZ[;:(UO')$NKR>8Z3AB'",7<[2I4X)X(..M '=4444 %%%% !1110
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MO<@$@?A0 7OP_BN7U&"WUK4;/2]3E::]L(?+V2,WW]K%2R!NX!YR>F:M^*O
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MJH+T[KC!/[P[0G//]T ?A6;=^!O#5]#:13Z6A2T@%M#LD="(AT0E2"R^QR*
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MKVJO*8/ NHW%[96\OAG2=-\J_CNKK4+2X+)(B2>9MAB.3'N(7(R ,=^*]6H
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M (&D@#(649"8)SCL37I2?#_PK&LBIH\*AW$G#O\ (P;<-G/R#=SA<"K8\(Z
MNH:A??V9"9]1C,=WDDK,IQG<F=O.!DXS0!S_ (=T34[#QNUY=1>'[!'TXQ/9
MZ9*VZ3#@I(4*+POSKG_:Q7=5D:+X7T;P\\KZ78K!)* KR%V=BHZ+N8D@#TZ5
MKT >=:'IFE:OJ_CN77;6WGF6_,$AN$#&.U$*%,9^ZN"QX[\UR$5LE_I?PEFU
M&VBFGFE\N1YHPS21A#L#$]1C!YKU?5O!OA[7+TWFHZ9'-<,@1W#LGF*.@<*0
M''LV:NW.AZ9>3:?+/9QL^G/OM,<"$XQP!QTXH O1QI#$D42*D: *JJ,!0.@
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M[P_\1].U3PW>ZU?Q7%A;6L[H7EMI%5E\QD0*2/G<X&57)!.*[6O#M.O;?_A
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M^4RB0 ]BR$C\Z .XN/B%I::)K5[#!?\ VC2H?-FM)K.6.4 @E6*D9V'!^;H
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MWUIX<GN- DNS:K>Q3[I3ARAE\D+GR]P/.[..<4 =FRAE*L 0>"#WH"@*%
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MFVL<EC@ #L>F*RI/B"6MM#-IHTTUWJEQ/:&V:8*T$\0;<K'!! 92"?3G!Z4
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M^6RXX(V\G-8LOQ#9+*SGAT:2>6[U>;28X4G .^,N V2,8)3\ <Y.* .W  &
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M-YHD,>3P"%P@[?**[/5_#>F>(9[2>_,\\,!$BVXG802$'*ET!P^#@C-;- '
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M=,C)ZFKGB7Q9JUKJ/B9=+>);70M',\K/'N)NF!9%^@1<D?[0IM[H>G:)\/\
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M#6KNYG#6TK,4688P<J.1Z]Z9!X7U>^T[0-,UM[)H-'N(I_/@D8O<F$$1Y0J
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M;2TMK"V2VL[>*W@C&$BB0(JCV X%>(:/I*_\*M\!>1=7<4M[K5N7D\]G,?\
MK1F,,2$X]!C/-;6N7EWX(OO%5II%Y>M"-$AO(4N;A[@PS/*\193(2>F#C.,B
M@#UNBO.O"T6HV?BJU2STSQ+;Z9+:R+?-K%P)0THVE)%_>.0Q^<$# Y''%;?Q
M%U"[T[P9<-8W#VUQ<3P6JSH<-$))51F!['#'![&@#8N];MK/7M.T>1)3<:@D
MSQ,H&T",*6W'.?XAC@UI5YI=:/:^&_B7X9\F]N_LGV&_=EN[EY_+*K'N<%R2
M,C&1G'' &367HUU(GB#PS-:_\)(UOJTLL5Q?:C<XCOD:%W5EB\PF,Y4%2%7
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M75U)/ME$I0LI<DC(ZC/:@#N:*Y7XA)J,?A634]*FF2\TN5+]8XW*B=(SEXV
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M'#:73P;I9'?]X2A!. @ !XZUQ_VK69O#6CVIUV^^TS>,9;&6\28AVBS,I [
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M"W\#S:YJ=QIUM=?:X-/E9"B2!BR_/MWE5)R 6[#KBMVSU?3-1FFALM1M+F6
MXE2"=7:,_P"T >/QHM]9TN[E\JVU*SFD\KSML<ZL?+SC?@'[N>_2@#"M?!"6
M5ZGV?6M3CTN.Z-VFF(Z+$LA8MC<%W[-Q)V;L9]N*ZJJ=AJNG:K&\FG:A:WB1
MG:[6\RR!3Z$J3@UAZAXRLDU'1K;2[JQOQ>ZA]CG,,X<P_NW?^$\'*8P?>@#(
MT'07@TKQ!X#OH[B.P?SVLKF-?E:VG+$J&((WHS,"#['&*USX&T\IX77[3=8\
M. "VY7]YA GS\>@[8K?U"Y:STVZNE4,T,+R!3T) )_I63X;\56&N:7I;R7ME
M'J=Y9173V23J9%WH&.%SNQS0!FZ-:7&K^/M2\2SP2P6EK;_V98+*A4R@/NEE
MP>Q8!0>X7/>NCUC3$UC3);)[BXMMY5EFMGV21LK!E93[$#KD'H:L6]W;7=N+
MBVN(IH#G$D;AEX.#R.."#2V]S!=VZ7%M-'-"XRDD3!E8>Q'!H Y2;P!#?V6H
MQZKK%_?W5^D,4EU((T9(XI/,5%55"@;LD\9.:U]5\-V6L:M97]TTI:U@N+<1
M*0%=)@H?/&>BC&".IJY/K&EVM_%87&I6<-Y+CR[>2=5D?/3"DY--O-;TG3M_
MV[5+*U\LJK^?<(FTL,J#D\$@''K0!S5M\/$@;29)/$&JSRZ1(IL7D\K]U&%*
M&/ 3#;E."QRW P14A^'6F'PWK^A_:[O[/K=Y)>3OE=Z.Y4D+\N,?*.H-=-<Z
MG865D+VZOK:"T(!$\LJJA!Z?,3CFLW6/%^BZ+X=;79KV&:Q&!&\$J-YI)QA#
MG!/X]C0!K6ENMI9P6R$E(8UC4MU( QS6%/X0@E\4W&MI?7,:WENMO>V8"-%<
MHH8+NRI88#'H1_.HG\9V47BG[#)=V*:7_9@OOMS3J$SYOEXW9VX_K6ZVJ:>N
MF_VBU_:BQV[OM)F7RL>N[.,?C0!AZ+X/.CW5HS:[JEW:6*&.SM)G0)$I&WDJ
MH,F!P-Q./KS2P^"+"#P)/X26XN393),C2DKY@$CLYQQC@L<<5MQZKITME'>Q
MW]J]I*P6.=9E*.2< !LX))XI]G?6FH0F:RNH+F(,4+PR!U##J,CN* *%QX>M
MKG5M%U%I9A+I*RK"H(VOO0(=W'H.V*R]4\!:=JVG>(K*:YNDCUV:.:X9"N4*
M!  F1T^0=<]36_?:OINF-$NH:C:6C3';&+B98RY]!DC/X4MYJNG:>&-[?VMM
ML3S&\Z94PF<;CD],G&?6@"G;^';:V\01ZRLLQG33UL A(V[ ^[/3.<_A61)X
M!ME"RV6J7MG>QZC<:A%=1B-F1IL^8F&4J5(/<9X'-;IU_1@UJIU>P#78S; W
M*9F[?)S\WX4Z\UO2=.W_ &[5+*V\LJ'\^X1-I;)4')XS@X]<4 <Q+\-;"73=
M6L?[5U+RM2FBNG9G0LEPFT^:#MZL44D'CK@"KESX,FEN$O8/$>IVNHM;BVNK
MN%8=UT@)(+*4*AAN.&4 C-+XG\5R:'J'AJ"UAAN(M8OUM6D+?=1AG<N.M;=[
MK>DZ;/'!?ZG96LTO^KCGN$1G^@)R: )K"SCT_3[>RA:1HX(UC5I7+N0!C)8\
MD^]8.I>#_M6L7.J:=K6H:3<7D:Q7GV3RR)@H(4X=6VL <!ACBN@6ZMWN7MDG
MB:XC4,\0<%E!Z$CJ :CEU.PA^T^;>VT?V4 W&Z51Y((R"_/RY'K0!D6?@W3-
M/N-"DL_-B3189H;>,,"&$@4,6R,D_+G/J35[3M#M]-U;5M1BDE:74Y4EE5R-
MJE8P@V\=,*.N:GBU?3)[ 7\6HVDEF2%%PDZF,DG &[..I ^M26E]:7Z.]G=0
M7"1N8W:&0.%<=5..A'I0!E^)O#47B6VLE-[<V5Q972W=M<6^TLDB@CHP((PQ
MX(I^F^'8-.O=5NQ<SS3ZGY1G:3;U2,1Y& ,9 R?>KE_J^F:5Y?\ :.HVEGYI
MQ']HG6/>?0;B,TZZU33[%2UW?6MN!'YI,LRIA,@;N3TR0,^XH YR/P%!9V&D
M1:7JU]87>EVQM(KR(1L\D1P2KJRE6&0#TX(KH=(TU-(TR&R2XN+GR\EIKF3?
M)(Q))+'W)/3 '08%.75=.?3?[26_M6L-N[[4)E,6/7?G&/QK'LO%4.I>,?[)
MLI+:YL3I@O4NH)0X9C*4*@@XQQ0 _6/"QU'55U6QU:]TJ_\ (^S2RVHC;S8L
MDA65U89!)((Y&356;P/%]HL9['6M4LIK>T^Q22QR*[W$.=V&9U)#9R=PP1DU
MT.HZA;:5IMSJ%Y(([:VB:65SV51DUF^'-:FU73;:;4$@L[V[C-S%9"3,B0$_
M*6'4G!&<# )Q0!F:9\/M/TN;2C#>WC0Z5=W%S9PN4VQB8$,F=N2H+,1DYYZF
MM.7PQ:2^,X/$YFF%W#9&R6($>64+;LGC.<^]'B36YM)TVYGT](+R\M(Q<S61
MDQ*\ /S%1US@'&1@D8K2T^_MM4TZVO[.026US$LL3C^)6&10!S5M\/=,M?#]
MQI,5W> 2W[:C'<AE$L$Y8,&0XQP1W!X)!IUSX&CU'0-5TS5-:U*^?4P@FN9&
M12@0@J$15"*..>,G//:M&Z\6:/9>)K7P_/=Q)?7$32*ID4!<%0%.3G<V_P"4
M8YP:I>&_&=EJVGPOJ%W8V=[/<SP16S3JK2".9HP54G)SM[=Z .H P /2L#6O
M"ZZGJEOJUGJ5WIFIP1- +FV"-OB)R4975@1D9''!K3O=7TS39(8[_4;2U>8X
MB6>94+GT4$\_A5R@#D;SX>:7>^"[OPS)<WGDWDWVBYNRZF:67>'+DD8R2H'3
MITKKJS]0UO3M/E%M/?VD5XZ%H;>695>3Z*3D_A69HGBRSNO!^DZ[J]U9Z=]N
M@20^=,$0,PSM!8\T 4;ZTN-%^(UOK<,$LMAJMLMA>>4A8PRH28I& _A(+*3T
M'&:G;P#I<F@7NF3S74LUY<F\EOV8"X\_.5D5@,*5P H P ,>M7=7\7Z)HESI
MD%Y?0H=1DVPMYJ!0NUFWL21A/EQGU(K0GUC3+6\AL[C4;2&ZG_U4$DZJ\G^Z
MI.3^% ',3V-UK?C_ $L2),=/\/1-(]S+'M%S=2)M4+P =JEF)'&6 KLR 00>
MAI:H7&MZ39WT=C<ZI907<F-D$MPBR-GIA2<F@#G-,^'EKINFZ=IW]K7\]GIM
M\EY9Q2^7^ZV[\)D*"5.\]>>!C%:FH>$M-U75+^]O/,E%]IPTZ:'(">6&9LCC
M(;+GG/85HWFKZ9IP<WVHVEJ(U#/Y\ZIM!) )R> 2"!]*LP3PW4"3V\L<T,@W
M))&P96'J"."* ,/1?#4^EWPN[O7M3U-XX3! MTR!8T)!.0BKN;@?,V3^M7]>
MT2T\1Z)=:3?>9]GN% +1MM9""&5E/8@@$?2KB7,$EQ+;I/&T\0!DC5P60'ID
M=1G!Q42ZG8/8O?+?6S6B9W3B53&N.#ELX&* .;@\!1-JUOJ>JZSJ.J7<-O+;
M W'EJIBD4 KM10/7GJ<\G@8AMOAVD']E,_B#59I-(D4V#/Y7[F,*4,> F&RI
MP6.3P,$=[>E^-+&>YU>/4[NQL5M-3>QMS+<*GG 1QMD;CR?G[>U:MU?7<7B&
MPLXY-.%K-'(TJRS%;AB!QY:8PP]3VH PX_AY9I;:K9G4]0-E?71O(X 4'V6<
MN)/,C8+N!# $9)'L:U]$T*;2Y[BYN]8OM3NIPJ&2Y**J*N<!4154=3DXR?6K
MG]L:8-3_ +-_M&S^WXS]E\]?-QC/W,Y_2L31_&=E=2:C'J=W8V$D&J3V%NDL
MZH9A&0 0&/).>U &IX@T&U\1::+2YDFA:.5)X)X&"R0RH<JZD@C(]P>IK)B\
M#PR)JLFI:K>ZC?:E9-827<PC5HH2#\J*BA1R<]#DXKJJBM[JWNT9[:>*9%8H
MS1N& 8<$''<>E &3<>&+2YMM"@::<+HTT<T!!&7*1M& W'3#'ICFMNL^;7='
MMK%;Z?5;&*T=BJSR7"+&2#@@,3C.0?RJ==0LF@@F6\MS%<,%AD$J[92>@4YY
M)P>GI0!SNF_#_2-,L_$%I&]Q)#K9D$ZR,#Y:/O\ D3CA09&(SGK2V_@/3K;P
MM9:"MS=-#:W:7GGNRF2619?-RQQ@Y;KQTKI1<0&Y:V$T9N%02&+<-P4D@-CK
MC(//M2SSPVL#SW$L<,,8W/)(P55'J2>E &;<:!;7'B)-::647"V,ED$!&W8[
M*Q/3.<J.]8MM\.].LO">EZ%:WU["VE3-/97RLOG1.68D_=VD'>P((P1710ZU
MI5QI[:A!J=G+9(<-<I.K1CZL#CN*&UO2DM[FX;4[)8+5S'<2&X4+$_\ =8YP
MIY'!]: ,"'P#9A$>ZU"]N[TZC#J4UW*4WRR1<(I 4*$ XP *VO[#M_\ A*3K
M_F2_:39?8O+R-FS?OSTSG/O5VUNK>^MDN;2XBN()!E)8G#JP]B.#3+K4+*Q_
MX^[RWM\JS_OI53Y5QN/)Z#(R>V: *^MZK!H^FO<W%M=W*$[!#:VS3NY(/&U0
M>O3)X]37-?#?PD/#_@Y[>]M?+GU!WFN+>1MYC1AM2(GN%0*OYUUEMJ=A>6)O
MK6^MI[, G[1%*K1X'7Y@<<4W3]7TW5D=]-U"TO40X=K:99 I]#M)Q0!S=E\/
MK>U?3X9M9U*[TO395FLM/F,?EQ,OW,L%#N%_A!)Q@=<4E]\/;>\GU=$UG4K;
M3M69I+RQA,81Y&4*6#%2PS@$@'!QSQQ6SXKUB3P_X4U35X8DEDL[=YEC<D!B
M!T.*2R\0V9\,:;K.J75K8)=VT4S--*$16= V 6/O0!HZ?9IIVFVME$S-';0I
M"K-U(4  GWXKGM0\%)=ZA>W%KK6I:=;ZBP:^MK5D"S,%"[@Q4LA*@ E2,X]>
M:WUU*Q>VAN5O;9K>=@L4HE4K(3T"G."3[4VPU;3=5$AT[4+2\$1VR&WF638?
M0[2<&@"O9:%;6&O:EJ\4DIFOXX8Y$8@JHB#!<<9YW'.2:RM/\":?II\/^5<W
M3?V&]P\&XK\YF#!MW';<<8Q6S;Z[I%VQ6VU6QF82"'$=PC'>02%X/WL \=>#
M4G]KZ9_:?]F_VC:?;\9^R^>OFXQG.S.>GM0!D:KX3^V:R^KZ=J][I-]-"L%P
M]J(V$R*25W*ZL-PR<,.>:KR_#_26TW0;".6YBAT6]2^A(<%I95)8F0D<[BQ)
MQCKVK??5]-CN5MGU&T6X:3REB:90Q?&=H&<[L$''6KA( R>!0!B6/ABTL/%F
MJ>(HYIFNM2BBBEC8C8HC&!MXS^9J?Q'H5OXF\/7NC74DL<%VFQWB(# 9!XR"
M.U2V^M:=?P7,FG:A:7AMP?,%O,LFTXZ':3CI7+>'_&6H^(/ .B^($32K2XOK
MGRY8[N=HXPHD="$/)+D*,#OS0!O6GAFUL]:M-42:8S6NG?V<BL1M,>Y6W'C[
MV5'M[5/HVAV^B?VA]GDE?[=>R7LGF$?*[XR!@=.*L7.JZ=9W4-K=7]K!<SG$
M,,LRJ\G^Z"<G\*HWNK2?:=).GW6E26MW,5D::YPSJ/\ GCC(=L]J (-8\+?V
MGK,.JVVK7VFW2P&UE:UV?O82V[:=RG!!Z,,$9-3^&O#L'A?37TZSN)Y+/SI)
M88Y=I\D.Q8HI !(R2?FR>>M4-)\9V5Q<:I#JEW8V#VNJ2V%NLLZH9@BH<@,>
M3\_:EU'Q//9?$+1O#:V\;07]M-.\I)W*4' ';F@#'\80Q6GBNUU/_BH;)Y+,
MP27VD6XN%D4-D1.FQR#R2K8'4\U%X0\%";PMI?V^*ZL6MM9DU>WMW(\Q 6?R
MTDSD_=;)[Y[]:[A=7TQ]2;34U&T:_49:U$ZF4#U*9S^E6998X(7FFD2.*-2S
MNYPJ@<DDGH* ,/6O#"ZIJEOJUGJ5UIFIP1- +FV"-OB8@E&5U8$9&1QP:HR?
M#_3VT"/38KV]CN8[[^T1J =3.;K.3(<C:2<D8QC'%5/"'CN7Q9K>J)$=+BTV
MSGE@C476ZYEV$?O=N,>6<]<UU5AK6E:J\B:=J=G>-%_K%MYUD*?7:3B@#B?$
MG@LV7AGQ3J4=[J&J:K?:0]M(90I,I4,5VHB@ _-C &.!WR3J:-X+6*?1[V]U
M74+N/3H@;*RN-FRW8IMSD*&8@$@;B2/KS726^KZ;=W"V]MJ-I-,T9E6.*968
MH#M+  YQGC/KQ5B>>&U@>>XECAAC&YY)&"JH]23TH CO[--0TZZLI698[B)X
MF9>H# @X]^:R)?"=G+I.@Z<9YQ%HLT$L# C<YA7:N[CH0><8K4M=4TZ^LFO;
M._M;BT7.9X9E=!CK\P..*98ZUI6IQ2RV&IV=W'%_K'@G60)]2#Q0!ACP0D=_
M*]OK6IV^G37?VR33H718VEW;CAMN]5+<E0V"2?6JNH?#BTU%-4M9=7U)-,U&
M5[B2QC9 BS-R7!V[C\PW!2<9YQ72Q:YI$]['90ZK8R74B"1($N$+LI&0P4')
M&.<^E9<'C'2]4DUJTTN]LVO=-##]_.HC9A&&W9!)V L S8X(- #K+PE;VGB>
M7Q!+>7-S?36"6,IDV!752#OPJC#$CG''M6=IGP\M=-T[3=/_ +6O[BTTR^2\
MLHY?+_=;0X"9"@E?G/7G@=*WK/5X5TFSN-3O=.BFF@\UFAN 8FP,L49L949Z
MU/#K&EW-B+Z#4K.6T9@@G2=6C+$X W XSD@8H ACT.WC\3SZ\))3<S6B6C(2
M-@5'9@1QG.7/>L'XDZ=)JN@Z?:1PSR*^K6?F>0#N5/-&YLCD8'.>U=8;B!;E
M;9IHQ.ZEUB+#<RC&2!UP,CGWJK!KFD74MQ%;ZK8S26P+3I'<(QB ZE@#\OXT
M 9.G>$%M=4N-3O\ 5K[4[V6V-G'+<B-?)A)R0H15&2<$DC)P*HVOPZM=.T/1
M-/TW5K^TFT<R_9KQ?+:3;(275@RE2#GTXP*G7QK::QX9OM2\/WFF&>VF,7_$
MPN1'$N)2FYRN2JL 2I[\5OWNKZ=I5O'-J>H6=FC\*\\ZQJQ] 6(S0!S=K\.[
M"TN%=-1U!XQJ4>J^7(R-FX5"C,6VY._@D9ZCC%;R:';IXHFUX22_:9;-+,ID
M; JNS@],YRQ[U:;4;%(89GO+=8IAF)S*H5^"WRG// )X["FV&IZ?JL!FTZ^M
MKR)6VE[>99%!],J3S0!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "O&HK/3IO@=X@U&_AA.J&2]EN)W4>:MTLS[/FZA@0@
M'X5[+6#/X+\-W.K'5)M(MGO#()6<@X9QT<KG:6]R,T <4]E%<?&7P\;VSA::
M70'DG#Q [I-PR3QUK*%JEKJOQ=FL+6)+FVMHFMFCC :(FV?)3'0_2O6WTFPD
MU>+5GM4-_%$84G/WE0G)7Z9HMM(T^TOKZ]@M(TN;\J;J0#F7:,+GZ#B@#S_P
M_H=_#K'A:]/_  C=E;0VLB1)8R.);J%HONX*C< =CGZ9[US>EZ;!9_LZI>VE
MO MW=JBW5PXPSQ&Y56#L.=FP8([ 5ZMI7A'P_H=X]WINEP6T[*4WJ"=JDY*K
MD_*,]A@5<M=%TVST8:/!90KIP1H_LQ7*;6SD$'J#D_G0!Y=XFTK6M-L=?U M
MH5E-_P (]/$;72W</(@9<2%2!PHW@'MNK2UG3]$LM7^'#:=!;1.;L+"8E +P
M^0Q)XZC)7\_>NUTKPGH.B+<+IVF00BX01RYRY=!T4EB?EY/'2J^G^!O#.ESQ
M366CV\,L,@EB<9)C8 @;<G@89N!QSTH TM=_Y%_4O^O67_T UY1%8:9;?"GP
M+>Z=! M_]MT\Q3(H\QI6<"0;NIXW@CT'M7L<T4<\,D,JAHY%*LI[@C!%8=GX
M)\-:??V][::/;17%LH6%E!Q'A=N0N< XXSC/O0!Y_JUU<>%[CQ1X/LSLFUR5
M)M''H;EO+F ] C;G]@:]4TO3K?2-)M--M5VV]K"D,8_V5&!_*N:BT/4]9\=6
MVO:S96UI;:3'+%I\:2^;)(\F TK' "C:,!>>23784 >+^-Y#=Z#XTU.ST_2;
M6V@NO(FNKEG>ZFGC" ,G9,':%'MG S75:3I5AJ/Q0\7RWMI#<E+:Q11,@<*&
MC?=@'UP/RKH;GP9X<O-0N;^XTBVEN;I2LS,"0^5VDD=,E>,XSCO5[3M$TW29
M))+&U2%Y(XXW8$DLL8(0$GT!- 'DW@N**\F^'MKJ"++9I87S6\<HW*9DD"C@
M\$JF<>G-5_%UM;1:1\2+:VAB6PAOM.DC15&R.=O+\W;V!/RYQZFO5I_"6@W.
MCP:3+ID#65NV^&+D>4V2<J0<J>3R#WI\?A;0XM!FT1-+MQILV?-M]O#DG)+'
MJ3D#D\\"@#F)=(TZ?XQP1RV4#Q6^@;HHC&-B,9R,A>F<$_F:XZ""Y\S3=-L8
M+$VJ>*]22*WO,BW#*',:D*#T.XJ,=0*]<T[P[I.DR126-DD+Q0&V1@22(]Q?
M;DGIN)-,G\,:)=:?<6$^FP/;7%PUS+&0>92<E\]0V><B@#RWQ-HUU:>%M=BO
M9],47>M6+-:Z7(VVV<M&&R" 59AM;\<]Z]@LK"STVU6VL;6&V@7[L4,811^
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M!DA\AB2<=>2O)_O'UK(T;2-8U/PO#=,WAZT?^V&G:_N)'6Z6X6Z.03C&XD;
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M(MW<(D<LHZNJYV@_3<?SH LT444 %%%% !1110 4444 %%%% !1110 4444
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MM9;4X)#@;B'7(P1UY'6J%IJ?B?QC>ZA-HFI6NCZ/:7+VL,SVGVB6Z=#AVP6
M5,Y ZDX-7[7X@:7K&KV6G>'0=7,KYN9H,B*UCP?F9B,9S@!>I]JP?#/B'3O
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ML79[6Y021,RE20?8U=K@_ASJ]E9>!/!NG3RE;K4+0K;($)#E%+-R.!QZUWE
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M^UF\R:&"*X8@?*8Y,["#T.=IK.D\;Z*FC6VIH]Q-'=SO;VT,,#/--(C,K!4
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M:IHWP[\/7EUHH;0P(K:6]-U^^4L^SS/+V_<W$#[V>^* /6@H48  'M05##!
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M$DGAMK)W8*V?F''*C:<GIR.<U8C\8Z3=6^F2Z>\E\VIQ/-:1VZC<Z(!O/S$
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M<8K+\1Z9>7GBWPE=V\#26]E=3O<.",1JT#J"?J2!Q72I#%$\CQQHC2-ND*J
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MVFWB?$W4-4:!A92:3! DN1@NLLA*^O 8?G73T4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 C E2 <''!]*\,G35?^%<>.
M9[K4_MFS6WA$30JFZ1;B(;\CID #'05[I7G,W@/6Y-*\3:.MWI_V#5-0;4()
M"'$J,TR2%6&,8 4@$>U %J;6==\,^*+6WUG4X=1LKVPNKDI':B(P/ %8A2"2
M5(8CYLGCK6)X>^(5Q=:EH,DWB*QU!M6D$=QID$ 4V1="RE6ZMM("MNSG.1BN
MUUOPTVL>)=)U!Y$^R6MM=V\T1SN<3*@X^FT_G53P]H_BK2QINFW6I:>VDZ>G
ME"2*)O/N45=J*X;Y4QP25))*]LF@#K:\\\(:58^(]>\3Z[J]K#>W<6JS:? +
MA X@AAPH50>%R22<=<UZ'7%W'AK7]'U^_P!4\*WNGB'4G$MW8:@C^6)0 #(C
M)R"0!D$'./R (]9M+/X=Z!K6K:!;".:]EA6.S)Q;I.[",,J#[H)8%L=<4^&^
MU_P_XMT72]5U:/5;75UF0/\ 95A:"6--_&T\J0&&#R,#FFS>"=4UC0=7AUS6
MS+J.HF-XS;J1;V;1,&C\M">?F&23RWM5FST'7M0\2Z;J_B*?3@-+246T-@'(
M>21=K.Q?IA<@*,]3S0!Q]KXI\:-X)T+Q4=2LY&O+J*V:P:U 1P\AC#%P=P.<
M'C QQSU.S=:[XBT#4?$6FWFIQ:@\&@R:K:S_ &58C$ZEUVE1P5R 1GGM5JW\
M"WL/P^T/PZ;N W&GW<%P\H!VL(YO,('&<D<4[QGH4V_Q%X@\V/R#X9N++R^=
MV[YWSZ8QQ0!1AUSQ1IT/A;6=2U&WN;36;BWMI[%+4)Y!F7*,KYR2#@'/!R<
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MUXB_Y%C5O^O.;_T UP?AOP[KVM>$_!]M?7EA_8MI':7P9%?[1+L0-'&P/R@
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M;BXRC( P^Z@.[) )!('2L^P^'-]9^%&L!J%NNHP:RVK6<X0M&K[LA7'!((+
MX]: )+S7=?\ #>HZEI5]J4>H%M%N-1L[IK98W22+@HRK\K#YE(.!W'-0VVM^
M*+1?"6K7^IV\]MK<T-O-8I:A1%YD3.K*^<D@KSG@Y. *OR>$]:UBZU/4=:N+
M!+R;2I=-M(;3>8HA)RSLS $DD+T' '>KMUX5N9](\)V:W$0?1;FWFE8YQ((X
MF0A?J3WH ZNO.X_$FK7/C.[TYM?L=/N8+X1PZ/=VVP75MQ\ZR'EF8%B-N0"
M".IKT2N)UKPUXBUR<V-W=Z7+I?VU+J*Y:)A=0*KAPB #;D8VA\YP>030!S-F
M_B*UTWQUJFDZK!91:?JU[<+"UL)?M#(BL0Q)^5<  8YZG/05L:_XIO=FGS)X
MDL-$CN--2ZC@\C[1/+(PSAE(XC' R.2<],5KP>$[J+P_XLTXW$)DUJXNYHF&
M<1B6,* WTQSBJ-OX0UW3;\OIU[8+%=Z;;6-U+*C&6$Q*R[HL<'(8G#8P0#ST
MH P+S5I->\7?"75I8UCEO(+J9T7H&:!20/;-:WPZ_P"1Q\?_ /857_T&C3O
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MK27X7R(;WR[-EC*[HO+1N_WL,S#/L?2@"'QGJ=UHO@O6=3LF5;JUM'EB9EW
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M2/32[8LD0\JRG'[QC\Q..A4#B@#N:*** "BBB@ HHHH **** "BBB@ HHHH
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M1M,,@O\ 5K&U,94.)[A$VEL[<Y/&<''K@T 6;"RBT[3[>R@+F*"-8T,CEF(
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M+F-N@(" +M[;-O?.<G/644 8_AG0/^$:T:+2TU&\O880%A:ZV%HT  5!M4<
M#OD^]<;IG@ZYU34O%[2ZCJVE17FJ.CK %5;F#RHQD;T..2XW)CN,G''I5% &
M':^%-.LM:L-3MO-B:QT\Z=!"I'EB+*GTSD;0.M4=2\#PWNH7]S::QJ>FIJ0
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M+94 !N_  SVK#@\$Q[KN34=9U+4YY[*2P26Y,8,,+XW!0B 9.%RQ!/ KJ:*
M.;T_P5IVG)X<6*>Z8:"DB6V]E^<.FP[^.>#VQ5J/PQ9QRZ]()9\ZT0;C)'R?
MNA'\G'' SSGFMJB@#F8O ^FQ7OAB[6>ZW^';=[>U!9<2*T8C)?Y>3@#ICFH6
M^'VEM:Z]!]IO!_;-VM[*X=0T,JL&4QG;Q@J#SFNLHH X]OA];2W-S=7.LZI<
M75Y8RV-W-(T>9XG& ,!,+MZC:!SUSDYZ;3+"+2]*L]/A9VBM8$@1G(+%54*"
M<=\"K5% ',:AX+CN]?NM<M-8U+3M1N88X&DMFC*A%SQM=&'.>IY&!C'.6?\
M"!Z?!I&EV>GWE[8W&F,[VU[$ZM-N?/F%MRE6W$Y((ZXZ8KJJ* .<C\&VBP::
MLU]?W,MC?G4!/-*&>64JRG=Q@+ASPH &!4E_X0TS4[[5;J\\V3^T[-+*>+<
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MC:J >^>I/4G Q;\,^%H?"T=U;VFH7DUG+*TL5M.4*6Y9F9@A"@X)8]2:WJ*
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MFBEO(ECN8%(\J5E^[(1C.\#Y<@].U:U% !1110 4444 %%%% !1110 4444
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MKI%M$]OO\IU7YAO #9/4Y  Y]!Z4 >2Z#!#+\+_A>98HWSKRH=Z@\%KCCZ'
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MR7A0> 6.!^57HO%'B"RU'2X-=T>QMHM6+16S6]TTAAFV%UCER@Z@$97/(Z4
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M^4%+)("H&=K9RI(XQSUK(;XA:Y'H5CK\GA^W&E:E<0Q6NVZ)EC620*KRKMP
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M3VYH Z>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M26,UG&ZHQD20C&6( RI#<GH:[ZJ,&D6-MJUUJD$'EW=VB).ZNP$FW[I*YQD
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MZ1:BP\KRPHC 8<8W;L9W=]W7/-<Q>:7?-\4K;3M+U.6Q6+PZJ-=%5FFV+.0
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MCRX\1?:%,<NG1V0AV\@K(S[L^GS8K*C\$3IX*\0Z!]MC,FJSW<J2[#B/SF)
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MC>1I,R'<ZY;Y0 1G&#TS1=)>3>'O"VC>(K'5+_6'$K/IL-TB"=8QMWSR!@"
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M+[3M1F*R,2,1@?,>1R!UH ZVBN'^&TDZ1>(+"6"6VBLM3,<%K+/YQMU,4;[
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MGF;?O\W?UW[AG/\ 3BNDHH YW2O!UGI>MKK+7VH7NHBV:U:XO)@Y:,LK8P
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MI46RNX)0LT6U-G7!!RO!!&#Z5>T318-#LWMX9[FX>65III[F3?)*YQDD].@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHD,,BW%A:3B-Q*2NV0J642  ,-N>,YQ0!VU%<AX'ET8OJ<&DRZG 4=&FTO4
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M?E_:(AED!ZX^HR/QK+TOPO?6=I_9UYK$=WI/V=K<V2V,<*["-N,KR!BNFHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %>4V#PV31_:HX[_2M&TF>VF6.V</(?-B\M90X \PE
M&..W+$X:O5J* /-5:QD:+69M>:RNI[N2:::SM_,BBD,*HL>74C[B ;B/F.<8
MR ,][G4;V437ZM;WEU_9LCV!MB&OBCAMR$\QX[CG;M.<9S7K5% 'FLTFD>($
MU1(W^QV]O97=I;VUM;LTQ5R/-E*@<Y*Y51R023R<#;T75-9NY;U-/N(-6LXI
M(_+O+O\ <;LJ2ZC9'AMIV\X'WB"<BNOHH \AU6QO-*\'^(K^UMII(=2FU*VO
M($0EMYN)A#,!^(0^JE3T6NH\5:*\_B/34MI9H+?6Y#9ZJL0XEB2-Y%)/\).P
MQENZOCL,=M10!QAN=.\/^+-5?58A#!<VT$=G*8"R&)5(:%< X(;)V]]PP#63
MJ\UG81RS:=$;*2;38HQHM_I^^.[C4,4B4+RK_,5(!.,C*^OI-% 'E^I6FKSZ
M7XG5O(32;C4BEY%]D9[A(6CC$DD;;]I*CG[IQ@D9( J6ZB6?.E!)_P"T5UB[
MNI3'$6<0/'-MD'J#&Z(.>3@=J]+HH \Q.L:HFDW.D:'?3:F+BWM[2RNI+?R?
M(F?<K E5'"1KOY!*XP<Y%:_A*UO/#NNW.C3Z=!9V%W"MQ9);SM,D;1JL<BEB
MBX)&Q@,<G>:[>B@"I;/J)O+@74-JEJ#^X>*5F=A_M*5 'X$UYCI]GJ-G'=Z=
M:PSK%XDOKR*215(^SNMW*'D)[;H#P?6)?6O6:* /+--C@TK1-+=;W^RKJ.WN
M(4%S9&:VFC,['RR!@[N!P""0>A[(^F3ZE?V^A3Z8]G8:_#:W]U B$);F*(B2
M/I@<QVPQQU->J44 <5X$-[J-Q?:MJ44B7444&F?.I&3"N96&>QD=QGOL%=K1
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>exhibit1013-zerondaxexec004.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY/"\\<>#RB%0QST'+K_D4VTNKZ;4;Z"XTTV]K"4%O<F97^T C+':.5P>.>M
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MCJ*"0,9(&>E "T53N=4L[/4;&PGEVW-\SK;I@G=L7<WTP!5R@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N&^%C(N@:G;
MN1]OAU>\%Z#][S#*2"?JI7FNYKF=5\"Z1JFJ2:HLE_I]_*H6:XTZ[>W:8#H'
MVG#?4\T 9OC_ %J"V\$^)6TB\CCO[?RH;IX"!)"9&1221T(1L@]L>U4KS0=,
M\(^,O")T"U2S:\GEM+J.(D?:(O)9LO\ WBK*#N//-=99>%-$T_09]$@L$^P7
M ;[1&Y+F8M]YG8G+$^I.:K:3X+TO2-0BODEOKJX@C,5LU[=O-]G0]0@8\9
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MP$",>$  !]#N.<YKJ[7P+H]IJ,5U&UZ8H)S<06;W;M;PRDD[EC)P#DDCL,\
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MY+3S?,(>6%/M" %NO*J%S75>&=-L]!^)6O:7I<"6M@^GVMS]FCX02%I%+ =
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MK'F@#QF+1;.W^$D?B *[ZM8ZDJ6EV\A:2"-+P1*BDGA=HQCIR:["[T+3=?\
MB]J=MJL*W5LFCV[BUD.8V;S)!N*]"0.!Z;JZ<^#]'/AIO#_DR?V>TQF*>8<[
MC+YO7K]_FL.]\)OJWQ'U#4)_MUK =,@B@O+2X:%]P>0NH*GI@KD'CIW% '!:
M\SK\'KFR\QY+>P\2-:6S.Q8^2EP0HR>N!Q^%=UJFG6GB/XJ?V5K,"7>GV>CK
M<P6DW,;2O*RLY7H2 H STS6W/X'T&?PQ;^'6MG&G02+*J+*VXN&W;BW4DL23
MGKFK&M>%[#7+JWO)9+JVO;=62.ZLYVAE"-U4E>JG .#0!YT--NIO!?B.'3&=
MY?#&O27&D@L6VK$$D,0/4C#2)CW [5T&E7\/C7Q_::K;,7TS1].26/GK<7*A
MN?=8@/H7K?:WA\&^'1!HNBW=_ASB"!PTDCMDEW>1AG)ZL23STJK\/O"W_")>
M%8K*6**.[GD>YN5BY59'/W1[* JC_=H \PM?#]D/A-X>UM!(FL-J,,:WR2$2
MHC7)C*JV>%VD\#COUKL8-/M?"OQ'U&WT.U6V@D\.M=/;QYVR3)*0K$=VP<9[
MUU2>#]'C\.VFA+#)]@M9DFB3S#D,LGF#GJ?FJ^='LSK_ /;11OMOV7[)NW''
ME[M^,=,Y[T >5^$-'U>:'PKK5GX?CM[F1HY[[5CJ"O)>Q2(3)O7&3DMN .=N
MT8Z4]_#FF:MH7Q$U"_M_M%S:W]Z;5W8_Z.5B5@R?W6W<DCK@>E=WI_@71=-U
M""Z@^UF.V=I+6TDNG:WMW;.2D9. ?F./3)QBK\?AS38K'5K-8W\G59)9;H;S
MEFD4*V#VX Z4 >>:AI=CKGBOX9W.IVD5U-=Z?.9WE7)DVP(ZY^C,Q^IKUFN>
MU'P9I6HV^DQ,UW ^DKMLYK:X:*2-=H0C<#G!  -6K?1WA\67VL>8/+N+2& )
MO)^9&<DXZ#AE''O0!KT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;BQN<""56W"4GH% R6/!X'H:Y:SO=-L_C+X@:\G@AG;2[7RGE8+\H+EP"?\
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M'U'%:=U<PV5I-=7#B."%#)(Y'W5 R3^5<E* /C/:D  MX?E!/KBXCQ_,UV5
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M)X7\,WFJF/SI8U"P0]Y96.U$_%B/PS6V,X&>37F?BU]5\3_$+3M%T1+.6/0
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MB8$I%Y# @XZ<[1CV]J /5*X:3Q%XJU'QEKNBZ';:,(=*^S[I+UY0S^;'OXV
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M%S_LFL;PG:M>:)X)CN/%>G*MO+$]O81:?B<2HC"2-F$A(.-X9BH]^M 'I/\
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M>1W*1OLD"Y#(W7#*<$<>HKS[Q;=Z5>Z.EUX?GM[:"'Q) VH7IAWP>:  9&Y
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MDUF^^VD7;_99C;B!C%@8!4>C;@#W ![U=UC5(M%TFXU":*>9(5!\N!-\CDD
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M0ZD%"0P8$8P>:FT?Q5_:6J#3;W2+[2KN2 W,$=WL/G1 @$@HS88%ERIP1D4
M=#6;=>']%OKEKB\T?3[B=\;I9K9'8X&!DD9Z5I5Y?X5\8:Q%XQU*TURY\[2;
MW5KJQTZ8J%^SS1.<0D@=&3&TGG*D4 >EVUK;V<"P6L$4$*_=CB0*H^@%5[31
M]+L+J:ZL]-L[>XF_ULL,"H\G?YB!D_C7/Z9KDX\:^,8+Z[QIVFQ6DD88 +"K
M1.SG.,]L\^E,L?'\-U-IKW.BZE8Z=JDBQ6-]<"/9*S#* JK%DW8^7<.>.E '
M4?V?9?99;;[);_9YBQDB\L;'+'+$C&#D]<]:COM)TW5(4AU#3[2[BC.42XA6
M15/J 0<5SE]X\6WU'5[&RT+4]1GTEE^U^0(PJ(8PX8%F&>"<*.?E/'3/2:7J
M5MK&DVFI6;%K:[A6:(D8.UAD9'8\T /FL;.YMTMY[6"6!""L;QAE4CI@'@8[
M4Z:SMKB:&:>VAEE@):)W0,T9/4J3T_"N5\5:KJLWB#2O"^B72V5S>QR7-S>F
M,.T$"8'R*>"S,P )Z<T^RT+Q+HVLV;V_B*?5=,D)6\@U,)YB#!P\;H@YS@;2
M,<]: .C;3+!]1347L;9KY%V)<F)3*J^@;&0.3^=1V>BZ5IUQ+<6.F6=K/-_K
M98(%1G[\D#)_&N7TW6M1F^,.M:-)=,VG6^FPS108&%<D9.<9_6J6C#7/'L=S
MK0\0WND:4;B2'3[>P2,,Z(Q3S)&=6))*GY1@ 4 =KI6E0:3#<1P9/GW,MRYP
M!\SL6/ ].GX<\U/?65OJ-A<6-U&)+>XC:*5#_$K#!'Y&LWPW!KUK8S6VOW5O
M>2Q3,L%U$NQIHN,%U PK=0<<<5)XFO[S2_"VJW^GP^=>6]K)+#'C.YPI(X[_
M $[T 5=!T&:S\.0Z-K1MM1CM&\NWDD3<7B7_ %9<$8#@8!QGIGO2:AH%QJWB
MO3K^\EB_LW3 9K>W7)9[@@KO?C&%4G:!GEB>U<[X=COM233M5T3QX^L$NC7]
MO<F(Q-&?OA51 T3#L">V#6UJ_C6+3+^]MH-(U#4$TZ-9-0FM@FVV5AN PS L
MVWYB%!X(]: .HJG+I6G3WZ7\VGVLE[&NU+AX5,BCT#$9 Y-4+;Q18W?B--&C
M63S);!=0@GP/+FB+;?E.<Y&1D8Z$54F\<:;"FNRM#<M#I$Z6KNB!O/G8#$<8
MSDMEE7G')_&@#H+6TMK&V2VM+>*W@3.V*% BKDY. .!R34.H:1IFK(B:EIUI
M>K&<H+F!9 I]1N!Q61I_BU;E]0M[[2[S3KZRMQ=/:SE&9XCG#(R,5/*D'G@]
M:JZ3X]MM6T&XUU-)U*+2XK87"3O&I,YQRB*"22#QZ$]#CF@#H[O3+"_LQ9WE
MC;7%J,?N)HE=..GRD8XJ6WMH+2W2WMH8X8(QM2.-0JJ/0 <"L/1_%1U'49]-
MO=(O=+OHK<72PW)C;S(B2-P*,PR",$'!&1619?$RTOK32]171-4CTC4)8X$O
MY%C")*YVA2N_=C=\I;&,]S0!V-I9VMA;BWL[:&VA!)$<,8103UX'%0PZ/I=M
MJ$FH0:;9Q7LO^LN$@59'^K 9-8NL>,UT[4[JPL]'U#59;*)9[TV@3%NC D9W
ML-S$ G:N3BG7GC*W4:<FE6%WJUSJ%O\ :X8+?8A$(Q\[F1E"C+ 8/)/% '00
MVUO;O*\,$4;3-OD*( 7;&,G'4\#FJ1\/Z*1<@Z/I^+I@UP/LR?OB#D%^/F.>
M>:=HFL6VO:3#J-H)%CD+*8Y5VO&ZL59&'8A@0?I6+\0;V^L?#D!TZ]DLYY]0
MM;<SQ!2RK)*JMC<",X)[4 =*EK;QO,Z01*TYS*P0 R'&/F]>!CFH9M*TZXT\
M:?-86LED %%L\*F, =!M(Q7'L=:\+>*]!M)?$-UJ]IJLTEO);WD40>,K&SB1
M&15X&W!!R.:T+KQS%::C)')H^HC38KQ;*34BJ")968*/E+;RNY@-P7&: .BC
MTZQBL/L$=G;I9[2GV=8E$>T]1MQC'M26&FV&E6_V?3K*VLX,[O+MXEC7/KA0
M!5+2_$%MJFKZOI:Q2PW6ERHDRR@?,KKN1UP3E2,_D:Q3\1M-_L>PU-+&_EM]
M0OWL+01HI:9EWX8#=]UBA ^HS@<T ;GB;2Y=;\+:MI4#HDU[9RVZ.^=JLZ%0
M3CMS1I.@:?I:131V%FE_Y*Q37,4*AY,  Y;&2..]<]'\0I)9[ZPC\+ZNVK6.
M'N+$&'*1D9#[]^P@]@"22#QQ6A)XVL'T'2=3L;:ZOI-7P+*TB"B60E2Q!W$*
MH4 Y).!B@#7?0])DN;BY?2[)I[E/+GE:W0M*O]UCC+#V-8>K>&K_ %K5]/M[
MA[&#PWI\T=Q':PH?-E=!\BM_"J!N<#.< <42^/;"U\,ZAK5Y9W=L=.N%MKVT
M=5,L+LR+V)!&)%;()R#QZ5)8^,3<ZU_95UH>I6-S+;/=6BW'E_Z2BD @;7.U
MOF'RMCKSB@#HIK:"Y\OSX8Y?+<2)O4-M8=&&>A'K0+:!;EKD0QBX9 C2A1N*
M@Y )ZXR3Q[URO@'Q3J/BFQOKB^TR:U6*\FCBD8Q[2JR,H3Y6)W*  20 3T)K
MKZ *ITVP:P:Q-E;&S;.ZW,2^6<G)RN,<GFF1:1ID&GG3X=.M([(_\NR0*(^N
M?N@8ZUSOC;Q5J/AV]T&WL-+FO/M]\L+F,Q_,NUB47<PPQP"">, \]*SI_$FH
MV7Q(U.TAL-2U$MI=M+%80R*%C.^3>Q+L$4_='!R>,9QP =V]M!)/%.\,;319
M\N1E!9,]<'MGO44&F6%M>S7L%C;174_^NGCB57D_WF R?QK 7QU83>&M/U>U
MM+R>34)C;6UBJJ)FF!8,AR0HV[&R2< *:TM!U^/7$ND:TN+*\LY?)N;2XV[X
MF*AARI((((((/- &O1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %<5\+X)++PO=:=."+FRU.[AFSU),I<'\593]"*[6JB:=#
M%J4M]#NCEF4+,J_=EQPI(_O <9';@YP, 'E2Q7?_  H75-%.G:@-0A6> P&T
MDW,[3NP"\?-P0<C(YZUU$A,GQ/T*YBM[C[.-(GB:46[A%9GC*J3C .%/!]*[
M<D#J<4M 'DWAR*W-G!X7U_0M8N-8LKLLN\SFUD(D++.'SL P<GOG( )XKUFB
MB@ KB?&VGZE;:[H/BO2[*2_?2FECNK.''F2P2J Q0'JRD @=Z[:B@#B9?'=S
MJ;06GAK0=2GO9)%$CW]G);06RY^8NS 9.,X"Y)-9OQ T^]N_B+\/KBVL[B:"
MVNYVGECB9EB!\O!8@87H>OI7I%% '!^)(-0\/^/+3Q?::=<ZC8R6)T^_@M4W
MS1J'WI(J=6Y)! YQ5R#QE=ZWJME::!HM\]N9 ;V\O[62WBBB'4+N +.>, #'
MK7844 %</XCU?33J5UI?BOPQ-=:<-K65TE@]Y'*"/F!VJ3&X.1CN,'-=Q10!
MY /#NH-\/V\NQU6&PMM>6^LK%7=;N*R! VH,[E89=@N<]!UKI?">FZ->W^IW
M-K;:[/#+;+:O=:N\Q$R$L2B++\V!GDX RQQWKNJ* /*?!6CZM+XEL-.U6TN%
MLO"4,T%M/+&56Y=W*1NI/#!85 XZ%JJ76BVEK?\ B'3=6M?%%Q-?ZA--;VVG
MRSBWNXIB#C*_NUQDAMQ' KV&B@#SO6=+N?\ A<O@^XALYWLK6QN8WG$99(SL
M( 9N@)]ZM^.Y[J/6-#CN)-6BT!_.^VOI:RF0R +Y2L8AO"GYNG?&:[FB@#Q:
M.QND\-_$;3XM)U>-[V$7%E'<I--)+&854?.V27R/N$[ATQQ76^*[&[GT7P5'
M#:S2-!K-A)*J1DF-5!W,V.@'<GI7>44 >>?VG+X.\5>*)+K2]1NEU.2*[L&M
M+5YA,PB5#$2H(1@R_P 6!@YJGXALW_X2RQU[7(=;LK:ZTA+>3^R)IG-O.KLY
MC<PC<P.\@'&,KVS7I]% &#X.LK>P\,VR6UG>V<<C23>3?.7F!=RQ+DDG)SG!
MY&>>:R?B9IDFKZ'I=HEM-<1MK%IYRPALB/S/F.5Y4 =^,5VE% '.Z7X%\.:-
MJ*:A9Z=_I<8(CFFGDF9 >NW>QVY]JX?6DO-2U/Q/8ZI%XBGU%Y'BTFTM'GBM
M3"8QM8M&0GWBV[>3TQCM7K5% 'EMW;RR?![0=6@@GAU+PW!;W8CGB:)P8$"S
M(0P!P5#CT/%.&F7EU\'?$>HM:ROJ>OPSW[0HA9\2#]U& .3B,(,>N:[#7= M
M/%@6VGU2Y^PPOLNK*VD0).1@[)3@MCIP",@\UOJH50J@!0, #H!0!P>MV-U+
M<_#\QVLSBVO%:?;&3Y0^SL,M_=&>.:9=:->:AXV\8Q)#)''?:'#;0SLA"%R)
M1@-T)&X9KT"B@#RKPEIVGS7F@6\MGXI?4K$!YTO9I_LUE*D94GYSL;.2J[,\
M'L*VO"=C=6^D^-4FM9HVGUF^DB#QD&165=K+GJ#V(ZUVS75NMRELT\0G=2RQ
M%QN8#J0.I%2T >.:IIFHQ_!GP8/[.O'FTZ[LKBY@2!C*B(3N.S&>,CC%>M:?
M?0ZG8Q7ENLRQ2C*B:%HGQG'*L 1^(JS10 5S7CN748?"LSZ:;M7\Z$3O9J6G
M2 R*)3&!D[@F[ISZ5TM% 'D^EVZ1^)M;DL;'7#8WVAF*UGOQ<2M,Z&0MS+ED
M^\,*<9Z@<\WI-.O?^%??#ZW%G<>=;7FEM/'Y3;H@H&XL,97'?/2O2J* /,4O
M+CP[/XRTB;2M1N+K4KN6[L#!:/)'<"6)5V[P-J[2I!W$8%;OA?4?[!\%^#=/
MO;.\6>[MX+3 BQY,@BS^\S@K]TCUS76075O<^9]GGBE\MS&_EN&VL.JG'0CT
MI)[2"YEMY9HP[V\GF1$_PMM*Y^N&8?C0!-7"VLDFG?&#53<6EV(M2L;9+:=+
M=WB+)YFX,X!"D9'4C]17=44 >/*;RT^&%WX!.E:@^N'SK*("TD,,BO(Q$WFX
MV!-K9))R"",5T+/+X4\?W-Y<V.H75E?:9;P13VEJ\^)8BX*,$!*Y# @GCKS7
MH%<]KN@1:CJMK=Q:[?Z3?F-H%-K,@\Y/O$;'5@2.3D#(H \WL].NM4\ 17;6
MMZOV+Q1<7=U!8N1.B>9(C["G)*[\_+UVG%;2:39W_A;QC+HMIKT\UUICVL=Q
MJ;RL]T1&Y"QK+\^ 6(Z $MQ7?:'HMGX>TB'3;$2>3%N.Z1MSNS$LS,>Y)))^
MM:- 'FOF2:OH/@%[6ROO]#U.W6X66UDC:+9;NK$A@/E!(&[IGO3_ !'H-_K'
MB+QC;6\$@^V^'HK>"5E(1Y-TWR[NF>1GTS7HS,%4LQ 4#))[4V*6.>))89$D
MC<!E=#D,#W!'6@#SCPI::7>:]I<\5KXIDO+.%Y)&U.6X\JS<IL*?O>&8[B!M
MSTS6S\-K.XLO#]]'<VTL$CZK>2!94*DJ96(;![$=#78T4 %>/:3X3OM2O=9\
M-WEG/%IVDV=[::?-(A5)#<R%D9#T.Q% XZ9KV&B@#S3PC!JFJ>&O$NOZI87-
MMJ6I6XMUMYHBL@6* +PIYYD,A'KD5DKIVH6WP/\ #"/IUX9[&[M;BXMU@8RH
MB3Y8[,;N!SC%>PT4 <;!YE_\3M/U6&VN192:!*HED@>,!C/&0IW %6P"<'!X
MJ;P-:W%J_B;[1!+%YNNW,L?F(5WH0F&&>H.#S765!<WMK9A#=7,, <[5,L@7
M<?09H Y_XBV5SJ/P[UZTLX'GN)+1PD48RS'K@#N>.E8XF;6?$7@34;6TO1;0
MB[65IK5XS$?(V_,& QD\ GKVS7?T4 >8:[H&I:K)\1[>WM9M]TMF]L<%!.8X
ME)5&Z$Y7;QT)J]X4M=)O/$L%Y9P>)Y9K:V?-QJ\D^R!G*@Q 2]6.,G;D#:.>
ME=ZL\+SO LL;31@%XPP+*#T)';.*DH *\[T7PM_;?ACQ3I6HPSVQN==O9K>5
MD*NA\S='*F?0@$$=:] >>&*6.*26-))21&C, 7(&3@=^*DH \C\-Z=XBUU/B
M!;:Q8RVFI7MC#8^:Z%8IY%BEC,B-C!4_*W'3=5J2\G\2:-X6\/V^E:E!?VEY
M9RWXGM)(X[58,%SYA 5LE<+M)SFO4J* .+T:SN8]?\=R/;2JEQ<1&%F0@2@6
MR#Y3WYR..]0^&_#4VH_#CPU:75]J^E36UG&'2TF-N^=H!#C&>/2NZHH X+Q#
MIU_X>UW0?$=A;7NK0V-J^GWT:GS;EX6VD2 ?QL&7)'4YJ_9^,+K7-8L[71-&
MOOL>XM>WE_:R6Z1H ?E0, 6<G'08 KJ5NK=[E[99XFG10SQ!P64'H2.H%2T
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M9SX(<S(07C/./N$,/H:XR[\$:]/I/B71DTC3&GU*XN9EUJ:4,[JY)1=NW<&
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M:&4LQW=C@;3[4ECX=O[>P\90NL>_5KN>:UP_56@1!GTY4UD/X7UBS_X12?\
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MHC2@&(GT!9-N?<4OQ#L_$>M:6^CZ1H]O<6\I@E:ZEOA$59)5<KLVG/"#G/\
M%TXY -[Q'H$?B2PAL+BYFBM!.DEQ%$<?:$&?W;$<A2<9QZ5RO@[3=.3Q;XAC
MT"!$\,^1';R1+S!)= MYGE@\8"E5;'!/TJYXE3Q=K7A.*WMM*AM+N>Y"7EO'
MJ(!-L,[@DNS@MP,XX!-:?AA]6@B6PN_#-GHVGV\.(/L]\)AP?N[0BXXR<YH
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M,\GCI6EI>CW=IXW\0ZK*$^RWT-HD)#9),8<-D=OO"@#HJ*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKSOP]'XA\3Z9%XH
MMO$-Q;SS7LABL'53:BW29D\MEV[BQ52=V<Y- 'HE%<KHNI7EQXO\8VDUPSV]
ME);"W0](PUNK-CZDYKD/[=\07O@GX?O;ZM+#>ZM<I!=7.U2S*T;Y.",9&,CM
MD"@#UFBO._$,>LVWB7PCX9L?$%_%#>07@NKMBC3N$$;!L[<;N2 <<9SCBJNN
MZS./%4^A2:MXAM[;3;& K+IEFUQ+-,^[YY66-A@!1\N "2WI0!Z=2,RHI9B
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M("N6R 5ZC  ]\@'KE%>?>(=7^W7FFH-:UBU\_3Q="PT:T:6?<Q&)'8*V$'0
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MV3C&<$C-=M3=Z;]FY=^,[<\XH Y2[\(W[>(]2U+3==-E;ZJD:WT'V82.2B[
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MFEMQ*DNU7*G<IR#D>]1ZWX<T_7_LS78GCN+5B]O<VTS0RQ$C!VNI!P1P1T-
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M_6]-U+Q7\/8K&]@N7\R65O)</M4VK@;L=,\XSUP?0UQ\@)^%WQ2P.GB*X/\
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MVBCNM L&LYYI5"-&@<2A6)QPQ!(IL.H:(GCCP3=Z>L=AI,VFW@M5E40K@LA
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M=[I&H:/?:7>1V9O$262-C+#G:65D8@,#@$=LB@#<MM)TVSNI;JUT^U@N)?\
M62Q0JKO]2!DT[4?M_P!@E_LPVPO<#ROM(;R\YYW;>>F>E<9H'C'3[?P'H5WI
M]MJM_)J4CPV-K<3"2YF8,Y;<[-C "L22> !5/Q-XQFFTK3YQ:ZCIMW9Z_:6]
M[9Y_>,"=VT%"1(K C&#@]* .K\*^'GT"QN3=7*W6I7UPUU>W"IM#R-V4=E
M 'M[UI-I.FOJ"Z@^GVK7J\"X,*F0?\"QFLG1?%+ZGK5UHU]I%WI>H0P+<K%.
M\;B2)B5#!D8C@C!%:>N3Q6OA_4KB<S"**UE=S VV3:$).T]FQT/K0!+<:987
M=S#<W-C;37$)S%+)$K-'_NDC(_"G)8V<9A*6L"^1N\G;&!Y>>NWTSWQ7(:9X
MOBC\/^'X=(TS4]4N+^S-Q##+.GFB)-H9I)'8 G+J.I))KJ]+U :IID%Z+:XM
MO-7)AN8]DD9S@AAZY'T].* +E47T72I#<E],LF^U?\?&8%/G=_GX^;\:YO7/
M%6JZ?\0-&T.TTF:XM;J":25U>,;\;!D;F! 7))[G(QFN?T7QS=:/I.MW5WIF
MJ:C966KWBW5XLBD6\8F(  =@S!5QPHP!^0 /1?['TS:%_LZTVK%Y 'D+@1YS
MLZ?=SVZ52\2Z7J&IZ9'!IEQ:1.DJNT-Y;B:"=!UC<=0.AR.1BJ6J^,OL6H7%
MII^CWNJM:0+<7C6K(!"C9*CYF&YB 3M';ZUOV%];ZGI]M?VD@DMKF)9HG'\2
ML,@_D: ,#PQX:NM+O=3U+4Y;1[R_6*(PV<12"&*,$(B@\G[S$GWZ5NV6F:?I
MJ.EC8VUJLAW.((E0,?4X'-86I>,&M/$,^@V.C7NHZC%;)=;(6C12C%ADL[ #
M!7ZG<,=\)IOCFPU1= ,-M<H=9DGB19  87A5BZOSZH1QF@#H+/3[+3HFBL;2
MWM8V8NR01A 6/<@#K39--L9;U+V2RMWNXUVI.T2F11Z!L9 YK U;QU8:.OB%
MI[:X9=#6W:<KCYQ+TV\]N^:J-X_ECU:/2Y?#.JI>7<1FT^,F+_2E!&<G?B,@
M')#XP/? (!U=MI]E9[/LMG;P;$*+Y42KM4G) P.!GG'K2_8;0$$6L'$IF'[L
M<2'^/_>Y//6O._$7C8WGA[3=1@AO[&:T\1P6=]:*<R[E;YX_D.'!!'?!R*Z&
MT\<0K=:A:ZUIMUHUQ969OV2X9'#VXR"ZLC$<$8(Z\CK0!T_V>#SFF\F/S70(
MS[1N91V)].3Q[U6M='TNQV_9--L[?:YD'E0*F&(P3P.N"1FL32_&1O;Z&TOM
M%OM,>[MWN;,W)C/GHH!(^5CM8 @[3V^AI?"/C$>,+=+VTTB]M].>(/'=SE K
MOG#( "2<<C.,9!H V/[$TG%P/[+LL7+!YQ]G3]ZP.06X^8YYYJU%:V\$DLD,
M$4;S-ND9$ +GU)'4U0U_7;7P[I+ZA=K+( Z11PPKNDED<A511W))%95IXON)
MKZ?3+O0+VSU9;4W<%H\L3?:4!P=CAMNX$@$$C&1VH Z*XLK6[Q]IMH9L!E'F
M1AL!A@CGU'6DMK"SLK3[+:6D$%MS^YBC"ISUX Q7FWPEO]5UJ74]6U1-6DDE
MN)T$T]ZK6Z .,1)"&^5A_>VXZ\\UWGB+7[?PYI)OKB*6=FD2&&"$ O-*[!51
M<D#))H M66E:=IR2)8V%K:I(<NL$*H&/O@<U)]BM?L\=O]FA\F(J8X_+&U".
MA Z#':N$M/$E[/\ $P17]G?Z:EOH4T\UE(XD5B)4PZ["58XW#UZCZZ=KXYDE
ME6*Z\.ZE9R7%G)>6*2F,M=*@!*X5CL?##Y6QU]J .CETG39[S[9-I]I)=;2G
MGO"I?;C&-Q&<8[4EQHVEWGD?:=-LY_LX A\V!6\L#^[D<?A6-<>-]-B\#P>*
MHXYIK:XCB:&"/'F.\C!0@&<;MQP?H:C3QF\NIR0P:#J,UC#=BRFOHMC*DV0#
M\@;>5!(!8# Y[#- '55%%;6\$DLD,$<;RMND9$ +GU)'4U(<@$@9/I7-V?C7
M3KGP7=>)GCF@M[19OM$$F/,C>,D,A&<;LCCZB@#9MM)TVSNI;JUT^U@N)?\
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M.P QM'UW#'?'+^,/%K:MX;\*ZEI4UY8F;Q);VMS"7,<BD%UDB<*>1D<CH>*
M/14TG38_M.S3[1?M7_'QB%1YW^_Q\W4]?6B+2M.@L#81:?:QV9ZVZ0J(S_P'
M&*PM1\9/!JU]I^EZ'?:L^G*K7KV[1JL19=P4;V&]]O.!ZCN:ETOQKINKZM8V
M-LLNR_T_[?:SL $E4-AD]0ZY&10!T$D$,KQO)%&[1-NC+*"4.,9'H<&A;>%)
M995AC$DH D<*,OC@9/?%<Q=^/+*VN=4@CLKJXDL;J&QC$04_:;F1=WEIDCE0
M1N)P!^%(WCRTM-*U6YU33[NQN]+,8GLFVR2,9.(MA4E6W'@<]0<XQ0!T8T^R
M46X6SMP+;_48B7]U_N\?+^%/%I;"*:(6\0CF+&5-@Q(6ZEAWSWS7")X@U*^^
M)7AZRNK"^THFRNY);669624?N]C91BK$888/(_$$]CKNJKH>A7VJO;RW"6<+
M3/'%C<RJ,G&?;)H E?2]/DN(+A[&V:>W&V&1H5+1#T4XR/PIC:+I3Q1Q/IED
MT<3F2-# I".>2P&.#[UD:GXWTW3-0T"T9)9?[:(,,D8&V-24"L_/ +2(![FL
MCQMXOTRWT?Q+:W4>J+#I*6IN9K";RI-TKC:J,"""!@GV..] ';16EM TK16\
M4;3-NE*( 7/JWJ?K45EI6G::9#86%K:F0Y<P0JFX^^!S7*R^*]53XEVGAZ#2
M9Y;!].^T-()(\D&2-?-Y;.U<L"/O$G(!'-8/A3QY<Z;X.M;K4=-U.\LH[N6&
MZU1I%98RUPRKPS;V4!E!(&!T[$  ]+^PVGV5;7[+!]F4@B'RQL&#D<=.O-3D
M!E((!!X(/>EKS2^\8:U>77CW3#IMQ;0:79-Y-RLL8,+&!G#$AMV6X*XZ=\&@
M#T065H(881:P^5"0T2>6-L9'0J.Q'M3_ +/!YSS>3'YKJ$9]HW,HZ GTY/'O
M7$>'?&TGV3PY:W^DZA%;ZE#'#;ZE,R%9Y?*W<C<7&[:Q!(YJZ/'L!NA(-*O?
M[&-Y]A&JY3RO-W^7]W=NV;_EWXQGVYH Z&UT;2[''V33;.WVN9!Y4"IAB,%N
M!UP2,U*MA9K%/$MI ([AF:9!&,2$]2PQR3WS5BO/[/\ MCQUJVKS+KM[I.C:
M?>/8V\6G[%DF>/AY'=E;C=D #'2@#M8-+TZV^S_9["UB^SAA!Y<*KY6[[VW
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M2TN=%O[*QU8[;"]F,>R5MI8 J&+)N )&0,T\>-P-3ABFT34(--GO?L$.H2;
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M;5;.YD^)WAR[2WE:VAL;Q9)@A*(S&+:">@)P<?0UUE5[R_L]/B$M[=P6T9.
M\T@0$^F2: /*;_3=6AM=0FBTB\N'7QO'>I$D)S)"JQG>N>-O!&[IGO5G7K"\
M\>:OK$^FV-[!;Q^'YK".2\MGMS+<2.&" . 2!LP3C'->J@@@$'(/>B@#S3PY
M8Z9=ZO9SP:7XH^V6MM(SR:I/<F.VD9-A0"4X=CD_=R.,YZ5O_#*SN=/^&^AV
MMW;RV]Q';XDBE0HRG<>H/(KK** .4\?V%Y=Z/87=E;274NF:E;7[6\0R\J1M
M\P4=S@D@=\51LYY/$_Q#T_5[6QOH-.TRQGC::[MG@,LLK)\BJX#' 0DG&.E=
MS4-S=VUFBO=7$4",P16E<*"QZ 9[GTH XSX4V%YIWA.ZAO;6>VE.I7+A)HRA
M*E\@X/8^M6_B%:7<VD:9?6EK-=MIFJVU])! NZ22-&.X*.Y ;./:NNHH \NO
M[[6-9\7W^KZ%I6H0B/PU<P6=Q<VK1>9<>8K* K@$=L9 S@]AFJNC0(GC#PQJ
M5KIWB1X%CF@O+S45N7;SY$&,H^=H!!RX 7D<\<>MU6DGM[B2>PCO$2Z$>66-
MU\V,'@-@YQ[$C% 'ENDZ/<CXA_\ "(F/.B:1>OKL1S\H$@_=18[;96E;_@(J
MUJBM%XFEGT+3]>TW7WU!!+%''(UC>1;U#2R''E8,>3G(8'CK7<:!X;M?#XNY
M([BZN[N\D$ES>7;AY92!A02   !P   *V: "O)-9T>Y_X6'-X3ACW:/K]S#K
M%S@\(L7^N4C_ &W2'_OHUZW6'HWA>VTC4KO4WO+V_P!0N5$;7-Y(K,L8)(C4
M* %7))P!R>N: ,"6YD\*>/\ 6]2O+"_GL-6MK8PSV=J]QLDB#*8V" D$A@02
M,=>:YVST[4M!3PSX@O\ 2[WRUU:_O+JW@A::6V2Y5]F47)XRN<=,UZ[10!Q/
M@YKNZ\8^+-3FTZ[L[:\-H;8W,1C,BK&5)P>G/;J,C.#Q6CX^TRXU3P9?I91L
M]];!;NU51EC+$PD4#W)7'XUTM% 'CM[::[9^%[;Q;9:3>MK<^H7MP]FL+&5(
M[A&C0%>OR[+<GTVU;U#PG!X>O_#[W<6L-IEMHXT^272'G#QS*P8,XA.XJV6[
M$9 S7J]% 'E]OHACU/P1/8:/J5M;#4;RYG6[9Y98]\;@/*Q)*EC@X)SDXZT[
MQ#I<%EXZU/4=3@\1/:7]K!]GDT:2X'[R/<K1N(3U(*D%N.3R*].HH R?#-C#
MIOAK3[2"RELHTA!%M-)YCQ9Y*LV3D@DUQ/B32X+/QW?:GJ</B![*^LX%@ET>
M2X&)8RX,;K"<\AE*EN.O(KTRB@#SO1-%>P\7>&6MM)N[.QAT6Y5DF8R&!WDC
M;8[\_-][OV-4Y=*U _#WXAVPL+G[1=ZA?O;Q>4VZ96 VE1C+ ]L=:],2X@DG
ME@2:-I8L>9&K LF>F1VS4E 'F,>K#0OB;-+=65Y+#_PCUHDC6UN\SQ-YDF 4
M0%L'GG'! S6+?Z%J\_A?1;G^R[Q9;SQF-5>V\HF2WA=W(+@?=P,$YZ9YKU&/
M3+"'Q=/J@NC_ &C<620-;EUQY2.Q#!<9ZN03G'2M>@#SZVOYO!WB3Q,+S2]3
MNH]1N5O;*2SM'G$I,2J8R5!VL&3^+ P<UBWFBWOA#X8^&M:FB U/PY(+J:)6
M&3%*Q$T0/3[K_F@KUNL/6O"]MX@OK66_O+UK2!E<Z>LBB"5U;<K.,;FP<<9Q
MP.* .%O/"EY'X T.>Y@O9KQ-475]42R=TG9I0_F;-I#;E\P<#DA,5#?Z%#>^
M'M6U'0-)UV6:&YLY@^I23-+>I#)YA5$F.\  MC(&2>*]8^T0?:1;>='YY3S/
M*W#=MSC=CKC/&:DH \^CU"?Q#\2M U&UTK4HM.MK*[1KFZM'A'F-Y?RD, 1T
MZG@G.,X-=[<01W5M+;S*'BE0HZGNI&"*DHH \6TKPWKM]X:UV.]LKF.]T;3X
M]-TPR1D&9K>5I5=/4,5A (]*DU_1]6U/X+^)[PZ5>?VMK=\+O[%Y+&=$$\:H
MI7&>(XP?SKV6B@#@KOS],^*^DZA-8WLEG<:*; 306[R*DQF1L.5!V# SDX%8
MS:1J7_"AKC3O[/NOMQFD(MO);S"#>%A\N,_=Y^G->H"[MC>&S%Q%]J">88=X
MW[,XW;>N,\9J:@ KR[4(KN#Q%\1[-M-OW;5[!&LI8[5WCEVVA0C>!@-N&,'D
MDC%>HT4 <#J.G7KZ)\/HTM)V>UO[1[A1&<PJ+>0$L/X0"0.>YKFM)\.V5K&F
M@:II?B>ZOUOV!CBN+E;)XS,76;.[R@H4AB.NX8QFO8Z* "O.M-O;OP#J^LV-
M_I.HW6E7M])?V=Y8VS7 7S.7C=5R5(;.#C!!KT6B@#SG7G\1>+?"NHW*:)+;
M0V]W;7.GVDXVW-RL4BN^]2<+G!VKUXYZBIWNI/%OC;0[ZQT_48+/28+J2>:\
MM'M\R2($6-0X!8]2<<<#FNVFU"RMKF*VGO+>*>;B*)Y0K/\ 0$Y/X59H \IM
M-(U%?A7X(LVT^Z%S;:E8O/"86WQ*LV6++C( '))Z59\<V=R-8\77IMY?LI\&
MR1"?8=A</,2N[IG!!Q[UZ;6=KUK9ZCH=[IM_<?9[:^A:T=]X4_O 4PI/&[GC
MKS0!P"W=QXEA\$Z5;Z5J$$UA<V][>R36SI#"D43# D(VON) &TGCTK"EAOKB
MVTV]OM-\27>N66L0W.INZW#0Q1+<?\LHQ\CC;@@(IX!/U]FM;>.QL8;9&/EP
M1K&&<\X48R?RIUM=6][;I<6D\4\#YVR1.&5L'!P1P>: ."L=/O1X5^(41L[A
M9+N]OGMT,3!IE:!0I48R<G@8K+\3+?\ ACPMX4\565JYU'3;..QGMF&UI%FC
M"!2#SE90AQ]:]2FN(+<(9YHXO,<1IO8+N8]%&>I/I6/?^%[;5->M-3O;R]FC
MM'66"Q:11;I*.DFT#)89XR2!Z4 /\)Z&/#GA;3]*+;Y88AYS_P!^5OF=OQ8L
M:P_%_GZ;XO\ #7B'['=75C:+<V]S]EA:9XO-5=K[%!)&4P<#C(KLY)$BC>21
MU2- 69F. H'4D^E-@GANH$GMY8Y87&4DC8,K#U!'6@#R'4[/5M:L_'E_#HM_
M&+FXTZXM898"DD\<.PMM4_Q80G;U&0" >*Z**_F\0?$C1-2M=+U*+3H+"[C-
MQ<VCPCS&,9VX8 CIP3P><9P:] I&=44L[!5'4DX% 'E^EZ3J$7[.TVF-87*7
MYTVX06IB82EBSX&W&<G/ZU<T'3;Z'6O DDME<(EMX=>&=FB($4FV#Y6XX;@\
M'G@UZ*#D9'2FJZNNY6##U!S0!Y1J&DZI%<:KJ::9=S+9>+8=1\J.(EYH! B,
MT8_CQN)X_NFM;2=3;5_C$UTME=6T']@%8C=1&*20>>"6V-\RC)P,@'@]L5V6
MM:1:Z]IKV-Q-/$"RNDMO+LDC=3E64CH015/1/"UOHU_<ZC)?7VHZA<1K$]U>
MR*SB-22$4*JJHR2>!R>M $GBVTGOO!FN6EM&9+B?3YXXD7JS-&P 'U)KC-%-
MQJ.H?#Z>/3M0A33[2XM[HW%H\7E.((UYW <$Y /0X.*]':Y@2X2W::-9Y%+)
M$6 9@.I ZD#(I9+B"*6**2:-))B1&C, 7(&3@=\#F@#RWQ#X>U&_N_&<L=E>
M.HU+3KR)8=T;W"11QF01,,?, &P0<[AZUO>#K+2GUVZU#3['7P4MA!]LU>6X
M^;+;C&B3'=P5!) QS7<44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5PFG>(_%>M1+K>EV.G3Z,UXT$=H=RW,D*R&-I0Y
M8(#D%MI'0=<UW=>?Z5H_B_0;0>'=,CL4TY+QI8M4:;+QV[2F1D,17E^64'..
M0: $U[QIJ^A:K+)<W&A16D=Y% NFM-F]FB9E7S5(? /S%MNWH.36:FJQ:'\5
MO'FJSJ6BL]'MYV4=6"IG ^N,4V^\%^(I-,UC2[?3=++3ZB]^NI23?O;D><)5
MC(VY4\!22< #@<\:<O@C4-5\2^++N^$5O::YI45FFR3>T;A,-D8&0#^>* 'Z
M)XUU"76]-L=2O="N_P"U(9'C339"7M9$3?L?+'<-H;Y@%Y7IS5"P\;^*I?#6
MA>*+NVTE--OIX()K5$D\X"1Q'YBMNP.3D+@\=\UL^'=)UB&\MA>^'="T]+:!
MDENK<AY+B3&T-'A5V+U)SD\X]ZJ1^#M57X7Z%X>(@^W64UH\OS_+B.97;!QS
MP#0!'JNO^(=9M/%;Z9%IPTK2_.LVBF5S/<,D>9"K!MJ8W8&5.2.<5%8:SJVF
M^"?"<=G>Z'IMJVC6[M>:M)\KN(TQ&JAU/3DMSCTJ:;0/%&G'Q-I>E6ME-8ZU
M/+<Q7DMR4:V:5 K@IM.[!!(P1UYQ4%GX3UW2[K1YH],TW4)(M"MM,9KF; LY
M8\[G VG<IR.F"=HZ4 22>/=9O[3P=_8]E9?:?$$<^X7!8I"\: D@J1E1\Q]2
M !QUKT"S%R+* 7K1-="-?.:%2$+X^8J"20,YQDUY[H'@[6["X\&"[CMPF@O>
MQS2)+GS4D0A' P,9)Y':O2* .9TSQ-,?$GB'2-66" Z<$N8)$! DM67.XY)Y
M5E8$C Z<5S-O\0-6OK/1T,FCZ5=:I#-?+-?[A'#:APL0V[QND8,#]X #/%)\
M3M*DO]?T"WTVY6'4=4\W2[E%^\]DXW2M]%V_FU;7B+PQ,-9TO5M,TBPU)+2T
M>QDL+I@@,9*E60E2 5*XY'()H JP^,]4U'PU!=VLNBVDR7LMG?7US/FUB,>?
MG0;E+A_EP,\;N>E4I/B)J:^$8M1MH-/O;U=;72G-NY,$^6QOC.>,@KC).#GK
M5B\\-ZV7T#4?[#T:XELI+EIM,A?RH4\W 1@Q4AF0+@G:,[C@523P5XA:Q>SG
MBL0?^$CM]7$D,N$,>5:1 N,C;MP/7VH ]!TA=473HQK+VCWV3O-FC+'C/  8
MD],5S?B#6/L?Q*\(:9_9]C-]N6\/VJ6+=-!LCS^[;^'/0^HKLJY'7O#E_J/Q
M$\)ZY!Y7V/2UNQ<;FPW[R/:N!WYH P+CQKXL/A[6?$%O;:2MCI%Y<0O!(DAD
MN8XI"I*L&PAVCN#D@\ 5Z5%()8DD7.UU##/H:X5O".J'X=^)=#Q#]LU&XO9(
M/G^7$LC,F3CC@C-=Q;1M%:0QMC<B*IQZ@4 <;=^-;S3[7QBMQ;P&\T:11:(H
M($RRH##NYZER5.,=*;;^-=0N='\-;+>V_M74M1-E=0X8K%Y1?SV49SP(SC)[
MCK2>)/!^H:IXZTS4K5H1IC^3_::,V&;R)#+%@=_F.#["C2/!^H6?Q&OM6N&A
M.D(TT]@@;YUFG$7FDCMRC8_WS0!RWAW7?$?AWX<1:S!%IS:1:7LRRP2JYGF1
MKIE9E8$*N"QP"#G;G/.*ZB3Q+#8_$G7K>?3[)(;#11>R7B0_Z0Z@Y*%L\J .
M!ZU W@W53\(KCPUB#^T))9&'[SY,-<F4<X_NG\ZLW'@V[OO'VO:C<&-=,U/1
M1IP96RX8GYN/H: )]!U7QC>MI6H7MCILFEZE'YC16Q99K)67<A9F;$G8': 0
M3QD5QWA+7?$>@?#70]56+3CHT<R020.KFX9'GV%PX.T'+<+@\#KS@==X?MO&
M=LNCZ5>0V%M8Z<@CN+N*;S6O55-J!4*C9G@DD]L"J2>#=5'PDLO#1$']H0RP
ML_[SY,+<B0\X_NB@#T*O(KV\\07+?%"&]O+62RM;)XQ$L;@KFU++LRQ"\'YN
M.3SQTKUVO/+_ ,,Z\=4\;PV]K;2V7B&TQ#<&XVM%(+?R@K)MYRV.<\"@ TC7
M?$>E#PG'J,6G'2]55+5(HE?SX&\DNA9B=K9"<@ 8SP356'XD74A@U8W>B?V3
M-?"U%@)#]L6,R^4)2=V,YPQ3;]T]:Z"_\.W]Q!X.2/RLZ3=12W.6_A6!T.WU
MY85CZ-X4U717@TF+0-"FM(;LR+JLV&D,!<OM\O;GS #M!W8X!]J /1:\J\2Z
M_P"(=>\#^+K^UBTY=$ACN[-(65_/D5 R/+OW;1SDA=O('45ZK7F-WX7\66_A
MSQ%X6TZUL'L=0DN9+:^DN2I1)B6,;1[>6R2N<XP<]L$ O:IXAUC1],L?LMYH
M.GVL>FQRK)JDOS74FWF-%#J5P /F.>6X'%4O[?U[6?'/A&>PN+6WL+_27O?L
M\B.W#"(L&PP#,,_*<<<\'-3R^%-;BUB[>+3].NEO]/M[1;RXDRUB40J^$VG<
M"3N !&3UQUJ/3?#?B;2[GP=>C3[.:72M/?3+J'[7MPOR 2JVWGA,[<9YQ0 R
M/XD73F/5OM>B?V3)?BU%@)#]M$1E\H2D[L9SAMFW[O>O3:\ZTCPIJNC21:3%
MH&A36D5XTBZK/AI/(,A?:8]N?, .T'=C@'VKT6@#SZ;Q7XGO;#6]<TB#2_[*
MTN:>-;>X20S70AR)&#A@$R0P7Y3TYKG/%!U#Q+\2?!<T!TN6RO+*>YL8KVU:
M15#1*Q,B[@&/IC&..M;\GA_Q1INF:YX>TNTL9K'4Y[B2WOI;DH;59R2X:/:2
MQ4LV,'GC.*O/X.NK?QAX.N[0HVG:)8S6DC.V'.8PB8'?IS0!VR JB@XR!C@8
M%>6:?XHUW1I_'>K:I<6EU::=="-+=5=#YGEQB,*2Q"(<C/'4D^U>J5YQ=^#=
M9NY_&.F-#:C3];E%W;WIFR8Y55-JM'MY&Y!DYZ4 3V/C74(M0FT^^OM"U":3
M3IKRWETQB5C>/&Z-P78D?,"&R,X/%4D\;^*H_ 4'BNXLM+*7?V06UH@<,3)(
MJ.68M@9SE?3C.:U[#2-7N%O1<>'-$TA6L9(%-LP>265AC(8*NU.O!R3GMCF&
M?PEJ<GPNT7P\HA^W69LO-^?Y?W4B,^#CGA3B@!O]N>-$\6-X:<:(US-9?;HK
MM8I?+A0/L960OESDK@@KU)]JR]5\:W<O@>QOM0TK2[F^CUX:;<12Q&2$.DC(
M9(P3D'C(R>,UV#:+=GXCQ:Z-GV-=(>S/S?-YAF5QQZ8!YKD=2\!ZU=>%VT^,
M6_GGQ*^J<R<>296<<X^]@CB@#<N-<\3ZAXMUO0]%32X4TZ."07%Y'(^3(I.W
M:K#N#SV Z'/%6+QEJVI^$=#U>V?1]+%ZCF[NM1E_=0,O&U5WJ6+,#CG@#G-;
MNDZ-=V?C3Q%JLNS[-?I:K#ALMF-7#9';EA7'Z9X,UW1K;PW*=,T_5);"TN;:
M2VGN-B1/)*'6525.>!M/&<'B@"MJGBSQ!K>D>$[O3KK3[>2?7#93F/>\4LD9
MD 92&&8FV9QU.1SQSN)XF6P\?^(8+VPL%&FZ-'>37D$.V>0 992Q/*C!P*RA
MX.\3VNC6,26UC<W6F>(6U1 L_EI<QN9"0/E.P@R=#GI6M_PAU_J'C+Q!J-^D
M4-CJ^C)8D1R;V1R,..@R!DX/>@".+Q7XGL['1-<U>#2_[*U2>")K:!)!-:B;
MB-BY8A\$J&&T=>*AN?%WBR;3_$VI6$&D1VN@W=S$5G21GN4B&X@88!3M[\Y/
M88Y?'X?\4:GINA>']5M+&"QTN>WDN+Z*Y+FZ6 @H%CV@J6*KG)XYQFK\/A?4
M8_"WC/3F$7GZO<WLMM\_&V5-J;CVYZT =;87:W^G6MXBE5N(4E"GJ P!Q^M<
MS?:WKNH^*[W0_#YT^ :=!%+=7%]$\@+R;BB*JLN.%R6R>HXKH='M9+'0]/M)
ML>;!;1Q/M.1E5 ./RKF[S3-=T;Q?J&N:+8VVHPZG;PQW%O+<^0T<D6X*P.T@
MJ5;!'7B@"A!XZU/4]-T>TL;2TAUZ_N[BSE6<L\%NUON\UN,%AP,#(^\,GBK%
MYXD\3Z7906-[I]A_;-YJ*V-E.C'[-,I0N9BFXNH4*P*D]1P<&J,'@K6=(L=%
MU*T-I=ZY8WMS>7,+2&.*?[3GS$5L$C&5P2.=O/6K-_HOBS5[6WU6Y%C'JECJ
M2WMEIXDS&D00HT32A<EF#,=V" <#I0!)?^(O%.@V#G5K+3Y)!J%I;0W< 98I
MXYI K80N65ESW.#D=>:U;_Q!=6OC%-'2*$P-I,U]O8'=O1T4#KC&&/;/O6+J
M^C^+O$>AWSW:6-K<+=6USI^G^;O5/)<.V^4*,ER.PP,#WJ6WTCQ'J7C'^W=2
ML[2RA_LB:Q2VCN/-979T8%FV@'.#TZ8'KP 9=EXY\32>!(?%5[!I%O;78@CA
M4K)B O($::4[O]6,DX'.,9/IV7AN[U:[M9GU.73;E-P-O>:<3Y4Z$==I9L$'
M(^\<UDZ-HVNZ%\-]*TJV@L;C4;2%(Y[>=SY4R@_.@;'!(Z$@CU%9=E9:MX1T
MGQ!K5KI&GZ>]U-;M;Z3%,7B0@A';Y0HWONZ*.JKZF@#T6N#\8^+=8\/7%_/'
M<Z#:V=G )HK>^F_?W^ 681X<;.FT95LFN\KS;6?"&N7=[XJM[:PTV5-<7]WJ
MEQ)^\MT\D1^7LVD\$'!!P-V>V" :<WB/Q!J?BF;1M$CTZ&)=.@OA<WD;OM\P
MN-I56&<X&.1C!Z\51M?'.M:KI?AZULK:Q@UO5+BYAE>4.\$(MRPD<*"&;) P
M,C[W)XK4\,Z'JMIXBDU74((8%DTFUM#&DN\B2-GW<X'&&'-8EKX/U_1[;0]0
MLX+6YU#2[Z^D:U:?8LT-P['A\'# ;#R,=: +W@I]0;Q_XS74U@%V@L5=K?(C
M<>6^&4')&1C@DX.1D]:M?%:]U+3OASJEUI=PMO*BJ'D(;<$8A3L((VMDCGTS
M4OA31];M?$OB+6=9CMHCJGV8Q0P2F01"-64J20,GD<XY)-7/'FA77B7P1JND
M631K<W$0$?F'"E@P;!/;.,4 <M=?\)&/B;IT4$FFMJCZ#*)9VB<01K]H4[@F
M[<3]T8W#DDYXQ4H^(&I1Z-'!<C3+?66U>726GE9EM5,8+-*03G&T#"[LDD#-
M;.G:9K%SXSL_$&HV<%F!I,EI+ EQYI20S*PP<#(VKGVSBL2?P/J0CN+Q;:RN
MKJ'Q!/J<%K<-^[GAD3848X.UL$D<'! H Z#PAXEFUJ;5+"[GL+FZTZ5%-SI[
M9AF1UW*P!)*GA@1D\CKS5CQ?KUUH6F6O]GPPRZA?WD5C:B<GRP[G[S8YP &/
M'I3O#%G>V\5W+>Z3IFEF:0>5;60!*H!_RT< !FSD\#@'J:A\::)?:QIEE)IG
MDF_TZ_AOX(YF*I*4)RA(!QE689QUQ0!R,^K:EH/Q$OM0\0"UG:P\,37 DLT:
M-9E$RG&UBQ5L@CJ1R#[#1T?QMJ+ZOI]GJ-YH5W_:4$KQ)ILA+VTB)OV/ESN!
M4-\PV\KTYJ.Y\*Z]XGUW4KW6K>UT^UO="ETQ(89_.>)F<,&)P 3U/'' J]H.
MCZS'<0)>>'="T];>V:.2YMR'DN)"NT-'A5V+U)SD\X]Z ,JP\;>*9/#_ (?\
M2WEMI2:;J,]O!-;1I)YRB5@GF*Y;'WCG;@\=\UHR^(_$^J2Z[=:#'I:6.D3R
M6PCNTD:2ZDC4%P&5@$&3M!PW(IB^$-4'PV\.Z"1#]ML)[.2;Y_EQ%*K-@XYX
M!Q0VC>*-$D\066BV5E=VFKW,MU#<S71C-K)*H#[UVG< 1N&#WQ0 D?C/6-=U
M?2;+0(;&*/4=&&I^=>*S^1EPI!"L-W4#''/.>,',;QUXM3PG>^(9+32$ATBZ
M>VO8-LA:Y,<FQVB;=\@QT#!N0:WM!\'7&@^)=*FB=)+"QT ::7)PS2"16SCT
M(4FJ%SX,U:7X=>)M#40?;-1OKJ>#,GR[9)MZY..#B@"__;6/B[<:2-/L<IH/
MVH7OE?Z0?WP7RR^?N=\>M8UAXW\4R^'-!\37=MI2:;?SP036L:2><HD<)YBO
MNP/F.=N#QWS6X/#6H?\ "U;CQ%^Z^P/H?V ?/\_F^:&Z>F.]4$\'ZHOPQT'0
M"(?MUC-:/-\_RXCE5VP<<\ T )XH\::MX=OKRXEN-"ALK66-4L)ILWEU$=NY
MUP^%ZG"E3G;SUIB:MK=O\4]>^TWMK_9%AIL4\D/EOD19D;*_-@/D<G'( &!B
MJ&K^"O$%U9>)=,MM/TPG4KN2\CU267,C*2&6+;MR",!,YP!R*V)- UF?QE>W
M\UA;MIVLZ7'9WF+K#VK /NP-OSCY\9XH K1>+_$UMHNE>)]1M],&BZA+ &M8
MD<3V\4S 1N9"VUB-RY&T=:T-(\0^(M:\7ZOI\,.G0Z9I5Z(9I75S)*A16 7!
MP&!)R3Q@C ZFLN/PWXHOO#^D>$]1M;&/3K"6W$^H1W)8W$,# H%CVY5FVKG)
MP.>M='X9T.\TK6O$UW<^7Y6HWXN(-K9.SRU7GT.0: -Z]NXM/L+F]G)$-O$T
MKD==J@D_H*X.+Q=XFM=(TGQ)J<&EC1]1F@5K6%'$]M',0(W,A;:Y&Y<C:.O%
M=UJ%G'J.FW5C,2(KF%X7(ZX8$'^=<#'X<\47^A:/X5U*UL8M/T^6W\_4([DL
M;F*!@4"Q[<JS;5SDX'.,T 96C6&JW?QRU^6[.D3R6L-J2TEJ[%(SR!$2WR-Z
MGD9[5Z5XAN[ZP\.:E>Z;'%+>V]L\L,<H)5V4$[2 0><8ZUBZ3X>OK/XD^(==
ME\O[%?VUM'#ALME%PV1VKJR 001D'J#0!P.J_$*6WG\,26-O!+9:C#%=7TCY
MS!!(\4:$8/7=+WSPIK)\=Z_?7[ZE9V]M#):Z5JVF1Q')#33M(KLI;H  4'3J
M34ND?#G4H=#\2Z=?20MY]J;#2G5R3' CR/$6]#N=?^^!5N'P;K+^#8+>Z^SG
M6+C6X]5OBK_)D3AR%..<(J@?2@#3LM<UZV\4W&@ZXNFS^9IKW\$MI&Z ;7",
MC!F.?O#D8[\5A>&O&5[=>!/"JZ3IFEV>IZW-/%##'$4M;=8VD9WV*<GA>@(R
M6ZUU-[H=Y/X[CUA/+^RKH\UF<M\WF-(C#CTPIYKE=$\#Z]H?@SPF(4M9=;T"
M>>0V[3$1S1RF0,@?!P=K@@XQD4 +XNNO$HTK2X]5L+1KZW\160M9K=]D-V"<
MJ<$LR8)P<YZ9&:Z/1-:UQ?%]UX>US^SY9!9+?03V4;QC:7*%65F;D$#D&J-Y
MHWBG7HK*XU-;2!HM:M;R.SCDW"W@C^]E]HWN3D^G:MD:-=_\+%;7/D^QG219
M_>^;S/.+]/3'>@#0\07'V/PWJESY,4WDV<LGE2KN1\(3M8=P>A%<'9>,[T>'
MO",5D-#T8ZK9O-YMS$RVT93;B*-0R\G<2,MT4]:[W7K.74?#NIV,&WSKFTEA
MCW' W,A S^)KCK/0->TKP7H>BRZ)I6M6\%IY-Y97$H7]X,;65F4J1]X$$ \@
M@T =KI4M_-I=O)J<,,-Z5_>I ^Y,YZJ?0]?QK \8:)HUTT6L^(4N+W3K",J+
M!86FC9W90)#&H)9ATZ$ $GWJ]X.T>YT#PK9:;=LAFAWG;&Y98PSLRQJ3R0H(
M4'T6H==_X2BTU>VO]$2WO[+R6BN--FE$)W9RLB2;3SU!!XQ[T >:1WZ6GP[6
M"V>X71M6\2?9;>VMY-\T5HWS& !22K,48;<Y ?!Q6Q#%I-E8>++#2O#^HZ'J
MLFBR2#2R%*3J%8+)&L;,"V2%.#GIQ5]?!.M7&DW]_,UE;Z[/K$>L6]NKEH(G
MC"JL;-@$[E!#,!U;VJ_;Z/XFU77KS7[Q+31KQ-,>PL(HY?M.QV8.9'.T C*J
M N.F: ,#PA#X5T>_T%+CP;>:1J,T:Q6NH75N$66;R_F&0Q*LPW8# 9YKU>N#
M?3?%GB2^T2+7;#3["UTR[2]FF@NC*US+&#M"+M&Q23DY.>U=Y0!YEIMQ?7^E
M>-/%]M)$-0,L]K8O,I98K:WR,  @@L0[=>I'7%95M/X@DLOAE.\MI=:C,)#
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ML0<%=ZC/0]*J:$FI0>!$\6:MXLNHKFYTA9"TP5K6VW(I5_* !9QQWY)/'.*
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MVO,+VYU*7XB^%]1\3Z0FCPPO+;64MO.MR)IY4($<CX4J, D#:03W% DUG7M
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MFAN8+R62*1.JL(S@BF^*+6XU>U^&%]<:I?K/>36BR&.0 !S%N,@XX<D]?TH
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M$6W(D$H4')SQC;^M<O#\-KM-*L='E\2S2:5IUU%<6< M55EV2!PKOGYQC('
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MHUPTL+?=E 6(@-ZC(!Q[5Z9?^"M$U+5Y=3N(9Q/.JI<)'<R1QW 7A1*BL%?
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MFVU6>_CO-6OK.\G\J.:Z<QG+95@Q02$ $=L]J?K&AWMMX8TG2M0AAL[>;Q=
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M ^E1BZMM4^)VJ7FF3Q7-M;^'_(N9H&#)YK2ED4D<;@H8_0U9^#O_ "2?0/\
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M-9-0F@9%$ *[L ,P+MM^8@=B.YQ3;OQNG]L)I6DZ3=:K=2V,=_%Y+HB-$Y8
MEG( ^Z/<[ACO@ Z<VT!CBC,$92(@QKL&$(Z8';%1MI]DUZMZUG;F[4;1.8QO
M ]-V,UP6J_$6]DTSPY>Z-I%P_P#:.I_8YXI&C5T=2X>'EL!B4.&Z8'49%>AQ
M,SPH[QF-V4%D)!*GTR.* 'U%]EM_*DB\B+RY23(FP8<GKD=\]ZR/&5[;:=X/
MU6\O/M7V>&W9I/LDOERX_P!ELC!]ZRO^$RBLAHFF6.EW]_=7^FBZM8Q(NXJ
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M8W@L)=/^5Y6G;;L1"#AMV]<'/KZ4 =4;.U-I]D-M";;&WR2@V8]-O2I0 H
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M![C% '2M:6SK,K6\3"?_ %H* ^9QCYO7CCFD@L;2UV?9[6"'8FQ?+C"[5SG
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M ITL4<T312HLD;C#(PR"/0BN4F\?6LEUIEMI6G76IS:G8F]M!"50,H*C#%B
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M)HY)-EN\3;6,AR&QT8[C@\$\C/<06=ROQ7OKTV\HM6T6")9RAV%Q-*2H;ID
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MI;A7#")4< D84Y;ID@>]2W%[<>,?$GAG[+I.IVD.FW+7MY+>VCP",B)D$8+
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M90NUF483!P26P,'C.#7KE9NCZ);:+]O^S/*WVV\DO)/,(.'?&0, <<?_ %Z
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MD2LS,7; !+,W0#  [US?PLT3%UJM\TXNM.LWDTG29!T-LLK.Q![\L%R/^>=
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M/D)Z].C$#&: /4J*\<<Z\/!?BK43XHU3S_#MY<PV)611O6(A@9N/WA.=O/&
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MYKFF6-T+6XO(Q<[=_DKEW"_WBJY('N>*N"1C;^9Y;!MN[8>N<=*X3X/2&_\
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MQ.(LJV_Y#SGHV?;I71MXAOM.\=3:5JLMI'ID]DUU8S")E8E#^]1F+$$J"&X
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M!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^;S[9M[+L?&,X!Y_'-,C\-:1%J>JZ@+-6N=51([TNQ99E5=H!4G &#C@<]Z
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MP,GB@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD)F@:"2.56QE0R,NY0?4C'?M7 6TD=C?6.HWC+'I=IXRU#[0[\)$SAUC9CT
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M>R::EMJ$<IU-9&L]H;$NSEP#C ([@X/7CBI;OQ#I-A?RV-U>QPW$-H;V57!
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M5=00,$8)X/;.#7G/B]<:EX[E*%K>&ZT>>Z4#.8E(+DCN !D^PK1\0:EI^O\
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M#;3EBN <]B<XYQCFN<U35=-U_P >>#!HE[;WKV[W%S*]M('$4!A*_-CH&8J
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M=/J<]^VFKIH9-XN%)W*6SMV@*3NSC&*2#X@6RW&L6^J:==:=+H]FMU=K(5?
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MZY/J?A^*T>9DOFWW,,B\_*X4;E*@\-R#C'>@#J;BUM[R$PW,$4\3=4E0,I_
MT"V@"1(((PL7^K 083C''IQ7 Z#H>M^+-#MM?U7Q/J]C<7\8N(+73I5BAMHV
M&47!4[S@C):L;7/%>NV_PT\3P76H&+6]$OH;1[Z ",RHTL163'12R.01TZT
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MAINK2+%97<LL;99QF,.@.4W <=>2 <4MGX]6]U34X$TBY6QTF>>'4+]Y$$<
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M>*"X,@17ZX5V3/X[<_C6Q0!'Y$7G^?Y2>=MV>9M&[;UQGKBF1V-I%=274=K
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M"B2@*K!PI)*Y#C(R>1533?#VNIXDT75M6O;>[FMM.N(+J2-=F9))$8!5 ^Z
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MC)X'6@!EYXN\4:/:^)89UL+Z[T'[-=/)# T8GM9,EQMWG:ZA6.<D<=*Z*_\
M$LTGB+P[I>C^1,FHH]Y<2LI;9:JHPPP1@LS* 3GOQ3K70WMO%GB35;XVYT_4
M;:VA56;M&L@?<#P!\X[^M<Q\)-(>.WO]5EN/M5NCG3-*F(^]90NVTCV)8_\
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M0Z?K7ANR\3^);?2=*TZZFM8S#IMO(TL3O'O)=RJKEVW   =AD\T >B5Y_?\
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M:?:O ]S>Q7#%VCC</Y:QE!SE0-V[&!G&>* (++6(_#_Q!^*FKRH9$L[:RFV
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M10 4444 %%%>/H-;N? >O^)CXDU-+W3;J]DM$2?$02&5B$=.CYP1ST& ,8H
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MPKKOAZ&/7M6O(-5F>QO$N[DR98Q,RR)G_5D%?X>,'I66/$VL+\-VT?[9(?%
MU+^P1<$_.92_$N>O^J^?- 'I$>J1R:U-I@MKL211"4S- PA8$XP'Z%O:K<T@
MA@DE*LP12Q5!EC@= .YKSE;[6U^)'B'1K"_FE-OX?1[..>3<HGZ*YSQDG&34
M7AW4#'%J$3:OK\.JQZ7))<:;K )?S !^^B8\;0<CY"1R.!B@#T/3+]-4TZ&]
MC@N8%E&1'<Q&.1><?,IY%6Z\CT'6=7UOPOX!TN75;R*36!<2WMY')B=TA!.T
M/U&25R1S@4>(M4U?PW8^,=(M=6O9A9VEI>6-Q<2EYH?,D*LA?JPRN1GG!(H
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MV-H5'F- DCJA\M3W 8X'KBK]I<^) =:LM C\1-%)I;26TFM1L'CNE8#"._\
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M7[\7>LBVEN9(S'I\L3NR[(T)Q\O ##J5)SS5?5;V_P!4TSXKVMSJ-YY-B/\
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M6 3QW,+PDX$BN"I/3&: .:L/ \5G>Z7>R:A-<7=G>7%[+(R*OVB6:,HV0.%
M!X ]*-5\#0ZE=ZQ=B_F@N-0DM)HY$0'[/);G*, ?O<]0:Z.]O$L[6>7*M)'"
M\HC+8+!1FJ'AWQ!!KNB:9>EH8;F]M([HVHE#,@90?8D#/7% &)_P@D\M[?WM
MWKUQ<7.HZ>]A=LT"!64AMI0#[FW<>.<]Z=_PKZV_LSPK8_;Y=OAZ>.:)M@S,
M5&,-Z?A75_:K?[3]F^T1?:,;O*WC=CUQUJCI7B#3=:EOH[*X61K*X:WEY'WE
M"DD<\CY@,^N: )=;TJ'7="O])N'=(;R!X'9/O*&!&1[\USJ>"]0BM],FB\1R
MIJVGQ-;QWHM$P\#;?W;Q]#@HI!SG(KJHKVTGA>:&ZADB3.YTD!5<=<D4J7EK
M).\"7,+3(NYHPX+*/4CTH YYO!_G+H;76K7=U<:7>->&:;!:9V# @]E7Y^ .
M  !6A_8,?_"7GQ#Y[>:; 6/DX^7'F;]V?7M5=?%%OJ.F:G/HA@N[FQE> Q33
M")6=" ?FYPO/7%:@OHH;*">^E@MFD5<AI1M#$= QQG^M '.R>!+>3P9J'ALW
MLHBO;F2X:;8-REYO-P!]>*MGPE"?&-[XC^U2>;=Z<+ P[1M5=V=V?6F^(O%+
M:%KOAW35M!.-7N6@,ADV^5A<YQ@Y_2FZ-XM74_%'B31YK=+=-'D@C$[2Y\WS
M%+="!C&,=3F@!O\ PA<'_"*Z)H/VR3R]*FMI4EVC,AA8, 1VSBLV^^'+7MKJ
M>G_V_=Q:7>7,EXEJD*?NYF;?DOU90_S!>/J:[B26.( R.J D*"QQDGH*=0!R
M7_"%,VOWNHRZJ\D&IV:6NIVA@7;<[8V0,#U3[Q.!4^B>&-1TNZM3=>)+V^M+
M.(Q6ULT:QC&  9"O^L( P,X]<9KH(;NVN))(X;B*1XCB14<$H?<#I4U &%XA
M\/2ZS/IUY9ZB^GW^GRL\$XB648=2K*5/!!!_#%8L7P[6*>1FUFZF234[?57$
ML:EFGBV[CD8X;:. ,#MQ75RWZ/I]U/I\EO=20HQ5?. 4N!D*S#.WGOVIMC?-
M)IMM/?\ V>VN)(M[QI.'52!EL-QN ]: ,W4_"5GJVM75_=R.T=SI;Z9+ !@&
M-FW%L^O:LBW\ W?GZ+)J/B2[ODT:=9+2-H$0;0I7#X^\V"/F]NG)KKO[1L1#
M',;RW\J4[8W\U=KGT!SS5>ZO+V+6[&UBMK=[299#-,]P%DC(&5VICY\GKR,4
M 0>*?#\7BGPW>:--/);I<!")8P"497#J<'KRHXJ#3?#<UKKT>M7NIO>7HT_[
M#(WDK&''F%]V!T/.,>U1>%_%1\17FOP/:K;C2=0DLMWF;O,"_P 1X&/IS6[%
M>VL\#3PW,,D*YW2)("HQUR10!S#>!(A821V^HSP7@U675;:[5%)AED+97:>&
M7#,I!Z@UM:)I=WIL5PU_JUQJ5U/)YCR2*$1.  J(.%''U)))-:$=Q!,[I%-&
M[)C>JL"5SR,^E9&J>(!IGB31M*>%3'J*W#-.TFWRA$@;ICG.?48H Y8:/J=[
M\3O$]QIVJ3:9*MG9(LOD+*D@(DR-K<$@@8(/&3ZUH1?#\:=!I']BZQ<6-UI\
M4T+7#1),9UE8/(6#<;BXW ]O0BNOBN8)X!/#-')"1D2(P*_F*;'>VLUN;B*Y
MA> =9%D!4?CTH Y"W^'4-O#;VXU:YDM[;64U>)9$!?S!DLK-_$&+$Y[5J:YX
M8EU3Q!I6M6>IR6%W8+)'\L2R++&^W<I#=/NCFMR.ZMY9Y(([B)Y8_OQJX++]
M1VH6[MWN'MTN(FG09>,."RCU(ZB@#E4^'UC]E\1P2WD[+K=Y]L9E 5K>0$%2
MA]0P!&?2K4/AC4Y+>^74O%&H7$]Q"(8Y8%6W$ !R&55X+YZD]0,8QQ5*P\<3
MZOXQU+1M.L+5[33B$FNY;T*TCE"P$:!3N&1@G(]:TE\4Q6.E:7/KHM[.[OYQ
M;K#!.)D#DG&'XR,#)..* #1O#EW9:Q)J^J:Q)J=\;<6L;?9TA6./=N(VKU).
M,G/;@"EUG0=4O;]KK3/$5SIPDA$,T/DK-&0"2&4-]QOF()'7C(XK?!#*&4@@
MC(([UFZ7X@T[6;J_M[*X622QG,$H!'W@JL2/4?.!GUS0!0T7P?9Z%JL%Y:32
M[(-*ATQ(GP?DC9F#$]R=U9Y\!&"&W?3]7EM;ZVU&YOH;@PJX'GEMZ%#P1AL9
MZ\"NL@O+6Z+BWN89C&<.(W#;3Z''2I))8X4+RNJ(.K,<"@#@[[X81W^AZ]I,
MNN7;0:S+%<3.\:EUF4IN<'CAM@^7H.U;\_A:&?QK8^)3<N);2S>T6':-K!CG
M)/K6[)+'$NZ1U1<@98X&:B:\M4NEMFN85N&&5B+@.1[#K0!G^';?4K:SNEU.
M>6:1KV=HC*06$1<[!QQC&,=\$9YJC)X.@D\4ZKKINY!)J.GBQ:+:,(H_B!]:
MZ,2(SL@=2ZXW*#R,],T1R)*@>-U=#T93D&@#G&\'P-X>\/:1]KDV:+-:RQR;
M1F4P   CMG%2^-[&WU#P;J5O<VU[<1^6'V6(!G#*P960'@L" <=\=^E/F\21
MV_C!]$G2.*%-.%\UT\NT#,A3:0>/?.:V1/"5C82QE9/]60PP_?CUH \NT&)]
M?^(.E:@FI7^L165C<)=W=S9&VB7?L"1JNT#=]\MU[>@%;T'P\:.VM-*FUVZG
M\/V<ZS0Z<T* _*VY$:3JR*<<=>!DUU>HZI9Z58W5Y=SHD5K$9I>1D* 3T_ X
MI^GW]OJFGP7MK('AF174Y'0C.#[\T <S?>"KF2]U.32M?N=,M=5;?>V\<"/E
MRH5GC9N48J!D\\C-+<>!E@NM-NO#^IRZ1<6-D-/!6%9EDMP00K*W<$9!]SUS
M74SW5O:JIN)XH0QVJ9'"Y/H,]ZR?#_B$:S;:G/+$ELECJ%Q9DF3((B;;O)P,
M9ZX[4 -\+>&8O"UC=VT5W/=?:;R2[>6?&\L^,Y(Z\C/XT)X9B3QU)XI^TN9G
MT\6'D;1M"B3?NSUSVK8@N8+J(2V\T<T9Z/&P8'\12075O=!C;SQ3!3M8QN&P
M?0X[T <0OPWF33[.P7Q'="UTVX2XTR/R$Q RON&__GI@949QP3WK03P':8\6
M+)>3.GB,8F 4 Q?(4^7UZYYKIX+JWN@QMYXI@IVL8W#8/H<5(\B1KN=U49 R
MQQR>E ',:9X0FM+O0[J]UB2]GTB&:")C L8=)%10"!Z!.O?-1ZIX:OK:R\2W
M.BWLZ:EJTL4T93:IB9%1, GL0O/L3BNGANK>Y:18+B*5HSM<(X8J?0XZ4B7E
MK+</;QW,+SI]^-7!9?J.HH +ZU%[87-HS%5GB:,L.HW C/ZUA/X/@?0/#VD_
M:Y-FBS6LL<FT9E, P 1VS6CIOB#3M5O]0LK.X62:QE$4P!'4JK<>H 8#/KD5
MHO(D2[I'5%R!EC@9- '*CP9=07TXL?$-Y9Z5<79O);**-0V\MN<++]Y59N2!
MZG!&:Y'Q/]ETW5_$MG'>Z[9+J*^8^GPV/F)?R-&%_<R*K%=V K#(/7IUKU)K
M^S6!YVNX!"C;7D,@VJ?0GL:=)=6\-O\ :)9XDA(!\QG 7GISTH XO3/!5Y%H
MGANYM]1DTK7-/TN.QFD6)94=-JED93UPPR"".]3S_#V";PS+I@U2Y%]+?KJ4
MFHLBEVN0P;<5^[CY0 O0 "NP$T1\O$J'S!E,,/F'MZUB^+/$2^&O"^IZQ'"E
MU)8QAV@\S;G)'!.#CKGI0!37P8LOBB+7[[4)+FY&DG3)5\H(LH+EB_'0\]!6
M=;_#VZAAT>.3Q+=2_P!BRH=/!MT"QHJE-K ??)4XW'IC@<G.]!XJTYKG2;*>
M58KW4K4W,<6X$* %)!/_  ,8]>:W* .+'P^0KKMJ^K7!T[5;EKT6ZQJ'M[DL
MK^8DG7AD! /'UK9T71M2L;N:ZU37KC4YGC6-%,2PQ1J"3D(O!8YY8^P&*L:/
MJ%U=Z>LVI0VMK.TK((X;D2J<'C#8')';M5ZWNK>[0O;3Q3*#M+1N& /IQ0!+
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !
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M&H$LZ2QGS=S=6!&2<^E=U;>!_#UJMT([%V>[M7M+B22XD=Y8F^\&9F))]\Y
MP :2P\#>'M,U&WOK6Q99;8$6ZM<2/'#D8)1&8JI(ZD#/7UH XW3-)M] UG35
MU71=/OK>ZU"3['K]E*/-D>7>0LXZL""5/++P.*P&TVPM/@SXZFMK*VAE.H7<
M)>.)5;8LXVKD#H.PZ"O4K/P1X?L-434+>R=98Y&EBC-Q(T43MG+)$6V*>3R
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MI2\T<@PPD8ME^.A;.,#&,5JS:)IT_P#9WFV^[^S7$EI\[?NV"E >O/RDCG-
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M,KVNEN6BW#S@&;*+AL<=.F*]+?P;H#V>J6C:>##JEQ]INU\U\R2Y!W@YRIR
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M-E)+#J"A+II[F66251T4R,Q; [ 'B@#FM5T:Q\/>./",FCV,-O<2Q7L4KQH
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M#X>Z5IUMXG\9SP6%K%-'JK1)(D*JRH8XR5! X&><=,U9^+J&3X?3H'9"UW:
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M0:RMND<,5VL.SKCRV0J"I/0G(SF@#T?1]:L->LC=Z=,9(E<QN&C:-T<=596
M92..".]:%<3X5\5QG3[IM6O[&?&JKI\&HVD16.^=E3:0!D;LG83G&5ZUVU !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %0I:6T=P]PEO$L[C#R*@#-]3U-344 0?8K3S9)/LL/F28\QO+&
M7QTR>].EM;>>2.2:"*1XSE&= 2I]03TJ6B@!HC02-($4.P +8Y('2A(TB7;&
MBHO7"C IU% $)M+9IFF:WB,KKL9R@RR^A/I3?L%GY21?9(/+CR$3RQA<]<#'
M%6** &/%'(H62-64$$!AD CI3R 1@C(-%% $,%I;6L;1V]O%"C')6- H)^@J
M1$2- D:JB+P%48 IU% $-Q:V]V@2Y@BF4'($B!@#Z\TZ:WAN(C%-#')&>J.H
M(_(U)10 Q(8X]VR-%W8SA0,X&!^E,DL[6:W%O+;0O",8C9 5'X=*FHH 88HR
M4)C3,?W/E'R]N/2H[R W5C<6X;:98V0$]LC%3T4 8WAO0(M!T'2[%UAFNK*T
MCMC<K& S!5 Z]<<=*U'M;>2X2X>")ID&$D* LH]CU%2T4 -$:*S,$4,_WB!R
MWUJ-K.U=8E:VA81',8* [#ZCTJ:B@"+[+;[MWD19W^9G8/O?WOK[T-;6[SB=
MH(S,%VB0H-V/3/I4M% $1M;=K<V[01& C!B*#;CZ=*#:V[6WV8P1&#&WRB@V
MX],=*EHH B6V@2)(E@C6.,@H@0 *1TP.U2T44 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4456;4+)'*/
M>6ZLIP095!!_.@"S138Y$E0/&ZNAZ,IR#3J "BBH;:\MKP2&VN(IA%(T4AC<
M-L=3AE..A!ZB@":BBB@ HHHH **** "BBB@ HHHH **** "BBJ][?6FFV<EW
M?74-K;1XWS3.$1<G R3P.2!0!8HI%974,I#*PR"#P145K>6U]!YUI<13Q;F3
M?$X9=RD@C([@@@^XH FHHHH **** "BD9E12S$*H&23T JDNM:6YL@NI6C&_
M!:T F7_2 !DE.?FP"#Q0!>HHHH **** "BH8KRVGN9[:*XBDGMRHFC5P6CW#
M(W#MD<C-34 %%%% !1110 4444 %%%% !115&\UG2]/NH+6]U*SMKBX(6&*:
M=4>4DX 4$Y//'% %ZBBH;J\MK& SW=Q%;PAE4R2N%4$D #)]20![F@":BBB@
M HHJ"YO+6S56NKF&!6. 97"@G\: )Z*165U#*P92,@@Y!%+0 4444 %%%% !
M1110 4444 %%%% !115:UU"ROGN$M+N"X:WD,4PBD#&-QU5L=#[&@"S1110
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M/.!M0:+XJU/Q-X<U;6$TNUBTDS"2&VG>0REX2F\$H,<X^7L,\G@5$?!.I_\
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M5-.&G6T-O(TJ6\8W,"SE5+$NV3@# % &UJ>O7=GKOA6RC6+RM5EE2XW*<@+
MT@V\\<@>O%9O@?6_$?B5I]0OI+&'3H+FXM1#'"WF2E)" ^XMA0  ,8.2"?05
M%!H?BO4=?\,ZAJZ:7;0Z.\GF16T[R&;="T>\$H,<D87T)YZ"MCP5H-UX=T.6
MRO'A>5[RXG!B8D;9)&8=0.<'F@#HZ*** "BBB@ HHHH **** "BBB@ HHHH
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M 8ZY!*C.:TM;EELO$UMX9:Y\4W5A9Z:+DOI\KO<2R22N 9) 0Q"A3@=.>>E
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M?NG!/53Q6]<:=J'AKQEX/M(/$&J75I>S3I=Q7=R9/,=8'8-D]!GDKTR%P!W
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M28;*?9"D@DC # 8<':P)//OTKL8;VUN)I88+F&66(XD1) S(?<#I4] '$/\
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M &)I]C::M<6USI^HR:A;W0C5R'=G8J5/!'[PC\!76/?V<=VMH]W MRXRL+2
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MDBB0)&BA551@ #@ 4/-%$R+)(B%SM0,P&X^@]:'FBC=$>1%>0D(I8 MCT]:
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MG+(D(>%(TVNNT\*.O<GO@=*V/$>AIXAT@V37,EM(LL<\-Q& 6BDC<.K8/!Y
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M[>YAEDB.)%CD#%#Z$#I0!@:)X6OM*NK4W'B._O;2RB,5K;.J( N,#S"H!D(
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MO@#)KH)+JWB"F2>) RE@6<#( R3] *@.JZ<+>.X.H6HAE;;')YR[7/H#G!-
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MO8ZI&B7]I&B?OMB"/AR,J"H ('7':NHFO;6VECBGN88I)3B-'D"ES[ ]:GH
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M@J1Z@@T >8^(K:WTRY^(UAID,<%BWA]+B6&%0J).5E&0HX!*@$^N!7?^!?\
MDGWAO_L%6O\ Z*6I+7PAH5II-]ID5CFUOPPN]\KN\^1@[G8ECQQUX[5J65G;
MZ=86]C:1^5;6T2PQ("3M10 !D\\ "@"<]*\^^%CRQ?!C3)+<9F6WN&C&,Y82
M28_6O0:I:1I%CH6EP:;IEN+>S@!$<08MMR23R23U)H \H\(Z'JL^E^#M4BL=
M L\217#ZBMXYNKH.A\U6!C&YFRQ*EC@K[5)X?T;3_P#A O&^K-:Q/?F;58TN
M'0%XT&_Y%)Y4<DX'4DUZ#9>"O#VG:JNI6NGA+A':2,>:YCB9L[F2,ML0G)Y4
M#J:N0>']*MM+O--AM MG>M*]Q%O8[S+G?SG(SD]/PH \QF\,Z.MG\-2MA")+
MJ1%NI HW7"M;,["0]7!(&0<CMTINN6EOIUG\5[*R@CM[5;*VE6")0J*S0MN(
M4<#.!FO4FT'3&33$-J"NED-9C<W[HA"@[\_*2.<U%<^&M(O/[4^T68?^U8TB
MO?G8><J@JHX/& 3TQ0!Y_IVF6>J^(O <-];QW$*>&FD\J1=R,0(,;E/!QG//
M< ]JJ01V5M9ZSH<>DPWD<WBTP6-B\IAMU;R4E^? /[L89MN""<#%>H6^@Z9:
MW-E<PVH2:QMC:6[;V/EQ';\O7G[J\GGBJEWX/T*^M[F">QRMS=B^D9)71O/
M"^8K @J< #Y2/U- 'D7B&T$?A#XCVES9Z;$;6XLY5@LANAAE94#,F5&&(ZX
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MB\;?$!Y'"JCVKL2<8'V5>?IP:[BL+4/!V@ZIJ_\ :EW8;[LJJ.PE=5E5>@=
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M$4!NH ZUSFO^&KSQ#>VMM<7\,>@1/'++8QV_SW#(=P5GW8"9"G 7/'6NEHH
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MG+&B9V(JYQG QTIU% #)88IXS'-&DB'DJZ@C\C2&"(OO,2;N.=HSQT_*I**
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#L%VW_ **6@#H*,\X[UPVH:]XAU.77$\.6[M+I<_V>%=L)CGE$:.1(7=6
M.\*-N,8SDYP(;*76KSXG2Q3WKVO_ !(H9_LI1'6!WD8,H(X/*CGOCTQ0!W^<
M]**\N\+:_J>G^ -'GEN9+Z]U;4Y;6,LB95C-.S-R5!)"-@$@ X[<5:U[7_&>
M@^&O$E[+!'''9+'+875TD;/(I(#HZ1O@$$\-C!':@#T>D)"@DD #DDUGZ3!J
MT(N3JM[;W)DEWPB& QB),#Y3R=V#GGBK=U;1WMG/:S F*:-HW ."5(P>?QH
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M,C6^6(?.0/F)SM)P>E 'K5%<;X$EU$3ZO:W%MK$6FQR1O8G5LF;#*=Z;B26
M9<C))^;%=E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,UTTES!%*D4DT:2."41F + =2!WQ3H9HKB%9H)4EB<95T8,"/8B@!]>5>"/
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M"W,#"4K-&1"2),,/D(&<'TXYJ*74]/@B$LU];1QF/S0[RJ!LX^;)/3D<].:
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M427=Q($W9CS@J  !P<8Q@ "NSC01QJ@.0H KF/&_C.W\(: M^B0W5Q/(D=O
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M=/6IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<?E!Q(Z,4_N,5(W+['(H XO3--T-_BCH!T^.&[LU\.L]O/(!(S;)HPC[CR2
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MD.TXRIVD;E.!\IR/:@#ROP[:6VK6GPXMKM(;BU^V:H/+7YHF5#+L4 ]5&U<
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MWD!]F1P3R#[EJZ_5[>"T^-?@Z"VACAA33[L+'&H55&.P' KJ#X&\-&VN[?\
MLF$07D*P7$89@LBKRN1G[PQ][K[U9M?"NBV5S87,%EB?3XWBM9&E=VC5\[AD
MDYSD]<T >7)I^G3_  ,U76KN"'^V2US<RW;*/.6Z6=MOS=000H ]/K71Z'H]
MEK'Q$\3RZQ8P74J6=@NR>,.J%HFWX!XR< 9]JZ:7P/X;GU5M2DTN-KAIA.PW
MOY;2#^,QYV%O<C-:L&FV=MJ-W?PP*EU=A!/("<N$!"^W )H YKX5LS?#310S
M$[8W09.<*LC #\  *IP6-GJWQ9UV/5K:&Y^RZ;:BRCN$#JL;F3S&4'CE@H)_
M"NQTW3;/1]/BL+"!8+6+.R-22%R23U]R:I:SX6T;7YHIM2LO,FB4HDJ2O$X4
M]5W(02OL3B@#QO6;2UD^&BI]GBDMK3Q4]K8NR!MMM]H("J3_  ]1CIQ7N]M:
MV]E;I;VL$4$"9VQQ(%5><\ <#FLZ;PQHEQH]MI$FG0_V?:NCPVZY5493E2,8
M[\UK4 >5:SJLO@+7?%%I; _\3J 7^EH.]XQ6%T'J2S1O]":FTGPU8Z=XZT/P
M[>PQ7-KIWAXO;I,H9&N#,!-( >-QX_[ZK<OM$U'Q'XVTV\U+3H+72]$EDFMG
M,HDDNI2,*V!]Q1][!.2<>E;^L^'-)\0"#^T[02M 2T,BR-')&3P=KH0PSWYY
MH \K"1VMV;.U"IIMMXZ@2W1>$CS'ET4=  ['@=R:V?%DB2>+?%Z*P9D\',K@
M'H=TQP?P(/XUVK^$= D\/C0FTR'^S =P@&1ALYW;@=V[/.[.?>F6O@SP_91W
M"0::B_:;9K6=C([-+$<Y#,22>IY)S[T 5/A]I%AIG@O2);2UBCFNK&"6XF5
M'F<H"2[=3RQZ],UU%0VEK#8V<%I;1B.""-8HT!^ZJC 'Y"IJ "BBB@ HHHH
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M$IV_NR 0>-WH,TA^(OD^&I=3N='F2ZMM5&EW-G','*2EPN5; ### C@9SVH
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M$N Z2QR-A723:,C.<Y48(KH+_75L/$FCZ.;<NVI+.PEW8$?E*K=,<YW4 :V
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MMKZ#/DW,231Y&#M8 C]#0!/M&[=@9Z9IODQ!V?RTW-C<=HR<>M8'CN]L]/\
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MU[<S6T(!E,,IE574$\_?4XZX->L5%=74%E:375U*D-O"ADDD<X5% R23V %
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MPP)& 03SZBL2TT77]/M]/UR;1IY+FQ\17MY/90E6<PSAU+)R V-P(]:];HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MICMW<NT83;M)Y*AMPX[5T^C^'Y=+\4ZYJ6^+[-?QVJ0QJ3N01(RG/&.XQUH
MXU?'NIWVC^&;BYU.RT"/4K65Y[^:W\V(SHP41#+ (#\S?,>@P*FO1KUWX]\-
MK'=Z?#J4NBW/G74*&6)1YD1+QJ2,YXP"<#=WQS?TSPSXGT+POIFD6IT6_BA@
MDBNK6\+K&Y:0LKJP0D\'!4KBIO#G@F[T/4]"N'N;>2+3].N+614!'SR2K( @
M_N+@@9.< 4 <]KGC/6]/^'/B&YN3976I:1JPL/.:W_=S+NC(8H20#B3UZBNB
MOM2\2:AX\OO#^EWUK8VL%A#=&XDMO.=69G7:!N YV@Y/3;[Y&=K_ ,/=3U;P
MMXHTN&ZM$FU;5UOX6=FVH@\KAL+G/[L],]13KA=;7XMZO+H@LI)5TBU5X+QV
M1'!DEP0RAB",=,'.3TH S+_7[[Q5X>T/0M0$:75]KCZ;J?D95)([=F:0+W <
M(OYD5L^(O$6HV?BI]&MM9TW0TCM8Y+%;ZWS'?2$L"F_< H7"C ^;YL^U9FJ^
M'+KPIX:T769Y%NKK2]8;4]3DA4X*3%A,5'7"AP?HIKH?$VEZ_KL-U;6/]AW^
MCW]N%07V[,!((+KM4B0'((R5P>] %;Q"9-'\<^%-9 6.34';2KY8SE9 R%X_
MKM=3@XZ,:[JO/]0LS>>+O"'AN"5KA=#07][,>J[8S'%G_:9BQQZ FNIT2[U*
MYN=834%B$=O?M%:-&A7=#L1@3GJ068$CC(H /$]]=:=X?N;JSNK&TE3:/M%\
M^V&)2P#,>F2 3@9&3@5Y^WQ U&#P_P"*VM=7LM6ETJ&WGMKZ*WV*PE8J59<D
M9&T\CU%=OXPT2[US2K:.P:W^U6EY#>1QW.1%*8VSL<@$@'UP>0*YC4? _B'6
MG\0M?WFG)_;>GQ0,(2Y%M+$S% N5^=#NR2<'.<#% '1:]JU_:^*M TFSECBC
MU&.[\QWCWE62,%"!D=">1WKS&U?6I?AG87D]_%>S2^)8C!&\6S;(+UL[FR20
MS8[# XYKOH-"\3ZAXKT/6];ETJ)=-2=#;V;R/N,B!=VYE'<#C' [G/&98^!=
M?M]"AT2:?33:6>LQZA;3([[WC%P96#KMP&P<#!(]Q0!8E\3:UX7UK5;36[RW
MU.W@T635HWBMO(93&VUH\;FR#D8/6FKK7BG1XO#^JZO?65U:ZM=06UQ9Q6OE
M_9C,/D*/N);:V <CGVK7UKPBVM^);F[N)4%A<Z)-I<B@GS 9'5MPXQ@ 'OUK
M.@\+^)K]="T_7+C2_P"SM'N(KCSK5I#+=M$/W>Y64!!G#'!;)'&* '>&-7\1
MZ]K>M2S7EI#I6E:G<V8A6WS)<!1\N6S\H7*GH<\]*XP:YKOB#X<^!]2CO;:Q
MFO-<C@E6&U&PMYS[&P&' V<K_%GJ*]*\+^'[G0TUY;B6)SJ.JW%[%Y9/RI)M
MP#D=>.<5RME\/-:T[X;^'M$@NK!]4T;4EOU+LXAE*RN^TD+N'#]<=10!O:3X
MAO;/Q+K>B:_<0L;.VCOK:X6/RQ);E<2$C)^ZZG\"*O\ @K4]2UKPM;:MJ:HD
MMZ6GAB5=OEPLQ,8/J=N#GWKC/B'8MKNJ^&M-M[R&+7KHO9W\-J^[;:.F;C/0
MA1M&TD#)/O7<ZG-?:?=Z%:Z9%"+22Y\BX0H24B$3D;<<+@J!D^H'4T ;5>3^
M(-4\1>(? WB_5H+RTCTN)+VTBL3;Y:2*,,C2&3=D-PQ QC@#OD>L5YO>>"_$
MZZ+X@\.:;=:6NDZG)<2Q3S-)YT(ERS1[0NTC<2-V<@'H30!L>&=9NYO$)T9R
MGV2WT6SN$ 7YM[[P<GTPHKC]4UGQ!KVG^%+F/4XK1YO$4UJ0MMN&4>948_,,
M@*G*]SSGBNI;PYXBTSQ!!JFC/IDOF:9#874=X\B[&C)(=-JG</F/RG'0<UG#
MP%KEIX7T6UM;RQGU/2M8DU$-.72*96>0X)"DJ<2=@1D4 32>+;K2_&GBF"[C
M@EM=(T9+W<D0221@N6!;T..!VK/T+X@74NK:5;OK^D:U)J<4A>RLE"/:2K&9
M%4$,2RG:4R1G.#[5M'P1=7WBGQ#J6HS6XM-9TE+!XX68LC;<.>0!CDX[U;T;
M3?%\(MK6_NM)AMK6W:(3VJ,\MP^W:CLK* F/O$ MD\=* ,_P-XBU37YH9Y=>
MTN]5X2U[IZ0&"XL)>,+@DD@'*G<!T!![5V6JW\>E:1>ZC*I:.T@>=P.I"J6/
M\JY73O#VOW/BG3=8UQ-'CET^*2,SV.\RW990OSY4;5'WMN6YQ76:A91:GIEU
M87&?)NH7ADQUVL"#^AH X)-?\4Z;I.A^(]3O;*>RU*>W2XL([79]F2<@*4DW
M$L5++G(YYZ5>\.ZMXCUWQ3K4;7EK!I6DZE);>6+?=)<+L4A=V?EVYSG!SG'&
M*KP>$O$MW8:+H6K7.F'2-+FAD-Q TAGNEAP8U9"NU,D*6(9NG%;_ (8T"YT2
M\\037$L3KJ6IO>1",G*H41<-D=?E/3- &Y<NT=K+(OWE0D9]0*\OL/&GB.'X
M=0^+M4O=.3[:D,%M;M!MCAD>0)YTC[N5ZL5 &  ,]Z]1GC,MO+&" 70J,^XK
MC+7P3=Q_#+3O#CW<":E8"*6&X4%HQ-%()%.#@E<C!]B: ,)/B#>P1:U:66LZ
M=XBFMK!;V"[M(?\ 5_O D@=$8YVA@XP02,CWJS>>+-8L/ NL:W8Z[I.O1P>0
M;6XMX]C!VD"O'(@) X(P<@\G(XKHHK7QG-;7LLMSH]C=%$%I#;JTT>Y6RQD9
ME5L,/EP!P.>37%>-/#NIP>%?%&LZC'IME<7L-I;^3II9E)6X!\UV95W/\^.G
M '4T =))K>O^&_$VG6VNWUI?66IP7#X@MO*-M)$GF$ [CN4J&'//%9J^)O%-
MKX5T_P :7EW9-IUT\$DVF);8,5O*ZJI67=DN RDY&#SP*V!X;US6O$=C?>(V
MTT6FG03QPI9,Y:=Y5V,[A@-@VYPH+<GK6='X,\23:!8>$[VZTUM!M)8@UTC/
M]HGAB<,D93;M4_*H+;CTZ4 +-K'BS4;CQ7_9^HV5G!HMPRP[[7S6FQ"K[&^8
M;1R>1DG=VQS6N_&VI7DFB :OI_A^/4-(AOH9KRW\R.XG?.8MQ8!0HV_[1W5T
MUCX:NK4>*P\T)_MBX>6#!/R PK'\W'7*GIGBLK_A&_$]GX;T[1(%T+4;*/3(
M;.>"_P!X5)47:SJ0AWJ>."!TZC- $DFO:E'\3-!T:XBLP+G2GGN&C3<1(#R$
M<\[<^W-<AX?U+Q-H/PO_ .$AM;NT_L[3[BX<V#6^YIXA<OO)DW?*W+8P,?*,
MYS76Z=X%O-.\4^&M1%[%-;:1H_\ 9\A?(DD;&-P&,8_&LN+P-XJ7P<WA&2[T
MHZ9<S.T]RK2>=%$\I=D1=N&)!ZDC&3P<9H V;+7KFY^*NJ:-L@^QQ:3'<HXC
M D+,P'+=2/:N \-ZY=>'_@%H%W:1P/(^I^21/&'7:UPX/![^]>DVGA:ZMOB1
MJ'B/S8/L=QIL=FD0)WJRMG)XQC\:YB+X9ZJGPKTKPJ;RR^V6=^+EY=S>65$K
M/@?+G.&':@#1LQK$GQIU-#JJ?9(=.@?R/L_6,O)A0=W!!YW8YZ8K$TWXA7B>
M K.\GN--T^ZOM7EL1=21!8;=%+$R%<@$[5P.1DD5V+:#J]M\1GU^S:R>PN[.
M.UN4F=UECV,Q!0 $-G=W(K"TGX>ZKI/A*RM([JR;5M/U634;=FW&%]VX%&.,
M@%789 .#CK0!43XA7G]D:S%;:O8:BVGW-JIU>W@WQQV\QPTCQJQR4VMG!QT/
MK72Z9<:_JGAF\;3O$&CZA.TB_8=2BCRC+\I82(I(##YAP?3(%3+:^,FTZXF-
MSI$-^9T>&U16: 1 89&D*AB6Y.X+QQP>:QQIGB#PQH7B36[2VTJ/5[UXI8;&
MU1WMP5PO8*6=LGG YVY[F@#T"N%\:^(;[2=1\J/Q)I&CQ+:^;#'<1^=-<R9/
M!7(VIP!D9))/I7=5QNH>'-=_X2C5;[3)M/6VU:VBMYII]WG6P0,#Y:@8;(;.
M"1@^M '-7>J-KGC_ .%.JO&(VO;*[N&0=%+6ZL0/SK3^&O\ R,GCW_L-O_*C
M3/ NLP:CX%N;N>PQX<MY[:81.Y\U6B$:,N5'/&2#T[9K;\)>&+O0-6\2W=S-
M#(FJZBUW"(R<JI&,-D#GZ9H M^,=>F\-^%[K4;:%)KH&.*"-R=K22.J+G';+
M GV%8IO_ !+HWB+3-(U'5K6]36(IXX;A+/RS;3HF\':&(=",\'!XZUO>*]!_
MX27PW=:6L_V>638\,VW/ER(P=#CN-RC/M65:Z'X@U/Q-IFK^(3IL*:6DOV>&
MP=Y/,ED7:78NJX 7.%&>O6@#FOA!8ZBD_B:ZGU"&6(:[=QS(+0*\DH*Y??NR
M!_LX./6NH^)LEY#\.-=ELKK[/(EHY9MFXE-I#*.1@D'KVJ3P3X:NO#,&M1W<
MT,AO]7N+^/RB3M23;@'('/'/:M#Q5HS^(?"FJ:1%*L4EY;/$CL,A6(X)]LT
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MEKOB6SN"GE:?>I!!M7!VF%'.?7EC70US'A/0-3T>]UR\U2YMIYM3NUN1]G#
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M@#J9[RVMIK>&>=(Y;ES'"C'!D8*6('KPI/X54TK6K76)M2BMEE#:?=FTFW@
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MG[OI6W<:G86EU#:W-];0W$W$44DJJ\G^Z"<G\* ,?2?"K6>LC6-2U>[U:_2
MV\,EPD:+#&2"VU44#)(&6//%6/#/AJV\+V5W:VLTTJW-Y+=L9<9#.<D# ''%
M;55+G5-/LIXH+N^MH)ICB*.6959_]T$Y/X4 4/$_AR+Q-IL-K)=3VDMO<QW<
M%Q!M+1RH<J<,"#]"*73/#R:?K-SJKWD]S=W-K!;3/(% ;RMWS84  DN<XX]
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MT(>&_"UAI1?S)88\SRYR9)6.YVSWRQ)K6GN(+9 \\T<2E@H:1@H)/0<]S4E
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MV^YBB$?PG+NV!TW8ZBM/3?!KV>HV%S>:]J.HPZ;N^PP7(CQ$2I3+,JAG(4D
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MZU+3DFG">69 [(73KM;:1N7V.10!YQX%ED>^^'S3.S#^S=3CA9SRT:RH(_\
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M %OGE=V[&>G&,XKI-:UJQ\/Z7)J6I2F*UC9%=]I."[!!T]V%<7+_ ,G$0?\
M8L'_ -*35SXO(LGPUU!' *M/:@@]Q]HCH T_^$YT;^S(KX+?,EQ.8+:(6<GF
MW+ ;LQIC<RXYW8QBG2>.O#\.D6VJ2W;QVUQ<FT7="X=9@&)C9,;E;Y",$=<>
MHK \?HUKXH\,ZC+K$NC6,275N]^B1E87<(5#&1650P1ADCT&>:PI+:P^S>'[
MNRU2ZU6*\\813O=W$2()7$+J63:JJ5^0<@<D&@#L5^(^A,+A%CU,WEN?WMB-
M/F^T*N,[S'MR%Q_%TZ=S5Z?QIHL.EZ=J$4TUW'J0W6<5I \LLPQDD(HSP.N<
M8[UEZ.J_\+;\3MM&[^S[$9Q[R_X"O/- !LM(\$ZC<:Y+HEB=/O+7[<B1E8Y#
M.&"L9%95#!3@\?=QF@#U:;QKH<.AVVK"XED@N9OL\$44#M-)+D@QB/&[<"IR
M,<8-<]9?$*U'B37Y;VZGBTBTBLD6.6V9'MY96D5MX*AER0G7@<$<&L!#INC7
M7ACQ%_:EU>:,=8O);G4+N)4422Q&-9/E4*$+*<-C'S9[UHZ9'I7C;Q=X\MH6
M6;3[[3[.$7"#*R?+*-ZGN 1P?5: /0-1UJQTJXL+>ZD837\XM[=%0L7?!/;H
M  23T%.U?5[/0]/:]OI&6(,J (A=W=B JJJ@EB20 !7G?@&>^\4>(+:ZU6-U
ME\,6;:=)O'WKUF*R.#W_ ':+_P!_*Z[QP-*/AX?VQ<W-G;"XB9;RWX:UD# I
M(3@A0"!DD8YYH =!XVT6:V65I+F!OMD5BT%Q;/'+'-(1L#(PR <CGI[UIOK-
MC'K7]D/-MNQ:F\*E2%$0;:3NZ=37E.H:W<W6B2S7.J0ZSINCZ[ITW]L00A1)
M$'4ONV?*2G&2O'-7]4O[?Q7XTUB+0;A;OS?"=S;PSPG*/*9!PK=#C(R1W..H
M- '8Z9XZT/5[^&SM9+E6N59K26:UDCBN@HRQB=@ ^!SQVYKG_!OQ'M+KPWHG
M]LW%U)>W>V&2\^QL(/.9B%0R*H0,>!C\ZF\,^+O#U]8>&M'MH_M>I+;JC6Z1
M O8-'%AC(#@QX(V^I)XS7-P*J_L^Z#M '^DV9X]3>+0![&2 ,G@5S6G>/-!U
M/4H+*WFN1]I9DM;B2UD2"Y9<Y$<A&UNAZ'G'&:V-9MYKO0]0MK<XGFMI(XSG
M&&*D#]:X7PGXJT*7P]X6\/K%]HUB**.W>S6(-+8RQQ[7DD#8V!2",]3NXSF@
M#?\ ^%@^'_MGD^;=>1]H^R_;OLDGV7S<[=GFXVYSQG.,]Z?J7CO1=,O[VQD^
MVSW=CM-S#:V<DS1J4#[CM!PN&'/^%>;?VE9'X+#P6)$_X2;'V#^S/^6_G^=]
M[;UV_P >[ICG-=OX=0#QUX]) +%[-6;'7%JO^)H U[WQIHMI:Z;.DL]W_::>
M99Q6=N\TDJ8!+!5&0 ",YZ9KEH?&37GAGQAJD^NS65E9:D(;:\CM [V\>V'Y
M?+*\G<S AAD9/I7.^#=1M- E\%:MK%Q':Z=/X=DM([F8[8TF\U'P6/"DJ#C/
M7%4];NX+_P"%WQ,N[92()M85XR5*[E/V?#8/9NH^M 'H\_CB*U\::;X<^R7L
MXN;3SFN$M)&Y)0*1@8V_,VYNBD '%2:3XFTZ&T\1WUYK[W-KIU_+%.\]N(A:
M;<?NEP,N!G@\DY[UAW-_::7\4?#,]_<1VT-QH3VT+RG:KRF2,A ?4^E<G;P3
M3>&O'<L<3S1VOC W4\2+N+Q1RQL_'? !/X4 >J:7XRTK5;Q[-%O+6Z6$W @O
M;22!Y(AU=0X&X?3I5.S^(WAV^EL!!+=F"_=([>Z:TD$#2-]V/S"-N[MC/7CK
M6)?ZOIWBGQYH,^@WD-_#IUG>2W<]NVY(UDC544L.-Q/.WK\M9,2JOP4\%;5
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M:!'96SSLL/\ ST8(#A?<]>U)?^,M&L8=.D66>\;44\VTBLH'G>5  2X503M
M(Y/K7G4,BZ5KD-UJ'BF;P];WFA6)MYPD)2;RU8.FZ1&^8;@=HY.[O5G2)-*\
M'>)O#MY=WLT&C3Z#+;VMYJ"B+$AF$NU^ $)4\#C[N* .O\#>()O$7_"03M<F
M>W@U5X+7,>PI$(XR%(P#D%FSGD'@]*ZRN$^&=U#?'Q9=6ZE89M>FDCRI7<IB
MB(;!]>OXUW= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%(V0I(&3C@9KS;0O'NK0Z-XEU77M/7[/8ZE+;0I!.'<R!U18
M%&T9^8_?)YSTH ]*P**Y;3_%&HCQ!::-KVBIIT]]$\MH\-V+A'*8+HQVKM8
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M8V@<4JJJ*%50H'  &,4M% #0BJS,% 9NI Y-.P*** "FA%#EPH#'J0.33J*
M&[$W[]J[\8W8YQ3J** &LB.NUE5E]",BG8'I110 A56(+*#@Y&1TI:** &HB
M("$55!.3@8YIV*** "FK&B A4503DX&,FG44 %-\M!N^1?FY;CK]:=10 8%%
M%% !36174JZAE/4$9%.HH 0JI7:0"N,8QQ0    , = *6B@!I1"RL54LO0XY
M%#(K%2R@E3D$CI3J* "F[$WE]J[B,$XYQ3J* &LBOC<H;!R,C.#0Z+(,.H8=
M<$9IU% !1BBB@!K(C@!E5@#D9&<&AD5QAU##K@C-.HH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\E/A_6YM'\4
MZ,FDW"W@UQ]8LII"H@N5$R2*@;/#$ CD8'<UZU10!PT?]H^*/&VAZFVC7VF6
M6D1W#NU\JJTDLB! B@,<@#<2>G2KGC"ROTU7P_K]A92WQTJXE,UK"1YCQ2QE
M&*9(!(.#C//-=;10!YYK(\1^(;*UUA=#D@&E:O#>6EC(RK<SPJA63<-Q56.]
MBHR/N\]:@U2PU7Q3?ZUJZ:/>6<">'[G3K6&Z"K+<32\G"@G"C:HYQDFO2J*
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M?>W-W/?)<6$EJMO.8HG=@1.F =XQT&21CVJ]10 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<C)\2= 2[NK
M9$U2=[6=[>5K?39Y%$B'##<J$'!KKJ\J\'ZOXBLG\1Q:7X7_ +2M_P"W[T^?
M_:$<//F<C:PSQZT >EZ=?PZGI\-[ LRQ2C*B:)HW'..58 C\:M5Y]<F\\4>.
M;31=7%WI]I#I OIK*VO&0O,\I0!I(R"P4+T!QDUS>H7^KQ:/)HT&L7J-9^+H
M-.@NS,3+Y+A6"LQY?&\CYLYP,T >RT52TG2X=&TV*QMY;B6.,DA[F9I9"223
MEF))Y-<CXFMYM3^)&AZ4VH7EO83:?=27$-M</%YVUH\#*D$<GJ,'&1G!- '=
MT5Y"]]?Z7<SZ'%J-[);V'BNP@ADDG9G\B4(YB9B<LHR1R3QQ6_XCOKN+QIJT
M$5W.D2>%9IUC20A5D$A <#LWOUH [^BO'9+34+3X6Z)JT>N:G_:NJRZ9YMT]
MTS; SJ %4G &&P?[W?-:.M33^ ?$$_\ 9=Y?3V]QH=[=M!=W4EP!/ %99 7)
M(SN(('!]* /4:*\LELI_#FB^%?$%OJNI3ZA=WEG%?&>\DD2Z6<@./+)*KC=E
M=H&,5)IPETWQ;"OB"77K/4YM1D$-Z+AY+"\C9F\N';N*)\N  5!RO!H ]/HK
MQC3]0UO5;=-=LM.\2S:R^HLRSK.OV+R%G*F'R_,QM$8(SLW;N<UL$3:;XQ:3
MQ!+KUG<3:I_H6HQ7#/8RPL^(X&0,53(PIW*#GD-0!Z?117E<=G/XA\/>*/$E
MQJNI0:C:W5XMB8+R2..U6 D(/+!"MG;EMP.<T =IXA\767AV]T^PDM+V]O\
M4"_V>ULH@[L$&6/)   /K6^IW(&P1D9P>HKQF^L(?$?C_P"'VH7DEZDNKZ9+
M<7 AO)8]K?9T/R;6&P>H7&>^:]F50JA1G &.3DT 9FI>(-/TW3]6NY)3*-*A
M,UU%#@N@";\8)')7D<U?M;A+NTAN8P0DT:R*&ZX(R,UXY/I%O!%\6;E9;QGA
MAD11)=R.I#6H8Y4M@GT)Z#@8%;4.GR>']4\$7EOJ6H23:C)]GO5FNG>*93;L
MX_=D[5VE1C:!B@#T#3]2.H27B&PO+7[-.T(:YC"B;'\:8)RI['BKU>1:9+X@
MU;3/'<%C<WMS-!XB9%B2Z*2?9U=2\43D_(2NX#&.O:NN\"7%A)'J-O92ZQ$8
M94\S3M69VELR5Z N22K8R/F(ZXH ZN>>&UMY+BXE2*&)2[R.V%50,DDGH*Y%
M?BAX9.V5I;Z.Q=@JZA)83+;$DX'[PKC'OT]ZB^+!_P"*&9)&*V<E[:QW9SC$
M)F4-D^G0?C76WEM9RZ7/:W4<7V%H6CD1@ GEXP1],4 9WB/Q3I_AG3;>]NUG
MG%U.EO;16J>8\TCYVJHR <X/>J6I>.+33)M+M)-+U674=1C:2*PAA5ID5?O%
M_F"C'U->3W&G#4/AY\,;B]EO/-DU:VM/EN9$'D[Y-I ! #;0N''S =#71ZQX
M5T\?&/P]9"XU3RI=.G9F.I3[P5P!A]^X#U //?- 'KM%>,1ZAK>J17FM6.G>
M)KC65U*46TT,X%FL4<Q3R3&90"I52"2F=Q)S72:!93ZO\1O%$UYJ=^UOIE]"
M;2U2Y=8U9H5+$J#R/0=.6XYH ]#K-T;7=/U^&YET^5I$MKF2UE)0KB1#AASU
MZ]:TJX#X3?\ ()\0_P#8P7O_ *$* ._I"0!DD#MS7 ^.[^=_$VB:,;75KJQF
M@N+FXM]+E\N64H4506WH0HWDD!N3MK!NGU]/#VCV]S/JNGQCQ1!;VZWA1YI+
M8NK)YARV2K9 YYVC.: /7,C.,C/7%+7GT5Q>6/Q)UZ:YU2ZGMK'1X)_**QX(
MS+N'"\9VYR.<^P $^EZIXLU$Z%J=O"[V-]&LEY',(!%$CIE6B*MO."1PV<CT
M- '=45Q'@J]\1ZYOU"_U:W-K;WMW:O;1V@'FA)"JMNSE<8Z<Y]:[>@"%[J%+
MJ*V9_P!]*"RH 2<#J3Z#D<GN0*JW6N:99:1+JUU>1PV$0):XDR%QG&0>^3TQ
MG/;-0WGA^VO?$%AK37%W%<V:L@2&8K'*I[2+_$ 3D>]<#XC\.V7A^Y\%:+]H
MNY]&DUO>ZWDQE"N(SY,8)_@!& M '20_$SPX\L(G>_LX)V"PW5Y830P2$],.
MR@#/OBMR/7K67Q//H"I-]K@M4NV<@;"C,5 !SG.5/:K.J6VGW>F7$.JQV\E@
MR$SK< >7M'.6SQ@8S7G\^C6^L_&"]MGN+B*Q70K<F.TG:'S!YKA1O0A@H] 1
MGB@#TNBO);+4GM/"6O:7>:QJXCMO$3Z;9M;L9;N5/D984<G.2"PW$Y [\4:=
M>7FG:QXETN"WUG3K/^P&O8K;4;SSY(Y077>C"1RH.!QNZC.* /6J*\;N;6[T
M[X9>'O%RZQJLFLXL'>5[V0HZ2,BF-H\[",-R<9)Y)))KH8;*?Q-XI\57$^J7
M]LVES1VVGK!<O&D!$2N7* A7)9N=P(P,4 >AT5XEI6L7VJZ7X2TZ^BU[4[9M
M'>]N(].N"LTTGF!%,CF1&*J,\!NI&>E>D^!FU7_A'/*U>&\CEBN)8X3>D&=H
M-Q,9<@D%MI )SSB@#6U/4CIJVS"PO+OS[A("+6,.8MV?G?)&$&.3SUZ5>K@O
MBE?7=C:^%S:74]N9?$5I%(8I"F]#ORIQU!].E5K?37\1_$GQ=8ZAJ.H_V=:+
M9F.U@O)(5#/$23E"".G0'!)R0<"@#T:H+V]M=.LIKR]GCM[:%2\DLC850.Y-
M<K\,[R[NO")CO+J:ZDM+VYM5FF;<[(DK*NX]SC S[53^*@233_#EO<X_LZ?7
MK2.]#?=:/+'#?[.X+F@"VGQ0\,D1RRO?V]E(P6.^GT^:.W;/3]X5P ?4X%=B
MK*ZAE(92,@@Y!%07MO:7&GSV]]'$]F\;+,DH&PICG.>,8KAY;6#Q#XZ.A&YG
MAT+3M)AF@MK&Y>!)&D9E#;HR"554  SCF@#T"BO&[G4=7?2=/TE-9OD:U\9_
MV4+P2GSGM]CD!F_B(#8R<\J">E;T6EKI/Q*70;:^U,Z9J>CS23PRW\TA$BR*
MN]'9BR-AB,@B@#O;+4+34H7FL[B.>-)'B9D.0'4E6'U!!%6:\.\(VG]G_ WQ
M#J]K=7T=Z8KT!Q=R80J[895W85N/O  GUK6B2]T+X2'QE_:NH76N3:1%MDGN
M6:./S @!$9.W*Y!R1DD$GJ: /6ZY2+XB>'SIFI:E=3RV5IIVHOILTD\?652!
MQMW?+SU./?%8]WIC>#?$'A>2PU'4IQ?WAL;U+J\DG%QNB=A)AR0K!DSE<=2*
MJ_#.RBU'3/&UI.6\F;Q+>I(%.-RG9E?H1QQSSQB@#NK7Q#I-[KEWHMO>I)J-
MI&DDT !!56 (.<8(P1T)QD5IU52P@34#>X)F\KR4SC")D$A?J0,_0>E4/%EO
MJEUX6U"'179=0>/$6R3RV/(W!6_A8KD ]B0: )]?UNV\.:)<:K>)*]O!MW+$
M 6.Y@HP"0.I'>M*O%]=FLCX \46EF^MV5RD=JTFF:P[R- 3,!YB,[,65B.S$
M97MFNGEM!X4\?Z*L.J7[V^H6=XU]]KNGF5FB5&$FUB0IY/W0!CC H ]!KDS\
M0M(&@Z_K!@O/L^AW<EG<KL7<SH5!*#=@CYAU(KCM"O9K?Q'X6NK,>(VAU2:6
M.XOM2N!Y5\AA=U98?,.SE05PJ\?6L1_^27?%7_L/W?\ Z''0![E:7*7EG!=1
MAA'-&LBANH!&1G\ZIR:W;1^)(-"*2_:IK5[M6 &S8K*I!.<YRP[4[0?^1=TS
M_KTB_P#0!7'^(-+36/BQI5I+<7,,!T:X:46\S1-(OFQ_+O4A@,X/!'3'0F@#
MT"BO)[>\,'A[4M&NM2UF6.'Q&]A:16LI>ZN(@JR" 2%@0,%LL6&%'6J376L6
MNA^))++^UK7_ (1W4;:^@LKN[\V7R?+5Y8G8.VY"I=@"Q[4 >RT5YUJVOW&H
M>*YKS3+F1M.T'19-0D6-R$GGF0F)7 ^\ BEN?[PK+\*OK'VWPY?6MAXF:2Y
M.K7-_.KV\Z/&3O5?,;;A]I7:H^7(H ]9K&U/Q1IFF:5+J+2-<017:V;_ &?#
M%96D$>#DCHS<_C6O)&)8GC8L%=2I*L0>?0CD5X5#I,=O\+M9FM[BZ6>7Q"L(
M>6X>4+MOE 8*Q(W=R<9/?- 'N]%>8ZHTW@CQ1<MIMY?SQ2:!>7DD-W=23AIH
M2I5QO)P3N((&![5!X5.K)JOA^ZM=/\3?Z0I&K7&HSAX)U:,D2*OFMM(?;C:H
M^4D4 >JT45XC+%J ^&5UXI76]4&KVFIR+:R&[D*1I]L\O88\[7&"?O G&!T
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M% !1110 4444 %%%% !1110 4444 %96AZ#;Z!%?1VTLL@O+V:]?S".'D;)
MP!QZ5JUQTWC+4K[5KZQ\,^'CJL=A(8+FZFO%MHA*.L:$JQ8COP #0!IZWX87
M5-3MM5M-1NM,U.WC:%;FV"-OB8@E&5U(89 (XX-4E\ Z:NEVED;F[=H-4359
M+AV4R7%PK;LN<8P>!@ < 8Q5[P_XE76+*[DO+&?2[JQD,5W;W)&(R #D./E9
M2#D,*OV6LZ5J<,LUAJ=G=11?ZQX)UD5/J0>* +U<+XDT6ZU3XDZ'+!/>68@T
MZZ*WMNH(BD+QX!W J<C=P1SSZ9'51Z]H\UT+6+5;%[@Q^:(EN$+E,9W8SG&.
M<],4MOKFDW=E+>VVJ64UK"2)9X[A&1"/[S X'XT <^?A]8OH-SI\NH7SW=Q>
MKJ$FI%E$_P!H4@JXPNT8V@ 8QBGV_@6%;Z\O[W5M0OKZ\T]]/FFF*#]VQS\J
MJH"X[ #'))R3706^KZ;>7DUG;:C:3W4/^M@BF5GC_P!Y0<C\:2+6-+GU&33X
M=2LY+Z/.^V2=3(OU4'(H X[QEX;$7P_T?P_:)=7$%M=V%OE 3)Y22(I8E1Q@
M#)(QBMBQ\&0Q:G<:AJNI7FL7$MJUDINQ&%C@8Y90J*H);C)/)Q7344 <A8>
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M8MC(_@)XS44'BQ3=:4E]826<&KC_ $*5G#9;;N"2 ?<8KD@9(X(SGB@"K>>
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M*MKB>2TDED0%GLY"\1/^RQZBDN]8TVQN8K6ZU"T@NIA^Y@EF57D_W5)R?PH
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MAL#&/WAZ8Z"MN+0[>+Q-<ZZLDIN+BUCM60D; J,S CC.<N>]97B/Q5+HVO\
MAFPMX(IHM8N6A>0L?D4*""N.O6E\/^)Y]8\7>)]&DMXXXM'D@2.12<R>8A8Y
M^F* -^_LX=1TZYL;@$PW,30R!3@[6!!Q^!KG-(\#Q:8=#,NK7UZ=%,@M#,(Q
MA&B$80[5&0 .#UR>373SW$-K"TUQ-'#$N,O(P51DX')]R!5>TU?3;^YFMK/4
M;2XN(#B:*&97:/\ W@#D?C0!D7G@S3;^37FN)+AAK/DF8*X7RFB4!&0XR""
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MBL;"VCMK6$8CBC7"J.O\^:IZSX;T?Q T#:K81736Y/E%\@KGJ,@]#@9'0XH
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M%!]@N /P  KK? __ "5#XB_]?%E_Z*:NJA\):#;M:M%ID*&TN'N;?&<12/\
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MY5"27"Y!< 8Y&<$XXSC- &I1110 4444 %%%% !1110 4444 %%%% !1110
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M 'N$TT=O!)/,X2*-2[NQX4 9)-8&E>-M(U:X\E!>6Q:!KF)[RU>!9H1C+H6
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M\::/#IVFWD#W%Z-33S+.&T@:6650 20H&0 ",YQC..M9FBH/^%I>,7*\_8[
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MNFTAMW3 KV+2O^019?\ 7!/_ $$4 <]>_$70K*:^B*W\QT^5H[UK>SDD6WP
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MBZO8ZW\8[J\TX^;;?V"B+<!2%F(G))4_Q 9QGU!':@#T.BBB@ HHHH ****
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M+I-[?:GJ&HMJ6JWNU9;DQ")5C3.V-$!.U1DGJ<DY-=!110 4@ !)  SUI:*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KB;GXI:%9>5]J
MLM<@\Z40Q>;I,Z^9(>BKE>6.. .:[:N ^*?W?!G_ &--C_[/0!N6_C&"]TV^
MN[/1];E:T"$V[V#PR2[CCY!)M#8P2>>*Z&-M\:N592P!VMU'L:XWXM75Q9?"
M[6[BTGEMYT2/9+$Y1E_>H.".165<VTNM_$?2]+N;Z]6P?PX;B>"&Y>,3,)5
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M1(UW@:$MV-MW*O[S[0!V;[O'W/N^U>IT %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWRX')^E<]X1ATN\3POIMQX@UZXU.P:-GTDQQA;.6*,@^9B,%4'*@EN=PZYH
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MJR?#7PZK JPL8\@C!'%>>^-M2FU/3O&-E=:KJ*ZC#))':Z-:1JJM;JJD2O\
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M//\ ]\T>'9+S7O#?BK7+^&1;BVT,:.N]2"7CA9IB/J[C_OF@#6U7Q+>1:?\
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MRR;R/D.T'(SC)&*Z#56T+6[Q_"^H,LUR\ NS;_,K! ^ X88VD,.""#6THVJ
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M?;87MO:I;R[U.]D4AA@'(Q[BI_'WA^3Q!HEJL5C#?O97L5V;*8@+<*N0R9/
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M10J!P5R6?DD' %=5)HGB/5='UJTUG5;(M?63VD,-I;E8HBRL#(2Q+,3N'&0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% $2V\"SM.L,8F<8:0*-Q'N>M2T44 %%%% !1110 4444 %%%% #'
MBCEV^8BOM8,NX9P1T(]Z?110 4444 %%%% !1110 4444 %%%% !3719$9'4
M,C AE89!'H:=10!0_L/2?^@79?\ @.G^%']AZ3_T"[+_ ,!T_P *OT4 4/[#
MTG_H%V7_ (#I_A1_8>D_] NR_P# =/\ "K]% %#^P])_Z!=E_P" Z?X4?V'I
M/_0+LO\ P'3_  J_10!0_L/2?^@79?\ @.G^%']AZ3_T"[+_ ,!T_P *OT4
M4/[#TG_H%V7_ (#I_A1_8>D_] NR_P# =/\ "K]% %#^P])_Z!=E_P" Z?X4
M?V'I/_0+LO\ P'3_  J_10!#;6EM9H4M;>*!6.2(D"@G\*FHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!&/J*L0R>;#')L>/>H;8XPRY'0^]>8"RL[1_BG<V\:QW2I( RL=P5K1'/?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC]]N'.>%I\_C/49+*.Y2[TBP@N=0N8+>:YCDE=H8B4!6)6!D9F5CD$ #'!H
M[ZBO/]+\>7]S::?=W,5JUK_:\FE7LT<;H,GB*50QRBEBH(;.-W6NET'6+G6-
M0UDF.)=/M+O[);.H.^1D4>:2<XP')48'\)H VZ*\\\;Z-IR"^FEGOKWQ!J*F
M/2+>*X97@<* IC"D!5#?.SG\3T%6O$.DZ7!:0:CXKO+J^E6UCM8;.&1E$EQ@
M[C$B$%I&/?L!V&: .QM[*VLDF%E;06YFD:5_+C"AY#U9L8R3W/4UE:!H,^G7
MNHZIJ-U%=:IJ#)YLD,/EHB(,(BJ23@9)R2223[4_PC:ZG9>$M+MM9E:74(X%
M$S.^]L^A;N0, GN1FJ7CJPU34-%MTTR*6X6.[CDN[2*X\A[F 9W1J^1@DE3U
M&0",\T ;K:;8-;W%NUE;&"Y9FGB,2[92W4L,88GOFH]2T72M8BCBU/3;.]CC
M.46Y@60*?;(.*XC0KK0K#6)S86FL:'J/V*5O[+OE98;@+@[P"65F7IE&S@G-
M:D7BV^?P[X,U$PV_FZY-;QW"A6VH)(7D.SGCE1C.>* .M@AAMX$AMXXXX8QM
M1(U 50.P Z4C6MNUTETT$1N40HDQ0;U4X) /4 X''L*\RL]8UBYU?P]#ICV&
MG6\^LZE%-#';N5E\HR_,V'&20,_[V&[8I)/BA<F"XU2&?3FM8;IHETS[/*US
M)$LFPN) VT,<%@NTC'&<T >G):V\=Q+<)!$L\P599 @#.%SM#'J0,G&>F35>
M71],FTP:9+IUH]@H"BU:!3$ .@"8Q2ZK8OJ>E7-E'>3V;3H4^T6Y D0'J5)Z
M''?M7FTC0Z+=:[JWA'SETS3-'N1<R&5Y(9[M0&3;N)W,FUMS#^]C.<X /1X-
M$TJULX[.WTRSBM8Y!*D*0*J*X.0P4# 8$ YZYHU'1=*UCRO[3TVSO?).Z/[3
M LFP^HW XKA#ID/A<>$-3LI[@W5[=Q6M_))<._VI98G+,X)()# ,#VY[5'=Z
ME=ZUXR\,ZU'=21:0VI26ME"K8%PGD3%IF'<,R@+GLN?XJ .HU;P9IVHZEIUU
M':V4*0W;7-VGV9?]*S$\>']?O]\]*VK#2]/TJT^RZ=8VUI;Y+>5;Q*BY/4X
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M\4D5O&D"P1QB0 .V!DEB!CDX'/%4;'P%/;1:';7&O3W%GHDZ26</D*GRJK(
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MU'4&@%M')Y*Q)%%NW$*H[DX))/8=,5:T+1$T.WO(UG:9KJ\FO'=A@[I&+8_
M8'T%:M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>exhibit1013-zerondaxexec005.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM=T=\3;Q$A9"L'#$?WN<$]3D9Z"NWN_"VD7]QJDUW;><=3MTMKI68[7C3=M
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MCV:O->6(EO%8F6\$Q42!V_C#!B>>F.*]*TW0K#2AJ"VT1VZA=/=W =MP:1P
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M*Z^)]MYT?VA=3U%S%N&X*=O..N/>M/0IH;+Q3X,N-0D2*WD\*K%:/*0%\_\
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MI:G#!YZEXQRQ91U;"@_+SUZ5CZ_XJN;/Q9X-L=.EMY;#6GG\V0#=N18U92C
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M0R,JDC* XW+D?,N>XR*\[GDD\8Z3XY\5Z>'DC;3'TS3-H^8QK&7E(_WG;'_
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M!0!6UKQ+JK>(QX<\-V5K<:A' +BZN+QV6"V1B0H(499FP< 8X&:GT/5?$?\
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MO:2I\2-$%_'F]M_!MNKEQ\R/YN&_'J/SK9\!@)X@\;JHPO\ ;1; Z9,49)H
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MTS5%C75]*N/(N?+&%D5ANCE4<X#*<X[$&NA"("I"J"HP..@]/T%<-I\\5O\
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MI<6B8"P2PJ\:XX&%(P,5GZ[XE31[NTL+?3[K4M2NP[PVEL4!V)C<[,[!549
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M:*Y):=#$I$I( )88^8X '/I18Z?9:9;"VT^SM[2 '(BMXEC4'UP !7.R>/\
M3(=(O[R:WNH[JRNQ9/IY53.TQ.$50#AMX((.<$<]C56'QAJ3_$:?0I-'N([&
M&PCG>5GB_=EF;,C'?]S VX )R"<8YH Z^[L[6_MVM[RVAN(6()CF0.IQR.#Q
M2_9H!=&Y\F/[04\LR[1OVYSMSUQDYQ7,Z7XZM]2O+!7TK4+6QU-BNGWTX01W
M)"EAP&++N4$KN R!5 _$ZT_L]M471-4;2H;AK>ZO=L82!A(8\D;]S#."2H(
M/KD  ZZ;2--N+22TGTZTEMI7,DD+PJR.Q.2Q4C!.><U'/H6D73VSW&E6,K6H
M"VYDMT8P@= F1\N/:N>LO%FI77Q*U#P^=(N!8VUO$WG;H\*6+GS#\^=K *
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M*8K_ ,8>!"-*LV_MBPFNDN)4W36P\D/M1NV<X/K5GPUXIUSQ!?+<1KI#Z?\
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M::E#J+6&I3Z)=RSV$UU;OIDC,L;Q %HW!8YX8$,,9P>*JW?@_6+RZ\9Z6]O
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MO-%DUOQ#IOB77H?$%[8R:?=74%A;0;/)409 ,BE27+,I)R>AXQ26>J:MXO\
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M#YD)V@E26;=S@'/7BL_3?%<GA7X&W%\5%O<I=75G8Q.P^1S.ZH,]"$Y/IA*
M/3]+U_2=:ENXM-OX+I[.3RKA8FSY;<\'\C^5:->'^']9\+^$_%OAB+0];M;N
M"]M1I>HB)_O39W1S'W+LP)[!J]PH 9'-%,9!%*CF-MCA6!VM@'!]#@CCWI]>
M+Z5<ZCX:\-^-M3M-5O)[Q==DL(?M11T#L\,8F8!1EP&^G'2NN"ZEX6\9>'[%
MM;O]2L]7\^&=+XHQ21(S(KH548SM8$=.10!W$DB11M)(ZI&@+,S' 4#J2:SK
MS4M,>]M=&NF65]3@E:.(IN26-0N_)Z8PXZ]<UC?$V-Y/AMKYCN9H"EE(^8B
M6 4Y4Y!X/0URLND71\0> K&'6;U&DTZ\9[IBC3*A6 E4.W [ '!P/?F@#U"S
MM(+"SAM+:/RX(4"1IDG:HX YJ:O);OQ+J^B:=JVCOJE]<-%KT.G0WPA$URD$
MD2RMA57YW W '!ZCTKH_!.IWLVL:I8&36;K3(XHIK6YU6S>&0,2P>/+(NX#"
ML#C^(B@#MZ*XCQ]KDUAJ&AZ4ESJ%M!?O,]Q-IUNTUQLC4':H56(RS+DXX -9
M5IJ/B*Y\*ZI<VEYJ"RZ->&>TFU.W-N;ZV"!S'*'5?5UWX'*@^M 'I;,%4LQ
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M=0T^#2K@6-HEL4&9%C5FDDRIWY+#C@8'O70>!];N/$?@K2M5NPHN;B'][M&
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M*K&K+E .V,#MTK2KQRY77-$U#Q[=6.I3W-YI;Z?="1PN^X@1&9HWP,'Y-PR
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M<4 >@2RQP0O--(L<2*6=W. H'4DGH*IW6KVMGJ%A92><9;XL(3'$SI\HR=S
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M' 8<XKE]&\7:MJ"Z5K4%SXAN+R\O4\^Q_LV3[$ML\FTA6\O **0V_=R5.>M
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M#*&!!4C((/&*\U$XT+6?&%AJFC7UY)K$_G6LD-JTL=S$T*H(BX&U-I# [R
M<UD7?BJ32/@%H2R7:P7^IVT5A!-(V/+#?*9"?14!.?7% 'J.C:]I7B&VDN=(
MOX;R&.0Q.\39"L #C]16C7COA;7?"^@?$:QTSP[JEM<Z9J]BELZ1-_J[F!<(
MQ_WTX]R*]BH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(8CWK8T33=5LI+F?5M8_M">;:%6.#R88E7/"IN8Y.>22<\=,5JLZ*RJS*"W
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MU6LA(#*$"&6/YQL8@#@[AQ70Z)H]KH&B6>DV086UI$(DW')('<^YZGZU>!!
M(.0>A%(75652P!;H">M '%ZEX#NKZ37;:+76MM)UIC+<VR6P,@D,:H=LF[A3
MM4D8]1D9H\1?#]_$NA:3976KM#>6*M%)=P6^/.B="DB;=WRAACN<8KMLU1OM
M7LM-N+&"YEVR7T_V>  9W/M9OP&%/- &9KOA?^T6TJYTV[&G7^E,WV241"1
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MQC/4UVU-WKOV;AOQG;GG% '#3_#RYO5UX7NO-.=<LEM[L_9@NV1-VQT^;Y5
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M?Q)?30(/^7B,E?,@/LPZ>A KU^J&F:/9:.+L6493[7=27<V6+9D?[QYZ=.E
M'D5WXG^VVGQ&\0Z'.Z^=I6GO%(O#QY616^C+\WT(KH=6\.:-X7UCP?)H5E#;
MR75[]AN/*&#=0/"Y8R?W^54Y.>:ZS3_!>@:7<:S+:V"+_;)S?1LQ9)/O9&T\
M '>V0/6H])\$:-H]_!>0B\FEMD,=J+N[DF6V0C!$88D+QQGKCB@#R[3]#L-,
M\#:GXAL+""*[T;Q'+=;XHP&,,4Y#)D?PB-GXK934TL_'TWC::8C3I[RYT<L#
ME?*BA#*W_?V&4?\  J[NT\&:/9-JPA2X\C5?,-U;-<.829/OE4)PI.>2*BF\
M!^'I_",7A>2S<Z5$VY8Q*P8'<6SNSG))/?O0!YJEE+:CX97%RN+O4=5FU"X]
M2\P\SGZ!@/PI\^BZ7:Z5\5[FWL+>*>'S8HY$C 9$:!690>P)Y^M>KZAX<TS4
M[O2[FY@)DTN3S;3:Y4(V,=!UX[&J%UX&T2[OM5NI$NE.JQ&*\B2Y=8I05V[B
M@.-VT8S0!RK:#IN@>)/ EYIUNL%W=220W=P/OW*FV9CYA_B^90>>E5M!T*UT
M/6=-L=>T&)KB[>:"+7+68.FHET=BMPOWOF7)P=PR.#7HUQH=A=3:9+-$6?37
M+VWS'Y24*'/K\I(YK,TWP-HNE7\%U;K=L+4L;6WFNY)(;8L"#Y<;$A>"1[ \
M8H \X\-:?HUG\*[5/[(\^XU75FM?(MW$/VMDN)2B2OC_ %853GKP,57U2&6R
M\.^/],%C:Z3'$^G2+9V,_F10.[C++\J@$A5) %>D+\/- 2UN;:,7L<,UR+M$
M2\D MY0Q;?%S^[.6/3KFE/P\\/%+I##<D7<21W.Z[D)GV/YBNY)^9PW\1YP2
M.E '.ZMI5EX2\<Z1-H-HEK+<:9J'G^6.;@QJC(7_ +S;B3D\G-<]-X?TBW^&
M?A+6HH475+N]T^:XNP?WMR\DJLX=NK<DG!Z;17K]SI%E=ZM9:G-&6NK))4A;
M<< 2 !LCH<[1UKGX_AKX;B\M1#=M!#.L]O;->2-#;N'#YC0MA>1V[$CH30!Q
M5_\ \C3\8/\ L#0_^DK5>&A:=HDGP^U2PMUBU&YNHX;FZ'^LN%>V<L';^+D
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MZ$:"1R5>3#*P9L*HSU&?>O5[3P_I]E_:/DQOG46#7):1F+D($SDGCY5%4)_
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M2(H55TZ4  8 &TU2\-:'<WGC74_&.I:4=-FGMTL[6WD96E\M>6D?:2 S':
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M;#\<<]1P<UK6NCV5GJMWJ4$6RYNXXHI2&."L>[8 .@QN/2@#QK3M)T_5]/\
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M!X]X9U'2[+Q_IUI9G4I)Y-'GCEN)]/GC>:YDGC=I&W(, G/S'@<#/2G[HO\
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MN[;44:*PC,ET'1D>% "=S(P# 8!.<<XIMEXT\.ZCJT>F6FJ12W<@8QH%8"3
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M+3=2CN;@QM+LC5N%5MAR<8!W#&#S^%6=6\0:3H7D_P!J7T5KY^[RM^?GVC)
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M3A>><8]O>I=;U+2]8\0>!8]"NK>XF2\-POV=PWEVP@<.3C[H.5'/?BG?#?\
MY&'QW_V''_\ 010!Z#1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSM[: DDQPQ*BDGJ< 8I++3+#35=;"QMK59#N<01*@8^IP.:YNT\>P75U:O\
MV5>QZ1>7/V2UU-BGERR9*K\H;>%8@@,1SQTS52Y^),<-MJ=Y!H&I7-AI5U+;
MW]RAC"Q>6VUB 6!?CYN!P"* .SNK2VO;=[>[MXKB!^&CE0.K?4'@TRWT^RLU
MVVUG;P#8(\11*ORC.%X'3D\>]<FOB[4Y?B8N@P:7++IQT]+GSE>/D,^!+RV=
MHY7&,YYQCFM[Q#X@@\/6D$DEO/=7%U.MM:VL &^:1LD 9( & 223@ 4 7;+3
M+#31(+"QMK42'<X@B5-Q]3@<TEKI6G6,DTEI86MN\QS*T4*H9/\ >('/XUS3
M^-+E[/5[8:%>6^MV%NLYL7DB)>-L@2(^[:RC!SSGC&*R?@[-J%]X574M2&JR
MSW:+(UU>WHFCF.Y_]6FX^6!P",+GCKB@#OQ96@AAA%K"(H6#1)Y8VH1T*CL1
M[4\00BX:<11B9E"&3:-Q4<@9ZXY/%<UKOC-]%NKU4T+4;RTT^)9KZ[BV*D2D
M;OE#,#(0HR=O3ZTE_P"-1#KCZ-IND7FJ7HLX[U%@9$1HV+#.YV &-OU.X8[X
M -^STO3].:5K&QM;5I3F0P0JF\^IP.:9%HNE02O+#IEG'(\@E=T@4%G'(8D#
MDCUKDK?XG6MS866JQZ)J0TB>9+>6]<(H@E9@FTKNW$!B 6 QGIFM'4/&;P:G
M?V6F:%?ZK_9H4WLENT:K$2N[:N]@7;;S@>H[T =41D8/2J*:+I4=E)9)IEFM
MI*VZ2!8%".?4KC!/ K-LO%^G:C?Z-;68DE35K.2\@F  4(FS((Z@_./R-4[_
M ,?Z?IT&HS36ETR6&IQ:;)L4,6=PA#*,Y(^<<=>* .FM;.VL;=;>SMX;>!?N
MQPH$4?0#BG-!"\T<SQ(TL8(1RH+*#UP>V<#\JY1?&\XN-0L;CP[?VNHVUD;Z
M&VDEB)GA#;20RN5!!Z@FL[P_X]U*Z\*:'<7>AW5SJ^II^XABDA43A4#-*"7P
MB\]#@Y[4 =O-IUC<1SQSV=O+'<$&97B5A+C@;@1ST'7THATZQMY(Y(+.WB>.
M/RD9(E4JF<[00.!GMTJ+1]2.K::ETUG<V<A9D>WN4VNC*2I'&01D<$$@C!%<
M[?>/5MY=3DL]#U"_T[2I&COKV QA8V49<*K,&?:#S@?G0!U4%K;VHD%O;Q0B
M1S(_EH%W,>K''4^]11:7I\%])>PV%K'=R_ZR=(5$C_5@,FN<U+Q[;VVKVNEZ
M;I=YJMW>6*WUL+8H%DC9B,EF("C SD^H'4T[XFWD]A\.=9NK:XEMYHXE*RQ.
M59?G7H1R.* .L(!&",@U4LM*T[33(;&PM;4R'+F"%4WGWP.:P;'QH)]<M=-O
M]'OM,%]&\MC-<F,K.$&Y@0K$HVWYL-CC/TJ/3O'<-_=6#/I-];:9J4ABL-0E
M*;)VP2/E#;E#!25)'/MF@#HDTO3X[][^.PM4O'&&N%A42,/=L9-!TO3SJ U
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M5OM0T^\M+C29H8;VS?:TB>:RA&!4D,I#9R#V- '6P6\-K$(K>&.*,$D)&H4
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MIKT.G"6SG\KS)]N2"0>8QG# ]2*T[[QL\6M:II&G:#?ZE>::(WG$+1HH1TW
M[F8<]@.IP: .G2VMXKB6XC@B2:;'F2*@#/@8&3U.!ZTEW9VM_;-;WEM#<0-]
MZ*9 ZGZ@\5R[^/K2XL]%DTC3KO4KK6(6N+>VB*(RQJ!N9V9@JX) Z\GI6AX:
M\4V_B?\ M$06ES;/87'V:9+A0K"3:K$8!/0G'X<9'- &D=)TT]=/M#^[6+_4
MK]P'(7IT! ('M4ES!O4S0Q0&\CC8022KG:2/4<@$@9QZ5@:[XOET>[NHH-!U
M&_AL8!<7EQ#L5(D.3\N]@7;"DD+[>M;OVT3:5]NLXFN@\/G0QH0IE!7*@%B
M">.I'6@#%\-^'KRPU'4=9UBY@N=7U HKFW0K%#$@PD:9)..223U)]JV-7LWU
M'1;ZQC95>YMY(59N@+*1D_G7$>&?B%>7G@NWU?5-(N3<W5TUO9QPF,F[<R.%
M5!N^7:%Y+8^Z3S6G<_$"UT_0=6U#4M-N[2XTF2)+NS=D9U$C*$<,"593NSG/
M8CM0!K>'_#EGHVF:<CVEHVHVUG%;27:1 .^Q I^;&<<5K16\,'F>3#''YCF1
M]B@;F/5CCJ>.M<E-X\:V&G+<^'M3BGU.>6*SMSY?F2!4#JQ&["ALX^8C&#G
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MYEZ$D G'(KCO'&K3P7^MR6>N:W]ITZT$D-MIEJ3#:N$+YN&P5;=P<$C"]N]
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MY#J+PJP#L"&3R\X\O:Q&T'TYJ?P_X5GTC7]1UJ\U9[^\U"&*.8F$1J#&6QM
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M]ID^SF?.?,,6[9NSSG'7GK5^+0--A@U2". B/5)'ENQO;]XSH$8]>/E4#C%
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M(/FSG[P!ZUQ_BC0+N;Q!JEQ#X0EOWNX46&XMM1\J&5@N!]IB9U#;3T.ULC%
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M>P@O8'AMXQM2,O C-M'09/.!7<52M-)LK+4+^_MXBMS?NCW#[B=Y50B\'@<
M#BKM 'A%P"WA#XHJ&9"?$( 9>H_?1\BNOU'0--T'X@:%%H\,6E_;M-OXKF:$
M;2^U8RKN?XF!).X\^]=2?!>@M9ZK:FS;R=5N?M5XOG/^\EW!LYSQRHX&!5^^
MT/3M2O[:]O+<2S6T4L,98G;LE #@KT.0HZT >:Z-H=CI$T.BZUX7L[:\FTV:
M&*_LY!);ZDJJ&?S5P#NX#?.#WP:IZ!8:4OPT\&Z?%H,%]>:I()Q:EQ!#<2(C
M$O.VT[E &<$') ]*]%TGP7HNC7:W-O'=2/'$881=7<LZP1G&5C5V(4' ''88
MJI%\.?#UOIT5C E]##!-Y]N8[^8/;M@@B-MV4!#$$#@YH \O\1K);_"+Q_8M
M;6MI';:Q"J6MI*9(8,M;LRH2J\;B3C P2:[6_P#^2Z^'?^P)-_Z$:WI?AWX9
MFT_4+!K&3[)J B^TPBYD"R&,@JWWOO?*N6ZG')-:TGA_39=?MM<> G4+:!K>
M*7>WRQDY(QG!^N* /&CH&G?\*:_MQ8 NK)JF8KY>)H?]/\O"-U48)X'&23UK
MH=<L;?PCXMU!_#MI'8NWA6\F*6Z[0\L;*4<@=6&3R>>:[S_A$M%_X1W^P/LI
M_LWS?.\KS6SO\WS<[LY^_P ]?;I5R71K"?6$U66#?>);/:ARQQY3$,RE>AR5
M':@#SGPGX?U&VU'PQJ%IH&F:7"L1%S=0ZAYDM]&\1/SCRUWMNVODDXP:P;30
MM-MO@OI?B".UC_MB*[@DCOB/WJ?Z6$VANH7:<;>GXUZEI/@G0]%OXKRTAN"\
M"LELDUU)+';*W41(S$(#TX'3CI4X\)Z,/#<?AX6I_LR-E98?-;(*R"0?-G/W
M@#UH Y7PMHVF1_%OQK<II]JL\)LWBE$2AD:2)C(0<<%CR?7O7HE8X\,:8OB9
MO$,:3QZ@Z!)6CN'5)0%*KO0':Q )QD<5L4 >;VOA_1]?^*?B]-7LX+U8K>RV
M03J&5=T; L%/&[@#/4<^M<_H!CUGP_X7TE](CUZ[MUO7@BO[G9;+!',8E>3*
MOO(&U5^4XY/%=:?!2ZIXX\27^HQ7<%O<1VJ6UQ:W;PNZA&$BY1@=N=N0>#Q6
MS<^!]!N+?3H%MIK5-/B,-N;2YD@98SC<A9&!93@9!/- 'F]@)=,\(:/XI147
M_A'M8NH)4AD,B+9/.T;HK$ LJ@J5) X7H*D\5*-:\._$#Q03NB$:Z78-U_=0
MN/,8'T:4M_WS77ZWH#:/H%_HWA?0&N!K E217N +:U+C!8JS<+\Q.U!R1VXK
M6L_!VEP>!X/"<\1FT]+=8) &*&3');(.02V3QZT <AJGA#0K;XB^%[2+3XEM
M[RTN_ML>.+S9Y;+YW_/0[CN^;.3UK#N(GLM$UC0].M(WL'\8):"R\WR8C$R(
MYBW ':C/@8 _B([UZ]/I%E<ZM9:G+$6N[))$@?<1M#X#<9P<[1UJG-X3T6>S
MU.TEL]\.I7'VFY!D;+2X4!@<Y4C8N,8P1F@#S'Q'HVI:7X4\7.VE6&BV%S;6
MK+96-T)52838,@4(H7<NT<#DI717WAO1]'^(GAJVL-.MX8=0L[ZWO5"#_2D"
M(?WO]\Y)Y.2<G-=''X&T)=,OK"6&XN4O]GVJ6YNI)99=ARH,C,6P.P!QU]:U
MKG2;*[U6QU*:(M=V(D6W?<1M$@ ;CH<@#K0!QGP;TZRL_A_:W-M:00SW$LXF
MDCC"M)MGD"[B.N!P,]*[Y_N-EMO'WO3WK)T+PQIGALW0TQ)XH[E_,:%KAWC0
MDDG8K$A,EB3C&?PK790RE6 *D8(/0B@#ROPUI,/AG5])L]4T.WCO94FBM==L
M)@5OV,;.?.'#;BJEN=PR.#6)IV@Z;8_"CPCKL%I&NK"\L7%[C][AIE4KNZ[=
MIQMZ8KTW3/ ^AZ3>Q75M%<DP*RVT4UW+)';!A@B-&8JF1QP.G%6AX5T== L]
M#%J?[/LVC>"+S&RIC8,G.<G! ZF@#R[QDL5S9>)M=T_0K7=:7ZH=9O+O%S'-
M$R+B!0APH88 W#.3ZUTMC_R7_5_^P#%_Z-%;UY\/_#M_<7TMS:32)>EGF@-S
M((3(PPT@C#;0Y'\0&:T++PSI=AK!U:&*4WYM$LVGEG>1FB4@@'<3DY'WCR?6
M@#DO@?\ \DITS_KK<?\ HYZ[Z[N([2RGN9F*Q0QM(Y'4 #)JGH.@Z=X:TB+2
MM*@,%G$6*1EV?!8ECRQ)ZDUH21I+&T<BAD<%64C((/44 >-Z191VVN^"KNW\
M/66F6NI23 3&[\Z[O(7MW<^>-@#9^5CEFP<5TGPFTK3K+2M7GM;&V@F.K7<)
MDCB"L8UE(5<CL.P[5L6WP[\.VHMO+ANRUI*LEJ[WTS-;[<@)&2V53!(*C@]\
MX%:6D^&-,T34+Z\T])XGO9&EFC^T.T6]CEF5"=JDGJ0* -BO%;E8I)=*\1:=
MH5K;0W7B*+R]5GN]U[/NGV,-H3[A&X!2_"CI7M5<H_PY\-R+,C6USY;R>;'&
M+R4+;OO#EH1NQ&=PSE<?EQ0!QMO_ ,C'\8_^O.#_ -)9*[+X9?\ ),O#O_7C
M'_*M&/PIH\4^LS+;-YFLQK'?,97/FJJ%!U/'RDCC%7M*TRTT72[;3;",Q6EM
M&(XD+%MJCH,GDT 4_%EK!>>$=7@N88YHC:2DI(H8$A20<'T(!_"O)[ZPL['X
M;_# VEK# ;C6=,GF\I OF2&,Y=L=6.!S7MLT4<\,D,J!XY%*NIZ$$8(KF[?X
M?^'K?3K+3Q;W,EK8WB7MJDMW*_DR(,+MRW"C^[T]J .3D\/:5K?B[XB/J=E%
M=^5';B)9EW"(FU&64'HW ^;KQ6;8Z396?A?X<:[%"HU>YU"S6>^/,TJR1L&5
MGZE<8&#T %>J1Z'I\5WJ=TD!$VIA1=MO;Y]J;!QGCY>.,5 /#&DC3=*T\6Q^
MRZ5)'+9IYC?NVC!"'.<G )ZYH \KM=*UG7+#4-3MM!TTZJ=7FD36I[_9/"T=
MP55-OEDA0JA-N[!!]ZV-4TJ'1O$-YK&KZ);ZE83ZG'.FM6LP%U8G<BJC#KL5
M@!\K="<CK793^!]!N-5?4)+>?=).+F2W6YD%O)*,8D:(-L+< Y([4DW@?0I]
M4>_>&YS).+F2V%W*+>24$$.T0;86R >G49H Z.N \;Z=9ZK\0/!-EJ"++;2&
M]WPO]V7$2D*P[C(SCOBN_K'UKPQI7B":TGU&"1YK3?\ 9Y(YGC:(MC+*5((/
MRC!ZB@#RK6X3I-_XH\/Z/:QKI<NJ:4C622>3$/._UD>0#L5]J X'1NG-=IX/
MT74=+\3:A,=&T[1=/N+6/-C970E7SE9AYFT(H7*G!P.=HK:M_!>A0:->Z4;1
MY[>^?S+IKB9Y))GXPS2,=V1@8.>,#%6-%\-:=H+SRV@N)+BXVB6XNKAYY7"Y
MVKN<DX&3@=.: ->BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *P'\;>'(]:_LAM3C%YYP@(V-L$I_P"69DQL#_[.<UOUY;X6
MUKP_IW@=='U[R)]1CU26&?3V57FDN&N69"(SR>JMGT&>U '8ZCXX\-Z5J$MC
M>ZFL<T)438B=DAW=/,=5*I_P(BIM4\7:%HUU]EOK\)<&)9EB2-Y'=&+ %0H)
M;[K=,],]*X2RU72M)\*^.[#6+JWAO3?W[2P3.!),L@)C*J>6#*5 Q]*M>#K.
M:V\<:5'?1D7MOX.LXI-X^96\U@P_,?I0!UTGC3P]'HUIJW]I(]G=L4MVBC=V
MD89R B@L2,'(QQCFJNH>)K*XM="O=/\ $%O:VU]J$<",UL9?M1)(,(Z&-B01
MD]".E</I<=E]A1CKRZ'J<.O:H;"YDC#1']ZP=&#87!!'&0>..AJMK>JRZOIW
M@FXGCLQ*GC".)YK)<0W)61@94]F//4\YYH ]%UOQKHFDS7=A)J"IJ$,.\KY;
MLL1(RF]@-J9XQN(S532_&UC;^#_#^HZ]>!+S4;*.<I%"SLYV N0B G:,\G&!
MFN<M=5TO2HOB)9:Q<P1WDM[-(()6 >>)X$$853RV>0 ,\\5BZ$;JVN_"LXU^
MWT2.;PI;QPSW,".DC*V9$!8@ X9#[@>U 'J%YXQ\/:?965Y<ZK EM>QM);2#
M+"557<<8!YQVZGH.:AO/'7ANP2V>YU'8+B!;E!Y$A*Q-T=P%S&ONV._I7!V6
MGV46L?#B*WOQJ=HU[J-Q%<&#RE8E'?*J>@#=.V ".,58U)I;3QSXO%UXGM-$
M@GAMY=EU;))Y\ AVDJ689 8."!GD^] '>:KXLT/19;:*^O@LMRADB2*-Y69!
MU?" X7G[QXJIX(UV?Q#I-]>331S*FI74$+Q@;3$DA"=.O&.>]<CX:ETWPQXS
MBAU'5(Q;MX;LX[&\O/W'FQQL^X?-T/*DKUK9^%,D$WA>_EMEVP/J]XT:[<84
MRG QVXH ZC6=?TS0((IM2N?)65_+B54:1Y&QG"JH+'@$\"IM+U6QUK3X[_3K
MA;BVDSM=01R#@@@\@@@@@\BN6\9ZF]MXBT&Q6^L=+\Y+F7^T[J%':+8$&R,N
M<*6#')]%-0_"RZCN-)UH"\^U2#6+EVD90C.&(*N4'W=PY''>@#J-9\0Z7X?C
MA?4KGRO.8K$B1M([D#)PJ L<#KQQ5:X\8Z!;:5::F^HH]K>$K;&)'D:4C.0J
M*"Q(P<\<8YQ65XS2S.JZ1*/$*:'K$2SFSGGC#PR*0@D1@V%.?E.-P;@D=#7%
MQ:I>ZCK?AW5)-3T[1%>#4+5+V*W5[6:99UW,FX@#S I8$G)P>M 'I$OC+P]!
MIMGJ$FJPK:7I86\N#ARH)*]."-IX/.1CKQ3M/\7:#J>GWM];:BGV>QS]J,JM
M$T&!G+JX!''/(YKS27^R],G\*WTNLQZE93>)+FXDO/(\J(2&-P2.VT."VX''
M4YJUKNLP)KWC35]-6ROK./3K&UG>51+;F9I6&7QPP1'!(]NU '?Z?XRT#5+>
M\FM+_*V<7G3B2&2-DCP3OVLH)7 /(!'%10^._#,]G=WD6JQM;6BQM-+Y;[1Y
MGW #CYF/3:,G/&,UY[=7JMXHUR.;Q%%J\C>%[F-9TCCC3<#N,:[.&(!W$9)
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M&6&&ZN(5D0R"569/F("DJ ?<*: /69O&'A^"PLKZ35(1:WP;[-*,D2;5+$#
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M?1!?:A#)=E!'"]TR "3=T(8JX#=S0!VL/C'0+C1[C54U%/L=M((IV=&5HG)
M"LA 93EAU'>H[/QOX=U"XN8+741)+;P-<.ODR#=$O5TROSCW7->:^+9+?5(_
MB%>V3QSZ=(FF6[RQD-'+,LHW@$<$A64'\J[C6U5/BEX0VJ%_T2_7@8X BXH
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MC;0%HF,,9:'_ %1VC*<8X]...*CN=/LKUXVN[.WG:([HS+&&*'U&1Q6?K_B
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MI=^?]BG^R[?M'EMY6[IOQQG\:R-$\.V/AR2ZNC>7-U>WK+Y]Y?2AI)-HPJY
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M %EQM/\ P(BN@EL]0T?QOI.F'Q!JEU!K-G=K<^=*/W<B*A$D6!B,_,>!QTH
M[J*:WO;<M#+%/"Q9"R,&4D$JPR/0@@_2J^E:+IFA6AM=*L+>R@+%C'!&$!8]
MSCJ:XWX.6;0^ +:Z>\NIVN)9B4FDW*A$T@^48XSU/J:U_'][>Z5X<CU>SGDB
M&GWD%Q<*A_UL <"13[;6)_"@#J:HW^JPZ=/9Q2PW,C7<PA0PPLX4GNY'W5]S
MQ7#CQ%J'_"T#*;QO[ \XZ1Y9/[OSQ!Y^_P"O5,UB#Q#KCVG@[43J-RJ:YXB=
MS'NX^RLQ$<?^[M /XT >IWVKV.GV6H74\ZE-/A::Y5#N>-0I;E1ST!(]:LVM
MQ'>6D-S"28IHUD0D8.",BO()]-:.X^+,[:C?R^3:,HCDFRC!K3/S#'.W.!Z"
MM:TBU+0)O!%V-;O[@:E(EK=6LK@P;6@9AL3'R[2HP>I[DT >G50U#6;#3;#4
M+R>=3'I\1FN5C.YHU"[N5'.<<CUJ_7C%QIK1Q_%F=M1OY?*MY$\N2;*,&M0<
ML,<D=!Z"@#V.WG2ZMHKB(DQRH'4D8X(R*CL["UTZ%H;.WC@C:1I"J# +,2S'
MZDDFO/+6+4M U#P7<?VW?W(U-A;7=M*X,&# SC8F/DVE1CN1U)K&TCQ-K.HQ
M:?KML?$UQ?7-\IEMA9.;'[,TNTHIV[1M3G?G.5.3S0![)7,:Y>>$/#>L0ZSJ
M_P!BM]4F7RH9C%OG=0.0H4%B,>@KIZX7PU''=_%'QE>7(#W=I]EM;?=R8H#%
MOPOH&8DGZ4 =+H?B71O$D,LND7\5T(FVRJN5>,^C*0"OXBM6N7\5?8_#FF:W
MXLM;2+^V(=.=?-YRX7)4,.A ;'/7'&:P)HM5\+-X7U)M?U&_?4;Z"SOX;J0-
M%)YJGYD7'R;6 (V]N#F@#T>BO'KZYUV3PKXP\0CQ%J,5QH^JW:V4,3@1!(Y.
M%<8^<8XP>  ,=\]# -3T7QUX;BDUJ^O8]9MKDW<-PX,:NB*X:-0/D&21@=J
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MBN%\%WU^?$%_8A=?ETC[,DT,VLV[HZ2[B'0,P!8$;3[<UT7BO59=#\):OJL
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MN<F/<3\N,XXSBNICN()@YCFC<(<,58':?0^E(MS TOE+-&9-N_8&&=OKCTH
MEKE]:\(27NN+KNC:O-H^K>4()98XEECGC!R!)&W!(['((KI(9X;A-\,J2)G&
MY&!&?PI([B"9&>*:-T4D,RL" 1US0!S%EX&B8ZE/KVHSZS?:A:M9S32(L2I
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M+?5=+N].NE+6]U"\,H!P2K @_H:GCECEB$L<BO&1D,IR#^--AN8+A"\,T<B
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M(_,AE21#QN1@1^8H DHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ5&91"<;>@//'KFJ^K>"M"UJ_DO+RVF,LRJEPL5S)$EPJ]!*JL X'N#QQTH
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M^LKLQ/)96JNDL<3X^996?:Y4')R!G!Q76:M>)I^D7EY+:S74<$+2/!"@=Y%
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M1<'[V$).<X!7UKK;UKE;"X:R2-[H1,84D.%9\?*">PSBO()K?Q1HD_A*VN-
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M'&#0!T[6=J]TMT]M"UPB[5E* N!Z ]<5SFK^%KO6=0L[66XLX/#EK,EP;*"
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M$8 P..IW#'>KWC>_U'2_!FJ7NE!OML40*,D>\H-P#.%[E5+-CVH WU4*H50
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M22\>W= R!P2 B$YD;:,X'L.M:.G:_#J6NZMI202(^G" N[\!_-0L,#J,8[T
M78]-L(8UCBLK9$63S558E #_ -X#'7WK.\7Z%)XE\+WFD0S)"]QLQ(X) VNK
M=O\ =K(A^("7VD:+<:;I-Q=W^L)));V0D1"J(<.SN3@ <?4D"L?6_%MS<7WA
M2[BT_48)UU2>UN-.R [R+"X"9SM9=Q4AL[<<\8H ]#ALK6VEEE@MH8I)3F1T
MC"ESZDCK4D44<$8CBC2-!G"HH &>>E8?AWQ+)K5[J6G7FF2Z=J.G-'YT#R+(
M"L@)1E9>"#@_3%0ZUXM?2_$5MH5II-Q?W]U:M<Q+&ZHN%8 AF8X48.<_AU-
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M$:1BVA$<>=B^6,+G@X';.3^=>8_$#Q3/J7PTGO+5;K3+VVU2*TN8A+AXI%D
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M8=*O8DU&73H;2VEA*S2)!*I>0IU ^8XSSA<UZG#?6EQ=7%K#=027%MM\^))
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YO)XN\3W'AJ_\
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MW@TVQ5GM[@I-*P\T*6D'/J3ZD\T >ET5Y-HVL:QXAL/!VBW&K7<7VP7SWMW
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MXLXX_$;:.]GYOF:U&^Z.=7 (5VY(96SCMM.* .]HHHH **** "BBB@ HHHH
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M>VNHT#[0R[75E/#*1U''0<U0B\$(=(U^WO=2FNK_ %V(Q7=ZT:J0NPHH5!P
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ML53(X^4#CB@#C=*TN'PYKFF'4M&L+R&XU&0V7B&QF_?/)*7(68<%L@E<@LO
MXKDI[:"X^$_Q!:>".1HO%4SQET!*-YL*Y&>AP2/H37K]GX(\/V&J)J%O9.LL
M<C2Q1FXD:*)VSEDB+;%/)Y '6I!X-T :1J>E?V>ILM4G>YO(C(Y\R1\%FSG(
M.5'3&,<4 <CK=G;6'QB\!6MG;Q6]O';7X2*% B*/+SP!P*PDTO3+SX,ZYXAO
MK>$ZZ7O+I[YE'GQW$<KA 'ZKC:@ !Z?6O3;;PEHMK=:9=);2-<:6DB6DLMQ)
M(T8DSOR68[LY_BSCM5>X\!^'+G4I+Z73V+RS"XEB$\@@DE'.]H@VQFR,Y(H
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M%M[,7(.X$D'![4 <?XGMQH^H^,-*T6WA@T^<Z49[>-O)A1I92CCY1\@=0 Q
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ME!Q@Y( KKKC2K*ZU"QOIH-US8ES;/N(V;UVMQG!R..<TW5M'L-<L&L=1MQ-
MS!L;BI5@<AE8$%2#T((- 'GT?AR*WT?Q:OB.+3-(TF58KE8-.N3(+.55.95^
M1=C$B-@ .2#ZUE^'M0U*^TCQ1KNLF1/%UEI!6U@>/888/)WI(BY/+ODMZ$;>
M,5Z'%X(\/QV!LC8M)"UREU)YT\DC32KC:9&9B7 P.&)' XK1GT73[G6(-6EM
M@;Z")X$E#$9C;JK '##O@YP>10!YOX9T#4[:Y\+:C::1H6G110'?/;7K/-?1
MO"3AAY2[R6VODL<8-3^"]$\.W7@GPYK^I&&#59+E;AM1W!)I;EG(*,_5LDE=
MO?I78Z5X*T#1;]+VQLF2:-66$//)(D ;[PC1F*H#_L@>E,A\"^'+?6%U2+3L
M7"S&X1?.D,22GK(L6[8&YZ@9H X&>1(_@=XPWL%Q>:@IR>YN& 'ZBMK3M*TY
MOC3=SM86IF71+>=7,*[A(9'4N#C[V !GK@5O77P\\+WMQ>S7&FL_VUF>XB^T
M2B)W889_+#;0Q_O 9[YK0N/"^D76NVNM26SC4+6,11S1SNF4!R%8*P##)SA@
M: /']% F\"PV,Q/V&]\:&WO%S@/$7SM;V+!0?K72>)+"ST7Q7J5MI%K#:0W?
MA>\>[@MT"(=A C<J.,_,PSZ5W$7@_0(M$N]'73D.GW<S3S0L[,&D8@ELDY!R
M 1@C&.*;8>#M#TZ&]CAM9'-]%Y-S+<7$DTDD>"-N]V+ 8)X!H X-=$TW2M#^
M&^I65G%%J$M]:++=JH\V420.7#-U(/H:ZCXGR.O@QHM[1V]Q>6MO=.IQB%YE
M5^>P(.#[&N@DT#3);33;5[4&'3)(Y;1=[?NF12JGKS@$CG-6K^PM-4L)[&^@
M2XM9T*212#(8&@#A-1T32=*^(_ANTTW3;2W@U"SO+>_MH856.:%44KO4#!PQ
MQR/XB*K?!S2]/@TK6+N&PM8[E=7NX!,D*AQ&&&$W 9V\#CI78Z-X2T;0KM[N
MQMY?M+QB+SKBXDG=8P<[%:1B57/8<5;TC1-.T*WF@TVW\B*:=[B1=[-ND8Y8
M\D]?3I0!R7BF"'5_&<=A#H.G:G=VNG&62359RMO#%(Y'RIL;+DH><# '7FN3
M\/6=OKG_  K.#442ZM_L.H9B<[T<(8PH(/WE&%P#Z"O3]6\)Z+K>H17U_:-)
M<1Q^5N29T#QYSL<*0'7/.ULCKZTFG^$=$TNYMI[.S,<EJTS09F=A%YV/,"@L
M0 =HXZ#MC)H P_ EM!I^O^,M/LXD@LX=31HH(UVHA>"-FV@<#)YP*P]6T^]U
MWXA>(X&T'2=7B@M+:&,:E=&/R(W5F)C C?JV[+<'Y1Z5Z/::796-Y>W=M#LG
MOI%EN&W$[V"A0<$\< #BL_6?".BZ_=+=:A;2-.L?DF2&XDA9X\YV,48;ESV.
M1R: /-=8T&$ZC\,8=9@T^_O'=K>ZN JRK<JL7RY8CYQWY[FM"/P_H\7QUNH8
M=&T_9%X?6XBB%L@59A/PX&.&]^M>A3^'-(N)=*E>R0-I1S9!"5$/R[> "!C
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M6W?OX/RXSWZ5YIHUUI%Q::@+SQ1+8ZA%XBDGLM4DCC0AFMUVO(I4($D3?C(
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M5E0 L' 91M8]>#UKS[[? (]0NIM3:]M[3Q;97MU<2HB,UOY4:B8JH V;MI#
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MBNKL[&Z3XGZM?M;R"TETNVB28CY6=9)25!]0"/SKJ:* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\F\83R^(]6T[4DD8
M:1I6NV=K; 'BXN//42R>ZKR@]R_M7K)&1BO.]8^$VCR:?96VCQW-N(;V"5DD
MU.YV")9 SA1O(#8S@@#![CK0!+:Z-IOBGX@^*CK=C!?QV"VUG;1W*!UB5HO,
M<J#T)+]>O KD;&>TDA\(6WB>5)=!LKK4;-GO#F%I8G*0>:6X.$# 9[BNYN-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNFD\\AT8>7R6&Z/;NQC JU%_Q]?&7_KW'_I-)7H:^"O#R:S_ &JNG@77G?:
M/-?RQ+_ST\O=LW_[6,YYJP/#&C!M8862YUA=M^=[?OAM*\\\<$CC% 'G&G>3
M?^&_A]I,>C6VIZA_9GVJ);Z<I;1*L:JSNH5M[?, HQQR<BL2^1T^'/CNQ(MK
M=8=>MU$5@Y\J%C);[A'D#'S9[#!S7K-UX)\/WECIUG)8LL6FIY=H8IY(WB3
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M  *CD8!R.>>:O#P1X;73KG3TTN-+6XE6>1$=E_>* %92#E2 HY7%7M&T'3=
MMY(=.MS&)7\R5WD:1Y&P!EG<ECP .30!I4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 445Y]%K\O@7Q)>:;XDU
M"231;P27>FW]RY8Q[1F2W9CR2!ROJ..3Q0!Z#17!:#J]]%I.K>._$4]S;6$L
M1EM-.+'$%LHRK%>AD?@_B!6A9>,;[^T],M-:\/RZ7'JF5M)C<K+\X4OLD  V
M,5!QUY&,T =;17)'QU"/ $WBO["_EQ.Z?9_,&3MF,77'J,]*ZV@ HKD];\8W
M.G>*8_#NG:'+J5_+9B\0+.L2[=Y4[BPX QU[D@8J"]\>/:RW]U'HTLVB:=<_
M9KO4!.H*," Y6/JRH3@G(Z' .* .SHKC;KQKJ#:YK.E:1X<FU";26C\]OM*Q
M*RO&'&W(Y8Y(Q[<D9%0W'Q'BD70!I&DW&HS:Y:R3VD0D6,@IMRK$\#&XY.>-
MIZ\4 =Q17'7WC:]MI;X6OAZ:[BTN)'U-TN4!A8H'9(P1^\95()Z=1WIUSXVN
M)+VXCT30YM6M[2&*>XEBG5'VR+O41H>7.WG''H.: .OHKD=4\:7-K>ZC'IVA
M3ZA;Z7&KW\RS+&8\KOVHI&78(02..H&<TV3QQ/=:Q-IFAZ*^IS+9P7J2&X6&
M-HI-V"6(.#P,#!SGM@T =A17FNH_$'5;NW\)7>AZ4QCU6[>.:*69%8L@D#0D
MD''S+G</[OO7I*DE 67:Q'(SG% "T5P9\2Z[-\1-8T3[ HTVVT]'W"=<IN,G
M[WIDYP%VYXQGO65X-\9W]AX-\*M?:-<-IMT(+(ZB]PI?S7^4,8SSM+<;B<]\
M8Q0!ZC17(ZKXSO=*NKF:7P[=?V-:7"6\]^\H0Y8J-Z1D9= 6'S9['&<5!I/B
M37+WXF:WHLNGJ--LXH,.)E_=[A(0^,9;?A1C/RXH [6BBO.]+OO[8L/%GBZ_
M\Z:S1;FTL[=)2@%M""&*D=&=@WS=1@>E 'HE%>87VHI8^ O#OC?24N+:"PCB
M::V>=I#):2,%=&)^\5R&#'D%3ZUZ<"" 0<@]#0 M%<5J'B37(?BE8Z#;:>LF
MGO8O/(?.52P\R-3)R,C9EAMSSGZ5SGA3QIJ&B^!K6\NM'N;K2X;R6*YU!KE0
MR[KEU!5#RZC<H)R.AQTH ]8HKD=5\:7%E>ZFEAH<VH6>D '4+A)U0H=H<K&I
M^^P0@D9'7'6F77CF1O$D>B:/HTNISR6<5\DBSK&GDNQ!8EAQC XZG</<T =C
M17&3^/'BEN+M=&E?0;:\^QS:EYZ@JX<1LPCZE%<X+9SP3@XKLZ "BN*EUW2[
M+XD:K%+:7*W5IHOVN:Y$[,AB#_=$73=WSU[5H^'_ !'J6KS0?;/#\UC;75O]
MIMKD3K,C+QA7VCY&(8$#D'!YXH Z2BBO/[/XESW>D:;KC>'+B+1+R:.![MKE
M=T;.^P'9C+*&(&>/8$<D ] HKD;WQE>_VAJ<&C:!+J<&E$)>3"Y6+Y]H8I&"
M#O8*1GIR<5T6DZI:ZWI%GJEDQ:VNXEFC)&#AAGD>M %RBO/_ (AW$T/BGP*D
M4TD:R:OM<*Q 8;>A]15Z^\>26DM_<Q:+-/HFFW'V:\U 3JI1@0'*Q]65">3D
M=#@'% '945R=YXSGCUK4;/3]$GO[;2U0W]RDRKY99=^U%/,A"X)&1UQUJ.U\
M:7^JZ'HU_H_AVXNY=3@:?8TPCB@48X>4@C<<\#'//I0!V%%>5^)?$3:W)\/M
M1M?/M%N=;$4T!?!5D+(Z-C@X92/>O5* "BN3N?&-R/&-QX;T_0Y;RXMTAFEE
M\]8T6)\[F)(ZK@87J<]L&H!X\<R+>?V-+_8#7OV(:EYZYW^9Y6_R^OE[_EW9
MSWQB@#LZ*Y2T\7WM]J3K:^'[B;2DOGL6O4G4LKHQ1F,74(&!&<YQSC%<]I?Q
M!UF#1O%NKZOI&;;2;V6-%2X3*[/+'E<+SC);<?7% 'IE%>>>(_$R2:!IU]K.
M@7<-M/J]O%9(M[L=PV2DK;.@]4.?>M?5/&-Y;ZKJ%EI&@S:K_9B*]\Z3K'L+
M+N"(#]]]O...HYR: .LHK@X?%VLWGQ*M=*MM-;^RIM*2\Q+(L;A7=1YC*1N!
M7E=F?>J^A>,-*T_POJVH6FG7@*ZU)9):FX,SW-RS*H"EC\H)(XZ  T >B45R
M,/C.YM[R\L-9T5K"^AL9+^%%N5F2>-/O . ,,"1D$=\\U6LOB!<W)T.ZN/#\
M]KI.LO'#;W;7"LPD=2RAHP,A3@@-GT.!F@#MZ**Y+7?&5]HLU_-_PCMU-I.G
M;3=7K2B/@@%FB0C]X%!Y.1R"!G% '6T5R=YXPO?^$BO]#TC09-0N[.&*<L;E
M8HRCANK$'!XX'.>>F*KI\05O=+T&;2=)EN[_ %D2&&SDE$7EB+B4N^#@*>.A
MR2* .THKSC0O$DMMJ'Q U;4()K86!AD:VEDW>64M@2%(X()&01UR#4N@ZUJ6
MBZ1HGAVVTZ75M=?3Q?WGFW(B6(.Q)+.0>2Y8  ?P]@* /0J*X>Y^)-O;:#::
MA_95TUQ+JG]DS609?,BN &RN>C<J,<X.X'BNLTNXO+K389]0L?L-TV?,MO.$
MNSD@?,.#D8/XT 7**P?$'B.32;RPTZQT]M1U2^WF&W$HB4(@!=V<YV@9 Z$D
MFLQ_'4PM;.%=!NQK=W=26B:=(X3YHQN=_,/!C"X.X YR.* .QHKB;CXAKI^C
MZW<:GI,MM?Z,T/VFT$PD#)*P".C@?,#D]@<J1BIX_&&I#65TN\\-RVMQ=6LM
MQIX:[1O/\O&4? _=MAAZCWH Z^BO,="^)&I0_#_2M>UK2Y)WOKQ+:-H)%+2[
MW< A0!C&T+COZUTLOB+Q D-E%'X2F?49TDEEA-VHB@56P 9L%2S9!"@>OIF@
M#J:*X_\ X3Q;K3=%DTK2IKO4-6$AALWE6+RQ'Q*7<Y "GC@')(Q6/K7CO7T.
MA)8Z#-;7$^JFRNH+B55W,JL2BL005;@B0>F* /2**PM/\2"^NM<MVM&BDTAU
M23YP=Y,2R<<<8W8_"LZ+QAJ&HZ3HUWH_AR>\EU*T^UE6G$44"X'RM(006.[@
M <X)X H ZZBO+?$7B(ZW>?#K4K,SVT5WJI66$M@@KE61L<'# C\*]2H **Y.
M;QC<MXQNO#=AH<MW/:B"2:;SUC1(I,Y8Y'4<84<GGIBH(_'CR217AT:4:!+>
M?8H]2\]<ER_EAS'U$9?Y0V<\@XQ0!V=%<G9>+[[4-0/V;P]<2Z5]LDLOMJ3J
M6#HQ0LT74)N4C.<XYQBN>TOXA:Q;Z#XJUG6=)S;:5?2Q(J7"97:R+Y7"\XR3
MN[T >FT5Y]XB\2*^C:3>:WH%W!%<:U;PV2+>['(8$I*^SH.N8SGWK4U3QE>6
M^IZC::1H$^JII:JU])'.L90E=^R-3S(VW!QQU SF@#K:*X2W\6ZU>?$N+28-
M-/\ 94FEQW?[R14<*[X\PJ1N!&"NS\:K:!XQTJP\)7VH66FW@+:Q)90VC7)E
MDN+EF"@*SGY02<XZ  T >B45R,?C6XMKC4++6=%:PO[;3WU"*-+E94GB3[VU
MP!A@< @CN#S5>R\?7-Q+H<]SX?GM=*UETBM;MKA6;S&0LH:,#(4X.#GTR!F@
M#MJ**XRY\;Z@VJZUI^E>&YM0DTAU%PWVE8E96C#C;D<MR1M]NHR* .SHKB+G
MXBI(^AQZ/I$^I3:U9M=6B"58_N[<JY/"X!))_P!G'.15FX\8:E)J-Y8Z1X=D
MU"73T0WQ^UI&(Y&7=Y:$@[V /L.1S0!UU%>:7GBM]1\7>$]4T2VN+V/4-+NG
MBM?,$8+;HOOD\+MPV3SZ#.:?XC\9V5W\.==O=9T:ZC;3;M;2\L8KPHV_?'@K
M*F#CYU.>,\B@#TBBO/+S6-3L_BK>VVF:=+J,LFBV[K ;@11H!++EBQR ?NC@
M$GZ TW5_&.EZGX>T#4+S3+O?+KL5DUL+DQ/;7*LRG<5/S@$'CH010!Z+17$:
M5XEUR]^(WB#1Y]/4:98Q0X83KF,,LC!\8RV_"\9^7%9OAWQO86'P_P##=[IF
MC7K0:I>R6=O:M=&657W2GEWZY9#U( !]!0!Z317&+X_%E!KO]O:5)IUSH\"7
M,D23+.)8WR$*, .2RE<$#G%.M?&M^OB#1]&U;P[-I]QJOF&%OM*RH%2,N<D#
M[PP 1_M#!/- '8T45S.G>,[6[\,ZKK%U UH=*DN(KR!G#&-HLY&>,Y&"/J*
M.FHKBX?&^H:A);VNE>')+F_-E%>W<,EVL2VRR9*(6(.7(!., #UJSIGCJTU6
MXT&&"SF1M5^TJRR$!K>2#[Z,.YSD?AF@#JZ*R-,UU-2US6M,6!D;2Y8HVD+9
M$F^,/D#MC.*UZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *XGXIZ-<ZYX3@M;2R:\E74+>3RU3<0H?YC^6<^U=M5!];TE
M-7327U.S74G&5M#.OFD8SPF<] 3TZ4 9WCC1)_$7@G5M)M"HN+BW(B#' +C!
M4'T!( _&N?N)]2\8:SX:C.A:CIT>FW8O[V6\C"*K+&RB-#GY\L_4<8%>@44
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M\]PEBT&G)H5M:1,"6161V^0,>3@8KL;BXAM+:6YN)4B@A0R22.V%10,DDGH
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MN=FY'5P#CG!VX_&J^FZ-K#^,(O$.IK91,=*-G+#;RL^)/.W@@E1D;<?CV[T
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MHR/1=JKCT%74T#7M=\06.I>(ET^UBT^":."&QF>4R22KL9V+*NT!<X7GKR:
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M'PP7^(@]!W-06DERNK7&DH_BBWL[S0[B=SJET?,>6-H\21G>S)D,01\HY'%
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M:KXAO]0:]LWLLNJ1I$C @D(@"E^?O'/IP*EU3P?;:GX+M_#9NYX8[:.!8;E
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M02[$55( R^P#S&   +>YQGFNFHH Y>+P/9Q>&=#T,74YATBY@N(I"!N<Q-N
M;C&#WQ5+QOX=632_$^MPM-)=W&@2V(@5<@@!V! '))+8KM:* .)T/P8^W0KK
M4-8O;JVTV)9;.QF1 L,ACV@LP 9]H) SR.^:LQ?#[3!IOB&PFGN)8=;O7O93
MD*T,A((*$#C:5!&<]*ZVB@#E[+PRVGZFNO:UK5WJUQ96[QVYDA11"AP7(2-?
MF<A0,]>P%8GA/2(M5^(&L^,H[2YM[*1%@LUN8VC,KE5$LP1@"N0B*"1DX->A
MT4 <I=>"G>_O9++7M0T^QOYA/=VEOL&]\ ,5?&Y-VT9P?7&,UJ6'A^"P\2:O
MK:32--J:0))&V-J>4K 8[\[N:UZ* ,C0+34+1=2^WSS3"6_FEM_-<,4B)&U1
MCH.N!V!&>:UZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *\5E(FB\/ZW9:3I=A97GB2%H)VE:2^F+SE7+,1_$-V5R<+
MQVKVJN:;X?\ A9OM&=(C_P!(?>P\Q_E;>'RGS?N_F /RXY% '$)H>F7OACXE
MWEW8P3W(O;\)+*@9HPL09=I/W<,2>.]7/#-K;:YXT']LP0WC1>&[$VZ7*!QM
M?=YC 'N2 ":[^/0=,BLK^S2T46^H/(]TFX_O6==K$\]P,<52U#P7X>U06?VO
M3E<V<7D0,DCHRQ_W"5(++QT.10!B?"=((_"-REJVZW75+P1-G.4\YL'/?C%.
ML_WGQKU1I?OQ:' L.?[C2N6Q^('Y5U6EZ18:+:M:Z;:I;0-(TICC^[N8Y8@=
MN>W2L76]&O5\5Z5XDTJ-99X4-E>P%@IEMG(.03QN1@& [@D4 < G_'O\9?\
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M)K>9"DD<BY5U/!!%8UEX+\/:?:WMM;Z<!'>PFWN/,E>1GBP1LW,Q(7!/ (%
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MJ^Q0+#]JN&N9L$G?*V-S<^N!5N@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6MV&EZ5+J<\K26L3;&:WC:8YW;<;4!)PW!],'TH T:* <@&B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR#Q9K
MWAG6_B1+H_B'5+6VTK2+)T9)GQYMS.NTX]=D9//9FKUXYVG:0#C@D9K!\)>&
M%\+Z3+:O=&]N[BYDNKJ[:/89I7;).,G'&!U[4 8?PG\1)K?@\6;7<=U<Z3*U
MC),C9$JIQ'(/9EQSZ@UJ>/=5O=+\/1KILWV>\OKRWL8I]H;RC+(%+8/!(!./
M>K$'AD6GC>Z\1VUWY:7EHEO=6GEY$KH?DDW9X('RXP>*G\4: GB70Y-/:X>U
ME\Q)H+A%#&&5&#(P!ZX(Z>F: .1@TRZTKXM:/!-JMWJ$)TFZ:-KLJTB'?%N&
MY0,CH1D<<\XP!AZ'XB\0ZG\,=#U.ZO=4DBDOYEU.[T^%7N4A4R!2J[3QN" D
M D"NUT[PEJ:>*K;Q%J^N)>W4%I):^5%:>3'M8J00-Q(.5.<YSD=,55T3P-J7
MAOPKI^DZ1XB,5Q93RR^=):[HIE<L2KQ[^V>"&ZB@#&FU;4;J#PI:Z-XMDO(-
M0U&>!KX0J)?)$;MM<$8\Q<=2HY R/6MKVM:YX8MO%NDQZS=71M+2UO;*ZN-I
MFC$DNQU)"@,,KQQWJ76O#%UI^K^%K==5)U*\UJXO9;Q( JB4V['B/)^7Y%!&
M<D9YR<UNR?#^34[#Q -:U;[3J&LPQPM<06_E) D>2@1"S'AB6.3S[4 7/$-[
M>KXT\-Z7!>2V]M?0WHF\K&25C7:PR#R"217GF@:C>Z!\-+&>/5M3,FK:S):.
MZQ"=[=?.F9WB14)+L%.<AN3D 8KT"T\):L_B/2M<UG7TO;C3DFC2.&S\F-ED
M4 G&\D-P"3TX  '>C9_#R[M-%DTM=='E6]]]OTN1;0![63S&<[CNQ(#O(QA>
M"?P )_ ^JWESJFK6#2ZM=Z="L4MI=:G9O#+EMP>,ED7=@J"#C^+':KWC/4KS
M3AX?^R3M%]IUJVMYMN/GC;=N4^QP*T-$T[5;-KF;5]7&H3SE<+'!Y,4*@=$7
M<QR<Y)).>.F*B\4^'W\1:;!##>&SN[6ZBO+:X\OS DD9R,KD;AU&,CK0!SGB
MK7-3L=?\16]M=O%%;>%9+V%0!\DX>0!QQUPH_*JL,^N:5=^#M3N->N[LZQ,D
M%Y:R*@@&^!G!0!05VE1SDD]ZTG\"7M[<ZQ>:GKHN+O4])?3'*6FQ(@2V&1=Q
M.!N/!.2<G/8:UWX6%U!X;B^V%?[%GCF!\O/G;8FCQU^7.[/?I0!YOKS:OXA^
M$FO^*)=;NA]H^T!+#"?9U@64QA<;=V["YW9SGVXK6USQ%=7'B;5].&J:W8+I
MD$*6JZ7I[SJ\SQB0M*5C?(^91MXX!J_??#6_N=#U+P[!XD^SZ#>222QVXLPT
MD1=B^SS-XR@<YQ@'MFMF_P#"VJ#5[K4-"UQ-.>^ACBNUDM!,&* JLB?,-KX.
M.<C@<<4 <S'J7B+Q-XHT33&U*\T6.[\/+>WL4,865)1( 0N]3M.2!R.F?K7J
M &%QD].M8%OX8^S^++776OY9F@TK^S2DJY:3YU?S&?/7Y>F.]=!0!X3/87$'
MP]^(T[ZI?7135IK<1W#(58J\.)#A0=V,#@XQVKO$&K:!X]T*SFUV\U&#5H;G
M[1%<*@1)(U5@T8505')&,GCWYIMS\/+J>T\2Z<NN*FFZW<-=^4;3<\,S,A)W
M[QN7Y,8P.O7CGI-0T$7_ (ET76/M.PZ8)QY6S/F>:H7KGC&/0YH \[TCQ#XC
MU+X?3WOVK4)W37)(+J:RB5[B.T5CGRUP<D?+V)P2:[CP5>PWVCS2VVOR:S;"
MX98I9X]DT(P,QR< E@<GE0<$?4YVD^!K[0?#[6&E^('ANO[0DOEG-ME&WYS&
M\>[YEY]0<@'M6SX=T&?1SJ%S>WJWE_J$XGN)8X?*3(144*F3@ *.I)- &!XU
MACU+QQX*TB\42:=//=7$L+<K))%$#&".^"Q./:I/BM:6Y^'VH7Y"QW>FA;JS
MG PT,JL"I4]L]/QK<\3>&H/$ME!&UQ-9WEK,+BTO(,;X)!T(SP002"#P16+)
MX,UG6)+>+Q/XD74=.@E67[';V(MUG93E?-.YBP!YVC )% ',WVDW%[\;M-+:
MQJ=M)/HC7!,3Q@Q?O!F-<H?E^N3[U0T&.X\.ZY\1]875M1N'T@^;Y<K(5NF$
M#$>;A 3@]-NVO2IO# F\>VOBC[608+!K+[-Y?WMS[MV[/X8Q^-5K+P5;P7OB
MJ6YN3<6_B%AYL/E[?+7RRA&<G.0>N!0!S/AC7-1/B#18DO\ 7]2COHW&H_;]
M-DAAA?RRZO&QC4*-P*XR<AAZ5H_"U]9U?PW9^(=8UJZNY+F*2);8A1$H60@.
M<#)<[3SG&#C'%;&A^']<TZYM1J'B0WME9Q&*&".U$1DX #2MN.\@#L%&>:M^
M$?#P\*^%[+11<_:1:AQYVS9NW.S=,G'WL=: .>^-'_))-=_W8?\ T<E=S#_J
M8_\ ='\JQ/&?AL>+_"5]H1N_L@NP@\X1[]NUU;[N1G[N.O>J$&A>,XY(_,\9
MVKQ*1N0:,HW =L^9Q0!Q=_XOU2>;6M1L[W73?V-_+!9:=:Z;)):2QQ/M*NPC
M(+/AN=PVY'3%7K+3+FY^(_C>5-<U6#RK2U=1&\8X>.4A3E#PA)V_KFNE;PCJ
MMO?7JZ7XA:QTR^NC=SP+:AI4=B"XCDW?*&(SRIQDXJ<>%;F+QI?ZW;ZFJ6FI
M01PWMFUON9_+5E4I)N&W[WH>GY 'G>AZE=:)\.O!MFFJZJD>KDM-+;P>?+!$
MD98I"JH2,G;R0Q )-7K_ ,4:]:>#-9:RN]1+6FI6D=A>ZC:-#)+%(Z JX95W
M8)92<<C%=#I_P_U'3] TRP3Q ANM'F\S3+H60'EIM9621=_S@JQ!P5[5>O\
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MZ;_DX>W_ .Q9/_I0:6\^&,]YH.JZ1)K[/#?ZA'J'FR6H,BRC:9,D, 0Q4$
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M3YAM< XYR.!QQ0!@WNNW>I6F@_;]4UC3+NXTX7$^FZ38L]SYIP"[_(Q6,'<
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MWX;Z'9W&M!=#D*SS61M096VRE_+$N[A"P!^[GMG%>@Z5X>&F>(M>U;[3YO\
M:TD+F+R\>5Y<83&<_-G&>@H \_.JZ^OPY'Q".NW?VKB\.GX3[+Y'F8\K;MSG
M9_%G.:W6&L^+-?\ $266O7>EQZ5(EM9I;JFUI3$KEY0RDL,L!MXX![FE'P[N
M_P"RQX>.N@^&!-Y@LOL@\[R]^_R?-W?<S_LYQQFKVI^#]2?5]2O=#U_^RTU5
M$6]C-J)3N5=@DC.X;&VX'<< T <WK'B#4)_$E]I=[JVKV,FG6D 4Z-I[SI)<
MNFYG<B-_E'R@*<9&:L:9JFN>+]:TS3KJ]OM%\K18KZ[CMD$<KW#N4P=ZG"C8
MQQCOS6Y-X/U&SO3=>']>-C)-:16MT;JW^U&7RP0DF2RD28)!)R#QD<4Z\\(:
M@NJV6K:1KIM]0AL187$MW;_:!<Q@[@S ,N'#9.??I0!QOA^_U/2X;: 7A,MQ
MXVN;:[D10!,NV0G([9*@\5N>*->U2RU3QC%;7CQI9>'5N[8 #]W+^^^8<=?E
M7\JG3X<RV^AK:6^N2?;XM8;5X+R6W#8E.<AUR-P(9LX(Z]JE?P%=W9U^?4-=
M\^[UK3/L$KK:[$BQO 9%W'C#CY2>H)SSP 4'DU&P\%V5_J?BR^BN=5>W:0Q6
MXE==REC#;(JD[B.,D,>">*Y?Q-JUU??"OQW87%QJ%Q%83VZV\FHP^5<;',3[
M7&U>A)P2.017H^I^%;BYTO0XK'4EMK_1G1X+B2#S$<B,QL&3<."K'H>*Q;_X
M:W>HZ7XBL;CQ"7&NK"\\K6@+),A7YEPX&TA0 O;CD]P#M]-_Y!=I_P!<$_\
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MK:7DMFXE !+QG!(P3QZ5#;^*+.YU'7[)(9Q)HFS[02!A]T?F#9SSQZXYK@?
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M5+U8;N";2T9KVQN(]D\)"EL%<XY X(.#ZUFV?Q NK^T@N[;P7XCDM[B-98I
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M?3:S.^H7$RQ[%\Q\ H%R<!=H7!).0:ZZ@ HHHH **** "BBB@ HHHH ****
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M ^AH WM%\,6&AW$]S#)=W-W,JQO<7ER\\FQ<X0%B<*"2<#UYK9KG]:\2):>
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ML2D,0HBW!L;>G4"N1\(?$&Y\0^(6L[RQCMK&^BDN='G!.ZXBCD*-N!_BP%8
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M5E;:=90V=G!'!;0H$CBC&%51T %5-(T*PT,WYL8V3[==O>S[G+;I7QN(ST'
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MT2ZTFSM3';7:N+@EV:28N,,S.26)([DUI:?8P:9IMK86JE;>UA2&)2<D*H
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M\P0_9TV!L8W;<8SCO38/#^BVTZ3V^CZ?%*ARLD=LBLI]00.* .7\8_\ )0?
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MEV[NG;%>D/I]E(T[26D#M<*$F+1@F11T#<<CV-4O^$7\/_\ 0"TS_P !(_\
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MY-<K\75+_#+5%#%29+8;AU'^D1\UV]1W%O!=PM#<0QS1-@E)%#*<'(X/N :
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MT[Q'I-KX7T>]M[[4=2NX,);2"0PQ)*LCRMMSM4!>IZYXKT1F5$+NP55&22<
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M^!S5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDM9VM(]*G1YQ&3&K%C@%N@/M0!0M[VY\1>(=<L[GQG=:+J5I>O!9Z="84 C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDLL-QYJE3$\9PX8'IC&?I5C1]5MM<TBUU2S\S[-=1B2(R(5)4]#@^O6@"O\
M\(SHO_"/?V!_9T/]D[=OV7!V8W;L?GS2ZMX;T?7+>"'4K"*X2W.82<AH^,':
MP((R.O/-4M6\9:;I.HR:>8;^\NHHA-/'8VKS&!#G!?:.,X.!UXZ5RGC_ ,>2
MP:9X>'AVYNUCUB\@7[?;6?F_N7W9$>X$&7C[I&?:@#NHO#^DP#3A#I\$8TW=
M]C"+@0Y!4[0/4$_G6E5+1V9]'M&>6ZE8Q#+W<8CF;W=0  ?; KB+_P"($]RG
MC:QM+.\MIM(LY&M[EK9@ XA+Y8D8'.-H/4<\T ;,_P -/!ES<2W$WAVS>65R
M[L0<LQ.2>OK5U_!?AR31[?26TFW^PVSEX(AD>4Q))*D'(SD]#WK.\/\ CO3K
M_P#LBQG^VK<WL \FZEM62&YD";G"/C!/!/H<<9JVGCG1I-5%BIN]C7)LUO#;
M/]F:<''EB3&-V01Z9XSF@"U<^$M N]$@T:;2K9M.MV#PP!=HC89^88Y!Y//7
MD^M/7POHB:Q!JRZ;"M_!$(8YQD$(%*@'GG@D<UKUQS?$WPXD:SLUX+,3FWEO
M/LK^1!('*;9'QA>1^1!.,B@#7TOPCX?T2^>]TW2K>VN&!7>@^Z"<D*.B@GL,
M5H:;IMGI%A%8Z?;I;VL6=D2=%R23^I)K(TOQGI6JZG+IZ+>6TZ0&Z47EL\(E
MA!P9$+ 97)'YU#IOCS1]5N4AMXM07SX7GM'ELW1;M%&28B1\W!!QU(.: -;6
M-"TOQ!:K;:K91742/O0..4;U4CD'Z5 WA307T)-$.E6O]FQG<EN$P%;.=P[A
MLY.>O-<2_P 66'@S4-;71KWS(+UK>(-:2",J9BBEF]<#D=F('>NJO/&VFV0M
MD>TU22YGA-P;6*R=IHH@<%W3&5&>.>3VS0!;@\)Z#;:/<:3#I<"V-PVZ>+!/
MFGCECU8\#DGM5^XTVSNKRVO)[=)+BV#B&1AR@<8;'U Q6'J'CS0=.ATZ1IYK
M@:E T]DMK TK3@;>%4#);YQQ]?0TV;Q[H]O=&&6+4%1#&MQ/]C?RK9W"E4E;
M&%;#+GTR,XH NZ5X0\/Z)>M>:;I5O;7!4J'0'Y5)R0H/"@^@Q447@;PS#936
M4>C6RVLTRSR0@':74D@XSQ@D]*Z"N5O/B#H=E=7,<@O7MK2;R+J^CM':W@DR
M 5:0# P2,]AWQ0!K7?AW2+[6;;6+FPBDU&V7;#<<AE&<XXZC))YJC%X$\+0W
M$L\>B6JR22"4D*<!@P?*C.%^8 \8Z4:EXVTG3-:&CN+NXU I'(L%K;M*S(Y(
M#?+V&TY/0<>HK?FE$$$DI5W"*6*HI9C@9P .I]J ,UO#6C/KK:VVGPG4FC\M
MI\'++C;@CH>#CGM4.E^#_#VC332Z?I-M \R&)R%S\AZH <X7_9&!7#S_ !)N
M-2\(#5X8[C31%K,,$DLEN51K<W)0C+#!.P?-CH3VKLM-\7Z=J]Y=Z?''?V=Y
M#!]H\N[M7A=HLX\Q0PY&>/KVH GT?PEH&@7+W.EZ7!;3.FS>N20N<[5R?E&<
M<# XJSK&@Z7K]O'!JEG'<QQ/YD>[(*-C&01@C@D5SFC^-='L_!VC:C=:O>7\
M-_*\,%W+;8EF<%S@H@Z_(5  YP.YK1L_&^C75IJEQ,US8_V4H>\BO8&BDB0@
ME6VGJ" <8ZXH LQ>$?#\,WFQ:3;1N)(91L7: \0Q&<#C*C&/I5]],L9-0:_D
MM8VNF@^S-(PR3%G.P^V:P]/\>:/?ZE9:=LOK6\O0S00W=H\)=%4MO&X?=PIY
M_E4FD^-](UF_@M;9;U/M*LUI//:O'%=!1DF-B,-QS[CD4 /L/ WAC3)HYK+1
MK:&2*431L 248 @;<G@?,W XYZ5MW5K!>VLMK=0QS6\JE)(Y%#*ZGJ"#U%9G
MBR\N-/\ !VMWMK(8KFWL)Y8G !VNL;$'GW%8_A_QWIU^-(L9_MHN;V!?*NI;
M5DAN9 FYPCXP3P3Z''&: -&V\$^&[33[NQ@TF!;>\"K<+R3*HZ*23DJ/3.*T
MKK2;"]>S>XM(W:RD$MLV,&)@,97'3CC%9">.=&?518@W>QKDV:WGV9_LS3YQ
MY8DQC=GCTSQG-.M_&NDW>O2Z-;+>37<$[03^7;,4@*J&R[=%4YP">I!]* ,?
MPM\/--M=+MGUO2K674X;J>8/G<.9G="<<,0&&,@XKL(=-LX-1N=0BMT2[N51
M)I1]YPF=H/TR?SK%TWQSHVJZC!:6_P!K5;IG6TN9;9T@N2N21&Y&&X!/N <9
MJAIWB[2K'3-?U*\UJZNK6RU9[69YX GV9BRH(UP!E 6'S'/4\T ; \(>'QK?
M]L?V3;?;_,\WS=O_ "TZ;\=-W^UC/O21^#O#T6LG5TTFW6^\PR^: >)#U<+T
M#>^,TS2?&&FZOJ[Z7'%?6UV(?M$:7EJ\/G19 WIN'(R1[\]*U-4U*WT?2KO4
MKQF6VM8FFE*KDA5&3@=^!0!G6G@[P]8:L=4M=)MXKW<SB10?E9OO%1T4G)R0
M!U-+#X0\/V^LG5X=)MDOR[2>:%Z.>K = Q[D#)JII_CO1M2U2UL8A>1F]#&S
MGGM7CAN<#)\MR,-QS[CIFBP\=Z)J5[/;VS73+;>;]IN#;L(;<QDA@[]%/RD@
M>G/<4 6K?P=X>M=8.K0:3;I?;VD$@!X=NK!>@8Y/(&>:U+^PM=3L9K&^@2XM
M9T*212#*L#V-8&F^/-'U.\M;=([^ 7H)LIKFT>*.ZP-WR,PYR.0#C(Z5=M/%
M6DWOA:3Q'%.PTV..21W="K*(R0P*]005/% $NF^&]'T=H'L+".!H(6MXF!)*
MQLV\KDGH6YHG\-:-<V-W93Z=!);7<YN)XV7(>4X)?V;@<CTK*LO$%G?^-+6"
M'5+Q6N-'6]33G@"Q^6S\2EB-P?G&W/X5A>(OB-;SZ3;OHDE[%YVHV\$-X]HR
MPW"F95D$;L,'Y=WU )'2@#N-(T73="M#:Z79QVT+.78)U9CU9B>2>G)]*@UG
MPQHOB$Q-JNGQ7+0@B-VR&4'J,@@X/<=*HZAXYT;3=1GM)_M;+;.L=U=16SO!
M;,V,"1P,+U&?3(SBGZCXSTK3=6ETV1;R::"-9;I[:V>5+5&Z&1E'RY )^@ST
MH TXM'TZ"XM9X;*&.2TA-O;E%QY49QE5 X ^5?RJ&X\.:/=66H6<^GP26^H2
M>;=QL,B5\ ;C[_*OY"LWX>:G>:SX T;4=0G,]W/!NDD( +'<1G XKF?B!XMU
M*S\7:!X>T^75+**Z:9KJ>SL?.DD58PRK%N5@W)^; .* .VM/#.C6-Q9W%MI\
M4<UE$T-O)R6C1CD@$GOFK5GI5AI]G):6MI%%;R.[O$!E69R2Q(/J2:P;OQWI
M&F2S6TBZE=&RC5KV>"R>1;;*Y_>E1@'') Z>@J;5/'6B:5<6MN[W%S/=VWVJ
MUCLX&F:=,@?(%ZGG/T!/:@"WH_A/0= N)+C2M,@M9I%V%T!)"YSM&?NKGL,"
MK&L:%I>OVT=OJEG'<QQN)$#9!1NF01@C@FKZ-OC5P"-P!PPP1]:Y>[^(.AV=
MU<QR?;7MK2;R+F^CM7:V@DR 5:0# P2 >P[XH 9KG@ZS&BWL>B:+I+3W A26
MWND(AGCCP IV_=.T8#8."!6?X8\'2PZU>:C?:/8Z7:26'V"/3[>;SMRLQ:1Y
M'P,D\#OP*V]1\:Z3INM?V.ZW=QJ!2.006MNTK%') ;Y?X1M.3T''J*Z*@"B^
MBZ;)H@T:2RA?31"L MF7*;   N#Z8'Y56L/"VA:9875C::9;I;78Q<(R[_.&
M,88MDL,<<UQ_A#XCVS^&M*;6I+Z6XGE,$U^+1O(25I"J*S@;0<;1[9&:Z/5/
M'&CZ3J$]I<?:W%KM^USPVSR16NX9'F.!A>"#[ Y.* +%CX.\/:=97EI::5!'
M!>Q^5<KRQD3!&TDG.,$\=!FK[:38/+8R-:QE[#/V4X_U65VG'_ 3BLJ_\;:3
M8:X=&*W=QJ&(V\BVMVE.Q\X?C^$8Y/0<>HII\<Z,NJFQS=[!<_8S>"V?[,)\
MX\LR8QNSQZ9XSF@#5?1-,D;4&DL87_M$ 7@=<B<!=H# ]?EXJE9^#?#VGV-Y
M96VE0);WJ>7<KRQE3&-I).<8)XSQFLZ'Q+866L^+I+C5KN>/28H9KFU: !+1
M?+9OW9 R^X DY)P15BP\<Z/J.K6NGQ+>H;U6-G/-:ND-SM&X^6Y&&XY]".F:
M -J72[*>6REEMD9[)BULQ_Y9$J5R/^ DBJUAX=TC2]2O-1L;"*WN[QBUQ(F1
MYA)R21TR3R?6K]T[1VDSJ<,L;$'T.*X'P;\1;.Z\.Z -5DO7N;R..%[]K1A;
MO<,/N>8!MW9XXXSQUH [#6?#ND>($A75+&*Y,))B9LAD)ZX88(SWYYIDGAG1
M)?#_ /8+Z9;_ -E8 ^RA,)PVX<#W&?K5&]\<Z-8:E-9S&[9+>58;F[CMG:WM
MY&QA7D P#\RY],C.*Y/Q%XNU.;XH6?AVUGUBRL(K0SS?9-/$DD[^9M'+*W[K
M'\0XZ\^@!ZA6%-X-\.SW=_=2Z3;M-J";+IL']Z,@\C..JCGVJE<_$+0K6ZN$
M?[:UK;3_ &>XOTM7:VADS@JT@&!@D GH#U-6+_QKI.GZZ=%9;R?40(V\BVMF
ME.U\X;C^$8.3T''J* -F;3[2XOK6]F@1[FTW^1(>L>X8;'U K-M/"'A^PU<Z
MK:Z3;17I9F$JK]UF^\5'12>Y &<U6'CG1CJHL0;O8;G[&+S[,_V8SYQY?F8Q
MNSQZ9XSFNDH YWQUH]WK_@Z]TRQ5&N)FB*AVV@[948\_135G3/">@Z/>37>G
MZ7;P3S)Y;NJY^3.=HS]U?88%<CXS^(UM!X7UE]&DO8[BW8P1:@+5C;F97 95
MD(VD]1Z$\ YKHGUBUA\?2:?+J]PLB:5]J:Q:)1"J"3!EWXSN[8SC'- $EOX$
M\+VB*L&BVT8699T(!RKKG:5.<@#<W XY/'-:EII.GV-E+96UI%';2L[R1 95
MBY);(/J2<UDZ3XVTC5[E88UO+?S86N()+NU>%)XEQET9@ 0 0?7!STIFE>.]
M&U?4+>S@%Y']K#-9S7%J\<5T%&3Y;$8;CGW'(H L6O@OPY96MM;6^DP)#:W0
MO($Y(CF  #C)X( %/U#PAX?U74UU&^TFVGNQMS(Z_>V_=W#HV.V0<4T>+](/
MA:/Q&)9/[-D955_+.[+2",?+U^\:@N_&^D66J2V,JWA6&9+>>[2U=K>&1L81
MY , _,OL,C.* +%_X.\/:GJG]I7NDV\UWE2TC _.5^[N'1L=L@UL3P17-O)!
M,@>*5"CJ>C*1@BN?;QOI":N; K>;5N19M=BU?[.LY./+,F,9R0/3/&:)/'.C
M1:JUBQNRB7(M)+P6SFV2<D 1F3& <D#T!."<T :K:+IKVEC:-9QF"P>-[6/'
M$3(,(1]!5.7PAX?GUH:Q+I-LU^'$GFE>KCHY'0L.Q(S6=KOCG3M/?5+&+[8]
MQ90DSW$%JTD-JY7*[W P.Q] .N*T?!U[<ZEX)T*^O)3+<W-A!++(0!N=D!)X
MXZF@#1MM-L[.ZN[JWMTCGO'#W#KUD8#:"?P %9UIX0\/V.KG5;;2;:*]+,XE
M5?NLWWBHZ*3W( )S3-7\7:?I&HC3C!?7M[Y7G/!8VS3-''G 9L= 2#CN<=*K
MW7C[P]::;IFH&[DEMM3WBT:&%G,C*I)7:!G=QC&,YXZT 78_">@176H7*:5;
M>;J(87F5RLP/7<IXY[\<TNC>%M#\/RR2Z7IT-M+(H1Y!EF*CHN220/;I6A8W
M:W]A!=K#/")D#B.>,I(N>S*>0?:N>U/Q_HVEWNH6;QW]Q<:=M-VEK:/+Y*E
M^]B!@+@CGZ^AH Z&^L;74[&:RO8$GMIT*21.,AE/8U2N/#>C7>G6.GW&G026
MEBR/:PLORQ%!A2/H.*S;7Q]H=[J-E:P-=-%?-LM;PVSBWF?!.Q9",$X!_$$=
M:?)XYT:/56L2;LHER+1[P6SFV2<G'EF3& V2!Z9.,YH UY])L+G5;74YK6-[
MZT5U@F(^:,,,,!]16>_@WP[)=7URVDVYEO\ 'VHX.)2&#9(SC.54Y]JI7_Q
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M5[:WBM+6*V@0)#"@CC0=%4# 'Y5A6?AF<>*'U[5=3:_FB1XK&(0"*.UC<Y;
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MQ'YNAW$0>/47P@#1KC<-RX&]3_#R.*]5HP,YQS0 5XXFKV.D_#?Q#X1O6/\
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MMP760?N]WE\!R^[&,\]JZSPI:27$WQ"BB&R>?59HT<\=84 Y^IKT' SG'-%
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M%Y)&3V[U<U_PO<W_ ('\,12Z7]NETEK>6YT\L TJB(QNH)(&X;LCD [<9YH
ML7OC^YTC2-6EU/1PNI:7-;)-;6]QYBR).X5'1BH)ZMP0.5Q[U;MO%]_;:^^F
M>(=*ATY6L9+Z&:&Z\X;(R ZO\JX8!@>,CWKF[KPPUUX5U1-%\('2&GO+(QQO
M(HFG2.9'9G4,0H'S8&XD\\#BM_Q+X>N]:\76C+&19/H]]9RSY&(VE\L+QUZ
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M+(N6 )&U3C.<,:U1X;F;2]&;3?# TA$\0P7DEL)%+B%01YDF"0&Z?*"<#'X
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M6ZO_ &KID6K>'QI]EJDKPVKFYW3(X5G ECV@+N5#T8XZ&JNC:AXMDLM-T5=
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M@G&<C% 'I]%>:76O^*KS1O%'B/3M1MX;;2YKJ&VL&M@PD6 $,[/G.XD,0.G
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M>"UFP+C[4+;[5)]G$V<^8(=VS=GGIUK:U35;#1-/DU#4[J.UM(R \LAPJY(
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M"PFA=%R8?FB09!ZD%<UNOX0U37]6N+SQ/<6)B_LZ;3X(;$/@"7'F2$OT;
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MX'(Q0!P<=I/'\)T\6MJ>I/K%M=EH)C>2;407>S9LSM*E<YR"3GT %=/!I_\
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MDC:JEFV\;FR<&N5\(^ 3?^#[:#5;S5K:VENIIKK2FVI',1<.5W!EW@$!20"
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M6(R2IJEW)=W"S$$;G4*RC 'RX4<'/UK/T?P7#H]W:.NL:K<VEBI6RLIYE,4
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M+=Z?>07=L^=LL$@=3CKR.*LUQ?@:*.WUSQG;PHL<*ZQN6-1A06@B)P/<UVE
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M,\-M>)=MHMFTZPB .T8/R!=@&.APO&>N.*=_PB'AX2Z=+_9-MYFF@"S?;S"
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M('G?;U(49P/<UR-A;>/M:TN+5SX@LM,FN(Q-#IHL!+'&I&55W)W$XQDC&#G
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M@MF;! =^W#*3C.,C.*HCQZP\:ZMHATC4)(+&V23S(;5F9F.\GOC:0J[?4YH
MV]2\)>']8DMI-1TBUN7MD\N)I$R53^[[K['BG3^%]"NM)&ES:7;/8B0S+"4^
M57)+%AZ'))R/4USWA[XC6^H^#+77=1LKJ"2XD$,4,5NQ-Q(Q.U8AR7X')Z<&
MM)O'>C1:#>:O<_:;:*RG2WNX9X2DL#LRA0RGM\ZG/3!S0!I1>&]%@L+6PBTR
MV2UM)EN((E0 )(#D./\ :R<YIFL>%]#\0212:MIEO=R1 JCR+R >HR.WMTJ;
M1=9AUVQ-Y!;7D$6\JGVJ!HFD& 0Z@\E3G@UHT 9-YX8T._EL);K2[61]/Q]D
M.P#R<8P%QT' XZ<55_X0;PO_ *5_Q(K+_2F#R_N^IW;N/3YAGC'-=!10!1&C
M::ME>68LH1;7K2/<Q[?EE+_?+>N>]4]2\)>']8-J=0TBUN3:IY<)D3.U/[ON
MOL>*VJ* ,H^&M%:UM[4Z9;>1;W/VN&/9\J39+;P.QRQ/XU<BTZS@N;NXBMXT
MFNRIN' YD(7:,^N  *LT4 <9XF\+--:Z5;:;X?T;4=.L=R_8+LF(H"!M,4@#
M;<<Y!'(^E'A[P/;IH-]:>(+&PF-_?->O:PKF&W^551$. ?E5 ,@#O79T4 4M
M+TC3]$LA9Z99Q6MN&+;(EP"QZD^I]S4LUA:7%Y;7DUNCW%KN\B1AS'N&&Q]1
MQ5BB@"DVCZ;(U\SV,#F_ 6[W(")@%V@,#UXXJMH_AC1/#[ROI.F6]H\H"N\:
M_,0.@R><#TZ5K44 9FD^'M(T$W)TK3X+/[2^^80K@,>>WXG\ZDU;1=-UVT%K
MJEE#=0A@ZK(N=K#H0>H/N*OT4 9=OX;T6TCL8[?3+:-+!F>U54 $3,,%A[G)
MYZ\FLOQIX637/#^LK86L U>]L3:+.WREESD*Q],UU%% &+I?A30])O3J%GI5
MK!?.FUYHTP>>3CTR>3C&:OVFEV%A9-96MI#%:N79H57Y26)+9'N2<_6K=% &
M+IOA#P]I N18:/9P"Y0Q3!8P=Z?W.?X?]GI3;#P;X;TR&ZAL]%LXX[J/RIU\
MO<'3^Z<Y^7VZ5N44 8ECX0\/:;97=G9Z1:Q07B>7<(%SYJ8(VL3R1@GCWK+\
M5:#J6IZ)%X5TBSLK;1YX5@N+EY/F@A! *1Q[>3M& 21BNOHH BM;:&SM(;6W
M01P0HL<:#HJ@8 _(5!J.E6&KPQPZA:Q7,<4JS(LBY"NO1A[BKE% %>&PM+>]
MN;R*W1+FZV^?(!\TFT87/T!K.N?">@7FCP:3<:3:R6$!W0PE.(SSRO<'D]/6
MMFB@#)?PQH<FAIHK:5:'34P4MO+&Q3G.0.QSSGK26_A;0K71Y](@TJV2PN,F
M: )Q*3U+=V/ Y/I6O10!R_BGPT=>O_#P-O!-8V=V[W44N"#&873&#UY8<5J:
M9X<T;1[*>SL--MX+>X),R!,B7(P=V?O<<<UJ44 8^D>%-!T"XDGTK2K:UF==
MADC3YMO7:#V'L.*L1Z'I<.COI$=A -.<.K6VP;"')+9'N23^-:%% &)9>$/#
MVG/;/::1:PO:L[0NJ?,I< -SU.0 .?0>E1Q^"?#,.ES:9'HEFME-()7A"?+O
M'1AZ$=L8Q6_10!D+X7T)-"?1!I5K_9CG+VWEC:QSG)]3GG/6G:5X9T31)!)I
MFF6]K((S'OC3#%2<D$]3SZUJT4 07ME;:C936=Y D]M,I22)QE64]0:ACTC3
MXIK.6.TB62RA,%LP7F*,@ JOH,*OY5=HH KVUA:6<US-;VZ1274GFSLHP9'P
M%R??  _"K%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %>(7=S ?!?CW16)_M :])<FV*'<8FN8MK].0<U[?10!Q^N(Q
M^*'A%PI*BUU $@<#B'%<'X4CTN+X86G]MRW^GHFM7#PZA:@JUG)E]KL<'"D$
MKD@CYL'K7ME% '*^ M4OM4TJ\:[O3J,$%VT5IJ!A\HW4053OP  <,67(&#MS
M6)#JD'@+QEK_ /;8EM])U>=+VUO_ "V:(2; KQN0#M.5!&>"*]%HH \_L[Q/
M&OQ"TO6-,CE;1M%MYP+UXV1;B:8*NU-P!8*H))Z9-8OAB*1?AE\0E,;AFOM4
M*@CDY3C%>M44 >.M:O#X.^'&I7-]>Z;8V=KY=S=VJC?;F2 !6;<K +D;22.-
MW:FZC9:?/HMO>Z;>ZIJD=YXGL#+=7R+B?854LFU5RF %SCDJ:]DHH *\E\'>
M+M#\,ZQXRMM8O3:S2^(+F6-6AD;<AV@$%5(Z@UZU10!Y?XIU33M8U;PYXBMM
M;O;/1H1=6LVHVB;3#(PC*[MZ'"G81G'7'/-9>J1:=9>%]/UFSO-4O+$^*K:]
MNKV^C&65<(TJ[57]W\HYQS7LE% 'EUS>VUS\0];ACN AUW0(4TV0J0LY/F?=
M./\ :!JEX1BTJ^?PQ8S:]K]SJ=@4=M+=(PEE)'&5;S/W8*J.5'S<Y'7K7KU%
M '$_"^(Q>'M2S&49M8O6.1C/[T\_EBH?&6KM:^*=.L;[6+O1])DM))1/:(/,
MGG#*!$&VL1\I)V@9/X5WE% 'B>@_O4\%VCI/]HL_$5\+B.=?WD3$S.N_MG!4
MY]ZW/$0@TKXAZC>ZKXAU+1+2]L;?[/<6H39*T9D#1DM&WS#<" ,9W'K7J%%
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M,%B<JBY.%E1B<>P!/X5!IU]::Q\5+?4["47%G+X><1SJIP?]) /7W'Z5W=%
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MU\QOG:10KG.>,@#I52?P;HT]YI=WY4\4^F1+!;O#<R1GRQC"-@C>ORCALYH
MXOPUI,/AG7M'AU;1(/M4TTL=IXAL9@?MK,COB<<-EE!/.X9 P17=^+/^1-US
M_L'S_P#HMJJ:;X'T/2=0AN[6*YS;EC;0RW<DD-L6!!\N-F*IP2.!P#@8K1\1
M6TU[X9U:UMTWSSV<T<: @;F9" .?<T >8+HFF:1X6^'^MZ;!&FJS7NGI)>)_
MK;A95 D5FZL"I/!Z <8Q5;4UBE\GQ'INA6L$<OB&+R]7N+S-Y*WVD1L%4)_J
MR RA2_W>U=QX8\!Z9I]CHEW<V]P+ZSMHR+>2Z=X8)B@#LD>XHK9+<@=R15B;
MX=>&Y_M*R6UR8YY#,(OM<H2&0OO+Q+NQ&Q89RN#U[$T <E>ZI-X%N_%^BVP/
MF7ZB_P!&0=Y9V$3(/I*5;'HU.G\-Z?;W>G^&;;P]9ZU-I.D()FU*Z\JVA$C-
MEP-CGS&9&)( P.];D^AW?B/QWI5]?:0]IIWA\RFWGN)5>2[E.%4@*20@"[LM
M@DXXZUNZKX1TC6=334+N*?SQ$(7\JX>-9HP20DBJ0'7)/!SU- 'F.@VEMXAN
M?AO#JX6[B;2+O=%*=RS;3'M5@?O 8!P?[HJCXQMXM,\"_$S1[%!%IEI?6;6\
M*?<B:3R6D51V&XYP.F:]._X5WX<$=LJ6URAM/-^RNEY*K6_F$%O+8-E>5&,=
M.1W.9V\"^'W\-7?A^2TDDL+R3SKG?.[232;@VYI"=Q.5'.>V* .,U6SNM<\>
M:C:R^'+'78+33+5(8KV[\I81)O+.@*-EB5QN&"-HKNO!]MJ%GX0TRVU25);R
M&$1O(DOF!@#A3N_B^7'-)J_A'2=:N(KBX6ZBN(XO(\ZTNI(':+.=C%&!9<]C
M6M965MIUC!96<*0VT"".*-!@*H& !0!RMM_R6341ZZ%;_P#H^6N$LK2WU6S\
M,VTW[RVG\4Z@'"MPZ?OR0<=5(X([@FO4-8\):3KFHPZA=+=1W<49A\ZUNI(&
M>,G)1BC#<N><&DM/!^AV$=C':V7E1V-U)=VZ+(V(Y'#!B!GI\[<=!VH \S\2
MV\/AY?B!8:/&NGV3V^F$Q6P\M(_-D,<K*!PN4ZX]*V]8T+2O#?Q#\)G0[&"S
MD:WO_P!Q @59"D(VL5'4\XSU/X5W%SX9TB\GU.6YLUE;4X$M[L.Q(DC3=M&,
M\8W'D8-4=-\"Z'I>HVNH11W4UY:AEAGN;N69D4J5V@LQ^7!.!T[T >>^$-&U
M:ZL/"FLVVA:=;7#317-SJ_\ :&9[M) ?-#KL!8L"3M+'!48Z5O?#+0]/:?7-
M9EMUDU!-;OHHIGY,4?F'*KZ DL3ZY^E=+9^!M"L-3COH+><&&1IH+=KF1H()
M&SEDB+;5/)Z#C)QBM32M'L=%AN(K"(QI<7$ES("Y;,CG+'GID]J .<^*UK!<
M_#'7O/ACE\JV:2/>H.UQT8>A'K6#+X:T:;QKX2TQM.MQIZZ1<RFT6,")SNB/
MS*.",G=@]P#7HVI:=:ZMIMSI]]")K6YC,4L9)&Y2,$9'(K-TSPGI6DSV4\"W
M,DUG#)!!)<7,DK*CE2RY8G(^5<>F.* /(_%=O%8?"SQ_IUK&(K.UUY%@A7A8
ME+6[%5'898G'O75^,=#_ .)Q?ZU>:#:^(=--E''+&)@MUIX0,S-$&XY!W<%6
MR*ZZ_P#!>A:EINJ:?=6C/;:I<"ZNT$KC?(-N#D'(^XO XXINK>"M%UF]DN[E
M+M))HQ%<+;W<L*W"#HLBHP#C!(Y[<4 ;&GSPW.FVMQ;NSP2PH\;N22RD @G/
M.<5Q_@ETA\8^-[2X(&H'44GP?O- T2B,CU PP]J[>*-(8DBB14C10JJHP% Z
M 5B:YX/T;Q!=0WEY!*E["NR.[M9W@F5?[N]""1['B@#GM>@MM4^+>A60BCG$
M>EWG]H1LH93 ^Q45QW!;/!]ZX?P]X9T&;X5^-KR31K![JWGU)89FMU+QA%)0
M*<9 ! QZ5Z_H7AC2?#B3#3;8I+<,&GGED:664CH6=B6/Y\4RU\*:/9Z+J.D0
M6S+9:BTSW,?F,=YE&'YSD9]NE 'ET&EQ0^&?AW8Z=H-C=1:E +F\M'<01WDJ
M6P93(P4[L99L$')6EUS1=0L?#+65U:P:9:7'B6R:UM+.Z\T6H8J'"L%7;\V6
M  &-U>GW/A/1[K0K+1G@D6UL @M#',Z20%!M4JX.X$#C.:BC\%Z''IL=C]FD
M>-+Q+XO).[R23J00[N3N8\#J>V.E &II>DV&B6"6.F6D5K:IDK%$N%!/)KC-
M=_Y+9X3_ .O"\_D*[^L#7O!NC>)+ZUO=1BN/M-JC)#+!=20LJMU&48=<4 0_
M$*\NM/\ A[KMU9.T=PEH^UU."F>"P/8@$G-<CI_A2XAU6 _\(OI&DZ6^GSV]
MY#!>"<7B;04+)Y:[BK#[QR?F-=CIO@C1=+DG:);V99X6@ECN[Z:=&1L9&UV(
M[>GK3]'\&Z-HEU]IM8[F258C!$;JZDG\F(XRB!V.U>!P/04 >2VOAW19/AC\
M/)GTFR:6YUBT6=S N90[,'#''((50<]<"MK4=&GUCQ3XILX_#&G:C#9I!9VC
MW%X(#8Q>0K#REV-M^9B=P(Z8[5VB?#KP['HC:.D-V+(3K<1)]LES;NI)4Q'=
ME,$GICK4U_X$T/471YUO0X@6VE:.]F0W,2]%E(8&3J>6R>3S0!QEOH":U\2=
M*L_$L<5]+#X5A>X0MOCEF$Q7<?[PR6(SW(/85ZQ6;#H.FV^L)JL-L([M+,6*
M%6(580VX*%Z=?:M*@#Q5EB>?0O$.G:%:VD-YXAB\O59KS=>W DF96!4)]PKN
M&TOPH'%68?\ C_\ C+_U[+_Z325VI^''AMDD0V]UL,GFQ(+R4+;/O#YA&[]V
M=PSE<?E6BGA/1D?6W%LV[6T"7Y,K'S0$*>OR_*3TQ0!3^''_ "3;PY_V#X?_
M $$5ROQ T/2;WXG>!S=:;:3F\FNDN?,A5O.58@5#9'S =L]*]&TS3;71]+M=
M-LHS':VL:Q1(6+;5 P!D\FH+_0M/U+5=-U.ZA+W>FL[VKAR-A==K< X/'K0!
MY1<:+?ZW+XL-MX=TZ>X@O9+6TU*:^$,E@(D7RO+78=BKPW!&<G-;VD:-9>(_
M%_BN7Q);07-W9+:V\;/S]F7R Y:,_P &79CN&#Q[5U.I^!]"U;49KVZ@GW7&
MW[3%%<R1Q7.WA?-16"O@ #D=.#3M2\%Z)JNJ'4;B&=)WC6*<07,D27"+T615
M(#@9/![<=* /)_#D=UJ6E^"-.&CVNM6J:3<W*V=Y.(HGD\Y5WG*L&*JW (XW
MDUHWV@72V?A/1M6BBAMW\13)';07)E6.V:.0^3OP#@99,>G%>B2>!]";2;#3
MHX)[>/3RQM);>YDCEAW9W!9%(;!SR,X_*IX?"&B6\&FPQ6A5--N#<VY\UB1*
M0=SL2<N3N;.[/6@#D==T?2KGQ$NC6'A:PU$:;IHW1WUSY-I:1R.V-BA'^<[&
M^8 8 '-<Y:7$MTOP=FGD:20F8%V.2<1@#GOP*]1U3PCI&L:HFHW<4_GB(0R>
M5</&LT8)(215(#KDG@YZGM4-MX&T&T?3&BM9?^)7-)-9!KB1A"S_ '@ 3]WT
M'0=J .BKE?'6C7.M:?81VT-E=M;WBW#:?>OMBO%5&!0G!Z9##((RHS6GH^B#
M2]2UJ[!7_B8W8N H).,1HG.>Y*D\<<BI-:T&PU^WBBO5E!AD\V&6"9HI(GP1
MN5U((."1^- 'E&KV&A7^DZ!;#P\MA);^+(;6ZT^X"RK 9 &>-",CRV&QL# /
MI5KQG8V-X/%;V'ARRN!I5BMN]]>W7EBS*0[U6V0(Q4J&4]5R<"N\E\"Z#-H?
M]DO!.8?M(O#*;F3SS..DOF[MV[CKGIQ39? /A^XNGGG@N9?-C2.>-[N4QS[%
MVJTB[L.P 'S-D\ ]>: .0L-.LKSXJV&H3Z?;7%ZWA>*]\QX@6:X$B@29_O8
M&>N*R_".D:O?:9X7UJWT+3K>[>ZBNKG63?YN+E7)\Y778"<@M\I8X('I7HT?
M@?18KK2[J-;Q+C3(A#!*MY*&,8;<$<[OG7(Z-D=NE%KX&T*SU1+^&WG!BF:>
M&W:YD:WBE;.72(ML4\GH.,\4 ='161H>B#1[C6)5*XU"_:\V@D[<HBGKZE"?
M09Q6O0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK?VI!]@N)A!'.<X\PG&T\94Y'.<8[U<TG5['7=.CU#39_.M9"0DFQES@X/#
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M;ZG!I%M&EU ES+ KQ1R,B;%P2 "55P#GU'>@#IY/%^@1Z"FMMJ47]GN_EK*
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MAM1G@1Y9%,F#$A<X &T,1SG*\4 =!=>,/#]E:65W/JD"P7T;26KC+"91C.W
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M@X/0C-<EX0U+3+;5OA]->W,"*GA^:)99' 6.7=&,$GA3C*\^N.]9_C*2.Z\
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MO[S,0 .H.,YP<XKH3TKQ;3;1A^S/:"U C^5)YF$>_P"070:1B/X@%!)'H,4
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M.-+6X3".)_OLV[8/E'7.>0*UHO'UO/HD%W%IEXVHSWKZ>NFY3S1<)NWJ6SM
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M_2[F]N9KF=WGW2S2%V.)G R3ST%;OB+Q1%X=N-,MVLKF[FU&9H(([<#)<(6
MY('.,9)P.IP* -!=*MK6QN;?3(H=.>96Q);0HI5R,!\8P2.O(KE-,\':N=6T
MNYUB[THV^F2-/&FGV9A:YF*%!)+S@$!B<#N?PJW#X^M8;#6YM8T^ZTVXT;RS
M<VS%9682#]WL*DAMQX'O3[;QC='48].U'P]>V%[=0236,4DT3"Y*#)CW*V%?
M!'!X]^* -]])TV2XEN'T^T:>9=DDC0J6=?0G&2*G%M +G[2((_M&SR_-V#=M
MSG;GKC/:N5^'7B74_%/APZAJ5@UN3-*(Y=Z%9%$LBX 4Y&T*%)(&3R,U%\1=
M5GTA/#-Q";D[M;AC>&V)W3@QRXCQD Y..#QG&: .GCT?3(HS''IUHB&03%5@
M4 N.C=/O>_6G'2M.9YW:PM2]P,3,85S+_O<<_C7.P^/+>#^UH];TVYTFZTRV
M%W)#*R2^9"<@,A0D$Y&W'KBK>C^*9;[5ETS4=&N]*NY;<W-NEPZ.)8P0&Y0G
M# LN5/K0!LW6G6-];K;W=G;W$"X*QRQ*ZC'3 (Q3_LMOY<4?V>+9"08EV#"$
M# *^GX5'J6HVVD:7=:C>R>7:VL32ROC.%49/UKG;#QM)-J&FV^IZ#?:7%JF1
M8SSO&P=MI8*X5B48J"0#Z$=: .I$,0G,XB03,H0R;1N*CD#/IR:;<6T%Y T%
MS!'/"_#1RH&5OJ#Q7F'AGQW=:5X6GN[[2]2O;"TO[E+S4?,4B$?:'QA6;>ZJ
MI7.!@#CL<:UO?W+_ !VNK,7<S67_  CRS+!YA\O=YP&X+TSCO0!VJ:=8QV7V
M)+.W6TQCR!$HCQU^[C%6:\\\.>---M?A_I-_I]IJMX;^Z>UL[6XG$MQ+)O?(
M+L<!1M8Y)P *U;7QY#+=ZM9W>D:A:W>E6BW5S 561CDMA4VDAR0H((X^8="#
M@ ZI8(5G>=8D$S@!I HW,!T!/>J[Z3ILMS)<R:?://*NR25H5+.O3!.,D>U<
M[#XTNR]Y:W7AV\M-1ALC?0VLDT1\^(':<,&PI!(R#ZCK6;X>\>:A<>#-%O=0
MTBXGU;4R([6"%XQ]J.TLT@^;"( #G=@C'3F@#N_LMO\ :%N/(B\]4V+)L&X+
MZ ]<>U,6PLTB\M;2 1^9YNT1@#?G.[&.N>]<S)X^MH='EN)M,NTU*.^73CIF
M4,IN& *J&SM*E2&W9QC\JHZ-K=_J/Q4N+6[M;O3_ "M%5GLY90Z;S,<.I4E6
MR"!GKP1VH [::V20O(H$=P8S&LZH"Z ^A(]<''3BN*LO!FLRZAIAUB^TM[73
M[D7>ZRLC#+>3*K*CR\[1C<20!R?2N@\8:O=:#X1U35+*V-Q/:VSRJH91MPI.
MXY/('4CJ<<5C6WC:[31M#6?1+J;6]4BW0V<<D0+JJ!FE+;MJ)R.O/(&* .PC
M@AA:1HHD0R-O<JH&YO4^IXJ2L7P]XBCUX7D3VD]E?6,WDW5I.5+1L0&!!4D,
MI!!!'6MJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "O/]$\+#5_#_ (NTG5K:>"*]UN[EA=D*L 64I*F?0@$'VKT"B@#Q
M:S\/^*M?T[Q_9:K8RQ:G/96EM%.Z%8KQX?,^=&/!#84GT+=JZ>ZOKGQEK7AB
M*WT?4[-=/O1?WLEY:/"L)6-U$8+ !R6?^'(P,UZ%10!Y)::5?7?@OQ?X?.G7
MT.IQ:A=7]H[VS".1A+YL1C?&&)(' .:CN+77[?PQ%XQMM'O3KLFJW%XUB(6,
MRQ21M J%<9X586_"O7Z* /+=1\+7FF2?#2QM;2>=-,N/]+EBC+*AV#<[$= 6
MSR:KZE;7\:?$K2O[*U%Y]21Y[-X[5WCF7R%7 <#&[(QMZUZU10!Q>L6%Y)JO
M@62*TF=;6X=IRJ'$0^S.OS'^'D@<]S6'H,3P>*=-.@Z9KVDK)-(=6TZYC?[%
M$I1B2A;Y-WF;<>6<$$\8KU"B@#QO3SJUCX)31FT_7;;[)K3G4S:V\JN]J\LC
M9B=1EARF=G.":K7NDW1T[QG:Z?H.LQPZC#8S6*SQS2O*L<F'RS;BK=]A.=O.
M!SCVVB@#C/%6E7>I>,_#QAAE, L]0BEG5"4B+QH%W'MGG'KBN/>XU2Y^'_A_
MPROAW5EU#3KFRCO-UHXCC6*5 75\8<' /RYXR3@"O8Z* /*[W1]3?Q3\4)ET
M^Z,5]I$4=JXA;$[BW92J''S'/&!WK8U+3KV33/A^B6<[-:7UL]PHC),*BWD4
MEO[H!('/<UWE% 'B>L7%]H?PBU_PO<:-?_:K<W(^TM 1;O"TK2"02_=/RM]W
M[V>W<>SVW%K%_N#^5<O=?#W3;RYN/-O]4_L^YN/M,^F"Y_T:1\ACD8W8)&2H
M8#VKK: /(?%UA?ZM-XMLKO3M=O=1E5DTE('F2T6#R1\V5(C+;M^0V23@8KI/
M"4-S+XQO]1>RNX+:?2+%$:X@:/+*9=RX8#D9&1[BNZJ 7EJUZUD+F$W:IYC0
M"0;PF<;BO7&>] 'EQT6^MOA"EXUO);:IHE_<:K LRE#\EQ(Y!SV:,M]=PKK/
MA[:2_P!@2ZU=QE+W6[A]0E5NJ*_^K3_@,80?G6CXA\,VWB5(8+Z\O5LD/[ZT
MAE"1W(R#B3C)''0$=3FMI5"J%4 *!@ =!0!ROC_3[R[T>PN[&VDNI=,U*WOS
M;Q\O*D;?,JCNV"2!WQ643<>+/&<&IVFGWUO8V&F7,'FWEL]N99IBH"*K@$@!
M22<8R:[E;RU>\DLTN86NHU#O") 753T)7J!4] 'D?AZWO[CP[X LFTG4H9](
MU!4O%GM'01XAE&[)&"N2!NZ<BK7C#P[J6K:SXK-O97,B/9:=)"4RGGF&9Y'1
M'X^; ['()%>I44 >5C2M/O=+\13Z1HOB,W/]B7%NEQJ<ER69I%/[E(YB23E5
MY QG R:[[PK!+:^$-%MYHFBEBL($>-UP481J"".Q%:U% '"_$N>2U'A2XBMW
MN6CU^%O*C&68"*7.T=SC.!W-8FMPWOBBZ\6:O8Z7J,=L/#<FFVZW%J\4ES,Q
M=R$1@&(' Z<D\5Z'JVB6VLRZ;)</*IT^\6\B\L@9=590&R#QASZ=JTJ . UO
M3;^+PQX/OX+&>>31I[:XN+2-,R^6(C&^U>I9=V<=>#4EA ?%7CJZU=M.NX='
M32&T[-[;M UPTDFYL(P#;0H R0.3Q7=T4 >6^!M%UE_$5G!K-I<1VOA:UELK
M.:9"JW+N[*LB'N!"B#ZL:ATG2Y+;3O'"ZSX<OKVQN_$,DOD)$P=X2RXEC'!;
M! (V\\<5ZQ4 O+5KUK(7,)NE3S&@$@WA<XW%>N,]Z /'M=T_6-1^&GB_3]/@
MUV^T]C:C3(]0AD-RQ$BF4*&'F%!@8W#^]V%=2[S^&/&TFL7.GW]QI^H:7! 9
M+2V>=H9HBWRLB L 0_!QC(KOZK7NHV6FQ"6_O+>UC)VAYY50$^F2: /,M/T3
M5?.T34)M.N8C>>*;C4WA9"6MH7BD53)C[IX7/H6QUKJ],L[F/XFZ_>/;RK;2
MV%FD<Q0A'96EW 'H2,C/U%=4"& (((/(([TM '+_ !!TN\U7PE,FGPF>ZMYX
M+I( <&7RI%<J/<A3CWQ66MS-XK\=^'[^TTW4;6RTB.XEGFOK5[?+R($6-0X!
M8C))(XX'-=Y10!PWPPT^]T[2]=2]M)[9I=<NYHUFC*%T8KAAGJ#V-6_BA87>
MI_#C5[6QMI+FY98V6&)=S-MD1B .YP#Q7744 <5ISS:I\2;?6HK&^AL9-":(
M/<VSQ%7^T#Y2& P<#./3FN.\0:%J\_@_58(M,O))I/%[W*1K Q9HO-SY@&.5
MQWZ5[-10!YCXRBQK&H7&F:7K]EXD"*ME>:<CM!>D*-@E('E[0V5(?! &0<8K
MTR/?Y2>9CS-HW;>F>^*=4%O>6MVTRVUS#,T+F.41R!C&XZJV.A]C0!PMM/>>
M!/$6N)<:3J%[HVJ79OX+FPMS.T4KJ!(DB+\P&5!! (YJSHT5_P")/'2^)KC3
MKK3]-LK-K2RBO$\N:9W8%Y"G55PH !Y/6NS-S MTML9XQ<,A=8BXWE00"0.N
M 2.?>I: /)-%T75(?@?XCTZ33KM+Z8WWE6[0L)'W$[<+C)SV]:L:IH4BZ=X'
MO]0LM6:UL=--K>1Z>TR7$#/'%ABL1#D QD$#U''%>IT4 >57.AJ^C:'+I&B:
MM!')XIMKR9;QI)9F1?E,S[R6084?>Q@ 9QFO5:** /.O%TEUIOQ/\.ZT-)U.
M]LK>RN(Y6L;1YRK-C .T<5/KVI2>./"FM:'8:-K5K=2V;-$U_8O;H[ @A [<
M9)_KZ5WU% 'F_A_3=+O=72>RT7Q)'<P6DN;C5KBYV0.X"F-1*Q#$\Y*Y VCG
MD5@6J7Z_#/PC VBZL+C0=6M)+V V4F\*A;<R+C+@9'*YZU[/10!Y+J.FVL?B
M/6[_ %'2?$]Q%JRPW5DNGM<QA\PJC12+&0$<%?XP.#UXK>T;19=.^)-H\.G3
MVVG0>&(;2,METC99B?*\SH6 QW]Z[RB@#-L-8CO]4U.P6VN(GT^1$9Y% 63<
M@8%.>1SCZ@UA_%"PN]2^'.KVMC;27-RRQLL,2[F;;*C$ =S@'BNHBM8()IYH
MHE62=@\K#JY"A03^  _"IJ .*TYYM4^),&M16-]#8R:$T0>YMGB*O]HSM(8#
M!P,X].:Y.Y\.WFU]0O-/U1K6U\3WT\T=GYD<[02@JLL>PAF .T_+U&>M>PT4
M <GX(L;"!-1O+#3=5M$N9E7S=3EE:6X"+@/ME)91R0,XSC/I3O'NCZAJ>DV-
MWI,:S:CI-]%?P0,VT3;,AH\]LJS?CBNJHH X>7QQJ>HPQVFA>%]735)653_:
M=FT-O;C/S,[YPP S@*234$-Y/X0\6>))+O2M3N[?4Y8KNTEL;1YP[")4:,[0
M=ARO&[ P>M=_10!Y=X9\.:KI&H^ X[NSD#6UIJ+W3(I9('F9'",PX!Y(]]IQ
M5M-+OQX:^)47V*X\V]N;MK9/*.9PULB@H/XLD$#'>O1J* /*K'4G\/\ CZR>
MZT^]DC7PK:1S"WMVEDB82/U106QP0<#@XS52*SU2WLK>[U"RUJWTC5=:O;Z\
MM;%)1<(CC]PL@B^< D9('<C->G+HELGB637@\OVJ2S6S*Y&S8KLX.,9SECWK
M2H \:L=)OXX'LH]$U.W \76>H(DT<DF+8B/#&0YR1M.[D[3UKN)=.FF^*CW,
MMI(]@^@FW:5D)C+&?)0GIG'./2NMJO?6S7EE-;I<SVK2+M$T! =/=<@C/U!H
M \O\"Z7>OXO.D7@+V/@[SH+20G/F-,<QD^Z0_+[;J]78D(Q5=S8X&<9K,T#0
M+/P[I[6EF9I#)*TTT\[[Y9I&^\[MW)X_(5J4 >5:1 \6N6B^'M+U_2XI5F_M
M73;J.3['"#&Q_=EOEW>9MQY9P03P!4RZ1J(^$W@^Q^P7/VNWNM.::#RFWQA9
M5+%EQD8&2<]*]/HH \6\3V&H:G:>(H;G2_$%]K:WSO;;3,+5+17#)L (C<E!
MC;@L6/([CJ-+M+R;XPZIJXL;N.PN=$A6.:6!D4MN!V\@88#JO45W4UY:V]Q!
M;S7,,<UP2(8WD :0CD[0>3CVJ2::*W@DGGD2**-2[R.P554<DDGH* .)^#^G
MWNE_#+3+/4+2>TN4><O#/&4=<RN1D'GD$&K_ (GL[FX\6^#YX;>62&WO9WF=
M$)6,&WD +'L,D#GN:ZA'61%=&#(P!5E.01ZBG4 >7>)O#VJZEJ7C=K2RE=I(
M]+GM=R[5N&A9G9%8\$\8^I%:ANYO%OC;PY=VFF:E:VFD^?/<RWUH]O\ .\?E
MK&H8#<?F).,CCK7<0W,%SYGD3QR^4YCDV.&V..JG'0CTJ6@#AOA9]HL_"IT6
M]L+VUO+"XG$OGV[(C[YI&4HQ&'&".GJ*F^(<5ZR>&KFRT^XOC::W#<2QVZ;F
M$:QR[F_7C/<@=Z[.B@#R;Q!I=_XYOO$-_I^G7T$"Z-'96XNX7MGN91-YQ"A@
M& ^4+DXY:MGPI8Z3/XCAO+/1_$<<MM;/FYU>>XVQ,Q4&-5F8[B<9)7@;1SR*
M] HH Y_QQH]QK_@C6-*M,?:;BV98@3@,PY S[D8_&N;NKZZ\8ZCX7M;?1]3L
MSI]\E]?27EJ\*0[(V&P,P <EF ^7(QS7HE% 'C<<FIQ?#;5_"K>']5_M/4+B
M[BM?]$?RW669\.SXVH!DGYB. ",@BNBTW1[VT^,SW1M9S8IX;2V%T8SY;2"4
M?+NZ;L#..M=[]I@-T;7SX_M 02&+>-X0G&['7&01FI: /%/"VCZQHO@+P7J$
M^CW[2Z1J=Q)=6:P-YZQ2>:F\1]3C<IP.<&KFH:AK&I>)/&%WI%E?6MV=%M1;
M+Y>RX9/-DW,$/*OC?M!YX%>F:[H=MK]BEM<37,#1RK-#/;2^7)%(O1E/XG@@
MCFH-"\,VNA37ERMU=WM[>%?/N[R0/(X4$*O   &3@ #J: ."TJP1/&JW6F:1
MKB:?>:/<6:7-^+AV>?<C_-YI)C4@'!.T$@X[9S;+3IKGPCX.>]TG7HX]"WVN
MH0P1303KOCQOCV89U#!<[<\$^]>TT4 >37&CI#IUGKVCZ%K0CM-=AO)X[MY9
M;JZA6,QF0)(2XQOX4\D+TZ5NZ+<76K_%&XUA=*O[733HRV\4]U;-%YC"8L>&
M&1UZ'!XSC&*[RHI[F"U17N)XX59PBF1PH+$X &>Y/ % &1XSL[C4/ ^O6=I$
MTMQ/I\\<4:]68QD #ZFN*L[FXMKKPIXD_LC5C:6FG2:9>1&RD\Z!B(R'$>-S
M+E""0#7J-% ''^#K>ZN=?\2^(9K.XL[?4YH%MHKF,QR%(H]N]E/*Y). <' K
ML*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\OO_'/BI?!VI^,;&VTI]*A>5;:UDCD\XHCF,2LX8 _,"2H X[YZ^H5X
MAKT>J:;\+/$&@V=QI4^DP3S117D=R6F.Z8L+<Q;>)-S;2=W3M0!Z?I.NW5_X
MNUW298X1!I\-K)$R@[F,JN6W<X_A&, ?C7/6_C#6M0\':-JPN-$TPWCS"ZO+
MYB(80CLJA4+J69L?WN,&KDNE>(]*\8:CJFD6=E=V^JVMO$YN+@Q&VDB##<0%
M.]2&S@8/';K6)IO@O7M$L_#+_8M/U:?38+J"6WN)_+16EE#K*IVMS@8/&<-Q
M0!*_Q"UB7PWHMU86^FW-_>ZR^DNRLQ@<CS )$(.0I**W?@GK6IK6L^)-)CLH
M;K5O#.GN8&>:]O25CFEW<1QH9 P&,$L2>O2LJS\%>((UTV"Y%DPLO$C:JTT4
MA DC<2%L)CY2&< #)X[UL:OH6L#QK-J]A8Z?>QW5C':)+=R8-DRNY+!=IW [
MP< C)7J.M %"V\;:WK<OAF#2+:QA?6=-ENY'N59Q;LA0$@!AN'S$8XSD'(P:
MQ_$?B?Q-<^#-1B-Q96VH:?KD.GW$T$<@652\3*R#?E<[P&!)R,CC-;/A+PAK
M.DWWAU[Y+98])L+FR=HYBQDW.A1@,#&0IR.U1ZQX*UBZT7Q-%;?9C<WNLQ:E
M:(\A"NJ>5\K''RD^6WKVH EU3Q=JUOK,NC1ZMX=L;NQM8Y;F:_#(EQ*^XA(U
M,@*KA<EB6QN'%0O\19=4318M.O=)TF2^T[[?//JC;D3YM@C0!TW$L&YSP%Z<
MU8N]"UQ=<GUR/P]I%]-J5K$EQ:75R/\ 1IH]P#*YC.Y2K#(P#\O%/O\ PQJ=
MOJ6F:Q#I6D:I<1Z?]BO+-L019W;P\65; #%Q@]C0!O\ A#7SXE\.PZ@ZPK.)
M)()A ^^/?&Y0E#W4XR/8BN<\9>,=7\.7-_<"]T"VM+.-98;.[ES<WPQE]F'&
MSNJ_*V2*Z[0;6[M-&@BOH;*&Z^9I([%-L2DDD!<]<# SQDC.!TKAM9\&Z]=G
MQ98VMGIC)K;-(FJ3RDRQJ8E01;-I/!4@'=@!B<9&" :LVO\ B/4_%FHZ)HO]
MFV\-M:6]RMS=Q/(1YF_Y2JL,YVCG(Q@]<C%31_'FI78\*7-]:VL5EK#3V=PR
M!LQ7<;,% )/W7V. ",YQS6KX;T75+3Q)J&K:A#!"+NPLX!''+OVO%YF[G X^
M88-<YJV@G0?@O<VFJ7,-O>V,DM[;3*V0LPG:6+;W))*K^)% '6Z3KMWJOB_6
M[&*.$:7I@B@\W!WR7##>XSG&%4J,8SD]:J>)==UNT\5:)H6C166[4H;AWGND
M9A#Y>PAL*PR,,1CN2.1S5KP/I-QI/A:W%\,:E>,][>G'_+>4[V'X9"_116'X
MN;48_B7X4ETN*&>XCL[YC!-(8UE7]T"NX [3SD'!Z8[YH EM?%.OG3_$%E<1
M:9_;>D7$<33LYBM3'(%99FW-D *22N>JX!YK,/Q#U"W\/^*Y4N]&U2[T6WBN
M(;JR!,$HDW?*RAR004.<-W%.NO!NNZA::EJEW;6+ZE>ZK;7SZ:9R87A@ 586
M?;R2 3G&,XJ'4_!WB;4X?% -GIL US38H8XHISBV>-GPA.P;LA\EN,'(P>M
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M-K5IA\X9 IW -DC![X-6]&\'7&B^+-)NH71].L/#XTO<3AV<2(P./0A3WZT
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MG&&.];B9(DD)&.F(VQ_OFLQO &K2^&O'NG,]LLNN7\MS:'>2-K8*AN.#Q[T
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M,Z3Z+H]Q-#IH7[L<L^V2=0?]@_+_ ,"- '<^*=4GT/PGJVJVR1O/9VDL\:R
ME2RJ2 <$'''K7-0^)?$MC?>'KG6(M-_LW6Y5MQ%;HXEM9'C+H"Q8A\[2#P,'
MIFM?XA?\DX\2?]@V?_T UAV>D>(]<?PO'J=M90:=I+QWC7,5P7>Z=8BL>$VC
M9][)R3Z#/6@!MQXUU73_ !%:07MYH/EW.I+9?V5%+NO(D=BJ2%@Y!/W25V\
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M7VGVUS<6A+6\DT88Q$XY7/0\#\JT** "J\EA:S7T%]);QM=0*Z12D?,BMC<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51U'5[
M/2GLUO)#']LN%MH3M)!D8$J"1TS@CGOQ5ZL7Q9HI\0>&+W3XW\NY9!);2?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M91OO9(Y"2&+( A/7(/!/!J]?>)[S0;WQ(S66GS:I;V^FQ":*-HQ<33,Z#?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M31>^$=4NM?@UF/Q&T=U#:K;)OLHY O\ ?=03\I8]<=@!TKKJ* ,1+/6XK[2
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MO.=8FATI)C,=0L1;+$K0F,+G&)7)89921A3TSSZG10!RVD^$[[1UM+*V\07
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+ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>exhibit1013-zerondaxexec006.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M732U@T)=KWSE 5\X";/O'CG/2LJ_\8V-OI-OJ-HC7<,NI)IV0=F',WE,>1R
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M) QD@9Z4 +15-]4LTUF+26E_TV6![E(\'_5JRJ3GH.7'^15R@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/^$K\&6?[I];O+0V ']VZ^2;'L/*D/XUM:G96\'QG\+6"1+]FCT:XA$9&1L
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M1[?9X"5)'LTF\_@*SO%FBZ9?_%KP>UWI]M.TMO>>89(PV[8J%,YZ[221Z9-
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MM;R74CP6[-G<8XR=JGD]!QDXQ5JR\6:%J&FW>H0:C']FLP3<M*K1&$8S\RL
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MGW-$/AO2[?5=6U..!A=:JB)=OYC$.$7:N!G X/:M*>:.WMY)Y6VQQJ7<X)P
M,G@5PL?Q#L==\%ZGJMEJD6C-:3&-KFXMVF2-?.*(Q7"YW@= ?EW<]* -L>!M
M 70]*T86C_8=+N5NK1/.;*2*6().<GECP:Z":))X9(9!E'4JPSV(Q6/J7BS1
M-%E6WU'44CN#"LPC$;,SJ20"JJ"3RIX'/!JJOQ!\*.;/9K4#+>;1"ZJQ7+'
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MDB^5@DK#J$<C:YX/ )K,\/\ BFZN_%WC2RU&>&/3]&>#RG("[$:-F<LWX=:
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M2SQNC19Z;E8!AGMQS0!2N_ ]C_8<FGV9E\R:\@NIKFYN'DED9'0DLY)).U<
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MY0W%>T+;0+<M<+#&)W4*TH4;B!T!/7%$5M!;^9Y,$<?FN7DV(!O8]2<=3[T
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MXBF\K5--BD\MPVQQ%RIQT(]*]J(R,'I5*'1],MXUCATZTC1)?.54@4!9/[P
M'WO?K0!PUG#&=<^*#E%+.(D8D=5%F./U/YUG1Q1Q>!_A7Y:*O^G6)X&.6MY"
M?S)KU(6T :9A!&#-_K3L'[SC'S>O''-)]DMO+AC^SQ;("#$NP8C(& 5'; ]*
M /&=/M)+GP]<:5J/C"TL#_;,B2V)L0]QY_VHNA!#[F+':P('0^@KV*#4;.ZO
MKNR@N$>YLR@N(P>8RR[ES]1S0VF6#7XOVL;8WBC N#$OF >F[&:9:Z7!:ZI?
MZ@A8SWOE^9G& $7"@8'N>N>OIB@#G/&VHO:ZAX?LXYK&R:ZNI,:C>0K(+8K$
MQ^3<0 [#*@D],]:\XNKZ)_"/B=Y-22\\OQ1:3/<%5C#QG[/B3:. IP<-T/6O
M<+RQM-0@\B]M8+F'(;RYHPZY'0X-,?3-/D$P>QMF$R!)0T2GS%'0-QR!Z&@"
M:">&Z@2:WE26)QE7C8,K#V(ZUY#J-U;QV'Q:LWGB6Y??(L)<!V7[*O('4CWK
MUZ""&U@2"WB2*%!A(XU"JH] !TJ"32]/FN7N9;"U>>1/+>5H5+,G]TG&2/:@
M#BM6AC@U+X<)$BHL=PR(%&-J_9'X'MQ7*>&;1[GPUH&G:CXPM+>2#4D']FBQ
M!N%NHYBQ4D/NR2"2Q'0DGBO9VMX':)FAC8Q',9*@[#C''IQQ4*Z98+?F_6QM
MA>,,&X$2^81Z;L9H 74;4WVEW=HK;3/"\0;TW*1G]:X7P'XOT73O!EGI6L:A
M:Z9J6D0BTO+6[E6)T:,8W $C(( ((R#FO0ZI7>CZ9?SI/>:=9W$R?<DF@5V7
MZ$C(H X'5O$-KJ^I>"O$4L,UKHB:E<)YMVH16)B=89>>BL>A..HK$\:W$&HW
M'C^]TV6.:SCT&"WN)8F#(TX=V R."0A&?3(KV*>W@NH'@N(8Y87&&CD4,K#T
M(/%0Q:98061LH;&VCM#D&!(E$9S_ +(&* .,U>U@7X@_#]1"@6&WO1&,?=Q"
M@&*Y#Q$UO%9>*S<J#:KXMLFE7&05Q 6X[Y&:]H:"%I8Y6BC,D0(C<J,IGK@]
MLUA^)O#G]M65O#:^1;R)J-M>RL5QYGER*QSCJ2%QS0!QWBC6[-O&;:GI0MM3
M&G^&[V6Z2-A(CH2AC1R,C!(8X],U6TR^SX[\(+/XAL=0S9W 6.S@2*&WWQIM
MC4J3UV\*3G"UZA::;86 E%G96UN)3ND$,2IO/J<#FF0Z/I=O'''!IMG$D<GF
MHJ0*H5_[P '!]^M 'D]K#'%^S]X>\M%7%U9OP/XC=KD_7DU<\77%YX5\1ZS8
MZ<K ^+;=%LMHX2]W+"Y]OD=7)_V#7J7V*T%LML+6'[.A!6+RQM&#D8'3@\US
M_P#PCVHZCXO@UC6+JU>TTXR'3K6WC8$,XQYDC$\L%X  P,DT ;6D:7;:+H]E
MIMJH$-I L,?'.% &?J<9KSK5=0@T/4-3N]*UFPOK275$%]H-["/-,[.BDQ'A
ML_=8 A@<9!KU*JCZ7I\E^M^]A:M>*,+<&%3(/HV,T 27WD_V?<_:=WD>4WF;
M02=N#G '/3TYKRB"ZN8+*#0-*UBP\06EUI%TFES1QJMW9A8?D#%3@J?E7.%.
M<9KUZJEKI>GV,TLUI86MO++S(\4*HS_4@<T >776I:7J'PZ\%:;I5Q!)J'VK
M3Q!;QL#)$\94R$J.1M"ON)_K67JD,\]Q\7DM]VX/8LV%W?(JY?CO\H;BO98=
M+T^WO9+V&PM8[J3[\Z0J';ZL!DU-':V\4LLL<$2238,KJ@!?'3<>_P"- '"Z
M#$E[XULKZ3QA9ZO=0Z?+LAL[-4'DNR<LRLP RJX!]\=ZM?$UEAT32;J<@6-M
MK5E->,?NK$)!DM[ E<UU=GIMAIWF?8;*VM?,.Y_(B5-Q]3@<U/+%'/$\4T:R
M1N"K(XR&'H0>M 'GIU'3=1^,J/87$-PT?AZ9)986#KGSHR%W#C(!SC_:'K7+
M^!HK1_A;X,D.O+HNJQ2W;6-Q+&'B8^9('1@V%.5/3(/''0U[%:Z7I]BJK:6-
MM;A%*J(H53:"<D# Z$@4DFDZ;+8BQDT^T>S!R+=H5,8/7[N,=S0!YA!K8N-7
M\)ZMJ@L(+2VU34+6>\M?EM99RA5)03TW$.,DGYL\U-XQN] UN&R_LN&*6-O%
M5C#>S1H/+N). ?F'#X4A2?PKTQM/LGL?L+V=NUIMV^08P8\>FW&,4)IUC%;Q
M6\=G;I!"P>*)8E"HPY!48P#]* .#\4?;(/B=I\T>N6VCI+I,D4-Q<VZR([B4
M,Z#<R@-C8>O(6L,K8Z3_ ,(1<C6H;VQ?7;N;[:8O(B!=920H)P%W[L'.#VKU
MF\L+/48/(OK2"ZBSN\N>,.N?7!I+C3K&[M%M+FRMYK9<;89(E9!CI@$8XH \
MEOXKB]\8?%6*PR]Q-HUN(A'R6)MS@#W/:M+4M4TK5M%\ VFBW-O-<C4;.6*&
M%P7BBC0^82!RH"Y!SZXKTN.TMH9GFBMXDE<!7=4 9@. ">^*BM]+T^TNI;JV
ML+6&XE_UDL<*J[_4@9- 'EXAB'PF^(3"-<O?ZHS''4AV /Z#\J]'TS4K1A::
M:;A#??8H[@PY^;R_N[OIGBKWV.U\B6#[-#Y4I8R1[!M<GJ2.^>]5QI5N-:&J
M@$3K;?95   ";MQ[9Z@=\<?6@#%\?:@=/\/0D)9YGOK>#SKV,20V^Z08E93@
M':>1R.<5YCX@NQ)!\0XI=:CU25M'M<3I&D8DVO*&VA>&"DX)&<'(/2O<;BW@
MN[=X+F&.:%QAXY%#*P]"#P:K_P!D:9L1/[.M-B1^4J^0N%3KM'' ]NE ')^(
MX1%XW\#16RK&5%['& ,!1]FX'TX'Y5PLVJ:0/@/I.EM/!_:4=Q;Q-;;AYL<R
MW*F0LO4'[V2?7WKV]H(7ECE>)&DBSY;E02F1@X/;BJQT?3#<33G3;/SIL>;)
MY"[I,'(W'&3R >?2@"[7B$<UI<?#&]T]Y89)D\3 3VY8%E4WP^\O4 @]Z]OJ
MF-)TT32S#3[42S,&E?R5RY!R"QQR0>>: .,\27/V#XCPWBVXG,/AN]<Q8_UN
MUXR%_'I^-<YIFI>9XH\ R3Z]I]RCK*PM+*W2*&S#VS[8P021D_* 3SM/'%>O
M&"(SK.8D,RJ5$A4;@IZC/IP*JQ:-I<$8CBTVSC02B8*D"@>8.CXQ][WZT <C
M\*+JW?PQ<VBSQ&YAU&[\V$.-Z9G?&1U%=Y5>"PL[:XFN+>T@BGG.99(XPK2'
M_:(&3^-6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *X.?XG00V5UJ7]A:BVE6-V]I>W@,86%EDV9"EMSCH3@< ^N0.\K
MR>ZT?4F^$'BFQ73[HW<^HW3Q0"%M\BFYW A<9((Y^E '8Z=XQ-WK\>DWNC7N
MG/<6[W5I)<%")XU(W<*Q*L-P.T\U#I_C=[R_LX)] U"RBU$2'3YK@H//**6V
ME0VZ,E02-P[=JK^)K34W\<:'>:=;2.T&FZ@JR["425ECV!CT&2._H:X_2K>7
M^UO!^J?V7XEFN;:XQJUS?+<.5ED@=/EC;(VASRR+M48YYH [Z+QSILG@*7Q:
M8YDM8HG=X& \Q75BIC(Z;MPQ^(JQXFNYQ\/M8O4$MI<?V7-* &P\3>43U'0@
M]QZ5PESH]S_PLF7PBD>=%OKR/Q#+@Y"JN0\9'HTRQM^)KT#Q?!+<^"M>MX(G
MEFETZX2.-%+,[&-@  .I)H Y[P_XX?[+X>@U#2-0@M=2BC@M=2F="L\OEY&0
M&++NP2"1S[5<7Q["UT)?[)O/[&:\^PC5=R>69=_EYV[MVS?\N[&,^W-<Z);W
M7;/P7H2Z-J5M=Z==6MS?//:ND4*PH<XD(VMN.  ">O.*S=(\.65K'%H.IZ1X
MENK]+\@K'<7*V31^<76;.[R@H7#;>NX8QF@#T[Q+KUOX8\/7>LW4<DD%J%9U
MCQN(+!>,_6L!O'\T>KQZ7+X8U1+R[A,VGQEHO])4$9R=V(R <D-CCWP#8^)E
MG<ZA\.]7M;.WEN+B18PD42%V;]XI. .3P#1JEG<R?$[P[=I;RM;0V-XDDP0E
M$9C%M!/0$X./H: &1_$&S/A^749M/O([R._.F'3AM:5KK( C4@[3G.<YQCFI
M;;QO!'+J-OK>G7&D75A9F^DCF=) \ R"Z,A(.",$=<D>M<A-HVJPB_U---NI
M?L/C ZEY"Q'?/;^4J%HP?O8W$C'7:0*DU_3K[QWJ&M7FFV-Y!;+H$UA ]Y;M
M;M<3R.'PJN =HV 9( RU %O4O%FHZEJO@Y6TK4M)BO=361#)*F+B'R9#M<(Q
MP>5.UOUP<.D\3&WT/QS=:);ZI/>:?<SQRF>Y5EB<(3OC#M@1KC.T<^@J"YU2
M\\17W@M+?0=6A6QOTDO7N+-XA PA==N2.1DGYAD#CGD5%I.D:E'H_P 48WL+
MI7O;J\:U5HF!G#1$*4X^;)X&* ,_1-3%A\/]!U#7$\1^9J%_9[;@ZIO,\C@D
M,,.=L7JAQGCBNYU;QL-.OM0AMM&OM0M]+57U&X@*!8 5W8 9@78+AB%Z COQ
M7':QHVJ2_"OP%9QZ==O=6M[I[7$*PL7B"J=Q88R .^>E/U;1K>P\2>(_[3TW
MQ)=C4)A<68TN:X6*X#1*AC?RV"*P93DOCY2.<"@#L;OQFO\ :XT[1])N]7=+
M9+NX>V>-5BC?.SEV&YF )"CM4'PQOY=3\!VEY-/-.TMQ=$23,2Q7[1(%!SSP
M !CMBL>PW^"?%VHE]&U.6PU"PLTM/L<#W.QH4:,Q,RYP<8(+8!YYK8^&5I>V
M7@.T@U&TDM+L7%TTD$BD%=UQ(P_#!!![B@!M]X]%O+J<MGH5_?Z=I4C17UY"
MT8",HRX568,^T=<#UZT_4?'L-OK%KI6FZ7=ZK=WEBE_;"V**KQLQ&2S$!1@9
MR?4#J:YV.XO?#FD>*/#\FBZG=7MY=W<M@UO:O)%<+/DKF0#:F"V&W$8QFKGA
MO0+[1_'>D1S02-#9^$XK)[D(?+,JRC*ANF<#./2@#M=:UBTT#1KK5;YF6WMD
MW,$&6/. H'<DD >YKC/$/BZ]F\*^(K2YTG4=$U%-(GN[9WD4[E"D95XV.UP2
M..".M;GQ!TN\UCP5?6VGQ>==HT5Q'#G'F&.59-OU(4@>]87B#7[[Q3X8\06&
MF^'M42W;2)]TMU;/"YG*X6)(R,N>N2..G7- &AHOC1Y+G1+"^T>_MHM2BVV=
M],R%9V6/<<J&++D D;AD^U3_ /";E-3ACFT/4(--GO?L$6H2; K3;BH^3.\*
M6& V.>/6JNK6%W)>^ VCM9F6UNMTY6,GRA]F=<MZ<D#GN:XB>WOKBVL+R]TO
MQ'=ZY9:S#=:D[BX:&.)+C/[F,'9(-NT@(IX!)]P#M[OXA^3_ &P]IX?U&]AT
M:>2.^EC:-514 8LNY@6."3@<\<XR*O7WC.-+ZQL=)TN[U:ZN[07WEP,B".W)
MP'8NP&2> .^#TK&L-.O1X9^(,;6=PLEY>WKVZ-$P:96@0*5&,G)! QWJEI0O
M?#&NZ1J5WI.I3VMSX=M;)C:VK2O#/&22CJHRH(;J>,@YH W+?XB65[HXO;/3
MKV:>74'TZVL]JK++*H)/4@*  223Q@U))X^M;?2+NXN]-O(=1MKN.R;3?D:5
MIY,>6JD':0P8$'/3/I7GUEIMQJ6F_P!K7-CJ'E6?BB_DO;;3Y'%Q$D@925,9
MW$JQ&0O49ZUJW6C1C2DUO1=$UQEM-:M;R47KRR7-Y%$"I9$D)<8#G ."=OTH
M W=+US4-0^*R6=Y9WFG&/1'DDLY95="WGH!("A*MQD9ZC!%=+KNN3Z5):6]G
MI-WJ5W=,PCB@*HJA1EF=V(51R,=R>E<SI5W<ZU\5%U:+2]0M],71'MTN+JV>
M'?)YR,1A@"..F<9P<<<U+XV,QU_24O8M9ET$PS>:FE";<]QE/+$GE?-MQOQR
M!GK0!;'CN*XT_3WL=)O+G4;V::!;#=&CQO"2)0[,VT!2/4YR,5OZ/J3:KIJ7
M3V5S92%F1[>Y3:Z,I*D<9!&1P02",&O+--LK:W\/G3]=\-Z]$L&JW4R7-JLS
MS69=BT;*Z9=P5)!92PR/FZUW_@=M3;PVO]J-=NPGE%N]ZFVX: .?+,@XPVW'
M4 ],\T 4KKQ]'!<W;PZ+J%SI-E<_9;K48MA2.0$!L)NWLJDX) XYZXJ.+Q#I
M]KXP\6A5U%[C3;.*XN$>?="5\LL!$A.%.!STR:RM(U34_"-OJ>AIX?U&]U%M
M3GELBD+>1/'+)O#-, 53 8[L\C'>H9-)U$^-OB/<?8+GR;S288[:01-MF<0$
M%4./F.>,"@#=M/B%!<>'I->ET>_@T]EA%FS;"]Y)(=H2- V<[L#)P#G(XYHG
M\?C3M/U.;5]#O["ZL(XYFMW9'\R-WV!D=25.#U&<BLN[TC4?^%5^$S#8SR7F
MD?V=>2V07$K^4%WH%/\ $!GCU&*3Q3J6I^,O"/B"RTO0;];9+:-XI+J%H))Y
M1(&9$C8 D!5Z]R<#- '9WNN0V/B#2M'>*1I=169HW&-J^4%)S]=U<G%\5+9]
M*L=9;0=331KJ40?;/D.V0DJ!L#;F&X8R!C/K2'49_$?Q!\+W]II&J0V%I#>+
M+/=VCP[7=%PN& (^[UZ$G )P:R+71]37X.>'+!M.NA=PZC;/+ 86WHHNMQ)7
M&0 .?I0!U</CN**XU2WUG2;S2IM/L3J)25HY/,MQD%@48C((P1]*@N_&FIPZ
M'J=T_A?4;6XM[%KR 2O$R2(.I+JQ4,N=Q4G) .,U#K-G=?\ "P;Z]_LB;4+0
M^&WA,07"3MYV3%N/&XKVK"L;*YF@UO3O#L&O#19M%N(_LFJQR*(;D@"-(3*-
MW0OD E1QS0!T6E>,=5E\*Z'=3>'KVYU348E*0Q-$%<"-7:4ONVHISP"<]L5+
M+\0K*'1["^;3KXRW>H-IIM%53+'<+ORAYP>4P"#CD'@9KDX;NXN=#\(V]]8>
M)(='M;(VU]!:VUQ%*URD<00,$ <Q_?P1\I(Y/%1:/I>H1QZ3:'1]1MVM?%KW
M;I+&[^7 \<I5C(<A@,@%LGGJ>: .UM_'=M''K0UK3[G29](@6YGBF9)-T3 [
M60H2#DJ1CUXHM?' 225=;T6^T9%M'O8Y+DHZO$@!;)0G:P!!VGFN=\8>'-4U
MK6?%L5G:R$W&C6JV[LI"2R1S2/L#'C/ '_ A5W6-6U#QQH6IZ'INA:C;+<:;
M,)I[^%K<1S$82)0P^<DYR1P .IS0!JV7CE'F1=5T>]TF.>UDN[62X*,)8T 9
M@0C$JP4@[3VSZ59T'Q1<:S<PI/H&H6$-S!]HM;B8HZ2)QPQ1CL;# X;KSZ5R
M6A6.FSWUM<P>'O$UQ?6=I*[IJMS<>5%(8]AB'G,5<MN(RN0!S4_@^,VWB:VB
MT"VU^ST8VTAO;+4XI5AMG^78L1D&<YW9"DKC\* .SDUZ&+Q7#H$D,BS3V;7<
M4QQL8*X5E]=PW _0UCZ?\0M+U#1=?U18IXX-&:02!\9E102'3GHV"!GTJI\2
M8=3M;?3/$&BV4]YJ.FRRHL,"%V9)8F0\#GAO+/X5S&K>$-0T^YT7P_964\VG
M:I8VEEJ4\2%DC^SRAV9ST&]6<<]: .PO_',UG UQ'X;U.XM[>SCO+V13&HMT
M9=VT;F'F, "2%Z>M/U+QW%:ZY;Z/IVDWFJ7MS9)?0+;E%5HV8C)+$!0,9R?4
M#J:Y;Q99WFIZOXFL;RQUV\GE@6/1HK9YH[0*81N9F0A,A]V0^20  #G%7_"E
MM=R^.-+U!K"\AME\*Q6S/<6[Q[95FY0[@,-QG'ISTH W;;QH+[Q1>:'9:/>3
MO8W AN[@%%CA4J&#DDY.<D8 )X--T[QL;S4["WN=#U"PM=2=TL;JXV 2LJEL
M,@.Y,JK$;ASCM57PY9:C:ZYXYG6UDCDN+U7M'E0JLN(% ()ZC=Q7':=;SF[\
M):G)I?B6>^M;M3K%S>+</LE>)T(6-OE*[V^\BX48YYH ZO\ X6;$=,.K+H.H
MG2(;AK>ZO-T8$+"3R\[2VYAG!) XSZ@@6;'Q3JUU\2]2T!M)E&GVMO$WF^9'
M\A8R'S#\V2&PH  R,<@5SLFCZD?@7JFG#3[K[<\UR5MO);S&!NV8$+C)RO/T
MK;M3/IOQ=U22>PO3;ZE8VR6]S';L\6Z/?N#.!A3R.N* .ZHJCH^HG5M*@OFL
MKJR,P)^SW<>R5,$CYE[=,_C5Z@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *#R,444 8>A>%[70[J[O/M=Y?W]WM$UW
M>R!Y"JYVH, !5&3P .M;E%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !6'K7AB+6+V"^CU+4=.O(8VB$]C,%+(2"58,K*1D9Z9%;E%
M&=H>B6?A[2H]/L1)Y2LSL\KEWD=B69V8]6)))-:-%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7"6_C3Q+?QW]UIWA*&ZLK2[GMMPU,++)Y3E20ACQ
MDXX&?QKNZ\L\*:7XHO\ 3M:33?$%GI]E)K%^NTZ>994_?ODAS(!GT^7B@#N+
M/Q=H=UHEGJTFHVUK;W=L+I!=2K&P3C)()[$@'MDT^TU.:Y\13VJ7FE2V0M4F
MBCAF+7.3_$R]-A'0UQ-WX9TRQ^('@?1?($UE8Z9=+&DP#!BOEX+#H3GGZ\U2
MU'[1#\3?&O\ 9X*W*>%Q]G$8P0X!VX_'% 'I%MXBT2]U%].M=8L)[Z/.^VBN
M4:1<=<J#GBI!KFDF]2R&J61NGD:%8!.N\NHRRA<YR 02.V:\VO;;38/AWX$F
MTJ.!;G[;IWV1X@ S,Q'F<CGE=^[\<UL?#_3K-_$/C/4'MXVNAKLL:RLH+*HC
M0X![?>/2@#T"L#1/&6B:_J&I65A?6\DMA*4<"9#O4*I+J <E 6VY]0:WZ\5U
M",0^#/B<UM&$<:NR.T:X80D0^8..VW=0!ZQIWB'1=8FEATS5[&]EB_UB6UPD
MA7Z@$XK2K@=>M[&U\9>!#I,4$<IFF1?(4 &U\ABW3JN=F.V<5WU $%M>6MZ)
M3:W,,XBD:*0Q.&V..JG'0CN*IW'B+1+6P%_<:Q8169<QBX>Y01E@<%=V<9!!
MX]J\^\1:I-X#\2>(%M5.WQ!:"XTY!WOP5A*@>K;XV/T-6-(T"UT/Q]X;T2X5
M)(++P_(+7S!D-<^:OG.N?XB#GZ$T >@1ZMILMI;W4>H6KV]RXC@E692DK'@*
MIS@D^@J274+*":2&:[@CECA,[H\@!6,<%R.R\'GI7C\_E07]XMMM33(O'%GY
M>WA$<JGF8[ ;S^9-;?B>>*7QSXEC1U9XO"$BR '.TEW.#[X(/XB@#T&RU?3=
M1FEBL=0M;J2%4:18)E<H'&5)P> 1R/6KE<O\.].L[#P#H36UO'&\^GP22NJ@
M-(S(&)8]^2:D^(+W4?P\\0/9EA.+"7:4Z@;3G'X9H U-/U[1]5N)K?3M5LKR
M:'_6QV]PLC)VY /%,M_$6B7>I/IMMK%A-?)D-;1W*-(,=<J#GBN4U*W\.VNA
M:?-I20QZQ_9%P-&-ME6<>1D_=X(^Z?FXSC'-85W;Z;#\+O!$VEQP"[^UZ<;1
MXP-[2EE\SD<Y(W[OQS0!Z/<^)=!LY5BNM:TZ&1I3"%DND4F08RN">HR./<5+
M!KFDW6IS:;;ZG9RW\()EMHYU:1,=<J#D5Y?)IME/X/\ BK=2VT4D_P!MO0)'
M4$@) C+@]L,2?K6HUC:V.M_#-K:".)RLR,RJ S VI)R>^2,G/?F@#M_^$ET$
MW5O:C6M.-Q<$B&(72;I""5(49YY!''<$5+8:YI.JSSP:?J=G=RVYQ,D$ZNT9
M_P!H \5X[+I=DWP)O[@VT?GR:JSF4#YPWV_9D-U'R\5TGB>U&F^-C_8]NEO<
M'PM?+&($"Y*LFP8'H>E '>V>NZ1J-[/966J65S=0?ZV&&=7>/G'*@Y'-1+XF
MT![NWM$UO3FN+D9@B%TA:7G'RC.3R#T]*\_\,:3?.O@B[:Z\.VUM!&&M1:AU
MGN$: [TY.&.#N;W7-9$&G6<'P!MKR.VB%U]LBF\[:-^_[:JAMW7.WCZ<4 >M
MWVO:/IEW#:7^JV5K<S_ZJ*>X5'?MP"<FEU'7=(TB2&/4M4LK-YCB);B=8RY]
MLD9KB--M]&N]0^(1\21V[A;O;<F<<I:>0A3GJ!]\C'?..:S8[6[U#Q;XB33A
MHTMA_9UFD9U996;[(8B1M.<[=V_)/.>M 'I5]K>E:7N^WZG9VNR,2MY\ZIA"
M<!N3TSQGUJ$^)] $EHAUO3@]Z ;5?M29F!. 4Y^;GCBN!\.:3$/'GAZWO)[?
M4S:>%1Y=ROSI)B55#KGKE3U]S6%/I=C;_!GQC+%:Q))'JET8W"#*;+G";3V
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M=2(K6DY;R8U[3$\*X[CH*XFUM_[!OM/=H=)UG0;O66-I>Q';=6]Q+(_+'D2
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M110 4444 %%%% !1110 57L["UT^.2.T@2%))7F=4& 78Y9OJ22:L5P5G?\
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M:Z['<&&&ZMYK:3RY[>[A,<D9(!&0>Q!!!&16K0 4444 %%%% !1110 4444
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MD-M?V84(\D<LFZ-B\;8/S @<9P>M5K[3H+1OAJFGKJ+VIU:6<-?(!-AR7)8
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M<0W6ML<QQ,>2JGN,DT <%X<\;:]'X=U+4=5LK>YE?5I+*QABNCN>9IBBQ<H
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MBBB@ HHHH **** "BBB@ HHHH **** ([B".ZMI;>4$QRH48 X)!&#S7"?\
M"F/!7_/E>?\ @?-_\57?T4 >?M\%_!+*5:PNRI&"#?S8/_CU ^"_@D  6-V
M.@%_-_\ %5Z!10!Y^/@MX(4L5L+H%CDD7\W/_CU+_P *8\%?\^5Y_P"!\W_Q
M5=_10!P'_"F/!7_/E>?^!\W_ ,51_P *8\%?\^5Y_P"!\W_Q5=_10!P'_"F/
M!7_/E>?^!\W_ ,51_P *8\%?\^5Y_P"!\W_Q5=_10!P'_"F/!7_/E>?^!\W_
M ,51_P *8\%?\^5Y_P"!\W_Q5=_10!P'_"F/!7_/E>?^!\W_ ,574^'O#FF^
M%]-.GZ5%)';F0R%9)6D.X@ \L2>PK6HH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,O7/#^G>([1+74XY9;=6W&))WC5_9@I&X>
MQR*T8HHX8DBB14C10JHHP% X  ]*?10 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#*S8PY:-7!7VPPZT :E%4;F_F@U6RLTT^YFBN Y>Z3;Y<&T9&_)SST& :O4
M%%5-4U2QT739]1U&Y2VM(%W22N> /ZGL .37,Q_$G1_,A-Y9:OIUK.P2*\OK
M!XH&)^[\Y^[GMNQ0!V-%<]XD\6V_AV[TRQ^PWE_J&INZ6MM:A=S;!N8DLR@
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M:^C:&X@D_P!8/+\TX4!@5 4$;17>6'@:SL;ZTF.IZI<VMC(9;.RN)U:&!B"
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MNWB:6X<K%$)F^4+G;U&<D9[9P*W=,\#66E7EK)#J6J/9V;L]II\DX,$!((X
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ML-Q;J2V!T4-'D^Y6NET'P_:>'[:>.WDGGFN9C/<7-R^^6:0@#<QP!T
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MC\:Z"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK7\1:K-X!\3:Q=1)E=?L!+:HHX.HIB,*!_M!T/OM- '?2>)] AB:636]-6-
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M/3FDD\0:-#>+:2:M8K<M*81";A-^\ ,5QG.<$''H1ZUY3I.F:OJ/A,F:_P!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 444FY=VW(W8SC/.* %HHI%977<I!'J#0 M%%% !1110 44U75
MQE&##ID'-+N7=MR-V,XSSB@!:*** "BBB@ HHHH ***:75652P#-T!/)H =1
M12*RN,JP8>H.: %HIH=2Y0,"PZC/(IU !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX?( "IXQQD<\GBKOQ257T_PVCJ&5O$5B"",@C>: .FTWQ/H.LS&'3-:TZ]E
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M)I]\2!I95;&\D*,?08'M0!W-%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>F0* .HHKC]%\;W?B#1!J^G>&-0>SEE5;=GFA5ID+,K/C=E0NWH>3GC-=A0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDFGZUXI7P)X?\877B&666>XMHY[(6\0ADB>41G.%W;SG=D$ = *V?"-I>_\
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M_:9E@A\UPOF2-T1<]2?2LGP+_P D^\-_]@NV_P#12US7Q8_UG@G_ +&>S_\
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MEO+0IN23< &93R2#@\BG^'O!5WI&I:'>76HPSG2]*;3 L<!3S%W*5;EC@@(
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M[[]NT$ 9"Y(':N_HH XB[\&:NMYKD6E:U;VNEZV[2W,4EJ7EB=D".8VW #<
M.H..U=+X>TLZ'X;TS26E$QLK6*W,@7;OV*%SCMG%:5% ',^)O#FH:KK.B:QI
M=_;VM[I3S;1<P&6-UE0*V0&4Y&..:9%X1>/0/%&F?;%)UN>ZF63R_P#4^<FW
M!&><?AFNIHH Y"'P2\7BC0M8^WC&EZ6; QB/!D)&-X.>/I@TEIX7UV;5M)GU
MO6;6]M])D:6W>.T,<\K%&0&1MQ'1CD*!DXKL** "O/S\/]3_ +&?PNNLVX\,
M/,6,7V4_:1$7WF$2;]NW/&[;G'%>@44 <Y%X7:+XAR^*!=+L?3%L!;"/D8DW
M[MV?PQBL^W\ 1"R\66=W>F2+7[I[@&--K09 QCDY((!S79T4 <Q:Z+XDGCN8
M]:UVUGC>T>VCCM;0Q*S,,>:^68EN.@P.3^&GX:T@Z!X9TS2&F$QLK9(#*%V[
M]HQG'.*U** ,GQ-H,7B70+C2Y9G@,FUXYT&6BD1@R,!WPP''>LNP\-ZO/XBL
M]:\0ZE:74NGQ216D5G;-$BEP \C;F8EB!C P!DUU5% '.^#/##>%-)N;%[H7
M)FO)KK>$VXWMG;C)Z>M7O$6BQ^(=!NM+EF>'S@"DR#)C=6#(P'?#*#CVK4HH
M Y-_#_B+4],U:TUK7+607EA)911VEH8XT+*096W,Q+<] 0,5/+X5>0^%3]K4
M?V$P9OW?^N_<F+CGY>N>]=+10!YC\1/#S6GAOQCJ;719=6>P 15P8O+DC3KG
MG/7IQ71V?AK5YO$]EK&NZK:W8TV*2.SCMK8Q9:0 -))EFRVT8P,#DUU3(KJ5
M=0RGL1D4M 'G^F_#:;3/!VG:3#JRC4=-OVO[2\\CY0Y9CM9-W*E6*GD>M:=G
MIKZ)J5]XL\5:O9?:#;):^9&GD6]M"&SCYF))9B,DGT KK::Z+(I5U#*>H(R#
M0!YU\+-#BA?5]=A\TV%U</#I*RKMV68D9QM'4*SNQ&>P6M(^ Y#\/9/"_P#:
M"[WNC<?:/*X'^D^?C;G_ (#U]Z[7I10!SNJ^%8]6\2)J5Q,#;'3)].EM]O+K
M*RDG=GCA2.G>H-"T+Q'I\ME;WVOP7&G6,1BBCAM-DEP-NU3*Q8C@?W0,GGVK
MJ:* .,3P+(GP]TSPO]O4O920.;CRN'\N42?=SQG&.M7;#PY?Z;XXU768+^W;
M3]4$37%L\!\Q7CCV#:X;&#P3D&NFHH IZOIR:OHM_IDKLD=Y;R6[.O50ZE21
M^=<E:^#_ ! -1T"_O=;LI)-')BCBBLV2-X638Y/SD^81C!Z#'3DUW-% '&+X
M%D7X<6OA3^T%WP21/]I\K@[)Q+]W/?&.M17?@K5Q<:[;Z7K5O:Z3K<C37,<E
MJ7FB=T"OY;;@!NP.H..U=Q10!G:!IAT7P[IFE-*)396L5N9 NW?L0+G';.*S
M/%WA9_$[:&5NUM_[,U2'4#F/=Y@CS\G48SGK7244 %8MCH36?BS5];-P&6_@
MMXA%LP4\K?SG/.=_Z5M44 <#9> ]4T:#1I-)U>T6]T]+J%GN;5GC>.>7S#A0
MX(92!WYYJ>#P#+_PB>O>'KS4Q<PZC-)<0W!AQ+'(YW[FYPQ#X88 Z5V]% ''
M6O@0+X'NM"NM0:2^NYVO)M02,*3<F02+(%SV(7C/1<5K:+8^((KR6YUO5K:Y
M!C$<=O9VQBC7!R7.YF8L>G4 #M6W10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7B\CQ?VCI'B'2],O56[U^*,:S=7H\V
MX1YBC((Q_P L\9"@XP #BO:*XYOAKHC0^1]IU,0QS"XM(A=';9R;]^Z(?PG/
M<YP"0, F@#!TK0+#Q5#K^M:K=SV^I0ZO<0P7R3E'LDA?:BID[5&!DY'.XYJ2
MTT*P\9:EXLO-9GF%Q97[6=G.D[(;*-(D99(\'"DEBV>_TKH+[X>Z-?WMQ/++
M?I!=R++=V45RRV]RXQ\SIW)P,XQG'.:?JW@+2=7O[JZDFO[87JJE[#:7+11W
M:J, 2*.O''&"1Q0!P^HVE[X@\3>(8&T>ZUS[%'!;65VE^D'V8F!7\Q1N'S,S
M;MP'8#M5RST637O'UM8^*5:66/PQ:O=6GG'RWG\V0,QVG#8.?;D>@KK]2\#:
M7J%TT\<]]8&6!;>=+"X,*SQ*"%5P/0$@$8.#C-8MUX/-Y\17FC^W6%G!HD%M
M;7=E*8RA663,8/((VE>"#V/4"@#B;C3;:^T_0["]5[J"P\9RZ7;M+(S-]F&\
M["<Y., 9Z_+6E?Z=?:[K7B>.#P_=7TUC,MEIUS'J"P_8-L*,A168$'<VXGOT
M[5W<W@'19?#MGHR&[@BL[D7<-Q%.1.)\DF0N<Y8EFSGUI+_P'IE_/)*]YJ<1
MN(DAO%@NV07BJ-H\W'4XX)&"1Q0!SFCZ3_PE7C#6E\3QO)=Z9:6,44:S%1;R
M/#OD=-IP&+D_,/[O%:_PE_Y)GI/[SS/FG^?^]^_DYK1U#P1IE_J?V])[^QE:
M!;>=;*Y,*SQ+G:K@=<9(!&#@]:T]"T2R\.:-!I6G(R6D!;RU8Y(W,6(_-C0!
MY'?Q)?6?Q@CN=TJ0D21JS'",L+$$?C7J7A#3[33/"FF06<(BC:WCD*@DY9E!
M)Y]ZB3P;HZG7\QRNNO#%ZK2<,-I7Y?3@FKVAZ-'H.E1:?#=7=S%%PCW<OF.!
M@ +G X % 'E-X\1O;+Q'I>F7N)]?BC76KJ]'F3*UQY;QK&/^66-R@'' !Q5Q
MO#]CK.G?$&^U#SIIK._NOLA,S 6[+ C!D /#9QS["NLD^&VB2PR0-<:D+?S_
M +1;PBZ.RTDW^9OB'\)W9ZYQD@8!-;%OX9T^VL=6M$\XQZK))+=%GR2SH$;!
M[<** .#T>VB\9>)M/@U\/=PVWARSNHX7=@K32D[Y< C+?*!GM6Y\+8A!H.K0
MK*\RQZU>H)';<S@2D9)[D^M:-SX%TR=M.D@N=0L;BPM%LHY[.Y,<CP#&$<XY
M'&?7/2M+0/#VG^&=/DL=,1TMWF>?:[EL,QR<$\XH \OOK+5_$5_XIN;;0;J\
MU."_EMM/U%-02+[&8U7RPJE@0,_,>/FW&MJRT"V\3^//$\.OQ//'%;6)^R^:
MPC21HFW-@'DC& >W..M=+J7@72M3O[JY>>_@CO2IO+6WN3'#=$ #+J/4  X(
MR!SFM:TT6TL=8U#5(0XN+]8EFRWRXC!"X';@F@#QW3=.M=?'PN?5D:[DF6\M
MY7D=MSI'')L!.>Q'6K,UGK>OR^(-1L= N;G68M4GBL=3&H)&+;RI-J($+#"X
M7D8^;<>N:[^7X?Z.VDZ380S7UK_94CR6EQ;W&R5"^=PW8Z'<1TI]WX#TJ\OY
M[AI[^.&ZE6:ZLXKDK!<.,?,Z>IVC.",XYS0!SNFZ/;ZU\6?$\VHB65=/&GSP
M6_FL$28QD[\ X)&WC/')KGO"UGKNJ6.A>(+7P_<C5)[M+FZU9M03]]$S_O$*
M;L[=A("XXVBO6+/1+.QUO4M7A$GVK41$)\ME?W:E5P.W!-95MX$TJUU&.YCG
MO_L\5P;J*P-R?LT<I).Y4^I) S@$Y H \\O=(L]9^&7B[Q-?-(=8>2^ N/-8
M-&B.R+".<;-J@;>^:]>TG_D#6/\ U[Q_^@BN<OOAOHE^^HK)/J*6>HN\MQ8Q
M716!I&',FW^]G!],@'%=7!"EM;Q01YV1H$7/7 &* /"_#(EO_A7X%@DNKA?M
M'B(Q2NDI5V0F?*[AR,CCV[5L:]HFGZ7/XZT6S@,>FMX=6_%L'8HLX,P#@9X/
MR+GUQS7=:=X$T72]'TK2[9;C[-I=Y]MM]TF3YGS=3CD?.W%7[KPUIM[J%_>7
M$;O)?V(L)UWX5H<L<8['YVYH \]LM(LIF\!^'&B9-(N].EO[FW61@MS,L46
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MVX$$-ZC:N/H*MWO@[2+[2='TR6.5;72)H9[54?!#1#"9]1B@#EK#_DN'B?\
M[ T'\ZL?!+_DD>B?]M__ $?)74Q>&]/A\27NO*)?MMY;K;2DO\NQ>F!V-5-/
M\%:5I?A_3-%M'NX[/3KD7,.)CN+!R^&/=<L>* .BHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<= #TVBN8_X3W2?^?/7?_!)=_P#QNC_A/=)_Y\]=_P#!)=__ !N@#IZ*Y?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=@@X./[U>H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ8DMGU/-;M% &!9>"O#NG26LMII<<<MK(9(9=[%U) !^8G)& !@DC@5OT44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFV1ASABAX49Z@BM:\FN=!L?B-:^'7DCMK&UADMDC<L+>5HV,NSKC "M@=":
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-[)K-M83WFFZB+JWE</8VTL7V:1%W;6WL=RD @'Y3D=.: /0:*\ZA\7^)O\
MA!=.\17$%@O]H-;G,-K+*ME$RDO+(H;<XR!@#&-W).,T^Z\>7-AX86_.H:)J
M#W-_'96MY:%Q"-PR6ECRS*5 ;Y0Q)P.F: /0J*\V_P"$_P!4CM]7$)L-5;3H
M(KW[1;6TD22P;\3)M9B5D506!R0<CBNJM->EU'Q:^GV0ADTZ"P2XGGP2QDE/
M[M5.<8V*S'@]5Z4 ;]%<1=6$'B?XA:CI^J>;+8Z;I]NT-L)613)*TFZ0[2,D
M!% ].<=:Y2*]GO+?P[8ZA]MUB"WO-1M);&%R9KE8I"D<K<@,J 8.YARP/)H
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M6Q^ P/H*U:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
D@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>exhibit1013-zerondaxexec007.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 44F1G&>?2EH **** "BBB@#S:;0M5\7_$6^U1KW4='M-%
M066GRQPJ&F=AF9QYBD8Z+D#G'6EM="U3PA\1K/41>ZAK%GKD9M+^:2%289$&
M87;RU QC*Y(XSUK0OOAW<WE_<W2^./%5N)I6D$,-Z%2/))VJ-O &< >E0?\
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M .A_\8?^!X_^)H ZV\U=;?P[-J\5K<S!;8SI;K"WFN=N0FS&0QZ8QQ7!^%/
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MPPR!3D;E0 X/U%:5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 453U#5;+2EB:\F\OS6VH C,6.,\  GH*I?\)5H_\ S\2_
M^ TO_P 30!LT5C?\)5H__/Q+_P" TO\ \31_PE6C_P#/Q+_X#2__ !- &S16
M-_PE6C_\_$O_ (#2_P#Q-'_"5:/_ ,_$O_@-+_\ $T ;-%8W_"5:/_S\2_\
M@-+_ /$T?\)5H_\ S\2_^ TO_P 30!LT5C?\)5H__/Q+_P" TO\ \31_PE6C
M_P#/Q+_X#2__ !- &S16-_PE6C_\_$O_ (#2_P#Q-'_"5:/_ ,_$O_@-+_\
M$T ;-%8W_"5:/_S\2_\ @-+_ /$T?\)5H_\ S\2_^ TO_P 30!LT5C?\)5H_
M_/Q+_P" TO\ \31_PE6C_P#/Q+_X#2__ !- &S16-_PE6C_\_$O_ (#2_P#Q
M-'_"5:/_ ,_$O_@-+_\ $T ;-%8W_"5:/_S\2_\ @-+_ /$T?\)5H_\ S\2_
M^ TO_P 30!LT5B)XNT20$I=NP!*DK;R'!'!'W:=_PE6C_P#/Q+_X#2__ !-
M&S16-_PE6C_\_$O_ (#2_P#Q-'_"5:/_ ,_$O_@-+_\ $T ;-%8W_"5:/_S\
M2_\ @-+_ /$T?\)5H_\ S\2_^ TO_P 30!LT5C?\)5H__/Q+_P" TO\ \31_
MPE6C_P#/Q+_X#2__ !- &S16-_PE6C_\_$O_ (#2_P#Q-'_"5:/_ ,_$O_@-
M+_\ $T ;-%8W_"5:/_S\2_\ @-+_ /$T?\)5H_\ S\2_^ TO_P 30!LT5C?\
M)5H__/Q+_P" TO\ \31_PE6C_P#/Q+_X#2__ !- &S16-_PE6C_\_$O_ (#2
M_P#Q-'_"5:/_ ,_$O_@-+_\ $T ;-%8W_"5:/_S\2_\ @-+_ /$T?\)5H_\
MS\2_^ TO_P 30!LT5C?\)5H__/Q+_P" TO\ \31_PE6C_P#/Q+_X#2__ !-
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MC_A*M'_Y^)?_  &E_P#B: -FBL;_ (2K1_\ GXE_\!I?_B:/^$JT?_GXE_\
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M_P"?B7_P&E_^)I\/B;2)YXH$NF$DK!$#0NH+'H,E<4 :U%%% !1110 4444
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M\D@# !J]XPT2]U?P_:#3Q&VH:?=V]]!'(VU9'B8-L)[9&1GUQ5[_ (2C2O\
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M_/2Z_P# *;_XBC_A*-*_YZ77_@%-_P#$4 9^MZ/?7GC[PKJD$(:SL$O!</O
MV>9&H3@G)R0>E=16/_PE&E?\]+K_ , IO_B*/^$HTK_GI=?^ 4W_ ,10!L45
MC_\ "4:5_P ]+K_P"F_^(H_X2C2O^>EU_P" 4W_Q% &Q16/_ ,)1I7_/2Z_\
M IO_ (BC_A*-*_YZ77_@%-_\10 GAO\ X\[W_L(W7_HUJV:Y'P_XDTR*TO [
MW.6O[EABTF/!E8CHM:W_  E&E?\ /2Z_\ IO_B* -BBL?_A*-*_YZ77_ (!3
M?_$4?\)1I7_/2Z_\ IO_ (B@#8HK'_X2C2O^>EU_X!3?_$4?\)1I7_/2Z_\
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M (!3?_$4 ;%%8_\ PE&E?\]+K_P"F_\ B*/^$HTK_GI=?^ 4W_Q% &Q16/\
M\)1I7_/2Z_\  *;_ .(H_P"$HTK_ )Z77_@%-_\ $4 )X@^]I/\ V$8OY-6S
M7)ZSK]A<MIOD_:W\J]CD?%E-\J@-D_<]ZU/^$HTK_GI=?^ 4W_Q% &Q16/\
M\)1I7_/2Z_\  *;_ .(H_P"$HTK_ )Z77_@%-_\ $4 ;%%8__"4:5_STNO\
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M*_YZ77_@%-_\11_PE&E?\]+K_P  IO\ XB@#8HK'_P"$HTK_ )Z77_@%-_\
M$4?\)1I7_/2Z_P# *;_XB@#8HK'_ .$HTK_GI=?^ 4W_ ,11_P )1I7_ #TN
MO_ *;_XB@!)?^1TM/^P=-_Z,BK9KDY-?L#XIMKH?:_(6REC+_8IL!B\9 ^YZ
M _E6I_PE&E?\]+K_ , IO_B* -BBL?\ X2C2O^>EU_X!3?\ Q%'_  E&E?\
M/2Z_\ IO_B* -BBL?_A*-*_YZ77_ (!3?_$4?\)1I7_/2Z_\ IO_ (B@#8HK
M'_X2C2O^>EU_X!3?_$4?\)1I7_/2Z_\  *;_ .(H V*XKQ[H>L7$NF:_X9A2
M77--=T2-W""6&12K*2<#@[6&?0UN_P#"4:5_STNO_ *;_P"(H_X2C2O^>EU_
MX!3?_$4 9ND>%WT/X<G08/WMV;*19'S_ *V=U)9B3ZL3U[8IW@_PK9Z/X8T6
M*ZTBRBU.VLXDFD6%"XD" -\X')SGG-:'_"4:5_STNO\ P"F_^(H_X2C2O^>E
MU_X!3?\ Q% &Q16/_P )1I7_ #TNO_ *;_XBC_A*-*_YZ77_ (!3?_$4 ;%%
M8_\ PE&E?\]+K_P"F_\ B*/^$HTK_GI=?^ 4W_Q% &Q16/\ \)1I7_/2Z_\
M *;_ .(H_P"$HTK_ )Z77_@%-_\ $4 ;%%8__"4:5_STNO\ P"F_^(H_X2C2
MO^>EU_X!3?\ Q% &Q6-XB_U6F_\ 81@_]"I?^$HTK_GI=?\ @%-_\16;JVN6
M%\^F06[3F0ZA 1OMI$'#>K*!0!U5%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!C>+O\ D2]=_P"P=<?^BVK9K&\7?\B7KO\
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M]=(9?.T_[&+8LI//ER;S@C_:XXKM@<@$@CV/:@!:*** "BBB@ HHHH ****
M,;PW_P >=[_V$;K_ -&M6S6-X;_X\[W_ +"-U_Z-:LGQSK^JV#:9HWAWR3KF
MIRL(O.7<L<4:EG<C\A_P*@#KZ*P_!_B!?$_A6PU7;LFECVSQ]/+E4[77';#
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M8.>G% '<T5DZ)XBLM=-REO'=07%L5$UO=V[0RIN&5)5AT.#@CT-:U !1110
M4444 %%%% !1110 5C>(O]5IO_81@_\ 0JV:QO$7^JTW_L(P?^A4 ;-%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C>+O^1+
MUW_L'7'_ *+:MFL;Q=_R)>N_]@ZX_P#1;5LT %%%% !1110 4444 %%%% !1
M110!C:K_ ,A_0?\ KM-_Z*:K^I?\@J\_ZX/_ .@FJ&J_\A_0?^NTW_HIJU;B
MXBM;:6XF<)%$A=V/90,D_E0!Y?IFC7DWPM\):]H\>=<T>RCF@3I]HC*_O(#[
M,.GH0*PM)O$N_"=CXD6*7^S;?QA-J%QE#F*%BX#L!_=+J3Z<^E=W#X\U![.U
MU67PI?QZ)<E"EV)HWD5'("R-"#N"\@\$D ]*Z^:]M+>:*&>ZABEE.(T>0*SG
MV!ZT >7ZW?VOB/7?$.JZ-.EWI]IX5N;6:ZA^:-I7.Y4#=&("DG'3(]:DUZ,+
M\&?"BJN,-I7 '3YHZ]/CDA9GCB>,F,X=5(^4^A':HY+ZSAAEFDNH$BB;;([2
M *A]">QH S?%^CR>(/!^K:3"P6:[M7CC)/&\CY<^V<5S&A_$S0+/0K:TUZY;
M2M7M(5AN;&XB82!U&#L 'S@XR-N>M=V;RV6W6X-S"('QMD+C:<],'I3%O;*6
M295N;=WMO]:!(I,7^]_=Z'KZ4 >;_$35;K7?@=K=_<:7/I_F[/*@G/[PQ^>F
MUF&/E)'.WM4FM6]Y9Z+X#\46MI-=IHL:&Z@A7=)Y,L 1W5>Y7@XKT6VO[.\@
M:>UNX)XER&DBD#*,>I!IHU*P-Q';B]MC/*H:.,2KN=?4#.2* .2N?BCH$UNB
M>'Y&US4YB%@L+56#DD_QDC]V!U);I6S-I&MS:ZE\GB6>"Q#(S:<MK"R$ #<N
M\KNY(/.>]:L]Y96<J)<7-O!),<()'"ES[9ZTZYO;2S,8NKJ& R':@ED"[CZ#
M/4T 3T444 %%%% !1110 4444 8WAO\ X\[W_L(W7_HUJX32;37?&'C+5_%V
MDZO;6%K S:58F>Q-QYD2$%W7YUP&?//.0/:N[\-_\>=[_P!A&Z_]&M6OO3?L
MW+OQG;GG% 'G'A"'4/"'C[4?#VJ7<5U%K2MJEK/%!Y*&8'$R!=S8.-K=?7UJ
MWX_O;;2O%G@K4[^9;>Q@O+@2W#\(A:!@N3VR:[W<,9R,>M8UKX@BNO$NKZ-)
M"(QIT5O(9FD&'\W?@8QQC9ZG.: /+IX;!6\3:-K/BC5+)[W4YV72K:&%FNXI
MFRC1AHRS9# 9!X*GIBNQ\+PB/XI>-B<LRP:<@=NI'E/G^5=N[1H [E5 _B8X
MJM=WLEK=64*65Q<+<R%&EB *P *3N?)''&.,\F@#R6>('X#ZXI0'?J<VX8Z_
MZ=7::D/^+NZ 0./[*O!G_@<5=!K^LQ>'M"O-7G@GGAM(S+(D 4MM R2,D#]:
M='JC2W=C$EA<M#=0&8W "^7%C;A6YSDYXP.QH \:\(Q[OAOX'5DSCQ2#@C_:
MFKIO%U]=Z7XP\2WUC$KW$7AJ$KNCW@?OY 6*]]H)./:O3Z* /(=/OK.7Q];-
M;^(KO6HKK1;JVANY_+\N2?=$QBB*(H)P,D<X_ UA7&HVE]\&?!UM;3I+/9:K
M90W,:_>B<%LJP[&O;]*O'O\ 3HKF2QN+%F+#[/<!0Z88CG!(YQD<]"*N  =!
MB@#SRVUO3?"7CSQ8VOW<=DM^UO<VDTV0)XUA"%5/=E93\HYY''-8GA*PN+/4
M?AXEW;O#(8-5G6*1<-$LCJZ@CL=K#BO72H.,@''(S2T <=X2&/&7C?C .H0?
M^DT=9ZZQI_A3XD>)+C7KJ.Q@U*WM9;.><X201HRN@;IN!YV]?FKT&L^TU%;F
MR>YN[2:Q6.9H]MUM!.&VAA@D8;@CZT >/ZA:W$/PZ\-2RP20K=>+$NH8G4JR
M123R,F1VR"#^->N^)+2>_P#"^KV=K_Q\7%E-%%SCYF0@?J:CC\002>+)?#OV
M:X2YCLQ>>:P7RV0OL&,'.<@]0.E:] 'DWA+^R]3O?#$)\4ZM?W]BOFC33#"!
M9NL11EEVQAD W%0">3CK5*"('X#:.AC&#J<.1CKF^YKV4  D@#)ZGUI: /-O
M%H_XKG53CC_A#[OG_MJ*QXM9T[6O"G@'0=-E#ZK#=:?++:*#YEND*AI'8=EP
M#@]]PQG->IZA;QZSHM]913J%N8I;8R+\VPD%#QW(.>/:L[2[JQT/1%L6F,JZ
M1!#9RSA0-[A5 4#.<G*\=,MC.<X /,+C3[O4;+XL6UI \TQOX9!$@R9%3#,H
M'<D*1BNIO=>TSQ?XN\(KX?NDO&L[B2\NGA!/V>+R67:_]TL6 VGGBNPU+Q!9
MZ9):6\B337UYG[/9P*&EDP,L>N !W8D#WJ*/7D;4H=,FL+VQO+I'>+SHT93M
M')W(S+GD<9S[8YH \X&G3KXK;X<^4W]EMJ8UH''R?8L^88OIYX"_0UU&D(/^
M%A>/6*\F"R&<=1Y+UL:!X:FTS4KW5]3U(ZEJMVJQ-/Y(B2.)<E8T0$X&22>3
MDUT- 'D%FFWX4_#H!<8U73SC'_30YJDUK9"/7?#^M>*=6L[BYU6<?V3;10L]
MPLLI9'C#1EV!# Y!XP>F*]LI,#(.!D=Z .(T",#QCX_)7DRVPR1U M5_^O7&
MZ+?VND1?"F_U&9;:T73[J)II.%5VC3:I/8G!Q7I%UXQM;6\U:T.EZO)/IL2S
M%(K0M]I4X_U//SX) /2MC3KZ#5M,M-0M]Q@N8DFCWK@[6 (R.QYH Y3XM1O)
M\,=8V*6$8AE<#NB3(S?^.@UG?$YUGN/ DL1WHWB2T967D$'/->@W-M#>6LUK
M<1K+!,ACD1AD,I&"#^%9WAO1Y= T6+2Y+UKR*V)2W=TPZPC[B,<G<5'&[C(
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ME;86WJP"G:5R1QN'(S7HG@."P^R:G?:?JE]JB7EX7>[ND11*ZHJ%H]BJ"N%
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M%%% !1110 4444 %%%% !1110!C>+O\ D2]=_P"P=<?^BVK9K&\7?\B7KO\
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MT;WP!H5[/J<C+=PIJ@/VR""Z>.*9B,%R@.-V._?OFKR>%=,CU+3[]/M/GZ?
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M"6=WI%Q)+$LA WJ\8##^Z0&/(K6E\-Z0=*U*TO(S-#J"G[;+/(2THV[<LW;
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MN2_"S';<$-&5V9V[08]F['2E.E:QK\>OW]KH%E+JRZM.MOK$U^(Y;8Q2[8U
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ML!3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *QO$7^JTW_L(P?^A5LUC>(O]5IO_81@_P#0J -FBBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH QO%W_(EZ[_ -@ZX_\
M1;5LUC>+O^1+UW_L'7'_ *+:MF@ HHHH **** "BBB@ HHHH **** ,;5?\
MD/Z#_P!=IO\ T4U;-8VJ_P#(?T'_ *[3?^BFK9H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH QO#?_'G>_P#81NO_ $:U;-8WAO\ X\[W
M_L(W7_HUJV: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *QO$7^JTW_L(P?^A5LUC>(O\ 5:;_ -A&#_T*@#9HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,;Q=_R)>N_]@ZX_]%M6
MS6-XN_Y$O7?^P=<?^BVK9H **** "BBB@ HHHH **** "BBB@#&U7_D/Z#_U
MVF_]%-6S6-JO_(?T'_KM-_Z*:MF@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#&\-_P#'G>_]A&Z_]&M6S6-X;_X\[W_L(W7_ *-:MF@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L;Q%_JM-_["
M,'_H5;-8WB+_ %6F_P#81@_]"H V:*** "BBB@ HHHH **** "BBB@ HHHH
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M?VKJW_0NW'_@3#_\51_:NK?]"[<?^!,/_P 56S10!C?VKJW_ $+MQ_X$P_\
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M^A=N/_ F'_XJB7_D=+3_ +!TW_HR*MF@#&_M75O^A=N/_ F'_P"*H_M75O\
MH7;C_P "8?\ XJMFB@#&_M75O^A=N/\ P)A_^*H_M75O^A=N/_ F'_XJMFB@
M#&_M75O^A=N/_ F'_P"*H_M75O\ H7;C_P "8?\ XJMFB@#&_M75O^A=N/\
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ME.\;-K;N<'((QGI0!ZO'(DT22QL&1U#*PZ$'H:=4=O"EO;101H$2- BJ#D*
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MKF6,/);>9O,1/\); R1WXZUPOB;PSK'C'79KU$^P+H1#:,944_:+D%6,C?\
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MLZGJ45N6^P:M=SKD9^5@LR\ D ;P#C-='KC7^F:'&VB:9%?/;/'_ *(2%+1
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M=-U]4@ELRSS17!DEN'$K%XR)"=NT E<#)&W'%>A444 %%%% &-+_ ,CI:?\
M8.F_]&15B^(_M&M^-M,\,K?7=I8BRFO[HVDQBDEPZ(B;UY RQ)P><"MJ7_D=
M+3_L'3?^C(JR/$=O?Z7XNTWQ/9:=<:A"EI+8WD%MM,JHS*Z.JDC=AEP1G.#0
M [P9<75OJ?B'P]<WD]XNE7,?V>>X??(898PZJS'EBIW#)YQBN6\0ZKIQ^(>M
M6VLZ_KUE;6MK:F"#3)K@ %@Y=V6(' ^YR:W]&75]/A\0^*)M$N&O=4NX6ATT
M.HE6! D2ECD@-C<Y&3CIUJ_J>OZOHVMW2-X9N]0L9(T-K<:<JLY;'S)*&88Y
MZ'I@T 1KXDLM$L- ,,DM_H=\PA&K271E,;-_J_,)&2&/R[B>#@&M+P]XA_X2
M)[^:VM2NG03F"WNR^?M17AV5<<*&R <G.#7$VWA?6W\%:9X/GLQ!%J,TUQJD
MJ$,EI"TID,*'NYW!01D#D^E=1X)M=2T:QG\/7]NQ@TQA%8W@ "W%N1\F<='4
M?*W'. ><T 8EUJFJVGQ7U6WTK3?[0F?2;9Q')<^3$@$DN26P>3D  #GVQ6K:
M^,[W5="LKO2= GN+ZXN)+::UDF"):R1E@_F2 $  K@<<Y%4[Q]4T7XDZCK"Z
M)>WVFSZ;!!OM%5G$BO(<!21D8/..F1[D<ZGA[5;>QTJ?6-%OKNPN[^^OK_3+
M1PS)),VZ$. P#!1NSS@$T =2OCR>6PM4AT;.LSZA+IQLI+H+&DL:LS$R[3E=
MJY&%R<CBK$_BW48;6PMV\/R+KE[<201V,EP%3]V-S2>;C_5XP<[<DD#%<AIN
MC2V.B:EI6K^!9[G3I-6>Z\BW96,$;H#&T6&!9E(VL5((SQD5&_A:_FL=)O\
M4](U/4-.L;ZZ$6GS3[KN.TE50A)WY8JR9V[B=K>U 'HWAW76UN"[2XLS97UE
M<&VNK8R!PCX# JV!N4JRD' Z]*S)?%NHR:Q?6^G: U[9:?<I;74R7064,55B
M4BQ\P <=6&<'&<5-X+TZVL=/NI;;0)-%2XN"RQ32EY9%  #N,G:3@C;D\ ?0
M<QXJTVZO-;N9M/\ #.HVGB(2HMEJ]E*%AEC&W#3'<,@#<"K*>!@9S0!O:UXP
MU+1IKVY;P[*VBV,J1W%[)<"-R#MR\<97YU7=UW#.#CI65;7$D?QXU52TC1)H
M"/Y:Y//FCH/6N>\3^&M2U6'Q/;R^&[S4-9EN9);._ED!A2V&"BQDMPV 5V@?
M>.3Q6Y)I6NW7Q"UK6[&RGM5N_#7D6DLP"E+@G*J>>"#C/TH W-+\6ZE/J^G6
M6K^'WTR/5(Y'LV:Y$CY1=Q65-HV-MR<9/0BLF+XDZE<Z'J6M6OA:233].\Y9
MY#> ,S1R88(NW)&P;L\<\=LUBZ+HD]KK_A35+7PEJ-K]D9H=2N;DAIY))(64
MORY+(&Y+?[0P.*Z[P!H]S8>$9['5+0QM)>7;-%( =R/*Q'X$']: +^J^*H;)
M-"^Q0_;9-9N$BMU5]O[LJ7:7H>%49_*N%N?$?C*/QLI_T5K*#.ER7:QSBT%Q
M(596:+.21C;N!P"^-PJ;X=:3>'Q-=07C"6R\*B72]/DW;MY=]Y;V98_*3'UK
MU2@#S#QUK7B^PU*TM=/CBNQ;-'J4RV:RQ,L$?#K(<D.K-G"#D@=#C-=_H<]W
M=:/;W-[-:S2S+Y@>UC9$*GE<!B3T(Z_D.E:%% !6-XB_U6F_]A&#_P!"K9K&
M\1?ZK3?^PC!_Z%0!LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% &-XN_Y$O7?^P=<?\ HMJV:QO%W_(EZ[_V#KC_ -%M6S0!
MS?CG1[S7?#?V*Q17G^UVTN&8*-J3([<GV!K*^(_A&_U[3S?:"8TUF.WEM"';
M:MQ;RJ5>-C[9W#/0CWJ*74M6UWQKK.C0>)UT/^SS$EO;1V\3RW :,.9#Y@.5
MR2N%QTY-:_\ ;U[X?T.PC\0Q_;=9N)&@CATR/<UR1DAE4X"_(-S9.!SSTH R
M4T/7-"U/1M:L+"/4)(]&CTR]M!.L; H0RNC-\IP=P(R.HQ5&3P9K=SI\=U/%
M NH7?B6#5[F%)05@A0J-@8XW$*HSCJ2<5TMMXZTFXDT^,Q7<$E[=R6.R:+:8
M+A%W>7)SP2.F,@U:U+Q9I6DZL^G7<CI)%8OJ$TFW*10J<%F/7D\  '.#0!3U
M;0KN]\?Z#JJQ(]C:6MW#.689S($"C'?.#2W'P_\ #3Z)J>F6>DVE@FH0&"62
MUA5&QV/'7!Y'TJ;1O%]IJ]^+%K#4=/N7@-Q#'?0",SQ@@%DP3TRN0<$9'%9_
MA_XCZ7XG>U_LC3]6N(IF*R3BV'EVQ!(Q(V[ /&<#)P03C- %2PN_B#I&FQZ5
M+H%CJD\""*/4EU 11R #"LZ%=P.,9 SDYQ5?QCX3\2:Y\)[G0Y;R+4M<G=)'
MDPL4>?-#E5Z?*HX&>3BM:V^(FE75S:@66II8W=Q]EMM2DMP+>60DJ #G=@D8
M!*@'UJ2Z\=V,.K:CI5KINJZA?:>RK<0V=N'*AD#!LE@,8..3DD' .#0!7\1>
M%]2O;/0=1TF:"'7=$PT GSY4JL@62-B.0& ZCTJ*:Z\>ZVL5E'I-MX>4NIGO
MVO$N7"@Y(B0+@D],MQCM6B?'>COX>T[6+875TFI/Y=I;00[IY7&=RA21@KM;
M)) &.M,7Q]I+:7)=F"^2YCNA9-I[0?Z3YY&0@3."2OS9SC'.>* -#5/^0_H/
M_7:;_P!$M6S7(V_B"VUW6]*$4%S:W-K=2Q7%K=($EB8P,PR 2,$$$$$@UUU
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &-X;_P"/.]_[
M"-U_Z-:MFL;PW_QYWO\ V$;K_P!&M6S0 4444 %%%% !1110 4444 %%%% !
M1110 5CZ]X:T_P 2)!%J1N7MHF):VCN&2*;D'$B@@. 0.#[^M;%% " !5"J
M !@ =J6BB@ HHHH **** ,;Q!][2?^PC%_)JV:QO$'WM)_[",7\FK9H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "L>'PSIT7B*377^T3WY4I&T\[2+
M I^\(U)PF<#.!6Q10 4444 %%%% !1110!C2_P#(Z6G_ &#IO_1D5;-8TO\
MR.EI_P!@Z;_T9%6S0 4444 %%%% !1110 4444 %%%% !1110 56U"R74+":
MT>>X@648,EM*8Y%_W6'(JS10!0T;1;#0-,CT_3H?*@0EN6+,[$Y9F8\LQ/))
MJ_110 4444 %8WB+_5:;_P!A&#_T*MFL;Q%_JM-_[",'_H5 &S1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C2_\
M(Z6G_8.F_P#1D5;-8TO_ ".EI_V#IO\ T9%6S0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5C>(O]5IO_81@_P#0JV:QO$7^JTW_ +",
M'_H5 &S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?8?$'_0;M/\ P7__ &R@#9HK&^P^(/\ H-VG_@O_ /ME'V'Q!_T&[3_P7_\
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M /ME &S16-]A\0?]!NT_\%__ -LH^P^(/^@W:?\ @O\ _ME &S16-]A\0?\
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M<D@XVXSS0!ZS17DLOBKQ%+H.E16>H3I._B5-,2]N[+RVN+=D9E=HV5>1D X
MR4[9K5DU35?"/C"XL;G6+O5K!]%GU';=K&'22)AG:45?E(/3'% 'HM8/_"9Z
M!_:M[IB7K27=DC/<K%;R.L05=Q!95*YP#\N<]L9K@_#_ (GU&[O="9=:U>^F
MU3Y-0@?3&BAM=\997A<Q  (P"\LVX'-4_!UK?:9:_$748=;OVEL;^] 5Q$5E
MD6+(D?"9W9P>"%XZ4 >M6>J65]I]M?03C[/<A3"TBF,MGH,, 03Z$9JY7B6M
MSZIKOA?X9W]SK-XD]]J-JLIB$8'F$,?- *'YAV_A]JW]=U/4=+\02V6H^*=1
MTB&*&%=,O);6-[:Y?;\YG?9C<6X(R@QR.M 'IU%(N=HR03CG'2EH **** "B
MBB@ HHHH **** ,;PW_QYWO_ &$;K_T:U6Y]9TVVU:UTF:]@34+I6:&V+_.X
M4$D@>F ?RJIX;_X\[W_L(W7_ *-:N;US2K&R^)OA&\M[9$N;R[NWN)>K2$6K
M 9)[ #@=!0!TVM^*=#\.>4-7U*&U:;/EHV2S =2%&3@>O2K]C?6NI64-[8W$
M=Q;3+NCEB8,K#V(K%UZYT3PW=MX@N;9I=5GB6R@2++S7')98HUSC))).,>I.
M!2>!M$N=!\+Q6MZL<=S+-+<RPQ'*0F1V?RU]EW8_ T ='17E=[/KVH6_CN\3
MQ%?6BZ+<2M91VX0#*0+)A\J=RY[<=6Z\8M6MYK=GJG@S4[C6[FY_MTE+RS8(
M($W0-(OE@#*[2 ,Y)/>@#TJBO)_[0U^^\ W_ (\BUZ\AN8C/<V]BH3[,L,4C
M 1LNW+$JIRV<Y/'2M6V?5?%?C#7+-==O].TZ"TLIXH[0HKAY48_>*GCCD=SC
MTP0#T!YHHGC221$:1ML89@"YP3@>IP"?P-5;#5K/4Y[Z&UD+O8S_ &><%2-L
MFU6QSUX8<BO(TEU+Q0WPVN[W6+Z&YN9+J*62V*)\\<<H\P J0&(&#VP> *T;
M?3M1N9_']Y::Y>Z<+34))85M=@W2K;QG+[E.Y>%&T8[^V #UBFRR+#$\KG"(
MI9C["O*]0\0ZC<VNBZEJVJZMI&EW>C6]PE[IT >)+IP2_G?*Q"@%, X7[W->
MBEVD\-[WN8[IFL\FXB&$E.S[RC)P#U')ZT 3:7J5KK&EVNI64ADM;J-98G*E
M<J1D'!Y%6Z\9T7^V/#WPR\,>)8]<NW$?V2.2P(3[.UN[K'M"[<[L,#NSUSVX
M$NH>+=5N)]<U"SO->-_87\L%E86FG226DB1/M*NPC()?#9.X;<CIB@#V&BO/
M FL^(_%?BRS'B"_T^SL#;FUCM=BLKO;JQW%E)V@\XXR2<]JPX?&E]K%IX8M[
M^_U:U2XTC[==RZ1:-+--)N"*/E1MB\,QX&20* /3==U_3/#>FMJ&JW/D6P=4
M!V,Y9CT4*H))/H!45GXDL+Z\M;6)+Q9;F W$8EM)(P$!P=Q91M.1T.#7DOBQ
MM3UOP=X;N=1O=4AGC\0Q68,D(@,R"1PDY1DR'V[?;.>*Z^2ZU.T^*6F>&AK%
M[)8R:)+([2%#(TF\@.2% W =.,<=* ._BFBG4M%(DBJQ0E&! 8'!'U!&*?7C
M/AJ+6;'X</>V.H:S<";5Y5O!;JDDT4 GD$CQ+MR78X+=>Y %>@^";V&^TF>2
MUU^;6+=;@K&]S'LG@X&8Y. 2P.3RH.".O6@#I:*** ,;Q!][2?\ L(Q?R:M#
M4-1L])L);[4+F*VM81F265MJJ/K6?X@^]I/_ &$8OY-61\0[2XFTO2KR&SEO
M8=.U6"\NK:%-[R1+N!PO\1!(;'^S0!N:+XBTCQ%#++I-_%=+$VV0)D,A/3*G
M!&?<5J5YSH^L1ZM\83<6-I=06L^A-ODN(&@,S),NUMC -@!R 2.><=*TO%EQ
MJDOC3PSH]CJ<]A;7\5X;EH0N\A%C(VE@0#R1G'&3WQ0!VE%>2 >(I-$\8D^*
MM24^'9IQ9.HCWR;8A*/..WYQR!V[^V-BVU#4_&'B"VT[^U+K3;2'1K:^G^PE
M4DEFFS@;B#A5"G@=2>: /0Z:[I%&TDC*B*"S,QP !U)->4CQ!XAN+;3-+75W
MCNXO$LVCSWHC7=-"L;L&*XV[L;>V-R]#TJ/Q%_:5II?CW09-<U&YMK724O8)
M9F0RKN60/&6"C*G8.V<$X- 'ILVLV,&IV&GO-FXOTDDM@H)#J@4L<CCHP^N:
MOUY,^DW9UCX>64.L7J-+87C/=-L:9$,<)*H=N!Z D' ]^:G?4/$5I8>(=*@O
M]3OETS5H(VNH422\6T>-'<*-N&8;L9P3@GT% 'J54;75K.\U._TZ"0M<V!C%
MPI4C;O7<O/0\>E8W@B]@OM,N7M=?GUBW6<JC746R>W^49CDX4D@Y(RH.".O6
MN<M]'O=8^)'C2.'6KW3(4^QG-D5#NY@X+%@>!CH,9SSTH ]*HKQVV\;:AK-E
MX=M-0OM4MA+93SWLVD6C2S321S>2OW4;8I*LQ..N!Q5RWUOQ'J(\+Z>;^^LY
M+G4KRTDN9K7R9;B!(W9)"CJ,,5 YQC=SCM0!ZM2,P52S$!0,DGH*\IU#Q#K'
MAB'Q7I:ZK=WAM)[".SNKB,331"Y.UN%7YRN"5&#S@<U-975]J$FL:/!J7B5]
M,?33<+>W]FT$L,RMAD5WC (92.,'&&QB@#J;7X@>'[[3;C4;26\N+.!U0S1V
M,Q5RS%1L.WYQD')7..]=+YT7G^1YB>=MW^7N&[;G&<>F>]>%:?<ZGX:_9]L=
M7TW6+Y+B9X51&*%(!YY!"#;D9!YR3782V%T_QNO)(=3O0T>B1W$<.]1&3YK+
MY9^7.S(!ZYR3SVH ](HKSCP/J=S/J]M;ZCX@U1-9-NS:AI&IVP0,_&6@(4#:
M#G[I8%2,^M>CT %%%% !1110!C2_\CI:?]@Z;_T9%5K5]:TW0;$WFJ7D5K;[
M@@>0_>8] !U)]A567_D=+3_L'3?^C(JY?Q9)J4WQ,\.6NGV]M-+%974\)NF(
MBCDRBER ,DA20 .[]10!VFDZQIVN6"WVEW<5U;,2HDC.<$=0>X(]#5VN5\&Z
M@UQ<ZY8WFFVEEJUG>#[:;/\ U<[.BLLH)&>5QUYXK+GCU;7OB!K^CIKU[I]A
M:V=K*BVFP.)'\SG<5/'RY([X'/7(!WU%>0:?J_B)O!OACQ=<Z_=275S?6UM/
M:*J+;R1-+Y1RNW.XCYMV>IX &*VXAK/BJX\37T.OWVFC3;V6RL8+;8(PT2*2
M\@93ORQZ=,"@#T2F2S10('FD2-2P4%V !). .>Y) KS'2M;UGQCK&@0C5;C3
MK:^\/_;;I;0*&,@D53L+ [>3U]./>L;69-3U+PW:6EYK5\[V'B]--$ZE%>6,
M2KL9_EP77C!QC(Y!H ]=@U:SN=7O-+BD)N[-(Y)DVD!5DW;>>ASM/2KM>:6N
MAW=_\1_$5E'KNH6D4.GV DG@9!/,P$H4LQ4C^\3@#)([<'/B\0ZU>^%/#=_J
ME_JT.G,ES'J%]I4 :7S8Y-D;. K%4(5R2HZXSQ0!ZW5+2M6L]:LVNK&0R0K+
M)"6*E?F1BK#!]P:K^&Y_M7AVQF_M5-5#QY%\B!!,,G!(' ..#[@\#I7EFFVV
MLV7P\USQ#8Z]=VTFG7M]<6UK&$\AE29V82 J2Q;YAU&!C'?(![117DNJ>*[O
M5=:U9(]1UVQ^Q00BRBTRP>=&E>%92TI6-L\NJ[21P">^:T;2]UWQ/XIM+&?4
M;[2+>7P_;7US;VZA)4G9W#*"RDK[\9^4=.: /2:J:IJEEHNF7&I:C<+;V=NN
M^65LD*/H.3]!7E8\6ZI_8^CZ5>ZEJ.Z34KZUN;ZQMC+<R16[$+A44X+93+ =
M ?6LWQE<:AJGPF\3K=7FL&WTZYC%K+>6QMWNX6:(@2*R MM8L,C&< T >J6?
MB[2[]=/: 7N-0=T@,EE*F2H!).Y1M&",$X![5M)-%*\B1R([1-MD56!*' .#
MZ'!!_$5YUJ5SJ?A_Q)X#TJ#6+ZXM[^>?[2;AD9I%$:E5)"C@'I61HUIK=G;^
M/[S2=2U.ZOX=3:".(F-RPVP[I I49E"9"]N ,4 >OT5Q_@:_M[UK];7Q#?:E
M%'Y8:UU*'9=6C\Y#953AN, C@@X)[=A0 5C>(O\ 5:;_ -A&#_T*MFL;Q%_J
MM-_[",'_ *%0!LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% &-XN_P"1+UW_ +!UQ_Z+:MFL;Q=_R)>N_P#8.N/_ $6U;- !
M1110 4444 %%%% !1110 4444 8VJ_\ (?T'_KM-_P"BFK4N8?M%I-!NV^8C
M)G&<9&*R]5_Y#^@_]=IO_135LT >?Z-X,\7Z)H-MHMIXQLXK2WC\I'72,R!?
M8F4C/OBKD?@+^R-,T.+P]?BUO-'65(I;J+SEF64YD$B@J>6 ;((P17:44 <E
M=>$M0U&TT8:CK?VB[L-634Y)?LX56VAAY2+GY5&[@DL>.^:N:AX6CU+Q9#K,
M\X,":=-826VS[XD923NSQP,8QWKH:* .5T'PYKVE26%K<^(4GTK3T\N"&.TV
M2S*%VH)7W$':/[H7) )J/3_!+6.G^++7[>'_ +?N;B<-Y./(\U-N,9^;'7MF
MNNHH X.[^'EQ)X0\-:3::LD5[H$\-Q!<O;[DD:,$89-P.#GUJSJOA?Q-JEI>
M6,OB.T-EJ, BNXWT\L8\IM<P_O/E##G#;L'GVKLZ* (X(5M[>.!,[(T"+DY.
M ,5)110 4444 %%%% !1110 4444 8WAO_CSO?\ L(W7_HUJPM:\'^(=5\16
MFK1>*XK<6,LDEG$=,5_*#H4()WC=P3VK=\-_\>=[_P!A&Z_]&M6')XSU>>>^
MNM*\/?;](L+MK2:1+@_:)64A9&BB"D,%.>K G!Q0 :CX.UV\\16FMV_B>*&Z
MM[(6J^9IJRJ&/,CJ"XVECC/L ,XKIM(MM1M+'RM4U%-0N=Q/GI;B$8[#:"?S
MS7.W7BW6;G4-6B\/Z);WUKI+^5<RSW9A:64*':.)0C9(!'+$#)Q4/_">W&I7
MFD6N@:4MV^JZ:;^%Y[CREB 901)A6(QN[9YP,<Y !HIX05;'Q3;?;2?[>DE<
MMY7^HWQ+'CK\V-N>U.D\)K(GA=/MI']A,K#]W_KL0F+U^7KGO7)Z[XZU^;PO
M%-8Z?!::A#KD>EWB&Z)"N)4X1MG*N#@D@$ ]#6U%J<+?%6RT^\T:&/5WT+SW
MO([EG$:^:08@"H##=D[L ^U $4WP]NVL+K0H-?,/ANZF>22R%J#*J.^]XEEW
M<(23_"2 <9KHM-\/IIOB/5M62?(U"*WC$ 3 B$2L!@YYSN]!C%<G:?$?5KC0
M-.\1R>'H8=$N)XX)7-X3,A>3R]ZILP5#$#D@GTQ72V7B4W=QXCB^R!/[&F\H
M'S,^=^Z63/3Y?O8[]* ,0?#RXM='\/6^G:V(+[1)YI8;F2T\Q7$F_<"F\=GQ
MG=VK9L_"WV6W\11&\+G6IWF9O*QY1:)8\=>?NY[=:I0^*=<U71M%O-&T&&1]
M0LEO)7NKHQPP A2$WA"68[N.!TS6%?\ C?7=1O/!<VB6,"0ZK),98)[HH6>.
M.0-&Q"-A01D,.I4<#K0!MCPCK5GIEE8:5XF$$$.GQ6,T=Q9"96V+M\Q!O&QB
M.H.X<#TKH+#1X=-\.6VBV[MY%O:K:QN_)VJNT$^]<E!XFTG3/%_CJ>73!;R:
M5;6T]Y>)*6:Y'E%E&P\*0/E&#S5NU\7ZS!>:1_;NAV]E9ZQ((;:2&\,KPR%2
MRI*I10"0#RI.#Q0!3L?AU?6^E:1H=UXB-SHFG213?9S9A9)6C.X*9-Q^3<,X
MVYP ,UHOX0U2"^O1I?B)['3+ZZ-U/;K;!I5=B"_ER[OE#$9.5."3CK61+\1=
M771+[7HO#L)TK3KJ6"[9[W$K!)2A:-=F" ,$Y(YR!TR?1 0R@CD$9% &/I^@
M"QUS7=3^TESJS1,8]F/*V1"/KGG.,]JP;/P%=Z1I^B#1];6WU'3+-K(W$MIY
MD=Q$2&PT>\$$, 00W'/7-=O10!R6J^"Y]9T+2;"\UJ::XL=1CU"2ZDB!,S*S
M-MV@@*/FP.N !UJY<>%A/X^M/%/VPJ;>Q:S^S>7][<V[=NSQ],5T-% '$:=X
M)UG1[">ST[Q08(5O7N[0?8@?+WLS,DOS_O5._P#V2" :V_#N@SZ0^H75[?+>
MZAJ$PFN)4A\E/E144*F3@ *.I)-;E% !1110!C>(/O:3_P!A&+^35-KNF7.J
MZ8;>RU.?3;I9%DBN81G:RG.&7@,IZ%3U%0^(/O:3_P!A&+^34GB;7SX?T^"2
M*U-W>7=S':6EOOV"25\X!;!V@ $DX/ H @T'PW<Z?JEWK&K:F-2U2YC2#S4@
M$,<42DD(B9.,DDDDG)QZ58O]!%]XHT;6OM)0Z;'<((MF?,\T*.N>,;?0YS6+
M<>,]3T?3-0DUS0&BO+9X8[=;68R0WCRMM18Y&5<$-PP(XZ\U+;^*]5L]872M
M?TJVM;BXM);JTDM+HS1R^7@O&244JP# ]""* +"^$%6P\4VOVT_\3Z25RWE?
MZC?$L>.OS8VY[55?P9>V=SI]]HFLI9W]OI\>G3/-:>='<1I]TE-ZD,#D@Y[X
MYK/L?B!JUQ8:#K%SX?AM]'U::&W#_;-TT;R\*Q38 4W<9W9Q@X'2JUCXBUR[
MNO'::O86LVF:>KKY*W;9 $ /ECY!D,,DMG()P >M &S:^ XK6#2!_:,DEQ9Z
MF^J7,[QC-U,ZN&R 0%'S\8S@*![U8U/P;%JE[X@GEO&5-9TU+!D6/F(*'^8'
M//\ K.F.U8FF>,3:>'O!UMHWA]2=9MW%M:_:B%M]B!L%RI)7&<G&>. 3Q5A_
M']Y9:9K!U+2(H]2TJ\MK::&&Y+1NL[(%=7*@]'S@CM[T 7],\(7MM>>'[O4-
M82[FT:&>!#':>4)4D5%&1O."-G7OGM3I?"5Y'>ZQ?:;KDEG=W]Y%=HP@#*FR
M(1['7<-ZD#/4<X]*OWNOFS\5V&B?93(+JTGN?-5N5\LH-H7'.=_KVK'L_%NN
M'5-/M-4T""R_M2.4V2_;"TB.B%PDPV#82H/*EL8Q0!K^'M!N-)FU&]O[];W4
M-0E62>6.#R4&U BJJ9., =22367<^$-6B\1ZQK6C>(5LIM4$2R1RV0F1!&FT
M$?./FZD'IS@@UR'_  E6H77PF\0ZOXHTBVU"RBNY%6!;Q@9 +G;L)"#:J?+@
M\D@<@5V=YXEO_P"UK70M TRWN;S[$MY,;JY,44$9.U1D*Q+$@\8[9H @B\!/
MI-GHW]@:J;*]TRW>V\^>#SUN(W(9PZ[EY+C<"",'/6KL?A2X:[T"[O=8FN[G
M2IYYY))(@//:5'0@ '"*-_ YX 'O64_Q$F_LO3Y8M$=]0N-5?2)[/[0!Y,ZJ
MY^_C!7*CG X;/;%:WA[Q%J%_K>IZ+K&G06=_91Q3 VUP9HY8Y-V""54@@J00
M10!!J/@>'4KOQ!/)?2(VK"U*&- &MI(,E'!)^;YL'&!TQWJYI^B:P!>MK&O"
M^>X@\B-(;7R(HQSEMNYB6.>3GMC%=!10!PEQ\-EG^&-IX,_M4JMNR-]K\CEM
MLF_[F[CTZUJ:CX5NKGQE'X@LM7-IOLA8W,/D;S)&'+@H^X;&RQYP?I73T4 <
MIIWA754UC3K[6=?74ETQ7%JJV8B<EUV%I&W'<=N>@49.:ZNBB@ HHHH ****
M ,:7_D=+3_L'3?\ HR*H?$7AV;5KJPU'3]0_L_5+!G\BX,(E0HX ='3(RIP#
MU!! -32_\CI:?]@Z;_T9%5;7_$-Y9:M8Z+H]A%>ZI=QR3[9YS%%%$F 79@K'
MDL  !_*@"7PUX=?0Q?7%W?-?ZEJ$_GW5T8Q&&(4*JJH)VJJ@ #)^M266@BS\
M5ZKKGVDN;^""$P[,;/*W\YSSG?Z<8K%E\::DMOIMF/#[Q:_?W,UNEG<3%(E\
MH9>7S-IW1XP00O.0*KW?Q!N=)TC7I-3TA$U/16@,UO!<%XYHY6 5T<J#_>X*
M]5QWH M0^ UA\$Z3X<_M$D:=<PW G\G_ %GER^9C;NXSTSDT7G@W4EO-6.BZ
M^-.L]7<RW<#6@E99"H5GB;<-I8 =0W/-+%XIUV+7XM(U#0K6WFOK2:XT_;>E
MPS1[<QRG9\A^8<KN ]ZXS_A*[RZ^##:WXIT>WU.W>Z CC%XRF7-PR_-A!MV$
M #&<@<XH ] TSPA:Z1K=A?6<S+;V6E?V9%;E<G;O5@Q;/7Y<=.^:S+[X?-<Z
M3>VL&K&&YFUK^V8)S;AA%(&#!2N[YAQZCK5K4?%&K#Q7=>'='T>"YN8;2*[\
M^XNC%$%9G4@X1CGY1C'7)Z8Y@TGQX=4'AH'33#)J\US;S(9L_9W@5]PZ?,"4
M([<'/M0!JZ/X>GT[7=0U>ZOUN;F^MK:&4+!Y:AH@^6 W'[V_IVQU-9=CX.U?
M1-(T^ST;Q'Y#VOGA_/M/-BF$DADR4W@AES@$-Z\<U;F\57*ZAXCLK72)+N?2
M$MS%'%)\UPTJD@<CY0.YYXR?:LC4O&&O6NE>([6?3+*WUG3M.^W1&&\,D31'
M>"P8H"&4HWRD8)QR <T =3X=T5/#VAP::L[3E&=WE90N]W=G8X' &YC@=A7)
M_P#"N-171[S1(_$I72=0N)9KN+[&#(1)(69(WW_("#@Y#=R,9Q5*37I3I/@&
M;Q#H\%U>WUY L$R7;'RF:,$3'Y!ECSE>@]36W=^+]9GO-7_L'0[>]L](D,5S
M+/>&)Y9%4,Z1*$8$@$<L0">* )[[PEJ":I>7F@:XNE+?11QW4;6@FY1=JO&=
MPV-MP.=PX''%:%IX<^R^*#K1O9)6.FQ6&R1<L=CLV\MGDG=Z5BGQW<ZCJ.F6
M6@:4EX^I:6-1AEN+CRDC7< 0^%8C&>V3G QW&SX4\02^(=-N);FS%I>6EW+9
MW,*R>8JR1G!VM@9!!!Z#K0!D+X#DMK2%K'5C!J5MJ5S?V]TUN'5?.9B\;)N^
M9<-CJ#P#Q4FK^#+W7O!.IZ#J>O//<ZA('>[^S@)%AE(5(]W"_)TW$Y).:["B
M@#F]7\)C5M>\-ZH;TQ'1'D<1^7GSMZ!>N?EQC/>J*>"]2M=0UV;3_$;VEOJD
MXNU1+4&2&<;.=^[#(=F"A7D$C-=E10!SVA^'[VQU>[U?5M3CO]0N(8[<-#;>
M1&D:%F "[F))+DDD^G2NAHHH *QO$7^JTW_L(P?^A5LUC>(O]5IO_81@_P#0
MJ -FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH QO%W_(EZ[_ -@ZX_\ 1;5LUC>+O^1+UW_L'7'_ *+:MF@ HHHH **** "B
MBB@ HHHH **** ,;5?\ D/Z#_P!=IO\ T4U;-8VJ_P#(?T'_ *[3?^BFK9H
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MTW_L(P?^A4 ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!C>+O^1+UW_L'7'_HMJV:QO%W_ ")>N_\ 8.N/_1;5LT %%%%
M!1110 4444 %%%% !1110!C:K_R']!_Z[3?^BFK9K&U7_D/Z#_UVF_\ 135L
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8WAO\ X\[W
M_L(W7_HUJV:QO#?_ !YWO_81NO\ T:U;- !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!C>(/O:3_ -A&+^35LUC>(/O:3_V$8OY-
M6S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% &-+_R.EI_V#IO_ $9%6S6-+_R.EI_V#IO_ $9%6S0 4444 %%%% !1110
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M/]JZHN+^Y7Y;G&<2MSTZUK?\(]_U%]6_\"O_ *U &S16-_PCW_47U;_P*_\
MK4?\(]_U%]6_\"O_ *U &S16-_PCW_47U;_P*_\ K4?\(]_U%]6_\"O_ *U
M&S16-_PCW_47U;_P*_\ K4?\(]_U%]6_\"O_ *U &S16-_PCW_47U;_P*_\
MK4?\(]_U%]6_\"O_ *U &S16-_PCW_47U;_P*_\ K4?\(]_U%]6_\"O_ *U
M&S16-_PCW_47U;_P*_\ K4?\(]_U%]6_\"O_ *U &S16-_PCW_47U;_P*_\
MK4?\(]_U%]6_\"O_ *U &S16-_PCW_47U;_P*_\ K4?\(]_U%]6_\"O_ *U
M&S16-_PCW_47U;_P*_\ K4?\(]_U%]6_\"O_ *U &S16-_PCW_47U;_P*_\
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MF:25 \;#."N'*[<8X% 'LM4;F]N8-5LK2/3IIX+@/YMTC*$M]HR-P)R=QX&
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ME/O\X7#[VEWC!W'C/&!] *K6/@33;7<MQ>:EJ$7V9[2**]N2ZPPN &50 .H
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MC&BCS .<YX*C)[@'BKFL^*M1TC5K/P]?>*-&TV[2R-W<ZC=P!5F+2,J(D9D
M'"G)R>@]: .TU_0[/Q)H=UI&H"3[-< !C&VU@00P(/8@@'\*KZ=X9MM/U.'4
MC=WMU>Q69LO.N90S.ADWY; &3GOZ5PP^)CZC8Z'$-8TC1IKR*XDNK^X(>$>3
M)Y6(@6 ;>V6&3PH/6I;?Q[K&IV>A1:;-IDUW=ZI<:;/<HI>!_+1F$J -T("M
MC//3(ZT =5-X(TJ6RGMP]W$\FH/J27$4NV6&=R260XX')&"",$@YK0T30K?0
MX)UBN+JZFN)/-GN+N7S))&P ,G@       8KC(-5\:W.H>(M&34],6?1=DHO
M39$_:!)'O5/+WX3&&!;)[8'6J\OQ%EO;?P_$=7TK0)+_ $M=1N+J] 9020HC
MC5F7.3N.2> * .IU#P+I>IZG>W<\]\L5^%^V6<<^V"X*KM#,N,YP ." <#(-
M<[#X&D3QQLCN]7@M;31(+:WU&.4"0D2R$QEMNUOE*\$=E/7FF6OCK6M9A\-0
M:8^G?:=1N;RSN9PIDA!A!_>QX;E2%W 9YR!GO69XMUSQ&O@OQMI=SJ-N;O2#
M"#=PVQC,\,R [=N[Y&&?O GIT[T ;6M^"((F\(Z5I\%X;*VU"6:>X21C*C-%
M(?-9^NXN0<^N/I6]!X&TR/3M9M9[F^O)=8B\F\N[F8-,Z;2H4$    G&!WK:
MTN*\ATV!+^ZCNKH#YYHX?*5N>,+N;'&!U[5<H YT^"]*)\.9-Q_Q3Z!++YQT
MV!/GXYX4>E5;_P"'ND:A?74SW&H16M[*)KRPAN-MO<N,?,ZXSS@9P1G'-=91
M0!RE_P##[2-1N-1:>>_%IJ)+7-BEQM@>38%W[0,[L 'KC(!QD4P_#ZQ%TU[#
MJNL07[6\=LUW%<@2-&F< _+@YSR<=AC%==10!S+>!-$_L_0[%$FC@T6Z6[M0
MLG)D!)RY.=V223ZDTFH>!=-U&_NKDW>HV\-ZRO>VEM<;(;D@ 9<8SR  =I&0
M.:Z>B@"*YMH+NTEM+B)9+>:,QR1L.&4C!!]L5@:3X*L-*NHYC>ZC?"&%K>WB
MO;CS$@C; *J,#/  RV3@8S7244 >9Z[\/H]-L]%72I=5O(K35[22&TEG,D5I
M&)@6*KC. N>6)P,UT-]\/]*O[W49FN]2BM]2.Z\LX;C;!,^T+N*XSG &><''
M(-=710!@1>#]+BU71=14S^?H]J;2URXQL*[3N&.3@5332;7P6=3U6PBUF]6]
MG:9].MR)5$KG+,B<8R>N3@9KJZ* ./\ AQX7;PSX=E^T6R6U[?W+W<\"-N$.
MX_)$#W"J /KFF>-]#EUS6O"J+%<FWAOI))IK<E6@_<OM?</NX;;@^N*[.B@#
MF(? VF)INLVD]S?7<FL1^5>7=Q,&F=-I4*"    3@ =Z2;P+ISKI@M[S4K-[
M"S6P62UN-C2P#&$<XY^[G(P>N#7444 <SIG@32-)N+&2U:Z"6%S/<VL+2 I"
M95(=5&/N_,2!G@FM6TT6ULM9U+58O,^TZ@(A-N;*_NU*K@=N#6C10 4444 %
M8WB+_5:;_P!A&#_T*MFL;Q%_JM-_[",'_H5 &S1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 8WB[_D2]=_[!UQ_Z+:MFL;Q=
M_P B7KO_ &#KC_T6U;- !1110 4444 %%%% !1110 4444 8VJ_\A_0?^NTW
M_HIJV:QM5_Y#^@_]=IO_ $4U;- ',W_ANYN_B%H_B%)H1;65I- \9SO8OC!'
M&,<>M0^.O"UWXIBT-;2>&(Z?JT-])YN?F1-V0, \\UUE% '/^)M$O=1FTS4=
M*EMTU+3)VEB6YSY4JLA1T8C)&0<@@'! XK'U?PWXEUK2;66[NM+.IVFJ1ZA!
M;!6^S!4!41%L;CU+;L=<<8%=Q10!Q-EX;\0MXR?7=2N=/9+O3S97$$)<?9U#
M%D\LD?/R3DMMZ\>E8UAX \1P_#V+PE=7.E&*TN(9+:XB:3<ZK/YK;P5X..!C
M->GT4 <_?:!<77CG2-=26(6]E:7$#QG.YC(4P1QC'RFL2Y\"WLSZ_/'>6\=S
M=ZI!J=@Y4L(WB5,"0<<$J0<=C7=T4 <7J>@^)_$/AC7=/U2XTN"2^M?(MH+7
M>T<9YR[.RAB3D< 8&.^:NZ_X:NM6L_#D,,T*-I>I6UY*7SAUC5@0N!U.>,UT
M]% '&6'AK6])^(NM:W:2Z?+IFL_9S<)*SK-$8D*_( "ISG/)'^/9T44 %%%%
M !1110 4444 8WAO_CSO?^PC=?\ HUJXRZ\%>)WT74M$MGTE+6346U".Y:1_
M-N29_.5)!L^7!P"P+<*!BNS\-_\ 'G>_]A&Z_P#1K5QVD^/CIA\2G4;75M0A
ML=7N1+/;PB1+2 $;0Q)' &3A<D#D]J +S:!XNTNZUA=!ETJ.'6)?M3RSR.7L
MIV15D9!LQ(/E!&=O/45)/X?\4:1K6IWOA^?3KG^U8HA.U^[1M%/&GE^: BD,
M" "5XY%:>J^-K+3ITAM['4=38VHO'-A"'$<)SAR68=<' &3QTIMWXYT^'[*+
M&RU'53<VBWP%A"'*0-]UVW,O7!P!D\'B@#.F\-^(--U5=4T]].U6YN+"&UO?
M[1)AWRQ[MLR[$8<[VRN!T&#3K[PEJU]XA\%ZG+=63MHOGF]*J8_,:2,+^[4
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MN#1]&\=:;=V5X+N]U.^-E&MK(_VLN JA2 03GCZ8/2O0_#?_ !YWO_81NO\
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MG_L(Q?R:MF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0DM+P_VGJ:XO[E?EN2,XE;GZUK?\(^O_ $%=6_\  H_X4GAO_CSO?^PC=?\
MHUJV: ,?_A'U_P"@KJW_ (%'_"C_ (1]?^@KJW_@4?\ "MBB@#'_ .$?7_H*
MZM_X%'_"C_A'U_Z"NK?^!1_PK8HH Q_^$?7_ *"NK?\ @4?\*/\ A'U_Z"NK
M?^!1_P *V** ,?\ X1]?^@KJW_@4?\*/^$?7_H*ZM_X%'_"MBB@#'_X1]?\
MH*ZM_P"!1_PH_P"$?7_H*ZM_X%'_  K8HH Q_P#A'U_Z"NK?^!1_PH_X1]?^
M@KJW_@4?\*V** ,?_A'U_P"@KJW_ (%'_"C_ (1]?^@KJW_@4?\ "MBB@#'_
M .$?7_H*ZM_X%'_"C_A'U_Z"NK?^!1_PK8HH Q_^$?7_ *"NK?\ @4?\*/\
MA'U_Z"NK?^!1_P *V** ,?\ X1]?^@KJW_@4?\*/^$?7_H*ZM_X%'_"MBB@#
M"F\+07'E^;J6J/Y;B1,W1^5AT/ZU+_PCZ_\ 05U;_P "C_A6Q10!C_\ "/K_
M -!75O\ P*/^%'_"/K_T%=6_\"C_ (5L44 8_P#PCZ_]!75O_ H_X4?\(^O_
M $%=6_\  H_X5L44 8__  CZ_P#05U;_ ,"C_A1_PCZ_]!75O_ H_P"%;%%
M&/\ \(^O_05U;_P*/^%'_"/K_P!!75O_  */^%;%% &/_P (^O\ T%=6_P#
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M8XW8QD=CFL7Q997NIZSXELKS3]<O9I8%CT:.W>:.T"F+YF9D(3(?=G?DD
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M?+5O_!9/_P#$4 ;-%8W_  DMI_SY:M_X+)__ (BC_A);3_GRU;_P63__ !%
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M>90* .JHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M65OI%_J<UI MQ>_8@A%NASC.]EW,<$A1DX%6=*\6Z=K&LR:;:B7>+*&_AE8
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M_P!"JE8>-K2]URUTQ].U*T-ZCR65Q<PJL=R%&3MPQ8<'.& XJ[XB_P!5IO\
MV$8/_0J -FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH QO%W_(EZ[_V#KC_T6U;-8WB[_D2]=_[!UQ_Z+:MF@ HHHH ****
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M+_Q)HFEZA!87^K6=M=W&/*AEF56;)P, GN>* +BM=C3PSQQ->"+)16(0R8Z
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MY34=1.C?"OQ1X8NK"].IQ/>G'V9_+>)Y&D$WF8V;=K9ZYR,8S7M5<AJ/@/\
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MC!'!H XKP"T*77P]:\*K!_8]Z+4RG \_S5SC/\6S/ZU3NO(8^(6TB2TCL?\
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M+#*T4D3X(W*ZD,IP2.#52+P=H4-A:6:V;&*UO%OXRTSLYN <B1F)RYY_B)H
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MBBB@ HHHH **** "BBB@#&\7?\B9KO\ V#[C_P!%M6S6-XN_Y$O7?^P=<?\
MHMJV: "BBB@ HHHH **** "BBB@ HHHH Y_Q#<O:ZOH4L=I/=,)Y1Y4&W<?W
M3<_,0/UJ?^W+O_H7-6_\@?\ QVC5?^0_H/\ UVF_]%-6S0!C?VY=_P#0N:M_
MY _^.T?VY=_]"YJW_D#_ ..ULT4 8W]N7?\ T+FK?^0/_CM']N7?_0N:M_Y
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M"YJW_D#_ ..T?VY=_P#0N:M_Y _^.ULT4 8W]N7?_0N:M_Y _P#CM']N7?\
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M"YJW_D#_ ..T?VY=_P#0N:M_Y _^.ULT4 8W]N7?_0N:M_Y _P#CM']N7?\
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MID2!F./)F1%*DGMM=0?PJC\+_MFJZ3=>+=3C"7VM,C;1T6&-=B >Q(=O^!T
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ME.\;,,#R0<@]\8K;M["\T7XGQW$>D7+Z9<Z1!91RVV'CMV1V.')(( !'..:
M.\HHHH QO$'WM)_[",7\FKE_"NG3:5\2]=MI]1NK^9]-M9I9[AOO.7ER0HX4
M< !1P /QKIO$995TLHNYA?QD+G&3AN,URVG#Q@GCJZUJ?PI'';WMM!:N!J<;
M&(([DOT^;A^GM0!L_$2\N;7PD\-I.]O/?75O9":,X:,2RJC$'L=I.#6.VC6O
M@WQQH%OX?C^RP:M%<V\\+2.\;ND?F1R$$_>&U@3U(-;'B+2=7\2Z+JVGM#;V
MDL-Q%-I<YDW"1HRLBLX'W?F!4^W-4X+3Q%K/B6QUO5M%CT^/2+>;[/:K=I*]
MQ/(H4G<.%4*"!GG+<XH AM?'M]?26>BP:?$OB<W307UHY)CM8TP7F)ZE"I79
MZE@.QKIO%6L_\(]X4U75PH9[2V>5%/0L!\H/XXKC[7PEXAT^[M_%J.L_B6>?
M.I6HEQ%);-@>0A/ ,8"E3W(;.<UU'C?29M=\#ZUIEN,SW%HZQ+ZOC*C\2 *
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M0,)&VL-S E@WR\G&#CK0!%J6K)KWCWX4ZO'&8EO8+V<1DY*[H$.,]\9K:O\
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M HHHH QM5_Y#^@_]=IO_ $4U;-8VJ_\ (?T'_KM-_P"BFK9H **** "BBB@
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MTU*%Y;*XCGC21HF9#D!U.&7Z@\4 9.I^-?#>CW,UO?ZM!#/ P66,@EDRH;)
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M]T,;R3@>;(.,A20W7J!0!VEQX_\ #T?AW4M9M[]+B&P3,J ,KAB,JI!&1NZ
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MM/G5;A[/3=JO*45L-(S1EARN]05R/[U '7:G+9^#=(OM5M-,9X#-]JO4@;D
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MKEC]YC(23]>:QK;2K[6]$N9+>RCU>VMO$FH27&F2W'E"Z3>ZKACP2I((!X-
M'?7.H6/@\:-IJV;0Z5/)]DCG$A9;=S_JT8'D*W*@YP#@<#%=#7EVJKI=W\$O
M$$-C#>6D5HDY-K>-F2TFC;>(P<G@,!MP3P17HVESR76DV5Q+_K)8$=_J5!-
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MO/H[3O:1WGG"1EE15D; P&PS#/.?6NT\1?ZK3?\ L(P?^A4 ;-%%% !1110
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M;H0%.?E ))X[FL*[:_?2]$U+6#XAGT=]"MB+K2KF0/;7&TF26548,^05.2&
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MVT=S?)#$C?8E<9 D^;EL G:FX\<9H ENO VE7!TYXI]0LYK"U%E%-:731.T
MQ\C$=1P#ZYIB_#_1(;&*ULS>61AN9;F&:UN&22)I/O@-_=/H<C@4R/X@:?=Z
M1I5]IUC?WTNJ^8;2TA1!*RQDAW.6"JHXY+?Q#N:S-;^(SV]CH=SI>E7LYOM3
M%C/$T:"2%E+!XB"XQ)\IQ_#P3GID D\0>%7?0K;PCI4%P;34;GS=3OII"[",
M,'D+.>6D<@*/8GH!71MHS_\ "76VKHX2"'3Y+0Q!SR2Z,IV]!@*W/7YO:H/%
MUY<6_@#6[VW::UN4TR:6,YP\3",D<@\$'T-96@^.H;@:+9WFGZG NH1*EK?W
M$:B*YD";C@[BP) )&X#/:@!_C;09=>UCPNGD3/;07TDD\D+E&A'DN%<,#D$-
MMP1WQ5VW\$:3#INKV<KWETVKQ^7>W-S.7FD7:5 W=@ 3@#IFJ5Q\1=/@^TW(
MTS4Y=(M9S;SZK'&A@1@VUCC=O*@\%@I'!JS?^-K>VUF\TBSTG4]2O[2..9X[
M1$(*."0P9F [=.ISP#S@ DN_!&E75GI$$<M[:/I$7D6EQ:W!CE2/:%*EAU!"
MC.?2HD^'^AQ6,UM;B\@,EV+X3QW+"9)]@0NK]<E0<YSG)SUJ?3_&FEZHV@BU
M6X8:U%-+;DH!L$0&\/SP><<9Y!IM[XVTZREU.$V]Y+/874-H8HD4M/+*JLBQ
M_-Z,,DXQ@T :.B:#::#!-';/<327$OG3W%S*9)97P%RS'T   Z "N1A\%'4_
M%WBV[O'U*QCNYX%BFM+AH?M$0@164XZ@,"/4<X(R:U+OQG/#H5WJ:Z1);-I\
MNV]M]3F%NT:;<[E90ZOG*X //(SGBL;P-XN\2ZUI-Q#<:;"U_9B0S?;KD02[
MF)>)3&L9VJ4*C=[=#S0!UL/A;2;:]TFZMX#$VDV[VUHB,=J1L%!!'?[HYJMJ
MW@S3M5U&:_\ M&H65Q<1B*Y:QNFA^T(,X#@=< D \'!QFN2\,^/]:UGQ?=V8
ML(C:W+H;/SKI5B$<?R3F%PF9OFR>WU KT^@"M86%KI>GV]A90K!:VZ".*->B
MJ.@JO;Z)9VNNWVLQ*XO+V..*8EL@K'G;@=OO&M&B@#CV^&VA-"T)EU$0K-Y]
MM&+MMMF^_?NA'13N[\\$@<$U8N? .C7=WJL\K7NS5$ N[=;EA$[  "3;V<;1
MSZBNHHH YNP\%:;I^K6VK)<ZA-J,*/&US/=,[S(V/D?/51M! X //4FK?B+_
M %6F_P#81@_]"K9K&\1?ZK3?^PC!_P"A4 ;-%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!C>+O\ D2]=_P"P=<?^BVK9K&\7
M?\B7KO\ V#KC_P!%M6S0 45SNJ^-=*TK4I=/,=_>7<*J\\=C927'DJ1D%R@(
M7(YQUQ6MI6JV6MZ9!J.G7"W%I.NZ.101GG!X/(((((/((H N5Y[HUW!H?Q<\
M46>I2+!)K"6MS8R2':)E2/8R@GN#VZX.:]"JAJVAZ5KUJ+;5M.MKV$'*I/&'
MVGU&>A^E %>3Q+I:>([?0$G,VH31O*8X1O\ *1>\A'W0<X&>IKSSP/;O=^-O
MBG;1-MDFN(XU;T)64 UZ/H_AW1O#T+Q:1IEK9(YR_D1!2WU/4_C4UGI&G6%Y
M=W=I9007%XP>YEC0!I6&<%CWZG\Z .2^%>K63^ ['36DC@O]+0VM[:R,%>&1
M"0=P]#US[UTNB>(].\0F].F2M/#:3F!IPO[MW !.QNC 9P2.]0:MX,\-:Y=B
M[U30["ZN.!YLD(+$#L3U/XUK6MI;6-K':VEO%;V\8VI%$@55'H .!0!-1110
M!C:K_P A_0?^NTW_ **:MFL;5?\ D/Z#_P!=IO\ T4U;- !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% '#VGA==5U*'68-2NK&]L;^]C#0
MA&$D;S$LC!E/]T<CFA_AK"]FMD-=U-;.WN1=:?"OEXM)1)Y@(^7+X.0 ^0 3
M]:W_  W_ ,>=[_V$;K_T:U;- &-I/ARVTF75Y4DDN#JEP;B=9<8W% I P!QA
M?UKRR/2'OHM$T*SC\3[K/4X9$L=0M]L&GQ1R;F;S@@$@V@JOS-PW%>V44 <K
M=^"1-?WDMIKFI6%E?S">\L[9D597P 2'V[TW;1G:1GVJTOA=8?&4OB*UU*Z@
M:YB2*ZM5"&.<(&"$DKN&-W8CI7044 8'B'PK#X@O=,O6OKNSN=->22WDMBH(
M9EVY.X$''IT/(.:I1^ ;&73-7MM3O;O4+G5V1KJ\D*I)E,>7L"@!=F,CCKZU
MUE% ',Z?X0,.J+J>J:S>ZM>10/;V[W"QH($;&XJJ* 6.!ECSQ2KX*L5\*:7X
M>^TW'V;3I()(Y,KO8Q.&7/&.2.>*Z6B@#D+[P#%=WNK-%K6HVMAJQ+WMC#Y>
MR1R@0D,5++D 9 /-/D\$RI;VT&G>(M4L(X[**QE6+RW$L:#:&PZD(^"?F7'Z
M5UE% %;3K"WTK3+73[12EM:PI#$I.<*H '/T%6:** "BBB@ HHHH **** "B
MBB@#"\3J7ATY%&6:^0#_ +Y:O--$U2>W\ ^%=+F?6-.M+29K?67MK69)HB%<
MHN0N[:6 RR9[#(S7I_B#[VD_]A&+^35LT >'7%G.^@>([&*QU8M+KMC=PK>)
M+)+) 3" Y9LD_=.03E<8(&*[KQ),VB?$'1M?N;>YETTV-Q92RV\#S>0[,CJ6
M5 3@[2,@5V]8^NZ#)K#VD]MJM]IMW:LQBFM64@AA@AT<%6'U'':@#RJ:WN-;
M7Q)?QVFH01VWB6VO)8K<,ER(1"@+*H^8-M8/CJ.G6K^I:59:GX0\7W.AKX@U
M&>33EMUN=0\QO/ +/LC#@,=N3VQEL#/->C^'O#\'AZTGCCN)[JXNIVN;FZN"
M#)-(0 2<  #      %:] &9X>U*WU70K2ZM?-\HQA?WL+Q,"!@_*P!ZUY1%?
M2CX4ZEX5.EZ@-8OI[J&U@-G)B823OB3?MVA1DYR1C;GH1GVJB@#SJQOH_!'B
MKQ"-6@O6AO\ [//:3P6LDPF*0K&T?R X8%> <<,*S_"NB:CIFH^ UO+.6*2.
MWU.69=I(@,KJZHQZ X;&/4&O5:* /)->L+Y6\77:6-S(D.OZ?>;8XF9I(HUA
M+E!_%C!Z>AJ_/J46N^.IM1M]'O[_ $E?#MS"0UJ\?VIC)&6C4.%))''.,\XZ
M&O3** /.O!DP3Q&+'1+W6+OP_P#8W::+5(9 +24,H2-'D4,<J7RN3C:.:[]+
M2VC\G9;Q+Y*E8L(!Y8/4+Z#@=/2IJ* (39VS*ZM;PE7<2."@PSC&&/J>!S["
MIJ** "BBB@ HHHH **** "BBB@#S?XL6=S?Z-J5M:023SMI$I6.-2S-B> G
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MTW_L(P?^A4 ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"V4?8=?_Z#=K_X ?\ VRMBB@#'^PZ__P!!NU_\ /\ [91]AU__ *#=K_X
M?_;*V** ,?[#K_\ T&[7_P  /_ME'V'7_P#H-VO_ ( ?_;*V** .1\/V>MM:
M7GEZQ;*!?W((-EG)\ULG[]:WV'7_ /H-VO\ X ?_ &RJ-CK&FZ%HE_?:K>PV
M=JNHW(,DS;1DS-@#U/M6UJ.JV&D:>]_J%W%;6J8S+(V!ST'N3V% %/[#K_\
MT&[7_P  /_ME'V'7_P#H-VO_ ( ?_;*ET?Q#I/B".5]+OH[GR6"RJN0T9/3<
MIP1GW%:= &/]AU__ *#=K_X ?_;*/L.O_P#0;M?_   _^V5L44 8_P!AU_\
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M((H R/L.O_\ 0;M?_ #_ .V4?8=?_P"@W:_^ '_VRMBB@#'^PZ__ -!NU_\
M #_[91]AU_\ Z#=K_P" '_VRMBB@#'^PZ_\ ]!NU_P# #_[91]AU_P#Z#=K_
M . '_P!LK0-[;"\:T\]/M*Q><80?F"9(#8],@C\*KZ'K-MX@T.SU:S$@MKN,
M21B0 -@^H!- %?[#K_\ T&[7_P  /_ME'V'7_P#H-VO_ ( ?_;*V*SM=UJU\
M/:3)J5X)#!&\:,(U!;+NJ#@D=V% $'V'7_\ H-VO_@!_]LH^PZ__ -!NU_\
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M)%!4\L V01@B@#F9/%7B&70=)BL]0G2>3Q*NF)>W5D8VN+=HV97:-E7D9 X
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M :0*#@!CQQU(H \^4:DOPL/B]]>U9]4M;MS#F\?RPBW9CV,F<.",\L">0.@
MJ[K6HZEJVO>)A##XG>YL)A;::VEOM@A=8E;+KO <EFY# C;@5V9\#V1\#2>%
M/M5Q]E=V<S<;_FF,OICJ<?2C4O!KW>IWUW8:[J&EIJ(47T5L$(E*KMW*S*2C
M;0 2OH.XS0!Q&HZ0VJ?%?PK)J$VI6MU?:3+-<1Q7LL9AD"+E4VM\@SU P#WJ
M+4[F\U+3_BU;76H7K0V2@VZ"Y<","%CM&#PI(Y7H>]>D3^%K6;Q5IFOF><3Z
M?;26T<9.596ZEB>2?QJFG@73PWBG?<7#IXC&+E<@>6-A3Y./0]\T <I=:;=Z
M?HWAQB/$=YH(L"UPNFWLIN(YF"%6.&#L@&["J2!Z5W_AFXANO#6GS6^I2:E"
MT(V7<HP\HZ988'S=CWR#FL6'P;J=K:626WB[4X[FUB-N)O)A97BXPIC*[<C'
M#=>3DFM_1-(M]!T>VTRU:1XH%(WR'+.22S,3ZDDG\: -"BBB@ HHHH \Q^+;
MS+!$D4:R^;%'&Z,V%=3=V^5)[ ]#[&MJVO\ 6M+\;:9INNOIM\-1MYS:W-K:
MF%[=XPK/&<LV5((YR.1R*NZ]I%IKVN#2[Y6:VN=,G1]IPP_>Q$$'L00"#ZBE
MTCP@]EK,>K:GK5[J]Y;PM;VK7*QJ(4;&[ 11EC@98\\4 4/'3WDFM>$[&UU"
MZLH[R_DBG:WD*%T\ER1Q].#V.".16!9Z%/=:[XOT1]>UL:?IBPRV:KJ$@DC>
M2'<29,[F *\*21R>#7?ZIH4&JZGI%]++(CZ9<-/&JXPY*,F#[88TRV\.V]MJ
M^MZBLTIDU98EE4XPGEH4&W\#WH X'0]0O_&,WA32M0U&\BMWT#^TKLVL[0O<
MR;EC 9T(; R6(!&2:K7VH:O:07V@0:S? V7B:RM+>\:4M*(9@C;&8_?QN(^;
M.1C.:[!/ 4-II^BQZ;JMW97VD6YM8+Q%1F>(XW*ZL"K X!]B.*?%X#LDT^*"
M2]NIKC^U(]5N+J3;OGF1@1G  "_*!@ 8 H YO4-/DTOQ#KFA0ZIJLEA<^'GO
M2LU]+(Z3))MW*Y.Y<@\@'!K&T_1\^&?AC;P7U[$;N82/+]H9WC!M&W+&6)V#
M ( 7&,Y'->GW7ANUO/$$NK322EY=.;3FB& IC9]Q/KGM65I/@-=-M]$@FUB\
MO(]%G,EF)4C7:GE&,(=JC( 8G/6@#G'MM;M+GQGX?T.^U&Y%NEC<6R2WC/,B
MR%O.2.5R2"50XR>":Z'P)=64KZE!:7>M!HFC,NG:P7::T)!Y#.22K8R.2/E.
M*O7OA"&[U#5K^/4;VUN=12V'F6[!3"T!8H5XYR6Y!R".*GT/PZ^E7MYJ%YJ=
MQJ6H7:1QR7$R(F(TW;554  &78^I)H Y6^T8:W\7[^WFO;RWMET2W9TM+AH6
MD/FR@9=2&P.> >3C/2N>37]4DM],\/74VM7\,6JZC:SR6#XN[F*W(" N&4_Q
MC<003M]S7H&I^#VO/$DGB"QUF\T[47M4M T2(Z;%9FP5<$');\,#'?,"> ;2
MVT?3[6QU&\MK^QGDN8M1&UY6EDSYA<$;6#;CD8]/2@#D)[KQ FDV%B9];TV&
M3Q+!;6LUX^+DVKQDE6.3NPVX L3T7.<5)K=_?^"+_P 46NF:A?SPKHD5[ MY
M</<-#,TKQ%E+DG'0XSC(KLQX.26TL8[W5KZ\N+;4DU)IYF7,DB@@+M PJ8/W
M5 _4U/J/A'3]6U6_O;QI)%OM-&FRPY 7R]S-D'J&RQ_(4 <CH=K?OKT-C!;^
M+H=+NK26.^EU.X8$2C:4DC<.61C\X(7 Y''%<AH,$ND? C7]8L-0U&"\#SQH
MRWDFU,3@;E7.%;U8<G)]:]<T7PY=Z;?+=7OB'4=3,4)@@CGV(B*2,E@@&]_E
M'S-[^IK.B^'EA%X"O?"0O+DVMV[NTQV[UW/O..,=: .=;3EU#XE^$9Y[R_WR
M:*\[;+R1067RNP/0_P 0Z-WS4OA^2XL?%%I!K]WK]EK4MS*"\TK26%^IWE4C
MY*)A<$#"L-N.:Z>]\'+/J6BZA::I=65UI<!M@\:(PFB.W*L&!'.T<BH[7P7)
M%?63W6OZC>V%A.;BTLYPAV/@A=TFW>X7<<9/IG.* .KHHHH *QO$7^JTW_L(
MP?\ H5;-8WB+_5:;_P!A&#_T*@#9HHHH **** "BBB@ HHHH **** "BBB@
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M%I\DXNUN JM#^[502 QX)!Q0!I7?CO41'JVH:;X?^V:/I,LD5S<&[$<KF/\
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M4 4 *?4>G4U)10 WRTWE]B[V&"V.2/2HH;*UMP!!;0Q!6+ )&%P3U/'>IZ*
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M%%% !1110!C:K_R']!_Z[3?^BFK9KG_$-[;:?J^A7%W,L40GE!9NF3$U3_\
M"6:#_P!!.']?\* -FBL;_A+-!_Z"</Z_X4?\)9H/_03A_7_"@#9HK&_X2S0?
M^@G#^O\ A1_PEF@_]!.']?\ "@#9HK&_X2S0?^@G#^O^%'_"6:#_ -!.']?\
M* -FBL;_ (2S0?\ H)P_K_A1_P )9H/_ $$X?U_PH V:*QO^$LT'_H)P_K_A
M1_PEF@_]!.']?\* -FBL;_A+-!_Z"</Z_P"%'_"6:#_T$X?U_P * -FBL;_A
M+-!_Z"</Z_X4?\)9H/\ T$X?U_PH V:*QO\ A+-!_P"@G#^O^%'_  EF@_\
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M'_"6:#_T$X?U_P * -FBL;_A+-!_Z"</Z_X4?\)9H/\ T$X?U_PH V:*QO\
MA+-!_P"@G#^O^%'_  EF@_\ 03A_7_"@#9HK&_X2S0?^@G#^O^%'_"6:#_T$
MX?U_PH V:*QO^$LT'_H)P_K_ (4?\)9H/_03A_7_  H V:*QO^$LT'_H)P_K
M_A1_PEF@_P#03A_7_"@#9HK&_P"$LT'_ *"</Z_X4?\ "6:#_P!!.']?\* -
MFBL;_A+-!_Z"</Z_X4?\)9H/_03A_7_"@#9HK&_X2S0?^@G#^O\ A1_PEF@_
M]!.']?\ "@#9HK&_X2S0?^@G#^O^%'_"6:#_ -!.']?\* "7_D=+3_L'3?\
MHR*MFN1D\2:.?%=M<"_C\E;&5"^#@,7C('3K@'\JU?\ A+-!_P"@G#^O^% &
MS16-_P )9H/_ $$X?U_PH_X2S0?^@G#^O^% &S16-_PEF@_]!.']?\*/^$LT
M'_H)P_K_ (4 ;-%8W_"6:#_T$X?U_P */^$LT'_H)P_K_A0!LT5C?\)9H/\
MT$X?U_PH_P"$LT'_ *"</Z_X4 ;-%8W_  EF@_\ 03A_7_"C_A+-!_Z"</Z_
MX4 ;-%8W_"6:#_T$X?U_PH_X2S0?^@G#^O\ A0!LT5C?\)9H/_03A_7_  H_
MX2S0?^@G#^O^% &S16-_PEF@_P#03A_7_"C_ (2S0?\ H)P_K_A0!LT5C?\
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M3+F32+[2);N!HPXN[L)&@8\;BN2"1TXYKSU[.UCL_BW)';0K(B2JK+& 5!M
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MO;S7 U&[CGDG0%DA2,>7R>0 N"/SJEX1LUU?Q1X8EUF!;F9/",4N)UW?/Y@
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M.\EN[8RW 4>8_F6SL^YNIR>N:H:7H^LZKX;>Z(\.VLAUF29]0N976Z2X6Z(
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M_P!A&#_T*@#9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** ,;Q=_R)>N_]@ZX_P#1;5LUC>+O^1+UW_L'7'_HMJV: "BBB@ H
MHHH **** "BBB@ HHHH P=?M8+W4](M+F,203M/'(AZ,K0N"/R-9H^%G@D
M>'[< ?[;_P#Q5:^J_P#(?T'_ *[3?^BFK9H P;GP7X=O-*L],GTN)K2S)-LH
M9@82>NU@=P_.LKP_X.CT?Q3XE9;"WCT6_MK6&&$8(<*L@D#+[E^<]<FNSHH
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MWTN)(+2Z%Y FYB(Y@  PR>P XZ5HKHVGHVH,MJ@.HG-V>?WOR[.?^ @"KU%
M&>=#TPVVG6YLX_)TUD:S3G$)52JD?1215-_!WAZ36O[8;2H#?>8)O,YP9!T?
M;G;N_P!K&?>MRB@!" P(/0\5SUKX#\+V5W:W5MHUO'+:E3#C=M1@,!MN<;@/
MXB,^]=%10!A7/@OPY>ZC<W]SI-O+<W*E9F;)#Y7825SC.WC=C..]0S^ O"]S
M+#+-H\+M$B1C<S894^Z'&</C_:S71T4 8FJ^#_#^MWJWFHZ7#<3A0A9LC>H.
M0K '#@>C9%+JWA+0==NH;K4M,AN)X4\M'.5.S.=IP1N7_9.16U10!5T[3;/2
M;-;.PMTM[=69Q&G0%F+-^9)/XUD3^!O#-S=7EQ-H]N\MYN,Y;.&+?>8#.%8X
MY(P3ZUT-% &8/#^DC5+34_L49OK.'[/;SG)9(\8V@_B?SI]KH6EV5_?WUM91
M1W6H%3=2 <R[00,_F:T** .<MO 7A>T5%@T>!-DRS(06RC+G;M.<J!N;@<<G
MBM:STC3]/M9[6UM(XX)Y'EECQD.SG+$@^I)J[10!SMAX$\,:9/#-9Z/!%+#*
M)8FRQ,; $#;D\#YCP..>E2VG@WP[8:M_:EKI4,=V'9U<$X1FSN95SM4G)Y '
M4UNT4 %%%% !1110 4444 %8WB+_ %6F_P#81@_]"K9K&\1?ZK3?^PC!_P"A
M4 ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!C>+O\ D2]=_P"P=<?^BVK9K&\7?\B7KO\ V#KC_P!%M6S0 4444 %%%% !
M1110 4444 %%%% &-JO_ "']!_Z[3?\ HIJV:QM5_P"0_H/_ %VF_P#135LT
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8WAO_CSO?\
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M^/5LT4 8WV?Q+_T$])_\%\G_ ,>H^S^)?^@GI/\ X+Y/_CU;-% &-]G\2_\
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M>H^S^)?^@GI/_@OD_P#CU;-% &-]G\2_]!/2?_!?)_\ 'J/L_B7_ *">D_\
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M !1_#M7'>N\H **** "BBB@ HHHH QO#?_'G>_\ 81NO_1K5Y_;W-Q!\4_'
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M;Q%_JM-_[",'_H5 &S1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 8WB[_D2]=_[!UQ_Z+:MFL;Q=_P B7KO_ &#KC_T6U;-
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M0_Z%G5?^_MK_ /'JV** ,?\ MG4/^A9U7_O[:_\ QZC^V=0_Z%G5?^_MK_\
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M5?\ O[:__'JV** ,?^V=0_Z%G5?^_MK_ /'J/[9U#_H6=5_[^VO_ ,>K8HH
MQ_[9U#_H6=5_[^VO_P >H_MG4/\ H6=5_P"_MK_\>K8HH Q_[9U#_H6=5_[^
MVO\ \>H_MG4/^A9U7_O[:_\ QZMBB@#'_MG4/^A9U7_O[:__ !ZC^V=0_P"A
M9U7_ +^VO_QZMBB@#'_MG4/^A9U7_O[:_P#QZC^V=0_Z%G5?^_MK_P#'JV**
M ,?^V=0_Z%G5?^_MK_\ 'J/[9U#_ *%G5?\ O[:__'JV** ,?^V=0_Z%G5?^
M_MK_ /'J/[9U#_H6=5_[^VO_ ,>K8HH Q_[9U#_H6=5_[^VO_P >H_MG4/\
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M4/\ H6=5_P"_MK_\>K8HH Q_[9U#_H6=5_[^VO\ \>H_MG4/^A9U7_O[:_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_:'WNIORA#'.6&WC!K7T2TU*/Q[8ZR^BZJEK)HKVTTUW(C2"7S$<[@&.!@'
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MX4URS\%>';*XTZ2.YM?$BWDT99<I#O<[^O3!% '4+XZGTV;6;?Q'I26$VFV
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MB'(Z!BF.:VS_ &KXJ\5>'[J70KW2[327EN+AKPH"\K1E%1-K'<!N)+<#@>M
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M(4M6:33[VVDNER/W2K ZL3SV) XJ?XI6LUQ\/[^6WC,DEF\-YL'5EBD5V_\
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M"0PX(R!7-7?@7Q!<:-XBT_[7IC?VKJ<5^CXD39M:)B",'_GE@=>N<]J](HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/<^&8-)TW2@+"[>&_$^;20JH!4(#A&PPK<L--L-1^(_CB2ZMH;C%I9HID4,
MK1/NQGUP/R% ':#7-(;44TY=4LC?2*'2V%PGF,I&00N<D8YIMWK^C6%['97F
MK6%M=R8V037*([9Z84G)KR?3=/M+?X8?#RZBMXUN3J]BQF"C>2TA!RW7IQ]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMF>*U8KE=[#@<8/? Y.*JZ-XTCMO"/AM]06]U#5;_3H[EHK.W,LK#:N^0A>
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M#-<V3,UM*ZY:(G&2/R'Y5SUEX]LW\,Z3J5[:7J7FH*JQ6<=JYEF?8&8QKU*
M$G<>,=ZVM#\0V/B"&X:T\Z.:VD\JXM[B(QRPO@'#*?4$$'H: )X]'TZ+6)M7
MCLX5U&:(0R7(7YV08PI/IP/RJ)?#NCK:ZC;#3K?R-2D:2\C*Y$S-]XMZDU1U
MOQEINA7K6<T%]<SQP_:)UL[9I?(BR0'?'0?*WOP>*;?>-]'LKFUME-S=W%Y:
MB[M8K2!I6FC)ZJ!]<\XXH O:;X;T;1VMVT_3X8&MXGAB*YRB,P9E!/8D _A1
M<^&M%N[.ZM+C38)+>[N/M,\;+Q)+Q\Y]_E'Y4[0M>LO$6F_;K$RA!(\4D<T9
M22*13AD93R"#6?J_C;2=&OY[2=+V8VJ+)>2VULTL=JK<@R,.G'/<XYZ4 ;2:
M?:1ZA-?I BW<T:QR2@?,RJ25!^FX_G18Z?::9:BULH$@@#,X1!@;F8LQ_$DG
M\:Q-1\;:5I^I/IJQWMY>BW2Y6"RMVF9XV) 88[?+R?<>HJG!\2_#URME- ;V
M2SNY$A6\%J_D1R/PJ.^.&R0#Z$\XH U=3\'^'=9U%-0U+1[2YND 'F2)DL!T
M#=FQ[YJ;6O#.B^(HX4U?38+L0DF,R+RF>N".0#W'>LK4/'^D6%_J%B(-1NKC
M3V NTM+1I?)4J'W,1P%P?QP<=#69KGB>>3QIX!32;_.E:Q]J>4(!MG01*R'D
M9&,Y[4 =O:VEO8VD5K:01P6\2A(XHU"JBCH !TK*OO!WAW4M4.IWFCVLUZP
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M90-+(\6 2^WL!N'7')QUJ.?QYH4-EIEV)IY8]3WK:K% S.[IU3;C(;/&,=:
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MDA-S?OJ<7G6D-E TLDD8 )?:.@&1UQUQ0!+<>#?#EU:W-K-H]JT%S,L\L83
M:0<!N.A]QBKMIH6EV-]]MM;***Z^SK;>:H^;RE^ZGT&!6,OQ"\.MHEUK N91
M8VMVME-(T179(VW@@\C&\9STYSTIS>.=.6QM;C[%JIEO)'2VM/L3B>8* 2X0
M\[,$')QU% %NS\&^'-/U3^TK31[2&\#,RR*GW"W4J.BD]R *OIH^G);7UNMI
M$(;YW>Z0#B5G&UBWU  K)?QMHZZ/::C$;F?[7*T$%K# S3O*N=Z>7U!7:V<X
M Q3)/'FA0Z/#J<TL\4,EW]A9'@8213X/R.F,@\?CD8SD4 76\-VG]N:5J402
M)=-MI+>&)4YVL% &<\ !3QCN.>.=FN03XC:2\MS;+8:P=0M\%]/^P/\ :-A&
M0^W^[[YZX'4BKK^-M&&B:=JEN]Q=QZD<6<-M"SRS'!) 3J, '.< 8H Z*BN9
MD\>:%#I%MJ4TL\<,]V;+RV@;S8YP&)C9,;@WRD8QSD8SD55N?B%8)HVMW45C
MJ*7FDP>=+9W%JR2;2"5?']S@Y/8 YQ0!V%%8_A?6V\0^';/4GM9K:2:)&=)8
MC'\Q4$E0>2O/![UFWWQ!T6PNKN-TOY;:RE\F[O8;1WM[=^,AW'ID9QG'>@#J
MJ*YO5/&^DZ7K":2R7ES?O"D\<%I;M,SHQ8!AM[#:23T QZBNDH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ*#Q!IL7P
MS\3Z"V[^U;V\U""UM1&2]R\DKJI08^;!.">VWFO;:Q_#>@KX>TR2S%P9]]U/
M<[RFW'F2,^,9/3=C- '+^&;.2U^)^JI,N98M$L8B^.I!?//U%<]'J]GH_P /
M/$7A*]W_ -OR27T$5EY9,ETTSN8W08^92'7GM@^E>PT4 >3^)VO_  %-I.MV
M\+S7%SHYTB=8QNS<HFZ!CCKE@ZY]#3/$V@?\([H?PUTB,%VM=>M/-<<[G.XN
MWXL2?QKUNB@#RN+6K+P[-XYT?4]XU&]O)KFTM_+9FNXY(5"!,#YN05/IWQ6+
MIT::</"VH:EKU_H5C/X8MK=+NW"!3*A+-&Y=& )#@CIG:?2O;J.M 'D=H=,\
M+:KX2UF2XOQH<D-^GVS48PK1RS2+(&<*H"A\-C@<8KH/ 5Y%J/BGQG?6\;K;
MSWL#1,Z%=Z^0HW@'L<9![@UWG6B@#@+N^MM-^.$+7LGDK>Z&EM;,P.)9?M#'
M8#ZX(./>N=CA9?V=[%!&0WVBW.W;S_Q_*:]AHH \5\;ZE-J5EXRL;K5=0CU"
M$R16FC6D:@20"-3YK_(692-Q)W <8'.*Z+2]9T]/BW),URHBU71;86+X.V<A
MW)"GN>:](HH HZ/K%GKVEQ:C8.SVTK.JLR%3E6*'@\]5-</X:1A\7?B(Q4A6
MBL,''!_<&N]L;&#3K06ULI$89W^9B269BS$D]RS$_C5F@#@O@NC)\)=#5U*L
M!-D$8/\ KI*FTK_1_C'XBCEX>ZTRTF@SW1&=&Q_P(C\Z[>L75O#ZZCK&EZO;
MW)M;^P<@2!-PEA;[\3#(R#@$'L0#0!ROPT!AU;QV\@V+_;\[;FX&,#GZ5>^$
MRM_PKNQE*E4GFN)XE(Z(TSLOY@@_C71>(=)EUS19],CO7LTN0(YI8TRYB/WU
M4Y^4D9&><9Z5>M+6"PLX+.UB6*W@C6.*->BJ!@ ?A0!Y)J=[;V\OQ6TN9]E]
M=6S3P0LIS+&+0 LOJ,C%=%J\9$WPZ"H0$NUS@?='V62N_HH \3\.V&G_ -G:
M9X=U7Q)KW]J6]^JOHT21821)MZR?ZK=Y? ??NZ'KVKOOB79W%YX*G^S_ &C,
M%Q;W$GV=0TGEQS(SE0002 "P&#TZ&NN[T4 >1SQZ3J&D^*M1T[Q%J^O7$7AZ
MYMS/.L9A574ML!2-<OE<XYP#[UK74/[_ .&"^7\J/R,?=_T1ORKT;I10!XQX
MU4K%\2V,+2*9])(0#[_^KX'\JZ636+'Q3\2?#+Z-,;E=,BNY;UU0CR Z!%1L
MCABW\)Y^6NJ\4:$/$OA^?2FN#;B5XG\P)NQLD5^F1UVX_&MB@#PKPU%+:_#K
MP_J<L,K6NF>)7NKL*A8I%F1?,P.2%+ _3)KLK633_&?Q$N;NQ9;W1H]#>PN;
MA ?+D>20'RPW1L*"3CIN%>AU7OH;F:QEBLKE;6X9<1S-%Y@0^NW(S^= 'EO@
MF"^U/Q+8Z)J2NR>"TEA:1AQ-*Y*0-^$(S]6%9NE6&G_8$\-ZQXDUZ/4%U)D;
M1K=(B&/V@NDBYBW>7]V0MNQUY[5ZGX;\/)X>LIT:ZDO+RZG:XN[N4 --(<#.
M!P    !T K9H \4FLM/1O$.A:YXCUVUGO-4N"NE6B1$W4<TFY&C#1$MD,,G=
MP0>F*]6\1:,FN>%M1T=SD75J\(9NS%< _@<&M6B@#Q*QN[O6?#UWXZN8)5NM
M+N-/55=3NVVZC[1@>A,\X]\5?M[RYTOPOH-Y>7\NCVVOZC<7^HWZHN^'S%9X
MD!92$R-BYQVQWKUZB@#Q73[C0_(URWU?4=7MP-<CN[;4F^6> -;J(YW.W 1@
M&4$KCY@"!7?^ ]5O=4TV^^U7PU*WM[LPVFHB$1?:H]BG=@<'#%EW#@[:ZNB@
M#S#3_%&C>'/&GCHZM,+</=0-&S(2)L6Z913CEO\ 9Z_-6-HUQ=Z'I?AG1-;U
M6]T.U71A,GV:,>=<3M(?W.2C'*J5^0#)+>U>H:3H*Z7K&M:@+@RG5+A)RA3'
ME[8U3&<\_=SVZUL4 >*>'2)H/AW;NKF:SU:_CN8Y!EXI )6P_P#M<J?QKK+V
M^MM,^-]J][)Y*7NAK:V[,#B27[03L!]<$&N_IKAFC8(VUB#AL9P?7% 'D$.F
MW"^+_P#A79A;^RH]2_ML-CY/L?WQ%]//X^@KT?QA%)/X)UZ&%&DEDTZX5$49
M+$QL  *A\/\ AJ32K^]U34-1?4M5O J27+1"-4C7.V-$&=JY)/4Y)R:Z"@#R
M+3M;TZ/_ (0+Q"UR'TFRTZ33KJX"G;:3M%%C?Q\N=I7/0'%=-X,E35?%_BO7
MK/<VEWC6L-M/M(6=HHR'9<]1E@N>AVFNWQ10!YEXJU267Q1K&EW>KW]@$LXA
MIME8HHDOW=6W?,4);#87 ( Y)]:K> )8KKQ#X5DB.\0^$! YQ]R1)8E93Z$$
M$?A7JU% ''^ %*_\)1E2,^(+LC(ZCY:X_5DL]-\2^*X-:\1ZQI:WTJS06UHD
M9%]$T*)A T;%GRK+@'TX[U[!1UH X#PU8)I_Q'N+:)9S%;^';*&-IP-^%>0?
M,1QNX&<=ZYN.%E^ ML@C(;^TU. O/_(1KV.B@#S"P\4:-X<\:^.CJTPMP]S
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M..U:<VGZM:>/_$4R:5<7%GK.GPQ1743)LB>-) 0X+ C)88P#UJ-O#VJGX?\
M@K3OL;?:]/N].DNH]RYC6(KO.<X.,=LT ;'Q(U?4M"\!:KJ.E!!<Q0G]XS[3
M$#QO7@Y8$C ./K7.76H:\OQ T"0:9;2:K-HMRI@%V?)3][&=S2;,XP.RDY./
M>NI\?Z3=ZYX"UG3+",27=Q;%8D+ ;FR#C)XYQ6;IMMJ>H>--'UJ?2;FQMX](
MGMI5N&3<DADC(!"L>H4D?KB@!L'CVZDT=MVD*-;&JMI LEN,QM.!N+>9MSLV
M?-G;GC&*VO#^NW6I7>HZ;J=E%::GI[)YJ0S&6-T<$HZ,54X.&&"!@J:XC4O!
ME_=0:G<7.CB^2/Q.^HK9,ZYNK=H5C.W)QGDD D?=]ZZKP7I=M8_;[BU\++H$
M,SHL:,R^=,J@_,ZJ2%P2<#)/TH S]8%UXJ\?2>'#?W5GI&G627-VMI*8I+B2
M1B%0N.0@"D\$9)K0T[PRWA;5'OK/6KP:(+=S<6-Y,]P%8<AXW8EEXSD<@U5U
MS3M9T;QDOBG1;#^TH;BT%IJ%BDBI(0K%DD0L0"1D@@D<5)#-XD\4W-Q#<Z8^
MB:&]I+"\=T4>XN'<8!PA(15Y[Y.>E %2#QYJGV#3M=O="BM_#VH31QQ3"[+7
M$2R,%CDDCV!0I)7@,2,]Z;?>/-83_A(I-/\ #\,]OH$SK<R2WAC,B+&KG8 A
MRV"<@X P.3G S/[-\1:GX0TCP5<Z%/;-:O:Q7>H-+&;<PP.K;HR&W,S!%P"H
MQDYZ5J1Z!JBZ/\08#:-YFJ37#6:[E_>AK947'/&6!'.* +-EXUU";5]$6[T5
M+?2M<W"RG^T[IE(C,B^9'MPNY0<88X[UG?\ "QM7?0[O7X_#<9TC3[B6&[8W
MO[TK'(59XUV88 #)R1SD=LF[-H6I,G@ +:DG3)%-Y\R_N@+9DYYY^8@<9KD=
M*?7-1^'&K>';#0YYSJ-Y>P07JR1B&-'G<.9,L&!7YC@*<\8[X .YU_Q1K.G?
M:[K3M"BNM,LK87,US/=&(S+M+%81M.XA1W(Y.*CNO&.H7'B&+1M#TB*[EFTR
M/48Y[FY,,:H[,N&PK'/ QC.<]L9KE]=\(7EWJ&O6<WALZM+<VT<.DW]PT9@M
M(Q"$/#-E&#AF^5>21R.HWO"NEZI'XGM-2N].FM(5\.V]DPE9"5F25]R_*Q[8
M.?0COQ0 _3OB"]T="-WI?V5-0O)].N'\_<+:ZC+ )]WY@Q5L'CZ5N6_B!KOQ
MI>Z#!:AH;&TCFN+K?]R20G;'MQ_=!;.?3BN/N?#-TOPT\10WH%E=Q:C=ZG:2
MNP^1EF:6)\@\ X'X$UN_#JVN7\/2:YJ$0CU#7)FU"9?[BL (T^@C"_K0!:UG
MQ'?P^(8?#^B:?!>:BUL;N5KJX,,4,6[:"2%8DDY  '8FL>Z^)$EKH,-X=%=K
M\:P-'N;%9P2DQS]UL88'Y<<#[W:K>KVVI:-X[7Q'::7<:G9W.G"RGBM63S8G
M20NK .R@J=Q!P>,"N?;PKKD]E9WLM@4N[OQ;#J\]L)%)MH!\OS'."0J@G&>3
MQ0!Z-I4NH3Z;%)JEK#:WC9\R&&7S57DXPV!GC':N:B\7:Q#JFGKJF@QV6G:C
M=M:6[FZW7"-ABADCV@ -L/1CC(S77N&,;!" Q!P3V->-6'AC4[>+P_<_\(=,
M-6TV^CFU34))(FGNS\P8QL7RRDMN.XKC  ![ '27'Q#UA=)U76+?P["^F:1=
MSV]V[WNV1UB<J6C780>,$Y(YR!G&:Z/2O$PU#Q/JFB36P@DM(H;BWDWY^T0R
M#[X&!C# J1S7-'PYJQ^&GBW2_L;?;;ZZU![:+>N9%DD8H<YP,@CK53XC66HV
M$?A_4=(*1ZO<(VB,I;!99TP#[['4/^= ':>%/$#>)])DU-;406K7,L=JV_=Y
MT2,5$G08W$'CGC'-85UXWU9H]7U'2M"AN]'TB:2*>62[,<TQB_UAB3800O(Y
M89QQ76Z3IMOHVD6>F6J[8+2%(8Q[*,?G7 ?8_$.AZ/XA\-VF@W%Z=0N+F2QO
M8Y8Q JSDG]Z68,I0L<X!SCB@#'\;7%]XF\>^$+2+3[2_TB[MYKJUMYKUXDNA
MY2MND 0[2N>/O9]LUZ#XSN;;3O >K7%Y8+=V\-HS26GF%!( /N[@,CZUSY\*
M:A9>,? 300F:PT73Y[6XN P 4^2J+P3GDCM70>/-.N]7\":WI]C"9KJXM7CB
MC! W,>@R>* .7?Q%KB>(/!%CH^GVL6FWVG-/]G>[8941H=I.PGY PQ_>[XQ6
MYI/BO5]8OA-;Z)"^C&\ELS.EYF>,HS*7>+: %RO3<2 0<5C3:5K&F:AX"U%-
M(N+Q=-T^2TO(K=X]\3O%&H/S, 0"IS@U&VD7USXNL[VU\+7&DZLE^'O=2MYT
M%K<6P)W9 ;+EEQP4R">O% '7^*->DT&SM&M[:.XNKV[2T@2:;RHP[ G+O@X&
M%/0$DX'>L^7Q5J>GV^G+JNBK;W5UJT>FLJ7.^,AE+"5&V@L.,8(!SG\;WBZ)
MI]'6%M 37+1Y0+JS)7?Y>#\R!B 6#;>,CO@YKAE\/:W!H,,]GI-Z+6QUZ'4+
M+2KBX5YTME0*ZABQ .XNP4MP.* -SQWKS-IWBO0!;X\KP[+>B??R=WF)MVX[
M;<YSWINC^+-5LU\.0ZKHL5MIFJ*EO:W"W6^57\O<@E3: NX*>C''>LS5=+\0
M>(+WQ1?_ -B3VL=]X<:QLXII(_,:3=(=K ,0I.[UQC&3G(%K[)KVN3>%-+N]
M#GL4T>YBN[R[DDC,3M%&RJL6UBS;F;/(& .: -CP_P"*]7UV6VNTT2$:+=R2
M1QW$5YOEBV[L&6/: H)7& Q()&:PM"\8V.G>%-4O=,T$0SMKLEA#9I<D_:;E
MF50Q9A\N<Y/!P!18:1?2>+]/O[7PM<:'?K<,VK744Z?9+F/:P("JWSEF*D$H
M".YK-T_PAX@M/"-TPTXF_M/%!U>WM3(H-Q$'' .< E=V,^E &M:WNJ2_%E(]
M9T^&VGB\/3L1;W!EBD4SQ<ABJD'@@@CCWS4OA#7Y9OAKH=UX9\-)']KEDCCL
MVNF\FV >3<[R%2=N5)Z$Y8"I+.'6]7^(7]N3Z)<Z?IPT6:SC%R\?FF0RQM\R
MJQP" <<_PG.,BN:TCPIK&G_#_P 'Z?JV@W-_;6,]RVI:7%)&6?<TAB8@L%<
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M0(BMP,L6.3G@"FZWXHUG1&T?1=:UJRTRZN/M$D^IQ0[PT49 3:A!"N^X$@Y
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M^Q"7[#%Y9*KC!!!8 ;V!QF@#V&BLCPS<7-WH<4USJ=GJ>YF\N]M  DT>3M)
MX#8X('&17#>(_&6H:-JUY,OB2Q=K:]BB71X+;S T+,BD22XRDF&8XS@8 YH
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MYC>^,-:\,VWBJSO]0AOKC37LQ:7DT C ^TG;F14X(0@GC&14FB>);W5]3O\
M0;/Q5'J6^P^U0ZBEFJ- ZN%="N K A@1W'/6@#;NO$G@J[O1K4NL6DDFA%E:
M9)B5A,N(SG'!R<#O77 @@$=Z\&\/:EK/A7]G+^W;'448@#[/ ]LA6$F[*L<_
MQ9!/7I7:S1ZK+\;H1'JK) NA_:!!Y"$%/.0-'D_WBH.[J.E 'HM%>>>"/$6J
M:UJ,/VOQ#:276QSJ&BS6H@FLV["/^)@#@$MD$'.>U=!XBU>\T[7O#%I;.JPW
M]\\-P"H.Y1"[@#TY44 ='17G7BGQ=J^E/XV%I,BC2;"TGM 8P=KR%]V?7.T=
M:M2:IXB\/>)-$76-4AO;+5C+'+"ELL?V618S(-C#EE^4K\V3WH [NBO+3XE\
M41>"(O'LFI0FT9EN&TC[,NP6S2!<"3[V\*=V>F>,5I2WWBC6/$'BNRL-9BT^
MVTEXOL["U25G+0*^UMW\.2?<[NHQR >@45C>$M7EU_PCI&K3HJ37=K'+(J=
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MY8A\\<9[5U-% 'G5W%K)^+NI2Z++9B9-&MP\5X&\MP99><KR""/0]3]19M/
M-U;P:"9+Z&6ZL]6EU6^DV%1-)('W!!V&7 &>PKN!!"+AIQ$@F90C2!1N*CH"
M>N.3^=24 <KJN@ZO#XH/B#P_/9">>U6UNK>]#['"L61PR\AAN88Q@@]JJ?\
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MB+?P5JF@WNFR^'KRR"V^E)I<C7L;$J%8MYB!3R22<J2!P.:Q-?TR/PQ\+9M
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M3)M*O$X_A=6 93[$"I-1U&+38H9)HYW$LZ0*(8FD(9C@$@=%]3T% %RBBB@
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M<,<_<&.1WH \T\*+K4S>&M6M=)U_[7<M'+J=]=7B-;W,,B$L0GFG !*E<*"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q=8T;4+V^@O=,UNXTZ>*-H
MFC*":&120<F,D#<".&!!ZCD5M44 <1<_#TRZ7;VD6M3K(+]M1NI9H$D%W.>A
M=.%P#C"]!M7TK1N/"]]J6E26FJZ[+<SK-'<6ES';)$UM(ARK #(;GJ#VR.]=
M-10!A:-X>EL-3NM6U'47U'4KB)(/-,0B6.)22$51G'+$DDG)^E-UKPW)J&JV
MVL:=J4FFZI!$T'G+&LB21,02CHW49 ((((K?HH YW2_#$NGG4[R75I[G6-0C
M$;WS1JOEA00@1!P I8G'.2>2:6^\/:C-/9WEGXANK6^@MQ;RNT:R0W ZEFB.
M &SSE2#SCI70T4 <Q:^%+NW&J7C:[.VM:A''$;\0(!"B$E52/&,?,W7).:WM
M0LQJ&F75DSE%N(7B+ 9(#*1G]:LT4 84WAJ*;P*WA<W+B(Z=]@\_:-V/+V;L
M>O?%8VO^#()-.U>XS>73S:?;6ZPVP42!K=V='0L<;MQ!P?[OO7;44 >::3I>
MHZ_XNDO[N74WMQHTUC)<WEC]D >1T(5(R 3@*Q+<@D@9].J'A2$67AFV^U/C
M0FC:-MH_>[86BY].&S^%=#10!QR_#ZT2'Q B7TRMJT@DC;:/]$(D:5=GKB1V
M?ZFGCP0;0:')I6J/:7.E6C6:R/ LHEC;;N)4D88E <@]SUKKJ* /.]7\--HG
MA37=*A.HZQ)K4SRVZ+!EX[E@#O>0?*HWA6R0 ,<9X%=CX=T@:%X?LM-#^8\$
M8$DG_/20\N__  )BQ_&M.B@#D9?"&J+XCU#6K/Q&T$UYM7#V4<IBC4<(I)X7
M.3CN3DT7OA'5+K7X-9C\1M'=0VJVR;[*.0+_ 'W4$_*6/7'8 =*ZZB@#$2SU
MN*^T@/J9N(85F^W-Y2()L@>7P.00?3CKGM4VN:/+J\-N;;4KK3KJVE\V*: @
MC.""'0\.I!/!_#%:M% ',6_A2XGU:'4M=U=]2FMXI(K>-(%@CC$@ =L#)+$#
M')P.>*HV/@*>VBT.VN->GN+/1)TDLX?(5/E560!R/O$*V >._'-=K10!R"^!
M?L_]GR6>J20W-EJ-S?)(T(<'SR^]"N?1R ?:I;;PC>:>\EMIVOW%II3W+7/V
M5($+H6?>R)(>B%B>,$\D UU5% &;K^ERZUH-YIL-]+8O<Q^7]HB&60'KCZC(
M_&LO2_"]]9VG]G7FL1W>D_9VMS9+8QPKL(VXRO(&*Z:B@#DK#P3)%/IRZEK,
MVI6.E@BRMI847:=A0&1A_K"$) X'7/)I+SX:^%KF]TZXAT33;;['<><R16<8
M$PV,NUN.F6#?517744 9NF0ZC'?:HU[.9+=[D&S4A1LB\M,CC_;W]>:R;WPM
MJ#^);O6],UY["6Z@B@EC^RI*"(RQ!!;I]\UU%% ')0>!((4MGDU&XGNUU5=5
MN+F55W3RA"F,  *N,  =,5+JO@FUU>;7)9KN:-M4CME!C S \#,R.I/4[F!P
M?2NHHH XR?P3+=W=WJ.L:G-JDTVE3Z:T$<*0JT;E3\O/#94\D]^P%<_HUAJF
MJ>)O"[SG6)H=*28S'4+$6RQ*T)C"YQB5R6&64D84],\^IT4 <MI/A.^T=;2R
MMO$%P-'LY-T-H(4#[ 21&TG4H.G0'  S2/X&L9=;UW4))Y'35K9K=[<J-L6]
M%61E]V$:9_W:ZJB@#C8_ ?V;2M'AM-6E34-,N9;I+V6%9/-DEW^873(SG>>A
M&.*BG^'KW$6M+)KMP[ZJ8)I9'A4E)XF4JXQ@;?D VXZ#K7;T4 <L_A748M0N
M-0T_7VM+N]BC2^;[(CK*Z+M$BJ3\C8X[C@<<5?M/#JVNOP:LU[//+%IPL#YN
M"S@/NWL?[Q/M6U10!FZ/#J,*WW]HSF;?>2O;Y"@I"3\J_+Z<]><8SS4=IH$%
MOJ.M74C>>FK.C2PNHV@+$L>/<$+^M:U% '#V'PUM-.T2YTZ'4[O<=034+2X(
M!>U=%58U&<A@%0+SU!-;*^'KN[T_4[76M7DU!;^W-NR+"L4<:$$':HR<G=R2
M3T'3%;]% '%-\.;672-&L9=0GD;3[IKF:8J-UWND\R17] S!2?I72ZWI?]M:
M1/8?:[BT:3!2XMWVO&P(8$?B!P>",BM"B@#DD\#1W<6L'7=1EU.YU2V6TEF$
M2PB.)=Q4(HS@[F+9.><5=L="U:.3.H^(IKV)8&A2);=(@V0!O?&=S<=L#D\5
MT%% '/0>&KBP\,:5I&FZQ/:RZ;'&B7 C5A*%7;AT/!!ZXR.0.:SSX!2:*]GN
M=4E;5;F[AO1>0PK&(I8AA"J<C&,@Y)SD\],=C10!SPAN]&LKZ^UF_N]8$B*G
MV:VLOE"\C"1)DDG=R23P.P%4_AUX=E\.^%DCNDD2[N7\V1)6W/&H 6*,GOLC
M5%^H-=;10!S^K>&[BZUE=8TK57TV^:W^S3-Y"RI+&&++E3_$I+8/N<@U13P+
M'81:5)H^I36=[IT<L0N)(Q-YZRL'D\Q3C)+C=D$8/M7744 <</ 2K&MTNK3C
M6EOVU#^T/*7F4Q^65\OILV?+C.>^<T]O L=Y#JDFIZG-<ZCJ!@)NXHUB\@PG
M=%Y:\XVL2>2<YYXKKJ* ,#2/#D]GK$NL:GJ;ZCJ#0"VCD\E8DBBW;B%4=R<$
MDGL.F*M:%HB:';WD:SM,UU>37CNPP=TC%L?@,#Z"M6B@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>exhibit1013-zerondaxexec008.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5VGCGKVJZ"#G!!QUH 6BBB@ HI 0PR""/:C(R1D<=: %HH!!&0<BB@ HHHH
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M_P 7S $>G:L?PSINMZMIVCZ_;>'HUU66^6ZGUEM07S)4,I$D;+C.W9E F<#
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M/'X<A%A&_A=KHQP9"B99&42 =F /7VKN+?P#H-K(6ABN$3[7#>^7]H<KY\0
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MD.6>(.PC8GOE ISWKA)M"T?4/"/CS4+N$'4+35[]K2X5CYL,H(,8CP>"7VC
MZ\#F@#V5G5,;F"Y.!DXR:2:5889)6!*HI8A1DX ["O*FEBU/Q!J.B>+[ZTM+
MA]*M?*%[&A#*T9\YHRQP&$F[..>%_N\>B>'(8[;PYI\$5Y/>Q1PJL=S/]^51
MP&/KD8Y[T 8MG\0=(O+?0I5NK<+J\C1Q/N)4.I \O..7RP&.!P3VYN>-?$-Q
MX9\,76J6D,$\T&PF.9RORLX7. .<;O;ZUNBUMPJ*((@J-O0!!A6]1Z'D\^]>
M):A/8:M\%]7U'4Q;MKR7[?;&EQYL4PN<!.>0!'@ ?W?QH ]P9U3&Y@N3@9.,
MFL?6];;3]0TK3+<)]LU29XXGD!*1A(V=F(!!/W0,9'7K7%ZK/IFL>-/$.C:]
MJ-G;0R6</V$W:(5:!D.]HF8X!#YR1SPOIPE]I.F-XB^'4,H3449;F+[3>1*T
MEPBVYV%LCGL1GUS0!W^D7&HO81_VS#;6]^692D$FY' )PRYYY&#CMFKY=5."
MP'U->23+I.OW/BG3=?UBWTZ^MM0;871%N(H5VF%X6/(& ,;>Y/\ >YT;7P]I
M.K_$[6X-2M!<J--L9MLW!,@:3YR!T;@<^Y'<T >E;UW;=PSZ9I ZLS*&!9>H
M!Z5Y+I&BVT>@>--7TZR5]9TW4]3_ +.D7):%MF $'X]/I[59TI-&NTTGQ!H&
ML0RZG'8S"&TM(T5[@F(DK.!ECM8 Y/1CZF@#L?%7B&XT'^R?LT,$PN]2M[.;
MS'(:-9'"[@ .3UZD?C715XLTFC7G@+P+JV^W?4&UFQ:YN7(\TS&0>=O/7[V<
M@^@]!7?_ !&OKJP\ :G=V9EW(L9D:$G>(3(HD*D=/D+<]NM '4*ZOG:P.#@X
M.<&@.K,RJP)7J >E><ZX=&@T?6-9\&3Q-JSZ(ZQII[CRQ&IRLA1>-XR=I//!
M'8U'=V]FG_"!:GX;2-)[FZCB=H<9GM&B9I=^/O8P#D]&]S0!Z470'!90<XZ]
M_2E#*6*A@2.HSTKP_4=)TX?#GQW>BVC^U6.MW36DW\5N5D3'EG^#\,9KL&TG
M3].^*NFPVEK%"E_H]S]K"C_CX(>/#.?XFY/)R>30!W^]=P7<,GH,T%U5E4L
MS= 3R:\+L-"LS\(_#NNZ='CQ'%>0K:7*N3(S&Y*&/.?N[2V5Z<$^M;<XTKQ!
M<^*M.\0:S!IU_;ZBQ5I$5;B*%=IA>%FY P!C;W)_O<@'K+.J EF P,G)I6=4
M&68*.F2<5YJFA:7JGQ'U^WU&T2ZB;1K1W2X7(9R9069>F[@<]NU9FBPZKJ/@
MKP9=Z=)8W]_;Z9)NTS4>4NHLHI*MSM=<* 2",.0>": /7&D1%W,ZJOJ3@55O
M-4L["YLK:XF59KV4Q0)GEV"EC^ "GGZ>M>;V.HZ%K$GA^"*T2U(T21T@U-PU
MO;P[U1ODXWOE" 05^7)SR!6+HW]GZAX?^%T^H?9;@+++!-)/M? $$F$8G_@/
M!]J /8H'U ZK=I.MJ+$)&;<HS&4MSOW@C '3&/>K8=68J&!*]0#TKRV^DN;#
M7OB5/H:XO1I-I+#Y7)W[)OF4>O<>]2W-O9K:^ -4\.+&MS<W<,3O#]Z>V:-F
MF#X^]C;N)/1AZF@#TPN@."R@YQU[^E<W>:YKD.MZI86^D6TL<-E]ILYFNPHD
M<8!608_=Y).#WV-^'F>I:3I\?P_\=:@MM&+NPUVX:TF_BMRLD9'EG^#\,9Z&
MO<#&C!@44A_O<?>^OK0!2T2_FU30[*_N+;[+-/"LCP[MVPD= >X]#6*GB#5=
M4O[T:);6DMOIVHK8W,<[%7D&U&=T8<#;OZ$'.T\CBNH(#*58 @C!![UXV83I
M7@SXCWVAVD45_;ZK/%');QA9(HML.\*0,C"[CQT(S0![&KJQ(5@2IP<'H:7>
MI;:&&?3->?:C9V4/B?P9=^&XH8X[SS(YQ;@!9[/RBV7QU .W!/=O>F?#+0=*
M^PS:H+2,WUMJ=_##-DEHT,S#:/08[>Y/>@#T0L%ZD#ZT!E8 A@0>A!ZUY_XG
MTO3]1^*GARWOH4EBN-/O%DC<_++M,9"L/XAU.*Y*XT^+2M$U*"( :/I_BVU^
MPNYRMNGF1^:JD]$#$CZYH ]NS30Z'HRG SU[5YCJ+:=<>-_&D2-;NLGA^,NJ
M$?,X,V2<=2/E_2L?4O#^CVGP8T?5X[9(KV>WTKS[H.0Y >(<G/8,1[#CH!0!
M[.&5B0K X.#@]#2!U+%0P+#J >17E>MZ1)X9\87LO@^W,,\WA^ZFN8(<E6E4
MCR7([N6+ 'J<'WI9(K9O#?@+6- "#49;RUC,T?WYXW4_:%D/5N S-G."N>M
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M^DV$<B74&F61NX4VPN8E4J.P# $J/I6/J7C'[-J]WIFFZ+J&K3V,:R7AM?+
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MYT&/6I$<:H$M9BH $-YY>["X_A;:X]CCL>.HH I1:-I<%XUY%IMI'=,Q<S)
MH<L>ISC.3DY-6I8HYXGBFC62-P59'&0P/4$'J*PI_%5HOC!?#(2Y%PUH9VE6
M!BJY957!VD'JQ)Z# !K!\&^-;8Z3#;Z[K DU&;4;BUC:1,;B)G5%)50JD@
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MSF\47@C>R027$<\;Q/&AZ,5< X/8XP:>GB'3&2Z8SO']E"&99H7C9=Y(7Y6
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M.G^W:/J,,@2)L+LBB:4 [CEUV@D8_"O5Z* /')-*NM8TK6]"\,RZY)H\^DR
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MFU@!A<9;YAEAQ60^K1:[\5/ &K0*4BO-)N)U4GE=R9P?ITK1U#POJ5IX@O\
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M-H *@DYY/2LKPKX.UNPN?#D6JK"T.E-?W4DD;@B2>:1@F%Z\([GVSBM)]/\
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M0S7"PMY^\;?E1R>(^>AYK<\0WWB%/BCX=L+"ZM8[*6VN)&BD#X?;LW;@" 2
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M]).3UP&![9%<A?\ @OQ!+INKZ=!H^FO/-J+WZZI),/,N5\X2I'C;E6P N2<
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M:C;% 0DC !)]!BNQ\$ZCJ.I^%;6?58YUO%:2)VG@,+R!795<H0"NY0K8P.M
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MY6\\0W\FH,!J<-SILD=K&'C+!XF,8"A6VCJ<@_C77>.[C4K;3+)[)M02T^U
M:A)IL8>X2#8W* @_Q[,X!.,XH ZJBO-I-9A?PI8B#QI>W-O<7[1I-;69>^E0
M*3Y 4*2'!Y+% =HY ZG+'B77&\,O#:ZE>QW$'BB#38;B^@"SF%_+;$JD#)_>
M$=!D 4 >NT5YO%I^LGQY>^&#XJU8Z<VG1W_FEH_M"N9&3:K[,!3C)&.H&,#.
M<>'Q?JD^@>&;"^U#4@]U-?)=W>G6IEN9$MY"B@!5;;NRI+ =CTS0![!4?VB'
MS)(A*ADC4.Z Y90<X)'7G!Q]#7,> ]2O[[3K^*]_M"1+6\:*UN;^U:"6>$JK
M*65E7)!++G SMS6%H=C,OQ9\97']J7["WAM76(NNQ@Z2D*1MSA2?EP1[YH [
MO2=4MM:TR'4+03""7.T31-$W!(.58 CD'K5VO'-$\1^(M4^'7@2X_MB:.^U3
M5GMKFZVJ6:/,XZ$8R HQQU SFMFPT[6[WQ5XA\.'Q7JRV-A%;SPS!H_M&^56
MX+[>4!0G&!UZ\4 >E5!>WMMIUC/>WDR0VT"&261S@*H&237DUOXTU#5])\)V
M]]>ZK +O39+R]GTFU:6>5E98U'R(VQ226) ZX'&:?=:CJ&O:-X=T35!>-%=>
M(3;R27ELT$EW:Q;I4+H0/O (#P,E30!ZK8WD>H6,%Y")!%.@D02(4;!&1E3R
M/H:@M]8LKG6+O2DE(OK5$DDB=2I*-T9<_>7@C(Z$8-<1XRU&\LO$<O\ :.LZ
MMHND_98S8WME )+=9LMO\\[6_P!C .%QGFK7BEC8^)?!&M1S))/+=_V=-+$,
M+/'-&3ZGC<@8#)Q0!WE%8GBZ]-AX8O)UU0:8V%47?DF5DW,!\J#.YCG &#R1
MP:\[F\2ZGI^D^,;:TU#6F2STF.]M)=5@\NXBD)D5L94$K\H(R.N10!ZY+$D\
M+PRJ&C=2K*>X/!%9UW=Z7X3\/"64"VTVR2.)512P1<A%  Y[@5R8;5]$\6^%
MVGUR\O8]8\]+RWF">4K+"9 8@%!4 KCJ<CKD\UR>L?VOK?P@D\4W6MW;R7\D
M<LEBVS[.D1N%"HHVY!4;3G.20<]: /:)YDMK>6>3=LC0NVU23@#)P!R:R-!L
M-"D:3Q!IFGK#<:B-\D[PE)7&>A#<CGG'%7-=GDMO#^I3PN4EBM971AU5@A(-
M>:Z5K6OZOHGP\B&LSP3:NMP+VX55+N%C9LC(P&XX..#SS0!ZS3#-$)U@,J"9
ME+B/<-Q4$ G'IDCGW%<EX/GOK?Q%XET*ZU&YOX-/EMVMYKH@RA98]Q4L ,X(
M./K67=:?+/\ ':!AJE_&BZ(;@1(ZA>)T4QX*_<; )'7/<=* .VTC5K/7--2_
ML)#);.[HK%2O*.4;@^ZFKU>)Z:NK:1\*CXEM-<O(7LKV9H;- GD,GVQE97!7
M+$Y;G/'&.G.IKOB34+O7?$26^H:];3:8X@T^'3M.>>%Y!&KDS%8V#99@-I(P
MHSWS0!ZQ162+S4KSPB+VVMO*U2:P\V."4;=DQCR%8'IAN#FN)\-ZV5AOFF\5
MZA#?0::\M[9:Y:A6MY0!^^7A?W8.<A<@Y'([@'IE%>6^']<O(?$EI9Q:KKE]
M;7VFW$TDFJ6AA4RQ[")(<HIVG>>.@^6LZVO?$X\'>$/$ \37C7^J75O9RQNB
M- $ERN[9MR7'#9)ZY[<  ]CHKRS5-=U;P7=^*K1-4N]22WTF&^M6O=KO%*\C
MQ_PJ,KD*<8[5>\+:K?)XJM;*&Z\1:A87-M(;J35=/DA$,R[2K*QC4 ,"XV]L
M"@#L]=U_3?#>F-J&JW/D6P94!",Y9CP%"J"23Z 59T^^BU*QBO(%F6.4959H
MFB<<XY5@"/Q%>=?&6P>XL/#\POKN$'6;6'RXF4+EF/S\@G<.QSCV-7H+;4M9
M\6:EX?\ ^$AU6WLM%M8,RQ.@GN)9=[;G?9T4*   !ZT >@45Y&?$7B/4+'PY
MIZ:L\%Z^M76E7=W'&H,JQAQOVXP&P 1VW#ICBMF2TU:X\>#PROB/4XM/@T2.
M=Y49//DD\YUR7*X&1C.!_"/?(!Z'5#4-8LM+GLK>YE(GO9O)MXD4LSMC)X'8
M 9)Z =:\KCU+Q(GP\7Q7-XCO'O+"^%NL*JBPSQK<B$^8NW+,PR<Y';'OUFG?
M\3/XP:W--R-&T^WM[=3T4S%G=A[D(HSZ"@#M7;8C-@G SA1DGZ54TG5K+7--
MBU#3YO-MY,@$J5((."I!Y!!!!!Z5P/AK5+U_$UO;:QK^IV>MM--Y^F7MN!;7
M$8W8%NP4#@;2"&)P#D'/&IX:_P")=\2?%NE1<6LRV^HH@Z))(K+(?^!% ?SH
M [>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "O)?#7A74]?\*ZG8KKC6NE7VIWBW=O]F#R%?/8,(Y-PV!@,'(;J2.M
M>M4TN@8*64%N@SUH Q+'PU'8^++S6XY_EN+.&T6W"8"",L0<YY^]TQVK$N?
M-ZUOJ>EV7B VNA:E-)+<6GV4-*@D.9$CDW856R>JG&3BNW9U499@![FD+H'"
M%E#'D+GDT <GXO\  =OXHTW3[2"]?339!HEDB3<3 \9CDBY(P&7'/; JUXC\
M(0Z\F@QQW/V2+1]0AO8T6/<'$>0$ZC YZ\_2NDS5#4;N^MGLQ8Z>+Q9;A8YS
MYZQ^1&>LG/WL?W1R: .<O/!-\VI:N^FZ\;'3]8.^]MOLH=M^P(S1ON&PLH&<
M@^HQ38/ UYI=KHS:-K2VNH:=IZZ<\TMIYL=Q$,$93<""",@ANY'.:ZR\NTL[
M6:9L,T<;2!-V"VT9JIH6L)K7AS3M8,8MUO;>.<1L^=F]0<9XSUH P[SP=?RC
M1KRU\02KK6FB5?MMS;B43K)RZN@*\9 Q@\8%7/#'A>7P_=ZO=SZF]_/J<Z3R
MN\03:P0*< $\<<#L,#GK71,ZHI9V"J.Y.!61I6NKJFM:WIPMS&=+FCB,F_/F
M;XUDSC'&-V._2@#DI=/U2[^*^N2Z3J:V%PFF6B[I;?SHW!:7.5W*<C P<^O!
MS5X?#Y[32M&33-8:#5-+N9;H7LUN)!,\H;S=Z9'#;CT/&!74M=7PUQ+1=.!L
M# 9&O?/4;9,XV>7U/'.[I5S>FX+O7<>0,\F@#A;KX<2WVE^);:\UQYKG7E@\
MZX-L!Y;1_P!U0W3& !G@#J3S71ZUI>JW<EK/I&L_V?/ &5ED@\Z&96Q]Y-RG
M(QP0>,GUK2O+N#3[&XO+E]D%O&TLC>BJ,D_D*QY/%-N-6\/VD,)EBUJ*6:.8
MMM\M417&5QSD-[8H QCX N;>'2[C3];\G5[&YN;EKJ6U#QS-<$F4&,,,#.,8
M/&.],/P[N#'J$W]O.^HW6H6^I1W+VP(CFB4#E-W*G!XR, @9.,UW2NKJ&5@R
MGH0<BA75UW(P93W!R* .!O\ X=7NI+K1N_$1>36;)+:[;[&,!D8E&C&_Y5 8
MC;SGKG-=/J.@C4/$.B:L;@H=+,Q$6S/F>8FSKGC'7O5/6_%PTC7(-'M]%U+4
M[R6V:ZVV8C^6,,%).]U[D?G5GP_XGM?$!O(EM;NQO;)U2YM+Q DD>X94\$@@
MC."">E %;PCX9NO"T-W9G4UN]/>>2:VB-OL>'>[.P+[COY;T%-N?"L\GC4Z_
M;ZBD<-Q:+:7EG);^8)D5F(PVX;3\Q'0UKZE>WMLD!T^P6^=KA8IE^T+%Y2'[
MS\]<<?+U.:NLZ(0&95+' R<9- '#P?#Z\6QLM$N=?:?P[9S)+%9FU E94;<D
M;R[N5! Z*"<#FNJU[28]>\/ZAI,LC11WMN\#2*,E=P(R/IFKY8*,D@ <\T @
M@$$$'H10!RNE^$KVVO\ 0K[4-72\GTFWFME,=KY0D60(!GYC@CR_QSVJIK?P
M]36=&\4:<=3:$:]<Q7!?R-WD[!&,8W#=GR_;K5[6/'FDZ)XJL= N8[AI[K8#
M-&H,4!<E8Q(<Y&X@@<5TY( ))P!U)H YC5O#FM7;RIIWB+[):7%LMO/;SV@G
M P""T?S#:2#SG<.!Q6O'H\=OX<31;6XG@CCM!:Q31MB2,!-H8'^\.#GUK0#*
M1D$$$9R#2;U)8;AE>O/2@#CCX'N]5FD?Q-K*:FOV&:QB6"T%OA)=N]F.YLM\
MBXZ >E:.B:'KEC>12ZIXC:_@MX3#%#':B$-G'SR'<=[8'; Y/'-="K*ZAE8,
MIZ$'(I%='7<K*R^H.10!R>F>!+?3?'%[XC%X\D<QD>"S,8"V\LH02N&SR6\L
M=NYH?PAJ<%]>C2_$3V.F7UT;J>W6V#2J[$%_+EW?*&(R<J<9..M=9YB$L-ZY
M7[PST^M*K*RAE8%3R"#Q0!BZ;X>73_$VNZS]I,AU;R,P[,>5Y2%.N><YST&*
MYF/X=:E%IFG:>OB7_1](N$GTU/L0PA5LCS?G_>?*2O&WKG!/3OU=74,K!E/0
M@Y% ="6 925^\ >E ',#P:H\,^(M&^W'&LSW<QE\K_4^?GC&?FVY]1GVJ*[\
M'W\6HPZEH6MC3KW[$EE<-):"9)D3[K;=PPPRV#D]<8KH=)U:SUNP%[82^9 9
M)(PV,9*.4;]5-7: .._X0J]L6T^ZT?7I8=1MK0V<US>P_:?M*%M^6&Y2&#$D
M$'C)&,5TNE64VGZ9!:W%[-?3(#YES-@-(Q.2<#@#G@=A@5:61&W;74[3@X/0
MU4TG5K/7-,AU&PE\RVFW;'QC.&*G]0: /-/#_AC5-=T?Q)90:Z;+3;[6;^.[
M@-J)'*F5@WEON&S<O!R&]17677A"[MM7;4O#FK1Z7++:QVMQ%+:^?&ZQY$;
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MRF-C*X.0PP.0<T >7:KIVM:/I.I6R:+;:;IFIZC80KIEM?#8-SE95#!0(UD
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M@+N&WMU7-=#>^&M'T;XA^'+:PL8HHM2M+ZWOUQG[6@1#^]S]\Y)Y/)R:Z-/
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M:%'<3:>/*;5KN\V/;31QJP%NH0D8)4]5W,36ZKM)\?;!VY9O"^3]?/-='?>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKRS4O'&MVW
MBF6.)[;[- UQ &\J;R,"6(;W4)O+)DJ2N4RX^8<B@#U.BO/_ !MXIU;2];@L
MK *\:&"<K$CB0DR$>6Q*E2K@8PI+\'"GLNO>+-3M_!6G7]M+:-<W\,@<P13
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MSLT;  !03R36Y10!YJT=]:/X!UHVEX]CI]JUK?1"W?S(&DA10YCQN(!4@\<
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M2H+XV5W9>:"?L]W'LE3!(^9>W3/T(J]10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,<\=:]*CN8)IIH8IXWEA($J*X+1DC(W#MD<\T 2T444 %%%% !1110 4444
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M7?V2V=0=\C(H\TDYQ@.2HP/X30!MT5YYXWT;3D%]-+/?7OB#45,>D6\5PRO
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MJ<USJ.H& F[BC6+R#"=T7EKSC:Q)Y)SGGBNNHH P-(\.3V>L2ZQJ>IOJ.H-
M+:.3R5B2*+=N(51W)P22>PZ8JUH6B)H=O>1K.TS75Y->.[#!W2,6Q^ P/H*U
M:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
=** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>exhibit1013-zerondaxexec009.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "D I:* "BBB@"E?:3I^I)MOK*WN!C'[V,-_.L)
M_ASX4,XGCT:&&96W"2$E3G\#7544U)K9BLAJKM4 = ,4ZBBD,CGA2XA>&091
MU*L/4&D,*- 8"/W979CVQBI:*!6176S@46X"?\>XQ'[<8_E45UI=K=SB:56\
MP+MRK$<=>WUJ[134FM4)Q35K%<VD+6RP,I,:XP"?0Y%*MK$ER\ZKB1P Q'?%
M3T478^5%86%NML]N(QY3DEAZYZTZ2TBD$(=<^4P9.>A%3T478N5=AK*&4J>A
M&#5*WTBTM95DB5U*]!O.!^%7Z*$VM$-Q3=V4KK3+6\D$DT>6 VY!(R/0U:6-
M4C$:J H& !V%/HHN[6!12=R*WMX[:%8HEVH.@I(;>."(QQKA22Q'N3DU-11=
MA9%&'2;."<31Q8922N2<+]!VHN=)M+N7S94)8C!PQ&X>_K5ZBGS2O>XN2-K6
M&JH50H& !@"G445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !158:C8M'#(+VW*3MLA82KB1NF%.>
M3["K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW=U-<RW5P;5LQ1O(Q8JG^R/>NIH **** "BBB@ HHHH **** "BBB@ HHHH
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M77<" YV@9.< D]:O16VHZIXLNO#8\0ZK!8Z/8PN\T<B"XN992Y#.^WHJKC
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5CV+*1G]:XWP/XRT.T\%6-CJFHVNF7^DVZ6EY:W<JQ21/&H4_*3R#C((ZYH
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M6TL[A%.UR9%!/&>4)'I7,6,GFV]A?:??PZ=IP\77[)=RPB2*(NCB)BI(&#G
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MY"\UF%E5UGV#+1YX < @X/&.]8\'Q)CFTG2M7.A7Z:;?W/V7SMR%HY"[(HV
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M< !FX8@ <9QDUZ'0!Y[X[T/PC91OJ-UX<M=2US4)1#:0$'?<S$8 Z\  9)[
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M/+*EYX>T/2(_LDD+2VN)))96&-RD*NQ,;N#DG(Z8K,\/>%_$,%MX-M]0L[6
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MZ_XI+*_A.W6!Q',=4LA&[+D*WGI@D=^: .RFACN(6AF0/&XPRMT8>A]1[4X
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M^&M.L[G3IH854Z=;?9K;Y1N5<;>6ZGCC'3D_@ :]%%% !1110 4444 %%%%
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M'GC[V>_2L[3O!^H:7/#;6OB*>/0X+DW$=BD"AP"Q;RS+G)CW'IC..,XKKJ*
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M0_#R=+*UT6;7Y9O#EK.LL=@;91(51MZ1M+GYD! XV@X &:[JB@#G8_"B1_\
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MWQ RHH9[F\=B!U87; 'Z\#\J[_XB6]S=?#O7X;16:9K*3"H,EAC+ #OD9&*
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MJJW8 ^,6ED#!.B7(/N/.BJKX[N;>Q\7^![J[GC@MX[^</+*P5%S P&2>!DT
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M([1G<C,H)4^H]*DHH 8\,4CQN\:,T9RC,H)4XQD>G%(((A))((D#R !VVC+
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M4 1"V@$<L8@C"2DF1=@PY/7([YIDMA9S- TMI!(UN<PEHP3&?]GCCH.E6**
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS7 )VGIZCO@9Z4 >B45XP]_K>J#5=6L--\2W&LQ:E,EE-!.HM$CBE*"(QF4
M@JIW$IG))]*Z*VTJ;QIJGB>YN-6U&RN+"_:QT\VUR\:6NR-&W[%(#DLQ)W9R
M..* /1:*\]MM.D\5>,O$%EJ^HWQATA+:WMTM+F2V&]X@[RD1L,L2>,Y  K#T
M;4-0\4CPEHFIZC=F!QJ#7<D,[0O=_9Y/*CRZ$-WR<'DB@#UZBO&=5FU72].\
M<V=OK=^S6>HZ;%:3R3L[PH[1?+DGGAL'/WN^<FNIM; ^'/B9IME9WVH2VVHZ
M=</<1W5W).&DC:/$@WD[3\Q'&![4 =?I&I-JNGI=M87EB69AY%Y&$D&#C) )
MX/4<U>KR3P9=VM_\%XM4\3:GJ1BM9IYI)X[Z6.5L2,JKN5@S=0 N>N*9)!K?
MASP';-<3:N;O7=5A1[:.Z:6>U@?)\F-Y&R'VK@G(Y8^@H ]>J":]MK>ZMK::
M=$GN2RPH3S(54L<?0 FN/\$KJ%OK6I6XTW6;/1&ABDMTU682O'-E@X5O,<[2
M-AP3P<U1\::1;:A\4/!0FENU$RWBL(;J2+[D89<;6&#ECDCJ.#D"@#L](UNV
MUHZ@+9)5^PWDEG+Y@ RZ8R1@GCD>GTK2KQU=%%UH/Q!U8ZAJ$%Q8ZE?S6@MK
MIX5B=$#;B%(#$D ?-G@<8YK0U>[&NO:!QX@U"\31X9Y+?2K@6T=K)("1,[^8
M@+''"G. O3F@#TN6]MH+NWM)9T2XN-WDQD\OM&6Q]!4]>.VMO_PD7B3X:ZAJ
M-Q>-<WFD32S-'=21[G6.,Y 5@!DDYQ][OG KT+QO8ZA?^$;Y=)N)H-2A47%L
MT3E2TB'<%..H;&TCIS0!T%%>=GQ(_BW6O##:;--'9Q6+:U>I%(5W<;(XF(Z_
M/OR#UV5S["[@^%</C_\ M74'UXB.]=OM<GDL&D&8?*SLV;3MQC.><T >R45Q
M6CWES)K/CQ)+F5DM[A!"&<D1#[,A^7TY)/'>N1T_[?KTGP\T^XU?48[>^T26
M2],-RZ//M6,C+ YSGOUP2,\T >P2R"&%Y6SM12QQ[51T#6K;Q%H-GK%FDJ6]
MW&)(UE #@>X!(_6IIX5M](DA0L5C@* LQ8D!<<D]3[UX]\-]5F\167ASPY+/
M=Z986-BMR%&Z)]396((1AC]VAZ@'+?2@#VRBO)I-.FU?2_'FHW.K:HLNFW]V
M+!8;V2-;<I$K@@*1GD]#D #@#)J[IKS^-?$-I9:K>7:V=OH5I>-!;7+P>=/-
MG+L8R"0 N ,XR30!Z917DNDZIJ=EJNER7&HW5Q9Z?XAN]"D:64L98W4&%I.S
M,K;5W'GGWJOIWBV_TI?$&N7=Y/+;:KI]QJ.FQ2.66,Q3-&B(#P-RO <#UH ]
M)N?$UE:>++'PY)'.;R]@>XC=5'EA4ZY.<Y_"MFO);6RN=*^)W@>TO)IKB[AT
M*83R2N7=Y,98DGD\YJGX:OM;U.WT/7K;3O$DFIW=W'+>7,DZFSDMW?#J(_-P
M%53\N$!RHH ]:U;4H=&T>]U.X5V@LX'GD6, L552QQD@9P/6IK2Y2]LH+J,,
M(YXUD4-U 89&?SKR2^L9-?\  GC3Q%=:C?K>H]_%"JW3B**&+<@B\O.P@A3D
MD9RV>N*U-(M&\3^(VT^\OK^"STK1[%H(;2Z>#,LJL3(2A&X@*  <CKQ0!Z;1
M7B=EJ^J3:-H&EWDNL:HEUJ6I&[-A-LGN%AD(50V]=J98$@$<+@<5Z!X$_M..
MSU&WOK34K>TBNS]@&I.'F$)53M9@S9PV\ DDXQ0!UE8_B7Q+8^%=*%_?K.ZO
M*D$44";Y)9&.%51QR?K7-/9?\)9X_P!?L-1N[Y+'28;9+>WM;N2 %Y59VD8H
M02> !G@8/%<)XA236O _AV;4KN\N+JU\2KIAG^TNOFQK,ZAR%(&_ 'S_ 'NO
M/- 'M]A=M?6,5R]K<6C2#)@N% D3V8 D?K6=J7BC3-.TQM0,C7$"WBV3?9\,
M5E,@CP<D=&//T-7[;3H+33%T^-[@PJA0-).[R8.?XV);//7.:\2MM)C@^%M]
M+;W%TEQ-XB2'?)</*%VWH"L%8D;NY.,GOF@#WBBO+]5>;P1XEOSIEY?30MX=
MO+YX;NZDG!GA*E7&\G!.X@@8'M3/"HU:+6-!N+73O$P2X1AJUQJ5PLD,X:,L
M)%7S6VG>%QM4<,10!Z;=75O8VDMU=3)#;PH7DDD;"HHZDFN4A^)WAJ5X6>2^
M@M)V"0WUQ8RQV\A/3$C*!SZG J#XJ[6\+V,,YQ83:M9QWN>GD&4;L^V<5UNH
MVUA<:7<6^HQ6[V!C(F2<#R]@Z[L\8&* +=%< MC'XJ\=:YI]W=WD>FZ1;VL=
MI;V=W);KND1G,A,9!)   [#!XKG=/O=4UJ3PCI=UJ]\!_:&I6-S/%,4>YCA#
M!=S#')"@;NO4@@\T >LW]];Z9IUS?W;^7;6T332OC.U%!)/Y"L#3?&B:KI5I
MJ5MH.MFWNYXXHBUNF2CC(F(W\1CN>O(XKA]6TY4T+XD:&UW?R6&F6RW5HDEY
M*S1EK9F*EBVYDR,[6)'/(JK<Q2:#\._AW)IU[?PM?ZIIGVC-Y*P96C.Y "QP
MA_NC"^U 'L\L@BB>1LX12QQ[51T/5[?7]#LM6M$D2WNXEEC64 , ?4 D9_&N
M'BL9/$^L^+[VZU&_@DTVX-G8K#=/&D 6%6+E 0KEF8YW @@8Z5S&C7LUUI?A
M'1I;+6KW3X] 2[>WTF;RF>1GV NWF(=JA3@ ]6&: /;Z@O;VVTZRFO+R9(+:
M%2\DCG 4#N:\MA77;V\\':1JMUJUBLT^H12AY]D\]NB[HO,9&/S;=H)!SU(.
M3FLCQ=:&W\(_$'1OME])9:7<6DMFLMW([1^8B%D+%LLN6/RL2._44 >Q7&I&
MWU6RL187DJW0<FYBC!AAVC/[QLY&>@P#DU>KSC4Q+HWQ.\!:19WEZ+%X;[S(
MI+J23S<1[AO+$EL$\9SCM6+=:BR:I9ZUIK>(;@S:[' VIS7 2TDB>?RVA6'S
M.4 ) 8)U&<T >D:7XFLM6\0ZUHMO'.MSI!A%PSJ C>8I9=I!)/ YR!4VO^(-
M.\-:8=1U29HK82+'N5"QW,<#@>]<=X*_Y*S\1O\ KII__HEZ3XV_\D[;_K]M
MO_1@H ]%K(\2>([#PKHSZIJ'FF%76-4A3>\CL<!5'<FN8O\ 3WUWXI7VF7=_
M?IIL>CP3&UM[J2%6D,LHW$H01P.QYXSG%<)XCMWU+X6:;+?7E[<3V>NFQ25[
MJ0%XUN60%L'#, H 8\CL: /;]-O6U#3XKI[.YLVD!S!=*%D3!(Y )';/7O5J
MO.UTB+4_'$_AN:\U(:1I6G1S1P+J$RO+++(^7>0-O; 7 !.!FN=N;_5Y](TS
M2%UF^1K?Q@^D_;%F/G26X1\;F_B8 XR>Z@]J /9J*\WET)9/B);>&_[1U0:1
M%H1F:%;Z4-*WV@@%G#;OXO7/ '3BN9D@OH/AGJFOMK>JR:EHU_+#92M>2 )'
M'<; K*#M?(R"6!)&!VH ]NJ WMLM^E@9T%V\1F6+/S% 0"V/3+ ?C7F/CFY$
MU[XBGLSXBN[O3+0%)+&X$%MIT@C+Y.9%$A.0S##<8'M4EG81:G\8=,O[B6Z\
MZ7PY'>L$NI%7S!*@QM#8VX'*_=)Y()H ]#TS4FU*.X9K"\L_)G:$"ZC"&3;C
MYUP3E#G@^W2KU>+:9K>K2>%-6MAJ=VLM[XR;2Q<^:3);PNZ A"?N\9 QTSQ6
M_J,#^$O$R:=IE[?&RU'2+R1X9[N2;RI8@I616=B5)#$'!QTH ]*HKR.TMKG3
M_#G@+Q$-6U.;4K^YL8;IY;N1DEBF3!0QD[> 1SC.1DDDYKT/Q??3:9X,UR^M
MR5GM[">6,CLP0D'\Z )='UZUUUKUK))FM[6=K?[0P CF=?O;#G) /!. ,@XS
M6I7G4D5GI'PN\-:8)]0C6=;:)8=-XGNV*[V16R-N[#$MD8&>:R+3^W;G3O$>
MDZ=;:Q'#9:A:O_9\]^#=BW9%:6))@[8SU'SYP2,C- 'KE%<GX$N+"6TOX;&?
M5E$-P!)8:J7,UF2H.S+DL5/WA\Q')P:ZR@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "N"L] $&K>)_"U_;3OHVNF2]MYX
MU.%,@"S1EL85@WS+GJ"?2N]KF/%GC*Q\/Z)JLUM=V,^J6-N9OL33KO./50=P
M% %5?!Z:=>V>O7NO:M>7FFHX$KK&Q>';S'L5.<X!R!N)[],2^!=-NXK;4];U
M*!H+[6[LW;0/]Z&( +%&WN$ S[DCM6]=:SIE@UO'?ZC:6LMQ_JDGG5#(?103
MS^%<KXQ\>_V#KVE:%I[Z6;Z^,AEDOKKRXK944-\^,D%L\=,T =Q16)9:M.VH
MZHM]=:0MG:1Q.K07),D8*98S X"#NI[CFKL&LZ7=7[V-OJ5G->(-SV\<ZM(H
M]2H.10!>HJDNL:8^IMIJZC:-?J,FU$ZF4#KG9G/Z5F^(_%5AHFF:FR7MD^IV
MEG+<I9/.HD?8A8?+G=CB@#?J.>4PV\DJQ22E%+"./&Y\#H,D#)^M0Z;=->Z7
M:7;*%:>%)"HZ LH./UK T7QI8WCWT6IW=C8SQ:G<6-O').J-,(VV@@,<DGVH
M IZ%(N@Z.VF0^&]?F@:6:5O.C@)/F.SL#B0#&6(^E86E^%M*TO0]9T9/#?B:
M6QU202.DA@S#C&P1D29&W"XSG&!7HU_J^FZ4(SJ.H6EF)3MC-Q,L>\^@W$9-
M8>N^*)]*\9>%]$B@BDAUEKD22L3E/+0,-O8YS0!AZ;:W%KJT6J:E8^*M6N[>
M%H+9KJ.U40*V-Q 1E!8X +')H738%\'V'AH:#XE^R63PO')MM]Y,<@<9^?'4
M<\=*[6;7-)MM033Y]4LHKV3&RVDN$61L],*3DU82\M9//V7,+?9SMFPX/EG&
M<-Z<<\T 8_\ PDMS_P!"SK?_ 'Q#_P#'*X^;19H;^[N-%M_&.BQWDAEN+:T%
MJ8F<_>90[-L8]R*]%_M*Q^PI>B]MOLKX"3^:OEL2<##9P<GBLKPWX@EU:;4M
M/OX$M]5TR?RKB)"2K*PW1R+GG:R\\]"".U '+-HUBOAZ#2;;PYXEMVM[D7L5
MZAA:X%QWE+-(=S')!R""#C%-&D^=9ZRFHZ9XIO[W5K7[)/>2QVRND6" J*K!
M5 W$].2<FO1;BX@M+=[BYFCAAC&YY)&"JH]23P*KP:SI=S8?;[?4K.6SW;?M
M$<ZM'G(&-P.,Y('XT <I-B:_T*[;P]XA#Z-O\@!(,/NC,9W?O/0YXQS7-^,[
M&2ZT;76M_#OB!IM8O;*6=6CC(41O$N%V.6'RKU]>X%>GVFKZ9J%Q-;V6HVES
M/ <310SJ[1G_ &@#D?C6)X@\9V6FPQKIUW8WEV+^WM9[=9U9HA)*J$D Y!&>
M] &%96,D6K-J.IZ;XIU>86SVD(O([7;%$V-P 1ER3@ L>2!2:-97.CW5HWV7
MQA=6=BI2SLYOLPCB!&W!*N&? X&XG'UYKT.::*WA>::1(XHU+.[L J@<DDGH
M*Q=#\8:)X@TM-0M+^!8FF,.V25 P;>R*",\;MI*CJ010!P\OAF.;P_K.@OI_
MBPZ7J4IF$&RU_P!'8R>8VQMV>6'\6>/SK4O;:2YU_3-9M]*\3V=U8P?9CY,=
ML5GAW!BC!G/4J.1@UU[^(=$BT]=0DUC3TLF<HMPUR@C+ X(#9QG@\>U3W&JZ
M=:6 O[F_M8;(@$7$DRK&0>AW$XYH X"+0[%-*UW3I/#WB62'6+Y[^5B( \4K
M$,#&0_&TJ",YZ=ZEL+.>'46U'4K#Q5JMZ+9K6&6YCM5$,;8W;51E&XX&6.3Q
M71Z1XGCU7Q!KEFK6YLM/CMI8KF.3(D61&8DGI@;>HK7T_5-.U:%IM.O[6\B5
MMK/;S+( ?0E2>: .(^PP_P#"-:/H7]@>)/L^E2V\L+[;?>QA8,N[Y\<XYP!7
M9V.GM;7U]>->7DHO&1Q!/)E+?"A=J#^$'&3[YJQ>7UIIULUS?74%K;K]Z6>0
M(H^I/%1-J^F)IO\ :3:C:"PQG[49U\K&<9WYQ^M %RL?PWX<M?#%C<6EI+-*
MD]U+=,92"0SG) P!Q5Y-2L)-/_M!+VV:RVE_M*RJ8]OKNSC%1PZUI5S8&_@U
M.RELPP0W"3JT>XD #<#C.2!^- &'J/@E;O4;^[L=:U'2QJ0 OHK0Q[9B%V[A
MN4E&V\$KCH._-+=^!K0MI,ND7]WH\^F6YM()+4(V83MRC!U8'[H.>N>:V6UW
M2$LIKQM5L1:PR&*6<W";(W'56;. >1P:I:QXPT31+"QO;F^@:"]GCA@>.5"'
MW,%W DX*KG)/84 /\-^&K3PQ;7D%I/<3"[NGNY'N'#,78*&.<#.=N?J34L>@
M6T7BJ?Q )93<S6B6C1DC8%5BP(XSG+'O4KZ[H\4]M!)JMBDUTH:WC:X0-*#T
M*C/S ^U:% '*R>"(SJ%Q);ZUJ=K875S]KN+"!T6-Y<@DAMN]0Q&2 PSSZTS5
MO <&I7VH3P:OJ.GP:F NHVUJR!+C"[<_,I*$KP2I&16]_;FD_P!I_P!F_P!J
M67V__GU^T)YO_?&<_I7)ZIX_*>/X/"^FR:3\L FNKF\N]H!\S88D SF3O@T
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M:Z?5-2ATG3Y;V>.XDCCQE+:!IG.3@8502>M+8:II^JPM-IU_:WD2MM9[>99
M#Z$J3S5/Q)XAM/#.D&_NDEE+2+#!!"NZ2>5CA44=R3_6@#GOAKX:.C6&IZE-
M9264VK7DEPEK+]ZW@W,8XR.Q&YFQVW8J5/AS9HD=@=6U%M"CN!<)I!,?DA@^
M\+NV[R@;G;NQ36\8^(--:WGU[PA)9Z=-(L;7%M>K<O 6.%,B!0<9(R5)Q737
MVMZ3I<T<.H:I96DLO^K2XN$C9_H"1F@#$OO \5WK.H7T.KZC9PZFJ+?VD!39
M/M78#DJ67*X!VD9%2Z;X*L-,N-!GBN+EFT6S>S@#E<.C!02V!U^4=,5MW6I6
M%B ;R]MK<%&D!FE5/E&,MR>@R,GW%5F\2:$L%M.VM:<(;DE8)#=)ME/3"G/S
M?A0!H2QB:%XF) =2I(]ZY<> =-3P_HNEPW-W%)HSJ]E>HRB:,CKSC!##@C&"
M*WKW6-+TW?\ ;M2L[78H=O/G5-JDD G)X!((_"G2ZII\&G#4)K^UCLBH87+S
M*(\'H=Q.,4 9L'A6S@T[7;)9IS'K4TTT[$C*&1 A"\=,*,9S5*?P1$K:=/IF
MK7VFWUE9+8"YA$;&6%<85U=2IP1D$ 8)-;\>JZ=-:0W<5_:O;3L$BF692DC$
MX 5LX)^E10:SI^HVMS)I>HV-VT (8QW"NJ-@X#E2<=* ,:;P'I<O@Z;PYY]V
ML4TOVB2[\P&=IO,$AE+8QN+#TINI?#[2-3L- LI'N(X-%,?DK&P'FHFWY'XY
M4[%)QCI6GI^LHGAR#4]9OM+ARN99[>Y!MLY(&UVQD?UJX^KZ9'IHU)]1M%L"
M,BZ:=1$1Z[\X_6@"A=>&;2[\7V'B1YIQ=65O);QQJ1L97ZD\9S^-4+#P1'IU
MY (-:U-=+MYS<0:8'01(Y).-P7>4!)(4MC\.*Z2UNK>]MDN;2XBN()!E)8G#
MJP]B.#4%_K&EZ48AJ.I6=F93B/[1.L>\^@W$9H YB_\ AQ:WHU:V36=3MM+U
M5WFN;"%HQ&97'S,&*E@"?F*YP3UXR*S/$.GV^B^(+.:/_A);0?V<EJ][I, G
M%PJ$XCD4(Q5^<AP!U(SZ=Y=ZKIU@&-Y?VMN%C\TF:94PF0-W)Z9(&?<4@U;3
MFTW^TAJ%J;#;N^U"9?*QTSOSC'XT <-X5\$._@G3(YS=Z/J-M=SWEH\94RVP
MD=\(VX,#E& 8'/YBNST32#H]I)$]_=WTTTIFFN+IP6=C@<  *HP    !6=8>
M*8M2\8/I-E);7-C_ &:EZEU!('#,960@$'!'RUO2W5O#-##+/%'+.2(D=P&D
M(&2%'? YXH P=5\)_;=9?5M/U>^TF]FA6"X>U$;"9%)*[E=6&X9.&'/-07'@
M'29O#VE:(DES%;:;>1WL;*X+R2*Q;+D@YW%B3TZ]JZ5[JWCN8K:2>))Y@QCB
M9P&<#K@=3C/-5;37-)U"[DM++5+*YN8O]9##<([I]5!R* +]<;'\.[2.UO++
M^U=0.GW%\M^EJ?+VPR"42G:=N[!8="3Q[\UU)U&R%I)=F\M_LT1823>:NQ"I
MP<MG P>#4=SK&F63E+K4;.!QM!66=5(W<+U/?!QZXH J7OARRU#78]5N2[NM
ME+8F$X\MXY"I;(QG/RXZ]S5'1?"!TB[M9&UW5+RVLHS'9VL[H$B4C'.U09"!
MP-Q./KS72.ZQHSNP5%&69C@ >IJI#K&EW+2+!J5G*8HUFD"3JVQ&&0QP>%(Y
M!Z4 +JFEV6M:7<Z;J$"SVEPA26-NX_H>X/:N5_X5RDT"6&H>)=<O](C(Q83S
M)M<#HKNJAW7V)KJ=/UC3-621]-U&SO5C.'-M.L@4^AVDXK \$^,E\1>!;?Q)
MJGV73U=I!(3)MC0*Y4$LQXZ4 6-2\(+<ZL=4TS5;W1[N2!;:=K-8RLL:YV@J
MZL 5R<,,$ TMEX*TO3FT$VKSHNC&9H07#>:TJD.SDC))+$\8Y-;EG>VNH6J7
M-E<PW-N_W989 Z-]".#5+4KZ[MM6TNW@ETY8;AW69;F8I*P !'E*!\Q]<]!0
M!3NO"%E=GQ(7GN!_;\"P7.TK^[41F/*<=<'/.>:@O? VGWVA^'])DN;I8=#G
MMY[=E*[G:%=JA^,8/?&/PK6N=?T:S<)=:O80,9#$!+<HI+C&5Y/49''7D5HT
M <K?^!X;O5[^]M]7U&QAU)5&H6MNR;+C:NW.2I9"5X)4@D?G4:> K>TL-(BT
MO5K^PN]+MC:0WD7EL[Q'&5=64JPR >G!'%1ZG\1-+CTOQ++I<]O<WNBQ,YB:
M52)2$#$K@Y*C<%)]0170:?KFFZA*+6'4+.2^6,/+;1SJTD? SE0<CKWH HVW
MA&TM[G1+@WE[/-I/GF.2>4.TS2C#ER1[DC& /IQ4&I^!M-U6'Q%%<37(771$
M+C:P'EF-0JE./]D'G-;4>L:9+J3Z;'J-H]\@RULLZF51[KG(_*K;NL:,[L%1
M1EF)P /6@#FX_!L;:QH.KWVJWM[?Z.DZ1RRB-?-\T%3O"J!P.!C'3G-9K_#6
MV>S%E_;FJ+9P7(NK"!3'MLY?,\P,OR9;!R 'W  GZT6WC77M:@:_\/>$FO=*
M)(AN;F_6W>X .-R(5/!QP6(S70Z1XBM=4T2#4YHY=.$C^4T-Z/*=)-VW8<\$
MYX&.M $6D>%[71_$&M:U%<3RW.KF$SK(5VJ8E*C;@#KGFE\5^&+3Q=HATJ]F
MGBA,J2[H2 V5.1U!&*MMKVCK8-?MJUB+)',;7!N$\L,.JELXS[5+'JNG2V4=
MY'?VKVLC!8YUF4HY)P &S@DGB@"O'H=O'XFN->$DIN9[2.T9"1L"HS,".,YR
MY[UBW/P^TVZ\.C17NKL6XU$ZCO#+N\PR&3'W<;<L1TSCO73R7EM#-Y,ES"DO
MEF78S@-L'5L>@R.:K0ZYI%S>K90:K8RW3H)%@CN$9RI&0P4'.,<YH SM8\+#
M4=7BU>QU2\TO4D@-LT]L$;S(L[MK*ZL#@Y(/49-5X_ >EQ6&DVB377_$NU'^
MTO-9PTEQ/\VYI"1SDN2<8[8Q73.ZQHSNP5%&68G  ]:XBV\;Z[K%NVH^'_"+
MWVDY/DW$]\MN]PH.-T<94\''&XC- '2_V%;_ /"5?\)!YDOVG[%]B\O(V;-^
M_/3.<^]9DO@;3Y?">H^'3<W0M;^XDN)) 5WJSR>80.,8SQTZ5?T[Q-IU_P"'
M(=<FD.GVC@[_ +=B$Q,#@JV[@$$$5<BU?39]/^WPZC:266<?:$F4QYSC[P..
MI H Y_4? =KJ-_J<C:IJ$-CJF#>V,3((YG"!-V=NX<!<@'!QSQD40^!UM]3T
MC4H=;U!;O3K463R8B_TF .&".-F!T RN#COGFMH>(=$9;IAK&GD6G_'R1<I^
MYYQ\_/R\^M3)JVFRVD-W'J%J]M.VV*99E*2'GA6S@G@]/2@#GH/A[I,.A:II
M)FNWBU#4'U$R[P)(9B58&,@<;2H(SGWS4UIX,1+JZO=2U:^U2^FM&LEGN!&O
MDQ-U"*BA02<$D@DX%;=AJVFZI%)+I^H6EW'&=KM;S+(%/H2"<4VRUK2M2$QL
M=3LKH0?ZTP3J_E_[V#QT[T 9K>$;)M"T+23/<>3HTMM+ V5W.8!A=W&.<<XQ
M^%:^HV,.IZ9=V%P"8;J%X9 /[K @_H:@BUW1Y[V.SAU6QDNI4$D<"7"%W4C(
M8*#DC'.?2I+>XO)-1O89['R;6+9]GN/.#>?D9;Y1RNT\<]>M '%Z)H5WJ_A:
MPT74YKS3M8\.7"QPWL*##[%*)(F\%75HVP1ZY!Z5>3X>PPSW=S!KVKQ7-TT4
MTDXDC+&=,@2_<P<@E2OW<<8&!CLJ:[%(V94+D D*.I]N: ,C0?#ZZ*UY/+?7
M-_?7KJ]Q=7 4,VU=J@*@"@ =@.YK9K)\.:U)KVDB\FT^?3YED>*2VG(+(RG!
MY'!K6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGW'M7KTNGVD^H6U_+ C75LKI#*>J!\;@/KM'Y5C0^ O"UO<M<1:):I*T@E!
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M6\$F^+SL*Q9#@<$,IZ#G/>L#Q,1J/B;6TM=-T@MI^F1K>WNJ%W'EOYC!$0<
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MM-NQ>+"@7,2F/RRP'8-D#\:\[\)I>3_#WP!;6\=G)')JUT3'?%O(:0"8QAL
MGKD@>H%>T:-X7T3P^\KZ7I\5O)* KR EF91T&YB3@>G2FCPGH*Z -#&EV_\
M9BMO6WQ\JMNW9'<')SD4 9/@O2[S3=1U]KN;2@;BYCD:TTUV*6\GE@-D$#:6
M 5O?KWK*\=_\E)^'G_7W=?\ HM:[72=%T[0K,VFF6D=M"7+LJ=68]6)/)/3D
MTZ[TC3[^^LKVZM8Y;FR9GMI&ZQ%A@D?44 >:V^D:?=^'_B;=7-G#-.;Z]022
M(&*A8%90">F"2>.]>@>%7:7P?HDCL6=K"!F8]23&M64T;3H[>^MTM(Q%?N\E
MTHZ2LZA6)^H %6;:WAM+6&VMXQ'#"@CC0=%4# 'Y4 >/WEI:Q>'_ (LO';PI
M(DLJJRH 0I@0X'MFMZ^TNRTKQ#\/386D,$GF31%D0!F4VKDACU.2 >>_-=9<
M>#_#]WJ%[?3Z7 ]S>Q&&Y?D>:A&,,,X/ QGK6A+IEE//932VR-)9,6MF/6(E
M2I(_X"2* /(?"VD:O?\ A?PU>R/X>M-NH1W)NW=UNI)O-/F(21@NWSJ1GV[5
MZMXCM)[_ ,,:M9VO_'Q<64T47^\R$#]35>+PAX?@UHZO%I-NM^7,OF@'ASU<
M+T#'N0,UMT <1X2OKC5/AAI \.W=G;7EM:Q6\HNHBZPO&H5T90RD'(/?WKD=
M>UF_\3?#?44U2XM)WM_$4-BMQ8J4CD198OF7YCW8\@UZ#J7@#PIJ]_)?7VAV
MLMS(<R. 5\P_[04@-^.:TY- TF72XM,;3[<6,+*\=NB!40J=RD =,$9H Y'4
M]+TZ#XD^%M-:QMHM-2SNY;:W6)5C-P/+&=N,%@A./QKE=:2&TO?%<%HJ1:;#
MX@TF0+&,1I*6C,N,<#G:3[FO6=7T/3->MDM]4LX[F-'#INR"C>JD<@^X-01^
M%]#BT*71$TNV&FRY\RWV95R3DD]R<@')YX% '(^)YHV^(TL*NID3PK>,R@\@
M&1,9_(U@)8:9;?"WP%>Z=! M^;W3C%,BC>TK,!*-W4\;P1Z#VKT ^#-&T_3;
MM=(TR""[>TF@20$[CO R"Q.3DJO7T%5/"G@32='TS1+BYTJV76;.RACDE7D+
M*(PK,!TR<'Y@,F@#<\26D]_X7U>SM<_:+BRFBBQ_>9"!^IK(^'^K6%Y\/-(E
M@FC1+2SC@N%8A?(>- KJV?NX(/7MS755S>H?#_PGJFHO?WN@V<MS(=TC[2/,
M/JP'#?B#0!SNI:IIOBGQ?X(GC(N='F>^:/S8R(Y9XU 0X8<\>85/XBN:\800
MP1?$>TLD6*RVZ8[I%\JK.T@W$8Z,5"$_A7K6HZ!I.K:;'I]]802VD94QQ;<"
M,KT*XQM([8Q4$/A30K?1I=(BTR!;"9Q)+#@_O&R#N8]2<@<D]A0!R=_X?TB+
MXL>'8H]-M4B72[D^6L0"G8T87(Z'&XXSTKD[NUL1I4EC<)&FG+X_\HQ=$$9Z
MKCH%.3QTY->S2:=:2ZE#J+P(UY#&T4<IZJK$%@/K@?E7,^)_!\.HP:?!86-N
M86UN/4+]'QME7!$A(/4D8XH YGQ1)IOA_P ::W*E@CV3>%W:]M;<^4)3YP2,
M$KC:2&<;NH'TID5M=Z;XXAM+J'1[60^'+L>1IBL-J!H]H<M]['S8.!WKOK'P
MAX?TZUO;:UTJ!8;Y=ERK OYJXQM8L22,$\=!FH[;P1X:LQ!]GTB!&@9VC?DL
M"RA6RQ.3D #!]!Z4 >>6^EV-G\-?AY=V]K%'<G4--<S!!O)=ANRW7D$CZ<5H
M:IJ]_HEW\2KFUN;EC:1V;0[Y&D\@/'\[*"3@#); XXKT+^PM+_L^RL/L47V2
MQ>-[:+M$T?W"/IBFPZ#ID%[?7B6B^??J%NF9F83 # # G! ' ]!Q0!R@TBXM
MKDZK8^)X+:VN]-E140.\<C;=RW&6D;E>I;'(/)Z4G@Z\GA\1-H^L:9<:=K,=
MCN(2X,UM>(K*#,A)X;)&<C=\PR3BM_3/!'AK1H;R'3]'MX([R-HIPN3N1NJ\
MGA3GH,"K]CHFGZ;+YMM"PD\L1!Y)7D94!SM4L3A?8<4 7(8(K>%8H(TCC7[J
M(, ?A4E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %>;^'OB/:V^EW+:W+>RF#4;B":\2T9H;91,RQB1U&%^7;[X()ZU
MZ17B4.OZ9!\,O%&A2-C5;V[U"&UM-A\RZ>25U1D'\0R<9'3:: /7K76+.\U>
M^TN%V:ZL5B>8;> ) 2N#W^Z:QV\>:.=/L+NV2^O#?B1K>"UM7DE98VVNQ4#@
M X&3ZBN:TO5;/PAXYUB#7+G[/+=:=I_V;<I)N&C1U<)@?,VXC@<\UA:')I5O
MX)\+W%_K-WX<U)(KO[-J "^6 9SOADW JV2%.T_W>#0!WEUXGTZ\U+PM+:ZU
M<PQ:E)+Y$$< *W6U1E9"PRFT_0YR#1>?$?0;)KW<+^5+"9X;R2"S>1+8J<$N
MP& .OX#-<7<:A?ZOKGPNOM00?:'NKS<Z1&,2*!M63:?NAE ;'^U6E;1X\ _$
MOY.6OM4/3K^Z% '7ZMXQTO2+B.W9;N[F>#[24LK9IS'#T\QMHX7KCUP<5'?>
M.-'LQ;&+[9??:+87B_8+5Y]L!Z2-M'"G\^#QQ7GR-%I&N?:M4\37WA^WO=&L
M6MYH5CV3^6C!TR\;?,"00HY._O5F:+0?#]EI/V;Q)J?AV_BTQ?LUU?0KMN82
M[,(I$*X9E)/RC##<,4 =K>^/=$L_+9#>7D;6R7CR6=J\RQ0/DK(Y4?*" 3ZX
M!XKI(9H[B".>%U>*10Z.IR&!&017DFHZW"D%OK4^LW'AGQ3+I4$DMO)"&M[W
MY6*H(V!+$,67"D,-V.:]3TJXN+O1[*YNX/L]S-;QR30_\\W*@LOX'(H Y_4?
MB%H>FW&H0NM],^G/MO/L]H\@MQM#;W(& N#U]CZ&IK/QUHE]J]KI\#77^F;A
M:736SK!<%1DA)",,< ^QQQ7-6Z?Z/\4CMY:609QU'V1:9(FW1/A6%7&V>VX
MZ?Z(] '41^.M&EU9;!?M>U[DV:79MG%N\X)!C$F,%L@CTR,9K1TSQ#IVK6%U
M>VTQ$-I-+!<>8I4Q/&<.&!Z8Z_2O(+W71?66G7VH:Y=F]MM=@FO],CC1+?3H
MDN@,R )N&..2V23GIG&MXMAO--\3ZAH.G!Q;^-4C$<B#Y89%(2X;\83N^HH
M]/T?5;;7-(M=4LO,^S72"2(R(5)4]#@^O6LC5O'.C:-J$]I<B\?[*$:[F@M7
MDBM0W*F1@,+QS].:Z"UMH;.TAM;=!'#"BQQH.BJ!@#\A7D'C35);]?&>G7.L
M7MM>11O#9:/9Q(#<Q>0#YKY0LZDELD$ !<=: .OFUS4!\9K71$NC_9DFAM=&
M *N#)YI4-G&>GOBJ/@GQFX\%ZGK/B._9UM]4GMU?R\L0&"HBJHRQR< 8R:S]
M+N8;[XRZ'=VLBS6\GA0%9$.0?WQ[USNA121> H-0:*1[;3?&!O+H*A8K"KD%
ML#DA2P;\* /2S\0=$BM;^:[2_LI+&%;B>WNK1XY1$6VB0*1\RYZD=.]:=_XF
MTO3=:TO2;F<B[U/?]F55)!V@$Y(X&<C&>IKC+@Z=X]\<R?V9.EWI<>AW%G=W
M</S1EIF7;&&Z%@%+8'2N5T][[6O#6I^(9X7^W>&K:SMH\CDRVK>;<8]=W H
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MR;5+;NF#3Y[6Q1O$FA:WXFU>SFO-4N"-)M8HF:ZCF?<C1AHRS9##)!X(/3%
M'>V7CB.Y\<ZKX?DL;J*&QBC8W+6[A0Q$A8NW14PJ[2>O-7-(\:Z1K5]#:6XO
M(FN8VEM)+BU>)+I%ZM&S#YN"#ZX.>E<5J17_ (33QWHGG^7J&KZ+#%IZ/PUP
MPAF!VGO@GFCPG_9.J:IX<4>*-8U&^L8S*+!XH@MFPB*,LNV-63&XJ 3R<=:
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MLO L$;-9:Q_9\SE1\NRV4B;/U6"'_OJM.&*27XF_$9(T9F?2K=4 'WCY)X%
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M"CDA2HSCG!KF?%.O:;X@N%E\(>*-:N]:FDA6*QTZ=_(50Z[V=<80;=V22.:
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M"CQ6$(@$:6J.<MW)9R  6XX'2NBHH *,#.<<^M%% !1110 @  P  /:EHHH
M*P/$_AZ[\26Z6']K/9Z7*"M[!%""]PF1E1(3\@(R#@'(/:M^B@!D420Q)%$B
MI&BA551@*!P *< !T %+10 @ !) '/6EHHH ,#.<<T@ '0 4M% !2  9P ,T
MM% "8 )( R>M+110 5C>%M!7PSX;L](%Q]I^S!@)BFS=N8MTR<=?6MFB@!,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=C[R6!(VKC<P(!.0", T =-16.WBK0DT"+7#J<']FS8$4X)(<DX"J!R6R",
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M]<-R-,O$N?LTGE2E <*WIG&#^%3:IJUAHM@]]J5REM;(0"[^I.  !R23V'-
M%RBL_1]<TW7[1KK3+M+B)7,;D J48=592 0>1P1WJ;4=1M-)L);Z_G6"UA ,
MDC=%&<?S- %JBL73?%V@:QJ4FG6&IPSW:*7\L9&Y0<%E)&&&>ZY%)9^+_#^H
M:L=+M-4AEO S*$&<.5^\%;&UB.X!.,4 ;=%8"^,=!NKN73K35H#?!)3L"LVP
MQY#%N.,%3UZX.*AT[Q/I]KX/LM8U77;2YAE^47L41C2=BQ ")R<\8P,G@T =
M+1619>*=#U#2[G4K;4H&M+7/VB1R4\G R=X;!7CU%8,?CJTU3Q?H&GZ->Q3V
MEVERUR#&RN-B*R$!@" <GG&#CVH [6BBL ^-_#0U;^S#J\'VKSO(QAMGF_W-
M^-N[MMSG- &_17FNL_$&4_$N#PS8ZG:65I%!YMS/+:/,\DOF[/) !&..=W(K
MTJ@ HKD9_%6IQ^/=-T0Z2(=-NS.@NIG^>5HTW$HHZ+R!D]><#N;&L7_BF76C
MI^@6-E'#% )9;W40YC=B2!&@3!)&,DYXR.* .FHK#\(Z\_B7PW;ZE-;BWG+R
M131*VY5DC=D;![C*DBKVJ:UINB0PS:G>16L4TGE(\IP"V"V,]N%)Y]* +U%<
MRGQ"\*203S+K$6('5'0QN) 2"1A,;CD G@'@&KZ^*=";P\->&J6_]E$9%SN^
M4\XQZYSQCKGB@#7HK%LO%V@ZC8WM[:ZC&T-BA>ZW*R-"H!;+*P# 8!/3G%00
M^.O#%QJ4&GQ:Q UQ<,$A #;78C.T-C;N_P!G.>V* .AHKD+;XBZ-<^-[KPRK
MD2P*BB4AOGE+,#'C;QC ^;.#FLWPU\3=*D\/P3^(M5MK>^>>9&"HP5%$SHFX
M@$)D*.6(S0!Z#16)J_B_0-"N8[?4M3AMY73S I!;"9QN; .U<YY.!Q6TK*Z*
MZ,&5AD$'((H 6BO.O'GCZ31?$FC^']/U"ULI;II#>74]J\WV=%0,N%!&XMG'
M7BNCO/&_AW294M=1UB!;D1H\A"-A PX9\ B,'K\Q% '145Q^L>);VT^(OA71
M;5X6L-4ANI)CMR6V1[E*MZ5'X4\63ZA/XN?5Y[>&TTC4Y;>.0@($B49RQ_K0
M!VE%<]:>.?#5]#=2V^JQE;6 W,P9'1EB'5P& )7W&15^ZU_2;(:>;B^BC&HR
M+':9/^N9AD ?7(H TJ*Y_P 1^(+2PLM0MX]8MM/OK:V6X:6>(RK"C/M#,HQD
M$@C&:?<^*]%TF&W34M4A6>2V6<81LRJ>-RJ 2<GL,F@#=HK%_P"$NT#_ (1]
M==_M2#^S&;:)\G!;.-N,9W9XQC-2:5XFT;6YVATV_BN)5C$K1J"&52Q7D$<'
M*D8//% &M15/5=3M=&TNYU&]?9;VZ;W8 GCZ"N(7XEVUY;>%=3AFAM;#4)9%
MOQ+D^25MS)M#$#)!VC('- 'H=%8UAXLT'4].N]0M=3A:ULR1<N^8_)P,_,&
M(X]14FC>)-'\0B;^R[U+AH<>8FUD90>A*L <'G!Q@T :M%%% !1110 4444
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MUBL;:.WB8/'$D2A$8'((&, @\YH X?7US\1[_:/F;PG..._[X8_F?SJ[\/\
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M!'<. 2!O^7"\CEJZQ55%"J J@8  P *AO+*TU"V:VO;6&Y@;&Z*:,.I^H/%
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M3\=EJOX25[98Z5IVEB0:?I]K:"0Y?[/"L>X^IP!FIHK.UA>9XK:&-ISNE94
M,A]6]?QH \8UNYCU_P"&_C_Q9&#Y6I-'!;$_\\8=BC'U<R5U6D11O\2=#=T#
M-'X5RA(^Z3+&,C\"1^-=T--L5L/L LK<6>,?9Q$OEXSG[N,=>:D6UMTF698(
MEE6/RE<( P3KM!]..E 'CB20VFHV]U=LD>FP>.+LS.YPD;&-@C'L!O/7U-=/
MH%YI]]\8_$$^G21RJ=+MEEEB(*NX=P2".#@;1]5([5TVOZ-<WNDR6^D/96LS
MSB:1+BU62&XY^99%ZX;NPYX%4?#'AJ\TW5KW5]3DLA=7$,5M%;V$12&WA0L0
MJYY))<D]* -?Q""WAK50 239S  ?[AKS/1I;._TSX3(DD-P(3AU5@VR1;1C@
M^A! /X5Z]5*VT?2[+;]ETVS@VN9%\J!5PY&"PP.I'&: /*?&,<K:GX\,3B-%
M;1I9W,>\+&KDNS+QN 49(]!75>'+?SO'$M_/XKLM7O$TWRFAL[,1JL;2!E9F
M#L,Y#8'7YB:[3[+;B26001;Y@%E;8,N!P Q[XR>OK45CIFGZ7&T>GV-M:(YW
M,MO$L88^I  YH M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% ",2%) R0.@[UY_H/Q"NIM-U_4=:TFZM[>POY+:+88V9F#*B
MP *Q)DW'&?N\]:]!KQN33+ZYT3Q5H_\ 9NJ"\A\1/JR+'%)'Y\ G1_W4HP-Y
M7) !SD4 =R/'"6]IJ[:II%[I]YIED;Y[61HW:6$!OF1E8J>5((R,'%53\1H(
M])MM5FT34X[&\NH;:S<JA:Y,@8AE4-G&5P,X)R"*YV72["^T'Q3<:/I_B2>X
M.BS6L=QJ;W#-(74GRHTF^8D%1R!C)Q6QK.G7DGA?P+#'9SL]MJ6GO,BQDF)5
M0[BP_A [YZ4 6X_'US+J%WI*^%=4_MFW1939>9#S"V<2>9OV8R,8SG/8\XKZ
MAXOTC4].\(:H#JL<6IZE'%;I;R^41)D@K, ?F0$$$<]*T+*TN5^*NKWC6\HM
MGTJVC28H=C,))25#="1D<>XK@XM%U4>%/AY"=-O/-M?$1FN$\ALPQ^?*=S#'
MRK@@Y/'- ';WOCWR;W6+2QT#4M0DTA\7AA,:JJ[ ^X%F&XX)^4<_*>G&;5QX
MQWV^FR:-H]]JS7]J+R-8=D82(@8+,[ !CN&%R3UJAI-C=QW_ (]9[691<W0:
M M&1YH^S(,K_ 'N01QWKE;&&\M['PS8ZU:>(?[.30(%AM=/$\9:[SATE,9!4
MA=F-Y"CYLT ;^I?$&[DO_"9T32;J[L]8\QV&8D=ML;DQ_,PVLI ))XXP":O6
M/B/2;7Q-XS:6?4$_LJ.WEO3<3;X$4Q%AY*9^7@'/')Q7%Z7'>Z1IW@2ZN])U
M,+HU[>P7R1VDLKQEU<*0 ,NIW#YAD'US5N[\-:IJ^L_%6WBM)X_[2MK1;.21
M"B3,L+<*QX/. ?3/- '8:?XW^T7^G0:AH6H:9#JF18SW)C*RMMW!6"L2C%02
M ?0]ZH2?$VW73YM470M3?2K2X>WO+P>6%@99"A.TMN<="2H. ?4$"I=:A-XQ
MOO"UG::5J5J]A?QWU\]U:/"EOY<;#9N8 ,Q9@!MSQDU0FTK43\$O$5B+"Z-Y
M+/>F.W\EO,<-<,5(7&3D8(]J /5:R?$.OVWAW3X[F>*:>2:9+>WMX #)-*WW
M47) ]3DD  &M1.$7Z"N3\>6EVT>AZK:VLUV-*U..ZG@@7?(T6UT8JO5B-^<#
MG@T /B\93RMJ%C)H%]!K5I;K<K8/)$3-$S;=Z.'V$ YSD@\5S_P:N]2U7PT-
M7U0ZM-<7@9FNKN[$D,I$CC$488^7C&#\HS[U?T]Y?$/CVYU^UL[R'3;?1VL4
MDNK=X&GE>0.=J. Q"A0,XZFI_A)97>G?"_1;2^MIK:YC67?#-&4=<RN1D'D<
M$&@#L9Y&BMY9$B:5D0L(UQER!T&>YKG/^$YTS_A 1XO"3&R,/F>2 /,W;MGE
MXSC=O^7KUKIZ\D31[D?$=_!XCSHHOAXCSG@)R/*QZ>>-V/04 =?=^-9$O[JS
MT_P_J.I2V,:/?>0T2B LNX(-S#>^.<+GMZU<L?&&FZG?:/;V8DE35;.2\@E
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MO'Y3;I@T2A2@QE@2,#'6M/4-.NY=>^'[+;3^7;K<"X=8SB'-HRC<?X>>.>]
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MVEH\RW&^-%\O<H(4AD(^;'!S60GAG5-*M_A=8R6DTLFGSL;MHD+K"2F3N(X
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M/<2/:NL,<,(5C()<;#N & "3S@X- 'KM<CXOU;5#K&C>&M%N5L[S4S+)+>%
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MN_)21 T</ #.[L!DG@#))(-,/CN"Z@TTZ-I5[J=S?6[W*V\9CB:*-&"/O+L
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M:+&^,D8W+D$9'7D$5F^'_#MIX=MIT@EN+F>YE,US=73AY9G( RQ  X
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M>59&&]8QO#88;@-WR^AY.: /5***\W?QMXDD\-7/C&VMM-;08)'9;1E?[3+
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M<"-H)9(]K*X(.1D#!'XX[=7X5LKO3/">DZ??I$EU:VD4$@B?>N40+D' ]/\
M]=:;SPQRQQ/*BR2DB-&8 O@9.!WP.:DH YCXA)+<^"-1TZV7?=ZBGV*W3^\\
MAV_D!ECZ!2>U6-.N+JRU^+P\D436%KI<3K,"?,WABF".@!"Y'T/I6V8(FG6=
MHU,J*55B,E0>N/3/]*JZOJ]GH>FO?W[LENCHA95+'+N$7@>["@"ZRJRE6 *D
M8(/0BO,/A?HK)J^K7GGK<:;IDDNE:0XY'D^:9'.>^"43(_YYUW-W+I>N7-]X
M=O;22=%C1YTE@81.I(( ;&&.0. >*T+*RM=.LXK.RMXK>VA7;'%$H55'H *
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MP[I.C0^4L<<=J5DF=LY8EU50%Z8&">,\=*Z>B@ HHHH **** "BBB@ HHHH
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MM]2MO"NG)K-S)<:D80]R\G7>WS%?H,[?PJAX[U2^T_2;"VTZ<VUSJ>HP6"W
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MOG0/R%P.V2<5<OO!VKZF);2\\3/+I5Q*DT]LUH"Y(*L520M\B%ER!@D X!H
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MQW\0:CJ":G=BPO8[EU*EGC9A)'A1LPR]!Q@U07Q5K%K\/]2TN2Y:3Q3:W_\
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M+R*XM7%H%940DA&^;YB<_>XZ=*UO&?@:W\8M8-)>R6AMV9)3&F3/ ^-\1Y&
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M"NM>'O#OB&WT?69)#<F:YL(EME$D$KL7QO+88$G'(&,UV\898U#G<P !/J:
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MF !1XMW(^4'(8<B@#G+KQ!K6E/J_AB/5)IITU:QL;749E5I8HKD G/&&90'
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MD'Y#D]\CM0!KT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !3#+&)1$9$$A&0FX9(^E/KQ=-(TW4/A'K7BJ]@C/B'=>77V\C]
M_#-'*XC57ZJ!L4!1Q^= '>Z]XQETSQ18>'M.TL7]_=0M<-ON1"D4:G&22#DY
M[8I+7QE/J/C34= T_2A-!IOEB[O'NE3#.A90B8);I@G(Q7'7&AZ5J?QCT)]0
MTBRD>[T-KJY22!2'FW#YF!'+#IFI/!OA[18/B)X\:'2K*-K"2W^R%8%'D;H6
MW;./ESWQ0!Z5I5Y=W6DQ76I626%RP8R0"X$RQX) ^<  \ 'VS5U9$:/S%=2F
M,[@>,?6O#?!D4>H> _AMHUZH?2[V]O#<Q-]R4Q^<\:-Z@L,X/7 K>\5Z1I^C
MI::+H,,-S;W^MP_;-'-TL<*?N7<1X /EJY16(((..F#0!ZHLL;QB175D/1@<
M@_C0KH^[8RMM.TX.<'TKQ;Q-I&I:5X$\7B33;/1[*>2QDMK*SN1*L,OG*'8
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M$B,@<.I5NA!X--,\(C:0RH$4X+;A@'ZUXCKEG'9Z5XET.Q+0:;;>); 6JQ'
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M34XS>^880NUMID R4#XVEA_=!S[57O?'WA?3I98KK5HT>&5H90(W;RF!P=Y
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MK%#Y*S;S@+S_  YQG#$9QG!Q7.-\1K/4+/Q9%IA*W>CV\SP.Z,1*4B#%B"H
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MUOP]JUC"(8KN^LI+43LO(#*0,D<X!.<5/IFC6>G1Q2):6RWGDK'+<1Q /)@
M<MC)Z=Z /)/#MH]QX:TC3=1\86MM)#JBJ=.%BK7"W27!;;D-NR6!);'1B3Q6
MW:0Q?\(1\3W\M=SWVI;CCDXA&*]'&FV OS?BRMA>$8-P(E\PCTW8S4@M;<1S
M1BWB"3$F5=@PY/!+#OGOF@#RJ>YATVP_M/3?$5A:Z@FB6IO],U.(-#=QK&2F
M"2""067*DCL1FFZKKKWXUU4NK'0%32[<&U%HCW-X9(2RQ\\D L4  ZYZ5ZC/
MI.FW3P-<:?:3-!@0F2%6,>/[N1Q^%22:?92WD=Y):6[W48VI.T8+J/0-C(%
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M/XK6;3Q+=,]S((2X#E/LJ_,%ZX]ZBAB;3OAEX&\60@^9HD,+SX'+6LBA)A^
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M= 'G>M:II>M>(/ T>A75O<S)>&Y7[.X;RK80.&SC[H.5'/?BG_#?_D8?'?\
MV''_ /017;6FEZ?82R26=C:V\DIS(T,*H7^I YJ:*V@@:1H88XVE;?(40 NW
MJ<=30!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 (Q(4D#) Z>M>0ZGXUUS4_ 7BRZN;.YT[[!J/D17$<R QA9XE,?R,6+
M%LD<'. 37K]>-W-IJ)\*>-]"&D:D;V76WO8<6CF.:)KB)@4<##'&3@<@ ^E
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M:V^F327=Y+>VCP",^4R+&-P&YB6YVY&!UH UAXXLCX%C\5_99_LKNJ"'C?\
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M\K.$VE=VY@&(!8#'UYK0U7QPNG7FHI;Z/>WUII0!U&[@*!8,J'("E@7(4AB
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M-%J6C+(\L$CN6: ^4#TROW@5//I0!TDOC75)?&^AZ;9Z)=_8;VQ:YD$OEQR
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M;7-M,06BE7&1E201@@@@\@BF>(/$,>A+9Q):3WU_?2F&UM("H:5@I8G+$!5
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MVH6MU]I()W31N49-O& K<YZXX[UT_B#PW/K7BC2+L[/L,%I>V]Q\V&_?*BC
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MJUO=M*=O<Q1%!ACVW'BNYHH XRXTK7M#\5:AK&BVEOJ<.IV\*7$5Q<^0Z2Q
MJK@[2""IY'!R.*I:5X(U'3KGPK-+-!-+97EY>:@ZD@&2='^X".0&8#G' S7H
M%% ')VWAV^BU3QE<-Y7EZOY?V;#<_+;B,[N./F%<G96.MZ#XN\+6-I;VUS?6
M'A8PW$#S%%D"R1*P5\'!W8(R.<8XSFO5);B&!HEFFCC,K^7&'8#>V"=HSU.
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MK7C&RUB_T+R=%=1<"XB>6)I3%Y\08%X]XY7<.,UO;%#E]HW$ %L<D#M^II:
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MD+9,R2Y(E$A<D#'W><9Z^U<XOA'Q$OPJB\+-:VANK>:(1NMS\KHDXD+'*\9
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MW6-%1F!!503C&#U)SD\] )+[P/%??#5/!AOG2);6*V^U",%L(5.=N>^WU[T
M9,QU/6O'%EI']LWMG8OH$=W,+5PKO)YFW(;!VYSR1SP!ZUD6FL:U>VVF>&CK
M%VLDNOWNG2:@I G:WMP[ ;L<,0%&[&:[VU\-I:^)8=9%RS-'IBZ?Y6S@@/NW
M9SU[8KE?$7ART\/Z0+UKV_CF&N2:E%?6MJ)?LC3%MWF)GYH\$J<<\B@"]X:;
M4[/X@ZYHUUJMS?65M8VTML+A@74.TF=Q &3D8SUP!GUK4\>'5(?"5U?:--)'
M?6!6[5$/$RQG<\9]0R[ACUQ7/> 87O/&/B#6TO+F_M9[>V@%]-"8EGD7>6\M
M<#"*"H^N>2<FNWU?5K#1=.DO=2E\JU7 9MC/UX P 2: .0O_ !/+JOB#1VTF
MYD&FV^F2:U>>6<>:C+B&,GW.XD?[-8C7.MZ=X!TSQU)K]_/?2M;7-Q:,X^S/
M%-(JF-8\?+A7&".<CK6S\+O# TGP_>W4]M-%_:<[/%;W(^>&T!(AB8=L*2<=
MMU30?#V9+2STB?7II_#UG.DL-@UNH<A&W)&\N<LBD#C / YH 73=5OY;3QXT
MEU(S6-Y,EL2?]4HMT8 ?B2?QK!CO-;UN]\#::NN7MI%J6@FXO98& D=@L3;@
M2#AB3C..A-=)>^!KJ:_UEK/7YK/3M9.^\M%MU9BY0(Q20G*A@!G@GT(JUI_@
MV.PU#P]=B]=SHVFG3U4Q@>:"$&X\\?<Z>] '2PQ^3!'%O=]BA=[G+-@=2?6O
M,K"Y6S^*OQ%N6NX[01:=:O\ :)%W+%B$G<1W ZX[XKU"N0NO -K>ZMXHO9[R
M4IX@M([62-4 \D*FW<#W/?I0!S&AZMJ</B&QL]/O]=O/[0TVYDWZS"8XY)T"
M%)(@0"JDL<KTP12Z%<RW5O=65UXB\06NL?V;(UYI^HIL<R  ^; ^  H.1\N0
M0PX&*Z#_ (0;4KC4+'4+[Q/<37EK%);AXK=81Y+J P4 _*^0#OR>0..*LV7A
M"^;48+O6]>DU/[+;RV]LHMEA*B0!69R"=S8 '8=>* *_PHLS:_#?17-S<3>?
M;))MF?<(^/NKQPOM4WBO4;W0O$?AW5%N9!I,UP;"^AS\@,O^JD]L. "?1JO^
M$/#USX7T*+29M4-_!;@);$P",QQCHIP3N/OQ69\2KVQ/A2[T::*>XO\ 4H6C
ML;:"-F>28$;""!A=K;3D],4 <]KOB?5U;Q/JME=W"6<-W;:+9+"GF;9"ZB>5
M4Q\S@OM7W7%.L=:OK!M;C34->M-)73&G34==L9";6X#;3MW ;\A@0O/*G'7%
M=+9^"H1\/K?PW<W$@F"+))=1GYQ<[Q(903W\SYN:;<>#M0U72M2L];\1W%X]
MW"D4;10+#'!M;<'$>2"VX DD\@8XH YW0M7O+?Q#>:=%=Z_):R:++=@ZS&5D
M$J,J[H\@$ A^1T! K:^&<.HW?A73]=U76+V]NKZTC+12./*C Z%5 ^\1U))R
M2:EC\%Z@^MQZQ>^(7N;TVDME/_HJI&\+X("J#\A##=G))R1TQC=\.:,OAWPY
MI^CI,9ULX%A$I7:6QWQVH R?'>I7UG8:79:?<M:S:KJ<-@;E "T2-N9F7/&[
M"D#ZUEQVU[IWC3_A&#KFJ3Z?J.FO<I)+.&GMY8Y%!V28SA@W0YY''6NG\2:!
M%XBTQ+5KB2VGAG2YMKF( M#*ARK '@^A!Z@FJ>C^&;FTUV77-6U4ZEJ36_V6
M)U@$,<46[<0J@GDG!))[#I0!ROP,T\P_#NQO?MEW)YQF7R'DS%'B9^57'!..
M>:W/B'K-SI>GZ7;6LEY$=0OTMI9+&(R3K'L=V\M0#\Q"8SCC)/:M/P9X8C\'
M^%[70X[IKI+=I")63:6W.S=,G^]BI_$6A#7K*"-+J2TNK6X2ZM;E%#&*5<@'
M:>&!!(([@F@#S:_U[7K'PKXB6RFUN&&WGL6T^\U6W>.7]Y,JR1DL 7 Q]</C
M-;$NF:M!\0(/#Z^*-7:PO=->[N&>5?-#I(J_NVV_NP=XR .W&*V[OP;>ZKH-
M]8:MK\]W/=SPRF40A(XA$ZL%2// .WDY).:UI=!23Q?;^(/M#!X;*2S$.W@A
MW5MV?;;C'O0!YS_:^OMH>G:=%K=RMQ'XNDT@WK;3*]NHE^]Q@M@#J.JC-7M2
M:]T6^\4>'9-4O-0L9O#DM_$;V0221.-\;*&P"5/!P>F*/%/A5M/AT>VM[V</
M?>+OM_G1H T#2)*PQU!"G'7@]ZZ&'P7/*^LW6K:PU]J&I6)T\3K;B)8(<-PJ
M G)RQ))//'2@#D?#=S>WGAWX?>&[:_N+&WO-.DN;J:V8+*RQ*N$5L';DODD<
MX%2ZC?\ B'2HO%%C9:I>7;>');34H&F8-)-;L&:6!V ^881R">>E=*G@+[+H
MOA^VL-5DMM1T.,QVU[Y(<,K+M=7C)P00!QD$$#FI(;/3_!=CJFKZ]J3WESJ,
MB_:[EK?A\+M2-8T!PH&0!SDD\\T 5+O7+C7/%VGPZ1>R)IMKI;ZE=-&>)?-&
MV!#^3/CV%<G;3^(AX.\':^OB?4#J&J75M:3*Y5H1'+E<B,C!<<-N.<G/;@=/
M\,?"SZ/X1N'N(YX)]3=G6.?F2" #;#&WNJ <=B36G'X(BC\,^'=%^W.5T6YM
M[A9?+&93$<@$9XS0!RNJZUJO@NZ\66EOJ=Y?I!I4%Y:M>MYKPRR2/&<''(R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%4=6UBQT
M2S6ZOY3'&\B0H%4LTCL<*JJ,DDGL*C77+)[W4;,>?YVGQK)/F!\89=PVG&'.
M.RYH TJ*QK?Q3I5PVE@2RQ_VH&-IYT#Q[RO)4[@-K8R0#@G!Q6S0 4444 %%
M%4]5U:PT/3I-0U.ZCM;2+ >60X5<D ?J0* +E%5Y;ZUATY]0DGC%FD1F:;.5
M$8&[=GTQS4EO<17=M%<P2"2&5!)&Z]&4C((_"@"2BBB@ HHHH **** "BBB@
M HHHH ***I:OJUGH>ES:EJ$IBM8<;W"EL9(4<#GJ10!=HHK%UOQ=X?\ #<\4
M.L:K;V4DJEXUE)!8 XR* -JBLC1?%.A>(_,&CZM:WK1<NL,@+*/4CJ![UKT
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M*** "BJ,>K6LNLSZ4OF_:H8EE?,+!-IZ8?&TGV!S5Z@ HHHH **** "BBB@
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M#NQN3=7]^!:"4)MVP;MTLK+DX4*2.O4BO288D@@CAC&$C4*H] !@4 /HHHH
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M3R,%8(54GY5 W D\D\5E^'O%>JWLF@:HEYKUW=:C<QB]LWTV06<<,F>8W\L
M;,J=VXY .<YKHFO-*3QC_P )!:MK,(GMOLU];?V#>,MR!_JVSY8PRY(S@Y!Q
MQ5#19#HSV5G'K>MG1+%RT%HOAR[64ISMC>78=R+GLH)P,F@"GJ'B2[M=:6^M
M->U6^?\ MF.T>.*R(T]8FF$9BWE,%U!^\&^\/PJ\FJWT?C22WU;7]2TJ];4M
MEG;36X-C=6V[Y41MN"[+WW!@QZ'&*RI=+1]+_LJ/7-8CT^WO/MMC&/#%V6CD
M\[S0)&V_O%!)&!MZY)X%:%TTE_,+:^US6+C2/MB7AMV\,W?G9602!!+MX0,!
MCY<@<9[T )]IUW6_#GB#Q5!X@O+.6SFN_L-I$$\@) 6 $BE26+%#DYXSQC%6
M+.^U;Q=XJ%LFL7FFZ=-H=I?F.TVB022%^ S*<#'7O\H]\T+JTB,6JZ;I^L:S
M::)JDTDMQ;?\(U=O*GF?ZU8Y-@"ALGJIQDXK;T^ZT73?$DVJVZZRL3:?!8I;
M#0KS"+$S$'=Y?/#8QCM0!DVOB"]N_!VD1ZEX@O8+EK^YM96L+4R7=ZL+NH"!
M5;;T4L=O;J,UEWFIZGK/A73(3>7/VJU\716=O=7D 68*"2K2)@#< W<#..:O
MQ6-M8)ITNEZGJT%]8W%Y*LLWAJ\D1DN7WLI3:.1\N#GMTYJN^C6;V<MK_;6O
M;6U>/5TF/ARZ\U)@/GRVS:<MAA\H"],$= #8N)-1T77M7\/SZM>:E976@S7L
M;7A5I(I$.Q@"JCY2&!QC@BN:T+7I;'P'X#TA;K4;2VO;:>:XFTVV::<K&1A5
M"JQ4$N,G'08XS706Q@EU#4M2UG4-5O+^ZL#I\+0^&[R&."(DDX7:Q))P2<]@
M*K6EE9:9H'A^UT[4-8AU+1%=(+Q_#EVZ2(_WU>/8.#\O1L@J#0!U?@/4[_4-
M+O4OC?2+:WCPVUS?6S02SP[59692J\C<5)P,[<UU5<CHRZAJ6E"*'7]1^VQW
MB7%S<W.E26X=-V3#&DH&$(&,@L1USS774 %<]XQ\,CQ+HZQP3?9=3M)!<:?=
MCK#,O0_[IZ$>AKH:* /,?",E_P#$/6H?$&N6R6]KHCFWM[)7W*UZHQ+,?93P
MO7')J_ FL>+M7\1R0Z_?:9%IEV;&RBM=@7>L:LSR;E._+...!@?C70^$_#0\
M+6%Y:B[-S]IOIKS<8]FWS#G;C)SCUK.O/"&J1ZGJESH6O+IL.JD/=1268F*R
M;0IDC.Y=K$ 9R&&1F@#(\'^+=2\0ZYX<DGEVPWOA^6ZGA4 *9EFC3</3JWYU
MO^#M1O-1E\2"[G:46NM3V\.['R1JL9"CVY/YU3D\"26$FB3>'-473IM+LVL0
M9[;[0LL+%2=PW+\VY0<@]>U:GA7PTWAJWU&-[^2^DOKY[UY9$"G<ZJ"...JD
M\8ZXQQ0!-XLO3I_A>^N5U--,94 %VT7F^62P'"?Q,<X P>2.#TKSL^,K_P /
MV_B<6]SJ]Y%::7'>6IUJV,4J2L[1]U4LF=IZ=B*]%\3:$?$.BM9)=&UG6:*X
M@GV;PDD;AU)7(W#*\C-<_-\/[C4KZ]N=9UH7G]HV!L;V-+7RUVY)0Q?,=FTD
MGG=DT +<:#KFDZ??2R^([G4K2339Q=Q7BJ3YNSY7BVJ-H^\"IXQBN:^'7B"?
MQ/8Z#H>F7QLK+1]/MY+Y@,2W;;=OEID<1@@AF')/ QUKK+;PCK,K'^V/$\EZ
MD=G):01Q6WD+\Z[3)* Y\QL#CH!SQS21^ EM;#PW]BU$V^IZ'$D"7@AR)X@
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M8+74LJN')P0%Y?/?@ >]:]CH(LO%&KZU]HWG48K>/R=F/+\H.,YSSG?Z#&*
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M%KT.KZWK,6H7%M;/;6XALQ;@*Y4LS?,VYCL7T YXYH Z>BBB@ HHHH ****
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M@CC)/S'J30!V=%><:'<>)/$&DZ!XEM-0MH%GE26\62]=HI(6)#1"+R]JLIP
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M_"NETV"ZM;>'7I(3:W+9>W=68-&3D\*<@<G@"@#V1F5<;F R<#)ZFAF51EF
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MAE8N&$C%F!)YY+&JND^"])T>_BOHFO;FX@C,5NUY=R3_ &=#U6,,3MS@#/7
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MQ0ZG?I#-*I=(@K.Y4=6VJ"0/?I65KGQ#T/18]&E^TI<0:K,%CEB)91'@DR9
M.<$ 8Z\^U '3V=I;V%E!9VL2Q6\$:QQ1KT55& !^ K$M?!.AV>G1V$-M(+>.
M_&HJIE8GSPVX-G/3(Z=*QX?B%I]CK_B"VUK4(8+6TGB6TQ&Q8QM CLQ !. 7
MZD #(KH=2\5:'I-I:W5YJ,217:[K<H#(95QG<H4$D8(.>G(H GFT/3[C5WU2
M6$O<O:-9,2QVF(MN*XZ=>]8\'P_T2WT2+2D:_P#(MYA-:N;V0R6K 8'E/G*
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M9&1@UR,?PW\/111QJM]M@D$EJ#>R_P"B$-NQ%S\@SZ=N*MW/C[PM9S^3<:S
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M<V<EJL[+R RD8)ZXR<XJMH'ARRT?3M/#6=F=1M[.*VDNXX0'?:@4_-C...]
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M(I'ZUZGI9)TBR).28$_]!%2?8;0PSP_98/*G):9/+&V0GJ6'<GOFIE4*H50
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M 3[5+#XX5]2MHIM%U&WT^[NVL[:_E"!))06 &S=O525(!(YX]:K:Q8W<FJ>
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M+LJNR-XB?E !W,3C( !ZC/6N:U+7GUG6/ B#2-0LQ%J2^>;RV:'9)Y$@V+N
MW?Q9(R.!SS5W0[76].\#^,S86D\.J/J6HS6:O&59R22C*".<\8/0T ;FF^-?
MM=[':WVB7^F/<6KW=I]I,9\^-,;A\K':P#*=IQUJA8_$NWO;72]1;0]2@T?4
M9(X8M0E\O8LCG #*&W!=WR[L8S[<UR]M#"GB/1M1LK'Q'):_8KJWN;S4A<R,
M9G1< K)G8/E.6 "Y.,\<5]+O)]>^%OACPO;:7J OI6LR\AM7\F.%)%D,OFXV
M8VKTSG)QC- &[I_C&^TF[\7L^F:IJT%CJDLDKQR)MMH!%&<+O89Z,=J_ID9W
M)]?TRX\;>&8HYM2,NH6<MQ;>5-MMV39NS(F?F.#QQQ5#3]/O$T7XA(UG.KW5
M]=-;J8R#,#;H 5X^8$@@8[BLK3]*U%/&/PWG:PNEBM-$>*XD,+!87\D#:YQ\
MISQ@T =(GQ @DN5ECT?4'T9KO[&-54(8C)OV9V[M^S=\N_&,UV%>:^%=6U'P
MQH=GX5_L#4;G5K>[>#/DNMNT+2EO/\[:5V[&SCKGC%>DMG:=N,XXS0!REMXX
M6;4K2*;1=1M;"]N6M+6_F"!))!NP"F[>H;8V"1SQTS2:?X\M]2U6_M8=,O1:
MZ;//!?7S[!# 8@>>N3G'0#C(SC->?P1W<T/A[4+S3_$MUK%GJ44^L2SK<M'#
MRP(CB^XPR01Y:G"CKSSU6@Z%>W7A?QYIKV\MM+J.J:B(#*A3>LBA5<9ZJ?7I
M0!LZ1XU34KZQ@N-'O]/AU)&DT^XN-FVX 7=C"L2A*_, P&0#Z8I+#QPMYJ5C
M!/HFHV5GJ,CQ65Y<! LSJ&;!0-N3(5B-P&<5RGAK3K.6XTE8M,\3MJ]C"TC_
M -HSW'V:SF6,K_RT.QLDD#9G@YX%9EC'/)-X3U*:P\37.HVMZCZQ/=K<LL4C
M1NI"1'Y2-S?>1<*N.>: /:"0 22 !U)KBXOB-;R0P:BVC:A'H-Q.((M58Q^6
M2S;%<INWA"W 8CN/6NONX/M5E/;[MOFQLF[TR,9KR9OM]]\-+'P%_8^HQZRO
MD6<Q:T<01I'(I:;S<;"NU<C!R20,4 6)]5UK5?C0VFRVFM1V%C;1R);6M]'"
MG^MQY\@$@WH1_"<G'\->F:I>2:?I=S>16KW3PQEQ#&RJSX[ L0/S-<A8V-XG
MQLU6^:UG%F^C11I<&,B-G$F2H;H3[5V5_$\VG7448R[Q.JCU)! H \L7QIK-
M[X>\#ZO>6E[#+<Z@JR1V[+_IH,$A 55;[I;'#XP1DXZUUT'CRU2VUIM6TZ\T
MRYTA$DN+>4I(S+)GRRA1B&W$$8SUXKC_  ]'=W/A_P"'UI_9>HQ3:3?B.\6>
MSDC\HB"49R1@KD@;NF2!5OQ=X?U+5M6\8K;6=RXEL=.>$H"GG-%*\C(C_P![
M QP>"10!V6C>)WU'5'TN_P!)N]*OQ!]ICBN&1O-BSM+ HQ&02 0>1D5HZUK%
MIH&CW.J7S,+>W7<VQ<LQ)P% [DD@#W-<CX1L])G\1F^L++Q(SP6K1F[U>6XV
MH7928E68Y)^4$D#' YK6^(.F7FJ^#+N&PA,]U%)#<I"#S+Y4JR%1[D*0/?%
M$<'CF*(WJZYI5[HKVMHU]_I.QU>$<$AD9AN!QE3SR.M-LO&[37MC;W^@:CIJ
MZDK&PDN&B(F8+NV':Q*,5&0&]^]9'B'4;[Q[X;UK1=)T:_AADT]F^TWT+VQ,
M^05A57 W$X.6S@<=<T7>HS>,M5\+V]II6I6IL+Y;^^>[LY(5@V1NOE[F #,6
M?'RYX&: -Z+QQIDO@.3Q<R31V<43N\+@"165BI3&<;MPQUJM>^._LTDZP:#J
M5V+*WCGU$Q>6/L@9=^TAF!=PO)"YXQZURUUX?U-O&DWA9;&X/AZ\U6/6Y+GR
MR8@@4L\);IDS(IV^AHUG2;>P\5^(Y-4M/$LR:B\<]F-)DN!'/^Z5&C;RCM5L
MIU?'!'/% '6W?CB(:N-*TK2KS5;M[**^B%NR*CQ.6 ;<[ #[HZ]=PQWP1>.(
MKW0=/U'3M(U"[N+Z9X([)557CD0L'#LQ"J%*'DGGC'6J7A[2)--\>R"*QGM[
M&+P_9VT1?+*I1Y/W>_HS 8SS7+V\&HV.E:7;ZC;ZW;Z.^JZD]ZMA%,LS$RL8
M<^6/,V-ECD<'Y>U '82_$*Q@T:WOY]/ODEDU+^RY+0*K2Q7'/R\'#9P,$'G<
M*ANO'ES#I^O(^@7MKJVEV8O!:321-OB.[$@97*D#:<C.>,#)XKD-,TV]1+>S
M71]4@\KQA#?;+B.60K;O$=KM(<[L8PWS':>#VSTGB+2[^\\6>)3;VDSI<>%3
M;0R!#M>4O-\@;INY''N* +&E^.-0FT+0_-\/WMSK&HVOGK;QR0KO140M-DOM
M529!@$[N>@KK=*U :KID%ZMM<6WF@DPW,>R1"#@AA]0?8]1Q7FD<^F7_ (1\
M-1ZKH_B.U>QM%@6_M+6>.>TG6.,,N%7=M;^]@J2N*[GP9)JDGA2R;6?/-Y\X
MS<($E:/>WEEU'1BFTD>N: &:UXI;3M632;#2;O5=1,'VF2&V9$$46=H9F=@,
MD@@ <G!JFWCRUN(-+&E:;?:A?:E$\\5FH6)XT0[7,A<@+AOEZ\GIFJ6HW,GA
MCXAWFL7-A?W.G:CI\4*RV=L\YCEB9_D94!(W!Q@],@U3-_J-GXKTKQ?JVB7M
MO;7>E264\-O&US):-YHD0NJ+N^9>N <'@^M &M)\1-.AT4:A/8WT<J:BNFW%
MGL5IH9SV(!(8<@@J3G(Q39/'4\<>KV\WAZ^M=4L++[:EI+)$?.A)(W!E<KP0
M<@G/IFN7?2]2OG;6?[,O(DU#Q9974<#PL)$MXPJ>8Z]4!VD\XP,9K?US3;VZ
M\=:G)#:S/%+X8DMTE"'893*<)NZ;N<XH ?HGC74[CP=HE]=:!?7&J:BB".&$
MQ 3?N@[2[MVV-#S@,0>V*A\0^,--N?!#:G=QZQ9B+4%M)X+6817$4ROM*EE;
M!7..AP0:YZSO;B3PMX-L[NU\16NE6EL;74X[6UN(I3.D2"-3L <H3OY7@G&3
M63J6DZC)\/M:TNWT354N!XACNHX)(I9G,+E2K;SG>0 =V"<$<]J /3=0\9-;
MZ_>:'8:)?:EJ%K#'.R0M&BE'W<[G8 8VXQU.>.AQ$GCVTN](TB[TS3[R]NM6
M#FVLEV)(/+XD+EB%4*>"<]2,9S3M)M+F/XE^);I[>5;>6SLECF9"$<KYNX ]
M"1D9QTR*X"RT">TTCPMJ&JVFMPVEM_:-O="P\Z.>#S+@O&Y6/YRA"\X!ZJ:
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M*<G[.Z,H:.0%VS]_AN,[3Q0!W=%>96/CCQ3+X:T/Q1=VNE)IE]/!!-;(LGG
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M=BHVX%263Y0V%(/4>]-OO"FL#7M3>WTS2[F+4K*"VBO)#M%@$0JP6,@DKSN
M!'/!/>O0Z* /,SH/B-_">G:'J/A;1M5MX=/CM526Z"M!*@*&3<5.58!6&W#+
MR.>M7+'P_P"(_"NHPW^GPP:RUQIEM9WRRW/DN9H00L@8@Y!#$$'GH>:[(:O9
MG7CHN]OMHMA=E-IQY98KG/3J.E0Z[X@T_P .6<-UJ4K1Q33I;H50MEW.%'%
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MD$ YQSD],5K:-X9U"Q\8Z=JDPB^S6_AU-.?#Y/G"16.!Z8!YKH)M=TZ&YTN
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M())6#%44L0HR< 9X'>J^F:C#JVG07UNLRQ3+N431-&XYQRK8(Z=Z .%D\/\
MBC3=+USP[I=G93V.ISW$EO?27)0VR3DEPT>TEBI9L8//&<5LZ'X7GT7Q7]IC
M*MI\6BVNG1,6^<M$S]1]"*ZRB@#GO!FC7>A:)-:7@02O?7,XV-D;9)6=?QP1
M6#)HGB;2[_Q)9Z3:6<]CK<S7,=U+<[#:R/&$?<FT[_NY&"/0XKOZ* /,K;P7
MJ>DP:!>?V+IVL3VNCQZ9=VEQ(J[60[E=&92.I<'IP15W4O#VOK#X5U&TTW2W
MOM*NI9I[&U?[/"1(C+A&(/(R,G')R<#I7H%% 'G4WA;5K'5-6^Q>'=$U%=3N
M3=17E\03:NZJ'5UVY=006&TC.<<5O:5H-W8^/-:U9UB6RN[.U@A"'!!CW[OE
M[#YABNGHH \[NO!FK2_#GQ/H:B#[9J5[=3P9D^7;)+O7)QP<5T6IZ+=W?C?P
M]JT03[+807:39;#9D$87 [_=-=%4<D\,+1K+*B-*VR,,P!=L$X'J< G'L: /
M--'\":U8^$]/TV86_P!H@\1IJ3XDR/)$NX\XZX[5M>)/!USXA\0ZC(SI'97F
M@2:<),Y996DW X]!UKM:* .'T;2M>CF#'PYX>TF>"U=!=1@2M+.1A64*JE4Z
MD@G)!Q[TW0] U1O&,.N76A:?HK1VTD5VUG<!S?.Q7!("CA=I.6YYQ7=44 <G
MXWT?5-1.AWNDV\-S<:7J*7;6\LOE>8FQE(#8.#\PI^C:)J%OJWBB]NHXHQJK
MPO"BR;L;;=48$X_O UU-% 'E^F^#]>T<>'Y?[*T[4Y+31UT]X[B?:MM*&W&0
M94Y!& <<_**;;^$?$VFZ-X<6*SM+J[T+5+B;8+CRUNHI/,PX.T[#^\^Z<]*]
M.DGAA>)))41I6V1JS %VP3@>IP"?H#573]7L]4FOX;5V9[&X-M."I&V0*K8'
MKPPYH 9K%E+JOAR_L!MBFN[22$9.0K,A'7T!-<?H?A[7RW@IM1L;>U.@I+;S
M!+GS/,7[.(U<<#&6SQV]:]!K+U+Q!I^DZGIFG7<K+<ZG(T=LH0D,RC)R1TX/
M>@#D?$/@[5=2A\=I;B'.M0VR6FZ3'*1[6W<<<U8U31M8?1[#2IO#NDZ[8+81
M0M#<3"-H9U7#-N*D%2,8(P1@]<\=U10!E^&].N=(\,Z9IMY<?:+FUMHXI9<D
M[F50"<GG'UKD]$TCQ?H%C;>&K&&Q33K>Z+)JC3;G^S&0OL\HK]_!VYSCO7H%
M% 'G,GA_Q1INDZYX;TRSLIK'4IKA[>_DN2AMDG)+!H]I+%2S8P>>,XJ7Q;X*
MU232-%7PQ+$E_IUJ^G;YFV@V\D7EDY'=2J,!ZBN_DD6*)Y'.%12Q^@JKI6IV
MNM:5:ZG9.7M;J,2Q,RE25/(X/2@#E-;\&F&W\./I6G6>H+H<;6XL;LA5FB9
MIPQ! <%%/(YYJ.3PUJM[9Z,[:9I>G26^N1WTEM9\".!5889@ '?GJ !SCMD]
MW65'XBTZ7Q#=:$DK&_M8%N)4V' 1NAST- ',^*?".J:UJ^OSVDL427V@KI\+
MLY!\T22,0<=%(8#/N:AL-!UP>*=)U?\ L+3=-LX+6:R>SMYP6C#["),A0&Y3
M&WL.<\X'7>']>T_Q-HEOJ^ER-)9S[O+9D*D[6*G@\]0:EN=7L[35['2YG875
M\LC0*%)#", MD]OO"@#C(_!^JK\+M$\/$0_;K.:U>4;_ )<1S*[8/?@&M/2-
M)UC2_B#K]Z;2"72M6:&47 GP\31Q!-I3'.2.N>E==10 4444 %%%% !1110
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MB%/,B.'3(QE3V([5REEX,O\ [;I3ZSK[:E:Z2WF6D M5B)D"E5>1@QWD G&
MO/-=A0!X1I-C=?\ "K/"TT6IW1N+OQ##L:8AU@87,HW*N.Y^8YSDUU=]JVI>
M"]8\0VZZI>:G;PZ VJ0K?L'9)E=EP" /E/''MQ6CIOP[GL-+L]*?7#-86&IQ
MZA9H;4*T861Y"C-N^;);K@8QTK:U#PG:ZIKUWJ-W*SPW>E-I<MN%QE&<L6W9
MZ\XZ4 <GX7U74U\1Z1$EQXEOH+R*1=1;4]/DBACD";UDC8HH0%@5VYQ\P]*[
M+QC$\W@S65CN)K=Q9RN)(6VL"JENN.^,'V)JKHGA[6-.NK=M0\22WUK:0F*"
M!;<1;N@#2D$[V '' '4XK=U"SCU'3;JQE+".YA>%RO4!@0<?G0!Y)9W]QI'A
M7P/HXU'7#;:E8_:[B2RB,UPJI%%MBCV(2J9<'.,@#&>:FN]?\2#PW8P07>I6
MLS>)8=/MKR_M3%+-;.,@NK*-V"Q!.!G972VG@74K/2-'A3Q$/[1T;,=C=_8@
M%$!14,3Q[OG!"@YR#D#TJ[<>#[F_T_3(=0UN:ZN;/58]3>=X@ Y0DB-5!^1>
MPY./?- &-<66J1^-M+\,1>)-5^Q-I4]Q<3M(IGD(F7!W;< C=C('W>/>N?EN
M?$4?@;Q'K#>)]1-SX>OKFWM,; LR0R<&8;?G)!QV& .,Y)],DT%9/&%OXA^T
M$-#8R6?D[."&=7W9S_LXQCO65+X'CE\+>(=#^WL%UFZN+AI?*YB\ULX SSC\
M* .JA?S88Y,8W*&Q]163XL?58_"VH-HBN=1$?[H1@%^HW;0>"VW.,]\4D-OJ
M<7BO=]HD.DKIRQ^45 7S@Y^8'KG;U'0<>M7=7L9M2TN:UM[Z>QG?!CN8?O1L
M""#@\$<8([@D=Z /.&\3MIGA/7KO1_$&H7=S$+>%;36(,7%C-)((][;@"5^8
M$ @C*G!YQ6OK$.L^!M#U?68==NM3M8=/=_)U##LMP/NNK #"\G*_EBK<G@-]
M5AU4^(=5-]<ZA:I:>;;VXMQ"B,74J,M\P<[LD]AQ3X_!=Y??:AXEUZ;58YK)
M[)8HX!;HJ/\ ><J"=TG ^;MV% &5/'J_A2[\,WDFOW^H_P!I7L=E?0W3*T;&
M1&(>,!1LPR]!QBL5)O$5QX#UOQ1_PDM^EWIES>/:PJ5\DQPRM\LBXR^0".O
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M&QC++)&Q0!!N&W ."&'IFND\*^ [7P[H%_I=U>2:D;\>7//*FUFB$8B5.">
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MW%KEZ6EGLK9[/*_9S!(P3;MQG=@@[LYSGM@#MK7P=J3WUE-J_B)]1CT])%M
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ML^K:C<Q73ZA%"(_*DBV^5L3) "[1P2<Y.3S6UHNE:K97%Q<ZMK;:C+*JHB)
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ME+#5(])N?(2&15^W$1;LNIYD92 V>O/- 'H D1G9 ZEUZJ#R*&D12 SJ"QP
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ML[O,,6[;NW<].O/6HKWX>^'K^ZOY9X;HQZ@6:ZMENY%@D<KM+F,-MW8QSCJ
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M6+!0O08)-9L?C#2M5TG5IM&ODFN;&W:1HVC9&0[25)5@#@XZ]#6?X:\:P/\
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MN&5L%2%/?&.M %Z[\!Z%=" 1QW5D(;9;3%C=R0;X5SMC?8PW 9/7GD\T^_\
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MG K=HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&/-D+*">,\ X_P!D^E=Y;VT%I D%M#'#"@PL<2!57Z <"H;K2]/O@XO+"UN
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M:X$2B0CT+8S0!XWKNM->:%/=2:K864;:\H.D6]LBNGEW:AI)6SN#?+O+8 Y
M[UMWNI6^C7]W=Z1K6GZEI]QJZ"[T2[B!F$[RJK-">&SG#@$$<9!Q@UZ.VD:8
MTMQ*VG6ADN1MG<P+F4>C''S#ZT#2--%ZEZ-/M!=(H59_)7>H P &QD#% 'FE
MEJ>EZ9X-\=V.KW-O%>_;M0,\$K@/+YF3&0IY(92H7'TJYX.LYK?QSIZ7T9%[
M!X0LHY"X^96\QMP_,<_2O0)M+TZYO([R>PM9;J+_ %<TD*LZ?1B,BIQ!"+@W
M B3SBH0R;1N*YSC/7&2>* /(-*U![2VT^PAGL+ SZ]JI34;N%9/LVQWXCW$
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M@)!Z]>:[FJR:;8QV:V:65NMJI!6!8E" @Y&%QCKS5F@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<= 2/I6KK%E=:[XAN;C4/#&I7T%W91)I<4Y"Q6DGSB3SEWX4Y*'.&.!@<\4
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MVGO66QE(?QC;WR].8%$69/H-I_*@#>B\<2V5[JEKXBTH:;)8V!U(&*Y%PLD
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M#NVT!1R6/!QVR<"IE\-:O+>_%("R=1J\"QV+,0!,?(=>#]2!S5K1[74K[4O
MMU)I%[9IIEI<VUT+E I1O)C4'@G@D$ ^U &@OQ!-OI.JRZEI,EOJFG7<=DUC
M#,)?.ED"F((^!PV\=0,<U/%XQOK74)=.US15L+LV4M[;>5=B:.=8\;UW;5*L
M,CC!&#UKG]9\,ZS<ZEXFOK6R:26/5[#4;.-F"BZ$,<>Y03T/##GN*O7%IJ/C
M'Q/;W_\ 95YIEE8:==0(U\JH\LTX5<!02=JA<D^IXS0!LMXQ1?#GAS5_L38U
MJ:TB$7F?ZGSP#G./FQGVS[50\*>(=>U7QCXEL;ZRBCL;*X2*,K<!C#^[4X V
M@MNR6R3QG%<Y;PZ_>^'/!NB'PW?V\FC7UC]MFGV!-L6%)0AB6'\6>@ ]:Z3P
MW!?Z9X^\417.F78MM1N([FWO%53"5$2J03G(;((QB@#M:*** "BBB@ HHHH
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M>QI^YN(Y5#*Y /!&<'!ZJ<=: .U_X0K0/^?.3_P*E_\ BJ/^$*T#_GSD_P#
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MJ&9R?F^=B0 ,XY;VH ]FHKD/ OBAM?.JV;ZC::FVGSHB7UJH5)XW0,I(!(#
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MSUXKN:* .3NO"MW/HWA&R6> 2:+=6T\Y).'$<3(0O'4EAC.*K:;X>\2Z*_\
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M$15V; + ;ASG/')(QQ7744 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR?.3A@5Y(QP: .VU&\:PT^>Z2TN+MHEW""W4-(_LH) S^-36\IGMHI3$\1=
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M5K$T-JUZT>(%;&X@(JY8@ %CDXJS=:R6U33(=/U#1VMYIY8;A9KG]ZS(.5B
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M>W9EFE\U=D17[P8YP".^>E5[SQ!HVG*S7NK6%LJA68S7")@-G:>3WP<>N#0
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M&EMJ]@-0)P+4W">;GTV9S3Y];TJUN?LUQJ=G%/YB1>5).JMO?[BX)SENP[T
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M\1:\NBD;?[-%TOE[/^>8?;O"8XQNZ5JZAX.M+B>QN=-N[G1[NQ@-K#-8A/\
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MR(OR+MVX10Q.>3D >IKL* .&\56=O>_$WP3'<Q)+&L=^X1QE20D1!([X//U
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MH;Y=SAB ?^ C/O[UUESX*\-7FH7%_<:+9RW5RI6:1D^_E=I)'3)!(SUK)N/
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M/5;&UL[[3+>:WM %MU*X\H 8PI'(& !4=[X0\/:A8VEE<Z1:O;68VVZ!-OE
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MYGDTW^R[F)!DNS)N@./:4;<^CUW?A+0QX<\*Z?I1;=+#$#,_]^5OF=OQ8DT
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M"P:3RF9HV25"CQNI*LK*>0001BN2T27[9\2[2]&G26"R^&49;>1 K19N"=I
MX!Z<5?\ AXK)9:^&4KG7[XC(QQYIH W8M?L)=2U2P\QDGTQ(Y+G>N %=2RL#
MW& ?R-9L'CK1+GPBOB:*28Z>T@B \H^9O,GEA=O7.XC\#FN2^)4=W8:_&]BD
MA;Q'IYT5BB_=D,J[&/T227GVJNVFM%\18O"$,#+IO]HQ:ZI"_*(TAV[<]/\
M7(I_&@#>N_&$&D0>,[V&[O\ 4IM*(+6CP#9;ML) 4J 2G&22>*JW/CJ<:KX0
MNGBOH+:_MKIIK,6K>9/(JQE-B8+$98X/IR>!6#]FGF3XQ1QPR.\J8C4*27_<
M/T]:U]+U"SUCQ%\/;JPE6XABL+R-G4'".(H00<]#VH [?0/$5EXBMKB6T2XB
MDMIC!<6]S$8Y8G !PRGV(.>G-:U<?X31E\9>-B5(#7\!!(Z_Z-'784 %%%%
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MQ[#)Z<XY[5B2>+-5TG2+^^UW1(HE@BCDMVL;OSX[AG;:L88JI#;BHZ8^;.:
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M-/=GYE8QL7RRDMN.XKT  /;HSX=U;_A7'C'3/L;?;+^ZU![:+<N9%D=BASG
MR".M>B44 >>/X8U*X^)5G?26K+IW_"-&PEG#+\LI<_+C.<X.?2L[PGX3BTV;
M1K&?P)''J%@5%SJSR)Y1V#Y98R&+,S$*<%1C)STKU2B@#S33M(OI/%^GW]IX
M6N="OUN&;5KF*=/LES'L8$!5;YRS%2"4!'.:]$OK87NGW-HS;1/$T9/IN!']
M:?<3Q6MM+<3N$AB0N[GHJ@9)_*DM;F&]M(;JVD$D$R+)&Z]&4C((^H- 'E+6
M/BFY\%:'X7/ANXCGTNYLUN;EIHO)DBAD7YHR&W,2 &Y P >^ =2:UU_3+SQA
MIMKH-Q>#69FGM+Q)(Q"N^%4(DRP88*] #FO1Z* //?#WA[5;/Q!X1N;BS9(;
M'PY]CN&+*?+F_=_+P>?NGD<<5#=>&]7D\7^/;U;)C;ZEI"6]H^]?WL@B*E1S
MQSQSBO2** .&O="U*7P_X%MDM6,VFWMG+=KN'[I4@=6)YYP2!QFN2UG^V="^
M&'BCP\-*,EO"UVR:D)XS 87D9\$;M_F?,5V[>N.<5[-7,W/@#PY=ZC+>36<I
M,TPN)K<7,@@EE!!WO$&V,<@'D<]Z -ZP!73K52,$1("#]!7F/BCPM?:MJOB>
M&X\,_P!JW=]&%TO4)WC,%I'Y(7 #-E&#[B,+R2#D#D>DZEJ]AH\4,NH74=ND
M\RP1L_\ %(WW5'N<5=H X?PIINIIXH.IW>G36D+Z':6N)60D2H\FY?E)[$'\
M:S'\,72_"?5[.^ LKR"ZN]0MI78?NF6=Y8GR#P.!^!->EUDZYX;TWQ''##JD
M<TT$3;O)6=TCDZ<.JD!QP.&R* ,7X<6]S+X>DU_4(A'J&NS&_E7^XA $29]!
M&%_,U'\6/,/PWU+RMOF>;;;-W3/VB/&:[-0JJ%4  #  ["J6KZ39ZYILFGW\
M9DMI&1F4,5)*L&'(]U% '%ZAIVJ^,_$EBUUHUUI-G86=W'+)<O&WF2S1^7A-
MC'*@%CN.,\51\(^&(K&[T>WF\!QVM]8J!=ZH\B>7N52 \6&+,6.#R%P"<UZA
M10!P?AW0=3LOAEJVE7%HT=].;_RXBRDMYCR%.0<<@C\ZRM)\/ZWH&D>"-3_L
MN6YN=)LY;2^L8G3S0L@'S+E@I*E!QGD&O4:* /+-1\,Z]K<>O>(4TUK:]GN[
M"XL=/GD02,EJV[#D$JK-N? SQQFMBU&M:U\1-)UJ;0KK3]-MK"X@_P!*>/S/
M,8QGE59L XP.>QR!QGNZ* ,SQ'I1UWPSJFDJXC:\M9(%<]%+*0#^9KBS;Z_X
MBMO#6CW>@7.G_P!F7=O<WUU-)&8F\D9 BVL6;<P'4# ZUZ/10!QGA?1M0L/B
M#XUU&ZMC'::A):&UE+ B0)$5;@'(P3WKH]>LY=0\/:G90 &:XM)8DR<#<R$#
M]36A10!Y-+HNO:IX7\ 6O]AW=M/HFJV7VM)GCXCB0!I5PQRN?QXZ5TMKHNHQ
MZCX\E:V8)J13[(=P_>XME0XYX^88YQ7:44 >?'P]JO\ PB?P]L_LC?:-+N[.
M2\3<O[I4@=6)YYPQ XS6-I_@N#3[E],N? J:C=?;WD35))$$#0-*7#L=VX.J
MG&W:<E1S@UZU10 5Y1J.AZZ=,^(.BQZ+<RMJTTEW9W*/'Y4@9(U"<L"&RIZC
M''7U]7HH Y37=)U"[\3^$[NUA)BLGN3/)D8BW0,JDC//S$#BN#T_PQJ5O'X>
MNO\ A#IAJVF7T<VJ7\DD33W9^96,;%\LI+;CN*]  #V]GHH XOP7::EI&N>)
MK&]TNXCAN]4GU""]#(871P@"_>W!N#QC''6K?Q'TB]UWX?ZMIVG0^==RHACC
MW ;RKJV,GC.%-=310!QVG0:CJ'C^VU^;2KFQM7T5[=DN2F])//!"D*QZJ,\=
MO?BN:O?!E_<:?=376C_;E@\3W&H_86=<W-LX*Y7) W8;< 2/NXKTG^U[#^VO
M['^U1_VCY'VG[/\ Q>5NV[OIGBKM '*>"]+MK%;^XM?"ZZ#%.Z*B.R^=,J@_
M,ZJ2%P6; R3]*;X_T[5-0TW23I%H+JYM=6MKHQEP@VHQ)R3T'^-=;5*UU>PO
M=1O=/MKJ.2[L2@N8EZQ;AE<_44 <+?Z1J_C#6-7OGTJXTN#^P;C2[=;UDWR3
M2G);",P"C:!G/.:BCA\1:M_PAD$GARZLH]'NXFO7N)8NJPNF4VL=RY/4X/(P
M#SCTRB@#S2WTB^F\7V-]:^%KC1=36[+ZG>PSH+2YAPV> V9"WRD90$'DGBL^
MT\):['X/\1V3Z>XN;KQ4+Z%-Z_/!Y\+;^N.BL<'GCI7IUGJ]A?WM[9VMU'+<
M63JES&O6)B,@'\*NT <5XH\-WFN>*8]D96RFT.]L9+C(PCRE O'7H"?PK&\*
M^'4L[S353P#%8:A90G[1J$\J"/S0FT&(JS,VX]R!@$]^*].HH \PTO2=1C\0
MPZAH_A.?0YQ!.=2BEN$6TNY#&0BJJ,V?WF#OVCC.>N*M^%='GM_%L5[IWAN\
M\.V1MY!J-O+*GD33$KL\M$=AQAOF 7@^]>B44 9^N?:?[$NQ:6$.H3&,@6DS
M!5F'=23QR,]>/6O,9?!EWJFF:Y::1H-UI&E36\#Q:9?S+LFN8YA(=JJ["-2J
MA2<@'(XXS7KU4]5U:PT33I=0U.Z2VM(L!Y9.BY( _4@4 >?VOAV&?3==_LOP
M*=&DETF:VCDG>,32RNI'EJ%9ALX'S$CG'%;S^&9=4^%%OX<NT\FZ.E108)_U
M4R1KM.1_==0>/2NN!! (Z&B@#@O"&CZW)IVNZSX@L_(UO5$6'R-ZMLCCBV*
M02.6+MU_B%8F@^&M>T'PEX(OCI4D]_H;7"W6GI(GF-'-N!*DG:6'RG&>>:]8
MHH \X\0Z;K?B[2H+[4O#J&"QU-+B#29'7SYK<1E'WG<4WY<L!D?= )R:6TT>
M*VT34Y+/X=PQ6=S+%'+83/'Y]S"N=S%=Q0%2<J"W//0XKLQXBT@KJ;?;XL:7
MG[:<G]Q@%CN_ $U=L[NWU"R@O+259;>>-9(I%Z.I&01]10!RG@+3+K35U3%C
M>:;I,LR&PL+R8220@+ASPS;5+=%SQ@],UV-%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <IXZU?5
MM*MM$31I88[F^U6&S9IH]ZA'5\DCV(!X(Z8SS6'?Z_XA\.77B+2[O5$U"6#0
M9=5L;MK9(VC9-RE&5?E89VD<>H.:O?$R*XFA\+QVLX@N#K]OY4C+N"L$D(R.
M,C/49'%)/X.UG6'UZ^UB[L5O[_27TJU2U5_*AC;<2S%N22Q'T [T 4/[;\4V
M_AS19YM4MWU'Q'<6T-N/LJA+!71G=NO[P[1WXS[<4NIZIXLTB\U;08=42_OO
M[);4]/NGM45]T;A7B95&UL@C!P#R:W=2\)W%WX7T2RMKN*'4]&:WFMIV0M&9
M(TVD,.#M8%AZ\^U/T;0-4_X2:?Q%KMQ9M>&T%E!!9JWEQ1[M[$EN69CCL, 4
M 4+SQ=<:G'X/CT.14FUR1;B0E0WEVR)OEZ]#RJY]36&OCG6H])\8RJT#W=IK
MO]F:?NB 5-[JBEL?>QN)YZXK<\(^ Y/#?B"]OIKN.>U5'M],A52/LT+RM*RG
M/4Y91QV454_X5S<OI7BFU;4(DFU;5?[2M)D0GR'#*Z;@>O*\X[&@"EJ']J:%
M\0M"GU?4_P"U(;?3-0G64P+$_P JQEU(7C' QQGDYS5;P]X_NKK4=!DE\0VV
MH-JL@CNM-BM=GV/>A92CXR0I 4[B<YR,5T"^%-=U7Q+8ZOXAN]/:."TN+1[2
MS1PI64*"P9N<G!SZ #KS5OP_HOBG2_[.TZYU6P?2=/3RU:*$^?<HJ[45]WRK
MC@DKR2O;)H X3Q%?^(O$/PEU'Q)+J<7V&\;*:;]G4+'#YX52)/O%^ QSQU&!
MUKVBO,;KX?>(W\)7/A&WU73H]%\PO;R&)_/V>9YBQMSM !XW#D@8P,UV]O/J
M;>+;Z"3!TM+2%X3Y9&)69PPW?Q<*#@=,CUH H>-M8O\ 2]/TZWTN2.&]U/4(
M;"*>1-XAWY+/M[D*K8![XKF84U73/B=>B^U!;Z6+PT\D-R85C8CSLX95^4D$
M=0!P1QZ];XNT"XU_3;465S';W]C>17MK)*I9/,3/# <[2"P./6LFT\+:[/XE
MO-<U>^L6EN-*?3U@M4<)%E]P(+<MW)/'4#'% '-V?C'Q+?>"/!%U:W5NFHZU
M>-;3R/ I0#$F&VC'3:#@8SC'>K>L^*;S3==_X1^\\81:<]E91RR7KV*L]W*Y
M; V8*JJA1G&"=W45?TGX?WFGZ!X.TY[V!WT&[:XE<*<2@B087W^<=?2M;5-#
MUN#Q'-K?AZXL%EN[9+>Z@OE<H=A8I(I7G(WL".A&.10!S^F>*];\82:)I^GW
MD>DS3Z8U_>W*0"4Y63R@L:OP 6#')!. *J>(8/%,FO\ @BUU#6(;>[:]N$\R
MV@5D8I%)MEVMT)0X*\@$G%='>>&M>BU'3-;T[4[2XUFWLC97;7L)6*Z0D-G"
M?<(89&,\'%5;[PCXBFAT&^36+6ZUK3;R6Z=[J-A"XE5E**%.550P"_2@# B.
MJK\0/B@^B2!-3CM;%[<L@8,ZPYVX/KC'XUT-QXQN-7L_" T.18Y]=E6:0E0W
ME6Z+NFZ]P<)]35S3- ;0?&/B;Q/?WULEKJ<=MP3L$7E1[26)XP3TK ^&NC0/
MX@U[7;28S:0L\MKI!Q\BQL_F3%/53(< ]PE '=>(=670?#FI:LT?F"SMI)]F
M<;BJD@?CBN._M/Q1H2>'=4U35XKZ#5;N"UNK,6JQK 9A\IC8?,=K8'S9R/2N
MWU?38-9T:]TRYSY%W \$FWJ%8$$CWYKDK?PIXAO&T2SUS4-/ET[1YX[A&MHG
M$MT\8(C+Y.%Q]X@9R1VH 3PAJ/B+7M=UBXNM3BCTS3=6NK)+5+9=TZK]W<_4
M!<KC')P<UH?$C6;WP]\/M6U73W1+NW1#&SH& S(H/!X/!-6_"V@3: NLB::.
M7[?JL]\FP'Y5D(PISW&*;XY\/3>*_!FHZ';SQP2W:JJR2 E5PZMSCZ4 8MQJ
M?B'4O&%KHEAJ<=C;R:*E]+,+=9'5_,*_*#QSQUR  >,G(R[;Q9XAO+#3=%2]
MACUBXUJZTR34! "/+M][-((S\NXJH&.G)KK;/P[-;>+H=9:>,Q1Z0FGF, [B
MPDW;OI6%)X#U*"(7=A?6J:I;ZY<ZK:M*C&,I,6#1/CD95NH[B@#)\_5]$\1^
M.[BXO4NKRS\/Q2P7)A52^T3LI91\N0<CC@XZ<U,?$_B2^T_X?P6%[!!=:]:R
M&ZF>!6"D0A]X7U'S$#H3C/%:8\&:U=R^*+O4M0LVN=<TL62I C".!@LBC&>2
MOS@YZYSP.!4^G^"KJS?P06NX6_X1V"6*; /[TM#Y8*^G//- &#K7C&]L];O]
M'D\6V^FSZ3;0J'ELE<WT[1[RSC&$3E1A<')// K0L?$FM^,KZQL]*OET9?[(
MAU"ZD%NLS^9*2!& _ 4;6)/4\=*UK_0=?M-?U#4_#MYI\8U..,7"7L;MY<B+
MM$B;>ORX!4_W1S3+[PYKUMK<&MZ+J%E+J#6*65X+^)@D^TEEE'EXVMDMQC&#
MCC% '.ZG#XGF\=>!X=0U6&UO'AO#*MK"KQ[D498;N?G4C@_=YQ6?97.K6.I_
M%&^T1E^WVMY!.B,@82*B%F3!]5! QSG%=3=>$=?6Y\,ZC!J]O>:GI/VA;B2^
M1@LXF W8V\C;C 'ICFK>C:$GA;6?%.N:EJ%JEGJEQ',&D;8L0"[<,6XY)% #
M+KQ3/JFJ^%+30IE$>J*=0N7*ABMHJ@XYZ%F=5SVYKL:\U^%&B1P_VIK,4CRV
M$DSVFD%UQMLED=QM_P!DL[8]0JUV?AR?4[BQN6U7'FK>3I$1$8\Q+(0AP?8=
M>_7O0!ROB*#4KGXL:3!IEXME(^CW DN#$)&1/-C/RJ>,DX'.1@GBL]O&'B#2
M;:>34+N*XCT/6TLM3F$"IYUK(J[92!]UE+KD#CBNFUSP]K%QXOL?$.D7EI')
M:64EMY%RK%9=[J<$KR!QG([@<8K-?2-/T#PEX@?QAJ=F'UJ266\=3L0;D"B.
M(,<L0JC'<F@#7CUB^OOB++I-I(HTW3K%9;SY02\TI_=IGMA5+<>HIOCK5[W1
M=&MKBTG:TB>[2.[O5M_/-K"0Q,FSG/(5<D$#=GM5+X7:/>Z9X-@NM5+MJNHD
M7-RT@P^-H6-3Z815X['-=#KD&LRV\#Z)>6\%S%*':.YCW13I@@HQ'S+U!!'<
M=P: .33Q%J<-IX<:+7;'5H+_ %H6OVVWC7][;F)VPP'"N&7!V^@Z<BG>)/&=
M]X?U;Q+@)-;Z=I,%S;PLN,S22.G)ZXR%J-_ >K&Q-W%=Z=#K/]LIJZQQQ,+4
M,L?E%,?>P5R2W4D]*DE\!ZAK-QK\VO7]NQUC3H[0K:(P%NR,Q!7=R0,J>>IS
MT&* 'ZA8^*[#1M4_M/5[?5+&72K@S9MUA>"4)QLV_>0_,/FY&!S61HM[XBT/
M0_ UY-JD4UAJ)M;%]/%LH6-'A.QA)]XL-HSG@Y. *WUT'Q;J44\6M:Q8B(6$
MUK'%91NJSR.NWS9=WIV4>IYJ>?PG<2Z#X4T\7,0?1;BUFE8@XD$494A?KGO0
M!O:UJ2:-H6H:HZ%TL[:2X*@_>"*6Q^E<OH\GBV&VT_6]1U6UO+"XMC<7MI]G
M$7V8&/>OE,.6P>"&/(YXKK=1L(=4TN[T^Y!,%U"\$@'7:RE3^AKE-(\.>)XO
M[.L-5U>SDTC3XC%MM8W66]79L42Y.  .2%SDB@##'B+Q3:^#;+QS<ZI"]K.\
M,TVE"V4(EO*ZJ LGW]X5@<DXSGBK<VH^*M5OO%J66M16$&CS[;;%HDC2'R5?
M:V[^')ZCGYNHQ3H_ VNOH=GX5N]2L9/#MK+&?,6-_M,L,;ATB;G:.B@L.H'2
MM^Q\-SVDOBAVGC8:Q.98\ _NQY*QX/XKF@#DKOQIJ-U'H,UQK</ARUU#28;M
M+M[4212W+_>B9VX0*-IQD$[NO%=-I>LZG-XX;2+N:W>)-$M[MQ ,H9FD=696
M/)4[1C-4H?#?B?3= T_2+&]TFZM(M-BLI[>_@8H'1<&12O+ CJK?W1@C)J.V
M\%ZUH%]IEUH-_92M;Z3%I4XOXWPRQL661=IZY)^4G&.] '*>+-7O-:\&Z3<7
MKJ\D?C$6ZE5"X1)I%4<>P%=#IL>J_P#"WO$TO]K PVUE;,(9(E5&0B4JA;&5
M"DDY')[TDWPWOY?"MCI#:G#)-;:[_:CSNA'F+YCOC Z-\WTK2U3P?J=UXGUF
M\MKRU33]:TX65VKJWG1;5=0T>.#]_OZ4 9'ASQ??2^*M'L)?$EKK2ZC',+A+
M>T\N*WD1-X,4F!O7AEY)/0\52B\2^+O^$#B\8RZO!LAN=C6 M$VS1"X\H[GZ
MAL<C;@<#KR:W+/PIXF%_X<O+R^TL?V*?)2WMXW"21-&8W8D\[\8P,8'/)SQ*
M? UW_P *O/A3[7#]H,A?SL'9_P ?'F].O3CZT 5/#\.IO\8?%32:L[V\$-IF
M P+AT992B9ZC:2>1U[UT/C36[O0]!233UC-_=W4-E;&4919)7"AB.X&2<>U0
M6_A_5+'X@W^N6UQ9MIVI0PI=12*WFHT2L%V$<8.[G-7_ !5H!\1Z&UE'<?9K
MF.6.XMI]N[RY8V#*2.XR,'V)H P1J.N^'O%%GI&I:L-4@U*SN)8)GMDB>&6$
M*2/DX*D-W&<CK4GPXOO$&N^'K/7M:U**5+RW!2TBMU0(0<;RPY);!.. ,X[9
M,MMX<UK4-?BUCQ!<V'FVEI+;6D%DK[%:3&^1BW.2%  [>IK4\'Z)+X;\(Z9H
MT\R32V<(C:1 0K'/49H H^*=4U)=:T30-*NDL[C4VF=[MHA(8HHE!.U3P6)9
M1SD#GBLO4-2\5Z5#IVASWMI)J6I:D;:VU$0C(MQ&9&D:/[OF#:1CH>#[5M>)
MM OM1OM*U;2;F"'5-,>0Q"Y4M%*DB[71MO(SA2".A'2LNX\):_?6<%]=ZQ;M
MKUKJ'VZV(C;[-"-FPP@9W;"I.3UR<T 9>K^)/$'AE?$NF7.I)?7-KHQU2QO&
MMT1AAF1E=5^4X(!!P.M7!J'B;3_$'AU;[5XIX-<$L<ENMJJBU<0F12C=6P5P
M=V<]>*=>^"=7UNV\076K7ED-4U+3O[-@6W5O)MXLL>2>6)9LDX'05N:AX=FO
M-3\,W2SQJND2O)(I!S(#"T?'XMF@#S?3=7U_P[\-?$NN0ZI]IN4UB1$22! -
MQNPCMG'\0)XZ#M77ZS=:WH>F6,>I^+[*UDN;AS-=?9%\P+MR(H(L,&P<Y9LG
M%49?A_K4GAK7O#WVZP^Q7M_]MM9=CB1<SK*5?MT! Q71>(=#U6ZU[2M:T>:R
M%U91S0-'>JQ0I+LRPV\A@4'U!(XH Y>P\9ZQJVE:5IMI?0_VE?:K<6 U(VV!
MY4(9S*(CP'*A1@\9)X[5!X\M_%5KX/FM]0UF*6,:G:+#=1P*LD\;2IQ(N,*5
M?^[PP'(%:,/@+6K6,S1:K:2:C:ZJ^IV=Q)$P#M*I$J2J#PIW'&T\<59U7PCX
MBUWPYJ,.HZO:G4KBZ@N;>-$;[-;^4RL$&?F.[:23ZGIQ0 ][KQ!J?BF;P[9Z
MY]D73+*&6[O1:1O)/+(6V@*V550$).!GGM6)/XS\23:7I%K;S6L>JOKTNBW<
MQAS&^P./,"GIT5L ]B.,UT,N@>)+?6QK^G7&E#4;JT2VO[>99/(8H24="/F!
M&XC!ZCTJM!X!N(+;0\W\<MU::P^K7TQ0J)I'#[@HYQRX SV% '8Z=!=6NGPP
MWMZ;VY1<27!B6/S#GKM7@?A7G/B?QCJ&BZI?SKXELF>TNHD31X+;S0T1*@B6
M7&4D(+'&0!@=<UZA7G6H>!-?N=,UO1K?4["'3;^\EOTD,3&8NSB0(_.-H8#D
M9) Q@4 6[;4?$6K?$C6]*M]3BM-*TI[25E^SJ[RATW&/)Z X;+=1QBN9L/B7
M/<O9:J/$%O+]JOUA;1%M>8X&DV B3&XN 0YYQU&*[W0M O-/\3Z[K5Y- S:I
M':#RX0<(T495NO8D\>U4-'\.^)-$^SZ3::G8)H5O<&1'\EC<F$L6\DY^7'.W
M=UQV!YH Z76-172-$O\ 4G0NEG;R3E1W"*6Q^E><>'/'-U=ZQHD$GB2WU-M6
M#)<VL-H(_L3F,NI1L?,H(VG=GJ#[5Z7J%E#J6FW5A< F"YA>&0#KM8$']#7.
M:)I?BVP^QVMYJ>G26-C"8D\F%A)=X7:GF$Y"8X)VYR?;B@#"A\4^(Y]43P7N
M1/$45P7N+\0CR_L0((G5>FY@0FWLV3TJ\][XH\1:KK_]A:K!80Z1/]D@@DME
MD%U,(U=O,8\JN7"_+@]_:F+\/[N*UAU2/4(CXM6\-Y)J#(=DA;Y6A(Z^5L 4
M#M@'K5B[\,^([/4]8E\.ZE86MMK#"6?[1&[26LNP(TD6" Q( .&QR/PH R1)
M./CP))E1+@>$]SJAW*K^?R >XS5I/%>K-\,/#FN&9/M]]/9)._EC#"255? Z
M#@FM2#P?<1?$"+Q#)>B:W31!IC+)GS782;BY/3D?K6'!X#\2#P_IGA^;5-._
ML[2KN":!XXG$LZ1RA@LF>%XSTSD@<CG(!*_B/59?&MWITGB"UTRYBO%2UTJ[
MM0J7EOA<LLIY9FRV-IX( (JO=>)?$DVI_$2UTV:+SM$2UEL4\E3D&,NZGCYM
MP4@>F:V-=\->(M<DFTZYOM-ETB2Z2X2:2 _:8%5@VQ,?+D8P'ZX/.35[0O"\
M^D^,O%&MRSQ20ZPUN8XE!RGEH5.[ZYH I7WBN?4;KPC;:%*J_P!L'[9,Y4-L
MM$0,XYZ$EE7/KFN4TWXE3W<FG:H-?MYOMM\D+Z(MK_JH'DV*1)C<74%6.3@\
MC KJ/!G@27PQJ][=W%XES"L9M=-C52#;VQE>0H<]3E@/HHJ71?#OB31!:Z3:
MZG8)H5K.71_)8W+0[BPA.?E'7;N'.!T!YH X^TN=6L=8^*5]HC+]OM;JWG1&
M0,)%1"S)@^J@@8YSBNQNO%$^J:MX4M-"F41ZFIU"Y<J&*VBJ#CGH69U7/;FG
MZ1H2>%]<\5:[J6H6L=EJD\4H,C;!$%4KABW')(K#^%&B1P#5-9BD>6PDF>TT
M@NN-MDLCN-O^R6=L>H5: .O\7ZZWAGPEJ>L1Q"62UA+1HW1G) 4'VR1FL!KS
MQ)X:UK0$U;6(]3MM5N#9SI]E2+R)3&SJ8RO)7*D8;)]ZZ?Q%HD'B3P[?Z/<.
MR17<)C+KU0]F'T.#^%8%OX<\0ZEJ^D7/B.]T^2#27,T26<;AKB;84#ON/RX!
M)P,\GK0!7\!:CXB\0"?5-1U.+[%#=7-JEI';*#)LD(#L_4$=,#TR>M:'CO5]
M5TBQTG^QY(DNKS58+,F9-R[7W Y'Y'C!XJWX/T";PWHLMC/-',[W<]P&0$#$
MDA8#GN,UC?$V*>>Q\.QVTP@G;7K3RY2NX(WS8)'<9[4 4KO7/$/AW4=;TJ\U
M1-09="FU2RNFMDC:)XSM*%5X89*D?B.:SM9\1>*M(^$%SXLN-4@DO;J"SFMX
M!:($M@[J&'^V6##.>A'%;TGA'6=6NM9U#6;NP6\NM)DTJUCM%?RXD?)9V+<D
MEMO Z!>].\1>";K6OA5%X1BNX8[E+:VA,[ [,Q%"3CKSL/YT -U"_P#$&H>/
MY?#^G:HFGVBZ3%>-,+=975S(ZX4-QS@=<].!SD<[%XG\7_\ "#P>+)]5MMMK
M>+;364=JNVY07 A=BQY5B<D;< 8KO(- FB\<S:^9D,,FF1V0BP=P99'<M]/F
MK#/@6[/PWE\,?;(//>[-P)L';@W7GX]>G'UH S?&_BW4-#O=6FA\365N]A"L
MMOI<5KY[3 +N(G;&8RQR!@CC!S5^?5O$6K?$*71-.U*.PL(].M[YG-NLKY9V
M!09_O<<GIMXZYINJ>"=;NT\2Z=::E90:9KCO-)*T3-<(S1*A3KM*Y4<]<$CT
M(U=#\-ZA9>*)-;OI[9GETR"R>. -@.C,2PSV.X4 <K?Z]?ZMHOQ4L;N1&@TZ
M"6*W"H%*J8&)R1U_&K/A;6K[2+;P#;32*=&U31HK904 ,=TL:NOS=<,H8 >H
MK07P)=B'QTGVR#/B,,(>#^YS&R?-Z\GM69XPM;?0OA?I>@/?1-K]E':#3$B(
M,LEU&5"%$/)!(()[ F@#J/#&L7VN:SX@N&D7^R;:[^Q62! "6C&)7SU(+G _
MW3735D>%]%7P]X9T_2@V]X(@)9/[\AY=OQ8L?QK7H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(UW
M5;+2WTI;VV,YN[^.U@(16\N5@Q#\],!3R.>:UZX7XG6YN[?PO;">2#S=?MT,
MD3;74%) =I[''0]JYOQ'<7'@74O$-EH5Q=);RZ"+R..2=YO(G\X1;T+DD9#Y
MZXRM 'KK':I."<#.!WJGI-_)J>F0W<UA<V#R9S;70 D3!(YP2.<9Z]#7!^'[
M+4].\0Q&RT37-/TR2SE2^.I7J3AY1@QR#$KD-]\'& <CTKF?#D]]J?PX^'<<
MNIWJ/>:M+%<3).PDD3_2,J6SGH,9ZC@C! H ]OHKQ[7)[GP@/&^GZ-=W4-NE
ME92P"2=Y#;O-(T3LA8DCC!Z]16U/HD?AKXA>#K73;Z^6TN3=B>VFNY)1(R0$
MA_F)YYY[9P<<4 >CT5E>)W>+PGK,D;LCK8SLK*<$$1M@@UYQ'8/HOAWP1XC@
MU"_EU2\N;"&[DDNY'6XCG #(4)VX&1C XVYZT >N45Y1HT<R1>./$\UU=W%W
MH^HZB+"%KA_*BVQY^YG#9W8YSC QBB73CX?\,^%_$MI?WTFJW%U9?;)9+N1Q
M=K.5#JR$E<?-D8'&!B@#U>J,NH2QZS!8#3[IXI8FD-VH7RHR/X6.<Y/TKS=]
M>O?"^@>,-"\Z6;4K2Z":5O<L[I=G]R 3R=KEA_P&IXH;K0_BCX4T;[;<S10Z
M%*)=TK$3.O5V!/))R>: .\\0ZY;^'-#N-5NHY9(8"@98@-QW.%&,D#JPK3KP
MV_TQ=1^"_P#PE=S>WCZM>R13W$C7+E'#7*CR_+)VA0,8 '!45J:NVIZ]KOB@
MQ:5KUW=65Q]ETV>QO$BBM&6)&!VF5<L6;<25((P/:@#UZLSP_KEOXBT>/4[6
M.6.*226,+*!NRDC(>A/=37$Z993^+O&&J1>()+N*32[&R6.WM[IXA#-+&7D?
MY&&6W< \CY:U/A,&7X<6 >3S6$]T#)_>/VF3G\: .IN[BP>YBTN[:)Y;N-V2
MWD7=YBIC=QTP-R_G5J.-(8UCB14C4855& !Z 5YWKNC65Y\:-!DF6<LVG3RG
M;<2(-R/'MX# 8]1T/?-8JVCZI\-=7\;S:A?1ZZAN[J"9+J15M_)D<)$J [=N
M$ ((.<G- 'L%%5M.N6O-+M+IUVO-"DC+Z$J#C]:\E\77A#:YKFF0:Y<W-A?*
MBZF;L16]JR,BM$D>\;USD-\AR6/)H ]CHKSA-$B\2^.O&5MJ5W?-:6QM1!!%
M=21+&[0 EQM(R>!C/'7CFLSP[JVHVL'@/Q'>7D\UOJ=J-*OM[DCS#DPR$?WB
MRE2W^T* /6J*X_P-+/J]QKGB26:1[?4+PQ62%B46WA_=JRCMN8,Q]>*@\=QS
M7.O^$+%+NYMXKJ_ECG^SRM&73R')7(.><8SU'48/- ';T5Y19^&+:YUSQGHT
MEYJ7]F::(9;*W%]*!!))#N9@V[<>0" 20,GCFJ,.K:AKUMX0LKZRU75X'T+[
M;<06-R(7FERB!Y&,B9 Y. >K XH ]EHKR/R-;ED\(:1JLFIV*2ZI>0A9+K]_
M):B)V17=&.3M^7.<\9SGFGVOAJWN-5\;:1)>ZD=.TORY+" 7TH\AY( [,&W9
M;Y@,!B0.>.30!Z-)KEO'XGM]!,<IN)[22[5P!L"HRJ0><YRX[5>N+>"[@:"Y
MACFB;[T<BAE/?D&O)-+MV\5:]X*.J75PWG^&&EN3',T;7!W19#,I!Y.&.#SC
MTS5>YO[_ $]+KPM;MJ=[8IXC6T1(;G$[6YM_.,"R,P(&1C)8';D9H ]G551
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M)YAW2!G7<">ISW]: /4**\IM=#77U\<W5[J.H"2RU*X2R\J\DC%J5B1@RA6
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWE6\2HN3U. ,5;KRW6DM;KXFZQ%?Z-JVK11Z?:M%'8R$>429<DCS$ZX'KTH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /(Z$*D9 )P%8EN020,^G5#PI"++PS;?:GQH31M&VT?O=L+1<^G#9_"NAHH
MXY?A]:)#X@1+Z96U:021MM'^B$2-*NSUQ([/]33QX(-H-#DTK5'M+G2K1K-9
M'@642QMMW$J2,,2@.0>YZUUU% 'G>K^&FT3PIKNE0G4=8DUJ9Y;=%@R\=RP!
MWO(/E4;PK9( &.,\"NQ\.Z0-"\/V6FA_,>","23_ )Z2'EW_ .!,6/XUIT4
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M\FO'=A@[I&+8_ 8'T%:M% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
K %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>exhibit1013-zerondaxexec010.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.12;E )R,#J<]* %HKG_ !=XIC\*:=9W;VK7(N;V*T"J^W:7)^;H>F.E=!0
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MQ!X<L/$MK;P7QG0VTZW$$UO,T4D4@! 96'(X)_.LRY^'F@WDEV;@7LD%XO\
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M[JTBNW2"9R,;VC!P6X'X@&@#5\,_\BIH_P#UXP?^@"HO&'_(DZ__ -@ZX_\
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M>3[DDAD'++T."QX/&>>PJG8:%=W_ (>DLK*RAU.PT?Q#>QKI%S<>6D\"EE1
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M _P?Y<:IB]T^08'\1N%)/U.3^=1ZM%=3^+?BS%9!C<-H]N$"?>/[@Y ]\9H
M]&LO&>@:PUS;Z3JMM<W4432!%)^8#^)<_>&>XR*RO"7Q!TK5])T6+4-4M5UF
M^MXV>%00#(RYV@] ?]G.:;!K'A2]M-!AM7MKB]-A(UAY(#F!!#A\X^X,87GO
MQUKF(((H?@WX&\N-4Q?Z;(,#&&,RDGZG)_.@#UJXN(K2VEN)W$<,2%Y'/15
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MK]D?@>W KEO#-G<77A70+._\6:=;&'4T/V(6&;E;I)BS(6$F=Q(;)V]&)Z4
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MAID6L6S79D,*J"=K2#J@;&TM[ YKG-/U7PW>>&O#%I9/;SZHUB5TQ8<,\#B
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M*ZDL-2BE%JGF3K@JT:XSN*D XX/.*P_B6532-&N+C L(-:M);TM]U8@_5O\
M9#%2:RO$-S;W_CYY-.FCF,'AR\%X\+!@%8KY:L1WR&('U- '::3XGT779Y8=
M+U&&[DBC25Q%D[5<94YZ<CMUK6KE?AI!%;_#3PZL2*BM8Q.0!U9ER3^))KJJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*,V&&02IP1FN3^'_ (ODL?A78:GJ\]]J5Y<7LEM FXRS3R&5@B L?0=R  *
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M4,K#T(/45R.F^+-2O/B1JN@-I%PME:0PD3;H\(6\P[V^?)5@%  !(QR!794
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MB@#H8]-L(=/_ +/BLK9++:5^SK$HCVGJ-N,8IEOH^EVE@]A;:;9PV<F=]O'
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M6_;K="!1*?\ @>,_K6+)X>U/5?%]KJFKSV?]GZ8SOI]M K%F=AM\R4MQD+D
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M.^)(?$"WD9M+BQO;&;R+JTN=N^-B P.5)!!!!!!YK;H **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K#3[1=3
M?4A @O7A$#3?Q&,$L%^F23^-6:* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2I]0MIM-)V*\0&Z.1=['^)2#D9 / H ]%HKS;_A+O&$:>&[J2UTAX?$ 6.&
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MG]^YW?<9\\IWQ5"Q\8^*#I7AG7KZ#2ET[5Y[:WDM8DD\V/SN!('+8QNP=N.
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M+$!>& ')Z'/.*M:MK>LW/BP>'=!-C!+#9B\NKJ\B:55#,51%167).UB23P*
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M  FFMSQ3I/HVC3S6NE;?NHTS"68#_=.$_.O2;VRMM1LIK.\A2>VF4I)$XRK
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M<YKURN%D^'<K6,VB)KLJ>&IIS*^G"W7>%9][1"7.0A;/&,X.,T <_>:5]O\
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MQNMQ/',@)*Y4D88$G!SWZ50?X?)%H^FP:?JTUOJ5C>O?KJ$D2R&6:3=YA=.
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MD;PL!E0H/RL2H);)^F* .(T?Q#X@U#X>:#.-8G2^N_$8LWN3AF$1=UQ@\'
MP#Z"NQT+[;I'Q#O]!?5;Z_LGTR*^3[;()'CD,CHP#8'! !Q2:7\.H=,T#2]*
M749)%L-5&IB0Q %R&9MF,\#YNM;ZZ$B^+Y/$'GMO>P6R\G;P )&?=G_@6,4
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MQ2M)YOS-G+J'R0O';).*WM-\-_8+K6[F2\,TNK,CRGR]H0K$L9P,GKMS^.*
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ([K&A=V"JHR6)P
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MVIV\5S FA/(MO,H9'83@#*GAL9)P>_/:@#T 21E58.I5_NG/#?2EW+N*[AN
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MHRGY4 =WJ%]>036:V-G#=)+<"*X9KD1F%.[ $'<1_=XJ\TT22K$TJ+(_W4+
M%OH*\7O]&FT72?AQ'>?\A"Z\01WEZQ')FER[9^F<?A6WIF@Z%XCM_%FI^(A$
MEU#K%Q$=0=PDMG'$1Y>R0_ZL  -QZ\T >FO-%'(D;RHKO]U2P!;Z#O0\T4;H
MCR(KO]U2P!;Z>M>.W>EW_B34?&#KHFFZC,ES]FM]2N[_ ,J6S584:-HQY9V@
M%M^X$9)/I5SQ!HLUM-?:YKFBV7B"T:R@^V2PSA;K3FCC!<Q9'3^,;2K9/TH
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M%;Q#:D9>W1FV@<#)YXKN* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB_"7J1AV41.ZQ _=,C %4!_VB*=X)U6ZUOP3H^IWK*UU=6J2RLJ[06(YX[4
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MLTDP"RN8E)D [,<<]!UJ2YL[6]B$5W;0SQ@A@DJ!@".AP: /$[.^A%C]MGU
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M@MU=MS"*,("?4X[T ><:5]EU/6M)NO\ A,[?59;>QGDM[6VLT3;$R!3O*$[
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MLK$G QN.3G'RGKQF>V\<>=IFHR/HM^NJZ?<):S:8FV23S'V["&!V["&!W$@
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M5?.W:QR,G&-IS7!Z?X5U(^!C]LTO4";3Q/+?R6L6^*>6 Y4M'@AB</N&#SC
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MAN[GPAXI\2O<:/J=[;ZG-'=VDMC:M,&;RE1HVV_<(*\%L#!ZUE#PUJWA_P
M^%M0CL9+C6M#N?M,EK;C>[1S.WG1+CJ0LG_CE &IXP\9:9_8'BF.YM=0>RT>
M2WAGFLY_*:21V4[48$$%=R[OKBMK4O%4EIK%OHVF:1<:G?-:B[E1)4C$,6=H
M)9R 6)!P/8]*XG7_  OJH^ NH60LI[C7-1=+ZZABC+2--).CL,#GY1Q_P&MZ
MYDNO#?C^35IM+U&[L=0TN&W#V5LTS1S1LQVLJ\@$.,$\9% %/PKXOD@\/SS?
M9[V_OM0UV\@LK-F D(#LVTECA%50<^F,5MR>/H+?29YKC2[J/5(;U-/.F;D,
MC7#@%%5L[2I5@V[/3/IBN&B\.ZA+I=EJ>K:-JBQV^O7\]U:6C2)<+%-NPZ>6
M0S ';]TG()QFK]SHB1:7;:WHOA[6$6SURWO)8KN266ZNX8T*%PDC%@1O.%/)
M"].E &YI&LZAJ'Q6DM;VSNM/:+1-SVDDH="QGX=2IVGCC/7@BN]KS_3;N]U+
MXE7&NKHVI0:<FAF")[BW:-Y7$VX@*>0>> <$X)Z8KLM%U2/6]$LM4BBDACNX
M5F6.4 ,H(S@X[T <UK/B?6++XC:1H5IICS6=Q;2RRL)8QOP4&X9.0$R<CJ<\
M9Q7/:%XWO=%T'5KRYTG4+^PLM5NQ=7OG+^Y3SV "JQW.%4CIP!QV.-SQ&+FQ
M^)7AW5O[/O;FR%I<6LDEK TOEN[(5W!>@X//2LA]'U(_"/Q98"PN?MEQ<Z@T
M,'EG?(&F8J5'4Y!!% '3ZYXNN=*N+E;3P_?:A;6=N+FZN(V2-$0Y.$W$>8P"
MDD#VYR:SIO&.IS?$+2=*T_3GGTN[T\W?FB2-=ZLT8$G)R H+97J<]#BL#Q#I
MU]J&J:W97VEZU>RRVD4>CI \J6J9BPY=E(0$29)W\D   ]*ETDWMEXD\':G-
MH^J_9CH/]FR;;-RT$P>/B1<91?E/S'C'/2@#TZYDDBM99(83/*B%DB#!2Y X
M7)X&>F37D9\::SJO@;0M:OK2Y@+:_" UNZDW,?GR QJJG/ 4+@_>->PUX[HE
MCJ?_  A?AW1)-'U**\TGQ##)<^9:L$V&YD?>K8PRA2"2.!D4 =K;^+7N[C5=
M*U71[K3+NVL3>",SH_FPG<N5=#PP(QCMQ6?HGB^"/PIX=71=+O[Z;4XI6MK:
M>Z4R!(S\[/*Y[9'J>14NL:=>S>/-1NH[29[=_#3VZRJA*M*96.P'^]CG%<YI
M6EQ6OPV\*V/B#P[J[F"*0F>Q207-C+N.WY4^<!@3R..!D<T >FZ1J#ZIID5W
M)97-E(Q97M[E=KHRL5(]",C@C@C!'6LW7/$TFFZI;Z3IVESZIJ<\+7'D12)&
M(XE(!=F8@#)( '<YI/!/]J#PQ"-6:Z:82RB(W@ G,.]O*,N/X]FW/?UYS65K
M;7.@_$*'Q$VG7U[I]QI9L9#90&9X9%E+J2B\[2&(R.A S0!C>)/$<VIZCX"N
M[7[;8K<ZNT-Q;2$QL"N0R. <$9!]0>M=%J7C:73+RX:30;XZ3:W"6UQJ)95"
MLQ4;E0G<R L 6'OC.*Y_7X]<\0W_ (&U*;0[BV,6KM-+" 7:"'D(TF.%)&"1
MVSBL/Q+IFHZG:>(8KG1]>OM;6^>2W?,HMDM5D#)Y8!\MB4&-H!8L3GUH ]2L
M=?AOM8UK34A=7TIHED<D8??&)!CZ XK#M_'S:E9Z4^CZ'=7UU?V1OOLXFCC\
MJ(,%R68@$DG  _2LVWO[S2?%_B2<:)JMPNM1VT]BT=JVTD0A"DC=(B".=V,"
ML:RTN"V\&^&+37- UZ*ZMM/Q%?Z6DOVBVESS&1'\RY&#\P*G\* .VN?&$I>P
MMM-T.^N]1N[7[6UG(5@:WB! _>%S@'<< <Y(/89K7T+6;?7]'@U*V21$EW Q
MRC#QNK%65AZA@0?I7F4NC7WV[1M9\5V.MW7FZ0MI.VFO,)HIED9U\Q8&!.Y7
MY/(##MFO0?"%A!I_ANWCM]-N--21GF^S7,QEE4LQ.78DG<<Y(SP3B@"'6?$]
MQI^L#2M.T6YU2[2V%W,D4L<82,L5&"Y&YB5; 'I7.W'B._7XD)]@TW4+PW7A
M^&>.P9A#Y9,SY:0.0$(&%/?.!]+'C>"QFU:)[O1]=%S';_Z'JVBK(TJL2<Q'
M9TZ*1ORIR>F#1X9LM<_X3*SO]:MY!<-X:MX;F;9\AG$K%ER.-W.2!0!HV_C<
MWV@6M_8:)?7%[<73V9L1M#0RH6#AWSM51M/.><CUKF?B%XIGU#X/^(;RV2ZT
MO4;*YCM9XQ+AX9!-'D!T/(*L#D=0:J"PU.SM(H[ZQUD:1)K^HRWL5@DHED1F
M8PDB/#F,GGCCIVK+U;0]3D^&?CC1[30-3BGN=1AN[2W:-Y6>)C!C#\[F 1MP
MR=N* .POKRZ7XT>';5;F86TFD3.\(<[&8'@D="?>N^ED$4+R$9"*6Q]*X6]T
MR^?XQ>']06SG-G#I,T4DX0[$<GA2>@/M7;W2EK.=5!),;  =^* .+L?B3]LM
M-(U)M OH='U.6*WCO7DC^620X *9W;=WR[OZ8)M7WCF6*YU3^S=!O-2LM)<I
M>W,4D:A650SJBL07*@C/3TYK!31]2'PE\(V'V"X^UV]UI[30>6=\8252Q8=1
M@ DU)#<7_A9/%6E/HFIWDU_?7%W826MLTD4PF (5G'"%6R#NQQSS0!?O_&NH
M/XP\-V>D:>UWIFIVDEUYBR1KYJ80AAN.5VALD=\\=*[NO+HM)O\ PKJO@!I[
M"\NX;#3)K*YDLX&F\N5ECQD+R%R#STXKU&@#@(?B>LND1ZV?#]^NB";R;B^,
MD>(3OV$[,[F4'&2.G/7%:K^,WD\877ARQT6ZN[BT> W$RR(L<44@!WDL>V?N
MCDX..E>=:9=7NK?!W_A%;31M0DO;Z2:&&=+<FWV-<L3(T@^5=HW9!YR.G(-=
M_P"'=.NK7XB>,+J6VE2VN$L5@F92%EV1,&VGO@XS0 6WCU+BXMICI%TFBW=W
M]CM]3+IM>0L44E,[@C,,!O<<#-)-X]V7-S+;Z'?7.CVEU]DN-1B9"%D#!6*Q
MYWLJL<$@=CC.*X[PWX8LK&+3-#U#P]X@N-2M+I5DD-S<+9!4?<LX._RR,!2%
M SGC%;.BZAJ_A.RO/#\7A[4+S4/[1F>TE6(BVEBEE+AWF&0F QR#SD=#F@!E
MGK\VE?$+XDW=S+<3V>F65I<);^82% @+,%!X!.*["Z\2P6O]@[K>1O[9F6*/
M!'[LF-I,G\%QQ7$7/A[5;SQ1\41'93*FIZ9!!9RNA5)G^SLI"L>#AB ?2I%O
M+_6[KP/'#H.K01Z==*;V2ZM6B$3"W=<<_>&<_,..G/- $?C;QS=7O@3Q#<Z;
MI=_'IT8DMHM5CF5<R*VTL%!WA=P*[A^0&374:GXQEL;VZM+#1;O4_P"SH$FO
MY(9$7R0PW!0&(+OM&[ [$<\UP5XFKV?PKU?P3'X>U6?5(VN$CDCMF,,L;3-(
M)%DZ'*M]T?-GM6EK&B6]EXLUR[U/2/$%['J*0RVATJ6X"LRQ"-HW$3 *<J#E
MN,-UXH ]/LKR#4;"WO;5Q);W$2RQ./XE89!_(U@:]XJN](N[F*U\/WVH0V=N
M+FZGC9(T1#GA-Q'F-A22![<Y-;&BV46G:'864%J;6*"W2-;<R>9Y0"@;=W?'
M3/M7GOBJQO-1\1:]:7NFZS?&:VC31EMWE2U7,9#EV0A00^2=_. , ]* .DNO
M'"_VK:Z9I6E7.IW5WIZ:C!Y;K&IB9B,LS$;>WY@5J>&O$$7B32?MJ6TMK)'-
M);SV\N"T4J,5921P>1U%<AX+M+W_ (2+1[N;3[RVAB\+0V<AN(&CVS)+AD.1
MUXS[C!Z5N^!;*ZLK36UNK>6$RZW>31B12NY&D)5AGJ".AH T-?\ $!T>6RM+
M:QEO]1OG9;>VB=4R%&79F;A5 QSZD#O6//\ $*VMM*MKJ72[T74FIC2I;)=I
MDBN-I8+G.U@<#!!P0P/'-5?'^CBZUK0=6N+/4KJPM!<0W*::\JS() A5P(R&
M8 I@@9^]G'%9/]A*;'09])T+5+2)O$T5U,MY))+,T:QNGG/O)9!PHP>G'K0!
MN1>/-0FO[W28_"=\=9M%65[3[1%L\IAP_F9V\GC;US]"0X_$:UFL_#TUAI=Y
M>2Z['*UK A56#1@;E8DX&,G)S@;35G3;*ZC^)VOWKV\JVLUA:)',5(5V4R[@
M#W(R,_6N!TK[;X='PW^UZ9>--;IJ?G6R1$S*I(Y"=3@$' Y(Z9H V_&7BZ?4
M?AKXL5;>ZTC5],"1SPF4;XRQ5E970\AE/!'O70'Q3+9QZ1I-CIL^JZK/8)=/
M&LJQB.( #>[L>[' ')/-<;K^F:IK_AOX@ZK;:3?H-56UALK:6!EGE6$ %_+/
MS $L<9&<"MT)=^&_%6GZW/IM_<V-QH<5C+]DMVFD@EC8L-R*"V"&(R!P1S0!
MJ6OQ LYVTQ9;&YMS=W\FF3B4KFTNE&1&^"0=V."..1ZU;U?QI8:+J]U8W,4I
M2STYM0N9DP1&F[:JXZEF(.![5RJ>%[[6/!'BB>>"2PO=2U&35+!)L+) R!/)
M+?W6)C!/H&JGI^DZAXU^&_B/76M]FI^(@LL$);;B*' BCSVW;6.?]N@#L+3Q
ME-]HEMM5T.ZTRY^QR7MO'+*C^=&F-PRIX<;ERI]:G\)^*9?%EFNH1:/<VFGR
MPI)!<3NG[TD?, H.1M/&3P>U<IIFEZ9=S74^G^'O$45Q%ITZBXU2>X/ENZ@>
M4B2L=Y/<KQ\HY.:ZWP':3V/@'0;6Z@>"XAL8DDBD7:R,%&01V- %GQ%X@A\/
M6,,SV\UU<7,Z6UK;0XWS2MG"@D@ 8!))X !K,M_%]W-+J&GRZ#<0:W:0+<K8
MM/&1/$S;=Z29VX!!SG'3WIOCFSO&;0M7L[2:\_LK45N)K>%=TC1%&1BJ_P 3
M#<#CO@U4TH7.N^/;OQ$FGWMII\.D_8(C>0-"\TC2;V(1L-M  &2!DDXH R?@
MO-J&I>&1K&I)J,UQ>[V:]N;XRQS$2N,)%N/EXQCH,UVVL>(8=%U31[2Y@D,6
MIW#6RW (VQR;2RJW^]@@>XK"^$FGWFE?##1K+4+6:UNHA-OAF0JZYF<C(/3@
M@_C6EXZT9M<\'WUO"XCNX5%S:2DX\N:,[T.>W(QGT)H 35O&FGZ-J]Y8W,<G
MEV6G'4+JX7!6)-VU5QU+-@X'M4%AXRGDU33[+5M!N]*&IAOL4LLL;AV"[MCA
M3E&VY(!]",YKD;'1M0\:_#3Q)K/D"/5/$@$T$3'&(HL"&//OM)_X'6Q<WEWX
MQUWPRD.C:G8QZ==_;KV2]MFA6,K&RB-2WWR6?^'(P,YH U_^$YM/^$#?Q7]C
MF^SH[(8<C?Q,8NO3J,_2B;QFY\7W/ANQT6ZO+JV,#3R+(B1QQ2#)<EC_  _W
M>I[=*X*X35HOA??>#X_#^JR:G%=2;G%JWDM&;HRAU?HV5(P!DY[8!-=QH=A=
MP?$OQ;>RVTJ6UQ!8K!,R$+(563<%/?&1GZT 2Z/XQGUBZMGCT"^32KQW2VU#
M<CJVW=RZ*2R*=IP3[9QFNDNY9H+266WMVN9D4E(58*7/ID\#\:\UTB"6+Q5I
M\FAZ/KNCS273MJUE,K_8 A5MS*3\A8OMVF/KDY'6O4* /%_!7BB]L-"\1>,=
M;L]4NO)FG#2O?AHP!*H$21;L*1_>QV(SS7=2^-Y8;"WFDT&]6YO[KR-,M#)'
MYETNW=YAYQ&N 2=W(QTKB8- U=?@AXGTTZ9=B^GO+AHK?RF\QP9000O4Y'-=
MEXLM+NVU3POK]O97%W%I4THN8+=-\@CEB*;U4<MM..!S@F@ F^($=CI>N3ZE
MI-S:7VC1)-<69D1R\;_=9'!PP."/8CFF2>/[B'5K;3I?#.H+-J$3R:8/,C_T
MH+@L&^;]WA6#?-V]^*YCQ+I^I^)K/QEK-KI-_'%<:5#I]E!-;LDUP5=G9A&?
MF ^8 9'.#77:M8W4OC_PA=1VTK6]M!>K-*J$K&62,*&/;.#CZ4 :7AGQ&/$5
MK>%[*6QN[*Z:TN;:5E8I(H!X9>""&!!K<KE/"%E=6FL^+9+BWEB2XU8RPLZD
M"1/)C&Y?49!&?:NKH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HKG?%NNWFD1:;::9' ^I:G>+:6Y
MG!,<?REF=@""0%4\ C)Q6,^L>)8K_5?#5U=::VHKIPO[.^CM76-H]^QU>/S,
MAAV(;'(/;% '70:SI=R;D0:E9RFUYN!'.K>3U^_@_+T/7TJ2RU"RU.W^T6%Y
M;W<.2OF02K(N1U&0<9KY]BL-7MOV;IKN&?2H[&:$&14LF6X=?/((:3S,$Y/7
M;TR/>N^_MR_\/'3/#8U3PUI4SVAO)+N:V,,*QY"HBQF4;G)#9.[HO2@#TVL;
M5[+2M6U33+6ZO%2]L9QJ$%NDJAVVADR5/)7YCT[]ZXS_ (6!K5_:>&X]*ATU
M[W4[NZL9V)9X5>(,/,0@\I\N['.1QGO6G%J]]#\4=+T*^M]-FG?1#<37L=N5
ME+B0J54DG"'KMY^M '<T5Y=:^-?%C^#].\77"Z4NGO<1Q3V:0OYCHTPB+J^_
M"G)R%P>._8:T_B/Q+?7_ (@N-&33AIVB2F P3QNTMW(L8=P'# )C< .&R>M
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M;D'<(6RC,)%YRH(V'!SW% 'HS ,I4]",&F6]O#:6T5M;Q+%!$@2.-!@*H&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !6>=:LAKRZ*KL]Z8#<.B+D1QYP"Q
MZ#)S@=3@^E:%>9:'JLFG^&/'OB[:)+[[=>%-W]R ;(D/L-OZF@#TBXF%M;2S
MF.201H7*1KN9L#. .Y]J@TO5+/6M+M]1L)A-:W";XW'<>X[$'@CL17.>'M!U
MBTFTS4F\27MXDT&[4(+LATD9E!#1  >7ANPXQQ[U7\$?Z#XJ\9Z+'Q:VU_'=
M1+V3SX@[ >@W9./>@#MZ*** "BBB@ HHHH **** "BBB@#.UG7=+\/67VS5K
MZ&T@+!5:0\LQ[*!R3["JFB>,- \1SRV^EZE'-<1+N>%D:.0+Z[' ./?%8-Q'
M'??&VWBO '2QT,W%FC\A9'F*NX]]H4?C747VFZ:^H6^L7%JCWUE')Y$V2'52
M/F'N".QS0!I45Y$U]K<'PVB^(#:[?MJ!V7CV?F#[*8FD ,(CQP-AQG[V><UK
M-;:IK_B7QE;OX@U*SM=/DB%I':2A-C-;HQ)."2,\[>G)SGC !U_B#Q-IGAFW
MMY=1DEW7,P@@A@A:625ST554$DU+9:Y!?7_V-+:]CD^S)<[IK9XU"MT7)'WA
MGE>HKR/65N?$D/PPU6\U*]2YOY(UE,,H0*WEY,BC'RL3WKHIM?U'1/'?B2U^
MVW%S9Z5X;%U%#.^[=(@^\?5CCD^] '?:IK%IHZVC7;,HN[J.TBVKG,CG"@^@
M]ZOUY#J&F:A%HG@?5;K7;^]FO=7T^6ZCN'#1EW.[,8Q\F#P .,'GG%0S^)M9
MO#J>KV3>)IM1M]1ECM+2ULG>R:&*79Y;84ABP5LMG()XQB@#V2HWN((YXH'F
MC6:7)CC9@&?'7 [XR,UYRT&JZ[J_C16\0:E9P:;.HLX[24)L8VZ.=QP25S_#
MTY;.<C&5:_:O$7BOX>:C=ZE?1SWFC2W$H@E"+O"Q%L#' 8GD=^* /4;#58=0
MN;V"*&Y1K27RG,T+(K'U0G[P]Q5B[N8[*SGNIB1%#&TCD#)V@9/\J\TL/$-\
M8OB&;S79+*.QU#R;:Y>+SOLRD  (G<DG 'J1UZ5'8:E<K=>(])$VN26+:$]T
MBZTI$JR?.I*DC.TC'!Z$'I0!W%MXLTZ\TG2=3M4NYK75)%C@:.W9BN[(!<#[
MJ\<D\"ME+B"2>2!)HVFB"F2,,"R YP2.HS@X^E>-:;JM_IGPY^%ZV-U+ MWJ
MEO;SA#CS(V9LJ?8UI6V@WU]XX^(<=AK>I07B1V_V9A/A0[PLR@\=%)P!V% '
MJ]%>;CQ7?>)M'\'6EA/):W^J3[[\Q_*T4=O_ ,?"^V7 3_@5>D4 %4=.UG3]
M6DNX[&Z662SF,%PF"&C<=B" ?QZ&KU>=>/A/X+O&^(&E1*^Q%M]5M"VT7,9(
M6-\_WU8@9]#CM0!V_P#;.GG6SHPNE;41#]H,"@DK'G&XD# Y]:O5P>GV%UX+
M\$:[XDOREUXAN+:2_O9>JEU0E(A_L+PH_$UGR#5_#ECX8UMM?U&^GO[RUM[^
M&XD#0R"?@E$Q\FUB",=A@YH ],HKS<:WJ?\ PK;QM?\ VV;[59W>I);R[OFB
M5&8(!],#%=_ISM+IEI([%G:%&8GN2HH LT5@^,;P6/ABYD_M23369DC6XBA,
MTF6<#;&@Y+MG:.N"<XXKSYO%>J:%8>*XK2?5F6VM+26S.LIF:&2:1HB>>2N0
MK 'N#0!ZS=W,5E9SW4Q(B@C:1R!DA5&3_*HM,U&WU?2K34K1F:VNX5FB+#!*
ML,C([<&N3N_#NI:-I>JRCQ!?7]B^ESK/#?L)&\W:<.C #:,9!7ITKFOAWKL_
MBBVT'1K.]EL+'1M-MI;A0"DM\^S;A<C_ %*L""1U/'3D@'KE%>17#ZW=^%/&
M&O?\)'J4,^D:A?\ V**&0+&JQ.2%<8^<<8P>  ,#KG=@EOO&/BR_LI-5OM/L
MM.L;5Q'82^4TDLRLY9FQD@   =.M 'H%%>6^'_$FL+JN@/J6H/-;F\O]%NW;
M"I)+$Q:*4@<!B(V!^M4M-\:ZM9Z)XEU&^NI93>6!U32$;_EFKRR11QK_ .0#
M_P #H ]*/B'3QXI'AS>_]HFT^VA-AV^5NV9SZY[5JUY+"USHOQ:MWO97NKJS
M\&;II'.6E=9<L2?<@TGAG7-9GN?#NH1R>)KNXOW0ZDES9.MF(Y$)W1G;M4(V
MW!!Y&<YS0!Z9K6L6F@:1<:I?LRVMN 9"J[B,D#I]2*OUXCK*:EKOP<OO%=SK
M5\T]Z?,:S9Q]G6+SPJQA,<$  [NN1SD&NQC35?$OB[Q(L6MWMA'I#Q6]E#;L
M!&9#$)&>12#O!+ 8/&!^- '>T5XOIOBG4M3T?PI97]YKC)<:;+>W<NE1-)<3
M.) B E02JC))(Z_**]#\"WNI7GA]AJD=Z)8+F6&*6]@,,TT(;]V[*0.=I )Q
MR0: .EK,O/$&FV45C*]PLD5[=K9P/#\ZM*Q( R/=2#Z8J[=0?:K2:W\Z6'S$
M*>9"VUTR,94]C7AVC6%P?A;X*DAU*Z$]YKT.'E8.(#OF&4!& >_.<F@#W>BO
M.&NKOPSXB\0:7)XCNA8KHBZA'=ZB?M!M)"\B%@."P^4';Z\"J6B7MV_B)M'C
MU'Q+]DO=(FG:74U,<@E1HP)(B1E00YR,8''% 'J%O<074"SV\T<T+_=DC8,I
M^A%25PGP@M#;_#72)C=7,QN(=^V9]RQ\D80=A7=T 4-&UBTU[2X]1L69K>1G
M52R[3E7*'CZJ:OUXCI<&JZ5\))?%%GKE]%<6$UQ-!:(X%N46Y?<CICYMWS<D
MY&1CI78V_B:7P]XB\36VL7,DEFMH-9L3(<D0[<21C_=<# _VJ .]HKG_  3'
MJB^$;"769Y)M1N4-Q/O/W"YW!!Z!00N/:KOB2>6U\+:O<02-'-%93.CJ>58(
M2"/QH TZ*\F-_K&E?#O1M6GUK5;J^\0-912M$HE:W1U+-Y$87[Y7()Y)/-3V
M^LWUE8>(86U'7K#2UMX7M=1U:Q=IH96<H\:!@#(3\FWK@MWZ4 >I45Y58:GK
MJW/B+2=%FUN2;^R%NK)=94"99BSJ=A;L<# ;@,/2HG\3MH_ACQ!=Z7K6KR7]
MO;1#^SM<A/GVTKR!!*"P&5^;H,KE>O:@#UJBN!E@U#PCXF\-HNN:CJ%OJ<[V
MEW'>RB0%O+9UD3CY.5.0.,'I7,Q76NI\,X/&,GB+46OX+H;(/,'DM']J\HJZ
MX^;(SR3D<8Z4 >R445ROCO4;VST_2[+3[EK6;5=3AL3<H 6B1MS,RYXW84@?
M6@#JJPM \6Z7XFEN!I1N9H8&*FY-LZ0N0<$(Y #8/I7.QVM[IWC3_A&/[<U6
M;3]1TU[A))9]T]O+'(H)20C.&#=#GD<=:H? S3_)^'EE>_;+N3SFF7R'DS$F
M)GY5<<$XYH ].HH(R,5Y>OBC5=(\&^(])N+F2Y\0Z;>?8+21SF2;SV'V9_<X
M?_QPT >H45YY96>I:YXFU'0KK7]3@M]#L[2+?:3>7)<32(6:5VQD]!@=.O%4
MO#_B36+W4_"-K=WKR/\ :]2L[ME 47/D!@C,!QG@'ZYH ]0HKRKQ=XAU>QL_
MB)):W\T;Z>UA]DPV/*WJA;'IG)S]:]"T/2Y]*LGCNM3N]0GED,LDMRP.&(&5
M0 #:F1PO;- &G15;4;O[!IEW>;=WV>%Y=OKM4G'Z5Y;X9UO69[GP[?QR>)KR
M>_=/[32YLG6S$<B$[HSMVJ%;;@@\C.<T >MT5XQ)>>(1\.;CQ8GB._\ M]IJ
M+QV\)<>08_M?E[9$Q\_!/.>  !C%='(=2\/>,WT\:WJ%[!>:+<W+"[D#;)HV
M4!TP!MR&/RCB@#T2LK3_ !#I^J:SJNDVKN;O2VC6Y5D("EU++@]^!7G%M<:Y
MIW@?PQXOF\0ZA<W<TEF+JWD<&"6*5E0KLQPV&!W=<YJ ZU/X=U[XN:M:A3<V
MRV;1;AD!S$P!([@$@_A0!['17GEY:ZEX4U/PXYU_4[]-3NQ87L=U*&#,\;,)
M(^/W9#+T'&#6>OBC6+;P!J.CR7;R>*+;4/[%BF;[\DDC?NI?^_;;L_[)H ]3
MHKSF*QU35_&>O:(_B+5(+*PL;,H;>7;(9&1QO+8)YVY([G&>E8FG:CKQ\'^$
M_%EQK]]+>W=_:VT]N& MWB>3RR"@'WB/FW=<DXP,  'L-%>.ZAXCUB\N->O[
M)_$KZC8W\L%A;65F[V;+$VW8^%(8N0V23D9&,8KH8X-2\2^-_$EA)K>IV%A:
M0VCQ0VD@C=7DC8GYL$@#'3N3STH [V2X@ADBCEFC229BL2LP!<@$D*.YP">.
MP-25XK U]XHG^&=Y?ZK?QW-T+J.5[>41Y:.-QO QPQZ$^E>U4 %%<KXCOKS2
M_%OABX6XD73KN>6QN8L_*7="T38]=R$?\"KCM,\;:E90>)-5O[MY;6[L)M3T
MF-^D:QS21*@^H,!_X%0!Z:^JPIK4>E&&Y,TD)F$@A8Q  XP7Z!O;K46H>(--
MTVR2\EN%>!KE+3=#\^)6?R]IQTPW!].:X2PN-;M_'^@>';[5;QUD\-F2[_><
MM<;L,_\ O YP?85R]E83Q_"=)X]1NGN+CQ!&J_:'\Q(V6^(#!?4GD^IH ]VH
MKA]+2]T3XDIHYU?4+^RN]*>Z9;V02%)4E1<J<# (<\#BNXH **\X\;7[_P!L
M7\5OK.N^?:6(DCM-'@.VV<[B))WY#;L#"G'"GCG-16=[JWBGQ'HEK)J]W96M
MWX:BU"Y2S<(S2LX^Z<?+][J.> /6@#TRBO)8==UK2M'@U6?5+FYL]#\03Z=?
M-*P)FM"_EAY,=60E3GZUUVF7U[J_Q$U<QW,@TG2K>.T\I3\DMR_[QV]RJE!_
MP(T =91110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<%HVFQV&M^)O"6I0LUAK$DM_:L1\LL<HQ-'GLRMDXZX;-=[41N;<.B&
M>,.Y(12XRQ'4#UH Y/3O"]UHDMI>ZMXGN;S3]'A<6T30K$%7;MW2LO\ K"%X
M' ]<9I? 5G<R1ZOXBO87@GUR[^TQQ2##QVZJ$B##L=HS_P "KK$GAED>..5'
M>,X=58$K]1VH2>&25XDE1I$^^@8$K]1VH DHJ+[3;[T3SX][YV+O&6QUQZU%
M/?0Q6MU-&Z2M;(S.BN,@@$X/ITH M45D^'==AU[0M-U#$<$U[:QW/V;S0S(&
M4''8G&>N*TC/"LRPM*@E895"PW$>H% $E%1M<0HP5Y8U8L% + ')Z#ZU)T&3
M0 45%'=6\T32Q3Q/&IPS*X('U-<QX/\ &4_B^:\GATR.WTR*62*&=KH-+*R-
MMR8POR@\\[CTH ZRBLZXURPM=:M-(EF O+J.26-/]E-N<^GWACUYJGX=\2PZ
M[923R)':N+R>U2)I0Q?RI"F1P.N,X[9H P_&-O9WVJ6T\+:Y8ZSIQ/V>_L=-
MEG7:P&Y#A"LBGC([$=N:S]-VKK4&L:_=>(M8O+5&2U4Z#-!#!N&&8(J'+$<9
M)/%>BR3PPLBRRHC.<(&8 L?0>M24 >3)I-NMC'HC7?B)O#4<XE73CH,V[:'W
MB(R[<E W;&<<9KH+*]T^RU/7KT6VO,=7D1V4Z-<#R]L2Q\?+S]W-6[KQO++J
MEWI^@:!?:U)9/Y5U-#)'%#')W0.[#<P[@=*TO#WB>U\06UTPM[BQN;.3RKNU
MNU"20MC/."000<@@X(H XJ/3M-2Q\)VNWQ 1X=D5T;^Q+C]_A=O/R\?K5QX]
M)F\6ZIKD]KKTB:CIXL);8Z-< ;,\G=M[]*]!%Q"?,Q-&?+^_\P^7OSZ4D=Q!
M+#YT<T;Q?WU8%?SH \HATK]SHUK>:KXDNK+1KJ&>RA/A^9#B(_*'8+ESM^4'
MCJ3@FKX0V]]<C3]0\2V6E75V;R:SBT.;>'+!G"2[<JK'DC!ZG!&:]++J"H+
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MH,L@8;@/<4 8,OA."?QT?$TEP6)TPZ<UJ4&TJ7WELY_#%5M%\):AH\MC;_\
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M9D+E%?.54G&1@]^1FJOC.QL?&OC'1-&M%G>73[AGU.58V6-+; )B9B,$NRH
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M;O/?1>3=*)Y!',H7:-R!MI(' .,CMS4VC>%M+T*XEN;1;F2XE01M-=74D[A
M<A SL2%SV% &U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<Y<>//#5IJ4EC-J866*402.(9#%'(>-C2A=BMST+"NCKQF/4
M]-L_@SKN@7L\(UL/>VTEDS#SY+B25S'A.K9W(00.GTH VO%7CVX@\?V/ANPU
M+^SX!"\MW<?V=)<.7! 5%&.GJPR/>O3*\T$<T/QF\-Q7!S.GAUUD.<Y8,,_K
M7I= '!WGQ&MIY/%FG6 DCO=(M))(96A?:[K$SG.5P,$#J?F[9%:'A[QWHVJI
MI=A)J ;5+JW5L>2ZI)($!<*^W8Q'.0#Q@^E<G>7EM#K/Q7LY;B)+F:R1XH6<
M!Y%%D<E1U(&.U7]0C2+P_P##)8T"A=0LU4 8P/LLG% '5_\ "9^'SK7]D_V@
M/M?G?9_]4_E^;_SS\S;LW_[.<^U;U>)Z1;+/X?CT;4_&,=G*NK-&^F"S1YQ.
M+HNN,'><G#;L=#GI7ME ''ZGXAUN^\47'A[PQ#9"6RB26^O;X,T<)?E$5%(+
M,0,]0 *N:'=^*H]6FT_Q!964L'E>;#J-AE(R<X*.CDL&[Y!(Q6#!J=IX0^)6
MO_VW.EG9ZX+>XL[R<[8F:./RWC+G@-P" >QJKHVJW$WQ%L;/2O%]UX@L#%/)
M?JJQ/#;\#RAOC4#));C.>* .KL/'/AK4Y)$M-423RH'N)7,;JD:(VUBS$ +@
M@\$YQSTYI^D>,] UR]6SL+YFN'C,L:2V\D/FH.K)O4;Q[KFO-K"QDF_9TU%+
M.%GEDEN995C'S2*MTQ?Z_(I%=+JVKZ7X@\7^"DT*]MKR6&XENG:V</Y5OY+*
M=V/N@EE&#WH ZO\ X2?1CX?&O?;5_LPL%$^QL9+^6.,9^]QTJIJ?COPWI%Y<
MVEYJ!6YM2!/%';RR-&"H;)"J<+A@=W09ZUY@VM:=%\#H]&:\A_M-+P0O:!P9
M49;W<VY>H  SD\<CU%=3I>MZ+H_Q(\>'5+RVM&<VC[KAP@D1;9<@9ZXSR!_>
M'K0!Z%:W4%]:0W=K,DUO,@DCD0Y5U(R"#6+XM\1R>'K*U6SM!>:G?W"VME;E
MMJM(<G+'LJ@$D^U4/A=!-;?#30XYT9&,)=588(1G9D_\=*U6^(7F:;>>'/$I
MADEM-(OF:\$:EBD,D;(TF!R0N03[4 2B[\>Z7<VLVH6VD:I9RRK'<1:=')'-
M &.-Z[V(=1WZ'%:>J^-_#VBWTME?7Y2>%0\PC@DE$*GH9&12$!Z_,1QS52Y^
M(?AX&SATN^AUB\O)4CAM=/E660@GEFP?E51DDMCI7/Z3K&DZ!)X[MM>N[>VN
M6U&:Y,<[A6FMWB3R]H/WA@%<#//% '8:CXOT+2I8HKN_42S0?:(4BC>5I8\@
M90(#NZC@9..>@JA_PLCPEY%O.-74PSD 2""0K&2Q4>8=O[OD$?/BN0\$65Q:
M>)O!T%_&5N8/"C_*X^:,^;'@>Q"G%5;F&-/A-\1MJ*-VJZ@3@=2)!C^0H ]$
MU/QIX?T>]GLKV^9;J!4>2"."25PK D-M122/E.2.!WQD4^Y\8Z!:Z39:F^H+
M):WW_'JT$;RM-QGY40%C@ YXX[UR>FZMI6E_%;7WU*[M[5Y-+LO+EN'"+@!R
MPW'C/0X]CZ5SWA_4GM-,\/VZW]GHMI>2ZE>6^HW4*%HXO.RJ1F3A=RON]P*
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MFZ!!%+J5P8A,_EQ(D3RO(V,X5$!8\ G@56\(7UI?^$M*EL[F&XC6UB1FB<,
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MZ3JZ>(+#P[KPMKA%8Q V5Y")R"P#D<,RAQM;< V>0<T =W?>,M T^TLKF;4
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M9 B,<OM'7IR"!FI;OQP/[9@TK2-*N-4N;G3DU& QR+&C1,Q&2S=.@^NX<=<
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M++&VYG&8PZ Y3<!QUY(!Q7,:1?:SK7QEUA+ZPU$0::+816Z:B$BM0R$EV16
MDW=<<XZ&@#U*YLK2\A$-U:PSQ*00DL8901[&I/)BWQOY2;HP0AVC*@]<>E)<
M7$5K;2W$[A(8D+NQZ*H&2?RKB8OB.QATFZN?#M_;66L74-O87#R1D/YC *6
M)*<'< >H!YS0!VK6T#B4-!&1-Q*"@^?C'/KQQS3(K&T@\KRK6"/R01'LC V
M]0/2N;LO&QU'Q#?Z7;:/<M%IURT%[>-*BQPJ%#!N3EL\C Y&,GM3=,\<F_N=
M-:?1KNSTW56*:?>RNA$IVEEW(#E-RJ2N>OM0!TATVP/GYLK;]^<S?NE_>'U;
MCG\:F2"&.621(D623&]E4 MCID]ZY:+QK-_:5K'=:!?6FFWEV;.VO9F4%I!N
M W1YW*K%3@GVX&:@\$^)]9\0:KX@AU#3&M[>SOW@CD\V,B,JD?[HA3DG)9MW
M3G&: .THHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJO4@>U6* "O'?L&J'P?X@T$Z/J(O%U\7:'[,WERQ->(X9&Z-\N2<= #7L5%
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M=B[5X'8=A[5R_B?1M4N/$6C:SIMG97YLHYXFMKR8Q*IDV8D5@K<C80>.C<4
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MX  QR>: (/@C_P DCT7ZS_\ HYZZSQ/_ ,BGK/\ UXS_ /HLUE?#?PY>^$_
M>G:+J+0M=6YEWF%BR_-(S#!('9AVK<UFTDU#0M0LH2HEN+:2)"QP,LI S^=
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M6=%L-4A4K%>6\=PBGJ ZA@#^=<AX^:^7Q/X+_LU83>&^G6,S E%S;N"Q Y(
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %9^CZQ::Y9/=V1<Q)/)
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MM&UBTU[35O[(N8&DDC&]=IRCE&X^JFDUS7-/\.:-<:MJD_DV=N 7?:6/)
M'))) _&O(-%U:\MO"_A?1FEU4Q7=QJ<UV^D1GSY/+N& "E>54L^21SP!WJ+Q
MNNHWWPCU=]1DUJ-+#44CL_MP,4EQ SQ%3*I'SE26 )_NYZT >M6?B:"\DTY%
MTW5HC?\ F;#-9.@BV#/[PG[F>V>M;=>=:I)>Z%\1? NC6VJZA+9W/VXW"W%P
M7,VV,,NXGK@GCTK#N&UF?P3XH\1GQ%JD=WI=_>_8HXI]L:I%*V%=?XQQCG@#
M  '< ]AHKRS6=;N]5\5:A9R2>)(H+*TM_(71(F($LB%R\A7KCY0%/'!XJ73+
MK6_%FO:7I>KW>HZ6UOH<=[=PVLAMY)+AY"F6QSM&PG;TRU '?:5K%IK"WAM"
MY%I=26DNY<?O$.&QZCWK0KA_AC'+#INOQ3SF>6/7KQ'F( ,A# ;B!QD]>*=X
MSN4DUJPL#J.M@F"24Z?HJ,)GY $CR C:@Y&.,D]\8H [:BO)=-U76M>MO EM
M)J][;&^^WQ7DD9"2RK#D+GL'^7KVR2.>:2]U75]&B\1^'K;5[V3;J]A96EY<
M2>9- ERJ%_F/7&6P3TS0!Z7-K%I!KMKH[E_M=S!)/& OR[4*ALG_ ($*LWMT
MME8W%VT<LJPQM(8X4+NP SA5')/H.]<#!I#Z/\6M%@&I7MY VE7107DQE=&W
MQ;OG/)!XX/3G%=3XTNI[+P-K]U:RO#<0Z=<21R(<,C"-B"#Z@T :ME=+?6,%
MVD4T2S1K((YD*.H(SAE/(/J*GKRRTN]6U@_#VS;6;ZWCU'1I9KZ2&3$DQ6.$
MYW=FR3\W7!.,$YJ%M7U?3K;4_#T6K7CD^([?2X+Z9_,GAAF1';#$<D#< 3D\
MCTH ],U?5+;1-'N]4O"PMK6)I92BY.T#)P*DT^^AU/3;6_MBQ@NH4FC+#!VL
M 1D?0UP7BS0KW1/ 7BT'6;R^TZ737,4-ZYEEBD"G<1(>2I&.#T(XI?#U]=1:
MEX!L4N)%M9O#SR20AOE=E2#:2/49/YT >BUD-=Z4/&"69@']L-8-*LWE\^0)
M%!7=_O$'%<#J6NZLTNLZ=#J5Q";OQ3;Z7',K?/;PO%&S>7G[IX;'H6J+5OM'
M@WQMJ=Y!?75\+3PI<W%N+V0RNC"5."QY*Y /.>_;& #UJBO*]"O-=CU735L/
M^$FN#=VTJWLFKP,(%E\LM'(F1A!O&W XPPXXJ[X'O'&L6]IJ&JZ]!K)M6-YI
MVK LD[C;F2!ON[0<_<.,$<#% 'H]%87C&\6R\+W4AU.73BY2-;B"'S9<LX&V
M-1U=L[1Z$Y[5YS=:YJ>G:1XTM;6ZUV".UTF*\M3JKDW$,C&16*MDG:=@ZG@@
MT >QT5YW+:ZCI/BOPS&VO:G<#6EN(;U)9\Q[A 7#1KTC((XQVK.7Q+K(^'TN
MAF\D_P"$I34O["%P3\Y<MD3>O^I^?/J* /2Y]1M+<70>=#):P^?-$K NB<X)
M7K@[6QZX-&F:A!J^E6FI6I8V]W"D\188.U@",CMP:\PM='\CQUXZ8ZEJ,OV7
M3("JRW)82;X9>''\0'4#M46DV^H:'X5\ ZO#K6H/)=S6-I-;-+_HYAE3&T1]
M 0,?-UR,]Z /4+/5([V^OK1;:[B:S=5:2: HDF1G*,>&'J15ZO([S7]72+XJ
ME=1N0=.6,V>)#^XS&2=GIS6SY>HZ%XL\*2MK>H7?]K>='?0SR[HF(@,@*)T3
M#+V[=<T >AT5XQ<W&NS?"H^-8_$6I1ZC=NLKPB;]PL3SA1&B?PX!'(Y)!SG-
M>ST %%>3Z3?ZM#H/BWQ5<ZQ?W$FDW6HQ6=F9?W&U"VW>O\6#P.< *,=ZDT*\
MUV/5=-6P_P"$FN#=VTJWLFKP,(%E\LM'(F1A!O&W XPPXXH ]4HKRG0]1GM[
M:[BN]8\06NNII<SW-AJH)6615&98&^Z K9^X<8(X&*9 ^L:5X5\(>*9-?U*Z
MN[R:QCNX)9MT$L4VU2 G0,-P.[J2"3G- 'K-%>--XAUJ^6^UFR7Q/-J46HR+
M;6]O;LUB88YBGED#Y6)56RW4,>O%=%;VFJ^,-0\2747B#4--ET^_>QL([:3$
M49C1#OD3I)N9CD'MP,4 =\+F W36HGC-PJ"1H@PWA22 Q'7!((S[&JVD:I'K
M&GK>1VUW;JS,OEW<!BD&#CE3SCTKA=%TN0_&;6II]1O7DAT^UD*K,1&Q8R97
M;_<!R0O;-<]H>NZ]J/PU\,3?VS=I>WGB$6DMT7W/Y9>08YX. !@'C@4 >Q16
M5K!=W%U%;QI<7.WSI54!I-HPNX]\#BIZ\IUK5=2\$7OBFVM-4OKR*+0TO[?[
M=,9FAF,CQY!/\/ ..G%7KFPU3PWXA\'PQ^(M3NX+Z[:.]CNI]_F,(78$>BY!
MRO3A>F.0#TBLJX\1:;;G2R+@3)J<_D6LD!#H[;6;J.,84\U-K<)N-#OHA--"
M3 ^)(7*.O&<@CI7CVE:7+_P@WPWC@U&\CDN]01O,:3>808)01'GA>,XZX)S0
M![A17DVJZOJGA ^,+"TU._NTM[:REM'NG-Q+ \\C1-M)Y;LP![BMCPE<ZA%X
MJ^R0Q^)9-)ELV:5]:B?,<ZLN"K-V92V5Z?*,8H [Z66.")Y99%CC12SNYP%
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M]HN H W&0$;$4GGIDD>E><^*7NM;^%EE=7U]J)FM-;-D/-DVNZ+<%5,H'!D
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M3\,7"Z[J=^-0O5L;Z*\G\Q)"\;$.JG[A#+T7 P<4[X>1:CJLNH:QJ.M:A/\
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M9/E  )]^E>ASW5O:A#<3Q0[SM7S'"[CZ#/4T3W5O:A3<3Q0ASM4R.%R?09H
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M@_<X4K\OKU[UL7OAZ*]U+0KUIW5M(=W10HQ)NB,?/IP<UI37MK;!C/<PQ!2
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MU>1@H'XFE\^$*C>:FUQE#N&&XSQZ\<T <UX@\*V=_<ZOJETES=+=:.=/DLX
M-[J&=\H2?ODM@9XSBN(TA)=<\5>$S#JFK:HVFN\L[7EB;9;./R67:_R@-(6*
MC.3]TXP,D^MV]S;W<7FVT\4T><;XW##/U%8MYXG@@U_0]-MA#=)J<L\331S
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MNS,)F(P203Q^&* //[W0M2TVV\374FE:+H]I+X<N8I+/3KHOYKJ#LD*>6@&
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M5X=\6^"GT&QMK.6:YEM7%L@7SK?R69MV/O %5.3GGFN1CT338O@A_;:V</\
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M!H(9=[#"'DKC./Q(KG="T._O_&]UXNUG2X].G%HMC9VQE660)N+,[LI*Y)(
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MZT4]GY:KY17]VVT*-K###.3ZUN:1HMIJGQ;UZ?5K:"ZGM+*PD177<BR[7^<
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M(KD+6\L=5^)^@WEE<07<']A7!CEA<.N1+$#@COU'YU?\ \7/B\#I_P )#/\
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MBXAU*R+1Q$%K8!"I5\?<.>,'&<'TKU^@#G]4\;:!HVHO8WUZZ31A#,RP2.D
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M-P.YN>3^IJ*XAB\KQ;I&K^,/[+2YU6X\S3OLD<DLR2L#&T8(WME2H&W.,>U
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MMRD6G%5'VF;>0J1OT4MN.-WIR:EMO&-Q'J$^G:SHLFG7JV;WL""X65)XT^\
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M"U$>&H[K2M,DAOX]6BTZ\AED3=!)YB93N&#J<!AT#9H ]%6*-)'D6-5=\;F
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MX\QMJ"-Q@%BWRX.,$CM1_P )M/9PZLNKZ++8WMAI[ZBL N%E$\*@YVN. 00
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M\TL<LL$4DD9RCL@)7Z'M6=X:UZ+Q+H,&J1026_F,Z20R8+1NC%&4XX."IYK
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MZ8C55&>XK3E^V>,/&&D7L.E:A866EVUT9);^ PEY)D"*BJ>3@;B3TZ<UWX
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M;#*.0"&//J.:QXM+UV/PX=0GT6[%Q;^+FU62SC4-*8"QSL ^\0&[=<&O7:*
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M_M)X([50L.IQR$AIH4FCF55P#SN0CG'#&@"I!XSUE_#&F)+%:KXAN-9_LJ=
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MUK!;.S@,0<N\FQ3@\<!3C% %2?7?&=MK>AV;3Z4PU^*0QK]F<?861 Y)._\
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M>L+G+8==PP< <8/.3TK)LIO$EM+X\O-&NK"WBLM4FN"+FW:4SNL$9*<,NP8
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M7.K:E-Y-G;+ND?:3CD   =220/QJC9>*(;X:<4TK5XQ?LZH9;)E$6T YD_N
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M<N,D<_=R<9H S;WP=*^OS:II>M7.E_:K>.WNXH8D82+'G:5+ [& 8C(J+3/
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MH#7:1S12EQ'(CE&VMM8':?0^AJ.XO;2T#&XNH80BAF,D@7:"< G/;- &=?\
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MBD(".'&UB>F#WS4(U73C!+.+^U,4+;99/.7:A]"<\'ZT 3P0BWMXH59W$:!
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M*-9;P[X7U+6$@$[6<#3"(MM#8'3/:KEMJ=G<AE6Z@,R('EC60%HQC^(=OQH
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M?#/A>#PR=7,-Q)-_:6HRZ@^\ ;&DQE1CL,4>)/"\'B2YT6::YDA.EW\=\@0
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MAB0)'&@PJJ!@ #L * /-=,T?2-<@\>7>NVEO<7*ZC<V[2W"!GA@2-?+"D\J
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M+2-<RL\B2*%=78MEP0!]XG&!C&*TY-"TV6WTZ![4&+39$DM%W-^Z9%*J>O.
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MNF6=M:.]O>AX[= @95C7:2!]2,_X5U%GX.T&QL+VRCL!)#?+MNOM$KS-,N,
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M/,6B_N9=B0OL,"I]&\*Z/H$\L^GVSK-(@C:6:>29]@.0H9V)"^PXH V:***
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M7Q+J_AVP#K'XS6/[,ZCB&;(CN3_WZ(?/J*Z*TL;:Q^+UK:V\2I#;>&1%$O\
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MTO3Y8YH!&&42%@J$J-NXDEAS6YX8B7_A:'C^0*!(6L%W8YQ]GH U&\?>'%U
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ML9N8V')V$?)GVP:U- U[4;[XF^+=&N)P]AI\=HUM'L4;"\>YN0,G)]37 _\
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M#X*N ,'*,""...M '6^3%A!Y:83E1M'R_3TI0B*[.%4,W5@.37FVN^/?$/\
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MLC!511U))Z"@#CO!VF:8FMW%]I_AC4]-"VPA^U:C-)O?<P+(L;LW VJ=W'/
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MZ-CR-A[\5#)#J5IH/ABW_MW4VN_$MU;K>W37!)C3RFD98?\ GGG 7(YQ[\T
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M6<LUR\DMNS.R,HD)W$?*",GC)K2O]&O;/QSH.FIXAUDV^L6MRVH WC9=H@C
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M(P#D#.<F@#UVBO)XK'4=8TGQIJ<OB'5X;C3=1O5L%@O'1(?+&X94'##/&&R
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M%PDC?QXW8.>N!776]Y<M\5K^R-Q*;5-&@E6$N=@<S2 L!TR0 ,^U '54444
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M$8@AV@9 !SGK72W>IZ?8/&EY?6UL\APBS2JA?Z9/-/N+ZTM!FYNH8?E+_O)
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M0GELK*J(!M4?+SQDYY/2NMKC? /C2Y\;6<NHFULK:R<M]GC2Z\RXP&*YD3:
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M;>V]MYAVIYTJIN/H,GF@#G] \$PZ%=:9<#4+BY;3K!]/A$JJ/W3,K#. ,D!
M,]ZKZI\/+'5=#UC2Y;VY2/5-1&H2.H7*/\GRCCI\@_.MK4/$^E:9K5AI-U=(
MEU?!S&"Z@ *,Y;)XSG ]34FFWMW<W^I17*V0AMY0L)@GWN5Q_P M!CY#[<T
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M.G6-@^EQK;6);[,L3M&8]WWL,I!Y[Y//?--D\#>&I;.YM#I,2V]S*DSQHS(
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MF9UAD"D,S HNTL AZ<X)JG\3[.UNO^$3^T6T,N?$-K'^\0-\C;MR\]C@9'?
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MV;,_(:%B"R$=""0*YS5? >FVOA/7K70=/"W][I\MK&TD[.3E3M0,[':N<<#
MH Y^ZTO2]+@^'5[I%O!'>2WT,?GQ* \T3P.92S#EL\$D]ZR4T_3I_@9JVM7D
M$/\ ;):ZN9;ME'G+=+,VWYNH((4#VKT70_!>BZ3+::@FG)'J,4.W?YC,L;$#
M?L4DJN><E0,U)+X'\-SZJVI2:7&UPTPG8;W\MI!_&8\["WN1F@#E+#2K75_B
M[>3:M:17$L.BVD@CF0,JREG^;:>-PY /;)JY\-=/LK>_\82P6EO%(FOW$*ND
M:J5CV1':"!PN><=*[./2[*+5IM42W47TT2PR39.6122!CIP2:K6GAO2+#7+K
M6;6S$5_=C$\BNV'Z<E<[<\#G&: .?^)"K/:^';.X :PNM<MHKM&^ZZ?,0K>J
MEP@JH=*TZW^+/V"UL;5;2[T-GO;98E$;E9E$;,N,$\N 3Z>U=KJ6F66L:?+8
M:C;1W-K*,/'(,@\Y'T(/(/:JFC>&M(T SMIMGY4D^/-E>1Y)'QT!=R6('89P
M* .-^!UG:Q?"W2;N.VA2YE\X23+& [@3/C)ZG%7O'4L>G^*_!6JWA"Z=;W\T
M4TC?=C>6%EC9O0;NYZ9KK-'T?3] TN'3=+MEMK.'=Y<2DD+DECU)/4DU-?6%
MIJ=E+97UM%<VLR[9(I5#*P]P: *^JZWIVBPP27]R(A<3I;P@ LTDCG 50,D]
M>W;FN TO2M)U>P\?76MVMO/<C4;J&66= SQ0I&OE@$\J O(QZYKK-)\!>&-#
MODO=/TF..YC!$<DDCRF,'^YO)V_ABI-3\$^'=8OWOK_3$EGD"B4B1U68+T\Q
M5(#X_P!H&@#@?"EFFN^)_#$FMP+=R+X2CE*W"[P7\P .0>IP3U]36%XGL;1/
MA!XKC6VA"6/B*:*U&P?N$-RF53^Z.>@KVY=*L4U-=26V1;M;?[*L@R,1;MVW
M'3&:I7/A30[S2[S3;C3T>SO+@W5Q$6;$DI8,6/.>H!XH XWQ19VMA\5/AS!9
MVT-O"'U B.% BC,0SP.*Q9=.TN]^&7CS4M1MX'U'[9J/F7#J/,21"5C4-U
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M12/;7D(Z1SQL5<#VR,CV(KGO"G]GZCXP?4(/%\_B&Y@L#$76&$11H[JP!:)
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MTW2F15=MJ2/%M^522/XB0".*NVOC"\U'Q=?Z%8Z&\J:=<)%=W;7 18T9 P8
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M@9Z9KBI/B$8]*TZX_L6=[VZU-]*DLUE4M%.H?(W=&&4Z\<-GM3AX_:P@U_\
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M1PV]V;I7=9)!E-T8'"L> <^F0,XH [C !)P,GK[TUHHV"AHU(4Y7(Z'VKC/
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ME_<?:9]S9R^U5X]!A10!YCI%O>^#?%OAVR>PGOY+3PN8KJ.T =U/G*25!(W
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M P%(!!.3CI0!?&MZ[X>\5)9:Y?VM_9W.G7%Z#!:^28&A*EE'S'<I#=^>*P]
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MF9E4DDXX X [U+XK\-76LRZ=J6E7B6>LZ7(TEK+*A:-@PP\;@<[6&.G(QQ0
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M4+E<8 /R]>3731VMWXCU7Q=J$FKZA:RZ7<FTL$@N6CB@V0J^]D!VON9N=P/
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M%1%& H'0 =A7C-_XHUG4?#'AV>TO+F.[TFP?4]4"2$&4V\BQ,CXZABLQ(/\
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MP<D@GGC!&: /4["\CU'3K:]A#"*XB29 PP0K $9]^:;J>H0Z3I-YJ-P',%I
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MJT:";4IWG>VE.YH83Q'"?]U,#'8DUMZ%XFCU;3[J>]LY])GLI#%=P7F!Y3
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M'-.A71KJ$V^F3.7N(]JE3M*+D(0.>V_WJE%I&GV'@;X;7MM:0QW;WVFLUPJ
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M64]_:7TMNK75FKK;R$G,8< -CZ@#\JHW?A30[ZWO(+G3XWCO+@74_P S M*
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M%XDRW6P>8KB]"@ANHPO'TKI_#G@Z[B\3:5J#^'K/0[;38Y2RQ7?VA[B1TV
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MXL[>VBN'U+3MDL:@/)N 9\D<G)&3GN!6?J4]Q;M\8I+5G20&U!9.H0H0Y'_
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MXX!-1:+X9T?P\9FTNR6!Y@!)(79W8#H-S$G R<#.!0!K4444 %%%% !1110
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M^!SP?I5,_$KPT!YGGW9MEF,$UT+.0PP.'*;9'V[5Y'<]"#T(K&N%5)_A<%
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MNK_*Q *';P16AIOB5+;Q3X;\0>))+?38KW09X!,X,432">-AC=]W<J[@#ZT
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M7$DMT(%C23.Q1\K9<@$XX'O4'PNN6O/!GVAQ(#)?WC;9?O*//? /TZ4 =D
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M$NDZCI?A"^T^S%I<6D\D^TSM*ZKAG&XG:-I&[.22>,8)]:HH \W70-5'PO\
M".F?8I/MMG=:>]Q#QF,1R*7)^@!JO);Z[I&G>+_#]OH%Y>2:I<W5Q97<13R-
MLZY^=BP(*DGC'/&.M>D0WUK<7=S:PW$;W%J5$\:G+1EAN7([9'-6* ,KPQ;3
M6?A/1K6XC,<\-C!'(AZJP0 C\Q7#:5X/OY/&6JV&H6C+X?@%X]E)D;7-WL+*
M!_L_O1_P*O1K.^M=0C>2TN(YTCD:)V0Y"NIPRGW!&*L4 >5>'O#OB"3P5XJE
MU>R=-7NM-&F6\1(+2)#;E%8'/\;LY_&E72=8TG0_AS=G2+NY?1E*WMM;A6E3
M= 4Z$@'!Z\UZI10!P^FZ1J$>F^.EDM)$?4+R>2U5L9D5K=%!'_ @1^%9>D6&
MK>%+W1=6DT>\O()/#]MI]U#:A7EMYHN1E21E3N8<9P1[UZ910!Y2^@:Y;:=!
MKSZ3.]RWB8ZQ+I\3*TT<!C,0'7!<#:Q /<U:N=-UO7]0\8W?]CW%G'J6@+:6
M27!4.[XE&& )"G+#C/0C.#D#TRB@#!\&3W$OA/3HKK3[NPGMH([=XKI0K%D1
M02,$_+G.#[=*S-!T6[3Q'XU>Z@>*VU&XB\B0X^=?(521]#D5U\DB11O)(P5$
M!9F/0 =34&GZA9ZK8Q7UA<QW-K*,QRQ-E6&<<'Z@T >8^$_"UO82:+I]UX)N
M/[2L'47&HR3D6X\L?+-&=QW$D*0NT8R<XQ6/K_\ ;&@?![6/"L^AW8:T\T?;
MSL^SO 9BX<'=DL00-N,YZX%>T7EY;:?9S7EW,D%M"A>25SA44=235+4M/T[Q
M5X=DLYV\_3K^$'=$^-Z'!!!'KQ0!S+-JN@>/M=NXM#O=0@U:"V^S2VVS8DD:
MLI60LPVCD'//&?I7*67@VYL]%\*76M>'[G44L[.XM+RSMV_>Q,TN])% 8;AP
M01GHP.*]EHH \UET:RC\-VMO<_#Z=M-GN99Y+:WG\RZMGX$<F-P(9E'.ULKQ
MUYQ3.F^(;*S\)ZE/INIWR:;J=S)]F+K+=QVSJZQ!R6PS %<\G%>K44 96G:R
M]]K6J:<]E)!]A$)61V!\T2+NX Z8((_"N?\ &=O?P^*?">MVNF76H6^G37(N
M([0*T@$D112 2,C/7FNQ2"*.262.)$>4AI&50"Y P"3WX 'X5)0!YJB:WX=L
M_$VBP>'[V_?4;NYN;"X@V>21/SB1BPV;6)SD<@<9KMO#>E-H?AC2M*=P[V=I
M% SCHQ50"1^(K4HH \:N].\1V_PNO? T'AR]FO86>-+L%/(EA\XN&5MV2Q7
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M'.7'DM'\O'JP/..*A\(:#JWAVYU>VN9+*73KB^FO+=XR_G R/N*N",<>H)H
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MEUFWFD#BS_X\6CVD[?F_> AMHW=^?8Q7W@37M5LO%YO;VP^UZ];VT<8BWB.
MQ;LCD9(P1SU)SP.E=1J&A7%WXQT+64EB$&G07,<B'.YC($ QQCC:<T <;-X[
MU32] O;?4=0LDOX->_L<:E+%LC5"@D\UDSC(7(QG&<5!)\1+Z'P_XD^P:M8Z
MS<Z9]DDMKV&,*LJRR!"CJ"0&&&&1V8'%;LW@?4"NIW%O=VJWSZZ-8L2X8H"(
MU39)WY <'&<9!J;5O#WB3Q%X7U2PU.YTV&XNI(#;PV^XQ0JDBNV7*AF+8/8
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MPKIFF:@;=KBSMTMRUNQ*,$&T'D Y( )]Z //XO%7C#_A F\:27UD;>TED+V
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MCNRRQR*R%",J"0>?2L]_#?B?39]:CT*XTL6FL2M<NUT9 ]K,Z!9"@4$.#C<
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MCVM*PP78DEFQVRQ)Q[UQMUX%UV73/%FCQW&G?8=8O'OK>5F<2H[/&Q5AMQM
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M#P#T[UV6BZ'K#>++GQ'KKV*W!LUL;>WLF=T2/?O9F9@"6)QQC@#O0!U5%%%
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MR-H&!Q0!Z517C>G7&H67@'Q)XM?5+^XU&TFOH+-9+AFCA7S64'83AB"<Y/8
M=!5ZT75-.N96T_3_ !/:V3Z9<B^EU:Y$@,H3='*I\URK9# XP.1QQ0!ZM17D
M,%O=Z3X-\'>*5UC4Y]3N)K!+HRWDCQSQ3;5*&,G;P&X(&<C))-,\2ZD\5QJF
MM::WB&ZN+34XXUOQ<".R@"R(CP"(R#>OWE)V')/7B@#V&BO.M/LY]7^*7BDW
M>I:A]CTJ6RFMK2*Y=(]YA#$D \CY?N]#N.0:Y[PW?:WJ5OH>NVVG>)9-3N[N
M.6\N9)P;.2W=\.HC\T@*JGY<(#E: /5];U:WT'1+W5KI9&M[.%II%B +%0,G
M ) S^-7(95F@CE4$*ZAAGK@C->,:G92:[\*_$WBBZU*_&H2M>!5%TXBCA21H
MQ#Y6=F-J]2,Y.<YKV+3_ /D&VO\ UQ3^0H JZ-K=MKB7KVJ2J+2\ELY/, &7
MC;:Q&">,]/Y5I5XY::$;KP]XYU<:IJ%O=V6JZE+9FVNWB2%D8MDJI 8D]=P/
M&!Q6WH_B&YTWQ):7VJW4@T[Q!HL=\@D<E(+B*,-*JCHH*'=@=U- 'I%%<K\/
MA?S^%UU74I9FN=5F>_\ +E<MY,<AS'&H/0!-O'J35.ZU&7PY\2S]MNY?[(UF
MQ9XQ+(2D%Q ,L%!X4-&<\=2IH [:BO(K";5=6B\-V]]?WT$7BG4+J_G5+AD>
M.V6,O% C Y12NPG;@]:C\47-YX:MO&.BZ?J-]]DATZUO;5I+IWDMF:4HZK(Q
M+8.T'!/'/K0![#17)Z]=7$7Q"\(6\<\J0SK>^;$KD+)MC4C<.AP>F>E6/'VK
MW6A> ]8U*Q;9=0P'RGQG8S$*&_#.?PH WYK:"Y\OSX(Y?*<21[T#;''1AGH>
M3S4M>>7FF-X-UWPM+8:EJ4_V^]^PWR75Y),MQNB=O,(<D*P9,Y7'7'2CX:64
M]]!=:W?ZG?W5Q'?7=M!')<N8XXQ*W&W."<YY/08 Z4 >AT444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7)WW@9'UBZU31]:U
M'1;F\(-TMH4:.9@,;BCJP#8[C%=95"36])AU%=.EU2R2^;&VV:X02G/3"YS^
ME &(GP_T=?#UUI+/=R/=S"YFOI)LW+SJ05EWXX8$#'&!CIUI]GX-2.\N;[4M
M6O=4OIK1K-)[@1KY,3=0BHH )."202<"K9\6Z/\ \)/+X>%W%_:$< F*F1<$
MDD;.N=_&<8Z$&JGA/QE9:_H>DSW5W8V^IW]N)OL0G7?SGHI.XCB@"4>#K$:-
MX?TS[1<>5H<T$UNV5W.8D*J&XZ$'G&*Q?'_AH-X=\6ZI:+<SWVH:8EMY"+NR
M(RQ&T 9).\UV$VKZ9;7\5A/J-I%>3?ZNW>=5D?Z*3DTVZUG2K%V2[U*SMW5E
M5EEG5"&;.T')ZG!QZXH PM.\%1Q:E87U[JM_?I81LME:W.S9;[EVDY50SG;\
MH+$D GJ>:I1?#:"*UL;?^W]5:+3)DDTU28L6NT\ #9\_'RY;) Z8YSUSZE8Q
MVD5V][;+;2[1',95"/NZ8;.#GM4>I7Z6EM,L=Q9QWGD22PI<R[%.T9RW?:#C
M)'04 9?_  AUC_PCNM:+]HN/(U:6YEF?*[D,Q);;QCC/&0:<GA&R3Q3::_YT
MYN+;3O[.6,E=C1[MV3QG/XX]JLPZY:VNB65[K.HZ9;-.BYE6Y @9R/X';&X>
ME6[S5]-T^U2ZO=1M+:WDQLFFF5$;/3!)P: ,'2_!*:5<VJQ:WJ;Z99.7M=.9
MT$41(( +!0[*,G"LQ XZXHLO!(MKZRDN-<U.]LK"4S6=E<,A6)\$ EPH=]H8
MXW,?QKJ(Y$EC62-U=& 964Y!!Z$&JE[K&F:;+%%?ZC:6LDQQ$L\ZH7/^R">?
MPH CUW1K;Q!HEUI5VTB0W"X+Q'#(000P/J" ?PKGSX 2:]-_>:]J=S?26DUE
M<3/Y0\V&0#Y-H3"A2-PV@'.<YS72ZAJ^F:2B/J6HVEDDAPC7,ZQACZ#<1FGR
M:C8PQQ22WEND<H+1LTJ@. -Q(.>> 3].: ,J7PI9S:7H-@T\XCT6:":!@1ES
M$A50W'0@\XQ6-??#:UO8=5LEUK4[?2=3DDFFT^)HP@E?DLK%2P&[YMN<9]N*
MZ,^)=!%DMZ=;TT6COY:S_:X_+9O[H;.,^U)?ZA<PZMI,%M+IHMKIG\T7$Y65
MP%!'DJ!ASZ^@H T+:!;:UA@4DK$@0$]2 ,5R=W\/;6Z;Q!'_ &K?QV6N!FN;
M1/+V+(0H+J2I8'"CC..>G2N@GU_1K:5([C5K"*1Y#$JR7**6<'!4 GD@]JFO
M=5T[36B6^O[6U:9ML0GF5"Y]%R>3]* *M[H-O?:OH^I222K+I;2-$JD;7WQE
M#NX]#VQ65IO@A-+NK98-:U/^R[24S6VF[T$4;'/&X*'9!DX4L1TZXKIH+B"Y
M0O;S1RH&*%HV# ,#@CCN#Q6>U]=CQ0EB)-.^QFT\TH9C]JW[L9"8QY>/XL]>
M* -0@$$$9!ZBN)3X=+9B6VT?Q)K6E:9,S,UC;2)L3)R1&S*6C!.> >_%=*FO
MZ-)=0VL>K6#7$Z[H8EN4+R#U49R1]*JV'BS1]2\07^B6UW$U[9;0Z^8OSD@D
MA<')*X^;CB@"E<>!=,&FZ5:Z9+/I<NDLS65S;$%XRPP^=X(8-GYLCD\U$? -
MC-H^HV=W?WMS<ZE/#<7=](4$LC1,K(  H55&P  #H36]:ZWI-]>26=IJEE<7
M46?,ABN$=TQURH.15JYNK>RMVN+J>*"%<;I)7"J,G R3QU(H HW.AV]UXBT_
M6GDE%Q90S0QH"-K"3;DGC.1L&.:QX/ 6G6_A/5_#JW-T;74Y9I99"5WJ9#D[
M>,<=L@UTUQ=6]I&)+F>*%"P0-(X4%B< 9/<FJLFMZ3#J*Z=+JEDE\^-MLUP@
ME.>F%SF@#$NO!$+C2)=/U6^TZ]TNU%E'=0"-FDAPH*NK*5/W0>G!J*#X=Z;;
M:/=V$=]?^9/J/]IK>-(IFBN<*-X.W!SMY!!!W,.E=4ES!)<2P)-&TT04R1JP
M+(#G&1U&<''TJNVKZ8D$<S:C:+%('*2&=0K!<EB#GG&#GTQ0!AR^"8[S1[RQ
MU+6-1OI;R>&:6XE9 08G5E5$50BC*\X&3D\UJW.AV]SXCL=;>243V<$L"("-
MC+(5))XSGY!WK0M[B&[MX[BVFCF@E4/')&P974]""."*I-K^C+<0V[:M8":9
MBL49N4W2$':0HSDD$$<=Q0!RR?#"R'A4>&Y-7U&738KA)[9&\O= %8MM!"9(
M)/.<GTQ6CJ/@BWU'5=0NCJ=_!:ZFB+?V4+(([C:NP9)4LORX!"D9 YK<U#6=
M+TGR_P"TM2L[/S#A/M,ZQ[C[;B,TM[JVFZ;;)<7VH6MK Y 26>945B>F"3@T
M 8&G^!+2QU+0K]]0O+FXT:T>T@,NP!XV&!NVJ.0, $8Z<Y-=4R[E*GH1BJ5W
MK6E:?!#/>ZG9VT,W^JDFG5%D_P!TD\_A3KW5]-TR&.:_U&TM(I3B-YYEC5SZ
M D\T <[IGP^TW2_#FBZ)#=7;6^DWPOH7<KN=PS-AL#&,N>@':MA_#]L_B*?6
MC++Y\UB+%DR-H0.S9'&<Y8]ZM7NKZ;IL$<]_J%I:Q2'"23S*BL?8D\TV\UG2
M].CADO=2L[9)_P#5-/.J"3_=R>>O:@#"M_ &F6W@JR\,)<7?DV+B6VN@ZB:*
M0.75P<8R"3VQBI+3P9&DNH76HZI>ZEJ%[:&R:ZG$:F.$Y^5%10HY.3P<G%:4
M]_=)XBLK..73OLDT+NZR3D7#$=#&F,,OJ<U,VMZ2FI#36U2R%^>EJ;A/-/\
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MI_=!4@[>!QTIE]X)\-ZE%:QW.CVS):Q>3"$!3;'_ '/E(ROL>* .#LKNSO\
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MPM[ZTE$MM<1K+%(O1E89!_(US]]X^T/3]1FM9FNS';RK!<WD=L[6]O(<85Y
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M*[G:%D9'*CN0&!Q[&A_B9HEZ;>V\.LVM:C<2*JVL"LIC4D;GD8K^["C)Y^E
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M%NO#<]T!J]W#&E[%9F39&Q(8*""/,R,!2,]>*W-&0?\ "UO%+E>?L-B <?\
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MCF>Y\I!$[$$M\IQC"XQDDMVP370>)-=@\-Z#<:I/$\PCVJD,?WI79@J*/JQ
MH U  !@ "EKD(?%.M0:O%I&K:%;6M]>VTLVG^3?&2*5XP"8G;RP4."#D!AC/
MI7+?"6._O]5U[6M0T^)KA]0N87OFO7D=,,O[E4*@;!V;(Z=* /6**XC4]?\
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M5H]*N;%)P2LC8PR-C# @J1D#.>V* .ZI" 1@@$5P\?C'Q&^N77A\^&;8:O%
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M6%A_:0:VN?/62'+ \E5(8%<8QSFK.C>(]=O-0LX=4\-/96U]"TL$\%P9Q%@
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M@#K:0@'J :Y"/QUO\ :9XH_L['VZ2!/LWG?<\V41YW;><9STYJ#P[K_B"_\
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MQ!]JDR>7EBQZ +Z^E:?ACQ!_PD-C<R26C6=Y9W+VEW;EP_ERIC(##&X$$$'
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MJWZ "BBB@!  ,X &>M+110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH8#..<=*]>HH \YTW28+>TU:ZTOX>BW1H$A\B]E19;Q2V9$V[F4 +TW$9/'
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M]P*L&=?E8%?FYP0:5_#-_'XP^'MU;:-'9V6FP78NXH)0\=JTD6 H)P6^8D9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%4G&",GH,C-;-G>6^H64%Y:3)-;3H)(I$.0RD9!% $]%86I^,O#^CZC]@O\
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M">XM]-O#+/;@&6*2%XG4'H=K@$@XZCB@#8HHHH **** "BBB@ HHHH ****
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ML[>/R 1%LB4>6#U"X'&?:II(8I2ADC1RC;D+*#M;U'H: /.O$IN;7XHQ3_\
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M6+'S%/0?2LZ2YN_$_CKPY-%I&HV<.D?:)[N2[MS$JN\9C6-&/#G+$Y7(P.M
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M 3P2>F<XSWKL-*>XU_XD_P!N1Z=?VFGV>EM9A[VW:!I97E5B%5@"0 G7IDT
M=Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>QNX7N#&/G5!N1MIS@J>,#->C5E:IXAT_1]1TNPNW=9]3F,-L%0D%@,G)[4
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M+21I9@HN%CN)(X[@+]T2HK!7Q_M \<=*S_!7B#4-:UKQ9;7LJO%IVIM;6P5
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M$&H:E\0?&.D7,JM9Z8UH+5 @!7S(RS9/4\CO0!V-%%% !1110 4444 %%%%
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M5M'B2#1+"*)0D:6T:JH'  48%2Q6%G!;-;16D$<#9S$D8"G/MTJ<    8 Z
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MES);0O/&,)*T8++]#U%2"*-6=EC0-)RY Y;C'/KQ0!S/PU.?AIX<S_SX1?\
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M$F5'SC&.?7B@#Q[Q!_R3'X6_]A+2?_11K9LM7TO1=:\?6NLW,$5U/<B9(I6
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3;^28V6YT$B;F52N<A@O;<:W_$5C8_VQH_AFSTV&9(+2:Z6"[O7AM50,JY8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !117!^,M+O-1\6:4W]B7FJ:?%93AHX+H0*)6>/:6;<O\*MZ]>E
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MDMG4'?(R*/-).<8#DJ,#^$T ;=%>>>-]&TY!?32SWU[X@U%3'I%O%<,KP.%
M4QA2 JAOG9S^)Z"K7B'2=+@M(-1\5WEU?2K:QVL-G#(RB2XP=QB1""TC'OV
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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; HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>exhibit1013-zerondaxexec011.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 >;ZW%+'JDSPNT4R$%64X/2I](\:W-NZP
MZD#+'G!D_B7Z^M6O%$!BU<R8XD0'/TX_I7+WUOQYJ#_>_P :^<K3J4*S<'U/
MIJ-.EB*,5470]:M[B*Z@2:%P\;C*L.]2UP/@75'2Y?3G8F-P73/8]Z[.[U"V
MLES-( 3T4<DU[F$K?6*:DCP,70^K5'"1;I*QK+75O]2%K%"0NTL68\XK:KIE
M!Q=I'+&<9J\3SSQSIWD:A'>H,+.,-_O#_P"M_*K?@+4!_I%@[<_ZR,?S_I70
M^)-/_M'19XP,R*-Z?45YMHM\=-U>WN<X56PWT/!KP*Z^K8Q5%LSZ'#OZU@G3
M>\?Z1Z_7G7CB_P#M&JI:HV4@7G_>/7],5WUQ=1V]G)<LV(T0N3[8KR%VFU+4
M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBRQJ<A74<, 23S5C6] L]>A@2Z:XBDMY/-@N+:9HI8FP02K+SR"01T.: /-
M=.OQX?\ #<-C>:;IL^M31:EIEQ)D1ND!E$(*D@QL2K  X.?PKI- LK;0/B;J
MFBZ3$MOI<NEPWC6T?$<4WF.F57HNY0,@=<5L'P/HK:,=-=+EP;G[9]I:Y<W'
MG]I?,SNW8 &?3CI5S1/#=AH+W,UNUQ-=714W%U=3-++)M&%!8]@.@'% ')>.
M=+M]:^(O@O3KP,]G-%J'GQ!BHE4)$0IQVR!D=^G>L/4M(FU?Q3XCL(_#,>IP
M:=';V=BS7PA^PIY"L#&".#N8G<.?E [5ZA=:+97NM:=JTR,;O3UE6W8,0 )
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MF5]DF9>G7";=WMUKHO%ES'JWC30$T&XBN+R/3]0=VMG#;8VA"IDCL9-N/<4
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ML2B$H2=HD/\  6QM#>V<UJ0:C:7-]=64,Z/<VFSSXQUCW#*Y^HYKR!+NPC^
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M_P!49SC[Q#'!/TP*(?MJ>*]<W>(-.TJ.;3+)\7]H)?-@$1#%29%^4-OR.>M
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MJ"]UC3KV7X;06MY#/*;J.3;&X;"BV<<XZ<GOZ'TKF;@$^"OBY@9_XFLW\UH
M]./B6WOM0\/26&LV<=KJ!FQ!)"S/=;!R(VXV[3G.1S4UUX[\+V5S]GN-:MHY
M1,8&4D_(X;:0QQA>>,G XKDO$MS!=_$3X936TT<T3->X>-@RG]RG<5F7$$0^
M&'Q,?RUW/JNH%CCDD,,?E0!Z18>*]"U35I=+LM3@GO8@6:)2<D X)!Z, >#C
M-1VWC+P[>:H^FV^K6\EVF\>6I/S%/O!3C#$8.0"<8KG-52.S\8^ /)APL5K>
MJJ(/X1 N%'Y"N5M=5:Z3P'=R:II44%QJ*7$6EV-LJ+9JT<@P7W$]6VG(&23Z
M4 =]H'Q#T'7;75;E;N*"'3II%D>1B!Y:G DR0, ^G6MG1O$.D^((Y7TN]CN1
M"P610"K(2,C*D C(Z<<UY&\P;P1KD,=Y!"UOXO>6Z\Q1((HA=+\[ID$J#M)Z
M<#K7<^&K5V\:WU]<>)K'5;T6$<,L-G:>4JIO9D9F#L"?OX'7!H [:BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SCX?T5C=
M%M(L";LYN2;9/WQSGY^/FYYYK1KA6^)UJ+.ZU!-#U633+*X>WO;Q5CVP,CE2
M=N_<PZ,2H. ?7( !U<VAZ1<7GVR;2K&2ZV>7Y[VZ%]N,;=Q&<8XQ4T^GV5U:
MI:W%G;RVZ8VPR1*R+CI@$8&.U8&M>-%TFXN$@T74=0@L[=;F[N+8($BC()!&
MY@7. 3A<\5'J?CRULM7MM*LM-OM3O+JR6]MTM57#QEB,Y9AC &<GCH.IQ0!T
M5_IMCJD @U"RMKN$,&$=Q$LB@CH<$$9IO]D:9YYG_LZT\XLC&3R%W93[ASCJ
MO;T[5SU]X]MK*[O"-+OYM,L)Q;WNI1A/*@?C/!8,P7<-Q ./P-%]XZ6#5=5T
MVQT+4M2N=+V&Z%N(PJHT8<,"S#/!P%')(/% '4?9H/M7VGR8_M&SR_-VC?MS
MG;GKC/.*KV6CZ7IT\T]CIMG:RS',LD$"HS_[Q Y_&N.O?B!<R:]X4BTC2KF\
MT_6;>2YWJ8E9U" X&YQ@KD%L_09YKOJ *5OH^EVE]+?6VFV<-W-_K9XX%61_
M]Y@,G\:NU'/,EM;RSR$B.-"[$ DX R>!UKF](\9KJ6I6UE=:-J.FF]@:XLGN
MA'B=%P3PK$JV&!VM@XH W_[/LC:R6IL[?[-*6,D/E+L<L<DD8P<GDU%?Z-I>
MJB(:CIMG>"+F/[1 LFSZ;@<5REE\3;2^LM,U)=$U2/2+^6.!;^18PB2.VT K
MOW8W?*6 QGUJ37?&PC37+6PTO4;B+38GCN]0M]@2WD*;N 6#,5!!.T'% '57
MFEZ?J-JMM?6-M=6ZD%8IX5= 1T(!&*DBLK2"XEN(;6&.>4*))$C 9PHPH)')
MP.!Z5D^"KB:[\"^'[FYEDFGETZW>221BS.QC4DDGDDGO5;QUK5WI&A10Z:P7
M4]2NHM/LW89$<DAQO(_V5#-^% &S9Z/I>G3S3V.FV=K--S+)! J-)_O$#)_&
MBVT?2[*\FO+33;."ZF_ULT4"J\G?YF R?QKFI+BRTCQGX9T*2]UJ:[>TF\IF
MNBT4H5?F:8$Y=NX/8^E4;.0^(](\50:#J6LP:C9:K,L<MS<E@MQ'@A$ ./))
MXV'C!/% 'H%46T72GU(:DVF637XZ71@4RC_@>,_K57PIKJ>)O"NG:RJ>6;J$
M,Z?W''#+^# C\*LZSJL6BZ5-?RP3SB/:!#;IODD9B%55'J21[>M %DVEL;P7
MAMXC=!/+$VP;PF<[=W7&><5-7&7/C6Z;1];$>A7]OK&FP"5K.1H2P5U8K(&#
M[64;6SSGY2,5YJ_B;Q)IGP7FU:-/$!OKY(2^J7-[')&FZ0 F-?,+("&*C"CL
M>,9H ]NDT329KF>YETNR>>X3RYI6MT+2+Q\K'&2.!P?05:>V@DFAF>"-I8<F
M)V0$QY&#M/;(XXKC+'Q"^AVMCHD.CZ]?:O-&\_V2ZNHI9TB#8,DDIDVA23@#
M=[8J>?XCZ5;:!#JTMK?*&U#^S9K;RP9H)^<JR@\].Q.<C% '21Z/I<.HOJ,6
MFV:7TG#W*P*)6^K8R:NUR<OC66-M/M%\.ZE)J]Y')-_9P:(20Q(VTN[%P@!R
M,<]\5#\/-6GUF+Q'<3273*FM31QQW).Z%0D?[O!)VX)/ XSF@#I!HNE+J9U,
M:99B_/6Z$"^;Z??QG]:;)H.CS7DMY+I5B]U,ACDF:W0NZD8*EL9(QQBJ?C'6
M;CP]X1U35;2U>XFMK=Y%52N%(4_,<D?*.IQSCH#7'WGBS5/[3\#WDMCJ4;WD
M5UYFGQ.F;IO*0J<*^S&26&XC:,DXH [V[T32=05UO=+LKE7"AA-;H^X+G;G(
M[9./3)K+UCPPNI:WX>N$CM18:89Q+;.G#H\)C"A<8QST/:JT/CZR_LK4KF]T
M^^M+O3KA+6:P=5>9I7V^6J;6*MNW+@Y_3FM#1/$8U:]NM/NM.NM-U&V1)'MK
MDHQ,;YVNK(Q5AE2.O!% &E9Z98:?:&TLK&VMK8YS##$J)SU^4#%,T_1]+TGS
M/[-TVSL_,.7^S0+'N/OM S5N218HVD<X1068^@%>>Z!;^(/'.E+XAN/$E_I%
MM=EGL;*P2(".+)"F1F5B[$#)Z#F@#M[?1]+M+Z6^M]-LX;R;_67$<"K(_P!6
M R?QJ3^SK'[$;+[';_9223!Y2["2=Q^7&.O/UKG'UG4O!O@V[U+Q7/'?FREV
MBXM$"M+$SJJLRG"JWS<@'''%$GC@1V=J[:%J8O+^X:&PL2J":X4*&,G+81<'
MG<01W% '02:1IDU_]OETZT>\V&/[0T"F3:1C;NQG&.U5[?0;"TU:*_MH8X##
M:&TCBBC5$5"X<X 'J!QT'/J:Q3X_LH-*U*ZO-/O;6ZTR>&&[LI AD0RLJHP(
M8JRG=G(/8UL7VOVUAKMEI,D4K37=O/<(R@;0L6W<#SG)WC% &M5*'1]+M]0D
MU"'3;..]D^_<I HD;ZL!DUR=C\3;2]M--U'^Q=4AT>_D2&/4)5C$:R.< ,H?
M<!N^7=C&>^.:[F@"BVBZ4^I#4FTRR:_'2Z,"F4?\#QG]:=<Z1IE[>0WEUIUI
M/=0?ZJ:6!6>/O\K$9'X5RVN7^KZUXS3PMI&H-ID%O:"\O[V*-7EPS%4C3<"%
M)P23@\8JYI6E>(=#UD";76U70WA8R&_"BX@D&,%610&4\Y!QC'6@#H$TZQB^
MS^796Z?9L^1MB4>5G@[>/ESDYQ27&F:?=W<%W<V-M-<VYS#-)$K/&?\ 98C(
M_"N6M_B);3K:7KZ/J4.BWDZP6^J2"/RG9FVJQ7=O5&/ 8KW'3-&H?$.&SFUF
M.WT/4[T:-(1?/"(PL:! ^\;G&[@G@<_*<XXR =G5'^Q=*.I_VE_9EE]O_P"?
MKR%\W_OO&?UK LO'MM>:KIEO_9=_#9:KN%AJ$JH(IR%+=-VY00"06 S5)_B=
M:BSNM030]5DTRRN)+>]O%6/; 4<J3MW[F'1B5!P#ZY  .U2VMXKB6XC@B2>8
M*)9%0!GV]-QZG&3C-4Y- T:6ZFNI-)L'N)UVRRM;(7D'HQQDCZUD:UXS72KB
MX2#1=1U""TMUN;NXM@@2*,@D$;F!<X!.%SQ27WC>WAU>'2M/TR]U.\N+%+^!
M+;8%>)F(R6=@%QCOZC&30!N7NCZ7J,T,U]IMG=2PG,3SP*[1_P"Z2./PJQ]F
MMQ=FZ\B+[24\LS;!O*9SMSUQGG%<-K/C/2K_ ,*:=JLO]LV:2:JEFT-K((IH
MYP[*4DP<%<@Y )R,5JZOXUBTR_O;>#2-0U"/3HUDU">V";;8$;@,,P+MM^8A
M0< CUH V['2H+"^U&\CR9;^599.  -J*@ Q_NYR><D^U7B 001D'M7*WWCB&
M"ZECT_2-0U6&W@CN+F>S"%8D<%EP&8,Y*C.%!XQ]*ZA'$D:NN=K $9&* *=A
MHNE:6\CZ?IEG9O+_ *QK>!8R_P!< 9JS;VUO:1>7;010QEBVV- HR3DG [DU
MR7B3Q9J6D>-= T:TTBXNH+Y9GD:-HP7V+T7<XQMR&.<9!&,G(K#TOQQ=:1%X
MHFN=.U;5+6PUBZ,]Q&RLMK"",*-[ G R=J@X'IF@#TT@,"" 0>"#50Z1IK:;
M_9ITZT-AC'V4PKY77/W,8Z\]*Q=1\91VUXMIIFE7VKS+;+>3"SV 10MG:279
M<LV#A1DG!K;TS4;75]+M=1LI/,MKJ)98FQC*D9''8T 9VKZ'))X<;3-"%C8;
M2I2&2T5[=E!R8V3&-K<@D<C.169X<\*7=GK-QJNJKID;M9K8P66G1%8(HMQ=
ML[NI9CZ <=ZTO%'BJS\*6UE/>6]S.+RZ6TB2W0,QD968#&1G.W QW(JE-XRG
MC:UM8O#FISZI+ US+8(T0>WB#%0SL7"Y)!P 23@^E &U;Z#H]HD*6VDV,*02
M&6)8[=%$;GJRX'!]Q5JUL[6Q@$%I;0V\()(CA0(H)Y/ KG9/&L,]CID^CZ5?
MZI)J,331PPJB&-5P&WL[!5()VXSG.:C_ .$[MKBQTN;3-+O[^ZU)97BM(_+1
MT$3!9=Y=@HVL0O4Y/2@#I;RQM-1M7M;ZU@NK=_O13QAT;Z@\&H5T?2TSMTVS
M7,'V?B!1^Z_YY]/N_P"STK$N/&T*6VF"VTG4;C4=2$AAT[8L<RB/AR^]@J@'
MC.><C&<U!)\1--M]%N-0N[*^MY+2]CL;NT=%,L,CE0"0I(9<,""I.1T]* .A
ML]%TK3A&+'3+.U$>[9Y$"IMW8W8P.,X&?7 I(=#TFWD>2'2[*-WE$[,EN@+2
M#.') Y89//7DUDZ7XO6\UFXTJ_TF^TN[CM?MB+<^6WFPAMI8&-FY!QE3SS4>
MD>-4U+4K*TN-&U'3TU&-Y+":Z"8G"C<1A6+(=ISA@.,T =)]F@%R;GR8_M!3
MRS+M&XKG.W/7&23BJUEHNE:=<2W%CIEE:SR_ZR2"!49_J0,FO.O!WQ EM/!6
MEW6JV&JW-GYI@N=8D961':4J,[FWE02JEL8'3M6E9ZU-;?%KQ5'>W\RZ79:7
M!<>4\C&.+C+,%Z XSG% '=Q6=K!%)%%;0QQR,S.B( &+?>)'<GOZU7ET;2Y]
M.73I=-LY+%3E;9X%,8[\+C%8VC^,TU/4+2TN=(U#3OM\336,ET$Q<*H!/"L2
MK8.=K '&?2NGH Y67PWJ&I>*K&]U*2R32=)=I-/M+9&W-(5VJ\A/ V@G 7N<
MYXKJJX^^\?PVLNI/;:+J5]I^ER-'?7UN(]D3*,N K,&?:#SM!Q4M[XYMXM9C
MTC3=,OM5O)K&._A6UV!'A9F&[<[ #&WO_>&,T =#?Z98:I"L.H65M=Q*VX)<
M1+(H/K@@\U%<Z)I-[=Q7=WI=E/<PX\N:6W1G3'3#$9%<XWQ(TP:7IEZECJ$C
MW]W)9+:K&OG1W"!LQL"V <KCKCD$D#FIH/'M@EIK$FK6=WI5QI$:RW5O<;6;
M8V=C(48ALD$<'KQ0!UE5;W3+#4A$+^QMKH1-OC\^)7V-ZC(X/O6'IOC W.L6
MNF:EHFH:3/>QO)9_:O+(F"C++\C-M8#G:<<9K!N/B<]YX5U36-&T#4I(;2UF
M?[3((UC25"1M.7RV/O'&>..O% '>?8+/[/-;_9(/(G+-+'Y8VR%OO%AT.>^>
MM0WNBZ5J0A%]IEG="#_5>? K^7_NY''X5B:)XN:\.@V>H:==6M]JEK).N_RR
MN(U0LWRL<!MX('7UQ2:CX]TS3(=5EGM[HIIE]#93%$#$M($(91G) WC/?@X!
MH ZH# P.E,FABN(7AGB26)QAD=0RL/0@]:YW3?%HO]9GT>]TB_TN\%J;N);@
MQGS80VTL"C, 02,@\C(KD(/'4ECX#\*WV@V>KZA!J>HBV\R_FCDGQYS HS,X
MRS88*>@ Y(XH ]&T_1M*T@.--TVSL@_W_LT"Q[OKM S1)HNE3:BNHRZ99/?)
MC;<M IE7'3#8S^M4M$\20ZU?:E8&TN+.]TYHUG@N-NX!T#*P*D@@\CKU!J7P
M[K]OXETK^TK.*9+5II(XFE 'FA&*[Q@GY20<4 :*VT"7$EPL,:SR*%>4* S
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M5E,2CM@^4?\ OH4VQ\.ZAK6LZSJ_B"TBLUOM/73(K-)A*5ARQ=G8 #)+]!T
MK!TOP/XBA\$7RWIMW\1_:;6>V82?)_HPC6($]L[&)_WS0!VGAO7+C7;G6V:*
M)+.SOWL[9ESND\L .QYQ]\L!CTK&F\1^)=4O-;;P];Z9]BTB9K8B\$ADNI54
M,ZJ5(" ;@ 2&YK:\':--H'A/3]/N2K7:(9+EE.0TSDO(<]_F8U@'2_$_A^\\
M00:+IUK?6VK7+W<$\MUY7V:5T"N'7!+*"NX;>><4 0/X[U?5[[0+7P[9V6=9
MTQKU7O2Q6W(*YW;3R "1@=3CD#-=7XBUT>&?"M[K-U&)FM(-YCC. [\ *,]
M6('XUSFB>"KK0O$'AMXG26RTO1I+&67."TA9#D+Z'!-=#XNT(^)O">HZ.LHA
MDN8L1R$9"N"&4GVW 4 88U[Q1I6K:5::[%I)35B\,+VBR#[/.$+JK[B=ZG:1
MD;>1TKAI=2\07WPVU&\U.6"[V^($$*1EP^Y;U<IEB0$X 4=A7<+I_B3Q%KNA
MW&M:;;:=:Z3*UR_EW0F-Q-L*+M  VJ-S'GGH,=ZQ8?"7B)?#FH: ]C;B,:TM
M_;W0N01+&;H2D%<94A0?QH V?^$LUG0]<NK+Q)%I[0+I<VIQRV <%5B(WHV\
MG<<,"&&.G2H-#\;ZC<:MH\&IRZ+)#K"MY45A,6EM7"&0))DD-E01D!<$=.:T
M/$7A6XUWQ,)F*K82Z+=Z?*^?F5I2F,#OP#5/POH>IV5YIT5WX6T&Q6RB*3W\
M(5Y+A@NT-$ H*9/)W=N/>@#(M/'_ (IF\)'Q7+8:7'I,$WES1CS#*ZB<1O(O
M.  N>#DY4GIQ717?C*>#XC6OA]+>)M.=$CFN23N2X=))$0=L%8C_ -]"F^&?
M"4]M\-)/#.K*@DG2ZCDV-N 6620@Y^C"L&Q\&>)8_ \\ES]F;Q3]OM[Z(^;E
M"T(C15+>A1&_[[- !K7C.6YMK*ZFTC3KJU;Q8FF6AN(R^%4E3.N3PX8, 1T%
M;/\ PE.N7OBC4;#35T@II]TD,EA<2,MW,A56:53G:%PQQD'.T\BL[4? FHGP
M;X,TBT\I[C2M3M;V\9GP#MW-*P]268G\:F\4^'];U^^DMVT+3&D6X1['7$F\
MN6TC#*>5P7+##=#M.1TH AU3XB7MK+K%];/HPTW2+EH);6>8B[N!'CS63YL+
M@Y !!SM[9KN-8=9/#M^Z'*M:2$'U&PUP[^$]1L-3U6&U\,Z'J27]\]W#J-Z%
M)@$A!=9$*[FP=Q&T\Y'2N]U&V:XTB[M854-) \:#H,E2!0!Y'H6KII/PI^'6
M_3;*]^U:M!;#[5'O\DL\G[Q/1QC@^]=7?^)_$\^M^)K#1[;2UCT01OYMV)#Y
MH:$2; %(P<Y^;H..#SC'3P'K:^!/ VD%(/M>C:M!=W8\W@1HSD[3W/S#BNHM
M- OH=;\973K'Y6K"'[+AN3M@"'/I\U &19^-=?EC\,ZO<V.GQZ/KL\=NL"ES
M<0F1"4<MG:02O3' (YK-O_$5Z=.^)1TJST^PN],R#=11%9)AY3$NQ!Y<#[I[
M5LKX4U0>$?!&F[8OM&CW=I+=C?P%CC96P>_)%5D\%:J\?Q$B?R4&O@BR8OD<
MQ,OS>G)% '6>$WU&3POITFJ2P2W+P(V^$-@J5&,[B26]3ZURDOC/Q)/HFI^*
M-/L]-;0[&6;;;R[_ +1<10L5=PX.U3\K$ J>G6NL\+#48_#EG!JMBEG=01+"
M8TG$H(50-V0!UQTKC'\.>*++PUJG@ZQLK233[R2X2#4GN<>3!,S,P:/&2R[V
M P<'CI0!I2>*]<U+QD=$T*WT\VWV&WOS=7>_B-RP(PIY8\8Z <YSP*WO%>O/
MX>T0W4$"W%W--%:VL+-M5Y9'"+D]ADY/L*SM'\-7.E^.+K4%"_V<=*MK*$[O
MF+1LV<CZ$5<\9:'=:]H(AL'C2_MKF&\M3+G89(G# -CL<$?C0!E7GB7Q%X8T
MO5[WQ'I]G<0VEJ)X+G3RR)*Y;:(2KDL&R5^;D8/KQ3H=>\2:5KFCV?B*'2V@
MU9FAC>Q$BFWF"%PK;B=X(4C(QR.E5]3TCQ/XRT?6+#58+;2+6>U6.UMUF$[>
M>&WB1G &%R%&!GN:D73_ !'XBU[0[G6M-MM.M=)D:Y?R[H3&XF*%%V@ ;5&Y
MCSST&* ,B/QWXH;PG'XK>RTI=+CN?*G@_>>=(@G\HNASA<>A!S@G(SBMFX\0
M^(-1UO6[;1;;3S8Z/MBF^T[_ #+F0H'94(.$P"!D@\U1/@[5C\()/#6R'^T6
ME9@OF?+@W1EZ_P"[5EM*\2Z-XAU\Z18VMU9ZU(LZ7$ESY9M)?+$;%EP2X^4,
M,?3WH YKPWJZ6&A?"VS;3;*Y:]21%GGCW26^$!S&?X2>AJ]I6L:^8?B%=:J]
MA>V=@]POV9T=E+);H0@!; C(SD=223WI]EX'UJ"#X=(Z0YT$R?;<2=,H -OK
MS5P>'->A?QSIRV4#VFMK/-:W?V@##O"$",F,CD=<XH --\5ZA<Z)X2T[0[#3
MK:_U6Q-T59&%M:1(JYPBD$\L !D?6FWOCW6-*TK68[NPM)M9TF]M;=T@+"*>
M.=EVLN3E3AB,$G!'>DLO"NNZ'I_A&_L[:"ZU#2+!K&[LS.$$J,JYV/C&59 >
M>"">E1W?@_7-5LM9U"YAMX-2U74;&;[*LVY88+=TP"^!EL!B<<<XH W-,US7
MH/&2:#KL6FLMS9/=V\MD'&PHZJR-N)S]\$,,=.E4?']]KUKK?A6WTBZMH4NM
M0V,)0_SL(W(#;2,ICMZ@>E;-UH]W+\0=-UE0GV.WT^>W<EOFWN\9''IA353Q
MMI&JWT^@:AI-M%=S:7J N'MY)A%YB%&4X8@@$;A0!SEG<>)8?%?CE]%CTT-#
M<02RO>!V61A:Q_(H4@CH>2>,C@\XO-X_NM2CT2+3)-*T^XOM,74II=3D/EQJ
MQ"A% *EB6W<Y& O0YK8TC1-0M]2\5W=S'&@U62.2!5DW8Q;HA!_X$#7,6G@G
M4M)M?#]W)H6GZU/:Z0FG7=G/(@V,IW*Z,RD'DL#TX(H [;PGKW_"2>'H=0:.
M..;?)#,D;[T$D;E&VMW4E<@^A%<'XH\0^(->\!^++^UMM/&AQI=6:1MO^T2*
MF4:7=G:!D$[<=!UKT/P]:3V6B6\-U:6%I<?,TD%@FV%"23@>I P">,G)P*X*
M[\,^++?PMX@\):?8V<EG>R7,EK?O=;=L<K%_+9,9W98KG..<]L$ TX-82#X@
M>'M*_LRSD>70S.+PQYG0#C8K=E/I3_"_B_6-9M8M7N/['?27A>6>.UD;[188
M!8+)D_,>"" %P?:G'POJO_"P=$UI!"+:ST9K.1F;)$I/'R]Q5&'PMJNK^(K.
M]U+0=/TJ:.*:/4+ZRN 3?J\;)M"@ XW$/\_(V@<]: -+0=>\6ZHFDZM+IFGM
MH^IX80P,PN+6)E+)([,=K\8R  1GC-<IX3U]_#NA^-;N"W%S=R^+;BVM86;:
M'ED9%4$]ADY/L*Z;P[9^,].M=&T&6VLH+'3=L4^HK/YANH44JJK'C*L?ER2>
M,'&:RK7P#K*:%XBAW6\5_-XD?6=.+/E&PZ,@?'(SM(/IF@#8?Q1KV@ZK_9^O
MVUC=-/87%W:/IRNF]X0"\15BW)##!!_"H-.\6Z_-X:O==D.AWUDFF2WD4EA(
MW[F54W"*0%B6SSR,8VG(&:F_LWQ+K?B.WUN[L;32I--LKB*QADG^T;[B4*-[
M[0/D 4# .3D]*S8_"&IZMJ=[<R:'8^'S<Z7<V5TUM.)!>22@!6*JH&%PQR?F
M^;% '07?BBZM].\)W*P0EM9NH(9@<X0/"SDKSURH'.:R;#QKK=Q+XAU&XM;"
M+0]!NKN&X;YS/,(E)78,X!^[DGKDX Q5>#1?%FH1>$K:^TRTLX=#NX7G9;L2
M&<)$R;U  P.>AY^;VYT]*\(71\/>+])U I&NLZA>RQ.AW8CF "D^_M0!7T+Q
MIJ,^M:39ZI-HLJ:M&YB33YBTEK(J>9LDR3N^4-\P Y'3FN]KAO#&BZG:W]B+
MOPKH6G+:0E9KV#:\D[[=H,6U04!Y)W<\XQWKJ](DU*;38WU:WAM[TL^^.!]R
M ;CMP?=<$^YH O4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!B:CX.\.:MJ0U#4-%L[F[XS+)$"6QTW?WL>^:V^E%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%#"F^2:1CA40=R30!IT5S%IXS2YFO+.31-5M]4MH%N/[/D2/S9HRVW<A#E"
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MANY((Y)P.^2.:L)XYTY-+U.[O[:\T^732BW-I<1@R@O_ *O:$)#;B<#!Z\4
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MGB9Y+"VNUN'1=RQN81P3TZD@>M=;_P (LO\ T&];_P# T_X4?\(LO_0;UO\
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M];_\#3_A0!S+:S%XD^)/A:\TVTO6L;:WO!)=2VLD2AW1/D^<#D;?IS]:]%K
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MH&2/I7H?_"++_P!!O6__  -/^%,E\.001&6;Q!K,<:]6>_( _$T <S<&:_\
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MUFVUG<"7XE$V\H^T/^Y^0_O/]$4?+Z\\<=ZZ+_A%E_Z#>M_^!I_PH_X19?\
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MK)$-P" $MEB%'(&!GVSZC0!P7AFX;QOK.OW]_)(VFZ?J#Z=9V8<K'^[ WR.
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MQ(JF)SCNH*Y(QGGI4^H>%;[5/"7B&UL?"&E:'-=01PVT4/E":4AMS%W3Y0O
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M^_*-DD'<&^7DXQQUJAIWA'7UN/AR]Q8I$/#Z7$-X?/5N#&J(RX/(;&<=1WH
M]1KS+3]0FLOBI\0K@,9!:Z?:RI&S';D0Y_#.*]-K@5\+:J/&GC?4C"GV75M/
MB@M&\P99UB*D$=N?6@!EEXT\0FW\-:K?Z;I\6E:W+# L<<KF>)I4)5SD;=I(
MZ=0".>M<[IL-_+\9O$VHZM;://\ V7!;2-)(KN;>+86S#D<-@9/3GI753>&M
M3?PCX*T]84^T:5=6$ETN\858DP^#WP?3K3[/PK>OXZ\8WMV@33M8M+>WAD5P
M6.V,J_'48SWH J1>-?$$6D:;XDO]-L(]!OY85\M)7-Q!'*P6.1B1M/WE) Z9
MZFKVG>)]=U?Q;JVF6EA8I8:3=B*XN)I'WNAC# (!QNR3G.!C'KQC+H/BC4/#
M&D^#K[2X8;2SDMTN=36Y5DEA@96&Q!\P9MBCD #GK72>&]%OM-USQ5=7,:K%
MJ%\LUN0P.Y1$JY/IR#0!R]O\0_$TGAO1/$;Z+I[6&I31VPMDG83[W)56!(VA
M2PZ<G!S[#?L/$FO1:YJNBZIIUG/?V]@M_:K82D+,I++Y9,F,-N7&>G/:LJU\
M(ZQ%\./"FC/ @O=.OK2:Y3S!A4CEW,0>AX]*L>*_"NLZOK>N7.GE8UN_#XL8
M9#)MS+YKL5/< J<9]Z )M*\5:Y<:T=%O%T5[ZXL9+JV-I.SI%(A4&.7O_&.1
MUP>*Y"'Q/J0^"UMK7B"RT_5TFND\J.X+.6S.PR^>ZG&W'8"NBT?0=3MO&&D:
MO!X5L](L(K6:SEMH)8O,3=L(D8KPP^3  R>_? PW\&^*+CX21^$GTN..[L;N
M,QR_:D*7""9G+#GY< C@\T =K?Z_K=YXGO-#\.V]@6T^".6[N+YGV[I,E(U"
M<YPI)/;(XK+3X@:C?6_A]+#2H/M^IW%S9S032G;;S0AMWS <J"I/3)'O5VZL
M=<T'QEJFLZ5I0U6UU6"$2Q+<I"\,L090?GX*E2.G((Z5G:-X,U73KWPK<W A
MDEM[R^O=1:-_E1[A'P%SR0"P'X9H W_"^O:EJ&I:SI&L6]K'?Z7)$&DM&8Q2
MI(FY2 W(/4$>U7?%&NKX;\/76J& W#Q[4BA#;?,D=@B+GMEF'/:JFC:1>6?C
M3Q-J4R*+6_\ LOV=@P);9&5;([<FI/&FAW'B'PM=6%G)''>;HY[=I/N^9&ZN
MH/L2N/QH RY_$^O^';+4KOQ-IEHUK:V1NDN=.D8H6!QY)#\[CD8/3Z4D'B3Q
M%INIZ-%XBL=.CM=7D\B-K21R]O,4+JC[AALA2,C'(Z57U/3O%'C72-5TO4M/
M@T6QGL6ACC>=9W>X)!5\IP$&.G4YZ"E:R\2>)M5T :QI$>FVVE7(O9Y?M22^
M?,J,BB,+R%RY)+8/;% #V\<W0^&-UXK^QP_:(9)4$&X[#LN#$.>O09K,-W%8
M?'76+R<D0V_AD2N1_=64$_H*HW?AKQ=_P@FI^#;?2(&C-Q+)#?M=IMEC:<R@
M!.H;G'. .N3T.]>>$;^_^(^L:E*BII=]H!TX2AP6$A?GY>O3O0!@:WK/B+6-
M%\*:EJ-A8PZ?J&M:?- L$C&6%6E5D\S(PV5ZD8P<<'MZU7EW]C>,;W0_#&B7
M&C06Z:-?63W%T+M&%Q' RC**.1P-QW8/& #GCU&@#B[?Q1K>H>-=7T>TLK%+
M#2)H?M5U/(P8QO&KX0 <ORW7   ]:HZ9X_O[I])U"XATQ=(U:Y6W@BBG)NH0
M^1$[CH=Q R!]W<.O-;&B:#=VOBKQ=>7<:BTU26 P,'!+*L(1LCMR#UKG?#'A
M&YT=]*TV7P9H>ZPD DUMEB9I43.UT &\2GY<D\ Y.30!L>&O%&N>(+F.[CM-
M,?2I)Y(9(X;@_:K3:6 :0'@Y*@%1R-PZX-1CQS='X8)XK^QP_:&D5/(W'9S<
M"+KUZ'/UJE#H.L7OBS3-2G\-V>EW]K<L]YJUI<*%NXMK#8$'S'<2I^?ICJ:R
MW\-^+O\ A W\'1Z1!L@N@ZWQNTVSQ"X\T;4ZAL8SNP.#UX% %I9;J#XR^*Y;
M(0FY30X6C$V=F0<\XYK?^&-[J^I> ],O-8FBGDFA#QRJS,[J>[D_Q9]*B@\-
M:B/B;KNLO&BV%[I<=K%)O!.\'G(ZU9^'5CJVD>$+/1]7TX6DU@@@5UG619@,
M_,,=!['F@"+XF:I!H_A6.YN-,M=10WL$?DW(RH); ;ZCM1=^(?$-UXLU70-%
MLM/W6,$$_P!IO'?;^\#?*0O))*\>@!]J/B7X?U#Q+X6CL=,B62X6]@F*LX4;
M5;)Y-7M+TB\M?'?B'59446E[;VD<+!@23&)-W';[PH L^$M>;Q-X6L=7>W%O
M).K"2(-N"NK%& /<94U7\2Z]>Z??Z7I&DV]O-J>IM)Y1N6(BB2-=SNVWD]5
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M+!]I*>4VWR]VW._&W.>V<^U7J\];Q#J.E_$V]TJ:]FN=-L?#7VTQNJ!I)5D
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MKG3S!;ETC\P-;L8URO!&,MP0:KS:GXK3X>V'B]?$,WGZA-;/-:&&/R88I9E
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M .@NKJ"QM)KNZE2&W@0R22.<!% R2?PJCH7B'3/$EB;W2IY)K8-M$C021AN
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MS:@HT%3%-<!1(%\\_*Q4 '!SS@<'VS0!Z%1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<*?AVQT3QAIW]J#_BHKJ2X$GD?\
M>^_'&-WS8QUXKNJ* .-/@[4[2]TZ[TG68;::#3(],N&FM/,WHAR'0;AM;)/7
M<.1P<5G6OPYU&P31?L?B!$DT6:[>S=[0ON28@[9?G^;'S D8R".A&3V7]NZ:
M?[4/VD8THXO#M.(_D$GIS\I!XJW:74-[907=N^Z">-98V((RK#(.#[&@#B;O
MX?76I^'O$EMJ.KQOJFO&/S[J*V*QQ+'@(JH6)P #U;)S6E-X-,OB?PQK/VX
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M\[9P06C(=<$@\ALCBNIHH X4> ;RUEO+;3=:%OI=_:P6UU&]OOGQ%$(ALDW
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M1W]]%<//HXTR>W2 HKG>&9P=QP#R-O.,]:SK?P%J?V#3]"O-=BN/#UA-')%
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MLKI[GQ,B:C(\;P-;VFVWA"'.W86+,&R=V6],8Q7444 <+=> K[5++59=1U>
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M[UI[R:[,KH%8F1MQ!QP3[\?05O=*Q?%?B2U\(^&[K6KN*6:*#:!'%C<[,P4
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M12SS7+.TZGIYF>N,<=,4 =#1110 4444 %%%% !1110 4444 %%%% !1110
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M^YBN;64926)LJ><']>*S]5\6^']$OH[+4]6MK6X<!@DC<@$X!;^Z">YP*SO
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MN.WKB!6'Y$D_4FI)]3FFEO88;S3-+%IHEJ)YY[7SI[P.C$(N67Y0<@#!)9J
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MPR6SM]E02!0\K;_FR., #D@^U>J@AE#*001D$=Z\'M_^37-4_P"NDO\ Z54
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M2-K C&,$DD].IKW*N0F\ 6]S,T4^M:M+I+W/VIM,>5&A+[M^-Q7?LW<[=V*
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MP(S^Z'V5A\W]WGCGO7H5% 'B,LEW=6VE7VH1^([K6;/6(;C54=;C[/:QK/\
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M0N9'C\L. @'&X<Y)XQC ZU3TOQYJES+H\]T-'%IK3>7;P03,T]JS(7C\WG#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_F[ @G=MP.3B@#L**X/7/&NE7OP_U35I9M:TN*SN!;70ME1+NWE#H-HR2O\
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M*"RJ/,R-JJ 3CD[NHH ]%HJAHK7KZ+9MJ,]K<79B!DFM<^5(?[R^Q'/XU?H
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MK"V$3;#AR+<@A3WY]*[C7=!@U^&SD6X:WN[.=;FTNHL%HV'7V*L"01W!K8H
M\02PO/\ A77PLB^R3^9!KMH\J>6<QJ'?)8=A]:[C7_\ 2OBSX/@B^:2TMKZY
MFQ_#&R+&I/U8_I7;UC:;H5O9:]J>K27+7.H7A569L#R85^Y&H[+U/N230!LT
M444 %<?\3H9;CP3+'#$\C_;+0[44DX%Q&3P/:NPJCJ6FMJ*QJM_>VFPDYM9
MI;/KD&@#@?B9I=[I4&H>(M'MI)UOK&33]4M85RTB,A6*8 =61FP?]DGTJ.PF
M'AK7/#FMZI%/'ITWAJ*P:=86<03*5?:X4$KN!ZGNN*[ ^&V#*I\1ZT&;. ;E
M,G_QRE_X1B3_ *&'6_\ P(3_ .(H \WU2"YE\-:QX@^QW265UXFMKZ-3 P?[
M/&8U,NS&X [2>F<8-;<Z-K'QDM+ZS64V=SX8=([@Q,J@M*<=0,'G.#S76_\
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MB2 3>$_LB7!4A#(6Q][U[UTNC> QHNFK90>(=9V+)))\DJ*,N[.>-I[L:O\
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M=<NVV7$485XHBI+0*58X4'Y,X ! ..<GF@#J?^$(\)_]"OHO_@!%_P#$T?\
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MA/\ Z%?1?_ "+_XFC_A"/"?_ $*^B_\ @!%_\36]10!@_P#"$>$_^A7T7_P
MB_\ B:/^$(\)_P#0KZ+_ . $7_Q-;U% &#_PA'A/_H5]%_\  "+_ .)H_P"$
M(\)_]"OHO_@!%_\ $UO44 8/_"$>$_\ H5]%_P# "+_XFC_A"/"?_0KZ+_X
M1?\ Q-;U% &#_P (1X3_ .A7T7_P B_^)H_X0CPG_P!"OHO_ ( 1?_$UO44
M8/\ PA'A/_H5]%_\ (O_ (FC_A"/"?\ T*^B_P#@!%_\36]10!@_\(1X3_Z%
M?1?_   B_P#B:/\ A"/"?_0KZ+_X 1?_ !-;U% &#_PA'A/_ *%?1?\ P B_
M^)J%_A]X.DNHKD^&-*$D08*%M4"D'KE0,-[9!QVKI** ,'_A"/"?_0KZ+_X
M1?\ Q-'_  A'A/\ Z%?1?_ "+_XFMZB@#!_X0CPG_P!"OHO_ ( 1?_$T?\(1
MX3_Z%?1?_ "+_P")K>HH P?^$(\)_P#0KZ+_ . $7_Q-'_"$>$_^A7T7_P
M(O\ XFMZB@#!_P"$(\)_]"OHO_@!%_\ $T?\(1X3_P"A7T7_ , (O_B:WJ*
M.>LO GA/3IVGM?#FF),9O/$AME9D?C!4D':!C@# ':NAHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#GKCP-X:NM5;4IM)B>Y>43/\S!'D'1
MVCSL9N.I&:Z&BB@ HHHH *R]%\.:3X>2==+LU@,[!YG+L[R$<#<S$DX[9/%:
ME% !1110 4444 %%%% !1110!3LM+LM.FO);2 1O>3FXN#N)WR;0N>3QPH''
MI5RBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1L[3MQG'&:YG
MPIX/AT#2YH[YX=0U"ZN9;J[NFA \R1VSP#G  P,9[5T]% ' ^(_ UHT_B'4?
M/>'3-2TOR;VTMH-SF2/)25 .K <;<<USVF:A-XC\<>#Y%\26>N/9">:7[!;F
M-8(S"R[YAN;$C,5&.,<\5Z_34CCC+%$52QRV!C)]Z .5T_P1%!X.U3P[>W/G
M0ZA+<NTB+M*"5RPQR>5SU]J?:^']>O(IK7Q%K5O=V+V;VAAM;4Q&8.,&20LS
M?-C/"X')KJ:* .7T+1/$>GSV<.H:];W&GV,1BCC@M/+DN.-JF5BQ&0/[H&3S
M[52A\!R1> ])\-_V@A>PNH;@S^4</LF\S&,\9Z=:[6B@#F-7\'0ZUK][?74_
M^BW>COI<D*K\P#.6+AOQ]*72='\2PRQIJVO6US:P6[0)';VAC:8D !Y26;D
M=%P,D_2NFHH XY?!$B^!=%\.?;EWZ;-;2&?R^)/*D#XQGC.,=:GL_#6J:;XL
MUO5+/4K86>K!9'BDMR9(I5C"*5;=C;P"01[5U5% %33(;VWTRWAU&Z6[O$0"
M:=(Q&)&[D*.GTJW110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !10"#T-% !1
M0"#T-% !1110 4444 %%%% !1110 444A(&,D#- "T4F1DC(R.M*"",@Y% !
M1110 444=* "BBB@ HH) &2<"B@ HHI 0>A!Q0 M%&1G&>:* "BBDR 0"1D]
M* %HHHH **0$'H0:6@ HHI-RX)R,#OF@!:*** "BBB@ HHHH ** 01D'(H)P
M,F@ HI-PXY'/3WHR"2 1D=: %HHI"0!DD >] "T4F1G&1GTI: "B@$'H<TF1
MG&1GTH 6BBB@ HHHH **"0!D]** "BBB@ HHHH **** "BC(SC/-% !11D9Q
MGK10 4444 %%("#T(-+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5S/C[6KK0O!]W<6! OYF2UM2>TLKA%/
MX;L_A735QOQ0MYG\%27D$;2/IMS!?E%'++%(K-^2[C^% $VHSV?PX^'DSVZF
M3[%!MB#<M<3L< GN69SD_4USW@I-5\(^*8O#VN7]Q=_VQ8K>PRSR%]MT@Q/&
MI/;!# =,"M+Q1H=QXYUS0+9D=O"T2'4)KF*?9Y\N,1*I4AAC);/3WS5+Q-\.
M5MK&#5O#/VZ77=-G2YM$N=1EE63##>G[QR!N7(SQ0!I9/ASXI06T'RV'B."6
M1HAT6[A )<#MN0\^I7-=M7"ZF[:O\5?#$,<;*^EV=S?72D@^5YJB)%)'&<[O
MRKNJ "BBB@!LD:RQ/&XRC@JPSC(->90^*)?AL]_H.O27-["JM<:',Q+R7:EL
M?9R>29%9@/=3GM7I]<?XUT2_U?6/"<]E;>='8:JMQ<-N4>7&%(SR>><<#)H
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MU-);^8IVLZE8XMV<8"A1UQUH QM4N8;N^^$=S;6RVD$QWQVZ,6$2F!"%!/4
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MAV2235KN\%O=+<1>5%%-(WS2?-N! )8  YR!P<BM,^#K[_A8\<_DL=(7PO\
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M\?,%) )&<X.*\[T7P;J^DWW@3S8DE&G?;Y=0EC<;8WG4L ,G)&YB.!VKTJ@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "D95=2K*&4C!!&012T4 4M*TJST33H[#3XC%:Q$^7&79@@)S@9)P.>!T'0
M5=HHH HV.D6.G75[=6T.VXOI1+<2LY9G8# Y). !P .!V%7J** "BBB@ HJ&
M\>:*RN)+:,2SK&S1QDX#,!P/Q-><>'-<U36;*Y"^,!)?"Q=[NQFL4AN+&8 '
MY$*@E0=RG=N['- 'I@(89!!![B@D*,D@#U->2^&KN_TGX3>')9/%$=C'=&,&
M:6W5Y8X]I_=PH%.]B0.6!P,U0UW6]4UWX>7Z_P!LRR"RUZ"S^T_9%B>YC+PN
MI=&4;2"XZ 9V],&@#VJBO,-;\4W5IXBN-"G\6/IATZTB;[1]@65[N9]QRP"%
M50 +PH!.X\\5VGAG5;CQ#X/T_4I5-K=75L"X5?\ 5R8P2 >V02,T ;0(/0@]
MN*6O%=+U37O#WPOUO6[;5GN+O^V'1$EAC"[C>!7.0O\ &&/T[8KKM;N-7T*P
MT^WU+QG';R7$\C2W*62F=AM&(X(@K @'))() Q0!WE58M2LYM2N-.CG5KNW1
M))8@#E%?.T_CM/Y5YO8^+];UG3M$TJUU$17U]JEU9OJ7V4*QA@#,7$3#"NRA
M1@C )/%4KK5]3\(:YXXOKF\CO+NWL=.C@N98@N[?)(BLZKQP7YV@9"]!F@#U
M^BO/O"/BB:Z\5'2!KTFNVLMFUQ]HDL_(:&564%.%4%6#9'4C:>35GQOKEYI6
MKZ?!)K,NAZ3+#(SZBEHLP\X%0L;EE94&"QR0,XQD4 =Q17F.K^+[J#4],T>[
M\3P:=_Q+%O9M0L;43BY=F*H$!5@J_*S'CN #3[#Q9K7B.V\-Z9:WJV-[?_:V
MN[Z.W!.RW;9NC1Q@;R5/(. 30!Z717G7B#4?&6@Z9HUFVI6DM]>:XEC'=^2/
MWENZ.5:1, !@1DA<9VCD9-0:YXCO-(URU\.7WBV6R,%C]JFU%;!'EN'>1E1=
MH0JJ@*<\9/'/6@#TLD @$@$]/>H+^^MM,L)[Z]F6&UMT,DLC9PJCDGBO)6U+
M6/%&L_#Z[_M:2SEGDOHV,5LNWS(DD4RJK@GYU['H#QS7=_$?_DFWB/\ [!\W
M_H)H Z&TNH+ZS@O+:026\\:RQ..C*PR#^(-35YDNJS6/A#P=;CQ(FC02Z3$S
M>3;?:+J9A%'@*A1AL&3DXST'%3>&O&.K7UUX5GOKA'LM5@O+:3$(0&X@<[9.
M1E=R(_R]!Z4 >CT5Y5IOQ!U5?#WB?4=0D5G6U_M'2%$8'[F1Y(X5X'S?,B<G
MGYZ]"AM=3E\-P6TVH-#JAMT$MVD2$B3 W,%(V\G/&.] #-*\3Z+KEY<VFF:C
M#=S6QQ,(LD*<X^]T//H:UJ\-\ W^KZ'\)-'FL=2S-JNH?V?:Q2P(8[9WN'#2
M9 #,<!C@G&<=J[634]<\.>(6TB]U=M3AO-+N+JVGFMXTDAEBQD?( I4A@>1G
MB@#O:*X_X>7&O:KX<LM<UK51<&^M8W2V2!$6+C[VX#)+=3V&< <50\:Z[=V&
MJRPQ>*4TL16?G0VMM9_:9I9,MS*-C;8^ !C&?FYXH [^BO.;;7_$'B36M"L[
M/45TV#4/#Z:E.T<"2,CEE'R;@1_%CG(QGC/-5(?%NOZ?IL%]?WR7%KI>ORZ5
MJ<ODJGG0$A$F.!\I5F7.W - 'J-%<Q:ZO?ZC\1+_ $^WF"Z5I=G&+A=@R]S(
M=RC.,X5!G _O"JVN7^K7_C>R\-:9J3:9&+![^YN(X4DD8!PB(N\$#DDDX[=J
M ':A)X.BU&Y\4:A.K3:5-]EDFEDD9+:4A1@1_=#8=?F SSUKKJ\4GUS6_"W@
M+QWJ5O=QC58/$6S[0L0*MD6ZEMIR!D'IVS73>)O$.HVGBJ:QE\1+X?A\B)M.
M>>T5[>[D.=PDD8'&" -H*G!SS0!Z+5&76=/AUF#2)+I%U"XB:6* @Y9%ZGTK
MDYKOQ'XA\2ZUI^EZRFE)I$<*#9;I*)YY(_,.XN#A "HP,$Y/-9=RUY_PN?PH
MVI+"M[_8DYN! 28P_P#%M)YQG.,T >G45Y4?$7B=O ;^/UU<" $W*Z1]FC\H
MVXDV[2^-^_;SNSC/&,5=O?$>I'QE<V,OB./1Y!/$-.LKJT7R+Z(JA)\TC)8D
MNN%8$8'!H ](HKCM/U[49X?&K23@G3+N6.T^11L40(X'3GYF)YK AU[Q1K-]
MX3TVSU9+,ZIH(O;NX^S([+(/+)=01C)R1CH-V<<"@#U"JNHZ?!JMA+977F^3
M* &\J5HFX.>&4@CIV->6ZSX[O8K[73#XC%I/I$I@M=/^P^8MXR("QD;:2-[$
MJ I7&,UZ)J6O+8>#KKQ!Y)*PV+7@B;@G";@I_E0!<TO2K'1--AT_3;9+>TA&
M$C3H.<DY/))/))Y-59?$^BPZ\FA/J,/]J. 1;#)8 C(SCIQZXKC_ .T?$^AV
MOAS6=1UL7T6IW5O;W=D;6-(X?/X!C91N^5B!\Q.1GI6?X)TW4D^+7C5I-;FD
M\B2S\_-O$/M(,)V@X7Y=O^SC/>@#U:BN8\::G-IUK8A-<AT>*:?;+/Y/G3L-
MI(6%-K!F)QG(.!FH_ .NW.NZ->M=7)NWL[^6U6Y:#R6F1<%69,#:V& (P.G2
M@#JLC)&1D=12UYE8+JD/Q*\<W0UB4I:6ENZPF&/# QS,BYQD!"3C'7OFGZ/J
MWB23X<IXEU/Q-9VTM[:P,AGME6*U!(#.,#+NPR0IXW$#&* /2JJSZE9VU_:6
M,TZI<WF_R(R#F38,MCZ"O,1X]U'3])\4+;ZF^K/8Q6K65U=V?V=P\[F/#+M4
M,%8 @@<YQ5O4+;5=&^(/A%M5UA]5A6*^D\Q[=(G1A"-P 0 %3QCC(P>3G@ ]
M-HKR/0?B!>7EUH-ZVO?;)-4N4CN=)6RVI;))G:4DV@DH2N26(//3BNX\;ZEJ
M&E>'Q<Z>\D/^D1I<7,5OY[V\);YY F#N('L<9SCB@#I**\PO?&5QI_ABUE@\
M5VM_#J&IK:PZLENK/;Q;"[[XU&TR#:0!M_B!(J"'QYJ":?JEC9:F-3G%Y9VN
MGZE/:^7DW+;/G4!02A5CP #E: /5J*X#7I?%OA7PQX@O9-;CU"&"P,UK<RP(
MDT4P/*E578R8P03SGCGK5/5O$&M:%I6D#4_$*PSZW<;GN5LU86,0C+LD:@'>
M<[5#,#U)Q0!Z42%&20!ZFEKQ/Q#K^HZWX.U&TCUR6XBLM6LXTOA:+&;J*1XR
MNY2H 9&S]T ':,CDUZ^+6[72#:G49#=^44^V>4F[=C[^W&W/?&,4 9=EIOAW
MP@WF0#R)=3N4A,TTKS23RG(12[%CZX&<"NAKPK28M4;X7^#)UU+SI[G7H&@$
MT2[8&,DN3\N"PS\W)]LBNWAU37=&\0:WHUYK<%Z(](&HVUW?1)"L#;G0AS&
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M% !1110 4444 %%%% !1110 4444 %%%% $5S')-:S113-!(Z,JRJ 2A(X8
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M[+<_:)H@"$C<DE0 ",L!D[1TYK=UNVU6YLD_L>^BM+N.59!YT6^.51G*.."
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M;EK2-HLP1@X)=BX7@\<$]/I6YI]]/>2WB3:=<6@MYS%&TQ4B=1_&N">#[X-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLYV,&5E(SR.,@GB@#SZPN;K49]+\)7=[=2::-?O[)Y#.PDF@@0O'&S@[B,D
M\Y(3%;VMZ1I^@:2=(CO-7N[>_P!1C%MI5K<?/G:6:'S&;*Q':6.6&!G'6MZ3
MP)HYT&UTJ%KNW^R3FY@NXIL7"S$DM)O.<L=S9R"#GI5?_A7FF?9-OV_4_P"T
M#=B].J>>IN3*%* Y*[<;"5V[<8/2@#SS6GG@^'7Q$TM[6>RM[22W,-G-<^>;
M<.L;%0V3P3\V,\9KU[3I3!X7M)E7<T=DC >N$!K!E^&VD366K6DEYJ31:M$B
M7FZ<,9'4@^9DKG><8/;'85UEM;I:VD-M'DQQ((UW<G &.: /%Y],V_"C2_%
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MR2[9(9P% :,@<8VCKGJ>H-,/@:PFTJ\L;R_U*]:\FAFGN;B8&5C$RL@&%"J
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MRQ51@9/K5V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+@AAO#ZVLRA')]=K;6_ T >KI?6DE]+8I<PM=Q(KR0!P713T)'4 X-<)XO\
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M '01^'M&BT?^R(]+LUT[(/V40J(\@A@=O3.0#GU%:5<[J?C.PT[5%TZ.UO\
M4+CR!<RBQ@\T0Q$D!FY'7!P!DG'2K_A_7['Q-H\>JZ:SM:2O(B,XQNV.4)^F
M5./:@!5\/Z.NKS:LNF6@U">/RY;GRAO=>!@GN, ?E4>E>%]!T.XDN-*T>RLY
MI1AW@A521G.,CM[=*S+GQYIEKJ<MJ]KJ#6T-TMG-J"P9MHIF( 5FSGJR@D#
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MEJGB/3+#5891'X/MI;;S)$(6:=G:-&&?O 0H#GU>O5R0H))  Y)-*"",CD4
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MA@,>O%>OT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI=\UM<W,D[;F78"NQ0.6R><D #'7-<WHO@K^R9X-,D\":9=RPWA;^VIO)*M
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M+.G3M',BFW8RJV\AB,K@'[N3Q0!M^*?$#>'M,AFAM?M5Y=7,=I:0%]@DED.
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M')&2,':Z$,,]\'FIM)T?3]"L%L=,M4M[=6+;5))+$Y))/))]2<U>HH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_CA"[V\+/_PCGF E 3O%P &^H'&: .@\9^*;;P?X8O-7G\N22),PP-*$,S]
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MR+*YEGM[C-L.<?*[8R/KWKB=.M+9/%GQ,=;>%9$2#:P0 KNM<G'ID]?6N?\
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M#6-/*VG_ !\D7*?N><?/S\O/K7E7BO2+^R\,^,I;V71XFNDL/,L]+D;]VXF
M\Q@0"I9<#/?9[5T=_P"'](C^+/A^*/3;5(ETJY/EK$ IV-&%R.AQN.,]* .A
MUSQ3%86FBW=A);7=MJ.HQ6AF60,@1]V6# X.-M:]AJVG:K&\FG:A:WB1MM=K
M>99 I]"5)P:\;N[6Q_LEK&X2--.7Q_Y1BZ((SU7'0*<GCIR:O>/8AI>O^)%T
M6)+8R>%6>Z6W7:.)@JL0.^PR<]<"@#U6RUG2]2\[[#J5G=>0<2^1.K^7_O8/
M'XTMKJNG7LQAM+^UN)1&)2D4RNP0]&P#T/8UP-GHFH6VN6%Y+_PC=E%'IEQ"
MD&FNX>YA*J1PP&Y5(4Y[;O>M#X2:796?PYT6Z@MHEN;BV#33;1O?GNW4@< #
ML * .NU#5M-TF)9=2U"ULHW.U6N9EC#'T!8BN?\ ''CBU\)>&/[4A:VNIYBB
MVL+7 42[F W ]U .215*.VM[[XP:DFI0Q3-#I$!LDF4, C2/YC*#WR%!/TKS
M[7;:W/PNU5(X8VL[;Q0\5@=H(2'[0,JA[+NW#CTH ]FT;49+G08[Z_N=-9MK
M-+-8S[[< $\ASC@ <^AS7/2_$2PN]'L]0T9X;@2ZM#I\J.XW(KSF+?A2< [2
MRYZC%=?':V\5M]FCMXD@P1Y2H N#U&.G->*:?I]G-\)="A:WC"W/B6.*;:H!
M=?MKC!(]CB@#V6PU?3=4\W^S]0M+ORCMD^SS+)L/H<$XI++5],U*6:*QU&TN
MI(3B5()U<QGT8 \?C7F?C.W&D^)=>.CP):R-X/N&Q;H$R5E !P.X!.#5_P /
MZ)?PZ_X9O6/ANRMH;61(H[!W$MU"T8P "!N .QO;\: .S\2>(K7PSI7VVYCE
MF>258+>WA7=)/*QPJ*/4_P!#6"_B_P 1Z<8;C6O!LMOI\DBH\UI>K=20[C@%
MXU4$C)&=I./>HOB)(MA?>%-8NN-.L=64W3G[L0=&17;T 8CGWJ3Q]K.OZ#HU
MQKFDZGH\5A;VWF>5=PL[32<D!6#@<C: ,'F@#JKS5],T\L+W4;2V*J&833*F
M%)P"<GH3Q]:9<ZWI-G?1V5UJEE!=R8V02W"+(V>F%)R:X8:?::S\98)=2M8K
MC9X;BF$<J!D60S,-VT]P"P'IDU1L;'2[WP5X]NM6@MY+K[=J N99E!=-F?+
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MTY4%]HF8!0W4#CITR3ZT >A4444 %%%% !1110 4444 %%%% !1110 4444
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M;9Z3:?9;"W2"#>S[$Z;F)9C^))-8MWXZT&QM)+JXN)$ACU%M,9O*8_OU!)4
M#)Z<8ZU9T3Q5I^NW=U9PQW=M>VRJ\EM>6[0R!&SM8!ARIP>10!MT444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW): 1@'GGYAVSZ]*YSQ);7MEX1\:37%A<1K=:[;75MO 'FIYMNHQSP<J>N*
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M1G"S)L&S<JGH6QT-<9<>./&*_#GQ%JYM+5)(-0E@CN!>9:!?.V;57RL-M^4
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ME/8M?1W=O>"X"HH#%7&U<-M.1C(X/--TSQCJ$E[IJ:SHL>G6FJQL]G*MUYK
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD=W!+$'#RQ*9"0P/ ;YQTXX-=[=7UK9-;K<SI$US*(80W\;D$A1[X4G\*L4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1/!=CC25N+R^NH]-G>Z5+B4.)YV)/F2<<D$D@# &>G HF\$Z3.=<CD,YM-:
M-U:!@(Q(!CS4XRKG ).>2 >M '/^(](D\#>&]:UC0]3OE T]D^S7%P]P#,2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHNLJ-LC@2^6']1O Z]P*[:RBAM_C+?1V*)'$^AQO>+$ !YOG$1EL?Q;=WX4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'.ADMY$7JRD#\J
MX[P=X TS1]&T674-*LSK5E BO.HW8D QN'8G'&[&:[6B@#$O/!_AW4-5;5+O
M1[2:]8 -,Z9+8& 3V) Z$\BKEOHNFVMQ;7$%E%'-:VWV6!U',</'R#VX'Y5?
MHH Q)?"'AZ?6AK$ND6K7X<2><4Y+CHQ'0L/7&:2[\&^'+[5)=2NM&M);R5=L
MDK)DOQMR1T)QQGK6Y10!C7'A/0+J[L[J?2;62>S18X'9,E%4Y4>X!Y&>AJ73
M_#>C:5+%+8:=!;O$KI&8UQL5R&8#T!(!Q[5J44 9=SX<T:\LKZRN--MY;:^E
M\ZZC9<B63CYC[_*O/L*N65E;:=90V=G"L-O"NV.->BCTJQ10!A0>#/#=O87E
MC%HMFMI>,'N(?+^1R#D'';!.1CI5O1] TG0(9(M*L(;596W2%!RY[%B>3^-:
M5% &;K/A_2?$-O'!JUA#=QQMN3S%Y0^H/4?A44_A?0KG1H='ETJU;3X"#%;B
M,!8R.A7'0\GD<\FM>B@#*M_#6B6NBRZ/#I=JFG39\VW\L%9,]2WJ?<\U'IOA
M+0-'>-]/TJVMY(U=5=%^;#8W#/4YVKU]!6S10!0CT33(M$_L9+& :;Y9B^R[
M<IL/48].:?I>DV&B:?'8:;;);6L>=D2=!DY-7** ,-O!WAQ]8_M9M&M#?>9Y
MOF^7_P M/[^.F[_:QFM*'3K.WU"YOXK>-+NZ"+/*!\T@0$*#],G\ZM44 <_/
MX&\+7-[<WD^A63SW.3,YC^^3U..F3W/4U/JWA/0-=NX[K5-)M;J>-=H>1,DK
MG.T_WAGL<BMFB@"J--LEU,:D+:,7BP?9Q,!\PBSNV_3/-+;Z=9VMW=W<%ND=
MQ=LK7$BCF0JNT$_0 "K-% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\+_B"\&[[<;[5#)M^\'Y_7;C'X5ZO7-Z?H-UI/B[4[NU\I](U8":XA8X:*Y
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MSN+J#_70PSJ[Q\X^90<CGUJGI&L-+I[3ZI?:/N-TT$;V5SNC/.%4EL?O/5:
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M>*,.X;S/.96=W.,EB5SD8ZFFW/@G3;J'5T>:Z5M2NTO3(CA7@F0($:,XX(V
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MK&6UNK#^S4O4NH) ^YC*R$ @XQ\M;MS?6ED$-W=00!R0IED"[L DXSUP 3]
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MC]V5"   J&&W!SG).:KQ_#;28_"&D^&A=7OV/3+M;N&0LOF,X=GPQVXQECT
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M6BW=C>65QIMO);7LQGN(V7(DD./G/OP.?:@#EM,@L;?XV:LEE'%&QT6%IUC
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MC+ ]P3S^->4Q6NG2_ SQ!>WT4)U,R7LES,RCS%NQ,^S)ZA@0@'X5[(
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M9V7&K7L9TKVCNR1+CT"%935[^QKV+QWJ>EZ=:Z++;6>CV=O!'JBN=MO^\#;
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MC$;-&N"R@E@">_+$Y//- &I1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 <EX]UZ;P]!H5TERT$$NKPPW
M)5-Q>(I(2N,$G) Z<^E._P"%AZ)'9ZC<727]HVG*DES!<VCQRI&YPLFTC)7/
M<=,<U1^)LZ6MOX8N98GDBAU^VD<(A8A560EL#DXZ_A5*V;3/&WQ#U.:RD2^T
M<:"=.N9XN8V>24ML#="0N3QTW4 =IJFNV.D+8M=2,?MUREK;B-=Q>1\XZ=L
MG/0 4NJZW9:-)8+>NZ"^N5M86"DKYC9V@GMG&*\X\"I?ZSXCL=/U1'/_  AL
M$EJ[L.)KAF*1N/7$*@Y]7KNO&>A-XC\)W^FQ-LN63S+:3H4F0[HSGM\P'X9H
M MWNOZ?I^KV>F7$I6YNHY9D&/E5(P"S,>BCD<FLK3_'VBZC>6D$:WT,5\Q2S
MNKBT>.&Y."0$<C!R 2,XSVS7&:.+[X@:%XH\2?9WBN[K2&TBRB8;2K"(F;'U
MF8KG_8I\^N:=XDT3P=H>D2>9JD%]92SVJH1)9K#@R&08^3&"O/7/&: .^'BG
M2SHVJ:MYDGV32Y)X[EO+.5:+._ []/QK4CN8Y+-;I2?*:,2 XYP1FO'KW7+'
M3?!?Q T&XD(U>6\U%X[,*3(\<F660#^YM.<], UZK9_\BS;_ /7FO_H% &%9
M?$GP_?FP>$WPM+YUB@O7M'6 R-TC,A&-V>/KQG(JZGC329?$,FA0+>3WT,_D
MS+%;,RPG:&W.P&%7YAR>ISZ&O+['6=.U3X/>'O"]E)G7)Y+1([,*?,7;,KF7
M'9-JEMW3FN[\%QA?&?CJ39AFU&$;L=0(%_Q- $NB^+=+MO"UYJUSK5U?6T5[
M)!YLUOMDW[@HB1$&6Y( P,FM"R\::7>"_5X[VSN+&W-U-;7ELT4OE8/SA3]X
M<$<=^*\KT&*2'P'::B\4C6NF^+VO+L*A8K"&*E\#DA2P;Z#-=)JNHVGB;Q-J
M>IZ+.MW867AN[MY[N'F-I)""L8;H2 I)QTR* .W\/>*M.\3I)+IB7;6ZHCK<
M26[)')N&<(Q&&(Q@XZ'BL[_A-!_PL1_"_P#9]V42U64SBW<C<S$9ST"8'WNF
M>.U6O ,8C^'?AM0NW_B66Y(QCDQJ3^M<WJ5U!:_&&YM[BX6VDU+0$MK-GR!)
M+YS_ "J?49!Q0!N0_$+0I[J)$^VBTFG^S1:@UJXM9)<[=HDQCDC /0GO6OXB
MUA?#_AV_U9H)9Q:PM)Y<2%B<#T';U/89->4MJEG??"73O!5N2/$@^S6;:=M/
MFQ21RH7=AV4!2V[I[UZ?XOBDG\%:]%$C/(^G7"JJC)8F-@ * .0?Q_-)-X,O
MY$O+6VU".<W5J+5MTSB%641J068;F^4CK736OC?1;C1]0U*22XM8].?R[N&Y
M@:.6)SC"E,9).X8QG.>*XO0M1L=7O?AC)93I<+;6MQ!*4Y\N1;5 RGT(S57Q
M-9W$^J>-I86N$2VU/2KJ5[= TBQHB%V4$$$J!NP0?N]#0!Z3HOB6RUR:XMX8
MKNVN[<*TMM>0-#(%;.UL'JIP>1Z&FZWXGL-"N+2UFCNKF\N]QAMK2!I9&5<;
MFP.@&1R?6N=\'+I5_P")[O4[#Q)J6O316:V[W$JQ>0JL^X(&1%RX()QS@-[T
MW7M1M/#OQ2T_5]7F6UTVXTB6SCN9.(TF$JOM)Z E>F>N* #P]XY@:P\0ZGJ%
MU--:1:R;2SC6 F4YCCVQ*@&XMN9N",@YSTJ;7OB1::?X.U36;*SNWNK%Q#):
M7%LZ/#(0"OF+U52"#NZ'(YKC[777@T[6KRWN7TNPOO%I6>_:$;K>!H482 ."
M%W$* S#C?ZUFZQ-%<>&_B-;VU[>W[36]I<V\MT!YMQ"N TB@*N4!!&0.@![T
M >K77C73[2*TW6>J/=74;RI91V3M.L:G!=DQE1G'7KGC-;6FZC::OIMOJ%C,
M)K6X0/&X&,@^QY!]CTKS'6-4TZX\:Q:^/%=QI6CW^E+%;:A:^7Y<KQRR;XRT
MB, ?F! XS@]<5W'@BSM++PE91V,M[+;.9)D>]0)*V]V<DJ   2Q(X'!% %BP
M\3Z7J/AZ;7(9F6Q@$IF:1"K1^62'#*>01M-4)O'>DHEEY,&H7<]Y:K>1VUK:
M/)*L)Z.RC[H/;/)KA_$5C=6GBO4/!=LD@L?%ES%>*Z=(E'_'X,^I"+_W\K=.
MI:=X0^)&LW&M3QV-EJ%C:BRN)?EC_=;U>,'H&^93M[YH Z:U\7:-?+H[6MRT
MJZLTB6I"$99%+,&SRI&TC![C%7;75[2\U>_TN%F-U8"(SJ5P!Y@)7![\ UY-
M8R#1AX;\1ZDKV>E2Z_J%T))D*B&*=)!$6'\(/!Y_O"NL\&:C!JWC[QA?6A9[
M65+'R92I E 1QN7/49!P>_4<4 ;VM>+].T.]^R3Q7UQ.L/VB5+.U>;R8LD;W
MVC@9#>_!JM_;EG<>-=+MH-9G(N].:YALTB!AF0GB0OC(/H,U@^-KS2].\0O>
M+XBN?#VM+9*(Y7C#P7L89B$*,"'923P,,-_?-9T$][J/Q6\*W=Y;FUN[CPTS
MS1A2!%(QR5YZ8)Z4 =-+\2_#L*23.]Z+19O(2[^R/Y$T@;:51\88YS^1QG%6
M=1\>:1IVH7]@8K^ZN[#:;F*TM'E,:E X8X& N&'/UQG!KS"YUJPB^"MKX:='
M_MFREMX;JU,9W6[)<KEVXX!['ON%>@:#'CQOX^8K]Z6U&<=1]E7_ .O0!UMA
M?VVIZ=;ZA9RB:UN(EEB=1]Y2,@UYKJ/Q(N]1\'>*;NQM[S3KC3+KR89Y+9E
M421J0Q88#_,V5Z@5T_PQ!'PR\/ @@BR3@UYW?WEK_P (9\1=%>11J']MS7)M
M6!WF%IH</C^Z<]: /3],\9Z7JNL+I<27L%Q)$TUN;FU>);B,$9:,L/F'(_ Y
MK,T7Q?IMOX9.H2:I?ZJKW[VL1-K^^DER?W2(@YP >?0$DT_7U/\ PLWP:0.!
M#J R!T^2.N#\*KI2?#93K-U>:=&FOW#P:A;_ "FTE!;:[$@@*02N2"/FP>M
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ML?2O/]%L['^SK7PWJWB?64U&/4=CZ+#'$3O%P760?N]WE]'+[L8SSVK9$?\
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M(8\=W9HPH_,UA77B/2M5T'P!I]D&DNK75-/6XC\L@VC(-I5\CY6SP!WY/04
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MK0Z+ BW"@[)B)GR5/\0&<9'<&@#T*BBB@ HHHH **** "BBB@ HHHH ****
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M4-=B^)M@8M)@DU.;090UL+P^1%_I"_,TFS., =%SD@>];5CXPU+4?#\EQ:Z
MTFK1:@^G368G_=Q2*<,[2;?]6!SG;GD#% '7T5YGXI\<:[;^"M<D@T^&RUC3
M+N&UN=MSO5!)L*R1L4^;(=1@@8R3VP?1+*2[DL8Y+ZWBM[HC,D44ID53[,57
M/Y"@"Q17G=G\1]3N=#TSQ#)X<2'1+N:."24WN98R[^7N";,% QQU!/7&*T[O
MQ=J\^H:M%H.A0W]MI+^5<RS7GDM)(%#M'$H1LD CDD#)Q[T =C15#1M7MM<T
M.SU:T+?9KN%9DW#D C.#[CI7/^'?%NK:ZEI?G0HX]'OHWDM[F*\$CQ@ D>:F
MT;<XQP6P>#0!U]<8_@C4;N2"UU'Q-<WNCP72W2VLL"^:Y5]Z(\V<LH;'8'@<
MU(GCG?X%TGQ+_9^/[0EMX_L_G?ZOS9 F=VWG&<]!FF7OC'5FO=4_L3P]_:5C
MI,ODW4@N=DLD@4,ZPQ[3O*AAU(R>!0!V5&!G/>O-;75-:C^(7BT:+I*WLC16
M,I6ZN#;K&/*.%^ZQWG/3  P<D<9[7PUKD7B7PW8:S#$T*7<0D\MCDH>A&>^"
M",T :N!G..:*\VMO&.GZ+8^.-5M=#\M],U+9<@7+,;IRRJ7Y!V]>@STK7_X2
M[6[?68].O_#T4,M[:3W&GJE[O,C1 $Q2?)\C$,.1N'UH [*C SGO7'S>/H!\
M/;/Q3;69GEO!$D%D),,\[N$\O=CJ&R,X_A/%0ZAXWU"V.JWEKHB7.D:/(8KZ
MX^U;9-RJ&D\I-OS! ><E<X.* .VHKCKCQ=JMSX@U/1M"T2&]EL8H9C/->>5&
MRR*6 X0G<<<#IU)([X=WXZUO4[KP3<:'I\(M]7,SR03W6PLZ1ONC8A&P%(W!
MAU( P* /1+&Q@T^%XH P5Y9)F+')+NQ9C^9/T'%6:X&V\3Z/I?BGQY<2::;9
M])BMIKRZ68N;H&(LH"'A2!\HQUS5VT\7:O#J&DQ:]H45A;:L_E6TL5YYS1R%
M2RI*NQ<$@'D$C(Q[T =C1@5YW)\2-3&A7/B!?#B?V197,D%W(U[B3"2F,O&N
MS# #!.2.<CMDZUWXLU4ZYJ5EI.A1W\&EO$EV?M829BZ*_P"[CVD-A6'5ER00
M.E '745GZYK%OH&AWFJW2NT-K$9"B#+,>RCW)P/QK#M/$VMC4?[,U30[>UU"
MXLY+JQ2.]\R.4I@-&[;!M8;EY 88)]* .L P,"@ #I7&67Q CU4Z/:Z?I[2:
MI>R.EW9O)M-@L9Q*TAP?NM@ 8&[(QBLVW\6Z;I%YXXO(-&\N?3[J".=Q<D_:
MY'^5"=PQ& 2 <9XR: /1<9&#17G?BWQ3XJTSP-KMV^CP6-[:PJT=S#>>;$4?
M(WH2@)=3CY2 .0<UW&E37L^F02ZC;Q6]TR_/'%,95'/&&*KG(P>G>@"U(GF1
MLA+#<",J<$?0UR%OX+U%[S3?[8\2SZG8Z9.+BV@>V5)&D4$(TL@.7*Y]!D\G
M-=C10 48&,8XHHH *YV]\,SZIXFM=1U'4S-I]E()[33E@"JDP7 =WR2Y&6(&
M!@GOBNBHH .M%%%    ,"BBB@ HHHH *,#.<<T44 &!Z48%%% !1110 4$ ]
M1110 4444 ! /44444 %& >HHHH **** #&*,"BB@ QSFC ]*** "C&1BBB@
M QQBCI110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '*^-=,O[G^Q=5TVV-W<:3?K<M;*P5I8RC(X4
MD@;L-D9(Z5S^IZ5K'B:X\2:R-(N;)9/#\NEV5M<E!-.[[F+$*Q"C.U1D^IKT
MJB@#-\/6TUGX9TJUN$,<T-G#'(A_A8( 1^8KE'T;6(?BIK6MV^GK+;2:&L%N
MTKA8Y9@V0AZD#WQ7>T4 >=^$])EMO%B7>E^';_P]IQMI!?VT\J>3+,2NSRD5
MV QA\L HP15_QOHNHZIXC\'7-E:M-#8ZEYURX('EIMQDY/\ *NUHH \ED\&P
M6FJ:M;77@?\ MBXO-0DN+:^,JK 8I6W$2'=N4KEA@*<X&.M=,FBWZ?&;^V1:
ML-,&@"T$^1CS?/W;<9S]WFNTHH XOX?VNHZ2-8TJ_P!+N8,:C<W,5T2ABF22
M0LNTALYP>00*@NO[8T;XC:GK,>AW=_IMQI]O!NM2AD\Q6D/"LPR.>>>XZ\X[
MNB@#R.X\(:\_A_PR6L#]M/BI=7O84=3]FC>1V.3G!V@KG'>H_%/A34-8?Q5;
MS>&'U+5+MW;3M2G=###!Y:[43+91P0PP%Y)!)QS7L%% ''^%[*_'B[6M5NK"
M:T@O+&Q6(3%=VY!)O4@$\C</SKCX? %[JFE>"=,UC393:6MS?MJ""7;L1S(4
MR5.<,2O3UYKV"B@#@["_UWP5X7UBVU"PEU*'18]]C=>:JFZMQT5CV=!P>.<#
M%=X.13)88YXFBFC22-NJNH(/X&FW,"W5K+;NTB+*A0M&Y1@",9##D'W'(H \
MN\-:)./B5>Z/\C:)X?N9=0M@IR%EN5!6,CMLS,1_O"KRP:]X=MO$NC6N@76H
M'4KNXN;"ZA>,0CSQDB4LP*[6)['(Z5VNB:!IWAZS>VTZ%D620RRO)(TDDKGJ
MSNQ)8^Y-:= 'FUGH^J>#->T>>'2;K5K6/0(M+=K(IN6:-]V2'9?E.3SVQ6]X
M T[4M-T6^35;86UU-J=U<%%<,-KR%@0>XYKJZ* .0T+1;R+Q3XTFNX&CM=1F
M@\B3(_>*( C$?0Y'-<OX4\(PZ9+H^GW'@7_B8V$BB?57E40D1_=F0ABS,2%.
MW:,$G.,5ZO10!XUI<NM7_P /=;\/6.AW%P^HWM];P7:.@AC5YW5C(2P92OS'
M@'/&.^.TT'0KS3?'^JW30M]A;3+.VAG)&':/>&&.O<?G71Z3I%GHEFUI8QLD
M+2R3$%BWS.Q=CD^Y-7J /)+'P7;V%U)IEUX&_M*Z.H/(FI/*JP- \I<.YW;@
MRJ<;=IR5'KFM#7M*O;[Q$T]EX7N[+7EO(_)UFTG58)( ZY,IW M\@(*%3Z#C
MFO2Z* /)/^$,M[34=2LKOP-_:]Q=:C)/!?M*JP&&1]Y\QMVY2@9A@*<X&.M=
M=I&DWMMKOC.>6W9(;Z:)K5LC]X!;HAQ_P($<UUM% 'E>GZ-K>B)\/+Q]&NKG
M^S+":UO8;=D,D32(@!P6 (RIR0:ZOXCZ3>ZY\/\ 5M.TZ'SKN5$,<>X#>5=6
M(!/&<*:ZFB@#CM/AU#4?B!::_)I=U96K:+);LMSL#I)YZD*0K'J%)^GOQ7-W
M?AW5DM;O[3I-U>:=)XGN+RZL8'4/<VS(0AQN 9=^TE2><=*]5HH \:N_">KG
MPUXRT[3_  Q]@6_DM;RQMH6C";4:/='PV!)\A)'3)X)[^MZ?=O?Z?%<R6=Q9
MO("3;W(42)SCG:2/?KWJU10!YE'X:UA?@QI.BFQ?^T89K9I(-RY4+<J[<YQP
MH)ZU=B&M^%-0\26]KH%WJ<>J7;WUE/;O&$#NBJR2[F!4!ESG!X/X5Z!10!A>
M$=%F\.>#-+TAW22XM+94<@_*7QDX/IDFN0T?1[MO%EC>6/AB\\/RDRG66$R?
M9+@&-@ BJY#G>58-M4X!SZ5Z910!Y#!IOB5O FB^%?\ A'+I)],O+8W-R\D?
ME/''.IW1D-EL@ \@8 /? .Y'_P )%X4OO$5IIV@3:D=3O7OK"Y1T$*/(JAEF
MRP90K+G@'(/'->A44 <KX?TS4;7QGXEO[V$+'>1V0CE3[LC)&P?:,Y !/>G_
M  \TV\T?P%I.GZA 8+J&-A)&Q!*G>Q[<="*Z>B@#R.X\)ZX^@_$.W73W,NIZ
MH)[-=R_ODWJ<CGC@'KBNUUG3;RY\>^%]0A@+VMI'>">0$80NB!??D@UT]% '
MF.F^$=6B\=I8S6N/#%A?SZO:REAM:615VQA<Y&QWE;\JJWGA"*UUK6TN?!!U
MR>_O7N;.\\U5AVR8)64E@5VMNZ*<C&*]8HH Y;0-(N;#QMXDNVMO*LKB&RCM
MF!&&\M'# =^,CK7'66A:[HNC> [MM&NKJ32+B[-W:V[(95$HD52,L >H[]Z]
M:HH \MNO!>JZOK'Q*CD@-O!K5O:I8S.PVNZ1$'H20 V :TYAK?BS4?#D%UH%
MWID>F7:WU[-<O'M,B(RJD6UB6!9LYP!@?A7?T4 >93>&M8;X-:YHJV+G4;B:
M[:*#<N6#W#,O.<<J0>M.\9Z5=ZEJ5V;7PM=KKBA5TO6[&=451@8,S;@0%;=E
M2K CIUKTNB@#G_&>B3^(O!6I:3"4-S/#^[W\*SJ0P!] 2H'XUS?A[3;6POY=
M2L/A]/ILMK:.2\DJ>;)*<?NH@&((//S$@=/?'HE% 'FFD>&_$'A_6K;Q4T7V
MO4-7DVZY:1E<1(W^K,?_ %RX4\G<"3UIVGZ)J^GZIX]NY-"2_@U"[A>"UF=
MMU$!B0#/&<$X#8!.*])HH \AN/"NI7GA3Q98Z)HU_INFW=G&MGIM],I)G5F+
ME%WL$4C:,9 )':O0M/UC4+DZ4K:!>6T-Q')]H>X=%:V*8VAE4G.[G&#QCFMR
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@##\7:__P (UX;N=12+S[D;8K:'_GK,[!47_OHC/MFL
MUKRYTK4_"NF:IXDE.H70F$D2VBE;YU0,PW!?W87/&,9'7-5OB9\FG^'KE_\
MCWMM?LI9R>BIO(R?;)6J7C7_ )*O\.O^NM]_Z*6@#22]OM6'BBUT3Q$\NI6=
MP%BCDM%5+9P,B(DK\ZMC!;J,\&MOPMKT7B;PU8ZO%&8OM$>7B/6.0$JZ_@P(
M_"N2^'?_ ".?Q _["J_^@&KOPJ^?PA/<)_Q[W.I7DT'IY9F;&/;@T :?C/5-
M8T+3(M7TN!+JWM)-]_:[,R20?Q-&<\,O7'<9JCXA\9-]ATFV\+M!>ZKK>#8[
MLF-(N"\S@<[5'XYX]:[(@$8/(KS+X9:-86'BOQF]O;A#;:A]EM^21#"?WA1,
M_=7<Q.!0!UVI^*].T*XAT^[>ZN]0,(E>*RLY)G"#@R,J [5SGK^&:GMO%.C7
MATG[->"8:L'-FR*Q$FQ2S9X^4@ \''(QUKETU;3_  Q\3/$<^NWD-C%J%K:2
M6<]RX1'6-75T#'C()!V]?FKEM)FCT9O!^MZD?L.E2ZMJ<R2W V+#'.)#%NS]
MT-U&?6@#URUU:SO-3O\ 3H)2UU8&,7";2-N]=R\]#QZ4:MJUEHFFRZAJ$WE6
MT6-S!2Q))   &2220 !U)KD?!6HVVJ^.?&=[9OYEM(]GY4H'RR 0D;E]02#@
M]#U'%:/C_4YM*\/02Q316J2WL$,UY+$LBVB,XS+AN,CC!/ )!H MVGC/1;K3
MM0O7GFM$TX;KQ+R!X9(01D$HP!P1TQU[5'IOCG1-3U&UTZ*2ZAO;H,T,%S:2
M0NRA=V[#*/E(!P>AQCK7E.KS1W8\9Q6^K7.L^99Z=<132B/==0PSN93&$50Z
M*,C(![\UU]UXAT?Q#\4?!LND7,=XD<5[ON8>4&Z($)N_O<9(ZCC/6@#I-.\?
M^'=56>2UNY6M[>!YY[AX'6*)4.&#.1@-WV]<<U8TKQCH^KR31Q27%O)##]I*
M7EL]N6A_YZ+O RGN.G>O.]*L)[O]G6ZALHG:9VN)2L2Y9PMTS-@=SM4C'?I3
MKZVM_$]MJ9TSQA=^(M230[M(4C@A"(LJJ-C-&BX9BHPIYX/% 'H.C^,M'UR]
M6TM'N5EEB,T'VBUDA6XC&,O&7 #CD=/4&MF[NDLK.:ZD65DB0NRQ1M(Y ]%4
M$D^PKS7PM)INKZ_X?F3QC=ZO<V<$DT=FMO"HMP8]C++Y: I]X !CU'M7ISC*
M,!UP: /,F^);ZAX8\.ZW%YVGQ7&K1P7GF6[;&A(E)",R_-]Q>4YSQ77V'C31
M;^+47\Z>T.FQB6ZCO;9X'CC()#E7 .T@'GVKS#P[>V5W\/OA_8QSQ2W-EKT"
M7, (+0O^_(##J#QGFM[Q=J%QI7B_Q/?6L,<LT7AJ A9(]ZC]_*"Q7N%!)Q[4
M =99^.M&O8KMHUU!)+:W^TF"6QE262'. Z(5RZY],T_P3XI7Q?X:MM4^RS6T
MDB@NCQ.JY/\ <9@-X]QD5PVG7]K+\0[?R_$TVMK<:+=6\5U((A&\V^)C%$8U
M4$@#)')'YUTGPEU&SO/AQH]O;7,4LUI;K%<1JV6B?GY6'8_6@#I=:UVQT"UC
MGOFE_?2"&&*&)I9)7()"JB@DG )_"N-\=^.)(OAC?Z]X;O)(+F"XC@)E@VO"
M_F*KHR2+P<'H1WS6CX[U9]/N]"@?4XM(M+JXD$^INB$P;8R553("JEN1DCL?
M6O+O$-W#+\,/'=NM_-=S?VU!.'N0JRR1,+?9*54*-K;3@X&0* /4;O7=2B^,
M&G:$EQC39M(>Y>'8O,@D(#;L9Z=LXKLZ\[OO^3@-)_[ ,O\ Z-->B4 <?H_B
M[3+;PM<ZO>:]+J-M'>/!Y[6GEOOW!1$J*,L<G P,FJ^G^,UU'Q[/:K<36^F6
M^CFYG@N[<P/#*)<%F#@,!L(]L<UY[H3BU\!Z9J4^196'C%KB[?&1''EEWGV#
M,IK6\2W=OXL\4>)5\/RK>%_"<D"36YW+,XER45APW!QQW.* /1='\9:/K=U]
MFM9+F.1HC/%]IM9(!-$, O&7 W+R.1ZBF:3XXT/6=0BL[26Y#3JSVTDUK)''
M<JOWC$[ !\=>#TYZ5Q6FWEE?7UCJ%GXKNO$%]I^GW%S;V"VT(6/,>TI+Y: J
M22 %;G(Z<5EV&MVL^M^![^?Q,VIJ7?[3%'%"EM9R26T@6(!%!5B<J%9B>.G2
M@#TK2O&VB:QJ$5G:2W.Z<,UM++:R1Q7(7[QB=E"OCKP>G/2NAKRSPGJUM9:[
MHFD^'_$"ZMI%P)%_LZXC4W&F(L98$L,,H! 3:XSR ":]&TG5['7--CU'39_/
MM9"RI)L9<E6*MPP!ZJ1^% &'XN\9Q>%;K2+=[2YN&O[H0GR;>23:FUB2-H.6
MX&%ZGD]JEU#QUH6F7K6US+<@Q*C7,B6LC1VH<97S7"XCR#WQCJ<5C_$FZ@T^
M\\(7UW*D%I!K:---(<)&#%(,L>P]ZY2[DM(KSQ=::GXPN-,@O[EIDLHH(9#?
M02Q(%:+<A9R1E,*>"O:@#TC6O&6CZ%=BUNGN99Q%Y\B6EK).8HLX\Q]@.U>#
MR?0UAW7CF*T\<1PBYENM*N-%CN[6&SMS.\TC2N-RA%+$;!]!BL[3]4TOP3XQ
MU]->O1:P7-E9/:377'GQQ1%&4>KAN2HY^;I5K0);:[^)EO=6VGO80R>&(6BM
MI(EC:)6N'.TJ.%[<4 ;Q\=^'5T>QU5KYA:7TK00MY+[C(H8E"N,AOD88QDG@
M=149\8:9J>A:[+;7EWITVFV[O<M<6;I-:@H663RG7+< D#!SBN$L$5KC1590
M0/&]\0".F//(K1\3C&K?$G'?PS'_ .@7% '5)XOTS3= T2>YOKK49M1@5K8P
M6;--=_(&+B)!D<')X &:DM_'?A^ZMY9XKN0QQ7D5BY,+@B:3;M0@C(.6 .1P
M<@XQ7":'?VNA7/P^U75IX[;3I/#9M4N)CMCCF(B;!8\*2JG&>N*SKB_MKK3_
M !1K%N#]@A\4V-T\@4X\I?))DQ_=(^;/H<T >Q2:Q8Q:RNDO-MO&MFNPI4X\
MI6"EMW3J169I/C71-9OX[2TEN \R,]M)-;211W*K]XQ.P <#KQVYZ5Q>K:C;
M>*?'&H1:#<I>;_"EY!%/ VZ-I6D3"JPX)&5SCIFH/"[Z=J<_AB-_%U[J-U91
MF9-+2UA!MBL+(ZR;$#( &*X8\G'6@#N]+\;:)K&H16=I+<[IPQMI9;62.*Y"
M_>,3LH5\=>#TYZ5T->6>%-6MK+7=$TKP_P"(%U;2+@2+_9MQ&IN-,18V8$L,
M,H! 3:XS\P )KT;2=7L=<TV/4-.G\^UD9E638RY*L5;A@#U!% &7XKU2/3!H
M_F:Q)IOVG4X;==EL)OM!;/[DY!VAL?>XQCK46I>/-"TR\O;.5[N:YL2/M,5M
M9RS&%2H?<VU3A<,.>G7T-8/Q9^YX-_[&>S_]GJUH2+_PEOQ";:,M-;@G'4?9
M5_Q- '26/B;2=2U&.PM+H2SRV27\8"$!X&. X)&#S^(JO=>,M#LGU))KIMVG
M210SJD3L3)(,HB #YV.1PN3SS7G-I*OA_P "^ /&1#>5IUNEK?%1UMIEVY/K
MM<(?SHN-*O+/P+H&MW=U+I\]UK8U?4KJ.-7-MYRN%8A@1A T:G(XZ]J /0E\
M;Z%_8]WJ<UQ-;06<J0W27,#Q20.Y4*'1@" =R\XQ@YIMGXYT:]N;BVB%\L\-
MNUTL4EC,C3Q#@O$I7,@R1]W).:\\UR'3[KPKXGO[;Q#/KSSW&G6\]RT4:PG9
M<*0$:-0K$!\'&<<"NUU@?\77\,X'73KX?K#0!EQ?$&#6_ ":X]]=Z#FX1&N!
M8M(.9"JJN]<."  2,X)KJ=8\6Z7HM\EC,+NXO&B\XV]G:R7#I'G&]@@.T9]>
MM>-7%_:3_L\V-C%<1O=V5[#'=0!OGA8W#8##J"<=Z]"CU;3O#'Q+\23:[>0V
M,6H6UI+9SW+A$D6-65U5CQD,<[>OS4 ;\_CCP];V.FWIOO,@U(,;1HHG<RE1
MDJ !G=VVXSGC&:;!XYT*?2KS4#-<0K92K!<036TB3I(V-J>61N);<, #G-<!
MX;MG74O \TL+1Q76J:K=V\<BX*Q.DC)P>F00?QJ]JBZ4?$OCC^U[FXM+47&E
ML+RWX:VD"923."% 8#)/'K0!Z!HOB"PUZ.<VGGI+;N$G@N8'AEB)&1N1P",C
MD'H:U*\_\-^+X[2UUVXU;7+;5-+TYX%368(,"7?QL81Y#,I*C*_WAG'->@4
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M /0F@"]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN [,2I=/,CP-FY5)&"W8'&:F\/\ B[4->DL[D>'Y(M(OM_V>]2Y61@!D@RH
M-@.#W.#@'% '5E0V,@'!R,T8 ).!SU]Z6B@!-J[=NT;?3'%! (P0"#QBFRLZ
MPNT:!Y I*H6QN/89[5YSX<\>:PWAN^U+5M,\V1M3DL[&*&=2TLC3%%A^Z  O
M WGJ 30!Z.L4:1B-454'10, ?A2X&0<#([UR#>.O[-M-7.OZ8UA>:9!'<-!#
M,)Q.DA*H8VPN27!7! P<5F^(?$6LS^%/$=EJOA^;2YCHUQ<03PW'GQG"$%6<
M*-CC(..<\X/% '?B*,;L1H-QRWR]3ZT211R@"1%< Y 89P:XC1/%]_"_AVRU
M'0WMK+4XEBM;PW(=V<1;QOCQ\NX*2.2?7%0S_$B^33-1U:#PU)+IFEW4UO>3
M&[56 CD*LT:[?GXP3DCKC)P: ._(!() R.E!53G*@[N#QUKCWU?3!\5H[(V3
M_;3H7VK[<;E@@A\TC9Y?W<YYW=>U)I7C;4-3DT^['AJY31-1D\NVO4F$D@!S
MM>2(+E$;'7)QD9Q0!TU]IEKJ&F2Z=*FVVE&UTC^7*YR1]#T/UJY7(?\ "8ZC
M#J5J+WP[-::5=WWV&&ZDG E+DE59H=N51B.#NS@@XYK-\!S2R>//'Z/([*E_
M"$5F)"C8>GI0!WS11M(LC(I=?NL1R/H:Y_\ X1J[O/%D.LZKJ2W,%D7.GV<<
M'EK"S#!=SN.]MN0#P!D\5T=% #'BCE $B*^#D;AG!I6C1RI9%8J<C(S@UQ7]
MN:?:_$#Q%$FFR_;K+2TN9;@W+%94 R$"'Y5/'44VR^(%[<+H-[<^'GMM)UF2
M*&"Y-TK2+)(I*[H]OW200&SZ' SB@#M_+C\SS-B^9C&['./3-+M7!&T8/7CK
M7D&E7>HWWQ>\27NLZ=^YTA+9@#J3;+!#$6+*H $F[&2,#'O746OCZ]:'3-2O
MO#SVFAZG-'%;W9NE>1?,.(VDBV_*K9'1CC(S0!V^T<<#CI[4U8HT=G5%#M]Y
M@,$_6N2L?&EYJ7B'4]-L]"=X-,NG@N[M[D*J@(&4JN,L2<C';&<\XK*A^)]X
M^DZ1K4GA><:5J<B012)=*TOG,#M41X'REAM#%AZXQ0!W>GZ?!IEI]FM]VSS)
M)26.26=R['\68FK)4'&0#BN3L?&-XU[J^GZIH,MMJ&GVBWB6]K-]I-S&VX#9
MA5^;*D8QU[TVV\7:N;R;3[_PZMIJ!L6OK6(7P=9E4@,K-L&Q@67L1SUH ZU(
MTB0)&BHH_A48%(D4<8 2-% Y 48Q7D\?BR>\^%NB:OXITIKLW-[;K&T-X8C(
MS,<2'8!C!_AY!KLK_P 5:B=>O=(T'0QJ<VGQH]V\EV+=49QN5%RK;F*\]@,C
MGF@#IEBC1F9(U5F.6(&"?K2A%  "@ '(&*XL_$1;J'P\=*TF:\FUN.<PQ-*(
MS$\6 RN2"  2V3_L\ Y K7\,^(YM=.HVU[I_V#4-.N/(N(!,)5Y4.K*X R"&
M'84 ;V!G.!GIFD2../=L15W')VC&3ZTZB@!B11Q;O+C5-QR=HQDT1Q1Q*5C1
M4!.<*,<UD>+/$,?A7PU=ZU+;M<);&/=$C8)#.J<<'INS^%9UCXMO_P#A(K72
M-9T)M-:^ADELI!=+-YFS!9'  V, 0<9(Z\T =40&!! (/!!IHBC5541J HP
M!T%<'I?Q+>^\*S^)[G09K71HX-R2_:%=YIMX3RT3 ."QP&..1TQS6I9^+;^+
M6[/3/$&B+I;WT4DEK(EX)U8H-S(V%7:P7GN#@\T =5M'' XZ>U-,49<N8TWD
M8+8Y(]*X!OB5=IH]MK;^&IAI%[<1PV<_VI=[AY JLZ;?D!&2.3V!QFM6'QC>
M7OC+4/#]AH;SC3IHDN[MKD(D<<B*X8 C+'DC:/[IY'% '6TF!DG R>OO7(VG
MC'46U/3HM2\.S:?8ZE.]O:3RS@R[PK,HDBV@IN"-CD]LXK+G^)MU#I5YK(\.
M2-I%A>/:WEQ]J ==LOEED3;\XZ$\CKCG!H ]"VK@#:,#H,=*;Y4>YF\M=S##
M'')'O7)P>-;J#6OL&M:&^G)+92WMM(+@2LZ1XWJR@#:X# X!(]ZL^'?$NJ:S
M):R7?A]K.RO+?[1;7,=TLZ[>"%D  V,0V1U'!YH Z4*J] !]!1M7;MVC![8I
M:* &&*-F1FC4E/NDC[OT]*5HT9E9D4LOW21R/I2NVU&;&<#->?67Q+N[G1-.
M\03>&Y+?0;N2.)[LW:EXB[;-WE[>4WG&<@]\8H ] V*!@*,9ST[TV>$30R1A
MVC9T*>8APRY[@^M<K;^,KN^\7:AH=EHC2QZ;.D=Y>/<A$C1D#!@",L>3\H_N
MYR,BJ*?$2Y.FQ:\^@.GAJ698UOS=#S0C/L64P[>$)(_BS@YQ0!:L_!VK2:AI
M<NN>(5U&UTN7S[>-+,1/)+M*J\K[CN(#'H%R>3795P-AXOU9/&OBR#4[2./1
MM(BBD:03@F%/+=]^-N6+@#(S\N.]6K3QQ?F32)]4\/-8:9J\J0VMQ]K61U=Q
MF,21A1LW8[%L$@&@#8\-^'ET"PEMWE2Y=[RXNED\O:5\V1GP.3TSC/>MO:-V
M[ SC&:\PT[X@Z]:67B?5-6T99+#3-4,#F*Z!:W0")64 )\X7<7W9YR1VKM-5
M\1II^KZ'IL%O]JGU:5@FV3 CB1-SR9P<@?*,=]PYH V1#&H($: %MQ 4<GU^
MM.VKMV[1CTQ7GEI\3;NXT&T\12>&I(=!EE6*:Z-VI>++^7N$>WYD#<$Y!Z\8
MYK3U/QO=6<^JRV6AO>Z7H[;;^[%R$92%#N(TP=^U2"<E?09H ZXQ1M(LC1J7
M7[K$<CZ&H(=/@@U&ZOUW&>Y2-')/&U-VT#\68_C7-W7C*];5+VWT?0FU2VL%
MB:ZECNE20^8@<>7&0=_RD'DKGH*ZX'(S0 4444 %%%% !1110 4444 %%%%
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M?L0GS$XP3TQWXYJ]H%CXLMI[.#59]*%E:0F-FM0[273  *S!@!'ZD MD]\4
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M\P%WW;AQC&/?K0!D+K7BG1X?#^K:O?V=U:ZM<P6]Q9Q6OE_9C,/D*/N);:V
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M(MT<.!G,AS\H/0=:O5P?C2_O+7X@>!+>WNYXH+FZN5GCCD*K*!&I 8#@X]Z
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M(H\QMIW@#Y0!AJYWPK=W<?@#3]-M;J:T&J^*)+.:>%MLBQ$LS!6_A)V8S[T
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M><B-R<_[%17[7EQK^L:2Z>*KP:1;V]K93:;<%0DAA#F60^8N]R6'WMPP/<T
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MT(817,*3('&"%8 C/OS7EEW9S>(?#/CG7+K4]0CNK6>_MK9$NG6&**%2H0Q
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M+(N(^&.XEB,)\N,^I% $.L>$Y+3PYXFU&XO[S6-8N=(GM4EE1 5CV,1&B1J
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M*QGLKR)9K:XC,<L;=&4C!!JO>Z)IFI:2-+O+.*:R"JJQ,.%V_=P>H(P,$<T
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M[U"WE!,<OC548 XR#/&#7O59$7A;1(+-K2/3HEMVNQ>E 3@SA@V_KUR ?PH
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M6;3DFU:"*[+V[!&A9FW!2P^8849*]^*[71?%6G:[>W-E EY;WELJR26]Y;/
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MIK[QII%G!821FZOFOX?M%M%8VSS.\6 2^U1D+\PY..M8VAH/^$H^(3;1EIX
M3CJ/LJ?XFN1T36?LNC^$]/OM<ET.Q.@),D]O&GG74NX Q*SHW0!3M49.X>E
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M^I3ZKI$OG,_DH%!6+GHI 92O3#5V>AZI'KF@:?JL2[4O+>.<+_=W*#C\,XH
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MPMM25K:_L]+>X!TZTOY?,FACV*&_B8A2V<*22/QKKZ* ,;Q;J4.D>$-7OYV
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M]O;;3K*:\O)D@MH5+R2N<*JCJ35.#3].O=5M_$<!\V=[/R(I5?Y6A=@_ ]R
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M9RQQH.K,4( _.N%\2>'=6O/@##H%O922:JNG641M@1N#H8MPZXXVG\J]+HH
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M]7(_<@@X)Y_E5K4?#FK7UUX\T7^S+C;K+)<V=X2OD,5C3",=VX$LN.E>IT4
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M>U+2A,83>6LEOY@&=F]2N?UH X7PWXPO9_%.FZ;-XCL-:6_MYFF6TM]B6TJ
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MKN$<L;!U)'<9&#[&LVRT#6[_ ,36VM^(I=/1K&VD@M;>P+LNZ3&^1F< YPH
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M(K)7/F2,,>8S,,J!_=&?O'DX%:'A32)M \)Z5I$\B236=LD+O'G:Q48R,]J
M-*\6X>RN%M76.Y,;")V&0KXX)'?G%>8ZC\0]77P9X;U&R2+[=-%)=:FICSB*
MW&+@ =CO( ]*]4KA='\ /9>(O$%U>7$4VG7T<L-I;H#F%)G+S YXY8C&.PH
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M/#GB&[\0Z/J&NS:2YTHN5N[2-A/=%HV3#@@!%^;<0"1D#&*[6@#BYK_7]?\
M%FL:5I&J1:7;:0L*-(;43-/-(F_G<<!0"O3DDGFN%\6ZEJGBKPSX(U"6ZAM9
M)/$$%I-;K '1;A))$,@)/*_+]T^O6N_N]!U_3O$VI:OX=ETUUU2.(7,-^74)
M)&NU74H#G*X!4XZ=:S[CX>7 \-^%]*MKZ-Y-)UB+4[F:52OG$.[R8 S@EG.
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MS])N+*:63G:XA8%@O&><<9JC=^#O$D=MXBTC2[[34TG699Y_-F5_/@:8?O$
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M[25*_0YQ7:^(-%U*?6=.US1)+07]I'+;O%=[A'-%)M)!902I#(I!P>]9>O\
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M+OQ($<2.VT@(>3U+5ZAH&C)HMBT?VJZNIIV\Z>:YF:0O(0 2,GY1Q]T8 ]*
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MOBQ_$7F2_:FL18F/(V; Y?.,9SD^OX58AU?3+BR2]@U&TEM'8(DZ3JR,Q.
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M WY!R&P ,B@#RC5O.C\+_%&WG:Q\R,6YD2P0K"',:AL D\\#/N*Z+3+"UO\
MQYX7%W!',L/A;S461=P#;XAG!]F/YUV \%^'%BGB71[98Y[<6TJ*I DC!R%(
M[\\YZUH0Z1807<%W%:QI/!;_ &6*0#E8L@[![94?E0!S'PZBCMXO$UO"BQPQ
M:_=+'&HPJ#"' '89)JM-:VS_ !UMW>WB9O\ A'GD!9 3O%P@#?4#O7:6>GVF
MGFX-I D7VF9IYMO\<C8RQ]S@54U#P[I&JZC9ZA?6$4UY9-NMYCD,AR#U'49
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M1F8?VU'(5:.%CR3$0<R[<KN!&<]NE &GI&F6-_\ %'Q!+=VL-PT6F6*H)4#
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M0AE89!&.XK)N/"'A^[UD:O/I-O)?!U?S2O5E^ZQ'0L.Q(R,5MT >(Z!;6S^
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M;5I96C &9&51\HY'XG KSCQ!JUWJ/PY\:62:S_;VG6UO ;;4A$JLS,_S1$J
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MD;6^8;: .BTGQ?I=GX$TW6)]4O-2BNG\F"9K;_2+J0NP"B-!UX(X'09JPGQ
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M 7W=,=Z]L[4 >6:C\2+K4?!OB6]LK>[TZ?3KT0Q3RVS(H031H0Q88#X9LKU
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MP/A!L.6Y/!P!@<G/ !T/AO0(_#NEM:+<274TLTES<7,@ ::5VW,Q X'/0#H
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MSLK&WMY-$GT=+Y"USM+1NZ_O<;#\PY 3."#G(Z4 >@$9&#1TK@/^%AW_ /9
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M!482DME=I7L#GM7I%% 'DL?AR_B3P[#K'AB?6;6#0;>UBM-Z&*VNU^^9 S
M$;1N ;&TX%16?A?7ETKP)9OI,D<FBZNYN\,FP1AB1(OS<H<C'?CI7K]% %74
MO^07=_\ 7!__ $$UY/HD>L^(OAKX7\.)HES'&WV.674"Z>0+>-EDR#NW%R%
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MZC;@=>N:O44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYLH[R>S:="GVBW($B ]2I/0X[]J\VD:'1;K7=6\(^<NF:9H]R+F0RO)#/=J
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>exhibit1013-zerondaxexec012.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BLCQ/XBM/"?AV[UN^CGDMK4*72!07.Y@HP"0.K#O6I%*LL"3#(5U##/8$
M9H ?11U&15/4=4L]*6V:\E\L7-PEM%P3ND<X4<4 7**Q[#7DOO$.LZ3Y!C.F
M>1NE+Y$GFJ6'';&,5KD@#)( ]Z %HHH) &2<"@ HHHH **0$'H0:,C.,C/I0
M M%4[#5+/4Y+U+27S&L[@VT_!&V0*K$>_#"KE !12 @]"#]* 0<X(..M "T4
MF1D#(R>U+0 44=*HK=WS:VUJ=.(T\6_F+?><N#)NQY>S[W3G=TH O449!)&>
ME9&BZ\FLW.KPB PG3KYK(DOGS"$1MP]/OXQ[4 :]%4Y=4LX=7M]*>7%Y<123
M1QX/*(5#'/0<NO\ D5;R,XR,^E "T5CZ%KR:V=3"P&'[#J$MB=SYWE,?,/3.
M>E5[[Q0ECXUTGPV;5G?4()9A.'P$V#.,8YS]: .@HI,C.,C/I2T %%%% !2
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MLJR1*ZE>@WG _"K]%";6B&XIN[*5UIEK>2"2:/+ ;<@D9'H:M+&J1B-5 4#
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M;%?:1YCA0>G;.: -JBB@$'H<T %%%)D9(R,CK0 M%("",@@CUH!##(((]10
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MRB:0+F-]H ^8?."W4[N:(]"L-'T[X>:S9Q%-4NKRUAN;O<3),DENY96/<<#
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M;M>*$O([6[>%+H 8 D53SQQG@XXKH;>WAM+:*VMXUB@B01QQH,!5 P !Z 4
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MFC<WU@DD<#AR  XPV1T-9<G@#1)!K$9^V"WU9S)=6PNG\HN6#,ZKG"L2HY%
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M5^S'@>W _*N7\._V;=^ H+2?7(M+OX-?G>VF(#^5.)I"@=3Q@C=UQG(P<XH
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MU2<!FP/E&>YP*VJ\J\7:G+-=>-((K[3=+CMK5+>5#:B2YU O#N49+#CY]B@
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MZ)>6VKZ1$#):SF)O+WJ3'+D.59..<'/!&* .Q@T?2[6^EOK?3;.&\F_UEQ'
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M\H!X.>E>A@@C(Y%% 'C5AH%E;QR>']5M?%-Q?'49 +:WFG%I+$TY=9@<^4%
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MKD XYYKV.B@#@'OSXO\ &GAJXTZQU"*VTMI[F[FN[22 (S1%%C&\#<V6R<9
M ZUUVB:Q#KNGF\@@N(%$TL)2X0*X:-RAX!/=3BM&H;6T@LH/)MHQ''O=R!W9
MF+,?J22?QH \O\6Q7FHZOXFL+R'7[B=X%CT:VLVGCMG4P_,SM'A"0Y;<'/0
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MILI9[:15WE),L=WR[OF&.5Z<UF/X*U#7[Z]DNM#L?#_VK3+BSNY+2<2?:Y)
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M?:C]E&M^(+0V\=M"Y,4"+&R1IO(&3EB2<8K8U'0+ZYE\'M&L>-*N!)<Y;H!
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ME"",Q-MR1U((&?6S!H'B/R/"]Q>^&[*\;2+1[%K&6\4KNV1!;@$J1_ PQ@D
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M;G' )[\T >DT5Y/XRUN[TR36I[+Q%K,UUI4"-#!9V9>WA94#$7+["K%NIY&
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M,[NO3OUZ=Z +%%>5^'=?NU\4^'HX]:UG4X=5$R7,MY9&&UD*Q-(KP908&5P
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M"IW@E@,9' ]>: .PTC5K/7=)MM4T^0R6ERF^)RI4D?0\BKM<?\*_^27>'O\
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M#;E?7!Z4 <YI_@_5XI;<:GXGEO;:SMW@MH8[<0YW+LW2D,?,('3@#//6IO\
MA"E_X130-"^WG&D3VDPF\K_6^0P.,9XSCU./>K/C3Q2G@_PE=Z^;7[8EN8_W
M2R;-VYU7[V#_ 'L]*+CQ2L'CNQ\,?9"S75D]W]H\SA=K8V[<<_7- &GK.DVN
MNZ+>:5>J3;7<312;3@@$=1[CJ*YZR\(:F^I:7<Z[KPU*'2B7M(DM!"6DVE!)
M(=QW, 3C 49.:ZT.I<H&&X#)&>11O7>$W#<1G;GG% '"GX=W)T_6-+_MP?V=
M?Z@-0CB-H-\+^>LK#=N^8';@<#&>];^J>&8=5\0VFIW$V8H+.XM'M]G$BS;<
MG=GC 7T[U?M-7LKZ_O[*"7=/8.J7 QPK,H<#/?@BKV: .6T+PSK&DS6,-QXD
MDNM,L$,=O;+;"-W7;M42ON._:/0+D@$U?\*^'AX8T-=,6Y-R!/--YA39_K)&
M?&,GINQ^%;&]"Y3<N\#)7/.*P-"\4KK?B+Q!I M#"='FBB,IDW>;O4MG&.,8
M]Z .AHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** .1\>FUN+32]+GTZ34IKV]40V0F$4<Q1&<^:Q!_=@*
M21@Y('%>?@S6]CJN@M;0Z=I\_B>RM)[.SN"\4,4J1M(BOA<*QZ@ 8W$5ZUKG
MA^Q\0001WGGH]O*)H)K>9HI(GP1E64@C@D?C6:O@#PZL%_;_ &25H+]$6YC:
MXD(D9<8DY.?,R =_WLC.: ./\?\ A/PUI'@OQ0NGQP02/8I.=.1E$<;*Q"SK
M'C*L<E=PX./6EUK3[/2_&_POM+"VBMK=7O&$42A5!,2DG ]22:[&W\"Z'#8:
ME:2Q7-W_ &E%Y-W-=W+S2R( 0%WL<@#)QC%/@\%Z1!+H\S?:YYM':1K.6XNG
MD9-X ;))Y&   >G:@#@H=$TS7/!?B_Q!JL"2:Q'<WY6\?_6VAA+"-4;J@4*I
MP/QJSHVF6OBOQK#-K]JEYO\ #%A/+;SKF-I6:3+,O0D9.,],FNNOO .@ZC>W
M-Q-'=+'=N)+JUBNY$@N'&/F>,':QX&>.<<YK8BT>R@UF75HXBMW+;I;,P8X\
MM"64 =!RQH YSX89C\&"V#,8K6]N[>(,<[8TG<*N3V  'X5<\>S6J^&3:W5M
M<70O;F&VCMH)1$9W9QA"QZ*<?-[9K8TK2+/1;-K6QC*1--),06+?.[%F//N3
M3=:T6RU_3C97RR&/>LB/%(8WC=3E65AR"".HH \NM-$O+FY\9>';2RT[13);
M6$J6-O<EK?>7?<I(5=OF*@5@!T(/-=7X%6QL]2U73T\/MH&H*D,MQ8QRJ]NR
MG>%DBV\<[6!X!^49%7#\._#K&9GANGDGA6*>1KR4O,5?>KLV[)=6Y#=1T'
MK3T7PW8Z$]Q-;O=3W-SM$US=W#SRN%SM7<Q/ R< >IH M:Q_R!+_ /Z]I/\
MT$UXY#X9TR/P1\.[^.$QW][=V<%S=HQ666&2)@T9<<[=H"X[ <8KVR>%+BWD
M@D&8Y%*,,XR",&LH>%M*&F:1IP@?[-I,L4MHOF-E&C!"DG/. 3UH \^O(=)\
M+:UXVL[>VEM=*DTNT=K73R(B9)&DC^3LK-\HS^-1V'AN.?Q7J/AJ?0['0[34
MO#[^9:V5SYH+"5525AL4!QN;GG..M>B:AX4T?5)M1EO+8R-J-NEM<?O&&Y$)
M*XP>""Q.1STJC'X2TO1)UUJV@U*\U*UBD&\WCR37*L!\C%V 8?*N QP",\4
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M:YTK4HVDL[E0LB*Q4D @]1R.0* ."71K#7/B)I=MJ=NEU:KX9CD-O(,QNPE
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M"U+4+R[NH;AQ>C_2;<7,BP3,%VAVC!VE@ .<=@>HS5W2O#6G:/=?:K43M/\
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M[3Q#;Z-K<-M>+;_:X@\,\)G^=#DCH50_*P('8BO1O!6I?VOX1L;XVMM;&3S
MT=J,1$K(RET_V6(W#V:@!+KQQX:LM3?3KC5H8[A)!%)E6*1N>BLX&U3R."17
M*^+O'\UEXWL/#>GZG;6"&)Y+RZFLWG*L,;4501USUYK'AU#3;3X.>)]*U">$
M:L);^&>V=AYLEP\K^7A>I)W1D'Z5J".>'XN>$(KK)N$T"19<]=XQG]: /0]1
MU.STBQ>]U"X2WMD95:1^@+,%7\R0/QK/TKQ?H&MWDUIIVI13W$2>:R!64E,X
MWKD#<ON,BL/XN^7_ ,*TU+SE+Q>;;;U SE?M$>1BJNJ7]AJOQ(\*MI-U;W/D
M65[+.UNX8+"R($SCH"V,?2@#HK'QOX:U+SS::O;R+!;_ &J9^0L<?]YF(P.H
M.,YYHT_QMX=U3[1]CU)7:"$W#HT;HWE#JZJP!9?<9KS6SM53]FO3_*AS"/)N
M+I47):,7(:0GU^4$GV%=9J=_8ZO\2O!QTFZ@NG@CNYIVMW#A(&B"C<1T!<KC
MZ4 7] ^(NAZUX;GUN2X6S@@D9)1)N^4>8R)S@9+!0<#)YQUK6M?%.AWND7.J
MPZE#]BM21<229C\DCDAPP!4\C@CN*\BTRXW_  R\(K;ZG;VC6.O.;N611*+4
MM+<"-I$R,#<5ZD=0>U:&N6JQVNK:K-XB@UI%U+3&U7[-:>7''%%)DDX9@QVL
MI/H%&: .XO/B-X=A\.ZGJ]K>K<BPC+/!L='+$$H""N0&(P&QBA?%5MJ;>'+F
MSUF"TBU"1E-M+;L[7)"@E%8XVD'OCFL;QOJOA_5- \5)IS07>IQZ%(9;JW <
M+$=Q5"XXSG+;?3FLS7+NVO-9^%DMK<13Q^>R[HG##(A7(R.] '=:CXV\-Z3J
M#V-]JL45Q'M\T;698MW3>P!5,_[1%3:IXLT+1I_(O]1CBF\I91&%9V9&) *A
M02WW6Z9Z$UPFGZEI>E^&/'UGK%S;PW?]H7SSPS. \J2#,9"GDAE*@8^E3>#+
M.:#QKHZ7T9%[!X.M8WWCYD;S2&'UXY^E 'H6EZI8ZUIT.H:;<I<VDP)25.AP
M<'Z$$$8K@;[X@37/Q0C\-V6IVUG8V\:F9WLWE>>;S=IB'("C'\7(^M;'PW 7
M2-84#"KKE^ !V'G-6?9Y_P"%^:ICK_8$7_HV@#HF\<>&DU4Z8VK0BY$WD'Y6
MV"7^X7QM#=L9SFI;SQ=H-AJHTNYU*-+XRQP^1M8MNDY08 Z'UZ#OBO+Q>V*_
M &XT62:+^V<R6K6>X>>;PSG V]=V[#?3FNN\,P#_ (6SXPFE56N$M-/3?CD9
M1RV/J5'Y4 ;7CSQ#=>%?!E]K-E##+<6YB")-G8=\J)S@@]&-95_K7CGP_9R:
MEJ6EZ/J-A I>X33I9$G1!RS*'!#8&3C(--^,9 ^%FKDD ![;)/\ U\1U8\3>
M/O#MIH5TEKJEGJ-]/$T5M96<RS2S2,,*H523U/6@#6N/&&A6FD6&ISWZI;7Z
M![7",[R@KNX106.!UXX[U8M/$FC7T]E#:ZA#,]]"T]L$)(E13AB#TX)Y'45Y
MC::/JGAO4_!]C-K5MI$L6A20">Y@69/.WHTD8RR@-C'.>0AJ:XL(M(\*6'BJ
MQU5-4_LK69;V2YA@\I&@ED*7*HN2-O+-D''R\4 >E77B#2;*[NK6ZOX89;6V
M^U3AS@1Q9(#,>@Y!]ZRY_&.G7_AG6[_0[U)KBPM))=KQLK(P1F4E& .#C@XP
M<5Y]J$$VJ>"=>\7>8(UU75[:42M'O"6,$ZHC%>ZX5G([@UJ7=N)O^$GOYO%=
MIK%XGAV:%XK2T$:K&P9D9F5V!.0V!UP2: .ET/QE:IX"T37/$%Y%!-?0(3M0
MYDD89PB+DD^P!K4B\7:!-H[:LFIP_84F$#RG(\N0L%"L",J<L."!UKS?PS-#
M8_\ "LKW4)$BLO[)GACEE(5$G94(!)X!*A@/7FJ7BR:TN[;QYJ$16?2)-1TJ
M-GB^9))$=!+C'4X*@X[B@#U/3/&'A_69KB&PU..:6WC\V1-K*?+_ +XR!N7W
M&15:/X@^$Y9XHEUNVS-'YJ.VY4*[=_WR-N=O.,Y]JYW7KZQU7Q_HSZ3<P7)@
MTB_>Y>W<.%B94$>2.Q;./QK&BM;<_##X9Q&%"AU33V*[>"2&)/XDF@#T?2_%
M>AZS#>36.HQNEES<[PT9B&"<L& (& 3GIP:9IOC'P_JT=R]EJ4<@MHO/E!1D
M(C_O@, 2O'49%>>^.H)YM9\<QVH;>V@6CN%7)*B60MQW^4&K-Q$M[<S7LGC&
MQU6XAT.\,5O960CS"ZKRS*[ #(7 /OCO0!VMGXX\-7^I6^GVNK0R7-P,PJ%;
M;)QNP&(VEL=LY'I5#1_B/H.JS:T&N%MX=+E8-++N >-53+\J,?,^W;R3CWKG
M)H8X? 7PR$:*H%_II&!CDQ')_')_.JUE)HTUCX^TW5]473P^OF3S 1OB/[GR
MY-O/RAPO)&WU.* /1]&\1:3X@29M+O%G\E@LJE61D)&1E6 (SVXYK,OO'.F6
M'C:T\,2DBXGA+F3#81]R!$P%YW;B<YP-O/6J?A#5;NX\0:KIM]=:9J<]M! _
M]J6$80RHQDQ'( 2 PVDX!QAN@JMJ5S;VGQJTEKF>.%9=%GCC,C!0[F9,*,]3
M[4 ;DOCCPU#JITV35H5N5E$#?*VQ9#_ 7QM#>Q.:TM:NI;'0=1O(2!+!;22I
MD9&Y5)'ZBO)$O=/B^ ^I:-<S0_VQNN+:2T+#SFNVG;:-O4L6*D>W->GZZLJ>
M"-268YE&G2ASZMY9S0!E^&/'NC:O9Z1:SZG =7N[6-WC"LJM*4#.JMC:2#GY
M0<BM.7QAX?AUH:1)J<2WWF"+9AMHD/(0OC:&/]TG/M7G2W^F7GP^^'FGZ;/
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MI[D!BJ@,!(%.&*,1A\=]I-<MXU@GD\::;%9*1=2:%J<<6S@EML>T?F:QO#4
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M /+3ARJL<]6$;X_W:HW7C^RAEO((+"[NKB+4?[,MX8MN;F?8'8+D@!5!Y8X
MP: .J2WACMQ;I#&L 78(U4!0OICIBJ]KI6G65M);6FGVMO!+GS(HH517SP<@
M#!KG&\?06VG:W-J.EWEE>Z- +BXLG9&9HV!*LC*2K X(Z\$8-<UXY\5:A?\
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M:,"%MH8HH9@78*<D+_.M#3_%FGZIJ]E868DD6\TW^TH9P %,>Y5 ]<_,* -
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M0(2?E.Y2%4\<]:KZ'X(O=$O_  CB:*:+2K2\2[ES@M+,5;*CTW;OPQ0!G?\
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M6<$ DE0".!C&2OAG1M;\.Z1'!:V5A MSJK3RV2S%H[*U8<K&<#+ @'& ,L:
M.SHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4>W=NC7.0<#GBI=/\<VUU/''?:9J&EI/;/=6LEXJ;9XD +$;68JP!!VL <4
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MQ)I\D*E<><!Y ^4G@\C'UK7U?4+[Q#XG&J>'+.]\S2-&O0DMQ:/"&N9 OEQ
M2*-Q!3)[=*[G7M#@\06$5I<2R1I'<PW(,>,EHW#@<]B16I0!Y#HYC/BWPIJ,
M"^([N-1+#>7>HK<,JSR1X"A'&%Y!RR@*,@9])8]-OA\!=,LOL5P+M9K8M!Y3
M;QB\5CE<9Z<_2O6:ACNK>::2&*>)Y8_OHK@E?J.U 'ENJ>']2U7QG\18(+:9
M1?Z-##;2LA5)'\LC:&/!YX/I4VA6^E7FH6<\5EXJU"]LK2622#49)O*@<QE#
M$?-PI9MQ4;<CC/2O4J* /-/![K!XEL[7P])K@T8VTAO;'4H91'8L-OEK&TB@
M@YW#:"PP,]A6I\7[2YOOA9K5M9V\MQ.XAV10H79L3(3@#D\ UV]% 'F7BS['
M!>^>J:_IFN1V,8M+W38))$NR 2(F5596VMV<#[W7%>A:6]Y)I%D^H(J7K0(;
MA%Z+)M&X#\<U;HH \:O[JXL_ _C/PS_9>I2ZM/=WTD,4=G(R212.7$@?&W&T
M],Y)&,9KL?#%I<0^._$4\MO*D4ECIRI(R$*Q59=P![D9&?3-=I10!XUI0O=/
M\/>&++5O[<LM(*WQG73XYEE:?SR8D?RQO52I8C&,G%5[!+S3XM%W:-JS-8>)
MKFYGA>&261(720ARQSYAVL#D$DGCDD9]MHH \HU83>))/'&M:?9WALV\/'3[
M<R6SQM<R@2NVQ& 8XW!>G)Z54326L;7P;J6JG6[2R7P_'93R:=YRRV\H",!(
ML8W;3\PZ<$#->Q44 <9X?O-.\.Z%8>58:Q''JVI,B_;,O-OD+8DDW'*JVW//
M/S#(R:Z36Y+Z+0-1DTQ=]^MK*ULN,YE"G8,?7%6+BS@NF@:>,.8)!+'DGY7
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MV-LVKFWNK5()@(XVCV9A/ YPGWL8)- '96&N:G_PE\?A_48[0R#2_MLDMN&
MW^:4P-QZ8Q^-8%_\0-3M],^T6VG6\]PWB2318XBQ4,H9U5L]B2HR>G)XJS<6
M_B:/Q59>)X- CEDFTUK&YL3?(K0$2[U;?C# CKCD>]9D'@W7_P"S;!+F.W-U
M'XL_M>?RY/E\DLS$KG_>Z=: -2]\3Z_:ZA::$\N@0:N+1KN[N)W=;<*9"L:(
M"0Q8X.23Q@\'(KH?"VNCQ)X=MM3,2Q2.7CEC5]P61'*, >XRIP?3%8'B;PW/
M)XLBUZ'P_8Z]$]D+.6UN3&K1E7+(ZEP1CYF!'!Z=:Z7P_9S6.AVT%Q9V-G.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME954;2RG!Y S@\9[\US5YXD\26FC/IL.JE]1L_%$.E+>21*3+"X!7> ,$X<
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M#+  <# ]ZQM+\1:_XMNO"4*:I)IT>HZ7<RWYMD3<7BD1-R%@0I)SV. Q[X(
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MNY[3Q4+[7!/=^(;:.&646NU82BLN57=]W## SGCDG-:FG>$?L&I:!=_;=_\
M9.EMIVWRL>;GR_GSGC_5].>O6NFR#WZ49&<9H \Z\3>&K;2-&U34KC4KB%I-
M;CU:&Z@M?,^QN%2,%TS\Z  [CQPQ]*@\&R/J_P 2;[68]676(8]*2VEO8(?+
MMQ(9=PCC&3T49/)Y;KV':G74'B__ (1\P'=]@^W>=NXQYFS;C]<UK# '& *
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MRNV-5W?*NU0!DD]^:WET';XUD\1?:?OZ<MCY&SIB0ONW9]\8Q^-;-% '$P^
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M:?#=:9:3I '*1>89) PX^[O50I(]:[F#P?HUM9Z9:0V[I%IUU]L@_>,6,Q#
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M#*A22-QD,I&""/0B@#S34/#VE>%9O!U]H<"PW5UJ,-G<2HQW7<4D;[_,_O\
M0-D]"*Y8Z'IUG\-?',MG:QV\PUZ2U66,898ENHMJCV':O4]+\"Z1I5]:W4;W
MUP;-2MG'=7;RQVH(P?+5CQQQGDXXIC^ -$D.JJ3>"#5)O/N;87+>5YN]7+JO
M0,609/X4 <QK&F6G@[QKIT^@6PMY;K2=0:X"L3]H>)8V1GR?F;)/)Y.:S_"&
MBZKN\+:O9>'TM)7"2W^IG4%D>^BDC)<NN,L2Q#C.<8XKU"ZT:SO-8LM4F1FN
MK*.6.$[N LFW=D=_NBLG3/ VC:5?V]U;F\9+5F:TMI;IW@MBP()C0G X) ]
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MTGER'[#8!)5P?E82$X/H<#\A7">'5O8X? [V^J6NF)Y&IQ03W5OYT8D^T?<
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M607&L3/,(R(,_+""3]Z3OZ+GUH Z.]\8^'M.LK.\NM5@C@O8_-MVY)D3 .X
M#.W!'/09J74?%.AZ596MY>:G D%WC[,RG?YV1G*A<EACG(KB;_[1'\2G;3M<
MTS2K=]$A6TDN+431R1K(^]8SYB 8RA.,\$>E4?#45CH?BOPJ)]6@N]/;1[Q;
M&]:/R(WD:X5R$5B<80X'/(% ':^$?$;^(KG7F6:":TM+X0VLD/1HS%&X)/?E
MC735P?PWGL[G4/&4U@4:V?7'963[K?NH\L/4$Y.>^:[R@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M32+!9YF#RR"V0,[ [@6.,D@@'GO6-=^.($U?^RM-TN^U6\:SCO8UMM@1XG+
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M>SDN@FVX1,;L!6)4C<#M8 X]*V-7U$:1H]YJ+6\UPMK"TS10@%V"C)"@D G
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M""""""00:UZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH Y#QW;7*R>']8@M9KJ/2M26>XA@0N_E,CH
M651RQ7<#@<XS6?:/)XA\;:EK]G:W::;#HIL(Y+BW>$SRM(7.U7 8@  9QU/%
M=_10!XRVDZE_PS#_ &9_9]W]O^S@?9?);S<_:<XV8STYZ=*Z+Q-87DWC?X=3
MQ6D\D5L]QY\BQDK%F)0-Q_AR?6O1** /-=%UF\\(6FHZ"=#U"]U4ZG/):)'
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M\+>./$YN]-U"==5:WN+%[:U>59F6(1M&64$*05_B(&#G->A4V21(HVDD=41
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MM))$NEG)*'S -JXW8;<1C%=WX?\ #MKX>M[A8I[BZN;J4S7-W<L&EF? &20
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M(4\U5 RP!(/&>,UT7AVZEU;XFZKJL=A>0:?)I4$4$]Q;O%YVV20D@, 1UZ$
MX /0BN\J.2>*)HUDE1&D;:@9@"QQG ]3@&@#G_B!9W.H?#[7K2TA>:XELI!'
M&@RSG'0#N?:N7@U);7Q!H7BIK+4FTMM)?39V%C*9+>0.C@M'MW[3M*Y (R!7
MIE% ''^"8+B?4_$FO2VL]K;ZI>HUM%<1F-S''$J!RIY7<02 <'&*["BB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** .<\7>(I=!M["&U^RB]U"Y%O"]X^V&+Y6=G<\9 53QD9) K%@
M\8ZW/IFL"VM]-U'4M&FB>9;)F:.ZMV7<3%R2LF PP2>5[YK5\:^'Y]9BTR[M
M;.UO9]-N_/\ L=U@1W"%&1DR00#AL@D8R!6<NF^(ET"^BTO1=)T*[OITBC^R
ME=UM#C#2NR@!W&6*@#C(Y/- #[7Q]'J3:EJNG)'+X:TRQ,\]X0=\LNS?Y<?.
M/E7&[/<X]:JZ3XZOO[2TR/6)M%>WU.*1T6PF+26C+&9-DF2=WRAOF '(Z<T6
MW@.;28M3\.Z<Q/AG5;!XF$DFZ2TN"FPN,_>#CD^C#/>G:!X>U 26UI?^%=#T
M^*&V:&YO8-CR3L5V9BPH* Y).[GG&.] %C0O$/BS5H]*U@Z78/HNI,"(8G87
M%M$P)21V8[6XQD  C/&:B;QQ?#X6W7BK[-;_ &N&25!%\VPA;@Q#OGH,]>M)
MX<L?&>E6>C^'FMK*&QTYECFU(3!_M-N@(55BQE6(V@DGC!QFL2[\+>+CX'U+
MP=;Z?9^0UQ+)#?M=#]Y&TYE"[,9#<X.3@<]: -)-;URT^)GB-KNZMCHVFZ=%
M/)" ^1%B5@5&<;^/F..0 .U2Z)XYU&YU'11J3Z,UMK.5BALIBTUHY0R*LF20
MV0I!("X;%37_ (;U2;QMK,HM(YM(US34LIIQ.%>W*AP3L(^;(?M4?A?0-3L+
MG3+:Z\+:%:+8Q[)]2C"O)<%5VJT0"@H2<$EO<<YS0!V][+/!87$UM;_:+B.)
MFCAWA/,8#A=QX&3QDUP^E^--4_M>33=1FT2ZF?3IKR,Z;*6\AX]NZ.0%CG[X
MPPQG!XKIO%NEW6M^$=5TRQE$5U=6SQ1LQ(&2.A(Z ]/QKCH_#>N2:W8ZA#X=
MT[2[5+"XL&M()TW1[PA$A(4!AE<;1R.N><  DL?&GB9M,\-:Y?66F)IFL36]
MN\$>_P Z,RC D#$[<;N=N,X(YS4.O^(?$&M>'?&$]A;:?_8UBEW8LDF_[1-L
M0B1U8': "3@$'.WJ,UHGPKJ9\#>$-)V1?:M+N;"6Y&_@+"1OP>_2J%SX?\56
M6F^*/#^FV%I-9ZO-<SV]\]UM\D3C+(R8R6!+8(..1G&* .T\*_\ (H:+_P!>
M$'_HM:\XDL-5U'X^SBYBT>X^S:;')$+B!W$</G\%<GB7_:Z5Z;H5I+8>'M-L
MYP!-;VL44@!R-RH >?J*PK?P_?Q_%>\\0LL?]GRZ2EHK;_F\P2;CQZ8[T <#
MK^K)J_P:\>.FFV5C]GU:6W*VD>P2E98OWC^KG/)]JZZ[\57T%[:Z)I=QH]K)
M!IT-S//JDA"L7R$C4 @Y^4DGG QP<UC2> =<;X;>,=#$<'VW5=6FN[8>:-IC
M9XV&3V.%/%:VI>%[RVUV/5H?#^GZXLVGPVDUO<NBM#)&6VNK.I&TAB".O /-
M '4^&-<7Q)X;L=66(1&X0[XPVX(X)5@#W 8'GO7/^+_%.MZ#/>S0'1+>RM+?
MST2_GQ+?$ EEC 8;<8P"0<D],5T^B6LUEHMI;W,%E!.L?[R*QCV0JQY(0>F3
M^/6N&UOPEK-YJ_B=(-*T^Y&LQJL&IW,@+6B>2$*;-I/4$C'&6R>E &G-XHUW
M4O$PT?0K>P1'TJ#41<WH=@F]G&TJI&3PN.1CGGH*JZ9X]U&8>'9M0LK:&WO[
MVXTR\>,L1%=(S*FTD_=<H1SR,CFKGA?0M6M/$46IZA;1VZ_V';6+(LH<B6-W
M)Z=L$'/O63J7AQM.^%&OVVJSQ6DL=S=:A!.'R(W\YI8FSZYVC'7G% '56.O7
M.H>-M5TF&&+^S]-MXA-,<[S<298*.<8"8)[Y85%XQ\0W&@PZ:EJ]E!)?W?V?
M[5?DB"#Y&;+8(R3MV@9')ZU'\/\ 3KJS\+I>:B@74]4E?4+P8QMDDY"X[;5V
MKC_9J[XFCU*6RB2RTJQU:W9R+NRNF"^8F#C:6RN0<'##D=Q0!F#Q'K=G=^'K
M/4K6Q$VHWLMO)+;N61XUB9UD3G(SM'!SCFH=7\<RZ->>*4EM$EBTBWM'MU4D
M--).64*3T W!1G'<]:Q;?P?KNF:?IE[8Z=;+-8ZQ+?1:0+KY(8)(S&8UD(P"
M"2V.GS$5)=>#=?U\^+9K]+6QFU:"R-FJR^8(I(&9@KD 9YVY('<@9QD@%_5[
MGQ4GA[7[77;/3Y+9]'N9$N[ LJQN$(,;*Y).0<AAQP<@53T+7_$.DZ?X/%_;
M:=_9.IK!91I&7^T1$PED9F)VG.SD #&>IK2N(O&'B"PU2VOM/M--MI-,FMTM
MUN!,T]PZX#;@!M0<^YSSTJ2\\.:A-H_@RV18_,TF[MI;K+\!4A9&QZ\D4 =?
M,[QP2/'&97525C! +'' R>!FN&T7QAJTGB73]*U:31)'OX97$.GS%Y+.1 &*
M2?,0W!(R,<BNLUZRN-3\/:G86LWD7%S:RPQ2YQL9D(!X]":X/2_#>N6^K>&;
MY/#FFZ;;Z6KV\\$$ZEW#Q[6EW!0" 0,+U.3F@!EGX^\4/X/L/&%W8:6FCNZ+
M<P(9//"-)Y9D4YVC!.=I!X[^FH_B/Q9J.L>(K+1;32E31YE17NO,)GS$KA %
M(P>3\W3E>.M<IX8TSQ%XB^%&C>'5L;8:;<^6TFH_:,%(5FWE?+QG?\NT<X[Y
M'0:^G7/B*V\4>.1HNFV]\);Y$7S+D1&&3[/'\QR#N7D=.?E[YX *MYK<?B/Q
MW\*]9BC,:WD-[+Y9.=A, R,]\'(K1M_&<&E7'CZ].D6<9TFXC4&V39)=NPPO
MF-W.X@9[ T6G@+4--U;X>^0T4MMH$%Q'>2;L$M)$%RH[@MG\*:_@#4[U?'L,
MSQ0+K=Q%-8R[MV&C&5+ =!N _"@#H+*^\96UQ+'JNEZ?=HUH\T+Z?(8PLJ](
M7\P\[L\.,#@Y K*TOQ=K=QK(T>YN/#\][=6,MQ ;&1G6VE0KF.4;B2/GZC&=
MIXIVIVGC?Q1I&I6%Q;6>C12:=+ %2X\XSSL  0P V(!GW^;IQ4&FZ!K*>*-$
MU5?#NG:596UO-9R6MO.I= X3]X2% 893 7KW[X !SEMXDU6#X,Z;K&MVVFZQ
M]HNXA$EW&TG#2L"S[CRP/3'3BNYO-=U[4/%&H:+X>CTZ,:;%$]U<7ZNX:20%
ME150C'RC)8D]1Q7(-X*\3W'PLM/"DMA;1W.GWD31S"Z#+/&LC,6''R\$<&NJ
MN=/UW0O%^JZQH^FPZG;ZM%#YL37(A>&6)2H.2""I4CW!'2@#/B\?:MJ,/AN+
M3M.M5OM5ENK:XCG=BMO+!D,<CJN58XZD8'&<UN^%M<U._P!0UK2=9CM!?:7-
M&C2V@81RI(@=2 Q)!Y((R:Q-%\%:GI=YX4FF>&62RGOKG4'1L#S+A6.$!Y(!
M;'T&:W]&T>[L?&'B;4IE06VH/;& ALD[(MK9';F@!/$^O7NFW>DZ5I4,$NIZ
MK,\<)N2?*B1$+N[ <G    QDGK6!J/CC6=#TSQ/#J-M8/JVCVL=Y"\(<0W$;
MD@':3N4@J01D]JV_%>CZC<ZCHFN:3%%<7NDS2-]FED\L31R(4=0V#ANA&>.*
MYO5_"6O^(M-\5W]U:P6NH:K8QV-G9B</Y:(2V7<#&69B>.@ YH [3P]<:S>6
M+76L16<)F(DMX;<L6CC(!"R$\%_7'%4?%&K:QI]Q;1V$ND65NZ,TM[JLN(PP
M(VQJH922<DYZ #O706T;16L,;?>1%4_4"N.\0Z'J<OC2#6+;1['5H#8?9$2[
ME"BUDWEC)@J<@@@';S\M %&/Q[K&IP^$UTJQLOM&N1W/F&9V:.%X< L"O++]
M[CJ>.1UIE[X^UO2-*UN*]L+*?6-)O+2%EMRPBN(YV7:RY.5;!88).".]8=MI
MGB#PYJ_@C3OLEM-?6+:H%3S@J741VMD'!V$AN >Z^AS4GBK1]83P]K^N7\4%
MEJ&K:GIRPVXD\T0)%+&J;F& 2223B@#L++7M>L_%EMH?B"'3BNH6LL]I-8[Q
MM:,KOC8,3GA@0PQTZ5YSX:U9-&^ N@7#Z;97X?5/*\J\CWHI:=_F _O#L:]"
MM=-UW6/&ECK.KZ=!IUOIEK-%#&ER)FFEEVAFR ,* O&>>>E<K#\/-?3X1:/X
M<:.#^T;74EN95\T;0@F9^#W."* .LU#7_$-[XAU32_#=OIQ_LJ.,W#WV\^=(
MZEEC3:1M^7&6.?O#BH]:\2>(K6&UECAT?2%:S$\O]KW():;O H5AT[OR.1@=
M:2\T[Q'H?BG6=3T+3K;48=8CB)66Y\DV\T:; QR#N0C:>.>#5";PSXA&O2W=
MU8:;K%Q>:=!:F^G*JMG(N_S&6,@DJ2P8!<9(P<=: *LGB77]:\6>";C3);6V
MLM3T^6[-O+O.3M0L'P0&QN^7CKG-3Q>,X-(O/']ZVD6D9TB6$;K9-DEV[+A?
M,;N<D 'L#4&F^&O$VE?\(5=+IEO/+HMK/87,(NPN58(JR*Q'(^7..O-2R^ -
M2OW\?PSO% FN2PR64N[=AHQD%AV&X#\* -B#7O$>E:[H]EXBATQH-69XHWL0
MZFWF"%PC;B=P(!&1CD=*PXO'?BAO"</BN2QTM=+2Y\F>#]YYTB>?Y1=#G"X/
M8@YP3D9Q6NNG^(_$7B#0[K6=,MM-M=)D>X?9="8W$Q0HNT #:HW,>>>@Q5(^
M#]6_X4^?#6R+^T3*6V^9\N/M7F]?]V@"Z?%&N7GBC4M/TQ-(*:=<I"]C<2,M
MU.A5&:1#G:%PQQD'.T\BNV9@JEF. !DFO/O%?A_6_$%Y+;-H.FO()T:PUQ)A
M'+:("#R,%RPPW0X.1TKT%U#HR,,JPP10!YQ_PG/B$>&5\9-9Z</#QD#?9OG^
MU"W+[/,W9VYQ\VW'3OFM2+Q'X@U'Q]JF@Z?;:>MCIDEL\]Q/OW-'(@8JH!P7
M^]@]!CG.:P_^$5\3MX,7P&]G:_V<&$!U;[3UMA)N_P!5C/F;?EQTSSFNJT31
M+RP\;^*-4F5!::C]D^SD-DGRXRK9';DT :NO:O#H&@7^KW"EXK.!YF5>K8&<
M#Z]*Y>/Q)XGTRYT237K;2Q9ZO,MLJVOF"2UE="R!BQ(<?+@D!>:Z3Q+HR^(O
M#.I:.TGE_;+=X0^,[21P?P.*Y<:7XGU^Z\/VVLZ=:V-MI-REW//'="7[3)&I
M5 B@ JI)W'=SQB@#C;_4?$-[\.?&LVK3V]S'!K!A1(@^X.EQ$-J[B0$XX'O7
M=+XFUS2/$D%CXBATX6EW9SW43V6_="80I9'+'#?*WW@!R.E8<_A+Q&^A>+-"
M6QMS%J&J-J%K=_:1APT\;["N,@@*W/M74>(O#EQK7BG2+G"_88;.]M[AMV&'
MG*BC []#0!BZ-X]U"ZN]$FOWT8V6LN(XK>TF+7%H60O'YG)#9 P<!<$CK5_P
M;XC\0>)Y[BZGM=/M]+M[FXM6V[S+*Z.0&7G 7& <\DYZ"J7A?P[J>F2Z58W/
MA?0H%L%"3ZJH5GN JX5HU"AE8G!)8\<]<UM^!M$O-!T.XM+Y4662_N9UV-N&
MQY"R_H: )O%VO7.@Z;:?8((IK^_O(K&U68D1B1R?F;'.T ,>/2N/?5M1T3XC
M7^H>(4M6:P\,R3F2R#*DJ"8-PK$E6R",9/8YYP.K\:Z-?ZMIUA-I:Q/?:9J$
M-_#%*^Q92F04+<XRK-SZXKG[CPQKOB?7]4O-8M(-.L[[0I=,2*.<3/$S.#N8
M@ $]3QQP.>: +4/BCQ+8-H5[KEKI@T_6+B*W$5KO\VU>4$Q[F8X<9PIP%P3Q
MFEB\3>*=4:]U+1=-L+G2;2]>U%L[,+FY"/L=T;(1>=V 1R!U&:@71_%&MKX>
MTW5]/M;.VTFZANKB[CNO,^TM"/D")@$ M@G=C&,<TMII7B_0$O\ 1=&M;(VM
MS?R7-MJ<DX_T:.1][JT1&68$L!@X.1G% &Q9>)KJZA\5NT,(.C7,D,.,_.%A
M60%N>N6(XQ6/;^,=?U2\T"QTVUT]9]4T1=2DEG#E(6RF> <LOS8 R#R.>*2?
M1?$]C?>*;/3K"UGM-<D,T5[)<[/L[-"L;!DQEB-N1C@YY(JQX<\+ZGIFM^';
MJY2,16'AP:=/M?)$P:,X'J/D/- &0_CSQ8GA?4M<;3])6/1+F6VOXBTA-PT;
M[7,1S\@QC&[.3G\=36O&FH)K>I6.DS:-"NF0QO*-2E*O<.Z[Q''@C;\NWYCG
MEAQQ4-QX0U:3P#XOT=4B^UZI?WD]L/,X*22;ER>W%)J?A>_M/$>I:C:^&]*U
MM=2BA(-XR*;:9$\OG<IRA 4\<Y!XYH GC\9ZQKFL:?8^'[:R2.^T:/5!/>;B
M(=SD%2%(W'H,<=SGC!PM9\6>)M0T/0WMFL[*]'B-=+O0ADV/(DI VD$'RSM.
MX'D@XKKM.\/WMIXUM]3>*U2V31$LF%L-B"42[B$3LN.E<]>^#]=31B;:W@GN
M[?Q4VLQP&8()8O,+!=V,*Q![T :+^*/$4_B*^TJQ716N-.\E9;.:1TGN]R*[
MO%DX5?F(&0W*G)%=W7G/BG0_$'B6&6UN/#>F&XD5&LM36Y"RZ<2%)R<;F9&W
M$%2 W' YKT4 A0"<GU]: ."G\9:QI^OVD.H?V+';W6HBR6PCGW7D:LQ5)6(8
MJ<\$J!P&ZY%5[GQAXJET_P 2ZEI]GI2VF@W5Q$XN/,+W"1#<0N#A3M[G.2>@
MQSE0^#?$=MI6GVD6AZ;]ITS4TOI+SSU\W4=LV[@[<J2#DECU &,=.D@\,ZDG
MA3QGI[)&+C5KF^EM1OX(E3:F3VYH >WBC6=9UY--\.PV$:16$-]<RWP=O];G
M9&H4C!PI)8Y^E-^%DDDWA&>2:+RI7U.]9X\YV$SOD9[XJK:Z)XB\-ZW%J.FZ
M=;Z@EWI=M9W4+70A,4T((#9(.5(8CCGBMGP'HNHZ#X<>SU4Q-=M>7$[-$<JP
M>1F!'IG/2@#)U>_\0CXMZ1I]G=6J6#6$TS1.'^9=\8<L <%A_">V3ZU7D\;>
M(I?#][XML[+36T"VDD*V[[_M,T$;E6D#YVJ?E8A<'@=:UM;TK5T\?Z-K^G64
M5Y;Q6LMG<(TXB:,.RL'&0=V-IXK!;PSXHMO"5]X(M;*U;3[AYHHM4:YQY=O*
MY8AH\9+@,P&.#QS0!Z5#,EQ!'-&=T<BAU/J",BO+/%'B'Q!KW@3Q9?VMMIXT
M.)+JS2-M_P!HD5,HTH;.T#()VXZ#K7J-O EK:Q6\>=D2!%SZ 8%>9W?AKQ9;
M^%_$/A/3["SDM+V2YDM;][K;MCE)?RV3&=V6*YSCG/;! -B#7=<OM0CT+P\F
MGH;#3[>:[N;Y7<;I%.Q%52.RDDD_A6[X2U]_$6AB[GMUM[N*:6UNH5;<J2QN
M4;![C(R/8U@QZ1K_ (=U^;5=+TZ'4H[^QMX+FW-R(7BEA!"L"005(;![\=ZV
MO!NAW.@Z"T-])&]_<W,UY=&+.P22N6(7/.!D#/?% %?Q1K&LZ==PQ6$NBV5L
M8F=KS59L*[YP(U4,#G');H..M<;XDUH>(X?ACK'E>2;O5H9&CSD*V.0#W&<\
MUT6N:%JC^-GU6VTBPU.&>P2UB>[D %DZNY9MI!W*0RD[>3MQ[UBP>"=?_L;P
M192V\"OH.IB2=A,"'B4G#KQWS]V@"]X4_P"2S>/_ /KG8?\ HDUT_BS7Y?#^
MDPRVMNEQ?7=U%9VD4C;4:61L#<1T4<D_2LW0?#M_I_Q'\5ZW.L8LM32T%N0^
M6/EQ[6R.W-7?&6B7>MZ3;'3FB%_87L-];+,2$=XVSM8CH""1GWH R)?$7B73
MM2N-%U%=*:^FT^2\L;J!)%B)C(#HZ%B<@,""#S7'VE[X@N/"GPZO+E[>]OIM
M04V[.[@L#;R#,K$DD@DDD=AQ79PZ/K>O>)O[9U>QATR.VT^6SMK<7 F=GE(W
M.Q4   * !UZGBLK0O#'B*/2/!UC?V$%NV@W@,CK<AQ+&(9$WC@8Y8<=: +<O
MCG5=#B\20:[;V,UYI45O+ ]H6CCG$[%$4[R2N'&"<G@YI;?QMJ-M/J-E?S:-
M>W,>ES:A;2Z<[&/,>-T;@L3U92#D9&>!BCQ#X*O]<U+Q.ZF!8M0L[-+5I3N4
MRP2-)AQ_=SM!]B:DMM#U*[LM60^%=&T7SM.EMXA 4:625P1]]5 6/V/)Z\8H
M U?!>K:[KVCPZOJMO8V]M>6\4UK%!O,@!7+%R>,'@@#H#R3735D^%M/GTGPE
MHVG7047%I8P02A3D!E0*<'OR*UJ "BBB@ HHHH **** "BBB@ HHHH ****
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M8$[B3W.,<5M3V6N6WCRTT%?%6IO9ZC82W-P["/S$>-E'[H[,(#O'&#P#CGD
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M^4(XRGWL\YSGH,5B6WP\U)+'1M.N_$IGL-&NH+BSB6R",1$V561MYW?+\H(
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M&/:M>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** //_ (L:;97^F: ;NUBG(UNTB'F*#\CR .OT( !J
ME%X:TF_^+M]:7%I&]E8Z3:-!:](T96<(=H_NC('IFNZU[0;#Q'IAL-121HO,
M656BD,;HZG*LK#D$&F:?X=L--U%M0A\][M[:.U>::9I&=$)*Y+'D\G)ZF@#R
MO4Q#(\?B33=#CC$GB"(1ZU<WO^E2'[2(V54"?ZL@,H4L/EYQ5_\ L;3=<T?X
M@:UJL*2:E;7MY!#=O_K+:.*,>6$/\(QSQUR<YKKYOASX>G%RDD=X89I3.D(O
M)!';R%]Y>)<X1MW.1ZGL34EY\/\ 0;Z\N;B9+P"["BZ@2\D6*Y(& TB X8X
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M!@D'UJII7@?1M(O[>\A^V326B%+1;J[DF2U4C!$:L2%XXSUQQ0!Y=/H6G?\
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MOJ<7V>R&ZY:0-&81C(+!@" 1T..>U4_'VH?V=X7+>39R>==6\&^]CWPP[Y5
ME<=PIPW4<@5P4LNG7?B/Q1::YXF2XMY-*M$>_@A6,(PF?!4+D,$9ER>0.0<
M&@#T_1O$FD>(1,=+O5G,! E3:R,F>A*L <'!P<8.*K:AJGV7Q9IUDVKV\"2P
M2R-8M 6DGVC.Y7S\H7N,<UD>$]4O)O$NH:9?W>F:M/!:12KJEC$$9D9G CE
M) 8$%@ <8).!5#7_ /DN7A#_ *\+O_T&@"+PMX^G\4>/=1LHM2MHM-M9C%;6
MHLW,ER A)<R$@)@\XQR./>NVUGQ!I6@112:G=K )F*Q+M9W<@9.U5!)P.N!Q
M7(_#O_D:_'O_ &%Q_P"@"F^*Q>1?$K2)H]9MM)233)XH+BZMQ*AD\Q"R#+*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#:L[PJSJ/0,1D"I$LK6-H&2VA4P*4A*Q@>6IZA?0<#@>E3T4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M454U34[31M+NM2OI1%:VT9DD<]@/YGVK/L]8U2[BTB7^P9HXKY6>X+7" V8Q
ME-ZGEBW3"YP>M &W116.GB"-?%3Z!<P-!,\'VBUE+96X0'#@>C*2,CT(- &Q
M116/XH\267A+P[<ZWJ"3O:VVP.L"AG.Y@HP"0.K#O0!L44BL'17'0C/-+0 4
M444 %%%% !1110 445D/K@N=)O;O1;9M4FM9GM_LZ.(B\B-M=0SX'!SSTXH
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M*:4QHW^CR9RP!QQGL:;+I&O7E[?^(=>BL;0VVDSVMM:V<S2_?PS.[E5_N
M>M==?:/::A?Z=>W"N9M/E:: AL ,R%#D=^&-6KF!+JUFMY03'*A1L'!P1@T
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MD@Y!R"".000"".A%9^C^$['1]0DU 7%]>WSQ>0+F^N#,Z1YSL7/ &>3CKWH
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M?"V,P1E#J-@Y7;P28G8_F>33/'$<IU3Q\+?"[M,TYY3LW#8)7WD@=1L#9]J
M/1].\6Z!JUO=7%CJMO/':)YDY5O]6F"=Q!YVX!YZ<4VT\9>'+_5(]-M=8M);
MR1=R1*_+\9(!Z$@<XZBN(U"TFFFU*^NO%&EZA<Q^';M%M["R,6Z!@"&9O,<8
M! Q]3BI+FWAM_"'PQ$,:H%U"QQM&,;H'W?GW]: .I\,>.='\5WVI6FGSHTME
M.T8 ;)E0!/W@XX&YMOX5N2:C9PZC!I\EPBW=PC211$_,ZKC<1],C\ZX_X=3Q
M?;O&5OYJ>?\ \)%<OY>X;MNV/G'7'O4WQ =-*DT#Q.YVII6H*MP_]V"8&)R?
MH60_A0!T]KK&G7MU>VUM>0RS6+!+I%;F(D9 ;TZ&L9?$UK<ZW9O;:YI[:;-8
M/="#8QED4$_O%;.-@QZ5Y=-<7?A[14U-5*WWC#2YE [FZEGW1?B$N6'_  "N
MGCTZ'2/C-X8TVW'[FT\.O GT5L#^5 %R7XGV>H^'FU#1I8/,BU6&SE64[L1-
M<>7O[8W*"P]*ZW1_%&AZ_//!I6IV]W+  9$C;D ]#[CW'%>40&VNOA6EE(T<
MA_X294FA)!(!ONC#W!KO)E5?C-8E0 6T"<''<">+'\S0!U5]?VFF6,M[?7$=
MO:PKNDEE;:JCW-9MKXNT"]TJYU.WU6W>SM3MGESCRCQC<#R.HZU1\>WWV+0K
M9!!9R/=7]O;H]ZFZ&%F<8D89&=I&1R.<<UYGXAGD>U^)$5SJMOJ,_P#9ED&F
M@A$*L0\@( #-G' )SUX[4 >L6WC+PY=W=U:V^L6LL]K&TLJ*V2$7[S#^\!WQ
MFKSZSIL>B_VR]["--\H3_:2WR;",AL^E<MKUM!#\0/ T,<*)$J7L00+P$\@?
M+].!Q7(6]O(UU%\+'#&&WU4W#9Y!TQ<3J"?]\K'^% 'LD<BRQK(ARC ,I]0:
MP5\<^%VN[>U77+,S7+;(EW_>;)7&>@.01@]:Z"O$S9VS_L_D-"A$NJAGX^\3
MJ&W)_P" \?2@#U72?%.A:Y/<0:9JEM=2VX#2+&_(7^][CW'%)I7BO0=;NI;;
M3-5MKJ:)2[)&^3M!QN']X9XR,BN%\>03MXKU".P0BX?P??(@C')Q(F /S./K
M4FA6KW>J>%;J7Q3I%PEO:R/9VEE8&-WB,.TJ6\UL*,H>G510!UL7COPK/=06
MT>O61EG3?&/,P",;NO0''.#SBJU]XVTRY\*Z_J.@:C:WESIEG+,5&2%8(S+N
M'!P<=>_K7GUG8VK_  5\"PM!&8Y-5LBZE>&+3D-GZ@G\ZV/&JA?$_B_: -W@
MQRV.Y#RB@#L-"\::)K#VM@FJVDFJ20!WMT;G=M!<+ZD<Y )(QS5M?%>@/K9T
M9=6M3J 8IY&_G>!DKGINQ_#UK@[JXTVYT3X:V^DR0M<+?VK11Q$;TC6%O-R!
MR !PWOUK)T*QO+SPI8V=]XITNR5-7^:V-@6N5NUN2VW=YN=Q8==OW6]* /4O
M^$JT+^U4TO\ M2W-^\S6ZVX;+^8JAF7'L"#^-:EQ<0VEM)<7,R0P1*7DDD8*
MJJ.I)/05Q'@*WA'BCQQ<B-?.;5_++XYVB)"!^9-6/BFI/@.Y9E+6R7-L]T ,
MY@$R%\^V,D^V: -:P\9^'-4CN7LM7MI1:Q&>8 D%8QU?!Y*^XXKF/ ?CRX\8
MZ_JBM?Z<EI!/-%;644+F9XT*@2ERV,'/3;5K5KFUO?B?X0_LZ:&:2*WO)+@P
M,&VVYC4+NQV+[<?2H/A)_P @CQ%_V,-Y_-: -[Q5XTTOPBVG)J$JJU]<K"H+
M8VK_ !.>.@X_.LN/XA:=9^(==M]7U&TMK&V:W^QN0=TBO"'8GKD#(YQQD9IO
MQ(D2&;P?+*ZI&OB*W+.QP!\DG4T>'H;>;X@^.I]D<AD%FF_ .4-N#C/H: .C
MU#Q/HFEV%M?7NIV\5M= &WDW;O-!&<KC)88YX[5?L[RVU&SBO+.>.XMIE#QR
MQL&5AZ@BO%?"@U$'P4]MJMEIQ;P_*EO->VQF1G$JEU4;TPVW:>O0&O2O 5G'
M9>'9%AU6#4HI;RXE6>VA,40+2,65%W-\H;=C!Q0 GB#Q-?VVNVWA[0+"&\U>
M>$W,C7$ACAMH0=N]R 2<G@ #/!HTK5?%4.N1:;K^D6C0SQLT=_ICNT2,O\,B
MN 5)[')!K(N[VW\-_%M[S5)5M[+6--C@M[J4[8Q-&[$QECP"0P(SUQ5>\UO4
M[;QYI%G8^+X=3AOKU_-TR&VB8P6^QFR77+  A1DXSF@#KXO%>@SZLFE1:K;/
M?L\D8MU;+;H\[P1VQ@]?0U'I_C+PYJNHC3['6;2>Z.[;&C_?V]=IZ-CVS7"Z
M-9R/X.^)CV$7_$PGU/4T1D'SL0OR@?B3CW-2:C=Z9>>%/A_!I$T#SG4+!K:.
M%@65%'[PX'( 3<&_6@#T+^W-,_L^\O\ [;%]DLVD2XES\L31_?!^F.:J:CXP
M\/:2Q6^U:V@<(DFQF^8J^=I ')SM;IZ&O.;C4K*T^&'Q!MI[F)+C^T-2C$18
M;RSL=O'7D$'Z5KZ)<Z?;?%68W4L,5PWAVT$+2,!\NYRP!/\ P$_A0!Z%97UK
MJ5E#>V5Q'<6TR[HY8F#*P]0:Y[Q!XFO[;7;;P]H%C#>:O/";EVN)"D-M"#MW
MN0"3D\ #WJG\+]I\+W<D&/L,FJWCV>W[ODF9MNWVZXJK=WUOX;^+CWFJ2I;V
M6L:;'!;W4IVQB:)V)C+'@$A@1GK0!KZ1J_B:/7%TKQ!I%N%FB:2'4--9W@RN
M,HX891N>.QJW!XS\-W.K?V7#K-H]Z7,0C#_><=5!Z%O8'-5K[Q787E_-H.D3
MF\U*2SEEWVI#I;X7Y3(P/RDDX ZUP,MSI\OP-\/6-C)#_:1DL8K>%2/,6Z69
M-_'4,"')_&@#T;4/&OAK2II(K[6;2"2.7RI%=^4; //H,,O/3D5+;^+- N]:
M_L>WU:UEU#!Q"CY)QR0#T)'<#D5Q,-O"T'Q5D:)2[O(C$CDJ+12!^I_.F^1%
M;Z-\*O*C5-L\ &T8^]:.6_,\F@#L)/'7A:&ZCMI-<LUFDD,04R=&#%<$]OF!
M'..E6-6\6:!H5W':ZIJMM:SR*&"2-R%)QN/]T9[G KR^WNM&3X0^.8)9+<7#
M7NH!XV(W-*9&$7'4G.S'T]JM:Q?WCV?B>W>[TW3'L],@M[SS;7S;F_=K?<%S
MN&!ERB\$YS]* /2-3\4:'HTACU'4[>WD$:RA';YBI) ( Y.2#T]#5'5/$EM+
MH-AJFE:YIL-M<W,<:7,ZF2.4$D%%P1AB1CV(/%<OX36&Y\=:)<G9*Z^#[?9)
MUP3)@X/K7+:X G@>1% ")XYD55'0#SVX% 'KVJ>*]!T2]CL]2U6VM;B0!@DC
MX(!. 3_=&>,G I-4\6:!HEY'::GJUK:SR*&5)'P0I. 3_=&>YP*\_O8KQ_$G
MCN&;7]*TRVE,9N%OK(RL]N;=5# ^8OR_?&,'G/K3KR'^P;*\N],U_2[Z2WTF
MWCU;3]3AVK=QI$=KJ2<J64G@[AD\\YH ]7!R,CI56\U*RT][9+RYCA:ZF$$&
M\X\R0@D*/<X-0:;JME=+;VT3QPW+6D=S]C) >.-N!E>PR"/PK-\<Z'+K_A&\
MM;4[;^("YLG'59XSO0CZD8^A- &S<:E96M]:64]S''<W9<6\1/S2;1EL#V')
MK,L?&?AO4M3&G6>LVDUV2RK&C_?*]0IZ,1[$UP-E?S^/H=>\464;@VNA-86"
M '(NI(O,FQ[@F-/P-27MWIEU\/\ P);:5+ ]T;W3_LL<3 NK(1YAP.1A0^[\
M<T >D#6M--E>W@O(C;6+2)=29XB,?+AOIWJY#+'/#'-$X>.10R,.A!Y!KR:3
M4K*R\ ?$JWN+F*.<W^I((F8!R9%^3 Z\Y&*]+T#_ )%S2_\ KTB_] % &?;Z
M]%#JGB$WVL6#6FG"-VBC0J]HI4D^:22#G&1@#@58LO%OA_4M6;2[/5K6:^4$
M^2C\G'7'8X[XZ5Y;?_\ 'Y\:?^O2W_\ 2=ZZO5+>*VU;X;I!&L:Q3O&@48VK
M]D?@>W H Z8>+_#S:W_8PU>T.H[_ "_(W\[_ .[GIN_V<YIM]XR\.:;J9TZ]
MUFT@NP5#1N_W"W0,>BY]R*XOP??^'H/AUI5GKK0O>)J)CDMR-TWVW[0V#M'S
M;MW.?3GI5>RN]-M?AUXZMM4E@2[%YJ/VJ.5@'=V+>7P>3E2FW\,4 >@:KXJT
M'0YC#J>J6]K*$639(V&*LQ52!WR0?R-5[SQSX7L+@P7>N6<,JRM"RL_W'!P0
MW]WGC)XKC_#5F_\ PLS2#J$>Z]M_!UL&\P9*R>:P8_7J/Q-5=-O-%@\._$V.
M\EMTE.HWQG61@&9"F$X/49R![YH ]$UCQ-HN@>3_ &IJ4%L9LF)6.6<#J0!D
MD#UZ4LWB;0[?3K749=5M%LKK/D7!D&R3"ECANG16/X&N"\$/_9_BNW&MR+#>
M/X8T];=IVVG"AO. )[AMI(^E8,-O!>6>@XC633+CQQ/)9KCY&A_>D;1TVE@W
MM0!Z?<>.?#%K8VE[/K-LEO>*7@8D_.H."P&,X![]*KZKX_T+2=>TG2IKN(MJ
M,;2K*KY5$QE#QU#'@8K)U[4I/^$TOK>"\TO219:7')/>75KYTL\;N_[M!N7Y
M 5.>N2P&*Y?PQ=0Q7'PIDFGC15TV^C+.X #!(QMY[\=* /3I_%>@6VM+H\VK
M6J:@S*@@+\AF^ZI/0,>P/)K9KQ9;&\O="\2V%YXHTO3()-:N!/%-8&2=9#-F
M-@WFC)(\LK\O3'I7M(Z<T <WI/B*W&G7=UJ6MZ=/&FH-:K- IC2,D@+$V2?G
M!.">G-2VWC?PS>6][/;:S:RQV2>9<%6^XG9O<>XXKR;3X8[CX?:Q#*@>*3QL
MJ.K#(8&XB!!KO-90#XI)L4!F\,W2G Z@31X'ZG\Z -/1/'^A:OX33Q#)>0V=
ML !,)9/]2YZ(3W/(X%;&CZ]I6OP23:5?0W21MLDV'E&]&!Y!^M>4Z+=6O_"+
M?"V>XGB.G6]QMN"6!6.8PN(MWH=W3/>NPTJ6*Z^+^M36#I);II-M%=O&<KY_
MF2%02/X@GZ8H ZK5-6T_1+%KW4[N*UMU(7?(< D] /4GT%58?%.A7&EQZG%J
MELUE),(%FWX7S"<!3Z'/8UD>-;V2&\\/V, L8KB[O6\J]OHO,2U9(G;<JY&7
M(RHY'4UYW(T=]8ZS;W%[!J(D\7V DDCB$:2@B$$A,G@X(SDYQF@#U.W\;^&;
MNUO;F#6K5X;)0]PP;_5J> Q_V??I6I>ZI8Z;9K>7EU'#;LR(LC'ABQ 4#UR2
M*X_4]/MM1^*S6-S&&@N_#,T,R_WE,ZC'Y$_G7-^&I+K7M5T#PC?[G?PK-++J
M#$<2-$=EJ?Q#;_\ @- 'KLAVQL<A< G)Z"N<TCQ19)X8L-0U;7M-G^TM(JWD
M ,4,I4N3M#$XPJG.3_":Z"Z_X])O^N;?RKQ'P?#%<?#SX7QS(KI_;4K;6&1D
M?:"/U H ]6MO&GAN\L9;V#6+9K>*9()'W$;'8X4,#R,GIGK6G>ZE9:<ULMW<
MQPM=3"" ,>9)#DA1[\&N U+0HO$/C'QOH[87[;H]F WI(#+L;Z@A3^%4O#.I
MW/CS7]*NY 0^@:8QN W;4),QD$?[(1C[;Q0!WMMXKT"\UA](MM6M9;]2RF%7
MY++]X ]"1W Y%077CGPO97 @N=<LXI?-:$JS_=96VD-_=^8$9.!D&O.?"EE<
MW?AGP?%=^*-+@CM[R%XK); _://0DR1EO-^\?G#';W)Q5Q;: ?"_XD/Y2;I+
M_5&<XY)4G'Y8% ':2>.='C\;CPL\Z"[, DW%OXRP CQCJ0<U)HVOPG1+_4=2
MUO39[>VN9$>Y@!CCB52/D;<3\P[GOFN;TJXCC^+5GYTJ(TOA2 )O8 NWGMP,
M]37&:053P)YUQC[!#XV$EZ6^X(A*.6_V0Q3- 'L&F^+-!U>"ZFL-4MYDM4WS
MX)!C7&=Q!Y P#S4=IXS\.7VIQ:;:ZS:2WDR[HXE?[_&[ /0G'..M<?XKG@N_
M&\[V$L<K0^&;T7CQ," C%?+#$=\AB!]:BEMX;?P+\,A%&J;;_3B-HQRT3%C^
M.3GZT >I457MK^TO)+B.VN(IGMI/*F5&!,;X!VGT."./>K% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 0W=I;7]K):WEO%<6\@P\4R!U8>A!X-5X=$TJVL$L(-,LHK-'#K;I HC#
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M]NAE7'3#D9'YU?KE/A[XHO?%OA>'4KVPEMG<MAV"A)1O8#9AB>  #D#FNKH
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MARTMO/V'8SJ[9 ;IGH<5T_AS2K+2+2[AL;K[2DU[/<NVX':\CEF7CT)^M;%
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M+M,M[^VTW5H=*TO5H9A<0B2*XN(O+=9)(X]H<!2X]R V*]-HH \8\16VG?\
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M#;6&F/;WTMZMR&\_RX_D"IC())!.>F#@FMGPWX?U#3=!\26ES&BRWVHWMQ
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MRI(]LUMP:9K>N^*H-;U334TR&PLIK>VMS<+*\DDNW<Q*\!0% '?GM0!CVWQ
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MPIVCJ<Y.> !S;7PCJ7_"T#J3+'_8*R-J"C>,F[,*P_=_W06SZFC_ (1;5?\
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M/[*BC:Y>]=QYLCJ66--O3Y<$L?[PXKG-;\#ZY>^%]4L8((C/<>)6U&,&4 &
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M;_1HP_EDGMDOR/:@#G-5U"/5? 7PTOHK&VL8YO$-HPMK9=L<?S2#"BNFT/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% %+4K+3[J.&?44C,=E*+J-Y&VB)U!P^<]@3UXK*T[QYX4
MU;4%L+'7[">Z8X2-91ESZ+V;\,UD?$Q1=6OAW2IB18ZCK=O;W:YP)(\,VP^S
M,JBNEU7PYI&M:9'IU]8QO:Q,K1(GR&(J004*X*].Q% &I4-Y:07]E/9W48EM
M[B-HI8ST96&"/Q!KBE_M;Q7XG\06\.O7NE6FDR1VMNEFL>7E,8=GDW*=PRP
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MMI=\3)B1<9 W 9'/49!]:O5Y OBSQ"_@[Q?=QZB?MEEXH^PVCNBD1Q>?$H3
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M+V7R80D3."WN0"%'N<"KU<5XXUK4=+\1^#K:RN6AAOM3\FY4 'S$V]#D?RH
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MJT$)CN8K(6"!6PBPAMP4+TZT :E>>ZYI%CKGQ?L[+4D$]H-"DD:V<G9*1.H
M8?Q 9S@]P#VKT*N(UGPO)K/Q)M[V9;N&TBTAXTO+:8Q/',9E. P.<E=W'3%
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MMTZ3,\F/H5=/^!5>O(;B/Q-XXMY?$.EZ1:R"(RQWEEYI>V^SJH*GS%^4$.,
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M;NO4#//U%<WX2OKF#1_"]@MUI^D2)I$]V-1OH!)((#-\L:;F4 ;=K'D\!>*
M/49_%.A6UE:7LVJVJ6MXC/;RE_ED"KN.#]*I3>*],U'PQJ.I:/K5I&MJK*]S
M,C,MNP_OIP?PXKSKPMY-XGP]21EG\O5=4)#)MPP\YERO\)Z'';BK7BP!8_BN
M ,9L;-CCN?*;G]!0!Z%<>*-)T?2=/N=6U6W4W42M'(BG]\=H)94&3MYS[ C-
M/O\ Q=H&FV-I>W6JVZ6]X-UNZG?YHQDE0N20 1D]LUY[;"_C\2>')+?6++2A
M)X6@2&6\MO-5R&!D5<NN#@QD\G@>U2Z;IMO96NCS:-XRL%U6..\DMI9[3;;7
M,$DX:1 I;@*X&"K9QZB@#U&TN[>_LX;NTGCGMYE#QRQMN5U/0@UGZUXFT;P\
M(O[5U"*V,V?+5LEF ZD  G R,GH*K>"M175O"-A>I9V]F'#@PVP_=95V4LG^
MRQ!8>QK#\1ZI)'XW^R0W^F:.;?2OM$FHW5N))71I"/+3+* H*9/7DCB@#H[W
MQ7H.G6EK=7>JVL5O=1--!*7RLJ* 25(Z\$?G4%WXV\-6"6CW6KV\2W<*SP[L
M\QMT<\?*I]6P*\R\,I!>2?"M) LHB?4LJRXVNJDC*]B" <=L"MB_6[3QQXS2
M3Q!INE02PV[LM]9^:9;?R=I*DR+\H82 C!Y/O0!ZFK!U#*05(R"#P17(:CXT
MM]%\;W>G:K=P6VG1Z=#<1EE)=I6DD! QDGY4S@#L36UX7M%L?"FD6B79O(X;
M.)$N"A0RJ% #;3R,C'!K!MX8V^--_,R*9$T&!58CD SR9Q^0H W)?%6A0Z'#
MK3ZI;_V=.0(9PV1(3P H')/!X SP?2A?%6A-I=OJ8U2V^Q7$P@CF+84R$XVG
MT.0>#C%>3V"74;^&WMM0MM.ACUO5XDN+F#S8HY"[;!MW* 2!(!SWJSK6FP-I
M2>9K%KK"WOB^S^U?9[;RHEDPBNH&Y@<@ D@]2?>@#T=_''AJ/2K;4VU>#[)=
M,R0. Q,A4X;:H&2!CDXQ6?K7C6UTW6?#CI?VG]BZC%<RRW).X$(JE-I'J6QC
MG/ K*\1B_B^*5D]MJ]EI0?1W2"6\MO-1V$H,BK\ZX;!0]>@K!M(M,TG7_ 3S
M:M;7]FUWJDL5VL/DPJ[D<*"2 H<D YQR,=J /2+7QAX?O;2"ZM]5@>&>Z%G&
MV2,SGI&01D,?0XK0N=3LK.]L[.XN$CN;QF6WB/WI"HW-CZ#FO-)]&3Q7J?Q%
MATV12&:S:TGB(*B\BC+9!'&0?+!J]X)U,^.O$W_"421E8--L([*)&'"W4@#W
M&/=?D3\Z /1R0H))  Y)-<_:>.?#%_.D%KK5K+(\JPHJL?G8G V\?,,C&1D5
M-XQCN)?!&O1V@8W#Z=<+$%ZEC&V,>]>?:EJ6A7FD?#2&PGMI9TU"S,2Q,"T4
M80ALX^[SM!![CVH ]"3Q;H$NKKI4>J0-?M+)"( 26WQC+@^F!ZT:5XO\/ZW?
M/9:;JMO<W"*7V(3\R@X)4GA@#W&:X_PM)#ING?$?53:+<21:M>L\9',JI$K!
M/IRWYFLS3+V0^+_ GVC6=,G5X)C':6%L(HK56MSM0-N)P<8 .,[#Z4 =W#X[
M\+7%W:VL6MVKS71580"<,S=%SC )[ \FHM,\=:1JGBW4_#T,H%S9;5W$G]XV
M&+@<<;=O//.:X"W@BA_9ZTDQQJI^UVTF0.=QO5R?K6C=N[>(?BK9VTH%_<6$
M'V:(-AW/V1ONCJ?PH [S2O%F@ZW>R6>FZI;W-PBEMB$_,H."RYX89[C(KG_$
M?Q$TRWLFCT34[2XOTO8(&0@L"&F1'VG@,0&/0G%<_I=K-J"^&9H_%NF7$L%G
M*^GV=G8>7(5-N4*EA(VT#*YR!RH[UF3:AHS_  9\(V<<UNUVMW8JL(8;TF65
M?,)7J#]_)]_>@#VRL2Z\7^'[+65TBXU6WCOBRIY1)X9ONJ3T!.1@$Y.16W7B
MGB_5I;KP[XHE6_TW3[==4:#^SHK4&>X>-T!E=]V<D+NR%X51S0!Z=J?C/P[H
MT\T&H:M!!- P62,Y++E0W( )Q@@YZ#(J;4/%.AZ78VEY>:G EO>8-LZDOYP(
MSE0N2PQSD5SWAR*WF^(7CJ<)')YGV)-_!W(;<'&?3FN/\!7,%I?^!)]1F2*W
M?P[/%:O,P"^=YJ%@">^P?E0!Z%X1\1OXBN=>99H)K2TOA#:R0]&C,4;@D]^6
M-=-7!_#>>SN=0\936!1K9]<=E9/NM^ZCRP]03DY[YKO* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGFP/+4R9VIUSNP,],8KE/B]KVJZ)X25=*CO(Y+F>.)KRV=%,(+@;02P(9LD
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M2WEII=E;W4N?,GBMT1WSURP&37)VWCK3=*\->&7CM]8OAJ\3"S$A66X=E7<
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M]QEEE8R;4C7<?YD  &@#I;?P=:R^(]?U#5K2POK;4)H);>.:$2&,QQ!"2&&
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MV:"W2Z!4QH/W<@\L*0 &;J>U>J^'_#UKX=LYH8)9[B:XF:>YNKEPTL\AZLQ
M Z      5K,RHI9B H&22> * /+8-,O[GQ3\49([*Y\O4-/MTM'>)E$S?9F&
M%) R02 1V/6DF#W_ ,'M)U&TM[F#4_#,5O<A+F!X6$D$:^:GS 94IO&1P?PK
MTO\ M&Q\B&?[9;^3.P2*3S5VR,>@4YY/!X%9GB/PU'XFBBMKO4+V*P'_ !\6
MENRJER,@[7.TMCCH",@G- &#X2T635_"-YJ-U/>6-WXAN#J#RVTOES11DCRD
M#=L1J@_$UG?$'P[=6OP]33[*;5=6E_M*WEW7#FXEQO&>0,[1C\*]*1%C1410
MJJ,!0, "EH XZZL[AOC!IMX+>4VR:+/&9MAV*YE0A=W3.,\5R%]H]K9:KXDL
MM6M_%$\M_>R36MOILLX@O(Y57Y3L_=J0=RMO(X /2O8*C$\1G: 2H9E4.8]P
MW!3P#CKC@T >2W^BVFC>(-=CU&+Q/Y-X(I+%-+EN"EP!"L9C;R_E#@IC+8X(
MYQ7H&DWMIIMSIOA>*SNX&BTQ9HC( R+'&5CV%\\N-RY_/-;U5)%L(]4AFE:%
M;Z2-HH=[X9ER&8*,\] 3CT% %NO%++5GE^&>O>'8-,OYM1O[N^M[016KO'+Y
MDSKN,@&U=I)SN((VY[BO:ZR] T.#P]IK6-M)))&T\L^Z3&<R.SD< <98XH \
MUO=%@T3Q#K*ZM_PDK)=Q6[VATA[C9<E8%B:,B+@-E/XL<,.:WM$T=].^)-AY
M%A<P6%OX6CM4,@+",B;_ %9?H6 ]^V:] HH \GT_Q FE#QY:/IU_<2W&JW M
MOLUH\PFD,2+Y>5!"GI][ P?8U3C\-GPY=Z2^N-KL-N=!MK0S:0\_R3Q%MT;B
M')(._P"4GC@UZAH^AP:++J;P22.=0O7O)-^/E=E52!@=/E%:E 'E4UK'X?O?
M .HQ:3JT&F6IOC-&\3W,\#3IE?,"[FR6)^F>:ANKJYTW0?'OA\Z5J4VI:A<W
MLUJL5I(R2QRQ\.) -O'.1G.1@ GBO6Z* /*+E;N2\BL-4BU\PC2+5-,M;!IX
M8Y9BK"02/'C:P.T?.0 .:I6%E?3?\*HVZ=?+_9WFPWF^V=?(98E4[LC@9!P>
MA[5[)10!G:;K$.IWFI6L<%Q$^GW @D,J!0Y*JP*\\KAASQ47BF*2?PCK444;
M22/83JB(,EB8V  '<UH06D%M)<20QA7N)/-E;N[;0N3^"J/PJ:@#R?0M+OX[
M?X5"6PN5^R1S_:0T+#R2;=@-_'R\\<]ZZ>UL[@?&'4+PV\HMFT2&-9RAV%A,
MY*ANF<8.*[&HKBX@M83-<31PQ+U>1@JC\30!X_::!96ZW.@:M;>*;B]?49=M
MM;33K:S1/,764$?N@H# MD@Y!XS6AXUTG5X?$U_8:3:W#6GBV"&WN;B*,LML
MZ.$D=B.%!A8CGJ5KU..1)8UDC=71P&5E.00>A!IU '!7RIX3\?6^JR65T=&E
MT=-/62UMWF^SO'(6565 6"E6P#CJM<\FFZG!Y?BUM+O?(_X26346LQ"3.MJT
M/DB0Q_>W<!MN,X->O44 >=:_XFU+6=)>:PL-7LM&CU"WCFO88I$N)K<@F5DC
MVB10#L&X#)!;'2N1U2PG;3?&MOIVDZW(FH6]A+8?;$GE>X6.4A\M)DJ<G.UB
M#MYP!G'MT%S;W2NUO/',$8HQC<-M8=0<=#[5+0!P$E\WBCQ_X;FLK#4(8M)6
MYFO)+JU>$1L\?EK&"P 9LDGY<C ZUQ^E>'M1/PVMC<6.IQ&Q\1O>316ZO'<&
M'+*6C PQ(#[N.H!Q7M]% 'GNAW.CZ);:]XEM;3Q'<P06Z*]S?&5Y+A$W,1&L
MQ#87<>3@<G'0UZ!'()8DD4$!E# 'KS4=W:07]G-:748DMYD,<B$\,I&"#[$5
M-TH \]^)T&J69T[7=$LY[J]CCN;!DMT+-MFB.UCCLLB(?QK%U3PM=V'B+3/#
M-E9S2Z/J45@+N98R8T%IN+!FZ#>JQ#GKBO7** //+/4V\&:YXHAO].U&?[?>
M_;K%[6SDF%QNB13'E 0K!DQAL<$'I6=X8\.:EHNM> K>[M9-UGI-VMPZJ62%
MW*,$+#@'DCWP:]4HH \MU+0M1U+X@>-XHK698[_P\+6"=D(C:0J1@-TSDU!-
MJL^M:9X)TZVT754N-/U*S:_\ZRDC6VV*5(W$ 'D]1D8'..*]4-S;K<K;-/&+
MAEW+$7&XKZ@=<5+0!Y;;Z#>2?$B?1)[&9M"2\GUH3-&?*=I85C\O=TR'>5L?
MC4?@G2]5D75IM4L[F.72M+_L.T,L9!F"%RSKG[P8"+D=<5ZM10!XSX=L[_0?
M"GP[U>\TV^\G2VNX[V)+9VEA$H<*YC W8! SQT-3:C8ZCXI?Q]/9Z9?Q1W<&
MGO9>;$T#W(A9F;;N ()VX&<'E>F:]@HH X#PE:Z1=>)5OK&'Q--);VK*;K5Y
M)]D1<KF(";DM\H)V@@;1STKOZBBN;>=Y4AGCD>)MLBHX)0^AQT-*T\2S)"TJ
M"5P65"PW,!U('?&1^= 'A,NB:L?@+?V(TN]^V-JYD6W^SOYA7SP<A<9QCG-=
M[<WS>$O'^M:C?6-_/9:K:VQ@FM+5Y\21!U,1" D$[@1G //-=[10!Y3JL,LW
MB:U\0^(+37M+@O\ 2HXBFE33LT$R2.WER>2,G*N,9&,@BKVCZ/\ 8_$?@Q[/
M3-1M;..TU"1UO,O)$TK1M^\;G#,2QP3GJ.QKTBB@#S"ZLH$NO%K:SHVHW&GS
MZS ZRVL<GF0@0)B=-OS$*PQE,D9/8&LNYL=3U#3;:[EF\0WNB:9K"O!<,LD5
M\ULT!1W& LC!7?KC<5W=:]?FGBMH6FGE2*)1EG=@JCZDU)0!Q_@>STY)M4O]
M/@UK;</'&;K59)2]P$!P5$OSA1N(Y SVK1\<VEQ?^ ]?M+6)IKB:PF2.-!EG
M8H< #N36\S*BEF(50,DDX %,@GANH5FMY8Y8GY5XV#*?H10!YG:ZA]FU/PQX
MG-CJ3:=%I<FF77^@R^9;2?NV#&/;N*DJ5W $5O\ @R&XN]=\3>('M9[:UU.Y
MA%JEQ&8W=(H@F\J>0&.<9 .!78T4 <M\2;:>\^'&O6]K!)//):LJ11(69CQP
M .35?5[2XD\?>#)TMY6A@@O1+(J$K&3'&!N/09P<9KL:* /*+Z/5K%_$DB1Z
MG;6=QXCA-U-9Q/YQM/)0,T>T;B-P )7D#-8FJ6$SZ+X]MK#2];,>HV-K+8?:
MTGFDG5&*L<OE@<G(0D'!!QUQ[E45O<V]W%YMM/'-&21OC<,,CKR* //M%T:^
M\):O=:$WVN^TO74:6/46CWRPW)3#B9E'1NJL<8/%8WA+1[%5\/:5>VGBF35K
M"2/SX)9I_LEL\0XD!;]V4) VA2>&'%>OT4 9VDZQ#JYOQ#!<0FRNWM)!.@4L
MRX.Y>3E2&!![BM&H;:T@M/-\B,)YLC2R8_B<]2:FH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#A_B
M7)<10>&7M(5FN!K]MY4;MM5FVR8R>P]3SQ4MEXB\10:QK&BZE96%WJ-K8+?V
M?V)FB28,74(WF$[3N3KG&#6CXKT>[U=]!-HJ$66K0W<VYL8C57!QZGYAQ6'X
MM\(ZMK6KZ[<631)'>:%'8Q,TFW=(LSN5..0I5@,^YH @@\::^;F_TT/H.HZD
MNER7]L-/=F17C90T,@W$Y.X8(([\5I7OC9Y/#/AV_P!(ABFO-=F@BMXI,E4W
M#=(3@YPBAL^XJGI&AZS#XSTW6O\ A']/TRQ6RELI+2WF0M""R,)"54!LE-NT
M=!@YYP(_#'@C4=*\8O-=F(Z)IAN6T=%?+*;APSY';:-RCV:@"&Y^(UY$;O54
MDT8:-:WQM6M7F/VR1%D\MY5YP.<D*5Y Z\UZ37FUKX1O],N[C3X?"^A7T$M^
M]Q'JEV$8QPR2;V5TV[F=<LHP<=.1C%>DT >87'C[Q-%X<U#Q(FGZ8=-TV^DM
MIH3O\Z=$F\O<ASA3@CKG)!Z<5O67B#Q!;>+[71];M=/\N_LY;FV^QE]\;1E=
MT;ECAN''S#;TZ5ES^#=7D^&.N:"J0_;KR]GGB'F?*5>X\P9/;Y:V?$7A[4-4
M\4Z??6DBQ10Z=>VS3;L-')*$"$#VVDT 9VE^,M8_X272]-U<Z)G4C*GV2RG+
MSV3JA<"0[B&X4@D <^M<UXK\0^(/$7PPO]:^S:>NAW<BK#$N_P"T)&)U59&;
M.TY(!V@# /4XQ6AI7A77K2;PI*GAW3+)-%D\NX2&=2]R&A:-I=P48 SNP<EL
MGICF"X\*>+U\ 2^"+>PLS;P28BU!KH?OH1+YBKLQE6Q@')QP>M &YKGC;48-
M8U>UTN718X](1?-34)BLEU(4\PI'@C;A2HW$'D].*[+2M1BU?1[+4H 1#=P)
M.@/4*RAAG\ZXC5?"]_:^)-8OK/PUI&M)JGER1R7K(IM950(=VY260[5;Y><Y
M&.]=):WMW:>(K'0OLUHMI_9C3,\ *A)$=$VA/X4(8X^A]* )_%.K3:%X4U75
MH(TDFL[62=$DSM8JI(!QVKE)/%7BZ#5-$MGL-)9==C<VB!I UJRH'_>G.'&W
M/"@<C&>]=1XOTRYUGP;K.F684W-W9R0Q!C@%F4@9/:LZ[T"^FUWP==HJ>5I0
MF%R2W(W0;!CU^:@#)_X3O5;#3-9@U&RLY];L-0AT^!+8LD-P\P0QGYLE?O\
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M(D$;QQ*C);IMC4@ 80=E]!Z5Q$_BWQ+=V6M:UI%IIC:3I4TT0AN/,\^Z$/\
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MYF[.W./FVXZ=\UH?V%J^H?$?1_$EU9Q6UO%I<EM<1>>'9)&8D $#D8[UC_\
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MK"ICMT;<Q:1@.<!5)..2:Z%-)UBP^)D^KPV45QIM_8PVTLOGA&@:-F.=I'S
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M.1H3M? &[[Y&?2@#UJBO/YI-5\,>+[33FUR^U&UU33[J3_2]A:&:$*VY2JC
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M%6I?#VOPPV1T_P 4RK<0PF*X>]MA.DY)W;]H9=K Y P<8P.U=*'5F958$KU
M/2@NH(!8 GH,]: .7TW0K_0+CP[IMA>32:;;17'VW=&H$K-AE8G^$[V8A1V)
M]*ZJFLZH"68*!U).*7>H8+N&XC(&>30!'<VT5Y:36LZ!X9D:.13_ !*1@C\C
M7&6G@._6+2]-O_$!N]$TN:.6VM?L@25_+_U2R2;B&"\=%&<#-=N74,%+ ,>@
MSR:1G5!EF"CU)Q0!CZ#X>&AWFM7 N3-_:=\UX5V;?+RJKMZG/W>O'6MJJ5YJ
MUG87UA97$NV>_D:.W7&=Q5&<_084U=H J:K8_P!IZ1>V!D\L74#P[\9V[E(S
MCOUKC;+P1XFM-%MM%7QP\>GP0+;C[-IJ1S>6HV@"0LV#@=<9KO:175UW(P93
MW!S0!RT_@>UM]$TFQT*<Z;/I$OFV4Y3S<,0ROO!(W!@S9Y!R<U<MO#]S/H>I
M:?KNIMJ;:@'69A$(HT1EV[8TR=H YY).236XKHX)5E;!P<'-&]=P7<-Q&0,\
MXH Y7PWX%M]%\+W^C7UX^I-J.\7=RZ;&E5D$8&,G&$ '7WJ?0_#^MZ=<VOV_
MQ(U[9V<1BA@2U$1?@ -*VX[R .P49YKI"ZJP4L 6Z GK0752 S %N ">M '#
M67PV2Q\)IH\>JR"ZM]1.I6MZL(!AEW$CY"2&&"01GD$]*KZ_X:O+;P]XIUS5
M]374-3DT2XM(S#;^1'%%L9BJKN8DEL$DGL*]!9U0$LP4#J2<53U#5K/2VLUN
MY=AO+A;:$8SND8$@?DIYH X_0O"6H7EGX:FU+6_M.FZ;'%<VMH+8(_F"/"&2
M3=\VT,<849XSFKD_@)9O!6L^'/[1(&IW,]P9_)_U?F2>9C;NYQTSD5V-% &)
MJ7AR/4_$FF:M+-A+*"X@: ID2B8(#SGC&ST.<UG:'X5U?1Y+"U;Q))-H^GY6
MWM5M@DC(%*HDDFX[E4'C"KG STK3N?$$<'BC3-%6'S/M\$\PG5^$\HIQC'.=
M_KVJUI5Y>W5D\VI:>-/E61E$7GK+E0>&W#CGT[4 <\_@16^'UYX4_M$@7,DK
M_:?)^[OF,OW=W.,XZ^]7'\,W4?CD^([/4UACFMDMKNU>WW^8J%BI5]PVGYO0
MUT>Y=N[(VXSG/%"LK*&4@J>A!XH I:/:7ECI<-MJ&H-J%TF[?<M$(R^6)'RC
M@8! _"KU-5T==RNK+Z@Y%.SCK0 44F]=^S<-V,XSSB@NJXRP&3@9- #94\R)
MX\XW*1GZUC>#_#H\)^%+#0UNC="T5E\XILW98MTR<=?6MS/&>U% '#W7@*^:
M'5-,L/$!M-#U2:26XM?L@>5/,YD6.3< H;)ZJ<9.*MW7@^\AUY-3T#5TTP-9
M1V,T+VHF!CC)*%<L-K ,1SD>U=674.$+ ,>0,\FE9E499@ .Y- &+X3\.KX6
M\/Q:2ET]TL<LL@E=<,=\C/@\G)&[&>^,UMT4W>N_9N&[&=N><4 <QXV\%Q>,
MK6RB>]>S:VF+,Z)N,D3*5DCZC 8'K[4FH>"H=0\<Z=XD-XR):(H>S$?RS.@D
M$;DYX*^:W;TK8EURR34+S3T??>6EJMU)&!C",6"\^I*&F^'M:37_  _IVJK&
M(#>VR7 A+[B@89QGC/UQ0!EP>#EA\3>)=9^W$G6[>* Q>5_J=D>S.<_-G.>@
MK+7X;(OA/PQH7]JG&A:A%?";R/\ 7;&8[<;OESOZY/2N[+J'"EAN/(&>3065
M>K <XY/>@!:**3>N[;N&[&<9YQ0!RW_"%K_PBOB#0_MYQK$UU*9O*_U7GDG&
M,\XSZC/M3+CPCJ%MJ@U/0=92PNI;2.UNA-:>?',(\['V[E*L,D=2,'I76%E!
M + $G &>II-Z%R@8;@,E<\T <5/\/3'H>C6FFZL]O?:7>F^6\G@$OG2MNWEU
MRO4N>AXXKM(@ZQ(LCAY H#,%P&/<X[4I=5QN8#)P,GO2LRJ"68  9))H 6N&
MD^'*OI_B6U_M0C^W-02^+>1_J=KJ^W&[YONXSQUZ5U<%W?2:Q<VTFG".RC16
MAN_/5O-8]1LZKCU/6K@=6+ ,"5ZX/2@#&U/PY%J?B/3=5EF^2SM[BW:W*9$H
MF" Y.>,;?3G-8^D>"M3TU]-M)/$L\VC:8^ZUM$@\N1@ 0B2R!OG50>FT9P,]
M*Z72M7LM:T\7UC+YEN7D0.1CE'*-U[94U=5U90RL"IZ$'B@#@S\.[HZ8WA\:
M[CPPTWF?8?LH\W9OW^3YN[[F?]G..,UT6F^'AIWBG6];%R7.J+;J8=F/*\I6
M7KGG.[T&,5M!U8D!@2#@X/2ESSCO0!Y)X5\)ZEX@\$36)UPV^D7M_=?:K7[,
M&D*BY<%4DW#:&"C.5/4XZUV%YX4U&'6[S4_#VM1Z8]_'''=1RV@G4E!M5T^9
M=K!>.X.!Q6[J]U?66G/-ING?VA<AE"V_GK#D$\G<W' YJZSJBEF8*!U).,4
M<G9> [73;CPN]K=R"+05N %=-S7#3+AF9LC!R2W0]>U1:EX(N[W4-:,&MM;:
M;K07[;;K;@R%A&(SLDW?*"JC(VD]<$9K3\7^*8O"6BI?M:R7<LL\=M!!&P4R
M2.< ;CP![UJ6-U<2Z=#/J%LEE<,/GA\X2!#GIN  - '+6G@K4K+6-$U2+78_
MM-A8#3KG-E\MS '## W_ "-QC.3ZX[5-IGA#5-)F@M+7Q$\>A6]P9X[-+8"4
M L6\HR[N8\GIMSCC-==D4WS$V;]Z[<9W9XQ0 ZFR(LD;1L,JP(/T-&] 5&Y<
MM]WGK]*&=5(#, 6.!D]: ."@^'FJ16&D6;>)0T6BSQR:<OV(  +D?O0'^<[2
M5!&W&2<$UIGP2I\':WX?^WG&J37,IG\K_5^<Y;&W/.,XZC/M6_)JUG'K4.D-
M+_ILT#W"1X_@5E4DGMRX_6DTVZOKK[7]NT[[%Y5P\</[]9/.C'W9./NY_NGD
M4 >?>/K*R\4:GHGA6QGE?5;:X NWA4CR+1HB)MYZ .I4 9Y)%>FQQI%&L<:A
M44!54#  '04*Z."496 ."0<T;UW;=PW$9QGG% #JY[6O"PUCQ7X=UTWAB.C-
M<$0^7N\[S4"]<_+C&>AS70TW>@<)N&XC(7/- '+_ /"%K_PBWB'1/MYQK,]W
M,9O*_P!5YY)QC/S;<^HS[5#XL\!1^*-)TVS&I264UDK1&XCCW&2%XS')'C(P
M&&.><8KL,CUHR,9S0!SVM>&GO6TNYTF\73;[2]RVTAA\V/RV4*T;)D94@+T(
M(*BJ\GA.\O+72QJ.MR75U9:HNI/*80JN0& C5<_(N&XY/3OFNG+H&"EAEN@S
MUI2ZJ0"P!;H">M '.:EX1BU/6-6OI;ME34=)_LMXE3E%RY+AL]?WG3':LE?
M%[-I_AFVU#7$G;0+R.XB>.S\OS(XU"JA&\X/'WO?I7<LZJ0&8 DX&3UK)\,Z
MZOB30X]36W-N'EFB\LONQY<C1YS@==N?QH Q+SP9J2W>K'1=?&G66KN9;N!K
M02LLA4*[Q-N&TL .H;GFK^F>$+72-<L+ZSF*V]EI/]EQ6Y7/RAU8,6SU^7'3
MOFK=YKRVGBG3M$:#)O;>>?SM^ @C*<8QSG?Z]JUPRL 0P(/0@]: .1?P]J>B
MV-T-(OY#/>ZZM])MA7B*21/,0Y)X"!CNZ\<"NOHS10 5Q$_P[6>#QA%_:97_
M (20J2?(_P"/?"X_O?-^E=JKHX)5E8#@D'- =2Q4,-P&2,\T 8UWX=%UK^@Z
MI]J*G24F01[,^;YB!>N>,8SWKC?'?AH6/AS6Y1=R-_:^M64YV)M:']Y"G!R<
MGY<YQ7IN>,T=: .3MO"5_+K;:KK>M)?SQ6DEI:+%:"%8E?&]R-QW.=H'8<=*
M5/ ]O_PKVU\)S7LC"VBC6.[C0*ZR(P9' R<$, <9K0O_ !-96EOKIBS/<:-;
M?:+B$?+_ ,LRZKGW"_AFK^F7Z:EIEI>!0AN($G\O=DJ&4''ZT 8>F^&-0_X2
M"WUK7M834;FT@>&T2&U\B./?C>Y&YB6(4#J !VJ'3/ EOIOCB\\1B]>2.8R2
M061CPMO+*$$KAL\EO+';N:W["[OKB>]2\TX6D<,Q2"3SUD\]/[^!]WZ'FKOF
M( Q+KA?O<]/K0!R;^$=4@OKT:5XA>PTV^NC=3VZVP:578@OY<N[Y0Q&3E3@D
MXZU?M_#(@U3Q)>_:RW]M",%/+_U.R(1]<_-G&>U3V>O+>>*=2T18,&RMX)_.
MWY#B7?QC'&-GKWK8H Y1?!2CP]X8TG[><:%<6\XE\K_7>4I7&,_+G/J<4R'P
MCJEE=S0Z=XA>TT>:\-X]JML#*I9][HDN[Y49LG&TGDC-=:K*V=K X.#@]#2*
MZL2%8$J<$ ]* ,.S\-"TG\12_:BW]LR^:1Y>/*_=+'CK\WW<]NM8\?@.ZLSX
M7ET[6EAN=#M#9,\EKYBW$9"@_+N&T_)UR>M=;>W]MIUE<7ES*J0V\332'KA%
M&2<4^TNH;VT@NH&W131K(A(P2I&1Q^- &=H2:HDNK_VE.\L;:@[69= I6#:F
M%P.P;> 3R>M:]&><44 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!Q/Q"C2]N?"^DW(SI]_JRI=1D_+
M*JQNZHWJ"RCCOBN,\2V\/A;7/&(T!1:!?#T!6. [%@+3.K; .$X);CH237J^
MN:#8>(M/%EJ$;M&LBRQO'(8WBD7E75E(*L/45GV/@C0[&6\F$$UQ+>VWV6[D
MNYWF:>/)/SEB<GG'TP.@% '&6O@FZN;Y[)?#=EH6E7FFSV=XMO?";SR0OER%
M0HRZG/S<GYJKVNI3^+]+\'^%KK)NH[AFUE,YPMFVTAO]^397?Z-X/TO0[S[7
M;F\FG6+R(GN[J2<PQ9!V)O)VC@=/05+I_A;2-+U_4-;M+79?ZACSY-Y(./0=
M!D@$XZF@#RRVTO6M<M+_ %:T\/6KZP=6F>+69=0"2PF.<JL84KD(%79MS@@^
M]6=3OKK3?&7Q5O;)F2YATBV>-UZH1"?F'TZ_A7?S^!=#N-4DOGCN0)9Q<RVJ
MW4@MY9@00[1 [2<@'IR1DYJ]%X:TJ+6=3U46VZZU.)(KO>Q99$5=H&T\=./>
M@#@[W0-)\,0^"=2T.VCM[V;4;:VEN(OOW44J-YGF'^//WLG."*Q8O#ND7?PZ
M\8ZS<1*^I6E[J,MM=%CYEJT<C,@C/\/S<\==U>CZ7X%T32;ZVNH5O)39@BSB
MN;N26.U!&#Y:L2%XX]AQ7/>'_AW:75A?_P!MV]Y$9]4N9Y+5;ITAN4,S-&9$
M5MK<8Z\XP#TH IZ5HUCXJ\>:DVNVB7:MHMA(\$PRGF,),L5Z;AS@]LG%<]I^
MCV<'PN\,^(1&7UF/4K9$OG8F4(+GR@F[^YLXV]*]D@T>RMM9NM6BC*W=U%'#
M*VXX*IG: .@^\:HIX0T=/#UKH2P/]@MIEFB3S&R&63S <YR?FYH \UO=+U3Q
M'>>+;B+P_;7=_'J$MO::K+?B*2Q\M5\O8"I*@<.<$;MQS6YIWARP\1?$#Q2G
MB"RBO#';6 ,$GS1J[1-N8#IGC /4<XZUT^I>!M$U74)[RX2Z7[3M-U!%=21P
MW6T8'F(I ;@ <]0,'-:UKH]E9ZK?:E!&5N;X1+.VXX(C!"X'08!/2@#QK2=+
ML-:3X6G5+2&],JWEO(9T#EXXXY-BG/4 C(KW.N9F\!:%+I.FZ<L=U!'ICM):
M2V]T\<L1;.[#@YYW&KVE:*=.UK6K_>"-0EB<+N+8"1A<G/0D@\#T'<F@#%^(
MS&33=%T]V9;34=8MK2["L5WQ,22A([,553[''>L'QAHVD^&-$U&WT.X.GC49
MK*&[LK:4(D,3S!&E5!RA8$J3T./45Z%J^CV.NZ9+I^HP>=;28)7<5((.001R
M"" 0165:^!]#M[#4+2:":]&HJ$NY;VX>:251]T%V.0!VQC'7K0!S=]HVF^%O
M'OA^'0;.&PBU"TO8KR&W7:DJQQJR,RC@D-QNZ_-7,:?H6GV/PR\&:_!;@:P+
MRP/VTG]Z5:54*;NNS:=NWIBO3]*\'Z7I-X]XC7EU=M#Y GO;J2=TBZ[%+$[1
M].O>I1X4T@:!8Z(('^PV+Q/ GF-E3&P9.>IP0* .,LO#^C^*[KQC?>(0!<VV
MI26L5XTFQ[&&.-"C1L>(\9+Y[D\YK)OM.N_$GB#Q0HT.WULV_DVUI?7&H+$]
MJOD(ZO'\IP2S%]RXS^%=]JO@30M8U&>\N8[E6N0HNXH+J2.*Z"\+YJ*0&P..
M>W%.U7P1HNKW;W,R74#2Q+#<):74D"7$:]%D5" P )'T..E ''Z?H,&M_$0V
MWB>&&]N(O#MFT]O(=\3S;Y SXZ-@YP>VZN<_LJPOK/PW8WEK'=VUGXMN=-MS
M.-Y-JIEPF3U7@<?[(]*[JX\&+?\ Q O+N2*ZM+)-*M[>UN;*X:!E97DW("A!
MQM*\'CIZ5LW'@709] L=%6WF@M;&83VS03NDL<@S\X<'=N.YLG/.: .ACC2&
M)(XU"H@"JH&  .@KD/B=+(O@[[.LCQQ7=[:VMPZ,5(B>95?GMD$C\:UM-T'^
MSO$6HZDLC,EU;6T 5I&=B8MX+,3W(91_P')ZU>U;2;+7-*N-,U& 3VEPNV2,
MDC/.1@CD$$ @CH10!PW]@Z3H/Q<\/Q:3:PV<<FFW9>W@&U 08P&VC@$]">^T
M>E<QX3T>ZUOX:QQ6L-K>&#7YYY-/NI-D=XBE@8R<'N0PR",J,UZ7IG@K2-+U
M2#5(S>7&H0QO$MS=W<DS[&QE26)X&W@=LGU-1IX"T&'1TTR"&X@BCNFNXI8;
METEBE;.65P<C()&.F#0!PP_LV];0_#::7<:7I\VN2QZGI<T@*)(MN95B&T[3
M$QVL .#Z5?\ $^BZ3HEI#HNDW+0V.J:Y9PW]A%, EO&^<JJCF,2;1D9YR<5U
MI\#Z&VBOIDD-Q(CW NS</<N9_/&,2^;G=O  &<]..E$7@?08]'O-,DMY;F*]
MD$MS-<3O)-*XQM8R$[LC Q@C&.* .1U7PII<?C.3PUI=K%96&LZ'<"ZM[==L
M:NCH(Y=HX# L1GO56TU2?QI9^#/#MSDW$4K7&LH>2/LC;-K>SR[:]!T;PMIV
MB7<UY"UU<7LR"-[J\N7GEV Y"!F)PN><"ETWPMI&DZYJ.LV=KY=]J)!N'+D@
MX.> >!DG)QU- 'EFGZ7K6MV,VL6OAZU;6&U665-:DU +-&8[@KY>TKD)M79L
MS@CZUO:#X8TK7O''C6;5+5;KRKY8X4D)*Q;X$#D#U(P,^U=5+X%T.75'OFCN
M0)+@74EJ+J06\DP((D:+.TMD ].2,GFM*UTFSTBXU._M+>1KB^?SYU#9,CJH
M48!.!P .PH \MBGN;_PM9?#>XE9K]-4_LNY;.&-E%B7S/8&+8O\ P*O8T541
M410JJ,  8 %<5X:T.YO/&NJ>,=2THZ;-/ EG:V\C*TOEKRTC[20&8[0 #P%K
MMJ /&TT;3M6^&7B+Q3J$*MKZR7UPM\Q_?6TD,CB-4;JH 11@5?M]*MO%/Q/M
MFUN 3K_PC5K<O;OPAF\U\,1WQEL#W]A777?@#0+V]N)Y8KH0W,WGW-FEU(MO
M/)P=SQ [220">,''.:UTT6Q37WUM8R+Y[9;1GW''EABP&.G4GF@#0KQ,:587
M/P;O?&-Q&H\2'SKW^TC_ *^.99F"JK=0!M"[>F.U>V5R\GP_T"6]DG:*Z\B2
M?[3)9"ZD%L\N<[S%G:3D9QC&>U ')V&D:?+\3/$]])IUNMVFDV]PK^6-T<KK
M('8'L3T-9%AH.G:;\/\ P'KEM;JNK->Z>&O/^6K([!60MUV;3MV],5Z?=>$]
M+N_$']MM]ICO3#Y$AAN'1)D&<!U!PV-QQFG_ /"+:5_8NFZ1Y#_8].DADMD\
MPY5HB"F3U."!UZT >6OI>LZ^/$-_:^'[6;5EU:=+76);\1RVIBDVQJJE<JH"
MCC.&R?6NBTG0['5_B[XKNM1@$[V/]GRVZ,25CE,1.\#NPVC![<^M=+>>!=#O
MM2FO)H[D">59KBV2ZD6WGD7&&>,':QX';G SFM6TT:RLM7U#5((V6[U 1"X8
ML2&\M2JX'0<$]* ':S_R ]0_Z]I/_037D-MHFG:7\-/!WB.QB4:T)]/Q=@_O
M9-[*C1%NI7:2NWH *]@U2)Y])O(HUW2/ ZJH[DJ0!7'>$/A_86>A>'IM0@NU
MO+*WAE-G)=.T$5P$ 9Q'G:&SGD=R3UYH R?#>DVLFO\ C?7'MQ<7]AJDQLM^
M2(G\E"2H]6X!/H!62^D:?I_PFT;Q;9Q+_P )$6L[LZ@.9YI994$BLW5@0[+M
M/'MQ7K&G:-9:5/?S6D;(]_<&YN"6)W2$!<\].%'%8]M\/] M;V&>.*Z,,$_V
MB"R:ZD:VAESG>L1.T'))'& 3QB@#DK#POHGB#5O'TFK6\=RT=^RQ^:<_9_W"
M'>G]UC_>'/RCTK*T6R3Q=K?@A-=5KJ.7PV\EQ'(QQ/AX\;_7G#>Y KJ+'P'#
MJ6L>*9]6COK>.]U E#;W;PBY@\J,;7"-\RY##GGD^M==%X=TR#5+/48;?RY[
M.T-G $8A4B)!VA>G\(H \TO+F?2O'GQ'N;#*36N@1/!M_A98B5Q],"I_#?AB
M[%_H<T?ABQT^QEMGBU&9;]9FU"%XC_K%VC>2VULDGJ?6O0HO#>EQ:YJ&L"WS
M>:A"D%R68E711@#:>.E4](\$Z-HM]#=VPNW:W1H[5+BZDE2V4]1&K$A>./IQ
MTH \U\,:?H]O\*='A&C_ &JZU?4VA-M"XA%VT<TS*LS8.8PJ'(P>!BJVLI-8
M^"?B)IRV5MID=O<63QV5I-YL4#/Y1.T[5QG )&!R:])3X=:#%9RVD/V^*$W(
MNH5CO9!]FE!8[H>?DSO;..N>:<_P[\.O;7UN8+DQ7\21W2FZD/G%'WAVR>7S
M_%U/- &!XAT#3_ LVA^)-)MQ!#97?E:DP))EAGVH\CD\L0P1L_6M7P>G]K^)
M/$/BE_FCFG_LZR/;R("0Q'LTF\_@*M^.AJ5]H-QHFFZ,]]+J<+VYF=T6"W##
M!>0D[N 20%!SCM6SH6D6^@:#8Z3:_P"IM(5B4D<M@<L?<G)/UH XOXW''PQO
M/^OBW_\ 1JTLN@Z;KWQ9UF+5;6.\MX]*M&%O,-T98O*-Q7H2!G![9-=AK_A_
M3O$VDR:7JD32VKLKLJN5.5((Y'/45+%I%G#K5SJZ1L+RXA2"1]QP40L5&.G5
MC0!X?JVF65U\*_#3W-M'/);Z_P#88Y)1N98!<R+Y>3SMPH&/85V]MX<T74_B
M)J6CWVF6LFF:5IUO]@L'C!A3S6D,CA.F<@#-=-)X*T.71[?2GMI#:6]Y]NC3
MS6R)=[/G.<XW,>.E3:SX4TW6[V*^F:[MKV*,PBYLKEX)#&3DH2I&5SS@]#TH
M \I>U%_IN@:+-+*]A;^+[FPA/F'<;91*-F[KC!*]>E=//X7T6?XIVFCR:?"V
MEV_A\LED5_=$_:.,KT(&XG![\]A771^$=$AM-)M8;3RX-*G^T6BJ[?+)A@6)
MSEB=S$YSDG-7O[(L_P"WAK7EM]N%K]DW[CCR]V_&.G7O0!XM+H&G6_PGU[5%
MAW7^EZC/'I]R[$R6J17.$2-CRJCG@>IKH?&]M::OJ?B5XM BU*;3;!4GO+Z\
M\I+,^6T@\@;&.[#!B>.<#-=S)X0T>30+[1&@<V%[,\TZ>8V69WWL<YR/FJ._
M\%:+J6K3:A<QW!>X51<PK<.L-QM&%,B X8@>OH* .'TG3+#5/B7X9O[ZS@N+
MN7PS'>O+(@+-.KQ;9,_WAV-8EG/,GA7QC;I-)%%=^-6M+B1&*E89)HU?D=,@
MX_&O3H_ FC0R:3+$U]'-I4?DVTJWD@<Q;@WEN<_,F0/E/&!CI5B'P9H46FZM
MI_V+S+35KF2ZO(Y'8AY'P21SE>0",8P1Q0!R>I:1IWA?QSH]OH-G#8PZCIU]
M'>06Z[4=8T5D<J.-P)(W=>:YZQT+3]/^'W@37;>W"ZLU[IP:]S^]9'<*4+==
MFT[=O3 KTS3/!VE:7<S72M>75U+";<SWMT\[K%_<4L3M&>>.O>IO^$6TG^Q-
M.T?R'^Q:=)#);)YARK1$%,GJ<$#KUH V:\672=/OOA#JOB^[B7_A(\W5V-1/
M^OAFCE<(JMU4#:J[1Q[5[37+S_#_ $"XO99Y(KKR9I_M,UDMU(+:67.=[1 [
M2<@$\8)'(H X;4KFXT^3Q-H0)BG\2I936R#C#W.()\>F-I:I-+4W=UX<\%DD
MC1]8N9)QG)\FV.Z#/L?.A_*O1M0\,Z5J>NZ;K-W;E[[3MWV=PY 7=UR!P?;/
M2BU\,Z59^);WQ!!;E=2O8UCFEWD@J H&!T'W5Z=<"@#R+^PM/C^#5QXB^S@Z
MQ;WDDMO>$_O("MX0 A_A7KP.#DGO6IJNFWWB3Q'XOSX=MM2F@F6UM;R>_$+V
M($*,IC!4E3N8ON!&3]*]$/A+1SX8D\.F!_[-D9F:/S&SEI#(?FSG[QS4.K^"
M=&UJ_FO+D7<;W"+'=+;74D*7*#HLBJ0&&"1]..E '*:-HT7B7QIJT/BNUAOK
MK3=-L(HTD^98G>-FE=/0EQ]X<_**U_A*%7X<V(64RJ+BZ D8Y+#[1)R3WS6K
MJ?@K1M4OXKUUNK:=(!;,;.ZD@\R$=(W"$94<UHZ+HMAX>TN/3=-A\FTC9V2/
M).W<Q8XSVRQH X[Q;I=EK'Q/\*V>HQK-;-97K- _W9<>40K#N.^/]FN9O-(>
MRA\71:'%M3PSJEOJFG0)]U#Y*O-$OHI!;Y1QDUZ;K7A72]>O;6]O4G%W:(Z6
M\\$[Q/%N*Y*E2"#\HY],CH35)K"/P;H,L>A:+>:K<7,[/(GGAI)9&!S)+)(P
MXX )YQQQ0!DZ-=0>,?B%_;=NWF:;I%@D=JW8SW"B1V'N(]@_X$:W?&]U:VG@
M[46O%NGAD18-EK)LD=I&"*JMVR6 SZ$U#X!\+CPAX1M=+81BX)::Y,7W?,8Y
M('L.%'LHK9U?2;/7-*GTV_B,EM. '4,5/!!!!'(((!!]10!Y)<6DFD7/BVP3
M1;'1(I?"D\[6=E<^:C,-ZJ[#8H#8)'?..M:)T'3=&;X?:G96RQZA=W4<-U==
M9+A)+9RPD/\ $"0.#TQQBNN'P^T+=)(XO99YK:6UN)I;R1WN(Y%VLLA)^; Q
MCTP,5K3>'].GBTJ.2)BNER++:C>?D94*#/K\K'K0!Y?)<W.B^'-<^'ENY6]?
M4$L=-)ZBUNB6#>^Q1,">VT5ZW864&FZ?;6-LFRWMHEBC7T51@?H*X[3M&NM=
M^(:^*]1T9]-CT^T-I9I<,AFE9B=TA"$A5 ) &<_,37<T >/2:+I<.M?%>YBL
M+=)X+,>5(L8#)YEH6?![;B23ZU830=.T2W^'FJV%NL6HW%W!#<78_P!9.DEN
MY8.?XAD# / QQBNXNO!>CW>KW^I.MTDVH6YM[M([EUCG784RR X)"D@'M5V7
MP]IT]OI4#Q,8]*E26T&\_(R(47/KPQZT >/79/\ PB/Q=YZ:D_\ 2NFU?PYI
M=KJ'@[0?LRG3]3O9;C40Y)^URI;LRF3/WLL,D'@XKKG\$Z')9:W:-;2>3K4I
MFO1YK?.QZD'/R].U6]:\.:=K]A#:7J2A;>198)896CDA=> RNI!!P3^= '*^
M$M,L=(^)_BNSTZ-8;9;.Q*P)PD1/FDJH_A'? ]:L?%6-9?"5M&TK1*^J6:F1
M&VE 9E&0>Q'K6[HGA32M O+J\L4G-U=HB7$T\[RO+M+$%BQ))^8\^F!T JA\
M0=&GUWP];6,%K]I!U&U>:/CF)95+DY[;<T <SJMII'@CQJDFG0'3["?0[R6_
MCL_E)$6PK(!TW_,P#=>:J>'+$Z/XW\+K!H%MHL=[97*OY=YYLUTJHC S (!N
M!P<Y;DFNYL_!&BVLE[)(EU>27EN;25[VZDG80'K&I8DA>>U16?@'1+&YLKI#
M?R75DX:"XFO9'=5 (\O)/W,$_+TH \UT;PQI$WP,UG6;FSCN-0>ROPLTHW&-
M4DD*JN>@#*&X[\UNKIMIX13P5XETZVBM;5HH]/U$1*%!CG"E7;Z2[23_ +5=
M[9^&=*L?#<GA^*W)TR1)4>%W)W+(6+C.<\EC7+>(_#MS#X1;P7HFFWMY!?)Y
M1O+RY\R*S3(&26;=\H *JHQD"@"YX$C_ +4O==\5OS_:EV8K0_\ 3K#F-"/3
M<0[?B*[2JFF:=;Z1I5IIUHNVWM85AC'^RHP/Y5;H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@##\5Z
MB=+T87"ZM;Z6?.C3[1<0&5>3C;M!')Z9[4:IXPT#1KB:WO\ 44BGA",\01G<
M!LD':H)(^4].F.:Y?XU?\B"O_80MO_0Q6AI$49^+GB:8H#(NG62JV.0"921^
M.!^5 $NL?$;0M);1&%PMQ!JS_)-'N*K%M8^9PISRH7;UY]JT-3\:^'-'O#:7
M^J113JBNZ[6;RU/0N0"$!_VL5YEI$\%GH?PZGGEC@MX];OE,DC!57Y[@ 9/
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M.:Y36(8X/%'P[CB142.6>-548 7[(_ ]N!^5<D8'%RWPL /DMK/GX[?V:?\
M2",_[W[N@#TJ]\:^'-.N(8+O58HI)8TE 96PJ-]UG.,(#_M8J35/%^@Z-<2V
M]_J,<4\:H[1!&=\-NP0J@DCY6Z=,<UYW?1RIK'CJVO?%%AH]M-,&GANK(2M+
M;M;HJLI+@D<,H !Y![G%;WA6R2U^(NH1M(;B6WT&PA%PZ;6<9DR<'D9V@D4
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M75[*D4%M82I+(V3RV >% R23@<4 6-4\:^'=&OVLM0U2*&X0*TB[681 ]"Y
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M2*6\W.JH V'9?O!6(VL1@Y )Q@U7G\?>%K680S:S C>:86^5B$<.4(8XPOS
MC+8Z5YO;:Q]KC\#7DNKZ9'#/J4=PNEV5ND:62LD@PS9)!!;:<XR2>.*NM!$O
MP9\<L(U!DOM2=SC[Q$K $_D/RH ]&U7Q9H6B7T=EJ.HQP7,B>8(RK,53.-S8
M!VKGNV!5;P-K-UX@\(6FIWK(T\LDP)C7 (65U''T45S>B:GI^E>/?%3:Q=V]
ML9K*QEA:Y<+OA6)@V,]0&W9^M:'PCV?\*RTGRT*)NN-JD8*CSY,#% $MWXPM
M]%@\47]YJT%[%IA&VTA@9'@;:2(V;G<6(ZXP*W=%U^QUS1+;5()56&91][(V
ML1RO(&<'CWKRIP3!\9@ 2=AZ?]<'K?N1<:II_AJ[\/7>EW]W;::P;3;LAHKF
M,K$'PPSM=2%&3_?P>#0!Z2"",@@CUHW+C.X8/O6'X.N[34O!>E3VED]I:O;*
MB6TAR8U4;=N>XXX/<5Y9=3:=;_"O4[622VCGM_$C!(B5#1XOE)P.WRG\C0!Z
M='X@NO\ A/;O09X;=+2+34ODF#'<<R,A#9X &TG^M6?[7DU;04U'P]+9RB20
M;)+IB(VC$FUCE>>0"5_"L%5@N_C#=QN(YH9/#D.5.&5E-Q)V[BN%M8=,/P#T
M=XH[7[5'<V;2,@7>K?:E7+8YSC<.?>@#VYY8XP2\BJ -QW'&!ZT>;'O5-Z[F
M&5&>2/:N!DT;2]0^,.IP7EC;W$4FAP2212H&5V\Z09*G@G ')KD=,L;*'X<^
M"-62%/[036[:%;L\R"/[0R; YYV[>-O3VH ]L,T2RK$TB"1AE4+#)^@JK'JU
ME+K,^DQS*UY!$DTJ _<5B0N?<[3QZ5Y+XOOM.ETWQ)=V<L$,]MKMLKR74FZY
M:9)(5/E\@QQA<X^]D;N@K:D^RQ_$7Q1<V,=HVH2:-;S6#;5+22D389/4DXY'
M6@#TI98VD:-9%+K]Y0>1]13B0HR2 ,XYKRSPFGA[64\+:K;:Z/[4MUVFV@6-
M9W<KB5)AC<PR"23W&<\\[7Q/M[::R\.M< !1KUFIDW;2JE\'##D4 =PDB2 E
M'5@#@[3G!]*2.:*8$Q2(X4X.U@<'TKR76;#2O"OB+Q2;.WFMM!?P^)-0M]//
ME[9VD*H5QPK%-WX<FI[ V/\ PL&[LVETOR+GPVH:WM&!C)60[5)S\[!3UP.#
MT% 'J:RQN<*ZL<9P#GCUH2:*2,R)*C(,Y96! Q[UXQ9V5AH_P>T'7H;98WE2
MSBU.\1-[FU\T%PW]Y1P"/[O'3BKOB33/#[>&/%^H:;JT-^;G2"\T-L(_LZ,H
M/ER$(,!SR!Z@'TH ]:$L;,55U+* 2 >0#TK%G\0?;?#%WJN@&UNWC,BQ&>;R
MXF*.48E^<+\K$'OBN3BTS3]/\?\ A/[):PQ'4-)NUNRJC-R L)'F'^/J>3FK
MGPGBT]/!PC@CMENA=70G5%4. +F7;NQSP.F: .PTZ_:ZT>RO;N+['+<0QR/#
M(W,;,H)3/J"<5<!! (.0>XKC?&-GJ-QK.GSZ.^GW-];VTY;2M0'[NZB8H&*M
M_"X( SC'S<\&M?P;>6VH>#=(N;.TDM+9K5%CMY#DQJHVA<]P,<'N.: *X\?^
M%3<0P#6K??-)Y2G#;0^XKM9L84Y!&"1FK5YXNT'3]4_LRZU**.]\R*+R,,6W
M29V# '?!YZ#OBO*(=0TC_A16N:>)H/M\MS=1_9]P\R2=KAO+PO4G[F,>GM79
M>&;<?\+8\5RS*&N8[#3TW]QE7W?F5'Y4 ;NDZY 5UVXO-=L[BWL+N1'98O)%
MHJ]8W)/S$?WN*L:/XMT+7IY(--U!)IHT\PQLC(Q3IN 8 E?<<5Y$R%O#GQ =
ME+VT7BQ9;I0,Y@6:,OD>@ R?8&NYU2^L]6^)GA4Z5=0736]M>2W+V[APD+(H
M7<1V+XQ]* .DTCQ;H.OW9M=*U**ZF$(G*QAN$) !)Q@'D<=>:O0ZK8SWE[9Q
MW*&XL=IN4Y!BW+N4GZCFN2^#\,</PKT3RT"[TD=L#JQD;DUB?$.:;0O$5Q):
M963Q+I?]EQ[?^?D2*B'Z[)G_ .^* .\C\5:'-X>&OQZC$VE$X%R,[<[]F,8S
MG=QTIJ>+M!DUA=(34HFU!IG@\A0Q8.@#,#QQ@$<GBO.!8I;>+H?A_"A%H-7B
MU95/3[,L6\CZ>>F/QKI_A]#&NN^-YP@$KZXZ,V.2!&A _P#'C^= $;?$&RT3
MPI9:E?:K!J[W5Z+9)[:!H4(,@5CC#?<!)]\<=:TK7XA:->>+T\/P2%GDM4N$
MFVN S,3A,%>/EP<D]\5Y=HDB0_!G09I75(HO$T3N[' 51<G))["NTNKR)_BK
MJ@M[N$37GAJ-;-O, \US+)C8<\\XZ4 ==8>,/#^IZJ=-L]3AFN\L%0 @.5^\
M$8C:^.^TG%5G\?>%HYXH7UF -)(8@=K;5<,4PS8POS CYB.E<%X3MQ>Z5X)B
MG\7V/^C21/;Z;%IX$ZR1QL'C9@Y(P-X9B /7K4<L,:? +Q,RHH9[J]=B!U87
M3 'ZX4?D* /8+JYALK2:ZN9!'!!&TDCGHJJ,D_D*Q;'QMX;U+4XM.M-6@ENI
M@3$@# 28&2%8C!('4 Y%2>+O^1'UW_L&W'_HMJ\_>^TR^\(?#BQTN>![Q+^P
M98(V!DC$:'SLJ.1@!@V?6@#T ^,/#XUO^QSJ</V[S/)\O!QYF,[-^-N[_9SG
MVI3XNT$:PND?VE$=0:8P"W 8MO"AB#@<<,.3QS7EVF6<UUX;?3-1\7V5@?[9
M=)+$V >X%Q]J++A@^XECM8';T/H*['P-#&/%_CJ<(/-;5$0MCD@0J0/U/YT
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MQR?SJ,6%F%C46D 6.0RH!&,*YSEAZ'D\^YJQ10 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%5-4U.TT;2[K4KZ416MM&9)'/8#^9]J;I%[/J.DVU[<6;V<DZ"3[/(P
M+(#R V.^,9';I0!=HK'\1:^GANRBO[FW=['SECN9D/\ Q[JQP)".Z@D9QT!S
M6N"" 0<@]"* %HKE;SQS##?7MO8Z'K.JI8N8[J>Q@1DC< $J-SJ68 C(4&M[
M2M4M-:TJVU*PE\VUN8Q)&^,9!]1V/M0!<HK)\1:['X>T^&[D@:8274-L%5L8
M,D@0'\,YK6H **** "BBB@ HHHH **IZEJEGI%G]KOIO*@\R.+=@GYG<(HP/
M5F JY0 45E>'O$%IXETQK^R29(EGD@(F4!MR,5/0GC(HTSQ!::KJNK:=;I,L
MVERI#.74!6+*&&W!Y&#WQ0!JT444 %%8'B/Q9;^'+K3K5]/U"^N=0:18(;*-
M78E%W-G<R]N?PJMIWCFSO-8M]*O-+U;2;JZ#?9AJ%N$68J,D*RLPR!S@D4 =
M11110 453L]3L[^XO8+:;S)+*807 P1L?:KXSWX9>E-U:\O+&P:>PTU]1N R
M@6Z2K&2">3N;C@<T 7J**IS:G9P:K:Z9)-B[NHY)(8\$[E3;N.>@QN7KZT 7
M**HZ?=WMU->+=Z:]FD,QCA=I5?ST'1P%^Z#Z'FKU !1110 4444 %%<<_P 0
M[=M2U"RM/#NOWQT^X-M/+:VR.@< $@?.">".U;7A_P 3:9XEMII=/ED\R!_+
MN+>:,QRP/_==&Y!H UZ**9*[)"[(AD<*2J XW'TR: 'T54TRYNKS38;B]L6L
M;EP2]L\BR&,YZ;EX/KQZU;H ***IZGJ=GH]BU[?3>5;JZ(6P3R[!5&!SRS 4
M 7**R8M=CD\67.@>0PD@LH[LS;N"'=EVX]MGZUK4 %%%% !1110 4444 %%%
M% !116+XL\2VWA'P[<:Q=PRS)$558HL;G9F"@#/'4T ;5%4]+N;R\T^.>_T]
MK"X;.ZW:59"G/'S+P>.:N4 %%%% !116!;^*(KCQS>>&!;.);:S2[,^X;6#-
MC;B@#?HHHH **** "BBB@ HJG?ZG9Z:UHMW-Y9N[A;:$8)WR,"0./8'\JN4
M%%%% !14<\H@@DE(R$4MCUP,U0\/:PGB#P[I^KQPM"EY LPC8Y*AAG&: -.B
MJ&N:HFB:#J&JO$95LK:2X,:G!8(I; /X58LKD7EC;W2J5$T2R!2>F1G'ZT 3
MT451GO+R/5[2UBTUY;257,UX)5"PD#@%3\S9]NE %ZBBB@ HHK$U/Q18Z?I^
MO7$9-Q+HL!FN85RI'[OS N2,9*X_.@#;HJ"SN1>6-O<JI431+(%)Z9&<5/0
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M]T=US_9UZ\"SM_>91QGW&#5E/!6A1>'/["@M7@LQ()@T4K"42A@PD\S.[?D
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MH X=O"NCZA\4;K3;FS633K;0K8):$GRS^^E )&><<XSZYZXKF;5[NYTOPSH
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MO&JJY^7PEG /0YG_ %Z5!;>#/-^'&D3Z9;+>7MXEG=ZC#<7+)_:*K&3Y1;D
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MZ+I7BK0M;2X;3M3@N/LZ[Y54D,B_WB#SCWZ56B\=>%IKJ.V37K$RR1><N90
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M^M&D0R?\)',7BW?-M-S%SCKCFNS\2PM'\0O#"6:K'+_9VHQQ[1C&$BVCZ T
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MCOAA^=<[I$L<'@+X5RRNL<:ZFNYW. /DFZF@#TVWUI6\1:C$^KV#VEO:I/\
M9D0B:%2,EW;."I'3BFQ^.O"TMT+9->L3*T/G@&4 % N\G)XX7DC.0*XEV5_B
M=X^92"IT&(@@\$>6:C:QM3X%^%49@CV?;K%\;>Y@=B?Q;F@#T33O%.A:M8W5
M[9:I;2VUIG[1)OVB+ SELXP,<Y-5H?''ANYTN^U&WU:WEM[)0]P5)R@/W20>
M<'L>AKB/$5['IGB+Q[<-9VURKV6F(T5R,PDN[H&D'=1D$^PIIGN#XVUN"[UF
MTU*X_P"$9E4M:VXA52'SLQN;) ;/7(##UH ['2?'V@ZCX3MO$,U[#:V\NQ)%
M=\F.5E#>7T^9AGH!6[INIV.L6,=[IUU%<VTF=LD;9!(."/8@]J\DLYIYM&^&
M$EAJEC:".S>(W%S%YT4<Y@3:I =<,0) .?6NZ\#6?V9=;F_MFTU1[G4&DF:T
MMS%''+L164#<V3P"3GJ30!LZKXBT?1'5-3U&"U9HS(JR-@LH(!('?EE''K4<
M?BG09=";6TU6U.F*<-<[_E!SC!]#GC'7FN9\036,'Q@\+/>O&G^@78A:0@ 2
M$QXY/?&X?C7-G4%BU;73IZ6#6U_XHMX+6YND\R""<0!I)0 1E@R8'(^8CF@#
MTB#Q7H-UH\NK0ZI;M80N(Y9MV!&Q(&U@>0<L.#ZBHSXS\.#3IM0_MBU-I#<&
MU:4-D>:.=@_O'![9KR3Q#.T_AWXE1S:G!J$NZPW3P1")7(95)"ACT(VDYZK[
M5VWC.VN+3Q7X-33KNRTR"(74,,ES;^9"DGEIL7:&7!*B0#GUH ZP>)]#.EV^
MI_VK:_8;A_+BN#( C-SQGL1M;.>F#5$^//#;:-J.J6^JP3P:>NZ?83E2?N@@
MC/S'@'H:X.\TR(6UAYVK6>KBZ\9023FVMS%$DFS#J 6;/*@GGJ36IXH4#QCX
MK"#!?P>2V/XCOF H [7PUXALO%&@VVJV3J4E12Z!L^4Y4$H3ZC.*=K/B71O#
M_E?VKJ,-JTV?+1SEGQU(4<D#N:I^!9X;CP%H!AE20+IUNC%&!PPB7(..]9$4
M\%I\8M1?4)8XFET>$63RL "BR/YH4GODJ2/I0 WQW\1;/PYX/BU72KNRNKB\
M*BR+L6C<;@&;Y>H4'D9KI/#5\^HZ#;W4FHVNHN^[-S:1&.-\,1PI)(QC'7M7
MC^ME7^%.M36^#83>*6DLBOW6B-PO*_[)8-BO=J ,6]\6^'].U9-+O-6M8;UB
MH\EWY!;[H)Z*3VSC-)JGB_P_HLLT6HZM;6\L)421LWS+N&1P.>@S7F7C;4IK
MOP[XVDBO-,TZVCNGMGLUM=]S=R(J?.S;A@X (PIPJY[5V'AR."?XG>+KD*DC
M&UL%63@_*R.2 ?0X'Y"@#J+;7-+O;J"VMK^"::>V%W$J/GS(<XWCU&2*FCU*
MSFU*?3H[F-[R!%DEA!RR*V=I/IG!KR'2HSI/PZ\&^+8AC^QIY([G'>TEE:.3
MZ[?E8>FTUV_P]A:[L=1\33*1/KMTURFX<BW7Y(%_[X ;_@5 &OX@U&33Y=)6
M/4K*R^TW\<#"Z0L9P<_NTP1ASV)S]*CU+QIX;TB66*_UBU@DBD\N1&;YE; ;
MD#H,,ISTY%<S\5/^/SP-_P!C-:?UI^CVT#ZY\1Y&B0O).D;DC[RBU3@^W)_.
M@#M+?5].N[UK.WO(9;A85N#&C9/EM]UQZ@^M07/B31;-;\W.I6\0T\H+HL^/
M*+C*@^YR,#KS7F5A<1^&M!^'WC"5BMJNFQZ;J#_],7C#1D^RR*/^^J@:POX?
M#'AG69KB"RNM7U[^T[J:ZB\R.%I8Y/)#+N7@#RU'(PQ% 'J-OXIT.ZTHZI#J
MENUDLHA:;=@+(6"A6SR#EAP?45!:>-?#5\+PVNLVLHLXS+/M;[J?WO=?<9%>
M<^)-.SH/B>:\UNQU::ZOM,BNHK2U,*1LLR#GYVRQ5ESSV%==JJ*GQ7T38H4G
M1[Q#M&,@/%@?2@!D'C^SU[PA!K&F:I8Z:S7"1R?;%,@3+$!#C'S,!Q70ZQXJ
MT+P_-'#JNIP6LLBEUC<Y;:.K8'('OTKQNZGAE_9Z\,I'*CO'>VRNJL"5/FMP
M?2O0M)N;6R^)_C ZE-##));V<ENT[!<VXC(;:3_"'W9^M '2W?B71+&VM[FY
MU6UC@N8S+!*9!MD4 $E3WX(_,5%!XN\/W.BSZQ%JUJVGP-LEG+X$;<?*<\@\
MCCKR/6O,O"ENDMW\/B\0-K]KU::T5AP(LL8R!Z8((_"M*]M;*X\3>,H;C4UT
MI_[4TV6UN2@94N!"K)N4\$$CG.,^N: /1M(UO3->M&NM+O8KJ%7*,T9^ZP[$
M=0>1P?6K]<EX-U*YN]0UNTU"+37U"TEB$U]IZX2Y#)E=P.2'4#!&3CC%=;0
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M3M(MS;Z986ME"3N,=M"L:D^N% YK-\5Z%/K]GI\$#Q(;;4K:[?S<X*1N&8#
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MQP .?2H].T?3-(@:#3=.M+*%SEH[>%8U8^I  S7.:?\ $73-16]N$L=0BL+
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MQ PQ925Y 8 D5G'XIZ6M@FIMI>K+I(N#;3WS1)Y<#^84^8;]Q&<<J".1WR
M=='I.G0VMO:Q6%JEO;.'@B6%0L3#H5&,*>3R/6IC:6S7+7)MXC.T?E-*4&XI
MDG:3UQDDXZ<US^G>-+6[U:?3;S3K_2YX[4WJ&^1%$D ."XVL<8)&0<$9Z4W2
M/&]KJM]96[:9J-E%J",]A<74:JET -WRX8E3M^8!@"0* -W3]+T_2;=K?3;&
MVLX68N8[:)8U+'J<*!SP.?:FZEHVEZS$D6J:=:7L:'<BW,*R!3ZC<#BN5E^)
MVGQVEQ?+I&K2:=9W#V]Y=K$FRW97V$GY\L.A^4' (SSQ3CXVN8_B%>Z'+I=R
MNG6MBD[W.$PN2V9"=^?+PH P,Y!XQ0!U<NF6$]DEE-8VTEJFW9 \2E%V],*1
M@8[5:KG-#\7IK=U!$='U2RCNH3<6L]U$FR=!CD%6;:<,#AL'%:6N:U9^'M(G
MU.^9Q!%@;8UW.[$A551W))  ]Z %DT+2)KZ6^ETJQ>[FC,4L[6Z%W0C!4MC)
M&.,>E36FFV.GY^Q65O;914/DQ*F5484<#H!P!VK$T[QC%=:D^FWVE:AI=[]G
M:ZBANUC_ 'T:\,5*.PR,C()!&:7PKXRMO%\(NK#3=0BL6B$B75Q&JH[=T&&)
M)'0]L@\\4 0^)O#NHZKI:^']).GZ?HMPACO&5")5C)^98E VC<,C)Z9)P:Z6
MWMXK2VBMH$$<,*".-%Z*H& !^%<UXRUO4;*32=&T5HH]5UBX:&*>5-RP1HI>
M23;_ !$ <#IDU!'H?B[2;ZSN+3Q+)J\)E5;RUU"*- 8S]YXV105(ZA3D&@#J
MKFRM+PPFZM89S!()8C+&&\MQT9<]"/4<TJ6=M&\[);PJUP<S%4 ,AQC+>O
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M5POPOU*^U.Q\2-?7<URT&OW<$1E<MLC79A1GH!D\5W5 !1110 4444 %%%%
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M%/,FAO7E\BQD6,J=V\!3G)4;<\'TKJOB7;S77PWUZ"WADFF>U8)'&I9F.1P
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M$E523C>C!E/O@@'\*GH \LT[0-0O_@_XDTN*VECO;BZOFBB=2C2'SF91S_>
M !]ZM^&X-(U#Q!;75HWBBZN;6VE8R:FTWEVK, IC/F 9<_[.?N_2O2*CEGAA
M*"65(S(P1-S ;F/8>IH \6\+C4=)^%_@ZTOO[6TW3FN;H:D]I%(LZ#?*8P=H
M+JK-C) ].>:9=6MPGA#Q9;1:?J^Y=9M=0C2YCEEFDMOW'S[FR6.$8E<DKC!
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MH!4A@<$<$5G?:?%$-EX,U$>)KEI]?,4%U$\,1BB$D)?=&-N0Z[>I)!/48XH
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M<8KJZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<NL<N[Y5))[$C/'/-=-?W=];7%DEIIK7<<TNR>03*GV=/[Y!Y;Z#FKV0.IH
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M)FOP+HL?,B6-F18@>R[0%V]#FN]LOASH5D]B0^H3+I\JRV27%X\BVVWHJ G
M'^ I;[X<Z#J$VH&;[:MOJ#-)<V<=VZP22,,&0H#C=T.?4 ]10!S5JS?\+A\,
M+D[?^$9)QGC[U<Y#H=C!\'+?Q,L;'6K>[62"\+G?$!>;-JGLNW/'0Y)ZFO6T
M\+Z9'KMGK*QR?;;2S^Q1-O.!%G.".Y]ZB_X1#2/^$5_X1ORI/[-W;MGF'=GS
M/-^]U^]0!R$&C6'B/7/&NHZMN-Y87/V:SG+D-9QI C!H^?E)9BQ/>NB^&9)^
M&GATDDDV4?)^E8/BC2)?^$DU.X3PKJEY]L@14DT^_"07C!<!;F,NH 4X&<,"
MO7TKK_".D2Z!X0TC29V5IK2UCBD*]-P'./;.: -JJ>JZ?'JVCWNG3'$=U \+
M'T#*1G]:N44 >%W>HW^N>'-#*,XO/"^FMJ-TJMR9[>81!3]1#/\ G5[Q;.NM
M:%\0_$,4A>VBM8--M'!_A3;)(1]6D _X#7I6G^$=&TR[UBYMK8B36&W7FYR0
M_P![( [#+L>/6J\'@;0[;P=+X5C@E&ERAA(IE)=MS;B2W7.: .,71-,OOB%X
M*ENK**5WT-I69ADET$6P_49.*QI_#VG2_#7Q9KLD);5+74+^6UN2YWVQ2=B/
M+/\ #R"3CKGFO4;[P?IE]<:3<%[N"?2T\JWEMKAHVV$ %&(^\#M'6GGPGI1\
M/ZAHABD^PW[S23KYAR3*Q9\'MR30!RMII-AXP\>>(8_$%LE]%I]O9QVD$V2D
M8DC+NX7IN+<;NORUC>%;NXGU3P+'-/),L%QJ]M%+(Q8R1QY5,GO@ #/M7?:I
MX-TW4[U+T37UE=B$6[S6-TT+2QCHKXZXR<'J,]:;=^"-%N=+TVPACGLDTP[K
M*6SF:*2$D$'##DY!.<YSGF@#SOQI!!>:;\4_.19?(:TDCSSL<0)R/?DUZOHF
MG6>E:-:V=A;I;VZ("L:# !/)_4DUEP^!="AT[5K'R)I(=64+>>9.SM(0NW<6
M)SN/4GUYK6TC3(]'TV*QBN+JX2+($EU,99"/0L>: +U%%% 'SPS,O[.]V5)!
M_MH\@_\ 3P*]"N]"T_Q!\6M5MM5@%U:)H]LWV>0GRV8R2@,1W(&<>F:W#\/O
M#Y\+/X<,$W]G/<?:63SCNW[MV=W7K6U'H]G%KL^LJC?;)[=+=VW<%%+$#'U8
MT >-6NCVL'PITKQ)^\DUFUU*)(+QY&,D<:W@A$8.>%V<8Z'DUOO;PWWQ/\>V
MMU&)8&T>WS&W(/R9_F*[<>#]('AI/#XBD_L])A,J^8=VX2^;U_WZGB\-Z;#K
MVH:TL3&\U"%(+@LY*LBC &.U 'F.BZ;I*?#KP;IL>C/?W.I@7)L8YA#%<ND7
MS/.Q!RH!!QW.W@UF:A807/@74;2\L(8DL/%<5O!:K+YJ6R,T):-6P/ER[<8&
M,XKTF#X<:-;:?:V=O<ZK$MG*9+21+YP]N"-I1&SPI'&*D;X=^'VT[4+!8[I+
M:^DCFD1;E_EE3&)5.<ASM4ENI(YH YVY@CTSXV:3:V,(C@@\.2B*!.%&)#@
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M/"XX*]#DGJ:].L_A]HUG/87*S:C)<V$BM;3S7CN\: %?+!)^X02"O?O4-O\
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MW@$VFV3V[7+!0UNJ.'QGL'SD>XIFA+I-U\1]$N-*MO+L%\,N]FC1E2B&= "
M>1P3^!H [S2]5L-;T^._TVZCNK63.V6,Y!P<$>Q![5GC5"OC"XL'U6S\F.P$
MYL1&?.3YL>86SC;VQCK63\/0%C\3JHPH\0WF .W*FL2;_DN>L?\ 8K_^U10!
MUMMXX\,7E_;65OK5K)<704PJK'#[AN !Z9((.,YYZ5J6.JV.IVCW5G=1S01N
M\;NIX5E.&!]""*\MA@BA^#O@/RXU3&H:;(,#HS2J2?J<G\Z;XDN+GP[JWB;P
MO8DI+XH:*;3<=%DF/E7!_ #?[9H ]!N/&_AJTL+2]FUBW6WO%+V[\GS%'5@
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M3K/6+::Z8LJ(K<2%>H5NC$>Q-<;X>LY)/#?Q*:QC_P")A/JNHQQLH^8L(QL
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M72=,TE(A=SVR(T\\TB[@BE@0JA<$G&<F@#LDL[6.[DNTMH5N95"R3+& [@=
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MEF"A00.^>1Q5;6?$UA+!X8NKE-;LFO=52VC@B;R6$N2NR<9^:/(.0,@\$9H
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M7/(;;GMGBO1M:U&71_#UWJ$5I+<R6T!D$*LNXX'J2!QU//8XS0!/J&E:=JT
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M)0)6;[Q;CYB>Y/6N-3XHV,NF1:JFC:K_ &8)1!=W3(BK:2%]A5@6W'!(R5!
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MES>-<"!+:7; ^U 6\Y<_-Q]WK@T6/C1-0U"*.'1M3_L^:X>UBU'8AB>1"P/
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M;&Y-S/J=\\40A;?(K394J,9((Y!%=1K=K</\0?"5PEO*T$-K?"614)6,E(\
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M><;P[QNGC\N1HP["-G7^%BFTD>I-;U% 'B_C""_U:T\66=U!XANM7$L@L+2
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M"T\WR(PGFR-+)C^)SU)J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC_1(=@SY@Y#.&!3 !R-W)XJSXN\/3WNN:7K=MI-GJYM8I;>:QNBHWHY4AD+
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MUR^\4WFA^'H]/0Z?;QRW=Q?*[#=)NV(JH1V4DG/<<5C2_$+5IM-T$V.F6O\
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MH8"C2RS.N.&4 +'UZ\G(Z8YL7/AK49?#?@NQ5(_.TFZLY;H;^ L<15L'OR:
M*_P]O_$-_JOB<ZM=6LUO!JDL 6/?N1U2/A-Q($>,G'7))[UWM<!80:[X1;QG
M<G3[:2TFGN-5M;IKD!68HN(V7&1]TY:NXL9I+BPMIYH_+EDB5W3^ZQ )% 'G
M]CK/B2+QUXV\VXLY+'3;>%T@(D^4&*1TVC. 3QO/?'%7-'\2^+-4\'+KYT_2
ME^U00O:PF9D\O=@/)*S'&P#+ +S@8ZFB;0M;@\8>*9H+*&?3]=LXT6X^T!3
M\<+IM*$9.21R.E17?A75#\-/#ND?98+JZTTVCW5D\H$=R(L;H]QXQGGGC@4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!B>)O#W_"06=J(KMK*]LKE;JTN50/Y<B@CE3C<I!((R.M8\W@>[U'3[
MT:OK\]QJ4\\-Q!<PQ>7':/"<QF.(LP'.<Y/S9^E=-J>JV>CV\4][+Y:2SQVZ
M8!)+R,$4?F15.U\01W/B?5=&,/E_V?!!,9B_#^;OXQCC&SUYS0!S]]X9OHK?
M5M<UO58]1OH]*GM;=8;7R(XD926.W<Q+,0.<]!C%9_A7PEJ&I>%_"+7^M^;I
M%G!:WT5F+4+(9%C#(K2;N44G@;0>!DG&:[O4+J^MI;-;/3OM:2SA)W\]8_(C
M/5\'[V/0<U=+*N,D#)P,GO0!YE<6>G^,?BQ87VF2/-9Z5%G4I54B*29&/D1Y
MQ\S*S.Q],"NS7P\%\;OXD^TG+:<MA]GV=,2%]V[/OC&/QIWB;Q!'X;T.?4FA
M^T>3)$AB#[3^\D5 <X/3=G\*V: .%U#P/:0Q^-[Z\FN;N#7H4:2WMH?WL7E1
MD?)S\[<Y P.1CFN:TBYD\0^-O"<L7B%]=?3_ #Y9V2R-NEM&82@\T9/[QF*C
MKV. .<^O!E+%0P+#J,]*-ZERFX;@,D9YH Y!O BM\/;GPI_:)Q.\C_:?)^[O
MF,OW=W;..OO5P>&;N#QU-XBM-46*"Z@CAN[1[;>9/+W;2K[AM^]Z&NC+JI +
M $],FJ>DZK9ZWI=OJ5A)YEK<+NC<@C(SCH?I0!4\2Z!'XCTD6C7#VT\4T=Q;
M7,8!:&5&W*P!X/(Y'<$UE6_A"^GU&YU/6]8COKY[%[& PVODQP(_+$+N8EB0
M,G/;%=;10!F>'-''A_PWIVCB?SQ96Z0>;MV[]HQG&3C\ZHZ]X<N=0U:QUG2M
M173]4M(WA$DD'G1RQ/@E'7<I/*@@@C!KH:KWTUQ;V,\MI;?:KA(RT<'F!/,8
M#A=QX&?4T <?=?#PWGAC5-/GU=WU34KM+V?4/(&/-1D* 1YX0! ,9]>:V-,\
M.W5MXC;7+[44NKN33X[*01V_E*2LCOO W''W\8]NM75UJ*&32;34$^RZAJ*$
MI;;M^UU3>Z[AP<=,]ZAT+Q!'K9U(>3Y'V+4);'YGSYA3'S#@8SGI0!B)X#EM
M;.W:PU?R-2M=0N;ZWNFM]Z@3LQ>-DW?,N&QG(.0#Q4]WX/O=3TFVMM3UU[FZ
MBU.'46F^SA4_=L"(T3=\J\>I.23SFM^2ZOEUF"U33M]B\3-)>>>H\MQT79U.
M?6KI=0P4L QZ#/6@!:\QTS1]9U'Q'XW_ +*UQ=.$VH+#,)+7SN/(C^9/F7:W
MS'DY'3CBO2IYH[:WDGE8+'&I=V/8 9)K";Q9:O=^&H[:)IK?7E=X9B=NQ1"9
M02I'<<8XQ0!7T[P3;:5J^B7EI<LL&DZ<]A'"R9+ABIW%L]?E].<U%>>$M4CU
M;4[S0=>738]4VM=Q268FQ(%V^9&=R[6*@9R&&1FNM5E=0RL&![@YH5E<95@P
M]0<T >8W'AM]+\=>&-)T*]-D;#1+A8998O-5L21 [URN[.23@CGFMC_A7K3:
M2\%UJQFO[C5HM4NKO[. )'1E(14W?*N% ')QUYK4\1^+D\/ZGING)I6H:C=Z
M@LK11680D"/:6SO9?[PJ/3/&L%[K4&CWVD:II%[<(SVR7T2!9PHRP1D9@2!R
M0<<4 3:[X6&M^)/#VL&\,)T>6601>7N\W>H7&<C;C'H:I+X1U2TO;F/3?$36
M>DW5X;R6V6U!E5F;<ZI+N^56;)^Z2,G!KK=R[MNX;L9QGG%&Y=VW(W8SC/-
M'&:GX"EU#6?$%PNK^58:]:K!>6OV8,X98S&K))N&,9!P5.<>].M_!^L?VWI6
ML7_B)+F[L%>'8MCY<3PN & 7>2KDJ"6R1P!MKI=/U:SU1KP6DN_[)<-:S<8Q
M(H!(]_O"FZE>7MM' =/T\7[M<+',HG6/RD/WGYZXX^7J<T 8VDVNG?#OP+:V
M6IZDAL[)2C7,D>T-N8D?*,_WL8YK'^%'AW^R=&O=1:*>(:A<,;2*X&)(;-6;
MR4([<$MC_:KORRJ0&8 G@9/6J?\ :MG_ &V-'\W_ $W[/]J\O!_U>[;G/UH
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ME;I!YNW;OVC&<9./SK+\<>#4\9Z7;VGVY[&2&4N)TCW$HR-&Z=1PRN173T4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%_JM[IBWFE?;KRYTZS,TLK[@BJ (W" G<Q.WT'% 'KE-=TBC:21U1%!+,QP
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M<C!!C&#@ =:?)=:_K'Q#.BP:W-8Z?'I-O>R>3$A=G+L" 6!P&XS_ +N!C)H
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M5Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *\]T?3((-2\5^"=3!6WU62:^M&Z>;#,,2JI_O(^?^^@:]"I"H)!(!(Z
M'TH YC2].UW262XUSQ);S:?86[*%CM?)\P #]Y,Q9N0!_#M')-5/ %O-='6O
M$\\;QG7+SSK='&&%LBA(B1V) +?1A79$!@0P!![&EZ4 %%%% !1110 4444
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MN/TJU@>?XER-$A>2Y:-R1]Y1:I@'V^8_G67X)N(;?Q+X9DOY4C#^#;9;9Y6
M!8-F0 GOC9GVH [?PAX@E\10:M.[0/%;:G-;6[P_=>)=NTYR<D@]171UPGPL
M>TETWQ#)8;/LCZ]=M"4^Z5)7!'MZ>U=W0!R_A_Q]H7B*XU6*UO(5_L^1PS-(
M,-$JJ3+[+EB.?2K^D>+- U^X>WTK5;:ZF1=YCC?YMO3< >H]QQ7EM_(&\#_$
M:W5P67Q$\L\2GY_(#P&0XZXVAOPS77ZW<6=Y\0?! TR6"65/M4C&!@P6V,)&
M3CHI8ICMF@#O*Y;Q'XJ7P]XFT.UNI[:WTV[BNGN9IN"IC";,'/<OC&#GC%=3
M7!>+Y+*'XG>!7OFC5 +[RVD("B0I&%Z]^P]R* .GM?$^AWNC2ZQ;ZK:OIT.1
M+<>8 L9'4-GH>1P?45+I&O:5K]N\^E7T-U'&VQS&>4/7!'4?C7D?B$M-K7B>
MYT^XMX].&O:5YUPZ>9 KJHWLX! (#&+=R.G-=SX8LKA?&6JWMYK^G:A>M9P1
M3P6-J8@@#.49_G;+8+#Z8H [2L>\\5Z!I^K)I5WJ]I#?.5 A>0 @M]T'T)[9
MZUL5YAXCG71+GQ%JMA?:7J6GM/&^K:-?1_/Y@1%_=MZE0A"L"">AYH [>^\5
M:#INJ1Z9>ZM:P7LFW$+R $;ONY],]L]:QI?%L]K\3;S0KIK>+2;;1/[1>5E(
M96$FTDG.-H7/:N,N+6[NHO'EI>>(-(TRTEOY1=I>61DF$;1IY;AO,7C;MV_*
M>1QFMK38WB^/3QR2F61/"T:M(1C>1.N3CWH L> O'EQXQUW4PU]IB6D$TT=M
M911L9VC1E E9RV,'/0+W'-=KJFKZ?HED;S4[R*UMPP7?(V,L>@'J?85Y]\-U
MU)O"7B(:1):QWW]OW?EM=HSQCYUSD*0>F>_6E\21^)$UOP@VHZEH]O="ZNE6
MY%J[6ZR&(>6"K2 [B!( =W>@#MT\3Z&^F0:FNJVGV&>3RHY_, 0OS\N>QX/!
M]*HCQ_X3:RFNQKUD887$;G?R&() QU.0">G0'TK@-2TQ!;P?:-5LM5^U^,+-
MKE;6W,<,<FU5=<%FR2 ">>I-=99VT'_"ZM5F\I/-&B6XW8YYED!_11^5 '03
M^*-"MK*UO9M6M([6Z1I()FE&V10,D@]^*R->\:VJ^ -7\0^';RUO7LHF*G[R
MJXQPPX(Z].*\]T![&"V^&C7QC2W34=3"F3 56#RA/I\VW'OBK7BQXIH_BI-:
M,C6QL+1)&0Y4S!6W<CN%*9_"@#T9?%>FV'AS2]2UN^M[1[V"-P&.-[E Q"KR
M3U]ZN6_B31;N.PDM]3MI4OV9+5DD!$K*,D#W&#QUXKA]$DBM_'/AB2^=$BD\
M+(EFTI 'FAD,@7/\6W;^%9;Z9)JNA^,M1T8*S6&O'4M,9.5>:)$,FW'4,0Z\
M<$DT >JSZI8VU]#93W44=S-&\D<3-@LBXW-]!D<U3TCQ1H6O32PZ5JEM=R1#
M<ZQ/DA<XW#U'N.*\RO[A_&7A[QIXPL [0G2_[/T_ ^;R@OF3D#W9BO\ P"KE
MY97UYY-TGB;2+JZBT2\^P6NFV+1/)$T0 Y\QL*&\LCCK0!T.K_$/3/-TZWT+
M4[&\N)M5M[2= V[]V\FQRN",XZ9&0#6IHFNW<OB/5?#^JK$+VTVW%O)&I59[
M9R0K8)/S*05;MD ]ZX*]O=%F\$_#.&UEMWE&I:;Y*1L"RXP'R!R.>#[D=ZZF
M]Y^-6D^5]\:)<&?']SS4VY_X%F@#MZ*KV5]::E:)=V-S%<6[YV2Q,&5L$@X(
M]P1^%6"<#- &-!XL\/W6M-H\&KVDFH*S(8%DYW+]Y1V)'<#D5D^&?%5UJ>O>
M+;74&MHK31[I8HI -N$VEB7)..W7BN#75);RQ\'7S7NE6EG=:U'/!I5I;8>
M%W!9I-_7+8;Y0-SXJKJ*2/IWQ8$:LRC4+=I0O7R@5,GX; V?:@#US2/%F@:]
M<O;Z7JUM=3(N\QQO\Q7IN [CW'%0Q^./"\MY;6B:Y9-/=$"%!(/F)X ]B>P/
M)K!URYLKSQUX&&E2P2RH]Q)F!@0MMY!!)QT4DH!VSBN5AMX8?V>+5XXU5S=Q
M2E@.=_VU1NSZXX^E 'I]]XJT'3=4CTR]U:T@O7 (ADD ;GIGTSVSUK1LKRVU
M&RAO+.9)[:9 \<J'*NIZ$5YQ9W6E6TOQ'AUJ2!9I+MC)'*1OD@-N@B !Y/<
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MR@,P;TP"#7ED]QITWP:\)VNG20F_,^GI:QH1O6Y61/,XZAAB3/XU=AU&SL-
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M.O8C/%=%!JJ^(?BAHE_86=Z=/ATZZC-W-:R1*79HSM^< \ #G&.3CH<>A44
M>*>%=+U"+X?>#H);"Y26'Q.)9(WA8,B;I?F(QP.1S[UM>.=#U'6=>\3P65M*
M[3^&8XXB%.V219Y&V ],D8X]Q7J-0WEK'?64]I*7$<\;1L4<JP!&#@CD'W%
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MGS^[F/TC:7_OD5ZI6"OAA)/%"Z[?:A=7DD <65O+L$5KN&&*A5!+$<98DX-
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M:0KR":0[-W3)X_.O3** /,M!M])U'5K:XM?^$INKRUM)G8ZDTWEVCLFTQGS
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51U'5[
M/2GLUO)#']LN%MH3M)!D8$J"1TS@CGOQ5ZL7Q9HI\0>&+W3XW\NY9!);2?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M91OO9(Y"2&+( A/7(/!/!J]?>)[S0;WQ(S66GS:I;V^FQ":*-HQ<33,Z#?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M31>^$=4NM?@UF/Q&T=U#:K;)OLHY O\ ?=03\I8]<=@!TKKJ* ,1+/6XK[2
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MO.=8FATI)C,=0L1;+$K0F,+G&)7)89921A3TSSZG10!RVD^$[[1UM+*V\07
MT>SDW0V@A0/L!)$;2=2@Z= < #-(_@:QEUO7=0DGD=-6MFMWMRHVQ;T59&7W
M81IG_=KJJ* .-C\!_9M*T>&TU:5-0TRYENDO985D\V27?YA=,C.=YZ$8XJ*?
MX>O<1:TLFNW#OJI@FED>%24GB92KC&!M^0#;CH.M=O10!RS^%=1BU"XU#3]?
M:TN[V*-+YOLB.LKHNT2*I/R-CCN.!QQ5^T\.K:Z_!JS7L\\L6G"P/FX+. ^[
M>Q_O$^U;5% &;H\.HPK??VC.9M]Y*]OD*"D)/RK\OISUYQC/-1VF@06^HZU=
M2-YZ:LZ-+"ZC: L2QX]P0OZUK44 </8?#6TT[1+G3H=3N]QU!-0M+@@%[5T5
M5C49R& 5 O/4$ULKX>N[O3]3M=:U>34%O[<V[(L*Q1QH00=JC)R=W))/0=,5
MOT4 <4WPYM9=(T:QEU">1M/NFN9IBHW7>Z3S)%?T#,%)^E=+K>E_VUI$]A]K
MN+1I,%+BW?:\; A@1^('!X(R*T** .23P-'=Q:P==U&74[G5+9;2681+"(XE
MW%0BC.#N8MDYYQ5VQT+5HY,ZCXBFO8E@:%(EMTB#9 &]\9W-QVP.3Q7044 <
M]!X:N+#PQI6D:;K$]K+IL<:)<"-6$H5=N'0\$'KC(Y YK//@%)HKV>YU25M5
MN;N&]%Y#"L8BEB&$*IR,8R#DG.3STQV-% '/"&[T:ROK[6;^[U@2(J?9K:R^
M4+R,)$F22=W))/ [ 53^'7AV7P[X62.Z21+NY?S9$E;<\:@!8HR>^R-47Z@U
MUM% '/ZMX;N+K65UC2M5?3;YK?[-,WD+*DL88LN5/\2DM@^YR#5%/ L=A%I4
MFCZE-9WNG1RQ"XDC$WGK*P>3S%.,DN-V01@^U==10!QP\!*L:W2ZM.-:6_;4
M/[0\I>93'Y97R^FS9\N,Y[YS3V\"QWD.J2:GJ<USJ.H& F[BC6+R#"=T7EKS
MC:Q)Y)SGGBNNHH P-(\.3V>L2ZQJ>IOJ.H- +:.3R5B2*+=N(51W)P22>PZ8
MJUH6B)H=O>1K.TS75Y->.[#!W2,6Q^ P/H*U:* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
+ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>exhibit1013-zerondaxexec013.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **JVM_;W9<12 LAPRG@C\*LTE)/8;36C%HHHIB"BBDH 6BL&Z
M\6Z7:74MO,\HDC8JP$9ZUJ6%_#J5HMS;L3&W3(Q6<:U.4N6+U-)4:D8\TE9%
MJBDJCJ>K6ND0+-=,P5FVC:,\U4I**YGL1&+D[16I?HK'T[Q+I^J70M[9I#)M
M+<H0,"M*ZN8[.UDN)=WEQC<V!DXI1J0E'FB]"I4YQERR5F345SJ^--'9@HEE
M&3C_ %9KH%8.H93D$9!I0JPJ? [CG2G3^-6'44E8$WC'28)WB:23<C%3A"1D
M43JPIZS=A0I3J:05SH**JV-]%J-HES!N,;]"PQ534_$-AI,ZPW3N'8;AM4GB
MG*I",>9O0(TYRERI:FK15'3-6M=6A:6U8LJMM.1@@U>IQDI*\=B91<7:2LPH
MK,U37;+1VB6[9P9 2NU<]/\ ]=.TO6;35UD:U9B(SAMRXJ?:PYN2^I?LI\O/
M;3N:-%(>A-<[_P )MH__ #TE_P"_9HG5A3^-V"G2G4^!7.CHKG/^$VT?_GI+
M_P!^S1_PFVC_ //27_OV:S^M4?YD:?5*_P#(_N.CHK.TO6;35TD:T9B(R VY
M<=:B_P"$ALQ)(C+.AC<(Q:(@9) '/XBM/:PLG?1F3I33<6M4:U%5[:\ANI9X
MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
M,I&"#WJ"PM$L+&&UC^[&H7Z^]6:[\-15*DH'GXFLZU5U#RCQ'H[:1J3*H_T>
M0EHCZ#T_"NM\&:S]LL?L4SYF@'RDG[R]ORK5U_24U?3'AP/-7YHV]#7F5E=W
M&CZHLR@B6%\,I[]B*\BHG@L3SKX6>Q3:Q^&Y'\<3T/Q5K(TO32D;?Z1-\J =
M0.YK@=#TJ36-32$9V [I&]%I-8U.76=3:<@X/RQIZ#M7H?AK1ETG35#@?:)/
MFD/]/PIJ^.Q-_L1!_P"P8:WVY&O#$D$*11J%1!@ =A7 >/?^0K!_UR_K7H=>
M>>/?^0K!_P!<OZUV9FDL.UZ'%E3OB5\S'T'6)-&U!90286XE0=QZ_45ZM;SQ
MW4$<\3AHW7*D=Z\?6PF?36OE&8DD\M\?P\ C^==!X0\0?8IQ87+XMY#\C'^!
MO3Z5P9?BG2:IU-GL>AF6%59.K3W6Y:^(/^OL/]U_YBI_A_\ ZB\_WA_*H/B#
M_K[#_=?^8J?X?_ZB\_WA_*M8_P#(Q?\ 70QE_P BQ?UU.S;[I^E>)*I9@HZD
MX%>VM]TUXG&P656/0,#1G&\/G^@9+_R\MY?J;J^#=890PACP1D?O!2_\(9K/
M_/&/_OX*Z2/QQIJQ*I2;( 'W:=_PG6F?W)O^^:E8; _S_B6\5F%_@_ ?X1T>
M\TF&Y6[15,C KAL],UJ76D1W23J[G;-*LAXZ8 &/TJW:7*7EI#<QYV2H'7/7
M!J>O6I481IJ"U1XU6M.=1SEHRCINFKIRR 2-(9""S,.2>YJ]116L8J*LC*4G
M)W844450@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#&\0::U_:!HAF6+)4>H]*X=TP2CK@]"#7J&*S=0T>PNP9)D\MN\B
MG'YUY^+PGM'SQ>IZ.#QOLER26AY_H0:R\0QR#[J*[_4;35N]O6+M+(VZ5CFK
M]VND:-;7>IK.]S';0-O5<#@\$@].,YKFH?%NCQRB5=(DG'4-+/G/X 8KMR6"
MI4I/?7H<6=2EB:L>316ZG:>$+"1$EOY@09?E3/IZUU5<QH7C72M7=;<'[+.>
M%CD(PWL#_2NGKHK2E*;<CFHTU3@HH0C(Q7E'B73SIVMS(!B.0^8GT->L5R?C
MG3OM&FQWJ#YX#AO=37E9E1]I1NMUJ>MEE?V5=)[/0QK[7_/\&V]IO_?L?*?G
MG:O^/'ZTSP1IQN=5:Z=?W=N."?[QZ?UKF*]4\+:=_9VAQ*PQ)+^\?ZG_ .MB
MO-P?-B:ZE/:*/2QO+A</*$-Y,VZ***^B/G KS[QUI\4%[#=Q_*TPPX ZD=Z]
M!KBOB!_J[/\ WC7#F,4\.[]#ORV36)BEU,OP3817FK232C/V=0RK[GO7I.*X
M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN5O_',$.K7.
MF:5H^IZU<VA"W)L8T\N%B,[6=V4;L=AF@#JJ*Q?#OB>Q\2PW)MH[FVN;23RK
MJTNX_+F@;&0&7GJ.002#6SD9(STZT +12 AAD$$>HI: "BDR 0,\GI2T %%9
M/B'Q'8>&K%+F^,KM+((8+>",R2SR'HB*.IK)L_'<+ZK::=JNBZKHTMXVRU>^
MC3RY7QD(&1F 8^AQ0!UE%)D @9&3T%!( R2 /4T +129&0,C)Z"EH **** "
MBJ]_=&QT^XNEMI[DPQLX@MU#228&=J@D9)[5+#(9H(Y3&\9=0VQQAER.A]Z
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MD&I*.@HI 020",CK02 0"1D]* %HI 020",CK1D9QD9]* %HI,@$#(R>@H)
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MHEAC!.2%4 #GZ"K% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?U:^DLK#5(+BX16;8F3N"G#%3C#@'^[FICXFT4:&NM_VC!_9KD!;@'Y22VT
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MZG?^ 8M#GMYI1?I-"L# E+80N'Z=%P5'Y"I/A]_R.7C[_L*I_P"@4 =+XO\
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M>WTS4X+F:!0\B*2"%/1AGJON,BFZ5XMT#6[U[/3=4@N;A%+;$)^90<%E)X8
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MOCZ_&G>$+F5K:TG$DL$.+Q-T*%Y54.X_NJ3N_"O.=<N9&O\ QK%<ZW;ZG/\
M\(LRF6&%8ER#(2H 8[B P/7C=B@#U&Q\7^']2U;^R[/5;>:]PQ$2D_-M^]M.
M,-CN 3BL'QA\1-,TG1=772M3M9-8LQM6)@67>"-RYZ%@,Y4'(Q[56U2"*WO?
MALD,:HL=SL0*,;5^R/P/;@5QEW?Z9'^SU=:?=SP?VDL\D<MNS#S?M N2S97K
MG^+Z4 >JZOK-U!XKT#1K/9_IAFGNBRY*PQIV]"7=!GZTZU\:^&[[5%TVVUBV
MDNF<QHH)P[#JJMC:Q'H":YTI<:UXG\9W]IDRV.G#2;-E_P">I0ROCWW/&/\
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MQ;(DC!4;EQUY9>G7(KBKV:Y;XDZQ/;>(M,TZ*?3+9H9;NV$Z30JT@?8WF*
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MZ&FS^+_#]MI%KJLFJV_V*[.+>526\T\Y"@9)(P<\<8YKD?!]I+%X\MOMT?\
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MS3;YD;2!$=E. K?,"P&1QQZ42^-S%;V0;0-3&HW\KI9Z>PC6:1$ 8R'+;44
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MWLBQ-&7CA;(5F+N-SDJW R3@T =1%;6\#RO#!%&\S;Y&1 "[8QDXZG ZFI"
MRE6 ((P0>]16ERE[90742NL<T:R*)%*L 1D9!Y!]JYG4/'*6M[J,5EHFI:G!
MI9Q?7-KY>R)MH8J S NP4@D*#C/K0!O6FBZ58",6>F65MY;,Z>3 J;6888C
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M%<O=_$>"!-5FM]"U6[MM(GDAOYXA&%A"=6&YP6XYP,D#KCBMZS\1V=]KSZ3
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MJ2"I!R"#6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWYF )&=N<C=7L5% '(>![/3D?5+_ $^WUD+<21H;G59)"]P$7AE$GSA1N(Y
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MA'#YYN C0/''(H!4CYLEAR.E/E\+ZD_A#P9IH6+[1I-S8270W\ 0KA\'O[4
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M K&UOPGK%WK7B40:7I]RNLQ(D&I7,@+6BB((4V;23R"PP<9;)Z4 0O?:O?\
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ME;EUM_*?=OA'W&;T8\Y% %ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** *R:?:1ZE-J*0(+R:-8I)1U9%)*C\"Q
M_.K-%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !5:?3[2ZO+2\G@1[BT+-!(>L99=K8^H.*LT4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!6GT^TNKVTO)H$>XM"Q@D/6,LNUL?4<59HHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:?56.'9\A8T =?[A);)QD<5U'A;7%\2>&;#5Q&(S<1Y=%;<%<$JP![C<#@T
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M7G?P=_Y%_7/^P[=_S6O1* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M87+R27$C3-,,8D\TMOWC P<\8QTHM_!6AV^G:C9&WFG74D\N\EN+F2669<$
M&1F+8 )Q@\5-XDU2]L- N[S1TLKF[@(/EW$I52,\C*Y.[L!W-:(O8H[>![MX
M[:24#]W(X!#$9*^Y% $$^BV%S/ILTL!:337+VIWL-A*%/7GY21SFL0?#CPRL
M906MR$$@DA O9@+9@V_]S\W[KYAGY<5U0(8 @@@\@BHI+NVB8+)<1(2X0!G
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MYD%[<2K<+);O&SQB%W5EWJ"5W*/F'%=G>7EMI]E->7DR06T"&221S@*HY)-
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M_#ITWPSXF\.2W.J*^DS:#+#8WUTGD(SF<2$8;[I*%<#N%J35=8T&36/!>KV
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M ,"@#QFWTM=4\1S_  \F4_8[&\OK]EQP()8AY0_![E_^^*L^$;N;Q(FJZQ=
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M/"%UX1UK3?"MQ!+')K%K 4$,<G[Y79,3><N<D9R26ZG!Y)&>^2PLX[C[0EI
MLX&/-$8#8QCKC/2DAT^RMYYIX;.WBFG_ -;(D85I/]X@<_C0!Y MS'I7@[5'
MC)ATJ'QA,M\8$#"*W\WJ5P1M!V9&,8[5M7.F>'KNTUZZTGQ3E]0^R":YB\J2
MVBE$JB(LJ *2QP&!/*GGM7HL6GV4$<D<-G;QI*,2*D0 ?Z@#FFQZ7I\-D;**
MQMDM2<F!85"$]?NXQ0!S7@J\O9-2URRU73+6UU6VDA-S/9,3!=;D^5U!Y5MJ
M@$'V]:C\::H]KK^@62WUEI8N!<2'4[J)',.Q5^2,O\JLP8Y)[*:ZZVM+:RA\
MFTMXH(LYV1(%&?H*2ZL[6]C$=W;0W"*P8+*@< CO@]Z /%]-F@O;;3(VNQ>L
M/'7FL[HJLX,4C)(4&,!OO#BM#XAP3SZMXUCM49I&\-VSLJ=643R%O_'0:]8^
MQ6GG&;[+#YI8.7\L9+ 8!SZ@$@5)Y,0E,OEIYC+M+[1DCTSZ<T ><:MKFAZQ
MX]\ C2KNVNBLMPX-NP;RHVMGP#C[N<< _P!T^E=?XOCTR;PEJ46L3R0:>\6V
M::($M&"1AA@'H<'.,#'/&:T8-,L+7'V>QMH<.7'EQ*N&(P3P.N.]664,I5@"
MI&""."* /&?$FIWMUX8\5:5-J>GZ_P"1I4=PFIV<2K(J>;S'+L)7. 6&,< G
M%=+J&NZ7K'Q+\&+IM]!>!([QW:!PZJ&A&W)' )P>.O%=U;:?964316MI!!&Y
MRR11A0Q]P!3;?3;&T"BVLK:$(2RB.)5VD\$C ZF@#Q.UU/2Y_P!G^+1K:X@_
MM::80Q6@8><T[7.Y2%Z^C9]*U=7M[F[\=_$FVLPS7,OAZ-(U7JS&,X ]STKU
M==,L$GBG2QMEFB7;'((E#(/0'' Y-<UX:\*ZE8>*]8\2:Q?6L][J$<4(BM(F
M2.-$''WB22>/\] #E-,B36)-":W\9V]_=PV,[V-E;6:(R!H"A#LA.P LOWL<
MJ!UK2\'Z_P"&3X0\'Z3.(+C4D\J!+-45YK>Y1"'=DZIM(;+>_O7H$%A9VLTL
MMO:00RRG,CQQA2Y]R.M$=A9Q7;W<=I ES(,/,L8#L/=NIH XKX6W=LVFZS8B
MXB-W#K%ZTD&\;T!E."5Z@5WM01V=K#<2W$5M#'/+_K)%0!G^IZFIZ "BBB@
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MC1 4#*<L1DL3C ]"3@5RQ&IZOX(T3P6=#U*WU"W>TANYI;<K!$D#H6D67[K
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MIMGJ5]/JFY+&TFG#SR;=Q8O(QQ@ $DD^E '=T5YUX@^(.I6VC6TMCH=W#?\
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M_L;S6 _V<1,&FA)&9(^A;;]X;>>..:].2]M9+N6T2YA:YB4-)"L@+H#T)7J
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M)S@8/%.\<^"=2U_6K>XTR:&*WO;<6&K;V*LUN)5DRF!RV!(O/9ZNZ]H6I_\
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MMJ8[2)T>UE="R#<S$./E()PO/-5KSP=JEYK/C&SEBMSI'B*)"MV)B)+=UA"
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M+4+G/G7*1 2/GDY;KS6E10 4444 %%%% !1110 4444 %%%% !1110 4444
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M110 45DZ[XGT;PTEL^L7\=HMS)Y4)<$[F_ ' ]SP*UJ "BBB@ HHHH ****
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M6;S9R&:=I%96W'L/F. .  !TJ_!H44'BJ\UX3.9;JUBMC$0-JA&8@Y]]WZ4
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MW$EO'<1//'R\:N"R_4=17FYTC3[/XLZJ]EI5DDUMX>BFME2W0;) [J"O'!P
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M2&.9)XFBD(".'!5B>F#WKE?')@NI=#THZ5#J=W=7;/;P74QCMP8XV8M)@-N
M'1<')QZ5YZUMYFBW^ESQ6L$2^-+2$P6$A\J+=Y.]4. 1R6[#!)H ]KM[NVN]
M_P!FN(IMAVOY;AMI]#CH:Q=9\40:=<:3#;>3=F]U-+"39,/W)9';)QGGY,8X
MZUPGBFUA\->(O$/]@VL5AN\(SS%+2,1C>DF%?"X&X GFI-2T+0M*7X<S:9:6
MT$SZC;J'A0*9D,+DLQ'WCG!R<_>/K0!Z1K>LV7A_1[K5-0DV6UM&9'QU.!G
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ML;S4&1GH<$CZ$U6N?#VCW'Q9LK&73;4V-OH+O':^4ODAOM YV8Q_$>W4YZT
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MI/\ Z?!"L\D)1A^[8D!@2,$9!'!.*HW/C'0;--1:>_"C3IDM[C$;G$K %47
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M6\D8E1" S*64 CYAT['/2M&'6+&?6;G2(I]]];1)+-&$;"*^=N6QC)P>,YH
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MMY)Q^\944E5YZG% &7%HFH:]X_M=?U;2H[&VT>*6*R5I5DDG=S@R';D*H4<
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M0\_48 )-+O\ QO9-;,!\DP78CNOJI93SWQ7;6\:?\+JOWVC>- @&['/,\G^
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M &MY)Z^G:N,TKQ5JNEW7C%H-%N]5@LM7FEFD%PJ"*(1H=J!OO$ ,=HQU'<T
M>H45Q=[\0!_:6GZ?HVCSZK<:CIRZA:A)5C#(2/O%N%X.<_0=33[_ ,=O9RZC
M/%HEQ<:3I<OE7]\LRCRV !?:AY<(&&X\=\9Q0!V-%<GKOC&[T>:^EA\/7=WI
MNGQ+-=WHD6-=A7<3$&_UFU>3@CTZT_4O%\Z:H^G:'HTVL3PVR75QLG2)8T?.
MP9;JS!20/3O0!U-%>:OXGO+CX@V%SI>G7MW]L\/^;'8R/Y&P^=RTF[A2.F<$
MY( KL?#/B!?$>EO=?99+2>"XDM;BVD8,8I8VVLN1P1[CUH V:*YK5/%-S!KS
M:+H^CR:I?0P+<7 \]84A1B0H+-G+'!P,=!UK-N/B3:QZ1I%[!I=W/+J-W)8B
MT!598KA V8V[9W+MSG'.>E ';T56T^>ZN=/AFO;/['<NN9+?S!)Y9]-PX->3
M:MXM\0:MX&\=M>6;V:6-R\$,T<ZYA*F(>7\N"3RS;O?% 'L5%<M8^+[F7Q'9
MZ5J.A7&GKJ$4DMC-),CF38 65U'*-M(..:S=+^)*ZCH=UKLFAW5OH]M%(6N3
M*K%YE?8(D3JQ/][@9XH [NBN8L/%ER]]-8:OHEQIUXMHU[#$DBW'G1J0&"[?
MXP2HV_[0P34%CXQU&>]BL[WPW<6-S>6DEU81R7"$S[ I,;8_U;_,O!R.O/%
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MMDA8\X#<=:U=!\0ZCJMPD=]X?N=/CFM_M$$_G+-&ZY'RL5^Z_P P..XS@\4
M=#1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0Y+;4;U+?^QXF'VJWCD?8CEMY)8':6&T#!/I78:GX>NKW5O"UTCP^5I4LCW
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M<5F"7*8\ME9B>&!;*C X& *Z&WTC4O#FF+X@C\0ZA>B'3Y9[VVO93,EPXCW
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MC(KTZ>\M;4,;BYAB"KO;S'"X7.,G/;/>F'4;$& &]MP;C_4CS5_>?[O//X4
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MI[FM^XO[.TECBN;N"&20X1)) I;Z GFG3W=M;!C/<11!5+GS'"X4<9Y[<]:
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MS74VSO+:PR2B,2,BLPC?<H)'.#@9'OB@"6BBB@ HHHH **** "BBB@ HHHH
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M%LYX!ZC'7BL"XOK6T\;?$6SN;F**ZO-,MVMHI'"M,%MY-Q0'[V.^.E/N$5/
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MEEF62V\D60 R4W8_>?7FGQ>.=%N+&^N8FO-]G&LDEO)8S)-M8X5A&4W,I/<
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MV@UZ-YI7.%C7?.-S'H!R.36U?(^J_$[Q:FFR++)=^%,6SQMD.6^Z01USD<T
M=WI/C30M:OTL[*YE:256>!I+>2-+A5^\8G90K@?[)/KTKG?%/Q'L8]#N#H5[
M*+M;N&"*X-H_DRGST214D9=CD*6Z$]"1TK#\."UU<^&(5\:27MY:PF2WTZ.U
MB5K9E@9&60HNY  Q7YL9..IK)FUS2/\ A2ND:$)XO[6MY[6&:S!'FP2)<+O9
MUZJ.#R>/F'K0![I2,<(3G&!U]*J6^JV5UJEYIL,X>\LEC:XBVD; X)7G&#D
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M/<<#C/45U->07OB+0]7TKX>6FFW$-Q<0:G9%XXCDVH"%2K_W#GC!ZX/I7K]
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M^'M9^QOLUF:UA6+>,Q>?C!)QSC/XUF3_ ! O2=;>P\,W%Y;Z+<R0WDHN43A
M"2@(^9L<[>.W)S0!W)12RL5!*]#CI33%&V[=&IW_ 'LC[WUJ*PO8-3TZUO[5
MMUO<Q+-$V.JL 0?R-<%HMG?^/S?:U>:[JMCIPNY;?3[33;DVX$<;%#([+RS%
M@>"<"@#T&6WAGC\N:&.2,?PNH(_(T[8NY6VC*C ..E<@+W4/ WA^Z;6;Z76A
M]J2'3< "YF\PA4C<\*6W$_-Z<FI;?QC=0W]SIVM:*VGWJ63WT"K<K,D\:?>
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M^[DL%O)$>Y$2P0\*N78'<Q.0![$DT =80&4@@$'@@]ZC6UMT1$6")43(10@
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M]HL+VQ>ZCV\PJD;!BWI@D5SVJ:)J5W9WC7'AW5KS7X-5^TRWCLQB-NER'40
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M]#0!QLNNZSXBL[VS@\-WUE;G3IQ.]ZFQC,5PD<8!._\ BRW3I52XT?46\&^
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MSEBMI7<;FD1E*DJ.,(<^A/?K69=^!=3GM[Z-9[0&?Q-%K"Y9N(5\O*GY?O\
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M!FR&?+;1R>G%6-&T/7SXXF\2:RUA&LNFBS6VM9'?RL2;_O,HW9R3G [#'&:
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M+W^;N^]ELXVXQQS5_6OB3/:7>N7,&NZ):QZ1<-"FDW&//O!&!YAW;P5).X*
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M:7N"S>0T9^4VW3/E;, <9W#=5NXT'Q5IFJ:U+X=DTP0:RZSLUT[A[.?8$9U
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MR,#(!O\ CK6[OPYX+U+5[%4:YMD5D$@RIRZCG\":P+G4_&=IXLL-#DO]+?\
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M/2@#T6BBO/=.MKW6?BGXFCN-7U%+'2I;*6WM(;ADC+M"&.X#JO'W>AW'.>*
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MMHS@^N,9K4LO#\%CXEU76TFD:;48X(WC;&U1$& QWYW&KBZII[SSP+?VK30
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MT <U<_#RQN=*M=/:]N0EOK)UA6 7)D+L^P\?=RY]^*L:CX-DN=3OKK3]=O\
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MND?E9 $=D1AT(+A>#UP*PO&NG:#IUO<V6G>5 E[JFG)K-M"VU$@:3;DJ.%W
M8)[@<UZ+JFE6&M:?)8:E:QW-K)C=&_J#D$'J"#T(Y%4+3P?X?LM*N],ATR(V
MEX<W*2EI#,>GS,Q+'';)X[4 <AXAL;/2?'EC'I-K!:_:=$OUO([= @:- GEE
M@..&) /OBL>WT?3['X?_  ZO[:TACO7U#36:Y"#S&\S 8%NI!!QCTP.PKT?3
M/".A:/\ :396 5[F/RI9))7E=D_N[G)(7V!Q5D^']*.G6&GFS3[+I[Q26L>X
MXB:/[A'.>,=Z //UTZ+0=8AN[W3-,U;2KO6C);ZM;2;;JWGEF(42?WP';9PW
M08*\8K(2PLK;X;_$Z2"TMXI%U'4(5:.,*1& N$! ^Z/3I7I<?@OP[%K']JII
MJ"[\XS@^8^P2GJXCSL#=\XSGFAO!?AY[C4YSIJ[]41DO0)'"S!L9RN< G R0
M : .$BT^RN?$'PJ-Q:6\IDTB</YD:MNVV\17.1S@DD>F34T<L<7P\^)AD=5
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MCMD\4 :E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5SJ>-]#?5QIRSS[S<&U6X^S2?9VG'_ "R$N-A;MC/7CKQ715XEH=O;
MOI%EX>U7QA>0WD6I^6VB1VT!D$JW!=6'R>9L) ??G&">: /0[WXB>';"2[22
M>ZD^Q2M%=M#9RR+;%>ID*J0J^YZX..E<YXY\;WEKXKT'0M*O+VS@NQ++<W=M
MIK7+NHC#((@48.#GDJ#COBDLD7_A#/B:=HRU]J63CK^X6JQ_Y'7X3?\ 8-N?
M_29* .OO?'FAZ7/+;7,UY*UJBF\FALI9$M\C(,K*I"''.#T]JFU7QOH6CW,-
MM<7,DEQ/;BY@BMX'F::,L%!3:#NZYP.V3TKCK+7=*\-6?C?3=;NHK>^EU&ZN
M([>4X>ZCE4>7Y8ZOD?+@9P1BF>$M.GL/&_A.TOXR+NU\([65QS&PDC!'U )%
M '8ZGX\T'2;Z2TNI[C= $-S)':R21VV[E?-=5(3(.>34FK>-=$T:[:VN9KAW
MCB$T[6]M),EO&>CR,@(0'!Z]AGI7)6/B+1O"MQXRL/$+)]IFU*6ZCLW4,][#
M)&@18U/^LS@ICL1SBLR^DBT[Q-XH74O$\_ARWO$@GBM#;VY^T0^0J%5WHQ+*
M59=JG^= 'H.I>--%TN^%C)+//>-;K<I!:6TD[R1L2 RA <CY3]/Q%4XOB3X8
MF6TDBNYY+>Z=(Q<K:RF&-V.%21]N$8GL3D=\5C>&K&'3_B1;VL32R);>%+6&
M-YUVR%1*X^8=CP,CUKGF15^ =\54#.J.3@=_[1 _H* /1=5\;:)HVH2V=W-/
MO@56N9(K:22.V#?=,KJ"$SUY/3GI2ZEXTT;2]0ET^1[F>^CB28VUK:R3.R-G
M# (#D?*<GH.,]1GSW4C#8ZWXRLM7\77&C1WEQYHLUMX'-Y"\*(/+WH6<\,FU
M3P1VS72^&;..S^(^I6ZEW^SZ%81+)*,.0#*.?0G S0!/JWQ*TRS@\/W-C'<7
MUMJ\^U9(;65\1@-NP%7)<,H&SKUXXKM$8.BN 0&&1D8/Y5XG:W5OIWAOP3?7
MDJ6]G;^)+SS9I#M2,&2X R>@%>V1R)-$DL;!XW4,K*<@@]"* .:NOB!X?L[V
M>WEGN/+MYO(N+M+61K>&3(&UY0NU3D@'GC/.*YCQ=XUU"/X@:=X=L+S4+"V$
M#RW,UOI37$DC#&T("C KZLH(]ZR(]7T[3?A5K_A:^FC'B O>VHL"?W\\LLCF
M-D3JP.]2&''Y5LB"6U^+_A2WG.9HO#\B2'.<L" ?UH ]'N9UM;66X=9&2)"[
M"-"[$ 9X49)/L.37FK_$M]2\(Z;K5MYNGJVLP6]RTMNPC-N9V4X9UPWR+R5^
MZ>.#7I]>':+>6=Q\-/#&F">)[NS\2VZ7=MD%X2UY(0'7J,CUH ]2TSQCH^JS
MWD$<EQ;36D0GFCO;:2W81'/[P!P,KP>:-&\8Z/KMX+6T>Y25XC/"+BUDA$\>
M0-\9<#>O(Z>HKC/'EE=:AXKUNTLD9[F;PA.J(O5SYP^4>YZ?C4OAB33=8\2:
M'<1^,[K6KBTMY98[5;:!5MU9 C"4QH"AY&%;NO3B@#T/4M1MM(TRZU&]<QVM
MK$TTKA2VU5&2<#D\5B)X\T"33I[])[@VL4J0JXM9/W\C<*L0VYD.01\N>E+\
M0O\ DG/B3_L&W'_HLUROB6![?PIX&NX[Y]-LK*6 S7<4:.+96MV17(<%=H9@
M"2.-V: .L7QMH;:3-J)FN$6&<6TEN]M(+A9CC;'Y6W?N.00,<CGI65K?Q+TW
M3]#34+2"[GE-['9O ]I*KPL67<'7;E3L;*@_>XQFN<,/AV:TU34[OQ??W@EO
M[5/[:CBB2.WGC5MCJZ((RN&VL2".0#5+6];N+WPA=27FHVVIV>FZ]8XUBWB"
M)/&&C9F;;E<J3M)''3I0!Z#=>/-"L[N&SEDN_MDT4<R6HLY3*4<G!*;<C&UL
MYZ8YQ2Z5KEJVJ^)1-KIN(M.D4S12VXB2R7:21OP-X(&<G.,5BZ5<6FH?&6\O
MK66*XBD\/P&*:-@RLIF?D$=0<"N2N+*ZU%/B_:V4;27#RPE8TZN A)4>I(!&
M* /0K?XA:#=1SM&;X-%;FZ2.2QF1YXACYX@5RXY'3UK(@\=PZSX-T769+^YT
M-[J\@A?_ $%G$KL"?*7>O*M_?'''6K@\6^'/$;QV>CA-1NVT^:198(U?[&I4
M#:YZHS' V]3CD<5YY=:C97WP>\"PVMU%-+:ZM80W"(P)B<;LJP['V- 'K&K^
M,M(T:_>QG-W/<QQB::.SM))S#&>C/L4[1P>M%YXUT&RBT^1KQI1J,+368MX7
ME,ZKMR%"@DGYUXZ]?0USEEK>E^%?'/B_^W[V"Q-Y)!=6TEPP03Q"$)A,_>*L
MK# YY]ZP_!]C-::C\.X[N!H9/L>J3)'(N&C5W1D&.QVL* .\B\<Z%-HLNJ">
M<1Q7'V1X&MI!.)^,1^5C=NY'&*T=%UVQUZVEFLFE!AD,4T4\+121. #M9& (
M."#]#7G%T-*_M+Q=_:M]<:;&NO6S07\.!]EF^S(5=B00%Z@EACYL=ZZOP)K%
MUJD6JQSW]MJL5K="*'5;:((MT-BDY"_*2I.TE>.* -K6_$&G^'X87OI)-]Q)
MY4$$$32RS/C.%102>!GVJBGCC0#HESJTEV\-M:3)!<K/"\<D$C,J@.C ,O++
MR1C!STK(\6W,.D>/?"VLZC(L.F11W=L]S(<1P2R*A0LW1<A6&37'>(I8-8L_
M'.KV;+/I5U=Z1;Q3KS'.\<R"0J>C ;E7(XXH ],TGQAI&M:H^FVS74=TL7GH
MES:R0^;%G&]-ZC<N2.1ZU?UG6;'P_IDFHZE*8;2-E5Y A;;N8*"<#IDCGM7.
MZK_R5GPV?73;W_T*&NDU?2[?6M&O=+NUS!=PM"_L&&,CW'6@!NI:U8Z0UDEY
M*5:^N5M;=50L7D8$@<=!@$D]!6.WQ \/)>M;FXN/*6X^RM>"UD^S"7.-AFV[
M,YXZXSWKD/ TE_XC\0V,>J(PD\(VLEG,S#A[QF,>\>O[I <_]-*R!J5BGP3D
M\'/-&?$F&L?[-S^_,YF/S;.N.=^[ICG- 'K]MJ]E=ZAJ%A#*6N-/*"Y7:1L+
MKO7GH>#VI=)U6SUO2K;4["0R6ER@DB<J5ROT/(KA+/6]/\.^._&$.JW:0W%T
MMG):QN</=8@"?NQU<[E(P,G-;7PN_P"28>'O^O-?ZT :.M^+M*T"Z2TNVN9;
MEXS,8;2UDG=(P<%V" [5SW-5KWQ]X<L4M&:]>8WMM]JM5MX7E:=,@?*%!R<L
M..O7T-8LFL:?X6^)FNW6O7<5E;W]A:M9SSG:C"+S!(@)_BRP.WJ<U4T^>SU#
MXE>%KRTTY[&V?0[F6"WDA6-HP9$P=HX&02?QH Z?4/'6A:9>-;7,UR#$J/<2
M):R/':A^5\UPI$>?<^YXI^L^-=%T.\:UNY+EY(HA/.;:UDF6WC.</(44A1P>
MOI7GFH^19:KXRL-8\77&CI>732BQ2W@=KR&2)%!CWH7<G!3"G@KVJ37;]HI=
M>T.37I[ VFGPV]E9001?:=3S!]YMZ,S?,2N%QMP22* .SN/'5K#XZLO#B6US
M*EQ:F?[1%;2.N2R!""%(V88Y?H, $BK=OXWT.YU9=/CGGW/,UM'<&VD%O)*N
M<QK*1L+<'@'L:X70=8TZ'QAX.NY;^W2WNO"XM()FD&V2<21@Q@]VR",=<C%9
MWABWMY-(T+0M3\87BWUK?QJVB1VT!DCFBEW9.$\P)E=Q<G&#UYH [7Q9\0-/
MT_1]?BL+BX%]8V\J"Y2T=X(K@(2J-)M*;LXX)ZD#KQ76:5/)<Z/8SRMNEEMX
MW=L8R2H)->17&MZ9I?PX\;:!?SQKK/VC4,VC?ZV7S"SI(%ZE=I#;N@ ]J]:T
M+_D7]-_Z]8O_ $ 4 <?!X_ATSQ#XGM-7FNIHK&[01);6;R^1#Y*,6?RU.%W%
MN6]\=*ZJQ\2:3J.IC3[2Z$MPUHEZ@"G:\#G"NIQ@C/ITKA=-\2Z'H'BOQ[_:
M]W!:E[J-U,Q"^>!;IE$S]YAG[HY^8>M9<-O<^#O W@GQ9<PRK)I,(@U"/;\W
MV6;C!'7*,8SCZT >J66LV.HZCJ%C:RF2?3W6.Y^0A59EW  ]"<$9QTSS6+XM
M\9P^%;S1[9[2YG:_NA$QBMY)-J;6)(V@Y;('R]<$GM2^ -,GL/"L5Q>KMU'4
MY'U"\]1)*=VW_@*[5_X#67\1[J#3]0\'W]Y*D%I!K*F6:0X2,&*0 L>PH C@
M\?PZ?XB\36^J2W<MO9SQ&"*WLGD:"$P([,^Q<JNYCRWN.U;-]K]G)KGA<6^N
MM##J:RR06\=N)%OE"*PRY&4V@@]LYQ61X?:&;Q!\0)XBCK+- 0Z\AE^R(1SW
M'/ZUR&F?\?OP6_Z]+K_T0E 'ID/C;1+C5UTY)KC>\[6R3M:R"!YESF-92NPL
M,$8SU&*Z&O*K+5K32O$%G;>'M>%U!=:JT5QX>NHU,UJS.QDD3HZ!3EL-D8/!
MYKTO4M0M]*TRZU"[?9;6T332-Z*HR?Y4 <)XV\<ZMHVNO;Z+;0W%II-LE[K&
MY2S")I%4(F#PVS>_/85V>H:_IFEZ&=9N[M4L-BN)0"VX-C;M Y).1@#KFO.?
M"7A[Q;J6C7VMG4=+MCXD9KJXM[NP>9EB8;4C+"1?E"8P,<9-8\5S<Z5X4@\/
MZLYED\(:]9O=2!3\UENW1RXY.T CCG 6@#TZQ\;Z'J%W)9QRW,5Y%;O=2VUQ
M:R121QKMR2K*"/O#'KVJ&U^(7AR\T^XU"&[F-C!%'(UP;:0(V_&U5./F?) V
MC)R<=:Y2ZUG3-<^)5S<Z7-'=0KX8N8S=1<HY\U#M5NC8SSCINQUS5-K:1?@A
MX/N()I+2&TELKJXGAC5S"@/S2;2"#M+!CD'H30!Z#:>,M%N=/O[QYY;1-/4-
M=QWD#PR0@C()1@#@CI@<]N:CM?&VBW-GJ%PSW5M_9]N;JXBNK22&18<$[PC*
M"R_*>1GI7G6MVD.J:/X@U'3O%5YKUS!'9+<7,5O"8UBCN!*0IC0*[*-[$<\$
M ]<5/J']GZAI?BG4(/%\_B&Y@\-W41=881#&CKN +1(!ORGW3R!F@#M!\1_#
M1N$B-S<J)D+V\C6<H2YQC(B.W]XW(&%R3VS5NU\:Z%=:1?ZF;F2W@T]_+NTN
M8'BDA;C *,-V3D8P.<\5S-W%']O^%Z;%VJ6VC'3%HV/Y"L+Q/!/)JWC>:&66
M%+75-)N9Y(HP[1QHB%G"D$-M'S8((^6@#T*'QOHDNG:C>R27-LNFQB6ZBN;6
M2*6-""0VQ@&(.#@@=C26GCG0[W4TL(9+KS98WDMV>TE5+E4&6\IBN),#GY<Y
M[9KSW6UL+[P_XOU&W\5S^(;F+0VMWF$4(A122RKOB4*6!!..2 U=7K2*GB;X
M>*BA0L\R@ =!]D?B@#2\&>,HO%\-\\=I<P?9[J6)3);R(K(KE5.Y@!NP.5'(
M[UU%>9^ _$NCZ'X;UX:C?QP26&JW;W47+21*TY"DH 6P21SBO3* "N(T7QC=
M3^(/&-O?QE[/1KB&.!;6W>24JZDG*KDL<XZ"NWKSGP%_R43XB?\ 7[;_ /HM
MJ %^%'B?5/%FERZIJE_=2R3;F%M]@\JWA =E CEVCS#@<_,<5VL^M6-KK=GI
M$TI2]O(WDMT*'$@3&[#=,@$''7%<=\$O^22:+]9__1SUH?$:TF70[?7[-"U[
MH-PM^@7J\:\2I]#&6_(4 ;-[XIT;3[V]M+N\6*2QM1>7)93MBC)(!+8QDD'"
M]3Z5!I7C+2-7O39Q&[M[GRC.D5Y:20-+&.KH'4;AR.E>>WMG/J_P\UWQ6())
MFU;48+[R@A+FQ@E0(N/^N:%\?[5;M[JVG>*_'_AAM O8-06QANYKJ6V<.L22
M1;%5B. 68CY3S\O2@#JQXJT=M LM;%RW]GWKQ)!)Y;98R,%3C&1DD=:V3P,U
MX?;Z_IK_  I\+Z)'=(^IV]]91W-JIS);E+A0QD7JHS@9/4D5[A0!Y=H/CF\U
MSXAZO'-?WUGH^GLJQ6QTME1E\HLS3R,F8L$9 )7..]=CHOC/1]>O1:6;W22O
M$9X1<VLD(GB! WQEU&Y>1T]17$:;>SZ=K'Q8O;6W6XN(#')'"R[@["!B 1W'
MMWJ'2=4M)/'OA2;_ (2IM81K:XB,I6%+>*5T0K$FQ1AC@_(22,#UY +.O>,;
MZT^%3:WHOB&2_N!?K"+V2S2,X,NUEV%<<#C.*]4KYV_YMT/_ &&?_;BOHF@#
MD=*\>6FH^*-<TB2WN((M,*YN);>1$QLW.78C"@=LGYAR,BK6F>.M#U:^MK2W
MDNHVNP3:27%I+#'<@#)\MV4!N.>.U<)JI^TZO\4=#@F5=5O[>)K2V+8DN +7
MG8/XNA'%7[_7=)\3KX)T_0KJ&YNX=1M[J6"$Y>UBC1M_F ?<Z[<'&2<4 >H5
MS=AX[T#4]2AL;:XGS<.R6T[VTB07#+G<(Y"-KD8/0\XXS6QJ\$UUHM];VYQ/
M+;R)&<XPQ4@?K7!^$O%.@/X;\*Z#Y8N=8BCBMVLEB5I;*6.,J\CJ>4"D'YNO
M/&<T ="?B!X>6]-N;BX\H7'V4WGV63[,)<[=GG;=F<\=<9[T[5/'>A:3>WME
M/)=2W5D%:XBMK224QJ5#;SM4X7!&3TKS8:E8K\$V\'&6/_A),&Q_LS/[\S^=
M][9UQ_'NZ8YS77Z1&!XT^(6[#/Y-FK-CK_HQH V;;Q]X>O-0LK6"ZF=;U@EM
M<_9I!;RN1NV+*5VEL=L]1CKQ45W\1O#EG+=I)<73BRF:&[>*SED2V*G!,C*I
M"C/<]<5QMLJK\,?AH% '_$ST\\>IW9_G3+3Q'HFE:'\0[&_N88;N?4[_ ,N"
M0X>YW*%4(/XSGC SCOUH ZC4O$M[;_%'1M,ANMVDW&ES74D<<:OYC+G:P.,]
M.P/-= GBC1Y/"I\2K> Z2(#<>?M/W!UXQG/&,8SGBO/-+M;BQ^)/@.TNU*W,
M'AHQR@]0RJ 1^8JO+83)XFF^&PB;^S;K4UU93CY!8Y,CQ^P\Y0O_  *@#U^W
MG2YMHKB/=LE0.NY2IP1D9!Y!]JPI_&^@6_A0>)I;QETHMM\WRGW;M^PC9C=G
M<".G:NAKQ^+3EN_'<_@6>,M81:A<ZRP X\B2(!5^GFS/_P!\T >E:CKVGV<U
MM9279CN+V&66W*1E_EC7<S=,8 (Z]<XKDC\0[;2?#OAFX%S>:V-4N/*^VK8.
MI=,OEMB+]X;<!0,G!..#6'X+DN-:.HW=X&\SP_HIT4EAUG!;S6^N$B_.LO2;
MF"P^%WPROKN58;6WUA6FF<X2-?WXRQ[#)ZT =I#X_BL/$WB6VU.2\EMK5X&M
MX;>R>1X8F@5W9PBY49;JWT[5W%E>VVHV-O>V<JS6UQ&LL4B]&4C(/Y5QGAMX
M;CQ?X\N(2DB2O:%9%Y#K]E4CGN.?UJ]\,?\ DF7AW_KR2@!9/&T$?Q"'A8V=
MV3]E$QF6VD(WEL#D+C9C.7Z9XSG-8WAGXD60T2)M=NKA[@WD\$MRMFYAA_?N
MD:R.J[%.-O4YY!/7-2W-_::?\<H_MEQ';_:]!2"W,K;?-D^T-\BYZMR.*YN1
M%7]GK62% +7%T3QU/VQN?T% '?-K=M;^-;ZSGUQE6VTW[5)8/;@)$@;F;S<9
M/IMS[U8T7Q=I.O79M;1KI)_*\]$N;22 RQ9 WIO4;ER1R/4>M<1J M6^,7B1
M;^*6:S;PKB>.)2SO&7^8 #DG&>E7_!NL?\5)!I&G^)(?$FE?87E28HAFLMK(
M%1W3 .X$\, WR4 >BT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !3/*C\WS=B^9C&_'./3-/KSWQU/J^OZ_:^$O#^I7%A<I:
MRZA=W-O(49 %*PH2.S.<D>BT >@[5P1@8/7CK1M7(.T9'3CI7(Z/XWMI_AN/
M%&H*R-:V[&]B4?,LT?RNF/4L./J*CM_&NI1ZUHFEZOX;>PEU=W$#K=+*JJL9
M<[L*,,, ;>G/!.#0!V#11NZNT:LZ_=8C)'TIV!NW8&>F:X6P^(SW=EJ6J2Z)
M+!H^FFX2YNS<*29(F("HF,MD <\ %L<X-7K?QG<VMTT'B/1SI&ZSEO87%R)P
MT<8!D5L ;74,#CD=>>* .J:*-W5V169?NL1DCZ4/%'(RLZ*Q4Y4D9P?:N5TG
MQA>W6H:;!J>A/IT.JQL]A*;D2%B%W[9% &QBF3C+=",UC0_%&ZDT/3M??PQ.
M-'O)EM_-2Z5I1(S%1MCP-R[AMSD?3') /1<#.<#/3-&Q=NW:,>F*X^'QS):7
MNJVGB'2O[,DL+#^TLQW G$D )!.0!A@1C'/7K4NG^+K][^VM-8T)M-:]MY+B
MS(N1+OV ,R/@#8^"#CD<'GB@#J6BC=U=D5F3E21DCZ4[ SG SZUP-C\1KRZT
M_1=7E\.20:-JDT-N+EKM3)&\AV@F/;RF[C=D'OC%6?"WB+7=5\:>);"]L8TL
M;*=(XR)U)B_=J<8"@MNSNSGC.* .S:*-TV,BLA_A(R*?17DOC'QEJ&M?#W4K
M^TT:2'1II5BMM06Z'F-MG5=YC !5"00#DGD<8- 'JYBC,HE,:F0# ;'('UIV
MT;MV!GUK'T_7UO\ 7=<TL6Y0Z4T*F3?GS/,C#],<8SCO7-GXDR2V'AF6RT*6
MYNO$$,TEO;K<!=C(%."Q&,8))/8 \'I0!WM,$4:DD1J"QR2!U/K7&6VL6Q^)
M9M+C27AU@: MU+,+QG15\P Q!/NDAOX\9.*K6/Q'O+O3M&UB7PY)!HVIS16X
MN6NU,D;R':#Y>WE-W&<@]\8H [[ SG STS34BCC+%$52QRQ QD^]<;?>/+J&
M76I[+0);S2M&=HKN[6X56WJH9PD9'S!<C)R.^ <5T^C:B-8T/3]3$1B%Y;1W
M C+9V;U#8SWQF@"\0""",@]C2%5*E2 5(P01QBN-\?\ B#6M";0$TBU27[;J
M<5O(6E";LY/E\J<;@#\W;'O61::UKEMX[\6II^BG4+@)9220M>"*.']QRH8@
MY8G.,#'!)(XR >CB*,1>4(T$>,; O&/I0(HQ%Y0C01XQLVC&/I7(1>.VU.RT
M5M"TIKV]U2U:\6"6<0K!$N Q=\-_$P4  Y.>E;OA[6TU_2A=BW>VF262"XMY
M""T,J,5=21P>1P>XP: --45<;5 P,# [4H4 D@ $]>.M<M\2;RYT_P"'.N7=
MG<2V]S%;%HY8G*LAR.01R*Y#Q#!I^@^%KK5]-\>ZL-2MX?,MXY=6^T+++CY8
MS&V=VX\8]Z /5DBCC+%$52QRVT8R?4T"&)00L:#)W'"CKZUR]SXIU1;FSTRP
MT,7NK-8I>7<3W(@2!6X"[B&RQ8, ,?PG)%5T\=S:D--CT'1C>W5Y:/=O#<7*
MV_DJC[&4G#98/D8'''6@#L'BCE*F2-7VG*[AG!]J=@$@X&1T-<#=>+?$$GCC
MP[86VCM#:WME+<3V]Q,J29R@.[Y3@ID\ _-GVJYI7C.ZU^]U2WAT%QI^GW%S
M:75VUT -\>0 JXR<X!/IN')YH [$HC*RLJD-]X$=?K0B+&@1%"J. %& *\]\
M.>,+.W\!>'9-$T68S:I))#8Z<]V6(*LY<M*^3M 4DG!/( %1^)_&WB*T\.EX
M-"DL-2CU*"TF$DP9,,Z$&-RN'5P2N< KD\9% 'HSHLB%'4,IX((R#0(T5 @1
M0@Z*!P*Y.[\6:LM[)8:?X=^V7EI;)<7\8O%182^2L:-M.]R%)Z =.>:8WCI]
M0NM-M?#NE_VE->V"ZBWFW @6&%CA<G#98G(VX['F@#L,#(.!D=ZK:E'?3:?+
M'IMS#;79 \N::$RHO(SE0RYXSW%<I\-+R6_TS7;B5)HV;7+O]U,<M'\P^4\D
M<=..*T?B#=W%C\/M>NK2>2"XBLY&CEB8JR$#J".0: +?AGP^GAW39(&N7N[N
MXG>YN[IU"M/*W5L#@#@ #L !6MY4?F^;Y:^9C&_'./3->::G:OX671-0TSQ/
MJ]U=W%];6[65Y?FX2X21@' 5LD$ ELCIBMJ]\>3VLE_>1:*\VA:=<FVN[_[0
M%964@.RQX^94)P3D=#@'% '9-%&SJ[(I=?NL1R/I2@!1@  >@KDQXQO+GQI>
M^'-/T-[DV,D'VJZ-R$2.*10V[!')&3A1UVGD5D:+XOTG3-"\2ZC:Z5<QFWUV
M:S-N+EI7N[DLB@KN/R!BP^4<#!H ]!DBCE $B*X!R PS@T[ SG SZUREMXQN
M;;56T[Q'I*Z5*;22\ADCNA/')''CS!G:I#*"#C'3O7+ZWXIU;6++PI=S:)+I
M]A?ZW8O;3"Z#LR%\@2* -FY><98=C@T >HM%&[J[(K,GW21DCZ4IC0R"0HI<
M# ;'('UIU07DL\-E-+;0">=$+)$S[ Y[#=@X^N* )/)B(4>6GR'*_*.#[4"*
M,2F4(OF$8+8YQZ9KQU?%.NZIX(\&ZQJ%H[SRZY#Y?D2KNN@1-A=H "\@#GCC
M)KLT\>/9-K4/B#23IUQI=HMZ4AN!<":)BP&TX7YMRE<$=2.: .O,49D\PQH7
MQMW%><>F:?TKFM)\37\^M1:5K6B_V7<W-NUS:[;D3+(JE0ZD@#:XW+QR.>O%
M=+0 QX8I,;XT;!W<J#SZUS_B3PU=^);FWMKC4DCT(,CW-DD'SW+*VX*TF[A"
M0N0%R<'GFN4LO%>JZAHOCJ77])5]-TZ2YC,<5YM8!(DS""J@\Y9M^<Y;':M.
MU\8_9;'PKIVD:%+.^JZ6+BTA:ZP(E1(SM=V!) 5OO<GCH2: .[IKHDBE7164
M]0PR*\^/Q)U/^R-2U!/"LA71Y9(M44WJ@1%.6\L[?WF%PW\/!%;-]XNO'U%K
M+0-&.JR0VL=W<%KD0!$DSL49!W.0I..!TYYH ZD*HS@ 9Z\4;%X^4?+TXZ52
MT;5;;7-&L]4M"WV>[B65 PPP!'0CU'0UF^*_$Y\,PZ:RZ?+?27]ZME'%$X4[
MV5BO7CJN.V,Y[4 ;HBC$IE$:B0C!?')'UIQ 88(!![&N-7QZ; ZQ#X@TE].N
M]-M5O/*BG$XGB8E5*-A>=PVX(')%30^,+ZWN)[76M#_L^Z%C+?6R)="99DCQ
MO4L%&UQN7(P1SP30!UO08%9^M:=/J6F36]G?RZ?=/M*742ABI!!Y!X8'&".X
M)KA-5\:#5_AEJ.O:KX9F71&MH)8T^WF.2XW.H890!D"MC!S\P'0 UT%WXIN8
MM0L]%T/2/M]\UDMW(DMUY,<$1.U=SE6)8D$ 8[$F@"71/#-[:Z])K>LZG%?7
MQM?L<*V]KY$446[<<+N8DD@9.>U=*  NT 8]*XL_$$2Z1:R6NDRR:Q<:@^FC
M37F53'.F2X9\$;0!NW '((XYJOX7U&^OOB9XA6_M'LYH=/M%>W\[S$!W2G<C
M<9!!'. >V.* .[CC2) D:*BC^%1@4B0QQJ52-%4G)"J #23M(EO(\,8EE5"4
MC+;0S8X&>V?6O&_!NMSV=YXP\6Z_82N+'4;J%[C[>TAA"[=MND7"MR0 W'44
M >S[1QP..GM1@ DX&3U]ZY2R\6ZDNLZ=IVNZ#_9G]IA_LDB78G&]5W%' 4;6
MV@GC(X(S2>$_&%YXKD::+0WMM.C:6)[J2X!_>HY7:J8R00,[N,'CG% '5)#%
M&FQ(T5#_  JH IV 2#@<=/:FS-(D$C11B20*2B%MNXXX&>WUKQRX\5:[JWP_
M.IZG:L@CU^(1-!,&=U6[P8@H ^Z %!)^:@#V/RH]S-Y:9;[QQU^M/KE-/\6W
MS:]<:1J^A/8W*V37T @N!<>=&K!6' &'!(XYSGK4=CXOU:6_MK+4?#;6$]_:
MRW%@C788R,@!,<@VCRVPP_O#KZ4 =?2!0"2  3U..M<=\-M?UCQ)X9^WZO;(
MA:>812K*&W@32#;M"C;M "YYSC-;GB;4+O2?#&I:A8P+/<VUN\J(S[!P,DYP
M>@R<=\8[T :JJ%&%  ]!6%XHT/4?$%D-.MM6%A8SJT=Z$@WRRQG&51]P"9&X
M$X/7M7"'Q!KEQ'\.M1N[%Y;ZX\PB&*=?]*W6F0[' " DDD8.T ]:Z6/Q\]O9
M:U_:ND26VI:7+#"UG#.)A.TV/*"/A?O$XY Q0!U]K;0V=I#:V\8C@A18XT7H
MJ@8 'X"G1Q1Q B.-4R<G:,9-8.B^(KR\U>?1]7TL:=J$<"W*(EP)TEB)*Y#8
M'((P01W'7-=#0 P0Q!F81H&8Y8A1D_6GUY%X4M;+6="EO]8\;:Q:W9N[E61=
M::((JRNJ_*3P, 5K^&O&5]#X+@GG$NLW<^IRZ?IDA(C-\@9MDC-C &U6);'1
M>Y- 'HH4 D@ $]?>FK#$BA5C15!R %  /K7'R>.YK:UNH+O1C%K4%W!9BR%R
MI1VFYC82X'R$9Y(R"I&*SO%?B_Q-IWAGSX]#-A?C4(+9RURKH59TP48KA@P)
M0\ J<^E 'H6Q-NW8NWTQQ3JXR[\::I#XCA\/6_APW&J/8QWKH+Q5CC5G96RY
M7L5'0<EAP.352R\4Z+I>K^.KQ[&>W.E-"]Y-]H:3[02A*[$/"'M@=2>: .\\
MM#()-B[P,;L<X^M(L4:.SI&JL_+$#!/UKD1XLU^))TO?"<EM.;1[JV(NA)&V
MW&4D<+^[?!SCD'!P:S/#OC;6I/!OA^6\TP7FM:J ML@N%03@)O:5R%Q& ,\
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MD^T:C=WKVD?&9E>%54CZD$5F7GAB.SULW^J^&M1U:&[TZU2/[$Y#0S1J59'
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M,,RY..5Q@'!QGC.!#<^+->TKPQI6HZKJ^F6LNNRPK \D&V+3XS&SLS$M^\;
M'' W'TJG;66H^)_%/C&!KVPGN+G0$LB]JQ:WMY',NV/=C+8!#$XS\W3I76:A
MX7OI?#OA^*SFMAJNB&&2(S;C#(RQF-U) R%96;G&1QQ0!RX^)DEMH^KQ+K.E
MZA/:W=K;P:JH"P;9\_/(H; *;9,X/.!TS3)OB)=VFD>)8[/7--UJ?3]/2]M;
MZVB 7EBK(ZAB,@@$8[-[5TU[X>\0:WHLPU&YTVWU&.\AO+".W5GAA:(@@.Q
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M%%% !1110 4444 %<M+X&L9?">I^'C=7 M]0N);B20;=ZF23S"!QC&>*ZDD
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MW::C8W]L;FSO;>Y@4D&6&574$=>0<466HV.I1-+87EO=1JVUF@E5P#Z$@]:
M+-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_0[+['IMJMO!N+D DEF/5F)R2?<G-+;Z186NJWFIPVRK>W@19YLDLX084<]
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M?#Z;M3GC;4-0G=)[;8%\I@0A"A5V,.1U]ZW=/T:RU/QYXU;5;6WNY4L[*/\
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M%+X;VME;0VUNC:AMBAC"*N8E/ '%8#:9IZ_#_P"*$BV-L'BU*]1&$2Y10D9
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M=][8I.U,]]H% &5\5^/A=KYR1_HXY';YUK)UFRTG0O%O@BYTFV@@S]I1VMT
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MNEO(HS(Y"3+]UAD\8].GM4NJ>#O#^M:@+[4-,BGN,*K,68"0+T#J" X'HP-
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M'F0.BL@D95PS#!;"_,!T)P:TM:\1V&@M;QW(N);BY+""VM8'FEDVC+$*H)P
M1D].17+?">_M'\/7>EBXC^WVE_=?:+;/SQ;IW(W#J,U!XTS8^/\ 2]1NM?ET
M*RETZ:V6^58B@E\Q'V,9%95W 9'3.S% '1S>.?#\-AIUZUX[0ZB72VV0.S.Z
M [DV@;@V01MQG/'6L_4OB#8KX4UK4]/AO6O-.1T>VELI1)#+Y99#(F,JAX.X
M\8[US.G6EC'K?@F:RO;J_M[O5=0NA<742H9&:&0EE4*!M+ L"!SG-6=7_P"/
MWXK_ /8)A_\ 2:6@"UX.\:&'P9;:OXBU/4KJXO#$$CDTPQ%I'7(C@5$!E'N,
M],YQ71Q^.=#;2-2U*26X@33 #>PSV[QS09&1N0C/(Y!'!KB+::/3-!^%NN7K
M>7I=E:A+F9ONPF2V"H[>@SQD\#=5'Q9=P:W:_$#6M+E6?2QH\%I]IB.8YIE9
MV;:W1MH8 D>M 'H?_"=:&--EU#?=?9UN!;0G[+)FYD/00KC,F><%<C@]J='X
MYT)](N-1:>>-;>86\MO);NMPLK8VQ^41N+'(P .<UA^*'BTFX\$:O<#R])T^
M=EN7Q\D(>!D1V]%#$#/;-9/BO6=.U^"VU71YIK6PT[6H3=ZS;PHR./*=/,4D
M$.J%U4DC [=* .UA\9Z+)I%]J4LTUM%8,%NHKF!XY86.-H*$;LG(Q@'.>*Q]
M>\;QS^"O$=WH[W5GJFFVAE,=W:M%+$2"4;9(.0<'!P1P:YN>^M['2M=UK2_$
MDVK//<6-I=ZI/;Q/!;H),&1=B!'*+(23S@XSTK$UR_LV/C,1Z]<:JEQX=5;>
M[N3'^_*/(7$1155E7<.0#SGF@#U'2/&^D:G?VNG+)<K<W,1>WDFM7CCNMHRQ
MB<@!\=>.W(XK%\'^,93H_BG4O$-_NM].URXM(F\L96-2H1 %&6.6P.I)-4KK
M6=-\0ZWX'T_1YDEN[.Y^T7,*??M(D@9660=4.65<''-<I903/X3\17,<\UO%
M9^.'N;B>% [0QJZ9D"D$';D-R#TH ]BT7Q'8:\;B.V%Q%<6Q43VUU \,L>X9
M4E6 ." <'IP?2LSQAXR3PI-I$1LKJY:_NU@/DV[R;5P2<;0<OQPO4\^AK/\
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M!GWG)'GR\$UZI?>*M2?7;_2M!T--2DTY$:[DENQ;JK.-RQI\K;FVX/8#(YH
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M55'H!BG44 -5$50JHH"] !TIV*** "FJBH"$4*"<G QS3J* &HB1@A%503G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7 Z)-_;VM^)_$=XIF@T^2;3+& MA52,?O6'N[<9ZX4"N^KSWPA_H.F^
M--%F^6YL]1NIMIZF*8>9&WT()'X&@#(%Q#/\(=)\8:#I_P#9L^D*]W;VRS-(
M/*$C":)F/+*RACST./2O5+6XCO+2&YA.8IHUD0^H(R*\@T>\%I^S)$@4O-=V
M<MG!&.LDDLKQJH'<Y;]*]8TFS.GZ-8V3'+6]O'$2.^U0/Z4 7**** "BBB@
MHHHH **** "BBB@#SWQ';V^I_$VWT_4-6O;*R71C.$M[][8-)YP7)VL,G!-,
M\.ZO>:9)XJM=-EO?$5EITMNMB&G\UVDD7YXO-.<JI*DDY*@GKBM+5/"L&M?$
M>*]U32+:^TR/2#"K7,22*LWG X ;/.W/.*E\7:$R>#AIVA:<%MDN87GL;';"
M9H!(#*BXP 2N>XST[T 5YO&]_IMCX@&K:/#%J.CV2WWDP79DCGC;?C#E 0<H
MP.5_.LCQ!XR\5_V%I.H6>C6]E%J&I6D4!DO?WCQNZD!AL.W>,@]2H/<\5E3^
M%[\)XI32?"+Z;9ZOHGD6L,?E*1*IDXE ; 9MPQC/&,D'..H\7:1J<_@S05L[
M&2ZN=-O+*ZEMHV4.RQ$%@N2 3^- "IK-G%\4%MK_ $F.#4T\/"ZGOENF=8T$
MN&B"X (!R=^ 3Z5-IGC74+F;2+B_T1+/2=9?98W N=\@)4NGFIM 7>JG&&;!
MP#6=-H.I:S\39-6EL)[73;SPP;)GE*[HI6E)V$!C\P![9'O5#PGX7BL+C1[6
M7P(L&HV( NM3EE7R=R*0)(B&+,6(!P5&,G/2@#I?#GBO5=?>SO!H4::-?;_)
MNHKL221[<X,J;1MSC'!;!(!JA\6KTV/AO3'-_<65N^KVT=S-!,T3"$D[_F4@
M@8JCI.DWA\7Z=?V7A>[T"Z$KMK$B3)]DN%*,,*JL=Y+E6#;01@YK9^)&G:CJ
M&CZ4VFV$M]+::M;7;PQ,H8I&Q+8W$#]: .1M]2TI/%N@6_@GQ3J6HW$MV!?6
ML]])<0_9=IWL?,R PXQ@YKKM4\9ZA;7&KS:;HB7NF:*=M].UUY<A8('<1)M(
M8JK G)7)X%9'B)->\;16.GP^%;K2C%>0W!U&]FA!MPC!B8PC,Q8@8[=>:I:E
MX2BM=?UU[GP4VO2:C<_:;*Y61%C7<BAHY26!0!@3D Y#>O% '2S>,=2O-?O-
M(T'1H;V2"U@NUN)[LQ1,D@8X.$8@\# QSDY(QS%;>/+C5=*T-])TE9-3U99F
M%M<7'EI (6VREW"DD!L 87G/:K6A:-<Z?XXUNZ-H(;"6PLH+<JP*YC$@91WX
MRO45Q</@JZ@T?PW=:MX=DU-+%KZ*ZL$93*JRSEXY%!8 XP,C.</[4 +\1_%&
MK:E\-;K[-9"SE2^%AJ2B[(:%Q(GRH0OSJX(Y^7@]#G%:]LUGH?BSP?HTWAFV
MM;^6&\:W:"_>1+4!22!E1OW#KD<9[U3\0>%;N]^&%Q8:/X873)[C4([A;%)5
M+E%D7YW.=H;:H) )QCK6_KVBZC=_%3PEJT%LSV-E#=K<3 C$9>/"Y&<\GTH
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M0FY@0,$@N0!WP.>:TI/$_B 3V6EIH-K_ &Y<127,ENU\1#!"K!0S2!"2Q)
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M7VU&87%E<)(@5&,:JT<I9@54,N<@'AO48KTB.S$6C)8PQ1PJEN(4C0Y5 %P
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M<FGV\5T4\V0^89'8A6( ' '/- '94444 %%%% !1110 4444 %%%% !1110
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MQF3"D=4(5E^;)R!S5/5I?$FH^$/#6MZEJ<$\&I:GI\[V:VP06ZO*K)L8<G'
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MBF0/4UU%OK%]?_$2\TNW=1I>F62&Z^4$M<2'*KGL @SQ_>% '34444 %%%%
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MJHC5"#^58^B^%_%&DQ:;HRZQ:)H>G3!DDB1A=31*25A?/R@<@$CD@=!7<T4
M<;I'A[Q+HA@TFRU'3TT."Y:5)#$S7/DER_DX/R=]N_KCMGFLZ\\%>(EL/$.B
M:;J.GQZ/J\L\P>6-S/"9AET 'RE2V>>H!/!XKT.J,NH21ZS!IXT^[>.6)I#=
MJJ^3&1_"QSG)[<4 /TJT:PT>RLW8,]O;QQ,R]"54#(_*N$;P7XHATO7M(L]3
MTT6.M7ES-+)+&YEMTF8[@F.&.T]\8.>3V]&HH \M^(FFV=VGASPYHU^(M;CE
M^Q1)$P:2.T>(I,7'\*[,')[@8KTRUMH;*SAM+=!'!!&L<:#HJJ, ?D*%L[5+
MM[M+:%;F0!7F" .P'0%NIJ:@#B]1\*ZU+KNMS:??64-CK<4<=S))&QG@VH4/
MEX^4Y'3/0DG!IWACPGJ6DZIIM[?W%JYM-$32BL&[YBDF0_/JH&??-;]EKEO?
M:YJFDQQRK/IOD^:S ;6\Q2PV\YZ#G(%']N6__"4'0/+E^TBR^V[\#9LW[,=<
MYS[4 <IJ&DZ5X?\ !?B:T\2:C;1V>J75Y<@[L$"4EE50?O.., =\5>^&FD7N
MF>#X+C5BS:MJ+?;+QG&&W, %4^F$"C'J#757%G:W31M<6T,QB;?&9$#;&]1G
MH:FH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KQ];:74_AIJOCB74;^/74-W=02I=R*D BD<)$(P=FW"8((.<G->P5QUQ
M\.["X-U;C4]2BTB[G-Q<:5'(@@D<MN89V[PK'DJ& Y- ')7.CV.K_&30YKA+
MI3>Z(UW*J7DR8?<. 0P*C_9&![5T7QDMH[CX8:JTGF9A,4B;)&7GS%7G!&1A
MCP<CH>H%='+X9LI?%EKXC,DRW=M:-:)&I CV,<Y(QG/XU-XAT*T\2Z!>:/?&
M1;:Z3:[1-AEP000>>00#0!Q%UX:LKCXGV.DF6\2PBT"1F1;N7?(/M ^5I-V\
MC)SU[ =.*P?[1OX=.M_#RG5;ZS'B2\LC';7&+F2WB1G6(2,RG&<9.X':I%>E
M:;X7BL-6M]5FU&^OKZ&R:R,MR4^=#)YF2%4<@@ 8[#UYJK+X%TZ2SN88[J]A
MFEU)]4CN8W4203MU*?+C&,C!!R"<YH K>!(M3MI-6M[C3M2L=,$R/I\6HS++
M(@*_.H8.YVAAD9/\5<UXF\/:???&W04G^U;;NQN))=EY*ARH &TJPVCCHN >
M]>A:)H@T:*???WE_<7$GFS7%VX+,<   * J@ #@ 5%=>&[.[\56'B*26<7=C
M!)!&BL/+*OUR,9S^- '!1V#>(?#7BCQ+=:AJ$6J6US>BSDBNY(UM%@+!%" A
M?X<G(.<FDM%G\9>-])CU&\O(K.X\+6U_/;6]P\2O*TAZ[2"!\W;K@=A74WWP
M_L[R;4%CU74[33]2D,M]86\B"*=FX8Y*EEW8^;:PS6M!X;L;;Q(NN0F1)UL%
MT]85($:Q*^\8&,YR<=<8[4 >7RW.N:N=9U2PTCQ!<ZU#J<T=C=0W:);1)%+L
M6(QF4 J0I#90Y+$^E;L5C)XDO_&.J7.HWUO=:;=-:V'E73QI:B.%&W; =K;F
M8D[@<CCI713^!K:34+B:'5M3M;.ZN!=7-A!*JQ2R9!)SMWKN(!(5@#7+^*+)
M+;Q!KFS3?% %_$I:'34\RUU%MFWYR%)B/ 5OF7(&>: *GAHS>*)?"FBZG>7C
MV*>'%U"9$N7C:YE+J@+LI#, ,G&>I%9GBO4=0TOX?^,=-M]1O-NE:O!#:3F=
MC*D3^4_E[\[CC<1R<XXKN-+\"LOAOPVDE]=:;K6EV*V_VJS9"0"J[XR&5E9<
M@=1U&15B[^'6D7OA.Z\/SW-\T=Y<"ZNKHR*9YI=P;<Q*X_A P!C XQ0!G76E
MKK_Q0U73[Z[O3IT6EVTGV6&YDB5G+RC<=A!Z#IG!XSG KG='GO-;M/!WAZ^U
M"]>SFNM26X=;ATDG2V<K&C.I#$<C//.VO4(=$MH/$=WKBO*;FYMH[9T)&P*A
M8@@8SGYSW]*X_7_#%IH>CZ4MI!KDWV2_FN%O=-*O=6IE+LY";#O0EMI7:>,=
M<4 6/!<,UAXW\7Z8;^ZN;6U^QBW2XF:0PJT;-MRQ)[]3SC&<UW5>;^$O#<UX
M?%=PS:SI]MJ[0QPW-PQBO7V(0TO(RA+,<# P!T P*]&C3RXD3<S;5 W,<D^Y
MH XWXG*&\.:>K %3K%B"",@CSUKE=<9O"/AWQ3X.N"?[/N-,NKK19&/1-A,E
MOGU0G(_V3[5Z7KNA6WB"SAM;J25$AN8KE3$0"6C<,H.0>,CFJGB[PCIGC313
MIFI^<B!PZ30,%DC/0[201R"0>.AH X.]N)M2UZRTN?2]:U*QM-$MIDM],N1!
MB63<#(Y\Q"<! %Y..:;)>:_;ZE\,[?5I;RWNY+FZBN8Y)1NE51A#)M)#$J%)
MZ\DUW%]X.AN9K.YLM4U#3;RVM19_:+5DW2PCHKAU93@Y(. 02:)/!.FR7'AZ
M8SWF[0F=K8M+N,A9<$R%@2WKP10!YI+H]I:^&/BG<Q?:/,BGN(%WW,CC9Y4;
M<AF()S_$1G'&<5TS:;_PC?BSPA/:7E])+J(GBOO-NG=;C%NT@.PDJI#+QM
MZ=*V[KX?6-U-KW_$RU&*UUQ6%U:(Z>6'90ID7*$AL*.Y'M6S=Z!:WFHZ/>R2
M3"327=X I&&+1F,[N.>">F.: /+?#$^N:E;Z#KMKI'B!]3NKJ.:]OI+M#:RP
M.WSJ(_-.%53\H" @J*Z+P%IS:CKOB'5[Z^O9Y;+7;RWM(FN'\J),\_)G!^]C
MG. !C%;ECX&MM/O8&@U;4QIUO.;B#3/-401N23QA=Y4$DA2Q ]*U=$T&UT$:
M@+629_M]]+?2^:0</)C(& /EXXZGWH X_P"(^E6NH^)/!@N//Q)J1B;R[B2/
MY?*<\;6&#D=1SVSBLZ#PW:ZOKWCUKFYO56WN(_(6"ZDBV.+6,[_E(W-TQNSC
M'N:[GQ)X9@\21V6^\N[*XL;@7-O<6K*'1P"/XE((()ZBGV/ANUL)-7D6>XD?
M565[AI&7((C6/*X QPH/?G\J //+;6=1O-;^$<LU[.6OK*Y>Z D($S"W0Y<=
M"<Y//<U<TV)]*\60#Q"NMVNIS:A((=32Y:2SO%9F\N$KN*Q_*0 I4'*\&NH@
M\!Z7;W'AB9)[LMX<ADAM 77#AT"'S/EY. .F.:2#P/!%?V\LFKZI/8VUS]JM
M]/FD0Q1R9)!SMWD G(!8@<4 :?B;78/#/AK4-9N<%+2$N%_OMT5?Q8@?C7BI
MOO[$\*:-K*Z7KA\1Z=?-JE]+)I4Z)+YI_P!(0N5P!LP,]/D%>T>(/#=GXEBL
MH;Z6<06MU'=>3&P"S,G*J^0<KGG Q6K-#'<0203('BD4HZ,,A@1@@T <'J30
M^+?'NEZ8]W<'1O[';4T2VN'A$[M(JH24() 4Y SU-<E=S:I;>&=;M8M:O6FA
M\7PVD-TTQ:1(_P!R I/?&>?4YSUKH-5\+VOA:+0(K0>)FCL8YH$U+30L\\,;
M$,(I(Q&=R'L=IV[14GA3P4E]X=ODU""_LH+G7/[4MXYFQ/A-FPR[@>6*%B#S
MSVH IZY9)I_B;3_#,-AKNIZ7%827KV]I?$22RM(%W22/*K$#G@-U8<<51EN]
M=*^'M!U?2]=N(&>^E:UBN46YGAC91#YCB0 X63G#9)49S7HVM^&H]8O+6_AU
M"\TW4+97CCNK0IN,;8W(P=65E) /(X(R*JS>";1]/T^&#4M1@O-/=Y(-064/
M/N?/F;BRE6#9Y!&.!C&!0!PUPNNII6A:==MJVEPR^*!;V_G7(-P;-H7;8SJS
M9P=R@DDC:IZ@5H:=X6M;KQMXC\/R7NI_V/;6]M<0VHOYODED#@MNW;C]S."2
M,G..E=6G@RR^S:;%->W]Q+8ZA_:(GFE#/+-M9?FXQMPYX4#&!BM&UT.VM/$&
MHZU')*;F_BABE5B-@$>[;@8SGYSG)/:@#R;3M9U'6]*\'6%_;:OJT#Z7-<W$
M-C<".2X=)%C0R,70D $D_-R2"<UH&/7'A\+Z7J$NJZ<DNMW$""6Y_P!(>T\F
M1E5W1CDX^7.<C .<\UU\?@"QM=)TFST_4=0LKC2E=+6]B9#+L<Y96!4JP/'!
M7L*MP^#K*(:07N[Z>73+J2[26:4,\TCJRL7..GSG@8 X[<4 >=>)-.CL=*^(
MVB13WATZTT^WO+:&2[D?RG=9-V&+$E3M!*DD>U>H^&;"#3?#=A;VWF^7Y*O^
M]E>0Y(!/+$G\.U5;[P?INHSZ[+</<'^VK2.TN5# !40. 4XX/SGKGH*OZ)I;
M:-I4-@VH75]Y0VK-=%=^WL/E4#@>V: /*+FPEN/ 'BKQ#+J>I'4=.O[YK&1;
MR11;B.9B %!VD=>H/&!T KI;>T7QEXVUNVU:>[-IIEM:+;V\%U)"H>6,NTAV
M,"6Z 9Z8KH3X-TX^&=5T'SKK[+J<L\LS[EWJ9F+-M.W  )XR#^-,U#P;%<ZB
M-0L-6U'2KMK=;:>6S:/]_&N=NX.C#<,G#  C- 'GD-WJ>M6_@S3+C5KT;M5O
M[">XCF*O<11"11N8=257&[KGGK7K2Q6NB:&8UE>&TLX#^\D<R%$4=26R3@#O
MFLFW\$:3:#0%MC/$FB/));J'!WLZE6+D@DD[B>,<FMZ[M8;VSGM+A-\,\;1R
M+ZJPP1^1H \I\/32VGBKPK-:6NO16^J><L]YJ=X'^WKY+2*YB\QMARH(^5<
MXK/CM)X_A/%XM;4]2?6;>[W0S&\DVH@N_+V;,[2I7.<@DY],"N[M?AY;V\VE
MSOKFKSW&E.#922R1DQ1A2ABP$P593@DC<<#D8JY_PA&F_P#"%GPMY]U]A+[_
M #-R^9GS?-Z[<?>XZ=/SH Y^77W\%>(_%<&H322V<EH=9L!(Y;D#9)$I/^WL
M(4=-]=/X+TZ]TOPCI\&I3RSZ@T?G73RL6/F.=S#GL"<#V%<WXGTL>-/&FB67
M]EWJ6VCW+7%W>SPM'$ZC!$2$_P"L#,$)QP M>A4 >6^$+&2ZTGQ'KMW?WT]W
M;7FHV]J&N7V0QAFX"YP3D]3T  &,5F>'+B[UWPW\.M'OKZ\:VU%+N>\9;AUD
MG\H$JA<'=C+9//.VO2]+\,V6DZ3?Z=!+.T-[///(SL"P:4DMC ' SQ_6N6UK
MPK9^'O#'A^RLH-<GCTF<^3>Z<5>[M@P;+;-A$BG.T@+T/3B@#E?$<$]CIGQ(
MTM=0N;BVM8].%JMQ,TI@#-NVY8DGGUYP!G-=3<:+%HOC[0[&VO-1>#6+.]BO
MQ->ROYQ14(?EOD;YFY7&,\8JIX=\'IK<?BPWL>JVVGZN]LB2WHV7<WE#+2,&
M'RY8X (' X &*[R\T2VO==TS5Y'E%QIRS+$JD;6$H4-N&,_PC&"* /*?"NA7
M;_"?3+C2X+ZZ\W4))-1M8;]XWN($EF7:A+ *<E20"N[:<G)KT'P+/82Z/<QZ
M?+J82&Z9'M=3+&:S;"GRCNR<<@C)/#=<55M/AW;Z?8&SLM=UBWBBN3<V>R6/
M_1&)<L%^3YE.]LA]W;ZUNZ%H,.A07"K<W-W<74QGN;JY93)*^T+D[0  %50
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M+C78?$'@NSU8WL,FS4T:.YE#/)&I3RC)M)#,$(YR><^M4?$E_J&SQJEOJ%S
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ME6)L+>$."GE^^1DGWS0!YG=6]S<?!YO&7]KZC'K5VRS32K>2!"KSA?*"9VJ
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M:6*,V7E^=(9'53$Q"ECDG&>,G.,5#K&C0:Y\8DM;N:X6U&@;Y(H)VB,O^D$
M%E(;:,YP#UQ73>'_  G:>';W4;V&[O+JZU$QM<RW3JQ=D! ;@#&<].@P  !4
M6K^#X-3U]-=AU/4+#4H[7[+'+:LF%3<6.596!R3WR.!T(S0!Y_'>ZCHVER:H
MM_=S6GA?Q%-9RB29G,EBX0,'R?G*>8""<XVUV6BSSZW\0M;U%;B0Z;ID2:;
MBN?+DF.))7QT)&47/UJ'5-.L_"G@RZT:UTS4]:EU$3AU6(RO<32 [FE< *@)
M/WC@ #CI6OX)\._\(KX0T_27;?<1ION),YWRL=SG/?DG\ * .@HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+($ "Y'L /RK7HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+K&F/I9U1=1M&T\+N-T)E\K'3._./UH NT5G6WB#1;R,R6NKV$Z"$SEH[A&
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MO/'MB@#7HIJ.LB*Z,&1@"K*<@CU%8GBSQ&/#&CK=I:F\NYYX[6UM%?89Y7;
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M?2H]3L_#*?O$DNA OVN5>N2K;MJ=L<$UZ9;V\%I;16UM"D,$2A(XXU"JBC@
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M7UY;&#4+K[" ;V:TM&ECMLC=\[#OCD@9(%/U7QSHVDRV43-<W4M];FYM([.
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M7RWW+J]@6&TY'+]: .XTK58E\4:3ILNL:RUU)IKS?9+VW1/,4.1YDF%&''3
MP,=JOV/CK1]0U&"UA6\6*YE:&UO)+=EM[AUSE4?H3\K8['!QFN=UB"6;XYV
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MTS1:A 866'G]Y@]5X//;'.*@TOQUI&J7B6VR]LVFA:XMWOK9H4N(EY9D+=0
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M F9-J7(D<J"#EL D#!R1TH [NW\<Z1);W\MVE[IS6, N9H;ZV:*3RCG#JO\
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M)>['D6)R&:-=A!^7DY(]!G&:Z+2O$XU'Q/J.B26WD/;V\-W;2;\_:89!]X#
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M/K>N^(;?XFZ+I%C;6SV$UK-*X>Y*&0 H"Q&PX*Y.!GG)R17.:+XGUCP_X?\
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M;R2RN85E\Q1(F#E6P,@A@>@ZT ;U%<I?>)]7G\07^D^'M(MKU]-2-KN6ZNS
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M4ND@*+M8!@>,C@BN5\1>)M8UWPQHVH3:+':Z5?ZK9/:RK=;Y0OGJ5,B;0%#
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MY@CGA</%(H=&'1@1D&@#BF35O"_B[7KZWT.[U6SU?R9HC:/&#%*D8C*.'9<
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M^TJ]T;PW+:ZA;F"9K^ZE"$@_*\K,IX/<$&NJHH **** "BBB@ HHHH ****
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M,[LY"KV4%L >@% '+>-_$=]I6HW:P^*+/3?L]F)K>SCM?M$L[_,3YHVG8AP
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M*4+$D]L'=0!R+:]XIO\ PKJOC*RU6&"TM'N)+;3&M59)88&93O<_-N;8QX(
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MQP#@9KLZ\Q\,OJ&J>/?$E_;ZI8WEP-*AMQ<VJ[K:&?=(5C4Y.X ;6/.<L>G
MKT>Q6Z33[9+V1);M8E$[QC"L^!N('8$YH GKQIX;O2/&WBSQCIR22R:;J*1W
MUNG/VBS:",O@?WD(WCZ&O9:P=#T"72]8\07DLL<D>J72SH@!^0"-4P?^^: .
M4NM>M;3X@:MX@@9;FUA\))>(4/$B"61Q@^X%/&K>*-&L/#^NZEJT-Y;ZG<V\
M-U8BU5$@$_ ,;#YCM) ^8G(STI^C?#(:9K>N>9>++H=_8/86]J 0]O$[,[(#
MTV@N^/0$5/;^$?$-S%HNF:SJ.GRZ5I$\4R/;Q.)KHQ?ZL."=J\X)QG)':@#
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MNGD6X:1U<Y5B5&">, 8 QW->S4 %0O:6TES'<O;Q-/&"$E9 64'J >HJ:B@
MJ-X(9)8Y9(D>2(DQLR@E"1@X/;CBI** "BBB@ J%;2V6Z>Z6WB%PZ[6E"#>P
M]">I%344 %%%% !1110!#]DMOM?VK[/%]IV[/.V#?M],]<>U3444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $<4$, <0Q)&'8N
MVQ0-S'J3CJ3ZU)110 4444 -=$DC:.15=&!#*PR"#V(IL$$-K"L-O%'%$O"I
M&H51] *DHH **** "BBB@ HHHH **** "F2Q1SQ-%+&LD;##(XR"/<4^B@"*
MVM;>SA$-K!%!$.0D2!5'X"I:** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@"&ZL[6]B\J[MH;B/.=DJ!QGU
MP:D1$C14155%&%51@ 4ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&6\LGCAAP,YZUO> [JVFTB\M[>SFLVL[V2WFMGN?/2)P%8B-^Z?,,#C'(P*
M-RWU:SNM6O=+BD)N[-(WG3:0%$F[;ST.=IZ5=KR7Q=(\-Q\3I(G9'72;(JRG
M!!Q+6^NEVV@_$C08]/\ -C%]8W?VLM*S>>R&(JSY/+99N>O)H [NBO,/#$&C
M76E6.O:Q?S6^OOJLD4DRSL)3-YS*+<KS\FW"[,8QSQUKTJ.Y@FFFABGC>6$@
M2HK@M&2,C<.V1SS0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)='MF";OE!,LV3CUX%5O&NG7]QK&G7<FF7>L:)##(MQ86DXC<2DKMD*EE$@
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MT7P]IC^/YY]+BE@L]$7R7(N)'$]S(N2IW,1A$8?\"?\ V: /0**** "BBB@
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-** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>exhibit1013-zerondaxexec014.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
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M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7:0Q&<C !SS3;WQAJNCZ)?WVL>'OL\MJ]N$6*[$D4RRR"/*OM!!4G)!7T]:
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M[E5 _I4=_HMGJ=_87EVC2-82&6",M\@D(P'*]"P&<$],G%:% !1110 4444
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M TB\C)WJ"1GG)J"X\-23:+IS:3X7ETM?^$BM+IX7EWRM#&PS+("3M.,_+D\
M?2NS_P"$+\/_ //@?^_\G_Q5'_"%^'_^? _]_P"3_P"*H KWNG7<GQ+TG4D@
M8V<.FW,,DO&%=GB*C\0I_*N)\5>%M;OO!7C>RMM.EDN;_7$N+:,$9EC @RPY
MZ?(WY5WW_"%^'_\ GP/_ '_D_P#BJ/\ A"_#_P#SX'_O_)_\50!6L]-O(_B7
MJ6I/ PLY=*MX4EXPSK)(2OX!A^=<?8Z+K.ACP_JS:7/<26&IZEYUG$R><T5P
M[%70$@-C"G&<X-=S_P (7X?_ .? _P#?^3_XJLG7?!W@H):0ZE&+66XG$-I(
M+N1)/-/0(=W4\T 5O!5S=WGQ \9W-W:-:,ZV.V!V!=%\M\!MI(W$8) )QD"I
M/B38ZC<GPS=Z=IMQ?_V?K$5W-%;[=_EJK9QN('<=ZT+#X=>&-.B9(K&1W<YD
MEEN9&>0^K,6YHMO#_A&]O;NSMHXY;FS*K<1)<R%HBPRH8;N,B@!;7Q1J6HW
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M.TD;NAP?RH QO.UCQ#X\\,ZG_P (_?V&GV*70F>\V*P=XP!\H8_+QC/<GVK
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M!,5&\1DE0V.<$]LUY>OB3QC-X/U3Q2FH62Q:9<7.+(VN1<Q12L#N?.5.T$#
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MSX5^TV_VN621Q+\VP!K@RCMGH<=.M %>]\2:N_C2]TN/7-.TR>":);/3KZ#
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M26?_ "5GQ]_V"K?_ -%FIKKP/XEDT74-$M[S2X[&34'U"&9@YEF8S><$EXP
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MD8]-S,H!]C4^B>';[^V-5UKQ UG)>7\,=J+>UW-%% F[Y=S %B2Q).!VK/\
M!'@2Y\.27S:I=Q7NZ%;"S*YS'9H6*H<]SNYQQP* .>T3XDSWEYH=W+X@TRZ_
MM:Y2&71X8P)+19,["'SEF4[0V1CDXQBM'2_$'BC4;+Q-J[W]K#9:1<7]O#;B
MV!:8Q;MC,V> OR\ <X.>M:_A[0_%&C1Z=I#7NFG1M/\ D6=$8W$\2@A$92-J
MD<98$YV]!FI-,\)W=CX9\2:6\\#2ZK=7L\3+G:@FSM#<=1GG% &-:Z]XHM8O
M"6L:A?VDUKK<T-O-8QVVWRO-B9E99,Y)!7GC')QBLE_B?())-5'B'3!&FH&
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MXR%XZY8'G%4/^$;\1ZAK6DS:S-I$D6EW)G2^@1ENI@%8!"N J [OFP2#CH*
M.0TK7/$/A_X8:SKR:C'>7 U9TCB> +\S7>QSG)^]N.!_#79IJ'B#2?$OAO2=
M2U&WO&U)KM[AHK;R@H2-65%Y)P"3R>36.W@'7F\)ZOX<:YTW[+-J O+2<%]^
M#<"9A(,8!P"!C-=+XHT/5+[5=%UC1I+/[;IDDO[F\++'*DB;6&Y02", C@T
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M<W=@#C)[@'J*Z0:1'J'C<^&)KS41H^EZ7',D*WTJ/-))(XW/(K!VP%P 3WH
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MDFX9'^<X/:@#M*HZOJ1TK3VNUL+R^*LJ^19QAY#DXR 2.!U/->;:V+CPO?\
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M'# @C#'@BI-+\/PZ9JVH:F+F>>YOXX$F:7;@F)2H8  <G))[>F*UZ* .1B\
M6MGI6DVNG:G?65UI2R);7L>QI-DARZL&4JRDXXQV!K?T;2UT?3EM!=7-VVYG
M>>ZDW/(S$DD] .3T  '85?HH YG6?"#ZM=W<L6O:G8V]]&(KRV@,;)*H&WC>
MI*$C@E2/SYIEQX%LI=;&H07EW;1/8KI]S:1[#%/"H(53N4L,;CR"#74T4 <9
M:_#U()=)FD\0:K<3Z3(/L3R>5^ZB"E#'@)A@RG!8_-P,$4Z/X>64=IJ=E_:>
MH&RO+HWD4(9 ;2<OYGF1L%W9# $9)'MUKL:* ,;1-"ETJ:YN;O5[[4[NX"JT
MMR54*JYP%1%51U.3C)]:7Q!X>@U^&VWW$]I=6<PGM;NW($D+X(R,@@@@D$$$
M$&MBB@#F[+P=;V]MJ_VJ_N[Z]U:+R;J]FV!]FTJJJ%4*H 8X '4\YK3T'1X/
M#^@V.D6TDDD%G$(D>0C<0/7  S6C10!P'Q)M3XHMK?PG:V-\]Y/<0S?;$A98
MK1 WS2&3&W=MW*%!S\U=)J_A:QU72+/3U>:S^P/')936Q >W=!A2N01TR,$$
M$&MNB@#EH/ UF]OJPU6]N]4NM5M_LMS<W&Q6$0! 1 BA5 W$\#J<FHK'P(MO
MJ>DZA>Z[J>HW&E%A:_:#&%5&C*%2%49X.2QY) YKKJ* ,KP]H%MX<TU[&UEE
MDC>XEN"TI!.Z1RQ' '&36!\1=+EU>+PU;QI<[1KD+O);@[H5$<GSY XP<<GC
M.*[2B@#DT\"P2PZR=2U6^U"\U6S-C+=S"-6CAPPVHJJ%'WB>G)JSKG@RQU[P
M?#X:N+BXCM(EA421E=Y\O&.H(YVC/%='10!EPZ%;P>)KO75DE-Q<VT=LZ$C8
M%1F((XSGYCWK+7P-IZ^#X/#0N;K[)#<+<+)E=Y83>=@\8QNXZ=*ZBB@#C=1^
M'=GJ9U:"75=1CTS5'::>PC9!'YS* 7#;=W4!MN<9'0]*UM-\,Q:?KCZP][<W
M-[)8Q64CR[ '5"2&PJCYB6.>WM6Y10!YV=,C\6_%&QUI-.O(++1H'22>YA:$
M7,V3Y:JK %@F7;=TRPQ7HE%% '/1>#]/B\;S>*A).;R6W\DQ%AY8.%!<#&=V
MU%7.>@J+1/ ND:'%K4,?FW$.KR.T\<Y!"HV[]VN ,(-[8^IKIJ* .2T_P'%:
M7.G&[UK4M0L]+8/86ER8]D+ %5)*J&<J"0"Q.*T+#PM9Z?I^LV<4T[1ZM<SW
M,Q8C*-*,,%XZ#MG-;M% ','P/IXTW0+:&YN8;C0@BV=XA7S=JJ%*MQ@JP&&&
M.:Y?0_!-QJUIXCAN=2U73K.^UF\^TVD855N8C)P064LH9>"5(R*]/HH Y^3P
M?IS^)[77-TJR6VGG3TMU(\KRB<],9SVZUD0?#>&&#3HCK^K.NE2H^G;C%_HR
MKD;<;,-E3MRV3CICG/;T4 <=+\.[.6YFC&J:@FD3W?VR7259/(>7<'/.W>%+
M#<5#8S4\W@B-M0N9+;6M3M+"[N1=7-A Z+'))D$D-MWJ&(!8*PSSZUU5% !7
M.Z9X,TW2_$FL:W$TSS:H )(I"#'&/XMHQGYCR<D\UT5% '):7\/=+TGP7J/A
MB"YNWM;]9%EFD93* R!.#C'"JH'':G77@6WEM/#L=IJE]97&@Q>3:W,7EERA
MC$;!@RE3D*.U=710!@1^$[./1]>TT3SF+6I;B6=B1N0S+M;;QV'3.:K7/@J,
MSV5WIFK7VF7UM9K8FX@$;&:%>@=74J2#D@@ C)KJ** .2E\ :?\ V'8Z?9WM
M[:W%C=&]AOT96F,[;M[ON!#;MS9!&*(? %@(==6[O[^\EURV2WO9IG7<VT.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD#C4/.WL%#*K*$4@$9YSVK1^)/\ R37Q'_UX2_\ H-4/$W_)$]0_[ 9_]%4
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MH]I/>KM/FO&"6V_=SV;';.<5A66L:A)\8M7TA[ISI\.DQ3QP<;5<N 6]:S?
M7C60?#'2M5UVXN;Z_N[B6")(HM\T[B1\*JCT5?8 #F@#T:6))X7AE4-'(I5E
M/<'@BHK&PM-,L8;*QMX[>UA7;'%&N%4>@%81\<Z,FA3:I+]JC$-P+1[5X&^T
M"<XQ%Y?4L<@C'!!SG%)9>.M&N[NZM)!=6=S9VC7EU%=P&-H8P>2V?8YXR,4
M7-:T&*]AO[JSM;'^UKBS-JLUU#O1TSD(X[KG^=<OX;\'7EOXCT_49]$TG1+7
M3HI@D%A,93<2R!5+L2BX4*N .3S70Z)XRT_7+];*.VO[2>2#[3 MY;&+SXL@
M%TSU W+QP>1Q65\)]8U#7? %K?ZG=/<W3S3*TKXR0)& Z>PH ZJUTG3[+3/[
M-MK.&.QPP-N$&PAB2P(]"2<_6JFD>%]#T'SO[+TNVM3. LAC3EE'1<^GMTJQ
MK.LV6@Z7+J.H2F.WCP/E4LS,3A551R220 !69I_C/3[Z>ZMI;:_L;NVMS=-;
M7MN8Y&B'5UZAAGC@\'K0!9TOPEX?T6>:;3=(M+6692CM'& =I.2H]%]AQ5D:
M'I:V-G9"Q@%K9.DEM%M^6)D^Z5'8BJ/ASQ;I_BI#+ID%Z;;RTD6YEMRD3[A]
MU6/WF'0@=#Q5[6]8M/#^CW&J7Q<6T !<HNX\D*./J10!*VF6+7LUXUK$UQ-"
M()9"N2\8)(4^HY/'O5#3?"7A_1Q<#3M(M+;[2GER[$^\G]WV7V'%6KK6+2SU
MC3]+E+_:;\2M  N01& 6R>W!%<[:_$S0KN.RN(HM1^PW<JPK>FT80)(QP$9^
MQS@=P#P30!TAT;339V5H;*$V]DT;VT>WB(IPA7TQVJ.'P]I%OKDVM0Z?!'J4
MR[);E5P[CCK^0_*LO4O'6DZ7?W-M-'>R1VA5;RZAMV>&U+ $"1QTX()QG /.
M*=J/C;3=/U6YTM+;4+V_MXTE>WL[8RL4;.&&.,#'/U'7- &KJ^B:9KUHMKJM
ME#=PJXD59!G:PZ$'J#R?SJI_PB/A[;*HT:S595B215B #",@Q@@?W<#'T%<5
MX\^($H\,:'<^&Y;Y(]8O(8A>0VN\I&Q8,J[ACS<K@*1ZUT$7BZTTJWL].,.N
MZGJ!M_/>+[)ON4CR0&E"A54D@@#J<=* .@U;1-,UZU6VU2RANX58.JR+G:P[
M@]0?<5-I^G6>DV,5EI]K%;6L0PD42A5'<\?6L&Z\?Z!:Z/INJFXFDM=1=HK<
MQ0LS,X#$H5Z[LJ5QC.>*+KQQ8VJVB'3M7EO;F W'V&*S9IXHP<;I%_A&>.3S
MVS0!>U;PGH&NW4=SJFDVMW/&NQ7E3)VYSM/J,]CQ2ZKX4T#7'A?4])M+IH%V
M1F2,<+_=]U]NE49?'>C_ &73Y[%;S4FOX6G@AL;<R2&-3AF8<;0"<<X.>.M/
MN/&VD1Z9IM[;"ZOO[2W?9(+6 O+)M&7^7C&W'.<8/% &IJ.BZ9J^F_V=J%A;
MW-E\N()$!0;>F![4_4=)T_5M/:PU"SAN;1L9BD0%>.F/0CL:XSQ!XXA6T\,:
MK87-Q%9W&K&VNHO)/FG;'*#$4QNW;U P.2<8ZU<U#QG#?^%?$YL%O;#5=,L)
M93#=P^7+&3&Q1P#D$9'!YZ4 ;D/A?0K?2#I,6E6J6!D$K0!/E9P0P8^IR <G
MT%2:QX=T?7Q -6TZWO/(8M%YJYVYZX]CW'0USNB>,$M?!/AF?41>7^J:E9)(
ML-K#YDLQ" N^!@ #(R3@<BNFT?5[/7=-CO[%V,+EE*NA1T925964\A@001[4
M 4W\'^')6D+Z+9-YLAE<&(8+E2A..F=I(_&I+/PMH6GZ9=:;::7;16=V&%Q$
M$XER,'<>IXXYK(\?:[-X?M]"NDN9((9-7ABN-B[B\15R5P 2<D#@<DT[_A86
MD)9ZI/=6VI6DFF1+/<6UQ:E)1$QP) O\2]<D=,'- &K?>%]#U+3+73KS2[::
MTM%"V\;)Q$ , *>HXXXK0LK&UTVRBL[*WBM[:%=L<42A54>P%4M4\0:?I-K9
M7$\C.E]<16UL(EW&1Y/NX]L9.?05J4 8VJ>$O#^M7R7NIZ1:75R@"B22/)(!
MR ?[P]CFG:OX6T+7I(I-5TJVNGB78CR)R%_NY';VZ5GW/CS2+75);-XKYH8;
ME;2:^2V)MHIF( 1G['+*">@)&33=1\>Z7I]_J-BMKJ5Y<Z<5^U1VEJ9/*4H'
M#$],8;ZG!P#@T =+!!#:V\=O;Q)%#&H1(XU"JJCH !T%4;SP]I&H:K:ZI=Z?
M!-?VG^HN&7YTYSP?KS5;3O%>DZKJ<%A:3.\MQ8IJ$#%"%EA8XR#Z@XR.HS5F
MPURSU+5=2T^V,C2Z<Z1W#;?D#,NX*#W(&,^F: %&@Z4-(BTD6$']GQ%2EOM^
M12K;EP/9@#5:X\(>';K4;C4+C1K.6[N4,<TKQ EP5VG/N5XSUQQ5W5]6L]#T
MN?4M0E\JVA +,%+$DG   Y))(  ZDUCVGCK1YHK]KQ;O3)+" 7,\.H0&)Q"<
MX<#G<,@CCG/'6@"Z/"F@B]L;T:5;"ZL(Q%;2[?FB0=%!]!D_G6C>V5MJ-E-9
MWD"3VTRE)(G&593U!K#TKQII^J:E!I[6FHV-Q<QM+;+?6QB%PJ\L4)ZD @D'
M!QVJ0>,=)/A-/$NZ;^SG95!\OYLF41#C_>- &E#I.GV\]M/%:1)+:P?9H'"\
MQQ<?(/;Y5_*I;6PM+%[AK6W2)KF4SS%!CS)" "Q]\ #\*PKKQQIEOXAFT*.W
MU"ZU"!XUEBM;9I-BNH8.2.BC(R3ZU#X)\8/XMBU!WT^YM1;7<L*-)"45D5RH
M!)/W^/F':@#9UCP]I&OI"FK:?!>"!]\7FKG8?4&I!H^G+:7MJ+.$07S.]S'M
MXE9QARWKD=:DU+4;32--N-0OYU@M;=#)+(W15'\_I6/I7C.PU34X=/:TU&PN
M;B-I;9+ZV,7GJN-Q0GJ0""0<'!Z4 6M3\*:#K$%M#J.E6UQ':KL@#I_JUQC:
M#UQ@#CIQ6I!!#:V\=O;Q)%#&H1(T4*JJ.  !T%8'A[QKIGB>X,>F0WTD81B]
MPUN5B1E;:4+]-_?'IS6[=W4%C9SW=S(L5O!&TLLC=%51DD_0"@#-U7PIH&MW
MD=WJ>DVEW<1@*LDL8)*@Y /J,]CD5:U/1=,UJUCMM2L8+N".02I'*@8*PZ$#
MUY-96C^---UB[^RB"^LI&MS=1?;K<PB:$$ NI/4#(SG!Y'%4H/B5H4YLV\K4
M8X+ZX2WLKB6T9([EF8*"C'J,G/.#CD @&@#HM5T?3M<L_LFIV<-U;[@X25<X
M8="/0^XJ*W\.:-:V5I9P:;;1V]I,)X(U0 1R#/SC_:Y//O69=^.M(L]2FM9$
MO6AMYUM[B]2W+6\$K8PKOV/S+GL,C)%,U'Q[I>GZAJ%@MKJ5Y=:<5^U1VEJ9
M#&I0.&)'&,-]3@X!P: -Z32[&6\FNY+2%YYH!;2NRY+Q9)V'U&6/'O46CZ'I
MGA^R-GI-E%:6Y<R&.(8&X@ G]!^59UYXTTFVL=,NH!<WQU./S;."SA,DLJ;0
MQ8+V !&2<8S3=-\;Z+JM[86EO).LU\LWE++$4(>(XDC8'E77/(/;F@"[=^&=
M#O\ 5HM5N]+M9KZ, +.\8+8'3ZXSQGI3]-\/:1I#QOI^GP6S10F!#&N-L9;>
M5'MN.<4L.N6<_B&YT2(R-=VL"3S$+\B!R0H)_O'!./2K=[>6^G6,][=S+#;0
M1M)+(W15 R2: ,/7-/U*UTJXL_"^G6"RW\DC3RW$A1(F?[TA4*=Y//'%:'AW
M0[;PWX=L-&M.8;2$1AB,%CW8^Y.3^-9>G>.M-U"\M[4V>IVDEW&TEF;NT:,7
M04;CY9/4XYP<'':N7\%^)]4\2>/=9:ZFUF*TM+IH+>S^RJD$:A/^6QV[@^>0
M,]?;B@#T^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *\2@U_3XOAIXGT%E<ZK>WFH06ML(F+7+R2NJE..<$X/IMYKVVLCPY
MH2^'M,DLEN#.'NI[C<5VX\R1GQC/;=B@#EO#-E+:?$[5$F4EXM$L8C)C@D%\
MX/X"N?CU:UT;X?\ B+PE>K*=>DDOH(;,1,7NC,[F-TX^92''/;!S7L%% 'D_
MB;^T? DFD:W:P23W$^CG1YUC4MFX5-T#''7Y@ZY]#3?$WA\^']!^&^DQ*TAM
M->L_.=03N?YB[GZL2?QKUJB@#RK5M3MM)\27<GA[5+^UUF74$6XT&>'?%>$L
MJM(@P2H*_-O4XXY'6LO4-(OM5U'XNVEG!(\\\=F85 /[W;&25'J3C'XU[310
M!YO?Z]I_C+7?"5OH3O-):7PO;O$;+]EC6)U*R9'RL2P7;UK'EMY!^S[JT8B;
MS&GNCMV\G_3&[?2O8** .(T3_1OB]XKBEXDN[&RN(,]XT#HV/^!?SK!T+4[:
MQ\1Z;9>&-4OWM[F[=;W0+R')L5(=F<-C,85@."2#NX[5WFJ>'TO];TS6+>X-
MK?6+,OF!-PFA;[\3#(X. 0>Q&:UW#%&",%;!P2,@'Z4 <5H7[_XM>+)XO]5#
M:65O(1T,F';'U"L/SKK=3!.E7@')\A__ $$U1\-Z!%X>TZ2$3M<W-Q,]S=W3
M@!IY6/+$#H.@ [  5L4 >+^#K>0>%/A:KPN"E]<E@5/R_)/C/IVKN-$1E^*'
MBURI"M::?AL<' FKL,XHH RO%$4D_A+68849Y9+&=411DL3&P %>=^'[ZUU5
M_A>UF_G"SAFM[C"$>5*MF 5.1P0:]9HR/6@#R+Q=#*UO\5-L3GS+6SVX4_-^
MZ[>M6=1FTFRM-"N)];U#P[J\>C0+#>I%OAN%Q_JF4@ARIYV\'YN#S7JE% &7
MX:O+[4/#&F7FIP>1?3VT<D\6TKM<J">#R/IVKCO'MO>^*_$VC^$+"?[/%'_Q
M-+ZX:'S$54.(D*Y ;+\E<] #7HM% 'E7BC2O$7AK5-)\:7FM+JJZ;*(+J*&P
M$+&UE(5S\K'=M.T@8]Z2/6+30H/'.DWT4SWU]=W%U:0K"S?:XI85"E2!@@8(
M)S@8YQ7JU<KK/A34]2NK_P"R^*+VSL;] EQ:^4LNT;=I\IF_U>1UZ\\T <CX
M2A+:_P##Z0QDJGA9OFQP#B+O],U2U"VL;+4O%>FZYKVNV3WU[)+%I]BB,+Z*
M5% \L&-BS'E#SQM[5Z[864&FZ=;6%JFRWMHEAB7.<*H  _(58H \=OK2RT'Q
M)X@@U;Q#KFEP74=N]HEL$;[:BP+&5&8VW2 H1M!'4<<UT'AS3H]-^(UM;01W
M(M[?PK:P1FY \P!9G 5B.-V ,XKT*B@#QV2WD'P(U&,0MYAU.0[0O)_XF'7'
MTI=4ALM.U_Q7:ZWK^MZ=]ON/.@M+%$(OHGA1<(&C8L^59" >PZ=:]AHH X3P
MW8+8?$34((TF\J#0[&&-Y@-^%:48)'&>!G%<?%*NE^&?!^H7H>&TM?$MV\\I
M0XC4R7 !.!P,D<^]>UT4 ,BE2:))8VW(ZAE/J#TKS>[C'_"[]2EFM);BV_X1
M4J\<:9,H\[E!ZDCC&:]+HH \S\&:G'%XBLM+T#7+S5M$:UD:6VNX\OIVW;L7
MS, \Y*[&R1CVKTRBB@#Q]+>1?V>K.(1,)//A.S;S_P ?RGI^M1ZC;V-CJOBO
M3]<U[7;%KZ\>6&PL41A?12QJ (PT;%FX*$9XP.G6O9,YHH \JETJ;_A;D]C;
M"7'_  AIMHI).N[S<#)'&:R9-?L;SX>>$]!@CF;5+&\TZ*\MO)8-:F.1%8OD
M?+R,#UW?6O:Z* "O+]1(/Q!\9:2TAAO-:T:&&PW @2L(Y0<'IP2*]0HH \BD
MUBTU[P=X6\,:>LO]M0W%BMQ:>4RO9^0RF1GR/E V$9[Y&*]=HHH \RLO$NE^
M&O&7CB35V>W2:YA:&1HF(G(MT!12!RPXX[[N.]<UI6E2^'4\-3Z[J^IZ!;OH
M0M_M%N% 242M)Y4A9&VG:XP..4([5[E10!SO@>SL[/PO#]ADU"2WGEEN%?4%
M"RN7D9BQ  P"26' X(KG_BY&\NE>'!&C.1XAM"=HS@?-S7H5% 'GFGQR#X[Z
MW(4;8=%A ;'!.\<9KA/#-G+!\//!.HW5W?Z;96=[>K<W5JH\RW$AD"N=RL N
M1M)QQNKWZB@#QVZMK"&RM?$EA>ZQJME!XAMKF^O+N,-O1(C'YL81%+(NY03C
M^$XZ5-J?B-[KQKKVK^'8&N)8/"S?9I3"<3,)B<J"/F S^)!%>EZWILNK::UM
M;ZE<Z=.'62.YMFPRLIR,@\,IZ%3P16?H?AJ;3]7NM9U+59-3U*XA2W$IA6)(
MXE)8*JKZDDDDG/% '#:-?6+_ !"\.W5OKFI:O;26ES ;VZ'[KSV\L^6F%4 X
M4DCZ#J#6Q\%(WB^&=FDB,C?:+CAA@_ZUJ]"HH X_XC0S'1M,OHX9)H=-U:UO
M;E(U+,8D?YB%')QG=CVK#O\ 4;7Q5XO&H:)(;JQT_1+R.XNHU.PO)MVQ@XY;
MY2<#I7IE% '+_#B+R?AOX=C*%"+"+*D8P=O-1_$VVGN_AQK45M"\THA5PB#+
M$*ZL<#OP#7649H \YD\0Z?XE^(_A*?2)'NK6&&]\RX6-@@9HUPN2/O<'([<>
MM8L-O(O[/NDQ")@XGM24V\C_ $Q2>*]@HH \9O[:QL]1\5:9KFO:]9/?7LLD
M6G6*(POHI44#RP8V+,>4//&WM78>&K3[)\1O$4860I'IVGQH\G4@"4<GH3TS
MBNVHH \0F@F_X5CX&3RGW+XI1F7:<@?:)^3[5U[ZK9>$_B1K]YKDWV6TU2UM
M6M+EU)1C$'5X\@?>R0<=3FO0** /&[&PN1!X/N)[26)+OQ/<WT<,B$-%$_FL
MF1VXP?QKI;_5;3PI\2]0U+6I&M[#4--@2WNF1F0/&[[H\@'#$."!WKOZ* /(
MM1N89/$VG>(+^\U;PKIE]I/E0O$B)M=9G;9)E&"EE<,!QG![C%/-U;:+8^'K
M--9UC2] O?MEU)?3Q*MQ+*7#*A.SY VYV "@D8%>M44 >%VEY':6NDF:*^D:
MS\7S7$Z3Q,TZ1.DK+(X SG:=QP.QK;U:[@\1ZAXUUG26-QIT7AA['[0BG9+-
M^]<A3_%@$9QZUZS10!XK:VXL=/\  VIZAJVH:-I_]@?9'O+4*/*E_=L%<LC!
M0P![#E1S7HG@6UL;?0)9]/N-2N8+N[EN//U!5625B<%P J_*V,C@9SGO739H
MH X?XERBWM_#-RT$LT<&O6TLBQ(78*JR$D <G'7\*J6$NG^,?B-?WED1>:.F
MAG3[B8*1'(\DNXH">N%!SCINKT/-5[Z*YGL9HK.Z%K<,N(YC&)-A]=IZT >6
M^";>^U'Q-9:'J*NT7@M)8C(XXFE<E8&_"$9^K"O6JQO#?AZ/P]93H;F6\O+J
M=KB[NY@ \TAP,X'     '  K9H \0\4ZK+J6FZ^E[JFIMJ=OJ1']DP1A88;:
M.92)' 3+ HN[<3R2 *[3PZ4G\2>.[J(;HKB2V>.0#AU-HF"/4<UW=% 'CT:R
M:%\-?!'B]8I/,T2&,72*/F:UE 208[D':P_W:[GP!ID]AX5BN+U=NHZE(^H7
MGJ))3NV_\!7:O_ :G\0^&9?$ES;PW>IR)HZE'GT](E_TAE;< S]=N=N5'7'6
MNAH Y'XCV\\GAF"ZAADG6PU"UO9H8E+,\4<JL^ .N!DX]JP/%NMVOC;PQKEG
MX<M)=1,%M%,UW%$0LA697,"D@%FVJ3@>H'4UZ;10!YW<ZW8>,/&?A0Z%*UTM
MA--=7<JQL!;H860(Q(X9F8#;UX-<BVL6T?P?'A?$S:U;7:1W-H(FW0A;P,6;
MC 7&,'OD5[E10!Q/AJ$K\4?',IC(W#3PKD=0(6Z&J_PQO;=(M=TAW*:A;ZO=
MRRP,I#*C2DJW(Z'/%=]10!RGQ)L+K4? .I06<#SS+Y4WDH,M(L<J.R@=R54\
M=ZQY]:L/&'C?PJ^A3-=1Z?)/=7<RQL! K0E C$@89F8?+UX->AT4 <3\)H3#
M\.K)6C*.;BZ+ C!_X^)/Z8K=\67E_IWA'5KS3(O-OH;61X4V[LL%..._KCO6
MS10!XK+);ZCX@L!I^NZEJZW>DWUFE[= "+[3(B;8TPJA3QDCMP.H-27/B&PO
MO"'@;28(9OMMEJ>F1W43P,GV1D94(8D  YX ZD$GH#7LK*&4J20",<'!KCX/
M!%ZUUIZZIXEO=2T_3K@7-O;S1(',BYV&24<OMSGMD@9S0!PLMAIZ-K^@ZYKW
MB"WN+O5+@KI5FL9^U1S2;D>,&,D@AAD[N"IZ8KM- A9/%OCTE&^:6V 8C[P%
MJGY]Z[>B@#QSPQ=1^&XO!.N:MO@TQM >Q>=D)6"4NCC?@?+N"D9]JW/$=T-<
M\&KXKTG3YH)=&OSJ%J7CV-=1(<2,!UVNF_KR<"O1ZP?$_A^Y\26J6']K366G
M2 I>0PQJ7N$./EWGE 1D' Y!H S?A["UWIM]XEG1EGUZZ:[4,/F6W'RP*?\
M@ !_X$:L_$33;O5_A]K=C8QM+<R6Y*1KU?:0Q4>Y (_&NDAACMX(X(45(HU"
M(BC 50, "GT ><7VNZ?XRU_PE!H3O/)9WOVV[(C9?LL:Q.I5\CY6)8+MZU8^
M'4;IXB\=%T90VM,5)&,C:.17?T4 %%%% !1110 4444 %%%% !1110 4444
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M:P(Y9?WN/LT)*!W/'.TR*,<=ZQ=#\/7%EXG\.ZG8^"CI5M;1R6UXVZ'SW=T
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MHG@LIU#"7S%9N^5.Y0Q(7 H TKSQ1IFJZK\/[UM(6=]6,DEM-)*5:S/EJ3@
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M79SN(?:"6.>E7;W5-7U7QSX&>^T9],19[@E)9HY&D?[,^2NQB-@]3@G<.!W
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M .X#H>.]<YKFO:SX>M])M-4\11V\^L7#R27BV:D642QAC'&N#N.XJ S ]2:
M/2**\H_X3C6I=)2#3M2AN[A-?M]/CU![;:MQ#*H(+)@<@D@[<?=XQFM.W;Q;
M)XQU#PP?$_[J.SBODOOL47G)N9D\L+C81E<Y(SQCOD 'HE<_XQAT&XT,0^([
MAX;"298SLGDBWLV0%)0@D')&#Q7)V_BS4[[P/H%]>Z_:Z3-<S30W5PD'F33&
M)W0>3%M8$DKD\<#I5&^\=ZS'\.UU&WO4ENX=<&GFZ-L$\^(28W&-A\I*D9&!
M@^E 'J5A8VNEV$%C90K!:VZ".*->BJ. *L5PTMSXCUGQOKVC6.M#3;.Q@MI$
MD2V220-(K\?,,;?ER<\\#&.:V/ VLW?B#P7INIWVS[7*C+*4& S*[(2!VSMS
M^- '0T5R_BW6+_0=1\/WL<H&E2WPM+]"@/$HVQONZ@*^,_[U9U]XBU6;Q)XC
MBT^]L[73]&T]5:2\&(OM;@N&9@,[43&0.[4 =O)(D43R2-M1 68GL!60/%>A
M-I5AJ8U*(V5_,MO:S8.)9"2 HXZY4_E7&Z'XFN;S5M1T<Z\^M6SZ1)=K<267
MV=HW#!2JX50RD,".N,=:Y_0->U#0/@YX!?3Y5C:[U>*TFW(&W1/++N'(XZ#D
M<T >U$A02>@Y-5]/U"TU73X+^QG6>UG7?%*O1AZUQIOO$.O^(/$2Z;JJ65IH
M[K;0V_V='%S)Y8=C(Q^8+\P7Y2/6KOPN_P"28>'?^O-?ZT ==17,>--3FTZU
ML1'KEOH\4TY66=HO-F8;20L,>TAF)QG(.!FN2B\9Z]=>'M/%EJ$4MVWB/^R3
M>2VNP31%6(=HR!@X*D@8SM[9H ]4JG+>V&FRV5D\D<#7+F&VB"X#$*6V@#@8
M )_"O/\ 4?%.M^#Y_$UM?Z@-6^Q:3'J-I++ D3*[.\>Q@@ *[E!]<9INHV.O
M6/B[P,-6UD:D)+V5G+6Z1&*3[/)PNP#*G)ZY(P.>: /3JI6FKZ??W][8VMTD
MMU8LJW,8SF,L,KGZ@5=KRS4?&>MVW_"RC%<H#HBP&Q_=+^[W(2<\?-R.^: /
M4Z*X:.^\1:3XQ\/VVH:LEY;:RLZRVPMD1;9TC\P>6P^8C@CYB?6NYH Y/2CX
M0\,^()=&LKJ-=9O2KRI+.\\\F!\NYF)( '0$CVZUUE>.:!;:O8^/?B+=KKDC
MS64=O)*3;1?Z0?L[E<\?+MP.G7O74R^)-47P?X(U 3K]IU6YL([MO+7YUE3+
MX&,#)].E '3#Q%I!;5%%]'G2EW7PY_<#:6YX] 3Q2:!;Z4EE+?Z.0UOJ<IOF
MD#,1(S@?,,] 0!Q7F47_ !\_&;_KW_\ ;:2N\^'7_)-_#?\ V#H?_0!0!N:C
MJ5EI%A+?ZC=16MI",R2RMM5><#GZG%)IFJ66LZ?%?Z?<+<6LN=DB@@'!(/7W
M!KS[XWVUS-X(1XKUHH%NX5DA$:L)"9%VDDC(QZ#KGFM&2;Q#=>*8_"UOX@>'
M[)8?;;K4!:1&64O(RH@4C8H 4Y.,GB@#NZ*\KN_&/B6/1+>UAN;<ZO#XF71)
M;@PC9,I4E7*_PY#(2 >QQBMB27Q'/XB@\*0^(FCFMK WMWJ0LXC),7E940(1
ML4 *<G&3@>] '>45YKK7BC6-)GT70]:UNUTJ[E@FGN]0MK?S=ZHP5 BLI"EM
MVXY! P0*Z3P+KT_B#099KF9;B6VNI;;[2D9C6X53\L@4],J5R/7- '345@>,
M-0GTW0A-!JMII>Z>-'NKA=Y1">?+7!W2'H 17#/XWUB+POXA:RU,7]SIU_9Q
M6UY/:^294F>,%73: ,;F&0!Q@T >L55OM1M--6!KR=85GG2WC+?Q2.<*OU)K
MB9]:UOPKXE>VU35?[5LY=)N;\*;9(3$\)4D+M_A(;H<D8ZU@ZH/$=SH/@W5]
M4UA+M-0UC3IY;46R1K;[Y%91&PY(&=IW9SUR.X!Z]117E7B#QU=)K.OI;^(H
MM-?26\JUL39^:+MQ&';S&P2 2VP;2",9H ['QC?>&HM/BL/$FHBUANF^2-;A
MXGEQU \LAB.>>W/-3P:SX;T6_M/"]O=VMO=+&JP6,?55QQP.G'K7GFHQZEK/
MQ9\+7MOJ\UF;W29+F ?9XV-LI4$H-PYSGJ>:BTHZCHGQ"^(FJRZQ+.-+MK:Y
MN%-O&/M2B!F"DX^7&,?+C/>@#V6J6IZ39ZO%;QWL1D6WN([F,!BN)$;<IX]#
MVKS?0?'=P-5TC[1XB35TOXI#>6T=EY0LW$9D!1@ 2ORE/F)/(.:V/#DOC'6=
M.TGQ$-7MC;Z@1+-ISVZJD$#@D&-P"Q=1M/S'!YZ4 =M>6L&H6-Q9W"[X)XVB
ME4'&588(R.G!HL[2&PL;>SMEV06\:Q1KDG"J, 9/7@5PGPLAU 0^()KS5)+I
M?[9NXBC1(OSK)@OD#/..G0=J]"H *J:AJFGZ3 L^I7]K9PLVQ9+F98U+8)P"
MQ'. ?RJW7GWQ4FM[=/"LMU:R74":Y$7@CA,S./*EX"#.[Z4 =;8^)-"U.Y%M
M8:UIMW.02(H+I)&('4X!S6I7!1Z_HXLM2FTCPY>Z;?6]C/-'<7&C-;JI5"?O
M,H'X=ZFN?$>IQ^&?!%ZLZB?5;NRBNVV#YUDB+. ,<9([4 =O56[U*SL6M5N;
MA(S=3""#/\<A!(4>^%/Y5PNB7OBGQ#J7B.0:Z+.RTS4KFSACCM(W:3"@KDL.
M NY2.Y.<UR.E0:J?AS\/I(]2$L]QK$30&:)=MOE)@>F"_<\GGIF@#W*BO,]0
M\5:WX1?Q/:W^H+JK65A!>6<\T"QE6E=H]KA  5# '@9QFHM/\9W<=[=V4'B,
M:XKZ7<7*W!LA";:>, @8"@%6!) .2-O4YH ]1HKD_ $^NZGX=L]:UK4TN#?V
MD,J6T<"HL/R\G<.26R"<\#H*ZR@!LD4<T9CE170]589!_"G5P'C#Q!?:?XFC
ML9/$ \/6#VBO;7<EHLD4\Y9@R.[ A  $.."=QYK5TG6-2G\<7>E7<T+PPZ3:
MW&(5^3S7:0.5/4J=HQF@#JJJWNHVFG&V^USK%]IG6WAW?QR-G"CW.#7GMEXJ
MUW5[/1=,AODM[_5-1OXFO?(5C#!;N_W5/REB BY(/<\TSQ9;^);?3]#M;^^M
M;JZ7Q);"RO3'M+(5;!E1<#<IS]W ( Z4 >GT5Q^@WNLV7CB_\/:GJAU.(6$5
M]!.\"1.FYW1D.P $?*".,UTNJ7R:7I%[J$BEDM8'G91W"J6(_2@"W17#Z WB
MZ6TTG7KO6+:ZL[R$7%[8M;K&MNC)N7RF4;B5. 0Q.>>E8A\1^*(O T7CZ35D
M-NQ2Y?2/LR>6+=I NT/C?O"G.<XSQB@#U.BN4TO6[^YU;QA!+*#'ILZ):C8!
ML!MT<Y]?F)/-<O;^)/%&L?\ "$V5IJD=K-K6E27%W<FV1RK*(VW*I&,\D8Z?
M-G!QB@#U/(SC//I17G'ARUU4?%SQ$+C6Y9TMK2S#H;>-1*K+*57@?+M))XZY
MYKT5W6.-G;[J@D_2@!U%>5GQ)XH3P*GCY]53[.2MRVD?9D\L6YDV[=^-^_:<
MYSC/&,5LVFH>(M8^)&N:9!JJ6FE:3):2%!;H[RAXPQCR>@.&R>O(QB@#;UCP
M5H.NWS7M]:R_:'C$4KP7,L/G(.BN$8;QSWS6W;6T%G:Q6UM$D4$*"..-!A54
M#  'IBI:\NUGQA?Z7K<LJ^)K>X:+5(K8Z3;6F^(0M(J$/-MRLH#;C\V 1C!H
M ]1HKSN35O$^JMXHU33-4BM;;1KB6UM[%K976=HD#.7<_,,DD#&,8Y!K+?QW
M=W*:#9W?B)=&:;1(-1N;M+197FEDX"A2I55&UB>.X Q0!ZQ17F%EXL\0Z^_A
M*VL[V&S?4H;Y;R<6X;F!E42(K=,\D \?/R#C%./BO7]/LM4T>2]BNM4CUN#2
MK6_D@5<+,J,'=%P"5#-TP#@4 >FT5P&N-XV\-Z'J=ZFK1:I#9+%=QN]NB32(
MK?OHF55VXV<AA@YX]ZT;GQ%<:EXK\.Z=HMPOV6YMGU*\D"!LVV (P,]-S-VY
MPIH ZZBBO.?"WB+5-3\0)!>>(H([]9I1>:#<VHB:*,;MIB;&Y\84YRP()Z4
M=YIVHVFK6,=[83K/;2%@DB]#@E3^H(JU7B^A7GB+0OA=9>(;;5D2TM;HK_9W
MV9&66-KHHVYS\P;YB1@@# &.IK:\;^+-0T2]U>:#Q/;026$*RV^EPVGG^9A=
MQ$[;24+<@8(P,&@#T ZQIXUM=&-TG]HM!]I%OSN,6[;N],9XHTK6-/UNU>YT
MVZ2YA21HF=,X#KP1SZ5PHD$W[0%G*!@/X8W8],SFI/@S_P B=>_]A:Z_]"H
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MA2+Q7:WVHIJ4FG0VDMG=3P+&5-PYCPX0 $*P!X&<9J]X2\4RW?BHZ/\ V_\
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M ,/3M#ELO%NMZRTR-'J,5LB1@'*>4'!S]=WZ4>$-"E\->%[/29IDFD@,A,B
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ME%7;@#&>1UYH X_PKI^K67B+1YK30M9LK.2&1-3N+Z_CF6X)3*2;1*QW[QU
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M:REO?.*.CR,^&#-PZQX*Y_G7?#X>Z2FG:C:17%]$;[4SJOGI(HDAN,@AD.W
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M%Y;Z?YOB$HEQ(BE5;,)C4@XRI< 8[YQ0!Z7IFLZ9K=NT^E:C:WT*MM9[:99
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCVL>P;86484J.Q /%<OH_P /]-,VI7&O:587=Q+JMQ=V[N@<B-WW*#D?C@Y
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M;]OE_(S;NAS]W&..M &W169=^)-#L-033[S6+"WO9,;+>6Y19#GI\I.>:TZ
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MGQ9>Z=92VMSI\5C#=17,#[]Y=Y%(R#@@;!^M '2T444 %%%% !1110 4444
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MY+$-J/+&"=N<[3ZC/8\5=_LVR%_'?"UB%U%"8(Y0OS+&2"5'MD#CVH M
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M\337%O%*\>GV2(9%#8#>;NZ^NT5Q'AV/49(O T%C_9XV1ZI]G6_1FB$BSX
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M2D\C1 F0$8.?<CJ>M6[70]+L;LW5M8017!@6V,BK\QB7[J9]!B@#Q?P4(Y/
MGPQBNPIL'U>Y\P/]TR S^4#_ ,"Z>]=WH,=E'\8O%"V:QJ?[/M#.(P !)E^N
M.^-M=,WA;06T$:&=)M#I:DE;7RQL4Y+9 ['))S4FE^'M'T1BVF:;;6C&,1DQ
M(%)4$L 3WY9C^)H TZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K ;QAI2^%[WQ"3-]@LWE24^7\V8W*-@=^0:WZ\/U'5[>
MT^%OBGPRZ3MK2W5YFT6%BVQIV<2=,;-ISGH>G4B@#TO4/&^G6&JW6EI::C>W
M]M&DKV]G;&1MC D-UQ@8YSW(QFL#Q+XNDNCX%OM"OI%L=6U6..3"X\R,YRK
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M'K$\5OYB[2D05"%P0",9/!Y%;FMZW:Z#9)<723R&65888;>,O)+(V<*JCJ<
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MS5Y)FD"#B9/+5ESD9'6K/@W6-0U#QIXUL[NZ>6WL;R&.VC;&(U*$D#\:X72
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M.2JDGH<=>U<OX/N;3_A9-ZT&H:A?6]UI<2VMW?$G[04DD+[#M *C<.W7..*
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M4"("Q8X'J3R3[FK%>6_#:_U.R^#OAI=)TY+RYG>6/,TOEQ0KYLA+NP!..,8
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M"+36Z/<0ZQ<:CJ'ER#;!YHD.!DC=@N%XSZ]*],HH *\JNM)\3V/A3Q/X3LM
MEN?MDEV]I?">)86BF+-ALL&#_,5QC&<'('->JU1DUC3XM9BTA[E1J$T1FC@P
M<L@."?3K0!YS?>#_ +-K1U"_\'+XA2ZT^VB55:+?;3QJ5*G>P&QAM^89P5/%
M:6J^&-1DNO 1L]*M[>'3+DRWD-LX$=N"G(7."1N)Z"O0J* /)?$WA'4M5NO%
M<$GAB/4K^_W'3M5N7B:.WA\I0$7<=R.&#8PO)8$G'-:U@GB#1_$MQJD?AJ[N
M8]4TZUBV+/"IMIHMX*R9?[IW [EW?3/%>B44 >21>#O$*^&? EI)8@W.F:Y]
MJO0LB8CC\V1MW7D88' R>>E=1HUEJFF?$GQ)-+IDSZ?JQMY8;U)$V)Y<.PJP
M+;LY'& >M=G10!R_C72K^^BTC4-,@%S=Z5?I=BV+A#,FUD=03P&PV1GCBJNC
MV>IZKXXF\2WNF3:9;1:=]@MH+ET:60M('=R$9@H^50!G/4UV547UC3X]9BT=
M[E1J$L)G2#!RR X+>G6@#G/A9HNH^'?ASI>EZK;FWO83-YD1=6V[I78<J2.A
M!ZTWQ/9:I'XY\-ZY8Z9-J%M:Q7,%PD,B*Z>8$VMAV (^4YYKLZHZ5K&GZY9?
M;--N5N+?>R>8H(&Y3@CGWH XO_A&]6_X5YXRTS[(?MFH76H26L6]?WBRLQ0Y
MS@9R.I'O6=J/A 6VO7.H7O@U/$2WMG;K'AHMUO-&FPJV]AA" IW#.,'CI7J=
M% %'1K,6&BV5K]EM[0Q0JK6]O_JXSCE5]@<UP>J:-J-_XGBN;?PL]AK$5^C?
MVW;7"+#);+("=X#!G)C!4J5/)ZXKTJB@#QJ\\):M)9W /A);G6X-5^VRZM+)
M"7N8EN ZK"Q;<#LP-IV@!2.]=5:Z%JAL/'@>R:-]6>1[-&=,ONME0#@D#Y@1
MSZ>E=W10!PLF@:HVG> (A:G?I4L+7@WK^Z"VS(>_/S$#C-8.B^"8]+G@TR;P
M):7ES%>EO[9E:+RF@\PL'/._S I V[>HSG%>L44 9VOZ9_;?AW4M*W^7]MM9
M;??_ '=ZE<_K7$?8O$>NV'AS0KW09;!=-NK:>^O))XVB<0<@1;6+'<0.H&!G
M-=_J&H6FE:?/?WTRPVL"[Y)&!(4>O%2V]Q%=VT5S X>&5!(C#^)2,@_E0!S/
M@[2;[2]0\42WD'E)>ZO)<VYW [XS&@#<'CD'@\U?\51S3:,8DT2+6H'D47-E
M(5!>+G)3?A2P.T@$CH><XK1OM2L]-%N;R=8A<3I;Q;L_-(W"K]35J@#QW5_!
MVN7OP^UG3=,TBYMK>XU"";3]+N+E'>"-=F_DN54$AB%W''XXKN[+2KV+XDZM
MJKP8LI].MX8Y=P^9U>0L,9SP&';O73 @@$'(/<4M 'F4?A;6E^$5AHALC_:,
M5_'*\/F)P@O/,)SG'W.>OZUIVN@:I'\2_%.K/:D6-[IT,-O+O7YW5<$8SD?B
M*[JB@#Q_2_"6LV'@3P;8ZKH$NHP:?+<'4-*26)BQ8N8F(9@C@$YQG^+/:G1>
M$M<CTZZT^+P]'9QMXEM=5B2WDB$*08CW* "/F38<\ $],UZ]10 5RFDZ1?6W
MB#QC<S0%8=0FB:U;<#Y@%NJ'OQ\P(YQ75U5O-2L["6UCNIUB>[F$$ .?GDP6
MVC\%)_"@#RVS\*ZG:6OAJ+5_"QUJWM=&6U^Q/+$T=M=;LEG#MM(*X&X;B-IX
MYHL?#WB+2-'\*'^P))I=!U2Z,T%M)$OFQ2>9MDBRP&WYQP<$8Z=Z]<HH \WD
MLO$>GS>+M.M= FN5UN5[BUNQ/$L49>%4829;<"I7L#GVZU8\/^'-6LO$/A2Z
MN+0I#8^&Q97+;U/ES?N_DX//W3R,CCK7H%% 'E5_X.6VUS6S+X&MM>EU"[-S
M9WLC1!(]ZKN27<=P"L"?E#9!]:]#M);N+4VT\:8L.G0VT9BNEE&UGR08PG4;
M0 <]\UI44 %<QK&E7MUX_P##&I0P;K.RAO%N)-P&PNL83C.3G:>GI73T4 >8
M>)O!FL1^-=,N]#MQ-I%WJMMJ&H0[U7[/-$W,J@D9#*>0.<J#5Y(/$'ABZ\1V
MEAH,VIQ:I=R7MG<0S1*B/(BAEEWL"H##.0#D'UKT&B@#'\*:*WAWPGI6CO()
M)+2V2)W7H6 ^8CVSFL"VT'5H_B7XDU9(O)M;S388+6Y+*095![9SP<=17;T4
M >/:5X7U*SD\+W<7@O[/>Z7<J=3NVD@:XNW,;H[J^[+)N;<=Q!Y&!Q4S>#M?
M/@+X@Z<-//VO5=7N+FRC\U/WL;,A5LYP,X/!P:];HH \_DL-:T/Q'H>LP:-<
M:C$FB_V;<0VTL8DBDW(P/SLH(X(X/%94?A;Q%+I<7VG3E2Y;Q@FJR1I,C!(-
MX8L#GG'YG'2O1]5UC3]$LQ=ZE<K;P%UC#L"1N8X X]:O4 >?^,?#$=UXMM=<
MN?#0\0V9L3:26Z^7YD+!RZ.HD900=S \Y'%=/X6L/[-\/6\']DVVDL2SM96S
M!DBRQ.,C@G&,XXSG%6]0UC3]+FLXKVY6%[R86]N&!_>2'HHQ1;ZQI]WJUYI4
M%TCWUD$:XA .8PXRN>W(H Y5HM9\,^+==O[/0[C5K35_)FC^S2Q*T4R1B,J^
M]E^4[5.X9QSQ5'P_X0U;1[[P89XDD^PQ:@]])&XVQR3LKA1GDC)89 [5Z-10
M!S7AW2[VQ\4>*[RY@V07UW#);ON!WJL"*3@'(^8$<XJEXWL=3?5O#.KZ=ITN
MH#3+UY)X(719"CQ,F1O(!P2.]=E10!QFEZ+J44'C7SK0QMJ=U)+:J74EU-NB
M#H>/F!'/I7+CP5)9C0;W5?"0UU4T*VL)[96B:2VGB&<C>P4J=Q!(/&T5ZC8Z
ME9ZG'+)9SK,D,SP2%<_+(APR\^AJU0!D^&;'^S?#MG;'3+;3&"EFL[9MT<18
MDD ]^O/OFN+M=3U32_B-XVDLM$N-5C=K,!+:6-&206XQNWLHVG/49(QTYKTJ
MJ5KI-G9ZE?ZA!$5N;\H;A]Q.\HNU>"<# ]* /,;;P9J.E6WAV#5?#X\0VMO8
MS+)9I)&8X;N27S"S+(P4C#%=W.,=.:ETCPKKMM8^&+&725A_LG7Y[B9HGC$7
MDOYK*\8W9V_O%&, CTKU:B@#C-6LM4M?B?I>MVVF37MB^G/83-#(@,#-*K!V
M#,,K@'ID\=*T_&^AW'B/P?J&F6CHMU(JO"7^Z71U=0?8E0/QKH*JOJ5FFJ1:
M8TZB\EB:=(N<E%(!;\"P_.@#D/*UKQ1XHT"[O-"N-)M-)>2XF-S-$QEE:,HJ
MQ[&;*C<3N.,X'%3^!M$U'2-4\637UL88[[6)+FV.]3YD9 PW!..G0X-=E10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
MEL_C"_L_$=ICQ-#>M-K"6,NFVUGNMXHGDV#]]LSYBY!.6QG(Q7J5><#P'XAC
MT:STF+5]/6TTN^2]L?\ 1WW3,LWF 3'=TY(^7J<'/&" 5Y]5\67VF>+]3MM>
M6SCT2\NDMH5M(W\U8D#[7+#I@X&,'J23Q6SH_B;4'\76MKJ,BBPUC28[ZP&T
M 12*!YT>>IX96YZ<U;M_"5Q#H'BG3FNHS)K5Q=3(X4XB\V,* ?7&,URWCVQA
MDT+PYX8T_4D_X2>!X;>V$!!D1#&8Y79>JIY98Y/H* .M\#ZMJ&OZ3=:Q>2[K
M6[O)6T^/8%V6RMM3.!DEL%LGU%4_$E_KC^-]%T+2M16RM[RTN);B7R5D9-A3
M!7<,9^;'/'.<' KJ]/L8-,TZVL+5-EO;1+#&OHJC _05Q'BF'49?BAX<.EW$
M$-W'I]XZ_:$+1N-T0*M@@XYZCH0.O2@"LOB36;33?$&F:AKUG;WFE:A# =5G
M@ +02JK@B-1M:7#$  8)QQ69<^.M6M/!_B^:TU9[^;2&MFM;V:S$,C+(5RK(
M5 X^89VC@UMMX$U9K=]1?4+)]??5H]49FB;[/E(S&L6,[MH0]>N:@U/X?ZYJ
MMIXDBNM7LW?78(/-80,HAEB<8"#)^3;QSSGGO0!2\7:=XDBF\)QWGB9VGN=;
M0_NK2)4A8Q,0%!!W!<-C=G.[GH*WM.\3W6D:GXIT_P 0W7G?V7&-0MYBBH9+
M1E)Q@  E65ES[BM'QAX>OM=BTF;3+FW@O=,OTO(OM*%HWPK*5.T@]&[>E<CX
MSL+7Q7XS\/Z3:WL4NHJK1:TEJ<J+0%'=).25RZ* #S\QH [;P=-JUUX3T^[U
MR0/J%S'Y\@"!1&'.Y4P!_"I ^HKE)EOXOC7>3-J\RVMOH:7)A$*$&/S6!CSC
M.,KG/7G&<5Z1T&!7*WWAK4'\>Q^(+.XM#:S6"V%Y;W$;%C&)"^4(/4[B.>*
M.7_X2#Q1;>";3QW/JZO!*T5Q+I(MHQ$MO)(%VJ^-^\*P.2<9'2O4J\]C\":T
MVB6WA6XU6S?PW;RH01"WVJ2%'#K$QSM'0 L!R!TKT*@#Q^'XC74S)JZ:\'9M
M0\K^PULLK]G\[R\^9MW>9M^?.[';%;>N>*M?T#6KKP[\MWJ&K/G0;AD554'A
MUDP/^67WL_Q @=:U--\-^(M'D73=/U>SBT-;MKA2;<M<K&SF1H02=N,DC=C(
M!Z9YJ&^\ ?VT^L7VJWH;5;IU^P7,2D?V>D9W1"//.=WS,>-V<=* ,O7O%%U9
M>(AH%QXJ;2_L5A%++>"Q65[J9RPY7:550$R0 "=V >*@C\5^)?$$_A"TL+V/
M3I-7L[IKN7[.'V/"RC>BN.^&P#Q\P)SBNBFT#Q)!J<>LZ=?Z:-3GLH[34$N(
M7,,K(6*R)M(((W-P>,'VS5A?#%\_B+P]JUWJ8NI=,M)X)W:((T[R!?F '"CY
M3Q0!DB?Q1KVKZU9Z7KRV0T;RK9"UI&_VN<Q!V:3(.U<L!A<=S3CXAUV/XG66
MAS&#RW\/F\EMH@"IN1(5.UR-VWC _E5K4/#.OV^M:M>^'-4LK6/5U3[2MU"S
MM!(J[/,B*L!DJ!P>,@'VIR>#+J/QK9ZZ-5=Q;Z+_ &87D&Z9GW;O-)/!/?IU
MH P/#GB^^:TN=1OO$<=W<VEA+<ZEHMQ:+;S6SJN[$8P&*@@J2V[/!S4?AKQM
M>7&L:"LOB :J=4REW9K8^4MFQC+J8V"@E01L.XG.0:VQX0UG5]0M)/$U[IUS
M#9V\UNKVENT<MP)8S&Q<DD*,$G:.,\]JO:!H_BC3GL+2^UBRDTRPC\I1!;D2
MW0"[4\PL2%P,$[>I'8<4 =57)^--4FT]].B3Q#%HT,SOYCI!Y]S+@#"Q(58$
M<Y8XXX]:U?#DNJ36%PVK',PO)TC/E>7F(2$(<?0#GN,'O5#7="U6?Q'8:YHU
MU91W,%M+:2)>Q,Z;'9&W+M(.X%!]0>U ')VOB_Q!J>E>&X[._B6YO-6NM.GN
MGM0!*D8EQ)Y9^ZV%#;>.1@\<5+>>*M=\,6OC&VNKY=4GTN&UELKB:%(VS.2@
M5P@ (# 'H.*T-+\!ZC8W>G&?4X;B&QU:?45<QD22"5'#!NV=SYXXQ5O6? O]
MM7/B=IKP1Q:S:6T$>U<M"\)<ACZ_,RG'M0!CW=AK6G_$3P0FIZR=41WO#YCV
MZ1,CBW;(&P %3GC(R,=3GCN=?NIK'PYJ=W;MLG@M)98VP#AE0D'!]Q7-P>&?
M$E[XGT+6M<U/3W.E><!!9PNHD\R,H6)8GYLXXZ  ]<UU.KV3:EHM_8(X1KFW
MDA#$9"EE(S^M ' VNK^*+.V\'ZU?:RES#K4]O;W%@+5%1!+$6#*P&[<"!GG!
MR< #BFMK'BC5/#NM^*[#65M8+&6Y-IIWV6-XY8X&8'S&(W[FV-]TC&1717'A
M.:;0_"NGBZC#:+<6LTC[3B411E"!Z9SFLN?P5KL5AJVA:;JME#H>IS2R.9(&
M:XMUE),B)@[2#EL$]-W>@#L]+OEU/2;+4$4JEU DRJ>P90V/UK@[J]\0^(8_
M%UU9ZLMI9:7+-90V7V=&6<I$"YD8C<,EL#:1C'>O0;2UBL;*"T@7;#!&L4:^
MBJ,#]!7&7/A#78;O7K?2=4LH-*UN1IIQ- S302.@1S&00#N !YZ'L: .6L/%
M;V>C^%=#_M\Z' GAZUNWN([43O*[+M5 "K  ;&)XR<@ BFZAK5QX@E^&FH78
M7[0VKRQR,J%%<H2F\ \@-MW8]ZZNU\'ZSHD6CW&BWUB;ZTTJ+2[E;N)S%,B<
MJXVD$$'=ZY#=JGU+P?J6J7'A6YO-62>YT>Z-S<2M#L\\D=% X4#H.O YR>:
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MD:[RI!; )/7J<UE^)HY;;X9_$JS>\GNH[;5(8HFGE+LJ V^%R>3CIGJ<9/-
M'N<4@FA24 @.H8 ^]$L,4\3131I)&PPR.H(/U!KRW5S<ZSXPN-/FT75-6L['
M3+8PPV5ZEN(GDWDR'=(F6^4 $9QM/3-=UX075D\)Z='KJ.FII%LG$CJ[$@D
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MI\$D-JDSQH\DK/ND.TC) 4 9Z<UP/BZ 7OPGU=+R6>Y?1==DL+2:6=RQB$Z
M!N?G(!VY.>E 'MVE7L^H:?'<W.GW&GROG-O<,A=>>,["1SUZU<JIINF6ND6*
M6=DCI A)57D:0\G)Y8D_K7DLMR!J6F:]I=IK#"YUZ.$ZQ=7BA9XWF\MHUA#?
MZO!(7Y1]T&@#V6BO(9-&BU;0_'^IWEU>M<:??WIL2EU(@MBD:N&4*0,Y]>P
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M"O:3Z9&88?LY"JT)&/*88.4X! [$9&*R3X]TV#Q)>6]YJ.G0:/'8V]S!>-,
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MJ+@1NTI8']VV/E(P",YY K&\.Z+-J/CBTU06VO"WM+":":\UL;)I6D*A8U7
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MO(=$LLF10=KDMN//?(Z_6O2*KI86D=_+?I;1+=S(L<DP4;W5<X!/<#)_.K%
M'BD$6D'X(^+G98#/]LO?,) W"?SF\KWS]S%=)X>L8[GXL:S<7\"27<.DV(S(
MH.UB&W$>^1UK2\,^ --LK**36=*T^YU*&[N)XY_+#E5:9Y$Y(Z@-^!Z5UL=A
M:17TU]';1+=SJJ2S!0&=5SM!/<#)_.@#R32M#;Q%9_$_38CBY?5WDMF'59D
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M+$MU;QS+%*LT8D4':ZG*L/<'H: /+_'<4L'B7Q!_9T?ES/X/G_U0P3B7';N
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M6V>-75&BB"E0Y#,!CH"0#^% 'F4FDRS^'?&%UIL8%]HWB:74;)%&!OCCB9E
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MXM#-;;!>*@!;RN<DX(.& /(IG@/Q;/XOT:6]GT^>U*SRJK-'M1U$CJH4Y.6
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#Y@+#E@5R3GTS6VO[OXXNL? F\.AY@.Y6XPA/O@L* .WHHHH **** "BBB@
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M"W2YC#B.!HMQV@] 7+9^GM7)>'+.#5W^'EM?(+JSC;55B27YEDBC<"+(/W@
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M.,U.9HEE2(RH)) 2B%AE@.I []17!Z7IFG:W\0?&?]LV=O>20&V@A2YC#B.
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M=SIVAZ7JWQ-\8G4;&"[$<-DB)/&'5 T3;L \ G Y]J .ZGO+6UMOM-Q<PPP
M ^;(X5>>G)XHCOK25(7CNH'2?B)ED!$G^[Z_A7CW@V&+59/A_8ZJBW%C'I=W
M+!%.-R/,DBH,@\$JA./2C5+6/2[WQ5=:;$L=CX>UFQU***(81"8U^TJH'0%6
M)('>@#V03PM.T EC,RJ&:,,-P![D=<5S>N>+AI?B7P[I5O%%<IJUQ-!)*)/]
M28U!/ ZGG&*X5-632?$]QX_F?-E?75]8%\_*888AY6/J]M)C_?J!-,ETJ^^%
M$-Q_Q]33W5U<D]3+*@D;/XL1^% 'L+W]G'>)9O=P+=.,K"9 '8>H7J:CO=3M
M+(F.6Y@2Y9"\<+R!6DP.PZFO(?[&UG7-.\27$5IX?CN#K-QC5+VZ=+BV>.7$
M>"(SM"A4 &[D'WK<L=-TS5;SX@W>MV\$MS#=&+S95!:"%+=&0J3RO)9@1CGF
M@#L="\2V^I>$M+UR_>WL1>P))MDE 5689V@G&:U_M=MY4LOVB+RXN)'WC"<9
MY/;@@UY%X*L[35=4\&VFIV\5S:P>%?/MX9T#)YID168 \$[<#Z&LR.V$=C=Z
M7I,5K<6,GCAH/(N9"L#JL *1L0&^0.J@#!'R@4 >XVUU;WD"SVL\4\+?=DB<
M,I^A%)=S&VLYYPNXQQL^/7 S7)^#-(U#2]<UV2[BTBTBN?(<6.FSLZQ2 ,&<
MJ47;N&SMSMS73ZI_R";W_K@__H)H S?#7B:UUW1=+NI);:&]OK1+G[()@74,
MN>!U(]\5J/J%E'>)9O>6ZW3C*P-*H=A[+G)KR*TT;3K'X;^ -1MK.&.^;4--
M9KH(/-;>P# MU(P<8Z8 ':H_%16XTK7]:L=(TRW@CUA4-_<3,UX\\<R(6C^7
MY!E<!=W0'@9H ]FBGBG#F&5)-C%&V,#M8=0<=#[5FW6J3C4=-BL3836L\DB3
MN]R%==H_Y9J =YSU&1BN#U?5V\ >(/%@C4[-4LQJ6GH!P;O(A=1ZEF:)OQ-4
MKS0E\-:_\*=)SNDMY+KS6_OR&-6=OQ8DT >J2:II\+HDM_:H[N8U5IE!9QU4
M<\GVJ2YO;2RV?:KJ&#S&VIYL@7<?09ZFO)&T+2[OP1\2;^YL8)[M+W4C'-*@
M9H]@++M)^[AN>.YK6T>SM-?\>E=;MX;WR?#MHUO'<H'7$A?S' /&20H)_"@#
MTF.:.8,8I$<*Q4E6!P1U'U%$LL<$32S2+'&HRSN< #W)KA_A,D$?A2\2UD,E
MNNK7@B<MNW)YIP<]^,<UH?$S_DF?B/\ Z\9/Y4 =%_:-CY<\GVVWV6YQ,WFK
MB,_[1SQ^-.2]M)+/[8EU"UKMW><) 4QZ[NF*\PUS1([&R\%Z=I6F:<\=Y="2
MXCNR8X[J9;=F4S,JL6.<MR#D@5'-IL^EV][8:AI>C7!U76+86NDVEXXMX9_+
MWL9?D&%(C#E=IR>W- 'J<%[:75K]IM[F&:WP3YL<@9..O(XK%?Q3 _BC2-*L
MFM[JWOX;F0W$4H8(8MG QP<[_P!*\MU)9K:S\8Z=<1V%K;OJ6EQWD.G,1 B2
M,HDZ@8W *&XKL+G2]*TSXP^'5TZUM[61]-N_-B@0(, QA3M'&?O#/M[4 >AU
M6DU"RANX[26\MX[F3[D+2@.WT7.35FO%?&VVZT?Q?K%CI&F0Q6UWY4FHW<S-
M=-/%L4&(;3L . !NYY.!F@#V"YU.PLPYNKZV@"$*QEE5=I/0')XS3KB^M+.W
M%Q<W4$$!QB260*O/3D\5PVG:)IFK_$[Q@^I6,%X$ALD19T#JH:)MV >,G Y]
MJY?P9##JD_@"RU2-+FTBTF\D@BG 96E614'!X)5,X]* /3=#U\ZQJVN68B18
M]-N4A217W>:&B63=_P"/8K<K@OA[;6=GX@\:V]@J);1ZJJJB?=0^2F5 [ '(
MQVQBN]H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KE]+T2\T;Q;JQAA6;1-7/VI_F&8+G 5P5/57 !XS@@YX-=16,WBK1
ME\/W6NF[/]G6K2+--Y3_ "E&*-\N,G# C@4 0:;X(\.:/?QWUCIJQSQ;O)S*
M[K#NZ^6K,53/^R!4'AS1KU==U?Q%JT0BO;YE@@@#!OL]M'G8I(R-S$EC@D<@
M=JFU+QMHFEWT]A--<2WL")));VUI+,X1@2&PBGC Y/0<9ZBEN/&NA6^DZ?J2
MW;W$&H\6:VT#RR3G&3M106X .>..] '045P^B^.+>XO_ !9>WNH!=&TZ:W6
MO"4,0:)2RE<!BV\D;2,YXQVK7A\;Z'+IFHW[SSV\>G*'NX[BUDBEB4C()C90
MV".A YP: .AHKF?^$^T VK7,<]S+'Y_V>(16<KM.^"?W2A<N, \KD<=:S]7^
M)>DV$.C36J7-U'J%Y]G;9:3%H@N[>"H7.\%0-F-W4XP* .VHKG-2\<Z%I5T]
MM/+=/+%$LTXM[.6;[.C#(:78IV<<\X-6-1\6Z-IMM8S/<O<?;UW6D=I"\\DZ
MX!W*J DC!!STYH VZ*P/^$TT#_A'WUS[=_H22^2V8G$@ESM\LQXW[\D#;C-9
M>D>+FUKXA2:=:RS+8QZ3Y\EM<6QADCF\W'S!U##Y2..G.: .SHK+\1ZW%X<\
M.WVKS1R2):PM)LCC9R2!Q]T$@9ZGH!R>!7'2_$,/=^$;TO/;:?J$-PUW UH^
M]Y%CC*J@*[V^9\#:/F]Z /0;@SK;2&V2-YPI\M)'**S=@2 2![X/TK@-5\%3
M:UJ$E_>^$]!:ZE&)9(M9N8C*/]O9"-WXYK5O_&.EWW@[5-3L]9FTM;-O*GN)
M+)FEM7RO#0NN<\CMWJW?>,M'T9+:*\N;F>5[9;AC;V<DI$7_ #U<(IV*2#UQ
MW]* ,Z?0]4N-"31)/"WAS^S4 "6Z:E*JI@Y!7%N""#SD<YJ"U\,:A9:;?V$/
MAG0S!J"E+LR:S<2/,N,89VA+'@D#GC/%=O;SQ75M%<02+)#*@>-U.0RD9!'M
MBL+QKXAD\-^&IKNUC6;4)G2VL86Y$D\AVH,=QW/L#0!3>PUZ2XT^X?0-",NG
M;OLC?VK/^ZW+L./W'/R\<YK#\4^&O$>JZ3J$5MX?T47&H75K/=,FIR,9?*=,
M9#PA<;4P>>G8G@]'X)\07FMZ=>6^JI#'K&FW<EI>)""$+ Y5U!.=K*01^-17
M/Q'\+V;W7GWTJQ6TC1/<?993"9%ZHL@7:S#T!)Z^E %#2_#6HZ-=3W-CX:T-
M)YH_):1]9N)"(^NQ=T)VK[+@59BTC6(?#XT%?#7A\Z6(O)^S-JDS+L].8,UI
M7GC/0[+6VT:6YE;45>)3;Q6\CL/,SM;@8V\<GH.,XR*:GC;0GU@:8MS+YIG-
MJ)OL\GD&8=8A+MV%^V,]>.M &%;>$KRTL+ZRC\,:(T-]&(KGS=:N9'D0=%+M
M"6P,G !XS6G/9^(+BZL;F70="::P9FMF_M6;]V64H<?N.?E)'-6I_&VA6^KM
MILES+YB3+;R3"WD,$<K8Q&TH78&.1P3WJ+4O'_A[2KF]MKBYN&FL6 ND@M)9
M?(&T-N?:IPN&'S=/R- &1!X4O;;6!JL7A;05NA*TR_\ $XN"BR-U=8_)V!CD
M\@9YJW_8^L?V7?:;_P (YH/V._>62YB_M:?$C2$ER3Y&1DD]*T+7QSX?O=6M
MM.M[N1Y+HD6\WV>00S,!DJDI78Q !X!]NM++XVT*'5SIKW,OF+.+9YA;R&!)
MCC$;2[=@;D<$]3CK0!@ZAX0N]4NQ<W?A;0GDV+&^W6;E%E5>%#JL(#@#CY@:
MT(]-UR+7'UE/#V@KJ#VXMFF&JS9,0.0N/(QC/M5G4/'_ (>TVXO()KBYDELG
MV72P6<LOD?*&W/M4X7##YNG7T.*U]X_T^U\5:/H\44]Q%J-NTXN(;>5UVG9Y
M94JI# [CD]%P,XS0!G6?@^ZL-2CO[;PKH*31.9(E_MBX,<3GJR1F'8AY/( K
M1CTW7(K?4;=/#VA"+49'DNU_M:?]ZSJ%8G]QQD #C%=?7.VOCC0;W5DTZ&YF
M,DDKP13-;2+!+(N=R)*5V,PP> >QH QCH/B%=9T6_@T?0HAI-O);P1C4YC\C
M*J@9,'0!?0D\<\<[GVGQ=_T"-$_\&DO_ ,CU4NOB-X9LWG$EY.RVTS07,L=I
M*\=NZL4/F,%P@R#R3SUZ5=U7Q?H^CZA'8W,L\ER\7GF.VMI)S'%G'F/L4[5S
MW- &/KN@ZIXEBB35_#.@7/DG=$_]JSH\9_V76 ,/P-)HF@ZIX=AFBTOPSX?@
M$YS,YU6=WE_WF: LWXFM#P!K-UK_ (2AU&[N%N))+BY42*J@,BS.JXQQ]T#F
ML7XF^,KOPY'I-AILTUM=W]]%#)<K8O.(HF+;BGRE6?CA.21V[T +IWA&[TG4
M([ZR\+:#'/%N,.=8N&2'=U\M&A*IG_9 J\-(UD:=J&GCP[H7V34'E>ZC_M:?
M$K2??)/D9&?:M?0-:M;]#8+?3W5]:P127#3VK0.1(#M9E*@ G:> .,=!56?Q
M[X;M].L;^74"+:^:5;9O(D)D:/.X ;<Y^4@#N>!G- &'?^#[O4[A9[OPMH;N
M(UA8+K-RBR(O"JZK" X X^8&I-1\+WVJZE'J%YX7T%[E(Q%N75[A Z Y"NJP
M .OLP(JU:?$.QO?&4.@Q6MZ%FLDN5D>RF4AF; !!7Y5QU8\ \9R"*SO!WQ(L
M;OP[H_\ ;5[,^H73>3)<"T<0B5G(5#(J[%8C'&: +:^'-12#3(5\,:"(]+E,
MUFO]K3_N7))R/W'/4]<U'=>%KZ\U.\U&X\+Z"]S>Q>3<DZO<!9DV[?F7R=I.
M.,XS[UMZEXVT+2=2DL;NYE$D)07$B6\CQ6^[[OFR*I5,Y'WB.N:=J'C/0],U
M<Z3/<RG4/W?^CQ6\DC8?.T_*#Q\IR>@[XR* ,"Q\)WNG7%K<6WAG1%N+5F:*
M9M;N6?Y@ 06,)+#"CAL@8'%10^"IX-.;3X_"FA"S:=;GR?[:N2JR*205!A^4
M D\# ]J]#KG;3QQH-[JR:=!<S&265X8IFMI%@ED7.Y$E*[&(P> >QH Q]8\-
M:CKUTMUJ/AO1)+@1^498]:N8F9,YVL4A&Y?8Y%6TTO6HIM.EC\-^'XVTV-H[
M/9J<RB%6 #  08P0!^57+SQWX?L-4DL+B[E#Q2K#-,MO(T$,C8PKRA=BDY'!
M/?FJ6D^)95\0^,UU6]CCTW29H?*9PJB)#"KMD@9/))YS0!-;6OB*SO;V\M]"
MT)+B]=7N'&JS?O"JA5/^HXP !Q5O[3XN_P"@1HG_ (-)?_D>HY_'6@VZVF^>
MY,MY;_:;:!;.4RRID#Y4"[B><XQG'/09J1/&N@/X>;7/MQ6R64P-NB<2"7.W
MR_+QNWYXVXS0!DVFA:I8QZG';>&?#\::H[R7@&JSGSF;(;.8.,Y/ ]:C;PWJ
M#>%_^$:/A?0/['P!]E&K3@8W[^OD9^]SUK43Q[X?-G=W,US<6PLVC%S%<VDL
M4L7F,%0E&4-M)/WL8]ZTKKQ#I=EKUCHEQ=!-1OE=[>':QWA02><8' /4\X-
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M>)XC IW??# $'Y6XZ_F*FT7Q5I6O7$MO9O<)<1H)3#<VTD#F,\!U5U!*GU%
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MN..Z5VD0[W*1NWWF5"=JDY/( K4U35++1=-FU#4)Q!:P@%W()QDX  ')))
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ME>*S?'U[::=XL\$W=^RI;17TY=VZ)^X;#'T ."3V SVKNT1(T"1JJ(HP%48
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M155$"(H50,  8 %+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"T7F#,GD,02#CC./PKG7_M?Q)9^&-%DT#4+&;3[RVN;^>X15A00<D(P)W[F
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MWVA;YQ,&V>5G'7?@=.]=;7D\NBW!^*DGAN-5.B3W,?B.8 _=< J4(]&E5'_
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M'(I,H?/.57A<9R>E:6H>'=3?XH1I%:.VAWES;ZI<3C[J301R($/N6$+?\!H
MZ&+QG;W,7A=K:U:5]?&^-=^/)01^8['CG;P,>IKCOAYXEFTOX<6TK13ZC?WF
MJS6MK!YN#(Y=C@LWW5"JQ)[ 5H>#/#VIVGC*[^WVCQ:=H\<]OIDC])%GG:0E
M?]U B5SNE>#M2C^'^D#4=&NYGT_6IKJXL48I+) ^]24P021N# 9&<$4 =Q-X
M^^Q:9J+:AI,L.K65Q#;?V?',LGG238\K8^ "&SU(&-K<<5E+K]\OQ,MVUJQ?
M3%M="NKB:-;CSHF021G>& &2,,"" 1]#6?<^'/,T2?4M \+7MG+:ZG9WB0W4
M[&>]2!LD;78[,;GP"<G\JM7]IJOC#Q5/.FCWNGZ?-X?O+!)KV,1MYLA3JH)(
M'IGKAO;(!HQ?$2\$6BW-YX:N+6SUJZA@LIC<JQQ(?E,B@?(=OS <]",@U9O?
M'DEK+?W4>BRS:'IUR;:\U 3JI1@0'98\994)P3D=#@'%<IJ&I:I/HW@?3;K0
MKNQ>SU:PBN9;C:$9T^7$1!.\'!;/0 >]*_A2UM=0UBPU#PAJ6K7-YJ,L]O-%
M<NEM)%*^[YV#X3;N8$%<G QG- 'JM]--;V,\UM +B9$+)$7";SZ;NWUKR1/%
M>N:GX+\%ZQJ%I*UQ-K46S[/*NZ[!2; VC 7G P>.,FO8&C_<&->/EVC\J\F\
M/Z9JY\)>"]*FT6_M[G1M7B-UYL8"[ LV74YY7E>?<4 =?9>,KHSZQ9ZGH-Q;
M:CIMLMV+:VE%R;B-MVW80!ELJ1C%,B\8:J)KRRO?#IM=2CL3?6\'VQ76:,,%
M8%P!M8$C(P>O6LGQ7I6O2:_XDO-(@N \VB6\,$L)VLS+-(71&[/L/'N15#2=
M&,/C)+S2_#.H6&FW>DW%D)+D$R><61@T@+$JI (!/)(/'0D ZOX=ZSJVO^"]
M/U#6(%2XFB5A*'4^<"/O[5 "_2K^F>(DO_$6L:++;-;W.FF-@6?(FB=<JZ\>
MH(([$5E_#3[7;^!].TV^TV\L;JPA6WE6YC"AF'=3DY'O6'\3[?4-/U/2]6T3
M:+_44?0G&[!(F!,;_P# &!;Z$T :<'Q#-_:6+:;H\EU=:E<W$=A"9PBRPPG#
M3,Q'R+Z#!/(ZYJ1_B +;3=0>^TF2WU'3KRWM;FS\X,!YS*$=7 PRD-GH#P1Q
M5?4M$E\,ZKX6U'3-/N+W3])M)=/GAME#2K&RIM<+D;N4YQS\V>:Q-5T/6M9T
M_P 5Z[#I-S%)>W-A):6,V%FDCM75F)&?E+9? // ]: /0)]=2#Q79:"8&+W5
MI+<B;=PH1D&,>^_]*EUS4KC2M/$UIIL^HW+R)%';P\99CC+-T51U+'I7+6<N
MHZW\2-,UC^Q;^RTV'3;B#S+R,(YD9XS@KDX&!QGK@]L$W_']O>W&EZ>L%O>W
M-DM_&VH06+$2R6^UL@8()&[82 <D T 5;OX@G3/#^N7VIZ0]M>:-)$ES:K<!
MP5D*[65P.1AL] >"*L2>+]3CALXF\-RIJFH3.ME9/=("T*J&,LC $1XS@KR<
MD#O7 ZAX<U%]"\:6.G>&;VTBU-+.>QAQN)5'4,&.3A^"VW/ /M79>/M"6_U;
M0M5GTR[U*RLO/BN;>S=A*%D"X=0K*6PR $ ]&Z'% '1^'M=_MVTN&DM'L[NT
MN&MKJV=PWER* >&'# AE(/H:9I_B%+WQ1JVA26S03V"12HQ?(GCD!^9>.,$%
M3[U4\%:?:V6EW,EKH<^D)<7#2"*XF:260 !0[Y)*D@?=R< #Z5A_$+3=<M]1
ML]=\-6<ES?R6L^F3+'U"2+F.0^R2 '_@5 %J+XB"\M;=M.TB6ZN;Z_GM-.A\
MX*+A(<[YBQ'R)P?4]/6L[Q3XHGU'P#XQLKBSDTS5]-M?WT2S!P%=<HZ.,9!P
M>P((-6+_ ,.S>&)/!UYIEC-?6FA12VEQ#;*#*R21J#(JDC<=R D#GYC65K&C
MZOK^E>.M7CTJ[@;4[&*SL;290LT@C#$L5SQEGP ><"@#J/#/B ?\4]H3PN\L
M^A)>FX+_ -WRU(([D[\YSVJ&\^(,5I:W,XTN>8PZV-&$<;@M(Y (89'<D#!_
M.LJ.WU+P_J_A75I-'O[N"+0?[.N([2,/)#+^Z8;ER./D(SV-4+;1=<GM3+<:
M3/!++XSCU$Q'#%(,)\Q(XXZ$CC(- &_<>-M5@CUNSN- ^RZM8V'V^&+[6LB2
MQ9*EMVT8*E3D8Y]:30O%/B&?P7H-W+H$M]JE_%'@I.JQNOE!S-(X7$8;G"X/
M/ I=<T;4+WQGJTT%L[0W'AE[..4\*9C(Y"Y]<$&N;ABU"X\-^#[74O#^NMIF
MG6QM-0LHT*O),D4:QN55@6CR'YSC.,T =-=?$6.R\.1ZI<:3<"==4&EW-HD@
M9HI=VT[2.''0CIG(Z5%J&M@^(_!L>MZ%-:ZG>3W*P(E_N6WVJ.6VX63*XX/2
MN7MO#VK)HZZ<F@W-J8O%EMJ"Q#YT6W+*V0V3G:!AO0UU?B_2;^^^('@>]MK6
M26VLI[IKF51Q$&C4*3]2* .>TOQ+-X>UKXBZI-#/>6UEJ%OOB$G,<9&&90<]
M,Y(]J[W5?$D6GZCH=C! ;N?5YRD81\!8U0N\F>X QQWR*YSPOX>N/^$E\>KJ
MEBZV&J7*",N/EFC,95L>W.*S?AE87]SJUU/J;"5?#L;:%9R Y$FQR7D^NT1+
M_P !- '>^(-;CT#2C>/!)<2-(D$%O&0&FE=@J(">!DGKV&37/7?CZ;2=-UF3
M5]%:UO\ 2[=+MK9+D2+-$[%0RN .A!!!'&/>K7Q"T2;6_#D206KW;6EY!=M:
MH^QIT1OG16R,,5+8Y'.*X_4O#L%]X1\3_P!A>$M2LIIK)((7O)7,UP=VYD6-
MF8A1@<Y&23CIF@#K8?&.H?VW:Z;>>'I+7^T()9=.=KI6,S1J&V.H'[LD'/4U
MB^&O'NK3>$GU35=+,L\^H/:6$<4R9GD:9U6/H H0* 6/4 FM_7-/N[CQQX1O
M(;=WM[1KOSY .(]T.%S]3Q7!V_A_4I_!<6D7F@Z@\NC:V]]+$/D%W"TLN?)<
M,,G9)GJ.F.] '87GC^32M%URYU31WM[_ $>..:6T6X#K)'(<*R28&1D,.0,%
M:I>(?$BR:9HEWK?AZYACN=<MX;%%OMCG<"4E<)T[YC.?>L;5O#D=]X%\5+H7
MA34+*:YMXH(3=2NT]UAMQ'ELQ*JN>.><GCCGH?B/I%_JECX72PM))VMM=M+B
M81C.R-0VYC[#(H LWGC34/[9UK2])\.R:A-I)C,SFZ6)&5XPXP2#EN2,>W)&
M12?\)[]NBT1-"TJ34+S5;0WJPO,L(AA& 2[$'G<P4  Y.:FT73KR#Q7XRN9;
M=TAO);<V[D<2!;=5./H1BN2\-Z;J_A7_ (135)]&O;E5T-M-NK>W4-- _F*Z
MDJ2,@X(..G% '<^%?% \3QZDWV":R>PO&LY(IF!;>JJ6Z<<%L<$YQG/-=!7"
M_#:6XGF\6SW5O]GFDUR1C%N#%/W46%)'&0, XXSFNZH **** "BBB@ HHHH
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M;& QE9 C)C<V1\P(/6K>K:Y>Z5XWT.RE\LZ3JD<L ;;\R7*C>OS>C*& 'J*
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MD:4D*"?7 )_2MRB@#GM5T"XO_$7AK4$>$0:8\YG5B=S!X3&-O'/)[XXKE_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM%MY93,,IN4$%<>F>: .Q\J/_GFOY4>5'_SS7\JR/"&MR^(_"6F:Q/$D,MY
M)6C0DJI/89KE9/B!J;^$9=4MK&T^V?VT=+BCD9A'CS?+#,1S[G% 'H/E1_\
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M//$D_A+P?>:U;P1SRP-$HCD)"G=(J'I_O4 =)17,>(?%4ECJ,&AZ+:KJ&O7
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M3P 3P "2>E>C,JNA1U#*PP01D$5G6/AW1-,N6N=/T;3[2=OO2V]JD;'\0,T
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ML"W<BA'G$8$C*.@+=2..E 'D%I$TWC.R\ E3Y&FZ[/JQ4=%M@HFB'T\R;'_
M:Z*7_DXB#_L6C_Z4&N]6QM%OFOEM8!=NGEM<",>8R_W2W7' XI396IOA?&VA
M^UB/RA/Y8\S9G.W=UQGG% 'EFBZ#<ZKX%>_THJFN:7K%]<V#GHS"=]T3?[+K
ME3^![5D)-)XY\-_$:YTJWD,UQ+9S+;,/GWQ11L\1']X%&7ZU[9;VMO:1F.V@
MBA0L7*QH%!8G).!W)YIEM8V=G)-):VL$#SOYDS11A3(WJQ'4^YH Y"_\5Z9K
MOAVWU/2O&MKHD0'F3.ZPNXX^XRR?=8'MUKC]4U>]O_"'PXU77+C_ $A_$$,D
ML\R"$% TFUB,  ;0I^G->IR>&=!FO_M\NB::]YG=]H:T0R9]=V,YJU?:98:I
M"L.H6-M=Q*VY4N(ED4'ID @\\F@""W\0:-=SI!;:O833/PL<=RC,WT .37!?
M%[2(+@>'[Q'FM[FZU*'2IY8'V-):SDB2,GN../3GUKNK7PUH-E<I<VFB:;;S
MH<I+%:HC+]"!D5>N;.VO!&+JWAG$4@EC$J!MCCHPST(]: "TM8+&SAM+6)(;
M>%!''&@P%4#  J:BB@#RV>37O%'Q.NM4T*+39K/PZK6$1OI75#<. 9678IY4
M80YJ;P>^J^&?B!J>AZW'9PIKH;4[,6;LT0F&!,@+ ')&'QBO1K:SM;)&2TMH
M8$=R[+$@4%CU)QW/K1+9VL\\$\UM#)- 289'0%HR1@E2>1D>E 'DGAS2;S_A
M57A;Q+HT>_6=(B>1(Q_R]0%V\R$^N0,CT8#UK'O-2MM7^#GCG4[5R;:Z\0":
M-F&#M:2V//H:]TMK6WL[=+>U@B@@082.) JJ/8#@56_L72OL4UE_9EE]DF?S
M)8/(79(V0=S+C!/ Y/H* .?\4^./#^G^'[OR]2M+RZFB:*WM+:599)Y&&%55
M4DG)(J]X'TFXT+P/HNF7?%S;VJ+*,YVMC)'X$X_"K]EH&C:=/YUCI%A:RXQO
M@MD1OS K1H BNK:*\M)K6=0\,T;1NI[J1@C\C7C_ (#$NKZ_I'AV^'F?\(E;
MW<-QN&0TA<PQ9_[9!B/K7LM5X;&TMKB>X@M8(I[@@S21QA6D(Z;B.3C)ZT >
M1>#EEU'Q;H?AF?<R^$/MC3%NC'?Y5O\ ^0SD?2N@T'_DNOBS_L'VO\A7>PV-
MI;W4]U#:P1W$^/.E2,!Y,=-Q')Q[TJ65K'>27B6T*W4JA9)EC =P.@+=2!0!
MYO\ ";7-(L?!;P7FJV-O,+^Z)CFN$1@#*>Q-3>.M1L3XN\ 7XO;<V?VZ<_:/
M-7R\>7C.[..O%=BWA+PV[EF\/:2S,<DFRC))_*IY?#^BSVD-I-I%A);09\J%
M[9"D>>NU2,#/M0 MKKND7UPL%IJMC<3-DB.*X1V..O .:\:L?^2)?$'_ +"M
MY_Z$E>QV?AW0]/N5N;+1M/MIUR%EAM41AG@X(&:F&DZ:MI-:+I]J+:=B\T(A
M79(QZEEQ@DX[T <-XLC?PGJ'_"66RG^SKV!;368U'08Q%<8]5)VM_LGVKGM(
MG31=#^&7B2\RNEVMG+:74V,B S(H1V]%RN">V17L4T$-Q \$T220NI1XW4%6
M4]00>"*8EG:Q68LX[:%+4)L$"Q@(%]-O3'M0!YWXW\17EF8[W0/&D#2SRPQV
MVDP0P3M-EU#8."WW2Q_"G)J-CIWQTU:2^O+>U1M$A56GE5 3YAX!)KM[#P]H
MFE3M/IVCZ?9S-]Z2WMDC8_BH%+>^']&U*X^T7^D6%U-@+YD]LCM@=LD9H FL
MM5T[4M_V"_M;KR\;_(F5]N>F<'CH?RKS>T\/6"_'6YM@K_8XK$:Q':;OW2W;
MOY;2A>F<#/U.:]&L-'TS2C(=.TVSL_,QO^SP+'NQG&=H&<9/YU.+.V%X;P6\
M(NBGEF?8-Y3.=N[KC/.* )J:Z++&T;J&1@593T(/:G44 >,>#$EN?$VD>#YL
MO'X4N;V:7?\ QJ"%MS_WS,Q'^[1X>B>[\8:1X*<$P>&=1O+V13_SS&#:G_R/
M_P".UZ_'8VD-Y-=Q6L"7,X EF6,!Y .!N;J<>]$=C:17LMY':P)=3 +).L8#
MN!T!;J<>] 'FMU)KOBCXGSW^A1:=-9^&U:SC-]*ZH;F09E9=BG)5<*<],U-X
M3?5?#/Q$U'1];CLH8_$ ;4;06<C-$)UP)E!8 [B,.:]&MK.ULD=+6VA@61S(
MXB0*&8]6..I/K1-9VMQ-#--;0RRP$M"[H&:,D8)4GI^% 'G?PJMXKK3?&EO/
M&)(9?$=ZDB-T92$!!_"N:62]DTQ/A*TDGVI=1^S/-GYO[, \T/GU*X3]*]HM
MK*ULA*+6VA@$LAED\J,+O<]6..I/K2?8;07QOOLL'VPIY9N/+'F;,YV[NN,]
MJ //OB':60\0^"+26^DTNS2XN$^T03^08E$!P _\/0#\<5M>';71+/50UIXQ
MO-4GD0HMM<ZL+@'N2$]0!U],UTE_I6G:JB)J-A:WBH<H+B%9 I]MP.*KVGAO
M0K"Y2YL]%TZWG3.R6&U1&7(P<$#(X)H TZ\V^(+ZAXC\3Z1X2T=+65X"-5OU
MNG98C&C 1HY4$X9N<8_A%>DU"EG:Q7<MW';0I<S +),J .X'0$]3B@#S"^D\
M1>&OB!I7B?7(=+AL;_;I-V;"61A\Q)B=PZC&&XSZ&I[7P]'XENO'EB93!<KJ
M\<UI<K]Z"=8(RCCZ']"17I%W9VM_;M;WEM#<0,06CF0.IP<C(/'6EBM;>"26
M2&"*-YFWRLB %VQC+$=3@ <^E 'F7@C79]>^)M])?0?9]3M=%BM+Z''"3I/)
MNQ_LD$,/9A2?$#P_8WGQ%\*HXD2+69'M]1BC?:EU'"HDC#CO@C'TXKTN.QLX
MKV6\CM8$NI0%DG6,!W Z MU-.EL[:>>&>:WADF@),,CH"T9(P2I/3(]* )54
M*H50  , #M2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5YMX?M/$'B>;7;IO%^IV:VVL75I##!% 45$?"_>C)/!]:]
M)KRG1/AQI'B"U\4OK&F2Q7MSK%\L-RV]'"%OD=1D CG(/0T 68_%.M?\*W\8
M7$FH)/?Z++<6T&HQ1JHFV*"'V_=W#=@XXXJU-XBUN]TCP;H^FW:0ZMK=DMQ<
MW\D8?R8UB5I'"]"S%@!GCDU2\B\?X*:YH3:.UMJ-A:S63P6]L52=@.)(@!\P
M<8;CN33VT[5-*TOP+XDM=.N+M]+TY;6_LHD_?F*2) 2JGJRLH^7J>: -Z#P_
MXGTG4[*>S\3SZG:&4+>VVJ)'S&>K1M&@(8=E/![D5#9^)6A^)?B'3-1U.&&Q
MM[6U>VBF=$ 9@VX@G!/05S'B(:;XPU&&;P[I.OMK<EQ 7NY$N;:"W1'4OO#E
M4^XI& "236U!X9LM5^*WB2XU?1(+RU^QV@MY+NU$B;L-NVE@1GIG'M0!:N/$
M$M]\3++1].U9&L9M)GDD%NR/ME#J%;//(!Z=/:L;5K#Q)I_C7PYHD?C?5F@U
M1;II9&AM]R>4BL-O[O'.><UH1^&[32/B]ID^DZ-#961TF=99+6U$<>_S%P&*
M@#./6KOB*TN9?BAX*N8[>5X(([\2RJA*Q[HE"[CT&3TSUH Z;2+&XTZP6WNM
M2N-1E#$FXN%0.<]L( ./I6;XAT;4=0?[39>(]0TQ8HB#%;1Q,KD9.3O0G/;\
M*Z"HKD$VDP ))1L ?2@#SWX>KK6I>%]*\4:MXKU&=9(6FGM6BA$1 W#L@;'&
M>M2:#;^)/&VDQ^(9_$M[H\%YF2RLK&*+$463L,A=6+L1@GH.:T/AMITJ?"K2
M-.OH)8)#:O'+%(A1URS=0>1P:RO#/B.3P7H4'AOQ#IFJ"ZTX&"">UL9)XKN,
M'Y&1D!P=N,@XP: -[P9K6I7DVKZ+K3QRZIH]PL4D\2;%GC=0\<FW^$D=0.,B
MNJKC_!.GW[7^O>)-2M)+*?6;B-HK27&^*"--D>\#HQY)';-3?$.[U*'PG-9:
M-!-+J.I2+8PM&A81>8<-(Q'W0JY.3T.* .2L/&FM2>*+;Q!-=9\(:CJ4FE6\
M6Q<)@!8Y]V,X>17')P 17J]>:WOPJNIO![>'HO%FI-9QPA8+=X8 @9>4R1'N
M^\ <YS[UUG@S5+W6/"=A=:G:S6NH"/R[J*:,HPD7Y6.#V)&1[&@"#Q1I&IW2
M37UCXDU#35@MF/D6\<3(S+D[CO0G)X'7M6)\/[;7-2\/:1XBU#Q3J-T;BW\V
M2T>*$1$D$=0@;@\]>U=KJBL^D7J(I9F@<  9).TUS_P[MI[3X::';W,$D,\=
MFJO%(A5E//!!Y% '->#['Q)XA\$Z?KL_CK4[:XN83*P\BW:)""1R#'TX]:K:
MUXVUQ_@2OB:"X6VU0ND?GPH-KXG\LNH8$88#/XU2T'X5Z=JWPFL]VE_9/$+6
M_F+)<!@?-5R0KHQQM. "".AK0\=-=>(O@8PL]$N;:Z/V=&TZ.V8-"R2J&54
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M,U[J\RV(EC0L((W_ -9(Q'0!<C/J10!S&B>,M;F\3V.MWMR3X6UV\FL+&$H
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M4M-N#;WD$:&.4 $J3(H/!!'0FLCXA6^N:5X=U?Q%IWBG4;8V\ ECLUBA,2D
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MPG8WFF^$-'L=0)-[;V<4<^7W?.% //?GO5G6T>30-1CC5F=K64*JC))*G@4
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MC03W@C+NPVYN'ST(]!^54_A;X-\/W.B+JLVG*]];ZE<>5,9'ROES'9WQQ@4
M>KT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"VT)VD@R,"5!(Z9P1SWXJ]6+XLT4^(/#%[I\;^7<L@DMI/\ GG,A#1M^# 4
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M]!",N&VAPH'J01CZBK$,GFPQR;'CWJ&V.,,N1T/O7F LK.T?XIW-O&L=TJ2
M,K'<%:T1SW_O<U96*WU?Q#X;TO6F,FFMH'VB*&20JDUP"@8GD;BJ'(!Z;B:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)VY.T<=/2KNE>.;V36;:PGO--U$75O*X>QMI8OLTB+NVMO8[E(! /RG(Z<T
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#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>exhibit1013-zerondaxexec015.jpg
<TEXT>
begin 644 exhibit1013-zerondaxexec015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 \4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **JVM_;W9<12 LAPRG@C\*LTE)/8;36C%HHHIB"BBDH 6BL&Z
M\6Z7:74MO,\HDC8JP$9ZUJ6%_#J5HMS;L3&W3(Q6<:U.4N6+U-)4:D8\TE9%
MJBDJCJ>K6ND0+-=,P5FVC:,\U4I**YGL1&+D[16I?HK'T[Q+I^J70M[9I#)M
M+<H0,"M*ZN8[.UDN)=WEQC<V!DXI1J0E'FB]"I4YQERR5F345SJ^--'9@HEE
M&3C_ %9KH%8.H93D$9!I0JPJ? [CG2G3^-6'44E8$WC'28)WB:23<C%3A"1D
M43JPIZS=A0I3J:05SH**JV-]%J-HES!N,;]"PQ534_$-AI,ZPW3N'8;AM4GB
MG*I",>9O0(TYRERI:FK15'3-6M=6A:6U8LJMM.1@@U>IQDI*\=B91<7:2LPH
MK,U37;+1VB6[9P9 2NU<]/\ ]=.TO6;35UD:U9B(SAMRXJ?:PYN2^I?LI\O/
M;3N:-%(>A-<[_P )MH__ #TE_P"_9HG5A3^-V"G2G4^!7.CHKG/^$VT?_GI+
M_P!^S1_PFVC_ //27_OV:S^M4?YD:?5*_P#(_N.CHK.TO6;35TD:T9B(R VY
M<=:B_P"$ALQ)(C+.AC<(Q:(@9) '/XBM/:PLG?1F3I33<6M4:U%5[:\ANI9X
MXV):%@K\=\9JQ5IIZHEIK1A1113$%%%% !1110 4444 %%%% !1110 4444
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M2W+2SR<?4FM\TJV@J<>IAE-%.HZLMHG:>!-.\NVEOW',GR)]!U_6NP=5="K
M,I&"#WJ"PM$L+&&UC^[&H7Z^]6:[\-15*DH'GXFLZU5U#RCQ'H[:1J3*H_T>
M0EHCZ#T_"NM\&:S]LL?L4SYF@'RDG[R]ORK5U_24U?3'AP/-7YHV]#7F5E=W
M&CZHLR@B6%\,I[]B*\BHG@L3SKX6>Q3:Q^&Y'\<3T/Q5K(TO32D;?Z1-\J =
M0.YK@=#TJ36-32$9V [I&]%I-8U.76=3:<@X/RQIZ#M7H?AK1ETG35#@?:)/
MFD/]/PIJ^.Q-_L1!_P"P8:WVY&O#$D$*11J%1!@ =A7 >/?^0K!_UR_K7H=>
M>>/?^0K!_P!<OZUV9FDL.UZ'%E3OB5\S'T'6)-&U!90286XE0=QZ_45ZM;SQ
MW4$<\3AHW7*D=Z\?6PF?36OE&8DD\M\?P\ C^==!X0\0?8IQ87+XMY#\C'^!
MO3Z5P9?BG2:IU-GL>AF6%59.K3W6Y:^(/^OL/]U_YBI_A_\ ZB\_WA_*H/B#
M_K[#_=?^8J?X?_ZB\_WA_*M8_P#(Q?\ 70QE_P BQ?UU.S;[I^E>)*I9@HZD
MX%>VM]TUXG&P656/0,#1G&\/G^@9+_R\MY?J;J^#=890PACP1D?O!2_\(9K/
M_/&/_OX*Z2/QQIJQ*I2;( 'W:=_PG6F?W)O^^:E8; _S_B6\5F%_@_ ?X1T>
M\TF&Y6[15,C KAL],UJ76D1W23J[G;-*LAXZ8 &/TJW:7*7EI#<QYV2H'7/7
M!J>O6I481IJ"U1XU6M.=1SEHRCINFKIRR 2-(9""S,.2>YJ]116L8J*LC*4G
M)W844450@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#&\0::U_:!HAF6+)4>H]*X=TP2CK@]"#7J&*S=0T>PNP9)D\MN\B
MG'YUY^+PGM'SQ>IZ.#QOLER26AY_H0:R\0QR#[J*[_4;35N]O6+M+(VZ5CFK
M]VND:-;7>IK.]S';0-O5<#@\$@].,YKFH?%NCQRB5=(DG'4-+/G/X 8KMR6"
MI4I/?7H<6=2EB:L>316ZG:>$+"1$EOY@09?E3/IZUU5<QH7C72M7=;<'[+.>
M%CD(PWL#_2NGKHK2E*;<CFHTU3@HH0C(Q7E'B73SIVMS(!B.0^8GT->L5R?C
MG3OM&FQWJ#YX#AO=37E9E1]I1NMUJ>MEE?V5=)[/0QK[7_/\&V]IO_?L?*?G
MG:O^/'ZTSP1IQN=5:Z=?W=N."?[QZ?UKF*]4\+:=_9VAQ*PQ)+^\?ZG_ .MB
MO-P?-B:ZE/:*/2QO+A</*$-Y,VZ***^B/G KS[QUI\4%[#=Q_*TPPX ZD=Z]
M!KBOB!_J[/\ WC7#F,4\.[]#ORV36)BEU,OP3817FK232C/V=0RK[GO7I.*X
M'X??\?E[_N+_ #-=]4Y9%+#IHK-)-XEI] KSSQ[_ ,A6#_KE_6O0Z\\\>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@!*Y'Q+?2SW@L8V(1?O =S775R5QIL]UKUTR
M(2-PPQZ#BO)SA59453I_:>MNQV8+D51RGT13ATH:G9W>F\!;BVDA+$=-RD9_
M,U\]:5K$^CW,FGZ@C!(W*-GK&0<$?2OK*PT]+&(J.7;[S5Y+\4_A5<:K=OKO
MA^$/<.,W-JN 7/\ >7W]17IY-3^JTO93ZG+CI^UJ<\>AR\4RNJRQ/D'E64U[
M-X'\0G6]*,4[9N[;"N3U8=F_I7R_9ZAJ.@736]Q#*@4XD@F4J5/T/0UZC\._
M$]NNOV\D,HV3'R94)P1GIG\<5ZE>E>-T<U.=SW>HKJWCN[:2"49212IJ6EKS
M6KJS-T[.Z.2B\!V,<R.;F=@K [2!@^U=8  H Z"L[6UD&FS3Q7$L+PHSC81\
MQQWXI(Q+;Z))(;B620Q&0.Y!(.WMQ4TL-3I+W%:Y5;%5*LK5'>QI45S]GJ=U
M/)I4;QS('7YW;&)/D)_GS1J<]R=<\B-[KRQ;J^VW(!SN(R<UO[)WL<_MH\O,
M=!69K&AVVM",7#./+Y&TTW4Y9;?0@Z23A_W8+#!DY89_&H]%N)9YK@>;/);I
M@?Z0 '5^XQZ=*B5%3@^;5&D,0Z=1<NC'Z/X?M=%DE>W9R9  =Q]*UJYR[USR
MM; $X%O&PC>/^\3U;\.*N:[<20Q6OERRQJ\P5C$,L1@].*(8=02C%60IXKVC
M<Y.[1L5C:MX<M-8N$FN&D#*NT;33].DNC97+3-,54GR7F7:Y7'<?7-4]%>YN
M&AEFDO3E=Q+E?+;],T5,/&<6IZI#IXF5.2<-&S1TC1[?1K=X+=G*N^\[CWQC
M^E:%94=Q-_:6IQM(=D<:&,'ME3G%.M/-O-#@9[B5)&0,9$(#?J*4:2A%):()
M5G.3;U9'J_AZRUB1))PRR(,;DX)'H:DT?1+;1DD6W9R)#D[C3="$TEBMQ-<S
M2L^>'(P,'MQ1:7DPTBYN&)DDC:7&?8G J7A8*;FEKW+6*FZ:@V[=C5/(Q7+_
M /"":9_STF_[ZK2L+>8^1=OJ4LAD&60XV-GL!VJ#59;N*\:0RW"6B(,-;[3M
M/<L#R:*F&IU7::O85/%U*,7*#M<J?\()IG_/2?\ [ZH_X033/^>DW_?5=-$P
M>)&#;@0#GUI]<_U+#_R(ZOKV(_G9EZ/H=MHPE%NSGS,9W'TK4HHKHA",%RQ5
MD<\YRG+FD[L****HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[KX?W%I<_#WP^]B5,(L(DPO\+*H# ^X8$'WH B7Q]H\MGHE[!Y\MKJUX+%)
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M;:AJ$%S-#/<K;_Z.@8IE68L02. $.<59USQ+9:'X7F\0.'N;*.-) ;?!+JQ
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M^T-#;%%$4>2H9G=E R00!U.#7F.L?\D7^'G_ &$-/_DU>@:WH;ZGXF>_\/\
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M>K*7<R1!_P"$XX.:?KVN^*?#/@N^U34$T>;4(YH8X%MUE\K#R(AW9.<_,>E
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M5/=3P:GL-(LM,N;^XM8RDE_/]HN"6)W/M"YYZ<*.E9?B.;Q5;,]QHAT;[)%
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MI;.-HH&M+F2W*(<97Y"./E'Y5SU[\0[FV\<_8$LX6\/PWD6FW-\2=Z74B,P
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M!CK7>&V@:Y6X:&,SJI592HW 'L#UQ5:?1-)NKL7=QIEE+<CI-);JSC_@1&:
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MM[>$PPP11Q,22B( "3UX'K3H88K>%88(DBB085$4*JCV H ?7#>%?^2I^/\
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MI 8H2&B0QC;&1T*CMCVJ2>WANH6AN(8YHF^\DBAE/?D&@!Z_='TKRXZ!I_\
MPOX1>6WV<Z7_ &P;?<?*^V"7RO-V]-VWOZ\UZE47V>#[3]I\F/[1L\OS=HW;
M<YVYZXSSB@"6N-^*_P#R2WQ#_P!>W_LPKLJCF@BN86AGB26)QAD=0RD>X- '
M)^.-)NM<^%VH:?9(9+I[1'CC'5RA5]H]SMQ^-26OQ(\*3:"NJRZS:0*(]TMO
M)*!-&W=#'][<#QC'/:NK      '0"J3:-I;WPOGTVS:[!R+@P*9,_P"]C- '
M/?#6PNK+P='+>P/;S7US/>^0XPT2RR,RJ1V.TCCWK.O[^W\*_%>34-6D6VTW
M6-.CMXKR4XCCGB=CY;-T7*MD$]<5Z!45Q;07<#07,$<T+\-'(@93]0: .=?Q
M5I.N:I)X=TNX^W2S6LC3W%HRR16H(PN]@<98G@#)XZ8YK#^'_BC2-+\'VNB:
MQJ%IIFIZ0GV6[MKN98F4IP&&XC*D8((XYKN[.PL].A\FQM(+6+.=D$81<_0"
MHKS1],U&5);W3K.YD3[KS0*Y7Z$CB@#R#7&_M7P=\1O$\",NGZF]M'9LRD><
MD.Q#(,_PL2<'VKI?'$4GA2^N/%-JC'3K^W^QZQ$HSMRI6*XQZJ3M;_9(]*]#
MEMX)X#!-#')"1@QNH*D?0\4LL4<\3Q2QK)&XVLCC(8>A% 'EVGR>%[GX>^"M
M)\41^7'<V$;VMV[^4D4J(O E!!1R#QZX/TJ?1C*VM:YX:TC7Y]<TIM)9Q)<3
MB<VL[$JL?FCJ"N3@DD;?>O1)=/LI[(64MG;R6H 40/$I0 =!MQBEL[&ST^#R
M+*U@MH<Y\N&,(N?H* .#\!^,/#^G?#S3;?4M6M+&ZTVV%O=V]S*(Y8G3Y2"A
MY[<<<UQNIQ2P? J:\N8F@2]UH7L:RC:1$]R"I(/3(Y^AKVBXT72KJ[6[N-,L
MYKE<8FD@5G'_  (C-6;FUM[R$PW4$4\1Y*2H&4_@: ,N'Q?X9N)XX(?$6DRR
MR,$1$O8V9F)P  &Y)-<]\1?^0EX)_P"QAA_] DKJH]!T:*19(])L$="&5EMD
M!4CH0<5<EMX9S&9H8Y#&V]"Z@[6]1GH?>@"2N ^)$Z^'[_PYXO(/EZ;=M;W1
M'_/"9=I)^C!/SKOZBN+:"[@:"YACFB;[T<BAE/?D&@#R3R7\+>"?"'BZ\!$]
MO>-=ZBV.=EYGS,_0O'_WS4Z6,UK^SWK%W=+B\U.SN-1N#ZO-EQ_XZ5'X5ZI-
M;6]Q;FWF@CD@( ,;H"I Z<'BE>WADMS;R0QM 5VF-E!4CTQTQ0!@^&/^2<:-
M_P!@B#_T2*SOA-_R2SP__P!>Y_\ 0FKL4BCCB6)$58U7:J*, #T ]*;#!#;0
MK#!$D42#"I&H51] * /)?AMX+L=8\%07TVHZU#))<W(*6NI2PQC$SCA58 =*
MW/A;9II\_C"TCDFD2'7)$#SR&1R!''RS'DGW-=]!;PVL0BMX8XHP20D:A0"3
MD\#WHBMX8&D:*&.,R-O<HH&YO4^I]Z .(\>2_P!C>(_"OB>X1CING3SPWCJI
M/DK,@42''\((&3[UJW/CS05N["ST^\BU6\OI5CB@T^596"GK(V#A44<DFNE9
M5=2K*&4C!!&0152RTG3=-=WL=/M+5I/OF"%4+?7 YH X?PMJ]AX6\0>)="UN
M[AL+BXU.74;62Y<1I<0RX.58\$J001[4D,\/B_XD7%_I$J7&G:=I,MD]Y&<Q
MR3RL#L5NC;57)(Z9%=W>Z;8ZE$(K^RM[J,'(6>)7 /T(J:"WAM8%@MX8X8D&
M%CC4*JCV H \[^'7BK0])^'UCI^JZI::??:9&UO>6UU,L<D3JQSE2<\]1CK7
M.+'*WPPNM1>)XX=4\4I?6XD4JQB>[3:2#TR!GZ$5Z[<Z+I5[<K<W6F6<]POW
M998%9A]"1FK4L$-Q&(YHDD0$,%=01D'(.#Z&@#RKXCQ2>$+;Q!J,",=&\06,
M]O>(HX@O#$RQRX[!^$;WVFM*\_X1+4=/\-Z1XCW6MU_9L=Q8WS3&WVG:H98Y
M0P(?H2O<8ZUZ'/;PW4+0W$,<T3?>210RGZ@U%<Z=8WMJMK=V5O/;KC$4L2L@
MQTX(Q0!X[K5[-_PA?CW2;?6Y]<TBRLX3;WL\@E9)&)WQ&0??P I]1NP:Z&QM
M_!-N]M/_ ,+ NF:,J^R3Q*64D8."I?!'M7H*:=8Q67V*.SMTM",>0L2A,?[N
M,56_X1W0_P#H#:?_ . J?X4 <+_:^F:3\<=5FU'4;2SBDT6!4>XF6-6/F$X!
M8C-=[IVMZ3K!D&F:G97OE8\S[-<+)LSG&=I.,X/Y4ZYTC3+R7S;K3K2>3&W?
M+ K''IDBI+33K&PW_8[*WMM^-WDQ*F['3.!SU- '!_&O_D0D_P"PA;?^ATW7
MM+N-6^,5K!;:M>Z8ZZ [F:TV;F'VA1M.]6&.<].PKT*XMK>[C\NY@CFCR&VR
M(&&1T.#2^1#]H%QY2><%V>9M&[;G.,]<9[4 9FAZ/=:0DRW6N7^J&0@JUYY>
M8\9Z;%7KGOZ5KT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDDA#,&C#'=F/KD]L5ZG7&^$K&[MO&?C6>>VFBAN;R!H)'0A90(0"5)ZC/'%
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MJ<K\R;)FV8^F!^53^,M-/Q"\73>&8YS'9:/9-<32*V +R52( ?\ =&7_ !H
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ML%E:QVUM$L4,:[41>@%344 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[7$1F/G3JGR9 W<GIE@,^I'K2+KND/I!U==4LSIH&XW8G7R@,X^]G'7BO+?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 R9#)!(@"DLI W=.G?%<F=
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M'??$'0[*VTJ=6NKI=6B>2R6V@+O+MVY4+UW98#'USC!H P/^%:0?]"WX/_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5H;NT &R4"-MCDHVT,,XX'*5;LM.M(O$'@2:P&ISVL^HZC=-+J" 2,S1-\Y
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MP'RS.WEML3"@*<*21TZ#J#7K-%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\#!R3@G.<4 =]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<AX\\%S>+;>T>QU'^SM0MC(BW(CW_NI4*2)C
M(Z@CGL177T4 5=-T^WTG3+73K1-EM:Q+#&OHJC _E61>^&I+OQWI7B,7*JEE
M:S6YA*9+E\<YSQC%=#10!A^)-!?73HY2X6'^S]2AOCE<[P@;Y?;.[K6-\0_
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MQ6)I'@_7M*73]*3Q!&N@:?.)84BA9+F1 25A=]VTH,X.!D@8KMZ* *.FP:A
M+O\ M"\2Z+W+O!LB">5"?NH<=2/7O5ZBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]"QHO_@!%_\ $T?\(5X4_P"A8T7_ , (O_B:W:* ,+_A"O"G_0L:+_X 1?\
MQ-'_  A7A3_H6-%_\ (O_B:W:* ,+_A"O"G_ $+&B_\ @!%_\357_A7GA<=-
M.=1V"W4P ^@#\5T]% ',?\*\\,?] ^7_ ,#)O_BZ/^%>>&/^@?+_ .!DW_Q=
M=/10!A:=X.T+2;Z.]LK-X[B/.UC<ROC((/#,1T)K=HHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU.X2VLX;9E_>LPR#N) "X[^XH Z*BN3U#QG-9ZSI>B1:%=W&KWMM]JDMDFC
MMXP<'<Y;!(.1QG.*WK"\N[J>\2YTV6T2"8I#(\BL)U_O@*>!['F@"]1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[1DY*-P01GGD<'I0!YF%FNK72=%DN[HVEIXPGT^)Q,V\VZQR$(7SDC!*YSG
M]JUM,\&:-=^-?%>ARP2'2+:&UF@L1,XBCDE1]S@9^]\@QZ9-=G!X,T>VM-*M
MH8I4CTRZ-Y"?,)9I2&!9R>6)WL3GO5^VT6TM-:U'5H@_VJ_2))\ME<1A@N!V
M^\: /,8I;"_^$?AF]U2R.K:Y<6ZVFG122N&EE;@9((X 7<Q/8&M&]\.V6A:!
MX:\*2V]]K5T[RS&T2X$45RRKF1I6;I&I<$+Z[>#6ZWPVT<0Z3';W>J6ITF!H
M+5[>Z*,JL<MSCJ>F?2K=QX)L[FWLEDU35_M-D[O#>_;#YZAP R[B.5( XQV%
M 'E>NO,/A7J5I+$8$L_$ZV\5N9O-\A Z'RPW< L<5U7C'2_L?B#4]:UO2KV^
MTEDC>'4;"YQ-I811N(CR.-P+EESU.0:Z&3X;:!)IUWI_^F+9W5S'=O#]H) E
M0#Y@3DY; +$DY-6=4\#:9JM[=W$MUJ,,5[C[;:V]T4AN<*%^=?=0 <$9 YH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG&>F35>71],FTP:9+IUH]@H"BU:!3$ .@"8Q2ZK8OJ>E7-E'>3V;3H4^T6Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>vyne-20211231_g1.jpg
<TEXT>
begin 644 vyne-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M\#Z-\2_VP_V9=#\0:3INN:/?:KKYN;&_MDN;>=5TIR Z."K8.#R.H%;&J_\
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M[2M?Y.Z_$*Q?B/\ $/1_A+X UKQ1X@O$T_0_#]G)?7UPW_+.)%R<>K'H!W)
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M+3PLIU$HQ4;\_-;WOY;=NFVVO4_6;5/VLFT?Q-#8?\(?K5RLMXUL[VNZ26S
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M_P!WQ):V$@^]W#RCT]%[]_2O=_\ ]7TH)R:*\V4KG#*5PKUG]D+_ )'?5/\
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M#H/IGG\*XJZOH;*SDN)IHX;>-=SRNVU5'N:3QIJ7]K>*+J3.55_+7Z#BN?\
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MGI4W3JRA_6Y7HHHKS3J"O6?V0O\ D=]4_P"O'_VHM>35ZS^R%_R.^J?]>/\
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M%*@-<N_&7[4GA^QLV.EV>J&XQ<'R]'M/]$<2S(MG.QN 1;F&..22Z4-*K2*
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M^">N>/\ Q!#=:2L-U-9J\$]L\HC=-TC.LJ[N"K!AD^JUZ!\-/!MQX"\$^']
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M..>U.T.UM=/TU+>R@%O:0$K$J_<*]<KR<J<GFL_Q!HLFKWQ\RW::W "*=RL
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M?A6WMV'[^3][-_O'M^' _"MRO&PU/DII'Y?F&(]K7<EML@HHHK<X@K)\<?\
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MJGI^J/H&BBBOK#\U"L_Q%X4TOQ?:0V^K:;I^J06\\=U%'=VZ3I'+&=R2*&!
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MTGO)IO1\LTXIV>J9^Q4O[=GPWM]OFZEJ,;,H?:;"1L9&>HX/U%-_X;S^&?\
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M6XC89C#RB+;&[C& 01D@$]<>&^&/VI/BYXWNK/1]&UO^T/&%U?RVAT:/PU9
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M4O@?0;S5-'LAIMAXFG:W;5K6W5=J@'S_ "V=5X61E+#KUYK]>?\ AT-\'?\
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MV-[9PZ;9VI7YU$9E+F5G .\MT %?N+_PZ&^#O_/KXC_\&K?X4?\ #H;X._\
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M5_ANWA76_#ML=/O(TM]3N[1K*#4-3@!&8Y)?-(^8#G:!GOW%?M%_PZ&^#O\
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M(E:?2K5V.YGB1B?4D"F+J6****0PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
%BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>vyne-20211231_g2.jpg
<TEXT>
begin 644 vyne-20211231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M*HPPGU:G+F9Z[1117Y2?(A1110 4444 %%%% !11FB@ HHHH **** "BBB@
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M=1_G?]?,N.&GV1\\KX9OMV[S+Q?XOO/4BZ;J5NNY+J^C_P"VKK7T+_PB=_\
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M1I/^63.%8'TKNU.X;E->=4HU*;M-6.N%2,E>+)****@L**** "BBB@ HHHH
M**** /QQ_P"#@O\ ;7UW4_C#'\&M&OKK3] T.VAN];CBDV?VC<RA98T?#<QH
MAC8*?XFW?PK7PGXI_9LUCPE^S[H?Q'FU3PU=:1KNI/I:6EEJ*W5]:RK%YO\
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M=JL3C'SQ$'8P8 [DV]*X\TXDH5J4Z$4TSCSKC##5Z-3#4TXO74[W]O+Q'?\
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M4UY9XAZ91110 4444 (J[:6BO#/VNOVT_#_[,OAR8S7$<^L2#;# GS-N]/\
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M.&SC&Y?FK8CMUB3:J[:D6.LRBO#9K&/E7;4\<-3+'3TCH A6&G_9_K4NRG4
M1>2:7R*F\IJ/+H A\BG>74WDT>30!#Y='EU-Y-'DT 5_(H\BK'DTGE?6@"LU
MOFD^S_6K/EUR_P :/BUH_P !_A?K7BW7I6ATO0[=IY=B[FD;[J(O^T\C*J_[
M35I1I2J5(TZ:NY%1C*<N6)N-#3&AK\@/CA_P5L^+7Q0\47%QH>L?\(9H^_\
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MN+E%\QK.9?FBG3_:5E5O]I=R_=:NK)Z_U''TJV(7NIE85RP^)A.JK69^5?\
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M*5)57[-M5E6&)?E&UMOS!MS9[RX^,?A"S^U>=XJ\-P_8PC7&[4X5\C?]S?\
M-\N[^'/WJMZ)\1?#_B2UO+C3M<T?4+?3^;J6WO8I4M>OWRI^3HWWO[IH \LU
M?]C32_%^OZ_J6H:IK-A/J6LQZA;/IEPJ/#$MI+ \3;XRNV9[F[EE15VLTV.?
MFW6/^&)_#AT:2QCUCQ##;M=)>JL/V2)89U:?YT5;?:ORW$B;,;%7;M567=7H
M&E_&+PCJVH6EK:>*/#MQ=7R-);11:C"\EPBEU+( WS+F*3I_SS;^Z:E\ _$S
M1?B2NIOH6H6^J6^DW@L9KBWD$L+2>1%/\CK\K#9,G(_BR.U ')?!S]F32/@E
MKL%UINJ:Q=QVEA-IUK;7/V98;6.6X^TOL$4*-\TN[JVU<X %>H=**J:SK-OH
M&ES7EU(L-M;IO=ST44;Z(#A_VBOCKI?[/OPZNM8U"41LL;F%2-V2!G./05^-
MWQR^,^L?M)_$RYUK5)I)(V9EMX_O*J>O^UN^]\WS+]VO5?\ @HM^U?>?M!?%
M.ZT.SF;^Q-)FV[!_$ZG@?\!^;YE^5MW^S7!?"?P?;Z)I;:]?QK)'"VVUB?Y?
MM$O][_=7^]7TV%POL8<G7JSQJE9U)<W3H:7A?1;;X2^'?[2O/+759HO-B$GW
M;.+_ )ZM_M-_#_=J/X ZAK7Q4\276M*JQ^&_FBB2X1EN[B96^9VW?PUR=GH\
MW[4'Q"N[5YKR'1-+EWW5P$VKJ$OW=G\/RU]9?#?P'#IMC;6UO"L<-NBHB!?N
MJM>;C,5[67+'X4=N'H\L>:6YH>!_!?S)\E>L>&?"\=G&K%:A\)^&5M8U=EKJ
M(XZ\\Z CCJ:..B..IHXZ #R_W;54\-N]QH\;-;+:MN8>4/NK\U7XQ5;P_;S6
M_P!ICFN/M#+.S+\VYHPWW5H N1QU+''3HXZDH] &B.LGQI\0-'^'>EM>:Q?V
M]E"O]]OF;_=6O&OVEOVY-'^$5K<V.CR0WFI0LT4MPZLT%NZ_>5?[\G^RM?$7
MQ ^-'B3XR:Y)<7%Y>.LC?Z^5OWC?[B_=1:].AE\OBJZ?F=]/!V]ZKIY=?^ ?
M47QN_P""DR:7))9^&[>.W;[JSSKYDK?[J+]W_@5?-OC/XV>+/BIJ#375S=2*
MS??NW\QO^ HORI_X]5'P'\)[KQ%>,EG:R74WWG?=_P"A.U>]?#/]C>;4MDFJ
M3-C_ )Y6_P J_P#?5=_[NA_=_,[.94O[OY_U]Q\]_P#"+W&L/_IUS<7DC?-L
M+?+_ -\+\O\ "M==X8^!^K:Q&OV'1+IT9MJOY7EK_P!]-7V9X)_9ST7PK&GE
MV=NCK_'MW2?]]5W-CX5M;,?)"K?6N.IF$/L1OZG)+%TUM&_J?&>A_LC^)M0V
MJ]K9VJ?]-)?,_P#0:Z2S_8G\03;6>_T]/[NR)_\ XFOKE-/6+[J*O_ :D^S5
MC_:53[-ON(^O3Z)?<?)LG[#>L?>75+?=[V[51N/V*_$5KN\NZTM_O-S$Z_\
MLM?8'V1J/LU']I5O+[D/Z]4\ON1\,ZY^ROXLT^-MVE0W*1_\\)EW,O\ =Q_P
M'_T*N#\3?">YT>39J&E7EJZC<WG0-_-:_1Y[)7^\BM_P&L_4O"=GJ492:WC9
M6^\-ORU<<R_GB'UQ/XXKY:'YLII]_IZ;K.\DDCW?<E_>K_X]\W_?-=W\-?VM
M?&'PGD15NKC[,OWHI6:YMF_X"WS)V^[NKZC\>?LG^'?%BR.EFMK,W_+2W_=M
M7@_Q(_9'USPSYCV.W5;?T*^7/_\ 95VT\72J*U_DSJIUX25H2^3V_P OR/=O
M@S^WAX=^($<=OK2QZ3=2?*LH?S+:3_@7\->Z6=Y#?VL<UO)'-#(NY75MRM7Y
M6ZGX3FT?5)5A6:QO(_OQ%=K-_O+]UONUZ%\#_P!KWQ%\%M02&2YW6LC?/;S[
MFM9OO-\O\43,S?[NU:RQ&!C+X-'^!%3#0D^7X7^ O_!<3XN:E;^&])\!ZAHK
M)9W6J0:]I&L0O^ZN(HH)X+BWE5A\LJ23(VY=RM'*OW6^]]+_ +,_Q4\0_'+]
MDFX\06NE-H$=QI;VOAQ)%:6ZF6*#REN'5&7[\JMM1&^ZJ_/\WRX/QT^'?@[_
M (*;?!>ST2&_72M<TG4;>]0R)^_M5W*MPJ_WE>)GV_P[E1F^[7T9X;\,V/@W
MPW8:/IMM':Z;I=NEK:P)]V&)%545?]U56M\9C*4<%3H<MIIN_P#7F>UC,RP\
M<LH854[5(-W_  U^?^9\/?L^_&CQ-\5/AE\"O!=_JG@?QL_C1M5EU*\U_39=
M7GTN6P2">))5:Y^>Y_>M\[,FU7B;;\GSSZ/_ ,%--?UC6_'4-@GA_5;/0_"6
MIZ]ILKZ7]CE6XM;CREBN(5U">18V7YOG\B1OE;8JLK5]R21U#)'6/]J49-N=
M+\?-OMZ+Y'++/,-*3<Z&_GW;?;M9?+S/CBU_;D\?Q^#?&;74?P]_MC0?^$<G
MM[F=UTRS6+4[?[3,K+=7B+++%&K*J_:8O,^]\OW:Y+3_ -J)KCXR3?%&XN=C
M0_"*:Z\\>'VV_)KCQ+MLEO'W*V%_Y>MK*V_>J_=^\#'3&CJ8YI15[4M_/RUZ
M"AG6&C>U"U_/R5^G6USX$\2?MF>,_BQ\.]'U3_A(-!\+IX=^*%CI%[JEHK+I
M]Q9/$SJ]UY-\\30;MWFHMRT<GR?.NWYM+5/VF]:T76/$-NC^'[&QN/B#-H,_
MB'4Y[RZTS3X%M4E65DEN]J;V.U426*)?[M?<<D=021U4LTHOW?9:>O\ P"I9
MYAG'E]@K>O\ P/ST/S@^('[57C2Z\)Z?J4>C^']->3P6WBBZBN[6>3[1MO5M
M5:+]ZNV*5625-V[Y77YFKU.2SCU3P_"EY&R6-]$LZ_-N:U=E5MRM_P"A?[-?
M5/BSPVMY;EE%>1>./"/^L^2LY9E"Z=&GR?JNQX^:8C#8J"A2I<EK_P!?(^7?
M&WA&Y\*ZPRM\LT+;XI$^[(O\+K_LM7WI_P $U_VS?^$^T=?".O7&-3L\+'(Y
MZ_IM56_A%?+OBCPNNN6;:;-\MQ'N:RD/][^XW^RW]YONUY;I.M:A\,/&EMJU
MBTD-UI\N[ ^5O]I?_LJ[W&%:E;[+_!GS*YX3\U^)^WZCY:.M>3_LB?M#6?[0
M?PMM=0B;_2X4"3IGYOK7JZ_**^8K494IN$SV:=13CS(=1116984444 &T'M1
MC%%% &/J5[<6GB;385\QK6Z69) L&Y0X"LC%]WR_*'&-K;L]MM;%<[X\MMUE
M8WACW2:;?0W"L((Y&1=VQRN\KL^1VRRG=MW8W?=/14 8/C_P9!\0_"-]HMW-
M=6L-\@!EMF02Q[6# KO5EW9 ^\I%>:^+_P!EOPMJ$VEV>I>(->BDU#6;N]AB
M>6V*ZA>SXNGRC0E=Z+;.R,JJR*TN&YKO?C)\.1\6OAU?: ;K[&E\\#/+Y7F?
M+',DI7;D9W!-O7O7AWCC]@2&_P#%DVJ0>,4T.SDNKD6\<>G^6T*7$$MK%:[U
MF6-HD\Y41/+SY:B)=NXM0!VP_8K\/0Q:6MMKGBJQDTFUL+2":UN;=)]EG"T$
M1\WR?,5FC9M^QEW9K0_X9/T4Z)-IMQK7B*ZL?^$=OO"]K%(UJ/L-E=^1O5'6
M$,S+]G3:92_?.[->:W_[#WV6;2[:\\8:7\T5QIMBCZ--&2)4O97@79=KN3]\
M\NQ]VUH?EVH?+KHOA)^RVW@GXC:7XF;Q;9ZU_9*/:M'%I:6P4K'+ T2-%+LC
M16+,8V1OWBNQ^=MRA5FS0^'O['T/A[P;I]KJGB'6+C5;5(X7GMOLZQK"B7J+
M @:'_5[;^XY;=)DK\_RU<\,?L=>'?#']AQQZKXBN+?PS.D^FQ3R6^+?;<K=.
MN5A5F5Y55FW$XZ+LKC_#_P"QZ=9\3W&K:]=:6L<GB6]U.73HM.$D>I6[:A?3
MQ+=,TK+,_E7"*K%5\M59-K?P]]\&?V?5^&=F\=QJC7GS6CH-/2;3(Y'MT9?.
MG5)F\Z:7=^]9OEDV)N3Y: LP\5_#+PO8_ /0=)N/$6IZ=X=\-Z?%:V.K6EVB
MW+(UF]C$XD5-K.R3?+L7YG9>"/E.%X%_9>\*:EX%5O#OBC7/[%UFW8/):+9>
M7=?Z1=3HX7[-MC9);F7;Y81?E4,K?-NR/ O[ NG>%;/38[_5[/6OL:11W37.
MD#_3DCETN10X,C< :=*J[MVW[8_HWF5?"/[ 9\/ZAYE_XFL]6M=EI T+Z+L\
MZ""]L+KRI?WS)(K?8G3+1[E6Y/S%4"D)._E_9:T>[\3:;J5QK'B"[;2=1?5+
M2)VMUCAFENH[J8_+"&8231JQW,=OW4V+\M6_#_P*TOX?>#/%UB/$GB*WL?$4
M4SW$[WD5L-(WH_F2VWEQI';M\Y?=M^\H/:O-I/\ @GGI;6$-O_:VGA8?#SZ,
M/^),G_'TUTD_V_\ UG^M5$\K^]M_C_AJWXD_873Q#K=Y(VMZ:FG&WU"VL+0Z
M'\NGQ72WN(ALG57B1[L/M=,[H%V-'NX -:']A#PC;Z5J%FU]K[0ZD8FF"R6\
M/^K6\486.%57/VZ;=M'\*?[6[T3X9_#2/X:0ZMLU34M7N=:O5O;BXO5@5]ZV
M\%N%"PQQ1JHCMX^ OK7G%U^QXFIZY=75YJNFR6=Y/;2S6Z:+CSDBO-/N#;R%
MIF#P*MD88DV_NXYR/GV_-T_P1^$$WPV\2>*KN13#97UZ8='L_D*:?8*SS[!L
M&%W7-Q<N!_#&8D_@% 'I1;-?&O\ P58_:R_X5CX _P"$6TBXVZMJAVDHWS+_
M /L_Q#WKZP^('C.S^'_@^^UB]D6*VL8C*Y-?BC^TA\7+S]H#XW:KK5S(S0M.
MT4'S;EV*WWO[K?[W]W;7JY70O>O+IMZG#C*O_+M=3#^$_@.3Q=KB1,VR%?WM
MQ._W847YF9F_AK=^,'B;5/$'B31/#_ANW;]\^R*,JNV&U5MKLR_WF_BVUU7A
M_0_^$1\'V]@B[-0UA5GNO[T,/\"?WEW?>9?[M=YX!\)KNC=D5G7Y5.WYJZ<?
M7Y8^RC\S'"T^9^TE\C9^$OPWMO#>DVUC:PK'#"NWC^+_ &J]V\#^%UCC1F7Y
M:YWP#X5^Y\M>H:?:"SMU1:\>1Z!-#&L:JJKQ5B..FQ1U8C7%2 JKMI\4=$8J
M:..@!T<=9Z?9=+\5,FR1;G4HM^?^6;;/_9OFK55=M5]8CNULUDLTCDN(Y%;8
M_P#$F[YEW?P_+0!:;;'&SN=B1KN8G[JBOD+]M#]N>/2[.;0_#MPPM9-T3W$#
M?O;YMO2)OX8_[S_Q?,M:G[>7[7D/A/3[GPWI-TW[E]E[)!+MDN'V_+;I_L_=
MW,M?$NAZ/>>,-86\O%\R>3:BHB_*J_PHB_P_Y:O:P>$Y+3DM7M_F>IA</[.T
MK7D_P\R2WM;_ ,=:HMY?G=\W[J)%_=0K_=5?\M7J6C?#G3? ?A^/6/%$DEG8
MLRK%:1+NN+C<VW[O]WYOF_V:Z3X9^#-+\&^(=%L+YEF\0:Y+]GLXD3S5LV96
M97E5?X=WWFKW_P""O['MMX3\8/XL\57]QXB\2S0>0J3[6M;-/[L2?=__ &JC
M$8[E?+3>O?\ R%6Q2B_W;N^_^1YQ\+?AAX[^+D<+:7;_ /"NO"6R*>WN/*5K
MRZVNVY67^%67;\U?5VF:2MG;HB+]U=K';][_ &JMV]OM_AVK_#5F.&O)E*4O
M>D>;?F^(ACMZDCM_]FK4=O4T=O2$4UMZ=]CJ\+=C3OLM %'['_G--^QUI?8Z
M;]EH SOL_P!:BDM_]FM0V["HY+?_ &: ,F2W6JMYIJ7$95TW+6U);U7DAH \
MA^+?[.>D_$"S=I+9?.7YDE1=LD;?[U?)OQD^!5_\/WD^U0R7-A\VVX";MOR_
M==:_0>2WKF_&G@6U\4:?)%)'&WF+M8%?E:NS#XR5/W9:HZJ.*<5R3U7];'YV
M>#?'>K?"/Q!;7EK>7BPVK[HGC?\ >6_S;OE_O)_>6OOK]F?]J"P^.6CQVMTT
M-MKT<2NR;E\N\7^^G_LR_P -?+'[0?[/,W@6\FO+6.23369F>/;N:U_W?]FO
M*/!OBR_^$?BBVO+6XFMH%E257C_UENW\+K_L_P!Y?XJ]:I3A7@M=.C['?*,)
MP2D[QZ/M_7_#'ZJ/'MJ,QUPO[-_QTMOCGX'CN':.+5K556\B1]R_[+JW\2M7
M?21UX-2FZ<W!GE5*<J<N1E>2.J\L=7F7-0R1UF9E1EW5!)'5J05'(N: *,T>
M[Y6^[7'^-/#"S1EE7=7;2QU5O+-;N%D:@#YK\?>%_+#,J[?[M>6_%#PS_;&G
MMJB+_I$>U+P?WO[K_P#Q5?37Q \*YW_+7C_B#2UTN\=I%WVLP:*=-OWD:O2R
M_$<K]E/9G+BJ=X\ZW1B?L*_M%7'[/OQ<AM9G;^R-5E"R)N_C^[_E:_6'2]1A
MU;3X;J!M\-P@=#Z@U^)_Q \+R>&]8DCB?YH6WQ2H?O+V;<M?H]_P3;_:-7XO
M?"R+2+R9?[2TE/+*;ANVKP?EW%L?[U=&88?FI\W6/Y&&#J<L^7HSZ<HHHKP3
MU0HHHH **** ,[Q+IW]LZ#?6I19/M$+H%>))%W8X^5_E;G^]Q47A;5O[<\.6
M-X3N:XA1F_>(YW8Y4LAV%LY^[Q6F\NT5QWA36(K&+4]/\R/?IM[*NP3Q,T:2
M-YJ;E0+L^5_E5OFV@,=WWJ"HTV]BU\5O"3?$3P->:*MXMBUVT3"1HO.C8)*C
MF.6/<N^)]NQTW#<CLN>:\8M_V6)I=8\0?;IM AL/M=E<:-:KI:MIMNZRVUQ=
MNEIYOR).UM"FUI=RLLK#Y7VUZKXA\<)9JS,]<'XB^+"1[OWG_CU<]3$1B>OA
M<IJUMD<OKG[,'F:?J$/_  EK6SWEP+C[1;6'ESS%5OUW7#>:WG2/]NVRO\GF
M1Q;?EW;EX^X_9=ALXM;=O%4<.I:QJ%]>?:[/2_(DM8KJWO(FM4_>LRQ+)<H^
MW=_RP7^+YEWO$GQD5=VV3_QZN!USXN.TC?/_ ./5PU,<CZK \+SE\1U_P?\
M@VWPS^(>DZVOB+3[F/2X)K;[.FDLOF([3OM1Y9I?)VR3,W[I5W?,K?*U?1>@
M^,DNROSU\<Z;\5G\Y?WE>I_#OXD-<2)NDHHXR\AYAPS*G"Y].6-\MQ'5M!FN
M*\%^(%O+=?GKK[:?>BUZ5.7,?"8B@Z<K,L4445H<P5&Z_/\ >J2F_P#+7\*
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MW[QJPKSQ ['<S[?JU<';_'#PW=SLC:I#"VS>OG;HU;_=W?Q5X-^U!^T!I?Q
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MS2R;*\-3HS^);=5_PY](_L&:0_G:A??O$MY%\A$^SMY<A7:V[?\ PM\WW?\
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MC_XI_4(8Y!#N\Z:W4Q[]^_(5V_U>U<^N\;<X-;%Q=1V-O)+*Z1QQJ7=V.U5
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M5F;E5QC%=#169T&/IOA'3=(*M#90+,NS]X1ODW)%Y2L7;YF;R_EW==M;%%%
M!1110 5D^(?$D'AR!?,5YKBXW_9[6%E\^Z95+%4#,NYMH]:JZOXBN);]M/TF
M&&ZO(S_I$DC+Y5I]QML@!W[G1FV[5/3FK7A[PS%X?,LGF375Y<8$]U-M\V?;
MG9NV@+PIQ\JT 54\/W>LW?G:I(OV>-]T-G!(VSY7?:[G"LVY&7<C97*]Z/'W
MP_M?'W@NYT.::\L+6X0)OLI?(EC _N,/NUT%% 'C^D_L+?#/3H,7'A_^UYOX
MKB_N))IF^IR*L:I^Q'\+]2MW1?"EE;2,/EE@=TDC]P=U>L9S1F@#P=?@3\0/
M@HCMX"\2?V]I:MN_L;7V\QE]HKC[R_\  OE_V:L>#?VO-+36UT7QMI.H>!M;
M^5 M\-UM,W^Q+C;7N&:Q/&7@#1?B'I$EAK6FV>I6LBX\N>/=CZ'M^% &=\3]
M9\GX/Z_?:;,&=--GF@DA.[)V$@BOP(\<?%2VU3X7ZY:ZE'OU"^O9;CS=O[]9
MMWRLO_Q-?M'J/[+?B;X5233_  U\221V4GW]"U=C/9R#NJG^&OSG^-'[#7C+
MX,?$OQ!XGF\ 2:A;ZM(\ZVZ;IH=/9F^9HF^[M;_:^:JCL3(^1/@CXD\7?%C3
MKS0Y))+&QM?^/JTC7RY+C_:?_9K[#_X)#R:AH?QZ\.VT+2*EGJEQIWR?\^_R
MMM_W5W-_WU7@_AOX9^/I/B(FK>'_  _<:+-N:">>XB9HV1OO*R+\S-_=K[@_
M8!^$?C#X+2S:AI?@'5-2U^2)XK*XO_W%K;B3[]P[?QR2?W?X56M-23]#/''Q
M T?X:^'Y=3US4+?3[&$<R2OMS[#U->'W'B_QQ^US.;?PZMYX+\"LQ2?5)TVW
MVH)Z1+_"K5M>#?V4KKQ9XBB\2?$[5#XHU:-M\%@!MT^QYXVI_$U>VV]M':0K
M'&JQQQC"JHVJHK$T.5^$?P4\._!30ELM"L5AW#]]</\ //<-_>=^]=?11G%
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MTLBL>B_E05^F/I6;QT&FO9K\.UNWS,GFE-IKV4=?)=K::?/\CX"T:;XX>./
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M'1T4"BN0\\*,444 &**** #%&*** "C%%% !BC%%% !BC%%% !1110 4444
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M?V:_ -]\#M4\/^(;R/1].U!8XK[77DMK6^D/VQ;K!F9-@#3_ ,&W;\V%4<4
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MDZA93I9:"^FW"JMFL0U#<^IRK+)_H7SMMDK]9** /C.;3_BWX7G^,/Q<\-_
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? %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122009880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 02, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VYNE THERAPEUTICS INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-3757789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">520 U.S. Highway 22, Suite 204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bridgewater<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">775-7936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VYNE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,165,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001566044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125906344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Florham Park, NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122222776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 42,250<span></span>
</td>
<td class="nump">$ 57,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">605<span></span>
</td>
<td class="nump">855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities (Note 6)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivable, net of allowances</a></td>
<td class="nump">7,583<span></span>
</td>
<td class="nump">15,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory (Note 7)</a></td>
<td class="nump">7,291<span></span>
</td>
<td class="nump">7,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other expenses</a></td>
<td class="nump">5,119<span></span>
</td>
<td class="nump">4,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_OperatingLeaseRightOfUseAssetCurrent', window );">Operating lease right of use assets (Note 10)</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">63,186<span></span>
</td>
<td class="nump">87,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net (Note 8)</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets (Note 10)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Prepaid and other expenses</a></td>
<td class="nump">3,506<span></span>
</td>
<td class="nump">4,345<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total&#160; Non-current Assets</a></td>
<td class="nump">3,860<span></span>
</td>
<td class="nump">6,483<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total&#160; Assets</a></td>
<td class="nump">67,046<span></span>
</td>
<td class="nump">93,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="nump">6,510<span></span>
</td>
<td class="nump">4,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities, Current</a></td>
<td class="nump">8,593<span></span>
</td>
<td class="nump">11,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee-related obligations</a></td>
<td class="nump">2,752<span></span>
</td>
<td class="nump">4,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits', window );">Liability for employee severance benefits</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (Note10)</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">18,410<span></span>
</td>
<td class="nump">21,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities (Note 10)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">853<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt (Note 13)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">33,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">457<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-term Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,484<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">18,410<span></span>
</td>
<td class="nump">56,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 12)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock: $0.0001 par value; 20,000,000 shares authorized at December&#160;31, 2021 and December&#160;31, 2020, respectively; no shares issued and outstanding at December&#160;31, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $0.0001 par value; 150,000,000 shares and 75,000,000 shares authorized at December&#160;31, 2021 and December&#160;31, 2020, respectively; 53,577,744 and 43,205,221 shares issued and outstanding at December&#160;31, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">688,156<span></span>
</td>
<td class="nump">603,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(639,525)<span></span>
</td>
<td class="num">(566,196)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Equity</a></td>
<td class="nump">48,636<span></span>
</td>
<td class="nump">37,493<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">$ 67,046<span></span>
</td>
<td class="nump">$ 93,742<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability for amount due employees, in addition to wages and any other money that employers owe employees, when their employment ends through a layoff or other termination. For example, a company may provide involuntarily terminated employees with a lump sum payment equal to one week's salary for every year of employment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_OperatingLeaseRightOfUseAssetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right of Use Asset, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_OperatingLeaseRightOfUseAssetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790124819784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">53,577,744<span></span>
</td>
<td class="nump">43,205,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">53,577,744<span></span>
</td>
<td class="nump">43,205,221<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122226408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">$ 14,755,000<span></span>
</td>
<td class="nump">$ 20,993,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">3,348,000<span></span>
</td>
<td class="nump">1,392,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">24,958,000<span></span>
</td>
<td class="nump">43,533,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">54,481,000<span></span>
</td>
<td class="nump">89,543,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and in-process research &amp; development impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">54,345,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ContingentStockConsiderationRemeasurementGainLoss', window );">Contingent Stock Remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">84,726,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">79,439,000<span></span>
</td>
<td class="nump">272,147,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Loss</a></td>
<td class="nump">68,032,000<span></span>
</td>
<td class="nump">252,546,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">5,610,000<span></span>
</td>
<td class="nump">4,390,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">135,000<span></span>
</td>
<td class="num">(1,110,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss Before Income Tax</a></td>
<td class="nump">73,777,000<span></span>
</td>
<td class="nump">255,826,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax (Benefit) Expense (Note 16)</a></td>
<td class="num">(448,000)<span></span>
</td>
<td class="num">(258,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="nump">$ 73,329,000<span></span>
</td>
<td class="nump">$ 255,568,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per share basic (in dollars per share)</a></td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="nump">$ 7.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per share diluted (in dollars per share)</a></td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="nump">$ 7.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic (in shares)</a></td>
<td class="nump">51,469<span></span>
</td>
<td class="nump">32,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted (in shares)</a></td>
<td class="nump">51,469<span></span>
</td>
<td class="nump">32,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">$ 13,824,000<span></span>
</td>
<td class="nump">$ 10,202,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">License revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Revenues</a></td>
<td class="nump">$ 931,000<span></span>
</td>
<td class="nump">$ 791,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ContingentStockConsiderationRemeasurementGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Stock Consideration, Remeasurement Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ContingentStockConsiderationRemeasurementGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121963528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="nump">$ 73,329<span></span>
</td>
<td class="nump">$ 255,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized gains from marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Losses on marketable securities reclassified into net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total Other Comprehensive Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total Comprehensive Loss</a></td>
<td class="nump">$ 73,329<span></span>
</td>
<td class="nump">$ 255,573<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122920824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,120,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 17,575<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 328,156<span></span>
</td>
<td class="num">$ (310,587)<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">(255,573)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(255,568)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Exercise of options, vesting of restricted stock units and shares under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">367,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Exercise of options, vesting of restricted stock units and shares issued under employee stock purchase plan</a></td>
<td class="nump">554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Stock-based compensation</a></td>
<td class="nump">18,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification', window );">Deemed dividend to warrants holders due to warrant modification</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment', window );">Classification of stock awards to derivative liability</a></td>
<td class="num">(975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,951,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">61,642<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">61,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of stock related to merger (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,765,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock related to merger</a></td>
<td class="nump">$ 196,170<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">196,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2020</a></td>
<td class="nump">43,205,221<span></span>
</td>
<td class="nump">43,205,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 37,493<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">603,685<span></span>
</td>
<td class="num">(566,196)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">(73,329)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,329)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Exercise of options, vesting of restricted stock units and shares under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">364,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Exercise of options, vesting of restricted stock units and shares issued under employee stock purchase plan</a></td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Stock-based compensation</a></td>
<td class="nump">8,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,007,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">$ 75,982<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">75,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (shares) at Dec. 31, 2021</a></td>
<td class="nump">53,577,744<span></span>
</td>
<td class="nump">53,577,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 48,636<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 688,156<span></span>
</td>
<td class="num">$ (639,525)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from modification of warrants that is deemed dividend</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The excess of the fair value of the modified award over the fair value of the award immediately before the modification pertaining grantees not employed or providing services after the modification and reclassified from additional paid-in capital to derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125415816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of stock issuance costs</a></td>
<td class="nump">$ 4,215<span></span>
</td>
<td class="nump">$ 4,151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122940648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (73,329,000)<span></span>
</td>
<td class="num">$ (255,568,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">109,000<span></span>
</td>
<td class="nump">341,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and in-process research &amp; development impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">54,345,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ContingentStockConsiderationRemeasurementGainLoss', window );">Contingent stock right remeasurement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">84,726,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_GainLossOnSaleAndDispositionOfFixedAssets', window );">Loss from sale and disposal of fixed assets</a></td>
<td class="nump">93,000<span></span>
</td>
<td class="nump">2,101,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Changes in marketable securities and bank deposits, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(142,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Debt prepayment premium</a></td>
<td class="nump">1,432,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">8,080,000<span></span>
</td>
<td class="nump">18,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Non-cash other expense (income), net</a></td>
<td class="nump">2,472,000<span></span>
</td>
<td class="num">(654,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating asset and liabilities, net of effects of businesses acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Decrease (increase) in trade receivables, prepaid and other assets</a></td>
<td class="nump">7,709,000<span></span>
</td>
<td class="num">(17,138,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Decrease (increase) in other non-current assets</a></td>
<td class="nump">841,000<span></span>
</td>
<td class="num">(4,171,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">(Decrease) in accounts payable and accruals</a></td>
<td class="num">(2,675,000)<span></span>
</td>
<td class="num">(12,975,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">(Decrease) increase in inventory</a></td>
<td class="nump">113,000<span></span>
</td>
<td class="num">(6,048,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Decrease (increase) in other liabilities</a></td>
<td class="num">(1,212,000)<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(56,367,000)<span></span>
</td>
<td class="num">(137,082,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of fixed assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(113,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired through merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">38,641,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale and maturity of marketable securities and bank deposits</a></td>
<td class="nump">1,027,000<span></span>
</td>
<td class="nump">50,579,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">1,027,000<span></span>
</td>
<td class="nump">89,107,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Debt repayment (Note 13)</a></td>
<td class="num">(36,432,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of options and issuance of shares under the employee shares purchase plan</a></td>
<td class="nump">522,000<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Withholding tax from net exercise of restricted share units</a></td>
<td class="num">(294,000)<span></span>
</td>
<td class="num">(141,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of issuance costs</a></td>
<td class="nump">75,981,000<span></span>
</td>
<td class="nump">61,639,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">39,777,000<span></span>
</td>
<td class="nump">61,808,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">(Decrease) Increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(15,563,000)<span></span>
</td>
<td class="nump">13,833,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate on cash, cash equivalents and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of the year</a></td>
<td class="nump">58,418,000<span></span>
</td>
<td class="nump">44,584,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of the year</a></td>
<td class="nump">42,855,000<span></span>
</td>
<td class="nump">58,418,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">42,250,000<span></span>
</td>
<td class="nump">57,563,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">605,000<span></span>
</td>
<td class="nump">855,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash shown in statement of cash flows</a></td>
<td class="nump">42,855,000<span></span>
</td>
<td class="nump">58,418,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplementary information on investing and financing activities not involving cash flows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of shares under employee share purchase plan</a></td>
<td class="nump">169,000<span></span>
</td>
<td class="nump">387,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Additions to operating lease right of use assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsIncurred', window );">Additions to operating lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_InterestReceived', window );">Interest received</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">2,385,000<span></span>
</td>
<td class="nump">3,941,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1', window );">Fair value of assets acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">117,270,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1', window );">Less liabilities assumed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,827,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1', window );">Net acquired (See &#8220;Note 3- Business combination&#8221;)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">111,443,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_NonCashAcquisitionOfBusinessCashAcquired', window );">Less cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">38,641,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired', window );">Merger net of cash acquired</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 72,802,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in lease obligation from new lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ContingentStockConsiderationRemeasurementGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Stock Consideration, Remeasurement Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ContingentStockConsiderationRemeasurementGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_GainLossOnSaleAndDispositionOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Sale and Disposition of Fixed Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_GainLossOnSaleAndDispositionOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_InterestReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_InterestReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_NonCashAcquisitionOfBusinessCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as part of a non-cash business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_NonCashAcquisitionOfBusinessCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net assets acquired in non-cash acquisition, net of cash acquired included in the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125068072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">NATURE OF OPERATIONS</a></td>
<td class="text">NATURE OF OPERATIONS<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Company</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">VYNE Therapeutics Inc., ("VYNE" or the "Company") is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. The Company's most advanced product candidate, FMX114, which is in Phase 2a, is being evaluated for the potential treatment of mild-to-moderate AD.  The Company is also in the pre-clinical stages of developing products containing BET inhibitor compounds.  Its initial BET inhibitor candidate in development is VYN201, a locally administered pan-BET inhibitor, which the Company is exploring in various immuno-inflammatory diseases, including skin diseases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In addition, the Company continues to explore opportunistic transactions that may enhance its pipeline portfolio, as well as support its current operations and fund its future growth. The Company is a Delaware corporation, has its principal executive offices in Bridgewater, New Jersey and operates as&#160;one&#160;business segment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Strategic Business Review and Sale of the MST Franchise</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the second quarter of 2021, the Company conducted a review of its commercial and research and development portfolio to determine how to optimally deploy capital and drive shareholder value. During the course of this review, the Company carefully considered the revenues received from the commercialization of AMZEEQ and ZILXI and the associated costs to drive those revenues, the protracted negative impact of the COVID-19 pandemic during the commercial launches of both AMZEEQ and ZILXI, the payor landscape, as well as the costs to develop each of its pipeline products. During this process, the Company evaluated several strategic options including the acquisition of marketed assets, out-licensing its approved products outside of the United States, and possible partnering or co-development relationships with interested parties. Following its review, the Company determined to initiate a process to explore a possible sale or license of its topical minocycline franchise, including AMZEEQ, ZILXI, FCD105 (the Company&#8217;s former Phase 3 proprietary novel topical combination foam formulation of minocycline and adapalene for the treatment of moderate-to-severe acne vulgaris) and the underlying Molecule Stabilizing Technology platform.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 12, 2022, VYNE entered into an Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with Journey Medical Corporation (&#8221;Journey&#8221;) pursuant to which the Company sold its Molecule Stabilizing Technology franchise, including AMZEEQ, ZILXI, and FCD105 (the &#8220;MST Franchise&#8221;), to Journey. The assets include certain contracts, including the license agreement with Cutia Therapeutics (HK) Limited (&#8220;Cutia&#8221;), inventory and intellectual property related to the MST Franchise (together, the &#8220;Assets&#8221;). Pursuant to the Agreement, the Buyer assumed certain liabilities of the MST Franchise including, among others, those arising from VYNE&#8217;s patent infringement suit initiated against Padagis Israel Pharmaceuticals Ltd. There were no current or long-term liabilities recorded by the Company which were transferred to the Buyer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Pursuant to the Purchase Agreement, VYNE received an upfront payment of  $20.0&#160;million and will receive an additional $5.0&#160;million on the one-year anniversary of the closing of the transaction. VYNE is also eligible to receive sales milestone payments of up to  $450.0&#160;million in the aggregate upon the achievement of specified levels of net sales on a product-by-product basis, beginning with annual net sales exceeding $100.0 million (with products covered in three categories (1) AMZEEQ (and certain modifications), (2) ZILXI (and certain modifications), and (3) FCD105 and other products covered by the patents being transferred, including certain modifications). In addition, VYNE is entitled to receive certain payments from any licensing or sublicensing of the assets by Journey outside of the United States.  See Note 17 - Subsequent Events for additional discussion of the disposition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By leveraging its drug development and clinical development capabilities and strong network of discovery and preclinical science partners, the Company has transitioned its strategic focus to develop therapies for the treatment of immuno-inflammatory conditions. The Company expects to continue to invest in FMX114 for the treatment of mild to moderate atopic dermatitis and enrolled the first patient in its Phase 1b/2a proof-of-concept study in October 2021. On January 19, 2022, the Company announced findings from the Phase 1b safety portion of the Phase 1b/2a trial evaluating FMX 114. The findings support trial continuation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on August 12, 2021, the Company announced a transaction with In4Derm Limited, a company incorporated and registered in Scotland (&#8220;In4Derm&#8221;). In4Derm is a spin-out of the University of Dundee&#8217;s School of Life Sciences which has discovered and is developing proprietary Bromodomain and Extra-Terminal Domain ("BET") inhibitors for the treatment of immunology and oncology conditions. On April 30, 2021, the parties entered into an Evaluation and Option Agreement (the &#8220;Option Agreement&#8221;) pursuant to which In4Derm granted the Company an exclusive option to obtain exclusive worldwide </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rights to research, develop and commercialize products containing In4Derm&#8217;s BET inhibitor compounds, which are new chemical entities for treatments in all fields for any disease, disorder or condition in humans. On August 6, 2021, the parties entered into a License Agreement granting the Company a worldwide, exclusive license that is sublicensable through multiple tiers to exploit certain of In4Derm&#8217;s pan-BD BET inhibitor compounds in all fields. The Company paid a $1.0&#160;million cash payment to In4Derm upon the execution of the Option Agreement and $0.5&#160;million in connection with entering into the License Agreement. Pursuant to the License Agreement, the Company has agreed to make cash payments to In4Derm upon the achievement of specified clinical development and regulatory approval milestones with respect to each licensed topical product in the U.S. of up to $15.75&#160;million for all indications. In addition, the Company currently expects to exercise the Oral BETi Option following the selection of a lead candidate for the program. Upon exercise of the exclusive Oral BETi Option, the parties will sign a license agreement (the &#8220;Oral License Agreement&#8221;), and the Company will be required to pay In4Derm a $4.0&#160;million cash payment. The Oral License Agreement will include cash payments of up to $43.75&#160;million payable to In4Derm upon the achievement of specified clinical development and regulatory approval milestones with respect to each licensed oral product in the U.S. for all indications. The license agreements also provide for tiered royalty payments of up to 10% of net annual sales across licensed BET inhibitor products by the Company. In4Derm is entitled to additional milestones upon the achievement of regulatory approvals in certain jurisdictions outside the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial BET inhibitor candidates in development are VYN201 and VYN202. VYN201 is a pan-bromodomain or pan-BD BET inhibitor. It is a first-in-class &#8220;soft&#8221; pan-BD BET inhibitor that is being developed to address diseases involving multiple, diverse inflammatory cell signaling pathways.  With the VYN201 program, the Company is attempting to develop a therapy that is locally acting and is rapidly cleared through the body's metabolic process so as to avoid systemic absorption. The Company is continuing to evaluate VYN201 in a variety of preclinical models and will announce an initial indication for VYN201 following such evaluation. With respect to the VYN202 program, the Company is exploring multiple BET inhibitor compounds that are highly selective for bromodomain 2 ("BD2"). By selectively inhibiting BD2, the Company believes VYN202 could have a more targeted anti-inflammatory effect with an improved benefit/risk profile. The Company is diligently working with In4Derm to develop a lead molecule for the VYN202 program. Once a lead candidate has been selected, the Company intends to exercise its option with respect to these BET inhibitor compounds and commence an IND-enabling preclinical safety program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company transitioned from a commercial organization to one focused on research and development, the Company streamlined operations by eliminating the vast majority of planned expenditures supporting its commercial operations. Furthermore, following its decision to divest the MST franchise, the Company reduced its workforce by terminating approximately 70 employees. The Company incurred a one-time charge of $1.6&#160;million  in the year ended December 31, 2021 in connection with this restructuring plan, consisting of $1.4&#160;million of employee termination costs, including severance and other benefits, and retention payments of $0.2&#160;million.  Additional charges of $0.2 million related to retention payments are anticipated through June 30, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reverse stock split and recasting of per-share amounts </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 10, 2021, our Board of Directors approved a one-for-four reverse stock split of our outstanding shares of common stock. The reverse stock split was effected on February 12, 2021 at 5:00 p.m. Eastern time. At the effective time, every four issued and outstanding shares of our common stock were converted into one share of common stock. No fractional shares were issued in connection with the reverse stock split, and in lieu thereof, each stockholder holding fractional shares was entitled to receive a cash payment (without interest or deduction) from the Company&#8217;s transfer agent in an amount equal to such stockholder&#8217;s respective pro rata shares of the total net proceeds from the Company&#8217;s transfer agent sale of all fractional shares at the then-prevailing prices on the open market. In connection with the reverse stock split, the number of authorized shares of our common stock was also reduced on a one-for-four basis, from 300&#160;million shares to 75&#160;million shares. The par value of each share of common stock remained unchanged. A proportionate adjustment was also made to the maximum number of shares issuable under the Company&#8217;s 2019 Equity Incentive Plan, 2018 Omnibus Incentive Plan and 2019 Employee Share Purchase Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless noted, all common shares and per share amounts contained in the consolidated financial statements have been retroactively adjusted to reflect a 1-for-4 reverse stock split.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Reverse Merger</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2019, Menlo Therapeutics Inc. ("Menlo"), Foamix Pharmaceuticals Ltd. (&#8220;Foamix&#8221;) and Giants Merger Subsidiary Ltd. (&#8220;Merger Sub&#8221;), a wholly-owned subsidiary of Menlo, entered into an Agreement and Plan of Merger (as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated as of December 4, 2019, the &#8220;Merger Agreement&#8221;). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Foamix, with Foamix surviving as a wholly-owned subsidiary of Menlo (the &#8220;Merger&#8221;) on March 9, 2020 (the &#8220;Effective Date&#8221;). The combined Company changed its name to VYNE in September 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting purposes, the Merger is treated as a &#8220;reverse acquisition&#8221; under generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;) and Foamix is considered the accounting acquirer. Accordingly, upon consummation of the Merger, the historical financial statements of Foamix became the Company&#8217;s historical financial statements, and the historical financial statements of Foamix are included in the comparative prior periods. See &#8220;Note 3 &#8211; Business Combination&#8221; for more information on the Merger.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Serlopitant</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was developing serlopitant, a small molecule inhibitor of the neurokinin 1 receptor, or NK1-R, given as a once-daily, oral tablet, for the treatment of pruritus, or itch, associated with various conditions including prurigo nodularis, or PN. On April 6, 2020, the Company announced top line results from two Phase III clinical trials evaluating the safety and efficacy of once-daily oral serlopitant for the treatment of pruritus (itch) associated with PN, studies MTI-105 and MTI-106. Neither study met their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based on a 4-point improvement responder analysis. The Company does not currently intend to further pursue the development of serlopitant. As a result, in the second quarter of 2020, the Company recorded a full impairment charge related to the IPR&amp;D and Goodwill assets in its unaudited condensed consolidated statement of operations and comprehensive loss. See "Note 3 - Business Combination" for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, the Company has funded operations primarily through private and public placements of its equity, debt and warrants and through fees, cost reimbursements and payments received from its licensees. The Company commenced generating product revenues related to sales of AMZEEQ and ZILXI&#160;in January 2020 and October 2020, respectively.  AMZEEQ and ZILXI were sold as part of the sale of the MST Franchise on January 12, 2022 and, as such, the Company will no longer be generating revenue from the sale of these products.  The Company has incurred losses and experienced negative operating cash flows since its inception and anticipates that it will continue to incur losses until such a time when its product candidates, if approved, are commercially successful, if at all. The Company will not generate any revenue from any current or future product candidates unless and until it obtains regulatory approval and commercializes such products.  For the year ended December&#160;31, 2021 the Company incurred a net loss of $73.3 million and used $56.4&#160;million of cash in operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had cash and cash equivalents of $42.9 million. The Company's cash and cash equivalents are held in money market accounts. The Company also received proceeds of $20.0&#160;million from the sale of the MST Franchise in January 2022 and will receive an additional payment of $5.0&#160;million on the one-year anniversary of the sale.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following the sale of the MST Franchise, the Company is refocusing its limited resources on its immuno-inflammatory pipeline and intends to support the FMX114 and the BET inhibitor development programs. Research and development activities for these programs, including preclinical and clinical testing of the Company's drug candidates, will require significant additional financing. The future viability of the Company and its ability to continue as a going concern is dependent on its ability to raise sufficient working capital through either debt or equity financings to fund our operations and successfully develop commercially viable drug candidates.  There is no assurance the Company will be able to achieve these objectives under acceptable terms or at all.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that its audited consolidated financial statements are issued. The accompanying audited consolidated financial statements have been prepared assuming that the Company will continue as a going concern and contemplate the realization of assets and the satisfaction of liabilities in the normal course of business. The Company's ability to continue as a going concern is expected </span></div>to be impacted by the outcome of the plans outlined above, including the Company's ability to raise additional capital to fund its operations, positive results from clinical trials for FMX114, and the successful development and positive results from clinical trials for the BET inhibitor programs. Based on its current plans and assumptions, the Company believes that absent sufficient proceeds received from equity transactions, financing transactions or business development transactions, the Company will not have sufficient cash and cash equivalents to fund its operations beyond one year from the issuance of these financial statements. Accordingly, the Company will, over the course of the next twelve months, require significant additional financing to continue its operations. In addition, the amount of proceeds the Company may be able to raise pursuant to its existing shelf registration statement on Form S-3 may be limited. As of the filing of this Annual Report on Form 10-K, the Company will be subject to the general instructions of Form S-3 known as the "baby shelf rules." Under these instructions, the amount of funds the Company can raise through primary public offerings of securities in any 12-month period using its registration statement on Form S-3 is limited to one-third of the aggregate market value of the shares of its common stock held by non-affiliates of the Company. Therefore, the Company will be limited in the amount of proceeds it is able to raise by selling shares of its common stock using its Form S-3 until such time as its public float exceeds $75 million. These factors raise substantial doubt about the Company's ability to continue as a going concern. Failure to successfully receive additional financing will require the Company to delay, scale back or otherwise modify its business and its research and development activities and other operations. The accompanying financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121176600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SIGNIFICANT ACCOUNTING POLICIES:<div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Basis of presentation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;).  Certain prior period amounts have been reclassified to conform to current year presentation.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Use of estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results may differ from those estimates.  Significant items subject to such estimates and assumptions include accounting for business combinations, impairments of goodwill and intangible assets and revenue recognition. Actual results could differ from the Company&#8217;s estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and government measures taken in response to the pandemic have had a negative impact on the Company's operations. Access to healthcare providers has been limited, which has negatively impacted sales and the Company's ability to execute its commercial strategy with respect to AMZEEQ and ZILXI. The length of time and extent to which the COVID-19 pandemic will directly or indirectly impact the Company's business, results of operations and financial condition and liquidity will depend on future developments that are highly uncertain, subject to change and will continue to evolve with geographical re-openings, surges in cases, the emergence of new strains and the vaccination effort. In addition, the Company further assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2021 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, inventory and related reserves, impairments of long-lived assets and revenue recognition. In 2020, the Company recorded impairments of goodwill and certain indefinite-lived intangible assets; however, these were unrelated to the impact of COVID-19 (See "Note 3 - Business Combination" for more information). The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Business Acquisition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated financial statements include the operations of an acquired business after the completion of the acquisition. The Company accounts for acquired businesses using the acquisition method of accounting, which requires, among </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other things, that most assets acquired and liabilities assumed be recognized at their estimated fair values as of the acquisition date and that the fair value of In-Process Research and Development and Goodwill be recorded on the balance sheet.&#160;Transaction costs are expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recorded in connection with an acquisition can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting.&#160; For example, the Company uses fair value in the initial recognition of net assets acquired in a business combination and when measuring impairment losses.&#160; The Company estimates fair value using an exit price approach, which requires, among other things, that Company determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of non-financial assets and, for liabilities, assuming that the risk of non-performance will be the same before and after the transfer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may use one or all of the following techniques:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost approach, which is based on the cost to acquire or construct comparable assets, less an allowance for functional and/or economic obsolescence.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fair value methodologies depend on the following types of inputs:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for identical assets or liabilities in active markets (Level 1 inputs).</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means (Level 2 inputs).</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unobservable inputs that reflect estimates and assumptions (Level 3 inputs).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A single estimate of fair value can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Foreign Currency Translation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions and balances originally denominated in dollars are presented at their original amounts. Balances in non-dollar currencies are translated into dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-dollar transactions and other items in the statements of operations (indicated below), the following exchange rates are used: (i) for transactions - exchange rates at transaction dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization, etc.) - historical exchange rates. Currency transaction gains and losses are presented in financial income or expenses, as appropriate.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Principles of consolidation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated upon consolidation.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt">Cash and cash equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers as cash equivalents all short-term, highly liquid investments, which include short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Marketable securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketable equity securities:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's marketable equity securities are recorded at fair value, with unrealized gains and losses included in other income, net in the consolidated statement of operations.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">h.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Inventory</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the date the Company obtains regulatory approval for its product candidates, inventory costs related to commercial production are expensed as research and development expense. Once regulatory approval is obtained, the Company capitalizes such costs as inventory. Inventories are stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first-out (&#8220;FIFO&#8221;) method. The Company periodically reviews its inventory levels and writes down inventory that is expected to expire prior to being sold, inventory in excess of expected sales requirements and inventory that fails to meet commercial sale specifications, with a corresponding charge to cost of goods sold.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.73pt">Property and equipment</span></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Property and equipment are stated at cost, net of accumulated depreciation and amortization.</span></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">The Company&#8217;s property and equipment are depreciated by the straight-line method on the basis of their estimated useful life.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual rates of depreciation are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 7 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 14 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 - 14 years</span></div></td></tr></table></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are amortized by the straight-line method over the expected lease term, which is shorter than the estimated useful life of the improvements.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">j.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt">Impairment of long-lived assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests long-lived assets for impairment whenever events or circumstances present an indication of impairment. If the sum of expected future cash flows (undiscounted and without interest charges) of the assets is less than the carrying amount of such assets, an impairment loss would be recognized. The assets would be written down to their estimated fair values, calculated based on the present value of expected future cash flows (discounted cash flows), or some other fair value measure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2021 and 2020, the Company did not recognize an impairment loss for its long-lived assets.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">k.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Goodwill and other indefinite lived intangible assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill and other intangibles that have indefinite lives for impairment annually as of the end of the fiscal year or when events or changes in circumstances indicate the carrying value of these assets might exceed their current fair values.  Impairment testing is based upon the best information available including estimates of fair value which incorporate assumptions market participants would use in making their estimates of fair value.  In 2020, the Company recorded full </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impairment charges related to its $4.5&#160;million of goodwill and $49.8&#160;million of IPR&amp;D (See "Note 3 - Business Combination" for more information).  No impairment was recorded in the years ended December&#160;31, 2021.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">l.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.73pt">Allowance for doubtful accounts</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An allowance for doubtful accounts is maintained for potential credit losses based on the aging of trade receivables, historical bad debts experience and changes in customer payment patterns. Trade receivable balances are written off against the allowance when it is deemed probable that the receivable will not be&#160;collected.&#160;Trade receivables, net are stated net of reserves for certain sales allowances and provisions for doubtful accounts. Provisions for doubtful accounts were not material for the years ended December&#160;31, 2021 and 2020.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">m.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.17pt">Debt</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt discounts created as a result of the allocation of proceeds received from a debt issuance to warrants issued are amortized to interest expense under the effective interest method over the life of the recognized debt liability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs include the costs of debt financings undertaken by the Company, including legal fees and other direct costs of the financing. Debt issuance costs related to a recognized debt liability are presented on the consolidated balance sheet as a direct deduction from the carrying amount of the debt liability and are amortized to interest expense over the term of the related debt, using the effective interest method.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">n.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. Lease expense for operating leases is recognized on a straight-line basis over the expected lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">o.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Contingencies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain conditions may exist as of the date of the financial statements, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company&#8217;s management assesses such contingent liabilities and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#8217;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management applies the guidance in ASC 450-20-25 when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability is recorded as accrued expenses in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material are disclosed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantees are disclosed.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">p.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Share-based compensation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for employees&#8217; and directors&#8217; share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period using the straight-line method. Forfeitures are recognized as they occur.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based payments related to the employee share purchase plan (&#8220;ESPP&#8221;) are recognized based on the fair value of each award estimated on the first day of the offering period and recognized as an expense over the offering period using the straight-line method.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to recognize compensation costs for awards conditioned only on continued service that have a graded vesting schedule using the straight-line method based on the multiple-option award approach.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">q.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Revenue recognition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its revenue transactions under FASB ASC Topic 606,&#160;Revenue from Contracts with Customers. In accordance with ASC Topic 606, the Company recognizes revenues when its customers obtain control of its product for an amount that reflects the consideration it expects to receive from its customers in exchange for that product. To determine revenue recognition for contracts that are determined to be in scope of ASC Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once the contract is determined to be within the scope of ASC Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when such performance obligation is satisfied.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers include a limited number of national and select regional wholesalers (the &#8220;distributors&#8221;) and certain independent and specialty pharmacies, together (the "customers"). These distributors subsequently resell the product, primarily to retail pharmacies that dispense the product to patients. Net product revenue is typically recognized when customers obtain control of the Company&#8217;s products, which occurs at a point in time, typically upon delivery of product to the customers. The Company evaluates the creditworthiness of its customers to determine whether it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur. The Company does not assess whether a contract has a significant financing component if the expectation is such that the period between the transfer of the promised goods to the customer and the receipt of payment will be less than one year. Standard credit terms do not exceed 75 days. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that would have been recognized is one year or less or the amount is immaterial. Shipping and handling costs related to the Company&#8217;s product sales are included in selling, general and administrative expenses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net product revenues through&#160;December&#160;31, 2021&#160;were generated through sales of AMZEEQ, which was approved by the FDA in October 2019 and was commercially launched in the United States in January 2020 and ZILXI, which was approved by the FDA in May 2020 and was commercially launched in the United States in October 2020. Product revenue is recorded net of distribution fees, trade discounts, allowances, rebates, copay program coupons, chargebacks, estimated returns and other incentives. These reserves are classified as either reductions of accounts receivable or as current liabilities. The estimates of reserves established for variable consideration reflect current contractual and statutory requirements, known market events and trends, industry data and forecasted customer mix. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net product revenues only to the extent that it is probable that a significant reversal of the amount of the cumulative revenues recognized will not occur in a future period. Actual amounts may ultimately differ from these estimates. If actual results vary, estimates may be adjusted in the period such change in estimate becomes known, which could have an impact on earnings in the period of adjustment. See &#8220;Note 4 &#8211; Revenue Recognition&#8221; for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2020, the Company announced that it entered into a license agreement with Cutia for our minocycline products and product candidate, if approved, on an exclusive basis in Greater China.  Under the terms of the agreement, Cutia will have an exclusive license to obtain regulatory approval of and commercialize AMZEEQ, ZILXI and, if approved in the U.S., FCD105 in the Greater China territory.  The Company will supply the finished licensed products to Cutia for clinical and commercial use.  The Company received an upfront cash payment of $10.0 million.  The license was determined to be a distinct performance obligation of the arrangement, therefore the Company recognized the revenues from the upfront license fee when the license is transferred to the licensee and the licensee is able to use and benefit from the license.  The disposition of the MST Franchise included the license agreement with Cutia including the rights to future revenues under that agreement.  See "Note 4 - Revenue Recognition" for more information.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">r.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt">Research and development costs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses include costs directly attributable to the conduct of research and development programs, including the cost of clinical trials, clinical trial supplies, salaries, share-based compensation expenses, payroll taxes and other employee benefits, lab expenses, consumable equipment and consulting fees. All costs associated with research and developments are expensed as incurred.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt">Income taxes:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deferred taxes</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is recognized to the extent that it is more likely than not that the deferred taxes will not be realized in the foreseeable future. Given the Company&#8217;s losses, the Company has provided a full valuation allowance with respect to its deferred tax assets.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Uncertainty in income tax</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows a two-step approach in recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the available evidence indicates that it is more likely than not that the position will be sustained based on technical merits. If this threshold is met, the second step is to measure the tax position as the largest amount that has more than a 50% likelihood of being realized upon ultimate settlement.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">t.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt">Loss per share</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the weighted-average number of common stock outstanding during the period in which the reverse merger occurs was based on:</span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">The number of common stock outstanding from the beginning of that period to the merger date was computed on the basis of the weighted-average number of common stock of the legal acquiree (accounting acquirer) outstanding during the period multiplied by the exchange ratio established in the merger agreement</span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">The number of common stock outstanding from the merger date to the end of that period was the actual number of common stock of the legal acquirer (the accounting acquiree) outstanding during that period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted, is computed on the basis of the net loss for the period divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share is based upon the weighted average number of common stock and of common stock equivalents outstanding when dilutive. Common stock equivalents include outstanding stock options and warrants which are included under the treasury share method when dilutive.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following stock options, restricted stock units (&#8220;RSUs&#8221;), warrants and incremental shares to be issued under the employee stock purchase plan (&#8220;ESPP&#8221;) were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented (share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding share options, RSUs and shares under ESPP</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,306,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,994,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">u.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt">Fair value measurement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is based on the price that would be received from the sale of an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows:</span></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1:&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2:&#160;&#160;&#160;&#160;Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.</span></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3&#160;&#160;&#160;&#160;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers counterparty credit risk in its assessment of fair value.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Concentration of credit risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, restricted cash, marketable securities and accounts receivables. The Company deposits cash and cash equivalents with highly rated financial institutions and, as a matter of policy, limits the amounts of credit exposure to any single financial institution. In addition, all marketable securities carry a high rating or are government insured. The Company has not experienced any material credit losses in these accounts and does not believe it is exposed to significant credit risk on these instruments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2021, the Company's three largest customers collectively represented 41% of product revenue and 58% of accounts receivable.  For the year ended December&#160;31, 2020, the Company's largest three customers collectively represented 96% of product revenue and 90% of accounts receivable.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">w.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt">Comprehensive loss</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss includes, in addition to net loss, unrealized holding gains and losses on available-for-sale debt securities and derivative instruments designated as cash flow hedge (net of related taxes where applicable). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification adjustments for gain or loss of available-for-sale securities are included in other income, net in the consolidated statement of operations.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">x.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Newly issued and recently adopted accounting pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Guidance Issued:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2020-4, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" (ASU 2020-4), which provides guidance to alleviate the burden in accounting for reference rate reform by allowing certain expedients and exceptions in applying generally accepted accounting principles to contracts, hedging relationships, and other transactions impacted by reference rate reform. The provisions of ASU 2020-4 apply only to those transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. Adoption of the provisions of ASU 2020-4 are optional and are effective from March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-4 on its consolidated financial statements.  Currently, the Company does not expect the adoption of the new standard to have a material impact to the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued Accounting Standards Update No. 2016-13,&#160;&#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#8221;&#160;(ASU 2016-13), which requires companies to measure credit losses of financial instruments, including customer accounts receivable, utilizing a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Subsequent to the issuance of ASU 2016-13, the FASB issued several additional Accounting Standard Updates to clarify implementation </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guidance, provide narrow-scope improvements and provide additional disclosure guidance. As a smaller reporting company, the Company will adopt ASU 2016-13 effective January 1, 2023 or at such time where it is no longer a smaller reporting company.  Currently, the Company does not expect the adoption of the new standard to have a material impact to the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the FASB issued Accounting Standards Update No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes," which clarifies and simplifies certain aspects of the accounting for income taxes.  The standard is effective for years beginning after December 15, 2020, and interim periods beginning after December 15, 2020.  This guidance became effective during the first quarter of 2021. The adoption of the new standard did not have a material impact to the Company's consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121118344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATION</a></td>
<td class="text">BUSINESS COMBINATION:<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2019, Menlo entered into the Merger Agreement with Foamix, and Merger Sub, a direct and wholly-owned Israeli subsidiary of Menlo. On March 9, 2020, the Merger was completed and Foamix is now a wholly-owned subsidiary of the Company. The combined Company changed its name to VYNE in September 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Effective Date, each ordinary share of Foamix was exchanged for 0.5924 shares of common stock of Menlo. In addition, on the Effective Date, Foamix shareholders received one contingent stock right (a &#8220;CSR&#8221;) for each Foamix ordinary share held by them. The CSRs were issued pursuant to the Contingent Stock Rights Agreement (the &#8220;CSR Agreement&#8221;), dated as of March 9, 2020, by and between Menlo and American Stock Transfer &amp; Trust Company, LLC, and represented the non-transferable contractual right to receive shares of common stock of Menlo depending on the results of Menlo&#8217;s phase III clinical trials evaluating the safety and efficacy of once daily oral serlopitant for the treatment of prurigo nodularis (the &#8220;Phase III PN Trials&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company announced that each of Menlo&#8217;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. Accordingly, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into 1.2082 additional shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of 1.8006 shares of Menlo common stock for each Foamix ordinary share.  The CSR conversion resulted in the issuance and delivery of 74,544,413 additional shares of Menlo common stock underlying the CSRs, adjusted retrospectively to 18,636,103 shares of common stock upon the reverse stock split effective February 12, 2021.  Following the conversion of the CSRs, pre-Merger Foamix shareholders and pre-Merger Menlo stockholders owned approximately 82% and 18% of post-Merger Menlo, respectively, each calculated on a fully diluted basis. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting purposes, the Merger is treated as a &#8220;reverse acquisition&#8221; under U.S. GAAP and Foamix is considered the accounting acquirer. Accordingly, upon consummation of the Merger, the historical financial statements of Foamix became the Company&#8217;s historical financial statements, and the historical financial statements of Foamix are included in the comparative prior periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under reverse acquisition accounting, the U.S. dollar amount for common stock in the financial statements is based on the value and number of shares issued by Menlo (reflecting the legal structure of Menlo as the legal acquirer) on the Merger date plus subsequent shares issued by the Company. The amounts in additional paid-in capital represent that of Foamix and include the fair value of shares deemed for accounting purposes to have been issued by Foamix on the merger date and the fair value of the Menlo equity awards included in the purchase price calculation. The Foamix additional paid-in capital was also adjusted for the difference between the number of common stock and the historical number of shares of Foamix&#8217;s ordinary shares.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company incurred transaction costs of approximately $11.7 million, which are recorded in the consolidated statements of operations and comprehensive income. This amount includes $8.1 million of severance benefits for employees terminated after the Effective Date. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is the Merger Consideration (as defined in the Merger Agreement) was transferred to effect the Merger:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deemed (for accounting purposes only) conversion of Menlo equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration*</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* This amount reflects total consideration prior to reduction in respect of the CSRs (which had a fair value of $19.6 million as of the Merger Date) that were issued to Foamix shareholders and that reduced the Menlo stockholders&#8217; relative ownership in the combined company. If the effect of the CSRs is included, the total consideration deemed paid by Foamix, as the accounting acquirer, to Menlo stockholders and equity award holders in the Merger would be reduced to approximately $111.4 million, as shown in the purchase price allocation table below.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on Foamix&#8217;s closing share price of $2.99 as of March 9, 2020, the Merger Consideration under reverse acquisition accounting was approximately $131.1 million, consisting of $123.8 million for the deemed (for accounting purposes only) issuance of 41.4&#160;million Foamix shares assuming that no upwards adjustment was made to the Exchange Ratio relating to the CSR, and $7.3 million for the fair value of Menlo equity awards deemed (for accounting purposes only) to be converted into Foamix equity awards. The converted stock options represent the fair value of such options attributable to service prior to the Merger date using the Foamix closing share price of $2.99 as of March 9, 2020 as an input to the Black Scholes valuation model to determine the fair value of the options.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed its analysis of the allocation of the purchase price to the fair values of assets acquired and liabilities assumed as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 9, 2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,827)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,827)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated purchase price*</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Reflects reduction in the purchase price deemed paid to Menlo stockholders in the Merger on the assumption that the CSRs, in an aggregate value of $19.6 million, convert into additional shares of the combined company for the Foamix shareholders, thereby resulting in a lower percentage of the combined company&#8217;s outstanding shares being owned by Menlo stockholders following the Merger.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is recorded with the acquisition of a business and is calculated as the difference between the acquisition date fair value of the consideration transferred and the values assigned to the assets acquired and liabilities assumed. Goodwill is not amortized but is tested for impairment at least annually. None of the Goodwill recognized is expected to be deductible for income tax purposes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purchase price of the transaction and the excess purchase price over the fair value of the identifiable net assets acquired, are calculated as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 9, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: fair value of net assets acquired, including other identifiable intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,545&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company announced that each of Menlo&#8217;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. The Company does not intend to further pursue the development of serlopitant.  As such, the Company recorded a full impairment charge of $4.5 million related to goodwill in its consolidated statements of operations and comprehensive loss for the year ended December&#160;31, 2020.  There were no impairment charges in the year ended December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In-Process Research and Development (&#8220;IPR&amp;D")</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D recognized relates to Menlo&#8217;s once</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">daily oral serlopitant for the treatment of pruritus (itch) associated with PN that has not reached technological feasibility as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible asset</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired indefinite life intangible assets*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of identified intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,800&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Represents acquired IPR&amp;D assets which are initially recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the associated research and development efforts. Accordingly, during the research and development period, these assets will not be amortized into earnings; instead these assets will be subject to periodic impairment testing. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of IPR&amp;D has been estimated utilizing a multi-period excess earnings method under the income approach, which reflects the present value of the projected cash flows that are expected to be generated, less charges representing the contribution of other assets to those cash flows that use projected cash flows with and without the intangible asset in place.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company announced that each of Menlo&#8217;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. The Company does not intend to further pursue the development of serlopitant.  As such, the Company recorded a full impairment charge of $49.8 million related to the IPR&amp;D asset in its consolidated statements of operations and comprehensive loss for the year ended December 31, 2020.  There were no impairment charges in the year ended December&#160;31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CSR</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CSR was issued pursuant to the CSR Agreement, dated as of March 9, 2020, by and between Menlo and American Stock Transfer &amp; Trust Company, LLC, and represented the non-transferable contractual right to receive shares of common stock of Menlo depending on the results of Menlo&#8217;s Phase III PN Trials. The Company recognized a liability of $19.6 million in the consolidated balance sheet as of March 9, 2020. The liability was measured at fair value and categorized as level 3 as of the acquisition date in accordance with ASC 805-31-25-5 and subsequently at each reporting date thereafter. The fair value of the CSR was estimated as the incremental value that Foamix would be able to achieve on a probability weighted basis assuming three different potential probabilities of the following scenarios: (a) serlopitant significance was achieved in both Phase III PN Trials (b) serlopitant significance was achieved in only one Phase III PN Trial and (c) serlopitant significance was not achieved or was not determined on or before May 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company announced that each of Menlo&#8217;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. Accordingly, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into 1.2082 additional shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of 1.8006 shares of Menlo common stock for each Foamix ordinary share.  The CSR conversion resulted in the issuance and delivery of 74.5 million additional shares of Menlo common stock underlying the CSRs, adjusted retrospectively to 18.6 million shares of common stock upon the reverse stock split effective February 12, 2021.  Following the conversion of the CSRs, pre-Merger Foamix shareholders and pre-Merger Menlo stockholders own approximately 82% and 18% of post-Merger Menlo, respectively, each calculated on a fully diluted basis.  The conversion of </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the CSR also affected the Exchange Ratio of the pre-Merger Foamix equity awards and warrants outstanding as of March 9, 2020 and increased the awards available for grant under the Company's equity plan.    </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration associated with the CSR was recognized and measured at fair value as of the acquisition date in accordance with ASC 805-30-25-5. An acquirer's obligation to pay contingent consideration should be classified as a liability or equity in accordance with ASC 480, Distinguishing Liabilities from Equity, ASC 815 Derivatives and Hedging, and other applicable U.S. GAAP.&#160;The contingent consideration associated with the CSR was initially measured at fair value and subsequently measured at fair value at each reporting date. The CSR was classified as a liability, as it was settled by issuing a variable number of the Company's common stock.  On April 6, 2020, the Company recorded $84.7 million of expense in its consolidated statements of operations and comprehensive loss to remeasure the CSR liability in its consolidated balance sheet to its fair value of $104.4 million (calculated based on 74,544,413 shares issued, adjusted retrospectively to 18,636,103 shares of common stock upon the reverse stock split effective February 12, 2021, and a share price of $1.40 on April 6, 2020) and then settled in connection with the issuance of shares. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pro Forma</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual Menlo net loss included in the Company&#8217;s consolidated statements of operations and comprehensive income for the year ended December 31, 2020 (for the period from March 9, 2020, the Effective Date, through December 31, 2020, which are not indicative of the results to be expected for a full year) and the supplemental unaudited pro forma revenue and net loss of the combined entity had the acquisition been completed on January 1, 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual Menlo results of operations for the period from March 9, 2020, the Effective Date, through December 31, 2020 included in the consolidated statement of operation for the year ended December 31, 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss attributable to Menlo</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma Menlo results of operations for the year ended December 31, 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year  ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTAL PRO FORMA COMBINED RESULTS OF OPERATIONS:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss per share - basic and diluted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjustments to the supplemental pro forma combined results of operations, included in the above, are as follows:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acceleration of stock based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Adjustments</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,130)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited pro forma consolidated financial results have been prepared for illustrative purposes only and do not purport to be indicative of the results of operations that actually would have resulted had the acquisition occurred on the first day of the earliest period presented, or of future results of the consolidated entities. The unaudited pro forma consolidated financial information does not reflect any operating efficiencies and cost savings that may be realized from the integration of the Merger.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121242552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text">REVENUE RECOGNITION<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues for the year ended&#160;December&#160;31, 2021&#160;were primarily generated from sales of AMZEEQ&#160;which was commercially launched in the United States in January 2020 and ZILXI which became available in pharmacies nationwide on October 1, 2020.  The Company&#8217;s customers include a limited number of national and select regional distributors and certain independent and specialty pharmacies, together (the "customers"). The distributors subsequently resell the product, primarily to retail pharmacies that dispense the product to patients. Net product revenue is typically recognized when customers obtain control of the Company&#8217;s products, which occurs at a point in time, typically upon delivery of product to the customers. For the year ended December&#160;31, 2021, three customers accounted for 17%, 15% and 9% of product revenue, respectively.  For the year ended December&#160;31, 2020, three customers accounted for 42%, 39%, and 15% of product revenue, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Sales Provisions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenue is recorded net of distribution fees, trade discounts, allowances, rebates, chargebacks, estimated returns and other incentives, described below. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company calculates its net product revenue based on the wholesale acquisition cost that the Company charges its customers less provisions for (i) trade discounts and allowances, such as distributor fees and discounts for prompt payment, (ii) estimated rebates to third-party payers, patient co-pay assistance programs, chargebacks and other discount programs and (iii) reserves for expected product returns.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for distribution fees, trade discounts and chargebacks are reflected as a reduction to trade receivables, net on the consolidated balance sheet. All other provisions, including rebates, other discounts and return provisions are reflected as a liability within accrued expenses on the consolidated balance sheet. Provisions for revenue reserves described below reduced product revenues by $62.9 million and $39.5 million for the years ended December&#160;31, 2021 and December&#160;31, 2020, respectively. The revenue reserve accrual was $5.5 million and $5.8&#160;million at December&#160;31, 2021 and December&#160;31, 2020, respectively and was reflected in accrued expenses in the consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Distribution Fees and Trade Discounts and Allowances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Company pays fees for distribution services and for certain data that distributors provide to the Company and generally provides discounts on sales to its distributors for prompt payment. These fees and discounts are contractual in nature and the Company expects its distributors to earn these fees and discounts, and accordingly deducts the full amount of these fees and discounts from its gross product revenues at the time such revenues are recognized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Rebates, Chargebacks and Other Discounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales made under managed-care and governmental pricing programs in the U.S. are subject to rebates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Managed Care rebates relate to contractual agreements to sell products to managed care organizations and pharmacy benefit managers at contractual rebate percentages in exchange for volume and/or market&#160;share. Chargebacks relate to contractual agreements to sell products to government agencies and other indirect customers at contractual prices that are lower than the list prices the Company charges wholesalers. When these government agencies or other indirect customers purchase products through wholesalers at these reduced prices, the wholesaler charges the Company for the difference between the prices they paid the Company and the prices at which they sold the products to the indirect customers. The Company estimates the rebates and chargebacks it expects to be obligated to provide and deducts these estimated amounts from its gross product revenue at the time the revenue is recognized. The Company estimates the rebates and chargebacks that it expects to be obligated to provide based upon (i) the Company's current contracts and negotiations, (ii) estimates regarding the payer mix&#160;based on third-party data and utilization, (iii) inventory held by distributors and (iv) estimates of inventory held at the retail channel. Other discounts include the Company&#8217;s co-pay assistance coupon programs for commercially-insured patients meeting certain eligibility requirements. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to pay associated with product that has been recognized as revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Product Returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with industry practice, customers are generally allowed to return products within a specified period of time before and after its expiration date.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company estimates the amount of product&#160;that will be returned and deducts these estimated amounts from its gross revenue at the time the revenue is recognized. T</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he information utilized to estimate the returns provision includes: (i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> historical industry information regarding rates for comparable pharmaceutical products and product portfolios</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (ii) external data with respect to inventory levels in the wholesale distribution channel, (iii) external data with respect to prescription </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demand</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for products and (iv) remaining shelf lives of products at the date of sale. The Company estimates that between 1% and 2% of product sold to wholesalers will be returned. The Company does not estimate returns for </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales made to the pharmacies as they are not contractually permitted to return product and the Company did not accept any returns from pharmacies in the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> December&#160;31, 2021</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License Revenues</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2020, the Company announced that it entered into a license agreement with Cutia for AMZEEQ as well as certain of the Company's other topical minocycline product candidates, once approved, on an exclusive basis in Greater China.  Under the terms of the agreement, Cutia will have an exclusive license to obtain regulatory approval of and commercialize AMZEEQ, ZILXI and, if approved in the U.S., FCD105 in the Greater China territory.  The Company will supply the finished licensed products to Cutia for clinical and commercial use.  Outside of the license transferred, the Company does not have any additional performance obligations under the arrangement.  In exchange for the license, the Company received an upfront cash payment of $10.0 million.  The license was considered functional IP as the licensee was able to use and benefit from the license without the continued involvement of the Company.  The disposition of the MST Franchise included the license agreement with Cutia including the rights to future revenues and obligations under that agreement.  The Company recorded $10.0&#160;million of license revenue in the year ended  December&#160;31, 2020.  No license revenue was earned in the year ended December&#160;31, 2021.   </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Contract Liabilities&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any contract assets (unbilled receivables) related to product sales or as of&#160;December&#160;31, 2021, as customer invoicing generally occurs before or at the time of revenue recognition.  The Company did not have any contract assets (unbilled receivables) related to its license revenues as of December&#160;31, 2021 or 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any contract liabilities as of&#160;December&#160;31, 2021 or 2020, as the Company did not receive payments in advance of fulfilling its performance obligations to its customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales Commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions are generally attributed to periods shorter than one year and therefore are expensed when incurred. Sales commissions are included in selling, general and administrative expenses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Component</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected not to adjust consideration for the effects of a significant financing component when the period between the transfer of a promised good or service to the customer and when the customer pays for that good or service will be one year or less.&#160;Standard credit terms do not exceed 75 days.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty Revenues&#160;</span></div>The Company is entitled to royalty payments with respect to sales of a product developed by a customer in collaboration with the Company. Revenues in the amount of $0.9 million and $0.8 million were recorded during the year ended December&#160;31, 2021 and 2020, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121136232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s assets and liabilities that are measured at fair value as of December&#160;31, 2021, and December&#160;31, 2020, are classified in the tables below in one of the three categories described in "Note 2 - Fair value measurement" above:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sold its marketable securities during the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121240888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">MARKETABLE SECURITIES</a></td>
<td class="text">MARKETABLE SECURITIES<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities as of  December&#160;31, 2020 consisted of mutual funds securities.  Realized gains and losses on sales of the securities, are included in the consolidated statement of operations as other income, net.  The Company did not hold any marketable securities as of December&#160;31, 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily determinable fair value are measured at fair value. The changes in the fair value of equity investments are recognized through other income, net in the consolidated statements of operations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s marketable securities:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli mutual funds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and 2020 there were no available-for-sale debt securities.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has considered factors regarding other than temporary impaired securities and determined that there were no securities with impairment that is other than temporary as of December&#160;31, 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and 2020, the Company received aggregate proceeds of $1.0 million&#160;and $38.5 million, respectively, upon the sale and maturity of marketable securities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125095816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORY</a></td>
<td class="text">INVENTORY<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost and net realizable value with cost determined on a first-in, first-out basis by product. The Company capitalizes inventory costs associated with products following regulatory approval when future commercialization is considered probable and the future economic benefit is expected to be realized. The Company commenced capitalizing inventory for AMZEEQ and ZILXI upon FDA approval in October 2019 and May 2020, respectively. The Company periodically reviews its inventory levels and, if necessary, writes down inventory that is expected to expire prior to being sold, inventory in excess of expected sales requirements and inventory that fails to meet commercial sale specifications, with a corresponding charge to cost of goods sold. There were no material inventory write-downs during the years ended December&#160;31, 2021 and 2020.  All inventory was sold or written-off in connection with the sale of the MST Franchise.  See Note 17.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s inventory:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,404&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121192360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense totaled $0.1 million and $0.3 million for the years ended December&#160;31, 2021 and 2020, respectively.</span></div>During the years ended December&#160;31, 2021 and December&#160;31, 2020, the Company disposed of fixed assets in the net amount of $0.1&#160;million and $2.1 million. Loss on disposal of fixed assets during the year ended December&#160;31, 2020 relates to the write-off of laboratory and leasehold improvements in Israel due to a reduction in office space.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121195064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCRUED EXPENSES</a></td>
<td class="text">ACCRUED EXPENSES<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales provisions (see Note 4)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercialized product accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Accrued Expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,593&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,452&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125090856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">OPERATING LEASE</a></td>
<td class="text">OPERATING LEASE<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for corporate offices and vehicles. The properties primarily relate to the Company&#8217;s principal executive office in Bridgewater, New Jersey and office space in Israel.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 13, 2019, the Company signed an amendment to the original lease agreement for its principal executive office in Bridgewater, New Jersey (the "Lease Amendment&#8221;). The Lease Amendment includes an extension of the lease period of the 10,000 square feet previously leased under the original agreement (the "Original Space") and an addition of 4,639 square feet (the "Additional Space&#8221;). The Company entered the Additional Space following a period of preparation by the lessor completed during September 2019 (the "Commencement Date"). The lease is due to expire on August 31, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Lease Amendment, the Company recognized an additional right of use asset and liability in the amount of $0.7 million. The Additional Space was considered a new lease agreement and was recognized as a right of use asset and liability, in the amount of $0.3 million, on the Commencement Date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease agreement for the office space in Israel expires in December 2022.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company entered into operating lease agreements in connection with the leasing of vehicles. The lease periods are generally for three years. To secure the terms of certain of the vehicle lease agreements, the Company has made prepayments to the leasing company, representing approximately three months of lease payments. These amounts have been recorded as part of the operating lease right to use assets.  In connection with the strategic business review and sale of the MST Franchise certain vehicle leases were transferred to members of the commercial workforce resulting in the elimination of $0.5&#160;million of right of use assets and $0.5&#160;million of right of use liabilities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs for the year ended December&#160;31, 2021 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office lease expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles lease expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease costs include an immaterial amount of variable lease payments for the years ended December&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows, for amounts included in the measurement of lease liabilities are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had a lien in the amount of $0.6 million on the Company&#8217;s cash in respect of bank guarantees granted in order to secure the lease agreements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121113736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE SAVINGS PLAN<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">EMPLOYEE SAVINGS PLAN</a></td>
<td class="text">EMPLOYEE SAVINGS PLANBeginning September 2017, the Company has retirement savings plans available to all employees of the Subsidiary, which are intended to qualify as deferred compensation plans under Section 401(k) of the Internal Revenue Code (the &#8220;401(k) Plans&#8221;). The Company made contributions to these 401(k) Plans during the years ended December&#160;31, 2021, and 2020 of approximately $0.4 million and $0.8 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121103624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation and contingencies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may periodically become subject to legal proceedings and claims arising in connection with its business. As of December&#160;31, 2021, there are no claims or actions pending against the Company that, in the opinion of management, are likely to have a material adverse effect on the Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2021, the Company received a paragraph IV certification notice (the &#8220;Notice&#8221;) from Padagis Israel Pharmaceuticals Ltd. (f/k/a Perrigo Israel Pharmaceuticals Ltd. (&#8220;Padagis&#8221;)) advising that Padagis has submitted to the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) an Abbreviated New Drug Application (&#8220;ANDA&#8221;) seeking approval to manufacture and sell a generic version of the Company&#8217;s product AMZEEQ&#174; (minocycline) topical foam, 4% in the United States prior to the expiration of the Company&#8217;s U.S. patents Nos. 8,865,139, 8,945,516, 8,992,896, 9,675,700, 10,086,080, 10,137,200, 10,213,512, 10,265,404, 10,398,641, 10,517,882, 10,821,187, and 10,849,847 (the &#8220;Listed Patents&#8221;), which are listed in the FDA&#8217;s Approved Drug Products with Therapeutic Equivalence Evaluations, otherwise known as the &#8220;Orange Book.&#8221; The Notice alleges that the Listed Patents are invalid, unenforceable, and/or will not be infringed by the commercial manufacture, use or sale of the generic product described in Padagis&#8217;s ANDA.</span></div>On August 9, 2021, the Company initiated a patent infringement suit against Padagis in the United States District Court for the District of Delaware arising from Padagis&#8217;s ANDA filing with the FDA. The patent infringement suit asserts each of the Listed Patents. As a result, under applicable law, the FDA cannot grant final approval to Padagis&#8217;s ANDA before December 30, 2023, or a court decision in Padagis&#8217;s favor. VYNE is seeking, among other relief, an order that the effective date of any FDA approval of Padagis&#8217;s ANDA be no earlier than the expiration of the Listed Patents, the latest of which expires on September 8, 2037, and such further and other relief as the court may deem appropriate. Padagis filed its response and counterclaim on October 1, 2021. The Company filed its response to such counterclaim on October 22, 2021. The liabilities associated with this matter have been transferred to Journey in connection with the Sale.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125073240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LONG-TERM DEBT</a></td>
<td class="text">LONG-TERM DEBT<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2019, Foamix entered into a Credit Agreement (the "Credit Agreement") to secure up to $50 million from two lenders, one of which is a significant stockholder of the Company and is considered a related party, and a Securities Purchase Agreement with one of the lenders for gross proceeds of approximately $14 million, before deducting offering expenses (see "Note 14 - Share Capital" for more information).  On March 9, 2020, the Company entered into an Amended and Restated Credit Agreement and Guaranty (as further amended on August 5, 2020, the "Amended and Restated Credit Agreement"), whereby the Company has guaranteed the indebtedness obligations of the borrower and granted a first priority security interest in substantially all of our assets for the benefit of the lenders.  As of December&#160;31, 2020, $35.0 million was drawn under the Amended and Restated Credit Agreement.  The Company did not incur the remaining $15.0 million under the Amended and Restated Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loans available under the Amended and Restated Credit Agreement were comprised as follows: (a) $15 million that was funded on July 29, 2019 (the &#8220;Tranche 1 Loan&#8221;), (b) $20 million that was funded on December 17, 2019 (the &#8220;Tranche 2 Loan&#8221;) and (c) up to $15 million that was available prior to September 30, 2020 (the &#8220;Tranche 3 Loan&#8221;). The Tranche 2 Loan was borrowed following the FDA&#8217;s approval of the Company&#8217;s NDA for AMZEEQ and listing of AMZEEQ in the FDA&#8217;s &#8220;Orange Book,&#8221; in addition to maintaining its arrangements with a third party for the commercial supply and manufacture of AMZEEQ. The Company did not incur the Tranche 3 Loan. Subject to any acceleration as provided in the Amended and Restated Credit Agreement, including upon an event of default (as defined in the Amended and Restated Credit Agreement), the loans will mature on July 29, 2024 and bear interest equal to the sum of (A) 8.25% (subject to increase in accordance with the </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">terms of the Amended and Restated Credit Agreement) plus (B) the greater of (x) the one-month LIBOR as of the second business day immediately preceding the first day of the calendar month or the date of borrowing (if such loan is not outstanding as of the first day of the calendar month), as applicable, and (y) 2.75%. A fee in an amount equal to 1.0% of the aggregate principal amount of all loans made on any given borrowing date shall be payable to the lenders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans were scheduled to mature on July 29, 2024. However, following discussions with the Company's lenders regarding the revenue targets included in the Amended and Restated Credit Agreement, the revenue expected to be generated for the trailing twelve month period ended June 30, 2021 and the Company's strategic business review discussed in Note 1, the Company determined to prepay its outstanding indebtedness in addition to a 4% prepayment fee and accrued but unpaid interest in the total amount of approximately $36.5&#160;million on August 11, 2021. Following the prepayment, the Amended and Restated Credit Agreement and the security interests thereunder were terminated. As of December&#160;31, 2021 there was no debt outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Perceptive Credit Holdings II, LP ("Perceptive") was one of the lenders and the administrative agent under the Amended and Restated Credit Agreement. As of August 11, 2021, the date of the prepayment, affiliates of Perceptive were holders of more than 5% of the Company's outstanding common stock. In connection with the prepayment of the Company's indebtedness, Perceptive received $18.3&#160;million, representing their portion of the principal amount, interest and prepayment premium.  As of December 31, 2021, Perceptive was no longer a related party. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on July 29, 2019, the lenders under the Credit Agreement were issued warrants to purchase up to an aggregate of 1,100,000 of Foamix ordinary shares, at an exercise price of $2.09 per share (the &#8220;Warrants&#8221;), which represented the five-day volume weighted average price of the Foamix ordinary shares as of the trading day immediately prior to the issuance of the Warrants. In connection with the completion of the Merger, the exchange ratio was applied to the Warrants such that they became exercisable for 651,640 shares of the Company's common stock, and the exercise price was adjusted to $3.53.  Following the Phase 3 PN Trial results, the Warrants were further adjusted for the CSR and reverse stock split and they are currently exercisable for 495,165 shares of our common stock with an exercise price of $4.64 per share. Payment of the exercise price will be made, at the option of the holder, either in cash or as a reduction of common stock issuable upon exercise of the Warrant, with an aggregate fair value equal to the aggregate exercise price ("cashless exercise"), or any combination of the foregoing. The Warrants are exercisable pursuant to the terms, and subject to the conditions, thereof and expire on July 29, 2026. Any Warrants left outstanding will be cashless exercised on the Warrants' expiration date, if in the money. The Warrants issued were classified as equity in accordance with ASC 815-40. Proceeds received under the Tranche 1 Loan were allocated to the Warrants and the Tranche 1 Loan on a relative fair value basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020 the Company incurred offering expenses of $1.1 million in connection with transactions contemplated by the Credit Agreement and the Securities Purchase Agreement, which were allocated to the Warrants, shares and debt consistently with the allocation of proceeds. The Company incurred additional expenses in the amount of $0.3&#160;million from the borrowing of Tranche 2 Loan, allocated only to the debt.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021 the company recorded interest expense of $5.6&#160;million comprised of interest on debt of $3.8&#160;million and discount costs of  $1.8&#160;million.  The interest expense includes a debt prepayment fee of $1.4 million and the write-off of discount costs of $1.6&#160;million associated with the Company's prepayment of outstanding indebtedness resulting in a total extinguishment loss of $3.0&#160;million   During the year ended December&#160;31, 2020 the company recorded interest expense of $3.9 million and $0.5 million relating to the interest and discount cost, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125099576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS' EQUITY<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred stock</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company's Certificate of Incorporation, as amended, authorizes the Company to issue 20,000,000 shares of preferred stock, par value $0.0001 per share.  There were no shares of preferred stock issued and outstanding as of December&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of preferred stock may be issued from time to time in one or more series.  The voting powers (if any), preferences and relative, participating, optional or other special rights, and the qualifications, limitations and restrictions of any series of </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preferred stock will be set forth in a Certificate of Designation filed pursuant to the Delaware General Corporation Law, as determined by the Company's Board of Directors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of common stock authorized under the Company's Amended and Restated Certificate of Incorporation was proportionately reduced in connection with the Company's 1-for-4 reverse stock split in February 2021.  On July 19, 2021, the Company held its meeting of Stockholders (the "Annual Meeting").  Following the approval by the holders of a majority of the outstanding shares of common stock at the Annual Meeting, the Company filed a Certificate of Amended and Restated Certificate of Incorporation to increase the number of authorized share of common stock from 75,000,000 to 150,000,000 shares of common stock, par value $0.0001 per share.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors, subject to the prior rights of holders of all classes of preferred stock outstanding. The Company has never declared any dividends on common stock.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to entering into the Credit Agreement on July 29, 2019, Foamix issued to the lenders Warrants to purchase up to an aggregate of 1,100,000 of its ordinary shares, later exchanged to Warrants to purchase up to 1,980,660 shares of Menlo's common stock, adjusted retrospectively to 495,165 shares of common stock upon the reverse stock split effective February 12, 2021.  Upon close of the Merger, each Warrant received one CSR as described in Note 3 - Business Combinations.  The warrants were exercisable immediately following the closing of the Credit Agreement, subject to the terms of the warrant, and are due to expire on July 29, 2026. Any Warrants left outstanding will be cashless exercised on the Warrants' expiration date, if in the money.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exchange of Warrants from Foamix warrants to Menlo warrants and the additional CSR was accounted for as a modification, by analogy, from the modification's guidance under ASC 260-10-S99-2.  The Company assessed the significance of the modification of the Warrants by comparing the fair value of the Warrants immediately before and after the amendments.  In its assessment, it also considered additional qualitative factors.  The Company concluded that the change of terms was not significant.  Therefore, the incremental fair value, in the amount of $41 thousand, of the modified Warrants over the original ones (as of modification date) was recognized in retained earnings as a deemed dividend to the Warrant holders in the year ended December 31, 2020.  No amounts were recognized in the year ended December&#160;31, 2021.   </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuance of stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2019, the Company entered into a Sales Agreement (the "2019 Sales Agreement") with Cantor Fitzgerald &amp; Co., or Cantor Fitzgerald, to sell shares of the Company's common stock, from time to time, with aggregate gross sales proceeds of up to $50.0 million through an at-the-market equity offering program under which Cantor Fitzgerald acted as our sales agent.  The issuance and sale of shares of common stock by us pursuant to the 2019 Sales Agreement were deemed an "at-the-market" offering under the Securities Act.  Cantor Fitzgerald was entitled to compensation for its services equal to up to 3.0% of the gross proceeds of any shares of common stock sold under the 2019 Sales Agreement.  During the year ended December 31, 2020, the Company issued and sold 1,175,000 shares of common stock at a weighted average price per share of $7.00 pursuant to the 2019 Sales Agreement for $8.0 million in net proceeds, all of which was sold during the three months ended December 31, 2020. In addition, from January 1, 2021 through January 25, 2021, the Company issued and sold an additional 2,778,012 shares of common stock at a weighted average price per share of $9.76 for $26.3 million in net proceeds. Effective as of January 25, 2021, the Company terminated the 2019 Sales Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company entered into a new sales agreement (the "Sales Agreement") with Cantor Fitzgerald to sell shares of the Company's common stock, from time to time, with aggregate gross sales proceeds of up to $50.0 million through an at-the-market equity offering program under which Cantor Fitzgerald will act as the Company's sales agent. The issuance and sale of shares of common stock by us pursuant to the Sales Agreement are deemed an "at-the-market" offering under the Securities Act. Cantor Fitzgerald is entitled to compensation for its services equal to up to 3.0% of the gross proceeds of any shares of common stock sold under the Sales Agreement. During the year ended December&#160;31, 2021, the Company issued and sold 1,955,313 shares of common stock at a weighted average per share price of $1.57 pursuant to the Sales Agreement for $2.9&#160;million in net proceeds.  This agreement was in effect as of December&#160;31, 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 28, 2021, the Company entered into a Securities Purchase Agreement with certain institutional and accredited investors for the sale of an aggregate of 5,274,261 shares of common stock of the Company, at a purchase price of $9.48 per share in a registered direct offering. The offering was completed on January 28, 2021 and the Company received approximately $46.8 million in net proceeds, after deducting placement agent fees and other offering expenses. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2020, the Company completed an underwritten public offering of 7,776,875 shares of common stock at a price to the public of $7.40 per share.  The net proceeds of the offering were approximately $53.6 million, after deducting underwriting discounts and commissions and other offering expenses.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, the Company issued 36,500,335 shares to legacy Foamix shareholders.  On April 6, 2020, pursuant to the terms of the CSR Agreement, the Company issued 74,544,413 shares to legacy Foamix shareholders, adjusted retrospectively to 18,636,103 shares of common stock upon the reverse stock split effective February 12, 2021</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790127016808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE BASED COMPENSATION</a></td>
<td class="text">SHARE BASED COMPENSATION<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity incentive plans:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Merger, the Company adopted Foamix&#8217;s 2019 Equity incentive plan (the &#8220;2019 Plan&#8221;). As of December&#160;31, 2021, 979,795 shares remain issuable under the 2019 Plan.  In addition, the Company adopted the 2018 Omnibus Incentive Plan (the "2018 Plan") in January 2018.  As of December&#160;31, 2021, 147,550 shares remain issuable under the 2018 Plan.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Employee Share Purchase Plan:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Merger, the Company adopted Foamix's Employee Share Purchase Plan ("ESPP") pursuant to which qualified employees (as defined in the ESPP) may elect to purchase designated shares of the Company&#8217;s common stock at a price equal to 85% of the lesser of the fair market value of the common stock at the beginning or end of each semi-annual share purchase period (&#8220;Purchase Period&#8221;). Employees are permitted to purchase the number of shares purchasable with up to 15% of the earnings paid (as such term is defined in the ESPP) to each of the participating employees during the Purchase Period, subject to certain limitations under Section 423 of the U.S. Internal Revenue&#160;Code.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, 2,232,207 shares remain available for grant under the ESPP.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, 71,890 shares were issued to employees pursuant to the ESPP. During the year ended&#160;December&#160;31, 2020, 61,031 Foamix ordinary shares were purchased by Foamix employee pursuant to the ESPP prior to the Merger, which were later exchanged for 36,155 shares of the Company's common stock and one CSR in the Merger, adjusted retrospectively to 9,038 shares of common stock and one CSR upon the reverse stock split effective February 12, 2021, and 38,716 shares were issued to employees after the Merger.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Options and RSUs granted to employees and directors:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2021 and 2020, the Company granted options as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Award amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise price range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees and Directors:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,686,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.68- $11.08</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 year -4 years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">970,813&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 years -4 years</span></div></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Award amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise price range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees and Directors:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,327,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.84- $12.52</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 year -4 years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">654,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 year -4 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options and RSUs granted to employees and directors during 2021 and 2020 was $9.4 million and $11.9 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of RSUs granted to employees and directors is based on the share price on grant date .</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option granted is estimated using the Black-Scholes option pricing method. The volatility is based on a combination of the Company&#8217;s historical volatility, historical volatilities of companies in comparable stages as well as companies in the industry, by statistical analysis of daily share pricing model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected term of the options granted in dollar terms. The Company&#8217;s management uses the expected term of each option as its expected life. The expected term of the options granted represents the period of time that granted options are expected to remain outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underlying data used for computing the fair value of the options are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:67.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.195%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of stock option</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.02-$6.75</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.47-$7.68</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68.38%-69.38%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60.44%-69.83%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.50%-1.29%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.31%-1.26%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 years</span></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Modification of share-based compensation:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Merger, all outstanding options and RSUs granted by Foamix were exchanged for stock options and RSUs of Menlo&#8217;s common stock according to the Exchange Ratio. In addition, for each option and RSU the holder received a CSR as described in Note 3- Business Combination. This transaction was considered by the company to be a modification under ASC 718, Compensation - Stock Compensation. The modification did not affect the remaining requisite service period. As a result of the modification, for outstanding options and RSUs granted to Foamix employees and consultants, the Company recorded immaterial incremental compensation expense.  As described in Note 3 - Business Combination, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into 1.2082 shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of 1.8006 shares of Menlo common stock for each Foamix ordinary share.  The conversion was considered by the company to be a modification under ASC 718. As a result of the modification, for outstanding options and RSUs granted to Foamix employees and consultants, the Company recorded incremental compensation of $1.8&#160;million and $11.8 million for the years ended December&#160;31, 2021 and December&#160;31, 2020, respectively.  As of December&#160;31, 2021 there is $0.9 million of unrecognized incremental compensation expense related to the modification which will primarily be amortized using a graded vesting method over the next 1 year.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted to holders who are no longer employed or providing services to the Company are accounted for in accordance with ASC 815-40, Derivatives and Hedging. Under this guidance, the awards are classified as a derivative liability because the award no longer exchanges a fixed amount of cash for a fixed number of shares. Accordingly, as of March 9, 2020 the Company reclassified $1.6 million from additional paid-in capital to derivative liability on the consolidated balance sheet. Prior to the reclassification of these awards as a liability instrument, the Company recorded an incremental compensation expense of $0.6 million due to the above mentioned modification in accordance with ASC 718. Subsequent to the reclassification of these awards as a liability instrument, the Company recorded incremental compensation expense of $1.0 million for the year ended December&#160;31, 2020.  There was no incremental compensation for the year ended December&#160;31, 2021.  As described in Note 3 - </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business Combination, on April 6, 2020, the Company announced that study MTI-105 and study MTI-106 did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis.  Accordingly, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into 1.2082 shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of 1.8006 shares of Menlo common stock for each Foamix ordinary share.  On April 6, 2020, the awards are exchangeable for a fixed amount of cash for a fixed number of shares and were remeasured to fair value and reclassified from derivative liability to additional paid-in capital.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger, Menlo recognized all expenses relating to awards outstanding as of the Effective Date. These awards were subject to acceleration upon the change of control per the previous Menlo stock option plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of outstanding and exercisable options and RSUs:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of options outstanding for the year ended December&#160;31, 2021, and related information:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,274,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,686,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(70,827)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(435,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,410,706)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,043,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,971,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:4.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average remaining contractual term of outstanding and exercisable options as of December&#160;31, 2021, is 7.0 years and 5.5 years, respectively.  Total unrecognized share based compensation for options at December&#160;31, 2021 is $6.4 million, which is expected to be recognized over a weighted average period of 2.3 years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no intrinsic value of outstanding and exercisable options as of December&#160;31, 2021</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of RSUs outstanding for the year ended December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.421%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of RSUs</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">719,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awarded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">970,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(293,034)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(134,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,262,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total unrecognized compensation expense related to the unvested portion of the Company's RSUs at December&#160;31, 2021 was $5.6 million, which is expected to be recognized over a weighted average period of 2.27 years.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share-based compensation expenses:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the effect of share-based compensation on the statements of operations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,080&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121051768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAX</a></td>
<td class="text">INCOME TAX: <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes and the related tax expense (benefit) is as follows:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:71.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss before taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,777&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of income taxes at the U.S. federal statutory rate to the provision for income taxes is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax provision at statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax provision, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D Impairment &amp; CSR Remeasurement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IP Gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense for the years ended December&#160;31, 2021 and 2020 differed from the amounts computed by applying the U.S. federal income tax rate of 21% to loss before tax expense as a result of nondeductible expenses, changes in state effective tax rates, foreign taxes,  tax credits generated, true up of net operating loss carryforwards, and increase in the Company&#8217;s valuation allowance. The Company applies the elements of FASB ASC 740-10 regarding accounting for uncertainty in income taxes. This clarifies the accounting for uncertainty in income taxes recognized in financial statements and required impact of a tax position to be recognized in the financial statements if that position is more likely than not of being sustained by the taxing </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">authority. Included in Other Liabilities on the Consolidated Balance Sheets, are the total amount of unrecognized tax benefits of approximately $2.8&#160;million and $3.1 million as of December&#160;31, 2021 and 2020, respectively, net of the federal benefit, if recognized, would favorably affect the Company&#8217;s future effective tax rate. The Company&#8217;s policy is to recognize interest and penalties related to tax matters within the income tax provision. Tax years beginning in 2017 are generally subject to examination by taxing authorities, although net operating losses from all years are subject to examinations and adjustments for at least three years following the year in which the attributes are used. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of the Company's deferred tax assets and liabilities are as follows:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carry forward</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85,671&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70,129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less - valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(85,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(69,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax assets, net of valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realization of deferred tax assets is contingent upon sufficient future taxable income during the period that deductible temporary differences and carry forward losses are expected to be available to reduce taxable income. As the achievement of required future taxable income is not likely, the Company recorded a full valuation allowance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company recorded valuation allowance against its net deferred tax assets of approximately $85.6 million and $69.7 million, respectively. The change in the valuation allowance during the years ended December&#160;31, 2021 and 2020 was an increase of approximately $15.8 million and a decrease of approximately $1.3&#160;million, respectively. A valuation allowance has been recorded since, in the judgment of management, these assets are not more likely than not to be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences and carryforwards become deductible or are utilized. As of December&#160;31, 2021, the Company had federal and state pre-tax net operating loss carryforwards of approximately $315.0 million and $105.6 million, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, research and development credit carryforwards for federal and state purposes are approximately $6.7 million and $1.2 million, respectively. As a result of U.S. tax reform legislation, federal net operating losses generated beginning in 2018 and subsequent years carryforward indefinitely, however, the Company has federal net operating losses that pre-date U.S. tax reform legislation which begin to expire in 2031 and federal credit carryforwards that begin to expire in 2031. State net operating loss carryforwards begin to expire in 2031, and the state credit carryforwards began to expire in 2031. Sections 382 and 383 of the Internal Revenue Code of 1986 subject the future utilization of net operating losses and certain other tax attributes, such as research and development tax credits, to an annual limitation in the event of certain ownership changes, as defined. The Company may have undergone ownership changes and therefore may be materially limited in the amount of NOL and R&amp;D tax credit available for utilization in the future. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generated research and development tax credits but has not conducted a study to document the qualified activities. This study may result in an adjustment to the Company&#8217;s research and development credit carryforwards; however, until a study is completed and any adjustment is known, a partial reserve has been presented as an uncertain tax position which </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is offset against the gross research and development deferred tax asset. A full valuation allowance has been provided against the Company&#8217;s research and development credits and, if an adjustment is required, this would be offset by an adjustment to the deferred tax asset established for the research and development credit carryforwards and the valuation allowance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Uncertain tax positions:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC No. 740, Income Taxes, requires significant judgment in determining what constitutes an individual tax position as well as assessing the outcome of each tax position. Changes in judgment as to recognition or measurement of tax positions can materially affect the estimate of the effective tax rate and consequently, affect the operating results of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity of the Company unrecognized tax benefits (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at January 1, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for prior year positions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for current year positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions related to expiration of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for prior year positions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for current year positions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions related to expiration of statute of limitations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,799&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance related to research and development tax credit positions acquired through the Merger.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company began liquidation proceedings of its Israeli subsidiary, VYNE Pharmaceuticals Ltd., to align with its business strategy. As a result thereof, the Company's intellectual property was assigned to the U.S. parent company and we recognized a $163.0 million taxable gain in 2020 for Israeli income tax purposes. However, the taxable gain was fully offset by net operating loss carryforwards, resulting in no income tax expense to the Company.  In addition, there was also no Israeli withholding tax due by the U.S. parent company. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate Restructuring is subject to complex tax and transfer pricing regulations administered by taxing authorities in the U.S. and Israel. The relevant taxing authorities may disagree with the Company&#8217;s determinations as to the income and expenses attributable to specific jurisdictions. If such a disagreement were to occur, and the Company&#8217;s position were not sustained, the Company could be required to pay additional taxes, interest and penalties, which could result in one-time tax charges, higher effective tax rates and reduced cash flows than otherwise would be expected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has tax assessments that are considered to be final through tax year 2015.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790124804024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Sale of Minocycline Franchise </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Note 1, On January 12, 2022, VYNE entered into a Purchase Agreement with Journey  to sell its MST Franchise for $25.0&#160;million of cash consideration which comprises an upfront payment of $20.0&#160;million and an additional $5.0&#160;million on the one-year anniversary of the closing of the transaction. VYNE is also eligible to receive sales milestone payments of up to $450.0&#160;million in the aggregate upon the achievement of specified levels of net sales on a product-by-product basis, beginning with annual net sales exceeding $100.0 million (with products covered in three categories (1) AMZEEQ (and certain modifications), (2) ZILXI (and certain modifications), and (3) FCD105 and other products covered by the patents being transferred, including certain modifications). In addition, VYNE is entitled to receive certain payments from any licensing or sublicensing of the assets by Journey outside of the United States.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company anticipates recording an estimated gain from the sale of the MST Franchise in the first quarter of 2022 ranging from $13.5&#160;million to  $14.5&#160;million.  The Company does not anticipate paying any federal or state income taxes based upon the utilization of net operating losses.  The estimated gain is based on net proceeds ranging from $21.3&#160;million to  $22.3&#160;million  including estimated transaction costs ranging from $2.7&#160;million to $3.7&#160;million. Under the Purchase Agreement, the Company is obligated to indemnify Journey against certain potential liabilities and for breaches of representations, warranties and covenants under the agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Agreement, Journey assumed certain liabilities of the MST Franchise including, among others, those arising from VYNE&#8217;s patent infringement suit initiated against Padagis Israel Pharmaceuticals Ltd (see Note 12). There were no current or long-term liabilities recorded by the Company which were transferred to the Buyer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Agreement includes customary representations and warranties, as well as indemnification rights for breaches of representations, warranties, and covenants, as well as certain other matters, subject to customary deductibles, caps, and other limitations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The criteria for reporting the MST Franchise as held for sale was met after the balance sheet date, and therefore, the assets of the MST Franchise were classified as held and used as of December&#160;31, 2021.  The total carrying amounts of the MST assets a were disposed were approximately $7.8&#160;million, as of December&#160;31, 2021.  These assets consist primarily of inventory of  $7.3&#160;million. No liabilities were transferred. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 31, 2021, the Company has sold an aggregate of 2,465,500 shares pursuant to the Sales Agreement for gross proceeds of $1.5&#160;million. </span></div>In addition, on March 15, 2022, the Company entered into a purchase agreement (the "Equity Purchase Agreement"), with Lincoln Park Capital Fund, LLC ("Lincoln Park") which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company may sell to Lincoln Park, at the Company's discretion, up to $30.0&#160;million of shares of its common stock over the 36-month term of the Equity Purchase Agreement. Upon execution of the Equity Purchase Agreement, the Company issued 1,667,593 shares of its common stock to Lincoln Park as commitment shares in accordance with the closing conditions contained within the Equity Purchase Agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790119343608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text">Basis of presentationThe Company&#8217;s financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;).  Certain prior period amounts have been reclassified to conform to current year presentation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text">Use of estimates<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results may differ from those estimates.  Significant items subject to such estimates and assumptions include accounting for business combinations, impairments of goodwill and intangible assets and revenue recognition. Actual results could differ from the Company&#8217;s estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and government measures taken in response to the pandemic have had a negative impact on the Company's operations. Access to healthcare providers has been limited, which has negatively impacted sales and the Company's ability to execute its commercial strategy with respect to AMZEEQ and ZILXI. The length of time and extent to which the COVID-19 pandemic will directly or indirectly impact the Company's business, results of operations and financial condition and liquidity will depend on future developments that are highly uncertain, subject to change and will continue to evolve with geographical re-openings, surges in cases, the emergence of new strains and the vaccination effort. In addition, the Company further assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2021 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, inventory and related reserves, impairments of long-lived assets and revenue recognition. In 2020, the Company recorded impairments of goodwill and certain indefinite-lived intangible assets; however, these were unrelated to the impact of COVID-19 (See "Note 3 - Business Combination" for more information). The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Acquisition</a></td>
<td class="text">Business AcquisitionThe Company&#8217;s consolidated financial statements include the operations of an acquired business after the completion of the acquisition. The Company accounts for acquired businesses using the acquisition method of accounting, which requires, among <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other things, that most assets acquired and liabilities assumed be recognized at their estimated fair values as of the acquisition date and that the fair value of In-Process Research and Development and Goodwill be recorded on the balance sheet.&#160;Transaction costs are expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recorded in connection with an acquisition can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting.&#160; For example, the Company uses fair value in the initial recognition of net assets acquired in a business combination and when measuring impairment losses.&#160; The Company estimates fair value using an exit price approach, which requires, among other things, that Company determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of non-financial assets and, for liabilities, assuming that the risk of non-performance will be the same before and after the transfer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may use one or all of the following techniques:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost approach, which is based on the cost to acquire or construct comparable assets, less an allowance for functional and/or economic obsolescence.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fair value methodologies depend on the following types of inputs:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for identical assets or liabilities in active markets (Level 1 inputs).</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means (Level 2 inputs).</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unobservable inputs that reflect estimates and assumptions (Level 3 inputs).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A single estimate of fair value can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text">Foreign Currency TranslationTransactions and balances originally denominated in dollars are presented at their original amounts. Balances in non-dollar currencies are translated into dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-dollar transactions and other items in the statements of operations (indicated below), the following exchange rates are used: (i) for transactions - exchange rates at transaction dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization, etc.) - historical exchange rates. Currency transaction gains and losses are presented in financial income or expenses, as appropriate.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text">Principles of consolidationThe consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated upon consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text">Cash and cash equivalentsThe Company considers as cash equivalents all short-term, highly liquid investments, which include short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable securities</a></td>
<td class="text">Marketable securities<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketable equity securities:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's marketable equity securities are recorded at fair value, with unrealized gains and losses included in other income, net in the consolidated statement of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">InventoryPrior to the date the Company obtains regulatory approval for its product candidates, inventory costs related to commercial production are expensed as research and development expense. Once regulatory approval is obtained, the Company capitalizes such costs as inventory. Inventories are stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first-out (&#8220;FIFO&#8221;) method. The Company periodically reviews its inventory levels and writes down inventory that is expected to expire prior to being sold, inventory in excess of expected sales requirements and inventory that fails to meet commercial sale specifications, with a corresponding charge to cost of goods sold.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text">Property and equipment<div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Property and equipment are stated at cost, net of accumulated depreciation and amortization.</span></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">The Company&#8217;s property and equipment are depreciated by the straight-line method on the basis of their estimated useful life.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual rates of depreciation are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 7 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 14 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 - 14 years</span></div></td></tr></table></div><div style="margin-top:7pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are amortized by the straight-line method over the expected lease term, which is shorter than the estimated useful life of the improvements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text">Impairment of long-lived assetsThe Company tests long-lived assets for impairment whenever events or circumstances present an indication of impairment. If the sum of expected future cash flows (undiscounted and without interest charges) of the assets is less than the carrying amount of such assets, an impairment loss would be recognized. The assets would be written down to their estimated fair values, calculated based on the present value of expected future cash flows (discounted cash flows), or some other fair value measure.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and other indefinite lived intangible assets</a></td>
<td class="text">Goodwill and other indefinite lived intangible assetsThe Company reviews goodwill and other intangibles that have indefinite lives for impairment annually as of the end of the fiscal year or when events or changes in circumstances indicate the carrying value of these assets might exceed their current fair values.  Impairment testing is based upon the best information available including estimates of fair value which incorporate assumptions market participants would use in making their estimates of fair value.  In 2020, the Company recorded full impairment charges related to its $4.5&#160;million of goodwill and $49.8&#160;million of IPR&amp;D (See "Note 3 - Business Combination" for more information).  No impairment was recorded in the years ended December&#160;31, 2021.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Allowance for doubtful accounts</a></td>
<td class="text">Allowance for doubtful accountsAn allowance for doubtful accounts is maintained for potential credit losses based on the aging of trade receivables, historical bad debts experience and changes in customer payment patterns. Trade receivable balances are written off against the allowance when it is deemed probable that the receivable will not be&#160;collected.&#160;Trade receivables, net are stated net of reserves for certain sales allowances and provisions for doubtful accounts. Provisions for doubtful accounts were not material for the years ended December&#160;31, 2021 and 2020.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt discounts created as a result of the allocation of proceeds received from a debt issuance to warrants issued are amortized to interest expense under the effective interest method over the life of the recognized debt liability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt issuance costs include the costs of debt financings undertaken by the Company, including legal fees and other direct costs of the financing. Debt issuance costs related to a recognized debt liability are presented on the consolidated balance sheet as a direct deduction from the carrying amount of the debt liability and are amortized to interest expense over the term of the related debt, using the effective interest method.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">LeasesLeases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. Lease expense for operating leases is recognized on a straight-line basis over the expected lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain conditions may exist as of the date of the financial statements, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company&#8217;s management assesses such contingent liabilities and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#8217;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management applies the guidance in ASC 450-20-25 when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability is recorded as accrued expenses in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material are disclosed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantees are disclosed.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based compensation</a></td>
<td class="text">Share-based compensation<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for employees&#8217; and directors&#8217; share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period using the straight-line method. Forfeitures are recognized as they occur.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based payments related to the employee share purchase plan (&#8220;ESPP&#8221;) are recognized based on the fair value of each award estimated on the first day of the offering period and recognized as an expense over the offering period using the straight-line method.</span></div>The Company elected to recognize compensation costs for awards conditioned only on continued service that have a graded vesting schedule using the straight-line method based on the multiple-option award approach.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text">Revenue recognition<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its revenue transactions under FASB ASC Topic 606,&#160;Revenue from Contracts with Customers. In accordance with ASC Topic 606, the Company recognizes revenues when its customers obtain control of its product for an amount that reflects the consideration it expects to receive from its customers in exchange for that product. To determine revenue recognition for contracts that are determined to be in scope of ASC Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once the contract is determined to be within the scope of ASC Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when such performance obligation is satisfied.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers include a limited number of national and select regional wholesalers (the &#8220;distributors&#8221;) and certain independent and specialty pharmacies, together (the "customers"). These distributors subsequently resell the product, primarily to retail pharmacies that dispense the product to patients. Net product revenue is typically recognized when customers obtain control of the Company&#8217;s products, which occurs at a point in time, typically upon delivery of product to the customers. The Company evaluates the creditworthiness of its customers to determine whether it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur. The Company does not assess whether a contract has a significant financing component if the expectation is such that the period between the transfer of the promised goods to the customer and the receipt of payment will be less than one year. Standard credit terms do not exceed 75 days. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that would have been recognized is one year or less or the amount is immaterial. Shipping and handling costs related to the Company&#8217;s product sales are included in selling, general and administrative expenses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net product revenues through&#160;December&#160;31, 2021&#160;were generated through sales of AMZEEQ, which was approved by the FDA in October 2019 and was commercially launched in the United States in January 2020 and ZILXI, which was approved by the FDA in May 2020 and was commercially launched in the United States in October 2020. Product revenue is recorded net of distribution fees, trade discounts, allowances, rebates, copay program coupons, chargebacks, estimated returns and other incentives. These reserves are classified as either reductions of accounts receivable or as current liabilities. The estimates of reserves established for variable consideration reflect current contractual and statutory requirements, known market events and trends, industry data and forecasted customer mix. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net product revenues only to the extent that it is probable that a significant reversal of the amount of the cumulative revenues recognized will not occur in a future period. Actual amounts may ultimately differ from these estimates. If actual results vary, estimates may be adjusted in the period such change in estimate becomes known, which could have an impact on earnings in the period of adjustment. See &#8220;Note 4 &#8211; Revenue Recognition&#8221; for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2020, the Company announced that it entered into a license agreement with Cutia for our minocycline products and product candidate, if approved, on an exclusive basis in Greater China.  Under the terms of the agreement, Cutia will have an exclusive license to obtain regulatory approval of and commercialize AMZEEQ, ZILXI and, if approved in the U.S., FCD105 in the Greater China territory.  The Company will supply the finished licensed products to Cutia for clinical and commercial use.  The Company received an upfront cash payment of $10.0 million.  The license was determined to be a distinct performance obligation of the arrangement, therefore the Company recognized the revenues from the upfront license fee when the license is transferred to the licensee and the licensee is able to use and benefit from the license.  The disposition of the MST Franchise included the license agreement with Cutia including the rights to future revenues under that agreement.  See "Note 4 - Revenue Recognition" for more information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development costs</a></td>
<td class="text">Research and development costsResearch and development expenses include costs directly attributable to the conduct of research and development programs, including the cost of clinical trials, clinical trial supplies, salaries, share-based compensation expenses, payroll taxes and other employee benefits, lab expenses, consumable equipment and consulting fees. All costs associated with research and developments are expensed as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text">Income taxes:<div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deferred taxes</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is recognized to the extent that it is more likely than not that the deferred taxes will not be realized in the foreseeable future. Given the Company&#8217;s losses, the Company has provided a full valuation allowance with respect to its deferred tax assets.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Uncertainty in income tax</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows a two-step approach in recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the available evidence indicates that it is more likely than not that the position will be sustained based on technical merits. If this threshold is met, the second step is to measure the tax position as the largest amount that has more than a 50% likelihood of being realized upon ultimate settlement.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss per share</a></td>
<td class="text">Loss per share<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the weighted-average number of common stock outstanding during the period in which the reverse merger occurs was based on:</span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">The number of common stock outstanding from the beginning of that period to the merger date was computed on the basis of the weighted-average number of common stock of the legal acquiree (accounting acquirer) outstanding during the period multiplied by the exchange ratio established in the merger agreement</span></div><div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">The number of common stock outstanding from the merger date to the end of that period was the actual number of common stock of the legal acquirer (the accounting acquiree) outstanding during that period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted, is computed on the basis of the net loss for the period divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share is based upon the weighted average number of common stock and of common stock equivalents outstanding when dilutive. Common stock equivalents include outstanding stock options and warrants which are included under the treasury share method when dilutive.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following stock options, restricted stock units (&#8220;RSUs&#8221;), warrants and incremental shares to be issued under the employee stock purchase plan (&#8220;ESPP&#8221;) were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented (share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding share options, RSUs and shares under ESPP</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,306,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,994,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value measurement</a></td>
<td class="text">Fair value measurementFair value is based on the price that would be received from the sale of an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows:</span></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1:&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</span></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2:&#160;&#160;&#160;&#160;Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.</span></div><div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3&#160;&#160;&#160;&#160;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers counterparty credit risk in its assessment of fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risks</a></td>
<td class="text">Concentration of credit risks<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, restricted cash, marketable securities and accounts receivables. The Company deposits cash and cash equivalents with highly rated financial institutions and, as a matter of policy, limits the amounts of credit exposure to any single financial institution. In addition, all marketable securities carry a high rating or are government insured. The Company has not experienced any material credit losses in these accounts and does not believe it is exposed to significant credit risk on these instruments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2021, the Company's three largest customers collectively represented 41% of product revenue and 58% of accounts receivable.  For the year ended December&#160;31, 2020, the Company's largest three customers collectively represented 96% of product revenue and 90% of accounts receivable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive loss</a></td>
<td class="text">Comprehensive loss<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss includes, in addition to net loss, unrealized holding gains and losses on available-for-sale debt securities and derivative instruments designated as cash flow hedge (net of related taxes where applicable). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassification adjustments for gain or loss of available-for-sale securities are included in other income, net in the consolidated statement of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Newly issued and recently adopted accounting pronouncements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Newly issued and recently adopted accounting pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Guidance Issued:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2020-4, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" (ASU 2020-4), which provides guidance to alleviate the burden in accounting for reference rate reform by allowing certain expedients and exceptions in applying generally accepted accounting principles to contracts, hedging relationships, and other transactions impacted by reference rate reform. The provisions of ASU 2020-4 apply only to those transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. Adoption of the provisions of ASU 2020-4 are optional and are effective from March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-4 on its consolidated financial statements.  Currently, the Company does not expect the adoption of the new standard to have a material impact to the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued Accounting Standards Update No. 2016-13,&#160;&#8220;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#8221;&#160;(ASU 2016-13), which requires companies to measure credit losses of financial instruments, including customer accounts receivable, utilizing a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Subsequent to the issuance of ASU 2016-13, the FASB issued several additional Accounting Standard Updates to clarify implementation </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guidance, provide narrow-scope improvements and provide additional disclosure guidance. As a smaller reporting company, the Company will adopt ASU 2016-13 effective January 1, 2023 or at such time where it is no longer a smaller reporting company.  Currently, the Company does not expect the adoption of the new standard to have a material impact to the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the FASB issued Accounting Standards Update No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes," which clarifies and simplifies certain aspects of the accounting for income taxes.  The standard is effective for years beginning after December 15, 2020, and interim periods beginning after December 15, 2020.  This guidance became effective during the first quarter of 2021. The adoption of the new standard did not have a material impact to the Company's consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121099144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Useful Lives of Property, Plant, and Equipment</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual rates of depreciation are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 7 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 14 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 - 14 years</span></div></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following stock options, restricted stock units (&#8220;RSUs&#8221;), warrants and incremental shares to be issued under the employee stock purchase plan (&#8220;ESPP&#8221;) were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented (share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding share options, RSUs and shares under ESPP</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,306,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,994,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122122808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock', window );">Schedule of Merger Consideration to be Transferred</a></td>
<td class="text">The following is the Merger Consideration (as defined in the Merger Agreement) was transferred to effect the Merger:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deemed (for accounting purposes only) conversion of Menlo equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total consideration*</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,079&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* This amount reflects total consideration prior to reduction in respect of the CSRs (which had a fair value of $19.6 million as of the Merger Date) that were issued to Foamix shareholders and that reduced the Menlo stockholders&#8217; relative ownership in the combined company. If the effect of the CSRs is included, the total consideration deemed paid by Foamix, as the accounting acquirer, to Menlo stockholders and equity award holders in the Merger would be reduced to approximately $111.4 million, as shown in the purchase price allocation table below.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed its analysis of the allocation of the purchase price to the fair values of assets acquired and liabilities assumed as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 9, 2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,270&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,827)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,827)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated purchase price*</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Reflects reduction in the purchase price deemed paid to Menlo stockholders in the Merger on the assumption that the CSRs, in an aggregate value of $19.6 million, convert into additional shares of the combined company for the Foamix shareholders, thereby resulting in a lower percentage of the combined company&#8217;s outstanding shares being owned by Menlo stockholders following the Merger.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock', window );">Schedule of the Calculation of Goodwill from the Merger</a></td>
<td class="text">The purchase price of the transaction and the excess purchase price over the fair value of the identifiable net assets acquired, are calculated as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 9, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: fair value of net assets acquired, including other identifiable intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,545&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock', window );">Schedule of IPR&amp;D Assets Acquired through the Merger</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D recognized relates to Menlo&#8217;s once</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">daily oral serlopitant for the treatment of pruritus (itch) associated with PN that has not reached technological feasibility as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.530%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible asset</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired indefinite life intangible assets*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of identified intangible assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,800&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>* Represents acquired IPR&amp;D assets which are initially recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the associated research and development efforts. Accordingly, during the research and development period, these assets will not be amortized into earnings; instead these assets will be subject to periodic impairment testing.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of Pro Forma</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual Menlo results of operations for the period from March 9, 2020, the Effective Date, through December 31, 2020 included in the consolidated statement of operation for the year ended December 31, 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.200%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss attributable to Menlo</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma Menlo results of operations for the year ended December 31, 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year  ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTAL PRO FORMA COMBINED RESULTS OF OPERATIONS:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss per share - basic and diluted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjustments to the supplemental pro forma combined results of operations, included in the above, are as follows:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acceleration of stock based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Adjustments</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,130)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of consideration to be transferred to effect the Merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the calculation of goodwill from the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of in-process research and development indefinite lived intangible assets acquired in the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121078488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Fair Value Measurements, Recurring and Nonrecurring</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s assets and liabilities that are measured at fair value as of December&#160;31, 2021, and December&#160;31, 2020, are classified in the tables below in one of the three categories described in "Note 2 - Fair value measurement" above:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121136792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s marketable securities:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli mutual funds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121111976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s inventory:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,404&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790124792536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property And Equipment</a></td>
<td class="text"><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual rates of depreciation are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 7 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 14 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 - 14 years</span></div></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computers and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790124804584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Components of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales provisions (see Note 4)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercialized product accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Accrued Expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,593&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,452&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790124790664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Operating lease costs</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs for the year ended December&#160;31, 2021 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office lease expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles lease expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows, for amounts included in the measurement of lease liabilities are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.77</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of lease liabilities</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122109992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock', window );">Schedule of share-based compensation awards granted for options and RSUs during the period</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2021 and 2020, the Company granted options as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Award amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise price range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees and Directors:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,686,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.68- $11.08</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 year -4 years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">970,813&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 years -4 years</span></div></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Award amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise price range</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees and Directors:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,327,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.84- $12.52</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 year -4 years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">654,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 year -4 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of underlying data used for computing the fair value of the options</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underlying data used for computing the fair value of the options are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:67.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.195%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of stock option</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.02-$6.75</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.47-$7.68</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68.38%-69.38%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60.44%-69.83%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.50%-1.29%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.31%-1.26%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of the number of options outstanding</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of options outstanding for the year ended December&#160;31, 2021, and related information:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,274,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,686,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(70,827)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(435,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,410,706)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,043,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercisable at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,971,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of the number of RSUs outstanding</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the number of RSUs outstanding for the year ended December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.421%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of RSUs</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">719,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awarded</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">970,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(293,034)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(134,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,262,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of share-based compensation expenses</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the effect of share-based compensation on the statements of operations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,080&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the share-based compensation awards granted during the period, exercise price range, vesting period and expiration of awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790126696984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock', window );">Schedule of Loss Before Income Tax Taxes and Current Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes and the related tax expense (benefit) is as follows:</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:71.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loss before taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,777&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,826&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of income taxes at the U.S. federal statutory rate to the provision for income taxes is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal income tax provision at statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income tax provision, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D Impairment &amp; CSR Remeasurement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IP Gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowances</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets and liabilities</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of the Company's deferred tax assets and liabilities are as follows:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carry forward</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85,671&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70,129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less - valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(85,555)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(69,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax assets, net of valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity of the Company unrecognized tax benefits (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at January 1, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for prior year positions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for current year positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions related to expiration of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for prior year positions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additions for current year positions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions related to expiration of statute of limitations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,799&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance related to research and development tax credit positions acquired through the Merger.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of loss before income tax taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118342440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 12, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 06, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 12, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment </div>
<div>employee </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_RoyaltyPaymentPercentMaximum', window );">Royalty percent, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Number of employees terminated | employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,329,000<span></span>
</td>
<td class="nump">$ 255,568,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash used in operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56,367,000)<span></span>
</td>
<td class="num">$ (137,082,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash and investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_PaymentsForLicensingAgreements', window );">Payments for licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vyne_TopicalBETiOptionAgreementMember', window );">Topical BETi Option Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_PaymentsForLicensingAgreements', window );">Payments for licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum', window );">Milestone payments upon achieving certain criteria, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vyne_OralBETiOptionAgreementMember', window );">Oral BETi Option Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_PaymentsForLicensingAgreements', window );">Payments for licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum', window );">Milestone payments upon achieving certain criteria, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1', window );">Expected cost remaining</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=vyne_RetentionPaymentsMember', window );">Retention Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=vyne_MenloPremergerMember', window );">Menlo - Premerger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount', window );">Upfront payment</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable', window );">Additional consideration receivable</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_PeriodOfClosingTransaction', window );">Period of closing transaction</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales', window );">Milestone payments receivable upon achievement of net sales</a></td>
<td class="nump">$ 450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales', window );">Milestone payments upon achieving certain criteria, exceeding annual net sales</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected cost remaining for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Upfront Payment Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Milestone Payments Receivable Upon Achievement of Net Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone Payments Upon Achieving Certain Criteria, Exceeding Annual Net Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone Payments Upon Achieving Certain Criteria, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_PaymentsForLicensingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Licensing Agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_PaymentsForLicensingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_PeriodOfClosingTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period Of Closing Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_PeriodOfClosingTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_RoyaltyPaymentPercentMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty Payment, Percent, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_RoyaltyPaymentPercentMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=vyne_TopicalBETiOptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=vyne_TopicalBETiOptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=vyne_OralBETiOptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=vyne_OralBETiOptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=vyne_RetentionPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=vyne_RetentionPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=vyne_MenloPremergerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=vyne_MenloPremergerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122206440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 23, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of long-lived assets to be disposed of</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provisions for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">In process research and development impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 49,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=vyne_FoamixMember', window );">Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from royalties</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790119388600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Life (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">14 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125478296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Equity Awards Not Included in the Calculation of EPS (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember', window );">Outstanding share options, RSUs and shares under ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">5,306,352<span></span>
</td>
<td class="nump">4,994,333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">495,165<span></span>
</td>
<td class="nump">495,165<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790124864488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES - Concentrations of Credit Risks (Details) - Customers - Three Largest Customers<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=vyne_ThreeLargestCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=vyne_ThreeLargestCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118071848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 12, 2021 </div>
<div>shares</div>
</th>
<th class="th"><div>Apr. 07, 2020</div></th>
<th class="th">
<div>Apr. 06, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>USD ($) </div>
<div>contingentStockRight </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ContingentStockRightSharesConversion', window );">Number of common stock issued per CSR (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationEffectiveExchangeRatio', window );">Effective exchange ratio of Foamix ordinary shares into Menlo common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement', window );">Share issued and delivered upon CSR conversion (in shares) | shares</a></td>
<td class="nump">18,636,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,544,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders', window );">Ownership percentage of parent by subsidiary stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_PostMergerParentOwnershipByPreMergerParentStockholders', window );">Ownership percentage of parent by parent stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationConsiderationTransferredGross', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131,079,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,757,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards', window );">Deemed (for accounting purposes only) conversion of Menlo equity awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,322,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and in-process research &amp; development impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">54,345,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock', window );">Value of CSR converted into additional shares of the combined company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ContingentStockConsiderationRemeasurementGainLoss', window );">Contingent stock right remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">84,726,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, fair value of liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">In process research and development impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">49,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember', window );">Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessAcquisitionContingentStockRightIssued', window );">Number of contingent stock rights issued (in CSR) | contingentStockRight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationConsiderationTransferredGross', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 123,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes', window );">Number of shares deemed (for accounting purposes only) issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards', window );">Deemed (for accounting purposes only) conversion of Menlo equity awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for income tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember', window );">Foamix | Employee benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember', window );">Foamix | Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ExchangeRatio', window );">Exchange ratio per ordinary share for common stock (share per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessAcquisitionContingentStockRightIssued', window );">Number of contingent stock rights issued (in CSR) | contingentStockRight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessAcquisitionContingentStockRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of contingent stock right issued in connection with the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessAcquisitionContingentStockRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquiree Common Stock Rights Converted to Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred consisting of the conversion of equity awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationConsiderationTransferredGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer prior to the reduction in respect of the contingent stock rights issued to acquired shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationConsiderationTransferredGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationEffectiveExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective exchange ratio of ordinary shares for shares of common stock from the merger as adjusted for the conversion of contingent stock rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationEffectiveExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares deemed, for accounting purposes only, to be issued in the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ContingentStockConsiderationRemeasurementGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Stock Consideration, Remeasurement Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ContingentStockConsiderationRemeasurementGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ContingentStockRightSharesConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued per each contingent stock right.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ContingentStockRightSharesConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the exchange of ordinary shares of acquiree for common stock of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_PostMergerParentOwnershipByPreMergerParentStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of post-merger Menlo ownership held by pre-merger Menlo stockholders, as a percent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_PostMergerParentOwnershipByPreMergerParentStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of post-merger Menlo ownership held by pre-merger Foamix shareholders, as a percent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number shares issued upon conversion of common stock rights arising form the certain events as provided for in the commons stock rights agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125019096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Consideration Transferred in Merger (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 123,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards', window );">Deemed (for accounting purposes only) conversion of Menlo equity awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,322<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationConsiderationTransferredGross', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock', window );">Value of CSR converted into additional shares of the combined company</a></td>
<td class="nump">$ 19,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember', window );">Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders</a></td>
<td class="nump">123,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards', window );">Deemed (for accounting purposes only) conversion of Menlo equity awards</a></td>
<td class="nump">7,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationConsiderationTransferredGross', window );">Total consideration</a></td>
<td class="nump">131,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration net of the effect of CSRs</a></td>
<td class="nump">$ 111,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquiree Common Stock Rights Converted to Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred consisting of the conversion of equity awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationConsiderationTransferredGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer prior to the reduction in respect of the contingent stock rights issued to acquired shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationConsiderationTransferredGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122963048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Purchase Price Allocation (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Allocations of purchase price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock', window );">Value of CSR converted into additional shares of the combined company</a></td>
<td class="nump">$ 19,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember', window );">Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Allocations of purchase price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">38,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities', window );">Investment in marketable securities</a></td>
<td class="nump">22,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">In-process research and development</a></td>
<td class="nump">49,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,545<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets</a></td>
<td class="nump">117,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(5,827)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities</a></td>
<td class="num">(5,827)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase price</a></td>
<td class="nump">$ 111,443<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquiree Common Stock Rights Converted to Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790126696984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Goodwill (Details) - Foamix<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationGoodwillAbstract', window );"><strong>Business Combination, Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase price</a></td>
<td class="nump">$ 111,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets', window );">Less: fair value of net assets acquired, including other identifiable intangibles</a></td>
<td class="num">(106,898)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 4,545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of net assets acquired including other identifiable intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121934792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION - IPRD and CSR (Details) - Foamix<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract', window );"><strong>In-Process Research and Development</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Acquired indefinite life intangible assets</a></td>
<td class="nump">$ 49,800<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Fair value of identified intangible assets</a></td>
<td class="nump">$ 49,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122923304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Pro Forma (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Loss attributable to Menlo</a></td>
<td class="nump">24,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationAbstract', window );"><strong>SUPPLEMENTAL PRO FORMA COMBINED RESULTS OF OPERATIONS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenues</a></td>
<td class="nump">20,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 252,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Loss per share - basic (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Loss per share - diluted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalIncomeStatementElementsAbstract', window );"><strong>Adjustments to the supplemental pro forma combined results of operations, included in the above, are as follows:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_AdjustmentsToSupplementalProformaTransactionCosts', window );">Transaction costs</a></td>
<td class="num">$ (14,931)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation', window );">Acceleration of stock based compensation</a></td>
<td class="num">(7,199)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations', window );">Total Adjustments</a></td>
<td class="num">$ (22,130)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalIncomeStatementElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalIncomeStatementElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of acceleration of stock based compensation as adjustment to pro-forma results of the combined operation after business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of adjustments to supplemental proforma combined results of operations of the combined operation after business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_AdjustmentsToSupplementalProformaTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount pertaining to transaction costs as adjustment to pro-forma results of the combined operation after business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_AdjustmentsToSupplementalProformaTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118128632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 23, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Product Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances', window );">Product sales provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,900,000<span></span>
</td>
<td class="nump">$ 39,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Revenue reserve accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_EstimateOfProductReturnRateMinimum', window );">Minimum estimated product return (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_EstimateOfProductReturnRateMaximum', window );">Maximum estimated product return (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,755,000<span></span>
</td>
<td class="nump">20,993,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=vyne_FoamixMember', window );">Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Product Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Proceeds from royalties</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=vyne_AllowanceForSalesReturns1Member', window );">Allowance For Sales Returns</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Product Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Revenue reserve accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">License revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Product Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Product Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 931,000<span></span>
</td>
<td class="nump">$ 791,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customers | Revenue Benchmark | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Product Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customers | Revenue Benchmark | Customer Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Product Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customers | Revenue Benchmark | Customer Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Product Sales</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_EstimateOfProductReturnRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum estimate of product sales return rate at reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_EstimateOfProductReturnRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_EstimateOfProductReturnRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum estimate of product sales return rate at reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_EstimateOfProductReturnRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate of fee the entity pays for distribution services and certain date that distributors provide to the entity and sales discounts given by the entity, including, but not limited to, early payments of accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=vyne_AllowanceForSalesReturns1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=vyne_AllowanceForSalesReturns1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=vyne_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=vyne_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=vyne_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=vyne_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=vyne_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=vyne_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122239656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENT - Assets and Liabilities Measured at Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125160792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES - Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=vyne_IsraeliMutualFundsMember', window );">Israeli mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,027<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=vyne_IsraeliMutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=vyne_IsraeliMutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125579784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities,available-for-sale</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale', window );">Permanent impairment loss, debt securities, available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sale and maturity of marketable securities</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 38,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121060744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125930648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORY - Schedule of Inventory Components (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSupplies', window );">Raw materials</a></td>
<td class="nump">$ 3,298<span></span>
</td>
<td class="nump">$ 4,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">3,960<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 7,291<span></span>
</td>
<td class="nump">$ 7,404<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118019896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 905<span></span>
</td>
<td class="nump">$ 998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="nump">551<span></span>
</td>
<td class="nump">443<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, net</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vyne_ComputerEquipmentAndSoftwareMember', window );">Computers and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 419<span></span>
</td>
<td class="nump">$ 419<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vyne_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=vyne_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125785112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 109<span></span>
</td>
<td class="nump">$ 341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_GainLossOnSaleAndDispositionOfFixedAssets', window );">Disposed of fixed assets</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">2,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale', window );">Proceeds from sale of fixed assets</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_GainLossOnSaleAndDispositionOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Sale and Disposition of Fixed Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_GainLossOnSaleAndDispositionOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790124886456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_AccruedSalesProvisionsCurrent', window );">Accrued Sales Provisions</a></td>
<td class="nump">$ 5,489<span></span>
</td>
<td class="nump">$ 5,772<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional services</a></td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_AccruedResearchAndDevelopmentCurrent', window );">Research and development</a></td>
<td class="nump">969<span></span>
</td>
<td class="nump">862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Marketing</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_AccruedCommercializedProductCurrent', window );">Commercialized product accruals</a></td>
<td class="nump">596<span></span>
</td>
<td class="nump">1,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total Accrued Expenses</a></td>
<td class="nump">$ 8,593<span></span>
</td>
<td class="nump">$ 11,452<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_AccruedCommercializedProductCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Commercialized Product Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_AccruedCommercializedProductCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Research And Development Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_AccruedSalesProvisionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Sales Provisions Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_AccruedSalesProvisionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790119512472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASE - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 13, 2019 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_OperatingLeaseRightOfUseAssetCurrent', window );">Operating Lease, right of use assets, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 338<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, right-of-use liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349<span></span>
</td>
<td class="nump">$ 1,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_RestrictedInvestmentsToSecureLeaseAgreements', window );">Lien on marketable securities to secure lease agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vyne_OriginalSpaceMember', window );">Original Space | Bridgewater, New Jersey</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_FacilitySpaceUnderLease', window );">Facility space leased | ft&#178;</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, right-of-use liability</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vyne_AdditionalSpaceMember', window );">Additional Space | Bridgewater, New Jersey</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_FacilitySpaceUnderLease', window );">Facility space leased | ft&#178;</a></td>
<td class="nump">4,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, right-of-use liability</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_VehicleLeasePrepaymentPeriod', window );">Vehicles lease prepaid period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_OperatingLeaseRightOfUseAssetsTransferred', window );">Right of use assets transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_OperatingLeaseLiabilityTransferred', window );">Right of use liabilities transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_FacilitySpaceUnderLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Size of the facility under lease, in square feet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_FacilitySpaceUnderLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_OperatingLeaseLiabilityTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liability Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_OperatingLeaseLiabilityTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_OperatingLeaseRightOfUseAssetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right of Use Asset, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_OperatingLeaseRightOfUseAssetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_OperatingLeaseRightOfUseAssetsTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right of Use Assets Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_OperatingLeaseRightOfUseAssetsTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_RestrictedInvestmentsToSecureLeaseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lien on marketable securities in respect of bank guarantees granted in order to secure lease agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_RestrictedInvestmentsToSecureLeaseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_VehicleLeasePrepaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period of prepaid to secure lease of vehicles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_VehicleLeasePrepaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vyne_OriginalSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=vyne_OriginalSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=vyne_BridgewaterNewJerseyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=vyne_BridgewaterNewJerseyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vyne_AdditionalSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=vyne_AdditionalSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118043992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASE - Schedule of Operating Lease Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=srt_OfficeBuildingMember', window );">Office lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease costs</a></td>
<td class="nump">$ 357<span></span>
</td>
<td class="nump">$ 961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease costs</a></td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 390<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=srt_OfficeBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=srt_OfficeBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125961400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASE - Schedule of Cash Paid for Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=srt_OfficeBuildingMember', window );">Office lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">$ 373<span></span>
</td>
<td class="nump">$ 971<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Operating Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 390<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=srt_OfficeBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=srt_OfficeBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121942264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING LEASE - Schedule of Supplemental Information Related to Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 1,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">9 months 7 days<span></span>
</td>
<td class="text">1 year 11 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">13.10%<span></span>
</td>
<td class="nump">13.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790125026424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING LEASE - Schedule of Maturities of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 1,610<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790121058280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE SAVINGS PLAN (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Company contributions to 401(k) plans</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790115095144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 11, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 29, 2019 </div>
<div>USD ($) </div>
<div>lender </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 12, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 17, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_RepaymentOfDebtPrepaymentFeePercentage', window );">Prepayment fee, percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Debt repayment (Note 13)</a></td>
<td class="nump">$ 36,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,432,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Principal amount, interest and prepayment premium</a></td>
<td class="nump">$ 18,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNetAbstract', window );"><strong>Debt offering expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts', window );">Incurred expenses related to Credit Agreement and Securities Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">debt prepayment penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,610,000<span></span>
</td>
<td class="nump">4,390,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Discount cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_NumberOfLenders', window );">Number of lenders involved | lender</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementMember', window );">Amended And Restated Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Base interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DebtInstrumentFeePercent', window );">Debt instrument fee as a percent of the aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementMember', window );">Amended And Restated Credit Agreement | One-month LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember', window );">Amended and Restated Credit Agreement, Trench 1 Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember', window );">Amended and Restated Credit Agreement, Trench 2 Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNetAbstract', window );"><strong>Debt offering expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts', window );">Incurred expenses related to Credit Agreement and Securities Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember', window );">Amended and Restated Credit Agreement, Trench 3 Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vyne_ShareholderLenderMember', window );">Shareholder Lender | Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ClassOfWarrantAbstract', window );"><strong>Warrants issued</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of ordinary shares that may be purchased by exercise of warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">495,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">651,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vyne_ShareholderLenderMember', window );">Shareholder Lender | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vyne_ShareholderLenderMember', window );">Shareholder Lender | Registered Offering Per Securities Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_NumberOfLenders', window );">Number of lenders involved | lender</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_GrossProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentOfFinancingAndStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ClassOfWarrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>n/a</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ClassOfWarrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_DebtInstrumentFeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument, as a percent of the aggregate principal amount of all loans outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_DebtInstrumentFeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_GrossProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross proceeds from issuance of common stock before deducting offering expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_GrossProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_NumberOfLenders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of lenders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_NumberOfLenders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_RepaymentOfDebtPrepaymentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of Debt, Prepayment Fee, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_RepaymentOfDebtPrepaymentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vyne_ShareholderLenderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vyne_ShareholderLenderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vyne_RegisteredOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vyne_RegisteredOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790114192360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Common Stock, Preferred Stock, and Warrants Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 12, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 12, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 28, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 09, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 06, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>contingentStockRight </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 25, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 29, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification', window );">Deemed dividend to warrants holders due to warrant modification | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of issuance costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,981,000<span></span>
</td>
<td class="nump">61,639,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement', window );">Share issued and delivered upon CSR conversion (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,636,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,544,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember', window );">Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessAcquisitionContingentStockRightIssued', window );">Number of contingent stock rights issued (in CSR) | contingentStockRight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification', window );">Deemed dividend to warrants holders due to warrant modification | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of shares issued pursuant to the merger (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,544,413<span></span>
</td>
<td class="nump">36,500,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=vyne_FoamixMember', window );">Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification', window );">Deemed dividend to warrants holders due to warrant modification | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=vyne_FoamixMember', window );">Foamix | Shareholder Lender</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of ordinary shares that may be purchased by exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">495,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">651,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vyne_CantorSalesAgreementMember', window );">Cantor Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_SaleOfStockConsiderationReceivableOnTransaction', window );">Consideration receivable on transaction | $</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received in a transaction | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of issuance costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock', window );">Commission from gross proceeds from issuance of common stock</a></td>
<td class="nump">3000.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,778,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,955,313<span></span>
</td>
<td class="nump">1,175,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 7.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vyne_RegisteredDirectOfferingMember', window );">Registered Direct Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received in a transaction | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,274,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vyne_PublicStockOfferingMember', window );">Public Stock Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received in a transaction | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,776,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_CommonStockVotingRightsNumberPerShare', window );">Number of votes entitled to each ordinary share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessAcquisitionContingentStockRightIssued', window );">Number of contingent stock rights issued (in CSR) | contingentStockRight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants | Foamix | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of ordinary shares that may be purchased by exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,980,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessAcquisitionContingentStockRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of contingent stock right issued in connection with the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessAcquisitionContingentStockRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission from Gross Proceeds From Issuance Of Common Stock, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_CommonStockVotingRightsNumberPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of votes entitled to each ordinary share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_CommonStockVotingRightsNumberPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from modification of warrants that is deemed dividend</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_SaleOfStockConsiderationReceivableOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Consideration Receivable on Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_SaleOfStockConsiderationReceivableOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number shares issued upon conversion of common stock rights arising form the certain events as provided for in the commons stock rights agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vyne_ShareholderLenderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=vyne_ShareholderLenderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vyne_CantorSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vyne_CantorSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vyne_RegisteredDirectOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vyne_RegisteredDirectOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vyne_PublicStockOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vyne_PublicStockOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790117793000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE BASED COMPENSATION - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 12, 2021 </div>
<div>contingentStockRight </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 09, 2020 </div>
<div>USD ($) </div>
<div>contingentStockRight</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>contingentStockRight </div>
<div>shares</div>
</th>
<th class="th"><div>Apr. 06, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ContingentStockRightSharesConversion', window );">Number of common stock issued per CSR (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessCombinationEffectiveExchangeRatio', window );">Effective exchange ratio of Foamix ordinary shares into Menlo common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment', window );">Additional paid in capital reclassified to derivate liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term of outstanding options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term of exercisable options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized share based compensation expense, options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of exercisable options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember', window );">Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessAcquisitionContingentStockRightIssued', window );">Number of contingent stock rights issued (in CSR) | contingentStockRight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue', window );">Fair value of options and RSUs granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
<td class="nump">11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment cost not yet recognized, weighted average period of recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized share-based compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment cost not yet recognized, weighted average period of recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember', window );">Employees and consultants | Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental compensation costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="nump">$ 11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost', window );">Incremental compensation costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod', window );">Incremental compensation costs, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember', window );">No longer employed or providing services | Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental compensation costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment', window );">Additional paid in capital reclassified to derivate liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessAcquisitionContingentStockRightIssued', window );">Number of contingent stock rights issued (in CSR) | contingentStockRight</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued during the period (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,890<span></span>
</td>
<td class="nump">61,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vyne_A2019PlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">979,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vyne_A2018PlanMember', window );">2018 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vyne_EmployeeStockPurchasePlanMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,232,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Percentage of fair market value used as purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Percent of annual earnings that may be used to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vyne_EmployeeStockPurchasePlanMember', window );">ESPP | Common stock | Foamix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Stock issued during the period, conversation units (in shares) | shares</a></td>
<td class="nump">9,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_BusinessAcquisitionContingentStockRightIssued', window );">Number of contingent stock rights issued (in CSR) | contingentStockRight</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vyne_EmployeeStockPurchasePlanMember', window );">ESPP | Common stock | Menlo | Employees and consultants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Stock issued during the period, conversation units (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessAcquisitionContingentStockRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of contingent stock right issued in connection with the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessAcquisitionContingentStockRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_BusinessCombinationEffectiveExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective exchange ratio of ordinary shares for shares of common stock from the merger as adjusted for the conversion of contingent stock rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_BusinessCombinationEffectiveExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ContingentStockRightSharesConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued per each contingent stock right.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ContingentStockRightSharesConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total fair value of options and equity instruments other than options granted during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Arrangement, Plan Modification, Unrecognized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Arrangement, Plan Modification, Unrecognized Costs, Recognition Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The excess of the fair value of the modified award over the fair value of the award immediately before the modification pertaining grantees not employed or providing services after the modification and reclassified from additional paid-in capital to derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=vyne_FoamixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=vyne_FoamixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vyne_A2019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vyne_A2019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vyne_A2018PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vyne_A2018PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vyne_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vyne_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=vyne_MenloMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=vyne_MenloMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118926200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Compensation Related Costs, Share Based Payments - Options and RSU Grants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">1,686,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">1,686,405<span></span>
</td>
<td class="nump">1,327,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price range, minimum (in dollars per share)</a></td>
<td class="nump">$ 1.68<span></span>
</td>
<td class="nump">$ 5.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price range, maximum (in dollars per share)</a></td>
<td class="nump">$ 11.08<span></span>
</td>
<td class="nump">$ 12.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSU, award amount (in shares)</a></td>
<td class="nump">970,813<span></span>
</td>
<td class="nump">654,427<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118098664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Compensation Related Costs, Share Based Payments - Schedule of Underlying Data Used for Computing the Fair Value of the Options (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Apr. 06, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value of stock option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">68.38%<span></span>
</td>
<td class="nump">60.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">69.38%<span></span>
</td>
<td class="nump">69.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.31%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">1.29%<span></span>
</td>
<td class="nump">1.26%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value of stock option</a></td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 3.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value of stock option</a></td>
<td class="nump">$ 6.75<span></span>
</td>
<td class="nump">$ 7.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118266136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Compensation Related Costs, Share Based Payments - Summary of the Number of Options Outstanding Under the Plan (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">4,043,952<span></span>
</td>
<td class="nump">4,274,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">1,686,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(70,827)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(435,569)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(1,410,706)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">4,043,952<span></span>
</td>
<td class="nump">4,274,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Outstanding and exercisable (in shares)</a></td>
<td class="nump">1,971,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 13.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">5.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">7.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">8.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in dollars per share)</a></td>
<td class="nump">17.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in dollars per share)</a></td>
<td class="nump">9.20<span></span>
</td>
<td class="nump">$ 13.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding and exercisable (in dollars per share)</a></td>
<td class="nump">$ 12.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118015832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Compensation Related Costs, Share Based Payments - Summary of Number of RSUs Outstanding (Details) - RSU - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">719,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awarded (in shares)</a></td>
<td class="nump">970,813<span></span>
</td>
<td class="nump">654,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(293,034)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(134,822)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">1,262,400<span></span>
</td>
<td class="nump">719,443<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122195832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE BASED COMPENSATION - Schedule of Share-based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">$ 8,080<span></span>
</td>
<td class="nump">$ 18,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">1,714<span></span>
</td>
<td class="nump">4,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">$ 6,366<span></span>
</td>
<td class="nump">$ 13,354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118912680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX - Schedule of Income (Loss) Before Income Tax Taxes and Current Tax Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract', window );"><strong>Loss before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before taxes</a></td>
<td class="nump">$ 73,777<span></span>
</td>
<td class="nump">$ 255,826<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(456)<span></span>
</td>
<td class="num">(258)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current taxes</a></td>
<td class="num">(448)<span></span>
</td>
<td class="num">(253)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract', window );"><strong>Loss before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before taxes</a></td>
<td class="nump">69,196<span></span>
</td>
<td class="nump">211,447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract', window );"><strong>Loss before income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before taxes</a></td>
<td class="nump">$ 4,581<span></span>
</td>
<td class="nump">$ 44,379<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122177080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX - Income Tax Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal income tax provision at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income tax provision, net of federal benefit</a></td>
<td class="num">(0.01%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent', window );">IPR&amp;D Impairment &amp; CSR Remeasurement</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(11.42%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent', window );">Transaction Costs</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.07%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent', window );">IP Gain</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(14.65%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowances</a></td>
<td class="num">(20.27%)<span></span>
</td>
<td class="nump">6.16%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax rate differential</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="num">(0.11%)<span></span>
</td>
<td class="num">(0.27%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.61%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Gain on Intangible Assets, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development and Contingent Stock Right Remeasurement, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Transaction Costs, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790117764104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">$ 3,083<span></span>
</td>
<td class="nump">$ 2,799<span></span>
</td>
<td class="nump">$ 3,083<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">69,743<span></span>
</td>
<td class="nump">85,555<span></span>
</td>
<td class="nump">69,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance, deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,800<span></span>
</td>
<td class="num">$ (1,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain', window );">Intellectual property acquired, taxable gain</a></td>
<td class="nump">$ 163,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_IncomeTaxLineItems', window );"><strong>Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_IncomeTaxLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>IncomeTax Line Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_IncomeTaxLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liquidation of Subsidiary, Intellectual Property Acquired, Taxable Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118101848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAX - Schedule of Deferred Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry forward</a></td>
<td class="nump">$ 73,259<span></span>
</td>
<td class="nump">$ 55,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carryforwards</a></td>
<td class="nump">7,905<span></span>
</td>
<td class="nump">7,387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share based compensation</a></td>
<td class="nump">3,281<span></span>
</td>
<td class="nump">4,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Accrued expenses and other</a></td>
<td class="nump">1,226<span></span>
</td>
<td class="nump">2,325<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">85,671<span></span>
</td>
<td class="nump">70,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less - valuation allowance</a></td>
<td class="num">(85,555)<span></span>
</td>
<td class="num">(69,743)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use assets</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(345)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total gross deferred tax liabilities</a></td>
<td class="num">(116)<span></span>
</td>
<td class="num">(386)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790122162840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX - Schedule of Activity of the Company Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at the beginning of the period</a></td>
<td class="nump">$ 3,083<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for prior year positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for current year positions</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions related to expiration of statute of limitations</a></td>
<td class="num">(456)<span></span>
</td>
<td class="num">(258)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at the end of period</a></td>
<td class="nump">$ 2,799<span></span>
</td>
<td class="nump">$ 3,083<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790126898744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX- Schedule of Rollforward of Valuation Allowance (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DeferredTaxAssetsValuationAllowanceRollForward', window );"><strong>Deferred Tax Assets, Valuation Allowance [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at the beginning of the period</a></td>
<td class="nump">$ 69,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</a></td>
<td class="num">(15,800)<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at the end of period</a></td>
<td class="nump">$ 85,555<span></span>
</td>
<td class="nump">$ 69,743<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_DeferredTaxAssetsValuationAllowanceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_DeferredTaxAssetsValuationAllowanceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139790118473752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 15, 2022</div></th>
<th class="th"><div>Jan. 12, 2022</div></th>
<th class="th"><div>Feb. 01, 2019</div></th>
<th class="th"><div>Jan. 25, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 16, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 12, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Carrying amount of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=vyne_CantorSalesAgreementMember', window );">Cantor Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,778,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,955,313<span></span>
</td>
<td class="nump">1,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received in a transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_SaleOfStockConsiderationReceivableOnTransaction', window );">Consideration receivable on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of franchises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of franchises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Contingent consideration receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable', window );">Additional consideration receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales', window );">Milestone payments receivable upon achievement of net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales', window );">Milestone payments upon achieving certain criteria, exceeding annual net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Cantor Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,465,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received in a transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Lincoln Park Equity Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="nump">1,667,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_SaleOfStockConsiderationReceivableOnTransaction', window );">Consideration receivable on transaction</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vyne_EquityPurchaseAgreementPeriodInForce', window );">Term of equity purchase agreement</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Estimated gain on sale of MST Franchise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Estimated gain on sale of MST Franchise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Upfront Payment Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Milestone Payments Receivable Upon Achievement of Net Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_EquityPurchaseAgreementPeriodInForce">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Purchase Agreement, Period in Force</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_EquityPurchaseAgreementPeriodInForce</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone Payments Upon Achieving Certain Criteria, Exceeding Annual Net Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vyne_SaleOfStockConsiderationReceivableOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Consideration Receivable on Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vyne_SaleOfStockConsiderationReceivableOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vyne_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vyne_CantorSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vyne_CantorSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=vyne_LincolnParkEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=vyne_LincolnParkEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>vyne-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:vyne="http://vynetherapeutics.com/20211231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vyne-20211231.xsd" xlink:type="simple"/>
    <context id="i5c93a1c774774356afee639d2e955920_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ife41df1c5a4f4200865c68bb2315c953_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i830539361e424a33bbef8df83b329bbb_I20220302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="id7f1ccafb608431fb6c6c1da15102473_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i415666db8d7a40719c40bd0b1f9fa2de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2bd7331082874ff88a6ef07310db1b10_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibe95dbd24c1e41a1bb7c8821c5966526_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i479c60f4404d43ad9851018c65b3dd34_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i516662a4a0d6421a948606bc11a4248c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f3508ae7116426b88ab53b907d0b8a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i78c293e52180494c8c19af75d240a16f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if47e65e7cf8947d280a6cd3bc2ec52ee_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i79b1207beabf4c39905094c110517562_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if43043bf29704f0480ca31e8929ace71_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic5d5892bfe124a9f9812002e2a561ca7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i413ad6395c874b3ea0fb49e390a331d2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4e006948a7a24010afaf3207af41b5d5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifc3ae6194fdc4591b66a1cbe7d6fe9e4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia95c98274f654d0dbb3883e6494fb991_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f00e75a6bfd46a897f7a483a51d3bf3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id9705c601c1a4a6790f6dd8fdbe9823f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i730514296aa347cbbdbbd7988e9b1db9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iecd12d821ca244dd9d27b10250b62aa9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if44b2ce2087d41208cbc3e7cc5adaaec_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i236481f63a1745d09a131f29f465b969_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2ae89d2530b0476aae8a3aac2954a443_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7905f84f35ea488095252b0854ef24b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9b1bde6ee6947c3815be0701e98b131_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b6992a9bef14397a85f536344720b58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i704f51eae14f4b16a31b91248c1468b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-12</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-12</instant>
        </period>
    </context>
    <context id="i3f84161efc234efd80e4eaa6e6f105d5_D20210806-20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="i477ed4d994a24491901ffcdf33bca2bc_D20210806-20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vyne:TopicalBETiOptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="iccf5d6ca3a0e4b62ae5cb3f221bd420c_D20210806-20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vyne:OralBETiOptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-06</startDate>
            <endDate>2021-08-06</endDate>
        </period>
    </context>
    <context id="i0d600c9dd1a04a7c8e003a167844054e_I20210806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <instant>2021-08-06</instant>
        </period>
    </context>
    <context id="ia5eadddfbc494126bf9aa92fd1fba8f3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ida05e158eeb4498bad602ba50db10863_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">vyne:RetentionPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i50aaf6903e0449e78c0c8a43db1571f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5cf7aa626774cfea6cad9737b2d831f_I20210212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:MenloPremergerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-12</instant>
        </period>
    </context>
    <context id="iba55a12228574923bbb188bfa1675bd5_I20210212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <instant>2021-02-12</instant>
        </period>
    </context>
    <context id="if700df1c23de4808b1135e843d318a8a_D20210212-20210212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <startDate>2021-02-12</startDate>
            <endDate>2021-02-12</endDate>
        </period>
    </context>
    <context id="i0a6e3943e4f3499aa05c5f1b79ea9be6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if1a583001e26487cab80e9da2a4c8bf1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if1270645810f47e9a7e83fb038ed2bf1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic5fd0d9bbcec4faaa99fa1d6f9cfcd5a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i842ae2d9ee184a8ab5883bcf17a70e63_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie53f456c44c141d9a86e97266cc12298_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd175173768e4ea8aed9f33191f66791_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8bc82390929346cc83aa1a859f646cb1_D20200423-20200423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-23</startDate>
            <endDate>2020-04-23</endDate>
        </period>
    </context>
    <context id="icb7ed5c301ca4a1fb4df13b64075b204_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vyne:ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idf66ae22fce94621a923fc88150b0de4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vyne:ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0e320cc859974d9a8611825211a48e4d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i04c5ebd48f7b4ed7a5b18e2619c3dc71_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i748a6a56555e4b559d51845f4cf5e925_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0e802c47b5b948f28423b29c6ae7b1ed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i89b5ce1d295243118db097ac730c0000_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6ada4de775684974955fee5f4e5ae4f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:ThreeLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib5a47ebbee0041dab8fdf54e6e3642fa_I20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-09</instant>
        </period>
    </context>
    <context id="ic28ecddbecb14089bf87f872b42485b0_I20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <instant>2020-04-06</instant>
        </period>
    </context>
    <context id="i1b5ca9e470654e73af6168a009123651_D20200406-20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <startDate>2020-04-06</startDate>
            <endDate>2020-04-06</endDate>
        </period>
    </context>
    <context id="ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <startDate>2020-04-07</startDate>
            <endDate>2020-04-07</endDate>
        </period>
    </context>
    <context id="ic600bdee39bf4a4880487b43ba9df188_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5d104d36f6484a09b3af55f5a52b179a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4ea3fe3e2a474e2c836df31770569ca5_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="ic9db52a2ac30420c84e995e7b348eeb8_I20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-09</instant>
        </period>
    </context>
    <context id="ie3d87335d72c46baae89c74cf256abfc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idcd1310cc41948fda92510020e6c5311_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia44d040e2d58449fb2c8ccba534d3561_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icd2d1d4d5236485dbd015be1f3e9a186_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1c4616f3027c41d7a959089637cbe325_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0de48e6f1dee484cb5de248475e21cc0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4538b4163a484df9a5150bc090ab457d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">vyne:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i629adb3cec5646989a6518dee4a69029_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">vyne:AllowanceForSalesReturns1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifdd96b5be5604cd99fd57eea397b6062_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1d39c3ca7874b59904e3c0e861e4215_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f3653857bf949f4a2ef81a87a83f1fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i894c1d96a0e74f408876a0655283cf8d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2b2fcf164d44dcfa785ffe4c6fc0674_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">vyne:IsraeliMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e9681eeba6644f3af02c673a4fd06b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">vyne:IsraeliMutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic65e68488b4a44bfb1349485e00bc902_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fff6625e4e44353b52824e303e6c56c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibcce6081c1204eeebe23dd6751efbbda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i61ea3c6a2b9643c4b0c38a30feec97fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2e122d5e1c4441fb4e5269084ca195c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i958fd692be7048b692433788e3424109_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic48701016b5b4663afd273a98b086ca0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i101ececdf4914f5ba6e572e864e4cf66_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99a4341caaaf441eaf0074526a0a8807_D20190313-20190313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vyne:BridgewaterNewJerseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:OriginalSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-13</startDate>
            <endDate>2019-03-13</endDate>
        </period>
    </context>
    <context id="i941659ebe9434514a406d1f56a59ad1c_D20190313-20190313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vyne:BridgewaterNewJerseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:AdditionalSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-13</startDate>
            <endDate>2019-03-13</endDate>
        </period>
    </context>
    <context id="i51a910c9c1a147509aff2e6f87810f5c_I20190313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vyne:BridgewaterNewJerseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:OriginalSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-13</instant>
        </period>
    </context>
    <context id="i31d953cfd865427281cfadfbca27bacf_I20190313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">vyne:BridgewaterNewJerseyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vyne:AdditionalSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-13</instant>
        </period>
    </context>
    <context id="id5c046f0b00a43cd82cd79465a32a139_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i095f99f5dad646848e17f3e6cf867662_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if7f07698396e4710961b022584df3af9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icdc06dd768af4cf19fdbabdfd9a1e045_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9d3b1bab5fa44cbfa425becb06eecfc7_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vyne:ShareholderLenderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="if989d0b1c2c24f45b11a284fac301a66_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i284a65a8749542cdb95cbcc24fe35192_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vyne:ShareholderLenderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:RegisteredOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i0c259adecd3644dbaca374ee117b6d25_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia96474a494374f3385b000f4f8d33fca_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementTrench1LoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i577c52ea7b5b40aab1df1b785fc2c96e_I20191217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementTrench2LoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-17</instant>
        </period>
    </context>
    <context id="i04ea1c0a01244363ac01049f1f6c7857_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementTrench3LoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic10e4840e05c4e729cd9e69af333a006_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e9df17c9abb40a896c4e95cd18226bd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66e2d83dcb2e4d44a68e3d1c04503e5c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia7de8816c3eb465d9f44397038347e0a_I20210811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <instant>2021-08-11</instant>
        </period>
    </context>
    <context id="iaac44e519733479cb2fd74f4d69991a1_D20210811-20210811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-11</endDate>
        </period>
    </context>
    <context id="i9949f940927a4c1fb5d8ac40b1e2e0e4_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vyne:ShareholderLenderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i0fb8e95fc2ea4faea89832a8d5669b5e_I20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vyne:ShareholderLenderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-09</instant>
        </period>
    </context>
    <context id="id99703f9fd5b41b2b59fde641c5048bd_I20210212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vyne:ShareholderLenderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-12</instant>
        </period>
    </context>
    <context id="i888b43bee8a74b63b94b21ef02c0a940_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementTrench2LoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i160f84d5cf9d48ca8c977e79e5f245b3_D20190729-20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">vyne:AmendedAndRestatedCreditAgreementTrench2LoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-29</startDate>
            <endDate>2019-07-29</endDate>
        </period>
    </context>
    <context id="i74ce2a3821c540e0b8de1b57d9790d94_I20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-29</instant>
        </period>
    </context>
    <context id="i34dafd0890e345cb94a8cf7a2e26625f_D20190701-20190729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-29</endDate>
        </period>
    </context>
    <context id="i5f0643079f4b4a46a6f72aa2aa70777a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic653c6de73fb47fea4bbe97cf2f5f3ab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0aa0866aa6994b3b9cbbaddb8ed97944_D20190201-20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-01</endDate>
        </period>
    </context>
    <context id="i371ccbf335764d51b576f9a2336b47b2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i88edc7fdfcf4414e8659f3d6de7a6b5a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd040f22c54846a4803901905b00f633_D20210101-20210125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-25</endDate>
        </period>
    </context>
    <context id="i9789581a138e48bf9397a195c54b4c33_I20210125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-25</instant>
        </period>
    </context>
    <context id="i66bbeb9a734f427982630691149f765d_I20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="i0b46cdcdfa37452ab8c70071f20ab9c7_D20210812-20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="ib74ed9a5f0a84a079fd6937d9d2f0453_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i65dd613b82a44b218deffd9c0f7db2f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i347a6acc4a7a45968674fa63bfa3890b_D20210128-20210128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-28</startDate>
            <endDate>2021-01-28</endDate>
        </period>
    </context>
    <context id="ica625a9375d843ae871ac0d4b3db4352_I20210128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-28</instant>
        </period>
    </context>
    <context id="i343a467bc0454f449ea44b8054c6e2f8_D20200609-20200609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:PublicStockOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-09</startDate>
            <endDate>2020-06-09</endDate>
        </period>
    </context>
    <context id="if1c5a77b02644689af601da56f6c2307_I20200609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:PublicStockOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-09</instant>
        </period>
    </context>
    <context id="ibea690c21df9415993df8d2c1da95438_D20200406-20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-06</startDate>
            <endDate>2020-04-06</endDate>
        </period>
    </context>
    <context id="i9dd45671031841d1ab0aae6c9fc9d75b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:A2019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic18e51c0667246cbb9cd142b80514de6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:A2018PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3cd6043c4c234199b9b39bb81ff103fa_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i9421373d63f34d70a76e0ec736a99720_I20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-09</instant>
        </period>
    </context>
    <context id="ia3e6b0bf97f5479c821f53984e43e031_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic37e0b69a2f040aa8c7b53683361dfe7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icb7a10a25f4249d48fcd322e6ea012e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie35e2089123c4e50850717116e3c90ef_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf20f8bca32849c7beef794c32d2f471_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idde6935cd313421a8ac1426f77884c47_D20210212-20210212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-12</startDate>
            <endDate>2021-02-12</endDate>
        </period>
    </context>
    <context id="ie847d448f04746f790f534394d63097f_I20210212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:FoamixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-12</instant>
        </period>
    </context>
    <context id="i1daa38912a5c4a1a9f1feaf635f77377_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vyne:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">vyne:MenloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5da521456996427aba1e3f15e8a37411_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i900d5480233e4f9c83938266d12b66f5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i23969f5a8552485eb663535fe65f545a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iac3a8466dc0e4c3ea25864b0e9da2b0c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icd305dde41e4448ebecd3c0983d175b3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b3949f3bcbc41f89845a01280213f01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic658972e380d477b81bc9fbdfd31f1db_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1049c5e9d3584238a13d1718e53ffeb3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0696c6f2ddb34f69be35f2bef6534641_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18c931db2ae34ddd8e0b75d2ddb9a6f1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0ab92efb006543c0bfb4d9c671f0e6af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5feca1c387ef4ac081bc860e994a1d02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib17baf4771f74c3c866143773332d0a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d8e2ecb65594adebbdada392434f3f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i131bd9ea97144427b459ae81f53e00d2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1aa6bb8253084128a90e0a1ebdf5b6fa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i918df004225b4092a0bff129ac010d6a_D20200309-20200309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="i2d96d676c73c4e51b5dc524d8d621a7f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">vyne:FoamixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iedd0ba546c49493ba7382642df9946c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9309bf238b44411e899d0dcb4c8d3ef9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f658b6e836f41c9b28abeb2f9bc238f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i50ff6dddfd3c429499a4b8c9b226e7d6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i71a86bb6a8854c5296b3511aacf7bb04_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic066d03c70d147b5b20e324f40a88075_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if82c661f8a794fdeb31d8f9e4a475fc6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i23a16cc6e5f846549e1725fbd52458c5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i910b930cd3714339a6b839e5f00372e1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibc98456d2d1a44c78bb669199d845601_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d4bddd1b58c43bc9015bf6630359989_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5fc0c8d37b2d4747aeb77bdce809b14b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icef12beb3e494c14b255e4114f030a13_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibcb524dbad1a4c1982574e2fe8ad19da_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i74d4ee98eed24dd08f8c5f7e4d4cbd41_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib3d169fae4d94cbd8c3022cba3a08fdf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iff8c8e02a0374a409dd8fd2818c71588_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie156775f95034bcb81ccb6f76520718e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie287f45e91a4400282fc74f2a820b92e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3a90103da5ca44acb0b6ef28d135f8d8_D20220101-20220316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:CantorSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-16</endDate>
        </period>
    </context>
    <context id="i99e857b122b54103af3bf50d59fa8745_I20220315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:LincolnParkEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-15</instant>
        </period>
    </context>
    <context id="i8601e3d553e140d586df45d81ee2c321_D20220315-20220315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001566044</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vyne:LincolnParkEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-15</startDate>
            <endDate>2022-03-15</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>vyne:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="employee">
        <measure>vyne:employee</measure>
    </unit>
    <unit id="contingentstockright">
        <measure>vyne:contingentStockRight</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="lender">
        <measure>vyne:lender</measure>
    </unit>
    <unit id="vote">
        <measure>vyne:vote</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF80L2ZyYWc6ZjllMjE0NTNlZWYxNDM1YWFkZmRkYjdlN2FkOWYxMzMvdGFibGU6ZWE1Y2RlYzE5ODQ2NGUwMTkxZWU2NTcyYTlkZDZkMjUvdGFibGVyYW5nZTplYTVjZGVjMTk4NDY0ZTAxOTFlZTY1NzJhOWRkNmQyNV8yLTEtMS0xLTIxMzkw_f8314a79-1095-4571-8783-89fa1e8ad9c9">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF80L2ZyYWc6ZjllMjE0NTNlZWYxNDM1YWFkZmRkYjdlN2FkOWYxMzMvdGFibGU6ZWE1Y2RlYzE5ODQ2NGUwMTkxZWU2NTcyYTlkZDZkMjUvdGFibGVyYW5nZTplYTVjZGVjMTk4NDY0ZTAxOTFlZTY1NzJhOWRkNmQyNV8zLTEtMS0xLTIxMzkz_350592f3-b659-454b-90cb-2d6bf561629e">0001566044</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF80L2ZyYWc6ZjllMjE0NTNlZWYxNDM1YWFkZmRkYjdlN2FkOWYxMzMvdGFibGU6ZWE1Y2RlYzE5ODQ2NGUwMTkxZWU2NTcyYTlkZDZkMjUvdGFibGVyYW5nZTplYTVjZGVjMTk4NDY0ZTAxOTFlZTY1NzJhOWRkNmQyNV80LTEtMS0xLTIxMzk1_08e5ce5b-67da-49d8-90c5-a521047b5265">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF80L2ZyYWc6ZjllMjE0NTNlZWYxNDM1YWFkZmRkYjdlN2FkOWYxMzMvdGFibGU6ZWE1Y2RlYzE5ODQ2NGUwMTkxZWU2NTcyYTlkZDZkMjUvdGFibGVyYW5nZTplYTVjZGVjMTk4NDY0ZTAxOTFlZTY1NzJhOWRkNmQyNV81LTEtMS0xLTIxMzk3_cca336ce-fc58-40ae-9309-b4d06d31fbff">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjcvZnJhZzo3ZjVkZDQ2MDUxMDU0NWIxYjgxZjEwZjA4NGQwOTA2MC90ZXh0cmVnaW9uOjdmNWRkNDYwNTEwNTQ1YjFiODFmMTBmMDg0ZDA5MDYwXzM1_009fb1d1-e57e-495e-b576-ca5596829340"
      unitRef="number">0.25</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjYvZnJhZzphOGY4NjUxZTJiZWY0OWM1YTNiYjVkZTk1MmM3ZTMwZS90ZXh0cmVnaW9uOmE4Zjg2NTFlMmJlZjQ5YzVhM2JiNWRlOTUyYzdlMzBlXzMw_13e41c0f-8061-435e-b5ac-6fca7d0882a3"
      unitRef="number">0.25</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <dei:DocumentType
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTA2_08f9ab4a-a794-4eca-a115-04ce9c8e09c9">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6N2MxMTlkMzMxYjI2NGM5Mzk4OWFjNDhlOTMwNTQwZjIvdGFibGVyYW5nZTo3YzExOWQzMzFiMjY0YzkzOTg5YWM0OGU5MzA1NDBmMl8wLTAtMS0xLTIxMzE5_454019e8-3b8a-4e57-8f95-a8b7ede30f29">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8xMjk_836ab1bb-ec4b-46c2-894b-f727fd050d66">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8xMjk_486988a2-06a5-4868-9719-2126a369bee8">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6ZjQxMWQ4NDZkYzdjNDlhZWFiNGFjZjI4NzdkMzQ0YWMvdGFibGVyYW5nZTpmNDExZDg0NmRjN2M0OWFlYWI0YWNmMjg3N2QzNDRhY18wLTAtMS0xLTIxMzIx_879acaa8-0137-4509-8edb-f0421e57f12d">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTE1_964ed15b-a6a1-4d32-9a29-12959b373726">001-38356</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTA3_3fe50e57-e50c-412d-b15c-3027fde06409">VYNE THERAPEUTICS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MWU5MmJlYTgwOTc3NDk3MTkyNDNkODdjYWQ2YTdmYmEvdGFibGVyYW5nZToxZTkyYmVhODA5Nzc0OTcxOTI0M2Q4N2NhZDZhN2ZiYV8wLTAtMS0xLTIxMzI2_993e7bc4-4893-41d8-b507-814444bb3cbf">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MWU5MmJlYTgwOTc3NDk3MTkyNDNkODdjYWQ2YTdmYmEvdGFibGVyYW5nZToxZTkyYmVhODA5Nzc0OTcxOTI0M2Q4N2NhZDZhN2ZiYV8wLTItMS0xLTIxMzI5_cbccf2e0-20b0-4915-831b-dd0956429be8">45-3757789</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTA4_2af6a5ac-07e1-40f1-88d9-75ae540550af">520 U.S. Highway 22, Suite 204</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTE2_95def352-7fe3-42de-96de-4fc1e0312ab8">Bridgewater</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTE3_5aecc775-7b10-42bb-85b9-d4d51d8de36d">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTEw_6c96db3d-03b8-4668-9cee-34886900fe1b">08807</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl80MTc_b7fb3ef8-0894-4346-a281-ae5ee375c7de">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTEx_d3aef15f-c77c-48ab-ac80-62d889bddd63">775-7936</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGZmZTk1Y2MwZWM5NDVmZWFmMGRiNTI0ZDAwYjVhOWEvdGFibGVyYW5nZTowZmZlOTVjYzBlYzk0NWZlYWYwZGI1MjRkMDBiNWE5YV8xLTAtMS0xLTIxNDA1_8754fd78-9670-4cd6-899a-34d5933c839a">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGZmZTk1Y2MwZWM5NDVmZWFmMGRiNTI0ZDAwYjVhOWEvdGFibGVyYW5nZTowZmZlOTVjYzBlYzk0NWZlYWYwZGI1MjRkMDBiNWE5YV8xLTItMS0xLTIxNDA4_6be3f274-7298-491b-9fbd-0193b44af5aa">VYNE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGZmZTk1Y2MwZWM5NDVmZWFmMGRiNTI0ZDAwYjVhOWEvdGFibGVyYW5nZTowZmZlOTVjYzBlYzk0NWZlYWYwZGI1MjRkMDBiNWE5YV8xLTQtMS0xLTIxNDEw_277b6eaa-ac21-4d1a-abad-ca040a4f7cee">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTE5_3d17fd93-1b11-425d-b875-1dcb36aa615b">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTE4_f99d32f2-15b7-4df2-8b1a-a323767bbac9">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTA0_a0ea41cd-3eb6-418c-8ab9-e99b82b55f0f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTIw_a826d37a-46eb-4586-a690-39c7724c7db4">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGRjZjBhNWZhZGNjNDRmMWJkZmIyZTdhYzljYTczMWEvdGFibGVyYW5nZTowZGNmMGE1ZmFkY2M0NGYxYmRmYjJlN2FjOWNhNzMxYV8xLTAtMS0xLTIxNDE2_7e78f730-1fee-4a8e-85db-2b533725bfc5">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGRjZjBhNWZhZGNjNDRmMWJkZmIyZTdhYzljYTczMWEvdGFibGVyYW5nZTowZGNmMGE1ZmFkY2M0NGYxYmRmYjJlN2FjOWNhNzMxYV8xLTQtMS0xLTIxNDE5_41a54362-d489-49eb-bc4e-e30dfc57fd85">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGFibGU6MGRjZjBhNWZhZGNjNDRmMWJkZmIyZTdhYzljYTczMWEvdGFibGVyYW5nZTowZGNmMGE1ZmFkY2M0NGYxYmRmYjJlN2FjOWNhNzMxYV8yLTQtMS0xLTIxNDIx_9ecf1616-3d50-4c3b-8288-1297046ea4c2">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTEy_e83af971-0d74-4f26-bd2c-14aed21ea65f">true</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTEz_b3a9c653-7e85-4d50-85f2-3707a9e4cfcb">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zNTIy_69f7f730-89a3-4684-b672-e966811941c6">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ife41df1c5a4f4200865c68bb2315c953_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8yNzM4_d659229d-2e92-4575-af28-54e555650639"
      unitRef="usd">155400000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i830539361e424a33bbef8df83b329bbb_I20220302"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xL2ZyYWc6NjQ4MjlmNzNlNDJlNDM4NTkwOGFjNzc2YjFlYThmYWIvdGV4dHJlZ2lvbjo2NDgyOWY3M2U0MmU0Mzg1OTA4YWM3NzZiMWVhOGZhYl8zMTY0_d0d18ef9-f701-48f5-8866-f2e662b5cb5b"
      unitRef="shares">56165599</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF85Ny9mcmFnOjMxMTE0MDc1NGI3MTQzNTJhM2U5YWY0MTFhOWVmMjA1L3RhYmxlOmY5OGMzODRhNTYwYzQ4ZThhOTMxMGYyZmJjOTc5MjA4L3RhYmxlcmFuZ2U6Zjk4YzM4NGE1NjBjNDhlOGE5MzEwZjJmYmM5NzkyMDhfMi0wLTEtMS0zMDc0Ni90ZXh0cmVnaW9uOmZjOWRjNjI2OTViZDRiOWViNTZmMDRjZGZiY2MyZDc0XzI1ODM4NTIzMjUyOTcz_60e5f222-d427-404d-9e07-7e7149072458">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF85Ny9mcmFnOjMxMTE0MDc1NGI3MTQzNTJhM2U5YWY0MTFhOWVmMjA1L3RhYmxlOmY5OGMzODRhNTYwYzQ4ZThhOTMxMGYyZmJjOTc5MjA4L3RhYmxlcmFuZ2U6Zjk4YzM4NGE1NjBjNDhlOGE5MzEwZjJmYmM5NzkyMDhfMi0wLTEtMS0zMDc0Ni90ZXh0cmVnaW9uOmZjOWRjNjI2OTViZDRiOWViNTZmMDRjZGZiY2MyZDc0XzI1ODM4NTIzMjUyOTky_f126f79e-ea26-4eb6-9a5a-84f0d84755de">Florham Park, NJ</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF85Ny9mcmFnOjMxMTE0MDc1NGI3MTQzNTJhM2U5YWY0MTFhOWVmMjA1L3RhYmxlOmY5OGMzODRhNTYwYzQ4ZThhOTMxMGYyZmJjOTc5MjA4L3RhYmxlcmFuZ2U6Zjk4YzM4NGE1NjBjNDhlOGE5MzEwZjJmYmM5NzkyMDhfMi0wLTEtMS0zMDc0Ni90ZXh0cmVnaW9uOmZjOWRjNjI2OTViZDRiOWViNTZmMDRjZGZiY2MyZDc0XzIxOTkwMjMyNTU2OTY_3dfc02e8-8895-42b5-ac56-77c31cb0ad8a">238</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQtMS0xLTEtMTc2ODk_f4c9ce67-9cce-486c-b843-1be59552484d"
      unitRef="usd">42250000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQtMy0xLTEtMTc2ODk_dd2b64cb-4089-4f60-b10e-48598fdb9ed1"
      unitRef="usd">57563000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUtMS0xLTEtMTc2ODk_bfe03fb0-2620-435b-a9d1-1a520121d86d"
      unitRef="usd">605000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUtMy0xLTEtMTc2ODk_c801fe3a-4d75-43d5-a866-4098a243033b"
      unitRef="usd">855000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzctMS0xLTEtMTc2ODk_97df8f51-643e-4ac2-9821-8d13199f0578"
      unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzctMy0xLTEtMTc2ODk_e2aa0e43-b39f-4f02-baaa-cc3ded537e77"
      unitRef="usd">1027000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzgtMS0xLTEtMzM1NDg_4b77e0af-b05a-4fde-bd37-4cb5261fab03"
      unitRef="usd">7583000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzgtMy0xLTEtMzM1NDg_6862724f-8489-4aa7-8432-23cf5360a57d"
      unitRef="usd">15819000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzgtMS0xLTEtMTc2ODk_9b82e42b-13e6-4612-ad55-521581a8a6f5"
      unitRef="usd">7291000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzgtMy0xLTEtMTc2ODk_ae495480-8aef-4c29-9b1e-7b6a750d5ecb"
      unitRef="usd">7404000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEwLTEtMS0xLTE3Njg5_cdc861ce-4d08-492b-9a4c-d9870a0c3671"
      unitRef="usd">5119000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEwLTMtMS0xLTE3Njg5_56724078-05d4-4495-9859-e3f258e8ed18"
      unitRef="usd">4591000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <vyne:OperatingLeaseRightOfUseAssetCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEyLTEtMS0xLTM1NTA0_22a8ec2e-e6e8-403f-a9a7-f91729d5bb88"
      unitRef="usd">338000</vyne:OperatingLeaseRightOfUseAssetCurrent>
    <vyne:OperatingLeaseRightOfUseAssetCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEyLTMtMS0xLTM1ODYz_ef748d5c-6553-4eda-9371-e2ed558ea6fd"
      unitRef="usd">0</vyne:OperatingLeaseRightOfUseAssetCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEyLTEtMS0xLTE3Njg5_7c94aa10-9884-4a15-88d6-f1c8679e0a5d"
      unitRef="usd">63186000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzEyLTMtMS0xLTE3Njg5_05dd54c7-e88a-4d04-8522-a98866d7efd5"
      unitRef="usd">87259000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE3LTEtMS0xLTE3Njg5_d75b656d-7ada-4650-875e-d3c36d5aced2"
      unitRef="usd">354000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE3LTMtMS0xLTE3Njg5_18551e06-55e7-4301-8240-1cfed6c34575"
      unitRef="usd">555000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE4LTEtMS0xLTE3Njg5_f60fcf1b-430e-46a9-b042-01f329906a91"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE4LTMtMS0xLTE3Njg5_b27c21d7-90bf-483c-9c64-1e702bdb7a98"
      unitRef="usd">1583000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE5LTEtMS0xLTE3Njg5_7f66297d-9e76-4321-9127-c2600abe229d"
      unitRef="usd">3506000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzE5LTMtMS0xLTE3Njg5_bff2f8f8-174d-4b3d-9704-0384b6ac28e8"
      unitRef="usd">4345000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzIwLTEtMS0xLTE3Njg5_584680b7-b19a-489d-a089-a6144c50559f"
      unitRef="usd">3860000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzIwLTMtMS0xLTE3Njg5_5520c588-05c4-43f7-a5b3-93829dc488f5"
      unitRef="usd">6483000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzIyLTEtMS0xLTE3Njg5_0b42c0db-e454-4b07-8ed0-28ab7e25e1a0"
      unitRef="usd">67046000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzIyLTMtMS0xLTE3Njg5_c46f4c7a-8ee6-4eec-afe9-45f10c964016"
      unitRef="usd">93742000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzI4LTEtMS0xLTI5Njk3_7a143e92-6c8d-44cd-b6db-1361a0a3cead"
      unitRef="usd">6510000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzI4LTMtMS0xLTI5Njk3_c9b3774d-270f-4272-8d20-2a6a58535b2d"
      unitRef="usd">4780000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzI5LTEtMS0xLTI5Njk3_92a7ff73-316c-4835-b2e7-f1ada8516b47"
      unitRef="usd">8593000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzI5LTMtMS0xLTI5Njk3_cb06964a-dbba-462d-859e-aaa08b68e3e7"
      unitRef="usd">11452000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMwLTEtMS0xLTI5Njk3_f431f924-3d38-4618-b654-40d29bf01414"
      unitRef="usd">2752000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMwLTMtMS0xLTI5Njk3_decb5c44-5888-478d-b9e1-ec717611fd83"
      unitRef="usd">4360000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMxLTEtMS0xLTMxNjgx_c6bf71d5-dbe3-45ed-a185-0c2e9ef5ac52"
      unitRef="usd">206000</us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits>
    <us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMxLTMtMS0xLTMxNjgx_9ec084cd-a339-48ff-893d-5f958fb8dad7"
      unitRef="usd">312000</us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMxLTEtMS0xLTI5Njk3_9163b1b7-7ef2-4f7c-928c-6d38f7ff491d"
      unitRef="usd">349000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMxLTMtMS0xLTI5Njk3_fb9cab36-563d-48a3-9211-2cb9f4181408"
      unitRef="usd">757000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMyLTEtMS0xLTI5Njk3_e5969fcc-88cf-41a1-b64a-8da4fdb5402f"
      unitRef="usd">0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMyLTMtMS0xLTI5Njk3_83e8f617-bb2b-447e-b548-8b1bb7a8c015"
      unitRef="usd">104000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMzLTEtMS0xLTI5Njk3_5dd37d2e-f4a9-4083-ac6e-59a2267f1b44"
      unitRef="usd">18410000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzMzLTMtMS0xLTI5Njk3_84900924-f757-4662-b6fe-f1662bf3088a"
      unitRef="usd">21765000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzM4LTEtMS0xLTI5Njk3_04ba5b0c-cbd5-4f22-8e75-2b35f6f0cbf9"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzM4LTMtMS0xLTI5Njk3_c18225e9-27ad-443b-8102-6c7cc8201d8c"
      unitRef="usd">853000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzM5LTEtMS0xLTI5Njk3_14748d2e-8299-41cb-8e9b-4a5a13a6bbcc"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzM5LTMtMS0xLTI5Njk3_9e7b3f86-b55e-4fd3-b4a7-3ea3e46cab25"
      unitRef="usd">33174000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilities
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQwLTEtMS0xLTI5Njk3_22f770bb-8d35-4d8a-b411-c99931cf5c53"
      unitRef="usd">0</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQwLTMtMS0xLTI5Njk3_7a10a7cb-c833-4fce-8098-c3b8f632589c"
      unitRef="usd">457000</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQxLTEtMS0xLTI5Njk3_70e9fb29-cff9-4cbd-899e-48e8df7e84aa"
      unitRef="usd">0</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQxLTMtMS0xLTI5Njk3_77944091-6ad0-4fc5-a4d5-f3a7687bfea6"
      unitRef="usd">34484000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQyLTEtMS0xLTI5Njk3_d3536970-c3f7-465c-91cb-ecc5641d565d"
      unitRef="usd">18410000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQyLTMtMS0xLTI5Njk3_18cad749-795c-42bd-84b2-078de0cc61ca"
      unitRef="usd">56249000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQzLTEtMS0xLTI5Njk3_fff944bd-da0b-417c-9ad7-ffa6b026275a"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQzLTMtMS0xLTI5Njk3_ec84571f-61a7-475b-a2c2-57612658f895"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfMjI_a6665e37-42e5-4ba0-80c0-8c5874af0a57"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfMjI_ed44bf2d-6604-4a10-befe-c4e1b33d06a8"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfMzY_0aeaba44-600e-417b-91f9-7efbaf20f74e"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfMzY_c3788f94-a235-4955-8856-394985c457e5"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfODU_7893e53d-0555-44bb-9226-bd867f181b74"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfODU_dd5afb82-2ebc-41bb-b971-a20ef79aeb91"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfODU_e247aec9-998b-4747-afed-1b9d7587f84a"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2YzZWFkNjk4MTZhNGExNWE0MGU3NjRjNDE4MTBhOThfODU_e36df299-1436-4b59-bce3-966589f58074"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTEtMS0xLTI5Njk3_25d6625b-48bb-4e8c-81f2-819b292e98e6"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ1LTMtMS0xLTI5Njk3_1baa291f-bbed-40c8-a8b4-704cc7e118ce"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfMTg_7bc2de5a-d58c-40e5-a856-19cdcd7dec97"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfMTg_9033aef7-e9ab-4306-ad10-c4578255375e"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfMzI_ffcda176-3269-4538-a549-1c6b53e17258"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfNDY_be1b8fba-57e9-4c04-b8cf-37c364455c87"
      unitRef="shares">75000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfOTU_2b24fd20-bdd1-4fd1-b17d-c70ec5d49b28"
      unitRef="shares">53577744</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfOTU_83b77ba7-0bca-476f-ab14-b486249cb4ea"
      unitRef="shares">53577744</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfMTAy_c6d6aec2-3f71-4751-a16f-fe23b15e97a5"
      unitRef="shares">43205221</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTAtMS0xLTI5Njk3L3RleHRyZWdpb246Y2UwNTczNTQyMDkyNDI2Nzk4N2FkMDQ1MmNkYjBkN2FfMTAy_e5e0738e-083e-4422-a34b-0e904801f6bd"
      unitRef="shares">43205221</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTEtMS0xLTI5Njk3_3323a023-c60e-46bc-9f6a-30de3d6ff7be"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ2LTMtMS0xLTI5Njk3_d4909e44-088b-4195-9c73-db9ae89912fe"
      unitRef="usd">4000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ3LTEtMS0xLTI5Njk3_3e5abe6a-4cd4-4d4b-af66-df1412c5be0e"
      unitRef="usd">688156000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ3LTMtMS0xLTI5Njk3_35cc23b9-6065-44e3-b5f4-8ace66c6f005"
      unitRef="usd">603685000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ4LTEtMS0xLTI5Njk3_73b3d97d-ba02-43dc-9c93-128ee6cd33ff"
      unitRef="usd">-639525000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ4LTMtMS0xLTI5Njk3_8970245f-16ba-4805-8456-7b8526925b8a"
      unitRef="usd">-566196000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ5LTEtMS0xLTI5Njk3_6d048e65-aa84-49b3-9efc-5094f2924ca7"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzQ5LTMtMS0xLTI5Njk3_7b6b340f-e71c-4ebc-ad7a-b786aca184b0"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUwLTEtMS0xLTI5Njk3_d9ab8751-13ff-4a7c-8ddb-ea8a7940a546"
      unitRef="usd">48636000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUwLTMtMS0xLTI5Njk3_737d8638-ae57-4a2c-993f-5c5c030be569"
      unitRef="usd">37493000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUxLTEtMS0xLTI5Njk3_4c70e11a-4add-452c-9f0a-a0c678068d05"
      unitRef="usd">67046000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDYvZnJhZzpjMDI2ZjMzMjY0Njg0YWNmYTU3MDc0NTBiMTQ1ZjJhOC90YWJsZTo0Y2NiYmZiYTc1M2I0ODM0OTYxYWRiMTJkZjA0NTY0Ny90YWJsZXJhbmdlOjRjY2JiZmJhNzUzYjQ4MzQ5NjFhZGIxMmRmMDQ1NjQ3XzUxLTMtMS0xLTI5Njk3_49877752-33b9-4311-8587-01c8bc60a932"
      unitRef="usd">93742000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bd7331082874ff88a6ef07310db1b10_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzMtMS0xLTEtMTc2ODk_e3dad63e-3e7e-4eb2-bc7c-ecd4505762fa"
      unitRef="usd">13824000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe95dbd24c1e41a1bb7c8821c5966526_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzMtMy0xLTEtMTc2ODk_07668c08-f8e5-47f8-9c0d-42f4fda0cb4f"
      unitRef="usd">10202000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i479c60f4404d43ad9851018c65b3dd34_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzQtMS0xLTEtMTc2ODk_1023e1ad-5efa-460f-8905-6c4d1c32780b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i516662a4a0d6421a948606bc11a4248c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzQtMy0xLTEtMTc2ODk_dae6c0ee-f78c-43b9-85e4-6de47d2ccd7d"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f3508ae7116426b88ab53b907d0b8a7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzUtMS0xLTEtMTc2ODk_2e4105e8-2c01-4fed-8d43-05740d13bc9e"
      unitRef="usd">931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78c293e52180494c8c19af75d240a16f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzUtMy0xLTEtMTc2ODk_c19a2ae7-ab93-4f55-a387-eedb4f459ef0"
      unitRef="usd">791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzctMS0xLTEtMTc2ODk_ef8b06d5-d621-49fa-bba7-a65f6861c8f6"
      unitRef="usd">14755000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzctMy0xLTEtMTc2ODk_d49bd0c2-5e5b-4682-b888-fe3cc28d7d38"
      unitRef="usd">20993000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzktMS0xLTEtMTc2ODk_31168b83-36a8-4b5f-9fd8-9957c75f8794"
      unitRef="usd">3348000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzktMy0xLTEtMTc2ODk_33b38b4d-8112-4487-8bce-048866ea259d"
      unitRef="usd">1392000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzEyLTEtMS0xLTE3Njg5_c31bacfa-8c6a-4baf-8296-55478dc94cec"
      unitRef="usd">24958000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzEyLTMtMS0xLTE3Njg5_382f7f5e-60a3-4366-8363-b2777a36344e"
      unitRef="usd">43533000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzEzLTEtMS0xLTE3Njg5_cc83bdbe-f70d-4f69-9224-41336dcf3d65"
      unitRef="usd">54481000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzEzLTMtMS0xLTE3Njg5_81e47005-1510-4f36-bd28-efdf2019f4c7"
      unitRef="usd">89543000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE0LTEtMS0xLTE3Njg5_5fe25075-dfff-42fb-8173-dd4a5aeb56d9"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE0LTMtMS0xLTE3Njg5_cfebeb8e-d194-4481-9853-3928717fadec"
      unitRef="usd">54345000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <vyne:ContingentStockConsiderationRemeasurementGainLoss
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE1LTEtMS0xLTE3Njg5_67c6a973-347d-4097-8749-04e717030849"
      unitRef="usd">0</vyne:ContingentStockConsiderationRemeasurementGainLoss>
    <vyne:ContingentStockConsiderationRemeasurementGainLoss
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE1LTMtMS0xLTE3Njg5_6b7a4e8f-da87-47eb-af77-ee9d97f74319"
      unitRef="usd">-84726000</vyne:ContingentStockConsiderationRemeasurementGainLoss>
    <us-gaap:CostsAndExpenses
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE2LTEtMS0xLTE3Njg5_1c97a9ac-5dcf-4e1a-992a-5da8de76363d"
      unitRef="usd">79439000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE2LTMtMS0xLTE3Njg5_f33f9185-28fb-4d91-ad3b-629d44444130"
      unitRef="usd">272147000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE3LTEtMS0xLTE3Njg5_4c58516d-fa99-4a15-a6b1-e2fc3516081d"
      unitRef="usd">-68032000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE3LTMtMS0xLTE3Njg5_27f7023c-a9bd-4799-9b3f-a25d0e0b5712"
      unitRef="usd">-252546000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE4LTEtMS0xLTE3Njg5_ce7d74c1-7479-475c-99c8-5e1b1a01c6f3"
      unitRef="usd">5610000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE4LTMtMS0xLTE3Njg5_d9692822-6abd-4031-92bf-7eab9f7dabe6"
      unitRef="usd">4390000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE5LTEtMS0xLTE3Njg5_38d175d7-961f-4cf0-808d-4c86be94a1c1"
      unitRef="usd">-135000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzE5LTMtMS0xLTE3Njg5_69a23f92-cab5-4029-9ea3-b156d1866b9b"
      unitRef="usd">1110000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIwLTEtMS0xLTE3Njg5_346ce697-d2d5-4f05-a6ea-15fce82368a0"
      unitRef="usd">-73777000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIwLTMtMS0xLTE3Njg5_2eb75a17-a63f-4313-ba70-5adfc00405ce"
      unitRef="usd">-255826000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIxLTEtMS0xLTE3Njg5_59cd0275-83d1-4c0a-96a9-d52acb1694fb"
      unitRef="usd">-448000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIxLTMtMS0xLTE3Njg5_ad9551d9-e67c-45f3-9e5f-9dcbc47ad881"
      unitRef="usd">-258000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIyLTEtMS0xLTE3Njg5_03088a12-916d-4ad9-86f6-ce999a519fab"
      unitRef="usd">-73329000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzIyLTMtMS0xLTE3Njg5_3cbc7b16-433e-4aa3-b2f6-964905a560c1"
      unitRef="usd">-255568000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI0LTEtMS0xLTE3Njg5_04063859-ef3d-46c9-af1a-6742a57af29d"
      unitRef="usdPerShare">1.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI0LTEtMS0xLTE3Njg5_84f603f7-7a58-49d7-8749-6052f786f94e"
      unitRef="usdPerShare">1.42</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI0LTMtMS0xLTE3Njg5_115eb86b-4ba4-46fc-b4ea-6f74e0ea4154"
      unitRef="usdPerShare">7.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI0LTMtMS0xLTE3Njg5_869b53e8-5721-4a47-8362-b56396172c95"
      unitRef="usdPerShare">7.88</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI2LTEtMS0xLTE3Njg5_2ee30812-0e72-46ef-9d03-7fa6841bf08c"
      unitRef="shares">51469000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI2LTEtMS0xLTE3Njg5_bf729396-b8f7-41f5-ad53-82216c0c599f"
      unitRef="shares">51469000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI2LTMtMS0xLTE3Njg5_560a810f-2a70-408d-bd1f-8a9f4e53ca20"
      unitRef="shares">32418000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMDkvZnJhZzoyMjhjOGYxNTcyYWQ0YmRjOWEyZjAwODE5NmQ2N2UzNS90YWJsZTowN2EwZmQ5ZDNiN2E0MDIyYTEwYWZjZDdlZGFkZWY3NS90YWJsZXJhbmdlOjA3YTBmZDlkM2I3YTQwMjJhMTBhZmNkN2VkYWRlZjc1XzI2LTMtMS0xLTE3Njg5_80ca1c92-fa93-445b-9907-7b3f4cdc617a"
      unitRef="shares">32418000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzItMS0xLTEtMTc2ODk_e48a146e-e460-466d-a8b0-6226c0e539fc"
      unitRef="usd">-73329000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzItMy0xLTEtMTc2ODk_0e26baef-54e5-4dfc-9a27-ca221b5b68a5"
      unitRef="usd">-255568000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzQtMS0xLTEtMTc2ODk_6634b41e-325a-42e7-a84d-4be7f1ac54fe"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzQtMy0xLTEtMTc2ODk_1f0727f2-9638-4d31-8d2a-06171577dd02"
      unitRef="usd">1000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzUtMS0xLTEtMTc2ODk_7bb6d9bf-bf67-4cd8-928a-1335b35248f5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzUtMy0xLTEtMTc2ODk_da6c1f14-7ca4-44de-8e23-21d5c77c4b95"
      unitRef="usd">6000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzgtMS0xLTEtMTc2ODk_d0544862-37fb-4266-a367-22d0c0e41c65"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzgtMy0xLTEtMTc2ODk_42267e7d-2ff9-4668-985b-f45655d780ce"
      unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzktMS0xLTEtMTc2ODk_6e717f82-2ab4-40d8-b576-31ae6f6e956d"
      unitRef="usd">-73329000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTIvZnJhZzphZjIwNGE1OTJjZGY0ODEzYjI5ODlkZjg0Zjk2N2RlNS90YWJsZTphYzBkMzEyNGZmMWM0ODQzYjYzODA4ZTBjNDdlZDI2NC90YWJsZXJhbmdlOmFjMGQzMTI0ZmYxYzQ4NDNiNjM4MDhlMGM0N2VkMjY0XzktMy0xLTEtMTc2ODk_93f60177-48bf-4fc5-a82a-a895e151f8fb"
      unitRef="usd">-255573000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if47e65e7cf8947d280a6cd3bc2ec52ee_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTEtMS0xLTE3Njg5_699598b8-a562-4736-8275-fcba610a26e3"
      unitRef="shares">9120078</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="if47e65e7cf8947d280a6cd3bc2ec52ee_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTMtMS0xLTE3Njg5_edee0ac0-3f75-4362-9207-48648b5eb5aa"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79b1207beabf4c39905094c110517562_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTUtMS0xLTE3Njg5_c90d514d-ea7b-4b50-9f8a-dd9b9c52fc2d"
      unitRef="usd">328156000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if43043bf29704f0480ca31e8929ace71_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTctMS0xLTE3Njg5_1d8767cd-f56c-4ef4-848d-3d8d816d3b87"
      unitRef="usd">-310587000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic5d5892bfe124a9f9812002e2a561ca7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTktMS0xLTE3Njg5_6e3a2848-df0a-4529-8ef9-756417c9d40a"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i413ad6395c874b3ea0fb49e390a331d2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE3LTExLTEtMS0xNzY4OQ_8aa65f1a-41b1-4f84-a97a-219e732f424b"
      unitRef="usd">17575000</us-gaap:StockholdersEquity>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4e006948a7a24010afaf3207af41b5d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE5LTctMS0xLTE3Njg5_8a768d61-7103-48b6-9ee6-3fecaec05c7a"
      unitRef="usd">-255568000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifc3ae6194fdc4591b66a1cbe7d6fe9e4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE5LTktMS0xLTE3Njg5_082e695f-298e-4f85-8556-f56f5c204df0"
      unitRef="usd">-5000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzE5LTExLTEtMS0xNzY4OQ_648c7edb-3f71-4c9d-8e8e-f89d6906b32f"
      unitRef="usd">-255573000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIwLTEtMS0xLTE5OTk3_29dcf0b1-703b-4e0f-b1d8-e88d5f4f05d9"
      unitRef="shares">367269</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIwLTUtMS0xLTE5OTk3_fc57c25a-a084-4897-bee6-eed9779bb42d"
      unitRef="usd">554000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIwLTExLTEtMS0xOTk5Nw_f0249a0f-6b23-4808-a8b9-2f0f90e7f373"
      unitRef="usd">554000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIxLTUtMS0xLTE5OTk3_335e62f8-637c-4767-a50a-737b99c64c91"
      unitRef="usd">18100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIxLTExLTEtMS0xOTk5Nw_9b821c7e-a534-486c-9c3a-82e167bff30f"
      unitRef="usd">18100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification
      contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIxLTUtMS0xLTE3Njg5_805cc5a2-2ed0-41b5-89b0-c95538a335bc"
      unitRef="usd">-41000</vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification>
    <vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification
      contextRef="i4e006948a7a24010afaf3207af41b5d5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIxLTctMS0xLTE3Njg5_7aafd345-188d-4595-93fc-f0707c3ca48a"
      unitRef="usd">41000</vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification>
    <vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIxLTExLTEtMS0xNzY4OQ_2002658f-e716-4203-b1bb-f5c02fea68b5"
      unitRef="usd">0</vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification>
    <vyne:ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment
      contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIyLTUtMS0xLTE3Njg5_1b089feb-bf8d-43e8-b10d-4b27e1927dc0"
      unitRef="usd">975000</vyne:ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment>
    <vyne:ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIyLTExLTEtMS0xNzY4OQ_0692c709-70d7-4fca-8658-d91d792d8f70"
      unitRef="usd">975000</vyne:ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTAtMS0xLTE5OTU5L3RleHRyZWdpb246NzhjZjY4ZTMxNDJmNDU2M2JlZmMwM2RlNGU0MTg2NDlfMTA5OTUxMTYyNzg3Nw_a45dece5-6167-4bb3-aad5-e1577696920d"
      unitRef="usd">4151000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTEtMS0xLTE5OTk3_77dc127d-b4c0-40a9-a3d6-82174ae362c3"
      unitRef="shares">8951875</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTMtMS0xLTE5OTk3_9d979b81-2b1c-4fff-8966-0b510001521e"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTUtMS0xLTE5OTk3_aead2c7c-c8c7-4945-b25f-cc07f0c2fb0a"
      unitRef="usd">61641000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTExLTEtMS0xOTk5Nw_007413b2-cc4d-42b6-bf1a-476a76567592"
      unitRef="usd">61642000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTEtMS0xLTE5OTk3_0197e6cd-440e-4140-8891-e34b71a9c879"
      unitRef="shares">24765999</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i43179fc55e8f4ea08c1a71aa10f5face_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTMtMS0xLTE5OTk3_b17cc078-ec92-43d2-87d0-c500e00bf8f2"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="if152aacf3a594629b502a9ac950cfd14_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTUtMS0xLTE5OTk3_77c01a8d-c13c-4cab-a261-546a6f90eb23"
      unitRef="usd">196168000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTExLTEtMS0xOTk5Nw_47d5dce5-6bd9-4bab-9e4a-31641ebf5eaf"
      unitRef="usd">196170000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia95c98274f654d0dbb3883e6494fb991_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTEtMS0xLTE3Njg5_035fd9ee-cf8f-423a-a0b5-0dcf977159d9"
      unitRef="shares">43205221</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia95c98274f654d0dbb3883e6494fb991_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTMtMS0xLTE3Njg5_e46cbbd4-dadf-4a30-9921-cc1646290d31"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f00e75a6bfd46a897f7a483a51d3bf3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTUtMS0xLTE3Njg5_95564fb6-1362-4324-ac5f-a6122552b137"
      unitRef="usd">603685000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id9705c601c1a4a6790f6dd8fdbe9823f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTctMS0xLTE3Njg5_8be053a2-f8ea-479a-b156-55616eb96f45"
      unitRef="usd">-566196000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i730514296aa347cbbdbbd7988e9b1db9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTktMS0xLTE3Njg5_9db97d20-57e5-4ce1-8663-ddc912e4e11f"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzIzLTExLTEtMS0xNzY4OQ_7eb7b734-e23c-4816-aeca-2dd04ce14647"
      unitRef="usd">37493000</us-gaap:StockholdersEquity>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iecd12d821ca244dd9d27b10250b62aa9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTctMS0xLTE3Njg5_02501293-b195-445e-8c4a-0e2f8d26c9e8"
      unitRef="usd">-73329000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if44b2ce2087d41208cbc3e7cc5adaaec_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTktMS0xLTE3Njg5_af47bd19-7886-4784-b93b-cb03aa416637"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI1LTExLTEtMS0xNzY4OQ_e2d3a499-2f96-4203-a03a-609b870a6c50"
      unitRef="usd">-73329000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i236481f63a1745d09a131f29f465b969_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI2LTEtMS0xLTE3Njg5_799e68d2-a115-44a7-ab5c-7558e6c79fb6"
      unitRef="shares">364937</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2ae89d2530b0476aae8a3aac2954a443_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI2LTUtMS0xLTE3Njg5_f0049241-8be6-4b0e-81f7-62599225bf7c"
      unitRef="usd">410000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI2LTExLTEtMS0xNzY4OQ_04bdf1fe-d727-4f32-9ea4-c21bdffcfe16"
      unitRef="usd">410000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i2ae89d2530b0476aae8a3aac2954a443_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTUtMS0xLTE3Njg5_f66128da-d0fb-4375-b574-ff173e5ac14b"
      unitRef="usd">8080000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzI3LTExLTEtMS0xNzY4OQ_9bb628ad-dfff-46c3-950d-e3cea5c1fb34"
      unitRef="usd">8080000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMwLTAtMS0xLTE3Njg5L3RleHRyZWdpb246NWViY2RlMWZiMTk5NDNmZjg1ZTRjNWU1YWEyOGU5ZWFfMTA5OTUxMTYyNzg3OQ_5d64dcfc-a017-4761-9e85-ec0f98d7c5c4"
      unitRef="usd">4215000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i236481f63a1745d09a131f29f465b969_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMwLTEtMS0xLTE3Njg5_6338d9e2-3934-417c-b4d0-a05758cd36a2"
      unitRef="shares">10007586</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i236481f63a1745d09a131f29f465b969_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMwLTMtMS0xLTE3Njg5_54eeebb8-c336-42eb-b7cc-83897092bc2c"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2ae89d2530b0476aae8a3aac2954a443_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMwLTUtMS0xLTE3Njg5_e47ed337-0a4d-49e5-97c9-97180491ec6e"
      unitRef="usd">75981000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMwLTExLTEtMS0xNzY4OQ_2df11bfb-8d76-42b4-87b6-5e0f7fb74593"
      unitRef="usd">75982000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7905f84f35ea488095252b0854ef24b6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTEtMS0xLTE3Njg5_93045687-ce1d-4d0a-abb5-ad24e7eb10d5"
      unitRef="shares">53577744</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7905f84f35ea488095252b0854ef24b6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTMtMS0xLTE3Njg5_1f63190c-83b5-4cea-9ac1-306a1116bb5e"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib9b1bde6ee6947c3815be0701e98b131_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTUtMS0xLTE3Njg5_61ff04de-e2a0-427c-93cb-8c6ae919987f"
      unitRef="usd">688156000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4b6992a9bef14397a85f536344720b58_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTctMS0xLTE3Njg5_b03a24a5-3728-4bbd-b9d3-1e3254b7d97d"
      unitRef="usd">-639525000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i704f51eae14f4b16a31b91248c1468b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTktMS0xLTE3Njg5_ffcda9ec-87ff-401c-bd96-9d5d24abcb7d"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTUvZnJhZzo2ZjZiODJjZDJmNzg0ZTdhOTUwNDJkMDNmYTBhYjU1Ny90YWJsZToxZjgyNzI1YjFmOGU0NjJmYjQxMTg1MDI5YjhkNGE4OS90YWJsZXJhbmdlOjFmODI3MjViMWY4ZTQ2MmZiNDExODUwMjliOGQ0YTg5XzMzLTExLTEtMS0xNzY4OQ_4c2b8c26-a4d7-4036-96a3-26ad8e67f70f"
      unitRef="usd">48636000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMtMS0xLTEtMTc2ODk_2a22a810-7634-4ab5-98c6-b33010e49952"
      unitRef="usd">-73329000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMtMy0xLTEtMTc2ODk_ddfaa7b6-8faf-465e-a45c-bac329c0a895"
      unitRef="usd">-255568000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzUtMS0xLTEtMTc2ODk_7693a026-27cf-4d2e-9c61-23d1c74782b6"
      unitRef="usd">109000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzUtMy0xLTEtMTc2ODk_b1e11b09-145c-4fbf-a446-927a3b16dd5f"
      unitRef="usd">341000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzYtMS0xLTEtMTc2ODk_bb149673-f84c-4cdd-be67-7250f5a57aec"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzYtMy0xLTEtMTc2ODk_bd9ad5cf-0dde-4a34-b303-e3988e9494c8"
      unitRef="usd">54345000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <vyne:ContingentStockConsiderationRemeasurementGainLoss
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzctMS0xLTEtMTc2ODk_084351a1-9dc1-43cd-8d30-4e5a946c37db"
      unitRef="usd">0</vyne:ContingentStockConsiderationRemeasurementGainLoss>
    <vyne:ContingentStockConsiderationRemeasurementGainLoss
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzctMy0xLTEtMTc2ODk_152659f8-f50c-4b28-8de7-22858395ad3b"
      unitRef="usd">-84726000</vyne:ContingentStockConsiderationRemeasurementGainLoss>
    <vyne:GainLossOnSaleAndDispositionOfFixedAssets
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzgtMS0xLTEtMTc2ODk_6f111da3-40f9-4f0e-922b-bed63110e56b"
      unitRef="usd">-93000</vyne:GainLossOnSaleAndDispositionOfFixedAssets>
    <vyne:GainLossOnSaleAndDispositionOfFixedAssets
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzgtMy0xLTEtMTc2ODk_468883d9-ba21-4366-b8ac-3e10b55f6e10"
      unitRef="usd">-2101000</vyne:GainLossOnSaleAndDispositionOfFixedAssets>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzktMS0xLTEtMTc2ODk_c5877a0a-fb54-48a9-995d-a61b393bfe46"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzktMy0xLTEtMTc2ODk_caf69821-0354-4d02-b6d4-471c4470d788"
      unitRef="usd">142000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzEwLTEtMS0xLTMwMTcw_ba43f333-82a7-4e4d-a438-4fe5a1c5a5e9"
      unitRef="usd">-1432000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzEwLTMtMS0xLTMwMzQ0_df488150-aa65-48a6-973c-8d8ea5bfa469"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:ShareBasedCompensation
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzExLTEtMS0xLTE3Njg5_d296f183-512c-4559-8948-91cc3f69868b"
      unitRef="usd">8080000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzExLTMtMS0xLTE3Njg5_929612df-df34-4e5a-8927-1f92c53f9f3e"
      unitRef="usd">18100000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzEyLTEtMS0xLTE3Njg5_40c5b5f7-0c49-4cf5-8687-f877f0121496"
      unitRef="usd">-2472000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzEyLTMtMS0xLTE3Njg5_00aa4842-10f5-4e45-9676-1d9185fdd6de"
      unitRef="usd">654000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE0LTEtMS0xLTE3Njg5_206aa785-368a-460a-bd54-3c97d289817b"
      unitRef="usd">-7709000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE0LTMtMS0xLTE3Njg5_a3856915-54ad-44ae-906e-a0ae1741f78c"
      unitRef="usd">17138000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE1LTEtMS0xLTE3Njg5_444195e0-560c-4e45-91fd-f654ed4fe731"
      unitRef="usd">-841000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE1LTMtMS0xLTE3Njg5_c152e8ed-d57b-4a62-9c83-99b9c7fccebe"
      unitRef="usd">4171000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE2LTEtMS0xLTE3Njg5_9be6871d-3dbf-4a4d-9f21-ceb1f7ba7a10"
      unitRef="usd">-2675000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE2LTMtMS0xLTE3Njg5_9753c9e2-e0fd-4c7c-a362-0ce39d77f362"
      unitRef="usd">-12975000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE3LTEtMS0xLTE3Njg5_a44b63f5-5ad1-4a51-8269-492b5142306a"
      unitRef="usd">-113000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE3LTMtMS0xLTE3Njg5_d3ac9b07-c708-49ff-a7cb-f62a7018984a"
      unitRef="usd">6048000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE4LTEtMS0xLTE3Njg5_3027eabc-fdea-4e7f-863f-0c23b39c2d12"
      unitRef="usd">-1212000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE4LTMtMS0xLTE3Njg5_547581f3-a460-4f08-a99e-84f8c26fad1c"
      unitRef="usd">1000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE5LTEtMS0xLTE3Njg5_87a79601-b25a-4b9e-a588-71ce0a1b8c3b"
      unitRef="usd">-56367000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzE5LTMtMS0xLTE3Njg5_758a752e-9044-492e-b43a-fadb7938dd9a"
      unitRef="usd">-137082000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzIxLTEtMS0xLTE3Njg5_44c33459-7255-4330-b8b7-c277c4c05368"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzIxLTMtMS0xLTE3Njg5_e3434320-de2d-4c07-a2f9-f4a92156a900"
      unitRef="usd">113000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI0LTEtMS0xLTE3Njg5_8135bda9-529d-45bd-97ff-9d08663e0a36"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI0LTMtMS0xLTE3Njg5_1c159922-3eb4-4c73-8835-f01597f6bd48"
      unitRef="usd">38641000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI1LTEtMS0xLTE3Njg5_9809c9ab-8a48-454b-9cf2-d4037e853718"
      unitRef="usd">1027000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI1LTMtMS0xLTE3Njg5_5b32ff89-9d3c-47eb-9b4f-9791979bc752"
      unitRef="usd">50579000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI2LTEtMS0xLTE3Njg5_cf0fc821-ea65-4b27-b064-94f59d3d5551"
      unitRef="usd">1027000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI2LTMtMS0xLTE3Njg5_faf92cab-9cee-4079-a598-e0e0eacf40fe"
      unitRef="usd">89107000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI4LTEtMS0xLTE3Njg5_865709e9-40d6-48bd-b216-bbb5b886f21d"
      unitRef="usd">36432000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI4LTMtMS0xLTE3Njg5_969a6647-521a-432c-97a8-20139a523f05"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI5LTEtMS0xLTE3Njg5_087f06ba-15ab-4b0a-ad08-62bca8fa19d0"
      unitRef="usd">522000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzI5LTMtMS0xLTE3Njg5_c3b30b27-7c69-4d37-be5d-e37d507ddcfc"
      unitRef="usd">310000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMwLTEtMS0xLTE3Njg5_0fecce9b-f97b-4187-a426-b33d7fae67ad"
      unitRef="usd">294000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMwLTMtMS0xLTE3Njg5_1fdf5cfa-3306-4c82-be7e-8be390a14dfe"
      unitRef="usd">141000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMxLTEtMS0xLTE3Njg5_55332cef-26fa-4157-9ebc-586bac4ac726"
      unitRef="usd">75981000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzMxLTMtMS0xLTE3Njg5_1a738cb4-e3a0-488e-a142-aa9108e6f1d9"
      unitRef="usd">61639000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM1LTEtMS0xLTE3Njg5_583837be-28a4-4cdf-ab1d-0385f290fddb"
      unitRef="usd">39777000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM1LTMtMS0xLTE3Njg5_c239cdc7-452c-4d52-bcbd-1a8c3417e837"
      unitRef="usd">61808000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM2LTEtMS0xLTE3Njg5_9d4943ca-a35d-4c19-9bba-b3ccaf3d4e78"
      unitRef="usd">-15563000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM2LTMtMS0xLTE3Njg5_23c9a204-bcaa-4e59-be80-4254980b2ed5"
      unitRef="usd">13833000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM3LTEtMS0xLTE3Njg5_c9ede75d-9173-4cba-857c-1ecaeb2e6d77"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM3LTMtMS0xLTE3Njg5_b091ddcf-e640-4744-9b65-754e820d610a"
      unitRef="usd">1000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM4LTEtMS0xLTE3Njg5_03e15d01-04c7-4993-b704-d3c6232c86fa"
      unitRef="usd">58418000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i413ad6395c874b3ea0fb49e390a331d2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM4LTMtMS0xLTE3Njg5_6baa82b2-d1ce-4b61-9090-7aa9b037150f"
      unitRef="usd">44584000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM5LTEtMS0xLTE3Njg5_e67b5bd3-5bb2-4b19-98b7-1e4dde312eb6"
      unitRef="usd">42855000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzM5LTMtMS0xLTE3Njg5_fe655758-ada7-4506-b050-0d7393d817f4"
      unitRef="usd">58418000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQxLTEtMS0xLTE3Njg5_64ce4476-4e5f-459d-8597-f1a7ed8cccb2"
      unitRef="usd">42250000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQxLTMtMS0xLTE3Njg5_d4f050d3-cd41-44ec-926a-b340e083ffb5"
      unitRef="usd">57563000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQyLTEtMS0xLTE3Njg5_394ec21a-fffd-4014-9510-a8b9a57a498b"
      unitRef="usd">605000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQyLTMtMS0xLTE3Njg5_7f9344ab-9796-4e7e-a569-ab8254c5d8d8"
      unitRef="usd">855000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQzLTEtMS0xLTE3Njg5_b03362a2-da93-4d13-8b54-a4bb93da0398"
      unitRef="usd">42855000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTozMTg0ODliOWYzYTI0MWY4OTM0N2ZmMDVlNTA3MGRmNi90YWJsZXJhbmdlOjMxODQ4OWI5ZjNhMjQxZjg5MzQ3ZmYwNWU1MDcwZGY2XzQzLTMtMS0xLTE3Njg5_548784af-50d0-4564-92e4-66b6a7812477"
      unitRef="usd">58418000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:StockIssued1
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzQtMS0xLTEtMTc2ODk_0cc48c6b-5ced-44ba-be2a-2121960abb6b"
      unitRef="usd">169000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzQtMy0xLTEtMTc2ODk_d1ad9b62-da03-41c0-94b2-0fab06d15e44"
      unitRef="usd">387000</us-gaap:StockIssued1>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzYtMS0xLTEtMTc2ODk_c9859cd7-669d-4fb1-8929-26d005b54803"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzYtMy0xLTEtMTc2ODk_4211e096-0bbc-4569-9a5c-a445d8cb8b93"
      unitRef="usd">1350000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzctMS0xLTEtMTc2ODk_bb710cdf-5af7-4e0f-90a4-10de3ffa9a0a"
      unitRef="usd">0</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzctMy0xLTEtMTc2ODk_fc0a4c65-b6ae-4a24-a181-ba2f83e59356"
      unitRef="usd">1350000</us-gaap:CapitalLeaseObligationsIncurred>
    <vyne:InterestReceived
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzExLTEtMS0xLTE3Njg5_2fbf51e7-6a23-488a-9975-144e2286683a"
      unitRef="usd">17000</vyne:InterestReceived>
    <vyne:InterestReceived
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzExLTMtMS0xLTE3Njg5_fab9539a-33d8-4c89-b128-1535b66b3314"
      unitRef="usd">102000</vyne:InterestReceived>
    <us-gaap:InterestPaidNet
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzEyLTEtMS0xLTE3Njg5_f689b74c-712d-424c-a295-1b4a2b82c9fe"
      unitRef="usd">2385000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzEyLTMtMS0xLTE3Njg5_d67f5d60-f808-4818-93d8-c222bc567f5f"
      unitRef="usd">3941000</us-gaap:InterestPaidNet>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE0LTEtMS0xLTE3Njg5_3f840b88-285f-4b40-8998-ec0fa188d76a"
      unitRef="usd">0</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE0LTMtMS0xLTE3Njg5_4fde525e-f5d9-46cf-bfbb-374053315651"
      unitRef="usd">117270000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE1LTEtMS0xLTE3Njg5_aefb4c53-80b4-4acb-ab59-5bdb8690a4ba"
      unitRef="usd">0</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE1LTMtMS0xLTE3Njg5_067b349f-2d54-45f2-a248-2cfcbc94a566"
      unitRef="usd">5827000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE2LTEtMS0xLTE3Njg5_893d9c15-f5c3-403a-b062-8007451650d9"
      unitRef="usd">0</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE2LTMtMS0xLTE3Njg5_067d4b97-fad1-492f-a3bb-1adee2ea8c37"
      unitRef="usd">111443000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
    <vyne:NonCashAcquisitionOfBusinessCashAcquired
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE3LTEtMS0xLTE3Njg5_f64f3fb7-d074-48d9-83ed-23e23aafb686"
      unitRef="usd">0</vyne:NonCashAcquisitionOfBusinessCashAcquired>
    <vyne:NonCashAcquisitionOfBusinessCashAcquired
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE3LTMtMS0xLTE3Njg5_0501851c-7647-4be2-acef-2bf95caacd80"
      unitRef="usd">38641000</vyne:NonCashAcquisitionOfBusinessCashAcquired>
    <vyne:NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE4LTEtMS0xLTE3Njg5_71f0c346-c98b-43e7-9384-e5d3760c5b0c"
      unitRef="usd">0</vyne:NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired>
    <vyne:NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMTgvZnJhZzplMmQ0ODNjNWNmNTM0NTFiODU1Mzc3OTM0N2NhMDY0Yi90YWJsZTpmOTQ5NDA5YjM5M2M0NDFiYmEwNDYxMjBlNmZkYzdiYi90YWJsZXJhbmdlOmY5NDk0MDliMzkzYzQ0MWJiYTA0NjEyMGU2ZmRjN2JiXzE4LTMtMS0xLTE3Njg5_401fbec7-2337-4118-926e-89ac00e21676"
      unitRef="usd">72802000</vyne:NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired>
    <us-gaap:NatureOfOperations
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzIxOTkwMjMyNjc0NjI_dff68b2c-102b-4a07-8295-6e2348b662c4">NATURE OF OPERATIONS&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The Company&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;VYNE Therapeutics Inc., ("VYNE" or the "Company") is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. The Company's most advanced product candidate, FMX114, which is in Phase 2a, is being evaluated for the potential treatment of mild-to-moderate AD.  The Company is also in the pre-clinical stages of developing products containing BET inhibitor compounds.  Its initial BET inhibitor candidate in development is VYN201, a locally administered pan-BET inhibitor, which the Company is exploring in various immuno-inflammatory diseases, including skin diseases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;In addition, the Company continues to explore opportunistic transactions that may enhance its pipeline portfolio, as well as support its current operations and fund its future growth. The Company is a Delaware corporation, has its principal executive offices in Bridgewater, New Jersey and operates as&#160;one&#160;business segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Strategic Business Review and Sale of the MST Franchise&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in the second quarter of 2021, the Company conducted a review of its commercial and research and development portfolio to determine how to optimally deploy capital and drive shareholder value. During the course of this review, the Company carefully considered the revenues received from the commercialization of AMZEEQ and ZILXI and the associated costs to drive those revenues, the protracted negative impact of the COVID-19 pandemic during the commercial launches of both AMZEEQ and ZILXI, the payor landscape, as well as the costs to develop each of its pipeline products. During this process, the Company evaluated several strategic options including the acquisition of marketed assets, out-licensing its approved products outside of the United States, and possible partnering or co-development relationships with interested parties. Following its review, the Company determined to initiate a process to explore a possible sale or license of its topical minocycline franchise, including AMZEEQ, ZILXI, FCD105 (the Company&#x2019;s former Phase 3 proprietary novel topical combination foam formulation of minocycline and adapalene for the treatment of moderate-to-severe acne vulgaris) and the underlying Molecule Stabilizing Technology platform.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 12, 2022, VYNE entered into an Asset Purchase Agreement (the &#x201c;Purchase Agreement&#x201d;) with Journey Medical Corporation (&#x201d;Journey&#x201d;) pursuant to which the Company sold its Molecule Stabilizing Technology franchise, including AMZEEQ, ZILXI, and FCD105 (the &#x201c;MST Franchise&#x201d;), to Journey. The assets include certain contracts, including the license agreement with Cutia Therapeutics (HK) Limited (&#x201c;Cutia&#x201d;), inventory and intellectual property related to the MST Franchise (together, the &#x201c;Assets&#x201d;). Pursuant to the Agreement, the Buyer assumed certain liabilities of the MST Franchise including, among others, those arising from VYNE&#x2019;s patent infringement suit initiated against Padagis Israel Pharmaceuticals Ltd. There were no current or long-term liabilities recorded by the Company which were transferred to the Buyer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Pursuant to the Purchase Agreement, VYNE received an upfront payment of  $20.0&#160;million and will receive an additional $5.0&#160;million on the one-year anniversary of the closing of the transaction. VYNE is also eligible to receive sales milestone payments of up to  $450.0&#160;million in the aggregate upon the achievement of specified levels of net sales on a product-by-product basis, beginning with annual net sales exceeding $100.0 million (with products covered in three categories (1) AMZEEQ (and certain modifications), (2) ZILXI (and certain modifications), and (3) FCD105 and other products covered by the patents being transferred, including certain modifications). In addition, VYNE is entitled to receive certain payments from any licensing or sublicensing of the assets by Journey outside of the United States.  See Note 17 - Subsequent Events for additional discussion of the disposition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;By leveraging its drug development and clinical development capabilities and strong network of discovery and preclinical science partners, the Company has transitioned its strategic focus to develop therapies for the treatment of immuno-inflammatory conditions. The Company expects to continue to invest in FMX114 for the treatment of mild to moderate atopic dermatitis and enrolled the first patient in its Phase 1b/2a proof-of-concept study in October 2021. On January 19, 2022, the Company announced findings from the Phase 1b safety portion of the Phase 1b/2a trial evaluating FMX 114. The findings support trial continuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, on August 12, 2021, the Company announced a transaction with In4Derm Limited, a company incorporated and registered in Scotland (&#x201c;In4Derm&#x201d;). In4Derm is a spin-out of the University of Dundee&#x2019;s School of Life Sciences which has discovered and is developing proprietary Bromodomain and Extra-Terminal Domain ("BET") inhibitors for the treatment of immunology and oncology conditions. On April 30, 2021, the parties entered into an Evaluation and Option Agreement (the &#x201c;Option Agreement&#x201d;) pursuant to which In4Derm granted the Company an exclusive option to obtain exclusive worldwide &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rights to research, develop and commercialize products containing In4Derm&#x2019;s BET inhibitor compounds, which are new chemical entities for treatments in all fields for any disease, disorder or condition in humans. On August 6, 2021, the parties entered into a License Agreement granting the Company a worldwide, exclusive license that is sublicensable through multiple tiers to exploit certain of In4Derm&#x2019;s pan-BD BET inhibitor compounds in all fields. The Company paid a $1.0&#160;million cash payment to In4Derm upon the execution of the Option Agreement and $0.5&#160;million in connection with entering into the License Agreement. Pursuant to the License Agreement, the Company has agreed to make cash payments to In4Derm upon the achievement of specified clinical development and regulatory approval milestones with respect to each licensed topical product in the U.S. of up to $15.75&#160;million for all indications. In addition, the Company currently expects to exercise the Oral BETi Option following the selection of a lead candidate for the program. Upon exercise of the exclusive Oral BETi Option, the parties will sign a license agreement (the &#x201c;Oral License Agreement&#x201d;), and the Company will be required to pay In4Derm a $4.0&#160;million cash payment. The Oral License Agreement will include cash payments of up to $43.75&#160;million payable to In4Derm upon the achievement of specified clinical development and regulatory approval milestones with respect to each licensed oral product in the U.S. for all indications. The license agreements also provide for tiered royalty payments of up to 10% of net annual sales across licensed BET inhibitor products by the Company. In4Derm is entitled to additional milestones upon the achievement of regulatory approvals in certain jurisdictions outside the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial BET inhibitor candidates in development are VYN201 and VYN202. VYN201 is a pan-bromodomain or pan-BD BET inhibitor. It is a first-in-class &#x201c;soft&#x201d; pan-BD BET inhibitor that is being developed to address diseases involving multiple, diverse inflammatory cell signaling pathways.  With the VYN201 program, the Company is attempting to develop a therapy that is locally acting and is rapidly cleared through the body's metabolic process so as to avoid systemic absorption. The Company is continuing to evaluate VYN201 in a variety of preclinical models and will announce an initial indication for VYN201 following such evaluation. With respect to the VYN202 program, the Company is exploring multiple BET inhibitor compounds that are highly selective for bromodomain 2 ("BD2"). By selectively inhibiting BD2, the Company believes VYN202 could have a more targeted anti-inflammatory effect with an improved benefit/risk profile. The Company is diligently working with In4Derm to develop a lead molecule for the VYN202 program. Once a lead candidate has been selected, the Company intends to exercise its option with respect to these BET inhibitor compounds and commence an IND-enabling preclinical safety program.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the Company transitioned from a commercial organization to one focused on research and development, the Company streamlined operations by eliminating the vast majority of planned expenditures supporting its commercial operations. Furthermore, following its decision to divest the MST franchise, the Company reduced its workforce by terminating approximately 70 employees. The Company incurred a one-time charge of $1.6&#160;million  in the year ended December 31, 2021 in connection with this restructuring plan, consisting of $1.4&#160;million of employee termination costs, including severance and other benefits, and retention payments of $0.2&#160;million.  Additional charges of $0.2 million related to retention payments are anticipated through June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reverse stock split and recasting of per-share amounts &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 10, 2021, our Board of Directors approved a one-for-four reverse stock split of our outstanding shares of common stock. The reverse stock split was effected on February 12, 2021 at 5:00 p.m. Eastern time. At the effective time, every four issued and outstanding shares of our common stock were converted into one share of common stock. No fractional shares were issued in connection with the reverse stock split, and in lieu thereof, each stockholder holding fractional shares was entitled to receive a cash payment (without interest or deduction) from the Company&#x2019;s transfer agent in an amount equal to such stockholder&#x2019;s respective pro rata shares of the total net proceeds from the Company&#x2019;s transfer agent sale of all fractional shares at the then-prevailing prices on the open market. In connection with the reverse stock split, the number of authorized shares of our common stock was also reduced on a one-for-four basis, from 300&#160;million shares to 75&#160;million shares. The par value of each share of common stock remained unchanged. A proportionate adjustment was also made to the maximum number of shares issuable under the Company&#x2019;s 2019 Equity Incentive Plan, 2018 Omnibus Incentive Plan and 2019 Employee Share Purchase Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless noted, all common shares and per share amounts contained in the consolidated financial statements have been retroactively adjusted to reflect a 1-for-4 reverse stock split.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Reverse Merger&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 10, 2019, Menlo Therapeutics Inc. ("Menlo"), Foamix Pharmaceuticals Ltd. (&#x201c;Foamix&#x201d;) and Giants Merger Subsidiary Ltd. (&#x201c;Merger Sub&#x201d;), a wholly-owned subsidiary of Menlo, entered into an Agreement and Plan of Merger (as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated as of December 4, 2019, the &#x201c;Merger Agreement&#x201d;). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Foamix, with Foamix surviving as a wholly-owned subsidiary of Menlo (the &#x201c;Merger&#x201d;) on March 9, 2020 (the &#x201c;Effective Date&#x201d;). The combined Company changed its name to VYNE in September 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For accounting purposes, the Merger is treated as a &#x201c;reverse acquisition&#x201d; under generally accepted accounting principles in the United States (&#x201c;U.S. GAAP&#x201d;) and Foamix is considered the accounting acquirer. Accordingly, upon consummation of the Merger, the historical financial statements of Foamix became the Company&#x2019;s historical financial statements, and the historical financial statements of Foamix are included in the comparative prior periods. See &#x201c;Note 3 &#x2013; Business Combination&#x201d; for more information on the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Serlopitant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was developing serlopitant, a small molecule inhibitor of the neurokinin 1 receptor, or NK1-R, given as a once-daily, oral tablet, for the treatment of pruritus, or itch, associated with various conditions including prurigo nodularis, or PN. On April 6, 2020, the Company announced top line results from two Phase III clinical trials evaluating the safety and efficacy of once-daily oral serlopitant for the treatment of pruritus (itch) associated with PN, studies MTI-105 and MTI-106. Neither study met their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based on a 4-point improvement responder analysis. The Company does not currently intend to further pursue the development of serlopitant. As a result, in the second quarter of 2020, the Company recorded a full impairment charge related to the IPR&amp;amp;D and Goodwill assets in its unaudited condensed consolidated statement of operations and comprehensive loss. See "Note 3 - Business Combination" for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since inception, the Company has funded operations primarily through private and public placements of its equity, debt and warrants and through fees, cost reimbursements and payments received from its licensees. The Company commenced generating product revenues related to sales of AMZEEQ and ZILXI&#160;in January 2020 and October 2020, respectively.  AMZEEQ and ZILXI were sold as part of the sale of the MST Franchise on January 12, 2022 and, as such, the Company will no longer be generating revenue from the sale of these products.  The Company has incurred losses and experienced negative operating cash flows since its inception and anticipates that it will continue to incur losses until such a time when its product candidates, if approved, are commercially successful, if at all. The Company will not generate any revenue from any current or future product candidates unless and until it obtains regulatory approval and commercializes such products.  For the year ended December&#160;31, 2021 the Company incurred a net loss of $73.3 million and used $56.4&#160;million of cash in operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had cash and cash equivalents of $42.9 million. The Company's cash and cash equivalents are held in money market accounts. The Company also received proceeds of $20.0&#160;million from the sale of the MST Franchise in January 2022 and will receive an additional payment of $5.0&#160;million on the one-year anniversary of the sale.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Following the sale of the MST Franchise, the Company is refocusing its limited resources on its immuno-inflammatory pipeline and intends to support the FMX114 and the BET inhibitor development programs. Research and development activities for these programs, including preclinical and clinical testing of the Company's drug candidates, will require significant additional financing. The future viability of the Company and its ability to continue as a going concern is dependent on its ability to raise sufficient working capital through either debt or equity financings to fund our operations and successfully develop commercially viable drug candidates.  There is no assurance the Company will be able to achieve these objectives under acceptable terms or at all.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-15, Disclosure of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that its audited consolidated financial statements are issued. The accompanying audited consolidated financial statements have been prepared assuming that the Company will continue as a going concern and contemplate the realization of assets and the satisfaction of liabilities in the normal course of business. The Company's ability to continue as a going concern is expected &lt;/span&gt;&lt;/div&gt;to be impacted by the outcome of the plans outlined above, including the Company's ability to raise additional capital to fund its operations, positive results from clinical trials for FMX114, and the successful development and positive results from clinical trials for the BET inhibitor programs. Based on its current plans and assumptions, the Company believes that absent sufficient proceeds received from equity transactions, financing transactions or business development transactions, the Company will not have sufficient cash and cash equivalents to fund its operations beyond one year from the issuance of these financial statements. Accordingly, the Company will, over the course of the next twelve months, require significant additional financing to continue its operations. In addition, the amount of proceeds the Company may be able to raise pursuant to its existing shelf registration statement on Form S-3 may be limited. As of the filing of this Annual Report on Form 10-K, the Company will be subject to the general instructions of Form S-3 known as the "baby shelf rules." Under these instructions, the amount of funds the Company can raise through primary public offerings of securities in any 12-month period using its registration statement on Form S-3 is limited to one-third of the aggregate market value of the shares of its common stock held by non-affiliates of the Company. Therefore, the Company will be limited in the amount of proceeds it is able to raise by selling shares of its common stock using its Form S-3 until such time as its public float exceeds $75 million. These factors raise substantial doubt about the Company's ability to continue as a going concern. Failure to successfully receive additional financing will require the Company to delay, scale back or otherwise modify its business and its research and development activities and other operations. The accompanying financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities or any other adjustments that might be necessary should the Company be unable to continue as a going concern.</us-gaap:NatureOfOperations>
    <us-gaap:NumberOfReportableSegments
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzU4Ng_cd73892d-a5f0-4fcb-bc95-79bbbbb00650"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount
      contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MDAxMTU_9dcc8788-e8ab-4b27-a4d2-5b6c65656cc4"
      unitRef="usd">20000000</vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount>
    <vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable
      contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MDAxMjY_e814d8a0-ff07-4dc7-80bc-48a204b5e041"
      unitRef="usd">5000000</vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable>
    <vyne:PeriodOfClosingTransaction
      contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMwOTQ2Mjk_69b8a917-36fa-4ea6-9178-b060dd8d7d38">P1Y</vyne:PeriodOfClosingTransaction>
    <vyne:DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales
      contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MDAxMzM_c918adb4-8cf9-435d-ba6b-cf25dc3aa0b0"
      unitRef="usd">450000000</vyne:DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales>
    <vyne:MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales
      contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMwOTQ2MDQ_2ff7e952-568b-4145-9944-51eaa594fd67"
      unitRef="usd">100000000</vyne:MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales>
    <vyne:PaymentsForLicensingAgreements
      contextRef="i3f84161efc234efd80e4eaa6e6f105d5_D20210806-20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTE5NjA_e49ba9f4-bd30-426f-81b0-d25221684124"
      unitRef="usd">1000000</vyne:PaymentsForLicensingAgreements>
    <vyne:PaymentsForLicensingAgreements
      contextRef="i477ed4d994a24491901ffcdf33bca2bc_D20210806-20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTE5NDY_ca9140b7-cfaa-423d-980e-0df7328be621"
      unitRef="usd">500000</vyne:PaymentsForLicensingAgreements>
    <vyne:MilestonePaymentsUponAchievingCertainCriteriaMaximum
      contextRef="i477ed4d994a24491901ffcdf33bca2bc_D20210806-20210806"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTE5MzA_396ef6c0-7518-4bd8-b353-5b3d15baab01"
      unitRef="usd">15750000</vyne:MilestonePaymentsUponAchievingCertainCriteriaMaximum>
    <vyne:PaymentsForLicensingAgreements
      contextRef="iccf5d6ca3a0e4b62ae5cb3f221bd420c_D20210806-20210806"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTE5NzQ_afb0869f-3273-4f94-a2d2-e21b0960a3af"
      unitRef="usd">4000000</vyne:PaymentsForLicensingAgreements>
    <vyne:MilestonePaymentsUponAchievingCertainCriteriaMaximum
      contextRef="iccf5d6ca3a0e4b62ae5cb3f221bd420c_D20210806-20210806"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTE5ODg_f69dcc2b-97bd-4776-b206-3289dbe66a76"
      unitRef="usd">43750000</vyne:MilestonePaymentsUponAchievingCertainCriteriaMaximum>
    <vyne:RoyaltyPaymentPercentMaximum
      contextRef="i0d600c9dd1a04a7c8e003a167844054e_I20210806"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMxMTIwMDQ_ca03480d-b4f0-4a57-a4f9-52b833ffbf92"
      unitRef="number">0.10</vyne:RoyaltyPaymentPercentMaximum>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzg3OTYwOTMwOTQ1NzI_1b10ca0a-e7d0-47d7-a0b1-2fa73e839030"
      unitRef="employee">70</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringCharges
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE2OTk1ODc_db9f28f0-eaab-4d68-bb15-d40f9ecd406a"
      unitRef="usd">1600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia5eadddfbc494126bf9aa92fd1fba8f3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE2OTk2MDc_92fd55f6-00ea-4e22-8ed8-459bd1bde29a"
      unitRef="usd">1400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ida05e158eeb4498bad602ba50db10863_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE2OTk2MjQ_f3c4b1ef-fea4-4cd7-b55c-43f5d8d72e00"
      unitRef="usd">200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1
      contextRef="i50aaf6903e0449e78c0c8a43db1571f7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE2OTk2NDA_bb70dcd0-8394-4a23-b63d-d38e42ee4bf1"
      unitRef="usd">200000</us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia5cf7aa626774cfea6cad9737b2d831f_I20210212"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzI2NjY_15b1d6cc-3acf-489e-9c98-3c180ff04f8f"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iba55a12228574923bbb188bfa1675bd5_I20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzI2Nzk_a7b1dc44-c750-493b-ad27-acfdc56c3686"
      unitRef="shares">75000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:NetIncomeLoss
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MjAzMzY_4bcd192e-1a37-4295-84f6-f1d2640f8cff"
      unitRef="usd">-73300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MjAzNDQ_28f34dde-c9e7-4006-8bc3-183d0d7ae3ed"
      unitRef="usd">-56400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzExNTQ0ODcyMTU5ODcy_b358fbd1-f185-4ccb-bcda-251b353013d6"
      unitRef="usd">42900000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount
      contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MjYxMzY_9dcc8788-e8ab-4b27-a4d2-5b6c65656cc4"
      unitRef="usd">20000000</vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount>
    <vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable
      contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMjQvZnJhZzo3NDJhNDQ4NjBmZTE0MTE4YjA4NTA3M2Y4ZjBmZWFkZi90ZXh0cmVnaW9uOjc0MmE0NDg2MGZlMTQxMThiMDg1MDczZjhmMGZlYWRmXzEwOTk1MTE3MTkwMTg_e814d8a0-ff07-4dc7-80bc-48a204b5e041"
      unitRef="usd">5000000</vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzIxOTkwMjMyODc0OTI_3842e994-1c67-4476-81eb-6fdf20fa3a56">SIGNIFICANT ACCOUNTING POLICIES:&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"&gt;Basis of presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;).  Certain prior period amounts have been reclassified to conform to current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results may differ from those estimates.  Significant items subject to such estimates and assumptions include accounting for business combinations, impairments of goodwill and intangible assets and revenue recognition. Actual results could differ from the Company&#x2019;s estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic and government measures taken in response to the pandemic have had a negative impact on the Company's operations. Access to healthcare providers has been limited, which has negatively impacted sales and the Company's ability to execute its commercial strategy with respect to AMZEEQ and ZILXI. The length of time and extent to which the COVID-19 pandemic will directly or indirectly impact the Company's business, results of operations and financial condition and liquidity will depend on future developments that are highly uncertain, subject to change and will continue to evolve with geographical re-openings, surges in cases, the emergence of new strains and the vaccination effort. In addition, the Company further assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2021 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s allowance for doubtful accounts and credit losses, inventory and related reserves, impairments of long-lived assets and revenue recognition. In 2020, the Company recorded impairments of goodwill and certain indefinite-lived intangible assets; however, these were unrelated to the impact of COVID-19 (See "Note 3 - Business Combination" for more information). The Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#x2019;s consolidated financial statements in future reporting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;c.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt"&gt;Business Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s consolidated financial statements include the operations of an acquired business after the completion of the acquisition. The Company accounts for acquired businesses using the acquisition method of accounting, which requires, among &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;other things, that most assets acquired and liabilities assumed be recognized at their estimated fair values as of the acquisition date and that the fair value of In-Process Research and Development and Goodwill be recorded on the balance sheet.&#160;Transaction costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recorded in connection with an acquisition can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting.&#160; For example, the Company uses fair value in the initial recognition of net assets acquired in a business combination and when measuring impairment losses.&#160; The Company estimates fair value using an exit price approach, which requires, among other things, that Company determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of non-financial assets and, for liabilities, assuming that the risk of non-performance will be the same before and after the transfer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may use one or all of the following techniques:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Income approach, which is based on the present value of a future stream of net cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Cost approach, which is based on the cost to acquire or construct comparable assets, less an allowance for functional and/or economic obsolescence.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fair value methodologies depend on the following types of inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for identical assets or liabilities in active markets (Level 1 inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means (Level 2 inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Unobservable inputs that reflect estimates and assumptions (Level 3 inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A single estimate of fair value can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;d.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transactions and balances originally denominated in dollars are presented at their original amounts. Balances in non-dollar currencies are translated into dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-dollar transactions and other items in the statements of operations (indicated below), the following exchange rates are used: (i) for transactions - exchange rates at transaction dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization, etc.) - historical exchange rates. Currency transaction gains and losses are presented in financial income or expenses, as appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;e.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt"&gt;Principles of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated upon consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;f.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers as cash equivalents all short-term, highly liquid investments, which include short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;g.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"&gt;Marketable securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marketable equity securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's marketable equity securities are recorded at fair value, with unrealized gains and losses included in other income, net in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;h.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the date the Company obtains regulatory approval for its product candidates, inventory costs related to commercial production are expensed as research and development expense. Once regulatory approval is obtained, the Company capitalizes such costs as inventory. Inventories are stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first-out (&#x201c;FIFO&#x201d;) method. The Company periodically reviews its inventory levels and writes down inventory that is expected to expire prior to being sold, inventory in excess of expected sales requirements and inventory that fails to meet commercial sale specifications, with a corresponding charge to cost of goods sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.73pt"&gt;Property and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt"&gt;Property and equipment are stated at cost, net of accumulated depreciation and amortization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt"&gt;The Company&#x2019;s property and equipment are depreciated by the straight-line method on the basis of their estimated useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Annual rates of depreciation are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - 14 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 - 14 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized by the straight-line method over the expected lease term, which is shorter than the estimated useful life of the improvements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;j.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests long-lived assets for impairment whenever events or circumstances present an indication of impairment. If the sum of expected future cash flows (undiscounted and without interest charges) of the assets is less than the carrying amount of such assets, an impairment loss would be recognized. The assets would be written down to their estimated fair values, calculated based on the present value of expected future cash flows (discounted cash flows), or some other fair value measure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2021 and 2020, the Company did not recognize an impairment loss for its long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;k.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"&gt;Goodwill and other indefinite lived intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews goodwill and other intangibles that have indefinite lives for impairment annually as of the end of the fiscal year or when events or changes in circumstances indicate the carrying value of these assets might exceed their current fair values.  Impairment testing is based upon the best information available including estimates of fair value which incorporate assumptions market participants would use in making their estimates of fair value.  In 2020, the Company recorded full &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;impairment charges related to its $4.5&#160;million of goodwill and $49.8&#160;million of IPR&amp;amp;D (See "Note 3 - Business Combination" for more information).  No impairment was recorded in the years ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;l.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.73pt"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An allowance for doubtful accounts is maintained for potential credit losses based on the aging of trade receivables, historical bad debts experience and changes in customer payment patterns. Trade receivable balances are written off against the allowance when it is deemed probable that the receivable will not be&#160;collected.&#160;Trade receivables, net are stated net of reserves for certain sales allowances and provisions for doubtful accounts. Provisions for doubtful accounts were not material for the years ended December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;m.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.17pt"&gt;Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt discounts created as a result of the allocation of proceeds received from a debt issuance to warrants issued are amortized to interest expense under the effective interest method over the life of the recognized debt liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt issuance costs include the costs of debt financings undertaken by the Company, including legal fees and other direct costs of the financing. Debt issuance costs related to a recognized debt liability are presented on the consolidated balance sheet as a direct deduction from the carrying amount of the debt liability and are amortized to interest expense over the term of the related debt, using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;n.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. Lease expense for operating leases is recognized on a straight-line basis over the expected lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;o.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain conditions may exist as of the date of the financial statements, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company&#x2019;s management assesses such contingent liabilities and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#x2019;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management applies the guidance in ASC 450-20-25 when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability is recorded as accrued expenses in the Company&#x2019;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material are disclosed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantees are disclosed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;p.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for employees&#x2019; and directors&#x2019; share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period using the straight-line method. Forfeitures are recognized as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based payments related to the employee share purchase plan (&#x201c;ESPP&#x201d;) are recognized based on the fair value of each award estimated on the first day of the offering period and recognized as an expense over the offering period using the straight-line method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to recognize compensation costs for awards conditioned only on continued service that have a graded vesting schedule using the straight-line method based on the multiple-option award approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;q.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its revenue transactions under FASB ASC Topic 606,&#160;Revenue from Contracts with Customers. In accordance with ASC Topic 606, the Company recognizes revenues when its customers obtain control of its product for an amount that reflects the consideration it expects to receive from its customers in exchange for that product. To determine revenue recognition for contracts that are determined to be in scope of ASC Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once the contract is determined to be within the scope of ASC Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when such performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customers include a limited number of national and select regional wholesalers (the &#x201c;distributors&#x201d;) and certain independent and specialty pharmacies, together (the "customers"). These distributors subsequently resell the product, primarily to retail pharmacies that dispense the product to patients. Net product revenue is typically recognized when customers obtain control of the Company&#x2019;s products, which occurs at a point in time, typically upon delivery of product to the customers. The Company evaluates the creditworthiness of its customers to determine whether it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur. The Company does not assess whether a contract has a significant financing component if the expectation is such that the period between the transfer of the promised goods to the customer and the receipt of payment will be less than one year. Standard credit terms do not exceed 75 days. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that would have been recognized is one year or less or the amount is immaterial. Shipping and handling costs related to the Company&#x2019;s product sales are included in selling, general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net product revenues through&#160;December&#160;31, 2021&#160;were generated through sales of AMZEEQ, which was approved by the FDA in October 2019 and was commercially launched in the United States in January 2020 and ZILXI, which was approved by the FDA in May 2020 and was commercially launched in the United States in October 2020. Product revenue is recorded net of distribution fees, trade discounts, allowances, rebates, copay program coupons, chargebacks, estimated returns and other incentives. These reserves are classified as either reductions of accounts receivable or as current liabilities. The estimates of reserves established for variable consideration reflect current contractual and statutory requirements, known market events and trends, industry data and forecasted customer mix. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net product revenues only to the extent that it is probable that a significant reversal of the amount of the cumulative revenues recognized will not occur in a future period. Actual amounts may ultimately differ from these estimates. If actual results vary, estimates may be adjusted in the period such change in estimate becomes known, which could have an impact on earnings in the period of adjustment. See &#x201c;Note 4 &#x2013; Revenue Recognition&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2020, the Company announced that it entered into a license agreement with Cutia for our minocycline products and product candidate, if approved, on an exclusive basis in Greater China.  Under the terms of the agreement, Cutia will have an exclusive license to obtain regulatory approval of and commercialize AMZEEQ, ZILXI and, if approved in the U.S., FCD105 in the Greater China territory.  The Company will supply the finished licensed products to Cutia for clinical and commercial use.  The Company received an upfront cash payment of $10.0 million.  The license was determined to be a distinct performance obligation of the arrangement, therefore the Company recognized the revenues from the upfront license fee when the license is transferred to the licensee and the licensee is able to use and benefit from the license.  The disposition of the MST Franchise included the license agreement with Cutia including the rights to future revenues under that agreement.  See "Note 4 - Revenue Recognition" for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;r.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.07pt"&gt;Research and development costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expenses include costs directly attributable to the conduct of research and development programs, including the cost of clinical trials, clinical trial supplies, salaries, share-based compensation expenses, payroll taxes and other employee benefits, lab expenses, consumable equipment and consulting fees. All costs associated with research and developments are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;s.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:29.61pt"&gt;Income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Deferred taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is recognized to the extent that it is more likely than not that the deferred taxes will not be realized in the foreseeable future. Given the Company&#x2019;s losses, the Company has provided a full valuation allowance with respect to its deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Uncertainty in income tax&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows a two-step approach in recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the available evidence indicates that it is more likely than not that the position will be sustained based on technical merits. If this threshold is met, the second step is to measure the tax position as the largest amount that has more than a 50% likelihood of being realized upon ultimate settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;t.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.17pt"&gt;Loss per share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of the weighted-average number of common stock outstanding during the period in which the reverse merger occurs was based on:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The number of common stock outstanding from the beginning of that period to the merger date was computed on the basis of the weighted-average number of common stock of the legal acquiree (accounting acquirer) outstanding during the period multiplied by the exchange ratio established in the merger agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The number of common stock outstanding from the merger date to the end of that period was the actual number of common stock of the legal acquirer (the accounting acquiree) outstanding during that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share, basic and diluted, is computed on the basis of the net loss for the period divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share is based upon the weighted average number of common stock and of common stock equivalents outstanding when dilutive. Common stock equivalents include outstanding stock options and warrants which are included under the treasury share method when dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following stock options, restricted stock units (&#x201c;RSUs&#x201d;), warrants and incremental shares to be issued under the employee stock purchase plan (&#x201c;ESPP&#x201d;) were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented (share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding share options, RSUs and shares under ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,306,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,994,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;u.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.94pt"&gt;Fair value measurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is based on the price that would be received from the sale of an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1:&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2:&#160;&#160;&#160;&#160;Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3&#160;&#160;&#160;&#160;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;v.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"&gt;Concentration of credit risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, restricted cash, marketable securities and accounts receivables. The Company deposits cash and cash equivalents with highly rated financial institutions and, as a matter of policy, limits the amounts of credit exposure to any single financial institution. In addition, all marketable securities carry a high rating or are government insured. The Company has not experienced any material credit losses in these accounts and does not believe it is exposed to significant credit risk on these instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2021, the Company's three largest customers collectively represented 41% of product revenue and 58% of accounts receivable.  For the year ended December&#160;31, 2020, the Company's largest three customers collectively represented 96% of product revenue and 90% of accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;w.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.28pt"&gt;Comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss includes, in addition to net loss, unrealized holding gains and losses on available-for-sale debt securities and derivative instruments designated as cash flow hedge (net of related taxes where applicable). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassification adjustments for gain or loss of available-for-sale securities are included in other income, net in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;x.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"&gt;Newly issued and recently adopted accounting pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Guidance Issued:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2020-4, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" (ASU 2020-4), which provides guidance to alleviate the burden in accounting for reference rate reform by allowing certain expedients and exceptions in applying generally accepted accounting principles to contracts, hedging relationships, and other transactions impacted by reference rate reform. The provisions of ASU 2020-4 apply only to those transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. Adoption of the provisions of ASU 2020-4 are optional and are effective from March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-4 on its consolidated financial statements.  Currently, the Company does not expect the adoption of the new standard to have a material impact to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued Accounting Standards Update No. 2016-13,&#160;&#x201c;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#x201d;&#160;(ASU 2016-13), which requires companies to measure credit losses of financial instruments, including customer accounts receivable, utilizing a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Subsequent to the issuance of ASU 2016-13, the FASB issued several additional Accounting Standard Updates to clarify implementation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;guidance, provide narrow-scope improvements and provide additional disclosure guidance. As a smaller reporting company, the Company will adopt ASU 2016-13 effective January 1, 2023 or at such time where it is no longer a smaller reporting company.  Currently, the Company does not expect the adoption of the new standard to have a material impact to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2019, the FASB issued Accounting Standards Update No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes," which clarifies and simplifies certain aspects of the accounting for income taxes.  The standard is effective for years beginning after December 15, 2020, and interim periods beginning after December 15, 2020.  This guidance became effective during the first quarter of 2021. The adoption of the new standard did not have a material impact to the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MDk_14be6dec-8e1f-4c67-b521-f1cb819b7b5d">Basis of presentationThe Company&#x2019;s financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;).  Certain prior period amounts have been reclassified to conform to current year presentation.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTA_795023f2-476d-4309-b753-9324672791e5">Use of estimates&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results may differ from those estimates.  Significant items subject to such estimates and assumptions include accounting for business combinations, impairments of goodwill and intangible assets and revenue recognition. Actual results could differ from the Company&#x2019;s estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic and government measures taken in response to the pandemic have had a negative impact on the Company's operations. Access to healthcare providers has been limited, which has negatively impacted sales and the Company's ability to execute its commercial strategy with respect to AMZEEQ and ZILXI. The length of time and extent to which the COVID-19 pandemic will directly or indirectly impact the Company's business, results of operations and financial condition and liquidity will depend on future developments that are highly uncertain, subject to change and will continue to evolve with geographical re-openings, surges in cases, the emergence of new strains and the vaccination effort. In addition, the Company further assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2021 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s allowance for doubtful accounts and credit losses, inventory and related reserves, impairments of long-lived assets and revenue recognition. In 2020, the Company recorded impairments of goodwill and certain indefinite-lived intangible assets; however, these were unrelated to the impact of COVID-19 (See "Note 3 - Business Combination" for more information). The Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#x2019;s consolidated financial statements in future reporting periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTE_29cd7faf-6559-4a9e-bfd1-a62fab36be3a">Business AcquisitionThe Company&#x2019;s consolidated financial statements include the operations of an acquired business after the completion of the acquisition. The Company accounts for acquired businesses using the acquisition method of accounting, which requires, among &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;other things, that most assets acquired and liabilities assumed be recognized at their estimated fair values as of the acquisition date and that the fair value of In-Process Research and Development and Goodwill be recorded on the balance sheet.&#160;Transaction costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recorded in connection with an acquisition can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting.&#160; For example, the Company uses fair value in the initial recognition of net assets acquired in a business combination and when measuring impairment losses.&#160; The Company estimates fair value using an exit price approach, which requires, among other things, that Company determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of non-financial assets and, for liabilities, assuming that the risk of non-performance will be the same before and after the transfer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may use one or all of the following techniques:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Income approach, which is based on the present value of a future stream of net cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Cost approach, which is based on the cost to acquire or construct comparable assets, less an allowance for functional and/or economic obsolescence.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our fair value methodologies depend on the following types of inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for identical assets or liabilities in active markets (Level 1 inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means (Level 2 inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Unobservable inputs that reflect estimates and assumptions (Level 3 inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A single estimate of fair value can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTI_a5767680-3d67-4f75-b839-3b0e5d92fc4b">Foreign Currency TranslationTransactions and balances originally denominated in dollars are presented at their original amounts. Balances in non-dollar currencies are translated into dollars using historical and current exchange rates for non-monetary and monetary balances, respectively. For non-dollar transactions and other items in the statements of operations (indicated below), the following exchange rates are used: (i) for transactions - exchange rates at transaction dates or average rates; and (ii) for other items (derived from non-monetary balance sheet items such as depreciation and amortization, etc.) - historical exchange rates. Currency transaction gains and losses are presented in financial income or expenses, as appropriate.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTM_3c7b6e45-0ba5-4651-abde-ac2cb468e1ed">Principles of consolidationThe consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany balances and transactions have been eliminated upon consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTQ_3a18a933-9575-491b-89c9-9d0d9985e82c">Cash and cash equivalentsThe Company considers as cash equivalents all short-term, highly liquid investments, which include short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTY_dcd83bd2-ce71-47c3-8246-b8de8949ef44">Marketable securities&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marketable equity securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's marketable equity securities are recorded at fair value, with unrealized gains and losses included in other income, net in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTg_3cf59f2f-f0f6-435c-8bd2-558f480e4975">InventoryPrior to the date the Company obtains regulatory approval for its product candidates, inventory costs related to commercial production are expensed as research and development expense. Once regulatory approval is obtained, the Company capitalizes such costs as inventory. Inventories are stated at the lower of cost or net realizable value. The Company determines the cost of inventory using the first-in, first-out (&#x201c;FIFO&#x201d;) method. The Company periodically reviews its inventory levels and writes down inventory that is expected to expire prior to being sold, inventory in excess of expected sales requirements and inventory that fails to meet commercial sale specifications, with a corresponding charge to cost of goods sold.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MTk_156191c0-5a5c-4188-9edb-52afedddf8c4">Property and equipment&lt;div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt"&gt;Property and equipment are stated at cost, net of accumulated depreciation and amortization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt"&gt;The Company&#x2019;s property and equipment are depreciated by the straight-line method on the basis of their estimated useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Annual rates of depreciation are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - 14 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 - 14 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized by the straight-line method over the expected lease term, which is shorter than the estimated useful life of the improvements.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjA_21fbf068-bfad-451d-a502-7ad98dc5bc0c">&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Annual rates of depreciation are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - 14 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 - 14 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0a6e3943e4f3499aa05c5f1b79ea9be6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzEtMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjozZjY5MzY1NWEyOTQ0ZGMyOGU0MDcwZDk4ZjljMTVhZF80_4743eac8-02be-4a17-a136-658929fd1748">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if1a583001e26487cab80e9da2a4c8bf1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzEtMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjozZjY5MzY1NWEyOTQ0ZGMyOGU0MDcwZDk4ZjljMTVhZF85_d9654643-e803-4927-add3-493b1948046b">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if1270645810f47e9a7e83fb038ed2bf1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzItMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjo3ZWM1MmQ3NjhjNWQ0ZTdiYjZlMTYzNjEwYjZmZThkY180_b89ba0f3-d5d8-4250-8268-f4f78299748b">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic5fd0d9bbcec4faaa99fa1d6f9cfcd5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzItMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjo3ZWM1MmQ3NjhjNWQ0ZTdiYjZlMTYzNjEwYjZmZThkY185_b8905e0f-df9d-46c5-af96-485180bdd4c1">P14Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i842ae2d9ee184a8ab5883bcf17a70e63_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzMtMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjpjMWQyZGY0NmRlYTM0NmE0OTdlNjU1MGU5Yzc5NDdiOV80_7107d355-4c06-4b71-aec0-ad08654ab2fb">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie53f456c44c141d9a86e97266cc12298_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo2ZmI5ZGY2NDdlOTE0NTgxYmI1M2EyOGRlZjBmZTgyNC90YWJsZXJhbmdlOjZmYjlkZjY0N2U5MTQ1ODFiYjUzYTI4ZGVmMGZlODI0XzMtMS0xLTEtMTc2ODkvdGV4dHJlZ2lvbjpjMWQyZGY0NmRlYTM0NmE0OTdlNjU1MGU5Yzc5NDdiOV85_c6986f96-801e-461a-8e92-d069e9f9f640">P14Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjE_faa1cb17-94c4-4774-9e6d-b119f6972aaf">Impairment of long-lived assetsThe Company tests long-lived assets for impairment whenever events or circumstances present an indication of impairment. If the sum of expected future cash flows (undiscounted and without interest charges) of the assets is less than the carrying amount of such assets, an impairment loss would be recognized. The assets would be written down to their estimated fair values, calculated based on the present value of expected future cash flows (discounted cash flows), or some other fair value measure.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzg3OTYwOTMwNTQxODI_32864cde-f70e-4bbc-a63f-19548ed338bc"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzg3OTYwOTMwNTQxODI_790169db-8fbe-4302-a785-e69b2be18d4f"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjI_ccdc82d6-49ee-4b9a-9b9f-0f00172152a8">Goodwill and other indefinite lived intangible assetsThe Company reviews goodwill and other intangibles that have indefinite lives for impairment annually as of the end of the fiscal year or when events or changes in circumstances indicate the carrying value of these assets might exceed their current fair values.  Impairment testing is based upon the best information available including estimates of fair value which incorporate assumptions market participants would use in making their estimates of fair value.  In 2020, the Company recorded full impairment charges related to its $4.5&#160;million of goodwill and $49.8&#160;million of IPR&amp;amp;D (See "Note 3 - Business Combination" for more information).  No impairment was recorded in the years ended December&#160;31, 2021.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEyMDY2_24a8902d-5023-4d48-81a1-671c45d22cf1"
      unitRef="usd">4500000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="idd175173768e4ea8aed9f33191f66791_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEyMDg1_55cb14a4-0ccf-4458-93fe-636bb07b7bea"
      unitRef="usd">49800000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzg3OTYwOTMwNTkxNzk_920572e4-d0a4-45d1-9cad-6c894b1dfa22"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjM_0074da50-c437-465f-90ea-e4beeafed65c">Allowance for doubtful accountsAn allowance for doubtful accounts is maintained for potential credit losses based on the aging of trade receivables, historical bad debts experience and changes in customer payment patterns. Trade receivable balances are written off against the allowance when it is deemed probable that the receivable will not be&#160;collected.&#160;Trade receivables, net are stated net of reserves for certain sales allowances and provisions for doubtful accounts. Provisions for doubtful accounts were not material for the years ended December&#160;31, 2021 and 2020.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEyNjcw_3d83089c-0ec7-4f9b-8466-b2c4e88b301f"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEyNjcw_d66be5b0-176f-40d1-be7e-d26d6f865c65"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DebtPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjQ_090623db-7849-47a2-a8f9-118606e1bef4">Debt&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt discounts created as a result of the allocation of proceeds received from a debt issuance to warrants issued are amortized to interest expense under the effective interest method over the life of the recognized debt liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt issuance costs include the costs of debt financings undertaken by the Company, including legal fees and other direct costs of the financing. Debt issuance costs related to a recognized debt liability are presented on the consolidated balance sheet as a direct deduction from the carrying amount of the debt liability and are amortized to interest expense over the term of the related debt, using the effective interest method.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjU_71bb280c-417e-4e09-b037-9f6744790cc4">LeasesLeases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. Lease expense for operating leases is recognized on a straight-line basis over the expected lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MjY_5bb8fae3-6e4b-42ba-9804-02d10b2b73c6">Contingencies&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain conditions may exist as of the date of the financial statements, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company&#x2019;s management assesses such contingent liabilities and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#x2019;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management applies the guidance in ASC 450-20-25 when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability is recorded as accrued expenses in the Company&#x2019;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material are disclosed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantees are disclosed.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3Mjc_58686d38-bbb7-4858-9dbe-4f2972e070ce">Share-based compensation&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for employees&#x2019; and directors&#x2019; share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period using the straight-line method. Forfeitures are recognized as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based payments related to the employee share purchase plan (&#x201c;ESPP&#x201d;) are recognized based on the fair value of each award estimated on the first day of the offering period and recognized as an expense over the offering period using the straight-line method.&lt;/span&gt;&lt;/div&gt;The Company elected to recognize compensation costs for awards conditioned only on continued service that have a graded vesting schedule using the straight-line method based on the multiple-option award approach.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3Mjg_96fbff83-1d96-458e-abe7-e8dcc3be1f61">Revenue recognition&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its revenue transactions under FASB ASC Topic 606,&#160;Revenue from Contracts with Customers. In accordance with ASC Topic 606, the Company recognizes revenues when its customers obtain control of its product for an amount that reflects the consideration it expects to receive from its customers in exchange for that product. To determine revenue recognition for contracts that are determined to be in scope of ASC Topic 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. Once the contract is determined to be within the scope of ASC Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when such performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customers include a limited number of national and select regional wholesalers (the &#x201c;distributors&#x201d;) and certain independent and specialty pharmacies, together (the "customers"). These distributors subsequently resell the product, primarily to retail pharmacies that dispense the product to patients. Net product revenue is typically recognized when customers obtain control of the Company&#x2019;s products, which occurs at a point in time, typically upon delivery of product to the customers. The Company evaluates the creditworthiness of its customers to determine whether it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur. The Company does not assess whether a contract has a significant financing component if the expectation is such that the period between the transfer of the promised goods to the customer and the receipt of payment will be less than one year. Standard credit terms do not exceed 75 days. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that would have been recognized is one year or less or the amount is immaterial. Shipping and handling costs related to the Company&#x2019;s product sales are included in selling, general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net product revenues through&#160;December&#160;31, 2021&#160;were generated through sales of AMZEEQ, which was approved by the FDA in October 2019 and was commercially launched in the United States in January 2020 and ZILXI, which was approved by the FDA in May 2020 and was commercially launched in the United States in October 2020. Product revenue is recorded net of distribution fees, trade discounts, allowances, rebates, copay program coupons, chargebacks, estimated returns and other incentives. These reserves are classified as either reductions of accounts receivable or as current liabilities. The estimates of reserves established for variable consideration reflect current contractual and statutory requirements, known market events and trends, industry data and forecasted customer mix. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net product revenues only to the extent that it is probable that a significant reversal of the amount of the cumulative revenues recognized will not occur in a future period. Actual amounts may ultimately differ from these estimates. If actual results vary, estimates may be adjusted in the period such change in estimate becomes known, which could have an impact on earnings in the period of adjustment. See &#x201c;Note 4 &#x2013; Revenue Recognition&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2020, the Company announced that it entered into a license agreement with Cutia for our minocycline products and product candidate, if approved, on an exclusive basis in Greater China.  Under the terms of the agreement, Cutia will have an exclusive license to obtain regulatory approval of and commercialize AMZEEQ, ZILXI and, if approved in the U.S., FCD105 in the Greater China territory.  The Company will supply the finished licensed products to Cutia for clinical and commercial use.  The Company received an upfront cash payment of $10.0 million.  The license was determined to be a distinct performance obligation of the arrangement, therefore the Company recognized the revenues from the upfront license fee when the license is transferred to the licensee and the licensee is able to use and benefit from the license.  The disposition of the MST Franchise included the license agreement with Cutia including the rights to future revenues under that agreement.  See "Note 4 - Revenue Recognition" for more information.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i8bc82390929346cc83aa1a859f646cb1_D20200423-20200423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzIxMDkz_326d1194-9eba-4d67-b6d1-45a63eb9375b"
      unitRef="usd">10000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3Mjk_f00bbd2d-78de-4a19-8a94-8ddaf6403e7b">Research and development costsResearch and development expenses include costs directly attributable to the conduct of research and development programs, including the cost of clinical trials, clinical trial supplies, salaries, share-based compensation expenses, payroll taxes and other employee benefits, lab expenses, consumable equipment and consulting fees. All costs associated with research and developments are expensed as incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzE_8c66664b-e3c1-4c87-a15f-d99791bc4f03">Income taxes:&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Deferred taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is recognized to the extent that it is more likely than not that the deferred taxes will not be realized in the foreseeable future. Given the Company&#x2019;s losses, the Company has provided a full valuation allowance with respect to its deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Uncertainty in income tax&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows a two-step approach in recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the available evidence indicates that it is more likely than not that the position will be sustained based on technical merits. If this threshold is met, the second step is to measure the tax position as the largest amount that has more than a 50% likelihood of being realized upon ultimate settlement.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzI_cb1aabfe-f170-4c7e-bdb4-dbd62a89b399">Loss per share&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of the weighted-average number of common stock outstanding during the period in which the reverse merger occurs was based on:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The number of common stock outstanding from the beginning of that period to the merger date was computed on the basis of the weighted-average number of common stock of the legal acquiree (accounting acquirer) outstanding during the period multiplied by the exchange ratio established in the merger agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The number of common stock outstanding from the merger date to the end of that period was the actual number of common stock of the legal acquirer (the accounting acquiree) outstanding during that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per share, basic and diluted, is computed on the basis of the net loss for the period divided by the weighted average number of common shares outstanding during the period. Diluted net loss per share is based upon the weighted average number of common stock and of common stock equivalents outstanding when dilutive. Common stock equivalents include outstanding stock options and warrants which are included under the treasury share method when dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following stock options, restricted stock units (&#x201c;RSUs&#x201d;), warrants and incremental shares to be issued under the employee stock purchase plan (&#x201c;ESPP&#x201d;) were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented (share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding share options, RSUs and shares under ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,306,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,994,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzM_46d4e116-dfcd-41db-b1ef-5c4fa43d6a14">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following stock options, restricted stock units (&#x201c;RSUs&#x201d;), warrants and incremental shares to be issued under the employee stock purchase plan (&#x201c;ESPP&#x201d;) were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented (share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding share options, RSUs and shares under ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,306,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,994,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icb7ed5c301ca4a1fb4df13b64075b204_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo3YjUyMDllNDY0YmE0ZTU3YmYxYTc0ZTRkNzEyMzY2NC90YWJsZXJhbmdlOjdiNTIwOWU0NjRiYTRlNTdiZjFhNzRlNGQ3MTIzNjY0XzItMS0xLTEtMTc2ODk_45f04a14-af31-48fe-9484-308dfd229169"
      unitRef="shares">5306352</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idf66ae22fce94621a923fc88150b0de4_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo3YjUyMDllNDY0YmE0ZTU3YmYxYTc0ZTRkNzEyMzY2NC90YWJsZXJhbmdlOjdiNTIwOWU0NjRiYTRlNTdiZjFhNzRlNGQ3MTIzNjY0XzItMy0xLTEtMTc2ODk_5227b551-c59d-4956-859f-34ab993a8055"
      unitRef="shares">4994333</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0e320cc859974d9a8611825211a48e4d_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo3YjUyMDllNDY0YmE0ZTU3YmYxYTc0ZTRkNzEyMzY2NC90YWJsZXJhbmdlOjdiNTIwOWU0NjRiYTRlNTdiZjFhNzRlNGQ3MTIzNjY0XzMtMS0xLTEtMTc2ODk_a0ee7aa7-623e-4819-baf1-fbadb5bc4a32"
      unitRef="shares">495165</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i04c5ebd48f7b4ed7a5b18e2619c3dc71_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90YWJsZTo3YjUyMDllNDY0YmE0ZTU3YmYxYTc0ZTRkNzEyMzY2NC90YWJsZXJhbmdlOjdiNTIwOWU0NjRiYTRlNTdiZjFhNzRlNGQ3MTIzNjY0XzMtMy0xLTEtMTc2ODk_160c1cb8-813b-4803-be18-b1a0d7d62409"
      unitRef="shares">495165</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzQ_f3a3a284-77c1-46f2-9ca7-c6a0c07cd2bf">Fair value measurementFair value is based on the price that would be received from the sale of an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1:&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2:&#160;&#160;&#160;&#160;Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data of similar or identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-align:justify;text-indent:-90pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3&#160;&#160;&#160;&#160;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzU_30245d06-11c2-4c42-a872-61504fc75ad0">Concentration of credit risks&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, restricted cash, marketable securities and accounts receivables. The Company deposits cash and cash equivalents with highly rated financial institutions and, as a matter of policy, limits the amounts of credit exposure to any single financial institution. In addition, all marketable securities carry a high rating or are government insured. The Company has not experienced any material credit losses in these accounts and does not believe it is exposed to significant credit risk on these instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2021, the Company's three largest customers collectively represented 41% of product revenue and 58% of accounts receivable.  For the year ended December&#160;31, 2020, the Company's largest three customers collectively represented 96% of product revenue and 90% of accounts receivable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzg3OTYwOTMwNjQxOTk_cfd1dfbc-7f69-45ec-9490-a8e010179090">Concentration of credit risks&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, restricted cash, marketable securities and accounts receivables. The Company deposits cash and cash equivalents with highly rated financial institutions and, as a matter of policy, limits the amounts of credit exposure to any single financial institution. In addition, all marketable securities carry a high rating or are government insured. The Company has not experienced any material credit losses in these accounts and does not believe it is exposed to significant credit risk on these instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2021, the Company's three largest customers collectively represented 41% of product revenue and 58% of accounts receivable.  For the year ended December&#160;31, 2020, the Company's largest three customers collectively represented 96% of product revenue and 90% of accounts receivable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i748a6a56555e4b559d51845f4cf5e925_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEwOTk1MTE2NjQ2Njg_7f8ce33c-61a9-4d64-b833-ccb7e0c2e162"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0e802c47b5b948f28423b29c6ae7b1ed_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzI4OTQ3_f071cbf7-7ebd-44f7-9130-2551e61fa9c9"
      unitRef="number">0.58</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i89b5ce1d295243118db097ac730c0000_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEwOTk1MTE2Nzc2MDQ_6f570df8-4dda-438a-bfc5-c46b70f005f4"
      unitRef="number">0.96</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6ada4de775684974955fee5f4e5ae4f9_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzEwOTk1MTE2Nzc2MDk_20296fe7-143d-4f4a-a12c-5f0be0926c67"
      unitRef="number">0.90</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3MzY_0e2dd187-e6b2-4a5d-8053-500c6b3ee446">Comprehensive loss&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss includes, in addition to net loss, unrealized holding gains and losses on available-for-sale debt securities and derivative instruments designated as cash flow hedge (net of related taxes where applicable). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassification adjustments for gain or loss of available-for-sale securities are included in other income, net in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzg3OTYwOTMwNjQyMDA_545a3590-a749-4610-b2c9-9963ce7ae150">Comprehensive loss&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss includes, in addition to net loss, unrealized holding gains and losses on available-for-sale debt securities and derivative instruments designated as cash flow hedge (net of related taxes where applicable). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reclassification adjustments for gain or loss of available-for-sale securities are included in other income, net in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzAvZnJhZzpjZDliMDY5ZWQ1Mzk0ZDAyOTAwOWJlNzVmZjQ4ZmM0Mi90ZXh0cmVnaW9uOmNkOWIwNjllZDUzOTRkMDI5MDA5YmU3NWZmNDhmYzQyXzYwNDczMTM5ODQ3Mzc_882550be-ccd3-45fc-8938-608e7da53a7d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"&gt;Newly issued and recently adopted accounting pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Guidance Issued:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2020-4, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting" (ASU 2020-4), which provides guidance to alleviate the burden in accounting for reference rate reform by allowing certain expedients and exceptions in applying generally accepted accounting principles to contracts, hedging relationships, and other transactions impacted by reference rate reform. The provisions of ASU 2020-4 apply only to those transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. Adoption of the provisions of ASU 2020-4 are optional and are effective from March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-4 on its consolidated financial statements.  Currently, the Company does not expect the adoption of the new standard to have a material impact to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued Accounting Standards Update No. 2016-13,&#160;&#x201c;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&#x201d;&#160;(ASU 2016-13), which requires companies to measure credit losses of financial instruments, including customer accounts receivable, utilizing a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Subsequent to the issuance of ASU 2016-13, the FASB issued several additional Accounting Standard Updates to clarify implementation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;guidance, provide narrow-scope improvements and provide additional disclosure guidance. As a smaller reporting company, the Company will adopt ASU 2016-13 effective January 1, 2023 or at such time where it is no longer a smaller reporting company.  Currently, the Company does not expect the adoption of the new standard to have a material impact to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2019, the FASB issued Accounting Standards Update No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes," which clarifies and simplifies certain aspects of the accounting for income taxes.  The standard is effective for years beginning after December 15, 2020, and interim periods beginning after December 15, 2020.  This guidance became effective during the first quarter of 2021. The adoption of the new standard did not have a material impact to the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzIxOTkwMjMyNjg3MDg_0385fa9f-b2b3-4dcd-af20-897d2d8c41b8">BUSINESS COMBINATION:&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 10, 2019, Menlo entered into the Merger Agreement with Foamix, and Merger Sub, a direct and wholly-owned Israeli subsidiary of Menlo. On March 9, 2020, the Merger was completed and Foamix is now a wholly-owned subsidiary of the Company. The combined Company changed its name to VYNE in September 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On the Effective Date, each ordinary share of Foamix was exchanged for 0.5924 shares of common stock of Menlo. In addition, on the Effective Date, Foamix shareholders received one contingent stock right (a &#x201c;CSR&#x201d;) for each Foamix ordinary share held by them. The CSRs were issued pursuant to the Contingent Stock Rights Agreement (the &#x201c;CSR Agreement&#x201d;), dated as of March 9, 2020, by and between Menlo and American Stock Transfer &amp;amp; Trust Company, LLC, and represented the non-transferable contractual right to receive shares of common stock of Menlo depending on the results of Menlo&#x2019;s phase III clinical trials evaluating the safety and efficacy of once daily oral serlopitant for the treatment of prurigo nodularis (the &#x201c;Phase III PN Trials&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 6, 2020, the Company announced that each of Menlo&#x2019;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. Accordingly, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into 1.2082 additional shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of 1.8006 shares of Menlo common stock for each Foamix ordinary share.  The CSR conversion resulted in the issuance and delivery of 74,544,413 additional shares of Menlo common stock underlying the CSRs, adjusted retrospectively to 18,636,103 shares of common stock upon the reverse stock split effective February 12, 2021.  Following the conversion of the CSRs, pre-Merger Foamix shareholders and pre-Merger Menlo stockholders owned approximately 82% and 18% of post-Merger Menlo, respectively, each calculated on a fully diluted basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For accounting purposes, the Merger is treated as a &#x201c;reverse acquisition&#x201d; under U.S. GAAP and Foamix is considered the accounting acquirer. Accordingly, upon consummation of the Merger, the historical financial statements of Foamix became the Company&#x2019;s historical financial statements, and the historical financial statements of Foamix are included in the comparative prior periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under reverse acquisition accounting, the U.S. dollar amount for common stock in the financial statements is based on the value and number of shares issued by Menlo (reflecting the legal structure of Menlo as the legal acquirer) on the Merger date plus subsequent shares issued by the Company. The amounts in additional paid-in capital represent that of Foamix and include the fair value of shares deemed for accounting purposes to have been issued by Foamix on the merger date and the fair value of the Menlo equity awards included in the purchase price calculation. The Foamix additional paid-in capital was also adjusted for the difference between the number of common stock and the historical number of shares of Foamix&#x2019;s ordinary shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020, the Company incurred transaction costs of approximately $11.7 million, which are recorded in the consolidated statements of operations and comprehensive income. This amount includes $8.1 million of severance benefits for employees terminated after the Effective Date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is the Merger Consideration (as defined in the Merger Agreement) was transferred to effect the Merger:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deemed (for accounting purposes only) conversion of Menlo equity awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total consideration*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* This amount reflects total consideration prior to reduction in respect of the CSRs (which had a fair value of $19.6 million as of the Merger Date) that were issued to Foamix shareholders and that reduced the Menlo stockholders&#x2019; relative ownership in the combined company. If the effect of the CSRs is included, the total consideration deemed paid by Foamix, as the accounting acquirer, to Menlo stockholders and equity award holders in the Merger would be reduced to approximately $111.4 million, as shown in the purchase price allocation table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on Foamix&#x2019;s closing share price of $2.99 as of March 9, 2020, the Merger Consideration under reverse acquisition accounting was approximately $131.1 million, consisting of $123.8 million for the deemed (for accounting purposes only) issuance of 41.4&#160;million Foamix shares assuming that no upwards adjustment was made to the Exchange Ratio relating to the CSR, and $7.3 million for the fair value of Menlo equity awards deemed (for accounting purposes only) to be converted into Foamix equity awards. The converted stock options represent the fair value of such options attributable to service prior to the Merger date using the Foamix closing share price of $2.99 as of March 9, 2020 as an input to the Black Scholes valuation model to determine the fair value of the options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company completed its analysis of the allocation of the purchase price to the fair values of assets acquired and liabilities assumed as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;March 9, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment in marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In-process research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated purchase price*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Reflects reduction in the purchase price deemed paid to Menlo stockholders in the Merger on the assumption that the CSRs, in an aggregate value of $19.6 million, convert into additional shares of the combined company for the Foamix shareholders, thereby resulting in a lower percentage of the combined company&#x2019;s outstanding shares being owned by Menlo stockholders following the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is recorded with the acquisition of a business and is calculated as the difference between the acquisition date fair value of the consideration transferred and the values assigned to the assets acquired and liabilities assumed. Goodwill is not amortized but is tested for impairment at least annually. None of the Goodwill recognized is expected to be deductible for income tax purposes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purchase price of the transaction and the excess purchase price over the fair value of the identifiable net assets acquired, are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 9, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: fair value of net assets acquired, including other identifiable intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 6, 2020, the Company announced that each of Menlo&#x2019;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. The Company does not intend to further pursue the development of serlopitant.  As such, the Company recorded a full impairment charge of $4.5 million related to goodwill in its consolidated statements of operations and comprehensive loss for the year ended December&#160;31, 2020.  There were no impairment charges in the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In-Process Research and Development (&#x201c;IPR&amp;amp;D")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The IPR&amp;amp;D recognized relates to Menlo&#x2019;s once&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;daily oral serlopitant for the treatment of pruritus (itch) associated with PN that has not reached technological feasibility as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired indefinite life intangible assets*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value of identified intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Represents acquired IPR&amp;amp;D assets which are initially recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the associated research and development efforts. Accordingly, during the research and development period, these assets will not be amortized into earnings; instead these assets will be subject to periodic impairment testing. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of IPR&amp;amp;D has been estimated utilizing a multi-period excess earnings method under the income approach, which reflects the present value of the projected cash flows that are expected to be generated, less charges representing the contribution of other assets to those cash flows that use projected cash flows with and without the intangible asset in place.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 6, 2020, the Company announced that each of Menlo&#x2019;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. The Company does not intend to further pursue the development of serlopitant.  As such, the Company recorded a full impairment charge of $49.8 million related to the IPR&amp;amp;D asset in its consolidated statements of operations and comprehensive loss for the year ended December 31, 2020.  There were no impairment charges in the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CSR&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CSR was issued pursuant to the CSR Agreement, dated as of March 9, 2020, by and between Menlo and American Stock Transfer &amp;amp; Trust Company, LLC, and represented the non-transferable contractual right to receive shares of common stock of Menlo depending on the results of Menlo&#x2019;s Phase III PN Trials. The Company recognized a liability of $19.6 million in the consolidated balance sheet as of March 9, 2020. The liability was measured at fair value and categorized as level 3 as of the acquisition date in accordance with ASC 805-31-25-5 and subsequently at each reporting date thereafter. The fair value of the CSR was estimated as the incremental value that Foamix would be able to achieve on a probability weighted basis assuming three different potential probabilities of the following scenarios: (a) serlopitant significance was achieved in both Phase III PN Trials (b) serlopitant significance was achieved in only one Phase III PN Trial and (c) serlopitant significance was not achieved or was not determined on or before May 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 6, 2020, the Company announced that each of Menlo&#x2019;s Phase III PN Trials (study MTI-105 and study MTI-106) did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis. Accordingly, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into 1.2082 additional shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of 1.8006 shares of Menlo common stock for each Foamix ordinary share.  The CSR conversion resulted in the issuance and delivery of 74.5 million additional shares of Menlo common stock underlying the CSRs, adjusted retrospectively to 18.6 million shares of common stock upon the reverse stock split effective February 12, 2021.  Following the conversion of the CSRs, pre-Merger Foamix shareholders and pre-Merger Menlo stockholders own approximately 82% and 18% of post-Merger Menlo, respectively, each calculated on a fully diluted basis.  The conversion of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the CSR also affected the Exchange Ratio of the pre-Merger Foamix equity awards and warrants outstanding as of March 9, 2020 and increased the awards available for grant under the Company's equity plan.    &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration associated with the CSR was recognized and measured at fair value as of the acquisition date in accordance with ASC 805-30-25-5. An acquirer's obligation to pay contingent consideration should be classified as a liability or equity in accordance with ASC 480, Distinguishing Liabilities from Equity, ASC 815 Derivatives and Hedging, and other applicable U.S. GAAP.&#160;The contingent consideration associated with the CSR was initially measured at fair value and subsequently measured at fair value at each reporting date. The CSR was classified as a liability, as it was settled by issuing a variable number of the Company's common stock.  On April 6, 2020, the Company recorded $84.7 million of expense in its consolidated statements of operations and comprehensive loss to remeasure the CSR liability in its consolidated balance sheet to its fair value of $104.4 million (calculated based on 74,544,413 shares issued, adjusted retrospectively to 18,636,103 shares of common stock upon the reverse stock split effective February 12, 2021, and a share price of $1.40 on April 6, 2020) and then settled in connection with the issuance of shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pro Forma&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actual Menlo net loss included in the Company&#x2019;s consolidated statements of operations and comprehensive income for the year ended December 31, 2020 (for the period from March 9, 2020, the Effective Date, through December 31, 2020, which are not indicative of the results to be expected for a full year) and the supplemental unaudited pro forma revenue and net loss of the combined entity had the acquisition been completed on January 1, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actual Menlo results of operations for the period from March 9, 2020, the Effective Date, through December 31, 2020 included in the consolidated statement of operation for the year ended December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss attributable to Menlo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pro forma Menlo results of operations for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year  ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SUPPLEMENTAL PRO FORMA COMBINED RESULTS OF OPERATIONS:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss per share - basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Adjustments to the supplemental pro forma combined results of operations, included in the above, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acceleration of stock based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited pro forma consolidated financial results have been prepared for illustrative purposes only and do not purport to be indicative of the results of operations that actually would have resulted had the acquisition occurred on the first day of the earliest period presented, or of future results of the consolidated entities. The unaudited pro forma consolidated financial information does not reflect any operating efficiencies and cost savings that may be realized from the integration of the Merger.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <vyne:ExchangeRatio
      contextRef="ib5a47ebbee0041dab8fdf54e6e3642fa_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzM1Ng_c55217e3-3330-4bf6-a3f1-b544ca3a708b"
      unitRef="number">0.5924</vyne:ExchangeRatio>
    <vyne:BusinessAcquisitionContingentStockRightIssued
      contextRef="ib5a47ebbee0041dab8fdf54e6e3642fa_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQ1Nw_33d24f3e-6af7-43d0-98dd-41bda8beb22f"
      unitRef="contingentstockright">1</vyne:BusinessAcquisitionContingentStockRightIssued>
    <vyne:ContingentStockRightSharesConversion
      contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE0NjQ_814572c3-1d65-490c-b1d6-881f5c3bc3a5"
      unitRef="number">1.2082</vyne:ContingentStockRightSharesConversion>
    <vyne:BusinessCombinationEffectiveExchangeRatio
      contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE1NjY_6b14ca04-1b71-4d8c-8476-93e782752a75"
      unitRef="number">1.8006</vyne:BusinessCombinationEffectiveExchangeRatio>
    <vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement
      contextRef="i1b5ca9e470654e73af6168a009123651_D20200406-20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE2OTE_5abbb05d-ad21-4539-b90a-a28b55fa73a8"
      unitRef="shares">74544413</vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement>
    <vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement
      contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE3ODM_fa2cd416-accc-4ff6-856e-03e9f1a41fbb"
      unitRef="shares">18636103</vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement>
    <vyne:PostMergerParentOwnershipByPreMergerSubsidiaryShareholders
      contextRef="ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE5OTE_1a06b835-1f26-4a6e-b8fd-71b9c962950c"
      unitRef="number">0.82</vyne:PostMergerParentOwnershipByPreMergerSubsidiaryShareholders>
    <vyne:PostMergerParentOwnershipByPreMergerParentStockholders
      contextRef="ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzE5OTg_6869781f-15d0-4b18-b4f5-b0f2abf2f4cb"
      unitRef="number">0.18</vyne:PostMergerParentOwnershipByPreMergerParentStockholders>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ic600bdee39bf4a4880487b43ba9df188_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzMzMDM_47ce7c06-aa5b-4996-97e1-8ba14405aa3f"
      unitRef="usd">11700000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i5d104d36f6484a09b3af55f5a52b179a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzM0MTg_33665a7e-26ea-44b4-8913-93f1447b9eb7"
      unitRef="usd">8100000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <vyne:ScheduleOfBusinessAcquisitionConsiderationTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzYwNDczMTM5NjU5MjY_93a036d5-5d7d-4995-a6a4-219f617fbe8f">The following is the Merger Consideration (as defined in the Merger Agreement) was transferred to effect the Merger:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deemed (for accounting purposes only) conversion of Menlo equity awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total consideration*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* This amount reflects total consideration prior to reduction in respect of the CSRs (which had a fair value of $19.6 million as of the Merger Date) that were issued to Foamix shareholders and that reduced the Menlo stockholders&#x2019; relative ownership in the combined company. If the effect of the CSRs is included, the total consideration deemed paid by Foamix, as the accounting acquirer, to Menlo stockholders and equity award holders in the Merger would be reduced to approximately $111.4 million, as shown in the purchase price allocation table below.&lt;/span&gt;&lt;/div&gt;</vyne:ScheduleOfBusinessAcquisitionConsiderationTableTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTozMzI4MDMyNGQxMGM0OGYwOTViNGM1ZGRkMzZlZGJlYS90YWJsZXJhbmdlOjMzMjgwMzI0ZDEwYzQ4ZjA5NWI0YzVkZGQzNmVkYmVhXzEtMS0xLTEtMTc2ODk_16a78ac6-d3f5-4f5c-97e7-2cb5147f99e8"
      unitRef="usd">123757000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <vyne:BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTozMzI4MDMyNGQxMGM0OGYwOTViNGM1ZGRkMzZlZGJlYS90YWJsZXJhbmdlOjMzMjgwMzI0ZDEwYzQ4ZjA5NWI0YzVkZGQzNmVkYmVhXzItMS0xLTEtMTc2ODk_e0c72c00-87a7-4d6e-8c24-452c792d9385"
      unitRef="usd">7322000</vyne:BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards>
    <vyne:BusinessCombinationConsiderationTransferredGross
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTozMzI4MDMyNGQxMGM0OGYwOTViNGM1ZGRkMzZlZGJlYS90YWJsZXJhbmdlOjMzMjgwMzI0ZDEwYzQ4ZjA5NWI0YzVkZGQzNmVkYmVhXzMtMS0xLTEtMTc2ODk_4106c4ea-3d80-4e36-a8b6-7e017954ec21"
      unitRef="usd">131079000</vyne:BusinessCombinationConsiderationTransferredGross>
    <vyne:BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock
      contextRef="i4ea3fe3e2a474e2c836df31770569ca5_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzM3NDE_35a31f22-1e63-41e2-b3ea-84264b7cc614"
      unitRef="usd">19600000</vyne:BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQxMDE_e9039a7e-6b68-42d0-a11c-86d40204b983"
      unitRef="usd">111400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:SharePrice
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQyMDE_efb824ca-82e0-4312-b0e9-3cb902bffdd1"
      unitRef="usdPerShare">2.99</us-gaap:SharePrice>
    <vyne:BusinessCombinationConsiderationTransferredGross
      contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQzMDU_8b635a3a-33be-4df1-8470-95f3434e5a68"
      unitRef="usd">131100000</vyne:BusinessCombinationConsiderationTransferredGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQzMjM_9bb0622c-7895-43e6-9bb1-e631bed96f7e"
      unitRef="usd">123800000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <vyne:BusinessCombinationSharesDeemedIssuedForAccountingPurposes
      contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQzODQ_f0e4e504-5c4c-4b06-9515-890eae12c5f3"
      unitRef="shares">41400000</vyne:BusinessCombinationSharesDeemedIssuedForAccountingPurposes>
    <vyne:BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards
      contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQ0OTM_62c36c6f-5900-4f34-aeed-9beb63934ad9"
      unitRef="usd">7300000</vyne:BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards>
    <us-gaap:SharePrice
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzQ3Nzc_efb824ca-82e0-4312-b0e9-3cb902bffdd1"
      unitRef="usdPerShare">2.99</us-gaap:SharePrice>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzYwNDczMTM5NjU5Mjc_382f7f1b-920c-4e33-b582-7deaab15fef4">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company completed its analysis of the allocation of the purchase price to the fair values of assets acquired and liabilities assumed as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;March 9, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment in marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In-process research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated purchase price*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Reflects reduction in the purchase price deemed paid to Menlo stockholders in the Merger on the assumption that the CSRs, in an aggregate value of $19.6 million, convert into additional shares of the combined company for the Foamix shareholders, thereby resulting in a lower percentage of the combined company&#x2019;s outstanding shares being owned by Menlo stockholders following the Merger.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzEtMS0xLTEtMTc2ODk_7ec7fc2e-5dbd-4595-b678-31bfdef7e5c7"
      unitRef="usd">38641000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzItMS0xLTEtMTc2ODk_226da1e9-b372-4b64-87d9-28a6e6a2ef96"
      unitRef="usd">22703000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzMtMS0xLTEtMTc2ODk_c9b4128a-0e76-471c-8ac8-e8d12af456ef"
      unitRef="usd">1581000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzQtMS0xLTEtMTc2ODk_803d74d9-82c7-4b04-b994-307aa74c8269"
      unitRef="usd">49800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:Goodwill
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzUtMS0xLTEtMTc2ODk_dbbde170-1d87-42fa-9891-d65c3a8e7c51"
      unitRef="usd">4545000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzYtMS0xLTEtMTc2ODk_bc9eb253-2add-49e9-b7a4-8af2287897be"
      unitRef="usd">117270000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzctMS0xLTEtMTc2ODk_0923fc50-8d37-41bc-ba91-530bd0df6270"
      unitRef="usd">5827000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzgtMS0xLTEtMTc2ODk_b4a17081-f365-4a4b-b408-10286e768e7e"
      unitRef="usd">5827000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2NDI3M2JiZjhiNzQ0NjdjYWY3ZmNhMjFmZTk1OTg4YS90YWJsZXJhbmdlOjY0MjczYmJmOGI3NDQ2N2NhZjdmY2EyMWZlOTU5ODhhXzktMS0xLTEtMTc2ODk_f4eaacb3-d297-4ce4-9a02-6397917620c0"
      unitRef="usd">111443000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <vyne:BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock
      contextRef="i4ea3fe3e2a474e2c836df31770569ca5_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzUyMTk_35a31f22-1e63-41e2-b3ea-84264b7cc614"
      unitRef="usd">19600000</vyne:BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzU3Njg_263a2790-8886-4415-93c6-4928f101ce19"
      unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <vyne:ScheduleOfBusinessCombinationGoodwillTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzYwNDczMTM5NjU5Mjg_332b4797-45eb-4463-a895-710911bffd8a">The purchase price of the transaction and the excess purchase price over the fair value of the identifiable net assets acquired, are calculated as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 9, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: fair value of net assets acquired, including other identifiable intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</vyne:ScheduleOfBusinessCombinationGoodwillTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo4NjdhNjdiZGI1YTY0YTJjYjQzMDdlZTY5NmNiMjNjOS90YWJsZXJhbmdlOjg2N2E2N2JkYjVhNjRhMmNiNDMwN2VlNjk2Y2IyM2M5XzEtMS0xLTEtMTc2ODk_1192d5a2-89d2-40c6-9943-54c35530b087"
      unitRef="usd">111443000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <vyne:BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo4NjdhNjdiZGI1YTY0YTJjYjQzMDdlZTY5NmNiMjNjOS90YWJsZXJhbmdlOjg2N2E2N2JkYjVhNjRhMmNiNDMwN2VlNjk2Y2IyM2M5XzItMS0xLTEtMTc2ODk_59e056e8-a1da-4eb9-a725-48a7d8f65237"
      unitRef="usd">106898000</vyne:BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets>
    <us-gaap:Goodwill
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo4NjdhNjdiZGI1YTY0YTJjYjQzMDdlZTY5NmNiMjNjOS90YWJsZXJhbmdlOjg2N2E2N2JkYjVhNjRhMmNiNDMwN2VlNjk2Y2IyM2M5XzMtMS0xLTEtMTc2ODk_39d5525a-3a5a-48cb-a535-2fdabda8c669"
      unitRef="usd">4545000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzY0ODU_24a8902d-5023-4d48-81a1-671c45d22cf1"
      unitRef="usd">4500000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwOTk1MTE2NDA3NDE_94f5e9c0-d9aa-4b62-9591-e2f0d58d24b3"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <vyne:ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzYwNDczMTM5NjU5MzY_5fe92181-f735-4718-a7f4-c37771b4e161">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The IPR&amp;amp;D recognized relates to Menlo&#x2019;s once&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;daily oral serlopitant for the treatment of pruritus (itch) associated with PN that has not reached technological feasibility as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible asset&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired indefinite life intangible assets*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value of identified intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;* Represents acquired IPR&amp;amp;D assets which are initially recognized at fair value and are classified as indefinite-lived assets until the successful completion or abandonment of the associated research and development efforts. Accordingly, during the research and development period, these assets will not be amortized into earnings; instead these assets will be subject to periodic impairment testing.</vyne:ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo1MDJhMDUyYjlhYWQ0NGYwOGYxNGZiZGJjMjRmNTc5My90YWJsZXJhbmdlOjUwMmEwNTJiOWFhZDQ0ZjA4ZjE0ZmJkYmMyNGY1NzkzXzItMi0xLTEtMTc2ODk_db0b4842-4b88-42c8-a6af-3011a16ab64d"
      unitRef="usd">49800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo1MDJhMDUyYjlhYWQ0NGYwOGYxNGZiZGJjMjRmNTc5My90YWJsZXJhbmdlOjUwMmEwNTJiOWFhZDQ0ZjA4ZjE0ZmJkYmMyNGY1NzkzXzMtMi0xLTEtMTc2ODk_638e8f42-5c5f-464d-9e62-6967487f9826"
      unitRef="usd">49800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="idd175173768e4ea8aed9f33191f66791_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzgxNTk_55cb14a4-0ccf-4458-93fe-636bb07b7bea"
      unitRef="usd">49800000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ie3d87335d72c46baae89c74cf256abfc_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwOTk1MTE2NDA3ODk_199a756b-18ce-41fe-81ae-44fdd10db4bb"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <vyne:BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock
      contextRef="i4ea3fe3e2a474e2c836df31770569ca5_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5Xzg3MDY_35a31f22-1e63-41e2-b3ea-84264b7cc614"
      unitRef="usd">19600000</vyne:BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock>
    <vyne:ContingentStockRightSharesConversion
      contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5Xzk4Mzk_814572c3-1d65-490c-b1d6-881f5c3bc3a5"
      unitRef="number">1.2082</vyne:ContingentStockRightSharesConversion>
    <vyne:BusinessCombinationEffectiveExchangeRatio
      contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5Xzk5NDE_6b14ca04-1b71-4d8c-8476-93e782752a75"
      unitRef="number">1.8006</vyne:BusinessCombinationEffectiveExchangeRatio>
    <vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement
      contextRef="i1b5ca9e470654e73af6168a009123651_D20200406-20200406"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwMDY2_106a7080-ce36-4bcd-9d02-49c0894644e0"
      unitRef="shares">74500000</vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement>
    <vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement
      contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwMTU4_d0f86763-4f8c-457c-beb0-68f112fb6dd5"
      unitRef="shares">18600000</vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement>
    <vyne:PostMergerParentOwnershipByPreMergerSubsidiaryShareholders
      contextRef="ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwMzY0_1a06b835-1f26-4a6e-b8fd-71b9c962950c"
      unitRef="number">0.82</vyne:PostMergerParentOwnershipByPreMergerSubsidiaryShareholders>
    <vyne:PostMergerParentOwnershipByPreMergerParentStockholders
      contextRef="ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzEwMzcx_6869781f-15d0-4b18-b4f5-b0f2abf2f4cb"
      unitRef="number">0.18</vyne:PostMergerParentOwnershipByPreMergerParentStockholders>
    <vyne:ContingentStockConsiderationRemeasurementGainLoss
      contextRef="i1b5ca9e470654e73af6168a009123651_D20200406-20200406"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzExMzgz_a28957e3-db1a-4a78-9e9f-b97b664887df"
      unitRef="usd">-84700000</vyne:ContingentStockConsiderationRemeasurementGainLoss>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzExNTUx_fd49f541-be1d-455b-84ad-f90e171fed14"
      unitRef="usd">104400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement
      contextRef="i1b5ca9e470654e73af6168a009123651_D20200406-20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzExNTc1_5abbb05d-ad21-4539-b90a-a28b55fa73a8"
      unitRef="shares">74544413</vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement>
    <vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement
      contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzExNjIx_fa2cd416-accc-4ff6-856e-03e9f1a41fbb"
      unitRef="shares">18636103</vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement>
    <us-gaap:SharePrice
      contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzExNzI2_14085b07-351d-4236-8cc4-e8167e96a5c3"
      unitRef="usdPerShare">1.40</us-gaap:SharePrice>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90ZXh0cmVnaW9uOjU0NDUyZjg1MTY4ZjQ0NWViOGE3ZjEzYTNhNmU5MDE5XzYwNDczMTM5NjU5NDQ_1782fbcc-d819-402b-93a2-657978b5be1d">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actual Menlo results of operations for the period from March 9, 2020, the Effective Date, through December 31, 2020 included in the consolidated statement of operation for the year ended December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss attributable to Menlo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pro forma Menlo results of operations for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year  ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SUPPLEMENTAL PRO FORMA COMBINED RESULTS OF OPERATIONS:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss per share - basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Adjustments to the supplemental pro forma combined results of operations, included in the above, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acceleration of stock based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZToxMmM3MDQ0YmNiNjQ0MzliOTczYTc5NGI1MzYxNjY0Mi90YWJsZXJhbmdlOjEyYzcwNDRiY2I2NDQzOWI5NzNhNzk0YjUzNjE2NjQyXzItMi0xLTEtMTc2ODk_0199e08c-b460-4f92-a961-d13a35a8adec"
      unitRef="usd">0</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZToxMmM3MDQ0YmNiNjQ0MzliOTczYTc5NGI1MzYxNjY0Mi90YWJsZXJhbmdlOjEyYzcwNDRiY2I2NDQzOWI5NzNhNzk0YjUzNjE2NjQyXzMtMi0xLTEtMTc2ODk_e7e30117-7293-4467-b580-d21add72d45e"
      unitRef="usd">24517000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzQtMi0xLTEtMTc2ODk_77cfb6be-e6c9-4c57-baba-eefa9ad747be"
      unitRef="usd">20993000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzUtMi0xLTEtMTc2ODk_76495b10-5ef6-4467-9d22-146ed38f5e4c"
      unitRef="usd">-252951000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzYtMi0xLTEtMTc2ODk_6f9c693a-3f05-49aa-879b-7bef21f41ecd"
      unitRef="usdPerShare">-7.53</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzYtMi0xLTEtMTc2ODk_9f0879c3-7860-4359-9376-bd3040648db1"
      unitRef="usdPerShare">-7.53</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <vyne:AdjustmentsToSupplementalProformaTransactionCosts
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzktMi0xLTEtMTc2ODk_f6e4493c-c130-4328-8562-4bbf0763cda0"
      unitRef="usd">14931000</vyne:AdjustmentsToSupplementalProformaTransactionCosts>
    <vyne:AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzEwLTItMS0xLTE3Njg5_deb7e26a-b41d-48ad-857e-e104d0ba1813"
      unitRef="usd">7199000</vyne:AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation>
    <vyne:AdjustmentsToSupplementalProformaCombinedResultsOfOperations
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzMvZnJhZzo1NDQ1MmY4NTE2OGY0NDVlYjhhN2YxM2EzYTZlOTAxOS90YWJsZTo2ZDgwYjQ5OGI4ZWM0NDY3OWRjZjc2MjA3YWYwYjc4Yi90YWJsZXJhbmdlOjZkODBiNDk4YjhlYzQ0Njc5ZGNmNzYyMDdhZjBiNzhiXzExLTItMS0xLTE3Njg5_27028568-1898-4b6b-93be-34ca43682043"
      unitRef="usd">22130000</vyne:AdjustmentsToSupplementalProformaCombinedResultsOfOperations>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzIxOTkwMjMyNjM5NjM_7c1a78a5-cbc7-4268-8b8d-8683b8b523ff">REVENUE RECOGNITION&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product revenues for the year ended&#160;December&#160;31, 2021&#160;were primarily generated from sales of AMZEEQ&#160;which was commercially launched in the United States in January 2020 and ZILXI which became available in pharmacies nationwide on October 1, 2020.  The Company&#x2019;s customers include a limited number of national and select regional distributors and certain independent and specialty pharmacies, together (the "customers"). The distributors subsequently resell the product, primarily to retail pharmacies that dispense the product to patients. Net product revenue is typically recognized when customers obtain control of the Company&#x2019;s products, which occurs at a point in time, typically upon delivery of product to the customers. For the year ended December&#160;31, 2021, three customers accounted for 17%, 15% and 9% of product revenue, respectively.  For the year ended December&#160;31, 2020, three customers accounted for 42%, 39%, and 15% of product revenue, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Sales Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product revenue is recorded net of distribution fees, trade discounts, allowances, rebates, chargebacks, estimated returns and other incentives, described below. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company calculates its net product revenue based on the wholesale acquisition cost that the Company charges its customers less provisions for (i) trade discounts and allowances, such as distributor fees and discounts for prompt payment, (ii) estimated rebates to third-party payers, patient co-pay assistance programs, chargebacks and other discount programs and (iii) reserves for expected product returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions for distribution fees, trade discounts and chargebacks are reflected as a reduction to trade receivables, net on the consolidated balance sheet. All other provisions, including rebates, other discounts and return provisions are reflected as a liability within accrued expenses on the consolidated balance sheet. Provisions for revenue reserves described below reduced product revenues by $62.9 million and $39.5 million for the years ended December&#160;31, 2021 and December&#160;31, 2020, respectively. The revenue reserve accrual was $5.5 million and $5.8&#160;million at December&#160;31, 2021 and December&#160;31, 2020, respectively and was reflected in accrued expenses in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Distribution Fees and Trade Discounts and Allowances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The Company pays fees for distribution services and for certain data that distributors provide to the Company and generally provides discounts on sales to its distributors for prompt payment. These fees and discounts are contractual in nature and the Company expects its distributors to earn these fees and discounts, and accordingly deducts the full amount of these fees and discounts from its gross product revenues at the time such revenues are recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Rebates, Chargebacks and Other Discounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product sales made under managed-care and governmental pricing programs in the U.S. are subject to rebates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Managed Care rebates relate to contractual agreements to sell products to managed care organizations and pharmacy benefit managers at contractual rebate percentages in exchange for volume and/or market&#160;share. Chargebacks relate to contractual agreements to sell products to government agencies and other indirect customers at contractual prices that are lower than the list prices the Company charges wholesalers. When these government agencies or other indirect customers purchase products through wholesalers at these reduced prices, the wholesaler charges the Company for the difference between the prices they paid the Company and the prices at which they sold the products to the indirect customers. The Company estimates the rebates and chargebacks it expects to be obligated to provide and deducts these estimated amounts from its gross product revenue at the time the revenue is recognized. The Company estimates the rebates and chargebacks that it expects to be obligated to provide based upon (i) the Company's current contracts and negotiations, (ii) estimates regarding the payer mix&#160;based on third-party data and utilization, (iii) inventory held by distributors and (iv) estimates of inventory held at the retail channel. Other discounts include the Company&#x2019;s co-pay assistance coupon programs for commercially-insured patients meeting certain eligibility requirements. The calculation of the accrual for co-pay assistance is based on an estimate of claims and the cost per claim that the Company expects to pay associated with product that has been recognized as revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Product Returns&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with industry practice, customers are generally allowed to return products within a specified period of time before and after its expiration date.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company estimates the amount of product&#160;that will be returned and deducts these estimated amounts from its gross revenue at the time the revenue is recognized. T&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he information utilized to estimate the returns provision includes: (i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; historical industry information regarding rates for comparable pharmaceutical products and product portfolios&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, (ii) external data with respect to inventory levels in the wholesale distribution channel, (iii) external data with respect to prescription &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;demand&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for products and (iv) remaining shelf lives of products at the date of sale. The Company estimates that between 1% and 2% of product sold to wholesalers will be returned. The Company does not estimate returns for &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sales made to the pharmacies as they are not contractually permitted to return product and the Company did not accept any returns from pharmacies in the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; December&#160;31, 2021&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;License Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2020, the Company announced that it entered into a license agreement with Cutia for AMZEEQ as well as certain of the Company's other topical minocycline product candidates, once approved, on an exclusive basis in Greater China.  Under the terms of the agreement, Cutia will have an exclusive license to obtain regulatory approval of and commercialize AMZEEQ, ZILXI and, if approved in the U.S., FCD105 in the Greater China territory.  The Company will supply the finished licensed products to Cutia for clinical and commercial use.  Outside of the license transferred, the Company does not have any additional performance obligations under the arrangement.  In exchange for the license, the Company received an upfront cash payment of $10.0 million.  The license was considered functional IP as the licensee was able to use and benefit from the license without the continued involvement of the Company.  The disposition of the MST Franchise included the license agreement with Cutia including the rights to future revenues and obligations under that agreement.  The Company recorded $10.0&#160;million of license revenue in the year ended  December&#160;31, 2020.  No license revenue was earned in the year ended December&#160;31, 2021.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets and Contract Liabilities&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have any contract assets (unbilled receivables) related to product sales or as of&#160;December&#160;31, 2021, as customer invoicing generally occurs before or at the time of revenue recognition.  The Company did not have any contract assets (unbilled receivables) related to its license revenues as of December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have any contract liabilities as of&#160;December&#160;31, 2021 or 2020, as the Company did not receive payments in advance of fulfilling its performance obligations to its customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sales Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales commissions are generally attributed to periods shorter than one year and therefore are expensed when incurred. Sales commissions are included in selling, general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financing Component&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected not to adjust consideration for the effects of a significant financing component when the period between the transfer of a promised good or service to the customer and when the customer pays for that good or service will be one year or less.&#160;Standard credit terms do not exceed 75 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalty Revenues&#160;&lt;/span&gt;&lt;/div&gt;The Company is entitled to royalty payments with respect to sales of a product developed by a customer in collaboration with the Company. Revenues in the amount of $0.9 million and $0.8 million were recorded during the year ended December&#160;31, 2021 and 2020, respectively.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idcd1310cc41948fda92510020e6c5311_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzgxMw_83fd54cb-fd78-4931-9ce0-91675db65a2a"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia44d040e2d58449fb2c8ccba534d3561_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzgxNw_455b04c7-fdb3-4347-a509-a5939a78fe86"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icd2d1d4d5236485dbd015be1f3e9a186_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzgyNA_179445c1-a6e0-4be5-8d29-975f29f27149"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1c4616f3027c41d7a959089637cbe325_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgwODE_88c231da-1f3f-4257-9008-4287bb6d4d27"
      unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0de48e6f1dee484cb5de248475e21cc0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgwODY_ea145acb-ddc1-462c-9d7b-a4c1421a2d99"
      unitRef="number">0.39</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4538b4163a484df9a5150bc090ab457d_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgwOTU_e6c56b71-69af-439d-8455-23fbc28c98ba"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <vyne:RevenueRecognitionDistributionTradeDiscountsAndAllowances
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzE4NjE_186d4000-3c14-4f49-8526-e8e7808fef3b"
      unitRef="usd">62900000</vyne:RevenueRecognitionDistributionTradeDiscountsAndAllowances>
    <vyne:RevenueRecognitionDistributionTradeDiscountsAndAllowances
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgxNzY_898dfbd4-bf34-432b-9a9b-39e0404db5d0"
      unitRef="usd">39500000</vyne:RevenueRecognitionDistributionTradeDiscountsAndAllowances>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i629adb3cec5646989a6518dee4a69029_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2Mzc5NTY_6140ff1f-9381-47ab-ba86-60b95d264a66"
      unitRef="usd">5500000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2Mzc5NDQ_8d32ec69-0884-4c6a-ad01-55ef3b785265"
      unitRef="usd">5800000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <vyne:EstimateOfProductReturnRateMinimum
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgyNTk_39995247-ba5f-4013-a92b-341e4489b0e9"
      unitRef="number">0.01</vyne:EstimateOfProductReturnRateMinimum>
    <vyne:EstimateOfProductReturnRateMaximum
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzgyNTQ_bb2a056f-8bb9-443a-9b56-dd25b7aa9b64"
      unitRef="number">0.02</vyne:EstimateOfProductReturnRateMaximum>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i8bc82390929346cc83aa1a859f646cb1_D20200423-20200423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzU4MzU_6c3a6c95-3ea7-4a58-b52e-f244daa986ec"
      unitRef="usd">10000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i516662a4a0d6421a948606bc11a4248c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzEwOTk1MTE2MzU4OTE_80503a02-0827-494a-8bf4-13b58b09afb8"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f3508ae7116426b88ab53b907d0b8a7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzc5NTA_235d20f4-4310-4b37-bdf2-cff4e01c519d"
      unitRef="usd">900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78c293e52180494c8c19af75d240a16f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzYvZnJhZzpmZmQ3YjNiOWM2ODc0MTIyOGYwNDE4ZWI3M2JlYTVjZC90ZXh0cmVnaW9uOmZmZDdiM2I5YzY4NzQxMjI4ZjA0MThlYjczYmVhNWNkXzc5NTc_7b44e72f-5932-49d5-9333-38b09ff2d218"
      unitRef="usd">800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90ZXh0cmVnaW9uOmY3MDJhMDdlYWU4MDQ1NWU5MDQxZWZkZTQ5MjkyNjZiXzIxOTkwMjMyNTc0NTM_6a8c971e-ed87-4a85-bc1d-1168dc11980c">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s assets and liabilities that are measured at fair value as of December&#160;31, 2021, and December&#160;31, 2020, are classified in the tables below in one of the three categories described in "Note 2 - Fair value measurement" above:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sold its marketable securities during the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90ZXh0cmVnaW9uOmY3MDJhMDdlYWU4MDQ1NWU5MDQxZWZkZTQ5MjkyNjZiXzYwNDczMTM5NTQ2NzA_3b2febab-551a-4ad6-92ae-f608ab8e183b">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s assets and liabilities that are measured at fair value as of December&#160;31, 2021, and December&#160;31, 2020, are classified in the tables below in one of the three categories described in "Note 2 - Fair value measurement" above:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:MarketableSecurities
      contextRef="ifdd96b5be5604cd99fd57eea397b6062_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTpkOTRlYWY1ZTE3NGQ0ZTg3YjMwYzMzMzgxOWZhZDFmNS90YWJsZXJhbmdlOmQ5NGVhZjVlMTc0ZDRlODdiMzBjMzMzODE5ZmFkMWY1XzItMS0xLTEtMTc2ODk_7ff90c42-69c8-4568-998d-b80c016a9eb6"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="ib1d39c3ca7874b59904e3c0e861e4215_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTpkOTRlYWY1ZTE3NGQ0ZTg3YjMwYzMzMzgxOWZhZDFmNS90YWJsZXJhbmdlOmQ5NGVhZjVlMTc0ZDRlODdiMzBjMzMzODE5ZmFkMWY1XzItMy0xLTEtMTc2ODk_5bb70f8e-386a-422f-9cd1-95192bba8c43"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTpkOTRlYWY1ZTE3NGQ0ZTg3YjMwYzMzMzgxOWZhZDFmNS90YWJsZXJhbmdlOmQ5NGVhZjVlMTc0ZDRlODdiMzBjMzMzODE5ZmFkMWY1XzItNS0xLTEtMTc2ODk_118f2105-f661-4a8c-b18b-6b473ec64067"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i3f3653857bf949f4a2ef81a87a83f1fa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTo4Y2M1NzgyZjVkMGI0YTAxODk5YzE1ZmNhNmM0OTAwOC90YWJsZXJhbmdlOjhjYzU3ODJmNWQwYjRhMDE4OTljMTVmY2E2YzQ5MDA4XzItMS0xLTEtMTc2ODk_9204264f-0d47-435d-9075-6cdfef08390b"
      unitRef="usd">1027000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i894c1d96a0e74f408876a0655283cf8d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTo4Y2M1NzgyZjVkMGI0YTAxODk5YzE1ZmNhNmM0OTAwOC90YWJsZXJhbmdlOjhjYzU3ODJmNWQwYjRhMDE4OTljMTVmY2E2YzQ5MDA4XzItMy0xLTEtMTc2ODk_5dcee104-3bfa-413b-b012-f08e24559715"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xMzkvZnJhZzpmNzAyYTA3ZWFlODA0NTVlOTA0MWVmZGU0OTI5MjY2Yi90YWJsZTo4Y2M1NzgyZjVkMGI0YTAxODk5YzE1ZmNhNmM0OTAwOC90YWJsZXJhbmdlOjhjYzU3ODJmNWQwYjRhMDE4OTljMTVmY2E2YzQ5MDA4XzItNS0xLTEtMTc2ODk_f59f23e4-f722-4d93-bbd2-a6c712e52159"
      unitRef="usd">1027000</us-gaap:MarketableSecurities>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzIxOTkwMjMyNTgyODg_520ad63d-6c67-4f66-82b9-3d06f64f79f7">MARKETABLE SECURITIES&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities as of  December&#160;31, 2020 consisted of mutual funds securities.  Realized gains and losses on sales of the securities, are included in the consolidated statement of operations as other income, net.  The Company did not hold any marketable securities as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities with readily determinable fair value are measured at fair value. The changes in the fair value of equity investments are recognized through other income, net in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s marketable securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021 and 2020 there were no available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has considered factors regarding other than temporary impaired securities and determined that there were no securities with impairment that is other than temporary as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2021 and 2020, the Company received aggregate proceeds of $1.0 million&#160;and $38.5 million, respectively, upon the sale and maturity of marketable securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzYwNDczMTM5NTU1MDU_237ebee3-f611-4afc-8577-310bc91e02ed">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s marketable securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="ib2b2fcf164d44dcfa785ffe4c6fc0674_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90YWJsZTo5OTc4ZGE4MTk4OTk0OGExOGFlYzNjMjM3NWRkZDlmOS90YWJsZXJhbmdlOjk5NzhkYTgxOTg5OTQ4YTE4YWVjM2MyMzc1ZGRkOWY5XzItMS0xLTEtMTc2ODk_0f78d0c9-9d83-46e0-8d28-eeadd6172e08"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i1e9681eeba6644f3af02c673a4fd06b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90YWJsZTo5OTc4ZGE4MTk4OTk0OGExOGFlYzNjMjM3NWRkZDlmOS90YWJsZXJhbmdlOjk5NzhkYTgxOTg5OTQ4YTE4YWVjM2MyMzc1ZGRkOWY5XzItMy0xLTEtMTc2ODk_db2bb627-bd95-4478-9f29-c954b3920c5a"
      unitRef="usd">1027000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90YWJsZTo5OTc4ZGE4MTk4OTk0OGExOGFlYzNjMjM3NWRkZDlmOS90YWJsZXJhbmdlOjk5NzhkYTgxOTg5OTQ4YTE4YWVjM2MyMzc1ZGRkOWY5XzYtMS0xLTEtMTc2ODk_3269e85d-ef64-48db-bdc2-07334328d1ed"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90YWJsZTo5OTc4ZGE4MTk4OTk0OGExOGFlYzNjMjM3NWRkZDlmOS90YWJsZXJhbmdlOjk5NzhkYTgxOTg5OTQ4YTE4YWVjM2MyMzc1ZGRkOWY5XzYtMy0xLTEtMTc2ODk_e094f7b3-d9b0-4ba1-bfd2-21454903d218"
      unitRef="usd">1027000</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzIxOTkwMjMyNTgyOTA_2e755e5b-ee1a-4c06-89ec-2525f30fb871"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzIxOTkwMjMyNTgyOTA_9ea98dba-4c0e-4dfb-8341-15f2f2f84584"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzEyOTc_a3c5a2dd-1c18-4410-b24b-5d38a7b76faf"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzEyOTc_c5556cd3-ad6e-4d8e-b9ce-a27ee151954d"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzE1MTc_933acc8e-da5a-4ece-a22c-f41226578d82"
      unitRef="usd">1000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDIvZnJhZzpjOTBkZTQxZWFiY2U0YTI4OTc1ODY1MTE5MGU5NjcxOC90ZXh0cmVnaW9uOmM5MGRlNDFlYWJjZTRhMjg5NzU4NjUxMTkwZTk2NzE4XzE1MjQ_e8c3112b-c458-473c-b4da-cc6e72dff44a"
      unitRef="usd">38500000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90ZXh0cmVnaW9uOmNkZGU2NjBlOTUyZDQxYzQ5NjQyZGRmZDliOWExN2U5XzIxOTkwMjMyNTY0OTA_136b41d7-e239-45c9-b226-7350e6ee520a">INVENTORY&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost and net realizable value with cost determined on a first-in, first-out basis by product. The Company capitalizes inventory costs associated with products following regulatory approval when future commercialization is considered probable and the future economic benefit is expected to be realized. The Company commenced capitalizing inventory for AMZEEQ and ZILXI upon FDA approval in October 2019 and May 2020, respectively. The Company periodically reviews its inventory levels and, if necessary, writes down inventory that is expected to expire prior to being sold, inventory in excess of expected sales requirements and inventory that fails to meet commercial sale specifications, with a corresponding charge to cost of goods sold. There were no material inventory write-downs during the years ended December&#160;31, 2021 and 2020.  All inventory was sold or written-off in connection with the sale of the MST Franchise.  See Note 17.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s inventory:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:InventoryWriteDown
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90ZXh0cmVnaW9uOmNkZGU2NjBlOTUyZDQxYzQ5NjQyZGRmZDliOWExN2U5XzgxNA_d5d18f2a-50d8-4453-bcae-49fe4d3dba12"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90ZXh0cmVnaW9uOmNkZGU2NjBlOTUyZDQxYzQ5NjQyZGRmZDliOWExN2U5XzgxNA_eebfa1c3-eb13-4783-b00c-7ddc4041de5e"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90ZXh0cmVnaW9uOmNkZGU2NjBlOTUyZDQxYzQ5NjQyZGRmZDliOWExN2U5XzYwNDczMTM5NTM3MDc_309d62f3-0a7f-4b16-879e-9cca9d597aff">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s inventory:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzItMS0xLTEtMTc2ODk_2a1ec11a-735c-4246-9027-91ff2fa4cf1b"
      unitRef="usd">3298000</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzItMy0xLTEtMTc2ODk_aeabcdf7-593b-4559-b9f4-3e4fc50d8738"
      unitRef="usd">4042000</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryWorkInProcess
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzMtMS0xLTEtMTc2ODk_a5cb272d-b4fa-40ba-9b58-c35b1064ba86"
      unitRef="usd">33000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzMtMy0xLTEtMTc2ODk_dce17c01-c70f-4980-a7d4-3f7fa510f977"
      unitRef="usd">662000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzQtMS0xLTEtMTc2ODk_81c70307-1a7b-4471-859c-e15f91a3251e"
      unitRef="usd">3960000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzQtMy0xLTEtMTc2ODk_e5d14729-c86a-45d7-978c-487117874e0c"
      unitRef="usd">2700000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzUtMS0xLTEtMTc2ODk_693b9013-ea71-4779-bdbe-2c16db3d0733"
      unitRef="usd">7291000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDUvZnJhZzpjZGRlNjYwZTk1MmQ0MWM0OTY0MmRkZmQ5YjlhMTdlOS90YWJsZTo4NGI3NzRjMTViNTc0NWJhYThmNTFiM2RlYmQwNjZlOS90YWJsZXJhbmdlOjg0Yjc3NGMxNWI1NzQ1YmFhOGY1MWIzZGViZDA2NmU5XzUtMy0xLTEtMTc2ODk_4d130917-83d4-4f19-948c-99aea15d5297"
      unitRef="usd">7404000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90ZXh0cmVnaW9uOjM2YzkwZTZmYWI1ZDRiMjJiOWRjZGZiMzc4NTI5ODAwXzIxOTkwMjMyNTYzMzU_a5b2585d-816d-4451-bfd7-53d46b2db203">PROPERTY AND EQUIPMENT&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense totaled $0.1 million and $0.3 million for the years ended December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;During the years ended December&#160;31, 2021 and December&#160;31, 2020, the Company disposed of fixed assets in the net amount of $0.1&#160;million and $2.1 million. Loss on disposal of fixed assets during the year ended December&#160;31, 2020 relates to the write-off of laboratory and leasehold improvements in Israel due to a reduction in office space.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic65e68488b4a44bfb1349485e00bc902_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzMtMS0xLTEtMTc2ODk_4c51a8b4-9605-49f3-81cc-a7094a163f5c"
      unitRef="usd">59000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1fff6625e4e44353b52824e303e6c56c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzMtMy0xLTEtMTc2ODk_9ccbcfc1-0f73-4ca1-a4ea-224a09d2c08e"
      unitRef="usd">59000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibcce6081c1204eeebe23dd6751efbbda_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzQtMS0xLTEtMTc2ODk_eaa5c5a6-fbb1-4e9a-b400-16d812a4d532"
      unitRef="usd">374000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i61ea3c6a2b9643c4b0c38a30feec97fd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzQtMy0xLTEtMTc2ODk_24981dad-ba7a-45c2-b606-4047e0f0f411"
      unitRef="usd">467000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib2e122d5e1c4441fb4e5269084ca195c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzUtMS0xLTEtMTc2ODk_6aa406a7-d6a4-48ad-b579-2667dcf09e1c"
      unitRef="usd">53000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i958fd692be7048b692433788e3424109_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzUtMy0xLTEtMTc2ODk_ff4a8ba8-8fae-4bd8-87d5-7dd7e8a03d75"
      unitRef="usd">53000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic48701016b5b4663afd273a98b086ca0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzYtMS0xLTEtMTc2ODk_d62de771-e268-4d47-8f3a-2dc0a95acc70"
      unitRef="usd">419000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i101ececdf4914f5ba6e572e864e4cf66_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzYtMy0xLTEtMTc2ODk_a31c25fd-18f7-4c78-b9d9-b40f4461e4f0"
      unitRef="usd">419000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzgtMS0xLTEtMTc2ODk_5871242f-9c2f-4625-afaf-8d4bded8fbea"
      unitRef="usd">905000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzgtMy0xLTEtMTc2ODk_6de320f0-101b-4e23-8f51-dfa7a1ec9586"
      unitRef="usd">998000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzEwLTEtMS0xLTE3Njg5_c2ae59d3-92b7-44be-b486-7ec6aa83961f"
      unitRef="usd">551000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzEwLTMtMS0xLTE3Njg5_3d3f6ba6-0c5d-46f5-a9ba-cc103a38e610"
      unitRef="usd">443000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzExLTEtMS0xLTE3Njg5_13ec1702-c85e-41be-84ce-9a8a015b796c"
      unitRef="usd">354000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90YWJsZTphNzUwZDU5MGE1MGE0NTU4OWFhYTEzZmU2NDY5NzM1Zi90YWJsZXJhbmdlOmE3NTBkNTkwYTUwYTQ1NTg5YWFhMTNmZTY0Njk3MzVmXzExLTMtMS0xLTE3Njg5_6b9e8ccc-9048-46cd-b9fb-ecf7c39fffdc"
      unitRef="usd">555000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90ZXh0cmVnaW9uOjM2YzkwZTZmYWI1ZDRiMjJiOWRjZGZiMzc4NTI5ODAwXzg1_9eef9a0a-e851-4f18-9bbb-196bb7a4ead8"
      unitRef="usd">100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90ZXh0cmVnaW9uOjM2YzkwZTZmYWI1ZDRiMjJiOWRjZGZiMzc4NTI5ODAwXzg5_7b860541-5ccb-4809-b982-6e1f1e7770f7"
      unitRef="usd">300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90ZXh0cmVnaW9uOjM2YzkwZTZmYWI1ZDRiMjJiOWRjZGZiMzc4NTI5ODAwXzEwOTk1MTE2Mjk0MTM_77fa8f4a-1f9c-4eca-b35e-5a1d188fdc72"
      unitRef="usd">100000</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNDgvZnJhZzozNmM5MGU2ZmFiNWQ0YjIyYjlkY2RmYjM3ODUyOTgwMC90ZXh0cmVnaW9uOjM2YzkwZTZmYWI1ZDRiMjJiOWRjZGZiMzc4NTI5ODAwXzI0OA_c23ff944-f03a-407b-b3b7-d3fd2e40f59c"
      unitRef="usd">2100000</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90ZXh0cmVnaW9uOjQyNTNkMDhlY2U5NzQ1ZGNhYTk3N2YzNzgyOWYwN2FiXzg3OTYwOTMwMjg1Nzg_193f4a9f-ff99-40e8-9ee5-f7ffea0ecf48">ACCRUED EXPENSES&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales provisions (see Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercialized product accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90ZXh0cmVnaW9uOjQyNTNkMDhlY2U5NzQ1ZGNhYTk3N2YzNzgyOWYwN2FiXzg3OTYwOTMwMjg1Nzk_2064f820-febe-4c91-8ab9-e88a46d08c5a">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales provisions (see Note 4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercialized product accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <vyne:AccruedSalesProvisionsCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzMtMS0xLTEtMzI1NzM_85f7b4db-fed6-4841-9261-c8eeb0558fa6"
      unitRef="usd">5489000</vyne:AccruedSalesProvisionsCurrent>
    <vyne:AccruedSalesProvisionsCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzMtMy0xLTEtMzI2MTc_60af797c-ce84-4fe2-984a-e6c3f976abbc"
      unitRef="usd">5772000</vyne:AccruedSalesProvisionsCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzQtMS0xLTEtMzI1ODE_cbcdf3dd-cf8d-4bb3-a480-9b51914e460f"
      unitRef="usd">1213000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzQtMy0xLTEtMzI5NzM_4a059e8c-1b1f-44d2-bf72-fc386ba5bf7f"
      unitRef="usd">696000</us-gaap:AccruedProfessionalFeesCurrent>
    <vyne:AccruedResearchAndDevelopmentCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzUtMS0xLTEtMzI1ODg_9f13a161-2762-422f-8492-c35b4842f90e"
      unitRef="usd">969000</vyne:AccruedResearchAndDevelopmentCurrent>
    <vyne:AccruedResearchAndDevelopmentCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzUtMy0xLTEtMzI5ODE_2be39021-54f0-4b8e-a58a-ca8fa7e3c414"
      unitRef="usd">862000</vyne:AccruedResearchAndDevelopmentCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzYtMS0xLTEtMzI1OTU_a4e1ebd4-165e-4c0d-9c10-27debf106631"
      unitRef="usd">0</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzYtMy0xLTEtMzI5ODg_782239b1-7b8b-4340-84aa-8239984905db"
      unitRef="usd">1322000</us-gaap:AccruedMarketingCostsCurrent>
    <vyne:AccruedCommercializedProductCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzctMS0xLTEtMzI5NjY_f5495129-a2c1-4cf8-b007-26f253aa07ba"
      unitRef="usd">596000</vyne:AccruedCommercializedProductCurrent>
    <vyne:AccruedCommercializedProductCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzctMy0xLTEtMzI5OTU_bf992c94-a162-4b63-91a7-2ee5cc796f42"
      unitRef="usd">1324000</vyne:AccruedCommercializedProductCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzctMS0xLTEtMzI2MDI_d94bb10c-7748-4936-893f-3a48f1d886a2"
      unitRef="usd">326000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzgtMy0xLTEtMzMwMDI_bc0d0686-592f-4f1f-b308-2d1b32646a51"
      unitRef="usd">1476000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzgtMS0xLTEtMzI2MDk_09a8a8d9-7d3b-4955-82da-7ea28acc349a"
      unitRef="usd">8593000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTEvZnJhZzo0MjUzZDA4ZWNlOTc0NWRjYWE5NzdmMzc4MjlmMDdhYi90YWJsZTo5OTlmNzVjYTdmNDM0NzZiYjIxMGYyMmM2ZjgxNTczMC90YWJsZXJhbmdlOjk5OWY3NWNhN2Y0MzQ3NmJiMjEwZjIyYzZmODE1NzMwXzgtMy0xLTEtMzI2MTc_3a1a8d88-cc29-4271-aeae-2d04f609aeb9"
      unitRef="usd">11452000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18yNDEx_ceb8fa0e-da49-4fdf-85d3-c36e3d95bcd6">OPERATING LEASE&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for corporate offices and vehicles. The properties primarily relate to the Company&#x2019;s principal executive office in Bridgewater, New Jersey and office space in Israel.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 13, 2019, the Company signed an amendment to the original lease agreement for its principal executive office in Bridgewater, New Jersey (the "Lease Amendment&#x201d;). The Lease Amendment includes an extension of the lease period of the 10,000 square feet previously leased under the original agreement (the "Original Space") and an addition of 4,639 square feet (the "Additional Space&#x201d;). The Company entered the Additional Space following a period of preparation by the lessor completed during September 2019 (the "Commencement Date"). The lease is due to expire on August 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Lease Amendment, the Company recognized an additional right of use asset and liability in the amount of $0.7 million. The Additional Space was considered a new lease agreement and was recognized as a right of use asset and liability, in the amount of $0.3 million, on the Commencement Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease agreement for the office space in Israel expires in December 2022.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, the Company entered into operating lease agreements in connection with the leasing of vehicles. The lease periods are generally for three years. To secure the terms of certain of the vehicle lease agreements, the Company has made prepayments to the leasing company, representing approximately three months of lease payments. These amounts have been recorded as part of the operating lease right to use assets.  In connection with the strategic business review and sale of the MST Franchise certain vehicle leases were transferred to members of the commercial workforce resulting in the elimination of $0.5&#160;million of right of use assets and $0.5&#160;million of right of use liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease costs for the year ended December&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office lease expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles lease expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating lease costs include an immaterial amount of variable lease payments for the years ended December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows, for amounts included in the measurement of lease liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.96&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had a lien in the amount of $0.6 million on the Company&#x2019;s cash in respect of bank guarantees granted in order to secure the lease agreements.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <vyne:FacilitySpaceUnderLease
      contextRef="i99a4341caaaf441eaf0074526a0a8807_D20190313-20190313"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y180ODk_0ba8d3ef-b2cf-476e-8dcf-87f4303b8b79"
      unitRef="sqft">10000</vyne:FacilitySpaceUnderLease>
    <vyne:FacilitySpaceUnderLease
      contextRef="i941659ebe9434514a406d1f56a59ad1c_D20190313-20190313"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y181OTM_cd87b867-c5c5-4969-962c-5ae3e3806300"
      unitRef="sqft">4639</vyne:FacilitySpaceUnderLease>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i51a910c9c1a147509aff2e6f87810f5c_I20190313"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y185NDk_83e7be14-0e45-44d9-94f2-934e5c7c3cbf"
      unitRef="usd">700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i51a910c9c1a147509aff2e6f87810f5c_I20190313"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y185NDk_8794716a-fc1f-4233-9b8d-e47d110c26cf"
      unitRef="usd">700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i31d953cfd865427281cfadfbca27bacf_I20190313"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18xMDg2_8ea629e3-ada0-45f2-a10c-402b2a1e4e43"
      unitRef="usd">300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i31d953cfd865427281cfadfbca27bacf_I20190313"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18xMDg2_a4a14e07-c090-4aca-bb59-b82428d2f48b"
      unitRef="usd">300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="id5c046f0b00a43cd82cd79465a32a139_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18yNDE2_d68aced6-1e07-4c7c-81dd-e9bb552eb59b">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <vyne:VehicleLeasePrepaymentPeriod
      contextRef="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18xNDk5_002a8c65-3b85-4de9-8704-e3f286457f88">P3M</vyne:VehicleLeasePrepaymentPeriod>
    <vyne:OperatingLeaseRightOfUseAssetsTransferred
      contextRef="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18xMDk5NTExNjMwMjEz_f66dd906-444b-4bf6-abb1-8179eddaeddf"
      unitRef="usd">500000</vyne:OperatingLeaseRightOfUseAssetsTransferred>
    <vyne:OperatingLeaseLiabilityTransferred
      contextRef="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18xMDk5NTExNjMwMjI3_15c86525-09a7-401c-b906-987c510e7085"
      unitRef="usd">500000</vyne:OperatingLeaseLiabilityTransferred>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18yNDE1_7b1242f5-ff9b-49b4-a003-c7d7ae0c5373">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease costs for the year ended December&#160;31, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office lease expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles lease expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows, for amounts included in the measurement of lease liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.77&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.96&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="i095f99f5dad646848e17f3e6cf867662_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6NGYyMWNlYjZkZTY5NGU5MzhmY2Y5NTI2ZTgzMzIwOTkvdGFibGVyYW5nZTo0ZjIxY2ViNmRlNjk0ZTkzOGZjZjk1MjZlODMzMjA5OV8yLTEtMS0xLTMyNDg1_019717ff-be3a-4dd4-ad64-06d546834c0e"
      unitRef="usd">357000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="if7f07698396e4710961b022584df3af9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6NGYyMWNlYjZkZTY5NGU5MzhmY2Y5NTI2ZTgzMzIwOTkvdGFibGVyYW5nZTo0ZjIxY2ViNmRlNjk0ZTkzOGZjZjk1MjZlODMzMjA5OV8yLTMtMS0xLTMyNDg1_418bf9e6-47d8-4d77-881b-1c5561e82688"
      unitRef="usd">961000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6NGYyMWNlYjZkZTY5NGU5MzhmY2Y5NTI2ZTgzMzIwOTkvdGFibGVyYW5nZTo0ZjIxY2ViNmRlNjk0ZTkzOGZjZjk1MjZlODMzMjA5OV8zLTEtMS0xLTMyNDg1_2c2d07fd-de27-443b-9320-a6c25144319c"
      unitRef="usd">434000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="icdc06dd768af4cf19fdbabdfd9a1e045_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6NGYyMWNlYjZkZTY5NGU5MzhmY2Y5NTI2ZTgzMzIwOTkvdGFibGVyYW5nZTo0ZjIxY2ViNmRlNjk0ZTkzOGZjZjk1MjZlODMzMjA5OV8zLTMtMS0xLTMyNDg1_5c9c232a-949d-427d-9769-003ca6035248"
      unitRef="usd">390000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeasePayments
      contextRef="i095f99f5dad646848e17f3e6cf867662_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6ZmYxMDI3ZDVhNjkxNGY2OWFjMjkwMmM2NjNlZmE5YjkvdGFibGVyYW5nZTpmZjEwMjdkNWE2OTE0ZjY5YWMyOTAyYzY2M2VmYTliOV8xLTEtMS0xLTMyNDg1_e3ed957a-a7ad-4803-beae-2c916452d89c"
      unitRef="usd">373000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="if7f07698396e4710961b022584df3af9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6ZmYxMDI3ZDVhNjkxNGY2OWFjMjkwMmM2NjNlZmE5YjkvdGFibGVyYW5nZTpmZjEwMjdkNWE2OTE0ZjY5YWMyOTAyYzY2M2VmYTliOV8xLTMtMS0xLTMyNDg1_42735f96-bad8-4f00-81ef-850e05302290"
      unitRef="usd">971000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i53958b7a8dab4ab18770075b84b286f1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6ZmYxMDI3ZDVhNjkxNGY2OWFjMjkwMmM2NjNlZmE5YjkvdGFibGVyYW5nZTpmZjEwMjdkNWE2OTE0ZjY5YWMyOTAyYzY2M2VmYTliOV8yLTEtMS0xLTMyNDg1_418d660e-d615-410e-b865-b6c4e3bbea84"
      unitRef="usd">434000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="icdc06dd768af4cf19fdbabdfd9a1e045_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6ZmYxMDI3ZDVhNjkxNGY2OWFjMjkwMmM2NjNlZmE5YjkvdGFibGVyYW5nZTpmZjEwMjdkNWE2OTE0ZjY5YWMyOTAyYzY2M2VmYTliOV8yLTMtMS0xLTMyNDg1_25183114-4246-4653-83dd-674483e6c933"
      unitRef="usd">390000</us-gaap:OperatingLeasePayments>
    <vyne:OperatingLeaseRightOfUseAssetCurrent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8xLTEtMS0xLTMyNDg1_47890850-500e-4f82-906a-fc5abcf3818c"
      unitRef="usd">338000</vyne:OperatingLeaseRightOfUseAssetCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8xLTMtMS0xLTMyNDg1_65f97efb-997d-41cb-b44e-1547fd8a7daf"
      unitRef="usd">1583000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8yLTEtMS0xLTMyNDg1_da48c8e8-2115-46be-805c-0ffed8d08690"
      unitRef="usd">349000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8yLTMtMS0xLTMyNDg1_2600f67b-6c61-4479-b918-1e83f58d2938"
      unitRef="usd">1610000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8zLTEtMS0xLTMyNDg1_f02efd63-97d5-45f8-9aca-2ebdfd9bfcdf">P0Y9M7D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF8zLTMtMS0xLTMyNDg1_cfb2a6d4-6b14-4e1f-855e-8d41b2c06e4d">P1Y11M15D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF80LTEtMS0xLTMyNDg1_f64507fb-7f59-486e-b9c2-2052d87f57bf"
      unitRef="number">0.1310</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YWU5OWI3MGI0MGI1NDk3MmEwYTA0YjRiZTUyZTZmZDAvdGFibGVyYW5nZTphZTk5YjcwYjQwYjU0OTcyYTBhMDRiNGJlNTJlNmZkMF80LTMtMS0xLTMyNDg1_0e7cf67d-b29e-4b70-8f71-83dad26cd322"
      unitRef="number">0.1310</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18yNDEy_4168fa65-d5a4-46b0-be55-7c8c7def72fa">&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YTg4ODI0OGM3ZDZhNGFmMGEwNDZlNWJlYWQyMzMwMmYvdGFibGVyYW5nZTphODg4MjQ4YzdkNmE0YWYwYTA0NmU1YmVhZDIzMzAyZl8wLTEtMS0xLTMyNDg1_3a064476-13a4-401b-aa7e-612c4ba42cfb"
      unitRef="usd">334000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YTg4ODI0OGM3ZDZhNGFmMGEwNDZlNWJlYWQyMzMwMmYvdGFibGVyYW5nZTphODg4MjQ4YzdkNmE0YWYwYTA0NmU1YmVhZDIzMzAyZl8xLTEtMS0xLTMyNDg1_ea4df25f-2cba-49ac-a926-5ffb987dd36d"
      unitRef="usd">32000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YTg4ODI0OGM3ZDZhNGFmMGEwNDZlNWJlYWQyMzMwMmYvdGFibGVyYW5nZTphODg4MjQ4YzdkNmE0YWYwYTA0NmU1YmVhZDIzMzAyZl8yLTEtMS0xLTMyNDg1_2ebb5c48-eb58-4513-a271-cea5e1d06107"
      unitRef="usd">366000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YTg4ODI0OGM3ZDZhNGFmMGEwNDZlNWJlYWQyMzMwMmYvdGFibGVyYW5nZTphODg4MjQ4YzdkNmE0YWYwYTA0NmU1YmVhZDIzMzAyZl8zLTEtMS0xLTMyNDg1_0d304644-9978-4a8c-9c96-c3c03a45b2d4"
      unitRef="usd">17000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGFibGU6YTg4ODI0OGM3ZDZhNGFmMGEwNDZlNWJlYWQyMzMwMmYvdGFibGVyYW5nZTphODg4MjQ4YzdkNmE0YWYwYTA0NmU1YmVhZDIzMzAyZl80LTEtMS0xLTMyNDg1_9fcaca36-ac94-484c-8048-124a91d9e84e"
      unitRef="usd">349000</us-gaap:OperatingLeaseLiability>
    <vyne:RestrictedInvestmentsToSecureLeaseAgreements
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xOTkxL2ZyYWc6YjVkYzg2ZDE2MGE0NDkzNzk0NjYyZTdkZWZmODEyNGMvdGV4dHJlZ2lvbjpiNWRjODZkMTYwYTQ0OTM3OTQ2NjJlN2RlZmY4MTI0Y18yMzA5_88816bc0-0303-454f-9dea-03d4f3b3ab27"
      unitRef="usd">600000</vyne:RestrictedInvestmentsToSecureLeaseAgreements>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTQvZnJhZzowMzE5MjNhOTE0OTI0NDEwYWEwNzA2OTA3OTRkOWRjZS90ZXh0cmVnaW9uOjAzMTkyM2E5MTQ5MjQ0MTBhYTA3MDY5MDc5NGQ5ZGNlXzIxOTkwMjMyNTYwNDE_07464a27-e6db-4046-955f-17b8f8651e36">EMPLOYEE SAVINGS PLANBeginning September 2017, the Company has retirement savings plans available to all employees of the Subsidiary, which are intended to qualify as deferred compensation plans under Section 401(k) of the Internal Revenue Code (the &#x201c;401(k) Plans&#x201d;). The Company made contributions to these 401(k) Plans during the years ended December&#160;31, 2021, and 2020 of approximately $0.4 million and $0.8 million, respectively.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTQvZnJhZzowMzE5MjNhOTE0OTI0NDEwYWEwNzA2OTA3OTRkOWRjZS90ZXh0cmVnaW9uOjAzMTkyM2E5MTQ5MjQ0MTBhYTA3MDY5MDc5NGQ5ZGNlXzQyNQ_5361f8c4-8942-42a7-96fe-c4859a39f2b4"
      unitRef="usd">400000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTQvZnJhZzowMzE5MjNhOTE0OTI0NDEwYWEwNzA2OTA3OTRkOWRjZS90ZXh0cmVnaW9uOjAzMTkyM2E5MTQ5MjQ0MTBhYTA3MDY5MDc5NGQ5ZGNlXzQyOQ_4c6185a5-d104-4753-a142-7c501d247b3e"
      unitRef="usd">800000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNTcvZnJhZzozOTkyMGRkNmNkNmM0YzA2OTM0OGNkNzk0M2JjYWVkOC90ZXh0cmVnaW9uOjM5OTIwZGQ2Y2Q2YzRjMDY5MzQ4Y2Q3OTQzYmNhZWQ4XzIxOTkwMjMyNTk4MTE_1336c5e2-5dfd-4e5a-bc6a-a07534d69ee2">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation and contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may periodically become subject to legal proceedings and claims arising in connection with its business. As of December&#160;31, 2021, there are no claims or actions pending against the Company that, in the opinion of management, are likely to have a material adverse effect on the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2021, the Company received a paragraph IV certification notice (the &#x201c;Notice&#x201d;) from Padagis Israel Pharmaceuticals Ltd. (f/k/a Perrigo Israel Pharmaceuticals Ltd. (&#x201c;Padagis&#x201d;)) advising that Padagis has submitted to the U.S. Food and Drug Administration (the &#x201c;FDA&#x201d;) an Abbreviated New Drug Application (&#x201c;ANDA&#x201d;) seeking approval to manufacture and sell a generic version of the Company&#x2019;s product AMZEEQ&#xae; (minocycline) topical foam, 4% in the United States prior to the expiration of the Company&#x2019;s U.S. patents Nos. 8,865,139, 8,945,516, 8,992,896, 9,675,700, 10,086,080, 10,137,200, 10,213,512, 10,265,404, 10,398,641, 10,517,882, 10,821,187, and 10,849,847 (the &#x201c;Listed Patents&#x201d;), which are listed in the FDA&#x2019;s Approved Drug Products with Therapeutic Equivalence Evaluations, otherwise known as the &#x201c;Orange Book.&#x201d; The Notice alleges that the Listed Patents are invalid, unenforceable, and/or will not be infringed by the commercial manufacture, use or sale of the generic product described in Padagis&#x2019;s ANDA.&lt;/span&gt;&lt;/div&gt;On August 9, 2021, the Company initiated a patent infringement suit against Padagis in the United States District Court for the District of Delaware arising from Padagis&#x2019;s ANDA filing with the FDA. The patent infringement suit asserts each of the Listed Patents. As a result, under applicable law, the FDA cannot grant final approval to Padagis&#x2019;s ANDA before December 30, 2023, or a court decision in Padagis&#x2019;s favor. VYNE is seeking, among other relief, an order that the effective date of any FDA approval of Padagis&#x2019;s ANDA be no earlier than the expiration of the Listed Patents, the latest of which expires on September 8, 2037, and such further and other relief as the court may deem appropriate. Padagis filed its response and counterclaim on October 1, 2021. The Company filed its response to such counterclaim on October 22, 2021. The liabilities associated with this matter have been transferred to Journey in connection with the Sale.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzIxOTkwMjMyNjY3ODU_9d4e5a9f-cd10-46a1-9b61-f0efd8b85671">LONG-TERM DEBT&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 29, 2019, Foamix entered into a Credit Agreement (the "Credit Agreement") to secure up to $50 million from two lenders, one of which is a significant stockholder of the Company and is considered a related party, and a Securities Purchase Agreement with one of the lenders for gross proceeds of approximately $14 million, before deducting offering expenses (see "Note 14 - Share Capital" for more information).  On March 9, 2020, the Company entered into an Amended and Restated Credit Agreement and Guaranty (as further amended on August 5, 2020, the "Amended and Restated Credit Agreement"), whereby the Company has guaranteed the indebtedness obligations of the borrower and granted a first priority security interest in substantially all of our assets for the benefit of the lenders.  As of December&#160;31, 2020, $35.0 million was drawn under the Amended and Restated Credit Agreement.  The Company did not incur the remaining $15.0 million under the Amended and Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The term loans available under the Amended and Restated Credit Agreement were comprised as follows: (a) $15 million that was funded on July 29, 2019 (the &#x201c;Tranche 1 Loan&#x201d;), (b) $20 million that was funded on December 17, 2019 (the &#x201c;Tranche 2 Loan&#x201d;) and (c) up to $15 million that was available prior to September 30, 2020 (the &#x201c;Tranche 3 Loan&#x201d;). The Tranche 2 Loan was borrowed following the FDA&#x2019;s approval of the Company&#x2019;s NDA for AMZEEQ and listing of AMZEEQ in the FDA&#x2019;s &#x201c;Orange Book,&#x201d; in addition to maintaining its arrangements with a third party for the commercial supply and manufacture of AMZEEQ. The Company did not incur the Tranche 3 Loan. Subject to any acceleration as provided in the Amended and Restated Credit Agreement, including upon an event of default (as defined in the Amended and Restated Credit Agreement), the loans will mature on July 29, 2024 and bear interest equal to the sum of (A) 8.25% (subject to increase in accordance with the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;terms of the Amended and Restated Credit Agreement) plus (B) the greater of (x) the one-month LIBOR as of the second business day immediately preceding the first day of the calendar month or the date of borrowing (if such loan is not outstanding as of the first day of the calendar month), as applicable, and (y) 2.75%. A fee in an amount equal to 1.0% of the aggregate principal amount of all loans made on any given borrowing date shall be payable to the lenders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loans were scheduled to mature on July 29, 2024. However, following discussions with the Company's lenders regarding the revenue targets included in the Amended and Restated Credit Agreement, the revenue expected to be generated for the trailing twelve month period ended June 30, 2021 and the Company's strategic business review discussed in Note 1, the Company determined to prepay its outstanding indebtedness in addition to a 4% prepayment fee and accrued but unpaid interest in the total amount of approximately $36.5&#160;million on August 11, 2021. Following the prepayment, the Amended and Restated Credit Agreement and the security interests thereunder were terminated. As of December&#160;31, 2021 there was no debt outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Perceptive Credit Holdings II, LP ("Perceptive") was one of the lenders and the administrative agent under the Amended and Restated Credit Agreement. As of August 11, 2021, the date of the prepayment, affiliates of Perceptive were holders of more than 5% of the Company's outstanding common stock. In connection with the prepayment of the Company's indebtedness, Perceptive received $18.3&#160;million, representing their portion of the principal amount, interest and prepayment premium.  As of December 31, 2021, Perceptive was no longer a related party. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, on July 29, 2019, the lenders under the Credit Agreement were issued warrants to purchase up to an aggregate of 1,100,000 of Foamix ordinary shares, at an exercise price of $2.09 per share (the &#x201c;Warrants&#x201d;), which represented the five-day volume weighted average price of the Foamix ordinary shares as of the trading day immediately prior to the issuance of the Warrants. In connection with the completion of the Merger, the exchange ratio was applied to the Warrants such that they became exercisable for 651,640 shares of the Company's common stock, and the exercise price was adjusted to $3.53.  Following the Phase 3 PN Trial results, the Warrants were further adjusted for the CSR and reverse stock split and they are currently exercisable for 495,165 shares of our common stock with an exercise price of $4.64 per share. Payment of the exercise price will be made, at the option of the holder, either in cash or as a reduction of common stock issuable upon exercise of the Warrant, with an aggregate fair value equal to the aggregate exercise price ("cashless exercise"), or any combination of the foregoing. The Warrants are exercisable pursuant to the terms, and subject to the conditions, thereof and expire on July 29, 2026. Any Warrants left outstanding will be cashless exercised on the Warrants' expiration date, if in the money. The Warrants issued were classified as equity in accordance with ASC 815-40. Proceeds received under the Tranche 1 Loan were allocated to the Warrants and the Tranche 1 Loan on a relative fair value basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020 the Company incurred offering expenses of $1.1 million in connection with transactions contemplated by the Credit Agreement and the Securities Purchase Agreement, which were allocated to the Warrants, shares and debt consistently with the allocation of proceeds. The Company incurred additional expenses in the amount of $0.3&#160;million from the borrowing of Tranche 2 Loan, allocated only to the debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021 the company recorded interest expense of $5.6&#160;million comprised of interest on debt of $3.8&#160;million and discount costs of  $1.8&#160;million.  The interest expense includes a debt prepayment fee of $1.4 million and the write-off of discount costs of $1.6&#160;million associated with the Company's prepayment of outstanding indebtedness resulting in a total extinguishment loss of $3.0&#160;million   During the year ended December&#160;31, 2020 the company recorded interest expense of $3.9 million and $0.5 million relating to the interest and discount cost, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9d3b1bab5fa44cbfa425becb06eecfc7_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEyOA_caf34afb-28c7-4399-833f-acec9da72090"
      unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <vyne:NumberOfLenders
      contextRef="if989d0b1c2c24f45b11a284fac301a66_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzIxOTkwMjMyNjY3ODY_3927fb9a-bedc-4e4c-b466-1c6da1d79777"
      unitRef="lender">2</vyne:NumberOfLenders>
    <vyne:NumberOfLenders
      contextRef="i284a65a8749542cdb95cbcc24fe35192_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI4Mg_52a42d03-d626-4101-b8fa-a103e1bad63a"
      unitRef="lender">1</vyne:NumberOfLenders>
    <vyne:GrossProceedsFromIssuanceOfCommonStock
      contextRef="i284a65a8749542cdb95cbcc24fe35192_I20190729"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzMzNg_22ba1f4f-a8f8-4475-8234-591d124a636a"
      unitRef="usd">14000000</vyne:GrossProceedsFromIssuanceOfCommonStock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0c259adecd3644dbaca374ee117b6d25_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI3NDg3NzkwNzc1MTk_7791fac1-f1b4-4a35-9191-7957f7a29a1c"
      unitRef="usd">35000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i0c259adecd3644dbaca374ee117b6d25_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzg4OQ_0a205b7b-c78f-424b-86ba-e394039d13cd"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia96474a494374f3385b000f4f8d33fca_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwNDQ_8aebe24c-9738-47b5-bca1-0048ccb64f99"
      unitRef="usd">15000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i577c52ea7b5b40aab1df1b785fc2c96e_I20191217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzExMDg_8d5e696b-07fb-4a09-8757-7a4e2fc8ef4d"
      unitRef="usd">20000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i04ea1c0a01244363ac01049f1f6c7857_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzExODU_8858909e-4757-4067-9c13-72cd57498ea3"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic10e4840e05c4e729cd9e69af333a006_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzE4MjU_22210759-9263-42e4-b316-26231cec177f"
      unitRef="number">0.0825</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2e9df17c9abb40a896c4e95cd18226bd_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzIxODU_e52fe66d-25d7-4668-9d85-f54fed869848"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <vyne:DebtInstrumentFeePercent
      contextRef="i66e2d83dcb2e4d44a68e3d1c04503e5c_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzIyMTc_118d785c-44fe-428e-b05b-e864f099fab9"
      unitRef="number">0.010</vyne:DebtInstrumentFeePercent>
    <vyne:RepaymentOfDebtPrepaymentFeePercentage
      contextRef="ia7de8816c3eb465d9f44397038347e0a_I20210811"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI3NDg3NzkwODAyMDg_07655148-3d8a-40d5-88ba-008f872ef903"
      unitRef="number">0.04</vyne:RepaymentOfDebtPrepaymentFeePercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iaac44e519733479cb2fd74f4d69991a1_D20210811-20210811"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI3NDg3NzkwODAyMTI_2c33296e-2408-4b70-9fac-73de1bb63fa3"
      unitRef="usd">36500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI3NDg3NzkwNzc1MjU_2f2dfe95-e859-442a-9027-048ec4cb49ed"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="iaac44e519733479cb2fd74f4d69991a1_D20210811-20210811"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzI3NDg3NzkwODA0MjE_5e8dd772-3258-475b-9c2a-c8fe82f9326a"
      unitRef="usd">18300000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i9949f940927a4c1fb5d8ac40b1e2e0e4_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzQzNDc_c87b372a-dcf0-4869-a82e-6914dd9e8a35"
      unitRef="shares">1100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i9949f940927a4c1fb5d8ac40b1e2e0e4_I20190729"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzQ0MDE_063eb6e0-dac8-4a6e-bf30-3412f19e18b7"
      unitRef="usdPerShare">2.09</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i0fb8e95fc2ea4faea89832a8d5669b5e_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzQ3MzA_ad35a5d0-3321-407e-bae5-152715347735"
      unitRef="shares">651640</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i0fb8e95fc2ea4faea89832a8d5669b5e_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzQ4MTA_bd05b6cf-18ed-4ff5-a59d-12688fa32e26"
      unitRef="usdPerShare">3.53</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="id99703f9fd5b41b2b59fde641c5048bd_I20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzQ5NjU_2e855fa1-f1f7-4ec1-acb8-544b2d28f1ea"
      unitRef="shares">495165</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="id99703f9fd5b41b2b59fde641c5048bd_I20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzUwMjE_5a4790b7-1b88-4e47-878b-5f804eebea4c"
      unitRef="usdPerShare">4.64</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzU3OTk_e970a24b-719e-4cb8-b94c-c75bab57b9b2"
      unitRef="usd">1100000</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="i888b43bee8a74b63b94b21ef02c0a940_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2Mzk4ODQ_7a2fb637-2647-43c6-a192-bc4927dcf902"
      unitRef="usd">300000</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:InterestExpense
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2Mzk1NzE_5f978f7a-5a44-40f8-9144-75efcc6ba2dd"
      unitRef="usd">5600000</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2Mzk5NzA_f1f22a8f-b794-47d6-9721-67fe206aefea"
      unitRef="usd">3800000</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2NDAwMDY_d51ddff9-00d9-43a2-a52c-7bb96e6eb582"
      unitRef="usd">1800000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2Mzk2OTU_95a5c68e-e2b3-4589-a401-895a64baed07"
      unitRef="usd">1400000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts
      contextRef="i160f84d5cf9d48ca8c977e79e5f245b3_D20190729-20190729"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2NDAxMTA_b9a5e683-79b1-4466-8dde-c0e16c0372f1"
      unitRef="usd">1600000</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzEwOTk1MTE2NDAyNTA_9d4c5f29-c47d-4b5b-bbce-b70d59c41219"
      unitRef="usd">-3000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzY5Mjg_9f01e870-5398-4000-a5bb-32f95df1aee0"
      unitRef="usd">3900000</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjAvZnJhZzo1MmZhY2E2YjUzZmY0Y2YwYmFmNDU4YWY3MDZiNzkxZi90ZXh0cmVnaW9uOjUyZmFjYTZiNTNmZjRjZjBiYWY0NThhZjcwNmI3OTFmXzY5MzU_fb2fa241-5f9d-4575-8c2e-bf6876ac7498"
      unitRef="usd">500000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzIxOTkwMjMyNzM3NTc_2c6d02b4-4b1c-4125-b3e6-06154d1ab26e">STOCKHOLDERS' EQUITY&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company's Certificate of Incorporation, as amended, authorizes the Company to issue 20,000,000 shares of preferred stock, par value $0.0001 per share.  There were no shares of preferred stock issued and outstanding as of December&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of preferred stock may be issued from time to time in one or more series.  The voting powers (if any), preferences and relative, participating, optional or other special rights, and the qualifications, limitations and restrictions of any series of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;preferred stock will be set forth in a Certificate of Designation filed pursuant to the Delaware General Corporation Law, as determined by the Company's Board of Directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of shares of common stock authorized under the Company's Amended and Restated Certificate of Incorporation was proportionately reduced in connection with the Company's 1-for-4 reverse stock split in February 2021.  On July 19, 2021, the Company held its meeting of Stockholders (the "Annual Meeting").  Following the approval by the holders of a majority of the outstanding shares of common stock at the Annual Meeting, the Company filed a Certificate of Amended and Restated Certificate of Incorporation to increase the number of authorized share of common stock from 75,000,000 to 150,000,000 shares of common stock, par value $0.0001 per share.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when and if declared by the board of directors, subject to the prior rights of holders of all classes of preferred stock outstanding. The Company has never declared any dividends on common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to entering into the Credit Agreement on July 29, 2019, Foamix issued to the lenders Warrants to purchase up to an aggregate of 1,100,000 of its ordinary shares, later exchanged to Warrants to purchase up to 1,980,660 shares of Menlo's common stock, adjusted retrospectively to 495,165 shares of common stock upon the reverse stock split effective February 12, 2021.  Upon close of the Merger, each Warrant received one CSR as described in Note 3 - Business Combinations.  The warrants were exercisable immediately following the closing of the Credit Agreement, subject to the terms of the warrant, and are due to expire on July 29, 2026. Any Warrants left outstanding will be cashless exercised on the Warrants' expiration date, if in the money.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The exchange of Warrants from Foamix warrants to Menlo warrants and the additional CSR was accounted for as a modification, by analogy, from the modification's guidance under ASC 260-10-S99-2.  The Company assessed the significance of the modification of the Warrants by comparing the fair value of the Warrants immediately before and after the amendments.  In its assessment, it also considered additional qualitative factors.  The Company concluded that the change of terms was not significant.  Therefore, the incremental fair value, in the amount of $41 thousand, of the modified Warrants over the original ones (as of modification date) was recognized in retained earnings as a deemed dividend to the Warrant holders in the year ended December 31, 2020.  No amounts were recognized in the year ended December&#160;31, 2021.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Issuance of stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 1, 2019, the Company entered into a Sales Agreement (the "2019 Sales Agreement") with Cantor Fitzgerald &amp;amp; Co., or Cantor Fitzgerald, to sell shares of the Company's common stock, from time to time, with aggregate gross sales proceeds of up to $50.0 million through an at-the-market equity offering program under which Cantor Fitzgerald acted as our sales agent.  The issuance and sale of shares of common stock by us pursuant to the 2019 Sales Agreement were deemed an "at-the-market" offering under the Securities Act.  Cantor Fitzgerald was entitled to compensation for its services equal to up to 3.0% of the gross proceeds of any shares of common stock sold under the 2019 Sales Agreement.  During the year ended December 31, 2020, the Company issued and sold 1,175,000 shares of common stock at a weighted average price per share of $7.00 pursuant to the 2019 Sales Agreement for $8.0 million in net proceeds, all of which was sold during the three months ended December 31, 2020. In addition, from January 1, 2021 through January 25, 2021, the Company issued and sold an additional 2,778,012 shares of common stock at a weighted average price per share of $9.76 for $26.3 million in net proceeds. Effective as of January 25, 2021, the Company terminated the 2019 Sales Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 12, 2021, the Company entered into a new sales agreement (the "Sales Agreement") with Cantor Fitzgerald to sell shares of the Company's common stock, from time to time, with aggregate gross sales proceeds of up to $50.0 million through an at-the-market equity offering program under which Cantor Fitzgerald will act as the Company's sales agent. The issuance and sale of shares of common stock by us pursuant to the Sales Agreement are deemed an "at-the-market" offering under the Securities Act. Cantor Fitzgerald is entitled to compensation for its services equal to up to 3.0% of the gross proceeds of any shares of common stock sold under the Sales Agreement. During the year ended December&#160;31, 2021, the Company issued and sold 1,955,313 shares of common stock at a weighted average per share price of $1.57 pursuant to the Sales Agreement for $2.9&#160;million in net proceeds.  This agreement was in effect as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 28, 2021, the Company entered into a Securities Purchase Agreement with certain institutional and accredited investors for the sale of an aggregate of 5,274,261 shares of common stock of the Company, at a purchase price of $9.48 per share in a registered direct offering. The offering was completed on January 28, 2021 and the Company received approximately $46.8 million in net proceeds, after deducting placement agent fees and other offering expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 9, 2020, the Company completed an underwritten public offering of 7,776,875 shares of common stock at a price to the public of $7.40 per share.  The net proceeds of the offering were approximately $53.6 million, after deducting underwriting discounts and commissions and other offering expenses.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, the Company issued 36,500,335 shares to legacy Foamix shareholders.  On April 6, 2020, pursuant to the terms of the CSR Agreement, the Company issued 74,544,413 shares to legacy Foamix shareholders, adjusted retrospectively to 18,636,103 shares of common stock upon the reverse stock split effective February 12, 2021&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE0NA_b5d4a349-6aaf-4796-a001-916d2ca1a240"
      unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE4NA_7a9c9a42-7745-42b0-82af-7ab2a0c16547"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzIxMA_39206bdb-91b0-4224-bfc1-130da654093a"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzIxMA_5eae0de2-1949-49b5-afc6-1beaacbd76b5"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzIxMA_cb3899ce-0aeb-4973-8e29-f429bd32d9e3"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzIxMA_ee589f41-e2bf-44d4-ae9f-2130c6f7ef17"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzEwOTk1MTE2NDY0MTg_be1b8fba-57e9-4c04-b8cf-37c364455c87"
      unitRef="shares">75000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzk3Ng_bc88e878-5f38-4cba-931d-e603f0d1e1df"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzEwMTM_280aea64-4093-4f83-af0e-b478fcd24ac5"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <vyne:CommonStockVotingRightsNumberPerShare
      contextRef="i7905f84f35ea488095252b0854ef24b6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzExODk_445b4324-903b-47a4-8242-1f5f064c4b74"
      unitRef="vote">1</vyne:CommonStockVotingRightsNumberPerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i74ce2a3821c540e0b8de1b57d9790d94_I20190729"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NTE_af98629b-1813-43de-87c3-6a8e8f5be9bc"
      unitRef="shares">1100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <vyne:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="i34dafd0890e345cb94a8cf7a2e26625f_D20190701-20190729"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE3MjQ_562bcc01-a24e-4408-b418-01587b324490"
      unitRef="shares">1980660</vyne:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="id99703f9fd5b41b2b59fde641c5048bd_I20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE3ODc_2e855fa1-f1f7-4ec1-acb8-544b2d28f1ea"
      unitRef="shares">495165</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <vyne:BusinessAcquisitionContingentStockRightIssued
      contextRef="ic9db52a2ac30420c84e995e7b348eeb8_I20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE5MjA_42260477-9c24-439a-b9be-611722936675"
      unitRef="contingentstockright">1</vyne:BusinessAcquisitionContingentStockRightIssued>
    <vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification
      contextRef="i5f0643079f4b4a46a6f72aa2aa70777a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzI3OTQ_d3de4e3f-5310-4f39-88d4-ace812a14641"
      unitRef="usd">41000</vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification>
    <vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification
      contextRef="ic653c6de73fb47fea4bbe97cf2f5f3ab_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzg3OTYwOTMwNTA3MTg_3ec1f325-cd2b-47ce-a62b-c22d1c6a8dfb"
      unitRef="usd">0</vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i0aa0866aa6994b3b9cbbaddb8ed97944_D20190201-20190201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzM1NzQ_b77211fe-6906-4adb-9a1b-20fdd2e0e63a"
      unitRef="usd">50000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <vyne:CommissionFromGrossProceedsFromIssuanceOfCommonStock
      contextRef="i0aa0866aa6994b3b9cbbaddb8ed97944_D20190201-20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzM5MTY_d7b71f35-947a-42ab-914d-360f3f699c85"
      unitRef="number">0.030</vyne:CommissionFromGrossProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i371ccbf335764d51b576f9a2336b47b2_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQwNzM_afa193c8-4685-4b87-bd4d-07bb27554402"
      unitRef="shares">1175000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i88edc7fdfcf4414e8659f3d6de7a6b5a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQxNDA_58b8d9f2-b94f-47bc-93a2-4c34ff08c951"
      unitRef="usdPerShare">7.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i371ccbf335764d51b576f9a2336b47b2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQxNzk_cc2c0bd1-91c4-4ffa-8306-1f7237f27eb8"
      unitRef="usd">8000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ibd040f22c54846a4803901905b00f633_D20210101-20210125"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQzNzI_fd4ffaf0-d23d-4614-b18e-91a9e16de2dd"
      unitRef="shares">2778012</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i9789581a138e48bf9397a195c54b4c33_I20210125"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQ0Mzk_52835fb0-9acf-4b8b-b18b-c7dcdb1f261a"
      unitRef="usdPerShare">9.76</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ibd040f22c54846a4803901905b00f633_D20210101-20210125"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQ0NDY_c32bd148-e2ff-47bd-a3c2-6721c9ef53be"
      unitRef="usd">26300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <vyne:SaleOfStockConsiderationReceivableOnTransaction
      contextRef="i66bbeb9a734f427982630691149f765d_I20210812"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NDkyNjc0NjI2OTA_bc566724-bd2c-42d3-b54f-63d2c506cb77"
      unitRef="usd">50000000</vyne:SaleOfStockConsiderationReceivableOnTransaction>
    <vyne:CommissionFromGrossProceedsFromIssuanceOfCommonStock
      contextRef="i0b46cdcdfa37452ab8c70071f20ab9c7_D20210812-20210812"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NDkyNjc0NjI2OTU_036c9792-39bc-4663-ab3c-b90a93da405f"
      unitRef="number">30.0</vyne:CommissionFromGrossProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ib74ed9a5f0a84a079fd6937d9d2f0453_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NDkyNjc0NjI2Nzc_43ed13fd-8722-472d-ba3d-c86f559712c1"
      unitRef="shares">1955313</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i65dd613b82a44b218deffd9c0f7db2f7_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NDkyNjc0NjI3MDA_46e86002-8b61-41f5-b6df-053eed994a11"
      unitRef="usdPerShare">1.57</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ib74ed9a5f0a84a079fd6937d9d2f0453_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzE2NDkyNjc0NjI2ODE_b310b61b-4977-4b7c-84f3-0b579e9f03ba"
      unitRef="usd">2900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i347a6acc4a7a45968674fa63bfa3890b_D20210128-20210128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQ3NTY_bd1c8f09-21e3-4030-81bc-49f2dee58f84"
      unitRef="shares">5274261</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ica625a9375d843ae871ac0d4b3db4352_I20210128"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQ4MjE_5e4b307c-2a6f-4732-960d-f56b17ab011a"
      unitRef="usdPerShare">9.48</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i347a6acc4a7a45968674fa63bfa3890b_D20210128-20210128"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzQ5NTM_3d5577ee-d367-4204-a84d-12fcfd92ecfe"
      unitRef="usd">46800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i343a467bc0454f449ea44b8054c6e2f8_D20200609-20200609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzUxMTQ_973ce5a2-5320-47ca-8e96-13b1da8b30e6"
      unitRef="shares">7776875</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="if1c5a77b02644689af601da56f6c2307_I20200609"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzUxNjg_0c7c78e3-48fa-45ac-88d9-6d3a74135052"
      unitRef="usdPerShare">7.40</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i343a467bc0454f449ea44b8054c6e2f8_D20200609-20200609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzUyMzU_15d135c4-0bf7-4e30-8019-b84f7b0f5d02"
      unitRef="usd">53600000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzU0MDQ_cc382fc0-0d70-44e6-99ad-1be018324e52"
      unitRef="shares">36500335</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ibea690c21df9415993df8d2c1da95438_D20200406-20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzU1MjA_13cb6fa3-c6e8-46d2-96a4-c804a6829cf9"
      unitRef="shares">74544413</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement
      contextRef="if700df1c23de4808b1135e843d318a8a_D20210212-20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjMvZnJhZzpmYWNkMGVlODE4M2M0MjU4Yjg1ZTEzOWEwMGY5OTQ0ZS90ZXh0cmVnaW9uOmZhY2QwZWU4MTgzYzQyNThiODVlMTM5YTAwZjk5NDRlXzU1ODI_fa2cd416-accc-4ff6-856e-03e9f1a41fbb"
      unitRef="shares">18636103</vyne:SharesIssuedUponConversionOfCommonStockRightsPerAgreement>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl84Nzk2MDkzMDI5NjMy_4c57cc27-02b9-4bde-8918-81cc9bae4fae">SHARE BASED COMPENSATION&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Equity incentive plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon closing of the Merger, the Company adopted Foamix&#x2019;s 2019 Equity incentive plan (the &#x201c;2019 Plan&#x201d;). As of December&#160;31, 2021, 979,795 shares remain issuable under the 2019 Plan.  In addition, the Company adopted the 2018 Omnibus Incentive Plan (the "2018 Plan") in January 2018.  As of December&#160;31, 2021, 147,550 shares remain issuable under the 2018 Plan.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Employee Share Purchase Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon closing of the Merger, the Company adopted Foamix's Employee Share Purchase Plan ("ESPP") pursuant to which qualified employees (as defined in the ESPP) may elect to purchase designated shares of the Company&#x2019;s common stock at a price equal to 85% of the lesser of the fair market value of the common stock at the beginning or end of each semi-annual share purchase period (&#x201c;Purchase Period&#x201d;). Employees are permitted to purchase the number of shares purchasable with up to 15% of the earnings paid (as such term is defined in the ESPP) to each of the participating employees during the Purchase Period, subject to certain limitations under Section 423 of the U.S. Internal Revenue&#160;Code.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, 2,232,207 shares remain available for grant under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, 71,890 shares were issued to employees pursuant to the ESPP. During the year ended&#160;December&#160;31, 2020, 61,031 Foamix ordinary shares were purchased by Foamix employee pursuant to the ESPP prior to the Merger, which were later exchanged for 36,155 shares of the Company's common stock and one CSR in the Merger, adjusted retrospectively to 9,038 shares of common stock and one CSR upon the reverse stock split effective February 12, 2021, and 38,716 shares were issued to employees after the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Options and RSUs granted to employees and directors:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the years ended December&#160;31, 2021 and 2020, the Company granted options as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Award amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Exercise price range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Vesting period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employees and Directors:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,686,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.68- $11.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1 year -4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;970,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2 years -4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Award amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Exercise price range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Vesting period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employees and Directors:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,327,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.84- $12.52&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1 year -4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;654,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1 year -4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of options and RSUs granted to employees and directors during 2021 and 2020 was $9.4 million and $11.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of RSUs granted to employees and directors is based on the share price on grant date .&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each option granted is estimated using the Black-Scholes option pricing method. The volatility is based on a combination of the Company&#x2019;s historical volatility, historical volatilities of companies in comparable stages as well as companies in the industry, by statistical analysis of daily share pricing model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected term of the options granted in dollar terms. The Company&#x2019;s management uses the expected term of each option as its expected life. The expected term of the options granted represents the period of time that granted options are expected to remain outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The underlying data used for computing the fair value of the options are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value of stock option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.02-$6.75&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.47-$7.68&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68.38%-69.38%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60.44%-69.83%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.50%-1.29%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.31%-1.26%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Modification of share-based compensation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger, all outstanding options and RSUs granted by Foamix were exchanged for stock options and RSUs of Menlo&#x2019;s common stock according to the Exchange Ratio. In addition, for each option and RSU the holder received a CSR as described in Note 3- Business Combination. This transaction was considered by the company to be a modification under ASC 718, Compensation - Stock Compensation. The modification did not affect the remaining requisite service period. As a result of the modification, for outstanding options and RSUs granted to Foamix employees and consultants, the Company recorded immaterial incremental compensation expense.  As described in Note 3 - Business Combination, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into 1.2082 shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of 1.8006 shares of Menlo common stock for each Foamix ordinary share.  The conversion was considered by the company to be a modification under ASC 718. As a result of the modification, for outstanding options and RSUs granted to Foamix employees and consultants, the Company recorded incremental compensation of $1.8&#160;million and $11.8 million for the years ended December&#160;31, 2021 and December&#160;31, 2020, respectively.  As of December&#160;31, 2021 there is $0.9 million of unrecognized incremental compensation expense related to the modification which will primarily be amortized using a graded vesting method over the next 1 year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards granted to holders who are no longer employed or providing services to the Company are accounted for in accordance with ASC 815-40, Derivatives and Hedging. Under this guidance, the awards are classified as a derivative liability because the award no longer exchanges a fixed amount of cash for a fixed number of shares. Accordingly, as of March 9, 2020 the Company reclassified $1.6 million from additional paid-in capital to derivative liability on the consolidated balance sheet. Prior to the reclassification of these awards as a liability instrument, the Company recorded an incremental compensation expense of $0.6 million due to the above mentioned modification in accordance with ASC 718. Subsequent to the reclassification of these awards as a liability instrument, the Company recorded incremental compensation expense of $1.0 million for the year ended December&#160;31, 2020.  There was no incremental compensation for the year ended December&#160;31, 2021.  As described in Note 3 - &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Business Combination, on April 6, 2020, the Company announced that study MTI-105 and study MTI-106 did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis.  Accordingly, on April 6, 2020, pursuant to the terms of the CSR Agreement, each CSR was converted into 1.2082 shares of Menlo common stock, resulting in an effective Exchange Ratio in the Merger of 1.8006 shares of Menlo common stock for each Foamix ordinary share.  On April 6, 2020, the awards are exchangeable for a fixed amount of cash for a fixed number of shares and were remeasured to fair value and reclassified from derivative liability to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Merger, Menlo recognized all expenses relating to awards outstanding as of the Effective Date. These awards were subject to acceleration upon the change of control per the previous Menlo stock option plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of outstanding and exercisable options and RSUs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the number of options outstanding for the year ended December&#160;31, 2021, and related information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,274,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,686,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(70,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(435,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,410,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,043,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,971,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The weighted average remaining contractual term of outstanding and exercisable options as of December&#160;31, 2021, is 7.0 years and 5.5 years, respectively.  Total unrecognized share based compensation for options at December&#160;31, 2021 is $6.4 million, which is expected to be recognized over a weighted average period of 2.3 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no intrinsic value of outstanding and exercisable options as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the number of RSUs outstanding for the year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;719,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;970,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(293,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(134,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,262,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total unrecognized compensation expense related to the unvested portion of the Company's RSUs at December&#160;31, 2021 was $5.6 million, which is expected to be recognized over a weighted average period of 2.27 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Share-based compensation expenses:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the effect of share-based compensation on the statements of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i9dd45671031841d1ab0aae6c9fc9d75b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNjc_dc1e0f15-a956-414e-9c73-6b3578e7c4b0"
      unitRef="shares">979795</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ic18e51c0667246cbb9cd142b80514de6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8zMjY_9a0a312c-9e2a-4b71-ba1a-e17953788fce"
      unitRef="shares">147550</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i3cd6043c4c234199b9b39bb81ff103fa_D20200309-20200309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl82NTM_c4cf296c-ab9c-4eaf-9b67-d17d121edba2"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i9421373d63f34d70a76e0ec736a99720_I20200309"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl84ODI_79bdc69b-0667-4c7c-9725-da17edcbe4ed"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia3e6b0bf97f5479c821f53984e43e031_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xMTA1_e2da3721-5136-4bed-907c-cf6d5a627ad9"
      unitRef="shares">2232207</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ic37e0b69a2f040aa8c7b53683361dfe7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xMTg0_5be0f518-4480-4a02-9f27-742c31b67c32"
      unitRef="shares">71890</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="icb7a10a25f4249d48fcd322e6ea012e8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xMjY3_421e26b2-4a94-4a26-9322-ed68aeffb6ba"
      unitRef="shares">61031</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="ie35e2089123c4e50850717116e3c90ef_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNDAw_33957555-4d8a-4c19-89f9-b46816b58d86"
      unitRef="shares">36155</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <vyne:BusinessAcquisitionContingentStockRightIssued
      contextRef="icf20f8bca32849c7beef794c32d2f471_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNDQ0_aa9d884b-7baa-4c76-a76d-dc0ad291e7e4"
      unitRef="contingentstockright">1</vyne:BusinessAcquisitionContingentStockRightIssued>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="idde6935cd313421a8ac1426f77884c47_D20210212-20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNDk0_0af6fff9-f7b0-4a1b-be85-3bef1310899f"
      unitRef="shares">9038</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <vyne:BusinessAcquisitionContingentStockRightIssued
      contextRef="ie847d448f04746f790f534394d63097f_I20210212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNTI0_ca8a7499-927a-4ac0-8324-2df32b475eef"
      unitRef="contingentstockright">1</vyne:BusinessAcquisitionContingentStockRightIssued>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i1daa38912a5c4a1a9f1feaf635f77377_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xNTkz_8fadc3c7-89f3-47fa-b0f8-f1040b41f678"
      unitRef="shares">38716</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <vyne:ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MzI2_60816800-7e5b-4f06-9134-071592d97298">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the years ended December&#160;31, 2021 and 2020, the Company granted options as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Award amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Exercise price range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Vesting period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employees and Directors:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,686,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.68- $11.08&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1 year -4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;970,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2 years -4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Award amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Exercise price range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Vesting period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employees and Directors:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,327,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.84- $12.52&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1 year -4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;654,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1 year -4 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</vyne:ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTEtMS0xLTI5NjY2_4fe45271-94c7-44cd-aa7a-d09612fb3eba"
      unitRef="shares">1686405</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTMtMS0xLTI5NjY2L3RleHRyZWdpb246MzI4YWQ1OTAyY2JjNDAyMjllYjNkZDkxZmM5YWMzNjFfNA_28c6c875-cb59-4ee3-bae4-ee9f973add19"
      unitRef="usdPerShare">1.68</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTMtMS0xLTI5NjY2L3RleHRyZWdpb246MzI4YWQ1OTAyY2JjNDAyMjllYjNkZDkxZmM5YWMzNjFfOA_8bef07e9-b20e-4062-925c-f3cb696d8629"
      unitRef="usdPerShare">11.08</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i5da521456996427aba1e3f15e8a37411_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTUtMS0xLTI5NjY2L3RleHRyZWdpb246ZjY4ZjM4YjAzNGYyNGQ0ZTlkMDkzYjNkYmQ3Yjk5MWVfNA_03e1888f-94dd-4210-9ab6-c4b6f46000d8">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i900d5480233e4f9c83938266d12b66f5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTUtMS0xLTI5NjY2L3RleHRyZWdpb246ZjY4ZjM4YjAzNGYyNGQ0ZTlkMDkzYjNkYmQ3Yjk5MWVfOA_c16ed683-ed4a-4dc7-84fa-f70771bfbbbb">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN18zLTctMS0xLTI5NjY2_a782342d-53b8-44e6-8529-d4f20f20d745">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN180LTEtMS0xLTI5NjY2_ad2242fd-cd01-487e-8c7b-c26e5c59286c"
      unitRef="shares">970813</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iac3a8466dc0e4c3ea25864b0e9da2b0c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN180LTUtMS0xLTI5NjY2L3RleHRyZWdpb246ZTUzYzM3MmNiZmY1NDJjZGE3NGM3YmYyZmJjMWJmZDlfNA_a68c3eeb-6394-46bd-8bb8-610c76bea9db">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="icd305dde41e4448ebecd3c0983d175b3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ZWYzZGVkYjNiMzJiNGNkZDk0OGY1MGRjNzQ0ZjEwYzcvdGFibGVyYW5nZTplZjNkZWRiM2IzMmI0Y2RkOTQ4ZjUwZGM3NDRmMTBjN180LTUtMS0xLTI5NjY2L3RleHRyZWdpb246ZTUzYzM3MmNiZmY1NDJjZGE3NGM3YmYyZmJjMWJmZDlfOA_79e49164-4b4b-49b3-80fc-e130688da16f">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTEtMS0xLTI5NjY2_476bf89b-3fca-4536-9c37-538b15fcb188"
      unitRef="shares">1327214</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTMtMS0xLTI5NjY2L3RleHRyZWdpb246MGQ3YTcxNTE2NGU1NDA2OThlM2RlMDFkMGFiMDk5YmVfNA_3debd19a-87c5-4ed2-910a-900af0267842"
      unitRef="usdPerShare">5.84</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTMtMS0xLTI5NjY2L3RleHRyZWdpb246MGQ3YTcxNTE2NGU1NDA2OThlM2RlMDFkMGFiMDk5YmVfOA_fdaf0c04-5b15-4684-bb68-846fff443c62"
      unitRef="usdPerShare">12.52</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i6b3949f3bcbc41f89845a01280213f01_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTUtMS0xLTI5NjY2L3RleHRyZWdpb246YWY5NzE2ZDM0OWE0NGZkZTk3ZmFjMThjYWFjYjg1NzVfNA_18eb280b-fcdd-4bf5-86cb-4e0aec2ca447">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic658972e380d477b81bc9fbdfd31f1db_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTUtMS0xLTI5NjY2L3RleHRyZWdpb246YWY5NzE2ZDM0OWE0NGZkZTk3ZmFjMThjYWFjYjg1NzVfOA_fea96945-2389-46da-8836-6f8ec984acb0">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl8zLTctMS0xLTI5NjY2_21bc9462-a431-4232-a9fa-e095e53d3713">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i1049c5e9d3584238a13d1718e53ffeb3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl80LTEtMS0xLTI5NjY2_d5bc1de9-07cd-4098-9bea-d573fb269d24"
      unitRef="shares">654427</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i0696c6f2ddb34f69be35f2bef6534641_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl80LTUtMS0xLTI5NjY2L3RleHRyZWdpb246NzhkNTZjYzFjNGY1NGViN2IzNzM2NDM2NzM5ZGRiYmJfNA_8d9af7df-1924-4b05-834a-d06126e62751">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i18c931db2ae34ddd8e0b75d2ddb9a6f1_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6Y2UwMGU3Zjk0MGU0NGNmMGEyZDY2MzFhOWJmYmFiY2YvdGFibGVyYW5nZTpjZTAwZTdmOTQwZTQ0Y2YwYTJkNjYzMWE5YmZiYWJjZl80LTUtMS0xLTI5NjY2L3RleHRyZWdpb246NzhkNTZjYzFjNGY1NGViN2IzNzM2NDM2NzM5ZGRiYmJfOA_07fda7d3-a85b-46ca-903a-bc17639afc7e">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <vyne:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue
      contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8yMDQ3_87cfbdb9-c60f-46ee-ad1d-8b9685464498"
      unitRef="usd">9400000</vyne:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue>
    <vyne:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue
      contextRef="i1049c5e9d3584238a13d1718e53ffeb3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8yMDU0_fed32638-fb2a-44e1-b7f3-383be4bd9cdc"
      unitRef="usd">11900000</vyne:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MzI1_72a7afa3-4a94-4540-9505-19b9b394d551">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The underlying data used for computing the fair value of the options are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value of stock option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.02-$6.75&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$3.47-$7.68&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;68.38%-69.38%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60.44%-69.83%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.50%-1.29%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.31%-1.26%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="i0ab92efb006543c0bfb4d9c671f0e6af_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8yLTEtMS0xLTI5NjY2L3RleHRyZWdpb246YTM5MmVkODkzNTY4NDNmMmIzZjE4ODI2Nzc3YjRjNmRfNA_c53c3802-b6c7-47a1-9383-d061895b3390"
      unitRef="usdPerShare">1.02</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i5feca1c387ef4ac081bc860e994a1d02_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8yLTEtMS0xLTI5NjY2L3RleHRyZWdpb246YTM5MmVkODkzNTY4NDNmMmIzZjE4ODI2Nzc3YjRjNmRfNw_0b2a10f6-cc03-408e-8fde-3c44d4ce19cd"
      unitRef="usdPerShare">6.75</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="ib17baf4771f74c3c866143773332d0a3_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8yLTMtMS0xLTI5NjY2L3RleHRyZWdpb246ZGEzOTllYzBiMThmNGQ1ZTljNjQxZmMzMWExMWIzMDVfNA_1eb075e6-a37d-4943-9c93-aca7f8035690"
      unitRef="usdPerShare">3.47</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i4d8e2ecb65594adebbdada392434f3f1_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8yLTMtMS0xLTI5NjY2L3RleHRyZWdpb246ZGEzOTllYzBiMThmNGQ1ZTljNjQxZmMzMWExMWIzMDVfNw_370fbec4-0920-4286-9325-aa9d7f02afbe"
      unitRef="usdPerShare">7.68</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8zLTEtMS0xLTI5NjY2_18fb1f18-8ccc-4ee7-961b-9371d638dbbb"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV8zLTMtMS0xLTI5NjY2_2784e26f-0d77-4016-bf66-a244b928cfb0"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV80LTEtMS0xLTI5NjY2L3RleHRyZWdpb246ZGNiNzcxZmVhNWI1NDA3ZDg2ODQ5ODE1MWNkZTc4ZWVfNA_9c827c91-5ca4-4f84-8137-564eb58dd6c6"
      unitRef="number">0.6838</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV80LTEtMS0xLTI5NjY2L3RleHRyZWdpb246ZGNiNzcxZmVhNWI1NDA3ZDg2ODQ5ODE1MWNkZTc4ZWVfNw_9fa383ed-b9cf-4c23-92af-e8242ce540e1"
      unitRef="number">0.6938</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV80LTMtMS0xLTI5NjY2L3RleHRyZWdpb246MmMxNjA1YTYzM2U2NGJkMmFiOTJkNzc3MzBiNGJmNjFfNA_5e0629f9-e5b1-4b0c-aa8c-f104f4c5f49d"
      unitRef="number">0.6044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV80LTMtMS0xLTI5NjY2L3RleHRyZWdpb246MmMxNjA1YTYzM2U2NGJkMmFiOTJkNzc3MzBiNGJmNjFfNw_a0e6a34a-8e45-4bf4-aa68-cd423c97f5b7"
      unitRef="number">0.6983</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV81LTEtMS0xLTI5NjY2L3RleHRyZWdpb246NjY3MTE2ZDdlZTg4NDViNGE5YThiODg3MzljYmYxYjhfNA_145cff13-0fbd-41d4-9c22-ddc41f16279c"
      unitRef="number">0.0050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV81LTEtMS0xLTI5NjY2L3RleHRyZWdpb246NjY3MTE2ZDdlZTg4NDViNGE5YThiODg3MzljYmYxYjhfNw_464d0503-301e-47fb-b3e7-aa01da0daa51"
      unitRef="number">0.0129</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV81LTMtMS0xLTI5NjY2L3RleHRyZWdpb246NjI1YTk2MGIxODQ1NDYwZGE5YWIxYzE3MWJmZDExZmFfNA_9e5df429-d05d-4cf2-be8b-964a35495d9c"
      unitRef="number">0.0031</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV81LTMtMS0xLTI5NjY2L3RleHRyZWdpb246NjI1YTk2MGIxODQ1NDYwZGE5YWIxYzE3MWJmZDExZmFfNw_eb8015a5-ab44-4abc-a0cf-b005aa0cac6d"
      unitRef="number">0.0126</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV82LTEtMS0xLTI5NjY2_34419977-1d35-4e2a-97da-c460260822d7">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic5eab73e5eaf4220814b12e3c6b31f61_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6ODVmZTZlNjZlNDdlNGRjMDlkNmEyN2Y1ZmVkOTRiNTkvdGFibGVyYW5nZTo4NWZlNmU2NmU0N2U0ZGMwOWQ2YTI3ZjVmZWQ5NGI1OV82LTMtMS0xLTI5NjY2_f2ab0c5b-28c7-4faf-8e77-22a60d5b2d24">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <vyne:ContingentStockRightSharesConversion
      contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8zNzgx_814572c3-1d65-490c-b1d6-881f5c3bc3a5"
      unitRef="number">1.2082</vyne:ContingentStockRightSharesConversion>
    <vyne:BusinessCombinationEffectiveExchangeRatio
      contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8zODcy_6b14ca04-1b71-4d8c-8476-93e782752a75"
      unitRef="number">1.8006</vyne:BusinessCombinationEffectiveExchangeRatio>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i131bd9ea97144427b459ae81f53e00d2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl8xMDk5NTExNjM1NDkz_676e7d55-fc9e-4617-b997-ce87e6d0602f"
      unitRef="usd">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i1aa6bb8253084128a90e0a1ebdf5b6fa_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl80MTc4_50acb4a5-bcc7-488c-b3a2-96f6f8f771d0"
      unitRef="usd">11800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <vyne:ShareBasedPaymentArrangementPlanModificationUnrecognizedCost
      contextRef="i131bd9ea97144427b459ae81f53e00d2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl80MjIz_1ef2b6bb-e037-46f8-9e78-5a7f5526c83c"
      unitRef="usd">900000</vyne:ShareBasedPaymentArrangementPlanModificationUnrecognizedCost>
    <vyne:ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod
      contextRef="i131bd9ea97144427b459ae81f53e00d2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl80Mzgx_02ca1feb-02a4-4aae-bdcc-967b587b6312">P1Y</vyne:ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod>
    <vyne:ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment
      contextRef="i918df004225b4092a0bff129ac010d6a_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl80Nzc3_8e8bb2ec-e121-45f7-82fd-9a20734c1dfc"
      unitRef="usd">1600000</vyne:ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i918df004225b4092a0bff129ac010d6a_D20200309-20200309"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl81MDA0_e12928be-cf73-45bf-8bfb-a6820d94f070"
      unitRef="usd">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i2d96d676c73c4e51b5dc524d8d621a7f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl81MjEw_a9ef5f76-0949-4cce-9a37-4f7c3049c5c9"
      unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <vyne:ContingentStockRightSharesConversion
      contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl81NzQ5_814572c3-1d65-490c-b1d6-881f5c3bc3a5"
      unitRef="number">1.2082</vyne:ContingentStockRightSharesConversion>
    <vyne:BusinessCombinationEffectiveExchangeRatio
      contextRef="ic28ecddbecb14089bf87f872b42485b0_I20200406"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl81ODQw_6b14ca04-1b71-4d8c-8476-93e782752a75"
      unitRef="number">1.8006</vyne:BusinessCombinationEffectiveExchangeRatio>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MzI0_81e28ebe-2474-4452-afdc-fa6e0c45d3a5">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the number of options outstanding for the year ended December&#160;31, 2021, and related information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,274,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,686,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(70,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(435,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,410,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,043,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,971,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMS0xLTEtMS0yOTY2Ng_961b7203-c962-4d47-a5d9-35a1127111cf"
      unitRef="shares">4274649</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMS0zLTEtMS0yOTY2Ng_08c29f51-83ee-4863-850e-232f77790959"
      unitRef="usdPerShare">13.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMi0xLTEtMS0yOTY2Ng_fbcaed6d-eeeb-4e5d-8130-9a17ebd11855"
      unitRef="shares">1686405</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMi0zLTEtMS0yOTY2Ng_137a790d-7dbb-4f6a-9334-1b698abe6564"
      unitRef="usdPerShare">5.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMy0xLTEtMS0yOTY2Ng_d01a134c-1ce1-405e-869c-7cc54bc1cc1a"
      unitRef="shares">70827</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xMy0zLTEtMS0yOTY2Ng_4f7929ca-b98b-4212-a473-3a1ddfe03c67"
      unitRef="usdPerShare">7.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNC0xLTEtMS0yOTY2Ng_adfc25d5-1be1-49ab-b671-bf893a5717e4"
      unitRef="shares">435569</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNC0zLTEtMS0yOTY2Ng_4f996f33-7c43-4e60-b1ee-cd9cbef96a9a"
      unitRef="usdPerShare">8.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNS0xLTEtMS0yOTY2Ng_f6935bca-1133-4b55-9f3d-bb2154c3e9fb"
      unitRef="shares">1410706</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNS0zLTEtMS0yOTY2Ng_21bb57cb-734f-4f00-8181-388ce033178b"
      unitRef="usdPerShare">17.53</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNy0xLTEtMS0yOTY2Ng_02bcc227-f8cd-44db-b4a2-88a95acb0814"
      unitRef="shares">4043952</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xNy0zLTEtMS0yOTY2Ng_068aae77-5b04-4b49-9b00-e4ce860daf49"
      unitRef="usdPerShare">9.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xOC0xLTEtMS0yOTY2Ng_5edf711b-1bb6-45ba-adf5-e610fb97a17a"
      unitRef="shares">1971922</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MWE5ZDc2ZTNiMWVhNDExMWEzZWMyNjIwMDFjNjkzMzEvdGFibGVyYW5nZToxYTlkNzZlM2IxZWE0MTExYTNlYzI2MjAwMWM2OTMzMV8xOC0zLTEtMS0yOTY2Ng_422975bc-837e-4a8e-b6d1-0c1aeae1e7ae"
      unitRef="usdPerShare">12.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl82NjA3_26875d50-e018-401e-bbc2-4fe4c6606512">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl82NjE0_751b51ad-8de6-449d-bae5-2fb933aa587a">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl82Njk4_e8956736-1794-47f7-bb12-ad76c2919384"
      unitRef="usd">6400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl82Nzcx_ac710145-5e86-4b7d-9408-2822847ac2ac">P2Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl84Nzk2MDkzMDMwMTYx_48488ab8-92e8-4cdb-a646-1448add9c3ce"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl84Nzk2MDkzMDMwMTYx_b6bf7722-8f32-4092-9126-cdfc5f1ed346"
      unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MzIz_a9c2447b-8847-44cb-9a79-c4dbc90a5d2e">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the number of RSUs outstanding for the year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.421%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;719,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;970,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(293,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(134,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,262,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iedd0ba546c49493ba7382642df9946c7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6NjM3YjlkMTY0M2E3NDJjNjljOGMxYWM4ODYwYzg4NzMvdGFibGVyYW5nZTo2MzdiOWQxNjQzYTc0MmM2OWM4YzFhYzg4NjBjODg3M18xMy0xLTEtMS0yOTY2Ng_ae87ae96-188e-4370-9f84-bb17988bfad6"
      unitRef="shares">719443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6NjM3YjlkMTY0M2E3NDJjNjljOGMxYWM4ODYwYzg4NzMvdGFibGVyYW5nZTo2MzdiOWQxNjQzYTc0MmM2OWM4YzFhYzg4NjBjODg3M18xNC0xLTEtMS0yOTY2Ng_c2ca1161-26f8-43c2-9183-c0b97cf1a5cd"
      unitRef="shares">970813</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6NjM3YjlkMTY0M2E3NDJjNjljOGMxYWM4ODYwYzg4NzMvdGFibGVyYW5nZTo2MzdiOWQxNjQzYTc0MmM2OWM4YzFhYzg4NjBjODg3M18xNS0xLTEtMS0yOTY2Ng_6060fa09-1ef4-41c6-b9e8-0294ac5373c6"
      unitRef="shares">293034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6NjM3YjlkMTY0M2E3NDJjNjljOGMxYWM4ODYwYzg4NzMvdGFibGVyYW5nZTo2MzdiOWQxNjQzYTc0MmM2OWM4YzFhYzg4NjBjODg3M18xNi0xLTEtMS0yOTY2Ng_73780001-4657-4e35-8003-8b3b5d479579"
      unitRef="shares">134822</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9309bf238b44411e899d0dcb4c8d3ef9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6NjM3YjlkMTY0M2E3NDJjNjljOGMxYWM4ODYwYzg4NzMvdGFibGVyYW5nZTo2MzdiOWQxNjQzYTc0MmM2OWM4YzFhYzg4NjBjODg3M18xOC0xLTEtMS0yOTY2Ng_c5495dba-aeb1-400c-8c85-01856b637cc6"
      unitRef="shares">1262400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i9309bf238b44411e899d0dcb4c8d3ef9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MTAx_e3966632-7d59-467e-be22-e9be77595a8c"
      unitRef="usd">5600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i23969f5a8552485eb663535fe65f545a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MTc0_eeadc303-5add-4b94-9208-53d85f406181">P2Y3M7D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGV4dHJlZ2lvbjpmZDAzNzMzNjc4Y2Q0YzlmOGMxNmQyMmFkNjM2NTE5Yl83MzI3_8c99ba4a-493e-49ec-aa88-dd9461f47a04">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the effect of share-based compensation on the statements of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i4f658b6e836f41c9b28abeb2f9bc238f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF8zLTEtMS0xLTI5NjY2_da8e645d-99cc-4a38-bfc6-2c0d94fab897"
      unitRef="usd">1714000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i50ff6dddfd3c429499a4b8c9b226e7d6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF8zLTMtMS0xLTI5NjY2_87ebb494-fd6d-4252-af41-12e93c717d0a"
      unitRef="usd">4746000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i71a86bb6a8854c5296b3511aacf7bb04_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF80LTEtMS0xLTI5NjY2_76338ea3-568c-4d04-bb9b-8bc0d5555ee3"
      unitRef="usd">6366000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic066d03c70d147b5b20e324f40a88075_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF80LTMtMS0xLTI5NjY2_b10042d1-66cd-4c13-bd34-edff561ce243"
      unitRef="usd">13354000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF81LTEtMS0xLTI5NjY2_ceb34c7a-b8a0-4579-81b1-def79fbac266"
      unitRef="usd">8080000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODE4L2ZyYWc6ZmQwMzczMzY3OGNkNGM5ZjhjMTZkMjJhZDYzNjUxOWIvdGFibGU6MzcyYTcxYmQ0ZTQ0NDI5Y2E4ZTVhMDU1YjBkNmE5MjAvdGFibGVyYW5nZTozNzJhNzFiZDRlNDQ0MjljYThlNWEwNTViMGQ2YTkyMF81LTMtMS0xLTI5NjY2_8b2bec86-43d7-4200-82ac-63c0c9637c1f"
      unitRef="usd">18100000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzIxOTkwMjMyNjIxNzU_14334a87-0db1-40e4-9925-fe8c3fcb6c8d">INCOME TAX: &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss before income taxes and the related tax expense (benefit) is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total loss before taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of income taxes at the U.S. federal statutory rate to the provision for income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal income tax provision at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income tax provision, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D Impairment &amp;amp; CSR Remeasurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IP Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax expense for the years ended December&#160;31, 2021 and 2020 differed from the amounts computed by applying the U.S. federal income tax rate of 21% to loss before tax expense as a result of nondeductible expenses, changes in state effective tax rates, foreign taxes,  tax credits generated, true up of net operating loss carryforwards, and increase in the Company&#x2019;s valuation allowance. The Company applies the elements of FASB ASC 740-10 regarding accounting for uncertainty in income taxes. This clarifies the accounting for uncertainty in income taxes recognized in financial statements and required impact of a tax position to be recognized in the financial statements if that position is more likely than not of being sustained by the taxing &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;authority. Included in Other Liabilities on the Consolidated Balance Sheets, are the total amount of unrecognized tax benefits of approximately $2.8&#160;million and $3.1 million as of December&#160;31, 2021 and 2020, respectively, net of the federal benefit, if recognized, would favorably affect the Company&#x2019;s future effective tax rate. The Company&#x2019;s policy is to recognize interest and penalties related to tax matters within the income tax provision. Tax years beginning in 2017 are generally subject to examination by taxing authorities, although net operating losses from all years are subject to examinations and adjustments for at least three years following the year in which the attributes are used. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant components of the Company's deferred tax assets and liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss carry forward&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;73,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;85,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;70,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less - valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(85,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(69,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realization of deferred tax assets is contingent upon sufficient future taxable income during the period that deductible temporary differences and carry forward losses are expected to be available to reduce taxable income. As the achievement of required future taxable income is not likely, the Company recorded a full valuation allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 and 2020, the Company recorded valuation allowance against its net deferred tax assets of approximately $85.6 million and $69.7 million, respectively. The change in the valuation allowance during the years ended December&#160;31, 2021 and 2020 was an increase of approximately $15.8 million and a decrease of approximately $1.3&#160;million, respectively. A valuation allowance has been recorded since, in the judgment of management, these assets are not more likely than not to be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods in which those temporary differences and carryforwards become deductible or are utilized. As of December&#160;31, 2021, the Company had federal and state pre-tax net operating loss carryforwards of approximately $315.0 million and $105.6 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, research and development credit carryforwards for federal and state purposes are approximately $6.7 million and $1.2 million, respectively. As a result of U.S. tax reform legislation, federal net operating losses generated beginning in 2018 and subsequent years carryforward indefinitely, however, the Company has federal net operating losses that pre-date U.S. tax reform legislation which begin to expire in 2031 and federal credit carryforwards that begin to expire in 2031. State net operating loss carryforwards begin to expire in 2031, and the state credit carryforwards began to expire in 2031. Sections 382 and 383 of the Internal Revenue Code of 1986 subject the future utilization of net operating losses and certain other tax attributes, such as research and development tax credits, to an annual limitation in the event of certain ownership changes, as defined. The Company may have undergone ownership changes and therefore may be materially limited in the amount of NOL and R&amp;amp;D tax credit available for utilization in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generated research and development tax credits but has not conducted a study to document the qualified activities. This study may result in an adjustment to the Company&#x2019;s research and development credit carryforwards; however, until a study is completed and any adjustment is known, a partial reserve has been presented as an uncertain tax position which &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is offset against the gross research and development deferred tax asset. A full valuation allowance has been provided against the Company&#x2019;s research and development credits and, if an adjustment is required, this would be offset by an adjustment to the deferred tax asset established for the research and development credit carryforwards and the valuation allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Uncertain tax positions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC No. 740, Income Taxes, requires significant judgment in determining what constitutes an individual tax position as well as assessing the outcome of each tax position. Changes in judgment as to recognition or measurement of tax positions can materially affect the estimate of the effective tax rate and consequently, affect the operating results of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity of the Company unrecognized tax benefits (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additions for prior year positions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additions for current year positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reductions related to expiration of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additions for prior year positions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additions for current year positions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reductions related to expiration of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Balance related to research and development tax credit positions acquired through the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company began liquidation proceedings of its Israeli subsidiary, VYNE Pharmaceuticals Ltd., to align with its business strategy. As a result thereof, the Company's intellectual property was assigned to the U.S. parent company and we recognized a $163.0 million taxable gain in 2020 for Israeli income tax purposes. However, the taxable gain was fully offset by net operating loss carryforwards, resulting in no income tax expense to the Company.  In addition, there was also no Israeli withholding tax due by the U.S. parent company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Corporate Restructuring is subject to complex tax and transfer pricing regulations administered by taxing authorities in the U.S. and Israel. The relevant taxing authorities may disagree with the Company&#x2019;s determinations as to the income and expenses attributable to specific jurisdictions. If such a disagreement were to occur, and the Company&#x2019;s position were not sustained, the Company could be required to pay additional taxes, interest and penalties, which could result in one-time tax charges, higher effective tax rates and reduced cash flows than otherwise would be expected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has tax assessments that are considered to be final through tax year 2015.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <vyne:ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzYwNDczMTM5NTkzOTI_fe787371-6142-41d1-b667-63b7ea376798">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss before income taxes and the related tax expense (benefit) is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total loss before taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</vyne:ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if82c661f8a794fdeb31d8f9e4a475fc6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzMtMS0xLTEtMTc2ODk_b74482c2-f8a5-444d-9705-eb68378b12cd"
      unitRef="usd">-69196000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i23a16cc6e5f846549e1725fbd52458c5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzMtMy0xLTEtMTc2ODk_d32703cb-9035-426f-b879-5e53056bbb30"
      unitRef="usd">-211447000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i910b930cd3714339a6b839e5f00372e1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzQtMS0xLTEtMTc2ODk_2d34c999-9da4-44a6-bd18-f4fc5089f165"
      unitRef="usd">-4581000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibc98456d2d1a44c78bb669199d845601_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzQtMy0xLTEtMTc2ODk_4095bb07-28fb-4619-926c-06ad5d4810f5"
      unitRef="usd">-44379000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzUtMS0xLTEtMTc2ODk_f92a8f38-928f-4dd2-8eef-c5f5a9de30af"
      unitRef="usd">-73777000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzUtMy0xLTEtMTc2ODk_6fa22733-4d88-4960-90d1-13d4f3f6ee77"
      unitRef="usd">-255826000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzgtMS0xLTEtMTc2ODk_e7137b30-86f0-4fa1-a6e0-e0f8b2f754ac"
      unitRef="usd">-456000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzgtMy0xLTEtMTc2ODk_ec0af24a-84cd-4b35-8a9b-f2aabea21d98"
      unitRef="usd">-258000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzktMS0xLTEtMTc2ODk_8fbf2b7a-1a57-420a-b5fa-5e89153e933e"
      unitRef="usd">8000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzktMy0xLTEtMTc2ODk_0319c85a-05bb-4a7c-aad5-ae24d602de1f"
      unitRef="usd">5000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzEwLTEtMS0xLTE3Njg5_c06d37b7-203f-402e-a570-c83b6b4887ef"
      unitRef="usd">-448000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo4YWIxYjA3YmM3OGU0MTUyOWFmMjAxODI2YTZhYzM0NS90YWJsZXJhbmdlOjhhYjFiMDdiYzc4ZTQxNTI5YWYyMDE4MjZhNmFjMzQ1XzEwLTMtMS0xLTE3Njg5_b846778d-6449-45d1-be3c-fab017786fe9"
      unitRef="usd">-253000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzYwNDczMTM5NTkzOTM_1aa77a8f-78fa-4e28-9be5-09a6c529854b">&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of income taxes at the U.S. federal statutory rate to the provision for income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.265%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal income tax provision at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income tax provision, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D Impairment &amp;amp; CSR Remeasurement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IP Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzItMi0xLTEtMTc2ODk_62bed4a7-99ce-4d6c-99b8-62c50319fa8f"
      unitRef="number">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzItNC0xLTEtMTc2ODk_0ec0305e-71a5-40c9-b58e-558a83c9b48f"
      unitRef="number">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzMtMi0xLTEtMTc2ODk_dc730c01-2497-4c01-bb3a-703efcaff373"
      unitRef="number">-0.0001</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzMtNC0xLTEtMTc2ODk_5b0ab92d-6ef9-449c-9300-ec2d4d3de7a9"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzQtMi0xLTEtMTc2ODk_60c33879-9940-4e18-ae67-d7de61ddb895"
      unitRef="number">0</vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent>
    <vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzQtNC0xLTEtMTc2ODk_b2f424a7-70a9-4c10-9178-069b04adcbfb"
      unitRef="number">-0.1142</vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent>
    <vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzUtMi0xLTEtMTc2ODk_dd0143ee-2d15-466f-a172-de8f4f14565f"
      unitRef="number">0</vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent>
    <vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzUtNC0xLTEtMTc2ODk_3f8c1bb4-9313-42d3-9daa-b32af87539f3"
      unitRef="number">-0.0107</vyne:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent>
    <vyne:EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzYtMi0xLTEtMTc2ODk_b340203f-2f89-4f77-bf42-c99dde36ccd6"
      unitRef="number">0</vyne:EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent>
    <vyne:EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzYtNC0xLTEtMTc2ODk_151602db-7586-480b-af1a-969fecfbfa36"
      unitRef="number">-0.1465</vyne:EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzctMi0xLTEtMTc2ODk_db6679b9-0bdd-43af-92dc-1a9cf3d3dcc7"
      unitRef="number">-0.2027</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzctNC0xLTEtMTc2ODk_d98bfdea-8982-4d69-b148-99ed66a918f4"
      unitRef="number">0.0616</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzgtMi0xLTEtMTc2ODk_55844611-cd62-49e0-abb3-caa99c600c7e"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzgtNC0xLTEtMTc2ODk_8dcc7ec7-52fe-4282-8178-b7528c0c086d"
      unitRef="number">0.0035</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzktMi0xLTEtMTc2ODk_b8a092c7-3c4f-4f0f-b3ff-30b4495b6cd8"
      unitRef="number">-0.0011</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzktNC0xLTEtMTc2ODk_ddb21e7e-649a-40b3-abcd-a67ebccfe892"
      unitRef="number">-0.0027</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzEwLTItMS0xLTE3Njg5_eeb50e7b-8643-46a3-85e3-2a42d82fb20a"
      unitRef="number">0.0061</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTpmM2EwZjA4MTViNTU0ODZlYmJkMGMxNjc0MDQ1NGZhMS90YWJsZXJhbmdlOmYzYTBmMDgxNWI1NTQ4NmViYmQwYzE2NzQwNDU0ZmExXzEwLTQtMS0xLTE3Njg5_e61e08a0-7bca-4628-9d34-79661e11efa4"
      unitRef="number">0.0010</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzEwOTk1MTE2MzQ0MzQ_5cb1585e-49af-4eb5-95a2-ec23f285284c"
      unitRef="usd">2800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzExMjA_f12655c8-6b19-4d2f-8e43-846ea05a7534"
      unitRef="usd">3100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzYwNDczMTM5NTkzOTQ_d7467d1e-97db-4166-9406-c0e186499656">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant components of the Company's deferred tax assets and liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss carry forward&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;73,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;85,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;70,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less - valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(85,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(69,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzMtMS0xLTEtMTc2ODk_005ffd1f-68ac-4ebf-bb8a-7a514f37e9b7"
      unitRef="usd">73259000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzMtMy0xLTEtMTc2ODk_0675e948-2ffc-46d7-aa29-3f937ae190fd"
      unitRef="usd">55514000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzQtMS0xLTEtMTc2ODk_980da19e-5392-4d9c-90c8-715fd376f515"
      unitRef="usd">7905000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzQtMy0xLTEtMTc2ODk_9fc9b79b-b28c-486e-9a34-060b2951bf96"
      unitRef="usd">7387000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzUtMS0xLTEtMTc2ODk_77e869cf-f152-453d-a46d-afce19fcdc2d"
      unitRef="usd">3281000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzUtMy0xLTEtMTc2ODk_b9ae5045-953b-4339-b510-4e7cd7edd2c3"
      unitRef="usd">4903000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzYtMS0xLTEtMTc2ODk_acb0693a-76a7-4c6f-9671-2efadd537e86"
      unitRef="usd">1226000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzYtMy0xLTEtMTc2ODk_9f6d2904-add2-47b9-a977-b6eeb55db67b"
      unitRef="usd">2325000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzctMS0xLTEtMTc2ODk_27f20a81-a7c4-4a29-9e2e-407e004efe8b"
      unitRef="usd">85671000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzctMy0xLTEtMTc2ODk_685a2d8a-b1c1-4672-9d7c-a13b437e777d"
      unitRef="usd">70129000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzgtMS0xLTEtMTc2ODk_f5206dd8-1ff3-4932-bb9f-872690279ea5"
      unitRef="usd">85555000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzgtMy0xLTEtMTc2ODk_ecdc5f59-5d08-42ca-b7d7-822ce69b5bd7"
      unitRef="usd">69743000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzExLTEtMS0xLTE3Njg5_85018529-4f2b-4e29-8c36-f1f9fbf50373"
      unitRef="usd">40000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzExLTMtMS0xLTE3Njg5_74081ae5-908f-411c-b53f-8628f2ce2a8d"
      unitRef="usd">41000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzEyLTEtMS0xLTE3Njg5_64c4328e-d6b6-4e5d-861f-8a158998e0c2"
      unitRef="usd">76000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzEyLTMtMS0xLTE3Njg5_34230e74-0438-4b12-80c1-d804da33e055"
      unitRef="usd">345000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzEzLTEtMS0xLTE3Njg5_c42efe2a-4314-47c4-a595-a164ffe73ac8"
      unitRef="usd">116000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzEzLTMtMS0xLTE3Njg5_ee76e6fe-6120-4d03-8e38-eab981c50311"
      unitRef="usd">386000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzE0LTEtMS0xLTE3Njg5_44286dd2-757f-4c5d-8386-7c91df502092"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZTo5ZTA0Y2M3ZmQwZWI0MzI4YjQzYjY0MTZjOTcxMWZlYS90YWJsZXJhbmdlOjllMDRjYzdmZDBlYjQzMjhiNDNiNjQxNmM5NzExZmVhXzE0LTMtMS0xLTE3Njg5_509666da-d9a8-4bd3-b9ae-09a8479af0f4"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzIyOTk_c87077b1-982a-493a-bba4-4d9b6ed462e0"
      unitRef="usd">85600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzIzMDY_11986982-9f10-4202-833c-b7118e805a7b"
      unitRef="usd">69700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzI0NDM_8704677b-b5af-4197-9bca-e371662339d9"
      unitRef="usd">15800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzEwOTk1MTE2MzQ3Mzg_3381a7df-693a-4197-8321-8962571b64e5"
      unitRef="usd">-1300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i6d4bddd1b58c43bc9015bf6630359989_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzI5NDY_039429ac-f537-423b-a8ba-00f5092cc6cd"
      unitRef="usd">315000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i5fc0c8d37b2d4747aeb77bdce809b14b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzI5NTM_eedeaecc-1bb2-4e68-86c5-b345b3441576"
      unitRef="usd">105600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i6d4bddd1b58c43bc9015bf6630359989_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzMwNzc_fd5e7576-9a93-4e84-a8f6-622f1a007da2"
      unitRef="usd">6700000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i5fc0c8d37b2d4747aeb77bdce809b14b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzMwODQ_66a067f8-867e-4688-b098-f4b2dd554afb"
      unitRef="usd">1200000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzYwNDczMTM5NTkzOTU_80ce4a03-0cfd-48da-9d7c-acc2d2c8fd6a">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity of the Company unrecognized tax benefits (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additions for prior year positions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additions for current year positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reductions related to expiration of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additions for prior year positions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additions for current year positions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reductions related to expiration of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Balance related to research and development tax credit positions acquired through the Merger.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i413ad6395c874b3ea0fb49e390a331d2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzAtMS0xLTEtMTc2ODk_8a0da086-a5f4-476d-99f1-e99bf109ddb4"
      unitRef="usd">714000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzEtMS0xLTEtMTc2ODk_80015fcf-6677-407b-a138-b40c67483b6b"
      unitRef="usd">2354000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzItMS0xLTEtMjEwNDg_e868bdb7-f68c-4944-af24-4d55dd730694"
      unitRef="usd">273000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzMtMS0xLTEtMjEwNTU_89a74c4f-cc9a-469c-864a-872ef28da8f3"
      unitRef="usd">258000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i415666db8d7a40719c40bd0b1f9fa2de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzItMS0xLTEtMTc2ODk_2a19bdb5-bbf2-4f40-80b5-96c75d925c1f"
      unitRef="usd">3083000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzMtMS0xLTEtMTc2ODk_0316008b-22e1-4283-81b7-192da0b7151a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzQtMS0xLTEtMTc2ODk_416c364f-83f0-4d49-bc63-42d3f4ae2da2"
      unitRef="usd">172000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzUtMS0xLTEtMTc2ODk_8c826c5a-a8c7-4347-b091-4538ce19f77d"
      unitRef="usd">456000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90YWJsZToyZGE0ZWE5MDEyNWU0Y2U2YjNkODg1NGE4OWVhNjkyZi90YWJsZXJhbmdlOjJkYTRlYTkwMTI1ZTRjZTZiM2Q4ODU0YTg5ZWE2OTJmXzYtMS0xLTEtMTc2ODk_ab77dcc5-dfc2-4365-bc9d-eb0c489874db"
      unitRef="usd">2799000</us-gaap:UnrecognizedTaxBenefits>
    <vyne:LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain
      contextRef="icef12beb3e494c14b255e4114f030a13_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xNjkvZnJhZzo2YTU5MWEzMzhlNGY0NjRmYWFiYzYzZjJjYThkODAyNi90ZXh0cmVnaW9uOjZhNTkxYTMzOGU0ZjQ2NGZhYWJjNjNmMmNhOGQ4MDI2XzU2MDE_0e1b8fdb-81f3-4273-ade6-56155082620b"
      unitRef="usd">163000000</vyne:LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i5c93a1c774774356afee639d2e955920_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF84Nzk2MDkzMDIzNjc5_db5533f0-27e4-43da-bccf-98590b031565">SUBSEQUENT EVENTS&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Sale of Minocycline Franchise &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As discussed in Note 1, On January 12, 2022, VYNE entered into a Purchase Agreement with Journey  to sell its MST Franchise for $25.0&#160;million of cash consideration which comprises an upfront payment of $20.0&#160;million and an additional $5.0&#160;million on the one-year anniversary of the closing of the transaction. VYNE is also eligible to receive sales milestone payments of up to $450.0&#160;million in the aggregate upon the achievement of specified levels of net sales on a product-by-product basis, beginning with annual net sales exceeding $100.0 million (with products covered in three categories (1) AMZEEQ (and certain modifications), (2) ZILXI (and certain modifications), and (3) FCD105 and other products covered by the patents being transferred, including certain modifications). In addition, VYNE is entitled to receive certain payments from any licensing or sublicensing of the assets by Journey outside of the United States.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company anticipates recording an estimated gain from the sale of the MST Franchise in the first quarter of 2022 ranging from $13.5&#160;million to  $14.5&#160;million.  The Company does not anticipate paying any federal or state income taxes based upon the utilization of net operating losses.  The estimated gain is based on net proceeds ranging from $21.3&#160;million to  $22.3&#160;million  including estimated transaction costs ranging from $2.7&#160;million to $3.7&#160;million. Under the Purchase Agreement, the Company is obligated to indemnify Journey against certain potential liabilities and for breaches of representations, warranties and covenants under the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Agreement, Journey assumed certain liabilities of the MST Franchise including, among others, those arising from VYNE&#x2019;s patent infringement suit initiated against Padagis Israel Pharmaceuticals Ltd (see Note 12). There were no current or long-term liabilities recorded by the Company which were transferred to the Buyer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Agreement includes customary representations and warranties, as well as indemnification rights for breaches of representations, warranties, and covenants, as well as certain other matters, subject to customary deductibles, caps, and other limitations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The criteria for reporting the MST Franchise as held for sale was met after the balance sheet date, and therefore, the assets of the MST Franchise were classified as held and used as of December&#160;31, 2021.  The total carrying amounts of the MST assets a were disposed were approximately $7.8&#160;million, as of December&#160;31, 2021.  These assets consist primarily of inventory of  $7.3&#160;million. No liabilities were transferred. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financing Activities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since December 31, 2021, the Company has sold an aggregate of 2,465,500 shares pursuant to the Sales Agreement for gross proceeds of $1.5&#160;million. &lt;/span&gt;&lt;/div&gt;In addition, on March 15, 2022, the Company entered into a purchase agreement (the "Equity Purchase Agreement"), with Lincoln Park Capital Fund, LLC ("Lincoln Park") which provides that, upon the terms and subject to the conditions and limitations set forth therein, the Company may sell to Lincoln Park, at the Company's discretion, up to $30.0&#160;million of shares of its common stock over the 36-month term of the Equity Purchase Agreement. Upon execution of the Equity Purchase Agreement, the Company issued 1,667,593 shares of its common stock to Lincoln Park as commitment shares in accordance with the closing conditions contained within the Equity Purchase Agreement.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI3OTM5_17af6d90-a247-43a0-bfa7-09db6b9e99d8"
      unitRef="usd">25000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount
      contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI4MDEw_9dcc8788-e8ab-4b27-a4d2-5b6c65656cc4"
      unitRef="usd">20000000</vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount>
    <vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable
      contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI4MDQ1_e814d8a0-ff07-4dc7-80bc-48a204b5e041"
      unitRef="usd">5000000</vyne:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable>
    <vyne:DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales
      contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI4MTgw_c918adb4-8cf9-435d-ba6b-cf25dc3aa0b0"
      unitRef="usd">450000000</vyne:DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales>
    <vyne:MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales
      contextRef="i578e194612ba430c8bfcb9cdff0fec2c_D20220112-20220112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI4MzI4_2ff7e952-568b-4145-9944-51eaa594fd67"
      unitRef="usd">100000000</vyne:MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ibcb524dbad1a4c1982574e2fe8ad19da_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTI4_f68645a9-e3cb-430f-ac97-a8ef4c293d7d"
      unitRef="usd">13500000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i74d4ee98eed24dd08f8c5f7e4d4cbd41_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTM3_ae83bb06-49fe-46a4-ad71-3809f5af5b08"
      unitRef="usd">14500000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ib3d169fae4d94cbd8c3022cba3a08fdf_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTUy_dd0b79dc-f787-4ad4-b38d-e866a8bf5893"
      unitRef="usd">21300000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="iff8c8e02a0374a409dd8fd2818c71588_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTYx_bb987394-cb59-4213-9cde-2f9569f056e3"
      unitRef="usd">22300000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="ie156775f95034bcb81ccb6f76520718e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTcw_00fee7b2-dd1d-4e1d-8924-a87ec1da452e"
      unitRef="usd">2700000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="ie287f45e91a4400282fc74f2a820b92e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjMxNTgw_a30cf224-7d3e-41cb-be9a-4f91df5f5de3"
      unitRef="usd">3700000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="id7f1ccafb608431fb6c6c1da15102473_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI5MDU0_e68199ab-2bec-4f95-886b-697024d110f0"
      unitRef="usd">7800000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8xMDk5NTExNjI5Njcx_75168722-0e57-4a28-bdb6-35c94cb68949"
      unitRef="usd">7300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1c9c93e29bcc45a88d591badcbcb18e7_I20220112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjU3ODg3_7fd09518-5ff7-4eb9-a501-7b734ad6f3d2"
      unitRef="usd">0</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i3a90103da5ca44acb0b6ef28d135f8d8_D20220101-20220316"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjYwNDgw_71ecb0dd-65ef-4e0d-9446-f2ece4da8eb8"
      unitRef="shares">2465500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i3a90103da5ca44acb0b6ef28d135f8d8_D20220101-20220316"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjYwNDkx_a6b12688-ba28-45e3-b663-6fb99d1b6ddc"
      unitRef="usd">1500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <vyne:SaleOfStockConsiderationReceivableOnTransaction
      contextRef="i99e857b122b54103af3bf50d59fa8745_I20220315"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjYwNTA1_c4fc82b9-d863-4382-a276-21ad0b53adde"
      unitRef="usd">30000000</vyne:SaleOfStockConsiderationReceivableOnTransaction>
    <vyne:EquityPurchaseAgreementPeriodInForce
      contextRef="i8601e3d553e140d586df45d81ee2c321_D20220315-20220315"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjYwNTIw_bf8c4e2a-e805-47d2-90fd-c9c2a79c8d2d">P36M</vyne:EquityPurchaseAgreementPeriodInForce>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i8601e3d553e140d586df45d81ee2c321_D20220315-20220315"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNlZTJmMzU5MDc1NTQ1NmQ4ODg3ODI3ZGI1ZWUxMWM0L3NlYzozZWUyZjM1OTA3NTU0NTZkODg4NzgyN2RiNWVlMTFjNF8xODcxL2ZyYWc6ZGU3ODRhNzMxNTRkNDg5ZTgyYmE5MjM3ZDIxMjdjODgvdGV4dHJlZ2lvbjpkZTc4NGE3MzE1NGQ0ODllODJiYTkyMzdkMjEyN2M4OF8yMTk5MDIzMjYwNTI4_ea182c59-326b-4bc6-83dc-3ee13bf92f84"
      unitRef="shares">1667593</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>130
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MR79W;Z?3($&6:IGL@X$@B<3ND[WN$W$4X-$3 70?0-\%N*>>X.T#O+H!G7U
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MK<JNWFX_8<T5%E20E.+QCKQ\[3$UZTS-;C*U9BC(9G7)4S\@&C]<LA&>E8$
M//ABUR13E31-172SW7NR:,KH7WCS&#U3/#"I"8>]E0X']_:0L"GP9F!4Z8MJ
MIXPM4=\M[)L(Z +L^EXI<QJX#;I7-OD 4$L#!!0    ( $R!<53KEK8IT 8
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M"Z:;?6D,].]SH86YN3$OO[8O.R_^ 5!+ P04    " !,@7%4*YJS3^$"  #
M"0  &    'AL+W=O<FMS:&5E=',O<VAE970T+GAM;*5676_:,!3]*U:TAU;J
MR!<AM()(-%"U4M>BTFT/TQY,8HA5Q\YL![K]^ME.FD'Y[G@@OO8]]YYS<QV[
MMV3\160(2?":$RKZ5B9E<67;(LE0#D6+%8BJE1GC.93*Y'-;%!S!U(!R8GN.
MT[%SB*D5]<S<F$<]5DJ"*1IS(,H\A_SW-2)LV;=<ZVWB"<\SJ2?LJ%? .9H@
M^;48<V793904YX@*S"C@:-:W!NY5[#H:8#R^8;04*V.@I4P9>]'&7=JW',T(
M$91('0*JQP+%B! =2?'X50>UFIP:N#I^BWYCQ"LQ4RA0S,AWG,JL;W4MD*(9
M+(E\8LM;5 L*=+R$$6'^P;+R#4(+)*60+*_!BD&.:?6$KW4A5@!N>P? JP'>
ML0"_!OA&:,7,R!I"":,>9TO M;>*I@>F-@:MU&"J7^-$<K6*%4Y&\>/#Y/'^
M;CAX'@W!]>!^\!"/P.1V-'J>@+,QY(C*#$F<0'(./H-/P 8B4[.B9TN57<>P
MDSK3=97)VY%IB)(6\-T+X#F>NP4>'P]WUN&VTMP(]QKAGHGG[X@WD5 BU8\2
ML!FXP132!$,"QDQ@TU\_!E,AN>JRGWN2^4TRWR1K[T@V5KV).$<I4"\T>;D
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M2MD#767J5CQ=LEI013 1F:S^14\UUNFA9"65R.M@8)#S8OU)G^M"[ 1@MR6
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MA--[GD'/LHX.CLDO;K;VR2'4OHR=Z0AWRKB"XU"9$ A(=L:-=ZB J1]N\A=
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M(BZ[.59Q1:;/7/<0J.4_$N8_8Y(G D!J6\OV=HM*7M_RV@O6I3,'K"M"%_-
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MCZ2C_Z%6EM-IN._MBL0J=Q3S(G8[UYB0Q+.MXY%,TF<!=HC8U@8T7!O\>$$
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M9[?MPND_6FK#U9T_&><D>HY,"GFX"S&7^^$3X ;C5??%3A2GAD,(J*2HV]4
MC8LX8F::?@%@V'L K@)BH\N" K'N)NDK3J<\O"]&CMNGN+G13,("K-I#@\R*
M1%9"IO:!K0>$4EM(T>?_7:V Z$KG'MO&#--#L3L8+U7<5PH> "G(^KFZR_J5
MH"'0R7(ACO.,TE4-)!A2BJ6I'?T8V"@.7.[JX=5L<387 [;+,?X'>G*]A74V
M;;'CRK=Y8Q=0?B9A0PCS;80P*5=AX+:5 LC25%1\UV<O\4"8_E(C0C('2Y0F
MI:>IF4@$P$ZU 4<RL,3SL=LZYLY^>>"E\FHW,"R<<M&N6C A(*_90V2KU.]Z
MIW5=G5\R&@50P-I%K$#!O@.JDI#!A',52QE@WFUNFU+\28CP8:L^Q,>])7UW
M6U.-89J)63)$F$9"Q"5!I^ZB\6V^MK;D%[^:)9"85W87XB&U.UI&( U''*^2
M(?.WT";+:KJLO/H$'HS?2Y8 OE[Z;TY/7ER]9U$NEF8>M03!@>([P2+Y);4&
MZ-$%CB^S9]-4'"&+.<##5T$10LQ]*\G: [!X_\M'L&UD_@H2#^7 1",8F\K6
M297$[\G*P$*<</\5W%!9W-.7UBS%.^^R?=5AU#D/<7!)\JZ/EMH2[1 1/U!Z
MBR4Q%GHJ?9^Q92(.3\)&YZ&B3*2XHX!2$,/+(GCOJJN,C?@#D57MD\X@)#ZT
M;C<J2LM;SU>?EQ;4T4/M7CS"WXC$.P;WK!LE_(Q 74IIQO7Q3 G@6=>V7:TS
M)'F-V?(# P/I,E9@T1@FH8C[[)3:XN5#7!UR:>BPM\K0,SR9)0 E5V[=04,0
M$)6I@U&AR-8[N .UI58\F4Z>IY@, JATXGR$N;X\%K#K 7\/X>W!DL/0)XF0
M#R3JHQ[<QAV]SH.H\&C@#KZ0N;BD25(6D3)! *BAA %382P4";*\$\1?="E^
MQ),!KGZ8W$X22#M[/OFZ9Y]H-D3(\! 0UF/%79]QE(-X#*'!1$7_(+#:E[9-
M%-VR*Z[X2F7L\H$@!9"CBJ3TW17O:PO]1_K_@9SL]@\ZT2O^_F%#&Y,TPYD5
MT?9A+COP?]SG0 'ZW#66,+K\B3LO6 W\HS4A<X(B= H M3]_0.V]D1P_T._;
MY><#]4I2DF>I_+! A;3F_UO];/V [AW5L??'*@PA6>/)# ^B#T8<96UWJB0
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MCFO0^NI1$PG2 0PYR24#G^@J7.$#=EBE!533PE[#DF7*'0/]O%BW=S!Y1[.
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M45DP#1N@EM$O#4</W)&=9&FVY"LP<"";*CN&3 7ZV2>@3"-4-V$+[XD7N"\
M.D!<-J;[;,53ZZS!<N?K<3Z@%51B1?]@Z C$(A2'=WA ( %V%2)FB'3(O/-[
M:IH0^EG/.KK 'P:.7)NV.8ZF-4K@C(0HBQ%)K'D\,1&=\Y]U$""*/!F']VP
M\!EO-AAD(\ABY0@V6'DU+_Z"XB"[3%%6(NX,;4EV60B!68.,)0J-/%:3IAL2
MN)\+-L:+M'+8:#3G0*>&KBU"'%J>+=<-X&OKGQ6427CZ',P?QZDC 8,-PBQ>
ML'"2'XAFTZA) =1KS4:U!>#FNEC"?"#I.L4OO(T/3:$[C<+!=H(E.@6C)"7R
M8!\M+!I3!/&D;A702/ =6( \-)U)0M-\WR.!+\DE/<(!-.2H"&((>(8&5C\
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MXG G4-01.=(SVQ;[.JBY(BU=Y_;%K"CWO,0 KM(J ,J%GZ7![L(@6%CT#*X
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M]%?,_8M)7OKM\T;2L7SS?M>8AK2/%*2"G2<P3.D"KM>%:L\LJ4QA^^^".]D
M@P"IL 8(G# MAF82/Z;RZ<*4G^&7&$R"3QBZO"<8QFM0"+RZG% ;VYO$[[0J
MX9/C@5I<(@M)P#)4L[/3&!_7-J\1A_G@4WC9^;64-V_!E=%H.?K37G<=735[
M4!\.NS!0RT_:V#63ODHI9B<=ZCV,4E%ZI@(S!J]1BSX=7H\'JX.%V[@OO(8=
MM#-J/?6/T*_A;#R!&PM[I*+);F.B&%.JR6%W.I."Y6#N6,L;,"G5-J6UA-4U
MDR&W NS/ADXZN)U$\+2#\_L]'%<:I$8PNA=#VU[IG%/-4E*/K\BP^149URB#
MV:43P/G[62)EPC]3_6WP?621&':N+W#PX))TX\)B-<FSX.CNEM'F2Q,,7R0!
MAIYN$1B-C?I!LW*U ;L0!$)2+\(%_79Z^CPD##[$H%B Y61; H8KQ17(75V<
MG<\F&BLP#8MG+ZJPP9:J=G(T 9%P23#0K#IKQ4-3<J)WA@ME TI[TY;W)65:
M%+5I63QOJIVA#U5C.J,R&L5D]>!1*KB&!KSYF6K67?$2 )B9@^6LDA)D+#,H
M43,AB"1(N1Z'U45@48FAYU3'+55"JL2$8R2L;H@\ I\83%80+/O\9CXK7K]\
M=7IRJ9]E2T"Z.\>]N2DR(8+] &'QO1;AV+()R57D)Q ?N8Z\CF=$8J_IX$=]
MNZ&4#PP9MJ 9C1S+4\ %J_[=Z<G\1!MBY'H0X=B=F0AN30@#]T5=NC\=)>%Y
MA] G\/G(R625(D(Q"Z&0K40K1>#U&)7U"9D8=P@$[2("DK_:@#?#!QAL2A^]
MMMHO (HL71\GEH?E!"N$0ZUWZ>)^N?E8O(9)R[7S"99*R9I4FMAA0 O&'"5M
M;KA,0#B@'1-H8W4<-@T'8A2.I\S!='_2O.CF^8GVM!N=\>/>/Z?PF0)D?CZ<
MA3,]@Y+T0A!,Z0YEZ**9'%?@B)^->*+-ST'(>P2_"%>R#UAO*$(&CT,G4V99
M%2%+.L>S-"#Y$'7"(.9+UML1<O8B"GALTRR2%]&;#IMP+"+>!D!_D+*C15]S
M56M\ ;BHE3YHO9AGDAD/W0I &6!J62"2XT'.5U8%GI:2/L2PC+N=T_P]QR7I
MV?O[D,6/5G;_4WA2629U8;J]1_KSW&R6?6=?;:F#*@TE8]4R7JM!^@O3+*A[
M8N_]7J&=1=I9TW4+# 1IM0U?M80#=N$P86WPD/)5P7D *@>$KK.\\+07%Y'.
MU>ZS)5MN&H(R(6JN\KU*6]/"<1FG1WA12BP)&EN%>?$S&/'I,J]>1)-:50SV
MY1*JBD 43#:ULO%=49CD2 D-O;GQ:*F>TZ3#$HD(I$Y'FO!AYOZNY1ROEE4*
M%P-@W=IX0T(X!DI#JL65<(!K6S2:\WQ=$R=M&!@D+Y )3.L&BWB A?IBQ3V%
MWE>+G.(V@XGR_\,;&R;5U(4''&=& D]G[=%R<9^$E.$=!<C6\V$!CRK&^^CQ
M''B5KE4OT=A9JG1BU-0'VV<%&Y2"#3M<+.44ER>_YV6X=<N@DT_!!/FCY)GB
M:2"B[VMQ.[T4P\'?2TD3=T2;U1.O>$=7>MKJ6,]IQA0JPA1X$"*D\C/ QAZ;
MH<GF)S?A"1X.-7#%!)U'K88E=IH&1&2B_ T6D07E*Z8,7GYA5ZYIM/>5JE%,
M@JBY3$IE; GPV:1.G%SY^L5+0PCUW,@5 K8X3"XPD0^[HT<8)35,%S,3Z7%4
MUV;1LI@765($)_\P\U+FJ%G4WOC(R3L148F^?@-/)..]RQ>[AR]A4DY/UYG(
MSFBS2FEWJ ?J.7&/;&ECDX,+">,KQ\95N*X[7^S?>23!/[R=\^(5TQ6GC0JW
MV\S_%9,2:PWO2?99>FPVI8F@-7$'' YV%>YY1Z%@^JYLY#86F$*?,&MSEG2,
M'<%X9P@8MWM9J-3J1Y1\S$JTV52S]#@M_V5HT)5IH\6'FT^A_C*+1/$AOI@1
MEBV2$C)W-B=]RZ&E@V;XBI8.2G%2%%K9*FW-S:QFM7_+%[8T ]=@\,@$WWDZ
M3B?#4MRQ\FDDIN'$%8Q_R&-BVNKH6?$_F'+>:2GGU"QE--^E&TMO!FXC.SF'
MQ@QC'N'2B\O9^<G3V?GE67$Q^^Z[B]GY^7GQ%^7WQ7>7L].GE^'?85Z\WCF#
M1!8I^7CW[ID'[BP*/*8SEW(_FMZ5D[_S&ZXR2G-X"E6G3KL(($@74M%I_6L9
MBVO0V(_O)=T''AZ[Z?26'[PU)E"P>SY+4I0X26B,C 8>\5;RSMJ!40 9E>.I
M=/+5]52?3:X'X<LW=N\+P:L:4MR1W9)%MAY=U@(P724'<F>)DE?6EQ 2<B 3
MCF3*E3'/1E?$' Z-IMR.)FZ:"95L0U>M\L&O:4YSU\KT]3YD/Z:XLZ)37SB<
M7AXEK*(4:'[-S5Q^/WM6O(LL&U\9$^15>(EP46Z7:7<ONZ%VR/Q&F.P6&+J.
M+WE%/EV&.W >O[]'R3Z?O!I&;^9@BPMO])R:;]IL1LR9*&#^*G;B*?-);IX'
M;EXW&2Y/KQ)(PQDP;7S>/<8P\?:J0IJDOP [_LX 62[]FE@J1ALPU_C)*0W(
MX[S01*KQ/M]"P<<L.S0#]UJ6I.O"'+=;Y:W&Z3FW6VK9QZI*O- R&< 7KY,+
M0?!BJ>22V]"@"\8I9/O3?@S*_.\=6TU/=CN1W" Q>05'YF#QC[/TBHCT;HBF
MFBKTC,JQX7:-O1-R8"K7=W2C&TR0':X? LK@VU'D#EAN^*U=>3_C+@Z?U"%\
MP@C[9<N7@&.:&SN:^):CR6E&-_7B-2/3ZZ=3-T +4E[(^1'47RQUQFNI8>2A
M&[6C\(W0;9^<JZL*OLI->I/SPWN,Y7UR<0O!6NT#6&#;/9[!T8L06K'G:;$F
M%8E6QTN$+3\.O.\ 6J:J?_#B&30>C2T3TJC%%UYW-@*3B]/?IXT:6O[$]5Q^
M^_L]M<.OHNUD3)M2Q31^!6W?/=U+VW<G^VF[(^0,PZSQJSANI?5\XB.M E+;
MMTH8[I.BP5EZG0KF"5"D=JY520_R'H,3/";\0X>]1MI)MR+)]>:)60$20##T
MF& X-%Y V AQQ6$X#RD=!IS"PH0^M_25./$19IC'Q[-"58LC**2<G%/+7343
M5(^NFOD7WACS!:/".SSO(Z<6N1>:TX*F:G>_FZ'EZAC3_PR7A\,F7X;QL\*P
M:QKR&1J*7RB_&\4O&O+D1>UE\<6+%EM:#K$]^$@IFWSPTY8PSMMV3H,?7\R*
M@P]6DJC%!_S;!TO?YW#(;8;?7GP+2/^U*1$&9%F:GRB4H!V8'@$>C61_T$3L
M07%X=?-)9C]2P">)1A\Q*9I44*A;I\FYQ0#PMRGR"\PY2:>STWGRCF<'!&0T
MTM.$(-K%RH5R/+;[A.\O("&DTXY?_64;:;?IC,2<,V$<E_FUV]*M#UH;R \B
MZ&W]B_OI!<SE^S'"B5_J_E3&,;5)D9WZ-=,)M-U:1GYS_>+=!_(C32N=%=FD
MHR-5U""@S?,5WVR_A\RK2GK?8]_6'I)#_*>M05UZU)/B+I;[TS,VO<6^UI^S
MG<N"D]R\ +R=IH>$E%8:V1^[WDQO8H-Q1_=4J)-DOC$^&#&";_"7=C/\<@<^
M=C"Z/3PI=CU&"]B%/PZ-Q2XEZ?VE\P!?K>^G3X]/SV?:%1!U\SHQXL?%2_;H
M;]@KB!DX/WL*9N"7)%:"1>9/9NJ>#*F]!:+V1,31^-IACEP;9[-$=0Y7VN4(
M6<D$:>DOM@?NNM29Q #<I1?O/[T/NL)'$X(JY-.SI0_DCKX9P7 <BXJE9\;"
M.38K9T>W: (E/(BW9U \3R8KF2_[7I9X/;5>I:^GPX-4R]:.9<)CVANU35#!
MM/\0*6&#AD70)7T-!^?MF4@URS.UU$4#,+6].^;.]/R2(KW+ -N@X\3)=^;H
M:& \J*%T@Y8^N6Y;I&&D<WSY!BI9NNC$@F@+'MN(<[)VO32>XA>4,-A@. N!
M*5X?0SF;O?/_VZE_L(/8J/@/F8#OCM&X'DB9]R.!,-'Q;RY.0,=O<.=! M1^
M7N7.-GUQ=J"=2B0TX9 TCT"Q3+BN?:M8892,IT-/2<V9#7O@&P8>T4/ LWR/
M1:RX\!W9@2^GEPK:.3&+O-Z$1.:CK^'L+@$AF#S=I$XJ2;=S*?%7D#@)&?D&
MEH^/B8)><?2P/,1XXW')F/KJM"?)5]-1B06_@$]R#?PM=>'30K_C[XJ_VBX^
MSE\0"#YYA;%";9?PZLG\F\L#;CG17_IV2U]TMVA[,+[TX]JB+<0'+K&9I.WU
M%YP@?//AC_\/4$L#!!0    ( $R!<51<"3-_8!(  (<^   9    >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;.U;:W/;.);]*RBO9]:>DF53DF,[KRK'<68\
ME8?+=GIK:FL_0"0DH4,1:H*TX_GU>^X%0((2Y233,[O5N_TEL4C@XN(^SGT
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MK*@,%2@B7=;O"\FUC 92J4L&#TH,I<L34D B+]D%SMTD&9Z@ ,]S3N(?%AK
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M(>BXXE.BJ:$TL _;IS] A=JI?!UNDQ)K92_]!C&NY -!4S;/FE8D]][Q8JJ
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M%("NAUF]L6KM!TBB+(TCORQH_J-V 72>*[K)9N,*M/\HXU]02P,$%     @
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MKM@TZ)TF'NB65MH#J=J-\E(1$X/;YLS$J*T"WZ^4HOW!.NBX??P;4$L#!!0
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MMY.&U.RV&8U/5-:![E-)/6\,FZ =R+-?4$L#!!0    ( $R!<51"M4163 8
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M2U8+.U>;3[BKY]3Q94H8_PN;)K9'BEEMK"IW8+)++ILO>]F]PP%@$+T"2':
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M;"]W;W)K<VAE971S+W-H965T,C(N>&ULG5EI;QLY$OTKA-;9V$!'EF3)<4[
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MEXM3!O'IY_^^>_<OMBK7+M:>^JDN;\F-"G^%4DLESD!?DJ@NK989@LZ^,((
MZ",(-5)&6MY#8'"A<DI(US96W":E@)%"V129ARQ<K_-0K0M95@MT06H-C8)_
ME05]MP[%537_'?1*<+6#W#0%W;(R\"TNUM<ZXWKX\\!.Z+R\RLC,:DV"2J&N
M"?%0,_(MKI+XC&[Z..$'H7*&W-L 9_!#<$$O)293%C-7TK953/U1P84PE22
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M\VG/7RG6#U85[F?(A;)69>YC(C@B0@OP_5(I6S^0@N9WZ<M_ U!+ P04
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MT;<EK]IS#5@BAW(6R/[S =]D9[=<9XP7J@'#7]P)G4H$'T)!*CO8;\)0\#I
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M1:[A!>Y.)&O 'XJ?NNAXCP2Q1D5HU\GXWWZ5X)10X_6\Z'M=LU_SV::R]N7
M:<^I);,%4?#LD_Y719:Z]'*/!E'Y*7F/QCP ,M0FPJT_(P,:!('K*@F;M -0
M!Q+N7<6B2D.OT5#%* 83E_.65>8'I"E5!5OR&Z3>::Q'8LP5T7,2.(X0%NI.
M.M\_W$= *=56+FG*RN[65]%]9?+\6*_06M5T8CM'K,&S'R%1MT;E#E7&:)MJ
MEQ5@@T6-K1L&.$"W9 QL*Q+DE[:;>#@[]RA(U<.$YD7&?H F'D0TTRD0W\A=
MXP"NG%*%[A^\!S70<H1:5 D _@P5SCD:\+=A]+[22^HB>EZCU:][:)Y&(P.[
M$@N:(+O!!_<>6PU7;4"/'\OMXVJ"8A[F6.L&YMS/41]-M13PS#2S/'I'E+59
MK7X30$WM..S[I\-%YV\C:\I_].<8@K1 N>X?),W=YO\WU^YO)^UR]^>=#U (
M("+ZU@6V#L+I^$08]X<8]Z,L-OPGE'E1EL6:+U=*@GM:@.>+HBC]#SJ@^5?2
MJ_\"4$L#!!0    ( $R!<52_UQ.<J@8  &4/   9    >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;*57;6\;N1'^*X1J%#:@Z&5E7W*I;<!.'-2'<^H[)6E[
M13]0NR.)/2ZY(;F6U5_?9\A]DYT8./2+M,LEGWEFYIDA>;ZS[G>_)0KBL=3&
M7XRV(51OIU.?;ZF4?F(K,OBRMJZ4 :]N,_65(UG$1:6>9K/9#]-2*C.Z/(]C
M]^[RW-9!*T/W3OBZ+*7;7Y.VNXO1?-0._*HVV\ #T\OS2FYH2>%S=>_P-NU0
M"E62\<H:X6A],;J:O[T^Y?EQPA=%.S]X%NS)RMK?^>6VN!C-F!!IR@,C2/P]
MT#O2FH% XVN#.>I,\L+A<XO^(?H.7U;2TSNK_ZZ*L+T8O1F)@M:RUN%7N_LK
M-?Z<,5YNM8^_8I?F9C^.1%[[8,MF,1B4RJ1_^=C$8;#@S>P["[)F019Y)T.1
MY7L9Y.6YLSOA>#;0^"&Z&E>#G#*<E&5P^*JP+EPN/U\O;W[Y?//QD[CY@M_E
M^30 EC].\P;B.D%DWX&89^+.FK#UXL845!P"3,&G(Y6UI*ZS%Q'?4SX1B_E8
M9+-L_@+>HG-R$?$6WW.R7GGZ6I,)XN8!OU[\ZVKE@X,D_OT"_&D'?QKA3_^?
M&+X(P:7WUE<RIXL1:LN3>Z#1<USQW)&EU"3L6MPI8_-]SKCB@Y,FWRI/XLJ+
M0GG(R%,AE!$?;2"!N/[-B)^DJ5&%8I[%,./WRS\_W@B DHN3@Q52W-<NWTI&
MVCBBD@WO5-B*GVSM#.T%)J'"M%"@<K?\-#"-?B&.LK/)#*K5F@L0+'/IMR*W
M*.F"G(QEN=NJG,?*RF&9%]*(NEH["$I4<A\M8N%1-AL@25/P/%D4BC&D%D<'
MAHP(6T3%T*L]28>I!I7O/+L++/Z6:^N5V;2OD(+Q,O:)28J# A/MK2"M-FJ%
M&,-31SD!2'C$W+,U0GDBW@U/SVAUQ3./3L^&?%4B)#<(XD8B!775<)0(%CU0
MZZ:O*%=KA?AKC.J(:-"9DT7V7%3.%G4>7JWVKYI'[DK*C\6*-@J>PJN8(GA=
M(S+]<GK,B0K^?C2?#>D=Q_D-FD<N'AH)@"*RCJP%VEBG@'$\/Q%7=[_=W/PB
MCCD+.;F SB]*6X!W'E/J3\;B.#L1O]W^_(_;EZ?QM^/%B?CP[OU\=A9?+<+B
MGI-9[6.\*E#A2*^(_8AI6Y/#A#'HYKJ.[GW;VD3<]I(9=UD&G H:%@8);@&Z
MQ$*/)=CMA58Y;TBL'-[95H/WI"2)4F-^^ZY$L!.RW-L)GXT*L+8,\,1/Q"<,
MO8/X&5R"2J[81<]4K(O>0.C0F<(&A&4;IA79,)9OBI^?#ZNO4=Q:.1_$5Q0Z
MJIIG<J4+S-HP<L0YFB\F9YT46+OSTW[@D&!AP<S8,&#*,4HL]V)-7-4ZAH;=
MXY38$J4C'[&.]\ZB5WX=E%;_33V@43E.&MP4@(;J]&UTGCBO6B2LXT50"LO:
M/_$JFT\6!UYEV6"@UTJ//N@!4)T/SQ GKP\ %_W[!%F%Z]&OYQUS',?;&(*_
MA6PVR:8%E8)*H]:]8"3[B;1U*K2L>87 :B57B%I0L4\6L<>N<!3#22VV"D=Q
M\S A27XL=M(YSE4SGXO)2!9TW?&5+<T)4_<U/C,M_C3PH./F<7JCOJ"'C+XC
MQ";2*/;2<IUP?7N.B<5GB:;?A9A+\L]_>I/-7__%-Y6.]6N'":E#^EKQ",S%
MZ+6!NI>%W""NM]Y)TN)^*W%<RPD*R]'#Q<\!3<:CCZ7=+SN)NG(D=OQC+(Y9
MZ"#<@!V$9S:O4"OE@6>I&/LNU.8R[5T19M"*VO!=UWMR2</][IGB <QTMN,M
MZ4G68J;ZQ"%N'B:PQ^*_%4O3U(3C,Z?_(SH8'PKA +U-:FK!J(H0,X4V]Q^<
MH=FMGC2B@?[,.R-FY+)J@--2K4K5V$[^YPY-SRD9F8*==;',G\L%++:DD[)C
M=]MAI$29RW5H!+N2&K/1_.*=I8 2DFFV3%A'XV$C_J8H8\9RC2EILVVM,DSM
MTP 6XAA*Y0IFVZ-H<B;8@%K,$=+4^4I;FT-+C6V9#.$$5EE&C6^R0L=ZC#U'
M[\71Z\F;MHN,7S3K.Y?B^<ESYP.*4SH>:I3A\Z!-)QR@+OK>]-$>B/FI7"?B
M@X(6<O;EBN](:=I2<9"?<3EL9FATPEN=3F/=Z8;WF?'I#V?CL]D,:9+0HJB>
M])9E/)+T=<$)WSBT_;ZALR/SX5;TK:/Z='#U*<EMX@6/8X2<I%M0-]K=(:_2
MU:F?GBZ@=]*AW7L<O=98.IN\/ANE FM?@JWB16IE ZH@/FYQ#R;'$_!];=%@
MFA<VT-VL+_\'4$L#!!0    ( $R!<53L@B[)4R4  #1\   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(W+GAM;,T]:6_;2)9_A?!<-B KEFSG[&[ <3I9#W)-
MG,SLSF(_E,B25!.*U+!(.YY?O^^JBZ)H)XU9+-"'+9-5KUZ]^])/MW7SU:ZU
M;K-OF[*R/Q^LVW;[_-$CFZ_U1MEIO=45_&59-QO5PJ_-ZI'=-EH5]-*F?#0_
M.7G\:*-,=?#+3_39Q^:7G^JN+4VE/S:9[38;U=R]U&5]^_/![,!]\,FLUBU^
M\.B7G[9JI:]U^V7[L8'?'OE5"K/1E35UE35Z^?/!Q>SYR_D3?(&>^*O1MS;Z
M.<.C+.KZ*_YR5?Q\<((0Z5+G+2ZAX'\W^E*7):X$</Q3%CWP>^*+\<]N]==T
M>#C,0EE]69=_,T6[_OG@Z4%6Z*7JRO93??L?6@YTCNOE=6GIO]DM/_OXY"#+
M.]O6&WD9(-B8BO^OO@DBHA>>[GMA+B_,"6[>B*!\I5KURT]-?9LU^#2LAC_0
M4>EM ,Y4>"O7;0-_-?!>^\OUU9OW5Z^O+B_>?\XN+B\_?'G_^>K]F^SCA[=7
MEU>_7F>''^O2Y$;;HY\>M; ?OO4HE[5?\MKS/6O/YMF[NFK7-ONU*G21+O (
M /70SAVT+^>C*[[2^30[G4VR^<E\-K+>J3_]*:UWNF>]BSRONZHUU2ISY\S^
M^V)AVP:HY7]&-CCS&YS1!F=[-GBIK+%9O<R 9:RN6H6D.(3)'UCF\UIGE_5F
MJZJ[/_[NZ7SVY(7-EJ9256Y4F5EX2 /[M#9;JQN=+;2N\/6M:G21&>2'O&X*
M>%H#R;7K;*4KW:BRO,._Z&T+3ZF GFUC8-UM"0B"=UO8^DME\)EKW(=@N]CH
MQN0J.T1HYB<OODROI]F;BXN/]/OLQ=$TRRYUTX*HP.7J)MO""S5LL\%=8C@;
MG9?*6K,TL$-;9WE=H0"B'[NF@5-E=UHU"3JF(]=U[J_K?!3/7ZS&DVC;F@T>
M:^BFOF^%#&^)T4Y0XA\'+PF0(J<T[1W?B$<@X..?G8&S N=7("OQ#<3%1GW5
MT5:J EQ:D*];W,G"+:DV4\LE"$"Z,8"B;NA>!>$ "SRO6WZU-&IA2M,"$TSH
M^<+8O*QMU]"1 #JD!-QZ^*5,\38% (,OX,^#1\7W]L$#5%9O-#VBOX'JL;!N
MT35(@N$5(DBBG6EVD;<=+ _( 3F,"+H#N.',3;9L:J"8=6TC'$VS:[.J@*YR
M!><  MY84$B+?Q"*:O@Q7X\@%( KNT+'? $7EBTZ"U1@+:!HLX #T\.3S !K
MFH:/#"=;U75Q:\J25C5 M-7*+$H=([/1-[KJ\)1Y#5 25?</"#N71>^(NW(@
M.C")B0]_O7IU/'N6P4.%WIB<MEO5-[JIB)@V6N$] \T 255(C/#+%HZA$2VX
M@W^3N'2M #-9I5<*E2H=%3!85S$P?X)CPRTQ.O <.>((EEMK5;;K' 01<$9]
M8PK=(/-;YOW2;%"P3++;M8';P,_=/B";>">@&:M*'4@I;,GD>(?[Z&\Z[X 6
M#:%M ^))*!%@TBMA,CRGW/[%N[__^NM?:,V_7[W]SRO&7:FK%3R'!&T\9;;"
M@0QC.XABNNP"V#9O 7"@$U/YWP1A*>B.CB;^LF'3@$+:.C 4\&-AV+(A/@0)
M4;#HP&TU\$Z!%[+L6F3@ DBKK+=,C2P8X-,UV"P 30=*@.3R)&:&? TDR@>F
M-5D =$01^J8N;[SBJ%>-V@(FB$R/T6($UK"X6+-BA9&#X212!80 ?(IJ!TY7
M@=F&]V&J<)<WP%["19E> H.UT^P*3EGP<2<QUN!X#?S:$!?!/T4F)XEY%!BA
M11*C8P<U)T(5SV61!H-\KN&6E$4J"^@V%9O ^ S+ZA;(@#&  ,5_!_/8UI5:
MH"Z]4:94R.?"1PYP=]JN^EK5M_Z>F##HYCU%*?H5;!^]6<!1G?TC2S1UMUKW
M!"\8"RPIF80'<.'Q)3(-^&W1P7$TP%#5K>-"@'HR*&  @_4M&0\H 8NZ6[3+
MKG0[\67F8&D86*JV=/FF NG6ULV=R+I2X0:HP9L;O2LOR[I:'9? ]<6](A*H
M Q!RDE(&/M$4>,(1.>RH!5A3PUW#D67+'0'](EO7M[!Y0[N 7"14=94[AURO
MDX31]1U>:YT=O*_A<DZSX^RETQ:705L<$!8W=9/0T9$([[Z-QY3"-TC26Y3M
M1B%&2$'!T4!K>HIVL$R0EFXU'AYP08RS!'#K!M#/BH4E#U(XJH^&*%](,B5@
M#PZR#]C.A4KY)35M!.:^^K9C1MMC;[0]'C>.'4(O<F!H:_:9V-^_RA#V'W)<
MMA(069'T1F,+Q1()G2(8#6H)>*:'04>!@>WNK"7&]; DM!#X#.EF9TV0N?C3
MJK\&J'FPAPH"Q8L$IVB=C3E!<PS>9?( 64*BG&3GIK;!^'.;[EB!:# A,)Y)
M_X5/D;(SC;=, 'G E2#LRXY>&C@R"S26<F);AG?P^:OJ^&-3DUGQ"5A2-7 ,
M?/Q54';T^QO'\@(3B04Q5A:J)#%&+C0@N5&551PQR.&XEO2DF*(HB?!ZT05!
MTU/,UB!I2"]4$G @U>"N7$X$9J=C,;+=E%SZMPRDH&$_ZA]=L1)#>5&#3!;>
M0<$G0M#K:T8XRC%:%_0-V%8W!LV-:K\=FY(2Z0JY2_0IV!(,>G2OK1_N8I)I
M0]32;4D[PB-D"G@1C=8/4BI8%Q;VHGL).@G^X 7#-'L-O^IO"K&2"O0.Z3HB
M /%#![=#RV*75/$X@]8Z&SEK7<GQ$:J@-D2#I6@+V(U 8JZ#N]#?0/&!DPN$
MI;9@Y*I\_1U\YO8H-(B&#4#+%C@M1P_<DJQF:M:DK]!Y(;DN-X9(!?A9+R%-
MH[N@_!7>$2[P7L#P 7+9J.:K%FO![>JU1WH>8[W%A$SL/! 0=&1(HSL [_""
M  +<:F[@-"VI&'[/B28T/[5E'EW@#QU[SU5='0?1&BAP0D24^*E$UKR>B(C&
MV*]N$0"*M"D'.5@ X#-6;3#2@(8>,X>7P0Y7T^QO2 YRR^3I1>3.YC71+A,A
M(*N3M82A$<=.I+D+\=A/"1M]5CHY7#2*<X#3N<\UFEET/)VO*[#QM7V>43SE
M\0L0?^PK]P@,+@CCE%["29 DB$WE1 I8WEIM'+> R;O.EK ?4+K;XAU?X]@6
M[J:1.%A.,$7'!C%1B3S8!@F+PA0="6*W F D%P)0@#A4C8K<X_3> X"7I)+N
MP0 *<F0$$02\0P6G[\!4V]EK BX?ZN6J9^0N0>PBU(I,QT<HIF"5&EV]>@$V
M@;8YNC73[$/7Q$*!E6Y=UBL4G,$SZUWPW59+!&3;M=$M_Z6K45L*?A&0@*I!
MY'!PCQB146ZSP[>H$;.9+'XT'5G=@N5?JN:A:T_PB7^.P/B0)1V<WC%%%X3W
MF;#GC&![40E7D^[HW]OC;L/]@).!=QPO%]X"D73#JV&0D[Q#)-D)4TK3U(NZ
M(9ME :P;%G,D#78*Z)4[>A3= =%X#"YHE,K?P'SW!KY4T8(Q9(U>8NYB)!XE
MBYZ&12\RU$!EB'B1/QMH\?^'_3%B]#_Q1O^347,=K 1M5E5V2>'@_(X-MW)O
M?/W'5_L<RRO25&PQ(AV;%6@II!:@]II4)EL9P.U [VP[BOB-;6#WH@M\3K.7
M;DUX&147+R#!;DI+X%*M0,7^:>VW8;,#O'[PY%@NX)5(H%Q_DT!.P]8*$";N
M +:';I4XX_X7=[:)BXM1U(V-L@BNMH\3$?D43Q6[+/*(TC#6(3)FSNR$6<&C
M24\4]B#&DX-Z+)[#FT<$?[+]\<[SB8XA)X)DC@+G7;FG7A#8AT96C.$_=.*
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MDQF7KD4BWQ?B_8[W?:^,+_3F[@;]S5 5GF>$>]HMG%.-[X;J3L5>55K3*37
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MX0<PF2RT6@Q[HK%PD@9_W_]:==1SBRT2*A3_9SQ6!JML^+/;-=;_JQ(7.43
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MEU'L+7!01V,.1/R*%;?0[:T6=\_WF,E)$A&R(T2C$2!@*&SI_,Y&=WU:H6(
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M*X8K;!L8;K>UYP&;$FH5WTGR63R2(8:)7"#"#NC!*2J:X7><A1R_*Q>Y#8E
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M3J?N"T?G2"W.7)_$(\PPOH2$O3/*+)Z[< RVP3&9A=1MVI,1-"92OO\F$FX
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M23['E9 Z&O:#[MX.^Z8F)37>6W!U50G[.D9EMH.H$^T5<[DNR2OB87\CUKA
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MD_.KRPALLY:-0&835F%EB!<K7$M^R=!Z![87QM!>\ 3MVSC\ U!+ P04
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M?0;3[P\7LZOI]3U\OF=S@>;+,+1$XE3#; -XT@!&.P"[$5PI:9<&IC+'_#U
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M*BKK0/>)I)[7ADW0C.CI'U!+ P04    " !,@7%47D5>7DL#   >"   &0
M 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6R=5FU/VS 0_BNG:)- @J9)^@*H
MK518MR'!0,"8IFD?W.326'/BS'8H_/N=G3240CN)+XGMW//<<W>V+Z.E5']T
MAFC@,1>%'GN9,>6)[^LXPYSICBRQH"^I5#DS-%4+7Y<*6>) N?##;G?@YXP7
MWF3DUJ[59"0K(WB!UPITE>=,/9VBD,NQ%WBKA1N^R(Q=\">CDBWP%LWW\EK1
MS&]9$IYCH;DL0&$Z]J;!R6G?VCN#>XY+O38&&\E<RC]V<IZ,O:X5A )C8QD8
MO1[P#(6P1"3C;\/IM2XM<'V\8O_L8J=8YDSCF10_>&*RL7?D08(IJX2YD<NO
MV,3C!,92:/>$96T;A1[$E38R;\"D(.=%_6:/31[6 $?=+8"P 81.=^W(J?S$
M#)N,E%R"LM;$9@<N5(<F<;RP1;DUBKYRPIG)U?7L9GIW_NT+7,RFMS/8NV-S
M@7I_Y!MBMS9^W#"=UDSA%J8@A$M9F$S#K$@P>4G@DZQ66[C2=AKN9/R$<0>B
MX #";ACLX(O:6"/'%VWANT JGX9?T[DVBK;#[QV<O9:SYSA[V_)7HF*&%PL0
MEAUBJ8U^*WGOH $Z<V RA"=D"M!F%2@GF,]1M7D!IA"8M15TP/0)[/&"0++2
MK$CT/ORTV-DF=MOR59KR&!L1^$A'WV;L T3](3V/!P'<8\9CVB&O;7I1SUH>
M=^$YFICI#%(K[,!%PW)9%109+V)16>=.+$).9)5".NT&9-IP"\[F7'##B7XS
MRO>'Y<(91C:<X68X+\.XK<I2.$U,D-#Z!JPO(\$,N3!R!=N4M^[\A9"-.BM[
M:1S*]+#2ED"C<?*B(WH&!_VCZ!5B/2EDV3MVEH.@"S_<#42RV -!%D2.]E9^
MAAI4.70[PR$$G>/!:_N$Z]B6!\@A0A!UB/3CZKWCK/3;L]+?N<DOF:E4K?RM
M&K]U:G82VH9UHDL6X]BCCJ11/:#W/R^O2D6'*'0Y[]EA!%$(=])6O(:6[,GN
M  W18  7J&GOYF5EW-:EA*(VL!<,]U]@5NZ>F@J]E3M_[<[.42U<9]+@"E!?
MW^UJV_RF]9W_;%YWSDNF%KRP6S@E*!68LJ;J;E1/C"Q=!YA+0_W$#3-JX*BL
M 7U/I32KB770_A),_@%02P,$%     @ 3(%Q5.."L8=&!0  ?PX  !D   !X
M;"]W;W)K<VAE971S+W-H965T,S8N>&ULM5=M;]LV$/XK!R\9&D"6]2XY2PPX
M+UW[H4V0M!V&81\8ZVP3D42/I.UXOWY'2E;=SE:,O7RPQ=?G[GC/'7D7:R&?
MU1Q1PTM95.JR-]=Z<3X8J,D<2Z9<L<"*9J9"EDQ35\X&:B&1Y79360P"STL&
M)>-5;W1AQ^[EZ$(L=<$KO)>@EF7)Y.8*"[&^[/F][< #G\VU&1B,+A9LAH^H
M/R_N)?4&+4K.2ZP4%Q5(G%[VQO[Y56;6VP5?.*[53AN,)4]"/)O.^_RRYQF%
ML,")-@B,/BN\QJ(P0*3&'PUFKQ5I-NZVM^AOK>UDRQ-3>"V*7WBNYY>]K <Y
M3MFRT ]B_0X;>V*#-Q&%LO^P;M9Z/9@LE19ELYDT*'E5?]E+<P['; B:#8'5
MNQ9DM;QAFHTNI%B#-*L)S32LJ78W*<<KXY1'+6F6TSX]>GPW?KB%J_'C[0U<
MWWVXO_WX./[T_NXCO/G$G@I49Q<#36+,XL&D@;RJ(8,#D'X 'T2EYPINJQSS
M;P$&I%^K9+!5\BKH1+S!B0NA[T#@!7X'7M@:'5J\\)#1<R:Q;YR9PSW;$,<T
MC*5DU0QM^[?QD]*2"/-[A["H%1998=$A811'^;) $%-0.X(GHJ3(4JPFYYK)
M7,&,=- T1\$&8F%F%+ JAX?'SPKRI>35#/0<88&2BWR?:SIU,1%^KA9L@I<]
M"F&%<H6]T?O*8FZ0205H7 9TX%@^H6P/W6I!#<^Q:Z])=U9M6GU;716I7E"@
MJW/XE? .PHV-O<!*L:3COGU!.>&*S))\@F#] %]0:6-N;2JM67!9G]5MN2C$
M!K$^FALN*<"%)(EWC1:^DV2)$WDQG/ANDO7IX[M>!KZU$?I18ZOO-0TZ7ABF
MGI/Y(?SX0Q;XP4\0-'/MZNU$AUW>_VU7&*1.X$=P$KM99.P*W#CHMBN)(R<*
MTE;][Q=OQSN8'K=,C[N97B=V0_0EG8\L-L;0G-(2+%7#:L/ZI=[R>,JXA!4K
MEC8ZS$C#I'W4[A;^B3;_6ZE T7D$AVL*6W^__0:*LO7DN0$SW/."_DGBIL3#
MT(W2_DE*;"3'KGA.F+#A6.3@P:G]$1'(WR1H)0KB0\'U!I+,#;/3?C(T'T@\
M-XIL+PM/X8&KY_Y4(@*G$*1@UD0PC>"YL7?:]]U@2+ANZ-MVLH-/BTM(&N\W
MWP[G)ZWSDV.=;TZT6MK#HM[V;.E%H#0QF[RPS[N=Z/L3EW%Y[2KK67-?-8\+
M_B=%T:MJ6&IL4]^A5.78:)1(3J%I7M7O(((ZAX]_ __%/@)HW7B%DMXT7U/
MO4T!=SO"F=Z3/R(G2",GB89P G[HA@G\W*38KTDM)M^VP#F\,8DK2,\@=?T,
MZ*DR16XVO(G"V(F3X1ED;A#7B<8,^T[D>T[J)6?@IVX<OJ:43TIY4>@,*=.<
MP- E+1OA]L#W[O"=84J_P.R@'!4.N])+VC(L_6<,L[?C*_3JA/X/Z/6]#D=Q
M:Y="%N!5?J3^T(FBL+YG"')[:YE;Q3@W&(:.%T9GNSSPPX@($IR][FC?"9*
M..9UN2MKW94=ZZZ#SQY\,6W<F^X[T8_W&"^*I7G,Z<9E.)U2'NS42M0/(CHK
M;=^#J@YQK._I8ZZ%!]*(R<G<YHX<5U3[+.S+<FLP'75*]WCDI%$"CU23D,(.
MS+ B(87=Q7)Z[7.K.94MD#AADE!*<,*8KG_('"_S3'!ECG_ 78.=HJ!$.;.E
MCR)+Z6E2UP?M:%M=C>NBXNORNC3[P.2,4WHK<$I;/;K1>B#K<J?N:+&P)<:3
MT%2PV.:<*D249@'-3X70VXX1T-:<H[\ 4$L#!!0    ( $R!<52ZO.,=V@4
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M\2OS;YE4D"!:A ](I1'72%+86]JJNH#"7HV$UR=!.X-)Q6#B9' NXAAVLIS
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M9?'ZN;C1(LU?ERZ$UB+.+S>,0FJ: ?#[2@B]NS%O8*M_ LS^ U!+ P04
M" !,@7%4Q28E_AH#  "9"0  &0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6S-5MM2VS 0_94=3Q]@IL677 A,DAE(@'J&A@R!]J'3!\5>)QIDRY7D)/Q]
M)<484XSAD3S$NNS9/7LDK33<<O$@UX@*=BG+Y,A9*Y6?NJZ,UI@2><1SS/1,
MPD5*E.Z*E2MS@22VH)2Y@>?UW930S!D/[=A<C(>\4(QF.!<@BS0EXO$<&=^.
M'-]Y&KBEJ[4R ^YXF),5+E#=YW.A>V[E):8I9I+R# 0F(^?,/YWZ%F M?E+<
MREH;3"I+SA],)XQ'CF<8(<-(&1=$?S8X0<:,)\WC;^G4J6(:8+W]Y/W2)J^3
M61*)$\Y^T5BM1\[ @1@34C!UR[??L4RH9_Q%G$G[#]O2UG,@*J3B:0G6#%*:
M[;]D5PI1 _C=-P!!"0@^"NB4@,Y' =T2T+7*[%.Q.DR)(N.AX%L0QEI[,PTK
MID7K]&EFUGVAA)ZE&J?&B_!J%EZ&D[/9'9Q-)C?WL[MP=@7SF^MP$EXLX!O,
MB!#$+ X<3%$1RN2A'KU?3.'@R^'059J$<>5&9<#S?<#@C8!GN3B"H/,5 B_P
M&N"3=O@4HR/H^!;N-\"G'X?_%]W5RE7R!95\@?77>2N;3-&8LL+JL\"H$%11
ME'"QBU@18PR)X"E,>)H7BMB-SA.X("*CV4K"' 4LUD0@_+[6CB%4F,H_+;0Z
M%:V.I=5]@U:8YH0*?3R5B<=XMOK&-,,8B)2H)"@.2X28RIQ+/<J3IH78ASBV
M(4SYV(RU8INZUFT6+WAW*][=5MY7G,=;RAC0YP08E[*)WMY3OX7>:XMNSS._
M9I*]BF2OE>1<\ TU=4^"KKL0\V*IDH+I$A;Q(E.-9'OODFVS>$&S7]'LM^^!
M##33"*6$6Y1(1+0&DL4PQ8VN]KG1MF6G'5=1CC_3 1A4M ;O)9^7R8MZ\O%S
M\K4]UK1B@W=W_VN+[LF@97^=5-Q/6KE?<I+278L(OO=<W+W/M#I^[=;QWSM#
M$6(L]P0$?R3,$&N\3OQ7.ON>UZ2S6[L&S:/E!Q$KJD\IPT1#O:-C?<;$_AVP
M[RB>VYMQR96^9VUSK=].*(R!GD\X5T\=<]E6K['Q/U!+ P04    " !,@7%4
M".=WC? "  #@"P  &0   'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6R]5M]O
MVC 0_E=.>=JDKHG#K[8")*"T0Z(4E79[F/9@D@M83>S,=D:1]L?/22!ATDBZ
MB?8EL9V[[^X^7SY==R/DLUHC:GB)0JYZUEKK^,JVE;?&B*IS$2,W7P(A(ZK-
M5JYL%4ND?N84A;;K.&T[HHQ;_6YV-I?]KDATR#C.):@DBJC<#C$4FYY%K/W!
M UNM=7I@][LQ7>$"]5,\EV9G%R@^BY K)CA(#'K6@%P-72=UR"R^,-RH@S6D
MI2R%>$XW$[]G.6E&&**G4PAJ7C]QA&&8(ID\?NQ K2)FZGBXWJ/?9,6;8I94
MX4B$7YFOUSWKP@(? YJ$^D%L/N.NH%:*YXE094_8Y+;MM@5>HK2(=LXF@XCQ
M_$U?=D0<.)!C#N[.P<WRS@-E65Y33?M=*38@4VN#EBZR4C-ODQSCZ:TLM#1?
MF?'3_<7D=C:YF8P&LT<8C$;W3[/'R>P6YO?3R6@R7L G&"O-3/7HPY/"( EA
MR@*$#]>H*0O5QZZM31HIF.WM0@[SD.Z1D,2%.\'U6L&8^^C_"6";_(LBW'T1
M0[<2\1J]<VB0,W =EU3@-0I2&AE>\PC>2$1QHE$J^ 5WC+,HB2I0FP5J,T-M
M'$&=2_,O2;T]@WE(N0;*?1C_2%ALFES#MZDQAXG&2'VO"-8J@K4J2RAO+<EO
M+32W]K>[JH9IP!:I5!4)M8N$VJ_GE+[4<-HI4#MOS^E%$>SB-)Q6PW1J.;TL
M$KJL1)K2I9!4"[D%+(I^3<L2IY0'Y^T))@=J1$Y#<0U.JY9CXI8YN?_%<FT3
MDU)O2.,=6"Z%B#1/Q'(U#FG6TUP*%JF6FOL@8!Y"D$C.="(Q(^$?V[H4(])^
M!\)+E2*=$Q%>C5,O':04,U(M0_5\US=X*53D\NWY=DO5<IW3\%V#4]7@]L'0
M%:%<9:.E D\D7.?S5W%:C*^#?&@KS?/9]X[*%>,*0@R,JW/>,7^*S,?)?*-%
MG(UP2Z'-0)@MUV8$1YD:F.^!$'J_20,40WW_-U!+ P04    " !,@7%4]?DC
MEN4"  "O!P  &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6S-54U/XS 0
M_2NCG$!B29JTI:"V4AL*&PE*1& YK/9@$K>Q<.Q@.Q3^/;:3AI:EW;VLM)?$
M'S-OWKRQ9H8K+IYDCK&"UX(R.7)RI<HSUY5IC@LDCWF)F;Y9<%$@I;=BZ<I2
M8)19IX*ZON?UW0(1YHR']BP6XR&O%"4,QP)D511(O$TQY:N1TW'6![=DF2MS
MX(Z')5KB!*O[,A9ZY[8H&2DPDX0S$'@Q<B:=LW!@[*W!#X)7<F,-)I-'SI_,
M)LI&CF<(88I391"0_KW@$%-J@#2-YP;3:4,:Q\WU&OW"YJYS>402AYP^D$SE
M(V?@0(87J*+JEJ^^XR:?GL%+.97V"ZO&UG,@K:3B1>.L&12$U7_TVNBPX=#I
M[W#P&P?_LT-WAT/0. 0VT9J93>L<*30>"KX"8:PUFEE8;:RWSH8P4\5$"7U+
MM)\:)]'E/+J(PLG\#B9A>',_OXOFEQ#?7$5A-$O@&R3ZX605Q< 7,&&*9(16
M1GJ8/5=$O<%DA40F8<X51"RE588S( Q4CB%$-*THLO72WK,X@8-SK!"A\E C
MRQP)+(>NTGD8-F[:<)[6G/T=G#L^7'.F<@DSIJ-M [A:@%8%?ZW"U-^+>([3
M8P@Z1^![?N<+0N'?NWM[Z 1M40*+U]V!=U,IJ1#+"%O6(@$OC8CR"&Z3>PGZ
MJA$/*JV @%D2QWOB=MNX71LWV!%WJ[P)3BM!%-%!9J]-71>"%Q#RHJS41U61
M8)JHA%@322S;GU<:&"*%"_EK#ZU>2ZNW5XXM6O*#UH%^9K4,AU\]HAJT;T%-
M,WL9]P*O'_3\H?NR6=O?[;JGI]T@"%J[+=;]EG5_+^L') 1B2NX1X*2%.OF?
MZC)H:0W^15T&7^C=Z_1[G\KR1[.:L[O1^PHLEG8D2$AYQ53= -K3=NI,;+/]
M=#[5TZ@>'A\P]2B[1F))F 2*%QK2.S[1+T;4XZ'>*%[:#OO(E>[7=IGKB8J%
M,=#W"\[5>F,"M#-Z_ Y02P,$%     @ 3(%Q5![$S"ZU @  K <  !D   !X
M;"]W;W)K<VAE971S+W-H965T-#(N>&ULS55=;]HP%/TK5J1)F]21$#Y**T""
MM'216HJ@[1ZF/9CD0BP<.[.=TO[[V4Y(H6NB/>QA+XE][7-\CF]R[W#/Q4XF
M  J]I)3)D9,HE5VZKHP22+%L\0R87MEPD6*EIV+KRDP CBTHI:[O>7TWQ80Y
MXZ&-+<1XR'-%"8.%0#)/4RQ>IT#Y?N2TG4-@2;:),@%W/,SP%E:@'K.%T#.W
M8HE)"DP2SI" S<B9M"^#@=EO-SP1V,NC,3).UISOS"2,1XYG! &%2!D&K%_/
M$ "EADC+^%5R.M61!G@\/K#/K'?M98TE!)Q^)[%*1L[ 03%L<$[5DN^_0>FG
M9_@B3J5]HGVYUW-0E$O%TQ*L%:2$%6_\4M[#$:#=KP'X)<!_#^C6 #HEH&.-
M%LJLK2NL\'@H^!X)LUNSF8&]&XO6;@@S65PIH5>)QJGQ*KR9A[,PF,P?T"0(
M[A_G#^'\!BWN;\,@O%ZAKRC@+ *F!#;7+A'?H$! 3!1:$KF3Z/,5*$RH_&*V
M6KT@I!X_) ( W6*Q!:G>5H:NTJK-V6Y4*IP6"OT:A6T?W7&F$HFN60SQ*8&K
M[5:>_8/GJ=_(> 51"W7:9\CW_/8'@H*_AWL-<CI5"CJ6KUO#MX1G8#F@*; H
MT;_2KH&S6W%V+6>GAG.&B4!/F.9P=II DS^3N#,T(PRSB&"*5@HKT'^F3A/.
MBBS_N-6$*-1A^;-!3J^2TVNT>"I!V/,S$":F2\5'WT0S7[?=\KQ/'Z6N&7?1
M_Q-W8JA?&>HW$DVBB.=,2;2$",@S7E-H8#VO6,__AZP-*CF#?YRU9K[>H"YK
MS;@+KRYK[E'AT]5E:_N!1#8W13VHHE7+F=A*^RX^U:VHZ!QO-$4?N],5C.B[
MI;#1E%[K7']AHN@-Q43QS);7-5>ZQ-EAHMLI"+-!KV\X5X>).:!JT./?4$L#
M!!0    ( $R!<52NNP.;EP8  & ;   9    >&PO=V]R:W-H965T<R]S:&5E
M=#0S+GAM;+U9;6_;-A#^*X31#2F0VB(EOW5)@"1VL@!+&L1K]V'8!UJB8Z*2
MJ))TG #]\3M*LBA'$I-BS;[8>KOC<\?C\YRHHZV07]6:,8T>DSA5Q[VUUMG'
MP4"%:Y90U1<92^'.2LB$:CB5]P.524:CW"B)!\3S1H.$\K1W<I1?NY4G1V*C
M8YZR6XG4)DFH?#ICL=@>]W!O=^&.WZ^UN3 X.<KH/5LP_3F[E7 VJ+Q$/&&I
MXB)%DJV.>Z?XXZ4_,0;Y$U\XVZK:,3*A+(7X:DZNHN.>9Q"QF(7:N*#P]\#.
M61P;3X#C6^FT5XUI#.O'.^\7>? 0S)(J=B[BOWBDU\>]20]%;$4WL;X3V]]9
M&=#0^ M%K/)?M"V?]7HHW"@MDM(8$"0\+?[I8YF(F@'I,B"E 7EF@(,. [\T
M\)\9^.,.@Z T")X9#+L,AJ7!\'D,N,-@5!J,7FLP+@W&^605V<VG9D8U/3F2
M8HND>1J\F8-\?G-KF!&>FE)<: EW.=CID[//BZN;^6*!SC]=GUW=G/YY]>D&
M?4 W5$IJB@0=S)BF/%;OCP8:QC-6@[#T?5;X)AV^+]BRCS Y1,0C6*VI9*K%
MR;G;R6DF^\@;YTZ\%O/9:\Q'A?GGQ0P=O'O_#@U0 :<3U-SM]9H:K],]KZ%(
M-4_O6:H76H1?\T7]BI$NW"/-6-A'/BYR6([4XN7R]5Z\5B\#J)NJ>$A5/"1W
MZW<5ST;!%:70:?AMPQ7/R>7O/^ :NM(L4?\XQO"K,?Q\C*!CC)M-LF02B14*
M19* ?V6RB[A2&Q:A#&Z=+^[0 4_+1+=E9U8,@8M%8-CYX03WB3<A1X.'%FQ!
MA2UP8INO5BRG4L0>PS6%R4=FU0B#]D+0A#\B(2.> L>7Z!!/M4#7+(W%7CQM
MH(,VT!.0F';0PPKTT EZ88#L\D?3"(@[AA DG&TRP&/2";4,5W*YJ646?4>=
M97Q6##JJ@YV,_!'V_ IN$5;SP7$P#(( ^^UQC:JX1LZX/FU3@+SFF2F*$)8A
M**F9B P0IQHM80HV2\4CGL^&2?I:Q!&8M'&2>Z@)Z7O>+X[B'E>8Q_\1<WGT
M$E[W,'CR MY)A7?B='0>"UCQ]T49H$SRD.4%$HDXIE+ERS&_9VK%DE];=1<#
M3?>*.VBO@&F%;NI&)Z!#@@S1G(>TI*E:,0F%W4:[A:MQ?7P?>^.IYWGM*+!G
M)=5SXI@QEL!J.H!&$5JM4&QR84#91F9" 0>(-'YZGZ] FH:L1A8E1U0,\<*L
M7Y0X]A8=\<?#<7<0M;X _X0@:D0!812H&6B!?D)T2V74#ALW*< GI!NTU2-,
MG* OA8BV/(X13S+*96*6#I1L.PK20.'M4]5E^4B]2(*AYW4#M:*&W:I6 34$
MS-,/F12A$5*8?D9EN$:_TB3[#:CY 5X6LCP.&U)[./[+X30?&09^'E%'/%8(
ML5L)O]!XDU>R50_-HD+M:!3EG0&-=P4.S^DU,P*X!#^1.<AH^M3:AP7-=3H=
MN>; ZB!V"^%YU;"5/84T+1M,0<*HVIB_5+<VG,,&I$DPWH=4SDE3ZQISTGP$
MG)%1=WQ6#[%;I6KQA75F/$0K*"3TL)NRF-,ECV')M@8[:N;?"P+7!%CQPVY9
MNDK1;5GW=[NZ-^MA9JO>H5G8BA:>O%F;BJWX8+?Z0#2-55RT5VUKN'4)-S6I
M42[31KD$TXEC-HA5+>)6K4*#7&\%5CL(?K.$D]K+AYOLZV\&;2M9[9I<TZ$
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MP6ODPA+?+5!V <X74IKMP-ZE_B5,?P-02P,$%     @ 3(%Q5(,K)'TS @
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MX@-^O\ /K^ '(8RD,*F&H4AH\D\''HHI%86?BOIAI<<!C1^@'MQ!Z(?^<CZ
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MXZ(X11<WBB_MN?*9*YT >[D .@-A&NCW<\[5]L8<5:O_,D;_ 5!+ P04
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ME= X^':9X-,,TB3@^5H(?0S,]%>/??@;4$L#!!0    ( $R!<51['MYHL (
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M1 X@T;Z@I1A8N935@VV+-(<"BWM60:F^K!@OL%13OK9%Q0%G1E10V^WU0KO
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M1_%:45RE926H7PGJ&]B@2] M:/GR#;H$E8\6Q*!"# QB_SC$'N(ZEQ&+T4X
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M([6;>5$L%0W)MJ9\6#.IBA'SF*@"$[CNH+['C,G'AJY(JI)U_AU02P,$%
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MRN!LH+=9M-6S[2A>VP*TXDJ7,]LL]8,#P@3H^8)SM>V8!=P3EOX#4$L#!!0
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M*@NDQ/BT<8X_#UG7*I02?Z3B6:]<(^O*2,I?]F:8G#8B:Y'(1&PL!(?_GL1
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MG!5_\6NY$34%&_8HV*6"?:K0MX)3*C@G"H[?HX!*!316P2T5W+$N>:6"=Z*
M^A3\4L$?NTM!J1",C2$L%<*Q,4#KF#GK-(H^IV"5[--L][H%C^F&>;YG16'E
M5;G  E]=,/H"F)*7]M1%7MJYOBS&.%-=N!1,?AM+/7&U_/7C_/[]QX?%]=/R
MS^#Z;Y]N?_T'^ N8TS25/;(4-/K\$WB4G4$8(^OC#9RMP6^8,9P)#GY1%ZJ7
MP)L%$3A.^(\7,R%]4RO,HM*/=X4?=H\?;P_;*8#V3\"V;/AIN0!O?NBR,C=;
MN2$K;87O,".\P\C";.0.9U-@!PU7?@ S4-CKM7H]8/4@K5IA;M4:;_5F8-OV
M3%KU"JN]1OYJ-O(!,^U:1#,19UN2B3S7.2SW&GX_(AT65(9AV)_4VS'Y<+\V
M'W=#^4BDU;#PK=?(O=G(@D13X,"&:\]4D!'N/8RW/*Y<9K+SJ_:WJ_:W\V6<
MGF7F">8<T$W1V."?#_)[<"M(RO]EL.Y4UIW<.NJQKG&#%[A1^ WP0>PHB_\C
MOW@39^7=KLJX+^Q[N7TU4#Q?R?$B_W<Q>Z[OY@C!1@BH"@%]70A[S, S3@XD
M=WU-DP0S#O:$%6'\"/X+=)ZZ0BK6"VJ>6E/I)CP):%"L$8Y;A>-^4T9BS@_#
MV7!;FWR:!I-$PV&O<MC[)H?E0,F%I"$)54->>X->FR0:7ON5U[[1ZR?R3!@G
MA<^ [Y-8 ,61M(O2"E-J?*BEVG:[/0@J#P*C!R6!?V/?S8/6COAN5]_=MP6A
MV]VA(TPV(@VK2,.OB/2[VS,<UYZ#8HU8H*7',<L8S8*05*9G'3_':R*G+$'!
MRW'0VM%D+<L*K&5T^CY(Z3K>Q!'.3S4RO$ZR*5;UATL<UB9'.-":-")DS<&&
MT31'$)Q%1)%)U$A))L^2\F8E$%$N@^EV]+Y<TV^421C =CV5DO6"\J#GA+T%
M!34I0ML8V5)5QQ$3U:R[)HF<;Q4*'?8RL/GR24:1J1Y7>S[02^5BC1X)/,>#
MEM,,Z:9#TD<N0@@Z/2%I)H9F*KZA.(U?#9P.-2-"=(:9 6J*@F:.^N60KF2_
MYG5TG$5+)&7Y-%IG*YD*U=-=4VOG(-PFJ+Z6U0P%S11UKI9MLQ*"_<6MJ0F:
MN4EO;Y/[]P>F&E0H/\6.@)2PK90S%_=-N9BQ9,NM;TLZGF0 Q^FA.JBY#IK)
M;KBX-9G \ S%;6M\M_\?^'Y?KCIBA+$UOMMF?"]V5:Z8PV'A''B03A-FVHK:
MT>,<9P];0YYMACQ=Z)3).1&S+\>*%SLLMQ5_ 2NBRC[:82YSLOH"R"MA4<QS
M$JO2,@#O=OOH@4(7>NY)_7?(>5(,G?#:78<<A(8YR=; ;9O/,G,9#F5@B1.Y
M!V^W3)5B)DQ[K3';=L^12XVQMAECYS3CLF%8T02,1"1^QJM$)BH#0J:)X\C0
M'N]*Z_6IHC6E-CW3<&J;X;3+,UE,LF;P",_>E]:-GA5\T"$9&$/0\&F;X?,<
M@]QMN6;=7=MSNHX079*A*3 -YO;PT4!ZJ[8_#VW+J*S2_:AP.\O(O)R*3AX"
M_M29YP'5ME[SB8LF&,=,,'WT'C<;Q0QJMTZ;3VS?#RQHGR2O0Q"&KNN<TO]#
MER#,3X#=678T3SE#YY!8IJ\ZXGWCP>^V7"6L.1A.?>\TWK84G+K^:; =IYB>
M,#5=.N9#R1/9QESDAY!%+'%&@(^;#6%RZC753>U1G7..)X&:?)P!\ODNG%R4
MUNL[BKS @!*.YBYG['GC.SIFX;1/%J[M(]OK.5\XFON<H4=@OT=]+\I5FO6-
M@A[O-/\Y9OY[/*R2."JK9DQ%:EIR@G-4I&8'9X@=OJ<BKTOK#>9V/-,C9XWA
MZ _ \&O41ES?][W [SEO(8VXZ(] W&O4QE)_BGJ<TSB)S#@Y[R7QID&-C.@<
MR(AJOS"8D5%G6_UTQ(&<R6.1D/QL2'"T.SF^R&U5<IT_+:"Q3S>01D=D1L?Z
M=LJE!X_:2.,:\LZQKQJ9T-@'';__<R34?IC1M],:[Y!Y#*]^4#_NLKSX@%_C
M])":]D/C'3K'HPU7HY8[%K7.>=Z^<[L&20/LNAK67#.L50DXNC7T,\F=VWX&
M#</ \KQ37V:U-S34VTT?,-O&&0<)V4A-:^K+)F3%"T/%!T'W^4L;*RH$3?/+
M'<&2K92 _'Y#)0:4']1[(-5K6U?_ U!+ P04    " !,@7%4T1Z0&38'  "'
M)   &0   'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6S-6FUOVS80_BN$L0$M
MD,:B7OQ2) $<.\$"+*D1+^N'81]HF;:)2J)'TG8R],?O*#&F;$NTVZ6;4;2U
M+-[Q(>_N>4ZT+M9<?)%S2A5Z3I-,7C;F2BT^-ILRGM.4R'.^H!G<F7*1$@67
M8M:4"T'))#=*DZ;O>:UF2EC6N+K(OQN*JPN^5 G+Z% @N4Q3(EZN:<+7EPW<
M>/WBD<WF2G_1O+I8D!D=4?6T& JX:FZ\3%A*,\EXA@2=7C9Z^.-M%&J#?,3O
MC*YEZ3/22QES_D5?W$TN&YY&1!,:*^V"P'\KVJ=)HCT!CK^,T\9F3FU8_OSJ
M_39?/"QF3"3M\^0SFZCY9:/30!,Z)<M$/?+U+]0L*-+^8I[(_%^T-F.]!HJ7
M4O'4& ."E&7%_^39;$3)(*PS\(V!OVN :PP"8Q#L&/CM&H/0&(2[,]091,8@
MVC' 88U!RQBT\KTO-BO?Z0%1Y.I"\#42>C1XTQ_R<.76L,$LTYDU4@+N,K!3
M5Z-?>H\WZ+HWNAF@_J?[X<W#J/?;W:<'] $]$"&(CCMZ-Z"*L$2^OV@JF%-;
M-F/C_[KP[]?XOZ7C<X3],^1[/HYYIE@VHYD:*1Y_R=-8SHF@LL)QW^WXGHAS
MY'5SQ][3:(#>_?2^RG^%YX';\X#&YRC !63CN1;ES?&^7"AK_=^Z_?<6>A=:
MA?]M\R9DPB8=_$TZ^+F_H"X=-(X/NE0GJ,]3X"])<@;H02X 9N 4A<8OJ#QN
M2%[RKWMK(B;HCU_!);I3-)5_.@ %&T!!#BBL ?2P3,=4(#Y%,4]3 "+UGB$F
MY1*F7L"M_N@1O6-P(]_"JA2]+:; 10UHKEU=X7/?Z_@7S54%MG"#+71BNYE.
M:4Z,B#['<[T]2!<,UVAO.4G9,^)BPC)@;(,.L4QQ=$^SA&^MIPIT6 6Z X)1
M#3K:@(Z<H'N3"=,1)0E:$#8!1"@F"Z;@6M X(5*R*8.M!9P3*MB**(H21L8L
M ;/J$B@F;)> =MN1YWG50%L;H"TGT,^Y*  2LJ*"Z+VE6BFA<I"N( &:M 30
MBHI4;SBHIE0DF^C[?*%76(5UX)ZSC5XH$=*1M^T-^O9;HJ?/5,1,DG%"7>C=
M<T8%>M1"D%AJ[EI&9[.,CM/E4P9)P6<9^QN6DN<P*HH^+I,#?=:?Z9D+>F<O
M25JAY]5F27<#L.M.Y]E,T)E.4B@MP:#CB=&*)$N:YT0!IYP;5="*&5HE:#6@
ML&=5U?M^6$<&VTQQ#*Z2VF,GKH*6'(F!K5+@$Y$*;+4"'R\6KQIK!$/D*ONJ
M&UHO0#?>HZ_HR)ZA;Z8N1P/71,/J!W8+R./HR;5N2^DX.I%06/+&;B:])4SL
M%R+4(()%2S0#7,".E6G?VI>3':8PG5=K/R*XZ^ 4;,D;NYFTO%$+LU$QEPIE
M7 ')*F19\0RM=ZD>NA+&)WK=9E@>"YUS.3]7M2B# X!\0^V!H7;41A/RXF)X
M;"D>?RO'?ZC@>+W\2N#[Q!ZU7$&PS([=U/ZIBAJWNUK+Q[YW&A7B6RKVW53\
MW^?8 4![.88[AY+,+SU7^.Y>.5TD_(72@@. ="4\^@,'2*#@@Z+D6P7P@Q.)
MLR5YWTWR=UDL\GFAW=NK*/U$$"^%J*9"X[E<6[A31855 W=';L.WVN*[GQ?^
M#?R*!P,7)BLNOEM<W)C.MDJB*)1*>.Y)<%X.KA2P<N*[V?N!HX1#]@E$BS*
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M'A$P:@2,7B. /OZD@-&/ G O.%30T8OT^J1; @Y:'PY.B"B9L-.UTS+=P3A
M3Z %=IG;JT+W1>QL)O@E:QE]0S?5]'&ADA:5G,>ZQJV%X] I]#-(Q8J5F5",
MIYT5<P-@F_7.>OU\X+Z(UO:QV_=WJE6M%1=J:^>X?R;5:O<%'/]JM=P D6-Y
MO2)R7T:[FV#W=J)?MEPXK=_CX9E4J'5P[+9P+>T"48M-<[[1 YW8,VN\W<UP
M- B&.#QPZXY^<3^*R*#;KTGKU\3MF^;-]R4V1UKS)/@\RD):YR7D%Q?."0!R
M?.&<B#SI<Z0U:^*VS+I4)SV.M,Y)HC,I56N[Q/T:_8)2N0$<'O>:R$J&OW,R
MS4&L[(%=HL0L\>H U]QM/@I<V:/PP?T9OIQ71_L6IOK2<$/%BNE=+(.EA@QZ
M TU65(?WJJ%X:<^_"Z[T:=I>KH&F($P'_7S)N7INF &:3RC3[U!+ P04
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M#/3[->?J:6)N+_UM=?X74$L#!!0    ( $R!<52O,W7-+P,  &\(   9
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MIG>GJB$K0,AS>C]9+)B9/XG?%(_2ZJ"ILSL(6;U";KVZ8;JK4%R771D06=\
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M@/Y]R;G:WICGXM4?3)/_ %!+ P04    " !,@7%4V5B M2L#   4$P  #0
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MYAS<.X_B]3D5;WX'&_T&4$L#!!0    ( $R!<527BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ 3(%Q5.\HK#?K!0
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MS-==A#EJ0P'$Q 1D$@L(QW3AYA%,0!:Q@'!,.$=M80*RB 6$8RX@)B8@BUA
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M>N?OU'L8/X]EN/5\K?'YWTGU>+FWW!Y_77Z=1 E75YSK^XKA^2]02P,$%
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MU:+(:E%DM2BR6A19[?^4]:?W^T^.GY_UX+KQ)9_-?WJ^_@U02P$"% ,4
M" !,@7%4!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( $R!<51D&)7%[0   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $R!<5297)PC
M$ 8  )PG   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ 3(%Q5+RNMQ#;!0  NQ@  !@              ("!# @
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $R!<534>!5O
M'@(  '$%   8              " @1T.  !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6Q02P$"% ,4    " !,@7%4ZY:V*= &  #X'   &
M@(%Q$   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ 3(%Q
M5"N:LT_A @  P D  !@              ("!=Q<  'AL+W=O<FMS:&5E=',O
M<VAE970T+GAM;%!+ 0(4 Q0    ( $R!<53?B>^:% 4  $X3   8
M      " @8X:  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M" !,@7%4F7<N.?4"  ! "   &               @('8'P  >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 3(%Q5+FQWEZ_!0  0A@  !@
M             ("! R,  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4
M Q0    ( $R!<50%N<HM=@(  %$%   8              " @?@H  !X;"]W
M;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !,@7%4Y+Y7 OP(   I
M)@  &               @(&D*P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
M4$L! A0#%     @ 3(%Q5#/L!UN2&   1D,  !D              ("!UC0
M 'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !,@7%42.CE
M !LD   %<0  &0              @(&?30  >&PO=V]R:W-H965T<R]S:&5E
M=#$Q+GAM;%!+ 0(4 Q0    ( $R!<51<"3-_8!(  (<^   9
M  " @?%Q  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @
M3(%Q5 )D^4/+#   O",  !D              ("!B(0  'AL+W=O<FMS:&5E
M=',O<VAE970Q,RYX;6Q02P$"% ,4    " !,@7%4>_:5#;X"  !=!@  &0
M            @(&*D0  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4
M Q0    ( $R!<52O8/GFQP,  /((   9              " @7^4  !X;"]W
M;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ 3(%Q5'_YBB!)!
MZP@  !D              ("!?9@  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q02P$"% ,4    " !,@7%4NM,Q/KP"  #G!0  &0              @(']
MG   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( $R!<50D
M[\&@MP(  )P%   9              " @?"?  !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL4$L! A0#%     @ 3(%Q5$*U1%9,!@  &Q   !D
M     ("!WJ(  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $R!<505PBI7(0T  /@F   9              "
M@4['  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ 3(%Q
M5$[I_&DT#0  H20  !D              ("!IM0  'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6Q02P$"% ,4    " !,@7%4O]<3G*H&  !E#P  &0
M        @($1X@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0
M   ( $R!<53L@B[)4R4  #1\   9              " @?+H  !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ 3(%Q5#=;.&PK!   TP@
M !D              ("!? X! 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q0
M2P$"% ,4    " !,@7%4&^]JG-('  #Z$P  &0              @('>$@$
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( $R!<50Z6(!J
MS0(  "P&   9              " @><: 0!X;"]W;W)K<VAE971S+W-H965T
M,S N>&UL4$L! A0#%     @ 3(%Q5*@G+*IX @  )P4  !D
M ("!ZQT! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " !,
M@7%4248EA(T"   H!0  &0              @(&:( $ >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( $R!<51+NX&LXP(   P&   9
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M970S-RYX;6Q02P$"% ,4    " !,@7%4SB/ZSXP%   0&   &0
M    @(&,. $ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (
M $R!<53%)B7^&@,  )D)   9              " @4\^ 0!X;"]W;W)K<VAE
M971S+W-H965T,SDN>&UL4$L! A0#%     @ 3(%Q5 CG=XWP @  X L  !D
M             ("!H$$! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"
M% ,4    " !,@7%4]?DCEN4"  "O!P  &0              @(''1 $ >&PO
M=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( $R!<50>Q,PNM0(
M *P'   9              " @>-' 0!X;"]W;W)K<VAE971S+W-H965T-#(N
M>&UL4$L! A0#%     @ 3(%Q5*Z[ YN7!@  8!L  !D              ("!
MSTH! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !,@7%4
M)7XZ+#(#  "Z"0  &0              @(&=40$ >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;%!+ 0(4 Q0    ( $R!<50T-E_E.P,  %,)   9
M      " @095 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%
M  @ 3(%Q5)O2<&5F @  %04  !D              ("!>%@! 'AL+W=O<FMS
M:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " !,@7%4@RLD?3,"  "5!
M&0              @($56P$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+
M 0(4 Q0    ( $R!<52=Z.C(K@,  /P)   9              " @7]= 0!X
M;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ 3(%Q5-@5\23G
M P  UQ   !D              ("!9&$! 'AL+W=O<FMS:&5E=',O<VAE970T
M.2YX;6Q02P$"% ,4    " !,@7%4A>&0D8("  #A!P  &0
M@(&"90$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( $R!
M<50@P/PG20(  /@%   9              " @3MH 0!X;"]W;W)K<VAE971S
M+W-H965T-3$N>&UL4$L! A0#%     @ 3(%Q5'L>WFBP @  M@8  !D
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M=#4V+GAM;%!+ 0(4 Q0    ( $R!<53P4=ZEX (  !\(   9
M  " @?)X 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @
M3(%Q5--TYLK. P  O@X  !D              ("!"7P! 'AL+W=O<FMS:&5E
M=',O<VAE970U."YX;6Q02P$"% ,4    " !,@7%4#3$96GH"  # !@  &0
M            @($.@ $ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4
M Q0    ( $R!<53P4P9,C (  ,X&   9              " @;^" 0!X;"]W
M;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ 3(%Q5.<I%UFU @
M"0<  !D              ("!@H4! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX
M;6Q02P$"% ,4    " !,@7%4:E2V:W$"  !.!@  &0              @(%N
MB $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( $R!<52<
MF2,[3 (  !H%   9              " @1:+ 0!X;"]W;W)K<VAE971S+W-H
M965T-C,N>&UL4$L! A0#%     @ 3(%Q5!2L]:NT!@  F1X  !D
M     ("!F8T! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $R!<50M#_ZZK@,  %H-   9              "
M@<*K 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ 3(%Q
M5)H+ C " P  #0@  !D              ("!IZ\! 'AL+W=O<FMS:&5E=',O
M<VAE970W,"YX;6Q02P$"% ,4    " !,@7%4Q)9IV/,"  "_"   &0
M        @('@L@$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0
M   ( $R!<52\Q,$)%P,   <*   9              " @0JV 0!X;"]W;W)K
M<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ 3(%Q5%"B7Z9E P  NPL
M !D              ("!6+D! 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q0
M2P$"% ,4    " !,@7%4][@)^:,#   N#   &0              @('TO $
M>&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( $R!<52(LDUW
M4P,  +D*   9              " @<[  0!X;"]W;W)K<VAE971S+W-H965T
M-S4N>&UL4$L! A0#%     @ 3(%Q5*\S=<TO P  ;P@  !D
M ("!6,0! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " !,
M@7%4''O@/+ "  "V!@  &0              @(&^QP$ >&PO=V]R:W-H965T
M<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( $R!<53G-:K_G@4  &P:   9
M          " @:7* 0!X;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#
M%     @ 3(%Q5-E8@+4K P  %!,   T              ( !>M ! 'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " !,@7%4EXJ[',     3 @  "P
M    @ '0TP$ 7W)E;',O+G)E;'-02P$"% ,4    " !,@7%4[RBL-^L%   [
M,P  #P              @ &YU $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ 3(%Q5'H$ UU< @  (2X  !H              ( !T=H! 'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 3(%Q5"XH"M@5 @  _"P
M !,              ( !9=T! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/ %8 5@"1%P  J]\!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>190</ContextCount>
  <ElementCount>497</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1007009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - NATURE OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/NATUREOFOPERATIONS</Role>
      <ShortName>NATURE OF OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - BUSINESS COMBINATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/BUSINESSCOMBINATION</Role>
      <ShortName>BUSINESS COMBINATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2118104 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2120105 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2123106 - Disclosure - MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/MARKETABLESECURITIES</Role>
      <ShortName>MARKETABLE SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2127107 - Disclosure - INVENTORY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INVENTORY</Role>
      <ShortName>INVENTORY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2131108 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENT</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2135109 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/ACCRUEDEXPENSES</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2138110 - Disclosure - OPERATING LEASE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/OPERATINGLEASE</Role>
      <ShortName>OPERATING LEASE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2145111 - Disclosure - EMPLOYEE SAVINGS PLAN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLAN</Role>
      <ShortName>EMPLOYEE SAVINGS PLAN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2147112 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2148113 - Disclosure - LONG-TERM DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/LONGTERMDEBT</Role>
      <ShortName>LONG-TERM DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2150114 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2152115 - Disclosure - SHARE BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATION</Role>
      <ShortName>SHARE BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2160116 - Disclosure - INCOME TAX</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INCOMETAX</Role>
      <ShortName>INCOME TAX</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2168117 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - BUSINESS COMBINATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/BUSINESSCOMBINATIONTables</Role>
      <ShortName>BUSINESS COMBINATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/BUSINESSCOMBINATION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2321303 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2324304 - Disclosure - MARKETABLE SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/MARKETABLESECURITIESTables</Role>
      <ShortName>MARKETABLE SECURITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/MARKETABLESECURITIES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2328305 - Disclosure - INVENTORY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INVENTORYTables</Role>
      <ShortName>INVENTORY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/INVENTORY</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2332306 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENT</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/ACCRUEDEXPENSESTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/ACCRUEDEXPENSES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2339308 - Disclosure - OPERATING LEASE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/OPERATINGLEASETables</Role>
      <ShortName>OPERATING LEASE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/OPERATINGLEASE</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2353309 - Disclosure - SHARE BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONTables</Role>
      <ShortName>SHARE BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATION</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2361310 - Disclosure - INCOME TAX (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INCOMETAXTables</Role>
      <ShortName>INCOME TAX (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/INCOMETAX</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - NATURE OF OPERATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails</Role>
      <ShortName>NATURE OF OPERATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/NATUREOFOPERATIONS</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Life (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Life (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Equity Awards Not Included in the Calculation of EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Equity Awards Not Included in the Calculation of EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Concentrations of Credit Risks (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES - Concentrations of Credit Risks (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - BUSINESS COMBINATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails</Role>
      <ShortName>BUSINESS COMBINATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - BUSINESS COMBINATION - Consideration Transferred in Merger (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails</Role>
      <ShortName>BUSINESS COMBINATION - Consideration Transferred in Merger (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - BUSINESS COMBINATION - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails</Role>
      <ShortName>BUSINESS COMBINATION - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - BUSINESS COMBINATION - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails</Role>
      <ShortName>BUSINESS COMBINATION - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2416410 - Disclosure - BUSINESS COMBINATION - IPRD and CSR (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails</Role>
      <ShortName>BUSINESS COMBINATION - IPRD and CSR (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2417411 - Disclosure - BUSINESS COMBINATION - Pro Forma (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails</Role>
      <ShortName>BUSINESS COMBINATION - Pro Forma (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2419412 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/REVENUERECOGNITION</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2422413 - Disclosure - FAIR VALUE MEASUREMENT - Assets and Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENT - Assets and Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - MARKETABLE SECURITIES - Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails</Role>
      <ShortName>MARKETABLE SECURITIES - Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2426415 - Disclosure - MARKETABLE SECURITIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/MARKETABLESECURITIESNarrativeDetails</Role>
      <ShortName>MARKETABLE SECURITIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - INVENTORY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INVENTORYNarrativeDetails</Role>
      <ShortName>INVENTORY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - INVENTORY - Schedule of Inventory Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails</Role>
      <ShortName>INVENTORY - Schedule of Inventory Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTNarrativeDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2437420 - Disclosure - ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails</Role>
      <ShortName>ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/ACCRUEDEXPENSESTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2440421 - Disclosure - OPERATING LEASE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails</Role>
      <ShortName>OPERATING LEASE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2441422 - Disclosure - OPERATING LEASE - Schedule of Operating Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails</Role>
      <ShortName>OPERATING LEASE - Schedule of Operating Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2442423 - Disclosure - OPERATING LEASE - Schedule of Cash Paid for Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails</Role>
      <ShortName>OPERATING LEASE - Schedule of Cash Paid for Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2443424 - Disclosure - OPERATING LEASE - Schedule of Supplemental Information Related to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails</Role>
      <ShortName>OPERATING LEASE - Schedule of Supplemental Information Related to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2444425 - Disclosure - OPERATING LEASE - Schedule of Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>OPERATING LEASE - Schedule of Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - EMPLOYEE SAVINGS PLAN (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLANDetails</Role>
      <ShortName>EMPLOYEE SAVINGS PLAN (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLAN</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - LONG-TERM DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/LONGTERMDEBTDetails</Role>
      <ShortName>LONG-TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/LONGTERMDEBT</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2451428 - Disclosure - STOCKHOLDERS' EQUITY - Common Stock, Preferred Stock, and Warrants Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Common Stock, Preferred Stock, and Warrants Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2454429 - Disclosure - SHARE BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>SHARE BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2455430 - Disclosure - Compensation Related Costs, Share Based Payments - Options and RSU Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails</Role>
      <ShortName>Compensation Related Costs, Share Based Payments - Options and RSU Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2456431 - Disclosure - Compensation Related Costs, Share Based Payments - Schedule of Underlying Data Used for Computing the Fair Value of the Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails</Role>
      <ShortName>Compensation Related Costs, Share Based Payments - Schedule of Underlying Data Used for Computing the Fair Value of the Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2457432 - Disclosure - Compensation Related Costs, Share Based Payments - Summary of the Number of Options Outstanding Under the Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails</Role>
      <ShortName>Compensation Related Costs, Share Based Payments - Summary of the Number of Options Outstanding Under the Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2458433 - Disclosure - Compensation Related Costs, Share Based Payments - Summary of Number of RSUs Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails</Role>
      <ShortName>Compensation Related Costs, Share Based Payments - Summary of Number of RSUs Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2459434 - Disclosure - SHARE BASED COMPENSATION - Schedule of Share-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails</Role>
      <ShortName>SHARE BASED COMPENSATION - Schedule of Share-based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2462435 - Disclosure - INCOME TAX - Schedule of Income (Loss) Before Income Tax Taxes and Current Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails</Role>
      <ShortName>INCOME TAX - Schedule of Income (Loss) Before Income Tax Taxes and Current Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2463436 - Disclosure - INCOME TAX - Income Tax Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails</Role>
      <ShortName>INCOME TAX - Income Tax Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2464437 - Disclosure - INCOME TAX - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails</Role>
      <ShortName>INCOME TAX - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2465438 - Disclosure - INCOME TAX - Schedule of Deferred Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails</Role>
      <ShortName>INCOME TAX - Schedule of Deferred Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2466439 - Disclosure - INCOME TAX - Schedule of Activity of the Company Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>INCOME TAX - Schedule of Activity of the Company Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2467440 - Disclosure - INCOME TAX- Schedule of Rollforward of Valuation Allowance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/INCOMETAXScheduleofRollforwardofValuationAllowanceDetails</Role>
      <ShortName>INCOME TAX- Schedule of Rollforward of Valuation Allowance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="vyne-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2469441 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://vynetherapeutics.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="vyne-20211231.htm">vyne-20211231.htm</File>
    <File>exhibit1012-stuartexecut.htm</File>
    <File>exhibit1013-zerondaxexec.htm</File>
    <File>exhibit211listofsubsidiari.htm</File>
    <File>exhibit231consentus2.htm</File>
    <File>exhibit31vynecertificateof.htm</File>
    <File>exhibit412.htm</File>
    <File>vyne-20211231.xsd</File>
    <File>vyne-20211231_cal.xml</File>
    <File>vyne-20211231_def.xml</File>
    <File>vyne-20211231_lab.xml</File>
    <File>vyne-20211231_pre.xml</File>
    <File>vyne-20211231xexx311.htm</File>
    <File>vyne-20211231xexx312.htm</File>
    <File>vyne-20211231xexx321.htm</File>
    <File>vyne-20211231xexx322.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>vyne-20211231_g1.jpg</File>
    <File>vyne-20211231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="680">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>136
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "vyne-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 27,
   "contextCount": 190,
   "dts": {
    "calculationLink": {
     "local": [
      "vyne-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "vyne-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "vyne-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vyne-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vyne-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vyne-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 623,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 2,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 6
   },
   "keyCustom": 63,
   "keyStandard": 434,
   "memberCustom": 30,
   "memberStandard": 38,
   "nsprefix": "vyne",
   "nsuri": "http://vynetherapeutics.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://vynetherapeutics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - NATURE OF OPERATIONS",
     "role": "http://vynetherapeutics.com/role/NATUREOFOPERATIONS",
     "shortName": "NATURE OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - BUSINESS COMBINATION",
     "role": "http://vynetherapeutics.com/role/BUSINESSCOMBINATION",
     "shortName": "BUSINESS COMBINATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118104 - Disclosure - REVENUE RECOGNITION",
     "role": "http://vynetherapeutics.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120105 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123106 - Disclosure - MARKETABLE SECURITIES",
     "role": "http://vynetherapeutics.com/role/MARKETABLESECURITIES",
     "shortName": "MARKETABLE SECURITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127107 - Disclosure - INVENTORY",
     "role": "http://vynetherapeutics.com/role/INVENTORY",
     "shortName": "INVENTORY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131108 - Disclosure - PROPERTY AND EQUIPMENT",
     "role": "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135109 - Disclosure - ACCRUED EXPENSES",
     "role": "http://vynetherapeutics.com/role/ACCRUEDEXPENSES",
     "shortName": "ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138110 - Disclosure - OPERATING LEASE",
     "role": "http://vynetherapeutics.com/role/OPERATINGLEASE",
     "shortName": "OPERATING LEASE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://vynetherapeutics.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145111 - Disclosure - EMPLOYEE SAVINGS PLAN",
     "role": "http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLAN",
     "shortName": "EMPLOYEE SAVINGS PLAN",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147112 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://vynetherapeutics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148113 - Disclosure - LONG-TERM DEBT",
     "role": "http://vynetherapeutics.com/role/LONGTERMDEBT",
     "shortName": "LONG-TERM DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150114 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152115 - Disclosure - SHARE BASED COMPENSATION",
     "role": "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATION",
     "shortName": "SHARE BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160116 - Disclosure - INCOME TAX",
     "role": "http://vynetherapeutics.com/role/INCOMETAX",
     "shortName": "INCOME TAX",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2168117 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://vynetherapeutics.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vyne:ScheduleOfBusinessAcquisitionConsiderationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - BUSINESS COMBINATION (Tables)",
     "role": "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONTables",
     "shortName": "BUSINESS COMBINATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vyne:ScheduleOfBusinessAcquisitionConsiderationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321303 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324304 - Disclosure - MARKETABLE SECURITIES (Tables)",
     "role": "http://vynetherapeutics.com/role/MARKETABLESECURITIESTables",
     "shortName": "MARKETABLE SECURITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328305 - Disclosure - INVENTORY (Tables)",
     "role": "http://vynetherapeutics.com/role/INVENTORYTables",
     "shortName": "INVENTORY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332306 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "role": "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTTables",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - ACCRUED EXPENSES (Tables)",
     "role": "http://vynetherapeutics.com/role/ACCRUEDEXPENSESTables",
     "shortName": "ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339308 - Disclosure - OPERATING LEASE (Tables)",
     "role": "http://vynetherapeutics.com/role/OPERATINGLEASETables",
     "shortName": "OPERATING LEASE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vyne:ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353309 - Disclosure - SHARE BASED COMPENSATION (Tables)",
     "role": "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vyne:ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vyne:ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2361310 - Disclosure - INCOME TAX (Tables)",
     "role": "http://vynetherapeutics.com/role/INCOMETAXTables",
     "shortName": "INCOME TAX (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vyne:ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - NATURE OF OPERATIONS (Details)",
     "role": "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
     "shortName": "NATURE OF OPERATIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "role": "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i0a6e3943e4f3499aa05c5f1b79ea9be6_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Life (Details)",
     "role": "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Life (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i0a6e3943e4f3499aa05c5f1b79ea9be6_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "icb7ed5c301ca4a1fb4df13b64075b204_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Equity Awards Not Included in the Calculation of EPS (Details)",
     "role": "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Equity Awards Not Included in the Calculation of EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "icb7ed5c301ca4a1fb4df13b64075b204_D20210101-20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i748a6a56555e4b559d51845f4cf5e925_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Concentrations of Credit Risks (Details)",
     "role": "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Concentrations of Credit Risks (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i748a6a56555e4b559d51845f4cf5e925_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ic28ecddbecb14089bf87f872b42485b0_I20200406",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vyne:ContingentStockRightSharesConversion",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - BUSINESS COMBINATION - Narrative (Details)",
     "role": "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
     "shortName": "BUSINESS COMBINATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ib45ce728bc654fcfa244d5ed617dd7c0_D20200407-20200407",
      "decimals": "2",
      "lang": "en-US",
      "name": "vyne:PostMergerParentOwnershipByPreMergerSubsidiaryShareholders",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - BUSINESS COMBINATION - Consideration Transferred in Merger (Details)",
     "role": "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails",
     "shortName": "BUSINESS COMBINATION - Consideration Transferred in Merger (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i0a1d7f6aa47048de87fc3398f7868341_D20200309-20200309",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i4ea3fe3e2a474e2c836df31770569ca5_D20200309-20200309",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vyne:BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - BUSINESS COMBINATION - Purchase Price Allocation (Details)",
     "role": "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails",
     "shortName": "BUSINESS COMBINATION - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ic9db52a2ac30420c84e995e7b348eeb8_I20200309",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ic9db52a2ac30420c84e995e7b348eeb8_I20200309",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - BUSINESS COMBINATION - Goodwill (Details)",
     "role": "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails",
     "shortName": "BUSINESS COMBINATION - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ic9db52a2ac30420c84e995e7b348eeb8_I20200309",
      "decimals": "-3",
      "lang": "en-US",
      "name": "vyne:BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vyne:ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ic9db52a2ac30420c84e995e7b348eeb8_I20200309",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416410 - Disclosure - BUSINESS COMBINATION - IPRD and CSR (Details)",
     "role": "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails",
     "shortName": "BUSINESS COMBINATION - IPRD and CSR (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vyne:ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ic9db52a2ac30420c84e995e7b348eeb8_I20200309",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417411 - Disclosure - BUSINESS COMBINATION - Pro Forma (Details)",
     "role": "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails",
     "shortName": "BUSINESS COMBINATION - Pro Forma (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i55b9cf8f47e248d2acc110453d3bd079_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vyne:RevenueRecognitionDistributionTradeDiscountsAndAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419412 - Disclosure - REVENUE RECOGNITION (Details)",
     "role": "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "vyne:RevenueRecognitionDistributionTradeDiscountsAndAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422413 - Disclosure - FAIR VALUE MEASUREMENT - Assets and Liabilities Measured at Fair Value (Details)",
     "role": "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENT - Assets and Liabilities Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - MARKETABLE SECURITIES - Marketable Securities (Details)",
     "role": "http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails",
     "shortName": "MARKETABLE SECURITIES - Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426415 - Disclosure - MARKETABLE SECURITIES - Narrative (Details)",
     "role": "http://vynetherapeutics.com/role/MARKETABLESECURITIESNarrativeDetails",
     "shortName": "MARKETABLE SECURITIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryWriteDown",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - INVENTORY - Narrative (Details)",
     "role": "http://vynetherapeutics.com/role/INVENTORYNarrativeDetails",
     "shortName": "INVENTORY - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryWriteDown",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - INVENTORY - Schedule of Inventory Components (Details)",
     "role": "http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails",
     "shortName": "INVENTORY - Schedule of Inventory Components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details)",
     "role": "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
     "shortName": "PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details)",
     "role": "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTNarrativeDetails",
     "shortName": "PROPERTY AND EQUIPMENT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfPropertyHeldForSale",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "vyne:AccruedSalesProvisionsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437420 - Disclosure - ACCRUED EXPENSES (Details)",
     "role": "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails",
     "shortName": "ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "vyne:AccruedSalesProvisionsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "vyne:OperatingLeaseRightOfUseAssetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440421 - Disclosure - OPERATING LEASE - Narrative (Details)",
     "role": "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails",
     "shortName": "OPERATING LEASE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vyne:RestrictedInvestmentsToSecureLeaseAgreements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i095f99f5dad646848e17f3e6cf867662_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441422 - Disclosure - OPERATING LEASE - Schedule of Operating Lease Expense (Details)",
     "role": "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails",
     "shortName": "OPERATING LEASE - Schedule of Operating Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i095f99f5dad646848e17f3e6cf867662_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "role": "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i095f99f5dad646848e17f3e6cf867662_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442423 - Disclosure - OPERATING LEASE - Schedule of Cash Paid for Lease Liabilities (Details)",
     "role": "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails",
     "shortName": "OPERATING LEASE - Schedule of Cash Paid for Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i095f99f5dad646848e17f3e6cf867662_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443424 - Disclosure - OPERATING LEASE - Schedule of Supplemental Information Related to Leases (Details)",
     "role": "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails",
     "shortName": "OPERATING LEASE - Schedule of Supplemental Information Related to Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444425 - Disclosure - OPERATING LEASE - Schedule of Maturities of Lease Liabilities (Details)",
     "role": "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails",
     "shortName": "OPERATING LEASE - Schedule of Maturities of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - EMPLOYEE SAVINGS PLAN (Details)",
     "role": "http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLANDetails",
     "shortName": "EMPLOYEE SAVINGS PLAN (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ia7de8816c3eb465d9f44397038347e0a_I20210811",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vyne:RepaymentOfDebtPrepaymentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - LONG-TERM DEBT (Details)",
     "role": "http://vynetherapeutics.com/role/LONGTERMDEBTDetails",
     "shortName": "LONG-TERM DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ia7de8816c3eb465d9f44397038347e0a_I20210811",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vyne:RepaymentOfDebtPrepaymentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451428 - Disclosure - STOCKHOLDERS' EQUITY - Common Stock, Preferred Stock, and Warrants Narrative (Details)",
     "role": "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Common Stock, Preferred Stock, and Warrants Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5f0643079f4b4a46a6f72aa2aa70777a_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "vyne:DeemedDividendToWarrantsHoldersDueToWarrantModification",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ic28ecddbecb14089bf87f872b42485b0_I20200406",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "vyne:ContingentStockRightSharesConversion",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454429 - Disclosure - SHARE BASED COMPENSATION - Narrative (Details)",
     "role": "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "SHARE BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455430 - Disclosure - Compensation Related Costs, Share Based Payments - Options and RSU Grants (Details)",
     "role": "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
     "shortName": "Compensation Related Costs, Share Based Payments - Options and RSU Grants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vyne:ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ic28ecddbecb14089bf87f872b42485b0_I20200406",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456431 - Disclosure - Compensation Related Costs, Share Based Payments - Schedule of Underlying Data Used for Computing the Fair Value of the Options (Details)",
     "role": "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails",
     "shortName": "Compensation Related Costs, Share Based Payments - Schedule of Underlying Data Used for Computing the Fair Value of the Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "ic9168dcbd62643b79352fd44dc90440d_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457432 - Disclosure - Compensation Related Costs, Share Based Payments - Summary of the Number of Options Outstanding Under the Plan (Details)",
     "role": "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails",
     "shortName": "Compensation Related Costs, Share Based Payments - Summary of the Number of Options Outstanding Under the Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "if47e65e7cf8947d280a6cd3bc2ec52ee_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "role": "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "if47e65e7cf8947d280a6cd3bc2ec52ee_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "iedd0ba546c49493ba7382642df9946c7_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458433 - Disclosure - Compensation Related Costs, Share Based Payments - Summary of Number of RSUs Outstanding (Details)",
     "role": "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails",
     "shortName": "Compensation Related Costs, Share Based Payments - Summary of Number of RSUs Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i23969f5a8552485eb663535fe65f545a_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459434 - Disclosure - SHARE BASED COMPENSATION - Schedule of Share-based Compensation (Details)",
     "role": "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails",
     "shortName": "SHARE BASED COMPENSATION - Schedule of Share-based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i4f658b6e836f41c9b28abeb2f9bc238f_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vyne:ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462435 - Disclosure - INCOME TAX - Schedule of Income (Loss) Before Income Tax Taxes and Current Tax Expense (Details)",
     "role": "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails",
     "shortName": "INCOME TAX - Schedule of Income (Loss) Before Income Tax Taxes and Current Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "vyne:ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463436 - Disclosure - INCOME TAX - Income Tax Reconciliation (Details)",
     "role": "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails",
     "shortName": "INCOME TAX - Income Tax Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i415666db8d7a40719c40bd0b1f9fa2de_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464437 - Disclosure - INCOME TAX - Narrative (Details)",
     "role": "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails",
     "shortName": "INCOME TAX - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "icef12beb3e494c14b255e4114f030a13_D20201201-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "vyne:LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465438 - Disclosure - INCOME TAX - Schedule of Deferred Income Taxes (Details)",
     "role": "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails",
     "shortName": "INCOME TAX - Schedule of Deferred Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i415666db8d7a40719c40bd0b1f9fa2de_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466439 - Disclosure - INCOME TAX - Schedule of Activity of the Company Unrecognized Tax Benefits (Details)",
     "role": "http://vynetherapeutics.com/role/INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails",
     "shortName": "INCOME TAX - Schedule of Activity of the Company Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i415666db8d7a40719c40bd0b1f9fa2de_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467440 - Disclosure - INCOME TAX- Schedule of Rollforward of Valuation Allowance (Details)",
     "role": "http://vynetherapeutics.com/role/INCOMETAXScheduleofRollforwardofValuationAllowanceDetails",
     "shortName": "INCOME TAX- Schedule of Rollforward of Valuation Allowance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469441 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "role": "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "id7f1ccafb608431fb6c6c1da15102473_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)",
     "role": "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vyne-20211231.htm",
      "contextRef": "i5c93a1c774774356afee639d2e955920_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 70,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails",
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r677",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails",
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vynetherapeutics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r205",
      "r354",
      "r359",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r281",
      "r311",
      "r382",
      "r385",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r627",
      "r631",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r281",
      "r311",
      "r382",
      "r385",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r627",
      "r631",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r205",
      "r354",
      "r359",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficeBuildingMember": {
     "auth_ref": [
      "r655",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Building [Member]",
        "terseLabel": "Office lease expenses"
       }
      }
     },
     "localname": "OfficeBuildingMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r202",
      "r354",
      "r357",
      "r566",
      "r626",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r202",
      "r354",
      "r357",
      "r566",
      "r626",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r281",
      "r311",
      "r361",
      "r382",
      "r385",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r627",
      "r631",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r281",
      "r311",
      "r361",
      "r382",
      "r385",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r627",
      "r631",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r149",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r149",
      "r154",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r203",
      "r204",
      "r354",
      "r358",
      "r629",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r203",
      "r204",
      "r354",
      "r358",
      "r629",
      "r655",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r149",
      "r154",
      "r263",
      "r383",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r14",
      "r56"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r8",
      "r38",
      "r206",
      "r207"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivable, net of allowances"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued Liabilities, Current",
        "totalLabel": "Total Accrued Expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails",
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Costs, Current",
        "terseLabel": "Marketing"
       }
      }
     },
     "localname": "AccruedMarketingCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r61"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r54",
      "r246"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r41",
      "r77",
      "r78",
      "r79",
      "r616",
      "r636",
      "r637"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r76",
      "r79",
      "r89",
      "r90",
      "r91",
      "r141",
      "r142",
      "r143",
      "r493",
      "r632",
      "r633",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r39",
      "r423",
      "r549"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r420",
      "r421",
      "r422",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Recognition and Exercise",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments required to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r101",
      "r119",
      "r294",
      "r524"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Discount cost"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r135",
      "r191",
      "r194",
      "r200",
      "r222",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r489",
      "r495",
      "r513",
      "r547",
      "r549",
      "r585",
      "r613"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total\u00a0 Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r74",
      "r135",
      "r222",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r489",
      "r495",
      "r513",
      "r547",
      "r549"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r135",
      "r222",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r489",
      "r495",
      "r513",
      "r547"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total\u00a0 Non-current Assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Non-current Assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "terseLabel": "Carrying amount of assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r210",
      "r213",
      "r225",
      "r592"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Debt securities,available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r392",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r381",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r381",
      "r384",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Number of shares issued pursuant to the merger (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "negatedLabel": "Loss per share - basic (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "negatedTerseLabel": "Loss per share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL PRO FORMA COMBINED RESULTS OF OPERATIONS:"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Schedule of Pro Forma"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill deductible for income tax purposes"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r470",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "negatedLabel": "Net loss"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r470",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r478",
      "r479",
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration net of the effect of CSRs"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails": {
       "order": 1.0,
       "parentTag": "vyne_BusinessCombinationConsiderationTransferredGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Deemed (for accounting purposes only) issuance of Foamix shares to Menlo stockholders"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r477",
      "r480",
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration, fair value of liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Goodwill [Abstract]",
        "terseLabel": "Business Combination, Goodwill [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Loss attributable to Menlo"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities",
        "terseLabel": "Investment in marketable securities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Acquired indefinite life intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "totalLabel": "Fair value of identified intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill [Abstract]",
        "terseLabel": "In-Process Research and Development"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]",
        "terseLabel": "Allocations of purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalLeaseObligationsIncurred": {
     "auth_ref": [
      "r124",
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in lease obligation from new lease.",
        "label": "Lease Obligation Incurred",
        "terseLabel": "Additions to operating lease liabilities"
       }
      }
     },
     "localname": "CapitalLeaseObligationsIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash acquired through merger"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r51",
      "r121"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r20",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "terseLabel": "Cash and investments"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r114",
      "r121",
      "r127"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of the year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of the year",
        "totalLabel": "Total cash, cash equivalents and restricted cash shown in statement of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r114",
      "r514"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "(Decrease) Increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Number of ordinary shares that may be purchased by exercise of warrants (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r65",
      "r262",
      "r594",
      "r620"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r264",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r265",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r141",
      "r142",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r37",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r37",
      "r549"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock: $0.0001 par value; 150,000,000 shares and 75,000,000 shares authorized at December\u00a031, 2021 and December\u00a031, 2020, respectively; 53,577,744 and 43,205,221 shares issued and outstanding at December\u00a031, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r84",
      "r86",
      "r87",
      "r95",
      "r598",
      "r622"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "negatedTotalLabel": "Total Comprehensive Loss",
        "terseLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computers"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r178",
      "r179",
      "r205",
      "r508",
      "r509",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r178",
      "r179",
      "r205",
      "r508",
      "r509",
      "r638",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r178",
      "r179",
      "r205",
      "r508",
      "r509",
      "r638",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r173",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of credit risks"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Product Sales"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r178",
      "r179",
      "r205",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r176",
      "r178",
      "r179",
      "r180",
      "r508",
      "r510",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r178",
      "r179",
      "r205",
      "r508",
      "r509",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r129",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r335",
      "r336",
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Revenue reserve accrual"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r99",
      "r566"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Operating Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating Expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r452",
      "r459"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r452",
      "r459",
      "r460"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current taxes:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r452",
      "r459"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r177",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customers"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r29",
      "r31",
      "r32",
      "r134",
      "r139",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r299",
      "r300",
      "r301",
      "r302",
      "r527",
      "r586",
      "r588",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r32",
      "r296",
      "r588",
      "r611"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r278",
      "r299",
      "r300",
      "r525",
      "r527",
      "r528"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r63",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Base interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r64",
      "r134",
      "r139",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r299",
      "r300",
      "r301",
      "r302",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r64",
      "r607"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Principal amount, interest and prepayment premium"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r64",
      "r134",
      "r139",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r299",
      "r300",
      "r301",
      "r302",
      "r326",
      "r329",
      "r330",
      "r331",
      "r524",
      "r525",
      "r527",
      "r528",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Issuance Costs, Net [Abstract]",
        "terseLabel": "Debt offering expenses"
       }
      }
     },
     "localname": "DeferredFinanceCostsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r34",
      "r35",
      "r443",
      "r587",
      "r610"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total gross deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r444"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r446"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r450",
      "r451"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carry forward"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r450",
      "r451"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "verboseLabel": "Accrued expenses and other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r449",
      "r450",
      "r451"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "verboseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r450",
      "r451"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Share based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r445"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less - valuation allowance",
        "periodEndLabel": "Balance at the end of period",
        "periodStartLabel": "Balance at the beginning of the period",
        "terseLabel": "Deferred tax assets, valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails",
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails",
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofRollforwardofValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r450",
      "r451"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Right of use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r450",
      "r451"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r380"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Company contributions to 401(k) plans"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLANDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r119",
      "r189"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "SHARE BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Contingent consideration receivable",
        "verboseLabel": "Cash consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails",
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r96",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r155",
      "r157",
      "r159",
      "r160",
      "r161",
      "r164",
      "r165",
      "r498",
      "r499",
      "r599",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Loss per share basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r96",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r157",
      "r159",
      "r160",
      "r161",
      "r164",
      "r165",
      "r498",
      "r499",
      "r599",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Loss per share diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Loss per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r137",
      "r432",
      "r461"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal income tax provision at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r432",
      "r461"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowances"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r432",
      "r461"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign tax rate differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r432",
      "r461"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income tax provision, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee-related obligations"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r417"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based payment cost not yet recognized, weighted average period of recognition (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r417"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share based compensation expense, options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r89",
      "r90",
      "r91",
      "r141",
      "r142",
      "r143",
      "r145",
      "r151",
      "r153",
      "r167",
      "r223",
      "r325",
      "r332",
      "r420",
      "r421",
      "r422",
      "r455",
      "r456",
      "r497",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r632",
      "r633",
      "r634",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r500",
      "r501",
      "r502",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r500",
      "r501",
      "r502",
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r287",
      "r299",
      "r300",
      "r362",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r377",
      "r501",
      "r554",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueConcentrationOfRiskTable": {
     "auth_ref": [
      "r508",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties. Such disclosure may also include quantitative information about the market risks of financial instruments that is consistent with the way the Company manages or adjusts those risks.",
        "label": "Fair Value, Concentration of Risk [Table]",
        "terseLabel": "Fair Value, Concentration of Risk [Table]"
       }
      }
     },
     "localname": "FairValueConcentrationOfRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r287",
      "r362",
      "r364",
      "r369",
      "r377",
      "r501",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r287",
      "r299",
      "r300",
      "r362",
      "r364",
      "r369",
      "r377",
      "r501",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r287",
      "r299",
      "r300",
      "r362",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r377",
      "r554",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair value measurement"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r236",
      "r237",
      "r240",
      "r241",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r236",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r119",
      "r494"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "terseLabel": "Estimated gain on sale of MST Franchise"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r119",
      "r303",
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Gain (loss) on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r303",
      "r304"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.",
        "label": "Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost",
        "negatedTerseLabel": "Debt prepayment premium"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r230",
      "r232",
      "r549",
      "r584"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill and in-process research &amp; development impairments"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r234",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and other indefinite lived intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r119",
      "r231",
      "r233",
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r387",
      "r388",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r119",
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "In process research and development impairment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r119",
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment of long-lived assets to be disposed of"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r243",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r93",
      "r191",
      "r193",
      "r196",
      "r199",
      "r201",
      "r581",
      "r596",
      "r601",
      "r624"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "negatedLabel": "Total loss before taxes",
        "negatedTotalLabel": "Loss Before Income Tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Loss before income taxes:"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r248",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails",
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails",
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r137",
      "r433",
      "r441",
      "r448",
      "r457",
      "r462",
      "r464",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAX"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAX"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]",
        "terseLabel": "Income Tax Examination [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]",
        "terseLabel": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofIncomeLossBeforeIncomeTaxTaxesandCurrentTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r152",
      "r153",
      "r190",
      "r431",
      "r458",
      "r463",
      "r625"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income Tax (Benefit) Expense (Note 16)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r88",
      "r429",
      "r430",
      "r441",
      "r442",
      "r447",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "(Decrease) in accounts payable and accruals"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "(Decrease) increase in inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating asset and liabilities, net of effects of businesses acquired:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Decrease (increase) in other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Decrease (increase) in other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Decrease (increase) in trade receivables, prepaid and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r92",
      "r188",
      "r523",
      "r526",
      "r600"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r101",
      "r292",
      "r298",
      "r301",
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r113",
      "r116",
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORY"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INVENTORY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r7",
      "r72",
      "r549"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory (Note 7)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r73",
      "r130",
      "r166",
      "r226",
      "r228",
      "r229",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSupplies": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.",
        "label": "Inventory, Raw Materials and Supplies, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSupplies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INVENTORYScheduleofInventoryComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INVENTORYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r221",
      "r582",
      "r605",
      "r654",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "verboseLabel": "MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Operating Lease"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r541"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r541"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r541"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r541"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "OPERATING LEASE"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r59",
      "r135",
      "r195",
      "r222",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r490",
      "r495",
      "r496",
      "r513",
      "r547",
      "r548"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r44",
      "r135",
      "r222",
      "r513",
      "r549",
      "r589",
      "r618"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r62",
      "r135",
      "r222",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r490",
      "r495",
      "r496",
      "r513",
      "r547",
      "r548",
      "r549"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r32",
      "r33",
      "r135",
      "r222",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r490",
      "r495",
      "r496",
      "r513",
      "r547",
      "r548"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total Long-term Liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Long-term Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Liabilities transferred"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicenseMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License [Member]",
        "terseLabel": "License revenues"
       }
      }
     },
     "localname": "LicenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licensing Agreements"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "One-month LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r32",
      "r286",
      "r297",
      "r299",
      "r300",
      "r588",
      "r614"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Debt outstanding"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt (Note 13)"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "LONG-TERM DEBT"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/FAIRVALUEMEASUREMENTAssetsandLiabilitiesMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r9",
      "r60"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Investment in marketable securities (Note 6)"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r170",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "NATURE OF OPERATIONS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash Flows From Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash Flows From Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r114",
      "r117",
      "r120"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Cash used in operations",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash Flows From Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r82",
      "r85",
      "r91",
      "r94",
      "r120",
      "r135",
      "r144",
      "r146",
      "r147",
      "r148",
      "r149",
      "r152",
      "r153",
      "r158",
      "r191",
      "r193",
      "r196",
      "r199",
      "r201",
      "r222",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r499",
      "r513",
      "r597",
      "r621"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "negatedLabel": "Net Loss",
        "negatedTerseLabel": "Net loss",
        "negatedTotalLabel": "Net Loss",
        "terseLabel": "Net Loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Newly issued and recently adopted accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplementary information on investing and financing activities not involving cash flows:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1": {
     "auth_ref": [
      "r124",
      "r125",
      "r126"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.",
        "label": "Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)",
        "totalLabel": "Net acquired (See \u201cNote 3- Business combination\u201d)"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": {
     "auth_ref": [
      "r124",
      "r125",
      "r126"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1": {
     "auth_ref": [
      "r124",
      "r125",
      "r126"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Liabilities Assumed",
        "terseLabel": "Less liabilities assumed"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office furniture and equipment"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r191",
      "r193",
      "r196",
      "r199",
      "r201"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "negatedTotalLabel": "Operating Loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r531"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r530"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liability",
        "verboseLabel": "Operating lease, right-of-use liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofMaturitiesofLeaseLiabilitiesDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r530"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities (Note10)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r530"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Operating lease liabilities (Note 10)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r532",
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right of use assets (Note 10)",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r539",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r538",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofSupplementalInformationRelatedtoLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r61"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r83",
      "r86",
      "r487",
      "r488",
      "r492"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "negatedTotalLabel": "Total Other Comprehensive Loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other Comprehensive Loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r77",
      "r80",
      "r81",
      "r220"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "terseLabel": "Losses on marketable securities reclassified into net loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r75",
      "r77"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "negatedLabel": "Net unrealized gains from marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r61",
      "r549"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Non-cash other expense (income), net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other expense (income), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale": {
     "auth_ref": [
      "r212"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale",
        "terseLabel": "Permanent impairment loss, debt securities, available for sale"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.",
        "label": "Payment of Financing and Stock Issuance Costs",
        "verboseLabel": "Incurred expenses related to Credit Agreement and Securities Purchase Agreement"
       }
      }
     },
     "localname": "PaymentOfFinancingAndStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "terseLabel": "debt prepayment penalty"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Payments of stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITYParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Withholding tax from net exercise of restricted share units"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of fixed assets"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r361",
      "r363",
      "r369",
      "r370",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "EMPLOYEE SAVINGS PLAN"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/EMPLOYEESAVINGSPLAN"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r392",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r36",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r36",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r36",
      "r549"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock: $0.0001 par value; 20,000,000 shares authorized at December\u00a031, 2021 and December\u00a031, 2020, respectively; no shares issued and outstanding at December\u00a031, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r49",
      "r50"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other expenses"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.",
        "label": "Prepaid Expense, Noncurrent",
        "terseLabel": "Prepaid and other expenses"
       }
      }
     },
     "localname": "PrepaidExpenseNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of franchises"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for royalties during the current period.",
        "label": "Proceeds from Royalties Received",
        "terseLabel": "Proceeds from royalties"
       }
      }
     },
     "localname": "ProceedsFromRoyaltiesReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r103",
      "r104",
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sale and maturity of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sale and maturity of marketable securities and bank deposits"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyHeldForSale": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.",
        "label": "Proceeds from Sale of Property Held-for-sale",
        "terseLabel": "Proceeds from sale of fixed assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyHeldForSale",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r108",
      "r419"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of options and issuance of shares under the employee shares purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product sales, net"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r54",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails",
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r251",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r53",
      "r245"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r24",
      "r25",
      "r247",
      "r549",
      "r606",
      "r619"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      },
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net (Note 8)",
        "totalLabel": "Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r52",
      "r247",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r24",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Useful Lives of Property, Plant, and Equipment",
        "verboseLabel": "Property And Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTTables",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r24",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails",
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r97",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provisions for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r45",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r371",
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r371",
      "r544",
      "r546",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Debt repayment (Note 13)",
        "terseLabel": "Debt repayment (Note 13)"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r427",
      "r565",
      "r673"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r20",
      "r121",
      "r127",
      "r583",
      "r615"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "periodEndLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r20",
      "r121",
      "r127"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSU"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected cost remaining for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost Remaining",
        "terseLabel": "Expected cost remaining"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCostRemaining1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "terseLabel": "Number of employees terminated"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r119",
      "r252",
      "r256",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r253",
      "r254",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r40",
      "r332",
      "r423",
      "r549",
      "r617",
      "r635",
      "r637"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r141",
      "r142",
      "r143",
      "r145",
      "r151",
      "r153",
      "r223",
      "r420",
      "r421",
      "r422",
      "r455",
      "r456",
      "r497",
      "r632",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r186",
      "r187",
      "r192",
      "r197",
      "r198",
      "r202",
      "r203",
      "r205",
      "r353",
      "r354",
      "r566"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total Revenues",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r356",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r537",
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Additions to operating lease right of use assets"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalty revenues"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Consideration received in a transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price per share (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r178",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Components of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r390",
      "r415",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r390",
      "r415",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of share-based compensation expenses"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r46",
      "r47",
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INVENTORYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r54",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESEstimatedUsefulLifeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r392",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of the number of RSUs outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r397",
      "r407",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of the number of options outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of underlying data used for computing the fair value of the options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r66",
      "r132",
      "r168",
      "r169",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r314",
      "r318",
      "r323",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r440",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofSharebasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Percentage of fair market value used as purchase price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "RSU, award amount (in shares)",
        "verboseLabel": "Awarded (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Percent of annual earnings that may be used to purchase shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Outstanding and exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Outstanding and exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r418"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r399",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "terseLabel": "Outstanding at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "periodStartLabel": "Outstanding at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost",
        "terseLabel": "Incremental compensation costs incurred"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r389",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryofNumberofRSUsOutstandingDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r392",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Exercise price range, minimum (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Exercise price range, maximum (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r388",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-based Payment Arrangement, Employee [Member]",
        "terseLabel": "Employees and consultants"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "auth_ref": [
      "r387",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-based Payment Arrangement, Nonemployee [Member]",
        "terseLabel": "No longer employed or providing services"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Fair value of stock option",
        "verboseLabel": "Closing share price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsOptionsandRSUGrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r412",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsScheduleofUnderlyingDataUsedforComputingtheFairValueoftheOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r418"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of exercisable options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of exercisable options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term of outstanding options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r30",
      "r590",
      "r591",
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r128",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r68",
      "r89",
      "r90",
      "r91",
      "r141",
      "r142",
      "r143",
      "r145",
      "r151",
      "r153",
      "r167",
      "r223",
      "r325",
      "r332",
      "r420",
      "r421",
      "r422",
      "r455",
      "r456",
      "r497",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r632",
      "r633",
      "r634",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r141",
      "r142",
      "r143",
      "r167",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r124",
      "r125",
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Issuance of shares under employee share purchase plan"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r36",
      "r37",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of stock related to merger (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [
      "r36",
      "r37",
      "r325",
      "r326",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "terseLabel": "Stock issued during the period, conversation units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r36",
      "r37",
      "r325",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares issued during the period (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r36",
      "r37",
      "r325",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r36",
      "r37",
      "r325",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Exercise of options, vesting of restricted stock units and shares under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r36",
      "r37",
      "r325",
      "r332",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CompensationRelatedCostsShareBasedPaymentsSummaryoftheNumberofOptionsOutstandingUnderthePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r68",
      "r325",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of stock related to merger"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r36",
      "r37",
      "r325",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r36",
      "r37",
      "r332",
      "r391",
      "r408"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Exercise of options, vesting of restricted stock units and shares issued under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r37",
      "r42",
      "r43",
      "r135",
      "r209",
      "r222",
      "r513",
      "r549"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r133",
      "r310",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r332",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Reverse stock split ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r521",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r521",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r521",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r521",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r550",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalIncomeStatementElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Income Statement Elements [Abstract]",
        "terseLabel": "Adjustments to the supplemental pro forma combined results of operations, included in the above, are as follows:"
       }
      }
     },
     "localname": "SupplementalIncomeStatementElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability for amount due employees, in addition to wages and any other money that employers owe employees, when their employment ends through a layoff or other termination. For example, a company may provide involuntarily terminated employees with a lump sum payment equal to one week's salary for every year of employment.",
        "label": "Supplemental Unemployment Benefits, Severance Benefits",
        "terseLabel": "Liability for employee severance benefits"
       }
      }
     },
     "localname": "SupplementalUnemploymentBenefitsSeveranceBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r253",
      "r254",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "negatedLabel": "Changes in marketable securities and bank deposits, net"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r428",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at the end of period",
        "periodStartLabel": "Balance at the beginning of the period",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails",
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for current year positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for prior year positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions related to expiration of statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofActivityoftheCompanyUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r171",
      "r172",
      "r174",
      "r175",
      "r181",
      "r182",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedTerseLabel": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase (decrease) in valuation allowance, deferred tax assets"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails",
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofRollforwardofValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "verboseLabel": "Vehicles lease expenses"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofCashPaidforLeaseLiabilitiesDetails",
      "http://vynetherapeutics.com/role/OPERATINGLEASEScheduleofOperatingLeaseExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r156",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r155",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "vyne_A2018PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Plan",
        "label": "2018 Plan [Member]",
        "terseLabel": "2018 Plan"
       }
      }
     },
     "localname": "A2018PlanMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_A2019PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Plan",
        "label": "2019 Plan [Member]",
        "terseLabel": "2019 Plan"
       }
      }
     },
     "localname": "A2019PlanMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_AccruedCommercializedProductCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Commercialized Product Current",
        "label": "Accrued Commercialized Product Current",
        "terseLabel": "Commercialized product accruals"
       }
      }
     },
     "localname": "AccruedCommercializedProductCurrent",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_AccruedResearchAndDevelopmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Research And Development Current",
        "label": "Accrued Research And Development Current",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentCurrent",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_AccruedSalesProvisionsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Sales Provisions Current",
        "label": "Accrued Sales Provisions Current",
        "terseLabel": "Accrued Sales Provisions"
       }
      }
     },
     "localname": "AccruedSalesProvisionsCurrent",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_AdditionalSpaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertaining to the additional leased facility space.",
        "label": "Additional Space [Member]",
        "terseLabel": "Additional Space"
       }
      }
     },
     "localname": "AdditionalSpaceMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails": {
       "order": 2.0,
       "parentTag": "vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of acceleration of stock based compensation as adjustment to pro-forma results of the combined operation after business acquisition.",
        "label": "Adjustments To Supplemental Proforma Acceleration Of Stock Based Compensation",
        "negatedLabel": "Acceleration of stock based compensation"
       }
      }
     },
     "localname": "AdjustmentsToSupplementalProformaAccelerationOfStockBasedCompensation",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of adjustments to supplemental proforma combined results of operations of the combined operation after business acquisition.",
        "label": "Adjustments to Supplemental Proforma Combined Results of Operations",
        "negatedTotalLabel": "Total Adjustments"
       }
      }
     },
     "localname": "AdjustmentsToSupplementalProformaCombinedResultsOfOperations",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_AdjustmentsToSupplementalProformaTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails": {
       "order": 1.0,
       "parentTag": "vyne_AdjustmentsToSupplementalProformaCombinedResultsOfOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount pertaining to transaction costs as adjustment to pro-forma results of the combined operation after business acquisition.",
        "label": "Adjustments To Supplemental Proforma Transaction Costs",
        "negatedLabel": "Transaction costs"
       }
      }
     },
     "localname": "AdjustmentsToSupplementalProformaTransactionCosts",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_AllowanceForSalesReturns1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance For Sales Returns1",
        "label": "Allowance For Sales Returns1 [Member]",
        "terseLabel": "Allowance For Sales Returns"
       }
      }
     },
     "localname": "AllowanceForSalesReturns1Member",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_AmendedAndRestatedCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Amended and Restated Credit Agreement entered into on March 9, 2020.",
        "label": "Amended And Restated Credit Agreement [Member]",
        "terseLabel": "Amended And Restated Credit Agreement"
       }
      }
     },
     "localname": "AmendedAndRestatedCreditAgreementMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_AmendedAndRestatedCreditAgreementTrench1LoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents trench 1 loan of the Amended and Restated Credit Agreement.",
        "label": "Amended And Restated Credit Agreement Trench1 Loan [Member]",
        "terseLabel": "Amended and Restated Credit Agreement, Trench 1 Loan"
       }
      }
     },
     "localname": "AmendedAndRestatedCreditAgreementTrench1LoanMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_AmendedAndRestatedCreditAgreementTrench2LoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents trench 2 loan of the Amended and Restated Credit Agreement.",
        "label": "Amended And Restated Credit Agreement Trench2 Loan [Member]",
        "terseLabel": "Amended and Restated Credit Agreement, Trench 2 Loan"
       }
      }
     },
     "localname": "AmendedAndRestatedCreditAgreementTrench2LoanMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_AmendedAndRestatedCreditAgreementTrench3LoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents trench 3 loan of the Amended and Restated Credit Agreement.",
        "label": "Amended And Restated Credit Agreement Trench3 Loan [Member]",
        "terseLabel": "Amended and Restated Credit Agreement, Trench 3 Loan"
       }
      }
     },
     "localname": "AmendedAndRestatedCreditAgreementTrench3LoanMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "xbrltype": "stringItemType"
    },
    "vyne_BridgewaterNewJerseyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertaining to the location in Bridgewater, New Jersey.",
        "label": "Bridgewater New Jersey [Member]",
        "terseLabel": "Bridgewater, New Jersey"
       }
      }
     },
     "localname": "BridgewaterNewJerseyMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_BusinessAcquisitionContingentStockRightIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of contingent stock right issued in connection with the business acquisition.",
        "label": "Business Acquisition, Contingent Stock Right Issued",
        "terseLabel": "Number of contingent stock rights issued (in CSR)"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentStockRightIssued",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vyne_BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Acquiree Common Stock Rights Converted to Common Stock",
        "label": "Business Combination, Acquiree Common Stock Rights Converted to Common Stock",
        "terseLabel": "Value of CSR converted into additional shares of the combined company"
       }
      }
     },
     "localname": "BusinessCombinationAcquireeCommonStockRightsConvertedToCommonStock",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of net assets acquired including other identifiable intangible assets.",
        "label": "Business Combination Assets Acquired Including Other Identifiable Intangible Assets",
        "negatedLabel": "Less: fair value of net assets acquired, including other identifiable intangibles"
       }
      }
     },
     "localname": "BusinessCombinationAssetsAcquiredIncludingOtherIdentifiableIntangibleAssets",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails": {
       "order": 2.0,
       "parentTag": "vyne_BusinessCombinationConsiderationTransferredGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred consisting of the conversion of equity awards.",
        "label": "Business Combination Consideration Transferred Conversion Of Acquirer Equity Awards",
        "terseLabel": "Deemed (for accounting purposes only) conversion of Menlo equity awards"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredConversionOfAcquirerEquityAwards",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_BusinessCombinationConsiderationTransferredGross": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer prior to the reduction in respect of the contingent stock rights issued to acquired shareholders.",
        "label": "Business Combination Consideration Transferred Gross",
        "terseLabel": "Consideration transferred",
        "totalLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredGross",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_BusinessCombinationEffectiveExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective exchange ratio of ordinary shares for shares of common stock from the merger as adjusted for the conversion of contingent stock rights.",
        "label": "Business Combination, Effective Exchange Ratio",
        "terseLabel": "Effective exchange ratio of Foamix ordinary shares into Menlo common stock"
       }
      }
     },
     "localname": "BusinessCombinationEffectiveExchangeRatio",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "vyne_BusinessCombinationSharesDeemedIssuedForAccountingPurposes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares deemed, for accounting purposes only, to be issued in the merger.",
        "label": "Business Combination Shares Deemed Issued For Accounting Purposes",
        "terseLabel": "Number of shares deemed (for accounting purposes only) issued (in shares)"
       }
      }
     },
     "localname": "BusinessCombinationSharesDeemedIssuedForAccountingPurposes",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "vyne_CantorSalesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cantor Sales Agreement",
        "label": "Cantor Sales Agreement [Member]",
        "terseLabel": "Cantor Sales Agreement"
       }
      }
     },
     "localname": "CantorSalesAgreementMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_ClassOfWarrantAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "n/a",
        "label": "Class Of Warrant [Abstract]",
        "terseLabel": "Warrants issued"
       }
      }
     },
     "localname": "ClassOfWarrantAbstract",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vyne_CommissionFromGrossProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission from Gross Proceeds From Issuance Of Common Stock, Percent",
        "label": "Commission from Gross Proceeds From Issuance Of Common Stock",
        "terseLabel": "Commission from gross proceeds from issuance of common stock"
       }
      }
     },
     "localname": "CommissionFromGrossProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_CommonStockVotingRightsNumberPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of votes entitled to each ordinary share.",
        "label": "Common Stock Voting Rights Number Per Share",
        "terseLabel": "Number of votes entitled to each ordinary share"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberPerShare",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vyne_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems and collection of computer programs and related data that provides instructions to a computer.",
        "label": "Computers and software [Member]",
        "terseLabel": "Computers and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_ContingentStockConsiderationRemeasurementGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Stock Consideration, Remeasurement Gain (Loss)",
        "label": "Contingent Stock Consideration, Remeasurement Gain (Loss)",
        "negatedLabel": "Contingent Stock Remeasurement",
        "negatedTerseLabel": "Contingent stock right remeasurement"
       }
      }
     },
     "localname": "ContingentStockConsiderationRemeasurementGainLoss",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_ContingentStockRightSharesConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued per each contingent stock right.",
        "label": "Contingent Stock Right Shares Conversion",
        "terseLabel": "Number of common stock issued per CSR (in shares)"
       }
      }
     },
     "localname": "ContingentStockRightSharesConversion",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "vyne_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer One",
        "label": "Customer One [Member]",
        "terseLabel": "Customer One"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_CustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Three",
        "label": "Customer Three [Member]",
        "terseLabel": "Customer Three"
       }
      }
     },
     "localname": "CustomerThreeMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_CustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Two",
        "label": "Customer Two [Member]",
        "terseLabel": "Customer Two"
       }
      }
     },
     "localname": "CustomerTwoMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_DebtInstrumentFeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument, as a percent of the aggregate principal amount of all loans outstanding.",
        "label": "Debt Instrument Fee Percent",
        "terseLabel": "Debt instrument fee as a percent of the aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFeePercent",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_DeemedDividendToWarrantsHoldersDueToWarrantModification": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from modification of warrants that is deemed dividend",
        "label": "Deemed Dividend To Warrants Holders Due To Warrant Modification",
        "negatedTerseLabel": "Deemed dividend to warrants holders due to warrant modification",
        "terseLabel": "Deemed dividend to warrants holders due to warrant modification"
       }
      }
     },
     "localname": "DeemedDividendToWarrantsHoldersDueToWarrantModification",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_DeferredTaxAssetsValuationAllowanceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Valuation Allowance",
        "label": "Deferred Tax Assets, Valuation Allowance [Roll Forward]",
        "terseLabel": "Deferred Tax Assets, Valuation Allowance [Roll Forward]"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceRollForward",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXScheduleofRollforwardofValuationAllowanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "label": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "terseLabel": "Additional consideration receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Upfront Payment Amount",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Upfront Payment Amount",
        "terseLabel": "Upfront payment"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationUpfrontPaymentAmount",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Milestone Payments Receivable Upon Achievement of Net Sales",
        "label": "Disposal Group, Milestone Payments Receivable Upon Achievement of Net Sales",
        "terseLabel": "Milestone payments receivable upon achievement of net sales"
       }
      }
     },
     "localname": "DisposalGroupMilestonePaymentsReceivableUponAchievementOfNetSales",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Gain on Intangible Assets, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Gain on Intangible Assets, Percent",
        "terseLabel": "IP Gain"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGainOnIntangibleAssetsPercent",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development and Contingent Stock Right Remeasurement, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development and Contingent Stock Right Remeasurement, Percent",
        "terseLabel": "IPR&amp;D Impairment &amp; CSR Remeasurement"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentAndContingentStockRightRemeasurementPercent",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Transaction Costs, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Transaction Costs, Percent",
        "terseLabel": "Transaction Costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsPercent",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXIncomeTaxReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertaining to the employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_EquityPurchaseAgreementPeriodInForce": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Purchase Agreement, Period in Force",
        "label": "Equity Purchase Agreement, Period in Force",
        "terseLabel": "Term of equity purchase agreement"
       }
      }
     },
     "localname": "EquityPurchaseAgreementPeriodInForce",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vyne_EstimateOfProductReturnRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum estimate of product sales return rate at reporting date.",
        "label": "Estimate of Product Return Rate, Maximum",
        "terseLabel": "Maximum estimated product return (as a percent)"
       }
      }
     },
     "localname": "EstimateOfProductReturnRateMaximum",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_EstimateOfProductReturnRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum estimate of product sales return rate at reporting date.",
        "label": "Estimate of Product Return Rate, Minimum",
        "terseLabel": "Minimum estimated product return (as a percent)"
       }
      }
     },
     "localname": "EstimateOfProductReturnRateMinimum",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_ExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the exchange of ordinary shares of acquiree for common stock of the entity.",
        "label": "Exchange Ratio",
        "terseLabel": "Exchange ratio per ordinary share for common stock (share per share)"
       }
      }
     },
     "localname": "ExchangeRatio",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "vyne_FacilitySpaceUnderLease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Size of the facility under lease, in square feet.",
        "label": "Facility Space Under Lease",
        "terseLabel": "Facility space leased"
       }
      }
     },
     "localname": "FacilitySpaceUnderLease",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "vyne_FoamixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertaining to the merger of Foamix.",
        "label": "Foamix [Member]",
        "terseLabel": "Foamix"
       }
      }
     },
     "localname": "FoamixMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONConsiderationTransferredinMergerDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONGoodwillDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONIPRDandCSRDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONPurchasePriceAllocationDetails",
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails",
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_GainLossOnSaleAndDispositionOfFixedAssets": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Sale and Disposition of Fixed Assets",
        "label": "Gain (Loss) on Sale and Disposition of Fixed Assets",
        "negatedLabel": "Loss from sale and disposal of fixed assets",
        "negatedTerseLabel": "Disposed of fixed assets"
       }
      }
     },
     "localname": "GainLossOnSaleAndDispositionOfFixedAssets",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://vynetherapeutics.com/role/PROPERTYANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_GrossProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross proceeds from issuance of common stock before deducting offering expenses.",
        "label": "Gross Proceeds From Issuance Of Common Stock",
        "terseLabel": "Gross proceeds from issuance of common stock"
       }
      }
     },
     "localname": "GrossProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_IncomeTaxLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IncomeTax Line Items",
        "label": "Income Tax [Line Items]",
        "terseLabel": "Income Tax [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxLineItems",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vyne_IncomeTaxTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Table",
        "label": "Income Tax [Table]",
        "terseLabel": "Income Tax [Table]"
       }
      }
     },
     "localname": "IncomeTaxTable",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vyne_InterestReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest received.",
        "label": "Interest received",
        "terseLabel": "Interest received"
       }
      }
     },
     "localname": "InterestReceived",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_IsraeliMutualFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Israeli Mutual Funds",
        "label": "Israeli Mutual Funds [Member]",
        "terseLabel": "Israeli mutual funds"
       }
      }
     },
     "localname": "IsraeliMutualFundsMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/MARKETABLESECURITIESMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_LincolnParkEquityPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lincoln Park Equity Purchase Agreement",
        "label": "Lincoln Park Equity Purchase Agreement [Member]",
        "terseLabel": "Lincoln Park Equity Purchase Agreement"
       }
      }
     },
     "localname": "LincolnParkEquityPurchaseAgreementMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidation of Subsidiary, Intellectual Property Acquired, Taxable Gain",
        "label": "Liquidation of Subsidiary, Intellectual Property Acquired, Taxable Gain",
        "terseLabel": "Intellectual property acquired, taxable gain"
       }
      }
     },
     "localname": "LiquidationOfSubsidiaryIntellectualPropertyAcquiredTaxableGain",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_MenloMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Menlo",
        "label": "Menlo [Member]",
        "terseLabel": "Menlo"
       }
      }
     },
     "localname": "MenloMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_MenloPremergerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Menlo - Premerger",
        "label": "Menlo - Premerger [Member]",
        "terseLabel": "Menlo - Premerger"
       }
      }
     },
     "localname": "MenloPremergerMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payments Upon Achieving Certain Criteria, Exceeding Annual Net Sales",
        "label": "Milestone Payments Upon Achieving Certain Criteria, Exceeding Annual Net Sales",
        "terseLabel": "Milestone payments upon achieving certain criteria, exceeding annual net sales"
       }
      }
     },
     "localname": "MilestonePaymentsUponAchievingCertainCriteriaExceedingAnnualNetSales",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_MilestonePaymentsUponAchievingCertainCriteriaMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payments Upon Achieving Certain Criteria, Maximum",
        "label": "Milestone Payments Upon Achieving Certain Criteria, Maximum",
        "terseLabel": "Milestone payments upon achieving certain criteria, maximum"
       }
      }
     },
     "localname": "MilestonePaymentsUponAchievingCertainCriteriaMaximum",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_NonCashAcquisitionOfBusinessCashAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash as part of a non-cash business acquisition.",
        "label": "Non Cash Acquisition Of Business, Cash Acquired",
        "terseLabel": "Less cash acquired"
       }
      }
     },
     "localname": "NonCashAcquisitionOfBusinessCashAcquired",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net assets acquired in non-cash acquisition, net of cash acquired included in the acquisition.",
        "label": "Non Cash Acquisition Of Business, Net Assets After Cash Acquired",
        "totalLabel": "Merger net of cash acquired"
       }
      }
     },
     "localname": "NonCashAcquisitionOfBusinessNetAssetsAfterCashAcquired",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_NumberOfLenders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of lenders.",
        "label": "Number Of Lenders",
        "terseLabel": "Number of lenders involved"
       }
      }
     },
     "localname": "NumberOfLenders",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vyne_OperatingLeaseLiabilityTransferred": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liability Transferred",
        "label": "Operating Lease Liability Transferred",
        "terseLabel": "Right of use liabilities transferred"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityTransferred",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_OperatingLeaseRightOfUseAssetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right of Use Asset, Current",
        "label": "Operating Lease, Right of Use Asset, Current",
        "terseLabel": "Operating lease right of use assets (Note 10)",
        "verboseLabel": "Operating Lease, right of use assets, current"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetCurrent",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_OperatingLeaseRightOfUseAssetsTransferred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right of Use Assets Transferred",
        "label": "Operating Lease, Right of Use Assets Transferred",
        "terseLabel": "Right of use assets transferred"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetsTransferred",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_OralBETiOptionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral BETi Option Agreement",
        "label": "Oral BETi Option Agreement [Member]",
        "terseLabel": "Oral BETi Option Agreement"
       }
      }
     },
     "localname": "OralBETiOptionAgreementMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_OriginalSpaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertaining to the original leased facility space.",
        "label": "Original Space [Member]",
        "terseLabel": "Original Space"
       }
      }
     },
     "localname": "OriginalSpaceMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_PaymentsForLicensingAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Licensing Agreements",
        "label": "Payments for Licensing Agreements",
        "terseLabel": "Payments for licensing agreements"
       }
      }
     },
     "localname": "PaymentsForLicensingAgreements",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_PeriodOfClosingTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period Of Closing Transaction",
        "label": "Period Of Closing Transaction",
        "terseLabel": "Period of closing transaction"
       }
      }
     },
     "localname": "PeriodOfClosingTransaction",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vyne_PostMergerParentOwnershipByPreMergerParentStockholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of post-merger Menlo ownership held by pre-merger Menlo stockholders, as a percent.",
        "label": "Post Merger Parent Ownership By Pre Merger Parent Stockholders",
        "terseLabel": "Ownership percentage of parent by parent stockholders"
       }
      }
     },
     "localname": "PostMergerParentOwnershipByPreMergerParentStockholders",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_PostMergerParentOwnershipByPreMergerSubsidiaryShareholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of post-merger Menlo ownership held by pre-merger Foamix shareholders, as a percent.",
        "label": "Post Merger Parent Ownership By Pre Merger Subsidiary Shareholders",
        "terseLabel": "Ownership percentage of parent by subsidiary stockholders"
       }
      }
     },
     "localname": "PostMergerParentOwnershipByPreMergerSubsidiaryShareholders",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_PublicStockOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Stock Offering",
        "label": "Public Stock Offering [Member]",
        "terseLabel": "Public Stock Offering"
       }
      }
     },
     "localname": "PublicStockOfferingMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_RegisteredDirectOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Registered Direct Offering",
        "label": "Registered Direct Offering [Member]",
        "terseLabel": "Registered Direct Offering"
       }
      }
     },
     "localname": "RegisteredDirectOfferingMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_RegisteredOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of entity stock pursuant to a Securities Purchase Agreement.",
        "label": "Registered Offering [Member]",
        "terseLabel": "Registered Offering Per Securities Purchase Agreement"
       }
      }
     },
     "localname": "RegisteredOfferingMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_RepaymentOfDebtPrepaymentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment of Debt, Prepayment Fee, Percentage",
        "label": "Repayment of Debt, Prepayment Fee, Percentage",
        "terseLabel": "Prepayment fee, percentage"
       }
      }
     },
     "localname": "RepaymentOfDebtPrepaymentFeePercentage",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_RestrictedInvestmentsToSecureLeaseAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lien on marketable securities in respect of bank guarantees granted in order to secure lease agreements.",
        "label": "Restricted Investments To Secure Lease Agreements",
        "terseLabel": "Lien on marketable securities to secure lease agreements"
       }
      }
     },
     "localname": "RestrictedInvestmentsToSecureLeaseAgreements",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_RetentionPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retention Payments",
        "label": "Retention Payments [Member]",
        "terseLabel": "Retention Payments"
       }
      }
     },
     "localname": "RetentionPaymentsMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_RevenueRecognitionDistributionTradeDiscountsAndAllowances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate of fee the entity pays for distribution services and certain date that distributors provide to the entity and sales discounts given by the entity, including, but not limited to, early payments of accounts",
        "label": "Revenue Recognition, Distribution, Trade Discounts and Allowances",
        "terseLabel": "Product sales provisions"
       }
      }
     },
     "localname": "RevenueRecognitionDistributionTradeDiscountsAndAllowances",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_RoyaltyPaymentPercentMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Payment, Percent, Maximum",
        "label": "Royalty Payment, Percent, Maximum",
        "terseLabel": "Royalty percent, maximum"
       }
      }
     },
     "localname": "RoyaltyPaymentPercentMaximum",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vyne_SaleOfStockConsiderationReceivableOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of Stock, Consideration Receivable on Transaction",
        "label": "Sale of Stock, Consideration Receivable on Transaction",
        "terseLabel": "Consideration receivable on transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivableOnTransaction",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails",
      "http://vynetherapeutics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_ScheduleOfBusinessAcquisitionConsiderationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of consideration to be transferred to effect the Merger.",
        "label": "Schedule of Business Acquisition Consideration [Table Text Block]",
        "terseLabel": "Schedule of Merger Consideration to be Transferred"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionConsiderationTableTextBlock",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vyne_ScheduleOfBusinessCombinationGoodwillTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the calculation of goodwill from the business combination.",
        "label": "Schedule Of Business Combination Goodwill [Table Text Block]",
        "terseLabel": "Schedule of the Calculation of Goodwill from the Merger"
       }
      }
     },
     "localname": "ScheduleOfBusinessCombinationGoodwillTableTextBlock",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vyne_ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of in-process research and development indefinite lived intangible assets acquired in the merger.",
        "label": "Schedule Of In Process Research And Development Assets Acquired Through Business Combination [Table Text Block]",
        "terseLabel": "Schedule of IPR&amp;D Assets Acquired through the Merger"
       }
      }
     },
     "localname": "ScheduleOfInProcessResearchAndDevelopmentAssetsAcquiredThroughBusinessCombinationTableTextBlock",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vyne_ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of loss before income tax taxes.",
        "label": "Schedule of Loss Before Income Tax Taxes and Current Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Loss Before Income Tax Taxes and Current Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfLossBeforeIncomeTaxTaxesAndCurrentTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/INCOMETAXTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vyne_ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the share-based compensation awards granted during the period, exercise price range, vesting period and expiration of awards.",
        "label": "Schedule Of Share Based Compensation By Share Based Payment Award Grants In Period [Table Text Block]",
        "terseLabel": "Schedule of share-based compensation awards granted for options and RSUs during the period"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationByShareBasedPaymentAwardGrantsInPeriodTableTextBlock",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vyne_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total fair value of options and equity instruments other than options granted during the reporting period.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options And Equity Instruments Other Than Options Grants in Period Total Grant Date Fair Value",
        "terseLabel": "Fair value of options and RSUs granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsGrantsInPeriodTotalGrantDateFairValue",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Plan Modification, Unrecognized Cost",
        "label": "Share-based Payment Arrangement, Plan Modification, Unrecognized Cost",
        "terseLabel": "Incremental compensation costs incurred"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementPlanModificationUnrecognizedCost",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Plan Modification, Unrecognized Costs, Recognition Period",
        "label": "Share-based Payment Arrangement, Plan Modification, Unrecognized Costs, Recognition Period",
        "terseLabel": "Incremental compensation costs, recognition period"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementPlanModificationUnrecognizedCostsRecognitionPeriod",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vyne_ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The excess of the fair value of the modified award over the fair value of the award immediately before the modification pertaining grantees not employed or providing services after the modification and reclassified from additional paid-in capital to derivative liabilities.",
        "label": "Share-based Payment, Modification of Terms, Incremental Compensation, Modification of Terms, Incremental Compensation Cost, Reclassified Adjustment",
        "negatedTerseLabel": "Classification of stock awards to derivative liability",
        "terseLabel": "Additional paid in capital reclassified to derivate liabilities"
       }
      }
     },
     "localname": "ShareBasedPaymentModificationOfTermsIncrementalCompensationModificationOfTermsIncrementalCompensationCostReclassifiedAdjustment",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://vynetherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vyne_ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share options RSUs and Shares Under ESPP [Member]",
        "label": "Share options RSUs and Shares Under ESPP [Member]",
        "terseLabel": "Outstanding share options, RSUs and shares under ESPP"
       }
      }
     },
     "localname": "ShareOptionsRestrictedStockUnitsRSUAndSharesUnderEsppMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESScheduleofAntidilutiveEquityAwardsNotIncludedintheCalculationofEPSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_ShareholderLenderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertaining to shareholders that are also lenders of debt.",
        "label": "Shareholder Lender [Member]",
        "terseLabel": "Shareholder Lender"
       }
      }
     },
     "localname": "ShareholderLenderMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/LONGTERMDEBTDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_SharesIssuedUponConversionOfCommonStockRightsPerAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number shares issued upon conversion of common stock rights arising form the certain events as provided for in the commons stock rights agreement.",
        "label": "Shares Issued Upon Conversion of Common Stock Rights, Per Agreement",
        "terseLabel": "Share issued and delivered upon CSR conversion (in shares)"
       }
      }
     },
     "localname": "SharesIssuedUponConversionOfCommonStockRightsPerAgreement",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/BUSINESSCOMBINATIONNarrativeDetails",
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "vyne_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants exercised during the current period.",
        "label": "Warrants exercised",
        "terseLabel": "Warrants exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/STOCKHOLDERSEQUITYCommonStockPreferredStockandWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "vyne_ThreeLargestCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest Customers",
        "label": "Three Largest Customers [Member]",
        "terseLabel": "Three Largest Customers"
       }
      }
     },
     "localname": "ThreeLargestCustomersMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/SIGNIFICANTACCOUNTINGPOLICIESConcentrationsofCreditRisksDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_TopicalBETiOptionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Topical BETi Option Agreement",
        "label": "Topical BETi Option Agreement [Member]",
        "terseLabel": "Topical BETi Option Agreement"
       }
      }
     },
     "localname": "TopicalBETiOptionAgreementMember",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/NATUREOFOPERATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vyne_VehicleLeasePrepaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of prepaid to secure lease of vehicles.",
        "label": "Vehicle Lease, Prepayment Period",
        "terseLabel": "Vehicles lease prepaid period"
       }
      }
     },
     "localname": "VehicleLeasePrepaymentPeriod",
     "nsuri": "http://vynetherapeutics.com/20211231",
     "presentation": [
      "http://vynetherapeutics.com/role/OPERATINGLEASENarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=SL116886442-113899"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13572-108611"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13587-108611"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r674": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r675": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r676": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r677": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r678": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r679": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r681": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r682": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r683": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r684": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4),(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>137
<FILENAME>0001628280-22-006545-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-006545-xbrl.zip
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MKNN>PI7/YZNK"<ADR0@*H<=8RL<!],YL(]U[G27SM/$(\!)L8:+&.M;((6[
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M[[QPG]!M[VK3L#)626\X5LLF^3+G#F :\TY3YV4B+.=[*Q-&YC)Z4HXY^T'
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MI;3RCN#Z(=XQ1?IE-9_"_TF0+W0L&8^^LL: 4-Q5'L'?OD5?#-*](_9C4]I
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MUH^L?H _^8JP/)\*L^-M\R'%W54E?W3K\7#C2-3.FCT:/ZX+;W;7+"M5;(.
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M,:M/\N'&W<1("6=<X!DN54E"+RD80%K,BO:-G)24QFM. RT-S.INV6&(B8'
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MG_! YT;7.'!=)J/N<>LWA*9+'RQ"7Q@W(.I#C_G<(A?%#@,&EJL-!M *3:&
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M$DYEWMX^;1]W6KLS)<H-WRC:ADSU1(F.USYW+,RQEI:M&'EAZ,U?-^.?6*/
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M<$$81$8TBG^!0RH6 VXG0Q @/LA7!*%OR\)ED<)5]D*T=;(L;;#/P'3<??1
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M+ARN]IQHG&XY\.L4)8)_\<O&5C"#);NBY7*@5F-4[QT6W 0[KN!C#X$R;UY
M J5-X']SK([!^+^60+E8BK:OBB;CVT 3,YA=*[/C0P^+R+L\5&T)Y#<P#3@
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MW3&VUA1]Y"=<?3C ?ANN%TJ;/?WJ:-+)KB8C-ND)'2IE7J<K!=#Q%PPCQ 9
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MH/U(8;X:>9,5_-\LG#N__3]02P,$%     @ 38%Q5":'5!(O%0  ;6(   X
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MK?%(P&?074BQ#1OP;XF53TAX1PL.&!U?5+^WZJ]C\-.%5B&Y8&+,E& E14I
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ML_GQ&ARPHJI@E)9>00YG"P,>B[-,Y$D_E]^_*64 L9DK#^ "!4Y#86)L^<>
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MD',WSLUX1U9)9L$38QD3QNJ%MZ8I4-[L_Q\ U;++_R,&^E]"O/I_4$L#!!0
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M_(!D<N#[<BL0!CW'M$@5"L(Y&9SQ(%@T/!LR/:4/_(#T22GBF!$EM*8LM<8
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M+*'-2T1LW,3,*, W(L'3,419,)A2@_T\:;F[<]>*M?FP#[:,MSX[T> B/T3
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M/"ES.C@D%?*4<0LJ!B HI)IX$JOCPPA_*AVSX*SGR5G7(?).:O#G(/+RNE-
M@E&4JL!BZPRA14B)UO"_%*5I.D\[ \W&YB13R+X3G%KA?$J#86D 1]88KU(;
M2."!:C,'UNI/(LE<&J!(:R2%T%HH<"_ Q[#&:.>,]-&F8*Q1 &2D ."?62/;
M71-NW@(L-WTCGR@D'1&2W!U,)R_]"9+2%%MK J4\%>!:1/M0!*4)I0(DTY Y
M M/9(^ETP%6".-HTN&!C133S4G 5J(MPJX7A<]#<<#8H^3@=5.)V*H$0<,DD
MF"Y,(JHB5,9,IR HO:+Y@$Q\0:7'T8IQBOE#K,VD4G&)-:;2,VF"HBJMNN%P
ML$\MD'1C0<G[QT4GB?,S#:8$6)9&Z92RP$BJ)!$4"84Q4R$5W(V77&<N1#[+
MQ)$/$[1&A@GKK LQ$Y<3;:2-59 X$*3!N$S'J\&DM:#2CX#A))V^OU!-'@ ,
M3<K &=#@H^NX;2\XZ4XHFCKE2$",7]5O"RMD]KT^0$DG,#62Q#ZE)&X.$()3
M%H74&1+2V<]%G U*/DXG<P9&O;:6Z50SKH04*0M:4 .8*A4:1U*('-F3<EZI
M=%$#LYH5W@[N6 GS(#)'Y-UM2OD ,F>U(%P#<'(G&=5>IEA;Y)BASC#*R=BF
M7%#S_G:E?!"YHYJ)U,2D3+ LF?(1'"7BS I/@FSB)F*T0[:8O72<NU+JP]#
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M!BP(+HWPDHK L%4&C$+C#0G*6"#6/$'O1M_F/3].D'^?6WT!>A/4\KJP!RL
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M!&4+!)U+8<3IJ#A;+2!TOJCVMFIG'!N<5\@)9JC>+WR#I9_C1@<K==-Q'0^
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MV9I6$N?)UFD?;,Z#[+C:)A#F76?]Y(WO>S!&8V9??;ZR22^*!YLJP%L;62R
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M'GI9OW5EWJ].V9.C,YDA=/[V6.XN%^G2ZTYD^RIU UYXRZ[H5T4"[*9]H!#
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M!VVZ@OZ-6\3Q3Q3X/_R5@9-[^MC/JX@%RLF@&J;D&<DWXW;IQ06R:G!3[O.
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MG$Z$+6@X&%I?E ?DG!HUJI,)[\<D D>+ZKR9E?JDT8?T8)\8QW<Y;MB[9HK
MFSPR>V!5V5A\VE%8T%SLRE]^Z%Y9\@5$)AJUUZ(-1M\,GF_:K[9\WWWYXZ;;
MOL]U(!.I"CE[=7#T^-NOGGSS^&3/$]P9M"[VD'>L_ZMB2D\N_[Y=Y?NF_K(J
ML^]+YNJ@WRI!QET43I:N5SK)#7DRFTQ0(ZQ5T,R J;(KZ_%ABD#R 78]RF[<
MFM[/?Y,V4(C<-_X"Q%=VP6*);%]*( 30H TFX0"XD7G)&YA8AMV_L&GX;NFK
MC;)FC<3<MK8:T\;<C2C,!KP*D&'3(K32@X$%^51+BZV%DF5&K;'?_)<<>^CF
M@=80[41:;00?7 W-17$IQEP%! O+85AK<_LF[!#Z"_^6CM)%49<6O6T+^9%
M,[FC#@Q%IAQB<'S"ER#:;V"2,61*\ 9@P0LY]+$"-CWSY6 I97C0D'.V(L%=
MWL4HJP O.,RL>!D_C,1L0PBJ!?N]>CLA)3HM%GC'R#X*([F6^ FT>,-THGC
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MZAJ@MY,6'DK_[%9ADNPVNO9?VFXPDOJ@R2"G!DUY,1ZT !6.A/:@+8*#(LB
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M<M%:D-NN8E%K? 1S)!)3[J"-!+QC@0DMM7(<+-'0@\XFF:+'L5'J#<R'@5C
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M48C:%H RQ9OT!3ZN]W%:R6::V;4W4M"ACQ5;8@AF(0W@P?3A@^.'9@[WK+V
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M*X;COK/!B"/U3;=<C0SMF"JQ4,33]\3KE:6 B1V[1%(8 LFM)];W&AQGESU
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M$8AC04=5AV]?G[(K>W)T?#*Q/B<^NVN5L>E1AZ2HK5S71#_O"P\/FP<[ F%
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M<(TE]%ET>]$$(\3D<^DD:7+R;2*L%3@:[Z"D&I*DG\(6[M6AI6Q.C"6MT)>
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M<(2X3*HJH;!F3MIPHN=1M8XP\MDH.%PG L[^=N<TKP#;,1MU@KJK)+4T]73
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MI(XP[M9QR2"$< 10V[H ^GCV(Y%.3]P=;-/4^HYR"P#B$];'-T[X&7'!WFI
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M#2[1W/#.IS$DFGMT[T/LD-O#]%74BL88@IE$ZG!XF/-!S:MO\598)A/[+7I
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MO$5>3=NLV)HB&/#T&KS.2KG4VMZ# H4Y"?)PG[5CVC@W1/\F\5:];M3!^A1
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MEL6<-'R5(4$-#2VMY7Y@KSW/E0?02N4"09\TG1H4/D3J/86!\YU_@;2+5<.
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M]L*.I74G(9FE=WJZ:@!\>AZ< FZ0>]XV>3'_(V>8DS'FRG(I&&6:D0XW$V\
M^;(Q'2=A;\ZI5D30J_[$^.F@D\[AN;: W+0G49I>A+'7K\8!X!(W6JE5\&"
M\'I%PQ@_& P /=AH\$E-ATGDG'-;M&XV=FAF=$5A21M,G]8TNLZS>%]G4(-A
MD^Q7_YS7G(6<2&VP@[DE>MHN2K*D3^6' R-I1 _@3<FU4\''IHR+3V'GIS@X
M&]"]5 +4:<,S3EP^Z]+#P-* 5$YNQ@G()2S(7&PF+1VBF5$8(#E: XQ#O-Y\
MEQ]A DQ&YDJ39! DXA)(*  8?-L'@*D@<H(_!1\V9]Z8G3-/SL@X9'H 5<9Y
M@"26-(LRC*JZ7-^LR1$!<;'0*FQ7 8!P%B\,'!VF'8'!!-):3]C03@I=XUOP
M_==C1LC<RYOH7^R8X(92<]YNN_N42 LI'%*VLK6P<#Q,SC 1N%)\RY],*819
MJ;YBZ?HV^DZ0H:"]"^#B,=_?9 3\2"VW7;%LE;8<IVKR9-A94=ES6WM)'3O&
M#<02\8E@NQ;GC7)CD]&T7DAGL207^$OY/)B4Z5K1CP-=,":^$-;UO*1,0RQ'
M.&U)GUWF\(.[YN*+"9,(UFK'MTB2"4@/Q3ZX F1UV]KR$A=FC[WQV)L?]MB;
MF_$L?R#LC:4UTC8V?]8/6S$^YN RJ:6PCF/Z6F&F,;B$+]+0L,_AQ H;%N6Q
M_='0CY*\19J6<@E?Y/%G4KTSP<AL(^_C/0IV^,0E;9C*H45GE\,R1H=*2;^E
MY(N;!X/7#[=L.#0-4O8"W'P-K<G@EV,T??+9@M^Z8F_!4F1FM.?,6SY?Y1PD
M[T+O(@/<UE450JR;[Q1<$_?\&KE(+=8J]XBV>0T/C.<:X_;;V.+C/N)#%+DI
M5#)*2'5BHI4Q7JGAJ-%L6D]6DJ@?4Y$1UY@55/5=+])DC61R/0D]3N=3JD96
M"VYV#\LA^'HTY[UGC!\HT==O>DV+G%CH!V=W0>E*\,8C>&?=GW0(>%OZ-[D%
MB^M2)MB8D.DKH?8&W\@=^N.2CZH5R#@9*K"Q/,)FW[8L'%<&(:MD+6\E!TJ5
M2 ]'K^K*/0RU#3$AQV7SAH@UVL9\'"Y>5PM)%,WS)0>RN2_4;CQ2YH)*1<AQ
MFEBK@'U%FS0W:=4QGY3@C!26;L6D"UD:QFNV/4TMQV!2G5T)SK'2HZ<:$3#:
M'WDX>L=Y.,J^]T?.%_",TZ1-RC(V9S@_Z1DVIZVA9J[.4NP7""IZ.RS,2(82
M"CUGYB9'QU T.RQC-RF;L+SH3$//G!%NF)#7O+[8?4R ^8Z3J+P R'$7L^'2
M/-PS%@77%=963#453)6/VVX*?J$SE6EOS0#0SN^\=AU(6@7=8F:!X\%E+K!?
M9D;N"4(L:)]0,C1)P+$DEMQG5"^(0F*J8L2^3[//,;_!=:3]ZO9TE /B5L1\
M$AS<:6(-1I5V7KIU38W8.8B7  OD2_&%D]M3I@/%*FV^=YUW1=-P<XJ4T?P3
MR;HDDHNPB-)5K: Z+5DJZPC#;59,^#S3C2X,:M,0_M(\(B(FO5_BP;@1^>2;
MNP4^J<4LK>6!6J%PYJYGW>1SOS@E@U'E"^L+[E'#T(6X'Q11R+2ALB3R*;X:
MU.M"(UC>$JP)$E/\S^A&^X45N]RX<&Y(,7K"1__W?[QZJB3T-*;NST"-YDLD
MO%K_'1Q_7$GH4L@5S!C/9*$)(/<$5Q&09X^F9^#<X7HQ_%[!=$IY7/0IB0'Z
MM'9-H&-)#@L.R:S8)PZ$>P#UIO%='F#IPK_>2.&IKSA<K7$O]<=*I:ZX]Z0P
M7G"^ZI!E&^>3#Z<-M;T<R.J<X?_]*/]Z<$S_EZ[5$\H[;UVAAP]O?NGL>756
M4E?.3 !_E^K9RNG"N7?I?>]-HK-GX7)<G;3J=ZI&:_.DL&J;+R8;TF-\V!\4
M>:=@&Q$"NLYM-GUD)+E\*B1AGQ=".[Q4$0^VA;@9Y-0$SV#%DITD;\@]F6+I
M$_LOL:64-5+^L@U2F^LLY:/\:'PTN\92_A]S9N\N(_?7EK-"<BHVQ:^\/#<U
M6;W?-?:'/#E?B RT3</J?<2@5D3:@LXK:3+BR;%LS/KNHR @F25*%3OF5*Z0
MX%FAOD(7:.#V\"?B]%A5NFF3'::$[B62DH>CUU8)1SA*SN]<#$2_GCHVNE''
MQAX',>NU4;2KYKP\_]1Q*47*\S:P$5Q&*,I@%F-Q*)":-*F[5=MI0PF,4IRK
MBT*M'V=@)2PQB&RDV[TH&/08IIQ[P=9R253/"1(S+UKII^ &'#7R;I&4+)TS
M9/;IH\A73 _'Q5QZ'0;^,-F>8GZ1D<!;:HG<BH8LU%'-5BU"G4BYI/87OB_U
M*\R%BR;B]>+0F+,3(5C*"XQ04<>Z1NU.21;Y($G<JE+ML()Z-P<PW?D^HX%[
M)S24$:O Y'V.2=:\4L+RPGH@T0Y)MP32_<]56+?48<+80IX"-C?ZY)D4/X4Q
M@9:-\<$D.EN]?<\XDR*!$]8Z6+<]&O ,FVD1.MA$2'(B3S (GB/T3]D**J5O
MUTJ4F^V'0C#9URC6ZQ'M'A51M]!>^&M;IHIH#C?I4OM/8L"(9H%/0CRPZJQ2
M[OPCS32ET$&."85#B+.K5D6*2T9?@\D$^;$=*BAX':NY SZRYY<(D6RJA7C5
M]#QAD;WU"FG*M<W&-&9M8W">PB>%H&SR(4>#HZ);+-@7L.%[%]P;,QFS$;7(
MMY'9.<NCYQ O9 QUT6[2ZL4M7<C_QVO5>:,./@$N3E>-I.9WC:H-8!<\]%F6
M=)>ZY&Z.,BZW>=N\8>]UJF-'I^6+O#K+%Z11I_Y;FV1Q@D]6=DSEV49L/9\G
M!WI\ )BVJH0&.CV3_[ASR^BCOJ'V@:L;YW34&((K'4KPE_(6,%W"928_VS/@
MI(/^\-X>A7,SGN4/A<+9-.),H"<V5?*>P?=(\BVBOGCT$/;X\:$(,(Z.CHX?
MWLGO'H8'),S>63'G,[O3&(-9';V "7=S)^GY)-IVOG9IJ$7$9\#U+M>.##N:
M%BD?&&[&0#M\.T5Q:.0O( YU.;HKI9-N>S"=DLU8#&MNE]+?IV64MJTG9:X+
MHS<BSS=F*/C>-Z(V]C4&.!DX(%2IR4+:;[[4*KWYB_2:Q<%?DCXLKZ5 K+.K
MLJ<"T21$KXX"=E<WFX:W^FT.'KF'$&Q<OLF3&M%W1'"W8 9VKN+'O6Z62"VY
M#0_F@[3>H.\:52BY:P-HMB5+!(C"4*N>MI0/A=^:E>AG!8045\ZF=!*YZ8.J
M9CU.<:ZD,)K?JAXTH"E'6[H&TM2!JMB[I_,-2+DP+=/K0WO>1&8C+DJ-L]=X
MUB%MS:J ;-HHWE:5\7[/6=Z#R:UG*^GUZD3"(A* <EN_2O"DC09.88$NQ?+
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M3G_R)XHI:I3PER!XC;<8)OB51A=,W]:G<G3]2<,GU*\D"RHZN%G2^C[)59P
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M<TY0.-*:L"\T+3TMR-RM6*#J0X'NUY9$(^;[:?BL #AH"L_[8'*TM(9C"3*
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M%PP7BH_!X$*!%"F0[3LMSE,>9XH1]R':"PY6F+7)>D0^5Q>9IXN/X5U;62;
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M<]>3ZR I'_9,V?2[T[5_=/ \JJEBCL.Y;)2H0T A,%?A/RC'T)[YKRX0\W<
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M&"&+=NG[=UCMG+8?W?F&__K-74X2#UQ;'JI-N?FZ,[9(T8.091'7@D-5Z6K
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M^?G%>WR%*HTG],$M3%S\HUX%GTLZ,W)A\:ZI;8C!&>UDA98:!O2!*Z*TR'9
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MTKG )*)I)5CDAGGFOSTZ?,3/TC-7,)UAT,(/^ZUF1\,84,2W8>+"SN5 :@G
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M2G!5AFL=/;QG_^1?"2VOWD/*9[MN([N'8P\I;2<ZL;Z$"7?MTJA#W;X8U@H
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M=XS1,\ER!_8"NQ[[C@2"*L%A1;7(X$,0!DI;IL?EU$&%CPX)KJA))OB9Q/Q
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M:1C0J\YUW; .F(LB&4EK$.82!#7NBT-T ?$MXS*147YP^.A/MS :UEUPBEV
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MX,SE*B(/NLREK%+BRB_41DW6?<FSPKVWS9BN4AE5M+D(IY?%1=7:B_<3;-3
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M*/PZ^(W_NP4/%EFRP(72XX].2_F>CJQP0]0H32ZXNO$WEL_)-I2]&_E0]5N
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M=JM,@Y<I&.A]_%0-_OLH>TG6/"[ODJQ?5Y"> CFU5_],?KX9I(,C[,*A>GS
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M\P0%0"*;.G#1<$KU_V))SJN1'; ),1I1%<DGHMU5B4NWGOAP>H[M58^)_JW
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M^U;'M<T&<:#9&K)A-D!%MN!(43K"N24-GJ:]Z"[7H"HW:H[ZAX0%24_.EL'
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M;DQZT@9I%V$XZH]ZF)X!1!0G83)\6?-;7CV*7I'#,>&G2=;TB0\9["C:9]D
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MVQFA"L*B?C)(\F$F^@ZU+K]'TT(4--Y+6 #;VAF#1,NY5L^Y?DVK(Z$'\B;
MG%\L08H=G_BF:1/;L"PG"F,K<NC6-K4[MO?@O)S6 =A@ZEZU.M)2]U-0]X1>
MXAG<=G6=$NQ@#-1M.22(3(_P.(H!B'YLA^[6MN=WJ+VJ.&^;T;\\G:*;_#KI
M27TD&9"K+ UYGFM9X2KY;]:_>EMWEFA)_XHE65]VE6L=)X^DLA2  G9V,!BR
MP7D2]#AFK0P/2GBTE8BKX6;ZE*Y"8VY2W:4DBG'$BQD'Q#-<BT21S2CC 74B
M?V6EB*WOI,%TO6IE97FZ;E65AQ+WA*H2QCS@@<=)9/@V!BX-XGO4(I9O>J[A
MQBQ"OR@8(I;]X(35UH5R;RK%_$W8-ZH@H@.[]HGW.<M'&;]W#.=EV%>K4D5^
MW SXFPH* @CP:YY$7'8K'@/(>Y8,<$9FJY2LAF\94TJ)XX8.\T$+L6PW(K;N
MN\1S;9_H-@>VI5NZ9Z].*6D]* VF\(<K)3F<%WY:):FW>LI#Z7U"3W$"E]G<
MBTG$/)< L /"8A>K&/W(=V-@[@;0NV=W7'-5PX4:Y%)IB&YR6UW@=.[06B;A
M/G=NMHX$;TP%+8#2LJD5LBES2BTQ0M]E/@L)C<*8V-Q@Q/=-!K\R+^*N8SE6
MA,76'=ORUST4<U.=*"^6]M>1#-[2_OIH?T)%B2TK]@V/$M.+ V)'OD$8@(XX
MIA_9^!_#TK>V3=?L&+:[$<3_LG*>48MONQH\B<XR88$5#*R$S<$@3/N\-;-6
MS,.L*?W%#JE'#2<"I/)]8C.#$N8$!N%F'%KP@>X9H+\X7D>W5CQML.U?L/%\
M8.6>F)8//!H?F-!E3#=V==,*"?.#B-@N, ,_L&+"3!KI7 ^H:YB@RU"S0U<]
MS+DINLR"GICI64"-HM\#'.3$\Z'&I1'09JT\FNNEN/HVYV[U',N>SJCE;N3:
MH4$ ?J"YN#0DOA]ZA'(C,)ANA$YL;6W3CF,\N(ENFZ/28"I>M1.EI>*U4O&$
MWA'YCF]ZIDD<AGJ';AG$-X.8N)P%?NQ&+.#.UK;=L?PF4?&Z_"0-URV.AQ<\
M*Q0+[54BE//7,P>^M?'J1_"6(#B.TD$Z;BV5C*OE3<OP)CJE85A>9+@T<HGO
M&#&QPU@GGNX!EPH])^"^#5 U</+9JAH[;JC[8P/)]]53*AAWD6VK;ZR2IB?3
M2GQF6K%ODI %%/0-TR<^9Q8)#.I$AN<X@1]@WQYCAM7PNDTH64](!OU[VA\<
M$)]KDABT4_9S+>DD+\ KNS9]HW+&%AUFD\$(+E)Y:]-!+F$HOP<0Y/G^SV'&
M !;)@&4W!T/>SX'QX7:S5)0M%L96R_56Q_4.KJ<U&=L)N>.[)#(CX'JQCE$>
MSHA!XY![IN5X#$<"6!W777N@^CDFJKP KK*V6$_+53:&JTS&C'C@4F9@LWL+
M["/+ #6*N3JA+(I#7;=U&G*,&=&.]_ <W<=B*X^= A,E/XJUI[T_3Z2/53J8
M]NH//N!Q,GQ=9/D6 'L*?J6].DJ'7#.<2A.'ZVNMUB?0 @$W%$(H!&G9Z7+L
M].=TV;4?1KKI4N)9D4'L4&?$=YA/(@K2-C <WX[!-+5G-(A^$L.T]30UT-/4
MTNR::79"!6(1L%,C\@EWW)#8-+:(S[&W>Q0&H>VRR/,,5($:0K,OP9ETQ(<S
M,WO7:]PUKH#\M_6=O]D<MQ%*$B!AF[JX%AX\W>D7:[\]9IC$QSQF&U@R\9S8
M(2'W?9]1PX]9()Q;EKGV$JR&.;=:GM?RO$=3,EN>MT:>-]D(&=1+%VQ"8EL6
M!YZ'$4P3>)[OV+Y.&77TT)"N-^JLJKWY8[G>'C2=9(53)&KGM>!$43H*>GSJ
MP$\]Z^(>NWP)5H (*5]Q0*8+EG$M8'D2RDD826\TY%,CYQZ<1+OYPO"9R+N/
M/#M!F*]6US<GI=T^RP9P6WGQNCV)5Z5HTUO1MHAHF^X^J=NZ8WG4)SRV0)UW
M0I^PV&#$<6V349?%)D[6:B &_($\IH7_0^'OV;&C6[%+7$8]8ON1:O3EZ-2,
M7;#L?)SQ8'3MZ7K4!F6(/Y(!UXJE)IWM/DSI8>98*Y;6QI8F+"[#H#SPG !'
M2=D@EN*0!#8'L12[-M<YLPUJ-Q(#6K&T$OA[CA]0BWN$NJ8!%K?MXN@ADP04
M= C'<,W0IUO;;M>;-K<;))9:$WNC3&PIT?4[*L6(/UTG!IM](LO[B_B%1QJ#
M+;%S+BWP7$M'PWP(%CAVWB'3!KFV@G1OB>NW 6F#,@?FBA)YG^LN9B_ N".A
M>#3J!SP[CH5(R8\K6"KQTGI[5R9[IIL,FIQ;NF>81.>N";H'QP0#W2)NS!S/
M-H)8]\*F(HQ20*?PID69M:),$+NF#XH)"3PPI6TCIH1%U"*>:1I.J(?4]^.M
M;6IT;&<Z*+K:@,%B7'GSR@!>LK19=4UDRSR>E'E,V#K4T9EGZ#$Q,9W?QIKG
M(#)BXC$_MCFU0F;J34695D%Y H3Q]!!T"=_$+H(6L6T:$-_77>(&5FR'40CV
M,=O:MLR.;:S-/'X4:2/LNM^'#-8MB@]J!1Q]EITG V$HNN,,/^18DO3X%IDI
M^K5?< W(+>W#NV_0_!JD0U@=XZ*PF01V=HY#>J]8-M326!M>\)PC\8H(/T/;
M+$X&;! F\"6@JJ$8@Y!WQVLP:M>@7FZ;71<[F%RE>8)P?9/QGIA)^?8ZB887
MA>"I/:A@IU>/L  V 2)@[B./?\=3\E/<\3NP:>V)JI3:/W''@K58G)NQ18$X
M*+6I$WF>YWJF&P64<\,([6\&]ME33UV4CIHKX' DR#C[3E@,IWS#>M?L)M_Z
M?1S_ /DF+G_RWN;>3ARO[78D(0"S365!WQL@7I[AMV!/K#%[T2XRE%3_=3>,
M7* I9 %(+5BP**=#LNU9\']27)W-#_X^.]K73O^]_VGGX_[GTX/=$^W@:'<^
M.3>%Q':/CTZ./QSL[9SN[VDGI_"OP_VCTQ/M^)VV>WSX\=/^O_>/3@[^WM<^
M')^<-/XTKSYW3[H@HGH]EN7 A('MIB-8,,I?S]U[3;[(XD AB"KN*01@B$M>
MY?Q-\</;*,FO>NSF33(0VQ /O55K*98[H].4N"CYL>(BOM^U#8J,1'DVU8L5
MC^D*'C,AKN5GKM[U#&/NQWIW_F>W+6N87>HZ]UKV]L^H1=>S66^A9>_P'M]I
MP_I37YUA@TKL;U32UAEGF<:!(4?:'@\Y*O2:98PI@@^]FIJ+8(ETQH;?&SKH
MYKK/ESSQB[LY?1G\>A83$):ND+JK7_-"/J\-SD19^OP;ZNMK*Z1N=\^<'BCW
MS-7%U\N#ZZ/W^_#<GY=?WY_IQWO[O\XN#^CQ7N_[U\MS_>OE=Q.>[U7NF:N+
MLU]_?#_\M7]S]/YK'_=PO/<7/'/VZWAOQ_YZ^L?E$;IH]@[,H]T)]TS_W>7A
M^[]^P?OU_V?OS9OBR+%WX:^2P?V]]W9'E!BMF5+W#2)HP-WT;<!MX^FQ_W%H
MA;2+*J86V_C3OT?*S*(V;# %%)#38QMJR51*.H^>L[\[>_OE[=>_^6$T\7PX
MX >[I]V#WP]P--$<?'B+__-UOS'-C Z.+3W:_?C><ZD)SSWR/,>(Y[E#6AJ,
M<DISB[U@*MA5)4C=5%0>./N\A;P6\MH$J2< >1>SD(<]S8WV 0GN!>(N6*0T
M+9#5E!(C3"ZU6%E^U'UAWG/(VZE*3._TS\X'_M3WAN4GG[CJ+]?1;W[8Z?N0
MUWANG>VC]C'N#3P,Y2LH^B>Z[ VS,.B?96=Z\-'7)BUOQX-R5/Y@4]G'6R_F
M(?N7)-F;$;WJN'HS6:T_^MTXH4T+[*/>Z\DZ;0_*(;RU"[_V3E["P_<=K/11
M.-9?9H^Z4'[Q#GWU@WY[RMWHE/M[@=CG.>.&$X\8%1IQZ@L@]MPA;GP1B+:"
M![\!IYFDA/[:%BE_9%#P\$7*[P0+6IF_F<S/,5L2<$&+0)'*F01FRPB*ZXUP
M3@HBBL(Y3#>VR).J-_5HN$T4A!CJWEO.9;*!MUT]'):A!.93]D;]V#HEZ_YH
M']KK)@&N'[:M(\V)B_=JLD VA0=LNP_CX2C&N\3BQ-M'._LO^H/7 &!'X1+N
M6IZS4LQ[L\!S"F-RITQ )N0%XM9)I*C4B# F#!-PX@6Q,IZS?DG +1;<.\U9
M 1:T,G\SF9_C.4[GE@3"46%COBUW'DE/&:+$"3@,+#<QWW)59<7O@>PT43@P
M6/]M@+BO3SZU 3\)Y_QQ?Z2[V55FT-M8PYYMF_+[)) -_K_L#]*9,1H-2C-.
MBL!Q_Z4>P.G1TL25'!DG"S318<&YS"EB13"(TSQ'F@%AI-1ABSTG-E\=3;R7
M'N8/8"A[MBAQ9V[?6\-%"PLW@X4Y)LDIS0M?.$1#4#'\!;1'*0P*7.1"N$+B
MV*9F54T\[Q80GH,+N&) W^<^MTX(>[;!/:N?H*=S#-Q9P..2$V"YX;"-!;H-
M_G]<])+Z@A1!4D2UX8AC)Y$118X8T3X/.2QL[NZF/OP*)&O-ZP^V&-MB[!I1
M[19C[PMCYSBV8B''I"@0ER8@'JQ 6E(-?RGAB2"PVJ:.MRS8DP'9MAK I!I
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MKP4_&'@7WYMN--LJ6*O#MKVIQI8'GP'?/K\WFK/ &$.2Z@)QSX&1<"81#U[
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M(6X,@M0;W8;1/ MGP3TRFHGB7BU-F]SU(\!%%NULG!,E/$8BCUFI26DGP:$
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MAVZ)?O-!/@QW?C GX<OQP)Y&&]XJ&FH\6O_"0U9;>EG5\1P>][>KU$XX[N"
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M.!,_+\S$R\-.JDP44[\.CO=14WFL^CG?A(U3)L=U5;[HS"=;;3F8M1>79_&
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M5<0B>RBIHM2JOPWFT\<F/&/[VK4.[ARNLIEY29)G:!!>6UD9340 (X7PA-?
MC\W?QW":ANA*!$4?H22=4W$VSPO_G@Y,R,+NDR$,VOF*HF; 2ZHRJF:U8END
M4,K>B%;.N7)GUJ):+X>IL 7D-S$E@>C4K8,-6PLY)\=$0K)LD+63WQQCF2Y/
MW+ALP0SJ3FRU' 9@,;.'JLJ(B1OO,)H7X\]Z7A!@T:#7HPCC*MX/U'%#$?--
M L91"]H<!?8KTG;(.<GS1^=B>(7 'ULV>$1+-1W,>+D=)VQLW]-OK5-^UDJA
MJ0U00REF!UUJ\X0P^7!%C"M>H3Y04;2;"]5I7FDJS;;.<AL,V;(2TW >RO_G
MU!*R5Y%DFX"KZ:S.8NI6U#VKF,S*W5L#R3TXBU*NCT69;_OI??CU+)TWR+PT
M3KU';UWNG86Y5&G!"R^!Y?08S[4G"A5X/ D++J)$Z(C/.<%%S%+."Z;"G*4Z
MQ5JM-/9EEO H"/#Z&5^>8S0[-4[1-[GR'D#FT.JU::^E'VE8[US&&9<L@%O3
M-.,J]/U(*N%+M=CU=QM69TP?RDJJ-3<T(0<.EDDU(K55HBG&6GNZ"<K40)>:
MJ;IR,I;:L<X^$S.A2V<(-IZ!N"D70TH8J-4!IV0[RWD+C4RX=Y6?;Y.*.9>*
M&6Y2,==B+FN5BKF85ZT*9L[!<"9!JGF@XSQF1<HR$><@D/.,LS26G"WCB:MY
MW(-@^$-;+F!,2I//@: LSBAP#'#.SX8>*>J<Z8P%1-SG#CS*N7Z D8-U8/*E
M2FMJS;).Y2!EJIS[^AZ\?G_@O;7-5UME2;LSF9T5,)*=$YDGUFDB>(_,J?)"
MZ\FV*4D[KA,B36LG,MJMQX]06QQZQ@,L;MFQ[LS:3IOOJ."$IMT'RL S!DK=
MYQ+$YA>$O>J:$-GE5)U;!RJE<5G+PU256+R35NT+)8]2AYMK]$Q])F"SP7+W
MY@-<ZJ;V0*X!>V30.6X<?[7;9*G3NB;Y+5<M1H"2KLMOPR(GZ!GX!U/K8"R3
M<E:Y((;CV@ZTA$[8,?H+[U,KYJ85/T6%IG':;&1TX:"VT?@,7Z#NQ8M\S\:S
MA8@]9A$HS;!&.C-N"S?!YA+6I-&8F%&Z8&_UE^[$- XQZ#D<49$6JUD+6%L%
M Z=-7S>C2IK'T0579*8;!F+RK]$A3R:]W3W38KMK7!)5$Y1J.Z]M6Q8\=./>
M==70Y)C Y)K=Y(S6VGB?-NAHY54'/;<"XH-[; 8J DH1H%*KFLMIINAYQ,8R
MN <"/TQ-+ SS4&O-NJ9& [38"K[,5T)1<V3[$)@4.5),\-WP7%/2U,<(./KX
MS,FN5'"W5@_P@/^#5&S)DL(MC;-J7,%T\&S%%C?^(XNJU\,-KLI0*PJJR*5]
M'C%R1%L%E(GF!RRL"V+5M<5:7@RZ<.[+Y[=>RKL[<X+L'IPYBY>;LBV2/^['
MH[-0_VTM5\!,HM:^C0K.<!TXM14FI6$FE-%1JR_<"4G3Y=DQTAHS[?8G8K.-
MW[^-!Q9RY89M="S6M*>J<[B;00ABS_;"5OE-=X#!&Y)VN 44MK$=U_F8-V*M
M;8:[(8+[)(*79.*L.,D$3DDU\2:21;MH:UKF]W.K8R'_9H(W!2C$MB0!*.E?
MJ(G!4X88PARB"T:7$L-U#U L'DW'317->,!@['-4:>L0Z8STNA[92I3!:#K9
MB+![)?MW4VR"Y!@;4F?-HQ9R)9-F2:JGX75EY^D;-+L[@=W 9QO&]6MWL.S"
MT'Q\V_TCJ//_W$ 'MWFDHX4JTP%CVF8<@\E.I%$98+!T[1&K^Y;D;P!CU&,"
M:&H^KKX+UM- HE%*+Z4;H#S>,BQZ/!X*]%Q2!?-6XV%.7BML?2FNZ5)RG!N;
MVDP7K-5!1>7AALI_!95_'#0VK;G[KGW:\NPXNW'1W3=N;>3J#H(HG_?JC$'*
MFJD%[3KZZ7[?U *U/JD%]Y2L_FHXABD,7E*=@KQNN,D1<)3^[#43#C951"[S
M8/^,QVF2)IGO10HK!HLT]D06Y5XD?!VK/"PD$[,1J"(JPDQAR[@H8SR(<C_W
M58";%/-(Y<5LYH'=GX[;H$YC2W[78J*5:_2B2:;&[VE"/JB_=.%5N8%/0\MK
MP&TU/5@KH.>8N(_UVS2#6.Y&EQN.L!_VF7 SND'- VQ)CR1&.K:NSAZO^I>[
M88P3N]&4B;BN+0?27VQ&Z-CXOD$AP1$0)W;";59?]8=[M]DN!*_L779>D]DU
ML7X,RCAW'4M:[: :615/42&31HW28+U9W+':E)N9,;XY0HH_ASN?&0"5YO#>
MW/4MQTG' .>CTQ/+V-U5?]"TGW;M$YOS?^K40!*"K;5J1?NJ!'L,&Y)A"EIF
MMXY1P.:.)Q:D:ZNC)W+[&4RVL4OM>6_7YZXY_?,JR=:U36C1%";I-9)=#9[.
MN"HOH,Q!\D> 3@NC/)I2,+T^TO6>$O=>5EE.L*L; =H6H =GD4Q%HEGL^8+'
M'DOBP.-":8_+4 J69#K0<V6XL1]E0D01;$;*9,2SV \2E421D#$+L[DRW+=U
M*:BI*:HWY'>5GRN7B*+8=\O JS+EEF"L5ITUT;W=V<>4'NG 0)P<I;2/IIBH
M2V@U)LD;45VU5JSV:26#W.30S>7019L<NK68R_KGT*W,B9O-H8-O4Q9'41H%
MK(@3H7RN0N U42R*/+VAE?6#4UB*M5%8(G\[N!>%A9<78/?/M![9:"YMS>7=
M&:QSQO,H\O(8K'Z6!\++<IE[N?)5GF>QSD(Y>W!$H;1(=1@JJ1B#DQ]E<&X2
M./XJ#WP6SFHN+Y<!,OZN>LO*!6IEW[DT*,HTG6^_TNLA,-EXXF$:UI8KSS2U
MG50_9V'-JH"P57;JFT!Q&7Q"$Q(U@-)D459>@CYF_EC --2(QMJA45((!:/#
M55*7*R8<3<>2.L:V0BE@-DY@%VUG;"R$A8'4F%^9^ QF")'E2C5?7*&O%EX=
M[.9)U]9"6J#&NJ8=5^/16)7G:\.D[PGER22UH*KPH0+&W%2#$6,^.0/6D45"
MA9[4:>"Q5$9>!AJ.)S*ELYSENF!S&DT69'DB"E$$><KR#-OMB3C)=9C[8<&P
MBJ#-F.L-:$"3?@/@R,IQUX:9W[&A;F.!+)AQO4ZW2P)9*VG5!M_OW_!REDN[
MEL_M3&\2(%CE3$T_U;P7T=6/4_,]FX2&SL,MRB'LND2EU6V>'TV\[F)]>/\]
MQ>OV7>7_1B=OL_[SLT@6<5Z$A5?X1>+!^DHO0TD0QUG!,E^S/)TK"/-9HH(4
M5,PT4TQSD662YTF0Q"'72:#8+.NOEO]WU<%7+@@Z5#'<,VPV=:FU\IL:'U/N
MT;*.SA6BA:G.:F!!-/!F[)T4S9DIWUJ*T&POVNX<891HT;P0II&FC= =;9AR
MZEE0MVBVE6-E/5WT=9J/COT33W:!16#M5P@(79@$4XS8Z8GK%(,BA&1#NRBY
MJE<IZ\Q4RJ%T*U07)1?=<8F,>,M^PNP/!VCX:O_54=6[R.1KML<QN!$8]2($
ME\]=?57:9MYNI!ZNHY%15R#A,-4338WZ M//I]%GAK""1EV*AUDZ$9I@R8<]
MU=SF[H!PQ4V+ZNIV T5DBWMJ\*Z9 4&J]DI3<J4G+3PB1/;&&&F%;EU:N<M-
M A@",5$!!QABXW,+3VW6%\%,2IKFHS&=NFLC/B-_.XWN07R^':.6-+E^VT,\
M[(%")Q>QB8TX;8O33V=!G 1Y('TOYB!)69!E7JZ5\$ 2%%HI561RSI(JLD*)
M0,L@%@$+<RY8(&#75![E(%2B.=1&MQT&"LSMQ3>84BL'OOVA93G%.%8>V\ :
M^[]"=@?/UB6+,XRL8WKQ5LY(1.2UQIHQV!G3_M2(^1L3-6Z7UOD@-S)<OXU<
MA-8R6KZYU<[5/:0(A0Y&\:A7J0-+<;7Y%A5[%CI@6FI$/>MUB]GRF%\D$3:R
MP,J"RYVS,"A$X2>9)PJN/!8'RN.Q'WHI5WFF9"RD/Q?N*)(B+?S83Z12+(C2
M/ Q8SKCP8\F$GI<%MS[7F$*_/F:4[<(T=KCB;4Y&X'(VC>YVKB_#BZQWT>4B
M8'VY)S'/;U3JY^[#'ZI;CGK\^GEW0/.BF_ZPS[()#,@!*58 :KY=+UHZ\W,=
MR=_V331_,H9_E!O9_KQ-/_UKHN9_B_/M+&%+?_:W@Z6_W?38*-W.H^16C_T7
M3=E,&U8&5_C_/(F>U#D.1#K/_4Y *^N>=\.EX>@+7OS'7(!]=B7-(MZ_\DY;
MM5>QSH^&=;X!UEE1V"U6!CL@G8^'TX'R[)REU+HH_KAA'?  SM'3<'3_9X^6
M ,74%#$X6Z]]Q[>UIXMXS6C2(>=JQ\W]CDM1$<1ZI07YSM^S3([Z/-%1SB+-
MBHCE.>? I.,B$&FN>2YT\CURU% G$B=!<P+)PH"P)*66S]5TC)T1'JB$/?GG
MK_+T>!B>]O?CT]<GX>&NZAT=[\%8YU].^OO!0;AW??3Z?>_T\L_^Z3&,^]+>
M\^^_+D0?KKT\[9]<]CZ=7I[XAR&\&[S7T>ZK[LGEQZ\GQ_OL]/7?_8/7ISUX
M1__?7_<F!Q_\+V^.X;_',CS:_?19O?Z;J?_OK]YIV/LL+N&=+T_B@Z\GP>$_
M,.[Q.__T]0&,_]&'-;LZW?W$3B][EP?'?U^<OLK\,P8*D^8R\_Q0:(_Q(/5X
M$"5>$F=YF!<J2%GVY$4T:XNM:%A5!#S.(M\/=)BP+)5<9+[.%0\YDYDH@@TA
M_6:$%)^I/(E9PB)/9W[DL3P$0E(*/T4BR%GFLT0\>9'.$1+N5SD3J+J#/%][
MX?2&4V$J.BT;GHV5<NJ12)PB"%,_87$6^ 5+=<Y3G46%\*-,JW##*-:"4>RO
M8A31Z3\'P4'_771X>7%Y^ \PBF,%SSJ%]SSY>GBY=P6?81X7GTX"D#@BRP7W
MB\A3L<H\%L:^EX5@4Q:L2+,PSS'U],F+^(X2!_04S+D30FK)"LYYGA<\4$F1
MRT*JF&\(Z3<CI!@)R8^U7WBJR)7'$AE[O,@3CV4QT)E0V!+QR8N _2B1\_ -
MI2/L\JVQPP.BVEO$LKM(I1^U! ]57&4LY#I4N=9!QGC&19QED9!%D/+4UTFT
MX3*_GLL<K. RH\N#?]Y=PSS\P_[[WLGQ ?QWSS\Z5KW#RX_!P>N/\<E7&<,<
MNT=_@[A* S]541Q[3/K 6T0:>%Q+'Y1;/P.-EXNP6*C7WBRN=!P5+$XD Q[%
M NPMEN@\#9-$RB ,\VQ#2+\9(<5G,LFS!.53!F8QB*N >YG.0T_Y2:[S(B\2
MYM]=7/V+O+W-%+]FQ'2Q;SE=;U?Z&\U+?3'L49^9\?"S2P 9:Q<.7!5C^FSQ
M1ZM\DIZF?'LJ :B WRC%WX$5T>6+HE"NTK$YET>36'FY3IDA]U+YM%_!%1^-
M=[OE:%CRWE'Q9C@X?X/  SL$C[7)$FE'!O?.P.(*I A2+V>2>;C\7JX3Y8D@
M ,8&DHWS8JYK>E[X(F9A*&.?93K,DT1'003BKP")*.9*N.NM6=C,ZG=-Q5RY
M3*URJ(G&U,3Y3E^4=%DO(()T8^LMAPZ%(&K=L9SVRXDITG:0MIPZ>=DL.LH_
MK!ZRW=DWK+&<]EO9>Q9XJD:[[3P%BZ%;4NFX[2N V7B8IMA%31_1JDTF7OFL
M!9M<(I^F*JJ*24L^'E\3,#@5.N'E%N;#('+BA-N0XRV ;]NUP'9Q,V-4OV-R
MXT0/3':C26U=UM=@"R;2DS9MY68PX)O6I;$J]=?/"-2N)+P0VU&L@;A)Z/+?
MDYNX-O2.R#6X8J3@=/0 :QY<3SX#$M]JS#??D$YUE=.R7XTM*,L43%N2!M/2
M@D;4XB$6N2PR=#2&+%,A!V4[\%D<J4@H/\U)//A.//A&/"@M8?=[Y?]YLG_X
MZ@9I,2LCCH=_:B- M#HJ6IKX\Z+[12OOJQX/P;(&.H(G^H].B,"\CT^NCHX/
MKN!=OL [G$5AEC"IM%> ,0VFEI >3Z+""_(8&)^*HDS(2@&XU89_BSZPV?![
MV_ T]X,D5\++"@P^1G[H\32+/9WD(A0ZR!0KGKP8#)UH=WO^8NZ+2<W;%TD
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M:$@!P]*-X'1Q]];JZ'9_:;<L30!BLV8&T8M,>@KC-_84$QSMZU4IBE:06M*
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M1YV1A0?O6AN%=JDXVWC-/-==?63-6=<VW81./YX!8O;'*]5[^/4I<CKEM9[
MG Z26)@4E!L4R\PAJG"*>"8L$EI+89C(I'/W37E=*0GP$2FO$QY8V317(3:R
M.'M4EFN\P<7].D,\*'&4;+#D<1U"[LIR?5S/C3L'>[],WRK+]5%9KBL2VQ6>
M^%?02O0] I[^F*XQ].=SI:Z^CPV_9[+NF^7COO7BO$E*[IN&_^W(\XFD6>7B
M5GEJKQ7S/A'5@0#K)?UM]LWNV>EI]]U4,'ZL3%]6,&Y\WDX:5SN^ZG"GT=)Q
MX\<_1^W64:_1^M2IDYUNN_?MO'&\WUV,!SV,V\<Z:7RN7S1^;./&U3?<[GTZ
M:GYNX_J/[:O]S]\[^UN;I-';6YJ<2R2V&F/I#=$:44)3)&*2(8&=(TY2[;!:
M^Y"L$\'?2\Y:E9I;0=YJA[U7D/>JD#<7 B^M5-JX##&1*.3;42 E'$6)I4Y[
MTVN6\+4/=#VFY+U WBOE9+XIG_X8#$]0IX]" -%H04*=3/NV)LE+IEWU0;X3
MI?S*;_>_YNM>P<^#X*>^('%)IA7)B$&*^N8XL9)(*,:13IC"OB:KY"E(7,DS
MI=^L4$)AQ:(O)DA4+/HD%ITOY*$MSG2,D<YBAZC@,9*9 0G!94X"BCJ196L?
MTO3)\L$S\NCO8*+ZU.EW1D>^,K./<WB4!+!DUK\>O#R[!% N_&>_[I5V\GS8
M\VU!/. 80">),X1EIGP1(8PX$QI9S)S ,B$,6V^0$>EB#/7CM),5LKE4+/QB
M$D+%PB_'PO,Y]LQ@FOG"7SP%"9^9#(F,:T1YAG'&,VICO?:!K&?Q*K'P[V!#
M>)FZ3K^M)?CY%^B7P>]G%\$:=ERA]O.A]MZ"X)6*1(D8)\A*D+EHE@FDC+*(
M: SG<&)\6:BU#]DZ$?BU*J.LC*OLI2M%50A:(>B+2\ 5@CXW@L[)O=3@)!8X
M0SPQ%%&'!1(4Y%XAI(6#SS B,H^@-*:_#(+>H_#4K?UQ[UN2Y</_5<-_?5B,
M3[YOGBJ_1Y[JBO5$Y"_?$_'KT+?D&E]^[<J^[X?H6XZ=^I2M54QB/2Q 87#5
M"+G7>V2_]PFN^09,NWT)0'#2)CN]]G$=WK=WV6P=GM?G<[:/ZZ1]Y?.R]WMM
M8/#]K9U._?B?3O/'#@#-?J=^I6FCM<V:6YOG<TFL5S"O \D48;YB)@>1R"<H
MA>)Q&6+ [ZDB1I$XF4]B950(D_K"FA0NLE8D*>,$1*V4PM=.S2<9?-UI?JWM
MM-K19F,KJGW;V_[JV[C>GM'ZV_>;9C?WFZXZ1U>=HZO.T57GZ(>NU6_;.7JY
M?)2^;1D/+PO==#*^'8U$-Q+)+94F[A8(9@4((7DL.!$2<T,-B'DDSA)C,I>8
M1*1$W)B7F"?J+1V#2UWF8A:GVAB*DTP03 65*F::*IMDKY[@5_6QK/I8OAB,
MO,L^EF^= /9^6UF^]<J]>.I<89M8*</FQ\%H_-=]2.9),>+WH:5'QUR\R""?
MPZN<;62L,,^] TKX8N7('OE"&IV>+W:4EP!Z2DC@+^KT^#7=%CIE-N64<T4E
MI2#/X@1$2\YL['O)Q^2^CM\;39.?AX.5"O%]G%DR]U6<'C6N]L[WMV!LGVL8
M_L&[]FCSQZ>C=JMVM=_;(XVM-FM<U?%^9\Y7T:O!V/X^:;1.SMNM/?@'\VH=
MLC;<6V\U>ONM=MPX/DGJ5]][RZ+PJ698PAXAD<;,5UA*$,=:(YG%H C@-'%,
MKWU@8H4B?%_)65LASRK-[2&-0V%J:4J8I9;2A"6*$4ZH3>+$IIJE^KX.TPIY
MGA=YYKRD0FNEG<8H=EF"J)8826HE(H3*6!BB8VY7#'F>0X9_7T*<+Q%U!KI5
M7KIQ-'#C<SFT5<;!C8W9899I#"<H)C&UUBI+$F/2C&'KE#*RDGK> 'L6DPNL
ME$PSF2+8%(RH%1(IV'N$4\,QD=2PA*Q]2+(GQV=4J06KRZLIMC+1J23>Y)YH
MJF*=<)G$SEHM,F<J.>%M>'5.3B!4<&RD04IF/HM $Z32.$4TIIF-7>PHQFL?
M:/I<O<17)8?@?0D*7Z3R80"^@*HMZ;\J37"CF$ L)L0PBS6E%#M%+2.IB+D7
M@P73E9CP!M"S)!1>2AJG,D,FE;XSL@<AE@E$TC0SVL4"]@]4E*I$P2_,JH)Q
M9U)!E,UBRA5\HDF2<6X32BB.124EO VKSDD)SE')E>2(.U\I7AGXE!GFRXQG
MELLX,1E;,5;]_:P)G\Z&P&AGE0'A%K<)Y9D/U4X54S1-$^D,R1(IN(IYJF5<
M209O #?M!<G I,38+,/(DI0C:F@&P)-(1(R.I6!2ZRP&I00_V7I9&1!6EU>!
M3:VVVC@J,'5,R=2RC%B>4DNU2]-*-'@;7IVO<YA@39@S"'.7(:HSCI0PPEO\
M'*4IMM2M'*_>(1N4X98P6'L[>[_6E4^U>#Q% ;DQ&N<7QY_GRJVO\.<9\>=P
M059@/,.$$H>$AO_0E# DG72(&U!3K.%.6;GV0<2+S3Z?E QZ!SN\(P/#[\K?
MSY7Y7?'W\_+WG'R1&IN0V,4(Y$&%J"4)Z (,(^-DYJO*"^8+F8JG%XY_%?[^
M3>*4O]C1Z$EQRJL2BOQBT<:8;)!W9%O:U/JLYWO$6@-@>#JTOJ.L!U@?N")[
M QAIWAFV\DJ]M#PYM15;4SL!G[O6?X C:'-J0VX\GJJ3Z4$G4^T\G$JY])DT
MC@_9@2;2,F$2)(@"U9<J"UHO3U%F=2HE3T2*W=H'QIZKDM,[%3!_;;9^+C&R
M8NLW8^OZ+%LG)G&IDBF*-3.@43K0*(622&L<)S+A-L7>HD5_-6_7.Q-)2@X(
M(LB$_->COET(C;EGPEE5.>X5%NB7 ?X7MP^&2G(5F#\$S"\69#2<6(VSF"#-
MF444@XS&J;9(2"YCS%0F4KWV(6'/%8O\]K7B7K<Q7869%6:ND,VUPLS'8.:<
M )PJ8;G6&HF8<A" M?&MZQ2RVF4Z$2"S&A^8R9[L4ED9S)RMK[E02?.VDDVW
MUM-\[5))6[>9YB)[<6K[(QN-?7UZ:Z+__0#.?509S"D69O,L?!\E]WZ%=--W
MRN>/KYEYB \$<(Z0L426,^RKX'(DE%((BU2IS*=Z&K[V(=Y8M#U%0'?=DCX>
M1 ),">VXHYDEE!LB02'&,66@+P.&9R*00%R2P"**5R3PG"3 #C+%TYA1C)C6
M"E$>^PZCG*#48H=MEF6QRSP)+-HI)B0 :QN-CVQT:7U).]LW@ IE":<<RQ.\
M'GF&#M3BMW4]&MK1J=6^TFGW<JX:XWV+$+]5'>#EJ+F\>MO=%>&VSH9P\#QD
M 9?^!$OJ'^&3@67_,O+Q/X,1/&?@(M>Y@ ]R-++CHN*@]?:-HJ:@O^)-,3QT
M K1F]&DXZ.T"(S9=*9C]M^V:3X.A_[+BX.4<7#MO^FKKK1JI'Y_$]5;](,N<
M!'B5",1AC:C5$JD$M%8FL<&<@]25D>68GM/3R@![11=/*8@=-S</-$F<$Y0B
M%R>^?6NF@!14ADSB@%UI[)CPS9UN.=XWHB^#T2B"G<\!1787 ,7,XM=M\!5'
MH;HU8.YX$&XX'W;&%@V<\T_M7J<G>MKK+JU-Y?%K>S24M@LO]D)H).&AYBPG
M3_@1'M;1-H(30-N-Q:,DBNY30?7VD^6)]>T9?G_U[<7+U[??U#J4N/TJ+[T&
MY24XK8=GUGSI2-7I=L8=.UK!4O>M6LG9<?UX[VI_:Y/N_VATFZ&7Q<YQ^T<-
MU&O3\]Q9/^[VZEOFJ-V9Y^QOEXU6XZ2^==1MDSWF>UGL?VZ BGZ2-(#G_7N;
M/]KG#?*I S);TFRU ?7KY_7C0PR_'6"1 -X+AX#9!;"Y!2G>6H9<YIR5,2C<
ME"]4JDUT#-!LJ9&,2II(JQ*:,1NG,?S%S7RI^\V/'W?V:EM1[3]?:XW=VN[M
M1>Z7BT)WO?+#"U/8KCX"I/ 'R2)EA0+G%5&51'5R0.*4.DYBY*RRB&J!$9=*
M@*;()4U-S#63\T2R8GBV7$XO]KZT8XP\F8TZHW$N*_M3R0VZW<&YMP8][:RH
MRC)799FKLLQ56>:J+/.SE&4NQU%>G-?,?Q>5A=_%(%^@J>Z*1OQX=3$"718>
MZC7+S@ADU%'TQ\C:J#$8VXC^^:0JG;^8)_J7+D3ZU/B;GY=]^U<A4GI[U.CK
MA* ^G@V'(93R7?1Q?*3*4?1Q9,U6M]>X^G[<;IE>8ZL>-Z[V.^WC[8OZY_9E
MO5<G^\>'\ Y]-7%-3_HXGC!00Y+&C\81J"5Q_>I;TNC]TZD?U\[WO67L:K_7
MW*J!2E(_GZF-?.5[/M8/.'.9HD:!FF)21#G%2) 4(\VM53%CW,ET[0-;IWR5
MBI16Y9$K5'K)")<*E5X9E2XGJ$3J+7V0QM)E(M-(6^Z[RUJ"!*<2V50G3F2I
M5,K'OJQG&5DA5/K]BAT!6S@[\GPANQ$\XV='VX7V%U4QE1=(/O/(-+WZGZRM
MH.GYH>G;C, $WQ]HI8U+#!"NXP91I1(D*8^14 P+3"U-8[?V :\3_.3,E*HN
MTNJR\C,FG-W*RA6W/HQ;KP4)'Y5[0&7,?!@MPK SB%)#D'(904XG/%62P1_
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M7&;/%0[TEK@Z6WYW4DERIDC1TLJ2]ZS;)<33"G?=5#9L=0KFW%( #,=1B-;
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M?]9$WT3__(,*#]?1/XNGIW\>$ST7'1PUL;W/&Z,QO.Z!Z2]Z^X<=Q/"WO2C
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M*I-2L%K/U>W;91I3\]AB<X!WL4TR); MN;46_!YQR$4M$',Q$4; 1YBT],J
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MX#RPC9YZR[FZWSR,ET(;!<Y X\"5<IHX;Y(+*8!K(,$U<O?+REWV!=$::;A
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MB*ODD&-1@?O%)%@<K"UX&RMT?K;R(3GC;?>8&J?U,^:,C=-Z5(-P?2C>V=^
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M$"IE B5X9L4GPJ']&,[\, HYZ9_UNZ=GA93I!+Y1L0:!5N<@O<0E\(@.>SG
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MCEN*M+9&6.\RIW4>]\"<+1LQC_+XW*H*=ZXS/ECYGYTIO/W0QJ);?*%V[>K
M_7[&K9G+>#DV;6XN0VIK,S.[<)A#XLX-,@YB]<A]U!('F[A9>F56Z#PL_G,S
M9S]!,/DBBZ1C*,Q'"R:G1WAJA#\&TA)Z9_E"^;8F!WQF?O5+S!T_FT!T0@*:
M0/3QC?;F_$ZWB"$I0APBSLE,[&.1#4F@* E.SBA+E,W55J/@/_K@0/21M?%E
MC"7?^39_ZNCW49_-"[7"SSYLGC#$3=C\N!9XKK> 4J.$\T@S%1&W.B(G T'8
M$QMM)%%9B ()76&/C/KP,-7[)0+N?Q=XZ%<3=%C'8R+:*\"HU4($[^JC[G$
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MCSJ@IGF;9Q>[PC^%"3RNKAM->8:\V/\YRAELT"1E^>1@Q"^09X1J2&>4JG2
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ML2@,XN#9:UWO6\:#W^5\>)WT%(*(ISD\+)7);E:,9JZ#=*[\8X2/C66G5>]
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M4RSM0DY,O:<@8E%8&N$/6GDX'"EQGEW0T^P"!&94@'JY&(Y'\$DP4=AP.)C
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M8J1@ <1TOE^V&841UY:A_?1JY!U,CD^_?PT]5W/=0%=]#X.6R"<1!,Q"&L[
MX9'E&%S#ZQ+]V4A(723O@8HB=HM_\\7_=;CW^:NN^YX#"Z_Z,7(9P:R#[V2&
M:N#JNL<]+)$88'I]?Y:DL5S\=NU#48I05 <OZTW/TR\-T[)*/?1++$^>UO6_
M;Z6";E22[RIQG)6^:0'=I8DY2'>H[FPGFPMD4SO:._P*>LER0#.I@8T56W7?
M5?T@9"HW7=UQ#!-6RG_V6K?GE&QM*2:&:[8.<;$#/XR]V'*Y87F1P<)0US6D
M C1!=[D^B8M6BLM<[875^^"G3F[NH>JO>?CK[*MI>CISHU@EGB22(<\T=-7S
M'<-V]<"QN TRU%_$V;9 Q^W,U6GG#(N@\K1&5@4H*MXK]>"W<716@E= >TRD
M>A HJ]+F""(C;KW(X <!7A%UI_1' 9ES0OM8?11U[7@P(FF6?[[."8CXD%-5
M1N$#8+]$B=;RN2M= >$&%,W"J%EQK1M0,BY#YT5CM0.!Q5BQF.HHD4/:N:+>
M;AN_GK.HJJZ+KRI&. O#'$M&_IQ3-G:J+[?2!4X$WG$4Z8'MA989A+ZFVT'L
M.*9FVK[O^<NBU]L6Q7AZ>_S /@+<HIF^9?@L5&/;= &WF('*O("IFA;;FF^$
MX$L@'2L8A]F<_1NC5CL.M="+3#<P(@M  ^,!F*<H!)SD![H5=(M^AXM^>OB5
MPV9G/ Q5/0@,U>*.IWI.:*N!:=GP?W J7.2[TZYR5:8U^1:Z^5<J2!@=P&E0
MS"C<$8=!9D.R.?/*BU M[#DJ=)P/LS)<\_ Z<BY[?P>$KMHOAY='O\*O<61S
M%_:$ZC/?A/WB6: D8T=U#"/6F::Y$3/ N;O"MWLP%=FM^0W6_'COSZ^.PS3'
MC5$SNERU',]3 \WWU-B"%8ELVV)Q@(#76%I#@KYA^"? F:AX/O5/^@0I<X[K
MH SX65(,"#WV*ETR"[Y FTB8"8@T@&?2%#\"' F>DB>4SS@H^#]C5%8B)-#4
M50J6$H\3D#R*YIYGEZ#;\FE 6%S= XI>(T",4,U=,1();JF?"+KYSV&2<]%;
M4X0CRA?-U:OTH@5/]Y43TK+7 M0%S_?H]3ANH:WG=@">9?/?S6FU"\7T#&K(
M],RR>OP!EA%.84P?86[3,4YL1#XS!HEP>;[!P_1-Z2,(U%YY#G/GG)P GH\8
M=(&XF(4_,AKE23 >\:('#:.Y*A:;KE%5'0N^#6-BJ)?2,71TD%PD(_%^Z6-A
MSTE.JW=>@M05Y\E0!J6@"4;9QV!8I0=5RL\%0QGZ >,"6<O/LI3//EU./LD,
MIT<"_ _,7 *>X$1TB4=E?QCI+.S0T?%[>OCC?[.+X:N]QJ@:9R!HD)NS*EL1
M\[V-:*4YO[4"6&:I%1 /VM+H^(*109>1CFR*T3B:H!Q$63@63\%+_@%Y2.($
MOX&JBPZ+<7G!Y14/X%))-9:D)$,13HUH(&LJ$CK@=%]=(9'S]MRK6BG!BB>#
MJJ=T\G8Q''#J/@:D8"X:+X?/OZ<@:""8RI#E(Y C>G/^HQ%2&.)?4FJ!(J#C
MM!1PG#* :TE#;[7%!!6]./H3$8N6X,C%LFQ8S;*5ESE'-?B#O[I,HM&Y+ 3?
M?$J>UFKU(RPHL@'LYX6/S-0K?R"!?*NHBFE/S5#CW_.\[-&0G7$UR#G[KK(8
M.OR2#2[9I'CV6WOGP;:3+_#L/D[C] PL'&<<W]DXA0*(, Y%:_Z25!I^"_K$
M-J8ORGF.L/&_$I-S(P:W0',!HMA.Y'F>ZQEN%-B<ZWIH?76Q2"(%C&+8IB _
M*2:&LM?+:$3G*H7X^G^#_+?7\^1A:ML(/!F8GA;Y&M-=W[)\YGF^&]MNK/G@
MB-J&9S_;#K6<H!,9%V"PRX->"@32S9R%6F\VHHB1T$4GZ$W=E?U(Z+B]\:X5
M=2T9WIZ2Q%.:.RFJ/  $@_#K938>(,0L!QA,YBO[V=$HO,!$D*0XQZ0"L,3X
MM=4<ZA*:;5M&@3M72C[--3(-YIX-',F"H,G)KG*4]177TGJ*N%"A@(^):%"*
M3T&',X @0@:+6X7J8>P1&.X<U#R"VDL$]J 58"PC1*_B,!)F((D0C[9L,8C_
M)8>]@08;H7!1'GAFXQ%U %099QA#;SS55W8ET(0W5[V )B@[)LR@BP)NY\H%
M9P6@PO)$H;5$()9I$Y6R."ZQ.PBY."^0J)_31V#MA2^$GQ!FAU:$-X;^5N/Y
M&N$+-%64#<D=/27GK62J-9R_MN,$)R'LU?& '\>?4CD]O^C4K"R7]#$;#-Z*
MW4GVXQ3>_F:0A=^?7'S@\^717OCK\/30AF=^'9]^^NII(;>89JI:&$>JY45,
M<ON&H1$9H1='#GL&\A*R(0*X?,RWQ+JATQ%GJ'AIRQ%N*,87T%]HI,PE(R=A
M,B6\@*MK,:(-$4A!4IZ3+Y:-H6-1\6(I'6A3MK5\?XF<*9L19F+ A@5_6?[P
M*DJ*X8!-7B8IC8<>>B7;DG ;P>54,B--N?BXQIU]36!/>5U(OEE^W*>/IK(S
MQ6>>VS<T:^''6E]?^-E5S>I:W_:=I9J][UM.5Z'S.Y70-VP@TNQ&RA\, &8^
M440(7YM"HC>X@?Y(T^T?:\Z\R2(P>G;HN59@<J;%@>5S$UP,T]0C P/FNG]]
MSOP"\_=8<N(G7][M:U_^WH>^[4^._OZD?38^&9^_'>'[]*-W^];QWW^=PSLF
M7Y+IG/@_OG\^_3CX?/K]\O 4QG#Z\=N7TR_)H8%C@W9.SVQHUSB&L?_GU\X,
MF;3'M(AIGJ,R.\;;W$ZD^GZLJ]SW@UC7_"@*K&>O7=UZPN5Y'DR+[D!_!=Q%
M;VV8)_ O'AW4.+B<_K7VSJ$PS[5AC]EP&F("U>S/L>-8A%E$9Y[K+^:;@$=^
MP_X>$_&659X',LNT^$B.#DSHVSR[^(!B]H'RH."['TI)>Q(TX/>DAO=GU3 L
MIQV'L>HXKHM%AP*L0.*I@:6%CFMY9N"(.FGVK15Q=VG_%CHX'.=Y>8 [JX6?
M"+'8UJBR7;%:\Y19IZ]6T%<'M;[ZMG]YM'?VE7N.%T2!J\:.%ZJ6;UDJBPV\
M5&/;4>2:FN,#;#3<6]>*WF+8^# 7)2GS&-45H3)Q#9&2)*HT!DRK&(OX:)U?
MT/&2/;P2JQ>OI<7>8_SL.-X9#@<P>\& GX@%/([?U\O7:;25--IA6Z-AL-AG
MKA5:L1J&/E,MQP]5S[$85E7BL>%%S(M-T&CV[&6<CB_I[H.(93JP8DZ'$5>[
MAG]U[9)''%U<?OR;K;<?@*YC8>BQ<XCO &"6]7B9[@/ M-4@B W5BBU-]33X
MU7="UXY\PP[U^-EKLZ=YZX*82^^0;<&?7=BR"UO>JZ]_R^OF]Q"V?'QD2O>/
MEZ6"UDQ0LIH7J(;!==4R/%/U],!5==^(F!:XNJVSM7$I=<#YSF.6W0G\(X7!
M#ZN6NQ#L>A3PGS,*V-*=T'2L6/7,& F>+5\-0L<$51R9L<6X0;<?=7?V)EP7
M@MV.$.RMX>3&S<WR*GG>$#=;):\44;XGG=Q%E.]-07^:/=,//<,);:8R+W15
MR[1<O*H,6-DVO9#K?NRZ6,_/[ACX-R&BK'<T_!UY]!W"\'71\'?1Z#M7Y9]G
M5#D+0%>'H:U&<6B *G=LP-I^I/) "RW/]UPKHO0LU_<?+6WT0])$WU=H]R%T
MB%(:I8:WL 1_0.,N' LE4?3H'$3I[)PN_!SR_(SG4Y?5EJ/^WJS+3@=I;:MG
M29X%$<@@@1F(A'LUS#/80K@#Z.8>7FTZ*'(&BTT,+$F4L'S24_[Z?+2O?#AG
MH#1#/B;)*)3WHZ@O*#APX,IE,CI7!%5# ?TJD&H!+Q">3='&$%]&%K=Z]F^\
MX3CB@P$/1WAU$KHU! F<"(K7 B]CBK7&9XBJ9<@H3!?*D>'27W*E<5V+K415
M%/)8-P(>F-SRK5"W L.VN:7K5JR9&M--D;4"<[R8SE-8GA^3E+]\7\_P<7Q2
MS>-!8X@?Y AWI#B>"H;%=RQ).TZC^7<6/QE@R;YJ7 ^\. I43X\Q?N.:*HNX
MH]J.;ML:.!&&AIQ&CGD5V5_)9XE7T 4=CJ%1^+<4?DET2==H)0%:7_F]R3/4
M:@+%%*^^3QKWS*^C].G)#2&9C]*L^5+DQ4\+/L5%TE>4 [R]+@+6/;&5Q!X9
M%!DV4?8?-^-Y-HC$E<>?2C3FV*<%VV=[N61R9!H=<04\]E$.WKL@)D6:EY*@
M*)-\*S_%U7Z\DI_#:V-.AZVAN+I\-A943S"1$5[N+D8<303.&/N)7V'CT7F6
M$X],2<-#\XCMB3D7[$%@EO@/)FS/]'/(.1,E!3O+.1?:<A[U07G!O.Q/4<J
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M0RGT^J*G/#=>*%\.WO_GX.JOX6?/S1?*V]T]7;/I5\&0/],9&<<?,N(]AKU
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MZ2N?T)4G(#2;9=!.:<3:6 %XJ.5E ZP\>I&"IUH%M<HZ5E6D+$,O/Z&"E"P
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MQ=;9V72I<,CS8CI)9A-7;3-(>:[LXAO,#1?U4T7"^+"\"'K%Q>;MOCQ!+:Y
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M/#'E,L</TDI=TO3C]>\B3J33TYC(:@$KNJ\K9E;9@>TPG"R2F?*-N'U^L&1
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M=\<S4=XC$C4]J#A6Q;M?%_/+JZ>88/Q(BF(L./Y/^' DQ 6#4'WE8UF*4A3
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MW00\7I=!\#J8[BL,;C6@MB]Z%T9=;RIH;@.:7:W9W"R558%R!I0RID$!<QO
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M+6_P'P51&:4CJNL?%@=]!P <\!#A'X[P%(>>%[H>T$.3]3G@(6%2,$MM0 )
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MAWBTTQO88O0(2R 4T7*2']@Y:,06ZCJH)-C HKW( 7'-47)+7$ = AD"RGS
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M5$-+\=?G8R!2)(+Y21(M(]'VD;\A?3M:; HX:)<&(3!68BT)/1=M!5_&\[
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MX5Q[71K;I(RP:?S9'H_YP#9#[F /96YQD=IO.MP=P!IQH1J"X>Q_;V&U6!@
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M)-;+B6\[K%%77@KEI5!>BE=S[Y/=_.&\%-60^RH(X<0%?BKHLX$(^%^CW<9
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MKC\JYC++7#[PH>U26J)B*4?YJ&(I!V0IGRY_42QEEJ5\,OO<4=SD*!]5W.2
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M1L-Z>PE]7+IN9#J XK 9&-!EU$U8KY__76.V#^KTA L)""_@^A^Y"T+1R0
M 03X\ABAS$24,N%@B+R"R!I),,PCDSWXZYN7*T,9]>Z;%U#0. P*=@I1\.;A
M^C/3V^R<??SR]3/!D=U_^_SY\NN_5Z*GXLWDJK'I79)6AR"P6\_E2Z3#/FO=
M2>%]K&7M])G(QYG*9"L2AZXGQ+&#8GCEC:L]^%J.L+3=+&L1!'$@-GE_\^OM
MY<.WK]?WK^"*!Z+=NXPJC>+4Y[]'MD\:%:F=<1"TWD"QJ[?.!F^38.B7Y+@8
M#RMN^#C#".0ZZ/%31K&) R&Q?2&JA1X2 #S@!Y@.=?\^'YG.$/41'(C053Q
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M?ZE[!D"2@/W9$']N2\:697N<!WL3O%NOJ36WQ0MXQ6#[&&(W)O/0P"6,=<H
MX?_[B!W=L<T]H^E\[=AKXGB4N'%#SQDL'3+_=,9L6B.T87^:>/8!:A(620C8
M5D#V\SF0$+,?M22D93KPZ<P%&$PB^J;*#5\[I&C#@<2%280#_;=OOX[-HNT'
M$MTW_S.:;Y!YT>8#";5HB=8SZBG\CJCQZ:QK@Y=ZAMB[QW%/[FEPL8(@Y!CR
MC"KSN0E.(/Q#C<BI;2!.]>OY;MD=+KY+C*'UF?^]J]T!<5!$0KBC%KGIMOLS
ME2QX&7:@I%L[OD&]'AA<9\5K4J2'$[3RS@:-:&UW-F> 8AQJU/'=X6 R[/?N
M.E/M[K;3[PRZVN2KIDTGA70\DXD$"H7K?1OZ?P*=1T+%C[%" 2\DF)U0F4Y&
MV(%6+0GT/S:/ M$V1SE>,'34_'BAG[=X_Z.F^$VF\-\';3"=#.^'(VW<F?;@
MU[+897"3X]8&9UN&6\04#>]1Q/:$V'UW^# ::U^UP:3W3>L/)T<!+LE4CI_:
M;%[FQV^+.V+L3SC>=[]V!E^T26\P^=J!SAGV[[3Q1/N?Q][TCZ,@*F$OQ_:B
MV;PJ@*V0@WH#%)?TWTC(.@$M0^(HDV<I67(5N&PVKX^F J=9-PE39_+UOC_\
M[3BV>\-,#NI5LWE3 %3@BCC;&N$UZ$P?QUI9KRB%6H)(2VDJBEAE4U<W;==W
M"#P()K7U>I)]>$<\3$WW,"!")C(\U";\RX4'^CG@5R=;-NE]&?3N>]W.8-KI
M=H>/@VEO\&4$UJ/;TPH-$SDC^8AI*R)4$D<HQ@]%#%'(\021Z(>1;5*=DD(#
M*1]#&62MIMI*#JH]D(''$/ ^#;"@2Z9X9AX1NX"=#+EV\Z)= CG!^81;T"$#
M[#A0OR=28AHKQE@^M5VJA0TGF_Q"(:<9;[?_-=>C*Y;H\^B2N6_VZ?SH$$M$
MR,&^4GD4NR#8&W%(R$-,X GX7518:I3AF\2>=RR/&M3TV0#1_O*I]]IYQH[A
M#FRO9^FF;Q"#LF5O-VJ3/==&93S:'U0CN5I=JSS87E"MPMHA>X[B]4.B@DC4
M$$$545A'1"T$M42Q:C)JJ.A)'7?![]J6#DUS>!U=>]YU &-O3-WO[K'U+(<H
MN0+=J#SJ7U"!ML4R11""$9=<2XVX?9ST!C#PN\.'V]Z +TJ+H)Q&+EUW*4TE
M.:.$7%",3;TQ*.ZD9S.1NN:*TDZZ<VEXU-$?3^G30[SP/.RD9D]A[G<NL.KN
M<*=T-1A_EQI$&/^I@RUW3AQF_JT'XBR(<QQ \TJ1X]Q6^<99'IRW!**81.;Z
M")DG#1"]-?(=?8E=,G*H3CJF&237'@?X/<SE>*LJWR7+@W<H!W%!*))T0EGT
MT1?;-IZI:1X'UEUN<APO5+XQE@?'D/$)-M$EO='X#EM&=S(^#G!)?G+H+E6E
MF1,ZQAH!;P3,3_ %YL^QV0DF?"1CNL--#MV5JB2BRUG6T[$1YUQ+W,;:-VWP
MJ(VU[A"6RD77>BG4\J7>M9*,\@1,4(Q+K0$H,5ZRF<B'R0VL'W+ 4<N1<=_I
MC;]U^H_:@]:9/(Y%\DH14-(92,='JZDD@UB,#^*,4)Q3W:$H'@^1L9%&1%I*
M.QFARH"ECD&1M([MN"[Q7'")^A3/J$G96:<'@EGG&=B[Q]3YADV_3,SD"-*D
M5K'%5MOYT&:G:;AD[OO%9*-0.,(>8N(1EU]+0_K0&?];FW9N^]I$ZP+$TX(I
M/:GT<C/:5I)!L8@-BOC4'(;B-E3"16Y"U7;2\TN%I(X&-*U7'[#S'8P%=,6$
MZ+[#S4H):UF4M=PT7JA*3A3A_48*BL2<+&#008?L&N3B)P?R4E42CF86D/7>
M-^@-8#TT'8X+'9R)B.03U962C.IO:.O8R<5GI%U2^31TW4XNL#8<ZCCU;!I_
MB$'*9B*W0C>JDO#3(C1.EB?HB2@'JV<]07MLY[5KK]:V!7^7\0F*,99""%Z=
MDFW!=C*T-D)0)*66R([&[+S'](_.X(X=8QNQM601 %/II3--6U&2^XDA&P1\
MT(91S7$H/@-)N$@GHW:KG5RFIF-2QYDIK5LC@S42-^B\8LM@N9YK=NBPA"DL
M+T1N%MNJDG.X[=C(4"2/*&V$GJQDT%N'>"FY^,EA554EL9N?"6N]O9=.MSM^
MU.ZTWT?:8%(LXK=+*I_9+I1DAD7  84LZMOOQ:>S= ;RF>RRG5S'[F)0QSEL
MIR]+&*T,#G(S=:6V$IDK23AJ:)2"8]:#+WVM,]&*X+!#*3=)UTHR<VC# '$.
MM>WTX@8IE5YNCV[:R=7.#@!U-$?;/7F(+[6'D]0\J4VUE<C.VD6G[N[3=@='
M2Y+AFB=V6XL^P2[17M;$<@\',"=_.:R*VDID$R5AC2]V-L(0EX8"<2? 8X!T
ML;L<86K,;8=W4BS+X(BPYY B![^EMA))$W+PF4C$9"(0&BA /(7BI 01/!-_
MO18?!<!F[.;6,3'9F6K/YKUW3'TH)E"N&FU0CF*J$9<>OZD6!?*19PN%.6E)
M'+0'[ 7;[/;\#6U%'C%RC0!SD=B%DVM$)),]G8S%@6KPI_*#%.%/Y:0*/T 5
MM(=1?_B'IDTZWZ#;)J-^IU >?QJY=(6K7BC) Q8A%Q2P08Q/O4$H874E7.0C
MZ5)M)7:34B&IY0CI#A\>>E.^O0,=VAWRFR"T0='[Y61LY"/F2DF>M8AQX[L'
M6_QJ!$Y_./@RU<8/=]IMH7WP+3IY]U\KR:1N1MY@](@QJ&E_ES!1:>1RVW2C
MMA+[ ]N]7TNC-)D.N_\N?3MW"K5T#%PTE63V;IQ)#>_53O9AUUZM;&OBV?KW
MD4/$Q0G\"5O&;RPD:7GN01?O'4>B=+Q=*&HK$?].0YK?%L&D(R[P%[2I0/B"
MI2&$E:AY2);?/WX+"Y([]LT!;3 I?#=2!@?YJ&TIR51MS@AQ3BC.JO9HE+C*
M5,9'NLMTT6XG,P^RD*GC=E-ZUQYD//-QE!M'56WEAZWN^U L4Y=8;CSZV[5=
MSYTLL4-N,7 =X5<6J76':U:&'<(<3QZ_\ FC!,)'D2?'_T)M)W;GXV(W468N
M^!?$12,N&X7"691*R.<S)-0 B2J<E$0*6A0\?+0,XIBOU%K<80\_0IFY[3!&
M/ML0!.78G-JUY_ 4]/:;:M2Q*B=7OTNUG0B=E5"_>$@TJBYB]65W[(I=M4V5
M^96GL8/(0,3>A#I\4EJI7OBK%79>.=0#?S4C#MLGYSTW]#WVD67VY78. I08
MF;C,!6(_HCIRQ;Q2V\D(50G%%-4+54S44.SV"V6+55)H+B_'ZGG2PWS AZC#
MM!.'_,=HW1[A<AV[5MN),-QA.A;I%ZO0EG+549O2/>38QC[K4/8Y8"/>[4=S
MQ?,*DFO)C=I.!JJR/?2MU $FML'E;BM6'96A-X">TJ:=WXN=#@R)I'&)RZ:2
M=GB3T2(@KF,OESF\O$TJC3=<*NUD6G'4XW6,,&SZ+WZ2%7J7]&W7O27@ A/Q
M/,4O\(^PU6+7=]@7 ^&Q?/;D4>5*;>%E2VVGG%C?@+Y[PI8)13^S:OP#B8J$
M+T$PXG41%U6*VO"W=4Z[W""YP6M,=-O2J4G+SHQY6<IQ;ZMMB7EE#Q&LV_SK
MC>-A]QAD,9%CI:KME$/P,:SJ'4-,L99WP3;39HB4RE LQEB.X87:3FR99=K9
M4$IL$-8T\RP%@HX.FDX]$:!@/CBV7A\M!VS4PJ+_1PSHK%MB025*7EYQ#(%R
M7;A4VXD=@DQ="*6' 8^@ BA> VZEPSJ<]$3 -K9-$QP4]HDF>\["DKR*[/KZ
M9VSI1W++<@J1Z\.5JDH<[VUUB EDCQN1:".SEOA/'F]9NH,VF++[A8O=I)N@
ME2],KY7DE301"R1XU+CKRP1[,EC(A\V-JB:_\;D+Q'_Z:/CU_,7]B-=K:LUM
M]D8\6Y8MZLY?P1LBSKMPP!@.?W;@T2!&QS+&Q/5X8)9_F:RS< @O.H7UF[YL
M]6UL/1 6 SU#>.9Z#M:]3V>>XY,S9.$5^716AI-%39-%$T).+S/'I!_7Q*&V
MP=KVZ<SPQ0=FSI#K@UCJ^>SIBV/[ZT]GHCCUR.H,>:*XYS387^Y'PUYA:O7@
M-\;H[#RS!T!OUK:+3<Y3?+Z/Q9E!FVS+HY8/7;\.OG*S]<F;Q_7<@1)!N+BS
MLGW+B_?-')ONIG..*Z1(MXG?9MAD<P+\0&;4R]F9XLW*AN&*G=<<77EOXQ5]
MD:O)=IDJ*,"M[U*+N"YX5#-J<6':?$YT_@7*%WV)K049L]>9Z!;@L+_!U&([
M"\4P6H/5R]'2J;VF8)ANM2D5NV2;L2G';#]=%7 <<6G#>1=F 1A<_(M4T!0N
M,P,X&<G1FR3>A$0Y&L1S(WNN"];ASG>@?J*Z?._!#;,EM1?BZ!0FB,Q&%F7S
M1@UWN;P<S>YRD[B =[SF8[I8>J*R\,L3<5P9HOF(WW44YIPHVT>;<MM5FW(?
MJ GUA7DEW&M]7(--T9>4/ %V7>* IV9U'9#B4 P&E+#/V"TZEN5C<T"\">;[
M'QD:<!SF!TRQ.L?@K>;83<0)_$.N;6Z6=J25?*NQ[3&[DF=L^P#-BCC3)6BH
M7+E3BU9!>SNMIG+#\DCV#,[=8E6H>XJGDO7AR,A>#N<=_2^?.L2)?Y"[B#=4
M7D9EQV$7LSMFN;7(Z47)**J@&QWC?V'(<9,YM>-W(XP<F]^-T-%U(!+5&,[Y
M_'J[FWF1J15'XEY9?=@[%Q\XE5=)4P8PHK&[Y"/6I0*P<-3#%"H^5M.9PPR[
M*>9('-2R[*JZ#$XQ@$&E2>P0%G=- Z\4X)[:L=^*V-;"K"L[A&1Z<+ B'4UU
MWK8/PAA_5/%8:[:G45;_*7GQ;DV9QI1G^(:6Q@NEY.@1\%YUV[1&V/DN7(/P
M0\0Y+6M^^BJ85I@%03:;]%9L08Y-MJ\'4Z3AZUZ03),]Q>:A+;#T_;'^U/;"
M?4LSQU"6?^B,D7R!CF2)1WE# 'DX5=8< "?7!0C9*M6]=^P5B^,PP<-YGNDB
M+WEYI7C3B92Y0@[5/99G\40B[Y%]YXGP*WDV8SA;'8HQJ6A/% IJ/. 7NO)7
MQXF0;)A5=HRD^$0BXG?'4#5$Y//>=L \LNT3%@#UG;7M2F)(A[!\[_#IR'9A
M1G,6Q($I#WX9/ENPQ%[2]>WKR"'Q7_C@7]HF&,?LKBC+[@TG4V"B@[Q<O@/,
M^$:XI 0IU*!,J2R/F";1/9\O/_F7$$+?<(I?6+79W)#9)X>RK>Q0VNQ:13FE
ML!3=SOL$)QL6JN!24&A!D-,;VSCA)VI& J',#CRZG$IH6[J#G=B.$-9CK^W)
MR>5MMC(HJ#(,[%Q^VVI%71;"8_[%@?Y*.6:5 #_,U01=%@&+9!88R]FZ%SE;
M68N5HES>.YX_)FOA0PSG=V3FP8P0/-\3$@Q.O" 2WRP?^;&5_)#1'0^]B,A4
M8.(W:1U#EMW4,X":SBFK-DP,V%HP.R8H"H5W2LNHJ"LK3E(.YWT6\)0X'HER
M[VWIM-7:M%\)$5<H!4&$_?M >\FJ$';HN0XF)GWPF>]R[UN&*V]4=ODJM(;M
ML01;"#NK?YW0)U:[H94G/:0PGXH.N7 K=6CEW'.-%:P"G@_$,NT1"]JPU8:\
M">EEJ]"* ONBW/,YQ@9KP*BR"XZ8'_?-9CZNV+H0MA\\ +[JEKJ+.:C?>^)(
MW'+P8!LP:^O! G)*G)4+$[L3;(C&-SSSEV3K(;!+)@;W>4Z)$>VW9INW]ZY7
M93?P'&HLR#,L29T!>?X7>!_D56YU9!15L#U=UO_#>9#MUPG:D#D-9)1^[]6&
M!AQ7T,?#>;"K,2:>[U@L=K OYIF'M JK#)8U=)TON>BZ:DXDS]3J8YAW72_T
M)/;XD5*2*K1I3)Z(Y?/0U$*<R[BC3%]G?C#3&H1G\?L6+-(L8[-*E^U'E.98
M57N9,P]5.5I&JU*UC-9-LN*SG3.K,2I8A?K'KI& FNS-* U*':'FAO=Q^<K,
MHS_C.:HE9P:Q.R-BHFPW*YY8F$B, <]PHT]RYZ@<Q[_##E"T:\$;>HQ=H"R6
ME0C/QJHD DKR89I9O J#E85*>^")./YVJ#3[]%DF026P"?,PAA8+N(#M%Z?E
M@@2N>_H"$X(\;EJ 0V67PHG56(=YWPM>BGMZL257_- _WPB+>1/B=$_^1=^!
M8BIP3&J3X99U+5(GY5JDX)J$PEET1Y!1D<2ZC6=Y'V2EBR61J^QQT?:15<%$
M#IT2QQSW$%6A71W#X*,/FY,UUO=$<S,*5Z$=>1( F%$?6KO[6L=(+=C#N1*3
MXMA^Q:;W&ACIH&[[HAQRHBK$-[Z1)=5-D7<7;??NF;/D1.\_ P6)M[!D)=C1
ME\S_@$6^::]9L9Q9NWN(JYJV>X_9J/)>N87AURQSE#);FUG^#0<=.#SX#9.?
MTI%C_D!*VLY6 O);I4D=H4:5L(&'^*IOX@!7-P3'6Q5<?1YE/'.4'\%A=\>3
M1\!?!#7XL-/<]3KI/B1[JBS/*G@98[*@KD?  -Y1 -(;PGAB 26YV[2/J@HM
MVWN:4NP-\VG%-SUW.-_<+Y.]BCZ,:647UL$$R]<JT)(GRH)X;LYI.8NJJO-Q
MQP?FL6^9[]OJRR[_WIM]@6Y9"^X@\*EJ.']TA;.^#[U\Q!5-U^$I+#FR7*ID
MD"*C6=3(_BW-ZVXB>GF;FN1464,Z)A[+-[6M\-S0/H@SBE<!8?')(G';1.@=
M3^RY]XR=E*C*;M;17M(J-#&*648N;SPSY_8UZ0JSK'+QA;%>$.$M'" ]IK"*
M1$J39ZACJ7=?;-MXAGJ6/H^=@U=%^F'DSTRJ\P5 /BLO(:C"""E[*V.4_WOT
M"Q_CK"OJGF2<HA<CN&?=V["\SPYIY")^_Y#>T*$+FB_,GEJT"NJ][03W*9[Q
MT%LL/3BG_YQ.6M502.AN@"[UJ0X3$+O>;?\Y\7UDE77+TB?<6%0K:^X-0CO@
MOHA1&:4(N/QXT72)K:#,SC1M>\RRP:L[[$4?J<P1<GOW&E95:?-=-%NERV2E
M2VRWN)&1<JCLX-N:YQ,7*T2S>73% A'G'??>8WD$SE5U("2YV-0JG<8=DE9A
MFY-=!> 0?O(!8)*,@63!JEHH<?7%'7T"7]4" QO>'/Q5Y/G=^63S+KZ%(DE*
M*\FOJAT4K>Q@%F*GUETW8R-NZTCO= DU6"Q35H.%5Y1O)/='KS[YMPM<:-4*
M?_[I_P%02P,$%     @ 38%Q5)O;L:K-)    VL! !4   !V>6YE+3(P,C$Q
M,C,Q7V-A;"YX;6SM?5M36TFR[OO\"I_>KZ?:=;],S,P.&N,>(FS# 7IZYDE1
MERQ;NX7$7A*^[%^_LR2!N0@0J$HL/">B@T9"ULJL_"IOE9GUE__\>CIZ]1FZ
MZ7 R_NM/[&?ZTRL8QTD:CC_^]:??3MX2^]-__NU/?_K+_R'DG[\<O7OU9A+/
M3V$\>[7;@9]!>O5E./OTZO<$TS]>Y6YR^NKW2??'\+,GY&_S?[0[.?O6#3]^
MFKWBE/.;?^W^;"0XEBTEB@I!I':46&TS\3QD"5[8',7__?AG8-GK%#1Q2C(B
M)56DO"8F> 6:AAB$F7_I:#C^X\_E1_!3>(7,C:?SEW_]Z=-L=O;GUZ^_?/GR
M\]?0C7Z>=!]?<TK%ZXM/_[3\^-=;G_\BYI]FSKG7\[]>?G0Z7/5!_%KV^I_O
MWQW'3W#JR7 \G?EQ+ ^8#O\\G;_Y;A+];+[F#]+UZLY/E%?DXF.DO$48)X+]
M_'6:?OK;GUZ]6BQ'-QG!$>17Y?^_'>U?/O+SMS',/D'GS^!\-HS3G^/D]'7Y
MT.O=@P_'!^_VW^R<[+WY9>?=SH?=O>._[^V='",+\Z^<?3N#O_XT'9Z>C>#B
MO4\=Y+_^5+X42>&,\04A_W'WE[W^3F/THW@^FB_).WR]_,I"3#URX>L,Q@D6
M2W/QX-$D7OO0J AFTEW\RY$/,)J_.SB?DH_>GPUVIE.830>22QG!:I)#TD32
M:(AWU!!I:-0ZFF!=OKXTA8\I,C(78O;3,)?D\FM?ES5[#:/9].*=^2H2RI8"
M_8_KSU\LWJ9<[)YW'>[F0?1"X4X,1!@KB;34$V>$(B%'25U@F0?6D)DE&==Y
MN@*)G2Z^FG0).E11/[WZ D6A++75@B;?Q6M8N;U7EI]X/3T_/9U_)QG.X/3B
MWQ?5M;&49Y-:2[P0(I)<1\H?)N.XI,)ZY($!)Y%*U+=)!>*1%\(2XX&'Y*R*
M#07]G9)U9,U?FJR?N-"5Q7V!.&U,!J^!N A(0I".6$G1:&I%0PX@DQ';WM2/
MYVG73S_MC%/YW]Y_GZ/S,,(OG>[,=GW7?4,WY1]^= X#K:*2Z"L0R1C*3C+D
MU2M*I,\R.L&H,JD)KVN1US_%]A2,W,1\?<E4VPA',)UUPX@.ZGI$!AITBM(3
M(;C'9<B!!$$I <JT$"$QULB8/Y+0_FG-&D!J*:UJD'KONS]@YL,(C@&5_' V
MA$OFJ70^&8FV/8 C,AI&?$)3#R:+3'660K71M/<0M0Y4Q(N#2BTIU#.Y,4[.
M$:-'$ 'QBH1]@-D%1=8*J2.:?J")$^F2)U[H2%30P"4HG;UM8X'OH6H=8,@7
M!XQJ<JB&C/WQ9WSVI/N&A RD-,IFB(0B@V@*C2 N:$%X<#(88] ;I$V0<)6*
M=22O7ISDG[S.U21]V,&9'Z:]KV<PG@+:KX.2I[C.8<H@8N"2A)1R\850.0EF
MB+/&<K1C0(5L H UB%L'%_K%X:*V5#:&2TE@#0[.H,-U&']\!WX*1V5%#_)O
M2%^AZS)7@*&FT C@2'5 LAP0;S4E*G.9E=+2"?=0VFWMIZTC??-BI-]FD=LE
M9!P$FS(&12P$#(JR,L0:*#D(ZKBV5H?<,O-V5T+F*4IP@JL^^W8X\N,9[K;B
MOY^5HX*BED%8;QW@"O.$7 IF29!"$JV]BQ2W8%+02/O=357_HO(GXN*VYJLD
MBFJPOW=#HGMF:53&$RJY(M(CFY8C74A)%,9PKW6;Z/M>LOH7:U>"1SUA-/*@
MKO!)K4^6EE"?H1V0&3()U#(B34%Q3MQDO06WZ7%YZ^V&U=641@415 /$NZ$/
MP]$\O$<%=CR;Q#\^34:XNM.BS&;?!E;'Z*C*Q$/)KQLJB0,6T%70W&@NK/!M
M=,9#E&W*^0I>0\C99AE)@.*I*&F)10:)D)9I2U/)>S3A]2'NGM=F5L7(S>VP
MH1A:;(0!/L!"#KYD,) ?I2-Q!J66@8%A"ID$TQKS?;**30'PU(6O)OG=R>GI
M<'8Z3X"/T^YD7$PVC&,A*"7-9:F3H0S5L<P)G;AH**&".<,$I]8U.NZZFZ@^
M6<:FR*@EF!8ZXB*X%2[HZ"0E-ON$7KYAQ")6"2AJ@A-)V]CF1.(V+;4R[(?^
M6TGKGG0^P06;7E"*S@VNM#$&G55+,9AAZ+MF$,+[%"RT3;"O(*JG)O(IR+@K
MR;ZI*&J>OG3GD%:PJ25/TJM(XB)WI#5!Y]<0S7)FEJ$>YVTR#G>2U%/+60D7
M%<10#15[IV>CR3> (QB5&M55S'H,: "*F@X8Y)HHB(T!HR4IK8\NT23:1 \/
MDM93*UH#)77%4@TMQ^=G9R,HYMR/?AO#G,CRZA<80Q[.IL?P&;I2OWOQQD"9
M4L%%@1B=RW%B+(L0<1%RIB%F1UFC8J-'D]JGL][*:&HKMD:9SXLU^':I'X7F
M02'S&$^@U0S6$B^=(X QIH\*HPO:IA[S?KKZ=%)<&3<5!5(/).5D<@6?3"@C
M9);$4QN1SRB)]9P3EG5($2(5F;=!QVJ"^G107!L6%430(J"[DHCEPEG+K"*.
M<2 R"4>L]H8XG9QTP4@';6I(5I+32#%>33Q':WRRCE#+<2MB\$R"Y9(H[9D,
MR=,HV^3^'R2MIR'>$[&RIH9\HF3J;8K)^.,)=*=O(,RNT&*8CERH0-!%Q$UO
MG"+><4=<UE*IS(.)C0X"5M+3TRBO$C0JR*"9T1Q0:F6*@9*L+<::7&/@X(PE
M,KH< 95_HF$KUK*G,5PM];#)NM>+VF[G=!V2C4HI$ NEPPK0TW?<(GL"%)/1
M)L';) /K'P(>(GF HEJDKI>-%(&;Y&PYUY6XN+(<S&<:28A%E$X)ZMI4"JT@
MID\&<$,DK#@'WVCIJY[_3,97J$@R<:!!$P$)>='XPV87B=?4^FB,S=DU <!-
M2OIDXRI+?Z-%KY?63FE8>/>C0S],^^-=?S:<^=% 0HK2 "=:9H6:5@GBP"42
M1 0PBAL#C;HW5Q/4)T-7&0@U1%"QG6WFAV-(>[X;HU\^W8GQ_/1\GD5] WD8
MA^B2*R\UAUAR[.B29T1LX&6:@LO<INC!A3;*X6':^I2$K(R2RH*I>2YV0<?<
M74.U=M;!)QA/AY]A?QPGI_!N,IU^@-E!/O%?!]EIYI1)I<BZ%(4Z1SQCB=#L
M/ O"1B:;G:,^AM ^Y25K*YR&(FM2C<0"6):<*9-8$-A:<^)I4B2SK"PU5-+<
MYH3USDBK2N6$95XQ9C.!TD"(!I^38,IL&H:1C*=H_$6;K-/3TJW/D&9ZE.3O
M*:MZRHHW3K$RPX0P21"0UB$I90-[#).I :<A2%#/EV+M32ZIEOR?N.XW(/"7
MUS=7YQV^KC7]Z/@$?[[?^W!R?/#VX'#O:.=D'_]ZG93'CT&ZXUM;S$-:AX%*
M@Y$N\\;?K=7 1N5HUH$$YP.1OE@I:BRA,J3H,*J&U&9#K2!F\X!\BK;WU\DD
MS8L*H?L\C# ]1@]@P+ERO/29"I[1W#.:25 L$NVY41;C1V%5H]#\+IH>:3Q(
M4^VQ*31NA^E51%$Q0/L,XW-XBXR7>M#.Q]GOP]FGW?/I#-GM]K[&T7F9J5<Z
M-O"_5!PXJT4*#,.!Y$IT8"P&D1GY%\$P(X+D4K0YW'T"L7VR1+6QU%IV%1."
MTWG%\;)%9SI(DE*O#46K*4LN0DCD7W"TFB)"5EGYT"9JNTG)(_- +T_7/'G9
MVPG?>$2@-X'0&$3I]4+FY'P2CO48?@ITJ%IE@^\3_E-TYQ1P@<K<GS>X%4>3
M>:OJ\MO1,P1J7&DW R]*6;$BWLYS*-X:AV&O8:WR6O>0U:?(;"-DK!C%5$D8
M]4[Z8(1_^O@KC'%?CY"PG70Z' ^GL[++/\,%;<8EJY2)972L+$%)Z7#&S6Y4
M,C1Z0Y-KDQM?C[X^6="JB&D@GFK0*0[BE^&H4+4_GOGQQV$8+=J<]T_/_+ [
M792H&ZMTLB324A::&():44FRU%9KZ9'Y-@4DZU#7IQ.6JK"I+IHZXUDNN[EF
M\_0NOIP.T]R?F(R/X!3\]+R;%QW_ZH?CN6MAO-4L)4ZR$89(FQ1Q-@22,W60
M1"ZD/Y0;>-JC'WFNTM;KJ@*.+8B@XGBO"^_R(G(8CL^1[J7[B53_ GG2+5/W
M&#3 =.\K*D44S'#LNV_[N)SS%%B).29S'8H; 3J8S@9>,@')Y^6L8(GJPSH!
M&&. !^=MHJY-HV]#IC9?[\7W7!@4+S4-I8/30NG)!2X)^O:49"^#9BH;S=J4
MP]P@I%=YEKZ \O:,MJ<+KWXKQM7 4*;(0V8DTS*BUF!@&(*VQ.)[-B27T4=Y
MGOSD\[J(?072IC*L6WV*#$ZN$W0!< L2F*8"F:*.2(;NBRN%D<@GONN-%JU&
M&MU+5Y_<R=Y"K)YDJZ'M [K%WP$?HE":QTRX\$@",D-"U(YPQ4*6DDDAVX#K
M&AE]=J DI\YJE8@HV3D9(:'\DR9"IV@U6$M3&[6^-0?J>7-.3\?C;<^@'RBH
M'!<@H4N%L6P_'0BN0#"NBB**1%*@Q$$T1 <:&=,,J&R3R+R#H$=Z&VW]UMIX
MVFSYGZW"8/?@_>'1WM_W/ASO_V/OW<%QU4*#VU_>NM[@ 78JE1VL*)2[+)*C
M3@>1N"60@1$9E"<N.4^\LDE';836;8+$>XBJZPN 9SE9AC1(H\O0>_1$G$-(
M:)&M!4-M;',&>(\O\-SG(77P<%.S/'W=ZP8=#Q2&'DZZ^<+/9MTPG,^O2CB9
M'/IYF14J/!4Y!DG,\G)^$S6Q)G@B' -=CJV%:AB5/)WP/D7&K>"U3=GV!I">
MQ4Q]M"2+B%99BD L1X<-33Y%*V]C4K[_@*RW;K^-._"CX?] ^OMD5(I.+G+<
M!^/O]YWL=,,I_ND-OAQ_/(1N.$F7" 2%$,LA$.T8)Q),<9U4N8!, +? (F]5
M;]>(HSY9EFVB?5WUL%7$;$5O'$$<^>ETF(>+*U)WTG^=3^?C%DN$N'.PN_]V
MTAW[$1SD[QQ>LA."XK34#V?F9:G,X@1U'RZY#U9S[:+E#4>FM&"I5X%:'[?
M=D'S?,'ASO'?W[X[^+UN4'CYI<V#P=7D5PH"RV5/?OKIL)M\'N*W_?+MMRFD
M_7&Y&VA:<K@[<3;\O.A>B)$%*7@@$8(IV05# L^6:.E%RLH+V6@TZOHT;CP^
MP,]'H4U/)COQO\^''=QY(P2ZC<E8$1UNPUQ.XG AG!"<@.,)O%/)^#8>V/HT
M]NJ$M1'0;DTA:"/!>N6HY:+&!65IKF'+[]-YQ_2@%,<&!8((HSV1#'\+VDF,
M@AP Y<H)VJ@R]6ZB^A1!;@E"M414\9*/201(\T1_,<6(XO=^5FSQMX.\ZF+'
M0095&L X21C98CSM,W$2?_.1 H:ZPKM&\PX>36J?#E:WI:*:BK.JIKIQG^RM
M^V:OOW'EDXM8"=W,KHQ">P.+_U^VA. OG_SX(QSY&>SE#'$VT-%II60F3+$R
M!MMP8F/I$&!4.2J,<:R-=[%=/BLDL5=A]+*\XRI&0]*.6V38&,"004E$C>*$
M1\DSX^BAVS8-V>O3V*<D18_QOB*CW@($-:LNUE:D8%1"LTF,+S?,1A:)-1;U
MJO5>>!!9A68E&4\**IXYB?[B0;HI"%J#].UP[,?Q.GW&\QB3#"2Y<F:E?2 ^
M^42\L%:"DH(U&JBZ/HU]\J->/D@W!4$]D$[&$>D[Z Y]-UN^N!*/(/GXYNED
MC"YC]VUQK=U%Z'+U*I\IB@X2&V!TPD%;13+0TH&9%?$LE&L#;/#&Z R\3819
MEX_&JSH?8'>0KY/!!HZFX%(9?J]R*6!$*^H!G7('V2H6F4<,/,?BK2:W3Z[5
M,Z+XUH9O+OIM[?TEJ2L72%O*>>!$@&2E?L\1IY@ESJN40@*.JNP9D?K@CG[N
MHKJ7!M=-,=#:IUH5F+!DK7>X#%(:263*!E?%:Z2/,R:DP<5J4V'VU.ATTX(S
M'E LV4>BC40=$A4C+H50ZBH9ZA&1N6DSZJ:W!6>-T')__=ECQ%!M7[R!LP[B
M<+XH^/L(YBL^3CNGY<CW?^;O#R+7/$-(A#F-#J:D& 4I5!L:1(S&Z\Q"FQ.E
M=:CK4Q"\)=Q4%]IVV_.CX]Y L,1@>(UAD2^# X0A*D ,&D,F&=O Z:6UYV\)
M3M6%]ER-^YYZR8!)HM"7*!--* G&H&>A68Z6I1S=C<KI'[)QOS%LMB"<.@"Z
M4C>W.,QZ,YR>31;^Z4%^._P*:>$C#PSW3E#NB:36E!'@MDPVH(1)*2#RB#_3
M6L!9^Y&/''O\\@'31AC5#-?WHLOOA"X2PO.BC4$ E2 @RU:69B/F##IG.9$4
M05*!]C0T:C]\@+!'WM_VHG'40E;U/!\D95IH :1F[VMA%V/A3X6B@UPN5UHT
M/?[>X1(>Y%S>6UQ*4OZVC[%QN=BRC%P9))6%]SJ2!(L9\^BX9>%(4EJC#L6
MW;3I_ZG&PCJ@-#\8*)]'_O5&LGWR'?SB<6E*.2Z,IXL@H@Q<4.!X&>K%B'0Z
MX&*@Y<XLFQA\X"*W.5]:3<\ZP+(_EG->03#5)V247-_U$0I<.Z6XY"3'TG*
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M*C#+IE++)/N.Y4>FUI8::='*GL*?G0I>Y->]P0AQ?QSZ_LC'618V]6 ,%T1
M,$2&4"("$K%YZKAW(F43&Q%E_3N.@0 M2;#MNUWN\?)]MP>C,;H!\Y5L])U]
MOZ%W<!(_=^'+-+QXD<]A?.7QUSM1 %C#+#&QT))S1<KUHB1;0456@CK5+.-R
M9RC'0)/]ZJ/%&IPI^@> O\-$SK^&80D?O!YVQS@9_.G7"#"]:[/?G_C>[0
MI%"<H5,8RHWEV4<TT0PZA1)"2%3$!+81H=I <PR<VKM66BRVF:V=<]QO!\-9
MJY@"[],08&;8QQA!&B-(T$D1*< 0CX"(5,&:P+*(,C3;@1Y]SS%0H45)MEV
MLA%+W_NOW>O)=<<EJ3@:1<0FC8"50!EHJTCT5*5D)7.RF?&QS=N/@1#5I=YV
M@<F\C= <+EI5L500S(%!B$9P&XD6!BTIP0VQTG@".DN6@$7:L/KCL;<<@]I;
MDV*% HE+).1P$L?3=,23?KJ$:2BY5'0LHCL?!O.TQ-->][K;+S_NZ"Q\<,")
MEZ4C'.B$GV0DN'%1PVG&S:K6->K;X'WA+-JCLBI43MQ#_?JS'WY""\<QY;4.
MGGC+:2F;2\1%R8C66@:7A'3-^G/N1J YFF.DQS:"KE'O\ AGRTTU<?[Y$HK<
M\%=8.>"6(:$AQ&C)>N"*XM8G)7$,_^0Z<5JIG^?&4(^1-ZVKJ%K!P[T,Z?/!
M&&:9X3>][OCUH/\%?U1">B6PQSHV18?<=X0*IHFT3*(1E341A@-.!^N,K'3>
MM2'2(Z%4507MI>+A9#+^/!AV_[OLGS0*HT 2@TMFP59*QJ@A,8MD@^=.5C)V
M'@%U)#QI2^PK*+%S1Z7[MVP9)U1IEDMX!/31@6=B@Z#HAKGHG/;:B#KYKH>^
MNJS*P?'6HEVAZ)T[&2&:UW[T^<-P4)H_I%???AM!.NO?7@M\$L?=+RAFM*8"
MEYK[D C7)=X+N/$YBS+P7G%*(0:HU-NT.<;CH4@-I:S@S\Z]B0K.\O^RT7WQ
MO6D&>#]=X3HV+ET3SG"KFS>OZ3 EJ;6:$:ZFP1S#2SD9(S$JR1,'*D.E7I^-
M,1X)?RHI905_=KXC%3E>C@&FE[^^Z19<7;3%X2*_FHQ0%J-R!WV@3KM44@15
M1(['XLU3$,CQH&3(CAE>)XFI ;@C84S;:EA!E9VO4UT:^*PDS5 M@*M,<N9
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M$V1S([0Z/S81?@U>3$;CP34,'T!<M&NW+@F?T,YVI:Q-EFZS&BTB;T6,5-#
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M;H'K(L\^IDR#EU4=[Z<Q'@&7*BOF(87,SCEZ9?W[,.Q&Z#@:G70THR9SZ3.
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MT_K/.;&'.;$M:UJ\GKZRR#LB21\!9S:84IU(+26.*D,,9>5$U NNG]5D>&I
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MLQ$/MHCM;**/ [GD32#^&=MI1<%;^.;;:.= 1!*"&<JI((I/J].2(=8Y18S
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M#%P[5'CP[A^"%;M)O,5HTR9P^1VX"4S4@D624D:G&&PB5CI'%,_H\:CLPG)
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MY'6 [*H=7*A7QE@M(2^&\2)RTFW$.>X!]10X,I3-&S0*N9HB[@J3 E=!<A;
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M;]Z]'41;I=LG#Z6=LL<X;FBCN"AR4E*A2?2J!HS&:IG0V:BMBLY..C[CP&K
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MD/>8</IUO5F3M!&)!5V+?PHH6QR$1,$7_=_4]K56"=F49-^Q/&=J[>F1 <_
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MK(14T6M7VF3I=Z$9J]]9F]7A4/.>RI60FP.YD#UV*CBN,%/^YNOAB$L0>4%
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MK+GF&N]<<X[QCC7GQ>3% H#AN9JF&H",C SP^O(#N%@$F*E"'>T  &UM@!
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ME:LI[2=I0$XE&>=YH(*M0'G9C+VK_L3((UC49>I1%WQ2_C=.<*3ELG^"%"\
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MR0W,\]3,SQ< ;ZW:.HA_=LLWY%>X+6</R XQ%=;*?:VR,E8KAE(S4GYJU7I
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M)F*5-J]?HR-8_D;[7"8;WPDM!L&QP"XNHWO/7<7;[M\[>(P<H'!VL>W'&%=
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M9IH[,O%)IZYOHN^M,>\'!&+37_X</M(-U?81J/XA@B3>Y69O3N:/V$669E\
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M@LJ9-2&]^X-5X0+\8PM7<%<6KSE>6Z53^F\V%AFZ_R.W1XZ(-J!A6GF:./J
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MYGP_>M(F[VW<ZAQKYQFE7I[?])&LKP*U[>-*KR*1C/>;Z.1Y6^<C@$4W&PU
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MD"^5.#MS9^"1]7FRBQ2JT42*9QK*T(B+9[P-,%V;7;;C. 372J>,;T\%CC:
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MZ(?9;:L3@3GU G(>N&S/)0X?VEC46/S@2Z]"M ["BQG^ ?BC&'/]W&H89GV
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M9^:BHF6QJ@O]Y5?6;IUE33XKJN):3<)N(75)7LF,87?]G&_-0X&S*O6X%NR
MA%?6UH:1]^8EX,;4^=#XGQ-N*@8@Y$644=+@E+]< "Q*X9PZMR<[,-VH84Q&
M3$I/T79_UHF!<Z8=["?VY_?)ES_*'5?*.MTZ#(C2INZ061Z<\.%WO9+EJL3I
M J_[R2S> ]4FGZ^H6D;LJQ?VWQ1J85\RPC"><U''*DMXN;KE5?J8FD1#794
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MF+CA_5@U.&9^_E /O K?Y==WQQLWMAL,GP-0 MIG]T;0+C?. 8;<1)I5@U0
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M6+A@$.C/#F;NVR3Z,"B(Q)&V?O+#U(\ B2VZ?$+QJ82],60G?UGZ'$#DB4/
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MM4\#W/?_87(?&W* ?^XCR*BHN\YE>[QQ1O.[&',,80E)7N9%BY&5QEG&2/3
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MU9GD0> ?-G+!+#V^ONX$'OS( *4FJ!W5N]%V^M%-E#OYAFL'YBE%LIY-FT8
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MT?Z\Q28N;V,L]%M<<J[JHIW9.EH<Y^XHV(&< JD2]%L0@>$+Z.M$QQ:IS,3
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MNCF#C(O4G<78T"$\&0_+2265\?I<E0A8GJU$?%.*R](.OLU>JP%C9[E]BI^
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M&98HB#)EU<9 3V<F MH[N@'Z*+@!57/*ON=> 5,7<N6I_9)5,46(^PG>N06
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MC9X"$R,NK>C4]5OLQMFZN-@&\TIXILY'W K!RV,3H38W;56<:J_KTGD>,5N
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MH^#5T04/X_9\X\](M70W[M5,]^^UYSL#CRPW-$S0D"M\) PMSINW."[0M^/
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MP> '%Z]F3MG!EQ6"?T KU_L1WA6HUI.D:L-7RUK!S>1KS-BJT8E>DM&$ZT^
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MU4S#C'KV#'(=82_\!R&/VK'X(J-["W"$5@+3_+/_!XGQG;DTQLP]-/8: 1>
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M8M<=N;??'7333J=]>AVAO.=X[^&A_6*F2!;#(;5'#@97(!S$N _PZ\PH3,G
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MCQ/F;<4,EYW?<0N72GSW42^AC0;*KR(?Z97W_(31:V)#:6YX#\#/LU6AFUN
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MDZ;TEXB6Q?,CG&3M831L>%.2,9#X[LD+I6)'/)(.Q)+[%NITJ1@6)FD]SFO
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M_JF,C(.?BM/IA<[#:=]-BCB!0'UY*U?8ICBD>E:W7VGE.U[#OKVR%QEBOQ-
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M3&[IQQ@?25[^G2S6_+,4L2[K)V]^^)\Y+^4C[Y^;H%@<9F% )+PQ21*(>!1
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MFC,4A\Q+(TA30>2R(<,PBY(4(H(C58X,\32SX<*CTJ;&C1MEP4)I"^KJ;(4
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M&I3':F2Z&1##:(T!01XZ,.-D>[A6?UV2= 8:$T9J$'<$O/$:Q.U38CH-XHY
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MO*Y;KM23,['>_ZB4RD W5+!<#]J.@^$Z<4!TAUX_=E3__T"M/%#:SYJ])FV
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MCIR6<-KTU[D(!O?8T07C^?S#<I6OGO]>+.1C2/G\,5_(SW#.@S255$"AH%A
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M:4".9JP<N7V\1)73-NSDIQA<WM?ONF!,O@"5[DAZ7>KZB4O=@XYD.%$%>>1
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MHWO1X:BG,1MBB=H%"Y9"CS%6T +-(4Y1N\08PW&J!4R6YZHV+?6C6;T%,G3
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MC9<:,K=2R!04IHA0E4::MJPMR&,]C(V%2AD!!%LQ'0R<HPA:F(:7XA*84MY
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M<_EH*BY]L[<$.[JT^OQ)]?F_Z3BT9;>?Q^.S<\:5+JBC(HV%*42JN,P@RJB
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M1L?!">T\=-#K>SL$'0?!PLGGQ(L]-]UUD;H[]5$I:2ZPZN"O;_3G5[J6)A_
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M$LSRU,F5M:<<8^.AZYN;K]\_?@ ?_\_]QR\/'Q\<2Y?W' P[3AH XL!DU6@
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M/^22/LJ]C?8$X2A+6)3!5 @$D6(24L4II 52N(B1$))-7LIT%0]KNES;,<M
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MTLIS7![G[*5-GW"$4YG@#$HN!$0%+B!3A$,110(+R8N(RVTF<_MCE4#B6DW
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MX["N].KJN#F];&0M#9FAQBNTB5,.4AF_T1+0;#6W(U3^T8S:X>]:+W@T<7P
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M<9!T2GG/AT5ONAGX0.B4FF\/?4X^V6^"?]$2:B*Y,][@Z_H?9?F_57D,6^9
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MW&>*GB>'S?"&3:K[NIS?0_F ?_YOL7Z2%1YE*:YR=;S"]AR',<M\$H LCRB
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ML%LFDA'4XO\(<Z(X6:AEI] Y\C(IZK07&=99(;LBYQ$YPP)H%_T^"Y5=A-T
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ME$.TAM8)/^Z8(K6/LZP>MGI22 /0^G3SW(ZE57N,S*E4TC"2K2G57R@C6TK
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MA!J:GHW1U>G&8QV=7_CQO*RDTH[()?!XC#/ORGA&7$R&NC)Y"YW<X!2:C57
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M>$:28)@B1GG.:5)>R3I.XK/D;':/0W\0U.PN\29&\SQFX]UX<KDLO0\B%:!
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M9*GP)8@&*HD402##*%>OK#$J2T]-O1S$NH=RO=F*C9[*K]%E U& VZX<-QE
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M8KP[@7 I"T"FRNP2FP2>1'PC=V73)PZ<E57;C:DB^*&=W'5,X2JZ7CH9G_:
M19^=] *7B=>E$I0F(+Z$IB!SF96D,?'-YFAM]_R!,ZB&1%I/2NEM%_OWGY_H
MX .^T?VJ^TWY5Y\A_U3^_NWST>WW%TY+ZT9_ 9?+<5S\-<[.5X_X>'#ZV^?#
MX_?'GPX_'YP>'7\\>4CU8GR.\O\>O)[YEI_OJ'I,[_67/<#)]A3"MR5,$^)T
MQR$A\S,_O1YI6B;WS2;CY*_'G7ZZQT"9G=9%D/WD-L)W%]>+V5D=)1YNV5*$
MA0TD9"^)CEQ+\)1Q6\= [X7\G2W$TL$&C=V[HJ21EI9I!8* +W,- 45CJ2L_
M\@#4"ZY%G5$63VD9-O*W?WP]L>-VTTYOI^=>=K%W:(V.)XM^-K.;+ZNXISU+
M;U-;F[.<)NTLD3(&_$,HXEARQ)H4*3..JTI9%DUL;2>780'_O,2O/"R-N$]+
M<ZZ1H5H 5V4U\C*A )>D*W?(* H6<DIHC]2Y='V.FG^%[>TU&'MZ+;:CAAH(
ML3SF ?_9P;?Q8B2L"S8(@YM]0NN6R=*D .W.*&($(55TN=*<O.<)&OH2;5=-
M?P<ZVXB]3?2\FYW[\73DI8F16D9RT*RT9&/$N:B( NVIT5D85L<L?9&DMA"T
ME<*_#Z(MI-\>C'Z%\P#S45:!FQPY09M3$.F8)S8A.SE+!9PYFEF=_G;/DM,<
M?+91]7H ;2'W <&38#SZ &=^<CA=CI=7W6IBB0O'<T#2$RME9GB04V^(*%,?
M<U*>L77E,0N(?SV;??T9O[I#RS]E>4E6+SN(///0H>_I>SJ9=A7GP$A847V]
M)K@(GB8N20"6T6<5'E]%4_H<<%.&?*>X+@2P&0SN/W&8S6%GE<UZD-_0(>Y?
M83J9H;U_#O,SF%]O80Z8Q(W1$.J37K4RM+1TA>4IILRI9VZS /9SWSZ<LK=7
MTJQ/B35@,70U39>QM*^>GI4IY:LZ)YA_79E5S*88G=*$.IF0'5,:KQN."X+[
M[" 9YNJ,=/H.84/GT_3LQO2IA@905<RJX_R J>O%1K.4R5$@H6N%KB"O\FB%
M8%:))+14=?#T(DG#VJ.]*GY60PL-P.GP_&(RNP(X@:\P+WWW;O9::XP(SI.8
M@B0R,TL\KCOT^9*V13Q15.H\]#Q!PT*I)W4_;AW4@^R'-FT^PQ+EAVJX:35Z
MPX-).H$3)"D92F,#/*M3= 1)C!R<T5JQC:R;%QXPK$?3+QYZ$V0#^\E*,@?S
M>2DT*WQT6ZW4GEM.,Q$<NEJ?2$)W?F=P#C3%'^I$:I\E9^CLRYX-G-U%W@!N
M[I&_P'/ZXVSJ[]XYQ5<+'[O;V>MEP3QR8(&OAB%*HR7Q)F:"!WB@TJ7L99TF
M(Z\DM(5S:R=HS/:GIP9@^&$<8;HH-9%G<X#[^[!B.B:: T&Z*=J(0942;TX"
M%XI!R=6,=0RB%TD:%EI5@3"KH96A3:73V<4X^LF;P]/Q:H3 +3<WS%CK &PB
M.I:B-*4$L2I1$I35$D1D1L2-;*;O/6E8XVD?R.E?X$.CYWB^CA,'EOK,#;$,
MT2\I2VAV*D6\8\QKFP-2O!%TUCYFV,C0WG#3GZ@;.-$>F9L?QE/H:OQ'"K3@
M"5E05H0R]Y&1X+H>RZ"-C$JAP[*/J\M;BH:N&:F;/K&=X!L T,?+ OOB[5[,
MYM?C%\^Z13C*1AC0BA+A3$9.(AJ2H"TN!6HU4UE'5\<(?YFFIJ[ M]3YXPS5
M?A0P] 'V;KRXF"W\Y)?Y[/+B:'K=]QW?C:NQ#9!N4W!+JMPX7?_PVP7*>;J\
M#HL<G,\NI\L1E5$('X%H=%AP85*%C-L2P'4ZNVPD'N ;G7=]4M74+?MNV!M6
M8S\J5%?M)58G!\M>E1@NEP&MA.QM:8K-2)0Q2Y *C,]5 7I'2U/W>0/"<DOM
M# W&U>",X_QV,BLN\#U#=T2I!V.X( )"N50/&HU2B;QXZKAW(F6SF</X\C.:
MBI7V )Z>I#DT*!ZL@5_'$U@L9U.X&_=V@_3?+E!1*&3X>MUTZ2,LRV#MQ2@*
M]'P-L\3$L@1XZ=J/?A')5E"1E:!.N==O4-N0TI3=W_?^5%TW0R/Q"8-W;)5K
M=YB7[H-OYV-\W-@??BMSWKJ6<]-+/[EE&$ *Q9D@*0A1]N.()JQ)1$L((5$1
MT^->N"_E0O5 S=!%Y'WC<>\:&AJ2-WR^G\V?B1R/8HP@C1$DZ-+"28 A'AD@
M4@5K LLBRLV:J*U_SM 5XKV?G/U)=6B O&I%_.J_C<\OST<N2<71:"R)YJI,
M^469::M(]%2E9"5S<C-C:YNG#SPD8]@]:1L-# VQS[,K/UE>7;.'5F<L$>1K
M1B!$([B-1 N#EJ8HP61I/ &=)4O (M6;V5[KGC+PM(O>(=.;1!N(J3[('.K2
M$KOYS"5)\2;:]VFVZKNQ.)R,S\?3\NN1SL('!YQXF= N!)WPE8P$#V=J.,UX
M(->Y@]Z.WJ$'6M0(QNY!<ZWA\^T7/S]#$] QY;4.GOC2%EQFY,%%R8C66@:7
MA'2A3M.*YZ@9>C9%=6QM(_76D/-P?1Q^NX!X_?HSE&Q)_ @;!<UE2&@I,EJJ
M@;BB>+Y+64K<I>0Z<:KKW$.^FM2A6V?O>3_K05\- +*;SO%E-D'E+,I<H>75
MQ]D2NG=/+B;CY=O9]"O^JL2'BRK9J&37XC)SA JFB;1,HI69-1&& ZX\ZXRL
M="_^2DHW@^./$=C?B[8:0./;V?GY;+KB!S=X6!Q<+K_,YN/_*C8"C<(HD,3H
MDNEM620V4D-B%LD&SUVM8<]KB-H,8S]&_+]O'30 IX^P/)K&V3E\F"T6(^.$
M8A$,X1%*WRJ>B0V"HG_LHG/::R,J]4&^3\9FD/DQXOF[R_GU('$KD$SAK!S$
MIWUBI?1J_#2??1TG2&^N?EN4H4"WDX .XG+\M6M*.PI<:NY#(ER7^P? (]Y9
ME)SW"@F$&$#5*=?8G,;-4/9C1.DK:ZB!?>J9$9!H:Y[@KKM$@)^O)A&MXLA,
M26JM9H2K+LAGD*G2,"1&)7GB0&LU<]^<QLVP]V.$]BMKJ 'LX7(J5UJ+]RC(
M=^-NY-6JX^--/]NRG*C3+BE'DNIFGY5 #06!RRDH&;)CAM=)9-R N,W0]F/$
M_FOII.4NG"='OWP\>G_T]N#CZ<';M\>_?3P]^OC+I^,/1V^/#K=J*[S^"WOK
MQOD*NGOJR'D08TD5Q)/NTVPRCJ4]_DT+Q-(OA$-P)$"B1.*!1P+EDNCD?'1:
MNNSJ]-EZF::= Q/CL^DXCZ.?+I\^Y!1%^@8__<=()"V"=)9DB_Q*:2,)W'E2
M.F<Y&KS,E;J$;$;?P$5H_2#F212B?]7\L#O4#=N][U2W7[R?'>MY/O:P<SD3
M,T F$$OC(RD5<9$;H@(-TK",-E2=;KCU=JXW?C%>'.='#[A:_7FW/+Q)SB8N
MB,VQM/ERFGBM!6&.N^B3#-KY*IQO1E^[.]<K$/-XYZJ@F@9,>/2#C_,A&HGG
M?@FE/SME05ND7LM22F R<5Q2HG+*@G+D+=0!UD,Z!JZBK0.@'43= %!NA^',
MSD.Y>2^W\"OLCQ1W3F=#"=CLB#1"$2N9(3DHD\#YI'(=%^]EF@8NIZVT _6C
M@@; ]'XV!S0$WY9QU5/</>]5&!],4_?CY#Y_=]LK=Q"\5Y9(428O0D;YB=)>
MS"N6D>\L3*J"M:U)'K;,HQ(4]Z/ !I#Z8+3 8UZ<*,.?</?FRB=DJ#0Y<-P3
MD1(UGELEO*@"QG54#5OS40EOO:FA!4B5L5[3]"@D_)@IJU$NF7H2LLWENA2(
M!>"$1\\I8Q:4J1>L_RYYPQ9RU )9[XK9&FU?81YF/>'M5S__ ZZ+V^/EO+OE
MNC8;A$]:97 $>.GCH;TCUF9/9 J*4HO.BZCC0;],T["U'960U9,*FH!3N:^:
MXD>>>+XA&%]Z_J"K&W(I4Q'$,>N(]QYDREPD6R><^A)%PU9V5()2+^)OX!3\
M-)]=P'QY]6E20L'35';<BZ[\X!%?5&30/#-DR1<_.2%?5$&ID?.>^P1!U#&R
M-J5PV&J02C"KHIX&8'=T?N''\ZXH>'Y337R</\RF9Q_&7R&MIJ\^B>FEF*Q%
MD"2.,I3)!>(#0WLS"QV=STKQ.D[G-M0.7!I2:]NKK;<&L/G+;);^'$\FN-R.
M4&73LS$:#,]SQI2(27!%<-.71#H7B<^.$>,AQTA% %H'D9O3.' 9224<5M)1
M ^B[ZYZP.)WCOHT<'I?+P&M!WNNN<#"9S/XL3=7?S^;O9I=AF2\G-Y^ZMFJ-
MURJA,8O61RRYXS80Z[T@2@66@,H2ZZE4>=(?%P,7I51"\&!Z;@#C[R \,6!*
M47U*29.<12XC0)&9@">%BR H!T:SKU-[]PPQ ]>=5$+<KE)O #@?2N(<? "_
M@"?[O 2)?CKS))4Y)Y(Z@\9O:>*A<)/W%,^ 3*L : U1 Q>75 )27UIH %"E
M4F:\O&FX^[9KKW8&TSA^REF9>T&Y%H6?4H"O$K&E[2X I\H&J1W4.4LWIW'@
MPI1JEPY5=-0 ^KKBK#>XC)"K\PN8+E:CLB^NYV<?34L#"/2KBO=_<]1;+R+-
MD$@,,1%ILBZMX#T>]<(SIVV,J=+L\=<3.W )2R4\UM9: \#\#%]A>@DE>;VL
MMR*RW\?++V\O%\O9.<R?+#L7T),/0)2CZ&+9@ Z^YY(HZJW,:&-06R?SY'5T
M#ES54LV1J*:K)I"X "2@7 B^0T8GLR[Z60KWIPNX7EPR"QMUY"0:ZM'FP,5E
M/>*%21ZB-SQ962<*LP%Q ]>V5,-<OUII &BKZM=3_^U)]#*'D(U@) E'D8\H
MB8_>D2R$TBZR;%6=7,R7*-H,4C_:34<O\F\ 1X=^7KJ(+#[!O#,4GK"C=$"Z
M+2X+JX@LC6Z\YI:@=(+D25"IZ]3Y?(>PS7)]?[3[BCZUT0"XWOOQ_#_]Y!*.
M\_OQU*,/Y"='T]+?YOPN1V:DM'4@  C/,I9)U$"LA$# 26$5BDS04 5B&Y&W
M&=!^M N)_C73 -S0GBR^S'5S^?'BC[=(PWA97HT8-5YY%1 #P1)9HLV>ECXB
MCAH\X6D6E2:CK"%J,VC]:#<%?6FA"4"=XZ._E-:Z7V%UXC]?OF.]26@^1F(9
MGO<R!D^L3B6K5%IKC%0ZUCDE-Z5P,ZC]:%<$5?33 .X^PI_W)#:?3?%EA'L[
M\V/^LC= D^=$B 3H)4=''+>>\,"XQX5E#*]S&_5:2C?#X8]VPU!57S]LH7(W
ML:W_,N7KK]U/D?)S/-0O408=LU((#S!<E6H73UP)>ID0 M#(K7T\"J3Y$N47
M,P/OU_@88U@()% 3B#2)$\^=(BF%P%SV]LFTU=HIF^V7)K\&*1LG:VZGD@;.
MS9/X!=+EI$S81G&E\>2R7&S<)<\??BNSJ2"M@L_G%Y<K'1[GQW[WO982(AD5
M4R 1'$K H=OM)4(H1P4L)(,V;)V3M7]>FBV/W@7$ ZO\ASV</Y91O454[V#I
MQY/^C^DG#]C/@;V>K_I'-X,H;5*4I !0KA$B<1(D$> $RBYQ+7^XODB]+;%N
MU!^CL0QECB3;C(:V]9:XC*\<I])SH0WC=234+Q_-F@2O06"]W?35JA[0?%C,
MEZ//96[YP;?Q8I0T"T;JTH"%:B(CC20P7SIL*,>T5Q VN_' ;[V'3?SI,2X?
M/';@,<D#ZGVVJQ):0,[-A'L90RJS(837DLB$:\_S7&P:F:D%I[S9J)AQ<^RL
M'CP,>G90V6.E;R&_@=7^ZWA:!AU=$\Z-9BD5'XG;TGE.,&)5HD0CU[%,0J)Y
MH[K[C13_X-$#JWX;Q<WZD.+0ZE_-N;HF7.MDLO".0%)EUAY+Q*D<B!<^"INL
M8*Q']=]_]#!.76_JWUJ* ZH_P7CT <[\Y!#/RN55M_D)+X+C!IW$TH=9FM),
M)*(+FP03.DH)S*]KT+Z ^->SV=>?\:L[_?]3EI=D];)3_#,/'7BZ_? FPZZ*
M&!A#*ZK?S<H@GU'6/L9,2\<_27'=^-*Z-%B"?%M%(7@EUL69-@/0_2<.<V[L
MK+)9#_(;>A3E^YD_'W^[WO2,23YK'=!=*Q4H/I5\,1Z(LX5WED#$S49/WO_6
MX92[O5)F?4BH@2#T>S1IEM#5ES^N]7US]:O_W[/YVXE?+#KH*RHITH 63G10
M&O!YXE(&(G1 \5 A_6/E]Y7ZM#F1PS9%;."8J:W8MC%[Q]A'?P[7"UMREI@0
MEN1H/5KKR!DN2USG@6M5TGIBI0O*5Q(Z;%2E&F V!^;.VFL G$?3;CK%8O%\
M&O_U*0$JQ@#H>%BJ2FFPXV4JM2>6:7 R<^NJ]9':@+QF@;@[0)XDQO>MK08@
MN./9\^%N1@M:MUFA!<,4B-*MC9:C)Q&@+B3C<_:5:G_ZXF#8OK0-60.#0**!
MI7"OI=+C1DJGLS>PZK($Z3B/*&4&Q9N)*B-II1/%^F>1L&1Q1X&H4J5>I!N3
M./ =WB (>KE#5H_J; "G-RV7[ACL1D6"MA2,,L1;]"@E<$<"0[<R&^69$DJ'
M6&>FZ_/T#)R3TP(">U!4 W"[OXX>VU@K\VM25M8H!D,5]8%HR2V1VJ$)!'@"
M20O6X5LT:UM]4UQ#X, C$%H 9 U5-H#0;HII&=3]3%^ND64L%)&1D%%4A7CB
MN0&B-6[NR1O)H8Y=NHZJ@6<@M(#%WI36!@!O9TQ^GEWY29'GJF\<KB;.F:22
M6F(2Q36412!!:D&XS5"J7E6".B..UY(U\%B$1B#8D]I^V&39F_%+Z;<%X +\
M,,[5TF;7/&H_";2;\EH_E=90[U!LF8!TCLB8$;11EF:\P((/03!?IY/%/E)I
M7RZ^6$4F@G7,24;*W%XB@Q/$<L])#KANG,X!EW/E)-GU%#:;_OH:U+R<_MJC
M>MHX>9_GYLW5*7Y%=P&1+0^@5>DE ;I,("R>%V[IRG :E3>@<IU"EPV(:R4Y
MMD]4;%J,M:6*6D9=8>CZID$HQ816C&@6D"5N%/$B6!*H]R(+&[BL-N?]>\0-
MB[K> ;%Q]=]VVFD <"MC&.:WK%Q?-B43-7/"$BI#*NYY)M:+<CB@M#1CU/HZ
MSNT+!#4*K&T5_TQ3AEVUT "8'I,OK$$O*@1BC?1$,F>)"TP1IBG3PD>*RZT*
MB+8!3[6(<6WP["+U!D!SG/,XPF,FE&5&>:N(4V6@"'K<Q!N5273<V!!<M4/N
M67*&C?#6!M#N&FBAG&B5$I0C<NTTH;R<[M;CAJF8)5T'?"FH%IM-U:Y0B+:'
MK/(*MO;VXFT!$S<U,DB?5$R2X$IY9]")A$)[]#Q+!E2FL)&?]B.6F+U*92^4
MF+U&?D/7&#THC@K9>T>=(TE%CK WKDQ+@P+[G)BC69K^%-]@B=FK%/=BB=EK
MI#BT^A\41[D<K K>$1K+N.)D*9K/*A#%:1#&<Q-B?Z6E#9:8;:W^K:78@#WY
MXB%X=[4#P+D3LK1,,:5H3E 2(I6$HUJM2 Q8JG9O]AW:6JD<&")LMYV"6H;<
MW7W02%LELBEK![(E$CTT8C.N2O3L<2FJJ(/8,^;NB&LTN+(E'C:%VY;*^6%O
M9&\6]^Q!(G 1Q_+JX$\_3XN/L^71='51/I[B$][Z2;R<=)3-\N&GDUH7N/U1
MMI_[WDJ2K'\]+"!PKR7: DR@,\!L&0-GBFD0?4C*"U\I9>F'Z;2D0U2V5%XJ
MA6:N]"H3W (<B2J[S)B-*M1)P/Z_I-/2:Q!8N=/2:U3=@)&Q(\]OKI[_@BY(
M$#(S.N9$8E9HXLN YZNBGGCT[*3@@1E9IQ"L(E.M7(#O'ZO]5MWT!IQFU]"]
M*CYTB86$8(D6-J*O*SEZS+D,N)24&E9:;-;)Z/@>93]TV4U_$-H(VEOJ<^@6
M%YVH5C,&2R'H<CZ.2T@GRUG\X[?I>+GX?/(;NB_=IQ:_H9TX/UQ<7-ST>Q#H
M<*.71*@H>?71 @F,)I(3M3E[51*YOF>B[TI$BQ#=%@JS ?32P/[X>^D$>WL#
MR)UFZ/HZ(HPJ%AI*S*.K3=#S=A2DX<+6\18>D-%BN=>.L-I=W U@I;=$^P Q
M29UQ9;C2QLXBR\%X/ 429\X8KBBK4UZXU_KN'Z6IV("6YG:0^/&7PL%Y\99'
MR!1X$31Q7,DRV9JA#20$;B>,^8QD1UJI#78?Y+=X^M=&7K_PWP(&/VPL^L'
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MMM55R[D/;WX[.?IX>'+R]OC7-T<?#TZ/CC]ND\_PW-?TEJ/P71I[RCMX<[E
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M5."D": L"W4:? )!0O.*^2Q5F\'#@[ [CA*$?ZNEV1OZ?N8ENI+)Q%@A&-:
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MHV(]D.E6U71*1PX[:>O)(X==1#=.DW*;RTPIJ:QTG2?C8YUFD,$S=$ !;,3
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MJ_1?5\O+%?V?YW>9I/6W6N.K\=[$U;2._5Y>+B<R2Y%CH3TB!]HC=. 0F"S
M=-'..Y]#V=KFGRB<V_G5 U?SMD+ _&CJ&'3+[L;?JQCSQ6:R_'E9M28CUR0G
M6N)U[L3J^Y/$O$"K @B#M-7H@N!SO3Z4BY,E.292M]K-7L@9N%IO%+#L76TG
M -7UKI/3Q[R\HEWUO)Q_WTA@.<E1TG]8IF5HQ+K!A].9 2)YT,XFD;:+U/=%
MZ#-4#!OGC .8?2FI[[ZX#4[R/Y[][>S]'V<?SUZ?__;^;3T&W^?D_I&G]'92
M_Q*%/9W,;Q* OQ(D7\]G*X3]Y_3RZVM""J%P<8.ZR"SC2D;0DOQ@E1U"D"[4
MB<82)6%"L39YM(X$'AILO/":SR3N7RYJ[\\D*;I/U7.0@ASC%&GY)9TAHL3B
M,[D1V[.PCR.(&PJ']?Q:X&D[OFBBJS%?G7YH"PXH-WKZ80UM5\OBHJZ0D\$H
MK&-) ]?D4I5BP26*<(.QY$SI4(QNDR,XD@FC9\=<'[\J&)DN_[&^<:)3,#Q+
M8ILE5<^\%80H$J1L:]NK+()J,W_T<7I.PSSM@I5M\]2#'D9PQ/: BU]^?*8_
M75V3- X#]RE!+*PV=8^2O,],QCLH':,LS&]W.6\%J5NBAL55'SI_"49[*F",
M6*J,;*Y9:F6Y-"9"U*O<M-(0"NW6PF157*F-4MHT9'B&J)%A:5_%OVB7]M/"
M& "UL=</6-K<NE6,,\002/?UUBW7'+Q6)# L4:>BB_:-#-3SA(T,6/L"8!M8
M/6IC#.!ZN/Y^R;/X]1LN_K%:A*$PS86ME0EHB8M8 *-U)"M-R\]XSE*;\O27
M*!LVNWJ</7!_58P26M?<;)8AR8K1<C&0K*@%JH9<SEJE2@L08U*)!],FN_ 2
M92.S7 ?AX$60':"4$8#L$U[DY2;0>9\O-T8X2L>-\ 6RKMT&,ZN7)+D"+:7A
M#I.2LLTHKT?)&1N<#M'X]NGWP>(?$$/+Q>7D=_RO^>)Z3U^NEA<KZ+4D<EVJ
M.W@D>7C):E/C.JR>##EGG?PI>OP=X-!7VZ!Y_/W#'L[TN*_U(-Z!P?$>O^7S
M<H^'S9I!$Y5(44%2CI,)U@F"H \IV2P8+1GO.K5@[H21)\D8QK#TH==YWT(>
MNESFFO3S6;Z>OV"\,XDVZ*CJL%J''H+/'KC-/&5=@NUXTOO@T<.IO2==S7L3
MW%C4_OF?\PWU(J?,BZ.(4M<3'E<*.&$<L*Q<9D1]QFX32QX\>IB I[':]Q/<
M:-1.&KR&;0PZT"XI((158PZC*?#/!KC22096-/)NY6^//'P8GZ"UZO<4WL!.
MP8?%/%W%R_/%I[SX<QK7J<IB2ZAMGD $+D&%LBDZ%K54I!@5L-NY4R=_X#$*
MAJVW[=EK/%C$XX#(\M4L;3A8;A:-LXPI3T$14_5.;F8D$<T]:%H^:!7%[[E3
MRF,7G#PD8S@'XG#-/H3)@6(>>B]Y=7$Q_R?2^OEUOMB$TY=7B]F2;TRC%":%
MG#BY0Y'V14XB<G6LEQ1D-)T(.>"+91!=7C0X* [5X[R14$>0Y7I',IDMKS=+
M'^NQ/ IPNJX7I<EG4B9"X*:P')-FV&;^SSTRAG-'^\7+X3(> 4 ^SG_@Q>6/
M&W1S:S5)@,D2R36C,(I"<0-66N8C"EELFRJ8>V0,Y[2V <C^,AX0("E/)^_R
M%[PXFUU.+W^L]]ML5?+U2+UP1T)8C6FS'H01+M0+3W>FR3\"CV6._^O+_,__
M38]>(>._5?T4UI^NX/#(2SN!09^ ?WJH0 ?&PIKJS6K@1#9'Q:!88ETQ'<$%
MCF"MBJI$+9Q+!P/A[AN'\3$.5MF\!_D-[6;>:]2>E5+.B "!HGA06M5IPX;X
MX"P:KESVC'7R*8?O<7^84IYL9;^+A$:P_S\P<.]NND\+AC'&'*%(K.-J*B?!
M*S#1"$0EN2YM1J\\35,GI)@3V QZ%O\8@?0A+^HW\$OF$TYNC=4RD;N4$B@;
M<ZV;HJC)TYH()D@AV]R+>8ZJD9VN[ZGYEP"UKQJ&WG8VM0&;?KNK#G73Y>5B
M&J[JYY\7F#)](\ZO9BMW_29N7TZ2B]X71B$7JY?R':$"2PY@&<<4@_%NNR_J
M$WO4WB2,K,+L,&0=41OC,&,/[SO4]@_O\^7KJT65_R33SNZM\5!\K7LI)8-+
MG$'D*<J$+%O1IE];!^)&5@32FU'K52E#V[:SY>7T&U[F\[)).*R3C!_I6[]/
M9]-O5]\F7G)9G!9UZL=JV01P+$G(G.L8D^;6A4Y&[.5WC>P$J =KU;-\QPP7
M_&O%#FK+H[%D95-MA& UL2.5!290Z1R)J=PM+GOY72-+R#2&RQ[R'<$N1GS$
MG-.RWN!;9Q^G]20CYCH99)(3<L<+KXVT2%!,&G#&ZQJP9$'A2V%6--F_GB5K
M9+%=/SM7?XH8 :I>N!9Z]M=FGGO=FNE_Z3/^-9$J!-1U\D9,@3Z$ E@G6KEH
M@D<9*!)ITUY\#V([(=">& );*VUO7/Z9%V'>NB? KZ_>?OS;JW=_G/U^]NK3
M'Q_IG_>?/]TGO5L_@,<?U%LO@ YT]M0'X%><+OZ&%U>K>.UBOKPBNF\N=&NM
M;!#!0] QDVN4!85M!#0M9/8IT']UF\CF.:H.-5N//?NV^X7A+L5B$9(DRZN0
M.0C6<N B<A^U)KBWN:;V+%G#YJ9ZP\BV,>I/%6-N1/+H8E[EBO=J1?+<X]H:
MH,=H/H89HL=[-"F"*XF 4$P&'ST!00ET7.F(OLUM]Z.8H<VPL'M#PG[/6%^6
MSNN L:O%HF[(L_1^/EM<?UG;*2]7"KE=,,P@BY@-I)@]*&,L8 DUP>:X1:E,
MT<\=P_8@I]YX&;'!VP6-3QJ\891^:E9R+25\5$IX>:NE_?LZ]?#6IC;W$ D<
MPS0SQC(B602#@M"7:!WXI#7H3(Z J7.#?)N6_"=AFB?695FT$I"LYG5PN:3(
MB6*VY%AQR%'DW%@\A[(P8D.\"_::&>*=5#R"I,T-X[_\N/GT/Z9DCA;QZX]W
M^<]\L6Z9$Z+0K!C(*B?RO5V (*0'$X@FYF5DKDWE9S?Z1H+*XX+G*0CWI\DQ
MX7,CQU7GW8?\7==HI>",\^2!2<_(!(0"/BA/P:=@T7'RTF)H"],N9(X$K3WB
MY"DH]JZT,2'R[>S[U>5R);'KZQ]<F2B+91"3EJ"$M\2*(,Y4M(RSX*5JO+\_
M)&HD:.L?"D^![D"]C!1B8L,*$TQ[3[N#"[KV >,,O/:T.*U..G$3* H]&L3$
MD%=VQ@&Q??0R)H@=X+/<GD#)G+56)$6G:VJ6%1)#[5 GO,PF:9:X9J.-:][M
M5#[<'L;C\"*/CHL1+(K?<?&/?%EE^*DRM.)Y8BBD5,H:L-P*XB'7*@_:0(Q(
MVAF/0LDV=>Z/43.2S?SXX)CWK*DQISY_?_7Q_YQ]?O7+N[-/9Z_I3SZ_/=OK
M4/K1Y_26GGR9RIX2CF]G?^;-R)4W.5P2J,[^^VIZ^>-6\S<IH-I2SM7;DL9P
M RI*4S?W E:8(-#()+&-<]2=QD-MU)TWO9UMWG6[&AZ\=99>Y\4E.3ZU"'M3
MQT$TWJ3/;@\.7)U!4^I(KQ3(1[9!@'=&0G#HE$I%HVO3[K<51\/:RD:HW3:$
MHX##N(M\'C-4^Q^W/_.TIJ:UX6'[#E -6+(.%-O4FXJ@BJ(XJN@$(O&8HLO!
ML3:UH<<SL(^Y%G>.5RU+(F DCDL!%3 #LF#!%LV4<#:ZT*9@\5FR3L;4[8*?
M+C[??HHY->?O,<X/..3>]15-[5IGWHYO[%PH3HK (4E1VPUK Z%68E-@DI5$
MVK9CF]J_XQF[3_%K3E<7^;R\^I-$7M6PZ6QT9XVMD@HJ9XRAMETFCX2<%%5/
M5Z,!SIGC+GDC1)NCE<XDGHP1W 57#QIC-U'8"'(OM_*[F=,B7%!&UE(J='7
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MR:)U$0U"<KPFI0-QXJ2!'#!F\CE1-/*6GJ9IV//$UE#J21<C0-63DGIWTX;
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M<E<^_YYQ\?F?\PG/7!E!?H;VM,$H[NO@W^Q 6L$H;++6JN.-!'N&T%%%'\<
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MY?SCQDY*KUWTWH(07H,R)![O(T6BJ)P6QF%(;;IS=2)O/(#:!P,/"PM[5LB
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M;^A-XEZ':+WJIAH=R*BQ=HB.X$L,H)DO7OCBLN]VVW*$/;1W4LJ3/;1WD="
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MG"$V533K\,=9GPS]R&G19ES6G@0/7 4W,-B/H.2Q8_GN<(#5H<A$4L 4;+;
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M>3TOG_/BV_*)W:;[;U8YD9CJ:%SZBYQ>I?^Z6E[6WYMXHU60M;M?\?4"GN.
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M5#<"#+[0U]<Z%460=5Z2K,Q(0.TMB)(5I^\5P]M,\3B\-?-IM<0]!(O]J7!
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M"\Y63Y=\VQ*8LXB-CLY.P^"3N9=I@O-QS'(OT!UYD_-^%1:KD?M#;#V;?U1
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M4!TNN$?:>TLA(@O9@"YDV:K*-: *$+-Q@N5DL;NCK?-H^[\7N$[1]G\?37>
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M!M5+!U![CQ?TJT^_XXR"B@MB[%G^/)U-JZ^RFG[%#6_+#7/)<\=I;8>BDZ9
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M2)EMLCQSR>.YG!BN"^YVR-&Y;;F%:Y:5<J E.@JQ6>U,FC,D;1*/Q@6GQ,\
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MJ1)%T)@P5&Q*,Z,>)):"^8C]Z!DE>I@H4Z ?<:)&E>MD<JU"$>&U82< 022
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M%;-(]?VVW6IK%H>]KNZ%41$CT"$VF5@7Y[I@)?NGX))IXF^@GU4MU6OMD%W
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M_@=02P$"% ,4    " !-@7%4W0"MK,,\  #]V@  '               @ $
M    97AH:6)I=#$P,3(M<W1U87)T97AE8W5T+FAT;5!+ 0(4 Q0    ( $V!
M<51.#W.,G#8  &W$   <              "  ?T\  !E>&AI8FET,3 Q,RUZ
M97)O;F1A>&5X96,N:'1M4$L! A0#%     @ 38%Q5,K;'3M, P  \0T  !X
M             ( !TW,  &5X:&EB:70R,3%L:7-T;V9S=6)S:61I87)I+FAT
M;5!+ 0(4 Q0    ( $V!<52*#R(,X (  (T(   8              "  5MW
M  !E>&AI8FET,C,Q8V]N<V5N='5S,BYH=&U02P$"% ,4    " !-@7%4K]BC
MGK$H  "+90$ '@              @ %Q>@  97AH:6)I=#,Q=GEN96-E<G1I
M9FEC871E;V8N:'1M4$L! A0#%     @ 38%Q5":'5!(O%0  ;6(   X
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M+3(P,C$Q,C,Q7V1E9BYX;6Q02P$"% ,4    " !-@7%428>N9TFH  "QK0
M%               @ %=HP4 =GEN92TR,#(Q,3(S,5]G,2YJ<&=02P$"% ,4
M    " !-@7%48>?WR?2+  !BCP  %               @ '82P8 =GEN92TR
M,#(Q,3(S,5]G,BYJ<&=02P$"% ,4    " !-@7%4_"'4O XQ 0"+7 P %0
M            @ '^UP8 =GEN92TR,#(Q,3(S,5]L86(N>&UL4$L! A0#%
M  @ 38%Q5-L L#.?OP  ;ZP( !4              ( !/PD( '9Y;F4M,C R
M,3$R,S%?<')E+GAM;%!+ 0(4 Q0    ( $V!<53C7*3%)P@  -4I   8
M          "  1')" !V>6YE+3(P,C$Q,C,Q>&5X>#,Q,2YH=&U02P$"% ,4
M    " !-@7%4H=+]R!\(  #/*0  &               @ %NT0@ =GEN92TR
M,#(Q,3(S,7AE>'@S,3(N:'1M4$L! A0#%     @ 38%Q5 %'F0+"!0  T1H
M !@              ( !P]D( '9Y;F4M,C R,3$R,S%X97AX,S(Q+FAT;5!+
M 0(4 Q0    ( $V!<52DI.KBJ@4  + :   8              "  ;O?" !V
M>6YE+3(P,C$Q,C,Q>&5X>#,R,BYH=&U02P4&     !( $@#4!   F^4(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
